,word,label,sentence_id
0,Development,O,0
1,of,O,0
2,active,O,0
3,glasses,O,0
4,for,O,0
5,mitigating,O,0
6,presbyopia,B-NAME_OF_DISEASE,0
7,has,O,0
8,become,O,0
9,an,O,0
10,active,O,0
11,area,O,0
12,of,O,0
13,research,O,0
14,facilitated,O,0
15,by,O,0
16,the,O,0
17,miniaturization,O,0
18,of,O,0
19,focus-tunable,O,0
20,lenses,O,0
21,as,O,0
22,well,O,0
23,as,O,0
24,the,O,0
25,increased,O,0
26,processing,O,0
27,power,O,0
28,of,O,0
29,modern,O,0
30,computers,O,0
31,Alcon,B-ORGANIZATION,1
32,the,O,1
33,global,O,1
34,leader,O,1
35,in,O,1
36,eye,O,1
37,care,O,1
38,dedicated,O,1
39,to,O,1
40,helping,O,1
41,people,O,1
42,see,O,1
43,brilliantly,O,1
44,has,O,1
45,commercially,O,1
46,launched,O,1
47,the,O,1
48,first,O,1
49,and,O,1
50,only,O,1
51,non-diffractive,B-TREATMENT,1
52,extended,I-TREATMENT,1
53,depth,I-TREATMENT,1
54,of,I-TREATMENT,1
55,focus,I-TREATMENT,1
56,intraocular,I-TREATMENT,1
57,lens,I-TREATMENT,1
58,IOL,B-TREATMENT,1
59,in,O,1
60,the,O,1
61,U.S,O,1
62,-,O,2
63,the,B-TREATMENT,2
64,AcrySof®,I-TREATMENT,2
65,IQ,I-TREATMENT,2
66,VivityTM,I-TREATMENT,2
67,IOL,B-TREATMENT,2
68,Vivity,B-TREATMENT,2
69,,O,2
70,This,O,3
71,new,O,3
72,presbyopia-mitigating,B-TREATMENT,3
73,lens,I-TREATMENT,3
74,is,O,3
75,now,O,3
76,available,O,3
77,to,O,3
78,all,O,3
79,U.S,O,3
80,ophthalmologists,O,4
81,for,O,4
82,patients,O,4
83,undergoing,O,4
84,cataract,B-NAME_OF_DISEASE,4
85,surgery,I-TREATMENT,4
86,Cataracts,B-NAME_OF_DISEASE,5
87,are,O,5
88,the,O,5
89,most,O,5
90,common,O,5
91,cause,O,5
92,of,O,5
93,vision,B-SIGN_AND_SYMPTOM,5
94,loss,I-SIGN_AND_SYMPTOM,5
95,globally,O,5
96,The,O,6
97,U.S,O,6
98,market,O,7
99,is,O,7
100,expected,O,7
101,to,O,7
102,grow,O,7
103,to,O,7
104,5,O,7
105,million,O,8
106,cataract,B-NAME_OF_DISEASE,8
107,surgeries,I-TREATMENT,8
108,by,O,8
109,2025,O,8
110,With,O,9
111,the,O,9
112,aging,O,9
113,population,O,9
114,the,O,9
115,number,O,9
116,of,O,9
117,people,O,9
118,in,O,9
119,the,O,9
120,U.S,O,9
121,with,O,10
122,cataracts,B-NAME_OF_DISEASE,10
123,is,O,10
124,expected,O,10
125,to,O,10
126,double,O,10
127,by,O,10
128,2050,O,10
129,Vivity,B-TREATMENT,11
130,is,O,11
131,a,O,11
132,first-of-its-kind,O,11
133,non-diffractive,B-TREATMENT,11
134,extended,I-TREATMENT,11
135,depth,I-TREATMENT,11
136,of,I-TREATMENT,11
137,focus,I-TREATMENT,11
138,IOL,B-TREATMENT,11
139,with,O,11
140,Alcon,B-ORGANIZATION,11
141,s,O,11
142,proprietary,O,11
143,non-diffractive,O,11
144,X-WAVE™,O,11
145,technology,O,11
146,which,O,11
147,stretches,O,11
148,and,O,11
149,shifts,O,11
150,light,O,11
151,without,O,11
152,splitting,O,11
153,it,O,11
154,Vivity,B-TREATMENT,12
155,delivers,O,12
156,monofocal-quality,O,12
157,distance,O,12
158,far,O,12
159,with,O,12
160,excellent,O,12
161,intermediate,O,12
162,at,O,12
163,arm,O,12
164,s,O,12
165,length,O,12
166,and,O,12
167,functional,O,12
168,near,O,12
169,vision,O,12
170,up,O,12
171,close,O,12
172,,O,12
173,The,O,13
174,lens,O,13
175,expands,O,13
176,Alcon,B-ORGANIZATION,13
177,s,O,13
178,growing,O,13
179,portfolio,O,13
180,of,O,13
181,presbyopia-mitigating,B-TREATMENT,13
182,IOLs,I-TREATMENT,13
183,to,O,13
184,meet,O,13
185,the,O,13
186,needs,O,13
187,of,O,13
188,cataract,B-NAME_OF_DISEASE,13
189,patients,O,13
190,who,O,13
191,are,O,13
192,interested,O,13
193,in,O,13
194,restoring,O,13
195,their,O,13
196,visual,O,13
197,performance,O,13
198,and,O,13
199,improving,O,13
200,their,O,13
201,lifestyle,O,13
202,With,O,14
203,the,O,14
204,introduction,O,14
205,of,O,14
206,Vivity,B-TREATMENT,14
207,Alcon,B-ORGANIZATION,14
208,continues,O,14
209,to,O,14
210,demonstrate,O,14
211,our,O,14
212,ongoing,O,14
213,commitment,O,14
214,to,O,14
215,growing,O,14
216,our,O,14
217,IOL,B-TREATMENT,14
218,portfolio,O,14
219,and,O,14
220,delivering,O,14
221,differentiated,O,14
222,innovations,O,14
223,that,O,14
224,meet,O,14
225,surgeon,O,14
226,and,O,14
227,patient,O,14
228,needs,O,14
229,said,O,14
230,Sergio,B-PERSON,14
231,Duplan,I-PERSON,14
232,President,O,14
233,North,B-GPE,14
234,America,I-GPE,14
235,at,O,14
236,Alcon,B-ORGANIZATION,14
237,We,O,15
238,now,O,15
239,offer,O,15
240,two,O,15
241,next-generation,O,15
242,presbyopia-mitigating,B-TREATMENT,15
243,IOL,I-TREATMENT,15
244,options,O,15
245,with,O,15
246,the,B-TREATMENT,15
247,PanOptix,I-TREATMENT,15
248,Trifocal,I-TREATMENT,15
249,for,O,15
250,patients,O,15
251,who,O,15
252,want,O,15
253,to,O,15
254,be,O,15
255,more,O,15
256,spectacle,O,15
257,independent,O,15
258,at,O,15
259,all,O,15
260,distances,O,15
261,and,O,15
262,Vivity,B-TREATMENT,15
263,for,O,15
264,patients,O,15
265,who,O,15
266,seek,O,15
267,to,O,15
268,improve,O,15
269,their,O,15
270,intermediate,O,15
271,and,O,15
272,near,O,15
273,vision,O,15
274,with,O,15
275,a,O,15
276,monofocal-like,O,15
277,visual,O,15
278,disturbance,O,15
279,profile,O,15
280,Also,O,16
281,available,O,16
282,in,O,16
283,toric,O,16
284,designs,O,16
285,Vivity,B-TREATMENT,16
286,is,O,16
287,built,O,16
288,on,O,16
289,Alcon,B-ORGANIZATION,16
290,s,O,16
291,trusted,O,16
292,and,O,16
293,proven,O,16
294,AcrySof,B-TREATMENT,16
295,IQ,I-TREATMENT,16
296,IOL,I-TREATMENT,16
297,platform,O,16
298,that,O,16
299,has,O,16
300,been,O,16
301,implanted,O,16
302,in,O,16
303,more,O,16
304,than,O,16
305,125,O,16
306,million,O,16
307,eyes,O,16
308,globally,O,16
309,According,O,17
310,to,O,17
311,results,O,17
312,from,O,17
313,a,O,17
314,U.S,O,17
315,clinical,O,18
316,trial,O,18
317,patients,O,18
318,who,O,18
319,had,O,18
320,the,B-TREATMENT,18
321,Vivity,I-TREATMENT,18
322,lens,I-TREATMENT,18
323,implanted,O,18
324,experienced,O,18
325,renewed,O,18
326,vision,O,18
327,and,O,18
328,lifestyle,O,18
329,benefits,O,18
330,including,O,18
331,94%,O,18
332,and,O,18
333,92%,O,18
334,of,O,18
335,Vivity,B-TREATMENT,18
336,patients,O,18
337,reported,O,18
338,very,O,18
339,good,O,18
340,or,O,18
341,good,O,18
342,vision,O,18
343,at,O,18
344,distance,O,18
345,and,O,18
346,arm,O,18
347,s,O,18
348,length,O,18
349,respectively,O,18
350,without,O,18
351,glasses,O,18
352,in,O,18
353,bright,O,18
354,light,O,18
355,with,O,18
356,vision,O,18
357,of,O,18
358,20,O,18
359,20,O,18
360,at,O,18
361,distance,O,18
362,and,O,18
363,greater,O,18
364,than,O,18
365,20,O,18
366,25,O,18
367,at,O,18
368,intermediate,O,18
369,Comparable,O,19
370,visual,O,19
371,disturbance,O,19
372,profile,O,19
373,to,O,19
374,a,B-TREATMENT,19
375,monofocal,I-TREATMENT,19
376,IOL,B-TREATMENT,19
377,The,B-TREATMENT,19
378,Vivity,B-TREATMENT,19
379,lens,I-TREATMENT,19
380,is,O,19
381,a,O,19
382,disruptive,O,19
383,technology,O,19
384,that,O,19
385,fills,O,19
386,a,O,19
387,gap,O,19
388,for,O,19
389,eye,O,19
390,surgeons,O,19
391,as,O,19
392,a,O,19
393,presbyopia-mitigating,B-TREATMENT,19
394,IOL,B-TREATMENT,19
395,option,O,19
396,for,O,19
397,those,O,19
398,patients,O,19
399,who,O,19
400,are,O,19
401,not,O,19
402,candidates,O,19
403,for,O,19
404,a,O,19
405,diffractive,O,19
406,IOL,B-TREATMENT,19
407,platform,O,19
408,but,O,19
409,want,O,19
410,some,O,19
411,spectacle,O,19
412,independence,O,19
413,said,O,19
414,Dr,O,19
415,Cathleen,O,20
416,McCabe,O,20
417,Chief,O,20
418,Medical,O,20
419,Officer,O,20
420,Eye,B-ORGANIZATION,20
421,Health,I-ORGANIZATION,20
422,America,I-ORGANIZATION,20
423,and,O,20
424,Medical,O,20
425,Director,O,20
426,The,B-ORGANIZATION,20
427,Eye,I-ORGANIZATION,20
428,Associates,I-ORGANIZATION,20
429,This,O,21
430,lens,O,21
431,has,O,21
432,a,O,21
433,monofocal-like,O,21
434,visual,O,21
435,disturbance,O,21
436,profile,O,21
437,a,O,21
438,low,O,21
439,incidence,O,21
440,of,O,21
441,severe,O,21
442,or,O,21
443,very,O,21
444,bothersome,O,21
445,glare,O,21
446,and,O,21
447,halos,O,21
448,and,O,21
449,provides,O,21
450,a,O,21
451,continuous,O,21
452,extended,O,21
453,range,O,21
454,of,O,21
455,vision,O,21
456,which,O,21
457,can,O,21
458,meet,O,21
459,the,O,21
460,needs,O,21
461,of,O,21
462,many,O,21
463,cataract,B-NAME_OF_DISEASE,21
464,patients,O,21
465,Vivity,B-TREATMENT,22
466,received,O,22
467,FDA,B-ORGANIZATION,22
468,approval,O,22
469,in,O,22
470,February,O,22
471,2020,O,22
472,and,O,22
473,it,O,22
474,was,O,22
475,made,O,22
476,available,O,22
477,to,O,22
478,select,O,22
479,U.S,O,22
480,ophthalmologists,O,23
481,in,O,23
482,September,O,23
483,2020,O,23
484,during,O,23
485,a,O,23
486,pilot,O,23
487,phase,O,23
488,ahead,O,23
489,of,O,23
490,the,O,23
491,current,O,23
492,national,O,23
493,launch,O,23
494,Vivity,B-TREATMENT,24
495,is,O,24
496,already,O,24
497,available,O,24
498,in,O,24
499,some,O,24
500,European,O,24
501,markets,O,24
502,Australia,B-GPE,24
503,New,B-GPE,24
504,Zealand,I-GPE,24
505,and,O,24
506,Canada,B-GPE,24
507,and,O,24
508,has,O,24
509,been,O,24
510,introduced,O,24
511,to,O,24
512,select,O,24
513,ophthalmologists,O,24
514,in,O,24
515,Latin,B-GPE,24
516,America,I-GPE,24
517,For,O,25
518,more,O,25
519,information,O,25
520,regarding,O,25
521,Vivity,B-TREATMENT,25
522,in,O,25
523,the,O,25
524,U.S,O,25
525,visit,O,26
526,vivityview.com,O,26
527,About,O,27
528,Cataracts,B-NAME_OF_DISEASE,27
529,A,B-NAME_OF_DISEASE,27
530,cataract,I-NAME_OF_DISEASE,27
531,is,O,27
532,a,B-SIGN_AND_SYMPTOM,27
533,cloudy,I-SIGN_AND_SYMPTOM,27
534,area,I-SIGN_AND_SYMPTOM,27
535,in,I-SIGN_AND_SYMPTOM,27
536,the,I-SIGN_AND_SYMPTOM,27
537,natural,I-SIGN_AND_SYMPTOM,27
538,lens,I-SIGN_AND_SYMPTOM,27
539,of,I-SIGN_AND_SYMPTOM,27
540,the,I-SIGN_AND_SYMPTOM,27
541,eye,I-SIGN_AND_SYMPTOM,27
542,that,O,27
543,affects,O,27
544,vision,O,27
545,As,O,28
546,a,B-NAME_OF_DISEASE,28
547,cataract,I-NAME_OF_DISEASE,28
548,develops,O,28
549,the,B-SIGN_AND_SYMPTOM,28
550,eye,I-SIGN_AND_SYMPTOM,28
551,s,I-SIGN_AND_SYMPTOM,28
552,lens,I-SIGN_AND_SYMPTOM,28
553,gradually,I-SIGN_AND_SYMPTOM,28
554,becomes,I-SIGN_AND_SYMPTOM,28
555,hard,I-SIGN_AND_SYMPTOM,28
556,and,I-SIGN_AND_SYMPTOM,28
557,cloudy,I-SIGN_AND_SYMPTOM,28
558,allowing,I-SIGN_AND_SYMPTOM,28
559,less,I-SIGN_AND_SYMPTOM,28
560,light,I-SIGN_AND_SYMPTOM,28
561,to,I-SIGN_AND_SYMPTOM,28
562,pass,I-SIGN_AND_SYMPTOM,28
563,through,I-SIGN_AND_SYMPTOM,28
564,which,I-SIGN_AND_SYMPTOM,28
565,makes,I-SIGN_AND_SYMPTOM,28
566,it,I-SIGN_AND_SYMPTOM,28
567,more,I-SIGN_AND_SYMPTOM,28
568,difficult,I-SIGN_AND_SYMPTOM,28
569,to,I-SIGN_AND_SYMPTOM,28
570,see,I-SIGN_AND_SYMPTOM,28
571,The,O,29
572,vast,O,29
573,majority,O,29
574,of,O,29
575,cataracts,B-NAME_OF_DISEASE,29
576,result,O,29
577,from,O,29
578,normal,B-CAUSE_OF_DISEASE,29
579,aging,I-CAUSE_OF_DISEASE,29
580,but,O,29
581,radiation,B-CAUSE_OF_DISEASE,29
582,exposure,I-CAUSE_OF_DISEASE,29
583,taking,B-CAUSE_OF_DISEASE,29
584,steroids,I-CAUSE_OF_DISEASE,29
585,diabetes,B-CAUSE_OF_DISEASE,29
586,and,O,29
587,eye,B-CAUSE_OF_DISEASE,29
588,trauma,I-CAUSE_OF_DISEASE,29
589,can,O,29
590,accelerate,O,29
591,their,O,29
592,development,O,29
593,Cataracts,B-NAME_OF_DISEASE,30
594,are,O,30
595,the,O,30
596,most,O,30
597,common,O,30
598,age-related,O,30
599,eye,O,30
600,condition,O,30
601,and,O,30
602,the,O,30
603,leading,O,30
604,cause,O,30
605,of,O,30
606,preventable,O,30
607,blindness,B-NAME_OF_DISEASE,30
608,Twenty,O,31
609,million,O,31
610,people,O,31
611,in,O,31
612,the,O,31
613,U.S,O,31
614,age,O,32
615,40,O,32
616,and,O,32
617,older,O,32
618,have,O,32
619,cataracts,B-NAME_OF_DISEASE,32
620,Cataracts,B-NAME_OF_DISEASE,33
621,are,O,33
622,treated,O,33
623,by,O,33
624,removing,B-TREATMENT,33
625,the,I-TREATMENT,33
626,eye,I-TREATMENT,33
627,s,I-TREATMENT,33
628,cloudy,I-TREATMENT,33
629,natural,I-TREATMENT,33
630,lens,I-TREATMENT,33
631,and,I-TREATMENT,33
632,surgically,I-TREATMENT,33
633,replacing,I-TREATMENT,33
634,it,I-TREATMENT,33
635,with,I-TREATMENT,33
636,an,I-TREATMENT,33
637,intraocular,I-TREATMENT,33
638,lens,I-TREATMENT,33
639,or,I-TREATMENT,33
640,IOL,I-TREATMENT,33
641,More,O,34
642,than,O,34
643,98,O,34
644,percent,O,34
645,of,O,34
646,cataract,B-TREATMENT,34
647,surgeries,I-TREATMENT,34
648,are,O,34
649,considered,O,34
650,successful,O,34
651,and,O,34
652,patients,O,34
653,typically,O,34
654,can,O,34
655,return,O,34
656,to,O,34
657,their,O,34
658,normal,O,34
659,routines,O,34
660,within,B-TIME_DURATION,34
661,24,I-TIME_DURATION,34
662,hours,I-TIME_DURATION,34
663,About,O,35
664,Presbyopia,B-NAME_OF_DISEASE,35
665,Presbyopia,B-NAME_OF_DISEASE,35
666,is,O,35
667,a,O,35
668,common,O,35
669,age-related,O,35
670,vision,O,35
671,condition,O,35
672,in,O,35
673,which,O,35
674,people,O,35
675,have,O,35
676,difficulty,B-SIGN_AND_SYMPTOM,35
677,focusing,I-SIGN_AND_SYMPTOM,35
678,on,I-SIGN_AND_SYMPTOM,35
679,things,I-SIGN_AND_SYMPTOM,35
680,up,I-SIGN_AND_SYMPTOM,35
681,close,I-SIGN_AND_SYMPTOM,35
682,It,O,36
683,involves,O,36
684,the,B-SIGN_AND_SYMPTOM,36
685,gradual,I-SIGN_AND_SYMPTOM,36
686,loss,I-SIGN_AND_SYMPTOM,36
687,of,I-SIGN_AND_SYMPTOM,36
688,the,I-SIGN_AND_SYMPTOM,36
689,eye,I-SIGN_AND_SYMPTOM,36
690,s,I-SIGN_AND_SYMPTOM,36
691,ability,I-SIGN_AND_SYMPTOM,36
692,to,I-SIGN_AND_SYMPTOM,36
693,focus,I-SIGN_AND_SYMPTOM,36
694,on,I-SIGN_AND_SYMPTOM,36
695,close,I-SIGN_AND_SYMPTOM,36
696,objects,I-SIGN_AND_SYMPTOM,36
697,such,I-SIGN_AND_SYMPTOM,36
698,as,I-SIGN_AND_SYMPTOM,36
699,smart,I-SIGN_AND_SYMPTOM,36
700,phones,I-SIGN_AND_SYMPTOM,36
701,computers,I-SIGN_AND_SYMPTOM,36
702,books,I-SIGN_AND_SYMPTOM,36
703,and,I-SIGN_AND_SYMPTOM,36
704,menus,I-SIGN_AND_SYMPTOM,36
705,Almost,O,37
706,everyone,O,37
707,will,O,37
708,experience,O,37
709,presbyopia,B-NAME_OF_DISEASE,37
710,to,O,37
711,some,O,37
712,degree,O,37
713,as,O,37
714,they,O,37
715,age,O,37
716,with,O,37
717,symptoms,O,37
718,often,O,37
719,first,O,37
720,appearing,O,37
721,as,O,37
722,an,O,37
723,individual,O,37
724,enters,O,37
725,their,O,37
726,40s,O,37
727,and,O,37
728,continues,O,37
729,to,O,37
730,worsen,O,37
731,into,O,37
732,their,O,37
733,60s,O,37
734,In,O,38
735,the,O,38
736,U.S,O,38
737,an,O,39
738,estimated,O,39
739,112,O,39
740,million,O,39
741,people,O,39
742,experience,O,39
743,vision,O,39
744,issues,O,39
745,due,O,39
746,to,O,39
747,presbyopia,B-NAME_OF_DISEASE,39
748,-,O,39
749,a,O,39
750,number,O,39
751,that,O,39
752,s,O,39
753,expected,O,39
754,to,O,39
755,continue,O,39
756,increasing,O,39
757,The,O,40
758,condition,O,40
759,is,O,40
760,not,O,40
761,a,O,40
762,disease,O,40
763,so,O,40
764,it,O,40
765,cannot,O,40
766,be,O,40
767,cured,O,40
768,however,O,40
769,there,O,40
770,are,O,40
771,safe,O,40
772,and,O,40
773,effective,O,40
774,ways,O,40
775,to,O,40
776,correct,O,40
777,presbyopia,B-NAME_OF_DISEASE,40
778,including,O,40
779,eye,B-TREATMENT,40
780,glasses,I-TREATMENT,40
781,contact,B-TREATMENT,40
782,lenses,I-TREATMENT,40
783,or,O,40
784,refractive,B-TREATMENT,40
785,surgery,I-TREATMENT,40
786,About,O,41
787,the,B-TREATMENT,41
788,AcrySof®,I-TREATMENT,41
789,IQ,I-TREATMENT,41
790,Vivity™,I-TREATMENT,41
791,IOL,B-TREATMENT,41
792,The,B-TREATMENT,41
793,non-diffractive,I-TREATMENT,41
794,AcrySof®,I-TREATMENT,41
795,IQ,I-TREATMENT,41
796,VivityTM,I-TREATMENT,41
797,Extended,I-TREATMENT,41
798,Vision,I-TREATMENT,41
799,Posterior,I-TREATMENT,41
800,Chamber,I-TREATMENT,41
801,Intraocular,I-TREATMENT,41
802,Lens,I-TREATMENT,41
803,Model,I-TREATMENT,41
804,DFT015,I-TREATMENT,41
805,referred,O,41
806,to,O,41
807,as,O,41
808,AcrySof®,B-TREATMENT,41
809,IQ,I-TREATMENT,41
810,VivityTM,I-TREATMENT,41
811,IOL,B-TREATMENT,41
812,is,O,41
813,a,O,41
814,UV-absorbing,O,41
815,and,O,41
816,blue,O,41
817,light,O,41
818,filtering,O,41
819,foldable,O,41
820,intraocular,B-TREATMENT,41
821,lens,I-TREATMENT,41
822,IOL,B-TREATMENT,41
823,,O,41
824,This,O,42
825,IOL,B-TREATMENT,42
826,compared,O,42
827,to,O,42
828,a,B-TREATMENT,42
829,monofocal,I-TREATMENT,42
830,IOL,I-TREATMENT,42
831,provides,O,42
832,an,O,42
833,extended,O,42
834,range,O,42
835,of,O,42
836,vision,O,42
837,from,O,42
838,distance,O,42
839,to,O,42
840,near,O,42
841,without,O,42
842,increasing,O,42
843,the,O,42
844,incidence,O,42
845,of,O,42
846,visual,O,42
847,disturbances,O,42
848,Potential,O,43
849,side,O,43
850,effects,O,43
851,As,O,43
852,with,O,43
853,any,O,43
854,surgery,O,43
855,there,O,43
856,is,O,43
857,an,O,43
858,implicit,O,43
859,risk,O,43
860,whether,O,43
861,or,O,43
862,not,O,43
863,the,B-TREATMENT,43
864,IOL,I-TREATMENT,43
865,is,O,43
866,implanted,O,43
867,The,O,44
868,complications,O,44
869,of,O,44
870,the,B-TREATMENT,44
871,IOL,I-TREATMENT,44
872,implantation,I-TREATMENT,44
873,surgery,I-TREATMENT,44
874,ranges,O,44
875,from,O,44
876,minor,O,44
877,side,O,44
878,effects,O,44
879,usually,O,44
880,temporary,O,44
881,to,O,44
882,serious,O,44
883,complications,O,44
884,Patients,O,45
885,with,O,45
886,previous,O,45
887,illnesses,O,45
888,or,O,45
889,disorders,O,45
890,such,O,45
891,as,O,45
892,chronic,B-NAME_OF_DISEASE,45
893,infections,I-NAME_OF_DISEASE,45
894,of,I-NAME_OF_DISEASE,45
895,the,I-NAME_OF_DISEASE,45
896,eye,I-NAME_OF_DISEASE,45
897,or,I-NAME_OF_DISEASE,45
898,eyelids,I-NAME_OF_DISEASE,45
899,or,O,45
900,diabetes,B-NAME_OF_DISEASE,45
901,may,O,45
902,present,O,45
903,a,O,45
904,higher,O,45
905,risk,O,45
906,of,O,45
907,complications,O,45
908,Temporary,O,46
909,surgical,O,46
910,complications,O,46
911,include,O,46
912,but,O,46
913,are,O,46
914,not,O,46
915,limited,O,46
916,to,O,46
917,reactions,O,46
918,to,O,46
919,medications,O,46
920,such,O,46
921,as,O,46
922,irritation,B-SIGN_AND_SYMPTOM,46
923,or,I-SIGN_AND_SYMPTOM,46
924,mild,I-SIGN_AND_SYMPTOM,46
925,allergic,I-SIGN_AND_SYMPTOM,46
926,response,I-SIGN_AND_SYMPTOM,46
927,bleeding,I-SIGN_AND_SYMPTOM,46
928,redness,I-SIGN_AND_SYMPTOM,46
929,itching,I-SIGN_AND_SYMPTOM,46
930,of,I-SIGN_AND_SYMPTOM,46
931,the,I-SIGN_AND_SYMPTOM,46
932,eye,I-SIGN_AND_SYMPTOM,46
933,sensitivity,I-SIGN_AND_SYMPTOM,46
934,to,I-SIGN_AND_SYMPTOM,46
935,light,I-SIGN_AND_SYMPTOM,46
936,swelling,I-SIGN_AND_SYMPTOM,46
937,corneal,I-SIGN_AND_SYMPTOM,46
938,edema,I-SIGN_AND_SYMPTOM,46
939,swelling,I-SIGN_AND_SYMPTOM,46
940,of,I-SIGN_AND_SYMPTOM,46
941,the,I-SIGN_AND_SYMPTOM,46
942,cornea,I-SIGN_AND_SYMPTOM,46
943,problems,I-SIGN_AND_SYMPTOM,46
944,with,I-SIGN_AND_SYMPTOM,46
945,the,I-SIGN_AND_SYMPTOM,46
946,iris,I-SIGN_AND_SYMPTOM,46
947,cell,I-SIGN_AND_SYMPTOM,46
948,growth,I-SIGN_AND_SYMPTOM,46
949,in,I-SIGN_AND_SYMPTOM,46
950,the,I-SIGN_AND_SYMPTOM,46
951,IOL,I-SIGN_AND_SYMPTOM,46
952,and,I-SIGN_AND_SYMPTOM,46
953,an,I-SIGN_AND_SYMPTOM,46
954,increase,I-SIGN_AND_SYMPTOM,46
955,temporary,I-SIGN_AND_SYMPTOM,46
956,eye,I-SIGN_AND_SYMPTOM,46
957,pressure,I-SIGN_AND_SYMPTOM,46
958,There,O,47
959,is,O,47
960,a,O,47
961,small,O,47
962,risk,O,47
963,of,O,47
964,needing,O,47
965,further,O,47
966,surgical,B-TREATMENT,47
967,treatment,I-TREATMENT,47
968,such,O,47
969,as,O,47
970,IOL,B-TREATMENT,47
971,replacement,I-TREATMENT,47
972,implanted,O,47
973,by,O,47
974,a,O,47
975,different,O,47
976,one,O,47
977,or,O,47
978,surgery,O,47
979,to,O,47
980,improve,O,47
981,vision,O,47
982,after,O,47
983,the,O,47
984,implantation,O,47
985,of,O,47
986,the,O,47
987,initial,O,47
988,IOL,B-TREATMENT,47
989,Johnson,B-ORGANIZATION,48
990,Johnson,I-ORGANIZATION,48
991,Vision,I-ORGANIZATION,48
992,Announces,O,48
993,Launch,O,48
994,of,O,48
995,TECNIS,B-TREATMENT,48
996,Eyhance™,I-TREATMENT,48
997,Toric,I-TREATMENT,48
998,II,I-TREATMENT,48
999,IOL,B-TREATMENT,48
1000,with,O,48
1001,TECNIS,O,48
1002,Simplicity™,O,48
1003,Delivery,O,48
1004,System,O,48
1005,a,O,48
1006,Next-Generation,O,48
1007,Monofocal,B-TREATMENT,48
1008,Intraocular,I-TREATMENT,48
1009,Lens,I-TREATMENT,48
1010,for,O,48
1011,Cataracts,B-NAME_OF_DISEASE,48
1012,Patients,O,48
1013,with,O,48
1014,Astigmatism,B-NAME_OF_DISEASE,48
1015,in,O,48
1016,Europe,B-GPE,48
1017,TECNIS,B-TREATMENT,48
1018,Eyhance™,I-TREATMENT,48
1019,Toric,I-TREATMENT,48
1020,II,I-TREATMENT,48
1021,IOL,B-TREATMENT,48
1022,offers,O,48
1023,all,O,48
1024,the,O,48
1025,benefits,O,48
1026,associated,O,48
1027,with,O,48
1028,the,B-TREATMENT,48
1029,TECNIS,I-TREATMENT,48
1030,Eyhance™,I-TREATMENT,48
1031,IOL,B-TREATMENT,48
1032,such,O,48
1033,as,O,48
1034,high-quality,O,48
1035,intermediate,O,48
1036,and,O,48
1037,20,O,48
1038,20,O,48
1039,distance,O,48
1040,vision,O,48
1041,whilst,O,48
1042,correcting,O,48
1043,patients,O,48
1044,astigmatism,B-NAME_OF_DISEASE,48
1045,Johnson,B-ORGANIZATION,48
1046,Johnson,I-ORGANIZATION,48
1047,Vision,I-ORGANIZATION,48
1048,a,O,48
1049,global,O,48
1050,leader,O,48
1051,in,O,48
1052,eye,O,48
1053,health,O,48
1054,and,O,48
1055,part,O,48
1056,of,O,48
1057,the,B-ORGANIZATION,48
1058,Johnson,I-ORGANIZATION,48
1059,Johnson,I-ORGANIZATION,48
1060,Medical,I-ORGANIZATION,48
1061,Devices,I-ORGANIZATION,48
1062,Companies,I-ORGANIZATION,48
1063,have,O,48
1064,announced,O,48
1065,the,O,48
1066,launch,O,48
1067,and,O,48
1068,availability,O,48
1069,of,O,48
1070,its,O,48
1071,TECNIS,B-TREATMENT,48
1072,Eyhance™,I-TREATMENT,48
1073,Toric,I-TREATMENT,48
1074,II,I-TREATMENT,48
1075,intraocular,I-TREATMENT,48
1076,lens,I-TREATMENT,48
1077,IOL,B-TREATMENT,48
1078,with,O,48
1079,TECNIS,O,48
1080,Simplicity™,O,48
1081,Delivery,O,48
1082,System,O,48
1083,for,O,48
1084,the,O,48
1085,treatment,O,48
1086,of,O,48
1087,cataracts,B-NAME_OF_DISEASE,48
1088,patients,O,48
1089,with,O,48
1090,astigmatism,B-NAME_OF_DISEASE,48
1091,in,O,48
1092,Europe,B-GPE,48
1093,This,O,49
1094,monofocal,B-TREATMENT,49
1095,lens,I-TREATMENT,49
1096,allows,O,49
1097,for,O,49
1098,high-quality,O,49
1099,vision,O,49
1100,at,O,49
1101,both,O,49
1102,intermediate,O,49
1103,and,O,49
1104,far,O,49
1105,distances,O,49
1106,and,O,49
1107,is,O,49
1108,specifically,O,49
1109,engineered,O,49
1110,for,O,49
1111,rotational,O,49
1112,stability,O,49
1113,The,B-TREATMENT,50
1114,TECNIS,I-TREATMENT,50
1115,Eyhance™,I-TREATMENT,50
1116,Toric,I-TREATMENT,50
1117,II,I-TREATMENT,50
1118,IOL,B-TREATMENT,50
1119,is,O,50
1120,the,O,50
1121,latest,O,50
1122,innovation,O,50
1123,in,O,50
1124,the,O,50
1125,industry-leading,O,50
1126,TECNIS®,B-TREATMENT,50
1127,Family,I-TREATMENT,50
1128,of,I-TREATMENT,50
1129,IOLs,I-TREATMENT,50
1130,It,O,51
1131,allows,O,51
1132,patients,O,51
1133,to,O,51
1134,achieve,O,51
1135,significantly,O,51
1136,improved,O,51
1137,intermediate,O,51
1138,vision,O,51
1139,compared,O,51
1140,with,O,51
1141,a,O,51
1142,standard,O,51
1143,aspheric,B-TREATMENT,51
1144,monofocal,I-TREATMENT,51
1145,IOL,B-TREATMENT,51
1146,along,O,51
1147,with,O,51
1148,20,O,51
1149,20,O,51
1150,distance,O,51
1151,vision,O,51
1152,With,O,52
1153,the,O,52
1154,novel,O,52
1155,haptic,O,52
1156,design,O,52
1157,of,O,52
1158,the,B-TREATMENT,52
1159,TECNIS,I-TREATMENT,52
1160,Eyhance™,I-TREATMENT,52
1161,Toric,I-TREATMENT,52
1162,II,I-TREATMENT,52
1163,IOL,B-TREATMENT,52
1164,along,O,52
1165,with,O,52
1166,excellent,O,52
1167,rotational,O,52
1168,stability,O,52
1169,I,O,52
1170,have,O,52
1171,been,O,52
1172,able,O,52
1173,to,O,52
1174,offer,O,52
1175,my,O,52
1176,patients,O,52
1177,immediate,O,52
1178,improvements,O,52
1179,in,O,52
1180,their,O,52
1181,functional,O,52
1182,vision,O,52
1183,while,O,52
1184,also,O,52
1185,correcting,O,52
1186,their,O,52
1187,astigmatism,B-NAME_OF_DISEASE,52
1188,said,O,52
1189,Dr,B-PERSON,52
1190,Filomena,I-PERSON,52
1191,Ribeiro,I-PERSON,52
1192,Head,O,52
1193,Director,O,52
1194,of,O,52
1195,Ophthalmology,O,52
1196,Hospital,B-ORGANIZATION,52
1197,da,I-ORGANIZATION,52
1198,Luz,I-ORGANIZATION,52
1199,Lisbon,B-GPE,52
1200,Having,O,53
1201,implanted,O,53
1202,the,B-TREATMENT,53
1203,TECNIS,I-TREATMENT,53
1204,Eyhance™,I-TREATMENT,53
1205,Toric,I-TREATMENT,53
1206,II,I-TREATMENT,53
1207,IOL,B-TREATMENT,53
1208,I,O,53
1209,can,O,53
1210,confidently,O,53
1211,say,O,53
1212,that,O,53
1213,this,O,53
1214,IOL,B-TREATMENT,53
1215,is,O,53
1216,a,O,53
1217,game-changer,O,53
1218,in,O,53
1219,the,O,53
1220,monofocal,O,53
1221,category,O,53
1222,and,O,53
1223,in,O,53
1224,helping,O,53
1225,my,O,53
1226,patients,O,53
1227,get,O,53
1228,back,O,53
1229,to,O,53
1230,spending,O,53
1231,more,O,53
1232,time,O,53
1233,doing,O,53
1234,what,O,53
1235,they,O,53
1236,love,O,53
1237,In,O,54
1238,a,O,54
1239,survey,O,54
1240,of,O,54
1241,17,O,54
1242,leading,O,54
1243,European,O,54
1244,ophthalmologists,O,54
1245,who,O,54
1246,had,O,54
1247,early,O,54
1248,access,O,54
1249,to,O,54
1250,the,B-TREATMENT,54
1251,TECNIS,B-TREATMENT,54
1252,Eyhance™,I-TREATMENT,54
1253,Toric,I-TREATMENT,54
1254,II,I-TREATMENT,54
1255,IOL,I-TREATMENT,54
1256,all,O,54
1257,rated,O,54
1258,their,O,54
1259,patients,O,54
1260,as,O,54
1261,being,O,54
1262,very,O,54
1263,satisfied,O,54
1264,with,O,54
1265,the,O,54
1266,lens,O,54
1267,Meanwhile,O,55
1268,more,O,55
1269,than,O,55
1270,79%,O,55
1271,perceived,O,55
1272,their,O,55
1273,patients,O,55
1274,as,O,55
1275,being,O,55
1276,very,O,55
1277,satisfied,O,55
1278,with,O,55
1279,their,O,55
1280,intermediate,O,55
1281,and,O,55
1282,distance,O,55
1283,vision,O,55
1284,Additionally,O,56
1285,94%,O,56
1286,of,O,56
1287,those,O,56
1288,surveyed,O,56
1289,were,O,56
1290,very,O,56
1291,satisfied,O,56
1292,with,O,56
1293,the,O,56
1294,handling,O,56
1295,while,O,56
1296,implanting,O,56
1297,the,O,56
1298,lens,O,56
1299,while,O,56
1300,nearly,O,56
1301,two,O,56
1302,thirds,O,56
1303,rated,O,56
1304,the,O,56
1305,overall,O,56
1306,performance,O,56
1307,of,O,56
1308,the,O,56
1309,lens,O,56
1310,as,O,56
1311,excellent,O,56
1312,compared,O,56
1313,to,O,56
1314,other,O,56
1315,toric,B-TREATMENT,56
1316,IOLs,I-TREATMENT,56
1317,More,O,57
1318,than,O,57
1319,80%,O,57
1320,also,O,57
1321,rated,O,57
1322,the,O,57
1323,rotational,O,57
1324,stability,O,57
1325,of,O,57
1326,the,O,57
1327,lens,O,57
1328,as,O,57
1329,excellent,O,57
1330,compared,O,57
1331,to,O,57
1332,other,O,57
1333,toric,B-TREATMENT,57
1334,IOLs,I-TREATMENT,57
1335,All,O,58
1336,those,O,58
1337,surveyed,O,58
1338,said,O,58
1339,they,O,58
1340,were,O,58
1341,very,O,58
1342,likely,O,58
1343,to,O,58
1344,continue,O,58
1345,to,O,58
1346,use,O,58
1347,the,O,58
1348,lens,O,58
1349,in,O,58
1350,the,O,58
1351,future,O,58
1352,With,O,59
1353,this,O,59
1354,rollout,O,59
1355,of,O,59
1356,TECNIS,B-TREATMENT,59
1357,Eyhance™,I-TREATMENT,59
1358,Toric,I-TREATMENT,59
1359,II,I-TREATMENT,59
1360,IOL,I-TREATMENT,59
1361,we,O,59
1362,are,O,59
1363,thrilled,O,59
1364,to,O,59
1365,extend,O,59
1366,the,O,59
1367,benefits,O,59
1368,of,O,59
1369,our,O,59
1370,most,O,59
1371,advanced,O,59
1372,monofocal,B-TREATMENT,59
1373,IOL,I-TREATMENT,59
1374,to,O,59
1375,cataract,B-NAME_OF_DISEASE,59
1376,patients,O,59
1377,with,O,59
1378,astigmatism,B-NAME_OF_DISEASE,59
1379,said,O,59
1380,Erin,B-PERSON,59
1381,McEachren,I-PERSON,59
1382,Regional,O,59
1383,Vice,O,59
1384,President,O,59
1385,EMEA,B-GPE,59
1386,Johnson,B-ORGANIZATION,59
1387,Johnson,I-ORGANIZATION,59
1388,Surgical,I-ORGANIZATION,59
1389,Vision,I-ORGANIZATION,59
1390,It,O,60
1391,s,O,60
1392,an,O,60
1393,important,O,60
1394,first,O,60
1395,in,O,60
1396,Europe,B-GPE,60
1397,for,O,60
1398,the,O,60
1399,monofocal,B-TREATMENT,60
1400,IOL,I-TREATMENT,60
1401,category,O,60
1402,as,O,60
1403,today,O,60
1404,most,O,60
1405,lenses,O,60
1406,in,O,60
1407,this,O,60
1408,category,O,60
1409,only,O,60
1410,correct,O,60
1411,vision,O,60
1412,to,O,60
1413,help,O,60
1414,patients,O,60
1415,with,O,60
1416,cataracts,B-NAME_OF_DISEASE,60
1417,see,O,60
1418,things,O,60
1419,at,O,60
1420,a,O,60
1421,distance,O,60
1422,and,O,60
1423,therefore,O,60
1424,don,O,60
1425,t,O,60
1426,improve,O,60
1427,the,O,60
1428,intermediate,O,60
1429,vision,O,60
1430,that,O,60
1431,is,O,60
1432,required,O,60
1433,for,O,60
1434,many,O,60
1435,important,O,60
1436,daily,O,60
1437,tasks,O,60
1438,This,O,61
1439,is,O,61
1440,another,O,61
1441,breakthrough,O,61
1442,in,O,61
1443,meeting,O,61
1444,the,O,61
1445,ever-changing,O,61
1446,and,O,61
1447,evolving,O,61
1448,needs,O,61
1449,of,O,61
1450,our,O,61
1451,patients,O,61
1452,across,O,61
1453,Europe,B-GPE,61
1454,and,O,61
1455,the,O,61
1456,world,O,61
1457,Cataracts,B-NAME_OF_DISEASE,62
1458,are,O,62
1459,the,O,62
1460,leading,O,62
1461,cause,O,62
1462,of,O,62
1463,blindness,B-NAME_OF_DISEASE,62
1464,globally,O,62
1465,and,O,62
1466,if,O,62
1467,left,O,62
1468,untreated,O,62
1469,cause,O,62
1470,vision,B-SIGN_AND_SYMPTOM,62
1471,to,I-SIGN_AND_SYMPTOM,62
1472,deteriorate,I-SIGN_AND_SYMPTOM,62
1473,over,I-SIGN_AND_SYMPTOM,62
1474,time,I-SIGN_AND_SYMPTOM,62
1475,Astigmatism,B-NAME_OF_DISEASE,63
1476,reduces,B-SIGN_AND_SYMPTOM,63
1477,distance,I-SIGN_AND_SYMPTOM,63
1478,and,I-SIGN_AND_SYMPTOM,63
1479,near,I-SIGN_AND_SYMPTOM,63
1480,visual,I-SIGN_AND_SYMPTOM,63
1481,acuity,I-SIGN_AND_SYMPTOM,63
1482,vision,I-SIGN_AND_SYMPTOM,63
1483,quality,I-SIGN_AND_SYMPTOM,63
1484,and,I-SIGN_AND_SYMPTOM,63
1485,depth,I-SIGN_AND_SYMPTOM,63
1486,perception,I-SIGN_AND_SYMPTOM,63
1487,In,O,64
1488,Europe,B-GPE,64
1489,astigmatism,B-NAME_OF_DISEASE,64
1490,affects,O,64
1491,over,O,64
1492,50%,O,64
1493,of,O,64
1494,those,O,64
1495,over,O,64
1496,the,O,64
1497,age,O,64
1498,of,O,64
1499,65,O,64
1500,and,O,64
1501,over,O,64
1502,20%,O,64
1503,of,O,64
1504,the,O,64
1505,population,O,64
1506,Toric,B-TREATMENT,65
1507,IOLs,I-TREATMENT,65
1508,are,O,65
1509,the,O,65
1510,most,O,65
1511,common,O,65
1512,method,O,65
1513,for,O,65
1514,astigmatism,B-NAME_OF_DISEASE,65
1515,correction,O,65
1516,in,O,65
1517,cataract,B-NAME_OF_DISEASE,65
1518,patients,O,65
1519,TECNIS,B-TREATMENT,66
1520,Eyhance™,I-TREATMENT,66
1521,Toric,I-TREATMENT,66
1522,II,I-TREATMENT,66
1523,IOL,I-TREATMENT,66
1524,is,O,66
1525,part,O,66
1526,of,O,66
1527,the,B-TREATMENT,66
1528,TECNIS®,I-TREATMENT,66
1529,Family,I-TREATMENT,66
1530,of,I-TREATMENT,66
1531,IOLs,I-TREATMENT,66
1532,which,O,66
1533,offer,O,66
1534,a,O,66
1535,variety,O,66
1536,of,O,66
1537,personalized,O,66
1538,vision,O,66
1539,options,O,66
1540,for,O,66
1541,people,O,66
1542,with,O,66
1543,cataracts,B-NAME_OF_DISEASE,66
1544,all,O,66
1545,with,O,66
1546,the,O,66
1547,goal,O,66
1548,of,O,66
1549,ensuring,O,66
1550,clear,O,66
1551,sharp,O,66
1552,vision,O,66
1553,to,O,66
1554,meet,O,66
1555,individual,O,66
1556,needs,O,66
1557,and,O,66
1558,lifestyles,O,66
1559,The,B-TREATMENT,67
1560,TECNIS®,I-TREATMENT,67
1561,IOL,I-TREATMENT,67
1562,platform,I-TREATMENT,67
1563,celebrated,O,67
1564,its,O,67
1565,20th,O,67
1566,anniversary,O,67
1567,earlier,O,67
1568,this,O,67
1569,year,O,67
1570,About,O,68
1571,Cataracts,B-NAME_OF_DISEASE,68
1572,and,O,68
1573,Presbyopia,B-NAME_OF_DISEASE,68
1574,Cataracts,B-NAME_OF_DISEASE,68
1575,are,O,68
1576,the,O,68
1577,leading,O,68
1578,cause,O,68
1579,of,O,68
1580,blindness,B-NAME_OF_DISEASE,68
1581,globally,O,68
1582,More,O,69
1583,than,O,69
1584,90,O,69
1585,percent,O,69
1586,of,O,69
1587,people,O,69
1588,develop,O,69
1589,cataracts,B-NAME_OF_DISEASE,69
1590,by,O,69
1591,age,O,69
1592,65,O,69
1593,If,O,70
1594,left,O,70
1595,untreated,O,70
1596,cataracts,B-NAME_OF_DISEASE,70
1597,cause,O,70
1598,vision,B-SIGN_AND_SYMPTOM,70
1599,to,I-SIGN_AND_SYMPTOM,70
1600,deteriorate,I-SIGN_AND_SYMPTOM,70
1601,over,I-SIGN_AND_SYMPTOM,70
1602,time,I-SIGN_AND_SYMPTOM,70
1603,Cataract,B-TREATMENT,71
1604,surgery,I-TREATMENT,71
1605,is,O,71
1606,the,O,71
1607,most,O,71
1608,common,O,71
1609,surgery,O,71
1610,performed,O,71
1611,around,O,71
1612,the,O,71
1613,world,O,71
1614,including,O,71
1615,more,O,71
1616,than,O,71
1617,4,O,71
1618,million,O,71
1619,times,O,71
1620,in,O,71
1621,the,B-GPE,71
1622,EU,I-GPE,71
1623,in,O,71
1624,2016,O,71
1625,Many,O,72
1626,people,O,72
1627,who,O,72
1628,have,O,72
1629,cataracts,B-NAME_OF_DISEASE,72
1630,experience,O,72
1631,other,O,72
1632,problems,O,72
1633,with,O,72
1634,their,O,72
1635,vision,O,72
1636,such,O,72
1637,as,O,72
1638,presbyopia,B-NAME_OF_DISEASE,72
1639,Cataract,B-TREATMENT,73
1640,surgery,I-TREATMENT,73
1641,is,O,73
1642,a,O,73
1643,unique,O,73
1644,opportunity,O,73
1645,to,O,73
1646,address,O,73
1647,presbyopia,B-NAME_OF_DISEASE,73
1648,without,O,73
1649,an,O,73
1650,additional,O,73
1651,procedure,O,73
1652,Presbyopia,B-NAME_OF_DISEASE,74
1653,is,O,74
1654,a,O,74
1655,progressive,O,74
1656,eye,O,74
1657,condition,O,74
1658,which,O,74
1659,makes,O,74
1660,it,O,74
1661,difficult,B-SIGN_AND_SYMPTOM,74
1662,to,I-SIGN_AND_SYMPTOM,74
1663,focus,I-SIGN_AND_SYMPTOM,74
1664,on,I-SIGN_AND_SYMPTOM,74
1665,close,I-SIGN_AND_SYMPTOM,74
1666,objects,I-SIGN_AND_SYMPTOM,74
1667,and,O,74
1668,usually,O,74
1669,becomes,O,74
1670,noticeable,O,74
1671,around,O,74
1672,40,O,74
1673,years,O,74
1674,of,O,74
1675,age,O,74
1676,According,O,75
1677,to,O,75
1678,the,O,75
1679,statement,O,75
1680,of,O,75
1681,Erin,B-PERSON,75
1682,McEachren,I-PERSON,75
1683,Johnson,B-ORGANIZATION,75
1684,Johnson,I-ORGANIZATION,75
1685,Surgical,I-ORGANIZATION,75
1686,Vision,I-ORGANIZATION,75
1687,EMEA,B-GPE,75
1688,regional,O,75
1689,vice,O,75
1690,president,O,75
1691,at,O,75
1692,the,O,75
1693,virtual,O,75
1694,European,O,75
1695,Society,O,75
1696,of,O,75
1697,Cataract,B-NAME_OF_DISEASE,75
1698,and,O,75
1699,Refractive,O,75
1700,Surgeons,O,75
1701,meeting,O,75
1702,In,O,75
1703,light,O,75
1704,of,O,75
1705,its,O,75
1706,rotationally,O,75
1707,stable,O,75
1708,design,O,75
1709,with,O,75
1710,continuous,O,75
1711,vision,O,75
1712,range,O,75
1713,the,B-TREATMENT,75
1714,Tecnis,I-TREATMENT,75
1715,Synergy,I-TREATMENT,75
1716,toric,I-TREATMENT,75
1717,II,I-TREATMENT,75
1718,IOL,B-TREATMENT,75
1719,brings,O,75
1720,the,O,75
1721,most,O,75
1722,advanced,O,75
1723,IOL,B-TREATMENT,75
1724,solution,O,75
1725,to,O,75
1726,cataract,B-NAME_OF_DISEASE,75
1727,patients,O,75
1728,with,O,75
1729,astigmatism,B-NAME_OF_DISEASE,75
1730,The,B-TREATMENT,76
1731,Tecnis,I-TREATMENT,76
1732,Synergy,I-TREATMENT,76
1733,toric,I-TREATMENT,76
1734,II,I-TREATMENT,76
1735,IOL,I-TREATMENT,76
1736,comes,O,76
1737,with,O,76
1738,its,O,76
1739,low-light,O,76
1740,capability,O,76
1741,and,O,76
1742,continuity,O,76
1743,without,O,76
1744,visual,O,76
1745,gaps,O,76
1746,The,O,77
1747,second,O,77
1748,product,O,77
1749,introduced,O,77
1750,by,O,77
1751,Johnson,B-ORGANIZATION,77
1752,Johnson,I-ORGANIZATION,77
1753,Vision,I-ORGANIZATION,77
1754,is,O,77
1755,for,O,77
1756,surgeons,O,77
1757,using,O,77
1758,the,B-SURGICAL_INSTRUMENT,77
1759,CATALYS™,I-SURGICAL_INSTRUMENT,77
1760,Precision,I-SURGICAL_INSTRUMENT,77
1761,Laser,I-SURGICAL_INSTRUMENT,77
1762,System,I-SURGICAL_INSTRUMENT,77
1763,This,O,78
1764,product,O,78
1765,CATALYS™,O,78
1766,System,O,78
1767,cOS,O,78
1768,6,O,78
1769,software,O,79
1770,brings,O,79
1771,new,O,79
1772,features,O,79
1773,for,O,79
1774,astigmatism,B-NAME_OF_DISEASE,79
1775,management,O,79
1776,such,O,79
1777,as,O,79
1778,speed,O,79
1779,and,O,79
1780,accuracy,O,79
1781,This,O,80
1782,software,O,80
1783,has,O,80
1784,been,O,80
1785,specially,O,80
1786,designed,O,80
1787,to,O,80
1788,focus,O,80
1789,on,O,80
1790,minimizing,O,80
1791,data,O,80
1792,entry,O,80
1793,verification,O,80
1794,and,O,80
1795,manual,O,80
1796,transcription,O,80
1797,errors,O,80
1798,while,O,80
1799,reducing,O,80
1800,time,O,80
1801,spent,O,80
1802,on,O,80
1803,calculations,O,80
1804,and,O,80
1805,the,O,80
1806,need,O,80
1807,for,O,80
1808,intraoperative,O,80
1809,aberrometry,O,80
1810,for,O,80
1811,toric,B-TREATMENT,80
1812,IOL,I-TREATMENT,80
1813,alignment,O,80
1814,It,O,81
1815,also,O,81
1816,includes,O,81
1817,iris,B-PART_OF_THE_EYES,81
1818,registration,O,81
1819,for,O,81
1820,automatic,O,81
1821,cyclorotation,O,81
1822,compensation,O,81
1823,Cataracts,B-NAME_OF_DISEASE,82
1824,are,O,82
1825,the,O,82
1826,leading,O,82
1827,cause,O,82
1828,of,O,82
1829,blindness,B-NAME_OF_DISEASE,82
1830,globally,O,82
1831,and,O,82
1832,if,O,82
1833,left,O,82
1834,untreated,O,82
1835,they,O,82
1836,happen,O,82
1837,to,O,82
1838,cause,O,82
1839,vision,B-SIGN_AND_SYMPTOM,82
1840,to,I-SIGN_AND_SYMPTOM,82
1841,deteriorate,I-SIGN_AND_SYMPTOM,82
1842,over,I-SIGN_AND_SYMPTOM,82
1843,time,I-SIGN_AND_SYMPTOM,82
1844,Astigmatism,B-NAME_OF_DISEASE,83
1845,makes,O,83
1846,a,B-SIGN_AND_SYMPTOM,83
1847,reducing,I-SIGN_AND_SYMPTOM,83
1848,effect,I-SIGN_AND_SYMPTOM,83
1849,on,I-SIGN_AND_SYMPTOM,83
1850,distance,I-SIGN_AND_SYMPTOM,83
1851,as,I-SIGN_AND_SYMPTOM,83
1852,well,I-SIGN_AND_SYMPTOM,83
1853,as,I-SIGN_AND_SYMPTOM,83
1854,near,I-SIGN_AND_SYMPTOM,83
1855,visual,I-SIGN_AND_SYMPTOM,83
1856,acuity,I-SIGN_AND_SYMPTOM,83
1857,vision,I-SIGN_AND_SYMPTOM,83
1858,quality,I-SIGN_AND_SYMPTOM,83
1859,and,I-SIGN_AND_SYMPTOM,83
1860,depth,I-SIGN_AND_SYMPTOM,83
1861,perception,I-SIGN_AND_SYMPTOM,83
1862,Throughout,O,84
1863,Europe,B-GPE,84
1864,astigmatism,B-NAME_OF_DISEASE,84
1865,affects,O,84
1866,over,O,84
1867,50%,O,84
1868,of,O,84
1869,those,O,84
1870,over,O,84
1871,the,O,84
1872,age,O,84
1873,of,O,84
1874,65,O,84
1875,and,O,84
1876,over,O,84
1877,20%,O,84
1878,of,O,84
1879,the,O,84
1880,population,O,84
1881,Predictability,O,85
1882,Level,O,85
1883,-,O,85
1884,Toric,B-TREATMENT,85
1885,IOLs,I-TREATMENT,85
1886,are,O,85
1887,the,O,85
1888,most,O,85
1889,predictable,O,85
1890,method,O,85
1891,for,O,85
1892,correction,O,85
1893,however,O,85
1894,implanting,O,85
1895,a,B-TREATMENT,85
1896,Toric,I-TREATMENT,85
1897,IOL,I-TREATMENT,85
1898,can,O,85
1899,be,O,85
1900,more,O,85
1901,challenging,O,85
1902,than,O,85
1903,a,B-TREATMENT,85
1904,conventional,I-TREATMENT,85
1905,spherical,I-TREATMENT,85
1906,IOL,I-TREATMENT,85
1907,due,O,85
1908,to,O,85
1909,the,O,85
1910,high,O,85
1911,degree,O,85
1912,of,O,85
1913,precision,O,85
1914,required,O,85
1915,to,O,85
1916,align,O,85
1917,the,B-PART_OF_THE_EYES,85
1918,lens,I-PART_OF_THE_EYES,85
1919,properly,O,85
1920,to,O,85
1921,correct,O,85
1922,astigmatism,B-NAME_OF_DISEASE,85
1923,Movement,O,86
1924,of,O,86
1925,the,B-PART_OF_THE_EYES,86
1926,lens,I-PART_OF_THE_EYES,86
1927,after,O,86
1928,implantation,O,86
1929,can,O,86
1930,also,O,86
1931,result,O,86
1932,in,O,86
1933,decreased,O,86
1934,vision,O,86
1935,and,O,86
1936,the,O,86
1937,need,O,86
1938,for,O,86
1939,realignment,O,86
1940,The,O,87
1941,most,O,87
1942,advanced,O,87
1943,software,O,87
1944,ever,O,87
1945,-,O,87
1946,In,O,87
1947,its,O,87
1948,press,O,87
1949,release,O,87
1950,Johnson,B-ORGANIZATION,87
1951,Johnson,I-ORGANIZATION,87
1952,Vision,I-ORGANIZATION,87
1953,said,O,87
1954,This,O,87
1955,is,O,87
1956,the,O,87
1957,best,O,87
1958,of,O,87
1959,both,O,87
1960,worlds,O,87
1961,for,O,87
1962,people,O,87
1963,with,O,87
1964,cataracts,B-NAME_OF_DISEASE,87
1965,and,O,87
1966,astigmatism,B-NAME_OF_DISEASE,87
1967,-,O,87
1968,our,O,87
1969,best,O,87
1970,Toric,B-TREATMENT,87
1971,II,I-TREATMENT,87
1972,IOL,I-TREATMENT,87
1973,in,O,87
1974,a,O,87
1975,preloaded,O,87
1976,delivery,O,87
1977,system,O,87
1978,with,O,87
1979,the,O,87
1980,most,O,87
1981,advanced,O,87
1982,software,O,87
1983,tool,O,87
1984,for,O,87
1985,ease,O,87
1986,speed,O,87
1987,and,O,87
1988,accuracy,O,87
1989,in,O,87
1990,aligning,O,87
1991,the,B-PART_OF_THE_EYES,87
1992,lens,I-PART_OF_THE_EYES,87
1993,These,O,88
1994,latest,O,88
1995,additions,O,88
1996,build,O,88
1997,on,O,88
1998,our,O,88
1999,proud,O,88
2000,history,O,88
2001,of,O,88
2002,raising,O,88
2003,the,O,88
2004,standard,O,88
2005,of,O,88
2006,care,O,88
2007,for,O,88
2008,patients,O,88
2009,with,O,88
2010,cataracts,B-NAME_OF_DISEASE,88
2011,and,O,88
2012,ensure,O,88
2013,we,O,88
2014,stay,O,88
2015,TRUE,O,88
2016,to,O,88
2017,our,O,88
2018,legacy,O,88
2019,of,O,88
2020,innovation,O,88
2021,The,B-TREATMENT,89
2022,TECNIS,I-TREATMENT,89
2023,Synergy™,I-TREATMENT,89
2024,Toric,I-TREATMENT,89
2025,II,I-TREATMENT,89
2026,is,O,89
2027,a,O,89
2028,newly,O,89
2029,designed,O,89
2030,innovative,O,89
2031,lens,O,89
2032,with,O,89
2033,a,O,89
2034,nearly,O,89
2035,flat,O,89
2036,defocus,O,89
2037,curve,O,89
2038,and,O,89
2039,a,O,89
2040,squared,O,89
2041,and,O,89
2042,frosted,O,89
2043,haptic,O,89
2044,design,O,89
2045,which,O,89
2046,provides,O,89
2047,resistance,O,89
2048,to,O,89
2049,rotation,O,89
2050,common,O,89
2051,in,O,89
2052,astigmatism,B-NAME_OF_DISEASE,89
2053,The,O,90
2054,new,O,90
2055,lens,O,90
2056,outperforms,O,90
2057,existing,O,90
2058,PC-IOLs,B-TREATMENT,90
2059,on,O,90
2060,the,O,90
2061,market,O,90
2062,due,O,90
2063,to,O,90
2064,its,O,90
2065,key,O,90
2066,features,O,90
2067,which,O,90
2068,include,O,90
2069,A,O,90
2070,broad,O,90
2071,range,O,90
2072,of,O,90
2073,continuous,O,90
2074,vision,O,90
2075,Continuity,O,90
2076,without,O,90
2077,the,O,90
2078,visual,O,90
2079,gaps,O,90
2080,present,O,90
2081,in,O,90
2082,trifocal,O,90
2083,technology,O,90
2084,covering,O,90
2085,33,O,90
2086,cm,O,90
2087,to,O,90
2088,distance,O,90
2089,Superior,O,90
2090,low-light,O,90
2091,performance,O,90
2092,for,O,90
2093,reading,O,90
2094,in,O,90
2095,dim,O,90
2096,lighting,O,90
2097,The,O,90
2098,new,O,90
2099,CATALYS™,O,90
2100,System,O,90
2101,cOS,O,90
2102,6,O,90
2103,software,O,91
2104,with,O,91
2105,advanced,O,91
2106,astigmatism,B-NAME_OF_DISEASE,91
2107,management,O,91
2108,is,O,91
2109,a,O,91
2110,collaboration,O,91
2111,with,O,91
2112,Cassini,B-ORGANIZATION,91
2113,Technologies,I-ORGANIZATION,91
2114,B.V,O,91
2115,The,O,92
2116,new,O,92
2117,software,O,92
2118,simplifies,O,92
2119,astigmatism,B-NAME_OF_DISEASE,92
2120,management,O,92
2121,workﬂow,O,92
2122,and,O,92
2123,increases,O,92
2124,operational,O,92
2125,efficiency,O,92
2126,by,O,92
2127,Minimizing,O,92
2128,data,O,92
2129,entry,O,92
2130,verification,O,92
2131,and,O,92
2132,manual,O,92
2133,transcription,O,92
2134,errors,O,92
2135,through,O,92
2136,direct,O,92
2137,input,O,92
2138,of,O,92
2139,preoperative,O,92
2140,keratometry,O,92
2141,and,O,92
2142,steep,O,92
2143,axis,O,92
2144,values,O,92
2145,data,O,92
2146,Reducing,O,92
2147,time,O,92
2148,spent,O,92
2149,on,O,92
2150,calculations,O,92
2151,by,O,92
2152,including,O,92
2153,calculation,O,92
2154,of,O,92
2155,accurate,O,92
2156,incision,O,92
2157,parameters,O,92
2158,using,O,92
2159,a,O,92
2160,built-in,O,92
2161,nomogram,O,92
2162,and,O,92
2163,automatic,O,92
2164,input,O,92
2165,of,O,92
2166,accurate,O,92
2167,incision,O,92
2168,parameters,O,92
2169,into,O,92
2170,the,O,92
2171,treatment,O,92
2172,planning,O,92
2173,screen,O,92
2174,Reduces,O,92
2175,need,O,92
2176,for,O,92
2177,intraoperative,O,92
2178,aberrometry,O,92
2179,for,O,92
2180,Toric,B-TREATMENT,92
2181,IOL,I-TREATMENT,92
2182,alignment,O,92
2183,with,O,92
2184,radial,O,92
2185,laser,O,92
2186,marks,O,92
2187,placed,O,92
2188,within,O,92
2189,a,O,92
2190,mean,O,92
2191,accuracy,O,92
2192,of,O,92
2193,0.6,O,92
2194,provide,O,93
2195,5.5,O,93
2196,greater,O,94
2197,precision,O,94
2198,compared,O,94
2199,to,O,94
2200,the,O,94
2201,manual,O,94
2202,marking,O,94
2203,of,O,94
2204,the,B-PART_OF_THE_EYES,94
2205,cornea,I-PART_OF_THE_EYES,94
2206,with,O,94
2207,an,O,94
2208,ink,O,94
2209,pen,O,94
2210,mean,O,94
2211,accuracy,O,94
2212,3.3,O,94
2213,Iris,B-PART_OF_THE_EYES,95
2214,registration,O,95
2215,addition,O,95
2216,for,O,95
2217,automatic,O,95
2218,cyclorotation,O,95
2219,compensation,O,95
2220,through,O,95
2221,collaboration,O,95
2222,with,O,95
2223,Cassini,B-ORGANIZATION,95
2224,Technologies,I-ORGANIZATION,95
2225,Increased,O,95
2226,levels,O,95
2227,of,O,95
2228,solutions,O,95
2229,for,O,96
2230,treating,O,96
2231,astigmatism,B-NAME_OF_DISEASE,96
2232,-,O,96
2233,The,O,96
2234,introduction,O,96
2235,of,O,96
2236,the,O,96
2237,CATALYS™,O,96
2238,System,O,96
2239,cOS,O,96
2240,6,O,96
2241,along,O,96
2242,with,O,96
2243,the,B-TREATMENT,96
2244,TECNIS,B-TREATMENT,96
2245,Synergy™,I-TREATMENT,96
2246,Toric,I-TREATMENT,96
2247,II,I-TREATMENT,96
2248,IOL,I-TREATMENT,96
2249,means,O,96
2250,that,O,96
2251,ophthalmologists,O,96
2252,and,O,97
2253,patients,O,97
2254,now,O,97
2255,have,O,97
2256,an,O,97
2257,increased,O,97
2258,range,O,97
2259,of,O,97
2260,solutions,O,97
2261,for,O,97
2262,correcting,O,97
2263,astigmatism,B-NAME_OF_DISEASE,97
2264,Toric,B-TREATMENT,98
2265,IOLs,I-TREATMENT,98
2266,are,O,98
2267,an,O,98
2268,excellent,O,98
2269,option,O,98
2270,for,O,98
2271,correcting,O,98
2272,astigmatism,B-NAME_OF_DISEASE,98
2273,in,O,98
2274,cataract,B-NAME_OF_DISEASE,98
2275,patients,O,98
2276,Now,O,98
2277,these,O,98
2278,patients,O,98
2279,can,O,98
2280,have,O,98
2281,the,O,98
2282,most,O,98
2283,advanced,O,98
2284,premium,O,98
2285,IOL,B-TREATMENT,98
2286,on,O,98
2287,the,O,98
2288,market,O,98
2289,-,O,98
2290,allowing,O,98
2291,for,O,98
2292,high-quality,O,98
2293,continuous,O,98
2294,vision,O,98
2295,even,O,98
2296,in,O,98
2297,low-light,O,99
2298,conditions,O,99
2299,in,O,99
2300,the,O,99
2301,new,O,99
2302,and,O,99
2303,improved,O,100
2304,TECNIS,B-TREATMENT,100
2305,Synergy™,I-TREATMENT,100
2306,Toric,I-TREATMENT,100
2307,II,I-TREATMENT,100
2308,IOL,I-TREATMENT,100
2309,Besides,O,100
2310,the,O,100
2311,CATALYS™,O,100
2312,System,O,100
2313,cOS,O,100
2314,6,O,100
2315,means,O,100
2316,that,O,100
2317,ophthalmologists,O,100
2318,now,O,100
2319,have,O,100
2320,highly,O,100
2321,advanced,O,100
2322,software,O,100
2323,to,O,101
2324,assist,O,101
2325,with,O,101
2326,speed,O,101
2327,and,O,101
2328,accuracy,O,101
2329,across,O,101
2330,a,O,101
2331,range,O,101
2332,of,O,101
2333,astigmatism,B-NAME_OF_DISEASE,101
2334,procedures,O,101
2335,TECNIS,B-TREATMENT,101
2336,Synergy™,I-TREATMENT,101
2337,Toric,I-TREATMENT,101
2338,II,I-TREATMENT,101
2339,IOL,I-TREATMENT,101
2340,has,O,102
2341,European,O,102
2342,CE,O,102
2343,Mark,O,102
2344,and,O,103
2345,is,O,103
2346,now,O,103
2347,commercially,O,103
2348,available,O,103
2349,across,O,103
2350,the,B-GPE,103
2351,EU,I-GPE,103
2352,CATALYS™,O,103
2353,System,O,104
2354,cOS,O,104
2355,6,O,104
2356,will,O,104
2357,be,O,104
2358,commercially,O,104
2359,available,O,104
2360,in,O,104
2361,EMEA,B-GPE,104
2362,from,O,104
2363,Q4,O,104
2364,2020,O,104
2365,About,O,104
2366,Cataracts,B-NAME_OF_DISEASE,104
2367,and,O,104
2368,Presbyopia,B-NAME_OF_DISEASE,105
2369,Cataracts,B-NAME_OF_DISEASE,105
2370,are,O,105
2371,known,O,105
2372,to,O,105
2373,be,O,105
2374,the,O,105
2375,leading,O,105
2376,cause,O,105
2377,of,O,105
2378,blindness,B-NAME_OF_DISEASE,105
2379,globally,O,106
2380,More,O,106
2381,than,O,106
2382,85,O,106
2383,percent,O,106
2384,of,O,106
2385,people,O,106
2386,develop,O,106
2387,cataracts,B-NAME_OF_DISEASE,106
2388,by,O,106
2389,age,O,106
2390,60,O,107
2391,In,O,107
2392,case,O,107
2393,not,O,107
2394,treated,O,107
2395,cataracts,B-NAME_OF_DISEASE,107
2396,cause,O,107
2397,vision,B-SIGN_AND_SYMPTOM,107
2398,to,I-SIGN_AND_SYMPTOM,107
2399,deteriorate,I-SIGN_AND_SYMPTOM,107
2400,over,I-SIGN_AND_SYMPTOM,107
2401,time,I-SIGN_AND_SYMPTOM,107
2402,Cataract,B-TREATMENT,107
2403,surgery,I-TREATMENT,107
2404,is,O,107
2405,the,O,107
2406,most,O,107
2407,common,O,107
2408,surgery,O,107
2409,performed,O,107
2410,around,O,107
2411,the,O,107
2412,world,O,108
2413,including,O,108
2414,more,O,108
2415,than,O,108
2416,4,O,108
2417,million,O,108
2418,times,O,108
2419,in,O,108
2420,the,B-GPE,108
2421,EU,I-GPE,108
2422,in,O,108
2423,2016,O,108
2424,Also,O,108
2425,Presbyopia,B-NAME_OF_DISEASE,108
2426,is,O,109
2427,indeed,O,109
2428,what,O,109
2429,many,O,109
2430,people,O,109
2431,who,O,109
2432,have,O,109
2433,cataracts,B-NAME_OF_DISEASE,109
2434,experience,O,109
2435,with,O,109
2436,their,O,109
2437,vision,O,109
2438,Cataract,B-TREATMENT,109
2439,surgery,I-TREATMENT,110
2440,is,O,110
2441,a,O,110
2442,unique,O,110
2443,opportunity,O,110
2444,to,O,110
2445,address,O,110
2446,presbyopia,B-NAME_OF_DISEASE,110
2447,without,O,110
2448,an,O,110
2449,additional,O,110
2450,procedure,O,110
2451,Presbyopia,B-NAME_OF_DISEASE,110
2452,is,O,110
2453,a,O,110
2454,progressive,O,110
2455,eye,O,110
2456,condition,O,110
2457,which,O,110
2458,makes,O,110
2459,it,O,110
2460,difficult,B-SIGN_AND_SYMPTOM,110
2461,to,I-SIGN_AND_SYMPTOM,110
2462,focus,I-SIGN_AND_SYMPTOM,110
2463,on,I-SIGN_AND_SYMPTOM,111
2464,close,I-SIGN_AND_SYMPTOM,111
2465,objects,I-SIGN_AND_SYMPTOM,111
2466,and,O,111
2467,usually,O,111
2468,becomes,O,111
2469,noticeable,O,111
2470,around,O,111
2471,40,O,111
2472,years,O,111
2473,of,O,111
2474,age,O,111
2475,Ocugen,B-ORGANIZATION,111
2476,Receives,O,111
2477,Fourth,O,111
2478,FDA,B-ORGANIZATION,111
2479,Orphan,O,111
2480,Drug,O,111
2481,Designation,O,111
2482,for,O,111
2483,the,O,111
2484,Same,O,111
2485,Product,O,111
2486,OCU400,B-TREATMENT,111
2487,AAV-NR2E3,I-TREATMENT,111
2488,Gene,I-TREATMENT,111
2489,Therapy,I-TREATMENT,111
2490,for,O,111
2491,the,O,111
2492,Treatment,O,111
2493,of,O,112
2494,Another,O,112
2495,Key,O,112
2496,Inherited,B-NAME_OF_DISEASE,112
2497,Retinal,I-NAME_OF_DISEASE,112
2498,Disease,I-NAME_OF_DISEASE,112
2499,IRD,I-NAME_OF_DISEASE,112
2500,PDE6B,B-NAME_OF_DISEASE,112
2501,Gene,I-NAME_OF_DISEASE,112
2502,Mutation-Associated,I-NAME_OF_DISEASE,112
2503,Retinal,I-NAME_OF_DISEASE,112
2504,Diseases,I-NAME_OF_DISEASE,112
2505,Fourth,O,112
2506,orphan,O,112
2507,drug,O,112
2508,designation,O,112
2509,for,O,112
2510,the,O,112
2511,same,O,112
2512,product,O,112
2513,OCU400,B-TREATMENT,112
2514,is,O,112
2515,distinct,O,112
2516,in,O,112
2517,Ophthalmology,O,112
2518,gene,O,112
2519,therapy,O,112
2520,and,O,112
2521,demonstrates,O,112
2522,its,O,113
2523,potential,O,113
2524,to,O,113
2525,treat,O,113
2526,many,O,113
2527,Inherited,B-NAME_OF_DISEASE,113
2528,Retinal,I-NAME_OF_DISEASE,113
2529,Diseases,I-NAME_OF_DISEASE,113
2530,Ocugen,B-ORGANIZATION,113
2531,announced,O,113
2532,the,O,113
2533,U.S,O,113
2534,Food,B-ORGANIZATION,113
2535,and,I-ORGANIZATION,113
2536,Drug,I-ORGANIZATION,113
2537,Administration,I-ORGANIZATION,113
2538,FDA,I-ORGANIZATION,113
2539,granted,O,113
2540,the,O,113
2541,fourth,O,113
2542,Orphan,O,113
2543,Drug,O,113
2544,Designation,O,113
2545,ODD,O,114
2546,for,O,114
2547,OCU400,B-TREATMENT,114
2548,in,O,114
2549,the,O,114
2550,treatment,O,114
2551,of,O,114
2552,PDE6B,B-NAME_OF_DISEASE,114
2553,gene,I-NAME_OF_DISEASE,114
2554,mutation-associated,I-NAME_OF_DISEASE,114
2555,retinal,I-NAME_OF_DISEASE,114
2556,diseases,I-NAME_OF_DISEASE,114
2557,Retinitis,B-NAME_OF_DISEASE,114
2558,Pigmentosa,I-NAME_OF_DISEASE,114
2559,RP,I-NAME_OF_DISEASE,114
2560,caused,O,114
2561,by,O,114
2562,PDE6B,B-CAUSE_OF_DISEASE,114
2563,mutation,I-CAUSE_OF_DISEASE,114
2564,is,O,114
2565,an,O,114
2566,inherited,O,114
2567,retinal,O,114
2568,dystrophy,O,114
2569,that,O,114
2570,leads,O,114
2571,to,O,114
2572,blindness,B-NAME_OF_DISEASE,114
2573,by,O,114
2574,midlife,O,114
2575,and,O,114
2576,is,O,114
2577,characterized,O,114
2578,by,O,114
2579,the,B-SIGN_AND_SYMPTOM,114
2580,progressive,I-SIGN_AND_SYMPTOM,114
2581,loss,I-SIGN_AND_SYMPTOM,114
2582,of,I-SIGN_AND_SYMPTOM,115
2583,photoreceptors,I-SIGN_AND_SYMPTOM,115
2584,with,I-SIGN_AND_SYMPTOM,115
2585,or,I-SIGN_AND_SYMPTOM,115
2586,without,I-SIGN_AND_SYMPTOM,115
2587,the,I-SIGN_AND_SYMPTOM,115
2588,loss,I-SIGN_AND_SYMPTOM,115
2589,of,I-SIGN_AND_SYMPTOM,115
2590,retinal,I-SIGN_AND_SYMPTOM,115
2591,pigment,I-SIGN_AND_SYMPTOM,115
2592,epithelium,I-SIGN_AND_SYMPTOM,115
2593,cells,I-SIGN_AND_SYMPTOM,115
2594,At,B-CAUSE_OF_DISEASE,115
2595,least,I-CAUSE_OF_DISEASE,115
2596,one,I-CAUSE_OF_DISEASE,115
2597,mutation,I-CAUSE_OF_DISEASE,115
2598,in,I-CAUSE_OF_DISEASE,115
2599,the,I-CAUSE_OF_DISEASE,115
2600,PDE6B,I-CAUSE_OF_DISEASE,115
2601,gene,I-CAUSE_OF_DISEASE,115
2602,has,O,115
2603,been,O,115
2604,found,O,115
2605,to,O,115
2606,cause,O,115
2607,autosomal,B-NAME_OF_DISEASE,115
2608,dominant,I-NAME_OF_DISEASE,115
2609,congenital,I-NAME_OF_DISEASE,115
2610,stationary,I-NAME_OF_DISEASE,115
2611,night,I-NAME_OF_DISEASE,115
2612,blindness,I-NAME_OF_DISEASE,116
2613,which,O,116
2614,is,O,116
2615,characterized,O,116
2616,by,O,116
2617,the,B-SIGN_AND_SYMPTOM,116
2618,inability,I-SIGN_AND_SYMPTOM,116
2619,to,I-SIGN_AND_SYMPTOM,116
2620,see,I-SIGN_AND_SYMPTOM,116
2621,in,I-SIGN_AND_SYMPTOM,116
2622,low,I-SIGN_AND_SYMPTOM,116
2623,light,I-SIGN_AND_SYMPTOM,116
2624,Ocugen,B-ORGANIZATION,116
2625,s,O,116
2626,Modifier,B-TREATMENT,116
2627,Gene,I-TREATMENT,116
2628,Therapy,I-TREATMENT,116
2629,Platform,I-TREATMENT,116
2630,offers,O,116
2631,a,O,116
2632,unique,O,117
2633,approach,O,117
2634,in,O,117
2635,ophthalmology,O,117
2636,by,O,117
2637,addressing,O,117
2638,multiple,O,117
2639,diseases,O,117
2640,with,O,117
2641,a,O,117
2642,single,O,117
2643,product,O,117
2644,A,O,117
2645,novel,O,117
2646,gene,O,117
2647,therapy,O,117
2648,product,O,117
2649,candidate,O,117
2650,OCU400,B-TREATMENT,117
2651,has,O,117
2652,the,O,117
2653,potential,O,117
2654,to,O,117
2655,be,O,117
2656,broadly,O,117
2657,effective,O,117
2658,in,O,117
2659,restoring,O,117
2660,retinal,O,117
2661,integrity,O,118
2662,and,O,118
2663,function,O,118
2664,across,O,118
2665,a,O,118
2666,range,O,118
2667,of,O,118
2668,genetically,O,118
2669,diverse,O,118
2670,inherited,B-NAME_OF_DISEASE,118
2671,retinal,I-NAME_OF_DISEASE,118
2672,diseases,I-NAME_OF_DISEASE,118
2673,It,O,118
2674,consists,O,118
2675,of,O,118
2676,a,O,118
2677,functional,O,118
2678,copy,O,118
2679,of,O,118
2680,a,O,118
2681,nuclear,B-CHEMICAL_COMPOUND,118
2682,hormone,I-CHEMICAL_COMPOUND,118
2683,receptor,I-CHEMICAL_COMPOUND,118
2684,NHR,I-CHEMICAL_COMPOUND,118
2685,gene,I-CHEMICAL_COMPOUND,118
2686,NR2E3,B-CHEMICAL_COMPOUND,118
2687,delivered,O,119
2688,to,O,119
2689,target,O,119
2690,cells,O,119
2691,in,O,119
2692,the,B-PART_OF_THE_EYES,119
2693,retina,I-PART_OF_THE_EYES,119
2694,using,O,119
2695,an,B-CHEMICAL_COMPOUND,119
2696,adeno-associated,I-CHEMICAL_COMPOUND,119
2697,viral,I-CHEMICAL_COMPOUND,119
2698,vector,I-CHEMICAL_COMPOUND,119
2699,As,O,119
2700,a,O,119
2701,potent,O,119
2702,modifier,O,119
2703,gene,O,119
2704,expression,O,119
2705,of,O,119
2706,NR2E3,B-CHEMICAL_COMPOUND,119
2707,within,O,119
2708,the,B-PART_OF_THE_EYES,119
2709,retina,I-PART_OF_THE_EYES,119
2710,may,O,119
2711,help,O,119
2712,reset,O,119
2713,retinal,O,119
2714,homeostasis,O,119
2715,and,O,119
2716,potentially,O,119
2717,offer,O,120
2718,longer,O,120
2719,benefit,O,120
2720,stabilizing,O,120
2721,cells,O,120
2722,and,O,120
2723,rescuing,O,120
2724,photoreceptor,B-SIGN_AND_SYMPTOM,120
2725,degeneration,I-SIGN_AND_SYMPTOM,120
2726,and,I-SIGN_AND_SYMPTOM,120
2727,vision,I-SIGN_AND_SYMPTOM,120
2728,loss,I-SIGN_AND_SYMPTOM,120
2729,In,O,120
2730,pre-clinical,O,120
2731,studies,O,120
2732,OCU400,B-TREATMENT,120
2733,has,O,120
2734,demonstrated,O,120
2735,improved,O,120
2736,vision,O,120
2737,signals,O,120
2738,in,O,120
2739,the,B-PART_OF_THE_EYES,120
2740,retina,I-PART_OF_THE_EYES,120
2741,where,O,120
2742,Electroretinogram,B-DIAGNOSTIC_TEST,120
2743,response,O,120
2744,reveals,O,121
2745,rescue,O,121
2746,under,O,121
2747,both,O,121
2748,Scotopic,O,121
2749,dim-lit,O,121
2750,as,O,121
2751,well,O,121
2752,as,O,121
2753,Photopic,O,121
2754,well-lit,O,121
2755,conditions,O,121
2756,The,O,121
2757,Company,O,121
2758,believes,O,121
2759,targeting,O,121
2760,multiple,O,121
2761,diseases,O,121
2762,with,O,121
2763,one,O,121
2764,product,O,121
2765,could,O,121
2766,also,O,121
2767,offer,O,121
2768,a,O,121
2769,smoother,O,121
2770,regulatory,O,121
2771,pathway,O,122
2772,and,O,122
2773,the,O,122
2774,ability,O,122
2775,to,O,122
2776,recover,O,122
2777,development,O,122
2778,costs,O,122
2779,over,O,122
2780,multiple,O,122
2781,therapeutic,O,122
2782,indications,O,122
2783,Ocugen,B-ORGANIZATION,122
2784,is,O,122
2785,planning,O,122
2786,to,O,122
2787,initiate,O,122
2788,two,O,122
2789,parallel,O,123
2790,Phase,O,123
2791,I,O,123
2792,II,O,123
2793,clinical,O,123
2794,trials,O,123
2795,next,O,123
2796,year,O,123
2797,targeting,O,123
2798,two,O,123
2799,unique,O,123
2800,IRDs,B-NAME_OF_DISEASE,123
2801,Following,O,123
2802,up,O,123
2803,on,O,123
2804,recent,O,123
2805,announcement,O,123
2806,of,O,123
2807,an,O,123
2808,ODD,O,123
2809,for,O,123
2810,RHO,B-NAME_OF_DISEASE,123
2811,mutation-associated,I-NAME_OF_DISEASE,123
2812,retinal,I-NAME_OF_DISEASE,123
2813,degeneration,I-NAME_OF_DISEASE,123
2814,and,O,123
2815,previous,O,123
2816,ODDs,O,123
2817,for,O,123
2818,both,O,123
2819,NR2E3,B-NAME_OF_DISEASE,123
2820,and,I-NAME_OF_DISEASE,123
2821,CEP290,I-NAME_OF_DISEASE,123
2822,mutation-associated,I-NAME_OF_DISEASE,123
2823,retinal,I-NAME_OF_DISEASE,123
2824,degeneration,I-NAME_OF_DISEASE,123
2825,the,O,123
2826,ODD,O,123
2827,for,O,123
2828,PDE6B,B-NAME_OF_DISEASE,123
2829,gene,I-NAME_OF_DISEASE,123
2830,mutation-associated,I-NAME_OF_DISEASE,123
2831,retinal,I-NAME_OF_DISEASE,123
2832,degeneration,I-NAME_OF_DISEASE,123
2833,continues,O,123
2834,to,O,123
2835,support,O,123
2836,Ocugen,B-ORGANIZATION,123
2837,s,O,123
2838,breakthrough,O,123
2839,modifier,B-TREATMENT,123
2840,gene,I-TREATMENT,123
2841,therapy,I-TREATMENT,123
2842,platform,I-TREATMENT,124
2843,s,O,124
2844,potential,O,124
2845,to,O,124
2846,treat,O,124
2847,multiple,O,124
2848,blindness,B-NAME_OF_DISEASE,124
2849,diseases,I-NAME_OF_DISEASE,124
2850,with,O,124
2851,a,O,124
2852,single,O,124
2853,product,O,124
2854,RP,B-NAME_OF_DISEASE,124
2855,is,O,124
2856,a,O,124
2857,group,O,124
2858,of,O,124
2859,heterogenic,B-NAME_OF_DISEASE,124
2860,inherited,I-NAME_OF_DISEASE,125
2861,retinal,I-NAME_OF_DISEASE,125
2862,diseases,I-NAME_OF_DISEASE,125
2863,associated,O,126
2864,with,O,126
2865,over,O,126
2866,150,O,126
2867,gene,O,126
2868,mutations,O,126
2869,affecting,O,126
2870,over,O,126
2871,1,O,126
2872,million,O,126
2873,individuals,O,126
2874,worldwide,O,126
2875,In,O,126
2876,addition,O,126
2877,40%,O,126
2878,of,O,126
2879,RP,B-NAME_OF_DISEASE,126
2880,patients,O,126
2881,cannot,O,127
2882,be,O,127
2883,genetically,O,127
2884,diagnosed,O,127
2885,confounding,O,127
2886,the,O,127
2887,ability,O,127
2888,to,O,127
2889,develop,O,127
2890,personalized,O,127
2891,RP,B-NAME_OF_DISEASE,127
2892,therapies,O,127
2893,Traditional,O,127
2894,gene,O,127
2895,therapy,O,127
2896,or,O,127
2897,gene,O,127
2898,editing,O,127
2899,approaches,O,127
2900,may,O,127
2901,require,O,128
2902,more,O,128
2903,than,O,128
2904,150,O,128
2905,products,O,128
2906,to,O,128
2907,rescue,O,128
2908,these,O,128
2909,patients,O,128
2910,from,O,128
2911,vision,B-SIGN_AND_SYMPTOM,128
2912,loss,I-SIGN_AND_SYMPTOM,129
2913,OCU400,B-TREATMENT,129
2914,a,O,129
2915,single,O,129
2916,product,O,129
2917,candidate,O,129
2918,has,O,129
2919,potential,O,129
2920,to,O,129
2921,address,O,129
2922,broad-spectrum,O,129
2923,RP,B-NAME_OF_DISEASE,129
2924,As,O,129
2925,principal,O,129
2926,investigator,O,129
2927,of,O,129
2928,numerous,O,129
2929,major,O,129
2930,clinical,O,129
2931,trials,O,129
2932,developing,O,129
2933,new,O,129
2934,medical,O,129
2935,and,O,129
2936,surgical,O,129
2937,treatments,O,129
2938,for,O,129
2939,retinal,O,129
2940,disorders,O,130
2941,I,O,130
2942,have,O,130
2943,been,O,130
2944,on,O,130
2945,the,O,130
2946,cutting-edge,O,130
2947,of,O,130
2948,many,O,130
2949,new,O,130
2950,ophthalmology,O,130
2951,treatments,O,130
2952,I,O,130
2953,am,O,130
2954,very,O,130
2955,encouraged,O,130
2956,by,O,130
2957,the,O,130
2958,potential,O,130
2959,for,O,130
2960,OCU400,B-TREATMENT,130
2961,given,O,130
2962,the,O,130
2963,uniqueness,O,130
2964,of,O,130
2965,Ocugen,B-ORGANIZATION,130
2966,s,O,130
2967,Modifier,B-TREATMENT,130
2968,Gene,I-TREATMENT,130
2969,Therapy,I-TREATMENT,130
2970,Platform,I-TREATMENT,130
2971,and,O,131
2972,the,O,131
2973,fact,O,131
2974,that,O,131
2975,FDA,B-ORGANIZATION,131
2976,has,O,131
2977,issued,O,131
2978,four,O,131
2979,ODDs,O,131
2980,for,O,131
2981,this,O,131
2982,product,O,131
2983,I,O,131
2984,look,O,131
2985,forward,O,131
2986,to,O,131
2987,Ocugen,B-ORGANIZATION,131
2988,commencing,O,131
2989,clinical,O,131
2990,trials,O,131
2991,for,O,131
2992,OCU400,B-TREATMENT,131
2993,next,O,131
2994,year,O,131
2995,and,O,131
2996,the,O,131
2997,potential,O,131
2998,of,O,131
2999,helping,O,131
3000,patients,O,131
3001,by,O,131
3002,restoring,O,131
3003,retinal,O,131
3004,integrity,O,131
3005,and,O,131
3006,function,O,131
3007,across,O,131
3008,a,O,131
3009,range,O,131
3010,of,O,132
3011,genetically,B-NAME_OF_DISEASE,132
3012,diverse,I-NAME_OF_DISEASE,133
3013,inherited,I-NAME_OF_DISEASE,134
3014,retinal,I-NAME_OF_DISEASE,134
3015,diseases,I-NAME_OF_DISEASE,134
3016,including,O,134
3017,broad-spectrum,O,134
3018,RP,B-NAME_OF_DISEASE,134
3019,said,O,134
3020,Carl,O,134
3021,D,O,134
3022,Regillo,O,134
3023,M.D,O,134
3024,F.A.C.S,O,134
3025,member,O,134
3026,of,O,134
3027,Ocugen,B-ORGANIZATION,134
3028,s,I-ORGANIZATION,134
3029,Retina,I-ORGANIZATION,134
3030,Scientific,I-ORGANIZATION,134
3031,Advisory,I-ORGANIZATION,134
3032,Board,I-ORGANIZATION,134
3033,and,O,134
3034,Professor,O,134
3035,of,O,134
3036,Ophthalmology,O,134
3037,at,O,134
3038,the,O,134
3039,Sidney,B-ORGANIZATION,134
3040,Kimmel,I-ORGANIZATION,134
3041,Medical,I-ORGANIZATION,134
3042,College,I-ORGANIZATION,134
3043,at,I-ORGANIZATION,134
3044,Thomas,I-ORGANIZATION,134
3045,Jefferson,I-ORGANIZATION,134
3046,University,I-ORGANIZATION,134
3047,Chief,O,134
3048,of,O,134
3049,the,O,134
3050,Retina,O,134
3051,Service,O,134
3052,at,O,134
3053,Wills,B-ORGANIZATION,134
3054,Eye,I-ORGANIZATION,134
3055,Hospital,I-ORGANIZATION,134
3056,and,O,134
3057,founder,O,134
3058,and,O,134
3059,former,O,135
3060,director,O,135
3061,of,O,135
3062,the,B-ORGANIZATION,135
3063,Wills,I-ORGANIZATION,135
3064,Eye,I-ORGANIZATION,135
3065,Clinical,I-ORGANIZATION,135
3066,Retina,I-ORGANIZATION,135
3067,Research,I-ORGANIZATION,135
3068,Unit,I-ORGANIZATION,135
3069,in,O,135
3070,Philadelphia,B-GPE,135
3071,I,O,135
3072,am,O,135
3073,thrilled,O,135
3074,to,O,135
3075,announce,O,135
3076,our,O,135
3077,fourth,O,135
3078,ODD,O,135
3079,for,O,135
3080,OCU400,B-TREATMENT,135
3081,from,O,135
3082,the,B-ORGANIZATION,135
3083,FDA,I-ORGANIZATION,135
3084,after,O,135
3085,announcing,O,135
3086,our,O,135
3087,third,O,136
3088,ODD,O,136
3089,for,O,136
3090,RHO,B-NAME_OF_DISEASE,136
3091,mutation-associated,I-NAME_OF_DISEASE,136
3092,retinal,I-NAME_OF_DISEASE,136
3093,degeneration,I-NAME_OF_DISEASE,136
3094,just,O,136
3095,a,O,136
3096,few,O,136
3097,days,O,136
3098,ago,O,136
3099,With,O,136
3100,no,O,136
3101,approved,O,136
3102,treatments,O,136
3103,that,O,136
3104,slow,O,136
3105,or,O,136
3106,stop,O,136
3107,the,O,136
3108,progression,O,136
3109,of,O,136
3110,RP,B-NAME_OF_DISEASE,136
3111,we,O,136
3112,are,O,136
3113,dedicated,O,136
3114,to,O,136
3115,driving,O,136
3116,the,O,136
3117,development,O,136
3118,of,O,136
3119,our,O,136
3120,Modifier,B-TREATMENT,136
3121,Gene,I-TREATMENT,136
3122,Therapy,I-TREATMENT,136
3123,Platform,I-TREATMENT,136
3124,forward,O,136
3125,and,O,136
3126,potentially,O,136
3127,addressing,O,136
3128,the,O,136
3129,unmet,O,136
3130,need,O,136
3131,of,O,136
3132,multiple,O,136
3133,gene,O,136
3134,mutations,O,136
3135,including,O,137
3136,mutations,O,137
3137,in,O,137
3138,the,B-CHEMICAL_COMPOUND,137
3139,PDE6B,I-CHEMICAL_COMPOUND,137
3140,gene,I-CHEMICAL_COMPOUND,137
3141,with,O,137
3142,only,O,137
3143,one,O,137
3144,product,O,137
3145,said,O,138
3146,Dr,O,138
3147,Shankar,O,138
3148,Musunuri,O,138
3149,Chairman,O,138
3150,Chief,O,138
3151,Executive,O,138
3152,Officer,O,138
3153,and,O,138
3154,Co-Founder,O,138
3155,of,O,138
3156,Ocugen,B-ORGANIZATION,138
3157,The,B-ORGANIZATION,138
3158,FDA,I-ORGANIZATION,138
3159,Office,I-ORGANIZATION,138
3160,of,I-ORGANIZATION,138
3161,Orphan,I-ORGANIZATION,138
3162,Products,I-ORGANIZATION,138
3163,Development,I-ORGANIZATION,138
3164,grants,O,138
3165,orphan,O,138
3166,designation,O,138
3167,for,O,138
3168,novel,O,138
3169,drugs,O,138
3170,or,O,138
3171,biologics,O,138
3172,that,O,138
3173,treat,O,138
3174,a,O,138
3175,rare,O,138
3176,disease,O,139
3177,or,O,139
3178,condition,O,139
3179,affecting,O,139
3180,fewer,O,139
3181,than,O,139
3182,200,O,139
3183,0,O,139
3184,patients,O,139
3185,in,O,139
3186,the,O,139
3187,U.S,O,139
3188,Orphan,O,139
3189,designation,O,139
3190,qualifies,O,139
3191,the,O,139
3192,sponsor,O,139
3193,of,O,139
3194,the,O,139
3195,drug,O,139
3196,for,O,139
3197,various,O,139
3198,development,O,139
3199,incentives,O,140
3200,of,O,140
3201,the,O,140
3202,Orphan,O,140
3203,Drug,O,140
3204,Act,O,140
3205,including,O,140
3206,a,O,140
3207,seven-year,B-TIME_DURATION,140
3208,period,O,140
3209,of,O,140
3210,U.S,O,140
3211,marketing,O,140
3212,exclusivity,O,140
3213,tax,O,140
3214,credits,O,140
3215,for,O,140
3216,clinical,O,140
3217,research,O,140
3218,costs,O,140
3219,clinical,O,140
3220,research,O,140
3221,trial,O,140
3222,design,O,140
3223,assistance,O,140
3224,the,O,140
3225,ability,O,140
3226,to,O,140
3227,apply,O,140
3228,for,O,140
3229,annual,O,140
3230,grant,O,141
3231,funding,O,141
3232,and,O,141
3233,waiver,O,141
3234,of,O,141
3235,Prescription,O,141
3236,Drug,O,141
3237,User,O,141
3238,Fee,O,141
3239,Act,O,141
3240,filing,O,141
3241,fees,O,141
3242,About,O,141
3243,OCU400,B-TREATMENT,141
3244,OCU400,B-TREATMENT,141
3245,AAV-hNR2E3,I-TREATMENT,141
3246,is,O,141
3247,a,O,141
3248,novel,O,141
3249,gene,O,141
3250,therapy,O,141
3251,product,O,141
3252,candidate,O,141
3253,with,O,141
3254,the,O,141
3255,potential,O,141
3256,to,O,141
3257,be,O,141
3258,broadly,O,141
3259,effective,O,141
3260,in,O,141
3261,restoring,O,141
3262,retinal,O,141
3263,integrity,O,142
3264,and,O,142
3265,function,O,142
3266,across,O,142
3267,a,O,142
3268,range,O,142
3269,of,O,142
3270,genetically,B-NAME_OF_DISEASE,142
3271,diverse,I-NAME_OF_DISEASE,142
3272,inherited,I-NAME_OF_DISEASE,142
3273,retinal,I-NAME_OF_DISEASE,142
3274,diseases,I-NAME_OF_DISEASE,142
3275,It,O,142
3276,consists,O,142
3277,of,O,142
3278,a,O,142
3279,functional,O,142
3280,copy,O,142
3281,of,O,142
3282,a,B-CHEMICAL_COMPOUND,142
3283,nuclear,I-CHEMICAL_COMPOUND,142
3284,hormone,I-CHEMICAL_COMPOUND,142
3285,receptor,I-CHEMICAL_COMPOUND,142
3286,gene,I-CHEMICAL_COMPOUND,142
3287,NR2E3,B-CHEMICAL_COMPOUND,142
3288,delivered,O,143
3289,to,O,143
3290,target,O,143
3291,cells,O,143
3292,in,O,143
3293,the,B-PART_OF_THE_EYES,143
3294,retina,I-PART_OF_THE_EYES,143
3295,using,O,143
3296,an,B-CHEMICAL_COMPOUND,143
3297,adeno-associated,I-CHEMICAL_COMPOUND,143
3298,viral,I-CHEMICAL_COMPOUND,143
3299,vector,I-CHEMICAL_COMPOUND,143
3300,As,O,143
3301,a,O,143
3302,potent,O,143
3303,modifier,O,143
3304,gene,O,143
3305,expression,O,143
3306,of,O,143
3307,NR2E3,B-CHEMICAL_COMPOUND,143
3308,within,O,143
3309,the,B-PART_OF_THE_EYES,143
3310,retina,I-PART_OF_THE_EYES,143
3311,may,O,143
3312,help,O,143
3313,reset,O,143
3314,retinal,O,144
3315,homeostasis,O,144
3316,potentially,O,144
3317,stabilizing,O,144
3318,cells,O,144
3319,and,O,144
3320,rescuing,O,144
3321,photoreceptor,B-SIGN_AND_SYMPTOM,144
3322,degeneration,I-SIGN_AND_SYMPTOM,144
3323,and,I-SIGN_AND_SYMPTOM,144
3324,vision,I-SIGN_AND_SYMPTOM,144
3325,loss,I-SIGN_AND_SYMPTOM,144
3326,jCell,B-TREATMENT,144
3327,is,O,144
3328,a,O,144
3329,first-in-class,O,144
3330,investigational,O,144
3331,treatment,O,144
3332,for,O,145
3333,RP,B-NAME_OF_DISEASE,145
3334,which,O,145
3335,has,O,145
3336,received,O,145
3337,FDA,B-ORGANIZATION,145
3338,Regenerative,O,145
3339,Medicine,O,145
3340,Advanced,O,145
3341,Therapy,O,145
3342,RMAT,O,145
3343,designation,O,145
3344,In,O,145
3345,addition,O,145
3346,to,O,145
3347,RMAT,O,145
3348,jCell,B-TREATMENT,145
3349,has,O,145
3350,received,O,145
3351,Orphan,O,145
3352,Drug,O,146
3353,designation,O,146
3354,from,O,146
3355,the,B-ORGANIZATION,146
3356,FDA,I-ORGANIZATION,146
3357,and,O,146
3358,the,B-ORGANIZATION,146
3359,European,I-ORGANIZATION,146
3360,Medicines,I-ORGANIZATION,146
3361,Agency,I-ORGANIZATION,146
3362,EMA,I-ORGANIZATION,146
3363,,O,146
3364,The,O,146
3365,phase,O,146
3366,2b,O,146
3367,trial,O,146
3368,was,O,146
3369,a,O,146
3370,multicenter,O,146
3371,randomized,O,146
3372,study,O,146
3373,that,O,146
3374,evaluated,O,146
3375,the,O,146
3376,safety,O,146
3377,and,O,146
3378,efficacy,O,147
3379,of,O,147
3380,intravitreal,O,147
3381,injection,O,147
3382,of,O,147
3383,jCell,B-TREATMENT,147
3384,therapy,I-TREATMENT,147
3385,in,O,147
3386,adult,O,147
3387,subjects,O,147
3388,with,O,147
3389,RP,B-NAME_OF_DISEASE,147
3390,A,O,147
3391,large,O,147
3392,and,O,147
3393,broad,O,147
3394,set,O,147
3395,of,O,147
3396,patients,O,147
3397,with,O,147
3398,RP,B-NAME_OF_DISEASE,147
3399,with,O,147
3400,best-corrected,B-DIAGNOSTIC_TEST,147
3401,visual,I-DIAGNOSTIC_TEST,147
3402,acuity,I-DIAGNOSTIC_TEST,147
3403,BCVA,B-DIAGNOSTIC_TEST,147
3404,between,O,148
3405,20,O,148
3406,80,O,148
3407,and,O,148
3408,20,O,148
3409,800,O,148
3410,were,O,148
3411,randomized,O,148
3412,to,O,148
3413,treatment,O,148
3414,versus,O,148
3415,sham,O,148
3416,Treatment,O,148
3417,consisted,O,148
3418,of,O,148
3419,a,B-TREATMENT,148
3420,single,I-TREATMENT,148
3421,intravitreal,I-TREATMENT,148
3422,injection,I-TREATMENT,148
3423,of,I-TREATMENT,149
3424,either,I-TREATMENT,149
3425,3,I-TREATMENT,149
3426,or,I-TREATMENT,149
3427,6,I-TREATMENT,149
3428,million,I-TREATMENT,149
3429,human,I-TREATMENT,149
3430,retinal,I-TREATMENT,149
3431,progenitor,I-TREATMENT,149
3432,cells,I-TREATMENT,149
3433,hRPC,I-TREATMENT,149
3434,,O,149
3435,The,O,149
3436,study,O,149
3437,evaluated,O,149
3438,changes,O,149
3439,in,O,149
3440,visual,O,149
3441,function,O,149
3442,and,O,149
3443,functional,O,149
3444,vision,O,149
3445,in,O,149
3446,subjects,O,149
3447,with,O,149
3448,RP,B-NAME_OF_DISEASE,149
3449,who,O,149
3450,received,O,150
3451,a,O,150
3452,single,O,150
3453,jCell,B-TREATMENT,150
3454,injection,O,150
3455,in,O,150
3456,comparison,O,150
3457,to,O,150
3458,a,O,150
3459,sham-treated,O,150
3460,control,O,150
3461,group,O,150
3462,The,O,150
3463,primary,O,150
3464,endpoint,O,150
3465,in,O,150
3466,the,O,150
3467,phase,O,150
3468,2b,O,150
3469,study,O,150
3470,was,O,150
3471,mean,O,150
3472,change,O,151
3473,in,O,151
3474,best,B-DIAGNOSTIC_TEST,151
3475,corrected,I-DIAGNOSTIC_TEST,151
3476,visual,I-DIAGNOSTIC_TEST,151
3477,acuity,I-DIAGNOSTIC_TEST,151
3478,BCVA,B-DIAGNOSTIC_TEST,151
3479,from,O,151
3480,baseline,O,151
3481,to,O,151
3482,month,O,151
3483,12,O,151
3484,Secondary,O,151
3485,endpoints,O,151
3486,included,O,151
3487,low,B-DIAGNOSTIC_TEST,151
3488,light,I-DIAGNOSTIC_TEST,152
3489,mobility,I-DIAGNOSTIC_TEST,152
3490,contrast,B-DIAGNOSTIC_TEST,152
3491,sensitivity,I-DIAGNOSTIC_TEST,152
3492,kinetic,B-DIAGNOSTIC_TEST,152
3493,visual,I-DIAGNOSTIC_TEST,152
3494,fields,I-DIAGNOSTIC_TEST,152
3495,and,O,152
3496,a,B-DIAGNOSTIC_TEST,152
3497,visual,I-DIAGNOSTIC_TEST,152
3498,function,I-DIAGNOSTIC_TEST,152
3499,questionnaire,I-DIAGNOSTIC_TEST,152
3500,In,O,152
3501,a,O,152
3502,post,O,152
3503,hoc,O,152
3504,exploratory,O,152
3505,analysis,O,152
3506,the,O,152
3507,primary,O,152
3508,and,O,152
3509,secondary,O,152
3510,endpoints,O,152
3511,were,O,152
3512,assessed,O,152
3513,in,O,152
3514,a,O,152
3515,target,O,152
3516,subgroup,O,152
3517,of,O,152
3518,patients,O,152
3519,meeting,O,152
3520,the,O,152
3521,following,O,152
3522,criteria,O,152
3523,1,O,152
3524,study,O,152
3525,eye,O,152
3526,with,O,152
3527,reliable,O,152
3528,fixation,O,152
3529,≥12°,O,152
3530,central,O,152
3531,diameter,O,152
3532,and,O,152
3533,or,O,152
3534,steady,O,152
3535,central,O,152
3536,fixation,O,152
3537,and,O,152
3538,2,O,152
3539,study,O,152
3540,eye,O,152
3541,did,O,152
3542,not,O,153
3543,have,O,153
3544,significantly,O,153
3545,worse,O,153
3546,BCVA,B-DIAGNOSTIC_TEST,153
3547,than,O,153
3548,the,O,153
3549,fellow,O,153
3550,eye,O,153
3551,≤15,O,153
3552,letters,O,153
3553,,O,153
3554,The,O,153
3555,phase,O,153
3556,2b,O,153
3557,clinical,O,153
3558,trial,O,153
3559,was,O,153
3560,specifically,O,153
3561,designed,O,153
3562,to,O,153
3563,learn,O,153
3564,more,O,153
3565,about,O,153
3566,the,O,153
3567,clinical,O,153
3568,effects,O,153
3569,of,O,153
3570,jCell,B-TREATMENT,153
3571,therapy,I-TREATMENT,153
3572,in,O,153
3573,a,O,153
3574,broad,O,153
3575,set,O,153
3576,of,O,153
3577,patients,O,153
3578,suffering,O,153
3579,from,O,153
3580,RP,B-NAME_OF_DISEASE,153
3581,to,O,153
3582,better,O,153
3583,understand,O,153
3584,three,O,153
3585,critical,O,153
3586,study,O,153
3587,variables,O,153
3588,the,O,153
3589,optimal,O,153
3590,jCell,B-TREATMENT,153
3591,dose,O,153
3592,the,O,153
3593,performance,O,153
3594,of,O,153
3595,clinical,O,153
3596,trial,O,153
3597,endpoints,O,153
3598,in,O,153
3599,the,O,153
3600,study,O,153
3601,population,O,153
3602,and,O,153
3603,the,O,153
3604,RP,B-NAME_OF_DISEASE,153
3605,patient,O,153
3606,population,O,153
3607,likely,O,153
3608,to,O,153
3609,realize,O,153
3610,the,O,153
3611,most,O,153
3612,pronounced,O,153
3613,improvement,O,153
3614,from,O,154
3615,a,O,154
3616,single,O,154
3617,jCell,B-TREATMENT,154
3618,treatment,O,154
3619,during,O,154
3620,the,O,154
3621,12-month,B-TIME_DURATION,154
3622,pivotal,O,154
3623,trial,O,154
3624,study,O,154
3625,period,O,154
3626,Phase,O,154
3627,2b,O,154
3628,Results,O,154
3629,A,O,154
3630,total,O,154
3631,of,O,154
3632,84,O,154
3633,patients,O,154
3634,were,O,155
3635,randomized,O,155
3636,of,O,155
3637,which,O,155
3638,74,O,155
3639,met,O,155
3640,criteria,O,155
3641,for,O,155
3642,the,O,155
3643,per,O,155
3644,protocol,O,155
3645,analysis,O,155
3646,The,O,156
3647,mean,O,157
3648,change,O,157
3649,in,O,158
3650,BCVA,B-DIAGNOSTIC_TEST,158
3651,from,O,158
3652,baseline,O,158
3653,to,O,158
3654,month,O,158
3655,12,O,159
3656,were,O,159
3657,2.8,O,159
3658,2.9,O,159
3659,and,O,160
3660,7.4,O,160
3661,letters,O,160
3662,in,O,160
3663,the,O,160
3664,sham,O,161
3665,N=26,O,161
3666,3.0×10,O,161
3667,hRPC,B-TREATMENT,161
3668,N=25,O,161
3669,and,O,161
3670,6.0×10,O,161
3671,hRPC,B-TREATMENT,161
3672,N=23,O,161
3673,treatment,O,161
3674,arms,O,161
3675,respectively,O,161
3676,In,O,161
3677,a,O,161
3678,post,O,161
3679,hoc,O,161
3680,exploratory,O,161
3681,analysis,O,161
3682,of,O,161
3683,the,O,161
3684,target,O,161
3685,subgroup,O,161
3686,n=37,O,162
3687,mean,O,163
3688,change,O,163
3689,in,O,164
3690,BCVA,B-DIAGNOSTIC_TEST,164
3691,from,O,164
3692,baseline,O,164
3693,to,O,164
3694,month,O,164
3695,12,O,165
3696,were,O,165
3697,1.8,O,165
3698,-0.1,O,165
3699,and,O,166
3700,16.2,O,166
3701,letters,O,166
3702,in,O,166
3703,the,O,166
3704,sham,O,166
3705,N=13,O,167
3706,3.0×10,O,167
3707,hRPC,B-TREATMENT,168
3708,N=13,O,168
3709,and,O,168
3710,6.0×10,O,168
3711,hRPC,B-TREATMENT,169
3712,N=11,O,169
3713,treatment,O,169
3714,arms,O,169
3715,respectively,O,169
3716,p=0.00,O,170
3717,for,O,170
3718,6.0×10,O,170
3719,hRPC,B-TREATMENT,170
3720,vs,O,170
3721,sham,O,170
3722,,O,170
3723,Supportive,O,170
3724,improvements,O,170
3725,in,O,170
3726,the,O,170
3727,6.0×10,O,170
3728,hRPC,B-TREATMENT,170
3729,target,O,170
3730,subgroup,O,170
3731,compared,O,170
3732,to,O,170
3733,the,O,170
3734,control,O,170
3735,sham,O,170
3736,group,O,170
3737,were,O,170
3738,also,O,170
3739,observed,O,170
3740,in,O,170
3741,all,O,171
3742,secondary,O,171
3743,endpoints,O,171
3744,which,O,171
3745,further,O,171
3746,support,O,171
3747,the,O,171
3748,BCVA,B-DIAGNOSTIC_TEST,171
3749,findings,O,171
3750,in,O,171
3751,this,O,171
3752,subpopulation,O,171
3753,Adverse,O,171
3754,events,O,171
3755,were,O,171
3756,generally,O,171
3757,minor,O,172
3758,and,O,172
3759,transient,O,172
3760,there,O,172
3761,was,O,172
3762,one,O,172
3763,serious,O,172
3764,adverse,O,172
3765,event,O,172
3766,in,O,172
3767,the,O,172
3768,3.0×10,O,172
3769,hRPC,B-TREATMENT,172
3770,arm,O,172
3771,of,O,172
3772,Grade,O,172
3773,3,O,172
3774,ocular,O,172
3775,hypertension,O,172
3776,that,O,172
3777,resolved,O,172
3778,with,O,172
3779,treatment,O,172
3780,but,O,172
3781,no,O,172
3782,serious,O,172
3783,adverse,O,172
3784,events,O,172
3785,nor,O,172
3786,any,O,172
3787,adverse,O,172
3788,events,O,172
3789,greater,O,172
3790,than,O,172
3791,Grade,O,172
3792,1,O,172
3793,mild,O,172
3794,in,O,172
3795,the,O,172
3796,higher,O,172
3797,6,O,172
3798,million,O,172
3799,cell,O,172
3800,treatment,O,172
3801,group,O,172
3802,during,O,173
3803,the,O,173
3804,12-month,B-TIME_DURATION,173
3805,study,O,173
3806,period,O,173
3807,that,O,173
3808,were,O,173
3809,related,O,173
3810,to,O,173
3811,the,O,173
3812,study,O,173
3813,treatment,O,173
3814,Based,O,173
3815,on,O,173
3816,these,O,173
3817,results,O,173
3818,the,O,173
3819,company,O,173
3820,plans,O,173
3821,to,O,173
3822,advance,O,173
3823,jCell,B-TREATMENT,173
3824,into,O,173
3825,a,O,173
3826,pivotal,O,173
3827,trial,O,173
3828,utilizing,O,173
3829,the,O,173
3830,data,O,173
3831,generated,O,173
3832,which,O,173
3833,is,O,173
3834,supportive,O,173
3835,of,O,173
3836,both,O,173
3837,the,O,173
3838,efficacy,O,173
3839,and,O,174
3840,safety,O,174
3841,of,O,174
3842,jCell,B-TREATMENT,174
3843,therapy,I-TREATMENT,174
3844,in,O,174
3845,a,O,174
3846,broad,O,174
3847,set,O,174
3848,of,O,174
3849,RP,B-NAME_OF_DISEASE,174
3850,patients,O,174
3851,The,O,174
3852,phase,O,174
3853,2b,O,174
3854,study,O,174
3855,also,O,174
3856,provides,O,174
3857,essential,O,174
3858,insights,O,174
3859,into,O,174
3860,the,O,174
3861,three,O,174
3862,critical,O,174
3863,study,O,174
3864,variables,O,174
3865,which,O,174
3866,are,O,174
3867,key,O,174
3868,to,O,174
3869,optimizing,O,175
3870,the,O,175
3871,probability,O,175
3872,of,O,175
3873,technical,O,175
3874,success,O,175
3875,of,O,175
3876,the,O,175
3877,upcoming,O,175
3878,jCell,B-TREATMENT,175
3879,pivotal,O,175
3880,trial,O,175
3881,There,O,175
3882,is,O,175
3883,currently,O,175
3884,no,O,175
3885,effective,O,175
3886,treatment,O,176
3887,for,O,176
3888,RP,B-NAME_OF_DISEASE,176
3889,and,O,176
3890,once,O,176
3891,photoreceptors,B-PART_OF_THE_EYES,176
3892,are,O,176
3893,lost,O,176
3894,they,O,176
3895,do,O,176
3896,not,O,176
3897,regenerate,O,176
3898,The,O,176
3899,promising,O,176
3900,results,O,176
3901,from,O,176
3902,this,O,176
3903,phase,O,176
3904,2b,O,176
3905,study,O,176
3906,suggest,O,176
3907,that,O,176
3908,jCell,B-TREATMENT,176
3909,therapy,I-TREATMENT,176
3910,in,O,176
3911,patients,O,176
3912,with,O,176
3913,RP,B-NAME_OF_DISEASE,176
3914,can,O,176
3915,result,O,176
3916,in,O,176
3917,significant,O,176
3918,slowing,O,177
3919,of,O,177
3920,visual,O,177
3921,deterioration,O,177
3922,and,O,177
3923,an,O,177
3924,improvement,O,177
3925,in,O,177
3926,function,O,177
3927,of,O,177
3928,existing,O,177
3929,photoreceptors,B-PART_OF_THE_EYES,177
3930,The,O,177
3931,primary,O,177
3932,goal,O,177
3933,of,O,177
3934,jCell,B-TREATMENT,177
3935,therapy,I-TREATMENT,177
3936,is,O,177
3937,to,O,177
3938,preserve,O,177
3939,and,O,177
3940,potentially,O,177
3941,improve,O,177
3942,vision,O,177
3943,by,O,177
3944,intervening,O,177
3945,in,O,177
3946,the,O,177
3947,disease,O,177
3948,process,O,178
3949,at,O,178
3950,a,O,178
3951,time,O,178
3952,when,O,178
3953,dystrophic,O,178
3954,photoreceptors,B-PART_OF_THE_EYES,178
3955,can,O,178
3956,be,O,178
3957,protected,O,178
3958,and,O,178
3959,reactivated,O,178
3960,We,O,178
3961,are,O,178
3962,excited,O,178
3963,to,O,178
3964,be,O,178
3965,continuing,O,178
3966,the,O,178
3967,development,O,178
3968,of,O,178
3969,jCell,B-TREATMENT,178
3970,investigational,O,178
3971,therapy,O,178
3972,based,O,178
3973,on,O,178
3974,these,O,178
3975,promising,O,178
3976,phase,O,178
3977,2b,O,178
3978,results,O,178
3979,for,O,178
3980,patients,O,178
3981,with,O,178
3982,this,O,178
3983,degenerative,O,178
3984,retinal,O,178
3985,disease,O,178
3986,Anthony,B-PERSON,178
3987,Joseph,I-PERSON,178
3988,MD,I-PERSON,178
3989,Ophthalmic,O,178
3990,Consultants,O,178
3991,of,O,178
3992,Boston,B-GPE,178
3993,who,O,178
3994,presented,O,178
3995,the,O,178
3996,phase,O,178
3997,2b,O,179
3998,data,O,179
3999,at,O,179
4000,the,O,179
4001,ASRS,O,179
4002,meeting,O,179
4003,said,O,179
4004,in,O,179
4005,a,O,179
4006,company,O,179
4007,news,O,179
4008,release,O,179
4009,We,O,179
4010,are,O,179
4011,thrilled,O,179
4012,to,O,179
4013,report,O,179
4014,these,O,179
4015,encouraging,O,179
4016,phase,O,179
4017,2b,O,179
4018,results,O,179
4019,from,O,179
4020,one,O,179
4021,of,O,179
4022,the,O,179
4023,largest,O,179
4024,studies,O,179
4025,ever,O,179
4026,conducted,O,179
4027,in,O,179
4028,RP,B-NAME_OF_DISEASE,179
4029,which,O,179
4030,indicate,O,179
4031,significant,O,179
4032,clinical,O,179
4033,activity,O,179
4034,of,O,179
4035,jCell,B-TREATMENT,179
4036,in,O,179
4037,patients,O,179
4038,agnostic,O,180
4039,of,O,180
4040,genetic,O,180
4041,subtype,O,180
4042,said,O,180
4043,Paul,B-PERSON,180
4044,Bresge,I-PERSON,180
4045,Chief,O,180
4046,Executive,O,180
4047,Officer,O,180
4048,jCyte,B-ORGANIZATION,180
4049,Inc,I-ORGANIZATION,180
4050,The,O,180
4051,phase,O,180
4052,2b,O,180
4053,results,O,180
4054,reported,O,180
4055,that,O,180
4056,jCell,B-TREATMENT,180
4057,therapy,I-TREATMENT,180
4058,had,O,180
4059,promising,O,180
4060,efficacy,O,180
4061,and,O,180
4062,was,O,180
4063,well,O,180
4064,tolerated,O,180
4065,in,O,180
4066,patients,O,180
4067,and,O,180
4068,we,O,181
4069,plan,O,181
4070,to,O,181
4071,advance,O,181
4072,jCell,B-TREATMENT,181
4073,into,O,181
4074,a,O,181
4075,pivotal,O,181
4076,clinical,O,181
4077,trial,O,181
4078,in,O,181
4079,2021,O,181
4080,There,O,181
4081,is,O,181
4082,currently,O,181
4083,no,O,182
4084,FDA,B-ORGANIZATION,182
4085,approved,O,182
4086,treatment,O,182
4087,option,O,182
4088,for,O,182
4089,RP,B-NAME_OF_DISEASE,182
4090,patients,O,182
4091,irrespective,O,182
4092,of,O,182
4093,genetic,O,182
4094,subtype,O,182
4095,We,O,182
4096,believe,O,182
4097,jCell,B-TREATMENT,182
4098,has,O,182
4099,the,O,182
4100,potential,O,182
4101,to,O,182
4102,be,O,182
4103,the,O,182
4104,first,O,182
4105,approved,O,182
4106,therapy,O,182
4107,to,O,182
4108,address,O,182
4109,this,O,182
4110,critical,O,182
4111,unmet,O,182
4112,medical,O,182
4113,need,O,182
4114,and,O,182
4115,dramatically,O,182
4116,improve,O,182
4117,the,O,182
4118,lives,O,182
4119,of,O,182
4120,patients,O,182
4121,with,O,182
4122,this,O,182
4123,progressive,O,182
4124,blinding,B-NAME_OF_DISEASE,182
4125,disease,I-NAME_OF_DISEASE,182
4126,which,O,182
4127,typically,O,182
4128,presents,O,182
4129,early,O,182
4130,in,O,183
4131,the,O,183
4132,lives,O,183
4133,of,O,183
4134,the,O,183
4135,approximately,O,183
4136,1,O,183
4137,3500,O,183
4138,people,O,183
4139,who,O,183
4140,are,O,183
4141,affected,O,183
4142,Eye,B-NAME_OF_DISEASE,183
4143,allergies,I-NAME_OF_DISEASE,183
4144,are,O,183
4145,the,B-SIGN_AND_SYMPTOM,183
4146,irritation,I-SIGN_AND_SYMPTOM,183
4147,of,I-SIGN_AND_SYMPTOM,183
4148,the,I-SIGN_AND_SYMPTOM,183
4149,eyes,I-SIGN_AND_SYMPTOM,183
4150,with,O,184
4151,allergic,B-CAUSE_OF_DISEASE,184
4152,factors,I-CAUSE_OF_DISEASE,184
4153,from,I-CAUSE_OF_DISEASE,184
4154,the,I-CAUSE_OF_DISEASE,184
4155,outside,I-CAUSE_OF_DISEASE,184
4156,reacting,O,184
4157,with,O,184
4158,redness,B-SIGN_AND_SYMPTOM,184
4159,itching,I-SIGN_AND_SYMPTOM,184
4160,and,I-SIGN_AND_SYMPTOM,185
4161,watering,I-SIGN_AND_SYMPTOM,185
4162,Approximately,O,185
4163,20%,O,185
4164,of,O,185
4165,the,O,185
4166,world,O,185
4167,s,O,185
4168,population,O,185
4169,has,O,185
4170,eye,B-NAME_OF_DISEASE,185
4171,allergies,I-NAME_OF_DISEASE,185
4172,Eye,B-NAME_OF_DISEASE,185
4173,allergies,I-NAME_OF_DISEASE,185
4174,can,O,186
4175,be,O,186
4176,hereditary,B-CAUSE_OF_DISEASE,186
4177,or,O,186
4178,occur,O,186
4179,from,O,186
4180,outer,B-CAUSE_OF_DISEASE,186
4181,factors,I-CAUSE_OF_DISEASE,186
4182,such,I-CAUSE_OF_DISEASE,186
4183,as,I-CAUSE_OF_DISEASE,186
4184,dusty,B-CAUSE_OF_DISEASE,186
4185,environments,I-CAUSE_OF_DISEASE,186
4186,Wood,O,186
4187,dust,O,186
4188,that,O,186
4189,occurs,O,186
4190,when,O,186
4191,cutting,O,186
4192,wood,O,186
4193,in,O,186
4194,the,O,186
4195,carpenter,O,186
4196,s,O,186
4197,workshop,O,186
4198,dust,O,186
4199,that,O,186
4200,flies,O,186
4201,on,O,186
4202,unpaved,O,186
4203,roads,O,186
4204,dust,O,186
4205,that,O,186
4206,occurs,O,186
4207,on,O,186
4208,construction,O,186
4209,sites,O,186
4210,in,O,186
4211,the,O,186
4212,city,O,186
4213,due,O,186
4214,to,O,186
4215,urban,O,186
4216,transformation,O,186
4217,dust,O,186
4218,formed,O,186
4219,from,O,186
4220,sand,O,186
4221,in,O,186
4222,the,O,186
4223,jean,O,186
4224,stone,O,186
4225,washing,O,186
4226,workshop,O,186
4227,in,O,186
4228,short,O,186
4229,all,O,187
4230,of,O,187
4231,these,O,187
4232,examples,O,187
4233,of,O,187
4234,dusty,B-CAUSE_OF_DISEASE,187
4235,environments,I-CAUSE_OF_DISEASE,187
4236,can,O,187
4237,easily,O,187
4238,trigger,O,187
4239,eye,B-NAME_OF_DISEASE,187
4240,allergies,I-NAME_OF_DISEASE,187
4241,Other,O,187
4242,than,O,187
4243,these,O,187
4244,examples,O,187
4245,getting,B-CAUSE_OF_DISEASE,187
4246,exposed,I-CAUSE_OF_DISEASE,187
4247,to,I-CAUSE_OF_DISEASE,187
4248,cigarette,I-CAUSE_OF_DISEASE,187
4249,smoke,I-CAUSE_OF_DISEASE,187
4250,less,B-CAUSE_OF_DISEASE,187
4251,tear,I-CAUSE_OF_DISEASE,187
4252,production,I-CAUSE_OF_DISEASE,187
4253,of,I-CAUSE_OF_DISEASE,187
4254,eyes,I-CAUSE_OF_DISEASE,187
4255,swimming,B-CAUSE_OF_DISEASE,187
4256,in,I-CAUSE_OF_DISEASE,187
4257,an,I-CAUSE_OF_DISEASE,187
4258,unhygienic,I-CAUSE_OF_DISEASE,187
4259,pool,I-CAUSE_OF_DISEASE,187
4260,touching,B-CAUSE_OF_DISEASE,187
4261,eyes,I-CAUSE_OF_DISEASE,187
4262,with,I-CAUSE_OF_DISEASE,187
4263,unclean,I-CAUSE_OF_DISEASE,187
4264,hands,I-CAUSE_OF_DISEASE,187
4265,applying,B-CAUSE_OF_DISEASE,187
4266,eye,I-CAUSE_OF_DISEASE,188
4267,makeup,I-CAUSE_OF_DISEASE,188
4268,such,I-CAUSE_OF_DISEASE,188
4269,as,I-CAUSE_OF_DISEASE,188
4270,mascara,I-CAUSE_OF_DISEASE,188
4271,and,I-CAUSE_OF_DISEASE,188
4272,eyeliner,I-CAUSE_OF_DISEASE,188
4273,can,O,188
4274,also,O,188
4275,cause,O,188
4276,eye,B-NAME_OF_DISEASE,188
4277,allergies,I-NAME_OF_DISEASE,188
4278,What,O,188
4279,Are,O,188
4280,the,O,188
4281,3,O,188
4282,Most,O,188
4283,Common,O,188
4284,Eye,B-NAME_OF_DISEASE,188
4285,Allergies,I-NAME_OF_DISEASE,188
4286,There,O,188
4287,are,O,188
4288,6,O,188
4289,types,O,188
4290,of,O,188
4291,eye,B-NAME_OF_DISEASE,188
4292,allergies,I-NAME_OF_DISEASE,188
4293,which,O,188
4294,differ,O,188
4295,according,O,188
4296,to,O,188
4297,the,O,188
4298,probability,O,189
4299,of,O,189
4300,having,O,189
4301,a,O,189
4302,low,O,189
4303,or,O,189
4304,high,O,189
4305,risk,O,189
4306,of,O,189
4307,damaging,O,189
4308,the,B-PART_OF_THE_EYES,189
4309,cornea,I-PART_OF_THE_EYES,189
4310,The,O,189
4311,most,O,189
4312,common,O,189
4313,types,O,189
4314,of,O,189
4315,these,O,189
4316,eye,B-NAME_OF_DISEASE,189
4317,allergies,I-NAME_OF_DISEASE,189
4318,are,O,189
4319,Perennial,B-NAME_OF_DISEASE,189
4320,Allergic,I-NAME_OF_DISEASE,189
4321,Conjunctivitis,I-NAME_OF_DISEASE,189
4322,Seasonal,B-NAME_OF_DISEASE,190
4323,Allergic,I-NAME_OF_DISEASE,191
4324,Conjunctivitis,I-NAME_OF_DISEASE,191
4325,allergic,B-NAME_OF_DISEASE,191
4326,rhinoconjunctivitis,I-NAME_OF_DISEASE,191
4327,and,O,191
4328,Contact,B-NAME_OF_DISEASE,191
4329,Allergic,I-NAME_OF_DISEASE,191
4330,Conjunctivitis,I-NAME_OF_DISEASE,191
4331,contact,B-NAME_OF_DISEASE,191
4332,dermatoconjunctivitis,I-NAME_OF_DISEASE,191
4333,,O,191
4334,1,O,191
4335,Perennial,B-NAME_OF_DISEASE,191
4336,Allergic,I-NAME_OF_DISEASE,191
4337,Conjunctivitis,I-NAME_OF_DISEASE,191
4338,It,O,191
4339,is,O,192
4340,a,O,192
4341,type,O,192
4342,of,O,192
4343,allergy,O,192
4344,that,O,192
4345,can,O,192
4346,be,O,192
4347,seen,O,192
4348,all,O,192
4349,year,O,192
4350,round,O,192
4351,Things,B-CAUSE_OF_DISEASE,193
4352,such,I-CAUSE_OF_DISEASE,193
4353,as,I-CAUSE_OF_DISEASE,193
4354,pet,I-CAUSE_OF_DISEASE,193
4355,hair,I-CAUSE_OF_DISEASE,193
4356,dust,I-CAUSE_OF_DISEASE,193
4357,and,I-CAUSE_OF_DISEASE,193
4358,pollen,I-CAUSE_OF_DISEASE,194
4359,are,O,194
4360,causing,O,194
4361,this,O,194
4362,allergy,O,194
4363,Its,O,194
4364,symptoms,O,194
4365,are,O,194
4366,similar,O,194
4367,to,O,194
4368,seasonal,B-NAME_OF_DISEASE,194
4369,allergies,I-NAME_OF_DISEASE,194
4370,However,O,194
4371,compared,O,194
4372,to,O,195
4373,seasonal,B-NAME_OF_DISEASE,195
4374,allergic,I-NAME_OF_DISEASE,195
4375,conjunctivitis,I-NAME_OF_DISEASE,195
4376,the,O,195
4377,symptoms,O,195
4378,of,O,195
4379,perennial,B-NAME_OF_DISEASE,196
4380,allergic,I-NAME_OF_DISEASE,197
4381,conjunctivitis,I-NAME_OF_DISEASE,197
4382,are,O,197
4383,milder,O,197
4384,This,O,197
4385,allergy,O,197
4386,is,O,197
4387,more,O,197
4388,common,O,197
4389,in,O,197
4390,children,O,197
4391,2,O,197
4392,Seasonal,B-NAME_OF_DISEASE,197
4393,Allergic,I-NAME_OF_DISEASE,198
4394,Conjunctivitis,I-NAME_OF_DISEASE,198
4395,This,O,198
4396,type,O,198
4397,of,O,198
4398,allergy,O,198
4399,becomes,O,198
4400,widespread,O,198
4401,in,O,199
4402,the,O,199
4403,spring,O,199
4404,season,O,199
4405,Because,O,199
4406,in,O,199
4407,this,O,199
4408,season,O,199
4409,the,O,199
4410,trees,O,199
4411,are,O,199
4412,blooming,O,199
4413,The,B-CAUSE_OF_DISEASE,200
4414,pollen,I-CAUSE_OF_DISEASE,200
4415,of,I-CAUSE_OF_DISEASE,200
4416,these,I-CAUSE_OF_DISEASE,200
4417,flowers,I-CAUSE_OF_DISEASE,200
4418,are,O,200
4419,starting,O,200
4420,to,O,200
4421,spread,O,200
4422,in,O,201
4423,the,O,201
4424,air,O,201
4425,It,O,201
4426,causes,O,201
4427,redness,B-SIGN_AND_SYMPTOM,201
4428,itchiness,I-SIGN_AND_SYMPTOM,201
4429,and,I-SIGN_AND_SYMPTOM,201
4430,watering,I-SIGN_AND_SYMPTOM,201
4431,in,I-SIGN_AND_SYMPTOM,202
4432,the,I-SIGN_AND_SYMPTOM,203
4433,eyes,I-SIGN_AND_SYMPTOM,203
4434,People,O,203
4435,with,O,203
4436,sensitive,O,203
4437,bodies,O,203
4438,can,O,203
4439,also,O,203
4440,face,O,203
4441,nasal,B-SIGN_AND_SYMPTOM,203
4442,discharge,I-SIGN_AND_SYMPTOM,203
4443,3,O,203
4444,Contact,B-NAME_OF_DISEASE,203
4445,Allergic,I-NAME_OF_DISEASE,203
4446,Conjunctivitis,I-NAME_OF_DISEASE,203
4447,As,O,203
4448,it,O,203
4449,can,O,203
4450,be,O,204
4451,seen,O,204
4452,from,O,204
4453,the,O,204
4454,name,O,204
4455,this,O,204
4456,allergy,O,204
4457,is,O,204
4458,caused,O,204
4459,by,O,204
4460,contact,B-CAUSE_OF_DISEASE,204
4461,lenses,I-CAUSE_OF_DISEASE,204
4462,People,O,204
4463,with,O,205
4464,sensitive,O,205
4465,eyes,O,205
4466,can,O,205
4467,have,O,205
4468,their,O,205
4469,eyes,O,205
4470,irritated,O,205
4471,by,O,205
4472,wearing,B-CAUSE_OF_DISEASE,205
4473,contact,I-CAUSE_OF_DISEASE,206
4474,lenses,I-CAUSE_OF_DISEASE,206
4475,Contact,B-CAUSE_OF_DISEASE,206
4476,lenses,I-CAUSE_OF_DISEASE,206
4477,will,O,206
4478,cause,O,206
4479,itching,B-SIGN_AND_SYMPTOM,206
4480,and,I-SIGN_AND_SYMPTOM,206
4481,redness,I-SIGN_AND_SYMPTOM,206
4482,in,I-SIGN_AND_SYMPTOM,206
4483,the,I-SIGN_AND_SYMPTOM,206
4484,eyes,I-SIGN_AND_SYMPTOM,206
4485,Generally,O,207
4486,it,O,207
4487,s,O,207
4488,not,O,207
4489,recommended,O,207
4490,to,O,207
4491,wear,B-CAUSE_OF_DISEASE,207
4492,contact,I-CAUSE_OF_DISEASE,207
4493,lenses,I-CAUSE_OF_DISEASE,207
4494,for,I-CAUSE_OF_DISEASE,208
4495,sensitive,I-CAUSE_OF_DISEASE,208
4496,eyes,I-CAUSE_OF_DISEASE,208
4497,Otherwise,O,208
4498,it,O,208
4499,may,O,208
4500,cause,O,208
4501,permanent,O,208
4502,damage,O,208
4503,to,O,208
4504,the,O,208
4505,eyes,O,208
4506,What,O,208
4507,Is,O,208
4508,Best,O,208
4509,for,O,208
4510,Eye,B-NAME_OF_DISEASE,208
4511,Allergy,I-NAME_OF_DISEASE,208
4512,Depending,O,208
4513,on,O,208
4514,the,O,208
4515,stage,O,208
4516,and,O,208
4517,type,O,208
4518,of,O,208
4519,the,O,208
4520,allergy,O,208
4521,eye,B-NAME_OF_DISEASE,208
4522,allergies,I-NAME_OF_DISEASE,208
4523,can,O,208
4524,cause,O,208
4525,vision,B-NAME_OF_DISEASE,208
4526,impairment,I-NAME_OF_DISEASE,209
4527,corneal,B-SIGN_AND_SYMPTOM,209
4528,damage,I-SIGN_AND_SYMPTOM,209
4529,or,O,209
4530,even,O,209
4531,serious,O,209
4532,health,O,209
4533,problems,O,209
4534,such,O,209
4535,as,O,209
4536,eye,B-SIGN_AND_SYMPTOM,209
4537,loss,I-SIGN_AND_SYMPTOM,209
4538,Therefore,O,209
4539,a,O,210
4540,person,O,210
4541,with,O,210
4542,an,B-NAME_OF_DISEASE,210
4543,eye,B-NAME_OF_DISEASE,210
4544,allergy,I-NAME_OF_DISEASE,210
4545,should,O,210
4546,definitely,O,210
4547,see,O,210
4548,an,O,210
4549,ophthalmologist,O,210
4550,first,O,210
4551,Antihistamine,B-TREATMENT,210
4552,eye,I-TREATMENT,210
4553,drops,I-TREATMENT,210
4554,which,O,211
4555,the,O,211
4556,doctor,O,211
4557,is,O,211
4558,going,O,211
4559,to,O,211
4560,prescribe,O,211
4561,will,O,211
4562,greatly,O,211
4563,benefit,O,211
4564,the,O,211
4565,patient,O,211
4566,And,O,211
4567,what,O,211
4568,else,O,211
4569,can,O,211
4570,be,O,211
4571,done,O,211
4572,for,O,211
4573,eye,B-NAME_OF_DISEASE,211
4574,allergy,I-NAME_OF_DISEASE,211
4575,The,O,211
4576,recommendations,O,211
4577,listed,O,211
4578,below,O,211
4579,can,O,211
4580,also,O,211
4581,be,O,212
4582,applicable,O,212
4583,●,O,212
4584,It,O,212
4585,is,O,212
4586,necessary,O,212
4587,to,O,212
4588,stay,B-TREATMENT,212
4589,away,I-TREATMENT,212
4590,from,I-TREATMENT,212
4591,dusty,I-TREATMENT,212
4592,environments,I-TREATMENT,212
4593,●,O,213
4594,Person,O,213
4595,that,O,213
4596,has,O,213
4597,an,B-NAME_OF_DISEASE,213
4598,eye,B-NAME_OF_DISEASE,213
4599,allergy,I-NAME_OF_DISEASE,213
4600,should,O,213
4601,not,B-TREATMENT,213
4602,wear,I-TREATMENT,213
4603,eye,I-TREATMENT,213
4604,makeup,I-TREATMENT,213
4605,●,O,213
4606,Eyes,B-TREATMENT,213
4607,should,I-TREATMENT,213
4608,be,I-TREATMENT,214
4609,protected,I-TREATMENT,214
4610,from,I-TREATMENT,214
4611,dust,I-TREATMENT,214
4612,pollen,I-TREATMENT,214
4613,and,I-TREATMENT,214
4614,harmful,I-TREATMENT,214
4615,sun,I-TREATMENT,214
4616,rays,I-TREATMENT,214
4617,by,I-TREATMENT,214
4618,wearing,I-TREATMENT,214
4619,sunglasses,I-TREATMENT,214
4620,●,O,214
4621,Eyes,B-TREATMENT,214
4622,shouldn,I-TREATMENT,214
4623,t,I-TREATMENT,214
4624,be,I-TREATMENT,215
4625,rubbed,I-TREATMENT,215
4626,especially,I-TREATMENT,215
4627,if,I-TREATMENT,215
4628,the,I-TREATMENT,215
4629,person,I-TREATMENT,215
4630,hasn,I-TREATMENT,215
4631,t,I-TREATMENT,215
4632,washed,I-TREATMENT,215
4633,their,I-TREATMENT,215
4634,hands,I-TREATMENT,215
4635,yet,I-TREATMENT,215
4636,●,O,215
4637,Looking,O,215
4638,at,O,215
4639,electronic,O,215
4640,devices,O,215
4641,such,O,215
4642,as,O,216
4643,cell,O,216
4644,phones,O,216
4645,and,O,216
4646,laptops,O,216
4647,can,O,216
4648,also,O,216
4649,tire,O,216
4650,and,O,216
4651,dry,O,216
4652,the,O,216
4653,eyes,O,216
4654,Therefore,O,217
4655,a,O,217
4656,lot,O,217
4657,of,O,217
4658,time,O,217
4659,should,O,217
4660,not,O,217
4661,be,O,217
4662,spent,O,217
4663,with,O,217
4664,such,O,217
4665,devices,O,217
4666,●,O,217
4667,Long,B-TREATMENT,217
4668,hot,I-TREATMENT,217
4669,showers,I-TREATMENT,217
4670,should,I-TREATMENT,217
4671,be,I-TREATMENT,217
4672,avoided,I-TREATMENT,217
4673,since,O,218
4674,the,B-CAUSE_OF_DISEASE,218
4675,vapor,I-CAUSE_OF_DISEASE,218
4676,of,I-CAUSE_OF_DISEASE,218
4677,chloride,I-CAUSE_OF_DISEASE,218
4678,in,I-CAUSE_OF_DISEASE,218
4679,tap,I-CAUSE_OF_DISEASE,218
4680,water,I-CAUSE_OF_DISEASE,218
4681,can,O,218
4682,damage,O,218
4683,the,O,219
4684,eyes,O,219
4685,●,O,219
4686,Swimming,B-TREATMENT,219
4687,in,I-TREATMENT,219
4688,an,I-TREATMENT,219
4689,unhygienic,I-TREATMENT,219
4690,pool,I-TREATMENT,219
4691,should,I-TREATMENT,219
4692,also,I-TREATMENT,220
4693,be,I-TREATMENT,220
4694,avoided,I-TREATMENT,220
4695,●,O,220
4696,Another,B-TREATMENT,220
4697,person,I-TREATMENT,220
4698,s,I-TREATMENT,220
4699,towel,I-TREATMENT,220
4700,should,I-TREATMENT,220
4701,never,I-TREATMENT,220
4702,be,I-TREATMENT,220
4703,used,I-TREATMENT,220
4704,According,O,220
4705,to,O,220
4706,a,O,220
4707,clinical,O,220
4708,study,O,220
4709,conducted,O,220
4710,by,O,220
4711,the,B-ORGANIZATION,220
4712,DRCR,I-ORGANIZATION,220
4713,Retina,I-ORGANIZATION,220
4714,Network,I-ORGANIZATION,220
4715,early,O,220
4716,treatment,O,220
4717,of,O,220
4718,diabetic,B-NAME_OF_DISEASE,220
4719,retinopathy,I-NAME_OF_DISEASE,220
4720,may,O,220
4721,slow,O,220
4722,the,O,220
4723,progression,O,220
4724,of,O,220
4725,the,O,220
4726,disease,O,220
4727,but,O,220
4728,it,O,220
4729,does,O,220
4730,not,O,220
4731,lead,O,220
4732,to,O,220
4733,an,O,220
4734,improvement,O,220
4735,in,O,220
4736,visual,O,221
4737,acuity,O,221
4738,compared,O,221
4739,to,O,221
4740,treating,O,221
4741,the,O,221
4742,disease,O,221
4743,at,O,221
4744,a,O,221
4745,more,O,221
4746,severe,O,221
4747,stage,O,221
4748,This,O,221
4749,study,O,221
4750,indicates,O,221
4751,that,O,221
4752,monitoring,O,221
4753,patients,O,221
4754,regularly,O,221
4755,for,O,221
4756,vision-threatening,O,221
4757,diabetes,B-NAME_OF_DISEASE,221
4758,complications,O,221
4759,and,O,221
4760,treating,O,221
4761,eyes,O,222
4762,only,O,222
4763,as,O,222
4764,needed,O,222
4765,is,O,222
4766,the,O,222
4767,best,O,222
4768,approach,O,222
4769,said,O,222
4770,Raj,O,222
4771,Maturi,O,222
4772,M.D,O,222
4773,Indiana,B-ORGANIZATION,222
4774,University,I-ORGANIZATION,222
4775,School,I-ORGANIZATION,222
4776,of,I-ORGANIZATION,222
4777,Medicine,I-ORGANIZATION,222
4778,and,O,222
4779,Retina,B-ORGANIZATION,223
4780,Partners,I-ORGANIZATION,223
4781,Midwest,I-ORGANIZATION,223
4782,who,O,223
4783,is,O,223
4784,the,O,223
4785,protocol,O,223
4786,chair,O,223
4787,for,O,223
4788,the,O,223
4789,four-year,B-TIME_DURATION,223
4790,study,O,223
4791,The,O,223
4792,report,O,223
4793,was,O,224
4794,published,O,224
4795,in,O,224
4796,the,B-PUBLICATION_VENUE,224
4797,Journal,I-PUBLICATION_VENUE,224
4798,of,I-PUBLICATION_VENUE,224
4799,the,I-PUBLICATION_VENUE,224
4800,American,I-PUBLICATION_VENUE,224
4801,Medical,I-PUBLICATION_VENUE,224
4802,Association,I-PUBLICATION_VENUE,224
4803,JAMA,I-PUBLICATION_VENUE,224
4804,,O,224
4805,Anti-vascular,B-NAME_OF_DRUG,224
4806,endothelial,I-NAME_OF_DRUG,224
4807,growth,I-NAME_OF_DRUG,224
4808,factor,I-NAME_OF_DRUG,224
4809,anti-VEGF,I-NAME_OF_DRUG,224
4810,drugs,I-NAME_OF_DRUG,224
4811,have,O,224
4812,been,O,224
4813,shown,O,224
4814,to,O,224
4815,significantly,O,225
4816,reduce,O,225
4817,the,O,225
4818,risk,O,225
4819,of,O,225
4820,vision,B-SIGN_AND_SYMPTOM,225
4821,loss,I-SIGN_AND_SYMPTOM,225
4822,in,O,225
4823,patients,O,225
4824,with,O,225
4825,diabetic,B-NAME_OF_DISEASE,225
4826,retinopathy,I-NAME_OF_DISEASE,225
4827,However,O,225
4828,eye,O,225
4829,care,O,226
4830,professionals,O,226
4831,have,O,226
4832,been,O,226
4833,uncertain,O,226
4834,about,O,226
4835,the,O,226
4836,ideal,O,226
4837,time,O,226
4838,to,O,226
4839,initiate,O,226
4840,treatment,O,226
4841,Anti-VEGF,B-NAME_OF_DRUG,226
4842,is,O,226
4843,administered,O,226
4844,through,O,226
4845,eye,O,226
4846,injections,O,226
4847,so,O,226
4848,doctors,O,226
4849,must,O,226
4850,consider,O,226
4851,factors,O,226
4852,such,O,226
4853,as,O,226
4854,the,O,226
4855,potential,O,226
4856,for,O,226
4857,side,O,226
4858,effects,O,226
4859,the,O,226
4860,cost,O,226
4861,and,O,226
4862,inconvenience,O,226
4863,of,O,227
4864,treatment,O,227
4865,and,O,227
4866,the,O,227
4867,potential,O,227
4868,benefits,O,227
4869,before,O,227
4870,deciding,O,227
4871,to,O,227
4872,proceed,O,227
4873,with,O,227
4874,treatment,O,227
4875,What,O,227
4876,Is,O,227
4877,Diabetic,B-NAME_OF_DISEASE,227
4878,Retinopathy,I-NAME_OF_DISEASE,227
4879,Diabetic,B-NAME_OF_DISEASE,227
4880,retinopathy,I-NAME_OF_DISEASE,227
4881,refers,O,227
4882,to,O,227
4883,the,B-SIGN_AND_SYMPTOM,227
4884,damage,I-SIGN_AND_SYMPTOM,227
4885,to,I-SIGN_AND_SYMPTOM,227
4886,the,I-SIGN_AND_SYMPTOM,227
4887,blood,I-SIGN_AND_SYMPTOM,227
4888,vessels,I-SIGN_AND_SYMPTOM,227
4889,in,I-SIGN_AND_SYMPTOM,227
4890,the,I-SIGN_AND_SYMPTOM,227
4891,retina,I-SIGN_AND_SYMPTOM,227
4892,which,O,227
4893,is,O,228
4894,the,O,228
4895,light-sensitive,O,228
4896,part,O,228
4897,of,O,228
4898,the,O,228
4899,eye,O,228
4900,as,O,228
4901,a,O,228
4902,result,O,228
4903,of,O,228
4904,diabetes,B-NAME_OF_DISEASE,228
4905,In,O,228
4906,its,O,228
4907,early,O,228
4908,stage,O,228
4909,the,B-CAUSE_OF_DISEASE,228
4910,weakening,I-CAUSE_OF_DISEASE,228
4911,of,I-CAUSE_OF_DISEASE,228
4912,retinal,I-CAUSE_OF_DISEASE,228
4913,blood,I-CAUSE_OF_DISEASE,228
4914,vessels,I-CAUSE_OF_DISEASE,228
4915,leads,O,228
4916,to,O,228
4917,fluid,B-SIGN_AND_SYMPTOM,228
4918,leakage,I-SIGN_AND_SYMPTOM,228
4919,into,I-SIGN_AND_SYMPTOM,229
4920,the,I-SIGN_AND_SYMPTOM,229
4921,retina,I-SIGN_AND_SYMPTOM,229
4922,a,O,229
4923,condition,O,229
4924,known,O,229
4925,as,O,229
4926,non-proliferative,B-NAME_OF_DISEASE,229
4927,diabetic,B-NAME_OF_DISEASE,229
4928,retinopathy,I-NAME_OF_DISEASE,229
4929,NPDR,I-NAME_OF_DISEASE,229
4930,,O,229
4931,The,B-SIGN_AND_SYMPTOM,229
4932,accumulation,I-SIGN_AND_SYMPTOM,229
4933,of,I-SIGN_AND_SYMPTOM,229
4934,fluid,I-SIGN_AND_SYMPTOM,229
4935,in,I-SIGN_AND_SYMPTOM,229
4936,the,I-SIGN_AND_SYMPTOM,229
4937,retina,I-SIGN_AND_SYMPTOM,229
4938,known,O,229
4939,as,O,229
4940,diabetic,B-NAME_OF_DISEASE,229
4941,macular,I-NAME_OF_DISEASE,229
4942,edema,I-NAME_OF_DISEASE,230
4943,is,O,230
4944,a,O,230
4945,complication,O,230
4946,of,O,230
4947,diabetic,B-NAME_OF_DISEASE,230
4948,retinopathy,I-NAME_OF_DISEASE,230
4949,that,O,230
4950,can,O,230
4951,cause,O,230
4952,vision,B-SIGN_AND_SYMPTOM,230
4953,loss,I-SIGN_AND_SYMPTOM,230
4954,As,O,230
4955,the,O,230
4956,disease,O,230
4957,progresses,O,230
4958,to,O,230
4959,proliferative,B-NAME_OF_DISEASE,230
4960,diabetic,I-NAME_OF_DISEASE,230
4961,retinopathy,I-NAME_OF_DISEASE,230
4962,PDR,I-NAME_OF_DISEASE,230
4963,where,O,230
4964,new,O,230
4965,abnormal,B-SIGN_AND_SYMPTOM,230
4966,blood,I-SIGN_AND_SYMPTOM,230
4967,vessels,I-SIGN_AND_SYMPTOM,230
4968,start,I-SIGN_AND_SYMPTOM,230
4969,to,I-SIGN_AND_SYMPTOM,230
4970,grow,I-SIGN_AND_SYMPTOM,231
4971,in,I-SIGN_AND_SYMPTOM,231
4972,the,I-SIGN_AND_SYMPTOM,231
4973,retina,I-SIGN_AND_SYMPTOM,231
4974,it,O,231
4975,can,O,231
4976,also,O,231
4977,pose,O,231
4978,a,O,231
4979,threat,O,231
4980,to,O,231
4981,vision,O,231
4982,Diabetic,B-NAME_OF_DISEASE,231
4983,Retinopathy,I-NAME_OF_DISEASE,231
4984,The,O,231
4985,Study,O,231
4986,Researchers,O,231
4987,funded,O,231
4988,by,O,231
4989,the,B-ORGANIZATION,231
4990,National,I-ORGANIZATION,231
4991,Eye,I-ORGANIZATION,231
4992,Institute,I-ORGANIZATION,231
4993,NEI,I-ORGANIZATION,231
4994,investigated,O,231
4995,the,O,231
4996,potential,O,231
4997,of,O,231
4998,the,B-NAME_OF_DRUG,231
4999,anti-vascular,I-NAME_OF_DRUG,231
5000,endothelial,I-NAME_OF_DRUG,231
5001,growth,I-NAME_OF_DRUG,231
5002,factor,I-NAME_OF_DRUG,231
5003,anti-VEGF,B-NAME_OF_DRUG,231
5004,drug,I-NAME_OF_DRUG,231
5005,Eylea,I-NAME_OF_DRUG,232
5006,aflibercept,I-NAME_OF_DRUG,232
5007,in,O,232
5008,preventing,O,232
5009,vision,B-SIGN_AND_SYMPTOM,232
5010,loss,I-SIGN_AND_SYMPTOM,232
5011,for,O,232
5012,people,O,232
5013,with,O,232
5014,non-proliferative,B-NAME_OF_DISEASE,232
5015,diabetic,I-NAME_OF_DISEASE,232
5016,retinopathy,I-NAME_OF_DISEASE,232
5017,NPDR,B-NAME_OF_DISEASE,232
5018,,O,232
5019,The,O,232
5020,study,O,232
5021,enrolled,O,232
5022,328,O,232
5023,participants,O,232
5024,some,O,232
5025,of,O,232
5026,whom,O,232
5027,had,O,232
5028,one,O,232
5029,eligible,O,232
5030,eye,O,233
5031,and,O,233
5032,others,O,233
5033,had,O,233
5034,two,O,233
5035,eligible,O,233
5036,eyes,O,233
5037,for,O,233
5038,a,O,233
5039,total,O,233
5040,of,O,233
5041,399,O,233
5042,study,O,233
5043,eyes,O,233
5044,The,O,233
5045,treatment,O,233
5046,group,O,233
5047,received,O,233
5048,preventive,O,233
5049,anti-VEGF,B-NAME_OF_DRUG,233
5050,injections,O,233
5051,at,O,233
5052,one,B-GPE,233
5053,two,I-GPE,233
5054,and,I-GPE,234
5055,four,I-GPE,234
5056,months,I-GPE,234
5057,after,O,234
5058,enrollment,O,234
5059,followed,O,234
5060,by,O,234
5061,injections,O,234
5062,every,O,234
5063,four,O,234
5064,months,O,234
5065,for,B-TIME_DURATION,234
5066,two,I-TIME_DURATION,234
5067,years,I-TIME_DURATION,234
5068,The,O,234
5069,treatment,O,235
5070,continued,O,235
5071,every,B-GPE,235
5072,four,I-GPE,235
5073,months,I-GPE,235
5074,for,I-GPE,235
5075,up,I-GPE,235
5076,to,I-GPE,235
5077,four,I-GPE,235
5078,years,I-GPE,235
5079,if,O,235
5080,NPDR,B-NAME_OF_DISEASE,235
5081,remained,O,235
5082,mild,O,236
5083,The,O,236
5084,control,O,236
5085,group,O,236
5086,received,O,236
5087,sham,O,236
5088,injections,O,236
5089,without,O,236
5090,the,O,236
5091,drug,O,236
5092,over,O,236
5093,the,O,236
5094,same,O,236
5095,period,O,236
5096,In,O,236
5097,the,O,236
5098,event,O,236
5099,that,O,236
5100,a,O,236
5101,vision-threatening,O,236
5102,complication,O,236
5103,such,O,236
5104,as,O,236
5105,diabetic,B-NAME_OF_DISEASE,236
5106,macular,I-NAME_OF_DISEASE,236
5107,edema,I-NAME_OF_DISEASE,237
5108,or,O,237
5109,proliferative,B-NAME_OF_DISEASE,237
5110,diabetic,I-NAME_OF_DISEASE,237
5111,retinopathy,I-NAME_OF_DISEASE,237
5112,PDR,I-NAME_OF_DISEASE,237
5113,developed,O,237
5114,additional,O,237
5115,anti-VEGF,B-NAME_OF_DRUG,237
5116,injections,O,237
5117,were,O,237
5118,given,O,237
5119,as,O,237
5120,required,O,237
5121,The,O,237
5122,Findings,O,237
5123,The,O,237
5124,results,O,237
5125,of,O,237
5126,a,O,237
5127,4-year,B-TIME_DURATION,237
5128,study,O,237
5129,funded,O,237
5130,by,O,237
5131,the,B-ORGANIZATION,237
5132,National,I-ORGANIZATION,237
5133,Eye,I-ORGANIZATION,237
5134,Institute,I-ORGANIZATION,237
5135,NEI,I-ORGANIZATION,237
5136,evaluated,O,237
5137,the,O,237
5138,effectiveness,O,237
5139,of,O,237
5140,treating,O,237
5141,people,O,237
5142,with,O,237
5143,non-proliferative,B-NAME_OF_DISEASE,237
5144,diabetic,B-NAME_OF_DISEASE,237
5145,retinopathy,I-NAME_OF_DISEASE,237
5146,NPDR,B-NAME_OF_DISEASE,237
5147,using,O,238
5148,the,O,238
5149,anti-vascular,B-NAME_OF_DRUG,238
5150,endothelial,I-NAME_OF_DRUG,238
5151,growth,I-NAME_OF_DRUG,238
5152,factor,I-NAME_OF_DRUG,238
5153,anti-VEGF,B-NAME_OF_DRUG,238
5154,drug,I-NAME_OF_DRUG,238
5155,Eylea,I-NAME_OF_DRUG,238
5156,aflibercept,I-NAME_OF_DRUG,238
5157,in,O,238
5158,preventing,O,238
5159,vision,B-SIGN_AND_SYMPTOM,238
5160,loss,I-SIGN_AND_SYMPTOM,238
5161,The,O,238
5162,study,O,238
5163,enrolled,O,239
5164,328,O,239
5165,participants,O,239
5166,each,O,239
5167,with,O,239
5168,one,O,239
5169,or,O,239
5170,two,O,239
5171,eyes,O,239
5172,that,O,239
5173,qualified,O,239
5174,for,O,239
5175,the,O,239
5176,study,O,239
5177,The,O,239
5178,treatment,O,239
5179,group,O,239
5180,received,O,239
5181,preventive,O,239
5182,anti-VEGF,B-NAME_OF_DRUG,239
5183,injections,O,239
5184,every,O,239
5185,4,O,239
5186,months,O,239
5187,for,B-TIME_DURATION,239
5188,2,I-TIME_DURATION,239
5189,years,I-TIME_DURATION,239
5190,and,O,239
5191,continued,O,239
5192,receiving,O,239
5193,injections,O,239
5194,every,O,239
5195,4,O,240
5196,months,O,240
5197,for,B-TIME_DURATION,240
5198,up,I-TIME_DURATION,240
5199,to,I-TIME_DURATION,240
5200,4,I-TIME_DURATION,240
5201,years,I-TIME_DURATION,240
5202,if,O,240
5203,NPDR,B-NAME_OF_DISEASE,240
5204,remained,O,240
5205,at,O,240
5206,a,O,240
5207,mild,O,240
5208,level,O,240
5209,Meanwhile,O,241
5210,the,O,241
5211,control,O,241
5212,group,O,241
5213,received,O,241
5214,sham,O,241
5215,injections,O,241
5216,without,O,241
5217,the,O,241
5218,drug,O,241
5219,over,O,241
5220,the,O,241
5221,same,O,241
5222,period,O,241
5223,We,O,241
5224,expected,O,241
5225,early,O,241
5226,treatment,O,241
5227,to,O,241
5228,prevent,O,241
5229,progression,O,241
5230,of,O,241
5231,diabetic,B-NAME_OF_DISEASE,241
5232,retinopathy,I-NAME_OF_DISEASE,241
5233,but,O,241
5234,even,O,241
5235,with,O,241
5236,preventative,O,241
5237,injections,O,241
5238,about,O,241
5239,one-third,O,241
5240,of,O,241
5241,eyes,O,241
5242,developed,O,241
5243,vision-threatening,O,241
5244,complications,O,241
5245,said,O,241
5246,Adam,B-PERSON,241
5247,Glassman,I-PERSON,241
5248,Jaeb,B-ORGANIZATION,241
5249,Center,I-ORGANIZATION,242
5250,for,I-ORGANIZATION,242
5251,Health,I-ORGANIZATION,242
5252,Research,I-ORGANIZATION,242
5253,Tampa,B-GPE,242
5254,Florida,I-GPE,242
5255,who,O,242
5256,directs,O,242
5257,the,B-ORGANIZATION,242
5258,DRCR,I-ORGANIZATION,242
5259,Retina,I-ORGANIZATION,242
5260,Network,I-ORGANIZATION,242
5261,coordinating,O,242
5262,center,O,242
5263,The,O,242
5264,final,O,242
5265,results,O,242
5266,of,O,242
5267,the,O,242
5268,study,O,242
5269,reinforced,O,242
5270,the,O,242
5271,earlier,O,242
5272,two-year,B-TIME_DURATION,242
5273,findings,O,242
5274,which,O,242
5275,suggested,O,242
5276,that,O,242
5277,preventive,O,242
5278,treatment,O,242
5279,reduced,O,242
5280,the,O,242
5281,risk,O,242
5282,of,O,242
5283,developing,O,242
5284,diabetic,B-NAME_OF_DISEASE,242
5285,macular,I-NAME_OF_DISEASE,242
5286,edema,I-NAME_OF_DISEASE,242
5287,or,O,242
5288,proliferative,B-NAME_OF_DISEASE,242
5289,diabetic,I-NAME_OF_DISEASE,242
5290,retinopathy,I-NAME_OF_DISEASE,242
5291,PDR,I-NAME_OF_DISEASE,242
5292,but,O,242
5293,there,O,242
5294,was,O,242
5295,no,O,242
5296,evident,O,242
5297,benefit,O,242
5298,to,O,242
5299,vision,O,242
5300,with,O,242
5301,no,O,242
5302,statistically,O,242
5303,significant,O,242
5304,difference,O,243
5305,in,O,243
5306,either,O,243
5307,visual,O,243
5308,acuity,O,243
5309,or,O,243
5310,rates,O,243
5311,of,O,243
5312,vision,B-SIGN_AND_SYMPTOM,243
5313,loss,I-SIGN_AND_SYMPTOM,243
5314,between,O,243
5315,the,O,243
5316,two,O,243
5317,groups,O,243
5318,On,O,243
5319,average,O,243
5320,the,O,243
5321,preventive,O,243
5322,group,O,243
5323,received,O,243
5324,11,O,243
5325,injections,O,243
5326,compared,O,243
5327,with,O,243
5328,an,O,243
5329,average,O,243
5330,of,O,243
5331,three,O,243
5332,in,O,243
5333,the,O,243
5334,sham,O,243
5335,group,O,243
5336,and,O,243
5337,34%,O,243
5338,of,O,243
5339,eyes,O,244
5340,receiving,O,244
5341,preventive,O,244
5342,treatments,O,244
5343,showed,O,244
5344,disease,O,244
5345,progression,O,244
5346,compared,O,244
5347,with,O,244
5348,57%,O,244
5349,in,O,244
5350,the,O,244
5351,sham,O,244
5352,group,O,244
5353,While,O,244
5354,the,O,244
5355,individual,O,244
5356,risk,O,244
5357,of,O,244
5358,complications,O,244
5359,per,O,244
5360,injection,O,245
5361,is,O,246
5362,low,O,246
5363,the,O,246
5364,risk,O,246
5365,increases,O,246
5366,with,O,246
5367,each,O,246
5368,additional,O,246
5369,injection,O,246
5370,said,O,246
5371,Jennifer,O,246
5372,Sun,O,246
5373,M.D,O,246
5374,M.P.H,O,246
5375,Joslin,B-ORGANIZATION,246
5376,Diabetes,I-ORGANIZATION,246
5377,Center,I-ORGANIZATION,246
5378,Harvard,I-ORGANIZATION,247
5379,Medical,I-ORGANIZATION,247
5380,School,I-ORGANIZATION,247
5381,Boston,B-GPE,247
5382,and,O,247
5383,chair,O,247
5384,of,O,247
5385,diabetes,B-NAME_OF_DISEASE,247
5386,initiatives,O,247
5387,for,O,247
5388,the,B-ORGANIZATION,247
5389,DRCR,I-ORGANIZATION,247
5390,Retina,I-ORGANIZATION,247
5391,Network,I-ORGANIZATION,247
5392,The,O,247
5393,results,O,247
5394,of,O,247
5395,this,O,247
5396,study,O,247
5397,indicate,O,247
5398,that,O,247
5399,the,O,247
5400,anatomic,O,247
5401,benefit,O,247
5402,from,O,247
5403,early,O,247
5404,anti-VEGF,B-NAME_OF_DRUG,247
5405,treatment,O,247
5406,does,O,247
5407,not,O,247
5408,result,O,247
5409,in,O,247
5410,improved,O,247
5411,visual,O,247
5412,acuity,O,247
5413,and,O,247
5414,so,O,247
5415,it,O,247
5416,may,O,247
5417,not,O,247
5418,be,O,247
5419,worth,O,248
5420,the,O,248
5421,risk,O,248
5422,and,O,248
5423,inconvenience,O,248
5424,to,O,248
5425,the,O,248
5426,patient,O,248
5427,of,O,248
5428,repeat,O,248
5429,preventive,O,248
5430,injections,O,248
5431,for,O,248
5432,NPDR,B-NAME_OF_DISEASE,248
5433,What,O,248
5434,Is,O,248
5435,Symblepharon,B-NAME_OF_DISEASE,248
5436,Symblepharon,B-NAME_OF_DISEASE,248
5437,is,O,248
5438,a,O,248
5439,medical,O,248
5440,condition,O,248
5441,characterized,O,248
5442,by,O,248
5443,the,B-SIGN_AND_SYMPTOM,248
5444,adhesion,I-SIGN_AND_SYMPTOM,248
5445,of,I-SIGN_AND_SYMPTOM,248
5446,the,I-SIGN_AND_SYMPTOM,248
5447,conjunctiva,I-SIGN_AND_SYMPTOM,248
5448,the,O,248
5449,clear,O,248
5450,membrane,O,248
5451,that,O,248
5452,covers,O,248
5453,the,O,248
5454,white,O,248
5455,part,O,248
5456,of,O,248
5457,the,O,248
5458,eye,O,248
5459,and,O,248
5460,the,O,248
5461,inside,O,249
5462,of,O,249
5463,the,B-PART_OF_THE_EYES,249
5464,eyelids,I-PART_OF_THE_EYES,249
5465,to,O,249
5466,the,B-PART_OF_THE_EYES,249
5467,cornea,I-PART_OF_THE_EYES,249
5468,the,O,249
5469,clear,O,249
5470,front,O,249
5471,part,O,249
5472,of,O,249
5473,the,O,250
5474,eye,O,250
5475,This,O,250
5476,adhesion,O,250
5477,can,O,250
5478,cause,O,250
5479,pain,B-SIGN_AND_SYMPTOM,250
5480,vision,O,250
5481,problems,O,250
5482,and,O,250
5483,increased,O,250
5484,risk,O,250
5485,of,O,250
5486,infection,O,250
5487,What,O,250
5488,Causes,O,250
5489,Symblepharon,B-NAME_OF_DISEASE,250
5490,Causes,O,250
5491,of,O,250
5492,symblepharon,B-NAME_OF_DISEASE,250
5493,include,O,250
5494,inflammatory,B-CAUSE_OF_DISEASE,250
5495,eye,I-CAUSE_OF_DISEASE,251
5496,diseases,I-CAUSE_OF_DISEASE,251
5497,such,O,251
5498,as,O,251
5499,vernal,B-CAUSE_OF_DISEASE,251
5500,keratoconjunctivitis,I-CAUSE_OF_DISEASE,251
5501,trachoma,B-CAUSE_OF_DISEASE,251
5502,and,O,251
5503,autoimmune,B-CAUSE_OF_DISEASE,251
5504,diseases,I-CAUSE_OF_DISEASE,251
5505,such,I-CAUSE_OF_DISEASE,251
5506,as,I-CAUSE_OF_DISEASE,251
5507,Stevens-Johnson,I-CAUSE_OF_DISEASE,251
5508,syndrome,I-CAUSE_OF_DISEASE,251
5509,Chemical,B-CAUSE_OF_DISEASE,251
5510,or,I-CAUSE_OF_DISEASE,251
5511,thermal,I-CAUSE_OF_DISEASE,251
5512,burns,I-CAUSE_OF_DISEASE,251
5513,to,I-CAUSE_OF_DISEASE,251
5514,the,I-CAUSE_OF_DISEASE,251
5515,eye,I-CAUSE_OF_DISEASE,251
5516,previous,B-CAUSE_OF_DISEASE,251
5517,ocular,I-CAUSE_OF_DISEASE,251
5518,surgeries,I-CAUSE_OF_DISEASE,251
5519,such,I-CAUSE_OF_DISEASE,251
5520,as,I-CAUSE_OF_DISEASE,251
5521,corneal,I-CAUSE_OF_DISEASE,251
5522,transplantation,I-CAUSE_OF_DISEASE,251
5523,or,I-CAUSE_OF_DISEASE,251
5524,glaucoma,I-CAUSE_OF_DISEASE,252
5525,filtration,I-CAUSE_OF_DISEASE,252
5526,surgery,I-CAUSE_OF_DISEASE,252
5527,and,O,252
5528,infections,B-CAUSE_OF_DISEASE,252
5529,such,I-CAUSE_OF_DISEASE,252
5530,as,I-CAUSE_OF_DISEASE,252
5531,bacterial,I-CAUSE_OF_DISEASE,252
5532,conjunctivitis,I-CAUSE_OF_DISEASE,252
5533,can,O,252
5534,also,O,252
5535,lead,O,252
5536,to,O,252
5537,symblepharon,B-NAME_OF_DISEASE,252
5538,Symptoms,O,252
5539,of,O,252
5540,Symblepharon,B-NAME_OF_DISEASE,252
5541,Pain,B-SIGN_AND_SYMPTOM,252
5542,or,I-SIGN_AND_SYMPTOM,252
5543,discomfort,I-SIGN_AND_SYMPTOM,252
5544,in,I-SIGN_AND_SYMPTOM,252
5545,the,I-SIGN_AND_SYMPTOM,252
5546,affected,I-SIGN_AND_SYMPTOM,252
5547,eye,I-SIGN_AND_SYMPTOM,252
5548,Decreased,B-SIGN_AND_SYMPTOM,252
5549,vision,I-SIGN_AND_SYMPTOM,252
5550,or,I-SIGN_AND_SYMPTOM,252
5551,blurred,I-SIGN_AND_SYMPTOM,252
5552,vision,I-SIGN_AND_SYMPTOM,252
5553,Redness,B-SIGN_AND_SYMPTOM,252
5554,swelling,I-SIGN_AND_SYMPTOM,252
5555,and,I-SIGN_AND_SYMPTOM,252
5556,discharge,I-SIGN_AND_SYMPTOM,252
5557,in,I-SIGN_AND_SYMPTOM,252
5558,the,I-SIGN_AND_SYMPTOM,252
5559,affected,I-SIGN_AND_SYMPTOM,252
5560,eye,I-SIGN_AND_SYMPTOM,252
5561,Sensitivity,B-SIGN_AND_SYMPTOM,252
5562,to,I-SIGN_AND_SYMPTOM,252
5563,light,I-SIGN_AND_SYMPTOM,252
5564,Photographs,O,252
5565,demonstrating,O,252
5566,symblepharon,B-NAME_OF_DISEASE,252
5567,grading,O,252
5568,Credit,O,252
5569,Research,O,252
5570,Gate,O,252
5571,The,O,252
5572,symptoms,O,252
5573,of,O,252
5574,symblepharon,B-NAME_OF_DISEASE,252
5575,may,O,252
5576,resolve,O,253
5577,on,O,253
5578,their,O,253
5579,own,O,253
5580,if,O,253
5581,the,O,253
5582,underlying,O,253
5583,cause,O,253
5584,of,O,253
5585,the,O,253
5586,adhesion,O,253
5587,is,O,253
5588,treated,O,253
5589,effectively,O,253
5590,However,O,253
5591,in,O,253
5592,some,O,253
5593,cases,O,253
5594,the,O,253
5595,symptoms,O,253
5596,may,O,253
5597,persist,O,253
5598,even,O,253
5599,with,O,253
5600,treatment,O,253
5601,particularly,O,254
5602,if,O,254
5603,the,O,254
5604,adhesion,O,254
5605,is,O,254
5606,extensive,O,254
5607,or,O,254
5608,has,O,254
5609,been,O,254
5610,present,O,254
5611,for,O,254
5612,a,O,254
5613,long,O,254
5614,time,O,254
5615,The,O,254
5616,length,O,254
5617,of,O,254
5618,time,O,254
5619,it,O,254
5620,takes,O,254
5621,for,O,254
5622,the,O,254
5623,symptoms,O,254
5624,of,O,254
5625,symblepharon,B-NAME_OF_DISEASE,254
5626,to,O,254
5627,pass,O,254
5628,varies,O,254
5629,depending,O,254
5630,on,O,254
5631,the,O,255
5632,severity,O,255
5633,of,O,255
5634,the,O,255
5635,condition,O,255
5636,the,O,255
5637,underlying,O,255
5638,cause,O,255
5639,and,O,255
5640,the,O,255
5641,type,O,255
5642,of,O,255
5643,treatment,O,255
5644,received,O,255
5645,Can,O,255
5646,Symblepharon,B-NAME_OF_DISEASE,256
5647,Lead,O,256
5648,to,O,256
5649,Other,O,256
5650,Eye,O,256
5651,Problems,O,256
5652,Symblepharon,B-NAME_OF_DISEASE,256
5653,can,O,256
5654,definitely,O,256
5655,lead,O,256
5656,to,O,256
5657,other,O,256
5658,eye,O,256
5659,problems,O,256
5660,Because,O,256
5661,the,B-PART_OF_THE_EYES,256
5662,conjunctiva,I-PART_OF_THE_EYES,256
5663,is,O,256
5664,adhered,O,256
5665,to,O,256
5666,the,B-PART_OF_THE_EYES,256
5667,cornea,I-PART_OF_THE_EYES,256
5668,the,O,256
5669,affected,O,256
5670,eye,O,256
5671,may,O,256
5672,be,O,256
5673,more,O,256
5674,susceptible,O,256
5675,to,O,257
5676,infections,O,257
5677,and,O,257
5678,inflammation,O,257
5679,which,O,257
5680,can,O,257
5681,cause,O,257
5682,further,O,257
5683,damage,O,257
5684,to,O,257
5685,the,O,257
5686,eye,O,257
5687,and,O,257
5688,vision,O,257
5689,In,O,257
5690,addition,O,257
5691,symblepharon,B-NAME_OF_DISEASE,257
5692,can,O,257
5693,cause,O,257
5694,the,B-SIGN_AND_SYMPTOM,257
5695,eyelid,I-SIGN_AND_SYMPTOM,257
5696,to,I-SIGN_AND_SYMPTOM,257
5697,turn,I-SIGN_AND_SYMPTOM,257
5698,inward,I-SIGN_AND_SYMPTOM,257
5699,a,O,258
5700,condition,O,258
5701,known,O,258
5702,as,O,258
5703,entropion,B-SIGN_AND_SYMPTOM,258
5704,which,O,258
5705,can,O,258
5706,lead,O,258
5707,to,O,258
5708,further,O,258
5709,discomfort,O,258
5710,and,O,258
5711,vision,O,258
5712,problems,O,258
5713,Symblepharon,B-NAME_OF_DISEASE,258
5714,can,O,258
5715,also,O,258
5716,cause,O,258
5717,the,B-SIGN_AND_SYMPTOM,258
5718,cornea,I-SIGN_AND_SYMPTOM,258
5719,to,I-SIGN_AND_SYMPTOM,258
5720,become,I-SIGN_AND_SYMPTOM,258
5721,thin,I-SIGN_AND_SYMPTOM,258
5722,and,I-SIGN_AND_SYMPTOM,258
5723,scarred,I-SIGN_AND_SYMPTOM,258
5724,which,O,259
5725,can,O,259
5726,affect,O,259
5727,vision,O,259
5728,and,O,259
5729,may,O,259
5730,lead,O,259
5731,to,O,259
5732,a,O,259
5733,condition,O,259
5734,known,O,259
5735,as,O,259
5736,corneal,B-SIGN_AND_SYMPTOM,259
5737,opacity,I-SIGN_AND_SYMPTOM,259
5738,This,O,259
5739,can,O,259
5740,make,O,259
5741,it,O,259
5742,difficult,B-SIGN_AND_SYMPTOM,259
5743,for,I-SIGN_AND_SYMPTOM,260
5744,light,I-SIGN_AND_SYMPTOM,260
5745,to,I-SIGN_AND_SYMPTOM,260
5746,enter,I-SIGN_AND_SYMPTOM,260
5747,the,I-SIGN_AND_SYMPTOM,260
5748,eye,I-SIGN_AND_SYMPTOM,260
5749,and,I-SIGN_AND_SYMPTOM,260
5750,reach,I-SIGN_AND_SYMPTOM,260
5751,the,I-SIGN_AND_SYMPTOM,260
5752,retina,I-SIGN_AND_SYMPTOM,260
5753,resulting,O,260
5754,in,O,260
5755,decreased,B-SIGN_AND_SYMPTOM,260
5756,vision,I-SIGN_AND_SYMPTOM,260
5757,In,O,260
5758,severe,O,260
5759,cases,O,260
5760,symblepharon,B-NAME_OF_DISEASE,260
5761,can,O,260
5762,also,O,260
5763,cause,O,260
5764,a,B-SIGN_AND_SYMPTOM,260
5765,loss,I-SIGN_AND_SYMPTOM,260
5766,of,I-SIGN_AND_SYMPTOM,260
5767,the,I-SIGN_AND_SYMPTOM,260
5768,tear,I-SIGN_AND_SYMPTOM,261
5769,film,I-SIGN_AND_SYMPTOM,261
5770,which,O,261
5771,is,O,261
5772,essential,O,261
5773,for,O,261
5774,maintaining,O,261
5775,the,O,261
5776,health,O,261
5777,of,O,261
5778,the,O,261
5779,eye,O,261
5780,and,O,261
5781,vision,O,261
5782,This,O,261
5783,can,O,261
5784,lead,O,261
5785,to,O,261
5786,dry,B-NAME_OF_DISEASE,261
5787,eye,I-NAME_OF_DISEASE,261
5788,syndrome,I-NAME_OF_DISEASE,261
5789,a,O,261
5790,condition,O,261
5791,in,O,261
5792,which,O,261
5793,the,B-SIGN_AND_SYMPTOM,262
5794,eye,I-SIGN_AND_SYMPTOM,262
5795,does,I-SIGN_AND_SYMPTOM,262
5796,not,I-SIGN_AND_SYMPTOM,262
5797,produce,I-SIGN_AND_SYMPTOM,262
5798,enough,I-SIGN_AND_SYMPTOM,262
5799,tears,I-SIGN_AND_SYMPTOM,262
5800,to,I-SIGN_AND_SYMPTOM,262
5801,keep,I-SIGN_AND_SYMPTOM,262
5802,the,I-SIGN_AND_SYMPTOM,262
5803,eye,I-SIGN_AND_SYMPTOM,262
5804,moist,I-SIGN_AND_SYMPTOM,262
5805,and,I-SIGN_AND_SYMPTOM,262
5806,comfortable,I-SIGN_AND_SYMPTOM,262
5807,Treatment,O,262
5808,Options,O,262
5809,for,O,262
5810,Symblepharon,B-NAME_OF_DISEASE,262
5811,Treatment,O,262
5812,options,O,262
5813,for,O,262
5814,symblepharon,B-NAME_OF_DISEASE,263
5815,may,O,263
5816,vary,O,263
5817,based,O,263
5818,on,O,263
5819,the,O,263
5820,severity,O,263
5821,of,O,263
5822,the,O,263
5823,condition,O,263
5824,and,O,263
5825,the,O,263
5826,underlying,O,263
5827,cause,O,263
5828,The,O,263
5829,goal,O,263
5830,of,O,263
5831,treatment,O,263
5832,is,O,263
5833,to,O,263
5834,separate,B-TREATMENT,263
5835,the,I-TREATMENT,263
5836,conjunctiva,I-TREATMENT,263
5837,from,I-TREATMENT,263
5838,the,I-TREATMENT,264
5839,cornea,I-TREATMENT,264
5840,restore,I-TREATMENT,264
5841,the,I-TREATMENT,264
5842,normal,I-TREATMENT,264
5843,anatomy,I-TREATMENT,264
5844,of,I-TREATMENT,264
5845,the,I-TREATMENT,264
5846,eye,I-TREATMENT,264
5847,and,O,264
5848,prevent,O,264
5849,further,O,264
5850,vision,B-SIGN_AND_SYMPTOM,264
5851,loss,I-SIGN_AND_SYMPTOM,264
5852,Here,O,264
5853,are,O,264
5854,some,O,264
5855,common,O,264
5856,treatment,O,264
5857,options,O,264
5858,for,O,264
5859,symblepharon,B-NAME_OF_DISEASE,264
5860,Corticosteroid,B-NAME_OF_DRUG,265
5861,eye,I-NAME_OF_DRUG,265
5862,drops,I-NAME_OF_DRUG,265
5863,Corticosteroid,B-NAME_OF_DRUG,265
5864,eye,I-NAME_OF_DRUG,265
5865,drops,I-NAME_OF_DRUG,265
5866,can,O,265
5867,help,O,265
5868,reduce,O,265
5869,inflammation,O,265
5870,and,O,265
5871,prevent,O,265
5872,further,O,265
5873,scarring,O,265
5874,They,O,265
5875,may,O,265
5876,be,O,265
5877,used,O,265
5878,to,O,266
5879,manage,O,266
5880,the,O,266
5881,symptoms,O,266
5882,of,O,266
5883,symblepharon,B-NAME_OF_DISEASE,266
5884,but,O,266
5885,are,O,266
5886,not,O,266
5887,a,O,266
5888,cure,O,266
5889,for,O,266
5890,the,O,266
5891,condition,O,266
5892,Antibiotic,B-NAME_OF_DRUG,266
5893,eye,I-NAME_OF_DRUG,266
5894,drops,I-NAME_OF_DRUG,266
5895,Antibiotic,B-NAME_OF_DRUG,266
5896,eye,I-NAME_OF_DRUG,266
5897,drops,I-NAME_OF_DRUG,266
5898,may,O,266
5899,be,O,266
5900,prescribed,O,266
5901,to,O,267
5902,prevent,O,267
5903,or,O,267
5904,treat,O,267
5905,eye,B-SIGN_AND_SYMPTOM,267
5906,infections,I-SIGN_AND_SYMPTOM,267
5907,which,O,267
5908,can,O,267
5909,be,O,267
5910,a,O,267
5911,common,O,267
5912,complication,O,267
5913,of,O,267
5914,symblepharon,B-NAME_OF_DISEASE,267
5915,Artificial,B-TREATMENT,267
5916,tears,I-TREATMENT,267
5917,Artificial,B-TREATMENT,267
5918,tears,I-TREATMENT,267
5919,can,O,267
5920,help,O,267
5921,to,O,267
5922,maintain,O,268
5923,the,O,268
5924,health,O,268
5925,of,O,268
5926,the,O,268
5927,eye,O,268
5928,and,O,268
5929,reduce,O,268
5930,the,O,268
5931,symptoms,O,268
5932,of,O,268
5933,dry,B-NAME_OF_DISEASE,269
5934,eye,I-NAME_OF_DISEASE,269
5935,syndrome,I-NAME_OF_DISEASE,269
5936,They,O,269
5937,can,O,269
5938,also,O,269
5939,help,O,269
5940,to,O,269
5941,prevent,O,269
5942,further,O,269
5943,scarring,O,269
5944,and,O,269
5945,vision,B-SIGN_AND_SYMPTOM,269
5946,loss,I-SIGN_AND_SYMPTOM,269
5947,Ointments,B-TREATMENT,269
5948,Ointments,B-TREATMENT,269
5949,may,O,269
5950,be,O,270
5951,prescribed,O,270
5952,to,O,270
5953,provide,O,270
5954,additional,O,270
5955,moisture,O,270
5956,to,O,270
5957,the,O,270
5958,eye,O,270
5959,and,O,270
5960,help,O,270
5961,prevent,O,270
5962,further,O,270
5963,scarring,O,270
5964,Surgical,B-TREATMENT,270
5965,intervention,I-TREATMENT,270
5966,In,O,270
5967,severe,O,270
5968,cases,O,270
5969,surgical,B-TREATMENT,270
5970,intervention,I-TREATMENT,270
5971,may,O,270
5972,be,O,270
5973,required,O,270
5974,to,O,270
5975,separate,B-TREATMENT,271
5976,the,I-TREATMENT,271
5977,conjunctiva,I-TREATMENT,271
5978,from,I-TREATMENT,271
5979,the,I-TREATMENT,271
5980,cornea,I-TREATMENT,271
5981,and,I-TREATMENT,271
5982,restore,I-TREATMENT,271
5983,the,I-TREATMENT,271
5984,normal,I-TREATMENT,271
5985,anatomy,I-TREATMENT,271
5986,of,I-TREATMENT,271
5987,the,I-TREATMENT,271
5988,eye,I-TREATMENT,271
5989,The,O,271
5990,procedure,O,271
5991,may,O,271
5992,involve,O,271
5993,a,B-TREATMENT,271
5994,surgical,I-TREATMENT,271
5995,separation,I-TREATMENT,271
5996,of,I-TREATMENT,271
5997,the,I-TREATMENT,271
5998,conjunctiva,I-TREATMENT,271
5999,from,I-TREATMENT,271
6000,the,I-TREATMENT,271
6001,cornea,I-TREATMENT,272
6002,or,O,272
6003,a,O,272
6004,procedure,O,272
6005,to,O,272
6006,correct,O,272
6007,the,O,272
6008,underlying,O,272
6009,cause,O,272
6010,of,O,272
6011,symblepharon,B-NAME_OF_DISEASE,272
6012,such,O,272
6013,as,O,272
6014,entropion,B-CAUSE_OF_DISEASE,272
6015,In,O,272
6016,conclusion,O,272
6017,symblepharon,B-NAME_OF_DISEASE,272
6018,is,O,272
6019,a,O,272
6020,serious,O,272
6021,medical,O,272
6022,condition,O,272
6023,that,O,272
6024,can,O,273
6025,have,O,273
6026,a,O,273
6027,significant,O,273
6028,impact,O,273
6029,on,O,273
6030,a,O,273
6031,person,O,273
6032,s,O,273
6033,vision,O,273
6034,and,O,273
6035,quality,O,273
6036,of,O,273
6037,life,O,273
6038,By,O,273
6039,understanding,O,273
6040,the,O,273
6041,causes,O,273
6042,symptoms,O,273
6043,and,O,273
6044,treatments,O,273
6045,of,O,273
6046,symblepharon,B-NAME_OF_DISEASE,273
6047,individuals,O,273
6048,affected,O,273
6049,by,O,273
6050,this,O,273
6051,condition,O,273
6052,can,O,273
6053,seek,O,273
6054,the,O,273
6055,support,O,274
6056,and,O,274
6057,care,O,274
6058,they,O,274
6059,need,O,274
6060,to,O,274
6061,manage,O,274
6062,their,O,274
6063,symptoms,O,274
6064,and,O,274
6065,improve,O,274
6066,their,O,274
6067,overall,O,274
6068,well-being,O,274
6069,An,O,274
6070,Introduction,O,274
6071,to,O,274
6072,Intraretinal,B-NAME_OF_DISEASE,274
6073,Microvascular,I-NAME_OF_DISEASE,274
6074,Abnormalities,I-NAME_OF_DISEASE,274
6075,Intraretinal,B-NAME_OF_DISEASE,274
6076,microvascular,I-NAME_OF_DISEASE,274
6077,abnormalities,I-NAME_OF_DISEASE,274
6078,IRMAs,B-NAME_OF_DISEASE,274
6079,are,O,274
6080,tiny,B-SIGN_AND_SYMPTOM,275
6081,blood,I-SIGN_AND_SYMPTOM,275
6082,vessels,I-SIGN_AND_SYMPTOM,275
6083,in,I-SIGN_AND_SYMPTOM,275
6084,the,I-SIGN_AND_SYMPTOM,275
6085,retina,I-SIGN_AND_SYMPTOM,275
6086,that,I-SIGN_AND_SYMPTOM,275
6087,deviate,I-SIGN_AND_SYMPTOM,275
6088,from,I-SIGN_AND_SYMPTOM,275
6089,their,I-SIGN_AND_SYMPTOM,275
6090,normal,I-SIGN_AND_SYMPTOM,275
6091,shape,I-SIGN_AND_SYMPTOM,275
6092,and,I-SIGN_AND_SYMPTOM,275
6093,size,I-SIGN_AND_SYMPTOM,275
6094,These,O,275
6095,abnormalities,O,275
6096,are,O,275
6097,commonly,O,275
6098,found,O,275
6099,in,O,275
6100,people,O,275
6101,with,O,276
6102,diabetic,B-NAME_OF_DISEASE,276
6103,retinopathy,I-NAME_OF_DISEASE,276
6104,and,O,276
6105,can,O,276
6106,lead,O,276
6107,to,O,276
6108,vision,B-SIGN_AND_SYMPTOM,276
6109,loss,I-SIGN_AND_SYMPTOM,276
6110,and,O,276
6111,blindness,B-NAME_OF_DISEASE,276
6112,if,O,276
6113,left,O,276
6114,untreated,O,276
6115,Intraretinal,B-NAME_OF_DISEASE,276
6116,microvascular,I-NAME_OF_DISEASE,276
6117,abnormalities,I-NAME_OF_DISEASE,276
6118,IRMAs,B-NAME_OF_DISEASE,276
6119,are,O,276
6120,considered,O,276
6121,a,O,276
6122,defining,O,276
6123,feature,O,276
6124,of,O,276
6125,severe,O,276
6126,non-proliferative,B-NAME_OF_DISEASE,276
6127,diabetic,I-NAME_OF_DISEASE,276
6128,retinopathy,I-NAME_OF_DISEASE,276
6129,according,O,277
6130,to,O,277
6131,the,O,277
6132,4/2/2001,B-DIAGNOSTIC_TEST,277
6133,criteria,I-DIAGNOSTIC_TEST,277
6134,from,O,277
6135,the,B-ORGANIZATION,277
6136,Early,I-ORGANIZATION,277
6137,Treatment,I-ORGANIZATION,277
6138,Diabetic,I-ORGANIZATION,277
6139,Retinopathy,I-ORGANIZATION,277
6140,Study,I-ORGANIZATION,277
6141,ETDRS,I-ORGANIZATION,277
6142,,O,277
6143,Compared,O,277
6144,to,O,277
6145,neovascularization,O,277
6146,NV,O,277
6147,in,O,277
6148,proliferative,B-NAME_OF_DISEASE,277
6149,disease,I-NAME_OF_DISEASE,277
6150,IRMAs,B-NAME_OF_DISEASE,277
6151,are,O,277
6152,slightly,O,277
6153,larger,O,277
6154,in,O,277
6155,caliber,O,277
6156,and,O,278
6157,have,O,278
6158,a,O,278
6159,more,O,278
6160,broad,O,278
6161,arrangement,O,278
6162,and,O,278
6163,are,O,278
6164,always,O,278
6165,contained,O,278
6166,within,O,278
6167,the,O,278
6168,intraretinal,O,278
6169,layers,O,278
6170,The,O,278
6171,presence,O,278
6172,of,O,278
6173,IRMAs,B-NAME_OF_DISEASE,278
6174,indicates,O,278
6175,that,O,278
6176,the,O,278
6177,retinal,O,278
6178,blood,O,278
6179,vessels,O,278
6180,have,O,278
6181,undergone,O,278
6182,changes,O,278
6183,and,O,279
6184,can,O,279
6185,be,O,279
6186,an,O,279
6187,early,O,279
6188,warning,O,279
6189,sign,O,279
6190,of,O,279
6191,more,O,279
6192,severe,O,279
6193,retinal,O,279
6194,changes,O,279
6195,to,O,279
6196,come,O,279
6197,4/2/2001,B-DIAGNOSTIC_TEST,279
6198,Criteria,I-DIAGNOSTIC_TEST,279
6199,The,B-DIAGNOSTIC_TEST,279
6200,4/2/2001,I-DIAGNOSTIC_TEST,279
6201,criteria,I-DIAGNOSTIC_TEST,279
6202,is,O,279
6203,a,O,279
6204,classification,O,279
6205,system,O,279
6206,developed,O,279
6207,by,O,279
6208,the,B-ORGANIZATION,280
6209,Early,I-ORGANIZATION,280
6210,Treatment,I-ORGANIZATION,280
6211,Diabetic,I-ORGANIZATION,280
6212,Retinopathy,I-ORGANIZATION,280
6213,Study,I-ORGANIZATION,280
6214,ETDRS,I-ORGANIZATION,280
6215,to,O,280
6216,categorize,O,280
6217,the,O,280
6218,severity,O,280
6219,of,O,280
6220,diabetic,B-NAME_OF_DISEASE,280
6221,retinopathy,I-NAME_OF_DISEASE,280
6222,The,O,280
6223,criteria,O,280
6224,are,O,280
6225,based,O,280
6226,on,O,281
6227,the,B-DIAGNOSTIC_TEST,281
6228,presence,I-DIAGNOSTIC_TEST,281
6229,and,I-DIAGNOSTIC_TEST,281
6230,extent,I-DIAGNOSTIC_TEST,281
6231,of,I-DIAGNOSTIC_TEST,281
6232,retinal,I-DIAGNOSTIC_TEST,281
6233,changes,I-DIAGNOSTIC_TEST,281
6234,such,I-DIAGNOSTIC_TEST,281
6235,as,I-DIAGNOSTIC_TEST,281
6236,microaneurysms,I-DIAGNOSTIC_TEST,281
6237,hemorrhages,I-DIAGNOSTIC_TEST,281
6238,and,I-DIAGNOSTIC_TEST,281
6239,exudates,I-DIAGNOSTIC_TEST,281
6240,The,O,281
6241,first,O,282
6242,number,O,282
6243,4,O,282
6244,refers,O,282
6245,to,O,282
6246,the,O,282
6247,number,O,282
6248,of,O,282
6249,quadrants,O,282
6250,affected,O,282
6251,by,O,282
6252,the,O,282
6253,retinal,O,282
6254,changes,O,282
6255,The,O,282
6256,second,O,283
6257,number,O,283
6258,2,O,283
6259,refers,O,283
6260,to,O,283
6261,the,O,283
6262,severity,O,283
6263,of,O,283
6264,the,O,283
6265,retinal,O,283
6266,changes,O,283
6267,within,O,283
6268,each,O,283
6269,quadrant,O,283
6270,The,O,284
6271,last,O,284
6272,number,O,284
6273,1,O,284
6274,refers,O,284
6275,to,O,284
6276,the,O,284
6277,presence,O,284
6278,of,O,284
6279,pre-proliferative,B-NAME_OF_DISEASE,284
6280,or,I-NAME_OF_DISEASE,284
6281,proliferative,I-NAME_OF_DISEASE,284
6282,diabetic,I-NAME_OF_DISEASE,284
6283,retinopathy,I-NAME_OF_DISEASE,284
6284,The,B-DIAGNOSTIC_TEST,284
6285,4/2/2001,I-DIAGNOSTIC_TEST,284
6286,criteria,I-DIAGNOSTIC_TEST,284
6287,provide,O,284
6288,a,O,284
6289,standardized,O,284
6290,method,O,284
6291,for,O,284
6292,evaluating,O,284
6293,the,O,284
6294,severity,O,284
6295,of,O,284
6296,diabetic,B-NAME_OF_DISEASE,285
6297,retinopathy,I-NAME_OF_DISEASE,285
6298,which,O,285
6299,helps,O,285
6300,guide,O,285
6301,the,O,285
6302,selection,O,285
6303,of,O,285
6304,appropriate,O,285
6305,treatments,O,285
6306,and,O,285
6307,monitor,O,285
6308,disease,O,285
6309,progression,O,285
6310,What,O,285
6311,Causes,O,285
6312,Intraretinal,B-NAME_OF_DISEASE,285
6313,Microvascular,I-NAME_OF_DISEASE,285
6314,Abnormalities,I-NAME_OF_DISEASE,285
6315,IRMAs,B-NAME_OF_DISEASE,285
6316,are,O,286
6317,most,O,286
6318,commonly,O,286
6319,caused,O,286
6320,by,O,286
6321,changes,B-CAUSE_OF_DISEASE,286
6322,in,I-CAUSE_OF_DISEASE,286
6323,blood,I-CAUSE_OF_DISEASE,286
6324,sugar,I-CAUSE_OF_DISEASE,286
6325,levels,I-CAUSE_OF_DISEASE,286
6326,in,I-CAUSE_OF_DISEASE,286
6327,people,I-CAUSE_OF_DISEASE,286
6328,with,I-CAUSE_OF_DISEASE,286
6329,diabetes,I-CAUSE_OF_DISEASE,286
6330,When,O,286
6331,blood,O,286
6332,sugar,O,286
6333,levels,O,286
6334,are,O,286
6335,elevated,O,286
6336,for,O,286
6337,a,O,286
6338,prolonged,O,286
6339,period,O,286
6340,of,O,286
6341,time,O,286
6342,it,O,286
6343,can,O,287
6344,damage,O,287
6345,the,O,287
6346,tiny,O,287
6347,blood,O,287
6348,vessels,O,287
6349,in,O,287
6350,the,B-PART_OF_THE_EYES,287
6351,retina,I-PART_OF_THE_EYES,287
6352,and,O,287
6353,cause,O,287
6354,IRMAs,B-NAME_OF_DISEASE,287
6355,to,O,287
6356,form,O,287
6357,High,B-CAUSE_OF_DISEASE,287
6358,blood,I-CAUSE_OF_DISEASE,287
6359,pressure,I-CAUSE_OF_DISEASE,287
6360,smoking,B-CAUSE_OF_DISEASE,287
6361,and,O,287
6362,a,B-CAUSE_OF_DISEASE,288
6363,family,I-CAUSE_OF_DISEASE,288
6364,history,I-CAUSE_OF_DISEASE,288
6365,of,I-CAUSE_OF_DISEASE,288
6366,diabetic,I-CAUSE_OF_DISEASE,288
6367,retinopathy,I-CAUSE_OF_DISEASE,288
6368,can,O,288
6369,also,O,288
6370,increase,O,288
6371,the,O,288
6372,risk,O,288
6373,of,O,288
6374,developing,O,288
6375,IRMAs,B-NAME_OF_DISEASE,288
6376,What,O,288
6377,Are,O,288
6378,the,O,288
6379,Symptoms,O,288
6380,of,O,288
6381,Intraretinal,B-NAME_OF_DISEASE,288
6382,Microvascular,I-NAME_OF_DISEASE,288
6383,Abnormalities,I-NAME_OF_DISEASE,289
6384,In,O,289
6385,many,O,289
6386,cases,O,289
6387,IRMAs,B-NAME_OF_DISEASE,289
6388,do,O,289
6389,not,O,289
6390,cause,O,289
6391,any,O,289
6392,symptoms,O,289
6393,in,O,289
6394,the,O,289
6395,early,O,289
6396,stages,O,289
6397,As,O,289
6398,the,O,289
6399,condition,O,289
6400,progresses,O,289
6401,patients,O,289
6402,may,O,289
6403,experience,O,289
6404,blurred,B-SIGN_AND_SYMPTOM,290
6405,vision,I-SIGN_AND_SYMPTOM,290
6406,difficulty,I-SIGN_AND_SYMPTOM,290
6407,seeing,I-SIGN_AND_SYMPTOM,290
6408,in,I-SIGN_AND_SYMPTOM,290
6409,low,I-SIGN_AND_SYMPTOM,290
6410,light,I-SIGN_AND_SYMPTOM,290
6411,and,I-SIGN_AND_SYMPTOM,290
6412,floaters,I-SIGN_AND_SYMPTOM,290
6413,in,I-SIGN_AND_SYMPTOM,290
6414,their,I-SIGN_AND_SYMPTOM,290
6415,field,I-SIGN_AND_SYMPTOM,291
6416,of,I-SIGN_AND_SYMPTOM,291
6417,vision,I-SIGN_AND_SYMPTOM,291
6418,In,O,291
6419,severe,O,291
6420,cases,O,291
6421,IRMAs,B-NAME_OF_DISEASE,291
6422,can,O,291
6423,lead,O,291
6424,to,O,291
6425,vision,B-SIGN_AND_SYMPTOM,291
6426,loss,I-SIGN_AND_SYMPTOM,291
6427,and,O,291
6428,blindness,B-NAME_OF_DISEASE,292
6429,Regular,O,292
6430,comprehensive,O,292
6431,eye,O,292
6432,exams,O,292
6433,are,O,292
6434,critical,O,292
6435,for,O,292
6436,early,O,292
6437,detection,O,292
6438,and,O,292
6439,treatment,O,292
6440,of,O,292
6441,IRMAs,B-NAME_OF_DISEASE,292
6442,How,O,292
6443,to,O,292
6444,Manage,O,292
6445,Intraretinal,B-NAME_OF_DISEASE,292
6446,Microvascular,I-NAME_OF_DISEASE,292
6447,Abnormalities,I-NAME_OF_DISEASE,292
6448,Managing,O,292
6449,intraretinal,B-NAME_OF_DISEASE,292
6450,microvascular,I-NAME_OF_DISEASE,292
6451,abnormalities,I-NAME_OF_DISEASE,292
6452,IRMAs,B-NAME_OF_DISEASE,292
6453,requires,O,292
6454,a,O,292
6455,comprehensive,O,292
6456,approach,O,292
6457,that,O,292
6458,involves,O,292
6459,the,O,292
6460,following,O,292
6461,steps,O,292
6462,Monitoring,B-PREVENTION,292
6463,blood,I-PREVENTION,292
6464,sugar,I-PREVENTION,292
6465,levels,I-PREVENTION,292
6466,The,O,292
6467,first,O,292
6468,step,O,292
6469,in,O,292
6470,managing,O,292
6471,IRMAs,B-NAME_OF_DISEASE,292
6472,is,O,292
6473,to,O,292
6474,maintain,B-PREVENTION,293
6475,good,I-PREVENTION,293
6476,blood,I-PREVENTION,293
6477,sugar,I-PREVENTION,293
6478,control,I-PREVENTION,293
6479,as,O,293
6480,high,B-CAUSE_OF_DISEASE,293
6481,blood,I-CAUSE_OF_DISEASE,293
6482,sugar,I-CAUSE_OF_DISEASE,293
6483,levels,I-CAUSE_OF_DISEASE,293
6484,can,O,293
6485,worsen,O,293
6486,retinal,O,293
6487,damage,O,293
6488,Regular,B-PREVENTION,293
6489,eye,I-PREVENTION,293
6490,exams,I-PREVENTION,294
6491,Regular,B-PREVENTION,294
6492,comprehensive,I-PREVENTION,294
6493,eye,I-PREVENTION,294
6494,exams,I-PREVENTION,294
6495,are,O,294
6496,essential,O,294
6497,for,O,294
6498,early,O,294
6499,detection,O,294
6500,and,O,294
6501,management,O,294
6502,of,O,294
6503,IRMAs,B-NAME_OF_DISEASE,294
6504,This,O,295
6505,includes,O,295
6506,monitoring,O,295
6507,the,O,295
6508,progression,O,295
6509,of,O,295
6510,IRMAs,B-NAME_OF_DISEASE,295
6511,and,O,295
6512,other,O,295
6513,retinal,O,295
6514,changes,O,295
6515,such,O,295
6516,as,O,295
6517,neovascularization,O,295
6518,Treatment,O,295
6519,for,O,295
6520,diabetic,B-NAME_OF_DISEASE,295
6521,retinopathy,I-NAME_OF_DISEASE,295
6522,Depending,O,295
6523,on,O,295
6524,the,O,295
6525,severity,O,295
6526,of,O,296
6527,diabetic,B-NAME_OF_DISEASE,296
6528,retinopathy,I-NAME_OF_DISEASE,296
6529,treatment,O,296
6530,options,O,296
6531,may,O,296
6532,include,O,296
6533,laser,B-TREATMENT,296
6534,therapy,I-TREATMENT,296
6535,intravitreal,B-TREATMENT,296
6536,injections,I-TREATMENT,296
6537,or,O,296
6538,vitrectomy,B-TREATMENT,296
6539,surgery,I-TREATMENT,296
6540,Lifestyle,B-TREATMENT,296
6541,changes,I-TREATMENT,296
6542,Making,B-TREATMENT,296
6543,lifestyle,I-TREATMENT,296
6544,changes,I-TREATMENT,296
6545,such,I-TREATMENT,296
6546,as,I-TREATMENT,296
6547,eating,I-TREATMENT,296
6548,a,I-TREATMENT,296
6549,healthy,I-TREATMENT,296
6550,diet,I-TREATMENT,296
6551,exercising,I-TREATMENT,296
6552,regularly,I-TREATMENT,296
6553,and,I-TREATMENT,296
6554,quitting,I-TREATMENT,297
6555,smoking,I-TREATMENT,297
6556,can,O,297
6557,help,O,297
6558,improve,O,297
6559,overall,O,297
6560,health,O,297
6561,and,O,297
6562,slow,O,297
6563,the,O,297
6564,progression,O,297
6565,of,O,297
6566,diabetic,B-NAME_OF_DISEASE,297
6567,retinopathy,I-NAME_OF_DISEASE,297
6568,Monitoring,B-TREATMENT,297
6569,for,I-TREATMENT,297
6570,other,I-TREATMENT,297
6571,diabetes-related,I-TREATMENT,297
6572,complications,I-TREATMENT,297
6573,People,O,297
6574,with,O,297
6575,IRMAs,B-NAME_OF_DISEASE,297
6576,should,O,297
6577,also,O,297
6578,be,O,297
6579,monitored,O,297
6580,for,O,297
6581,other,O,297
6582,diabetes-related,O,297
6583,complications,O,297
6584,such,O,297
6585,as,O,297
6586,nephropathy,B-NAME_OF_DISEASE,297
6587,and,O,298
6588,neuropathy,B-NAME_OF_DISEASE,298
6589,as,O,298
6590,they,O,298
6591,can,O,298
6592,have,O,298
6593,a,O,298
6594,significant,O,298
6595,impact,O,298
6596,on,O,298
6597,overall,O,298
6598,health,O,298
6599,and,O,298
6600,vision,O,298
6601,Selenium,B-CHEMICAL_COMPOUND,298
6602,is,O,298
6603,an,O,298
6604,essential,O,298
6605,mineral,O,298
6606,that,O,298
6607,plays,O,298
6608,a,O,298
6609,vital,O,298
6610,role,O,298
6611,in,O,298
6612,maintaining,O,298
6613,overall,O,299
6614,health,O,299
6615,and,O,299
6616,wellness,O,299
6617,particularly,O,299
6618,in,O,299
6619,regards,O,299
6620,to,O,299
6621,eye,O,299
6622,health,O,299
6623,and,O,299
6624,thyroid,B-NAME_OF_DISEASE,299
6625,eye,I-NAME_OF_DISEASE,299
6626,disease,I-NAME_OF_DISEASE,299
6627,One,O,299
6628,of,O,299
6629,the,O,299
6630,main,O,300
6631,ways,O,300
6632,that,O,300
6633,selenium,B-CHEMICAL_COMPOUND,300
6634,contributes,O,300
6635,to,O,300
6636,eye,O,300
6637,health,O,300
6638,is,O,300
6639,by,O,300
6640,acting,O,300
6641,as,O,300
6642,an,O,300
6643,antioxidant,B-TREATMENT,301
6644,Antioxidants,B-TREATMENT,301
6645,are,O,301
6646,substances,O,301
6647,that,O,301
6648,protect,O,301
6649,the,O,301
6650,body,O,301
6651,from,O,301
6652,damage,O,301
6653,caused,O,301
6654,by,O,301
6655,free,B-CAUSE_OF_DISEASE,301
6656,radicals,I-CAUSE_OF_DISEASE,302
6657,Free,B-CAUSE_OF_DISEASE,302
6658,radicals,I-CAUSE_OF_DISEASE,302
6659,are,O,302
6660,molecules,O,302
6661,that,O,302
6662,can,O,302
6663,damage,O,302
6664,cells,O,302
6665,leading,O,302
6666,to,O,302
6667,inflammation,O,302
6668,and,O,302
6669,disease,O,302
6670,Selenium,B-CHEMICAL_COMPOUND,303
6671,helps,O,303
6672,to,O,303
6673,neutralize,O,303
6674,free,B-CAUSE_OF_DISEASE,303
6675,radicals,I-CAUSE_OF_DISEASE,303
6676,preventing,O,303
6677,them,O,303
6678,from,O,303
6679,causing,O,303
6680,harm,O,303
6681,to,O,303
6682,the,O,303
6683,eyes,O,303
6684,Furthermore,O,303
6685,the,O,303
6686,human,O,303
6687,body,O,303
6688,requires,O,303
6689,selenium,B-CHEMICAL_COMPOUND,303
6690,for,O,303
6691,the,O,303
6692,proper,O,303
6693,functioning,O,304
6694,of,O,304
6695,the,O,304
6696,thyroid,O,304
6697,gland,O,304
6698,and,O,304
6699,the,O,304
6700,production,O,304
6701,of,O,304
6702,the,B-CHEMICAL_COMPOUND,304
6703,antioxidant,I-CHEMICAL_COMPOUND,304
6704,enzyme,I-CHEMICAL_COMPOUND,304
6705,glutathione,B-CHEMICAL_COMPOUND,304
6706,peroxidase,I-CHEMICAL_COMPOUND,304
6707,The,O,304
6708,Role,O,304
6709,of,O,304
6710,Selenium,B-CHEMICAL_COMPOUND,304
6711,in,O,304
6712,Managing,O,304
6713,Symptoms,O,304
6714,of,O,304
6715,Thyroid,B-NAME_OF_DISEASE,304
6716,Eye,I-NAME_OF_DISEASE,304
6717,Disease,I-NAME_OF_DISEASE,304
6718,Thyroid,B-NAME_OF_DISEASE,304
6719,eye,I-NAME_OF_DISEASE,304
6720,disease,I-NAME_OF_DISEASE,304
6721,also,O,304
6722,known,O,304
6723,as,O,304
6724,Graves,B-NAME_OF_DISEASE,304
6725,orbitopathy,I-NAME_OF_DISEASE,305
6726,is,O,305
6727,a,O,305
6728,condition,O,305
6729,that,O,305
6730,occurs,O,305
6731,as,O,305
6732,a,O,305
6733,result,O,305
6734,of,O,305
6735,an,B-SIGN_AND_SYMPTOM,305
6736,overactive,I-SIGN_AND_SYMPTOM,305
6737,thyroid,I-SIGN_AND_SYMPTOM,305
6738,gland,I-SIGN_AND_SYMPTOM,305
6739,It,O,305
6740,causes,O,305
6741,inflammation,B-SIGN_AND_SYMPTOM,305
6742,and,I-SIGN_AND_SYMPTOM,305
6743,swelling,I-SIGN_AND_SYMPTOM,305
6744,of,I-SIGN_AND_SYMPTOM,305
6745,the,I-SIGN_AND_SYMPTOM,305
6746,muscles,I-SIGN_AND_SYMPTOM,305
6747,and,I-SIGN_AND_SYMPTOM,305
6748,tissues,I-SIGN_AND_SYMPTOM,305
6749,surrounding,I-SIGN_AND_SYMPTOM,305
6750,the,I-SIGN_AND_SYMPTOM,306
6751,eyes,I-SIGN_AND_SYMPTOM,306
6752,leading,O,306
6753,to,O,306
6754,symptoms,O,306
6755,such,O,306
6756,as,O,306
6757,bulging,B-SIGN_AND_SYMPTOM,306
6758,eyes,I-SIGN_AND_SYMPTOM,306
6759,double,I-SIGN_AND_SYMPTOM,306
6760,vision,I-SIGN_AND_SYMPTOM,306
6761,and,I-SIGN_AND_SYMPTOM,306
6762,dry,I-SIGN_AND_SYMPTOM,306
6763,eyes,I-SIGN_AND_SYMPTOM,306
6764,Studies,O,306
6765,have,O,306
6766,shown,O,306
6767,that,O,306
6768,individuals,O,306
6769,with,O,306
6770,thyroid,B-NAME_OF_DISEASE,306
6771,eye,I-NAME_OF_DISEASE,306
6772,disease,I-NAME_OF_DISEASE,306
6773,have,O,307
6774,lower,O,307
6775,levels,O,307
6776,of,O,307
6777,selenium,B-CHEMICAL_COMPOUND,307
6778,in,O,307
6779,their,O,307
6780,blood,O,307
6781,compared,O,307
6782,to,O,307
6783,those,O,307
6784,without,O,307
6785,the,O,307
6786,condition,O,307
6787,Supplementation,O,307
6788,with,O,307
6789,selenium,B-CHEMICAL_COMPOUND,307
6790,has,O,307
6791,been,O,307
6792,found,O,307
6793,to,O,307
6794,reduce,O,307
6795,the,O,307
6796,severity,O,307
6797,of,O,307
6798,symptoms,O,308
6799,and,O,308
6800,improve,O,308
6801,the,O,308
6802,overall,O,308
6803,quality,O,308
6804,of,O,308
6805,life,O,308
6806,in,O,308
6807,those,O,308
6808,with,O,308
6809,thyroid,B-NAME_OF_DISEASE,308
6810,eye,I-NAME_OF_DISEASE,308
6811,disease,I-NAME_OF_DISEASE,308
6812,Selenium,B-CHEMICAL_COMPOUND,308
6813,is,O,308
6814,also,O,308
6815,essential,O,308
6816,for,O,308
6817,maintaining,O,308
6818,the,O,308
6819,health,O,308
6820,of,O,308
6821,the,B-PART_OF_THE_EYES,308
6822,retina,I-PART_OF_THE_EYES,308
6823,the,O,309
6824,part,O,309
6825,of,O,309
6826,the,O,309
6827,eye,O,309
6828,that,O,309
6829,detects,O,309
6830,light,O,309
6831,and,O,309
6832,sends,O,309
6833,signals,O,309
6834,to,O,309
6835,the,O,309
6836,brain,O,309
6837,The,B-PART_OF_THE_EYES,309
6838,retina,I-PART_OF_THE_EYES,309
6839,contains,O,309
6840,high,O,309
6841,levels,O,309
6842,of,O,309
6843,selenium,B-CHEMICAL_COMPOUND,309
6844,and,O,309
6845,research,O,309
6846,has,O,309
6847,shown,O,309
6848,that,O,309
6849,low,O,309
6850,levels,O,309
6851,of,O,309
6852,selenium,B-CHEMICAL_COMPOUND,309
6853,can,O,309
6854,lead,O,309
6855,to,O,309
6856,damage,O,309
6857,in,O,309
6858,the,B-PART_OF_THE_EYES,309
6859,retina,I-PART_OF_THE_EYES,309
6860,increasing,O,309
6861,the,O,309
6862,risk,O,309
6863,of,O,309
6864,eye,O,309
6865,disorders,O,309
6866,such,O,309
6867,as,O,309
6868,age-related,B-NAME_OF_DISEASE,310
6869,macular,I-NAME_OF_DISEASE,310
6870,degeneration,I-NAME_OF_DISEASE,310
6871,AMD,B-NAME_OF_DISEASE,310
6872,and,O,310
6873,cataracts,B-NAME_OF_DISEASE,310
6874,-,O,310
6875,two,O,310
6876,of,O,310
6877,the,O,310
6878,leading,O,310
6879,causes,O,310
6880,of,O,310
6881,blindness,B-NAME_OF_DISEASE,310
6882,In,O,310
6883,addition,O,310
6884,to,O,311
6885,its,O,311
6886,role,O,311
6887,in,O,311
6888,eye,O,311
6889,health,O,311
6890,selenium,B-CHEMICAL_COMPOUND,311
6891,also,O,311
6892,has,O,311
6893,a,O,311
6894,number,O,311
6895,of,O,311
6896,other,O,311
6897,benefits,O,311
6898,It,O,311
6899,supports,O,311
6900,the,O,312
6901,immune,O,312
6902,system,O,312
6903,helps,O,312
6904,to,O,312
6905,regulate,O,312
6906,thyroid,O,312
6907,function,O,312
6908,and,O,312
6909,may,O,312
6910,even,O,312
6911,have,O,312
6912,anti-cancer,O,312
6913,properties,O,312
6914,Where,O,312
6915,Is,O,312
6916,Selenium,B-CHEMICAL_COMPOUND,312
6917,Found,O,312
6918,In,O,312
6919,terms,O,312
6920,of,O,312
6921,food,O,312
6922,sources,O,312
6923,selenium,B-CHEMICAL_COMPOUND,312
6924,can,O,312
6925,be,O,312
6926,found,O,312
6927,in,O,312
6928,a,O,312
6929,variety,O,312
6930,of,O,312
6931,different,O,312
6932,types,O,312
6933,of,O,312
6934,food,O,313
6935,including,O,313
6936,meats,O,313
6937,seafood,O,313
6938,eggs,O,313
6939,dairy,O,313
6940,products,O,313
6941,and,O,313
6942,some,O,313
6943,types,O,313
6944,of,O,313
6945,nuts,O,313
6946,and,O,313
6947,seeds,O,313
6948,Some,O,313
6949,of,O,313
6950,the,O,314
6951,best,O,314
6952,food,O,314
6953,sources,O,314
6954,of,O,314
6955,selenium,B-CHEMICAL_COMPOUND,314
6956,include,O,314
6957,Brazil,B-GPE,314
6958,nuts,O,314
6959,tuna,O,314
6960,shrimp,O,314
6961,and,O,315
6962,sunflower,O,315
6963,seeds,O,315
6964,Whole,O,315
6965,grains,O,315
6966,such,O,315
6967,as,O,315
6968,brown,O,315
6969,rice,O,315
6970,and,O,315
6971,barley,O,315
6972,also,O,315
6973,contain,O,315
6974,selenium,B-CHEMICAL_COMPOUND,315
6975,However,O,315
6976,the,O,315
6977,selenium,B-CHEMICAL_COMPOUND,315
6978,content,O,315
6979,of,O,315
6980,foods,O,315
6981,can,O,315
6982,vary,O,315
6983,depending,O,315
6984,on,O,316
6985,the,O,316
6986,selenium,B-CHEMICAL_COMPOUND,316
6987,content,O,316
6988,of,O,316
6989,the,O,316
6990,soil,O,316
6991,in,O,316
6992,which,O,316
6993,they,O,316
6994,were,O,316
6995,grown,O,316
6996,or,O,316
6997,raised,O,316
6998,Selenium,B-CHEMICAL_COMPOUND,316
6999,is,O,316
7000,also,O,316
7001,found,O,316
7002,in,O,316
7003,water,O,317
7004,with,O,317
7005,the,O,317
7006,amount,O,317
7007,of,O,317
7008,selenium,B-CHEMICAL_COMPOUND,317
7009,in,O,317
7010,water,O,317
7011,sources,O,317
7012,varying,O,317
7013,depending,O,317
7014,on,O,317
7015,the,O,317
7016,location,O,318
7017,Some,O,318
7018,groundwater,O,318
7019,sources,O,318
7020,contain,O,318
7021,high,O,318
7022,levels,O,318
7023,of,O,318
7024,selenium,B-CHEMICAL_COMPOUND,318
7025,while,O,318
7026,others,O,318
7027,contain,O,318
7028,very,O,318
7029,little,O,318
7030,Selenium,B-CHEMICAL_COMPOUND,318
7031,can,O,318
7032,also,O,319
7033,be,O,319
7034,found,O,319
7035,in,O,319
7036,some,O,319
7037,types,O,319
7038,of,O,319
7039,seafood,O,319
7040,such,O,319
7041,as,O,319
7042,tuna,O,319
7043,halibut,O,319
7044,and,O,319
7045,sardines,O,319
7046,In,O,319
7047,terms,O,319
7048,of,O,319
7049,supplement,O,320
7050,form,O,320
7051,selenium,B-CHEMICAL_COMPOUND,320
7052,supplements,O,320
7053,come,O,320
7054,in,O,320
7055,different,O,320
7056,forms,O,320
7057,such,O,320
7058,as,O,320
7059,tablets,O,320
7060,capsules,O,320
7061,and,O,321
7062,liquids,O,321
7063,It,O,321
7064,is,O,321
7065,important,O,321
7066,to,O,321
7067,note,O,321
7068,that,O,321
7069,Selenium,B-CHEMICAL_COMPOUND,321
7070,is,O,321
7071,toxic,O,321
7072,in,O,322
7073,high,O,322
7074,doses,O,322
7075,The,O,322
7076,recommended,O,322
7077,daily,O,322
7078,dose,O,322
7079,for,O,322
7080,adults,O,322
7081,is,O,322
7082,55,O,322
7083,micrograms,O,322
7084,for,O,322
7085,adults,O,323
7086,Excessive,O,323
7087,intake,O,323
7088,can,O,323
7089,lead,O,323
7090,to,O,323
7091,hair,B-SIGN_AND_SYMPTOM,323
7092,loss,I-SIGN_AND_SYMPTOM,323
7093,skin,I-SIGN_AND_SYMPTOM,323
7094,rash,I-SIGN_AND_SYMPTOM,323
7095,and,I-SIGN_AND_SYMPTOM,323
7096,nervous,I-SIGN_AND_SYMPTOM,323
7097,system,I-SIGN_AND_SYMPTOM,323
7098,problems,I-SIGN_AND_SYMPTOM,323
7099,It,O,324
7100,is,O,324
7101,always,O,324
7102,recommended,O,324
7103,to,O,324
7104,consult,O,324
7105,a,O,324
7106,healthcare,O,324
7107,professional,O,324
7108,before,O,324
7109,taking,O,324
7110,any,O,324
7111,new,O,324
7112,supplement.,O,324
7113,In,O,324
7114,conclusion,O,324
7115,selenium,B-CHEMICAL_COMPOUND,324
7116,plays,O,324
7117,a,O,324
7118,crucial,O,324
7119,role,O,324
7120,in,O,324
7121,maintaining,O,325
7122,eye,O,325
7123,health,O,325
7124,and,O,325
7125,can,O,325
7126,be,O,325
7127,particularly,O,325
7128,beneficial,O,325
7129,for,O,325
7130,individuals,O,325
7131,with,O,325
7132,thyroid,B-NAME_OF_DISEASE,325
7133,eye,I-NAME_OF_DISEASE,325
7134,disease,I-NAME_OF_DISEASE,325
7135,Incorporating,O,325
7136,selenium-rich,O,325
7137,foods,O,325
7138,into,O,325
7139,the,O,325
7140,diet,O,325
7141,or,O,325
7142,consulting,O,325
7143,a,O,325
7144,healthcare,O,325
7145,professional,O,326
7146,about,O,326
7147,supplement,O,326
7148,options,O,326
7149,can,O,326
7150,help,O,326
7151,to,O,326
7152,ensure,O,326
7153,adequate,O,326
7154,intake,O,326
7155,of,O,326
7156,this,O,326
7157,essential,O,326
7158,mineral,O,326
7159,Panophthalmitis,B-NAME_OF_DISEASE,326
7160,is,O,326
7161,a,O,326
7162,serious,O,326
7163,and,O,326
7164,potentially,O,327
7165,blinding,O,327
7166,infection,O,327
7167,of,O,327
7168,the,O,327
7169,eye,O,327
7170,that,O,327
7171,involves,O,327
7172,the,B-PART_OF_THE_EYES,327
7173,entire,I-PART_OF_THE_EYES,327
7174,globe,I-PART_OF_THE_EYES,327
7175,of,I-PART_OF_THE_EYES,327
7176,the,I-PART_OF_THE_EYES,327
7177,eye,I-PART_OF_THE_EYES,327
7178,It,O,328
7179,is,O,328
7180,a,O,328
7181,rare,O,328
7182,but,O,328
7183,serious,O,328
7184,condition,O,328
7185,that,O,328
7186,requires,O,328
7187,prompt,O,328
7188,medical,O,328
7189,attention,O,328
7190,and,O,328
7191,treatment,O,328
7192,Causes,O,328
7193,of,O,328
7194,Panophthalmitis,B-NAME_OF_DISEASE,328
7195,Bacterial,B-CAUSE_OF_DISEASE,328
7196,infections,I-CAUSE_OF_DISEASE,328
7197,The,O,328
7198,most,O,328
7199,common,O,328
7200,cause,O,329
7201,of,O,329
7202,panophthalmitis,B-NAME_OF_DISEASE,329
7203,is,O,329
7204,a,B-CAUSE_OF_DISEASE,329
7205,bacterial,I-CAUSE_OF_DISEASE,329
7206,infection,I-CAUSE_OF_DISEASE,329
7207,such,I-CAUSE_OF_DISEASE,329
7208,as,I-CAUSE_OF_DISEASE,329
7209,Staphylococcus,I-CAUSE_OF_DISEASE,329
7210,aureus,I-CAUSE_OF_DISEASE,329
7211,or,I-CAUSE_OF_DISEASE,329
7212,Streptococcus,I-CAUSE_OF_DISEASE,329
7213,pneumoniae,I-CAUSE_OF_DISEASE,329
7214,These,O,329
7215,bacteria,O,329
7216,can,O,329
7217,enter,O,329
7218,the,O,329
7219,eye,O,329
7220,through,O,330
7221,a,O,330
7222,variety,O,330
7223,of,O,330
7224,means,O,330
7225,including,O,330
7226,a,B-CAUSE_OF_DISEASE,330
7227,penetrating,I-CAUSE_OF_DISEASE,330
7228,injury,I-CAUSE_OF_DISEASE,330
7229,trauma,I-CAUSE_OF_DISEASE,330
7230,or,I-CAUSE_OF_DISEASE,330
7231,a,I-CAUSE_OF_DISEASE,330
7232,surgical,I-CAUSE_OF_DISEASE,330
7233,procedure,I-CAUSE_OF_DISEASE,331
7234,Fungal,B-CAUSE_OF_DISEASE,331
7235,infections,I-CAUSE_OF_DISEASE,331
7236,Fungal,B-CAUSE_OF_DISEASE,331
7237,infections,I-CAUSE_OF_DISEASE,331
7238,such,I-CAUSE_OF_DISEASE,331
7239,as,I-CAUSE_OF_DISEASE,331
7240,Aspergillosis,I-CAUSE_OF_DISEASE,331
7241,and,I-CAUSE_OF_DISEASE,331
7242,Candida,I-CAUSE_OF_DISEASE,331
7243,can,O,331
7244,also,O,331
7245,cause,O,331
7246,panophthalmitis,B-NAME_OF_DISEASE,331
7247,These,O,331
7248,infections,O,331
7249,can,O,331
7250,occur,O,331
7251,in,O,331
7252,individuals,O,332
7253,with,O,332
7254,weakened,O,332
7255,immune,O,332
7256,systems,O,332
7257,or,O,332
7258,in,O,332
7259,those,O,332
7260,who,O,332
7261,have,O,332
7262,had,O,332
7263,previous,O,332
7264,eye,O,332
7265,surgeries,O,332
7266,Trauma,B-CAUSE_OF_DISEASE,332
7267,Trauma,B-CAUSE_OF_DISEASE,332
7268,to,I-CAUSE_OF_DISEASE,332
7269,the,I-CAUSE_OF_DISEASE,332
7270,eye,I-CAUSE_OF_DISEASE,332
7271,such,I-CAUSE_OF_DISEASE,332
7272,as,I-CAUSE_OF_DISEASE,332
7273,a,I-CAUSE_OF_DISEASE,333
7274,penetrating,I-CAUSE_OF_DISEASE,333
7275,injury,I-CAUSE_OF_DISEASE,333
7276,or,I-CAUSE_OF_DISEASE,333
7277,a,I-CAUSE_OF_DISEASE,333
7278,foreign,I-CAUSE_OF_DISEASE,333
7279,body,I-CAUSE_OF_DISEASE,333
7280,in,I-CAUSE_OF_DISEASE,333
7281,the,I-CAUSE_OF_DISEASE,333
7282,eye,I-CAUSE_OF_DISEASE,333
7283,can,O,333
7284,also,O,333
7285,cause,O,333
7286,panophthalmitis,B-NAME_OF_DISEASE,333
7287,In,O,333
7288,these,O,333
7289,cases,O,333
7290,the,O,333
7291,bacteria,O,333
7292,can,O,334
7293,enter,O,334
7294,the,O,334
7295,eye,O,334
7296,through,O,334
7297,the,O,334
7298,site,O,334
7299,of,O,334
7300,the,O,334
7301,injury,O,334
7302,and,O,334
7303,cause,O,334
7304,an,O,334
7305,infection,O,334
7306,Systemic,B-CAUSE_OF_DISEASE,334
7307,infections,I-CAUSE_OF_DISEASE,334
7308,In,O,334
7309,some,O,334
7310,cases,O,334
7311,panophthalmitis,B-NAME_OF_DISEASE,334
7312,can,O,334
7313,be,O,334
7314,caused,O,334
7315,by,O,334
7316,a,B-CAUSE_OF_DISEASE,335
7317,systemic,I-CAUSE_OF_DISEASE,335
7318,infection,I-CAUSE_OF_DISEASE,335
7319,such,I-CAUSE_OF_DISEASE,335
7320,as,I-CAUSE_OF_DISEASE,335
7321,sepsis,I-CAUSE_OF_DISEASE,335
7322,that,O,335
7323,spreads,O,335
7324,to,O,335
7325,the,O,335
7326,eye,O,335
7327,through,O,335
7328,the,O,335
7329,bloodstream,O,335
7330,Signs,O,335
7331,and,O,335
7332,Symptoms,O,335
7333,of,O,335
7334,Panophthalmitis,B-NAME_OF_DISEASE,335
7335,Redness,B-SIGN_AND_SYMPTOM,335
7336,and,I-SIGN_AND_SYMPTOM,335
7337,swelling,I-SIGN_AND_SYMPTOM,335
7338,of,I-SIGN_AND_SYMPTOM,335
7339,the,I-SIGN_AND_SYMPTOM,335
7340,eye,I-SIGN_AND_SYMPTOM,335
7341,The,I-SIGN_AND_SYMPTOM,336
7342,eye,I-SIGN_AND_SYMPTOM,336
7343,may,I-SIGN_AND_SYMPTOM,336
7344,appear,I-SIGN_AND_SYMPTOM,336
7345,red,I-SIGN_AND_SYMPTOM,336
7346,and,I-SIGN_AND_SYMPTOM,336
7347,swollen,I-SIGN_AND_SYMPTOM,336
7348,with,I-SIGN_AND_SYMPTOM,336
7349,the,I-SIGN_AND_SYMPTOM,336
7350,eyelids,I-SIGN_AND_SYMPTOM,336
7351,appearing,I-SIGN_AND_SYMPTOM,336
7352,puffy,I-SIGN_AND_SYMPTOM,336
7353,and,I-SIGN_AND_SYMPTOM,336
7354,swollen,I-SIGN_AND_SYMPTOM,336
7355,Pain,B-SIGN_AND_SYMPTOM,336
7356,The,O,336
7357,patient,O,336
7358,may,O,336
7359,experience,O,336
7360,severe,B-SIGN_AND_SYMPTOM,336
7361,pain,I-SIGN_AND_SYMPTOM,337
7362,in,I-SIGN_AND_SYMPTOM,337
7363,the,I-SIGN_AND_SYMPTOM,337
7364,affected,I-SIGN_AND_SYMPTOM,337
7365,eye,I-SIGN_AND_SYMPTOM,337
7366,which,I-SIGN_AND_SYMPTOM,337
7367,may,I-SIGN_AND_SYMPTOM,337
7368,be,I-SIGN_AND_SYMPTOM,337
7369,exacerbated,I-SIGN_AND_SYMPTOM,337
7370,by,I-SIGN_AND_SYMPTOM,338
7371,movement,I-SIGN_AND_SYMPTOM,338
7372,of,I-SIGN_AND_SYMPTOM,338
7373,the,I-SIGN_AND_SYMPTOM,338
7374,eye,I-SIGN_AND_SYMPTOM,338
7375,Decreased,B-SIGN_AND_SYMPTOM,338
7376,vision,I-SIGN_AND_SYMPTOM,338
7377,Vision,I-SIGN_AND_SYMPTOM,338
7378,may,I-SIGN_AND_SYMPTOM,338
7379,be,I-SIGN_AND_SYMPTOM,339
7380,decreased,I-SIGN_AND_SYMPTOM,339
7381,or,I-SIGN_AND_SYMPTOM,339
7382,lost,I-SIGN_AND_SYMPTOM,339
7383,completely,I-SIGN_AND_SYMPTOM,339
7384,Light,B-SIGN_AND_SYMPTOM,339
7385,sensitivity,I-SIGN_AND_SYMPTOM,339
7386,The,O,339
7387,patient,O,339
7388,may,O,339
7389,experience,O,339
7390,sensitivity,B-SIGN_AND_SYMPTOM,339
7391,to,I-SIGN_AND_SYMPTOM,339
7392,light,I-SIGN_AND_SYMPTOM,340
7393,Discharge,B-SIGN_AND_SYMPTOM,340
7394,The,O,340
7395,patient,O,340
7396,may,O,340
7397,experience,O,340
7398,a,B-SIGN_AND_SYMPTOM,340
7399,thick,I-SIGN_AND_SYMPTOM,340
7400,purulent,I-SIGN_AND_SYMPTOM,340
7401,discharge,I-SIGN_AND_SYMPTOM,340
7402,from,I-SIGN_AND_SYMPTOM,340
7403,the,I-SIGN_AND_SYMPTOM,340
7404,affected,I-SIGN_AND_SYMPTOM,340
7405,eye,I-SIGN_AND_SYMPTOM,340
7406,Difference,O,340
7407,Between,O,340
7408,Panophthalmitis,B-NAME_OF_DISEASE,340
7409,and,O,340
7410,Endophthalmitis,B-NAME_OF_DISEASE,340
7411,Panophthalmitis,B-NAME_OF_DISEASE,340
7412,and,O,340
7413,endophthalmitis,B-NAME_OF_DISEASE,340
7414,are,O,340
7415,both,O,340
7416,serious,O,340
7417,infections,O,340
7418,that,O,341
7419,affect,O,341
7420,the,O,341
7421,eye,O,341
7422,but,O,341
7423,there,O,341
7424,are,O,341
7425,some,O,341
7426,key,O,341
7427,differences,O,341
7428,between,O,341
7429,the,O,341
7430,two,O,341
7431,conditions,O,341
7432,Panophthalmitis,B-NAME_OF_DISEASE,341
7433,is,O,341
7434,an,O,341
7435,infection,O,342
7436,that,O,342
7437,affects,O,342
7438,the,O,342
7439,entire,O,342
7440,eye,O,342
7441,including,O,342
7442,the,B-PART_OF_THE_EYES,342
7443,eyelids,I-PART_OF_THE_EYES,342
7444,sclera,B-PART_OF_THE_EYES,342
7445,cornea,B-PART_OF_THE_EYES,342
7446,iris,B-PART_OF_THE_EYES,342
7447,and,O,342
7448,retina,B-PART_OF_THE_EYES,342
7449,Endophthalmitis,B-NAME_OF_DISEASE,342
7450,on,O,342
7451,the,O,342
7452,other,O,342
7453,hand,O,342
7454,is,O,342
7455,an,O,342
7456,infection,O,342
7457,that,O,342
7458,affects,O,343
7459,the,O,343
7460,internal,O,343
7461,structures,O,343
7462,of,O,343
7463,the,O,343
7464,eye,O,343
7465,including,O,343
7466,the,B-PART_OF_THE_EYES,343
7467,vitreous,I-PART_OF_THE_EYES,343
7468,humor,I-PART_OF_THE_EYES,343
7469,and,O,343
7470,the,B-PART_OF_THE_EYES,343
7471,retina,I-PART_OF_THE_EYES,343
7472,How,O,343
7473,to,O,343
7474,Diagnose,O,343
7475,Panophthalmitis,B-NAME_OF_DISEASE,344
7476,To,O,344
7477,diagnose,O,344
7478,panophthalmitis,B-NAME_OF_DISEASE,344
7479,an,O,344
7480,eye,O,344
7481,doctor,O,344
7482,will,O,344
7483,first,O,344
7484,perform,O,344
7485,a,B-DIAGNOSTIC_TEST,344
7486,thorough,I-DIAGNOSTIC_TEST,344
7487,eye,I-DIAGNOSTIC_TEST,344
7488,examination,I-DIAGNOSTIC_TEST,344
7489,This,O,344
7490,may,O,344
7491,include,O,344
7492,measuring,B-DIAGNOSTIC_TEST,344
7493,the,I-DIAGNOSTIC_TEST,344
7494,patient,I-DIAGNOSTIC_TEST,344
7495,s,I-DIAGNOSTIC_TEST,344
7496,visual,I-DIAGNOSTIC_TEST,344
7497,acuity,I-DIAGNOSTIC_TEST,344
7498,examining,I-DIAGNOSTIC_TEST,344
7499,the,I-DIAGNOSTIC_TEST,344
7500,eye,I-DIAGNOSTIC_TEST,344
7501,with,I-DIAGNOSTIC_TEST,344
7502,a,I-DIAGNOSTIC_TEST,344
7503,microscope,I-DIAGNOSTIC_TEST,344
7504,and,I-DIAGNOSTIC_TEST,345
7505,performing,I-DIAGNOSTIC_TEST,345
7506,a,I-DIAGNOSTIC_TEST,345
7507,test,I-DIAGNOSTIC_TEST,345
7508,called,I-DIAGNOSTIC_TEST,345
7509,a,I-DIAGNOSTIC_TEST,345
7510,slit-lamp,I-DIAGNOSTIC_TEST,345
7511,examination,I-DIAGNOSTIC_TEST,345
7512,to,O,345
7513,look,O,345
7514,for,O,345
7515,signs,O,345
7516,of,O,345
7517,inflammation,O,345
7518,The,O,345
7519,doctor,O,345
7520,may,O,345
7521,also,O,345
7522,take,B-DIAGNOSTIC_TEST,345
7523,a,I-DIAGNOSTIC_TEST,345
7524,sample,I-DIAGNOSTIC_TEST,345
7525,of,I-DIAGNOSTIC_TEST,346
7526,fluid,I-DIAGNOSTIC_TEST,346
7527,from,I-DIAGNOSTIC_TEST,346
7528,the,I-DIAGNOSTIC_TEST,346
7529,eye,I-DIAGNOSTIC_TEST,346
7530,to,O,346
7531,check,O,346
7532,for,O,346
7533,bacteria,O,346
7534,or,O,346
7535,other,O,346
7536,signs,O,346
7537,of,O,346
7538,infection,O,346
7539,In,O,346
7540,some,O,346
7541,cases,O,346
7542,imaging,B-DIAGNOSTIC_TEST,346
7543,tests,I-DIAGNOSTIC_TEST,346
7544,such,I-DIAGNOSTIC_TEST,346
7545,as,I-DIAGNOSTIC_TEST,346
7546,ultrasound,I-DIAGNOSTIC_TEST,346
7547,or,I-DIAGNOSTIC_TEST,346
7548,computed,I-DIAGNOSTIC_TEST,346
7549,tomography,I-DIAGNOSTIC_TEST,346
7550,CT,I-DIAGNOSTIC_TEST,346
7551,scans,I-DIAGNOSTIC_TEST,346
7552,may,O,346
7553,be,O,347
7554,used,O,347
7555,to,O,347
7556,help,O,347
7557,diagnose,O,347
7558,panophthalmitis,B-NAME_OF_DISEASE,347
7559,and,O,347
7560,to,O,347
7561,determine,O,347
7562,the,O,347
7563,extent,O,347
7564,of,O,347
7565,the,O,347
7566,infection,O,347
7567,Managing,O,347
7568,Panophthalmitis,B-NAME_OF_DISEASE,347
7569,The,O,348
7570,primary,O,348
7571,treatment,O,348
7572,for,O,348
7573,panophthalmitis,B-NAME_OF_DISEASE,348
7574,is,O,348
7575,antibiotics,B-TREATMENT,348
7576,to,O,348
7577,fight,O,348
7578,the,O,348
7579,infection,O,348
7580,and,O,349
7581,reduce,O,349
7582,inflammation,O,349
7583,Steroids,B-NAME_OF_DRUG,349
7584,may,O,349
7585,also,O,349
7586,be,O,349
7587,used,O,349
7588,to,O,349
7589,reduce,O,349
7590,inflammation,O,349
7591,and,O,349
7592,prevent,O,349
7593,complications,O,349
7594,In,O,349
7595,severe,O,349
7596,cases,O,349
7597,surgery,B-TREATMENT,349
7598,may,O,350
7599,be,O,350
7600,necessary,O,350
7601,to,O,350
7602,remove,O,350
7603,infected,O,350
7604,tissue,O,350
7605,and,O,350
7606,prevent,O,350
7607,the,O,350
7608,spread,O,350
7609,of,O,350
7610,the,O,350
7611,infection,O,350
7612,It,O,350
7613,s,O,350
7614,important,O,351
7615,to,O,351
7616,follow,O,351
7617,your,O,351
7618,doctor,O,351
7619,s,O,351
7620,instructions,O,351
7621,carefully,O,351
7622,and,O,351
7623,take,O,351
7624,all,O,351
7625,medications,O,351
7626,as,O,351
7627,prescribed,O,351
7628,It,O,351
7629,s,O,351
7630,also,O,351
7631,important,O,351
7632,to,O,351
7633,attend,O,351
7634,all,O,351
7635,follow-up,O,351
7636,appointments,O,352
7637,to,O,352
7638,monitor,O,352
7639,your,O,352
7640,progress,O,352
7641,and,O,352
7642,ensure,O,352
7643,that,O,352
7644,the,O,352
7645,infection,O,352
7646,is,O,352
7647,responding,O,352
7648,to,O,352
7649,treatment,O,352
7650,Managing,O,352
7651,Your,O,352
7652,Panophthalmitis,B-NAME_OF_DISEASE,352
7653,At,O,352
7654,Home,O,353
7655,Apply,B-TREATMENT,353
7656,a,I-TREATMENT,353
7657,warm,I-TREATMENT,353
7658,compress,I-TREATMENT,353
7659,to,I-TREATMENT,353
7660,the,I-TREATMENT,353
7661,affected,I-TREATMENT,353
7662,eye,I-TREATMENT,353
7663,to,O,353
7664,reduce,O,353
7665,pain,O,353
7666,and,O,354
7667,inflammation,O,354
7668,Keep,B-TREATMENT,354
7669,your,I-TREATMENT,354
7670,head,I-TREATMENT,354
7671,elevated,I-TREATMENT,354
7672,to,O,354
7673,reduce,O,354
7674,swelling,O,354
7675,and,O,354
7676,pressure,O,354
7677,in,O,354
7678,the,O,354
7679,eye,O,355
7680,Avoid,B-TREATMENT,355
7681,touching,I-TREATMENT,355
7682,or,I-TREATMENT,355
7683,rubbing,I-TREATMENT,355
7684,your,I-TREATMENT,355
7685,eye,I-TREATMENT,355
7686,as,O,355
7687,this,O,355
7688,can,O,355
7689,further,O,355
7690,irritate,O,355
7691,the,O,355
7692,infection,O,355
7693,Wear,B-TREATMENT,355
7694,protective,I-TREATMENT,355
7695,eye,I-TREATMENT,355
7696,gear,I-TREATMENT,355
7697,such,I-TREATMENT,355
7698,as,I-TREATMENT,356
7699,goggles,I-TREATMENT,356
7700,or,I-TREATMENT,356
7701,safety,I-TREATMENT,356
7702,glasses,I-TREATMENT,356
7703,to,O,356
7704,reduce,O,356
7705,your,O,356
7706,risk,O,356
7707,of,O,356
7708,further,O,356
7709,injury,O,356
7710,or,O,356
7711,infection,O,356
7712,Avoid,B-TREATMENT,356
7713,activities,I-TREATMENT,357
7714,that,I-TREATMENT,357
7715,may,I-TREATMENT,357
7716,further,I-TREATMENT,357
7717,irritate,I-TREATMENT,357
7718,the,I-TREATMENT,357
7719,eye,I-TREATMENT,357
7720,such,I-TREATMENT,357
7721,as,I-TREATMENT,357
7722,swimming,I-TREATMENT,357
7723,or,I-TREATMENT,357
7724,using,I-TREATMENT,357
7725,contact,I-TREATMENT,357
7726,lenses,I-TREATMENT,357
7727,Conclusion,O,357
7728,It,O,357
7729,is,O,357
7730,important,O,357
7731,to,O,357
7732,note,O,357
7733,that,O,358
7734,panophthalmitis,B-NAME_OF_DISEASE,358
7735,is,O,358
7736,a,O,358
7737,serious,O,358
7738,condition,O,358
7739,that,O,358
7740,can,O,358
7741,lead,O,358
7742,to,O,358
7743,severe,O,358
7744,complications,O,358
7745,including,O,358
7746,blindness,B-SIGN_AND_SYMPTOM,358
7747,If,O,358
7748,you,O,358
7749,suspect,O,358
7750,that,O,358
7751,you,O,358
7752,or,O,358
7753,a,O,358
7754,loved,O,358
7755,one,O,358
7756,may,O,359
7757,have,O,359
7758,panophthalmitis,B-NAME_OF_DISEASE,359
7759,it,O,359
7760,is,O,359
7761,essential,O,359
7762,to,O,359
7763,seek,O,359
7764,medical,O,359
7765,attention,O,359
7766,as,O,359
7767,soon,O,359
7768,as,O,359
7769,possible,O,359
7770,Early,O,359
7771,diagnosis,O,359
7772,and,O,359
7773,treatment,O,359
7774,can,O,359
7775,prevent,O,360
7776,severe,O,360
7777,complications,O,360
7778,and,O,360
7779,improve,O,360
7780,the,O,360
7781,chances,O,360
7782,of,O,360
7783,preserving,O,360
7784,vision,O,360
7785,in,O,360
7786,the,O,360
7787,affected,O,360
7788,eye,O,360
7789,Thygeson,B-NAME_OF_DISEASE,360
7790,s,I-NAME_OF_DISEASE,360
7791,Keratitis,I-NAME_OF_DISEASE,360
7792,also,O,360
7793,known,O,360
7794,as,O,361
7795,Thygeson,B-NAME_OF_DISEASE,361
7796,s,I-NAME_OF_DISEASE,361
7797,Superficial,I-NAME_OF_DISEASE,361
7798,Punctate,I-NAME_OF_DISEASE,361
7799,Keratitis,I-NAME_OF_DISEASE,361
7800,is,O,361
7801,a,O,361
7802,rare,O,361
7803,inflammatory,O,361
7804,disorder,O,361
7805,of,O,361
7806,the,B-PART_OF_THE_EYES,361
7807,cornea,I-PART_OF_THE_EYES,361
7808,It,O,361
7809,is,O,361
7810,characterized,O,361
7811,by,O,361
7812,the,B-SIGN_AND_SYMPTOM,361
7813,presence,I-SIGN_AND_SYMPTOM,361
7814,of,I-SIGN_AND_SYMPTOM,361
7815,small,I-SIGN_AND_SYMPTOM,361
7816,superficial,I-SIGN_AND_SYMPTOM,361
7817,lesions,I-SIGN_AND_SYMPTOM,361
7818,on,I-SIGN_AND_SYMPTOM,361
7819,the,I-SIGN_AND_SYMPTOM,362
7820,surface,I-SIGN_AND_SYMPTOM,362
7821,of,I-SIGN_AND_SYMPTOM,362
7822,the,I-SIGN_AND_SYMPTOM,362
7823,cornea,I-SIGN_AND_SYMPTOM,362
7824,which,O,362
7825,can,O,362
7826,lead,O,362
7827,to,O,362
7828,vision,B-SIGN_AND_SYMPTOM,362
7829,loss,I-SIGN_AND_SYMPTOM,362
7830,if,O,362
7831,left,O,362
7832,untreated,O,362
7833,Causes,O,362
7834,of,O,362
7835,Thygeson,B-NAME_OF_DISEASE,362
7836,s,I-NAME_OF_DISEASE,362
7837,Keratitis,I-NAME_OF_DISEASE,362
7838,The,O,362
7839,exact,O,362
7840,causes,O,362
7841,of,O,362
7842,Thygeson,B-NAME_OF_DISEASE,362
7843,s,I-NAME_OF_DISEASE,362
7844,Keratitis,I-NAME_OF_DISEASE,362
7845,are,O,363
7846,not,O,363
7847,fully,O,363
7848,understood,O,363
7849,but,O,363
7850,several,O,363
7851,factors,O,363
7852,are,O,363
7853,thought,O,363
7854,to,O,363
7855,contribute,O,363
7856,to,O,363
7857,its,O,363
7858,development,O,363
7859,Immune,B-CAUSE_OF_DISEASE,363
7860,system,I-CAUSE_OF_DISEASE,363
7861,dysfunction,I-CAUSE_OF_DISEASE,363
7862,Thygeson,B-NAME_OF_DISEASE,363
7863,s,I-NAME_OF_DISEASE,363
7864,Keratitis,I-NAME_OF_DISEASE,363
7865,is,O,363
7866,thought,O,363
7867,to,O,363
7868,be,O,363
7869,an,O,363
7870,autoimmune,O,364
7871,disorder,O,364
7872,in,O,364
7873,which,O,364
7874,the,B-CAUSE_OF_DISEASE,364
7875,immune,I-CAUSE_OF_DISEASE,364
7876,system,I-CAUSE_OF_DISEASE,364
7877,mistakenly,I-CAUSE_OF_DISEASE,364
7878,attacks,I-CAUSE_OF_DISEASE,364
7879,healthy,I-CAUSE_OF_DISEASE,364
7880,cells,I-CAUSE_OF_DISEASE,364
7881,in,I-CAUSE_OF_DISEASE,364
7882,the,I-CAUSE_OF_DISEASE,364
7883,cornea,I-CAUSE_OF_DISEASE,364
7884,Viral,B-CAUSE_OF_DISEASE,364
7885,infections,I-CAUSE_OF_DISEASE,364
7886,Some,O,364
7887,studies,O,364
7888,have,O,364
7889,suggested,O,364
7890,that,O,364
7891,viral,B-CAUSE_OF_DISEASE,364
7892,infections,I-CAUSE_OF_DISEASE,364
7893,such,I-CAUSE_OF_DISEASE,364
7894,as,I-CAUSE_OF_DISEASE,364
7895,adenovirus,I-CAUSE_OF_DISEASE,364
7896,or,I-CAUSE_OF_DISEASE,364
7897,herpes,I-CAUSE_OF_DISEASE,365
7898,simplex,I-CAUSE_OF_DISEASE,365
7899,virus,I-CAUSE_OF_DISEASE,365
7900,may,O,365
7901,play,O,365
7902,a,O,365
7903,role,O,365
7904,in,O,365
7905,the,O,365
7906,development,O,365
7907,of,O,365
7908,Thygeson,B-NAME_OF_DISEASE,365
7909,s,I-NAME_OF_DISEASE,365
7910,Keratitis,I-NAME_OF_DISEASE,365
7911,Genetic,B-CAUSE_OF_DISEASE,365
7912,predisposition,I-CAUSE_OF_DISEASE,366
7913,There,O,366
7914,may,O,366
7915,be,O,366
7916,a,B-CAUSE_OF_DISEASE,366
7917,genetic,I-CAUSE_OF_DISEASE,366
7918,component,I-CAUSE_OF_DISEASE,366
7919,to,O,366
7920,the,O,366
7921,development,O,366
7922,of,O,366
7923,Thygeson,B-NAME_OF_DISEASE,366
7924,s,I-NAME_OF_DISEASE,366
7925,Keratitis,I-NAME_OF_DISEASE,366
7926,Some,O,366
7927,studies,O,366
7928,have,O,367
7929,suggested,O,367
7930,that,O,367
7931,certain,B-CAUSE_OF_DISEASE,367
7932,genetic,I-CAUSE_OF_DISEASE,367
7933,mutations,I-CAUSE_OF_DISEASE,367
7934,may,O,367
7935,increase,O,367
7936,the,O,367
7937,risk,O,367
7938,of,O,367
7939,developing,O,367
7940,the,O,367
7941,disorder,O,367
7942,It,O,367
7943,s,O,367
7944,important,O,367
7945,to,O,367
7946,note,O,367
7947,that,O,367
7948,Thygeson,B-NAME_OF_DISEASE,367
7949,s,I-NAME_OF_DISEASE,367
7950,Keratitis,I-NAME_OF_DISEASE,367
7951,can,O,367
7952,have,O,367
7953,multiple,O,367
7954,causes,O,367
7955,and,O,367
7956,thus,O,368
7957,it,O,368
7958,can,O,368
7959,be,O,368
7960,challenging,O,368
7961,to,O,368
7962,identify,O,368
7963,the,O,368
7964,exact,O,368
7965,cause,O,368
7966,in,O,368
7967,an,O,368
7968,individual,O,368
7969,case,O,368
7970,What,O,368
7971,Are,O,368
7972,The,O,368
7973,Symptoms,O,368
7974,of,O,368
7975,Thygeson,B-NAME_OF_DISEASE,368
7976,s,I-NAME_OF_DISEASE,368
7977,Keratitis,I-NAME_OF_DISEASE,368
7978,It,O,368
7979,s,O,368
7980,important,O,368
7981,to,O,368
7982,note,O,368
7983,that,O,368
7984,the,O,368
7985,symptoms,O,368
7986,of,O,368
7987,Thygeson,B-NAME_OF_DISEASE,368
7988,s,I-NAME_OF_DISEASE,368
7989,Keratitis,I-NAME_OF_DISEASE,368
7990,can,O,368
7991,vary,O,368
7992,from,O,369
7993,person,O,369
7994,to,O,369
7995,person,O,369
7996,and,O,369
7997,not,O,369
7998,all,O,369
7999,individuals,O,369
8000,will,O,369
8001,experience,O,369
8002,all,O,369
8003,of,O,369
8004,the,O,369
8005,symptoms,O,369
8006,In,O,369
8007,some,O,369
8008,cases,O,370
8009,symptoms,O,370
8010,may,O,370
8011,come,O,370
8012,and,O,370
8013,go,O,370
8014,or,O,370
8015,may,O,370
8016,be,O,370
8017,mild,O,370
8018,and,O,370
8019,not,O,370
8020,require,O,370
8021,treatment,O,370
8022,Eye,B-SIGN_AND_SYMPTOM,371
8023,pain,B-SIGN_AND_SYMPTOM,371
8024,Thygeson,B-NAME_OF_DISEASE,371
8025,s,I-NAME_OF_DISEASE,371
8026,Keratitis,I-NAME_OF_DISEASE,371
8027,can,O,371
8028,cause,O,371
8029,pain,B-SIGN_AND_SYMPTOM,371
8030,or,I-SIGN_AND_SYMPTOM,371
8031,discomfort,I-SIGN_AND_SYMPTOM,371
8032,in,I-SIGN_AND_SYMPTOM,371
8033,the,I-SIGN_AND_SYMPTOM,371
8034,affected,I-SIGN_AND_SYMPTOM,371
8035,eye,I-SIGN_AND_SYMPTOM,371
8036,This,O,371
8037,pain,B-SIGN_AND_SYMPTOM,371
8038,may,O,371
8039,be,O,372
8040,mild,O,372
8041,or,O,372
8042,severe,O,372
8043,and,O,372
8044,may,O,372
8045,be,O,372
8046,accompanied,O,372
8047,by,O,372
8048,a,B-SIGN_AND_SYMPTOM,372
8049,burning,I-SIGN_AND_SYMPTOM,372
8050,or,I-SIGN_AND_SYMPTOM,372
8051,stinging,I-SIGN_AND_SYMPTOM,372
8052,sensation,I-SIGN_AND_SYMPTOM,372
8053,Redness,B-SIGN_AND_SYMPTOM,372
8054,of,I-SIGN_AND_SYMPTOM,372
8055,the,I-SIGN_AND_SYMPTOM,372
8056,eye,I-SIGN_AND_SYMPTOM,372
8057,The,I-SIGN_AND_SYMPTOM,372
8058,eye,I-SIGN_AND_SYMPTOM,372
8059,may,I-SIGN_AND_SYMPTOM,373
8060,appear,I-SIGN_AND_SYMPTOM,373
8061,red,I-SIGN_AND_SYMPTOM,373
8062,or,I-SIGN_AND_SYMPTOM,373
8063,inflamed,I-SIGN_AND_SYMPTOM,373
8064,due,O,373
8065,to,O,373
8066,the,O,373
8067,presence,O,373
8068,of,O,373
8069,inflammation,O,373
8070,in,O,373
8071,the,B-PART_OF_THE_EYES,373
8072,cornea,I-PART_OF_THE_EYES,373
8073,Light,B-SIGN_AND_SYMPTOM,373
8074,sensitivity,I-SIGN_AND_SYMPTOM,373
8075,Some,O,373
8076,people,O,374
8077,with,O,374
8078,Thygeson,B-NAME_OF_DISEASE,374
8079,s,I-NAME_OF_DISEASE,374
8080,Keratitis,I-NAME_OF_DISEASE,374
8081,may,O,374
8082,experience,O,374
8083,increased,B-SIGN_AND_SYMPTOM,374
8084,sensitivity,I-SIGN_AND_SYMPTOM,374
8085,to,I-SIGN_AND_SYMPTOM,374
8086,light,I-SIGN_AND_SYMPTOM,374
8087,known,I-SIGN_AND_SYMPTOM,374
8088,as,I-SIGN_AND_SYMPTOM,374
8089,photophobia,I-SIGN_AND_SYMPTOM,374
8090,Blurred,B-SIGN_AND_SYMPTOM,375
8091,vision,I-SIGN_AND_SYMPTOM,375
8092,The,O,375
8093,lesions,O,375
8094,on,O,375
8095,the,B-PART_OF_THE_EYES,375
8096,cornea,I-PART_OF_THE_EYES,375
8097,can,O,375
8098,cause,O,375
8099,blurriness,B-SIGN_AND_SYMPTOM,375
8100,or,I-SIGN_AND_SYMPTOM,375
8101,distortion,I-SIGN_AND_SYMPTOM,376
8102,of,I-SIGN_AND_SYMPTOM,376
8103,vision,I-SIGN_AND_SYMPTOM,376
8104,Tearing,B-SIGN_AND_SYMPTOM,376
8105,Some,O,376
8106,people,O,376
8107,may,O,376
8108,experience,O,376
8109,excessive,B-SIGN_AND_SYMPTOM,376
8110,tearing,I-SIGN_AND_SYMPTOM,376
8111,in,I-SIGN_AND_SYMPTOM,376
8112,the,I-SIGN_AND_SYMPTOM,376
8113,affected,I-SIGN_AND_SYMPTOM,376
8114,eye,I-SIGN_AND_SYMPTOM,376
8115,Foreign,B-SIGN_AND_SYMPTOM,376
8116,body,I-SIGN_AND_SYMPTOM,377
8117,sensation,I-SIGN_AND_SYMPTOM,377
8118,The,O,377
8119,patient,O,377
8120,may,O,377
8121,feel,O,377
8122,a,B-SIGN_AND_SYMPTOM,377
8123,scratchy,I-SIGN_AND_SYMPTOM,377
8124,or,I-SIGN_AND_SYMPTOM,377
8125,gritty,I-SIGN_AND_SYMPTOM,377
8126,sensation,I-SIGN_AND_SYMPTOM,377
8127,in,I-SIGN_AND_SYMPTOM,377
8128,the,I-SIGN_AND_SYMPTOM,377
8129,eye,I-SIGN_AND_SYMPTOM,377
8130,Reduced,B-SIGN_AND_SYMPTOM,377
8131,vision,I-SIGN_AND_SYMPTOM,378
8132,In,O,378
8133,severe,O,378
8134,cases,O,378
8135,Thygeson,B-NAME_OF_DISEASE,378
8136,s,I-NAME_OF_DISEASE,378
8137,Keratitis,I-NAME_OF_DISEASE,378
8138,may,O,378
8139,cause,O,378
8140,a,B-SIGN_AND_SYMPTOM,378
8141,significant,I-SIGN_AND_SYMPTOM,378
8142,reduction,I-SIGN_AND_SYMPTOM,378
8143,in,I-SIGN_AND_SYMPTOM,378
8144,vision,I-SIGN_AND_SYMPTOM,378
8145,Above,O,378
8146,picture,O,379
8147,shows,O,379
8148,the,O,379
8149,presence,O,379
8150,of,O,379
8151,small,O,379
8152,superficial,O,379
8153,lesions,O,379
8154,on,O,379
8155,the,O,379
8156,surface,O,379
8157,of,O,379
8158,the,B-PART_OF_THE_EYES,379
8159,cornea,I-PART_OF_THE_EYES,379
8160,Is,O,379
8161,Thygeson,B-NAME_OF_DISEASE,379
8162,s,I-NAME_OF_DISEASE,379
8163,Keratitis,I-NAME_OF_DISEASE,379
8164,Contagious,I-NAME_OF_DISEASE,379
8165,Thygeson,B-NAME_OF_DISEASE,379
8166,s,I-NAME_OF_DISEASE,379
8167,Keratitis,I-NAME_OF_DISEASE,379
8168,is,O,379
8169,not,O,379
8170,contagious,O,379
8171,because,O,379
8172,it,O,380
8173,is,O,380
8174,not,O,380
8175,caused,O,380
8176,by,O,380
8177,an,O,380
8178,infectious,O,380
8179,agent,O,380
8180,such,O,380
8181,as,O,380
8182,a,O,380
8183,virus,O,380
8184,or,O,380
8185,bacteria,O,380
8186,There,O,380
8187,is,O,380
8188,no,O,380
8189,evidence,O,380
8190,that,O,380
8191,the,O,381
8192,condition,O,381
8193,can,O,381
8194,be,O,381
8195,spread,O,381
8196,from,O,381
8197,person,O,381
8198,to,O,381
8199,person,O,381
8200,through,O,381
8201,contact,O,381
8202,or,O,381
8203,other,O,381
8204,means,O,381
8205,Treatment,O,381
8206,for,O,381
8207,Thygeson,B-NAME_OF_DISEASE,381
8208,s,I-NAME_OF_DISEASE,381
8209,Keratitis,I-NAME_OF_DISEASE,381
8210,Treatment,O,381
8211,for,O,381
8212,Thygeson,B-NAME_OF_DISEASE,381
8213,s,I-NAME_OF_DISEASE,381
8214,Keratitis,I-NAME_OF_DISEASE,381
8215,typically,O,381
8216,involves,O,381
8217,the,B-TREATMENT,381
8218,use,I-TREATMENT,381
8219,of,I-TREATMENT,381
8220,topical,I-TREATMENT,382
8221,eye,I-TREATMENT,382
8222,drops,I-TREATMENT,382
8223,or,I-TREATMENT,382
8224,ointments,I-TREATMENT,382
8225,to,O,382
8226,reduce,O,382
8227,inflammation,O,382
8228,and,O,382
8229,promote,O,382
8230,healing,O,382
8231,of,O,382
8232,the,B-PART_OF_THE_EYES,382
8233,cornea,I-PART_OF_THE_EYES,382
8234,In,O,382
8235,some,O,382
8236,cases,O,382
8237,oral,B-TREATMENT,382
8238,or,I-TREATMENT,382
8239,injectable,I-TREATMENT,382
8240,medications,I-TREATMENT,382
8241,may,O,382
8242,also,O,382
8243,be,O,383
8244,used,O,383
8245,to,O,383
8246,suppress,O,383
8247,the,O,383
8248,immune,O,383
8249,system,O,383
8250,and,O,383
8251,prevent,O,383
8252,further,O,383
8253,damage,O,383
8254,to,O,383
8255,the,B-PART_OF_THE_EYES,383
8256,cornea,I-PART_OF_THE_EYES,383
8257,Topical,B-NAME_OF_DRUG,383
8258,corticosteroids,I-NAME_OF_DRUG,383
8259,such,O,383
8260,as,O,383
8261,prednisolone,B-NAME_OF_DRUG,383
8262,acetate,I-NAME_OF_DRUG,383
8263,or,O,383
8264,loteprednol,B-NAME_OF_DRUG,384
8265,etabonate,I-NAME_OF_DRUG,384
8266,are,O,384
8267,often,O,384
8268,used,O,384
8269,to,O,384
8270,reduce,O,384
8271,inflammation,O,384
8272,and,O,384
8273,promote,O,384
8274,healing,O,385
8275,of,O,385
8276,the,B-PART_OF_THE_EYES,385
8277,cornea,I-PART_OF_THE_EYES,385
8278,These,O,385
8279,medications,O,385
8280,are,O,385
8281,typically,O,385
8282,administered,O,385
8283,as,O,385
8284,eye,O,385
8285,drops,O,385
8286,or,O,385
8287,ointments,O,385
8288,A,B-TREATMENT,385
8289,bandage,I-TREATMENT,385
8290,contact,I-TREATMENT,385
8291,lens,I-TREATMENT,385
8292,can,O,385
8293,also,O,386
8294,be,O,386
8295,applied,O,386
8296,to,O,386
8297,the,O,386
8298,eye,O,386
8299,to,O,386
8300,promote,O,386
8301,healing,O,386
8302,and,O,386
8303,reduce,O,386
8304,pain,B-SIGN_AND_SYMPTOM,386
8305,and,I-SIGN_AND_SYMPTOM,386
8306,discomfort,I-SIGN_AND_SYMPTOM,386
8307,Conclusion,O,386
8308,Thygeson,B-NAME_OF_DISEASE,387
8309,s,I-NAME_OF_DISEASE,387
8310,Keratitis,I-NAME_OF_DISEASE,387
8311,is,O,387
8312,a,O,387
8313,rare,O,387
8314,and,O,387
8315,chronic,O,387
8316,inflammatory,O,387
8317,disorder,O,387
8318,that,O,387
8319,affects,O,387
8320,the,B-PART_OF_THE_EYES,387
8321,cornea,I-PART_OF_THE_EYES,387
8322,It,O,387
8323,is,O,387
8324,caused,O,387
8325,by,O,387
8326,an,B-CAUSE_OF_DISEASE,387
8327,autoimmune,I-CAUSE_OF_DISEASE,387
8328,disorder,I-CAUSE_OF_DISEASE,387
8329,or,I-CAUSE_OF_DISEASE,387
8330,viral,I-CAUSE_OF_DISEASE,388
8331,infections,I-CAUSE_OF_DISEASE,388
8332,and,O,388
8333,symptoms,O,388
8334,include,O,388
8335,redness,B-SIGN_AND_SYMPTOM,388
8336,eye,I-SIGN_AND_SYMPTOM,388
8337,pain,I-SIGN_AND_SYMPTOM,388
8338,light,I-SIGN_AND_SYMPTOM,388
8339,sensitivity,I-SIGN_AND_SYMPTOM,388
8340,tearing,I-SIGN_AND_SYMPTOM,388
8341,and,I-SIGN_AND_SYMPTOM,388
8342,blurred,I-SIGN_AND_SYMPTOM,388
8343,vision,I-SIGN_AND_SYMPTOM,388
8344,Treatment,O,388
8345,includes,O,389
8346,topical,B-NAME_OF_DRUG,389
8347,steroids,I-NAME_OF_DRUG,389
8348,and,O,389
8349,immunomodulators,B-NAME_OF_DRUG,389
8350,and,O,389
8351,in,O,389
8352,severe,O,389
8353,cases,O,389
8354,oral,B-TREATMENT,389
8355,medication,I-TREATMENT,389
8356,and,I-TREATMENT,389
8357,corneal,I-TREATMENT,389
8358,transplants,I-TREATMENT,389
8359,Early,O,390
8360,diagnosis,O,390
8361,and,O,390
8362,treatment,O,390
8363,are,O,390
8364,crucial,O,390
8365,to,O,390
8366,prevent,O,390
8367,vision,B-SIGN_AND_SYMPTOM,390
8368,loss,I-SIGN_AND_SYMPTOM,390
8369,and,O,390
8370,manage,O,390
8371,the,O,390
8372,symptoms,O,390
8373,Sudden,B-NAME_OF_DISEASE,390
8374,vision,B-SIGN_AND_SYMPTOM,390
8375,loss,I-SIGN_AND_SYMPTOM,390
8376,is,O,390
8377,a,O,391
8378,serious,O,391
8379,medical,O,391
8380,condition,O,391
8381,that,O,391
8382,can,O,391
8383,be,O,391
8384,caused,O,391
8385,by,O,391
8386,a,O,391
8387,variety,O,391
8388,of,O,391
8389,underlying,O,391
8390,factors,O,391
8391,It,O,391
8392,can,O,391
8393,be,O,391
8394,a,O,391
8395,symptom,O,391
8396,of,O,392
8397,a,O,392
8398,number,O,392
8399,of,O,392
8400,serious,O,392
8401,conditions,O,392
8402,including,O,392
8403,retinal,B-CAUSE_OF_DISEASE,392
8404,detachment,I-CAUSE_OF_DISEASE,392
8405,stroke,B-CAUSE_OF_DISEASE,392
8406,and,O,392
8407,even,O,392
8408,brain,B-CAUSE_OF_DISEASE,392
8409,tumors,I-CAUSE_OF_DISEASE,392
8410,Understanding,O,393
8411,the,O,393
8412,causes,O,393
8413,of,O,393
8414,sudden,B-NAME_OF_DISEASE,393
8415,vision,B-SIGN_AND_SYMPTOM,393
8416,loss,I-SIGN_AND_SYMPTOM,393
8417,is,O,393
8418,crucial,O,393
8419,for,O,393
8420,early,O,393
8421,diagnosis,O,393
8422,and,O,393
8423,treatment,O,394
8424,One,O,394
8425,of,O,394
8426,the,O,394
8427,most,O,394
8428,common,O,394
8429,causes,O,394
8430,of,O,394
8431,sudden,B-NAME_OF_DISEASE,394
8432,vision,B-SIGN_AND_SYMPTOM,394
8433,loss,I-SIGN_AND_SYMPTOM,394
8434,is,O,394
8435,retinal,B-CAUSE_OF_DISEASE,394
8436,detachment,I-CAUSE_OF_DISEASE,394
8437,The,B-PART_OF_THE_EYES,394
8438,retina,I-PART_OF_THE_EYES,394
8439,is,O,394
8440,the,O,394
8441,light-sensitive,O,394
8442,layer,O,395
8443,at,O,395
8444,the,O,395
8445,back,O,395
8446,of,O,395
8447,the,O,395
8448,eye,O,395
8449,that,O,395
8450,sends,O,395
8451,visual,O,395
8452,signals,O,395
8453,to,O,395
8454,the,O,395
8455,brain,O,395
8456,If,O,395
8457,the,B-PART_OF_THE_EYES,395
8458,retina,I-PART_OF_THE_EYES,396
8459,becomes,O,396
8460,detached,O,396
8461,it,O,396
8462,can,O,396
8463,no,O,396
8464,longer,O,396
8465,function,O,396
8466,properly,O,396
8467,leading,O,396
8468,to,O,396
8469,sudden,B-NAME_OF_DISEASE,396
8470,vision,B-SIGN_AND_SYMPTOM,396
8471,loss,I-SIGN_AND_SYMPTOM,396
8472,Retinal,B-CAUSE_OF_DISEASE,396
8473,detachment,I-CAUSE_OF_DISEASE,396
8474,can,O,396
8475,be,O,396
8476,caused,O,396
8477,by,O,396
8478,a,O,397
8479,variety,O,397
8480,of,O,397
8481,factors,O,397
8482,including,O,397
8483,injury,B-CAUSE_OF_DISEASE,397
8484,certain,I-CAUSE_OF_DISEASE,397
8485,medical,I-CAUSE_OF_DISEASE,397
8486,conditions,I-CAUSE_OF_DISEASE,397
8487,and,I-CAUSE_OF_DISEASE,397
8488,even,I-CAUSE_OF_DISEASE,398
8489,certain,I-CAUSE_OF_DISEASE,398
8490,eye,I-CAUSE_OF_DISEASE,398
8491,surgeries,I-CAUSE_OF_DISEASE,398
8492,Another,O,398
8493,common,O,398
8494,cause,O,398
8495,of,O,398
8496,sudden,B-NAME_OF_DISEASE,398
8497,vision,B-SIGN_AND_SYMPTOM,398
8498,loss,I-SIGN_AND_SYMPTOM,398
8499,is,O,398
8500,a,O,398
8501,stroke,B-CAUSE_OF_DISEASE,398
8502,A,O,398
8503,stroke,B-CAUSE_OF_DISEASE,398
8504,occurs,O,398
8505,when,O,398
8506,the,B-SIGN_AND_SYMPTOM,398
8507,blood,I-SIGN_AND_SYMPTOM,399
8508,flow,I-SIGN_AND_SYMPTOM,399
8509,to,I-SIGN_AND_SYMPTOM,399
8510,the,I-SIGN_AND_SYMPTOM,399
8511,brain,I-SIGN_AND_SYMPTOM,399
8512,is,I-SIGN_AND_SYMPTOM,399
8513,interrupted,I-SIGN_AND_SYMPTOM,399
8514,depriving,I-SIGN_AND_SYMPTOM,399
8515,brain,I-SIGN_AND_SYMPTOM,399
8516,cells,I-SIGN_AND_SYMPTOM,399
8517,of,I-SIGN_AND_SYMPTOM,399
8518,oxygen,I-SIGN_AND_SYMPTOM,400
8519,and,I-SIGN_AND_SYMPTOM,400
8520,nutrients,I-SIGN_AND_SYMPTOM,400
8521,This,O,400
8522,can,O,400
8523,lead,O,400
8524,to,O,400
8525,vision,B-SIGN_AND_SYMPTOM,400
8526,loss,I-SIGN_AND_SYMPTOM,400
8527,in,I-SIGN_AND_SYMPTOM,400
8528,one,I-SIGN_AND_SYMPTOM,400
8529,or,I-SIGN_AND_SYMPTOM,400
8530,both,I-SIGN_AND_SYMPTOM,400
8531,eyes,I-SIGN_AND_SYMPTOM,400
8532,Strokes,B-CAUSE_OF_DISEASE,400
8533,can,O,400
8534,be,O,401
8535,caused,O,401
8536,by,O,401
8537,a,O,401
8538,variety,O,401
8539,of,O,401
8540,factors,O,401
8541,including,O,401
8542,high,B-CAUSE_OF_DISEASE,402
8543,blood,I-CAUSE_OF_DISEASE,402
8544,pressure,I-CAUSE_OF_DISEASE,402
8545,smoking,I-CAUSE_OF_DISEASE,402
8546,and,I-CAUSE_OF_DISEASE,402
8547,diabetes,I-CAUSE_OF_DISEASE,402
8548,Brain,B-CAUSE_OF_DISEASE,402
8549,tumors,I-CAUSE_OF_DISEASE,402
8550,can,O,402
8551,also,O,402
8552,cause,O,402
8553,sudden,B-NAME_OF_DISEASE,402
8554,vision,B-SIGN_AND_SYMPTOM,402
8555,loss,I-SIGN_AND_SYMPTOM,402
8556,Tumors,O,402
8557,can,O,402
8558,press,O,402
8559,on,O,403
8560,the,B-PART_OF_THE_EYES,403
8561,optic,I-PART_OF_THE_EYES,403
8562,nerve,I-PART_OF_THE_EYES,403
8563,which,O,403
8564,carries,O,403
8565,visual,O,403
8566,signals,O,403
8567,from,O,403
8568,the,O,403
8569,eye,O,403
8570,to,O,404
8571,the,O,404
8572,brain,O,404
8573,This,O,404
8574,can,O,404
8575,lead,O,404
8576,to,O,404
8577,vision,B-SIGN_AND_SYMPTOM,404
8578,loss,I-SIGN_AND_SYMPTOM,404
8579,in,I-SIGN_AND_SYMPTOM,404
8580,one,I-SIGN_AND_SYMPTOM,404
8581,or,I-SIGN_AND_SYMPTOM,404
8582,both,I-SIGN_AND_SYMPTOM,404
8583,eyes,I-SIGN_AND_SYMPTOM,404
8584,Brain,B-CAUSE_OF_DISEASE,404
8585,tumors,I-CAUSE_OF_DISEASE,404
8586,can,O,404
8587,be,O,404
8588,benign,O,404
8589,or,O,404
8590,malignant,O,404
8591,and,O,404
8592,can,O,404
8593,be,O,405
8594,caused,O,405
8595,by,O,405
8596,a,O,405
8597,variety,O,405
8598,of,O,405
8599,factors,O,405
8600,including,O,405
8601,genetics,B-CAUSE_OF_DISEASE,405
8602,and,I-CAUSE_OF_DISEASE,405
8603,exposure,I-CAUSE_OF_DISEASE,405
8604,to,I-CAUSE_OF_DISEASE,405
8605,certain,I-CAUSE_OF_DISEASE,405
8606,toxins,I-CAUSE_OF_DISEASE,405
8607,Other,O,405
8608,causes,O,405
8609,of,O,405
8610,sudden,B-NAME_OF_DISEASE,405
8611,vision,B-SIGN_AND_SYMPTOM,405
8612,loss,I-SIGN_AND_SYMPTOM,405
8613,include,O,405
8614,optic,B-CAUSE_OF_DISEASE,405
8615,neuritis,I-CAUSE_OF_DISEASE,405
8616,which,O,405
8617,is,O,405
8618,inflammation,O,405
8619,of,O,405
8620,the,B-PART_OF_THE_EYES,405
8621,optic,I-PART_OF_THE_EYES,405
8622,nerve,I-PART_OF_THE_EYES,405
8623,and,O,405
8624,giant,B-CAUSE_OF_DISEASE,406
8625,cell,I-CAUSE_OF_DISEASE,406
8626,arteritis,I-CAUSE_OF_DISEASE,406
8627,which,O,406
8628,is,O,406
8629,an,O,406
8630,inflammation,O,406
8631,of,O,406
8632,the,O,406
8633,blood,O,406
8634,vessels,O,406
8635,in,O,406
8636,the,O,406
8637,head,O,406
8638,It,O,407
8639,s,O,407
8640,important,O,407
8641,to,O,407
8642,seek,O,407
8643,medical,O,407
8644,attention,O,407
8645,immediately,O,407
8646,if,O,407
8647,you,O,407
8648,experience,O,407
8649,sudden,B-NAME_OF_DISEASE,407
8650,vision,B-SIGN_AND_SYMPTOM,407
8651,loss,I-SIGN_AND_SYMPTOM,407
8652,Early,O,407
8653,diagnosis,O,408
8654,and,O,408
8655,treatment,O,408
8656,can,O,408
8657,help,O,408
8658,prevent,O,408
8659,permanent,B-NAME_OF_DISEASE,408
8660,vision,B-SIGN_AND_SYMPTOM,408
8661,loss,I-SIGN_AND_SYMPTOM,408
8662,and,O,408
8663,improve,O,408
8664,your,O,408
8665,overall,O,408
8666,outcome,O,408
8667,Your,O,408
8668,healthcare,O,408
8669,provider,O,408
8670,will,O,408
8671,perform,O,408
8672,a,O,408
8673,thorough,O,408
8674,examination,O,408
8675,and,O,408
8676,may,O,408
8677,order,O,408
8678,imaging,B-DIAGNOSTIC_TEST,408
8679,tests,I-DIAGNOSTIC_TEST,408
8680,such,I-DIAGNOSTIC_TEST,408
8681,as,I-DIAGNOSTIC_TEST,408
8682,MRI,I-DIAGNOSTIC_TEST,408
8683,CT,I-DIAGNOSTIC_TEST,408
8684,scan,I-DIAGNOSTIC_TEST,409
8685,and,O,409
8686,an,O,409
8687,eye,O,409
8688,examination,O,409
8689,to,O,409
8690,help,O,409
8691,determine,O,409
8692,the,O,409
8693,cause,O,409
8694,of,O,409
8695,your,O,409
8696,vision,B-SIGN_AND_SYMPTOM,409
8697,loss,I-SIGN_AND_SYMPTOM,409
8698,Sudden,B-NAME_OF_DISEASE,409
8699,Vision,I-NAME_OF_DISEASE,409
8700,Loss,I-NAME_OF_DISEASE,409
8701,in,I-NAME_OF_DISEASE,409
8702,One,I-NAME_OF_DISEASE,409
8703,Eye,I-NAME_OF_DISEASE,409
8704,The,O,409
8705,primary,O,409
8706,cause,O,409
8707,of,O,409
8708,sudden,B-NAME_OF_DISEASE,410
8709,vision,B-SIGN_AND_SYMPTOM,410
8710,loss,I-SIGN_AND_SYMPTOM,410
8711,in,I-NAME_OF_DISEASE,410
8712,one,I-NAME_OF_DISEASE,410
8713,eye,I-NAME_OF_DISEASE,410
8714,is,O,410
8715,high,B-CAUSE_OF_DISEASE,410
8716,blood,I-CAUSE_OF_DISEASE,410
8717,pressure,I-CAUSE_OF_DISEASE,410
8718,also,O,410
8719,known,O,410
8720,as,O,410
8721,hypertension,B-CAUSE_OF_DISEASE,410
8722,High,B-CAUSE_OF_DISEASE,410
8723,blood,I-CAUSE_OF_DISEASE,410
8724,pressure,I-CAUSE_OF_DISEASE,410
8725,is,O,410
8726,a,O,410
8727,condition,O,410
8728,in,O,410
8729,which,O,410
8730,the,O,411
8731,force,O,411
8732,of,O,411
8733,blood,O,411
8734,against,O,411
8735,the,O,411
8736,walls,O,411
8737,of,O,411
8738,the,O,411
8739,blood,O,411
8740,vessels,O,411
8741,is,O,411
8742,too,O,411
8743,high,O,411
8744,This,O,411
8745,extra,O,412
8746,force,O,412
8747,can,O,412
8748,damage,O,412
8749,the,B-PART_OF_THE_EYES,412
8750,blood,I-PART_OF_THE_EYES,412
8751,vessels,I-PART_OF_THE_EYES,412
8752,in,I-PART_OF_THE_EYES,412
8753,the,I-PART_OF_THE_EYES,412
8754,eye,I-PART_OF_THE_EYES,412
8755,leading,O,412
8756,to,O,412
8757,vision,B-SIGN_AND_SYMPTOM,412
8758,loss,I-SIGN_AND_SYMPTOM,412
8759,Symptoms,O,412
8760,of,O,412
8761,sudden,B-NAME_OF_DISEASE,412
8762,vision,B-SIGN_AND_SYMPTOM,412
8763,loss,I-SIGN_AND_SYMPTOM,412
8764,in,I-NAME_OF_DISEASE,412
8765,one,I-NAME_OF_DISEASE,412
8766,eye,I-NAME_OF_DISEASE,412
8767,include,O,412
8768,blurred,B-SIGN_AND_SYMPTOM,412
8769,vision,I-SIGN_AND_SYMPTOM,412
8770,loss,I-SIGN_AND_SYMPTOM,412
8771,of,I-SIGN_AND_SYMPTOM,412
8772,peripheral,I-SIGN_AND_SYMPTOM,412
8773,vision,I-SIGN_AND_SYMPTOM,413
8774,and,I-SIGN_AND_SYMPTOM,413
8775,the,I-SIGN_AND_SYMPTOM,413
8776,appearance,I-SIGN_AND_SYMPTOM,413
8777,of,I-SIGN_AND_SYMPTOM,413
8778,a,I-SIGN_AND_SYMPTOM,413
8779,dark,I-SIGN_AND_SYMPTOM,413
8780,spot,I-SIGN_AND_SYMPTOM,413
8781,or,I-SIGN_AND_SYMPTOM,414
8782,shadow,I-SIGN_AND_SYMPTOM,414
8783,in,I-SIGN_AND_SYMPTOM,414
8784,the,I-SIGN_AND_SYMPTOM,414
8785,affected,I-SIGN_AND_SYMPTOM,414
8786,eye,I-SIGN_AND_SYMPTOM,414
8787,These,O,414
8788,symptoms,O,414
8789,can,O,414
8790,occur,O,414
8791,suddenly,O,414
8792,and,O,414
8793,without,O,414
8794,warning,O,414
8795,If,O,414
8796,you,O,415
8797,experience,O,415
8798,any,O,415
8799,of,O,415
8800,these,O,415
8801,symptoms,O,415
8802,it,O,415
8803,is,O,415
8804,essential,O,415
8805,to,O,415
8806,seek,O,415
8807,medical,O,415
8808,attention,O,415
8809,immediately,O,415
8810,Risk,O,415
8811,Factors,O,415
8812,for,O,415
8813,Sudden,B-NAME_OF_DISEASE,415
8814,Vision,I-NAME_OF_DISEASE,415
8815,Loss,I-NAME_OF_DISEASE,415
8816,Age,B-CAUSE_OF_DISEASE,415
8817,As,O,415
8818,we,O,415
8819,get,O,415
8820,older,O,415
8821,the,O,415
8822,risk,O,415
8823,of,O,415
8824,developing,O,416
8825,certain,O,416
8826,eye,O,416
8827,conditions,O,416
8828,such,O,416
8829,as,O,416
8830,age-related,B-CAUSE_OF_DISEASE,416
8831,macular,I-CAUSE_OF_DISEASE,416
8832,degeneration,I-CAUSE_OF_DISEASE,417
8833,cataracts,B-CAUSE_OF_DISEASE,417
8834,and,O,417
8835,diabetic,B-CAUSE_OF_DISEASE,417
8836,retinopathy,I-CAUSE_OF_DISEASE,417
8837,increases,O,417
8838,These,O,417
8839,conditions,O,417
8840,can,O,417
8841,lead,O,417
8842,to,O,417
8843,sudden,B-NAME_OF_DISEASE,417
8844,vision,I-NAME_OF_DISEASE,417
8845,loss,I-NAME_OF_DISEASE,417
8846,Age-related,B-NAME_OF_DISEASE,417
8847,macular,I-NAME_OF_DISEASE,417
8848,degeneration,I-NAME_OF_DISEASE,417
8849,AMD,I-NAME_OF_DISEASE,417
8850,is,O,417
8851,a,O,417
8852,degenerative,O,417
8853,disorder,O,417
8854,of,O,417
8855,the,B-PART_OF_THE_EYES,418
8856,retina,I-PART_OF_THE_EYES,418
8857,that,O,418
8858,affects,O,418
8859,older,O,418
8860,adults,O,418
8861,and,O,418
8862,can,O,418
8863,cause,O,418
8864,a,B-SIGN_AND_SYMPTOM,418
8865,loss,I-SIGN_AND_SYMPTOM,418
8866,of,I-SIGN_AND_SYMPTOM,418
8867,central,I-SIGN_AND_SYMPTOM,418
8868,vision,I-SIGN_AND_SYMPTOM,418
8869,Medical,B-CAUSE_OF_DISEASE,418
8870,conditions,I-CAUSE_OF_DISEASE,418
8871,People,O,418
8872,with,O,418
8873,diabetes,B-CAUSE_OF_DISEASE,418
8874,high,I-CAUSE_OF_DISEASE,418
8875,blood,I-CAUSE_OF_DISEASE,418
8876,pressure,I-CAUSE_OF_DISEASE,418
8877,and,I-CAUSE_OF_DISEASE,418
8878,high,I-CAUSE_OF_DISEASE,418
8879,cholesterol,I-CAUSE_OF_DISEASE,418
8880,are,O,418
8881,at,O,418
8882,an,O,419
8883,increased,O,419
8884,risk,O,419
8885,of,O,419
8886,developing,O,419
8887,eye,O,419
8888,conditions,O,419
8889,that,O,419
8890,can,O,419
8891,lead,O,419
8892,to,O,419
8893,sudden,B-NAME_OF_DISEASE,419
8894,vision,I-NAME_OF_DISEASE,419
8895,loss,I-NAME_OF_DISEASE,419
8896,Diabetes,B-CAUSE_OF_DISEASE,419
8897,can,O,419
8898,damage,O,419
8899,the,O,419
8900,blood,O,419
8901,vessels,O,420
8902,in,O,420
8903,the,B-PART_OF_THE_EYES,420
8904,retina,I-PART_OF_THE_EYES,420
8905,leading,O,420
8906,to,O,420
8907,diabetic,B-CAUSE_OF_DISEASE,420
8908,retinopathy,I-CAUSE_OF_DISEASE,420
8909,which,O,420
8910,can,O,420
8911,cause,O,420
8912,sudden,B-NAME_OF_DISEASE,420
8913,vision,I-NAME_OF_DISEASE,420
8914,loss,I-NAME_OF_DISEASE,420
8915,High,B-CAUSE_OF_DISEASE,420
8916,blood,I-CAUSE_OF_DISEASE,420
8917,pressure,I-CAUSE_OF_DISEASE,420
8918,and,I-CAUSE_OF_DISEASE,420
8919,high,I-CAUSE_OF_DISEASE,420
8920,cholesterol,I-CAUSE_OF_DISEASE,420
8921,can,O,421
8922,also,O,421
8923,damage,O,421
8924,the,O,421
8925,blood,O,421
8926,vessels,O,421
8927,in,O,421
8928,the,O,421
8929,eye,O,421
8930,leading,O,421
8931,to,O,421
8932,sudden,B-NAME_OF_DISEASE,421
8933,vision,I-NAME_OF_DISEASE,421
8934,loss,I-NAME_OF_DISEASE,421
8935,Genetics,B-CAUSE_OF_DISEASE,421
8936,Some,O,421
8937,eye,O,421
8938,conditions,O,421
8939,that,O,421
8940,can,O,421
8941,lead,O,421
8942,to,O,422
8943,sudden,B-NAME_OF_DISEASE,422
8944,vision,I-NAME_OF_DISEASE,422
8945,loss,I-NAME_OF_DISEASE,422
8946,such,O,422
8947,as,O,422
8948,retinal,B-CAUSE_OF_DISEASE,422
8949,detachment,I-CAUSE_OF_DISEASE,422
8950,are,O,422
8951,more,O,422
8952,common,O,422
8953,in,O,422
8954,certain,O,422
8955,families,O,422
8956,If,O,422
8957,you,O,422
8958,have,O,422
8959,a,O,422
8960,family,O,422
8961,history,O,422
8962,of,O,422
8963,eye,O,422
8964,conditions,O,423
8965,that,O,423
8966,can,O,423
8967,cause,O,423
8968,sudden,B-NAME_OF_DISEASE,423
8969,vision,I-NAME_OF_DISEASE,423
8970,loss,I-NAME_OF_DISEASE,423
8971,you,O,423
8972,may,O,423
8973,be,O,423
8974,at,O,423
8975,a,O,423
8976,higher,O,423
8977,risk,O,423
8978,Trauma,B-CAUSE_OF_DISEASE,423
8979,Injury,B-CAUSE_OF_DISEASE,423
8980,or,I-CAUSE_OF_DISEASE,423
8981,trauma,I-CAUSE_OF_DISEASE,423
8982,to,I-CAUSE_OF_DISEASE,423
8983,the,I-CAUSE_OF_DISEASE,423
8984,eye,I-CAUSE_OF_DISEASE,424
8985,such,I-CAUSE_OF_DISEASE,424
8986,as,I-CAUSE_OF_DISEASE,424
8987,a,I-CAUSE_OF_DISEASE,424
8988,blow,I-CAUSE_OF_DISEASE,424
8989,to,I-CAUSE_OF_DISEASE,424
8990,the,I-CAUSE_OF_DISEASE,424
8991,head,I-CAUSE_OF_DISEASE,424
8992,can,O,424
8993,lead,O,424
8994,to,O,424
8995,sudden,B-NAME_OF_DISEASE,424
8996,vision,I-NAME_OF_DISEASE,424
8997,loss,I-NAME_OF_DISEASE,424
8998,Additionally,O,424
8999,certain,B-CAUSE_OF_DISEASE,424
9000,eye,I-CAUSE_OF_DISEASE,424
9001,surgeries,I-CAUSE_OF_DISEASE,425
9002,such,I-CAUSE_OF_DISEASE,425
9003,as,I-CAUSE_OF_DISEASE,425
9004,cataract,I-CAUSE_OF_DISEASE,425
9005,surgery,I-CAUSE_OF_DISEASE,425
9006,can,O,425
9007,also,O,425
9008,increase,O,425
9009,the,O,425
9010,risk,O,425
9011,of,O,425
9012,sudden,B-NAME_OF_DISEASE,425
9013,vision,I-NAME_OF_DISEASE,425
9014,loss,I-NAME_OF_DISEASE,425
9015,Certain,B-CAUSE_OF_DISEASE,425
9016,medications,I-CAUSE_OF_DISEASE,425
9017,Certain,B-CAUSE_OF_DISEASE,425
9018,medications,I-CAUSE_OF_DISEASE,425
9019,such,I-CAUSE_OF_DISEASE,425
9020,as,I-CAUSE_OF_DISEASE,426
9021,blood,I-CAUSE_OF_DISEASE,426
9022,thinners,I-CAUSE_OF_DISEASE,426
9023,and,I-CAUSE_OF_DISEASE,426
9024,anti-inflammatory,I-CAUSE_OF_DISEASE,426
9025,drugs,I-CAUSE_OF_DISEASE,426
9026,can,O,426
9027,increase,O,426
9028,the,O,426
9029,risk,O,426
9030,of,O,426
9031,sudden,B-NAME_OF_DISEASE,426
9032,vision,I-NAME_OF_DISEASE,426
9033,loss,I-NAME_OF_DISEASE,426
9034,Toxins,B-CAUSE_OF_DISEASE,426
9035,and,I-CAUSE_OF_DISEASE,426
9036,environmental,I-CAUSE_OF_DISEASE,426
9037,factors,I-CAUSE_OF_DISEASE,426
9038,Exposure,O,426
9039,to,O,426
9040,certain,O,426
9041,toxins,B-CAUSE_OF_DISEASE,426
9042,and,I-CAUSE_OF_DISEASE,426
9043,environmental,I-CAUSE_OF_DISEASE,426
9044,factors,I-CAUSE_OF_DISEASE,427
9045,such,I-CAUSE_OF_DISEASE,427
9046,as,I-CAUSE_OF_DISEASE,427
9047,pesticides,I-CAUSE_OF_DISEASE,427
9048,and,I-CAUSE_OF_DISEASE,427
9049,pollutants,I-CAUSE_OF_DISEASE,427
9050,can,O,427
9051,increase,O,427
9052,the,O,427
9053,risk,O,427
9054,of,O,427
9055,sudden,B-NAME_OF_DISEASE,427
9056,vision,I-NAME_OF_DISEASE,427
9057,loss,I-NAME_OF_DISEASE,427
9058,How,O,427
9059,Is,O,427
9060,Sudden,B-NAME_OF_DISEASE,427
9061,Vision,I-NAME_OF_DISEASE,428
9062,Loss,I-NAME_OF_DISEASE,428
9063,Treated,O,428
9064,Treatment,O,428
9065,for,O,428
9066,sudden,B-NAME_OF_DISEASE,428
9067,vision,I-NAME_OF_DISEASE,428
9068,loss,I-NAME_OF_DISEASE,428
9069,will,O,428
9070,depend,O,428
9071,on,O,428
9072,the,O,428
9073,underlying,O,428
9074,cause,O,428
9075,For,O,428
9076,example,O,428
9077,retinal,B-CAUSE_OF_DISEASE,428
9078,detachment,I-CAUSE_OF_DISEASE,428
9079,may,O,429
9080,require,O,429
9081,surgery,B-TREATMENT,429
9082,while,O,429
9083,a,O,429
9084,stroke,B-CAUSE_OF_DISEASE,429
9085,may,O,429
9086,require,O,429
9087,medication,B-TREATMENT,429
9088,or,I-TREATMENT,429
9089,other,I-TREATMENT,429
9090,types,I-TREATMENT,429
9091,of,I-TREATMENT,429
9092,therapy,I-TREATMENT,429
9093,Conclusion,O,429
9094,In,O,429
9095,conclusion,O,429
9096,sudden,B-NAME_OF_DISEASE,429
9097,vision,I-NAME_OF_DISEASE,429
9098,loss,I-NAME_OF_DISEASE,429
9099,is,O,429
9100,a,O,430
9101,serious,O,430
9102,medical,O,430
9103,condition,O,430
9104,that,O,430
9105,can,O,430
9106,be,O,430
9107,caused,O,430
9108,by,O,430
9109,a,O,430
9110,variety,O,430
9111,of,O,431
9112,underlying,O,431
9113,factors,O,431
9114,Early,O,431
9115,diagnosis,O,431
9116,and,O,431
9117,treatment,O,431
9118,are,O,431
9119,crucial,O,431
9120,for,O,431
9121,preventing,O,431
9122,permanent,B-NAME_OF_DISEASE,431
9123,vision,I-NAME_OF_DISEASE,431
9124,loss,I-NAME_OF_DISEASE,432
9125,If,O,432
9126,you,O,432
9127,experience,O,432
9128,sudden,B-NAME_OF_DISEASE,432
9129,vision,I-NAME_OF_DISEASE,432
9130,loss,I-NAME_OF_DISEASE,432
9131,in,I-NAME_OF_DISEASE,432
9132,one,I-NAME_OF_DISEASE,432
9133,eye,I-NAME_OF_DISEASE,432
9134,seek,O,432
9135,medical,O,432
9136,attention,O,432
9137,immediately,O,432
9138,Don,O,432
9139,t,O,432
9140,ignore,O,433
9141,or,O,433
9142,delay,O,433
9143,seeking,O,433
9144,professional,O,433
9145,help,O,433
9146,as,O,433
9147,it,O,433
9148,can,O,433
9149,lead,O,433
9150,to,O,433
9151,permanent,B-NAME_OF_DISEASE,433
9152,vision,I-NAME_OF_DISEASE,433
9153,loss,I-NAME_OF_DISEASE,433
9154,Tritan,B-NAME_OF_DISEASE,433
9155,color,I-NAME_OF_DISEASE,433
9156,blindness,I-NAME_OF_DISEASE,433
9157,is,O,433
9158,a,O,433
9159,rare,O,433
9160,form,O,433
9161,of,O,433
9162,color,O,434
9163,vision,O,434
9164,deficiency,O,434
9165,that,O,434
9166,affects,O,434
9167,the,O,434
9168,ability,O,434
9169,to,O,434
9170,distinguish,O,434
9171,between,O,434
9172,blue,O,434
9173,and,O,434
9174,green,O,434
9175,colors,O,434
9176,The,O,434
9177,condition,O,434
9178,is,O,434
9179,caused,O,434
9180,by,O,434
9181,a,B-CAUSE_OF_DISEASE,434
9182,genetic,I-CAUSE_OF_DISEASE,434
9183,mutation,I-CAUSE_OF_DISEASE,434
9184,in,I-CAUSE_OF_DISEASE,434
9185,the,I-CAUSE_OF_DISEASE,434
9186,S-opsin,I-CAUSE_OF_DISEASE,434
9187,gene,I-CAUSE_OF_DISEASE,434
9188,which,O,434
9189,is,O,434
9190,responsible,O,434
9191,for,O,434
9192,the,O,434
9193,production,O,434
9194,of,O,434
9195,a,B-CHEMICAL_COMPOUND,434
9196,protein,I-CHEMICAL_COMPOUND,434
9197,called,I-CHEMICAL_COMPOUND,434
9198,opsin,I-CHEMICAL_COMPOUND,435
9199,that,O,435
9200,is,O,435
9201,found,O,435
9202,in,O,435
9203,the,O,435
9204,light-sensitive,O,435
9205,cells,O,435
9206,of,O,435
9207,the,O,435
9208,eye,O,435
9209,known,O,435
9210,as,O,435
9211,cones,B-PART_OF_THE_EYES,435
9212,Types,O,435
9213,of,O,435
9214,Tritan,B-NAME_OF_DISEASE,435
9215,Color,I-NAME_OF_DISEASE,435
9216,Blindness,I-NAME_OF_DISEASE,435
9217,There,O,435
9218,are,O,435
9219,two,O,435
9220,main,O,435
9221,types,O,435
9222,of,O,435
9223,tritan,B-NAME_OF_DISEASE,435
9224,color,I-NAME_OF_DISEASE,435
9225,blindness,I-NAME_OF_DISEASE,435
9226,Tritanomaly,B-NAME_OF_DISEASE,435
9227,This,O,435
9228,is,O,435
9229,the,O,435
9230,most,O,435
9231,common,O,435
9232,type,O,435
9233,of,O,435
9234,tritan,B-NAME_OF_DISEASE,436
9235,color,I-NAME_OF_DISEASE,436
9236,blindness,I-NAME_OF_DISEASE,436
9237,and,O,436
9238,it,O,436
9239,is,O,436
9240,characterized,O,436
9241,by,O,436
9242,a,B-SIGN_AND_SYMPTOM,436
9243,reduced,I-SIGN_AND_SYMPTOM,436
9244,sensitivity,I-SIGN_AND_SYMPTOM,436
9245,to,I-SIGN_AND_SYMPTOM,436
9246,blue,I-SIGN_AND_SYMPTOM,436
9247,light,I-SIGN_AND_SYMPTOM,436
9248,Individuals,O,436
9249,with,O,436
9250,tritanomaly,B-NAME_OF_DISEASE,436
9251,have,B-SIGN_AND_SYMPTOM,436
9252,difficulty,I-SIGN_AND_SYMPTOM,436
9253,distinguishing,I-SIGN_AND_SYMPTOM,437
9254,between,I-SIGN_AND_SYMPTOM,437
9255,blue,I-SIGN_AND_SYMPTOM,437
9256,and,I-SIGN_AND_SYMPTOM,437
9257,green,I-SIGN_AND_SYMPTOM,437
9258,colors,I-SIGN_AND_SYMPTOM,437
9259,as,I-SIGN_AND_SYMPTOM,437
9260,well,I-SIGN_AND_SYMPTOM,437
9261,as,I-SIGN_AND_SYMPTOM,437
9262,between,I-SIGN_AND_SYMPTOM,437
9263,blue,I-SIGN_AND_SYMPTOM,437
9264,and,I-SIGN_AND_SYMPTOM,437
9265,purple,I-SIGN_AND_SYMPTOM,438
9266,colors,I-SIGN_AND_SYMPTOM,438
9267,They,O,438
9268,may,O,438
9269,also,O,438
9270,perceive,B-SIGN_AND_SYMPTOM,438
9271,some,I-SIGN_AND_SYMPTOM,438
9272,shades,I-SIGN_AND_SYMPTOM,438
9273,of,I-SIGN_AND_SYMPTOM,438
9274,blue,I-SIGN_AND_SYMPTOM,438
9275,as,I-SIGN_AND_SYMPTOM,438
9276,green,I-SIGN_AND_SYMPTOM,438
9277,or,I-SIGN_AND_SYMPTOM,438
9278,gray,I-SIGN_AND_SYMPTOM,438
9279,Tritanopia,B-NAME_OF_DISEASE,438
9280,This,O,438
9281,is,O,438
9282,a,O,438
9283,rarer,O,438
9284,type,O,438
9285,of,O,438
9286,tritan,B-NAME_OF_DISEASE,438
9287,color,I-NAME_OF_DISEASE,438
9288,blindness,I-NAME_OF_DISEASE,439
9289,and,O,439
9290,it,O,439
9291,is,O,439
9292,characterized,O,439
9293,by,O,439
9294,a,B-SIGN_AND_SYMPTOM,439
9295,complete,I-SIGN_AND_SYMPTOM,439
9296,absence,I-SIGN_AND_SYMPTOM,439
9297,of,I-SIGN_AND_SYMPTOM,439
9298,sensitivity,I-SIGN_AND_SYMPTOM,439
9299,to,I-SIGN_AND_SYMPTOM,439
9300,blue,I-SIGN_AND_SYMPTOM,439
9301,light,I-SIGN_AND_SYMPTOM,439
9302,Individuals,O,439
9303,with,O,439
9304,tritanopia,B-NAME_OF_DISEASE,439
9305,have,B-SIGN_AND_SYMPTOM,439
9306,difficulty,I-SIGN_AND_SYMPTOM,439
9307,distinguishing,I-SIGN_AND_SYMPTOM,440
9308,between,I-SIGN_AND_SYMPTOM,440
9309,blue,I-SIGN_AND_SYMPTOM,440
9310,and,I-SIGN_AND_SYMPTOM,440
9311,green,I-SIGN_AND_SYMPTOM,440
9312,colors,I-SIGN_AND_SYMPTOM,440
9313,as,I-SIGN_AND_SYMPTOM,440
9314,well,I-SIGN_AND_SYMPTOM,440
9315,as,I-SIGN_AND_SYMPTOM,441
9316,between,I-SIGN_AND_SYMPTOM,441
9317,blue,I-SIGN_AND_SYMPTOM,441
9318,and,I-SIGN_AND_SYMPTOM,441
9319,purple,I-SIGN_AND_SYMPTOM,441
9320,colors,I-SIGN_AND_SYMPTOM,441
9321,They,O,441
9322,may,O,441
9323,also,O,441
9324,perceive,B-SIGN_AND_SYMPTOM,441
9325,blue,I-SIGN_AND_SYMPTOM,441
9326,colors,I-SIGN_AND_SYMPTOM,441
9327,as,I-SIGN_AND_SYMPTOM,441
9328,black,I-SIGN_AND_SYMPTOM,441
9329,Additionally,O,441
9330,some,O,441
9331,individuals,O,441
9332,may,O,441
9333,have,O,441
9334,a,O,441
9335,less,O,441
9336,severe,O,441
9337,form,O,441
9338,of,O,441
9339,tritan,B-NAME_OF_DISEASE,441
9340,color,I-NAME_OF_DISEASE,441
9341,blindness,I-NAME_OF_DISEASE,441
9342,known,O,441
9343,as,O,441
9344,Anomalous,B-NAME_OF_DISEASE,441
9345,trichromacy,I-NAME_OF_DISEASE,441
9346,in,O,441
9347,which,O,441
9348,individuals,O,441
9349,have,O,441
9350,normal,B-SIGN_AND_SYMPTOM,441
9351,trichromatic,I-SIGN_AND_SYMPTOM,441
9352,color,I-SIGN_AND_SYMPTOM,441
9353,vision,I-SIGN_AND_SYMPTOM,442
9354,but,I-SIGN_AND_SYMPTOM,442
9355,with,I-SIGN_AND_SYMPTOM,442
9356,some,I-SIGN_AND_SYMPTOM,442
9357,degree,I-SIGN_AND_SYMPTOM,442
9358,of,I-SIGN_AND_SYMPTOM,442
9359,reduction,I-SIGN_AND_SYMPTOM,442
9360,in,I-SIGN_AND_SYMPTOM,442
9361,the,I-SIGN_AND_SYMPTOM,442
9362,sensitivity,I-SIGN_AND_SYMPTOM,442
9363,of,I-SIGN_AND_SYMPTOM,442
9364,the,I-SIGN_AND_SYMPTOM,442
9365,blue-sensitive,I-SIGN_AND_SYMPTOM,442
9366,cones,I-SIGN_AND_SYMPTOM,442
9367,It,O,442
9368,s,O,442
9369,important,O,442
9370,to,O,442
9371,note,O,442
9372,that,O,442
9373,both,O,442
9374,types,O,442
9375,of,O,442
9376,tritan,B-NAME_OF_DISEASE,442
9377,color,I-NAME_OF_DISEASE,442
9378,blindness,I-NAME_OF_DISEASE,442
9379,are,O,442
9380,inherited,O,442
9381,in,O,442
9382,an,O,442
9383,autosomal,O,442
9384,recessive,O,442
9385,manner,O,442
9386,which,O,442
9387,means,O,442
9388,that,O,443
9389,it,O,443
9390,is,O,443
9391,caused,O,443
9392,by,O,443
9393,a,B-CAUSE_OF_DISEASE,443
9394,mutation,I-CAUSE_OF_DISEASE,443
9395,in,I-CAUSE_OF_DISEASE,443
9396,both,I-CAUSE_OF_DISEASE,443
9397,copies,I-CAUSE_OF_DISEASE,443
9398,of,I-CAUSE_OF_DISEASE,443
9399,the,I-CAUSE_OF_DISEASE,443
9400,S-opsin,I-CAUSE_OF_DISEASE,443
9401,gene,I-CAUSE_OF_DISEASE,444
9402,However,O,444
9403,the,O,444
9404,degree,O,444
9405,of,O,444
9406,color,B-NAME_OF_DISEASE,444
9407,vision,I-NAME_OF_DISEASE,444
9408,loss,I-NAME_OF_DISEASE,444
9409,can,O,444
9410,vary,O,444
9411,from,O,444
9412,person,O,444
9413,to,O,444
9414,person,O,444
9415,How,O,444
9416,Do,O,444
9417,I,O,444
9418,Know,O,444
9419,If,O,444
9420,I,O,444
9421,Have,O,444
9422,Tritan,B-NAME_OF_DISEASE,444
9423,Color,I-NAME_OF_DISEASE,444
9424,Blindness,I-NAME_OF_DISEASE,444
9425,The,O,444
9426,best,O,444
9427,way,O,444
9428,to,O,444
9429,determine,O,444
9430,if,O,444
9431,you,O,444
9432,have,O,444
9433,tritan,B-NAME_OF_DISEASE,445
9434,color,B-NAME_OF_DISEASE,445
9435,blindness,I-NAME_OF_DISEASE,445
9436,is,O,445
9437,to,O,445
9438,visit,O,445
9439,an,O,445
9440,eye,O,445
9441,doctor,O,445
9442,for,O,445
9443,a,B-DIAGNOSTIC_TEST,445
9444,comprehensive,I-DIAGNOSTIC_TEST,445
9445,eye,I-DIAGNOSTIC_TEST,445
9446,exam,I-DIAGNOSTIC_TEST,445
9447,During,O,445
9448,the,O,445
9449,exam,O,445
9450,the,O,445
9451,eye,O,445
9452,doctor,O,445
9453,will,O,445
9454,perform,O,445
9455,a,O,445
9456,series,O,445
9457,of,O,445
9458,tests,O,446
9459,to,O,446
9460,check,O,446
9461,your,O,446
9462,vision,O,446
9463,and,O,446
9464,color,O,446
9465,perception,O,446
9466,including,O,446
9467,a,B-DIAGNOSTIC_TEST,446
9468,tritan,I-DIAGNOSTIC_TEST,446
9469,color,B-NAME_OF_DISEASE,446
9470,blindness,I-NAME_OF_DISEASE,446
9471,test,I-DIAGNOSTIC_TEST,446
9472,A,B-DIAGNOSTIC_TEST,446
9473,tritan,I-DIAGNOSTIC_TEST,446
9474,color,B-NAME_OF_DISEASE,446
9475,blindness,I-NAME_OF_DISEASE,446
9476,test,I-DIAGNOSTIC_TEST,446
9477,typically,O,446
9478,consists,O,447
9479,of,O,447
9480,a,O,447
9481,series,O,447
9482,of,O,447
9483,images,O,447
9484,or,O,447
9485,patterns,O,447
9486,that,O,447
9487,contain,O,447
9488,blue,O,447
9489,and,O,447
9490,yellow,O,447
9491,colors,O,448
9492,The,O,448
9493,individual,O,448
9494,is,O,448
9495,asked,O,448
9496,to,O,448
9497,identify,O,448
9498,the,O,448
9499,colors,O,448
9500,in,O,448
9501,the,O,448
9502,images,O,448
9503,or,O,448
9504,patterns,O,448
9505,If,O,448
9506,the,O,448
9507,individual,O,448
9508,has,B-CAUSE_OF_DISEASE,449
9509,difficulty,I-CAUSE_OF_DISEASE,449
9510,distinguishing,I-CAUSE_OF_DISEASE,449
9511,between,I-CAUSE_OF_DISEASE,449
9512,blue,I-CAUSE_OF_DISEASE,449
9513,and,I-CAUSE_OF_DISEASE,449
9514,yellow,I-CAUSE_OF_DISEASE,449
9515,colors,I-CAUSE_OF_DISEASE,449
9516,they,O,449
9517,may,O,449
9518,have,O,449
9519,tritan,B-NAME_OF_DISEASE,449
9520,color,B-NAME_OF_DISEASE,449
9521,blindness,I-NAME_OF_DISEASE,449
9522,Additionally,O,449
9523,your,O,449
9524,eye,O,449
9525,doctor,O,449
9526,may,O,449
9527,also,O,449
9528,use,O,449
9529,other,O,449
9530,tests,O,449
9531,such,O,449
9532,as,O,449
9533,a,B-DIAGNOSTIC_TEST,449
9534,visual,I-DIAGNOSTIC_TEST,449
9535,acuity,I-DIAGNOSTIC_TEST,449
9536,test,I-DIAGNOSTIC_TEST,449
9537,to,O,449
9538,check,O,450
9539,your,O,450
9540,overall,O,450
9541,eye,O,450
9542,health,O,450
9543,and,O,450
9544,to,O,450
9545,rule,O,450
9546,out,O,450
9547,other,O,450
9548,causes,O,450
9549,of,O,450
9550,color,B-NAME_OF_DISEASE,450
9551,blindness,I-NAME_OF_DISEASE,450
9552,It,O,450
9553,s,O,450
9554,also,O,450
9555,worth,O,450
9556,noting,O,450
9557,that,O,450
9558,there,O,450
9559,are,O,450
9560,some,B-DIAGNOSTIC_TEST,450
9561,online,I-DIAGNOSTIC_TEST,450
9562,tests,I-DIAGNOSTIC_TEST,450
9563,and,I-DIAGNOSTIC_TEST,450
9564,color,I-DIAGNOSTIC_TEST,450
9565,vision,I-DIAGNOSTIC_TEST,450
9566,tests,I-DIAGNOSTIC_TEST,450
9567,available,O,450
9568,to,O,450
9569,check,O,450
9570,for,O,450
9571,color,B-NAME_OF_DISEASE,450
9572,blindness,I-NAME_OF_DISEASE,450
9573,however,O,450
9574,these,O,450
9575,are,O,450
9576,not,O,450
9577,always,O,450
9578,reliable,O,450
9579,or,O,451
9580,accurate,O,451
9581,and,O,451
9582,should,O,451
9583,not,O,451
9584,be,O,451
9585,considered,O,451
9586,a,O,451
9587,substitute,O,451
9588,for,O,451
9589,a,B-DIAGNOSTIC_TEST,451
9590,professional,I-DIAGNOSTIC_TEST,451
9591,eye,I-DIAGNOSTIC_TEST,451
9592,examination,I-DIAGNOSTIC_TEST,451
9593,While,O,451
9594,tritan,B-NAME_OF_DISEASE,451
9595,color,B-NAME_OF_DISEASE,451
9596,blindness,I-NAME_OF_DISEASE,451
9597,can,O,451
9598,be,O,451
9599,challenging,O,451
9600,for,O,451
9601,those,O,451
9602,who,O,451
9603,have,O,451
9604,it,O,451
9605,it,O,451
9606,is,O,451
9607,not,O,451
9608,a,O,452
9609,serious,O,452
9610,condition,O,452
9611,and,O,452
9612,does,O,452
9613,not,O,452
9614,usually,O,452
9615,affect,O,452
9616,an,O,452
9617,individual,O,452
9618,s,O,452
9619,quality,O,452
9620,of,O,452
9621,life,O,452
9622,However,O,452
9623,certain,O,452
9624,occupations,O,452
9625,such,O,452
9626,as,O,452
9627,those,O,452
9628,in,O,452
9629,the,O,452
9630,field,O,452
9631,of,O,452
9632,color,O,452
9633,design,O,453
9634,or,O,453
9635,graphic,O,453
9636,design,O,453
9637,may,O,453
9638,be,O,453
9639,more,O,453
9640,challenging,O,453
9641,for,O,453
9642,individuals,O,453
9643,with,O,453
9644,tritan,B-NAME_OF_DISEASE,453
9645,color,B-NAME_OF_DISEASE,453
9646,blindness,I-NAME_OF_DISEASE,453
9647,Conclusion,O,453
9648,Tritan,B-NAME_OF_DISEASE,453
9649,color,I-NAME_OF_DISEASE,453
9650,blindness,I-NAME_OF_DISEASE,453
9651,is,O,453
9652,a,O,453
9653,rare,O,453
9654,form,O,453
9655,of,O,453
9656,color,O,454
9657,vision,O,454
9658,deficiency,O,454
9659,that,O,454
9660,affects,O,454
9661,the,O,454
9662,ability,O,454
9663,to,O,454
9664,distinguish,O,454
9665,between,O,454
9666,blue,O,454
9667,and,O,454
9668,yellow,O,454
9669,colors,O,454
9670,It,O,454
9671,is,O,454
9672,caused,O,454
9673,by,O,454
9674,a,B-CAUSE_OF_DISEASE,454
9675,genetic,I-CAUSE_OF_DISEASE,454
9676,mutation,I-CAUSE_OF_DISEASE,454
9677,in,I-CAUSE_OF_DISEASE,454
9678,the,I-CAUSE_OF_DISEASE,454
9679,S-opsin,I-CAUSE_OF_DISEASE,454
9680,gene,I-CAUSE_OF_DISEASE,454
9681,inherited,O,454
9682,in,O,455
9683,an,O,455
9684,autosomal,O,455
9685,recessive,O,455
9686,manner,O,455
9687,and,O,455
9688,it,O,455
9689,is,O,455
9690,more,O,455
9691,common,O,455
9692,in,O,455
9693,men,O,455
9694,than,O,455
9695,women,O,455
9696,The,O,455
9697,most,O,456
9698,important,O,456
9699,diagnostic,O,456
9700,tool,O,456
9701,for,O,456
9702,Tritan,B-NAME_OF_DISEASE,456
9703,color,I-NAME_OF_DISEASE,456
9704,blindness,I-NAME_OF_DISEASE,456
9705,is,O,456
9706,the,B-DIAGNOSTIC_TEST,456
9707,tritan,I-DIAGNOSTIC_TEST,456
9708,color,I-DIAGNOSTIC_TEST,456
9709,blindness,I-DIAGNOSTIC_TEST,456
9710,test,I-DIAGNOSTIC_TEST,456
9711,The,O,456
9712,condition,O,456
9713,can,O,456
9714,be,O,456
9715,challenging,O,456
9716,but,O,456
9717,it,O,456
9718,is,O,457
9719,not,O,457
9720,a,O,457
9721,serious,O,457
9722,one,O,457
9723,and,O,457
9724,it,O,457
9725,doesn,O,457
9726,t,O,457
9727,affect,O,457
9728,the,O,457
9729,quality,O,457
9730,of,O,457
9731,life,O,457
9732,Balint,B-NAME_OF_DISEASE,457
9733,syndrome,I-NAME_OF_DISEASE,457
9734,is,O,457
9735,a,O,457
9736,rare,O,457
9737,neurological,O,457
9738,condition,O,457
9739,that,O,457
9740,affects,O,457
9741,the,O,457
9742,ability,O,458
9743,to,O,458
9744,perceive,O,458
9745,plan,O,458
9746,and,O,458
9747,initiate,O,458
9748,movement,O,458
9749,and,O,458
9750,to,O,458
9751,direct,O,458
9752,attention,O,458
9753,to,O,458
9754,visual,O,458
9755,stimuli,O,458
9756,It,O,458
9757,is,O,458
9758,named,O,459
9759,after,O,459
9760,the,O,459
9761,Hungarian,O,459
9762,neurologist,O,459
9763,Rezső,B-PERSON,459
9764,Balint,I-PERSON,459
9765,who,O,459
9766,first,O,459
9767,described,O,459
9768,the,O,459
9769,condition,O,459
9770,in,O,459
9771,1909,O,459
9772,Causes,O,459
9773,of,O,459
9774,Balint,B-NAME_OF_DISEASE,459
9775,Syndrome,I-NAME_OF_DISEASE,459
9776,The,O,459
9777,exact,O,459
9778,cause,O,459
9779,of,O,459
9780,Balint,B-NAME_OF_DISEASE,459
9781,syndrome,I-NAME_OF_DISEASE,459
9782,is,O,459
9783,not,O,459
9784,well,O,459
9785,understood,O,459
9786,but,O,459
9787,it,O,459
9788,is,O,459
9789,believed,O,459
9790,to,O,459
9791,be,O,459
9792,the,O,459
9793,result,O,459
9794,of,O,459
9795,damage,B-CAUSE_OF_DISEASE,459
9796,to,I-CAUSE_OF_DISEASE,459
9797,specific,I-CAUSE_OF_DISEASE,460
9798,areas,I-CAUSE_OF_DISEASE,460
9799,of,I-CAUSE_OF_DISEASE,460
9800,the,I-CAUSE_OF_DISEASE,460
9801,brain,I-CAUSE_OF_DISEASE,460
9802,including,I-CAUSE_OF_DISEASE,460
9803,the,I-CAUSE_OF_DISEASE,460
9804,parietal,I-CAUSE_OF_DISEASE,460
9805,lobes,I-CAUSE_OF_DISEASE,460
9806,and,I-CAUSE_OF_DISEASE,460
9807,the,I-CAUSE_OF_DISEASE,460
9808,superior,I-CAUSE_OF_DISEASE,460
9809,temporal,I-CAUSE_OF_DISEASE,460
9810,gyrus,I-CAUSE_OF_DISEASE,460
9811,This,O,460
9812,damage,O,460
9813,can,O,460
9814,be,O,460
9815,caused,O,460
9816,by,O,460
9817,a,O,460
9818,variety,O,460
9819,of,O,460
9820,factors,O,460
9821,including,O,460
9822,Stroke,B-CAUSE_OF_DISEASE,460
9823,A,B-CAUSE_OF_DISEASE,460
9824,stroke,I-CAUSE_OF_DISEASE,460
9825,or,I-CAUSE_OF_DISEASE,460
9826,sudden,I-CAUSE_OF_DISEASE,460
9827,loss,I-CAUSE_OF_DISEASE,460
9828,of,I-CAUSE_OF_DISEASE,461
9829,blood,I-CAUSE_OF_DISEASE,461
9830,flow,I-CAUSE_OF_DISEASE,461
9831,to,I-CAUSE_OF_DISEASE,461
9832,the,I-CAUSE_OF_DISEASE,461
9833,brain,I-CAUSE_OF_DISEASE,461
9834,is,O,461
9835,the,O,461
9836,most,O,461
9837,common,O,461
9838,cause,O,461
9839,of,O,461
9840,Balint,B-NAME_OF_DISEASE,461
9841,syndrome,I-NAME_OF_DISEASE,461
9842,The,O,461
9843,damage,O,461
9844,caused,O,461
9845,by,O,461
9846,a,B-CAUSE_OF_DISEASE,461
9847,stroke,I-CAUSE_OF_DISEASE,461
9848,can,O,461
9849,affect,O,461
9850,the,O,461
9851,areas,O,461
9852,of,O,461
9853,the,O,462
9854,brain,O,462
9855,responsible,O,462
9856,for,O,462
9857,movement,O,462
9858,and,O,462
9859,attention,O,462
9860,leading,O,462
9861,to,O,462
9862,the,O,462
9863,symptoms,O,462
9864,of,O,462
9865,Balint,B-NAME_OF_DISEASE,462
9866,syndrome,I-NAME_OF_DISEASE,462
9867,Trauma,B-CAUSE_OF_DISEASE,462
9868,Trauma,B-CAUSE_OF_DISEASE,462
9869,to,I-CAUSE_OF_DISEASE,462
9870,the,I-CAUSE_OF_DISEASE,462
9871,head,I-CAUSE_OF_DISEASE,462
9872,such,I-CAUSE_OF_DISEASE,462
9873,as,I-CAUSE_OF_DISEASE,462
9874,from,I-CAUSE_OF_DISEASE,462
9875,a,I-CAUSE_OF_DISEASE,462
9876,car,I-CAUSE_OF_DISEASE,462
9877,accident,I-CAUSE_OF_DISEASE,462
9878,or,I-CAUSE_OF_DISEASE,462
9879,fall,I-CAUSE_OF_DISEASE,463
9880,can,O,463
9881,also,O,463
9882,cause,O,463
9883,damage,O,463
9884,to,O,463
9885,the,O,463
9886,brain,O,463
9887,and,O,463
9888,lead,O,463
9889,to,O,463
9890,Balint,B-NAME_OF_DISEASE,463
9891,s,I-NAME_OF_DISEASE,463
9892,syndrome,I-NAME_OF_DISEASE,463
9893,Neurodegenerative,B-CAUSE_OF_DISEASE,463
9894,disorders,I-CAUSE_OF_DISEASE,463
9895,Some,B-CAUSE_OF_DISEASE,463
9896,neurodegenerative,I-CAUSE_OF_DISEASE,463
9897,disorders,I-CAUSE_OF_DISEASE,463
9898,such,I-CAUSE_OF_DISEASE,463
9899,as,I-CAUSE_OF_DISEASE,463
9900,Alzheimer,I-CAUSE_OF_DISEASE,463
9901,s,I-CAUSE_OF_DISEASE,463
9902,disease,I-CAUSE_OF_DISEASE,464
9903,and,I-CAUSE_OF_DISEASE,464
9904,multiple,I-CAUSE_OF_DISEASE,464
9905,sclerosis,I-CAUSE_OF_DISEASE,464
9906,can,O,464
9907,also,O,464
9908,cause,O,464
9909,Balint,B-NAME_OF_DISEASE,464
9910,s,I-NAME_OF_DISEASE,464
9911,syndrome,I-NAME_OF_DISEASE,464
9912,by,O,464
9913,damaging,O,464
9914,the,O,464
9915,brain,O,464
9916,Psychoanatomical,O,464
9917,substrates,O,464
9918,of,O,464
9919,Bálint,B-NAME_OF_DISEASE,464
9920,s,I-NAME_OF_DISEASE,464
9921,syndrome,I-NAME_OF_DISEASE,464
9922,-,O,464
9923,BMJ,B-PUBLICATION_VENUE,464
9924,Journal,I-PUBLICATION_VENUE,464
9925,How,O,464
9926,Can,O,464
9927,You,O,464
9928,Know,O,464
9929,If,O,464
9930,You,O,464
9931,Have,O,465
9932,Balint,B-NAME_OF_DISEASE,465
9933,s,I-NAME_OF_DISEASE,465
9934,Syndrome,I-NAME_OF_DISEASE,465
9935,The,O,465
9936,symptoms,O,465
9937,of,O,465
9938,Balint,B-NAME_OF_DISEASE,465
9939,syndrome,I-NAME_OF_DISEASE,465
9940,can,O,465
9941,vary,O,465
9942,depending,O,465
9943,on,O,465
9944,the,O,465
9945,extent,O,465
9946,of,O,465
9947,brain,O,465
9948,damage,O,465
9949,and,O,465
9950,the,O,465
9951,specific,O,465
9952,areas,O,465
9953,affected,O,465
9954,Common,O,465
9955,symptoms,O,465
9956,are,O,465
9957,listed,O,465
9958,as,O,465
9959,Difficulty,B-SIGN_AND_SYMPTOM,465
9960,with,I-SIGN_AND_SYMPTOM,465
9961,visually,I-SIGN_AND_SYMPTOM,465
9962,guided,I-SIGN_AND_SYMPTOM,465
9963,movements,I-SIGN_AND_SYMPTOM,465
9964,People,O,466
9965,with,O,466
9966,Balint,B-NAME_OF_DISEASE,466
9967,syndrome,I-NAME_OF_DISEASE,466
9968,may,O,466
9969,have,B-SIGN_AND_SYMPTOM,466
9970,difficulty,I-SIGN_AND_SYMPTOM,466
9971,initiating,I-SIGN_AND_SYMPTOM,466
9972,and,I-SIGN_AND_SYMPTOM,466
9973,executing,I-SIGN_AND_SYMPTOM,466
9974,visually,I-SIGN_AND_SYMPTOM,466
9975,guided,I-SIGN_AND_SYMPTOM,466
9976,movements,I-SIGN_AND_SYMPTOM,466
9977,such,I-SIGN_AND_SYMPTOM,466
9978,as,I-SIGN_AND_SYMPTOM,466
9979,reaching,I-SIGN_AND_SYMPTOM,466
9980,for,I-SIGN_AND_SYMPTOM,466
9981,an,I-SIGN_AND_SYMPTOM,466
9982,object,I-SIGN_AND_SYMPTOM,466
9983,or,I-SIGN_AND_SYMPTOM,466
9984,buttoning,I-SIGN_AND_SYMPTOM,466
9985,a,I-SIGN_AND_SYMPTOM,466
9986,shirt,I-SIGN_AND_SYMPTOM,466
9987,Difficulty,B-SIGN_AND_SYMPTOM,466
9988,with,I-SIGN_AND_SYMPTOM,466
9989,attention,I-SIGN_AND_SYMPTOM,466
9990,People,O,466
9991,with,O,466
9992,Balint,B-NAME_OF_DISEASE,467
9993,syndrome,I-NAME_OF_DISEASE,467
9994,may,O,467
9995,have,B-SIGN_AND_SYMPTOM,467
9996,difficulty,I-SIGN_AND_SYMPTOM,467
9997,directing,I-SIGN_AND_SYMPTOM,467
9998,their,I-SIGN_AND_SYMPTOM,467
9999,attention,I-SIGN_AND_SYMPTOM,467
10000,to,I-SIGN_AND_SYMPTOM,467
10001,specific,I-SIGN_AND_SYMPTOM,467
10002,visual,I-SIGN_AND_SYMPTOM,467
10003,stimuli,I-SIGN_AND_SYMPTOM,467
10004,such,I-SIGN_AND_SYMPTOM,467
10005,as,I-SIGN_AND_SYMPTOM,467
10006,a,I-SIGN_AND_SYMPTOM,467
10007,person,I-SIGN_AND_SYMPTOM,467
10008,s,I-SIGN_AND_SYMPTOM,467
10009,face,I-SIGN_AND_SYMPTOM,467
10010,or,I-SIGN_AND_SYMPTOM,467
10011,a,I-SIGN_AND_SYMPTOM,467
10012,car,I-SIGN_AND_SYMPTOM,467
10013,driving,I-SIGN_AND_SYMPTOM,467
10014,by,I-SIGN_AND_SYMPTOM,467
10015,Difficulty,B-SIGN_AND_SYMPTOM,467
10016,with,I-SIGN_AND_SYMPTOM,467
10017,visual,I-SIGN_AND_SYMPTOM,467
10018,memory,I-SIGN_AND_SYMPTOM,467
10019,People,O,467
10020,with,O,467
10021,Balint,B-NAME_OF_DISEASE,467
10022,syndrome,I-NAME_OF_DISEASE,467
10023,may,O,467
10024,have,B-SIGN_AND_SYMPTOM,467
10025,difficulty,I-SIGN_AND_SYMPTOM,468
10026,remembering,I-SIGN_AND_SYMPTOM,468
10027,what,I-SIGN_AND_SYMPTOM,468
10028,they,I-SIGN_AND_SYMPTOM,468
10029,have,I-SIGN_AND_SYMPTOM,468
10030,seen,I-SIGN_AND_SYMPTOM,468
10031,such,I-SIGN_AND_SYMPTOM,468
10032,as,I-SIGN_AND_SYMPTOM,468
10033,the,I-SIGN_AND_SYMPTOM,468
10034,location,I-SIGN_AND_SYMPTOM,468
10035,of,I-SIGN_AND_SYMPTOM,468
10036,objects,I-SIGN_AND_SYMPTOM,468
10037,on,I-SIGN_AND_SYMPTOM,468
10038,a,I-SIGN_AND_SYMPTOM,468
10039,table,I-SIGN_AND_SYMPTOM,468
10040,or,I-SIGN_AND_SYMPTOM,468
10041,the,I-SIGN_AND_SYMPTOM,468
10042,features,I-SIGN_AND_SYMPTOM,468
10043,of,I-SIGN_AND_SYMPTOM,468
10044,a,I-SIGN_AND_SYMPTOM,468
10045,person,I-SIGN_AND_SYMPTOM,468
10046,s,I-SIGN_AND_SYMPTOM,469
10047,face,I-SIGN_AND_SYMPTOM,469
10048,Difficulty,B-SIGN_AND_SYMPTOM,469
10049,with,I-SIGN_AND_SYMPTOM,469
10050,visual,I-SIGN_AND_SYMPTOM,469
10051,perception,I-SIGN_AND_SYMPTOM,469
10052,People,O,469
10053,with,O,469
10054,Balint,B-NAME_OF_DISEASE,469
10055,syndrome,I-NAME_OF_DISEASE,469
10056,may,O,469
10057,have,B-SIGN_AND_SYMPTOM,469
10058,difficulty,I-SIGN_AND_SYMPTOM,469
10059,perceiving,I-SIGN_AND_SYMPTOM,469
10060,visual,I-SIGN_AND_SYMPTOM,469
10061,information,I-SIGN_AND_SYMPTOM,469
10062,such,I-SIGN_AND_SYMPTOM,469
10063,as,I-SIGN_AND_SYMPTOM,469
10064,difficulty,I-SIGN_AND_SYMPTOM,469
10065,recognizing,I-SIGN_AND_SYMPTOM,469
10066,objects,I-SIGN_AND_SYMPTOM,469
10067,or,I-SIGN_AND_SYMPTOM,469
10068,faces,I-SIGN_AND_SYMPTOM,470
10069,Is,O,470
10070,Balint,B-NAME_OF_DISEASE,470
10071,Syndrome,I-NAME_OF_DISEASE,470
10072,Treatable,O,470
10073,While,O,470
10074,there,O,470
10075,is,O,470
10076,no,O,470
10077,cure,O,470
10078,for,O,470
10079,Balint,B-NAME_OF_DISEASE,470
10080,syndrome,I-NAME_OF_DISEASE,470
10081,treatment,O,470
10082,options,O,470
10083,can,O,470
10084,help,O,470
10085,to,O,470
10086,manage,O,470
10087,symptoms,O,470
10088,and,O,470
10089,improve,O,470
10090,function,O,470
10091,Treatment,O,470
10092,options,O,470
10093,include,O,471
10094,Physical,B-TREATMENT,471
10095,therapy,I-TREATMENT,471
10096,Physical,B-TREATMENT,471
10097,therapy,I-TREATMENT,471
10098,can,O,471
10099,help,O,471
10100,to,O,471
10101,improve,O,471
10102,motor,O,471
10103,function,O,471
10104,and,O,471
10105,coordination,O,471
10106,as,O,471
10107,well,O,471
10108,as,O,471
10109,help,O,471
10110,to,O,471
10111,prevent,O,471
10112,muscle,O,472
10113,weakness,O,472
10114,and,O,472
10115,contractures,O,472
10116,Occupational,B-TREATMENT,472
10117,therapy,I-TREATMENT,472
10118,Occupational,B-TREATMENT,472
10119,therapy,I-TREATMENT,472
10120,can,O,472
10121,help,O,472
10122,to,O,472
10123,improve,O,472
10124,the,O,472
10125,ability,O,472
10126,to,O,472
10127,perform,O,472
10128,daily,O,473
10129,activities,O,473
10130,such,O,473
10131,as,O,473
10132,dressing,O,473
10133,and,O,473
10134,grooming,O,473
10135,Speech,B-TREATMENT,473
10136,therapy,I-TREATMENT,473
10137,Speech,B-TREATMENT,473
10138,therapy,I-TREATMENT,473
10139,can,O,473
10140,help,O,473
10141,to,O,473
10142,improve,O,474
10143,communication,O,474
10144,skills,O,474
10145,such,O,474
10146,as,O,474
10147,speaking,O,474
10148,and,O,474
10149,understanding,O,474
10150,language,O,474
10151,Cognitive,B-TREATMENT,474
10152,therapy,I-TREATMENT,474
10153,Cognitive,B-TREATMENT,474
10154,therapy,I-TREATMENT,474
10155,can,O,474
10156,help,O,474
10157,to,O,474
10158,improve,O,474
10159,attention,O,474
10160,memory,O,474
10161,and,O,475
10162,other,O,475
10163,cognitive,O,475
10164,skills,O,475
10165,Medications,B-TREATMENT,475
10166,Medications,B-TREATMENT,475
10167,can,O,475
10168,be,O,475
10169,used,O,475
10170,to,O,475
10171,manage,O,475
10172,symptoms,O,475
10173,of,O,475
10174,Balint,B-NAME_OF_DISEASE,475
10175,syndrome,I-NAME_OF_DISEASE,475
10176,such,O,475
10177,as,O,475
10178,reducing,O,475
10179,muscle,O,475
10180,spasticity,O,475
10181,or,O,475
10182,improving,O,475
10183,memory,O,475
10184,Can,O,475
10185,Balint,B-NAME_OF_DISEASE,475
10186,Syndrome,I-NAME_OF_DISEASE,476
10187,Improve,O,476
10188,Over,O,476
10189,Time,O,476
10190,The,O,476
10191,prognosis,O,476
10192,for,O,476
10193,Balint,B-NAME_OF_DISEASE,476
10194,syndrome,I-NAME_OF_DISEASE,476
10195,can,O,476
10196,vary,O,476
10197,depending,O,476
10198,on,O,476
10199,the,O,477
10200,extent,O,477
10201,of,O,477
10202,brain,O,477
10203,damage,O,477
10204,and,O,477
10205,the,O,477
10206,specific,O,477
10207,areas,O,477
10208,affected,O,477
10209,Some,O,477
10210,people,O,477
10211,may,O,477
10212,experience,O,477
10213,improvement,O,477
10214,in,O,477
10215,symptoms,O,477
10216,over,O,477
10217,time,O,477
10218,while,O,477
10219,others,O,477
10220,may,O,478
10221,not,O,478
10222,Conclusion,O,478
10223,Balint,B-NAME_OF_DISEASE,478
10224,syndrome,I-NAME_OF_DISEASE,478
10225,is,O,478
10226,a,O,478
10227,rare,O,478
10228,neurological,O,478
10229,condition,O,478
10230,characterized,O,478
10231,by,O,478
10232,difficulties,B-SIGN_AND_SYMPTOM,478
10233,with,I-SIGN_AND_SYMPTOM,478
10234,visually,I-SIGN_AND_SYMPTOM,478
10235,guided,I-SIGN_AND_SYMPTOM,478
10236,movements,I-SIGN_AND_SYMPTOM,478
10237,attention,I-SIGN_AND_SYMPTOM,478
10238,visual,I-SIGN_AND_SYMPTOM,478
10239,memory,I-SIGN_AND_SYMPTOM,479
10240,and,I-SIGN_AND_SYMPTOM,479
10241,visual,I-SIGN_AND_SYMPTOM,479
10242,perception,I-SIGN_AND_SYMPTOM,479
10243,It,O,479
10244,is,O,479
10245,caused,O,479
10246,by,O,479
10247,damage,B-CAUSE_OF_DISEASE,479
10248,to,I-CAUSE_OF_DISEASE,479
10249,specific,I-CAUSE_OF_DISEASE,479
10250,areas,I-CAUSE_OF_DISEASE,479
10251,of,I-CAUSE_OF_DISEASE,479
10252,the,I-CAUSE_OF_DISEASE,479
10253,brain,I-CAUSE_OF_DISEASE,479
10254,including,I-CAUSE_OF_DISEASE,479
10255,the,I-CAUSE_OF_DISEASE,479
10256,parietal,I-CAUSE_OF_DISEASE,479
10257,lobes,I-CAUSE_OF_DISEASE,479
10258,and,I-CAUSE_OF_DISEASE,479
10259,superior,I-CAUSE_OF_DISEASE,479
10260,temporal,I-CAUSE_OF_DISEASE,479
10261,gyrus,I-CAUSE_OF_DISEASE,480
10262,Treatment,O,480
10263,options,O,480
10264,include,O,480
10265,physical,B-TREATMENT,480
10266,therapy,I-TREATMENT,480
10267,occupational,B-TREATMENT,480
10268,therapy,I-TREATMENT,480
10269,speech,B-TREATMENT,480
10270,therapy,I-TREATMENT,480
10271,cognitive,B-TREATMENT,480
10272,therapy,I-TREATMENT,480
10273,and,O,480
10274,medications,B-TREATMENT,480
10275,which,O,480
10276,can,O,480
10277,help,O,480
10278,to,O,480
10279,manage,O,480
10280,symptoms,O,480
10281,and,O,480
10282,improve,O,480
10283,function,O,480
10284,Binocular,O,481
10285,vision,O,481
10286,refers,O,481
10287,to,O,481
10288,the,O,481
10289,ability,O,481
10290,of,O,481
10291,the,O,481
10292,eyes,O,481
10293,to,O,481
10294,work,O,481
10295,together,O,481
10296,as,O,481
10297,a,O,481
10298,team,O,481
10299,to,O,481
10300,perceive,O,482
10301,depth,O,482
10302,and,O,482
10303,perceive,O,482
10304,a,O,482
10305,single,O,482
10306,image,O,482
10307,Binocular,O,482
10308,vision,O,482
10309,is,O,482
10310,graded,O,482
10311,based,O,482
10312,on,O,482
10313,the,B-DIAGNOSTIC_TEST,482
10314,degree,I-DIAGNOSTIC_TEST,482
10315,of,I-DIAGNOSTIC_TEST,482
10316,deviation,I-DIAGNOSTIC_TEST,482
10317,or,I-DIAGNOSTIC_TEST,482
10318,misalignment,I-DIAGNOSTIC_TEST,482
10319,between,I-DIAGNOSTIC_TEST,482
10320,the,I-DIAGNOSTIC_TEST,482
10321,two,I-DIAGNOSTIC_TEST,482
10322,eyes,I-DIAGNOSTIC_TEST,483
10323,Grades,O,483
10324,of,O,483
10325,Binocular,B-NAME_OF_DISEASE,483
10326,Vision,I-NAME_OF_DISEASE,483
10327,Dysfunction,I-NAME_OF_DISEASE,483
10328,Binocular,O,483
10329,vision,O,483
10330,can,O,483
10331,be,O,483
10332,graded,O,483
10333,based,O,483
10334,on,O,483
10335,the,B-DIAGNOSTIC_TEST,483
10336,degree,I-DIAGNOSTIC_TEST,484
10337,of,I-DIAGNOSTIC_TEST,484
10338,deviation,I-DIAGNOSTIC_TEST,484
10339,or,I-DIAGNOSTIC_TEST,484
10340,misalignment,I-DIAGNOSTIC_TEST,484
10341,between,I-DIAGNOSTIC_TEST,484
10342,the,I-DIAGNOSTIC_TEST,484
10343,two,I-DIAGNOSTIC_TEST,484
10344,eyes,I-DIAGNOSTIC_TEST,484
10345,There,O,484
10346,are,O,484
10347,three,O,484
10348,grades,O,484
10349,of,O,484
10350,binocular,O,484
10351,vision,O,484
10352,first,O,484
10353,grade,O,484
10354,second,O,484
10355,grade,O,484
10356,and,O,484
10357,third,O,485
10358,grade,O,485
10359,First,O,485
10360,Grade,O,485
10361,This,O,485
10362,is,O,485
10363,the,O,485
10364,normal,O,485
10365,state,O,485
10366,of,O,485
10367,binocular,O,485
10368,vision,O,485
10369,where,O,485
10370,the,O,485
10371,eyes,O,486
10372,are,O,486
10373,perfectly,O,486
10374,aligned,O,486
10375,and,O,486
10376,there,O,486
10377,is,O,486
10378,no,O,486
10379,deviation,O,486
10380,The,O,486
10381,eyes,O,486
10382,work,O,486
10383,together,O,486
10384,to,O,486
10385,focus,O,486
10386,on,O,486
10387,an,O,486
10388,object,O,486
10389,and,O,486
10390,produce,O,487
10391,a,O,487
10392,single,O,487
10393,image,O,487
10394,People,O,487
10395,with,O,487
10396,first-grade,O,487
10397,binocular,O,487
10398,vision,O,487
10399,have,O,487
10400,good,O,487
10401,depth,O,487
10402,perception,O,487
10403,and,O,487
10404,have,O,487
10405,no,O,487
10406,symptoms,O,487
10407,of,O,487
10408,double,O,488
10409,vision,O,488
10410,or,O,488
10411,eye,O,488
10412,strain,O,488
10413,Second,O,488
10414,Grade,O,488
10415,This,O,488
10416,is,O,488
10417,a,O,488
10418,mild,O,488
10419,form,O,488
10420,of,O,488
10421,binocular,B-NAME_OF_DISEASE,488
10422,vision,I-NAME_OF_DISEASE,488
10423,deviation,I-NAME_OF_DISEASE,488
10424,where,O,488
10425,the,B-SIGN_AND_SYMPTOM,488
10426,eyes,I-SIGN_AND_SYMPTOM,489
10427,tend,I-SIGN_AND_SYMPTOM,489
10428,to,I-SIGN_AND_SYMPTOM,489
10429,deviate,I-SIGN_AND_SYMPTOM,489
10430,slightly,I-SIGN_AND_SYMPTOM,489
10431,The,B-SIGN_AND_SYMPTOM,489
10432,eyes,I-SIGN_AND_SYMPTOM,489
10433,may,I-SIGN_AND_SYMPTOM,489
10434,not,I-SIGN_AND_SYMPTOM,489
10435,be,I-SIGN_AND_SYMPTOM,489
10436,perfectly,I-SIGN_AND_SYMPTOM,489
10437,aligned,I-SIGN_AND_SYMPTOM,489
10438,but,O,489
10439,they,O,489
10440,can,O,489
10441,still,O,489
10442,work,O,489
10443,together,O,489
10444,to,O,489
10445,produce,O,489
10446,a,O,489
10447,single,O,489
10448,image,O,489
10449,People,O,490
10450,with,O,490
10451,second-grade,O,490
10452,binocular,O,490
10453,vision,O,490
10454,may,O,490
10455,experience,O,490
10456,occasional,B-SIGN_AND_SYMPTOM,490
10457,double,I-SIGN_AND_SYMPTOM,490
10458,vision,I-SIGN_AND_SYMPTOM,490
10459,or,I-SIGN_AND_SYMPTOM,490
10460,eye,I-SIGN_AND_SYMPTOM,490
10461,strain,I-SIGN_AND_SYMPTOM,490
10462,but,O,490
10463,it,O,490
10464,is,O,490
10465,not,O,490
10466,severe,O,490
10467,enough,O,490
10468,to,O,490
10469,cause,O,490
10470,significant,O,490
10471,problems,O,490
10472,Third,O,490
10473,Grade,O,490
10474,This,O,491
10475,is,O,491
10476,a,O,491
10477,severe,O,491
10478,form,O,491
10479,of,O,491
10480,binocular,B-NAME_OF_DISEASE,491
10481,vision,I-NAME_OF_DISEASE,491
10482,deviation,I-NAME_OF_DISEASE,491
10483,where,O,491
10484,the,B-SIGN_AND_SYMPTOM,491
10485,eyes,I-SIGN_AND_SYMPTOM,491
10486,are,I-SIGN_AND_SYMPTOM,491
10487,misaligned,I-SIGN_AND_SYMPTOM,491
10488,and,I-SIGN_AND_SYMPTOM,491
10489,cannot,I-SIGN_AND_SYMPTOM,491
10490,work,I-SIGN_AND_SYMPTOM,491
10491,together,I-SIGN_AND_SYMPTOM,491
10492,to,I-SIGN_AND_SYMPTOM,491
10493,produce,I-SIGN_AND_SYMPTOM,491
10494,a,I-SIGN_AND_SYMPTOM,492
10495,single,I-SIGN_AND_SYMPTOM,492
10496,image,I-SIGN_AND_SYMPTOM,492
10497,People,O,492
10498,with,O,492
10499,third-grade,O,492
10500,binocular,O,492
10501,vision,O,492
10502,may,O,492
10503,experience,O,492
10504,constant,B-SIGN_AND_SYMPTOM,492
10505,double,I-SIGN_AND_SYMPTOM,492
10506,vision,I-SIGN_AND_SYMPTOM,493
10507,or,I-SIGN_AND_SYMPTOM,493
10508,eye,I-SIGN_AND_SYMPTOM,493
10509,strain,I-SIGN_AND_SYMPTOM,493
10510,and,I-SIGN_AND_SYMPTOM,493
10511,may,I-SIGN_AND_SYMPTOM,493
10512,have,I-SIGN_AND_SYMPTOM,493
10513,difficulty,I-SIGN_AND_SYMPTOM,493
10514,with,I-SIGN_AND_SYMPTOM,493
10515,depth,I-SIGN_AND_SYMPTOM,493
10516,perception,I-SIGN_AND_SYMPTOM,493
10517,This,O,493
10518,condition,O,493
10519,can,O,493
10520,lead,O,493
10521,to,O,493
10522,amblyopia,B-NAME_OF_DISEASE,493
10523,lazy,B-NAME_OF_DISEASE,493
10524,eye,I-NAME_OF_DISEASE,493
10525,if,O,493
10526,not,O,493
10527,treated,O,494
10528,promptly,O,494
10529,What,O,494
10530,Causes,O,494
10531,Binocular,B-NAME_OF_DISEASE,494
10532,Vision,I-NAME_OF_DISEASE,494
10533,Dysfunction,I-NAME_OF_DISEASE,494
10534,Binocular,B-NAME_OF_DISEASE,494
10535,vision,I-NAME_OF_DISEASE,494
10536,dysfunction,I-NAME_OF_DISEASE,494
10537,can,O,494
10538,cause,O,494
10539,a,O,494
10540,variety,O,494
10541,of,O,494
10542,symptoms,O,494
10543,including,O,494
10544,double,B-SIGN_AND_SYMPTOM,494
10545,vision,I-SIGN_AND_SYMPTOM,494
10546,blurred,I-SIGN_AND_SYMPTOM,494
10547,vision,I-SIGN_AND_SYMPTOM,494
10548,and,I-SIGN_AND_SYMPTOM,494
10549,headaches,I-SIGN_AND_SYMPTOM,494
10550,The,O,494
10551,causes,O,494
10552,of,O,494
10553,binocular,B-NAME_OF_DISEASE,494
10554,vision,I-NAME_OF_DISEASE,494
10555,dysfunction,I-NAME_OF_DISEASE,494
10556,can,O,494
10557,be,O,494
10558,divided,O,494
10559,into,O,494
10560,several,O,494
10561,categories,O,495
10562,Accommodation,B-CAUSE_OF_DISEASE,495
10563,disorders,I-CAUSE_OF_DISEASE,495
10564,Accommodation,B-CAUSE_OF_DISEASE,495
10565,disorders,I-CAUSE_OF_DISEASE,495
10566,occur,O,495
10567,when,O,495
10568,the,O,495
10569,eye,O,495
10570,s,O,495
10571,ability,O,495
10572,to,O,495
10573,adjust,O,495
10574,its,O,495
10575,focus,O,495
10576,on,O,496
10577,an,O,496
10578,object,O,496
10579,at,O,496
10580,different,O,496
10581,distances,O,496
10582,is,O,496
10583,impaired,O,496
10584,This,O,496
10585,can,O,496
10586,lead,O,496
10587,to,O,496
10588,binocular,B-NAME_OF_DISEASE,496
10589,vision,I-NAME_OF_DISEASE,496
10590,dysfunction,I-NAME_OF_DISEASE,496
10591,especially,O,496
10592,when,O,496
10593,trying,O,496
10594,to,O,497
10595,focus,O,497
10596,on,O,497
10597,near,O,497
10598,objects,O,497
10599,Neurological,B-CAUSE_OF_DISEASE,497
10600,conditions,I-CAUSE_OF_DISEASE,497
10601,Certain,B-CAUSE_OF_DISEASE,497
10602,neurological,I-CAUSE_OF_DISEASE,497
10603,conditions,I-CAUSE_OF_DISEASE,497
10604,such,I-CAUSE_OF_DISEASE,497
10605,as,I-CAUSE_OF_DISEASE,497
10606,brain,I-CAUSE_OF_DISEASE,497
10607,injury,I-CAUSE_OF_DISEASE,498
10608,stroke,I-CAUSE_OF_DISEASE,498
10609,or,I-CAUSE_OF_DISEASE,498
10610,brain,I-CAUSE_OF_DISEASE,498
10611,tumor,I-CAUSE_OF_DISEASE,498
10612,can,O,498
10613,cause,O,498
10614,binocular,B-NAME_OF_DISEASE,498
10615,vision,I-NAME_OF_DISEASE,498
10616,dysfunction,I-NAME_OF_DISEASE,498
10617,These,O,498
10618,conditions,O,498
10619,can,O,498
10620,affect,O,498
10621,the,O,498
10622,nerve,O,498
10623,pathways,O,498
10624,that,O,498
10625,control,O,498
10626,eye,O,498
10627,movement,O,498
10628,and,O,499
10629,alignment,O,499
10630,Trauma,B-CAUSE_OF_DISEASE,499
10631,Trauma,B-CAUSE_OF_DISEASE,499
10632,to,I-CAUSE_OF_DISEASE,499
10633,the,I-CAUSE_OF_DISEASE,499
10634,eyes,I-CAUSE_OF_DISEASE,499
10635,head,I-CAUSE_OF_DISEASE,499
10636,or,I-CAUSE_OF_DISEASE,499
10637,brain,I-CAUSE_OF_DISEASE,499
10638,can,O,499
10639,cause,O,499
10640,binocular,B-NAME_OF_DISEASE,499
10641,vision,I-NAME_OF_DISEASE,499
10642,dysfunction,I-NAME_OF_DISEASE,499
10643,such,O,499
10644,as,O,499
10645,a,B-CAUSE_OF_DISEASE,499
10646,concussion,I-CAUSE_OF_DISEASE,499
10647,or,I-CAUSE_OF_DISEASE,499
10648,a,I-CAUSE_OF_DISEASE,499
10649,skull,I-CAUSE_OF_DISEASE,499
10650,fracture,I-CAUSE_OF_DISEASE,499
10651,Exercises,O,499
10652,for,O,499
10653,Binocular,B-NAME_OF_DISEASE,499
10654,Vision,I-NAME_OF_DISEASE,499
10655,Dysfunction,I-NAME_OF_DISEASE,499
10656,While,O,499
10657,some,O,499
10658,causes,O,499
10659,of,O,499
10660,binocular,B-NAME_OF_DISEASE,499
10661,vision,I-NAME_OF_DISEASE,499
10662,dysfunction,I-NAME_OF_DISEASE,499
10663,may,O,499
10664,require,O,499
10665,medical,B-TREATMENT,499
10666,intervention,I-TREATMENT,499
10667,such,I-TREATMENT,500
10668,as,I-TREATMENT,500
10669,corrective,I-TREATMENT,500
10670,lenses,I-TREATMENT,500
10671,or,I-TREATMENT,500
10672,surgery,I-TREATMENT,500
10673,certain,B-TREATMENT,500
10674,exercises,I-TREATMENT,500
10675,can,O,500
10676,help,O,500
10677,improve,O,500
10678,the,O,500
10679,brain,O,500
10680,s,O,500
10681,ability,O,500
10682,to,O,500
10683,coordinate,O,500
10684,the,O,500
10685,eyes,O,500
10686,and,O,500
10687,improve,O,500
10688,binocular,O,500
10689,vision,O,500
10690,Here,O,500
10691,are,O,500
10692,some,O,500
10693,exercises,O,500
10694,that,O,501
10695,can,O,501
10696,be,O,501
10697,used,O,501
10698,to,O,501
10699,improve,O,501
10700,binocular,B-NAME_OF_DISEASE,501
10701,vision,I-NAME_OF_DISEASE,501
10702,dysfunction,I-NAME_OF_DISEASE,501
10703,Pencil,B-TREATMENT,501
10704,push-ups,I-TREATMENT,501
10705,Hold,O,501
10706,a,O,501
10707,pencil,O,501
10708,at,O,502
10709,arm,O,502
10710,s,O,502
10711,length,O,502
10712,in,O,502
10713,front,O,502
10714,of,O,502
10715,your,O,502
10716,face,O,502
10717,Slowly,O,502
10718,move,O,502
10719,the,O,502
10720,pencil,O,502
10721,towards,O,502
10722,your,O,502
10723,nose,O,502
10724,keeping,O,502
10725,your,O,502
10726,eyes,O,502
10727,focused,O,502
10728,on,O,502
10729,the,O,502
10730,pencil,O,502
10731,Once,O,502
10732,the,O,502
10733,pencil,O,502
10734,is,O,502
10735,about,O,503
10736,six,O,503
10737,inches,O,503
10738,from,O,503
10739,your,O,503
10740,nose,O,503
10741,hold,O,503
10742,the,O,504
10743,position,O,504
10744,for,O,504
10745,a,O,504
10746,few,O,504
10747,seconds,O,504
10748,and,O,504
10749,then,O,504
10750,move,O,504
10751,the,O,504
10752,pencil,O,504
10753,back,O,504
10754,to,O,504
10755,arm,O,504
10756,s,O,504
10757,length,O,504
10758,Repeat,O,505
10759,this,O,505
10760,exercise,O,505
10761,several,O,505
10762,times,O,505
10763,a,O,505
10764,day,O,505
10765,Near-far,B-TREATMENT,505
10766,focus,I-TREATMENT,505
10767,Hold,O,505
10768,a,O,505
10769,pen,O,505
10770,or,O,505
10771,pencil,O,505
10772,at,O,505
10773,arm,O,505
10774,s,O,505
10775,length,O,505
10776,in,O,505
10777,front,O,505
10778,of,O,505
10779,your,O,505
10780,face,O,505
10781,Focus,O,505
10782,on,O,505
10783,the,O,505
10784,pen,O,505
10785,or,O,506
10786,pencil,O,506
10787,for,O,506
10788,a,O,506
10789,few,O,506
10790,seconds,O,506
10791,then,O,506
10792,shift,O,506
10793,your,O,506
10794,focus,O,506
10795,to,O,506
10796,an,O,506
10797,object,O,506
10798,in,O,506
10799,the,O,506
10800,distance,O,507
10801,such,O,507
10802,as,O,507
10803,a,O,507
10804,clock,O,507
10805,on,O,507
10806,the,O,507
10807,wall,O,507
10808,Alternate,O,507
10809,focusing,O,507
10810,on,O,507
10811,the,O,507
10812,pen,O,507
10813,or,O,507
10814,pencil,O,508
10815,and,O,508
10816,the,O,508
10817,distant,O,508
10818,object,O,508
10819,for,O,508
10820,a,O,508
10821,few,O,508
10822,minutes,O,508
10823,Eye,B-TREATMENT,508
10824,movement,I-TREATMENT,508
10825,exercises,I-TREATMENT,508
10826,These,O,508
10827,exercises,O,508
10828,are,O,508
10829,designed,O,508
10830,to,O,508
10831,help,O,508
10832,the,O,508
10833,eyes,O,508
10834,move,O,508
10835,in,O,509
10836,coordination,O,509
10837,Examples,O,509
10838,include,O,509
10839,moving,O,509
10840,the,O,509
10841,eyes,O,509
10842,in,O,509
10843,the,O,509
10844,shape,O,509
10845,of,O,509
10846,a,O,509
10847,H,O,509
10848,or,O,509
10849,X,O,509
10850,or,O,509
10851,following,O,509
10852,a,O,509
10853,moving,O,509
10854,object,O,509
10855,with,O,510
10856,the,O,510
10857,eyes,O,510
10858,Vision,B-TREATMENT,510
10859,Therapy,I-TREATMENT,510
10860,Vision,B-TREATMENT,510
10861,therapy,I-TREATMENT,510
10862,is,O,510
10863,a,O,510
10864,type,O,510
10865,of,O,510
10866,rehabilitation,O,510
10867,that,O,511
10868,helps,O,511
10869,to,O,511
10870,improve,O,511
10871,visual,O,511
10872,skills,O,511
10873,and,O,511
10874,coordination,O,511
10875,of,O,511
10876,the,O,511
10877,eyes,O,511
10878,This,O,511
10879,can,O,511
10880,include,O,511
10881,exercises,O,511
10882,to,O,511
10883,improve,O,511
10884,eye,O,512
10885,tracking,O,512
10886,focusing,O,512
10887,and,O,512
10888,eye-teaming,O,512
10889,abilities,O,512
10890,Prism,B-TREATMENT,512
10891,glasses,I-TREATMENT,512
10892,Prism,B-TREATMENT,512
10893,glasses,I-TREATMENT,512
10894,are,O,512
10895,specially,O,512
10896,designed,O,512
10897,glasses,O,512
10898,that,O,512
10899,can,O,512
10900,help,O,513
10901,align,O,513
10902,the,O,513
10903,eyes,O,513
10904,by,O,513
10905,bending,O,513
10906,light,O,513
10907,They,O,513
10908,are,O,513
10909,often,O,513
10910,used,O,513
10911,in,O,513
10912,vision,B-TREATMENT,513
10913,therapy,I-TREATMENT,513
10914,to,O,513
10915,help,O,513
10916,correct,O,513
10917,double,O,513
10918,vision,O,513
10919,and,O,513
10920,improve,O,513
10921,eye,O,513
10922,coordination,O,513
10923,Palming,B-TREATMENT,513
10924,This,O,513
10925,exercise,O,514
10926,involves,O,514
10927,covering,O,514
10928,the,O,514
10929,eyes,O,514
10930,with,O,514
10931,the,O,514
10932,palms,O,514
10933,of,O,514
10934,the,O,514
10935,hands,O,514
10936,for,O,514
10937,a,O,514
10938,few,O,514
10939,minutes,O,514
10940,to,O,514
10941,relax,O,514
10942,the,O,514
10943,eyes,O,514
10944,and,O,515
10945,improve,O,515
10946,eye,O,515
10947,coordination,O,515
10948,Conclusion,O,515
10949,In,O,515
10950,conclusion,O,515
10951,binocular,B-NAME_OF_DISEASE,515
10952,vision,I-NAME_OF_DISEASE,515
10953,dysfunction,I-NAME_OF_DISEASE,515
10954,can,O,515
10955,cause,O,515
10956,a,O,515
10957,variety,O,515
10958,of,O,515
10959,symptoms,O,515
10960,including,O,515
10961,double,B-SIGN_AND_SYMPTOM,515
10962,vision,I-SIGN_AND_SYMPTOM,515
10963,blurred,I-SIGN_AND_SYMPTOM,515
10964,vision,I-SIGN_AND_SYMPTOM,515
10965,and,I-SIGN_AND_SYMPTOM,515
10966,headaches,I-SIGN_AND_SYMPTOM,515
10967,While,O,515
10968,some,O,515
10969,causes,O,515
10970,of,O,515
10971,binocular,B-NAME_OF_DISEASE,515
10972,vision,I-NAME_OF_DISEASE,516
10973,dysfunction,I-NAME_OF_DISEASE,516
10974,may,O,516
10975,require,O,516
10976,medical,B-TREATMENT,516
10977,intervention,I-TREATMENT,516
10978,certain,B-TREATMENT,516
10979,exercises,I-TREATMENT,516
10980,can,O,516
10981,help,O,516
10982,improve,O,516
10983,the,O,516
10984,brain,O,516
10985,s,O,516
10986,ability,O,516
10987,to,O,516
10988,coordinate,O,516
10989,the,O,516
10990,eyes,O,516
10991,and,O,516
10992,improve,O,516
10993,binocular,O,516
10994,vision,O,516
10995,What,O,517
10996,Is,O,517
10997,Ocular,B-NAME_OF_DISEASE,517
10998,Migraine,I-NAME_OF_DISEASE,517
10999,Ocular,B-NAME_OF_DISEASE,517
11000,migraine,I-NAME_OF_DISEASE,517
11001,also,O,517
11002,known,O,517
11003,as,O,517
11004,retinal,B-NAME_OF_DISEASE,517
11005,migraine,I-NAME_OF_DISEASE,517
11006,is,O,517
11007,a,O,517
11008,type,O,517
11009,of,O,517
11010,migraine,B-NAME_OF_DISEASE,517
11011,headache,I-NAME_OF_DISEASE,517
11012,that,O,517
11013,is,O,518
11014,accompanied,O,518
11015,by,O,518
11016,visual,B-SIGN_AND_SYMPTOM,518
11017,disturbances,I-SIGN_AND_SYMPTOM,518
11018,It,O,518
11019,affects,O,518
11020,about,O,518
11021,3%,O,518
11022,of,O,518
11023,the,O,518
11024,general,O,518
11025,population,O,518
11026,and,O,518
11027,it,O,518
11028,is,O,518
11029,more,O,518
11030,common,O,518
11031,in,O,518
11032,women,O,518
11033,than,O,518
11034,in,O,518
11035,men,O,518
11036,What,O,518
11037,Causes,O,519
11038,Ocular,B-NAME_OF_DISEASE,519
11039,Migraine,I-NAME_OF_DISEASE,519
11040,While,O,519
11041,the,O,519
11042,exact,O,519
11043,cause,O,519
11044,of,O,519
11045,ocular,B-NAME_OF_DISEASE,519
11046,migraines,I-NAME_OF_DISEASE,519
11047,is,O,519
11048,not,O,519
11049,fully,O,519
11050,understood,O,519
11051,there,O,519
11052,are,O,519
11053,several,O,519
11054,factors,O,519
11055,that,O,519
11056,may,O,519
11057,trigger,O,520
11058,an,O,520
11059,attack,O,520
11060,Here,O,520
11061,are,O,520
11062,some,O,520
11063,common,O,520
11064,causes,O,520
11065,of,O,520
11066,ocular,B-NAME_OF_DISEASE,520
11067,migraines,I-NAME_OF_DISEASE,520
11068,Stress,B-CAUSE_OF_DISEASE,520
11069,Stress,B-CAUSE_OF_DISEASE,520
11070,is,O,520
11071,one,O,520
11072,of,O,520
11073,the,O,520
11074,most,O,520
11075,common,O,520
11076,triggers,O,520
11077,for,O,520
11078,ocular,B-NAME_OF_DISEASE,520
11079,migraines,I-NAME_OF_DISEASE,520
11080,Stress,B-CAUSE_OF_DISEASE,521
11081,can,O,521
11082,cause,O,521
11083,changes,B-CAUSE_OF_DISEASE,521
11084,in,I-CAUSE_OF_DISEASE,521
11085,blood,I-CAUSE_OF_DISEASE,521
11086,flow,I-CAUSE_OF_DISEASE,521
11087,and,O,521
11088,can,O,521
11089,lead,O,521
11090,to,O,521
11091,the,B-CAUSE_OF_DISEASE,521
11092,constriction,I-CAUSE_OF_DISEASE,521
11093,or,I-CAUSE_OF_DISEASE,521
11094,dilation,I-CAUSE_OF_DISEASE,521
11095,of,I-CAUSE_OF_DISEASE,521
11096,blood,I-CAUSE_OF_DISEASE,521
11097,vessels,I-CAUSE_OF_DISEASE,521
11098,which,O,521
11099,can,O,522
11100,trigger,O,522
11101,a,B-NAME_OF_DISEASE,522
11102,migraine,I-NAME_OF_DISEASE,522
11103,Lack,B-CAUSE_OF_DISEASE,522
11104,of,I-CAUSE_OF_DISEASE,522
11105,sleep,I-CAUSE_OF_DISEASE,522
11106,Not,B-CAUSE_OF_DISEASE,522
11107,getting,I-CAUSE_OF_DISEASE,522
11108,enough,I-CAUSE_OF_DISEASE,522
11109,sleep,I-CAUSE_OF_DISEASE,522
11110,or,I-CAUSE_OF_DISEASE,522
11111,having,I-CAUSE_OF_DISEASE,522
11112,disrupted,I-CAUSE_OF_DISEASE,522
11113,sleep,I-CAUSE_OF_DISEASE,522
11114,patterns,I-CAUSE_OF_DISEASE,522
11115,can,O,522
11116,increase,O,523
11117,the,O,523
11118,risk,O,523
11119,of,O,523
11120,ocular,B-NAME_OF_DISEASE,523
11121,migraines,I-NAME_OF_DISEASE,523
11122,Bright,B-CAUSE_OF_DISEASE,523
11123,lights,I-CAUSE_OF_DISEASE,523
11124,Bright,B-CAUSE_OF_DISEASE,523
11125,lights,I-CAUSE_OF_DISEASE,523
11126,especially,I-CAUSE_OF_DISEASE,523
11127,flickering,I-CAUSE_OF_DISEASE,523
11128,or,I-CAUSE_OF_DISEASE,523
11129,pulsating,I-CAUSE_OF_DISEASE,523
11130,lights,I-CAUSE_OF_DISEASE,523
11131,can,O,523
11132,trigger,O,523
11133,an,O,523
11134,ocular,B-NAME_OF_DISEASE,523
11135,migraine,I-NAME_OF_DISEASE,523
11136,in,O,523
11137,some,O,524
11138,people,O,524
11139,Hormonal,B-CAUSE_OF_DISEASE,524
11140,changes,I-CAUSE_OF_DISEASE,524
11141,Ocular,B-NAME_OF_DISEASE,524
11142,migraines,I-NAME_OF_DISEASE,524
11143,may,O,524
11144,be,O,524
11145,more,O,524
11146,common,O,524
11147,in,O,524
11148,women,O,524
11149,due,O,524
11150,to,O,524
11151,hormonal,B-CAUSE_OF_DISEASE,524
11152,fluctuations,I-CAUSE_OF_DISEASE,524
11153,that,I-CAUSE_OF_DISEASE,525
11154,occur,I-CAUSE_OF_DISEASE,525
11155,during,I-CAUSE_OF_DISEASE,525
11156,menstruation,I-CAUSE_OF_DISEASE,525
11157,pregnancy,I-CAUSE_OF_DISEASE,525
11158,and,I-CAUSE_OF_DISEASE,525
11159,menopause,I-CAUSE_OF_DISEASE,525
11160,Medications,B-CAUSE_OF_DISEASE,525
11161,Some,O,525
11162,medications,B-CAUSE_OF_DISEASE,525
11163,such,I-CAUSE_OF_DISEASE,525
11164,as,I-CAUSE_OF_DISEASE,525
11165,oral,I-CAUSE_OF_DISEASE,525
11166,contraceptives,I-CAUSE_OF_DISEASE,525
11167,and,I-CAUSE_OF_DISEASE,525
11168,vasodilators,I-CAUSE_OF_DISEASE,525
11169,may,O,525
11170,increase,O,525
11171,the,O,526
11172,risk,O,526
11173,of,O,526
11174,ocular,B-NAME_OF_DISEASE,526
11175,migraines,I-NAME_OF_DISEASE,526
11176,Caffeine,B-CAUSE_OF_DISEASE,526
11177,and,I-CAUSE_OF_DISEASE,526
11178,alcohol,I-CAUSE_OF_DISEASE,526
11179,Consuming,B-CAUSE_OF_DISEASE,526
11180,large,I-CAUSE_OF_DISEASE,526
11181,amounts,I-CAUSE_OF_DISEASE,526
11182,of,I-CAUSE_OF_DISEASE,526
11183,caffeine,I-CAUSE_OF_DISEASE,526
11184,or,I-CAUSE_OF_DISEASE,526
11185,alcohol,I-CAUSE_OF_DISEASE,526
11186,may,O,526
11187,trigger,O,526
11188,an,O,526
11189,ocular,B-NAME_OF_DISEASE,526
11190,migraine,I-NAME_OF_DISEASE,526
11191,in,O,526
11192,some,O,526
11193,people,O,526
11194,Certain,B-CAUSE_OF_DISEASE,526
11195,foods,I-CAUSE_OF_DISEASE,527
11196,Some,O,527
11197,people,O,527
11198,may,O,527
11199,be,O,527
11200,more,O,527
11201,sensitive,B-CAUSE_OF_DISEASE,527
11202,to,I-CAUSE_OF_DISEASE,527
11203,certain,I-CAUSE_OF_DISEASE,527
11204,foods,I-CAUSE_OF_DISEASE,527
11205,such,I-CAUSE_OF_DISEASE,527
11206,as,I-CAUSE_OF_DISEASE,527
11207,aged,I-CAUSE_OF_DISEASE,527
11208,cheeses,I-CAUSE_OF_DISEASE,527
11209,processed,I-CAUSE_OF_DISEASE,527
11210,meats,I-CAUSE_OF_DISEASE,527
11211,and,I-CAUSE_OF_DISEASE,527
11212,chocolate,I-CAUSE_OF_DISEASE,527
11213,which,O,527
11214,can,O,527
11215,trigger,O,527
11216,ocular,B-NAME_OF_DISEASE,527
11217,migraines,I-NAME_OF_DISEASE,527
11218,What,O,527
11219,Are,O,527
11220,the,O,527
11221,Symptoms,O,527
11222,of,O,527
11223,an,B-NAME_OF_DISEASE,527
11224,Ocular,B-NAME_OF_DISEASE,527
11225,Migraine,I-NAME_OF_DISEASE,527
11226,The,O,527
11227,most,O,527
11228,common,O,527
11229,symptom,O,527
11230,of,O,527
11231,an,B-NAME_OF_DISEASE,527
11232,ocular,B-NAME_OF_DISEASE,527
11233,migraine,I-NAME_OF_DISEASE,528
11234,is,O,528
11235,a,B-SIGN_AND_SYMPTOM,528
11236,visual,I-SIGN_AND_SYMPTOM,528
11237,disturbance,I-SIGN_AND_SYMPTOM,528
11238,which,I-SIGN_AND_SYMPTOM,528
11239,can,I-SIGN_AND_SYMPTOM,528
11240,take,I-SIGN_AND_SYMPTOM,528
11241,the,I-SIGN_AND_SYMPTOM,528
11242,form,I-SIGN_AND_SYMPTOM,528
11243,of,I-SIGN_AND_SYMPTOM,528
11244,flashing,I-SIGN_AND_SYMPTOM,528
11245,lights,I-SIGN_AND_SYMPTOM,528
11246,zigzag,I-SIGN_AND_SYMPTOM,528
11247,lines,I-SIGN_AND_SYMPTOM,528
11248,or,I-SIGN_AND_SYMPTOM,528
11249,blind,I-SIGN_AND_SYMPTOM,529
11250,spots,I-SIGN_AND_SYMPTOM,529
11251,in,I-SIGN_AND_SYMPTOM,529
11252,the,I-SIGN_AND_SYMPTOM,529
11253,field,I-SIGN_AND_SYMPTOM,529
11254,of,I-SIGN_AND_SYMPTOM,529
11255,vision,I-SIGN_AND_SYMPTOM,529
11256,These,O,529
11257,visual,B-SIGN_AND_SYMPTOM,529
11258,disturbances,I-SIGN_AND_SYMPTOM,529
11259,are,O,529
11260,usually,O,529
11261,temporary,O,529
11262,and,O,529
11263,may,O,529
11264,last,O,529
11265,for,O,529
11266,a,O,529
11267,few,O,529
11268,minutes,O,529
11269,to,O,529
11270,an,O,529
11271,hour,O,529
11272,Other,O,529
11273,symptoms,O,529
11274,of,O,529
11275,ocular,B-NAME_OF_DISEASE,529
11276,migraines,I-NAME_OF_DISEASE,529
11277,may,O,530
11278,include,O,530
11279,Headache,B-SIGN_AND_SYMPTOM,530
11280,Ocular,B-NAME_OF_DISEASE,530
11281,migraines,I-NAME_OF_DISEASE,530
11282,may,O,530
11283,be,O,530
11284,accompanied,O,530
11285,by,O,530
11286,a,B-SIGN_AND_SYMPTOM,530
11287,headache,I-SIGN_AND_SYMPTOM,530
11288,that,I-SIGN_AND_SYMPTOM,530
11289,is,I-SIGN_AND_SYMPTOM,530
11290,typically,I-SIGN_AND_SYMPTOM,530
11291,one-sided,I-SIGN_AND_SYMPTOM,530
11292,and,I-SIGN_AND_SYMPTOM,530
11293,may,I-SIGN_AND_SYMPTOM,530
11294,be,I-SIGN_AND_SYMPTOM,530
11295,throbbing,I-SIGN_AND_SYMPTOM,530
11296,or,I-SIGN_AND_SYMPTOM,530
11297,pulsating,I-SIGN_AND_SYMPTOM,530
11298,in,I-SIGN_AND_SYMPTOM,530
11299,nature,I-SIGN_AND_SYMPTOM,530
11300,Partial,B-SIGN_AND_SYMPTOM,530
11301,or,I-SIGN_AND_SYMPTOM,530
11302,total,I-SIGN_AND_SYMPTOM,530
11303,loss,I-SIGN_AND_SYMPTOM,530
11304,in,I-SIGN_AND_SYMPTOM,530
11305,one,I-SIGN_AND_SYMPTOM,530
11306,eye,I-SIGN_AND_SYMPTOM,531
11307,This,O,531
11308,usually,O,531
11309,lasts,O,531
11310,10,B-TIME_DURATION,531
11311,to,I-TIME_DURATION,531
11312,20,I-TIME_DURATION,531
11313,minutes,I-TIME_DURATION,531
11314,before,O,531
11315,vision,O,531
11316,gradually,O,531
11317,returns,O,531
11318,An,O,531
11319,image,O,531
11320,showing,O,531
11321,what,O,531
11322,happens,O,531
11323,to,O,531
11324,vision,O,531
11325,when,O,531
11326,ocular,B-NAME_OF_DISEASE,531
11327,migraine,I-NAME_OF_DISEASE,531
11328,occurrs,O,531
11329,Can,O,531
11330,Ocular,B-NAME_OF_DISEASE,531
11331,Migraine,I-NAME_OF_DISEASE,531
11332,Cause,O,531
11333,Permanent,B-NAME_OF_DISEASE,531
11334,Vision,I-NAME_OF_DISEASE,531
11335,Loss,I-NAME_OF_DISEASE,532
11336,Visual,B-SIGN_AND_SYMPTOM,532
11337,disturbances,I-SIGN_AND_SYMPTOM,532
11338,caused,O,532
11339,by,O,532
11340,ocular,B-NAME_OF_DISEASE,532
11341,migraines,I-NAME_OF_DISEASE,532
11342,are,O,532
11343,usually,O,532
11344,temporary,O,532
11345,and,O,532
11346,will,O,532
11347,resolve,O,532
11348,on,O,532
11349,their,O,532
11350,own,O,532
11351,within,B-TIME_DURATION,532
11352,a,I-TIME_DURATION,532
11353,few,I-TIME_DURATION,532
11354,minutes,I-TIME_DURATION,532
11355,to,I-TIME_DURATION,532
11356,an,I-TIME_DURATION,532
11357,hour,I-TIME_DURATION,532
11358,In,O,532
11359,rare,O,532
11360,cases,O,532
11361,ocular,B-NAME_OF_DISEASE,532
11362,migraines,I-NAME_OF_DISEASE,532
11363,may,O,532
11364,be,O,532
11365,a,O,533
11366,sign,O,533
11367,of,O,533
11368,a,O,533
11369,more,O,533
11370,serious,O,533
11371,underlying,O,533
11372,problem,O,533
11373,such,O,533
11374,as,O,533
11375,a,B-CAUSE_OF_DISEASE,533
11376,brain,I-CAUSE_OF_DISEASE,533
11377,tumor,I-CAUSE_OF_DISEASE,533
11378,or,O,533
11379,an,B-CAUSE_OF_DISEASE,533
11380,arterial,I-CAUSE_OF_DISEASE,533
11381,blockage,I-CAUSE_OF_DISEASE,533
11382,which,O,533
11383,can,O,533
11384,cause,O,533
11385,permanent,B-NAME_OF_DISEASE,533
11386,vision,I-NAME_OF_DISEASE,533
11387,loss,I-NAME_OF_DISEASE,533
11388,Managing,O,533
11389,Ocular,B-NAME_OF_DISEASE,534
11390,Migraines,I-NAME_OF_DISEASE,534
11391,Medications,B-TREATMENT,534
11392,There,O,534
11393,are,O,534
11394,several,O,534
11395,medications,B-TREATMENT,534
11396,that,O,534
11397,can,O,534
11398,be,O,534
11399,used,O,534
11400,to,O,534
11401,treat,O,534
11402,ocular,B-NAME_OF_DISEASE,535
11403,migraines,I-NAME_OF_DISEASE,535
11404,including,O,535
11405,triptans,B-NAME_OF_DRUG,535
11406,and,O,535
11407,nonsteroidal,B-NAME_OF_DRUG,535
11408,anti-inflammatory,I-NAME_OF_DRUG,535
11409,drugs,I-NAME_OF_DRUG,535
11410,NSAIDs,B-NAME_OF_DRUG,536
11411,,O,536
11412,Triptans,B-NAME_OF_DRUG,536
11413,work,O,536
11414,by,O,536
11415,constricting,O,536
11416,blood,O,536
11417,vessels,O,536
11418,in,O,536
11419,the,O,536
11420,brain,O,536
11421,and,O,536
11422,relieving,O,536
11423,headache,B-SIGN_AND_SYMPTOM,536
11424,pain,I-SIGN_AND_SYMPTOM,536
11425,NSAIDs,B-NAME_OF_DRUG,537
11426,work,O,537
11427,by,O,537
11428,reducing,O,537
11429,inflammation,O,537
11430,and,O,537
11431,relieving,O,537
11432,pain,O,537
11433,Your,O,537
11434,healthcare,O,537
11435,provider,O,537
11436,can,O,537
11437,recommend,O,537
11438,the,O,537
11439,appropriate,O,537
11440,medication,O,537
11441,for,O,537
11442,you,O,538
11443,based,O,538
11444,on,O,538
11445,your,O,538
11446,specific,O,538
11447,needs,O,538
11448,Preventive,O,538
11449,medications,B-TREATMENT,538
11450,In,O,538
11451,some,O,538
11452,cases,O,538
11453,preventive,O,539
11454,medications,B-TREATMENT,539
11455,may,O,539
11456,be,O,539
11457,used,O,539
11458,to,O,539
11459,reduce,O,539
11460,the,O,539
11461,frequency,O,539
11462,of,O,539
11463,ocular,B-NAME_OF_DISEASE,539
11464,migraines,I-NAME_OF_DISEASE,539
11465,Preventive,O,539
11466,medications,B-TREATMENT,539
11467,may,O,539
11468,include,O,539
11469,beta,B-PREVENTION,539
11470,blockers,I-PREVENTION,539
11471,calcium,I-PREVENTION,539
11472,channel,I-PREVENTION,539
11473,blockers,I-PREVENTION,539
11474,and,I-PREVENTION,540
11475,anticonvulsants,I-PREVENTION,540
11476,Alternative,B-TREATMENT,540
11477,therapies,I-TREATMENT,540
11478,Alternative,B-TREATMENT,540
11479,therapies,I-TREATMENT,540
11480,such,I-TREATMENT,540
11481,as,I-TREATMENT,540
11482,acupuncture,I-TREATMENT,540
11483,chiropractic,I-TREATMENT,540
11484,care,I-TREATMENT,540
11485,and,I-TREATMENT,540
11486,herbal,I-TREATMENT,540
11487,remedies,I-TREATMENT,540
11488,may,O,540
11489,provide,O,540
11490,relief,O,540
11491,for,O,540
11492,some,O,540
11493,people,O,540
11494,with,O,540
11495,ocular,B-NAME_OF_DISEASE,540
11496,migraines,I-NAME_OF_DISEASE,540
11497,It,O,540
11498,is,O,541
11499,important,O,541
11500,to,O,541
11501,consult,O,541
11502,with,O,541
11503,a,O,541
11504,healthcare,O,541
11505,provider,O,541
11506,before,O,541
11507,using,O,541
11508,any,O,541
11509,alternative,O,541
11510,therapies,O,541
11511,to,O,541
11512,ensure,O,541
11513,that,O,541
11514,they,O,541
11515,are,O,541
11516,safe,O,541
11517,and,O,541
11518,appropriate,O,541
11519,for,O,541
11520,you,O,541
11521,Tips,O,542
11522,to,O,542
11523,Prevent,O,542
11524,Ocular,B-NAME_OF_DISEASE,542
11525,Migraines,I-NAME_OF_DISEASE,542
11526,There,O,542
11527,are,O,542
11528,several,O,542
11529,steps,O,542
11530,that,O,542
11531,you,O,542
11532,can,O,542
11533,take,O,542
11534,to,O,542
11535,help,O,542
11536,prevent,O,542
11537,or,O,542
11538,reduce,O,542
11539,the,O,542
11540,frequency,O,542
11541,of,O,542
11542,ocular,B-NAME_OF_DISEASE,542
11543,migraines,I-NAME_OF_DISEASE,542
11544,Here,O,542
11545,are,O,542
11546,some,O,542
11547,tips,O,542
11548,for,O,542
11549,preventing,O,542
11550,ocular,B-NAME_OF_DISEASE,542
11551,migraines,I-NAME_OF_DISEASE,542
11552,Identify,B-PREVENTION,542
11553,and,I-PREVENTION,542
11554,avoid,I-PREVENTION,542
11555,triggers,I-PREVENTION,542
11556,Keeping,B-PREVENTION,543
11557,a,I-PREVENTION,543
11558,headache,I-PREVENTION,543
11559,diary,I-PREVENTION,543
11560,can,O,543
11561,help,O,543
11562,you,O,543
11563,identify,O,543
11564,any,O,543
11565,potential,O,543
11566,triggers,O,543
11567,for,O,543
11568,your,O,543
11569,ocular,B-NAME_OF_DISEASE,544
11570,migraines,I-NAME_OF_DISEASE,544
11571,such,O,544
11572,as,O,544
11573,certain,B-CAUSE_OF_DISEASE,544
11574,foods,I-CAUSE_OF_DISEASE,544
11575,bright,I-CAUSE_OF_DISEASE,544
11576,lights,I-CAUSE_OF_DISEASE,544
11577,or,I-CAUSE_OF_DISEASE,544
11578,stress,I-CAUSE_OF_DISEASE,544
11579,Avoiding,O,544
11580,or,O,544
11581,minimizing,O,544
11582,your,O,544
11583,exposure,O,544
11584,to,O,544
11585,these,O,544
11586,triggers,O,544
11587,may,O,544
11588,help,O,544
11589,prevent,O,545
11590,ocular,B-NAME_OF_DISEASE,545
11591,migraines,I-NAME_OF_DISEASE,545
11592,Get,B-PREVENTION,545
11593,enough,I-PREVENTION,545
11594,sleep,I-PREVENTION,545
11595,Ensuring,B-PREVENTION,545
11596,that,I-PREVENTION,545
11597,you,I-PREVENTION,545
11598,get,I-PREVENTION,545
11599,enough,I-PREVENTION,545
11600,sleep,I-PREVENTION,545
11601,and,I-PREVENTION,545
11602,maintaining,I-PREVENTION,545
11603,a,I-PREVENTION,546
11604,regular,I-PREVENTION,546
11605,sleep,I-PREVENTION,546
11606,schedule,I-PREVENTION,546
11607,may,O,546
11608,help,O,546
11609,prevent,O,546
11610,ocular,B-NAME_OF_DISEASE,546
11611,migraines,I-NAME_OF_DISEASE,546
11612,Exercise,B-PREVENTION,546
11613,regularly,I-PREVENTION,546
11614,Regular,B-PREVENTION,546
11615,exercise,I-PREVENTION,546
11616,may,O,546
11617,help,O,546
11618,reduce,O,546
11619,the,O,546
11620,frequency,O,546
11621,and,O,546
11622,severity,O,546
11623,of,O,547
11624,ocular,B-NAME_OF_DISEASE,547
11625,migraines,I-NAME_OF_DISEASE,547
11626,Practice,B-PREVENTION,547
11627,stress,I-PREVENTION,547
11628,management,I-PREVENTION,547
11629,techniques,I-PREVENTION,547
11630,Techniques,B-PREVENTION,547
11631,such,I-PREVENTION,547
11632,as,I-PREVENTION,547
11633,deep,I-PREVENTION,547
11634,breathing,I-PREVENTION,547
11635,meditation,I-PREVENTION,547
11636,and,I-PREVENTION,547
11637,yoga,I-PREVENTION,547
11638,may,O,547
11639,help,O,547
11640,reduce,O,547
11641,stress,O,547
11642,and,O,547
11643,prevent,O,548
11644,ocular,B-NAME_OF_DISEASE,548
11645,migraines,I-NAME_OF_DISEASE,548
11646,Eat,B-PREVENTION,548
11647,a,I-PREVENTION,548
11648,healthy,I-PREVENTION,548
11649,diet,I-PREVENTION,548
11650,A,B-PREVENTION,548
11651,diet,I-PREVENTION,548
11652,that,I-PREVENTION,548
11653,is,I-PREVENTION,548
11654,rich,I-PREVENTION,548
11655,in,I-PREVENTION,548
11656,fruits,I-PREVENTION,548
11657,vegetables,I-PREVENTION,548
11658,and,I-PREVENTION,548
11659,whole,I-PREVENTION,548
11660,grains,I-PREVENTION,548
11661,may,O,549
11662,help,O,549
11663,prevent,O,549
11664,ocular,B-NAME_OF_DISEASE,549
11665,migraines,I-NAME_OF_DISEASE,549
11666,Consider,B-PREVENTION,549
11667,preventive,B-PREVENTION,549
11668,medications,I-PREVENTION,549
11669,In,O,549
11670,some,O,549
11671,cases,O,549
11672,preventive,B-PREVENTION,549
11673,medications,I-PREVENTION,549
11674,may,O,549
11675,be,O,549
11676,used,O,549
11677,to,O,550
11678,reduce,O,550
11679,the,O,550
11680,frequency,O,550
11681,of,O,550
11682,ocular,B-NAME_OF_DISEASE,550
11683,migraines,I-NAME_OF_DISEASE,550
11684,Your,O,550
11685,healthcare,O,550
11686,provider,O,550
11687,can,O,550
11688,recommend,O,550
11689,the,O,550
11690,appropriate,O,550
11691,preventive,O,550
11692,medication,O,550
11693,for,O,550
11694,you,O,550
11695,based,O,550
11696,on,O,550
11697,your,O,550
11698,specific,O,550
11699,needs,O,550
11700,Durysta,B-NAME_OF_DRUG,550
11701,bimatoprost,I-NAME_OF_DRUG,550
11702,and,I-NAME_OF_DRUG,550
11703,chloramphenicol,I-NAME_OF_DRUG,550
11704,is,O,550
11705,a,O,550
11706,prescription,O,550
11707,medication,O,550
11708,produced,O,550
11709,by,O,550
11710,Allergan,B-ORGANIZATION,551
11711,that,O,551
11712,is,O,551
11713,used,O,551
11714,to,O,551
11715,lower,O,551
11716,intraocular,O,551
11717,pressure,O,551
11718,IOP,O,551
11719,in,O,551
11720,people,O,551
11721,with,O,551
11722,open-angle,B-NAME_OF_DISEASE,551
11723,glaucoma,I-NAME_OF_DISEASE,551
11724,or,O,551
11725,ocular,B-NAME_OF_DISEASE,551
11726,hypertension,I-NAME_OF_DISEASE,551
11727,high,I-NAME_OF_DISEASE,551
11728,pressure,I-NAME_OF_DISEASE,551
11729,in,I-NAME_OF_DISEASE,552
11730,the,I-NAME_OF_DISEASE,552
11731,eye,I-NAME_OF_DISEASE,552
11732,,O,552
11733,It,O,552
11734,is,O,552
11735,a,O,552
11736,combination,O,552
11737,of,O,552
11738,two,O,552
11739,medications,O,552
11740,bimatoprost,O,552
11741,which,O,552
11742,is,O,552
11743,a,O,552
11744,prostaglandin,O,552
11745,analog,O,552
11746,and,O,552
11747,chloramphenicol,O,552
11748,which,O,552
11749,is,O,552
11750,an,O,552
11751,antibiotic,O,553
11752,What,O,553
11753,is,O,553
11754,Chloramphenicol,B-NAME_OF_DRUG,553
11755,Eye,I-NAME_OF_DRUG,553
11756,Drop,I-NAME_OF_DRUG,553
11757,Chloramphenicol,B-NAME_OF_DRUG,553
11758,eye,I-NAME_OF_DRUG,553
11759,drops,I-NAME_OF_DRUG,553
11760,are,O,553
11761,a,O,553
11762,topical,O,553
11763,medication,O,553
11764,used,O,553
11765,to,O,553
11766,treat,O,553
11767,infections,O,553
11768,of,O,553
11769,the,O,553
11770,eye,O,553
11771,and,O,553
11772,surrounding,O,554
11773,tissue,O,554
11774,Chloramphenicol,B-NAME_OF_DRUG,554
11775,is,O,554
11776,an,O,554
11777,antibiotic,O,554
11778,that,O,554
11779,is,O,554
11780,effective,O,554
11781,against,O,554
11782,a,O,554
11783,wide,O,555
11784,variety,O,555
11785,of,O,555
11786,bacteria,O,555
11787,including,O,555
11788,those,O,555
11789,that,O,555
11790,are,O,555
11791,resistant,O,555
11792,to,O,555
11793,other,O,555
11794,antibiotics,O,555
11795,It,O,555
11796,works,O,555
11797,by,O,555
11798,inhibiting,O,555
11799,the,O,555
11800,growth,O,555
11801,of,O,555
11802,bacteria,O,555
11803,and,O,555
11804,killing,O,555
11805,them,O,555
11806,Chloramphenicol,B-NAME_OF_DRUG,555
11807,eye,I-NAME_OF_DRUG,555
11808,drops,I-NAME_OF_DRUG,555
11809,are,O,555
11810,usually,O,555
11811,prescribed,O,555
11812,for,O,556
11813,infections,O,556
11814,of,O,556
11815,the,O,556
11816,eye,O,556
11817,and,O,556
11818,surrounding,O,556
11819,tissue,O,556
11820,caused,O,556
11821,by,O,556
11822,bacteria,O,556
11823,such,O,556
11824,as,O,556
11825,conjunctivitis,B-NAME_OF_DISEASE,556
11826,pink,I-NAME_OF_DISEASE,556
11827,eye,I-NAME_OF_DISEASE,556
11828,and,O,557
11829,keratitis,B-NAME_OF_DISEASE,557
11830,inflammation,I-NAME_OF_DISEASE,557
11831,of,I-NAME_OF_DISEASE,557
11832,the,I-NAME_OF_DISEASE,557
11833,cornea,I-NAME_OF_DISEASE,557
11834,,O,557
11835,They,O,557
11836,are,O,557
11837,typically,O,557
11838,used,O,557
11839,to,O,557
11840,treat,O,557
11841,severe,O,557
11842,or,O,557
11843,recurrent,O,557
11844,infections,O,557
11845,that,O,557
11846,are,O,557
11847,unresponsive,O,558
11848,to,O,558
11849,other,O,558
11850,antibiotics,O,558
11851,When,O,558
11852,to,O,558
11853,use,O,558
11854,Chloramphenicol,B-NAME_OF_DRUG,558
11855,Eye,I-NAME_OF_DRUG,558
11856,Drops,I-NAME_OF_DRUG,558
11857,Chloramphenicol,B-NAME_OF_DRUG,558
11858,is,O,558
11859,an,O,558
11860,antibiotic,O,558
11861,that,O,558
11862,is,O,558
11863,used,O,558
11864,to,O,558
11865,treat,O,558
11866,infections,O,558
11867,of,O,558
11868,the,O,558
11869,eye,O,558
11870,It,O,558
11871,is,O,559
11872,typically,O,559
11873,used,O,559
11874,when,O,559
11875,other,O,559
11876,antibiotics,O,559
11877,are,O,559
11878,not,O,559
11879,effective,O,559
11880,or,O,559
11881,when,O,559
11882,the,O,559
11883,infection,O,559
11884,is,O,559
11885,caused,O,559
11886,by,O,559
11887,bacteria,O,559
11888,that,O,559
11889,are,O,559
11890,resistant,O,559
11891,to,O,559
11892,other,O,559
11893,antibiotics,O,560
11894,Your,O,560
11895,doctor,O,560
11896,may,O,560
11897,prescribe,O,560
11898,chloramphenicol,B-NAME_OF_DRUG,560
11899,if,O,560
11900,you,O,560
11901,have,O,560
11902,an,O,560
11903,infection,O,560
11904,of,O,560
11905,the,O,560
11906,eye,O,560
11907,or,O,560
11908,surrounding,O,560
11909,tissues,O,560
11910,such,O,560
11911,as,O,560
11912,conjunctivitis,B-NAME_OF_DISEASE,560
11913,blepharitis,B-NAME_OF_DISEASE,560
11914,or,O,560
11915,keratitis,B-NAME_OF_DISEASE,560
11916,It,O,560
11917,is,O,560
11918,important,O,561
11919,to,O,561
11920,use,O,561
11921,chloramphenicol,B-NAME_OF_DRUG,561
11922,only,O,561
11923,as,O,561
11924,directed,O,561
11925,by,O,561
11926,your,O,561
11927,doctor,O,561
11928,and,O,561
11929,to,O,561
11930,complete,O,561
11931,the,O,561
11932,entire,O,561
11933,course,O,561
11934,of,O,561
11935,treatment,O,562
11936,even,O,562
11937,if,O,562
11938,your,O,562
11939,symptoms,O,562
11940,improve,O,562
11941,This,O,562
11942,will,O,562
11943,help,O,562
11944,to,O,562
11945,prevent,O,562
11946,the,O,562
11947,infection,O,562
11948,from,O,562
11949,returning,O,562
11950,and,O,562
11951,to,O,562
11952,prevent,O,562
11953,the,O,562
11954,development,O,562
11955,of,O,563
11956,antibiotic,O,563
11957,resistance,O,563
11958,Who,O,563
11959,Can,O,563
11960,Use,O,563
11961,It,O,563
11962,It,O,563
11963,is,O,563
11964,usually,O,563
11965,only,O,563
11966,prescribed,O,563
11967,by,O,563
11968,doctors,O,563
11969,for,O,563
11970,serious,O,563
11971,infections,O,563
11972,that,O,563
11973,are,O,563
11974,resistant,O,563
11975,to,O,563
11976,other,O,563
11977,antibiotics,O,563
11978,If,O,563
11979,you,O,563
11980,have,O,563
11981,an,O,564
11982,infection,O,564
11983,and,O,564
11984,are,O,564
11985,considering,O,564
11986,taking,O,564
11987,chloramphenicol,B-NAME_OF_DRUG,564
11988,you,O,564
11989,should,O,564
11990,speak,O,564
11991,with,O,564
11992,a,O,564
11993,healthcare,O,564
11994,professional,O,564
11995,for,O,564
11996,guidance,O,564
11997,on,O,564
11998,the,O,564
11999,appropriate,O,564
12000,treatment,O,564
12001,for,O,564
12002,your,O,564
12003,condition,O,564
12004,Who,O,564
12005,Can,O,564
12006,Not,O,564
12007,Use,O,565
12008,It,O,565
12009,Chloramphenicol,B-NAME_OF_DRUG,565
12010,is,O,565
12011,generally,O,565
12012,not,O,565
12013,recommended,O,565
12014,for,O,565
12015,use,O,565
12016,in,O,565
12017,children,O,565
12018,pregnant,O,565
12019,women,O,565
12020,or,O,565
12021,nursing,O,565
12022,mothers,O,565
12023,because,O,565
12024,it,O,565
12025,can,O,565
12026,cause,O,565
12027,serious,O,565
12028,side,O,565
12029,effects,O,565
12030,It,O,565
12031,is,O,565
12032,also,O,566
12033,not,O,566
12034,recommended,O,566
12035,for,O,566
12036,use,O,566
12037,in,O,566
12038,animals,O,566
12039,as,O,566
12040,it,O,566
12041,can,O,566
12042,cause,O,566
12043,serious,O,566
12044,adverse,O,566
12045,reactions,O,566
12046,and,O,566
12047,is,O,566
12048,not,O,566
12049,effective,O,566
12050,against,O,566
12051,certain,O,566
12052,types,O,566
12053,of,O,566
12054,bacteria,O,566
12055,Can,O,566
12056,Chloramphenicol,B-NAME_OF_DRUG,567
12057,Affect,O,567
12058,Pregnancy,O,567
12059,Fertility,O,567
12060,or,O,567
12061,Breastfeeding,O,567
12062,Chloramphenicol,B-NAME_OF_DRUG,567
12063,may,O,567
12064,be,O,567
12065,harmful,O,567
12066,to,O,567
12067,a,O,567
12068,developing,O,567
12069,fetus,O,567
12070,and,O,567
12071,it,O,567
12072,is,O,568
12073,not,O,568
12074,recommended,O,568
12075,for,O,568
12076,use,O,568
12077,during,O,568
12078,pregnancy,O,568
12079,Chloramphenicol,B-NAME_OF_DRUG,568
12080,can,O,568
12081,also,O,568
12082,pass,O,568
12083,into,O,568
12084,breast,O,568
12085,milk,O,568
12086,and,O,568
12087,may,O,568
12088,cause,O,568
12089,serious,O,569
12090,side,O,569
12091,effects,O,569
12092,in,O,569
12093,nursing,O,569
12094,infants,O,569
12095,It,O,569
12096,is,O,569
12097,not,O,569
12098,recommended,O,569
12099,for,O,569
12100,use,O,569
12101,by,O,569
12102,nursing,O,569
12103,mothers,O,569
12104,or,O,569
12105,women,O,569
12106,who,O,569
12107,are,O,569
12108,planning,O,569
12109,to,O,569
12110,become,O,569
12111,pregnant,O,569
12112,If,O,569
12113,you,O,569
12114,are,O,570
12115,pregnant,O,570
12116,nursing,O,570
12117,or,O,570
12118,planning,O,570
12119,to,O,570
12120,become,O,570
12121,pregnant,O,570
12122,you,O,570
12123,should,O,570
12124,not,O,570
12125,use,O,570
12126,chloramphenicol,B-NAME_OF_DRUG,571
12127,without,O,571
12128,first,O,571
12129,discussing,O,571
12130,the,O,571
12131,potential,O,571
12132,risks,O,571
12133,with,O,571
12134,a,O,571
12135,healthcare,O,571
12136,professional,O,571
12137,There,O,571
12138,is,O,571
12139,limited,O,571
12140,information,O,571
12141,available,O,571
12142,on,O,571
12143,the,O,571
12144,effects,O,571
12145,of,O,571
12146,chloramphenicol,B-NAME_OF_DRUG,571
12147,on,O,571
12148,fertility,O,571
12149,Some,O,571
12150,studies,O,571
12151,in,O,571
12152,animals,O,571
12153,have,O,571
12154,suggested,O,571
12155,that,O,572
12156,chloramphenicol,B-NAME_OF_DRUG,572
12157,may,O,572
12158,have,O,572
12159,an,O,572
12160,adverse,O,572
12161,effect,O,572
12162,on,O,572
12163,fertility,O,572
12164,but,O,572
12165,more,O,572
12166,research,O,572
12167,is,O,572
12168,needed,O,572
12169,to,O,572
12170,determine,O,572
12171,if,O,572
12172,this,O,572
12173,is,O,572
12174,also,O,572
12175,TRUE,O,572
12176,in,O,573
12177,humans,O,573
12178,If,O,573
12179,you,O,573
12180,are,O,573
12181,concerned,O,573
12182,about,O,573
12183,the,O,573
12184,potential,O,573
12185,effects,O,573
12186,of,O,573
12187,chloramphenicol,B-NAME_OF_DRUG,573
12188,on,O,573
12189,fertility,O,573
12190,you,O,573
12191,should,O,573
12192,speak,O,573
12193,with,O,573
12194,a,O,573
12195,healthcare,O,574
12196,professional,O,574
12197,for,O,574
12198,guidance,O,574
12199,How,O,574
12200,to,O,574
12201,Use,O,574
12202,Chloramphenicol,B-NAME_OF_DRUG,574
12203,Chloramphenicol,B-NAME_OF_DRUG,574
12204,is,O,574
12205,available,O,574
12206,in,O,574
12207,several,O,574
12208,forms,O,574
12209,including,O,574
12210,tablets,O,574
12211,capsules,O,574
12212,and,O,574
12213,an,O,574
12214,oral,O,574
12215,suspension,O,575
12216,liquid,O,575
12217,,O,575
12218,It,O,575
12219,is,O,575
12220,usually,O,575
12221,taken,O,575
12222,by,O,575
12223,mouth,O,575
12224,but,O,575
12225,it,O,575
12226,can,O,575
12227,also,O,575
12228,be,O,575
12229,given,O,575
12230,intravenously,O,575
12231,through,O,575
12232,a,O,575
12233,vein,O,575
12234,in,O,575
12235,a,O,575
12236,hospital,O,576
12237,setting,O,576
12238,The,O,576
12239,specific,O,576
12240,dosage,O,576
12241,and,O,576
12242,duration,O,576
12243,of,O,576
12244,treatment,O,576
12245,with,O,576
12246,chloramphenicol,B-NAME_OF_DRUG,576
12247,will,O,576
12248,depend,O,577
12249,on,O,577
12250,the,O,577
12251,type,O,577
12252,and,O,577
12253,severity,O,577
12254,of,O,577
12255,the,O,577
12256,infection,O,577
12257,being,O,577
12258,treated,O,577
12259,It,O,577
12260,is,O,577
12261,important,O,577
12262,to,O,577
12263,take,O,577
12264,chloramphenicol,B-NAME_OF_DRUG,577
12265,exactly,O,577
12266,as,O,577
12267,prescribed,O,578
12268,by,O,578
12269,your,O,578
12270,doctor,O,578
12271,Here,O,578
12272,are,O,578
12273,some,O,578
12274,general,O,578
12275,guidelines,O,578
12276,for,O,578
12277,using,O,579
12278,chloramphenicol,B-NAME_OF_DRUG,579
12279,Take,O,579
12280,chloramphenicol,B-NAME_OF_DRUG,579
12281,at,O,579
12282,evenly,O,579
12283,spaced,O,579
12284,intervals,O,579
12285,as,O,579
12286,directed,O,580
12287,by,O,580
12288,your,O,580
12289,doctor,O,580
12290,Do,O,580
12291,not,O,580
12292,crush,O,580
12293,chew,O,580
12294,or,O,580
12295,break,O,580
12296,the,O,580
12297,tablets,O,580
12298,or,O,580
12299,capsules,O,580
12300,Swallow,O,581
12301,them,O,581
12302,whole,O,581
12303,with,O,581
12304,a,O,581
12305,full,O,581
12306,glass,O,581
12307,of,O,581
12308,water,O,581
12309,If,O,581
12310,you,O,581
12311,are,O,582
12312,taking,O,582
12313,the,O,582
12314,oral,O,582
12315,suspension,O,582
12316,shake,O,582
12317,the,O,582
12318,bottle,O,582
12319,well,O,582
12320,before,O,582
12321,each,O,582
12322,dose,O,583
12323,Measure,O,583
12324,the,O,583
12325,dose,O,583
12326,carefully,O,583
12327,using,O,583
12328,the,O,583
12329,measuring,O,583
12330,spoon,O,583
12331,or,O,583
12332,cup,O,583
12333,provided,O,583
12334,Do,O,583
12335,not,O,583
12336,stop,O,583
12337,taking,O,583
12338,chloramphenicol,B-NAME_OF_DRUG,583
12339,early,O,583
12340,even,O,583
12341,if,O,584
12342,you,O,584
12343,feel,O,584
12344,better,O,584
12345,Stopping,O,584
12346,treatment,O,584
12347,early,O,584
12348,can,O,584
12349,allow,O,584
12350,bacteria,O,584
12351,to,O,584
12352,continue,O,584
12353,to,O,584
12354,grow,O,584
12355,which,O,584
12356,can,O,584
12357,lead,O,584
12358,to,O,584
12359,a,O,585
12360,relapse,O,585
12361,of,O,585
12362,the,O,585
12363,infection,O,585
12364,If,O,585
12365,you,O,585
12366,have,O,585
12367,any,O,585
12368,questions,O,585
12369,about,O,585
12370,how,O,585
12371,to,O,585
12372,use,O,585
12373,chloramphenicol,B-NAME_OF_DRUG,585
12374,you,O,585
12375,should,O,585
12376,speak,O,585
12377,with,O,585
12378,your,O,585
12379,doctor,O,585
12380,or,O,585
12381,pharmacist,O,586
12382,What,O,586
12383,to,O,586
12384,Do,O,586
12385,If,O,586
12386,You,O,586
12387,Miss,O,586
12388,a,O,586
12389,Dose,O,586
12390,If,O,586
12391,you,O,586
12392,miss,O,586
12393,a,O,586
12394,dose,O,586
12395,of,O,586
12396,chloramphenicol,B-NAME_OF_DRUG,586
12397,take,O,586
12398,it,O,586
12399,as,O,586
12400,soon,O,586
12401,as,O,586
12402,you,O,586
12403,remember,O,587
12404,If,O,587
12405,it,O,587
12406,is,O,587
12407,almost,O,587
12408,time,O,587
12409,for,O,587
12410,your,O,587
12411,next,O,587
12412,dose,O,587
12413,skip,O,587
12414,the,O,587
12415,missed,O,587
12416,dose,O,587
12417,and,O,587
12418,take,O,587
12419,the,O,587
12420,next,O,587
12421,dose,O,588
12422,at,O,588
12423,the,O,588
12424,regular,O,588
12425,time,O,588
12426,Do,O,588
12427,not,O,588
12428,take,O,588
12429,two,O,588
12430,doses,O,588
12431,of,O,588
12432,chloramphenicol,B-NAME_OF_DRUG,588
12433,at,O,588
12434,the,O,588
12435,same,O,588
12436,time,O,588
12437,to,O,588
12438,make,O,588
12439,up,O,588
12440,for,O,588
12441,a,O,588
12442,missed,O,588
12443,dose,O,588
12444,If,O,588
12445,you,O,588
12446,miss,O,588
12447,multiple,O,588
12448,doses,O,589
12449,of,O,589
12450,chloramphenicol,B-NAME_OF_DRUG,589
12451,or,O,589
12452,forget,O,589
12453,to,O,589
12454,take,O,589
12455,the,O,589
12456,medication,O,589
12457,for,O,589
12458,an,O,589
12459,extended,O,589
12460,period,O,589
12461,of,O,589
12462,time,O,589
12463,you,O,589
12464,should,O,589
12465,contact,O,589
12466,your,O,589
12467,doctor,O,590
12468,for,O,590
12469,further,O,590
12470,instructions,O,590
12471,It,O,590
12472,is,O,590
12473,important,O,590
12474,to,O,590
12475,follow,O,590
12476,the,O,590
12477,prescribed,O,590
12478,dosing,O,590
12479,schedule,O,590
12480,for,O,590
12481,chloramphenicol,B-NAME_OF_DRUG,590
12482,to,O,590
12483,ensure,O,590
12484,that,O,590
12485,the,O,590
12486,infection,O,590
12487,is,O,590
12488,treated,O,590
12489,effectively,O,590
12490,What,O,590
12491,to,O,590
12492,Do,O,590
12493,If,O,590
12494,You,O,590
12495,Overdose,O,591
12496,If,O,591
12497,you,O,591
12498,think,O,591
12499,you,O,591
12500,or,O,591
12501,someone,O,591
12502,else,O,591
12503,may,O,591
12504,have,O,591
12505,taken,O,591
12506,an,O,592
12507,overdose,O,592
12508,of,O,592
12509,chloramphenicol,B-NAME_OF_DRUG,592
12510,you,O,592
12511,should,O,592
12512,seek,O,592
12513,emergency,O,592
12514,medical,O,592
12515,attention,O,592
12516,right,O,592
12517,away,O,592
12518,Overdose,O,592
12519,symptoms,O,592
12520,may,O,592
12521,include,O,592
12522,nausea,O,592
12523,vomiting,O,592
12524,stomach,O,592
12525,pain,O,592
12526,diarrhea,O,592
12527,and,O,592
12528,fever,O,592
12529,If,O,592
12530,the,O,592
12531,overdose,O,592
12532,was,O,593
12533,recent,O,593
12534,you,O,593
12535,may,O,593
12536,be,O,593
12537,advised,O,593
12538,to,O,593
12539,induce,O,593
12540,vomiting,O,593
12541,or,O,593
12542,undergo,O,593
12543,gastric,O,593
12544,lavage,O,593
12545,stomach,O,593
12546,pumping,O,593
12547,to,O,593
12548,remove,O,594
12549,the,O,594
12550,excess,O,594
12551,medication,O,594
12552,from,O,594
12553,your,O,594
12554,system,O,594
12555,You,O,594
12556,may,O,594
12557,also,O,594
12558,be,O,594
12559,given,O,594
12560,activated,O,594
12561,charcoal,O,594
12562,to,O,594
12563,help,O,594
12564,absorb,O,594
12565,any,O,594
12566,remaining,O,594
12567,chloramphenicol,B-NAME_OF_DRUG,594
12568,in,O,594
12569,the,O,594
12570,stomach,O,594
12571,It,O,594
12572,is,O,594
12573,important,O,594
12574,to,O,594
12575,seek,O,595
12576,medical,O,595
12577,attention,O,595
12578,immediately,O,595
12579,if,O,595
12580,you,O,595
12581,suspect,O,595
12582,an,O,595
12583,overdose,O,595
12584,as,O,595
12585,chloramphenicol,B-NAME_OF_DRUG,595
12586,overdose,O,595
12587,can,O,595
12588,be,O,595
12589,serious,O,595
12590,and,O,595
12591,may,O,595
12592,cause,O,596
12593,serious,O,596
12594,side,O,596
12595,effects,O,596
12596,or,O,596
12597,death,O,596
12598,What,O,596
12599,Side,O,596
12600,Effects,O,596
12601,May,O,596
12602,Happen,O,596
12603,If,O,596
12604,You,O,596
12605,Use,O,596
12606,Chloramphenicol,B-NAME_OF_DRUG,596
12607,Like,O,596
12608,all,O,596
12609,medications,O,596
12610,chloramphenicol,B-NAME_OF_DRUG,596
12611,can,O,597
12612,cause,O,597
12613,side,O,597
12614,effects,O,597
12615,Some,O,597
12616,people,O,597
12617,may,O,597
12618,experience,O,597
12619,side,O,597
12620,effects,O,597
12621,while,O,597
12622,taking,O,597
12623,chloramphenicol,B-NAME_OF_DRUG,598
12624,while,O,598
12625,others,O,598
12626,may,O,598
12627,not,O,598
12628,have,O,598
12629,any,O,598
12630,side,O,598
12631,effects,O,598
12632,at,O,598
12633,all,O,598
12634,The,O,598
12635,most,O,598
12636,common,O,598
12637,side,O,598
12638,effects,O,598
12639,of,O,598
12640,chloramphenicol,B-NAME_OF_DRUG,598
12641,are,O,598
12642,nausea,B-SIGN_AND_SYMPTOM,598
12643,vomiting,I-SIGN_AND_SYMPTOM,598
12644,and,I-SIGN_AND_SYMPTOM,598
12645,diarrhea,I-SIGN_AND_SYMPTOM,598
12646,Other,O,598
12647,possible,O,598
12648,side,O,598
12649,effects,O,598
12650,of,O,598
12651,chloramphenicol,B-NAME_OF_DRUG,598
12652,include,O,598
12653,Loss,B-SIGN_AND_SYMPTOM,598
12654,of,I-SIGN_AND_SYMPTOM,598
12655,appetite,I-SIGN_AND_SYMPTOM,598
12656,Rash,B-SIGN_AND_SYMPTOM,598
12657,or,I-SIGN_AND_SYMPTOM,598
12658,itching,I-SIGN_AND_SYMPTOM,598
12659,Headache,B-SIGN_AND_SYMPTOM,598
12660,Dizziness,B-SIGN_AND_SYMPTOM,598
12661,Trouble,B-SIGN_AND_SYMPTOM,598
12662,sleeping,I-SIGN_AND_SYMPTOM,598
12663,Dry,B-SIGN_AND_SYMPTOM,598
12664,mouth,I-SIGN_AND_SYMPTOM,598
12665,Unusual,B-SIGN_AND_SYMPTOM,598
12666,tiredness,I-SIGN_AND_SYMPTOM,598
12667,or,I-SIGN_AND_SYMPTOM,598
12668,weakness,I-SIGN_AND_SYMPTOM,598
12669,Less,O,598
12670,common,O,598
12671,but,O,598
12672,more,O,598
12673,serious,O,598
12674,side,O,598
12675,effects,O,598
12676,of,O,598
12677,chloramphenicol,B-NAME_OF_DRUG,598
12678,may,O,598
12679,include,O,598
12680,Blood,O,598
12681,disorders,O,598
12682,including,O,598
12683,anemia,O,598
12684,and,O,598
12685,decreased,O,598
12686,white,O,598
12687,blood,O,598
12688,cell,O,598
12689,count,O,598
12690,Allergic,B-SIGN_AND_SYMPTOM,598
12691,reactions,I-SIGN_AND_SYMPTOM,598
12692,including,I-SIGN_AND_SYMPTOM,598
12693,difficulty,I-SIGN_AND_SYMPTOM,598
12694,breathing,I-SIGN_AND_SYMPTOM,598
12695,hives,I-SIGN_AND_SYMPTOM,598
12696,and,I-SIGN_AND_SYMPTOM,598
12697,swelling,I-SIGN_AND_SYMPTOM,598
12698,of,I-SIGN_AND_SYMPTOM,598
12699,the,I-SIGN_AND_SYMPTOM,598
12700,face,I-SIGN_AND_SYMPTOM,598
12701,lips,I-SIGN_AND_SYMPTOM,598
12702,tongue,I-SIGN_AND_SYMPTOM,598
12703,or,I-SIGN_AND_SYMPTOM,598
12704,throat,I-SIGN_AND_SYMPTOM,598
12705,Seizures,B-SIGN_AND_SYMPTOM,598
12706,Confusion,B-SIGN_AND_SYMPTOM,599
12707,or,I-SIGN_AND_SYMPTOM,599
12708,changes,I-SIGN_AND_SYMPTOM,599
12709,in,I-SIGN_AND_SYMPTOM,599
12710,mental,I-SIGN_AND_SYMPTOM,599
12711,status,I-SIGN_AND_SYMPTOM,599
12712,If,O,599
12713,you,O,599
12714,experience,O,599
12715,any,O,599
12716,of,O,599
12717,these,O,599
12718,side,O,599
12719,effects,O,599
12720,you,O,599
12721,should,O,599
12722,contact,O,599
12723,your,O,599
12724,doctor,O,599
12725,as,O,599
12726,soon,O,599
12727,as,O,599
12728,possible,O,599
12729,In,O,600
12730,rare,O,600
12731,cases,O,600
12732,chloramphenicol,B-NAME_OF_DRUG,600
12733,can,O,600
12734,cause,O,600
12735,serious,O,600
12736,side,O,600
12737,effects,O,600
12738,that,O,600
12739,may,O,600
12740,require,O,600
12741,immediate,O,600
12742,medical,O,600
12743,attention,O,600
12744,such,O,600
12745,as,O,601
12746,severe,B-SIGN_AND_SYMPTOM,601
12747,allergic,I-SIGN_AND_SYMPTOM,601
12748,reactions,I-SIGN_AND_SYMPTOM,601
12749,or,I-SIGN_AND_SYMPTOM,601
12750,blood,I-SIGN_AND_SYMPTOM,601
12751,disorders,I-SIGN_AND_SYMPTOM,601
12752,It,O,601
12753,is,O,601
12754,important,O,601
12755,to,O,601
12756,report,O,601
12757,any,O,601
12758,side,O,601
12759,effects,O,601
12760,you,O,601
12761,experience,O,601
12762,while,O,601
12763,taking,O,601
12764,chloramphenicol,B-NAME_OF_DRUG,602
12765,to,O,602
12766,your,O,602
12767,doctor,O,602
12768,This,O,602
12769,will,O,602
12770,help,O,602
12771,your,O,602
12772,doctor,O,602
12773,determine,O,602
12774,the,O,602
12775,best,O,602
12776,course,O,602
12777,of,O,602
12778,treatment,O,602
12779,for,O,602
12780,you,O,602
12781,and,O,602
12782,monitor,O,602
12783,for,O,602
12784,any,O,602
12785,potential,O,602
12786,problems,O,602
12787,Does,O,602
12788,Chloramphenicol,B-NAME_OF_DRUG,602
12789,Eye,I-NAME_OF_DRUG,602
12790,Drop,I-NAME_OF_DRUG,603
12791,Cause,O,603
12792,Any,O,603
12793,Interaction,O,603
12794,with,O,603
12795,Other,O,603
12796,Medicines,O,603
12797,and,O,603
12798,Supplements,O,603
12799,Chloramphenicol,B-NAME_OF_DRUG,603
12800,eye,I-NAME_OF_DRUG,603
12801,drops,I-NAME_OF_DRUG,603
12802,may,O,603
12803,interact,O,603
12804,with,O,603
12805,other,O,603
12806,medications,O,603
12807,and,O,603
12808,supplements,O,603
12809,that,O,603
12810,you,O,603
12811,are,O,603
12812,taking,O,603
12813,It,O,604
12814,is,O,604
12815,important,O,604
12816,to,O,604
12817,tell,O,604
12818,your,O,604
12819,doctor,O,604
12820,about,O,604
12821,all,O,604
12822,the,O,604
12823,medications,O,604
12824,and,O,604
12825,supplements,O,604
12826,you,O,604
12827,are,O,604
12828,using,O,604
12829,before,O,604
12830,starting,O,604
12831,treatment,O,604
12832,with,O,604
12833,chloramphenicol,B-NAME_OF_DRUG,605
12834,eye,I-NAME_OF_DRUG,605
12835,drops,I-NAME_OF_DRUG,605
12836,This,O,605
12837,will,O,605
12838,help,O,605
12839,your,O,605
12840,doctor,O,605
12841,determine,O,605
12842,if,O,605
12843,chloramphenicol,B-NAME_OF_DRUG,605
12844,is,O,605
12845,safe,O,605
12846,for,O,605
12847,you,O,605
12848,and,O,605
12849,help,O,605
12850,to,O,605
12851,prevent,O,605
12852,any,O,605
12853,potential,O,605
12854,drug,O,605
12855,interactions,O,605
12856,Some,O,605
12857,medications,O,605
12858,that,O,605
12859,may,O,605
12860,interact,O,605
12861,with,O,605
12862,chloramphenicol,B-NAME_OF_DRUG,605
12863,eye,I-NAME_OF_DRUG,605
12864,drops,I-NAME_OF_DRUG,605
12865,include,O,605
12866,Other,O,605
12867,antibiotics,B-NAME_OF_DRUG,605
12868,or,I-NAME_OF_DRUG,605
12869,antifungal,I-NAME_OF_DRUG,605
12870,medications,I-NAME_OF_DRUG,605
12871,Blood,O,605
12872,thinners,O,605
12873,such,O,605
12874,as,O,605
12875,warfarin,B-NAME_OF_DRUG,605
12876,Medications,O,605
12877,that,O,605
12878,weaken,O,605
12879,the,O,605
12880,immune,O,605
12881,system,O,605
12882,such,O,605
12883,as,O,605
12884,corticosteroids,B-NAME_OF_DRUG,605
12885,Medications,O,605
12886,that,O,605
12887,affect,O,605
12888,the,O,605
12889,blood,O,605
12890,such,O,605
12891,as,O,605
12892,methotrexate,B-NAME_OF_DRUG,605
12893,Medications,O,605
12894,that,O,605
12895,affect,O,605
12896,the,O,606
12897,liver,O,606
12898,such,O,606
12899,as,O,606
12900,phenobarbital,B-NAME_OF_DRUG,606
12901,If,O,606
12902,you,O,606
12903,are,O,606
12904,taking,O,606
12905,any,O,606
12906,of,O,606
12907,these,O,606
12908,medications,O,606
12909,you,O,606
12910,should,O,606
12911,tell,O,606
12912,your,O,606
12913,doctor,O,606
12914,before,O,606
12915,using,O,607
12916,chloramphenicol,B-NAME_OF_DRUG,607
12917,eye,I-NAME_OF_DRUG,607
12918,drops,I-NAME_OF_DRUG,607
12919,Your,O,607
12920,doctor,O,607
12921,may,O,607
12922,need,O,607
12923,to,O,607
12924,adjust,O,607
12925,the,O,607
12926,dosage,O,607
12927,of,O,607
12928,your,O,607
12929,medications,O,607
12930,or,O,607
12931,monitor,O,607
12932,you,O,607
12933,more,O,607
12934,closely,O,607
12935,for,O,607
12936,side,O,607
12937,effects,O,607
12938,It,O,608
12939,is,O,608
12940,also,O,608
12941,important,O,608
12942,to,O,608
12943,tell,O,608
12944,your,O,608
12945,doctor,O,608
12946,about,O,608
12947,any,O,608
12948,supplements,O,608
12949,you,O,608
12950,are,O,608
12951,taking,O,608
12952,as,O,609
12953,some,O,609
12954,supplements,O,609
12955,may,O,609
12956,interact,O,609
12957,with,O,609
12958,chloramphenicol,B-NAME_OF_DRUG,609
12959,eye,I-NAME_OF_DRUG,609
12960,drops,I-NAME_OF_DRUG,609
12961,For,O,609
12962,example,O,609
12963,some,O,609
12964,supplements,O,609
12965,such,O,609
12966,as,O,609
12967,zinc,B-NAME_OF_DRUG,609
12968,can,O,609
12969,interfere,O,609
12970,with,O,609
12971,the,O,609
12972,absorption,O,610
12973,of,O,610
12974,chloramphenicol,B-NAME_OF_DRUG,610
12975,If,O,610
12976,you,O,610
12977,have,O,610
12978,any,O,610
12979,questions,O,610
12980,about,O,610
12981,drug,O,610
12982,interactions,O,610
12983,with,O,610
12984,chloramphenicol,B-NAME_OF_DRUG,610
12985,eye,I-NAME_OF_DRUG,610
12986,drops,I-NAME_OF_DRUG,610
12987,you,O,610
12988,should,O,610
12989,speak,O,610
12990,with,O,610
12991,your,O,610
12992,doctor,O,610
12993,or,O,610
12994,pharmacist,O,610
12995,What,O,610
12996,Is,O,610
12997,Surfer,B-NAME_OF_DISEASE,610
12998,s,I-NAME_OF_DISEASE,610
12999,Eye,I-NAME_OF_DISEASE,610
13000,Pterygium,B-NAME_OF_DISEASE,610
13001,is,O,610
13002,characterized,O,610
13003,by,O,610
13004,a,B-SIGN_AND_SYMPTOM,610
13005,thickening,I-SIGN_AND_SYMPTOM,610
13006,of,I-SIGN_AND_SYMPTOM,610
13007,the,I-SIGN_AND_SYMPTOM,610
13008,conjunctiva,I-SIGN_AND_SYMPTOM,610
13009,tissue,I-SIGN_AND_SYMPTOM,611
13010,that,I-SIGN_AND_SYMPTOM,611
13011,takes,I-SIGN_AND_SYMPTOM,611
13012,on,I-SIGN_AND_SYMPTOM,611
13013,a,I-SIGN_AND_SYMPTOM,611
13014,wing-like,I-SIGN_AND_SYMPTOM,611
13015,or,I-SIGN_AND_SYMPTOM,611
13016,triangular,I-SIGN_AND_SYMPTOM,611
13017,shape,I-SIGN_AND_SYMPTOM,612
13018,and,I-SIGN_AND_SYMPTOM,612
13019,grows,I-SIGN_AND_SYMPTOM,612
13020,from,I-SIGN_AND_SYMPTOM,612
13021,the,I-SIGN_AND_SYMPTOM,612
13022,inner,I-SIGN_AND_SYMPTOM,612
13023,corners,I-SIGN_AND_SYMPTOM,612
13024,of,I-SIGN_AND_SYMPTOM,612
13025,the,I-SIGN_AND_SYMPTOM,612
13026,eye,I-SIGN_AND_SYMPTOM,612
13027,often,I-SIGN_AND_SYMPTOM,612
13028,extending,I-SIGN_AND_SYMPTOM,612
13029,onto,I-SIGN_AND_SYMPTOM,612
13030,the,B-PART_OF_THE_EYES,612
13031,cornea,I-PART_OF_THE_EYES,612
13032,Pterygium,B-NAME_OF_DISEASE,612
13033,can,O,613
13034,either,O,613
13035,affect,O,613
13036,one,O,613
13037,or,O,613
13038,both,O,613
13039,eyes,O,613
13040,Cases,O,613
13041,when,O,613
13042,it,O,613
13043,affects,O,613
13044,both,O,613
13045,eyes,O,613
13046,at,O,613
13047,the,O,613
13048,same,O,613
13049,time,O,613
13050,is,O,613
13051,referred,O,613
13052,to,O,613
13053,as,O,613
13054,bilateral,B-NAME_OF_DISEASE,613
13055,pterygium,I-NAME_OF_DISEASE,613
13056,What,O,613
13057,Symptoms,O,613
13058,to,O,613
13059,Expect,O,613
13060,from,O,613
13061,Pterygium,B-NAME_OF_DISEASE,613
13062,of,O,613
13063,the,O,613
13064,Eye,O,613
13065,Pterygium,B-NAME_OF_DISEASE,613
13066,is,O,613
13067,a,B-SIGN_AND_SYMPTOM,613
13068,benign,I-SIGN_AND_SYMPTOM,613
13069,non-cancerous,I-SIGN_AND_SYMPTOM,613
13070,growth,I-SIGN_AND_SYMPTOM,613
13071,that,I-SIGN_AND_SYMPTOM,613
13072,appears,I-SIGN_AND_SYMPTOM,613
13073,on,I-SIGN_AND_SYMPTOM,614
13074,the,I-SIGN_AND_SYMPTOM,614
13075,conjunctiva,I-SIGN_AND_SYMPTOM,614
13076,which,O,614
13077,is,O,614
13078,the,O,614
13079,clear,O,614
13080,membrane,O,614
13081,that,O,614
13082,covers,O,614
13083,the,O,614
13084,white,O,614
13085,part,O,614
13086,of,O,614
13087,the,O,614
13088,eye,O,614
13089,and,O,614
13090,lines,O,614
13091,the,O,614
13092,inside,O,614
13093,of,O,614
13094,the,O,614
13095,eyelids.Sometime,O,614
13096,you,O,614
13097,won,O,614
13098,t,O,614
13099,experience,O,614
13100,any,O,614
13101,symptoms,O,614
13102,prior,O,614
13103,to,O,614
13104,having,O,614
13105,pterygium,B-NAME_OF_DISEASE,614
13106,but,O,614
13107,it,O,614
13108,can,O,614
13109,also,O,614
13110,cause,O,614
13111,a,O,614
13112,variety,O,614
13113,of,O,614
13114,symptoms,O,614
13115,some,O,614
13116,of,O,614
13117,which,O,614
13118,may,O,614
13119,include,O,614
13120,Dryness,B-SIGN_AND_SYMPTOM,614
13121,and,I-SIGN_AND_SYMPTOM,614
13122,redness,I-SIGN_AND_SYMPTOM,615
13123,of,I-SIGN_AND_SYMPTOM,615
13124,the,I-SIGN_AND_SYMPTOM,615
13125,eye,I-SIGN_AND_SYMPTOM,615
13126,Pterygium,B-NAME_OF_DISEASE,615
13127,may,O,615
13128,cause,O,615
13129,the,B-SIGN_AND_SYMPTOM,615
13130,eye,I-SIGN_AND_SYMPTOM,615
13131,to,I-SIGN_AND_SYMPTOM,615
13132,feel,I-SIGN_AND_SYMPTOM,615
13133,dry,I-SIGN_AND_SYMPTOM,615
13134,and,I-SIGN_AND_SYMPTOM,615
13135,itchy,I-SIGN_AND_SYMPTOM,615
13136,and,I-SIGN_AND_SYMPTOM,615
13137,the,I-SIGN_AND_SYMPTOM,615
13138,affected,I-SIGN_AND_SYMPTOM,615
13139,eye,I-SIGN_AND_SYMPTOM,615
13140,may,I-SIGN_AND_SYMPTOM,615
13141,appear,I-SIGN_AND_SYMPTOM,615
13142,red,I-SIGN_AND_SYMPTOM,615
13143,and,I-SIGN_AND_SYMPTOM,616
13144,inflamed,I-SIGN_AND_SYMPTOM,616
13145,Sensitivity,B-SIGN_AND_SYMPTOM,616
13146,to,I-SIGN_AND_SYMPTOM,616
13147,light,I-SIGN_AND_SYMPTOM,616
13148,People,O,616
13149,with,O,616
13150,pterygium,B-NAME_OF_DISEASE,616
13151,may,O,616
13152,be,O,616
13153,more,B-SIGN_AND_SYMPTOM,616
13154,sensitive,I-SIGN_AND_SYMPTOM,616
13155,to,I-SIGN_AND_SYMPTOM,616
13156,bright,I-SIGN_AND_SYMPTOM,616
13157,light,I-SIGN_AND_SYMPTOM,616
13158,and,I-SIGN_AND_SYMPTOM,616
13159,may,I-SIGN_AND_SYMPTOM,616
13160,experience,I-SIGN_AND_SYMPTOM,616
13161,discomfort,B-SIGN_AND_SYMPTOM,616
13162,when,I-SIGN_AND_SYMPTOM,616
13163,exposed,I-SIGN_AND_SYMPTOM,616
13164,to,I-SIGN_AND_SYMPTOM,616
13165,it,I-SIGN_AND_SYMPTOM,616
13166,Blurred,B-SIGN_AND_SYMPTOM,616
13167,vision,I-SIGN_AND_SYMPTOM,616
13168,Pterygium,B-NAME_OF_DISEASE,616
13169,may,O,616
13170,cause,O,616
13171,the,B-SIGN_AND_SYMPTOM,616
13172,vision,I-SIGN_AND_SYMPTOM,616
13173,to,I-SIGN_AND_SYMPTOM,616
13174,be,I-SIGN_AND_SYMPTOM,616
13175,blurry,I-SIGN_AND_SYMPTOM,616
13176,or,I-SIGN_AND_SYMPTOM,616
13177,distorted,I-SIGN_AND_SYMPTOM,616
13178,particularly,O,616
13179,if,O,617
13180,it,O,617
13181,grows,O,617
13182,over,O,617
13183,the,B-PART_OF_THE_EYES,617
13184,cornea,I-PART_OF_THE_EYES,617
13185,which,O,617
13186,is,O,617
13187,the,O,617
13188,clear,O,617
13189,dome-shaped,O,617
13190,surface,O,617
13191,at,O,617
13192,the,O,617
13193,front,O,617
13194,of,O,617
13195,the,O,617
13196,eye,O,617
13197,that,O,617
13198,helps,O,617
13199,to,O,617
13200,focus,O,617
13201,light,O,617
13202,Difficulty,B-SIGN_AND_SYMPTOM,617
13203,with,I-SIGN_AND_SYMPTOM,617
13204,contact,I-SIGN_AND_SYMPTOM,617
13205,lenses,I-SIGN_AND_SYMPTOM,617
13206,Pterygium,B-NAME_OF_DISEASE,618
13207,can,O,618
13208,make,O,618
13209,it,O,618
13210,troublesome,B-SIGN_AND_SYMPTOM,618
13211,to,I-SIGN_AND_SYMPTOM,618
13212,wear,I-SIGN_AND_SYMPTOM,618
13213,contact,I-SIGN_AND_SYMPTOM,618
13214,lenses,I-SIGN_AND_SYMPTOM,618
13215,comfortably,I-SIGN_AND_SYMPTOM,618
13216,as,O,618
13217,they,O,618
13218,may,O,619
13219,not,O,619
13220,fit,O,619
13221,to,O,619
13222,your,O,619
13223,eyes,O,619
13224,properly,O,619
13225,and,O,619
13226,may,O,619
13227,cause,O,619
13228,discomfort,B-SIGN_AND_SYMPTOM,619
13229,Discomfort,B-SIGN_AND_SYMPTOM,619
13230,and,I-SIGN_AND_SYMPTOM,619
13231,foreign,I-SIGN_AND_SYMPTOM,619
13232,body,I-SIGN_AND_SYMPTOM,619
13233,sensation,I-SIGN_AND_SYMPTOM,619
13234,Some,O,619
13235,people,O,619
13236,with,O,619
13237,pterygium,B-NAME_OF_DISEASE,619
13238,may,O,619
13239,experience,O,619
13240,discomfort,B-SIGN_AND_SYMPTOM,619
13241,What,O,619
13242,Causes,O,619
13243,Pterygium,B-NAME_OF_DISEASE,619
13244,The,O,619
13245,exact,O,619
13246,cause,O,620
13247,of,O,620
13248,pterygium,B-NAME_OF_DISEASE,620
13249,is,O,620
13250,not,O,620
13251,fully,O,620
13252,understood,O,620
13253,but,O,620
13254,it,O,620
13255,is,O,620
13256,believed,O,620
13257,to,O,620
13258,be,O,620
13259,associated,O,620
13260,with,O,620
13261,exposure,B-CAUSE_OF_DISEASE,620
13262,to,I-CAUSE_OF_DISEASE,620
13263,ultraviolet,I-CAUSE_OF_DISEASE,620
13264,UV,I-CAUSE_OF_DISEASE,620
13265,light,I-CAUSE_OF_DISEASE,620
13266,wind,I-CAUSE_OF_DISEASE,620
13267,and,I-CAUSE_OF_DISEASE,620
13268,dust,I-CAUSE_OF_DISEASE,620
13269,Other,O,620
13270,possible,O,620
13271,risk,O,620
13272,factors,O,620
13273,for,O,620
13274,developing,O,620
13275,pterygium,B-NAME_OF_DISEASE,620
13276,include,O,620
13277,Living,B-CAUSE_OF_DISEASE,620
13278,in,I-CAUSE_OF_DISEASE,620
13279,a,I-CAUSE_OF_DISEASE,620
13280,sunny,I-CAUSE_OF_DISEASE,620
13281,or,I-CAUSE_OF_DISEASE,620
13282,dry,I-CAUSE_OF_DISEASE,620
13283,climate,I-CAUSE_OF_DISEASE,621
13284,People,O,621
13285,who,O,621
13286,live,B-CAUSE_OF_DISEASE,621
13287,in,I-CAUSE_OF_DISEASE,621
13288,areas,I-CAUSE_OF_DISEASE,621
13289,with,I-CAUSE_OF_DISEASE,621
13290,high,I-CAUSE_OF_DISEASE,621
13291,levels,I-CAUSE_OF_DISEASE,621
13292,of,I-CAUSE_OF_DISEASE,621
13293,UV,I-CAUSE_OF_DISEASE,621
13294,light,I-CAUSE_OF_DISEASE,621
13295,or,I-CAUSE_OF_DISEASE,621
13296,low,I-CAUSE_OF_DISEASE,621
13297,humidity,I-CAUSE_OF_DISEASE,621
13298,may,O,621
13299,be,O,621
13300,more,O,621
13301,at,O,621
13302,risk,O,621
13303,of,O,621
13304,developing,O,621
13305,pterygium,B-NAME_OF_DISEASE,621
13306,Working,B-CAUSE_OF_DISEASE,621
13307,outdoors,I-CAUSE_OF_DISEASE,621
13308,People,O,621
13309,who,O,621
13310,work,B-CAUSE_OF_DISEASE,621
13311,in,I-CAUSE_OF_DISEASE,621
13312,occupations,I-CAUSE_OF_DISEASE,621
13313,that,I-CAUSE_OF_DISEASE,622
13314,involve,I-CAUSE_OF_DISEASE,622
13315,prolonged,I-CAUSE_OF_DISEASE,622
13316,exposure,I-CAUSE_OF_DISEASE,622
13317,to,I-CAUSE_OF_DISEASE,622
13318,the,I-CAUSE_OF_DISEASE,622
13319,sun,I-CAUSE_OF_DISEASE,622
13320,wind,I-CAUSE_OF_DISEASE,622
13321,or,I-CAUSE_OF_DISEASE,622
13322,dust,I-CAUSE_OF_DISEASE,622
13323,such,I-CAUSE_OF_DISEASE,622
13324,as,I-CAUSE_OF_DISEASE,623
13325,farmers,I-CAUSE_OF_DISEASE,623
13326,construction,I-CAUSE_OF_DISEASE,623
13327,workers,I-CAUSE_OF_DISEASE,623
13328,and,I-CAUSE_OF_DISEASE,623
13329,sailors,I-CAUSE_OF_DISEASE,623
13330,may,O,623
13331,be,O,623
13332,more,O,623
13333,prone,O,623
13334,to,O,623
13335,pterygium,B-NAME_OF_DISEASE,623
13336,Being,B-CAUSE_OF_DISEASE,623
13337,male,I-CAUSE_OF_DISEASE,623
13338,Men,O,623
13339,are,O,623
13340,more,O,623
13341,likely,O,623
13342,to,O,624
13343,develop,O,624
13344,pterygium,B-NAME_OF_DISEASE,624
13345,than,O,624
13346,women,O,624
13347,Having,B-CAUSE_OF_DISEASE,624
13348,fair,B-CAUSE_OF_DISEASE,624
13349,skin,I-CAUSE_OF_DISEASE,624
13350,People,O,624
13351,with,O,624
13352,fair,B-CAUSE_OF_DISEASE,624
13353,skin,I-CAUSE_OF_DISEASE,624
13354,are,O,624
13355,more,O,624
13356,likely,O,624
13357,to,O,624
13358,develop,O,624
13359,pterygium,B-NAME_OF_DISEASE,624
13360,than,O,624
13361,those,O,624
13362,with,O,624
13363,darker,O,624
13364,skin,O,624
13365,Family,B-CAUSE_OF_DISEASE,624
13366,history,I-CAUSE_OF_DISEASE,624
13367,There,O,624
13368,may,O,625
13369,be,O,625
13370,a,B-CAUSE_OF_DISEASE,625
13371,genetic,I-CAUSE_OF_DISEASE,625
13372,component,I-CAUSE_OF_DISEASE,625
13373,to,O,625
13374,pterygium,B-NAME_OF_DISEASE,625
13375,as,O,625
13376,some,O,625
13377,people,O,625
13378,may,O,625
13379,be,O,625
13380,more,O,625
13381,predisposed,O,625
13382,to,O,625
13383,developing,O,625
13384,the,O,625
13385,condition,O,625
13386,due,O,625
13387,to,O,625
13388,their,O,625
13389,family,B-CAUSE_OF_DISEASE,625
13390,history,I-CAUSE_OF_DISEASE,625
13391,While,B-CAUSE_OF_DISEASE,625
13392,UV,I-CAUSE_OF_DISEASE,625
13393,light,I-CAUSE_OF_DISEASE,625
13394,wind,I-CAUSE_OF_DISEASE,625
13395,and,I-CAUSE_OF_DISEASE,625
13396,dust,I-CAUSE_OF_DISEASE,625
13397,are,O,625
13398,thought,O,625
13399,to,O,625
13400,be,O,626
13401,the,O,626
13402,main,O,626
13403,contributing,O,626
13404,factors,O,626
13405,to,O,626
13406,pterygium,B-NAME_OF_DISEASE,626
13407,it,O,626
13408,is,O,626
13409,not,O,626
13410,clear,O,626
13411,why,O,626
13412,some,O,626
13413,people,O,626
13414,are,O,626
13415,more,O,626
13416,prone,O,626
13417,to,O,626
13418,developing,O,626
13419,the,O,626
13420,condition,O,626
13421,than,O,626
13422,others,O,626
13423,Some,O,626
13424,research,O,626
13425,suggests,O,626
13426,that,O,626
13427,inflammation,B-CAUSE_OF_DISEASE,626
13428,may,O,626
13429,play,O,626
13430,a,O,626
13431,role,O,626
13432,in,O,626
13433,the,O,626
13434,development,O,626
13435,of,O,627
13436,pterygium,B-NAME_OF_DISEASE,627
13437,and,O,627
13438,that,O,627
13439,people,O,627
13440,with,O,627
13441,certain,O,627
13442,underlying,O,627
13443,health,O,627
13444,conditions,O,627
13445,such,O,627
13446,as,O,627
13447,dry,B-NAME_OF_DISEASE,627
13448,eye,I-NAME_OF_DISEASE,627
13449,syndrome,I-NAME_OF_DISEASE,627
13450,or,O,627
13451,autoimmune,B-NAME_OF_DISEASE,627
13452,diseases,I-NAME_OF_DISEASE,627
13453,may,O,627
13454,be,O,627
13455,more,O,627
13456,at,O,627
13457,risk,O,627
13458,Pinguecula,B-NAME_OF_DISEASE,627
13459,vs,O,627
13460,Pterygium,B-NAME_OF_DISEASE,627
13461,What,O,627
13462,Are,O,627
13463,the,O,627
13464,Differences,O,627
13465,Pinguecula,B-NAME_OF_DISEASE,627
13466,and,O,627
13467,pterygium,B-NAME_OF_DISEASE,627
13468,are,O,627
13469,two,O,627
13470,conditions,O,627
13471,that,O,627
13472,affect,O,628
13473,the,B-PART_OF_THE_EYES,628
13474,conjunctiva,I-PART_OF_THE_EYES,628
13475,which,O,628
13476,is,O,628
13477,the,O,628
13478,clear,O,628
13479,membrane,O,628
13480,that,O,628
13481,covers,O,628
13482,the,O,628
13483,white,O,628
13484,part,O,628
13485,of,O,628
13486,the,O,628
13487,eye,O,628
13488,and,O,628
13489,lines,O,628
13490,the,O,628
13491,inside,O,628
13492,of,O,628
13493,the,B-PART_OF_THE_EYES,628
13494,eyelids,I-PART_OF_THE_EYES,628
13495,While,O,628
13496,they,O,628
13497,have,O,628
13498,some,O,628
13499,similarities,O,628
13500,they,O,628
13501,are,O,628
13502,two,O,628
13503,distinct,O,628
13504,conditions,O,628
13505,that,O,628
13506,differ,O,628
13507,in,O,628
13508,several,O,628
13509,ways,O,628
13510,Location,O,628
13511,A,O,628
13512,pinguecula,B-NAME_OF_DISEASE,628
13513,is,O,629
13514,a,B-SIGN_AND_SYMPTOM,629
13515,small,I-SIGN_AND_SYMPTOM,629
13516,yellowish,I-SIGN_AND_SYMPTOM,629
13517,or,I-SIGN_AND_SYMPTOM,629
13518,flesh-colored,I-SIGN_AND_SYMPTOM,629
13519,bump,I-SIGN_AND_SYMPTOM,629
13520,that,I-SIGN_AND_SYMPTOM,629
13521,appears,I-SIGN_AND_SYMPTOM,629
13522,on,I-SIGN_AND_SYMPTOM,629
13523,the,I-SIGN_AND_SYMPTOM,629
13524,conjunctiva,I-SIGN_AND_SYMPTOM,629
13525,usually,I-SIGN_AND_SYMPTOM,629
13526,on,I-SIGN_AND_SYMPTOM,629
13527,the,I-SIGN_AND_SYMPTOM,629
13528,side,I-SIGN_AND_SYMPTOM,629
13529,of,I-SIGN_AND_SYMPTOM,629
13530,the,I-SIGN_AND_SYMPTOM,629
13531,eye,I-SIGN_AND_SYMPTOM,629
13532,closest,I-SIGN_AND_SYMPTOM,629
13533,to,I-SIGN_AND_SYMPTOM,629
13534,the,I-SIGN_AND_SYMPTOM,629
13535,nose,I-SIGN_AND_SYMPTOM,629
13536,It,O,629
13537,does,O,629
13538,not,O,629
13539,typically,O,629
13540,grow,O,629
13541,beyond,O,629
13542,the,B-PART_OF_THE_EYES,629
13543,conjunctiva,I-PART_OF_THE_EYES,629
13544,and,O,630
13545,does,O,630
13546,not,O,630
13547,affect,O,630
13548,the,B-PART_OF_THE_EYES,630
13549,cornea,I-PART_OF_THE_EYES,630
13550,which,O,630
13551,is,O,630
13552,the,O,630
13553,clear,O,630
13554,dome-shaped,O,630
13555,surface,O,630
13556,at,O,630
13557,the,O,630
13558,front,O,630
13559,of,O,630
13560,the,O,630
13561,eye,O,630
13562,that,O,630
13563,helps,O,630
13564,to,O,630
13565,focus,O,630
13566,light,O,630
13567,A,O,630
13568,pterygium,B-NAME_OF_DISEASE,630
13569,on,O,630
13570,the,O,630
13571,other,O,631
13572,hand,O,631
13573,is,O,631
13574,a,B-SIGN_AND_SYMPTOM,631
13575,raised,I-SIGN_AND_SYMPTOM,631
13576,fleshy,I-SIGN_AND_SYMPTOM,631
13577,growth,I-SIGN_AND_SYMPTOM,631
13578,that,I-SIGN_AND_SYMPTOM,631
13579,starts,I-SIGN_AND_SYMPTOM,631
13580,on,I-SIGN_AND_SYMPTOM,631
13581,the,I-SIGN_AND_SYMPTOM,631
13582,conjunctiva,I-SIGN_AND_SYMPTOM,631
13583,and,I-SIGN_AND_SYMPTOM,631
13584,can,I-SIGN_AND_SYMPTOM,631
13585,spread,I-SIGN_AND_SYMPTOM,631
13586,outward,I-SIGN_AND_SYMPTOM,631
13587,onto,I-SIGN_AND_SYMPTOM,631
13588,the,I-SIGN_AND_SYMPTOM,631
13589,cornea,I-SIGN_AND_SYMPTOM,631
13590,sometimes,O,632
13591,causing,O,632
13592,vision,O,632
13593,problems,O,632
13594,Causes,O,632
13595,Both,O,632
13596,pinguecula,B-NAME_OF_DISEASE,632
13597,and,O,632
13598,pterygium,B-NAME_OF_DISEASE,632
13599,are,O,632
13600,thought,O,632
13601,to,O,632
13602,be,O,632
13603,caused,O,632
13604,by,O,632
13605,exposure,B-CAUSE_OF_DISEASE,632
13606,to,I-CAUSE_OF_DISEASE,632
13607,ultraviolet,I-CAUSE_OF_DISEASE,632
13608,UV,I-CAUSE_OF_DISEASE,632
13609,light,I-CAUSE_OF_DISEASE,632
13610,wind,I-CAUSE_OF_DISEASE,633
13611,and,I-CAUSE_OF_DISEASE,633
13612,dust,I-CAUSE_OF_DISEASE,633
13613,However,O,633
13614,pterygium,B-NAME_OF_DISEASE,633
13615,is,O,633
13616,more,O,633
13617,likely,O,633
13618,to,O,633
13619,be,O,633
13620,associated,O,633
13621,with,O,633
13622,these,O,633
13623,factors,O,633
13624,and,O,633
13625,is,O,633
13626,believed,O,633
13627,to,O,633
13628,be,O,633
13629,more,O,633
13630,aggressive,O,633
13631,than,O,633
13632,pinguecula,B-NAME_OF_DISEASE,633
13633,Some,O,633
13634,research,O,633
13635,suggests,O,633
13636,that,O,633
13637,inflammation,B-CAUSE_OF_DISEASE,633
13638,may,O,633
13639,play,O,633
13640,a,O,633
13641,role,O,633
13642,in,O,633
13643,the,O,633
13644,development,O,633
13645,of,O,634
13646,pterygium,B-NAME_OF_DISEASE,634
13647,and,O,634
13648,that,O,634
13649,people,O,634
13650,with,O,634
13651,certain,O,634
13652,underlying,O,634
13653,health,O,634
13654,conditions,O,634
13655,such,O,634
13656,as,O,634
13657,dry,B-NAME_OF_DISEASE,634
13658,eye,I-NAME_OF_DISEASE,634
13659,syndrome,I-NAME_OF_DISEASE,634
13660,or,O,634
13661,autoimmune,B-NAME_OF_DISEASE,634
13662,diseases,I-NAME_OF_DISEASE,634
13663,may,O,634
13664,be,O,634
13665,more,O,635
13666,at,O,635
13667,risk,O,635
13668,Symptoms,O,635
13669,Both,O,635
13670,pinguecula,B-NAME_OF_DISEASE,635
13671,and,O,635
13672,pterygium,B-NAME_OF_DISEASE,635
13673,can,O,635
13674,cause,O,635
13675,dryness,B-SIGN_AND_SYMPTOM,635
13676,redness,I-SIGN_AND_SYMPTOM,635
13677,and,I-SIGN_AND_SYMPTOM,635
13678,discomfort,I-SIGN_AND_SYMPTOM,635
13679,in,I-SIGN_AND_SYMPTOM,635
13680,the,I-SIGN_AND_SYMPTOM,635
13681,eye,I-SIGN_AND_SYMPTOM,635
13682,as,I-SIGN_AND_SYMPTOM,635
13683,well,I-SIGN_AND_SYMPTOM,635
13684,as,I-SIGN_AND_SYMPTOM,635
13685,sensitivity,I-SIGN_AND_SYMPTOM,635
13686,to,I-SIGN_AND_SYMPTOM,635
13687,light,I-SIGN_AND_SYMPTOM,635
13688,However,O,635
13689,pterygium,B-NAME_OF_DISEASE,635
13690,is,O,635
13691,more,O,635
13692,likely,O,636
13693,to,O,636
13694,cause,O,636
13695,blurred,B-SIGN_AND_SYMPTOM,636
13696,vision,I-SIGN_AND_SYMPTOM,636
13697,particularly,O,636
13698,if,O,636
13699,it,O,636
13700,grows,O,636
13701,over,O,636
13702,the,B-PART_OF_THE_EYES,636
13703,cornea,I-PART_OF_THE_EYES,636
13704,and,O,636
13705,may,O,636
13706,cause,O,636
13707,the,B-SIGN_AND_SYMPTOM,636
13708,affected,I-SIGN_AND_SYMPTOM,636
13709,eye,I-SIGN_AND_SYMPTOM,636
13710,to,I-SIGN_AND_SYMPTOM,637
13711,appear,I-SIGN_AND_SYMPTOM,637
13712,swollen,I-SIGN_AND_SYMPTOM,637
13713,and,I-SIGN_AND_SYMPTOM,637
13714,red,I-SIGN_AND_SYMPTOM,637
13715,Pinguecula,B-NAME_OF_DISEASE,637
13716,on,O,637
13717,the,O,637
13718,other,O,637
13719,hand,O,637
13720,usually,O,637
13721,does,O,637
13722,not,O,637
13723,affect,O,638
13724,vision,O,638
13725,and,O,638
13726,may,O,638
13727,not,O,638
13728,cause,O,638
13729,any,O,638
13730,symptoms,O,638
13731,at,O,638
13732,all,O,638
13733,Treatment,O,638
13734,Pinguecula,B-NAME_OF_DISEASE,638
13735,is,O,638
13736,usually,O,638
13737,a,B-SIGN_AND_SYMPTOM,638
13738,benign,I-SIGN_AND_SYMPTOM,638
13739,self-limiting,O,639
13740,condition,O,639
13741,that,O,639
13742,does,O,639
13743,not,O,639
13744,require,O,639
13745,treatment,O,639
13746,In,O,639
13747,some,O,639
13748,cases,O,639
13749,artificial,B-TREATMENT,639
13750,tears,I-TREATMENT,639
13751,or,I-TREATMENT,639
13752,eye,I-TREATMENT,639
13753,drops,I-TREATMENT,639
13754,may,O,639
13755,be,O,640
13756,used,O,640
13757,to,O,640
13758,relieve,O,640
13759,dryness,B-SIGN_AND_SYMPTOM,640
13760,and,I-SIGN_AND_SYMPTOM,640
13761,discomfort,I-SIGN_AND_SYMPTOM,640
13762,Pterygium,B-NAME_OF_DISEASE,640
13763,on,O,640
13764,the,O,640
13765,other,O,640
13766,hand,O,640
13767,may,O,640
13768,require,O,640
13769,treatment,O,640
13770,if,O,640
13771,it,O,640
13772,is,O,640
13773,causing,O,640
13774,vision,B-SIGN_AND_SYMPTOM,640
13775,problems,I-SIGN_AND_SYMPTOM,640
13776,or,I-SIGN_AND_SYMPTOM,640
13777,discomfort,I-SIGN_AND_SYMPTOM,641
13778,Treatment,O,641
13779,options,O,641
13780,may,O,641
13781,include,O,641
13782,artificial,B-TREATMENT,641
13783,tears,I-TREATMENT,641
13784,sunglasses,B-TREATMENT,641
13785,to,I-TREATMENT,641
13786,protect,I-TREATMENT,641
13787,the,I-TREATMENT,641
13788,eyes,I-TREATMENT,641
13789,from,I-TREATMENT,641
13790,UV,I-TREATMENT,641
13791,rays,I-TREATMENT,641
13792,and,O,642
13793,a,B-TREATMENT,642
13794,wide-brimmed,I-TREATMENT,642
13795,hat,I-TREATMENT,642
13796,to,O,642
13797,shade,O,642
13798,the,O,642
13799,eyes,O,642
13800,In,O,642
13801,more,O,642
13802,severe,O,642
13803,cases,O,642
13804,surgery,B-TREATMENT,642
13805,may,O,642
13806,be,O,642
13807,necessary,O,642
13808,to,O,642
13809,remove,O,642
13810,the,O,642
13811,growth,O,642
13812,and,O,643
13813,restore,O,643
13814,vision,O,643
13815,How,O,643
13816,Is,O,643
13817,Pterygium,B-NAME_OF_DISEASE,643
13818,Treatment,O,643
13819,Treatment,O,643
13820,for,O,643
13821,pterygium,B-NAME_OF_DISEASE,643
13822,depends,O,643
13823,on,O,643
13824,the,O,643
13825,severity,O,643
13826,of,O,643
13827,the,O,643
13828,condition,O,643
13829,and,O,643
13830,the,O,643
13831,symptoms,O,643
13832,it,O,643
13833,is,O,643
13834,causing,O,643
13835,Some,O,643
13836,common,O,644
13837,treatment,O,644
13838,options,O,644
13839,for,O,644
13840,pterygium,B-NAME_OF_DISEASE,644
13841,include,O,644
13842,Artificial,B-TREATMENT,644
13843,tears,I-TREATMENT,644
13844,Using,B-TREATMENT,644
13845,artificial,B-TREATMENT,644
13846,tears,I-TREATMENT,644
13847,to,I-TREATMENT,644
13848,keep,I-TREATMENT,644
13849,the,I-TREATMENT,644
13850,eyes,I-TREATMENT,644
13851,moist,I-TREATMENT,644
13852,can,O,644
13853,help,O,644
13854,to,O,644
13855,relieve,O,644
13856,dryness,B-SIGN_AND_SYMPTOM,644
13857,and,I-SIGN_AND_SYMPTOM,644
13858,discomfort,I-SIGN_AND_SYMPTOM,644
13859,Sunglasses,B-TREATMENT,644
13860,and,I-TREATMENT,644
13861,a,I-TREATMENT,644
13862,wide-brimmed,I-TREATMENT,644
13863,hat,I-TREATMENT,644
13864,Wearing,B-TREATMENT,644
13865,sunglasses,I-TREATMENT,644
13866,and,I-TREATMENT,644
13867,a,I-TREATMENT,644
13868,wide-brimmed,I-TREATMENT,644
13869,hat,I-TREATMENT,644
13870,when,I-TREATMENT,644
13871,outdoors,I-TREATMENT,644
13872,can,O,645
13873,help,O,645
13874,to,O,645
13875,protect,O,645
13876,the,O,645
13877,eyes,O,645
13878,from,O,645
13879,ultraviolet,B-CAUSE_OF_DISEASE,645
13880,UV,I-CAUSE_OF_DISEASE,645
13881,light,I-CAUSE_OF_DISEASE,645
13882,and,I-CAUSE_OF_DISEASE,645
13883,wind,I-CAUSE_OF_DISEASE,645
13884,which,O,645
13885,may,O,645
13886,help,O,645
13887,to,O,645
13888,prevent,O,645
13889,the,O,645
13890,pterygium,B-NAME_OF_DISEASE,645
13891,from,O,645
13892,growing,O,645
13893,or,O,646
13894,recurring,O,646
13895,Corticosteroid,B-NAME_OF_DRUG,646
13896,eye,I-NAME_OF_DRUG,646
13897,drops,I-NAME_OF_DRUG,646
13898,In,O,646
13899,some,O,646
13900,cases,O,646
13901,corticosteroid,B-NAME_OF_DRUG,646
13902,eye,I-NAME_OF_DRUG,646
13903,drops,I-NAME_OF_DRUG,646
13904,may,O,646
13905,be,O,646
13906,prescribed,O,646
13907,to,O,646
13908,reduce,O,646
13909,inflammation,B-SIGN_AND_SYMPTOM,646
13910,and,O,646
13911,prevent,O,646
13912,the,O,646
13913,pterygium,B-NAME_OF_DISEASE,646
13914,from,O,646
13915,growing,O,646
13916,Surgery,B-TREATMENT,646
13917,If,O,646
13918,the,O,646
13919,pterygium,B-NAME_OF_DISEASE,646
13920,is,O,646
13921,causing,O,646
13922,vision,B-SIGN_AND_SYMPTOM,646
13923,problems,I-SIGN_AND_SYMPTOM,647
13924,or,I-SIGN_AND_SYMPTOM,647
13925,discomfort,I-SIGN_AND_SYMPTOM,647
13926,or,O,647
13927,if,O,647
13928,it,O,647
13929,has,O,647
13930,not,O,647
13931,responded,O,647
13932,to,O,647
13933,other,O,647
13934,treatments,O,647
13935,surgery,B-TREATMENT,647
13936,may,O,647
13937,be,O,647
13938,necessary,O,647
13939,to,O,647
13940,remove,O,647
13941,the,O,647
13942,growth,O,647
13943,and,O,647
13944,restore,O,647
13945,vision,O,648
13946,There,O,648
13947,are,O,648
13948,several,O,648
13949,different,O,648
13950,surgical,O,648
13951,techniques,O,648
13952,that,O,648
13953,can,O,648
13954,be,O,648
13955,used,O,648
13956,to,O,648
13957,remove,O,648
13958,pterygium,B-NAME_OF_DISEASE,648
13959,including,O,648
13960,simple,B-TREATMENT,648
13961,excision,I-TREATMENT,648
13962,conjunctival,B-TREATMENT,648
13963,autograft,I-TREATMENT,648
13964,and,O,648
13965,amniotic,B-TREATMENT,648
13966,membrane,I-TREATMENT,648
13967,grafting,I-TREATMENT,648
13968,It,O,648
13969,is,O,648
13970,important,O,648
13971,to,O,648
13972,see,O,648
13973,an,O,649
13974,eye,O,649
13975,doctor,O,649
13976,for,O,649
13977,a,O,649
13978,proper,O,649
13979,diagnosis,O,649
13980,and,O,649
13981,treatment,O,649
13982,if,O,649
13983,you,O,649
13984,are,O,649
13985,experiencing,O,649
13986,symptoms,O,649
13987,of,O,649
13988,pterygium,B-NAME_OF_DISEASE,649
13989,such,O,649
13990,as,O,649
13991,dryness,B-SIGN_AND_SYMPTOM,649
13992,redness,I-SIGN_AND_SYMPTOM,649
13993,or,I-SIGN_AND_SYMPTOM,649
13994,blurred,I-SIGN_AND_SYMPTOM,649
13995,vision,I-SIGN_AND_SYMPTOM,649
13996,The,O,650
13997,eye,O,650
13998,doctor,O,650
13999,will,O,650
14000,be,O,650
14001,able,O,650
14002,to,O,650
14003,recommend,O,650
14004,the,O,650
14005,best,O,650
14006,treatment,O,650
14007,plan,O,650
14008,based,O,650
14009,on,O,650
14010,the,O,650
14011,severity,O,650
14012,of,O,650
14013,your,O,650
14014,condition,O,650
14015,and,O,650
14016,your,O,650
14017,specific,O,650
14018,needs,O,650
14019,Do,O,650
14020,I,O,650
14021,need,O,650
14022,Pterygium,B-TREATMENT,650
14023,Surgery,I-TREATMENT,650
14024,Pterygium,B-TREATMENT,650
14025,surgery,I-TREATMENT,650
14026,may,O,650
14027,be,O,650
14028,recommended,O,650
14029,if,O,650
14030,the,O,650
14031,pterygium,B-NAME_OF_DISEASE,650
14032,is,O,650
14033,causing,O,650
14034,vision,B-SIGN_AND_SYMPTOM,650
14035,problems,I-SIGN_AND_SYMPTOM,651
14036,or,I-SIGN_AND_SYMPTOM,651
14037,discomfort,I-SIGN_AND_SYMPTOM,651
14038,or,O,651
14039,if,O,651
14040,it,O,651
14041,has,O,651
14042,not,O,651
14043,responded,O,651
14044,to,O,651
14045,other,O,651
14046,treatments,O,651
14047,such,O,651
14048,as,O,651
14049,the,O,651
14050,use,O,651
14051,of,O,651
14052,artificial,B-TREATMENT,651
14053,tears,I-TREATMENT,651
14054,or,O,651
14055,corticosteroid,B-NAME_OF_DRUG,652
14056,eye,I-NAME_OF_DRUG,652
14057,drops,I-NAME_OF_DRUG,652
14058,Color,B-NAME_OF_DISEASE,652
14059,blindness,I-NAME_OF_DISEASE,652
14060,also,O,652
14061,known,O,652
14062,as,O,652
14063,color,B-NAME_OF_DISEASE,652
14064,vision,I-NAME_OF_DISEASE,652
14065,deficiency,I-NAME_OF_DISEASE,652
14066,is,O,652
14067,a,O,652
14068,condition,O,652
14069,in,O,652
14070,which,O,652
14071,an,O,652
14072,individual,O,652
14073,has,B-SIGN_AND_SYMPTOM,653
14074,difficulty,I-SIGN_AND_SYMPTOM,653
14075,distinguishing,I-SIGN_AND_SYMPTOM,653
14076,certain,I-SIGN_AND_SYMPTOM,653
14077,colors,I-SIGN_AND_SYMPTOM,653
14078,While,O,653
14079,it,O,653
14080,is,O,653
14081,more,O,653
14082,common,O,653
14083,in,O,653
14084,men,O,653
14085,than,O,654
14086,women,O,654
14087,it,O,654
14088,can,O,654
14089,affect,O,654
14090,people,O,654
14091,of,O,654
14092,all,O,654
14093,ages,O,654
14094,and,O,654
14095,races,O,654
14096,There,O,654
14097,are,O,654
14098,three,O,654
14099,main,O,654
14100,types,O,654
14101,of,O,654
14102,color,B-NAME_OF_DISEASE,654
14103,blindness,I-NAME_OF_DISEASE,654
14104,protanopia,B-NAME_OF_DISEASE,654
14105,deuteranopia,B-NAME_OF_DISEASE,654
14106,and,O,654
14107,tritanopia,B-NAME_OF_DISEASE,654
14108,Protanopia,B-NAME_OF_DISEASE,654
14109,is,O,654
14110,a,B-SIGN_AND_SYMPTOM,654
14111,lack,I-SIGN_AND_SYMPTOM,654
14112,of,I-SIGN_AND_SYMPTOM,654
14113,sensitivity,I-SIGN_AND_SYMPTOM,655
14114,to,I-SIGN_AND_SYMPTOM,655
14115,red,I-SIGN_AND_SYMPTOM,655
14116,light,I-SIGN_AND_SYMPTOM,655
14117,deuteranopia,B-NAME_OF_DISEASE,655
14118,is,O,655
14119,a,B-SIGN_AND_SYMPTOM,655
14120,lack,I-SIGN_AND_SYMPTOM,655
14121,of,I-SIGN_AND_SYMPTOM,655
14122,sensitivity,I-SIGN_AND_SYMPTOM,655
14123,to,I-SIGN_AND_SYMPTOM,655
14124,green,I-SIGN_AND_SYMPTOM,655
14125,light,I-SIGN_AND_SYMPTOM,655
14126,and,O,655
14127,tritanopia,B-NAME_OF_DISEASE,655
14128,is,O,655
14129,a,B-SIGN_AND_SYMPTOM,655
14130,lack,I-SIGN_AND_SYMPTOM,655
14131,of,I-SIGN_AND_SYMPTOM,655
14132,sensitivity,I-SIGN_AND_SYMPTOM,655
14133,to,I-SIGN_AND_SYMPTOM,656
14134,blue,I-SIGN_AND_SYMPTOM,656
14135,light,I-SIGN_AND_SYMPTOM,656
14136,People,O,656
14137,with,O,656
14138,these,O,656
14139,conditions,O,656
14140,may,O,656
14141,have,B-SIGN_AND_SYMPTOM,656
14142,trouble,I-SIGN_AND_SYMPTOM,656
14143,distinguishing,I-SIGN_AND_SYMPTOM,656
14144,between,I-SIGN_AND_SYMPTOM,656
14145,certain,I-SIGN_AND_SYMPTOM,656
14146,colors,I-SIGN_AND_SYMPTOM,656
14147,such,I-SIGN_AND_SYMPTOM,656
14148,as,I-SIGN_AND_SYMPTOM,656
14149,red,I-SIGN_AND_SYMPTOM,656
14150,and,I-SIGN_AND_SYMPTOM,656
14151,green,I-SIGN_AND_SYMPTOM,656
14152,or,I-SIGN_AND_SYMPTOM,656
14153,blue,I-SIGN_AND_SYMPTOM,656
14154,and,I-SIGN_AND_SYMPTOM,656
14155,yellow,I-SIGN_AND_SYMPTOM,656
14156,How,O,656
14157,Do,O,656
14158,They,O,657
14159,Work,O,657
14160,One,O,657
14161,way,O,657
14162,that,O,657
14163,people,O,657
14164,with,O,657
14165,color,B-NAME_OF_DISEASE,657
14166,blindness,I-NAME_OF_DISEASE,657
14167,can,O,657
14168,improve,O,657
14169,their,O,657
14170,ability,O,657
14171,to,O,657
14172,see,O,657
14173,colors,O,657
14174,is,O,657
14175,through,O,658
14176,the,O,658
14177,use,O,658
14178,of,O,658
14179,contact,B-TREATMENT,658
14180,lenses,I-TREATMENT,658
14181,Contact,B-TREATMENT,658
14182,lenses,I-TREATMENT,658
14183,for,O,658
14184,color,B-NAME_OF_DISEASE,658
14185,blindness,I-NAME_OF_DISEASE,658
14186,work,O,658
14187,by,O,658
14188,filtering,O,658
14189,out,O,658
14190,certain,O,658
14191,wavelengths,O,658
14192,of,O,658
14193,light,O,658
14194,to,O,658
14195,improve,O,658
14196,color,O,659
14197,perception,O,659
14198,These,O,659
14199,lenses,O,659
14200,are,O,659
14201,not,O,659
14202,a,O,659
14203,cure,O,659
14204,for,O,659
14205,color,B-NAME_OF_DISEASE,659
14206,blindness,I-NAME_OF_DISEASE,659
14207,but,O,659
14208,they,O,659
14209,can,O,659
14210,help,O,660
14211,people,O,660
14212,with,O,660
14213,the,O,660
14214,condition,O,660
14215,see,O,660
14216,colors,O,660
14217,more,O,660
14218,accurately,O,660
14219,There,O,660
14220,are,O,660
14221,two,O,660
14222,main,O,660
14223,types,O,660
14224,of,O,660
14225,contact,B-TREATMENT,660
14226,lenses,I-TREATMENT,660
14227,for,O,660
14228,color,B-NAME_OF_DISEASE,660
14229,blindness,I-NAME_OF_DISEASE,660
14230,chromatic,O,660
14231,and,O,660
14232,anomalous,O,660
14233,Chromatic,B-TREATMENT,660
14234,lenses,I-TREATMENT,660
14235,are,O,661
14236,designed,O,661
14237,to,O,661
14238,correct,O,661
14239,red-green,B-NAME_OF_DISEASE,661
14240,color,I-NAME_OF_DISEASE,661
14241,blindness,I-NAME_OF_DISEASE,661
14242,and,O,661
14243,are,O,661
14244,made,O,661
14245,from,O,661
14246,a,O,661
14247,special,O,661
14248,pigment,O,661
14249,that,O,661
14250,absorbs,O,661
14251,light,O,661
14252,in,O,661
14253,the,O,661
14254,red,O,661
14255,and,O,661
14256,green,O,661
14257,wavelengths,O,661
14258,Anomalous,B-TREATMENT,662
14259,lenses,I-TREATMENT,662
14260,on,O,662
14261,the,O,662
14262,other,O,662
14263,hand,O,662
14264,are,O,662
14265,designed,O,662
14266,to,O,662
14267,correct,O,662
14268,for,O,662
14269,blue-yellow,B-NAME_OF_DISEASE,662
14270,color,I-NAME_OF_DISEASE,662
14271,blindness,I-NAME_OF_DISEASE,662
14272,and,O,662
14273,work,O,662
14274,by,O,662
14275,blocking,O,662
14276,certain,O,662
14277,wavelengths,O,662
14278,of,O,662
14279,blue,O,662
14280,light,O,663
14281,Both,O,663
14282,types,O,663
14283,of,O,663
14284,lenses,O,663
14285,are,O,663
14286,typically,O,663
14287,made,O,663
14288,from,O,663
14289,a,O,663
14290,soft,O,663
14291,flexible,O,663
14292,material,O,663
14293,that,O,663
14294,is,O,664
14295,comfortable,O,664
14296,to,O,664
14297,wear,O,664
14298,and,O,664
14299,easy,O,664
14300,to,O,664
14301,care,O,664
14302,for,O,664
14303,They,O,664
14304,are,O,664
14305,also,O,664
14306,available,O,664
14307,in,O,664
14308,a,O,664
14309,range,O,664
14310,of,O,664
14311,prescriptions,O,664
14312,to,O,664
14313,suit,O,664
14314,different,O,664
14315,vision,O,664
14316,needs,O,664
14317,They,O,664
14318,Are,O,664
14319,Effective,O,664
14320,But,O,664
14321,Don,O,664
14322,t,O,664
14323,Offer,O,664
14324,Permanent,O,665
14325,Solution,O,665
14326,While,O,665
14327,contact,B-TREATMENT,665
14328,lenses,I-TREATMENT,665
14329,for,O,665
14330,color,B-NAME_OF_DISEASE,665
14331,blindness,I-NAME_OF_DISEASE,665
14332,can,O,665
14333,be,O,665
14334,effective,O,665
14335,in,O,665
14336,improving,O,665
14337,color,O,665
14338,perception,O,665
14339,they,O,665
14340,are,O,665
14341,not,O,665
14342,a,O,665
14343,cure,O,666
14344,for,O,666
14345,the,O,666
14346,condition,O,666
14347,They,O,666
14348,may,O,666
14349,also,O,666
14350,not,O,666
14351,be,O,666
14352,suitable,O,666
14353,for,O,666
14354,everyone,O,666
14355,as,O,666
14356,some,O,666
14357,people,O,666
14358,may,O,666
14359,experience,O,666
14360,discomfort,O,666
14361,or,O,666
14362,irritation,O,666
14363,when,O,666
14364,wearing,O,666
14365,them,O,666
14366,It,O,666
14367,is,O,667
14368,important,O,667
14369,to,O,667
14370,consult,O,667
14371,with,O,667
14372,an,O,667
14373,eye,O,667
14374,care,O,667
14375,professional,O,667
14376,before,O,667
14377,using,O,667
14378,these,O,667
14379,lenses,O,667
14380,to,O,667
14381,determine,O,667
14382,whether,O,667
14383,they,O,667
14384,are,O,667
14385,the,O,667
14386,right,O,667
14387,choice,O,667
14388,for,O,668
14389,you,O,668
14390,In,O,668
14391,addition,O,668
14392,to,O,668
14393,contact,B-TREATMENT,668
14394,lenses,I-TREATMENT,668
14395,there,O,668
14396,are,O,668
14397,also,O,668
14398,other,O,668
14399,methods,O,668
14400,that,O,668
14401,can,O,668
14402,help,O,668
14403,improve,O,668
14404,color,O,668
14405,perception,O,668
14406,in,O,668
14407,people,O,669
14408,with,O,669
14409,color,B-NAME_OF_DISEASE,669
14410,blindness,I-NAME_OF_DISEASE,669
14411,These,O,669
14412,include,O,669
14413,color,B-TREATMENT,669
14414,filters,I-TREATMENT,669
14415,specialized,B-TREATMENT,669
14416,glasses,B-TREATMENT,669
14417,and,O,669
14418,computer,B-TREATMENT,669
14419,software,I-TREATMENT,669
14420,that,I-TREATMENT,669
14421,can,I-TREATMENT,669
14422,help,I-TREATMENT,669
14423,adjust,I-TREATMENT,669
14424,the,I-TREATMENT,670
14425,colors,I-TREATMENT,670
14426,on,I-TREATMENT,670
14427,a,I-TREATMENT,670
14428,computer,I-TREATMENT,670
14429,screen,I-TREATMENT,670
14430,Special,B-TREATMENT,670
14431,glasses,B-TREATMENT,670
14432,for,O,670
14433,color,B-NAME_OF_DISEASE,670
14434,blindness,I-NAME_OF_DISEASE,670
14435,are,O,670
14436,designed,O,670
14437,to,O,670
14438,help,O,670
14439,individuals,O,670
14440,with,O,670
14441,this,O,670
14442,condition,O,671
14443,perceive,O,671
14444,colors,O,671
14445,more,O,671
14446,accurately,O,671
14447,These,O,671
14448,glasses,B-TREATMENT,671
14449,use,O,671
14450,filters,O,671
14451,to,O,671
14452,selectively,O,671
14453,block,O,671
14454,certain,O,671
14455,wavelengths,O,671
14456,of,O,671
14457,light,O,671
14458,and,O,671
14459,enhance,O,671
14460,the,O,671
14461,contrast,O,671
14462,between,O,671
14463,different,O,671
14464,colors,O,671
14465,Enchroma,B-TREATMENT,671
14466,glasses,B-TREATMENT,671
14467,These,O,671
14468,glasses,B-TREATMENT,671
14469,use,O,671
14470,special,O,672
14471,filters,O,672
14472,to,O,672
14473,enhance,O,672
14474,the,O,672
14475,contrast,O,672
14476,between,O,672
14477,red,O,672
14478,and,O,672
14479,green,O,672
14480,which,O,672
14481,can,O,672
14482,help,O,672
14483,individuals,O,672
14484,with,O,672
14485,red-green,B-NAME_OF_DISEASE,672
14486,color,I-NAME_OF_DISEASE,672
14487,blindness,I-NAME_OF_DISEASE,672
14488,better,O,672
14489,distinguish,O,672
14490,between,O,672
14491,these,O,672
14492,colors,O,672
14493,Chromagen,B-TREATMENT,673
14494,glasses,B-TREATMENT,673
14495,These,O,673
14496,glasses,B-TREATMENT,673
14497,use,O,673
14498,lenses,B-TREATMENT,673
14499,with,I-TREATMENT,673
14500,a,I-TREATMENT,673
14501,red,I-TREATMENT,673
14502,filter,I-TREATMENT,673
14503,to,O,673
14504,help,O,673
14505,individuals,O,673
14506,with,O,673
14507,red-green,B-NAME_OF_DISEASE,673
14508,color,I-NAME_OF_DISEASE,673
14509,blindness,I-NAME_OF_DISEASE,673
14510,see,O,673
14511,red,O,673
14512,and,O,673
14513,green,O,673
14514,more,O,674
14515,accurately,O,674
14516,Color,B-TREATMENT,674
14517,correction,I-TREATMENT,674
14518,glasses,B-TREATMENT,674
14519,These,O,674
14520,glasses,B-TREATMENT,674
14521,use,O,674
14522,a,O,674
14523,combination,O,674
14524,of,O,674
14525,filters,O,674
14526,to,O,674
14527,help,O,674
14528,individuals,O,674
14529,with,O,674
14530,color,B-NAME_OF_DISEASE,674
14531,blindness,I-NAME_OF_DISEASE,674
14532,see,O,674
14533,all,O,674
14534,colors,O,675
14535,more,O,675
14536,accurately,O,675
14537,It,O,675
14538,is,O,675
14539,important,O,675
14540,to,O,675
14541,note,O,675
14542,that,O,675
14543,contact,B-TREATMENT,675
14544,lenses,I-TREATMENT,675
14545,or,O,675
14546,glasses,B-TREATMENT,675
14547,for,O,675
14548,color,B-NAME_OF_DISEASE,675
14549,blindness,I-NAME_OF_DISEASE,675
14550,are,O,675
14551,not,O,675
14552,a,O,675
14553,cure,O,675
14554,for,O,675
14555,color,B-NAME_OF_DISEASE,675
14556,deficiency,I-NAME_OF_DISEASE,676
14557,They,O,676
14558,can,O,676
14559,however,O,676
14560,greatly,O,676
14561,improve,O,676
14562,an,O,676
14563,individual,O,676
14564,s,O,676
14565,ability,O,676
14566,to,O,676
14567,perceive,O,676
14568,colors,O,676
14569,and,O,676
14570,can,O,676
14571,make,O,676
14572,a,O,676
14573,significant,O,676
14574,difference,O,676
14575,in,O,676
14576,their,O,676
14577,daily,O,676
14578,life,O,677
14579,Intraocular,B-TREATMENT,677
14580,lens,I-TREATMENT,677
14581,IOL,I-TREATMENT,677
14582,implantation,I-TREATMENT,677
14583,is,O,677
14584,a,O,677
14585,surgical,O,677
14586,procedure,O,677
14587,in,O,677
14588,which,O,677
14589,a,O,677
14590,lens,O,677
14591,is,O,677
14592,implanted,O,677
14593,inside,O,677
14594,the,O,677
14595,eye,O,677
14596,to,O,677
14597,replace,O,677
14598,the,B-PART_OF_THE_EYES,677
14599,natural,I-PART_OF_THE_EYES,677
14600,lens,I-PART_OF_THE_EYES,677
14601,IOL,B-TREATMENT,678
14602,implantation,I-TREATMENT,678
14603,is,O,678
14604,usually,O,678
14605,performed,O,678
14606,to,O,678
14607,correct,O,678
14608,vision,O,678
14609,problems,O,678
14610,such,O,678
14611,as,O,678
14612,nearsightedness,B-NAME_OF_DISEASE,678
14613,farsightedness,B-NAME_OF_DISEASE,678
14614,and,O,678
14615,astigmatism,B-NAME_OF_DISEASE,678
14616,or,O,679
14617,to,O,679
14618,replace,O,679
14619,a,O,679
14620,cloudy,O,679
14621,lens,O,679
14622,cataract,B-NAME_OF_DISEASE,679
14623,,O,679
14624,There,O,679
14625,are,O,679
14626,several,O,679
14627,types,O,679
14628,of,O,679
14629,IOLs,B-TREATMENT,679
14630,available,O,679
14631,including,O,679
14632,standard,B-TREATMENT,679
14633,IOLs,B-TREATMENT,680
14634,premium,B-TREATMENT,680
14635,IOLs,I-TREATMENT,680
14636,and,O,680
14637,accommodating,B-TREATMENT,680
14638,IOLs,B-TREATMENT,680
14639,Pros,O,680
14640,of,O,680
14641,IOL,B-TREATMENT,680
14642,implantation,I-TREATMENT,680
14643,Improved,O,680
14644,vision,O,680
14645,One,O,680
14646,of,O,680
14647,the,O,680
14648,main,O,680
14649,benefits,O,680
14650,of,O,680
14651,IOL,B-TREATMENT,680
14652,implantation,I-TREATMENT,681
14653,is,O,681
14654,improved,O,681
14655,vision,O,681
14656,After,O,681
14657,surgery,O,681
14658,most,O,681
14659,people,O,681
14660,experience,O,681
14661,a,O,681
14662,significant,O,681
14663,improvement,O,681
14664,in,O,681
14665,their,O,682
14666,vision,O,682
14667,with,O,682
14668,some,O,682
14669,achieving,O,682
14670,20,O,682
14671,20,O,682
14672,vision,O,682
14673,or,O,682
14674,better,O,682
14675,This,O,682
14676,can,O,682
14677,greatly,O,682
14678,improve,O,682
14679,daily,O,682
14680,activities,O,682
14681,such,O,682
14682,as,O,682
14683,reading,O,682
14684,driving,O,682
14685,and,O,682
14686,watching,O,682
14687,television,O,682
14688,No,O,682
14689,need,O,683
14690,for,O,683
14691,glasses,B-TREATMENT,683
14692,or,O,683
14693,contacts,B-TREATMENT,683
14694,Many,O,683
14695,people,O,683
14696,who,O,683
14697,undergo,O,683
14698,IOL,B-TREATMENT,683
14699,implantation,I-TREATMENT,683
14700,are,O,683
14701,able,O,683
14702,to,O,683
14703,completely,O,683
14704,eliminate,O,684
14705,their,O,684
14706,need,O,684
14707,for,O,684
14708,glasses,B-TREATMENT,684
14709,or,O,684
14710,contact,B-TREATMENT,684
14711,lenses,I-TREATMENT,684
14712,This,O,684
14713,can,O,684
14714,be,O,684
14715,a,O,684
14716,major,O,684
14717,convenience,O,684
14718,and,O,684
14719,may,O,684
14720,also,O,684
14721,save,O,684
14722,money,O,684
14723,in,O,684
14724,the,O,684
14725,long,O,684
14726,run,O,684
14727,Quick,O,684
14728,recovery,O,684
14729,IOL,B-TREATMENT,685
14730,implantation,I-TREATMENT,685
14731,is,O,685
14732,generally,O,685
14733,a,O,685
14734,quick,O,685
14735,and,O,685
14736,straightforward,O,685
14737,procedure,O,685
14738,with,O,685
14739,most,O,685
14740,people,O,685
14741,able,O,685
14742,to,O,685
14743,return,O,685
14744,to,O,685
14745,their,O,685
14746,normal,O,686
14747,activities,O,686
14748,within,O,686
14749,a,O,686
14750,few,O,686
14751,days,O,686
14752,In,O,686
14753,addition,O,686
14754,the,O,686
14755,recovery,O,686
14756,process,O,686
14757,is,O,686
14758,usually,O,686
14759,relatively,O,686
14760,painless,O,686
14761,with,O,686
14762,only,O,686
14763,mild,O,686
14764,discomfort,O,686
14765,reported,O,687
14766,by,O,687
14767,most,O,687
14768,patients,O,687
14769,Long-lasting,O,687
14770,results,O,687
14771,IOLs,B-TREATMENT,687
14772,are,O,687
14773,designed,O,687
14774,to,O,687
14775,be,O,687
14776,long-lasting,O,687
14777,with,O,687
14778,most,O,687
14779,lasting,O,687
14780,for,O,688
14781,several,O,688
14782,decades,O,688
14783,before,O,688
14784,needing,O,688
14785,to,O,688
14786,be,O,688
14787,replaced,O,688
14788,This,O,688
14789,means,O,688
14790,that,O,688
14791,the,O,688
14792,benefits,O,688
14793,of,O,688
14794,IOL,B-TREATMENT,688
14795,implantation,I-TREATMENT,688
14796,are,O,688
14797,likely,O,688
14798,to,O,688
14799,last,O,688
14800,for,O,688
14801,many,O,688
14802,years,O,688
14803,Cons,O,688
14804,of,O,688
14805,IOL,B-TREATMENT,689
14806,implantation,I-TREATMENT,689
14807,Risk,O,689
14808,of,O,689
14809,complications,O,689
14810,As,O,689
14811,with,O,689
14812,any,O,689
14813,surgery,O,689
14814,there,O,689
14815,is,O,689
14816,a,O,689
14817,risk,O,689
14818,of,O,690
14819,complications,O,690
14820,with,O,690
14821,IOL,B-TREATMENT,690
14822,implantation,I-TREATMENT,690
14823,including,O,690
14824,infection,B-SIGN_AND_SYMPTOM,690
14825,inflammation,I-SIGN_AND_SYMPTOM,690
14826,and,I-SIGN_AND_SYMPTOM,690
14827,bleeding,I-SIGN_AND_SYMPTOM,690
14828,In,O,690
14829,rare,O,690
14830,cases,O,690
14831,the,B-TREATMENT,690
14832,IOL,I-TREATMENT,690
14833,may,O,691
14834,become,O,691
14835,dislocated,O,691
14836,or,O,691
14837,damaged,O,691
14838,requiring,O,691
14839,additional,O,691
14840,surgery,O,691
14841,Limited,O,691
14842,visual,O,691
14843,range,O,691
14844,Standard,B-TREATMENT,691
14845,IOLs,B-TREATMENT,691
14846,can,O,691
14847,only,O,691
14848,correct,O,691
14849,for,O,691
14850,one,O,691
14851,distance,O,691
14852,either,O,691
14853,near,O,691
14854,or,O,691
14855,far,O,691
14856,This,O,691
14857,means,O,692
14858,that,O,692
14859,people,O,692
14860,who,O,692
14861,have,O,692
14862,IOLs,B-TREATMENT,692
14863,may,O,692
14864,still,O,692
14865,need,O,692
14866,glasses,B-TREATMENT,692
14867,or,O,692
14868,contact,B-TREATMENT,692
14869,lenses,I-TREATMENT,692
14870,for,O,692
14871,certain,O,692
14872,activities,O,692
14873,such,O,692
14874,as,O,692
14875,reading,O,692
14876,or,O,693
14877,driving,O,693
14878,at,O,693
14879,night,O,693
14880,Vision,O,693
14881,problems,O,693
14882,In,O,693
14883,some,O,693
14884,cases,O,693
14885,IOL,B-TREATMENT,693
14886,implantation,I-TREATMENT,693
14887,may,O,693
14888,result,O,693
14889,in,O,693
14890,vision,B-SIGN_AND_SYMPTOM,693
14891,problems,I-SIGN_AND_SYMPTOM,693
14892,such,I-SIGN_AND_SYMPTOM,693
14893,as,I-SIGN_AND_SYMPTOM,693
14894,glare,I-SIGN_AND_SYMPTOM,693
14895,halos,I-SIGN_AND_SYMPTOM,694
14896,or,I-SIGN_AND_SYMPTOM,694
14897,double,I-SIGN_AND_SYMPTOM,694
14898,vision,I-SIGN_AND_SYMPTOM,694
14899,These,O,694
14900,issues,O,694
14901,may,O,694
14902,be,O,694
14903,temporary,O,694
14904,or,O,694
14905,permanent,O,694
14906,and,O,694
14907,they,O,694
14908,may,O,694
14909,require,O,694
14910,additional,O,694
14911,treatment,O,694
14912,such,O,694
14913,as,O,694
14914,glasses,B-TREATMENT,694
14915,or,O,694
14916,further,B-TREATMENT,694
14917,surgery,I-TREATMENT,694
14918,Cost,O,694
14919,IOL,B-TREATMENT,694
14920,implantation,I-TREATMENT,694
14921,can,O,695
14922,be,O,695
14923,expensive,O,695
14924,and,O,695
14925,it,O,695
14926,is,O,695
14927,generally,O,695
14928,not,O,695
14929,covered,O,695
14930,by,O,695
14931,insurance,O,695
14932,unless,O,695
14933,it,O,695
14934,is,O,695
14935,medically,O,695
14936,necessary,O,695
14937,such,O,695
14938,as,O,695
14939,in,O,695
14940,the,O,695
14941,case,O,695
14942,of,O,695
14943,cataracts,B-NAME_OF_DISEASE,695
14944,Are,O,696
14945,You,O,696
14946,a,O,696
14947,Good,O,696
14948,Candidate,O,696
14949,for,O,696
14950,IOL,B-TREATMENT,696
14951,Implantation,I-TREATMENT,696
14952,There,O,696
14953,are,O,696
14954,several,O,696
14955,factors,O,696
14956,that,O,696
14957,can,O,696
14958,determine,O,696
14959,whether,O,696
14960,you,O,696
14961,are,O,696
14962,a,O,696
14963,candidate,O,696
14964,for,O,696
14965,IOL,B-TREATMENT,696
14966,implantation,I-TREATMENT,696
14967,These,O,696
14968,include,O,696
14969,Age,O,696
14970,IOL,B-TREATMENT,696
14971,implantation,I-TREATMENT,696
14972,is,O,696
14973,typically,O,697
14974,recommended,O,697
14975,for,O,697
14976,people,O,697
14977,over,O,697
14978,the,O,697
14979,age,O,697
14980,of,O,697
14981,50,O,697
14982,who,O,697
14983,have,O,697
14984,cataracts,B-NAME_OF_DISEASE,697
14985,or,O,697
14986,other,O,697
14987,conditions,O,697
14988,that,O,697
14989,affect,O,697
14990,the,B-PART_OF_THE_EYES,698
14991,natural,I-PART_OF_THE_EYES,698
14992,lens,I-PART_OF_THE_EYES,698
14993,of,I-PART_OF_THE_EYES,698
14994,the,I-PART_OF_THE_EYES,698
14995,eye,I-PART_OF_THE_EYES,698
14996,Health,O,698
14997,In,O,698
14998,order,O,698
14999,to,O,698
15000,be,O,698
15001,a,O,698
15002,candidate,O,698
15003,for,O,698
15004,IOL,B-TREATMENT,698
15005,implantation,I-TREATMENT,698
15006,you,O,699
15007,must,O,699
15008,be,O,699
15009,in,O,699
15010,good,O,699
15011,overall,O,699
15012,health,O,699
15013,This,O,699
15014,is,O,699
15015,because,O,699
15016,the,O,699
15017,procedure,O,699
15018,requires,O,699
15019,general,O,699
15020,anesthesia,O,699
15021,and,O,699
15022,involves,O,699
15023,making,O,699
15024,an,O,699
15025,incision,O,699
15026,in,O,699
15027,the,O,699
15028,eye,O,700
15029,Vision,O,700
15030,If,O,700
15031,you,O,700
15032,have,O,700
15033,vision,O,700
15034,that,O,700
15035,cannot,O,700
15036,be,O,700
15037,corrected,O,700
15038,with,O,700
15039,glasses,B-TREATMENT,700
15040,or,O,700
15041,contact,B-TREATMENT,700
15042,lenses,B-TREATMENT,700
15043,you,O,700
15044,may,O,700
15045,be,O,700
15046,a,O,700
15047,candidate,O,700
15048,for,O,700
15049,IOL,B-TREATMENT,700
15050,implantation,I-TREATMENT,700
15051,Lifestyle,O,700
15052,If,O,700
15053,you,O,700
15054,are,O,700
15055,someone,O,700
15056,who,O,700
15057,is,O,700
15058,active,O,700
15059,and,O,700
15060,engaged,O,700
15061,in,O,700
15062,outdoor,O,700
15063,activities,O,700
15064,you,O,701
15065,may,O,701
15066,be,O,701
15067,a,O,701
15068,good,O,701
15069,candidate,O,701
15070,for,O,701
15071,IOL,B-TREATMENT,701
15072,implantation,I-TREATMENT,701
15073,because,O,701
15074,these,O,701
15075,lenses,B-TREATMENT,701
15076,are,O,701
15077,resistant,O,701
15078,to,O,702
15079,glare,O,702
15080,and,O,702
15081,can,O,702
15082,improve,O,702
15083,vision,O,702
15084,in,O,702
15085,bright,O,702
15086,light,O,702
15087,Expectations,O,702
15088,It,O,702
15089,s,O,702
15090,important,O,702
15091,to,O,703
15092,have,O,703
15093,realistic,O,703
15094,expectations,O,703
15095,about,O,703
15096,the,O,703
15097,outcome,O,703
15098,of,O,703
15099,IOL,B-TREATMENT,703
15100,implantation,I-TREATMENT,703
15101,While,O,703
15102,these,O,703
15103,lenses,B-TREATMENT,703
15104,can,O,703
15105,significantly,O,703
15106,improve,O,703
15107,vision,O,703
15108,they,O,703
15109,may,O,703
15110,not,O,703
15111,restore,O,703
15112,perfect,O,703
15113,vision,O,703
15114,Overall,O,703
15115,IOL,B-TREATMENT,703
15116,implantation,I-TREATMENT,704
15117,can,O,704
15118,be,O,704
15119,a,O,704
15120,good,O,704
15121,option,O,704
15122,for,O,704
15123,people,O,704
15124,who,O,704
15125,want,O,704
15126,to,O,704
15127,improve,O,704
15128,their,O,704
15129,vision,O,704
15130,and,O,704
15131,reduce,O,704
15132,their,O,704
15133,dependence,O,704
15134,on,O,704
15135,glasses,B-TREATMENT,705
15136,or,O,705
15137,contact,B-TREATMENT,705
15138,lenses,B-TREATMENT,705
15139,However,O,705
15140,it,O,705
15141,is,O,705
15142,important,O,705
15143,to,O,705
15144,carefully,O,705
15145,consider,O,705
15146,the,O,705
15147,potential,O,705
15148,risks,O,705
15149,and,O,705
15150,limitations,O,705
15151,of,O,705
15152,the,O,705
15153,procedure,O,705
15154,before,O,705
15155,making,O,706
15156,a,O,706
15157,decision,O,706
15158,Staphyloma,B-NAME_OF_DISEASE,706
15159,is,O,706
15160,a,B-SIGN_AND_SYMPTOM,706
15161,bulging,I-SIGN_AND_SYMPTOM,706
15162,or,I-SIGN_AND_SYMPTOM,706
15163,protrusion,I-SIGN_AND_SYMPTOM,706
15164,of,I-SIGN_AND_SYMPTOM,706
15165,the,I-SIGN_AND_SYMPTOM,706
15166,eye,I-SIGN_AND_SYMPTOM,706
15167,s,I-SIGN_AND_SYMPTOM,706
15168,inner,I-SIGN_AND_SYMPTOM,706
15169,layers,I-SIGN_AND_SYMPTOM,706
15170,through,I-SIGN_AND_SYMPTOM,706
15171,a,I-SIGN_AND_SYMPTOM,706
15172,thinned,I-SIGN_AND_SYMPTOM,706
15173,area,I-SIGN_AND_SYMPTOM,706
15174,of,I-SIGN_AND_SYMPTOM,706
15175,the,I-SIGN_AND_SYMPTOM,706
15176,outer,I-SIGN_AND_SYMPTOM,707
15177,layers,I-SIGN_AND_SYMPTOM,707
15178,It,O,707
15179,is,O,707
15180,typically,O,707
15181,caused,O,707
15182,by,O,707
15183,a,O,707
15184,structural,O,707
15185,weakness,O,707
15186,in,O,707
15187,the,O,707
15188,eye,O,707
15189,and,O,707
15190,it,O,707
15191,can,O,707
15192,lead,O,707
15193,to,O,707
15194,vision,O,707
15195,problems,O,707
15196,if,O,707
15197,left,O,707
15198,untreated,O,707
15199,There,O,707
15200,are,O,707
15201,several,O,707
15202,types,O,708
15203,of,O,708
15204,staphyloma,B-NAME_OF_DISEASE,708
15205,including,O,708
15206,posterior,B-NAME_OF_DISEASE,708
15207,staphyloma,I-NAME_OF_DISEASE,708
15208,which,O,708
15209,affects,O,708
15210,the,O,708
15211,back,O,708
15212,of,O,708
15213,the,O,708
15214,eye,O,708
15215,and,O,708
15216,anterior,B-NAME_OF_DISEASE,708
15217,staphyloma,I-NAME_OF_DISEASE,708
15218,which,O,709
15219,affects,O,709
15220,the,O,709
15221,front,O,709
15222,of,O,709
15223,the,O,709
15224,eye,O,709
15225,Staphyloma,B-NAME_OF_DISEASE,709
15226,can,O,709
15227,also,O,709
15228,be,O,709
15229,classified,O,709
15230,as,O,709
15231,axial,O,709
15232,or,O,709
15233,non-axial,O,710
15234,depending,O,710
15235,on,O,710
15236,the,O,710
15237,direction,O,710
15238,of,O,710
15239,the,O,710
15240,bulge,O,710
15241,What,O,710
15242,Causes,O,710
15243,Staphlyoma,B-NAME_OF_DISEASE,710
15244,There,O,710
15245,are,O,710
15246,several,O,710
15247,potential,O,710
15248,causes,O,711
15249,of,O,711
15250,staphyloma,B-NAME_OF_DISEASE,711
15251,including,O,711
15252,inherited,B-CAUSE_OF_DISEASE,711
15253,and,I-CAUSE_OF_DISEASE,711
15254,acquired,I-CAUSE_OF_DISEASE,711
15255,factors,I-CAUSE_OF_DISEASE,711
15256,Inherited,B-NAME_OF_DISEASE,711
15257,staphyloma,I-NAME_OF_DISEASE,711
15258,is,O,711
15259,often,O,711
15260,caused,O,711
15261,by,O,711
15262,genetic,B-CAUSE_OF_DISEASE,712
15263,mutations,I-CAUSE_OF_DISEASE,712
15264,that,I-CAUSE_OF_DISEASE,712
15265,affect,I-CAUSE_OF_DISEASE,712
15266,the,I-CAUSE_OF_DISEASE,712
15267,development,I-CAUSE_OF_DISEASE,712
15268,of,I-CAUSE_OF_DISEASE,712
15269,the,I-CAUSE_OF_DISEASE,712
15270,eye,I-CAUSE_OF_DISEASE,712
15271,These,O,712
15272,mutations,O,712
15273,can,O,713
15274,cause,O,713
15275,the,O,713
15276,eye,O,713
15277,to,O,713
15278,be,O,713
15279,weaker,O,713
15280,or,O,713
15281,more,O,713
15282,prone,O,713
15283,to,O,713
15284,bulging,O,713
15285,Inherited,B-NAME_OF_DISEASE,713
15286,staphyloma,I-NAME_OF_DISEASE,713
15287,is,O,713
15288,typically,O,713
15289,present,O,713
15290,at,O,713
15291,birth,O,713
15292,or,O,713
15293,develops,O,714
15294,during,O,714
15295,childhood,O,714
15296,Acquired,B-NAME_OF_DISEASE,714
15297,staphyloma,I-NAME_OF_DISEASE,714
15298,on,O,714
15299,the,O,714
15300,other,O,714
15301,hand,O,714
15302,is,O,714
15303,caused,O,714
15304,by,O,714
15305,diseases,B-CAUSE_OF_DISEASE,714
15306,or,I-CAUSE_OF_DISEASE,714
15307,conditions,I-CAUSE_OF_DISEASE,714
15308,that,I-CAUSE_OF_DISEASE,714
15309,weaken,I-CAUSE_OF_DISEASE,714
15310,the,I-CAUSE_OF_DISEASE,714
15311,eye,I-CAUSE_OF_DISEASE,714
15312,s,I-CAUSE_OF_DISEASE,714
15313,structure,I-CAUSE_OF_DISEASE,714
15314,over,I-CAUSE_OF_DISEASE,714
15315,time,I-CAUSE_OF_DISEASE,714
15316,Some,O,714
15317,common,O,714
15318,causes,O,715
15319,of,O,715
15320,acquired,B-NAME_OF_DISEASE,715
15321,staphyloma,I-NAME_OF_DISEASE,715
15322,include,O,715
15323,High,B-CAUSE_OF_DISEASE,715
15324,myopia,I-CAUSE_OF_DISEASE,715
15325,Extreme,B-CAUSE_OF_DISEASE,715
15326,nearsightedness,I-CAUSE_OF_DISEASE,715
15327,can,O,715
15328,cause,O,715
15329,the,B-SIGN_AND_SYMPTOM,715
15330,eye,I-SIGN_AND_SYMPTOM,715
15331,to,I-SIGN_AND_SYMPTOM,715
15332,become,I-SIGN_AND_SYMPTOM,715
15333,elongated,I-SIGN_AND_SYMPTOM,715
15334,and,I-SIGN_AND_SYMPTOM,715
15335,thin,I-SIGN_AND_SYMPTOM,715
15336,increasing,O,715
15337,the,O,716
15338,risk,O,716
15339,of,O,716
15340,staphyloma,B-NAME_OF_DISEASE,716
15341,Trauma,B-CAUSE_OF_DISEASE,716
15342,A,B-CAUSE_OF_DISEASE,716
15343,blow,I-CAUSE_OF_DISEASE,716
15344,to,I-CAUSE_OF_DISEASE,716
15345,the,I-CAUSE_OF_DISEASE,716
15346,eye,I-CAUSE_OF_DISEASE,716
15347,or,I-CAUSE_OF_DISEASE,716
15348,other,I-CAUSE_OF_DISEASE,716
15349,injury,I-CAUSE_OF_DISEASE,716
15350,can,O,716
15351,weaken,O,716
15352,the,O,716
15353,eye,O,716
15354,s,O,716
15355,structure,O,716
15356,and,O,716
15357,lead,O,717
15358,to,O,717
15359,staphyloma,B-NAME_OF_DISEASE,717
15360,Inflammation,B-CAUSE_OF_DISEASE,717
15361,Inflammatory,B-CAUSE_OF_DISEASE,717
15362,conditions,I-CAUSE_OF_DISEASE,717
15363,such,I-CAUSE_OF_DISEASE,717
15364,as,I-CAUSE_OF_DISEASE,717
15365,uveitis,I-CAUSE_OF_DISEASE,717
15366,or,I-CAUSE_OF_DISEASE,717
15367,scleritis,I-CAUSE_OF_DISEASE,717
15368,can,O,717
15369,cause,O,717
15370,the,O,717
15371,eye,O,717
15372,to,O,717
15373,become,O,717
15374,weaker,O,718
15375,and,O,718
15376,more,O,718
15377,prone,O,718
15378,to,O,718
15379,bulging,O,718
15380,Scleritis,B-CAUSE_OF_DISEASE,718
15381,Scleritis,B-CAUSE_OF_DISEASE,718
15382,is,O,718
15383,a,O,718
15384,type,O,718
15385,of,O,718
15386,inflammation,O,718
15387,that,O,718
15388,affects,O,719
15389,the,B-PART_OF_THE_EYES,719
15390,sclera,I-PART_OF_THE_EYES,719
15391,or,I-PART_OF_THE_EYES,719
15392,white,I-PART_OF_THE_EYES,719
15393,part,I-PART_OF_THE_EYES,719
15394,of,I-PART_OF_THE_EYES,719
15395,the,I-PART_OF_THE_EYES,719
15396,eye,I-PART_OF_THE_EYES,719
15397,It,O,719
15398,can,O,719
15399,cause,O,719
15400,a,O,719
15401,range,O,719
15402,of,O,719
15403,symptoms,O,719
15404,including,O,719
15405,redness,B-SIGN_AND_SYMPTOM,719
15406,pain,I-SIGN_AND_SYMPTOM,719
15407,and,I-SIGN_AND_SYMPTOM,719
15408,sensitivity,I-SIGN_AND_SYMPTOM,719
15409,to,I-SIGN_AND_SYMPTOM,719
15410,light,I-SIGN_AND_SYMPTOM,719
15411,Glaucoma,B-CAUSE_OF_DISEASE,719
15412,This,O,720
15413,is,O,720
15414,a,O,720
15415,group,O,720
15416,of,O,720
15417,eye,O,720
15418,conditions,O,720
15419,that,O,720
15420,can,O,720
15421,damage,O,720
15422,the,O,720
15423,optic,O,720
15424,nerve,O,720
15425,which,O,720
15426,carries,O,720
15427,visual,O,720
15428,information,O,720
15429,from,O,720
15430,the,O,720
15431,eye,O,720
15432,to,O,720
15433,the,O,720
15434,brain,O,720
15435,It,O,720
15436,is,O,721
15437,often,O,721
15438,associated,O,721
15439,with,O,721
15440,high,B-SIGN_AND_SYMPTOM,721
15441,intraocular,I-SIGN_AND_SYMPTOM,721
15442,pressure,I-SIGN_AND_SYMPTOM,721
15443,or,I-SIGN_AND_SYMPTOM,721
15444,pressure,I-SIGN_AND_SYMPTOM,721
15445,inside,I-SIGN_AND_SYMPTOM,721
15446,the,I-SIGN_AND_SYMPTOM,721
15447,eye,I-SIGN_AND_SYMPTOM,721
15448,but,O,721
15449,it,O,721
15450,can,O,721
15451,also,O,721
15452,occur,O,721
15453,in,O,721
15454,people,O,721
15455,with,O,721
15456,normal,O,721
15457,eye,O,721
15458,pressure,O,721
15459,Signs,O,721
15460,and,O,721
15461,Symptoms,O,721
15462,of,O,721
15463,Staphlyoma,B-NAME_OF_DISEASE,721
15464,Symptoms,O,721
15465,of,O,721
15466,staphyloma,B-NAME_OF_DISEASE,721
15467,may,O,721
15468,vary,O,721
15469,depending,O,721
15470,on,O,721
15471,the,O,721
15472,type,O,721
15473,and,O,721
15474,severity,O,721
15475,of,O,721
15476,the,O,722
15477,condition,O,722
15478,but,O,722
15479,common,O,722
15480,symptoms,O,722
15481,include,O,722
15482,Blurred,B-SIGN_AND_SYMPTOM,722
15483,vision,I-SIGN_AND_SYMPTOM,722
15484,Staphyloma,B-NAME_OF_DISEASE,722
15485,can,O,722
15486,cause,O,722
15487,the,O,722
15488,eye,O,722
15489,to,O,722
15490,focus,O,722
15491,light,O,722
15492,incorrectly,O,722
15493,resulting,O,722
15494,in,O,722
15495,blurry,B-SIGN_AND_SYMPTOM,722
15496,or,I-SIGN_AND_SYMPTOM,723
15497,distorted,I-SIGN_AND_SYMPTOM,723
15498,vision,I-SIGN_AND_SYMPTOM,723
15499,Sensitivity,B-SIGN_AND_SYMPTOM,723
15500,to,I-SIGN_AND_SYMPTOM,723
15501,light,I-SIGN_AND_SYMPTOM,723
15502,People,O,723
15503,with,O,723
15504,staphyloma,B-NAME_OF_DISEASE,723
15505,may,O,723
15506,experience,O,723
15507,sensitivity,B-SIGN_AND_SYMPTOM,723
15508,to,I-SIGN_AND_SYMPTOM,723
15509,light,I-SIGN_AND_SYMPTOM,723
15510,or,I-SIGN_AND_SYMPTOM,723
15511,photophobia,I-SIGN_AND_SYMPTOM,723
15512,due,O,723
15513,to,O,723
15514,the,O,723
15515,bulge,O,723
15516,in,O,723
15517,the,O,723
15518,eye,O,724
15519,Distorted,B-SIGN_AND_SYMPTOM,724
15520,vision,I-SIGN_AND_SYMPTOM,724
15521,Staphyloma,B-NAME_OF_DISEASE,724
15522,can,O,724
15523,cause,O,724
15524,objects,B-SIGN_AND_SYMPTOM,724
15525,to,I-SIGN_AND_SYMPTOM,724
15526,appear,I-SIGN_AND_SYMPTOM,724
15527,distorted,I-SIGN_AND_SYMPTOM,724
15528,or,I-SIGN_AND_SYMPTOM,724
15529,stretched,I-SIGN_AND_SYMPTOM,724
15530,out,I-SIGN_AND_SYMPTOM,724
15531,as,O,724
15532,the,O,724
15533,eye,O,724
15534,is,O,724
15535,not,O,724
15536,able,O,725
15537,to,O,725
15538,focus,O,725
15539,light,O,725
15540,properly,O,725
15541,Eye,B-SIGN_AND_SYMPTOM,725
15542,pain,I-SIGN_AND_SYMPTOM,725
15543,Some,O,725
15544,people,O,725
15545,with,O,725
15546,staphyloma,B-NAME_OF_DISEASE,725
15547,may,O,725
15548,experience,O,725
15549,eye,B-SIGN_AND_SYMPTOM,725
15550,pain,I-SIGN_AND_SYMPTOM,725
15551,or,I-SIGN_AND_SYMPTOM,725
15552,discomfort,I-SIGN_AND_SYMPTOM,725
15553,especially,O,725
15554,if,O,725
15555,the,O,725
15556,condition,O,725
15557,is,O,725
15558,severe,O,725
15559,Feeling,B-SIGN_AND_SYMPTOM,726
15560,of,I-SIGN_AND_SYMPTOM,726
15561,pressure,I-SIGN_AND_SYMPTOM,726
15562,in,I-SIGN_AND_SYMPTOM,726
15563,the,I-SIGN_AND_SYMPTOM,726
15564,eye,I-SIGN_AND_SYMPTOM,726
15565,The,O,726
15566,bulge,O,726
15567,associated,O,726
15568,with,O,726
15569,staphyloma,B-NAME_OF_DISEASE,726
15570,can,O,726
15571,cause,O,726
15572,a,B-SIGN_AND_SYMPTOM,726
15573,feeling,I-SIGN_AND_SYMPTOM,726
15574,of,I-SIGN_AND_SYMPTOM,726
15575,pressure,I-SIGN_AND_SYMPTOM,726
15576,or,I-SIGN_AND_SYMPTOM,726
15577,discomfort,I-SIGN_AND_SYMPTOM,726
15578,in,I-SIGN_AND_SYMPTOM,726
15579,the,I-SIGN_AND_SYMPTOM,726
15580,affected,I-SIGN_AND_SYMPTOM,727
15581,eye,I-SIGN_AND_SYMPTOM,727
15582,Treating,O,727
15583,Staphlyoma,B-NAME_OF_DISEASE,727
15584,Treatment,O,727
15585,options,O,727
15586,for,O,727
15587,staphyloma,B-NAME_OF_DISEASE,727
15588,depend,O,727
15589,on,O,727
15590,the,O,727
15591,type,O,728
15592,and,O,728
15593,severity,O,728
15594,of,O,728
15595,the,O,728
15596,condition,O,728
15597,as,O,728
15598,well,O,728
15599,as,O,728
15600,the,O,728
15601,underlying,O,728
15602,cause,O,728
15603,One,O,728
15604,common,O,728
15605,treatment,O,728
15606,option,O,728
15607,for,O,728
15608,staphyloma,B-NAME_OF_DISEASE,728
15609,is,O,728
15610,eyeglasses,B-TREATMENT,729
15611,or,O,729
15612,contact,B-TREATMENT,729
15613,lenses,I-TREATMENT,729
15614,These,O,729
15615,can,O,729
15616,help,O,729
15617,correct,O,729
15618,vision,O,729
15619,problems,O,729
15620,caused,O,729
15621,by,O,729
15622,the,O,729
15623,bulge,O,729
15624,in,O,729
15625,the,O,729
15626,eye,O,730
15627,by,O,730
15628,refocusing,O,730
15629,light,O,730
15630,onto,O,730
15631,the,B-PART_OF_THE_EYES,730
15632,retina,I-PART_OF_THE_EYES,730
15633,In,O,731
15634,some,O,731
15635,cases,O,731
15636,eyeglasses,B-TREATMENT,731
15637,or,O,731
15638,contact,B-TREATMENT,731
15639,lenses,I-TREATMENT,731
15640,may,O,731
15641,be,O,731
15642,sufficient,O,731
15643,to,O,731
15644,improve,O,731
15645,vision,O,731
15646,and,O,731
15647,alleviate,O,732
15648,symptoms,O,732
15649,Surgery,B-TREATMENT,732
15650,is,O,732
15651,another,O,732
15652,option,O,732
15653,for,O,732
15654,treating,O,732
15655,staphyloma,B-NAME_OF_DISEASE,732
15656,The,O,732
15657,type,O,732
15658,of,O,732
15659,surgery,B-TREATMENT,732
15660,will,O,732
15661,depend,O,732
15662,on,O,732
15663,the,O,732
15664,location,O,732
15665,and,O,732
15666,severity,O,732
15667,of,O,732
15668,the,O,732
15669,bulge,O,733
15670,For,O,733
15671,example,O,733
15672,a,B-TREATMENT,733
15673,scleral,I-TREATMENT,733
15674,buckle,I-TREATMENT,733
15675,procedure,I-TREATMENT,733
15676,may,O,733
15677,be,O,733
15678,used,O,733
15679,to,O,733
15680,push,O,733
15681,the,O,733
15682,bulge,O,733
15683,back,O,733
15684,into,O,733
15685,place,O,733
15686,and,O,733
15687,strengthen,O,733
15688,the,O,733
15689,eye,O,734
15690,s,O,734
15691,structure,O,734
15692,In,O,734
15693,other,O,734
15694,cases,O,734
15695,a,B-TREATMENT,734
15696,corneal,I-TREATMENT,734
15697,transplant,I-TREATMENT,734
15698,may,O,734
15699,be,O,734
15700,necessary,O,734
15701,to,O,734
15702,replace,O,734
15703,the,O,734
15704,thinned,O,735
15705,area,O,735
15706,of,O,735
15707,the,O,735
15708,eye,O,735
15709,with,O,735
15710,healthy,O,735
15711,tissue,O,735
15712,In,O,735
15713,some,O,735
15714,cases,O,735
15715,medical,B-TREATMENT,735
15716,treatment,I-TREATMENT,735
15717,may,O,735
15718,be,O,735
15719,necessary,O,735
15720,to,O,735
15721,address,O,735
15722,the,O,735
15723,underlying,O,735
15724,cause,O,735
15725,of,O,735
15726,staphyloma,B-NAME_OF_DISEASE,735
15727,For,O,735
15728,example,O,736
15729,if,O,736
15730,the,O,736
15731,condition,O,736
15732,is,O,736
15733,caused,O,736
15734,by,O,736
15735,high,B-NAME_OF_DISEASE,736
15736,myopia,I-NAME_OF_DISEASE,736
15737,treatment,O,736
15738,may,O,736
15739,involve,O,736
15740,medication,B-TREATMENT,736
15741,or,O,736
15742,laser,B-TREATMENT,736
15743,therapy,I-TREATMENT,736
15744,to,O,736
15745,slow,O,736
15746,the,O,736
15747,progression,O,737
15748,of,O,737
15749,the,O,737
15750,condition,O,737
15751,If,O,737
15752,you,O,737
15753,think,O,737
15754,you,O,737
15755,may,O,737
15756,have,O,737
15757,staphyloma,B-NAME_OF_DISEASE,737
15758,it,O,737
15759,is,O,738
15760,important,O,738
15761,to,O,738
15762,see,O,738
15763,an,O,738
15764,eye,O,738
15765,doctor,O,738
15766,as,O,738
15767,soon,O,738
15768,as,O,738
15769,possible,O,738
15770,Early,O,738
15771,diagnosis,O,738
15772,and,O,738
15773,treatment,O,739
15774,can,O,739
15775,help,O,739
15776,prevent,O,739
15777,vision,B-SIGN_AND_SYMPTOM,739
15778,loss,I-SIGN_AND_SYMPTOM,739
15779,and,O,739
15780,other,O,739
15781,complications,O,739
15782,Your,O,739
15783,eye,O,739
15784,doctor,O,739
15785,can,O,739
15786,help,O,739
15787,determine,O,740
15788,the,O,740
15789,best,O,740
15790,treatment,O,740
15791,option,O,740
15792,for,O,740
15793,your,O,740
15794,specific,O,740
15795,condition,O,740
15796,Anabolic,B-NAME_OF_DRUG,740
15797,steroids,B-NAME_OF_DRUG,740
15798,are,O,740
15799,synthetic,O,740
15800,hormones,O,740
15801,that,O,740
15802,mimic,O,740
15803,the,O,740
15804,effects,O,740
15805,of,O,740
15806,testosterone,B-CHEMICAL_COMPOUND,740
15807,in,O,740
15808,the,O,740
15809,body,O,740
15810,They,O,740
15811,are,O,740
15812,often,O,740
15813,used,O,740
15814,by,O,740
15815,athletes,O,740
15816,and,O,740
15817,bodybuilders,O,740
15818,to,O,740
15819,enhance,O,740
15820,performance,O,740
15821,and,O,741
15822,increase,O,741
15823,muscle,O,741
15824,mass,O,741
15825,but,O,741
15826,long-term,O,741
15827,use,O,741
15828,of,O,741
15829,anabolic,B-NAME_OF_DRUG,741
15830,steroids,B-NAME_OF_DRUG,741
15831,can,O,741
15832,cause,O,741
15833,a,O,741
15834,number,O,741
15835,of,O,741
15836,serious,O,741
15837,side,O,741
15838,effects,O,741
15839,including,O,741
15840,damage,O,741
15841,to,O,741
15842,the,O,741
15843,eyes,O,741
15844,How,O,741
15845,Steroids,B-NAME_OF_DRUG,741
15846,Affect,O,741
15847,the,O,741
15848,Eyes,O,741
15849,There,O,742
15850,are,O,742
15851,a,O,742
15852,number,O,742
15853,of,O,742
15854,potential,O,742
15855,side,O,742
15856,effects,O,742
15857,associated,O,742
15858,with,O,742
15859,the,O,742
15860,misuse,O,742
15861,of,O,742
15862,anabolic,B-NAME_OF_DRUG,742
15863,steroids,B-NAME_OF_DRUG,742
15864,and,O,742
15865,some,O,742
15866,of,O,742
15867,these,O,742
15868,may,O,742
15869,affect,O,742
15870,the,O,742
15871,eyes,O,742
15872,Some,O,742
15873,possible,O,742
15874,side,O,742
15875,effects,O,743
15876,of,O,743
15877,anabolic,B-NAME_OF_DRUG,743
15878,steroids,B-NAME_OF_DRUG,743
15879,on,O,743
15880,the,O,743
15881,eyes,O,743
15882,include,O,743
15883,Glaucoma,B-NAME_OF_DISEASE,743
15884,Anabolic,B-NAME_OF_DRUG,743
15885,steroids,B-NAME_OF_DRUG,743
15886,can,O,744
15887,increase,O,744
15888,the,O,744
15889,pressure,O,744
15890,inside,O,744
15891,the,O,744
15892,eye,O,744
15893,which,O,744
15894,can,O,744
15895,lead,O,744
15896,to,O,744
15897,glaucoma,B-NAME_OF_DISEASE,744
15898,Symptoms,O,744
15899,of,O,744
15900,glaucoma,B-NAME_OF_DISEASE,744
15901,may,O,744
15902,include,O,744
15903,headache,B-SIGN_AND_SYMPTOM,744
15904,eye,I-SIGN_AND_SYMPTOM,744
15905,pain,I-SIGN_AND_SYMPTOM,744
15906,and,I-SIGN_AND_SYMPTOM,745
15907,vision,B-SIGN_AND_SYMPTOM,745
15908,loss,I-SIGN_AND_SYMPTOM,745
15909,Cataracts,B-NAME_OF_DISEASE,745
15910,Anabolic,B-NAME_OF_DRUG,745
15911,steroids,B-NAME_OF_DRUG,745
15912,can,O,745
15913,increase,O,745
15914,the,O,745
15915,risk,O,745
15916,of,O,745
15917,developing,O,745
15918,cataracts,B-NAME_OF_DISEASE,745
15919,which,O,745
15920,are,O,745
15921,cloudy,O,745
15922,areas,O,746
15923,in,O,746
15924,the,B-PART_OF_THE_EYES,746
15925,lens,I-PART_OF_THE_EYES,746
15926,of,I-PART_OF_THE_EYES,746
15927,the,I-PART_OF_THE_EYES,746
15928,eye,I-PART_OF_THE_EYES,746
15929,This,O,746
15930,can,O,746
15931,cause,O,746
15932,vision,B-SIGN_AND_SYMPTOM,746
15933,to,I-SIGN_AND_SYMPTOM,746
15934,become,I-SIGN_AND_SYMPTOM,746
15935,blurry,I-SIGN_AND_SYMPTOM,746
15936,or,I-SIGN_AND_SYMPTOM,746
15937,distorted,I-SIGN_AND_SYMPTOM,746
15938,and,O,746
15939,may,O,746
15940,require,O,747
15941,surgical,O,747
15942,treatment,O,747
15943,to,O,747
15944,correct,O,747
15945,Infections,B-NAME_OF_DISEASE,747
15946,Anabolic,B-NAME_OF_DRUG,747
15947,steroids,B-NAME_OF_DRUG,747
15948,can,O,747
15949,weaken,O,747
15950,the,O,747
15951,immune,O,748
15952,system,O,748
15953,making,O,748
15954,it,O,748
15955,easier,O,748
15956,for,O,748
15957,infections,O,748
15958,to,O,748
15959,occur,O,748
15960,in,O,748
15961,the,O,748
15962,eye,O,748
15963,Symptoms,O,748
15964,of,O,748
15965,an,O,748
15966,eye,O,748
15967,infection,O,748
15968,may,O,749
15969,include,O,749
15970,redness,B-SIGN_AND_SYMPTOM,749
15971,swelling,I-SIGN_AND_SYMPTOM,749
15972,and,I-SIGN_AND_SYMPTOM,749
15973,discharge,I-SIGN_AND_SYMPTOM,749
15974,Dry,B-NAME_OF_DISEASE,749
15975,eye,I-NAME_OF_DISEASE,749
15976,Anabolic,B-NAME_OF_DRUG,749
15977,steroids,B-NAME_OF_DRUG,749
15978,can,O,750
15979,cause,O,750
15980,dryness,B-SIGN_AND_SYMPTOM,750
15981,and,I-SIGN_AND_SYMPTOM,750
15982,irritation,I-SIGN_AND_SYMPTOM,750
15983,in,I-SIGN_AND_SYMPTOM,750
15984,the,I-SIGN_AND_SYMPTOM,750
15985,eye,I-SIGN_AND_SYMPTOM,750
15986,leading,O,750
15987,to,O,750
15988,dry,B-NAME_OF_DISEASE,750
15989,eye,I-NAME_OF_DISEASE,750
15990,syndrome,I-NAME_OF_DISEASE,750
15991,Symptoms,O,750
15992,of,O,750
15993,dry,B-NAME_OF_DISEASE,750
15994,eye,I-NAME_OF_DISEASE,750
15995,may,O,750
15996,include,O,750
15997,dryness,B-SIGN_AND_SYMPTOM,750
15998,itching,I-SIGN_AND_SYMPTOM,750
15999,and,I-SIGN_AND_SYMPTOM,750
16000,redness,I-SIGN_AND_SYMPTOM,750
16001,Central,B-NAME_OF_DISEASE,750
16002,serous,I-NAME_OF_DISEASE,750
16003,chorioretinopathy,I-NAME_OF_DISEASE,751
16004,Steroids,B-NAME_OF_DRUG,751
16005,can,O,751
16006,cause,O,751
16007,central,B-NAME_OF_DISEASE,751
16008,serous,I-NAME_OF_DISEASE,751
16009,chorioretinopathy,I-NAME_OF_DISEASE,751
16010,a,O,751
16011,serious,O,751
16012,side,O,752
16013,effect,O,752
16014,of,O,752
16015,steroid,B-NAME_OF_DRUG,752
16016,medication,O,752
16017,that,O,752
16018,causes,O,752
16019,a,B-SIGN_AND_SYMPTOM,752
16020,buildup,I-SIGN_AND_SYMPTOM,752
16021,of,I-SIGN_AND_SYMPTOM,752
16022,fluid,I-SIGN_AND_SYMPTOM,752
16023,underneath,I-SIGN_AND_SYMPTOM,752
16024,the,I-SIGN_AND_SYMPTOM,752
16025,retina,I-SIGN_AND_SYMPTOM,752
16026,This,O,752
16027,can,O,752
16028,lead,O,752
16029,to,O,752
16030,retinal,B-NAME_OF_DISEASE,753
16031,detachment,I-NAME_OF_DISEASE,753
16032,and,O,753
16033,vision,B-SIGN_AND_SYMPTOM,753
16034,loss,I-SIGN_AND_SYMPTOM,753
16035,Symptoms,O,753
16036,of,O,753
16037,CSC,B-NAME_OF_DISEASE,753
16038,may,O,753
16039,include,O,753
16040,blurred,B-SIGN_AND_SYMPTOM,753
16041,vision,I-SIGN_AND_SYMPTOM,753
16042,in,I-SIGN_AND_SYMPTOM,753
16043,one,I-SIGN_AND_SYMPTOM,753
16044,or,I-SIGN_AND_SYMPTOM,753
16045,both,I-SIGN_AND_SYMPTOM,753
16046,eyes,I-SIGN_AND_SYMPTOM,753
16047,and,I-SIGN_AND_SYMPTOM,753
16048,a,I-SIGN_AND_SYMPTOM,753
16049,sudden,I-SIGN_AND_SYMPTOM,753
16050,loss,I-SIGN_AND_SYMPTOM,753
16051,of,I-SIGN_AND_SYMPTOM,753
16052,vision,I-SIGN_AND_SYMPTOM,753
16053,It,O,753
16054,s,O,753
16055,important,O,753
16056,to,O,753
16057,note,O,753
16058,that,O,753
16059,these,O,753
16060,side,O,754
16061,effects,O,754
16062,are,O,754
16063,more,O,754
16064,likely,O,754
16065,to,O,754
16066,occur,O,754
16067,in,O,754
16068,people,O,754
16069,who,O,754
16070,use,O,754
16071,high,O,754
16072,doses,O,754
16073,of,O,754
16074,steroids,B-NAME_OF_DRUG,754
16075,for,O,754
16076,long,O,754
16077,periods,O,754
16078,of,O,754
16079,time,O,754
16080,such,O,754
16081,as,O,754
16082,bodybuilders,O,754
16083,If,O,754
16084,you,O,754
16085,are,O,754
16086,a,O,754
16087,bodybuilder,O,754
16088,using,O,754
16089,steroids,B-NAME_OF_DRUG,754
16090,and,O,754
16091,are,O,754
16092,experiencing,O,755
16093,any,O,755
16094,changes,O,755
16095,in,O,755
16096,your,O,755
16097,vision,O,755
16098,or,O,755
16099,other,O,755
16100,eye-related,O,755
16101,symptoms,O,755
16102,it,O,755
16103,s,O,755
16104,important,O,755
16105,to,O,755
16106,speak,O,755
16107,with,O,756
16108,your,O,756
16109,healthcare,O,756
16110,provider,O,756
16111,as,O,756
16112,soon,O,756
16113,as,O,756
16114,possible,O,756
16115,They,O,756
16116,can,O,756
16117,help,O,756
16118,you,O,756
16119,determine,O,756
16120,the,O,756
16121,cause,O,756
16122,of,O,756
16123,the,O,756
16124,problem,O,756
16125,and,O,756
16126,recommend,O,756
16127,the,O,756
16128,appropriate,O,756
16129,treatment,O,756
16130,How,O,756
16131,to,O,756
16132,Prevent,O,756
16133,Side,O,756
16134,Effects,O,756
16135,of,O,756
16136,Anabolic,B-NAME_OF_DRUG,756
16137,Steroids,I-NAME_OF_DRUG,756
16138,To,O,757
16139,prevent,O,757
16140,the,O,757
16141,negative,O,757
16142,effects,O,757
16143,of,O,757
16144,anabolic,B-NAME_OF_DRUG,757
16145,steroids,I-NAME_OF_DRUG,757
16146,on,O,757
16147,the,O,757
16148,eyes,O,757
16149,the,O,757
16150,best,O,757
16151,course,O,757
16152,of,O,757
16153,action,O,757
16154,is,O,757
16155,to,O,757
16156,avoid,B-PREVENTION,757
16157,using,I-PREVENTION,757
16158,these,I-PREVENTION,757
16159,drugs,I-PREVENTION,757
16160,altogether,I-PREVENTION,757
16161,If,O,757
16162,you,O,757
16163,are,O,757
16164,taking,O,757
16165,anabolic,B-NAME_OF_DRUG,757
16166,steroids,I-NAME_OF_DRUG,758
16167,for,O,758
16168,a,O,758
16169,medical,O,758
16170,condition,O,758
16171,be,O,758
16172,sure,O,758
16173,to,O,758
16174,follow,B-PREVENTION,758
16175,your,I-PREVENTION,758
16176,healthcare,I-PREVENTION,758
16177,provider,I-PREVENTION,758
16178,s,I-PREVENTION,758
16179,instructions,I-PREVENTION,758
16180,carefully,I-PREVENTION,758
16181,and,I-PREVENTION,758
16182,report,I-PREVENTION,758
16183,any,I-PREVENTION,758
16184,unusual,I-PREVENTION,758
16185,symptoms,I-PREVENTION,758
16186,to,I-PREVENTION,758
16187,your,I-PREVENTION,758
16188,provider,I-PREVENTION,758
16189,Ways,O,758
16190,to,O,758
16191,Improve,O,758
16192,Your,O,758
16193,Eye,O,758
16194,Health,O,758
16195,While,O,758
16196,Taking,O,758
16197,Anabolic,B-NAME_OF_DRUG,758
16198,Steroids,I-NAME_OF_DRUG,758
16199,Get,B-PREVENTION,759
16200,regular,I-PREVENTION,759
16201,eye,I-PREVENTION,759
16202,exams,I-PREVENTION,759
16203,It,O,759
16204,s,O,759
16205,important,O,759
16206,to,O,759
16207,have,B-PREVENTION,759
16208,regular,I-PREVENTION,759
16209,eye,I-PREVENTION,759
16210,exams,I-PREVENTION,759
16211,to,I-PREVENTION,759
16212,check,I-PREVENTION,759
16213,for,I-PREVENTION,759
16214,any,I-PREVENTION,759
16215,changes,I-PREVENTION,759
16216,in,I-PREVENTION,759
16217,your,I-PREVENTION,759
16218,vision,I-PREVENTION,759
16219,or,I-PREVENTION,759
16220,eye,I-PREVENTION,759
16221,health,I-PREVENTION,759
16222,This,O,759
16223,is,O,759
16224,especially,O,759
16225,important,O,759
16226,if,O,760
16227,you,O,760
16228,are,O,760
16229,taking,O,760
16230,anabolic,B-NAME_OF_DRUG,760
16231,steroids,I-NAME_OF_DRUG,760
16232,as,O,760
16233,they,O,760
16234,can,O,760
16235,increase,O,760
16236,the,O,760
16237,risk,O,760
16238,of,O,760
16239,certain,O,760
16240,eye,O,760
16241,conditions,O,760
16242,such,O,760
16243,as,O,760
16244,cataracts,B-NAME_OF_DISEASE,760
16245,glaucoma,B-NAME_OF_DISEASE,760
16246,and,O,760
16247,retinal,B-NAME_OF_DISEASE,760
16248,detachment,I-NAME_OF_DISEASE,761
16249,Eat,B-PREVENTION,761
16250,a,I-PREVENTION,761
16251,healthy,I-PREVENTION,761
16252,diet,I-PREVENTION,761
16253,A,B-PREVENTION,761
16254,diet,I-PREVENTION,761
16255,rich,I-PREVENTION,761
16256,in,I-PREVENTION,761
16257,fruits,I-PREVENTION,761
16258,vegetables,I-PREVENTION,761
16259,and,I-PREVENTION,761
16260,nutrients,I-PREVENTION,762
16261,such,I-PREVENTION,762
16262,as,I-PREVENTION,762
16263,lutein,I-PREVENTION,762
16264,and,I-PREVENTION,762
16265,zeaxanthin,I-PREVENTION,762
16266,can,O,762
16267,help,O,762
16268,support,O,762
16269,eye,O,762
16270,health,O,762
16271,These,O,762
16272,nutrients,O,762
16273,are,O,762
16274,found,O,762
16275,in,O,762
16276,foods,O,762
16277,such,O,762
16278,as,O,762
16279,kale,O,762
16280,spinach,O,762
16281,and,O,762
16282,eggs,O,762
16283,Stay,B-PREVENTION,762
16284,hydrated,I-PREVENTION,762
16285,Drinking,B-PREVENTION,762
16286,enough,I-PREVENTION,762
16287,water,I-PREVENTION,763
16288,can,O,763
16289,help,O,763
16290,keep,O,763
16291,your,O,763
16292,eyes,O,763
16293,moist,O,763
16294,and,O,763
16295,reduce,O,763
16296,the,O,763
16297,risk,O,763
16298,of,O,763
16299,dry,B-NAME_OF_DISEASE,763
16300,eye,I-NAME_OF_DISEASE,763
16301,syndrome,I-NAME_OF_DISEASE,763
16302,a,O,763
16303,common,O,764
16304,side,O,764
16305,effect,O,764
16306,of,O,764
16307,anabolic,B-NAME_OF_DRUG,764
16308,steroid,I-NAME_OF_DRUG,764
16309,use,O,764
16310,Avoid,B-PREVENTION,764
16311,rubbing,I-PREVENTION,764
16312,your,I-PREVENTION,764
16313,eyes,I-PREVENTION,764
16314,Rubbing,O,764
16315,your,O,764
16316,eyes,O,764
16317,can,O,764
16318,cause,O,764
16319,irritation,O,764
16320,and,O,764
16321,increase,O,765
16322,the,O,765
16323,risk,O,765
16324,of,O,765
16325,infection,O,765
16326,If,O,765
16327,you,O,765
16328,have,O,765
16329,itchy,B-SIGN_AND_SYMPTOM,765
16330,or,I-SIGN_AND_SYMPTOM,765
16331,dry,I-SIGN_AND_SYMPTOM,765
16332,eyes,I-SIGN_AND_SYMPTOM,765
16333,try,O,765
16334,using,O,765
16335,artificial,B-TREATMENT,765
16336,tears,I-TREATMENT,765
16337,or,O,765
16338,a,B-TREATMENT,765
16339,humidifier,I-TREATMENT,765
16340,to,O,765
16341,help,O,765
16342,alleviate,O,765
16343,symptoms,O,765
16344,In,O,765
16345,conclusion,O,765
16346,it,O,765
16347,is,O,765
16348,important,O,766
16349,to,O,766
16350,use,O,766
16351,anabolic,B-NAME_OF_DRUG,766
16352,steroids,I-NAME_OF_DRUG,766
16353,only,O,766
16354,under,O,766
16355,the,O,766
16356,supervision,O,766
16357,of,O,766
16358,a,O,766
16359,healthcare,O,766
16360,provider,O,766
16361,and,O,766
16362,to,O,766
16363,follow,O,766
16364,the,O,766
16365,recommended,O,766
16366,dosage,O,766
16367,and,O,766
16368,duration,O,766
16369,of,O,766
16370,use,O,766
16371,If,O,766
16372,you,O,767
16373,are,O,767
16374,using,O,767
16375,anabolic,B-NAME_OF_DRUG,767
16376,steroids,I-NAME_OF_DRUG,767
16377,and,O,767
16378,have,O,767
16379,concerns,O,767
16380,about,O,767
16381,their,O,767
16382,effects,O,767
16383,on,O,767
16384,your,O,767
16385,eyes,O,767
16386,it,O,767
16387,is,O,767
16388,important,O,767
16389,to,O,767
16390,speak,O,767
16391,with,O,768
16392,a,O,768
16393,healthcare,O,768
16394,provider,O,768
16395,In,O,768
16396,addition,O,768
16397,individuals,O,768
16398,who,O,768
16399,use,O,768
16400,anabolic,B-NAME_OF_DRUG,768
16401,steroids,I-NAME_OF_DRUG,768
16402,should,O,768
16403,have,B-PREVENTION,768
16404,regular,I-PREVENTION,768
16405,eye,I-PREVENTION,768
16406,exams,I-PREVENTION,769
16407,to,O,769
16408,monitor,O,769
16409,for,O,769
16410,any,O,769
16411,potential,O,769
16412,eye,O,769
16413,problems,O,769
16414,What,O,769
16415,Is,O,769
16416,Ocular,B-NAME_OF_DISEASE,769
16417,Albinism,I-NAME_OF_DISEASE,769
16418,Ocular,B-NAME_OF_DISEASE,769
16419,albinism,I-NAME_OF_DISEASE,769
16420,is,O,770
16421,a,O,770
16422,genetic,O,770
16423,condition,O,770
16424,that,O,770
16425,specifically,O,770
16426,affects,O,770
16427,the,O,770
16428,eyes,O,770
16429,In,O,770
16430,ocular,B-NAME_OF_DISEASE,770
16431,albinism,I-NAME_OF_DISEASE,770
16432,the,B-CHEMICAL_COMPOUND,770
16433,melanin,I-CHEMICAL_COMPOUND,770
16434,pigment,I-CHEMICAL_COMPOUND,770
16435,is,O,770
16436,markedly,O,770
16437,reduced,O,770
16438,in,O,771
16439,the,B-PART_OF_THE_EYES,771
16440,iris,B-PART_OF_THE_EYES,771
16441,and,I-PART_OF_THE_EYES,771
16442,retina,I-PART_OF_THE_EYES,771
16443,Melanin,B-CHEMICAL_COMPOUND,771
16444,is,O,771
16445,a,O,771
16446,pigment,O,771
16447,that,O,771
16448,gives,O,771
16449,color,O,772
16450,to,O,772
16451,the,B-PART_OF_THE_EYES,772
16452,iris,B-PART_OF_THE_EYES,772
16453,and,I-PART_OF_THE_EYES,772
16454,retina,I-PART_OF_THE_EYES,772
16455,it,O,772
16456,is,O,772
16457,essential,O,772
16458,for,O,772
16459,normal,O,772
16460,vision,O,772
16461,Its,O,772
16462,absence,O,772
16463,leads,O,772
16464,to,O,772
16465,visual,B-NAME_OF_DISEASE,772
16466,impairment,I-NAME_OF_DISEASE,772
16467,and,O,772
16468,ultimately,O,772
16469,permanent,B-NAME_OF_DISEASE,772
16470,vision,I-NAME_OF_DISEASE,772
16471,loss,I-NAME_OF_DISEASE,773
16472,Signs,O,773
16473,and,O,773
16474,Symptoms,O,773
16475,of,O,773
16476,Ocular,B-NAME_OF_DISEASE,773
16477,Albinism,I-NAME_OF_DISEASE,773
16478,Ocular,B-NAME_OF_DISEASE,773
16479,albinism,I-NAME_OF_DISEASE,773
16480,manifests,O,773
16481,clinically,O,773
16482,as,O,773
16483,Severely,B-SIGN_AND_SYMPTOM,773
16484,reduced,I-SIGN_AND_SYMPTOM,773
16485,visual,I-SIGN_AND_SYMPTOM,774
16486,acuity,I-SIGN_AND_SYMPTOM,774
16487,leading,I-SIGN_AND_SYMPTOM,774
16488,to,I-SIGN_AND_SYMPTOM,774
16489,impaired,I-SIGN_AND_SYMPTOM,774
16490,sharpness,I-SIGN_AND_SYMPTOM,774
16491,of,I-SIGN_AND_SYMPTOM,774
16492,vision,I-SIGN_AND_SYMPTOM,774
16493,in,I-SIGN_AND_SYMPTOM,774
16494,patients,I-SIGN_AND_SYMPTOM,774
16495,Loss,B-SIGN_AND_SYMPTOM,774
16496,of,I-SIGN_AND_SYMPTOM,775
16497,stereoscopic,I-SIGN_AND_SYMPTOM,775
16498,vision,I-SIGN_AND_SYMPTOM,775
16499,leading,I-SIGN_AND_SYMPTOM,775
16500,to,I-SIGN_AND_SYMPTOM,775
16501,trouble,I-SIGN_AND_SYMPTOM,775
16502,in,I-SIGN_AND_SYMPTOM,775
16503,perceiving,I-SIGN_AND_SYMPTOM,775
16504,the,I-SIGN_AND_SYMPTOM,775
16505,depth,I-SIGN_AND_SYMPTOM,775
16506,of,I-SIGN_AND_SYMPTOM,775
16507,things,I-SIGN_AND_SYMPTOM,775
16508,as,I-SIGN_AND_SYMPTOM,775
16509,a,I-SIGN_AND_SYMPTOM,775
16510,vision,I-SIGN_AND_SYMPTOM,775
16511,from,I-SIGN_AND_SYMPTOM,776
16512,both,I-SIGN_AND_SYMPTOM,776
16513,eyes,I-SIGN_AND_SYMPTOM,776
16514,is,I-SIGN_AND_SYMPTOM,776
16515,unable,I-SIGN_AND_SYMPTOM,776
16516,to,I-SIGN_AND_SYMPTOM,776
16517,combine,I-SIGN_AND_SYMPTOM,776
16518,Permanent,B-NAME_OF_DISEASE,776
16519,vision,I-NAME_OF_DISEASE,776
16520,loss,I-NAME_OF_DISEASE,776
16521,Nystagmus,B-NAME_OF_DISEASE,776
16522,uncontrollable,B-SIGN_AND_SYMPTOM,776
16523,rapid,I-SIGN_AND_SYMPTOM,776
16524,and,I-SIGN_AND_SYMPTOM,776
16525,pendular,I-SIGN_AND_SYMPTOM,776
16526,eye,I-SIGN_AND_SYMPTOM,776
16527,movements,I-SIGN_AND_SYMPTOM,776
16528,Strabismus,B-NAME_OF_DISEASE,776
16529,crossed,I-NAME_OF_DISEASE,776
16530,vision,I-NAME_OF_DISEASE,776
16531,in,O,776
16532,this,O,776
16533,both,B-SIGN_AND_SYMPTOM,776
16534,the,I-SIGN_AND_SYMPTOM,776
16535,eyes,I-SIGN_AND_SYMPTOM,776
16536,do,I-SIGN_AND_SYMPTOM,776
16537,not,I-SIGN_AND_SYMPTOM,776
16538,look,I-SIGN_AND_SYMPTOM,776
16539,in,I-SIGN_AND_SYMPTOM,776
16540,a,I-SIGN_AND_SYMPTOM,776
16541,parallel,I-SIGN_AND_SYMPTOM,776
16542,direction,I-SIGN_AND_SYMPTOM,776
16543,due,I-SIGN_AND_SYMPTOM,776
16544,to,I-SIGN_AND_SYMPTOM,777
16545,muscle,I-SIGN_AND_SYMPTOM,777
16546,imbalance,I-SIGN_AND_SYMPTOM,777
16547,in,I-SIGN_AND_SYMPTOM,777
16548,the,I-SIGN_AND_SYMPTOM,777
16549,eyes,I-SIGN_AND_SYMPTOM,777
16550,but,I-SIGN_AND_SYMPTOM,777
16551,look,I-SIGN_AND_SYMPTOM,777
16552,in,I-SIGN_AND_SYMPTOM,777
16553,different,I-SIGN_AND_SYMPTOM,777
16554,directions,I-SIGN_AND_SYMPTOM,777
16555,Photophobia,B-NAME_OF_DISEASE,777
16556,increased,B-SIGN_AND_SYMPTOM,778
16557,vulnerability,I-SIGN_AND_SYMPTOM,778
16558,to,I-SIGN_AND_SYMPTOM,778
16559,light,I-SIGN_AND_SYMPTOM,778
16560,Pathologies,O,779
16561,of,O,779
16562,the,B-PART_OF_THE_EYES,779
16563,optic,I-PART_OF_THE_EYES,779
16564,nerves,I-PART_OF_THE_EYES,779
16565,are,O,779
16566,present,O,779
16567,Ocular,B-NAME_OF_DISEASE,779
16568,albinism,I-NAME_OF_DISEASE,779
16569,does,O,779
16570,not,O,779
16571,significantly,O,779
16572,affect,O,780
16573,the,O,780
16574,color,O,780
16575,of,O,780
16576,the,O,780
16577,skin,O,780
16578,and,O,780
16579,hair,O,780
16580,it,O,780
16581,predominantly,O,780
16582,affects,O,780
16583,the,B-PART_OF_THE_EYES,780
16584,retina,I-PART_OF_THE_EYES,780
16585,and,O,780
16586,iris,B-PART_OF_THE_EYES,780
16587,Foveal,B-NAME_OF_DISEASE,780
16588,hypoplasia,I-NAME_OF_DISEASE,780
16589,is,O,780
16590,present,O,780
16591,Causes,O,780
16592,of,O,780
16593,Ocular,B-NAME_OF_DISEASE,780
16594,Albinism,I-NAME_OF_DISEASE,780
16595,Ocular,B-NAME_OF_DISEASE,780
16596,albinism,I-NAME_OF_DISEASE,780
16597,has,O,780
16598,two,O,780
16599,types,O,780
16600,Ocular,B-NAME_OF_DISEASE,780
16601,Albinism,I-NAME_OF_DISEASE,780
16602,Type,I-NAME_OF_DISEASE,780
16603,1,I-NAME_OF_DISEASE,781
16604,It,O,781
16605,is,O,781
16606,the,O,781
16607,most,O,781
16608,common,O,781
16609,type,O,781
16610,of,O,781
16611,ocular,B-NAME_OF_DISEASE,781
16612,albinism,I-NAME_OF_DISEASE,781
16613,It,O,781
16614,is,O,782
16615,known,O,782
16616,as,O,782
16617,the,O,782
16618,Nettleship-Falls,B-NAME_OF_DISEASE,782
16619,type,I-NAME_OF_DISEASE,782
16620,resulting,O,782
16621,from,O,782
16622,mutations,O,782
16623,in,O,782
16624,the,B-CHEMICAL_COMPOUND,782
16625,GPR143,I-CHEMICAL_COMPOUND,783
16626,gene,I-CHEMICAL_COMPOUND,783
16627,Ocular,B-NAME_OF_DISEASE,783
16628,Albinism,I-NAME_OF_DISEASE,783
16629,Type,I-NAME_OF_DISEASE,783
16630,2,I-NAME_OF_DISEASE,783
16631,Also,O,783
16632,known,O,783
16633,as,O,783
16634,Forsius-Eriksson,B-NAME_OF_DISEASE,783
16635,type,I-NAME_OF_DISEASE,783
16636,ocular,I-NAME_OF_DISEASE,783
16637,albinism,I-NAME_OF_DISEASE,783
16638,It,O,783
16639,is,O,783
16640,rarer,O,783
16641,than,O,783
16642,Ocular,B-NAME_OF_DISEASE,783
16643,Albinism,I-NAME_OF_DISEASE,783
16644,Type,I-NAME_OF_DISEASE,783
16645,1,I-NAME_OF_DISEASE,783
16646,resulting,O,783
16647,from,O,783
16648,mutations,O,783
16649,in,O,783
16650,the,B-CHEMICAL_COMPOUND,783
16651,CACNA1F,I-CHEMICAL_COMPOUND,783
16652,gene,I-CHEMICAL_COMPOUND,783
16653,Clinical,O,783
16654,manifestations,O,783
16655,of,O,784
16656,ocular,B-NAME_OF_DISEASE,784
16657,albinism,I-NAME_OF_DISEASE,784
16658,type,I-NAME_OF_DISEASE,784
16659,1,I-NAME_OF_DISEASE,784
16660,and,I-NAME_OF_DISEASE,784
16661,2,I-NAME_OF_DISEASE,784
16662,are,O,784
16663,as,O,784
16664,much,O,784
16665,the,O,784
16666,same,O,784
16667,except,O,784
16668,that,O,784
16669,type,O,784
16670,2,O,784
16671,has,O,784
16672,an,O,784
16673,additional,O,784
16674,defect,O,784
16675,in,O,784
16676,dark,O,784
16677,adaptation,O,784
16678,and,O,784
16679,protanopic,O,784
16680,color,B-NAME_OF_DISEASE,784
16681,vision,I-NAME_OF_DISEASE,785
16682,defect,I-NAME_OF_DISEASE,785
16683,color,B-NAME_OF_DISEASE,785
16684,blindness,I-NAME_OF_DISEASE,785
16685,,O,785
16686,How,O,785
16687,Is,O,785
16688,It,O,785
16689,Inherited,O,785
16690,Ocular,B-NAME_OF_DISEASE,785
16691,albinism,I-NAME_OF_DISEASE,785
16692,has,O,785
16693,an,O,785
16694,X-linked,O,785
16695,recessive,O,785
16696,inheritance,O,785
16697,pattern,O,785
16698,It,O,785
16699,majorly,O,785
16700,affects,O,785
16701,males,O,785
16702,It,O,786
16703,is,O,786
16704,passed,O,786
16705,from,O,786
16706,mothers,O,786
16707,carriers,O,786
16708,of,O,786
16709,the,B-CHEMICAL_COMPOUND,786
16710,gene,I-CHEMICAL_COMPOUND,786
16711,to,O,786
16712,their,O,786
16713,sons,O,786
16714,Each,O,786
16715,time,O,786
16716,a,O,786
16717,mother,O,786
16718,who,O,786
16719,is,O,786
16720,a,O,786
16721,carrier,O,786
16722,of,O,787
16723,the,B-CHEMICAL_COMPOUND,787
16724,gene,I-CHEMICAL_COMPOUND,787
16725,for,O,787
16726,ocular,B-NAME_OF_DISEASE,787
16727,albinism,I-NAME_OF_DISEASE,787
16728,gives,O,787
16729,birth,O,787
16730,to,O,787
16731,a,O,787
16732,son,O,787
16733,there,O,787
16734,is,O,787
16735,a,O,787
16736,50%,O,787
16737,probability,O,787
16738,that,O,787
16739,the,O,787
16740,son,O,787
16741,will,O,787
16742,have,O,787
16743,ocular,B-NAME_OF_DISEASE,787
16744,albinism,I-NAME_OF_DISEASE,787
16745,Carrier,O,787
16746,mothers,O,787
16747,with,O,787
16748,the,B-CHEMICAL_COMPOUND,787
16749,gene,I-CHEMICAL_COMPOUND,787
16750,do,O,787
16751,not,O,787
16752,have,O,787
16753,full-blown,O,787
16754,ocular,B-NAME_OF_DISEASE,787
16755,albinism,I-NAME_OF_DISEASE,787
16756,They,O,787
16757,have,O,788
16758,minor,O,788
16759,clinical,O,788
16760,manifestations,O,788
16761,like,O,788
16762,mottled,B-SIGN_AND_SYMPTOM,788
16763,pigmentation,I-SIGN_AND_SYMPTOM,788
16764,in,O,788
16765,the,B-PART_OF_THE_EYES,788
16766,retina,I-PART_OF_THE_EYES,788
16767,Biological,O,788
16768,males,O,788
16769,have,O,788
16770,one,O,788
16771,XY,B-CHEMICAL_COMPOUND,788
16772,chromosome,I-CHEMICAL_COMPOUND,788
16773,males,O,788
16774,have,O,788
16775,only,O,788
16776,one,O,788
16777,X,B-CHEMICAL_COMPOUND,789
16778,chromosome,I-CHEMICAL_COMPOUND,789
16779,so,O,789
16780,one,O,789
16781,mutated,O,789
16782,copy,O,789
16783,of,O,789
16784,the,B-CHEMICAL_COMPOUND,789
16785,GPR143,I-CHEMICAL_COMPOUND,789
16786,gene,I-CHEMICAL_COMPOUND,789
16787,would,O,789
16788,suffice,O,789
16789,to,O,789
16790,cause,O,789
16791,the,O,789
16792,typical,O,789
16793,symptoms,O,789
16794,of,O,789
16795,Ocular,B-NAME_OF_DISEASE,790
16796,Albinism,I-NAME_OF_DISEASE,790
16797,However,O,790
16798,biological,O,790
16799,females,O,790
16800,have,O,790
16801,XX,B-CHEMICAL_COMPOUND,790
16802,chromosomes,I-CHEMICAL_COMPOUND,790
16803,implying,O,790
16804,that,O,790
16805,they,O,791
16806,must,O,791
16807,inherit,O,791
16808,a,O,791
16809,copy,O,791
16810,of,O,791
16811,the,B-CHEMICAL_COMPOUND,791
16812,GPR143,I-CHEMICAL_COMPOUND,791
16813,mutation,O,791
16814,from,O,791
16815,both,O,791
16816,parents,O,791
16817,to,O,791
16818,be,O,791
16819,diagnosed,O,791
16820,with,O,792
16821,Ocular,B-NAME_OF_DISEASE,792
16822,Albinism,I-NAME_OF_DISEASE,792
16823,Is,O,792
16824,There,O,792
16825,a,O,792
16826,Cure,O,792
16827,for,O,792
16828,Ocular,B-NAME_OF_DISEASE,792
16829,Albinism,I-NAME_OF_DISEASE,792
16830,Presently,O,792
16831,Ocular,B-NAME_OF_DISEASE,792
16832,albinism,I-NAME_OF_DISEASE,792
16833,is,O,792
16834,irremediable,O,792
16835,chiefly,O,792
16836,because,O,792
16837,it,O,792
16838,is,O,792
16839,a,O,792
16840,disease,O,793
16841,with,O,793
16842,genetic,O,793
16843,origin,O,793
16844,The,O,793
16845,main,O,793
16846,aim,O,793
16847,of,O,793
16848,treatment,O,793
16849,in,O,793
16850,these,O,793
16851,patients,O,793
16852,is,O,793
16853,to,O,793
16854,improve,O,793
16855,or,O,793
16856,at,O,793
16857,least,O,793
16858,maintain,O,793
16859,the,O,793
16860,quality,O,793
16861,of,O,793
16862,their,O,793
16863,vision,O,793
16864,Many,O,793
16865,approaches,O,793
16866,and,O,794
16867,plans,O,794
16868,of,O,794
16869,action,O,794
16870,are,O,794
16871,available,O,794
16872,for,O,794
16873,people,O,794
16874,with,O,794
16875,Ocular,B-NAME_OF_DISEASE,794
16876,Albinism,I-NAME_OF_DISEASE,794
16877,which,O,794
16878,are,O,794
16879,stated,O,794
16880,as,O,794
16881,under,O,794
16882,Vision-correcting,B-TREATMENT,794
16883,devices,I-TREATMENT,794
16884,Low,B-TREATMENT,794
16885,vision,I-TREATMENT,794
16886,aids,I-TREATMENT,794
16887,Glasses,B-TREATMENT,794
16888,and,O,794
16889,contact,B-TREATMENT,794
16890,lenses,I-TREATMENT,794
16891,to,O,794
16892,help,O,794
16893,clear,O,794
16894,the,O,794
16895,vision,O,794
16896,for,O,794
16897,people,O,794
16898,with,O,794
16899,ocular,B-NAME_OF_DISEASE,794
16900,albinism,I-NAME_OF_DISEASE,794
16901,Handheld,B-TREATMENT,794
16902,magnifiers,I-TREATMENT,794
16903,are,O,794
16904,a,O,794
16905,blessing,O,794
16906,as,O,794
16907,well,O,794
16908,Sunglasses,B-TREATMENT,794
16909,transition,B-TREATMENT,794
16910,lenses,I-TREATMENT,794
16911,Special,B-TREATMENT,795
16912,filter,I-TREATMENT,795
16913,glasses,I-TREATMENT,795
16914,to,O,795
16915,help,O,795
16916,with,O,795
16917,photophobia,B-NAME_OF_DISEASE,795
16918,Alteration,B-TREATMENT,795
16919,to,I-TREATMENT,795
16920,indoor,I-TREATMENT,795
16921,lighting,I-TREATMENT,795
16922,can,O,795
16923,aid,O,795
16924,in,O,795
16925,seeing,O,795
16926,better,O,795
16927,as,O,795
16928,well,O,795
16929,Basic,O,795
16930,focus,O,795
16931,of,O,796
16932,treatment,O,796
16933,is,O,796
16934,on,O,796
16935,proper,B-TREATMENT,796
16936,eye,I-TREATMENT,796
16937,care,I-TREATMENT,796
16938,and,I-TREATMENT,796
16939,looking,I-TREATMENT,796
16940,for,I-TREATMENT,796
16941,signs,I-TREATMENT,796
16942,of,I-TREATMENT,796
16943,skin,I-TREATMENT,796
16944,abnormalities,I-TREATMENT,796
16945,What,O,796
16946,Is,O,796
16947,Inflammatory,B-NAME_OF_DISEASE,796
16948,Glaucoma,I-NAME_OF_DISEASE,796
16949,Inflammatory,B-NAME_OF_DISEASE,796
16950,Glaucoma,I-NAME_OF_DISEASE,796
16951,also,O,796
16952,defined,O,796
16953,as,O,796
16954,Uveitic,B-NAME_OF_DISEASE,796
16955,Glaucoma,I-NAME_OF_DISEASE,796
16956,is,O,796
16957,a,O,796
16958,disorder,O,796
16959,in,O,796
16960,which,O,796
16961,persistent,B-SIGN_AND_SYMPTOM,796
16962,or,I-SIGN_AND_SYMPTOM,796
16963,recurring,I-SIGN_AND_SYMPTOM,796
16964,IOP,I-SIGN_AND_SYMPTOM,796
16965,elevation,I-SIGN_AND_SYMPTOM,796
16966,results,O,796
16967,in,O,796
16968,morphological,O,796
16969,and,O,796
16970,physiological,O,796
16971,alterations,O,796
16972,of,O,796
16973,optic,B-PART_OF_THE_EYES,796
16974,disc,I-PART_OF_THE_EYES,796
16975,typical,O,796
16976,of,O,797
16977,primary,B-NAME_OF_DISEASE,797
16978,open-angle,I-NAME_OF_DISEASE,797
16979,Glaucoma,I-NAME_OF_DISEASE,797
16980,Inflammation,B-SIGN_AND_SYMPTOM,797
16981,of,I-SIGN_AND_SYMPTOM,797
16982,the,I-SIGN_AND_SYMPTOM,797
16983,ocular,I-SIGN_AND_SYMPTOM,797
16984,tissues,I-SIGN_AND_SYMPTOM,797
16985,is,O,797
16986,the,O,797
16987,cause,O,797
16988,of,O,797
16989,continuous,B-SIGN_AND_SYMPTOM,797
16990,or,I-SIGN_AND_SYMPTOM,797
16991,repeated,I-SIGN_AND_SYMPTOM,797
16992,elevations,I-SIGN_AND_SYMPTOM,797
16993,in,I-SIGN_AND_SYMPTOM,797
16994,intraocular,I-SIGN_AND_SYMPTOM,797
16995,pressure,I-SIGN_AND_SYMPTOM,797
16996,IOP,I-SIGN_AND_SYMPTOM,797
16997,in,O,797
16998,inflammatory,B-NAME_OF_DISEASE,797
16999,Glaucoma,I-NAME_OF_DISEASE,797
17000,Extreme,O,797
17001,cases,O,797
17002,of,O,798
17003,elevated,O,798
17004,intraocular,O,798
17005,pressure,O,798
17006,may,O,798
17007,accompany,O,798
17008,optic,B-SIGN_AND_SYMPTOM,798
17009,nerve,I-SIGN_AND_SYMPTOM,798
17010,cupping,I-SIGN_AND_SYMPTOM,798
17011,neuroretinal,I-SIGN_AND_SYMPTOM,798
17012,rim,I-SIGN_AND_SYMPTOM,798
17013,loss,I-SIGN_AND_SYMPTOM,798
17014,and,I-SIGN_AND_SYMPTOM,798
17015,visual,I-SIGN_AND_SYMPTOM,799
17016,field,I-SIGN_AND_SYMPTOM,800
17017,abnormalities,I-SIGN_AND_SYMPTOM,800
17018,Uveitic,B-NAME_OF_DISEASE,800
17019,Glaucoma,I-NAME_OF_DISEASE,800
17020,can,O,800
17021,be,O,800
17022,observed,O,800
17023,in,O,800
17024,the,O,800
17025,subsequent,O,800
17026,inflammatory,O,800
17027,disorders,O,800
17028,Posner-Schlossman,B-NAME_OF_DISEASE,800
17029,syndrome,I-NAME_OF_DISEASE,800
17030,Fuch,B-NAME_OF_DISEASE,800
17031,s,I-NAME_OF_DISEASE,800
17032,heterochromic,I-NAME_OF_DISEASE,800
17033,Iridocyclitis,I-NAME_OF_DISEASE,800
17034,Syphilis,B-NAME_OF_DISEASE,800
17035,Sarcoidosis,B-NAME_OF_DISEASE,800
17036,Juvenile,B-NAME_OF_DISEASE,800
17037,Rheumatoid,I-NAME_OF_DISEASE,800
17038,Arthritis,I-NAME_OF_DISEASE,800
17039,Herpes,B-NAME_OF_DISEASE,800
17040,Simplex,I-NAME_OF_DISEASE,800
17041,Kerato-uveitis,I-NAME_OF_DISEASE,800
17042,Varicella,B-NAME_OF_DISEASE,800
17043,Zoster,I-NAME_OF_DISEASE,800
17044,Iridocyclitis,I-NAME_OF_DISEASE,800
17045,Vogt-Koyanagi-Harada,B-NAME_OF_DISEASE,800
17046,Syndrome,I-NAME_OF_DISEASE,800
17047,Ocular,B-NAME_OF_DISEASE,800
17048,Toxoplasmosis,I-NAME_OF_DISEASE,801
17049,Scleritis,B-NAME_OF_DISEASE,801
17050,and,O,801
17051,Episcleritis,B-NAME_OF_DISEASE,801
17052,Diagnosis,O,801
17053,Of,O,801
17054,Inflammatory,B-NAME_OF_DISEASE,801
17055,Glaucoma,B-NAME_OF_DISEASE,801
17056,Diagnosis,O,801
17057,of,O,801
17058,inflammatory,B-NAME_OF_DISEASE,801
17059,Glaucoma,B-NAME_OF_DISEASE,801
17060,is,O,801
17061,clinical,O,801
17062,Any,O,801
17063,patient,O,801
17064,with,O,801
17065,recurrent,B-NAME_OF_DISEASE,801
17066,or,I-NAME_OF_DISEASE,801
17067,bilateral,I-NAME_OF_DISEASE,802
17068,uveitis,I-NAME_OF_DISEASE,802
17069,should,O,802
17070,have,O,802
17071,an,O,802
17072,ocular,O,802
17073,or,O,802
17074,systemic,O,802
17075,etiology,O,802
17076,investigated,O,802
17077,It,O,802
17078,is,O,802
17079,necessary,O,802
17080,to,O,802
17081,do,O,802
17082,an,B-DIAGNOSTIC_TEST,802
17083,appropriate,I-DIAGNOSTIC_TEST,802
17084,systemic,I-DIAGNOSTIC_TEST,802
17085,evaluation,I-DIAGNOSTIC_TEST,802
17086,focusing,O,802
17087,on,O,802
17088,arthritis,B-NAME_OF_DISEASE,802
17089,infections,O,803
17090,mucosa,O,803
17091,or,O,803
17092,skin,O,803
17093,lesions,O,803
17094,and,O,803
17095,respiratory,O,803
17096,symptoms,O,803
17097,All,O,803
17098,patients,O,803
17099,may,O,803
17100,benefit,O,803
17101,from,O,804
17102,a,B-DIAGNOSTIC_TEST,804
17103,complete,I-DIAGNOSTIC_TEST,804
17104,blood,I-DIAGNOSTIC_TEST,804
17105,count,I-DIAGNOSTIC_TEST,804
17106,and,I-DIAGNOSTIC_TEST,804
17107,syphilis,I-DIAGNOSTIC_TEST,804
17108,serology,I-DIAGNOSTIC_TEST,804
17109,while,O,804
17110,those,O,804
17111,of,O,805
17112,African,O,805
17113,heritage,O,805
17114,may,O,805
17115,need,O,805
17116,angiotensin-converting,B-DIAGNOSTIC_TEST,805
17117,enzyme,I-DIAGNOSTIC_TEST,805
17118,test,I-DIAGNOSTIC_TEST,805
17119,and,O,805
17120,a,B-DIAGNOSTIC_TEST,805
17121,chest,I-DIAGNOSTIC_TEST,805
17122,X-ray,I-DIAGNOSTIC_TEST,805
17123,Following,O,805
17124,points,O,806
17125,must,O,806
17126,be,O,806
17127,kept,O,806
17128,in,O,806
17129,mind,O,806
17130,during,O,806
17131,diagnosis,O,806
17132,of,O,806
17133,inflammatory,B-NAME_OF_DISEASE,806
17134,glaucoma,I-NAME_OF_DISEASE,806
17135,Ocular,B-DIAGNOSTIC_TEST,806
17136,History,I-DIAGNOSTIC_TEST,806
17137,Systemic,B-DIAGNOSTIC_TEST,806
17138,History,I-DIAGNOSTIC_TEST,806
17139,Including,I-DIAGNOSTIC_TEST,806
17140,infective,I-DIAGNOSTIC_TEST,806
17141,inflammatory,I-DIAGNOSTIC_TEST,806
17142,or,I-DIAGNOSTIC_TEST,806
17143,autoimmune,I-DIAGNOSTIC_TEST,806
17144,conditions,I-DIAGNOSTIC_TEST,806
17145,Visual,B-DIAGNOSTIC_TEST,806
17146,acuity,I-DIAGNOSTIC_TEST,807
17147,and,I-DIAGNOSTIC_TEST,807
17148,refraction,I-DIAGNOSTIC_TEST,807
17149,Slit,B-DIAGNOSTIC_TEST,807
17150,Lamp,I-DIAGNOSTIC_TEST,807
17151,Examination,I-DIAGNOSTIC_TEST,807
17152,Tonometry,B-DIAGNOSTIC_TEST,807
17153,Gonioscopy,B-DIAGNOSTIC_TEST,807
17154,OCT-RNFL,B-DIAGNOSTIC_TEST,807
17155,to,O,807
17156,determine,O,807
17157,damage,O,807
17158,by,O,807
17159,Glaucoma,B-NAME_OF_DISEASE,807
17160,Signs,O,807
17161,And,O,807
17162,Symptoms,O,807
17163,of,O,808
17164,Inflammatory,B-NAME_OF_DISEASE,808
17165,Glaucoma,I-NAME_OF_DISEASE,808
17166,General,O,808
17167,Clinical,O,808
17168,Features,O,808
17169,Blurred,B-SIGN_AND_SYMPTOM,808
17170,Vision,I-SIGN_AND_SYMPTOM,808
17171,Ocular,B-SIGN_AND_SYMPTOM,808
17172,pain,I-SIGN_AND_SYMPTOM,808
17173,Brow,B-SIGN_AND_SYMPTOM,808
17174,ache,I-SIGN_AND_SYMPTOM,808
17175,Photophobia,B-SIGN_AND_SYMPTOM,808
17176,Coloured,B-SIGN_AND_SYMPTOM,808
17177,haloes,I-SIGN_AND_SYMPTOM,808
17178,Elevated,B-SIGN_AND_SYMPTOM,808
17179,IOP,I-SIGN_AND_SYMPTOM,808
17180,Optic,B-SIGN_AND_SYMPTOM,808
17181,nerve,I-SIGN_AND_SYMPTOM,808
17182,head,I-SIGN_AND_SYMPTOM,809
17183,changes,I-SIGN_AND_SYMPTOM,809
17184,Specific,O,809
17185,Clinical,O,809
17186,Features,O,809
17187,Clinical,O,809
17188,Features,O,809
17189,and,O,809
17190,Treatment,O,809
17191,of,O,809
17192,Inflammatory,B-NAME_OF_DISEASE,809
17193,Glaucoma,I-NAME_OF_DISEASE,809
17194,depend,O,809
17195,on,O,810
17196,its,O,810
17197,type,O,810
17198,as,O,810
17199,each,O,810
17200,type,O,810
17201,has,O,810
17202,its,O,810
17203,own,O,810
17204,pathophysiology,O,810
17205,Open-Angle,B-NAME_OF_DISEASE,810
17206,type,I-NAME_OF_DISEASE,810
17207,This,O,810
17208,type,O,811
17209,of,O,811
17210,inflammatory,B-NAME_OF_DISEASE,811
17211,Glaucoma,I-NAME_OF_DISEASE,811
17212,is,O,811
17213,due,O,811
17214,to,O,811
17215,acute,B-CAUSE_OF_DISEASE,811
17216,trabeculitis,I-CAUSE_OF_DISEASE,811
17217,causing,O,811
17218,inflammation,B-SIGN_AND_SYMPTOM,812
17219,and,I-SIGN_AND_SYMPTOM,812
17220,edema,I-SIGN_AND_SYMPTOM,812
17221,of,I-SIGN_AND_SYMPTOM,812
17222,the,I-SIGN_AND_SYMPTOM,812
17223,trabecular,I-SIGN_AND_SYMPTOM,812
17224,meshwork,I-SIGN_AND_SYMPTOM,812
17225,Following,O,812
17226,signs,O,812
17227,might,O,812
17228,be,O,812
17229,observed,O,812
17230,in,O,812
17231,its,O,812
17232,cases,O,812
17233,Flares,B-SIGN_AND_SYMPTOM,812
17234,and,I-SIGN_AND_SYMPTOM,812
17235,cells,I-SIGN_AND_SYMPTOM,812
17236,in,I-SIGN_AND_SYMPTOM,812
17237,the,I-SIGN_AND_SYMPTOM,812
17238,AC,I-SIGN_AND_SYMPTOM,812
17239,Posterior,B-SIGN_AND_SYMPTOM,812
17240,Synechiae,I-SIGN_AND_SYMPTOM,812
17241,Keratic,B-SIGN_AND_SYMPTOM,812
17242,precipitates,I-SIGN_AND_SYMPTOM,812
17243,KP,I-SIGN_AND_SYMPTOM,812
17244,Irregular,B-SIGN_AND_SYMPTOM,812
17245,and,I-SIGN_AND_SYMPTOM,812
17246,small,I-SIGN_AND_SYMPTOM,812
17247,pupil,I-SIGN_AND_SYMPTOM,812
17248,Mashed,B-SIGN_AND_SYMPTOM,812
17249,potato-like,I-SIGN_AND_SYMPTOM,812
17250,membrane,I-SIGN_AND_SYMPTOM,812
17251,in,I-SIGN_AND_SYMPTOM,812
17252,the,I-SIGN_AND_SYMPTOM,812
17253,trabecular,I-SIGN_AND_SYMPTOM,812
17254,Angle-Closure,B-NAME_OF_DISEASE,812
17255,type,I-NAME_OF_DISEASE,812
17256,Chronic,B-NAME_OF_DISEASE,813
17257,anterior,I-NAME_OF_DISEASE,813
17258,uveitis,I-NAME_OF_DISEASE,813
17259,causes,O,813
17260,deposition,B-SIGN_AND_SYMPTOM,813
17261,and,I-SIGN_AND_SYMPTOM,813
17262,contraction,I-SIGN_AND_SYMPTOM,813
17263,of,I-SIGN_AND_SYMPTOM,813
17264,inflammatory,I-SIGN_AND_SYMPTOM,813
17265,debris,I-SIGN_AND_SYMPTOM,813
17266,in,I-SIGN_AND_SYMPTOM,813
17267,the,I-SIGN_AND_SYMPTOM,813
17268,anterior,I-SIGN_AND_SYMPTOM,813
17269,angle,I-SIGN_AND_SYMPTOM,813
17270,This,O,813
17271,inflammatory,O,813
17272,condition,O,814
17273,causes,O,814
17274,pulling,B-SIGN_AND_SYMPTOM,814
17275,of,I-SIGN_AND_SYMPTOM,814
17276,the,I-SIGN_AND_SYMPTOM,814
17277,iris,I-SIGN_AND_SYMPTOM,814
17278,over,I-SIGN_AND_SYMPTOM,814
17279,the,I-SIGN_AND_SYMPTOM,814
17280,trabecula,I-SIGN_AND_SYMPTOM,814
17281,and,I-SIGN_AND_SYMPTOM,814
17282,360°,I-SIGN_AND_SYMPTOM,814
17283,PS,I-SIGN_AND_SYMPTOM,814
17284,seclusio,I-SIGN_AND_SYMPTOM,814
17285,pupillae,I-SIGN_AND_SYMPTOM,814
17286,which,O,814
17287,causes,O,814
17288,angle,B-SIGN_AND_SYMPTOM,814
17289,closure,I-SIGN_AND_SYMPTOM,814
17290,and,I-SIGN_AND_SYMPTOM,814
17291,obstruction,I-SIGN_AND_SYMPTOM,814
17292,to,I-SIGN_AND_SYMPTOM,814
17293,aqueous,I-SIGN_AND_SYMPTOM,814
17294,humour,I-SIGN_AND_SYMPTOM,814
17295,flow,I-SIGN_AND_SYMPTOM,814
17296,Following,O,815
17297,signs,O,815
17298,might,O,815
17299,be,O,815
17300,observed,O,815
17301,in,O,815
17302,its,O,815
17303,cases,O,815
17304,Shallow,B-SIGN_AND_SYMPTOM,815
17305,AC,I-SIGN_AND_SYMPTOM,815
17306,Signs,O,815
17307,of,O,815
17308,previous,O,815
17309,inflammatory,O,815
17310,episodes,O,815
17311,360-degree,B-SIGN_AND_SYMPTOM,815
17312,posterior,I-SIGN_AND_SYMPTOM,815
17313,synechiae,I-SIGN_AND_SYMPTOM,815
17314,Secondary,O,815
17315,to,O,815
17316,Posner-Schlossman,B-NAME_OF_DISEASE,815
17317,syndrome,I-NAME_OF_DISEASE,815
17318,Painless,B-SIGN_AND_SYMPTOM,815
17319,decrease,I-SIGN_AND_SYMPTOM,816
17320,visual,I-SIGN_AND_SYMPTOM,816
17321,acuity,I-SIGN_AND_SYMPTOM,816
17322,with,I-SIGN_AND_SYMPTOM,816
17323,haloes,I-SIGN_AND_SYMPTOM,816
17324,White-eye,B-SIGN_AND_SYMPTOM,816
17325,Raise,B-SIGN_AND_SYMPTOM,816
17326,of,I-SIGN_AND_SYMPTOM,816
17327,IOP,I-SIGN_AND_SYMPTOM,816
17328,may,I-SIGN_AND_SYMPTOM,816
17329,go,I-SIGN_AND_SYMPTOM,816
17330,around,I-SIGN_AND_SYMPTOM,816
17331,40-80mmHg,I-SIGN_AND_SYMPTOM,816
17332,No,B-SIGN_AND_SYMPTOM,816
17333,synechiae,I-SIGN_AND_SYMPTOM,816
17334,Occasional,B-SIGN_AND_SYMPTOM,816
17335,cells,I-SIGN_AND_SYMPTOM,816
17336,KPs,I-SIGN_AND_SYMPTOM,816
17337,Open-angle,B-SIGN_AND_SYMPTOM,816
17338,Secondary,O,816
17339,to,O,816
17340,Fuch,B-NAME_OF_DISEASE,817
17341,s,I-NAME_OF_DISEASE,817
17342,heterochromaic,I-NAME_OF_DISEASE,817
17343,Iridocyclitis,I-NAME_OF_DISEASE,817
17344,Decrease,B-SIGN_AND_SYMPTOM,817
17345,in,I-SIGN_AND_SYMPTOM,817
17346,VA,I-SIGN_AND_SYMPTOM,817
17347,due,O,817
17348,to,O,817
17349,cataract,B-CAUSE_OF_DISEASE,817
17350,posterior,I-CAUSE_OF_DISEASE,817
17351,cortical,I-CAUSE_OF_DISEASE,817
17352,subcapsular,I-CAUSE_OF_DISEASE,817
17353,Floaters,B-SIGN_AND_SYMPTOM,817
17354,White,B-SIGN_AND_SYMPTOM,817
17355,stellate,I-SIGN_AND_SYMPTOM,817
17356,KPs,I-SIGN_AND_SYMPTOM,818
17357,over,I-SIGN_AND_SYMPTOM,818
17358,corneal,I-SIGN_AND_SYMPTOM,818
17359,endothelium,I-SIGN_AND_SYMPTOM,818
17360,Mild,B-SIGN_AND_SYMPTOM,818
17361,flare,I-SIGN_AND_SYMPTOM,818
17362,Iris,B-SIGN_AND_SYMPTOM,818
17363,heterochromia,I-SIGN_AND_SYMPTOM,818
17364,Open-angle,B-SIGN_AND_SYMPTOM,818
17365,+,I-SIGN_AND_SYMPTOM,818
17366,-,I-SIGN_AND_SYMPTOM,818
17367,NVA,I-SIGN_AND_SYMPTOM,818
17368,How,O,818
17369,Can,O,818
17370,It,O,818
17371,Be,O,818
17372,Treated,O,818
17373,Treatment,O,818
17374,of,O,818
17375,inflammatory,B-NAME_OF_DISEASE,819
17376,Glaucoma,B-NAME_OF_DISEASE,819
17377,depends,O,819
17378,upon,O,819
17379,three,O,819
17380,pillars,O,819
17381,1,O,819
17382,Treatment,B-TREATMENT,819
17383,of,I-TREATMENT,819
17384,inflammation,I-TREATMENT,819
17385,The,O,819
17386,primary,O,819
17387,objectives,O,820
17388,of,O,820
17389,inflammatory,B-TREATMENT,820
17390,treatment,I-TREATMENT,820
17391,are,O,820
17392,to,O,820
17393,give,B-TREATMENT,820
17394,symptomatic,I-TREATMENT,820
17395,relief,I-TREATMENT,820
17396,prevent,I-TREATMENT,820
17397,the,I-TREATMENT,820
17398,formation,I-TREATMENT,820
17399,of,I-TREATMENT,820
17400,posterior,I-TREATMENT,820
17401,synechiae,I-TREATMENT,820
17402,and,I-TREATMENT,820
17403,decrease,I-TREATMENT,820
17404,the,I-TREATMENT,820
17405,intensity,I-TREATMENT,820
17406,and,I-TREATMENT,820
17407,frequency,I-TREATMENT,820
17408,of,I-TREATMENT,820
17409,bouts,I-TREATMENT,820
17410,or,I-TREATMENT,820
17411,exacerbations,I-TREATMENT,820
17412,of,I-TREATMENT,820
17413,uveitis,I-TREATMENT,820
17414,Corticosteroids,B-NAME_OF_DRUG,820
17415,Topical,I-NAME_OF_DRUG,820
17416,Intravitreal,I-NAME_OF_DRUG,820
17417,Systemic,I-NAME_OF_DRUG,820
17418,Periocular,I-NAME_OF_DRUG,821
17419,Cycloplegics,B-NAME_OF_DRUG,821
17420,Antimetabolites,B-NAME_OF_DRUG,821
17421,like,I-NAME_OF_DRUG,821
17422,methotrexate,I-NAME_OF_DRUG,821
17423,T,B-NAME_OF_DRUG,821
17424,cell,I-NAME_OF_DRUG,821
17425,suppressors,I-NAME_OF_DRUG,821
17426,like,I-NAME_OF_DRUG,821
17427,cyclosporine,I-NAME_OF_DRUG,821
17428,Cytotoxic,B-NAME_OF_DRUG,821
17429,agents,I-NAME_OF_DRUG,821
17430,like,I-NAME_OF_DRUG,821
17431,cyclophosphamide,I-NAME_OF_DRUG,821
17432,2,O,821
17433,Treatment,O,821
17434,of,O,822
17435,Glaucoma,B-NAME_OF_DISEASE,822
17436,by,O,822
17437,antiglaucoma,B-TREATMENT,822
17438,therapy,I-TREATMENT,822
17439,Beta,B-NAME_OF_DRUG,822
17440,Blockers,I-NAME_OF_DRUG,822
17441,Carbonic,B-NAME_OF_DRUG,822
17442,Anhydrase,I-NAME_OF_DRUG,822
17443,Inhibitors,I-NAME_OF_DRUG,822
17444,Selective,B-NAME_OF_DRUG,822
17445,alpha,I-NAME_OF_DRUG,822
17446,2,I-NAME_OF_DRUG,822
17447,adrenergic,I-NAME_OF_DRUG,823
17448,agonists,I-NAME_OF_DRUG,823
17449,Prostaglandins,B-NAME_OF_DRUG,823
17450,analogs,I-NAME_OF_DRUG,823
17451,Miotics,B-NAME_OF_DRUG,823
17452,Hyperosmotic,B-NAME_OF_DRUG,823
17453,agents,I-NAME_OF_DRUG,823
17454,3,O,823
17455,Surgical,B-TREATMENT,823
17456,Treatment,I-TREATMENT,824
17457,Ophthalmologists,O,824
17458,should,O,824
17459,avoid,O,824
17460,intraocular,O,824
17461,surgery,B-TREATMENT,824
17462,in,O,824
17463,eyes,O,824
17464,with,O,824
17465,current,O,824
17466,inflammation,O,824
17467,However,O,824
17468,when,O,824
17469,medical,B-TREATMENT,824
17470,treatment,I-TREATMENT,824
17471,is,O,824
17472,ineffective,O,824
17473,surgery,B-TREATMENT,824
17474,may,O,824
17475,be,O,824
17476,necessary,O,824
17477,It,O,824
17478,is,O,824
17479,best,O,825
17480,to,O,825
17481,perform,O,825
17482,as,O,825
17483,minor,O,825
17484,surgery,B-TREATMENT,825
17485,as,O,825
17486,possible,O,825
17487,in,O,825
17488,these,O,825
17489,situations,O,825
17490,Recent,O,825
17491,research,O,825
17492,has,O,825
17493,proven,O,825
17494,the,O,825
17495,following,O,825
17496,techniques,O,825
17497,to,O,826
17498,be,O,826
17499,of,O,826
17500,some,O,826
17501,value,O,826
17502,Laser,B-TREATMENT,826
17503,Iridotomy,I-TREATMENT,826
17504,Antimetabolite,B-TREATMENT,826
17505,Therapy,I-TREATMENT,826
17506,in,I-TREATMENT,826
17507,association,I-TREATMENT,826
17508,with,I-TREATMENT,826
17509,trabeculectomy,I-TREATMENT,826
17510,Author,O,826
17511,Dr,O,826
17512,Muhammad,O,826
17513,Saad,O,826
17514,Resident,O,827
17515,Ophthalmologist,O,827
17516,at,O,827
17517,Al-Shifa,B-ORGANIZATION,827
17518,Trust,I-ORGANIZATION,827
17519,Eye,I-ORGANIZATION,827
17520,Hospital,I-ORGANIZATION,827
17521,in,O,827
17522,Rawalpindi,B-GPE,827
17523,Pakistan,I-GPE,827
17524,What,O,827
17525,Is,O,827
17526,Radial,B-TREATMENT,827
17527,Keratotomy,I-TREATMENT,827
17528,Radial,B-TREATMENT,827
17529,Keratotomy,I-TREATMENT,827
17530,RK,B-TREATMENT,827
17531,is,O,827
17532,a,O,827
17533,surgical,O,827
17534,procedure,O,827
17535,that,O,827
17536,was,O,827
17537,introduced,O,827
17538,in,O,828
17539,the,O,828
17540,1970s,O,828
17541,In,O,828
17542,this,O,828
17543,surgical,O,828
17544,technique,O,828
17545,multiple,O,828
17546,radial,O,828
17547,incisions,O,828
17548,are,O,828
17549,made,O,828
17550,in,O,828
17551,the,B-PART_OF_THE_EYES,828
17552,corneal,I-PART_OF_THE_EYES,828
17553,stroma,I-PART_OF_THE_EYES,828
17554,to,O,828
17555,correct,O,828
17556,mild,O,828
17557,to,O,828
17558,moderate,O,828
17559,myopia,B-NAME_OF_DISEASE,828
17560,This,O,828
17561,treatment,O,828
17562,is,O,828
17563,no,O,828
17564,longer,O,829
17565,the,O,829
17566,most,O,829
17567,common,O,829
17568,safest,O,829
17569,or,O,829
17570,stable,O,829
17571,refractive,O,829
17572,procedure,O,830
17573,It,O,830
17574,has,O,830
17575,been,O,830
17576,replaced,O,830
17577,with,O,830
17578,the,B-TREATMENT,830
17579,excimer,I-TREATMENT,830
17580,laser,I-TREATMENT,830
17581,which,O,830
17582,enables,O,830
17583,precise,O,830
17584,corneal,O,830
17585,incisions,O,830
17586,RK,B-TREATMENT,830
17587,was,O,830
17588,the,O,830
17589,first,O,830
17590,surgical,O,830
17591,procedure,O,830
17592,used,O,830
17593,to,O,830
17594,cure,O,830
17595,myopia,B-NAME_OF_DISEASE,830
17596,It,O,830
17597,consists,O,830
17598,of,O,831
17599,a,O,831
17600,variable,O,831
17601,number,O,831
17602,of,O,831
17603,deep,O,831
17604,85-90%,O,831
17605,thickness,O,831
17606,radial,O,831
17607,stromal,O,831
17608,incisions,O,831
17609,usually,O,831
17610,eight,O,831
17611,made,O,831
17612,throughout,O,831
17613,the,B-PART_OF_THE_EYES,831
17614,peripheral,I-PART_OF_THE_EYES,831
17615,and,I-PART_OF_THE_EYES,832
17616,mid-peripheral,I-PART_OF_THE_EYES,832
17617,cornea,I-PART_OF_THE_EYES,832
17618,resulting,O,832
17619,in,O,832
17620,a,O,832
17621,weakening,O,832
17622,and,O,832
17623,bulging,O,832
17624,of,O,832
17625,the,O,832
17626,peripheral,O,832
17627,and,O,833
17628,a,O,833
17629,flattening,O,833
17630,of,O,833
17631,the,B-PART_OF_THE_EYES,833
17632,central,I-PART_OF_THE_EYES,833
17633,cornea,I-PART_OF_THE_EYES,833
17634,Due,O,833
17635,to,O,833
17636,the,O,833
17637,manual,O,833
17638,nature,O,833
17639,of,O,833
17640,radial,B-TREATMENT,833
17641,keratotomies,I-TREATMENT,833
17642,the,O,833
17643,incisions,O,833
17644,are,O,833
17645,neither,O,833
17646,exactly,O,834
17647,radial,O,834
17648,nor,O,834
17649,symmetric,O,834
17650,Who,O,834
17651,May,O,834
17652,Require,O,834
17653,Radial,B-TREATMENT,834
17654,Keratotomy,I-TREATMENT,834
17655,Patients,O,834
17656,with,O,834
17657,mild,O,834
17658,to,O,834
17659,moderate,O,835
17660,myopia,B-NAME_OF_DISEASE,835
17661,with,O,835
17662,or,O,835
17663,without,O,835
17664,astigmatism,B-NAME_OF_DISEASE,835
17665,are,O,835
17666,good,O,835
17667,candidates,O,835
17668,for,O,835
17669,radial,B-TREATMENT,835
17670,keratotomy,I-TREATMENT,835
17671,RK,I-TREATMENT,835
17672,eye,O,835
17673,surgery,O,835
17674,How,O,835
17675,Is,O,835
17676,the,O,835
17677,Procedure,O,835
17678,Done,O,835
17679,This,O,836
17680,surgical,O,836
17681,treatment,O,836
17682,aims,O,836
17683,to,O,836
17684,modify,O,836
17685,the,B-PART_OF_THE_EYES,836
17686,cornea,I-PART_OF_THE_EYES,836
17687,s,O,836
17688,curvature,O,836
17689,by,O,836
17690,making,O,836
17691,radial,O,836
17692,incisions,O,836
17693,with,O,836
17694,a,B-SURGICAL_INSTRUMENT,837
17695,diamond,I-SURGICAL_INSTRUMENT,837
17696,knife,I-SURGICAL_INSTRUMENT,837
17697,Multiple,O,837
17698,incisions,O,837
17699,are,O,837
17700,given,O,837
17701,in,O,837
17702,the,B-PART_OF_THE_EYES,837
17703,cornea,I-PART_OF_THE_EYES,837
17704,s,O,837
17705,periphery,O,837
17706,leaving,O,837
17707,a,O,837
17708,central,O,838
17709,4mm,O,838
17710,optical,O,838
17711,zone,O,838
17712,to,O,838
17713,flatten,O,838
17714,the,B-PART_OF_THE_EYES,838
17715,cornea,I-PART_OF_THE_EYES,838
17716,s,O,838
17717,curvature,O,838
17718,This,O,838
17719,procedure,O,838
17720,provides,O,838
17721,an,O,838
17722,excellent,O,838
17723,refractive,O,838
17724,correction,O,838
17725,in,O,838
17726,low,O,838
17727,to,O,838
17728,moderate,O,838
17729,myopia,B-NAME_OF_DISEASE,838
17730,2,O,839
17731,to,O,839
17732,6D,O,839
17733,,O,839
17734,The,O,839
17735,treatment,O,839
17736,takes,O,839
17737,around,O,839
17738,15,O,839
17739,minutes,O,839
17740,and,O,839
17741,is,O,839
17742,typically,O,839
17743,performed,O,840
17744,under,O,840
17745,topical,O,840
17746,anesthesia,O,840
17747,which,O,840
17748,means,O,840
17749,the,O,840
17750,patient,O,840
17751,is,O,840
17752,awake,O,841
17753,Still,O,841
17754,the,O,841
17755,eyes,O,841
17756,are,O,841
17757,numbed,O,841
17758,with,O,841
17759,eye,O,841
17760,drops,O,841
17761,so,O,842
17762,minimal,O,842
17763,discomfort,O,843
17764,exists,O,843
17765,A,O,843
17766,variable,O,843
17767,number,O,843
17768,of,O,843
17769,4,O,843
17770,to,O,843
17771,24,O,843
17772,corneal,O,843
17773,incisions,O,843
17774,85-90%,O,843
17775,of,O,843
17776,total,O,843
17777,corneal,O,843
17778,thickness,O,843
17779,are,O,843
17780,created,O,843
17781,using,O,843
17782,a,B-SURGICAL_INSTRUMENT,843
17783,diamond,I-SURGICAL_INSTRUMENT,843
17784,knife,I-SURGICAL_INSTRUMENT,843
17785,and,O,843
17786,the,O,843
17787,focusing,O,843
17788,power,O,843
17789,of,O,843
17790,the,B-PART_OF_THE_EYES,843
17791,anterior,I-PART_OF_THE_EYES,843
17792,corneal,I-PART_OF_THE_EYES,844
17793,surface,I-PART_OF_THE_EYES,844
17794,is,O,844
17795,adjusted,O,844
17796,The,O,844
17797,varying,O,844
17798,number,O,844
17799,of,O,844
17800,incisions,O,844
17801,is,O,844
17802,determined,O,844
17803,by,O,844
17804,the,O,844
17805,degree,O,844
17806,of,O,844
17807,astigmatism,B-NAME_OF_DISEASE,844
17808,or,O,844
17809,myopia,B-NAME_OF_DISEASE,844
17810,correction,O,844
17811,required,O,844
17812,As,O,844
17813,a,B-CAUSE_OF_DISEASE,844
17814,steep,I-CAUSE_OF_DISEASE,844
17815,corneal,I-CAUSE_OF_DISEASE,844
17816,curvature,I-CAUSE_OF_DISEASE,844
17817,causes,O,844
17818,myopia,B-NAME_OF_DISEASE,844
17819,RK,B-TREATMENT,844
17820,helps,O,844
17821,to,O,844
17822,reduce,O,844
17823,this,O,845
17824,steepness,O,845
17825,This,O,845
17826,aids,O,845
17827,in,O,845
17828,the,O,845
17829,treatment,O,845
17830,of,O,845
17831,myopia,B-NAME_OF_DISEASE,845
17832,and,O,845
17833,astigmatism,B-NAME_OF_DISEASE,845
17834,Do,O,845
17835,The,O,845
17836,Surgeon,O,845
17837,Operates,O,845
17838,Both,O,845
17839,the,O,845
17840,Eyes,O,845
17841,at,O,845
17842,Once,O,845
17843,No,O,845
17844,the,O,845
17845,surgeon,O,846
17846,often,O,846
17847,waits,O,846
17848,approximately,O,846
17849,six,B-TIME_DURATION,846
17850,weeks,I-TIME_DURATION,846
17851,before,O,846
17852,operating,O,846
17853,on,O,846
17854,the,O,846
17855,other,O,846
17856,eye,O,846
17857,This,O,846
17858,delay,O,846
17859,allows,O,846
17860,the,O,846
17861,surgeon,O,846
17862,to,O,846
17863,evaluate,O,846
17864,and,O,846
17865,document,O,846
17866,the,O,846
17867,effects,O,846
17868,of,O,846
17869,the,O,846
17870,surgery,O,846
17871,on,O,846
17872,the,O,846
17873,first,O,847
17874,eye,O,847
17875,The,O,847
17876,surgery,O,847
17877,results,O,847
17878,on,O,847
17879,the,O,847
17880,first,O,847
17881,eye,O,847
17882,frequently,O,847
17883,affect,O,847
17884,how,O,847
17885,the,O,847
17886,surgeon,O,847
17887,operates,O,847
17888,on,O,847
17889,the,O,847
17890,second,O,847
17891,eye,O,847
17892,Many,O,847
17893,people,O,847
17894,who,O,847
17895,have,O,847
17896,radial,B-TREATMENT,847
17897,keratotomy,I-TREATMENT,847
17898,require,O,847
17899,further,O,847
17900,vision,O,847
17901,correction,O,847
17902,years,O,848
17903,later,O,848
17904,as,O,848
17905,over,O,848
17906,time,O,848
17907,patients,O,848
17908,who,O,848
17909,have,O,848
17910,RK,B-TREATMENT,848
17911,surgery,I-TREATMENT,848
17912,will,O,848
17913,become,O,848
17914,increasingly,O,848
17915,farsighted,O,848
17916,What,O,848
17917,Are,O,849
17918,Some,O,849
17919,Potential,O,849
17920,Complications,O,849
17921,Weak,B-SIGN_AND_SYMPTOM,849
17922,corneal,I-SIGN_AND_SYMPTOM,849
17923,integrity,I-SIGN_AND_SYMPTOM,849
17924,risk,O,849
17925,of,O,849
17926,rupture,O,849
17927,after,O,849
17928,trauma,O,849
17929,The,O,849
17930,extensive,O,850
17931,corneal,O,850
17932,wounds,O,850
17933,make,O,850
17934,the,B-PART_OF_THE_EYES,850
17935,cornea,I-PART_OF_THE_EYES,850
17936,a,O,850
17937,possible,O,850
17938,source,O,850
17939,of,O,850
17940,eyeball,B-SIGN_AND_SYMPTOM,850
17941,weakness,I-SIGN_AND_SYMPTOM,850
17942,This,O,850
17943,weakness,O,850
17944,could,O,850
17945,exacerbate,O,850
17946,any,O,850
17947,trauma,O,850
17948,or,O,850
17949,disorder,O,851
17950,Corneal,B-SIGN_AND_SYMPTOM,851
17951,infiltrates,I-SIGN_AND_SYMPTOM,851
17952,and,I-SIGN_AND_SYMPTOM,851
17953,scarring,I-SIGN_AND_SYMPTOM,851
17954,Healing,O,851
17955,RK,B-TREATMENT,851
17956,wounds,O,851
17957,with,O,851
17958,intersecting,O,851
17959,patterns,O,851
17960,can,O,851
17961,result,O,851
17962,in,O,851
17963,corneal,B-SIGN_AND_SYMPTOM,851
17964,scarring,I-SIGN_AND_SYMPTOM,851
17965,which,I-SIGN_AND_SYMPTOM,851
17966,can,I-SIGN_AND_SYMPTOM,851
17967,impair,I-SIGN_AND_SYMPTOM,851
17968,vision,I-SIGN_AND_SYMPTOM,851
17969,by,I-SIGN_AND_SYMPTOM,852
17970,changing,I-SIGN_AND_SYMPTOM,852
17971,corneal,I-SIGN_AND_SYMPTOM,852
17972,shape,I-SIGN_AND_SYMPTOM,852
17973,and,I-SIGN_AND_SYMPTOM,852
17974,limiting,I-SIGN_AND_SYMPTOM,852
17975,light,I-SIGN_AND_SYMPTOM,852
17976,Corneal,B-SIGN_AND_SYMPTOM,852
17977,ulcer,I-SIGN_AND_SYMPTOM,852
17978,infection,I-SIGN_AND_SYMPTOM,852
17979,Slow,O,852
17980,healing,O,852
17981,of,O,852
17982,RK,B-TREATMENT,852
17983,incisions,O,852
17984,increases,O,852
17985,a,O,852
17986,patient,O,852
17987,s,O,852
17988,susceptibility,O,852
17989,to,O,852
17990,infection,O,853
17991,and,O,853
17992,discomfort,O,853
17993,This,O,853
17994,can,O,853
17995,occur,O,853
17996,with,O,853
17997,even,O,853
17998,minor,O,853
17999,injuries,O,853
18000,such,O,853
18001,as,O,853
18002,rubbing,B-CAUSE_OF_DISEASE,853
18003,your,I-CAUSE_OF_DISEASE,853
18004,eyes,I-CAUSE_OF_DISEASE,853
18005,Visual,B-SIGN_AND_SYMPTOM,853
18006,Symptoms,I-SIGN_AND_SYMPTOM,853
18007,glare,I-SIGN_AND_SYMPTOM,853
18008,and,I-SIGN_AND_SYMPTOM,853
18009,starbursts,I-SIGN_AND_SYMPTOM,853
18010,After,O,853
18011,the,O,853
18012,RK,B-TREATMENT,853
18013,surgery,O,854
18014,the,O,854
18015,incisions,O,854
18016,reach,O,854
18017,the,O,854
18018,patient,O,854
18019,s,O,854
18020,pupil,O,854
18021,or,O,854
18022,visual,O,854
18023,axis,O,854
18024,Patients,O,854
18025,may,O,854
18026,experience,O,854
18027,mild,O,854
18028,to,O,854
18029,severe,O,854
18030,photophobia,B-NAME_OF_DISEASE,855
18031,light,B-SIGN_AND_SYMPTOM,855
18032,sensitivity,I-SIGN_AND_SYMPTOM,855
18033,or,O,855
18034,other,O,855
18035,visual,O,855
18036,symptoms,O,855
18037,Irregular,B-NAME_OF_DISEASE,855
18038,astigmatism,I-NAME_OF_DISEASE,855
18039,Deep,B-CAUSE_OF_DISEASE,855
18040,and,I-CAUSE_OF_DISEASE,855
18041,uneven,I-CAUSE_OF_DISEASE,855
18042,corneal,I-CAUSE_OF_DISEASE,855
18043,wounds,I-CAUSE_OF_DISEASE,855
18044,can,O,855
18045,result,O,855
18046,in,O,855
18047,an,B-SIGN_AND_SYMPTOM,855
18048,oddly,I-SIGN_AND_SYMPTOM,855
18049,shaped,I-SIGN_AND_SYMPTOM,855
18050,cornea,I-SIGN_AND_SYMPTOM,855
18051,which,I-SIGN_AND_SYMPTOM,855
18052,can,I-SIGN_AND_SYMPTOM,855
18053,be,I-SIGN_AND_SYMPTOM,855
18054,thin,I-SIGN_AND_SYMPTOM,855
18055,and,I-SIGN_AND_SYMPTOM,855
18056,fragile,I-SIGN_AND_SYMPTOM,855
18057,Regression,B-SIGN_AND_SYMPTOM,855
18058,of,I-SIGN_AND_SYMPTOM,855
18059,refractive,I-SIGN_AND_SYMPTOM,855
18060,error,I-SIGN_AND_SYMPTOM,855
18061,This,O,855
18062,might,O,855
18063,be,O,855
18064,seen,O,855
18065,in,B-TIME_DURATION,855
18066,the,I-TIME_DURATION,855
18067,first,I-TIME_DURATION,855
18068,few,I-TIME_DURATION,855
18069,months,I-TIME_DURATION,855
18070,after,O,855
18071,surgery,O,855
18072,Progression,B-SIGN_AND_SYMPTOM,855
18073,of,I-SIGN_AND_SYMPTOM,855
18074,refractive,I-SIGN_AND_SYMPTOM,855
18075,effect,I-SIGN_AND_SYMPTOM,855
18076,Progression,O,855
18077,might,O,855
18078,occur,O,855
18079,in,B-TIME_DURATION,855
18080,the,I-TIME_DURATION,855
18081,first,I-TIME_DURATION,855
18082,few,I-TIME_DURATION,855
18083,years,I-TIME_DURATION,855
18084,after,O,856
18085,surgery,O,856
18086,What,O,856
18087,Should,O,856
18088,You,O,856
18089,Expect,O,856
18090,After,O,856
18091,the,O,856
18092,Surgery,O,856
18093,After,O,856
18094,surgery,O,856
18095,the,O,856
18096,patient,O,856
18097,experiences,O,856
18098,moderate,O,856
18099,discomfort,O,856
18100,and,O,856
18101,requires,O,856
18102,oral,B-TREATMENT,856
18103,pain,I-TREATMENT,857
18104,medicine,I-TREATMENT,857
18105,for,B-TIME_DURATION,857
18106,several,I-TIME_DURATION,857
18107,days,I-TIME_DURATION,857
18108,In,O,857
18109,addition,O,857
18110,the,O,857
18111,physician,O,857
18112,prescribes,O,857
18113,antimicrobial,B-NAME_OF_DRUG,857
18114,eye,I-NAME_OF_DRUG,857
18115,drops,I-NAME_OF_DRUG,857
18116,to,O,857
18117,combat,O,857
18118,any,O,857
18119,infectious,O,857
18120,complications,O,857
18121,Radial,O,857
18122,incisions,O,857
18123,need,O,858
18124,months,B-TIME_DURATION,858
18125,or,I-TIME_DURATION,858
18126,even,I-TIME_DURATION,858
18127,years,I-TIME_DURATION,858
18128,to,O,858
18129,heal,O,858
18130,This,O,858
18131,sluggish,O,858
18132,recovery,O,858
18133,renders,O,858
18134,the,O,858
18135,patient,O,858
18136,prone,O,858
18137,to,O,858
18138,infection,O,858
18139,Author,O,858
18140,Dr,O,858
18141,Muhammad,O,858
18142,Saad,O,859
18143,Resident,O,859
18144,Ophthalmologist,O,859
18145,at,O,859
18146,Al-Shifa,B-ORGANIZATION,859
18147,Trust,I-ORGANIZATION,859
18148,Eye,I-ORGANIZATION,859
18149,Hospital,I-ORGANIZATION,859
18150,in,O,859
18151,Rawalpindi,B-GPE,859
18152,Pakistan,I-GPE,859
18153,What,O,859
18154,Is,O,859
18155,Zonular,B-NAME_OF_DISEASE,859
18156,Cataract,I-NAME_OF_DISEASE,859
18157,Zonular,B-NAME_OF_DISEASE,859
18158,cataract,B-NAME_OF_DISEASE,859
18159,is,O,859
18160,a,O,859
18161,type,O,859
18162,of,O,859
18163,cataract,B-NAME_OF_DISEASE,859
18164,that,O,859
18165,affects,O,859
18166,the,B-PART_OF_THE_EYES,859
18167,zonules,I-PART_OF_THE_EYES,859
18168,which,O,859
18169,are,O,859
18170,thin,O,859
18171,fibers,O,859
18172,that,O,859
18173,help,O,859
18174,hold,O,859
18175,the,B-PART_OF_THE_EYES,859
18176,lens,I-PART_OF_THE_EYES,859
18177,in,O,859
18178,place,O,860
18179,in,O,860
18180,the,O,860
18181,eye,O,860
18182,It,O,860
18183,is,O,860
18184,usually,O,860
18185,inherited,B-CAUSE_OF_DISEASE,860
18186,as,I-CAUSE_OF_DISEASE,860
18187,an,I-CAUSE_OF_DISEASE,860
18188,autosomal,I-CAUSE_OF_DISEASE,860
18189,dominant,I-CAUSE_OF_DISEASE,860
18190,trait,I-CAUSE_OF_DISEASE,860
18191,which,O,860
18192,means,O,860
18193,that,O,860
18194,a,O,860
18195,person,O,860
18196,only,O,860
18197,needs,O,860
18198,to,O,860
18199,inherit,B-CAUSE_OF_DISEASE,860
18200,one,I-CAUSE_OF_DISEASE,860
18201,copy,I-CAUSE_OF_DISEASE,860
18202,of,I-CAUSE_OF_DISEASE,860
18203,the,I-CAUSE_OF_DISEASE,860
18204,mutated,I-CAUSE_OF_DISEASE,860
18205,gene,I-CAUSE_OF_DISEASE,860
18206,from,I-CAUSE_OF_DISEASE,860
18207,one,I-CAUSE_OF_DISEASE,860
18208,parent,I-CAUSE_OF_DISEASE,861
18209,to,O,861
18210,develop,O,861
18211,the,O,861
18212,condition,O,861
18213,This,O,861
18214,means,O,861
18215,that,O,861
18216,if,O,861
18217,one,O,861
18218,parent,O,861
18219,has,O,861
18220,zonular,B-NAME_OF_DISEASE,861
18221,cataract,I-NAME_OF_DISEASE,861
18222,there,O,861
18223,is,O,861
18224,a,O,861
18225,50%,O,861
18226,chance,O,861
18227,that,O,861
18228,their,O,861
18229,child,O,861
18230,will,O,861
18231,also,O,861
18232,inherit,O,861
18233,the,O,862
18234,condition,O,862
18235,Zonular,B-NAME_OF_DISEASE,862
18236,cataract,B-NAME_OF_DISEASE,862
18237,can,O,862
18238,also,O,862
18239,be,O,862
18240,acquired,O,862
18241,which,O,862
18242,means,O,862
18243,that,O,862
18244,it,O,862
18245,develops,O,862
18246,later,O,862
18247,in,O,862
18248,life,O,862
18249,as,O,862
18250,a,O,862
18251,result,O,862
18252,of,O,862
18253,other,O,862
18254,factors,O,862
18255,such,O,862
18256,as,O,862
18257,trauma,B-CAUSE_OF_DISEASE,863
18258,radiation,I-CAUSE_OF_DISEASE,863
18259,exposure,I-CAUSE_OF_DISEASE,863
18260,or,I-CAUSE_OF_DISEASE,863
18261,certain,I-CAUSE_OF_DISEASE,863
18262,medications,I-CAUSE_OF_DISEASE,863
18263,It,O,863
18264,is,O,863
18265,important,O,863
18266,to,O,863
18267,note,O,863
18268,that,O,863
18269,not,O,863
18270,all,O,863
18271,cases,O,863
18272,of,O,863
18273,zonular,B-NAME_OF_DISEASE,863
18274,cataract,I-NAME_OF_DISEASE,863
18275,are,O,863
18276,inherited,O,864
18277,and,O,864
18278,it,O,864
18279,is,O,864
18280,possible,O,864
18281,to,O,864
18282,develop,O,864
18283,the,O,864
18284,condition,O,864
18285,without,O,864
18286,having,O,864
18287,a,O,864
18288,family,O,864
18289,history,O,864
18290,of,O,864
18291,it,O,864
18292,Symptoms,O,864
18293,of,O,864
18294,Zonular,B-NAME_OF_DISEASE,864
18295,Cataract,I-NAME_OF_DISEASE,864
18296,The,O,864
18297,main,O,864
18298,symptom,O,864
18299,of,O,864
18300,zonular,B-NAME_OF_DISEASE,864
18301,cataracts,I-NAME_OF_DISEASE,864
18302,is,O,864
18303,a,B-SIGN_AND_SYMPTOM,864
18304,decrease,I-SIGN_AND_SYMPTOM,864
18305,in,I-SIGN_AND_SYMPTOM,864
18306,vision,I-SIGN_AND_SYMPTOM,864
18307,This,O,864
18308,may,O,864
18309,be,O,865
18310,gradual,O,865
18311,or,O,865
18312,sudden,O,865
18313,and,O,865
18314,may,O,865
18315,affect,O,865
18316,one,O,865
18317,or,O,865
18318,both,O,865
18319,eyes,O,865
18320,Other,O,865
18321,symptoms,O,865
18322,may,O,865
18323,include,O,865
18324,Blurred,B-SIGN_AND_SYMPTOM,866
18325,vision,I-SIGN_AND_SYMPTOM,866
18326,The,O,866
18327,clouding,O,866
18328,of,O,866
18329,the,B-PART_OF_THE_EYES,866
18330,lens,I-PART_OF_THE_EYES,866
18331,can,O,866
18332,cause,O,866
18333,objects,B-SIGN_AND_SYMPTOM,866
18334,to,I-SIGN_AND_SYMPTOM,866
18335,appear,I-SIGN_AND_SYMPTOM,866
18336,blurry,I-SIGN_AND_SYMPTOM,866
18337,or,I-SIGN_AND_SYMPTOM,866
18338,distorted,I-SIGN_AND_SYMPTOM,866
18339,Glare,B-SIGN_AND_SYMPTOM,866
18340,and,I-SIGN_AND_SYMPTOM,866
18341,halos,I-SIGN_AND_SYMPTOM,866
18342,The,O,866
18343,clouding,O,866
18344,of,O,866
18345,the,B-PART_OF_THE_EYES,866
18346,lens,I-PART_OF_THE_EYES,866
18347,can,O,866
18348,cause,O,867
18349,light,B-SIGN_AND_SYMPTOM,867
18350,to,I-SIGN_AND_SYMPTOM,867
18351,scatter,I-SIGN_AND_SYMPTOM,867
18352,leading,I-SIGN_AND_SYMPTOM,867
18353,to,I-SIGN_AND_SYMPTOM,867
18354,glare,I-SIGN_AND_SYMPTOM,867
18355,and,I-SIGN_AND_SYMPTOM,868
18356,halos,I-SIGN_AND_SYMPTOM,868
18357,around,I-SIGN_AND_SYMPTOM,868
18358,lights,I-SIGN_AND_SYMPTOM,868
18359,Sensitivity,B-SIGN_AND_SYMPTOM,868
18360,to,I-SIGN_AND_SYMPTOM,868
18361,light,I-SIGN_AND_SYMPTOM,868
18362,The,O,868
18363,clouding,O,868
18364,of,O,868
18365,the,B-PART_OF_THE_EYES,868
18366,lens,I-PART_OF_THE_EYES,868
18367,can,O,868
18368,make,O,868
18369,the,B-SIGN_AND_SYMPTOM,868
18370,eye,I-SIGN_AND_SYMPTOM,868
18371,more,I-SIGN_AND_SYMPTOM,868
18372,sensitive,I-SIGN_AND_SYMPTOM,868
18373,to,I-SIGN_AND_SYMPTOM,868
18374,light,I-SIGN_AND_SYMPTOM,868
18375,causing,I-SIGN_AND_SYMPTOM,868
18376,discomfort,I-SIGN_AND_SYMPTOM,868
18377,in,I-SIGN_AND_SYMPTOM,868
18378,bright,I-SIGN_AND_SYMPTOM,868
18379,environments,I-SIGN_AND_SYMPTOM,868
18380,Difficulty,B-SIGN_AND_SYMPTOM,868
18381,seeing,I-SIGN_AND_SYMPTOM,868
18382,at,I-SIGN_AND_SYMPTOM,868
18383,night,I-SIGN_AND_SYMPTOM,868
18384,The,O,868
18385,clouding,O,869
18386,of,O,869
18387,the,B-PART_OF_THE_EYES,869
18388,lens,I-PART_OF_THE_EYES,869
18389,can,O,869
18390,make,O,869
18391,it,O,869
18392,harder,B-SIGN_AND_SYMPTOM,869
18393,to,I-SIGN_AND_SYMPTOM,870
18394,see,I-SIGN_AND_SYMPTOM,870
18395,in,I-SIGN_AND_SYMPTOM,870
18396,low,I-SIGN_AND_SYMPTOM,870
18397,light,I-SIGN_AND_SYMPTOM,870
18398,conditions,I-SIGN_AND_SYMPTOM,870
18399,such,I-SIGN_AND_SYMPTOM,870
18400,as,I-SIGN_AND_SYMPTOM,870
18401,at,I-SIGN_AND_SYMPTOM,870
18402,night,I-SIGN_AND_SYMPTOM,870
18403,Double,B-SIGN_AND_SYMPTOM,870
18404,vision,I-SIGN_AND_SYMPTOM,870
18405,In,O,870
18406,severe,O,870
18407,cases,O,870
18408,of,O,870
18409,zonular,B-NAME_OF_DISEASE,870
18410,cataracts,I-NAME_OF_DISEASE,870
18411,the,B-PART_OF_THE_EYES,870
18412,lens,I-PART_OF_THE_EYES,870
18413,may,O,870
18414,become,O,870
18415,dislocated,O,870
18416,leading,O,871
18417,to,O,871
18418,double,B-SIGN_AND_SYMPTOM,871
18419,vision,I-SIGN_AND_SYMPTOM,871
18420,What,O,871
18421,Are,O,871
18422,Some,O,871
18423,Risk,O,871
18424,Factors,O,871
18425,for,O,871
18426,Zonular,B-NAME_OF_DISEASE,871
18427,Cataract,I-NAME_OF_DISEASE,871
18428,There,O,871
18429,are,O,871
18430,several,O,871
18431,potential,O,871
18432,causes,O,871
18433,and,O,871
18434,risk,O,871
18435,factors,O,871
18436,for,O,871
18437,the,O,872
18438,development,O,872
18439,of,O,872
18440,a,B-NAME_OF_DISEASE,872
18441,zonular,I-NAME_OF_DISEASE,872
18442,cataract,I-NAME_OF_DISEASE,872
18443,including,O,872
18444,Trauma,B-CAUSE_OF_DISEASE,872
18445,Trauma,B-CAUSE_OF_DISEASE,872
18446,to,I-CAUSE_OF_DISEASE,872
18447,the,I-CAUSE_OF_DISEASE,872
18448,eye,I-CAUSE_OF_DISEASE,872
18449,such,I-CAUSE_OF_DISEASE,872
18450,as,I-CAUSE_OF_DISEASE,872
18451,a,I-CAUSE_OF_DISEASE,872
18452,blow,I-CAUSE_OF_DISEASE,872
18453,to,I-CAUSE_OF_DISEASE,872
18454,the,I-CAUSE_OF_DISEASE,872
18455,head,I-CAUSE_OF_DISEASE,873
18456,or,I-CAUSE_OF_DISEASE,873
18457,eye,I-CAUSE_OF_DISEASE,873
18458,injury,I-CAUSE_OF_DISEASE,873
18459,can,O,873
18460,cause,O,873
18461,damage,O,873
18462,to,O,873
18463,the,B-PART_OF_THE_EYES,873
18464,zonules,I-PART_OF_THE_EYES,873
18465,and,O,873
18466,lead,O,873
18467,to,O,873
18468,the,O,873
18469,development,O,873
18470,of,O,873
18471,a,B-NAME_OF_DISEASE,873
18472,zonular,I-NAME_OF_DISEASE,873
18473,cataract,I-NAME_OF_DISEASE,874
18474,Genetic,B-CAUSE_OF_DISEASE,874
18475,factors,I-CAUSE_OF_DISEASE,874
18476,Some,O,874
18477,people,O,874
18478,may,O,874
18479,be,O,874
18480,more,O,874
18481,genetically,O,874
18482,predisposed,O,874
18483,to,O,874
18484,developing,O,874
18485,a,B-NAME_OF_DISEASE,874
18486,zonular,I-NAME_OF_DISEASE,874
18487,cataract,I-NAME_OF_DISEASE,874
18488,due,O,874
18489,to,O,874
18490,inherited,B-CAUSE_OF_DISEASE,874
18491,genetic,I-CAUSE_OF_DISEASE,874
18492,factors,I-CAUSE_OF_DISEASE,874
18493,Medical,B-CAUSE_OF_DISEASE,874
18494,conditions,I-CAUSE_OF_DISEASE,874
18495,Certain,B-CAUSE_OF_DISEASE,874
18496,medical,I-CAUSE_OF_DISEASE,874
18497,conditions,I-CAUSE_OF_DISEASE,874
18498,such,I-CAUSE_OF_DISEASE,874
18499,as,I-CAUSE_OF_DISEASE,874
18500,diabetes,I-CAUSE_OF_DISEASE,874
18501,or,I-CAUSE_OF_DISEASE,874
18502,Marfan,I-CAUSE_OF_DISEASE,875
18503,syndrome,I-CAUSE_OF_DISEASE,875
18504,can,O,875
18505,increase,O,875
18506,the,O,875
18507,risk,O,875
18508,of,O,875
18509,developing,O,875
18510,a,B-NAME_OF_DISEASE,875
18511,zonular,I-NAME_OF_DISEASE,875
18512,cataract,I-NAME_OF_DISEASE,875
18513,Diagnosis,O,875
18514,of,O,875
18515,Zonular,B-NAME_OF_DISEASE,875
18516,Cataract,I-NAME_OF_DISEASE,875
18517,Zonular,B-NAME_OF_DISEASE,875
18518,cataracts,I-NAME_OF_DISEASE,875
18519,can,O,875
18520,be,O,875
18521,diagnosed,O,875
18522,by,O,875
18523,an,B-DIAGNOSTIC_TEST,875
18524,eye,I-DIAGNOSTIC_TEST,875
18525,care,I-DIAGNOSTIC_TEST,875
18526,professional,I-DIAGNOSTIC_TEST,875
18527,during,I-DIAGNOSTIC_TEST,875
18528,a,I-DIAGNOSTIC_TEST,875
18529,comprehensive,I-DIAGNOSTIC_TEST,875
18530,eye,I-DIAGNOSTIC_TEST,875
18531,exam,I-DIAGNOSTIC_TEST,876
18532,During,O,876
18533,the,O,876
18534,exam,O,876
18535,the,O,876
18536,eye,O,876
18537,care,O,876
18538,professional,O,876
18539,will,O,876
18540,assess,B-DIAGNOSTIC_TEST,876
18541,your,I-DIAGNOSTIC_TEST,876
18542,visual,I-DIAGNOSTIC_TEST,876
18543,acuity,I-DIAGNOSTIC_TEST,876
18544,which,I-DIAGNOSTIC_TEST,876
18545,is,I-DIAGNOSTIC_TEST,876
18546,a,I-DIAGNOSTIC_TEST,876
18547,measure,I-DIAGNOSTIC_TEST,876
18548,of,I-DIAGNOSTIC_TEST,876
18549,how,I-DIAGNOSTIC_TEST,876
18550,well,I-DIAGNOSTIC_TEST,876
18551,you,I-DIAGNOSTIC_TEST,876
18552,can,I-DIAGNOSTIC_TEST,876
18553,see,I-DIAGNOSTIC_TEST,876
18554,and,O,876
18555,will,O,876
18556,check,B-DIAGNOSTIC_TEST,876
18557,for,I-DIAGNOSTIC_TEST,876
18558,any,I-DIAGNOSTIC_TEST,876
18559,abnormalities,I-DIAGNOSTIC_TEST,876
18560,in,I-DIAGNOSTIC_TEST,876
18561,the,I-DIAGNOSTIC_TEST,876
18562,shape,I-DIAGNOSTIC_TEST,876
18563,or,I-DIAGNOSTIC_TEST,877
18564,size,I-DIAGNOSTIC_TEST,877
18565,of,I-DIAGNOSTIC_TEST,877
18566,the,I-DIAGNOSTIC_TEST,877
18567,eye,I-DIAGNOSTIC_TEST,877
18568,They,O,877
18569,may,O,877
18570,also,O,877
18571,use,O,877
18572,a,O,877
18573,device,O,877
18574,called,O,877
18575,a,B-DIAGNOSTIC_TEST,877
18576,slit,I-DIAGNOSTIC_TEST,877
18577,lamp,I-DIAGNOSTIC_TEST,878
18578,which,O,878
18579,allows,O,878
18580,them,O,878
18581,to,O,878
18582,examine,O,878
18583,the,O,878
18584,front,O,879
18585,of,O,879
18586,the,O,879
18587,eye,O,879
18588,in,O,879
18589,great,O,879
18590,detail,O,879
18591,to,O,879
18592,look,O,879
18593,for,O,879
18594,signs,O,879
18595,of,O,879
18596,a,B-NAME_OF_DISEASE,879
18597,cataract,I-NAME_OF_DISEASE,879
18598,In,O,880
18599,addition,O,880
18600,to,O,880
18601,these,O,880
18602,tests,O,880
18603,the,O,880
18604,eye,O,880
18605,care,O,880
18606,professional,O,880
18607,may,O,880
18608,also,O,881
18609,use,O,881
18610,a,B-DIAGNOSTIC_TEST,881
18611,test,I-DIAGNOSTIC_TEST,881
18612,called,I-DIAGNOSTIC_TEST,881
18613,a,I-DIAGNOSTIC_TEST,881
18614,tonometry,I-DIAGNOSTIC_TEST,881
18615,test,I-DIAGNOSTIC_TEST,881
18616,to,I-DIAGNOSTIC_TEST,881
18617,measure,I-DIAGNOSTIC_TEST,881
18618,the,I-DIAGNOSTIC_TEST,881
18619,pressure,I-DIAGNOSTIC_TEST,881
18620,inside,I-DIAGNOSTIC_TEST,881
18621,the,I-DIAGNOSTIC_TEST,882
18622,eye,I-DIAGNOSTIC_TEST,882
18623,This,O,882
18624,test,O,882
18625,is,O,882
18626,used,O,882
18627,to,O,882
18628,diagnose,O,882
18629,glaucoma,B-NAME_OF_DISEASE,883
18630,which,O,883
18631,is,O,883
18632,a,O,883
18633,condition,O,883
18634,that,O,883
18635,can,O,884
18636,cause,O,884
18637,damage,B-SIGN_AND_SYMPTOM,884
18638,to,I-SIGN_AND_SYMPTOM,884
18639,the,I-SIGN_AND_SYMPTOM,884
18640,optic,I-SIGN_AND_SYMPTOM,884
18641,nerve,I-SIGN_AND_SYMPTOM,884
18642,and,O,884
18643,lead,O,884
18644,to,O,884
18645,vision,B-SIGN_AND_SYMPTOM,884
18646,loss,I-SIGN_AND_SYMPTOM,884
18647,The,O,884
18648,optic,O,884
18649,nerve,O,884
18650,is,O,885
18651,a,O,885
18652,bundle,O,885
18653,of,O,885
18654,nerve,O,885
18655,fibers,O,885
18656,that,O,885
18657,connects,O,885
18658,the,B-PART_OF_THE_EYES,885
18659,retina,I-PART_OF_THE_EYES,885
18660,of,O,885
18661,the,O,885
18662,eye,O,885
18663,to,O,886
18664,the,O,886
18665,brain,O,886
18666,If,O,886
18667,a,B-NAME_OF_DISEASE,886
18668,cataract,I-NAME_OF_DISEASE,886
18669,is,O,886
18670,suspected,O,886
18671,the,O,886
18672,eye,O,886
18673,care,O,886
18674,professional,O,886
18675,may,O,886
18676,also,O,886
18677,recommend,O,886
18678,additional,O,886
18679,tests,O,886
18680,such,O,886
18681,as,O,886
18682,imaging,B-DIAGNOSTIC_TEST,886
18683,tests,I-DIAGNOSTIC_TEST,886
18684,to,I-DIAGNOSTIC_TEST,886
18685,get,I-DIAGNOSTIC_TEST,887
18686,a,I-DIAGNOSTIC_TEST,887
18687,better,I-DIAGNOSTIC_TEST,887
18688,look,I-DIAGNOSTIC_TEST,887
18689,at,I-DIAGNOSTIC_TEST,887
18690,the,I-DIAGNOSTIC_TEST,887
18691,inside,I-DIAGNOSTIC_TEST,887
18692,of,I-DIAGNOSTIC_TEST,887
18693,the,I-DIAGNOSTIC_TEST,887
18694,eye,I-DIAGNOSTIC_TEST,887
18695,and,O,887
18696,confirm,O,887
18697,the,O,887
18698,diagnosis,O,887
18699,These,O,887
18700,tests,O,888
18701,may,O,888
18702,include,O,888
18703,ultrasound,B-DIAGNOSTIC_TEST,888
18704,computed,B-DIAGNOSTIC_TEST,888
18705,tomography,I-DIAGNOSTIC_TEST,888
18706,CT,I-DIAGNOSTIC_TEST,888
18707,scans,I-DIAGNOSTIC_TEST,888
18708,or,O,888
18709,magnetic,B-DIAGNOSTIC_TEST,889
18710,resonance,I-DIAGNOSTIC_TEST,889
18711,imaging,I-DIAGNOSTIC_TEST,889
18712,MRI,I-DIAGNOSTIC_TEST,889
18713,,O,889
18714,Treatment,O,889
18715,Options,O,889
18716,for,O,889
18717,Zonular,B-NAME_OF_DISEASE,890
18718,Cataract,I-NAME_OF_DISEASE,890
18719,Treatment,O,890
18720,for,O,890
18721,zonular,B-NAME_OF_DISEASE,890
18722,cataract,I-NAME_OF_DISEASE,890
18723,typically,O,890
18724,involves,O,890
18725,surgery,B-TREATMENT,890
18726,to,I-TREATMENT,890
18727,remove,I-TREATMENT,890
18728,the,I-TREATMENT,890
18729,affected,I-TREATMENT,891
18730,lens,I-TREATMENT,891
18731,and,I-TREATMENT,891
18732,replace,I-TREATMENT,891
18733,it,I-TREATMENT,891
18734,with,I-TREATMENT,891
18735,an,I-TREATMENT,891
18736,artificial,I-TREATMENT,891
18737,lens,I-TREATMENT,891
18738,This,O,891
18739,surgery,O,892
18740,is,O,892
18741,called,O,892
18742,a,B-TREATMENT,892
18743,cataract,I-TREATMENT,892
18744,extraction,I-TREATMENT,892
18745,During,O,892
18746,the,O,892
18747,surgery,O,892
18748,the,O,892
18749,eye,O,892
18750,care,O,892
18751,professional,O,892
18752,will,O,892
18753,make,O,892
18754,a,O,892
18755,small,O,892
18756,incision,O,892
18757,in,O,892
18758,the,O,892
18759,eye,O,892
18760,and,O,892
18761,use,O,892
18762,a,O,893
18763,device,O,893
18764,called,O,893
18765,an,B-SURGICAL_INSTRUMENT,893
18766,ultrasound,I-SURGICAL_INSTRUMENT,893
18767,to,O,893
18768,break,O,893
18769,up,O,893
18770,the,B-PART_OF_THE_EYES,893
18771,lens,I-PART_OF_THE_EYES,893
18772,into,O,893
18773,small,O,893
18774,pieces,O,893
18775,The,O,893
18776,pieces,O,893
18777,are,O,894
18778,then,O,894
18779,removed,O,894
18780,through,O,894
18781,the,O,894
18782,incision,O,894
18783,Once,O,894
18784,the,B-PART_OF_THE_EYES,894
18785,lens,I-PART_OF_THE_EYES,894
18786,is,O,894
18787,removed,O,894
18788,an,B-TREATMENT,894
18789,artificial,I-TREATMENT,894
18790,lens,I-TREATMENT,894
18791,called,I-TREATMENT,894
18792,an,I-TREATMENT,895
18793,intraocular,I-TREATMENT,895
18794,lens,I-TREATMENT,895
18795,IOL,I-TREATMENT,895
18796,is,O,895
18797,placed,O,895
18798,in,O,895
18799,the,O,895
18800,eye,O,895
18801,to,O,895
18802,replace,O,895
18803,the,B-PART_OF_THE_EYES,895
18804,natural,I-PART_OF_THE_EYES,895
18805,lens,I-PART_OF_THE_EYES,895
18806,The,B-TREATMENT,895
18807,IOL,I-TREATMENT,895
18808,is,O,895
18809,typically,O,896
18810,made,O,896
18811,of,O,896
18812,a,O,896
18813,clear,O,896
18814,plastic-like,O,896
18815,material,O,896
18816,and,O,896
18817,is,O,896
18818,designed,O,896
18819,to,O,897
18820,mimic,O,897
18821,the,O,897
18822,function,O,897
18823,of,O,897
18824,the,B-PART_OF_THE_EYES,897
18825,natural,I-PART_OF_THE_EYES,897
18826,lens,I-PART_OF_THE_EYES,897
18827,Cataract,B-TREATMENT,897
18828,surgery,I-TREATMENT,897
18829,is,O,897
18830,generally,O,897
18831,a,O,897
18832,safe,O,897
18833,and,O,897
18834,effective,O,897
18835,procedure,O,897
18836,and,O,897
18837,most,O,897
18838,people,O,897
18839,experience,O,897
18840,improved,O,897
18841,vision,O,897
18842,following,O,898
18843,the,O,898
18844,procedure,O,898
18845,However,O,898
18846,like,O,898
18847,any,O,898
18848,surgery,O,898
18849,there,O,898
18850,are,O,898
18851,risks,O,898
18852,and,O,899
18853,complications,O,899
18854,that,O,899
18855,can,O,899
18856,occur,O,899
18857,including,O,899
18858,infection,B-SIGN_AND_SYMPTOM,899
18859,bleeding,I-SIGN_AND_SYMPTOM,899
18860,and,I-SIGN_AND_SYMPTOM,899
18861,retinal,I-SIGN_AND_SYMPTOM,899
18862,detachment,I-SIGN_AND_SYMPTOM,900
18863,Your,O,900
18864,eye,O,900
18865,care,O,900
18866,professional,O,900
18867,will,O,900
18868,discuss,O,900
18869,these,O,900
18870,risks,O,900
18871,and,O,900
18872,any,O,900
18873,potential,O,900
18874,complications,O,900
18875,with,O,900
18876,you,O,900
18877,before,O,901
18878,the,O,901
18879,surgery,O,901
18880,and,O,901
18881,will,O,901
18882,work,O,901
18883,with,O,901
18884,you,O,901
18885,to,O,902
18886,determine,O,902
18887,the,O,902
18888,best,O,902
18889,course,O,902
18890,of,O,902
18891,treatment,O,902
18892,In,O,902
18893,addition,O,902
18894,to,O,902
18895,surgery,O,902
18896,the,O,902
18897,eye,O,902
18898,care,O,902
18899,professional,O,902
18900,may,O,902
18901,recommend,O,902
18902,other,O,902
18903,treatment,O,902
18904,options,O,902
18905,such,O,902
18906,as,O,903
18907,eyeglasses,B-TREATMENT,903
18908,or,O,903
18909,contact,B-TREATMENT,903
18910,lenses,I-TREATMENT,903
18911,to,O,903
18912,help,O,903
18913,improve,O,903
18914,vision,O,903
18915,until,O,904
18916,the,O,904
18917,surgery,O,904
18918,can,O,904
18919,be,O,904
18920,performed,O,904
18921,It,O,904
18922,is,O,904
18923,important,O,904
18924,to,O,904
18925,follow,O,905
18926,the,O,905
18927,recommendations,O,905
18928,of,O,905
18929,your,O,905
18930,eye,O,905
18931,care,O,905
18932,professional,O,905
18933,and,O,905
18934,to,O,905
18935,attend,O,905
18936,follow-up,O,905
18937,appointments,O,905
18938,as,O,905
18939,advised,O,905
18940,to,O,905
18941,monitor,O,905
18942,the,O,905
18943,progression,O,905
18944,of,O,905
18945,the,B-NAME_OF_DISEASE,905
18946,cataract,I-NAME_OF_DISEASE,905
18947,and,O,906
18948,ensure,O,906
18949,the,O,906
18950,best,O,906
18951,possible,O,906
18952,outcomes,O,906
18953,Photopsia,B-NAME_OF_DISEASE,906
18954,Definition,O,906
18955,Briefly,O,906
18956,a,B-NAME_OF_DISEASE,906
18957,photopsia,B-NAME_OF_DISEASE,906
18958,is,O,906
18959,a,O,906
18960,flash,O,907
18961,or,O,907
18962,light,O,907
18963,floating,O,907
18964,in,O,907
18965,your,O,907
18966,eye,O,907
18967,They,O,907
18968,appear,O,907
18969,to,O,907
18970,be,O,907
18971,shiny,O,907
18972,and,O,907
18973,luminous,O,907
18974,They,O,907
18975,can,O,907
18976,be,O,907
18977,experienced,O,907
18978,in,O,907
18979,one,O,907
18980,eye,O,907
18981,or,O,908
18982,both,O,908
18983,eyes,O,908
18984,at,O,908
18985,the,O,908
18986,same,O,908
18987,time,O,908
18988,Photopsia,B-NAME_OF_DISEASE,908
18989,can,O,908
18990,either,O,908
18991,be,O,908
18992,temporary,O,908
18993,or,O,908
18994,they,O,908
18995,can,O,908
18996,be,O,908
18997,permanent,O,908
18998,How,O,908
18999,is,O,908
19000,Photopsia,B-NAME_OF_DISEASE,908
19001,Treatment,O,908
19002,Photopsia,B-NAME_OF_DISEASE,908
19003,is,O,908
19004,actually,O,908
19005,a,O,908
19006,symptom,O,908
19007,of,O,908
19008,another,O,908
19009,underlying,O,908
19010,cause,O,909
19011,Hence,O,909
19012,the,O,909
19013,treatment,O,909
19014,depends,O,909
19015,on,O,909
19016,the,O,909
19017,underlying,O,909
19018,cause,O,909
19019,There,O,909
19020,s,O,909
19021,not,O,909
19022,a,O,910
19023,single,O,910
19024,treatment,O,910
19025,If,O,910
19026,the,O,910
19027,patient,O,910
19028,is,O,910
19029,experiencing,O,910
19030,it,O,910
19031,due,O,910
19032,to,O,911
19033,age-related,B-CAUSE_OF_DISEASE,911
19034,macular,I-CAUSE_OF_DISEASE,911
19035,degeneration,I-CAUSE_OF_DISEASE,911
19036,injections,O,911
19037,of,O,911
19038,anti-VEGF,B-NAME_OF_DRUG,911
19039,help,O,911
19040,If,O,911
19041,the,O,911
19042,cause,O,911
19043,is,O,911
19044,optic,B-CAUSE_OF_DISEASE,911
19045,neuritis,I-CAUSE_OF_DISEASE,911
19046,usually,O,911
19047,the,O,911
19048,eye,O,911
19049,improves,O,911
19050,on,O,911
19051,its,O,912
19052,own,O,912
19053,If,O,912
19054,there,O,912
19055,s,O,912
19056,any,O,912
19057,damage,B-SIGN_AND_SYMPTOM,912
19058,in,I-SIGN_AND_SYMPTOM,912
19059,the,I-SIGN_AND_SYMPTOM,912
19060,structure,I-SIGN_AND_SYMPTOM,912
19061,of,I-SIGN_AND_SYMPTOM,912
19062,the,I-SIGN_AND_SYMPTOM,912
19063,eye,I-SIGN_AND_SYMPTOM,912
19064,in,I-SIGN_AND_SYMPTOM,912
19065,the,I-SIGN_AND_SYMPTOM,912
19066,optic,I-SIGN_AND_SYMPTOM,913
19067,nerve,I-SIGN_AND_SYMPTOM,913
19068,or,I-SIGN_AND_SYMPTOM,913
19069,the,I-SIGN_AND_SYMPTOM,913
19070,brain,I-SIGN_AND_SYMPTOM,913
19071,photopsia,B-NAME_OF_DISEASE,913
19072,may,O,913
19073,be,O,913
19074,permanent,O,913
19075,If,O,913
19076,the,O,913
19077,situation,O,913
19078,gets,O,913
19079,worse,O,913
19080,it,O,913
19081,indicates,O,914
19082,that,O,914
19083,the,O,914
19084,underlying,O,914
19085,cause,O,914
19086,is,O,914
19087,also,O,914
19088,getting,O,914
19089,worse,O,914
19090,It,O,914
19091,s,O,914
19092,of,O,914
19093,great,O,914
19094,importance,O,915
19095,to,O,915
19096,seek,O,915
19097,medical,O,915
19098,assistance,O,915
19099,What,O,915
19100,Are,O,916
19101,the,O,916
19102,Symptoms,O,916
19103,of,O,916
19104,Photopsia,B-NAME_OF_DISEASE,916
19105,Photopsia,B-NAME_OF_DISEASE,916
19106,i.e,O,916
19107,specks,B-SIGN_AND_SYMPTOM,916
19108,in,I-SIGN_AND_SYMPTOM,916
19109,the,I-SIGN_AND_SYMPTOM,916
19110,eyes,I-SIGN_AND_SYMPTOM,916
19111,float,I-SIGN_AND_SYMPTOM,916
19112,as,I-SIGN_AND_SYMPTOM,917
19113,you,I-SIGN_AND_SYMPTOM,917
19114,move,I-SIGN_AND_SYMPTOM,917
19115,your,I-SIGN_AND_SYMPTOM,917
19116,eyes,I-SIGN_AND_SYMPTOM,917
19117,or,I-SIGN_AND_SYMPTOM,917
19118,head,I-SIGN_AND_SYMPTOM,917
19119,It,O,917
19120,feels,O,917
19121,like,O,917
19122,something,O,917
19123,is,O,917
19124,in,O,917
19125,your,O,917
19126,field,O,917
19127,of,O,917
19128,vision,O,917
19129,However,O,918
19130,they,O,918
19131,re,O,918
19132,usually,O,918
19133,inside,O,918
19134,your,O,918
19135,eye,O,918
19136,optic,O,918
19137,nerve,O,918
19138,or,O,918
19139,brain,O,918
19140,that,O,918
19141,causes,O,919
19142,you,O,919
19143,to,O,919
19144,see,O,919
19145,these,O,919
19146,things,O,919
19147,in,O,919
19148,your,O,919
19149,field,O,919
19150,of,O,919
19151,vision,O,919
19152,This,O,919
19153,so-called,O,919
19154,photopsia,B-NAME_OF_DISEASE,919
19155,are,O,920
19156,more,O,920
19157,visible,O,920
19158,in,O,920
19159,the,O,920
19160,dark,O,920
19161,as,O,920
19162,they,O,920
19163,re,O,920
19164,bright,O,921
19165,and,O,921
19166,luminous,O,921
19167,In,O,921
19168,some,O,921
19169,cases,O,921
19170,where,O,921
19171,they,O,921
19172,re,O,921
19173,extremely,O,921
19174,flashed,O,921
19175,they,O,921
19176,may,O,921
19177,also,O,921
19178,be,O,921
19179,noticed,O,922
19180,during,O,922
19181,daytime,O,922
19182,When,O,922
19183,you,O,922
19184,experience,O,922
19185,these,O,922
19186,floaters,B-SIGN_AND_SYMPTOM,922
19187,accompanied,I-SIGN_AND_SYMPTOM,922
19188,by,I-SIGN_AND_SYMPTOM,922
19189,flashes,I-SIGN_AND_SYMPTOM,922
19190,you,O,923
19191,should,O,923
19192,immediately,O,923
19193,book,O,923
19194,an,O,923
19195,appointment,O,923
19196,with,O,923
19197,your,O,923
19198,ophthalmologist,O,923
19199,Below,O,924
19200,list,O,924
19201,is,O,924
19202,some,O,924
19203,of,O,924
19204,the,O,924
19205,symptoms,O,924
19206,of,O,924
19207,the,O,924
19208,condition,O,924
19209,Flashes,B-SIGN_AND_SYMPTOM,924
19210,and,I-SIGN_AND_SYMPTOM,924
19211,luminous,I-SIGN_AND_SYMPTOM,924
19212,light,I-SIGN_AND_SYMPTOM,924
19213,Floating,B-SIGN_AND_SYMPTOM,924
19214,shapes,I-SIGN_AND_SYMPTOM,924
19215,in,I-SIGN_AND_SYMPTOM,925
19216,the,I-SIGN_AND_SYMPTOM,925
19217,field,I-SIGN_AND_SYMPTOM,925
19218,of,I-SIGN_AND_SYMPTOM,925
19219,vision,I-SIGN_AND_SYMPTOM,925
19220,Moving,B-SIGN_AND_SYMPTOM,925
19221,dots,I-SIGN_AND_SYMPTOM,925
19222,Static,B-SIGN_AND_SYMPTOM,925
19223,Twinkling,B-SIGN_AND_SYMPTOM,925
19224,lights,I-SIGN_AND_SYMPTOM,925
19225,What,O,925
19226,Are,O,925
19227,the,O,925
19228,Causes,O,925
19229,of,O,925
19230,Photopsia,B-NAME_OF_DISEASE,925
19231,As,O,925
19232,mentioned,O,925
19233,earlier,O,925
19234,photopsia,B-NAME_OF_DISEASE,926
19235,is,O,926
19236,not,O,926
19237,a,O,926
19238,disorder,O,926
19239,on,O,926
19240,its,O,926
19241,own,O,926
19242,but,O,926
19243,a,O,926
19244,cause,O,926
19245,of,O,926
19246,another,O,926
19247,problem,O,926
19248,Some,O,926
19249,of,O,926
19250,the,O,926
19251,example,O,926
19252,causes,O,926
19253,of,O,926
19254,photopsia,B-NAME_OF_DISEASE,926
19255,are,O,927
19256,listed,O,927
19257,below,O,927
19258,Age-related,B-CAUSE_OF_DISEASE,927
19259,macular,I-CAUSE_OF_DISEASE,927
19260,degeneration,I-CAUSE_OF_DISEASE,927
19261,is,O,927
19262,seen,O,927
19263,in,O,927
19264,people,O,927
19265,aged,O,927
19266,over,O,927
19267,50,O,927
19268,Macular,B-PART_OF_THE_EYES,927
19269,part,I-PART_OF_THE_EYES,927
19270,of,I-PART_OF_THE_EYES,927
19271,the,I-PART_OF_THE_EYES,928
19272,maculares,I-PART_OF_THE_EYES,928
19273,helps,O,928
19274,us,O,928
19275,see,O,928
19276,clearly,O,928
19277,what,O,928
19278,s,O,928
19279,in,O,928
19280,front,O,928
19281,of,O,928
19282,us,O,928
19283,Photopsia,B-NAME_OF_DISEASE,928
19284,is,O,928
19285,one,O,928
19286,of,O,928
19287,the,O,928
19288,signals,O,928
19289,of,O,928
19290,degeneration,O,928
19291,Optic,B-CAUSE_OF_DISEASE,928
19292,neuritis,I-CAUSE_OF_DISEASE,928
19293,is,O,928
19294,an,O,928
19295,inflammation,O,928
19296,that,O,928
19297,damages,O,928
19298,the,O,928
19299,optic,O,928
19300,nerve,O,928
19301,resulting,O,928
19302,in,O,928
19303,problems,O,928
19304,when,O,928
19305,the,O,929
19306,images,O,929
19307,are,O,929
19308,processed,O,929
19309,in,O,929
19310,the,O,929
19311,brain,O,929
19312,The,O,929
19313,most,O,929
19314,common,O,929
19315,cause,O,929
19316,of,O,929
19317,it,O,929
19318,is,O,929
19319,multiple,B-CAUSE_OF_DISEASE,930
19320,sclerosis,I-CAUSE_OF_DISEASE,930
19321,Some,O,930
19322,flashes,O,930
19323,and,O,930
19324,flickering,O,930
19325,light,O,930
19326,in,O,930
19327,the,O,930
19328,field,O,930
19329,of,O,930
19330,vision,O,931
19331,Peripheral,B-CAUSE_OF_DISEASE,931
19332,vitreous,I-CAUSE_OF_DISEASE,931
19333,detachment,I-CAUSE_OF_DISEASE,931
19334,can,O,931
19335,cause,O,931
19336,serious,O,931
19337,structural,O,931
19338,problems,O,931
19339,as,O,931
19340,the,B-PART_OF_THE_EYES,931
19341,vitreous,I-PART_OF_THE_EYES,931
19342,humor,I-PART_OF_THE_EYES,931
19343,is,O,932
19344,the,O,932
19345,part,O,932
19346,within,O,932
19347,the,O,932
19348,organ,O,932
19349,that,O,932
19350,keeps,O,932
19351,it,O,932
19352,together,O,932
19353,When,O,933
19354,the,O,933
19355,gel,O,933
19356,detaches,O,933
19357,from,O,933
19358,the,B-PART_OF_THE_EYES,933
19359,retina,I-PART_OF_THE_EYES,933
19360,it,O,933
19361,may,O,933
19362,cause,O,934
19363,peripheral,B-SIGN_AND_SYMPTOM,934
19364,vision,I-SIGN_AND_SYMPTOM,934
19365,loss,I-SIGN_AND_SYMPTOM,934
19366,This,O,934
19367,usually,O,934
19368,happens,O,935
19369,as,O,935
19370,we,O,935
19371,age,O,935
19372,but,O,935
19373,it,O,935
19374,can,O,935
19375,also,O,935
19376,happen,O,935
19377,spontaneously,O,935
19378,and,O,935
19379,when,O,935
19380,it,O,935
19381,happens,O,935
19382,too,O,935
19383,fast,O,935
19384,photopsia,B-NAME_OF_DISEASE,935
19385,may,O,935
19386,occur,O,935
19387,Retinal,B-CAUSE_OF_DISEASE,935
19388,detachment,I-CAUSE_OF_DISEASE,935
19389,can,O,935
19390,lead,O,935
19391,to,O,935
19392,a,O,935
19393,change,O,935
19394,in,O,935
19395,our,O,935
19396,vision,O,935
19397,as,O,935
19398,our,O,935
19399,retina,B-PART_OF_THE_EYES,935
19400,collects,O,935
19401,information,O,935
19402,about,O,935
19403,the,O,935
19404,light,O,935
19405,and,O,935
19406,transmit,O,935
19407,that,O,936
19408,to,O,936
19409,the,O,936
19410,brain,O,936
19411,to,O,936
19412,convert,O,936
19413,it,O,936
19414,into,O,936
19415,images,O,936
19416,Retinal,B-CAUSE_OF_DISEASE,936
19417,detachment,I-CAUSE_OF_DISEASE,936
19418,is,O,937
19419,a,O,937
19420,serious,O,937
19421,condition,O,937
19422,that,O,937
19423,needs,O,937
19424,to,O,937
19425,be,O,937
19426,treated,O,937
19427,immediately,O,937
19428,Sudden,O,937
19429,photopsia,B-NAME_OF_DISEASE,937
19430,is,O,937
19431,one,O,938
19432,of,O,938
19433,the,O,938
19434,indicators,O,938
19435,of,O,938
19436,the,O,938
19437,condition,O,938
19438,Vertebrobasilar,B-CAUSE_OF_DISEASE,938
19439,insufficiency,I-CAUSE_OF_DISEASE,938
19440,is,O,938
19441,poor,O,938
19442,blood,O,938
19443,flow,O,938
19444,to,O,938
19445,the,O,938
19446,back,O,939
19447,side,O,939
19448,of,O,939
19449,the,O,939
19450,brain,O,939
19451,which,O,939
19452,causes,O,939
19453,a,O,939
19454,lot,O,939
19455,of,O,939
19456,damage,O,940
19457,One,O,940
19458,of,O,940
19459,the,O,940
19460,symptoms,O,940
19461,of,O,940
19462,that,O,940
19463,is,O,940
19464,the,O,940
19465,change,O,940
19466,in,O,940
19467,the,O,940
19468,visual,O,940
19469,field,O,940
19470,including,O,940
19471,photopsia,B-NAME_OF_DISEASE,940
19472,What,O,940
19473,is,O,940
19474,Migraine,B-NAME_OF_DISEASE,940
19475,Photopsia,I-NAME_OF_DISEASE,940
19476,A,B-NAME_OF_DISEASE,940
19477,migraine,B-NAME_OF_DISEASE,940
19478,aura,I-NAME_OF_DISEASE,940
19479,is,O,940
19480,a,O,941
19481,wave,O,941
19482,of,O,941
19483,activity,O,941
19484,in,O,941
19485,the,O,941
19486,brain,O,941
19487,The,O,941
19488,location,O,941
19489,of,O,941
19490,the,O,941
19491,activity,O,941
19492,in,O,941
19493,the,O,941
19494,brain,O,941
19495,determines,O,941
19496,the,O,941
19497,type,O,941
19498,of,O,942
19499,aura,O,942
19500,The,O,942
19501,most,O,942
19502,common,O,942
19503,one,O,942
19504,is,O,942
19505,visual,O,942
19506,Almost,O,942
19507,all,O,942
19508,the,O,942
19509,people,O,942
19510,who,O,942
19511,have,O,942
19512,migraine,B-NAME_OF_DISEASE,942
19513,with,I-NAME_OF_DISEASE,942
19514,aura,I-NAME_OF_DISEASE,942
19515,have,O,942
19516,this,O,942
19517,type,O,942
19518,A,B-NAME_OF_DISEASE,942
19519,migraine,B-NAME_OF_DISEASE,942
19520,aura,I-NAME_OF_DISEASE,942
19521,that,O,942
19522,affects,O,942
19523,your,O,942
19524,vision,O,942
19525,is,O,942
19526,common,O,942
19527,and,O,942
19528,its,O,942
19529,symptoms,O,942
19530,don,O,942
19531,t,O,942
19532,last,O,942
19533,very,O,943
19534,long,O,943
19535,You,O,943
19536,may,O,943
19537,experience,O,943
19538,bilateral,B-NAME_OF_DISEASE,943
19539,photopsia,B-NAME_OF_DISEASE,943
19540,meaning,O,943
19541,flashes,B-SIGN_AND_SYMPTOM,943
19542,of,I-SIGN_AND_SYMPTOM,943
19543,light,I-SIGN_AND_SYMPTOM,943
19544,and,I-SIGN_AND_SYMPTOM,943
19545,blind,I-SIGN_AND_SYMPTOM,943
19546,spots,I-SIGN_AND_SYMPTOM,943
19547,Unfortunately,O,943
19548,these,O,943
19549,symptoms,O,943
19550,can,O,943
19551,cause,O,943
19552,problems,O,943
19553,when,O,943
19554,doing,O,943
19555,Daily,O,943
19556,activities,O,943
19557,like,O,943
19558,reading,O,943
19559,or,O,943
19560,driving,O,944
19561,A,B-NAME_OF_DISEASE,944
19562,migraine,B-NAME_OF_DISEASE,944
19563,with,I-NAME_OF_DISEASE,944
19564,aura,I-NAME_OF_DISEASE,944
19565,isn,O,944
19566,t,O,944
19567,usually,O,944
19568,considered,O,944
19569,serious,O,945
19570,Retinal,B-NAME_OF_DISEASE,945
19571,migraine,B-NAME_OF_DISEASE,945
19572,is,O,945
19573,a,O,945
19574,rare,O,945
19575,condition,O,945
19576,that,O,945
19577,a,O,945
19578,person,O,945
19579,who,O,945
19580,experienced,O,945
19581,different,O,945
19582,symptoms,O,945
19583,of,O,945
19584,migraine,B-NAME_OF_DISEASE,945
19585,Retinal,B-NAME_OF_DISEASE,945
19586,migraine,B-NAME_OF_DISEASE,945
19587,causes,O,945
19588,repeated,B-SIGN_AND_SYMPTOM,945
19589,rounds,I-SIGN_AND_SYMPTOM,945
19590,of,I-SIGN_AND_SYMPTOM,945
19591,quickly,I-SIGN_AND_SYMPTOM,945
19592,diminished,I-SIGN_AND_SYMPTOM,945
19593,vision,I-SIGN_AND_SYMPTOM,945
19594,or,I-SIGN_AND_SYMPTOM,945
19595,blindness,I-SIGN_AND_SYMPTOM,945
19596,Unlike,O,945
19597,migraine,B-NAME_OF_DISEASE,945
19598,aura,I-NAME_OF_DISEASE,945
19599,retinal,B-NAME_OF_DISEASE,945
19600,migraine,I-NAME_OF_DISEASE,945
19601,affects,O,945
19602,only,O,946
19603,one,O,946
19604,eye,O,946
19605,If,O,946
19606,you,O,946
19607,experience,O,946
19608,photopsia,B-NAME_OF_DISEASE,946
19609,or,O,946
19610,visual,B-SIGN_AND_SYMPTOM,946
19611,loss,I-SIGN_AND_SYMPTOM,946
19612,in,I-SIGN_AND_SYMPTOM,946
19613,one,I-SIGN_AND_SYMPTOM,946
19614,eye,I-SIGN_AND_SYMPTOM,946
19615,be,O,946
19616,sure,O,946
19617,to,O,946
19618,seek,O,946
19619,medical,O,946
19620,assistance,O,946
19621,Eye,B-NAME_OF_DISEASE,946
19622,mucus,I-NAME_OF_DISEASE,946
19623,fishing,I-NAME_OF_DISEASE,946
19624,syndrome,I-NAME_OF_DISEASE,947
19625,is,O,947
19626,a,O,947
19627,cyclic,O,947
19628,condition,O,947
19629,resulting,O,947
19630,from,O,947
19631,the,B-CAUSE_OF_DISEASE,947
19632,constant,I-CAUSE_OF_DISEASE,947
19633,extraction,I-CAUSE_OF_DISEASE,947
19634,of,I-CAUSE_OF_DISEASE,947
19635,mucous,I-CAUSE_OF_DISEASE,947
19636,strands,I-CAUSE_OF_DISEASE,947
19637,from,I-CAUSE_OF_DISEASE,947
19638,the,I-CAUSE_OF_DISEASE,947
19639,eye,I-CAUSE_OF_DISEASE,947
19640,The,O,947
19641,condition,O,947
19642,itself,O,947
19643,starts,O,947
19644,with,O,947
19645,ocular,B-SIGN_AND_SYMPTOM,948
19646,irritation,I-SIGN_AND_SYMPTOM,948
19647,then,O,948
19648,leads,O,948
19649,to,O,948
19650,excessive,B-SIGN_AND_SYMPTOM,948
19651,mucus,I-SIGN_AND_SYMPTOM,948
19652,production,I-SIGN_AND_SYMPTOM,948
19653,thereby,O,948
19654,causing,O,948
19655,further,B-SIGN_AND_SYMPTOM,948
19656,irritation,I-SIGN_AND_SYMPTOM,948
19657,and,I-SIGN_AND_SYMPTOM,948
19658,more,I-SIGN_AND_SYMPTOM,948
19659,mucus,I-SIGN_AND_SYMPTOM,948
19660,discharge,I-SIGN_AND_SYMPTOM,948
19661,The,O,948
19662,treatment,O,948
19663,starts,O,948
19664,with,O,948
19665,eliminating,B-TREATMENT,948
19666,the,I-TREATMENT,949
19667,irritation,I-TREATMENT,949
19668,caused,I-TREATMENT,949
19669,which,I-TREATMENT,949
19670,is,I-TREATMENT,949
19671,the,I-TREATMENT,949
19672,patient,I-TREATMENT,949
19673,extracting,I-TREATMENT,949
19674,the,I-TREATMENT,949
19675,excess,I-TREATMENT,949
19676,mucus,I-TREATMENT,949
19677,Some,O,949
19678,of,O,949
19679,the,O,949
19680,most,O,949
19681,common,O,949
19682,causes,O,949
19683,of,O,949
19684,eye,B-NAME_OF_DISEASE,949
19685,mucus,I-NAME_OF_DISEASE,949
19686,fishing,I-NAME_OF_DISEASE,949
19687,syndrome,I-NAME_OF_DISEASE,949
19688,are,O,949
19689,as,O,949
19690,follows,O,949
19691,Dry,B-CAUSE_OF_DISEASE,949
19692,eye,I-CAUSE_OF_DISEASE,949
19693,syndrome,I-CAUSE_OF_DISEASE,949
19694,occurs,O,949
19695,when,O,950
19696,the,O,950
19697,eye,O,950
19698,tears,O,950
19699,are,O,950
19700,not,O,950
19701,of,O,950
19702,a,O,950
19703,quality,O,950
19704,to,O,950
19705,provide,O,950
19706,enough,O,950
19707,lubrication,O,950
19708,to,O,950
19709,your,O,950
19710,eyes,O,950
19711,This,O,950
19712,results,O,950
19713,in,O,950
19714,the,B-CAUSE_OF_DISEASE,950
19715,excessive,I-CAUSE_OF_DISEASE,950
19716,production,I-CAUSE_OF_DISEASE,950
19717,of,I-CAUSE_OF_DISEASE,950
19718,tears,I-CAUSE_OF_DISEASE,950
19719,to,I-CAUSE_OF_DISEASE,950
19720,the,I-CAUSE_OF_DISEASE,950
19721,point,I-CAUSE_OF_DISEASE,950
19722,where,I-CAUSE_OF_DISEASE,950
19723,they,I-CAUSE_OF_DISEASE,950
19724,overflow,I-CAUSE_OF_DISEASE,951
19725,Wiping,B-CAUSE_OF_DISEASE,951
19726,those,I-CAUSE_OF_DISEASE,951
19727,tears,I-CAUSE_OF_DISEASE,951
19728,will,O,951
19729,lead,O,951
19730,to,O,951
19731,inflammation,B-SIGN_AND_SYMPTOM,951
19732,irritation,I-SIGN_AND_SYMPTOM,951
19733,and,I-SIGN_AND_SYMPTOM,951
19734,even,I-SIGN_AND_SYMPTOM,951
19735,infection,I-SIGN_AND_SYMPTOM,951
19736,Conjunctivitis,B-CAUSE_OF_DISEASE,951
19737,pink,I-CAUSE_OF_DISEASE,951
19738,eye,I-CAUSE_OF_DISEASE,951
19739,can,O,951
19740,occur,O,951
19741,due,O,951
19742,to,O,951
19743,allergies,B-CAUSE_OF_DISEASE,951
19744,viruses,I-CAUSE_OF_DISEASE,951
19745,bacteria,I-CAUSE_OF_DISEASE,951
19746,or,I-CAUSE_OF_DISEASE,951
19747,anything,I-CAUSE_OF_DISEASE,951
19748,irritant,I-CAUSE_OF_DISEASE,951
19749,Along,B-SIGN_AND_SYMPTOM,951
19750,with,I-SIGN_AND_SYMPTOM,952
19751,redness,I-SIGN_AND_SYMPTOM,952
19752,and,I-SIGN_AND_SYMPTOM,952
19753,irritation,I-SIGN_AND_SYMPTOM,952
19754,the,I-SIGN_AND_SYMPTOM,952
19755,eyes,I-SIGN_AND_SYMPTOM,952
19756,get,I-SIGN_AND_SYMPTOM,952
19757,watery,I-SIGN_AND_SYMPTOM,952
19758,excessively,I-SIGN_AND_SYMPTOM,952
19759,It,O,952
19760,can,O,952
19761,also,O,952
19762,produce,B-SIGN_AND_SYMPTOM,952
19763,yellow,I-SIGN_AND_SYMPTOM,952
19764,or,I-SIGN_AND_SYMPTOM,952
19765,green,I-SIGN_AND_SYMPTOM,952
19766,mucus,I-SIGN_AND_SYMPTOM,952
19767,discharge,I-SIGN_AND_SYMPTOM,952
19768,Blepharitis,B-CAUSE_OF_DISEASE,952
19769,is,O,952
19770,inflammation,O,952
19771,of,O,952
19772,the,B-PART_OF_THE_EYES,952
19773,eyelids,I-PART_OF_THE_EYES,952
19774,The,O,952
19775,underlying,O,952
19776,cause,O,952
19777,of,O,952
19778,it,O,952
19779,may,O,952
19780,be,O,953
19781,either,O,953
19782,abnormal,B-CAUSE_OF_DISEASE,953
19783,or,I-CAUSE_OF_DISEASE,953
19784,insufficient,I-CAUSE_OF_DISEASE,953
19785,oil,I-CAUSE_OF_DISEASE,953
19786,secretion,I-CAUSE_OF_DISEASE,953
19787,in,I-CAUSE_OF_DISEASE,953
19788,your,I-CAUSE_OF_DISEASE,953
19789,tears,I-CAUSE_OF_DISEASE,953
19790,that,O,953
19791,lead,O,953
19792,to,O,953
19793,an,B-SIGN_AND_SYMPTOM,953
19794,excessive,I-SIGN_AND_SYMPTOM,953
19795,amount,I-SIGN_AND_SYMPTOM,953
19796,of,I-SIGN_AND_SYMPTOM,953
19797,tear,I-SIGN_AND_SYMPTOM,953
19798,production,I-SIGN_AND_SYMPTOM,953
19799,redness,I-SIGN_AND_SYMPTOM,953
19800,crusty,I-SIGN_AND_SYMPTOM,953
19801,eyelashes,I-SIGN_AND_SYMPTOM,953
19802,Dacryocystitis,B-CAUSE_OF_DISEASE,953
19803,is,O,953
19804,the,O,954
19805,infection,O,954
19806,of,O,954
19807,the,O,954
19808,tear,O,954
19809,ducts,O,954
19810,resulting,O,954
19811,from,O,954
19812,blockage,B-CAUSE_OF_DISEASE,954
19813,It,O,954
19814,s,O,954
19815,more,O,954
19816,common,O,954
19817,in,O,954
19818,infants,O,954
19819,but,O,954
19820,adults,O,954
19821,experience,O,954
19822,it,O,955
19823,too,O,955
19824,Body-focused,B-CAUSE_OF_DISEASE,955
19825,repetitive,I-CAUSE_OF_DISEASE,955
19826,behavior,I-CAUSE_OF_DISEASE,955
19827,BFRB,I-CAUSE_OF_DISEASE,955
19828,disorder,I-CAUSE_OF_DISEASE,955
19829,is,O,955
19830,more,O,955
19831,than,O,955
19832,having,O,955
19833,things,O,955
19834,as,O,955
19835,habits,O,956
19836,,O,956
19837,These,O,956
19838,are,O,956
19839,repetitive,O,956
19840,behaviors,O,956
19841,that,O,956
19842,are,O,956
19843,difficult,O,956
19844,to,O,956
19845,control,O,956
19846,and,O,956
19847,be,O,956
19848,harmful,O,956
19849,to,O,956
19850,your,O,956
19851,health,O,956
19852,Hair,O,956
19853,pulling,O,956
19854,skin,O,956
19855,picking,O,957
19856,and,O,957
19857,biting,O,957
19858,nails,O,957
19859,can,O,957
19860,be,O,957
19861,examples,O,957
19862,How,O,957
19863,to,O,957
19864,Stop,O,957
19865,Eye,B-NAME_OF_DISEASE,957
19866,Mucus,I-NAME_OF_DISEASE,957
19867,Fish,I-NAME_OF_DISEASE,957
19868,Syndrome,I-NAME_OF_DISEASE,957
19869,-,O,957
19870,Its,O,958
19871,Treatment,O,958
19872,The,O,958
19873,treatment,O,958
19874,of,O,958
19875,mucus,B-NAME_OF_DISEASE,958
19876,fishing,I-NAME_OF_DISEASE,958
19877,syndrome,I-NAME_OF_DISEASE,958
19878,starts,O,958
19879,with,O,958
19880,the,O,958
19881,patient,O,958
19882,overcoming,O,959
19883,their,O,959
19884,fishing,O,959
19885,habit,O,959
19886,Your,O,959
19887,doctor,O,959
19888,is,O,959
19889,likely,O,959
19890,to,O,959
19891,tell,O,959
19892,you,O,959
19893,to,O,959
19894,stop,B-TREATMENT,959
19895,touching,I-TREATMENT,959
19896,rubbing,I-TREATMENT,959
19897,your,I-TREATMENT,959
19898,eyes,I-TREATMENT,959
19899,and,I-TREATMENT,959
19900,pulling,I-TREATMENT,959
19901,at,I-TREATMENT,959
19902,your,I-TREATMENT,959
19903,mucus,I-TREATMENT,959
19904,If,O,959
19905,the,O,959
19906,condition,O,959
19907,caused,O,959
19908,your,O,959
19909,eyes,O,959
19910,to,O,959
19911,dry,O,960
19912,or,O,960
19913,developed,O,960
19914,conjunctivitis,B-NAME_OF_DISEASE,960
19915,or,O,960
19916,other,O,960
19917,eye,O,960
19918,condition,O,960
19919,then,O,960
19920,you,O,960
19921,may,O,960
19922,need,O,960
19923,additional,O,960
19924,treatment,O,960
19925,like,O,960
19926,lubricating,B-NAME_OF_DRUG,960
19927,eye,I-NAME_OF_DRUG,960
19928,drops,I-NAME_OF_DRUG,960
19929,warm,B-TREATMENT,960
19930,or,I-TREATMENT,960
19931,cold,I-TREATMENT,960
19932,eye,I-TREATMENT,960
19933,compresses,I-TREATMENT,960
19934,antibiotics,B-NAME_OF_DRUG,960
19935,and,O,960
19936,steroid,B-NAME_OF_DRUG,960
19937,eye,I-NAME_OF_DRUG,960
19938,drops,I-NAME_OF_DRUG,960
19939,Once,O,960
19940,you,O,960
19941,manage,O,960
19942,to,O,960
19943,stop,O,960
19944,fishing,O,960
19945,your,O,960
19946,mucus,O,960
19947,and,O,960
19948,treat,O,961
19949,the,O,961
19950,underlying,O,961
19951,cause,O,961
19952,your,O,961
19953,condition,O,961
19954,will,O,961
19955,improve,O,961
19956,and,O,961
19957,eventually,O,961
19958,your,O,961
19959,eyes,O,961
19960,will,O,961
19961,slow,O,961
19962,down,O,961
19963,their,O,961
19964,mucus,O,961
19965,production,O,961
19966,Hence,O,961
19967,you,O,961
19968,won,O,961
19969,t,O,961
19970,have,O,961
19971,the,O,961
19972,urge,O,961
19973,to,O,961
19974,fish,O,961
19975,However,O,961
19976,if,O,961
19977,you,O,961
19978,still,O,961
19979,feel,O,961
19980,like,O,961
19981,fishing,O,961
19982,even,O,961
19983,when,O,961
19984,the,O,962
19985,underlying,O,962
19986,cause,O,962
19987,is,O,962
19988,treated,O,962
19989,and,O,962
19990,your,O,962
19991,eyes,O,962
19992,stopped,O,962
19993,producing,O,962
19994,an,O,962
19995,excessive,O,962
19996,amount,O,962
19997,of,O,962
19998,mucus,O,962
19999,then,O,962
20000,you,O,962
20001,should,O,962
20002,consult,O,962
20003,with,O,962
20004,your,O,962
20005,doctor,O,962
20006,about,O,962
20007,it,O,962
20008,Mucus,B-NAME_OF_DISEASE,962
20009,Fish,I-NAME_OF_DISEASE,962
20010,Syndrome,I-NAME_OF_DISEASE,962
20011,Eye,I-NAME_OF_DISEASE,963
20012,Side,O,963
20013,Effects,O,963
20014,Untreated,O,963
20015,and,O,963
20016,neglected,O,963
20017,eye,O,963
20018,problems,O,963
20019,always,O,963
20020,increase,O,963
20021,the,O,963
20022,risk,O,963
20023,of,O,963
20024,you,O,963
20025,having,O,963
20026,a,O,963
20027,serious,O,963
20028,eye,O,963
20029,infection,O,963
20030,Furthermore,O,963
20031,the,O,963
20032,more,O,963
20033,you,O,963
20034,touch,B-CAUSE_OF_DISEASE,963
20035,and,I-CAUSE_OF_DISEASE,963
20036,rub,I-CAUSE_OF_DISEASE,963
20037,your,I-CAUSE_OF_DISEASE,963
20038,eyes,I-CAUSE_OF_DISEASE,963
20039,the,O,963
20040,greater,O,964
20041,the,O,964
20042,chance,O,964
20043,that,O,964
20044,your,O,964
20045,eyes,O,964
20046,will,O,964
20047,be,O,964
20048,infected,O,964
20049,even,O,964
20050,worse,O,964
20051,If,O,964
20052,you,O,964
20053,have,O,964
20054,mucus,B-NAME_OF_DISEASE,964
20055,fishing,I-NAME_OF_DISEASE,964
20056,syndrome,I-NAME_OF_DISEASE,964
20057,it,O,964
20058,means,O,964
20059,you,O,964
20060,are,O,964
20061,repetitively,O,964
20062,inclined,O,964
20063,to,O,964
20064,pull,O,964
20065,strands,O,964
20066,of,O,965
20067,mucus,O,965
20068,from,O,965
20069,your,O,965
20070,eye,O,965
20071,frequently,O,965
20072,As,O,965
20073,it,O,965
20074,will,O,965
20075,increase,O,965
20076,the,O,965
20077,likeliness,O,965
20078,of,O,965
20079,having,O,965
20080,eye,O,966
20081,irritation,O,966
20082,excessive,O,966
20083,mucus,O,966
20084,production,O,966
20085,and,O,966
20086,developing,O,966
20087,an,O,966
20088,infection,O,966
20089,the,O,966
20090,symptoms,O,966
20091,include,O,966
20092,redness,B-SIGN_AND_SYMPTOM,966
20093,in,I-SIGN_AND_SYMPTOM,966
20094,the,I-SIGN_AND_SYMPTOM,966
20095,eye,I-SIGN_AND_SYMPTOM,966
20096,tear,I-SIGN_AND_SYMPTOM,966
20097,production,I-SIGN_AND_SYMPTOM,966
20098,inflammation,I-SIGN_AND_SYMPTOM,966
20099,and,I-SIGN_AND_SYMPTOM,966
20100,pain,I-SIGN_AND_SYMPTOM,966
20101,How,O,966
20102,to,O,966
20103,Stop,O,966
20104,Eye,B-NAME_OF_DISEASE,966
20105,Mucus,B-NAME_OF_DISEASE,966
20106,Fishing,I-NAME_OF_DISEASE,966
20107,Syndrome,I-NAME_OF_DISEASE,966
20108,As,O,966
20109,it,O,966
20110,all,O,966
20111,starts,O,966
20112,with,O,966
20113,the,O,967
20114,patient,O,967
20115,pulling,O,967
20116,stands,O,967
20117,of,O,967
20118,mucus,O,967
20119,from,O,967
20120,the,O,967
20121,eye,O,967
20122,repetitively,O,967
20123,the,O,967
20124,treatment,O,967
20125,starts,O,967
20126,with,O,968
20127,the,O,968
20128,patient,O,968
20129,themselves,O,968
20130,It,O,968
20131,is,O,968
20132,of,O,968
20133,great,O,968
20134,importance,O,968
20135,to,O,968
20136,refrain,B-TREATMENT,968
20137,from,I-TREATMENT,968
20138,touching,I-TREATMENT,968
20139,or,I-TREATMENT,968
20140,rubbing,I-TREATMENT,968
20141,the,I-TREATMENT,968
20142,eyes,I-TREATMENT,968
20143,as,O,968
20144,they,O,968
20145,increase,O,968
20146,the,O,969
20147,chance,O,969
20148,of,O,969
20149,developing,O,969
20150,irritation,O,969
20151,and,O,969
20152,infection,O,969
20153,in,O,969
20154,the,O,969
20155,eye,O,969
20156,Is,O,969
20157,Mucus,B-NAME_OF_DISEASE,969
20158,Fishing,I-NAME_OF_DISEASE,969
20159,Syndrome,I-NAME_OF_DISEASE,969
20160,Dangerous,O,969
20161,to,O,969
20162,The,O,969
20163,Eyes,O,969
20164,The,O,969
20165,long-term,O,969
20166,consequences,O,969
20167,of,O,969
20168,eye,B-NAME_OF_DISEASE,969
20169,mucus,I-NAME_OF_DISEASE,969
20170,fishing,I-NAME_OF_DISEASE,969
20171,are,O,969
20172,still,O,969
20173,left,O,969
20174,unchecked,O,969
20175,the,O,969
20176,condition,O,969
20177,can,O,969
20178,cause,O,969
20179,serious,O,969
20180,infection,O,969
20181,and,O,969
20182,harm,O,969
20183,to,O,969
20184,your,O,969
20185,eyes,O,969
20186,Dry,B-NAME_OF_DISEASE,969
20187,eye,I-NAME_OF_DISEASE,969
20188,disease,I-NAME_OF_DISEASE,969
20189,DED,B-NAME_OF_DISEASE,969
20190,also,O,969
20191,known,O,969
20192,as,O,970
20193,keratoconjunctivitis,B-NAME_OF_DISEASE,970
20194,sicca,I-NAME_OF_DISEASE,970
20195,KCS,B-NAME_OF_DISEASE,970
20196,is,O,970
20197,a,O,970
20198,common,O,970
20199,disorder,O,970
20200,of,O,970
20201,the,O,970
20202,eye,O,970
20203,affecting,O,970
20204,millions,O,970
20205,of,O,970
20206,people,O,970
20207,around,O,970
20208,the,O,970
20209,world,O,970
20210,The,O,970
20211,prevalence,O,970
20212,of,O,970
20213,DED,B-NAME_OF_DISEASE,970
20214,ranges,O,970
20215,from,O,970
20216,5%,O,970
20217,to,O,970
20218,33%,O,970
20219,worldwide,O,970
20220,with,O,970
20221,increased,O,970
20222,prevalence,O,970
20223,among,O,970
20224,adult,O,970
20225,women,O,970
20226,and,O,971
20227,Asians,O,971
20228,Symptoms,O,971
20229,of,O,971
20230,DED,B-NAME_OF_DISEASE,971
20231,include,O,971
20232,discomfort,B-SIGN_AND_SYMPTOM,971
20233,pain,I-SIGN_AND_SYMPTOM,971
20234,burning,I-SIGN_AND_SYMPTOM,972
20235,foreign,I-SIGN_AND_SYMPTOM,972
20236,body,I-SIGN_AND_SYMPTOM,972
20237,sensation,I-SIGN_AND_SYMPTOM,972
20238,and,I-SIGN_AND_SYMPTOM,973
20239,visual,I-SIGN_AND_SYMPTOM,973
20240,disturbances,I-SIGN_AND_SYMPTOM,973
20241,Dry,B-NAME_OF_DISEASE,973
20242,eye,I-NAME_OF_DISEASE,973
20243,negatively,O,973
20244,affects,O,973
20245,the,O,974
20246,quality,O,974
20247,of,O,975
20248,life,O,975
20249,and,O,975
20250,results,O,975
20251,in,O,975
20252,approximately,O,975
20253,6,O,975
20254,billion,O,975
20255,in,O,975
20256,annual,O,975
20257,costs,O,975
20258,in,O,976
20259,the,B-GPE,976
20260,US,I-GPE,976
20261,Dry,B-NAME_OF_DISEASE,977
20262,eye,I-NAME_OF_DISEASE,977
20263,is,O,977
20264,commonly,O,977
20265,seen,O,977
20266,alongside,O,977
20267,many,O,977
20268,ocular,B-NAME_OF_DISEASE,978
20269,disorders,I-NAME_OF_DISEASE,978
20270,including,O,978
20271,glaucoma,B-NAME_OF_DISEASE,978
20272,cataracts,B-NAME_OF_DISEASE,979
20273,and,O,979
20274,refractive,B-NAME_OF_DISEASE,979
20275,errors,I-NAME_OF_DISEASE,979
20276,Pharmacological,O,979
20277,treatments,O,979
20278,for,O,980
20279,ocular,B-NAME_OF_DISEASE,980
20280,disorders,I-NAME_OF_DISEASE,981
20281,often,O,981
20282,contain,O,981
20283,preservatives,B-CAUSE_OF_DISEASE,981
20284,such,I-CAUSE_OF_DISEASE,981
20285,as,I-CAUSE_OF_DISEASE,981
20286,benzalkonium,I-CAUSE_OF_DISEASE,981
20287,chloride,I-CAUSE_OF_DISEASE,981
20288,These,O,981
20289,preservatives,O,981
20290,can,O,981
20291,cause,O,981
20292,DED,B-NAME_OF_DISEASE,981
20293,signs,O,981
20294,and,O,982
20295,symptoms,O,982
20296,including,O,982
20297,decreased,B-SIGN_AND_SYMPTOM,982
20298,epithelial,I-SIGN_AND_SYMPTOM,982
20299,cell,I-SIGN_AND_SYMPTOM,982
20300,integrity,I-SIGN_AND_SYMPTOM,982
20301,increased,I-SIGN_AND_SYMPTOM,982
20302,epithelial,I-SIGN_AND_SYMPTOM,982
20303,cell,I-SIGN_AND_SYMPTOM,983
20304,apoptosis,I-SIGN_AND_SYMPTOM,983
20305,eye,I-SIGN_AND_SYMPTOM,983
20306,irritation,I-SIGN_AND_SYMPTOM,983
20307,and,I-SIGN_AND_SYMPTOM,983
20308,increased,I-SIGN_AND_SYMPTOM,983
20309,risk,I-SIGN_AND_SYMPTOM,983
20310,for,I-SIGN_AND_SYMPTOM,983
20311,ocular,I-SIGN_AND_SYMPTOM,983
20312,allergies,I-SIGN_AND_SYMPTOM,984
20313,and,I-SIGN_AND_SYMPTOM,984
20314,delayed,I-SIGN_AND_SYMPTOM,984
20315,hypersensitivity,I-SIGN_AND_SYMPTOM,984
20316,reactions,I-SIGN_AND_SYMPTOM,984
20317,Surgical,B-CAUSE_OF_DISEASE,984
20318,interventions,I-CAUSE_OF_DISEASE,984
20319,to,I-CAUSE_OF_DISEASE,984
20320,treat,I-CAUSE_OF_DISEASE,984
20321,ophthalmic,I-CAUSE_OF_DISEASE,984
20322,disorders,I-CAUSE_OF_DISEASE,984
20323,and,I-CAUSE_OF_DISEASE,984
20324,diseases,I-CAUSE_OF_DISEASE,984
20325,can,O,984
20326,also,O,984
20327,cause,O,984
20328,dry,B-NAME_OF_DISEASE,984
20329,eye,I-NAME_OF_DISEASE,984
20330,due,O,984
20331,to,O,985
20332,the,B-CAUSE_OF_DISEASE,985
20333,resultant,I-CAUSE_OF_DISEASE,985
20334,inflammation,I-CAUSE_OF_DISEASE,985
20335,from,I-CAUSE_OF_DISEASE,985
20336,the,I-CAUSE_OF_DISEASE,985
20337,length,I-CAUSE_OF_DISEASE,985
20338,of,I-CAUSE_OF_DISEASE,985
20339,time,I-CAUSE_OF_DISEASE,985
20340,in,I-CAUSE_OF_DISEASE,986
20341,surgery,I-CAUSE_OF_DISEASE,986
20342,incision,B-CAUSE_OF_DISEASE,986
20343,site,I-CAUSE_OF_DISEASE,986
20344,disruption,I-CAUSE_OF_DISEASE,986
20345,to,I-CAUSE_OF_DISEASE,986
20346,the,I-CAUSE_OF_DISEASE,986
20347,corneal,I-CAUSE_OF_DISEASE,986
20348,nerves,I-CAUSE_OF_DISEASE,986
20349,and,O,986
20350,type,B-CAUSE_OF_DISEASE,986
20351,of,I-CAUSE_OF_DISEASE,986
20352,post-surgical,I-CAUSE_OF_DISEASE,986
20353,medication,I-CAUSE_OF_DISEASE,986
20354,Post-trabeculectomy,O,986
20355,patients,O,986
20356,have,O,986
20357,elevated,B-CAUSE_OF_DISEASE,986
20358,tear,I-CAUSE_OF_DISEASE,986
20359,film,I-CAUSE_OF_DISEASE,986
20360,osmolarity,I-CAUSE_OF_DISEASE,986
20361,and,O,986
20362,symptoms,O,986
20363,of,O,986
20364,dry,B-NAME_OF_DISEASE,986
20365,eye,I-NAME_OF_DISEASE,986
20366,intraoperative,B-TREATMENT,986
20367,use,I-TREATMENT,986
20368,of,I-TREATMENT,986
20369,lubricating,I-TREATMENT,986
20370,substances,I-TREATMENT,986
20371,can,O,987
20372,decrease,O,987
20373,post-surgical,O,987
20374,dry,B-NAME_OF_DISEASE,987
20375,eye,I-NAME_OF_DISEASE,987
20376,symptoms,O,987
20377,and,O,987
20378,treatment,O,987
20379,with,O,987
20380,dry,B-NAME_OF_DISEASE,987
20381,eye,I-NAME_OF_DISEASE,987
20382,medication,O,987
20383,post-operatively,O,987
20384,can,O,987
20385,help,O,987
20386,alleviate,O,987
20387,surgery-induced,O,988
20388,dry,B-NAME_OF_DISEASE,988
20389,eye,I-NAME_OF_DISEASE,988
20390,Dry,B-NAME_OF_DISEASE,988
20391,eye,I-NAME_OF_DISEASE,988
20392,symptoms,O,988
20393,following,O,988
20394,cataract,B-TREATMENT,988
20395,surgery,I-TREATMENT,988
20396,occur,O,988
20397,in,O,988
20398,42%,O,988
20399,15%,O,988
20400,and,O,988
20401,9%,O,988
20402,of,O,988
20403,eyes,O,988
20404,of,O,988
20405,patients,O,988
20406,at,O,988
20407,1,B-TIME_DURATION,988
20408,week,I-TIME_DURATION,989
20409,1,B-TIME_DURATION,989
20410,month,I-TIME_DURATION,989
20411,and,O,989
20412,3,B-TIME_DURATION,989
20413,months,I-TIME_DURATION,989
20414,after,O,989
20415,surgery,O,989
20416,respectively,O,989
20417,Additionally,O,989
20418,new,O,989
20419,research,O,989
20420,demonstrates,O,989
20421,the,O,989
20422,bilateral,O,989
20423,impact,O,989
20424,on,O,989
20425,the,B-PART_OF_THE_EYES,989
20426,corneal,I-PART_OF_THE_EYES,989
20427,sub-basal,I-PART_OF_THE_EYES,989
20428,nerve,I-PART_OF_THE_EYES,989
20429,complex,I-PART_OF_THE_EYES,989
20430,after,O,989
20431,cataract,B-TREATMENT,989
20432,surgery,I-TREATMENT,989
20433,potentially,O,989
20434,explaining,O,989
20435,worse,O,989
20436,dry,B-NAME_OF_DISEASE,990
20437,eye,I-NAME_OF_DISEASE,990
20438,symptoms,O,990
20439,after,O,990
20440,cataract,B-TREATMENT,990
20441,surgery,I-TREATMENT,990
20442,on,O,990
20443,the,O,990
20444,second,O,990
20445,eye,O,990
20446,Cyclosporine,B-NAME_OF_DRUG,990
20447,Cyclosporine,B-NAME_OF_DRUG,990
20448,A,I-NAME_OF_DRUG,990
20449,is,O,990
20450,a,O,990
20451,neutrally,O,990
20452,charged,O,991
20453,hydrophobic,O,991
20454,molecule,O,991
20455,with,O,991
20456,low,O,991
20457,aqueous,O,991
20458,solubility,O,991
20459,which,O,991
20460,poses,O,991
20461,challenges,O,991
20462,in,O,991
20463,making,O,991
20464,a,O,992
20465,safe,O,992
20466,and,O,992
20467,effective,O,992
20468,ocular,O,992
20469,drug,O,992
20470,delivery,O,992
20471,system,O,992
20472,Cyclosporine,B-NAME_OF_DRUG,992
20473,A,I-NAME_OF_DRUG,992
20474,reduces,O,992
20475,the,O,992
20476,underlying,O,992
20477,inflammation,O,992
20478,associated,O,992
20479,with,O,992
20480,DED,B-NAME_OF_DISEASE,992
20481,that,O,992
20482,interferes,O,992
20483,with,O,992
20484,tear,O,992
20485,production,O,992
20486,Initially,O,992
20487,cyclosporine,B-NAME_OF_DRUG,992
20488,A,I-NAME_OF_DRUG,992
20489,ophthalmic,O,992
20490,solutions,O,992
20491,were,O,992
20492,formulated,O,993
20493,in,O,993
20494,oil-based,O,993
20495,solvents,O,993
20496,such,O,993
20497,as,O,993
20498,castor,O,993
20499,oil,O,993
20500,or,O,993
20501,corn,O,993
20502,oil,O,993
20503,however,O,993
20504,oils,O,993
20505,caused,O,993
20506,side,O,994
20507,effects,O,994
20508,such,O,994
20509,as,O,994
20510,blurred,B-SIGN_AND_SYMPTOM,994
20511,vision,I-SIGN_AND_SYMPTOM,994
20512,burning,I-SIGN_AND_SYMPTOM,994
20513,and,I-SIGN_AND_SYMPTOM,995
20514,stinging,I-SIGN_AND_SYMPTOM,995
20515,and,I-SIGN_AND_SYMPTOM,995
20516,were,I-SIGN_AND_SYMPTOM,995
20517,poorly,I-SIGN_AND_SYMPTOM,995
20518,tolerated,I-SIGN_AND_SYMPTOM,995
20519,Additionally,O,995
20520,these,O,995
20521,oils,O,995
20522,provided,O,995
20523,low,O,995
20524,bioavailability,O,995
20525,of,O,995
20526,cyclosporine,B-NAME_OF_DRUG,996
20527,A,I-NAME_OF_DRUG,996
20528,to,O,996
20529,the,O,996
20530,ocular,O,996
20531,targets,O,996
20532,The,O,996
20533,limitations,O,996
20534,of,O,996
20535,oil-based,O,996
20536,cyclosporine,B-NAME_OF_DRUG,996
20537,A,I-NAME_OF_DRUG,996
20538,formulations,O,996
20539,lead,O,996
20540,to,O,997
20541,a,O,997
20542,need,O,997
20543,for,O,997
20544,cyclosporine,B-NAME_OF_DRUG,997
20545,A,I-NAME_OF_DRUG,997
20546,formulations,O,997
20547,with,O,997
20548,improved,O,997
20549,tolerability,O,997
20550,and,O,997
20551,bioavailability,O,997
20552,This,O,997
20553,review,O,997
20554,covers,O,997
20555,the,O,997
20556,immunopathophysiology,O,997
20557,of,O,997
20558,DED,B-NAME_OF_DISEASE,997
20559,as,O,997
20560,well,O,997
20561,as,O,998
20562,the,O,998
20563,mechanism,O,998
20564,of,O,998
20565,action,O,998
20566,of,O,998
20567,cyclosporine,B-NAME_OF_DRUG,998
20568,A,I-NAME_OF_DRUG,998
20569,and,O,998
20570,its,O,998
20571,role,O,998
20572,in,O,998
20573,modulating,O,998
20574,ocular,O,998
20575,inflammation,O,998
20576,compares,O,998
20577,the,O,998
20578,current,O,998
20579,ophthalmic,O,998
20580,cyclosporine,B-NAME_OF_DRUG,998
20581,A,I-NAME_OF_DRUG,998
20582,formulations,O,998
20583,and,O,998
20584,discusses,O,998
20585,the,O,998
20586,limitations,O,998
20587,and,O,998
20588,challenges,O,998
20589,of,O,998
20590,using,O,998
20591,cyclosporine,B-NAME_OF_DRUG,998
20592,A,I-NAME_OF_DRUG,998
20593,for,O,999
20594,the,O,999
20595,treatment,O,999
20596,of,O,999
20597,DED,B-NAME_OF_DISEASE,999
20598,Since,O,999
20599,Cyclosporine,B-NAME_OF_DRUG,999
20600,is,O,999
20601,a,O,999
20602,well-established,O,999
20603,stalwart,O,999
20604,of,O,999
20605,long-term,O,999
20606,management,O,999
20607,for,O,999
20608,dry,B-NAME_OF_DISEASE,999
20609,eye,I-NAME_OF_DISEASE,999
20610,disease,I-NAME_OF_DISEASE,999
20611,DED,B-NAME_OF_DISEASE,999
20612,Ophthalmologists,O,999
20613,have,O,999
20614,trusted,O,1000
20615,it,O,1000
20616,for,O,1000
20617,years,O,1000
20618,as,O,1000
20619,an,O,1000
20620,effective,O,1000
20621,immunomodulator,O,1000
20622,that,O,1000
20623,alleviates,O,1000
20624,dry,B-NAME_OF_DISEASE,1000
20625,eye,I-NAME_OF_DISEASE,1000
20626,symptoms,O,1000
20627,without,O,1000
20628,major,O,1000
20629,negative,O,1001
20630,side,O,1001
20631,effects,O,1001
20632,We,O,1001
20633,have,O,1001
20634,several,O,1001
20635,options,O,1001
20636,for,O,1001
20637,cyclosporine,B-NAME_OF_DRUG,1001
20638,Cequa,O,1001
20639,0.09,O,1001
20640,Sun,O,1001
20641,Ophthalmics,O,1001
20642,Restasis,O,1001
20643,0.05,O,1001
20644,Allergan,O,1001
20645,and,O,1001
20646,the,O,1001
20647,compounded,O,1001
20648,Klarity-C,O,1001
20649,Drops,O,1001
20650,0.1,O,1001
20651,Imprimis,O,1001
20652,,O,1001
20653,Several,O,1001
20654,more,O,1001
20655,are,O,1001
20656,in,O,1002
20657,the,O,1002
20658,pipeline,O,1002
20659,including,O,1002
20660,generic,B-NAME_OF_DRUG,1002
20661,Restasis,I-NAME_OF_DRUG,1002
20662,CyclASol,O,1002
20663,0.1,O,1002
20664,Novaliq,O,1002
20665,Ikervis,O,1002
20666,0.1,O,1002
20667,Santen,O,1002
20668,Pharmaceutical,O,1002
20669,and,O,1002
20670,OTX-CSI,O,1002
20671,ophthalmic,O,1002
20672,insert,O,1003
20673,0.3,O,1003
20674,mg,O,1003
20675,Ocular,O,1003
20676,Therapeutix,O,1003
20677,,O,1003
20678,Although,O,1003
20679,the,O,1003
20680,concentrations,O,1003
20681,range,O,1003
20682,from,O,1003
20683,0.05,O,1003
20684,to,O,1003
20685,0.1,O,1003
20686,we,O,1003
20687,have,O,1003
20688,found,O,1003
20689,cyclosporine,B-NAME_OF_DRUG,1003
20690,to,O,1003
20691,be,O,1003
20692,efficacious,O,1003
20693,at,O,1003
20694,all,O,1003
20695,levels,O,1004
20696,with,O,1004
20697,some,O,1004
20698,subtle,O,1004
20699,differences,O,1004
20700,The,O,1004
20701,choice,O,1004
20702,usually,O,1004
20703,comes,O,1004
20704,down,O,1004
20705,to,O,1004
20706,tolerability,O,1004
20707,and,O,1004
20708,affordability,O,1004
20709,As,O,1004
20710,a,O,1004
20711,topical,O,1004
20712,ophthalmic,O,1004
20713,agent,O,1004
20714,cyclosporine,B-NAME_OF_DRUG,1004
20715,poses,O,1004
20716,several,O,1004
20717,challenges,O,1004
20718,Firstly,O,1004
20719,it,O,1004
20720,is,O,1004
20721,a,O,1004
20722,hydrophobic,O,1004
20723,lipophilic,O,1004
20724,molecule,O,1004
20725,so,O,1004
20726,does,O,1005
20727,not,O,1005
20728,easily,O,1005
20729,penetrate,O,1005
20730,the,O,1005
20731,aqueous,O,1005
20732,layer,O,1005
20733,and,O,1005
20734,reach,O,1005
20735,the,O,1005
20736,eye,O,1005
20737,Secondly,O,1005
20738,it,O,1005
20739,can,O,1005
20740,cause,O,1005
20741,burning,B-SIGN_AND_SYMPTOM,1005
20742,or,I-SIGN_AND_SYMPTOM,1005
20743,stinging,I-SIGN_AND_SYMPTOM,1005
20744,on,I-SIGN_AND_SYMPTOM,1005
20745,instillation,I-SIGN_AND_SYMPTOM,1005
20746,As,O,1005
20747,a,O,1005
20748,result,O,1005
20749,manufacturers,O,1005
20750,need,O,1005
20751,to,O,1005
20752,formulate,O,1005
20753,a,O,1005
20754,vehicle,O,1005
20755,that,O,1005
20756,achieves,O,1005
20757,the,O,1006
20758,penetration,O,1006
20759,required,O,1006
20760,for,O,1006
20761,efficacy,O,1006
20762,produces,O,1006
20763,minimal,O,1006
20764,side,O,1006
20765,effects,O,1006
20766,and,O,1006
20767,feels,O,1006
20768,comfortable,O,1006
20769,for,O,1006
20770,chronic,O,1006
20771,use,O,1006
20772,-,O,1006
20773,a,O,1006
20774,notoriously,O,1006
20775,difficult,O,1006
20776,feat,O,1006
20777,The,O,1006
20778,tolerability,O,1006
20779,of,O,1006
20780,different,O,1006
20781,cyclosporine,B-NAME_OF_DRUG,1006
20782,formulations,O,1006
20783,hinges,O,1006
20784,primarily,O,1006
20785,on,O,1006
20786,the,O,1006
20787,vehicle,O,1006
20788,which,O,1006
20789,varies,O,1006
20790,among,O,1006
20791,different,O,1007
20792,products,O,1007
20793,Although,O,1007
20794,we,O,1007
20795,tend,O,1007
20796,to,O,1007
20797,favour,O,1007
20798,products,O,1007
20799,with,O,1007
20800,an,O,1007
20801,established,O,1007
20802,track,O,1007
20803,record,O,1007
20804,of,O,1007
20805,comfort,O,1007
20806,some,O,1007
20807,patients,O,1007
20808,might,O,1007
20809,tolerate,O,1007
20810,one,O,1007
20811,better,O,1007
20812,than,O,1007
20813,another,O,1008
20814,Because,O,1008
20815,we,O,1008
20816,have,O,1008
20817,used,O,1008
20818,Restasis-which,O,1008
20819,has,O,1008
20820,an,O,1008
20821,anionic,O,1008
20822,castor,O,1008
20823,oil-in-water,O,1008
20824,emulsion,O,1008
20825,vehicle1,O,1008
20826,-,O,1008
20827,for,O,1008
20828,many,O,1008
20829,years,O,1008
20830,we,O,1008
20831,know,O,1008
20832,to,O,1008
20833,expect,O,1008
20834,patients,O,1008
20835,to,O,1008
20836,be,O,1008
20837,comfortable,O,1008
20838,with,O,1008
20839,its,O,1008
20840,long-term,O,1008
20841,use,O,1008
20842,As,O,1008
20843,it,O,1009
20844,has,O,1009
20845,been,O,1009
20846,around,O,1009
20847,a,O,1009
20848,long,O,1009
20849,time,O,1009
20850,Restasis,B-NAME_OF_DRUG,1009
20851,is,O,1009
20852,also,O,1009
20853,covered,O,1009
20854,by,O,1009
20855,most,O,1009
20856,insurance,O,1009
20857,plans,O,1009
20858,Our,O,1009
20859,patients,O,1009
20860,have,O,1009
20861,also,O,1009
20862,tolerated,O,1009
20863,Cequa,B-NAME_OF_DRUG,1009
20864,well,O,1009
20865,which,O,1009
20866,has,O,1009
20867,a,O,1009
20868,nanomicelle-based,O,1009
20869,solution,O,1009
20870,Commercial,O,1009
20871,patients,O,1009
20872,can,O,1009
20873,obtain,O,1009
20874,Cequa,B-NAME_OF_DRUG,1009
20875,at,O,1009
20876,its,O,1009
20877,lowest,O,1009
20878,price,O,1009
20879,through,O,1009
20880,a,O,1009
20881,specialty,O,1009
20882,pharmacy,O,1009
20883,so,O,1009
20884,we,O,1009
20885,check,O,1009
20886,with,O,1010
20887,patients,O,1010
20888,in,O,1010
20889,advance,O,1010
20890,to,O,1010
20891,see,O,1010
20892,if,O,1010
20893,that,O,1010
20894,is,O,1010
20895,a,O,1010
20896,convenient,O,1010
20897,arrangement,O,1010
20898,The,O,1010
20899,third,O,1010
20900,current,O,1010
20901,option,O,1010
20902,Klarity-C,B-NAME_OF_DRUG,1010
20903,Drops,I-NAME_OF_DRUG,1010
20904,has,O,1010
20905,a,O,1010
20906,chondroitin,B-CHEMICAL_COMPOUND,1010
20907,sulfate,I-CHEMICAL_COMPOUND,1010
20908,glycerin,B-CHEMICAL_COMPOUND,1010
20909,and,O,1010
20910,dextran-based,O,1010
20911,solution,O,1011
20912,This,O,1011
20913,can,O,1011
20914,be,O,1011
20915,the,O,1011
20916,most,O,1011
20917,cost-effective,O,1011
20918,choice,O,1011
20919,However,O,1011
20920,in,O,1011
20921,our,O,1011
20922,limited,O,1011
20923,experience,O,1011
20924,it,O,1011
20925,also,O,1011
20926,seems,O,1011
20927,to,O,1011
20928,be,O,1011
20929,less,O,1011
20930,well,O,1011
20931,tolerated,O,1011
20932,We,O,1011
20933,use,O,1011
20934,both,O,1011
20935,cyclosporine,B-NAME_OF_DRUG,1011
20936,and,O,1011
20937,lifitegrast,B-NAME_OF_DRUG,1011
20938,Xiidra,I-NAME_OF_DRUG,1011
20939,Novartis,I-NAME_OF_DRUG,1011
20940,as,O,1011
20941,part,O,1011
20942,of,O,1011
20943,long-term,O,1011
20944,management,O,1011
20945,plans,O,1011
20946,With,O,1011
20947,cyclosporine,B-NAME_OF_DRUG,1011
20948,our,O,1011
20949,best,O,1011
20950,candidates,O,1011
20951,have,O,1011
20952,chronic,B-NAME_OF_DISEASE,1011
20953,dry,B-NAME_OF_DISEASE,1011
20954,eye,I-NAME_OF_DISEASE,1011
20955,and,O,1011
20956,possibly,O,1011
20957,wear,O,1011
20958,contact,B-TREATMENT,1012
20959,lenses,I-TREATMENT,1012
20960,so,O,1012
20961,they,O,1012
20962,need,O,1012
20963,long-term,O,1012
20964,relief,O,1012
20965,from,O,1012
20966,inflammation,O,1012
20967,It,O,1012
20968,can,O,1012
20969,take,O,1012
20970,up,B-TIME_DURATION,1012
20971,to,I-TIME_DURATION,1012
20972,3,I-TIME_DURATION,1012
20973,months,I-TIME_DURATION,1012
20974,for,O,1012
20975,cyclosporine,B-NAME_OF_DRUG,1012
20976,to,O,1012
20977,build,O,1012
20978,up,O,1012
20979,the,O,1012
20980,concentration,O,1012
20981,required,O,1012
20982,for,O,1012
20983,full,O,1012
20984,efficacy,O,1013
20985,so,O,1013
20986,we,O,1013
20987,tend,O,1013
20988,to,O,1013
20989,choose,O,1013
20990,it,O,1013
20991,for,O,1013
20992,patients,O,1013
20993,who,O,1013
20994,can,O,1013
20995,patiently,O,1013
20996,await,O,1013
20997,some,O,1013
20998,improvement,O,1013
20999,For,O,1013
21000,more,O,1013
21001,severe,O,1013
21002,cases,O,1013
21003,we,O,1013
21004,also,O,1013
21005,utilise,O,1013
21006,a,O,1013
21007,steroid,B-NAME_OF_DRUG,1013
21008,during,O,1013
21009,the,O,1013
21010,cyclosporine,B-NAME_OF_DRUG,1013
21011,induction,O,1013
21012,period,O,1013
21013,such,O,1013
21014,as,O,1013
21015,loteprednol,O,1013
21016,etabonate,O,1013
21017,ophthalmic,O,1013
21018,suspension,O,1013
21019,0.25,O,1013
21020,Eyesuvis,O,1013
21021,Kala,O,1013
21022,Pharmaceuticals,O,1013
21023,which,O,1013
21024,can,O,1013
21025,be,O,1013
21026,used,O,1013
21027,on-label,O,1013
21028,for,O,1013
21029,short,O,1013
21030,term,O,1013
21031,treatment,O,1013
21032,of,O,1013
21033,dry,B-NAME_OF_DISEASE,1013
21034,eye,I-NAME_OF_DISEASE,1013
21035,In,O,1013
21036,addition,O,1013
21037,our,O,1013
21038,patients,O,1013
21039,who,O,1013
21040,have,O,1013
21041,dry,B-NAME_OF_DISEASE,1013
21042,eye,I-NAME_OF_DISEASE,1013
21043,secondary,O,1013
21044,to,O,1013
21045,autoimmune,O,1013
21046,conditions,O,1013
21047,such,O,1013
21048,as,O,1013
21049,Sjogren,B-NAME_OF_DISEASE,1013
21050,s,I-NAME_OF_DISEASE,1013
21051,syndrome,I-NAME_OF_DISEASE,1013
21052,or,O,1013
21053,rheumatoid,B-NAME_OF_DISEASE,1014
21054,arthritis,I-NAME_OF_DISEASE,1014
21055,tend,O,1014
21056,to,O,1014
21057,respond,O,1014
21058,very,O,1014
21059,well,O,1014
21060,to,O,1014
21061,cyclosporine,B-NAME_OF_DRUG,1014
21062,From,O,1014
21063,a,O,1014
21064,clinical,O,1014
21065,standpoint,O,1014
21066,it,O,1014
21067,has,O,1014
21068,been,O,1015
21069,great,O,1015
21070,to,O,1015
21071,see,O,1015
21072,more,O,1015
21073,options,O,1015
21074,for,O,1015
21075,long-term,O,1015
21076,DED,B-NAME_OF_DISEASE,1015
21077,treatment,O,1015
21078,Whether,O,1015
21079,we,O,1015
21080,prescribe,O,1015
21081,an,B-NAME_OF_DRUG,1015
21082,immunomodulator,I-NAME_OF_DRUG,1015
21083,or,O,1015
21084,optimally,O,1015
21085,offer,O,1015
21086,some,O,1015
21087,combination,O,1015
21088,of,O,1016
21089,therapies,O,1016
21090,the,O,1016
21091,options,O,1016
21092,allow,O,1016
21093,ophthalmologists,O,1016
21094,to,O,1016
21095,tailor,O,1016
21096,effective,O,1016
21097,economical,O,1016
21098,and,O,1016
21099,comfortable,O,1016
21100,care,O,1016
21101,Myopia,B-NAME_OF_DISEASE,1016
21102,or,O,1016
21103,short-sightedness,B-NAME_OF_DISEASE,1016
21104,is,O,1017
21105,one,O,1017
21106,of,O,1017
21107,the,O,1017
21108,most,O,1017
21109,common,O,1017
21110,eye,O,1017
21111,health,O,1017
21112,issues,O,1017
21113,in,O,1017
21114,children,O,1017
21115,and,O,1017
21116,means,O,1017
21117,that,O,1017
21118,they,O,1017
21119,can,B-SIGN_AND_SYMPTOM,1017
21120,t,I-SIGN_AND_SYMPTOM,1017
21121,see,I-SIGN_AND_SYMPTOM,1017
21122,objects,I-SIGN_AND_SYMPTOM,1017
21123,that,I-SIGN_AND_SYMPTOM,1017
21124,are,I-SIGN_AND_SYMPTOM,1017
21125,far,I-SIGN_AND_SYMPTOM,1018
21126,away,I-SIGN_AND_SYMPTOM,1018
21127,causing,O,1018
21128,their,O,1018
21129,vision,B-SIGN_AND_SYMPTOM,1018
21130,to,I-SIGN_AND_SYMPTOM,1018
21131,blur,I-SIGN_AND_SYMPTOM,1018
21132,Symptoms,O,1018
21133,usually,O,1018
21134,appear,O,1018
21135,between,O,1018
21136,the,O,1018
21137,ages,O,1018
21138,of,O,1018
21139,8,O,1018
21140,and,O,1018
21141,12,O,1019
21142,and,O,1019
21143,can,O,1019
21144,get,O,1019
21145,progressively,O,1019
21146,worse,O,1019
21147,over,O,1019
21148,time,O,1019
21149,with,O,1019
21150,most,O,1019
21151,children,O,1019
21152,quickly,O,1019
21153,becoming,O,1019
21154,reliant,O,1019
21155,on,O,1019
21156,glasses,B-TREATMENT,1019
21157,to,O,1019
21158,see,O,1019
21159,clearly,O,1019
21160,into,O,1019
21161,the,O,1019
21162,distance,O,1019
21163,According,O,1019
21164,to,O,1019
21165,a,O,1019
21166,2019,O,1019
21167,study,O,1019
21168,in,O,1019
21169,the,B-PUBLICATION_VENUE,1020
21170,Investigative,I-PUBLICATION_VENUE,1020
21171,Ophthalmology,I-PUBLICATION_VENUE,1020
21172,and,I-PUBLICATION_VENUE,1020
21173,Visual,I-PUBLICATION_VENUE,1020
21174,Sciences,I-PUBLICATION_VENUE,1020
21175,journal,I-PUBLICATION_VENUE,1020
21176,more,O,1020
21177,than,O,1020
21178,32%,O,1020
21179,of,O,1020
21180,the,O,1020
21181,world,O,1020
21182,s,O,1020
21183,population,O,1020
21184,suffers,O,1020
21185,from,O,1020
21186,myopia,B-NAME_OF_DISEASE,1020
21187,with,O,1020
21188,that,O,1020
21189,figure,O,1020
21190,estimated,O,1020
21191,to,O,1020
21192,rise,O,1021
21193,to,O,1021
21194,50%,O,1021
21195,by,O,1021
21196,2050,O,1021
21197,Are,O,1021
21198,you,O,1021
21199,prescribing,O,1021
21200,contact,B-TREATMENT,1021
21201,lenses,I-TREATMENT,1021
21202,for,O,1021
21203,myopia,B-NAME_OF_DISEASE,1021
21204,management,O,1021
21205,We,O,1021
21206,ask,O,1021
21207,this,O,1021
21208,question,O,1021
21209,at,O,1021
21210,the,O,1021
21211,start,O,1021
21212,of,O,1021
21213,every,O,1021
21214,myopia,B-NAME_OF_DISEASE,1021
21215,management,O,1021
21216,lecture,O,1021
21217,we,O,1021
21218,deliver,O,1021
21219,Over,O,1021
21220,the,O,1021
21221,past,O,1021
21222,two,O,1021
21223,years,O,1022
21224,we,O,1022
21225,have,O,1022
21226,gone,O,1022
21227,from,O,1022
21228,having,O,1022
21229,audiences,O,1022
21230,with,O,1022
21231,no,O,1022
21232,hands,O,1022
21233,raised,O,1022
21234,to,O,1022
21235,now,O,1022
21236,having,O,1023
21237,audiences,O,1023
21238,with,O,1023
21239,upwards,O,1023
21240,of,O,1023
21241,20,O,1023
21242,percent,O,1023
21243,of,O,1023
21244,the,O,1023
21245,attendees,O,1023
21246,raising,O,1024
21247,their,O,1024
21248,hands,O,1024
21249,While,O,1024
21250,a,O,1024
21251,number,O,1024
21252,of,O,1024
21253,clinical,O,1024
21254,trials,O,1025
21255,are,O,1025
21256,still,O,1025
21257,ongoing,O,1025
21258,evidence,O,1025
21259,continues,O,1025
21260,to,O,1025
21261,mount,O,1025
21262,regarding,O,1025
21263,the,O,1025
21264,effectiveness,O,1025
21265,and,O,1026
21266,safety,O,1026
21267,of,O,1026
21268,soft,B-TREATMENT,1026
21269,contact,I-TREATMENT,1026
21270,lens,I-TREATMENT,1026
21271,CL,I-TREATMENT,1026
21272,#NAME?,O,1026
21273,myopia,B-NAME_OF_DISEASE,1026
21274,management,O,1026
21275,and,O,1026
21276,because,O,1026
21277,of,O,1026
21278,this,O,1026
21279,we,O,1026
21280,expect,O,1026
21281,the,O,1026
21282,number,O,1026
21283,of,O,1026
21284,eye,O,1026
21285,care,O,1026
21286,providers,O,1026
21287,prescribing,O,1026
21288,myopia,B-NAME_OF_DISEASE,1026
21289,management,O,1026
21290,to,O,1026
21291,increase,O,1026
21292,Myopia,B-NAME_OF_DISEASE,1026
21293,is,O,1026
21294,a,O,1027
21295,complex,O,1027
21296,trait,O,1027
21297,influenced,O,1027
21298,by,O,1027
21299,a,O,1027
21300,number,O,1027
21301,of,O,1027
21302,environmental,B-CAUSE_OF_DISEASE,1027
21303,and,I-CAUSE_OF_DISEASE,1027
21304,genetic,I-CAUSE_OF_DISEASE,1027
21305,factors,I-CAUSE_OF_DISEASE,1027
21306,and,O,1027
21307,the,O,1027
21308,mechanisms,O,1027
21309,underlying,O,1027
21310,onset,O,1027
21311,and,O,1027
21312,progression,O,1027
21313,are,O,1027
21314,not,O,1027
21315,fully,O,1027
21316,understood,O,1027
21317,Although,O,1027
21318,there,O,1027
21319,is,O,1027
21320,a,O,1027
21321,great,O,1028
21322,deal,O,1028
21323,to,O,1028
21324,learn,O,1028
21325,about,O,1028
21326,the,O,1028
21327,mechanisms,O,1028
21328,of,O,1028
21329,myopia,B-NAME_OF_DISEASE,1028
21330,and,O,1028
21331,why,O,1028
21332,individuals,O,1028
21333,respond,O,1028
21334,differently,O,1028
21335,to,O,1028
21336,different,O,1028
21337,stimuli,O,1028
21338,and,O,1028
21339,treatments,O,1028
21340,some,O,1028
21341,behavioral,O,1028
21342,pharmaceutical,O,1028
21343,and,O,1028
21344,optical,O,1029
21345,strategies,O,1029
21346,already,O,1029
21347,show,O,1029
21348,promise,O,1029
21349,in,O,1029
21350,clinical,O,1029
21351,trials,O,1029
21352,in,O,1029
21353,combating,O,1029
21354,myopia-many,O,1029
21355,of,O,1029
21356,which,O,1029
21357,can,O,1029
21358,be,O,1029
21359,incorporated,O,1029
21360,into,O,1029
21361,current,O,1029
21362,day,O,1029
21363,practice,O,1029
21364,Contact,B-TREATMENT,1030
21365,lenses,I-TREATMENT,1030
21366,used,I-TREATMENT,1030
21367,for,I-TREATMENT,1030
21368,myopia,I-TREATMENT,1030
21369,control,I-TREATMENT,1030
21370,can,O,1030
21371,be,O,1030
21372,either,O,1030
21373,bifocal,B-TREATMENT,1030
21374,or,I-TREATMENT,1030
21375,multifocal,I-TREATMENT,1030
21376,soft,I-TREATMENT,1030
21377,contact,I-TREATMENT,1030
21378,lenses,I-TREATMENT,1030
21379,as,O,1030
21380,well,O,1030
21381,as,O,1030
21382,the,B-TREATMENT,1030
21383,rigid,I-TREATMENT,1030
21384,contact,I-TREATMENT,1030
21385,lens,I-TREATMENT,1030
21386,designs,O,1030
21387,used,O,1031
21388,in,O,1031
21389,orthokeratology,B-TREATMENT,1031
21390,Investigators,O,1031
21391,have,O,1031
21392,proposed,O,1031
21393,several,O,1031
21394,mechanisms,O,1031
21395,to,O,1031
21396,explain,O,1031
21397,their,O,1031
21398,myopia,B-NAME_OF_DISEASE,1031
21399,control,O,1031
21400,effect,O,1031
21401,including,O,1031
21402,contact,O,1031
21403,lenses,O,1031
21404,correct,O,1031
21405,or,O,1031
21406,reduce,O,1031
21407,accommodative,O,1032
21408,lag,O,1032
21409,which,O,1032
21410,is,O,1032
21411,considered,O,1032
21412,a,O,1032
21413,stimulus,O,1032
21414,for,O,1032
21415,eye,O,1032
21416,elongation,O,1032
21417,they,O,1032
21418,reduce,O,1032
21419,the,O,1032
21420,peripheral,O,1032
21421,retinal,O,1032
21422,defocus,O,1033
21423,which,O,1033
21424,is,O,1033
21425,considered,O,1033
21426,to,O,1033
21427,increase,O,1033
21428,the,O,1033
21429,risk,O,1033
21430,of,O,1033
21431,eye,O,1033
21432,elongation,O,1033
21433,by,O,1033
21434,shifting,O,1033
21435,the,O,1033
21436,image,O,1033
21437,closer,O,1033
21438,to,O,1033
21439,the,B-PART_OF_THE_EYES,1034
21440,retina,I-PART_OF_THE_EYES,1034
21441,and,O,1034
21442,the,O,1034
21443,lenses,O,1034
21444,impose,O,1034
21445,myopic,O,1034
21446,defocus,O,1034
21447,across,O,1034
21448,areas,O,1034
21449,of,O,1034
21450,the,B-PART_OF_THE_EYES,1035
21451,retina,I-PART_OF_THE_EYES,1035
21452,which,O,1035
21453,is,O,1035
21454,considered,O,1035
21455,to,O,1035
21456,inhibit,O,1035
21457,eye,O,1035
21458,growth,O,1035
21459,Myopia,B-NAME_OF_DISEASE,1035
21460,is,O,1035
21461,a,O,1035
21462,nearly,O,1035
21463,silent,O,1035
21464,public,O,1036
21465,health,O,1036
21466,crisis,O,1036
21467,growing,O,1036
21468,in,O,1036
21469,prevalence,O,1036
21470,worldwide,O,1036
21471,year,O,1036
21472,upon,O,1036
21473,year,O,1036
21474,Preventing,O,1036
21475,high,B-NAME_OF_DISEASE,1036
21476,myopia,I-NAME_OF_DISEASE,1036
21477,with,O,1036
21478,myopia,B-NAME_OF_DISEASE,1037
21479,management,O,1037
21480,is,O,1037
21481,becoming,O,1037
21482,the,O,1037
21483,standard,O,1037
21484,of,O,1037
21485,care,O,1037
21486,for,O,1037
21487,children,O,1037
21488,and,O,1037
21489,adolescents,O,1037
21490,discovered,O,1037
21491,to,O,1037
21492,have,O,1037
21493,myopia,B-NAME_OF_DISEASE,1037
21494,Center-distance,B-TREATMENT,1037
21495,MF,I-TREATMENT,1037
21496,contact,I-TREATMENT,1037
21497,lenses,I-TREATMENT,1037
21498,including,O,1037
21499,soft,B-TREATMENT,1037
21500,lenses,I-TREATMENT,1037
21501,and,O,1037
21502,GP,B-TREATMENT,1037
21503,lenses,I-TREATMENT,1037
21504,can,O,1037
21505,provide,O,1037
21506,myopia,B-NAME_OF_DISEASE,1037
21507,control,O,1037
21508,in,O,1038
21509,children,O,1038
21510,Similar,O,1038
21511,to,O,1038
21512,daily,B-TREATMENT,1038
21513,wear,I-TREATMENT,1038
21514,contact,I-TREATMENT,1038
21515,lenses,I-TREATMENT,1038
21516,ortho-k,B-TREATMENT,1038
21517,lenses,I-TREATMENT,1038
21518,are,O,1038
21519,also,O,1038
21520,capable,O,1038
21521,of,O,1038
21522,generating,O,1039
21523,the,O,1039
21524,retinal,O,1039
21525,defocus,O,1039
21526,stimulus,O,1039
21527,that,O,1039
21528,retards,O,1039
21529,myopia,B-NAME_OF_DISEASE,1039
21530,progression,O,1039
21531,Atropine,B-NAME_OF_DRUG,1039
21532,by,O,1039
21533,itself,O,1039
21534,or,O,1039
21535,potentially,O,1039
21536,in,O,1039
21537,combination,O,1039
21538,with,O,1039
21539,myopia,B-TREATMENT,1039
21540,control,I-TREATMENT,1039
21541,contact,I-TREATMENT,1039
21542,lenses,I-TREATMENT,1039
21543,may,O,1039
21544,also,O,1039
21545,be,O,1040
21546,efficacious,O,1040
21547,With,O,1040
21548,so,O,1040
21549,many,O,1040
21550,options,O,1040
21551,already,O,1040
21552,available,O,1040
21553,and,O,1040
21554,more,O,1040
21555,forthcoming,O,1040
21556,it,O,1041
21557,is,O,1041
21558,incumbent,O,1041
21559,upon,O,1041
21560,eyecare,O,1041
21561,practitioners,O,1041
21562,to,O,1041
21563,offer,O,1041
21564,these,O,1041
21565,treatment,O,1041
21566,options,O,1041
21567,to,O,1041
21568,children,O,1041
21569,whom,O,1041
21570,they,O,1041
21571,have,O,1041
21572,diagnosed,O,1041
21573,with,O,1041
21574,myopia,B-NAME_OF_DISEASE,1042
21575,Doing,O,1042
21576,so,O,1042
21577,is,O,1042
21578,likely,O,1042
21579,to,O,1042
21580,improve,O,1042
21581,their,O,1042
21582,quality,O,1042
21583,of,O,1042
21584,life,O,1042
21585,and,O,1042
21586,also,O,1042
21587,decreases,O,1042
21588,their,O,1042
21589,likelihood,O,1042
21590,of,O,1042
21591,developing,O,1042
21592,detrimental,O,1042
21593,visual,O,1042
21594,complications,O,1042
21595,decades,O,1042
21596,in,O,1042
21597,advance,O,1042
21598,Myopia,B-NAME_OF_DISEASE,1042
21599,is,O,1042
21600,the,O,1042
21601,most,O,1042
21602,common,O,1042
21603,refractive,B-NAME_OF_DISEASE,1042
21604,error,I-NAME_OF_DISEASE,1043
21605,affecting,O,1043
21606,30%,O,1043
21607,of,O,1043
21608,adolescents,O,1043
21609,and,O,1043
21610,young,O,1043
21611,adults,O,1043
21612,worldwide,O,1043
21613,between,O,1043
21614,2000,O,1043
21615,and,O,1043
21616,2050,O,1043
21617,myopia,B-NAME_OF_DISEASE,1043
21618,s,O,1043
21619,worldwide,O,1043
21620,prevalence,O,1044
21621,is,O,1044
21622,projected,O,1044
21623,to,O,1044
21624,increase,O,1044
21625,from,O,1044
21626,23%,O,1044
21627,to,O,1044
21628,54%,O,1044
21629,The,O,1044
21630,prevalence,O,1044
21631,of,O,1044
21632,high,B-NAME_OF_DISEASE,1044
21633,myopia,I-NAME_OF_DISEASE,1044
21634,is,O,1044
21635,expected,O,1044
21636,to,O,1044
21637,increase,O,1044
21638,from,O,1044
21639,3%,O,1044
21640,to,O,1045
21641,10%,O,1045
21642,Higher,O,1045
21643,increases,O,1045
21644,in,O,1045
21645,prevalence,O,1045
21646,are,O,1045
21647,found,O,1045
21648,among,O,1045
21649,East,O,1045
21650,Asian,O,1045
21651,populations,O,1045
21652,Myopia,B-NAME_OF_DISEASE,1045
21653,is,O,1045
21654,an,O,1045
21655,abnormal,O,1045
21656,process,O,1045
21657,that,O,1045
21658,disrupts,O,1045
21659,emmetropization,O,1045
21660,Longer,O,1045
21661,axial,O,1045
21662,length,O,1045
21663,in,O,1046
21664,myopic,O,1046
21665,eyes,O,1046
21666,especially,O,1046
21667,in,O,1046
21668,high,O,1046
21669,myopes,O,1046
21670,-6,O,1046
21671,or,O,1046
21672,greater,O,1046
21673,or,O,1046
21674,axial,O,1046
21675,length,O,1046
21676,of,O,1046
21677,26mm,O,1046
21678,or,O,1046
21679,greater,O,1046
21680,increases,O,1046
21681,the,O,1046
21682,risk,O,1046
21683,for,O,1046
21684,developing,O,1046
21685,sight-threatening,O,1046
21686,complications,O,1046
21687,such,O,1047
21688,as,O,1047
21689,chorioretinal,B-NAME_OF_DISEASE,1047
21690,atrophy,I-NAME_OF_DISEASE,1047
21691,foveoschisis,B-NAME_OF_DISEASE,1047
21692,rhegmatogenous,B-NAME_OF_DISEASE,1047
21693,retinal,I-NAME_OF_DISEASE,1047
21694,detachment,I-NAME_OF_DISEASE,1047
21695,myopic,B-NAME_OF_DISEASE,1047
21696,maculopathy,I-NAME_OF_DISEASE,1047
21697,glaucoma,B-NAME_OF_DISEASE,1047
21698,and,O,1047
21699,cataract,B-NAME_OF_DISEASE,1047
21700,Progressive,O,1047
21701,myopia,B-NAME_OF_DISEASE,1047
21702,is,O,1047
21703,a,O,1047
21704,serious,O,1048
21705,ocular,O,1048
21706,condition,O,1048
21707,and,O,1048
21708,the,O,1048
21709,younger,O,1048
21710,that,O,1048
21711,children,O,1048
21712,are,O,1048
21713,when,O,1048
21714,diagnosed,O,1048
21715,with,O,1048
21716,myopia,B-NAME_OF_DISEASE,1048
21717,the,O,1049
21718,greater,O,1049
21719,the,O,1049
21720,risk,O,1049
21721,they,O,1049
21722,have,O,1049
21723,for,O,1049
21724,developing,O,1049
21725,high,B-NAME_OF_DISEASE,1049
21726,myopia,I-NAME_OF_DISEASE,1049
21727,The,O,1049
21728,burden,O,1050
21729,associated,O,1050
21730,with,O,1050
21731,visual,B-NAME_OF_DISEASE,1050
21732,impairment,I-NAME_OF_DISEASE,1050
21733,from,O,1050
21734,myopia,B-NAME_OF_DISEASE,1050
21735,complications,O,1050
21736,elevates,O,1050
21737,the,O,1050
21738,need,O,1050
21739,to,O,1050
21740,implement,O,1050
21741,myopia,B-NAME_OF_DISEASE,1050
21742,management,O,1050
21743,strategies,O,1050
21744,as,O,1050
21745,soon,O,1050
21746,as,O,1050
21747,possible,O,1050
21748,in,O,1050
21749,children,O,1050
21750,Typical,O,1050
21751,myopia,B-NAME_OF_DISEASE,1050
21752,control,O,1050
21753,strategies,O,1050
21754,include,O,1050
21755,contact,B-TREATMENT,1050
21756,lens,I-TREATMENT,1050
21757,options,O,1050
21758,such,O,1050
21759,as,O,1050
21760,soft,B-TREATMENT,1050
21761,multifocal,I-TREATMENT,1051
21762,MF,I-TREATMENT,1051
21763,lenses,I-TREATMENT,1051
21764,and,O,1051
21765,orthokeratology,B-TREATMENT,1051
21766,ortho-k,I-TREATMENT,1051
21767,and,O,1051
21768,low-dose,B-NAME_OF_DRUG,1051
21769,atropine,I-NAME_OF_DRUG,1051
21770,The,O,1051
21771,following,O,1051
21772,discussion,O,1051
21773,focuses,O,1051
21774,on,O,1051
21775,contact,B-TREATMENT,1051
21776,lens,I-TREATMENT,1051
21777,options,O,1052
21778,including,O,1052
21779,specialty,O,1052
21780,lens,O,1052
21781,options,O,1052
21782,for,O,1052
21783,myopia,B-NAME_OF_DISEASE,1052
21784,control,O,1052
21785,how,O,1052
21786,to,O,1052
21787,fit,O,1052
21788,these,O,1052
21789,lenses,O,1052
21790,and,O,1052
21791,follow-up,O,1052
21792,care,O,1052
21793,CONTACT,B-TREATMENT,1052
21794,LENS,I-TREATMENT,1052
21795,OPTIONS,O,1052
21796,FOR,O,1052
21797,MYOPIA,B-NAME_OF_DISEASE,1052
21798,CONTROL,O,1053
21799,Focusing,B-TREATMENT,1053
21800,light,I-TREATMENT,1053
21801,in,I-TREATMENT,1053
21802,front,I-TREATMENT,1053
21803,of,I-TREATMENT,1054
21804,the,I-TREATMENT,1054
21805,retina,I-TREATMENT,1054
21806,effectively,O,1054
21807,retards,O,1054
21808,axial,O,1054
21809,length,O,1054
21810,growth,O,1054
21811,in,O,1054
21812,humans,O,1054
21813,Contact,B-TREATMENT,1054
21814,lenses,I-TREATMENT,1054
21815,for,I-TREATMENT,1054
21816,myopia,I-TREATMENT,1054
21817,control,I-TREATMENT,1054
21818,function,O,1055
21819,by,O,1055
21820,simultaneously,O,1055
21821,focusing,B-TREATMENT,1055
21822,light,I-TREATMENT,1055
21823,onto-and,I-TREATMENT,1055
21824,in,I-TREATMENT,1055
21825,front,I-TREATMENT,1055
21826,of-the,I-TREATMENT,1055
21827,retina,I-TREATMENT,1055
21828,This,O,1055
21829,provides,O,1055
21830,acute,O,1055
21831,vision,O,1055
21832,for,O,1055
21833,daily,O,1056
21834,activities,O,1056
21835,and,O,1056
21836,also,O,1056
21837,a,O,1056
21838,defocus,O,1056
21839,stimulus,O,1056
21840,that,O,1056
21841,slows,O,1056
21842,axial,O,1056
21843,length,O,1056
21844,growth,O,1056
21845,Reducing,O,1056
21846,myopia,B-NAME_OF_DISEASE,1057
21847,progression,O,1057
21848,by,O,1057
21849,at,O,1057
21850,least,O,1057
21851,40%,O,1057
21852,is,O,1057
21853,considered,O,1057
21854,clinically,O,1057
21855,meaningful,O,1057
21856,On,O,1057
21857,average,O,1057
21858,soft,B-TREATMENT,1057
21859,MF,I-TREATMENT,1057
21860,contact,I-TREATMENT,1057
21861,lenses,I-TREATMENT,1057
21862,with,I-TREATMENT,1057
21863,center-distance-design,I-TREATMENT,1057
21864,optics,I-TREATMENT,1058
21865,slow,O,1058
21866,myopia,B-NAME_OF_DISEASE,1058
21867,progression,O,1058
21868,by,O,1058
21869,46%,O,1058
21870,Corneal,B-TREATMENT,1058
21871,reshaping,I-TREATMENT,1058
21872,with,I-TREATMENT,1058
21873,ortho-k,B-TREATMENT,1058
21874,lenses,I-TREATMENT,1058
21875,likely,O,1058
21876,employs,O,1058
21877,the,O,1058
21878,same,O,1058
21879,mechanism,O,1058
21880,for,O,1059
21881,slowing,O,1059
21882,myopia,B-NAME_OF_DISEASE,1059
21883,progression,O,1059
21884,As,O,1059
21885,an,O,1059
21886,alternative,O,1059
21887,to,O,1059
21888,typical,O,1059
21889,soft,B-TREATMENT,1059
21890,MF,I-TREATMENT,1059
21891,and,O,1059
21892,ortho-k,B-TREATMENT,1059
21893,designs,O,1059
21894,daytime-wear,B-TREATMENT,1059
21895,GP,I-TREATMENT,1059
21896,MF,I-TREATMENT,1059
21897,options,I-TREATMENT,1059
21898,such,I-TREATMENT,1059
21899,as,I-TREATMENT,1060
21900,corneal,I-TREATMENT,1060
21901,and,I-TREATMENT,1060
21902,scleral,I-TREATMENT,1060
21903,GP,I-TREATMENT,1060
21904,MF,I-TREATMENT,1060
21905,and,I-TREATMENT,1060
21906,hybrid,I-TREATMENT,1060
21907,lenses,I-TREATMENT,1060
21908,may,O,1060
21909,be,O,1060
21910,prescribed,O,1060
21911,for,O,1060
21912,myopia,B-NAME_OF_DISEASE,1060
21913,management,O,1060
21914,These,O,1060
21915,alternative,O,1060
21916,lens,O,1060
21917,options,O,1060
21918,may,O,1060
21919,best,O,1060
21920,suit,O,1060
21921,higher,O,1060
21922,amounts,O,1060
21923,of,O,1060
21924,refractive,B-NAME_OF_DISEASE,1060
21925,error,I-NAME_OF_DISEASE,1060
21926,and,O,1060
21927,astigmatism,B-NAME_OF_DISEASE,1060
21928,WHEN,O,1060
21929,AND,O,1060
21930,WHOM,O,1060
21931,TO,O,1060
21932,START,O,1060
21933,FITTING,O,1061
21934,Two,O,1061
21935,crucial,O,1061
21936,questions,O,1061
21937,to,O,1061
21938,consider,O,1061
21939,are,O,1061
21940,the,O,1061
21941,timing,O,1061
21942,of,O,1061
21943,myopia,B-NAME_OF_DISEASE,1061
21944,management,O,1061
21945,implementation,O,1061
21946,and,O,1061
21947,which,O,1061
21948,children,O,1061
21949,to,O,1061
21950,treat,O,1061
21951,Indeed,O,1061
21952,age,O,1061
21953,is,O,1061
21954,the,O,1061
21955,most,O,1061
21956,critical,O,1061
21957,factor,O,1061
21958,that,O,1061
21959,influences,O,1061
21960,myopia,B-NAME_OF_DISEASE,1061
21961,progression,O,1062
21962,The,O,1062
21963,younger,O,1062
21964,that,O,1062
21965,children,O,1062
21966,become,O,1062
21967,myopic,O,1062
21968,the,O,1062
21969,faster,O,1062
21970,myopia,B-NAME_OF_DISEASE,1062
21971,progresses,O,1062
21972,thereby,O,1062
21973,increasing,O,1062
21974,the,O,1062
21975,likelihood,O,1062
21976,of,O,1062
21977,developing,O,1062
21978,high,B-NAME_OF_DISEASE,1062
21979,myopia,I-NAME_OF_DISEASE,1062
21980,For,O,1063
21981,example,O,1063
21982,in,O,1063
21983,the,B-NAME_OF_STUDY,1064
21984,Correction,I-NAME_OF_STUDY,1064
21985,of,I-NAME_OF_STUDY,1064
21986,Myopia,I-NAME_OF_STUDY,1064
21987,Evaluation,I-NAME_OF_STUDY,1064
21988,Trial,I-NAME_OF_STUDY,1064
21989,COMET,I-NAME_OF_STUDY,1064
21990,study,I-NAME_OF_STUDY,1064
21991,children,O,1064
21992,6,O,1064
21993,or,O,1064
21994,7,O,1064
21995,years,O,1064
21996,old,O,1064
21997,progressed,O,1064
21998,twice,O,1064
21999,as,O,1064
22000,fast,O,1064
22001,as,O,1064
22002,the,O,1064
22003,children,O,1064
22004,who,O,1065
22005,were,O,1065
22006,11,O,1065
22007,years,O,1065
22008,of,O,1065
22009,age,O,1065
22010,Children,O,1065
22011,from,O,1065
22012,East,O,1065
22013,Asian,O,1065
22014,countries,O,1065
22015,experience,O,1065
22016,a,O,1065
22017,higher,O,1065
22018,rate,O,1065
22019,of,O,1065
22020,myopia,B-NAME_OF_DISEASE,1065
22021,progression,O,1065
22022,compared,O,1065
22023,to,O,1065
22024,Western,O,1065
22025,children,O,1065
22026,However,O,1065
22027,it,O,1065
22028,is,O,1065
22029,less,O,1065
22030,clear,O,1065
22031,whether,O,1065
22032,children,O,1066
22033,of,O,1066
22034,Asian,O,1066
22035,descent,O,1066
22036,in,O,1066
22037,North,B-GPE,1066
22038,America,I-GPE,1066
22039,progress,O,1066
22040,faster,O,1066
22041,compared,O,1066
22042,to,O,1066
22043,their,O,1066
22044,non-Asian,O,1066
22045,counterparts,O,1066
22046,For,O,1066
22047,example,O,1066
22048,the,B-NAME_OF_STUDY,1066
22049,COMET,I-NAME_OF_STUDY,1066
22050,study,I-NAME_OF_STUDY,1066
22051,reported,O,1066
22052,that,O,1066
22053,Asian-American,O,1066
22054,children,O,1066
22055,progressed,O,1066
22056,faster,O,1067
22057,compared,O,1067
22058,to,O,1067
22059,African-American,O,1067
22060,children,O,1067
22061,but,O,1067
22062,no,O,1067
22063,faster,O,1067
22064,than,O,1067
22065,Hispanic,O,1067
22066,and,O,1067
22067,Caucasian,O,1067
22068,children,O,1067
22069,In,O,1067
22070,contrast,O,1067
22071,another,O,1067
22072,study,O,1067
22073,by,O,1067
22074,Cheng,B-PERSON,1067
22075,et,O,1067
22076,al,O,1067
22077,demonstrated,O,1067
22078,an,O,1067
22079,increased,O,1067
22080,rate,O,1067
22081,of,O,1067
22082,axial,O,1067
22083,length,O,1067
22084,progression,O,1067
22085,in,O,1067
22086,Asian-American,O,1067
22087,children,O,1068
22088,consistent,O,1068
22089,with,O,1068
22090,East,O,1068
22091,Asian,O,1068
22092,counterparts,O,1068
22093,Given,O,1068
22094,the,O,1068
22095,available,O,1068
22096,evidence,O,1068
22097,there,O,1068
22098,is,O,1068
22099,a,O,1068
22100,rationale,O,1068
22101,for,O,1068
22102,preferentially,O,1068
22103,initiating,O,1068
22104,myopia,B-NAME_OF_DISEASE,1068
22105,control,O,1068
22106,in,O,1068
22107,ethnically,O,1068
22108,Asian,O,1068
22109,children,O,1068
22110,Parental,B-CAUSE_OF_DISEASE,1068
22111,history,I-CAUSE_OF_DISEASE,1068
22112,of,O,1068
22113,myopia,B-NAME_OF_DISEASE,1068
22114,is,O,1069
22115,also,O,1069
22116,a,O,1069
22117,factor,O,1069
22118,when,O,1069
22119,potentially,O,1069
22120,initiating,O,1069
22121,myopia,B-NAME_OF_DISEASE,1069
22122,control,O,1069
22123,Children,O,1069
22124,of,O,1069
22125,myopic,O,1069
22126,parents,O,1069
22127,are,O,1069
22128,at,O,1069
22129,increased,O,1069
22130,risk,O,1069
22131,of,O,1069
22132,developing,O,1069
22133,myopia,B-NAME_OF_DISEASE,1069
22134,Priority,O,1069
22135,for,O,1069
22136,initiating,O,1069
22137,myopia,B-NAME_OF_DISEASE,1069
22138,management,O,1069
22139,strategies,O,1069
22140,including,O,1069
22141,fitting,O,1069
22142,contact,B-TREATMENT,1069
22143,lenses,I-TREATMENT,1069
22144,for,I-TREATMENT,1069
22145,myopia,I-TREATMENT,1070
22146,control,I-TREATMENT,1070
22147,should,O,1070
22148,be,O,1070
22149,given,O,1070
22150,to,O,1070
22151,children,O,1070
22152,who,O,1070
22153,are,O,1070
22154,young,O,1070
22155,of,O,1070
22156,Asian,O,1070
22157,background,O,1070
22158,and,O,1070
22159,or,O,1070
22160,who,O,1070
22161,have,O,1070
22162,a,O,1070
22163,history,O,1070
22164,of,O,1070
22165,parental,O,1070
22166,myopia,B-NAME_OF_DISEASE,1070
22167,As,O,1070
22168,nearly,O,1070
22169,all,O,1070
22170,young,O,1070
22171,myopes,O,1071
22172,progress,O,1071
22173,myopia,B-NAME_OF_DISEASE,1071
22174,management,O,1072
22175,strategies,O,1072
22176,should,O,1072
22177,be,O,1072
22178,offered,O,1072
22179,to,O,1072
22180,myopic,O,1072
22181,school-aged,O,1072
22182,children,O,1073
22183,While,O,1073
22184,low-to-moderate,O,1073
22185,amounts,O,1073
22186,of,O,1073
22187,myopia,B-NAME_OF_DISEASE,1073
22188,in,O,1073
22189,children,O,1073
22190,are,O,1073
22191,well,O,1073
22192,understood,O,1073
22193,there,O,1073
22194,is,O,1073
22195,minimal,O,1073
22196,research,O,1073
22197,on,O,1073
22198,more,O,1073
22199,severe,O,1073
22200,pathological,O,1073
22201,early-onset,O,1073
22202,high,B-NAME_OF_DISEASE,1073
22203,myopia,I-NAME_OF_DISEASE,1073
22204,Young,O,1073
22205,children,O,1073
22206,usually,O,1073
22207,are,O,1073
22208,hyperopic,O,1073
22209,If,O,1073
22210,myopia,B-NAME_OF_DISEASE,1073
22211,onsets,O,1074
22212,earlier,O,1074
22213,than,O,1074
22214,5,O,1074
22215,years,O,1074
22216,of,O,1074
22217,age,O,1074
22218,consider,O,1074
22219,further,O,1074
22220,evaluation,O,1074
22221,including,O,1074
22222,genetic,B-DIAGNOSTIC_TEST,1074
22223,testing,I-DIAGNOSTIC_TEST,1074
22224,Early,O,1074
22225,myopia,B-NAME_OF_DISEASE,1074
22226,may,O,1074
22227,be,O,1074
22228,associated,O,1074
22229,with,O,1074
22230,systemic,O,1074
22231,conditions,O,1074
22232,such,O,1075
22233,as,O,1075
22234,Marfan,B-NAME_OF_DISEASE,1075
22235,syndrome,I-NAME_OF_DISEASE,1075
22236,or,O,1075
22237,Stickler,B-NAME_OF_DISEASE,1075
22238,syndrome,I-NAME_OF_DISEASE,1075
22239,Myopia,B-NAME_OF_DISEASE,1075
22240,control,O,1075
22241,strategies,O,1075
22242,can,O,1075
22243,be,O,1075
22244,offered,O,1075
22245,to,O,1075
22246,those,O,1075
22247,who,O,1075
22248,have,O,1075
22249,early-onset,O,1075
22250,high,B-NAME_OF_DISEASE,1075
22251,myopia,I-NAME_OF_DISEASE,1076
22252,However,O,1076
22253,the,O,1076
22254,parents,O,1076
22255,must,O,1076
22256,be,O,1076
22257,educated,O,1076
22258,that,O,1076
22259,their,O,1077
22260,child,O,1077
22261,s,O,1077
22262,response,O,1077
22263,to,O,1077
22264,treatment,O,1077
22265,may,O,1077
22266,not,O,1077
22267,be,O,1077
22268,as,O,1077
22269,effective,O,1077
22270,FITTING,O,1077
22271,SOFT,B-TREATMENT,1077
22272,LENSES,I-TREATMENT,1077
22273,All,O,1078
22274,soft,B-TREATMENT,1078
22275,MF,I-TREATMENT,1078
22276,lenses,I-TREATMENT,1078
22277,validated,O,1078
22278,for,O,1078
22279,myopia,B-NAME_OF_DISEASE,1078
22280,control,O,1078
22281,are,O,1079
22282,center,O,1079
22283,distance,O,1080
22284,in,O,1080
22285,design,O,1080
22286,Originally,O,1080
22287,prescribed,O,1080
22288,for,O,1080
22289,presbyopia,B-NAME_OF_DISEASE,1080
22290,both,O,1081
22291,aspheric,B-TREATMENT,1081
22292,and,I-TREATMENT,1081
22293,concentric-ring-design,B-TREATMENT,1081
22294,MF,I-TREATMENT,1081
22295,lenses,I-TREATMENT,1081
22296,can,O,1081
22297,be,O,1081
22298,prescribed,O,1081
22299,with,O,1081
22300,center-distance,B-TREATMENT,1081
22301,optics,I-TREATMENT,1081
22302,for,I-TREATMENT,1081
22303,myopia,I-TREATMENT,1081
22304,control,I-TREATMENT,1082
22305,Standard,B-TREATMENT,1082
22306,aspheric,I-TREATMENT,1082
22307,center-distance,I-TREATMENT,1082
22308,MF,I-TREATMENT,1082
22309,lenses,I-TREATMENT,1082
22310,consist,O,1082
22311,of,O,1082
22312,a,O,1082
22313,central,O,1082
22314,distance,O,1082
22315,zone,O,1082
22316,that,O,1082
22317,gradually,O,1082
22318,transitions,O,1082
22319,into,O,1082
22320,an,O,1082
22321,intermediary,O,1082
22322,add,O,1082
22323,power,O,1082
22324,before,O,1083
22325,extending,O,1083
22326,into,O,1083
22327,the,O,1083
22328,full,O,1083
22329,near,O,1083
22330,add,O,1083
22331,power,O,1083
22332,at,O,1083
22333,the,O,1083
22334,end,O,1083
22335,of,O,1083
22336,the,O,1083
22337,optic,O,1083
22338,zone,O,1083
22339,In,O,1083
22340,contrast,O,1083
22341,concentric-ring-design,B-TREATMENT,1084
22342,MF,I-TREATMENT,1084
22343,lenses,I-TREATMENT,1084
22344,have,O,1084
22345,a,O,1084
22346,central,O,1084
22347,distance,O,1084
22348,zone,O,1084
22349,surrounded,O,1084
22350,by,O,1084
22351,alternating,O,1084
22352,rings,O,1084
22353,of,O,1084
22354,near,O,1084
22355,and,O,1084
22356,distance,O,1085
22357,power,O,1085
22358,that,O,1085
22359,extend,O,1085
22360,throughout,O,1085
22361,the,O,1085
22362,remainder,O,1085
22363,of,O,1085
22364,the,O,1085
22365,optic,O,1085
22366,zone,O,1085
22367,Interestingly,O,1085
22368,the,B-TREATMENT,1085
22369,concentric-ring,I-TREATMENT,1085
22370,MF,I-TREATMENT,1085
22371,potentially,O,1085
22372,creates,O,1085
22373,optics,O,1085
22374,that,O,1085
22375,equally,O,1085
22376,balance,O,1085
22377,between,O,1085
22378,distance,O,1085
22379,and,O,1085
22380,near,O,1085
22381,correction,O,1085
22382,with,O,1086
22383,varying,O,1086
22384,pupil,B-PART_OF_THE_EYES,1086
22385,size,O,1086
22386,The,O,1086
22387,only,O,1086
22388,U.S,O,1086
22389,Food,B-ORGANIZATION,1086
22390,and,I-ORGANIZATION,1086
22391,Drug,I-ORGANIZATION,1086
22392,Administration,I-ORGANIZATION,1086
22393,FDA,B-ORGANIZATION,1086
22394,#NAME?,O,1086
22395,contact,B-TREATMENT,1086
22396,lens,I-TREATMENT,1086
22397,indicated,O,1086
22398,to,O,1086
22399,slow,O,1087
22400,the,O,1087
22401,progression,O,1087
22402,of,O,1087
22403,nearsightedness,B-NAME_OF_DISEASE,1087
22404,is,O,1087
22405,based,O,1087
22406,on,O,1087
22407,concentric-ring-design,B-TREATMENT,1087
22408,MF,I-TREATMENT,1087
22409,optics,I-TREATMENT,1087
22410,All,B-TREATMENT,1087
22411,other,I-TREATMENT,1087
22412,lens,I-TREATMENT,1087
22413,designs,I-TREATMENT,1087
22414,that,I-TREATMENT,1087
22415,create,I-TREATMENT,1087
22416,simultaneous,I-TREATMENT,1087
22417,center-distance,I-TREATMENT,1087
22418,MF,I-TREATMENT,1088
22419,optics,I-TREATMENT,1088
22420,may,O,1088
22421,be,O,1088
22422,prescribed,O,1088
22423,for,O,1088
22424,retarding,O,1088
22425,myopia,B-NAME_OF_DISEASE,1088
22426,progression,O,1088
22427,however,O,1088
22428,this,O,1088
22429,is,O,1089
22430,considered,O,1089
22431,an,O,1089
22432,off-label,O,1089
22433,use,O,1089
22434,in,O,1089
22435,the,B-GPE,1089
22436,United,I-GPE,1089
22437,States,I-GPE,1089
22438,As,O,1089
22439,the,O,1090
22440,goal,O,1090
22441,is,O,1091
22442,to,O,1091
22443,decrease,O,1091
22444,the,O,1091
22445,progression,O,1091
22446,of,O,1091
22447,myopia,B-NAME_OF_DISEASE,1091
22448,prescribing,O,1091
22449,soft,B-TREATMENT,1091
22450,MF,I-TREATMENT,1092
22451,contact,I-TREATMENT,1092
22452,lenses,I-TREATMENT,1092
22453,in,O,1092
22454,children,O,1092
22455,is,O,1092
22456,different,O,1092
22457,from,O,1092
22458,prescribing,O,1092
22459,them,O,1092
22460,to,O,1092
22461,presbyopes,O,1092
22462,In,O,1092
22463,addition,O,1092
22464,to,O,1092
22465,the,O,1092
22466,axial,O,1092
22467,length,O,1092
22468,and,O,1092
22469,refractive,B-NAME_OF_DISEASE,1092
22470,error,I-NAME_OF_DISEASE,1092
22471,other,O,1092
22472,factors,O,1093
22473,such,O,1093
22474,as,O,1093
22475,the,O,1093
22476,add,O,1093
22477,power,O,1093
22478,and,O,1093
22479,pupil,B-PART_OF_THE_EYES,1093
22480,size,O,1093
22481,need,O,1093
22482,to,O,1093
22483,be,O,1093
22484,considered,O,1093
22485,for,O,1093
22486,prescribing,O,1093
22487,lenses,O,1093
22488,that,O,1093
22489,create,O,1093
22490,effective,O,1093
22491,myopia,B-NAME_OF_DISEASE,1093
22492,control,O,1093
22493,Myopia,B-NAME_OF_DISEASE,1093
22494,control,O,1093
22495,with,O,1094
22496,soft,B-TREATMENT,1094
22497,MF,I-TREATMENT,1094
22498,contact,I-TREATMENT,1094
22499,lenses,I-TREATMENT,1094
22500,depends,O,1094
22501,on,O,1094
22502,focusing,O,1094
22503,some,O,1094
22504,light,O,1094
22505,in,O,1094
22506,front,O,1094
22507,of,O,1094
22508,the,B-PART_OF_THE_EYES,1094
22509,retina,I-PART_OF_THE_EYES,1094
22510,this,O,1094
22511,slows,O,1094
22512,growth,O,1094
22513,in,O,1094
22514,axial,O,1094
22515,length,O,1094
22516,thereby,O,1094
22517,retarding,O,1094
22518,myopia,B-NAME_OF_DISEASE,1094
22519,progression,O,1094
22520,Clinically,O,1094
22521,it,O,1094
22522,makes,O,1094
22523,sense,O,1094
22524,to,O,1094
22525,infer,O,1094
22526,that,O,1094
22527,higher,O,1095
22528,add,O,1095
22529,powers,O,1095
22530,may,O,1095
22531,provide,O,1095
22532,better,O,1095
22533,myopia,B-NAME_OF_DISEASE,1095
22534,control,O,1095
22535,because,O,1095
22536,they,O,1095
22537,can,O,1095
22538,focus,O,1095
22539,light,O,1095
22540,further,O,1095
22541,in,O,1095
22542,front,O,1095
22543,of,O,1095
22544,the,B-PART_OF_THE_EYES,1095
22545,retina,I-PART_OF_THE_EYES,1095
22546,compared,O,1095
22547,to,O,1096
22548,lower,O,1096
22549,add,O,1096
22550,powers,O,1096
22551,To,O,1096
22552,examine,O,1096
22553,this,O,1096
22554,hypothesis,O,1096
22555,the,B-NAME_OF_STUDY,1096
22556,Bifocal,I-NAME_OF_STUDY,1096
22557,Lenses,I-NAME_OF_STUDY,1096
22558,In,I-NAME_OF_STUDY,1096
22559,Nearsighted,I-NAME_OF_STUDY,1096
22560,Kids,I-NAME_OF_STUDY,1096
22561,BLINK,I-NAME_OF_STUDY,1096
22562,study,I-NAME_OF_STUDY,1096
22563,randomly,O,1096
22564,assigned,O,1096
22565,children,O,1096
22566,to,O,1096
22567,wear,O,1096
22568,either,O,1096
22569,commercially,O,1096
22570,available,O,1096
22571,single-vision,B-TREATMENT,1096
22572,contact,I-TREATMENT,1097
22573,lenses,I-TREATMENT,1097
22574,or,O,1097
22575,medium-,O,1097
22576,1.5,O,1097
22577,or,O,1097
22578,high-,O,1097
22579,2.5,O,1097
22580,add-power,O,1097
22581,soft,O,1097
22582,MF,O,1097
22583,contact,O,1097
22584,lenses,O,1098
22585,for,O,1098
22586,three,B-TIME_DURATION,1098
22587,years,I-TIME_DURATION,1098
22588,This,O,1098
22589,study,O,1098
22590,demonstrated,O,1098
22591,that,O,1099
22592,treatment,O,1099
22593,with,O,1099
22594,high-add-power,B-TREATMENT,1099
22595,MF,I-TREATMENT,1099
22596,contact,I-TREATMENT,1099
22597,lenses,I-TREATMENT,1099
22598,reduced,O,1099
22599,the,O,1099
22600,rate,O,1099
22601,of,O,1099
22602,myopia,B-NAME_OF_DISEASE,1099
22603,progression,O,1099
22604,more,O,1099
22605,effectively,O,1099
22606,compared,O,1099
22607,to,O,1099
22608,either,O,1100
22609,the,B-TREATMENT,1100
22610,medium-add-power,I-TREATMENT,1100
22611,MF,I-TREATMENT,1100
22612,or,O,1100
22613,the,B-TREATMENT,1100
22614,single-vision,I-TREATMENT,1100
22615,contact,I-TREATMENT,1100
22616,lenses,I-TREATMENT,1100
22617,Therefore,O,1100
22618,when,O,1100
22619,prescribing,O,1100
22620,soft,B-TREATMENT,1100
22621,MF,I-TREATMENT,1100
22622,lenses,I-TREATMENT,1100
22623,for,I-TREATMENT,1100
22624,myopia,I-TREATMENT,1100
22625,control,I-TREATMENT,1101
22626,consider,O,1101
22627,fitting,O,1101
22628,children,O,1101
22629,in,O,1101
22630,higher,O,1101
22631,add,O,1101
22632,powers,O,1101
22633,to,O,1101
22634,best,O,1101
22635,decrease,O,1101
22636,myopia,B-NAME_OF_DISEASE,1101
22637,progression,O,1101
22638,MF,O,1101
22639,optics,O,1101
22640,are,O,1101
22641,associated,O,1101
22642,with,O,1101
22643,increased,O,1102
22644,total,O,1102
22645,aberrations,O,1102
22646,including,O,1102
22647,higher-order,O,1102
22648,aberrations,O,1102
22649,which,O,1102
22650,disturb,O,1102
22651,visual,O,1103
22652,quality,O,1103
22653,especially,O,1103
22654,in,O,1103
22655,low-light,O,1103
22656,settings,O,1103
22657,These,O,1103
22658,visual,O,1103
22659,disturbances,O,1103
22660,increase,O,1103
22661,with,O,1103
22662,increasing,O,1103
22663,add,O,1103
22664,power,O,1103
22665,Nevertheless,O,1103
22666,most,O,1103
22667,children,O,1103
22668,easily,O,1103
22669,adapt,O,1103
22670,to,O,1103
22671,MF,O,1103
22672,optics,O,1104
22673,and,O,1104
22674,report,O,1104
22675,good-quality,O,1104
22676,visual,O,1104
22677,stereo,O,1104
22678,acuity,O,1104
22679,If,O,1104
22680,patients,O,1104
22681,are,O,1104
22682,bothered,O,1104
22683,visually,O,1104
22684,consider,O,1104
22685,prescribing,O,1104
22686,-0.25,O,1104
22687,or,O,1104
22688,-0.5,O,1104
22689,more,O,1104
22690,distance,O,1104
22691,power,O,1104
22692,to,O,1104
22693,relieve,O,1104
22694,their,O,1104
22695,symptoms,O,1104
22696,As,O,1105
22697,mentioned,O,1105
22698,above,O,1105
22699,defocused,O,1105
22700,retinal,O,1105
22701,images,O,1105
22702,induced,O,1105
22703,by,O,1105
22704,hyperopic,O,1105
22705,blur,O,1105
22706,retard,O,1105
22707,axial,O,1105
22708,length,O,1105
22709,growth,O,1105
22710,Prescribing,O,1106
22711,MF,B-TREATMENT,1106
22712,lenses,I-TREATMENT,1106
22713,that,I-TREATMENT,1106
22714,create,I-TREATMENT,1106
22715,myopic,I-TREATMENT,1106
22716,blur,I-TREATMENT,1106
22717,within,I-TREATMENT,1106
22718,the,I-TREATMENT,1106
22719,visual,I-TREATMENT,1106
22720,axis,I-TREATMENT,1106
22721,will,O,1106
22722,therefore,O,1106
22723,be,O,1106
22724,most,O,1106
22725,effective,O,1106
22726,in,O,1106
22727,retarding,O,1106
22728,myopia,B-NAME_OF_DISEASE,1106
22729,progression,O,1106
22730,To,O,1106
22731,maximize,O,1106
22732,the,O,1106
22733,myopia,B-NAME_OF_DISEASE,1106
22734,control,O,1106
22735,effect,O,1106
22736,consider,O,1106
22737,pupil,B-PART_OF_THE_EYES,1106
22738,size,O,1107
22739,when,O,1107
22740,prescribing,O,1107
22741,soft,B-TREATMENT,1107
22742,MF,I-TREATMENT,1107
22743,lenses,I-TREATMENT,1107
22744,for,I-TREATMENT,1107
22745,myopia,I-TREATMENT,1107
22746,control,I-TREATMENT,1107
22747,Ensure,O,1107
22748,that,O,1107
22749,the,O,1107
22750,near-add-power,O,1107
22751,optic,O,1107
22752,is,O,1107
22753,within,O,1107
22754,the,O,1107
22755,pupillary,O,1107
22756,visual,O,1107
22757,axis,O,1107
22758,during,O,1107
22759,normal,O,1107
22760,lighting,O,1107
22761,conditions,O,1107
22762,To,O,1107
22763,assess,O,1107
22764,this,O,1107
22765,take,O,1107
22766,a,O,1107
22767,corneal,O,1107
22768,topography,O,1107
22769,map,O,1107
22770,over,O,1107
22771,the,B-TREATMENT,1107
22772,MF,I-TREATMENT,1107
22773,soft,I-TREATMENT,1107
22774,lens,I-TREATMENT,1107
22775,on,O,1107
22776,the,O,1107
22777,eye,O,1108
22778,to,O,1108
22779,examine,O,1108
22780,the,O,1108
22781,centration,O,1108
22782,and,O,1108
22783,size,O,1108
22784,of,O,1108
22785,the,O,1108
22786,multifocal,O,1108
22787,optic,O,1108
22788,This,O,1108
22789,can,O,1108
22790,be,O,1108
22791,compared,O,1108
22792,to,O,1108
22793,the,O,1108
22794,photopic,O,1108
22795,pupil,B-PART_OF_THE_EYES,1108
22796,size,O,1108
22797,measured,O,1108
22798,under,O,1108
22799,normal,O,1108
22800,lighting,O,1108
22801,during,O,1108
22802,the,O,1108
22803,baseline,O,1108
22804,evaluation,O,1108
22805,Assessing,O,1108
22806,the,O,1108
22807,fit,O,1108
22808,of,O,1108
22809,soft,B-TREATMENT,1108
22810,MF,I-TREATMENT,1108
22811,lenses,I-TREATMENT,1108
22812,on,O,1108
22813,children,O,1108
22814,is,O,1108
22815,typical,O,1108
22816,to,O,1108
22817,assessing,O,1108
22818,any,O,1108
22819,soft,O,1108
22820,lens,O,1108
22821,on,O,1108
22822,the,O,1108
22823,eye,O,1108
22824,Ensure,O,1108
22825,that,O,1108
22826,the,O,1108
22827,lens,O,1109
22828,has,O,1109
22829,good,O,1109
22830,coverage,O,1109
22831,movement,O,1109
22832,and,O,1109
22833,on-eye,O,1109
22834,stability,O,1109
22835,The,O,1109
22836,average,O,1109
22837,corneal,O,1109
22838,diameter,O,1109
22839,and,O,1109
22840,sim,O,1109
22841,curvature,O,1109
22842,are,O,1109
22843,approximately,O,1109
22844,11.80m,O,1109
22845,and,O,1109
22846,43,O,1109
22847,respectively,O,1109
22848,however,O,1109
22849,this,O,1109
22850,may,O,1110
22851,vary,O,1110
22852,from,O,1110
22853,child,O,1110
22854,to,O,1110
22855,child,O,1110
22856,Custom,O,1110
22857,soft,B-TREATMENT,1110
22858,MF,I-TREATMENT,1110
22859,lenses,I-TREATMENT,1110
22860,are,O,1110
22861,available,O,1110
22862,in,O,1110
22863,variable,O,1110
22864,diameters,O,1110
22865,and,O,1110
22866,base,O,1111
22867,curvatures,O,1111
22868,to,O,1111
22869,fit,O,1111
22870,children,O,1111
22871,who,O,1111
22872,fall,O,1111
22873,outside,O,1111
22874,of,O,1111
22875,these,O,1111
22876,normative,O,1111
22877,parameters,O,1111
22878,Fitting,O,1111
22879,children,O,1111
22880,who,O,1111
22881,have,O,1112
22882,astigmatism,B-NAME_OF_DISEASE,1112
22883,in,O,1112
22884,soft,B-TREATMENT,1112
22885,lenses,I-TREATMENT,1112
22886,for,I-TREATMENT,1112
22887,myopia,I-TREATMENT,1112
22888,control,I-TREATMENT,1112
22889,can,O,1112
22890,be,O,1112
22891,accomplished,O,1112
22892,by,O,1112
22893,adding,O,1112
22894,a,O,1112
22895,toric,O,1112
22896,prescription,O,1113
22897,to,O,1113
22898,the,B-TREATMENT,1113
22899,MF,I-TREATMENT,1113
22900,lens,I-TREATMENT,1113
22901,Troubleshooting,O,1113
22902,visual,O,1113
22903,complaints,O,1113
22904,in,O,1113
22905,soft,B-TREATMENT,1113
22906,MF,I-TREATMENT,1113
22907,toric,I-TREATMENT,1113
22908,lenses,I-TREATMENT,1113
22909,can,O,1114
22910,be,O,1114
22911,challenging,O,1114
22912,because,O,1114
22913,it,O,1114
22914,may,O,1114
22915,not,O,1114
22916,be,O,1114
22917,apparent,O,1114
22918,whether,O,1114
22919,the,O,1114
22920,disturbance,O,1114
22921,in,O,1114
22922,vision,O,1114
22923,is,O,1114
22924,coming,O,1114
22925,from,O,1114
22926,the,O,1114
22927,MF,O,1114
22928,optics,O,1114
22929,or,O,1114
22930,from,O,1114
22931,uncorrected,O,1114
22932,astigmatism,B-NAME_OF_DISEASE,1114
22933,A,O,1114
22934,stepwise,O,1114
22935,approach,O,1114
22936,to,O,1114
22937,fitting,O,1115
22938,toric,B-TREATMENT,1115
22939,MF,I-TREATMENT,1115
22940,lenses,I-TREATMENT,1115
22941,in,O,1115
22942,children,O,1115
22943,would,O,1115
22944,start,O,1115
22945,with,O,1115
22946,fitting,O,1115
22947,a,B-TREATMENT,1115
22948,single-vision,I-TREATMENT,1115
22949,distance,I-TREATMENT,1115
22950,toric,I-TREATMENT,1115
22951,lens,I-TREATMENT,1115
22952,first,O,1115
22953,Once,O,1115
22954,it,O,1115
22955,is,O,1115
22956,established,O,1115
22957,that,O,1116
22958,the,O,1116
22959,lens,O,1116
22960,fits,O,1116
22961,well,O,1116
22962,and,O,1116
22963,that,O,1116
22964,the,O,1116
22965,patient,O,1116
22966,has,O,1116
22967,good,O,1116
22968,quality,O,1116
22969,of,O,1116
22970,vision,O,1116
22971,order,O,1116
22972,the,O,1116
22973,same,O,1116
22974,lens,O,1116
22975,with,O,1117
22976,MF,O,1117
22977,optics,O,1117
22978,FITTING,O,1117
22979,ORTHOKERATOLOGY,O,1117
22980,Overnight,B-TREATMENT,1117
22981,ortho-k,B-TREATMENT,1117
22982,received,O,1117
22983,FDA,B-ORGANIZATION,1117
22984,approval,O,1117
22985,to,O,1118
22986,correct,O,1118
22987,myopia,B-NAME_OF_DISEASE,1118
22988,in,O,1118
22989,2002,O,1118
22990,For,O,1118
22991,this,O,1118
22992,purpose,O,1118
22993,ortho-k,B-TREATMENT,1118
22994,is,O,1118
22995,highly,O,1118
22996,effective,O,1118
22997,Additionally,O,1118
22998,myopia,B-NAME_OF_DISEASE,1118
22999,management,O,1118
23000,with,O,1118
23001,ortho-k,B-TREATMENT,1118
23002,reduces,O,1118
23003,myopia,B-NAME_OF_DISEASE,1118
23004,progression,O,1118
23005,by,O,1118
23006,40%,O,1118
23007,to,O,1119
23008,60%,O,1119
23009,compared,O,1119
23010,to,O,1119
23011,spectacle,O,1119
23012,correction,O,1119
23013,alone,O,1119
23014,It,O,1119
23015,is,O,1119
23016,worth,O,1119
23017,noting,O,1119
23018,however,O,1119
23019,that,O,1119
23020,prescribing,O,1119
23021,ortho-k,B-TREATMENT,1120
23022,lenses,I-TREATMENT,1120
23023,for,O,1120
23024,myopia,B-NAME_OF_DISEASE,1120
23025,management,O,1120
23026,is,O,1120
23027,considered,O,1120
23028,an,O,1120
23029,off-label,O,1120
23030,use,O,1120
23031,This,O,1120
23032,may,O,1120
23033,be,O,1120
23034,disconcerting,O,1120
23035,to,O,1120
23036,some,O,1120
23037,parents,O,1120
23038,but,O,1121
23039,the,O,1121
23040,effectiveness,O,1121
23041,of,O,1121
23042,ortho-k,B-TREATMENT,1121
23043,is,O,1121
23044,nonetheless,O,1121
23045,well-established,O,1121
23046,for,O,1121
23047,myopia,B-NAME_OF_DISEASE,1121
23048,management,O,1121
23049,Modern,B-TREATMENT,1121
23050,ortho-k,I-TREATMENT,1122
23051,lenses,I-TREATMENT,1122
23052,have,O,1122
23053,a,O,1122
23054,reverse,O,1122
23055,geometry,O,1122
23056,design,O,1122
23057,The,O,1122
23058,primary,O,1122
23059,measurements,O,1122
23060,needed,O,1122
23061,to,O,1122
23062,order,O,1122
23063,these,O,1122
23064,lenses,O,1122
23065,empirically,O,1122
23066,include,O,1122
23067,a,O,1122
23068,manifest,O,1122
23069,refraction,O,1122
23070,horizontal,O,1122
23071,visible,O,1122
23072,iris,O,1122
23073,diameter,O,1122
23074,HVID,O,1122
23075,and,O,1122
23076,corneal,O,1122
23077,topography,O,1122
23078,Some,O,1122
23079,lenses,O,1122
23080,are,O,1122
23081,designed,O,1122
23082,from,O,1122
23083,flat,O,1122
23084,keratometry,O,1122
23085,flat,O,1123
23086,K,O,1123
23087,measurements,O,1123
23088,although,O,1123
23089,custom,O,1123
23090,lens,O,1123
23091,design,O,1123
23092,software,O,1123
23093,may,O,1123
23094,require,O,1123
23095,eccentricity,O,1123
23096,and,O,1123
23097,apical,O,1123
23098,radius,O,1123
23099,of,O,1123
23100,curvature,O,1123
23101,measurements,O,1123
23102,These,O,1123
23103,lenses,O,1123
23104,are,O,1123
23105,larger,O,1123
23106,in,O,1123
23107,overall,O,1123
23108,diameter-often,O,1124
23109,90%,O,1124
23110,to,O,1124
23111,95%,O,1124
23112,of,O,1124
23113,the,O,1124
23114,total,O,1124
23115,HVID,O,1124
23116,The,O,1124
23117,back,O,1124
23118,surface,O,1124
23119,of,O,1124
23120,an,B-TREATMENT,1124
23121,ortho-k,I-TREATMENT,1124
23122,lens,I-TREATMENT,1124
23123,has,O,1124
23124,a,O,1124
23125,minimum,O,1124
23126,of,O,1124
23127,four,O,1124
23128,curves,O,1124
23129,however,O,1124
23130,some,O,1124
23131,designs,O,1124
23132,that,O,1124
23133,correct,O,1124
23134,higher,O,1124
23135,amounts,O,1124
23136,of,O,1124
23137,myopia,B-NAME_OF_DISEASE,1125
23138,can,O,1125
23139,have,O,1125
23140,up,O,1125
23141,to,O,1125
23142,six,O,1125
23143,curves,O,1125
23144,Ortho-k,B-TREATMENT,1125
23145,lenses,I-TREATMENT,1125
23146,for,O,1125
23147,myopia,B-NAME_OF_DISEASE,1125
23148,management,O,1125
23149,should,O,1125
23150,center,O,1125
23151,well,O,1125
23152,and,O,1125
23153,the,O,1125
23154,lens,O,1125
23155,should,O,1125
23156,display,O,1125
23157,an,O,1125
23158,adequate,O,1125
23159,fluorescein,O,1125
23160,pattern,O,1125
23161,of,O,1125
23162,central,O,1125
23163,alignment,O,1125
23164,under,O,1125
23165,the,O,1125
23166,back-optic,O,1125
23167,zone,O,1126
23168,radius,O,1126
23169,BOZR,O,1126
23170,clearance,O,1126
23171,throughout,O,1126
23172,the,O,1126
23173,entire,O,1126
23174,reverse,O,1126
23175,zone,O,1126
23176,and,O,1126
23177,proper,O,1126
23178,landing,O,1126
23179,throughout,O,1126
23180,the,O,1126
23181,alignment,O,1126
23182,zone,O,1126
23183,The,O,1126
23184,lens,O,1126
23185,should,O,1126
23186,also,O,1127
23187,move,O,1127
23188,well,O,1127
23189,and,O,1127
23190,have,O,1127
23191,adequate,O,1127
23192,clearance,O,1127
23193,under,O,1127
23194,the,O,1127
23195,peripheral,O,1127
23196,zone,O,1127
23197,to,O,1127
23198,maintain,O,1127
23199,good,O,1127
23200,tear,O,1127
23201,exchange,O,1127
23202,Topographically,O,1127
23203,after,O,1127
23204,the,O,1127
23205,lens,O,1127
23206,is,O,1127
23207,removed,O,1127
23208,there,O,1127
23209,should,O,1127
23210,be,O,1127
23211,a,O,1127
23212,classic,O,1127
23213,bull,O,1127
23214,s-eye,O,1127
23215,pattern,O,1128
23216,of,O,1128
23217,an,O,1128
23218,even,O,1128
23219,flattened,O,1128
23220,treatment,O,1128
23221,zone,O,1128
23222,and,O,1128
23223,a,O,1128
23224,steepened,O,1128
23225,reverse,O,1128
23226,curve,O,1128
23227,zone,O,1128
23228,centered,O,1129
23229,within,O,1129
23230,the,O,1129
23231,pupillary,O,1130
23232,circumference,O,1130
23233,This,O,1130
23234,proper,O,1130
23235,centration,O,1130
23236,of,O,1130
23237,the,O,1130
23238,reverse,O,1130
23239,zone,O,1130
23240,allows,O,1130
23241,for,O,1130
23242,peripheral,O,1130
23243,defocus,O,1130
23244,to,O,1130
23245,be,O,1130
23246,generated,O,1130
23247,inside,O,1131
23248,the,B-TREATMENT,1131
23249,pupil,I-TREATMENT,1131
23250,thereby,O,1131
23251,maximizing,O,1131
23252,the,O,1131
23253,myopia,B-NAME_OF_DISEASE,1131
23254,control,O,1131
23255,effect,O,1131
23256,Adjacent,O,1131
23257,to,O,1131
23258,the,O,1131
23259,steepened,O,1131
23260,reverse,O,1131
23261,zone,O,1131
23262,a,O,1131
23263,more,O,1131
23264,pronounced,O,1131
23265,flattened,O,1132
23266,area,O,1132
23267,360º,O,1132
23268,around,O,1132
23269,should,O,1132
23270,be,O,1132
23271,visible,O,1132
23272,This,O,1132
23273,zone,O,1132
23274,represents,O,1132
23275,adequate,O,1132
23276,positioning,O,1132
23277,and,O,1132
23278,applanation,O,1132
23279,of,O,1132
23280,the,O,1132
23281,alignment,O,1132
23282,curve,O,1132
23283,within,O,1132
23284,the,B-TREATMENT,1133
23285,peripheral,I-TREATMENT,1133
23286,cornea,I-TREATMENT,1133
23287,With,O,1133
23288,the,B-TREATMENT,1133
23289,ortho-k,I-TREATMENT,1133
23290,lens,I-TREATMENT,1133
23291,removed,O,1133
23292,patients,O,1133
23293,should,O,1133
23294,be,O,1133
23295,able,O,1133
23296,to,O,1133
23297,achieve,O,1133
23298,their,O,1133
23299,best-corrected,O,1133
23300,visual,O,1134
23301,acuity,O,1134
23302,Any,O,1134
23303,residual,O,1134
23304,myopia,B-NAME_OF_DISEASE,1134
23305,may,O,1134
23306,be,O,1134
23307,corrected,O,1134
23308,with,O,1134
23309,regular,O,1134
23310,distance,O,1134
23311,spectacles,O,1134
23312,during,O,1134
23313,the,O,1134
23314,day,O,1134
23315,As,O,1135
23316,the,B-PART_OF_THE_EYES,1135
23317,cornea,I-PART_OF_THE_EYES,1135
23318,remains,O,1135
23319,molded,O,1135
23320,from,O,1135
23321,the,B-TREATMENT,1135
23322,ortho-k,I-TREATMENT,1135
23323,treatment,I-TREATMENT,1135
23324,the,O,1135
23325,peripheral,O,1135
23326,retinal,O,1135
23327,defocus,O,1135
23328,responsible,O,1135
23329,for,O,1135
23330,myopia,B-NAME_OF_DISEASE,1135
23331,control,O,1135
23332,remains,O,1135
23333,in,O,1136
23334,effect,O,1136
23335,even,O,1136
23336,with,O,1136
23337,over,O,1136
23338,spectacles,O,1136
23339,to,O,1136
23340,correct,O,1136
23341,residual,O,1136
23342,myopia,B-NAME_OF_DISEASE,1136
23343,After,O,1136
23344,lens,O,1136
23345,removal,O,1136
23346,the,B-PART_OF_THE_EYES,1136
23347,cornea,I-PART_OF_THE_EYES,1136
23348,should,O,1136
23349,be,O,1136
23350,clear,O,1136
23351,with,O,1136
23352,no,O,1136
23353,signs,O,1136
23354,of,O,1136
23355,punctate,O,1136
23356,epithelial,O,1136
23357,staining,O,1136
23358,negative,O,1136
23359,staining,O,1136
23360,or,O,1136
23361,stromal,O,1137
23362,opacities,O,1137
23363,Any,O,1137
23364,of,O,1137
23365,these,O,1137
23366,findings,O,1137
23367,indicates,O,1137
23368,mechanical,O,1137
23369,contact,O,1137
23370,of,O,1137
23371,the,O,1137
23372,lens,O,1138
23373,with,O,1138
23374,the,B-PART_OF_THE_EYES,1138
23375,corneal,I-PART_OF_THE_EYES,1138
23376,surface,I-PART_OF_THE_EYES,1138
23377,and,O,1138
23378,or,O,1138
23379,corneal,O,1138
23380,hypoxia,O,1138
23381,Additionally,O,1138
23382,patients,O,1138
23383,should,O,1138
23384,report,O,1138
23385,good,O,1138
23386,functional,O,1138
23387,vision,O,1138
23388,throughout,O,1138
23389,the,O,1138
23390,day,O,1138
23391,Spherical,B-TREATMENT,1138
23392,ortho-k,I-TREATMENT,1138
23393,lenses,I-TREATMENT,1139
23394,on,O,1139
23395,highly,O,1139
23396,astigmatic,O,1139
23397,corneas,B-PART_OF_THE_EYES,1139
23398,usually,O,1139
23399,result,O,1139
23400,in,O,1139
23401,poor,O,1139
23402,centration,O,1139
23403,leading,O,1139
23404,to,O,1139
23405,induced,O,1139
23406,irregular,B-NAME_OF_DISEASE,1139
23407,astigmatism,I-NAME_OF_DISEASE,1139
23408,glare,O,1139
23409,and,O,1139
23410,poor,O,1139
23411,visual,O,1139
23412,outcome,O,1139
23413,Limbus-to-limbus,B-NAME_OF_DISEASE,1139
23414,against-the-rule,B-NAME_OF_DISEASE,1139
23415,and,O,1139
23416,larger,O,1139
23417,astigmatic,O,1139
23418,errors,O,1139
23419,are,O,1139
23420,not,O,1139
23421,well,O,1139
23422,corrected,O,1139
23423,with,O,1139
23424,spherical,O,1139
23425,lens,O,1139
23426,designs,O,1139
23427,Therefore,O,1139
23428,toric,B-TREATMENT,1139
23429,ortho-k,I-TREATMENT,1139
23430,lenses,I-TREATMENT,1139
23431,are,O,1140
23432,indicated,O,1140
23433,to,O,1140
23434,achieve,O,1140
23435,effective,O,1140
23436,myopia,B-NAME_OF_DISEASE,1140
23437,treatment,O,1140
23438,and,O,1140
23439,visual,O,1140
23440,correction,O,1140
23441,in,O,1140
23442,astigmatic,O,1140
23443,patients,O,1140
23444,Corneal,B-DIAGNOSTIC_TEST,1140
23445,topography,I-DIAGNOSTIC_TEST,1140
23446,is,O,1140
23447,used,O,1140
23448,to,O,1140
23449,determine,O,1140
23450,whether,O,1141
23451,a,O,1141
23452,toric,O,1141
23453,design,O,1141
23454,is,O,1141
23455,needed,O,1141
23456,A,O,1141
23457,sagittal,O,1141
23458,height,O,1141
23459,difference,O,1141
23460,between,O,1141
23461,the,O,1141
23462,flat,O,1141
23463,and,O,1141
23464,steep,O,1141
23465,corneal,O,1141
23466,meridians,O,1141
23467,of,O,1141
23468,30,O,1142
23469,microns,O,1142
23470,or,O,1142
23471,greater,O,1142
23472,at,O,1142
23473,the,O,1142
23474,landing,O,1142
23475,chord,O,1142
23476,length,O,1142
23477,of,O,1142
23478,the,O,1142
23479,alignment,O,1142
23480,curve,O,1142
23481,suggests,O,1142
23482,that,O,1142
23483,the,O,1142
23484,treatment,O,1142
23485,may,O,1142
23486,benefit,O,1142
23487,from,O,1142
23488,adding,O,1142
23489,lens,O,1142
23490,toricity,O,1142
23491,LENS,O,1142
23492,DESIGNS,O,1142
23493,WITH,O,1142
23494,GP,O,1143
23495,OPTICS,O,1143
23496,In,O,1143
23497,general,O,1143
23498,daytime,B-TREATMENT,1143
23499,GP,B-TREATMENT,1143
23500,lenses,I-TREATMENT,1143
23501,offer,O,1143
23502,sharp,O,1143
23503,optics,O,1143
23504,and,O,1143
23505,are,O,1143
23506,a,O,1143
23507,great,O,1143
23508,option,O,1143
23509,especially,O,1143
23510,in,O,1143
23511,highly,O,1143
23512,astigmatic,O,1143
23513,children,O,1143
23514,Similar,O,1143
23515,to,O,1143
23516,soft,O,1143
23517,lens,O,1143
23518,designs,O,1143
23519,multifocal,O,1143
23520,optics,O,1144
23521,can,O,1144
23522,be,O,1144
23523,added,O,1144
23524,to,O,1144
23525,the,O,1144
23526,surface,O,1144
23527,of,O,1144
23528,a,B-TREATMENT,1144
23529,GP,I-TREATMENT,1144
23530,lens,I-TREATMENT,1144
23531,and,O,1144
23532,are,O,1144
23533,especially,O,1144
23534,useful,O,1144
23535,for,O,1144
23536,myopia,B-NAME_OF_DISEASE,1144
23537,control,O,1144
23538,in,O,1144
23539,highly,O,1144
23540,astigmatic,O,1145
23541,myopic,O,1145
23542,children,O,1145
23543,Although,O,1145
23544,this,O,1145
23545,lens,O,1145
23546,type,O,1145
23547,offers,O,1145
23548,improved,O,1145
23549,optical,O,1145
23550,quality,O,1145
23551,over,O,1145
23552,spectacles,B-TREATMENT,1145
23553,and,O,1145
23554,soft,B-TREATMENT,1145
23555,lenses,I-TREATMENT,1146
23556,in,O,1146
23557,highly,O,1146
23558,astigmatic,O,1146
23559,children,O,1146
23560,there,O,1146
23561,is,O,1146
23562,the,O,1146
23563,perception,O,1146
23564,that,O,1146
23565,it,O,1146
23566,is,O,1146
23567,difficult,O,1146
23568,to,O,1146
23569,adapt,O,1146
23570,to,O,1146
23571,GP,B-TREATMENT,1146
23572,lenses,I-TREATMENT,1146
23573,Nonetheless,O,1146
23574,80%,O,1147
23575,of,O,1147
23576,children,O,1147
23577,become,O,1147
23578,accustomed,O,1147
23579,to,O,1147
23580,corneal,B-TREATMENT,1147
23581,GP,I-TREATMENT,1147
23582,lenses,I-TREATMENT,1147
23583,which,O,1147
23584,is,O,1147
23585,the,O,1147
23586,same,O,1147
23587,adaptation,O,1147
23588,rate,O,1147
23589,as,O,1147
23590,for,O,1147
23591,adults,O,1147
23592,Additionally,O,1147
23593,with,O,1147
23594,the,O,1147
23595,availability,O,1147
23596,of,O,1148
23597,hybrid,B-TREATMENT,1148
23598,and,I-TREATMENT,1148
23599,scleral,I-TREATMENT,1148
23600,GP,I-TREATMENT,1148
23601,lenses,I-TREATMENT,1148
23602,as,O,1148
23603,well,O,1148
23604,as,O,1148
23605,improved,O,1148
23606,designs,O,1148
23607,of,O,1148
23608,newer,O,1148
23609,corneal,B-TREATMENT,1148
23610,lenses,I-TREATMENT,1148
23611,initial,O,1148
23612,lens,O,1148
23613,awareness,O,1148
23614,is,O,1148
23615,now,O,1148
23616,much,O,1148
23617,less,O,1148
23618,of,O,1148
23619,a,O,1148
23620,concern,O,1148
23621,Consider,O,1148
23622,prescribing,O,1148
23623,daytime,B-TREATMENT,1148
23624,GP,I-TREATMENT,1148
23625,multifocal,I-TREATMENT,1148
23626,lenses,I-TREATMENT,1148
23627,for,O,1148
23628,children,O,1148
23629,who,O,1149
23630,have,O,1149
23631,more,O,1149
23632,than,O,1149
23633,2.5,O,1149
23634,of,O,1149
23635,corneal,B-NAME_OF_DISEASE,1149
23636,astigmatism,B-NAME_OF_DISEASE,1149
23637,Corneal,B-TREATMENT,1149
23638,GPs,I-TREATMENT,1149
23639,Bitoric,B-TREATMENT,1149
23640,corneal,I-TREATMENT,1149
23641,GP,I-TREATMENT,1149
23642,lenses,I-TREATMENT,1149
23643,can,O,1149
23644,be,O,1149
23645,prescribed,O,1149
23646,to,O,1149
23647,correct,O,1149
23648,myopia,B-NAME_OF_DISEASE,1149
23649,and,O,1149
23650,astigmatism,B-NAME_OF_DISEASE,1149
23651,in,O,1150
23652,children,O,1150
23653,These,O,1150
23654,lenses,O,1150
23655,can,O,1150
23656,easily,O,1150
23657,be,O,1150
23658,ordered,O,1150
23659,empirically,O,1150
23660,through,O,1150
23661,a,O,1150
23662,contact,O,1150
23663,lens,O,1150
23664,laboratory,O,1150
23665,using,O,1150
23666,keratometry,O,1150
23667,values,O,1150
23668,and,O,1150
23669,cycloplegic,O,1150
23670,refraction,O,1150
23671,Similar,O,1150
23672,to,O,1150
23673,prescribing,O,1151
23674,soft,B-TREATMENT,1151
23675,toric,I-TREATMENT,1151
23676,MF,I-TREATMENT,1151
23677,lenses,I-TREATMENT,1151
23678,GP,B-TREATMENT,1151
23679,bitoric,I-TREATMENT,1151
23680,lenses,I-TREATMENT,1151
23681,must,O,1151
23682,be,O,1151
23683,well,O,1151
23684,centered,O,1151
23685,and,O,1151
23686,have,O,1151
23687,good,O,1151
23688,on-eye,O,1151
23689,stability,O,1151
23690,After,O,1151
23691,achieving,O,1151
23692,a,O,1152
23693,good,O,1152
23694,fit,O,1152
23695,the,B-TREATMENT,1152
23696,front-surface,I-TREATMENT,1152
23697,center-distance,I-TREATMENT,1152
23698,MF,I-TREATMENT,1152
23699,optics,I-TREATMENT,1152
23700,for,I-TREATMENT,1152
23701,myopia,I-TREATMENT,1152
23702,control,I-TREATMENT,1152
23703,can,O,1152
23704,be,O,1152
23705,added,O,1152
23706,Hybrid,B-TREATMENT,1152
23707,Lenses,I-TREATMENT,1152
23708,Hybrid,B-TREATMENT,1152
23709,lenses,I-TREATMENT,1153
23710,are,O,1153
23711,comprised,O,1153
23712,of,O,1153
23713,a,O,1153
23714,GP,O,1153
23715,center,O,1153
23716,surrounded,O,1154
23717,by,O,1154
23718,a,O,1154
23719,soft-lens-material,O,1154
23720,skirt,O,1154
23721,The,O,1154
23722,soft,O,1154
23723,skirt,O,1154
23724,of,O,1154
23725,the,B-TREATMENT,1155
23726,hybrid,I-TREATMENT,1155
23727,lens,I-TREATMENT,1155
23728,keeps,O,1155
23729,the,O,1155
23730,GP,O,1155
23731,lens,O,1155
23732,well,O,1155
23733,centered,O,1155
23734,and,O,1155
23735,stable,O,1155
23736,on,O,1155
23737,the,O,1155
23738,eye,O,1155
23739,This,O,1155
23740,makes,O,1156
23741,hybrid,B-TREATMENT,1156
23742,lenses,I-TREATMENT,1156
23743,a,O,1156
23744,good,O,1156
23745,choice,O,1156
23746,for,O,1156
23747,highly,O,1156
23748,astigmatic,O,1156
23749,myopic,O,1156
23750,children,O,1156
23751,who,O,1157
23752,have,O,1157
23753,active,O,1157
23754,lifestyles,O,1157
23755,and,O,1157
23756,for,O,1157
23757,whom,O,1157
23758,lens,O,1157
23759,dislodgment,O,1157
23760,may,O,1157
23761,be,O,1157
23762,a,O,1157
23763,concern,O,1157
23764,during,O,1157
23765,their,O,1157
23766,activities,O,1158
23767,Center-distance,O,1158
23768,MF,O,1158
23769,optics,O,1158
23770,are,O,1158
23771,available,O,1158
23772,on,O,1158
23773,hybrid,B-TREATMENT,1158
23774,lenses,I-TREATMENT,1158
23775,for,I-TREATMENT,1158
23776,myopia,B-NAME_OF_DISEASE,1158
23777,control,I-TREATMENT,1158
23778,As,O,1158
23779,these,O,1158
23780,lenses,O,1158
23781,generally,O,1158
23782,center,O,1158
23783,well,O,1158
23784,the,O,1158
23785,MF,O,1158
23786,optics,O,1158
23787,can,O,1158
23788,be,O,1158
23789,added,O,1158
23790,on,O,1158
23791,the,O,1158
23792,front,O,1159
23793,of,O,1159
23794,the,O,1159
23795,lens,O,1159
23796,during,O,1159
23797,empirical,O,1159
23798,ordering,O,1159
23799,Scleral,B-TREATMENT,1159
23800,Lenses,I-TREATMENT,1159
23801,Typically,O,1159
23802,fitted,O,1159
23803,in,O,1159
23804,adult,O,1159
23805,patients,O,1159
23806,scleral,B-TREATMENT,1159
23807,lenses,I-TREATMENT,1159
23808,are,O,1159
23809,indicated,O,1159
23810,in,O,1159
23811,pediatric,O,1159
23812,cases,O,1159
23813,when,O,1159
23814,it,O,1159
23815,is,O,1159
23816,difficult,O,1159
23817,to,O,1159
23818,achieve,O,1159
23819,an,O,1159
23820,acceptable,O,1159
23821,fit,O,1159
23822,or,O,1160
23823,sufficient,O,1160
23824,vision,O,1160
23825,with,O,1160
23826,other,O,1160
23827,lenses,O,1160
23828,such,O,1160
23829,as,O,1160
23830,in,O,1160
23831,cases,O,1160
23832,of,O,1160
23833,high,B-NAME_OF_DISEASE,1160
23834,myopia,B-NAME_OF_DISEASE,1160
23835,and,O,1160
23836,astigmatism,B-NAME_OF_DISEASE,1160
23837,In,O,1160
23838,such,O,1160
23839,cases,O,1160
23840,MF,O,1160
23841,center-distance,O,1160
23842,optics,O,1160
23843,may,O,1160
23844,be,O,1160
23845,placed,O,1160
23846,on,O,1161
23847,the,O,1161
23848,surface,O,1161
23849,of,O,1161
23850,a,B-TREATMENT,1161
23851,scleral,I-TREATMENT,1161
23852,lens,I-TREATMENT,1161
23853,for,I-TREATMENT,1161
23854,myopia,B-NAME_OF_DISEASE,1161
23855,control,I-TREATMENT,1161
23856,The,O,1161
23857,underlying,O,1161
23858,tear,O,1161
23859,lens,O,1161
23860,in,O,1161
23861,a,O,1161
23862,traditional,O,1161
23863,prolate-design,O,1161
23864,scleral,O,1161
23865,lens,O,1161
23866,generates,O,1161
23867,a,O,1161
23868,more,O,1161
23869,myopic,O,1161
23870,prescription,O,1161
23871,on,O,1162
23872,the,O,1162
23873,eye,O,1162
23874,However,O,1162
23875,an,O,1162
23876,oblate,O,1162
23877,reverse,O,1162
23878,geometry,O,1162
23879,design,O,1162
23880,can,O,1162
23881,be,O,1162
23882,created,O,1162
23883,in,O,1162
23884,which,O,1162
23885,the,O,1162
23886,base,O,1163
23887,curve,O,1163
23888,is,O,1163
23889,significantly,O,1163
23890,flattened,O,1163
23891,thus,O,1163
23892,creating,O,1163
23893,a,O,1163
23894,more,O,1163
23895,plus,O,1163
23896,prescription,O,1163
23897,on,O,1163
23898,the,O,1163
23899,eye,O,1163
23900,Therefore,O,1163
23901,a,B-TREATMENT,1163
23902,scleral,I-TREATMENT,1163
23903,lens,I-TREATMENT,1163
23904,that,I-TREATMENT,1163
23905,has,I-TREATMENT,1163
23906,a,I-TREATMENT,1163
23907,hyperopic,I-TREATMENT,1163
23908,or,I-TREATMENT,1163
23909,low-minus,I-TREATMENT,1163
23910,prescription,I-TREATMENT,1163
23911,with,I-TREATMENT,1163
23912,center-distance,I-TREATMENT,1163
23913,MF,I-TREATMENT,1163
23914,optics,I-TREATMENT,1164
23915,can,O,1164
23916,be,O,1164
23917,created,O,1164
23918,for,O,1164
23919,a,O,1164
23920,young,O,1164
23921,high,O,1164
23922,myope,O,1164
23923,needing,O,1164
23924,myopia,B-NAME_OF_DISEASE,1164
23925,control,O,1164
23926,COMBINATION,O,1164
23927,TREATMENTS,O,1164
23928,In,O,1164
23929,addition,O,1164
23930,to,O,1164
23931,contact,B-TREATMENT,1164
23932,lenses,I-TREATMENT,1165
23933,there,O,1165
23934,is,O,1165
23935,a,O,1165
23936,pharmacological,O,1165
23937,approach,O,1165
23938,to,O,1165
23939,myopia,B-NAME_OF_DISEASE,1165
23940,management,O,1165
23941,using,O,1165
23942,the,O,1165
23943,antimuscarinic,B-NAME_OF_DRUG,1165
23944,agent,I-NAME_OF_DRUG,1165
23945,atropine,B-NAME_OF_DRUG,1165
23946,The,O,1165
23947,mechanisms,O,1165
23948,of,O,1165
23949,both,O,1165
23950,contact,B-TREATMENT,1165
23951,lenses,I-TREATMENT,1165
23952,and,O,1165
23953,atropine,B-NAME_OF_DRUG,1165
23954,in,O,1166
23955,myopia,B-NAME_OF_DISEASE,1166
23956,management,O,1166
23957,are,O,1166
23958,not,O,1166
23959,entirely,O,1166
23960,understood,O,1166
23961,Different,O,1166
23962,mechanisms,O,1166
23963,may,O,1166
23964,be,O,1166
23965,involved,O,1166
23966,and,O,1166
23967,a,O,1166
23968,synergistic,O,1166
23969,effect,O,1166
23970,could,O,1166
23971,exist,O,1166
23972,if,O,1167
23973,contact,B-TREATMENT,1167
23974,lenses,I-TREATMENT,1167
23975,are,O,1167
23976,combined,O,1167
23977,with,O,1167
23978,low-dose,B-NAME_OF_DRUG,1167
23979,atropine,I-NAME_OF_DRUG,1167
23980,Long-term,O,1167
23981,studies,O,1167
23982,are,O,1167
23983,underway,O,1167
23984,evaluating,O,1167
23985,low-dose,B-NAME_OF_DRUG,1167
23986,atropine,I-NAME_OF_DRUG,1167
23987,combined,O,1167
23988,with,O,1167
23989,bifocal,B-TREATMENT,1167
23990,soft,I-TREATMENT,1167
23991,contact,I-TREATMENT,1167
23992,lenses,I-TREATMENT,1167
23993,and,O,1167
23994,with,O,1168
23995,ortho-k,B-TREATMENT,1168
23996,in,O,1168
23997,retarding,O,1168
23998,the,O,1168
23999,progression,O,1168
24000,of,O,1168
24001,myopia,B-NAME_OF_DISEASE,1168
24002,Regardless,O,1168
24003,of,O,1168
24004,whether,O,1168
24005,there,O,1168
24006,are,O,1168
24007,combination,O,1169
24008,effects,O,1169
24009,an,O,1169
24010,effective,O,1169
24011,strategy,O,1169
24012,may,O,1169
24013,be,O,1169
24014,to,O,1169
24015,start,O,1169
24016,young,O,1169
24017,children,O,1169
24018,on,O,1169
24019,atropine,B-NAME_OF_DRUG,1169
24020,and,O,1169
24021,then,O,1169
24022,continue,O,1170
24023,with,O,1170
24024,contact,B-TREATMENT,1170
24025,lenses,I-TREATMENT,1170
24026,as,O,1170
24027,soon,O,1170
24028,as,O,1170
24029,they,O,1170
24030,are,O,1170
24031,able,O,1170
24032,to,O,1170
24033,wear,O,1170
24034,them,O,1170
24035,FOLLOW-UP,O,1170
24036,CARE,O,1171
24037,AND,O,1171
24038,DISCONTINUATION,O,1171
24039,After,O,1171
24040,prescribing,O,1171
24041,myopia,B-NAME_OF_DISEASE,1171
24042,control,I-TREATMENT,1171
24043,contact,I-TREATMENT,1171
24044,lenses,I-TREATMENT,1171
24045,employ,O,1171
24046,follow-up,O,1171
24047,care,O,1171
24048,every,O,1172
24049,six,O,1172
24050,months,O,1172
24051,to,O,1172
24052,monitor,O,1172
24053,the,O,1172
24054,effectiveness,O,1172
24055,of,O,1172
24056,treatment,O,1172
24057,Cycloplegic,O,1172
24058,refraction,O,1172
24059,and,O,1172
24060,axial,O,1172
24061,length,O,1172
24062,measurements,O,1172
24063,are,O,1173
24064,the,O,1173
24065,standard,O,1173
24066,of,O,1173
24067,care,O,1173
24068,to,O,1173
24069,monitor,O,1173
24070,the,O,1173
24071,effectiveness,O,1173
24072,of,O,1173
24073,myopia,B-NAME_OF_DISEASE,1173
24074,control,I-TREATMENT,1173
24075,daytime,I-TREATMENT,1173
24076,use,I-TREATMENT,1173
24077,contact,I-TREATMENT,1173
24078,lenses,I-TREATMENT,1173
24079,Because,O,1174
24080,ortho-k,B-TREATMENT,1174
24081,corrects,O,1174
24082,refractive,B-NAME_OF_DISEASE,1174
24083,error,I-NAME_OF_DISEASE,1174
24084,by,O,1174
24085,reshaping,O,1174
24086,the,B-PART_OF_THE_EYES,1174
24087,cornea,I-PART_OF_THE_EYES,1174
24088,refractive,B-NAME_OF_DISEASE,1175
24089,error,I-NAME_OF_DISEASE,1175
24090,cannot,O,1175
24091,be,O,1175
24092,used,O,1175
24093,as,O,1175
24094,an,O,1175
24095,effective,O,1175
24096,treatment,O,1175
24097,indicator,O,1175
24098,If,O,1175
24099,ortho-k,B-TREATMENT,1175
24100,is,O,1175
24101,chosen,O,1175
24102,axial,O,1175
24103,length,O,1175
24104,is,O,1175
24105,the,O,1175
24106,most,O,1175
24107,accurate,O,1176
24108,measurement,O,1176
24109,for,O,1176
24110,the,O,1176
24111,evaluation,O,1176
24112,of,O,1176
24113,myopia,B-NAME_OF_DISEASE,1176
24114,progression,O,1176
24115,Based,O,1176
24116,on,O,1176
24117,currently,O,1176
24118,available,O,1176
24119,data,O,1176
24120,every,O,1176
24121,1,O,1176
24122,of,O,1176
24123,change,O,1176
24124,in,O,1176
24125,refractive,B-NAME_OF_DISEASE,1176
24126,error,I-NAME_OF_DISEASE,1176
24127,corresponds,O,1176
24128,to,O,1176
24129,a,O,1176
24130,0.28m,O,1176
24131,increase,O,1176
24132,in,O,1176
24133,axial,O,1176
24134,length,O,1177
24135,in,O,1177
24136,children,O,1177
24137,ages,O,1177
24138,6,O,1177
24139,to,O,1177
24140,7,O,1177
24141,years,O,1178
24142,and,O,1178
24143,to,O,1178
24144,a,O,1178
24145,0.32m,O,1178
24146,increase,O,1178
24147,in,O,1178
24148,axial,O,1178
24149,length,O,1178
24150,in,O,1179
24151,children,O,1179
24152,ages,O,1179
24153,12,O,1179
24154,to,O,1179
24155,13,O,1179
24156,years,O,1179
24157,There,O,1179
24158,is,O,1179
24159,evidence,O,1179
24160,for,O,1179
24161,accelerated,O,1179
24162,myopia,B-NAME_OF_DISEASE,1179
24163,progression,O,1179
24164,or,O,1180
24165,rebound,O,1180
24166,following,O,1180
24167,the,O,1180
24168,cessation,O,1180
24169,of,O,1180
24170,some,O,1180
24171,treatments,O,1180
24172,For,O,1180
24173,example,O,1180
24174,following,O,1180
24175,discontinuation,O,1180
24176,of,O,1180
24177,1%,B-NAME_OF_DRUG,1181
24178,atropine,B-NAME_OF_DRUG,1181
24179,myopia,B-NAME_OF_DISEASE,1181
24180,progressed,O,1181
24181,at,O,1181
24182,twice,O,1181
24183,the,O,1181
24184,normal,O,1181
24185,rate,O,1181
24186,but,O,1181
24187,less,O,1181
24188,acceleration,O,1181
24189,occurred,O,1181
24190,after,O,1181
24191,discontinuation,O,1181
24192,of,O,1181
24193,treatment,O,1181
24194,with,O,1181
24195,lower,O,1181
24196,atropine,B-NAME_OF_DRUG,1181
24197,concentrations,O,1181
24198,Interestingly,O,1181
24199,two,O,1181
24200,randomized,O,1181
24201,clinical,O,1181
24202,trials,O,1181
24203,showed,O,1181
24204,that,O,1181
24205,no,O,1182
24206,acceleration,O,1182
24207,occurred,O,1182
24208,when,O,1182
24209,one,O,1182
24210,year,O,1182
24211,of,O,1182
24212,treatment,O,1182
24213,with,O,1182
24214,progressive-addition,O,1182
24215,spectacles,O,1182
24216,or,O,1182
24217,MF,B-TREATMENT,1182
24218,soft,I-TREATMENT,1182
24219,lenses,I-TREATMENT,1182
24220,was,O,1182
24221,followed,O,1182
24222,by,O,1182
24223,one,O,1182
24224,year,O,1182
24225,of,O,1182
24226,their,O,1182
24227,discontinuation,O,1182
24228,With,O,1182
24229,this,O,1182
24230,in,O,1182
24231,mind,O,1182
24232,clinicians,O,1182
24233,should,O,1183
24234,be,O,1183
24235,aware,O,1183
24236,of,O,1183
24237,the,O,1183
24238,potential,O,1183
24239,for,O,1183
24240,accelerated,O,1183
24241,progression,O,1183
24242,once,O,1183
24243,myopia,B-NAME_OF_DISEASE,1183
24244,control,O,1183
24245,is,O,1183
24246,discontinued,O,1183
24247,and,O,1183
24248,should,O,1183
24249,monitor,O,1183
24250,patients,O,1183
24251,closely,O,1183
24252,CONTACT,B-TREATMENT,1183
24253,LENS,I-TREATMENT,1183
24254,RISKS,O,1183
24255,IN,O,1183
24256,CHILDREN,O,1183
24257,As,O,1183
24258,they,O,1183
24259,have,O,1183
24260,a,O,1183
24261,longer,O,1183
24262,time,O,1183
24263,to,O,1183
24264,live,O,1184
24265,with,O,1184
24266,potential,O,1184
24267,visual,O,1184
24268,consequences,O,1184
24269,contact,B-TREATMENT,1184
24270,lens,I-TREATMENT,1184
24271,safety,O,1184
24272,in,O,1184
24273,children,O,1184
24274,is,O,1184
24275,a,O,1185
24276,concern,O,1185
24277,Microbial,B-NAME_OF_DISEASE,1185
24278,keratitis,I-NAME_OF_DISEASE,1185
24279,MK,B-NAME_OF_DISEASE,1185
24280,is,O,1185
24281,the,O,1185
24282,most,O,1185
24283,severe,O,1185
24284,and,O,1185
24285,sight-threatening,O,1185
24286,complication,O,1185
24287,of,O,1185
24288,all,O,1185
24289,lens-related,O,1185
24290,adverse,O,1185
24291,events,O,1185
24292,Thankfully,O,1185
24293,the,O,1185
24294,risk,O,1185
24295,of,O,1185
24296,MK,B-NAME_OF_DISEASE,1185
24297,associated,O,1185
24298,with,O,1185
24299,soft,B-TREATMENT,1185
24300,lens,I-TREATMENT,1185
24301,wear,O,1185
24302,in,O,1185
24303,children,O,1185
24304,ages,O,1185
24305,8,O,1185
24306,to,O,1185
24307,12,O,1185
24308,years,O,1185
24309,is,O,1185
24310,no,O,1185
24311,higher,O,1185
24312,than,O,1185
24313,in,O,1185
24314,adults,O,1185
24315,and,O,1185
24316,may,O,1186
24317,be,O,1186
24318,substantially,O,1186
24319,lower,O,1186
24320,MK,B-NAME_OF_DISEASE,1186
24321,is,O,1186
24322,rare,O,1186
24323,in,O,1186
24324,soft,O,1186
24325,daily,O,1186
24326,disposable,O,1186
24327,lens,O,1186
24328,wearers,O,1186
24329,around,O,1186
24330,2,O,1186
24331,per,O,1186
24332,10,O,1186
24333,0,O,1186
24334,patient-years,O,1186
24335,of,O,1186
24336,wear,O,1186
24337,,O,1186
24338,This,O,1186
24339,risk,O,1186
24340,for,O,1186
24341,MK,B-NAME_OF_DISEASE,1186
24342,specifically,O,1186
24343,Acanthamoeba,B-NAME_OF_DISEASE,1187
24344,keratitis,I-NAME_OF_DISEASE,1187
24345,AK,B-NAME_OF_DISEASE,1187
24346,may,O,1187
24347,be,O,1187
24348,higher,O,1187
24349,in,O,1187
24350,overnight,O,1187
24351,ortho-k,B-TREATMENT,1187
24352,wearers,O,1187
24353,in,O,1187
24354,comparison,O,1187
24355,to,O,1187
24356,daily,O,1187
24357,soft,B-TREATMENT,1188
24358,lens,I-TREATMENT,1188
24359,wearers,O,1188
24360,Increased,O,1188
24361,risk,O,1188
24362,factors,O,1188
24363,for,O,1188
24364,AK,B-NAME_OF_DISEASE,1188
24365,in,O,1188
24366,overnight,O,1188
24367,ortho-k,B-TREATMENT,1188
24368,wear,O,1188
24369,include,O,1188
24370,rinsing,B-CAUSE_OF_DISEASE,1188
24371,and,I-CAUSE_OF_DISEASE,1188
24372,or,I-CAUSE_OF_DISEASE,1188
24373,storing,I-CAUSE_OF_DISEASE,1188
24374,lenses,I-CAUSE_OF_DISEASE,1188
24375,in,I-CAUSE_OF_DISEASE,1188
24376,tap,I-CAUSE_OF_DISEASE,1188
24377,water,I-CAUSE_OF_DISEASE,1188
24378,It,O,1188
24379,is,O,1188
24380,critical,O,1188
24381,to,O,1188
24382,educate,O,1188
24383,patients,O,1188
24384,about,O,1188
24385,the,O,1188
24386,hazard,O,1188
24387,that,O,1188
24388,tap,O,1189
24389,water,O,1189
24390,poses,O,1189
24391,and,O,1189
24392,to,O,1189
24393,demonstrate,O,1189
24394,the,O,1189
24395,correct,O,1189
24396,care,O,1189
24397,of,O,1189
24398,their,O,1189
24399,lenses,O,1189
24400,Uveitic,B-NAME_OF_DISEASE,1189
24401,glaucoma,B-NAME_OF_DISEASE,1189
24402,is,O,1189
24403,a,O,1189
24404,common,O,1189
24405,complication,O,1189
24406,of,O,1189
24407,uveitis,B-NAME_OF_DISEASE,1189
24408,affecting,O,1189
24409,some,O,1189
24410,20%,O,1189
24411,of,O,1189
24412,patients,O,1189
24413,The,O,1189
24414,term,O,1189
24415,uveitic,B-NAME_OF_DISEASE,1189
24416,glaucoma,B-NAME_OF_DISEASE,1189
24417,is,O,1189
24418,used,O,1189
24419,to,O,1189
24420,describe,O,1189
24421,glaucoma,B-NAME_OF_DISEASE,1189
24422,resulting,O,1189
24423,indirectly,O,1189
24424,or,O,1190
24425,directly,O,1190
24426,from,O,1190
24427,uveitis,B-NAME_OF_DISEASE,1190
24428,Glaucoma,B-NAME_OF_DISEASE,1190
24429,is,O,1190
24430,more,O,1190
24431,commonly,O,1190
24432,associated,O,1190
24433,with,O,1190
24434,anterior,B-NAME_OF_DISEASE,1190
24435,uveitis,I-NAME_OF_DISEASE,1190
24436,and,O,1190
24437,with,O,1190
24438,chronic,B-NAME_OF_DISEASE,1190
24439,forms,I-NAME_OF_DISEASE,1190
24440,of,I-NAME_OF_DISEASE,1190
24441,uveitis,I-NAME_OF_DISEASE,1191
24442,Uveitis,B-NAME_OF_DISEASE,1191
24443,and,O,1191
24444,its,O,1191
24445,treatment,O,1191
24446,can,O,1191
24447,lead,O,1191
24448,to,O,1191
24449,elevated,B-SIGN_AND_SYMPTOM,1191
24450,intraocular,I-SIGN_AND_SYMPTOM,1191
24451,pressure,I-SIGN_AND_SYMPTOM,1191
24452,IOP,I-SIGN_AND_SYMPTOM,1191
24453,,O,1191
24454,A,O,1191
24455,persistent,O,1191
24456,rise,O,1191
24457,in,O,1191
24458,IOP,O,1191
24459,can,O,1191
24460,lead,O,1191
24461,to,O,1191
24462,glaucamatous,B-NAME_OF_DISEASE,1191
24463,optic,I-NAME_OF_DISEASE,1191
24464,neuropathy,I-NAME_OF_DISEASE,1191
24465,and,O,1191
24466,visual,B-SIGN_AND_SYMPTOM,1191
24467,field,I-SIGN_AND_SYMPTOM,1192
24468,loss,I-SIGN_AND_SYMPTOM,1192
24469,Intraocular,B-SIGN_AND_SYMPTOM,1192
24470,pressure,I-SIGN_AND_SYMPTOM,1192
24471,IOP,I-SIGN_AND_SYMPTOM,1192
24472,elevation,I-SIGN_AND_SYMPTOM,1192
24473,in,O,1192
24474,uveitis,B-NAME_OF_DISEASE,1192
24475,can,O,1192
24476,be,O,1192
24477,secondary,O,1192
24478,to,O,1192
24479,open,B-CAUSE_OF_DISEASE,1192
24480,angle,I-CAUSE_OF_DISEASE,1192
24481,or,I-CAUSE_OF_DISEASE,1192
24482,angle,I-CAUSE_OF_DISEASE,1192
24483,closure,I-CAUSE_OF_DISEASE,1192
24484,mechanisms,I-CAUSE_OF_DISEASE,1192
24485,It,O,1192
24486,can,O,1192
24487,also,O,1192
24488,be,O,1192
24489,to,O,1193
24490,due,O,1193
24491,corticosteroid,B-CAUSE_OF_DISEASE,1193
24492,induced,I-CAUSE_OF_DISEASE,1193
24493,glaucoma,I-CAUSE_OF_DISEASE,1193
24494,The,O,1193
24495,pathogenesis,O,1193
24496,may,O,1193
24497,be,O,1193
24498,acute,O,1193
24499,in,O,1193
24500,onset,O,1193
24501,with,O,1193
24502,rapid,O,1193
24503,onset,O,1193
24504,inflammation,O,1193
24505,obstruction,O,1193
24506,of,O,1193
24507,intertrabecular,O,1193
24508,spaces,O,1193
24509,and,O,1194
24510,subsequent,O,1194
24511,increased,B-SIGN_AND_SYMPTOM,1194
24512,IOP,I-SIGN_AND_SYMPTOM,1194
24513,The,O,1194
24514,pathogenesis,O,1194
24515,may,O,1194
24516,also,O,1194
24517,be,O,1194
24518,chronic,O,1194
24519,with,O,1194
24520,repeated,O,1194
24521,bouts,O,1194
24522,of,O,1194
24523,uveitis,B-NAME_OF_DISEASE,1194
24524,leading,O,1194
24525,to,O,1194
24526,fibroblastic,B-SIGN_AND_SYMPTOM,1194
24527,infiltration,I-SIGN_AND_SYMPTOM,1194
24528,and,I-SIGN_AND_SYMPTOM,1194
24529,formation,I-SIGN_AND_SYMPTOM,1194
24530,of,I-SIGN_AND_SYMPTOM,1195
24531,scar,I-SIGN_AND_SYMPTOM,1195
24532,tissue,I-SIGN_AND_SYMPTOM,1195
24533,that,O,1195
24534,slowly,O,1195
24535,obstructs,O,1195
24536,the,B-PART_OF_THE_EYES,1195
24537,anterior,I-PART_OF_THE_EYES,1195
24538,chamber,I-PART_OF_THE_EYES,1195
24539,angle,I-PART_OF_THE_EYES,1195
24540,Management,O,1195
24541,of,O,1195
24542,uveitic,B-NAME_OF_DISEASE,1195
24543,glaucoma,B-NAME_OF_DISEASE,1195
24544,is,O,1195
24545,two,O,1195
24546,pronged,O,1195
24547,The,O,1196
24548,etiology,O,1196
24549,of,O,1196
24550,uveitis,B-NAME_OF_DISEASE,1196
24551,must,O,1196
24552,be,O,1196
24553,idenitifed,O,1196
24554,and,O,1196
24555,treated,O,1196
24556,Next,O,1196
24557,the,B-SIGN_AND_SYMPTOM,1196
24558,elevated,I-SIGN_AND_SYMPTOM,1196
24559,IOP,I-SIGN_AND_SYMPTOM,1196
24560,is,O,1196
24561,treated,O,1196
24562,making,O,1196
24563,sure,O,1196
24564,to,O,1196
24565,assess,O,1196
24566,for,O,1196
24567,steroid-induced,B-CAUSE_OF_DISEASE,1196
24568,ocular,I-CAUSE_OF_DISEASE,1196
24569,hypertension,I-CAUSE_OF_DISEASE,1196
24570,Medical,B-TREATMENT,1196
24571,and,I-TREATMENT,1196
24572,surgical,I-TREATMENT,1196
24573,therapy,I-TREATMENT,1196
24574,can,O,1196
24575,be,O,1196
24576,used,O,1196
24577,to,O,1196
24578,fully,O,1196
24579,treat,O,1196
24580,the,O,1196
24581,uveitis,B-NAME_OF_DISEASE,1197
24582,glaucoma,I-NAME_OF_DISEASE,1197
24583,Uveitis,B-NAME_OF_DISEASE,1197
24584,is,O,1197
24585,the,O,1197
24586,third,O,1197
24587,leading,O,1197
24588,cause,O,1197
24589,of,O,1197
24590,preventable,O,1197
24591,blindness,B-NAME_OF_DISEASE,1197
24592,but,O,1197
24593,many,O,1197
24594,people,O,1197
24595,who,O,1197
24596,suffer,O,1197
24597,from,O,1197
24598,this,O,1197
24599,group,O,1197
24600,of,O,1197
24601,diseases,O,1197
24602,lose,O,1197
24603,their,O,1197
24604,vision,O,1197
24605,via,O,1197
24606,other,O,1197
24607,another,O,1197
24608,mechanism,O,1197
24609,-,O,1197
24610,glaucoma,B-NAME_OF_DISEASE,1197
24611,Glaucoma,B-NAME_OF_DISEASE,1197
24612,is,O,1197
24613,the,O,1197
24614,sneak,O,1197
24615,thief,O,1198
24616,of,O,1198
24617,vision,O,1198
24618,a,O,1198
24619,blinding,O,1198
24620,disease,O,1198
24621,of,O,1198
24622,the,B-PART_OF_THE_EYES,1198
24623,optic,B-PART_OF_THE_EYES,1198
24624,nerve,I-PART_OF_THE_EYES,1198
24625,or,O,1198
24626,the,O,1199
24627,structure,O,1199
24628,that,O,1199
24629,connects,O,1199
24630,your,O,1199
24631,eye,O,1199
24632,and,O,1199
24633,brain,O,1199
24634,and,O,1199
24635,allows,O,1199
24636,you,O,1199
24637,to,O,1199
24638,see,O,1199
24639,It,O,1199
24640,causes,O,1199
24641,irreversible,B-SIGN_AND_SYMPTOM,1199
24642,vision,I-SIGN_AND_SYMPTOM,1200
24643,loss,I-SIGN_AND_SYMPTOM,1200
24644,which,O,1200
24645,at,O,1200
24646,first,O,1200
24647,is,O,1200
24648,usually,O,1200
24649,completely,O,1200
24650,unnoticed,O,1200
24651,by,O,1200
24652,the,O,1200
24653,patient,O,1201
24654,asymptomatic,O,1201
24655,because,O,1201
24656,it,O,1201
24657,affects,O,1201
24658,the,O,1201
24659,peripheral,O,1201
24660,vision,O,1201
24661,but,O,1201
24662,slowly,O,1201
24663,progresses,O,1201
24664,until,O,1201
24665,significant,O,1201
24666,central,B-SIGN_AND_SYMPTOM,1201
24667,vision,I-SIGN_AND_SYMPTOM,1201
24668,loss,I-SIGN_AND_SYMPTOM,1201
24669,occurs,O,1201
24670,Glaucoma,B-NAME_OF_DISEASE,1201
24671,itself,O,1201
24672,is,O,1201
24673,actually,O,1201
24674,a,O,1201
24675,much,O,1201
24676,more,O,1201
24677,common,O,1202
24678,disease,O,1202
24679,than,O,1202
24680,uveitis,B-NAME_OF_DISEASE,1202
24681,It,O,1202
24682,comes,O,1202
24683,in,O,1202
24684,many,O,1202
24685,different,O,1202
24686,forms,O,1202
24687,is,O,1202
24688,seen,O,1202
24689,on,O,1202
24690,examination,O,1202
24691,by,O,1202
24692,the,O,1202
24693,uveitis,B-NAME_OF_DISEASE,1202
24694,specialist,O,1202
24695,and,O,1202
24696,is,O,1202
24697,also,O,1203
24698,monitored,O,1203
24699,by,O,1203
24700,specialized,O,1203
24701,testing,O,1203
24702,of,O,1203
24703,optic,B-PART_OF_THE_EYES,1203
24704,nerve,I-PART_OF_THE_EYES,1203
24705,structure,O,1203
24706,OCT,B-DIAGNOSTIC_TEST,1204
24707,scan,I-DIAGNOSTIC_TEST,1204
24708,and,O,1204
24709,function,O,1204
24710,visual,B-DIAGNOSTIC_TEST,1204
24711,field,I-DIAGNOSTIC_TEST,1204
24712,testing,I-DIAGNOSTIC_TEST,1204
24713,looking,O,1204
24714,for,O,1204
24715,signs,O,1204
24716,of,O,1204
24717,progression,O,1204
24718,of,O,1204
24719,optic,B-PART_OF_THE_EYES,1204
24720,nerve,I-PART_OF_THE_EYES,1205
24721,damage,O,1205
24722,It,O,1205
24723,is,O,1205
24724,estimated,O,1205
24725,that,O,1205
24726,2,O,1205
24727,million,O,1205
24728,people,O,1205
24729,worldwide,O,1205
24730,have,O,1205
24731,uveitis,B-NAME_OF_DISEASE,1205
24732,and,O,1206
24733,that,O,1206
24734,the,O,1206
24735,percentage,O,1206
24736,of,O,1206
24737,patients,O,1206
24738,with,O,1206
24739,uveitis,B-NAME_OF_DISEASE,1206
24740,who,O,1206
24741,also,O,1206
24742,have,O,1206
24743,glaucoma,B-NAME_OF_DISEASE,1206
24744,ranges,O,1206
24745,between,O,1206
24746,10,O,1206
24747,and,O,1207
24748,40%,O,1207
24749,Just,O,1207
24750,as,O,1207
24751,in,O,1207
24752,non-uveitic,B-NAME_OF_DISEASE,1207
24753,glaucoma,I-NAME_OF_DISEASE,1207
24754,uveitic,B-NAME_OF_DISEASE,1207
24755,glaucoma,I-NAME_OF_DISEASE,1207
24756,is,O,1207
24757,more,O,1207
24758,commonly,O,1207
24759,seen,O,1208
24760,in,O,1208
24761,older,O,1208
24762,patients,O,1208
24763,Some,O,1208
24764,forms,O,1208
24765,of,O,1208
24766,uveitis,B-NAME_OF_DISEASE,1208
24767,are,O,1208
24768,more,O,1208
24769,prone,O,1208
24770,to,O,1208
24771,developing,O,1208
24772,glaucoma,B-NAME_OF_DISEASE,1208
24773,including,O,1208
24774,both,O,1208
24775,infectious,O,1208
24776,causes,O,1208
24777,such,O,1208
24778,as,O,1208
24779,some,O,1208
24780,types,O,1208
24781,of,O,1208
24782,virus,B-NAME_OF_DISEASE,1208
24783,associated,I-NAME_OF_DISEASE,1208
24784,uveitis,I-NAME_OF_DISEASE,1208
24785,and,O,1208
24786,non-infectious,O,1209
24787,causes,O,1209
24788,like,O,1209
24789,juvenile,B-NAME_OF_DISEASE,1209
24790,idiopathic,I-NAME_OF_DISEASE,1209
24791,arthritis,I-NAME_OF_DISEASE,1209
24792,associated,I-NAME_OF_DISEASE,1209
24793,uveitis,I-NAME_OF_DISEASE,1209
24794,Sometimes,O,1209
24795,uveitic,B-NAME_OF_DISEASE,1209
24796,glaucoma,I-NAME_OF_DISEASE,1209
24797,occurs,O,1209
24798,because,O,1209
24799,of,O,1209
24800,long-term,O,1209
24801,dependence,O,1209
24802,on,O,1209
24803,steroid,B-NAME_OF_DRUG,1209
24804,therapy,O,1209
24805,whether,O,1209
24806,by,O,1209
24807,oral,O,1210
24808,medication,O,1210
24809,or,O,1210
24810,eye,O,1210
24811,drops,O,1210
24812,vis-à-vis,O,1210
24813,either,O,1210
24814,poorly,O,1210
24815,controlled,O,1210
24816,inflammation,O,1210
24817,or,O,1211
24818,a,O,1211
24819,distinct,O,1211
24820,and,O,1211
24821,significant,O,1211
24822,rise,O,1211
24823,in,O,1211
24824,eye,O,1212
24825,pressure,O,1212
24826,caused,O,1212
24827,by,O,1212
24828,steroids,B-NAME_OF_DRUG,1212
24829,themselves,O,1212
24830,The,O,1212
24831,most,O,1212
24832,common,O,1212
24833,reason,O,1212
24834,why,O,1212
24835,glaucoma,B-NAME_OF_DISEASE,1212
24836,causes,O,1212
24837,vision,B-SIGN_AND_SYMPTOM,1212
24838,loss,I-SIGN_AND_SYMPTOM,1212
24839,is,O,1212
24840,because,O,1212
24841,of,O,1212
24842,high,B-SIGN_AND_SYMPTOM,1212
24843,pressure,I-SIGN_AND_SYMPTOM,1212
24844,in,I-SIGN_AND_SYMPTOM,1212
24845,the,I-SIGN_AND_SYMPTOM,1212
24846,eye,I-SIGN_AND_SYMPTOM,1212
24847,It,O,1212
24848,is,O,1212
24849,primarily,O,1212
24850,a,O,1212
24851,problem,O,1212
24852,with,O,1212
24853,fluid,B-SIGN_AND_SYMPTOM,1212
24854,balance,I-SIGN_AND_SYMPTOM,1212
24855,in,I-SIGN_AND_SYMPTOM,1212
24856,the,I-SIGN_AND_SYMPTOM,1212
24857,eye,I-SIGN_AND_SYMPTOM,1213
24858,which,O,1213
24859,creates,O,1213
24860,the,O,1213
24861,pressure,O,1213
24862,-,O,1214
24863,too,O,1214
24864,much,O,1214
24865,fluid,O,1214
24866,in,O,1214
24867,or,O,1214
24868,not,O,1214
24869,enough,O,1214
24870,fluid,O,1214
24871,out,O,1214
24872,,O,1214
24873,This,O,1215
24874,imbalance,O,1215
24875,is,O,1215
24876,then,O,1215
24877,treated,O,1215
24878,by,O,1215
24879,means,O,1215
24880,to,O,1215
24881,reduce,O,1215
24882,this,O,1215
24883,pressure,O,1215
24884,such,O,1215
24885,as,O,1215
24886,eye,B-TREATMENT,1215
24887,drops,I-TREATMENT,1215
24888,or,O,1215
24889,laser,B-TREATMENT,1215
24890,therapy,I-TREATMENT,1216
24891,and,O,1216
24892,less,O,1216
24893,commonly,O,1216
24894,surgery,B-TREATMENT,1216
24895,Cardiovascular,B-CAUSE_OF_DISEASE,1216
24896,and,I-CAUSE_OF_DISEASE,1216
24897,metabolic,I-CAUSE_OF_DISEASE,1216
24898,diseases,I-CAUSE_OF_DISEASE,1216
24899,have,O,1216
24900,also,O,1216
24901,been,O,1216
24902,thought,O,1216
24903,to,O,1216
24904,play,O,1216
24905,a,O,1217
24906,more,O,1217
24907,prominent,O,1217
24908,role,O,1217
24909,in,O,1217
24910,glaucoma,B-NAME_OF_DISEASE,1217
24911,specifically,O,1217
24912,hypertension,B-CAUSE_OF_DISEASE,1217
24913,and,O,1217
24914,diabetes,B-CAUSE_OF_DISEASE,1217
24915,But,O,1218
24916,in,O,1218
24917,uveitic,B-NAME_OF_DISEASE,1218
24918,glaucoma,I-NAME_OF_DISEASE,1218
24919,several,O,1218
24920,other,O,1218
24921,factors,O,1218
24922,may,O,1218
24923,be,O,1218
24924,in,O,1218
24925,play,O,1218
24926,including,O,1218
24927,scarring,B-CAUSE_OF_DISEASE,1218
24928,and,I-CAUSE_OF_DISEASE,1218
24929,poor,I-CAUSE_OF_DISEASE,1218
24930,blood,I-CAUSE_OF_DISEASE,1218
24931,flow,I-CAUSE_OF_DISEASE,1218
24932,due,I-CAUSE_OF_DISEASE,1218
24933,to,I-CAUSE_OF_DISEASE,1218
24934,chronic,I-CAUSE_OF_DISEASE,1218
24935,inflammation,I-CAUSE_OF_DISEASE,1218
24936,Scarring,B-CAUSE_OF_DISEASE,1218
24937,may,O,1218
24938,cause,O,1218
24939,abnormalities,O,1218
24940,in,O,1219
24941,the,O,1219
24942,outflow,O,1219
24943,pathway,O,1219
24944,of,O,1219
24945,fluid,O,1219
24946,from,O,1219
24947,the,O,1219
24948,eye,O,1219
24949,leading,O,1219
24950,to,O,1219
24951,higher,O,1220
24952,pressure,O,1220
24953,Abnormal,B-CAUSE_OF_DISEASE,1220
24954,blood,I-CAUSE_OF_DISEASE,1220
24955,flow,I-CAUSE_OF_DISEASE,1220
24956,and,I-CAUSE_OF_DISEASE,1220
24957,blood,I-CAUSE_OF_DISEASE,1220
24958,vessel,I-CAUSE_OF_DISEASE,1220
24959,inflammation,I-CAUSE_OF_DISEASE,1220
24960,can,O,1220
24961,also,O,1220
24962,damage,O,1220
24963,outflow,O,1220
24964,pathways,O,1220
24965,but,O,1220
24966,may,O,1220
24967,also,O,1220
24968,pose,O,1220
24969,a,O,1221
24970,threat,O,1221
24971,to,O,1221
24972,oxygen,O,1221
24973,delivery,O,1221
24974,to,O,1221
24975,the,B-PART_OF_THE_EYES,1221
24976,retina,I-PART_OF_THE_EYES,1221
24977,and,O,1221
24978,optic,B-PART_OF_THE_EYES,1221
24979,nerve,I-PART_OF_THE_EYES,1221
24980,ischemia,B-NAME_OF_DISEASE,1221
24981,which,O,1221
24982,can,O,1221
24983,also,O,1221
24984,cause,O,1221
24985,irreversible,O,1221
24986,damage,O,1221
24987,At,O,1222
24988,times,O,1222
24989,active,B-CAUSE_OF_DISEASE,1222
24990,inflammation,I-CAUSE_OF_DISEASE,1222
24991,is,O,1222
24992,felt,O,1222
24993,to,O,1222
24994,be,O,1222
24995,the,O,1222
24996,cause,O,1222
24997,of,O,1222
24998,high,B-SIGN_AND_SYMPTOM,1222
24999,eye,I-SIGN_AND_SYMPTOM,1222
25000,pressure,I-SIGN_AND_SYMPTOM,1222
25001,as,O,1222
25002,may,O,1222
25003,happen,O,1222
25004,in,O,1222
25005,herpes,B-NAME_OF_DISEASE,1222
25006,simplex,I-NAME_OF_DISEASE,1222
25007,iritis,I-NAME_OF_DISEASE,1222
25008,-,O,1222
25009,simply,O,1222
25010,treating,O,1222
25011,the,O,1222
25012,inflammation,O,1222
25013,causes,O,1222
25014,the,O,1222
25015,eye,O,1222
25016,pressure,O,1223
25017,to,O,1223
25018,return,O,1223
25019,to,O,1223
25020,normal,O,1223
25021,Glaucoma,B-NAME_OF_DISEASE,1223
25022,is,O,1223
25023,often,O,1223
25024,a,O,1223
25025,complicating,O,1223
25026,factor,O,1223
25027,for,O,1223
25028,patients,O,1223
25029,suffering,O,1224
25030,with,O,1224
25031,uveitis,B-NAME_OF_DISEASE,1224
25032,The,O,1224
25033,relationship,O,1224
25034,between,O,1224
25035,uveitis,B-NAME_OF_DISEASE,1224
25036,and,O,1224
25037,glaucoma,B-NAME_OF_DISEASE,1224
25038,is,O,1224
25039,quite,O,1224
25040,complex,O,1224
25041,and,O,1224
25042,often,O,1224
25043,multifactorial,O,1224
25044,which,O,1224
25045,makes,O,1225
25046,management,O,1225
25047,challenging,O,1225
25048,In,O,1225
25049,acute,B-NAME_OF_DISEASE,1225
25050,uveitis,I-NAME_OF_DISEASE,1225
25051,IOP,O,1225
25052,can,O,1225
25053,be,O,1225
25054,decreased,O,1225
25055,from,O,1225
25056,ciliary,O,1225
25057,body,O,1225
25058,shutdown,O,1225
25059,However,O,1225
25060,several,O,1225
25061,mechanisms,O,1225
25062,can,O,1225
25063,lead,O,1225
25064,to,O,1225
25065,uveitic,B-NAME_OF_DISEASE,1225
25066,glaucoma,I-NAME_OF_DISEASE,1225
25067,over,O,1226
25068,the,O,1226
25069,course,O,1226
25070,of,O,1226
25071,the,O,1226
25072,disease,O,1226
25073,such,O,1226
25074,as,O,1226
25075,open-angle,B-CAUSE_OF_DISEASE,1226
25076,mechanisms,I-CAUSE_OF_DISEASE,1226
25077,secondary,B-CAUSE_OF_DISEASE,1226
25078,angle,I-CAUSE_OF_DISEASE,1226
25079,closure,I-CAUSE_OF_DISEASE,1226
25080,and,O,1226
25081,steroid,B-CAUSE_OF_DISEASE,1226
25082,response,I-CAUSE_OF_DISEASE,1226
25083,MECHANISMS,O,1226
25084,THAT,O,1226
25085,LEAD,O,1226
25086,TO,O,1226
25087,UVEITIC,B-NAME_OF_DISEASE,1226
25088,GLAUCOMA,I-NAME_OF_DISEASE,1226
25089,Open-angle,B-CAUSE_OF_DISEASE,1226
25090,glaucoma,I-CAUSE_OF_DISEASE,1226
25091,Open-angle,B-CAUSE_OF_DISEASE,1226
25092,glaucoma,I-CAUSE_OF_DISEASE,1226
25093,is,O,1226
25094,the,O,1226
25095,most,O,1226
25096,common,O,1226
25097,cause,O,1226
25098,of,O,1226
25099,elevated,B-SIGN_AND_SYMPTOM,1226
25100,IOP,I-SIGN_AND_SYMPTOM,1226
25101,in,O,1226
25102,uveitis,B-NAME_OF_DISEASE,1226
25103,Inflammatory,O,1227
25104,cells,O,1227
25105,fibrin,O,1227
25106,and,O,1227
25107,debris,O,1227
25108,obstruct,O,1227
25109,the,B-PART_OF_THE_EYES,1227
25110,trabecular,I-PART_OF_THE_EYES,1227
25111,meshwork,I-PART_OF_THE_EYES,1227
25112,In,O,1227
25113,addition,O,1227
25114,cytokine-induced,O,1227
25115,inflammation,O,1227
25116,of,O,1227
25117,the,B-PART_OF_THE_EYES,1227
25118,trabecular,I-PART_OF_THE_EYES,1227
25119,meshwork,I-PART_OF_THE_EYES,1227
25120,can,O,1227
25121,disrupt,O,1227
25122,aqueous,O,1228
25123,outflow,O,1228
25124,as,O,1228
25125,well,O,1228
25126,Chronic,B-CAUSE_OF_DISEASE,1228
25127,inflammation,I-CAUSE_OF_DISEASE,1228
25128,leads,O,1228
25129,to,O,1228
25130,fibrovascular,B-SIGN_AND_SYMPTOM,1228
25131,proliferation,I-SIGN_AND_SYMPTOM,1228
25132,and,I-SIGN_AND_SYMPTOM,1228
25133,scarring,I-SIGN_AND_SYMPTOM,1228
25134,of,I-SIGN_AND_SYMPTOM,1228
25135,the,I-SIGN_AND_SYMPTOM,1228
25136,outflow,I-SIGN_AND_SYMPTOM,1228
25137,pathways,I-SIGN_AND_SYMPTOM,1228
25138,Closed-angle,B-CAUSE_OF_DISEASE,1228
25139,glaucoma,I-CAUSE_OF_DISEASE,1228
25140,Chronic,B-CAUSE_OF_DISEASE,1228
25141,inflammation,I-CAUSE_OF_DISEASE,1228
25142,may,O,1228
25143,induce,O,1228
25144,peripheral,B-SIGN_AND_SYMPTOM,1228
25145,anterior,I-SIGN_AND_SYMPTOM,1228
25146,synechiae,I-SIGN_AND_SYMPTOM,1228
25147,PAS,I-SIGN_AND_SYMPTOM,1228
25148,or,I-SIGN_AND_SYMPTOM,1228
25149,posterior,I-SIGN_AND_SYMPTOM,1228
25150,synechiae,I-SIGN_AND_SYMPTOM,1228
25151,PS,I-SIGN_AND_SYMPTOM,1228
25152,formation,I-SIGN_AND_SYMPTOM,1228
25153,In,O,1228
25154,the,O,1229
25155,angle,O,1229
25156,broad-based,B-CAUSE_OF_DISEASE,1229
25157,PAS,I-CAUSE_OF_DISEASE,1229
25158,can,O,1229
25159,cause,O,1229
25160,total,O,1229
25161,closure,O,1229
25162,of,O,1229
25163,the,O,1229
25164,angle,O,1229
25165,At,O,1229
25166,the,B-PART_OF_THE_EYES,1229
25167,pupil,I-PART_OF_THE_EYES,1229
25168,margin,I-PART_OF_THE_EYES,1229
25169,PS,O,1229
25170,can,O,1229
25171,block,O,1229
25172,the,O,1229
25173,flow,O,1229
25174,of,O,1229
25175,aqueous,O,1229
25176,fluid,O,1229
25177,from,O,1229
25178,the,O,1229
25179,posterior,O,1229
25180,to,O,1229
25181,anterior,O,1229
25182,chamber,O,1229
25183,which,O,1230
25184,results,O,1231
25185,in,O,1231
25186,iris,B-SIGN_AND_SYMPTOM,1231
25187,bombé,I-SIGN_AND_SYMPTOM,1232
25188,and,O,1232
25189,acute,B-SIGN_AND_SYMPTOM,1232
25190,angle,I-SIGN_AND_SYMPTOM,1232
25191,closure,I-SIGN_AND_SYMPTOM,1232
25192,Less,O,1232
25193,commonly,O,1232
25194,chronic,O,1232
25195,angle,O,1232
25196,closure,O,1232
25197,can,O,1232
25198,result,O,1232
25199,from,O,1232
25200,anterior,O,1232
25201,rotation,O,1233
25202,of,O,1233
25203,the,O,1233
25204,ciliary,O,1233
25205,body,O,1233
25206,as,O,1233
25207,a,O,1233
25208,result,O,1233
25209,of,O,1233
25210,inflammation,O,1233
25211,and,O,1233
25212,edema,O,1234
25213,Steroid-induced,B-NAME_OF_DISEASE,1234
25214,glaucoma,I-NAME_OF_DISEASE,1234
25215,Steroids,B-NAME_OF_DRUG,1234
25216,are,O,1234
25217,the,O,1234
25218,mainstay,O,1234
25219,of,O,1234
25220,treatment,O,1234
25221,of,O,1234
25222,uveitis,B-NAME_OF_DISEASE,1234
25223,Often,O,1234
25224,patients,O,1234
25225,can,O,1234
25226,develop,O,1234
25227,a,O,1235
25228,steroid,B-NAME_OF_DRUG,1235
25229,response,O,1235
25230,Corticosteroidinduced,B-SIGN_AND_SYMPTOM,1235
25231,IOP,I-SIGN_AND_SYMPTOM,1235
25232,elevation,I-SIGN_AND_SYMPTOM,1235
25233,is,O,1235
25234,primarily,O,1235
25235,due,O,1235
25236,to,O,1235
25237,increased,B-CAUSE_OF_DISEASE,1235
25238,outflow,I-CAUSE_OF_DISEASE,1235
25239,resistance,I-CAUSE_OF_DISEASE,1235
25240,and,O,1235
25241,is,O,1235
25242,thought,O,1235
25243,to,O,1235
25244,result,O,1235
25245,from,O,1235
25246,suppression,B-CAUSE_OF_DISEASE,1235
25247,of,I-CAUSE_OF_DISEASE,1235
25248,phagocytic,I-CAUSE_OF_DISEASE,1236
25249,activity,I-CAUSE_OF_DISEASE,1236
25250,which,O,1236
25251,leads,O,1236
25252,to,O,1236
25253,increased,O,1236
25254,deposition,O,1236
25255,of,O,1236
25256,glycosaminoglycans,B-CHEMICAL_COMPOUND,1236
25257,and,O,1236
25258,a,O,1236
25259,decrease,O,1236
25260,in,O,1236
25261,prostaglandin,B-CHEMICAL_COMPOUND,1236
25262,synthesis,O,1236
25263,Steroid,B-NAME_OF_DRUG,1236
25264,response,O,1236
25265,can,O,1236
25266,be,O,1236
25267,unpredictable,O,1236
25268,Often,O,1236
25269,it,O,1236
25270,is,O,1236
25271,seen,O,1236
25272,within,O,1236
25273,a,O,1236
25274,few,O,1236
25275,weeks,O,1236
25276,of,O,1236
25277,starting,O,1236
25278,therapy,O,1236
25279,However,O,1236
25280,patients,O,1236
25281,who,O,1236
25282,have,O,1236
25283,been,O,1237
25284,on,O,1237
25285,chronic,B-NAME_OF_DRUG,1237
25286,steroids,I-NAME_OF_DRUG,1237
25287,with,O,1237
25288,previously,O,1237
25289,normal,O,1237
25290,IOP,O,1237
25291,can,O,1237
25292,also,O,1237
25293,exhibit,O,1237
25294,steroid,B-NAME_OF_DRUG,1237
25295,response,O,1237
25296,EVALUATION,O,1238
25297,Just,O,1238
25298,as,O,1238
25299,the,O,1238
25300,severity,O,1238
25301,of,O,1238
25302,uveitis,B-NAME_OF_DISEASE,1238
25303,varies,O,1238
25304,widely,O,1238
25305,so,O,1238
25306,does,O,1238
25307,the,O,1238
25308,severity,O,1238
25309,of,O,1238
25310,glaucoma,B-NAME_OF_DISEASE,1238
25311,A,O,1238
25312,significant,O,1238
25313,percentage,O,1238
25314,of,O,1238
25315,patients,O,1239
25316,with,O,1239
25317,uveitis,B-NAME_OF_DISEASE,1239
25318,will,O,1239
25319,develop,O,1239
25320,glaucoma,B-NAME_OF_DISEASE,1239
25321,One,O,1239
25322,key,O,1239
25323,pearl,O,1239
25324,in,O,1239
25325,managing,O,1240
25326,patients,O,1240
25327,with,O,1240
25328,both,O,1240
25329,uveitis,B-NAME_OF_DISEASE,1240
25330,and,O,1240
25331,glaucoma,B-NAME_OF_DISEASE,1240
25332,is,O,1240
25333,to,O,1241
25334,discuss,O,1241
25335,glaucoma,B-NAME_OF_DISEASE,1241
25336,early,O,1241
25337,in,O,1241
25338,the,O,1241
25339,course,O,1241
25340,of,O,1242
25341,uveitis,B-NAME_OF_DISEASE,1242
25342,before,O,1242
25343,they,O,1242
25344,develop,O,1242
25345,glaucoma,B-NAME_OF_DISEASE,1242
25346,Set,O,1242
25347,expectations,O,1242
25348,for,O,1242
25349,the,O,1242
25350,risk,O,1242
25351,and,O,1242
25352,need,O,1242
25353,for,O,1242
25354,management,O,1242
25355,of,O,1242
25356,glaucoma,B-NAME_OF_DISEASE,1242
25357,Make,O,1242
25358,a,O,1242
25359,point,O,1242
25360,to,O,1242
25361,share,O,1243
25362,the,O,1243
25363,eye,O,1243
25364,pressure,O,1243
25365,with,O,1243
25366,the,O,1243
25367,patient,O,1243
25368,whether,O,1243
25369,it,O,1243
25370,is,O,1243
25371,of,O,1243
25372,concern,O,1243
25373,or,O,1243
25374,not,O,1243
25375,On,O,1243
25376,your,O,1243
25377,initial,O,1243
25378,exam,O,1244
25379,gonioscopy,B-DIAGNOSTIC_TEST,1244
25380,is,O,1244
25381,very,O,1244
25382,helpful,O,1244
25383,to,O,1244
25384,determine,O,1244
25385,the,O,1244
25386,extent,O,1244
25387,of,O,1244
25388,current,O,1244
25389,and,O,1244
25390,or,O,1244
25391,past,O,1244
25392,inflammation,O,1244
25393,As,O,1244
25394,you,O,1244
25395,follow,O,1244
25396,the,O,1244
25397,patient,O,1244
25398,serial,B-DIAGNOSTIC_TEST,1244
25399,gonioscopy,I-DIAGNOSTIC_TEST,1244
25400,provides,O,1244
25401,an,O,1244
25402,idea,O,1244
25403,of,O,1244
25404,whether,O,1244
25405,the,O,1245
25406,patient,O,1245
25407,has,O,1245
25408,had,O,1245
25409,flares,O,1245
25410,in,O,1245
25411,between,O,1245
25412,visits,O,1245
25413,even,O,1245
25414,if,O,1245
25415,they,O,1245
25416,may,O,1245
25417,be,O,1245
25418,symptomatic,O,1245
25419,especially,O,1245
25420,in,O,1245
25421,children,O,1245
25422,Gonioscopy,B-DIAGNOSTIC_TEST,1245
25423,should,O,1245
25424,be,O,1245
25425,performed,O,1245
25426,at,O,1245
25427,baseline,O,1245
25428,with,O,1245
25429,each,O,1245
25430,flare,O,1246
25431,and,O,1246
25432,yearly,O,1246
25433,at,O,1246
25434,minimum,O,1246
25435,If,O,1246
25436,significant,O,1246
25437,PAS,B-SIGN_AND_SYMPTOM,1246
25438,are,O,1246
25439,present,O,1246
25440,the,O,1246
25441,patient,O,1246
25442,s,O,1246
25443,risk,O,1246
25444,for,O,1246
25445,developing,O,1246
25446,chronic,B-NAME_OF_DISEASE,1246
25447,angle,I-NAME_OF_DISEASE,1246
25448,closure,I-NAME_OF_DISEASE,1246
25449,is,O,1247
25450,higher,O,1247
25451,Documenting,B-DIAGNOSTIC_TEST,1247
25452,a,I-DIAGNOSTIC_TEST,1247
25453,baseline,I-DIAGNOSTIC_TEST,1247
25454,disc,I-DIAGNOSTIC_TEST,1247
25455,photo,I-DIAGNOSTIC_TEST,1247
25456,and,O,1247
25457,optic,B-DIAGNOSTIC_TEST,1247
25458,nerve,I-DIAGNOSTIC_TEST,1247
25459,optical,I-DIAGNOSTIC_TEST,1247
25460,coherence,I-DIAGNOSTIC_TEST,1247
25461,tomography,I-DIAGNOSTIC_TEST,1247
25462,are,O,1247
25463,also,O,1247
25464,helpful,O,1247
25465,as,O,1247
25466,you,O,1247
25467,follow,O,1247
25468,patients,O,1247
25469,with,O,1247
25470,uveitis,B-NAME_OF_DISEASE,1247
25471,over,O,1247
25472,time,O,1247
25473,MEDICAL,O,1248
25474,MANAGEMENT,O,1248
25475,Glaucoma,B-NAME_OF_DISEASE,1248
25476,medications,O,1248
25477,If,O,1248
25478,a,O,1248
25479,patient,O,1248
25480,s,O,1248
25481,eye,O,1248
25482,pressure,O,1248
25483,is,O,1248
25484,elevated,O,1248
25485,-,O,1248
25486,it,O,1248
25487,varies,O,1248
25488,for,O,1248
25489,different,O,1248
25490,people,O,1248
25491,but,O,1248
25492,typically,O,1248
25493,above,O,1248
25494,22,O,1248
25495,mm,O,1249
25496,Hg,O,1249
25497,-,O,1249
25498,good,O,1249
25499,first-line,O,1249
25500,options,O,1249
25501,are,O,1249
25502,a,B-NAME_OF_DRUG,1249
25503,beta,I-NAME_OF_DRUG,1249
25504,blocker,I-NAME_OF_DRUG,1249
25505,or,O,1249
25506,carbonic,B-NAME_OF_DRUG,1249
25507,anhydrase,I-NAME_OF_DRUG,1249
25508,inhibitors,I-NAME_OF_DRUG,1249
25509,We,O,1249
25510,prefer,O,1249
25511,a,B-NAME_OF_DRUG,1249
25512,beta,I-NAME_OF_DRUG,1249
25513,blocker,I-NAME_OF_DRUG,1249
25514,if,O,1249
25515,there,O,1249
25516,is,O,1249
25517,no,O,1249
25518,contraindication,O,1249
25519,of,O,1250
25520,quick,O,1250
25521,onset,O,1250
25522,and,O,1250
25523,option,O,1250
25524,for,O,1250
25525,once,O,1250
25526,daily,O,1250
25527,dosing,O,1250
25528,Once,O,1250
25529,the,O,1250
25530,IOP,O,1250
25531,is,O,1250
25532,at,O,1251
25533,a,O,1251
25534,point,O,1251
25535,where,O,1251
25536,we,O,1251
25537,are,O,1251
25538,treating,O,1251
25539,it,O,1251
25540,with,O,1251
25541,a,B-TREATMENT,1251
25542,topical,I-TREATMENT,1251
25543,drop,I-TREATMENT,1251
25544,we,O,1251
25545,get,O,1251
25546,a,O,1251
25547,baseline,O,1251
25548,visual,O,1251
25549,field,O,1251
25550,as,O,1252
25551,soon,O,1252
25552,as,O,1252
25553,the,O,1252
25554,patient,O,1252
25555,is,O,1252
25556,over,O,1252
25557,the,O,1252
25558,acute,O,1252
25559,flare,O,1252
25560,My,O,1252
25561,second-line,O,1252
25562,choice,O,1252
25563,for,O,1252
25564,uveitic,B-NAME_OF_DISEASE,1252
25565,glaucoma,B-NAME_OF_DISEASE,1252
25566,is,O,1252
25567,a,O,1253
25568,combination,O,1253
25569,drop,O,1253
25570,with,O,1253
25571,a,B-NAME_OF_DRUG,1253
25572,beta,I-NAME_OF_DRUG,1253
25573,blocker,I-NAME_OF_DRUG,1253
25574,like,O,1254
25575,dorzolamide,B-NAME_OF_DRUG,1254
25576,hydrochloride-timolol,I-NAME_OF_DRUG,1254
25577,maleate,I-NAME_OF_DRUG,1254
25578,ophthalmic,I-NAME_OF_DRUG,1254
25579,solution,I-NAME_OF_DRUG,1254
25580,Cosopt,I-NAME_OF_DRUG,1254
25581,Akorn,I-NAME_OF_DRUG,1254
25582,or,O,1254
25583,brimonidine,B-NAME_OF_DRUG,1254
25584,tartrate-timolol,O,1254
25585,maleate,O,1254
25586,ophthalmic,O,1254
25587,solution,O,1254
25588,0.2,O,1254
25589,0.5,O,1254
25590,Combigan,O,1254
25591,Allergan,O,1254
25592,,O,1254
25593,If,O,1255
25594,a,O,1255
25595,third,O,1255
25596,agent,O,1255
25597,is,O,1255
25598,required,O,1255
25599,we,O,1255
25600,add,O,1255
25601,brimonidine,B-NAME_OF_DRUG,1255
25602,or,O,1255
25603,a,B-NAME_OF_DRUG,1255
25604,carbonic,I-NAME_OF_DRUG,1255
25605,anhydrase,I-NAME_OF_DRUG,1255
25606,inhibitor,I-NAME_OF_DRUG,1255
25607,At,O,1255
25608,this,O,1255
25609,point,O,1255
25610,we,O,1255
25611,typically,O,1255
25612,begin,O,1255
25613,collaborating,O,1255
25614,with,O,1255
25615,a,O,1256
25616,glaucoma,B-NAME_OF_DISEASE,1256
25617,colleague,O,1256
25618,If,O,1256
25619,the,O,1256
25620,patient,O,1256
25621,already,O,1256
25622,has,O,1256
25623,advanced,O,1256
25624,cupping,O,1256
25625,we,O,1256
25626,refer,O,1256
25627,to,O,1256
25628,a,O,1256
25629,glaucoma,B-NAME_OF_DISEASE,1256
25630,specialist,O,1256
25631,even,O,1256
25632,sooner,O,1256
25633,Early,O,1256
25634,collaboration,O,1256
25635,is,O,1256
25636,important,O,1256
25637,to,O,1256
25638,relieve,O,1256
25639,patient,O,1256
25640,anxiety,O,1256
25641,in,O,1256
25642,times,O,1256
25643,of,O,1257
25644,flare,O,1257
25645,as,O,1257
25646,well,O,1257
25647,as,O,1257
25648,prepare,O,1257
25649,for,O,1257
25650,surgical,O,1257
25651,options,O,1257
25652,if,O,1257
25653,needed,O,1257
25654,Often,O,1257
25655,if,O,1257
25656,the,O,1257
25657,patient,O,1257
25658,has,O,1257
25659,to,O,1257
25660,take,O,1257
25661,high-frequency,O,1257
25662,topical,B-NAME_OF_DRUG,1257
25663,steroids,I-NAME_OF_DRUG,1257
25664,-,O,1257
25665,cycloplegic,B-NAME_OF_DRUG,1257
25666,and,I-NAME_OF_DRUG,1257
25667,glaucoma,I-NAME_OF_DRUG,1257
25668,drops,I-NAME_OF_DRUG,1257
25669,-,O,1257
25670,we,O,1257
25671,look,O,1257
25672,into,O,1257
25673,preservative-free,O,1257
25674,options,O,1257
25675,eg,O,1257
25676,PF-Cosopt,B-NAME_OF_DRUG,1257
25677,Akorn,I-NAME_OF_DRUG,1257
25678,and,O,1257
25679,or,O,1257
25680,compounded,O,1257
25681,drops,O,1257
25682,from,O,1257
25683,ImprimisRx,B-ORGANIZATION,1257
25684,or,O,1257
25685,OSRX,B-ORGANIZATION,1258
25686,for,O,1258
25687,example,O,1258
25688,,O,1258
25689,The,O,1258
25690,surface,O,1258
25691,irregularity,O,1258
25692,and,O,1258
25693,discomfort,O,1258
25694,are,O,1258
25695,challenging,O,1258
25696,for,O,1258
25697,patients,O,1258
25698,and,O,1258
25699,their,O,1258
25700,drop,O,1258
25701,compliance,O,1258
25702,We,O,1258
25703,recommend,O,1258
25704,preservative-free,B-TREATMENT,1259
25705,artificial,I-TREATMENT,1259
25706,tears,I-TREATMENT,1259
25707,if,O,1259
25708,the,O,1259
25709,patient,O,1259
25710,is,O,1259
25711,on,O,1259
25712,two,O,1259
25713,drops,O,1259
25714,and,O,1259
25715,has,O,1259
25716,any,O,1259
25717,signs,O,1259
25718,of,O,1259
25719,surface,B-NAME_OF_DISEASE,1259
25720,keratopathy,I-NAME_OF_DISEASE,1259
25721,It,O,1259
25722,is,O,1259
25723,important,O,1260
25724,to,O,1260
25725,monitor,O,1260
25726,and,O,1260
25727,stress,O,1260
25728,compliance,O,1260
25729,with,O,1260
25730,medications,O,1260
25731,We,O,1260
25732,routinely,O,1260
25733,inquire,O,1260
25734,about,O,1260
25735,side,O,1260
25736,effects,O,1260
25737,and,O,1260
25738,tolerance,O,1261
25739,If,O,1261
25740,intolerance,O,1261
25741,is,O,1261
25742,affecting,O,1261
25743,compliance,O,1261
25744,intervene,O,1261
25745,early,O,1261
25746,Prostaglandin,B-NAME_OF_DRUG,1261
25747,analogues,I-NAME_OF_DRUG,1261
25748,and,O,1261
25749,cholinergic,B-NAME_OF_DRUG,1261
25750,agents,I-NAME_OF_DRUG,1261
25751,are,O,1261
25752,a,O,1261
25753,relative,O,1261
25754,contraindication,O,1261
25755,because,O,1261
25756,they,O,1261
25757,can,O,1261
25758,exacerbate,O,1262
25759,inflammation,O,1262
25760,through,O,1262
25761,further,O,1262
25762,breakdown,O,1262
25763,of,O,1262
25764,the,O,1262
25765,blood-aqueous,O,1262
25766,barrier,O,1262
25767,However,O,1262
25768,a,B-NAME_OF_DRUG,1262
25769,prostaglandin,I-NAME_OF_DRUG,1262
25770,analog,I-NAME_OF_DRUG,1262
25771,can,O,1262
25772,be,O,1262
25773,added,O,1262
25774,with,O,1263
25775,close,O,1263
25776,monitoring,O,1263
25777,if,O,1263
25778,a,O,1263
25779,patient,O,1263
25780,s,O,1263
25781,IOP,O,1263
25782,requires,O,1263
25783,it,O,1264
25784,Rho,B-NAME_OF_DRUG,1264
25785,kinase,I-NAME_OF_DRUG,1264
25786,inhibitors,I-NAME_OF_DRUG,1264
25787,-,O,1264
25788,which,O,1264
25789,act,O,1264
25790,on,O,1264
25791,the,O,1264
25792,trabecular,O,1264
25793,meshwork,O,1264
25794,cells,O,1264
25795,and,O,1264
25796,endothelial,O,1264
25797,cells,O,1264
25798,in,O,1264
25799,Schlemm,B-PART_OF_THE_EYES,1264
25800,s,I-PART_OF_THE_EYES,1264
25801,canal,I-PART_OF_THE_EYES,1265
25802,to,O,1265
25803,enhance,O,1265
25804,outflow,O,1265
25805,facility,O,1265
25806,-,O,1265
25807,may,O,1265
25808,be,O,1265
25809,of,O,1265
25810,value,O,1265
25811,Typically,O,1265
25812,these,O,1265
25813,are,O,1265
25814,used,O,1266
25815,as,O,1266
25816,third-,O,1266
25817,or,O,1266
25818,fourth-line,O,1266
25819,agents,O,1266
25820,in,O,1266
25821,my,O,1266
25822,uveitis,B-NAME_OF_DISEASE,1266
25823,algorithm,O,1266
25824,because,O,1266
25825,of,O,1266
25826,the,O,1266
25827,side,O,1266
25828,effect,O,1266
25829,of,O,1266
25830,hyperemia,B-NAME_OF_DISEASE,1266
25831,potentially,O,1266
25832,clouding,O,1266
25833,the,O,1267
25834,uveitis,B-NAME_OF_DISEASE,1267
25835,picture,O,1267
25836,Oral,B-NAME_OF_DRUG,1267
25837,carbonic,I-NAME_OF_DRUG,1267
25838,anhydrase,I-NAME_OF_DRUG,1267
25839,inhibitors,I-NAME_OF_DRUG,1267
25840,are,O,1267
25841,a,O,1267
25842,good,O,1267
25843,option,O,1267
25844,especially,O,1267
25845,while,O,1268
25846,working,O,1268
25847,to,O,1268
25848,reduce,O,1268
25849,the,O,1268
25850,inflammation,O,1268
25851,in,O,1268
25852,advance,O,1268
25853,of,O,1268
25854,surgery,O,1268
25855,Caution,O,1268
25856,must,O,1268
25857,be,O,1268
25858,exercised,O,1268
25859,due,O,1268
25860,to,O,1268
25861,their,O,1268
25862,side-effect,O,1268
25863,profile,O,1268
25864,including,O,1268
25865,impaired,B-SIGN_AND_SYMPTOM,1268
25866,renal,I-SIGN_AND_SYMPTOM,1268
25867,absorption,I-SIGN_AND_SYMPTOM,1268
25868,of,I-SIGN_AND_SYMPTOM,1268
25869,bicarbonate,I-SIGN_AND_SYMPTOM,1268
25870,leading,O,1268
25871,to,O,1268
25872,a,B-SIGN_AND_SYMPTOM,1268
25873,diuretic,I-SIGN_AND_SYMPTOM,1268
25874,response,I-SIGN_AND_SYMPTOM,1268
25875,that,I-SIGN_AND_SYMPTOM,1268
25876,ultimately,I-SIGN_AND_SYMPTOM,1268
25877,lowers,I-SIGN_AND_SYMPTOM,1268
25878,IOP,I-SIGN_AND_SYMPTOM,1269
25879,Adverse,O,1269
25880,effects,O,1269
25881,such,O,1269
25882,as,O,1269
25883,hypokalemia,B-NAME_OF_DISEASE,1269
25884,kidney,B-NAME_OF_DISEASE,1269
25885,stones,I-NAME_OF_DISEASE,1269
25886,metabolic,B-NAME_OF_DISEASE,1269
25887,acidosis,I-NAME_OF_DISEASE,1269
25888,agranulocytosis,B-NAME_OF_DISEASE,1269
25889,and,O,1269
25890,renal,B-NAME_OF_DISEASE,1269
25891,hepatic,I-NAME_OF_DISEASE,1269
25892,failure,I-NAME_OF_DISEASE,1269
25893,have,O,1269
25894,been,O,1269
25895,associated,O,1269
25896,with,O,1269
25897,this,O,1270
25898,class,O,1270
25899,of,O,1270
25900,medication,O,1270
25901,Cycloplegics,B-NAME_OF_DRUG,1270
25902,Mydriatic,I-NAME_OF_DRUG,1270
25903,agents,I-NAME_OF_DRUG,1270
25904,such,O,1270
25905,as,O,1270
25906,atropine,B-NAME_OF_DRUG,1270
25907,cyclopentolate,B-NAME_OF_DRUG,1270
25908,or,O,1270
25909,homatropine,B-NAME_OF_DRUG,1271
25910,are,O,1271
25911,often,O,1271
25912,added,O,1271
25913,to,O,1271
25914,the,O,1271
25915,uveitis,B-NAME_OF_DISEASE,1271
25916,regimen,O,1271
25917,to,O,1271
25918,prevent,O,1271
25919,PS,B-SIGN_AND_SYMPTOM,1271
25920,formation,I-SIGN_AND_SYMPTOM,1271
25921,and,O,1271
25922,to,O,1271
25923,relieve,O,1271
25924,discomfort,B-SIGN_AND_SYMPTOM,1271
25925,Tropicamide,B-NAME_OF_DRUG,1271
25926,can,O,1271
25927,be,O,1271
25928,used,O,1271
25929,as,O,1271
25930,well,O,1272
25931,in,O,1272
25932,times,O,1272
25933,of,O,1272
25934,coverage,O,1272
25935,and,O,1272
25936,availability,O,1272
25937,challenges,O,1272
25938,Avoiding,O,1272
25939,anti-inflammatory,O,1272
25940,medications,O,1272
25941,Nonsteroidal,B-NAME_OF_DRUG,1272
25942,anti-inflammatory,I-NAME_OF_DRUG,1272
25943,drugs,I-NAME_OF_DRUG,1272
25944,may,O,1272
25945,counteract,O,1273
25946,the,O,1273
25947,hypotensive,O,1273
25948,effect,O,1273
25949,of,O,1273
25950,some,O,1273
25951,glaucoma,B-NAME_OF_DISEASE,1273
25952,medications,O,1273
25953,such,O,1273
25954,as,O,1273
25955,brimonidine,B-NAME_OF_DRUG,1273
25956,Educate,O,1273
25957,patients,O,1273
25958,of,O,1274
25959,the,O,1274
25960,risk,O,1274
25961,of,O,1274
25962,steroid,B-NAME_OF_DRUG,1274
25963,response,O,1274
25964,and,O,1274
25965,glaucoma,B-NAME_OF_DISEASE,1274
25966,as,O,1274
25967,well,O,1274
25968,as,O,1275
25969,cataract,B-NAME_OF_DISEASE,1275
25970,at,O,1275
25971,each,O,1275
25972,visit,O,1275
25973,Development,O,1275
25974,of,O,1275
25975,steroid,B-NAME_OF_DRUG,1275
25976,response,O,1275
25977,can,O,1275
25978,be,O,1275
25979,unpredictable,O,1275
25980,Patients,O,1275
25981,who,O,1275
25982,have,O,1275
25983,been,O,1275
25984,on,O,1275
25985,chronic,B-NAME_OF_DRUG,1276
25986,steroids,B-NAME_OF_DRUG,1276
25987,without,O,1276
25988,IOP,O,1276
25989,elevation,O,1276
25990,can,O,1276
25991,still,O,1276
25992,develop,O,1276
25993,steroid,B-NAME_OF_DRUG,1276
25994,response,O,1276
25995,later,O,1276
25996,in,O,1276
25997,their,O,1276
25998,course,O,1276
25999,Periodic,B-DIAGNOSTIC_TEST,1276
26000,monitoring,I-DIAGNOSTIC_TEST,1276
26001,of,I-DIAGNOSTIC_TEST,1276
26002,IOP,I-DIAGNOSTIC_TEST,1277
26003,in,O,1277
26004,all,O,1277
26005,patients,O,1277
26006,on,O,1277
26007,steroids,B-NAME_OF_DRUG,1277
26008,is,O,1277
26009,essential,O,1277
26010,even,O,1277
26011,without,O,1277
26012,a,O,1277
26013,history,O,1277
26014,of,O,1277
26015,IOP,O,1277
26016,elevation,O,1277
26017,and,O,1277
26018,or,O,1277
26019,inactive,O,1277
26020,disease,O,1277
26021,If,O,1278
26022,the,O,1278
26023,patient,O,1278
26024,is,O,1278
26025,on,O,1278
26026,any,O,1278
26027,steroid,B-NAME_OF_DRUG,1278
26028,the,B-DIAGNOSTIC_TEST,1278
26029,eye,I-DIAGNOSTIC_TEST,1278
26030,pressure,I-DIAGNOSTIC_TEST,1278
26031,should,O,1278
26032,be,O,1278
26033,monitored,O,1278
26034,at,O,1278
26035,a,O,1278
26036,minimum,O,1278
26037,of,O,1279
26038,every,O,1279
26039,6,B-TIME_DURATION,1279
26040,months,I-TIME_DURATION,1279
26041,even,O,1279
26042,if,O,1279
26043,the,O,1279
26044,pressure,O,1279
26045,has,O,1279
26046,been,O,1279
26047,well,O,1279
26048,controlled,O,1279
26049,If,O,1280
26050,the,O,1280
26051,patient,O,1280
26052,is,O,1280
26053,unable,O,1280
26054,to,O,1280
26055,be,O,1280
26056,tapered,O,1280
26057,off,O,1280
26058,topical,B-NAME_OF_DRUG,1280
26059,steroids,I-NAME_OF_DRUG,1280
26060,and,O,1280
26061,continues,O,1280
26062,to,O,1280
26063,have,O,1280
26064,uncontrolled,O,1280
26065,IOP,O,1280
26066,or,O,1280
26067,the,O,1280
26068,patient,O,1280
26069,is,O,1280
26070,found,O,1280
26071,to,O,1280
26072,have,O,1280
26073,concern,O,1280
26074,for,O,1280
26075,underlying,O,1280
26076,systemic,B-NAME_OF_DISEASE,1280
26077,autoimmune,I-NAME_OF_DISEASE,1280
26078,disease,I-NAME_OF_DISEASE,1281
26079,we,O,1281
26080,refer,O,1281
26081,the,O,1281
26082,patient,O,1281
26083,to,O,1281
26084,a,O,1281
26085,rheumatologist,O,1281
26086,for,O,1281
26087,consideration,O,1281
26088,of,O,1281
26089,systemic,B-TREATMENT,1281
26090,immunosuppression,I-TREATMENT,1281
26091,This,O,1281
26092,is,O,1281
26093,done,O,1281
26094,early,O,1281
26095,to,O,1281
26096,provide,O,1281
26097,the,O,1281
26098,collaborating,O,1281
26099,rheumatologist,O,1281
26100,time,O,1281
26101,to,O,1281
26102,get,O,1281
26103,routine,O,1281
26104,labs,O,1281
26105,and,O,1282
26106,conduct,O,1282
26107,a,O,1282
26108,full,O,1282
26109,evaluation,O,1282
26110,When,O,1282
26111,the,O,1282
26112,patient,O,1283
26113,needs,O,1283
26114,systemic,B-TREATMENT,1283
26115,immunosuppression,I-TREATMENT,1283
26116,the,O,1283
26117,rheumatologist,O,1283
26118,can,O,1283
26119,be,O,1283
26120,ready,O,1283
26121,to,O,1283
26122,go,O,1283
26123,with,O,1283
26124,the,O,1283
26125,drug,O,1283
26126,and,O,1283
26127,prior,O,1284
26128,authorizations,O,1284
26129,Keep,O,1284
26130,in,O,1284
26131,mind,O,1284
26132,that,O,1284
26133,uncontrolled,O,1284
26134,glaucoma,B-NAME_OF_DISEASE,1284
26135,is,O,1284
26136,more,O,1284
26137,likely,O,1284
26138,to,O,1284
26139,cause,O,1285
26140,blindness,B-NAME_OF_DISEASE,1285
26141,than,O,1286
26142,uncontrolled,O,1286
26143,uveitis,B-NAME_OF_DISEASE,1286
26144,Systemic,O,1286
26145,immunosuppression,O,1286
26146,Oral,B-NAME_OF_DRUG,1286
26147,corticosteroids,B-NAME_OF_DRUG,1286
26148,may,O,1286
26149,be,O,1286
26150,considered,O,1286
26151,when,O,1286
26152,topical,B-NAME_OF_DRUG,1286
26153,corticosteroids,B-NAME_OF_DRUG,1286
26154,fail,O,1286
26155,to,O,1286
26156,control,O,1286
26157,intraocular,O,1287
26158,inflammation,O,1287
26159,or,O,1287
26160,in,O,1287
26161,the,O,1287
26162,perioperative,O,1287
26163,period,O,1287
26164,Education,O,1287
26165,regarding,O,1287
26166,side,O,1287
26167,effects,O,1287
26168,of,O,1287
26169,elevated,O,1287
26170,glucose,O,1287
26171,and,O,1287
26172,blood,O,1287
26173,pressure,O,1287
26174,gastritis,O,1287
26175,mood,O,1287
26176,swings,O,1287
26177,difficulty,O,1288
26178,sleeping,O,1288
26179,etc,O,1289
26180,is,O,1289
26181,key,O,1289
26182,especially,O,1289
26183,for,O,1289
26184,patients,O,1289
26185,with,O,1289
26186,diabetes,B-NAME_OF_DISEASE,1289
26187,and,O,1289
26188,hypertension,B-NAME_OF_DISEASE,1289
26189,Oral,B-NAME_OF_DRUG,1289
26190,steroids,I-NAME_OF_DRUG,1290
26191,are,O,1290
26192,typically,O,1290
26193,used,O,1290
26194,as,O,1290
26195,temporizing,O,1290
26196,agents,O,1290
26197,and,O,1290
26198,not,O,1290
26199,for,O,1290
26200,long-term,O,1290
26201,immunosuppression,O,1290
26202,because,O,1290
26203,of,O,1290
26204,the,O,1290
26205,side-effect,O,1290
26206,profile,O,1290
26207,Immunomodulatory,B-NAME_OF_DRUG,1290
26208,agents,I-NAME_OF_DRUG,1290
26209,have,O,1291
26210,a,O,1291
26211,significant,O,1291
26212,role,O,1291
26213,in,O,1291
26214,the,O,1291
26215,treatment,O,1291
26216,of,O,1291
26217,chronic,B-NAME_OF_DISEASE,1291
26218,noninfectious,I-NAME_OF_DISEASE,1291
26219,uveitis,B-NAME_OF_DISEASE,1291
26220,They,O,1291
26221,are,O,1291
26222,often,O,1291
26223,used,O,1291
26224,to,O,1291
26225,wean,O,1291
26226,patients,O,1291
26227,off,O,1291
26228,oral,B-NAME_OF_DRUG,1291
26229,steroids,I-NAME_OF_DRUG,1291
26230,and,O,1291
26231,to,O,1291
26232,reduce,O,1291
26233,risks,O,1291
26234,of,O,1291
26235,systemic,O,1291
26236,complications,O,1291
26237,of,O,1291
26238,corticosteroids,B-NAME_OF_DRUG,1292
26239,They,O,1292
26240,also,O,1292
26241,help,O,1292
26242,to,O,1292
26243,improve,O,1292
26244,long-term,O,1292
26245,control,O,1292
26246,of,O,1292
26247,uveitis,B-NAME_OF_DISEASE,1292
26248,and,O,1292
26249,thereby,O,1292
26250,glaucoma,B-NAME_OF_DISEASE,1292
26251,The,O,1293
26252,conventional,O,1293
26253,steroid-sparing,B-NAME_OF_DRUG,1293
26254,agents,I-NAME_OF_DRUG,1293
26255,include,O,1293
26256,antimetabolites,B-NAME_OF_DRUG,1293
26257,eg,O,1293
26258,methotrexate,B-NAME_OF_DRUG,1293
26259,mycophenolate,B-NAME_OF_DRUG,1293
26260,mofetil,I-NAME_OF_DRUG,1293
26261,and,O,1293
26262,azathioprine,B-NAME_OF_DRUG,1293
26263,and,O,1293
26264,T-cell,B-NAME_OF_DRUG,1293
26265,inhibitors,I-NAME_OF_DRUG,1293
26266,eg,O,1293
26267,cyclosporine,B-NAME_OF_DRUG,1294
26268,and,O,1294
26269,tacrolimus,B-NAME_OF_DRUG,1294
26270,however,O,1294
26271,these,O,1294
26272,medications,O,1294
26273,may,O,1294
26274,fail,O,1294
26275,to,O,1294
26276,control,O,1294
26277,uveitis,B-NAME_OF_DISEASE,1294
26278,in,O,1294
26279,up,O,1294
26280,to,O,1294
26281,40%,O,1294
26282,of,O,1294
26283,cases,O,1294
26284,Newer,O,1294
26285,classes,O,1294
26286,of,O,1294
26287,biologics,O,1294
26288,namely,O,1294
26289,the,O,1294
26290,TNF-α,B-NAME_OF_DRUG,1294
26291,inhibitors,I-NAME_OF_DRUG,1294
26292,have,O,1294
26293,shown,O,1294
26294,significant,O,1294
26295,success,O,1294
26296,in,O,1294
26297,the,O,1294
26298,treatment,O,1294
26299,of,O,1295
26300,chronic,B-NAME_OF_DISEASE,1295
26301,noninfectious,I-NAME_OF_DISEASE,1295
26302,uveitis,B-NAME_OF_DISEASE,1295
26303,Regular,O,1295
26304,communication,O,1295
26305,with,O,1295
26306,the,O,1295
26307,rheumatologist,O,1295
26308,is,O,1295
26309,essential,O,1295
26310,to,O,1295
26311,monitor,O,1295
26312,systemic,O,1296
26313,side,O,1296
26314,effects,O,1296
26315,SURGICAL,O,1296
26316,MANAGEMENT,O,1296
26317,When,O,1296
26318,it,O,1296
26319,s,O,1296
26320,required,O,1296
26321,-,O,1296
26322,Surgical,B-TREATMENT,1296
26323,intervention,I-TREATMENT,1296
26324,may,O,1296
26325,be,O,1296
26326,required,O,1296
26327,for,O,1296
26328,glaucoma,B-NAME_OF_DISEASE,1296
26329,when,O,1296
26330,medical,O,1296
26331,management,O,1296
26332,fails,O,1297
26333,to,O,1297
26334,control,O,1297
26335,IOP,O,1297
26336,The,O,1297
26337,success,O,1297
26338,of,O,1297
26339,surgery,O,1297
26340,depends,O,1297
26341,significantly,O,1297
26342,on,O,1297
26343,the,O,1297
26344,suppression,O,1297
26345,of,O,1297
26346,inflammation,O,1297
26347,during,O,1297
26348,the,O,1297
26349,perioperative,O,1297
26350,period,O,1297
26351,In,O,1297
26352,general,O,1297
26353,uveitic,B-NAME_OF_DISEASE,1297
26354,glaucoma,I-NAME_OF_DISEASE,1297
26355,patients,O,1297
26356,have,O,1297
26357,lower,O,1298
26358,success,O,1298
26359,rates,O,1298
26360,with,O,1298
26361,glaucoma,B-NAME_OF_DISEASE,1298
26362,surgical,B-TREATMENT,1298
26363,interventions,I-TREATMENT,1298
26364,Uveitic,B-NAME_OF_DISEASE,1298
26365,glaucoma,I-NAME_OF_DISEASE,1298
26366,patients,O,1298
26367,also,O,1298
26368,have,O,1298
26369,higher,O,1298
26370,rates,O,1298
26371,of,O,1298
26372,hypotony,B-NAME_OF_DISEASE,1298
26373,postoperatively,O,1298
26374,The,O,1298
26375,goal,O,1298
26376,is,O,1298
26377,to,O,1298
26378,not,O,1298
26379,have,O,1298
26380,to,O,1298
26381,perform,O,1298
26382,a,B-TREATMENT,1298
26383,glaucoma,I-TREATMENT,1298
26384,surgery,I-TREATMENT,1298
26385,while,O,1298
26386,the,O,1299
26387,patient,O,1299
26388,is,O,1299
26389,actively,O,1299
26390,inflamed,O,1299
26391,Oral,B-TREATMENT,1299
26392,glaucoma,I-TREATMENT,1299
26393,medications,I-TREATMENT,1299
26394,can,O,1299
26395,be,O,1299
26396,used,O,1299
26397,to,O,1299
26398,help,O,1299
26399,get,O,1299
26400,patients,O,1299
26401,through,O,1299
26402,their,O,1299
26403,active,O,1299
26404,uveitis,B-NAME_OF_DISEASE,1299
26405,phase,O,1300
26406,until,O,1300
26407,surgery,O,1300
26408,If,O,1300
26409,surgery,O,1300
26410,must,O,1300
26411,be,O,1300
26412,performed,O,1300
26413,in,O,1300
26414,an,O,1300
26415,actively,O,1301
26416,inflamed,O,1301
26417,eye,O,1301
26418,perioperative,B-NAME_OF_DRUG,1301
26419,steroids,B-NAME_OF_DRUG,1301
26420,are,O,1301
26421,essential,O,1301
26422,to,O,1301
26423,moderate,O,1301
26424,postoperative,O,1301
26425,inflammatory,O,1301
26426,response,O,1301
26427,Even,O,1301
26428,in,O,1301
26429,cases,O,1301
26430,of,O,1301
26431,quiesced,O,1301
26432,eye,O,1301
26433,perioperative,O,1301
26434,immunosuppression,O,1301
26435,is,O,1301
26436,key,O,1301
26437,to,O,1301
26438,moderating,O,1301
26439,any,O,1301
26440,postoperative,O,1301
26441,inflammatory,O,1301
26442,response,O,1301
26443,This,O,1301
26444,can,O,1301
26445,be,O,1301
26446,in,O,1301
26447,the,O,1301
26448,form,O,1301
26449,of,O,1301
26450,periocular,B-NAME_OF_DRUG,1301
26451,steroids,B-NAME_OF_DRUG,1302
26452,or,O,1302
26453,oral,B-NAME_OF_DRUG,1302
26454,steroids,B-NAME_OF_DRUG,1302
26455,In,O,1302
26456,urgent,O,1302
26457,or,O,1302
26458,emergent,O,1302
26459,cases,O,1302
26460,where,O,1302
26461,we,O,1302
26462,do,O,1302
26463,not,O,1302
26464,have,O,1303
26465,the,O,1303
26466,time,O,1303
26467,to,O,1303
26468,fully,O,1303
26469,quiet,O,1303
26470,the,O,1303
26471,eye,O,1303
26472,higher,O,1303
26473,doses,O,1303
26474,of,O,1303
26475,steroids,B-NAME_OF_DRUG,1304
26476,may,O,1304
26477,be,O,1304
26478,required,O,1304
26479,with,O,1304
26480,a,O,1304
26481,slower,O,1304
26482,postoperative,O,1304
26483,taper,O,1304
26484,Undesirable,O,1304
26485,interventions,O,1305
26486,Other,O,1305
26487,more,O,1305
26488,common,O,1305
26489,bridging,O,1305
26490,interventions,O,1305
26491,between,O,1305
26492,medical,O,1305
26493,therapy,O,1305
26494,and,O,1305
26495,surgery,O,1305
26496,such,O,1305
26497,as,O,1305
26498,selective,B-TREATMENT,1306
26499,laser,I-TREATMENT,1306
26500,trabeculoplasty,I-TREATMENT,1306
26501,and,O,1306
26502,cyclophotocoagulation,B-TREATMENT,1306
26503,are,O,1306
26504,pro-inflammatory,O,1306
26505,and,O,1306
26506,not,O,1306
26507,preferred,O,1306
26508,for,O,1306
26509,uveitic,B-NAME_OF_DISEASE,1306
26510,glaucoma,I-NAME_OF_DISEASE,1306
26511,They,O,1306
26512,include,O,1306
26513,Nd,B-TREATMENT,1306
26514,YAG,I-TREATMENT,1306
26515,laser,I-TREATMENT,1306
26516,peripheral,I-TREATMENT,1306
26517,iridotomy,I-TREATMENT,1306
26518,This,O,1306
26519,may,O,1306
26520,be,O,1306
26521,indicated,O,1306
26522,for,O,1306
26523,acute,B-SIGN_AND_SYMPTOM,1306
26524,angle,I-SIGN_AND_SYMPTOM,1306
26525,closure,I-SIGN_AND_SYMPTOM,1306
26526,secondary,O,1306
26527,to,O,1306
26528,extensive,B-SIGN_AND_SYMPTOM,1306
26529,PS,I-SIGN_AND_SYMPTOM,1306
26530,and,O,1307
26531,iris,B-SIGN_AND_SYMPTOM,1307
26532,bombé,I-SIGN_AND_SYMPTOM,1307
26533,Multiple,O,1307
26534,and,O,1307
26535,large,O,1307
26536,iridotomies,B-PART_OF_THE_EYES,1307
26537,may,O,1307
26538,be,O,1307
26539,required,O,1307
26540,due,O,1307
26541,to,O,1307
26542,closure,O,1307
26543,from,O,1307
26544,inflammation,O,1307
26545,Cycloablative,B-TREATMENT,1307
26546,procedures,I-TREATMENT,1307
26547,Either,O,1307
26548,transscleral,O,1307
26549,or,O,1307
26550,intraocular,O,1307
26551,these,O,1307
26552,procedures,O,1307
26553,can,O,1307
26554,exacerbate,O,1307
26555,inflammation,O,1307
26556,cause,O,1307
26557,hypotony,B-TREATMENT,1307
26558,and,O,1307
26559,lead,O,1307
26560,to,O,1307
26561,phthisis,B-TREATMENT,1307
26562,bulbi,I-TREATMENT,1307
26563,Thus,O,1307
26564,they,O,1307
26565,should,O,1307
26566,be,O,1307
26567,used,O,1307
26568,only,O,1307
26569,as,O,1307
26570,a,O,1307
26571,last,O,1307
26572,resort,O,1307
26573,for,O,1307
26574,refractory,B-TREATMENT,1307
26575,uveitic,I-TREATMENT,1307
26576,glaucoma,I-TREATMENT,1307
26577,and,O,1307
26578,treatment,O,1307
26579,must,O,1307
26580,be,O,1307
26581,carefully,O,1307
26582,titrated,O,1307
26583,Laser,B-TREATMENT,1307
26584,trabeculoplasty,I-TREATMENT,1307
26585,This,O,1307
26586,is,O,1307
26587,not,O,1307
26588,recommended,O,1307
26589,in,O,1307
26590,uveitic,B-NAME_OF_DISEASE,1307
26591,glaucoma,I-NAME_OF_DISEASE,1307
26592,because,O,1307
26593,of,O,1307
26594,angle,O,1307
26595,alteration,O,1307
26596,This,O,1307
26597,modality,O,1307
26598,especially,O,1307
26599,with,O,1307
26600,use,O,1307
26601,of,O,1307
26602,argon-based,B-TREATMENT,1307
26603,lasers,I-TREATMENT,1307
26604,has,O,1307
26605,the,O,1307
26606,potential,O,1308
26607,to,O,1308
26608,induce,O,1308
26609,inflammation,O,1308
26610,and,O,1308
26611,damage,O,1308
26612,the,B-PART_OF_THE_EYES,1308
26613,trabecular,I-PART_OF_THE_EYES,1308
26614,meshwork,I-PART_OF_THE_EYES,1308
26615,Minimally,B-TREATMENT,1308
26616,invasive,I-TREATMENT,1308
26617,glaucoma,I-TREATMENT,1308
26618,surgery,I-TREATMENT,1308
26619,MIGS,B-TREATMENT,1308
26620,-,O,1308
26621,The,O,1308
26622,use,O,1308
26623,of,O,1308
26624,MIGS,B-TREATMENT,1308
26625,is,O,1308
26626,becoming,O,1308
26627,popular,O,1308
26628,in,O,1308
26629,the,O,1308
26630,treatment,O,1308
26631,of,O,1308
26632,POAG,B-NAME_OF_DISEASE,1308
26633,and,O,1308
26634,is,O,1309
26635,under,O,1309
26636,evaluation,O,1309
26637,for,O,1309
26638,uveitic,B-NAME_OF_DISEASE,1309
26639,glaucoma,I-NAME_OF_DISEASE,1309
26640,patients,O,1309
26641,with,O,1309
26642,open,B-SIGN_AND_SYMPTOM,1309
26643,angles,I-SIGN_AND_SYMPTOM,1309
26644,Ab,B-TREATMENT,1309
26645,interno,I-TREATMENT,1309
26646,trabeculotomy,I-TREATMENT,1309
26647,increases,O,1309
26648,trabecular,O,1309
26649,outflow,O,1309
26650,by,O,1309
26651,removing,O,1309
26652,part,O,1309
26653,of,O,1309
26654,the,B-PART_OF_THE_EYES,1309
26655,trabecular,I-PART_OF_THE_EYES,1309
26656,meshwork,I-PART_OF_THE_EYES,1310
26657,These,O,1310
26658,procedures,O,1310
26659,may,O,1310
26660,have,O,1310
26661,an,O,1310
26662,advantage,O,1310
26663,over,O,1310
26664,small-lumen,O,1310
26665,devices,O,1310
26666,that,O,1310
26667,may,O,1310
26668,become,O,1310
26669,obstructed,O,1310
26670,from,O,1310
26671,inflammatory,O,1310
26672,debris,O,1310
26673,Canaloplasty,B-TREATMENT,1310
26674,may,O,1310
26675,be,O,1310
26676,of,O,1310
26677,special,O,1310
26678,interest,O,1310
26679,in,O,1311
26680,these,O,1311
26681,cases,O,1311
26682,because,O,1311
26683,this,O,1311
26684,procedure,O,1311
26685,dilates,O,1311
26686,and,O,1311
26687,maintains,O,1311
26688,a,O,1311
26689,patent,O,1311
26690,canal,B-PART_OF_THE_EYES,1311
26691,of,I-PART_OF_THE_EYES,1311
26692,Schlemm,I-PART_OF_THE_EYES,1311
26693,expanding,O,1311
26694,the,O,1311
26695,intertrabecular,O,1311
26696,spaces,O,1312
26697,that,O,1312
26698,are,O,1312
26699,compromised,O,1312
26700,as,O,1312
26701,a,O,1312
26702,result,O,1312
26703,of,O,1312
26704,glucocorticoids,B-NAME_OF_DRUG,1312
26705,More,O,1312
26706,investigation,O,1312
26707,is,O,1312
26708,necessary,O,1312
26709,in,O,1312
26710,regard,O,1312
26711,to,O,1312
26712,efficacy,O,1312
26713,in,O,1312
26714,patients,O,1312
26715,with,O,1312
26716,uveitic,B-NAME_OF_DISEASE,1312
26717,glaucoma,I-NAME_OF_DISEASE,1312
26718,Glaucoma,B-NAME_OF_DISEASE,1312
26719,drainage,I-TREATMENT,1312
26720,devices,I-TREATMENT,1312
26721,Glaucoma,B-NAME_OF_DISEASE,1312
26722,drainage,I-TREATMENT,1312
26723,devices,I-TREATMENT,1312
26724,are,O,1313
26725,the,O,1313
26726,preferred,O,1313
26727,first-line,O,1313
26728,surgery,O,1313
26729,in,O,1313
26730,uveitic,B-NAME_OF_DISEASE,1313
26731,glaucoma,B-NAME_OF_DISEASE,1313
26732,especially,O,1313
26733,in,O,1313
26734,cases,O,1313
26735,with,O,1313
26736,active,O,1313
26737,inflammation,O,1313
26738,The,B-TREATMENT,1313
26739,Ahmed,I-TREATMENT,1313
26740,Glaucoma,B-NAME_OF_DISEASE,1313
26741,Valve,I-TREATMENT,1313
26742,AGV,B-TREATMENT,1313
26743,is,O,1313
26744,often,O,1313
26745,favored,O,1313
26746,because,O,1313
26747,of,O,1313
26748,its,O,1313
26749,immediate,O,1313
26750,action,O,1313
26751,and,O,1313
26752,its,O,1313
26753,unidirectional,O,1313
26754,valve,O,1313
26755,mechanism,O,1313
26756,which,O,1313
26757,lowers,O,1313
26758,the,O,1313
26759,risk,O,1313
26760,of,O,1313
26761,postoperative,O,1313
26762,hypotony,B-NAME_OF_DISEASE,1313
26763,If,O,1314
26764,an,O,1314
26765,eye,O,1314
26766,can,O,1314
26767,tolerate,O,1314
26768,high,O,1314
26769,IOP,O,1314
26770,for,B-TIME_DURATION,1314
26771,6-Apr,I-TIME_DURATION,1314
26772,weeks,I-TIME_DURATION,1314
26773,a,B-TREATMENT,1314
26774,Baerveldt,B-TREATMENT,1314
26775,tube,I-TREATMENT,1314
26776,can,O,1314
26777,be,O,1314
26778,considered,O,1314
26779,because,O,1314
26780,it,O,1314
26781,has,O,1314
26782,a,O,1314
26783,lower,O,1314
26784,rate,O,1314
26785,of,O,1314
26786,reoperation,O,1314
26787,and,O,1314
26788,possible,O,1314
26789,lower,O,1314
26790,longterm,O,1314
26791,IOP,O,1314
26792,Although,O,1314
26793,no,O,1314
26794,investigations,O,1314
26795,have,O,1314
26796,formally,O,1314
26797,compared,O,1314
26798,AGV,B-TREATMENT,1314
26799,to,O,1314
26800,Baerveldt,B-TREATMENT,1314
26801,in,O,1314
26802,uveitic,B-NAME_OF_DISEASE,1314
26803,glaucoma,B-NAME_OF_DISEASE,1314
26804,studies,O,1314
26805,have,O,1314
26806,shown,O,1314
26807,positive,O,1315
26808,outcomes,O,1315
26809,for,O,1315
26810,both,O,1315
26811,Trabeculectomy,B-TREATMENT,1315
26812,Trabeculectomy,B-TREATMENT,1315
26813,should,O,1315
26814,be,O,1315
26815,avoided,O,1315
26816,in,O,1315
26817,eyes,O,1315
26818,with,O,1315
26819,active,O,1315
26820,inflammation,O,1315
26821,However,O,1315
26822,in,O,1315
26823,eyes,O,1315
26824,with,O,1315
26825,well-controlled,O,1315
26826,uveitis,B-NAME_OF_DISEASE,1315
26827,standard,B-TREATMENT,1315
26828,trabeculectomy,I-TREATMENT,1315
26829,or,O,1315
26830,the,B-TREATMENT,1315
26831,Ex-Press,I-TREATMENT,1315
26832,glaucoma,B-NAME_OF_DISEASE,1315
26833,filtration,I-TREATMENT,1315
26834,device,I-TREATMENT,1315
26835,Alcon,I-TREATMENT,1315
26836,with,O,1315
26837,anti-metabolite,B-NAME_OF_DRUG,1316
26838,agents,I-NAME_OF_DRUG,1316
26839,such,O,1316
26840,as,O,1316
26841,5-fluorouracil,B-NAME_OF_DRUG,1317
26842,and,O,1317
26843,mitomycin,B-NAME_OF_DRUG,1317
26844,C,I-NAME_OF_DRUG,1317
26845,which,O,1317
26846,help,O,1317
26847,minimize,O,1317
26848,excessive,O,1317
26849,scarring,O,1317
26850,and,O,1317
26851,decrease,O,1317
26852,failure,O,1317
26853,rates,O,1317
26854,can,O,1317
26855,be,O,1317
26856,considered,O,1317
26857,Glaucoma,B-NAME_OF_DISEASE,1317
26858,secondary,O,1317
26859,to,O,1317
26860,ocular,B-NAME_OF_DISEASE,1317
26861,inflammation,I-NAME_OF_DISEASE,1317
26862,is,O,1317
26863,potentially,O,1317
26864,blinding,O,1317
26865,and,O,1317
26866,requires,O,1317
26867,aggressive,O,1317
26868,multifaceted,O,1317
26869,management,O,1317
26870,Early,O,1317
26871,education,O,1317
26872,and,O,1317
26873,counseling,O,1317
26874,are,O,1317
26875,key,O,1317
26876,for,O,1317
26877,compliance,O,1317
26878,and,O,1318
26879,expectation,O,1318
26880,setting,O,1318
26881,Collaboration,O,1318
26882,is,O,1318
26883,often,O,1318
26884,required,O,1318
26885,with,O,1318
26886,uveitis,B-NAME_OF_DISEASE,1318
26887,glaucoma,B-NAME_OF_DISEASE,1318
26888,and,O,1318
26889,rheumatology,O,1318
26890,specialists,O,1318
26891,Increased,O,1318
26892,medical,B-TREATMENT,1318
26893,and,I-TREATMENT,1318
26894,surgical,I-TREATMENT,1318
26895,interventions,I-TREATMENT,1318
26896,are,O,1318
26897,also,O,1318
26898,creating,O,1318
26899,new,O,1318
26900,opportunities,O,1318
26901,for,O,1318
26902,vision,O,1318
26903,preservation,O,1319
26904,Inherited,B-NAME_OF_DISEASE,1319
26905,retinal,I-NAME_OF_DISEASE,1319
26906,diseases,I-NAME_OF_DISEASE,1319
26907,IRDs,B-NAME_OF_DISEASE,1319
26908,also,O,1319
26909,referred,O,1319
26910,to,O,1319
26911,as,O,1319
26912,inherited,B-NAME_OF_DISEASE,1319
26913,retinal,I-NAME_OF_DISEASE,1319
26914,dystrophies,I-NAME_OF_DISEASE,1319
26915,are,O,1319
26916,a,O,1319
26917,clinically,O,1319
26918,and,O,1319
26919,genetically,O,1319
26920,heterogeneous,O,1319
26921,group,O,1319
26922,of,O,1319
26923,neurodegenerative,O,1319
26924,disorders,O,1319
26925,primarily,O,1319
26926,involving,O,1319
26927,photoreceptors,B-PART_OF_THE_EYES,1319
26928,retinal,B-PART_OF_THE_EYES,1319
26929,pigment,I-PART_OF_THE_EYES,1319
26930,epithelium,I-PART_OF_THE_EYES,1319
26931,RPE,I-PART_OF_THE_EYES,1319
26932,and,O,1320
26933,or,O,1320
26934,the,B-PART_OF_THE_EYES,1320
26935,choroid,I-PART_OF_THE_EYES,1320
26936,Taken,O,1320
26937,as,O,1320
26938,a,O,1320
26939,whole,O,1320
26940,IRDs,B-NAME_OF_DISEASE,1320
26941,have,O,1320
26942,an,O,1320
26943,estimated,O,1320
26944,global,O,1320
26945,prevalence,O,1320
26946,of,O,1320
26947,about,O,1320
26948,1,O,1320
26949,in,O,1320
26950,2,O,1320
26951,0,O,1320
26952,individuals,O,1320
26953,affecting,O,1320
26954,more,O,1321
26955,than,O,1321
26956,two,O,1321
26957,million,O,1321
26958,people,O,1321
26959,worldwide,O,1321
26960,and,O,1321
26961,standing,O,1321
26962,out,O,1321
26963,as,O,1321
26964,the,O,1321
26965,leading,O,1321
26966,cause,O,1321
26967,of,O,1321
26968,blindness,B-NAME_OF_DISEASE,1321
26969,in,O,1321
26970,the,O,1321
26971,Western,O,1321
26972,working-age,O,1322
26973,population,O,1322
26974,AGTC-501,B-TREATMENT,1322
26975,Applied,I-TREATMENT,1322
26976,Genetic,I-TREATMENT,1322
26977,Technologies,I-TREATMENT,1322
26978,Corporation,I-TREATMENT,1322
26979,a,O,1322
26980,novel,O,1322
26981,gene,O,1322
26982,therapy,O,1322
26983,in,O,1322
26984,development,O,1322
26985,for,O,1322
26986,the,O,1322
26987,potential,O,1322
26988,treatment,O,1323
26989,of,O,1323
26990,X-linked,B-NAME_OF_DISEASE,1323
26991,retinitis,I-NAME_OF_DISEASE,1323
26992,pigmentosa,I-NAME_OF_DISEASE,1323
26993,RP,B-NAME_OF_DISEASE,1323
26994,showed,O,1323
26995,an,O,1323
26996,acceptable,O,1323
26997,safety,O,1323
26998,profile,O,1323
26999,and,O,1323
27000,visual,O,1323
27001,function,O,1323
27002,improvements,O,1323
27003,when,O,1323
27004,administered,O,1323
27005,in,O,1323
27006,the,O,1323
27007,study,O,1323
27008,s,O,1323
27009,higher,O,1323
27010,dose,O,1323
27011,groups,O,1323
27012,Patients,O,1323
27013,with,O,1323
27014,X-linked,B-NAME_OF_DISEASE,1323
27015,RP,B-NAME_OF_DISEASE,1323
27016,an,B-NAME_OF_DISEASE,1323
27017,inherited,I-NAME_OF_DISEASE,1323
27018,retinal,I-NAME_OF_DISEASE,1324
27019,disease,I-NAME_OF_DISEASE,1324
27020,that,O,1324
27021,begins,O,1324
27022,in,O,1324
27023,childhood,O,1324
27024,are,O,1324
27025,characterized,O,1324
27026,by,O,1324
27027,night,B-NAME_OF_DISEASE,1324
27028,blindness,I-NAME_OF_DISEASE,1324
27029,progressive,B-SIGN_AND_SYMPTOM,1324
27030,loss,I-SIGN_AND_SYMPTOM,1324
27031,of,I-SIGN_AND_SYMPTOM,1324
27032,peripheral,I-SIGN_AND_SYMPTOM,1324
27033,vision,I-SIGN_AND_SYMPTOM,1324
27034,and,O,1324
27035,eventual,B-SIGN_AND_SYMPTOM,1324
27036,loss,I-SIGN_AND_SYMPTOM,1324
27037,of,I-SIGN_AND_SYMPTOM,1324
27038,central,I-SIGN_AND_SYMPTOM,1324
27039,vision,I-SIGN_AND_SYMPTOM,1324
27040,Affected,O,1324
27041,patients,O,1324
27042,have,O,1324
27043,access,O,1324
27044,to,O,1324
27045,only,O,1325
27046,1,O,1325
27047,approved,O,1325
27048,treatment,O,1325
27049,voretigene,B-NAME_OF_DRUG,1325
27050,neparvovec-rzyl,I-NAME_OF_DRUG,1325
27051,Luxturna,I-NAME_OF_DRUG,1325
27052,Spark,I-NAME_OF_DRUG,1325
27053,Therapeutics,I-NAME_OF_DRUG,1325
27054,for,O,1325
27055,RPE65,B-CHEMICAL_COMPOUND,1325
27056,which,O,1325
27057,represents,O,1325
27058,about,O,1325
27059,1%,O,1325
27060,of,O,1325
27061,RP,B-NAME_OF_DISEASE,1325
27062,About,O,1325
27063,X-linked,B-NAME_OF_DISEASE,1325
27064,Retinitis,I-NAME_OF_DISEASE,1325
27065,Pigmentosa,I-NAME_OF_DISEASE,1325
27066,XLRP,B-NAME_OF_DISEASE,1325
27067,X-linked,B-NAME_OF_DISEASE,1325
27068,Retinitis,I-NAME_OF_DISEASE,1325
27069,Pigmentosa,I-NAME_OF_DISEASE,1325
27070,XLRP,B-NAME_OF_DISEASE,1325
27071,is,O,1325
27072,an,O,1325
27073,inherited,O,1325
27074,condition,O,1325
27075,that,O,1325
27076,causes,O,1325
27077,progressive,B-SIGN_AND_SYMPTOM,1325
27078,vision,I-SIGN_AND_SYMPTOM,1325
27079,loss,I-SIGN_AND_SYMPTOM,1325
27080,in,I-SIGN_AND_SYMPTOM,1325
27081,boys,I-SIGN_AND_SYMPTOM,1325
27082,and,I-SIGN_AND_SYMPTOM,1325
27083,young,I-SIGN_AND_SYMPTOM,1325
27084,men,I-SIGN_AND_SYMPTOM,1325
27085,Characteristics,O,1326
27086,of,O,1326
27087,the,O,1326
27088,disease,O,1326
27089,include,O,1326
27090,night,B-SIGN_AND_SYMPTOM,1326
27091,blindness,B-NAME_OF_DISEASE,1326
27092,in,I-SIGN_AND_SYMPTOM,1326
27093,early,I-SIGN_AND_SYMPTOM,1326
27094,childhood,I-SIGN_AND_SYMPTOM,1326
27095,and,I-SIGN_AND_SYMPTOM,1327
27096,progressive,I-SIGN_AND_SYMPTOM,1327
27097,constriction,I-SIGN_AND_SYMPTOM,1327
27098,of,I-SIGN_AND_SYMPTOM,1327
27099,the,I-SIGN_AND_SYMPTOM,1327
27100,visual,I-SIGN_AND_SYMPTOM,1327
27101,field,I-SIGN_AND_SYMPTOM,1327
27102,In,O,1327
27103,general,O,1327
27104,XLRP,B-NAME_OF_DISEASE,1327
27105,patients,O,1327
27106,experience,O,1327
27107,a,B-SIGN_AND_SYMPTOM,1327
27108,gradual,I-SIGN_AND_SYMPTOM,1327
27109,decline,I-SIGN_AND_SYMPTOM,1327
27110,in,I-SIGN_AND_SYMPTOM,1327
27111,visual,I-SIGN_AND_SYMPTOM,1327
27112,acuity,I-SIGN_AND_SYMPTOM,1327
27113,over,O,1327
27114,the,O,1327
27115,disease,O,1327
27116,course,O,1327
27117,which,O,1327
27118,results,O,1327
27119,in,O,1327
27120,legal,O,1327
27121,blindness,B-NAME_OF_DISEASE,1327
27122,around,O,1327
27123,the,O,1327
27124,4th,O,1327
27125,or,O,1327
27126,5th,O,1327
27127,decade,O,1327
27128,of,O,1327
27129,life,O,1327
27130,About,O,1327
27131,AGTC-501,B-TREATMENT,1327
27132,AGTC-501,B-TREATMENT,1327
27133,laruparetigene,I-TREATMENT,1327
27134,zosaparvovec,I-TREATMENT,1327
27135,the,O,1327
27136,Company,O,1328
27137,s,O,1328
27138,lead,O,1328
27139,gene,O,1328
27140,therapy,O,1328
27141,development,O,1328
27142,program,O,1328
27143,uses,O,1328
27144,an,O,1328
27145,engineered,O,1328
27146,AAV,B-CHEMICAL_COMPOUND,1328
27147,vector,O,1328
27148,to,O,1328
27149,insert,O,1328
27150,a,O,1328
27151,stabilized,O,1328
27152,and,O,1328
27153,functional,O,1328
27154,copy,O,1328
27155,of,O,1328
27156,the,B-CHEMICAL_COMPOUND,1328
27157,Retinitis,I-CHEMICAL_COMPOUND,1328
27158,Pigmentosa,I-CHEMICAL_COMPOUND,1328
27159,GTSase,I-CHEMICAL_COMPOUND,1328
27160,Regulator,I-CHEMICAL_COMPOUND,1329
27161,RPGR,B-CHEMICAL_COMPOUND,1329
27162,gene,I-CHEMICAL_COMPOUND,1329
27163,into,O,1329
27164,a,O,1329
27165,patient,O,1329
27166,s,O,1329
27167,photoreceptor,B-PART_OF_THE_EYES,1329
27168,cells,I-PART_OF_THE_EYES,1329
27169,AGTC-501,B-TREATMENT,1329
27170,is,O,1329
27171,comprised,O,1329
27172,of,O,1330
27173,that,O,1330
27174,stabilized,O,1330
27175,RPGR,B-CHEMICAL_COMPOUND,1330
27176,gene,I-CHEMICAL_COMPOUND,1330
27177,and,O,1330
27178,a,O,1330
27179,promoter,O,1330
27180,that,O,1330
27181,was,O,1330
27182,specifically,O,1330
27183,selected,O,1330
27184,due,O,1330
27185,to,O,1330
27186,its,O,1330
27187,ability,O,1330
27188,to,O,1330
27189,drive,O,1330
27190,efficient,O,1330
27191,gene,O,1330
27192,expression,O,1330
27193,in,O,1330
27194,rods,O,1330
27195,and,O,1330
27196,cones,O,1330
27197,maintain,O,1330
27198,photoreceptor,B-PART_OF_THE_EYES,1330
27199,function,O,1330
27200,and,O,1331
27201,delay,O,1331
27202,disease,O,1331
27203,progression,O,1331
27204,in,O,1331
27205,large,O,1331
27206,animal,O,1331
27207,naturally,O,1331
27208,occurring,O,1331
27209,preclinical,O,1331
27210,models,O,1331
27211,of,O,1331
27212,XLRP,B-NAME_OF_DISEASE,1331
27213,In,O,1331
27214,addition,O,1331
27215,published,O,1331
27216,NHP,O,1331
27217,studies,O,1331
27218,have,O,1332
27219,demonstrated,O,1332
27220,that,O,1332
27221,AGTC,B-ORGANIZATION,1332
27222,s,O,1332
27223,proprietary,O,1332
27224,AAV,B-CHEMICAL_COMPOUND,1332
27225,capsid,I-CHEMICAL_COMPOUND,1332
27226,has,O,1332
27227,as,O,1332
27228,much,O,1332
27229,as,O,1332
27230,twice,O,1332
27231,the,O,1332
27232,transfection,O,1332
27233,efficiency,O,1332
27234,in,O,1332
27235,photoreceptors,B-PART_OF_THE_EYES,1332
27236,compared,O,1332
27237,to,O,1332
27238,capsids,B-CHEMICAL_COMPOUND,1332
27239,used,O,1332
27240,in,O,1333
27241,competing,O,1333
27242,programs,O,1333
27243,AGTC,B-ORGANIZATION,1333
27244,was,O,1333
27245,granted,O,1333
27246,U.S,O,1333
27247,Food,B-ORGANIZATION,1333
27248,and,I-ORGANIZATION,1333
27249,Drug,I-ORGANIZATION,1333
27250,Administration,I-ORGANIZATION,1333
27251,FDA,I-ORGANIZATION,1333
27252,orphan,O,1333
27253,drug,O,1333
27254,designation,O,1333
27255,in,O,1333
27256,2017,O,1333
27257,as,O,1333
27258,well,O,1333
27259,as,O,1333
27260,European,O,1334
27261,Commission,O,1334
27262,orphan,O,1334
27263,medicinal,O,1334
27264,product,O,1334
27265,designation,O,1334
27266,in,O,1334
27267,2016,O,1334
27268,for,O,1334
27269,its,O,1334
27270,gene,O,1334
27271,therapy,O,1334
27272,product,O,1334
27273,candidate,O,1334
27274,to,O,1334
27275,treat,O,1334
27276,XLRP,B-NAME_OF_DISEASE,1334
27277,caused,O,1335
27278,by,O,1335
27279,mutations,B-CAUSE_OF_DISEASE,1335
27280,in,I-CAUSE_OF_DISEASE,1335
27281,the,I-CAUSE_OF_DISEASE,1335
27282,RPGR,I-CAUSE_OF_DISEASE,1335
27283,gene,I-CAUSE_OF_DISEASE,1335
27284,About,O,1335
27285,AGTC,B-ORGANIZATION,1335
27286,AGTC,B-ORGANIZATION,1335
27287,is,O,1335
27288,a,O,1336
27289,clinical-stage,O,1336
27290,biotechnology,O,1336
27291,company,O,1336
27292,developing,O,1336
27293,genetic,O,1336
27294,therapies,O,1336
27295,for,O,1336
27296,people,O,1336
27297,with,O,1336
27298,rare,O,1336
27299,and,O,1336
27300,debilitating,O,1336
27301,ophthalmic,B-NAME_OF_DISEASE,1336
27302,otologic,I-NAME_OF_DISEASE,1336
27303,and,I-NAME_OF_DISEASE,1336
27304,central,I-NAME_OF_DISEASE,1336
27305,nervous,I-NAME_OF_DISEASE,1336
27306,system,I-NAME_OF_DISEASE,1336
27307,CNS,I-NAME_OF_DISEASE,1336
27308,diseases,I-NAME_OF_DISEASE,1337
27309,AGTC,B-ORGANIZATION,1337
27310,is,O,1337
27311,a,O,1337
27312,leader,O,1337
27313,in,O,1337
27314,designing,O,1337
27315,and,O,1337
27316,constructing,O,1337
27317,all,O,1337
27318,critical,O,1337
27319,gene,O,1337
27320,therapy,O,1337
27321,elements,O,1337
27322,and,O,1337
27323,bringing,O,1337
27324,them,O,1337
27325,together,O,1337
27326,to,O,1337
27327,develop,O,1337
27328,customized,O,1337
27329,therapies,O,1338
27330,with,O,1338
27331,the,O,1338
27332,potential,O,1338
27333,to,O,1338
27334,address,O,1338
27335,real,O,1338
27336,patient,O,1338
27337,needs,O,1339
27338,AGTC,B-ORGANIZATION,1339
27339,s,O,1339
27340,most,O,1339
27341,advanced,O,1339
27342,clinical,O,1339
27343,programs,O,1339
27344,leverage,O,1339
27345,its,O,1339
27346,best-in-class,O,1339
27347,technology,O,1339
27348,platform,O,1339
27349,to,O,1339
27350,potentially,O,1339
27351,improve,O,1339
27352,vision,O,1339
27353,for,O,1339
27354,patients,O,1339
27355,with,O,1339
27356,an,O,1339
27357,inherited,O,1339
27358,retinal,O,1339
27359,disease,O,1339
27360,AGTC,B-ORGANIZATION,1339
27361,has,O,1339
27362,active,O,1339
27363,clinical,O,1339
27364,trials,O,1339
27365,in,O,1339
27366,X-linked,B-NAME_OF_DISEASE,1339
27367,retinitis,I-NAME_OF_DISEASE,1339
27368,pigmentosa,I-NAME_OF_DISEASE,1339
27369,XLRP,I-NAME_OF_DISEASE,1339
27370,and,O,1340
27371,achromatopsia,B-NAME_OF_DISEASE,1340
27372,ACHM,I-NAME_OF_DISEASE,1340
27373,CNGB3,I-NAME_OF_DISEASE,1340
27374,and,I-NAME_OF_DISEASE,1340
27375,ACHM,I-NAME_OF_DISEASE,1340
27376,CNGA3,I-NAME_OF_DISEASE,1340
27377,,O,1340
27378,Its,O,1340
27379,preclinical,O,1340
27380,programs,O,1340
27381,build,O,1340
27382,on,O,1340
27383,the,O,1340
27384,company,O,1340
27385,s,O,1340
27386,industry,O,1340
27387,leading,O,1340
27388,AAV,B-CHEMICAL_COMPOUND,1340
27389,manufacturing,O,1340
27390,technology,O,1340
27391,and,O,1340
27392,scientific,O,1340
27393,expertise,O,1340
27394,AGTC,B-ORGANIZATION,1340
27395,is,O,1340
27396,advancing,O,1340
27397,multiple,O,1341
27398,important,O,1341
27399,pipeline,O,1341
27400,candidates,O,1341
27401,to,O,1341
27402,address,O,1341
27403,substantial,O,1341
27404,unmet,O,1341
27405,clinical,O,1341
27406,need,O,1341
27407,in,O,1341
27408,optogenetics,B-NAME_OF_DISEASE,1341
27409,otology,I-NAME_OF_DISEASE,1341
27410,and,I-NAME_OF_DISEASE,1341
27411,CNS,I-NAME_OF_DISEASE,1341
27412,disorders,I-NAME_OF_DISEASE,1341
27413,and,O,1341
27414,has,O,1341
27415,entered,O,1341
27416,into,O,1341
27417,strategic,O,1341
27418,collaborations,O,1341
27419,with,O,1341
27420,companies,O,1341
27421,including,O,1341
27422,Otonomy,O,1342
27423,Inc,O,1342
27424,a,O,1342
27425,biopharmaceutical,O,1342
27426,company,O,1342
27427,dedicated,O,1342
27428,to,O,1342
27429,the,O,1342
27430,development,O,1342
27431,of,O,1342
27432,innovative,O,1342
27433,therapeutics,O,1342
27434,for,O,1342
27435,neurotology,O,1342
27436,and,O,1343
27437,Bionic,B-ORGANIZATION,1343
27438,Sight,I-ORGANIZATION,1343
27439,LLC,I-ORGANIZATION,1343
27440,an,O,1343
27441,innovator,O,1343
27442,in,O,1343
27443,the,O,1343
27444,emerging,O,1343
27445,field,O,1343
27446,of,O,1343
27447,optogenetics,O,1343
27448,and,O,1343
27449,retinal,O,1343
27450,coding,O,1343
27451,AGTC-501,B-TREATMENT,1344
27452,Applied,I-TREATMENT,1344
27453,Genetic,I-TREATMENT,1344
27454,Technologies,I-TREATMENT,1344
27455,Corporation,I-TREATMENT,1344
27456,a,O,1344
27457,novel,O,1344
27458,gene,O,1344
27459,therapy,O,1344
27460,in,O,1344
27461,development,O,1344
27462,for,O,1344
27463,the,O,1344
27464,potential,O,1344
27465,treatment,O,1344
27466,of,O,1344
27467,X-linked,B-NAME_OF_DISEASE,1344
27468,retinitis,I-NAME_OF_DISEASE,1344
27469,pigmentosa,I-NAME_OF_DISEASE,1344
27470,RP,B-NAME_OF_DISEASE,1344
27471,showed,O,1344
27472,an,O,1344
27473,acceptable,O,1345
27474,safety,O,1345
27475,profile,O,1345
27476,and,O,1345
27477,visual,O,1345
27478,function,O,1345
27479,improvements,O,1345
27480,in,O,1345
27481,the,O,1345
27482,study,O,1345
27483,s,O,1345
27484,higher,O,1345
27485,dose,O,1345
27486,groups,O,1345
27487,according,O,1345
27488,to,O,1345
27489,Robert,O,1345
27490,A,O,1345
27491,Sisk,B-PERSON,1345
27492,MD,O,1345
27493,FACS,O,1346
27494,from,O,1346
27495,the,B-ORGANIZATION,1346
27496,Cincinnati,I-ORGANIZATION,1346
27497,Eye,I-ORGANIZATION,1346
27498,Institute,I-ORGANIZATION,1346
27499,in,O,1346
27500,Ohio,B-GPE,1346
27501,Sisk,B-PERSON,1346
27502,outlined,O,1346
27503,the,O,1346
27504,safety,O,1346
27505,and,O,1346
27506,efficacy,O,1347
27507,findings,O,1347
27508,of,O,1347
27509,a,O,1347
27510,phase,O,1347
27511,1,O,1347
27512,2,O,1347
27513,study,O,1347
27514,of,O,1347
27515,AGTC-501,B-TREATMENT,1347
27516,gene,I-TREATMENT,1347
27517,therapy,I-TREATMENT,1347
27518,a,B-CHEMICAL_COMPOUND,1347
27519,recombinant,I-CHEMICAL_COMPOUND,1347
27520,adeno-associated,I-CHEMICAL_COMPOUND,1347
27521,virus,I-CHEMICAL_COMPOUND,1347
27522,AAV,I-CHEMICAL_COMPOUND,1347
27523,2,O,1347
27524,vector,O,1347
27525,for,O,1347
27526,X-linked,B-NAME_OF_DISEASE,1347
27527,RP,B-NAME_OF_DISEASE,1347
27528,resulting,O,1347
27529,from,O,1347
27530,mutations,O,1347
27531,in,O,1347
27532,the,B-CHEMICAL_COMPOUND,1347
27533,RPGR,B-CHEMICAL_COMPOUND,1347
27534,gene,I-CHEMICAL_COMPOUND,1347
27535,which,O,1348
27536,accounts,O,1348
27537,for,O,1348
27538,10%,O,1348
27539,of,O,1348
27540,RP,B-NAME_OF_DISEASE,1348
27541,cases,O,1348
27542,AGTC-501,B-TREATMENT,1348
27543,Trial,O,1348
27544,This,O,1349
27545,study,O,1349
27546,was,O,1349
27547,a,O,1349
27548,12-month,B-TIME_DURATION,1349
27549,open-label,O,1349
27550,dose-escalation,O,1349
27551,trial,O,1349
27552,that,O,1349
27553,included,O,1349
27554,29,O,1349
27555,male,O,1349
27556,patients,O,1350
27557,aged,O,1350
27558,6,O,1350
27559,years,O,1350
27560,and,O,1350
27561,older,O,1350
27562,with,O,1350
27563,the,O,1350
27564,RPGR,B-CHEMICAL_COMPOUND,1350
27565,mutation,O,1350
27566,All,O,1350
27567,patients,O,1350
27568,were,O,1350
27569,treated,O,1350
27570,with,O,1350
27571,1,O,1350
27572,subretinal,O,1350
27573,injection,O,1350
27574,in,O,1350
27575,the,O,1350
27576,study,O,1350
27577,eye,O,1350
27578,The,O,1350
27579,first,O,1350
27580,9,O,1350
27581,patients,O,1350
27582,received,O,1350
27583,peripheral,O,1351
27584,retinal,O,1351
27585,injections,O,1351
27586,as,O,1351
27587,part,O,1351
27588,of,O,1351
27589,a,O,1351
27590,safety,O,1351
27591,assessment,O,1351
27592,which,O,1351
27593,was,O,1351
27594,the,O,1351
27595,primary,O,1351
27596,outcome,O,1351
27597,and,O,1351
27598,the,O,1351
27599,rest,O,1351
27600,of,O,1351
27601,the,O,1351
27602,patients,O,1351
27603,were,O,1352
27604,treated,O,1352
27605,centrally,O,1352
27606,The,O,1352
27607,safety,O,1352
27608,assessment,O,1352
27609,also,O,1352
27610,included,O,1352
27611,immunologic,O,1352
27612,responses,O,1352
27613,to,O,1352
27614,the,B-CHEMICAL_COMPOUND,1352
27615,AAV,I-CHEMICAL_COMPOUND,1352
27616,capsid,I-CHEMICAL_COMPOUND,1352
27617,and,O,1352
27618,the,O,1352
27619,RPGR,B-CHEMICAL_COMPOUND,1352
27620,proteins,I-CHEMICAL_COMPOUND,1352
27621,expressed,O,1352
27622,Sisk,B-PERSON,1352
27623,explained,O,1352
27624,Key,O,1353
27625,secondary,O,1353
27626,outcomes,O,1353
27627,included,O,1353
27628,visual,O,1353
27629,function,O,1353
27630,measured,O,1353
27631,by,O,1353
27632,microperimetry,B-DIAGNOSTIC_TEST,1353
27633,Macular,I-DIAGNOSTIC_TEST,1353
27634,Integrity,I-DIAGNOSTIC_TEST,1353
27635,Assessment,I-DIAGNOSTIC_TEST,1353
27636,and,O,1353
27637,retinal,O,1353
27638,structure,O,1353
27639,seen,O,1353
27640,on,O,1353
27641,optical,B-DIAGNOSTIC_TEST,1353
27642,coherence,I-DIAGNOSTIC_TEST,1353
27643,tomography,I-DIAGNOSTIC_TEST,1353
27644,OCT,I-DIAGNOSTIC_TEST,1353
27645,,O,1353
27646,Safety,O,1353
27647,and,O,1353
27648,Vision,O,1353
27649,Results,O,1353
27650,with,O,1353
27651,AGTC-501,B-TREATMENT,1353
27652,The,O,1353
27653,safety,O,1353
27654,results,O,1353
27655,showed,O,1353
27656,that,O,1353
27657,no,O,1354
27658,serious,O,1354
27659,adverse,O,1354
27660,events,O,1354
27661,were,O,1354
27662,related,O,1354
27663,to,O,1354
27664,the,O,1354
27665,treatment,O,1354
27666,The,O,1354
27667,initial,O,1354
27668,surgical,O,1354
27669,approach,O,1354
27670,resulted,O,1354
27671,in,O,1354
27672,4,B-SIGN_AND_SYMPTOM,1354
27673,peripheral,I-SIGN_AND_SYMPTOM,1354
27674,retinal,I-SIGN_AND_SYMPTOM,1354
27675,detachments,I-SIGN_AND_SYMPTOM,1354
27676,related,O,1354
27677,to,O,1354
27678,dosing,O,1355
27679,targeting,O,1355
27680,the,B-PART_OF_THE_EYES,1355
27681,peripheral,I-PART_OF_THE_EYES,1355
27682,retina,I-PART_OF_THE_EYES,1355
27683,The,O,1355
27684,detachments,O,1355
27685,did,O,1355
27686,not,O,1355
27687,occur,O,1355
27688,when,O,1355
27689,the,B-PART_OF_THE_EYES,1355
27690,central,I-PART_OF_THE_EYES,1355
27691,retina,I-PART_OF_THE_EYES,1355
27692,was,O,1355
27693,targeted,O,1355
27694,Grade,O,1355
27695,1,O,1355
27696,to,O,1355
27697,2,O,1355
27698,intraocular,B-SIGN_AND_SYMPTOM,1355
27699,inflammation,I-SIGN_AND_SYMPTOM,1355
27700,developed,O,1355
27701,in,O,1355
27702,about,O,1355
27703,20%,O,1355
27704,5,O,1355
27705,29,O,1355
27706,of,O,1355
27707,patients,O,1355
27708,and,O,1355
27709,all,O,1356
27710,were,O,1356
27711,reported,O,1356
27712,as,O,1356
27713,resolved,O,1356
27714,About,O,1356
27715,one-third,O,1356
27716,of,O,1356
27717,the,O,1356
27718,patients,O,1356
27719,had,O,1357
27720,intraocular,B-SIGN_AND_SYMPTOM,1357
27721,pressure,I-SIGN_AND_SYMPTOM,1357
27722,elevations,I-SIGN_AND_SYMPTOM,1357
27723,related,O,1357
27724,to,O,1357
27725,corticosteroid,B-NAME_OF_DRUG,1357
27726,use,O,1357
27727,and,O,1357
27728,all,O,1357
27729,have,O,1357
27730,resolved,O,1357
27731,without,O,1357
27732,IOP,O,1357
27733,related,O,1357
27734,morbidities,O,1357
27735,The,O,1357
27736,immunologic,O,1357
27737,results,O,1357
27738,did,O,1357
27739,not,O,1357
27740,suggest,O,1357
27741,safety,O,1357
27742,concerns,O,1357
27743,The,O,1357
27744,microperimetry,O,1357
27745,sensitivity,O,1357
27746,improved,O,1357
27747,at,O,1357
27748,month,O,1358
27749,12,O,1358
27750,in,O,1358
27751,all,O,1358
27752,centrally,O,1358
27753,dosed,O,1358
27754,patients,O,1358
27755,across,O,1358
27756,the,O,1358
27757,central,O,1358
27758,36,O,1358
27759,points,O,1358
27760,which,O,1358
27761,corresponds,O,1358
27762,to,O,1358
27763,the,O,1358
27764,most,O,1358
27765,anatomically,O,1358
27766,and,O,1358
27767,functionally,O,1358
27768,intact,O,1358
27769,areas,O,1358
27770,in,O,1358
27771,the,O,1358
27772,patient,O,1358
27773,population,O,1358
27774,he,O,1358
27775,explained,O,1358
27776,Sisk,B-PERSON,1358
27777,also,O,1358
27778,noted,O,1358
27779,that,O,1358
27780,the,B-ORGANIZATION,1358
27781,FDA,I-ORGANIZATION,1358
27782,has,O,1358
27783,accepted,O,1358
27784,a,O,1358
27785,change,O,1358
27786,of,O,1358
27787,7,O,1359
27788,or,O,1359
27789,more,O,1359
27790,decibels,O,1359
27791,in,O,1359
27792,5,O,1359
27793,or,O,1359
27794,more,O,1359
27795,loci,O,1359
27796,in,O,1359
27797,the,O,1359
27798,central,O,1359
27799,microperimetry,O,1359
27800,as,O,1359
27801,clinically,O,1359
27802,meaningful,O,1359
27803,During,O,1359
27804,the,O,1359
27805,course,O,1359
27806,of,O,1359
27807,the,O,1359
27808,study,O,1359
27809,the,O,1359
27810,investigators,O,1359
27811,observed,O,1359
27812,that,O,1360
27813,patients,O,1360
27814,without,O,1360
27815,foveal,O,1360
27816,ellipsoid,B-PART_OF_THE_EYES,1360
27817,zone,I-PART_OF_THE_EYES,1360
27818,EZ,B-PART_OF_THE_EYES,1360
27819,integrity,O,1360
27820,before,O,1360
27821,the,O,1360
27822,treatment,O,1360
27823,did,O,1360
27824,not,O,1360
27825,have,O,1360
27826,improved,O,1360
27827,microperimetry,O,1360
27828,When,O,1360
27829,those,O,1360
27830,patients,O,1360
27831,were,O,1360
27832,excluded,O,1360
27833,from,O,1360
27834,analysis,O,1360
27835,50%,O,1360
27836,of,O,1360
27837,patients,O,1360
27838,were,O,1360
27839,responders,O,1361
27840,to,O,1361
27841,treatment,O,1361
27842,Another,O,1361
27843,2,O,1361
27844,patients,O,1361
27845,also,O,1361
27846,had,O,1361
27847,significant,O,1361
27848,improvements,O,1361
27849,in,O,1361
27850,microperimetry,O,1361
27851,compared,O,1361
27852,with,O,1361
27853,the,O,1361
27854,untreated,O,1361
27855,fellow,O,1361
27856,eye,O,1361
27857,Optimizing,O,1361
27858,Outcomes,O,1361
27859,with,O,1361
27860,AGTC-501,B-TREATMENT,1361
27861,In,O,1361
27862,addition,O,1361
27863,to,O,1361
27864,avoiding,O,1362
27865,treatment,O,1362
27866,targeting,O,1362
27867,the,B-PART_OF_THE_EYES,1362
27868,peripheral,I-PART_OF_THE_EYES,1362
27869,retina,I-PART_OF_THE_EYES,1362
27870,patient,O,1362
27871,selection,O,1362
27872,is,O,1362
27873,paramount,O,1362
27874,to,O,1362
27875,achieve,O,1362
27876,the,O,1362
27877,best,O,1362
27878,results,O,1362
27879,Advanced,O,1362
27880,disease,O,1362
27881,with,O,1362
27882,absence,O,1362
27883,of,O,1362
27884,baseline,O,1362
27885,microperimetry,O,1362
27886,or,O,1363
27887,a,O,1363
27888,foveal,O,1363
27889,EZ,B-PART_OF_THE_EYES,1363
27890,line,O,1363
27891,precluded,O,1363
27892,meaningful,O,1363
27893,microperimetry,O,1363
27894,or,O,1363
27895,visual,O,1363
27896,benefits,O,1363
27897,Sisk,B-PERSON,1363
27898,said,O,1363
27899,Clinical,O,1363
27900,trials,O,1363
27901,of,O,1363
27902,AGTC-501,B-TREATMENT,1363
27903,for,O,1364
27904,the,O,1364
27905,potential,O,1364
27906,treatment,O,1364
27907,of,O,1364
27908,X-link,B-NAME_OF_DISEASE,1364
27909,RP,I-NAME_OF_DISEASE,1364
27910,are,O,1364
27911,continuing,O,1364
27912,The,B-NAME_OF_STUDY,1364
27913,Skyline,I-NAME_OF_STUDY,1364
27914,trial,I-NAME_OF_STUDY,1364
27915,NCT03316560,I-NAME_OF_STUDY,1364
27916,is,O,1365
27917,an,O,1365
27918,expansion,O,1365
27919,of,O,1365
27920,this,O,1365
27921,phase,O,1365
27922,1,O,1365
27923,2,O,1365
27924,clinical,O,1365
27925,trial,O,1365
27926,and,O,1365
27927,the,B-NAME_OF_STUDY,1365
27928,Vista,I-NAME_OF_STUDY,1365
27929,trial,I-NAME_OF_STUDY,1365
27930,NCT04850118,I-NAME_OF_STUDY,1365
27931,is,O,1365
27932,a,O,1365
27933,phase,O,1365
27934,2,O,1365
27935,3,O,1365
27936,safety,O,1365
27937,and,O,1365
27938,efficacy,O,1365
27939,clinical,O,1365
27940,trial,O,1365
27941,Diabetes,B-NAME_OF_DISEASE,1365
27942,is,O,1366
27943,the,O,1366
27944,most,O,1366
27945,common,O,1366
27946,risk,O,1366
27947,factor,O,1366
27948,for,O,1366
27949,cataract,B-NAME_OF_DISEASE,1366
27950,Cataract,B-NAME_OF_DISEASE,1366
27951,remains,O,1366
27952,one,O,1366
27953,of,O,1366
27954,the,O,1366
27955,major,O,1366
27956,causes,O,1366
27957,of,O,1366
27958,blindness,B-NAME_OF_DISEASE,1366
27959,in,O,1366
27960,diabetic,O,1366
27961,patients,O,1366
27962,Some,O,1366
27963,studies,O,1366
27964,report,O,1366
27965,an,O,1366
27966,increased,O,1366
27967,risk,O,1366
27968,of,O,1366
27969,progression,O,1366
27970,whereas,O,1366
27971,others,O,1367
27972,report,O,1367
27973,that,O,1367
27974,this,O,1367
27975,progression,O,1367
27976,simply,O,1367
27977,represents,O,1367
27978,the,O,1367
27979,natural,O,1367
27980,course,O,1367
27981,of,O,1367
27982,the,O,1367
27983,disease,O,1367
27984,rather,O,1367
27985,than,O,1367
27986,a,O,1367
27987,surgical,O,1367
27988,outcome,O,1367
27989,The,O,1367
27990,findings,O,1367
27991,suggest,O,1367
27992,that,O,1367
27993,uncomplicated,O,1368
27994,phacoemulsification,B-TREATMENT,1368
27995,cataract,B-TREATMENT,1368
27996,surgery,I-TREATMENT,1368
27997,may,O,1368
27998,not,O,1368
27999,be,O,1368
28000,responsible,O,1368
28001,for,O,1368
28002,an,O,1368
28003,accelerated,O,1368
28004,rate,O,1368
28005,of,O,1368
28006,DR,B-NAME_OF_DISEASE,1368
28007,progression,O,1368
28008,postoperatively,O,1368
28009,Instead,O,1368
28010,the,O,1368
28011,findings,O,1368
28012,suggest,O,1368
28013,that,O,1369
28014,any,O,1369
28015,DR,B-NAME_OF_DISEASE,1369
28016,progression,O,1369
28017,that,O,1369
28018,does,O,1369
28019,occur,O,1369
28020,postoperatively,O,1369
28021,may,O,1369
28022,simply,O,1369
28023,represent,O,1369
28024,the,O,1369
28025,natural,O,1369
28026,history,O,1369
28027,of,O,1370
28028,the,O,1370
28029,disease,O,1370
28030,Although,O,1370
28031,macular,B-NAME_OF_DISEASE,1370
28032,edema,I-NAME_OF_DISEASE,1370
28033,was,O,1370
28034,common,O,1370
28035,after,O,1370
28036,cataract,B-TREATMENT,1370
28037,surgery,I-TREATMENT,1370
28038,it,O,1370
28039,often,O,1370
28040,followed,O,1370
28041,a,O,1370
28042,benign,O,1370
28043,course,O,1370
28044,and,O,1370
28045,any,O,1370
28046,progression,O,1370
28047,that,O,1370
28048,is,O,1370
28049,observed,O,1370
28050,postoperatively,O,1370
28051,probably,O,1370
28052,represents,O,1370
28053,natural,O,1371
28054,progression,O,1371
28055,rather,O,1371
28056,than,O,1371
28057,being,O,1371
28058,a,O,1371
28059,direct,O,1371
28060,effect,O,1371
28061,of,O,1371
28062,surgery,O,1371
28063,Compared,O,1371
28064,to,O,1371
28065,non-diabetic,O,1371
28066,patients,O,1371
28067,outcome,O,1371
28068,after,O,1371
28069,cataract,B-TREATMENT,1371
28070,surgery,I-TREATMENT,1371
28071,was,O,1371
28072,reported,O,1371
28073,to,O,1371
28074,be,O,1371
28075,worse,O,1371
28076,in,O,1372
28077,diabetic,O,1372
28078,patients--especially,O,1372
28079,in,O,1372
28080,those,O,1372
28081,with,O,1372
28082,diabetic,B-NAME_OF_DISEASE,1372
28083,retinopathy,I-NAME_OF_DISEASE,1372
28084,Cataracts,B-NAME_OF_DISEASE,1372
28085,and,O,1372
28086,diabetic,B-NAME_OF_DISEASE,1372
28087,retinopathy,I-NAME_OF_DISEASE,1372
28088,DR,B-NAME_OF_DISEASE,1372
28089,are,O,1372
28090,the,O,1372
28091,leading,O,1372
28092,causes,O,1372
28093,of,O,1372
28094,acquired,O,1372
28095,blindness,B-NAME_OF_DISEASE,1372
28096,worldwide,O,1372
28097,which,O,1372
28098,is,O,1372
28099,further,O,1372
28100,compounded,O,1373
28101,by,O,1373
28102,the,O,1373
28103,fact,O,1373
28104,that,O,1373
28105,patients,O,1373
28106,with,O,1373
28107,diabetes,B-NAME_OF_DISEASE,1373
28108,have,O,1373
28109,an,O,1373
28110,increased,O,1373
28111,risk,O,1373
28112,of,O,1373
28113,developing,O,1373
28114,cataracts,B-NAME_OF_DISEASE,1373
28115,Thus,O,1373
28116,many,O,1373
28117,patients,O,1373
28118,with,O,1373
28119,diabetes,B-NAME_OF_DISEASE,1373
28120,concomitantly,O,1373
28121,have,O,1373
28122,cataracts,B-NAME_OF_DISEASE,1373
28123,and,O,1373
28124,DR,B-NAME_OF_DISEASE,1373
28125,Although,O,1373
28126,extraction,O,1373
28127,is,O,1373
28128,the,O,1373
28129,standard,O,1373
28130,treatment,O,1373
28131,option,O,1374
28132,for,O,1374
28133,cataracts,B-NAME_OF_DISEASE,1374
28134,it,O,1374
28135,is,O,1374
28136,also,O,1374
28137,reported,O,1374
28138,to,O,1374
28139,worsen,O,1374
28140,existing,O,1374
28141,cases,O,1374
28142,of,O,1374
28143,DR,B-NAME_OF_DISEASE,1374
28144,a,O,1374
28145,microvascular,O,1374
28146,complication,O,1374
28147,of,O,1374
28148,diabetes,B-NAME_OF_DISEASE,1374
28149,leading,O,1374
28150,to,O,1374
28151,further,O,1374
28152,vision,B-SIGN_AND_SYMPTOM,1374
28153,loss,I-SIGN_AND_SYMPTOM,1374
28154,It,O,1374
28155,was,O,1374
28156,postulated,O,1374
28157,that,O,1374
28158,cataract,B-CAUSE_OF_DISEASE,1375
28159,extraction,I-CAUSE_OF_DISEASE,1375
28160,may,O,1375
28161,possibly,O,1375
28162,lead,O,1375
28163,to,O,1375
28164,a,B-CAUSE_OF_DISEASE,1375
28165,breakdown,I-CAUSE_OF_DISEASE,1375
28166,of,I-CAUSE_OF_DISEASE,1375
28167,the,I-CAUSE_OF_DISEASE,1375
28168,blood-retinal,I-CAUSE_OF_DISEASE,1375
28169,barrier,I-CAUSE_OF_DISEASE,1375
28170,and,I-CAUSE_OF_DISEASE,1375
28171,the,I-CAUSE_OF_DISEASE,1375
28172,blood-aqueous,I-CAUSE_OF_DISEASE,1375
28173,barrier,I-CAUSE_OF_DISEASE,1375
28174,and,I-CAUSE_OF_DISEASE,1375
28175,enhanced,I-CAUSE_OF_DISEASE,1375
28176,intraocular,I-CAUSE_OF_DISEASE,1375
28177,inflammatory,I-CAUSE_OF_DISEASE,1375
28178,response,I-CAUSE_OF_DISEASE,1375
28179,all,O,1376
28180,of,O,1376
28181,which,O,1376
28182,may,O,1376
28183,result,O,1376
28184,in,O,1376
28185,the,O,1376
28186,occurrence,O,1376
28187,of,O,1376
28188,DR,B-NAME_OF_DISEASE,1376
28189,in,O,1376
28190,patients,O,1376
28191,with,O,1376
28192,diabetes,B-NAME_OF_DISEASE,1376
28193,For,O,1376
28194,this,O,1377
28195,reason,O,1377
28196,current,O,1377
28197,DR,B-NAME_OF_DISEASE,1377
28198,care,O,1377
28199,guidelines,O,1377
28200,also,O,1377
28201,recommend,O,1377
28202,measures,O,1377
28203,of,O,1377
28204,preoperative,O,1377
28205,stabilization,O,1377
28206,for,O,1378
28207,patients,O,1378
28208,with,O,1378
28209,diabetes,B-NAME_OF_DISEASE,1378
28210,and,O,1378
28211,existing,O,1378
28212,vision-threatening,O,1378
28213,DR,B-NAME_OF_DISEASE,1378
28214,who,O,1378
28215,undergo,O,1378
28216,cataract,B-CAUSE_OF_DISEASE,1378
28217,extraction,I-CAUSE_OF_DISEASE,1378
28218,These,O,1378
28219,measures,O,1378
28220,include,O,1378
28221,optimizing,O,1378
28222,glycemic,O,1378
28223,control,O,1378
28224,and,O,1378
28225,performing,O,1378
28226,panretinal,O,1378
28227,photocoagulation,O,1379
28228,preoperatively,O,1379
28229,to,O,1379
28230,better,O,1379
28231,prevent,O,1379
28232,postsurgery,O,1379
28233,complications,O,1379
28234,such,O,1379
28235,as,O,1379
28236,neovascularization,B-SIGN_AND_SYMPTOM,1379
28237,and,O,1379
28238,vitreous,B-SIGN_AND_SYMPTOM,1379
28239,hemorrhage,I-SIGN_AND_SYMPTOM,1379
28240,among,O,1379
28241,this,O,1379
28242,group,O,1379
28243,of,O,1379
28244,patients,O,1379
28245,At,O,1380
28246,some,O,1380
28247,point,O,1380
28248,every,O,1380
28249,ophthalmologist,O,1380
28250,is,O,1380
28251,going,O,1380
28252,to,O,1380
28253,have,O,1380
28254,a,O,1380
28255,diabetic,O,1380
28256,patient,O,1380
28257,walk,O,1380
28258,into,O,1380
28259,the,O,1380
28260,office,O,1380
28261,who,O,1380
28262,is,O,1380
28263,going,O,1380
28264,to,O,1380
28265,have,O,1380
28266,a,O,1380
28267,visually,O,1380
28268,significant,O,1380
28269,cataract,B-NAME_OF_DISEASE,1380
28270,Diabetic,B-NAME_OF_DISEASE,1380
28271,retinopathy,I-NAME_OF_DISEASE,1380
28272,is,O,1381
28273,the,O,1381
28274,leading,O,1381
28275,cause,O,1381
28276,of,O,1381
28277,vision,B-SIGN_AND_SYMPTOM,1381
28278,loss,I-SIGN_AND_SYMPTOM,1381
28279,among,O,1381
28280,patients,O,1381
28281,with,O,1381
28282,diabetes,B-NAME_OF_DISEASE,1381
28283,and,O,1381
28284,a,O,1381
28285,primary,O,1381
28286,cause,O,1381
28287,of,O,1381
28288,blindness,B-NAME_OF_DISEASE,1381
28289,among,O,1381
28290,working-age,O,1381
28291,adults,O,1381
28292,As,O,1381
28293,a,O,1381
28294,result,O,1381
28295,the,O,1381
28296,purpose,O,1381
28297,of,O,1382
28298,the,O,1382
28299,study,O,1382
28300,was,O,1382
28301,to,O,1382
28302,evaluate,O,1382
28303,how,O,1382
28304,diabetic,B-NAME_OF_DISEASE,1382
28305,retinopathy,I-NAME_OF_DISEASE,1382
28306,influences,O,1382
28307,cataract,B-TREATMENT,1382
28308,surgery,I-TREATMENT,1382
28309,The,O,1382
28310,primary,O,1382
28311,aims,O,1382
28312,included,O,1382
28313,studying,O,1382
28314,preoperative,O,1382
28315,risk,O,1382
28316,factors,O,1382
28317,intraoperative,O,1383
28318,complications,O,1383
28319,and,O,1383
28320,postoperative,O,1383
28321,outcomes,O,1383
28322,Methods,O,1383
28323,The,O,1383
28324,study,O,1383
28325,examined,O,1384
28326,a,O,1384
28327,retrospective,O,1384
28328,clinical,O,1384
28329,database,O,1384
28330,study,O,1384
28331,of,O,1384
28332,217,O,1384
28333,107,O,1384
28334,eyes,O,1384
28335,that,O,1384
28336,underwent,O,1384
28337,cataract,B-TREATMENT,1384
28338,surgery,I-TREATMENT,1384
28339,at,O,1384
28340,eight,O,1384
28341,UK,B-ORGANIZATION,1384
28342,National,I-ORGANIZATION,1384
28343,Health,I-ORGANIZATION,1384
28344,Service,I-ORGANIZATION,1385
28345,hospitals,I-ORGANIZATION,1385
28346,between,B-TIME_DURATION,1385
28347,2000-2015,I-TIME_DURATION,1385
28348,Of,O,1385
28349,those,O,1385
28350,eyes,O,1385
28351,included,O,1385
28352,in,O,1385
28353,the,O,1385
28354,database,O,1385
28355,study,O,1385
28356,138,O,1385
28357,100,O,1385
28358,were,O,1385
28359,not,O,1385
28360,diabetic,O,1385
28361,41,O,1385
28362,59,O,1385
28363,were,O,1385
28364,diabetic,O,1385
28365,and,O,1385
28366,for,O,1386
28367,the,O,1386
28368,remaining,O,1386
28369,37,O,1386
28370,948,O,1386
28371,the,O,1386
28372,diabetic,O,1386
28373,status,O,1386
28374,was,O,1386
28375,not,O,1386
28376,recorded,O,1386
28377,Our,O,1386
28378,methods,O,1386
28379,for,O,1386
28380,the,O,1386
28381,evaluation,O,1386
28382,of,O,1386
28383,risk,O,1386
28384,factors,O,1386
28385,compared,O,1387
28386,prevalence,O,1387
28387,of,O,1387
28388,preoperative,O,1387
28389,risk,O,1387
28390,factors,O,1387
28391,and,O,1387
28392,co-pathology,O,1387
28393,between,O,1387
28394,diabetic,O,1387
28395,patients,O,1387
28396,and,O,1387
28397,non-diabetic,O,1387
28398,patients,O,1387
28399,In,O,1387
28400,the,O,1387
28401,evaluation,O,1387
28402,of,O,1387
28403,complications,O,1387
28404,we,O,1387
28405,compared,O,1387
28406,incidences,O,1387
28407,of,O,1387
28408,intraoperative,O,1388
28409,complications,O,1388
28410,between,O,1388
28411,diabetic,O,1388
28412,patients,O,1388
28413,and,O,1388
28414,non-diabetic,O,1388
28415,patients,O,1388
28416,during,O,1388
28417,cataract,B-TREATMENT,1388
28418,surgery,I-TREATMENT,1388
28419,Lastly,O,1388
28420,we,O,1388
28421,compared,O,1388
28422,postoperative,O,1388
28423,outcomes,O,1388
28424,between,O,1388
28425,diabetic,O,1388
28426,patients,O,1389
28427,and,O,1389
28428,non-diabetic,O,1389
28429,patients,O,1389
28430,after,O,1389
28431,cataract,B-TREATMENT,1389
28432,surgery,I-TREATMENT,1389
28433,Our,O,1389
28434,methodology,O,1389
28435,included,O,1389
28436,strict,O,1389
28437,inclusion,O,1389
28438,criteria,O,1390
28439,including,O,1390
28440,no,O,1390
28441,copathology,O,1390
28442,except,O,1390
28443,amblyopia,B-NAME_OF_DISEASE,1390
28444,no,O,1390
28445,simultaneous,O,1390
28446,surgical,O,1390
28447,procedures,O,1390
28448,except,O,1390
28449,intraocular,B-TREATMENT,1390
28450,injection,I-TREATMENT,1390
28451,and,O,1390
28452,clear,O,1390
28453,ETDRS,B-DIAGNOSTIC_TEST,1390
28454,grading,I-DIAGNOSTIC_TEST,1390
28455,of,I-DIAGNOSTIC_TEST,1390
28456,retinopathy,I-DIAGNOSTIC_TEST,1390
28457,was,O,1390
28458,required,O,1390
28459,Results,O,1390
28460,In,O,1390
28461,examining,O,1390
28462,preoperative,O,1390
28463,risk,O,1390
28464,factors,O,1390
28465,we,O,1390
28466,found,O,1390
28467,that,O,1390
28468,epiretinal,B-SIGN_AND_SYMPTOM,1390
28469,membranes,I-SIGN_AND_SYMPTOM,1390
28470,ERM,I-SIGN_AND_SYMPTOM,1391
28471,small,I-SIGN_AND_SYMPTOM,1391
28472,pupil,I-SIGN_AND_SYMPTOM,1391
28473,and,I-SIGN_AND_SYMPTOM,1391
28474,brunescent,I-SIGN_AND_SYMPTOM,1391
28475,white,I-SIGN_AND_SYMPTOM,1391
28476,cataract,B-NAME_OF_DISEASE,1391
28477,are,O,1391
28478,more,O,1391
28479,common,O,1391
28480,in,O,1391
28481,diabetics,O,1391
28482,Our,O,1391
28483,review,O,1391
28484,of,O,1391
28485,intraoperative,O,1392
28486,complications,O,1392
28487,found,O,1392
28488,that,O,1392
28489,posterior,B-SIGN_AND_SYMPTOM,1392
28490,capsular,I-SIGN_AND_SYMPTOM,1392
28491,rupture,I-SIGN_AND_SYMPTOM,1392
28492,dropped,I-SIGN_AND_SYMPTOM,1392
28493,nuclear,I-SIGN_AND_SYMPTOM,1392
28494,fragment,I-SIGN_AND_SYMPTOM,1392
28495,corneal,I-SIGN_AND_SYMPTOM,1392
28496,edema,I-SIGN_AND_SYMPTOM,1392
28497,and,O,1392
28498,overall,O,1392
28499,complication,O,1392
28500,rates,O,1392
28501,were,O,1392
28502,higher,O,1392
28503,among,O,1392
28504,diabetic,O,1392
28505,patients,O,1392
28506,In,O,1392
28507,our,O,1392
28508,examination,O,1392
28509,of,O,1392
28510,postoperative,O,1392
28511,outcomes,O,1393
28512,we,O,1393
28513,found,O,1393
28514,that,O,1393
28515,visual,O,1393
28516,acuity,O,1393
28517,good,O,1393
28518,vision,O,1393
28519,≤20,O,1393
28520,40,O,1393
28521,and,O,1393
28522,pseudophakic,B-NAME_OF_DISEASE,1393
28523,cystoid,I-NAME_OF_DISEASE,1393
28524,macular,B-NAME_OF_DISEASE,1393
28525,edema,I-NAME_OF_DISEASE,1393
28526,CME,B-NAME_OF_DISEASE,1393
28527,were,O,1393
28528,negatively,O,1393
28529,associated,O,1393
28530,with,O,1393
28531,diabetes,B-NAME_OF_DISEASE,1393
28532,and,O,1393
28533,degree,O,1393
28534,of,O,1393
28535,diabetic,B-NAME_OF_DISEASE,1393
28536,retinopathy,I-NAME_OF_DISEASE,1393
28537,The,O,1394
28538,effect,O,1394
28539,of,O,1394
28540,preoperative,O,1394
28541,diabetic,B-NAME_OF_DISEASE,1394
28542,macular,B-NAME_OF_DISEASE,1394
28543,edema,I-NAME_OF_DISEASE,1394
28544,DME,B-NAME_OF_DISEASE,1394
28545,on,O,1394
28546,visual,O,1394
28547,acuity,O,1394
28548,and,O,1394
28549,good,O,1394
28550,vision,O,1394
28551,was,O,1394
28552,similar,O,1394
28553,to,O,1394
28554,the,O,1394
28555,effect,O,1394
28556,of,O,1394
28557,having,O,1394
28558,moderate,O,1394
28559,non-proliferative,B-NAME_OF_DISEASE,1394
28560,diabetic,I-NAME_OF_DISEASE,1394
28561,retinopathy,I-NAME_OF_DISEASE,1394
28562,NPDR,I-NAME_OF_DISEASE,1394
28563,,O,1394
28564,As,O,1394
28565,we,O,1395
28566,evaluated,O,1395
28567,outcomes,O,1395
28568,we,O,1395
28569,looked,O,1395
28570,at,O,1395
28571,the,O,1395
28572,difference,O,1395
28573,in,O,1395
28574,preoperative,O,1395
28575,and,O,1395
28576,postoperative,O,1395
28577,visual,O,1395
28578,acuity,O,1395
28579,between,O,1395
28580,the,O,1395
28581,diabetic,O,1395
28582,and,O,1395
28583,non-diabetic,O,1395
28584,patients,O,1395
28585,Using,O,1395
28586,logistic,O,1395
28587,regression,O,1395
28588,analysis,O,1395
28589,for,O,1395
28590,pre-,O,1395
28591,and,O,1395
28592,postop,O,1395
28593,four,B-TIME_DURATION,1395
28594,to,I-TIME_DURATION,1395
28595,12,I-TIME_DURATION,1395
28596,weeks,I-TIME_DURATION,1396
28597,BCVA,B-DIAGNOSTIC_TEST,1396
28598,logMAR,O,1396
28599,0,O,1396
28600,with,O,1396
28601,95%,O,1396
28602,CI,O,1396
28603,we,O,1396
28604,examined,O,1396
28605,the,O,1396
28606,chance,O,1396
28607,of,O,1396
28608,having,O,1396
28609,poor,O,1396
28610,vision,O,1396
28611,postoperatively,O,1396
28612,We,O,1396
28613,examined,O,1396
28614,the,O,1396
28615,chance,O,1396
28616,of,O,1396
28617,having,O,1396
28618,pseudophakic,B-NAME_OF_DISEASE,1396
28619,cystoid,I-NAME_OF_DISEASE,1396
28620,macular,B-NAME_OF_DISEASE,1396
28621,edema,I-NAME_OF_DISEASE,1396
28622,postoperatively,O,1396
28623,using,O,1396
28624,logistic,O,1396
28625,regression,O,1396
28626,analysis,O,1396
28627,for,O,1396
28628,postop,O,1396
28629,CME,B-NAME_OF_DISEASE,1396
28630,with,O,1396
28631,95%,O,1396
28632,CI,O,1396
28633,We,O,1396
28634,also,O,1396
28635,wanted,O,1396
28636,to,O,1396
28637,determine,O,1396
28638,if,O,1396
28639,we,O,1396
28640,could,O,1396
28641,predict,O,1396
28642,postoperative,O,1396
28643,vision,O,1397
28644,based,O,1397
28645,on,O,1397
28646,preoperative,O,1397
28647,vision,O,1397
28648,and,O,1397
28649,diabetic,O,1397
28650,status,O,1397
28651,We,O,1397
28652,utilized,O,1397
28653,a,O,1397
28654,linear,O,1397
28655,regression,O,1397
28656,model,O,1397
28657,for,O,1397
28658,age,O,1397
28659,preop,O,1397
28660,DME,B-NAME_OF_DISEASE,1397
28661,diabetic,O,1397
28662,status,O,1397
28663,preop,O,1397
28664,visual,O,1397
28665,acuity,O,1397
28666,and,O,1397
28667,postop,O,1397
28668,visual,O,1398
28669,acuity,O,1398
28670,at,O,1398
28671,four,B-TIME_DURATION,1398
28672,to,I-TIME_DURATION,1398
28673,12,I-TIME_DURATION,1398
28674,weeks,I-TIME_DURATION,1398
28675,with,O,1398
28676,95%,O,1398
28677,CI,O,1398
28678,There,O,1398
28679,also,O,1398
28680,are,O,1398
28681,some,O,1398
28682,limitations,O,1398
28683,that,O,1398
28684,we,O,1398
28685,acknowledge,O,1399
28686,including,O,1399
28687,retrospective,O,1399
28688,design,O,1399
28689,missing,O,1399
28690,short-term,O,1399
28691,follow,O,1399
28692,up,O,1399
28693,data,O,1399
28694,and,O,1399
28695,missing,O,1399
28696,details,O,1399
28697,of,O,1399
28698,grading,O,1399
28699,of,O,1399
28700,cataract,B-NAME_OF_DISEASE,1399
28701,type,O,1399
28702,density,O,1399
28703,We,O,1399
28704,found,O,1399
28705,that,O,1399
28706,diabetics,O,1399
28707,are,O,1399
28708,seeing,O,1399
28709,worse,O,1399
28710,they,O,1399
28711,are,O,1399
28712,having,O,1399
28713,poor,O,1399
28714,vision,O,1399
28715,and,O,1399
28716,are,O,1399
28717,developing,O,1400
28718,more,O,1400
28719,macular,B-NAME_OF_DISEASE,1400
28720,edema,I-NAME_OF_DISEASE,1400
28721,after,O,1400
28722,surgery,O,1400
28723,The,O,1400
28724,worse,O,1400
28725,their,O,1400
28726,retinopathy,O,1400
28727,the,O,1400
28728,worse,O,1400
28729,their,O,1400
28730,outcome,O,1400
28731,This,O,1400
28732,study,O,1400
28733,provides,O,1401
28734,data,O,1401
28735,to,O,1401
28736,assist,O,1401
28737,in,O,1401
28738,the,O,1401
28739,planning,O,1401
28740,of,O,1401
28741,cataract,B-TREATMENT,1401
28742,surgery,I-TREATMENT,1401
28743,and,O,1401
28744,providing,O,1401
28745,informed,O,1401
28746,consent,O,1401
28747,in,O,1401
28748,diabetic,O,1401
28749,patients,O,1401
28750,It,O,1401
28751,would,O,1401
28752,be,O,1401
28753,reasonable,O,1401
28754,to,O,1401
28755,recommend,O,1401
28756,performing,O,1401
28757,cataract,B-NAME_OF_DISEASE,1401
28758,extraction,I-TREATMENT,1401
28759,on,O,1401
28760,diabetic,O,1401
28761,patients,O,1401
28762,early,O,1401
28763,before,O,1401
28764,the,O,1401
28765,development,O,1401
28766,of,O,1401
28767,significant,O,1401
28768,retinopathy,O,1401
28769,or,O,1401
28770,vision,O,1401
28771,decline,O,1401
28772,Individuals,O,1402
28773,with,O,1402
28774,glaucoma,B-NAME_OF_DISEASE,1402
28775,who,O,1402
28776,need,O,1402
28777,three,O,1402
28778,or,O,1402
28779,four,O,1402
28780,topical,O,1402
28781,medications,O,1402
28782,to,O,1402
28783,manage,O,1402
28784,their,O,1402
28785,pressure,O,1402
28786,are,O,1402
28787,in,O,1402
28788,a,O,1402
28789,difficult,O,1402
28790,situation,O,1402
28791,In,O,1402
28792,addition,O,1402
28793,to,O,1402
28794,battling,O,1402
28795,what,O,1402
28796,is,O,1403
28797,probably,O,1403
28798,an,O,1403
28799,aggressive,O,1403
28800,disease,O,1403
28801,they,O,1403
28802,also,O,1403
28803,struggle,O,1403
28804,with,O,1403
28805,the,O,1403
28806,tolerability,O,1403
28807,adherence,O,1403
28808,and,O,1403
28809,cost,O,1403
28810,of,O,1403
28811,multiagent,O,1403
28812,topical,O,1403
28813,therapy,O,1403
28814,Blindness,B-NAME_OF_DISEASE,1403
28815,may,O,1403
28816,develop,O,1404
28817,from,O,1404
28818,damage,B-CAUSE_OF_DISEASE,1404
28819,to,I-CAUSE_OF_DISEASE,1404
28820,the,I-CAUSE_OF_DISEASE,1404
28821,retinal,I-CAUSE_OF_DISEASE,1404
28822,ganglion,I-CAUSE_OF_DISEASE,1404
28823,cells,I-CAUSE_OF_DISEASE,1404
28824,and,I-CAUSE_OF_DISEASE,1404
28825,their,I-CAUSE_OF_DISEASE,1404
28826,axons,I-CAUSE_OF_DISEASE,1404
28827,in,I-CAUSE_OF_DISEASE,1404
28828,glaucoma,I-CAUSE_OF_DISEASE,1404
28829,an,I-CAUSE_OF_DISEASE,1404
28830,optic,I-CAUSE_OF_DISEASE,1404
28831,neuropathy,I-CAUSE_OF_DISEASE,1404
28832,It,O,1404
28833,is,O,1404
28834,the,O,1404
28835,second,O,1404
28836,most,O,1404
28837,common,O,1404
28838,cause,O,1404
28839,of,O,1404
28840,blindness,B-NAME_OF_DISEASE,1404
28841,in,O,1404
28842,the,O,1404
28843,globe,O,1404
28844,Older,B-CAUSE_OF_DISEASE,1404
28845,age,I-CAUSE_OF_DISEASE,1404
28846,a,B-CAUSE_OF_DISEASE,1405
28847,higher,I-CAUSE_OF_DISEASE,1405
28848,cup-to-disc,I-CAUSE_OF_DISEASE,1405
28849,ratio,I-CAUSE_OF_DISEASE,1405
28850,of,I-CAUSE_OF_DISEASE,1405
28851,the,I-CAUSE_OF_DISEASE,1405
28852,optic,I-CAUSE_OF_DISEASE,1405
28853,nerve,I-CAUSE_OF_DISEASE,1405
28854,a,I-CAUSE_OF_DISEASE,1405
28855,thin,I-CAUSE_OF_DISEASE,1405
28856,central,I-CAUSE_OF_DISEASE,1405
28857,cornea,I-CAUSE_OF_DISEASE,1405
28858,familial,B-CAUSE_OF_DISEASE,1406
28859,history,I-CAUSE_OF_DISEASE,1406
28860,and,O,1406
28861,higher,B-CAUSE_OF_DISEASE,1406
28862,intraocular,I-CAUSE_OF_DISEASE,1406
28863,pressure,I-CAUSE_OF_DISEASE,1406
28864,are,O,1406
28865,risk,O,1406
28866,factors,O,1406
28867,for,O,1406
28868,glaucoma,B-NAME_OF_DISEASE,1406
28869,which,O,1406
28870,has,O,1406
28871,a,O,1406
28872,complex,O,1406
28873,etiology,O,1406
28874,IOP,O,1406
28875,,O,1406
28876,The,O,1406
28877,only,O,1406
28878,known,O,1406
28879,modifiable,O,1406
28880,risk,O,1406
28881,factor,O,1407
28882,is,O,1407
28883,IOP,O,1407
28884,and,O,1407
28885,it,O,1407
28886,affects,O,1407
28887,how,O,1407
28888,quickly,O,1407
28889,damage,O,1407
28890,develops,O,1407
28891,Hence,O,1407
28892,the,O,1407
28893,goal,O,1407
28894,of,O,1407
28895,glaucoma,B-NAME_OF_DISEASE,1407
28896,treatment,O,1407
28897,is,O,1407
28898,to,B-TREATMENT,1407
28899,lower,I-TREATMENT,1407
28900,IOP,I-TREATMENT,1407
28901,through,I-TREATMENT,1407
28902,surgery,I-TREATMENT,1407
28903,laser,B-TREATMENT,1407
28904,therapy,I-TREATMENT,1407
28905,or,O,1407
28906,pharmaceutical,B-TREATMENT,1407
28907,therapy,I-TREATMENT,1407
28908,with,O,1407
28909,drugs,B-TREATMENT,1407
28910,typically,O,1407
28911,being,O,1407
28912,the,O,1407
28913,first,O,1407
28914,line,O,1407
28915,of,O,1407
28916,defense,O,1407
28917,Reducing,B-TREATMENT,1407
28918,intraocular,I-TREATMENT,1407
28919,pressure,I-TREATMENT,1407
28920,IOP,I-TREATMENT,1407
28921,to,I-TREATMENT,1407
28922,a,I-TREATMENT,1407
28923,target,I-TREATMENT,1407
28924,pressure,I-TREATMENT,1407
28925,that,I-TREATMENT,1407
28926,is,I-TREATMENT,1407
28927,sufficiently,I-TREATMENT,1407
28928,low,I-TREATMENT,1407
28929,to,I-TREATMENT,1407
28930,stop,I-TREATMENT,1407
28931,glaucomatous,I-TREATMENT,1407
28932,development,I-TREATMENT,1407
28933,is,O,1408
28934,the,O,1408
28935,aim,O,1408
28936,of,O,1408
28937,treatment,O,1408
28938,for,O,1408
28939,glaucoma,B-NAME_OF_DISEASE,1408
28940,and,O,1408
28941,ocular,B-NAME_OF_DISEASE,1408
28942,hypertension,I-NAME_OF_DISEASE,1408
28943,The,B-NAME_OF_DRUG,1408
28944,prostaglandin,I-NAME_OF_DRUG,1408
28945,analogs,I-NAME_OF_DRUG,1408
28946,beta-adrenergic,B-NAME_OF_DRUG,1408
28947,receptor,I-NAME_OF_DRUG,1408
28948,antagonists,I-NAME_OF_DRUG,1408
28949,beta-blockers,I-NAME_OF_DRUG,1408
28950,alpha,B-NAME_OF_DRUG,1408
28951,adrenergic,I-NAME_OF_DRUG,1408
28952,receptor,I-NAME_OF_DRUG,1408
28953,agonists,I-NAME_OF_DRUG,1408
28954,alpha,I-NAME_OF_DRUG,1408
28955,agonists,I-NAME_OF_DRUG,1408
28956,and,O,1408
28957,carbonic,B-NAME_OF_DRUG,1408
28958,anhydrase,I-NAME_OF_DRUG,1408
28959,inhibitors,I-NAME_OF_DRUG,1408
28960,are,O,1408
28961,the,O,1408
28962,four,O,1408
28963,most,O,1408
28964,popular,O,1408
28965,groups,O,1408
28966,of,O,1408
28967,IOP-lowering,B-NAME_OF_DRUG,1408
28968,drugs,I-NAME_OF_DRUG,1408
28969,CAIs,I-NAME_OF_DRUG,1408
28970,,O,1408
28971,For,O,1408
28972,many,O,1409
28973,individuals,O,1409
28974,a,O,1409
28975,single,O,1409
28976,medicine,O,1409
28977,is,O,1409
28978,insufficient,O,1409
28979,to,O,1409
28980,lower,O,1409
28981,IOP,O,1409
28982,to,O,1409
28983,the,O,1409
28984,desired,O,1409
28985,level,O,1409
28986,necessitating,O,1409
28987,the,O,1409
28988,use,O,1409
28989,of,O,1409
28990,two,O,1409
28991,three,O,1409
28992,or,O,1409
28993,more,O,1409
28994,drugs,B-TREATMENT,1409
28995,from,O,1409
28996,various,O,1409
28997,classes,O,1409
28998,in,O,1409
28999,the,O,1410
29000,treatment,O,1410
29001,regimen,O,1410
29002,While,O,1410
29003,early,B-TREATMENT,1410
29004,cataract,I-TREATMENT,1410
29005,extraction,I-TREATMENT,1410
29006,to,I-TREATMENT,1410
29007,lower,I-TREATMENT,1410
29008,IOP,I-TREATMENT,1410
29009,and,I-TREATMENT,1410
29010,accompanying,I-TREATMENT,1410
29011,angle,I-TREATMENT,1410
29012,surgery,I-TREATMENT,1410
29013,to,I-TREATMENT,1410
29014,restore,I-TREATMENT,1410
29015,outflow,I-TREATMENT,1410
29016,via,I-TREATMENT,1410
29017,Schlemm,I-TREATMENT,1411
29018,s,I-TREATMENT,1411
29019,canal,I-TREATMENT,1411
29020,are,O,1411
29021,common,O,1411
29022,in,O,1411
29023,the,O,1411
29024,surgical,O,1411
29025,initial,O,1411
29026,treatment,O,1411
29027,of,O,1411
29028,adult,O,1412
29029,glaucoma,B-NAME_OF_DISEASE,1412
29030,some,O,1412
29031,patients,O,1412
29032,reject,O,1412
29033,or,O,1412
29034,are,O,1412
29035,unable,O,1412
29036,to,O,1412
29037,undergo,O,1412
29038,surgery,O,1412
29039,necessitating,O,1412
29040,the,O,1412
29041,use,O,1412
29042,of,O,1412
29043,multiple,O,1412
29044,medications,O,1412
29045,to,O,1412
29046,control,O,1412
29047,the,O,1412
29048,disease,O,1412
29049,The,O,1412
29050,success,O,1412
29051,of,O,1412
29052,treatment,O,1412
29053,is,O,1412
29054,constrained,O,1412
29055,by,O,1412
29056,adherence,O,1412
29057,to,O,1412
29058,the,O,1412
29059,prescribed,O,1412
29060,regimen,O,1412
29061,as,O,1412
29062,multiple,O,1412
29063,medications,O,1412
29064,are,O,1412
29065,frequently,O,1412
29066,required,O,1412
29067,to,O,1412
29068,achieve,O,1412
29069,and,O,1412
29070,maintain,O,1412
29071,the,O,1412
29072,desired,O,1412
29073,IOP,O,1412
29074,Additionally,O,1413
29075,limiting,O,1413
29076,compliance,O,1413
29077,medications,O,1413
29078,can,O,1413
29079,cause,O,1413
29080,ocular,B-SIGN_AND_SYMPTOM,1413
29081,erythema,I-SIGN_AND_SYMPTOM,1413
29082,and,I-SIGN_AND_SYMPTOM,1413
29083,conjunctivitis,I-SIGN_AND_SYMPTOM,1413
29084,due,O,1413
29085,to,O,1413
29086,their,O,1413
29087,active,O,1413
29088,components,O,1413
29089,and,O,1413
29090,preservatives,O,1413
29091,When,O,1413
29092,opposed,O,1413
29093,to,O,1413
29094,monotherapy,O,1413
29095,combining,O,1413
29096,numerous,O,1413
29097,topical,O,1413
29098,medications,O,1413
29099,into,O,1413
29100,a,O,1413
29101,single,O,1413
29102,solution,O,1413
29103,has,O,1414
29104,a,O,1414
29105,number,O,1414
29106,of,O,1414
29107,advantages,O,1414
29108,including,O,1414
29109,a,O,1414
29110,lighter,O,1414
29111,therapeutic,O,1414
29112,load,O,1414
29113,cost,O,1414
29114,savings,O,1414
29115,less,O,1414
29116,exposure,O,1414
29117,to,O,1414
29118,preservatives,O,1414
29119,and,O,1414
29120,ease,O,1414
29121,of,O,1414
29122,administration,O,1414
29123,Our,O,1414
29124,patients,O,1414
29125,must,O,1414
29126,put,O,1414
29127,in,O,1414
29128,a,O,1414
29129,lot,O,1414
29130,of,O,1414
29131,effort,O,1414
29132,to,O,1415
29133,adhere,O,1415
29134,to,O,1415
29135,their,O,1415
29136,lifelong,O,1415
29137,glaucoma,B-NAME_OF_DISEASE,1415
29138,treatment,O,1415
29139,They,O,1415
29140,must,O,1415
29141,have,O,1415
29142,the,O,1415
29143,financial,O,1415
29144,means,O,1415
29145,to,O,1415
29146,purchase,O,1415
29147,their,O,1415
29148,prescriptions,O,1415
29149,be,O,1415
29150,able,O,1415
29151,to,O,1415
29152,recall,O,1415
29153,the,O,1415
29154,recommended,O,1415
29155,daily,O,1415
29156,dosage,O,1415
29157,be,O,1415
29158,able,O,1416
29159,to,O,1416
29160,tolerate,O,1416
29161,the,O,1416
29162,drops,O,1416
29163,well,O,1416
29164,enough,O,1416
29165,to,O,1416
29166,not,O,1416
29167,miss,O,1416
29168,doses,O,1416
29169,and,O,1416
29170,physically,O,1416
29171,be,O,1416
29172,able,O,1416
29173,to,O,1416
29174,successfully,O,1416
29175,administer,O,1416
29176,the,O,1416
29177,drops,O,1416
29178,That,O,1416
29179,is,O,1416
29180,a,O,1417
29181,lot,O,1417
29182,to,O,1417
29183,expect,O,1417
29184,of,O,1417
29185,the,O,1417
29186,patients,O,1417
29187,particularly,O,1417
29188,as,O,1417
29189,they,O,1417
29190,get,O,1417
29191,older,O,1417
29192,and,O,1417
29193,start,O,1417
29194,to,O,1417
29195,have,O,1417
29196,concurrent,O,1417
29197,health,O,1417
29198,issues,O,1417
29199,or,O,1417
29200,cognitive,O,1417
29201,decline,O,1417
29202,Several,O,1417
29203,studies,O,1417
29204,have,O,1417
29205,demonstrated,O,1417
29206,that,O,1417
29207,more,O,1417
29208,complicated,O,1417
29209,regimens,O,1417
29210,involving,O,1417
29211,more,O,1417
29212,than,O,1417
29213,1,O,1417
29214,or,O,1417
29215,2,O,1417
29216,bottles,O,1417
29217,cause,O,1417
29218,a,O,1417
29219,drop,O,1417
29220,in,O,1417
29221,adherence,O,1417
29222,Leung,B-PERSON,1417
29223,Rossi,B-PERSON,1417
29224,and,O,1417
29225,others,O,1417
29226,have,O,1417
29227,shown,O,1417
29228,us,O,1417
29229,that,O,1418
29230,when,O,1418
29231,you,O,1418
29232,add,O,1418
29233,a,O,1418
29234,second,O,1418
29235,or,O,1418
29236,third,O,1418
29237,bottle,O,1418
29238,with,O,1418
29239,preservatives,O,1418
29240,such,O,1418
29241,as,O,1418
29242,benzalkonium,B-NAME_OF_DRUG,1418
29243,chloride,I-NAME_OF_DRUG,1418
29244,the,O,1418
29245,incidence,O,1418
29246,of,O,1418
29247,ocular,B-NAME_OF_DISEASE,1418
29248,surface,I-NAME_OF_DISEASE,1418
29249,disease,I-NAME_OF_DISEASE,1418
29250,OSD,B-NAME_OF_DISEASE,1419
29251,increases,O,1419
29252,Then,O,1420
29253,in,O,1420
29254,a,O,1420
29255,vicious,O,1420
29256,cycle,O,1420
29257,patients,O,1420
29258,with,O,1420
29259,OSD,B-NAME_OF_DISEASE,1420
29260,become,O,1420
29261,even,O,1420
29262,less,O,1420
29263,adherent,O,1420
29264,More,O,1420
29265,than,O,1420
29266,ever,O,1420
29267,we,O,1420
29268,are,O,1420
29269,now,O,1420
29270,beginning,O,1420
29271,to,O,1420
29272,appreciate,O,1420
29273,the,O,1420
29274,eff,O,1420
29275,ect,O,1420
29276,of,O,1420
29277,adherence,O,1420
29278,on,O,1420
29279,longterm,O,1420
29280,IOP,O,1421
29281,control,O,1421
29282,in,O,1421
29283,our,O,1421
29284,patients,O,1421
29285,with,O,1421
29286,glaucoma,B-NAME_OF_DISEASE,1421
29287,Both,O,1421
29288,the,B-NAME_OF_STUDY,1421
29289,HORIZON,I-NAME_OF_STUDY,1421
29290,study,I-NAME_OF_STUDY,1421
29291,NCT0466445,I-NAME_OF_STUDY,1421
29292,looking,O,1421
29293,at,O,1422
29294,implantation,B-TREATMENT,1422
29295,of,I-TREATMENT,1422
29296,Hydrus,I-TREATMENT,1422
29297,Microstents,I-TREATMENT,1422
29298,at,O,1422
29299,the,O,1422
29300,time,O,1422
29301,of,O,1422
29302,cataract,B-TREATMENT,1422
29303,surgery,I-TREATMENT,1422
29304,and,O,1422
29305,the,B-NAME_OF_STUDY,1422
29306,LiGHT,I-NAME_OF_STUDY,1422
29307,study,I-NAME_OF_STUDY,1422
29308,ISRCTN32038223,I-NAME_OF_STUDY,1422
29309,in,O,1422
29310,which,O,1422
29311,first-line,O,1422
29312,selective,B-TREATMENT,1422
29313,laser,I-TREATMENT,1422
29314,trabeculoplasty,I-TREATMENT,1422
29315,SLT,B-TREATMENT,1422
29316,was,O,1422
29317,compared,O,1422
29318,with,O,1422
29319,medical,B-TREATMENT,1422
29320,therapy,I-TREATMENT,1422
29321,found,O,1422
29322,that,O,1422
29323,patients,O,1422
29324,with,O,1422
29325,the,O,1422
29326,surgical,O,1422
29327,laser,O,1422
29328,interventions,O,1422
29329,were,O,1422
29330,less,O,1422
29331,likely,O,1422
29332,to,O,1423
29333,progress,O,1423
29334,to,O,1423
29335,incisional,B-TREATMENT,1423
29336,glaucoma,B-NAME_OF_DISEASE,1423
29337,filtration,I-TREATMENT,1423
29338,surgery,I-TREATMENT,1423
29339,Despite,O,1423
29340,the,O,1423
29341,fact,O,1423
29342,that,O,1423
29343,we,O,1423
29344,have,O,1424
29345,drugs,O,1424
29346,that,O,1424
29347,theoretically,O,1424
29348,offer,O,1424
29349,the,O,1424
29350,same,O,1424
29351,IOP-lowering,O,1424
29352,impact,O,1424
29353,as,O,1424
29354,SLT,B-TREATMENT,1424
29355,or,O,1424
29356,minimally,B-TREATMENT,1424
29357,invasive,I-TREATMENT,1424
29358,glaucoma,B-NAME_OF_DISEASE,1424
29359,surgery,I-TREATMENT,1424
29360,MIGS,B-TREATMENT,1424
29361,we,O,1424
29362,aren,O,1424
29363,t,O,1424
29364,fully,O,1424
29365,using,O,1424
29366,the,O,1424
29367,benefits,O,1424
29368,of,O,1424
29369,those,O,1425
29370,medications,O,1425
29371,since,O,1425
29372,patients,O,1425
29373,aren,O,1425
29374,t,O,1425
29375,taking,O,1425
29376,them,O,1425
29377,consistently,O,1425
29378,More,O,1425
29379,MIGS,B-TREATMENT,1425
29380,and,O,1425
29381,SLT,B-TREATMENT,1425
29382,are,O,1425
29383,a,O,1425
29384,part,O,1425
29385,of,O,1425
29386,the,O,1425
29387,solution,O,1425
29388,but,O,1426
29389,certain,O,1426
29390,individuals,O,1426
29391,will,O,1426
29392,always,O,1426
29393,require,O,1426
29394,topical,B-TREATMENT,1426
29395,therapy,I-TREATMENT,1426
29396,in,O,1426
29397,place,O,1426
29398,of,O,1426
29399,or,O,1426
29400,in,O,1426
29401,addition,O,1426
29402,to,O,1426
29403,these,O,1426
29404,approaches,O,1426
29405,In,O,1426
29406,our,O,1426
29407,practice,O,1426
29408,the,O,1426
29409,initial,O,1427
29410,bottle,O,1427
29411,of,O,1428
29412,glaucoma,B-NAME_OF_DISEASE,1428
29413,medication,O,1428
29414,is,O,1429
29415,often,O,1429
29416,prescribed,O,1429
29417,as,O,1429
29418,a,O,1429
29419,branded,O,1429
29420,commercially,O,1429
29421,available,O,1429
29422,medication,O,1429
29423,These,O,1430
29424,medications,O,1430
29425,have,O,1430
29426,undergone,O,1430
29427,thorough,O,1430
29428,FDA,B-ORGANIZATION,1430
29429,testing,O,1430
29430,and,O,1430
29431,are,O,1430
29432,sold,O,1430
29433,accordingly,O,1430
29434,However,O,1430
29435,we,O,1430
29436,found,O,1430
29437,that,O,1430
29438,compounded,O,1430
29439,fixed-combination,O,1430
29440,glaucoma,B-TREATMENT,1430
29441,drops,I-TREATMENT,1430
29442,Simple,B-NAME_OF_DRUG,1430
29443,Drops,I-NAME_OF_DRUG,1430
29444,ImprimisRx,B-NAME_OF_DRUG,1430
29445,effectively,O,1430
29446,address,O,1430
29447,a,O,1430
29448,number,O,1430
29449,of,O,1430
29450,the,O,1430
29451,reasons,O,1430
29452,that,O,1431
29453,contribute,O,1431
29454,to,O,1431
29455,poor,O,1431
29456,adherence,O,1431
29457,as,O,1431
29458,the,O,1431
29459,regimens,O,1431
29460,get,O,1431
29461,more,O,1431
29462,complex,O,1431
29463,with,O,1431
29464,3,O,1431
29465,to,O,1431
29466,4,O,1431
29467,drugs,O,1431
29468,or,O,1432
29469,if,O,1432
29470,there,O,1432
29471,are,O,1432
29472,cost,O,1432
29473,and,O,1432
29474,adherence,O,1432
29475,difficulties,O,1432
29476,with,O,1432
29477,even,O,1432
29478,2,O,1432
29479,drops,O,1432
29480,Although,O,1432
29481,there,O,1432
29482,are,O,1432
29483,a,O,1432
29484,few,O,1432
29485,dual-drug,O,1432
29486,combinations,O,1432
29487,available,O,1432
29488,in,O,1432
29489,the,B-GPE,1433
29490,US,I-GPE,1433
29491,none,O,1433
29492,of,O,1433
29493,them,O,1433
29494,combine,O,1433
29495,a,B-NAME_OF_DRUG,1433
29496,prostaglandin,I-NAME_OF_DRUG,1433
29497,analogue,I-NAME_OF_DRUG,1433
29498,PGA,I-NAME_OF_DRUG,1433
29499,with,O,1433
29500,a,B-NAME_OF_DRUG,1433
29501,beta-blocker,I-NAME_OF_DRUG,1433
29502,and,O,1433
29503,none,O,1433
29504,contain,O,1433
29505,more,O,1433
29506,than,O,1433
29507,two,O,1433
29508,agents,O,1433
29509,With,O,1433
29510,Easy,B-NAME_OF_DRUG,1433
29511,Drops,I-NAME_OF_DRUG,1433
29512,I,O,1433
29513,can,O,1433
29514,reduce,O,1433
29515,the,O,1433
29516,patient,O,1433
29517,s,O,1433
29518,regimen,O,1433
29519,to,O,1434
29520,one,O,1434
29521,bottle,O,1434
29522,once,O,1434
29523,a,O,1434
29524,day,O,1434
29525,or,O,1434
29526,one,O,1434
29527,bottle,O,1435
29528,for,O,1435
29529,the,O,1435
29530,morning,O,1435
29531,and,O,1435
29532,the,O,1435
29533,evening,O,1435
29534,as,O,1435
29535,the,O,1435
29536,name,O,1435
29537,suggests,O,1435
29538,These,O,1435
29539,drugs,O,1435
29540,are,O,1435
29541,compounded,O,1435
29542,in,O,1435
29543,a,O,1435
29544,Pharmacy,B-ORGANIZATION,1435
29545,Compounding,I-ORGANIZATION,1435
29546,Accreditation,I-ORGANIZATION,1435
29547,Board-accredited,I-ORGANIZATION,1436
29548,503A,O,1436
29549,patient-specific,O,1436
29550,pharmacy,O,1436
29551,that,O,1436
29552,follows,O,1436
29553,many,O,1436
29554,of,O,1436
29555,the,O,1436
29556,same,O,1436
29557,high,O,1436
29558,manufacturing,O,1436
29559,standards,O,1437
29560,as,O,1437
29561,its,O,1437
29562,503B,O,1437
29563,facility,O,1437
29564,Every,O,1437
29565,batch,O,1437
29566,is,O,1437
29567,tested,O,1437
29568,for,O,1437
29569,potency,O,1437
29570,sterility,O,1437
29571,and,O,1437
29572,endotoxins,O,1437
29573,so,O,1437
29574,I,O,1437
29575,can,O,1437
29576,be,O,1437
29577,confi,O,1437
29578,dent,O,1437
29579,that,O,1437
29580,my,O,1437
29581,patients,O,1437
29582,get,O,1437
29583,a,O,1437
29584,high-quality,O,1437
29585,product,O,1437
29586,IOP,O,1437
29587,­,O,1437
29588,Fluctuation,O,1437
29589,is,O,1437
29590,the,O,1437
29591,Problem,O,1437
29592,The,O,1437
29593,issue,O,1437
29594,for,O,1437
29595,many,O,1437
29596,of,O,1437
29597,our,O,1437
29598,patients,O,1437
29599,who,O,1437
29600,are,O,1437
29601,using,O,1437
29602,topical,O,1437
29603,treatments,O,1438
29604,yet,O,1438
29605,are,O,1438
29606,still,O,1438
29607,advancing,O,1438
29608,or,O,1438
29609,have,O,1438
29610,poorly,O,1438
29611,managed,O,1438
29612,IOP,O,1438
29613,is,O,1438
29614,not,O,1438
29615,that,O,1438
29616,the,O,1438
29617,drops,O,1438
29618,are,O,1438
29619,not,O,1438
29620,functioning,O,1438
29621,rather,O,1438
29622,it,O,1438
29623,is,O,1438
29624,that,O,1438
29625,their,O,1438
29626,pressure,O,1438
29627,fluctuates,O,1438
29628,due,O,1438
29629,to,O,1438
29630,inconsistent,O,1439
29631,usage,O,1439
29632,of,O,1439
29633,the,O,1439
29634,drug,O,1439
29635,According,O,1439
29636,to,O,1439
29637,the,B-NAME_OF_STUDY,1439
29638,Advanced,I-NAME_OF_STUDY,1439
29639,Glaucoma,I-NAME_OF_STUDY,1439
29640,Intervention,I-NAME_OF_STUDY,1439
29641,Study,I-NAME_OF_STUDY,1439
29642,AGIS,B-NAME_OF_STUDY,1439
29643,visual,O,1439
29644,field,O,1439
29645,deterioration,O,1439
29646,is,O,1439
29647,linked,O,1439
29648,to,O,1439
29649,long-term,O,1439
29650,IOP,O,1439
29651,variation,O,1439
29652,of,O,1439
29653,more,O,1439
29654,than,O,1440
29655,3,O,1440
29656,mm,O,1440
29657,Hg,O,1440
29658,Fluctuations,O,1440
29659,more,O,1440
29660,than,O,1440
29661,triple,O,1440
29662,the,O,1440
29663,risk,O,1440
29664,of,O,1440
29665,advancement,O,1440
29666,in,O,1440
29667,AGIS,B-NAME_OF_STUDY,1440
29668,patients,O,1440
29669,with,O,1440
29670,low,O,1440
29671,mean,O,1440
29672,IOP,O,1440
29673,or,O,1440
29674,those,O,1440
29675,whose,O,1440
29676,pressure,O,1440
29677,appears,O,1440
29678,constant,O,1440
29679,when,O,1440
29680,we,O,1440
29681,meet,O,1440
29682,them,O,1440
29683,in,O,1441
29684,the,O,1441
29685,office,O,1441
29686,For,O,1441
29687,these,O,1441
29688,patients,O,1441
29689,simplifying,O,1441
29690,the,O,1441
29691,regimen,O,1441
29692,can,O,1441
29693,increase,O,1441
29694,adherence,O,1441
29695,sufficiently,O,1441
29696,to,O,1441
29697,stabilize,O,1441
29698,them,O,1441
29699,In,O,1441
29700,a,O,1441
29701,research,O,1441
29702,I,O,1441
29703,conducted,O,1441
29704,switching,O,1441
29705,my,O,1441
29706,patients,O,1442
29707,to,O,1442
29708,a,O,1442
29709,3-in-1,O,1442
29710,or,O,1442
29711,4-in-1,O,1442
29712,drop,O,1442
29713,led,O,1442
29714,to,O,1442
29715,decreased,O,1442
29716,IOP,O,1442
29717,across,O,1442
29718,the,O,1442
29719,majority,O,1442
29720,of,O,1442
29721,patient,O,1442
29722,types,O,1442
29723,especially,O,1442
29724,among,O,1442
29725,those,O,1442
29726,whose,O,1443
29727,prior,O,1443
29728,regimen,O,1443
29729,of,O,1443
29730,3,O,1443
29731,bottles,O,1443
29732,or,O,1443
29733,more,O,1443
29734,resulted,O,1443
29735,in,O,1443
29736,poor,O,1443
29737,control,O,1443
29738,8,O,1443
29739,In,O,1443
29740,the,O,1443
29741,trial,O,1443
29742,four,O,1443
29743,patients,O,1443
29744,were,O,1443
29745,able,O,1443
29746,to,O,1443
29747,postpone,O,1443
29748,scheduled,O,1443
29749,surgery,O,1443
29750,A,O,1443
29751,43-year-old,O,1443
29752,Black,O,1443
29753,American,O,1443
29754,woman,O,1443
29755,with,O,1443
29756,advanced,B-NAME_OF_DISEASE,1443
29757,glaucoma,I-NAME_OF_DISEASE,1444
29758,who,O,1444
29759,was,O,1444
29760,taking,O,1444
29761,brimonidine,B-NAME_OF_DRUG,1444
29762,timolol,I-NAME_OF_DRUG,1444
29763,Combigan,I-NAME_OF_DRUG,1444
29764,brinzolamide,B-NAME_OF_DRUG,1444
29765,Azopt,I-NAME_OF_DRUG,1444
29766,and,O,1444
29767,travoprost,B-NAME_OF_DRUG,1444
29768,was,O,1444
29769,one,O,1444
29770,of,O,1444
29771,these,O,1444
29772,patients,O,1444
29773,Travatan,B-NAME_OF_DRUG,1444
29774,,O,1445
29775,She,O,1445
29776,admitted,O,1445
29777,to,O,1445
29778,me,O,1445
29779,that,O,1445
29780,she,O,1445
29781,couldn,O,1445
29782,t,O,1445
29783,continue,O,1445
29784,taking,O,1445
29785,so,O,1445
29786,many,O,1445
29787,drops,O,1445
29788,because,O,1445
29789,her,O,1445
29790,eyes,O,1445
29791,were,O,1445
29792,always,O,1445
29793,red,O,1445
29794,We,O,1445
29795,talked,O,1445
29796,about,O,1445
29797,trabeculectomy,B-TREATMENT,1445
29798,and,O,1445
29799,I,O,1445
29800,made,O,1445
29801,the,O,1445
29802,decision,O,1445
29803,to,O,1445
29804,discontinue,O,1445
29805,the,B-NAME_OF_DRUG,1445
29806,PGA,I-NAME_OF_DRUG,1445
29807,and,O,1445
29808,start,O,1445
29809,her,O,1445
29810,on,O,1445
29811,Tim-Brim-Dor,O,1445
29812,PF,O,1445
29813,timolol,O,1446
29814,0.5,O,1446
29815,brimonidine,O,1446
29816,0.15,O,1446
29817,and,O,1446
29818,dorzolamide,O,1446
29819,2,O,1446
29820,to,O,1446
29821,help,O,1446
29822,her,O,1446
29823,ocular,O,1446
29824,surface,O,1446
29825,symptoms,O,1446
29826,before,O,1446
29827,the,O,1446
29828,procedure,O,1446
29829,Her,O,1446
29830,IOP,O,1446
29831,was,O,1447
29832,at,O,1447
29833,our,O,1447
29834,target,O,1447
29835,level,O,1447
29836,of,O,1447
29837,12,O,1447
29838,mm,O,1447
29839,Hg,O,1447
29840,at,O,1447
29841,the,O,1447
29842,next,O,1447
29843,follow-up,O,1447
29844,her,O,1447
29845,eyes,O,1448
29846,weren,O,1448
29847,t,O,1448
29848,inflamed,O,1448
29849,and,O,1448
29850,she,O,1448
29851,was,O,1448
29852,content,O,1448
29853,with,O,1448
29854,the,O,1448
29855,decreased,O,1448
29856,drop,O,1448
29857,burden,O,1448
29858,She,O,1448
29859,has,O,1448
29860,continued,O,1448
29861,using,O,1448
29862,this,O,1448
29863,routine,O,1449
29864,for,O,1449
29865,four,B-TIME_DURATION,1449
29866,years,I-TIME_DURATION,1449
29867,and,O,1449
29868,has,O,1449
29869,avoided,O,1449
29870,having,O,1449
29871,any,O,1449
29872,filtering,B-TREATMENT,1449
29873,surgery,I-TREATMENT,1449
29874,Clarity,O,1449
29875,of,O,1449
29876,Cost,O,1449
29877,and,O,1450
29878,Ingredients,O,1450
29879,Using,O,1450
29880,compounded,B-TREATMENT,1450
29881,combination,I-TREATMENT,1450
29882,drops,I-TREATMENT,1450
29883,also,O,1450
29884,allows,O,1450
29885,me,O,1450
29886,to,O,1450
29887,accurately,O,1450
29888,estimate,O,1450
29889,the,O,1450
29890,patient,O,1450
29891,s,O,1450
29892,costs,O,1450
29893,and,O,1450
29894,expectations,O,1451
29895,It,O,1451
29896,is,O,1451
29897,challenging,O,1451
29898,for,O,1451
29899,me,O,1451
29900,to,O,1451
29901,respond,O,1451
29902,to,O,1451
29903,a,O,1451
29904,patient,O,1451
29905,s,O,1451
29906,perfectly,O,1451
29907,fair,O,1451
29908,inquiry,O,1451
29909,of,O,1451
29910,How,O,1451
29911,much,O,1451
29912,is,O,1451
29913,that,O,1451
29914,going,O,1451
29915,to,O,1451
29916,cost,O,1451
29917,if,O,1451
29918,we,O,1451
29919,prescribe,O,1451
29920,three,O,1451
29921,different,O,1451
29922,drugs,O,1451
29923,to,O,1451
29924,them,O,1451
29925,in,O,1451
29926,any,O,1452
29927,manner,O,1452
29928,that,O,1452
29929,is,O,1452
29930,accurate,O,1452
29931,or,O,1452
29932,open,O,1452
29933,Depending,O,1452
29934,on,O,1452
29935,the,O,1452
29936,patient,O,1452
29937,s,O,1452
29938,insurance,O,1452
29939,coverage,O,1452
29940,co-pays,O,1452
29941,and,O,1452
29942,formulary,O,1452
29943,requirements,O,1452
29944,the,O,1452
29945,cost,O,1452
29946,to,O,1452
29947,them,O,1452
29948,might,O,1452
29949,be,O,1452
29950,15,O,1453
29951,or,O,1453
29952,300,O,1453
29953,They,O,1453
29954,are,O,1453
29955,also,O,1453
29956,very,O,1453
29957,likely,O,1453
29958,to,O,1453
29959,receive,O,1453
29960,generic,O,1453
29961,replacements,O,1453
29962,from,O,1453
29963,the,O,1453
29964,drugstore,O,1453
29965,The,O,1453
29966,bioavailability,O,1453
29967,and,O,1453
29968,effectiveness,O,1453
29969,of,O,1453
29970,the,O,1453
29971,active,O,1453
29972,ingredient,O,1453
29973,as,O,1453
29974,well,O,1453
29975,as,O,1453
29976,the,O,1453
29977,acceptability,O,1453
29978,and,O,1453
29979,safety,O,1453
29980,of,O,1453
29981,the,O,1453
29982,drop,O,1453
29983,as,O,1453
29984,a,O,1453
29985,whole,O,1453
29986,can,O,1453
29987,be,O,1454
29988,significantly,O,1454
29989,impacted,O,1454
29990,by,O,1454
29991,differences,O,1454
29992,in,O,1454
29993,the,O,1454
29994,pH,O,1454
29995,viscosity,O,1454
29996,and,O,1454
29997,other,O,1454
29998,characteristics,O,1454
29999,of,O,1454
30000,the,O,1454
30001,inactive,O,1454
30002,vehicle,O,1454
30003,ingredients,O,1454
30004,from,O,1454
30005,one,O,1454
30006,generic,O,1455
30007,to,O,1455
30008,another,O,1455
30009,Even,O,1455
30010,the,O,1455
30011,quality,O,1455
30012,of,O,1455
30013,the,O,1455
30014,dropper,O,1455
30015,container,O,1455
30016,might,O,1455
30017,vary,O,1455
30018,significantly,O,1455
30019,resulting,O,1455
30020,in,O,1455
30021,drops,O,1455
30022,spilling,O,1455
30023,out,O,1455
30024,too,O,1456
30025,quickly,O,1456
30026,and,O,1456
30027,the,O,1456
30028,patient,O,1456
30029,using,O,1456
30030,up,O,1456
30031,a,O,1456
30032,30-day,O,1456
30033,supply,O,1456
30034,much,O,1456
30035,sooner,O,1456
30036,Preservative-Free,O,1456
30037,Formulations,O,1456
30038,Finally,O,1456
30039,compounded,B-TREATMENT,1456
30040,drops,I-TREATMENT,1456
30041,enable,O,1456
30042,me,O,1456
30043,to,O,1456
30044,recommend,O,1456
30045,formulations,O,1456
30046,without,O,1456
30047,preservatives,O,1456
30048,preventing,O,1456
30049,the,O,1456
30050,glaucoma,B-NAME_OF_DISEASE,1456
30051,drugs,O,1456
30052,from,O,1457
30053,amplifying,O,1457
30054,the,O,1457
30055,toxicity,O,1457
30056,of,O,1457
30057,the,B-PART_OF_THE_EYES,1457
30058,ocular,I-PART_OF_THE_EYES,1457
30059,surface,I-PART_OF_THE_EYES,1457
30060,Approximately,O,1457
30061,half,O,1457
30062,of,O,1457
30063,our,O,1457
30064,glaucoma,B-NAME_OF_DISEASE,1458
30065,patients,O,1458
30066,also,O,1458
30067,have,O,1458
30068,OSD,B-NAME_OF_DISEASE,1458
30069,and,O,1458
30070,those,O,1458
30071,who,O,1458
30072,do,O,1458
30073,are,O,1458
30074,more,O,1458
30075,likely,O,1458
30076,to,O,1458
30077,progress,O,1458
30078,experience,O,1458
30079,negative,O,1458
30080,side,O,1458
30081,effects,O,1458
30082,from,O,1458
30083,topical,B-TREATMENT,1458
30084,glaucoma,I-TREATMENT,1458
30085,medication,I-TREATMENT,1458
30086,and,O,1458
30087,be,O,1458
30088,nonadherent,O,1458
30089,The,O,1458
30090,likelihood,O,1458
30091,of,O,1458
30092,future,O,1458
30093,Xen,B-TREATMENT,1458
30094,implantation,I-TREATMENT,1458
30095,or,I-TREATMENT,1458
30096,fusion,I-TREATMENT,1458
30097,surgery,I-TREATMENT,1458
30098,if,O,1458
30099,necessary,O,1458
30100,is,O,1458
30101,increased,O,1458
30102,if,O,1458
30103,we,O,1458
30104,can,O,1458
30105,reduce,O,1458
30106,the,O,1459
30107,impact,O,1459
30108,on,O,1459
30109,the,B-PART_OF_THE_EYES,1459
30110,ocular,I-PART_OF_THE_EYES,1459
30111,surface,I-PART_OF_THE_EYES,1459
30112,I,O,1459
30113,might,O,1459
30114,favor,O,1459
30115,separate,O,1459
30116,bottles,O,1459
30117,of,O,1459
30118,each,O,1459
30119,branded,O,1459
30120,medication,O,1459
30121,if,O,1459
30122,variables,O,1459
30123,like,O,1459
30124,cost,O,1459
30125,compliance,O,1459
30126,and,O,1459
30127,generic,O,1459
30128,substitution,O,1459
30129,were,O,1459
30130,completely,O,1459
30131,irrelevant,O,1459
30132,But,O,1459
30133,we,O,1459
30134,have,O,1459
30135,to,O,1459
30136,recognize,O,1459
30137,that,O,1459
30138,patients,O,1460
30139,are,O,1460
30140,not,O,1460
30141,getting,O,1460
30142,what,O,1460
30143,we,O,1460
30144,prescribe,O,1460
30145,and,O,1460
30146,are,O,1460
30147,not,O,1460
30148,consistently,O,1460
30149,instilling,O,1460
30150,the,O,1461
30151,medications,O,1461
30152,that,O,1461
30153,they,O,1461
30154,do,O,1461
30155,receive,O,1461
30156,with,O,1461
30157,resulting,O,1461
30158,IOP,O,1461
30159,fluctuation,O,1461
30160,and,O,1461
30161,disease,O,1461
30162,progression,O,1461
30163,A,O,1461
30164,simplified,O,1461
30165,regimen,O,1461
30166,of,O,1461
30167,compounded,B-TREATMENT,1461
30168,fixed-combination,I-TREATMENT,1461
30169,glaucoma,I-TREATMENT,1461
30170,therapy,I-TREATMENT,1461
30171,is,O,1461
30172,a,O,1461
30173,very,O,1461
30174,welcome,O,1461
30175,solution,O,1461
30176,to,O,1461
30177,these,O,1461
30178,real-world,O,1461
30179,problems,O,1461
30180,Herpes,B-NAME_OF_DISEASE,1462
30181,Zoster,I-NAME_OF_DISEASE,1462
30182,Ophthalmicus,I-NAME_OF_DISEASE,1462
30183,HZO,I-NAME_OF_DISEASE,1462
30184,commonly,O,1462
30185,known,O,1462
30186,as,O,1462
30187,shingles,B-NAME_OF_DISEASE,1462
30188,is,O,1462
30189,a,O,1462
30190,viral,O,1462
30191,disease,O,1462
30192,characterized,O,1462
30193,by,O,1462
30194,a,B-SIGN_AND_SYMPTOM,1462
30195,unilateral,I-SIGN_AND_SYMPTOM,1462
30196,painful,I-SIGN_AND_SYMPTOM,1462
30197,skin,I-SIGN_AND_SYMPTOM,1462
30198,rash,I-SIGN_AND_SYMPTOM,1462
30199,in,I-SIGN_AND_SYMPTOM,1462
30200,one,I-SIGN_AND_SYMPTOM,1462
30201,or,I-SIGN_AND_SYMPTOM,1462
30202,more,I-SIGN_AND_SYMPTOM,1462
30203,dermatome,I-SIGN_AND_SYMPTOM,1462
30204,distributions,I-SIGN_AND_SYMPTOM,1462
30205,of,I-SIGN_AND_SYMPTOM,1463
30206,the,I-SIGN_AND_SYMPTOM,1463
30207,fifth,I-SIGN_AND_SYMPTOM,1463
30208,cranial,I-SIGN_AND_SYMPTOM,1463
30209,nerve,I-SIGN_AND_SYMPTOM,1463
30210,trigeminal,I-SIGN_AND_SYMPTOM,1463
30211,nerve,I-SIGN_AND_SYMPTOM,1463
30212,shared,I-SIGN_AND_SYMPTOM,1463
30213,by,I-SIGN_AND_SYMPTOM,1463
30214,the,I-SIGN_AND_SYMPTOM,1463
30215,eye,I-SIGN_AND_SYMPTOM,1463
30216,and,I-SIGN_AND_SYMPTOM,1463
30217,ocular,I-SIGN_AND_SYMPTOM,1463
30218,adnexa,I-SIGN_AND_SYMPTOM,1464
30219,Herpes,B-NAME_OF_DISEASE,1464
30220,zoster,I-NAME_OF_DISEASE,1464
30221,ophthalmicus,I-NAME_OF_DISEASE,1464
30222,occurs,O,1464
30223,when,O,1464
30224,the,O,1464
30225,varicella-zoster,B-CHEMICAL_COMPOUND,1464
30226,virus,I-CHEMICAL_COMPOUND,1464
30227,is,O,1464
30228,reactivated,O,1464
30229,in,O,1464
30230,the,O,1464
30231,ophthalmic,O,1464
30232,division,O,1464
30233,of,O,1464
30234,the,O,1464
30235,trigeminal,O,1464
30236,nerve,O,1464
30237,Herpes,B-NAME_OF_DISEASE,1464
30238,zoster,I-NAME_OF_DISEASE,1464
30239,ophthalmicus,I-NAME_OF_DISEASE,1464
30240,represents,O,1464
30241,up,O,1464
30242,to,O,1464
30243,one,O,1464
30244,fourth,O,1464
30245,of,O,1464
30246,all,O,1464
30247,cases,O,1464
30248,of,O,1464
30249,herpes,B-NAME_OF_DISEASE,1464
30250,zoster,I-NAME_OF_DISEASE,1464
30251,Most,O,1464
30252,patients,O,1464
30253,with,O,1464
30254,herpes,B-NAME_OF_DISEASE,1464
30255,zoster,I-NAME_OF_DISEASE,1464
30256,ophthalmicus,I-NAME_OF_DISEASE,1464
30257,present,O,1464
30258,with,O,1464
30259,a,B-SIGN_AND_SYMPTOM,1464
30260,periorbital,I-SIGN_AND_SYMPTOM,1464
30261,vesicular,I-SIGN_AND_SYMPTOM,1464
30262,rash,I-SIGN_AND_SYMPTOM,1464
30263,distributed,I-SIGN_AND_SYMPTOM,1465
30264,according,I-SIGN_AND_SYMPTOM,1465
30265,to,I-SIGN_AND_SYMPTOM,1465
30266,the,I-SIGN_AND_SYMPTOM,1465
30267,affected,I-SIGN_AND_SYMPTOM,1465
30268,dermatome,I-SIGN_AND_SYMPTOM,1465
30269,A,O,1465
30270,minority,O,1465
30271,of,O,1465
30272,patients,O,1465
30273,may,O,1465
30274,also,O,1465
30275,develop,O,1465
30276,conjunctivitis,B-NAME_OF_DISEASE,1465
30277,keratitis,B-NAME_OF_DISEASE,1465
30278,uveitis,B-NAME_OF_DISEASE,1465
30279,and,O,1465
30280,ocular,B-NAME_OF_DISEASE,1465
30281,cranial-nerve,I-NAME_OF_DISEASE,1465
30282,palsies,I-NAME_OF_DISEASE,1465
30283,Permanent,O,1465
30284,sequelae,O,1465
30285,of,O,1465
30286,ophthalmic,B-NAME_OF_DISEASE,1465
30287,zoster,I-NAME_OF_DISEASE,1465
30288,infection,I-NAME_OF_DISEASE,1465
30289,may,O,1465
30290,include,O,1465
30291,chronic,B-NAME_OF_DISEASE,1465
30292,ocular,I-NAME_OF_DISEASE,1465
30293,inflammation,I-NAME_OF_DISEASE,1465
30294,loss,B-SIGN_AND_SYMPTOM,1466
30295,of,I-SIGN_AND_SYMPTOM,1466
30296,vision,I-SIGN_AND_SYMPTOM,1466
30297,and,O,1466
30298,debilitating,B-SIGN_AND_SYMPTOM,1466
30299,pain,I-SIGN_AND_SYMPTOM,1466
30300,Antiviral,B-NAME_OF_DRUG,1466
30301,medications,I-NAME_OF_DRUG,1466
30302,such,O,1466
30303,as,O,1466
30304,acyclovir,B-NAME_OF_DRUG,1466
30305,valacyclovir,B-NAME_OF_DRUG,1466
30306,and,O,1466
30307,famciclovir,B-NAME_OF_DRUG,1466
30308,remain,O,1466
30309,the,O,1466
30310,mainstay,O,1466
30311,of,O,1466
30312,therapy,O,1466
30313,and,O,1466
30314,are,O,1466
30315,most,O,1466
30316,effective,O,1466
30317,in,O,1467
30318,preventing,O,1467
30319,ocular,O,1467
30320,involvement,O,1467
30321,when,O,1467
30322,begun,O,1467
30323,within,O,1467
30324,72,O,1467
30325,hours,O,1467
30326,after,O,1467
30327,the,O,1467
30328,onset,O,1467
30329,of,O,1467
30330,the,O,1467
30331,rash,O,1467
30332,Timely,O,1467
30333,diagnosis,O,1467
30334,and,O,1467
30335,management,O,1467
30336,of,O,1467
30337,herpes,B-NAME_OF_DISEASE,1467
30338,zoster,I-NAME_OF_DISEASE,1467
30339,ophthalmicus,I-NAME_OF_DISEASE,1468
30340,with,O,1468
30341,referral,O,1468
30342,to,O,1468
30343,an,O,1468
30344,ophthalmologist,O,1468
30345,when,O,1468
30346,ophthalmic,O,1468
30347,involvement,O,1468
30348,is,O,1468
30349,present,O,1468
30350,are,O,1468
30351,critical,O,1468
30352,in,O,1468
30353,limiting,O,1469
30354,visual,O,1469
30355,morbidity,O,1469
30356,Herpes,B-NAME_OF_DISEASE,1469
30357,zoster,I-NAME_OF_DISEASE,1469
30358,also,O,1469
30359,referred,O,1469
30360,to,O,1469
30361,as,O,1469
30362,shingles,B-NAME_OF_DISEASE,1469
30363,is,O,1469
30364,a,O,1470
30365,common,O,1470
30366,infection,O,1470
30367,most,O,1470
30368,typically,O,1470
30369,caused,O,1470
30370,by,O,1470
30371,the,B-CAUSE_OF_DISEASE,1471
30372,reactivation,I-CAUSE_OF_DISEASE,1471
30373,of,I-CAUSE_OF_DISEASE,1471
30374,varicella,I-CAUSE_OF_DISEASE,1471
30375,zoster,I-CAUSE_OF_DISEASE,1471
30376,virus,I-CAUSE_OF_DISEASE,1471
30377,that,I-CAUSE_OF_DISEASE,1471
30378,lies,I-CAUSE_OF_DISEASE,1471
30379,dormant,I-CAUSE_OF_DISEASE,1471
30380,sometime,I-CAUSE_OF_DISEASE,1471
30381,for,I-CAUSE_OF_DISEASE,1471
30382,decades,I-CAUSE_OF_DISEASE,1471
30383,in,I-CAUSE_OF_DISEASE,1471
30384,the,I-CAUSE_OF_DISEASE,1471
30385,dorsal,I-CAUSE_OF_DISEASE,1471
30386,root,I-CAUSE_OF_DISEASE,1471
30387,nerve,I-CAUSE_OF_DISEASE,1471
30388,ganglion,I-CAUSE_OF_DISEASE,1471
30389,following,I-CAUSE_OF_DISEASE,1471
30390,primary,I-CAUSE_OF_DISEASE,1471
30391,chickenpox,I-CAUSE_OF_DISEASE,1471
30392,infection,I-CAUSE_OF_DISEASE,1471
30393,In,O,1471
30394,10-20%,O,1471
30395,of,O,1471
30396,cases,O,1471
30397,the,O,1471
30398,first,O,1471
30399,division,O,1471
30400,of,O,1471
30401,the,O,1471
30402,trigeminal,O,1471
30403,nerve,O,1471
30404,V1,O,1471
30405,is,O,1472
30406,involved,O,1472
30407,and,O,1472
30408,herpes,B-NAME_OF_DISEASE,1472
30409,zoster,I-NAME_OF_DISEASE,1472
30410,ophthalmicus,I-NAME_OF_DISEASE,1473
30411,occurs,O,1473
30412,A,O,1473
30413,patient,O,1473
30414,with,O,1473
30415,herpes,B-NAME_OF_DISEASE,1473
30416,zoster,I-NAME_OF_DISEASE,1473
30417,ophthalmicus,I-NAME_OF_DISEASE,1473
30418,typically,O,1473
30419,presents,O,1473
30420,with,O,1473
30421,a,B-SIGN_AND_SYMPTOM,1473
30422,painful,I-SIGN_AND_SYMPTOM,1473
30423,unilateral,I-SIGN_AND_SYMPTOM,1473
30424,vesicular,I-SIGN_AND_SYMPTOM,1473
30425,rash,I-SIGN_AND_SYMPTOM,1473
30426,in,I-SIGN_AND_SYMPTOM,1473
30427,a,I-SIGN_AND_SYMPTOM,1474
30428,dermatomal,I-SIGN_AND_SYMPTOM,1474
30429,distribution,I-SIGN_AND_SYMPTOM,1474
30430,It,O,1474
30431,may,O,1474
30432,but,O,1474
30433,not,O,1474
30434,always,O,1474
30435,present,O,1474
30436,with,O,1474
30437,ocular,O,1474
30438,involvement,O,1474
30439,including,O,1474
30440,painful,O,1474
30441,inflammation,O,1474
30442,of,O,1474
30443,the,O,1474
30444,anterior,O,1474
30445,and,O,1474
30446,rarely,O,1474
30447,posterior,O,1474
30448,structures,O,1474
30449,of,O,1474
30450,the,O,1474
30451,eye,O,1474
30452,including,O,1474
30453,conjunctivitis,B-NAME_OF_DISEASE,1474
30454,keratitis,B-NAME_OF_DISEASE,1474
30455,iritis,B-NAME_OF_DISEASE,1474
30456,and,O,1474
30457,uveitis,B-NAME_OF_DISEASE,1474
30458,This,O,1475
30459,is,O,1475
30460,a,O,1475
30461,clinical,O,1475
30462,diagnosis,O,1475
30463,but,O,1475
30464,can,O,1475
30465,be,O,1475
30466,confirmed,O,1475
30467,by,O,1475
30468,viral,B-DIAGNOSTIC_TEST,1475
30469,swabs,I-DIAGNOSTIC_TEST,1475
30470,History,O,1475
30471,Whilst,O,1475
30472,taking,O,1475
30473,a,O,1476
30474,patient,O,1476
30475,history,O,1476
30476,it,O,1476
30477,is,O,1476
30478,key,O,1476
30479,to,O,1476
30480,ascertain,O,1476
30481,when,O,1476
30482,the,B-SIGN_AND_SYMPTOM,1476
30483,rash,B-SIGN_AND_SYMPTOM,1476
30484,started,O,1476
30485,initiating,O,1476
30486,antiviral,B-TREATMENT,1476
30487,treatment,I-TREATMENT,1476
30488,within,B-TIME_DURATION,1477
30489,72,I-TIME_DURATION,1477
30490,hours,I-TIME_DURATION,1477
30491,from,O,1477
30492,the,O,1477
30493,onset,O,1477
30494,of,O,1477
30495,rash,B-SIGN_AND_SYMPTOM,1478
30496,is,O,1478
30497,essential,O,1478
30498,in,O,1478
30499,reducing,O,1478
30500,the,O,1478
30501,risk,O,1478
30502,of,O,1478
30503,long-term,O,1478
30504,ocular,O,1478
30505,complications,O,1478
30506,including,O,1478
30507,uveitis,B-NAME_OF_DISEASE,1478
30508,stromal,B-NAME_OF_DISEASE,1478
30509,keratitis,I-NAME_OF_DISEASE,1478
30510,and,O,1478
30511,pseudo-dendritis,B-NAME_OF_DISEASE,1479
30512,To,O,1479
30513,decipher,O,1479
30514,whether,O,1479
30515,there,O,1479
30516,is,O,1479
30517,an,O,1479
30518,ocular,O,1479
30519,involvement,O,1479
30520,it,O,1480
30521,is,O,1480
30522,pivotal,O,1480
30523,that,O,1480
30524,the,O,1480
30525,following,O,1480
30526,symptoms,O,1480
30527,are,O,1480
30528,enquired,O,1480
30529,about,O,1480
30530,eye,B-SIGN_AND_SYMPTOM,1480
30531,pain,I-SIGN_AND_SYMPTOM,1480
30532,diplopia,I-SIGN_AND_SYMPTOM,1480
30533,discharge,I-SIGN_AND_SYMPTOM,1480
30534,red,I-SIGN_AND_SYMPTOM,1480
30535,eye,I-SIGN_AND_SYMPTOM,1480
30536,photophobia,I-SIGN_AND_SYMPTOM,1480
30537,visual,I-SIGN_AND_SYMPTOM,1480
30538,loss,I-SIGN_AND_SYMPTOM,1480
30539,disturbance,I-SIGN_AND_SYMPTOM,1480
30540,floaters,I-SIGN_AND_SYMPTOM,1480
30541,and,I-SIGN_AND_SYMPTOM,1480
30542,flashing,I-SIGN_AND_SYMPTOM,1480
30543,lights,I-SIGN_AND_SYMPTOM,1480
30544,Systemic,O,1480
30545,symptoms,O,1480
30546,including,O,1480
30547,general,B-SIGN_AND_SYMPTOM,1481
30548,malaise,I-SIGN_AND_SYMPTOM,1481
30549,headache,I-SIGN_AND_SYMPTOM,1481
30550,and,I-SIGN_AND_SYMPTOM,1481
30551,fever,I-SIGN_AND_SYMPTOM,1481
30552,should,O,1481
30553,also,O,1481
30554,be,O,1481
30555,asked,O,1481
30556,It,O,1481
30557,is,O,1481
30558,then,O,1481
30559,important,O,1481
30560,to,O,1481
30561,enquire,O,1481
30562,about,O,1481
30563,past,O,1481
30564,medical,O,1481
30565,history,O,1481
30566,particularly,O,1481
30567,if,O,1481
30568,there,O,1481
30569,is,O,1481
30570,any,O,1481
30571,recent,O,1481
30572,systemic,O,1481
30573,illness,O,1481
30574,which,O,1481
30575,would,O,1481
30576,impair,O,1481
30577,immunity,O,1482
30578,thus,O,1482
30579,increasing,O,1482
30580,the,O,1482
30581,risk,O,1482
30582,of,O,1482
30583,developing,O,1482
30584,herpes,B-NAME_OF_DISEASE,1482
30585,zoster,I-NAME_OF_DISEASE,1482
30586,Additionally,O,1482
30587,asking,O,1482
30588,whether,O,1482
30589,there,O,1483
30590,is,O,1483
30591,any,O,1483
30592,history,O,1483
30593,of,O,1483
30594,immunosuppression,B-NAME_OF_DISEASE,1483
30595,including,O,1483
30596,malignancy,B-NAME_OF_DISEASE,1483
30597,HIV,B-NAME_OF_DISEASE,1483
30598,or,O,1483
30599,history,O,1483
30600,of,O,1483
30601,chickenpox,B-NAME_OF_DISEASE,1483
30602,would,O,1483
30603,aid,O,1483
30604,with,O,1483
30605,investigations,O,1483
30606,and,O,1483
30607,starting,O,1483
30608,stronger,O,1483
30609,antiviral,B-TREATMENT,1483
30610,treatment,I-TREATMENT,1483
30611,Likewise,O,1483
30612,asking,O,1483
30613,if,O,1483
30614,the,O,1483
30615,patient,O,1483
30616,is,O,1484
30617,on,O,1484
30618,any,O,1484
30619,immunosuppressive,B-NAME_OF_DRUG,1484
30620,medication,I-NAME_OF_DRUG,1484
30621,would,O,1484
30622,be,O,1484
30623,beneficial,O,1484
30624,Finally,O,1484
30625,taking,O,1484
30626,a,O,1484
30627,thorough,O,1484
30628,social,O,1484
30629,history,O,1484
30630,is,O,1484
30631,pivotal,O,1484
30632,to,O,1484
30633,ascertain,O,1484
30634,if,O,1484
30635,there,O,1484
30636,are,O,1484
30637,any,O,1484
30638,vulnerable,O,1484
30639,populations,O,1484
30640,including,O,1484
30641,children,O,1484
30642,and,O,1484
30643,pregnant,O,1484
30644,women,O,1484
30645,who,O,1484
30646,the,O,1484
30647,patient,O,1484
30648,has,O,1484
30649,recently,O,1484
30650,been,O,1485
30651,in,O,1485
30652,close,O,1485
30653,contact,O,1485
30654,with,O,1485
30655,that,O,1485
30656,may,O,1485
30657,require,O,1485
30658,urgent,O,1485
30659,medical,O,1485
30660,attention,O,1485
30661,if,O,1485
30662,showing,O,1486
30663,signs,O,1486
30664,of,O,1486
30665,varicella,B-NAME_OF_DISEASE,1486
30666,or,O,1486
30667,herpes,B-NAME_OF_DISEASE,1486
30668,zoster,I-NAME_OF_DISEASE,1486
30669,Examination,O,1486
30670,On,O,1486
30671,general,O,1486
30672,examination,O,1486
30673,look,O,1486
30674,at,O,1486
30675,the,O,1486
30676,pattern,O,1486
30677,and,O,1486
30678,distribution,O,1486
30679,of,O,1486
30680,the,B-SIGN_AND_SYMPTOM,1486
30681,rash,I-SIGN_AND_SYMPTOM,1487
30682,a,I-SIGN_AND_SYMPTOM,1487
30683,unilateral,I-SIGN_AND_SYMPTOM,1487
30684,not,I-SIGN_AND_SYMPTOM,1487
30685,crossing,I-SIGN_AND_SYMPTOM,1487
30686,the,I-SIGN_AND_SYMPTOM,1487
30687,midline,I-SIGN_AND_SYMPTOM,1487
30688,vesicular,I-SIGN_AND_SYMPTOM,1487
30689,rash,I-SIGN_AND_SYMPTOM,1487
30690,along,I-SIGN_AND_SYMPTOM,1487
30691,the,I-SIGN_AND_SYMPTOM,1488
30692,V1,I-SIGN_AND_SYMPTOM,1488
30693,dermatomal,I-SIGN_AND_SYMPTOM,1488
30694,distribution,I-SIGN_AND_SYMPTOM,1488
30695,would,O,1488
30696,highly,O,1488
30697,indicate,O,1488
30698,herpes,B-NAME_OF_DISEASE,1488
30699,zoster,I-NAME_OF_DISEASE,1488
30700,A,O,1488
30701,key,O,1488
30702,sign,O,1488
30703,to,O,1488
30704,be,O,1488
30705,aware,O,1488
30706,of,O,1488
30707,is,O,1488
30708,Hutchinson,B-SIGN_AND_SYMPTOM,1488
30709,s,I-SIGN_AND_SYMPTOM,1488
30710,sign,I-SIGN_AND_SYMPTOM,1488
30711,this,O,1488
30712,is,O,1488
30713,a,O,1488
30714,rash,O,1488
30715,involving,O,1489
30716,the,O,1489
30717,tip,O,1489
30718,side,O,1489
30719,or,O,1489
30720,root,O,1489
30721,of,O,1489
30722,nose,O,1489
30723,It,O,1489
30724,indicates,O,1489
30725,involvement,O,1489
30726,of,O,1489
30727,the,O,1489
30728,nasociliary,O,1489
30729,branch,O,1489
30730,of,O,1490
30731,the,O,1490
30732,trigeminal,O,1490
30733,nerve,O,1490
30734,and,O,1490
30735,is,O,1490
30736,strongly,O,1490
30737,correlated,O,1490
30738,with,O,1490
30739,ocular,B-NAME_OF_DISEASE,1490
30740,inflammation,I-NAME_OF_DISEASE,1490
30741,and,O,1490
30742,permanent,B-NAME_OF_DISEASE,1490
30743,corneal,I-NAME_OF_DISEASE,1491
30744,denervation,I-NAME_OF_DISEASE,1491
30745,Using,O,1491
30746,fluorescein,B-NAME_OF_DRUG,1491
30747,drops,I-NAME_OF_DRUG,1491
30748,to,O,1491
30749,determine,O,1491
30750,if,O,1491
30751,there,O,1491
30752,are,O,1491
30753,any,O,1491
30754,corneal,O,1491
30755,changes,O,1491
30756,is,O,1491
30757,also,O,1491
30758,essential,O,1491
30759,Finally,O,1491
30760,signs,O,1491
30761,of,O,1491
30762,infection,O,1491
30763,both,O,1491
30764,locally,O,1491
30765,purulent,O,1491
30766,discharge,O,1491
30767,and,O,1491
30768,spread,O,1491
30769,e.g,O,1491
30770,confusion,O,1491
30771,in,O,1491
30772,encephalitis,O,1491
30773,need,O,1491
30774,to,O,1491
30775,be,O,1491
30776,assessed,O,1491
30777,On,B-DIAGNOSTIC_TEST,1491
30778,ocular,I-DIAGNOSTIC_TEST,1491
30779,examination,I-DIAGNOSTIC_TEST,1491
30780,the,I-DIAGNOSTIC_TEST,1491
30781,external,I-DIAGNOSTIC_TEST,1491
30782,eye,I-DIAGNOSTIC_TEST,1491
30783,should,I-DIAGNOSTIC_TEST,1491
30784,be,I-DIAGNOSTIC_TEST,1491
30785,examined,I-DIAGNOSTIC_TEST,1491
30786,for,O,1491
30787,conjunctival,B-SIGN_AND_SYMPTOM,1491
30788,redness,I-SIGN_AND_SYMPTOM,1491
30789,acuity,B-DIAGNOSTIC_TEST,1492
30790,should,I-DIAGNOSTIC_TEST,1492
30791,be,I-DIAGNOSTIC_TEST,1492
30792,assessed,I-DIAGNOSTIC_TEST,1492
30793,using,I-DIAGNOSTIC_TEST,1492
30794,Snellen,I-DIAGNOSTIC_TEST,1492
30795,chart,I-DIAGNOSTIC_TEST,1492
30796,and,I-DIAGNOSTIC_TEST,1492
30797,viral,I-DIAGNOSTIC_TEST,1492
30798,swabs,I-DIAGNOSTIC_TEST,1492
30799,taken,O,1492
30800,for,O,1492
30801,herpes,B-NAME_OF_DISEASE,1492
30802,simplex,I-NAME_OF_DISEASE,1492
30803,varicella,B-NAME_OF_DISEASE,1492
30804,zoster,I-NAME_OF_DISEASE,1492
30805,if,O,1492
30806,there,O,1492
30807,is,O,1492
30808,diagnostic,O,1492
30809,uncertainty,O,1492
30810,e.g,O,1492
30811,if,O,1492
30812,the,B-SIGN_AND_SYMPTOM,1492
30813,rash,I-SIGN_AND_SYMPTOM,1492
30814,is,O,1492
30815,atypical,O,1492
30816,After,O,1492
30817,external,O,1492
30818,examination,O,1492
30819,of,O,1492
30820,the,O,1492
30821,eye,O,1492
30822,a,B-DIAGNOSTIC_TEST,1492
30823,dilated,I-DIAGNOSTIC_TEST,1493
30824,fundus,I-DIAGNOSTIC_TEST,1493
30825,examination,I-DIAGNOSTIC_TEST,1493
30826,can,O,1493
30827,then,O,1493
30828,be,O,1493
30829,performed,O,1493
30830,including,O,1493
30831,intraocular,O,1493
30832,pressures,O,1493
30833,Management,O,1493
30834,The,O,1493
30835,key,O,1493
30836,in,O,1493
30837,managing,O,1493
30838,patients,O,1493
30839,with,O,1493
30840,herpes,B-NAME_OF_DISEASE,1493
30841,zoster,I-NAME_OF_DISEASE,1493
30842,ophthalmicus,I-NAME_OF_DISEASE,1493
30843,regardless,O,1493
30844,of,O,1493
30845,ocular,O,1493
30846,involvement,O,1493
30847,is,O,1493
30848,initiating,O,1494
30849,antiviral,B-NAME_OF_DRUG,1494
30850,treatment,I-NAME_OF_DRUG,1494
30851,oral,B-NAME_OF_DRUG,1494
30852,aciclovir,I-NAME_OF_DRUG,1494
30853,is,O,1494
30854,first,O,1494
30855,line,O,1494
30856,within,B-TIME_DURATION,1494
30857,72,I-TIME_DURATION,1494
30858,hours,I-TIME_DURATION,1494
30859,of,O,1494
30860,the,O,1494
30861,onset,O,1494
30862,of,O,1494
30863,rash,B-SIGN_AND_SYMPTOM,1494
30864,Ocular,O,1494
30865,involvement,O,1494
30866,occurs,O,1494
30867,in,O,1494
30868,approximately,O,1494
30869,50%,O,1494
30870,of,O,1494
30871,HZ,B-NAME_OF_DISEASE,1494
30872,patients,O,1494
30873,without,O,1495
30874,the,O,1495
30875,use,O,1495
30876,of,O,1495
30877,antiviral,B-TREATMENT,1495
30878,therapy,I-TREATMENT,1495
30879,If,O,1495
30880,there,O,1495
30881,is,O,1495
30882,any,O,1495
30883,evidence,O,1495
30884,of,O,1495
30885,uveitis,B-NAME_OF_DISEASE,1495
30886,or,O,1495
30887,stromal,B-NAME_OF_DISEASE,1495
30888,keratitis,I-NAME_OF_DISEASE,1495
30889,topical,B-NAME_OF_DRUG,1495
30890,steroids,I-NAME_OF_DRUG,1495
30891,should,O,1495
30892,be,O,1495
30893,used,O,1495
30894,Immunosuppressive,B-TREATMENT,1496
30895,therapy,I-TREATMENT,1496
30896,should,O,1496
30897,be,O,1496
30898,used,O,1496
30899,for,O,1496
30900,scleritis,B-NAME_OF_DISEASE,1496
30901,Topical,O,1496
30902,anaesthesia,O,1496
30903,should,O,1496
30904,not,O,1496
30905,be,O,1496
30906,used,O,1496
30907,as,O,1496
30908,it,O,1496
30909,prevents,O,1496
30910,corneal,O,1496
30911,healing,O,1496
30912,and,O,1496
30913,may,O,1496
30914,worsen,O,1496
30915,corneal,O,1496
30916,denervation,O,1496
30917,Analgesia,B-NAME_OF_DRUG,1496
30918,and,I-NAME_OF_DRUG,1496
30919,lubricating,I-NAME_OF_DRUG,1496
30920,eye,I-NAME_OF_DRUG,1496
30921,drops,I-NAME_OF_DRUG,1496
30922,should,O,1496
30923,also,O,1496
30924,be,O,1496
30925,considered,O,1496
30926,Educating,O,1496
30927,patients,O,1496
30928,regarding,O,1497
30929,avoiding,O,1497
30930,close,O,1497
30931,contact,O,1497
30932,until,O,1497
30933,vesicles,O,1497
30934,have,O,1497
30935,fully,O,1497
30936,crusted,O,1497
30937,over,O,1497
30938,with,O,1497
30939,vulnerable,O,1497
30940,populations,O,1497
30941,particularly,O,1497
30942,children,O,1497
30943,and,O,1498
30944,pregnant,O,1498
30945,women,O,1498
30946,should,O,1498
30947,also,O,1498
30948,be,O,1498
30949,reinforced,O,1498
30950,by,O,1498
30951,healthcare,O,1498
30952,professionals,O,1498
30953,Complication,O,1498
30954,The,O,1498
30955,two,O,1498
30956,most,O,1498
30957,important,O,1498
30958,complications,O,1498
30959,of,O,1498
30960,herpes,B-NAME_OF_DISEASE,1498
30961,zoster,I-NAME_OF_DISEASE,1498
30962,ophthalmicus,I-NAME_OF_DISEASE,1498
30963,are,O,1498
30964,uveitis,B-NAME_OF_DISEASE,1498
30965,pain,B-SIGN_AND_SYMPTOM,1498
30966,and,I-SIGN_AND_SYMPTOM,1498
30967,photophobia,I-SIGN_AND_SYMPTOM,1498
30968,without,I-SIGN_AND_SYMPTOM,1498
30969,discharge,I-SIGN_AND_SYMPTOM,1498
30970,and,O,1499
30971,acute,B-NAME_OF_DISEASE,1499
30972,retinal,I-NAME_OF_DISEASE,1499
30973,necrosis,I-NAME_OF_DISEASE,1499
30974,pain,B-SIGN_AND_SYMPTOM,1499
30975,with,I-SIGN_AND_SYMPTOM,1499
30976,loss,I-SIGN_AND_SYMPTOM,1499
30977,of,I-SIGN_AND_SYMPTOM,1499
30978,vision,I-SIGN_AND_SYMPTOM,1499
30979,+,I-SIGN_AND_SYMPTOM,1499
30980,-,I-SIGN_AND_SYMPTOM,1499
30981,floaters,I-SIGN_AND_SYMPTOM,1499
30982,,O,1499
30983,Other,O,1499
30984,complications,O,1499
30985,include,O,1499
30986,conjunctivitis,B-NAME_OF_DISEASE,1499
30987,corneal,B-NAME_OF_DISEASE,1499
30988,pseudo-dendritis,I-NAME_OF_DISEASE,1499
30989,episcleritis,B-NAME_OF_DISEASE,1499
30990,post-herpetic,B-NAME_OF_DISEASE,1499
30991,neuralgia,I-NAME_OF_DISEASE,1499
30992,and,O,1499
30993,disciform,B-NAME_OF_DISEASE,1499
30994,keratitis,I-NAME_OF_DISEASE,1500
30995,Prevention,O,1500
30996,The,B-PREVENTION,1500
30997,recombinant,I-PREVENTION,1500
30998,herpes,B-NAME_OF_DISEASE,1500
30999,zoster,I-NAME_OF_DISEASE,1500
31000,vaccine,I-PREVENTION,1500
31001,is,O,1500
31002,recommended,O,1500
31003,for,O,1500
31004,adults,O,1500
31005,≥70,O,1500
31006,years,O,1500
31007,in,O,1500
31008,the,B-GPE,1501
31009,UK,I-GPE,1501
31010,and,O,1501
31011,has,O,1501
31012,been,O,1501
31013,shown,O,1501
31014,to,O,1501
31015,reduce,O,1501
31016,cases,O,1501
31017,of,O,1501
31018,herpes,B-NAME_OF_DISEASE,1501
31019,zoster,I-NAME_OF_DISEASE,1501
31020,by,O,1501
31021,38%,O,1501
31022,Public,O,1501
31023,health,O,1501
31024,education,O,1501
31025,campaigns,O,1501
31026,would,O,1501
31027,be,O,1501
31028,useful,O,1501
31029,to,O,1501
31030,highlight,O,1501
31031,the,O,1501
31032,importance,O,1501
31033,of,O,1501
31034,this,O,1502
31035,vaccination,O,1502
31036,to,O,1502
31037,this,O,1502
31038,population,O,1502
31039,given,O,1502
31040,the,O,1502
31041,severity,O,1502
31042,of,O,1502
31043,the,O,1502
31044,complications,O,1502
31045,that,O,1502
31046,may,O,1502
31047,arise,O,1502
31048,from,O,1502
31049,it,O,1502
31050,if,O,1502
31051,not,O,1502
31052,identified,O,1502
31053,or,O,1502
31054,treated,O,1502
31055,appropriately,O,1502
31056,Intraocular,O,1502
31057,pressure,O,1502
31058,IOP,O,1502
31059,is,O,1502
31060,an,O,1502
31061,important,O,1502
31062,factor,O,1502
31063,in,O,1502
31064,the,O,1502
31065,management,O,1503
31066,of,O,1503
31067,glaucoma,B-NAME_OF_DISEASE,1503
31068,Lowering,B-TREATMENT,1503
31069,of,I-TREATMENT,1503
31070,IOP,I-TREATMENT,1503
31071,delays,O,1503
31072,the,O,1503
31073,onset,O,1503
31074,and,O,1503
31075,progression,O,1503
31076,of,O,1503
31077,glaucoma,B-NAME_OF_DISEASE,1503
31078,and,O,1503
31079,remains,O,1503
31080,the,O,1503
31081,main,O,1503
31082,treatment,O,1503
31083,to,O,1503
31084,maintain,O,1503
31085,visual,O,1503
31086,function,O,1503
31087,IOP,O,1503
31088,is,O,1503
31089,usually,O,1503
31090,monitored,O,1503
31091,using,O,1504
31092,Goldmann,B-DIAGNOSTIC_TEST,1504
31093,applanation,I-DIAGNOSTIC_TEST,1504
31094,tonometer,I-DIAGNOSTIC_TEST,1504
31095,GAT,I-DIAGNOSTIC_TEST,1504
31096,,O,1504
31097,In,O,1504
31098,the,O,1504
31099,clinical,O,1504
31100,setting,O,1504
31101,despite,O,1504
31102,the,O,1504
31103,importance,O,1504
31104,of,O,1504
31105,IOP,O,1504
31106,assessment,O,1504
31107,the,O,1504
31108,efficacy,O,1504
31109,of,O,1504
31110,IOP-lowering,B-TREATMENT,1504
31111,treatment,I-TREATMENT,1504
31112,is,O,1504
31113,usually,O,1504
31114,based,O,1504
31115,on,O,1504
31116,a,O,1504
31117,few,O,1504
31118,IOP,O,1504
31119,measurements,O,1504
31120,annually,O,1504
31121,A,O,1504
31122,substantial,O,1504
31123,proportion,O,1504
31124,of,O,1504
31125,patients,O,1504
31126,show,O,1504
31127,progression,O,1504
31128,in,O,1504
31129,visual,O,1504
31130,field,O,1504
31131,defects,O,1504
31132,at,O,1504
31133,apparently,O,1504
31134,controlled,O,1504
31135,IOP,O,1504
31136,Studies,O,1504
31137,have,O,1504
31138,shown,O,1504
31139,that,O,1504
31140,IOP,O,1504
31141,fluctuates,O,1504
31142,during,O,1504
31143,the,O,1504
31144,day,O,1504
31145,and,O,1504
31146,over,O,1504
31147,longer,O,1504
31148,periods,O,1505
31149,In,O,1505
31150,one,O,1505
31151,of,O,1505
31152,the,O,1505
31153,first,O,1505
31154,studies,O,1505
31155,Drance,B-PERSON,1505
31156,found,O,1505
31157,that,O,1505
31158,the,O,1505
31159,range,O,1505
31160,of,O,1505
31161,diurnal,O,1505
31162,variation,O,1505
31163,in,O,1505
31164,patients,O,1505
31165,with,O,1505
31166,glaucoma,B-NAME_OF_DISEASE,1505
31167,was,O,1505
31168,two,O,1505
31169,to,O,1505
31170,three,O,1505
31171,times,O,1505
31172,that,O,1505
31173,of,O,1505
31174,normal,O,1505
31175,individuals,O,1505
31176,and,O,1505
31177,emphasized,O,1505
31178,that,O,1506
31179,a,O,1506
31180,single,O,1506
31181,office,O,1506
31182,IOP,O,1506
31183,reading,O,1506
31184,may,O,1506
31185,not,O,1506
31186,be,O,1506
31187,representative,O,1506
31188,of,O,1506
31189,the,O,1506
31190,IOP,O,1506
31191,most,O,1506
31192,of,O,1506
31193,the,O,1506
31194,time,O,1506
31195,Later,O,1506
31196,on,O,1506
31197,several,O,1506
31198,researchers,O,1506
31199,reported,O,1506
31200,that,O,1507
31201,highest,O,1507
31202,IOPs,O,1507
31203,were,O,1507
31204,measured,O,1507
31205,outside,O,1507
31206,office,O,1507
31207,hours,O,1507
31208,and,O,1507
31209,that,O,1507
31210,pressure,O,1507
31211,peaks,O,1507
31212,and,O,1507
31213,higher,O,1508
31214,diurnal,O,1508
31215,fluctuation,O,1508
31216,in,O,1508
31217,patients,O,1508
31218,with,O,1508
31219,controlled,O,1508
31220,office,O,1508
31221,IOP,O,1508
31222,were,O,1508
31223,associated,O,1508
31224,with,O,1508
31225,progression,O,1508
31226,of,O,1508
31227,visual,O,1508
31228,field,O,1508
31229,Intraocular,O,1508
31230,pressure,O,1508
31231,IOP,O,1508
31232,fluctuates,O,1508
31233,throughout,O,1508
31234,the,O,1508
31235,day,O,1508
31236,as,O,1508
31237,well,O,1508
31238,as,O,1509
31239,during,O,1509
31240,the,O,1509
31241,night,O,1509
31242,as,O,1509
31243,we,O,1509
31244,sleep,O,1509
31245,even,O,1509
31246,body,O,1509
31247,position,O,1509
31248,and,O,1509
31249,Circadian,O,1509
31250,rhythm,O,1509
31251,can,O,1509
31252,cause,O,1509
31253,variations,O,1509
31254,Typically,O,1510
31255,practices,O,1510
31256,measure,O,1510
31257,IOP,O,1510
31258,only,O,1510
31259,during,O,1510
31260,daytime,O,1510
31261,clinic,O,1510
31262,hours,O,1510
31263,but,O,1510
31264,high,O,1510
31265,IOP,O,1511
31266,at,O,1511
31267,night,O,1511
31268,can,O,1511
31269,contribute,O,1511
31270,to,O,1511
31271,disease,O,1511
31272,progression,O,1511
31273,even,O,1511
31274,in,O,1511
31275,cases,O,1511
31276,of,O,1511
31277,normal-tension,B-NAME_OF_DISEASE,1511
31278,glaucoma,I-NAME_OF_DISEASE,1511
31279,So,O,1511
31280,when,O,1511
31281,we,O,1512
31282,miss,O,1512
31283,nighttime,O,1512
31284,measurements,O,1513
31285,we,O,1513
31286,are,O,1513
31287,missing,O,1513
31288,important,O,1513
31289,data,O,1513
31290,that,O,1513
31291,can,O,1513
31292,help,O,1513
31293,us,O,1513
31294,understand,O,1513
31295,and,O,1513
31296,treat,O,1513
31297,our,O,1513
31298,patients,O,1513
31299,disease,O,1513
31300,Making,O,1513
31301,for,O,1513
31302,an,O,1513
31303,even,O,1513
31304,more,O,1513
31305,complicated,O,1513
31306,situation,O,1513
31307,IOP,O,1513
31308,also,O,1513
31309,varies,O,1513
31310,day,O,1513
31311,to,O,1513
31312,day,O,1513
31313,and,O,1514
31314,infrequent,O,1514
31315,measurements,O,1514
31316,-,O,1514
31317,such,O,1514
31318,as,O,1514
31319,a,O,1514
31320,single,O,1514
31321,office,O,1514
31322,visit,O,1514
31323,every,O,1514
31324,3,O,1514
31325,months,O,1514
31326,-,O,1514
31327,provide,O,1514
31328,just,O,1514
31329,a,O,1514
31330,snapshot,O,1514
31331,of,O,1514
31332,IOP,O,1514
31333,patterns,O,1514
31334,To,O,1514
31335,address,O,1514
31336,this,O,1514
31337,issue,O,1514
31338,the,O,1514
31339,eye-care,O,1514
31340,industry,O,1514
31341,has,O,1514
31342,developed,O,1514
31343,devices,O,1514
31344,to,O,1514
31345,measure,O,1514
31346,IOP,O,1514
31347,at,O,1514
31348,home,O,1514
31349,The,B-DIAGNOSTIC_TEST,1514
31350,iCare,I-DIAGNOSTIC_TEST,1514
31351,HOME,I-DIAGNOSTIC_TEST,1514
31352,tonometer,I-DIAGNOSTIC_TEST,1514
31353,became,O,1514
31354,available,O,1514
31355,in,O,1514
31356,Europe,B-GPE,1514
31357,in,O,1514
31358,2014,O,1514
31359,and,O,1514
31360,was,O,1514
31361,approved,O,1514
31362,by,O,1514
31363,the,B-ORGANIZATION,1514
31364,FDA,I-ORGANIZATION,1514
31365,as,O,1514
31366,a,O,1514
31367,prescription,O,1514
31368,medical,O,1514
31369,device,O,1514
31370,in,O,1514
31371,the,B-GPE,1514
31372,United,I-GPE,1514
31373,States,I-GPE,1514
31374,in,O,1514
31375,2017,O,1514
31376,A,O,1514
31377,handheld,O,1514
31378,device,O,1514
31379,like,O,1514
31380,the,B-DIAGNOSTIC_TEST,1514
31381,iCare,I-DIAGNOSTIC_TEST,1514
31382,tonometer,I-DIAGNOSTIC_TEST,1514
31383,used,O,1514
31384,by,O,1514
31385,health-care,O,1514
31386,professionals,O,1514
31387,in,O,1514
31388,clinics,O,1514
31389,the,B-DIAGNOSTIC_TEST,1514
31390,iCare,I-DIAGNOSTIC_TEST,1514
31391,HOME,I-DIAGNOSTIC_TEST,1514
31392,tonometer,I-DIAGNOSTIC_TEST,1514
31393,enables,O,1514
31394,patients,O,1515
31395,to,O,1515
31396,measure,O,1515
31397,their,O,1515
31398,own,O,1515
31399,IOP,O,1515
31400,Another,O,1515
31401,device,O,1515
31402,the,B-DIAGNOSTIC_TEST,1515
31403,Sensimed,I-DIAGNOSTIC_TEST,1516
31404,Triggerfish,I-DIAGNOSTIC_TEST,1516
31405,contact,I-DIAGNOSTIC_TEST,1516
31406,lens,I-DIAGNOSTIC_TEST,1516
31407,was,O,1516
31408,cleared,O,1516
31409,by,O,1516
31410,the,B-ORGANIZATION,1516
31411,FDA,I-ORGANIZATION,1516
31412,in,O,1516
31413,2016,O,1516
31414,This,O,1516
31415,contact,O,1516
31416,lens,O,1516
31417,is,O,1516
31418,worn,O,1516
31419,by,O,1516
31420,the,O,1516
31421,patient,O,1516
31422,overnight,O,1516
31423,sensors,O,1516
31424,embedded,O,1516
31425,in,O,1516
31426,the,O,1516
31427,contact,O,1516
31428,lens,O,1516
31429,measure,O,1516
31430,corneal,O,1516
31431,dimensions,O,1516
31432,which,O,1516
31433,are,O,1517
31434,then,O,1517
31435,translated,O,1517
31436,to,O,1517
31437,an,O,1517
31438,IOP,O,1517
31439,measurement,O,1517
31440,Because,O,1517
31441,our,O,1517
31442,practice,O,1517
31443,has,O,1517
31444,experience,O,1517
31445,only,O,1517
31446,with,O,1517
31447,tonometers,O,1517
31448,we,O,1517
31449,will,O,1517
31450,restrict,O,1517
31451,our,O,1517
31452,guidance,O,1517
31453,to,O,1517
31454,what,O,1517
31455,practices,O,1517
31456,and,O,1517
31457,technicians,O,1517
31458,need,O,1517
31459,to,O,1517
31460,know,O,1517
31461,as,O,1517
31462,they,O,1518
31463,train,O,1518
31464,patients,O,1518
31465,to,O,1518
31466,use,O,1518
31467,the,B-DIAGNOSTIC_TEST,1518
31468,iCare,I-DIAGNOSTIC_TEST,1518
31469,HOME,I-DIAGNOSTIC_TEST,1518
31470,device,I-DIAGNOSTIC_TEST,1518
31471,First,O,1518
31472,develop,O,1518
31473,a,O,1518
31474,protocol,O,1518
31475,Practices,O,1519
31476,interested,O,1519
31477,in,O,1519
31478,measuring,O,1519
31479,IOP,O,1519
31480,from,O,1519
31481,a,O,1519
31482,patient,O,1519
31483,s,O,1519
31484,home,O,1519
31485,must,O,1519
31486,first,O,1519
31487,determine,O,1519
31488,how,O,1519
31489,devices,O,1519
31490,will,O,1519
31491,be,O,1519
31492,purchased,O,1519
31493,and,O,1519
31494,distributed,O,1519
31495,to,O,1519
31496,patients,O,1519
31497,Will,O,1519
31498,the,O,1519
31499,patient,O,1519
31500,purchase,O,1519
31501,and,O,1519
31502,own,O,1520
31503,the,O,1520
31504,device,O,1520
31505,or,O,1520
31506,will,O,1520
31507,the,O,1520
31508,device,O,1520
31509,be,O,1520
31510,rented,O,1520
31511,either,O,1520
31512,from,O,1520
31513,the,O,1520
31514,device,O,1520
31515,company,O,1520
31516,or,O,1520
31517,a,O,1520
31518,health-care,O,1520
31519,practice,O,1520
31520,Will,O,1520
31521,patients,O,1520
31522,put,O,1520
31523,down,O,1520
31524,a,O,1520
31525,monetary,O,1520
31526,deposit,O,1520
31527,for,O,1520
31528,the,O,1520
31529,device,O,1521
31530,Will,O,1521
31531,insurance,O,1521
31532,be,O,1521
31533,billed,O,1521
31534,or,O,1521
31535,can,O,1521
31536,a,O,1521
31537,health,O,1521
31538,saving,O,1521
31539,plan,O,1521
31540,cover,O,1521
31541,the,O,1521
31542,cost,O,1521
31543,For,O,1521
31544,some,O,1521
31545,practices,O,1521
31546,a,O,1521
31547,research,O,1521
31548,grant,O,1521
31549,can,O,1521
31550,help,O,1521
31551,cover,O,1521
31552,the,O,1521
31553,cost,O,1521
31554,Also,O,1521
31555,how,O,1521
31556,will,O,1521
31557,practices,O,1521
31558,guarantee,O,1521
31559,that,O,1521
31560,patients,O,1521
31561,return,O,1521
31562,the,O,1521
31563,device,O,1521
31564,Well-established,O,1521
31565,loan,O,1521
31566,programs,O,1521
31567,in,O,1521
31568,other,O,1522
31569,specialties,O,1522
31570,eg,O,1522
31571,home,O,1522
31572,blood-pressure,O,1522
31573,cuffs,O,1522
31574,home,O,1522
31575,Holter,O,1522
31576,monitors,O,1522
31577,may,O,1522
31578,serve,O,1522
31579,as,O,1522
31580,models,O,1522
31581,for,O,1522
31582,eye-care,O,1522
31583,practices,O,1523
31584,Our,O,1523
31585,practice,O,1523
31586,is,O,1523
31587,currently,O,1523
31588,working,O,1523
31589,with,O,1523
31590,a,O,1523
31591,third-party,O,1523
31592,insurance,O,1523
31593,company,O,1523
31594,to,O,1523
31595,help,O,1523
31596,us,O,1523
31597,bridge,O,1523
31598,that,O,1523
31599,accident,O,1523
31600,gap,O,1523
31601,for,O,1523
31602,lost,O,1523
31603,or,O,1523
31604,damaged,O,1523
31605,devices,O,1523
31606,ICare,B-ORGANIZATION,1523
31607,offers,O,1523
31608,extended,O,1523
31609,warranties,O,1523
31610,with,O,1523
31611,a,O,1523
31612,deductible,O,1523
31613,to,O,1523
31614,cover,O,1523
31615,that,O,1523
31616,issue,O,1523
31617,as,O,1524
31618,well,O,1524
31619,Preparing,O,1524
31620,patients,O,1524
31621,to,O,1524
31622,measure,O,1524
31623,at,O,1524
31624,home,O,1524
31625,A,O,1524
31626,patient,O,1524
31627,s,O,1524
31628,ability,O,1524
31629,to,O,1524
31630,navigate,O,1524
31631,their,O,1524
31632,device,O,1524
31633,and,O,1524
31634,their,O,1524
31635,confidence,O,1524
31636,in,O,1524
31637,their,O,1524
31638,ability,O,1524
31639,are,O,1524
31640,critical,O,1524
31641,to,O,1524
31642,successful,O,1524
31643,measurements,O,1524
31644,Patients,O,1524
31645,should,O,1524
31646,be,O,1524
31647,trained,O,1524
31648,by,O,1524
31649,ophthalmic,O,1524
31650,professionals,O,1524
31651,who,O,1524
31652,know,O,1525
31653,the,O,1525
31654,ins,O,1525
31655,and,O,1525
31656,outs,O,1525
31657,of,O,1525
31658,the,O,1525
31659,device,O,1525
31660,This,O,1525
31661,can,O,1525
31662,be,O,1525
31663,accomplished,O,1525
31664,through,O,1525
31665,videos,O,1525
31666,teleconferences,O,1525
31667,and,O,1525
31668,or,O,1525
31669,in-person,O,1525
31670,sessions,O,1525
31671,Our,O,1526
31672,practice,O,1526
31673,utilizes,O,1526
31674,in-person,O,1526
31675,training,O,1526
31676,-,O,1526
31677,we,O,1526
31678,allot,O,1526
31679,15,O,1526
31680,minutes,O,1526
31681,for,O,1527
31682,these,O,1527
31683,sessions,O,1527
31684,-,O,1527
31685,and,O,1527
31686,videos,O,1527
31687,Links,O,1527
31688,on,O,1527
31689,MyEyes.ne,O,1527
31690,the,O,1527
31691,website,O,1527
31692,and,O,1528
31693,device,O,1528
31694,company,O,1528
31695,we,O,1528
31696,founded,O,1528
31697,to,O,1528
31698,facilitate,O,1528
31699,patients,O,1528
31700,obtaining,O,1528
31701,home,O,1528
31702,tonometers,O,1528
31703,features,O,1529
31704,three,O,1529
31705,YouTube,B-ORGANIZATION,1529
31706,training,O,1529
31707,videos,O,1529
31708,that,O,1529
31709,introduce,O,1529
31710,the,O,1529
31711,tonometer,O,1529
31712,and,O,1529
31713,provide,O,1529
31714,detailed,O,1530
31715,instructions,O,1530
31716,on,O,1530
31717,its,O,1530
31718,use,O,1530
31719,Whatever,O,1530
31720,mode,O,1530
31721,of,O,1530
31722,training,O,1530
31723,you,O,1530
31724,choose,O,1530
31725,make,O,1530
31726,sure,O,1530
31727,it,O,1530
31728,provides,O,1530
31729,instruction,O,1530
31730,on,O,1530
31731,Turning,O,1531
31732,the,O,1531
31733,device,O,1531
31734,on,O,1531
31735,and,O,1531
31736,off,O,1531
31737,The,O,1531
31738,function,O,1531
31739,of,O,1531
31740,each,O,1532
31741,of,O,1532
31742,the,O,1532
31743,buttons,O,1532
31744,on,O,1532
31745,the,O,1532
31746,device,O,1532
31747,The,O,1532
31748,meaning,O,1532
31749,of,O,1532
31750,indicator,O,1532
31751,lights,O,1532
31752,and,O,1532
31753,sounds,O,1532
31754,on,O,1532
31755,the,O,1532
31756,device,O,1532
31757,Keeping,O,1533
31758,the,O,1533
31759,device,O,1533
31760,clean,O,1533
31761,and,O,1533
31762,safe,O,1533
31763,for,O,1533
31764,use,O,1534
31765,Positioning,O,1534
31766,of,O,1534
31767,the,O,1534
31768,patient,O,1534
31769,Proper,O,1534
31770,insertion,O,1534
31771,of,O,1534
31772,the,O,1534
31773,probe,O,1534
31774,Obtaining,O,1535
31775,a,O,1535
31776,measurement,O,1535
31777,How,O,1535
31778,to,O,1535
31779,confirm,O,1535
31780,that,O,1535
31781,a,O,1535
31782,measurement,O,1535
31783,was,O,1535
31784,successful,O,1535
31785,How,O,1535
31786,to,O,1535
31787,upload,O,1535
31788,and,O,1535
31789,access,O,1535
31790,the,O,1536
31791,data,O,1536
31792,to,O,1536
31793,discuss,O,1536
31794,with,O,1536
31795,the,O,1536
31796,patient,O,1536
31797,s,O,1536
31798,eye-care,O,1536
31799,provider,O,1537
31800,Importantly,O,1537
31801,training,O,1537
31802,should,O,1537
31803,also,O,1537
31804,include,O,1537
31805,troubleshooting,O,1537
31806,for,O,1537
31807,unsuccessful,O,1537
31808,measurements,O,1537
31809,For,O,1537
31810,example,O,1537
31811,the,B-DIAGNOSTIC_TEST,1537
31812,iCare,I-DIAGNOSTIC_TEST,1537
31813,HOME,I-DIAGNOSTIC_TEST,1537
31814,must,O,1537
31815,be,O,1537
31816,held,O,1537
31817,by,O,1537
31818,the,O,1537
31819,patient,O,1537
31820,at,O,1537
31821,a,O,1538
31822,particular,O,1538
31823,distance,O,1538
31824,from,O,1538
31825,their,O,1538
31826,eye,O,1538
31827,and,O,1538
31828,at,O,1538
31829,a,O,1538
31830,particular,O,1538
31831,height,O,1538
31832,relative,O,1538
31833,to,O,1538
31834,the,B-PART_OF_THE_EYES,1538
31835,apex,I-PART_OF_THE_EYES,1538
31836,of,I-PART_OF_THE_EYES,1538
31837,their,I-PART_OF_THE_EYES,1538
31838,cornea,I-PART_OF_THE_EYES,1539
31839,We,O,1539
31840,find,O,1539
31841,that,O,1539
31842,patients,O,1539
31843,typically,O,1539
31844,need,O,1539
31845,more,O,1539
31846,instruction,O,1539
31847,in,O,1539
31848,obtaining,O,1539
31849,the,O,1539
31850,initial,O,1539
31851,alignment,O,1539
31852,adjustment,O,1539
31853,of,O,1539
31854,the,O,1539
31855,head,O,1539
31856,and,O,1539
31857,cheek,O,1539
31858,measurement,O,1540
31859,bars,O,1540
31860,and,O,1540
31861,uploading,O,1540
31862,their,O,1540
31863,data,O,1540
31864,to,O,1540
31865,the,O,1540
31866,clinic,O,1540
31867,software,O,1540
31868,In-person,O,1540
31869,training,O,1540
31870,allows,O,1540
31871,staff,O,1540
31872,to,O,1540
31873,give,O,1540
31874,patients,O,1540
31875,the,O,1540
31876,extra,O,1540
31877,help,O,1540
31878,they,O,1540
31879,may,O,1540
31880,need,O,1540
31881,Should,O,1540
31882,additional,O,1540
31883,troubleshooting,O,1541
31884,be,O,1541
31885,necessary,O,1541
31886,representatives,O,1541
31887,are,O,1541
31888,often,O,1541
31889,available,O,1541
31890,from,O,1541
31891,the,O,1541
31892,device,O,1541
31893,makers,O,1541
31894,or,O,1541
31895,company,O,1541
31896,renting,O,1541
31897,them,O,1541
31898,out,O,1541
31899,we,O,1541
31900,provide,O,1541
31901,our,O,1541
31902,patients,O,1541
31903,with,O,1542
31904,the,O,1542
31905,relevant,O,1542
31906,contact,O,1542
31907,information,O,1542
31908,Patient,O,1542
31909,education,O,1542
31910,-,O,1542
31911,Be,O,1542
31912,sure,O,1542
31913,to,O,1542
31914,inform,O,1542
31915,patients,O,1542
31916,how,O,1542
31917,and,O,1542
31918,when,O,1542
31919,they,O,1542
31920,will,O,1543
31921,receive,O,1543
31922,their,O,1543
31923,IOP,O,1543
31924,data,O,1543
31925,as,O,1543
31926,well,O,1543
31927,as,O,1543
31928,how,O,1543
31929,they,O,1543
31930,should,O,1543
31931,act,O,1544
31932,on,O,1544
31933,that,O,1544
31934,information,O,1544
31935,For,O,1544
31936,example,O,1544
31937,the,O,1544
31938,current,O,1544
31939,model,O,1544
31940,of,O,1544
31941,the,B-DIAGNOSTIC_TEST,1544
31942,iCare,I-DIAGNOSTIC_TEST,1544
31943,HOME,I-DIAGNOSTIC_TEST,1544
31944,device,I-DIAGNOSTIC_TEST,1544
31945,does,O,1544
31946,not,O,1544
31947,display,O,1544
31948,the,O,1544
31949,IOP,O,1544
31950,on,O,1544
31951,the,O,1544
31952,device,O,1544
31953,due,O,1545
31954,to,O,1545
31955,FDA,B-ORGANIZATION,1545
31956,regulations,O,1545
31957,the,O,1545
31958,IOP,O,1545
31959,data,O,1545
31960,are,O,1545
31961,stored,O,1545
31962,in,O,1545
31963,the,O,1545
31964,device,O,1545
31965,then,O,1545
31966,uploaded,O,1545
31967,to,O,1545
31968,the,O,1545
31969,clinic,O,1545
31970,software,O,1545
31971,on,O,1545
31972,the,O,1545
31973,cloud,O,1545
31974,Patients,O,1545
31975,have,O,1545
31976,immediate,O,1545
31977,access,O,1545
31978,to,O,1545
31979,their,O,1545
31980,data,O,1545
31981,on,O,1545
31982,the,O,1546
31983,cloud,O,1546
31984,if,O,1546
31985,they,O,1546
31986,own,O,1546
31987,the,O,1546
31988,device,O,1546
31989,If,O,1546
31990,however,O,1546
31991,patients,O,1546
31992,are,O,1546
31993,renting,O,1546
31994,the,O,1546
31995,device,O,1546
31996,through,O,1546
31997,a,O,1546
31998,third-party,O,1546
31999,such,O,1546
32000,as,O,1546
32001,MyEyes,B-ORGANIZATION,1546
32002,that,O,1546
32003,data,O,1546
32004,may,O,1546
32005,be,O,1546
32006,shared,O,1546
32007,with,O,1546
32008,the,O,1546
32009,doctor,O,1546
32010,and,O,1546
32011,the,O,1547
32012,patient,O,1547
32013,in,O,1547
32014,a,O,1547
32015,user-friendly,O,1547
32016,spreadsheet,O,1547
32017,once,O,1547
32018,the,O,1547
32019,rental,O,1547
32020,period,O,1547
32021,is,O,1547
32022,complete,O,1547
32023,Innovations,O,1547
32024,to,O,1547
32025,come,O,1547
32026,-,O,1547
32027,The,O,1547
32028,biggest,O,1547
32029,limitation,O,1547
32030,of,O,1547
32031,devices,O,1547
32032,that,O,1547
32033,patients,O,1547
32034,use,O,1547
32035,to,O,1547
32036,measure,O,1548
32037,their,O,1548
32038,own,O,1548
32039,IOP,O,1548
32040,is,O,1548
32041,that,O,1548
32042,they,O,1548
32043,must,O,1548
32044,wake,O,1548
32045,up,O,1548
32046,to,O,1548
32047,measure,O,1548
32048,-,O,1548
32049,so,O,1548
32050,we,O,1548
32051,still,O,1548
32052,miss,O,1548
32053,important,O,1548
32054,data,O,1548
32055,while,O,1548
32056,patients,O,1548
32057,sleep,O,1548
32058,We,O,1548
32059,might,O,1548
32060,miss,O,1548
32061,high,O,1548
32062,IOP,O,1548
32063,that,O,1548
32064,occurs,O,1548
32065,during,O,1548
32066,episodes,O,1549
32067,of,O,1549
32068,sleep,O,1549
32069,apnea,O,1549
32070,or,O,1549
32071,overnight,O,1549
32072,hypotension,B-NAME_OF_DISEASE,1549
32073,low,I-NAME_OF_DISEASE,1549
32074,blood,I-NAME_OF_DISEASE,1549
32075,pressure,I-NAME_OF_DISEASE,1549
32076,,O,1549
32077,Fortunately,O,1549
32078,surgical,O,1549
32079,implants,O,1549
32080,that,O,1549
32081,measure,O,1549
32082,IOP,O,1549
32083,are,O,1549
32084,now,O,1549
32085,in,O,1549
32086,development,O,1550
32087,The,B-DIAGNOSTIC_TEST,1550
32088,Eyemate-IO,I-DIAGNOSTIC_TEST,1550
32089,Implandata,I-DIAGNOSTIC_TEST,1550
32090,Ophthalmic,I-DIAGNOSTIC_TEST,1550
32091,Products,I-DIAGNOSTIC_TEST,1550
32092,recently,O,1550
32093,earned,O,1550
32094,Europe,B-GPE,1550
32095,s,O,1550
32096,CE,O,1550
32097,Mark,O,1550
32098,The,B-DIAGNOSTIC_TEST,1550
32099,implantable,I-DIAGNOSTIC_TEST,1550
32100,micro-sensor,I-DIAGNOSTIC_TEST,1550
32101,performs,O,1550
32102,continual,O,1550
32103,monitoring,O,1550
32104,of,O,1551
32105,IOP,O,1551
32106,in,O,1551
32107,glaucoma,B-NAME_OF_DISEASE,1551
32108,patients,O,1551
32109,Current,O,1551
32110,and,O,1551
32111,future,O,1551
32112,home,O,1551
32113,devices,O,1551
32114,can,O,1551
32115,change,O,1551
32116,the,O,1551
32117,way,O,1551
32118,we,O,1551
32119,practice,O,1551
32120,In-office,O,1551
32121,IOP,O,1551
32122,checks,O,1551
32123,might,O,1551
32124,be,O,1551
32125,reduced,O,1551
32126,clinic,O,1551
32127,flow,O,1551
32128,and,O,1551
32129,allocation,O,1551
32130,of,O,1551
32131,office,O,1551
32132,resources,O,1551
32133,would,O,1551
32134,change,O,1551
32135,and,O,1551
32136,improve,O,1551
32137,IOP,O,1551
32138,measurements,O,1551
32139,might,O,1552
32140,upload,O,1552
32141,directly,O,1552
32142,into,O,1552
32143,electronic,O,1552
32144,health,O,1552
32145,records,O,1552
32146,The,O,1552
32147,ophthalmic,O,1552
32148,professional,O,1552
32149,will,O,1552
32150,interact,O,1552
32151,with,O,1552
32152,IOP,O,1552
32153,in,O,1552
32154,a,O,1552
32155,new,O,1552
32156,and,O,1552
32157,exciting,O,1552
32158,way,O,1552
32159,that,O,1552
32160,can,O,1552
32161,save,O,1552
32162,sight,O,1552
32163,Eye,O,1552
32164,pressure,O,1552
32165,varies,O,1552
32166,separately,O,1553
32167,from,O,1553
32168,blood,O,1553
32169,pressure,O,1553
32170,IOP,O,1553
32171,management,O,1553
32172,is,O,1553
32173,not,O,1553
32174,the,O,1553
32175,same,O,1553
32176,as,O,1553
32177,blood,O,1553
32178,pressure,O,1553
32179,control,O,1553
32180,However,O,1553
32181,research,O,1553
32182,has,O,1553
32183,shown,O,1553
32184,that,O,1553
32185,those,O,1554
32186,with,O,1554
32187,high,B-CAUSE_OF_DISEASE,1554
32188,blood,I-CAUSE_OF_DISEASE,1554
32189,pressure,I-CAUSE_OF_DISEASE,1554
32190,are,O,1554
32191,more,O,1554
32192,likely,O,1554
32193,to,O,1554
32194,develop,O,1554
32195,glaucoma,B-NAME_OF_DISEASE,1554
32196,Glaucoma,B-NAME_OF_DISEASE,1554
32197,is,O,1554
32198,not,O,1554
32199,aided,O,1554
32200,by,O,1554
32201,extremely,O,1554
32202,high,B-CAUSE_OF_DISEASE,1554
32203,blood,I-CAUSE_OF_DISEASE,1554
32204,pressure,I-CAUSE_OF_DISEASE,1554
32205,Low,O,1555
32206,blood,O,1555
32207,pressure,O,1555
32208,which,O,1555
32209,must,O,1555
32210,be,O,1555
32211,moderate,O,1555
32212,to,O,1555
32213,extremely,O,1555
32214,low,O,1555
32215,for,O,1555
32216,the,O,1555
32217,visual,O,1555
32218,nerve,O,1555
32219,to,O,1555
32220,receive,O,1555
32221,enough,O,1555
32222,blood,O,1555
32223,flow,O,1555
32224,is,O,1555
32225,another,O,1555
32226,issue,O,1555
32227,Low,B-CAUSE_OF_DISEASE,1555
32228,ocular,I-CAUSE_OF_DISEASE,1555
32229,perfusion,I-CAUSE_OF_DISEASE,1556
32230,pressure,I-CAUSE_OF_DISEASE,1556
32231,appears,O,1556
32232,to,O,1556
32233,be,O,1556
32234,a,O,1556
32235,significant,O,1556
32236,risk,O,1556
32237,factor,O,1556
32238,for,O,1556
32239,glaucoma,B-NAME_OF_DISEASE,1556
32240,according,O,1556
32241,to,O,1557
32242,the,O,1557
32243,evidence,O,1557
32244,The,O,1557
32245,differential,O,1557
32246,between,O,1557
32247,blood,O,1557
32248,pressure,O,1557
32249,and,O,1557
32250,eye,O,1557
32251,pressure,O,1557
32252,can,O,1557
32253,be,O,1557
32254,thought,O,1557
32255,of,O,1557
32256,as,O,1557
32257,the,O,1557
32258,ocular,O,1557
32259,perfusion,O,1557
32260,pressure,O,1557
32261,a,O,1557
32262,complex,O,1557
32263,quantity,O,1557
32264,Blood,O,1557
32265,has,O,1557
32266,trouble,O,1558
32267,getting,O,1558
32268,into,O,1558
32269,the,O,1558
32270,eye,O,1558
32271,to,O,1558
32272,deliver,O,1558
32273,oxygen,O,1558
32274,and,O,1558
32275,vital,O,1558
32276,nutrients,O,1558
32277,if,O,1558
32278,the,O,1558
32279,blood,O,1558
32280,pressure,O,1558
32281,is,O,1558
32282,low,O,1558
32283,and,O,1559
32284,the,O,1559
32285,eye,O,1559
32286,pressure,O,1559
32287,is,O,1559
32288,high,O,1559
32289,Patients,O,1559
32290,with,O,1559
32291,high,B-CAUSE_OF_DISEASE,1559
32292,blood,I-CAUSE_OF_DISEASE,1559
32293,pressure,I-CAUSE_OF_DISEASE,1559
32294,who,O,1559
32295,take,O,1559
32296,medication,O,1559
32297,may,O,1559
32298,actually,O,1559
32299,experience,O,1559
32300,very,O,1560
32301,low,O,1560
32302,blood,O,1560
32303,pressure,O,1560
32304,readings,O,1560
32305,when,O,1560
32306,they,O,1560
32307,are,O,1560
32308,sleeping,O,1560
32309,Due,O,1560
32310,to,O,1560
32311,reduced,O,1561
32312,blood,O,1561
32313,flow,O,1561
32314,to,O,1561
32315,the,O,1561
32316,eye,O,1561
32317,and,O,1561
32318,optic,B-PART_OF_THE_EYES,1561
32319,nerve,I-PART_OF_THE_EYES,1561
32320,the,B-PART_OF_THE_EYES,1561
32321,optic,I-PART_OF_THE_EYES,1561
32322,nerve,I-PART_OF_THE_EYES,1561
32323,may,O,1561
32324,become,O,1561
32325,compromised,O,1561
32326,Research,O,1561
32327,on,O,1561
32328,how,O,1562
32329,blood,O,1562
32330,flow,O,1562
32331,affects,O,1562
32332,optic,B-PART_OF_THE_EYES,1562
32333,nerve,I-PART_OF_THE_EYES,1562
32334,injury,O,1562
32335,is,O,1562
32336,underway,O,1562
32337,We,O,1562
32338,now,O,1562
32339,know,O,1562
32340,that,O,1562
32341,there,O,1562
32342,is,O,1562
32343,a,O,1562
32344,direct,O,1562
32345,correlation,O,1562
32346,between,O,1563
32347,various,O,1563
32348,types,O,1563
32349,of,O,1563
32350,glaucoma,B-NAME_OF_DISEASE,1563
32351,and,O,1563
32352,decreased,O,1563
32353,blood,O,1563
32354,flow,O,1563
32355,to,O,1563
32356,the,B-PART_OF_THE_EYES,1563
32357,optic,I-PART_OF_THE_EYES,1563
32358,nerve,I-PART_OF_THE_EYES,1563
32359,Although,O,1563
32360,intraocular,O,1563
32361,pressure,O,1563
32362,IOP,O,1563
32363,continues,O,1563
32364,to,O,1563
32365,be,O,1563
32366,a,O,1563
32367,significant,O,1563
32368,risk,O,1563
32369,factor,O,1563
32370,for,O,1563
32371,glaucoma,B-NAME_OF_DISEASE,1563
32372,it,O,1563
32373,is,O,1563
32374,obvious,O,1563
32375,that,O,1563
32376,additional,O,1563
32377,factors,O,1563
32378,can,O,1563
32379,significantly,O,1563
32380,affect,O,1563
32381,the,O,1563
32382,onset,O,1563
32383,and,O,1563
32384,progression,O,1563
32385,of,O,1563
32386,the,O,1563
32387,condition,O,1564
32388,Blood,O,1564
32389,pressure,O,1564
32390,BP,O,1564
32391,is,O,1564
32392,a,O,1564
32393,clinically,O,1564
32394,modifiable,O,1564
32395,risk,O,1564
32396,factor,O,1564
32397,for,O,1564
32398,glaucoma,B-NAME_OF_DISEASE,1564
32399,that,O,1564
32400,has,O,1564
32401,gained,O,1564
32402,interest,O,1564
32403,more,O,1564
32404,lately,O,1564
32405,because,O,1564
32406,it,O,1564
32407,offers,O,1564
32408,the,O,1564
32409,potential,O,1564
32410,for,O,1564
32411,new,O,1564
32412,therapeutic,O,1564
32413,approaches,O,1564
32414,beyond,O,1564
32415,IOP,O,1565
32416,reduction,O,1565
32417,The,O,1565
32418,ocular,O,1565
32419,perfusion,O,1565
32420,pressure,O,1565
32421,OPP,O,1565
32422,which,O,1565
32423,controls,O,1565
32424,the,O,1565
32425,flow,O,1565
32426,of,O,1565
32427,blood,O,1565
32428,to,O,1566
32429,the,B-PART_OF_THE_EYES,1566
32430,optic,I-PART_OF_THE_EYES,1566
32431,nerve,I-PART_OF_THE_EYES,1566
32432,is,O,1566
32433,determined,O,1566
32434,by,O,1566
32435,the,O,1566
32436,interaction,O,1566
32437,between,O,1566
32438,blood,O,1566
32439,pressure,O,1566
32440,and,O,1566
32441,IOP,O,1566
32442,Hypotension,B-NAME_OF_DISEASE,1566
32443,should,O,1566
32444,enhance,O,1566
32445,the,O,1566
32446,negative,O,1566
32447,consequences,O,1567
32448,of,O,1567
32449,IOP,O,1567
32450,rise,O,1567
32451,whereas,O,1567
32452,hypertension,B-NAME_OF_DISEASE,1567
32453,should,O,1567
32454,protect,O,1567
32455,against,O,1567
32456,IOP,O,1567
32457,elevation,O,1567
32458,if,O,1567
32459,OPP,O,1567
32460,is,O,1567
32461,a,O,1567
32462,more,O,1567
32463,significant,O,1567
32464,factor,O,1567
32465,in,O,1567
32466,determining,O,1567
32467,ganglion,B-PART_OF_THE_EYES,1567
32468,cell,I-PART_OF_THE_EYES,1567
32469,injury,O,1567
32470,than,O,1567
32471,IOP,O,1567
32472,Conflicting,O,1567
32473,conclusions,O,1567
32474,about,O,1568
32475,the,O,1568
32476,contribution,O,1568
32477,of,O,1568
32478,systemic,B-NAME_OF_DISEASE,1568
32479,hypertension,I-NAME_OF_DISEASE,1568
32480,to,O,1568
32481,the,O,1568
32482,onset,O,1568
32483,and,O,1568
32484,progression,O,1568
32485,of,O,1569
32486,glaucoma,B-NAME_OF_DISEASE,1569
32487,are,O,1569
32488,drawn,O,1569
32489,from,O,1569
32490,epidemiological,O,1569
32491,studies,O,1569
32492,According,O,1569
32493,to,O,1569
32494,the,O,1569
32495,most,O,1569
32496,recent,O,1569
32497,study,O,1569
32498,glaucoma,B-NAME_OF_DISEASE,1569
32499,is,O,1569
32500,more,O,1569
32501,common,O,1569
32502,in,O,1569
32503,persons,O,1570
32504,with,O,1570
32505,blood,O,1570
32506,pressures,O,1570
32507,at,O,1570
32508,both,O,1570
32509,extremes,O,1570
32510,It,O,1570
32511,makes,O,1570
32512,sense,O,1570
32513,that,O,1570
32514,those,O,1570
32515,with,O,1570
32516,low,O,1570
32517,blood,O,1570
32518,pressure,O,1570
32519,would,O,1570
32520,have,O,1570
32521,less,O,1570
32522,OPP,O,1570
32523,and,O,1570
32524,hence,O,1570
32525,less,O,1570
32526,blood,O,1570
32527,flow,O,1570
32528,but,O,1570
32529,it,O,1570
32530,is,O,1570
32531,more,O,1570
32532,challenging,O,1570
32533,to,O,1570
32534,explain,O,1570
32535,why,O,1570
32536,people,O,1570
32537,with,O,1570
32538,high,O,1570
32539,blood,O,1570
32540,pressure,O,1570
32541,also,O,1570
32542,exhibit,O,1570
32543,elevated,O,1571
32544,risk,O,1571
32545,This,O,1571
32546,results,O,1571
32547,might,O,1571
32548,be,O,1571
32549,the,O,1571
32550,result,O,1571
32551,of,O,1571
32552,chronic,O,1571
32553,hypertension-related,O,1571
32554,intrinsic,O,1571
32555,blood,O,1571
32556,flow,O,1571
32557,dysregulation,O,1571
32558,which,O,1571
32559,would,O,1571
32560,make,O,1571
32561,retinal,O,1571
32562,blood,O,1571
32563,flow,O,1571
32564,less,O,1571
32565,resilient,O,1571
32566,to,O,1571
32567,changes,O,1571
32568,in,O,1571
32569,ocular,O,1571
32570,perfusion,O,1571
32571,pressure,O,1571
32572,Glaucoma,B-NAME_OF_DISEASE,1571
32573,is,O,1571
32574,not,O,1572
32575,a,O,1572
32576,systemic,O,1572
32577,disease,O,1572
32578,in,O,1572
32579,and,O,1572
32580,of,O,1572
32581,itself,O,1572
32582,however,O,1572
32583,it,O,1572
32584,is,O,1572
32585,known,O,1572
32586,to,O,1572
32587,have,O,1572
32588,systemic,O,1572
32589,risk,O,1572
32590,factors,O,1572
32591,The,O,1572
32592,vasculature,O,1572
32593,of,O,1572
32594,the,B-PART_OF_THE_EYES,1572
32595,optic,I-PART_OF_THE_EYES,1572
32596,nerve,I-PART_OF_THE_EYES,1572
32597,itself,O,1572
32598,plays,O,1572
32599,a,O,1572
32600,significant,O,1572
32601,role,O,1572
32602,in,O,1572
32603,the,O,1572
32604,interaction,O,1572
32605,between,O,1572
32606,glaucoma,B-NAME_OF_DISEASE,1572
32607,and,O,1572
32608,the,O,1573
32609,human,O,1573
32610,system,O,1573
32611,Similar,O,1573
32612,to,O,1573
32613,other,O,1573
32614,cells,O,1573
32615,the,O,1573
32616,approximately,O,1573
32617,1,O,1573
32618,million,O,1573
32619,ganglion,O,1573
32620,cells,O,1573
32621,that,O,1573
32622,form,O,1573
32623,the,B-PART_OF_THE_EYES,1573
32624,optic,I-PART_OF_THE_EYES,1573
32625,nerve,I-PART_OF_THE_EYES,1573
32626,must,O,1573
32627,both,O,1573
32628,breathe,O,1573
32629,and,O,1573
32630,consume,O,1574
32631,in,O,1574
32632,order,O,1574
32633,to,O,1574
32634,survive,O,1574
32635,Even,O,1574
32636,while,O,1574
32637,it,O,1574
32638,oversimplifies,O,1574
32639,the,O,1574
32640,two,O,1574
32641,processes,O,1574
32642,it,O,1574
32643,is,O,1574
32644,still,O,1574
32645,largely,O,1574
32646,TRUE,O,1574
32647,For,O,1574
32648,respiration,O,1574
32649,and,O,1574
32650,glucose,O,1574
32651,supply,O,1574
32652,which,O,1574
32653,are,O,1574
32654,both,O,1575
32655,necessary,O,1575
32656,for,O,1575
32657,the,O,1575
32658,production,O,1575
32659,of,O,1575
32660,adenosine,B-CHEMICAL_COMPOUND,1575
32661,triphosphate,I-CHEMICAL_COMPOUND,1575
32662,ATP,I-CHEMICAL_COMPOUND,1575
32663,the,O,1575
32664,visual,O,1575
32665,nerve,O,1575
32666,cells,O,1575
32667,rely,O,1576
32668,on,O,1576
32669,the,O,1576
32670,circulatory,O,1576
32671,system,O,1576
32672,Therefore,O,1576
32673,anything,O,1576
32674,that,O,1576
32675,harms,O,1576
32676,the,O,1576
32677,circulatory,O,1576
32678,system,O,1576
32679,has,O,1576
32680,the,O,1576
32681,potential,O,1576
32682,to,O,1576
32683,harm,O,1576
32684,the,O,1576
32685,visual,O,1576
32686,neurons,O,1576
32687,by,O,1576
32688,definition,O,1576
32689,Risk,O,1576
32690,Factors,O,1576
32691,For,O,1576
32692,instance,O,1576
32693,openangle,B-NAME_OF_DISEASE,1576
32694,glaucoma,B-NAME_OF_DISEASE,1576
32695,has,O,1576
32696,long,O,1576
32697,been,O,1577
32698,linked,O,1577
32699,to,O,1577
32700,diabetes,B-NAME_OF_DISEASE,1577
32701,mellitus,I-NAME_OF_DISEASE,1577
32702,as,O,1577
32703,a,O,1577
32704,risk,O,1577
32705,factor,O,1577
32706,There,O,1577
32707,may,O,1577
32708,be,O,1577
32709,more,O,1578
32710,evidence,O,1578
32711,than,O,1578
32712,ever,O,1578
32713,before,O,1578
32714,to,O,1578
32715,support,O,1578
32716,this,O,1578
32717,Having,O,1578
32718,said,O,1578
32719,that,O,1578
32720,the,O,1578
32721,connection,O,1578
32722,between,O,1578
32723,blood,O,1578
32724,pressure,O,1578
32725,and,O,1578
32726,glaucoma,B-NAME_OF_DISEASE,1578
32727,has,O,1578
32728,been,O,1578
32729,researched,O,1579
32730,for,O,1579
32731,a,O,1579
32732,long,O,1579
32733,time,O,1579
32734,Particularly,O,1579
32735,in,O,1579
32736,so-called,O,1579
32737,normal,B-NAME_OF_DISEASE,1579
32738,tension,I-NAME_OF_DISEASE,1579
32739,glaucoma,I-NAME_OF_DISEASE,1579
32740,low,B-NAME_OF_DISEASE,1579
32741,blood,I-NAME_OF_DISEASE,1579
32742,pressure,I-NAME_OF_DISEASE,1579
32743,has,O,1579
32744,been,O,1579
32745,connected,O,1579
32746,to,O,1579
32747,the,O,1579
32748,emergence,O,1579
32749,of,O,1579
32750,open-angle,B-NAME_OF_DISEASE,1579
32751,glaucoma,I-NAME_OF_DISEASE,1579
32752,It,O,1580
32753,is,O,1580
32754,appropriate,O,1580
32755,to,O,1580
32756,assess,O,1580
32757,the,O,1580
32758,connection,O,1580
32759,between,O,1580
32760,blood,O,1580
32761,pressure,O,1580
32762,and,O,1580
32763,glaucoma,B-NAME_OF_DISEASE,1580
32764,and,O,1580
32765,consider,O,1580
32766,the,O,1580
32767,role,O,1580
32768,of,O,1580
32769,optometrists,O,1580
32770,in,O,1580
32771,light,O,1580
32772,of,O,1580
32773,the,O,1580
32774,recent,O,1580
32775,publication,O,1580
32776,of,O,1580
32777,revised,O,1580
32778,blood,O,1580
32779,pressure,O,1580
32780,guidelines,O,1580
32781,established,O,1580
32782,by,O,1580
32783,the,B-ORGANIZATION,1580
32784,American,I-ORGANIZATION,1580
32785,College,I-ORGANIZATION,1580
32786,of,I-ORGANIZATION,1580
32787,Cardiology,I-ORGANIZATION,1580
32788,and,O,1580
32789,the,B-ORGANIZATION,1580
32790,American,I-ORGANIZATION,1580
32791,Heart,I-ORGANIZATION,1580
32792,Association,I-ORGANIZATION,1580
32793,Supporting,O,1580
32794,Research,O,1581
32795,An,O,1581
32796,investigation,O,1581
32797,conducted,O,1581
32798,in,O,1581
32799,2018,O,1581
32800,and,O,1581
32801,published,O,1581
32802,in,O,1581
32803,the,B-PUBLICATION_VENUE,1581
32804,American,I-PUBLICATION_VENUE,1581
32805,Journal,I-PUBLICATION_VENUE,1581
32806,of,I-PUBLICATION_VENUE,1581
32807,Hypertension,I-PUBLICATION_VENUE,1581
32808,found,O,1581
32809,a,O,1581
32810,nonlinear,O,1581
32811,association,O,1581
32812,between,O,1581
32813,the,O,1581
32814,existence,O,1581
32815,of,O,1581
32816,glaucoma,B-NAME_OF_DISEASE,1581
32817,and,O,1581
32818,systemic,O,1581
32819,blood,O,1581
32820,pressure,O,1581
32821,The,O,1581
32822,researchers,O,1581
32823,of,O,1581
32824,the,O,1581
32825,study,O,1581
32826,concluded,O,1581
32827,that,O,1581
32828,the,O,1581
32829,two,O,1581
32830,have,O,1581
32831,a,O,1581
32832,U-shaped,O,1582
32833,association,O,1582
32834,This,O,1582
32835,indicates,O,1582
32836,that,O,1582
32837,both,O,1582
32838,patients,O,1582
32839,with,O,1582
32840,low,O,1582
32841,and,O,1582
32842,high,O,1582
32843,blood,O,1582
32844,pressure,O,1582
32845,saw,O,1582
32846,a,O,1582
32847,rise,O,1582
32848,in,O,1582
32849,the,O,1582
32850,incidence,O,1582
32851,of,O,1582
32852,glaucoma,B-NAME_OF_DISEASE,1582
32853,4,O,1582
32854,137,O,1583
32855,adults,O,1583
32856,aged,O,1583
32857,40,O,1583
32858,or,O,1583
32859,older,O,1583
32860,who,O,1583
32861,participated,O,1583
32862,in,O,1583
32863,the,B-NAME_OF_STUDY,1583
32864,National,I-NAME_OF_STUDY,1583
32865,Health,I-NAME_OF_STUDY,1584
32866,and,I-NAME_OF_STUDY,1584
32867,Nutrition,I-NAME_OF_STUDY,1584
32868,Examination,I-NAME_OF_STUDY,1584
32869,Surveys,I-NAME_OF_STUDY,1584
32870,NHANES,I-NAME_OF_STUDY,1584
32871,from,B-TIME_DURATION,1584
32872,2005,I-TIME_DURATION,1584
32873,to,I-TIME_DURATION,1584
32874,2008,I-TIME_DURATION,1584
32875,were,O,1584
32876,included,O,1584
32877,in,O,1584
32878,the,O,1584
32879,study,O,1584
32880,In,O,1584
32881,the,O,1584
32882,study,O,1584
32883,sample,O,1584
32884,as,O,1584
32885,a,O,1584
32886,whole,O,1584
32887,glaucoma,B-NAME_OF_DISEASE,1584
32888,prevalence,O,1584
32889,was,O,1584
32890,1.20%,O,1584
32891,Separate,O,1584
32892,metrics,O,1584
32893,were,O,1584
32894,used,O,1584
32895,to,O,1584
32896,assess,O,1584
32897,the,O,1584
32898,association,O,1584
32899,between,O,1584
32900,these,O,1585
32901,two,O,1585
32902,chronic,O,1585
32903,diseases,O,1585
32904,systolic,B-DIAGNOSTIC_TEST,1585
32905,and,I-DIAGNOSTIC_TEST,1585
32906,diastolic,B-DIAGNOSTIC_TEST,1585
32907,blood,I-DIAGNOSTIC_TEST,1585
32908,pressure,I-DIAGNOSTIC_TEST,1585
32909,For,O,1585
32910,participants,O,1585
32911,who,O,1585
32912,did,O,1585
32913,not,O,1585
32914,take,O,1585
32915,antihypertensive,B-NAME_OF_DRUG,1585
32916,drugs,I-NAME_OF_DRUG,1585
32917,both,O,1585
32918,high,B-CAUSE_OF_DISEASE,1585
32919,systolic,I-CAUSE_OF_DISEASE,1585
32920,blood,I-CAUSE_OF_DISEASE,1585
32921,pressure,I-CAUSE_OF_DISEASE,1585
32922,more,O,1585
32923,than,O,1586
32924,or,O,1586
32925,equal,O,1586
32926,to,O,1586
32927,161,O,1586
32928,mm,O,1586
32929,Hg,O,1586
32930,and,O,1586
32931,low,B-CAUSE_OF_DISEASE,1586
32932,systolic,I-CAUSE_OF_DISEASE,1586
32933,blood,I-CAUSE_OF_DISEASE,1586
32934,pressure,I-CAUSE_OF_DISEASE,1586
32935,increased,O,1586
32936,the,O,1586
32937,risk,O,1586
32938,of,O,1586
32939,glaucoma,B-NAME_OF_DISEASE,1586
32940,less,O,1586
32941,than,O,1586
32942,or,O,1586
32943,equal,O,1586
32944,to,O,1587
32945,110,O,1587
32946,mm,O,1587
32947,Hg,O,1587
32948,,O,1587
32949,Similar,O,1587
32950,to,O,1587
32951,how,O,1587
32952,high,B-CAUSE_OF_DISEASE,1587
32953,and,I-CAUSE_OF_DISEASE,1587
32954,low,I-CAUSE_OF_DISEASE,1587
32955,diastolic,B-DIAGNOSTIC_TEST,1587
32956,blood,I-DIAGNOSTIC_TEST,1587
32957,pressure,I-DIAGNOSTIC_TEST,1587
32958,increased,O,1587
32959,the,O,1587
32960,risk,O,1587
32961,of,O,1587
32962,glaucoma,B-NAME_OF_DISEASE,1587
32963,greater,O,1587
32964,than,O,1587
32965,or,O,1588
32966,equal,O,1588
32967,to,O,1588
32968,91,O,1588
32969,mmHg,O,1588
32970,or,O,1588
32971,less,O,1588
32972,than,O,1588
32973,or,O,1588
32974,equal,O,1588
32975,to,O,1588
32976,60,O,1588
32977,mmHg,O,1588
32978,respectively,O,1588
32979,,O,1588
32980,Participants,O,1588
32981,in,O,1588
32982,the,O,1588
32983,research,O,1588
32984,with,O,1589
32985,systolic,B-DIAGNOSTIC_TEST,1589
32986,blood,I-DIAGNOSTIC_TEST,1589
32987,pressure,I-DIAGNOSTIC_TEST,1589
32988,between,O,1589
32989,11,O,1589
32990,mm,O,1589
32991,Hg,O,1589
32992,and,O,1589
32993,120,O,1589
32994,mm,O,1589
32995,Hg,O,1589
32996,and,O,1589
32997,diastolic,B-DIAGNOSTIC_TEST,1589
32998,blood,I-DIAGNOSTIC_TEST,1589
32999,pressure,I-DIAGNOSTIC_TEST,1589
33000,between,O,1589
33001,81,O,1589
33002,mm,O,1589
33003,Hg,O,1590
33004,and,O,1590
33005,90,O,1590
33006,mm,O,1590
33007,Hg,O,1590
33008,had,O,1590
33009,the,O,1590
33010,lowest,O,1590
33011,prevalence,O,1590
33012,of,O,1590
33013,glaucoma,B-NAME_OF_DISEASE,1590
33014,This,O,1590
33015,study,O,1590
33016,implies,O,1590
33017,that,O,1590
33018,in,O,1590
33019,terms,O,1590
33020,of,O,1591
33021,glaucoma,B-NAME_OF_DISEASE,1591
33022,a,O,1591
33023,blood,O,1591
33024,pressure,O,1591
33025,Goldilocks,O,1591
33026,scenario,O,1591
33027,in,O,1591
33028,which,O,1591
33029,there,O,1591
33030,is,O,1591
33031,an,O,1592
33032,ideal,O,1592
33033,range,O,1592
33034,is,O,1592
33035,recommended,O,1592
33036,Low,B-NAME_OF_DISEASE,1592
33037,blood,I-NAME_OF_DISEASE,1592
33038,pressure,I-NAME_OF_DISEASE,1592
33039,can,O,1592
33040,cause,O,1592
33041,ischemia,B-SIGN_AND_SYMPTOM,1592
33042,to,I-SIGN_AND_SYMPTOM,1592
33043,the,I-SIGN_AND_SYMPTOM,1592
33044,optic,I-SIGN_AND_SYMPTOM,1592
33045,nerve,I-SIGN_AND_SYMPTOM,1592
33046,and,I-SIGN_AND_SYMPTOM,1592
33047,decrease,I-SIGN_AND_SYMPTOM,1592
33048,ocular,I-SIGN_AND_SYMPTOM,1592
33049,perfusion,I-SIGN_AND_SYMPTOM,1592
33050,pressure,I-SIGN_AND_SYMPTOM,1592
33051,either,O,1592
33052,naturally,O,1593
33053,or,O,1593
33054,as,O,1593
33055,a,O,1593
33056,result,O,1593
33057,of,O,1593
33058,over-treating,O,1593
33059,hypertension,B-NAME_OF_DISEASE,1593
33060,This,O,1593
33061,aspect,O,1593
33062,might,O,1593
33063,be,O,1593
33064,particularly,O,1594
33065,important,O,1594
33066,in,O,1594
33067,the,O,1594
33068,context,O,1594
33069,of,O,1594
33070,normal,B-NAME_OF_DISEASE,1594
33071,tension,I-NAME_OF_DISEASE,1594
33072,glaucoma,I-NAME_OF_DISEASE,1594
33073,On,O,1594
33074,the,O,1594
33075,other,O,1594
33076,hand,O,1594
33077,systemic,B-NAME_OF_DISEASE,1594
33078,hypertension,I-NAME_OF_DISEASE,1594
33079,frequently,O,1594
33080,results,O,1594
33081,in,O,1594
33082,arteriosclerosis,B-NAME_OF_DISEASE,1595
33083,which,O,1595
33084,may,O,1595
33085,reduce,B-SIGN_AND_SYMPTOM,1595
33086,blood,I-SIGN_AND_SYMPTOM,1595
33087,flow,I-SIGN_AND_SYMPTOM,1595
33088,to,I-SIGN_AND_SYMPTOM,1595
33089,the,I-SIGN_AND_SYMPTOM,1595
33090,optic,I-SIGN_AND_SYMPTOM,1595
33091,nerve,I-SIGN_AND_SYMPTOM,1595
33092,even,O,1595
33093,if,O,1595
33094,it,O,1595
33095,may,O,1595
33096,not,O,1595
33097,be,O,1595
33098,harmful,O,1595
33099,in,O,1595
33100,the,O,1595
33101,short,O,1595
33102,term,O,1595
33103,Controversial,O,1595
33104,Link,O,1595
33105,Systemic,B-NAME_OF_DISEASE,1595
33106,hypertension,I-NAME_OF_DISEASE,1595
33107,and,O,1595
33108,glaucoma,B-NAME_OF_DISEASE,1595
33109,have,O,1595
33110,always,O,1595
33111,had,O,1595
33112,a,O,1595
33113,contentious,O,1595
33114,connection,O,1595
33115,In,O,1595
33116,fact,O,1595
33117,the,B-NAME_OF_STUDY,1595
33118,2008,I-NAME_OF_STUDY,1595
33119,Barbados,I-NAME_OF_STUDY,1595
33120,Eye,I-NAME_OF_STUDY,1595
33121,Studies,I-NAME_OF_STUDY,1595
33122,revealed,O,1595
33123,a,O,1596
33124,possible,O,1596
33125,link,O,1596
33126,between,O,1596
33127,systemic,B-NAME_OF_DISEASE,1596
33128,hypertension,I-NAME_OF_DISEASE,1596
33129,and,O,1596
33130,a,O,1596
33131,lower,O,1596
33132,incidence,O,1596
33133,of,O,1596
33134,glaucoma,B-NAME_OF_DISEASE,1596
33135,The,O,1596
33136,development,O,1596
33137,of,O,1596
33138,ocular,B-NAME_OF_DISEASE,1596
33139,hypertension,I-NAME_OF_DISEASE,1596
33140,is,O,1596
33141,thought,O,1596
33142,to,O,1596
33143,be,O,1596
33144,influenced,O,1596
33145,by,O,1596
33146,systemic,B-NAME_OF_DISEASE,1596
33147,hypertension,I-NAME_OF_DISEASE,1596
33148,according,O,1596
33149,to,O,1596
33150,more,O,1596
33151,recent,O,1596
33152,research,O,1596
33153,that,O,1596
33154,was,O,1596
33155,published,O,1596
33156,in,O,1596
33157,2014,O,1596
33158,Putting,O,1596
33159,Into,O,1596
33160,Practice,O,1596
33161,The,O,1596
33162,question,O,1596
33163,then,O,1596
33164,comes,O,1597
33165,as,O,1597
33166,to,O,1597
33167,what,O,1597
33168,eyecare,O,1597
33169,professionals,O,1597
33170,can,O,1597
33171,do,O,1597
33172,with,O,1597
33173,this,O,1597
33174,knowledge,O,1597
33175,given,O,1597
33176,that,O,1597
33177,modern,O,1597
33178,research,O,1598
33179,suggests,O,1598
33180,that,O,1598
33181,a,O,1598
33182,range,O,1598
33183,of,O,1598
33184,blood,O,1598
33185,pressure,O,1598
33186,that,O,1598
33187,is,O,1598
33188,not,O,1598
33189,too,O,1598
33190,high,O,1598
33191,and,O,1598
33192,not,O,1598
33193,too,O,1598
33194,low,O,1598
33195,is,O,1598
33196,ideal,O,1598
33197,for,O,1598
33198,the,O,1598
33199,patient,O,1598
33200,If,O,1598
33201,optometrists,O,1598
33202,are,O,1598
33203,not,O,1598
33204,already,O,1598
33205,doing,O,1598
33206,so,O,1598
33207,taking,B-DIAGNOSTIC_TEST,1599
33208,a,I-DIAGNOSTIC_TEST,1599
33209,patient,I-DIAGNOSTIC_TEST,1599
33210,s,I-DIAGNOSTIC_TEST,1599
33211,blood,I-DIAGNOSTIC_TEST,1599
33212,pressure,I-DIAGNOSTIC_TEST,1599
33213,as,O,1599
33214,part,O,1599
33215,of,O,1599
33216,a,O,1599
33217,glaucoma,B-NAME_OF_DISEASE,1599
33218,evaluation,O,1599
33219,is,O,1599
33220,a,O,1599
33221,simple,O,1599
33222,and,O,1599
33223,painless,O,1599
33224,technique,O,1599
33225,to,O,1599
33226,determine,O,1599
33227,whether,O,1599
33228,or,O,1599
33229,not,O,1599
33230,a,O,1599
33231,different,O,1599
33232,risk,O,1599
33233,factor,O,1599
33234,for,O,1599
33235,the,O,1599
33236,condition,O,1600
33237,exists,O,1600
33238,It,O,1600
33239,is,O,1600
33240,wrong,O,1600
33241,to,O,1600
33242,presume,O,1600
33243,that,O,1600
33244,just,O,1600
33245,because,O,1600
33246,a,O,1600
33247,patient,O,1600
33248,is,O,1600
33249,taking,O,1600
33250,an,B-NAME_OF_DRUG,1600
33251,oral,I-NAME_OF_DRUG,1600
33252,antihypertensive,I-NAME_OF_DRUG,1600
33253,drug,I-NAME_OF_DRUG,1600
33254,his,O,1600
33255,blood,O,1600
33256,pressure,O,1600
33257,is,O,1600
33258,managed,O,1600
33259,,O,1600
33260,In,O,1600
33261,actuality,O,1600
33262,taking,O,1601
33263,oral,B-NAME_OF_DRUG,1601
33264,antihypertensives,I-NAME_OF_DRUG,1601
33265,is,O,1601
33266,a,O,1601
33267,frequent,O,1601
33268,contributor,O,1601
33269,to,O,1601
33270,hypotension,B-NAME_OF_DISEASE,1601
33271,Nonselective,B-NAME_OF_DRUG,1601
33272,beta,I-NAME_OF_DRUG,1601
33273,blockers,I-NAME_OF_DRUG,1601
33274,such,O,1601
33275,timolol,B-NAME_OF_DRUG,1601
33276,Timoptic,I-NAME_OF_DRUG,1601
33277,Betimol,I-NAME_OF_DRUG,1601
33278,Alcon,I-NAME_OF_DRUG,1601
33279,are,O,1601
33280,known,O,1601
33281,to,O,1601
33282,have,O,1601
33283,systemic,B-NAME_OF_DISEASE,1601
33284,hypotension,I-NAME_OF_DISEASE,1601
33285,and,O,1601
33286,bradycardia,B-NAME_OF_DISEASE,1601
33287,in,O,1601
33288,their,O,1602
33289,medication,O,1602
33290,side,O,1602
33291,effect,O,1602
33292,profiles,O,1602
33293,in,O,1602
33294,addition,O,1602
33295,to,O,1602
33296,the,O,1602
33297,fact,O,1602
33298,that,O,1602
33299,low,O,1602
33300,blood,O,1602
33301,pressure,O,1602
33302,might,O,1602
33303,contribute,O,1602
33304,to,O,1602
33305,glaucoma,B-NAME_OF_DISEASE,1602
33306,Optometrists,O,1602
33307,who,O,1602
33308,treat,O,1602
33309,glaucoma,B-NAME_OF_DISEASE,1602
33310,patients,O,1602
33311,can,O,1602
33312,monitor,O,1602
33313,patient,O,1602
33314,safety,O,1602
33315,and,O,1602
33316,potential,O,1602
33317,lurking,O,1603
33318,factors,O,1603
33319,by,O,1603
33320,keeping,O,1603
33321,an,O,1603
33322,eye,O,1603
33323,on,O,1603
33324,measurements,O,1603
33325,like,O,1604
33326,systemic,O,1604
33327,blood,O,1604
33328,pressure,O,1604
33329,Proper,B-PREVENTION,1604
33330,eyelid,I-PREVENTION,1604
33331,closure,I-PREVENTION,1604
33332,and,O,1604
33333,a,B-PREVENTION,1604
33334,normal,I-PREVENTION,1604
33335,blink,I-PREVENTION,1604
33336,reflex,I-PREVENTION,1604
33337,are,O,1604
33338,essential,O,1604
33339,to,O,1604
33340,maintaining,O,1604
33341,a,O,1604
33342,stable,O,1604
33343,tear,B-PART_OF_THE_EYES,1604
33344,film,I-PART_OF_THE_EYES,1604
33345,and,O,1604
33346,a,O,1604
33347,healthy,O,1604
33348,corneal,B-PART_OF_THE_EYES,1604
33349,surface,I-PART_OF_THE_EYES,1604
33350,Patients,O,1604
33351,affected,O,1605
33352,with,O,1605
33353,lagophthalmos,B-NAME_OF_DISEASE,1605
33354,are,O,1605
33355,unable,B-SIGN_AND_SYMPTOM,1605
33356,to,I-SIGN_AND_SYMPTOM,1605
33357,fully,I-SIGN_AND_SYMPTOM,1605
33358,close,I-SIGN_AND_SYMPTOM,1605
33359,their,I-SIGN_AND_SYMPTOM,1605
33360,eyelids,I-SIGN_AND_SYMPTOM,1605
33361,and,O,1605
33362,they,O,1606
33363,may,O,1606
33364,describe,O,1606
33365,symptoms,O,1606
33366,of,O,1606
33367,dry,B-SIGN_AND_SYMPTOM,1606
33368,and,I-SIGN_AND_SYMPTOM,1607
33369,irritated,I-SIGN_AND_SYMPTOM,1607
33370,eyes,I-SIGN_AND_SYMPTOM,1607
33371,Common,O,1607
33372,morbidities,O,1607
33373,of,O,1607
33374,lagophthalmos,B-NAME_OF_DISEASE,1607
33375,are,O,1607
33376,corneal,B-NAME_OF_DISEASE,1607
33377,exposure,I-NAME_OF_DISEASE,1607
33378,and,O,1607
33379,subsequent,B-NAME_OF_DISEASE,1607
33380,keratopathy,I-NAME_OF_DISEASE,1607
33381,which,O,1607
33382,may,O,1607
33383,progress,O,1607
33384,to,O,1607
33385,corneal,B-NAME_OF_DISEASE,1607
33386,ulceration,I-NAME_OF_DISEASE,1607
33387,and,O,1607
33388,infectious,B-NAME_OF_DISEASE,1607
33389,keratitis,I-NAME_OF_DISEASE,1607
33390,It,O,1607
33391,is,O,1607
33392,important,O,1607
33393,to,O,1607
33394,recognize,O,1607
33395,lagophthalmos,B-NAME_OF_DISEASE,1607
33396,early,O,1607
33397,in,O,1607
33398,the,O,1607
33399,patient,O,1607
33400,s,O,1607
33401,course,O,1607
33402,and,O,1608
33403,begin,O,1608
33404,treatment,O,1608
33405,as,O,1608
33406,soon,O,1608
33407,as,O,1608
33408,possible,O,1608
33409,The,O,1608
33410,choice,O,1608
33411,of,O,1608
33412,therapy,O,1609
33413,requires,O,1609
33414,an,O,1609
33415,understanding,O,1609
33416,of,O,1609
33417,both,O,1609
33418,the,O,1609
33419,etiology,O,1609
33420,and,O,1609
33421,expected,O,1609
33422,duration,O,1609
33423,of,O,1609
33424,the,O,1609
33425,lagophthalmos,B-NAME_OF_DISEASE,1609
33426,Nocturnal,B-NAME_OF_DISEASE,1609
33427,lagophthalmos,I-NAME_OF_DISEASE,1609
33428,is,O,1609
33429,the,B-SIGN_AND_SYMPTOM,1609
33430,inability,I-SIGN_AND_SYMPTOM,1609
33431,to,I-SIGN_AND_SYMPTOM,1609
33432,close,I-SIGN_AND_SYMPTOM,1609
33433,the,I-SIGN_AND_SYMPTOM,1609
33434,eyelids,I-SIGN_AND_SYMPTOM,1609
33435,while,I-SIGN_AND_SYMPTOM,1609
33436,sleeping,I-SIGN_AND_SYMPTOM,1610
33437,This,O,1610
33438,can,O,1610
33439,result,O,1610
33440,in,O,1610
33441,a,O,1610
33442,range,O,1610
33443,of,O,1610
33444,conditions,O,1610
33445,from,B-SIGN_AND_SYMPTOM,1610
33446,mild,I-SIGN_AND_SYMPTOM,1610
33447,epithelial,I-SIGN_AND_SYMPTOM,1610
33448,changes,I-SIGN_AND_SYMPTOM,1610
33449,to,I-SIGN_AND_SYMPTOM,1610
33450,severe,I-SIGN_AND_SYMPTOM,1610
33451,exposure,I-SIGN_AND_SYMPTOM,1611
33452,ulcers,I-SIGN_AND_SYMPTOM,1611
33453,Katz,B-PERSON,1611
33454,and,O,1611
33455,Kaufman,B-PERSON,1611
33456,1977,O,1611
33457,,O,1611
33458,Lagophthalmos,B-NAME_OF_DISEASE,1611
33459,is,O,1611
33460,associated,O,1611
33461,with,O,1611
33462,exposure,B-CAUSE_OF_DISEASE,1611
33463,keratopathy,I-CAUSE_OF_DISEASE,1611
33464,poor,B-CAUSE_OF_DISEASE,1611
33465,sleep,I-CAUSE_OF_DISEASE,1611
33466,and,O,1611
33467,persistent,O,1611
33468,exposure-related,O,1611
33469,symptoms,O,1611
33470,There,O,1611
33471,are,O,1611
33472,a,O,1611
33473,variety,O,1611
33474,of,O,1611
33475,causes,O,1612
33476,of,O,1612
33477,lagophthalmos,B-NAME_OF_DISEASE,1612
33478,grouped,O,1612
33479,as,O,1612
33480,proptosis,B-SIGN_AND_SYMPTOM,1612
33481,eye,I-SIGN_AND_SYMPTOM,1612
33482,exposure,I-SIGN_AND_SYMPTOM,1612
33483,etiologies,O,1612
33484,and,O,1612
33485,palpebral,B-SIGN_AND_SYMPTOM,1613
33486,insufficiency,I-SIGN_AND_SYMPTOM,1613
33487,etiologies,O,1613
33488,Although,O,1613
33489,obvious,B-NAME_OF_DISEASE,1613
33490,lagophthalmos,I-NAME_OF_DISEASE,1613
33491,is,O,1613
33492,usually,O,1613
33493,detected,O,1613
33494,it,O,1613
33495,is,O,1613
33496,sometimes,O,1613
33497,difficult,O,1613
33498,to,O,1613
33499,recognize,O,1613
33500,obscure,B-NAME_OF_DISEASE,1613
33501,lagophthalmos,I-NAME_OF_DISEASE,1613
33502,due,O,1613
33503,either,O,1613
33504,to,O,1613
33505,eyelash,B-SIGN_AND_SYMPTOM,1613
33506,obstruction,I-SIGN_AND_SYMPTOM,1613
33507,or,I-SIGN_AND_SYMPTOM,1613
33508,overhang,I-SIGN_AND_SYMPTOM,1613
33509,of,I-SIGN_AND_SYMPTOM,1613
33510,the,I-SIGN_AND_SYMPTOM,1613
33511,upper,I-SIGN_AND_SYMPTOM,1613
33512,lid,I-SIGN_AND_SYMPTOM,1613
33513,anterior,I-SIGN_AND_SYMPTOM,1613
33514,and,I-SIGN_AND_SYMPTOM,1613
33515,inferior,I-SIGN_AND_SYMPTOM,1613
33516,to,I-SIGN_AND_SYMPTOM,1614
33517,the,I-SIGN_AND_SYMPTOM,1614
33518,most,I-SIGN_AND_SYMPTOM,1614
33519,superior,I-SIGN_AND_SYMPTOM,1614
33520,portion,I-SIGN_AND_SYMPTOM,1614
33521,of,I-SIGN_AND_SYMPTOM,1614
33522,the,I-SIGN_AND_SYMPTOM,1614
33523,lower,I-SIGN_AND_SYMPTOM,1614
33524,lid,I-SIGN_AND_SYMPTOM,1614
33525,in,I-SIGN_AND_SYMPTOM,1614
33526,a,I-SIGN_AND_SYMPTOM,1614
33527,closed,I-SIGN_AND_SYMPTOM,1614
33528,position,I-SIGN_AND_SYMPTOM,1614
33529,Although,O,1614
33530,obvious,B-NAME_OF_DISEASE,1614
33531,lagophthalmos,I-NAME_OF_DISEASE,1614
33532,is,O,1614
33533,usually,O,1614
33534,detected,O,1614
33535,it,O,1615
33536,is,O,1615
33537,sometimes,O,1615
33538,difficult,O,1615
33539,to,O,1615
33540,recognize,O,1615
33541,obscure,B-NAME_OF_DISEASE,1615
33542,lagophthalmos,I-NAME_OF_DISEASE,1615
33543,due,O,1615
33544,either,O,1615
33545,to,O,1615
33546,eyelash,B-SIGN_AND_SYMPTOM,1615
33547,obstruction,I-SIGN_AND_SYMPTOM,1615
33548,or,I-SIGN_AND_SYMPTOM,1615
33549,overhang,I-SIGN_AND_SYMPTOM,1615
33550,of,I-SIGN_AND_SYMPTOM,1615
33551,the,I-SIGN_AND_SYMPTOM,1615
33552,upper,I-SIGN_AND_SYMPTOM,1615
33553,lid,I-SIGN_AND_SYMPTOM,1616
33554,anterior,I-SIGN_AND_SYMPTOM,1616
33555,and,I-SIGN_AND_SYMPTOM,1616
33556,inferior,I-SIGN_AND_SYMPTOM,1616
33557,to,I-SIGN_AND_SYMPTOM,1616
33558,the,I-SIGN_AND_SYMPTOM,1616
33559,most,I-SIGN_AND_SYMPTOM,1617
33560,superior,I-SIGN_AND_SYMPTOM,1617
33561,portion,I-SIGN_AND_SYMPTOM,1617
33562,of,I-SIGN_AND_SYMPTOM,1617
33563,the,I-SIGN_AND_SYMPTOM,1617
33564,lower,I-SIGN_AND_SYMPTOM,1617
33565,lid,I-SIGN_AND_SYMPTOM,1617
33566,in,I-SIGN_AND_SYMPTOM,1617
33567,a,I-SIGN_AND_SYMPTOM,1617
33568,closed,I-SIGN_AND_SYMPTOM,1617
33569,position,I-SIGN_AND_SYMPTOM,1617
33570,A,O,1617
33571,diagnosis,O,1617
33572,can,O,1617
33573,usually,O,1617
33574,be,O,1617
33575,made,O,1617
33576,with,O,1617
33577,a,B-DIAGNOSTIC_TEST,1617
33578,focused,I-DIAGNOSTIC_TEST,1617
33579,history,I-DIAGNOSTIC_TEST,1617
33580,and,O,1617
33581,slit,B-DIAGNOSTIC_TEST,1617
33582,lamp,I-DIAGNOSTIC_TEST,1617
33583,examination,I-DIAGNOSTIC_TEST,1617
33584,Treatment,O,1617
33585,is,O,1617
33586,multipronged,O,1617
33587,and,O,1617
33588,may,O,1617
33589,include,O,1617
33590,minor,B-TREATMENT,1617
33591,procedures,I-TREATMENT,1617
33592,or,I-TREATMENT,1617
33593,ocular,I-TREATMENT,1617
33594,surgery,I-TREATMENT,1617
33595,to,I-TREATMENT,1617
33596,correct,I-TREATMENT,1617
33597,the,I-TREATMENT,1617
33598,lid,I-TREATMENT,1617
33599,malposition,I-TREATMENT,1617
33600,natural,B-TREATMENT,1617
33601,topical,I-TREATMENT,1617
33602,or,I-TREATMENT,1617
33603,oral,I-TREATMENT,1617
33604,agents,I-TREATMENT,1617
33605,and,O,1617
33606,punctal,B-TREATMENT,1617
33607,plugs,I-TREATMENT,1617
33608,to,I-TREATMENT,1617
33609,manage,I-TREATMENT,1617
33610,ocular,I-TREATMENT,1617
33611,surface,I-TREATMENT,1617
33612,effects,I-TREATMENT,1617
33613,Correct,O,1617
33614,and,O,1617
33615,timely,O,1617
33616,diagnosis,O,1617
33617,allows,O,1617
33618,greater,O,1617
33619,opportunity,O,1617
33620,for,O,1617
33621,relief,O,1617
33622,of,O,1618
33623,patient,O,1618
33624,suffering,O,1618
33625,and,O,1618
33626,prevention,O,1618
33627,of,O,1618
33628,severe,O,1618
33629,ocular,O,1618
33630,surface,O,1618
33631,pathology,O,1618
33632,as,O,1618
33633,well,O,1618
33634,as,O,1618
33635,educated,O,1618
33636,planning,O,1618
33637,for,O,1618
33638,future,O,1618
33639,ocular,O,1618
33640,surgical,O,1618
33641,procedures,O,1618
33642,While,O,1619
33643,severe,O,1619
33644,cases,O,1619
33645,can,O,1619
33646,usually,O,1619
33647,be,O,1619
33648,readily,O,1619
33649,diagnosed,O,1619
33650,we,O,1619
33651,may,O,1619
33652,find,O,1619
33653,it,O,1619
33654,challenging,O,1619
33655,to,O,1619
33656,diagnose,O,1619
33657,the,O,1619
33658,more,O,1619
33659,subtle,O,1619
33660,cases,O,1619
33661,which,O,1620
33662,can,O,1620
33663,masquerade,O,1620
33664,as,O,1620
33665,dry,B-NAME_OF_DISEASE,1620
33666,eye,I-NAME_OF_DISEASE,1620
33667,disease,I-NAME_OF_DISEASE,1620
33668,Challenges,O,1620
33669,with,O,1620
33670,Diagnosing,O,1620
33671,Mild,O,1620
33672,Cases,O,1620
33673,Unless,O,1620
33674,patients,O,1620
33675,have,O,1620
33676,been,O,1620
33677,told,O,1620
33678,by,O,1621
33679,others,O,1621
33680,quite,O,1621
33681,often,O,1621
33682,they,O,1621
33683,may,O,1621
33684,suffer,O,1621
33685,from,O,1621
33686,nocturnal,B-NAME_OF_DISEASE,1621
33687,lagophthalmos,B-NAME_OF_DISEASE,1621
33688,and,O,1621
33689,not,O,1621
33690,be,O,1621
33691,aware,O,1621
33692,of,O,1621
33693,it,O,1622
33694,Subtle,O,1622
33695,cases,O,1622
33696,are,O,1622
33697,not,O,1622
33698,easily,O,1622
33699,identified,O,1622
33700,in,O,1622
33701,our,O,1622
33702,exam,O,1622
33703,lane,O,1622
33704,either,O,1622
33705,because,O,1622
33706,many,O,1622
33707,of,O,1622
33708,these,O,1622
33709,patients,O,1622
33710,can,O,1622
33711,have,O,1622
33712,normal,O,1622
33713,voluntary,O,1622
33714,lid,O,1622
33715,closure,O,1622
33716,during,O,1622
33717,evaluation,O,1623
33718,Tsai,B-PERSON,1623
33719,et,O,1623
33720,al,O,1623
33721,2009,O,1623
33722,,O,1623
33723,In,O,1623
33724,addition,O,1623
33725,symptoms,O,1623
33726,typically,O,1623
33727,are,O,1624
33728,not,O,1624
33729,terribly,O,1624
33730,helpful,O,1624
33731,When,O,1624
33732,a,O,1624
33733,patient,O,1624
33734,presents,O,1624
33735,with,O,1624
33736,symptoms,O,1624
33737,of,O,1624
33738,foreign,B-SIGN_AND_SYMPTOM,1624
33739,body,I-SIGN_AND_SYMPTOM,1624
33740,sensation,I-SIGN_AND_SYMPTOM,1624
33741,hyperemia,I-SIGN_AND_SYMPTOM,1624
33742,and,I-SIGN_AND_SYMPTOM,1624
33743,reduced,I-SIGN_AND_SYMPTOM,1624
33744,acuity,I-SIGN_AND_SYMPTOM,1624
33745,practitioners,O,1624
33746,are,O,1624
33747,not,O,1624
33748,likely,O,1624
33749,to,O,1624
33750,routinely,O,1624
33751,jump,O,1624
33752,to,O,1624
33753,a,O,1624
33754,diagnosis,O,1624
33755,of,O,1624
33756,lagophthalmos,B-NAME_OF_DISEASE,1624
33757,In,O,1624
33758,reality,O,1625
33759,these,O,1625
33760,are,O,1625
33761,symptoms,O,1625
33762,of,O,1625
33763,almost,O,1625
33764,every,O,1625
33765,dry,B-NAME_OF_DISEASE,1625
33766,eye,I-NAME_OF_DISEASE,1625
33767,patient,O,1625
33768,Clinically,O,1625
33769,we,O,1625
33770,can,O,1625
33771,also,O,1625
33772,encounter,O,1625
33773,challenges,O,1625
33774,We,O,1625
33775,can,O,1625
33776,identify,O,1625
33777,lagophthalmos,B-NAME_OF_DISEASE,1626
33778,from,O,1626
33779,inferior,B-NAME_OF_DISEASE,1626
33780,superficial,I-NAME_OF_DISEASE,1626
33781,punctate,I-NAME_OF_DISEASE,1626
33782,keratitis,I-NAME_OF_DISEASE,1626
33783,but,O,1626
33784,if,O,1626
33785,patients,O,1626
33786,have,O,1626
33787,only,O,1626
33788,a,O,1626
33789,mild,O,1626
33790,case,O,1626
33791,and,O,1626
33792,their,O,1626
33793,appointment,O,1626
33794,time,O,1626
33795,is,O,1627
33796,late,O,1627
33797,afternoon,O,1627
33798,or,O,1627
33799,evening,O,1627
33800,those,O,1627
33801,corneal,O,1627
33802,finding,O,1627
33803,may,O,1627
33804,no,O,1627
33805,longer,O,1627
33806,be,O,1627
33807,present,O,1627
33808,To,O,1628
33809,accurately,O,1628
33810,identify,O,1628
33811,these,O,1628
33812,patients,O,1628
33813,practitioners,O,1628
33814,need,O,1628
33815,to,O,1629
33816,do,O,1629
33817,more,O,1629
33818,When,O,1629
33819,you,O,1629
33820,have,O,1629
33821,a,O,1629
33822,suspicion,O,1629
33823,of,O,1630
33824,nocturnal,B-NAME_OF_DISEASE,1630
33825,lagophthalmos,B-NAME_OF_DISEASE,1630
33826,that,O,1630
33827,a,O,1630
33828,pacurs,O,1630
33829,at,O,1630
33830,night,O,1630
33831,some,O,1630
33832,of,O,1630
33833,the,O,1630
33834,best,O,1630
33835,strategies,O,1630
33836,would,O,1630
33837,be,O,1630
33838,implemented,O,1630
33839,at,O,1630
33840,that,O,1630
33841,time,O,1630
33842,Addressing,O,1630
33843,the,O,1630
33844,environment,O,1630
33845,in,O,1630
33846,which,O,1630
33847,patients,O,1630
33848,sleep,O,1630
33849,can,O,1630
33850,be,O,1631
33851,helpful,O,1631
33852,such,O,1631
33853,as,O,1631
33854,using,O,1631
33855,a,O,1631
33856,humidifier,O,1631
33857,Taping,B-TREATMENT,1631
33858,the,I-TREATMENT,1631
33859,eyelids,I-TREATMENT,1631
33860,closed,I-TREATMENT,1631
33861,at,I-TREATMENT,1632
33862,night,I-TREATMENT,1632
33863,or,O,1632
33864,using,B-TREATMENT,1632
33865,commercially,I-TREATMENT,1632
33866,available,I-TREATMENT,1632
33867,eyelid,B-TREATMENT,1632
33868,weights,I-TREATMENT,1632
33869,can,O,1632
33870,go,O,1632
33871,a,O,1632
33872,long,O,1632
33873,way,O,1632
33874,in,O,1632
33875,addressing,O,1632
33876,exposure,B-NAME_OF_DISEASE,1632
33877,keratitis,I-NAME_OF_DISEASE,1632
33878,secondary,O,1633
33879,to,O,1633
33880,lagophthalmos,B-NAME_OF_DISEASE,1633
33881,Both,O,1633
33882,options,O,1633
33883,should,O,1633
33884,be,O,1633
33885,done,O,1633
33886,under,O,1633
33887,a,O,1633
33888,practitioner,O,1633
33889,s,O,1633
33890,supervision,O,1634
33891,While,O,1634
33892,both,O,1634
33893,artificial,B-TREATMENT,1634
33894,tears,I-TREATMENT,1634
33895,and,O,1634
33896,ointment,B-TREATMENT,1634
33897,assist,O,1634
33898,with,O,1634
33899,lubricating,O,1634
33900,the,B-PART_OF_THE_EYES,1634
33901,ocular,I-PART_OF_THE_EYES,1634
33902,surface,I-PART_OF_THE_EYES,1634
33903,ointments,B-TREATMENT,1634
33904,may,O,1634
33905,prove,O,1635
33906,to,O,1635
33907,be,O,1635
33908,more,O,1635
33909,effective,O,1635
33910,especially,O,1635
33911,when,O,1635
33912,used,O,1635
33913,in,O,1635
33914,conjunction,O,1635
33915,with,O,1635
33916,eyelid,B-TREATMENT,1636
33917,taping,I-TREATMENT,1636
33918,or,O,1636
33919,with,O,1636
33920,eyelid,B-TREATMENT,1636
33921,weights,I-TREATMENT,1636
33922,Practitioners,O,1636
33923,definitely,O,1636
33924,have,O,1636
33925,options,O,1636
33926,to,O,1637
33927,offer,O,1637
33928,to,O,1637
33929,patients,O,1637
33930,who,O,1637
33931,have,O,1637
33932,nocturnal,B-NAME_OF_DISEASE,1637
33933,lagophthalmos,B-NAME_OF_DISEASE,1637
33934,but,O,1637
33935,the,O,1637
33936,key,O,1638
33937,is,O,1638
33938,identifying,O,1638
33939,the,O,1638
33940,problem,O,1638
33941,As,O,1638
33942,always,O,1639
33943,an,O,1639
33944,effective,O,1639
33945,case,O,1639
33946,history,O,1639
33947,in,O,1639
33948,connection,O,1639
33949,with,O,1639
33950,a,O,1639
33951,problem-focused,O,1639
33952,exam,O,1640
33953,can,O,1640
33954,help,O,1640
33955,uncover,O,1640
33956,those,O,1640
33957,subtle,O,1640
33958,diagnoses,O,1640
33959,Start,O,1641
33960,by,O,1641
33961,asking,O,1641
33962,the,O,1641
33963,right,O,1641
33964,questions,O,1641
33965,Ask,O,1641
33966,patients,O,1641
33967,Do,O,1641
33968,you,O,1641
33969,notice,O,1641
33970,a,O,1641
33971,substantial,O,1641
33972,difference,O,1641
33973,in,O,1641
33974,symptoms,O,1642
33975,in,O,1642
33976,the,O,1642
33977,morning,O,1642
33978,as,O,1642
33979,opposed,O,1642
33980,to,O,1642
33981,in,O,1642
33982,the,O,1642
33983,evening,O,1642
33984,Are,O,1642
33985,there,O,1642
33986,differences,O,1642
33987,between,O,1642
33988,the,O,1642
33989,days,O,1642
33990,that,O,1642
33991,you,O,1642
33992,wear,O,1642
33993,contact,O,1642
33994,lenses,O,1642
33995,and,O,1642
33996,the,O,1642
33997,days,O,1642
33998,that,O,1642
33999,you,O,1643
34000,do,O,1643
34001,not,O,1643
34002,Can,O,1643
34003,you,O,1643
34004,come,O,1643
34005,in,O,1643
34006,for,O,1643
34007,a,O,1643
34008,morning,O,1643
34009,appointment,O,1643
34010,Practitioners,O,1643
34011,can,O,1643
34012,also,O,1643
34013,try,O,1643
34014,to,O,1643
34015,simulate,O,1643
34016,sleeping,O,1644
34017,in,O,1644
34018,the,O,1644
34019,office,O,1644
34020,by,O,1644
34021,asking,O,1644
34022,patients,O,1644
34023,to,O,1644
34024,gently,O,1645
34025,close,O,1645
34026,their,O,1645
34027,eyes,O,1645
34028,A,B-DIAGNOSTIC_TEST,1645
34029,slit,I-DIAGNOSTIC_TEST,1645
34030,lamp,I-DIAGNOSTIC_TEST,1645
34031,or,I-DIAGNOSTIC_TEST,1645
34032,transilluminator,I-DIAGNOSTIC_TEST,1645
34033,evaluation,I-DIAGNOSTIC_TEST,1645
34034,of,I-DIAGNOSTIC_TEST,1645
34035,the,I-DIAGNOSTIC_TEST,1645
34036,intrapalpebral,I-DIAGNOSTIC_TEST,1645
34037,area,I-DIAGNOSTIC_TEST,1645
34038,will,O,1645
34039,be,O,1645
34040,able,O,1645
34041,to,O,1645
34042,help,O,1645
34043,determine,O,1645
34044,whether,O,1645
34045,lagophthalmos,B-NAME_OF_DISEASE,1645
34046,is,O,1645
34047,present,O,1645
34048,Treatment,O,1645
34049,Options,O,1646
34050,Once,O,1646
34051,we,O,1646
34052,determine,O,1646
34053,that,O,1646
34054,a,O,1646
34055,patients,O,1646
34056,has,O,1646
34057,lagophthalmos,B-NAME_OF_DISEASE,1647
34058,there,O,1647
34059,are,O,1647
34060,a,O,1647
34061,few,O,1647
34062,options,O,1647
34063,for,O,1647
34064,contact,O,1647
34065,lens,O,1647
34066,patients,O,1647
34067,Because,O,1647
34068,the,O,1648
34069,condition,O,1648
34070,occurs,O,1648
34071,at,O,1648
34072,night,O,1648
34073,some,O,1648
34074,of,O,1648
34075,the,O,1648
34076,best,O,1648
34077,strategies,O,1648
34078,would,O,1648
34079,be,O,1649
34080,implemented,O,1649
34081,at,O,1649
34082,that,O,1649
34083,time,O,1649
34084,Addressing,O,1649
34085,the,O,1649
34086,environment,O,1649
34087,in,O,1649
34088,which,O,1649
34089,patients,O,1649
34090,sleep,O,1649
34091,can,O,1649
34092,be,O,1649
34093,helpful,O,1649
34094,such,O,1649
34095,as,O,1649
34096,using,O,1649
34097,a,O,1649
34098,humidifier,O,1649
34099,Taping,B-TREATMENT,1649
34100,the,I-TREATMENT,1649
34101,eyelids,I-TREATMENT,1649
34102,closed,I-TREATMENT,1649
34103,at,I-TREATMENT,1649
34104,night,I-TREATMENT,1649
34105,or,O,1649
34106,using,B-TREATMENT,1649
34107,commercially,I-TREATMENT,1649
34108,available,I-TREATMENT,1649
34109,eyelid,B-TREATMENT,1649
34110,weights,I-TREATMENT,1649
34111,can,O,1649
34112,go,O,1649
34113,a,O,1650
34114,long,O,1650
34115,way,O,1650
34116,in,O,1650
34117,addressing,O,1650
34118,exposure,B-NAME_OF_DISEASE,1650
34119,keratitis,I-NAME_OF_DISEASE,1650
34120,secondary,O,1651
34121,to,O,1651
34122,lagophthalmos,B-NAME_OF_DISEASE,1651
34123,Both,O,1651
34124,options,O,1651
34125,should,O,1651
34126,be,O,1651
34127,done,O,1651
34128,under,O,1651
34129,a,O,1652
34130,practitioner,O,1652
34131,s,O,1652
34132,supervision,O,1652
34133,While,O,1652
34134,both,O,1652
34135,artificial,B-TREATMENT,1652
34136,tears,I-TREATMENT,1652
34137,and,O,1652
34138,ointment,B-TREATMENT,1652
34139,assist,O,1653
34140,with,O,1653
34141,lubricating,O,1653
34142,the,B-PART_OF_THE_EYES,1653
34143,ocular,I-PART_OF_THE_EYES,1653
34144,surface,I-PART_OF_THE_EYES,1653
34145,ointments,B-TREATMENT,1653
34146,may,O,1653
34147,prove,O,1653
34148,to,O,1653
34149,be,O,1653
34150,more,O,1653
34151,effective,O,1654
34152,especially,O,1654
34153,when,O,1654
34154,used,O,1654
34155,in,O,1654
34156,conjunction,O,1654
34157,with,O,1655
34158,eyelid,B-TREATMENT,1655
34159,taping,I-TREATMENT,1655
34160,or,O,1655
34161,with,O,1655
34162,eyelid,B-TREATMENT,1655
34163,weights,I-TREATMENT,1655
34164,Practitioners,O,1655
34165,definitely,O,1655
34166,have,O,1655
34167,options,O,1655
34168,to,O,1655
34169,offer,O,1655
34170,to,O,1655
34171,patients,O,1655
34172,who,O,1655
34173,have,O,1655
34174,nocturnal,B-NAME_OF_DISEASE,1655
34175,lagophthalmos,I-NAME_OF_DISEASE,1655
34176,but,O,1655
34177,the,O,1655
34178,key,O,1655
34179,is,O,1655
34180,identifying,O,1655
34181,the,O,1655
34182,problem,O,1655
34183,As,O,1655
34184,always,O,1655
34185,an,O,1655
34186,effective,O,1655
34187,case,O,1655
34188,history,O,1655
34189,in,O,1655
34190,connection,O,1655
34191,with,O,1655
34192,a,O,1656
34193,problem-focused,O,1656
34194,exam,O,1656
34195,can,O,1656
34196,help,O,1656
34197,uncover,O,1656
34198,those,O,1656
34199,subtle,O,1656
34200,diagnoses,O,1656
34201,LASIK,B-TREATMENT,1656
34202,surgery,I-TREATMENT,1656
34203,is,O,1657
34204,one,O,1657
34205,of,O,1657
34206,the,O,1657
34207,world,O,1657
34208,s,O,1657
34209,most,O,1657
34210,frequently,O,1657
34211,performed,O,1657
34212,ocular,O,1657
34213,procedures,O,1657
34214,LASIK,B-TREATMENT,1657
34215,stands,O,1657
34216,for,O,1657
34217,Laser-Assisted,B-TREATMENT,1657
34218,In,I-TREATMENT,1657
34219,Situ,I-TREATMENT,1657
34220,Keratomileusis,I-TREATMENT,1657
34221,Keratomileusis,B-TREATMENT,1658
34222,is,O,1658
34223,the,O,1658
34224,medical,O,1658
34225,word,O,1658
34226,for,O,1659
34227,corneal,O,1659
34228,reshaping,O,1659
34229,These,O,1659
34230,reshaping,O,1659
34231,addresses,O,1659
34232,refractive,O,1659
34233,abnormalities,O,1660
34234,like,O,1660
34235,myopia,B-NAME_OF_DISEASE,1660
34236,hyperopia,B-NAME_OF_DISEASE,1660
34237,and,O,1660
34238,astigmatism,B-NAME_OF_DISEASE,1660
34239,so,O,1660
34240,that,O,1660
34241,light,O,1660
34242,rays,O,1660
34243,bend,O,1660
34244,appropriately,O,1660
34245,into,O,1660
34246,the,O,1660
34247,patient,O,1660
34248,s,O,1661
34249,retina,B-PART_OF_THE_EYES,1661
34250,and,O,1661
34251,get,O,1661
34252,focused,O,1661
34253,for,O,1661
34254,crisp,O,1661
34255,vision,O,1661
34256,This,O,1661
34257,correction,O,1662
34258,enables,O,1662
34259,patients,O,1662
34260,to,O,1662
34261,discard,O,1662
34262,their,O,1662
34263,glasses,B-TREATMENT,1662
34264,or,O,1663
34265,contact,B-TREATMENT,1663
34266,lenses,I-TREATMENT,1663
34267,How,O,1663
34268,It,O,1663
34269,s,O,1663
34270,Done,O,1663
34271,LASIK,B-TREATMENT,1663
34272,is,O,1663
34273,an,O,1663
34274,outpatient,O,1663
34275,operation,O,1663
34276,that,O,1663
34277,does,O,1663
34278,not,O,1663
34279,involve,O,1663
34280,pre-,O,1663
34281,or,O,1664
34282,post-operative,O,1664
34283,hospitalization,O,1664
34284,Using,O,1664
34285,an,O,1664
34286,excimer,O,1664
34287,laser,O,1664
34288,the,O,1664
34289,Ophthalmologist,O,1664
34290,reshapes,O,1664
34291,the,O,1664
34292,patient,O,1664
34293,s,O,1664
34294,corneal,B-PART_OF_THE_EYES,1664
34295,surface,I-PART_OF_THE_EYES,1664
34296,Following,O,1664
34297,steps,O,1664
34298,are,O,1664
34299,taken,O,1664
34300,during,O,1664
34301,the,O,1664
34302,procedure,O,1664
34303,The,O,1664
34304,eyes,O,1664
34305,are,O,1664
34306,numbed,O,1664
34307,using,O,1664
34308,topical,B-NAME_OF_DRUG,1664
34309,eye,I-NAME_OF_DRUG,1664
34310,drops,I-NAME_OF_DRUG,1665
34311,Eyes,O,1665
34312,are,O,1665
34313,maintained,O,1665
34314,in,O,1665
34315,an,O,1665
34316,open,O,1665
34317,position,O,1665
34318,using,O,1665
34319,an,B-SURGICAL_INSTRUMENT,1665
34320,eyelid,I-SURGICAL_INSTRUMENT,1665
34321,speculum,I-SURGICAL_INSTRUMENT,1665
34322,It,O,1665
34323,holds,O,1665
34324,the,O,1665
34325,patient,O,1665
34326,s,O,1665
34327,eye,O,1665
34328,open,O,1665
34329,and,O,1665
34330,inhibits,O,1665
34331,blinking,O,1665
34332,Using,O,1665
34333,the,O,1666
34334,laser,O,1666
34335,the,O,1666
34336,surgeon,O,1666
34337,creates,O,1666
34338,a,O,1666
34339,thin,O,1666
34340,corneal,O,1666
34341,flap,O,1666
34342,The,O,1666
34343,flap,O,1666
34344,is,O,1666
34345,raised,O,1666
34346,and,O,1666
34347,retracted,O,1666
34348,The,O,1666
34349,patient,O,1666
34350,is,O,1666
34351,instructed,O,1666
34352,to,O,1666
34353,focus,O,1666
34354,on,O,1666
34355,a,O,1666
34356,light,O,1666
34357,source,O,1666
34358,Accordingly,O,1666
34359,the,O,1666
34360,laser,O,1666
34361,then,O,1666
34362,reshapes,O,1666
34363,the,B-PART_OF_THE_EYES,1666
34364,cornea,I-PART_OF_THE_EYES,1666
34365,After,O,1666
34366,reshaping,O,1666
34367,the,O,1666
34368,surgeon,O,1666
34369,repositions,O,1666
34370,the,O,1666
34371,flap,O,1666
34372,which,O,1666
34373,attaches,O,1666
34374,itself,O,1666
34375,within,B-TIME_DURATION,1666
34376,two,I-TIME_DURATION,1666
34377,to,I-TIME_DURATION,1666
34378,three,I-TIME_DURATION,1666
34379,minutes,I-TIME_DURATION,1666
34380,How,O,1666
34381,Many,O,1666
34382,People,O,1666
34383,Get,O,1667
34384,LASIK,B-TREATMENT,1667
34385,Done,O,1667
34386,Every,O,1667
34387,Year,O,1667
34388,According,O,1667
34389,to,O,1667
34390,data,O,1667
34391,from,O,1667
34392,various,O,1667
34393,research,O,1667
34394,LASIK,B-TREATMENT,1667
34395,is,O,1667
34396,the,O,1667
34397,most,O,1667
34398,common,O,1667
34399,elective,O,1667
34400,surgery,O,1667
34401,in,O,1667
34402,the,B-GPE,1667
34403,United,I-GPE,1667
34404,States,I-GPE,1667
34405,Since,O,1667
34406,1999,O,1667
34407,when,O,1667
34408,the,B-ORGANIZATION,1667
34409,FDA,I-ORGANIZATION,1667
34410,initially,O,1668
34411,authorized,O,1668
34412,LASIK,B-TREATMENT,1668
34413,surgery,I-TREATMENT,1668
34414,around,O,1668
34415,10,O,1668
34416,million,O,1668
34417,Americans,O,1668
34418,have,O,1668
34419,had,O,1668
34420,the,O,1668
34421,procedure,O,1668
34422,Approximately,O,1668
34423,700,O,1668
34424,0,O,1668
34425,LASIK,B-TREATMENT,1668
34426,operations,I-TREATMENT,1668
34427,are,O,1668
34428,performed,O,1669
34429,annually,O,1669
34430,What,O,1669
34431,Are,O,1669
34432,the,O,1669
34433,Benefits,O,1669
34434,of,O,1669
34435,LASIK,B-TREATMENT,1669
34436,According,O,1669
34437,to,O,1669
34438,the,O,1669
34439,research,O,1669
34440,LASIK,B-TREATMENT,1669
34441,has,O,1669
34442,shown,O,1669
34443,to,O,1669
34444,be,O,1670
34445,an,O,1670
34446,excellent,O,1670
34447,option,O,1670
34448,among,O,1670
34449,refractive,O,1670
34450,operations,O,1670
34451,for,O,1670
34452,improving,O,1670
34453,visual,O,1670
34454,acuity,O,1670
34455,Recent,O,1670
34456,technological,O,1670
34457,advancements,O,1670
34458,have,O,1670
34459,made,O,1670
34460,LASIK,B-TREATMENT,1670
34461,significantly,O,1670
34462,safer,O,1670
34463,However,O,1670
34464,like,O,1670
34465,with,O,1671
34466,any,O,1671
34467,surgical,O,1671
34468,procedure,O,1671
34469,there,O,1671
34470,are,O,1671
34471,some,O,1671
34472,associated,O,1671
34473,complications,O,1671
34474,Additionally,O,1671
34475,LASIK,B-TREATMENT,1671
34476,offers,O,1671
34477,a,O,1671
34478,rapid,O,1671
34479,recovery,O,1671
34480,time,O,1671
34481,of,O,1671
34482,around,B-TIME_DURATION,1671
34483,24-36,I-TIME_DURATION,1672
34484,hours,I-TIME_DURATION,1672
34485,Are,O,1673
34486,You,O,1673
34487,a,O,1673
34488,Good,O,1673
34489,Candidate,O,1673
34490,for,O,1673
34491,LASIK,B-TREATMENT,1673
34492,Eye,I-TREATMENT,1673
34493,Surgery,I-TREATMENT,1673
34494,You,O,1673
34495,are,O,1673
34496,eligible,O,1673
34497,for,O,1673
34498,LASIK,B-TREATMENT,1673
34499,if,O,1673
34500,You,O,1674
34501,are,O,1674
34502,at,O,1674
34503,least,O,1674
34504,21,O,1674
34505,years,O,1674
34506,old,O,1674
34507,Your,O,1674
34508,refractive,O,1674
34509,error,O,1675
34510,has,O,1675
34511,not,O,1676
34512,worsened,O,1676
34513,for,B-TIME_DURATION,1676
34514,a,I-TIME_DURATION,1676
34515,minimum,I-TIME_DURATION,1676
34516,of,I-TIME_DURATION,1676
34517,one,I-TIME_DURATION,1676
34518,year,I-TIME_DURATION,1676
34519,Your,O,1676
34520,eyes,O,1676
34521,and,O,1676
34522,general,O,1676
34523,health,O,1676
34524,are,O,1676
34525,excellent,O,1676
34526,The,O,1676
34527,nature,O,1676
34528,of,O,1676
34529,your,O,1676
34530,job,O,1676
34531,suggests,O,1676
34532,laser,B-TREATMENT,1676
34533,eye,I-TREATMENT,1676
34534,surgery,I-TREATMENT,1677
34535,LASIK,B-TREATMENT,1677
34536,should,O,1677
34537,not,O,1677
34538,be,O,1677
34539,performed,O,1677
34540,if,O,1677
34541,Your,O,1677
34542,eyes,O,1677
34543,are,O,1677
34544,dry,O,1677
34545,Your,O,1677
34546,surgeon,O,1677
34547,has,O,1677
34548,determined,O,1677
34549,that,O,1677
34550,your,O,1677
34551,cornea,B-PART_OF_THE_EYES,1677
34552,is,O,1677
34553,too,O,1677
34554,thick,O,1677
34555,or,O,1677
34556,thin,O,1677
34557,An,O,1677
34558,active,O,1677
34559,eye,O,1677
34560,infection,O,1678
34561,is,O,1678
34562,present,O,1678
34563,You,O,1678
34564,have,O,1678
34565,or,O,1678
34566,formerly,O,1678
34567,had,O,1678
34568,an,O,1678
34569,inflammatory,O,1678
34570,eye,O,1678
34571,illness,O,1678
34572,injury,O,1678
34573,uveitis,B-NAME_OF_DISEASE,1678
34574,surgery,O,1678
34575,You,O,1678
34576,have,O,1678
34577,elevated,B-NAME_OF_DISEASE,1678
34578,Intraocular,I-NAME_OF_DISEASE,1678
34579,Pressure,I-NAME_OF_DISEASE,1678
34580,IOP,I-NAME_OF_DISEASE,1679
34581,Your,O,1679
34582,Diabetes,B-NAME_OF_DISEASE,1679
34583,is,O,1679
34584,not,O,1679
34585,under,O,1679
34586,the,O,1679
34587,control,O,1679
34588,Your,O,1679
34589,regular,O,1680
34590,activities,O,1680
34591,need,O,1681
34592,dim,O,1681
34593,lighting,O,1681
34594,such,O,1681
34595,as,O,1682
34596,nighttime,O,1682
34597,driving,O,1682
34598,You,O,1682
34599,are,O,1682
34600,now,O,1682
34601,taking,O,1682
34602,the,O,1682
34603,following,O,1682
34604,medications,O,1682
34605,sumatriptan,B-NAME_OF_DRUG,1682
34606,and,O,1682
34607,amiodarone,B-NAME_OF_DRUG,1682
34608,hydrochloride,I-NAME_OF_DRUG,1682
34609,You,O,1682
34610,should,O,1682
34611,discuss,O,1682
34612,proceeding,O,1682
34613,with,O,1682
34614,LASIK,B-TREATMENT,1682
34615,with,O,1682
34616,your,O,1682
34617,ophthalmologist,O,1683
34618,if,O,1683
34619,You,O,1683
34620,have,O,1683
34621,a,O,1683
34622,history,O,1683
34623,of,O,1683
34624,herpes,B-NAME_OF_DISEASE,1683
34625,eye,I-NAME_OF_DISEASE,1683
34626,infection,I-NAME_OF_DISEASE,1683
34627,You,O,1683
34628,are,O,1683
34629,now,O,1683
34630,using,O,1683
34631,isotretinoin,B-NAME_OF_DRUG,1683
34632,You,O,1683
34633,have,O,1684
34634,Diabetes,B-NAME_OF_DISEASE,1684
34635,but,O,1684
34636,it,O,1684
34637,is,O,1684
34638,well-managed,O,1684
34639,You,O,1684
34640,engage,O,1684
34641,in,O,1684
34642,activities,O,1684
34643,that,O,1684
34644,pose,O,1684
34645,a,O,1684
34646,risk,O,1684
34647,to,O,1684
34648,the,B-TREATMENT,1684
34649,LASIK,I-TREATMENT,1684
34650,flap,I-TREATMENT,1684
34651,including,O,1684
34652,contact,O,1684
34653,sports,O,1684
34654,You,O,1684
34655,have,O,1684
34656,a,O,1684
34657,history,O,1684
34658,of,O,1684
34659,crossed,B-NAME_OF_DISEASE,1684
34660,eyes,I-NAME_OF_DISEASE,1684
34661,or,O,1685
34662,squint,B-NAME_OF_DISEASE,1685
34663,You,O,1685
34664,have,O,1685
34665,a,B-NAME_OF_DISEASE,1685
34666,lazy,I-NAME_OF_DISEASE,1685
34667,eye,I-NAME_OF_DISEASE,1685
34668,or,O,1685
34669,amblyopia,B-NAME_OF_DISEASE,1685
34670,What,O,1685
34671,Are,O,1685
34672,the,O,1685
34673,Possible,O,1685
34674,Complications,O,1685
34675,As,O,1685
34676,with,O,1685
34677,every,O,1685
34678,other,O,1685
34679,surgical,O,1685
34680,procedure,O,1685
34681,LASIK,B-TREATMENT,1685
34682,has,O,1685
34683,its,O,1685
34684,share,O,1685
34685,of,O,1685
34686,problems,O,1685
34687,Important,O,1685
34688,ones,O,1685
34689,are,O,1685
34690,Dry,B-SIGN_AND_SYMPTOM,1685
34691,eyes,I-SIGN_AND_SYMPTOM,1685
34692,Visual,O,1685
34693,Symptoms,O,1685
34694,like,O,1686
34695,Glare,B-SIGN_AND_SYMPTOM,1686
34696,The,O,1686
34697,patient,O,1686
34698,has,O,1686
34699,difficulty,O,1686
34700,seeing,O,1686
34701,in,O,1686
34702,bright,O,1686
34703,light,O,1686
34704,Halos,B-SIGN_AND_SYMPTOM,1686
34705,The,O,1687
34706,patient,O,1687
34707,perceives,B-SIGN_AND_SYMPTOM,1687
34708,a,I-SIGN_AND_SYMPTOM,1687
34709,haze,I-SIGN_AND_SYMPTOM,1687
34710,of,I-SIGN_AND_SYMPTOM,1687
34711,light,I-SIGN_AND_SYMPTOM,1687
34712,surrounding,I-SIGN_AND_SYMPTOM,1687
34713,any,I-SIGN_AND_SYMPTOM,1687
34714,bright,I-SIGN_AND_SYMPTOM,1687
34715,item,I-SIGN_AND_SYMPTOM,1687
34716,Starburst,B-SIGN_AND_SYMPTOM,1687
34717,The,O,1687
34718,patient,O,1687
34719,sees,B-SIGN_AND_SYMPTOM,1687
34720,rays,I-SIGN_AND_SYMPTOM,1687
34721,of,I-SIGN_AND_SYMPTOM,1687
34722,light,I-SIGN_AND_SYMPTOM,1687
34723,emitted,I-SIGN_AND_SYMPTOM,1687
34724,by,I-SIGN_AND_SYMPTOM,1687
34725,bright,I-SIGN_AND_SYMPTOM,1687
34726,objects,I-SIGN_AND_SYMPTOM,1687
34727,Ghost,B-SIGN_AND_SYMPTOM,1687
34728,Images,I-SIGN_AND_SYMPTOM,1687
34729,It,O,1687
34730,appears,O,1688
34731,as,O,1688
34732,if,O,1688
34733,the,O,1688
34734,patient,O,1688
34735,is,O,1688
34736,seeing,B-SIGN_AND_SYMPTOM,1688
34737,double,I-SIGN_AND_SYMPTOM,1688
34738,image,I-SIGN_AND_SYMPTOM,1688
34739,Vision,B-SIGN_AND_SYMPTOM,1688
34740,impairment,I-SIGN_AND_SYMPTOM,1688
34741,in,I-SIGN_AND_SYMPTOM,1689
34742,low,I-SIGN_AND_SYMPTOM,1689
34743,light,I-SIGN_AND_SYMPTOM,1689
34744,Corneal,B-SIGN_AND_SYMPTOM,1689
34745,Flap,I-SIGN_AND_SYMPTOM,1689
34746,problems,I-SIGN_AND_SYMPTOM,1689
34747,such,I-SIGN_AND_SYMPTOM,1689
34748,as,I-SIGN_AND_SYMPTOM,1689
34749,uneven,I-SIGN_AND_SYMPTOM,1689
34750,healing,I-SIGN_AND_SYMPTOM,1689
34751,or,I-SIGN_AND_SYMPTOM,1689
34752,detachment,I-SIGN_AND_SYMPTOM,1689
34753,Infection,B-SIGN_AND_SYMPTOM,1689
34754,or,I-SIGN_AND_SYMPTOM,1689
34755,inflammation,I-SIGN_AND_SYMPTOM,1689
34756,of,I-SIGN_AND_SYMPTOM,1689
34757,the,I-SIGN_AND_SYMPTOM,1689
34758,cornea,I-SIGN_AND_SYMPTOM,1689
34759,Retinal,B-SIGN_AND_SYMPTOM,1689
34760,detachment,I-SIGN_AND_SYMPTOM,1689
34761,rarely,O,1689
34762,seen,O,1689
34763,How,O,1689
34764,Should,O,1689
34765,You,O,1689
34766,Prepare,O,1689
34767,For,O,1689
34768,LASIK,B-TREATMENT,1689
34769,Eye,I-TREATMENT,1689
34770,Surgery,I-TREATMENT,1689
34771,Pre-operative,O,1689
34772,preparation,O,1689
34773,for,O,1689
34774,LASIK,B-TREATMENT,1689
34775,relies,O,1689
34776,on,O,1689
34777,the,O,1690
34778,patient,O,1690
34779,s,O,1690
34780,objectives,O,1690
34781,medical,O,1690
34782,and,O,1690
34783,ocular,O,1690
34784,history,O,1690
34785,and,O,1690
34786,a,O,1690
34787,thorough,O,1690
34788,evaluation,O,1690
34789,Before,O,1690
34790,LASIK,B-TREATMENT,1690
34791,surgery,I-TREATMENT,1690
34792,the,O,1691
34793,following,O,1691
34794,procedures,O,1691
34795,are,O,1691
34796,performed,O,1691
34797,Test,B-DIAGNOSTIC_TEST,1691
34798,for,I-DIAGNOSTIC_TEST,1691
34799,Visual,I-DIAGNOSTIC_TEST,1691
34800,Acuity,I-DIAGNOSTIC_TEST,1691
34801,The,O,1691
34802,surgeon,O,1692
34803,should,O,1692
34804,evaluate,B-DIAGNOSTIC_TEST,1692
34805,the,I-DIAGNOSTIC_TEST,1692
34806,patient,I-DIAGNOSTIC_TEST,1692
34807,s,I-DIAGNOSTIC_TEST,1692
34808,vision,I-DIAGNOSTIC_TEST,1692
34809,with,I-DIAGNOSTIC_TEST,1692
34810,and,I-DIAGNOSTIC_TEST,1692
34811,without,I-DIAGNOSTIC_TEST,1692
34812,their,I-DIAGNOSTIC_TEST,1692
34813,most,I-DIAGNOSTIC_TEST,1692
34814,significant,I-DIAGNOSTIC_TEST,1692
34815,correction,I-DIAGNOSTIC_TEST,1692
34816,Detailed,B-DIAGNOSTIC_TEST,1692
34817,Ocular,I-DIAGNOSTIC_TEST,1692
34818,Examination,I-DIAGNOSTIC_TEST,1692
34819,The,O,1692
34820,surgeon,O,1692
34821,should,O,1692
34822,perform,O,1693
34823,a,B-DIAGNOSTIC_TEST,1693
34824,thorough,I-DIAGNOSTIC_TEST,1693
34825,Slit-lamp,I-DIAGNOSTIC_TEST,1693
34826,examination,I-DIAGNOSTIC_TEST,1693
34827,to,I-DIAGNOSTIC_TEST,1693
34828,rule,I-DIAGNOSTIC_TEST,1693
34829,out,I-DIAGNOSTIC_TEST,1693
34830,any,I-DIAGNOSTIC_TEST,1693
34831,contraindicated,I-DIAGNOSTIC_TEST,1693
34832,eye,I-DIAGNOSTIC_TEST,1693
34833,disease,I-DIAGNOSTIC_TEST,1693
34834,Corneal,B-DIAGNOSTIC_TEST,1694
34835,Topography,I-DIAGNOSTIC_TEST,1694
34836,This,O,1694
34837,investigation,O,1694
34838,maps,B-DIAGNOSTIC_TEST,1694
34839,the,I-DIAGNOSTIC_TEST,1694
34840,cornea,I-DIAGNOSTIC_TEST,1694
34841,s,I-DIAGNOSTIC_TEST,1694
34842,surface,I-DIAGNOSTIC_TEST,1694
34843,to,I-DIAGNOSTIC_TEST,1694
34844,determine,I-DIAGNOSTIC_TEST,1694
34845,the,I-DIAGNOSTIC_TEST,1695
34846,correct,I-DIAGNOSTIC_TEST,1695
34847,thickness,I-DIAGNOSTIC_TEST,1695
34848,and,I-DIAGNOSTIC_TEST,1695
34849,dimensions,I-DIAGNOSTIC_TEST,1695
34850,Assessment,B-DIAGNOSTIC_TEST,1695
34851,of,I-DIAGNOSTIC_TEST,1695
34852,pupil,I-DIAGNOSTIC_TEST,1695
34853,size,I-DIAGNOSTIC_TEST,1695
34854,The,O,1695
34855,Ophthalmologist,O,1695
34856,should,O,1695
34857,assess,B-DIAGNOSTIC_TEST,1695
34858,pupil,I-DIAGNOSTIC_TEST,1695
34859,size,I-DIAGNOSTIC_TEST,1695
34860,to,I-DIAGNOSTIC_TEST,1695
34861,determine,I-DIAGNOSTIC_TEST,1695
34862,the,I-DIAGNOSTIC_TEST,1695
34863,possibility,I-DIAGNOSTIC_TEST,1695
34864,of,I-DIAGNOSTIC_TEST,1695
34865,nighttime,I-DIAGNOSTIC_TEST,1695
34866,halo,I-DIAGNOSTIC_TEST,1695
34867,formation,I-DIAGNOSTIC_TEST,1695
34868,following,I-DIAGNOSTIC_TEST,1695
34869,the,I-DIAGNOSTIC_TEST,1696
34870,surgery,I-DIAGNOSTIC_TEST,1696
34871,Infection,O,1696
34872,inflammation,O,1696
34873,treatment,O,1696
34874,Any,O,1696
34875,current,O,1696
34876,infection,O,1696
34877,or,O,1696
34878,inflammation,O,1696
34879,must,O,1696
34880,be,O,1696
34881,treated,O,1696
34882,before,O,1696
34883,surgery,O,1696
34884,and,O,1696
34885,reviewed,O,1696
34886,with,O,1696
34887,the,O,1696
34888,Ophthalmologist,O,1696
34889,Author,O,1696
34890,Dr,O,1697
34891,Muhammad,O,1697
34892,Saad,O,1697
34893,Resident,O,1697
34894,Ophthalmologist,O,1697
34895,at,O,1697
34896,Al-Shifa,B-ORGANIZATION,1697
34897,Trust,I-ORGANIZATION,1697
34898,Eye,I-ORGANIZATION,1697
34899,Hospital,I-ORGANIZATION,1697
34900,in,O,1697
34901,Rawalpindi,B-GPE,1697
34902,Pakistan,I-GPE,1697
34903,Cataract,B-TREATMENT,1697
34904,eye,I-TREATMENT,1697
34905,surgery,I-TREATMENT,1697
34906,is,O,1697
34907,considered,O,1697
34908,one,O,1697
34909,of,O,1697
34910,the,O,1697
34911,most,O,1697
34912,frequent,O,1697
34913,and,O,1697
34914,safest,O,1698
34915,eye,O,1698
34916,surgeries,O,1698
34917,worldwide,O,1698
34918,Like,O,1698
34919,any,O,1698
34920,other,O,1698
34921,surgical,O,1698
34922,treatment,O,1698
34923,complications,O,1698
34924,remain,O,1698
34925,a,O,1698
34926,possibility,O,1698
34927,Since,O,1698
34928,Dr,O,1698
34929,Harold,O,1698
34930,Ridley,O,1698
34931,performed,O,1698
34932,the,O,1698
34933,first,O,1698
34934,intraocular,O,1699
34935,lens,O,1699
34936,IOL,O,1699
34937,implantation,O,1699
34938,in,O,1699
34939,1949,O,1699
34940,IOL,B-NAME_OF_DISEASE,1699
34941,displacement,I-NAME_OF_DISEASE,1699
34942,has,O,1699
34943,been,O,1699
34944,recognized,O,1699
34945,as,O,1699
34946,a,O,1699
34947,significant,O,1699
34948,complication,O,1699
34949,of,O,1699
34950,cataract,B-TREATMENT,1699
34951,surgery,I-TREATMENT,1699
34952,During,O,1700
34953,most,O,1700
34954,cataract,B-TREATMENT,1700
34955,surgery,I-TREATMENT,1700
34956,procedures,O,1700
34957,the,O,1700
34958,IOL,O,1700
34959,is,O,1700
34960,inserted,O,1700
34961,into,O,1700
34962,the,B-PART_OF_THE_EYES,1700
34963,capsular,B-PART_OF_THE_EYES,1700
34964,bag,I-PART_OF_THE_EYES,1700
34965,a,O,1700
34966,sac-like,O,1701
34967,structure,O,1701
34968,in,O,1701
34969,the,O,1701
34970,eye,O,1701
34971,that,O,1701
34972,formerly,O,1701
34973,housed,O,1701
34974,the,O,1701
34975,hazy,O,1701
34976,natural,O,1701
34977,lens,O,1701
34978,Occasionally,O,1701
34979,this,O,1701
34980,fragile,O,1702
34981,capsular,B-PART_OF_THE_EYES,1702
34982,bag,I-PART_OF_THE_EYES,1702
34983,or,O,1702
34984,the,B-PART_OF_THE_EYES,1702
34985,zonular,I-PART_OF_THE_EYES,1702
34986,fibers,I-PART_OF_THE_EYES,1702
34987,that,O,1702
34988,hold,O,1702
34989,it,O,1702
34990,in,O,1702
34991,place,O,1703
34992,rupture,O,1703
34993,compromising,O,1703
34994,the,O,1703
34995,IOL,O,1703
34996,s,O,1703
34997,support,O,1703
34998,Intraocular,B-NAME_OF_DISEASE,1703
34999,lens,I-NAME_OF_DISEASE,1703
35000,IOL,I-NAME_OF_DISEASE,1703
35001,dislocation,I-NAME_OF_DISEASE,1703
35002,has,O,1703
35003,been,O,1703
35004,documented,O,1703
35005,in,O,1703
35006,0,O,1703
35007,to,O,1703
35008,3,O,1703
35009,of,O,1703
35010,cataract,B-TREATMENT,1703
35011,surgery,I-TREATMENT,1703
35012,patients,O,1703
35013,What,O,1703
35014,Are,O,1703
35015,the,O,1703
35016,Signs,O,1703
35017,And,O,1703
35018,Symptoms,O,1703
35019,of,O,1703
35020,IOL,B-NAME_OF_DISEASE,1703
35021,Dislocation,I-NAME_OF_DISEASE,1703
35022,The,O,1703
35023,most,O,1703
35024,prevalent,O,1703
35025,sign,O,1703
35026,of,O,1703
35027,a,B-NAME_OF_DISEASE,1703
35028,displaced,I-NAME_OF_DISEASE,1703
35029,IOL,I-NAME_OF_DISEASE,1704
35030,is,O,1704
35031,a,B-SIGN_AND_SYMPTOM,1704
35032,change,I-SIGN_AND_SYMPTOM,1704
35033,in,I-SIGN_AND_SYMPTOM,1704
35034,vision,I-SIGN_AND_SYMPTOM,1704
35035,The,O,1704
35036,extent,O,1704
35037,to,O,1704
35038,which,O,1704
35039,one,O,1704
35040,has,O,1704
35041,vision,O,1704
35042,is,O,1704
35043,affected,O,1704
35044,depends,O,1704
35045,on,O,1704
35046,the,O,1704
35047,seriousness,O,1704
35048,of,O,1704
35049,the,O,1704
35050,dislocation,O,1704
35051,This,O,1704
35052,can,O,1704
35053,appear,O,1704
35054,as,O,1704
35055,Blurring,B-SIGN_AND_SYMPTOM,1705
35056,Double,B-SIGN_AND_SYMPTOM,1705
35057,vision,I-SIGN_AND_SYMPTOM,1705
35058,Seeing,B-SIGN_AND_SYMPTOM,1705
35059,the,I-SIGN_AND_SYMPTOM,1705
35060,edge,I-SIGN_AND_SYMPTOM,1705
35061,of,I-SIGN_AND_SYMPTOM,1705
35062,the,I-SIGN_AND_SYMPTOM,1705
35063,lens,I-SIGN_AND_SYMPTOM,1705
35064,implant,I-SIGN_AND_SYMPTOM,1705
35065,A,O,1705
35066,typical,O,1705
35067,clinical,O,1705
35068,course,O,1705
35069,indicating,O,1705
35070,intermittent,O,1705
35071,angle,O,1705
35072,closure,O,1705
35073,can,O,1705
35074,be,O,1706
35075,seen,O,1706
35076,with,O,1706
35077,IOL,B-NAME_OF_DISEASE,1706
35078,displacement,I-NAME_OF_DISEASE,1706
35079,Such,O,1706
35080,individuals,O,1706
35081,could,O,1706
35082,present,O,1706
35083,with,O,1706
35084,the,O,1706
35085,following,O,1706
35086,Ocular,B-SIGN_AND_SYMPTOM,1706
35087,discomfort,I-SIGN_AND_SYMPTOM,1706
35088,Headaches,B-SIGN_AND_SYMPTOM,1706
35089,Diagnosis,O,1706
35090,Of,O,1706
35091,a,O,1706
35092,Dislocated,B-NAME_OF_DISEASE,1706
35093,IOL,I-NAME_OF_DISEASE,1706
35094,After,O,1707
35095,determining,O,1707
35096,the,O,1707
35097,patient,O,1707
35098,s,O,1707
35099,visual,O,1707
35100,acuity,O,1707
35101,and,O,1707
35102,refraction,O,1707
35103,a,B-DIAGNOSTIC_TEST,1707
35104,comprehensive,I-DIAGNOSTIC_TEST,1707
35105,anterior,I-DIAGNOSTIC_TEST,1707
35106,and,I-DIAGNOSTIC_TEST,1707
35107,posterior,I-DIAGNOSTIC_TEST,1707
35108,segment,I-DIAGNOSTIC_TEST,1707
35109,slit,I-DIAGNOSTIC_TEST,1707
35110,lamp,I-DIAGNOSTIC_TEST,1707
35111,examination,I-DIAGNOSTIC_TEST,1707
35112,is,O,1707
35113,performed,O,1707
35114,to,O,1707
35115,diagnose,O,1707
35116,a,B-NAME_OF_DISEASE,1707
35117,displaced,I-NAME_OF_DISEASE,1708
35118,intraocular,I-NAME_OF_DISEASE,1708
35119,lens,I-NAME_OF_DISEASE,1708
35120,IOL,I-NAME_OF_DISEASE,1708
35121,,O,1708
35122,The,O,1708
35123,Ophthalmologist,O,1708
35124,should,O,1708
35125,do,O,1708
35126,a,O,1708
35127,thorough,O,1708
35128,dilated,O,1708
35129,fundoscopy,O,1708
35130,with,O,1708
35131,scleral,O,1708
35132,depression,O,1708
35133,If,O,1708
35134,a,O,1708
35135,thorough,O,1708
35136,examination,O,1708
35137,is,O,1708
35138,impossible,O,1708
35139,the,O,1708
35140,following,O,1708
35141,diagnostic,O,1708
35142,interventions,O,1708
35143,may,O,1708
35144,be,O,1708
35145,helpful,O,1708
35146,in,O,1708
35147,evaluating,O,1708
35148,a,B-NAME_OF_DISEASE,1708
35149,posteriorly,I-NAME_OF_DISEASE,1708
35150,displaced,I-NAME_OF_DISEASE,1708
35151,IOL,I-NAME_OF_DISEASE,1708
35152,behind,O,1708
35153,the,B-PART_OF_THE_EYES,1708
35154,iris,I-PART_OF_THE_EYES,1708
35155,in,O,1708
35156,the,B-PART_OF_THE_EYES,1708
35157,vitreous,I-PART_OF_THE_EYES,1708
35158,cavity,I-PART_OF_THE_EYES,1709
35159,B-scan,B-DIAGNOSTIC_TEST,1709
35160,Ultrasound,I-DIAGNOSTIC_TEST,1709
35161,Anterior,B-DIAGNOSTIC_TEST,1709
35162,Segment,I-DIAGNOSTIC_TEST,1709
35163,OCT,I-DIAGNOSTIC_TEST,1709
35164,Ultrasound,B-DIAGNOSTIC_TEST,1709
35165,Biomicroscopy,I-DIAGNOSTIC_TEST,1709
35166,What,O,1709
35167,Are,O,1709
35168,the,O,1709
35169,Types,O,1709
35170,of,O,1709
35171,IOL,B-NAME_OF_DISEASE,1709
35172,Dislocation,I-NAME_OF_DISEASE,1709
35173,In,B-NAME_OF_DISEASE,1709
35174,The,I-NAME_OF_DISEASE,1709
35175,Bag,I-NAME_OF_DISEASE,1709
35176,Dislocation,I-NAME_OF_DISEASE,1710
35177,Most,O,1710
35178,Common,O,1711
35179,In,B-NAME_OF_DISEASE,1711
35180,the,I-NAME_OF_DISEASE,1711
35181,bag,I-NAME_OF_DISEASE,1711
35182,dislocation,I-NAME_OF_DISEASE,1711
35183,is,O,1711
35184,caused,O,1711
35185,by,O,1711
35186,weak,B-CAUSE_OF_DISEASE,1711
35187,zonules,I-CAUSE_OF_DISEASE,1711
35188,and,I-CAUSE_OF_DISEASE,1711
35189,capsular,I-CAUSE_OF_DISEASE,1711
35190,fibrosis,I-CAUSE_OF_DISEASE,1711
35191,It,O,1711
35192,occurs,O,1711
35193,later,O,1711
35194,in,O,1712
35195,life,O,1712
35196,possibly,O,1712
35197,many,O,1712
35198,years,O,1712
35199,after,O,1712
35200,cataract,B-TREATMENT,1712
35201,surgery,I-TREATMENT,1712
35202,The,O,1712
35203,following,O,1712
35204,are,O,1712
35205,risk,O,1712
35206,factors,O,1712
35207,for,O,1712
35208,developing,O,1712
35209,it,O,1713
35210,PXF,B-CAUSE_OF_DISEASE,1713
35211,50%,O,1713
35212,Previous,B-CAUSE_OF_DISEASE,1713
35213,vitrectomy,I-CAUSE_OF_DISEASE,1713
35214,20%,O,1713
35215,Uveitis,O,1713
35216,2-15%,O,1713
35217,Trauma,O,1713
35218,5%,O,1713
35219,Retinitis,B-CAUSE_OF_DISEASE,1713
35220,Pigmentosa,I-CAUSE_OF_DISEASE,1713
35221,rarely,O,1713
35222,Out,B-NAME_OF_DISEASE,1713
35223,Of,I-NAME_OF_DISEASE,1713
35224,The,I-NAME_OF_DISEASE,1713
35225,Bag,I-NAME_OF_DISEASE,1713
35226,Dislocation,I-NAME_OF_DISEASE,1713
35227,It,O,1714
35228,occurs,O,1714
35229,earlier,O,1714
35230,and,O,1714
35231,less,O,1714
35232,frequently,O,1714
35233,than,O,1714
35234,in,B-NAME_OF_DISEASE,1714
35235,the,I-NAME_OF_DISEASE,1714
35236,bag,I-NAME_OF_DISEASE,1714
35237,dislocation,I-NAME_OF_DISEASE,1715
35238,Typically,O,1715
35239,it,O,1715
35240,follows,O,1715
35241,a,B-CAUSE_OF_DISEASE,1715
35242,failed,I-CAUSE_OF_DISEASE,1715
35243,IOL,I-CAUSE_OF_DISEASE,1715
35244,insertion,I-CAUSE_OF_DISEASE,1715
35245,in,I-CAUSE_OF_DISEASE,1715
35246,the,I-CAUSE_OF_DISEASE,1715
35247,sulcus,I-CAUSE_OF_DISEASE,1715
35248,after,I-CAUSE_OF_DISEASE,1715
35249,a,I-CAUSE_OF_DISEASE,1715
35250,posterior,I-CAUSE_OF_DISEASE,1715
35251,capsular,I-CAUSE_OF_DISEASE,1715
35252,breach,I-CAUSE_OF_DISEASE,1715
35253,Partial,B-NAME_OF_DISEASE,1715
35254,dislocation,I-NAME_OF_DISEASE,1715
35255,of,I-NAME_OF_DISEASE,1715
35256,the,I-NAME_OF_DISEASE,1715
35257,IOL,I-NAME_OF_DISEASE,1715
35258,is,O,1715
35259,presented,O,1715
35260,with,O,1715
35261,distorted,B-SIGN_AND_SYMPTOM,1715
35262,vision,I-SIGN_AND_SYMPTOM,1715
35263,It,O,1715
35264,might,O,1716
35265,get,O,1716
35266,complicated,O,1716
35267,into,O,1716
35268,a,O,1716
35269,Complete,B-NAME_OF_DISEASE,1716
35270,dislocation,I-NAME_OF_DISEASE,1716
35271,posteriorly,O,1716
35272,and,O,1716
35273,could,O,1716
35274,even,O,1717
35275,lead,O,1717
35276,to,O,1717
35277,Pigment,B-NAME_OF_DISEASE,1717
35278,dispersion,I-NAME_OF_DISEASE,1717
35279,anterior,I-NAME_OF_DISEASE,1717
35280,uveitis,I-NAME_OF_DISEASE,1717
35281,and,O,1717
35282,CME,B-NAME_OF_DISEASE,1717
35283,Complete,B-NAME_OF_DISEASE,1717
35284,dislocation,I-NAME_OF_DISEASE,1717
35285,of,I-NAME_OF_DISEASE,1717
35286,the,I-NAME_OF_DISEASE,1718
35287,IOL,I-NAME_OF_DISEASE,1718
35288,is,O,1718
35289,usually,O,1718
35290,posterior,O,1718
35291,and,O,1718
35292,most,O,1718
35293,commonly,O,1718
35294,inferiorly,O,1718
35295,The,O,1718
35296,patient,O,1718
35297,presents,O,1718
35298,with,O,1719
35299,visual,O,1719
35300,symptoms,O,1719
35301,of,O,1719
35302,blurred,B-SIGN_AND_SYMPTOM,1719
35303,vision,I-SIGN_AND_SYMPTOM,1719
35304,and,I-SIGN_AND_SYMPTOM,1719
35305,diplopia,I-SIGN_AND_SYMPTOM,1719
35306,Dislocation,B-NAME_OF_DISEASE,1719
35307,Of,I-NAME_OF_DISEASE,1719
35308,The,I-NAME_OF_DISEASE,1720
35309,IOL,I-NAME_OF_DISEASE,1720
35310,Capsular,I-NAME_OF_DISEASE,1720
35311,Tension,I-NAME_OF_DISEASE,1720
35312,Ring,I-NAME_OF_DISEASE,1720
35313,With,I-NAME_OF_DISEASE,1720
35314,Whole,I-NAME_OF_DISEASE,1720
35315,Bag,I-NAME_OF_DISEASE,1720
35316,It,O,1720
35317,is,O,1720
35318,frequent,O,1720
35319,and,O,1720
35320,happens,O,1720
35321,late,O,1720
35322,mainly,O,1720
35323,if,O,1720
35324,the,B-CAUSE_OF_DISEASE,1720
35325,zonules,I-CAUSE_OF_DISEASE,1720
35326,are,I-CAUSE_OF_DISEASE,1720
35327,fragile,I-CAUSE_OF_DISEASE,1720
35328,and,I-CAUSE_OF_DISEASE,1720
35329,feeble,I-CAUSE_OF_DISEASE,1720
35330,In,O,1720
35331,cases,O,1720
35332,of,O,1720
35333,zonular,O,1720
35334,instability,O,1720
35335,the,B-TREATMENT,1720
35336,CTR,B-TREATMENT,1720
35337,is,O,1720
35338,used,O,1720
35339,to,O,1720
35340,stabilize,O,1720
35341,the,B-PART_OF_THE_EYES,1721
35342,capsular,I-PART_OF_THE_EYES,1721
35343,bag,I-PART_OF_THE_EYES,1721
35344,and,O,1721
35345,IOL,O,1721
35346,during,O,1721
35347,and,O,1721
35348,after,O,1721
35349,cataract,B-TREATMENT,1721
35350,surgery,I-TREATMENT,1721
35351,The,O,1721
35352,most,O,1722
35353,frequent,O,1722
35354,reason,O,1722
35355,for,O,1722
35356,CTR,B-TREATMENT,1722
35357,usage,O,1722
35358,in,O,1722
35359,pseudo-exfoliation,O,1722
35360,is,O,1722
35361,why,O,1722
35362,some,O,1722
35363,studies,O,1722
35364,recommend,O,1722
35365,routine,O,1722
35366,CTR,B-TREATMENT,1722
35367,use,O,1722
35368,in,O,1723
35369,pseudo-exfoliation,O,1723
35370,patients,O,1723
35371,independent,O,1723
35372,of,O,1723
35373,zonule,O,1723
35374,stability,O,1723
35375,Management,O,1723
35376,Of,O,1723
35377,IOL,B-NAME_OF_DISEASE,1723
35378,Dislocation,I-NAME_OF_DISEASE,1723
35379,Depending,O,1723
35380,on,O,1723
35381,the,O,1723
35382,specifics,O,1723
35383,of,O,1723
35384,the,B-NAME_OF_DISEASE,1723
35385,IOL,I-NAME_OF_DISEASE,1723
35386,dislocation,I-NAME_OF_DISEASE,1723
35387,there,O,1723
35388,are,O,1724
35389,various,O,1724
35390,methods,O,1724
35391,for,O,1724
35392,managing,O,1725
35393,this,O,1725
35394,issue,O,1725
35395,Observation,B-TREATMENT,1725
35396,of,I-TREATMENT,1725
35397,the,I-TREATMENT,1725
35398,patient,I-TREATMENT,1725
35399,is,O,1725
35400,planned,O,1725
35401,particularly,O,1725
35402,if,O,1726
35403,the,O,1726
35404,patient,O,1726
35405,has,O,1726
35406,no,O,1726
35407,or,O,1726
35408,just,O,1726
35409,mild,O,1727
35410,tolerable,O,1727
35411,visual,O,1727
35412,problems,O,1727
35413,In,O,1727
35414,this,O,1727
35415,circumstance,O,1727
35416,the,O,1727
35417,IOL,O,1727
35418,is,O,1727
35419,stable,O,1727
35420,which,O,1727
35421,reduces,O,1727
35422,the,O,1727
35423,risk,O,1727
35424,of,O,1727
35425,retinal,O,1727
35426,complications,O,1727
35427,Advantage,O,1727
35428,No,O,1727
35429,Surgical,O,1727
35430,manipulation,O,1727
35431,is,O,1728
35432,required,O,1728
35433,Disadvantages,O,1728
35434,The,O,1728
35435,possibility,O,1728
35436,of,O,1728
35437,a,O,1728
35438,retinal,O,1728
35439,complication,O,1729
35440,exists,O,1729
35441,Contact,B-TREATMENT,1729
35442,lens,I-TREATMENT,1729
35443,complications,O,1729
35444,and,O,1729
35445,late,O,1729
35446,contact,B-TREATMENT,1729
35447,lens,I-TREATMENT,1729
35448,intolerance,O,1729
35449,should,O,1729
35450,be,O,1729
35451,considered,O,1729
35452,Implantation,B-TREATMENT,1729
35453,Of,I-TREATMENT,1729
35454,Secondary,I-TREATMENT,1729
35455,IOL,I-TREATMENT,1729
35456,Without,I-TREATMENT,1729
35457,Removal,I-TREATMENT,1729
35458,of,I-TREATMENT,1729
35459,The,I-TREATMENT,1729
35460,Dislocated,I-TREATMENT,1729
35461,IOL,I-TREATMENT,1729
35462,Advantage,O,1729
35463,Correction,O,1729
35464,of,O,1729
35465,aphakia,B-NAME_OF_DISEASE,1729
35466,and,O,1729
35467,visual,O,1729
35468,symptoms,O,1729
35469,Disadvantages,O,1729
35470,Risk,O,1729
35471,of,O,1729
35472,complication,O,1729
35473,remains-more,O,1729
35474,challenging,O,1729
35475,surgery,O,1729
35476,for,O,1729
35477,the,O,1729
35478,removal,O,1730
35479,of,O,1730
35480,IOL,O,1730
35481,and,O,1730
35482,surgical,O,1730
35483,management,O,1730
35484,of,O,1730
35485,retinal,O,1730
35486,complications,O,1730
35487,like,O,1730
35488,retinal,B-NAME_OF_DISEASE,1730
35489,detachment,I-NAME_OF_DISEASE,1730
35490,IOL,B-TREATMENT,1730
35491,removal,I-TREATMENT,1730
35492,with,I-TREATMENT,1730
35493,or,I-TREATMENT,1730
35494,without,I-TREATMENT,1731
35495,secondary,I-TREATMENT,1731
35496,IOL,I-TREATMENT,1731
35497,exchange,I-TREATMENT,1731
35498,is,O,1731
35499,usually,O,1731
35500,performed,O,1731
35501,for,O,1731
35502,IOLs,O,1731
35503,with,O,1731
35504,damaged,O,1731
35505,haptics,O,1731
35506,small,O,1732
35507,optics,O,1732
35508,or,O,1732
35509,highly,O,1732
35510,flexible,O,1732
35511,haptics,O,1733
35512,unsuitable,O,1733
35513,for,O,1733
35514,suture,O,1733
35515,support,O,1733
35516,IOL,B-TREATMENT,1733
35517,exchange,I-TREATMENT,1733
35518,New,O,1733
35519,IOL,O,1733
35520,placement,O,1733
35521,in,O,1733
35522,the,B-PART_OF_THE_EYES,1733
35523,anterior,I-PART_OF_THE_EYES,1733
35524,or,I-PART_OF_THE_EYES,1733
35525,posterior,I-PART_OF_THE_EYES,1733
35526,chamber,I-PART_OF_THE_EYES,1733
35527,depends,O,1733
35528,on,O,1733
35529,the,O,1733
35530,integrity,O,1733
35531,of,O,1733
35532,the,B-PART_OF_THE_EYES,1733
35533,capsular,I-PART_OF_THE_EYES,1733
35534,bag,I-PART_OF_THE_EYES,1733
35535,If,O,1733
35536,appropriate,O,1733
35537,capsular,O,1733
35538,support,O,1733
35539,is,O,1734
35540,present,O,1734
35541,an,O,1734
35542,IOL,O,1734
35543,can,O,1734
35544,be,O,1734
35545,positioned,O,1734
35546,in,O,1734
35547,the,B-PART_OF_THE_EYES,1734
35548,posterior,I-PART_OF_THE_EYES,1734
35549,chamber,I-PART_OF_THE_EYES,1734
35550,and,O,1735
35551,relocated,O,1735
35552,in,O,1735
35553,the,O,1735
35554,sulcus,O,1735
35555,If,O,1735
35556,the,O,1735
35557,capsular,O,1736
35558,support,O,1736
35559,is,O,1737
35560,insufficient,O,1737
35561,an,O,1737
35562,IOL,O,1738
35563,can,O,1738
35564,be,O,1738
35565,implanted,O,1738
35566,in,O,1738
35567,the,B-PART_OF_THE_EYES,1738
35568,anterior,I-PART_OF_THE_EYES,1738
35569,chamber,I-PART_OF_THE_EYES,1738
35570,ACIOL,I-PART_OF_THE_EYES,1738
35571,or,O,1738
35572,sutured,O,1738
35573,to,O,1738
35574,the,B-PART_OF_THE_EYES,1738
35575,sclera,I-PART_OF_THE_EYES,1738
35576,or,O,1738
35577,iris,B-PART_OF_THE_EYES,1738
35578,IOL,B-TREATMENT,1738
35579,repositioning,I-TREATMENT,1738
35580,It,O,1738
35581,is,O,1738
35582,the,O,1738
35583,most,O,1739
35584,common,O,1739
35585,elected,O,1739
35586,approach,O,1739
35587,with,O,1739
35588,three,O,1739
35589,basic,O,1739
35590,strategies,O,1739
35591,Repositioning,B-TREATMENT,1739
35592,in,I-TREATMENT,1739
35593,the,I-TREATMENT,1739
35594,sulcus,I-TREATMENT,1740
35595,or,I-TREATMENT,1740
35596,residual,I-TREATMENT,1740
35597,bag,I-TREATMENT,1740
35598,Iris,B-TREATMENT,1740
35599,suture,I-TREATMENT,1740
35600,fixation,I-TREATMENT,1740
35601,Scleral,B-TREATMENT,1740
35602,fixation,I-TREATMENT,1740
35603,Complications,O,1740
35604,Of,O,1740
35605,IOL,B-NAME_OF_DISEASE,1740
35606,Dislocation,I-NAME_OF_DISEASE,1740
35607,A,B-NAME_OF_DISEASE,1740
35608,dislocated,I-NAME_OF_DISEASE,1740
35609,IOL,I-NAME_OF_DISEASE,1740
35610,often,O,1741
35611,requires,O,1741
35612,explantation,O,1741
35613,or,O,1741
35614,repositioning,O,1741
35615,because,O,1741
35616,of,O,1741
35617,potential,O,1741
35618,complications,O,1741
35619,These,O,1741
35620,can,O,1741
35621,be,O,1741
35622,listed,O,1741
35623,as,O,1741
35624,corneal,B-NAME_OF_DISEASE,1741
35625,edema,I-NAME_OF_DISEASE,1742
35626,glaucoma,B-NAME_OF_DISEASE,1742
35627,intraocular,B-NAME_OF_DISEASE,1742
35628,inflammation,I-NAME_OF_DISEASE,1742
35629,macular,B-NAME_OF_DISEASE,1742
35630,edema,I-NAME_OF_DISEASE,1742
35631,retinal,B-NAME_OF_DISEASE,1742
35632,tears,I-NAME_OF_DISEASE,1742
35633,and,O,1742
35634,rhegmatogenous,B-NAME_OF_DISEASE,1742
35635,retinal,I-NAME_OF_DISEASE,1742
35636,detachment,I-NAME_OF_DISEASE,1742
35637,Author,O,1743
35638,Dr,O,1743
35639,Muhammad,O,1743
35640,Saad,O,1743
35641,Resident,O,1743
35642,Ophthalmologist,O,1743
35643,at,O,1743
35644,Al-Shifa,B-ORGANIZATION,1743
35645,Trust,I-ORGANIZATION,1743
35646,Eye,I-ORGANIZATION,1743
35647,Hospital,I-ORGANIZATION,1743
35648,in,O,1743
35649,Rawalpindi,B-GPE,1743
35650,Pakistan,I-GPE,1743
35651,Bimatoprost,B-NAME_OF_DRUG,1743
35652,is,O,1743
35653,a,O,1744
35654,medicine,O,1744
35655,that,O,1744
35656,helps,O,1744
35657,with,O,1744
35658,high,B-NAME_OF_DISEASE,1744
35659,pressure,I-NAME_OF_DISEASE,1744
35660,in,I-NAME_OF_DISEASE,1744
35661,the,I-NAME_OF_DISEASE,1744
35662,eye,I-NAME_OF_DISEASE,1744
35663,OCT,I-NAME_OF_DISEASE,1744
35664,and,O,1744
35665,open-angle,B-NAME_OF_DISEASE,1744
35666,glaucoma,I-NAME_OF_DISEASE,1744
35667,When,O,1744
35668,too,O,1744
35669,much,O,1744
35670,fluid,O,1744
35671,builds,O,1744
35672,up,O,1744
35673,in,O,1744
35674,your,O,1745
35675,eyes,O,1745
35676,the,O,1745
35677,pressure,O,1745
35678,in,O,1745
35679,the,O,1745
35680,eye,O,1745
35681,increases,O,1745
35682,Bimatoprost,B-NAME_OF_DRUG,1745
35683,drops,I-NAME_OF_DRUG,1745
35684,help,O,1745
35685,to,O,1745
35686,drain,O,1745
35687,the,O,1745
35688,excess,O,1746
35689,fluid,O,1746
35690,and,O,1746
35691,it,O,1746
35692,lowers,O,1746
35693,the,O,1746
35694,pressure,O,1746
35695,you,O,1746
35696,have,O,1746
35697,in,O,1746
35698,the,O,1746
35699,eye,O,1746
35700,High,O,1746
35701,pressure,O,1746
35702,is,O,1746
35703,a,O,1746
35704,condition,O,1746
35705,that,O,1746
35706,shouldn,O,1746
35707,t,O,1746
35708,be,O,1747
35709,neglected,O,1747
35710,If,O,1747
35711,you,O,1747
35712,don,O,1747
35713,t,O,1747
35714,treat,O,1747
35715,it,O,1747
35716,the,O,1747
35717,high,O,1747
35718,pressure,O,1747
35719,in,O,1747
35720,the,O,1747
35721,eye,O,1747
35722,can,O,1747
35723,lead,O,1747
35724,to,O,1747
35725,damage,O,1747
35726,in,O,1747
35727,your,O,1747
35728,optic,B-PART_OF_THE_EYES,1747
35729,nerves,I-PART_OF_THE_EYES,1748
35730,and,O,1748
35731,result,O,1748
35732,in,O,1748
35733,vision,B-SIGN_AND_SYMPTOM,1748
35734,loss,I-SIGN_AND_SYMPTOM,1748
35735,or,O,1748
35736,blindness,B-NAME_OF_DISEASE,1748
35737,How,O,1748
35738,Long,O,1748
35739,Does,O,1748
35740,Bimaoprost,B-NAME_OF_DRUG,1748
35741,Last,O,1748
35742,The,O,1748
35743,bottle,O,1748
35744,comes,O,1748
35745,in,O,1748
35746,5ml,O,1748
35747,Usually,O,1748
35748,this,O,1748
35749,amount,O,1748
35750,should,O,1748
35751,last,O,1748
35752,for,O,1748
35753,a,O,1748
35754,patient,O,1748
35755,for,B-TIME_DURATION,1748
35756,about,I-TIME_DURATION,1748
35757,8-Apr,I-TIME_DURATION,1748
35758,months,I-TIME_DURATION,1748
35759,It,O,1748
35760,can,O,1748
35761,be,O,1749
35762,said,O,1749
35763,that,O,1749
35764,there,O,1749
35765,are,O,1749
35766,112,O,1749
35767,doses,O,1749
35768,in,O,1749
35769,a,O,1749
35770,bottle,O,1749
35771,Sometimes,O,1749
35772,the,O,1749
35773,medication,O,1749
35774,is,O,1749
35775,used,O,1749
35776,daily,O,1749
35777,during,O,1749
35778,the,O,1749
35779,initiation,O,1749
35780,phase,O,1750
35781,What,O,1750
35782,Are,O,1750
35783,the,O,1750
35784,Side,O,1750
35785,Effects,O,1750
35786,of,O,1750
35787,Bimatoprost,B-NAME_OF_DRUG,1750
35788,Just,O,1750
35789,like,O,1750
35790,every,O,1750
35791,other,O,1750
35792,medicine,O,1750
35793,that,O,1750
35794,is,O,1750
35795,on,O,1750
35796,the,O,1750
35797,market,O,1750
35798,bimatoprost,B-NAME_OF_DRUG,1750
35799,eye,I-NAME_OF_DRUG,1750
35800,drops,I-NAME_OF_DRUG,1750
35801,have,O,1750
35802,some,O,1750
35803,side,O,1750
35804,effects,O,1750
35805,but,O,1750
35806,that,O,1750
35807,doesn,O,1750
35808,t,O,1751
35809,mean,O,1751
35810,everyone,O,1751
35811,will,O,1751
35812,experience,O,1751
35813,them,O,1751
35814,Some,O,1752
35815,of,O,1752
35816,the,O,1752
35817,common,O,1752
35818,side,O,1752
35819,effects,O,1752
35820,include,O,1752
35821,Change,B-SIGN_AND_SYMPTOM,1752
35822,in,I-SIGN_AND_SYMPTOM,1752
35823,eye,I-SIGN_AND_SYMPTOM,1752
35824,colors,I-SIGN_AND_SYMPTOM,1752
35825,People,O,1753
35826,who,O,1753
35827,use,O,1753
35828,eye,O,1753
35829,drops,O,1753
35830,for,B-TIME_DURATION,1753
35831,more,I-TIME_DURATION,1753
35832,than,I-TIME_DURATION,1753
35833,8,I-TIME_DURATION,1753
35834,months,I-TIME_DURATION,1753
35835,experience,O,1753
35836,this,O,1753
35837,kind,O,1753
35838,of,O,1753
35839,side,O,1753
35840,effect,O,1753
35841,The,O,1753
35842,color,O,1753
35843,change,O,1753
35844,may,O,1753
35845,be,O,1753
35846,permanent,O,1753
35847,and,O,1753
35848,may,O,1753
35849,be,O,1753
35850,more,O,1753
35851,obvious,O,1753
35852,if,O,1754
35853,the,O,1754
35854,drop,O,1754
35855,is,O,1754
35856,used,O,1754
35857,in,O,1754
35858,one,O,1754
35859,eye,O,1754
35860,only,O,1754
35861,Irritated,B-SIGN_AND_SYMPTOM,1754
35862,and,I-SIGN_AND_SYMPTOM,1754
35863,itchy,I-SIGN_AND_SYMPTOM,1754
35864,eyelids,I-SIGN_AND_SYMPTOM,1754
35865,Eye,B-SIGN_AND_SYMPTOM,1754
35866,pain,I-SIGN_AND_SYMPTOM,1754
35867,the,I-SIGN_AND_SYMPTOM,1754
35868,sensation,I-SIGN_AND_SYMPTOM,1754
35869,of,I-SIGN_AND_SYMPTOM,1754
35870,having,I-SIGN_AND_SYMPTOM,1754
35871,something,I-SIGN_AND_SYMPTOM,1754
35872,in,I-SIGN_AND_SYMPTOM,1754
35873,the,I-SIGN_AND_SYMPTOM,1754
35874,eye,I-SIGN_AND_SYMPTOM,1754
35875,Having,B-SIGN_AND_SYMPTOM,1755
35876,the,I-SIGN_AND_SYMPTOM,1755
35877,skin,I-SIGN_AND_SYMPTOM,1755
35878,around,I-SIGN_AND_SYMPTOM,1755
35879,the,I-SIGN_AND_SYMPTOM,1755
35880,eyes,I-SIGN_AND_SYMPTOM,1755
35881,darker,I-SIGN_AND_SYMPTOM,1755
35882,However,O,1755
35883,if,O,1755
35884,you,O,1755
35885,are,O,1755
35886,experiencing,O,1755
35887,one,O,1755
35888,of,O,1755
35889,the,O,1755
35890,more,O,1756
35891,serious,O,1756
35892,side,O,1756
35893,effects,O,1756
35894,mentioned,O,1756
35895,below,O,1756
35896,be,O,1756
35897,sure,O,1756
35898,to,O,1756
35899,call,O,1756
35900,your,O,1756
35901,doctor,O,1756
35902,straight,O,1756
35903,away,O,1756
35904,Shortness,B-SIGN_AND_SYMPTOM,1756
35905,of,I-SIGN_AND_SYMPTOM,1756
35906,breath,I-SIGN_AND_SYMPTOM,1756
35907,Feeling,B-SIGN_AND_SYMPTOM,1756
35908,Dizzy,I-SIGN_AND_SYMPTOM,1757
35909,Serious,B-SIGN_AND_SYMPTOM,1757
35910,allergic,I-SIGN_AND_SYMPTOM,1757
35911,reaction,I-SIGN_AND_SYMPTOM,1757
35912,Can,O,1757
35913,You,O,1757
35914,Use,O,1757
35915,Bimatoprost,B-NAME_OF_DRUG,1757
35916,on,O,1757
35917,Eyelashes,B-PART_OF_THE_EYES,1757
35918,Even,O,1757
35919,if,O,1757
35920,the,O,1757
35921,general,O,1757
35922,use,O,1757
35923,of,O,1757
35924,bimatoprost,B-NAME_OF_DRUG,1757
35925,ophthalmic,O,1757
35926,solution,O,1757
35927,is,O,1758
35928,to,O,1758
35929,treat,O,1758
35930,high,B-NAME_OF_DISEASE,1758
35931,pressure,I-NAME_OF_DISEASE,1758
35932,in,I-NAME_OF_DISEASE,1758
35933,the,I-NAME_OF_DISEASE,1758
35934,eye,I-NAME_OF_DISEASE,1758
35935,and,O,1758
35936,open-angle,B-NAME_OF_DISEASE,1758
35937,glaucoma,B-NAME_OF_DISEASE,1758
35938,it,O,1758
35939,is,O,1758
35940,also,O,1758
35941,used,O,1758
35942,to,O,1758
35943,treat,O,1758
35944,a,O,1758
35945,lack,O,1758
35946,of,O,1758
35947,eyelashes,B-PART_OF_THE_EYES,1758
35948,eyelash,B-NAME_OF_DISEASE,1758
35949,hypotrichosis,I-NAME_OF_DISEASE,1758
35950,,O,1759
35951,The,O,1759
35952,solution,O,1759
35953,helps,O,1759
35954,to,O,1759
35955,increase,O,1759
35956,the,O,1759
35957,growth,O,1759
35958,of,O,1759
35959,eyelashes,B-PART_OF_THE_EYES,1759
35960,and,O,1759
35961,make,O,1759
35962,them,O,1759
35963,longer,O,1759
35964,thicker,O,1759
35965,and,O,1759
35966,darker,O,1759
35967,However,O,1759
35968,the,O,1759
35969,bimatoprost,B-NAME_OF_DRUG,1760
35970,solution,O,1760
35971,is,O,1760
35972,only,O,1760
35973,available,O,1760
35974,with,O,1760
35975,a,O,1760
35976,doctor,O,1760
35977,s,O,1760
35978,prescription,O,1760
35979,You,O,1760
35980,cannot,O,1760
35981,buy,O,1760
35982,it,O,1760
35983,over-the-counter,O,1760
35984,Is,O,1760
35985,There,O,1760
35986,a,O,1760
35987,Generic,O,1760
35988,Version,O,1760
35989,of,O,1760
35990,Bimatoprost,B-NAME_OF_DRUG,1760
35991,Lumigan,B-NAME_OF_DRUG,1760
35992,bimatoprost,I-NAME_OF_DRUG,1760
35993,can,O,1760
35994,be,O,1760
35995,considered,O,1760
35996,a,O,1760
35997,generic,O,1760
35998,medication,O,1760
35999,and,O,1760
36000,it,O,1760
36001,s,O,1760
36002,more,O,1760
36003,budget-friendly,O,1760
36004,when,O,1760
36005,you,O,1760
36006,compare,O,1761
36007,it,O,1761
36008,o,O,1761
36009,the,O,1761
36010,brand,O,1761
36011,version,O,1761
36012,It,O,1761
36013,s,O,1761
36014,a,O,1761
36015,clear,O,1761
36016,eye,O,1761
36017,drop,O,1761
36018,solution,O,1761
36019,that,O,1761
36020,contains,O,1761
36021,active,O,1761
36022,bimatoprost,B-NAME_OF_DRUG,1761
36023,It,O,1761
36024,s,O,1761
36025,available,O,1761
36026,in,O,1762
36027,different,O,1762
36028,strengths,O,1762
36029,0,O,1762
36030,and,O,1762
36031,0,O,1762
36032,mg,O,1762
36033,per,O,1762
36034,ml,O,1762
36035,Can,O,1762
36036,Durysta,B-TREATMENT,1762
36037,Be,O,1762
36038,Removed,O,1762
36039,The,B-TREATMENT,1762
36040,bimatoprost,I-TREATMENT,1762
36041,implant,I-TREATMENT,1762
36042,is,O,1762
36043,made,O,1762
36044,of,O,1762
36045,biodegradable,O,1762
36046,material,O,1763
36047,which,O,1763
36048,means,O,1763
36049,it,O,1763
36050,will,O,1764
36051,break,O,1764
36052,down,O,1764
36053,naturally,O,1764
36054,over,O,1764
36055,time,O,1764
36056,You,O,1764
36057,don,O,1764
36058,t,O,1764
36059,need,O,1764
36060,another,O,1764
36061,operation,O,1764
36062,or,O,1765
36063,intervention,O,1765
36064,for,O,1765
36065,its,O,1765
36066,removal,O,1765
36067,Most,O,1765
36068,patients,O,1765
36069,reported,O,1765
36070,that,O,1765
36071,they,O,1765
36072,have,O,1765
36073,controlled,O,1765
36074,intraocular,O,1765
36075,pressure,O,1765
36076,levels,O,1765
36077,even,O,1765
36078,after,O,1765
36079,the,O,1765
36080,implant,O,1765
36081,is,O,1765
36082,dissolved,O,1765
36083,How,O,1765
36084,Durysta,B-TREATMENT,1765
36085,Works,O,1765
36086,Durysta,B-TREATMENT,1765
36087,is,O,1765
36088,an,O,1765
36089,implant,O,1765
36090,that,O,1765
36091,your,O,1766
36092,eye,O,1766
36093,doctor,O,1766
36094,administers,O,1766
36095,into,O,1766
36096,your,O,1767
36097,eyes,O,1767
36098,The,O,1767
36099,implant,O,1767
36100,can,O,1767
36101,only,O,1767
36102,be,O,1767
36103,implanted,O,1767
36104,for,O,1767
36105,one,O,1767
36106,time,O,1767
36107,for,O,1767
36108,each,O,1767
36109,eye,O,1768
36110,The,O,1768
36111,implant,O,1768
36112,has,O,1768
36113,a,O,1768
36114,medication,O,1768
36115,called,O,1768
36116,bimatoprost,B-NAME_OF_DRUG,1768
36117,which,O,1768
36118,helps,O,1768
36119,to,O,1768
36120,lower,O,1768
36121,the,O,1769
36122,pressure,O,1769
36123,in,O,1769
36124,the,O,1769
36125,eye,O,1769
36126,The,O,1769
36127,implant,O,1769
36128,is,O,1769
36129,made,O,1769
36130,of,O,1769
36131,biodegradable,O,1769
36132,components,O,1769
36133,meaning,O,1770
36134,that,O,1771
36135,it,O,1771
36136,will,O,1771
36137,be,O,1771
36138,dissolved,O,1771
36139,on,O,1771
36140,its,O,1771
36141,own,O,1771
36142,within,B-TIME_DURATION,1771
36143,a,I-TIME_DURATION,1771
36144,couple,I-TIME_DURATION,1771
36145,of,I-TIME_DURATION,1771
36146,months,I-TIME_DURATION,1771
36147,Many,O,1771
36148,patients,O,1771
36149,with,O,1772
36150,glaucoma,B-NAME_OF_DISEASE,1772
36151,need,O,1772
36152,to,O,1772
36153,apply,O,1772
36154,eye,B-TREATMENT,1772
36155,drops,I-TREATMENT,1772
36156,to,O,1772
36157,lower,O,1772
36158,their,O,1772
36159,eye,O,1772
36160,pressure,O,1772
36161,Who,O,1772
36162,is,O,1772
36163,a,O,1772
36164,Good,O,1772
36165,Durysta,B-TREATMENT,1772
36166,Candidate,O,1773
36167,Patients,O,1774
36168,with,O,1774
36169,Ocular,B-NAME_OF_DISEASE,1774
36170,hypertension,I-NAME_OF_DISEASE,1774
36171,and,O,1774
36172,open-angle,B-NAME_OF_DISEASE,1774
36173,glaucoma,I-NAME_OF_DISEASE,1774
36174,are,O,1774
36175,the,O,1774
36176,first,O,1774
36177,candidates,O,1774
36178,to,O,1775
36179,think,O,1775
36180,of,O,1775
36181,FDA,B-ORGANIZATION,1775
36182,approves,O,1775
36183,patients,O,1775
36184,with,O,1775
36185,OCT,B-NAME_OF_DISEASE,1775
36186,and,O,1775
36187,OHT,B-NAME_OF_DISEASE,1775
36188,to,O,1775
36189,have,O,1775
36190,implants,O,1775
36191,if,O,1775
36192,The,O,1775
36193,patient,O,1775
36194,is,O,1775
36195,not,O,1775
36196,allergic,O,1776
36197,to,O,1776
36198,bimatoprost,B-NAME_OF_DRUG,1776
36199,or,O,1776
36200,its,O,1776
36201,components,O,1776
36202,The,O,1776
36203,patient,O,1776
36204,doesn,O,1776
36205,t,O,1776
36206,have,O,1776
36207,any,O,1776
36208,infection,O,1776
36209,around,O,1776
36210,the,O,1777
36211,eyes,O,1778
36212,The,O,1778
36213,patient,O,1778
36214,has,O,1778
36215,a,O,1778
36216,good,O,1778
36217,response,O,1778
36218,to,O,1778
36219,topical,B-NAME_OF_DRUG,1778
36220,bimatoprost,I-NAME_OF_DRUG,1778
36221,The,O,1778
36222,patient,O,1778
36223,has,O,1778
36224,no,O,1778
36225,underlying,O,1778
36226,corneal,O,1778
36227,endothelial,O,1778
36228,problems,O,1778
36229,The,O,1778
36230,patient,O,1779
36231,has,O,1780
36232,undergone,O,1780
36233,SLT,B-TREATMENT,1780
36234,What,O,1780
36235,Are,O,1780
36236,the,O,1780
36237,Side,O,1780
36238,Effects,O,1780
36239,of,O,1780
36240,Durysta,B-TREATMENT,1780
36241,The,O,1780
36242,most,O,1780
36243,common,O,1780
36244,side,O,1780
36245,effect,O,1780
36246,reported,O,1780
36247,by,O,1780
36248,the,O,1780
36249,patients,O,1780
36250,is,O,1780
36251,eye,B-SIGN_AND_SYMPTOM,1780
36252,redness,I-SIGN_AND_SYMPTOM,1780
36253,Some,O,1781
36254,other,O,1781
36255,side,O,1781
36256,effects,O,1781
36257,are,O,1781
36258,pain,B-SIGN_AND_SYMPTOM,1781
36259,the,I-SIGN_AND_SYMPTOM,1781
36260,sensation,I-SIGN_AND_SYMPTOM,1781
36261,of,I-SIGN_AND_SYMPTOM,1781
36262,having,I-SIGN_AND_SYMPTOM,1781
36263,something,I-SIGN_AND_SYMPTOM,1781
36264,in,I-SIGN_AND_SYMPTOM,1781
36265,the,I-SIGN_AND_SYMPTOM,1781
36266,eye,I-SIGN_AND_SYMPTOM,1781
36267,dryness,I-SIGN_AND_SYMPTOM,1781
36268,and,I-SIGN_AND_SYMPTOM,1781
36269,irritation,I-SIGN_AND_SYMPTOM,1781
36270,blurred,I-SIGN_AND_SYMPTOM,1781
36271,vision,I-SIGN_AND_SYMPTOM,1781
36272,headache,I-SIGN_AND_SYMPTOM,1781
36273,and,I-SIGN_AND_SYMPTOM,1781
36274,loss,I-SIGN_AND_SYMPTOM,1781
36275,of,I-SIGN_AND_SYMPTOM,1782
36276,cells,I-SIGN_AND_SYMPTOM,1782
36277,in,I-SIGN_AND_SYMPTOM,1782
36278,the,I-SIGN_AND_SYMPTOM,1782
36279,inner,I-SIGN_AND_SYMPTOM,1782
36280,cornea,I-SIGN_AND_SYMPTOM,1782
36281,Rarely,O,1782
36282,people,O,1782
36283,are,O,1782
36284,allergic,O,1782
36285,to,O,1782
36286,bimatoprost,B-NAME_OF_DRUG,1782
36287,Make,O,1782
36288,sure,O,1782
36289,to,O,1782
36290,get,O,1782
36291,checked,O,1782
36292,before,O,1782
36293,using,O,1782
36294,the,O,1782
36295,solution,O,1783
36296,or,O,1783
36297,implant,O,1783
36298,Retinal,B-NAME_OF_DISEASE,1783
36299,pattern,B-NAME_OF_DISEASE,1783
36300,dystrophies,I-NAME_OF_DISEASE,1783
36301,as,O,1783
36302,the,O,1783
36303,name,O,1783
36304,implies,O,1783
36305,are,O,1783
36306,a,O,1783
36307,group,O,1783
36308,of,O,1783
36309,disorders,O,1783
36310,characterized,O,1783
36311,by,O,1784
36312,diverse,O,1784
36313,pigment,O,1784
36314,deposition,O,1784
36315,patterns,O,1784
36316,in,O,1784
36317,the,B-PART_OF_THE_EYES,1784
36318,macula,I-PART_OF_THE_EYES,1784
36319,s,O,1784
36320,retinal,B-PART_OF_THE_EYES,1784
36321,pigment,I-PART_OF_THE_EYES,1784
36322,epithelium,I-PART_OF_THE_EYES,1784
36323,RPE,I-PART_OF_THE_EYES,1784
36324,,O,1784
36325,The,B-PART_OF_THE_EYES,1784
36326,RPE,I-PART_OF_THE_EYES,1784
36327,located,O,1784
36328,in,O,1784
36329,the,B-PART_OF_THE_EYES,1784
36330,retina,I-PART_OF_THE_EYES,1784
36331,s,O,1784
36332,outermost,O,1784
36333,layer,O,1784
36334,is,O,1784
36335,rich,O,1784
36336,in,O,1784
36337,pigment,B-CHEMICAL_COMPOUND,1784
36338,particles,I-CHEMICAL_COMPOUND,1784
36339,such,O,1784
36340,as,O,1785
36341,melanin,B-CHEMICAL_COMPOUND,1785
36342,and,O,1785
36343,lipofuscin,B-CHEMICAL_COMPOUND,1785
36344,that,O,1785
36345,prevent,O,1785
36346,light,O,1785
36347,damage,O,1785
36348,A,B-SIGN_AND_SYMPTOM,1785
36349,yellowish,I-SIGN_AND_SYMPTOM,1785
36350,orange,I-SIGN_AND_SYMPTOM,1785
36351,or,I-SIGN_AND_SYMPTOM,1785
36352,brown,I-SIGN_AND_SYMPTOM,1785
36353,lipofuscin,I-SIGN_AND_SYMPTOM,1786
36354,accumulation,I-SIGN_AND_SYMPTOM,1786
36355,in,I-SIGN_AND_SYMPTOM,1786
36356,the,I-SIGN_AND_SYMPTOM,1786
36357,subretinal,I-SIGN_AND_SYMPTOM,1786
36358,region,I-SIGN_AND_SYMPTOM,1786
36359,characterizes,O,1786
36360,many,O,1786
36361,pattern,B-NAME_OF_DISEASE,1786
36362,dystrophies,I-NAME_OF_DISEASE,1786
36363,Typically,O,1786
36364,these,O,1786
36365,dystrophies,O,1786
36366,are,O,1786
36367,associated,O,1786
36368,with,O,1787
36369,a,O,1787
36370,favorable,O,1787
36371,visual,O,1787
36372,prognosis,O,1787
36373,however,O,1787
36374,gradual,B-SIGN_AND_SYMPTOM,1787
36375,central,I-SIGN_AND_SYMPTOM,1787
36376,vision,I-SIGN_AND_SYMPTOM,1787
36377,loss,I-SIGN_AND_SYMPTOM,1787
36378,remains,O,1787
36379,a,O,1787
36380,possibility,O,1787
36381,How,O,1787
36382,is,O,1787
36383,it,O,1787
36384,inherited,O,1787
36385,Mutations,B-CAUSE_OF_DISEASE,1787
36386,cause,O,1787
36387,pattern,B-NAME_OF_DISEASE,1787
36388,dystrophies,I-NAME_OF_DISEASE,1787
36389,in,O,1788
36390,any,B-CAUSE_OF_DISEASE,1788
36391,of,I-CAUSE_OF_DISEASE,1788
36392,several,I-CAUSE_OF_DISEASE,1788
36393,genes,B-CHEMICAL_COMPOUND,1788
36394,inherited,I-CAUSE_OF_DISEASE,1788
36395,in,I-CAUSE_OF_DISEASE,1788
36396,an,I-CAUSE_OF_DISEASE,1788
36397,autosomal,I-CAUSE_OF_DISEASE,1788
36398,dominant,I-CAUSE_OF_DISEASE,1788
36399,manner,I-CAUSE_OF_DISEASE,1788
36400,This,O,1789
36401,fact,O,1789
36402,means,O,1789
36403,that,O,1789
36404,a,O,1789
36405,parent,O,1789
36406,with,O,1789
36407,pattern,B-NAME_OF_DISEASE,1789
36408,dystrophy,I-NAME_OF_DISEASE,1789
36409,has,O,1790
36410,a,O,1790
36411,50%,O,1790
36412,chance,O,1790
36413,of,O,1790
36414,passing,O,1790
36415,it,O,1790
36416,on,O,1790
36417,to,O,1790
36418,their,O,1790
36419,child,O,1790
36420,regardless,O,1790
36421,of,O,1790
36422,gender,O,1790
36423,That,O,1790
36424,child,O,1790
36425,would,O,1790
36426,have,O,1790
36427,one,O,1790
36428,gene,B-CHEMICAL_COMPOUND,1790
36429,causing,O,1790
36430,the,O,1790
36431,disorder,O,1790
36432,and,O,1790
36433,one,O,1790
36434,normal,O,1790
36435,gene,B-CHEMICAL_COMPOUND,1790
36436,in,O,1790
36437,a,O,1790
36438,single,O,1791
36439,pair,O,1791
36440,of,O,1791
36441,genes,B-CHEMICAL_COMPOUND,1791
36442,For,O,1791
36443,instance,O,1791
36444,if,O,1791
36445,the,O,1791
36446,father,O,1791
36447,has,O,1791
36448,one,O,1791
36449,gene,B-CAUSE_OF_DISEASE,1791
36450,for,I-CAUSE_OF_DISEASE,1791
36451,pattern,I-CAUSE_OF_DISEASE,1791
36452,dystrophy,I-CAUSE_OF_DISEASE,1791
36453,and,O,1791
36454,one,O,1791
36455,normal,O,1791
36456,gene,B-CHEMICAL_COMPOUND,1791
36457,but,O,1791
36458,the,O,1791
36459,mother,O,1791
36460,has,O,1792
36461,two,O,1792
36462,normal,O,1792
36463,genes,B-CHEMICAL_COMPOUND,1792
36464,the,O,1792
36465,mother,O,1792
36466,will,O,1792
36467,always,O,1792
36468,pass,O,1792
36469,on,O,1792
36470,a,O,1792
36471,normal,O,1792
36472,gene,B-CHEMICAL_COMPOUND,1792
36473,from,O,1792
36474,that,O,1792
36475,pair,O,1792
36476,to,O,1793
36477,their,O,1793
36478,offspring,O,1793
36479,There,O,1793
36480,is,O,1793
36481,a,O,1793
36482,50,O,1793
36483,50,O,1793
36484,probability,O,1794
36485,that,O,1794
36486,the,O,1794
36487,father,O,1794
36488,will,O,1794
36489,give,O,1794
36490,the,B-CAUSE_OF_DISEASE,1794
36491,gene,B-CAUSE_OF_DISEASE,1794
36492,for,I-CAUSE_OF_DISEASE,1794
36493,pattern,I-CAUSE_OF_DISEASE,1794
36494,dystrophy,I-CAUSE_OF_DISEASE,1794
36495,or,O,1794
36496,the,O,1794
36497,normal,O,1794
36498,gene,B-CHEMICAL_COMPOUND,1794
36499,However,O,1794
36500,another,O,1795
36501,condition,O,1795
36502,might,O,1795
36503,arise,O,1795
36504,when,O,1795
36505,an,O,1795
36506,individual,O,1795
36507,carries,O,1795
36508,the,B-CAUSE_OF_DISEASE,1795
36509,disease-causing,I-CAUSE_OF_DISEASE,1795
36510,genetic,I-CAUSE_OF_DISEASE,1795
36511,mutation,I-CAUSE_OF_DISEASE,1795
36512,but,O,1795
36513,does,O,1795
36514,not,O,1795
36515,exhibit,O,1795
36516,the,O,1795
36517,phenotypic,O,1795
36518,condition,O,1795
36519,This,O,1795
36520,characteristic,O,1795
36521,is,O,1795
36522,non-penetrance,O,1795
36523,When,O,1795
36524,a,O,1795
36525,gene,B-CHEMICAL_COMPOUND,1795
36526,is,O,1795
36527,non-penetrant,O,1795
36528,it,O,1795
36529,appears,O,1795
36530,to,O,1795
36531,have,O,1795
36532,skipped,O,1795
36533,a,O,1795
36534,generation,O,1796
36535,For,O,1797
36536,example,O,1797
36537,in,O,1797
36538,a,O,1797
36539,family,O,1797
36540,where,O,1797
36541,many,O,1797
36542,members,O,1797
36543,including,O,1797
36544,a,O,1797
36545,child,O,1797
36546,and,O,1797
36547,grandparent,O,1797
36548,have,O,1797
36549,pattern,B-NAME_OF_DISEASE,1797
36550,dystrophy,I-NAME_OF_DISEASE,1797
36551,the,O,1797
36552,intervening,O,1797
36553,parent,O,1797
36554,with,O,1797
36555,the,O,1797
36556,dominant,O,1797
36557,gene,B-CAUSE_OF_DISEASE,1797
36558,for,I-CAUSE_OF_DISEASE,1797
36559,pattern,I-CAUSE_OF_DISEASE,1797
36560,dystrophy,I-CAUSE_OF_DISEASE,1797
36561,has,O,1797
36562,normal,O,1797
36563,eyesight,O,1797
36564,Types,O,1797
36565,of,O,1797
36566,Pattern,B-NAME_OF_DISEASE,1798
36567,Dystrophies,I-NAME_OF_DISEASE,1798
36568,1,O,1798
36569,Adult-onset,B-NAME_OF_DISEASE,1798
36570,foveomacular,I-NAME_OF_DISEASE,1798
36571,vitelliform,I-NAME_OF_DISEASE,1798
36572,dystrophy,I-NAME_OF_DISEASE,1798
36573,It,O,1798
36574,is,O,1798
36575,the,O,1798
36576,most,O,1798
36577,prevalent,O,1798
36578,kind,O,1798
36579,of,O,1798
36580,pattern,B-NAME_OF_DISEASE,1798
36581,dystrophy,I-NAME_OF_DISEASE,1798
36582,It,O,1798
36583,is,O,1798
36584,characterized,O,1798
36585,by,O,1798
36586,bilateral,B-SIGN_AND_SYMPTOM,1798
36587,symmetrical,I-SIGN_AND_SYMPTOM,1798
36588,grayish-yellow,I-SIGN_AND_SYMPTOM,1798
36589,round,I-SIGN_AND_SYMPTOM,1798
36590,lesion,I-SIGN_AND_SYMPTOM,1798
36591,within,I-SIGN_AND_SYMPTOM,1799
36592,macular,I-SIGN_AND_SYMPTOM,1799
36593,region,I-SIGN_AND_SYMPTOM,1799
36594,The,O,1799
36595,lesion,O,1799
36596,is,O,1799
36597,typically,O,1799
36598,one-third,O,1799
36599,to,O,1799
36600,one-half,O,1799
36601,the,O,1799
36602,diameter,O,1799
36603,of,O,1799
36604,a,O,1799
36605,disc,O,1799
36606,2,O,1799
36607,Butterfly-shaped,B-NAME_OF_DISEASE,1799
36608,pattern,I-NAME_OF_DISEASE,1799
36609,dystrophy,I-NAME_OF_DISEASE,1799
36610,It,O,1799
36611,is,O,1799
36612,commonly,O,1799
36613,observed,O,1799
36614,between,O,1799
36615,the,O,1799
36616,second,O,1799
36617,and,O,1799
36618,fifth,O,1799
36619,decades,O,1799
36620,of,O,1799
36621,life,O,1799
36622,They,O,1799
36623,manifest,O,1799
36624,as,O,1799
36625,yellow,B-SIGN_AND_SYMPTOM,1799
36626,and,I-SIGN_AND_SYMPTOM,1800
36627,melanin,I-SIGN_AND_SYMPTOM,1800
36628,pigmentation,I-SIGN_AND_SYMPTOM,1800
36629,in,I-SIGN_AND_SYMPTOM,1800
36630,the,I-SIGN_AND_SYMPTOM,1800
36631,fovea,I-SIGN_AND_SYMPTOM,1800
36632,typically,I-SIGN_AND_SYMPTOM,1800
36633,in,I-SIGN_AND_SYMPTOM,1800
36634,a,I-SIGN_AND_SYMPTOM,1800
36635,spoke-like,I-SIGN_AND_SYMPTOM,1800
36636,or,I-SIGN_AND_SYMPTOM,1800
36637,butterfly-wing-like,I-SIGN_AND_SYMPTOM,1800
36638,configuration,I-SIGN_AND_SYMPTOM,1800
36639,3,O,1800
36640,Reticular,B-NAME_OF_DISEASE,1800
36641,dystrophy,I-NAME_OF_DISEASE,1800
36642,is,O,1800
36643,usually,O,1800
36644,seen,O,1800
36645,in,O,1800
36646,the,O,1800
36647,5th,O,1801
36648,decade,O,1801
36649,of,O,1801
36650,life,O,1801
36651,Clinically,O,1801
36652,it,O,1801
36653,features,O,1801
36654,a,B-SIGN_AND_SYMPTOM,1801
36655,network,I-SIGN_AND_SYMPTOM,1801
36656,of,I-SIGN_AND_SYMPTOM,1801
36657,pigmented,I-SIGN_AND_SYMPTOM,1801
36658,lines,I-SIGN_AND_SYMPTOM,1801
36659,and,I-SIGN_AND_SYMPTOM,1801
36660,knots,I-SIGN_AND_SYMPTOM,1801
36661,in,I-SIGN_AND_SYMPTOM,1801
36662,a,I-SIGN_AND_SYMPTOM,1801
36663,fish,I-SIGN_AND_SYMPTOM,1801
36664,net-like,I-SIGN_AND_SYMPTOM,1801
36665,appearance,I-SIGN_AND_SYMPTOM,1801
36666,in,I-SIGN_AND_SYMPTOM,1801
36667,the,I-SIGN_AND_SYMPTOM,1801
36668,RPE,I-SIGN_AND_SYMPTOM,1801
36669,Lesions,O,1801
36670,are,O,1802
36671,up,O,1802
36672,to,O,1802
36673,five-disc,O,1802
36674,diameters,O,1802
36675,from,O,1802
36676,the,B-PART_OF_THE_EYES,1802
36677,macula,I-PART_OF_THE_EYES,1802
36678,and,O,1803
36679,typically,O,1803
36680,fade,O,1803
36681,with,O,1803
36682,age,O,1803
36683,4,O,1803
36684,Multifocal,B-NAME_OF_DISEASE,1803
36685,Pattern,I-NAME_OF_DISEASE,1803
36686,Dystrophy,I-NAME_OF_DISEASE,1803
36687,includes,O,1803
36688,multiple,B-SIGN_AND_SYMPTOM,1803
36689,irregular,I-SIGN_AND_SYMPTOM,1803
36690,white-yellow,I-SIGN_AND_SYMPTOM,1803
36691,specks,I-SIGN_AND_SYMPTOM,1803
36692,dispersed,I-SIGN_AND_SYMPTOM,1803
36693,across,I-SIGN_AND_SYMPTOM,1803
36694,the,I-SIGN_AND_SYMPTOM,1803
36695,macula,I-SIGN_AND_SYMPTOM,1803
36696,comparable,O,1804
36697,to,O,1804
36698,the,O,1804
36699,flecks,O,1804
36700,in,O,1804
36701,Stargardt,B-NAME_OF_DISEASE,1804
36702,disease,I-NAME_OF_DISEASE,1804
36703,5,O,1804
36704,Fundus,B-NAME_OF_DISEASE,1804
36705,Pulverulentus,I-NAME_OF_DISEASE,1804
36706,Fundus,B-NAME_OF_DISEASE,1804
36707,pulverulentus,I-NAME_OF_DISEASE,1804
36708,is,O,1804
36709,characterized,O,1805
36710,by,O,1805
36711,a,B-SIGN_AND_SYMPTOM,1805
36712,granular,I-SIGN_AND_SYMPTOM,1805
36713,appearance,I-SIGN_AND_SYMPTOM,1805
36714,and,I-SIGN_AND_SYMPTOM,1805
36715,punctiform,I-SIGN_AND_SYMPTOM,1805
36716,mottling,I-SIGN_AND_SYMPTOM,1805
36717,of,I-SIGN_AND_SYMPTOM,1805
36718,the,I-SIGN_AND_SYMPTOM,1805
36719,retinal,I-SIGN_AND_SYMPTOM,1805
36720,pigment,I-SIGN_AND_SYMPTOM,1805
36721,epithelium,I-SIGN_AND_SYMPTOM,1806
36722,RPE,I-SIGN_AND_SYMPTOM,1806
36723,within,I-SIGN_AND_SYMPTOM,1806
36724,the,I-SIGN_AND_SYMPTOM,1806
36725,macula,I-SIGN_AND_SYMPTOM,1806
36726,Due,O,1806
36727,to,O,1806
36728,the,O,1806
36729,RPE,B-SIGN_AND_SYMPTOM,1806
36730,mottling,I-SIGN_AND_SYMPTOM,1806
36731,Fundus,B-NAME_OF_DISEASE,1806
36732,pulverulentus,I-NAME_OF_DISEASE,1806
36733,might,O,1806
36734,be,O,1806
36735,confused,O,1806
36736,for,O,1806
36737,age-related,B-NAME_OF_DISEASE,1806
36738,macular,I-NAME_OF_DISEASE,1806
36739,degeneration,I-NAME_OF_DISEASE,1806
36740,however,O,1806
36741,OCT,B-DIAGNOSTIC_TEST,1806
36742,imaging,I-DIAGNOSTIC_TEST,1806
36743,can,O,1807
36744,help,O,1807
36745,differentiate,O,1807
36746,the,O,1807
36747,two,O,1807
36748,Symptoms,O,1807
36749,Due,O,1807
36750,to,O,1807
36751,the,O,1807
36752,benign,O,1807
36753,nature,O,1807
36754,of,O,1807
36755,the,O,1807
36756,symptoms,O,1807
36757,pattern,B-NAME_OF_DISEASE,1807
36758,dystrophies,I-NAME_OF_DISEASE,1807
36759,are,O,1807
36760,frequently,O,1807
36761,detected,O,1807
36762,during,O,1807
36763,routine,O,1807
36764,or,O,1807
36765,unrelated,O,1808
36766,eye,O,1808
36767,exams,O,1808
36768,In,O,1808
36769,rare,O,1808
36770,circumstances,O,1808
36771,patients,O,1808
36772,may,O,1808
36773,experience,O,1808
36774,substantial,B-SIGN_AND_SYMPTOM,1808
36775,vision,B-SIGN_AND_SYMPTOM,1808
36776,loss,I-SIGN_AND_SYMPTOM,1808
36777,caused,O,1808
36778,by,O,1808
36779,complications,O,1808
36780,such,O,1808
36781,as,O,1808
36782,choroidal,B-NAME_OF_DISEASE,1808
36783,neovascularization,I-NAME_OF_DISEASE,1808
36784,The,O,1808
36785,following,O,1809
36786,are,O,1809
36787,the,O,1809
36788,typical,O,1809
36789,symptoms,O,1809
36790,of,O,1809
36791,Pattern,B-NAME_OF_DISEASE,1809
36792,Dystrophies,I-NAME_OF_DISEASE,1809
36793,Metamorphosis,B-SIGN_AND_SYMPTOM,1809
36794,Decreased,B-SIGN_AND_SYMPTOM,1809
36795,Visual,I-SIGN_AND_SYMPTOM,1809
36796,Acuity,I-SIGN_AND_SYMPTOM,1809
36797,The,O,1809
36798,onset,O,1809
36799,of,O,1809
36800,these,O,1810
36801,symptoms,O,1810
36802,is,O,1810
36803,in,O,1810
36804,early,O,1810
36805,adulthood,O,1811
36806,or,O,1811
36807,later,O,1811
36808,but,O,1811
36809,many,O,1811
36810,individuals,O,1811
36811,are,O,1811
36812,asymptomatic,O,1811
36813,Diagnosis,O,1811
36814,Treatment,O,1811
36815,options,O,1811
36816,Primarily,O,1811
36817,Pattern,B-NAME_OF_DISEASE,1811
36818,dystrophy,I-NAME_OF_DISEASE,1812
36819,is,O,1812
36820,diagnosed,O,1812
36821,clinically,O,1812
36822,through,O,1812
36823,dilated,B-DIAGNOSTIC_TEST,1812
36824,fundus,I-DIAGNOSTIC_TEST,1812
36825,examination,I-DIAGNOSTIC_TEST,1812
36826,The,O,1813
36827,pattern,O,1813
36828,s,O,1813
36829,nature,O,1813
36830,and,O,1813
36831,description,O,1813
36832,determine,O,1813
36833,the,O,1813
36834,sort,O,1813
36835,of,O,1813
36836,pattern,B-NAME_OF_DISEASE,1814
36837,dystrophy,I-NAME_OF_DISEASE,1814
36838,a,O,1814
36839,patient,O,1814
36840,has,O,1814
36841,Fluorescein,B-DIAGNOSTIC_TEST,1814
36842,angiography,I-DIAGNOSTIC_TEST,1814
36843,FA,I-DIAGNOSTIC_TEST,1814
36844,fundus,B-DIAGNOSTIC_TEST,1814
36845,autofluorescence,I-DIAGNOSTIC_TEST,1814
36846,FAF,I-DIAGNOSTIC_TEST,1814
36847,electrooculography,B-DIAGNOSTIC_TEST,1814
36848,EOG,I-DIAGNOSTIC_TEST,1814
36849,and,O,1814
36850,electroretinography,B-DIAGNOSTIC_TEST,1814
36851,ERG,I-DIAGNOSTIC_TEST,1814
36852,can,O,1814
36853,provide,O,1814
36854,additional,O,1814
36855,data,O,1815
36856,to,O,1815
36857,stage,O,1815
36858,and,O,1815
36859,characterize,O,1815
36860,the,O,1815
36861,pattern,O,1815
36862,Currently,O,1815
36863,there,O,1815
36864,is,O,1815
36865,no,O,1815
36866,treatment,O,1815
36867,supported,O,1815
36868,by,O,1815
36869,evidence,O,1815
36870,for,O,1815
36871,Pattern,B-NAME_OF_DISEASE,1816
36872,dystrophies,I-NAME_OF_DISEASE,1816
36873,Despite,O,1816
36874,that,O,1816
36875,they,O,1816
36876,often,O,1816
36877,have,O,1816
36878,a,O,1816
36879,favorable,O,1816
36880,visual,O,1816
36881,prognosis,O,1816
36882,However,O,1816
36883,vision,B-SIGN_AND_SYMPTOM,1816
36884,loss,I-SIGN_AND_SYMPTOM,1816
36885,can,O,1816
36886,be,O,1816
36887,more,O,1816
36888,rapid,O,1816
36889,in,O,1816
36890,some,O,1816
36891,patients,O,1816
36892,due,O,1816
36893,to,O,1816
36894,secondary,O,1816
36895,problems,O,1816
36896,such,O,1816
36897,as,O,1816
36898,choroidal,B-NAME_OF_DISEASE,1816
36899,neovascularization,I-NAME_OF_DISEASE,1816
36900,and,O,1816
36901,retinal,B-NAME_OF_DISEASE,1817
36902,holes,I-NAME_OF_DISEASE,1817
36903,which,O,1817
36904,require,O,1817
36905,anti-VEGF,B-TREATMENT,1817
36906,injections,I-TREATMENT,1817
36907,and,O,1817
36908,surgical,B-TREATMENT,1817
36909,hole,I-TREATMENT,1817
36910,repair,I-TREATMENT,1817
36911,Role,O,1817
36912,of,O,1817
36913,Low-Vision,B-TREATMENT,1817
36914,Aid,I-TREATMENT,1818
36915,Low,B-TREATMENT,1818
36916,vision,I-TREATMENT,1818
36917,therapy,I-TREATMENT,1818
36918,is,O,1818
36919,most,O,1819
36920,effective,O,1819
36921,at,O,1819
36922,mitigating,O,1819
36923,the,O,1819
36924,impact,O,1819
36925,of,O,1819
36926,visual,B-SIGN_AND_SYMPTOM,1819
36927,loss,I-SIGN_AND_SYMPTOM,1819
36928,on,O,1819
36929,a,O,1819
36930,patient,O,1819
36931,s,O,1819
36932,life,O,1819
36933,Patients,O,1819
36934,will,O,1819
36935,most,O,1819
36936,likely,O,1819
36937,benefit,O,1819
36938,from,O,1819
36939,single-vision,B-TREATMENT,1820
36940,reading,I-TREATMENT,1820
36941,glasses,I-TREATMENT,1820
36942,and,O,1820
36943,may,O,1820
36944,need,O,1820
36945,monocular,B-TREATMENT,1820
36946,occlusion,I-TREATMENT,1820
36947,for,O,1820
36948,reading,O,1820
36949,Patients,O,1820
36950,can,O,1820
36951,utilize,O,1820
36952,monocular,B-TREATMENT,1820
36953,telescopes,I-TREATMENT,1820
36954,for,O,1820
36955,long-range,O,1821
36956,observation,O,1821
36957,Optivisors,B-TREATMENT,1821
36958,can,O,1821
36959,improve,O,1822
36960,visual,O,1822
36961,performance,O,1822
36962,for,O,1822
36963,people,O,1822
36964,who,O,1822
36965,want,O,1822
36966,to,O,1822
36967,be,O,1823
36968,able,O,1823
36969,to,O,1823
36970,do,O,1824
36971,household,O,1824
36972,repairs,O,1824
36973,A,B-TREATMENT,1824
36974,pair,I-TREATMENT,1824
36975,of,I-TREATMENT,1824
36976,bifocal,I-TREATMENT,1825
36977,spectacles,I-TREATMENT,1825
36978,with,I-TREATMENT,1825
36979,an,I-TREATMENT,1825
36980,add,I-TREATMENT,1825
36981,in,I-TREATMENT,1826
36982,the,I-TREATMENT,1826
36983,distance,I-TREATMENT,1826
36984,portion,I-TREATMENT,1826
36985,for,I-TREATMENT,1826
36986,intermediate,I-TREATMENT,1826
36987,vision,I-TREATMENT,1827
36988,and,I-TREATMENT,1827
36989,an,I-TREATMENT,1827
36990,add,I-TREATMENT,1827
36991,in,I-TREATMENT,1827
36992,the,I-TREATMENT,1827
36993,bifocal,I-TREATMENT,1827
36994,part,I-TREATMENT,1827
36995,for,I-TREATMENT,1827
36996,near,I-TREATMENT,1827
36997,work,I-TREATMENT,1827
36998,can,O,1827
36999,be,O,1827
37000,used,O,1828
37001,for,O,1828
37002,close,O,1828
37003,work,O,1828
37004,and,O,1828
37005,intermediate,O,1828
37006,vision,O,1828
37007,Dr,O,1828
37008,Muhammad,O,1828
37009,Saad,O,1828
37010,Resident,O,1828
37011,Ophthalmologist-Cornea,O,1828
37012,Department,O,1828
37013,Al-Shifa,B-ORGANIZATION,1828
37014,Trust,I-ORGANIZATION,1828
37015,Eye,I-ORGANIZATION,1828
37016,Hospital,I-ORGANIZATION,1828
37017,Rawalpindi,B-GPE,1828
37018,Pakistan,I-GPE,1828
37019,Fake,O,1828
37020,eyelashes,B-PART_OF_THE_EYES,1828
37021,or,O,1828
37022,falsies,O,1828
37023,are,O,1828
37024,synthetic,O,1828
37025,temporary,O,1828
37026,and,O,1828
37027,FALSE,O,1828
37028,hairs,O,1828
37029,adhered,O,1828
37030,onto,O,1828
37031,a,O,1828
37032,strip,O,1828
37033,to,O,1828
37034,be,O,1828
37035,pasted,O,1828
37036,on,O,1828
37037,the,B-PART_OF_THE_EYES,1828
37038,lash,I-PART_OF_THE_EYES,1828
37039,line,I-PART_OF_THE_EYES,1828
37040,with,O,1828
37041,temporary,O,1828
37042,glue,O,1828
37043,for,O,1828
37044,cosmetic,O,1828
37045,purpose,O,1828
37046,of,O,1828
37047,embellishing,O,1828
37048,the,O,1828
37049,eyes,O,1828
37050,Similar,O,1828
37051,to,O,1828
37052,these,O,1828
37053,are,O,1828
37054,eyelash,B-PART_OF_THE_EYES,1829
37055,extensions,O,1829
37056,glued,O,1829
37057,generally,O,1829
37058,by,O,1829
37059,a,O,1829
37060,professional,O,1829
37061,onto,O,1829
37062,natural,B-PART_OF_THE_EYES,1829
37063,lashes,B-PART_OF_THE_EYES,1829
37064,to,O,1829
37065,enhance,O,1829
37066,the,O,1829
37067,length,O,1829
37068,shape,O,1829
37069,volume,O,1829
37070,and,O,1829
37071,density,O,1829
37072,of,O,1829
37073,natural,B-PART_OF_THE_EYES,1829
37074,eyelashes,I-PART_OF_THE_EYES,1829
37075,What,O,1829
37076,Are,O,1829
37077,the,O,1829
37078,Risks,O,1829
37079,of,O,1829
37080,Wearing,B-CAUSE_OF_DISEASE,1829
37081,FALSE,I-CAUSE_OF_DISEASE,1829
37082,Eyelashes,I-CAUSE_OF_DISEASE,1829
37083,Infections,O,1829
37084,If,O,1829
37085,you,O,1830
37086,wear,O,1830
37087,your,O,1830
37088,artificial,O,1830
37089,eyelashes,B-PART_OF_THE_EYES,1830
37090,to,O,1830
37091,night,O,1830
37092,or,O,1830
37093,for,O,1830
37094,longer,O,1830
37095,than,O,1830
37096,one,O,1830
37097,day,O,1830
37098,bacteria,O,1830
37099,may,O,1830
37100,gather,O,1830
37101,on,O,1830
37102,the,O,1830
37103,FALSE,O,1830
37104,eyelashes,B-PART_OF_THE_EYES,1830
37105,and,O,1830
37106,under,O,1831
37107,the,O,1831
37108,eyelash,B-PART_OF_THE_EYES,1831
37109,adhesive,O,1831
37110,Furthermore,O,1831
37111,since,O,1831
37112,synthetic,O,1831
37113,eyelashes,B-PART_OF_THE_EYES,1831
37114,shouldn,O,1831
37115,t,O,1831
37116,get,O,1831
37117,wet,O,1831
37118,you,O,1831
37119,might,O,1831
37120,find,O,1831
37121,yourself,O,1831
37122,taking,O,1831
37123,fewer,O,1831
37124,showers,O,1831
37125,or,O,1831
37126,washing,O,1831
37127,your,O,1831
37128,face,O,1831
37129,less,O,1831
37130,frequently,O,1831
37131,Because,O,1831
37132,of,O,1831
37133,the,O,1831
37134,drop,O,1831
37135,in,O,1831
37136,skincare,O,1831
37137,cleanliness,O,1832
37138,there,O,1832
37139,may,O,1832
37140,be,O,1832
37141,more,O,1832
37142,dirt,B-CAUSE_OF_DISEASE,1832
37143,and,I-CAUSE_OF_DISEASE,1832
37144,bacteria,I-CAUSE_OF_DISEASE,1832
37145,than,I-CAUSE_OF_DISEASE,1832
37146,usual,I-CAUSE_OF_DISEASE,1832
37147,around,I-CAUSE_OF_DISEASE,1832
37148,the,I-CAUSE_OF_DISEASE,1832
37149,eyes,I-CAUSE_OF_DISEASE,1832
37150,which,O,1832
37151,can,O,1832
37152,cause,O,1832
37153,infections,O,1832
37154,Eye,B-NAME_OF_DISEASE,1832
37155,infections,I-NAME_OF_DISEASE,1832
37156,can,O,1832
37157,cause,O,1832
37158,swelling,B-SIGN_AND_SYMPTOM,1832
37159,discomfort,I-SIGN_AND_SYMPTOM,1833
37160,or,I-SIGN_AND_SYMPTOM,1833
37161,discharge,I-SIGN_AND_SYMPTOM,1833
37162,Damage,O,1833
37163,to,O,1833
37164,Your,O,1833
37165,Natural,B-PART_OF_THE_EYES,1833
37166,Lashes,I-PART_OF_THE_EYES,1833
37167,Your,O,1833
37168,natural,B-PART_OF_THE_EYES,1833
37169,lashes,B-PART_OF_THE_EYES,1833
37170,may,O,1833
37171,become,O,1833
37172,damaged,O,1833
37173,as,O,1833
37174,a,O,1833
37175,result,O,1833
37176,of,O,1833
37177,using,B-CAUSE_OF_DISEASE,1833
37178,fake,I-CAUSE_OF_DISEASE,1833
37179,eyelashes,I-CAUSE_OF_DISEASE,1833
37180,Your,O,1833
37181,lashes,B-PART_OF_THE_EYES,1833
37182,may,O,1834
37183,tear,O,1834
37184,or,O,1834
37185,thin,O,1834
37186,out,O,1834
37187,if,O,1834
37188,artificial,O,1834
37189,eyelashes,B-PART_OF_THE_EYES,1834
37190,are,O,1834
37191,applied,O,1834
37192,incorrectly,O,1834
37193,If,O,1834
37194,you,O,1834
37195,yank,B-CAUSE_OF_DISEASE,1834
37196,twist,I-CAUSE_OF_DISEASE,1834
37197,or,I-CAUSE_OF_DISEASE,1834
37198,scratch,I-CAUSE_OF_DISEASE,1834
37199,your,I-CAUSE_OF_DISEASE,1834
37200,eyes,I-CAUSE_OF_DISEASE,1834
37201,this,O,1834
37202,could,O,1834
37203,get,O,1834
37204,worse,O,1834
37205,Generally,O,1834
37206,speaking,O,1834
37207,the,O,1834
37208,gentler,O,1834
37209,you,O,1834
37210,are,O,1834
37211,with,O,1834
37212,your,O,1834
37213,artificial,O,1834
37214,eyelashes,B-PART_OF_THE_EYES,1834
37215,the,O,1834
37216,less,O,1834
37217,likely,O,1834
37218,it,O,1834
37219,is,O,1834
37220,that,O,1834
37221,you,O,1834
37222,may,O,1834
37223,hurt,O,1834
37224,your,O,1834
37225,real,O,1834
37226,ones,O,1834
37227,Pain,B-SIGN_AND_SYMPTOM,1834
37228,Contaminated,B-CAUSE_OF_DISEASE,1834
37229,fake,I-CAUSE_OF_DISEASE,1835
37230,eyelashes,I-CAUSE_OF_DISEASE,1835
37231,can,O,1835
37232,cause,O,1835
37233,a,O,1835
37234,serious,O,1835
37235,eye,O,1835
37236,infection,O,1835
37237,like,O,1835
37238,keratitis,B-NAME_OF_DISEASE,1835
37239,which,O,1835
37240,will,O,1835
37241,manifest,O,1835
37242,as,O,1835
37243,pain,B-SIGN_AND_SYMPTOM,1835
37244,and,I-SIGN_AND_SYMPTOM,1835
37245,redness,I-SIGN_AND_SYMPTOM,1835
37246,in,I-SIGN_AND_SYMPTOM,1835
37247,effected,I-SIGN_AND_SYMPTOM,1835
37248,eye,I-SIGN_AND_SYMPTOM,1835
37249,Adhesive,B-SIGN_AND_SYMPTOM,1835
37250,Allergies,I-SIGN_AND_SYMPTOM,1835
37251,Or,I-SIGN_AND_SYMPTOM,1835
37252,Burns,I-SIGN_AND_SYMPTOM,1835
37253,Skin,B-CAUSE_OF_DISEASE,1835
37254,reactions,I-CAUSE_OF_DISEASE,1835
37255,or,I-CAUSE_OF_DISEASE,1835
37256,sensitivities,I-CAUSE_OF_DISEASE,1836
37257,to,I-CAUSE_OF_DISEASE,1836
37258,the,I-CAUSE_OF_DISEASE,1836
37259,lash,I-CAUSE_OF_DISEASE,1836
37260,superglue,I-CAUSE_OF_DISEASE,1836
37261,used,I-CAUSE_OF_DISEASE,1836
37262,cause,O,1836
37263,the,O,1836
37264,majority,O,1836
37265,of,O,1836
37266,FALSE,O,1837
37267,eyelash,B-PART_OF_THE_EYES,1837
37268,issues,O,1837
37269,Chemical,B-SIGN_AND_SYMPTOM,1837
37270,burns,I-SIGN_AND_SYMPTOM,1837
37271,swollen,I-SIGN_AND_SYMPTOM,1837
37272,erythematous,I-SIGN_AND_SYMPTOM,1837
37273,skin,I-SIGN_AND_SYMPTOM,1837
37274,and,I-SIGN_AND_SYMPTOM,1837
37275,eye,I-SIGN_AND_SYMPTOM,1837
37276,complaints,I-SIGN_AND_SYMPTOM,1837
37277,were,O,1837
37278,among,O,1837
37279,the,O,1837
37280,mild,O,1837
37281,to,O,1837
37282,severe,O,1837
37283,symptoms,O,1837
37284,Eyelash,B-CAUSE_OF_DISEASE,1837
37285,glues,I-CAUSE_OF_DISEASE,1837
37286,frequently,O,1837
37287,contain,O,1837
37288,cyanoacrylates,B-CHEMICAL_COMPOUND,1837
37289,Rather,O,1837
37290,than,O,1837
37291,causing,O,1837
37292,a,B-SIGN_AND_SYMPTOM,1837
37293,chemical,I-SIGN_AND_SYMPTOM,1837
37294,burn,I-SIGN_AND_SYMPTOM,1837
37295,cyanoacrylate,B-CAUSE_OF_DISEASE,1838
37296,glue,I-CAUSE_OF_DISEASE,1838
37297,instead,O,1838
37298,causes,O,1838
37299,a,B-SIGN_AND_SYMPTOM,1838
37300,thermal,I-SIGN_AND_SYMPTOM,1838
37301,burn,I-SIGN_AND_SYMPTOM,1838
37302,Although,O,1838
37303,uncommon,O,1838
37304,these,O,1838
37305,burns,O,1838
37306,can,O,1838
37307,be,O,1838
37308,very,O,1838
37309,bad,O,1839
37310,Eyelid,B-NAME_OF_DISEASE,1839
37311,inflammation,I-NAME_OF_DISEASE,1839
37312,can,O,1839
37313,occasionally,O,1839
37314,be,O,1839
37315,misinterpreted,O,1839
37316,for,O,1839
37317,an,O,1839
37318,anaphylactic,O,1839
37319,reaction,O,1839
37320,Allergic,B-SIGN_AND_SYMPTOM,1839
37321,Reaction,I-SIGN_AND_SYMPTOM,1839
37322,The,B-CAUSE_OF_DISEASE,1840
37323,material,I-CAUSE_OF_DISEASE,1840
37324,used,I-CAUSE_OF_DISEASE,1840
37325,in,I-CAUSE_OF_DISEASE,1840
37326,manufacturing,I-CAUSE_OF_DISEASE,1840
37327,fake,I-CAUSE_OF_DISEASE,1840
37328,eyelashes,I-CAUSE_OF_DISEASE,1840
37329,or,I-CAUSE_OF_DISEASE,1840
37330,their,I-CAUSE_OF_DISEASE,1840
37331,glue,I-CAUSE_OF_DISEASE,1840
37332,can,O,1840
37333,trigger,O,1840
37334,a,O,1840
37335,host,O,1840
37336,s,O,1840
37337,immune,O,1840
37338,system,O,1840
37339,It,O,1840
37340,might,O,1840
37341,result,O,1840
37342,in,O,1840
37343,photophobia,B-NAME_OF_DISEASE,1840
37344,swelling,B-SIGN_AND_SYMPTOM,1840
37345,of,I-SIGN_AND_SYMPTOM,1840
37346,eyes,I-SIGN_AND_SYMPTOM,1841
37347,blurred,I-SIGN_AND_SYMPTOM,1841
37348,vision,I-SIGN_AND_SYMPTOM,1841
37349,discharge,I-SIGN_AND_SYMPTOM,1841
37350,from,I-SIGN_AND_SYMPTOM,1841
37351,eyes,I-SIGN_AND_SYMPTOM,1841
37352,with,I-SIGN_AND_SYMPTOM,1841
37353,mild,I-SIGN_AND_SYMPTOM,1841
37354,fever,I-SIGN_AND_SYMPTOM,1841
37355,Loss,B-SIGN_AND_SYMPTOM,1841
37356,of,I-SIGN_AND_SYMPTOM,1841
37357,Natural,I-SIGN_AND_SYMPTOM,1841
37358,Lashes,I-SIGN_AND_SYMPTOM,1841
37359,Appling,B-CAUSE_OF_DISEASE,1841
37360,and,I-CAUSE_OF_DISEASE,1841
37361,taking,I-CAUSE_OF_DISEASE,1841
37362,falsies,I-CAUSE_OF_DISEASE,1841
37363,off,I-CAUSE_OF_DISEASE,1841
37364,over,I-CAUSE_OF_DISEASE,1841
37365,and,I-CAUSE_OF_DISEASE,1841
37366,over,I-CAUSE_OF_DISEASE,1841
37367,again,I-CAUSE_OF_DISEASE,1841
37368,or,I-CAUSE_OF_DISEASE,1841
37369,incorrect,I-CAUSE_OF_DISEASE,1841
37370,use,I-CAUSE_OF_DISEASE,1841
37371,of,I-CAUSE_OF_DISEASE,1841
37372,falsies,I-CAUSE_OF_DISEASE,1841
37373,causes,O,1841
37374,loss,O,1841
37375,of,O,1841
37376,natural,B-PART_OF_THE_EYES,1841
37377,lashes,B-PART_OF_THE_EYES,1841
37378,if,O,1841
37379,used,O,1841
37380,for,O,1842
37381,a,O,1842
37382,very,O,1842
37383,long,O,1842
37384,time,O,1842
37385,Stye,B-SIGN_AND_SYMPTOM,1843
37386,It,O,1843
37387,is,O,1844
37388,a,B-SIGN_AND_SYMPTOM,1844
37389,tiny,I-SIGN_AND_SYMPTOM,1844
37390,painful,I-SIGN_AND_SYMPTOM,1844
37391,swelling,I-SIGN_AND_SYMPTOM,1844
37392,located,I-SIGN_AND_SYMPTOM,1844
37393,adjacent,I-SIGN_AND_SYMPTOM,1844
37394,to,I-SIGN_AND_SYMPTOM,1844
37395,your,I-SIGN_AND_SYMPTOM,1844
37396,lash,I-SIGN_AND_SYMPTOM,1844
37397,line,I-SIGN_AND_SYMPTOM,1844
37398,It,O,1844
37399,is,O,1844
37400,a,O,1844
37401,rare,O,1844
37402,possibility,O,1844
37403,How,O,1844
37404,to,O,1844
37405,Avoid,O,1844
37406,Eye,O,1844
37407,Problems,O,1844
37408,Associated,O,1845
37409,with,O,1845
37410,FALSE,B-CAUSE_OF_DISEASE,1845
37411,Eyelashes,I-CAUSE_OF_DISEASE,1845
37412,Eye,O,1845
37413,care,O,1845
37414,is,O,1845
37415,critical,O,1845
37416,with,O,1845
37417,the,O,1845
37418,use,O,1845
37419,of,O,1845
37420,any,O,1845
37421,cosmetic,O,1846
37422,material,O,1846
37423,Havocs,O,1846
37424,of,O,1846
37425,the,O,1846
37426,fake,O,1846
37427,lashes,O,1846
37428,can,O,1846
37429,be,O,1846
37430,prevented,O,1846
37431,by,O,1846
37432,Minimizing,B-PREVENTION,1846
37433,the,I-PREVENTION,1846
37434,quantity,I-PREVENTION,1846
37435,used,I-PREVENTION,1846
37436,of,I-PREVENTION,1846
37437,adhesive,I-PREVENTION,1846
37438,glue,I-PREVENTION,1846
37439,Removing,B-PREVENTION,1846
37440,the,I-PREVENTION,1846
37441,lashes,I-PREVENTION,1846
37442,gently,I-PREVENTION,1846
37443,Cleaning,B-PREVENTION,1846
37444,the,I-PREVENTION,1846
37445,eyelids,I-PREVENTION,1846
37446,after,I-PREVENTION,1846
37447,taking,I-PREVENTION,1846
37448,off,I-PREVENTION,1846
37449,the,I-PREVENTION,1846
37450,lashes,I-PREVENTION,1846
37451,Avoiding,B-PREVENTION,1846
37452,formaldehyde-containing,I-PREVENTION,1846
37453,glue,I-PREVENTION,1846
37454,Never,B-PREVENTION,1846
37455,exchanging,I-PREVENTION,1847
37456,lashes,I-PREVENTION,1847
37457,with,I-PREVENTION,1847
37458,anyone,I-PREVENTION,1847
37459,else,I-PREVENTION,1847
37460,Avoiding,B-PREVENTION,1847
37461,glittery,I-PREVENTION,1847
37462,or,I-PREVENTION,1847
37463,jeweled,I-PREVENTION,1847
37464,lashes,I-PREVENTION,1847
37465,Using,B-PREVENTION,1847
37466,oil-free,I-PREVENTION,1847
37467,makeup,I-PREVENTION,1847
37468,removers,I-PREVENTION,1847
37469,and,I-PREVENTION,1847
37470,cleansers,I-PREVENTION,1847
37471,Rubbing,B-PREVENTION,1847
37472,your,I-PREVENTION,1848
37473,eyes,I-PREVENTION,1848
37474,vigorously,I-PREVENTION,1848
37475,rather,I-PREVENTION,1848
37476,than,I-PREVENTION,1848
37477,playing,I-PREVENTION,1848
37478,with,I-PREVENTION,1848
37479,or,I-PREVENTION,1848
37480,picking,I-PREVENTION,1848
37481,at,I-PREVENTION,1848
37482,your,I-PREVENTION,1848
37483,eyelashes,I-PREVENTION,1848
37484,Signs,O,1849
37485,That,O,1849
37486,You,O,1849
37487,Have,O,1849
37488,an,O,1849
37489,Eye,O,1849
37490,Problem,O,1849
37491,Pain,B-SIGN_AND_SYMPTOM,1849
37492,burning,I-SIGN_AND_SYMPTOM,1849
37493,or,I-SIGN_AND_SYMPTOM,1849
37494,redness,I-SIGN_AND_SYMPTOM,1849
37495,in,I-SIGN_AND_SYMPTOM,1849
37496,your,I-SIGN_AND_SYMPTOM,1850
37497,eyes,I-SIGN_AND_SYMPTOM,1850
37498,Swelling,B-SIGN_AND_SYMPTOM,1850
37499,in,I-SIGN_AND_SYMPTOM,1850
37500,eyes,I-SIGN_AND_SYMPTOM,1850
37501,or,I-SIGN_AND_SYMPTOM,1850
37502,around,I-SIGN_AND_SYMPTOM,1850
37503,eyes,I-SIGN_AND_SYMPTOM,1850
37504,Increased,B-SIGN_AND_SYMPTOM,1850
37505,vulnerability,I-SIGN_AND_SYMPTOM,1850
37506,to,I-SIGN_AND_SYMPTOM,1850
37507,light,I-SIGN_AND_SYMPTOM,1850
37508,Discharge,B-SIGN_AND_SYMPTOM,1850
37509,from,I-SIGN_AND_SYMPTOM,1850
37510,eyes,I-SIGN_AND_SYMPTOM,1850
37511,like,I-SIGN_AND_SYMPTOM,1850
37512,purulent,I-SIGN_AND_SYMPTOM,1850
37513,clear,I-SIGN_AND_SYMPTOM,1850
37514,or,I-SIGN_AND_SYMPTOM,1850
37515,watery,I-SIGN_AND_SYMPTOM,1850
37516,Blurred,B-SIGN_AND_SYMPTOM,1850
37517,or,I-SIGN_AND_SYMPTOM,1850
37518,double,I-SIGN_AND_SYMPTOM,1850
37519,vision,I-SIGN_AND_SYMPTOM,1850
37520,Floaters,B-SIGN_AND_SYMPTOM,1850
37521,or,I-SIGN_AND_SYMPTOM,1850
37522,flashes,I-SIGN_AND_SYMPTOM,1850
37523,in,I-SIGN_AND_SYMPTOM,1850
37524,eyes,I-SIGN_AND_SYMPTOM,1850
37525,Grittiness,B-SIGN_AND_SYMPTOM,1850
37526,itching,I-SIGN_AND_SYMPTOM,1850
37527,and,I-SIGN_AND_SYMPTOM,1851
37528,irritation,I-SIGN_AND_SYMPTOM,1851
37529,in,I-SIGN_AND_SYMPTOM,1851
37530,eyes,I-SIGN_AND_SYMPTOM,1851
37531,Excessive,B-SIGN_AND_SYMPTOM,1851
37532,lacrimation,I-SIGN_AND_SYMPTOM,1851
37533,Patients,O,1851
37534,with,O,1851
37535,a,O,1851
37536,specific,O,1851
37537,type,O,1852
37538,of,O,1852
37539,age-related,B-NAME_OF_DISEASE,1852
37540,macular,I-NAME_OF_DISEASE,1852
37541,degeneration,I-NAME_OF_DISEASE,1852
37542,AMD,B-NAME_OF_DISEASE,1852
37543,are,O,1852
37544,very,O,1852
37545,likely,O,1852
37546,to,O,1852
37547,have,O,1852
37548,underlying,O,1852
37549,heart,B-SIGN_AND_SYMPTOM,1852
37550,damage,I-SIGN_AND_SYMPTOM,1852
37551,from,I-SIGN_AND_SYMPTOM,1852
37552,heart,I-SIGN_AND_SYMPTOM,1852
37553,failure,I-SIGN_AND_SYMPTOM,1852
37554,and,I-SIGN_AND_SYMPTOM,1852
37555,heart,I-SIGN_AND_SYMPTOM,1853
37556,attacks,I-SIGN_AND_SYMPTOM,1853
37557,advanced,B-NAME_OF_DISEASE,1853
37558,heart,I-NAME_OF_DISEASE,1853
37559,valve,I-NAME_OF_DISEASE,1853
37560,disease,I-NAME_OF_DISEASE,1853
37561,or,O,1853
37562,carotid,B-NAME_OF_DISEASE,1853
37563,artery,I-NAME_OF_DISEASE,1853
37564,disease,I-NAME_OF_DISEASE,1853
37565,linked,O,1853
37566,to,O,1853
37567,specific,O,1853
37568,types,O,1853
37569,of,O,1853
37570,strokes,B-NAME_OF_DISEASE,1853
37571,according,O,1853
37572,to,O,1853
37573,a,O,1853
37574,recent,O,1853
37575,study,O,1853
37576,from,O,1853
37577,the,B-ORGANIZATION,1853
37578,New,I-ORGANIZATION,1853
37579,York,I-ORGANIZATION,1853
37580,Eye,I-ORGANIZATION,1853
37581,and,I-ORGANIZATION,1854
37582,Ear,I-ORGANIZATION,1854
37583,Infirmary,I-ORGANIZATION,1854
37584,of,I-ORGANIZATION,1854
37585,Mount,I-ORGANIZATION,1854
37586,Sinai,I-ORGANIZATION,1854
37587,This,O,1854
37588,study,O,1854
37589,which,O,1854
37590,was,O,1854
37591,on,O,1854
37592,November,O,1854
37593,17,O,1854
37594,in,O,1854
37595,BMJ,B-PUBLICATION_VENUE,1854
37596,Open,I-PUBLICATION_VENUE,1854
37597,Ophthalmology,I-PUBLICATION_VENUE,1854
37598,is,O,1854
37599,the,O,1854
37600,first,O,1854
37601,to,O,1854
37602,pinpoint,O,1854
37603,the,O,1854
37604,specific,O,1854
37605,high-risk,O,1855
37606,cardiovascular,B-NAME_OF_DISEASE,1855
37607,and,I-NAME_OF_DISEASE,1855
37608,carotid,I-NAME_OF_DISEASE,1855
37609,artery,I-NAME_OF_DISEASE,1855
37610,diseases,I-NAME_OF_DISEASE,1855
37611,that,O,1855
37612,are,O,1855
37613,connected,O,1855
37614,to,O,1855
37615,the,O,1855
37616,eye,O,1855
37617,disease,O,1855
37618,The,O,1856
37619,results,O,1856
37620,may,O,1856
37621,lead,O,1856
37622,to,O,1856
37623,enhanced,O,1856
37624,screening,O,1856
37625,in,O,1856
37626,order,O,1856
37627,to,O,1856
37628,save,O,1856
37629,vision,O,1856
37630,identify,O,1856
37631,undiagnosed,O,1856
37632,heart,B-NAME_OF_DISEASE,1856
37633,disease,I-NAME_OF_DISEASE,1856
37634,and,O,1856
37635,prevent,O,1856
37636,harmful,O,1856
37637,cardiovascular,O,1856
37638,events,O,1856
37639,For,O,1856
37640,the,O,1856
37641,first,O,1856
37642,time,O,1857
37643,we,O,1857
37644,have,O,1857
37645,been,O,1857
37646,able,O,1857
37647,to,O,1857
37648,connect,O,1857
37649,these,O,1858
37650,specific,O,1858
37651,high-risk,O,1858
37652,cardiovascular,B-NAME_OF_DISEASE,1858
37653,diseases,I-NAME_OF_DISEASE,1858
37654,to,O,1858
37655,a,O,1858
37656,specific,O,1858
37657,form,O,1858
37658,of,O,1858
37659,AMD,B-NAME_OF_DISEASE,1858
37660,the,O,1858
37661,one,O,1858
37662,with,O,1858
37663,subretinal,B-SIGN_AND_SYMPTOM,1858
37664,drusenoid,I-SIGN_AND_SYMPTOM,1858
37665,deposits,I-SIGN_AND_SYMPTOM,1858
37666,SDDs,I-SIGN_AND_SYMPTOM,1858
37667,lead,O,1858
37668,author,O,1858
37669,R,O,1858
37670,Theodore,O,1858
37671,Smith,O,1858
37672,MD,O,1858
37673,PhD,O,1858
37674,Professor,O,1858
37675,of,O,1858
37676,Ophthalmology,O,1858
37677,at,O,1858
37678,the,B-ORGANIZATION,1858
37679,Icahn,I-ORGANIZATION,1858
37680,School,I-ORGANIZATION,1858
37681,of,I-ORGANIZATION,1858
37682,Medicine,I-ORGANIZATION,1858
37683,at,I-ORGANIZATION,1858
37684,Mount,I-ORGANIZATION,1858
37685,Sinai,I-ORGANIZATION,1858
37686,said,O,1858
37687,in,O,1858
37688,Mount,B-ORGANIZATION,1859
37689,Sinai,I-ORGANIZATION,1859
37690,news,I-ORGANIZATION,1859
37691,release,O,1859
37692,This,O,1859
37693,study,O,1859
37694,is,O,1859
37695,the,O,1859
37696,first,O,1859
37697,strong,O,1859
37698,link,O,1859
37699,between,O,1859
37700,the,O,1859
37701,leading,O,1859
37702,cause,O,1859
37703,of,O,1859
37704,blindness,B-NAME_OF_DISEASE,1859
37705,AMD,B-NAME_OF_DISEASE,1859
37706,and,O,1859
37707,heart,B-NAME_OF_DISEASE,1859
37708,disease,I-NAME_OF_DISEASE,1859
37709,the,O,1859
37710,leading,O,1859
37711,cause,O,1859
37712,of,O,1859
37713,death,O,1860
37714,worldwide,O,1860
37715,Furthermore,O,1860
37716,we,O,1860
37717,also,O,1860
37718,have,O,1860
37719,strong,O,1860
37720,evidence,O,1860
37721,for,O,1860
37722,what,O,1860
37723,actually,O,1860
37724,happens,O,1860
37725,the,O,1860
37726,blood,O,1860
37727,supply,O,1860
37728,to,O,1860
37729,the,O,1860
37730,eye,O,1860
37731,is,O,1860
37732,directly,O,1861
37733,diminished,O,1861
37734,by,O,1861
37735,these,O,1861
37736,diseases,O,1861
37737,either,O,1861
37738,by,O,1861
37739,heart,O,1861
37740,damage,O,1861
37741,that,O,1861
37742,diminishes,O,1861
37743,blood,O,1861
37744,supply,O,1861
37745,throughout,O,1861
37746,the,O,1861
37747,body,O,1861
37748,or,O,1861
37749,from,O,1861
37750,a,O,1861
37751,blocked,O,1861
37752,carotid,O,1862
37753,artery,O,1862
37754,that,O,1862
37755,directly,O,1862
37756,impedes,O,1862
37757,blood,O,1862
37758,flow,O,1862
37759,to,O,1862
37760,the,O,1862
37761,eye,O,1862
37762,A,B-CAUSE_OF_DISEASE,1862
37763,poor,I-CAUSE_OF_DISEASE,1862
37764,blood,I-CAUSE_OF_DISEASE,1862
37765,supply,I-CAUSE_OF_DISEASE,1862
37766,can,O,1862
37767,cause,O,1862
37768,damage,O,1862
37769,to,O,1863
37770,any,O,1863
37771,part,O,1863
37772,of,O,1863
37773,the,O,1863
37774,body,O,1863
37775,and,O,1863
37776,with,O,1863
37777,these,O,1863
37778,specific,O,1863
37779,diseases,O,1863
37780,the,B-SIGN_AND_SYMPTOM,1863
37781,destroyed,I-SIGN_AND_SYMPTOM,1863
37782,retina,I-SIGN_AND_SYMPTOM,1863
37783,and,I-SIGN_AND_SYMPTOM,1863
37784,leftover,I-SIGN_AND_SYMPTOM,1863
37785,SDDs,I-SIGN_AND_SYMPTOM,1863
37786,are,O,1863
37787,that,O,1864
37788,damage,O,1864
37789,Retinal,B-SIGN_AND_SYMPTOM,1864
37790,damage,I-SIGN_AND_SYMPTOM,1864
37791,means,O,1864
37792,vision,B-SIGN_AND_SYMPTOM,1864
37793,loss,I-SIGN_AND_SYMPTOM,1864
37794,and,O,1864
37795,can,O,1864
37796,lead,O,1864
37797,to,O,1864
37798,blindness,B-NAME_OF_DISEASE,1864
37799,One,O,1864
37800,major,O,1864
37801,form,O,1864
37802,of,O,1864
37803,early,B-NAME_OF_DISEASE,1864
37804,AMD,B-NAME_OF_DISEASE,1864
37805,consists,O,1864
37806,of,O,1865
37807,small,B-SIGN_AND_SYMPTOM,1865
37808,yellow,I-SIGN_AND_SYMPTOM,1865
37809,cholesterol,B-CHEMICAL_COMPOUND,1865
37810,deposits,I-SIGN_AND_SYMPTOM,1865
37811,called,I-SIGN_AND_SYMPTOM,1865
37812,drusen,I-SIGN_AND_SYMPTOM,1865
37813,which,O,1865
37814,form,O,1866
37815,under,O,1866
37816,a,O,1866
37817,part,O,1866
37818,of,O,1866
37819,the,B-PART_OF_THE_EYES,1866
37820,retina,I-PART_OF_THE_EYES,1866
37821,called,O,1866
37822,the,B-PART_OF_THE_EYES,1866
37823,retinal,I-PART_OF_THE_EYES,1866
37824,pigment,I-PART_OF_THE_EYES,1866
37825,epithelium,I-PART_OF_THE_EYES,1866
37826,RPE,I-PART_OF_THE_EYES,1866
37827,,O,1866
37828,They,O,1866
37829,can,O,1866
37830,deprive,O,1866
37831,the,B-PART_OF_THE_EYES,1866
37832,retina,I-PART_OF_THE_EYES,1866
37833,of,O,1866
37834,blood,O,1866
37835,and,O,1866
37836,oxygen,O,1867
37837,which,O,1867
37838,could,O,1867
37839,result,O,1867
37840,in,O,1867
37841,blindness,B-NAME_OF_DISEASE,1867
37842,The,O,1867
37843,production,O,1867
37844,of,O,1867
37845,drusen,O,1867
37846,can,O,1867
37847,be,O,1867
37848,slowed,O,1867
37849,down,O,1867
37850,with,O,1867
37851,the,O,1867
37852,right,O,1867
37853,vitamin,O,1868
37854,intake,O,1868
37855,Subretinal,B-SIGN_AND_SYMPTOM,1868
37856,drusenoid,I-SIGN_AND_SYMPTOM,1868
37857,deposits,I-SIGN_AND_SYMPTOM,1868
37858,SDDs,I-SIGN_AND_SYMPTOM,1868
37859,the,O,1868
37860,other,O,1868
37861,main,O,1868
37862,type,O,1868
37863,of,O,1868
37864,early,B-NAME_OF_DISEASE,1868
37865,AMD,B-NAME_OF_DISEASE,1868
37866,are,O,1868
37867,less,O,1868
37868,well,O,1868
37869,known,O,1868
37870,and,O,1868
37871,can,O,1869
37872,only,O,1869
37873,be,O,1869
37874,found,O,1869
37875,via,O,1869
37876,sophisticated,B-DIAGNOSTIC_TEST,1869
37877,retinal,I-DIAGNOSTIC_TEST,1869
37878,imaging,I-DIAGNOSTIC_TEST,1869
37879,These,O,1869
37880,deposits,O,1870
37881,which,O,1870
37882,accumulate,O,1870
37883,above,O,1870
37884,the,B-PART_OF_THE_EYES,1870
37885,RPE,I-PART_OF_THE_EYES,1870
37886,and,O,1870
37887,immediately,O,1870
37888,below,O,1870
37889,the,O,1870
37890,light-sensitive,O,1870
37891,retinal,B-PART_OF_THE_EYES,1871
37892,cells,I-PART_OF_THE_EYES,1871
37893,are,O,1871
37894,made,O,1871
37895,up,O,1871
37896,of,O,1871
37897,a,O,1871
37898,distinct,O,1871
37899,type,O,1871
37900,of,O,1872
37901,cholesterol,B-CHEMICAL_COMPOUND,1872
37902,and,O,1872
37903,are,O,1872
37904,where,O,1872
37905,the,O,1872
37906,damage,O,1872
37907,and,O,1872
37908,loss,B-SIGN_AND_SYMPTOM,1872
37909,of,I-SIGN_AND_SYMPTOM,1872
37910,vision,I-SIGN_AND_SYMPTOM,1872
37911,take,O,1872
37912,place,O,1872
37913,SDDs,B-SIGN_AND_SYMPTOM,1873
37914,have,O,1873
37915,no,O,1873
37916,known,O,1873
37917,treatments,O,1873
37918,Initially,O,1873
37919,Dr,O,1873
37920,Smith,O,1873
37921,and,O,1873
37922,a,O,1873
37923,group,O,1873
37924,of,O,1873
37925,Mount,B-ORGANIZATION,1873
37926,Sinai,I-ORGANIZATION,1873
37927,researchers,O,1873
37928,discovered,O,1873
37929,that,O,1873
37930,SDDs,B-SIGN_AND_SYMPTOM,1873
37931,were,O,1873
37932,more,O,1873
37933,prevalent,O,1873
37934,in,O,1873
37935,people,O,1873
37936,with,O,1874
37937,cardiovascular,B-NAME_OF_DISEASE,1874
37938,illness,I-NAME_OF_DISEASE,1874
37939,or,O,1874
37940,stroke,B-NAME_OF_DISEASE,1874
37941,The,O,1874
37942,results,O,1874
37943,of,O,1874
37944,the,O,1874
37945,groundbreaking,O,1874
37946,study,O,1874
37947,were,O,1874
37948,published,O,1874
37949,in,O,1874
37950,Retina,B-PUBLICATION_VENUE,1874
37951,s,I-PUBLICATION_VENUE,1874
37952,July,I-PUBLICATION_VENUE,1874
37953,edition,I-PUBLICATION_VENUE,1874
37954,By,O,1874
37955,examining,O,1874
37956,a,O,1874
37957,broader,O,1874
37958,patient,O,1874
37959,population,O,1875
37960,and,O,1875
37961,building,O,1875
37962,on,O,1875
37963,the,O,1876
37964,earlier,O,1876
37965,research,O,1876
37966,this,O,1876
37967,current,O,1876
37968,study,O,1876
37969,pinpoints,O,1876
37970,the,O,1876
37971,precise,O,1876
37972,severe,O,1876
37973,forms,O,1876
37974,of,O,1876
37975,carotid,B-NAME_OF_DISEASE,1876
37976,artery,I-NAME_OF_DISEASE,1876
37977,disease,I-NAME_OF_DISEASE,1876
37978,and,O,1876
37979,heart,B-NAME_OF_DISEASE,1876
37980,disease,I-NAME_OF_DISEASE,1876
37981,that,O,1876
37982,resulted,O,1876
37983,in,O,1876
37984,the,B-SIGN_AND_SYMPTOM,1876
37985,SDDs,I-SIGN_AND_SYMPTOM,1876
37986,of,O,1876
37987,AMD,B-NAME_OF_DISEASE,1876
37988,Researchers,O,1876
37989,analyzed,O,1876
37990,the,O,1876
37991,eyes,O,1876
37992,of,O,1876
37993,200,O,1876
37994,AMD,B-NAME_OF_DISEASE,1877
37995,patients,O,1877
37996,with,O,1877
37997,retinal,B-DIAGNOSTIC_TEST,1877
37998,imaging,I-DIAGNOSTIC_TEST,1877
37999,to,O,1878
38000,determine,O,1878
38001,which,O,1879
38002,patients,O,1879
38003,had,O,1879
38004,SDDs,B-SIGN_AND_SYMPTOM,1879
38005,Patients,O,1879
38006,provided,O,1879
38007,information,O,1879
38008,on,O,1879
38009,their,O,1879
38010,history,O,1879
38011,of,O,1879
38012,cardiovascular,B-NAME_OF_DISEASE,1879
38013,illness,I-NAME_OF_DISEASE,1879
38014,in,O,1879
38015,a,O,1879
38016,questionnaire,O,1879
38017,97,O,1879
38018,of,O,1879
38019,the,O,1879
38020,200,O,1880
38021,patients,O,1880
38022,had,O,1880
38023,SDDs,B-SIGN_AND_SYMPTOM,1881
38024,while,O,1881
38025,103,O,1881
38026,just,O,1881
38027,had,O,1881
38028,drusen,B-SIGN_AND_SYMPTOM,1881
38029,Of,O,1881
38030,the,O,1881
38031,200,O,1881
38032,47,O,1882
38033,had,O,1882
38034,significant,O,1882
38035,cardiac,B-NAME_OF_DISEASE,1882
38036,disease,I-NAME_OF_DISEASE,1882
38037,19,O,1882
38038,had,O,1882
38039,heart,B-SIGN_AND_SYMPTOM,1882
38040,damage,I-SIGN_AND_SYMPTOM,1882
38041,from,I-SIGN_AND_SYMPTOM,1882
38042,heart,I-SIGN_AND_SYMPTOM,1882
38043,failure,I-SIGN_AND_SYMPTOM,1882
38044,or,I-SIGN_AND_SYMPTOM,1882
38045,heart,I-SIGN_AND_SYMPTOM,1882
38046,attack,I-SIGN_AND_SYMPTOM,1882
38047,17,O,1882
38048,serious,O,1882
38049,valve,B-NAME_OF_DISEASE,1882
38050,disease,I-NAME_OF_DISEASE,1882
38051,and,O,1882
38052,11,O,1882
38053,stroke,B-NAME_OF_DISEASE,1882
38054,stemming,O,1883
38055,from,O,1883
38056,the,B-NAME_OF_DISEASE,1883
38057,carotid,I-NAME_OF_DISEASE,1883
38058,artery,I-NAME_OF_DISEASE,1883
38059,,O,1883
38060,86,O,1883
38061,percent,O,1884
38062,or,O,1884
38063,40,O,1884
38064,out,O,1884
38065,of,O,1884
38066,the,O,1884
38067,47,O,1884
38068,had,O,1884
38069,SDDs,B-SIGN_AND_SYMPTOM,1884
38070,The,O,1884
38071,153,O,1884
38072,AMD,B-NAME_OF_DISEASE,1884
38073,patients,O,1884
38074,who,O,1884
38075,did,O,1884
38076,not,O,1884
38077,have,O,1884
38078,these,O,1884
38079,serious,O,1884
38080,illnesses,O,1884
38081,however,O,1884
38082,had,O,1884
38083,57,O,1884
38084,SDDs,B-SIGN_AND_SYMPTOM,1884
38085,43,O,1884
38086,percent,O,1885
38087,,O,1885
38088,The,O,1885
38089,researchers,O,1885
38090,came,O,1885
38091,to,O,1885
38092,the,O,1885
38093,conclusion,O,1885
38094,that,O,1885
38095,AMD,B-NAME_OF_DISEASE,1885
38096,patients,O,1885
38097,were,O,1885
38098,nine,O,1885
38099,times,O,1885
38100,more,O,1885
38101,likely,O,1885
38102,to,O,1886
38103,suffer,O,1886
38104,SDDs,B-SIGN_AND_SYMPTOM,1886
38105,than,O,1886
38106,patients,O,1886
38107,without,O,1886
38108,these,O,1886
38109,severe,O,1886
38110,cardiovascular,B-NAME_OF_DISEASE,1886
38111,illnesses,I-NAME_OF_DISEASE,1886
38112,and,O,1886
38113,strokes,B-NAME_OF_DISEASE,1886
38114,This,O,1886
38115,work,O,1886
38116,demonstrates,O,1887
38117,the,O,1887
38118,fact,O,1887
38119,that,O,1888
38120,ophthalmologists,O,1888
38121,may,O,1888
38122,be,O,1888
38123,the,O,1888
38124,first,O,1888
38125,physicians,O,1888
38126,to,O,1888
38127,detect,O,1888
38128,systemic,O,1888
38129,disease,O,1888
38130,especially,O,1888
38131,in,O,1888
38132,asymptomatic,O,1888
38133,patients,O,1889
38134,says,O,1889
38135,co-investigator,O,1889
38136,Richard,O,1889
38137,B,O,1889
38138,Rosen,O,1889
38139,MD,O,1889
38140,Chief,O,1889
38141,of,O,1889
38142,the,B-ORGANIZATION,1889
38143,Retina,I-ORGANIZATION,1889
38144,Service,I-ORGANIZATION,1889
38145,for,I-ORGANIZATION,1889
38146,the,I-ORGANIZATION,1889
38147,Mount,I-ORGANIZATION,1889
38148,Sinai,I-ORGANIZATION,1889
38149,Health,I-ORGANIZATION,1889
38150,System,I-ORGANIZATION,1889
38151,Detecting,O,1889
38152,SDDs,B-SIGN_AND_SYMPTOM,1889
38153,in,O,1889
38154,the,B-PART_OF_THE_EYES,1889
38155,retina,I-PART_OF_THE_EYES,1889
38156,should,O,1889
38157,trigger,O,1889
38158,a,O,1889
38159,referral,O,1889
38160,to,O,1889
38161,the,O,1889
38162,individual,O,1889
38163,s,O,1889
38164,primary,O,1889
38165,care,O,1889
38166,provider,O,1890
38167,especially,O,1890
38168,if,O,1890
38169,no,O,1890
38170,previous,O,1890
38171,cardiologist,O,1890
38172,has,O,1890
38173,been,O,1890
38174,involved,O,1890
38175,It,O,1890
38176,could,O,1890
38177,prevent,O,1890
38178,a,O,1890
38179,life-threatening,O,1890
38180,cardiac,O,1890
38181,event,O,1890
38182,The,O,1890
38183,next,O,1890
38184,step,O,1890
38185,for,O,1890
38186,researchers,O,1890
38187,is,O,1891
38188,to,O,1891
38189,concentrate,O,1891
38190,on,O,1891
38191,patients,O,1891
38192,in,O,1891
38193,cardiology,O,1891
38194,and,O,1891
38195,neurology,O,1891
38196,clinics,O,1891
38197,in,O,1891
38198,order,O,1891
38199,to,O,1891
38200,further,O,1891
38201,examine,O,1891
38202,various,O,1891
38203,degrees,O,1891
38204,of,O,1891
38205,cardiovascular,B-NAME_OF_DISEASE,1891
38206,and,I-NAME_OF_DISEASE,1891
38207,carotid,I-NAME_OF_DISEASE,1891
38208,disease,I-NAME_OF_DISEASE,1891
38209,and,O,1891
38210,assess,O,1891
38211,that,O,1891
38212,potential,O,1891
38213,relationship,O,1891
38214,between,O,1891
38215,disease,O,1891
38216,severity,O,1892
38217,to,O,1892
38218,AMD,B-NAME_OF_DISEASE,1892
38219,with,O,1892
38220,SDD,B-SIGN_AND_SYMPTOM,1892
38221,This,O,1892
38222,condition,O,1892
38223,which,O,1892
38224,your,O,1892
38225,doctor,O,1892
38226,will,O,1892
38227,refer,O,1892
38228,to,O,1892
38229,as,O,1892
38230,nyctalopia,B-NAME_OF_DISEASE,1892
38231,will,O,1892
38232,cause,O,1892
38233,you,O,1892
38234,to,O,1892
38235,have,B-SIGN_AND_SYMPTOM,1893
38236,trouble,I-SIGN_AND_SYMPTOM,1893
38237,seeing,I-SIGN_AND_SYMPTOM,1893
38238,well,I-SIGN_AND_SYMPTOM,1893
38239,in,I-SIGN_AND_SYMPTOM,1893
38240,the,I-SIGN_AND_SYMPTOM,1893
38241,dark,I-SIGN_AND_SYMPTOM,1893
38242,or,I-SIGN_AND_SYMPTOM,1893
38243,in,I-SIGN_AND_SYMPTOM,1893
38244,poor,I-SIGN_AND_SYMPTOM,1893
38245,lighting,I-SIGN_AND_SYMPTOM,1893
38246,It,O,1893
38247,s,O,1894
38248,not,O,1894
38249,considered,O,1894
38250,as,O,1894
38251,a,O,1894
38252,disease,O,1894
38253,but,O,1894
38254,rather,O,1894
38255,a,O,1894
38256,symptom,O,1894
38257,of,O,1894
38258,underlying,O,1894
38259,eye,O,1894
38260,problems,O,1894
38261,more,O,1894
38262,specifically,O,1894
38263,retinal,O,1894
38264,issues,O,1894
38265,What,O,1894
38266,are,O,1895
38267,the,O,1895
38268,symptoms,O,1895
38269,of,O,1895
38270,night,B-NAME_OF_DISEASE,1895
38271,blindness,I-NAME_OF_DISEASE,1895
38272,The,O,1895
38273,most,O,1895
38274,common,O,1895
38275,symptom,O,1895
38276,is,O,1895
38277,having,B-SIGN_AND_SYMPTOM,1895
38278,a,I-SIGN_AND_SYMPTOM,1895
38279,blurry,I-SIGN_AND_SYMPTOM,1895
38280,sight,I-SIGN_AND_SYMPTOM,1895
38281,when,I-SIGN_AND_SYMPTOM,1896
38282,driving,I-SIGN_AND_SYMPTOM,1896
38283,at,I-SIGN_AND_SYMPTOM,1896
38284,night,I-SIGN_AND_SYMPTOM,1896
38285,People,O,1896
38286,with,O,1896
38287,night,B-NAME_OF_DISEASE,1896
38288,blindness,I-NAME_OF_DISEASE,1896
38289,find,O,1896
38290,it,O,1897
38291,difficult,B-SIGN_AND_SYMPTOM,1897
38292,to,I-SIGN_AND_SYMPTOM,1897
38293,see,I-SIGN_AND_SYMPTOM,1897
38294,the,I-SIGN_AND_SYMPTOM,1897
38295,stars,I-SIGN_AND_SYMPTOM,1897
38296,in,I-SIGN_AND_SYMPTOM,1897
38297,a,I-SIGN_AND_SYMPTOM,1897
38298,clear,I-SIGN_AND_SYMPTOM,1897
38299,sky,I-SIGN_AND_SYMPTOM,1897
38300,at,I-SIGN_AND_SYMPTOM,1897
38301,night,I-SIGN_AND_SYMPTOM,1897
38302,Entering,O,1897
38303,a,O,1897
38304,dark,O,1897
38305,room,O,1897
38306,is,O,1897
38307,also,O,1897
38308,very,O,1897
38309,problematic,O,1897
38310,for,O,1898
38311,them,O,1898
38312,especially,O,1898
38313,if,O,1898
38314,they,O,1898
38315,walked,O,1898
38316,into,O,1898
38317,a,O,1898
38318,dark,O,1898
38319,place,O,1898
38320,right,O,1898
38321,after,O,1898
38322,being,O,1898
38323,in,O,1898
38324,a,O,1898
38325,bright,O,1898
38326,environment,O,1898
38327,What,O,1899
38328,causes,O,1899
38329,night,B-NAME_OF_DISEASE,1899
38330,blindness,I-NAME_OF_DISEASE,1899
38331,Usually,O,1899
38332,the,O,1899
38333,underlying,O,1899
38334,cause,O,1899
38335,is,O,1899
38336,a,B-CAUSE_OF_DISEASE,1899
38337,retinal,I-CAUSE_OF_DISEASE,1899
38338,problem,I-CAUSE_OF_DISEASE,1899
38339,Some,O,1899
38340,of,O,1899
38341,the,O,1899
38342,other,O,1899
38343,causes,O,1899
38344,are,O,1899
38345,listed,O,1900
38346,below,O,1900
38347,Nearsightedness,B-CAUSE_OF_DISEASE,1900
38348,Glaucoma,B-CAUSE_OF_DISEASE,1900
38349,Cataracts,B-CAUSE_OF_DISEASE,1900
38350,Retinitis,B-CAUSE_OF_DISEASE,1900
38351,pigmentosa,I-CAUSE_OF_DISEASE,1900
38352,Keratoconus,B-CAUSE_OF_DISEASE,1900
38353,Diabetes,B-CAUSE_OF_DISEASE,1900
38354,Vitamin,B-CAUSE_OF_DISEASE,1900
38355,A,I-CAUSE_OF_DISEASE,1900
38356,deficiency,I-CAUSE_OF_DISEASE,1900
38357,Book,O,1900
38358,an,O,1900
38359,appointment,O,1900
38360,with,O,1900
38361,your,O,1900
38362,eye,O,1900
38363,doctor,O,1900
38364,to,O,1900
38365,pinpoint,O,1900
38366,the,O,1900
38367,underlying,O,1900
38368,cause,O,1900
38369,Can,O,1900
38370,Night,B-NAME_OF_DISEASE,1900
38371,Blindness,I-NAME_OF_DISEASE,1900
38372,be,O,1900
38373,cured,O,1900
38374,Depending,O,1900
38375,on,O,1901
38376,the,O,1901
38377,underlying,O,1901
38378,cause,O,1901
38379,of,O,1901
38380,night,B-NAME_OF_DISEASE,1901
38381,blindness,I-NAME_OF_DISEASE,1901
38382,it,O,1901
38383,can,O,1901
38384,be,O,1901
38385,curable,O,1901
38386,If,O,1901
38387,the,O,1901
38388,underlying,O,1901
38389,cause,O,1901
38390,is,O,1901
38391,nearsightedness,B-CAUSE_OF_DISEASE,1901
38392,vitamin,B-CAUSE_OF_DISEASE,1901
38393,A,I-CAUSE_OF_DISEASE,1902
38394,deficiency,I-CAUSE_OF_DISEASE,1902
38395,refractive,B-CAUSE_OF_DISEASE,1902
38396,surgery,I-CAUSE_OF_DISEASE,1902
38397,and,O,1902
38398,cataracts,B-CAUSE_OF_DISEASE,1902
38399,then,O,1902
38400,it,O,1902
38401,s,O,1902
38402,all,O,1902
38403,treatable,O,1902
38404,You,O,1902
38405,can,O,1902
38406,have,O,1902
38407,a,O,1902
38408,normal,O,1902
38409,level,O,1902
38410,of,O,1902
38411,vision,O,1902
38412,again,O,1903
38413,Causes,O,1903
38414,like,O,1903
38415,progressive,B-CAUSE_OF_DISEASE,1903
38416,conditions,I-CAUSE_OF_DISEASE,1903
38417,and,I-CAUSE_OF_DISEASE,1903
38418,genetic,I-CAUSE_OF_DISEASE,1903
38419,disorders,I-CAUSE_OF_DISEASE,1903
38420,may,O,1903
38421,sometimes,O,1903
38422,be,O,1903
38423,manageable,O,1903
38424,However,O,1903
38425,the,O,1903
38426,patient,O,1903
38427,doesn,O,1903
38428,t,O,1904
38429,have,O,1904
38430,a,O,1904
38431,full,O,1904
38432,recovery,O,1904
38433,How,O,1904
38434,can,O,1904
38435,I,O,1904
38436,cure,O,1904
38437,night,B-NAME_OF_DISEASE,1904
38438,blindness,I-NAME_OF_DISEASE,1904
38439,naturally,O,1904
38440,Having,B-TREATMENT,1904
38441,a,I-TREATMENT,1904
38442,healthy,I-TREATMENT,1904
38443,diet,I-TREATMENT,1904
38444,is,O,1904
38445,important,O,1904
38446,Consuming,B-TREATMENT,1904
38447,foods,I-TREATMENT,1904
38448,rich,I-TREATMENT,1904
38449,in,I-TREATMENT,1904
38450,Vitamin,B-TREATMENT,1904
38451,A,I-TREATMENT,1904
38452,can,O,1904
38453,help,O,1904
38454,your,O,1904
38455,night,O,1904
38456,vision,O,1904
38457,and,O,1905
38458,protect,O,1905
38459,your,O,1905
38460,eyes,O,1905
38461,from,O,1905
38462,forming,O,1905
38463,cataracts,B-CAUSE_OF_DISEASE,1905
38464,which,O,1905
38465,leads,O,1905
38466,to,O,1905
38467,night,B-NAME_OF_DISEASE,1905
38468,blindness,I-NAME_OF_DISEASE,1905
38469,Some,O,1905
38470,of,O,1906
38471,the,O,1906
38472,foods,O,1906
38473,rich,O,1906
38474,in,O,1906
38475,vitamin,O,1906
38476,A,O,1906
38477,are,O,1906
38478,as,O,1906
38479,follows,O,1906
38480,dark,O,1906
38481,green,O,1906
38482,and,O,1906
38483,leafy,O,1906
38484,vegetables,O,1906
38485,carrots,O,1906
38486,potatoes,O,1907
38487,dairy,O,1907
38488,products,O,1907
38489,broccoli,O,1907
38490,and,O,1907
38491,fish,O,1907
38492,Do,B-TREATMENT,1907
38493,eye,I-TREATMENT,1907
38494,exercises,I-TREATMENT,1908
38495,regularly,I-TREATMENT,1908
38496,When,B-TREATMENT,1908
38497,you,I-TREATMENT,1908
38498,wake,I-TREATMENT,1908
38499,up,I-TREATMENT,1908
38500,in,I-TREATMENT,1908
38501,the,I-TREATMENT,1908
38502,morning,I-TREATMENT,1908
38503,and,I-TREATMENT,1908
38504,before,I-TREATMENT,1908
38505,you,I-TREATMENT,1908
38506,go,I-TREATMENT,1908
38507,to,I-TREATMENT,1908
38508,bed,I-TREATMENT,1908
38509,and,I-TREATMENT,1908
38510,whenever,I-TREATMENT,1909
38511,your,I-TREATMENT,1909
38512,eyes,I-TREATMENT,1909
38513,feel,I-TREATMENT,1909
38514,tired,I-TREATMENT,1909
38515,doing,I-TREATMENT,1909
38516,eye,I-TREATMENT,1909
38517,exercises,I-TREATMENT,1909
38518,can,O,1909
38519,improve,O,1909
38520,your,O,1909
38521,vision,O,1909
38522,and,O,1909
38523,strengthen,O,1909
38524,your,O,1909
38525,eye,O,1909
38526,muscles,O,1909
38527,Rest,B-TREATMENT,1909
38528,your,I-TREATMENT,1910
38529,eyes,I-TREATMENT,1910
38530,when,I-TREATMENT,1910
38531,needed,I-TREATMENT,1910
38532,Avoid,B-TREATMENT,1910
38533,smoking,I-TREATMENT,1910
38534,Nicotine,B-CHEMICAL_COMPOUND,1910
38535,prevents,O,1910
38536,the,O,1910
38537,production,O,1910
38538,of,O,1910
38539,rhodopsin,B-CHEMICAL_COMPOUND,1910
38540,in,O,1910
38541,the,O,1910
38542,eyes,O,1910
38543,which,O,1910
38544,is,O,1910
38545,the,O,1910
38546,pigment,O,1910
38547,that,O,1911
38548,is,O,1911
38549,responsible,O,1911
38550,for,O,1911
38551,night,O,1911
38552,vision,O,1911
38553,Protect,B-TREATMENT,1911
38554,your,I-TREATMENT,1911
38555,eyes,I-TREATMENT,1911
38556,Avoid,B-TREATMENT,1911
38557,being,I-TREATMENT,1911
38558,exposed,I-TREATMENT,1911
38559,to,I-TREATMENT,1911
38560,bright,I-TREATMENT,1911
38561,sunlight,I-TREATMENT,1911
38562,without,I-TREATMENT,1911
38563,any,I-TREATMENT,1911
38564,protection,I-TREATMENT,1911
38565,The,O,1911
38566,more,O,1911
38567,you,O,1912
38568,push,O,1912
38569,your,O,1912
38570,eyes,O,1912
38571,to,O,1912
38572,adjust,O,1912
38573,to,O,1912
38574,sunlight,O,1912
38575,the,O,1912
38576,harder,O,1912
38577,it,O,1913
38578,will,O,1913
38579,be,O,1913
38580,for,O,1913
38581,them,O,1913
38582,to,O,1913
38583,adjust,O,1913
38584,to,O,1913
38585,the,O,1913
38586,dark,O,1913
38587,Always,B-TREATMENT,1913
38588,wear,I-TREATMENT,1913
38589,sunglasses,I-TREATMENT,1913
38590,when,I-TREATMENT,1913
38591,you,I-TREATMENT,1913
38592,are,I-TREATMENT,1913
38593,outside,I-TREATMENT,1913
38594,What,O,1913
38595,Vitamin,B-TREATMENT,1913
38596,treats,O,1913
38597,night,B-NAME_OF_DISEASE,1914
38598,blindness,I-NAME_OF_DISEASE,1914
38599,Apart,O,1914
38600,from,O,1914
38601,Vitamin,B-TREATMENT,1914
38602,A,I-TREATMENT,1914
38603,Vitamin,B-TREATMENT,1914
38604,E,I-TREATMENT,1914
38605,and,I-TREATMENT,1914
38606,C,I-TREATMENT,1914
38607,B6,I-TREATMENT,1914
38608,B9,I-TREATMENT,1914
38609,and,I-TREATMENT,1914
38610,B12,I-TREATMENT,1914
38611,Riboflavin,I-TREATMENT,1914
38612,Omega-3,I-TREATMENT,1914
38613,and,I-TREATMENT,1914
38614,Niacin,I-TREATMENT,1914
38615,help,O,1914
38616,with,O,1914
38617,night,B-NAME_OF_DISEASE,1914
38618,blindness,I-NAME_OF_DISEASE,1914
38619,How,O,1914
38620,Long,O,1914
38621,Does,O,1915
38622,Night,B-NAME_OF_DISEASE,1915
38623,Blindness,I-NAME_OF_DISEASE,1915
38624,last,O,1915
38625,There,O,1915
38626,s,O,1915
38627,no,O,1915
38628,certain,O,1915
38629,period,O,1915
38630,until,O,1915
38631,night,B-NAME_OF_DISEASE,1915
38632,blindness,I-NAME_OF_DISEASE,1915
38633,is,O,1915
38634,cured,O,1916
38635,Proper,O,1916
38636,treatment,O,1916
38637,should,O,1916
38638,be,O,1916
38639,performed,O,1916
38640,in,O,1916
38641,line,O,1916
38642,with,O,1916
38643,the,O,1916
38644,underlying,O,1916
38645,cause,O,1916
38646,of,O,1916
38647,night,B-NAME_OF_DISEASE,1916
38648,blindness,I-NAME_OF_DISEASE,1916
38649,The,O,1916
38650,results,O,1916
38651,vary,O,1916
38652,Does,O,1916
38653,night,O,1916
38654,vision,O,1916
38655,decline,O,1916
38656,with,O,1916
38657,age,O,1917
38658,Unfortunately,O,1917
38659,our,O,1917
38660,night,O,1917
38661,vision,O,1917
38662,deteriorates,O,1917
38663,as,O,1917
38664,we,O,1917
38665,age,O,1917
38666,While,O,1917
38667,there,O,1917
38668,are,O,1917
38669,many,O,1917
38670,conditions,O,1917
38671,that,O,1917
38672,worsen,O,1917
38673,our,O,1917
38674,ability,O,1917
38675,to,O,1917
38676,see,O,1917
38677,well,O,1917
38678,at,O,1917
38679,night,O,1917
38680,including,O,1917
38681,smoking,B-CAUSE_OF_DISEASE,1917
38682,sunlight,B-CAUSE_OF_DISEASE,1917
38683,and,I-CAUSE_OF_DISEASE,1917
38684,screen,I-CAUSE_OF_DISEASE,1917
38685,time,I-CAUSE_OF_DISEASE,1917
38686,there,O,1917
38687,are,O,1918
38688,also,O,1918
38689,things,O,1918
38690,that,O,1918
38691,can,O,1918
38692,be,O,1918
38693,done,O,1918
38694,to,O,1918
38695,improve,O,1918
38696,our,O,1918
38697,night,O,1918
38698,vision,O,1918
38699,Can,O,1918
38700,night-blind,O,1918
38701,people,O,1918
38702,see,O,1918
38703,in,O,1918
38704,light,O,1918
38705,People,O,1918
38706,with,O,1918
38707,night,B-NAME_OF_DISEASE,1918
38708,blindness,I-NAME_OF_DISEASE,1918
38709,have,B-SIGN_AND_SYMPTOM,1918
38710,trouble,I-SIGN_AND_SYMPTOM,1918
38711,seeing,I-SIGN_AND_SYMPTOM,1918
38712,both,I-SIGN_AND_SYMPTOM,1918
38713,in,I-SIGN_AND_SYMPTOM,1918
38714,dark,I-SIGN_AND_SYMPTOM,1918
38715,and,I-SIGN_AND_SYMPTOM,1918
38716,in,I-SIGN_AND_SYMPTOM,1918
38717,very,I-SIGN_AND_SYMPTOM,1918
38718,bright,I-SIGN_AND_SYMPTOM,1918
38719,environments,I-SIGN_AND_SYMPTOM,1919
38720,One,O,1919
38721,of,O,1919
38722,the,O,1919
38723,reasons,O,1919
38724,for,O,1919
38725,that,O,1919
38726,is,O,1919
38727,the,B-CAUSE_OF_DISEASE,1919
38728,structural,I-CAUSE_OF_DISEASE,1919
38729,weakening,I-CAUSE_OF_DISEASE,1919
38730,of,I-CAUSE_OF_DISEASE,1919
38731,the,I-CAUSE_OF_DISEASE,1919
38732,retina,I-CAUSE_OF_DISEASE,1919
38733,s,I-CAUSE_OF_DISEASE,1919
38734,cells,I-CAUSE_OF_DISEASE,1920
38735,that,I-CAUSE_OF_DISEASE,1920
38736,perform,I-CAUSE_OF_DISEASE,1920
38737,the,I-CAUSE_OF_DISEASE,1920
38738,light-sensing,I-CAUSE_OF_DISEASE,1920
38739,task,I-CAUSE_OF_DISEASE,1920
38740,and,O,1920
38741,result,O,1920
38742,in,O,1920
38743,an,B-SIGN_AND_SYMPTOM,1920
38744,inability,I-SIGN_AND_SYMPTOM,1920
38745,to,I-SIGN_AND_SYMPTOM,1920
38746,perceive,I-SIGN_AND_SYMPTOM,1920
38747,bright,I-SIGN_AND_SYMPTOM,1920
38748,light,I-SIGN_AND_SYMPTOM,1920
38749,What,O,1920
38750,is,O,1920
38751,cornea,B-PART_OF_THE_EYES,1920
38752,The,B-PART_OF_THE_EYES,1921
38753,cornea,I-PART_OF_THE_EYES,1921
38754,is,O,1921
38755,the,O,1921
38756,transparent,O,1921
38757,part,O,1921
38758,that,O,1921
38759,is,O,1921
38760,located,O,1921
38761,on,O,1922
38762,the,O,1922
38763,front,O,1922
38764,side,O,1922
38765,of,O,1922
38766,the,O,1922
38767,eye,O,1922
38768,It,O,1922
38769,can,O,1922
38770,be,O,1922
38771,said,O,1922
38772,that,O,1922
38773,the,B-PART_OF_THE_EYES,1922
38774,cornea,I-PART_OF_THE_EYES,1922
38775,acts,O,1922
38776,like,O,1922
38777,a,O,1922
38778,magnifying,O,1922
38779,glass,O,1922
38780,It,O,1922
38781,controls,O,1922
38782,the,O,1922
38783,amount,O,1922
38784,of,O,1922
38785,light,O,1923
38786,coming,O,1923
38787,to,O,1923
38788,our,O,1923
38789,eyes,O,1923
38790,and,O,1923
38791,helps,O,1923
38792,our,O,1923
38793,eyes,O,1923
38794,to,O,1923
38795,focus,O,1923
38796,on,O,1923
38797,the,O,1923
38798,objects,O,1923
38799,These,O,1923
38800,functions,O,1923
38801,aside,O,1923
38802,it,O,1923
38803,also,O,1923
38804,protects,O,1923
38805,our,O,1923
38806,eyes,O,1923
38807,from,O,1924
38808,harmful,O,1924
38809,particles,O,1924
38810,like,O,1924
38811,dust,O,1924
38812,and,O,1924
38813,germs,O,1924
38814,Corneas,B-PART_OF_THE_EYES,1924
38815,five,O,1924
38816,layers,O,1924
38817,are,O,1924
38818,made,O,1924
38819,of,O,1924
38820,cells,O,1924
38821,and,O,1925
38822,proteins,B-CHEMICAL_COMPOUND,1925
38823,Unlike,O,1925
38824,the,O,1925
38825,other,O,1925
38826,tissues,O,1925
38827,existing,O,1925
38828,in,O,1925
38829,the,O,1925
38830,body,O,1925
38831,interestingly,O,1925
38832,the,B-PART_OF_THE_EYES,1925
38833,cornea,I-PART_OF_THE_EYES,1925
38834,doesn,O,1925
38835,t,O,1925
38836,contain,O,1925
38837,any,O,1925
38838,blood,O,1925
38839,vessels,O,1925
38840,to,O,1925
38841,nourish,O,1926
38842,it,O,1926
38843,It,O,1926
38844,s,O,1926
38845,because,O,1926
38846,the,B-PART_OF_THE_EYES,1926
38847,cornea,I-PART_OF_THE_EYES,1926
38848,needs,O,1926
38849,to,O,1926
38850,be,O,1926
38851,clear,O,1926
38852,so,O,1927
38853,that,O,1927
38854,the,O,1927
38855,light,O,1927
38856,source,O,1927
38857,enters,O,1927
38858,the,O,1927
38859,eye,O,1927
38860,Instead,O,1927
38861,of,O,1927
38862,blood,O,1927
38863,vessels,O,1927
38864,the,O,1927
38865,fluid,O,1927
38866,produced,O,1927
38867,by,O,1927
38868,the,O,1927
38869,eyes,O,1927
38870,like,O,1928
38871,tears,O,1928
38872,and,O,1928
38873,aqueous,O,1928
38874,humor,O,1928
38875,nourishes,O,1928
38876,the,O,1928
38877,eyes,O,1928
38878,What,O,1928
38879,is,O,1928
38880,the,O,1928
38881,function,O,1928
38882,of,O,1929
38883,the,B-PART_OF_THE_EYES,1929
38884,cornea,I-PART_OF_THE_EYES,1929
38885,The,O,1929
38886,main,O,1929
38887,function,O,1929
38888,of,O,1929
38889,the,B-PART_OF_THE_EYES,1929
38890,cornea,I-PART_OF_THE_EYES,1929
38891,is,O,1929
38892,to,O,1929
38893,refract,O,1929
38894,and,O,1929
38895,bend,O,1930
38896,the,O,1930
38897,light,O,1930
38898,for,O,1930
38899,the,O,1930
38900,eyes,O,1930
38901,to,O,1930
38902,be,O,1930
38903,able,O,1930
38904,to,O,1930
38905,focus,O,1930
38906,on,O,1930
38907,items,O,1930
38908,The,O,1930
38909,majority,O,1930
38910,of,O,1930
38911,our,O,1930
38912,focusing,O,1930
38913,ability,O,1931
38914,is,O,1931
38915,thanks,O,1931
38916,to,O,1931
38917,our,O,1931
38918,cornea,B-PART_OF_THE_EYES,1931
38919,the,O,1931
38920,remaining,O,1931
38921,is,O,1931
38922,due,O,1931
38923,to,O,1931
38924,the,B-PART_OF_THE_EYES,1931
38925,lens,B-PART_OF_THE_EYES,1931
38926,Our,O,1931
38927,corneal,B-PART_OF_THE_EYES,1931
38928,epithelium,I-PART_OF_THE_EYES,1931
38929,helps,O,1931
38930,tears,O,1931
38931,to,O,1931
38932,spread,O,1932
38933,across,O,1932
38934,our,O,1932
38935,cornea,B-PART_OF_THE_EYES,1932
38936,and,O,1932
38937,keeps,O,1932
38938,it,O,1932
38939,moist,O,1932
38940,which,O,1932
38941,makes,O,1932
38942,our,O,1932
38943,vision,O,1933
38944,clear,O,1933
38945,Once,O,1933
38946,the,O,1933
38947,light,O,1933
38948,hits,O,1933
38949,our,O,1933
38950,cornea,B-PART_OF_THE_EYES,1933
38951,it,O,1933
38952,bends,O,1933
38953,or,O,1933
38954,refracts,O,1933
38955,the,O,1933
38956,coming,O,1933
38957,light,O,1933
38958,onto,O,1933
38959,the,B-PART_OF_THE_EYES,1933
38960,lens,B-PART_OF_THE_EYES,1933
38961,The,B-PART_OF_THE_EYES,1933
38962,lens,B-PART_OF_THE_EYES,1933
38963,re-focus,O,1933
38964,that,O,1933
38965,light,O,1933
38966,onto,O,1933
38967,our,O,1933
38968,retina,B-PART_OF_THE_EYES,1933
38969,-,O,1933
38970,the,O,1933
38971,part,O,1933
38972,in,O,1933
38973,the,O,1933
38974,back,O,1933
38975,of,O,1933
38976,the,O,1933
38977,eye,O,1933
38978,with,O,1933
38979,light-sensing,O,1933
38980,cells-,O,1933
38981,and,O,1933
38982,then,O,1934
38983,we,O,1934
38984,perceive,O,1934
38985,the,O,1934
38986,light,O,1934
38987,in,O,1934
38988,our,O,1934
38989,vision,O,1934
38990,We,O,1934
38991,can,O,1934
38992,think,O,1934
38993,of,O,1934
38994,this,O,1934
38995,process,O,1934
38996,as,O,1934
38997,taking,O,1934
38998,a,O,1934
38999,photo,O,1934
39000,with,O,1934
39001,our,O,1934
39002,camera,O,1935
39003,In,O,1935
39004,this,O,1935
39005,case,O,1935
39006,our,O,1935
39007,cornea,B-PART_OF_THE_EYES,1935
39008,and,O,1935
39009,lens,B-PART_OF_THE_EYES,1935
39010,act,O,1935
39011,the,O,1935
39012,same,O,1935
39013,way,O,1935
39014,as,O,1935
39015,the,O,1935
39016,camera,O,1935
39017,s,O,1935
39018,lens,B-PART_OF_THE_EYES,1935
39019,The,B-PART_OF_THE_EYES,1935
39020,retina,I-PART_OF_THE_EYES,1935
39021,can,O,1935
39022,be,O,1935
39023,seen,O,1935
39024,as,O,1935
39025,the,O,1935
39026,film,O,1935
39027,If,O,1935
39028,you,O,1935
39029,cannot,O,1935
39030,focus,O,1935
39031,well,O,1935
39032,on,O,1935
39033,the,O,1935
39034,item,O,1935
39035,the,O,1935
39036,image,O,1936
39037,on,O,1936
39038,your,O,1936
39039,film,O,1936
39040,will,O,1936
39041,be,O,1936
39042,blurry,O,1936
39043,The,B-PART_OF_THE_EYES,1936
39044,cornea,I-PART_OF_THE_EYES,1936
39045,also,O,1936
39046,functions,O,1936
39047,as,O,1936
39048,a,O,1936
39049,filter,O,1936
39050,that,O,1936
39051,screens,O,1936
39052,out,O,1936
39053,the,O,1936
39054,damaging,O,1936
39055,UV,O,1936
39056,wavelength,O,1936
39057,coming,O,1936
39058,from,O,1936
39059,the,O,1936
39060,sunlight,O,1936
39061,Why,O,1936
39062,is,O,1936
39063,the,B-PART_OF_THE_EYES,1936
39064,cornea,B-PART_OF_THE_EYES,1937
39065,important,O,1937
39066,As,O,1937
39067,the,B-PART_OF_THE_EYES,1937
39068,cornea,B-PART_OF_THE_EYES,1937
39069,does,O,1937
39070,the,O,1937
39071,majority,O,1937
39072,of,O,1937
39073,the,O,1937
39074,focusing,O,1937
39075,it,O,1937
39076,is,O,1937
39077,of,O,1937
39078,great,O,1937
39079,importance,O,1937
39080,It,O,1938
39081,s,O,1938
39082,our,O,1938
39083,cornea,B-PART_OF_THE_EYES,1938
39084,that,O,1938
39085,determines,O,1938
39086,how,O,1938
39087,much,O,1938
39088,light,O,1938
39089,will,O,1938
39090,be,O,1938
39091,reflected,O,1938
39092,on,O,1938
39093,our,O,1938
39094,lens,B-PART_OF_THE_EYES,1938
39095,and,O,1938
39096,then,O,1938
39097,onto,O,1938
39098,the,B-PART_OF_THE_EYES,1938
39099,retina,I-PART_OF_THE_EYES,1938
39100,In,O,1938
39101,short,O,1938
39102,it,O,1938
39103,plays,O,1938
39104,a,O,1938
39105,crucial,O,1938
39106,role,O,1938
39107,in,O,1938
39108,our,O,1938
39109,vision,O,1938
39110,Preventing,O,1938
39111,the,O,1939
39112,eye,O,1939
39113,from,O,1939
39114,germs,O,1939
39115,and,O,1939
39116,dust,O,1939
39117,and,O,1939
39118,acting,O,1939
39119,as,O,1939
39120,a,O,1939
39121,filter,O,1939
39122,the,B-PART_OF_THE_EYES,1939
39123,cornea,B-PART_OF_THE_EYES,1939
39124,is,O,1940
39125,very,O,1940
39126,important,O,1940
39127,in,O,1940
39128,visual,O,1940
39129,clarity,O,1940
39130,What,O,1940
39131,happens,O,1940
39132,if,O,1940
39133,the,B-PART_OF_THE_EYES,1940
39134,cornea,B-PART_OF_THE_EYES,1940
39135,is,O,1940
39136,damaged,O,1940
39137,Corneal,B-SIGN_AND_SYMPTOM,1940
39138,damage,I-SIGN_AND_SYMPTOM,1941
39139,is,O,1941
39140,the,O,1941
39141,most,O,1941
39142,common,O,1941
39143,cause,O,1941
39144,of,O,1941
39145,blindness,B-NAME_OF_DISEASE,1941
39146,in,O,1941
39147,the,O,1941
39148,world,O,1941
39149,especially,O,1941
39150,in,O,1941
39151,less,O,1941
39152,developed,O,1941
39153,countries,O,1941
39154,Clouding,B-SIGN_AND_SYMPTOM,1941
39155,or,I-SIGN_AND_SYMPTOM,1941
39156,scarring,I-SIGN_AND_SYMPTOM,1941
39157,in,I-SIGN_AND_SYMPTOM,1941
39158,the,I-SIGN_AND_SYMPTOM,1941
39159,cornea,I-SIGN_AND_SYMPTOM,1941
39160,usually,O,1941
39161,results,O,1941
39162,in,O,1942
39163,glared,B-SIGN_AND_SYMPTOM,1942
39164,or,I-SIGN_AND_SYMPTOM,1942
39165,blurry,I-SIGN_AND_SYMPTOM,1942
39166,vision,I-SIGN_AND_SYMPTOM,1942
39167,Corneal,B-SIGN_AND_SYMPTOM,1942
39168,damage,I-SIGN_AND_SYMPTOM,1942
39169,can,O,1942
39170,also,O,1942
39171,occur,O,1942
39172,with,O,1942
39173,the,B-CAUSE_OF_DISEASE,1942
39174,injuries,I-CAUSE_OF_DISEASE,1942
39175,affecting,I-CAUSE_OF_DISEASE,1942
39176,the,I-CAUSE_OF_DISEASE,1942
39177,outermost,I-CAUSE_OF_DISEASE,1942
39178,layer,I-CAUSE_OF_DISEASE,1942
39179,of,I-CAUSE_OF_DISEASE,1942
39180,the,I-CAUSE_OF_DISEASE,1942
39181,eye,I-CAUSE_OF_DISEASE,1942
39182,with,O,1942
39183,the,B-CAUSE_OF_DISEASE,1942
39184,scars,I-CAUSE_OF_DISEASE,1942
39185,from,I-CAUSE_OF_DISEASE,1942
39186,eye,I-CAUSE_OF_DISEASE,1942
39187,surgeries,I-CAUSE_OF_DISEASE,1942
39188,infections,I-CAUSE_OF_DISEASE,1942
39189,etc,I-CAUSE_OF_DISEASE,1942
39190,Does,O,1943
39191,a,B-TREATMENT,1943
39192,cornea,I-TREATMENT,1943
39193,transplant,I-TREATMENT,1943
39194,improve,O,1943
39195,vision,O,1943
39196,Corneal,B-TREATMENT,1943
39197,transplant,I-TREATMENT,1943
39198,surgery,I-TREATMENT,1943
39199,can,O,1943
39200,help,O,1943
39201,patients,O,1943
39202,with,O,1943
39203,the,B-SIGN_AND_SYMPTOM,1943
39204,damaged,I-SIGN_AND_SYMPTOM,1943
39205,cornea,I-SIGN_AND_SYMPTOM,1943
39206,to,O,1943
39207,restore,O,1943
39208,their,O,1943
39209,vision,O,1943
39210,by,O,1943
39211,replacing,O,1943
39212,their,O,1943
39213,original,O,1943
39214,corneal,B-PART_OF_THE_EYES,1943
39215,tissue,I-PART_OF_THE_EYES,1943
39216,with,O,1943
39217,an,O,1943
39218,organ,O,1943
39219,donor,O,1943
39220,How,O,1944
39221,long,O,1944
39222,does,O,1944
39223,it,O,1944
39224,take,O,1944
39225,for,O,1944
39226,a,B-PART_OF_THE_EYES,1944
39227,cornea,B-PART_OF_THE_EYES,1944
39228,to,O,1944
39229,grow,O,1944
39230,back,O,1944
39231,The,O,1944
39232,majority,O,1944
39233,of,O,1944
39234,corneal,B-SIGN_AND_SYMPTOM,1944
39235,abrasions,I-SIGN_AND_SYMPTOM,1944
39236,heal,O,1944
39237,in,O,1944
39238,a,O,1945
39239,few,O,1945
39240,days,O,1945
39241,but,O,1945
39242,the,O,1945
39243,condition,O,1945
39244,should,O,1945
39245,be,O,1945
39246,supported,O,1945
39247,with,O,1945
39248,antibiotic,B-NAME_OF_DRUG,1945
39249,drops,I-NAME_OF_DRUG,1945
39250,or,O,1945
39251,ointments,B-NAME_OF_DRUG,1945
39252,What,O,1945
39253,causes,O,1945
39254,the,B-PART_OF_THE_EYES,1945
39255,cornea,B-PART_OF_THE_EYES,1945
39256,to,O,1945
39257,fail,O,1945
39258,There,O,1945
39259,are,O,1945
39260,a,O,1945
39261,lot,O,1945
39262,of,O,1945
39263,causes,O,1946
39264,for,O,1946
39265,corneal,O,1946
39266,failure,O,1946
39267,However,O,1946
39268,the,O,1946
39269,most,O,1946
39270,common,O,1946
39271,one,O,1946
39272,is,O,1946
39273,endothelial,B-CAUSE_OF_DISEASE,1947
39274,decompensation,I-CAUSE_OF_DISEASE,1947
39275,when,I-CAUSE_OF_DISEASE,1947
39276,the,I-CAUSE_OF_DISEASE,1947
39277,endothelial,I-CAUSE_OF_DISEASE,1947
39278,cells,I-CAUSE_OF_DISEASE,1947
39279,die,I-CAUSE_OF_DISEASE,1948
39280,and,I-CAUSE_OF_DISEASE,1948
39281,the,I-CAUSE_OF_DISEASE,1948
39282,cornea,B-PART_OF_THE_EYES,1948
39283,gets,I-CAUSE_OF_DISEASE,1948
39284,edematous,I-CAUSE_OF_DISEASE,1948
39285,In,O,1948
39286,this,O,1948
39287,case,O,1948
39288,the,B-SIGN_AND_SYMPTOM,1948
39289,vision,I-SIGN_AND_SYMPTOM,1948
39290,gets,I-SIGN_AND_SYMPTOM,1948
39291,cloudy,I-SIGN_AND_SYMPTOM,1948
39292,and,I-SIGN_AND_SYMPTOM,1948
39293,worsens,I-SIGN_AND_SYMPTOM,1948
39294,How,O,1948
39295,do,O,1948
39296,you,O,1948
39297,keep,O,1948
39298,your,O,1948
39299,cornea,B-PART_OF_THE_EYES,1948
39300,healthy,O,1948
39301,Nutrition,B-TREATMENT,1948
39302,comes,O,1948
39303,first,O,1948
39304,Leading,B-TREATMENT,1948
39305,a,I-TREATMENT,1949
39306,healthy,I-TREATMENT,1949
39307,lifestyle,I-TREATMENT,1949
39308,with,I-TREATMENT,1949
39309,a,I-TREATMENT,1949
39310,nutritious,I-TREATMENT,1949
39311,diet,I-TREATMENT,1949
39312,helps,O,1949
39313,a,O,1950
39314,lot,O,1950
39315,with,O,1950
39316,our,O,1950
39317,vision,O,1950
39318,Performing,B-TREATMENT,1950
39319,eye,I-TREATMENT,1950
39320,exercises,I-TREATMENT,1950
39321,and,O,1950
39322,protecting,B-TREATMENT,1950
39323,the,I-TREATMENT,1950
39324,eyes,I-TREATMENT,1950
39325,from,I-TREATMENT,1950
39326,direct,I-TREATMENT,1950
39327,sunlight,I-TREATMENT,1950
39328,are,O,1950
39329,among,O,1950
39330,the,O,1950
39331,things,O,1950
39332,to,O,1950
39333,be,O,1950
39334,done,O,1950
39335,to,O,1950
39336,keep,O,1950
39337,your,O,1950
39338,cornea,B-PART_OF_THE_EYES,1950
39339,healthy,O,1950
39340,What,O,1951
39341,vitamin,B-CHEMICAL_COMPOUND,1951
39342,is,O,1951
39343,good,O,1951
39344,for,O,1951
39345,cornea,B-PART_OF_THE_EYES,1951
39346,Vitamin,B-CHEMICAL_COMPOUND,1951
39347,A,I-CHEMICAL_COMPOUND,1951
39348,helps,O,1951
39349,to,O,1951
39350,maintain,O,1951
39351,the,B-PART_OF_THE_EYES,1951
39352,cornea,B-PART_OF_THE_EYES,1951
39353,clear,O,1951
39354,This,O,1952
39355,vitamin,B-CHEMICAL_COMPOUND,1952
39356,is,O,1952
39357,the,O,1952
39358,rhodopsin,B-CHEMICAL_COMPOUND,1952
39359,component,O,1952
39360,which,O,1952
39361,is,O,1952
39362,a,O,1952
39363,protein,B-CHEMICAL_COMPOUND,1952
39364,in,O,1952
39365,the,O,1952
39366,eyes,O,1952
39367,that,O,1952
39368,helps,O,1952
39369,us,O,1952
39370,see,O,1953
39371,in,O,1953
39372,dim,O,1953
39373,light,O,1953
39374,Vitamin,B-CHEMICAL_COMPOUND,1953
39375,E,I-CHEMICAL_COMPOUND,1953
39376,is,O,1953
39377,a,O,1953
39378,potent,O,1953
39379,antioxidant,O,1953
39380,that,O,1953
39381,protects,O,1954
39382,our,O,1954
39383,eye,O,1954
39384,cells,O,1954
39385,What,O,1954
39386,foods,O,1954
39387,help,O,1954
39388,heal,O,1954
39389,the,B-PART_OF_THE_EYES,1955
39390,cornea,B-PART_OF_THE_EYES,1955
39391,Eating,B-PREVENTION,1955
39392,the,I-PREVENTION,1955
39393,rainbow,I-PREVENTION,1955
39394,is,O,1955
39395,always,O,1955
39396,known,O,1955
39397,to,O,1955
39398,protect,O,1955
39399,and,O,1955
39400,strengthen,O,1956
39401,our,O,1956
39402,eyesight,O,1956
39403,Carrots,O,1956
39404,are,O,1956
39405,rich,O,1956
39406,in,O,1957
39407,beta-carotene,B-CHEMICAL_COMPOUND,1957
39408,which,O,1957
39409,is,O,1957
39410,the,O,1957
39411,forerunner,O,1957
39412,of,O,1957
39413,Vitamin,B-CHEMICAL_COMPOUND,1957
39414,A,I-CHEMICAL_COMPOUND,1957
39415,As,O,1957
39416,mentioned,O,1957
39417,above,O,1958
39418,vitamin,B-CHEMICAL_COMPOUND,1958
39419,A,I-CHEMICAL_COMPOUND,1958
39420,helps,O,1958
39421,to,O,1958
39422,keep,O,1958
39423,our,O,1959
39424,cornea,B-PART_OF_THE_EYES,1959
39425,to,O,1959
39426,be,O,1959
39427,clear,O,1959
39428,Yellow-orange,O,1959
39429,bell,O,1959
39430,peppers,O,1959
39431,contain,O,1959
39432,Vitamin,B-CHEMICAL_COMPOUND,1959
39433,C,I-CHEMICAL_COMPOUND,1959
39434,Vitamin,B-CHEMICAL_COMPOUND,1959
39435,E,I-CHEMICAL_COMPOUND,1959
39436,zeaxanthin,B-CHEMICAL_COMPOUND,1959
39437,and,O,1959
39438,Lutein,B-CHEMICAL_COMPOUND,1959
39439,which,O,1959
39440,lower,O,1959
39441,the,O,1959
39442,risk,O,1959
39443,of,O,1959
39444,macular,B-NAME_OF_DISEASE,1960
39445,degeneration,I-NAME_OF_DISEASE,1960
39446,Incorporating,B-PREVENTION,1960
39447,green,I-PREVENTION,1960
39448,vegetables,I-PREVENTION,1960
39449,like,I-PREVENTION,1960
39450,broccoli,I-PREVENTION,1960
39451,and,I-PREVENTION,1960
39452,kale,I-PREVENTION,1960
39453,is,O,1960
39454,of,O,1960
39455,great,O,1960
39456,importance,O,1960
39457,as,O,1960
39458,they,O,1960
39459,have,O,1960
39460,nutritious,O,1960
39461,for,O,1960
39462,your,O,1960
39463,corneal,O,1960
39464,health,O,1960
39465,Color,B-NAME_OF_DISEASE,1961
39466,blindness,I-NAME_OF_DISEASE,1961
39467,is,O,1961
39468,a,B-SIGN_AND_SYMPTOM,1961
39469,deficiency,I-SIGN_AND_SYMPTOM,1961
39470,in,I-SIGN_AND_SYMPTOM,1961
39471,seeing,I-SIGN_AND_SYMPTOM,1961
39472,color,I-SIGN_AND_SYMPTOM,1961
39473,or,I-SIGN_AND_SYMPTOM,1961
39474,differentiating,I-SIGN_AND_SYMPTOM,1961
39475,colors,I-SIGN_AND_SYMPTOM,1961
39476,Color,B-NAME_OF_DISEASE,1961
39477,blindness,I-NAME_OF_DISEASE,1961
39478,is,O,1961
39479,an,O,1961
39480,inherited,O,1961
39481,vision,O,1961
39482,problem,O,1961
39483,mainly,O,1961
39484,but,O,1961
39485,can,O,1961
39486,arise,O,1961
39487,by,O,1961
39488,losing,B-CAUSE_OF_DISEASE,1961
39489,functionality,I-CAUSE_OF_DISEASE,1961
39490,in,I-CAUSE_OF_DISEASE,1961
39491,cone,I-CAUSE_OF_DISEASE,1961
39492,cells,I-CAUSE_OF_DISEASE,1961
39493,in,I-CAUSE_OF_DISEASE,1961
39494,the,I-CAUSE_OF_DISEASE,1962
39495,retina,I-CAUSE_OF_DISEASE,1962
39496,or,O,1962
39497,from,B-CAUSE_OF_DISEASE,1962
39498,heavy,I-CAUSE_OF_DISEASE,1962
39499,physical,I-CAUSE_OF_DISEASE,1962
39500,or,I-CAUSE_OF_DISEASE,1962
39501,chemical,I-CAUSE_OF_DISEASE,1962
39502,damage,I-CAUSE_OF_DISEASE,1962
39503,in,I-CAUSE_OF_DISEASE,1962
39504,the,I-CAUSE_OF_DISEASE,1962
39505,eye,I-CAUSE_OF_DISEASE,1962
39506,and,O,1962
39507,there,O,1962
39508,is,O,1962
39509,no,O,1962
39510,cure,O,1962
39511,to,O,1962
39512,eliminate,O,1962
39513,color,B-NAME_OF_DISEASE,1962
39514,blindness,I-NAME_OF_DISEASE,1962
39515,However,O,1962
39516,people,O,1962
39517,who,O,1963
39518,are,O,1963
39519,color,B-NAME_OF_DISEASE,1963
39520,blindness,I-NAME_OF_DISEASE,1963
39521,do,O,1963
39522,not,O,1963
39523,have,O,1963
39524,major,O,1963
39525,issues,O,1963
39526,in,O,1963
39527,living,O,1963
39528,as,O,1963
39529,they,O,1963
39530,maintain,O,1963
39531,adaptation,O,1963
39532,automatically,O,1964
39533,by,O,1964
39534,living,O,1964
39535,How,O,1964
39536,do,O,1964
39537,colorblind,O,1964
39538,people,O,1964
39539,see,O,1964
39540,colors,O,1964
39541,Color,O,1964
39542,blind,O,1964
39543,people,O,1964
39544,can,O,1964
39545,see,O,1964
39546,the,O,1964
39547,world,O,1964
39548,in,O,1965
39549,their,O,1965
39550,perception,O,1965
39551,but,O,1965
39552,this,O,1965
39553,does,O,1965
39554,not,O,1965
39555,mean,O,1965
39556,that,O,1965
39557,they,O,1965
39558,only,O,1965
39559,see,O,1965
39560,black,O,1965
39561,and,O,1965
39562,white,O,1965
39563,unless,O,1965
39564,they,O,1965
39565,are,O,1965
39566,completely,O,1965
39567,color,O,1965
39568,blind,O,1965
39569,They,O,1965
39570,only,O,1965
39571,see,O,1965
39572,the,O,1965
39573,colors,O,1965
39574,closer,O,1966
39575,to,O,1966
39576,each,O,1966
39577,other,O,1966
39578,or,O,1966
39579,maybe,O,1966
39580,they,O,1966
39581,even,O,1966
39582,have,O,1966
39583,a,O,1966
39584,border,O,1966
39585,color,O,1967
39586,catalog,O,1967
39587,to,O,1967
39588,define,O,1967
39589,the,O,1967
39590,colors,O,1967
39591,like,O,1967
39592,in,O,1967
39593,the,O,1967
39594,pantone,O,1967
39595,color,O,1968
39596,catalog,O,1968
39597,In,O,1968
39598,this,O,1968
39599,way,O,1968
39600,according,O,1968
39601,to,O,1968
39602,the,O,1968
39603,color,O,1968
39604,they,O,1968
39605,can,O,1968
39606,not,O,1968
39607,see,O,1968
39608,the,O,1968
39609,color,O,1969
39610,blind,O,1969
39611,type,O,1969
39612,differs,O,1969
39613,Symptoms,O,1969
39614,of,O,1969
39615,Color,B-NAME_OF_DISEASE,1969
39616,Blindness,I-NAME_OF_DISEASE,1969
39617,As,O,1969
39618,it,O,1969
39619,is,O,1969
39620,a,O,1969
39621,genetic,O,1969
39622,disorder,O,1969
39623,males,O,1969
39624,are,O,1969
39625,more,O,1970
39626,color,O,1970
39627,blind,O,1970
39628,than,O,1970
39629,females,O,1970
39630,as,O,1970
39631,the,O,1970
39632,non-color,O,1970
39633,blind,O,1970
39634,females,O,1970
39635,carry,O,1970
39636,the,O,1970
39637,gene,O,1970
39638,and,O,1970
39639,transfer,O,1970
39640,it,O,1970
39641,to,O,1970
39642,the,O,1970
39643,males,O,1970
39644,This,O,1970
39645,is,O,1970
39646,because,O,1970
39647,the,O,1970
39648,genes,O,1970
39649,of,O,1970
39650,colorblind,O,1970
39651,are,O,1970
39652,mostly,O,1970
39653,on,O,1970
39654,the,B-CHEMICAL_COMPOUND,1970
39655,X,I-CHEMICAL_COMPOUND,1970
39656,chromosome,I-CHEMICAL_COMPOUND,1970
39657,The,O,1970
39658,symptoms,O,1971
39659,of,O,1971
39660,color,B-NAME_OF_DISEASE,1971
39661,blindness,I-NAME_OF_DISEASE,1971
39662,are,O,1971
39663,can,B-SIGN_AND_SYMPTOM,1971
39664,not,I-SIGN_AND_SYMPTOM,1971
39665,define,I-SIGN_AND_SYMPTOM,1971
39666,the,I-SIGN_AND_SYMPTOM,1971
39667,color,I-SIGN_AND_SYMPTOM,1971
39668,difference,I-SIGN_AND_SYMPTOM,1971
39669,in,I-SIGN_AND_SYMPTOM,1971
39670,red,I-SIGN_AND_SYMPTOM,1971
39671,yellow,I-SIGN_AND_SYMPTOM,1971
39672,orange,I-SIGN_AND_SYMPTOM,1971
39673,and,I-SIGN_AND_SYMPTOM,1972
39674,green,I-SIGN_AND_SYMPTOM,1972
39675,losing,B-SIGN_AND_SYMPTOM,1972
39676,the,I-SIGN_AND_SYMPTOM,1972
39677,bright,I-SIGN_AND_SYMPTOM,1972
39678,and,I-SIGN_AND_SYMPTOM,1972
39679,vibrant,I-SIGN_AND_SYMPTOM,1972
39680,vision,I-SIGN_AND_SYMPTOM,1972
39681,and,I-SIGN_AND_SYMPTOM,1972
39682,seeing,I-SIGN_AND_SYMPTOM,1972
39683,in,I-SIGN_AND_SYMPTOM,1972
39684,the,I-SIGN_AND_SYMPTOM,1972
39685,duller,I-SIGN_AND_SYMPTOM,1972
39686,way,I-SIGN_AND_SYMPTOM,1972
39687,difficulty,B-SIGN_AND_SYMPTOM,1972
39688,in,I-SIGN_AND_SYMPTOM,1972
39689,defining,I-SIGN_AND_SYMPTOM,1972
39690,the,I-SIGN_AND_SYMPTOM,1973
39691,shades,I-SIGN_AND_SYMPTOM,1973
39692,sensitivity,B-SIGN_AND_SYMPTOM,1973
39693,to,I-SIGN_AND_SYMPTOM,1973
39694,the,I-SIGN_AND_SYMPTOM,1973
39695,light,I-SIGN_AND_SYMPTOM,1973
39696,Causes,O,1973
39697,of,O,1973
39698,Color,B-NAME_OF_DISEASE,1973
39699,Blindness,I-NAME_OF_DISEASE,1973
39700,The,O,1973
39701,main,O,1973
39702,cause,O,1974
39703,of,O,1974
39704,color,B-NAME_OF_DISEASE,1974
39705,blindness,I-NAME_OF_DISEASE,1974
39706,is,O,1974
39707,the,B-CAUSE_OF_DISEASE,1974
39708,inherited,I-CAUSE_OF_DISEASE,1974
39709,effect,I-CAUSE_OF_DISEASE,1974
39710,Moreover,O,1974
39711,chemical,B-CAUSE_OF_DISEASE,1974
39712,and,I-CAUSE_OF_DISEASE,1974
39713,physical,I-CAUSE_OF_DISEASE,1974
39714,damage,I-CAUSE_OF_DISEASE,1974
39715,to,I-CAUSE_OF_DISEASE,1974
39716,the,I-CAUSE_OF_DISEASE,1974
39717,eye,I-CAUSE_OF_DISEASE,1974
39718,aging,B-CAUSE_OF_DISEASE,1975
39719,eye,B-CAUSE_OF_DISEASE,1975
39720,diseases,I-CAUSE_OF_DISEASE,1975
39721,neural,B-CAUSE_OF_DISEASE,1975
39722,system,I-CAUSE_OF_DISEASE,1975
39723,or,I-CAUSE_OF_DISEASE,1975
39724,nervous,I-CAUSE_OF_DISEASE,1975
39725,system,I-CAUSE_OF_DISEASE,1975
39726,diseases,I-CAUSE_OF_DISEASE,1975
39727,and,O,1975
39728,strong,B-CAUSE_OF_DISEASE,1975
39729,medication,I-CAUSE_OF_DISEASE,1975
39730,may,O,1975
39731,cause,O,1975
39732,color,B-NAME_OF_DISEASE,1975
39733,blindness,I-NAME_OF_DISEASE,1975
39734,What,O,1975
39735,are,O,1975
39736,the,O,1975
39737,types,O,1975
39738,of,O,1975
39739,color,B-NAME_OF_DISEASE,1975
39740,blindness,I-NAME_OF_DISEASE,1976
39741,The,O,1976
39742,reason,O,1976
39743,that,O,1976
39744,people,O,1976
39745,who,O,1976
39746,have,O,1976
39747,color,B-NAME_OF_DISEASE,1976
39748,blindness,I-NAME_OF_DISEASE,1976
39749,see,O,1976
39750,the,O,1976
39751,colors,O,1976
39752,similarly,O,1976
39753,is,O,1976
39754,due,O,1976
39755,to,O,1976
39756,the,O,1976
39757,source,O,1976
39758,of,O,1977
39759,the,O,1977
39760,color,O,1977
39761,pantone,O,1977
39762,For,O,1977
39763,example,O,1977
39764,orange,O,1977
39765,is,O,1977
39766,derived,O,1977
39767,from,O,1977
39768,yellow,O,1977
39769,and,O,1977
39770,red,O,1977
39771,so,O,1977
39772,color-blind,O,1977
39773,people,O,1977
39774,can,O,1977
39775,not,O,1977
39776,differentiate,O,1977
39777,the,O,1978
39778,orange,O,1978
39779,color,O,1978
39780,and,O,1978
39781,red,O,1978
39782,but,O,1978
39783,can,O,1978
39784,have,O,1978
39785,an,O,1978
39786,idea,O,1978
39787,of,O,1978
39788,the,O,1978
39789,yellow,O,1978
39790,color,O,1978
39791,family,O,1978
39792,Let,O,1978
39793,s,O,1978
39794,have,O,1978
39795,a,O,1978
39796,look,O,1978
39797,at,O,1978
39798,the,O,1978
39799,types,O,1979
39800,of,O,1979
39801,color,B-NAME_OF_DISEASE,1979
39802,blindness,I-NAME_OF_DISEASE,1979
39803,and,O,1979
39804,have,O,1979
39805,more,O,1979
39806,information,O,1979
39807,on,O,1980
39808,the,O,1980
39809,issue,O,1980
39810,Complete,B-NAME_OF_DISEASE,1980
39811,color,I-NAME_OF_DISEASE,1980
39812,blindness,I-NAME_OF_DISEASE,1980
39813,Complete,B-NAME_OF_DISEASE,1980
39814,color,I-NAME_OF_DISEASE,1980
39815,blindness,I-NAME_OF_DISEASE,1980
39816,is,O,1980
39817,also,O,1980
39818,called,O,1980
39819,monochromacy,B-NAME_OF_DISEASE,1980
39820,in,O,1980
39821,that,O,1980
39822,the,O,1980
39823,person,O,1980
39824,can,B-SIGN_AND_SYMPTOM,1980
39825,see,I-SIGN_AND_SYMPTOM,1980
39826,any,I-SIGN_AND_SYMPTOM,1980
39827,color,I-SIGN_AND_SYMPTOM,1980
39828,but,I-SIGN_AND_SYMPTOM,1980
39829,only,I-SIGN_AND_SYMPTOM,1980
39830,a,I-SIGN_AND_SYMPTOM,1981
39831,white,I-SIGN_AND_SYMPTOM,1981
39832,and,I-SIGN_AND_SYMPTOM,1981
39833,black,I-SIGN_AND_SYMPTOM,1981
39834,vision,I-SIGN_AND_SYMPTOM,1981
39835,This,O,1981
39836,situation,O,1981
39837,is,O,1981
39838,so,O,1981
39839,rare,O,1981
39840,that,O,1981
39841,about,O,1981
39842,1,O,1981
39843,in,O,1981
39844,33,O,1981
39845,people,O,1981
39846,may,O,1981
39847,have,O,1981
39848,complete,B-NAME_OF_DISEASE,1981
39849,color,I-NAME_OF_DISEASE,1981
39850,blindness,I-NAME_OF_DISEASE,1981
39851,Blue-Yellow,B-NAME_OF_DISEASE,1982
39852,Color,I-NAME_OF_DISEASE,1982
39853,Blindness,I-NAME_OF_DISEASE,1982
39854,Blue-yellow,B-NAME_OF_DISEASE,1982
39855,color,I-NAME_OF_DISEASE,1982
39856,blindness,I-NAME_OF_DISEASE,1982
39857,is,O,1982
39858,a,O,1982
39859,less,O,1982
39860,common,O,1982
39861,color,B-NAME_OF_DISEASE,1982
39862,blindness,I-NAME_OF_DISEASE,1982
39863,type,O,1982
39864,that,O,1982
39865,people,O,1982
39866,can,B-SIGN_AND_SYMPTOM,1982
39867,not,I-SIGN_AND_SYMPTOM,1982
39868,distinguish,I-SIGN_AND_SYMPTOM,1982
39869,between,I-SIGN_AND_SYMPTOM,1982
39870,blue,I-SIGN_AND_SYMPTOM,1982
39871,and,I-SIGN_AND_SYMPTOM,1982
39872,green,I-SIGN_AND_SYMPTOM,1982
39873,and,I-SIGN_AND_SYMPTOM,1982
39874,yellow,I-SIGN_AND_SYMPTOM,1982
39875,and,I-SIGN_AND_SYMPTOM,1982
39876,red,I-SIGN_AND_SYMPTOM,1982
39877,This,O,1982
39878,type,O,1982
39879,of,O,1982
39880,color,B-NAME_OF_DISEASE,1982
39881,blindness,I-NAME_OF_DISEASE,1982
39882,is,O,1982
39883,also,O,1982
39884,tritanomaly,O,1982
39885,If,O,1982
39886,those,O,1982
39887,who,O,1982
39888,can,B-SIGN_AND_SYMPTOM,1983
39889,not,I-SIGN_AND_SYMPTOM,1983
39890,differentiate,I-SIGN_AND_SYMPTOM,1983
39891,between,I-SIGN_AND_SYMPTOM,1983
39892,the,I-SIGN_AND_SYMPTOM,1983
39893,color,I-SIGN_AND_SYMPTOM,1983
39894,purple,I-SIGN_AND_SYMPTOM,1983
39895,and,I-SIGN_AND_SYMPTOM,1983
39896,red,I-SIGN_AND_SYMPTOM,1983
39897,pink,I-SIGN_AND_SYMPTOM,1983
39898,and,I-SIGN_AND_SYMPTOM,1983
39899,yellow,I-SIGN_AND_SYMPTOM,1983
39900,blue,I-SIGN_AND_SYMPTOM,1983
39901,and,I-SIGN_AND_SYMPTOM,1983
39902,green,I-SIGN_AND_SYMPTOM,1983
39903,then,O,1983
39904,these,O,1983
39905,are,O,1983
39906,the,O,1983
39907,color,B-NAME_OF_DISEASE,1983
39908,blindness,I-NAME_OF_DISEASE,1983
39909,type,O,1983
39910,of,O,1983
39911,tritanopia,B-NAME_OF_DISEASE,1983
39912,Red-Green,B-NAME_OF_DISEASE,1983
39913,Color,I-NAME_OF_DISEASE,1983
39914,Blindness,I-NAME_OF_DISEASE,1983
39915,The,O,1983
39916,most,O,1983
39917,common,O,1983
39918,type,O,1983
39919,of,O,1983
39920,color,B-NAME_OF_DISEASE,1983
39921,blindness,I-NAME_OF_DISEASE,1983
39922,is,O,1983
39923,red-green,B-NAME_OF_DISEASE,1983
39924,color,I-NAME_OF_DISEASE,1983
39925,blindness,I-NAME_OF_DISEASE,1983
39926,Generally,O,1984
39927,the,B-SIGN_AND_SYMPTOM,1984
39928,common,I-SIGN_AND_SYMPTOM,1984
39929,confusion,I-SIGN_AND_SYMPTOM,1984
39930,in,I-SIGN_AND_SYMPTOM,1984
39931,colors,I-SIGN_AND_SYMPTOM,1984
39932,includes,I-SIGN_AND_SYMPTOM,1984
39933,red,I-SIGN_AND_SYMPTOM,1984
39934,brown,I-SIGN_AND_SYMPTOM,1984
39935,yellow,I-SIGN_AND_SYMPTOM,1984
39936,green,I-SIGN_AND_SYMPTOM,1984
39937,and,I-SIGN_AND_SYMPTOM,1984
39938,also,I-SIGN_AND_SYMPTOM,1984
39939,blue,I-SIGN_AND_SYMPTOM,1984
39940,and,I-SIGN_AND_SYMPTOM,1984
39941,purple,I-SIGN_AND_SYMPTOM,1984
39942,As,O,1984
39943,said,O,1984
39944,males,O,1985
39945,may,O,1985
39946,experience,O,1985
39947,red-green,B-NAME_OF_DISEASE,1985
39948,color,I-NAME_OF_DISEASE,1985
39949,blindness,I-NAME_OF_DISEASE,1985
39950,more,O,1985
39951,than,O,1985
39952,females,O,1985
39953,This,O,1985
39954,type,O,1985
39955,has,O,1985
39956,4,O,1985
39957,subtypes,O,1985
39958,of,O,1985
39959,color,B-NAME_OF_DISEASE,1986
39960,blindness,I-NAME_OF_DISEASE,1986
39961,Protanopia-,O,1986
39962,if,O,1986
39963,a,O,1986
39964,person,O,1986
39965,can,B-SIGN_AND_SYMPTOM,1986
39966,not,I-SIGN_AND_SYMPTOM,1986
39967,see,I-SIGN_AND_SYMPTOM,1986
39968,the,I-SIGN_AND_SYMPTOM,1986
39969,red,I-SIGN_AND_SYMPTOM,1986
39970,at,I-SIGN_AND_SYMPTOM,1986
39971,all,I-SIGN_AND_SYMPTOM,1986
39972,Can,O,1986
39973,be,O,1986
39974,called,O,1986
39975,a,O,1986
39976,red-blind,O,1986
39977,person,O,1986
39978,Deuteranopia-,O,1986
39979,if,O,1986
39980,a,O,1987
39981,person,O,1987
39982,can,B-SIGN_AND_SYMPTOM,1987
39983,not,I-SIGN_AND_SYMPTOM,1987
39984,see,I-SIGN_AND_SYMPTOM,1987
39985,the,I-SIGN_AND_SYMPTOM,1987
39986,green,I-SIGN_AND_SYMPTOM,1987
39987,at,I-SIGN_AND_SYMPTOM,1987
39988,all,I-SIGN_AND_SYMPTOM,1987
39989,Can,O,1987
39990,be,O,1987
39991,called,O,1987
39992,a,O,1987
39993,green-blind,O,1987
39994,person,O,1987
39995,Protanomaly-,O,1987
39996,if,O,1987
39997,a,O,1987
39998,person,O,1987
39999,can,B-SIGN_AND_SYMPTOM,1987
40000,not,I-SIGN_AND_SYMPTOM,1987
40001,see,I-SIGN_AND_SYMPTOM,1987
40002,the,I-SIGN_AND_SYMPTOM,1987
40003,red,I-SIGN_AND_SYMPTOM,1987
40004,bright,I-SIGN_AND_SYMPTOM,1987
40005,red,I-SIGN_AND_SYMPTOM,1987
40006,is,I-SIGN_AND_SYMPTOM,1987
40007,weaker,I-SIGN_AND_SYMPTOM,1987
40008,in,I-SIGN_AND_SYMPTOM,1987
40009,vision,I-SIGN_AND_SYMPTOM,1987
40010,but,I-SIGN_AND_SYMPTOM,1987
40011,green,I-SIGN_AND_SYMPTOM,1987
40012,and,I-SIGN_AND_SYMPTOM,1987
40013,blue,I-SIGN_AND_SYMPTOM,1987
40014,are,I-SIGN_AND_SYMPTOM,1987
40015,normal,I-SIGN_AND_SYMPTOM,1987
40016,Deuteranomaly-,O,1987
40017,if,O,1987
40018,a,O,1987
40019,person,O,1987
40020,can,B-SIGN_AND_SYMPTOM,1987
40021,not,I-SIGN_AND_SYMPTOM,1987
40022,see,I-SIGN_AND_SYMPTOM,1987
40023,the,I-SIGN_AND_SYMPTOM,1987
40024,green,I-SIGN_AND_SYMPTOM,1987
40025,bright,I-SIGN_AND_SYMPTOM,1987
40026,green,I-SIGN_AND_SYMPTOM,1987
40027,is,I-SIGN_AND_SYMPTOM,1987
40028,weaker,I-SIGN_AND_SYMPTOM,1988
40029,in,I-SIGN_AND_SYMPTOM,1988
40030,vision,I-SIGN_AND_SYMPTOM,1988
40031,but,I-SIGN_AND_SYMPTOM,1988
40032,red,I-SIGN_AND_SYMPTOM,1988
40033,and,I-SIGN_AND_SYMPTOM,1988
40034,blue,I-SIGN_AND_SYMPTOM,1988
40035,are,I-SIGN_AND_SYMPTOM,1988
40036,normal,I-SIGN_AND_SYMPTOM,1988
40037,How,O,1988
40038,To,O,1989
40039,Test,O,1989
40040,For,O,1989
40041,Color,B-NAME_OF_DISEASE,1989
40042,Blindness,I-NAME_OF_DISEASE,1989
40043,If,O,1989
40044,you,O,1989
40045,are,O,1989
40046,curious,O,1989
40047,about,O,1989
40048,how,O,1989
40049,to,O,1989
40050,test,O,1989
40051,for,O,1989
40052,color,B-NAME_OF_DISEASE,1989
40053,blindness,I-NAME_OF_DISEASE,1989
40054,continue,O,1989
40055,reading,O,1989
40056,the,O,1989
40057,following,O,1989
40058,titles,O,1989
40059,and,O,1989
40060,learn,O,1989
40061,more,O,1989
40062,about,O,1989
40063,color,B-DIAGNOSTIC_TEST,1989
40064,blindness,I-DIAGNOSTIC_TEST,1989
40065,tests,I-DIAGNOSTIC_TEST,1989
40066,Who,O,1989
40067,should,O,1989
40068,have,O,1990
40069,a,B-DIAGNOSTIC_TEST,1990
40070,color,B-DIAGNOSTIC_TEST,1990
40071,blindness,I-DIAGNOSTIC_TEST,1990
40072,test,I-DIAGNOSTIC_TEST,1990
40073,If,O,1990
40074,your,O,1990
40075,family,O,1990
40076,members,O,1990
40077,have,O,1990
40078,inherited,B-NAME_OF_DISEASE,1990
40079,color,I-NAME_OF_DISEASE,1990
40080,blindness,I-NAME_OF_DISEASE,1990
40081,you,O,1990
40082,should,O,1990
40083,also,O,1990
40084,have,O,1990
40085,a,B-DIAGNOSTIC_TEST,1990
40086,color,B-DIAGNOSTIC_TEST,1991
40087,blindness,I-DIAGNOSTIC_TEST,1991
40088,test,I-DIAGNOSTIC_TEST,1991
40089,Especially,O,1991
40090,in,O,1991
40091,childhood,O,1991
40092,it,O,1991
40093,can,O,1991
40094,be,O,1991
40095,understood,O,1991
40096,easily,O,1991
40097,in,O,1991
40098,painting,O,1991
40099,class,O,1991
40100,or,O,1992
40101,eye,O,1992
40102,vision,O,1992
40103,problems,O,1992
40104,What,O,1992
40105,are,O,1992
40106,the,O,1992
40107,types,O,1992
40108,of,O,1992
40109,color,B-DIAGNOSTIC_TEST,1992
40110,blindness,I-DIAGNOSTIC_TEST,1992
40111,tests,I-DIAGNOSTIC_TEST,1992
40112,There,O,1992
40113,are,O,1992
40114,7,O,1992
40115,types,O,1992
40116,of,O,1992
40117,color,B-DIAGNOSTIC_TEST,1992
40118,blindness,I-DIAGNOSTIC_TEST,1992
40119,tests,I-DIAGNOSTIC_TEST,1992
40120,four,O,1992
40121,of,O,1993
40122,them,O,1993
40123,test,O,1993
40124,red-green,B-NAME_OF_DISEASE,1993
40125,color,I-NAME_OF_DISEASE,1993
40126,blindness,I-NAME_OF_DISEASE,1993
40127,two,O,1993
40128,of,O,1993
40129,them,O,1993
40130,test,O,1993
40131,blue-yellow,B-NAME_OF_DISEASE,1993
40132,color,I-NAME_OF_DISEASE,1993
40133,blindness,I-NAME_OF_DISEASE,1993
40134,and,O,1993
40135,one,O,1993
40136,of,O,1993
40137,them,O,1993
40138,checks,O,1993
40139,whether,O,1993
40140,the,O,1994
40141,vision,O,1994
40142,is,O,1994
40143,complete,B-NAME_OF_DISEASE,1994
40144,color,I-NAME_OF_DISEASE,1994
40145,blindness,I-NAME_OF_DISEASE,1994
40146,The,O,1994
40147,most,O,1994
40148,common,O,1994
40149,color,B-DIAGNOSTIC_TEST,1994
40150,blindness,I-DIAGNOSTIC_TEST,1994
40151,test,I-DIAGNOSTIC_TEST,1994
40152,is,O,1994
40153,the,B-DIAGNOSTIC_TEST,1994
40154,color,I-DIAGNOSTIC_TEST,1994
40155,plate,I-DIAGNOSTIC_TEST,1994
40156,test,I-DIAGNOSTIC_TEST,1994
40157,For,O,1994
40158,example,O,1994
40159,the,B-DIAGNOSTIC_TEST,1994
40160,Ishihara,I-DIAGNOSTIC_TEST,1994
40161,color,I-DIAGNOSTIC_TEST,1995
40162,test,I-DIAGNOSTIC_TEST,1995
40163,checks,O,1995
40164,red-green,B-NAME_OF_DISEASE,1995
40165,color,I-NAME_OF_DISEASE,1995
40166,blindness,I-NAME_OF_DISEASE,1995
40167,Anomaloscope,B-DIAGNOSTIC_TEST,1995
40168,test,I-DIAGNOSTIC_TEST,1995
40169,checks,O,1995
40170,the,O,1995
40171,brightness,O,1995
40172,of,O,1995
40173,the,O,1995
40174,color,O,1995
40175,actually,O,1995
40176,the,O,1995
40177,lights,O,1995
40178,on,O,1995
40179,the,O,1995
40180,visuals,O,1995
40181,And,O,1995
40182,there,O,1995
40183,is,O,1995
40184,a,B-DIAGNOSTIC_TEST,1995
40185,hue,I-DIAGNOSTIC_TEST,1995
40186,test,I-DIAGNOSTIC_TEST,1995
40187,that,O,1996
40188,checks,O,1996
40189,the,O,1996
40190,shading,O,1996
40191,ability,O,1996
40192,in,O,1996
40193,colors,O,1996
40194,put,O,1997
40195,on,O,1997
40196,blocks,O,1997
40197,What,O,1997
40198,are,O,1997
40199,the,O,1997
40200,treatments,O,1998
40201,for,O,1998
40202,color,B-NAME_OF_DISEASE,1998
40203,blindness,I-NAME_OF_DISEASE,1998
40204,There,O,1998
40205,is,O,1998
40206,no,O,1998
40207,cure,O,1998
40208,or,O,1998
40209,treatment,O,1998
40210,for,O,1998
40211,inherited,B-NAME_OF_DISEASE,1998
40212,color,I-NAME_OF_DISEASE,1998
40213,blindness,I-NAME_OF_DISEASE,1998
40214,however,O,1998
40215,as,O,1998
40216,a,O,1998
40217,result,O,1998
40218,of,O,1998
40219,medication,O,1998
40220,side,O,1998
40221,affected,O,1998
40222,color,B-NAME_OF_DISEASE,1998
40223,blindness,I-NAME_OF_DISEASE,1998
40224,may,O,1998
40225,be,O,1998
40226,treated,O,1998
40227,by,O,1998
40228,doctor,O,1998
40229,control,O,1998
40230,Some,O,1998
40231,color,B-TREATMENT,1998
40232,filters,I-TREATMENT,1998
40233,and,O,1998
40234,color,B-TREATMENT,1999
40235,lenses,I-TREATMENT,1999
40236,may,O,1999
40237,be,O,1999
40238,used,O,1999
40239,to,O,1999
40240,help,O,1999
40241,distinguish,O,1999
40242,shades,O,1999
40243,and,O,1999
40244,combinations,O,1999
40245,In,O,1999
40246,daily,O,1999
40247,life,O,1999
40248,with,O,1999
40249,the,O,1999
40250,help,O,1999
40251,of,O,1999
40252,technological,O,2000
40253,development,O,2000
40254,gadgets,O,2000
40255,mobile,O,2000
40256,apps,O,2000
40257,help,O,2000
40258,to,O,2000
40259,correct,O,2000
40260,color,O,2000
40261,detecting,O,2000
40262,Also,O,2000
40263,having,O,2000
40264,an,O,2000
40265,adaptation,O,2000
40266,to,O,2001
40267,traffic,O,2001
40268,lights,O,2001
40269,foods,O,2001
40270,etc,O,2001
40271,makes,O,2001
40272,life,O,2001
40273,easier,O,2001
40274,How,O,2001
40275,do,O,2001
40276,color-blind,B-TREATMENT,2001
40277,glasses,I-TREATMENT,2001
40278,work,O,2001
40279,Another,O,2001
40280,option,O,2001
40281,to,O,2001
40282,make,O,2001
40283,life,O,2001
40284,easier,O,2001
40285,is,O,2001
40286,to,O,2001
40287,wear,B-TREATMENT,2001
40288,color-blind,I-TREATMENT,2001
40289,glasses,I-TREATMENT,2002
40290,As,O,2002
40291,color,B-NAME_OF_DISEASE,2002
40292,blindness,I-NAME_OF_DISEASE,2002
40293,is,O,2002
40294,a,B-CAUSE_OF_DISEASE,2002
40295,loss,I-CAUSE_OF_DISEASE,2002
40296,of,I-CAUSE_OF_DISEASE,2002
40297,function,I-CAUSE_OF_DISEASE,2002
40298,in,I-CAUSE_OF_DISEASE,2002
40299,cone,I-CAUSE_OF_DISEASE,2002
40300,cells,I-CAUSE_OF_DISEASE,2002
40301,which,I-CAUSE_OF_DISEASE,2002
40302,leads,I-CAUSE_OF_DISEASE,2002
40303,the,I-CAUSE_OF_DISEASE,2002
40304,wavelength,I-CAUSE_OF_DISEASE,2002
40305,to,I-CAUSE_OF_DISEASE,2002
40306,overlap,I-CAUSE_OF_DISEASE,2002
40307,so,O,2002
40308,poor,O,2002
40309,color,O,2002
40310,discrimination,O,2002
40311,occurs,O,2002
40312,Colorblind,B-TREATMENT,2002
40313,glasses,I-TREATMENT,2003
40314,help,O,2003
40315,filter,O,2003
40316,colors,O,2003
40317,and,O,2003
40318,the,O,2003
40319,user,O,2003
40320,can,O,2003
40321,see,O,2003
40322,the,O,2003
40323,color,O,2003
40324,combination,O,2003
40325,better,O,2003
40326,especially,O,2003
40327,red,O,2004
40328,and,O,2004
40329,green,O,2004
40330,Twitch,B-NAME_OF_DISEASE,2004
40331,is,O,2004
40332,a,B-SIGN_AND_SYMPTOM,2004
40333,repetitive,I-SIGN_AND_SYMPTOM,2004
40334,spasm,I-SIGN_AND_SYMPTOM,2004
40335,of,I-SIGN_AND_SYMPTOM,2004
40336,the,I-SIGN_AND_SYMPTOM,2004
40337,orbicularis,I-SIGN_AND_SYMPTOM,2004
40338,oculi,I-SIGN_AND_SYMPTOM,2005
40339,muscle,I-SIGN_AND_SYMPTOM,2005
40340,which,O,2005
40341,is,O,2005
40342,an,B-PART_OF_THE_EYES,2005
40343,eyelid,B-PART_OF_THE_EYES,2005
40344,muscle,O,2005
40345,that,O,2005
40346,helps,O,2005
40347,eyelid,B-PART_OF_THE_EYES,2005
40348,closures,O,2005
40349,Twitching,B-NAME_OF_DISEASE,2005
40350,mainly,O,2005
40351,occurs,O,2005
40352,in,O,2005
40353,the,B-PART_OF_THE_EYES,2005
40354,upper,I-PART_OF_THE_EYES,2005
40355,lid,I-PART_OF_THE_EYES,2005
40356,but,O,2005
40357,from,O,2005
40358,time,O,2005
40359,to,O,2006
40360,time,O,2006
40361,it,O,2006
40362,can,O,2006
40363,be,O,2006
40364,observed,O,2006
40365,in,O,2006
40366,the,B-PART_OF_THE_EYES,2006
40367,lower,I-PART_OF_THE_EYES,2006
40368,eyelids,I-PART_OF_THE_EYES,2006
40369,as,O,2006
40370,well,O,2007
40371,Eye,B-NAME_OF_DISEASE,2007
40372,twitching,B-NAME_OF_DISEASE,2007
40373,may,O,2007
40374,hardly,O,2007
40375,be,O,2007
40376,noticeable,O,2007
40377,or,O,2007
40378,severe,O,2007
40379,Usually,O,2007
40380,twitching,B-NAME_OF_DISEASE,2007
40381,is,O,2007
40382,nothing,O,2007
40383,serious,O,2007
40384,but,O,2007
40385,if,O,2007
40386,you,O,2007
40387,observe,O,2007
40388,involuntary,B-SIGN_AND_SYMPTOM,2007
40389,spasms,I-SIGN_AND_SYMPTOM,2007
40390,of,I-SIGN_AND_SYMPTOM,2008
40391,the,I-SIGN_AND_SYMPTOM,2008
40392,facial,I-SIGN_AND_SYMPTOM,2008
40393,muscle,I-SIGN_AND_SYMPTOM,2008
40394,it,O,2008
40395,s,O,2008
40396,better,O,2009
40397,to,O,2009
40398,seek,O,2009
40399,a,O,2009
40400,medical,O,2009
40401,examination,O,2009
40402,Why,O,2009
40403,is,O,2009
40404,my,O,2009
40405,eyelid,B-PART_OF_THE_EYES,2009
40406,twitching,B-NAME_OF_DISEASE,2009
40407,for,B-TIME_DURATION,2009
40408,days,I-TIME_DURATION,2010
40409,Generally,O,2010
40410,eye,O,2010
40411,twitching,B-NAME_OF_DISEASE,2010
40412,lasts,O,2010
40413,for,B-TIME_DURATION,2010
40414,a,I-TIME_DURATION,2010
40415,few,I-TIME_DURATION,2011
40416,days,I-TIME_DURATION,2011
40417,once,O,2011
40418,you,O,2011
40419,eliminate,O,2011
40420,what,O,2011
40421,triggers,O,2011
40422,it,O,2011
40423,Although,O,2011
40424,if,O,2011
40425,you,O,2011
40426,experience,O,2011
40427,it,O,2011
40428,longer,O,2011
40429,than,O,2011
40430,3-Feb,B-TIME_DURATION,2011
40431,weeks,I-TIME_DURATION,2011
40432,you,O,2011
40433,find,O,2011
40434,it,O,2011
40435,difficult,B-SIGN_AND_SYMPTOM,2011
40436,to,I-SIGN_AND_SYMPTOM,2011
40437,open,I-SIGN_AND_SYMPTOM,2011
40438,your,I-SIGN_AND_SYMPTOM,2011
40439,eyes,I-SIGN_AND_SYMPTOM,2011
40440,when,I-SIGN_AND_SYMPTOM,2011
40441,they,I-SIGN_AND_SYMPTOM,2011
40442,twitch,I-SIGN_AND_SYMPTOM,2012
40443,or,O,2012
40444,if,O,2012
40445,you,O,2012
40446,experience,O,2012
40447,spasms,B-SIGN_AND_SYMPTOM,2012
40448,of,I-SIGN_AND_SYMPTOM,2012
40449,facial,I-SIGN_AND_SYMPTOM,2012
40450,muscles,I-SIGN_AND_SYMPTOM,2012
40451,make,O,2012
40452,sure,O,2012
40453,to,O,2012
40454,set,O,2012
40455,an,O,2012
40456,appointment,O,2012
40457,with,O,2012
40458,an,O,2013
40459,ophthalmologist,O,2013
40460,Why,O,2013
40461,does,O,2013
40462,my,O,2013
40463,left,O,2013
40464,eye,O,2013
40465,twitch,O,2013
40466,Sometimes,O,2013
40467,the,O,2013
40468,twitching,B-NAME_OF_DISEASE,2013
40469,on,O,2013
40470,the,O,2013
40471,left,O,2014
40472,eye,O,2014
40473,may,O,2014
40474,be,O,2014
40475,an,O,2014
40476,indicator,O,2014
40477,of,O,2014
40478,some,O,2014
40479,diseases,O,2015
40480,such,O,2015
40481,as,O,2015
40482,facial,B-CAUSE_OF_DISEASE,2015
40483,paralysis,I-CAUSE_OF_DISEASE,2015
40484,convulsion,B-CAUSE_OF_DISEASE,2015
40485,disorders,I-CAUSE_OF_DISEASE,2015
40486,dystonia,I-CAUSE_OF_DISEASE,2015
40487,MS,B-CAUSE_OF_DISEASE,2015
40488,disease,I-CAUSE_OF_DISEASE,2016
40489,Parkinson,B-CAUSE_OF_DISEASE,2016
40490,s,I-CAUSE_OF_DISEASE,2016
40491,disease,I-CAUSE_OF_DISEASE,2016
40492,Tourette,B-CAUSE_OF_DISEASE,2016
40493,s,I-CAUSE_OF_DISEASE,2016
40494,syndrome,I-CAUSE_OF_DISEASE,2016
40495,and,O,2016
40496,brain,B-CAUSE_OF_DISEASE,2017
40497,tumors,I-CAUSE_OF_DISEASE,2017
40498,Why,O,2017
40499,does,O,2017
40500,my,O,2017
40501,right,O,2017
40502,eye,O,2017
40503,twitch,O,2017
40504,The,O,2017
40505,majority,O,2017
40506,of,O,2017
40507,twitching,B-NAME_OF_DISEASE,2017
40508,cases,O,2017
40509,seem,O,2017
40510,to,O,2017
40511,occur,O,2017
40512,in,O,2017
40513,the,O,2017
40514,left,O,2017
40515,eye,O,2017
40516,However,O,2017
40517,there,O,2018
40518,are,O,2018
40519,some,O,2018
40520,cases,O,2018
40521,when,O,2018
40522,the,O,2018
40523,twitching,B-NAME_OF_DISEASE,2018
40524,appears,O,2018
40525,on,O,2018
40526,the,O,2018
40527,right,O,2018
40528,eye,O,2018
40529,as,O,2018
40530,well,O,2018
40531,Fatigue,B-CAUSE_OF_DISEASE,2018
40532,stress,B-CAUSE_OF_DISEASE,2018
40533,eye,B-CAUSE_OF_DISEASE,2018
40534,strain,I-CAUSE_OF_DISEASE,2018
40535,excessive,B-CAUSE_OF_DISEASE,2018
40536,caffeine,I-CAUSE_OF_DISEASE,2018
40537,intake,I-CAUSE_OF_DISEASE,2018
40538,dry,B-CAUSE_OF_DISEASE,2018
40539,eyes,I-CAUSE_OF_DISEASE,2018
40540,nutrition,B-CAUSE_OF_DISEASE,2018
40541,problems,I-CAUSE_OF_DISEASE,2019
40542,and,O,2019
40543,allergies,B-CAUSE_OF_DISEASE,2019
40544,are,O,2019
40545,among,O,2019
40546,the,O,2019
40547,causes,O,2019
40548,that,O,2019
40549,lead,O,2019
40550,to,O,2019
40551,it,O,2019
40552,When,O,2019
40553,should,O,2019
40554,I,O,2019
40555,be,O,2020
40556,worried,O,2020
40557,about,O,2020
40558,eye,B-NAME_OF_DISEASE,2020
40559,twitching,B-NAME_OF_DISEASE,2020
40560,If,O,2020
40561,the,O,2020
40562,twitching,B-NAME_OF_DISEASE,2020
40563,lasts,O,2020
40564,for,B-TIME_DURATION,2020
40565,more,I-TIME_DURATION,2020
40566,than,I-TIME_DURATION,2020
40567,2,I-TIME_DURATION,2020
40568,weeks,I-TIME_DURATION,2021
40569,and,O,2021
40570,if,O,2021
40571,you,O,2021
40572,are,O,2021
40573,experiencing,O,2021
40574,muscular,B-SIGN_AND_SYMPTOM,2021
40575,spasms,I-SIGN_AND_SYMPTOM,2021
40576,in,I-SIGN_AND_SYMPTOM,2021
40577,other,I-SIGN_AND_SYMPTOM,2021
40578,parts,I-SIGN_AND_SYMPTOM,2021
40579,of,I-SIGN_AND_SYMPTOM,2021
40580,your,I-SIGN_AND_SYMPTOM,2021
40581,body,I-SIGN_AND_SYMPTOM,2021
40582,and,O,2021
40583,especially,O,2021
40584,if,O,2021
40585,the,B-SIGN_AND_SYMPTOM,2021
40586,affected,I-SIGN_AND_SYMPTOM,2021
40587,part,I-SIGN_AND_SYMPTOM,2021
40588,feels,I-SIGN_AND_SYMPTOM,2022
40589,weak,I-SIGN_AND_SYMPTOM,2022
40590,or,I-SIGN_AND_SYMPTOM,2022
40591,stiff,I-SIGN_AND_SYMPTOM,2022
40592,it,O,2022
40593,s,O,2022
40594,better,O,2022
40595,if,O,2022
40596,you,O,2022
40597,get,O,2022
40598,yourself,O,2022
40599,checked,O,2022
40600,Sometimes,O,2022
40601,prescribed,O,2022
40602,medicine,O,2022
40603,can,O,2022
40604,be,O,2022
40605,the,O,2022
40606,reason,O,2022
40607,for,O,2022
40608,your,O,2022
40609,twitching,B-NAME_OF_DISEASE,2022
40610,How,O,2022
40611,do,O,2022
40612,I,O,2022
40613,stop,O,2022
40614,my,O,2022
40615,eye,O,2022
40616,from,O,2022
40617,twitching,B-NAME_OF_DISEASE,2022
40618,Generally,O,2023
40619,there,O,2023
40620,s,O,2023
40621,no,O,2023
40622,cure,O,2023
40623,or,O,2023
40624,remedy,O,2023
40625,for,O,2023
40626,eye,B-NAME_OF_DISEASE,2023
40627,twitching,B-NAME_OF_DISEASE,2023
40628,but,O,2023
40629,still,O,2023
40630,there,O,2023
40631,are,O,2023
40632,some,O,2023
40633,things,O,2023
40634,you,O,2023
40635,can,O,2023
40636,do,O,2023
40637,to,O,2023
40638,relieve,O,2023
40639,it,O,2023
40640,Try,O,2023
40641,to,O,2023
40642,rewind,B-TREATMENT,2023
40643,and,I-TREATMENT,2023
40644,get,I-TREATMENT,2023
40645,some,I-TREATMENT,2023
40646,rest,I-TREATMENT,2023
40647,and,I-TREATMENT,2023
40648,stretch,I-TREATMENT,2023
40649,your,I-TREATMENT,2023
40650,body,I-TREATMENT,2023
40651,if,I-TREATMENT,2023
40652,you,I-TREATMENT,2023
40653,feel,I-TREATMENT,2023
40654,stiffness,I-TREATMENT,2023
40655,in,I-TREATMENT,2023
40656,your,I-TREATMENT,2023
40657,muscles,I-TREATMENT,2023
40658,Don,O,2024
40659,t,O,2024
40660,worry,O,2024
40661,too,O,2024
40662,much,O,2024
40663,about,O,2024
40664,the,O,2024
40665,twitching,B-NAME_OF_DISEASE,2024
40666,as,O,2024
40667,it,O,2024
40668,may,O,2024
40669,worsen,O,2024
40670,the,O,2024
40671,situation,O,2024
40672,Is,O,2024
40673,eyelid,B-NAME_OF_DISEASE,2024
40674,twitching,I-NAME_OF_DISEASE,2024
40675,a,O,2024
40676,symptom,O,2024
40677,of,O,2024
40678,stroke,B-NAME_OF_DISEASE,2024
40679,There,O,2024
40680,s,O,2024
40681,no,O,2024
40682,reason,O,2024
40683,to,O,2024
40684,be,O,2024
40685,concerned,O,2024
40686,about,O,2024
40687,something,O,2024
40688,serious,O,2024
40689,when,O,2024
40690,your,O,2024
40691,eyes,O,2024
40692,twitch,O,2024
40693,However,O,2024
40694,in,O,2024
40695,some,O,2024
40696,cases,O,2024
40697,the,O,2024
40698,twitching,B-NAME_OF_DISEASE,2024
40699,may,O,2024
40700,be,O,2024
40701,an,O,2024
40702,indicator,O,2024
40703,of,O,2024
40704,stroke,B-NAME_OF_DISEASE,2024
40705,or,O,2024
40706,TIA,B-NAME_OF_DISEASE,2024
40707,when,O,2025
40708,you,O,2025
40709,have,O,2025
40710,other,O,2025
40711,symptoms,O,2025
40712,Make,O,2025
40713,sure,O,2025
40714,to,O,2025
40715,seek,O,2025
40716,a,O,2025
40717,medical,O,2025
40718,examination,O,2025
40719,if,O,2025
40720,you,O,2025
40721,Suddenly,B-SIGN_AND_SYMPTOM,2025
40722,feel,I-SIGN_AND_SYMPTOM,2025
40723,dizzy,I-SIGN_AND_SYMPTOM,2025
40724,have,I-SIGN_AND_SYMPTOM,2025
40725,a,I-SIGN_AND_SYMPTOM,2025
40726,headache,I-SIGN_AND_SYMPTOM,2025
40727,or,I-SIGN_AND_SYMPTOM,2025
40728,lose,I-SIGN_AND_SYMPTOM,2025
40729,your,I-SIGN_AND_SYMPTOM,2025
40730,sense,I-SIGN_AND_SYMPTOM,2025
40731,of,I-SIGN_AND_SYMPTOM,2025
40732,coordination,I-SIGN_AND_SYMPTOM,2026
40733,Have,O,2026
40734,blurred,O,2026
40735,or,O,2026
40736,double,O,2026
40737,vision,O,2026
40738,or,O,2026
40739,loss,O,2026
40740,of,O,2026
40741,vision,O,2026
40742,in,O,2026
40743,your,O,2026
40744,Feel,B-SIGN_AND_SYMPTOM,2026
40745,numb,I-SIGN_AND_SYMPTOM,2026
40746,on,I-SIGN_AND_SYMPTOM,2026
40747,one,I-SIGN_AND_SYMPTOM,2026
40748,side,I-SIGN_AND_SYMPTOM,2026
40749,of,I-SIGN_AND_SYMPTOM,2026
40750,the,I-SIGN_AND_SYMPTOM,2026
40751,face,I-SIGN_AND_SYMPTOM,2026
40752,or,I-SIGN_AND_SYMPTOM,2026
40753,if,I-SIGN_AND_SYMPTOM,2026
40754,you,I-SIGN_AND_SYMPTOM,2026
40755,see,I-SIGN_AND_SYMPTOM,2026
40756,an,I-SIGN_AND_SYMPTOM,2026
40757,uneven,I-SIGN_AND_SYMPTOM,2026
40758,smile,I-SIGN_AND_SYMPTOM,2026
40759,Feel,B-SIGN_AND_SYMPTOM,2026
40760,your,I-SIGN_AND_SYMPTOM,2026
40761,arms,I-SIGN_AND_SYMPTOM,2026
40762,or,I-SIGN_AND_SYMPTOM,2026
40763,legs,I-SIGN_AND_SYMPTOM,2026
40764,are,I-SIGN_AND_SYMPTOM,2027
40765,weak,I-SIGN_AND_SYMPTOM,2027
40766,Experience,B-SIGN_AND_SYMPTOM,2027
40767,difficulties,I-SIGN_AND_SYMPTOM,2027
40768,when,I-SIGN_AND_SYMPTOM,2027
40769,speaking,I-SIGN_AND_SYMPTOM,2027
40770,or,I-SIGN_AND_SYMPTOM,2028
40771,understanding,I-SIGN_AND_SYMPTOM,2028
40772,Do,O,2028
40773,brain,B-NAME_OF_DISEASE,2028
40774,tumors,I-NAME_OF_DISEASE,2028
40775,cause,O,2028
40776,eye,B-NAME_OF_DISEASE,2028
40777,twitching,B-NAME_OF_DISEASE,2028
40778,When,O,2028
40779,the,O,2028
40780,twitching,B-NAME_OF_DISEASE,2028
40781,lasts,O,2028
40782,a,O,2028
40783,little,O,2028
40784,longer,O,2028
40785,than,O,2028
40786,we,O,2028
40787,expected,O,2028
40788,we,O,2028
40789,think,O,2028
40790,of,O,2028
40791,the,O,2028
40792,worst-case,O,2028
40793,scenario,O,2028
40794,and,O,2028
40795,convince,O,2028
40796,ourselves,O,2028
40797,we,O,2028
40798,have,O,2028
40799,a,O,2028
40800,serious,O,2028
40801,problem,O,2028
40802,like,O,2029
40803,a,B-NAME_OF_DISEASE,2029
40804,brain,B-NAME_OF_DISEASE,2029
40805,tumor,I-NAME_OF_DISEASE,2029
40806,Typically,O,2029
40807,symptoms,O,2029
40808,of,O,2029
40809,brain,B-NAME_OF_DISEASE,2029
40810,tumor,I-NAME_OF_DISEASE,2029
40811,include,O,2029
40812,serious,B-SIGN_AND_SYMPTOM,2029
40813,headaches,I-SIGN_AND_SYMPTOM,2029
40814,and,I-SIGN_AND_SYMPTOM,2029
40815,confusion,I-SIGN_AND_SYMPTOM,2029
40816,in,I-SIGN_AND_SYMPTOM,2029
40817,understanding,I-SIGN_AND_SYMPTOM,2029
40818,seizures,I-SIGN_AND_SYMPTOM,2029
40819,and,I-SIGN_AND_SYMPTOM,2029
40820,blurred,I-SIGN_AND_SYMPTOM,2029
40821,and,I-SIGN_AND_SYMPTOM,2030
40822,double,I-SIGN_AND_SYMPTOM,2030
40823,vision,I-SIGN_AND_SYMPTOM,2030
40824,In,O,2030
40825,some,O,2030
40826,cases,O,2030
40827,though,O,2030
40828,brain,B-NAME_OF_DISEASE,2030
40829,tumors,I-NAME_OF_DISEASE,2030
40830,don,O,2030
40831,t,O,2030
40832,even,O,2030
40833,show,O,2030
40834,any,O,2030
40835,symptoms,O,2030
40836,at,O,2030
40837,all,O,2030
40838,As,O,2030
40839,timing,O,2030
40840,is,O,2030
40841,very,O,2030
40842,crucial,O,2030
40843,make,O,2030
40844,sure,O,2030
40845,to,O,2030
40846,set,O,2030
40847,an,O,2030
40848,appointment,O,2030
40849,with,O,2031
40850,a,O,2031
40851,professional,O,2031
40852,if,O,2031
40853,you,O,2031
40854,experience,O,2031
40855,any,O,2031
40856,of,O,2031
40857,the,O,2031
40858,symptoms,O,2031
40859,stated,O,2031
40860,above,O,2031
40861,Can,O,2031
40862,dehydration,O,2031
40863,cause,O,2031
40864,eye,B-NAME_OF_DISEASE,2031
40865,twitching,B-NAME_OF_DISEASE,2031
40866,When,O,2031
40867,electrolytes,B-CHEMICAL_COMPOUND,2031
40868,such,O,2031
40869,as,O,2031
40870,magnesium,B-CHEMICAL_COMPOUND,2031
40871,are,O,2031
40872,imbalanced,O,2031
40873,in,O,2031
40874,your,O,2031
40875,body,O,2031
40876,you,O,2031
40877,may,O,2031
40878,experience,O,2031
40879,muscle,B-SIGN_AND_SYMPTOM,2032
40880,spasms,I-SIGN_AND_SYMPTOM,2032
40881,anywhere,O,2032
40882,in,O,2032
40883,your,O,2032
40884,body,O,2032
40885,A,B-CAUSE_OF_DISEASE,2032
40886,deficiency,I-CAUSE_OF_DISEASE,2032
40887,of,I-CAUSE_OF_DISEASE,2032
40888,vitamins,I-CAUSE_OF_DISEASE,2032
40889,especially,I-CAUSE_OF_DISEASE,2032
40890,D,I-CAUSE_OF_DISEASE,2032
40891,or,I-CAUSE_OF_DISEASE,2032
40892,B12,I-CAUSE_OF_DISEASE,2032
40893,also,O,2032
40894,affects,O,2032
40895,our,O,2032
40896,bones,O,2032
40897,and,O,2032
40898,muscles,O,2032
40899,In,O,2032
40900,both,O,2032
40901,cases,O,2032
40902,it,O,2032
40903,is,O,2033
40904,very,O,2033
40905,likely,O,2033
40906,to,O,2033
40907,observe,O,2033
40908,eye,B-NAME_OF_DISEASE,2033
40909,twitching,B-NAME_OF_DISEASE,2033
40910,Can,O,2033
40911,anxiety,B-CAUSE_OF_DISEASE,2033
40912,cause,O,2033
40913,eye,B-NAME_OF_DISEASE,2033
40914,twitching,B-NAME_OF_DISEASE,2033
40915,Whenever,O,2033
40916,we,O,2033
40917,feel,O,2033
40918,anxious,B-CAUSE_OF_DISEASE,2033
40919,we,O,2033
40920,feel,O,2033
40921,our,O,2033
40922,bodies,O,2033
40923,tense,O,2033
40924,up,O,2034
40925,and,O,2034
40926,we,O,2034
40927,end,O,2034
40928,up,O,2034
40929,feeling,B-CAUSE_OF_DISEASE,2034
40930,stressed,I-CAUSE_OF_DISEASE,2034
40931,This,O,2034
40932,condition,O,2034
40933,affects,O,2034
40934,our,O,2034
40935,nervous,O,2034
40936,system,O,2034
40937,causing,O,2034
40938,our,O,2034
40939,muscles,O,2034
40940,to,O,2034
40941,twitch,O,2034
40942,Does,O,2034
40943,depression,B-CAUSE_OF_DISEASE,2034
40944,cause,O,2034
40945,eye,B-NAME_OF_DISEASE,2034
40946,twitching,B-NAME_OF_DISEASE,2035
40947,Not,O,2035
40948,just,O,2035
40949,depression,B-CAUSE_OF_DISEASE,2035
40950,but,O,2035
40951,also,O,2035
40952,stress,B-CAUSE_OF_DISEASE,2035
40953,and,O,2035
40954,anxiety,B-CAUSE_OF_DISEASE,2035
40955,are,O,2035
40956,among,O,2035
40957,the,O,2035
40958,causes,O,2035
40959,increase,O,2035
40960,fasciculation,O,2035
40961,potential,O,2035
40962,Usually,O,2035
40963,these,O,2035
40964,twitches,O,2035
40965,are,O,2035
40966,called,O,2035
40967,BFS,B-NAME_OF_DISEASE,2035
40968,Whenever,O,2035
40969,you,O,2035
40970,feel,O,2035
40971,tense,O,2035
40972,it,O,2035
40973,s,O,2035
40974,of,O,2035
40975,great,O,2036
40976,importance,O,2036
40977,to,O,2036
40978,calm,O,2036
40979,down,O,2036
40980,Worrying,O,2036
40981,makes,O,2036
40982,the,O,2036
40983,twitching,B-NAME_OF_DISEASE,2036
40984,condition,O,2036
40985,even,O,2036
40986,worse,O,2036
40987,What,O,2036
40988,do,O,2036
40989,ALS,B-NAME_OF_DISEASE,2036
40990,twitches,I-NAME_OF_DISEASE,2036
40991,feel,O,2036
40992,like,O,2037
40993,There,O,2037
40994,are,O,2037
40995,many,O,2037
40996,symptoms,O,2037
40997,of,O,2037
40998,ALS,B-NAME_OF_DISEASE,2037
40999,but,O,2037
41000,twitching,B-SIGN_AND_SYMPTOM,2037
41001,in,I-SIGN_AND_SYMPTOM,2037
41002,the,I-SIGN_AND_SYMPTOM,2037
41003,upper,I-SIGN_AND_SYMPTOM,2037
41004,and,I-SIGN_AND_SYMPTOM,2037
41005,lower,I-SIGN_AND_SYMPTOM,2037
41006,eyelids,I-SIGN_AND_SYMPTOM,2037
41007,is,O,2037
41008,only,O,2037
41009,one,O,2037
41010,of,O,2037
41011,the,O,2037
41012,many,O,2037
41013,symptoms,O,2037
41014,It,O,2037
41015,s,O,2037
41016,very,O,2037
41017,possible,O,2037
41018,to,O,2037
41019,oversee,O,2037
41020,the,O,2037
41021,early,O,2037
41022,symptoms,O,2037
41023,as,O,2037
41024,they,O,2037
41025,re,O,2037
41026,pretty,O,2037
41027,difficult,O,2037
41028,to,O,2038
41029,identify,O,2038
41030,Usually,O,2038
41031,they,O,2038
41032,go,O,2038
41033,unnoticed,O,2038
41034,and,O,2038
41035,gradually,O,2038
41036,get,O,2038
41037,worse,O,2038
41038,until,O,2038
41039,the,O,2038
41040,diagnosis,O,2038
41041,is,O,2038
41042,sought,O,2038
41043,If,O,2038
41044,you,O,2038
41045,cannot,B-SIGN_AND_SYMPTOM,2038
41046,chew,I-SIGN_AND_SYMPTOM,2038
41047,while,I-SIGN_AND_SYMPTOM,2038
41048,speaking,I-SIGN_AND_SYMPTOM,2038
41049,or,I-SIGN_AND_SYMPTOM,2038
41050,walking,I-SIGN_AND_SYMPTOM,2038
41051,İt,O,2038
41052,can,O,2038
41053,be,O,2038
41054,an,O,2038
41055,indicator,O,2038
41056,of,O,2038
41057,an,O,2038
41058,early,O,2038
41059,symptom,O,2038
41060,ALS,B-NAME_OF_DISEASE,2038
41061,doesn,O,2038
41062,t,O,2039
41063,affect,O,2039
41064,our,O,2039
41065,abilities,O,2039
41066,or,O,2039
41067,comprehension,O,2039
41068,In,O,2039
41069,some,O,2039
41070,cases,O,2039
41071,twitching,B-SIGN_AND_SYMPTOM,2039
41072,in,I-SIGN_AND_SYMPTOM,2039
41073,the,I-SIGN_AND_SYMPTOM,2040
41074,upper,I-SIGN_AND_SYMPTOM,2040
41075,and,I-SIGN_AND_SYMPTOM,2040
41076,lower,I-SIGN_AND_SYMPTOM,2040
41077,eyelids,I-SIGN_AND_SYMPTOM,2040
41078,is,O,2040
41079,accompanied,O,2040
41080,by,O,2040
41081,other,O,2040
41082,symptoms,O,2040
41083,like,O,2040
41084,irritation,B-SIGN_AND_SYMPTOM,2040
41085,or,I-SIGN_AND_SYMPTOM,2040
41086,blurred,I-SIGN_AND_SYMPTOM,2040
41087,double,I-SIGN_AND_SYMPTOM,2040
41088,seeing,I-SIGN_AND_SYMPTOM,2040
41089,Frontera,B-ORGANIZATION,2040
41090,Therapeutics,I-ORGANIZATION,2040
41091,has,O,2041
41092,initiated,O,2041
41093,a,O,2041
41094,clinical,O,2041
41095,trial,O,2041
41096,for,O,2041
41097,its,O,2041
41098,gene,B-TREATMENT,2041
41099,therapy,I-TREATMENT,2041
41100,FT-002,B-TREATMENT,2041
41101,which,O,2041
41102,is,O,2041
41103,intended,O,2041
41104,for,O,2041
41105,the,O,2041
41106,treatment,O,2041
41107,of,O,2041
41108,X-linked,B-NAME_OF_DISEASE,2041
41109,retinitis,I-NAME_OF_DISEASE,2041
41110,pigmentosa,I-NAME_OF_DISEASE,2041
41111,XLRP,B-NAME_OF_DISEASE,2041
41112,,O,2041
41113,The,O,2042
41114,first,O,2042
41115,patient,O,2042
41116,has,O,2042
41117,already,O,2042
41118,been,O,2042
41119,given,O,2042
41120,a,O,2042
41121,dose,O,2042
41122,of,O,2042
41123,the,O,2042
41124,gene,O,2042
41125,therapy,O,2042
41126,product,O,2042
41127,FT-002,B-TREATMENT,2042
41128,is,O,2042
41129,Frontera,B-ORGANIZATION,2042
41130,s,I-ORGANIZATION,2042
41131,third,O,2042
41132,gene,O,2042
41133,therapy,O,2042
41134,product,O,2042
41135,candidate,O,2042
41136,to,O,2042
41137,enter,O,2043
41138,clinical,O,2043
41139,trials,O,2043
41140,I,O,2043
41141,am,O,2043
41142,very,O,2043
41143,pleased,O,2043
41144,with,O,2043
41145,our,O,2043
41146,speed,O,2043
41147,of,O,2043
41148,execution,O,2043
41149,and,O,2043
41150,the,O,2043
41151,rapid,O,2043
41152,buildup,O,2043
41153,of,O,2043
41154,our,O,2043
41155,medical,O,2044
41156,and,O,2044
41157,clinical,O,2044
41158,operations,O,2044
41159,capabilities,O,2045
41160,As,O,2045
41161,a,O,2045
41162,company,O,2045
41163,we,O,2045
41164,now,O,2045
41165,have,O,2045
41166,three,O,2045
41167,gene,O,2045
41168,therapy,O,2045
41169,clinical,O,2045
41170,studies,O,2045
41171,running,O,2045
41172,in,O,2045
41173,parallel,O,2045
41174,Xinyan,B-PERSON,2045
41175,Li,I-PERSON,2045
41176,PhD,I-PERSON,2045
41177,President,O,2045
41178,and,O,2045
41179,Chief,O,2045
41180,Medical,O,2045
41181,Officer,O,2045
41182,of,O,2045
41183,Frontera,B-ORGANIZATION,2045
41184,said,O,2045
41185,in,O,2045
41186,a,O,2045
41187,company,O,2045
41188,news,O,2046
41189,release,O,2046
41190,FT-002,B-TREATMENT,2046
41191,was,O,2046
41192,manufactured,O,2046
41193,entirely,O,2046
41194,in-house,O,2046
41195,and,O,2046
41196,administered,O,2046
41197,to,O,2046
41198,the,O,2046
41199,first,O,2046
41200,patient,O,2046
41201,as,O,2046
41202,a,O,2046
41203,first-in-class,O,2047
41204,product,O,2047
41205,again,O,2047
41206,validating,O,2047
41207,the,O,2047
41208,maturity,O,2047
41209,and,O,2047
41210,advancement,O,2047
41211,of,O,2047
41212,the,O,2047
41213,company,O,2047
41214,s,O,2047
41215,AAV,B-CHEMICAL_COMPOUND,2047
41216,R,O,2047
41217,D,O,2047
41218,platform,O,2047
41219,technology,O,2047
41220,said,O,2047
41221,Yong,B-PERSON,2047
41222,Dai,I-PERSON,2047
41223,PhD,I-PERSON,2047
41224,founder,O,2047
41225,and,O,2047
41226,CEO,O,2047
41227,of,O,2047
41228,Frontera,B-ORGANIZATION,2047
41229,Therapeutics,I-ORGANIZATION,2047
41230,Driven,O,2047
41231,by,O,2047
41232,our,O,2048
41233,mission,O,2048
41234,to,O,2048
41235,develop,O,2048
41236,novel,O,2048
41237,and,O,2048
41238,best-in-class,O,2048
41239,gene,O,2048
41240,therapies,O,2048
41241,the,O,2048
41242,Frontera,B-ORGANIZATION,2048
41243,team,O,2048
41244,accelerated,O,2048
41245,the,O,2048
41246,R,O,2048
41247,D,O,2048
41248,process,O,2048
41249,to,O,2048
41250,enable,O,2048
41251,FT-002,B-TREATMENT,2048
41252,to,O,2048
41253,enter,O,2048
41254,the,O,2048
41255,clinic,O,2048
41256,smoothly,O,2048
41257,and,O,2048
41258,we,O,2048
41259,believe,O,2048
41260,FT-002,B-TREATMENT,2048
41261,could,O,2048
41262,greatly,O,2048
41263,improve,O,2048
41264,the,O,2048
41265,quality,O,2048
41266,of,O,2048
41267,life,O,2048
41268,for,O,2048
41269,XLRP,B-NAME_OF_DISEASE,2048
41270,patients,O,2048
41271,for,O,2048
41272,whom,O,2048
41273,there,O,2048
41274,are,O,2048
41275,currently,O,2048
41276,no,O,2048
41277,effective,O,2049
41278,treatments,O,2049
41279,This,O,2049
41280,year,O,2049
41281,the,O,2049
41282,company,O,2049
41283,expects,O,2049
41284,to,O,2049
41285,advance,O,2049
41286,additional,O,2049
41287,product,O,2049
41288,candidates,O,2049
41289,into,O,2049
41290,preclinical,O,2049
41291,and,O,2049
41292,clinical,O,2049
41293,studies,O,2049
41294,which,O,2049
41295,we,O,2049
41296,believe,O,2049
41297,may,O,2049
41298,provide,O,2049
41299,more,O,2049
41300,patients,O,2050
41301,with,O,2050
41302,curative,O,2050
41303,opportunities,O,2050
41304,About,O,2050
41305,FT-002,B-TREATMENT,2050
41306,Gene,I-TREATMENT,2050
41307,Theraphy,I-TREATMENT,2050
41308,FT-002,B-TREATMENT,2051
41309,is,O,2051
41310,a,O,2051
41311,potential,O,2051
41312,first-in-class,O,2051
41313,gene,O,2051
41314,therapy,O,2051
41315,drug,O,2051
41316,created,O,2051
41317,using,O,2051
41318,a,O,2051
41319,recombinant,O,2051
41320,adeno-associated,O,2051
41321,virus,O,2051
41322,that,O,2051
41323,is,O,2051
41324,designed,O,2051
41325,to,O,2051
41326,treat,O,2051
41327,X-linked,B-NAME_OF_DISEASE,2051
41328,retinitis,I-NAME_OF_DISEASE,2051
41329,pigmentosa,I-NAME_OF_DISEASE,2051
41330,XLRP,B-NAME_OF_DISEASE,2051
41331,caused,O,2051
41332,by,O,2051
41333,RPGR,B-CAUSE_OF_DISEASE,2051
41334,gene,I-CAUSE_OF_DISEASE,2051
41335,mutation,I-CAUSE_OF_DISEASE,2051
41336,XLRP,B-NAME_OF_DISEASE,2051
41337,has,O,2051
41338,no,O,2051
41339,known,O,2051
41340,treatment,O,2051
41341,globally,O,2051
41342,FT-002,B-TREATMENT,2051
41343,is,O,2051
41344,administered,O,2051
41345,through,O,2051
41346,an,O,2051
41347,intraocular,O,2051
41348,injection,O,2051
41349,of,O,2051
41350,a,O,2051
41351,recombinant,O,2051
41352,AAV,B-CHEMICAL_COMPOUND,2051
41353,virus,I-CHEMICAL_COMPOUND,2051
41354,that,O,2051
41355,carries,O,2051
41356,the,O,2051
41357,gene,O,2051
41358,for,O,2051
41359,the,O,2051
41360,expression,O,2051
41361,of,O,2051
41362,active,O,2051
41363,functional,O,2051
41364,proteins,O,2051
41365,that,O,2052
41366,repair,O,2052
41367,the,O,2052
41368,damaged,O,2052
41369,retinal,O,2052
41370,cell,O,2052
41371,structure,O,2052
41372,and,O,2052
41373,function,O,2052
41374,A,O,2052
41375,single,O,2052
41376,injection,O,2052
41377,of,O,2052
41378,FT-002,B-TREATMENT,2052
41379,has,O,2052
41380,the,O,2052
41381,potential,O,2052
41382,to,O,2052
41383,delay,O,2052
41384,disease,O,2052
41385,progression,O,2052
41386,or,O,2052
41387,restore,O,2052
41388,the,O,2052
41389,patient,O,2052
41390,s,O,2052
41391,visual,O,2052
41392,function,O,2052
41393,This,O,2052
41394,gene,O,2052
41395,therapy,O,2052
41396,drug,O,2052
41397,is,O,2052
41398,being,O,2052
41399,tested,O,2052
41400,in,O,2052
41401,XLRP,B-NAME_OF_DISEASE,2052
41402,patients,O,2052
41403,in,O,2052
41404,China,B-GPE,2052
41405,and,O,2052
41406,if,O,2052
41407,successful,O,2052
41408,will,O,2052
41409,be,O,2052
41410,the,O,2052
41411,first,O,2052
41412,AAV,B-CHEMICAL_COMPOUND,2052
41413,gene,I-TREATMENT,2052
41414,therapy,I-TREATMENT,2052
41415,drug,I-TREATMENT,2052
41416,used,O,2052
41417,to,O,2052
41418,treat,O,2052
41419,this,O,2052
41420,condition,O,2052
41421,TelomEYE,B-ORGANIZATION,2052
41422,Pharmaceuticals,I-ORGANIZATION,2052
41423,Corporation,I-ORGANIZATION,2052
41424,working,O,2052
41425,on,O,2052
41426,a,O,2052
41427,new,O,2052
41428,generation,O,2052
41429,of,O,2052
41430,ophthalmologic,O,2052
41431,therapies,O,2052
41432,announced,O,2052
41433,today,O,2052
41434,the,O,2052
41435,completion,O,2052
41436,of,O,2052
41437,a,O,2052
41438,successful,O,2053
41439,1,O,2053
41440,million,O,2053
41441,post-seed,O,2053
41442,funding,O,2053
41443,round,O,2053
41444,valuing,O,2053
41445,the,O,2053
41446,company,O,2053
41447,at,O,2053
41448,10,O,2053
41449,million,O,2053
41450,USD,O,2053
41451,The,O,2053
41452,round,O,2053
41453,was,O,2053
41454,co-led,O,2053
41455,by,O,2053
41456,healthcare,O,2053
41457,mogul,O,2053
41458,Mehmet,B-PERSON,2053
41459,Ali,I-PERSON,2053
41460,Aydınlar,I-PERSON,2053
41461,Re-Pie,B-ORGANIZATION,2053
41462,Venture,I-ORGANIZATION,2054
41463,Capital,I-ORGANIZATION,2054
41464,Fund,I-ORGANIZATION,2054
41465,and,O,2054
41466,investment,O,2054
41467,banker,O,2054
41468,Kerim,B-PERSON,2054
41469,Kotan,I-PERSON,2054
41470,along,O,2054
41471,with,O,2054
41472,other,O,2054
41473,angel,O,2054
41474,investors,O,2054
41475,With,O,2054
41476,this,O,2054
41477,financing,O,2054
41478,TelomEYE,B-ORGANIZATION,2054
41479,will,O,2054
41480,be,O,2054
41481,able,O,2054
41482,to,O,2054
41483,complete,O,2054
41484,phase,O,2055
41485,I,O,2055
41486,II,O,2055
41487,human,O,2055
41488,studies,O,2055
41489,for,O,2055
41490,their,O,2055
41491,novel,O,2055
41492,patented,O,2055
41493,therapy,O,2055
41494,in,O,2055
41495,ophthalmology,O,2055
41496,This,O,2055
41497,therapy,O,2055
41498,could,O,2055
41499,be,O,2055
41500,the,O,2055
41501,start,O,2055
41502,of,O,2055
41503,a,O,2055
41504,new,O,2055
41505,era,O,2055
41506,for,O,2055
41507,treating,O,2055
41508,many,O,2055
41509,ophthalmologic,B-NAME_OF_DISEASE,2055
41510,age-related,I-NAME_OF_DISEASE,2055
41511,disorders,I-NAME_OF_DISEASE,2055
41512,including,O,2056
41513,presbyopia,B-NAME_OF_DISEASE,2056
41514,cataracts,B-NAME_OF_DISEASE,2056
41515,and,O,2056
41516,macular,B-NAME_OF_DISEASE,2056
41517,degeneration,I-NAME_OF_DISEASE,2056
41518,TelomEYE,B-ORGANIZATION,2056
41519,is,O,2056
41520,a,O,2056
41521,privately,O,2056
41522,held,O,2056
41523,Canadian,O,2056
41524,ophthalmology,O,2056
41525,biotech,O,2056
41526,company,O,2056
41527,founded,O,2056
41528,in,O,2056
41529,September,O,2056
41530,2021,O,2056
41531,by,O,2057
41532,ophthalmologists,O,2057
41533,Iskender,B-PERSON,2057
41534,Alkin,I-PERSON,2057
41535,Solmaz,I-PERSON,2057
41536,MD,I-PERSON,2057
41537,Isilay,B-PERSON,2057
41538,Kavadarli,I-PERSON,2057
41539,MD,I-PERSON,2057
41540,and,O,2057
41541,entrepreneur,O,2057
41542,Kubilay,B-PERSON,2057
41543,Turkmen,I-PERSON,2057
41544,in,O,2057
41545,Ontario,B-GPE,2057
41546,Canada,I-GPE,2057
41547,The,O,2057
41548,founders,O,2057
41549,had,O,2057
41550,initially,O,2057
41551,self-funded,O,2057
41552,TelomEYE,B-ORGANIZATION,2057
41553,for,O,2057
41554,their,O,2057
41555,novel,O,2057
41556,formulation,O,2057
41557,development,O,2058
41558,patent,O,2058
41559,applications,O,2058
41560,and,O,2058
41561,pre-human,O,2058
41562,animal,O,2058
41563,trials,O,2058
41564,What,O,2058
41565,if,O,2058
41566,we,O,2058
41567,could,O,2058
41568,read,O,2058
41569,without,O,2058
41570,glasses,O,2058
41571,in,O,2058
41572,our,O,2058
41573,40s,O,2058
41574,and,O,2058
41575,beyond,O,2058
41576,TelomEYE,B-ORGANIZATION,2058
41577,launched,O,2058
41578,to,O,2059
41579,prevent,O,2059
41580,and,O,2059
41581,improve,O,2059
41582,age-related,B-NAME_OF_DISEASE,2059
41583,ophthalmologic,I-NAME_OF_DISEASE,2059
41584,disorders,I-NAME_OF_DISEASE,2059
41585,such,O,2059
41586,as,O,2059
41587,presbyopia,B-NAME_OF_DISEASE,2059
41588,cataracts,B-NAME_OF_DISEASE,2059
41589,and,O,2059
41590,macular,B-NAME_OF_DISEASE,2059
41591,degeneration,I-NAME_OF_DISEASE,2059
41592,each,O,2059
41593,of,O,2059
41594,which,O,2059
41595,is,O,2059
41596,a,O,2059
41597,major,O,2060
41598,medical,O,2060
41599,need,O,2060
41600,Presbyopia,B-NAME_OF_DISEASE,2060
41601,a,O,2060
41602,condition,O,2060
41603,which,O,2060
41604,makes,O,2060
41605,it,O,2060
41606,harder,B-SIGN_AND_SYMPTOM,2060
41607,for,I-SIGN_AND_SYMPTOM,2060
41608,the,I-SIGN_AND_SYMPTOM,2060
41609,eyes,I-SIGN_AND_SYMPTOM,2061
41610,to,I-SIGN_AND_SYMPTOM,2061
41611,focus,I-SIGN_AND_SYMPTOM,2061
41612,on,I-SIGN_AND_SYMPTOM,2061
41613,close,I-SIGN_AND_SYMPTOM,2061
41614,objects,I-SIGN_AND_SYMPTOM,2061
41615,after,I-SIGN_AND_SYMPTOM,2061
41616,early,I-SIGN_AND_SYMPTOM,2061
41617,40s,I-SIGN_AND_SYMPTOM,2061
41618,is,O,2061
41619,one,O,2061
41620,of,O,2061
41621,the,O,2061
41622,most,O,2061
41623,common,O,2061
41624,age-related,B-NAME_OF_DISEASE,2061
41625,ophthalmologic,I-NAME_OF_DISEASE,2061
41626,disorders,I-NAME_OF_DISEASE,2061
41627,in,O,2061
41628,the,O,2061
41629,world,O,2061
41630,with,O,2062
41631,an,O,2062
41632,estimated,O,2062
41633,2,O,2062
41634,billion,O,2062
41635,sufferers,O,2062
41636,worldwide,O,2062
41637,by,O,2062
41638,2030,O,2062
41639,according,O,2062
41640,to,O,2062
41641,the,B-ORGANIZATION,2062
41642,World,I-ORGANIZATION,2062
41643,Health,I-ORGANIZATION,2062
41644,Organisation,I-ORGANIZATION,2062
41645,It,O,2062
41646,is,O,2062
41647,a,O,2062
41648,fact,O,2062
41649,that,O,2062
41650,everyone,O,2062
41651,over,O,2062
41652,the,O,2062
41653,age,O,2063
41654,of,O,2063
41655,40s,O,2063
41656,faces,O,2063
41657,the,O,2063
41658,need,O,2063
41659,for,O,2063
41660,reading,O,2063
41661,glasses,O,2063
41662,eventually,O,2063
41663,TelomEYE,B-ORGANIZATION,2063
41664,treatment,O,2063
41665,has,O,2063
41666,a,O,2063
41667,unique,O,2063
41668,formulation,O,2063
41669,that,O,2063
41670,prevents,O,2063
41671,the,B-NAME_OF_DISEASE,2063
41672,cellular,I-NAME_OF_DISEASE,2063
41673,aging,I-NAME_OF_DISEASE,2063
41674,of,O,2063
41675,the,O,2063
41676,compartments,O,2063
41677,of,O,2063
41678,the,O,2063
41679,eyes,O,2063
41680,and,O,2063
41681,may,O,2064
41682,even,O,2064
41683,rejuvenate,O,2064
41684,them,O,2064
41685,Starting,O,2064
41686,in,O,2064
41687,our,O,2064
41688,late,O,2064
41689,30s,O,2064
41690,daily,O,2064
41691,use,O,2064
41692,of,O,2064
41693,TelomEYE,B-ORGANIZATION,2064
41694,could,O,2064
41695,remove,O,2064
41696,or,O,2064
41697,delay,O,2064
41698,the,O,2064
41699,necessity,O,2064
41700,of,O,2064
41701,reading,O,2064
41702,glasses,O,2065
41703,at,O,2065
41704,later,O,2065
41705,stages,O,2065
41706,of,O,2065
41707,the,O,2065
41708,life,O,2065
41709,Patients,O,2065
41710,with,O,2065
41711,dry,B-NAME_OF_DISEASE,2065
41712,eye,I-NAME_OF_DISEASE,2065
41713,syndrome,I-NAME_OF_DISEASE,2065
41714,which,O,2065
41715,is,O,2065
41716,a,O,2065
41717,very,O,2065
41718,common,O,2065
41719,health,O,2065
41720,problem,O,2065
41721,may,O,2065
41722,have,O,2065
41723,beneficial,O,2065
41724,effects,O,2065
41725,as,O,2065
41726,well,O,2065
41727,Iskender,O,2065
41728,Alkin,O,2065
41729,Solmaz,O,2066
41730,M.D,O,2066
41731,Co-Founder,O,2066
41732,and,O,2066
41733,Chief,O,2066
41734,Medical,O,2066
41735,Officer,O,2066
41736,of,O,2066
41737,TelomEYE,B-ORGANIZATION,2066
41738,said,O,2066
41739,Advances,O,2066
41740,in,O,2066
41741,research,O,2066
41742,are,O,2066
41743,revealing,O,2066
41744,new,O,2066
41745,opportunities,O,2066
41746,to,O,2066
41747,translate,O,2066
41748,science,O,2066
41749,into,O,2066
41750,solutions,O,2066
41751,that,O,2066
41752,can,O,2067
41753,help,O,2067
41754,people,O,2067
41755,in,O,2067
41756,preventing,O,2067
41757,age-related,B-NAME_OF_DISEASE,2067
41758,ophthalmologic,I-NAME_OF_DISEASE,2067
41759,disorders,I-NAME_OF_DISEASE,2067
41760,Neither,O,2067
41761,our,O,2067
41762,scientific,O,2067
41763,platform,O,2067
41764,nor,O,2067
41765,our,O,2067
41766,patented,O,2067
41767,technology,O,2067
41768,has,O,2067
41769,ever,O,2067
41770,been,O,2067
41771,utilized,O,2067
41772,in,O,2067
41773,ophthalmology,O,2067
41774,before,O,2067
41775,We,O,2067
41776,are,O,2067
41777,fully,O,2068
41778,committed,O,2068
41779,to,O,2068
41780,delivering,O,2068
41781,this,O,2068
41782,therapy,O,2068
41783,potentially,O,2068
41784,reducing,O,2068
41785,the,O,2068
41786,magnitude,O,2068
41787,of,O,2068
41788,most,O,2068
41789,of,O,2068
41790,the,B-NAME_OF_DISEASE,2068
41791,age-related,I-NAME_OF_DISEASE,2068
41792,ophthalmologic,I-NAME_OF_DISEASE,2069
41793,disorders,I-NAME_OF_DISEASE,2069
41794,to,O,2070
41795,make,O,2070
41796,a,O,2070
41797,significant,O,2070
41798,long-term,O,2070
41799,and,O,2070
41800,sustainable,O,2070
41801,impact,O,2070
41802,on,O,2070
41803,lives,O,2070
41804,Bausch,B-ORGANIZATION,2070
41805,+,I-ORGANIZATION,2070
41806,Lomb,I-ORGANIZATION,2070
41807,and,O,2070
41808,Alfa,B-ORGANIZATION,2070
41809,Instruments,I-ORGANIZATION,2070
41810,announced,O,2070
41811,that,O,2070
41812,they,O,2070
41813,have,O,2070
41814,signed,O,2070
41815,an,O,2070
41816,exclusive,O,2070
41817,distribution,O,2070
41818,agreement,O,2070
41819,under,O,2070
41820,which,O,2071
41821,Bausch,B-ORGANIZATION,2071
41822,+,I-ORGANIZATION,2072
41823,Lomb,I-ORGANIZATION,2072
41824,will,O,2072
41825,market,O,2072
41826,and,O,2072
41827,distribute,O,2072
41828,Vitreocare,B-SURGICAL_INSTRUMENT,2072
41829,a,O,2072
41830,line,O,2072
41831,of,O,2072
41832,surgical,B-SURGICAL_INSTRUMENT,2072
41833,intraocular,B-SURGICAL_INSTRUMENT,2072
41834,dyes,I-SURGICAL_INSTRUMENT,2072
41835,from,O,2072
41836,Alfa,B-ORGANIZATION,2072
41837,Instruments,I-ORGANIZATION,2072
41838,worldwide,O,2072
41839,with,O,2072
41840,the,O,2072
41841,exception,O,2072
41842,of,O,2072
41843,Italy,B-GPE,2072
41844,where,O,2073
41845,Alfa,B-ORGANIZATION,2073
41846,Instruments,I-ORGANIZATION,2073
41847,is,O,2073
41848,headquartered,O,2073
41849,With,O,2073
41850,Alfa,B-ORGANIZATION,2073
41851,Instruments,I-ORGANIZATION,2073
41852,intraocular,B-SURGICAL_INSTRUMENT,2073
41853,dyes,I-SURGICAL_INSTRUMENT,2073
41854,the,O,2073
41855,agreement,O,2073
41856,expands,O,2073
41857,and,O,2073
41858,improves,O,2073
41859,Bausch,B-ORGANIZATION,2073
41860,+,I-ORGANIZATION,2073
41861,Lomb,I-ORGANIZATION,2073
41862,s,O,2073
41863,surgical,O,2073
41864,portfolio,O,2073
41865,offering,O,2073
41866,in,O,2073
41867,the,B-ORGANIZATION,2073
41868,European,I-ORGANIZATION,2073
41869,Union,I-ORGANIZATION,2073
41870,EU,B-ORGANIZATION,2073
41871,,O,2073
41872,Financial,O,2074
41873,terms,O,2074
41874,of,O,2074
41875,the,O,2074
41876,deal,O,2074
41877,were,O,2074
41878,not,O,2074
41879,disclosed,O,2074
41880,The,O,2074
41881,addition,O,2074
41882,of,O,2074
41883,these,O,2074
41884,clinically,O,2074
41885,proven,O,2074
41886,intraocular,B-SURGICAL_INSTRUMENT,2074
41887,dyes,I-SURGICAL_INSTRUMENT,2074
41888,to,O,2074
41889,our,O,2074
41890,already,O,2074
41891,comprehensive,O,2074
41892,surgical,O,2075
41893,portfolio,O,2075
41894,will,O,2075
41895,help,O,2075
41896,surgeons,O,2075
41897,enhance,O,2075
41898,the,O,2075
41899,visibility,O,2075
41900,of,O,2075
41901,targeted,O,2075
41902,eye,B-PART_OF_THE_EYES,2075
41903,tissues,I-PART_OF_THE_EYES,2075
41904,as,O,2075
41905,well,O,2075
41906,as,O,2075
41907,identify,O,2075
41908,transparent,B-PART_OF_THE_EYES,2075
41909,layers,I-PART_OF_THE_EYES,2075
41910,of,I-PART_OF_THE_EYES,2075
41911,the,I-PART_OF_THE_EYES,2075
41912,eye,I-PART_OF_THE_EYES,2075
41913,during,O,2075
41914,vitreoretinal,B-TREATMENT,2075
41915,corneal,I-TREATMENT,2075
41916,and,I-TREATMENT,2076
41917,cataract,I-TREATMENT,2076
41918,surgery,I-TREATMENT,2076
41919,Joe,B-PERSON,2076
41920,Gordon,I-PERSON,2076
41921,president,O,2076
41922,global,O,2076
41923,consumer,O,2076
41924,vision,O,2076
41925,care,O,2076
41926,and,O,2076
41927,surgical,O,2076
41928,Bausch,B-ORGANIZATION,2076
41929,+,I-ORGANIZATION,2076
41930,Lomb,I-ORGANIZATION,2077
41931,said,O,2077
41932,in,O,2077
41933,a,O,2077
41934,company,O,2077
41935,news,O,2077
41936,release,O,2077
41937,According,O,2078
41938,to,O,2078
41939,the,O,2078
41940,deal,O,2078
41941,Bausch,B-ORGANIZATION,2078
41942,+,I-ORGANIZATION,2078
41943,Lomb,I-ORGANIZATION,2078
41944,will,O,2078
41945,be,O,2078
41946,in,O,2078
41947,charge,O,2078
41948,of,O,2078
41949,all,O,2078
41950,sales,O,2078
41951,and,O,2078
41952,distribution,O,2078
41953,efforts,O,2078
41954,for,O,2079
41955,Vitreocare,B-SURGICAL_INSTRUMENT,2079
41956,intraocular,I-SURGICAL_INSTRUMENT,2079
41957,dyes,I-SURGICAL_INSTRUMENT,2079
41958,including,O,2079
41959,Vitreo,B-SURGICAL_INSTRUMENT,2079
41960,Lutein,I-SURGICAL_INSTRUMENT,2079
41961,for,O,2079
41962,vitreous,B-PART_OF_THE_EYES,2079
41963,staining,O,2079
41964,Single,B-SURGICAL_INSTRUMENT,2079
41965,Lutein,I-SURGICAL_INSTRUMENT,2079
41966,Blue,I-SURGICAL_INSTRUMENT,2079
41967,for,O,2079
41968,internal,B-PART_OF_THE_EYES,2079
41969,limiting,I-PART_OF_THE_EYES,2079
41970,membrane,I-PART_OF_THE_EYES,2079
41971,ILM,B-PART_OF_THE_EYES,2079
41972,staining,O,2079
41973,Double,B-SURGICAL_INSTRUMENT,2079
41974,Lutein,I-SURGICAL_INSTRUMENT,2079
41975,Blue,I-SURGICAL_INSTRUMENT,2079
41976,for,O,2079
41977,ILM,B-PART_OF_THE_EYES,2079
41978,and,O,2079
41979,epiretinal,B-PART_OF_THE_EYES,2079
41980,membrane,I-PART_OF_THE_EYES,2079
41981,ERM,I-PART_OF_THE_EYES,2080
41982,staining,O,2080
41983,Phaco,B-SURGICAL_INSTRUMENT,2080
41984,Lutein,I-SURGICAL_INSTRUMENT,2080
41985,for,O,2080
41986,anterior,B-PART_OF_THE_EYES,2080
41987,capsule,I-PART_OF_THE_EYES,2080
41988,staining,O,2080
41989,Trypan,B-SURGICAL_INSTRUMENT,2080
41990,Blue,I-SURGICAL_INSTRUMENT,2080
41991,for,O,2080
41992,anterior,B-PART_OF_THE_EYES,2080
41993,capsule,I-PART_OF_THE_EYES,2080
41994,staining,O,2080
41995,The,O,2080
41996,unique,O,2080
41997,common,O,2080
41998,thread,O,2080
41999,of,O,2080
42000,Vitreocare,B-SURGICAL_INSTRUMENT,2080
42001,intraocular,I-SURGICAL_INSTRUMENT,2080
42002,dyes,I-SURGICAL_INSTRUMENT,2080
42003,is,O,2080
42004,lutein,B-CHEMICAL_COMPOUND,2080
42005,a,O,2080
42006,natural,O,2080
42007,blue,O,2080
42008,light,O,2080
42009,filter,O,2080
42010,Research,O,2080
42011,has,O,2080
42012,shown,O,2080
42013,that,O,2080
42014,lutein,B-CHEMICAL_COMPOUND,2080
42015,is,O,2080
42016,a,O,2080
42017,safe,O,2080
42018,and,O,2081
42019,effective,O,2081
42020,dye,O,2081
42021,agent,O,2081
42022,and,O,2081
42023,its,O,2081
42024,antioxidant,O,2081
42025,properties,O,2081
42026,can,O,2081
42027,further,O,2081
42028,protect,O,2081
42029,the,B-PART_OF_THE_EYES,2081
42030,retina,I-PART_OF_THE_EYES,2081
42031,during,O,2081
42032,eye,O,2081
42033,surgery.1-,O,2081
42034,Moreover,O,2081
42035,Single,B-SURGICAL_INSTRUMENT,2081
42036,Lutein,I-SURGICAL_INSTRUMENT,2081
42037,Blue,I-SURGICAL_INSTRUMENT,2081
42038,and,O,2081
42039,Double,B-SURGICAL_INSTRUMENT,2081
42040,Lutein,I-SURGICAL_INSTRUMENT,2082
42041,Blue,I-SURGICAL_INSTRUMENT,2082
42042,are,O,2083
42043,formulated,O,2083
42044,with,O,2083
42045,the,O,2083
42046,new,O,2083
42047,high,O,2084
42048,purity,O,2084
42049,99%,O,2084
42050,molecule,B-CHEMICAL_COMPOUND,2084
42051,Pure,I-CHEMICAL_COMPOUND,2084
42052,Benzyl-Brilliant,I-CHEMICAL_COMPOUND,2084
42053,Blue,I-CHEMICAL_COMPOUND,2084
42054,PBB,I-CHEMICAL_COMPOUND,2084
42055,,O,2084
42056,PBB,B-CHEMICAL_COMPOUND,2084
42057,has,O,2084
42058,been,O,2084
42059,specifically,O,2084
42060,designed,O,2084
42061,in,O,2084
42062,order,O,2084
42063,to,O,2084
42064,improve,O,2084
42065,ILM,B-PART_OF_THE_EYES,2084
42066,binding,O,2084
42067,affinity,O,2084
42068,and,O,2084
42069,to,O,2084
42070,avoid,O,2084
42071,diffusion,O,2084
42072,into,O,2084
42073,retinal,B-PART_OF_THE_EYES,2084
42074,layers,I-PART_OF_THE_EYES,2084
42075,in,O,2084
42076,order,O,2084
42077,to,O,2084
42078,avoid,O,2084
42079,potential,O,2084
42080,cytotoxicity,O,2085
42081,on,O,2085
42082,off-target,O,2085
42083,tissues.,O,2085
42084,Currently,O,2085
42085,surgical,B-SURGICAL_INSTRUMENT,2085
42086,dyes,I-SURGICAL_INSTRUMENT,2085
42087,from,O,2085
42088,Alfa,B-ORGANIZATION,2085
42089,Instruments,I-ORGANIZATION,2085
42090,are,O,2085
42091,CE-marked,O,2085
42092,and,O,2085
42093,offered,O,2085
42094,for,O,2085
42095,sale,O,2085
42096,in,O,2085
42097,Switzerland,B-GPE,2085
42098,the,B-ORGANIZATION,2085
42099,EU,B-ORGANIZATION,2086
42100,and,O,2086
42101,the,B-GPE,2086
42102,UK,I-GPE,2086
42103,With,O,2086
42104,the,O,2086
42105,exception,O,2086
42106,of,O,2086
42107,Italy,B-GPE,2086
42108,Bausch,B-ORGANIZATION,2086
42109,+,I-ORGANIZATION,2086
42110,Lomb,I-ORGANIZATION,2086
42111,anticipates,O,2087
42112,starting,O,2087
42113,the,O,2087
42114,distribution,O,2087
42115,of,O,2087
42116,the,B-SURGICAL_INSTRUMENT,2087
42117,intraocular,I-SURGICAL_INSTRUMENT,2087
42118,dyes,I-SURGICAL_INSTRUMENT,2087
42119,in,O,2087
42120,all,O,2087
42121,EU,B-ORGANIZATION,2087
42122,nations,O,2087
42123,in,O,2087
42124,the,O,2087
42125,first,O,2087
42126,half,O,2087
42127,of,O,2087
42128,2023,O,2087
42129,Additionally,O,2087
42130,Bausch,B-ORGANIZATION,2087
42131,+,I-ORGANIZATION,2087
42132,Lomb,I-ORGANIZATION,2087
42133,and,O,2088
42134,Alfa,B-ORGANIZATION,2088
42135,Instruments,I-ORGANIZATION,2088
42136,are,O,2088
42137,investigating,O,2088
42138,the,O,2088
42139,legal,O,2088
42140,requirements,O,2088
42141,and,O,2088
42142,commercial,O,2088
42143,acceptance,O,2088
42144,of,O,2088
42145,surgical,B-SURGICAL_INSTRUMENT,2088
42146,dyes,I-SURGICAL_INSTRUMENT,2088
42147,in,O,2088
42148,other,O,2088
42149,countries,O,2088
42150,Robin,B-PERSON,2088
42151,Kuriakose,I-PERSON,2089
42152,MD,I-PERSON,2089
42153,a,O,2089
42154,fellow,O,2089
42155,physician,O,2089
42156,in,O,2089
42157,cornea,B-PART_OF_THE_EYES,2089
42158,and,O,2089
42159,refractive,O,2089
42160,surgery,O,2089
42161,at,O,2089
42162,the,O,2089
42163,Northwestern,B-ORGANIZATION,2089
42164,Memorial,I-ORGANIZATION,2089
42165,Hospital,I-ORGANIZATION,2089
42166,has,O,2089
42167,introduced,O,2089
42168,SightKick,B-TREATMENT,2089
42169,The,O,2089
42170,new,O,2089
42171,MacOS,O,2089
42172,application,O,2089
42173,is,O,2089
42174,specifically,O,2089
42175,designed,O,2089
42176,to,O,2089
42177,reduce,O,2089
42178,digital,B-NAME_OF_DISEASE,2089
42179,eye,I-NAME_OF_DISEASE,2090
42180,strain,I-NAME_OF_DISEASE,2091
42181,Digital,B-NAME_OF_DISEASE,2091
42182,eye,I-NAME_OF_DISEASE,2091
42183,strain,I-NAME_OF_DISEASE,2091
42184,is,O,2091
42185,a,O,2091
42186,growing,O,2091
42187,issue,O,2091
42188,considering,O,2091
42189,how,O,2091
42190,much,O,2091
42191,time,O,2091
42192,we,O,2091
42193,spend,O,2091
42194,in,O,2091
42195,front,O,2091
42196,of,O,2091
42197,screens,B-CAUSE_OF_DISEASE,2091
42198,tablets,I-CAUSE_OF_DISEASE,2091
42199,computers,I-CAUSE_OF_DISEASE,2091
42200,cellphones,I-CAUSE_OF_DISEASE,2091
42201,,O,2091
42202,An,O,2091
42203,average,O,2091
42204,person,O,2091
42205,blinks,O,2091
42206,15,O,2091
42207,to,O,2091
42208,20,O,2091
42209,times,O,2091
42210,each,O,2091
42211,minute,O,2092
42212,but,O,2092
42213,studies,O,2092
42214,show,O,2092
42215,that,O,2092
42216,using,B-CAUSE_OF_DISEASE,2093
42217,a,I-CAUSE_OF_DISEASE,2093
42218,screen,I-CAUSE_OF_DISEASE,2093
42219,reduces,O,2093
42220,this,O,2093
42221,by,O,2093
42222,more,O,2093
42223,than,O,2093
42224,half,O,2093
42225,When,O,2093
42226,your,O,2093
42227,blink,O,2093
42228,rate,O,2093
42229,slows,O,2093
42230,down,O,2093
42231,SightKick,B-TREATMENT,2093
42232,employs,O,2093
42233,artificial,O,2093
42234,intelligence,O,2093
42235,to,O,2094
42236,gently,O,2094
42237,prompt,O,2094
42238,you,O,2094
42239,to,O,2094
42240,look,B-TREATMENT,2094
42241,away,I-TREATMENT,2094
42242,from,I-TREATMENT,2094
42243,your,I-TREATMENT,2094
42244,screen,I-TREATMENT,2094
42245,for,I-TREATMENT,2094
42246,20,I-TREATMENT,2094
42247,feet,I-TREATMENT,2094
42248,while,I-TREATMENT,2094
42249,blinking,I-TREATMENT,2095
42250,for,I-TREATMENT,2095
42251,20,I-TREATMENT,2095
42252,seconds,I-TREATMENT,2095
42253,Additionally,O,2095
42254,it,O,2095
42255,reminds,O,2095
42256,you,O,2095
42257,to,O,2095
42258,blink,B-TREATMENT,2095
42259,every,I-TREATMENT,2095
42260,20,I-TREATMENT,2095
42261,minutes,I-TREATMENT,2095
42262,in,O,2095
42263,an,O,2095
42264,effort,O,2095
42265,to,O,2095
42266,maintain,O,2095
42267,a,O,2096
42268,healthy,O,2096
42269,tear,B-PART_OF_THE_EYES,2096
42270,film,I-PART_OF_THE_EYES,2096
42271,on,O,2096
42272,your,O,2096
42273,eyes,O,2096
42274,The,O,2096
42275,app,O,2096
42276,works,O,2096
42277,silently,O,2096
42278,in,O,2096
42279,the,O,2096
42280,background,O,2096
42281,and,O,2096
42282,offers,O,2096
42283,personalization,O,2096
42284,options,O,2096
42285,so,O,2096
42286,you,O,2096
42287,can,O,2096
42288,make,O,2096
42289,it,O,2096
42290,your,O,2096
42291,own,O,2096
42292,change,O,2096
42293,the,O,2096
42294,frequency,O,2096
42295,of,O,2096
42296,reminders,O,2097
42297,the,O,2097
42298,location,O,2097
42299,etc,O,2097
42300,,O,2097
42301,Users,O,2097
42302,may,O,2097
42303,check,O,2097
42304,how,O,2097
42305,frequently,O,2097
42306,your,O,2097
42307,blink,O,2097
42308,rate,O,2097
42309,has,O,2097
42310,been,O,2097
42311,in,O,2097
42312,the,O,2097
42313,unhealthy,O,2097
42314,or,O,2097
42315,healthy,O,2097
42316,range,O,2097
42317,thanks,O,2097
42318,to,O,2098
42319,statistics,O,2098
42320,built,O,2098
42321,into,O,2098
42322,the,O,2098
42323,device,O,2098
42324,SightKick,B-TREATMENT,2098
42325,encourages,O,2098
42326,users,O,2098
42327,to,O,2098
42328,blink,B-TREATMENT,2098
42329,at,I-TREATMENT,2098
42330,predetermined,I-TREATMENT,2098
42331,intervals,I-TREATMENT,2098
42332,especially,I-TREATMENT,2098
42333,when,I-TREATMENT,2098
42334,their,I-TREATMENT,2099
42335,blink,I-TREATMENT,2099
42336,rate,I-TREATMENT,2099
42337,is,I-TREATMENT,2099
42338,low,I-TREATMENT,2099
42339,which,O,2099
42340,helps,O,2099
42341,to,O,2099
42342,lessen,O,2099
42343,the,O,2099
42344,strain,O,2099
42345,on,O,2099
42346,their,O,2099
42347,digital,O,2099
42348,eyes,O,2099
42349,The,O,2099
42350,application,O,2099
42351,is,O,2099
42352,free,O,2099
42353,to,O,2099
42354,use,O,2099
42355,and,O,2099
42356,can,O,2099
42357,be,O,2099
42358,downloaded,O,2099
42359,from,O,2099
42360,the,O,2099
42361,Apple,B-ORGANIZATION,2099
42362,Mac,O,2100
42363,Store,O,2100
42364,LumiThera,B-ORGANIZATION,2100
42365,Inc,I-ORGANIZATION,2100
42366,a,O,2100
42367,commercial,O,2100
42368,stage,O,2100
42369,medical,O,2100
42370,device,O,2100
42371,business,O,2100
42372,that,O,2100
42373,provides,O,2100
42374,photobiomodulation,B-TREATMENT,2100
42375,PBM,I-TREATMENT,2100
42376,treatment,I-TREATMENT,2100
42377,for,O,2100
42378,ocular,O,2100
42379,disease,O,2100
42380,and,O,2100
42381,damage,O,2100
42382,announced,O,2100
42383,that,O,2100
42384,its,O,2100
42385,wholly-owned,O,2100
42386,subsidiary,O,2100
42387,acquired,O,2100
42388,the,O,2100
42389,assets,O,2100
42390,of,O,2100
42391,MacuLogix,B-ORGANIZATION,2100
42392,MacuLogix,B-ORGANIZATION,2100
42393,Inc,O,2100
42394,is,O,2100
42395,the,O,2100
42396,leader,O,2101
42397,in,O,2101
42398,early,O,2101
42399,diagnosis,O,2101
42400,of,O,2101
42401,dry,B-NAME_OF_DISEASE,2101
42402,Age-related,I-NAME_OF_DISEASE,2101
42403,Macular,I-NAME_OF_DISEASE,2101
42404,Degeneration,I-NAME_OF_DISEASE,2101
42405,AMD,I-NAME_OF_DISEASE,2101
42406,patients,O,2101
42407,and,O,2101
42408,developer,O,2101
42409,of,O,2101
42410,the,B-DIAGNOSTIC_TEST,2101
42411,wearable,I-DIAGNOSTIC_TEST,2101
42412,AdaptDX,B-DIAGNOSTIC_TEST,2101
42413,Pro®,I-DIAGNOSTIC_TEST,2101
42414,dark,I-DIAGNOSTIC_TEST,2101
42415,adaptometer,I-DIAGNOSTIC_TEST,2101
42416,With,O,2101
42417,the,O,2102
42418,use,O,2102
42419,of,O,2102
42420,the,O,2102
42421,equipment,O,2102
42422,eye,O,2102
42423,care,O,2102
42424,specialists,O,2102
42425,can,O,2102
42426,measure,O,2102
42427,dark,O,2102
42428,adaptation,O,2102
42429,which,O,2102
42430,is,O,2102
42431,utilized,O,2102
42432,to,O,2102
42433,diagnose,O,2102
42434,dry,B-NAME_OF_DISEASE,2102
42435,AMD,I-NAME_OF_DISEASE,2102
42436,in,O,2102
42437,patients,O,2102
42438,earlier,O,2102
42439,than,O,2102
42440,with,O,2102
42441,any,O,2102
42442,other,O,2102
42443,technology,O,2102
42444,The,B-DIAGNOSTIC_TEST,2102
42445,AdaptDx,I-DIAGNOSTIC_TEST,2102
42446,Pro,I-DIAGNOSTIC_TEST,2102
42447,was,O,2103
42448,introduced,O,2103
42449,in,O,2103
42450,2020,O,2103
42451,and,O,2103
42452,is,O,2103
42453,offered,O,2103
42454,for,O,2103
42455,sale,O,2103
42456,in,O,2103
42457,the,B-GPE,2103
42458,US,B-GPE,2103
42459,Canada,B-GPE,2103
42460,EU,B-ORGANIZATION,2103
42461,and,O,2103
42462,other,O,2103
42463,nations,O,2103
42464,The,O,2103
42465,core,O,2103
42466,technology,O,2103
42467,measures,O,2103
42468,the,O,2103
42469,inability,O,2103
42470,to,O,2103
42471,visually,O,2103
42472,adapt,O,2103
42473,to,O,2103
42474,low,O,2103
42475,levels,O,2103
42476,of,O,2103
42477,light,O,2103
42478,a,O,2103
42479,key,O,2103
42480,clinical,O,2103
42481,marker,O,2103
42482,seen,O,2103
42483,in,O,2103
42484,patients,O,2103
42485,with,O,2103
42486,early,B-NAME_OF_DISEASE,2103
42487,AMD,I-NAME_OF_DISEASE,2103
42488,Dark,O,2103
42489,adaptation,O,2103
42490,technology,O,2103
42491,has,O,2103
42492,been,O,2103
42493,validated,O,2103
42494,in,O,2103
42495,42,O,2104
42496,peer-reviewed,O,2105
42497,papers,O,2105
42498,stated,O,2105
42499,Greg,O,2105
42500,Jackson,O,2105
42501,Ph.D,O,2105
42502,former,O,2105
42503,MacuLogix,B-ORGANIZATION,2105
42504,Chief,O,2105
42505,Technology,O,2105
42506,Officer,O,2105
42507,and,O,2105
42508,Co-Founder,O,2105
42509,Over,O,2105
42510,1,O,2105
42511,million,O,2105
42512,AdaptDX,B-DIAGNOSTIC_TEST,2105
42513,tests,O,2105
42514,have,O,2105
42515,been,O,2105
42516,performed,O,2105
42517,and,O,2106
42518,about,O,2106
42519,200,O,2106
42520,0,O,2106
42521,patients,O,2106
42522,have,O,2106
42523,been,O,2106
42524,newly,O,2106
42525,diagnosed,O,2106
42526,The,O,2106
42527,purchase,O,2106
42528,was,O,2106
42529,made,O,2106
42530,around,O,2106
42531,four,O,2106
42532,months,O,2106
42533,after,O,2106
42534,LumiThera,B-ORGANIZATION,2107
42535,revealed,O,2107
42536,it,O,2107
42537,had,O,2107
42538,acquired,O,2107
42539,the,O,2107
42540,vision,O,2107
42541,testing,O,2107
42542,technology,O,2107
42543,from,O,2107
42544,Diopsys,B-ORGANIZATION,2107
42545,visual,B-DIAGNOSTIC_TEST,2107
42546,evoked,I-DIAGNOSTIC_TEST,2107
42547,potential,I-DIAGNOSTIC_TEST,2107
42548,VEP,I-DIAGNOSTIC_TEST,2107
42549,and,O,2107
42550,electroretinogram,B-DIAGNOSTIC_TEST,2107
42551,ERG,I-DIAGNOSTIC_TEST,2107
42552,,O,2107
42553,The,O,2107
42554,Diopsys,B-ORGANIZATION,2107
42555,product,O,2107
42556,line,O,2107
42557,is,O,2107
42558,a,O,2107
42559,diagnostic,O,2107
42560,and,O,2107
42561,monitoring,O,2107
42562,device,O,2107
42563,that,O,2107
42564,analyzes,O,2107
42565,the,O,2107
42566,electrical,O,2108
42567,activity,O,2108
42568,of,O,2108
42569,the,B-PART_OF_THE_EYES,2108
42570,retina,I-PART_OF_THE_EYES,2108
42571,in,O,2108
42572,response,O,2108
42573,to,O,2108
42574,a,O,2108
42575,light,O,2108
42576,stimulus,O,2108
42577,offering,O,2108
42578,a,O,2108
42579,quantitative,O,2108
42580,vision,O,2108
42581,measure,O,2108
42582,to,O,2108
42583,help,O,2108
42584,with,O,2108
42585,eye,O,2108
42586,illness,O,2108
42587,diagnosis,O,2108
42588,and,O,2108
42589,monitoring,O,2108
42590,AdaptDx,B-DIAGNOSTIC_TEST,2108
42591,Pro,I-DIAGNOSTIC_TEST,2108
42592,can,O,2108
42593,identify,O,2108
42594,dry,B-NAME_OF_DISEASE,2108
42595,AMD,I-NAME_OF_DISEASE,2108
42596,patients,O,2108
42597,at,O,2108
42598,the,O,2108
42599,earliest,O,2108
42600,timepoint,O,2108
42601,in,O,2108
42602,advance,O,2108
42603,of,O,2108
42604,pathology,O,2108
42605,and,O,2108
42606,before,O,2108
42607,vision,B-SIGN_AND_SYMPTOM,2109
42608,loss,I-SIGN_AND_SYMPTOM,2109
42609,stated,O,2109
42610,Clark,O,2109
42611,E,O,2109
42612,Tedford,O,2109
42613,Ph.D,O,2109
42614,President,O,2109
42615,and,O,2109
42616,CEO,O,2109
42617,LumiThera,B-ORGANIZATION,2109
42618,Inc,I-ORGANIZATION,2109
42619,The,B-DIAGNOSTIC_TEST,2109
42620,AdaptDx,I-DIAGNOSTIC_TEST,2109
42621,wearable,O,2109
42622,light-based,O,2109
42623,early,O,2109
42624,diagnostic,O,2109
42625,for,O,2109
42626,dry,B-NAME_OF_DISEASE,2109
42627,AMD,I-NAME_OF_DISEASE,2109
42628,adds,O,2109
42629,a,O,2109
42630,complementary,O,2109
42631,assessment,O,2109
42632,of,O,2109
42633,retinal,O,2109
42634,health,O,2110
42635,to,O,2110
42636,the,O,2110
42637,LumiThera,B-ORGANIZATION,2110
42638,product,O,2110
42639,line,O,2110
42640,further,O,2110
42641,expanding,O,2110
42642,LumiThera,B-ORGANIZATION,2110
42643,s,O,2110
42644,synergistic,O,2110
42645,platform,O,2110
42646,of,O,2110
42647,products,O,2110
42648,for,O,2110
42649,eye,O,2110
42650,care,O,2110
42651,professionals,O,2110
42652,We,O,2110
42653,are,O,2110
42654,excited,O,2110
42655,to,O,2110
42656,combine,O,2110
42657,diagnosis,O,2110
42658,treatment,O,2110
42659,and,O,2110
42660,monitoring,O,2110
42661,platforms,O,2110
42662,to,O,2110
42663,provide,O,2110
42664,a,O,2110
42665,complete,O,2110
42666,solution,O,2110
42667,for,O,2110
42668,dry,B-NAME_OF_DISEASE,2110
42669,AMD,I-NAME_OF_DISEASE,2110
42670,patients,O,2110
42671,The,O,2110
42672,news,O,2110
42673,from,O,2110
42674,LumiThera,B-ORGANIZATION,2110
42675,comes,O,2111
42676,after,O,2111
42677,the,O,2111
42678,company,O,2111
42679,s,O,2111
42680,13-month,B-TIME_DURATION,2111
42681,positive,O,2111
42682,U.S,O,2111
42683,LIGHTSITE,O,2111
42684,III,O,2111
42685,treatment,O,2111
42686,data,O,2111
42687,in,O,2111
42688,patients,O,2111
42689,with,O,2111
42690,intermediate,B-NAME_OF_DISEASE,2111
42691,dry,I-NAME_OF_DISEASE,2111
42692,Age-related,I-NAME_OF_DISEASE,2111
42693,Macular,I-NAME_OF_DISEASE,2111
42694,Degeneration,I-NAME_OF_DISEASE,2111
42695,AMD,I-NAME_OF_DISEASE,2111
42696,treated,O,2111
42697,with,O,2111
42698,the,O,2111
42699,Valeda®,B-TREATMENT,2111
42700,Light,I-TREATMENT,2111
42701,Delivery,I-TREATMENT,2111
42702,System,I-TREATMENT,2111
42703,were,O,2111
42704,announced,O,2111
42705,100,O,2111
42706,volunteers,O,2111
42707,were,O,2111
42708,enrolled,O,2111
42709,in,O,2112
42710,the,O,2112
42711,LIGHTSITE,O,2112
42712,III,O,2112
42713,experiment,O,2112
42714,and,O,2112
42715,they,O,2112
42716,are,O,2112
42717,receiving,O,2112
42718,Valeda,B-TREATMENT,2112
42719,treatments,O,2112
42720,every,O,2112
42721,4,B-TIME_DURATION,2112
42722,months,I-TIME_DURATION,2113
42723,A,O,2113
42724,13-month,B-TIME_DURATION,2113
42725,efficacy,O,2113
42726,timepoint,O,2113
42727,for,O,2113
42728,all,O,2113
42729,patients,O,2113
42730,met,O,2113
42731,the,O,2113
42732,predesignated,O,2113
42733,primary,O,2113
42734,best,O,2113
42735,corrected,O,2113
42736,visual,O,2113
42737,acuity,O,2113
42738,endpoint,O,2113
42739,with,O,2113
42740,a,O,2113
42741,statistically,O,2113
42742,significant,O,2113
42743,improvement,O,2113
42744,over,O,2113
42745,the,O,2113
42746,sham,O,2113
42747,group,O,2113
42748,p,O,2113
42749,=,O,2113
42750,0,O,2114
42751,,O,2114
42752,The,O,2114
42753,study,O,2114
42754,showed,O,2114
42755,improvements,O,2114
42756,in,O,2114
42757,best,O,2114
42758,corrected,O,2114
42759,visual,O,2114
42760,acuity,O,2114
42761,in,O,2114
42762,intermediate,B-NAME_OF_DISEASE,2114
42763,dry,I-NAME_OF_DISEASE,2114
42764,AMD,I-NAME_OF_DISEASE,2114
42765,subjects,O,2114
42766,with,O,2114
42767,over,O,2114
42768,50%,O,2114
42769,showing,O,2114
42770,a,O,2114
42771,line,O,2114
42772,or,O,2114
42773,better,O,2114
42774,improvement,O,2114
42775,on,O,2114
42776,the,O,2114
42777,eyechart,O,2114
42778,with,O,2114
42779,a,O,2115
42780,mean,O,2115
42781,of,O,2115
42782,9,O,2115
42783,letters,O,2115
42784,gained,O,2115
42785,for,O,2115
42786,the,O,2115
42787,responders,O,2115
42788,Previous,O,2115
42789,clinical,O,2115
42790,trials,O,2115
42791,as,O,2115
42792,well,O,2115
42793,as,O,2115
42794,the,O,2115
42795,crucial,O,2115
42796,US,B-GPE,2115
42797,research,O,2115
42798,will,O,2115
42799,support,O,2115
42800,the,O,2115
42801,FDA,B-ORGANIZATION,2115
42802,proposal,O,2115
42803,for,O,2115
42804,potential,O,2115
42805,US,B-GPE,2115
42806,clearance,O,2115
42807,Several,O,2115
42808,nations,O,2115
42809,in,O,2116
42810,Latin,B-GPE,2116
42811,America,I-GPE,2116
42812,and,O,2116
42813,Europe,B-GPE,2116
42814,have,O,2116
42815,currently,O,2116
42816,approved,O,2116
42817,the,O,2116
42818,use,O,2116
42819,of,O,2116
42820,Valeda,B-TREATMENT,2116
42821,Lumenis,B-ORGANIZATION,2116
42822,announced,O,2116
42823,that,O,2116
42824,the,O,2116
42825,OptiLight,B-TREATMENT,2116
42826,has,O,2116
42827,received,O,2116
42828,the,O,2116
42829,MedTech,B-ORGANIZATION,2116
42830,Breakthrough,I-ORGANIZATION,2116
42831,Award,O,2116
42832,for,O,2116
42833,Best,O,2116
42834,New,O,2116
42835,Technology,O,2116
42836,Solution,O,2116
42837,for,O,2116
42838,Ophthalmology,O,2116
42839,This,O,2116
42840,year,O,2116
42841,MedTech,B-ORGANIZATION,2116
42842,s,O,2116
42843,range,O,2116
42844,of,O,2116
42845,health,O,2116
42846,and,O,2116
42847,medical,O,2116
42848,technology,O,2116
42849,categories,O,2116
42850,attracted,O,2116
42851,more,O,2116
42852,than,O,2117
42853,3,O,2117
42854,900,O,2117
42855,nominations,O,2117
42856,from,O,2117
42857,over,O,2117
42858,15,O,2117
42859,countries,O,2117
42860,from,O,2117
42861,which,O,2118
42862,MedTech,B-ORGANIZATION,2118
42863,selected,O,2118
42864,OptiLight,B-TREATMENT,2118
42865,for,O,2118
42866,this,O,2118
42867,recognition,O,2118
42868,The,O,2118
42869,win,O,2118
42870,follows,O,2118
42871,Lumenis,B-ORGANIZATION,2118
42872,MedTech,B-ORGANIZATION,2118
42873,awards,O,2118
42874,for,O,2118
42875,Best,O,2118
42876,Overall,O,2119
42877,Medical,O,2119
42878,Device,O,2119
42879,Company,O,2119
42880,in,O,2119
42881,2021,O,2119
42882,and,O,2119
42883,Best,O,2119
42884,New,O,2119
42885,Surgical,O,2119
42886,Technology,O,2119
42887,Solution,O,2119
42888,in,O,2119
42889,2020,O,2119
42890,OptiLight,B-TREATMENT,2119
42891,is,O,2119
42892,the,O,2119
42893,first,O,2119
42894,and,O,2119
42895,only,O,2119
42896,light,O,2119
42897,treatment,O,2119
42898,FDA,B-ORGANIZATION,2119
42899,approved,O,2120
42900,for,O,2120
42901,management,O,2120
42902,of,O,2120
42903,dry,B-NAME_OF_DISEASE,2120
42904,eye,I-NAME_OF_DISEASE,2120
42905,disease,I-NAME_OF_DISEASE,2120
42906,Lumenis,B-ORGANIZATION,2120
42907,patented,O,2120
42908,innovative,O,2120
42909,Optimal,B-TREATMENT,2120
42910,Pulse,I-TREATMENT,2120
42911,Technology,I-TREATMENT,2120
42912,OPT,I-TREATMENT,2120
42913,offers,O,2120
42914,targeted,O,2120
42915,uniform,O,2121
42916,precise,O,2121
42917,and,O,2121
42918,controlled,O,2121
42919,treatment,O,2121
42920,that,O,2121
42921,safely,O,2121
42922,and,O,2121
42923,effectively,O,2121
42924,breaks,O,2121
42925,the,O,2121
42926,cycle,O,2121
42927,of,O,2121
42928,inflammation,O,2121
42929,associated,O,2122
42930,with,O,2122
42931,dry,B-NAME_OF_DISEASE,2122
42932,eye,I-NAME_OF_DISEASE,2122
42933,disease,I-NAME_OF_DISEASE,2122
42934,Dry,B-NAME_OF_DISEASE,2122
42935,eye,I-NAME_OF_DISEASE,2122
42936,disease,I-NAME_OF_DISEASE,2122
42937,is,O,2122
42938,highly,O,2122
42939,prevalent,O,2122
42940,and,O,2122
42941,difficult,O,2122
42942,to,O,2122
42943,manage,O,2122
42944,and,O,2122
42945,traditional,O,2122
42946,treatments,O,2122
42947,like,O,2122
42948,warm,B-TREATMENT,2122
42949,compresses,I-TREATMENT,2122
42950,and,O,2122
42951,artificial,B-TREATMENT,2122
42952,tears,I-TREATMENT,2122
42953,treat,O,2122
42954,the,O,2122
42955,symptoms,O,2122
42956,but,O,2122
42957,not,O,2122
42958,the,O,2122
42959,underlying,O,2122
42960,pathology,O,2122
42961,said,O,2122
42962,James,B-PERSON,2122
42963,Johnson,I-PERSON,2122
42964,managing,O,2122
42965,director,O,2122
42966,MedTech,B-ORGANIZATION,2122
42967,Breakthrough,I-ORGANIZATION,2122
42968,OptiLight,B-TREATMENT,2122
42969,is,O,2123
42970,leading,O,2123
42971,a,O,2123
42972,revolution,O,2123
42973,in,O,2123
42974,managing,O,2123
42975,dry,B-NAME_OF_DISEASE,2123
42976,eye,I-NAME_OF_DISEASE,2123
42977,disease,I-NAME_OF_DISEASE,2123
42978,with,O,2123
42979,breakthrough,O,2123
42980,technology,O,2123
42981,that,O,2123
42982,allows,O,2123
42983,doctors,O,2124
42984,to,O,2124
42985,treat,O,2124
42986,patients,O,2124
42987,quickly,O,2124
42988,in-office,O,2124
42989,With,O,2124
42990,broad,O,2124
42991,potential,O,2124
42992,for,O,2124
42993,tens,O,2124
42994,of,O,2124
42995,millions,O,2124
42996,with,O,2124
42997,dry,B-NAME_OF_DISEASE,2124
42998,eye,I-NAME_OF_DISEASE,2124
42999,disease,I-NAME_OF_DISEASE,2124
43000,OptiLight,B-TREATMENT,2124
43001,stands,O,2124
43002,out,O,2125
43003,from,O,2125
43004,the,O,2125
43005,crowd,O,2125
43006,to,O,2125
43007,become,O,2125
43008,our,O,2125
43009,2022,O,2125
43010,Best,O,2125
43011,New,O,2125
43012,Technology,O,2125
43013,Solution,O,2125
43014,for,O,2125
43015,Ophthalmology,O,2125
43016,he,O,2125
43017,further,O,2125
43018,explained,O,2125
43019,Lumenis,B-ORGANIZATION,2125
43020,introduced,O,2125
43021,OptiLight,B-TREATMENT,2126
43022,in,O,2126
43023,May,O,2126
43024,2021,O,2126
43025,and,O,2126
43026,recently,O,2126
43027,launched,O,2126
43028,a,O,2126
43029,national,O,2126
43030,media,O,2126
43031,campaign,O,2126
43032,featuring,O,2126
43033,singer-songwriter,O,2126
43034,and,O,2126
43035,actress,O,2126
43036,Mandy,B-PERSON,2126
43037,Moore,I-PERSON,2126
43038,This,O,2126
43039,Is,O,2126
43040,Us,O,2126
43041,to,O,2126
43042,increase,O,2126
43043,awareness,O,2126
43044,for,O,2126
43045,dry,B-NAME_OF_DISEASE,2126
43046,eye,I-NAME_OF_DISEASE,2126
43047,disease,I-NAME_OF_DISEASE,2126
43048,and,O,2126
43049,encourage,O,2126
43050,people,O,2127
43051,who,O,2127
43052,might,O,2127
43053,be,O,2127
43054,suffering,O,2127
43055,from,O,2127
43056,this,O,2127
43057,condition,O,2127
43058,to,O,2127
43059,seek,O,2127
43060,out,O,2127
43061,a,O,2127
43062,physician,O,2128
43063,who,O,2128
43064,offers,O,2128
43065,OptiLight,B-TREATMENT,2128
43066,www.TreatMyDryEye.co,O,2128
43067,,O,2128
43068,We,O,2128
43069,re,O,2128
43070,grateful,O,2128
43071,to,O,2128
43072,MedTech,B-ORGANIZATION,2128
43073,for,O,2128
43074,honoring,O,2128
43075,OptiLight,B-TREATMENT,2128
43076,for,O,2128
43077,its,O,2128
43078,innovation,O,2128
43079,and,O,2128
43080,impact,O,2128
43081,in,O,2128
43082,eye,O,2128
43083,care,O,2128
43084,said,O,2128
43085,Lumenis,B-ORGANIZATION,2128
43086,CEO,O,2128
43087,Tzipi,B-PERSON,2128
43088,Ozer-Armon,I-PERSON,2128
43089,Lumenis,B-ORGANIZATION,2128
43090,is,O,2128
43091,committed,O,2128
43092,to,O,2128
43093,raising,O,2128
43094,the,O,2128
43095,bar,O,2128
43096,for,O,2128
43097,patients,O,2128
43098,health,O,2128
43099,by,O,2128
43100,providing,O,2128
43101,cutting-edge,O,2128
43102,solutions,O,2129
43103,and,O,2129
43104,treatment,O,2129
43105,innovations,O,2129
43106,As,O,2129
43107,the,O,2129
43108,only,O,2129
43109,light-based,O,2129
43110,treatment,O,2129
43111,for,O,2129
43112,dry,B-NAME_OF_DISEASE,2129
43113,eye,I-NAME_OF_DISEASE,2129
43114,disease,I-NAME_OF_DISEASE,2129
43115,OptiLight,B-TREATMENT,2129
43116,has,O,2129
43117,the,O,2129
43118,power,O,2129
43119,to,O,2129
43120,elevate,O,2129
43121,dry,B-NAME_OF_DISEASE,2129
43122,eye,I-NAME_OF_DISEASE,2129
43123,management,O,2129
43124,and,O,2129
43125,improve,O,2129
43126,health,O,2129
43127,and,O,2129
43128,quality,O,2129
43129,of,O,2129
43130,life,O,2129
43131,for,O,2129
43132,millions,O,2129
43133,of,O,2129
43134,people,O,2130
43135,around,O,2130
43136,the,O,2130
43137,world,O,2130
43138,Viterbi,B-ORGANIZATION,2130
43139,Family,I-ORGANIZATION,2130
43140,Department,I-ORGANIZATION,2130
43141,of,I-ORGANIZATION,2130
43142,Ophthalmology,I-ORGANIZATION,2130
43143,and,O,2130
43144,Shiley,B-ORGANIZATION,2130
43145,Eye,I-ORGANIZATION,2130
43146,Institute,I-ORGANIZATION,2130
43147,both,O,2130
43148,part,O,2130
43149,of,O,2130
43150,UC,B-ORGANIZATION,2130
43151,San,I-ORGANIZATION,2130
43152,Diego,I-ORGANIZATION,2130
43153,Health,I-ORGANIZATION,2130
43154,has,O,2130
43155,received,O,2130
43156,funding,O,2130
43157,from,O,2130
43158,the,B-ORGANIZATION,2130
43159,Nixon,I-ORGANIZATION,2130
43160,Visions,I-ORGANIZATION,2131
43161,Foundation,I-ORGANIZATION,2131
43162,led,O,2131
43163,by,O,2131
43164,philanthropists,O,2131
43165,Brandon,B-PERSON,2131
43166,and,I-PERSON,2131
43167,Janine,I-PERSON,2131
43168,Nixon,I-PERSON,2131
43169,to,O,2131
43170,launch,O,2131
43171,the,B-ORGANIZATION,2131
43172,Nixon,I-ORGANIZATION,2131
43173,Visions,I-ORGANIZATION,2131
43174,Foundation,I-ORGANIZATION,2131
43175,Macular,O,2131
43176,Dystrophy-PRPH2,O,2131
43177,Research,O,2131
43178,Fund,O,2131
43179,The,O,2131
43180,new,O,2131
43181,initiative,O,2131
43182,will,O,2131
43183,focus,O,2131
43184,studies,O,2131
43185,of,O,2132
43186,the,B-CHEMICAL_COMPOUND,2132
43187,PRPH2,I-CHEMICAL_COMPOUND,2132
43188,gene,I-CHEMICAL_COMPOUND,2132
43189,and,O,2132
43190,related,O,2132
43191,mutations,O,2132
43192,and,O,2132
43193,help,O,2132
43194,upgrade,O,2132
43195,stem,O,2132
43196,cell,O,2132
43197,technologies,O,2132
43198,that,O,2132
43199,may,O,2132
43200,eventually,O,2132
43201,provide,O,2132
43202,a,O,2132
43203,proven,O,2132
43204,therapeutic,O,2132
43205,remedy,O,2133
43206,In,O,2133
43207,healthy,O,2133
43208,vision,O,2133
43209,a,B-CHEMICAL_COMPOUND,2133
43210,gene,I-CHEMICAL_COMPOUND,2133
43211,called,I-CHEMICAL_COMPOUND,2133
43212,PRPH2,I-CHEMICAL_COMPOUND,2133
43213,provides,O,2133
43214,instructions,O,2133
43215,to,O,2133
43216,make,O,2133
43217,a,B-CHEMICAL_COMPOUND,2133
43218,protein,I-CHEMICAL_COMPOUND,2133
43219,called,I-CHEMICAL_COMPOUND,2133
43220,peripherin,I-CHEMICAL_COMPOUND,2133
43221,2,I-CHEMICAL_COMPOUND,2133
43222,PRPH2,I-CHEMICAL_COMPOUND,2133
43223,which,O,2133
43224,plays,O,2133
43225,a,O,2133
43226,key,O,2133
43227,role,O,2133
43228,in,O,2133
43229,the,O,2133
43230,normal,O,2133
43231,functioning,O,2133
43232,of,O,2133
43233,photoreceptors,B-PART_OF_THE_EYES,2133
43234,that,O,2133
43235,detect,O,2133
43236,light,O,2133
43237,and,O,2133
43238,color,O,2133
43239,and,O,2133
43240,which,O,2133
43241,line,O,2133
43242,the,B-PART_OF_THE_EYES,2133
43243,back,I-PART_OF_THE_EYES,2134
43244,of,I-PART_OF_THE_EYES,2134
43245,the,I-PART_OF_THE_EYES,2134
43246,eye,I-PART_OF_THE_EYES,2134
43247,When,O,2134
43248,there,O,2134
43249,are,O,2134
43250,mutations,O,2134
43251,in,O,2134
43252,the,B-CHEMICAL_COMPOUND,2134
43253,PRPH2,I-CHEMICAL_COMPOUND,2134
43254,gene,I-CHEMICAL_COMPOUND,2134
43255,the,O,2134
43256,result,O,2134
43257,can,O,2134
43258,be,O,2134
43259,macular,B-NAME_OF_DISEASE,2135
43260,dystrophy,I-NAME_OF_DISEASE,2135
43261,an,O,2135
43262,impairment,O,2135
43263,of,O,2135
43264,the,B-PART_OF_THE_EYES,2135
43265,retina,I-PART_OF_THE_EYES,2135
43266,that,O,2135
43267,progressively,O,2135
43268,diminishes,O,2135
43269,the,O,2135
43270,ability,O,2135
43271,to,O,2135
43272,see,O,2135
43273,clearly,O,2135
43274,and,O,2135
43275,may,O,2135
43276,eventually,O,2136
43277,result,O,2136
43278,in,O,2136
43279,vision,B-SIGN_AND_SYMPTOM,2136
43280,loss,I-SIGN_AND_SYMPTOM,2136
43281,There,O,2136
43282,are,O,2136
43283,currently,O,2136
43284,no,O,2136
43285,effective,O,2136
43286,treatments,O,2136
43287,available,O,2136
43288,to,O,2136
43289,halt,O,2136
43290,or,O,2136
43291,prevent,O,2136
43292,the,O,2136
43293,disease,O,2136
43294,As,O,2136
43295,part,O,2136
43296,of,O,2136
43297,this,O,2136
43298,effort,O,2136
43299,the,B-ORGANIZATION,2136
43300,Nixon,I-ORGANIZATION,2136
43301,Visions,I-ORGANIZATION,2136
43302,Foundation,I-ORGANIZATION,2136
43303,is,O,2136
43304,collaborating,O,2136
43305,with,O,2136
43306,the,B-ORGANIZATION,2137
43307,Foundation,I-ORGANIZATION,2137
43308,Fighting,I-ORGANIZATION,2137
43309,Blindness,I-ORGANIZATION,2137
43310,to,O,2137
43311,build,O,2137
43312,capacity,O,2137
43313,to,O,2137
43314,improve,O,2137
43315,national,O,2137
43316,and,O,2137
43317,international,O,2137
43318,research,O,2137
43319,in,O,2137
43320,this,O,2137
43321,area,O,2137
43322,We,O,2137
43323,are,O,2137
43324,impressed,O,2137
43325,with,O,2137
43326,the,O,2137
43327,impactful,O,2137
43328,work,O,2137
43329,at,O,2137
43330,UC,B-ORGANIZATION,2137
43331,San,I-ORGANIZATION,2137
43332,Diego,I-ORGANIZATION,2137
43333,and,O,2137
43334,specifically,O,2137
43335,in,O,2138
43336,the,B-ORGANIZATION,2138
43337,Department,I-ORGANIZATION,2138
43338,of,I-ORGANIZATION,2138
43339,Ophthalmology,I-ORGANIZATION,2138
43340,and,O,2138
43341,at,O,2138
43342,Shiley,B-ORGANIZATION,2138
43343,Eye,I-ORGANIZATION,2138
43344,Institute,I-ORGANIZATION,2138
43345,the,B-PERSON,2138
43346,Nixons,I-PERSON,2138
43347,said,O,2138
43348,in,O,2138
43349,a,O,2138
43350,statement,O,2138
43351,We,O,2138
43352,believe,O,2138
43353,this,O,2139
43354,gift,O,2139
43355,can,O,2139
43356,accelerate,O,2139
43357,efforts,O,2139
43358,to,O,2139
43359,make,O,2139
43360,a,O,2139
43361,tremendous,O,2139
43362,impact,O,2139
43363,for,O,2139
43364,people,O,2139
43365,with,O,2139
43366,this,O,2139
43367,inherited,O,2139
43368,eye,O,2139
43369,disease,O,2139
43370,and,O,2139
43371,will,O,2139
43372,improve,O,2139
43373,the,O,2139
43374,lives,O,2139
43375,of,O,2139
43376,others,O,2140
43377,for,O,2140
43378,generations,O,2140
43379,to,O,2140
43380,come,O,2140
43381,UC,B-ORGANIZATION,2140
43382,San,I-ORGANIZATION,2140
43383,Diego,I-ORGANIZATION,2140
43384,Chancellor,O,2140
43385,Pradeep,B-PERSON,2140
43386,Khosla,I-PERSON,2140
43387,pointed,O,2141
43388,out,O,2141
43389,that,O,2141
43390,macular,B-NAME_OF_DISEASE,2141
43391,dystrophy,I-NAME_OF_DISEASE,2141
43392,is,O,2141
43393,a,O,2141
43394,challenging,O,2141
43395,disease,O,2141
43396,for,O,2141
43397,people,O,2141
43398,who,O,2141
43399,have,O,2142
43400,it,O,2142
43401,but,O,2142
43402,noted,O,2142
43403,that,O,2142
43404,UC,B-ORGANIZATION,2142
43405,San,I-ORGANIZATION,2142
43406,Diego,I-ORGANIZATION,2142
43407,Health,I-ORGANIZATION,2142
43408,has,O,2142
43409,the,O,2142
43410,expertise,O,2142
43411,to,O,2142
43412,discover,O,2142
43413,new,O,2142
43414,ways,O,2142
43415,of,O,2142
43416,treating,O,2142
43417,this,O,2142
43418,illness,O,2142
43419,and,O,2142
43420,creating,O,2142
43421,a,O,2142
43422,healthier,O,2142
43423,world,O,2142
43424,Macular,B-NAME_OF_DISEASE,2142
43425,Dystrophy,I-NAME_OF_DISEASE,2142
43426,Macular,B-NAME_OF_DISEASE,2142
43427,dystrophy,I-NAME_OF_DISEASE,2142
43428,is,O,2142
43429,a,O,2142
43430,rare,O,2143
43431,eye,O,2143
43432,disorder,O,2143
43433,It,O,2143
43434,affects,O,2143
43435,the,B-PART_OF_THE_EYES,2143
43436,macula,B-PART_OF_THE_EYES,2143
43437,or,O,2143
43438,central,B-PART_OF_THE_EYES,2143
43439,retina,I-PART_OF_THE_EYES,2143
43440,which,O,2143
43441,contains,O,2143
43442,the,O,2143
43443,most,O,2143
43444,light-sensitive,O,2143
43445,cells,O,2143
43446,or,O,2143
43447,photoreceptors,B-PART_OF_THE_EYES,2143
43448,It,O,2144
43449,differs,O,2144
43450,from,O,2144
43451,macular,B-NAME_OF_DISEASE,2144
43452,degeneration,I-NAME_OF_DISEASE,2144
43453,a,O,2144
43454,more,O,2144
43455,prevalent,O,2144
43456,eye,O,2144
43457,condition,O,2144
43458,caused,O,2144
43459,by,O,2144
43460,the,O,2145
43461,weakening,O,2145
43462,of,O,2145
43463,the,B-PART_OF_THE_EYES,2145
43464,retina,I-PART_OF_THE_EYES,2145
43465,and,O,2145
43466,macula,B-PART_OF_THE_EYES,2145
43467,as,O,2145
43468,people,O,2145
43469,get,O,2145
43470,older,O,2145
43471,Macular,B-NAME_OF_DISEASE,2145
43472,dystrophy,I-NAME_OF_DISEASE,2145
43473,is,O,2145
43474,linked,O,2145
43475,to,O,2145
43476,genetic,B-CAUSE_OF_DISEASE,2145
43477,abnormalities,I-CAUSE_OF_DISEASE,2145
43478,that,O,2145
43479,cause,O,2145
43480,retinal,B-SIGN_AND_SYMPTOM,2145
43481,cell,I-SIGN_AND_SYMPTOM,2145
43482,degeneration,I-SIGN_AND_SYMPTOM,2145
43483,for,O,2145
43484,no,O,2145
43485,apparent,O,2146
43486,reason,O,2146
43487,Some,O,2146
43488,forms,O,2146
43489,of,O,2146
43490,the,O,2146
43491,disease,O,2146
43492,occur,O,2146
43493,in,O,2146
43494,childhood,O,2147
43495,while,O,2147
43496,others,O,2147
43497,appear,O,2147
43498,later,O,2147
43499,in,O,2147
43500,life,O,2147
43501,According,O,2147
43502,to,O,2147
43503,Shyamanga,B-PERSON,2147
43504,Borooah,I-PERSON,2147
43505,MD,I-PERSON,2147
43506,assistant,I-PERSON,2147
43507,professor,I-PERSON,2147
43508,of,I-PERSON,2147
43509,ophthalmology,I-PERSON,2147
43510,at,O,2147
43511,Shiley,B-ORGANIZATION,2148
43512,Eye,I-ORGANIZATION,2148
43513,Institute,I-ORGANIZATION,2148
43514,and,O,2148
43515,one,O,2148
43516,of,O,2148
43517,the,O,2148
43518,investigators,O,2148
43519,on,O,2148
43520,the,O,2148
43521,PRPH2,B-CHEMICAL_COMPOUND,2148
43522,research,O,2148
43523,project,O,2148
43524,there,O,2148
43525,aren,O,2148
43526,t,O,2148
43527,many,O,2148
43528,viable,O,2148
43529,therapies,O,2148
43530,for,O,2148
43531,macular,B-NAME_OF_DISEASE,2148
43532,dystrophy,I-NAME_OF_DISEASE,2148
43533,and,O,2149
43534,even,O,2149
43535,fewer,O,2149
43536,promising,O,2149
43537,leads,O,2149
43538,to,O,2149
43539,develop,O,2149
43540,them,O,2149
43541,In,O,2149
43542,our,O,2149
43543,work,O,2149
43544,we,O,2149
43545,believe,O,2149
43546,we,O,2149
43547,ve,O,2149
43548,found,O,2149
43549,one,O,2149
43550,Borooah,B-PERSON,2149
43551,said,O,2149
43552,in,O,2149
43553,a,O,2149
43554,statement,O,2149
43555,But,O,2149
43556,that,O,2150
43557,work,O,2150
43558,is,O,2150
43559,still,O,2150
43560,in,O,2150
43561,its,O,2150
43562,fairly,O,2150
43563,early,O,2150
43564,phases,O,2150
43565,so,O,2150
43566,for,O,2150
43567,myself,O,2150
43568,and,O,2150
43569,my,O,2150
43570,colleagues,O,2150
43571,such,O,2150
43572,as,O,2150
43573,Dr,O,2150
43574,Radha,O,2150
43575,Ayyagari,O,2151
43576,funding,O,2151
43577,like,O,2151
43578,this,O,2151
43579,from,O,2151
43580,the,B-ORGANIZATION,2151
43581,Nixon,I-ORGANIZATION,2151
43582,Visions,I-ORGANIZATION,2151
43583,Foundation,I-ORGANIZATION,2151
43584,is,O,2151
43585,crucial,O,2151
43586,to,O,2151
43587,understanding,O,2151
43588,causes,O,2151
43589,and,O,2151
43590,treating,O,2151
43591,the,O,2151
43592,disease,O,2151
43593,Faculty,O,2151
43594,in,O,2151
43595,the,B-ORGANIZATION,2151
43596,Viterbi,I-ORGANIZATION,2151
43597,Family,I-ORGANIZATION,2151
43598,Department,I-ORGANIZATION,2151
43599,of,I-ORGANIZATION,2151
43600,Ophthalmology,I-ORGANIZATION,2151
43601,and,O,2151
43602,at,O,2151
43603,Shiley,B-ORGANIZATION,2151
43604,Eye,I-ORGANIZATION,2151
43605,Institute,I-ORGANIZATION,2152
43606,are,O,2152
43607,among,O,2152
43608,the,O,2152
43609,leaders,O,2152
43610,in,O,2152
43611,basic,O,2152
43612,research,O,2152
43613,investigating,O,2152
43614,the,O,2152
43615,causes,O,2152
43616,of,O,2152
43617,eye,O,2152
43618,disease,O,2152
43619,and,O,2152
43620,finding,O,2152
43621,remedies,O,2152
43622,The,O,2152
43623,institute,O,2152
43624,is,O,2152
43625,home,O,2152
43626,to,O,2152
43627,the,B-ORGANIZATION,2152
43628,Joan,I-ORGANIZATION,2152
43629,and,I-ORGANIZATION,2152
43630,Irwin,I-ORGANIZATION,2152
43631,Jacobs,I-ORGANIZATION,2153
43632,Retina,I-ORGANIZATION,2153
43633,Center,I-ORGANIZATION,2153
43634,Luxembourg-based,B-ORGANIZATION,2153
43635,Mitotech,B-ORGANIZATION,2153
43636,SA,I-ORGANIZATION,2153
43637,announced,O,2153
43638,that,O,2153
43639,the,B-ORGANIZATION,2153
43640,FDA,B-ORGANIZATION,2153
43641,has,O,2153
43642,granted,O,2153
43643,orphan,O,2153
43644,drug,O,2153
43645,designation,O,2153
43646,ODD,O,2153
43647,for,O,2153
43648,the,O,2153
43649,company,O,2153
43650,s,O,2153
43651,topical,O,2153
43652,cardiolipin,O,2153
43653,peroxidation,O,2153
43654,inhibitor,O,2153
43655,Visomitin,B-NAME_OF_DRUG,2153
43656,for,O,2153
43657,the,O,2153
43658,treatment,O,2153
43659,of,O,2154
43660,Leber,B-NAME_OF_DISEASE,2154
43661,s,I-NAME_OF_DISEASE,2154
43662,Hereditary,I-NAME_OF_DISEASE,2154
43663,Optic,I-NAME_OF_DISEASE,2154
43664,Neuropathy,I-NAME_OF_DISEASE,2154
43665,LHON,B-NAME_OF_DISEASE,2154
43666,a,O,2154
43667,rare,O,2154
43668,inherited,O,2154
43669,condition,O,2154
43670,that,O,2154
43671,can,O,2154
43672,cause,O,2154
43673,blindness,B-SIGN_AND_SYMPTOM,2154
43674,In,O,2154
43675,2022,O,2154
43676,Mitotech,B-ORGANIZATION,2154
43677,plans,O,2154
43678,to,O,2154
43679,begin,O,2154
43680,a,O,2154
43681,phase,O,2154
43682,2,O,2154
43683,study,O,2154
43684,with,O,2154
43685,Visomitin,B-NAME_OF_DRUG,2154
43686,in,O,2154
43687,LHON,B-NAME_OF_DISEASE,2155
43688,in,O,2155
43689,partnership,O,2155
43690,with,O,2155
43691,the,O,2155
43692,LHON,B-NAME_OF_DISEASE,2155
43693,clinic,O,2155
43694,at,O,2155
43695,the,B-ORGANIZATION,2155
43696,University,I-ORGANIZATION,2155
43697,of,I-ORGANIZATION,2155
43698,California,I-ORGANIZATION,2155
43699,Los,I-ORGANIZATION,2155
43700,Angeles,I-ORGANIZATION,2156
43701,Doheny,I-ORGANIZATION,2156
43702,Eye,I-ORGANIZATION,2156
43703,Institute,I-ORGANIZATION,2156
43704,UCLA,I-ORGANIZATION,2156
43705,,O,2156
43706,Visomitin,B-NAME_OF_DRUG,2156
43707,demonstrated,O,2156
43708,consistent,O,2156
43709,improvement,O,2156
43710,in,O,2156
43711,visual,O,2156
43712,acuity,O,2156
43713,over,B-TIME_DURATION,2156
43714,several,I-TIME_DURATION,2156
43715,years,I-TIME_DURATION,2156
43716,in,O,2156
43717,LHON,B-NAME_OF_DISEASE,2156
43718,patients,O,2156
43719,involved,O,2156
43720,in,O,2156
43721,a,O,2157
43722,3-year,B-TIME_DURATION,2157
43723,open-label,O,2157
43724,phase,O,2157
43725,2a,O,2157
43726,study,O,2157
43727,conducted,O,2157
43728,outside,O,2157
43729,the,B-GPE,2157
43730,United,I-GPE,2157
43731,States,I-GPE,2157
43732,Improvements,O,2157
43733,were,O,2157
43734,seen,O,2157
43735,in,O,2157
43736,patients,O,2157
43737,with,O,2157
43738,a,O,2158
43739,range,O,2158
43740,of,O,2158
43741,underlying,O,2158
43742,mutations,O,2158
43743,including,O,2158
43744,those,O,2158
43745,with,O,2158
43746,variants,O,2158
43747,such,O,2158
43748,as,O,2159
43749,G11778A,O,2159
43750,where,O,2159
43751,the,O,2159
43752,chances,O,2159
43753,of,O,2159
43754,improvement,O,2159
43755,are,O,2159
43756,low,O,2159
43757,Mitotech,B-ORGANIZATION,2159
43758,s,O,2159
43759,planned,O,2159
43760,phase,O,2159
43761,2,O,2159
43762,study,O,2160
43763,aims,O,2160
43764,to,O,2161
43765,develop,O,2161
43766,Visomitin,B-NAME_OF_DRUG,2161
43767,as,O,2161
43768,a,O,2161
43769,convenient,O,2161
43770,and,O,2161
43771,potentially,O,2161
43772,high,O,2161
43773,impact,O,2161
43774,treatment,O,2161
43775,for,O,2161
43776,LHON,B-NAME_OF_DISEASE,2161
43777,The,B-ORGANIZATION,2161
43778,US,I-ORGANIZATION,2161
43779,Orphan,I-ORGANIZATION,2161
43780,Drug,I-ORGANIZATION,2162
43781,Designation,I-ORGANIZATION,2162
43782,is,O,2162
43783,highly,O,2162
43784,encouraging,O,2162
43785,for,O,2162
43786,our,O,2162
43787,efforts,O,2162
43788,to,O,2162
43789,bring,O,2162
43790,Visomitin,B-NAME_OF_DRUG,2163
43791,to,O,2163
43792,young,O,2163
43793,people,O,2163
43794,whose,O,2163
43795,lives,O,2163
43796,have,O,2163
43797,been,O,2163
43798,radically,O,2163
43799,affected,O,2163
43800,by,O,2163
43801,LHON,B-NAME_OF_DISEASE,2163
43802,Natalia,B-PERSON,2163
43803,Perekhvatova,I-PERSON,2163
43804,Chief,O,2163
43805,Executive,O,2163
43806,Officer,O,2163
43807,of,O,2163
43808,Mitotech,B-ORGANIZATION,2163
43809,said,O,2163
43810,in,O,2163
43811,a,O,2164
43812,company,O,2164
43813,news,O,2164
43814,release,O,2164
43815,Visomitin,B-NAME_OF_DRUG,2164
43816,has,O,2164
43817,an,O,2164
43818,outstanding,O,2164
43819,safety,O,2164
43820,profile,O,2164
43821,and,O,2164
43822,our,O,2164
43823,preliminary,O,2164
43824,human,O,2164
43825,studies,O,2164
43826,have,O,2164
43827,demonstrated,O,2164
43828,effectiveness,O,2164
43829,in,O,2164
43830,LHON,B-NAME_OF_DISEASE,2164
43831,We,O,2164
43832,are,O,2164
43833,looking,O,2164
43834,forward,O,2164
43835,to,O,2164
43836,progressing,O,2165
43837,the,O,2166
43838,drug,O,2166
43839,in,O,2166
43840,LHON,B-NAME_OF_DISEASE,2166
43841,as,O,2166
43842,part,O,2166
43843,of,O,2166
43844,our,O,2166
43845,wider,O,2166
43846,ophthalmology,O,2166
43847,pipeline,O,2166
43848,The,B-ORGANIZATION,2166
43849,FDA,B-ORGANIZATION,2166
43850,s,I-ORGANIZATION,2166
43851,Office,I-ORGANIZATION,2166
43852,of,I-ORGANIZATION,2166
43853,Orphan,I-ORGANIZATION,2166
43854,Products,I-ORGANIZATION,2166
43855,Development,I-ORGANIZATION,2166
43856,OOPD,I-ORGANIZATION,2166
43857,promotes,O,2166
43858,the,O,2166
43859,development,O,2166
43860,and,O,2166
43861,testing,O,2166
43862,of,O,2166
43863,novel,O,2167
43864,medicines,O,2167
43865,for,O,2167
43866,diseases,O,2167
43867,that,O,2167
43868,affect,O,2167
43869,fewer,O,2167
43870,than,O,2167
43871,200,O,2167
43872,0,O,2167
43873,persons,O,2167
43874,in,O,2167
43875,the,B-GPE,2168
43876,United,I-GPE,2168
43877,States,I-GPE,2168
43878,Orphan,O,2168
43879,drug,O,2168
43880,status,O,2168
43881,confers,O,2168
43882,a,O,2168
43883,number,O,2168
43884,of,O,2169
43885,advantages,O,2169
43886,including,O,2169
43887,seven,O,2169
43888,years,O,2169
43889,of,O,2169
43890,market,O,2170
43891,exclusivity,O,2170
43892,upon,O,2170
43893,regulatory,O,2170
43894,approval,O,2170
43895,waiver,O,2170
43896,of,O,2170
43897,FDA,B-ORGANIZATION,2170
43898,application,O,2170
43899,fees,O,2170
43900,and,O,2170
43901,tax,O,2170
43902,incentives,O,2170
43903,for,O,2171
43904,eligible,O,2171
43905,clinical,O,2171
43906,trials,O,2171
43907,Signs,O,2171
43908,Symptoms,O,2171
43909,and,O,2171
43910,Treatment,O,2171
43911,of,O,2171
43912,LHON,B-NAME_OF_DISEASE,2171
43913,Leber,B-NAME_OF_DISEASE,2171
43914,hereditary,I-NAME_OF_DISEASE,2171
43915,optic,I-NAME_OF_DISEASE,2171
43916,neuropathy,I-NAME_OF_DISEASE,2171
43917,LHON,I-NAME_OF_DISEASE,2171
43918,is,O,2172
43919,an,O,2172
43920,inherited,O,2172
43921,form,O,2172
43922,of,O,2172
43923,vision,B-SIGN_AND_SYMPTOM,2172
43924,loss,I-SIGN_AND_SYMPTOM,2172
43925,Although,O,2172
43926,this,O,2172
43927,condition,O,2172
43928,usually,O,2172
43929,begins,O,2172
43930,in,O,2172
43931,a,O,2172
43932,person,O,2172
43933,s,O,2172
43934,teens,O,2173
43935,or,O,2173
43936,twenties,O,2173
43937,rare,O,2173
43938,cases,O,2173
43939,may,O,2173
43940,appear,O,2173
43941,in,O,2173
43942,early,O,2173
43943,childhood,O,2173
43944,or,O,2173
43945,later,O,2173
43946,in,O,2173
43947,adulthood,O,2173
43948,For,O,2173
43949,unknown,O,2173
43950,reasons,O,2173
43951,males,O,2174
43952,are,O,2174
43953,affected,O,2174
43954,much,O,2174
43955,more,O,2174
43956,often,O,2174
43957,than,O,2174
43958,females,O,2174
43959,Blurring,B-SIGN_AND_SYMPTOM,2174
43960,and,I-SIGN_AND_SYMPTOM,2174
43961,clouding,I-SIGN_AND_SYMPTOM,2174
43962,of,I-SIGN_AND_SYMPTOM,2174
43963,vision,I-SIGN_AND_SYMPTOM,2174
43964,are,O,2174
43965,usually,O,2174
43966,the,O,2174
43967,first,O,2174
43968,symptoms,O,2174
43969,of,O,2174
43970,LHON,B-NAME_OF_DISEASE,2174
43971,These,O,2174
43972,vision,O,2174
43973,problems,O,2174
43974,may,O,2174
43975,begin,O,2174
43976,in,O,2174
43977,one,O,2174
43978,eye,O,2174
43979,or,O,2174
43980,simultaneously,O,2175
43981,in,O,2175
43982,both,O,2175
43983,eyes,O,2175
43984,if,O,2175
43985,vision,B-SIGN_AND_SYMPTOM,2175
43986,loss,I-SIGN_AND_SYMPTOM,2175
43987,starts,O,2175
43988,in,O,2175
43989,one,O,2175
43990,eye,O,2175
43991,the,O,2175
43992,other,O,2175
43993,eye,O,2175
43994,is,O,2175
43995,usually,O,2175
43996,affected,O,2175
43997,within,B-TIME_DURATION,2175
43998,several,I-TIME_DURATION,2175
43999,weeks,I-TIME_DURATION,2175
44000,or,I-TIME_DURATION,2175
44001,months,I-TIME_DURATION,2175
44002,Over,O,2176
44003,time,O,2176
44004,vision,B-SIGN_AND_SYMPTOM,2176
44005,in,I-SIGN_AND_SYMPTOM,2176
44006,both,I-SIGN_AND_SYMPTOM,2176
44007,eyes,I-SIGN_AND_SYMPTOM,2176
44008,worsens,I-SIGN_AND_SYMPTOM,2176
44009,with,I-SIGN_AND_SYMPTOM,2176
44010,a,I-SIGN_AND_SYMPTOM,2176
44011,severe,I-SIGN_AND_SYMPTOM,2176
44012,loss,I-SIGN_AND_SYMPTOM,2176
44013,of,I-SIGN_AND_SYMPTOM,2176
44014,sharpness,I-SIGN_AND_SYMPTOM,2176
44015,visual,I-SIGN_AND_SYMPTOM,2176
44016,acuity,I-SIGN_AND_SYMPTOM,2176
44017,and,I-SIGN_AND_SYMPTOM,2176
44018,color,I-SIGN_AND_SYMPTOM,2176
44019,vision,I-SIGN_AND_SYMPTOM,2176
44020,Mutations,B-CAUSE_OF_DISEASE,2176
44021,in,I-CAUSE_OF_DISEASE,2176
44022,the,I-CAUSE_OF_DISEASE,2176
44023,MT-ND1,I-CAUSE_OF_DISEASE,2176
44024,MT-ND4,I-CAUSE_OF_DISEASE,2176
44025,MT-ND4L,I-CAUSE_OF_DISEASE,2176
44026,or,I-CAUSE_OF_DISEASE,2176
44027,MT-ND6,I-CAUSE_OF_DISEASE,2177
44028,gene,I-CAUSE_OF_DISEASE,2177
44029,can,O,2177
44030,cause,O,2177
44031,LHON,B-NAME_OF_DISEASE,2177
44032,These,O,2177
44033,genes,O,2177
44034,are,O,2177
44035,found,O,2177
44036,in,O,2177
44037,the,O,2177
44038,DNA,B-CHEMICAL_COMPOUND,2177
44039,of,O,2177
44040,cellular,O,2177
44041,structures,O,2177
44042,called,O,2177
44043,mitochondria,O,2177
44044,which,O,2177
44045,convert,O,2177
44046,the,O,2177
44047,energy,O,2177
44048,from,O,2177
44049,food,O,2177
44050,into,O,2177
44051,a,O,2177
44052,form,O,2178
44053,that,O,2178
44054,cells,O,2178
44055,can,O,2178
44056,use,O,2178
44057,Leber,B-NAME_OF_DISEASE,2178
44058,hereditary,I-NAME_OF_DISEASE,2178
44059,optic,I-NAME_OF_DISEASE,2178
44060,neuropathy,I-NAME_OF_DISEASE,2178
44061,currently,O,2178
44062,has,O,2178
44063,no,O,2178
44064,proven,O,2178
44065,treatment,O,2178
44066,Symptomatic,O,2178
44067,treatment,O,2178
44068,and,O,2178
44069,genetic,O,2178
44070,counseling,O,2178
44071,are,O,2178
44072,important,O,2178
44073,in,O,2178
44074,the,O,2178
44075,management,O,2178
44076,of,O,2178
44077,patients,O,2178
44078,with,O,2178
44079,Leber,B-NAME_OF_DISEASE,2178
44080,hereditary,I-NAME_OF_DISEASE,2178
44081,optic,I-NAME_OF_DISEASE,2178
44082,neuropathy,I-NAME_OF_DISEASE,2178
44083,RVL,B-ORGANIZATION,2178
44084,Pharmaceutical,I-ORGANIZATION,2178
44085,s,O,2178
44086,Upneeq,B-NAME_OF_DRUG,2178
44087,eye,I-NAME_OF_DRUG,2178
44088,drops,I-NAME_OF_DRUG,2178
44089,which,O,2178
44090,temporarily,O,2178
44091,lift,O,2178
44092,low-lying,O,2178
44093,eyelids,B-PART_OF_THE_EYES,2178
44094,won,O,2178
44095,a,O,2178
44096,2021,O,2178
44097,Best,O,2178
44098,of,O,2178
44099,Beauty,O,2178
44100,Breakthrough,O,2178
44101,Award,O,2178
44102,by,O,2178
44103,Allure,B-ORGANIZATION,2178
44104,Magazine,I-ORGANIZATION,2178
44105,Upneeq,B-NAME_OF_DRUG,2178
44106,is,O,2178
44107,a,O,2178
44108,prescription,O,2178
44109,eye,O,2178
44110,drop,O,2178
44111,that,O,2178
44112,has,O,2178
44113,been,O,2178
44114,approved,O,2178
44115,by,O,2178
44116,the,B-ORGANIZATION,2178
44117,FDA,I-ORGANIZATION,2178
44118,for,O,2178
44119,the,O,2178
44120,treatment,O,2178
44121,of,O,2179
44122,acquired,B-NAME_OF_DISEASE,2179
44123,blepharoptosis,I-NAME_OF_DISEASE,2179
44124,low-lying,I-NAME_OF_DISEASE,2179
44125,lids,I-NAME_OF_DISEASE,2179
44126,in,O,2179
44127,adults,O,2179
44128,Before,O,2179
44129,Upneeq,B-NAME_OF_DRUG,2179
44130,correction,O,2179
44131,surgery,O,2179
44132,was,O,2179
44133,the,O,2179
44134,sole,O,2179
44135,option,O,2179
44136,for,O,2179
44137,people,O,2179
44138,with,O,2180
44139,ptosis,B-SIGN_AND_SYMPTOM,2180
44140,who,O,2180
44141,wanted,O,2180
44142,to,O,2180
44143,truly,O,2180
44144,lift,O,2180
44145,their,O,2180
44146,eyelids,B-PART_OF_THE_EYES,2180
44147,Upneeq,B-NAME_OF_DRUG,2180
44148,is,O,2180
44149,able,O,2180
44150,to,O,2180
44151,temporarily,O,2180
44152,lift,O,2180
44153,a,O,2180
44154,patient,O,2180
44155,s,O,2180
44156,lid,B-PART_OF_THE_EYES,2180
44157,with,O,2180
44158,just,O,2180
44159,one,O,2180
44160,drop,O,2180
44161,average,O,2181
44162,lift,O,2181
44163,in,O,2181
44164,clinical,O,2181
44165,trials,O,2181
44166,was,O,2181
44167,1mm,O,2181
44168,with,O,2181
44169,some,O,2181
44170,patients,O,2181
44171,experiencing,O,2181
44172,lift,O,2181
44173,up,O,2181
44174,to,O,2181
44175,3mm,O,2181
44176,,O,2182
44177,It,O,2182
44178,can,O,2182
44179,make,O,2182
44180,a,O,2182
44181,significant,O,2182
44182,difference,O,2182
44183,for,O,2182
44184,patients,O,2182
44185,with,O,2182
44186,acquired,B-NAME_OF_DISEASE,2182
44187,ptosis,I-NAME_OF_DISEASE,2182
44188,changing,O,2182
44189,the,O,2182
44190,game,O,2182
44191,for,O,2182
44192,eye,O,2182
44193,care,O,2182
44194,specialists,O,2182
44195,looking,O,2182
44196,to,O,2183
44197,give,O,2183
44198,comprehensive,O,2183
44199,care,O,2183
44200,to,O,2183
44201,their,O,2183
44202,patients,O,2183
44203,Allure,B-ORGANIZATION,2183
44204,editors,O,2183
44205,view,O,2183
44206,clinical,O,2183
44207,data,O,2183
44208,and,O,2183
44209,gather,O,2183
44210,solicit,O,2183
44211,feedback,O,2183
44212,from,O,2183
44213,outside,O,2183
44214,judges,O,2183
44215,in,O,2183
44216,order,O,2184
44217,to,O,2184
44218,assess,O,2184
44219,the,O,2184
44220,product,O,2184
44221,s,O,2184
44222,quality,O,2184
44223,and,O,2184
44224,determine,O,2184
44225,whether,O,2184
44226,it,O,2184
44227,is,O,2184
44228,genuinely,O,2184
44229,a,O,2184
44230,breakthrough,O,2184
44231,Of,O,2184
44232,the,O,2185
44233,2021,O,2185
44234,winners,O,2185
44235,Allure,B-ORGANIZATION,2185
44236,wrote,O,2185
44237,We,O,2185
44238,present,O,2185
44239,seven,O,2185
44240,of,O,2185
44241,the,O,2185
44242,most,O,2185
44243,revolutionary,O,2185
44244,innovations,O,2185
44245,we,O,2186
44246,ve,O,2186
44247,ever,O,2186
44248,seen,O,2186
44249,-,O,2186
44250,ones,O,2186
44251,that,O,2186
44252,have,O,2186
44253,changed,O,2186
44254,the,O,2186
44255,way,O,2186
44256,we,O,2186
44257,approach,O,2186
44258,beauty,O,2186
44259,These,O,2186
44260,new,O,2186
44261,products,O,2186
44262,boggled,O,2186
44263,our,O,2186
44264,editors,O,2186
44265,minds,O,2186
44266,and,O,2186
44267,forever,O,2186
44268,changed,O,2186
44269,our,O,2186
44270,beauty,O,2186
44271,routines,O,2186
44272,We,O,2186
44273,are,O,2186
44274,grateful,O,2186
44275,to,O,2186
44276,receive,O,2186
44277,this,O,2186
44278,important,O,2186
44279,award,O,2186
44280,and,O,2186
44281,excited,O,2186
44282,that,O,2187
44283,the,O,2187
44284,ground-breaking,O,2187
44285,innovation,O,2187
44286,in,O,2187
44287,Upneeq,B-NAME_OF_DRUG,2187
44288,is,O,2187
44289,being,O,2187
44290,recognized,O,2187
44291,said,O,2187
44292,Dr,O,2187
44293,Ray,O,2187
44294,Douglas,O,2188
44295,an,O,2188
44296,aesthetic,O,2188
44297,reconstructive,O,2188
44298,and,O,2188
44299,oculoplastic,O,2188
44300,specialist,O,2188
44301,and,O,2188
44302,Global,O,2188
44303,Head,O,2188
44304,of,O,2188
44305,Scientific,O,2188
44306,Affairs,O,2188
44307,for,O,2189
44308,RVL,B-ORGANIZATION,2189
44309,Pharmaceuticals,I-ORGANIZATION,2189
44310,Until,O,2189
44311,Upneeq,B-NAME_OF_DRUG,2189
44312,there,O,2189
44313,was,O,2189
44314,no,O,2189
44315,pharmacologic,O,2189
44316,treatment,O,2189
44317,on,O,2189
44318,the,O,2189
44319,market,O,2189
44320,RVL,B-ORGANIZATION,2189
44321,is,O,2189
44322,passionate,O,2189
44323,about,O,2189
44324,continuing,O,2189
44325,to,O,2189
44326,provide,O,2189
44327,novel,O,2189
44328,solutions,O,2189
44329,for,O,2189
44330,both,O,2189
44331,vision,O,2189
44332,and,O,2189
44333,aesthetics,O,2189
44334,Upneeq,B-NAME_OF_DRUG,2190
44335,0.1,O,2190
44336,oxymetazoline,O,2190
44337,hydrochloride,O,2190
44338,ophthalmic,O,2190
44339,solution,O,2190
44340,works,O,2190
44341,by,O,2190
44342,triggering,O,2190
44343,the,O,2190
44344,levator,O,2190
44345,muscle,O,2190
44346,which,O,2190
44347,contracts,O,2190
44348,and,O,2190
44349,lifts,O,2190
44350,the,B-PART_OF_THE_EYES,2190
44351,eyelid,B-PART_OF_THE_EYES,2190
44352,The,O,2190
44353,dosage,O,2190
44354,is,O,2190
44355,one,O,2190
44356,drop,O,2190
44357,a,O,2190
44358,day,O,2190
44359,per,O,2190
44360,affected,O,2190
44361,eye,O,2190
44362,Some,O,2190
44363,patients,O,2190
44364,reported,O,2190
44365,seeing,O,2190
44366,a,O,2190
44367,difference,O,2191
44368,in,O,2191
44369,as,O,2191
44370,little,O,2191
44371,as,O,2191
44372,five,B-TIME_DURATION,2191
44373,minutes,I-TIME_DURATION,2191
44374,in,O,2191
44375,early,O,2191
44376,studies,O,2191
44377,with,O,2191
44378,complete,O,2191
44379,responses,O,2191
44380,taking,O,2191
44381,two,B-TIME_DURATION,2191
44382,hours,I-TIME_DURATION,2191
44383,Millions,O,2191
44384,of,O,2191
44385,Americans,O,2191
44386,may,O,2192
44387,suffer,O,2192
44388,from,O,2192
44389,an,O,2192
44390,often,O,2192
44391,undiagnosed,O,2192
44392,or,O,2192
44393,overlooked,O,2192
44394,condition,O,2192
44395,called,O,2192
44396,acquired,B-NAME_OF_DISEASE,2192
44397,blepharoptosis,I-NAME_OF_DISEASE,2192
44398,also,O,2192
44399,known,O,2192
44400,as,O,2192
44401,acquired,B-NAME_OF_DISEASE,2192
44402,ptosis,I-NAME_OF_DISEASE,2192
44403,or,O,2192
44404,droopy,O,2193
44405,eyelids,B-PART_OF_THE_EYES,2193
44406,says,O,2193
44407,Dr,O,2193
44408,Douglas,O,2194
44409,The,O,2194
44410,condition,O,2194
44411,not,O,2194
44412,only,O,2194
44413,affects,O,2194
44414,the,O,2194
44415,aesthetics,O,2194
44416,of,O,2194
44417,the,O,2194
44418,face,O,2194
44419,but,O,2194
44420,may,O,2194
44421,also,O,2194
44422,cause,O,2194
44423,vision,B-NAME_OF_DISEASE,2194
44424,impairment,I-NAME_OF_DISEASE,2194
44425,that,O,2194
44426,interferes,O,2194
44427,with,O,2194
44428,day-to-day,O,2194
44429,functions,O,2194
44430,such,O,2194
44431,as,O,2194
44432,reading,O,2194
44433,and,O,2194
44434,driving,O,2194
44435,We,O,2194
44436,are,O,2194
44437,excited,O,2194
44438,to,O,2194
44439,offer,O,2194
44440,a,O,2194
44441,noninvasive,O,2194
44442,option,O,2195
44443,to,O,2195
44444,increase,O,2195
44445,eyelid,B-PART_OF_THE_EYES,2195
44446,lift,O,2196
44447,Visit,O,2196
44448,Upneeq,B-NAME_OF_DRUG,2196
44449,to,O,2196
44450,learn,O,2196
44451,more,O,2196
44452,about,O,2196
44453,the,O,2196
44454,award-winning,O,2196
44455,drops,O,2196
44456,See,O,2196
44457,below,O,2196
44458,for,O,2196
44459,Important,O,2196
44460,Safety,O,2196
44461,Information,O,2196
44462,To,O,2196
44463,read,O,2196
44464,the,O,2196
44465,Allure,B-ORGANIZATION,2196
44466,2021,O,2196
44467,Best,O,2196
44468,of,O,2196
44469,Beauty,O,2196
44470,Breakthrough,O,2196
44471,Awards,O,2196
44472,article,O,2196
44473,click,O,2196
44474,here,O,2196
44475,Oyster,B-ORGANIZATION,2196
44476,Point,I-ORGANIZATION,2196
44477,Pharma,I-ORGANIZATION,2196
44478,announced,O,2196
44479,that,O,2197
44480,the,O,2197
44481,FDA,B-ORGANIZATION,2197
44482,has,O,2197
44483,approved,O,2197
44484,Tyrvaya,B-NAME_OF_DRUG,2197
44485,varenicline,O,2197
44486,solution,O,2197
44487,Nasal,O,2197
44488,Spray,O,2197
44489,0,O,2197
44490,mg,O,2197
44491,formerly,O,2197
44492,called,O,2197
44493,OC-01,B-NAME_OF_DRUG,2197
44494,for,O,2197
44495,the,O,2198
44496,treatment,O,2198
44497,of,O,2198
44498,the,O,2198
44499,signs,O,2198
44500,and,O,2198
44501,symptoms,O,2198
44502,of,O,2198
44503,dry,B-NAME_OF_DISEASE,2198
44504,eye,I-NAME_OF_DISEASE,2198
44505,disease,I-NAME_OF_DISEASE,2198
44506,The,O,2198
44507,approval,O,2198
44508,marks,O,2198
44509,the,O,2198
44510,first,O,2198
44511,and,O,2198
44512,only,O,2198
44513,nasal,O,2198
44514,spray,O,2198
44515,approved,O,2198
44516,for,O,2198
44517,the,O,2198
44518,treatment,O,2198
44519,of,O,2198
44520,dry,B-NAME_OF_DISEASE,2198
44521,eye,I-NAME_OF_DISEASE,2198
44522,disease,I-NAME_OF_DISEASE,2198
44523,Tyrvaya,B-NAME_OF_DRUG,2198
44524,is,O,2198
44525,thought,O,2198
44526,to,O,2198
44527,activate,O,2198
44528,the,O,2198
44529,trigeminal,O,2198
44530,parasympathetic,O,2198
44531,system,O,2198
44532,by,O,2198
44533,binding,O,2198
44534,to,O,2198
44535,cholinergic,O,2198
44536,receptors,O,2199
44537,resulting,O,2199
44538,in,O,2199
44539,enhanced,O,2199
44540,production,O,2199
44541,of,O,2199
44542,basal,O,2199
44543,tear,B-PART_OF_THE_EYES,2199
44544,film,I-PART_OF_THE_EYES,2199
44545,as,O,2199
44546,a,O,2199
44547,treatment,O,2199
44548,for,O,2199
44549,dry,B-NAME_OF_DISEASE,2199
44550,eye,I-NAME_OF_DISEASE,2199
44551,disease,I-NAME_OF_DISEASE,2199
44552,The,O,2199
44553,nasal,O,2199
44554,spray,O,2199
44555,is,O,2199
44556,a,O,2199
44557,highly,O,2199
44558,specific,O,2199
44559,cholinergic,O,2199
44560,agonist,O,2199
44561,that,O,2200
44562,is,O,2200
44563,sprayed,O,2200
44564,into,O,2200
44565,each,O,2200
44566,nostril,O,2200
44567,twice,O,2200
44568,daily,O,2200
44569,to,O,2200
44570,trigger,O,2200
44571,basal,O,2200
44572,tear,O,2200
44573,production,O,2200
44574,The,O,2200
44575,use,O,2200
44576,of,O,2200
44577,a,O,2200
44578,nasal,O,2200
44579,spray,O,2200
44580,to,O,2200
44581,treat,O,2200
44582,dry,B-NAME_OF_DISEASE,2201
44583,eye,I-NAME_OF_DISEASE,2201
44584,disease,I-NAME_OF_DISEASE,2201
44585,is,O,2201
44586,a,O,2201
44587,novel,O,2201
44588,technique,O,2201
44589,to,O,2201
44590,avoid,O,2201
44591,administrating,O,2201
44592,medication,O,2201
44593,onto,O,2201
44594,an,O,2201
44595,already,O,2201
44596,irritated,O,2201
44597,ocular,O,2201
44598,surface,O,2201
44599,In,O,2201
44600,addition,O,2201
44601,nasal,O,2201
44602,delivery,O,2201
44603,may,O,2201
44604,allow,O,2201
44605,some,O,2202
44606,patients,O,2202
44607,who,O,2202
44608,have,O,2202
44609,difficulty,O,2202
44610,independently,O,2202
44611,administering,O,2202
44612,topical,O,2202
44613,eye,O,2202
44614,drops,O,2202
44615,to,O,2202
44616,administer,O,2202
44617,independently,O,2202
44618,their,O,2202
44619,prescribed,O,2202
44620,dry,B-NAME_OF_DISEASE,2202
44621,eye,I-NAME_OF_DISEASE,2202
44622,disease,I-NAME_OF_DISEASE,2202
44623,therapy,O,2202
44624,The,O,2202
44625,approval,O,2202
44626,of,O,2202
44627,Tyrvaya,B-NAME_OF_DRUG,2202
44628,Nasal,I-NAME_OF_DRUG,2202
44629,Spray,I-NAME_OF_DRUG,2202
44630,marks,O,2202
44631,a,O,2202
44632,milestone,O,2202
44633,for,O,2202
44634,patients,O,2202
44635,and,O,2202
44636,eye,O,2202
44637,care,O,2202
44638,professionals,O,2202
44639,by,O,2202
44640,providing,O,2202
44641,a,O,2202
44642,new,O,2202
44643,drug,O,2202
44644,treatment,O,2202
44645,option,O,2203
44646,for,O,2203
44647,the,O,2203
44648,signs,O,2203
44649,and,O,2203
44650,symptoms,O,2203
44651,of,O,2203
44652,dry,B-NAME_OF_DISEASE,2203
44653,eye,I-NAME_OF_DISEASE,2203
44654,disease,I-NAME_OF_DISEASE,2203
44655,with,O,2203
44656,a,O,2203
44657,differentiated,O,2203
44658,route,O,2203
44659,of,O,2203
44660,administration,O,2203
44661,that,O,2204
44662,is,O,2204
44663,believed,O,2204
44664,to,O,2204
44665,leverage,O,2204
44666,a,O,2204
44667,nerve,O,2204
44668,pathway,O,2204
44669,that,O,2204
44670,can,O,2204
44671,be,O,2204
44672,accessed,O,2204
44673,within,O,2204
44674,the,O,2204
44675,nose,O,2204
44676,Jeffrey,B-PERSON,2204
44677,Nau,I-PERSON,2204
44678,PhD,I-PERSON,2205
44679,MMS,I-PERSON,2205
44680,president,O,2205
44681,and,O,2205
44682,CEO,O,2205
44683,of,O,2205
44684,Oyster,B-ORGANIZATION,2205
44685,Point,I-ORGANIZATION,2205
44686,Pharma,I-ORGANIZATION,2205
44687,said,O,2205
44688,in,O,2205
44689,a,O,2205
44690,company,O,2205
44691,news,O,2205
44692,release,O,2205
44693,The,O,2205
44694,drug,O,2205
44695,was,O,2205
44696,tested,O,2205
44697,in,O,2205
44698,over,O,2205
44699,1,O,2205
44700,0,O,2205
44701,patients,O,2205
44702,in,O,2205
44703,the,B-NAME_OF_STUDY,2205
44704,ONSET-1,I-NAME_OF_STUDY,2205
44705,ONSET-2,I-NAME_OF_STUDY,2205
44706,and,I-NAME_OF_STUDY,2205
44707,MYSTIC,I-NAME_OF_STUDY,2205
44708,clinical,I-NAME_OF_STUDY,2205
44709,studies,I-NAME_OF_STUDY,2205
44710,According,O,2205
44711,to,O,2205
44712,Schirmer,O,2205
44713,s,O,2205
44714,score,O,2205
44715,at,O,2205
44716,week,O,2205
44717,4,O,2205
44718,individuals,O,2205
44719,treated,O,2205
44720,with,O,2205
44721,Tyrvaya,B-NAME_OF_DRUG,2205
44722,exhibited,O,2205
44723,statistically,O,2205
44724,significant,O,2205
44725,improvement,O,2205
44726,in,O,2205
44727,tear,B-PART_OF_THE_EYES,2205
44728,film,I-PART_OF_THE_EYES,2205
44729,generation,O,2206
44730,in,O,2206
44731,these,O,2206
44732,trials,O,2206
44733,Sneezing,O,2206
44734,was,O,2206
44735,the,O,2206
44736,most,O,2206
44737,common,O,2206
44738,adverse,O,2206
44739,effect,O,2206
44740,to,O,2206
44741,the,O,2206
44742,medication,O,2206
44743,reported,O,2206
44744,by,O,2206
44745,82%,O,2206
44746,of,O,2206
44747,patients,O,2206
44748,Other,O,2206
44749,minor,O,2206
44750,side,O,2206
44751,effects,O,2206
44752,such,O,2206
44753,as,O,2206
44754,cough,O,2206
44755,throat,O,2206
44756,irritation,O,2206
44757,and,O,2207
44758,nose,O,2207
44759,irritation,O,2207
44760,were,O,2207
44761,reported,O,2207
44762,by,O,2207
44763,5%,O,2207
44764,to,O,2208
44765,16%,O,2208
44766,of,O,2208
44767,patients,O,2208
44768,Tyrvaya,B-NAME_OF_DRUG,2208
44769,Nasal,I-NAME_OF_DRUG,2208
44770,Spray,I-NAME_OF_DRUG,2208
44771,will,O,2208
44772,be,O,2208
44773,available,O,2208
44774,in,O,2208
44775,November,O,2208
44776,2021,O,2208
44777,in,O,2208
44778,cartons,O,2208
44779,containing,O,2208
44780,two,O,2208
44781,multidose,O,2208
44782,nasal,O,2208
44783,spray,O,2208
44784,bottles,O,2208
44785,with,O,2208
44786,a,O,2208
44787,prescription,O,2208
44788,Each,O,2208
44789,nasal,O,2209
44790,spray,O,2209
44791,bottle,O,2209
44792,provides,O,2209
44793,15,B-TIME_DURATION,2209
44794,days,I-TIME_DURATION,2209
44795,of,O,2209
44796,treatment,O,2209
44797,when,O,2209
44798,sprayed,O,2209
44799,twice,O,2209
44800,daily,O,2209
44801,into,O,2209
44802,each,O,2209
44803,nostril,O,2209
44804,Eye,O,2209
44805,care,O,2209
44806,providers,O,2209
44807,will,O,2209
44808,also,O,2209
44809,receive,O,2210
44810,samples,O,2210
44811,that,O,2210
44812,give,O,2210
44813,15,B-TIME_DURATION,2210
44814,days,I-TIME_DURATION,2210
44815,of,O,2210
44816,treatment,O,2210
44817,Arctic,B-ORGANIZATION,2210
44818,Vision,I-ORGANIZATION,2210
44819,of,I-ORGANIZATION,2210
44820,Shanghai,I-ORGANIZATION,2210
44821,and,O,2210
44822,Japanese-based,B-ORGANIZATION,2210
44823,ActualEyes,B-ORGANIZATION,2210
44824,announced,O,2210
44825,an,O,2210
44826,exclusive,O,2210
44827,licensing,O,2210
44828,agreement,O,2210
44829,for,O,2210
44830,Arctic,B-ORGANIZATION,2210
44831,Vision,I-ORGANIZATION,2210
44832,to,O,2210
44833,develop,O,2210
44834,and,O,2211
44835,commercialize,O,2211
44836,ActualEyes,B-ORGANIZATION,2211
44837,lead,O,2211
44838,product,O,2211
44839,candidate,O,2211
44840,AE-101,B-TREATMENT,2211
44841,for,O,2211
44842,the,O,2211
44843,treatment,O,2211
44844,of,O,2211
44845,corneal,B-NAME_OF_DISEASE,2211
44846,endothelial,I-NAME_OF_DISEASE,2211
44847,dysfunction,I-NAME_OF_DISEASE,2211
44848,in,O,2211
44849,Greater,B-GPE,2211
44850,China,B-GPE,2211
44851,and,O,2211
44852,South,B-GPE,2211
44853,Korea,I-GPE,2211
44854,Under,O,2211
44855,the,O,2211
44856,accord,O,2211
44857,ActualEyes,B-ORGANIZATION,2211
44858,may,O,2212
44859,receive,O,2212
44860,up,O,2212
44861,to,O,2212
44862,more,O,2212
44863,than,O,2212
44864,35-million,O,2212
44865,U.S,O,2212
44866,including,O,2212
44867,an,O,2212
44868,upfront,O,2212
44869,payment,O,2212
44870,future,O,2213
44871,regulatory,O,2213
44872,milestones,O,2213
44873,and,O,2213
44874,tiered,O,2213
44875,royalties,O,2213
44876,on,O,2213
44877,net,O,2213
44878,sales,O,2213
44879,Corneal,B-NAME_OF_DISEASE,2213
44880,endothelial,I-NAME_OF_DISEASE,2213
44881,dysfunction,I-NAME_OF_DISEASE,2213
44882,is,O,2214
44883,the,O,2214
44884,result,O,2214
44885,of,O,2214
44886,severe,O,2214
44887,endothelium,B-SIGN_AND_SYMPTOM,2214
44888,damage,I-SIGN_AND_SYMPTOM,2214
44889,caused,O,2214
44890,by,O,2214
44891,different,O,2215
44892,pathologies,O,2215
44893,including,O,2215
44894,Fuchs,B-NAME_OF_DISEASE,2215
44895,endothelial,I-NAME_OF_DISEASE,2215
44896,corneal,I-NAME_OF_DISEASE,2215
44897,dystrophy,I-NAME_OF_DISEASE,2215
44898,pseudophakic,B-NAME_OF_DISEASE,2215
44899,bullous,I-NAME_OF_DISEASE,2215
44900,keratopathy,I-NAME_OF_DISEASE,2215
44901,trauma,B-NAME_OF_DISEASE,2215
44902,glaucoma,B-NAME_OF_DISEASE,2215
44903,and,O,2215
44904,endothelial,B-NAME_OF_DISEASE,2215
44905,keratitis,I-NAME_OF_DISEASE,2215
44906,More,O,2215
44907,than,O,2215
44908,one,O,2215
44909,million,O,2215
44910,patients,O,2216
44911,suffer,O,2216
44912,from,O,2216
44913,corneal,B-NAME_OF_DISEASE,2216
44914,endothelial,I-NAME_OF_DISEASE,2216
44915,dysfunction,I-NAME_OF_DISEASE,2216
44916,in,O,2216
44917,China,B-GPE,2216
44918,and,O,2216
44919,in,O,2216
44920,the,O,2216
44921,most,O,2216
44922,severe,O,2216
44923,cases,O,2216
44924,the,O,2216
44925,most,O,2216
44926,effective,O,2216
44927,treatment,O,2216
44928,is,O,2217
44929,corneal,B-TREATMENT,2217
44930,keratoplasty,I-TREATMENT,2217
44931,a,O,2217
44932,demanding,O,2217
44933,and,O,2217
44934,technically,O,2217
44935,challenging,O,2217
44936,procedure,O,2217
44937,for,O,2217
44938,surgeons,O,2217
44939,AE-101,B-TREATMENT,2217
44940,is,O,2217
44941,a,O,2217
44942,novel,O,2217
44943,cell-injection,O,2217
44944,therapy,O,2217
44945,developed,O,2218
44946,using,O,2218
44947,cultured,O,2218
44948,human,B-PART_OF_THE_EYES,2218
44949,corneal,I-PART_OF_THE_EYES,2218
44950,endothelial,I-PART_OF_THE_EYES,2218
44951,cells,I-PART_OF_THE_EYES,2218
44952,combined,O,2218
44953,with,O,2218
44954,a,B-CHEMICAL_COMPOUND,2219
44955,Rho-associated,I-CHEMICAL_COMPOUND,2219
44956,kinase,I-CHEMICAL_COMPOUND,2219
44957,inhibitor,I-CHEMICAL_COMPOUND,2219
44958,A,O,2219
44959,study,O,2219
44960,published,O,2219
44961,in,O,2219
44962,the,B-PUBLICATION_VENUE,2219
44963,New,I-PUBLICATION_VENUE,2219
44964,England,I-PUBLICATION_VENUE,2219
44965,Journal,I-PUBLICATION_VENUE,2219
44966,of,I-PUBLICATION_VENUE,2219
44967,Medicine,I-PUBLICATION_VENUE,2219
44968,and,I-PUBLICATION_VENUE,2219
44969,Ophthalmology,I-PUBLICATION_VENUE,2219
44970,led,O,2219
44971,by,O,2219
44972,ActualEyes,B-ORGANIZATION,2219
44973,scientific,O,2219
44974,founders,O,2219
44975,Dr,O,2219
44976,Noriko,O,2219
44977,Koizumi,O,2219
44978,and,O,2219
44979,Dr,O,2219
44980,Naoki,O,2219
44981,Okumura,O,2219
44982,demonstrated,O,2219
44983,that,O,2219
44984,AE-101,B-TREATMENT,2219
44985,can,O,2219
44986,restore,O,2219
44987,corneal,B-NAME_OF_DISEASE,2219
44988,endothelial,I-NAME_OF_DISEASE,2219
44989,function,I-NAME_OF_DISEASE,2220
44990,as,O,2220
44991,well,O,2220
44992,as,O,2220
44993,vision,O,2220
44994,with,O,2220
44995,no,O,2220
44996,major,O,2220
44997,treatment-relevant,O,2220
44998,adverse,O,2220
44999,reactions,O,2220
45000,for,O,2221
45001,up,B-TIME_DURATION,2221
45002,to,I-TIME_DURATION,2221
45003,five-years,I-TIME_DURATION,2221
45004,post-operation,O,2221
45005,which,O,2221
45006,represents,O,2221
45007,a,O,2221
45008,paradigm,O,2221
45009,shift,O,2221
45010,in,O,2221
45011,corneal,O,2221
45012,regenerative,O,2221
45013,medicine,O,2221
45014,In,O,2221
45015,a,O,2221
45016,statement,O,2221
45017,Dr,O,2221
45018,Eddy,O,2221
45019,Wu,O,2221
45020,founder,O,2221
45021,and,O,2221
45022,CEO,O,2221
45023,of,O,2221
45024,Arctic,B-ORGANIZATION,2221
45025,Vision,I-ORGANIZATION,2221
45026,said,O,2221
45027,China,B-GPE,2221
45028,is,O,2221
45029,a,O,2221
45030,market,O,2221
45031,with,O,2222
45032,high,O,2222
45033,prevalence,O,2222
45034,of,O,2222
45035,corneal,B-NAME_OF_DISEASE,2222
45036,diseases,I-NAME_OF_DISEASE,2222
45037,as,O,2222
45038,well,O,2222
45039,as,O,2222
45040,huge,O,2222
45041,unmet,O,2222
45042,clinical,O,2222
45043,need,O,2222
45044,due,O,2222
45045,to,O,2222
45046,a,O,2222
45047,shortage,O,2223
45048,of,O,2223
45049,donor,O,2223
45050,corneas,O,2223
45051,The,O,2223
45052,market,O,2223
45053,potential,O,2223
45054,is,O,2223
45055,tremendous,O,2223
45056,for,O,2223
45057,more,O,2223
45058,accessible,O,2223
45059,therapies,O,2223
45060,with,O,2223
45061,greater,O,2223
45062,safety,O,2223
45063,and,O,2223
45064,efficacy,O,2224
45065,he,O,2224
45066,added,O,2224
45067,The,O,2224
45068,licensing,O,2224
45069,of,O,2224
45070,AE-101,B-TREATMENT,2224
45071,represents,O,2224
45072,not,O,2224
45073,only,O,2224
45074,a,O,2224
45075,corporate,O,2224
45076,milestone,O,2224
45077,of,O,2224
45078,incorporating,O,2224
45079,the,O,2224
45080,first,O,2224
45081,cell,O,2224
45082,therapy,O,2224
45083,in,O,2224
45084,our,O,2224
45085,pipeline,O,2224
45086,but,O,2224
45087,also,O,2224
45088,our,O,2225
45089,commitment,O,2225
45090,to,O,2225
45091,an,O,2225
45092,overall,O,2225
45093,portfolio,O,2225
45094,strategy,O,2225
45095,aimed,O,2225
45096,to,O,2225
45097,discover,O,2225
45098,and,O,2225
45099,deliver,O,2225
45100,breakthrough,O,2225
45101,therapies,O,2225
45102,for,O,2225
45103,patients,O,2225
45104,in,O,2225
45105,China,B-GPE,2225
45106,and,O,2226
45107,Asia,B-GPE,2226
45108,Iku,B-PERSON,2226
45109,Sugioka,I-PERSON,2226
45110,President,O,2226
45111,and,O,2226
45112,Chief,O,2226
45113,Executive,O,2226
45114,Officer,O,2226
45115,of,O,2226
45116,ActualEyes,B-ORGANIZATION,2226
45117,said,O,2226
45118,We,O,2226
45119,look,O,2226
45120,forward,O,2226
45121,to,O,2226
45122,collaborating,O,2226
45123,with,O,2226
45124,Arctic,B-ORGANIZATION,2226
45125,Vision,I-ORGANIZATION,2226
45126,to,O,2226
45127,develop,O,2226
45128,our,O,2226
45129,lead,O,2226
45130,clinical,O,2226
45131,candidate,O,2226
45132,AE-101,B-TREATMENT,2226
45133,The,O,2226
45134,potential,O,2226
45135,benefits,O,2226
45136,of,O,2226
45137,cell,O,2226
45138,therapy,O,2226
45139,are,O,2226
45140,significant,O,2226
45141,for,O,2226
45142,patients,O,2226
45143,suffering,O,2226
45144,from,O,2226
45145,vison,B-SIGN_AND_SYMPTOM,2226
45146,impairment,I-SIGN_AND_SYMPTOM,2226
45147,or,I-SIGN_AND_SYMPTOM,2226
45148,loss,I-SIGN_AND_SYMPTOM,2226
45149,caused,O,2226
45150,by,O,2226
45151,corneal,B-NAME_OF_DISEASE,2226
45152,endothelial,I-NAME_OF_DISEASE,2226
45153,dysfunction,I-NAME_OF_DISEASE,2226
45154,From,O,2226
45155,our,O,2226
45156,previous,O,2226
45157,research,O,2226
45158,AE-101,B-TREATMENT,2226
45159,has,O,2226
45160,great,O,2226
45161,potential,O,2226
45162,to,O,2226
45163,provide,O,2226
45164,a,O,2226
45165,less,O,2226
45166,invasive,O,2227
45167,and,O,2227
45168,more,O,2227
45169,effective,O,2227
45170,therapeutic,O,2227
45171,modality,O,2227
45172,compared,O,2227
45173,to,O,2227
45174,conventional,O,2227
45175,surgical,O,2227
45176,therapies,O,2227
45177,With,O,2227
45178,the,O,2227
45179,compelling,O,2227
45180,track,O,2227
45181,records,O,2227
45182,of,O,2227
45183,Arctic,B-ORGANIZATION,2227
45184,Vision,I-ORGANIZATION,2227
45185,s,O,2227
45186,management,O,2227
45187,team,O,2227
45188,in,O,2228
45189,research,O,2228
45190,and,O,2228
45191,commercial,O,2228
45192,fronts,O,2228
45193,we,O,2228
45194,are,O,2228
45195,confident,O,2228
45196,that,O,2228
45197,this,O,2228
45198,partnership,O,2228
45199,is,O,2228
45200,the,O,2228
45201,start,O,2228
45202,of,O,2228
45203,a,O,2228
45204,long-term,O,2228
45205,relationship,O,2229
45206,to,O,2229
45207,bring,O,2229
45208,our,O,2229
45209,novel,O,2229
45210,AE-101,B-TREATMENT,2229
45211,therapy,O,2229
45212,to,O,2229
45213,broader,O,2229
45214,markets,O,2229
45215,in,O,2229
45216,Asia,B-GPE,2229
45217,Alcon,B-ORGANIZATION,2229
45218,the,O,2229
45219,global,O,2229
45220,leader,O,2229
45221,in,O,2229
45222,eye,O,2229
45223,care,O,2229
45224,dedicated,O,2229
45225,to,O,2229
45226,helping,O,2229
45227,people,O,2229
45228,see,O,2230
45229,brilliantly,O,2230
45230,announced,O,2230
45231,the,O,2230
45232,U.S,O,2230
45233,launch,O,2230
45234,of,O,2230
45235,PRECISION1®,B-TREATMENT,2230
45236,for,I-TREATMENT,2230
45237,Astigmatism,B-NAME_OF_DISEASE,2230
45238,a,O,2230
45239,daily,O,2230
45240,disposable,O,2230
45241,silicone,B-TREATMENT,2230
45242,hydrogel,I-TREATMENT,2230
45243,SiHy,I-TREATMENT,2230
45244,contact,B-TREATMENT,2230
45245,lens,I-TREATMENT,2230
45246,designed,O,2230
45247,for,O,2230
45248,astigmatic,O,2230
45249,patients,O,2230
45250,PRECISION1,B-TREATMENT,2230
45251,for,I-TREATMENT,2230
45252,Astigmatism,B-NAME_OF_DISEASE,2230
45253,born,O,2230
45254,from,O,2230
45255,Water,O,2230
45256,Gradient,O,2230
45257,Technology,O,2230
45258,features,O,2230
45259,the,O,2230
45260,proven,O,2230
45261,PRECISION,B-TREATMENT,2230
45262,BALANCE,I-TREATMENT,2231
45263,8|4,I-TREATMENT,2231
45264,lens,I-TREATMENT,2231
45265,design,O,2231
45266,for,O,2231
45267,a,O,2231
45268,stable,O,2231
45269,contact,O,2231
45270,lens-wearing,O,2231
45271,experience,O,2231
45272,The,O,2231
45273,lens,O,2231
45274,offers,O,2231
45275,a,O,2231
45276,significant,O,2231
45277,opportunity,O,2231
45278,to,O,2231
45279,attract,O,2232
45280,new,O,2232
45281,contact,B-TREATMENT,2232
45282,lens,I-TREATMENT,2232
45283,wearers,O,2232
45284,and,O,2232
45285,reduce,O,2232
45286,contact,B-TREATMENT,2232
45287,lens,I-TREATMENT,2232
45288,dropouts,O,2232
45289,PRECISION1,B-TREATMENT,2232
45290,and,O,2232
45291,PRECISION1,B-TREATMENT,2232
45292,for,I-TREATMENT,2232
45293,Astigmatism,B-NAME_OF_DISEASE,2232
45294,are,O,2232
45295,now,O,2232
45296,widely,O,2232
45297,available,O,2232
45298,in,O,2232
45299,the,O,2232
45300,U.S,O,2232
45301,and,O,2232
45302,will,O,2232
45303,roll,O,2233
45304,out,O,2233
45305,concurrently,O,2233
45306,worldwide,O,2233
45307,beginning,O,2233
45308,in,O,2233
45309,February,O,2233
45310,2021,O,2233
45311,PRECISION1,B-TREATMENT,2233
45312,with,O,2233
45313,its,O,2233
45314,cutting-edge,O,2233
45315,SMARTSURFACE®,O,2233
45316,technology,O,2233
45317,has,O,2233
45318,become,O,2233
45319,the,O,2233
45320,fastest-growing,O,2233
45321,daily,O,2233
45322,disposable,O,2233
45323,contact,B-TREATMENT,2233
45324,lens,I-TREATMENT,2233
45325,brand,O,2233
45326,in,O,2233
45327,the,O,2233
45328,U.S,O,2233
45329,said,O,2233
45330,Sergio,B-PERSON,2233
45331,Duplan,I-PERSON,2233
45332,President,O,2233
45333,Alcon,B-ORGANIZATION,2234
45334,North,I-ORGANIZATION,2234
45335,America,I-ORGANIZATION,2234
45336,We,O,2234
45337,are,O,2234
45338,thrilled,O,2234
45339,to,O,2234
45340,build,O,2234
45341,on,O,2234
45342,this,O,2234
45343,momentum,O,2234
45344,by,O,2234
45345,introducing,O,2234
45346,PRECISION1,B-TREATMENT,2234
45347,for,I-TREATMENT,2234
45348,Astigmatism,B-NAME_OF_DISEASE,2234
45349,Alcon,B-ORGANIZATION,2234
45350,s,O,2234
45351,first,O,2234
45352,daily,O,2234
45353,disposable,O,2234
45354,SiHy,B-TREATMENT,2234
45355,toric,I-TREATMENT,2234
45356,lens,I-TREATMENT,2234
45357,at,O,2234
45358,a,O,2234
45359,mainstream,O,2234
45360,price,O,2234
45361,This,O,2234
45362,innovation,O,2234
45363,offers,O,2234
45364,Eye,O,2234
45365,Care,O,2234
45366,Professionals,O,2235
45367,a,O,2235
45368,lens,O,2235
45369,for,O,2235
45370,more,O,2235
45371,of,O,2235
45372,their,O,2235
45373,astigmatic,O,2235
45374,patients,O,2235
45375,to,O,2235
45376,start,O,2235
45377,in,O,2235
45378,and,O,2235
45379,stay,O,2235
45380,in,O,2235
45381,PRECISION1,B-TREATMENT,2235
45382,for,I-TREATMENT,2235
45383,Astigmatism,B-NAME_OF_DISEASE,2235
45384,born,O,2235
45385,from,O,2235
45386,the,O,2235
45387,Water,O,2235
45388,Gradient,O,2235
45389,Technology,O,2235
45390,of,O,2235
45391,DAILIES,B-TREATMENT,2235
45392,TOTAL1®,I-TREATMENT,2235
45393,features,O,2235
45394,the,O,2235
45395,proven,O,2235
45396,PRECISION,B-TREATMENT,2235
45397,BALANCE,I-TREATMENT,2235
45398,8|4®,I-TREATMENT,2235
45399,lens,I-TREATMENT,2236
45400,design,O,2236
45401,for,O,2236
45402,a,O,2236
45403,stable,O,2236
45404,lens-wearing,O,2236
45405,experience,O,2236
45406,Clinical,O,2236
45407,studies,O,2236
45408,show,O,2236
45409,the,O,2236
45410,toric,O,2236
45411,lens,O,2236
45412,settles,O,2236
45413,in,O,2236
45414,less,O,2236
45415,than,O,2236
45416,60,O,2236
45417,seconds,O,2236
45418,and,O,2236
45419,3º,O,2236
45420,of,O,2236
45421,ideal,O,2236
45422,orientation,O,2236
45423,for,O,2236
45424,a,O,2236
45425,99%,O,2236
45426,first,O,2236
45427,fit,O,2236
45428,success,O,2236
45429,rate,O,2236
45430,Additionally,O,2236
45431,a,O,2236
45432,single,O,2236
45433,6,O,2236
45434,o,O,2236
45435,clock,O,2237
45436,scribe,O,2237
45437,mark,O,2237
45438,makes,O,2237
45439,fitting,O,2237
45440,exceptionally,O,2237
45441,easy,O,2237
45442,Astigmatism,B-NAME_OF_DISEASE,2237
45443,is,O,2237
45444,a,O,2237
45445,common,O,2237
45446,vision,O,2237
45447,problem,O,2237
45448,caused,O,2237
45449,by,O,2237
45450,an,O,2237
45451,irregularly,O,2237
45452,shaped,O,2237
45453,cornea,B-PART_OF_THE_EYES,2237
45454,This,O,2237
45455,can,O,2237
45456,cause,O,2237
45457,images,B-SIGN_AND_SYMPTOM,2237
45458,to,I-SIGN_AND_SYMPTOM,2238
45459,blur,I-SIGN_AND_SYMPTOM,2238
45460,or,I-SIGN_AND_SYMPTOM,2238
45461,stretch,I-SIGN_AND_SYMPTOM,2238
45462,out,I-SIGN_AND_SYMPTOM,2238
45463,Alcon,B-ORGANIZATION,2238
45464,estimates,O,2238
45465,that,O,2238
45466,toric,B-TREATMENT,2238
45467,lenses,I-TREATMENT,2238
45468,which,O,2238
45469,correct,O,2238
45470,for,O,2238
45471,astigmatism,B-NAME_OF_DISEASE,2238
45472,represent,O,2238
45473,23%,O,2238
45474,of,O,2238
45475,the,O,2238
45476,9,O,2238
45477,billion,O,2238
45478,global,O,2238
45479,contact,B-TREATMENT,2238
45480,lens,I-TREATMENT,2238
45481,market,O,2238
45482,As,O,2238
45483,a,O,2238
45484,result,O,2238
45485,there,O,2238
45486,is,O,2238
45487,a,O,2238
45488,significant,O,2238
45489,opportunity,O,2238
45490,to,O,2238
45491,attract,O,2239
45492,new,O,2239
45493,contact,B-TREATMENT,2239
45494,lens,I-TREATMENT,2239
45495,wearers,O,2239
45496,and,O,2239
45497,reduce,O,2239
45498,lens,O,2239
45499,dropouts,O,2239
45500,For,O,2239
45501,example,O,2239
45502,studies,O,2239
45503,show,O,2239
45504,that,O,2240
45505,41%,O,2240
45506,of,O,2240
45507,patients,O,2240
45508,are,O,2240
45509,astigmatic,O,2240
45510,but,O,2240
45511,only,O,2240
45512,10%,O,2240
45513,wear,O,2240
45514,toric,B-TREATMENT,2240
45515,contact,I-TREATMENT,2240
45516,lenses,I-TREATMENT,2240
45517,Further,O,2240
45518,about,O,2240
45519,65%,O,2240
45520,of,O,2240
45521,contact,B-TREATMENT,2240
45522,lens,I-TREATMENT,2240
45523,dropouts,O,2240
45524,have,O,2240
45525,astigmatism,B-NAME_OF_DISEASE,2240
45526,Born,O,2240
45527,from,O,2240
45528,Water,O,2241
45529,Gradient,O,2241
45530,Technology,O,2241
45531,PRECISION1,B-TREATMENT,2241
45532,lenses,I-TREATMENT,2241
45533,feature,O,2241
45534,SMARTSURFACE,B-TREATMENT,2241
45535,Technology,I-TREATMENT,2241
45536,a,O,2241
45537,permanent,O,2241
45538,micro-thin,O,2241
45539,high-performance,O,2241
45540,layer,O,2241
45541,of,O,2241
45542,moisture,O,2241
45543,that,O,2241
45544,steps,O,2241
45545,up,O,2241
45546,from,O,2242
45547,51%,O,2242
45548,water,O,2242
45549,at,O,2242
45550,the,O,2242
45551,core,O,2242
45552,to,O,2242
45553,greater,O,2242
45554,than,O,2242
45555,80%,O,2242
45556,water,O,2242
45557,at,O,2242
45558,the,O,2242
45559,outer,O,2242
45560,surface,O,2242
45561,These,O,2242
45562,lenses,O,2242
45563,support,O,2242
45564,a,O,2242
45565,stable,O,2242
45566,tear,B-PART_OF_THE_EYES,2242
45567,film,I-PART_OF_THE_EYES,2242
45568,to,O,2242
45569,deliver,O,2243
45570,lasting,O,2243
45571,performance,O,2243
45572,Many,O,2243
45573,of,O,2243
45574,my,O,2243
45575,patients,O,2243
45576,want,O,2243
45577,long-lasting,O,2243
45578,comfort,O,2243
45579,from,O,2243
45580,their,O,2243
45581,daily,O,2243
45582,disposable,O,2243
45583,contact,B-TREATMENT,2243
45584,lens,I-TREATMENT,2243
45585,and,O,2243
45586,that,O,2243
45587,s,O,2243
45588,led,O,2243
45589,me,O,2243
45590,to,O,2243
45591,wholeheartedly,O,2243
45592,prescribe,O,2243
45593,PRECISION1,B-TREATMENT,2243
45594,said,O,2243
45595,Aaron,B-PERSON,2244
45596,Luekenga,I-PERSON,2244
45597,OD,O,2244
45598,Heritage,B-ORGANIZATION,2244
45599,Valley,I-ORGANIZATION,2244
45600,Eye,I-ORGANIZATION,2244
45601,Care,I-ORGANIZATION,2244
45602,California,I-ORGANIZATION,2244
45603,Now,O,2244
45604,with,O,2244
45605,PRECISION1,B-TREATMENT,2244
45606,for,I-TREATMENT,2244
45607,Astigmatism,B-NAME_OF_DISEASE,2244
45608,I,O,2244
45609,can,O,2244
45610,offer,O,2245
45611,my,O,2245
45612,astigmatic,O,2245
45613,patients,O,2245
45614,a,O,2245
45615,stable,O,2245
45616,next-generation,O,2245
45617,lens-wearing,O,2245
45618,experience,O,2245
45619,PRECISION1,B-TREATMENT,2245
45620,and,O,2245
45621,PRECISION1,B-TREATMENT,2245
45622,for,I-TREATMENT,2245
45623,Astigmatism,B-NAME_OF_DISEASE,2245
45624,are,O,2245
45625,available,O,2245
45626,in,O,2245
45627,optical,O,2245
45628,retailers,O,2245
45629,practices,O,2245
45630,and,O,2245
45631,online,O,2245
45632,throughout,O,2245
45633,the,B-GPE,2246
45634,United,I-GPE,2246
45635,States,I-GPE,2246
45636,Eye,O,2246
45637,Care,O,2246
45638,Professionals,O,2246
45639,with,O,2246
45640,or,O,2246
45641,without,O,2246
45642,fit,O,2246
45643,sets,O,2246
45644,will,O,2246
45645,have,O,2246
45646,access,O,2246
45647,to,O,2246
45648,order,O,2246
45649,trial,O,2246
45650,and,O,2246
45651,revenue,O,2246
45652,lenses,O,2246
45653,directly,O,2246
45654,from,O,2246
45655,Alcon,B-ORGANIZATION,2246
45656,or,O,2247
45657,an,O,2247
45658,Alcon-authorized,O,2247
45659,distributor,O,2247
45660,In,O,2247
45661,addition,O,2247
45662,PRECISION1,B-TREATMENT,2247
45663,and,O,2247
45664,PRECISION1,B-TREATMENT,2247
45665,for,I-TREATMENT,2247
45666,Astigmatism,B-NAME_OF_DISEASE,2247
45667,will,O,2247
45668,begin,O,2247
45669,to,O,2247
45670,roll,O,2247
45671,out,O,2247
45672,concurrently,O,2247
45673,worldwide,O,2247
45674,beginning,O,2248
45675,in,O,2248
45676,February,O,2248
45677,2021,O,2248
45678,The,B-NAME_OF_DRUG,2248
45679,nonsteroidal,I-NAME_OF_DRUG,2248
45680,anti-inflammatory,I-NAME_OF_DRUG,2248
45681,drug,I-NAME_OF_DRUG,2248
45682,NSAID,I-NAME_OF_DRUG,2248
45683,aspirin,B-CHEMICAL_COMPOUND,2248
45684,a,O,2248
45685,common,O,2248
45686,medication,O,2248
45687,used,O,2248
45688,to,O,2248
45689,reduce,O,2248
45690,pain,O,2249
45691,fever,O,2249
45692,or,O,2249
45693,inflammation,O,2249
45694,has,O,2249
45695,been,O,2249
45696,developed,O,2249
45697,into,O,2249
45698,nanorods,O,2249
45699,by,O,2249
45700,a,O,2249
45701,team,O,2249
45702,of,O,2249
45703,scientists,O,2249
45704,from,O,2249
45705,the,B-ORGANIZATION,2249
45706,Institute,I-ORGANIZATION,2249
45707,of,I-ORGANIZATION,2249
45708,Nano,I-ORGANIZATION,2249
45709,Science,I-ORGANIZATION,2249
45710,Technology,I-ORGANIZATION,2249
45711,INST,I-ORGANIZATION,2249
45712,an,O,2249
45713,autonomous,O,2249
45714,institute,O,2249
45715,under,O,2249
45716,the,B-ORGANIZATION,2250
45717,Department,I-ORGANIZATION,2250
45718,of,I-ORGANIZATION,2250
45719,Science,I-ORGANIZATION,2250
45720,Technology,I-ORGANIZATION,2250
45721,Government,I-ORGANIZATION,2250
45722,of,I-ORGANIZATION,2250
45723,India,I-ORGANIZATION,2250
45724,and,O,2250
45725,they,O,2250
45726,discovered,O,2250
45727,it,O,2250
45728,to,O,2250
45729,be,O,2250
45730,an,O,2250
45731,efficient,O,2251
45732,non-invasive,B-PREVENTION,2251
45733,small,I-PREVENTION,2251
45734,molecule-based,I-PREVENTION,2251
45735,nanotherapeutics,I-PREVENTION,2251
45736,against,O,2251
45737,cataract,B-NAME_OF_DISEASE,2251
45738,The,O,2251
45739,study,O,2251
45740,that,O,2251
45741,was,O,2251
45742,published,O,2251
45743,in,O,2251
45744,the,B-PUBLICATION_VENUE,2251
45745,Journal,I-PUBLICATION_VENUE,2251
45746,of,I-PUBLICATION_VENUE,2251
45747,Materials,I-PUBLICATION_VENUE,2251
45748,Chemistry,I-PUBLICATION_VENUE,2251
45749,B,I-PUBLICATION_VENUE,2252
45750,may,O,2252
45751,provide,O,2252
45752,an,O,2252
45753,affordable,O,2252
45754,and,O,2252
45755,simple,O,2252
45756,method,O,2252
45757,for,O,2252
45758,preventing,O,2252
45759,cataracts,B-NAME_OF_DISEASE,2252
45760,They,O,2252
45761,have,O,2252
45762,employed,O,2252
45763,self-assembled,O,2252
45764,aspirin,B-CHEMICAL_COMPOUND,2252
45765,nanorods,O,2252
45766,anti-aggregation,O,2253
45767,properties,O,2253
45768,as,O,2253
45769,an,O,2253
45770,efficient,O,2253
45771,non-invasive,B-PREVENTION,2253
45772,small,I-PREVENTION,2253
45773,molecule-based,I-PREVENTION,2253
45774,nanotherapeutic,I-PREVENTION,2253
45775,against,O,2253
45776,cataract,B-NAME_OF_DISEASE,2253
45777,Aspirin,B-CHEMICAL_COMPOUND,2253
45778,nanorods,O,2253
45779,suppress,O,2253
45780,the,O,2253
45781,aggregation,O,2254
45782,of,O,2254
45783,the,B-CHEMICAL_COMPOUND,2254
45784,crystallin,B-CHEMICAL_COMPOUND,2254
45785,protein,B-CHEMICAL_COMPOUND,2254
45786,and,O,2254
45787,different,O,2254
45788,peptides,B-CHEMICAL_COMPOUND,2254
45789,produced,O,2254
45790,from,O,2254
45791,it,O,2254
45792,which,O,2254
45793,are,O,2254
45794,essential,O,2254
45795,for,O,2254
45796,the,O,2254
45797,development,O,2254
45798,of,O,2254
45799,cataracts,B-NAME_OF_DISEASE,2254
45800,Through,O,2254
45801,biomolecular,O,2254
45802,interactions,O,2254
45803,they,O,2255
45804,stop,O,2255
45805,the,O,2255
45806,protein,B-CHEMICAL_COMPOUND,2255
45807,peptide,B-CHEMICAL_COMPOUND,2255
45808,from,O,2255
45809,aggregating,O,2255
45810,by,O,2255
45811,changing,O,2255
45812,the,O,2255
45813,beta-turn-like,O,2255
45814,shape,O,2255
45815,of,O,2255
45816,the,O,2255
45817,crystallin,B-CHEMICAL_COMPOUND,2255
45818,peptides,I-CHEMICAL_COMPOUND,2255
45819,which,O,2255
45820,is,O,2255
45821,what,O,2256
45822,causes,O,2256
45823,amyloid,B-CHEMICAL_COMPOUND,2256
45824,to,O,2256
45825,develop,O,2256
45826,into,O,2256
45827,coils,O,2256
45828,and,O,2256
45829,helices,O,2256
45830,which,O,2256
45831,do,O,2256
45832,not,O,2256
45833,aggregate,O,2256
45834,These,O,2256
45835,were,O,2256
45836,discovered,O,2256
45837,to,O,2256
45838,block,O,2256
45839,the,O,2256
45840,development,O,2256
45841,of,O,2256
45842,crystallin,B-CHEMICAL_COMPOUND,2256
45843,and,O,2256
45844,crystallin-derived,B-CHEMICAL_COMPOUND,2256
45845,peptide,I-CHEMICAL_COMPOUND,2256
45846,aggregates,O,2256
45847,which,O,2256
45848,prevent,O,2256
45849,cataract,B-NAME_OF_DISEASE,2256
45850,formation,O,2256
45851,The,B-CHEMICAL_COMPOUND,2257
45852,lens,I-CHEMICAL_COMPOUND,2257
45853,protein,I-CHEMICAL_COMPOUND,2257
45854,crystallin,I-CHEMICAL_COMPOUND,2257
45855,accumulates,O,2257
45856,to,O,2257
45857,form,O,2257
45858,opaque,B-SIGN_AND_SYMPTOM,2257
45859,formations,I-SIGN_AND_SYMPTOM,2257
45860,in,I-SIGN_AND_SYMPTOM,2257
45861,the,I-SIGN_AND_SYMPTOM,2257
45862,eye,I-SIGN_AND_SYMPTOM,2257
45863,lens,I-SIGN_AND_SYMPTOM,2257
45864,with,O,2257
45865,aging,O,2257
45866,and,O,2257
45867,other,O,2257
45868,diseases,O,2257
45869,impairing,B-SIGN_AND_SYMPTOM,2257
45870,vision,I-SIGN_AND_SYMPTOM,2257
45871,and,O,2257
45872,leading,O,2257
45873,to,O,2257
45874,cataract,B-NAME_OF_DISEASE,2257
45875,One,O,2257
45876,effective,O,2258
45877,therapeutic,O,2258
45878,approach,O,2258
45879,for,O,2258
45880,the,O,2258
45881,prevention,O,2258
45882,of,O,2258
45883,cataract,B-NAME_OF_DISEASE,2258
45884,formation,O,2258
45885,is,O,2258
45886,the,O,2258
45887,targeted,O,2258
45888,disaggregation,O,2258
45889,of,O,2258
45890,the,O,2258
45891,accumulated,O,2258
45892,alpha-crystallin,B-CHEMICAL_COMPOUND,2258
45893,protein,I-CHEMICAL_COMPOUND,2258
45894,and,O,2258
45895,crystallin,B-CHEMICAL_COMPOUND,2258
45896,derived,I-CHEMICAL_COMPOUND,2258
45897,peptide,I-CHEMICAL_COMPOUND,2258
45898,aggregates,O,2258
45899,in,O,2258
45900,old,O,2258
45901,and,O,2258
45902,cataractous,O,2258
45903,human,B-PART_OF_THE_EYES,2259
45904,lenses,I-PART_OF_THE_EYES,2259
45905,In,O,2259
45906,contrast,O,2259
45907,to,O,2259
45908,the,O,2259
45909,expensive,O,2259
45910,and,O,2259
45911,time-consuming,O,2259
45912,physical,O,2259
45913,procedures,O,2259
45914,often,O,2259
45915,employed,O,2259
45916,for,O,2259
45917,the,O,2259
45918,production,O,2259
45919,of,O,2259
45920,nanoparticles,O,2259
45921,the,O,2259
45922,aspirin,B-CHEMICAL_COMPOUND,2259
45923,nanorods,O,2260
45924,are,O,2260
45925,generated,O,2260
45926,utilizing,O,2260
45927,the,O,2260
45928,molecular,O,2260
45929,self-assembly,O,2260
45930,approach,O,2260
45931,which,O,2260
45932,is,O,2260
45933,low,O,2260
45934,cost,O,2260
45935,and,O,2260
45936,high,O,2260
45937,yield,O,2260
45938,The,O,2260
45939,chemical,O,2260
45940,mechanism,O,2260
45941,behind,O,2260
45942,aspirin,B-CHEMICAL_COMPOUND,2260
45943,s,O,2260
45944,anti-aggregation,O,2260
45945,behavior,O,2260
45946,and,O,2260
45947,the,O,2260
45948,nature,O,2260
45949,of,O,2260
45950,protein,B-CHEMICAL_COMPOUND,2260
45951,peptide,I-CHEMICAL_COMPOUND,2260
45952,#NAME?,I-CHEMICAL_COMPOUND,2260
45953,interactions,O,2260
45954,between,O,2260
45955,the,O,2260
45956,synthetic,B-CHEMICAL_COMPOUND,2261
45957,peptides,I-CHEMICAL_COMPOUND,2261
45958,and,O,2261
45959,aspirin,B-CHEMICAL_COMPOUND,2261
45960,were,O,2261
45961,investigated,O,2261
45962,by,O,2261
45963,computational,O,2261
45964,research,O,2261
45965,based,O,2261
45966,on,O,2261
45967,molecular,O,2261
45968,dynamics,O,2261
45969,MD,O,2261
45970,simulations,O,2261
45971,It,O,2261
45972,was,O,2261
45973,shown,O,2261
45974,that,O,2261
45975,the,O,2261
45976,interactions,O,2261
45977,between,O,2261
45978,peptide,B-CHEMICAL_COMPOUND,2261
45979,and,I-CHEMICAL_COMPOUND,2261
45980,aspirin,I-CHEMICAL_COMPOUND,2261
45981,inhibitor,I-CHEMICAL_COMPOUND,2261
45982,ultimately,O,2261
45983,changed,O,2261
45984,the,O,2261
45985,secondary,O,2262
45986,structures,O,2262
45987,of,O,2262
45988,peptides,B-CHEMICAL_COMPOUND,2262
45989,from,O,2262
45990,beta-turns,O,2262
45991,which,O,2262
45992,are,O,2262
45993,responsible,O,2262
45994,for,O,2262
45995,the,O,2262
45996,production,O,2262
45997,of,O,2262
45998,amyloids,B-CHEMICAL_COMPOUND,2262
45999,into,O,2262
46000,other,O,2262
46001,coils,O,2262
46002,and,O,2262
46003,helixes,O,2262
46004,inhibiting,O,2262
46005,its,O,2262
46006,aggregation,O,2262
46007,The,O,2263
46008,key,O,2263
46009,of,O,2263
46010,aspirin,B-CHEMICAL_COMPOUND,2263
46011,s,O,2263
46012,capability,O,2263
46013,to,O,2263
46014,suppress,O,2263
46015,the,O,2263
46016,development,O,2263
46017,of,O,2263
46018,amyloid-like,O,2263
46019,fibrils,O,2263
46020,by,O,2263
46021,the,O,2263
46022,model,O,2263
46023,cataract,B-NAME_OF_DISEASE,2263
46024,peptides,B-CHEMICAL_COMPOUND,2263
46025,was,O,2263
46026,disclosed,O,2263
46027,by,O,2263
46028,these,O,2263
46029,simulations,O,2263
46030,Several,O,2263
46031,natural,O,2263
46032,substances,O,2263
46033,have,O,2264
46034,already,O,2264
46035,been,O,2264
46036,identified,O,2264
46037,as,O,2264
46038,possible,O,2264
46039,crystallin,B-CHEMICAL_COMPOUND,2264
46040,aggregation,O,2264
46041,inhibitors,O,2264
46042,but,O,2264
46043,the,O,2264
46044,use,O,2264
46045,of,O,2264
46046,nonsteroidal,B-NAME_OF_DRUG,2264
46047,anti-inflammatory,I-NAME_OF_DRUG,2264
46048,medicines,I-NAME_OF_DRUG,2264
46049,NSAIDs,I-NAME_OF_DRUG,2264
46050,like,O,2264
46051,aspirin,B-CHEMICAL_COMPOUND,2264
46052,in,O,2264
46053,this,O,2264
46054,context,O,2264
46055,will,O,2265
46056,usher,O,2265
46057,in,O,2265
46058,a,O,2265
46059,new,O,2265
46060,way,O,2265
46061,of,O,2265
46062,thinking,O,2265
46063,Additionally,O,2265
46064,aspirin,B-CHEMICAL_COMPOUND,2265
46065,nanorods,O,2265
46066,nano-size,O,2265
46067,will,O,2265
46068,improve,O,2265
46069,drug,O,2265
46070,loading,O,2265
46071,reduce,O,2265
46072,toxicity,O,2265
46073,and,O,2265
46074,increase,O,2265
46075,bioavailability,O,2265
46076,As,O,2265
46077,a,O,2265
46078,result,O,2265
46079,the,O,2265
46080,administration,O,2265
46081,of,O,2265
46082,aspirin,B-CHEMICAL_COMPOUND,2265
46083,nanorods,O,2265
46084,as,O,2265
46085,eye,O,2265
46086,drops,O,2266
46087,will,O,2266
46088,serve,O,2266
46089,as,O,2266
46090,a,O,2266
46091,useful,O,2266
46092,and,O,2266
46093,practical,O,2266
46094,option,O,2266
46095,for,O,2266
46096,treating,O,2266
46097,cataracts,B-NAME_OF_DISEASE,2266
46098,without,O,2266
46099,surgery,O,2266
46100,COVID-19,B-NAME_OF_DISEASE,2266
46101,vaccines,O,2266
46102,have,O,2266
46103,been,O,2266
46104,at,O,2266
46105,the,O,2266
46106,forefront,O,2266
46107,of,O,2266
46108,public,O,2266
46109,health,O,2266
46110,efforts,O,2266
46111,globally,O,2266
46112,since,O,2266
46113,their,O,2266
46114,development,O,2266
46115,in,O,2266
46116,record,O,2266
46117,time,O,2266
46118,Although,O,2266
46119,the,O,2266
46120,vaccines,O,2267
46121,have,O,2267
46122,been,O,2267
46123,shown,O,2267
46124,to,O,2267
46125,be,O,2267
46126,effective,O,2267
46127,in,O,2267
46128,preventing,O,2267
46129,COVID-19,B-NAME_OF_DISEASE,2267
46130,infection,O,2267
46131,some,O,2267
46132,people,O,2267
46133,have,O,2267
46134,reported,O,2267
46135,side,O,2267
46136,effects,O,2267
46137,that,O,2267
46138,include,O,2267
46139,ocular,B-NAME_OF_DISEASE,2267
46140,inflammation,I-NAME_OF_DISEASE,2267
46141,Ocular,B-NAME_OF_DISEASE,2267
46142,inflammation,I-NAME_OF_DISEASE,2267
46143,also,O,2267
46144,known,O,2267
46145,as,O,2267
46146,uveitis,B-NAME_OF_DISEASE,2267
46147,is,O,2267
46148,a,O,2267
46149,condition,O,2267
46150,that,O,2267
46151,affects,O,2267
46152,the,B-PART_OF_THE_EYES,2268
46153,middle,I-PART_OF_THE_EYES,2268
46154,layer,I-PART_OF_THE_EYES,2268
46155,of,I-PART_OF_THE_EYES,2268
46156,the,I-PART_OF_THE_EYES,2268
46157,eye,I-PART_OF_THE_EYES,2268
46158,causing,O,2268
46159,pain,B-SIGN_AND_SYMPTOM,2268
46160,redness,I-SIGN_AND_SYMPTOM,2268
46161,blurred,I-SIGN_AND_SYMPTOM,2268
46162,vision,I-SIGN_AND_SYMPTOM,2268
46163,and,I-SIGN_AND_SYMPTOM,2268
46164,sensitivity,I-SIGN_AND_SYMPTOM,2268
46165,to,I-SIGN_AND_SYMPTOM,2268
46166,light,I-SIGN_AND_SYMPTOM,2268
46167,The,O,2268
46168,inflammation,O,2268
46169,can,O,2268
46170,also,O,2268
46171,lead,O,2268
46172,to,O,2268
46173,complications,O,2268
46174,such,O,2268
46175,as,O,2268
46176,glaucoma,B-NAME_OF_DISEASE,2268
46177,and,O,2268
46178,cataracts,B-NAME_OF_DISEASE,2268
46179,if,O,2268
46180,left,O,2268
46181,untreated,O,2268
46182,Research,O,2268
46183,has,O,2269
46184,shown,O,2269
46185,that,O,2269
46186,ocular,B-NAME_OF_DISEASE,2269
46187,inflammation,I-NAME_OF_DISEASE,2269
46188,can,O,2269
46189,occur,O,2269
46190,as,O,2269
46191,a,O,2269
46192,rare,O,2269
46193,side,O,2269
46194,effect,O,2269
46195,of,O,2269
46196,COVID-19,B-NAME_OF_DISEASE,2269
46197,vaccination,O,2269
46198,particularly,O,2269
46199,with,O,2269
46200,the,B-NAME_OF_DRUG,2269
46201,Pfizer-BioNTech,I-NAME_OF_DRUG,2269
46202,and,I-NAME_OF_DRUG,2269
46203,Moderna,I-NAME_OF_DRUG,2269
46204,vaccines,I-NAME_OF_DRUG,2270
46205,According,O,2270
46206,to,O,2270
46207,a,O,2270
46208,study,O,2270
46209,published,O,2270
46210,in,O,2270
46211,JAMA,B-PUBLICATION_VENUE,2270
46212,Ophthalmology,I-PUBLICATION_VENUE,2270
46213,there,O,2270
46214,have,O,2270
46215,been,O,2270
46216,several,O,2270
46217,cases,O,2270
46218,of,O,2270
46219,uveitis,B-NAME_OF_DISEASE,2270
46220,reported,O,2270
46221,in,O,2270
46222,individuals,O,2270
46223,who,O,2270
46224,have,O,2270
46225,received,O,2270
46226,these,O,2270
46227,vaccines,O,2270
46228,According,O,2270
46229,to,O,2270
46230,the,B-PUBLICATION_VENUE,2270
46231,Indian,I-PUBLICATION_VENUE,2270
46232,Journal,I-PUBLICATION_VENUE,2270
46233,of,I-PUBLICATION_VENUE,2270
46234,Ophthalmology,I-PUBLICATION_VENUE,2270
46235,ocular,B-NAME_OF_DISEASE,2270
46236,inflammation,I-NAME_OF_DISEASE,2271
46237,can,O,2271
46238,present,O,2271
46239,itself,O,2271
46240,as,O,2271
46241,aside,O,2271
46242,effect,O,2271
46243,of,O,2271
46244,COVID-19,B-NAME_OF_DISEASE,2271
46245,vaccines,O,2271
46246,Symptoms,O,2271
46247,of,O,2271
46248,ocular,B-NAME_OF_DISEASE,2271
46249,inflammation,I-NAME_OF_DISEASE,2271
46250,can,O,2271
46251,include,O,2271
46252,redness,B-SIGN_AND_SYMPTOM,2271
46253,pain,I-SIGN_AND_SYMPTOM,2271
46254,light,I-SIGN_AND_SYMPTOM,2271
46255,sensitivity,I-SIGN_AND_SYMPTOM,2271
46256,blurry,I-SIGN_AND_SYMPTOM,2271
46257,vision,I-SIGN_AND_SYMPTOM,2271
46258,or,I-SIGN_AND_SYMPTOM,2271
46259,even,I-SIGN_AND_SYMPTOM,2271
46260,vision,I-SIGN_AND_SYMPTOM,2271
46261,loss,I-SIGN_AND_SYMPTOM,2272
46262,It,O,2272
46263,is,O,2272
46264,important,O,2272
46265,to,O,2272
46266,note,O,2272
46267,that,O,2272
46268,while,O,2272
46269,ocular,B-NAME_OF_DISEASE,2272
46270,inflammation,I-NAME_OF_DISEASE,2272
46271,can,O,2272
46272,be,O,2272
46273,a,O,2272
46274,side,O,2272
46275,effect,O,2272
46276,of,O,2272
46277,COVID-19,B-NAME_OF_DISEASE,2272
46278,vaccination,O,2272
46279,it,O,2272
46280,is,O,2272
46281,not,O,2272
46282,necessarily,O,2272
46283,caused,O,2272
46284,by,O,2272
46285,the,O,2272
46286,vaccine,O,2272
46287,itself,O,2272
46288,Instead,O,2272
46289,it,O,2273
46290,may,O,2273
46291,be,O,2273
46292,a,O,2273
46293,result,O,2273
46294,of,O,2273
46295,the,O,2273
46296,body,O,2273
46297,s,O,2273
46298,immune,O,2273
46299,response,O,2273
46300,to,O,2273
46301,the,O,2273
46302,vaccine,O,2273
46303,In,O,2273
46304,other,O,2273
46305,words,O,2273
46306,the,O,2273
46307,vaccine,O,2273
46308,triggers,O,2274
46309,an,O,2274
46310,immune,O,2274
46311,response,O,2274
46312,that,O,2274
46313,can,O,2274
46314,sometimes,O,2274
46315,cause,O,2274
46316,inflammation,O,2274
46317,including,O,2274
46318,in,O,2274
46319,the,O,2274
46320,eye,O,2274
46321,However,O,2274
46322,it,O,2274
46323,s,O,2274
46324,important,O,2275
46325,to,O,2275
46326,note,O,2275
46327,that,O,2275
46328,the,O,2275
46329,incidence,O,2275
46330,of,O,2275
46331,ocular,B-NAME_OF_DISEASE,2275
46332,inflammation,I-NAME_OF_DISEASE,2275
46333,following,O,2275
46334,COVID-19,B-NAME_OF_DISEASE,2275
46335,vaccination,O,2275
46336,is,O,2275
46337,rare,O,2275
46338,The,O,2275
46339,benefits,O,2275
46340,of,O,2275
46341,vaccination,O,2275
46342,in,O,2275
46343,preventing,O,2275
46344,severe,O,2275
46345,COVID-19,B-NAME_OF_DISEASE,2276
46346,far,O,2276
46347,outweigh,O,2276
46348,the,O,2276
46349,risk,O,2276
46350,of,O,2276
46351,developing,O,2276
46352,uveitis,B-NAME_OF_DISEASE,2276
46353,If,O,2276
46354,you,O,2276
46355,experience,O,2276
46356,any,O,2276
46357,symptoms,O,2276
46358,of,O,2276
46359,ocular,B-NAME_OF_DISEASE,2276
46360,inflammation,I-NAME_OF_DISEASE,2276
46361,after,O,2276
46362,receiving,O,2276
46363,the,O,2276
46364,COVID-19,B-NAME_OF_DISEASE,2276
46365,vaccine,O,2276
46366,it,O,2276
46367,s,O,2276
46368,important,O,2276
46369,to,O,2276
46370,seek,O,2276
46371,medical,O,2276
46372,attention,O,2277
46373,right,O,2277
46374,away,O,2277
46375,Your,O,2277
46376,doctor,O,2277
46377,may,O,2277
46378,recommend,O,2277
46379,treatment,O,2277
46380,options,O,2277
46381,such,O,2277
46382,as,O,2277
46383,topical,B-NAME_OF_DRUG,2277
46384,or,I-NAME_OF_DRUG,2277
46385,oral,I-NAME_OF_DRUG,2277
46386,steroids,I-NAME_OF_DRUG,2277
46387,to,O,2277
46388,reduce,O,2277
46389,inflammation,O,2277
46390,and,O,2278
46391,relieve,O,2278
46392,symptoms,O,2278
46393,It,O,2278
46394,is,O,2278
46395,also,O,2278
46396,worth,O,2278
46397,noting,O,2278
46398,that,O,2278
46399,the,O,2278
46400,risk,O,2278
46401,of,O,2278
46402,developing,O,2278
46403,ocular,B-NAME_OF_DISEASE,2278
46404,inflammation,I-NAME_OF_DISEASE,2278
46405,as,O,2278
46406,a,O,2278
46407,side,O,2278
46408,effect,O,2278
46409,of,O,2278
46410,COVID-19,B-NAME_OF_DISEASE,2278
46411,vaccination,O,2278
46412,is,O,2278
46413,much,O,2279
46414,lower,O,2279
46415,than,O,2279
46416,the,O,2279
46417,risks,O,2279
46418,associated,O,2279
46419,with,O,2279
46420,COVID-19,B-NAME_OF_DISEASE,2279
46421,infection,O,2279
46422,itself,O,2279
46423,COVID-19,B-NAME_OF_DISEASE,2279
46424,can,O,2279
46425,cause,O,2279
46426,severe,O,2279
46427,respiratory,O,2279
46428,problems,O,2279
46429,and,O,2279
46430,in,O,2279
46431,some,O,2279
46432,cases,O,2279
46433,it,O,2279
46434,can,O,2279
46435,lead,O,2279
46436,to,O,2280
46437,serious,O,2280
46438,complications,O,2280
46439,such,O,2280
46440,as,O,2280
46441,blood,B-SIGN_AND_SYMPTOM,2280
46442,clots,I-SIGN_AND_SYMPTOM,2280
46443,heart,I-SIGN_AND_SYMPTOM,2280
46444,damage,I-SIGN_AND_SYMPTOM,2280
46445,and,I-SIGN_AND_SYMPTOM,2280
46446,even,I-SIGN_AND_SYMPTOM,2280
46447,death,I-SIGN_AND_SYMPTOM,2280
46448,In,O,2280
46449,conclusion,O,2280
46450,while,O,2280
46451,there,O,2280
46452,have,O,2280
46453,been,O,2280
46454,rare,O,2280
46455,cases,O,2280
46456,of,O,2280
46457,ocular,B-NAME_OF_DISEASE,2280
46458,inflammation,I-NAME_OF_DISEASE,2280
46459,following,O,2280
46460,COVID-19,B-NAME_OF_DISEASE,2280
46461,vaccination,O,2280
46462,the,O,2280
46463,benefits,O,2280
46464,of,O,2280
46465,vaccination,O,2280
46466,in,O,2280
46467,preventing,O,2280
46468,severe,O,2280
46469,cases,O,2280
46470,of,O,2280
46471,COVID-19,B-NAME_OF_DISEASE,2280
46472,outweigh,O,2280
46473,the,O,2280
46474,risks,O,2280
46475,If,O,2280
46476,you,O,2280
46477,experience,O,2280
46478,any,O,2281
46479,symptoms,O,2281
46480,of,O,2281
46481,uveitis,B-NAME_OF_DISEASE,2281
46482,after,O,2281
46483,vaccination,O,2282
46484,seek,O,2282
46485,medical,O,2282
46486,attention,O,2282
46487,promptly,O,2282
46488,and,O,2282
46489,follow,O,2282
46490,your,O,2282
46491,doctor,O,2282
46492,s,O,2282
46493,treatment,O,2282
46494,plan,O,2282
46495,What,O,2282
46496,is,O,2282
46497,Smartphone,B-NAME_OF_DISEASE,2282
46498,Vision,I-NAME_OF_DISEASE,2282
46499,Syndrome,I-NAME_OF_DISEASE,2282
46500,Smartphone,B-NAME_OF_DISEASE,2282
46501,Vision,I-NAME_OF_DISEASE,2282
46502,Syndrome,I-NAME_OF_DISEASE,2282
46503,also,O,2282
46504,known,O,2282
46505,as,O,2282
46506,digital,B-NAME_OF_DISEASE,2282
46507,eye,B-SIGN_AND_SYMPTOM,2282
46508,strain,I-SIGN_AND_SYMPTOM,2282
46509,is,O,2282
46510,a,O,2282
46511,condition,O,2282
46512,that,O,2282
46513,affects,O,2282
46514,people,O,2282
46515,who,O,2282
46516,spend,B-CAUSE_OF_DISEASE,2282
46517,long,I-CAUSE_OF_DISEASE,2282
46518,hours,I-CAUSE_OF_DISEASE,2282
46519,using,I-CAUSE_OF_DISEASE,2282
46520,digital,I-CAUSE_OF_DISEASE,2282
46521,devices,I-CAUSE_OF_DISEASE,2282
46522,such,I-CAUSE_OF_DISEASE,2282
46523,as,I-CAUSE_OF_DISEASE,2282
46524,smartphones,I-CAUSE_OF_DISEASE,2283
46525,laptops,I-CAUSE_OF_DISEASE,2283
46526,and,I-CAUSE_OF_DISEASE,2283
46527,tablets,I-CAUSE_OF_DISEASE,2283
46528,It,O,2283
46529,occurs,O,2283
46530,when,O,2283
46531,the,B-CAUSE_OF_DISEASE,2283
46532,eyes,I-CAUSE_OF_DISEASE,2283
46533,are,I-CAUSE_OF_DISEASE,2283
46534,exposed,I-CAUSE_OF_DISEASE,2283
46535,to,I-CAUSE_OF_DISEASE,2283
46536,prolonged,I-CAUSE_OF_DISEASE,2283
46537,blue,B-CAUSE_OF_DISEASE,2283
46538,light,I-CAUSE_OF_DISEASE,2283
46539,from,I-CAUSE_OF_DISEASE,2283
46540,these,I-CAUSE_OF_DISEASE,2283
46541,devices,I-CAUSE_OF_DISEASE,2283
46542,leading,O,2283
46543,to,O,2283
46544,various,O,2283
46545,uncomfortable,O,2283
46546,symptoms,O,2283
46547,such,O,2284
46548,as,O,2284
46549,eye,B-SIGN_AND_SYMPTOM,2284
46550,strain,I-SIGN_AND_SYMPTOM,2284
46551,headaches,B-SIGN_AND_SYMPTOM,2284
46552,dry,B-SIGN_AND_SYMPTOM,2284
46553,eyes,I-SIGN_AND_SYMPTOM,2284
46554,and,I-SIGN_AND_SYMPTOM,2284
46555,blurred,I-SIGN_AND_SYMPTOM,2284
46556,vision,I-SIGN_AND_SYMPTOM,2284
46557,What,O,2284
46558,Causes,O,2284
46559,Smartphone,B-NAME_OF_DISEASE,2284
46560,Vision,I-NAME_OF_DISEASE,2284
46561,Syndrome,I-NAME_OF_DISEASE,2284
46562,Smartphone,B-NAME_OF_DISEASE,2284
46563,Vision,I-NAME_OF_DISEASE,2284
46564,Syndrome,I-NAME_OF_DISEASE,2284
46565,is,O,2284
46566,caused,O,2284
46567,by,O,2284
46568,several,O,2284
46569,factors,O,2284
46570,including,O,2284
46571,blue,B-CAUSE_OF_DISEASE,2284
46572,light,I-CAUSE_OF_DISEASE,2285
46573,exposure,I-CAUSE_OF_DISEASE,2285
46574,screen,B-CAUSE_OF_DISEASE,2285
46575,glare,I-CAUSE_OF_DISEASE,2285
46576,and,I-CAUSE_OF_DISEASE,2285
46577,reduced,B-CAUSE_OF_DISEASE,2285
46578,blinking,I-CAUSE_OF_DISEASE,2285
46579,Blue,B-CAUSE_OF_DISEASE,2285
46580,light,I-CAUSE_OF_DISEASE,2285
46581,a,I-CAUSE_OF_DISEASE,2285
46582,high-energy,I-CAUSE_OF_DISEASE,2285
46583,visible,I-CAUSE_OF_DISEASE,2285
46584,HEV,I-CAUSE_OF_DISEASE,2285
46585,light,I-CAUSE_OF_DISEASE,2285
46586,emitted,I-CAUSE_OF_DISEASE,2285
46587,by,I-CAUSE_OF_DISEASE,2285
46588,digital,I-CAUSE_OF_DISEASE,2285
46589,devices,I-CAUSE_OF_DISEASE,2285
46590,can,O,2285
46591,penetrate,O,2285
46592,the,O,2285
46593,eyes,O,2285
46594,and,O,2285
46595,cause,O,2285
46596,damage,O,2285
46597,to,O,2285
46598,the,B-PART_OF_THE_EYES,2285
46599,retina,I-PART_OF_THE_EYES,2285
46600,leading,O,2286
46601,to,O,2286
46602,various,O,2286
46603,vision,O,2286
46604,problems,O,2286
46605,Screen,B-CAUSE_OF_DISEASE,2286
46606,glare,I-CAUSE_OF_DISEASE,2286
46607,on,O,2286
46608,the,O,2286
46609,other,O,2286
46610,hand,O,2286
46611,can,O,2286
46612,strain,B-SIGN_AND_SYMPTOM,2286
46613,the,O,2286
46614,eyes,O,2286
46615,and,O,2286
46616,cause,O,2286
46617,headaches,B-SIGN_AND_SYMPTOM,2287
46618,while,O,2288
46619,reduced,B-CAUSE_OF_DISEASE,2288
46620,blinking,I-CAUSE_OF_DISEASE,2288
46621,can,O,2288
46622,cause,O,2288
46623,dry,B-SIGN_AND_SYMPTOM,2288
46624,eyes,I-SIGN_AND_SYMPTOM,2288
46625,and,I-SIGN_AND_SYMPTOM,2288
46626,discomfort,I-SIGN_AND_SYMPTOM,2288
46627,How,O,2288
46628,Long,O,2288
46629,Does,O,2288
46630,Smartphone,B-NAME_OF_DISEASE,2288
46631,Vision,I-NAME_OF_DISEASE,2288
46632,Syndrome,I-NAME_OF_DISEASE,2288
46633,Last,O,2288
46634,The,O,2288
46635,duration,O,2288
46636,of,O,2288
46637,Smartphone,B-NAME_OF_DISEASE,2288
46638,Vision,I-NAME_OF_DISEASE,2289
46639,Syndrome,I-NAME_OF_DISEASE,2289
46640,also,O,2289
46641,known,O,2289
46642,as,O,2289
46643,Digital,B-NAME_OF_DISEASE,2289
46644,Eye,I-NAME_OF_DISEASE,2289
46645,Strain,I-NAME_OF_DISEASE,2289
46646,can,O,2289
46647,vary,O,2289
46648,depending,O,2289
46649,on,O,2289
46650,the,O,2289
46651,individual,O,2289
46652,and,O,2289
46653,the,O,2289
46654,severity,O,2290
46655,of,O,2290
46656,the,O,2290
46657,symptoms,O,2290
46658,In,O,2290
46659,most,O,2290
46660,cases,O,2290
46661,the,O,2290
46662,symptoms,O,2290
46663,are,O,2290
46664,temporary,O,2290
46665,and,O,2290
46666,can,O,2290
46667,be,O,2290
46668,alleviated,O,2290
46669,by,O,2290
46670,taking,B-TREATMENT,2290
46671,regular,I-TREATMENT,2290
46672,breaks,I-TREATMENT,2290
46673,from,I-TREATMENT,2290
46674,screen,I-TREATMENT,2290
46675,time,I-TREATMENT,2290
46676,adjusting,I-TREATMENT,2290
46677,the,I-TREATMENT,2290
46678,brightness,I-TREATMENT,2290
46679,and,I-TREATMENT,2291
46680,contrast,I-TREATMENT,2291
46681,of,I-TREATMENT,2291
46682,your,I-TREATMENT,2291
46683,device,I-TREATMENT,2291
46684,and,I-TREATMENT,2291
46685,positioning,I-TREATMENT,2291
46686,the,I-TREATMENT,2291
46687,screen,I-TREATMENT,2291
46688,at,I-TREATMENT,2291
46689,a,I-TREATMENT,2291
46690,comfortable,I-TREATMENT,2291
46691,distance,I-TREATMENT,2291
46692,If,O,2291
46693,you,O,2291
46694,experience,O,2291
46695,mild,O,2292
46696,symptoms,O,2292
46697,of,O,2292
46698,eye,B-SIGN_AND_SYMPTOM,2292
46699,strain,I-SIGN_AND_SYMPTOM,2292
46700,or,I-SIGN_AND_SYMPTOM,2292
46701,discomfort,I-SIGN_AND_SYMPTOM,2292
46702,they,O,2292
46703,may,O,2292
46704,go,O,2292
46705,away,O,2292
46706,within,B-TIME_DURATION,2292
46707,a,I-TIME_DURATION,2292
46708,few,I-TIME_DURATION,2292
46709,hours,I-TIME_DURATION,2292
46710,or,I-TIME_DURATION,2293
46711,a,I-TIME_DURATION,2293
46712,day,I-TIME_DURATION,2293
46713,after,O,2293
46714,reducing,B-TREATMENT,2293
46715,your,I-TREATMENT,2293
46716,screen,I-TREATMENT,2293
46717,time,I-TREATMENT,2293
46718,and,I-TREATMENT,2293
46719,practicing,I-TREATMENT,2293
46720,good,I-TREATMENT,2293
46721,eye,I-TREATMENT,2293
46722,care,I-TREATMENT,2293
46723,habits,I-TREATMENT,2293
46724,However,O,2293
46725,if,O,2294
46726,your,O,2294
46727,symptoms,O,2294
46728,are,O,2294
46729,severe,O,2294
46730,or,O,2294
46731,persistent,O,2294
46732,it,O,2294
46733,is,O,2294
46734,important,O,2294
46735,to,O,2294
46736,seek,B-TREATMENT,2294
46737,medical,I-TREATMENT,2294
46738,attention,I-TREATMENT,2294
46739,from,I-TREATMENT,2294
46740,an,I-TREATMENT,2294
46741,eye,I-TREATMENT,2294
46742,doctor,I-TREATMENT,2294
46743,or,I-TREATMENT,2294
46744,a,I-TREATMENT,2294
46745,qualified,I-TREATMENT,2294
46746,healthcare,I-TREATMENT,2294
46747,provider,I-TREATMENT,2294
46748,to,O,2294
46749,rule,O,2294
46750,out,O,2294
46751,any,O,2294
46752,underlying,O,2294
46753,eye,O,2294
46754,conditions,O,2294
46755,What,O,2294
46756,Can,O,2294
46757,You,O,2294
46758,Do,O,2294
46759,to,O,2294
46760,Prevent,O,2294
46761,Smartphone,B-NAME_OF_DISEASE,2294
46762,Vision,I-NAME_OF_DISEASE,2295
46763,Syndrome,I-NAME_OF_DISEASE,2295
46764,Preventing,O,2295
46765,Smartphone,B-NAME_OF_DISEASE,2295
46766,Vision,I-NAME_OF_DISEASE,2295
46767,Syndrome,I-NAME_OF_DISEASE,2295
46768,is,O,2295
46769,essential,O,2295
46770,to,O,2295
46771,maintaining,B-PREVENTION,2295
46772,healthy,I-PREVENTION,2295
46773,eyes,I-PREVENTION,2295
46774,and,I-PREVENTION,2295
46775,vision,I-PREVENTION,2295
46776,Here,O,2295
46777,are,O,2295
46778,some,O,2296
46779,tips,O,2296
46780,that,O,2296
46781,can,O,2296
46782,help,O,2296
46783,reduce,O,2296
46784,the,O,2296
46785,risk,O,2296
46786,of,O,2296
46787,digital,B-NAME_OF_DISEASE,2296
46788,eye,B-SIGN_AND_SYMPTOM,2296
46789,strain,I-SIGN_AND_SYMPTOM,2296
46790,Take,B-PREVENTION,2296
46791,breaks,I-PREVENTION,2296
46792,Taking,I-PREVENTION,2296
46793,frequent,I-PREVENTION,2296
46794,breaks,I-PREVENTION,2296
46795,from,I-PREVENTION,2297
46796,digital,I-PREVENTION,2297
46797,devices,I-PREVENTION,2297
46798,can,O,2297
46799,help,O,2297
46800,reduce,O,2297
46801,eye,B-SIGN_AND_SYMPTOM,2297
46802,strain,I-SIGN_AND_SYMPTOM,2297
46803,and,O,2297
46804,prevent,O,2297
46805,digital,B-NAME_OF_DISEASE,2297
46806,eye,B-SIGN_AND_SYMPTOM,2297
46807,strain,I-SIGN_AND_SYMPTOM,2297
46808,You,O,2297
46809,can,O,2297
46810,use,O,2297
46811,the,B-PREVENTION,2297
46812,20-20-20,I-PREVENTION,2297
46813,rule,I-PREVENTION,2297
46814,The,B-PREVENTION,2297
46815,20-20-20,I-PREVENTION,2297
46816,rule,I-PREVENTION,2297
46817,which,O,2297
46818,is,O,2297
46819,a,O,2297
46820,technique,O,2298
46821,that,O,2298
46822,can,O,2298
46823,be,O,2298
46824,used,O,2298
46825,to,O,2298
46826,prevent,O,2298
46827,eye,B-SIGN_AND_SYMPTOM,2298
46828,strain,I-SIGN_AND_SYMPTOM,2299
46829,and,O,2299
46830,digital,B-NAME_OF_DISEASE,2299
46831,eye,I-NAME_OF_DISEASE,2299
46832,fatigue,I-NAME_OF_DISEASE,2299
46833,It,O,2299
46834,involves,O,2299
46835,taking,B-PREVENTION,2299
46836,a,I-PREVENTION,2299
46837,break,I-PREVENTION,2300
46838,from,I-PREVENTION,2300
46839,looking,I-PREVENTION,2300
46840,at,I-PREVENTION,2300
46841,digital,I-PREVENTION,2300
46842,screens,I-PREVENTION,2300
46843,every,I-PREVENTION,2300
46844,20,I-PREVENTION,2300
46845,minutes,I-PREVENTION,2300
46846,and,I-PREVENTION,2300
46847,focusing,I-PREVENTION,2300
46848,on,I-PREVENTION,2301
46849,an,I-PREVENTION,2301
46850,object,I-PREVENTION,2301
46851,that,I-PREVENTION,2301
46852,is,I-PREVENTION,2301
46853,at,I-PREVENTION,2301
46854,least,I-PREVENTION,2301
46855,20,I-PREVENTION,2301
46856,feet,I-PREVENTION,2301
46857,away,I-PREVENTION,2301
46858,for,I-PREVENTION,2301
46859,20,I-PREVENTION,2301
46860,seconds,I-PREVENTION,2301
46861,Adjust,B-PREVENTION,2301
46862,your,I-PREVENTION,2301
46863,screen,I-PREVENTION,2301
46864,Adjusting,I-PREVENTION,2301
46865,the,I-PREVENTION,2301
46866,brightness,I-PREVENTION,2302
46867,and,I-PREVENTION,2302
46868,contrast,I-PREVENTION,2302
46869,of,I-PREVENTION,2302
46870,your,I-PREVENTION,2302
46871,screen,I-PREVENTION,2302
46872,can,O,2302
46873,help,O,2302
46874,reduce,O,2302
46875,eye,B-SIGN_AND_SYMPTOM,2302
46876,strain,I-SIGN_AND_SYMPTOM,2302
46877,and,O,2302
46878,screen,B-CAUSE_OF_DISEASE,2302
46879,glare,I-CAUSE_OF_DISEASE,2302
46880,Use,B-PREVENTION,2302
46881,eye,I-PREVENTION,2302
46882,drops,I-PREVENTION,2302
46883,Using,I-PREVENTION,2302
46884,eye,I-PREVENTION,2302
46885,drops,I-PREVENTION,2302
46886,can,O,2302
46887,help,O,2302
46888,keep,O,2302
46889,your,O,2303
46890,eyes,O,2303
46891,moisturized,O,2303
46892,and,O,2303
46893,prevent,O,2303
46894,dry,B-SIGN_AND_SYMPTOM,2303
46895,eyes,I-SIGN_AND_SYMPTOM,2303
46896,Wear,B-PREVENTION,2303
46897,glasses,I-PREVENTION,2303
46898,Wearing,I-PREVENTION,2303
46899,specialized,I-PREVENTION,2303
46900,glasses,I-PREVENTION,2303
46901,that,O,2303
46902,block,O,2303
46903,blue,B-CAUSE_OF_DISEASE,2303
46904,light,I-CAUSE_OF_DISEASE,2303
46905,can,O,2303
46906,help,O,2303
46907,protect,O,2303
46908,your,O,2303
46909,eyes,O,2303
46910,from,O,2303
46911,the,O,2303
46912,harmful,O,2303
46913,effects,O,2303
46914,of,O,2303
46915,blue,B-CAUSE_OF_DISEASE,2303
46916,light,I-CAUSE_OF_DISEASE,2303
46917,Practice,B-PREVENTION,2303
46918,good,I-PREVENTION,2303
46919,habits,I-PREVENTION,2303
46920,Practicing,I-PREVENTION,2303
46921,good,I-PREVENTION,2303
46922,habits,I-PREVENTION,2303
46923,such,I-PREVENTION,2303
46924,as,I-PREVENTION,2303
46925,proper,I-PREVENTION,2303
46926,posture,I-PREVENTION,2303
46927,adequate,I-PREVENTION,2303
46928,lighting,I-PREVENTION,2303
46929,and,I-PREVENTION,2303
46930,avoiding,I-PREVENTION,2304
46931,digital,I-PREVENTION,2304
46932,devices,I-PREVENTION,2304
46933,before,I-PREVENTION,2304
46934,bed,I-PREVENTION,2304
46935,can,O,2304
46936,help,O,2304
46937,reduce,O,2304
46938,the,O,2304
46939,risk,O,2305
46940,of,O,2305
46941,digital,B-NAME_OF_DISEASE,2305
46942,eye,B-SIGN_AND_SYMPTOM,2305
46943,strain,I-SIGN_AND_SYMPTOM,2305
46944,In,O,2305
46945,conclusion,O,2305
46946,Smartphone,B-NAME_OF_DISEASE,2305
46947,Vision,I-NAME_OF_DISEASE,2305
46948,Syndrome,I-NAME_OF_DISEASE,2305
46949,is,O,2306
46950,a,O,2306
46951,growing,O,2306
46952,concern,O,2306
46953,for,O,2306
46954,people,O,2306
46955,who,O,2306
46956,spend,B-CAUSE_OF_DISEASE,2306
46957,long,I-CAUSE_OF_DISEASE,2306
46958,hours,I-CAUSE_OF_DISEASE,2306
46959,using,I-CAUSE_OF_DISEASE,2307
46960,digital,I-CAUSE_OF_DISEASE,2307
46961,devices,I-CAUSE_OF_DISEASE,2307
46962,By,O,2307
46963,taking,O,2307
46964,preventive,O,2307
46965,measures,O,2307
46966,and,O,2307
46967,practicing,O,2307
46968,good,O,2307
46969,habits,O,2307
46970,you,O,2307
46971,can,O,2307
46972,reduce,O,2307
46973,the,O,2307
46974,risk,O,2307
46975,of,O,2307
46976,digital,B-NAME_OF_DISEASE,2307
46977,eye,B-SIGN_AND_SYMPTOM,2307
46978,strain,I-SIGN_AND_SYMPTOM,2307
46979,and,O,2307
46980,maintain,O,2307
46981,healthy,O,2307
46982,eyes,O,2307
46983,and,O,2307
46984,vision,O,2307
46985,OcuSciences,B-ORGANIZATION,2307
46986,has,O,2307
46987,recently,O,2307
46988,revealed,O,2307
46989,the,O,2307
46990,publication,O,2307
46991,of,O,2307
46992,a,O,2307
46993,study,O,2307
46994,on,O,2308
46995,Age-related,B-NAME_OF_DISEASE,2308
46996,Macular,I-NAME_OF_DISEASE,2308
46997,Degeneration,I-NAME_OF_DISEASE,2308
46998,AMD,B-NAME_OF_DISEASE,2308
46999,in,O,2308
47000,the,O,2308
47001,journal,O,2308
47002,Ophthalmic,O,2308
47003,Surgery,O,2308
47004,Lasers,O,2308
47005,and,O,2308
47006,Imaging,O,2308
47007,Retina,O,2308
47008,This,O,2308
47009,research,O,2308
47010,evaluates,O,2309
47011,the,O,2309
47012,extent,O,2309
47013,of,O,2309
47014,oxidative,O,2309
47015,stress,O,2309
47016,in,O,2309
47017,the,B-PART_OF_THE_EYES,2309
47018,retina,I-PART_OF_THE_EYES,2309
47019,and,O,2309
47020,the,O,2309
47021,malfunction,O,2310
47022,of,O,2310
47023,mitochondria,O,2310
47024,to,O,2310
47025,suggest,O,2310
47026,that,O,2310
47027,the,B-DIAGNOSTIC_TEST,2310
47028,innovative,I-DIAGNOSTIC_TEST,2310
47029,FPF,I-DIAGNOSTIC_TEST,2310
47030,measurement,I-DIAGNOSTIC_TEST,2310
47031,can,O,2310
47032,categorize,O,2310
47033,AMD,B-NAME_OF_DISEASE,2310
47034,patients,O,2310
47035,based,O,2310
47036,on,O,2310
47037,their,O,2310
47038,stage,O,2310
47039,thereby,O,2310
47040,providing,O,2310
47041,a,O,2310
47042,deeper,O,2311
47043,understanding,O,2311
47044,of,O,2311
47045,the,O,2311
47046,physiological,O,2311
47047,process,O,2311
47048,behind,O,2311
47049,AMD,B-NAME_OF_DISEASE,2311
47050,The,O,2311
47051,study,O,2311
47052,led,O,2311
47053,by,O,2311
47054,Dr,O,2311
47055,Rishi,O,2311
47056,Singh,O,2311
47057,a,O,2312
47058,staff,O,2312
47059,ophthalmologist,O,2312
47060,at,O,2312
47061,the,B-ORGANIZATION,2312
47062,Cleveland,I-ORGANIZATION,2312
47063,Clinic,I-ORGANIZATION,2312
47064,Cole,B-ORGANIZATION,2312
47065,Eye,I-ORGANIZATION,2312
47066,Institute,I-ORGANIZATION,2312
47067,and,O,2312
47068,President,O,2312
47069,of,O,2312
47070,Cleveland,B-ORGANIZATION,2312
47071,Clinic,I-ORGANIZATION,2312
47072,Martin,I-ORGANIZATION,2312
47073,Health,I-ORGANIZATION,2312
47074,was,O,2312
47075,a,O,2312
47076,prospective,O,2312
47077,observational,O,2312
47078,one,O,2312
47079,and,O,2313
47080,included,O,2313
47081,456,O,2313
47082,eyes,O,2313
47083,with,O,2313
47084,half,O,2313
47085,being,O,2313
47086,diagnosed,O,2313
47087,with,O,2313
47088,AMD,B-NAME_OF_DISEASE,2313
47089,and,O,2313
47090,the,O,2313
47091,other,O,2313
47092,half,O,2313
47093,being,O,2313
47094,age-matched,O,2313
47095,controls,O,2313
47096,The,O,2314
47097,patients,O,2314
47098,were,O,2314
47099,divided,O,2314
47100,into,O,2314
47101,groups,O,2314
47102,based,O,2314
47103,on,O,2314
47104,their,O,2314
47105,AMD,B-NAME_OF_DISEASE,2314
47106,stage,O,2314
47107,which,O,2314
47108,included,O,2314
47109,early,B-NAME_OF_DISEASE,2314
47110,AMD,I-NAME_OF_DISEASE,2314
47111,intermediate,B-NAME_OF_DISEASE,2314
47112,AMD,I-NAME_OF_DISEASE,2314
47113,geographic,B-NAME_OF_DISEASE,2314
47114,atrophy,I-NAME_OF_DISEASE,2315
47115,GA,I-NAME_OF_DISEASE,2315
47116,and,O,2315
47117,neovascular,B-NAME_OF_DISEASE,2315
47118,AMD,I-NAME_OF_DISEASE,2315
47119,The,B-DIAGNOSTIC_TEST,2315
47120,OcuMet,I-DIAGNOSTIC_TEST,2315
47121,Beacon,I-DIAGNOSTIC_TEST,2315
47122,OcuSciences,B-ORGANIZATION,2315
47123,functional,O,2315
47124,retinal,O,2315
47125,imager,O,2315
47126,was,O,2315
47127,used,O,2315
47128,to,O,2315
47129,capture,O,2315
47130,and,O,2315
47131,quantify,O,2315
47132,the,O,2315
47133,patients,O,2316
47134,FPF,B-DIAGNOSTIC_TEST,2316
47135,intensity,I-DIAGNOSTIC_TEST,2316
47136,and,I-DIAGNOSTIC_TEST,2316
47137,heterogeneity,I-DIAGNOSTIC_TEST,2316
47138,between,B-TIME_DURATION,2316
47139,August,I-TIME_DURATION,2316
47140,2018,I-TIME_DURATION,2316
47141,and,I-TIME_DURATION,2316
47142,December,I-TIME_DURATION,2316
47143,2021,I-TIME_DURATION,2316
47144,The,O,2316
47145,results,O,2316
47146,showed,O,2316
47147,that,O,2316
47148,intermediate,B-NAME_OF_DISEASE,2316
47149,geographic,I-NAME_OF_DISEASE,2316
47150,atrophy,I-NAME_OF_DISEASE,2316
47151,and,I-NAME_OF_DISEASE,2316
47152,neovascular,I-NAME_OF_DISEASE,2316
47153,AMD,I-NAME_OF_DISEASE,2316
47154,were,O,2316
47155,correlated,O,2316
47156,with,O,2316
47157,significantly,O,2316
47158,higher,O,2316
47159,FPF,B-DIAGNOSTIC_TEST,2316
47160,intensity,I-DIAGNOSTIC_TEST,2316
47161,while,O,2316
47162,all,O,2316
47163,stages,O,2316
47164,of,O,2316
47165,AMD,B-NAME_OF_DISEASE,2316
47166,were,O,2316
47167,associated,O,2317
47168,with,O,2317
47169,increased,O,2317
47170,FPF,B-DIAGNOSTIC_TEST,2317
47171,heterogeneity,I-DIAGNOSTIC_TEST,2317
47172,These,O,2317
47173,findings,O,2317
47174,suggest,O,2317
47175,that,O,2317
47176,mitochondrial,O,2317
47177,function,O,2317
47178,plays,O,2317
47179,an,O,2317
47180,important,O,2317
47181,role,O,2318
47182,in,O,2318
47183,the,O,2318
47184,progression,O,2318
47185,of,O,2318
47186,AMD,B-NAME_OF_DISEASE,2318
47187,said,O,2318
47188,Dr,O,2318
47189,Singh,O,2318
47190,The,O,2318
47191,ability,O,2318
47192,to,O,2318
47193,quantitatively,O,2318
47194,measure,O,2318
47195,mitochondrial,O,2318
47196,dysfunction,O,2318
47197,may,O,2318
47198,give,O,2318
47199,us,O,2319
47200,better,O,2320
47201,insights,O,2320
47202,into,O,2320
47203,how,O,2320
47204,and,O,2320
47205,when,O,2320
47206,to,O,2320
47207,treat,O,2320
47208,AMD,B-NAME_OF_DISEASE,2320
47209,patients,O,2320
47210,The,B-DIAGNOSTIC_TEST,2321
47211,OcuMet,I-DIAGNOSTIC_TEST,2321
47212,Beacon,I-DIAGNOSTIC_TEST,2321
47213,is,O,2321
47214,a,O,2321
47215,rapid,O,2321
47216,retinal,O,2321
47217,imaging,O,2321
47218,system,O,2321
47219,that,O,2321
47220,evaluates,O,2321
47221,mitochondrial,O,2321
47222,function,O,2321
47223,by,O,2321
47224,analyzing,O,2321
47225,flavoproteins,B-CHEMICAL_COMPOUND,2321
47226,It,O,2321
47227,operates,O,2321
47228,by,O,2321
47229,emitting,O,2321
47230,a,O,2321
47231,specific,O,2321
47232,wavelength,O,2321
47233,of,O,2321
47234,light,O,2321
47235,that,O,2321
47236,stimulates,O,2322
47237,the,O,2322
47238,flavoproteins,B-CHEMICAL_COMPOUND,2322
47239,in,O,2322
47240,the,B-PART_OF_THE_EYES,2322
47241,retinal,I-PART_OF_THE_EYES,2322
47242,mitochondria,I-PART_OF_THE_EYES,2322
47243,when,O,2322
47244,they,O,2322
47245,are,O,2322
47246,unable,O,2322
47247,to,O,2323
47248,generate,O,2323
47249,ATP,B-CHEMICAL_COMPOUND,2323
47250,effectively,O,2323
47251,As,O,2323
47252,a,O,2323
47253,result,O,2323
47254,the,O,2324
47255,dysfunctional,O,2324
47256,flavoproteins,B-CHEMICAL_COMPOUND,2324
47257,emit,O,2324
47258,a,O,2324
47259,particular,O,2324
47260,wavelength,O,2325
47261,that,O,2325
47262,the,O,2325
47263,device,O,2325
47264,records,O,2325
47265,and,O,2325
47266,measures,O,2325
47267,Scientific,O,2325
47268,evidence,O,2325
47269,has,O,2325
47270,established,O,2325
47271,that,O,2325
47272,mitochondrial,O,2325
47273,dysfunction,O,2325
47274,precedes,O,2325
47275,apoptosis,B-SIGN_AND_SYMPTOM,2325
47276,which,O,2325
47277,is,O,2325
47278,the,O,2325
47279,death,O,2325
47280,of,O,2325
47281,cells,O,2325
47282,The,B-DIAGNOSTIC_TEST,2326
47283,OcuMet,I-DIAGNOSTIC_TEST,2326
47284,Beacon,I-DIAGNOSTIC_TEST,2326
47285,is,O,2326
47286,currently,O,2326
47287,being,O,2326
47288,used,O,2326
47289,at,O,2326
47290,Cole,B-ORGANIZATION,2326
47291,Eye,I-ORGANIZATION,2326
47292,Institute,I-ORGANIZATION,2326
47293,under,O,2326
47294,Institutional,B-ORGANIZATION,2326
47295,Review,I-ORGANIZATION,2326
47296,Board,I-ORGANIZATION,2326
47297,Snow,B-NAME_OF_DISEASE,2326
47298,blindness,I-NAME_OF_DISEASE,2326
47299,also,O,2326
47300,known,O,2326
47301,as,O,2326
47302,photokeratitis,B-NAME_OF_DISEASE,2327
47303,or,O,2327
47304,ultraviolet,B-NAME_OF_DISEASE,2327
47305,keratitis,I-NAME_OF_DISEASE,2327
47306,is,O,2327
47307,a,O,2327
47308,condition,O,2327
47309,that,O,2327
47310,affects,O,2327
47311,the,O,2327
47312,eyes,O,2327
47313,as,O,2327
47314,a,O,2327
47315,result,O,2327
47316,of,O,2327
47317,prolonged,B-CAUSE_OF_DISEASE,2328
47318,exposure,I-CAUSE_OF_DISEASE,2328
47319,to,I-CAUSE_OF_DISEASE,2328
47320,the,I-CAUSE_OF_DISEASE,2329
47321,sun,I-CAUSE_OF_DISEASE,2330
47322,s,I-CAUSE_OF_DISEASE,2330
47323,ultraviolet,I-CAUSE_OF_DISEASE,2330
47324,UV,I-CAUSE_OF_DISEASE,2330
47325,rays,I-CAUSE_OF_DISEASE,2330
47326,reflecting,I-CAUSE_OF_DISEASE,2331
47327,off,I-CAUSE_OF_DISEASE,2331
47328,of,I-CAUSE_OF_DISEASE,2331
47329,snow,I-CAUSE_OF_DISEASE,2331
47330,or,I-CAUSE_OF_DISEASE,2331
47331,other,I-CAUSE_OF_DISEASE,2331
47332,bright,I-CAUSE_OF_DISEASE,2332
47333,surfaces,I-CAUSE_OF_DISEASE,2332
47334,It,O,2332
47335,is,O,2332
47336,a,O,2333
47337,temporary,O,2333
47338,condition,O,2333
47339,that,O,2333
47340,typically,O,2333
47341,resolves,O,2333
47342,on,O,2333
47343,its,O,2333
47344,own,O,2333
47345,but,O,2333
47346,can,O,2334
47347,cause,O,2334
47348,significant,B-SIGN_AND_SYMPTOM,2334
47349,discomfort,I-SIGN_AND_SYMPTOM,2334
47350,What,O,2334
47351,Causes,O,2334
47352,Snow,B-ORGANIZATION,2334
47353,Blindness,I-ORGANIZATION,2334
47354,Prolonged,B-CAUSE_OF_DISEASE,2334
47355,exposure,I-CAUSE_OF_DISEASE,2334
47356,to,I-CAUSE_OF_DISEASE,2334
47357,UV,I-CAUSE_OF_DISEASE,2334
47358,rays,I-CAUSE_OF_DISEASE,2334
47359,reflecting,I-CAUSE_OF_DISEASE,2334
47360,off,I-CAUSE_OF_DISEASE,2334
47361,of,I-CAUSE_OF_DISEASE,2334
47362,snow,I-CAUSE_OF_DISEASE,2334
47363,or,I-CAUSE_OF_DISEASE,2334
47364,other,I-CAUSE_OF_DISEASE,2334
47365,bright,I-CAUSE_OF_DISEASE,2334
47366,surfaces,I-CAUSE_OF_DISEASE,2334
47367,This,O,2334
47368,is,O,2334
47369,because,O,2334
47370,snow,O,2334
47371,reflects,O,2334
47372,up,O,2334
47373,to,O,2334
47374,80%,O,2334
47375,of,O,2335
47376,the,B-CAUSE_OF_DISEASE,2335
47377,sun,I-CAUSE_OF_DISEASE,2335
47378,s,I-CAUSE_OF_DISEASE,2335
47379,UV,I-CAUSE_OF_DISEASE,2335
47380,rays,I-CAUSE_OF_DISEASE,2335
47381,making,O,2335
47382,it,O,2335
47383,much,O,2335
47384,more,O,2335
47385,intense,O,2335
47386,than,O,2335
47387,sunlight,O,2335
47388,on,O,2335
47389,a,O,2335
47390,clear,O,2335
47391,day,O,2335
47392,Lack,B-CAUSE_OF_DISEASE,2335
47393,of,I-CAUSE_OF_DISEASE,2335
47394,protective,I-CAUSE_OF_DISEASE,2335
47395,eyewear,I-CAUSE_OF_DISEASE,2335
47396,or,I-CAUSE_OF_DISEASE,2336
47397,proper,I-CAUSE_OF_DISEASE,2336
47398,sunscreen,I-CAUSE_OF_DISEASE,2336
47399,use,I-CAUSE_OF_DISEASE,2336
47400,This,O,2336
47401,leaves,O,2336
47402,the,B-CAUSE_OF_DISEASE,2336
47403,eyes,I-CAUSE_OF_DISEASE,2336
47404,exposed,I-CAUSE_OF_DISEASE,2336
47405,to,I-CAUSE_OF_DISEASE,2336
47406,the,I-CAUSE_OF_DISEASE,2336
47407,harmful,I-CAUSE_OF_DISEASE,2336
47408,rays,I-CAUSE_OF_DISEASE,2336
47409,Certain,B-CAUSE_OF_DISEASE,2336
47410,medical,I-CAUSE_OF_DISEASE,2336
47411,conditions,I-CAUSE_OF_DISEASE,2336
47412,that,I-CAUSE_OF_DISEASE,2337
47413,make,I-CAUSE_OF_DISEASE,2337
47414,the,I-CAUSE_OF_DISEASE,2337
47415,eyes,I-CAUSE_OF_DISEASE,2337
47416,more,I-CAUSE_OF_DISEASE,2337
47417,sensitive,I-CAUSE_OF_DISEASE,2337
47418,to,I-CAUSE_OF_DISEASE,2337
47419,light,I-CAUSE_OF_DISEASE,2337
47420,People,O,2337
47421,with,O,2337
47422,conditions,O,2337
47423,such,O,2337
47424,as,O,2337
47425,lupus,B-NAME_OF_DISEASE,2337
47426,or,O,2337
47427,certain,O,2337
47428,medications,O,2337
47429,can,O,2337
47430,make,O,2337
47431,the,O,2337
47432,eyes,O,2338
47433,more,O,2338
47434,susceptible,O,2338
47435,to,O,2338
47436,UV,O,2338
47437,damage,O,2338
47438,Symptoms,O,2338
47439,of,O,2338
47440,Snow,B-ORGANIZATION,2338
47441,Blindness,I-ORGANIZATION,2339
47442,The,O,2339
47443,below,O,2339
47444,symptoms,O,2339
47445,may,O,2339
47446,appear,O,2339
47447,immediately,O,2339
47448,or,O,2339
47449,a,O,2339
47450,few,O,2339
47451,hours,O,2339
47452,after,O,2339
47453,exposure,O,2339
47454,and,O,2339
47455,may,O,2339
47456,last,O,2339
47457,for,O,2339
47458,a,O,2339
47459,few,O,2339
47460,days,O,2339
47461,Pain,B-SIGN_AND_SYMPTOM,2339
47462,and,I-SIGN_AND_SYMPTOM,2339
47463,redness,I-SIGN_AND_SYMPTOM,2339
47464,in,I-SIGN_AND_SYMPTOM,2339
47465,the,I-SIGN_AND_SYMPTOM,2339
47466,eyes,I-SIGN_AND_SYMPTOM,2340
47467,Sensitivity,B-SIGN_AND_SYMPTOM,2340
47468,to,I-SIGN_AND_SYMPTOM,2340
47469,light,I-SIGN_AND_SYMPTOM,2340
47470,Blurred,B-SIGN_AND_SYMPTOM,2340
47471,vision,I-SIGN_AND_SYMPTOM,2340
47472,A,B-SIGN_AND_SYMPTOM,2340
47473,feeling,I-SIGN_AND_SYMPTOM,2340
47474,of,I-SIGN_AND_SYMPTOM,2340
47475,sand,I-SIGN_AND_SYMPTOM,2340
47476,or,I-SIGN_AND_SYMPTOM,2341
47477,grit,I-SIGN_AND_SYMPTOM,2341
47478,in,I-SIGN_AND_SYMPTOM,2341
47479,the,I-SIGN_AND_SYMPTOM,2341
47480,eyes,I-SIGN_AND_SYMPTOM,2341
47481,Tears,B-SIGN_AND_SYMPTOM,2341
47482,and,I-SIGN_AND_SYMPTOM,2341
47483,swelling,I-SIGN_AND_SYMPTOM,2341
47484,of,I-SIGN_AND_SYMPTOM,2341
47485,the,I-SIGN_AND_SYMPTOM,2341
47486,eyes,I-SIGN_AND_SYMPTOM,2341
47487,How,O,2341
47488,to,O,2341
47489,Manage,O,2341
47490,Snow,B-ORGANIZATION,2341
47491,Blindness,I-ORGANIZATION,2341
47492,Resting,B-TREATMENT,2341
47493,the,I-TREATMENT,2341
47494,eyes,I-TREATMENT,2341
47495,and,I-TREATMENT,2341
47496,avoiding,I-TREATMENT,2341
47497,further,I-TREATMENT,2342
47498,exposure,I-TREATMENT,2342
47499,to,I-TREATMENT,2342
47500,UV,I-TREATMENT,2342
47501,rays,I-TREATMENT,2342
47502,Using,B-TREATMENT,2342
47503,over-the-counter,I-TREATMENT,2342
47504,pain,I-TREATMENT,2342
47505,relievers,I-TREATMENT,2342
47506,to,I-TREATMENT,2342
47507,reduce,I-TREATMENT,2342
47508,pain,I-TREATMENT,2343
47509,and,I-TREATMENT,2343
47510,inflammation,I-TREATMENT,2343
47511,Applying,B-TREATMENT,2343
47512,artificial,I-TREATMENT,2343
47513,tears,I-TREATMENT,2343
47514,or,I-TREATMENT,2343
47515,lubricating,I-TREATMENT,2343
47516,eye,I-TREATMENT,2343
47517,drops,I-TREATMENT,2343
47518,to,I-TREATMENT,2343
47519,alleviate,I-TREATMENT,2343
47520,discomfort,I-TREATMENT,2343
47521,Wearing,B-TREATMENT,2343
47522,dark,I-TREATMENT,2343
47523,glasses,I-TREATMENT,2343
47524,to,I-TREATMENT,2343
47525,protect,I-TREATMENT,2344
47526,the,I-TREATMENT,2344
47527,eyes,I-TREATMENT,2344
47528,from,I-TREATMENT,2344
47529,bright,I-TREATMENT,2344
47530,light,I-TREATMENT,2344
47531,5,O,2344
47532,Tips,O,2344
47533,to,O,2344
47534,Prevent,O,2344
47535,Snow,B-ORGANIZATION,2344
47536,Blindness,I-ORGANIZATION,2344
47537,If,O,2344
47538,you,O,2344
47539,are,O,2344
47540,spending,O,2344
47541,a,O,2344
47542,significant,O,2344
47543,amount,O,2344
47544,of,O,2344
47545,time,O,2344
47546,outside,O,2344
47547,in,O,2344
47548,snowy,O,2344
47549,or,O,2344
47550,icy,O,2344
47551,conditions,O,2344
47552,wearing,B-PREVENTION,2344
47553,protective,I-PREVENTION,2344
47554,eyewear,I-PREVENTION,2344
47555,such,I-PREVENTION,2345
47556,as,I-PREVENTION,2345
47557,sunglasses,I-PREVENTION,2345
47558,or,I-PREVENTION,2345
47559,ski,I-PREVENTION,2345
47560,goggles,I-PREVENTION,2345
47561,that,I-PREVENTION,2345
47562,block,I-PREVENTION,2345
47563,out,I-PREVENTION,2345
47564,UV,I-PREVENTION,2345
47565,rays,I-PREVENTION,2345
47566,Also,O,2345
47567,be,B-PREVENTION,2345
47568,aware,I-PREVENTION,2345
47569,of,I-PREVENTION,2345
47570,the,I-PREVENTION,2345
47571,UV,I-PREVENTION,2345
47572,index,I-PREVENTION,2345
47573,and,I-PREVENTION,2345
47574,taking,I-PREVENTION,2345
47575,precautions,I-PREVENTION,2345
47576,on,I-PREVENTION,2345
47577,days,I-PREVENTION,2345
47578,when,I-PREVENTION,2345
47579,it,I-PREVENTION,2345
47580,is,I-PREVENTION,2345
47581,high,I-PREVENTION,2345
47582,Take,B-PREVENTION,2345
47583,breaks,I-PREVENTION,2345
47584,from,I-PREVENTION,2345
47585,direct,I-PREVENTION,2345
47586,sunlight,I-PREVENTION,2345
47587,to,I-PREVENTION,2345
47588,give,I-PREVENTION,2345
47589,your,I-PREVENTION,2345
47590,eyes,I-PREVENTION,2345
47591,a,I-PREVENTION,2345
47592,rest,I-PREVENTION,2345
47593,This,O,2345
47594,can,O,2345
47595,be,O,2345
47596,done,O,2345
47597,by,O,2345
47598,finding,B-PREVENTION,2345
47599,a,I-PREVENTION,2345
47600,shaded,I-PREVENTION,2345
47601,area,I-PREVENTION,2345
47602,or,O,2345
47603,by,O,2345
47604,closing,B-PREVENTION,2345
47605,your,I-PREVENTION,2345
47606,eyes,I-PREVENTION,2345
47607,for,I-PREVENTION,2345
47608,a,I-PREVENTION,2345
47609,few,I-PREVENTION,2345
47610,minutes,I-PREVENTION,2345
47611,at,I-PREVENTION,2345
47612,a,I-PREVENTION,2345
47613,time,I-PREVENTION,2345
47614,Rest,B-PREVENTION,2345
47615,your,I-PREVENTION,2345
47616,eyes,I-PREVENTION,2345
47617,as,I-PREVENTION,2345
47618,much,I-PREVENTION,2345
47619,as,I-PREVENTION,2345
47620,possible,I-PREVENTION,2345
47621,and,O,2346
47622,avoid,B-PREVENTION,2346
47623,any,I-PREVENTION,2346
47624,further,I-PREVENTION,2346
47625,exposure,I-PREVENTION,2346
47626,to,I-PREVENTION,2346
47627,UV,I-PREVENTION,2346
47628,rays,I-PREVENTION,2346
47629,Over-the-counter,B-PREVENTION,2346
47630,pain,I-PREVENTION,2346
47631,relievers,I-PREVENTION,2346
47632,can,O,2346
47633,be,O,2346
47634,taken,O,2346
47635,to,O,2346
47636,alleviate,O,2346
47637,any,O,2346
47638,discomfort,O,2347
47639,and,O,2347
47640,a,B-PREVENTION,2347
47641,cool,I-PREVENTION,2347
47642,compress,I-PREVENTION,2347
47643,can,O,2347
47644,be,O,2347
47645,applied,O,2347
47646,to,O,2347
47647,the,O,2347
47648,eyes,O,2347
47649,for,O,2347
47650,relief,O,2347
47651,Avoid,B-PREVENTION,2347
47652,rubbing,I-PREVENTION,2347
47653,or,I-PREVENTION,2347
47654,touching,I-PREVENTION,2347
47655,your,I-PREVENTION,2347
47656,eyes,I-PREVENTION,2347
47657,as,O,2348
47658,this,O,2348
47659,can,O,2348
47660,cause,O,2348
47661,further,O,2348
47662,irritation,O,2348
47663,and,O,2348
47664,delay,O,2348
47665,the,O,2348
47666,healing,O,2348
47667,process,O,2348
47668,In,O,2348
47669,severe,O,2348
47670,cases,O,2348
47671,your,O,2348
47672,doctor,O,2348
47673,may,O,2348
47674,prescribe,O,2348
47675,eye,B-PREVENTION,2348
47676,drops,I-PREVENTION,2348
47677,or,I-PREVENTION,2348
47678,ointments,I-PREVENTION,2348
47679,to,O,2348
47680,help,O,2348
47681,speed,O,2348
47682,up,O,2348
47683,the,O,2348
47684,healing,O,2348
47685,process,O,2348
47686,Make,O,2348
47687,sure,O,2348
47688,to,O,2349
47689,limit,B-PREVENTION,2349
47690,time,I-PREVENTION,2349
47691,spent,I-PREVENTION,2349
47692,in,I-PREVENTION,2349
47693,the,I-PREVENTION,2349
47694,sun,I-PREVENTION,2349
47695,during,I-PREVENTION,2349
47696,peak,I-PREVENTION,2349
47697,UV,I-PREVENTION,2349
47698,hours,I-PREVENTION,2349
47699,10,B-TIME_DURATION,2349
47700,am,I-TIME_DURATION,2349
47701,to,I-TIME_DURATION,2349
47702,4,I-TIME_DURATION,2349
47703,pm,I-TIME_DURATION,2349
47704,,O,2349
47705,The,B-ORGANIZATION,2349
47706,National,B-ORGANIZATION,2349
47707,Eye,I-ORGANIZATION,2349
47708,Institute,I-ORGANIZATION,2349
47709,NEI,B-ORGANIZATION,2349
47710,has,O,2349
47711,developed,O,2349
47712,a,O,2349
47713,zebrafish,O,2349
47714,model,O,2349
47715,of,O,2350
47716,NEDBEH,B-NAME_OF_DISEASE,2350
47717,a,O,2350
47718,rare,O,2350
47719,genetic,O,2350
47720,disease,O,2350
47721,that,O,2350
47722,can,O,2350
47723,cause,O,2350
47724,coloboma,B-NAME_OF_DISEASE,2350
47725,a,O,2350
47726,condition,O,2351
47727,in,O,2351
47728,which,O,2351
47729,parts,B-SIGN_AND_SYMPTOM,2351
47730,of,I-SIGN_AND_SYMPTOM,2351
47731,the,I-SIGN_AND_SYMPTOM,2351
47732,eye,I-SIGN_AND_SYMPTOM,2351
47733,are,I-SIGN_AND_SYMPTOM,2351
47734,absent,I-SIGN_AND_SYMPTOM,2351
47735,due,O,2351
47736,to,O,2351
47737,developmental,O,2351
47738,defects,O,2351
47739,The,O,2351
47740,model,O,2351
47741,is,O,2351
47742,a,O,2351
47743,new,O,2351
47744,tool,O,2351
47745,for,O,2351
47746,understanding,O,2351
47747,the,O,2351
47748,embryonic,O,2351
47749,development,O,2351
47750,of,O,2351
47751,the,O,2351
47752,eye,O,2351
47753,Despite,O,2351
47754,advances,O,2352
47755,in,O,2352
47756,genetics,O,2352
47757,the,O,2352
47758,underlying,O,2352
47759,cause,O,2352
47760,of,O,2352
47761,coloboma,B-NAME_OF_DISEASE,2352
47762,in,O,2353
47763,most,O,2353
47764,families,O,2353
47765,remains,O,2353
47766,unclear,O,2353
47767,said,O,2353
47768,Brian,B-PERSON,2353
47769,Brooks,B-PERSON,2354
47770,M.D,O,2354
47771,Ph.D,O,2354
47772,chief,O,2354
47773,of,O,2354
47774,the,B-ORGANIZATION,2354
47775,NEI,B-ORGANIZATION,2354
47776,Ophthalmic,I-ORGANIZATION,2355
47777,Genetics,I-ORGANIZATION,2355
47778,and,I-ORGANIZATION,2355
47779,Visual,I-ORGANIZATION,2355
47780,Function,I-ORGANIZATION,2355
47781,Branch,I-ORGANIZATION,2355
47782,The,O,2355
47783,ongoing,O,2355
47784,mystery,O,2355
47785,is,O,2355
47786,partly,O,2355
47787,due,O,2355
47788,to,O,2355
47789,the,O,2355
47790,myriad,O,2356
47791,genes,O,2356
47792,that,O,2356
47793,must,O,2356
47794,be,O,2356
47795,turned,O,2356
47796,on,O,2356
47797,and,O,2356
47798,off,O,2356
47799,at,O,2356
47800,pivotal,O,2356
47801,moments,O,2356
47802,for,O,2356
47803,the,O,2357
47804,eye,O,2357
47805,s,O,2357
47806,normal,O,2357
47807,development,O,2357
47808,Cross,O,2357
47809,section,O,2357
47810,of,O,2357
47811,an,O,2357
47812,embryonic,O,2357
47813,rerea,O,2357
47814,mutant,O,2358
47815,zebrafish,O,2358
47816,eye,O,2358
47817,showing,O,2358
47818,coloboma,B-NAME_OF_DISEASE,2358
47819,In,O,2358
47820,normal,O,2359
47821,zebrafish,O,2359
47822,the,O,2359
47823,optic,O,2359
47824,fissure,O,2359
47825,closes,O,2359
47826,Credit,O,2359
47827,Brian,B-PERSON,2359
47828,Brooks,B-PERSON,2359
47829,National,B-ORGANIZATION,2359
47830,Eye,I-ORGANIZATION,2359
47831,Institute,I-ORGANIZATION,2360
47832,Brooks,B-PERSON,2360
47833,and,O,2360
47834,George,B-PERSON,2360
47835,studied,O,2360
47836,zebrafish,O,2360
47837,with,O,2360
47838,a,O,2360
47839,mutation,O,2360
47840,in,O,2360
47841,the,O,2361
47842,gene,O,2361
47843,rerea,O,2361
47844,which,O,2361
47845,is,O,2361
47846,the,O,2361
47847,zebrafish,O,2361
47848,equivalent,O,2361
47849,of,O,2361
47850,the,O,2361
47851,human,O,2361
47852,RERE,B-CHEMICAL_COMPOUND,2361
47853,gene,I-CHEMICAL_COMPOUND,2361
47854,mutants,O,2361
47855,showed,O,2361
47856,eye,O,2362
47857,defects,O,2362
47858,including,O,2362
47859,enlarged,O,2362
47860,optic,B-PART_OF_THE_EYES,2362
47861,stalks,I-PART_OF_THE_EYES,2362
47862,eye,B-PART_OF_THE_EYES,2362
47863,tissue,I-PART_OF_THE_EYES,2362
47864,in,I-PART_OF_THE_EYES,2362
47865,the,I-PART_OF_THE_EYES,2362
47866,brain,I-PART_OF_THE_EYES,2362
47867,and,O,2362
47868,coloboma,B-NAME_OF_DISEASE,2363
47869,as,O,2363
47870,compared,O,2363
47871,to,O,2363
47872,normal,O,2363
47873,zebrafish,O,2363
47874,The,O,2363
47875,optic,B-PART_OF_THE_EYES,2363
47876,stalk,I-PART_OF_THE_EYES,2363
47877,is,O,2363
47878,a,O,2364
47879,temporary,O,2364
47880,ocular,O,2364
47881,structure,O,2365
47882,that,O,2365
47883,connects,O,2365
47884,the,O,2365
47885,eye,O,2365
47886,and,O,2365
47887,the,O,2365
47888,brain,O,2365
47889,Brian,B-PERSON,2365
47890,Brooks,B-PERSON,2365
47891,M.D,O,2365
47892,Ph.D,O,2365
47893,left,O,2365
47894,and,O,2365
47895,Aman,O,2365
47896,George,B-PERSON,2365
47897,Ph.D,O,2365
47898,NEI,B-ORGANIZATION,2366
47899,Ophthalmic,I-ORGANIZATION,2366
47900,Genetics,I-ORGANIZATION,2366
47901,Visual,I-ORGANIZATION,2366
47902,Function,I-ORGANIZATION,2366
47903,Branch,I-ORGANIZATION,2366
47904,Credit,O,2366
47905,National,B-ORGANIZATION,2366
47906,Eye,I-ORGANIZATION,2366
47907,Institute,I-ORGANIZATION,2366
47908,The,O,2366
47909,rerea,O,2366
47910,mutation,O,2366
47911,changed,O,2366
47912,the,O,2366
47913,expression,O,2366
47914,of,O,2366
47915,critical,O,2366
47916,developmental,O,2366
47917,genes,O,2366
47918,Notably,O,2366
47919,the,O,2366
47920,rerea,O,2366
47921,mutation,O,2366
47922,disrupted,O,2366
47923,sonic,B-CHEMICAL_COMPOUND,2366
47924,hedgehog,I-CHEMICAL_COMPOUND,2366
47925,shh,B-CHEMICAL_COMPOUND,2366
47926,signaling,O,2366
47927,an,O,2366
47928,important,O,2366
47929,protein,O,2366
47930,that,O,2366
47931,guides,O,2366
47932,the,O,2366
47933,development,O,2366
47934,of,O,2366
47935,a,O,2366
47936,range,O,2367
47937,of,O,2367
47938,organs,O,2367
47939,and,O,2367
47940,tissues,O,2367
47941,including,O,2367
47942,the,O,2367
47943,optic,B-PART_OF_THE_EYES,2367
47944,stalk,I-PART_OF_THE_EYES,2367
47945,and,O,2367
47946,retina,B-PART_OF_THE_EYES,2367
47947,The,O,2367
47948,scientists,O,2367
47949,saved,O,2367
47950,coloboma,B-NAME_OF_DISEASE,2367
47951,by,O,2367
47952,blocking,O,2367
47953,the,O,2367
47954,shh,B-CHEMICAL_COMPOUND,2367
47955,route,O,2367
47956,at,O,2367
47957,a,O,2367
47958,separate,O,2367
47959,site,O,2367
47960,resulting,O,2367
47961,in,O,2367
47962,correct,O,2367
47963,closure,O,2367
47964,of,O,2367
47965,the,O,2367
47966,ocular,O,2367
47967,fissure,O,2367
47968,Our,O,2367
47969,zebrafish,O,2367
47970,model,O,2367
47971,helps,O,2367
47972,clarify,O,2368
47973,the,O,2368
47974,role,O,2368
47975,of,O,2368
47976,the,O,2368
47977,RERE,B-CHEMICAL_COMPOUND,2368
47978,gene,I-CHEMICAL_COMPOUND,2368
47979,in,O,2368
47980,eye,O,2368
47981,development,O,2368
47982,said,O,2368
47983,George,B-PERSON,2368
47984,Identifying,O,2368
47985,appropriate,O,2368
47986,model,O,2368
47987,systems,O,2368
47988,for,O,2368
47989,studying,O,2368
47990,coloboma,B-NAME_OF_DISEASE,2368
47991,is,O,2368
47992,essential,O,2368
47993,to,O,2368
47994,understanding,O,2368
47995,its,O,2368
47996,underlying,O,2368
47997,mechanisms,O,2368
47998,and,O,2368
47999,finding,O,2368
48000,targets,O,2368
48001,for,O,2368
48002,rescuing,O,2368
48003,defects,O,2368
48004,For,O,2368
48005,more,O,2368
48006,information,O,2368
48007,about,O,2368
48008,coloboma,B-NAME_OF_DISEASE,2368
48009,visit,O,2368
48010,the,O,2368
48011,NEI,B-ORGANIZATION,2369
48012,website,O,2369
48013,What,O,2369
48014,Is,O,2369
48015,Monkeypox,B-NAME_OF_DISEASE,2369
48016,Monkeypox,B-NAME_OF_DISEASE,2369
48017,is,O,2369
48018,a,O,2369
48019,zoonotic,O,2369
48020,disease,O,2369
48021,transmitted,O,2369
48022,from,O,2369
48023,animals,O,2369
48024,to,O,2369
48025,humans,O,2369
48026,spread,O,2369
48027,to,O,2370
48028,humans,O,2370
48029,by,O,2370
48030,a,B-CAUSE_OF_DISEASE,2370
48031,double-stranded,I-CAUSE_OF_DISEASE,2370
48032,virus,I-CAUSE_OF_DISEASE,2370
48033,known,I-CAUSE_OF_DISEASE,2370
48034,as,I-CAUSE_OF_DISEASE,2370
48035,the,B-CAUSE_OF_DISEASE,2370
48036,monkeypox,B-NAME_OF_DISEASE,2370
48037,virus,I-CAUSE_OF_DISEASE,2370
48038,It,O,2370
48039,is,O,2370
48040,contracted,O,2370
48041,by,O,2370
48042,humans,O,2370
48043,through,O,2370
48044,non-human,O,2370
48045,primates,O,2370
48046,and,O,2370
48047,rodents,O,2370
48048,Symptoms,O,2370
48049,produced,O,2370
48050,by,O,2370
48051,the,B-CAUSE_OF_DISEASE,2370
48052,monkeypox,B-NAME_OF_DISEASE,2370
48053,virus,I-CAUSE_OF_DISEASE,2370
48054,include,O,2370
48055,fever,B-SIGN_AND_SYMPTOM,2370
48056,with,I-SIGN_AND_SYMPTOM,2370
48057,chills,I-SIGN_AND_SYMPTOM,2370
48058,headache,I-SIGN_AND_SYMPTOM,2371
48059,flu-like,I-SIGN_AND_SYMPTOM,2371
48060,symptoms,I-SIGN_AND_SYMPTOM,2371
48061,myalgia,I-SIGN_AND_SYMPTOM,2371
48062,palpable,I-SIGN_AND_SYMPTOM,2371
48063,lymph,I-SIGN_AND_SYMPTOM,2371
48064,nodes,I-SIGN_AND_SYMPTOM,2371
48065,and,I-SIGN_AND_SYMPTOM,2371
48066,blister-like,I-SIGN_AND_SYMPTOM,2371
48067,skin,I-SIGN_AND_SYMPTOM,2371
48068,rash,I-SIGN_AND_SYMPTOM,2371
48069,Patients,O,2371
48070,recover,O,2371
48071,within,B-TIME_DURATION,2371
48072,the,I-TIME_DURATION,2371
48073,interval,I-TIME_DURATION,2371
48074,of,I-TIME_DURATION,2371
48075,two,I-TIME_DURATION,2371
48076,to,I-TIME_DURATION,2371
48077,four,I-TIME_DURATION,2372
48078,weeks,I-TIME_DURATION,2372
48079,naturally,O,2372
48080,How,O,2372
48081,Does,O,2372
48082,Monkeypox,B-NAME_OF_DISEASE,2372
48083,Affect,O,2372
48084,Our,O,2372
48085,Eyes,O,2372
48086,Monkeypox,B-CAUSE_OF_DISEASE,2372
48087,virus,I-CAUSE_OF_DISEASE,2372
48088,may,O,2372
48089,spread,O,2372
48090,to,O,2372
48091,the,O,2372
48092,eye,O,2372
48093,by,O,2372
48094,autoinoculation,O,2372
48095,or,O,2372
48096,self-inoculation,O,2372
48097,Self-inoculation,O,2372
48098,ensues,O,2372
48099,when,O,2372
48100,a,B-CAUSE_OF_DISEASE,2372
48101,diseased,I-CAUSE_OF_DISEASE,2372
48102,person,I-CAUSE_OF_DISEASE,2372
48103,scratches,I-CAUSE_OF_DISEASE,2372
48104,or,I-CAUSE_OF_DISEASE,2372
48105,rubs,I-CAUSE_OF_DISEASE,2372
48106,a,I-CAUSE_OF_DISEASE,2372
48107,blister,I-CAUSE_OF_DISEASE,2372
48108,or,I-CAUSE_OF_DISEASE,2372
48109,a,I-CAUSE_OF_DISEASE,2372
48110,vesicle,I-CAUSE_OF_DISEASE,2372
48111,and,I-CAUSE_OF_DISEASE,2372
48112,then,I-CAUSE_OF_DISEASE,2372
48113,touches,I-CAUSE_OF_DISEASE,2372
48114,the,I-CAUSE_OF_DISEASE,2373
48115,eyes,I-CAUSE_OF_DISEASE,2373
48116,transmitting,O,2373
48117,the,O,2373
48118,disease,O,2373
48119,from,O,2373
48120,one,O,2373
48121,part,O,2373
48122,of,O,2373
48123,the,O,2373
48124,body,O,2373
48125,to,O,2373
48126,another,O,2373
48127,What,O,2373
48128,Signs,O,2373
48129,and,O,2373
48130,Symptoms,O,2374
48131,Are,O,2374
48132,Seen,O,2374
48133,in,O,2374
48134,the,O,2374
48135,Eyes,O,2374
48136,Ocular,O,2374
48137,Manifestations,O,2374
48138,of,O,2374
48139,the,B-CAUSE_OF_DISEASE,2374
48140,monkeypox,B-NAME_OF_DISEASE,2374
48141,virus,I-CAUSE_OF_DISEASE,2374
48142,are,O,2374
48143,Conjunctivitis,B-SIGN_AND_SYMPTOM,2374
48144,Blepharitis,B-SIGN_AND_SYMPTOM,2374
48145,or,I-SIGN_AND_SYMPTOM,2374
48146,swelling,I-SIGN_AND_SYMPTOM,2374
48147,of,I-SIGN_AND_SYMPTOM,2374
48148,eyelid,I-SIGN_AND_SYMPTOM,2374
48149,margins,I-SIGN_AND_SYMPTOM,2374
48150,Keratitis,B-SIGN_AND_SYMPTOM,2374
48151,Corneal,B-SIGN_AND_SYMPTOM,2374
48152,ulcer,I-SIGN_AND_SYMPTOM,2374
48153,Corneal,B-SIGN_AND_SYMPTOM,2374
48154,scarring,I-SIGN_AND_SYMPTOM,2374
48155,Loss,B-SIGN_AND_SYMPTOM,2374
48156,of,I-SIGN_AND_SYMPTOM,2374
48157,vision,I-SIGN_AND_SYMPTOM,2374
48158,rarely,I-SIGN_AND_SYMPTOM,2374
48159,Redness,B-SIGN_AND_SYMPTOM,2374
48160,in,I-SIGN_AND_SYMPTOM,2374
48161,eyes,I-SIGN_AND_SYMPTOM,2374
48162,pink,I-SIGN_AND_SYMPTOM,2374
48163,eyes,I-SIGN_AND_SYMPTOM,2375
48164,Itching,B-SIGN_AND_SYMPTOM,2375
48165,in,I-SIGN_AND_SYMPTOM,2375
48166,eyes,I-SIGN_AND_SYMPTOM,2375
48167,How,O,2375
48168,to,O,2375
48169,Treat,O,2375
48170,Eye,O,2375
48171,Conditions,O,2375
48172,Associated,O,2375
48173,with,O,2375
48174,Monkeypox,B-NAME_OF_DISEASE,2375
48175,First,O,2375
48176,and,O,2375
48177,foremost,O,2375
48178,isolating,B-TREATMENT,2375
48179,oneself,I-TREATMENT,2375
48180,at,I-TREATMENT,2375
48181,home,I-TREATMENT,2375
48182,when,I-TREATMENT,2376
48183,monkeypox,B-NAME_OF_DISEASE,2376
48184,symptoms,I-TREATMENT,2376
48185,appear,I-TREATMENT,2376
48186,till,I-TREATMENT,2376
48187,the,I-TREATMENT,2376
48188,rash,I-TREATMENT,2376
48189,has,I-TREATMENT,2376
48190,completely,I-TREATMENT,2376
48191,gone,I-TREATMENT,2376
48192,away,I-TREATMENT,2376
48193,As,O,2376
48194,soon,O,2376
48195,as,O,2376
48196,the,O,2376
48197,patient,O,2376
48198,starts,O,2376
48199,noticing,O,2376
48200,ocular,O,2376
48201,symptoms,O,2376
48202,an,O,2376
48203,appointment,O,2376
48204,with,O,2376
48205,an,O,2376
48206,ophthalmologist,O,2376
48207,must,O,2376
48208,be,O,2376
48209,made,O,2376
48210,There,O,2376
48211,is,O,2376
48212,no,O,2376
48213,agreed,O,2376
48214,treatment,O,2376
48215,for,O,2376
48216,Monkeypox,B-NAME_OF_DISEASE,2376
48217,it,O,2376
48218,usually,O,2376
48219,goes,O,2376
48220,away,O,2376
48221,on,O,2376
48222,its,O,2376
48223,own,O,2376
48224,within,B-TIME_DURATION,2376
48225,two,I-TIME_DURATION,2376
48226,to,I-TIME_DURATION,2376
48227,four,I-TIME_DURATION,2376
48228,weeks,I-TIME_DURATION,2376
48229,Most,O,2376
48230,people,O,2376
48231,improve,O,2376
48232,fully,O,2376
48233,without,O,2376
48234,requiring,O,2376
48235,any,O,2376
48236,treatment,O,2376
48237,but,O,2376
48238,if,O,2376
48239,a,O,2376
48240,rash,B-SIGN_AND_SYMPTOM,2376
48241,becomes,I-SIGN_AND_SYMPTOM,2376
48242,infected,I-SIGN_AND_SYMPTOM,2376
48243,Doctors,O,2376
48244,might,O,2376
48245,prescribe,O,2376
48246,antiviral,B-TREATMENT,2377
48247,antibiotic,I-TREATMENT,2377
48248,for,I-TREATMENT,2377
48249,superadded,I-TREATMENT,2377
48250,bacterial,I-TREATMENT,2377
48251,infections,I-TREATMENT,2377
48252,or,I-TREATMENT,2377
48253,anti-inflammatory,I-TREATMENT,2377
48254,medications,I-TREATMENT,2377
48255,to,O,2377
48256,treat,O,2377
48257,severe,O,2377
48258,ocular,O,2377
48259,problems,O,2377
48260,Treatment,O,2377
48261,is,O,2377
48262,given,O,2377
48263,based,O,2377
48264,on,O,2377
48265,the,O,2377
48266,symptoms,O,2377
48267,and,O,2377
48268,for,O,2377
48269,corneal,B-SIGN_AND_SYMPTOM,2377
48270,scarring,I-SIGN_AND_SYMPTOM,2377
48271,prescription,O,2377
48272,might,O,2377
48273,include,O,2377
48274,glasses,B-TREATMENT,2377
48275,and,I-TREATMENT,2377
48276,contact,I-TREATMENT,2377
48277,lenses,I-TREATMENT,2377
48278,soft,I-TREATMENT,2377
48279,or,I-TREATMENT,2377
48280,rigid,I-TREATMENT,2377
48281,for,O,2377
48282,the,O,2377
48283,protection,O,2377
48284,of,O,2377
48285,the,O,2377
48286,eyes,O,2377
48287,Laser,B-TREATMENT,2377
48288,treatment,I-TREATMENT,2377
48289,or,I-TREATMENT,2377
48290,corneal,I-TREATMENT,2378
48291,transplantation,I-TREATMENT,2378
48292,once,O,2378
48293,the,O,2378
48294,virus,O,2378
48295,has,O,2378
48296,gone,O,2378
48297,away,O,2378
48298,For,O,2378
48299,pink,B-SIGN_AND_SYMPTOM,2378
48300,eye,I-SIGN_AND_SYMPTOM,2378
48301,associated,O,2378
48302,with,O,2378
48303,monkeypox,B-NAME_OF_DISEASE,2378
48304,several,O,2378
48305,options,O,2378
48306,are,O,2378
48307,available,O,2378
48308,for,O,2378
48309,an,O,2378
48310,instance,O,2378
48311,the,O,2378
48312,use,O,2378
48313,of,O,2378
48314,Lubricant,B-TREATMENT,2378
48315,eye,I-TREATMENT,2379
48316,drops,I-TREATMENT,2379
48317,or,I-TREATMENT,2379
48318,artificial,I-TREATMENT,2379
48319,tears,I-TREATMENT,2379
48320,to,O,2379
48321,relieve,O,2379
48322,itching,B-SIGN_AND_SYMPTOM,2379
48323,in,I-SIGN_AND_SYMPTOM,2379
48324,the,I-SIGN_AND_SYMPTOM,2379
48325,eyes,I-SIGN_AND_SYMPTOM,2379
48326,Cold,B-TREATMENT,2379
48327,compresses,I-TREATMENT,2379
48328,reduce,O,2379
48329,the,O,2380
48330,swelling,B-SIGN_AND_SYMPTOM,2380
48331,in,I-SIGN_AND_SYMPTOM,2380
48332,the,I-SIGN_AND_SYMPTOM,2380
48333,eyelids,I-SIGN_AND_SYMPTOM,2380
48334,Abstinence,B-TREATMENT,2380
48335,from,I-TREATMENT,2380
48336,the,I-TREATMENT,2380
48337,use,I-TREATMENT,2380
48338,of,I-TREATMENT,2380
48339,contact,I-TREATMENT,2380
48340,lenses,I-TREATMENT,2380
48341,No,B-TREATMENT,2380
48342,makeup,I-TREATMENT,2380
48343,until,O,2380
48344,the,O,2380
48345,eyes,O,2380
48346,are,O,2380
48347,healthy,O,2380
48348,How,O,2380
48349,to,O,2380
48350,Prevent,O,2380
48351,Monkeypox,B-NAME_OF_DISEASE,2380
48352,Patients,O,2380
48353,must,O,2381
48354,isolate,B-PREVENTION,2381
48355,themselves,I-PREVENTION,2381
48356,completely,I-PREVENTION,2381
48357,till,I-PREVENTION,2381
48358,the,I-PREVENTION,2381
48359,disease,I-PREVENTION,2381
48360,disappears,I-PREVENTION,2381
48361,completely,I-PREVENTION,2381
48362,Sharing,B-PREVENTION,2381
48363,of,I-PREVENTION,2381
48364,private,I-PREVENTION,2381
48365,items,I-PREVENTION,2381
48366,like,I-PREVENTION,2381
48367,garments,I-PREVENTION,2381
48368,or,I-PREVENTION,2381
48369,towels,I-PREVENTION,2381
48370,with,I-PREVENTION,2381
48371,others,I-PREVENTION,2381
48372,must,I-PREVENTION,2381
48373,be,I-PREVENTION,2381
48374,avoided,I-PREVENTION,2381
48375,A,B-PREVENTION,2381
48376,new,I-PREVENTION,2381
48377,towel,I-PREVENTION,2381
48378,should,I-PREVENTION,2382
48379,be,I-PREVENTION,2382
48380,used,I-PREVENTION,2382
48381,every,I-PREVENTION,2382
48382,time,I-PREVENTION,2382
48383,you,I-PREVENTION,2382
48384,need,I-PREVENTION,2382
48385,one,I-PREVENTION,2382
48386,Have,B-PREVENTION,2382
48387,no,I-PREVENTION,2382
48388,physical,I-PREVENTION,2382
48389,interaction,I-PREVENTION,2382
48390,with,I-PREVENTION,2382
48391,others,I-PREVENTION,2382
48392,Rinse,B-PREVENTION,2382
48393,your,I-PREVENTION,2382
48394,hands,I-PREVENTION,2382
48395,over,I-PREVENTION,2382
48396,and,I-PREVENTION,2383
48397,over,I-PREVENTION,2383
48398,again,I-PREVENTION,2383
48399,with,I-PREVENTION,2383
48400,soap,I-PREVENTION,2383
48401,and,I-PREVENTION,2383
48402,water,I-PREVENTION,2383
48403,Do,B-PREVENTION,2383
48404,not,I-PREVENTION,2383
48405,have,I-PREVENTION,2383
48406,any,I-PREVENTION,2383
48407,sort,I-PREVENTION,2383
48408,of,I-PREVENTION,2383
48409,physical,I-PREVENTION,2384
48410,contact,I-PREVENTION,2384
48411,with,I-PREVENTION,2384
48412,pets,I-PREVENTION,2384
48413,If,B-PREVENTION,2384
48414,you,I-PREVENTION,2384
48415,are,I-PREVENTION,2384
48416,a,I-PREVENTION,2384
48417,contact,I-PREVENTION,2384
48418,lens,I-PREVENTION,2384
48419,wearer,I-PREVENTION,2384
48420,shift,I-PREVENTION,2384
48421,to,I-PREVENTION,2384
48422,glasses,I-PREVENTION,2384
48423,up,I-PREVENTION,2384
48424,until,I-PREVENTION,2384
48425,your,I-PREVENTION,2384
48426,symptoms,I-PREVENTION,2384
48427,vanish,I-PREVENTION,2384
48428,Change,B-PREVENTION,2384
48429,the,I-PREVENTION,2384
48430,pair,I-PREVENTION,2384
48431,of,I-PREVENTION,2384
48432,your,I-PREVENTION,2384
48433,contact,I-PREVENTION,2384
48434,lenses,I-PREVENTION,2384
48435,once,I-PREVENTION,2384
48436,the,I-PREVENTION,2385
48437,disease,I-PREVENTION,2385
48438,has,I-PREVENTION,2385
48439,healed,I-PREVENTION,2385
48440,Do,B-PREVENTION,2385
48441,not,I-PREVENTION,2385
48442,touch,I-PREVENTION,2385
48443,your,I-PREVENTION,2385
48444,eyes,I-PREVENTION,2385
48445,or,I-PREVENTION,2385
48446,face,I-PREVENTION,2385
48447,after,I-PREVENTION,2385
48448,touching,I-PREVENTION,2385
48449,blisters,I-PREVENTION,2385
48450,Keep,B-PREVENTION,2385
48451,yourself,I-PREVENTION,2385
48452,hydrated,I-PREVENTION,2385
48453,Vaccinations,B-PREVENTION,2385
48454,are,O,2385
48455,also,O,2385
48456,available,O,2385
48457,for,O,2385
48458,high-risk,O,2385
48459,patients,O,2385
48460,and,O,2385
48461,patients,O,2385
48462,who,O,2385
48463,have,O,2385
48464,a,O,2385
48465,disease,O,2385
48466,in,O,2385
48467,the,O,2385
48468,initial,O,2385
48469,stages,O,2385
48470,White,B-NAME_OF_DISEASE,2385
48471,dot,I-NAME_OF_DISEASE,2385
48472,syndrome,I-NAME_OF_DISEASE,2385
48473,is,O,2385
48474,a,O,2385
48475,term,O,2385
48476,used,O,2385
48477,to,O,2385
48478,describe,O,2385
48479,a,O,2385
48480,group,O,2385
48481,of,O,2385
48482,eye,O,2385
48483,conditions,O,2385
48484,that,O,2385
48485,are,O,2385
48486,characterized,O,2385
48487,by,O,2385
48488,the,B-SIGN_AND_SYMPTOM,2385
48489,presence,I-SIGN_AND_SYMPTOM,2385
48490,of,I-SIGN_AND_SYMPTOM,2385
48491,white,I-SIGN_AND_SYMPTOM,2385
48492,or,I-SIGN_AND_SYMPTOM,2385
48493,yellowish,I-SIGN_AND_SYMPTOM,2385
48494,dots,I-SIGN_AND_SYMPTOM,2385
48495,in,I-SIGN_AND_SYMPTOM,2385
48496,the,B-PART_OF_THE_EYES,2385
48497,retina,I-PART_OF_THE_EYES,2385
48498,the,I-SIGN_AND_SYMPTOM,2385
48499,light-sensitive,I-SIGN_AND_SYMPTOM,2385
48500,layer,I-SIGN_AND_SYMPTOM,2385
48501,at,I-SIGN_AND_SYMPTOM,2385
48502,the,I-SIGN_AND_SYMPTOM,2385
48503,back,I-SIGN_AND_SYMPTOM,2385
48504,of,I-SIGN_AND_SYMPTOM,2385
48505,the,I-SIGN_AND_SYMPTOM,2385
48506,eye,I-SIGN_AND_SYMPTOM,2385
48507,,O,2385
48508,These,O,2385
48509,dots,O,2385
48510,which,O,2385
48511,are,O,2385
48512,known,O,2385
48513,as,O,2385
48514,white,B-SIGN_AND_SYMPTOM,2385
48515,dot,I-SIGN_AND_SYMPTOM,2385
48516,lesions,I-SIGN_AND_SYMPTOM,2385
48517,or,I-SIGN_AND_SYMPTOM,2385
48518,chorioretinal,I-SIGN_AND_SYMPTOM,2385
48519,lesions,I-SIGN_AND_SYMPTOM,2385
48520,are,O,2385
48521,usually,O,2385
48522,seen,O,2385
48523,in,O,2385
48524,the,B-PART_OF_THE_EYES,2385
48525,macula,I-PART_OF_THE_EYES,2385
48526,the,I-PART_OF_THE_EYES,2385
48527,central,I-PART_OF_THE_EYES,2385
48528,part,I-PART_OF_THE_EYES,2385
48529,of,I-PART_OF_THE_EYES,2385
48530,the,B-PART_OF_THE_EYES,2385
48531,retina,I-PART_OF_THE_EYES,2385
48532,and,O,2385
48533,can,O,2385
48534,be,O,2385
48535,a,O,2385
48536,sign,O,2385
48537,of,O,2385
48538,an,O,2385
48539,underlying,O,2385
48540,eye,O,2385
48541,condition,O,2385
48542,or,O,2385
48543,disease,O,2385
48544,Types,O,2385
48545,of,O,2385
48546,White,B-NAME_OF_DISEASE,2385
48547,Dot,I-NAME_OF_DISEASE,2385
48548,Syndrome,I-NAME_OF_DISEASE,2385
48549,Acute,B-NAME_OF_DISEASE,2385
48550,zonal,I-NAME_OF_DISEASE,2385
48551,occult,I-NAME_OF_DISEASE,2385
48552,outer,I-NAME_OF_DISEASE,2385
48553,retinopathy,I-NAME_OF_DISEASE,2385
48554,AZOOR,I-NAME_OF_DISEASE,2385
48555,This,O,2385
48556,is,O,2385
48557,a,O,2385
48558,rare,O,2385
48559,condition,O,2385
48560,that,O,2385
48561,affects,O,2385
48562,the,B-PART_OF_THE_EYES,2385
48563,outer,I-PART_OF_THE_EYES,2385
48564,layers,I-PART_OF_THE_EYES,2385
48565,of,I-PART_OF_THE_EYES,2385
48566,the,B-PART_OF_THE_EYES,2385
48567,retina,I-PART_OF_THE_EYES,2385
48568,and,O,2385
48569,is,O,2385
48570,characterized,O,2385
48571,by,O,2385
48572,the,B-SIGN_AND_SYMPTOM,2385
48573,sudden,I-SIGN_AND_SYMPTOM,2386
48574,appearance,I-SIGN_AND_SYMPTOM,2386
48575,of,I-SIGN_AND_SYMPTOM,2386
48576,white,I-SIGN_AND_SYMPTOM,2386
48577,dots,I-SIGN_AND_SYMPTOM,2386
48578,or,I-SIGN_AND_SYMPTOM,2386
48579,patches,I-SIGN_AND_SYMPTOM,2386
48580,in,I-SIGN_AND_SYMPTOM,2386
48581,the,B-PART_OF_THE_EYES,2386
48582,retina,I-PART_OF_THE_EYES,2386
48583,It,O,2386
48584,is,O,2386
48585,often,O,2386
48586,accompanied,O,2386
48587,by,O,2386
48588,vision,B-SIGN_AND_SYMPTOM,2387
48589,loss,I-SIGN_AND_SYMPTOM,2387
48590,and,O,2387
48591,can,O,2387
48592,be,O,2387
48593,triggered,O,2387
48594,by,O,2387
48595,certain,O,2387
48596,medications,O,2387
48597,or,O,2387
48598,diseases,O,2387
48599,Multiple,B-NAME_OF_DISEASE,2388
48600,evanescent,I-NAME_OF_DISEASE,2388
48601,white,B-NAME_OF_DISEASE,2388
48602,dot,I-NAME_OF_DISEASE,2389
48603,syndrome,I-NAME_OF_DISEASE,2389
48604,MEWDS,I-NAME_OF_DISEASE,2389
48605,This,O,2389
48606,is,O,2389
48607,a,O,2389
48608,rare,O,2389
48609,condition,O,2389
48610,that,O,2389
48611,affects,O,2389
48612,young,O,2389
48613,healthy,O,2389
48614,individuals,O,2389
48615,and,O,2389
48616,is,O,2389
48617,characterized,O,2389
48618,by,O,2389
48619,the,B-SIGN_AND_SYMPTOM,2389
48620,sudden,I-SIGN_AND_SYMPTOM,2389
48621,appearance,I-SIGN_AND_SYMPTOM,2389
48622,of,I-SIGN_AND_SYMPTOM,2389
48623,multiple,I-SIGN_AND_SYMPTOM,2389
48624,small,I-SIGN_AND_SYMPTOM,2389
48625,white,I-SIGN_AND_SYMPTOM,2389
48626,dots,I-SIGN_AND_SYMPTOM,2389
48627,in,I-SIGN_AND_SYMPTOM,2389
48628,the,B-PART_OF_THE_EYES,2389
48629,retina,I-PART_OF_THE_EYES,2389
48630,It,O,2389
48631,is,O,2389
48632,often,O,2389
48633,accompanied,O,2389
48634,by,O,2389
48635,vision,B-SIGN_AND_SYMPTOM,2389
48636,loss,I-SIGN_AND_SYMPTOM,2389
48637,and,O,2389
48638,may,O,2389
48639,resolve,O,2389
48640,on,O,2389
48641,its,O,2389
48642,own,O,2390
48643,within,B-TIME_DURATION,2390
48644,a,I-TIME_DURATION,2390
48645,few,I-TIME_DURATION,2390
48646,weeks,I-TIME_DURATION,2390
48647,to,I-TIME_DURATION,2390
48648,months,I-TIME_DURATION,2390
48649,Punctate,B-NAME_OF_DISEASE,2390
48650,inner,I-NAME_OF_DISEASE,2390
48651,choroidopathy,I-NAME_OF_DISEASE,2390
48652,PIC,I-NAME_OF_DISEASE,2390
48653,This,O,2390
48654,is,O,2390
48655,a,O,2390
48656,rare,O,2390
48657,condition,O,2390
48658,that,O,2390
48659,affects,O,2390
48660,the,B-PART_OF_THE_EYES,2390
48661,choroid,I-PART_OF_THE_EYES,2391
48662,a,I-PART_OF_THE_EYES,2391
48663,layer,I-PART_OF_THE_EYES,2391
48664,of,I-PART_OF_THE_EYES,2391
48665,blood,I-PART_OF_THE_EYES,2391
48666,vessels,I-PART_OF_THE_EYES,2391
48667,and,I-PART_OF_THE_EYES,2391
48668,connective,I-PART_OF_THE_EYES,2391
48669,tissue,I-PART_OF_THE_EYES,2391
48670,under,I-PART_OF_THE_EYES,2391
48671,the,B-PART_OF_THE_EYES,2392
48672,retina,I-PART_OF_THE_EYES,2392
48673,and,O,2392
48674,is,O,2392
48675,characterized,O,2392
48676,by,O,2392
48677,the,B-SIGN_AND_SYMPTOM,2392
48678,presence,I-SIGN_AND_SYMPTOM,2392
48679,of,I-SIGN_AND_SYMPTOM,2392
48680,small,I-SIGN_AND_SYMPTOM,2392
48681,white,I-SIGN_AND_SYMPTOM,2392
48682,dots,I-SIGN_AND_SYMPTOM,2392
48683,in,I-SIGN_AND_SYMPTOM,2393
48684,the,I-SIGN_AND_SYMPTOM,2393
48685,choroid,I-SIGN_AND_SYMPTOM,2393
48686,It,O,2393
48687,is,O,2393
48688,often,O,2393
48689,accompanied,O,2393
48690,by,O,2393
48691,vision,B-SIGN_AND_SYMPTOM,2393
48692,loss,I-SIGN_AND_SYMPTOM,2393
48693,and,O,2393
48694,may,O,2393
48695,be,O,2393
48696,triggered,O,2394
48697,by,O,2394
48698,certain,O,2394
48699,medications,O,2394
48700,or,O,2394
48701,diseases,O,2394
48702,Acute,B-NAME_OF_DISEASE,2394
48703,posterior,I-NAME_OF_DISEASE,2394
48704,multifocal,I-NAME_OF_DISEASE,2394
48705,placoid,I-NAME_OF_DISEASE,2394
48706,pigment,I-NAME_OF_DISEASE,2394
48707,epitheliopathy,I-NAME_OF_DISEASE,2394
48708,APMPPE,I-NAME_OF_DISEASE,2394
48709,This,O,2394
48710,is,O,2394
48711,a,O,2394
48712,rare,O,2394
48713,condition,O,2394
48714,that,O,2394
48715,affects,O,2394
48716,the,B-PART_OF_THE_EYES,2394
48717,retina,I-PART_OF_THE_EYES,2394
48718,and,O,2394
48719,is,O,2394
48720,characterized,O,2395
48721,by,O,2395
48722,the,B-SIGN_AND_SYMPTOM,2395
48723,sudden,I-SIGN_AND_SYMPTOM,2395
48724,appearance,I-SIGN_AND_SYMPTOM,2395
48725,of,I-SIGN_AND_SYMPTOM,2395
48726,multiple,I-SIGN_AND_SYMPTOM,2395
48727,small,I-SIGN_AND_SYMPTOM,2395
48728,white,I-SIGN_AND_SYMPTOM,2396
48729,or,I-SIGN_AND_SYMPTOM,2396
48730,yellowish,I-SIGN_AND_SYMPTOM,2396
48731,dots,I-SIGN_AND_SYMPTOM,2396
48732,in,I-SIGN_AND_SYMPTOM,2396
48733,the,I-SIGN_AND_SYMPTOM,2396
48734,retina,I-SIGN_AND_SYMPTOM,2396
48735,It,O,2396
48736,is,O,2396
48737,often,O,2396
48738,accompanied,O,2397
48739,by,O,2397
48740,vision,B-SIGN_AND_SYMPTOM,2397
48741,loss,I-SIGN_AND_SYMPTOM,2397
48742,and,O,2397
48743,may,O,2397
48744,resolve,O,2397
48745,on,O,2397
48746,its,O,2397
48747,own,O,2397
48748,within,B-TIME_DURATION,2397
48749,a,I-TIME_DURATION,2397
48750,few,I-TIME_DURATION,2397
48751,weeks,I-TIME_DURATION,2398
48752,to,I-TIME_DURATION,2398
48753,months,I-TIME_DURATION,2398
48754,How,O,2398
48755,It,O,2398
48756,Is,O,2398
48757,Diagnosed,O,2398
48758,White,B-NAME_OF_DISEASE,2398
48759,dot,I-NAME_OF_DISEASE,2398
48760,syndrome,I-NAME_OF_DISEASE,2398
48761,is,O,2398
48762,typically,O,2399
48763,diagnosed,O,2399
48764,through,O,2399
48765,a,O,2399
48766,comprehensive,O,2399
48767,eye,O,2399
48768,examination,O,2399
48769,which,O,2399
48770,may,O,2399
48771,include,O,2399
48772,a,B-DIAGNOSTIC_TEST,2399
48773,dilated,I-DIAGNOSTIC_TEST,2399
48774,fundus,I-DIAGNOSTIC_TEST,2399
48775,exam,I-DIAGNOSTIC_TEST,2399
48776,an,I-DIAGNOSTIC_TEST,2399
48777,examination,I-DIAGNOSTIC_TEST,2399
48778,of,I-DIAGNOSTIC_TEST,2399
48779,the,I-DIAGNOSTIC_TEST,2399
48780,back,I-DIAGNOSTIC_TEST,2399
48781,of,I-DIAGNOSTIC_TEST,2399
48782,the,I-DIAGNOSTIC_TEST,2399
48783,eye,I-DIAGNOSTIC_TEST,2399
48784,using,I-DIAGNOSTIC_TEST,2399
48785,special,I-DIAGNOSTIC_TEST,2399
48786,instruments,I-DIAGNOSTIC_TEST,2399
48787,and,O,2399
48788,imaging,B-DIAGNOSTIC_TEST,2400
48789,tests,I-DIAGNOSTIC_TEST,2400
48790,such,I-DIAGNOSTIC_TEST,2400
48791,as,I-DIAGNOSTIC_TEST,2400
48792,optical,I-DIAGNOSTIC_TEST,2400
48793,coherence,I-DIAGNOSTIC_TEST,2400
48794,tomography,I-DIAGNOSTIC_TEST,2400
48795,OCT,I-DIAGNOSTIC_TEST,2400
48796,or,O,2400
48797,fluorescein,B-DIAGNOSTIC_TEST,2400
48798,angiography,I-DIAGNOSTIC_TEST,2400
48799,a,I-DIAGNOSTIC_TEST,2400
48800,test,I-DIAGNOSTIC_TEST,2400
48801,that,I-DIAGNOSTIC_TEST,2400
48802,involves,I-DIAGNOSTIC_TEST,2400
48803,injecting,I-DIAGNOSTIC_TEST,2400
48804,a,I-DIAGNOSTIC_TEST,2400
48805,dye,I-DIAGNOSTIC_TEST,2400
48806,into,I-DIAGNOSTIC_TEST,2401
48807,the,I-DIAGNOSTIC_TEST,2401
48808,bloodstream,I-DIAGNOSTIC_TEST,2401
48809,to,I-DIAGNOSTIC_TEST,2401
48810,visualize,I-DIAGNOSTIC_TEST,2401
48811,the,I-DIAGNOSTIC_TEST,2401
48812,blood,I-DIAGNOSTIC_TEST,2401
48813,vessels,I-DIAGNOSTIC_TEST,2401
48814,in,I-DIAGNOSTIC_TEST,2401
48815,the,I-DIAGNOSTIC_TEST,2401
48816,eye,I-DIAGNOSTIC_TEST,2401
48817,,O,2401
48818,Managing,O,2401
48819,White,B-NAME_OF_DISEASE,2401
48820,Dot,I-NAME_OF_DISEASE,2401
48821,Syndrome,I-NAME_OF_DISEASE,2401
48822,Treatment,O,2401
48823,for,O,2402
48824,white,B-NAME_OF_DISEASE,2402
48825,dot,I-NAME_OF_DISEASE,2402
48826,syndrome,I-NAME_OF_DISEASE,2402
48827,depends,O,2402
48828,on,O,2402
48829,the,O,2402
48830,underlying,O,2402
48831,cause,O,2402
48832,of,O,2402
48833,the,O,2402
48834,condition,O,2402
48835,and,O,2402
48836,may,O,2402
48837,include,O,2402
48838,the,O,2402
48839,following,O,2402
48840,Medications,O,2402
48841,Corticosteroids,B-NAME_OF_DRUG,2403
48842,or,O,2403
48843,other,O,2403
48844,immunosuppressive,B-TREATMENT,2403
48845,medications,I-TREATMENT,2403
48846,may,O,2403
48847,be,O,2403
48848,used,O,2403
48849,to,O,2403
48850,reduce,O,2403
48851,inflammation,O,2403
48852,and,O,2403
48853,improve,O,2403
48854,vision,O,2403
48855,in,O,2403
48856,some,O,2403
48857,cases,O,2403
48858,of,O,2403
48859,white,B-NAME_OF_DISEASE,2403
48860,dot,I-NAME_OF_DISEASE,2404
48861,syndrome,I-NAME_OF_DISEASE,2404
48862,Laser,B-TREATMENT,2404
48863,treatment,I-TREATMENT,2404
48864,Laser,B-TREATMENT,2404
48865,treatment,I-TREATMENT,2404
48866,may,O,2404
48867,be,O,2404
48868,used,O,2404
48869,to,O,2404
48870,destroy,O,2405
48871,abnormal,O,2405
48872,blood,O,2405
48873,vessels,O,2405
48874,or,O,2405
48875,to,O,2405
48876,seal,O,2405
48877,leaking,O,2405
48878,blood,O,2405
48879,vessels,O,2405
48880,in,O,2406
48881,some,O,2406
48882,cases,O,2406
48883,of,O,2406
48884,white,B-NAME_OF_DISEASE,2406
48885,dot,I-NAME_OF_DISEASE,2406
48886,syndrome,I-NAME_OF_DISEASE,2406
48887,Observation,O,2406
48888,In,O,2406
48889,some,O,2406
48890,cases,O,2406
48891,white,B-NAME_OF_DISEASE,2406
48892,dot,I-NAME_OF_DISEASE,2406
48893,syndrome,I-NAME_OF_DISEASE,2406
48894,may,O,2406
48895,resolve,O,2406
48896,on,O,2406
48897,its,O,2407
48898,own,O,2407
48899,without,O,2407
48900,treatment,O,2407
48901,In,O,2407
48902,these,O,2407
48903,cases,O,2407
48904,the,O,2407
48905,condition,O,2407
48906,may,O,2407
48907,be,O,2407
48908,monitored,O,2407
48909,by,O,2407
48910,an,O,2407
48911,eye,O,2407
48912,doctor,O,2407
48913,to,O,2407
48914,ensure,O,2407
48915,that,O,2407
48916,it,O,2407
48917,does,O,2407
48918,not,O,2407
48919,progress,O,2407
48920,or,O,2407
48921,cause,O,2408
48922,further,O,2408
48923,vision,B-SIGN_AND_SYMPTOM,2408
48924,loss,I-SIGN_AND_SYMPTOM,2408
48925,It,O,2408
48926,is,O,2408
48927,important,O,2408
48928,to,O,2408
48929,follow,O,2408
48930,the,O,2408
48931,treatment,O,2408
48932,plan,O,2408
48933,recommended,O,2408
48934,by,O,2408
48935,an,O,2408
48936,eye,O,2408
48937,doctor,O,2409
48938,to,O,2409
48939,manage,O,2409
48940,the,O,2409
48941,symptoms,O,2409
48942,of,O,2409
48943,white,B-NAME_OF_DISEASE,2409
48944,dot,I-NAME_OF_DISEASE,2409
48945,syndrome,I-NAME_OF_DISEASE,2409
48946,and,O,2409
48947,prevent,O,2409
48948,vision,B-SIGN_AND_SYMPTOM,2409
48949,loss,I-SIGN_AND_SYMPTOM,2409
48950,If,O,2409
48951,symptoms,O,2409
48952,persist,O,2409
48953,or,O,2409
48954,are,O,2409
48955,severe,O,2409
48956,it,O,2409
48957,is,O,2409
48958,important,O,2409
48959,to,O,2409
48960,see,O,2409
48961,a,O,2409
48962,doctor,O,2409
48963,for,O,2409
48964,further,O,2409
48965,evaluation,O,2409
48966,and,O,2409
48967,treatment,O,2409
48968,What,O,2409
48969,is,O,2409
48970,intumescent,B-NAME_OF_DISEASE,2409
48971,cataract,B-NAME_OF_DISEASE,2410
48972,Intumescent,B-NAME_OF_DISEASE,2410
48973,cataracts,I-NAME_OF_DISEASE,2410
48974,are,O,2410
48975,mature,O,2410
48976,or,O,2410
48977,older,O,2410
48978,stages,O,2410
48979,of,O,2410
48980,cataract,B-NAME_OF_DISEASE,2410
48981,This,O,2410
48982,cataract,B-NAME_OF_DISEASE,2410
48983,is,O,2410
48984,the,O,2410
48985,result,O,2410
48986,of,O,2410
48987,degeneration,B-CAUSE_OF_DISEASE,2410
48988,in,I-CAUSE_OF_DISEASE,2411
48989,lens,I-CAUSE_OF_DISEASE,2411
48990,proteins,I-CAUSE_OF_DISEASE,2411
48991,leading,O,2411
48992,to,O,2411
48993,swelling,B-SIGN_AND_SYMPTOM,2411
48994,of,I-SIGN_AND_SYMPTOM,2411
48995,lens,I-SIGN_AND_SYMPTOM,2411
48996,followed,O,2411
48997,by,O,2411
48998,shallow,B-SIGN_AND_SYMPTOM,2411
48999,Anterior,I-SIGN_AND_SYMPTOM,2411
49000,chamber,I-SIGN_AND_SYMPTOM,2411
49001,secondary,I-SIGN_AND_SYMPTOM,2411
49002,angle,I-SIGN_AND_SYMPTOM,2411
49003,closure,I-SIGN_AND_SYMPTOM,2411
49004,glaucoma,I-SIGN_AND_SYMPTOM,2411
49005,and,I-SIGN_AND_SYMPTOM,2411
49006,vision,I-SIGN_AND_SYMPTOM,2412
49007,impairment,I-SIGN_AND_SYMPTOM,2412
49008,What,O,2412
49009,are,O,2412
49010,the,O,2412
49011,causes,O,2412
49012,of,O,2412
49013,intumescent,B-NAME_OF_DISEASE,2412
49014,cataract,B-NAME_OF_DISEASE,2412
49015,Etiology,O,2412
49016,Main,O,2412
49017,Factors,O,2412
49018,leading,O,2412
49019,to,O,2412
49020,the,O,2412
49021,development,O,2413
49022,of,O,2413
49023,Intumescent,B-NAME_OF_DISEASE,2413
49024,Cataract,I-NAME_OF_DISEASE,2413
49025,are,O,2413
49026,-,O,2413
49027,Untreated,B-CAUSE_OF_DISEASE,2413
49028,immature,I-CAUSE_OF_DISEASE,2413
49029,cataracts,I-CAUSE_OF_DISEASE,2413
49030,Exposure,B-CAUSE_OF_DISEASE,2413
49031,to,I-CAUSE_OF_DISEASE,2413
49032,UV,I-CAUSE_OF_DISEASE,2414
49033,rays,I-CAUSE_OF_DISEASE,2414
49034,Heatwaves,B-CAUSE_OF_DISEASE,2414
49035,exposure,I-CAUSE_OF_DISEASE,2414
49036,Infrared,B-CAUSE_OF_DISEASE,2414
49037,light,I-CAUSE_OF_DISEASE,2414
49038,exposure,I-CAUSE_OF_DISEASE,2414
49039,Radiation,B-CAUSE_OF_DISEASE,2414
49040,exposure,I-CAUSE_OF_DISEASE,2414
49041,in,I-CAUSE_OF_DISEASE,2414
49042,eyes,I-CAUSE_OF_DISEASE,2414
49043,over,I-CAUSE_OF_DISEASE,2414
49044,long,I-CAUSE_OF_DISEASE,2414
49045,periods,I-CAUSE_OF_DISEASE,2414
49046,of,I-CAUSE_OF_DISEASE,2414
49047,time,I-CAUSE_OF_DISEASE,2414
49048,Electric,B-CAUSE_OF_DISEASE,2414
49049,Sparks,I-CAUSE_OF_DISEASE,2414
49050,Eye,B-CAUSE_OF_DISEASE,2414
49051,rupture,I-CAUSE_OF_DISEASE,2414
49052,Signs,O,2414
49053,and,O,2414
49054,symptoms,O,2414
49055,of,O,2414
49056,intumescent,B-NAME_OF_DISEASE,2414
49057,cataract,B-NAME_OF_DISEASE,2414
49058,Irritation,B-SIGN_AND_SYMPTOM,2414
49059,or,I-SIGN_AND_SYMPTOM,2414
49060,discomfort,I-SIGN_AND_SYMPTOM,2414
49061,in,I-SIGN_AND_SYMPTOM,2414
49062,eyes,I-SIGN_AND_SYMPTOM,2414
49063,Constant,B-SIGN_AND_SYMPTOM,2414
49064,fatigue,I-SIGN_AND_SYMPTOM,2414
49065,and,I-SIGN_AND_SYMPTOM,2414
49066,strain,I-SIGN_AND_SYMPTOM,2414
49067,in,I-SIGN_AND_SYMPTOM,2414
49068,eyes,I-SIGN_AND_SYMPTOM,2414
49069,Blurred,B-SIGN_AND_SYMPTOM,2414
49070,Vision,I-SIGN_AND_SYMPTOM,2414
49071,due,O,2414
49072,to,O,2414
49073,opacification,O,2414
49074,of,O,2414
49075,lens,O,2414
49076,Diminution,B-SIGN_AND_SYMPTOM,2414
49077,in,I-SIGN_AND_SYMPTOM,2414
49078,visual,I-SIGN_AND_SYMPTOM,2414
49079,acuity,I-SIGN_AND_SYMPTOM,2414
49080,Vision,B-SIGN_AND_SYMPTOM,2414
49081,may,I-SIGN_AND_SYMPTOM,2414
49082,be,I-SIGN_AND_SYMPTOM,2414
49083,reduced,I-SIGN_AND_SYMPTOM,2414
49084,to,O,2414
49085,movement,O,2414
49086,of,O,2414
49087,hands,O,2414
49088,or,O,2414
49089,counting,O,2414
49090,fingers,O,2414
49091,hindering,O,2414
49092,day,O,2414
49093,to,O,2414
49094,day,O,2414
49095,activities,O,2414
49096,of,O,2414
49097,patient,O,2414
49098,Trouble,B-SIGN_AND_SYMPTOM,2414
49099,seeing,I-SIGN_AND_SYMPTOM,2415
49100,in,I-SIGN_AND_SYMPTOM,2415
49101,dim,I-SIGN_AND_SYMPTOM,2415
49102,light,I-SIGN_AND_SYMPTOM,2415
49103,Need,B-SIGN_AND_SYMPTOM,2415
49104,brighter,I-SIGN_AND_SYMPTOM,2415
49105,than,I-SIGN_AND_SYMPTOM,2415
49106,usual,I-SIGN_AND_SYMPTOM,2415
49107,light,I-SIGN_AND_SYMPTOM,2415
49108,for,I-SIGN_AND_SYMPTOM,2415
49109,reading,I-SIGN_AND_SYMPTOM,2415
49110,Holding,B-SIGN_AND_SYMPTOM,2415
49111,objects,I-SIGN_AND_SYMPTOM,2415
49112,closer,I-SIGN_AND_SYMPTOM,2415
49113,to,I-SIGN_AND_SYMPTOM,2415
49114,the,I-SIGN_AND_SYMPTOM,2415
49115,eyes,I-SIGN_AND_SYMPTOM,2415
49116,for,I-SIGN_AND_SYMPTOM,2415
49117,clear,I-SIGN_AND_SYMPTOM,2415
49118,vision,I-SIGN_AND_SYMPTOM,2415
49119,Inability,B-SIGN_AND_SYMPTOM,2415
49120,to,I-SIGN_AND_SYMPTOM,2415
49121,differentiate,I-SIGN_AND_SYMPTOM,2415
49122,colors,I-SIGN_AND_SYMPTOM,2416
49123,Double,B-SIGN_AND_SYMPTOM,2416
49124,vision,I-SIGN_AND_SYMPTOM,2416
49125,Frequent,B-SIGN_AND_SYMPTOM,2416
49126,changes,I-SIGN_AND_SYMPTOM,2416
49127,of,I-SIGN_AND_SYMPTOM,2416
49128,eye,I-SIGN_AND_SYMPTOM,2416
49129,glasses,I-SIGN_AND_SYMPTOM,2416
49130,Managing,O,2416
49131,intumescent,B-NAME_OF_DISEASE,2416
49132,cataract,B-NAME_OF_DISEASE,2416
49133,Diagnosis,O,2416
49134,The,B-DIAGNOSTIC_TEST,2416
49135,Image,I-DIAGNOSTIC_TEST,2416
49136,Test,I-DIAGNOSTIC_TEST,2416
49137,is,O,2416
49138,used,O,2416
49139,for,O,2416
49140,sure,O,2416
49141,diagnosis,O,2416
49142,of,O,2416
49143,intumescent,B-NAME_OF_DISEASE,2417
49144,cataract,B-NAME_OF_DISEASE,2417
49145,Slit,B-DIAGNOSTIC_TEST,2417
49146,lamp,I-DIAGNOSTIC_TEST,2417
49147,bio-microscopy,I-DIAGNOSTIC_TEST,2417
49148,shows,O,2417
49149,an,B-SIGN_AND_SYMPTOM,2417
49150,opaque,I-SIGN_AND_SYMPTOM,2417
49151,white,I-SIGN_AND_SYMPTOM,2417
49152,lens,I-SIGN_AND_SYMPTOM,2417
49153,with,I-SIGN_AND_SYMPTOM,2417
49154,a,I-SIGN_AND_SYMPTOM,2417
49155,rigid,I-SIGN_AND_SYMPTOM,2417
49156,and,I-SIGN_AND_SYMPTOM,2417
49157,inflexible,I-SIGN_AND_SYMPTOM,2417
49158,anterior,I-SIGN_AND_SYMPTOM,2417
49159,capsule,I-SIGN_AND_SYMPTOM,2417
49160,Anterior,B-DIAGNOSTIC_TEST,2417
49161,segment,I-DIAGNOSTIC_TEST,2417
49162,optical,I-DIAGNOSTIC_TEST,2417
49163,coherence,I-DIAGNOSTIC_TEST,2417
49164,tomography,I-DIAGNOSTIC_TEST,2417
49165,revealing,O,2417
49166,a,O,2417
49167,lens,O,2417
49168,thickness,O,2417
49169,of,O,2417
49170,5.3,O,2417
49171,mm,O,2417
49172,or,O,2417
49173,more,O,2417
49174,Intumescent,B-NAME_OF_DISEASE,2417
49175,cataracts,I-NAME_OF_DISEASE,2417
49176,resulting,O,2417
49177,from,O,2418
49178,trauma,O,2418
49179,show,O,2418
49180,a,B-SIGN_AND_SYMPTOM,2418
49181,capsule,I-SIGN_AND_SYMPTOM,2418
49182,break,I-SIGN_AND_SYMPTOM,2418
49183,and,I-SIGN_AND_SYMPTOM,2418
49184,pigment,I-SIGN_AND_SYMPTOM,2418
49185,residues,I-SIGN_AND_SYMPTOM,2418
49186,on,I-SIGN_AND_SYMPTOM,2418
49187,the,I-SIGN_AND_SYMPTOM,2418
49188,anterior,I-SIGN_AND_SYMPTOM,2418
49189,lens,I-SIGN_AND_SYMPTOM,2418
49190,capsule,I-SIGN_AND_SYMPTOM,2418
49191,Scheimpflug,B-DIAGNOSTIC_TEST,2418
49192,densitometry,I-DIAGNOSTIC_TEST,2419
49193,is,O,2419
49194,utilized,O,2419
49195,to,O,2419
49196,measure,O,2419
49197,the,B-SIGN_AND_SYMPTOM,2419
49198,opacity,I-SIGN_AND_SYMPTOM,2419
49199,of,I-SIGN_AND_SYMPTOM,2419
49200,the,I-SIGN_AND_SYMPTOM,2419
49201,lens,I-SIGN_AND_SYMPTOM,2419
49202,high,I-SIGN_AND_SYMPTOM,2419
49203,density,I-SIGN_AND_SYMPTOM,2419
49204,means,I-SIGN_AND_SYMPTOM,2419
49205,a,I-SIGN_AND_SYMPTOM,2419
49206,large,I-SIGN_AND_SYMPTOM,2419
49207,nucleus,I-SIGN_AND_SYMPTOM,2419
49208,more,O,2419
49209,likely,O,2419
49210,to,O,2419
49211,be,O,2419
49212,intumescent,B-NAME_OF_DISEASE,2419
49213,cataract,B-NAME_OF_DISEASE,2420
49214,Physical,O,2420
49215,Examination,O,2420
49216,During,O,2420
49217,the,O,2420
49218,course,O,2420
49219,of,O,2420
49220,cataract,B-NAME_OF_DISEASE,2420
49221,development,O,2420
49222,Intumescent,B-NAME_OF_DISEASE,2420
49223,cataract,I-NAME_OF_DISEASE,2420
49224,lies,O,2420
49225,between,O,2420
49226,immature,B-NAME_OF_DISEASE,2420
49227,cortical,I-NAME_OF_DISEASE,2420
49228,and,I-NAME_OF_DISEASE,2420
49229,mature,I-NAME_OF_DISEASE,2420
49230,corticonuclear,I-NAME_OF_DISEASE,2420
49231,cataract,I-NAME_OF_DISEASE,2420
49232,stages,I-NAME_OF_DISEASE,2420
49233,Intumescent,B-NAME_OF_DISEASE,2420
49234,cataract,I-NAME_OF_DISEASE,2420
49235,is,O,2420
49236,however,O,2420
49237,somewhat,O,2420
49238,a,O,2421
49239,later,O,2421
49240,stage,O,2421
49241,of,O,2421
49242,cataract,B-NAME_OF_DISEASE,2421
49243,It,O,2421
49244,appears,O,2421
49245,clinically,O,2421
49246,as,O,2421
49247,a,B-SIGN_AND_SYMPTOM,2421
49248,white,I-SIGN_AND_SYMPTOM,2421
49249,crystalline,I-SIGN_AND_SYMPTOM,2421
49250,opacity,I-SIGN_AND_SYMPTOM,2421
49251,in,I-SIGN_AND_SYMPTOM,2421
49252,the,I-SIGN_AND_SYMPTOM,2421
49253,lens,I-SIGN_AND_SYMPTOM,2421
49254,cortex,I-SIGN_AND_SYMPTOM,2421
49255,In,O,2421
49256,intumescent,B-NAME_OF_DISEASE,2421
49257,cataract,B-NAME_OF_DISEASE,2421
49258,there,O,2421
49259,are,O,2421
49260,prominent,B-SIGN_AND_SYMPTOM,2421
49261,sectoral,I-SIGN_AND_SYMPTOM,2421
49262,markings,I-SIGN_AND_SYMPTOM,2421
49263,present,I-SIGN_AND_SYMPTOM,2421
49264,in,I-SIGN_AND_SYMPTOM,2422
49265,the,I-SIGN_AND_SYMPTOM,2422
49266,anterior,I-SIGN_AND_SYMPTOM,2422
49267,cortex,I-SIGN_AND_SYMPTOM,2422
49268,Effective,O,2422
49269,treatments,O,2422
49270,The,O,2422
49271,only,O,2422
49272,choice,O,2422
49273,is,O,2422
49274,surgery,B-TREATMENT,2422
49275,for,I-TREATMENT,2422
49276,the,I-TREATMENT,2423
49277,removal,I-TREATMENT,2423
49278,of,I-TREATMENT,2423
49279,the,I-TREATMENT,2423
49280,opacified,I-TREATMENT,2423
49281,lens,I-TREATMENT,2423
49282,this,O,2423
49283,process,O,2423
49284,is,O,2423
49285,known,O,2423
49286,as,O,2423
49287,lens,B-TREATMENT,2423
49288,extraction,I-TREATMENT,2423
49289,or,O,2423
49290,cataract,B-TREATMENT,2423
49291,removal,I-TREATMENT,2423
49292,Intracapsular,B-TREATMENT,2423
49293,extraction,I-TREATMENT,2423
49294,with,O,2424
49295,emulsification,B-TREATMENT,2424
49296,and,I-TREATMENT,2424
49297,aspiration,I-TREATMENT,2424
49298,of,I-TREATMENT,2424
49299,nucleus,I-TREATMENT,2424
49300,In,O,2424
49301,Intracapsular,B-TREATMENT,2424
49302,extraction,I-TREATMENT,2424
49303,lens,O,2424
49304,is,O,2424
49305,removed,O,2424
49306,along,O,2424
49307,with,O,2424
49308,its,O,2424
49309,capsule,O,2424
49310,Emulsification,B-TREATMENT,2424
49311,and,I-TREATMENT,2424
49312,aspiration,I-TREATMENT,2424
49313,are,O,2424
49314,used,O,2424
49315,to,O,2424
49316,remove,O,2424
49317,the,O,2424
49318,ruptured,O,2425
49319,inner,O,2425
49320,part,O,2425
49321,of,O,2425
49322,lens,O,2425
49323,Recently,O,2425
49324,the,O,2425
49325,removed,O,2425
49326,cataract,B-NAME_OF_DISEASE,2425
49327,is,O,2425
49328,replaced,O,2425
49329,by,O,2425
49330,a,B-TREATMENT,2425
49331,plastic,I-TREATMENT,2425
49332,intraocular,I-TREATMENT,2425
49333,lens,I-TREATMENT,2425
49334,In,O,2425
49335,this,O,2425
49336,scenario,O,2425
49337,the,B-PART_OF_THE_EYES,2425
49338,inner,I-PART_OF_THE_EYES,2425
49339,parts,I-PART_OF_THE_EYES,2425
49340,of,I-PART_OF_THE_EYES,2425
49341,the,I-PART_OF_THE_EYES,2426
49342,lens,I-PART_OF_THE_EYES,2426
49343,are,O,2426
49344,taken,O,2426
49345,out,O,2426
49346,leaving,O,2426
49347,the,B-PART_OF_THE_EYES,2426
49348,capsule,I-PART_OF_THE_EYES,2426
49349,intact,I-PART_OF_THE_EYES,2426
49350,and,O,2426
49351,the,O,2426
49352,intraocular,O,2426
49353,lens,O,2426
49354,is,O,2426
49355,placed,O,2426
49356,inside,O,2426
49357,the,B-PART_OF_THE_EYES,2426
49358,capsular,I-PART_OF_THE_EYES,2426
49359,bag,I-PART_OF_THE_EYES,2426
49360,How,O,2426
49361,to,O,2426
49362,prevent,O,2426
49363,intumescent,B-NAME_OF_DISEASE,2426
49364,cataract,B-NAME_OF_DISEASE,2426
49365,Getting,B-PREVENTION,2426
49366,immature,I-PREVENTION,2426
49367,and,I-PREVENTION,2426
49368,untreated,I-PREVENTION,2426
49369,cataract,I-PREVENTION,2426
49370,surgically,I-PREVENTION,2427
49371,removed,I-PREVENTION,2427
49372,before,I-PREVENTION,2427
49373,it,I-PREVENTION,2427
49374,reaches,I-PREVENTION,2427
49375,a,I-PREVENTION,2427
49376,mature,I-PREVENTION,2427
49377,age,I-PREVENTION,2427
49378,Intumescent,B-NAME_OF_DISEASE,2427
49379,Cataract,I-NAME_OF_DISEASE,2427
49380,is,O,2427
49381,chiefly,O,2427
49382,due,O,2427
49383,to,O,2427
49384,the,B-CAUSE_OF_DISEASE,2427
49385,inappropriate,I-CAUSE_OF_DISEASE,2427
49386,hydration,I-CAUSE_OF_DISEASE,2427
49387,of,I-CAUSE_OF_DISEASE,2427
49388,the,I-CAUSE_OF_DISEASE,2427
49389,lens,I-CAUSE_OF_DISEASE,2427
49390,leading,O,2427
49391,to,O,2427
49392,swelling,B-SIGN_AND_SYMPTOM,2427
49393,in,O,2427
49394,it,O,2427
49395,Factors,O,2427
49396,which,O,2427
49397,may,O,2427
49398,lead,O,2427
49399,to,O,2428
49400,it,O,2428
49401,must,O,2428
49402,be,O,2428
49403,kept,O,2428
49404,under,O,2428
49405,a,O,2428
49406,strict,O,2428
49407,surveillance,O,2428
49408,as,O,2428
49409,an,O,2428
49410,example,O,2428
49411,Diabetes,B-NAME_OF_DISEASE,2428
49412,Mellitus,I-NAME_OF_DISEASE,2428
49413,Abstinence,B-PREVENTION,2428
49414,from,I-PREVENTION,2428
49415,exposure,I-PREVENTION,2428
49416,of,I-PREVENTION,2428
49417,heat,I-PREVENTION,2428
49418,and,I-PREVENTION,2428
49419,other,I-PREVENTION,2428
49420,radiations,I-PREVENTION,2428
49421,for,I-PREVENTION,2428
49422,longer,I-PREVENTION,2428
49423,periods,I-PREVENTION,2428
49424,of,I-PREVENTION,2428
49425,time,I-PREVENTION,2428
49426,to,O,2428
49427,decrease,O,2428
49428,irritability,O,2428
49429,in,O,2428
49430,the,O,2429
49431,eye,O,2429
49432,Using,B-PREVENTION,2429
49433,glasses,I-PREVENTION,2429
49434,and,I-PREVENTION,2429
49435,eye,I-PREVENTION,2429
49436,shields,I-PREVENTION,2429
49437,while,I-PREVENTION,2429
49438,being,I-PREVENTION,2429
49439,exposed,I-PREVENTION,2429
49440,to,I-PREVENTION,2429
49441,sun,I-PREVENTION,2429
49442,This,O,2429
49443,will,O,2429
49444,diminish,O,2429
49445,the,O,2430
49446,effect,O,2430
49447,of,O,2430
49448,heat,O,2430
49449,directly,O,2430
49450,on,O,2430
49451,eyes,O,2430
49452,Prevention,B-PREVENTION,2430
49453,of,I-PREVENTION,2430
49454,eye,I-PREVENTION,2430
49455,trauma,I-PREVENTION,2430
49456,by,I-PREVENTION,2430
49457,using,I-PREVENTION,2430
49458,eye,I-PREVENTION,2430
49459,wear,I-PREVENTION,2430
49460,protection,I-PREVENTION,2430
49461,for,I-PREVENTION,2430
49462,UV,I-PREVENTION,2430
49463,and,I-PREVENTION,2430
49464,infra-red,I-PREVENTION,2430
49465,radiation,I-PREVENTION,2430
49466,Toxic,B-NAME_OF_DISEASE,2430
49467,Anterior,I-NAME_OF_DISEASE,2430
49468,Segment,I-NAME_OF_DISEASE,2430
49469,Syndrome,I-NAME_OF_DISEASE,2430
49470,TASS,B-NAME_OF_DISEASE,2430
49471,is,O,2430
49472,a,O,2430
49473,rare,O,2430
49474,but,O,2430
49475,serious,O,2430
49476,complication,O,2430
49477,that,O,2430
49478,can,O,2430
49479,occur,O,2430
49480,after,O,2430
49481,ocular,O,2430
49482,surgery,O,2430
49483,It,O,2430
49484,is,O,2430
49485,characterized,O,2430
49486,by,O,2430
49487,inflammation,B-SIGN_AND_SYMPTOM,2430
49488,and,I-SIGN_AND_SYMPTOM,2430
49489,damage,I-SIGN_AND_SYMPTOM,2430
49490,to,I-SIGN_AND_SYMPTOM,2430
49491,the,I-SIGN_AND_SYMPTOM,2430
49492,front,I-SIGN_AND_SYMPTOM,2430
49493,part,I-SIGN_AND_SYMPTOM,2430
49494,of,I-SIGN_AND_SYMPTOM,2430
49495,the,I-SIGN_AND_SYMPTOM,2430
49496,eye,I-SIGN_AND_SYMPTOM,2430
49497,the,I-SIGN_AND_SYMPTOM,2430
49498,anterior,I-SIGN_AND_SYMPTOM,2430
49499,segment,I-SIGN_AND_SYMPTOM,2430
49500,which,O,2430
49501,includes,O,2430
49502,the,O,2430
49503,cornea,B-PART_OF_THE_EYES,2430
49504,iris,B-PART_OF_THE_EYES,2430
49505,and,O,2430
49506,lens,B-PART_OF_THE_EYES,2430
49507,In,O,2430
49508,this,O,2430
49509,article,O,2430
49510,we,O,2430
49511,will,O,2430
49512,focus,O,2430
49513,on,O,2430
49514,the,O,2430
49515,symptoms,O,2430
49516,of,O,2430
49517,TASS,B-NAME_OF_DISEASE,2430
49518,and,O,2430
49519,how,O,2430
49520,to,O,2430
49521,recognize,O,2430
49522,them,O,2430
49523,Symptoms,O,2430
49524,of,O,2430
49525,TASS,B-NAME_OF_DISEASE,2430
49526,The,O,2430
49527,symptoms,O,2431
49528,of,O,2431
49529,TASS,B-NAME_OF_DISEASE,2431
49530,usually,O,2431
49531,appear,O,2431
49532,within,B-TIME_DURATION,2431
49533,a,I-TIME_DURATION,2431
49534,few,I-TIME_DURATION,2431
49535,days,I-TIME_DURATION,2431
49536,of,O,2431
49537,surgery,O,2431
49538,and,O,2431
49539,may,O,2431
49540,include,O,2431
49541,Inflammation,B-SIGN_AND_SYMPTOM,2432
49542,and,I-SIGN_AND_SYMPTOM,2432
49543,swelling,I-SIGN_AND_SYMPTOM,2432
49544,of,I-SIGN_AND_SYMPTOM,2432
49545,the,I-SIGN_AND_SYMPTOM,2432
49546,eye,I-SIGN_AND_SYMPTOM,2432
49547,This,O,2432
49548,may,O,2432
49549,cause,O,2432
49550,the,B-SIGN_AND_SYMPTOM,2432
49551,eye,I-SIGN_AND_SYMPTOM,2432
49552,to,I-SIGN_AND_SYMPTOM,2432
49553,appear,I-SIGN_AND_SYMPTOM,2432
49554,red,I-SIGN_AND_SYMPTOM,2432
49555,and,I-SIGN_AND_SYMPTOM,2432
49556,swollen,I-SIGN_AND_SYMPTOM,2432
49557,Redness,B-SIGN_AND_SYMPTOM,2432
49558,and,I-SIGN_AND_SYMPTOM,2432
49559,pain,I-SIGN_AND_SYMPTOM,2432
49560,in,I-SIGN_AND_SYMPTOM,2432
49561,the,I-SIGN_AND_SYMPTOM,2432
49562,eye,I-SIGN_AND_SYMPTOM,2432
49563,TASS,B-NAME_OF_DISEASE,2432
49564,can,O,2432
49565,cause,O,2432
49566,significant,B-SIGN_AND_SYMPTOM,2433
49567,discomfort,I-SIGN_AND_SYMPTOM,2433
49568,and,I-SIGN_AND_SYMPTOM,2433
49569,pain,I-SIGN_AND_SYMPTOM,2433
49570,in,I-SIGN_AND_SYMPTOM,2433
49571,the,I-SIGN_AND_SYMPTOM,2433
49572,affected,I-SIGN_AND_SYMPTOM,2433
49573,eye,I-SIGN_AND_SYMPTOM,2433
49574,Decreased,B-SIGN_AND_SYMPTOM,2433
49575,vision,I-SIGN_AND_SYMPTOM,2433
49576,TASS,B-NAME_OF_DISEASE,2433
49577,may,O,2434
49578,cause,O,2434
49579,a,B-SIGN_AND_SYMPTOM,2434
49580,decrease,I-SIGN_AND_SYMPTOM,2434
49581,in,I-SIGN_AND_SYMPTOM,2434
49582,vision,I-SIGN_AND_SYMPTOM,2434
49583,due,O,2434
49584,to,O,2434
49585,the,B-CAUSE_OF_DISEASE,2434
49586,inflammation,I-CAUSE_OF_DISEASE,2434
49587,and,I-CAUSE_OF_DISEASE,2434
49588,damage,I-CAUSE_OF_DISEASE,2434
49589,to,I-CAUSE_OF_DISEASE,2434
49590,the,I-CAUSE_OF_DISEASE,2434
49591,eye,I-CAUSE_OF_DISEASE,2434
49592,Discharge,B-SIGN_AND_SYMPTOM,2434
49593,from,I-SIGN_AND_SYMPTOM,2434
49594,the,I-SIGN_AND_SYMPTOM,2434
49595,eye,I-SIGN_AND_SYMPTOM,2434
49596,TASS,B-NAME_OF_DISEASE,2434
49597,may,O,2434
49598,cause,O,2434
49599,a,B-SIGN_AND_SYMPTOM,2434
49600,watery,I-SIGN_AND_SYMPTOM,2434
49601,or,I-SIGN_AND_SYMPTOM,2434
49602,purulent,I-SIGN_AND_SYMPTOM,2434
49603,discharge,I-SIGN_AND_SYMPTOM,2434
49604,from,I-SIGN_AND_SYMPTOM,2434
49605,the,I-SIGN_AND_SYMPTOM,2434
49606,eye,I-SIGN_AND_SYMPTOM,2434
49607,The,O,2434
49608,severity,O,2434
49609,of,O,2435
49610,symptoms,O,2435
49611,can,O,2435
49612,vary,O,2435
49613,widely,O,2435
49614,from,O,2435
49615,mild,O,2435
49616,to,O,2435
49617,severe,O,2435
49618,What,O,2435
49619,Causes,O,2435
49620,TASS,B-NAME_OF_DISEASE,2435
49621,Contamination,B-CAUSE_OF_DISEASE,2435
49622,of,I-CAUSE_OF_DISEASE,2435
49623,the,I-CAUSE_OF_DISEASE,2435
49624,eye,I-CAUSE_OF_DISEASE,2435
49625,or,I-CAUSE_OF_DISEASE,2435
49626,surgical,I-CAUSE_OF_DISEASE,2435
49627,instruments,I-CAUSE_OF_DISEASE,2435
49628,during,I-CAUSE_OF_DISEASE,2435
49629,surgery,I-CAUSE_OF_DISEASE,2435
49630,Poor,B-CAUSE_OF_DISEASE,2435
49631,hygiene,I-CAUSE_OF_DISEASE,2435
49632,or,I-CAUSE_OF_DISEASE,2435
49633,infection,I-CAUSE_OF_DISEASE,2435
49634,control,I-CAUSE_OF_DISEASE,2435
49635,practices,I-CAUSE_OF_DISEASE,2435
49636,during,I-CAUSE_OF_DISEASE,2435
49637,surgery,I-CAUSE_OF_DISEASE,2435
49638,A,B-CAUSE_OF_DISEASE,2435
49639,pre-existing,I-CAUSE_OF_DISEASE,2435
49640,eye,I-CAUSE_OF_DISEASE,2435
49641,infection,I-CAUSE_OF_DISEASE,2435
49642,that,I-CAUSE_OF_DISEASE,2435
49643,is,I-CAUSE_OF_DISEASE,2435
49644,not,I-CAUSE_OF_DISEASE,2435
49645,properly,I-CAUSE_OF_DISEASE,2435
49646,treated,I-CAUSE_OF_DISEASE,2435
49647,before,I-CAUSE_OF_DISEASE,2435
49648,surgery,I-CAUSE_OF_DISEASE,2435
49649,Use,B-CAUSE_OF_DISEASE,2435
49650,of,I-CAUSE_OF_DISEASE,2435
49651,contaminated,I-CAUSE_OF_DISEASE,2435
49652,solutions,I-CAUSE_OF_DISEASE,2436
49653,or,I-CAUSE_OF_DISEASE,2436
49654,medications,I-CAUSE_OF_DISEASE,2436
49655,during,I-CAUSE_OF_DISEASE,2436
49656,surgery,I-CAUSE_OF_DISEASE,2436
49657,Allergic,B-CAUSE_OF_DISEASE,2436
49658,reactions,I-CAUSE_OF_DISEASE,2436
49659,to,I-CAUSE_OF_DISEASE,2436
49660,medications,I-CAUSE_OF_DISEASE,2436
49661,or,I-CAUSE_OF_DISEASE,2436
49662,solutions,I-CAUSE_OF_DISEASE,2436
49663,used,I-CAUSE_OF_DISEASE,2436
49664,during,I-CAUSE_OF_DISEASE,2436
49665,surgery,I-CAUSE_OF_DISEASE,2436
49666,Managing,O,2436
49667,TASS,B-NAME_OF_DISEASE,2436
49668,Treatment,O,2436
49669,for,O,2436
49670,TASS,B-NAME_OF_DISEASE,2436
49671,typically,O,2436
49672,involves,O,2436
49673,medications,O,2436
49674,to,O,2436
49675,reduce,O,2436
49676,inflammation,B-SIGN_AND_SYMPTOM,2436
49677,and,I-SIGN_AND_SYMPTOM,2436
49678,swelling,I-SIGN_AND_SYMPTOM,2436
49679,such,O,2436
49680,as,O,2436
49681,topical,B-NAME_OF_DRUG,2436
49682,or,I-NAME_OF_DRUG,2436
49683,oral,I-NAME_OF_DRUG,2436
49684,corticosteroids,I-NAME_OF_DRUG,2436
49685,Other,O,2436
49686,medications,O,2436
49687,such,O,2436
49688,as,O,2436
49689,nonsteroidal,B-NAME_OF_DRUG,2436
49690,anti-inflammatory,I-NAME_OF_DRUG,2436
49691,drugs,I-NAME_OF_DRUG,2436
49692,NSAIDs,I-NAME_OF_DRUG,2436
49693,and,O,2437
49694,antibiotic,B-NAME_OF_DRUG,2437
49695,eye,I-NAME_OF_DRUG,2437
49696,drops,I-NAME_OF_DRUG,2437
49697,may,O,2437
49698,also,O,2437
49699,be,O,2437
49700,used,O,2437
49701,to,O,2437
49702,help,O,2437
49703,manage,O,2437
49704,pain,O,2437
49705,and,O,2437
49706,prevent,O,2437
49707,infection,O,2437
49708,In,O,2437
49709,severe,O,2437
49710,cases,O,2437
49711,additional,B-TREATMENT,2437
49712,surgery,I-TREATMENT,2437
49713,may,O,2438
49714,be,O,2438
49715,necessary,O,2438
49716,to,O,2438
49717,remove,O,2438
49718,any,O,2438
49719,debris,O,2438
49720,or,O,2439
49721,foreign,O,2439
49722,bodies,O,2439
49723,that,O,2439
49724,may,O,2439
49725,be,O,2439
49726,causing,O,2439
49727,the,O,2439
49728,inflammation,O,2439
49729,How,O,2439
49730,Can,O,2439
49731,TASS,B-NAME_OF_DISEASE,2439
49732,Be,O,2439
49733,Prevented,O,2439
49734,There,O,2439
49735,are,O,2439
49736,several,O,2439
49737,ways,O,2439
49738,to,O,2439
49739,help,O,2439
49740,prevent,O,2440
49741,TASS,B-NAME_OF_DISEASE,2440
49742,Use,B-PREVENTION,2440
49743,sterile,I-PREVENTION,2440
49744,technique,I-PREVENTION,2440
49745,during,I-PREVENTION,2440
49746,surgery,I-PREVENTION,2440
49747,To,O,2440
49748,reduce,O,2440
49749,the,O,2440
49750,risk,O,2440
49751,of,O,2440
49752,infection,O,2440
49753,it,O,2440
49754,is,O,2440
49755,important,O,2440
49756,to,O,2440
49757,use,B-PREVENTION,2440
49758,sterile,I-PREVENTION,2440
49759,technique,I-PREVENTION,2440
49760,during,I-PREVENTION,2440
49761,eye,I-PREVENTION,2440
49762,surgery,I-PREVENTION,2440
49763,This,O,2441
49764,includes,O,2442
49765,wearing,B-PREVENTION,2442
49766,sterile,I-PREVENTION,2442
49767,gloves,I-PREVENTION,2442
49768,using,I-PREVENTION,2442
49769,sterile,I-PREVENTION,2442
49770,instruments,I-PREVENTION,2443
49771,and,I-PREVENTION,2443
49772,solutions,I-PREVENTION,2444
49773,and,I-PREVENTION,2444
49774,properly,I-PREVENTION,2444
49775,sterilizing,I-PREVENTION,2444
49776,all,I-PREVENTION,2444
49777,equipment,I-PREVENTION,2444
49778,Choose,B-PREVENTION,2444
49779,a,I-PREVENTION,2444
49780,qualified,I-PREVENTION,2444
49781,and,I-PREVENTION,2444
49782,experienced,I-PREVENTION,2444
49783,surgeon,I-PREVENTION,2444
49784,It,O,2444
49785,is,O,2444
49786,important,O,2444
49787,to,O,2444
49788,choose,B-PREVENTION,2444
49789,a,I-PREVENTION,2444
49790,qualified,I-PREVENTION,2444
49791,and,I-PREVENTION,2444
49792,experienced,I-PREVENTION,2444
49793,surgeon,I-PREVENTION,2444
49794,to,I-PREVENTION,2444
49795,perform,I-PREVENTION,2445
49796,your,I-PREVENTION,2445
49797,eye,I-PREVENTION,2445
49798,surgery,I-PREVENTION,2445
49799,Surgeons,O,2445
49800,who,O,2445
49801,are,O,2445
49802,well-trained,O,2445
49803,and,O,2445
49804,have,O,2445
49805,experience,O,2445
49806,with,O,2445
49807,the,O,2445
49808,specific,O,2445
49809,procedure,O,2445
49810,you,O,2445
49811,are,O,2445
49812,undergoing,O,2445
49813,are,O,2445
49814,less,O,2445
49815,likely,O,2445
49816,to,O,2445
49817,make,O,2445
49818,mistakes,O,2445
49819,that,O,2445
49820,could,O,2445
49821,lead,O,2445
49822,to,O,2445
49823,complications,O,2445
49824,Follow,B-PREVENTION,2445
49825,post-operative,I-PREVENTION,2445
49826,instructions,I-PREVENTION,2445
49827,After,O,2445
49828,eye,O,2445
49829,surgery,O,2445
49830,it,O,2446
49831,is,O,2446
49832,important,O,2446
49833,to,O,2446
49834,follow,B-PREVENTION,2446
49835,your,I-PREVENTION,2446
49836,surgeon,I-PREVENTION,2446
49837,s,I-PREVENTION,2446
49838,instructions,I-PREVENTION,2446
49839,for,I-PREVENTION,2446
49840,post-operative,I-PREVENTION,2446
49841,care,I-PREVENTION,2446
49842,including,I-PREVENTION,2446
49843,taking,I-PREVENTION,2446
49844,prescribed,I-PREVENTION,2447
49845,medications,I-PREVENTION,2447
49846,and,I-PREVENTION,2447
49847,attending,I-PREVENTION,2447
49848,follow-up,I-PREVENTION,2447
49849,visits,I-PREVENTION,2447
49850,This,O,2447
49851,can,O,2447
49852,help,O,2447
49853,to,O,2447
49854,prevent,O,2447
49855,complications,O,2447
49856,and,O,2447
49857,ensure,O,2447
49858,the,O,2447
49859,best,O,2447
49860,possible,O,2447
49861,outcome,O,2447
49862,Avoid,B-PREVENTION,2447
49863,rubbing,I-PREVENTION,2447
49864,your,I-PREVENTION,2447
49865,eyes,I-PREVENTION,2447
49866,Rubbing,B-CAUSE_OF_DISEASE,2447
49867,your,I-CAUSE_OF_DISEASE,2447
49868,eyes,I-CAUSE_OF_DISEASE,2447
49869,after,I-CAUSE_OF_DISEASE,2447
49870,surgery,I-CAUSE_OF_DISEASE,2448
49871,can,O,2448
49872,increase,O,2448
49873,the,O,2448
49874,risk,O,2448
49875,of,O,2448
49876,infection,O,2448
49877,and,O,2448
49878,other,O,2448
49879,complications,O,2448
49880,It,O,2448
49881,is,O,2448
49882,important,O,2448
49883,to,O,2448
49884,resist,O,2448
49885,the,O,2448
49886,temptation,O,2448
49887,to,O,2448
49888,rub,O,2448
49889,your,O,2448
49890,eyes,O,2448
49891,and,O,2448
49892,follow,O,2448
49893,your,O,2448
49894,surgeon,O,2448
49895,s,O,2448
49896,instructions,O,2449
49897,for,O,2449
49898,caring,O,2449
49899,for,O,2449
49900,your,O,2449
49901,eyes,O,2449
49902,after,O,2449
49903,surgery,O,2449
49904,Use,B-PREVENTION,2449
49905,caution,I-PREVENTION,2449
49906,when,I-PREVENTION,2449
49907,using,I-PREVENTION,2449
49908,contact,I-PREVENTION,2449
49909,lenses,I-PREVENTION,2449
49910,If,O,2449
49911,you,O,2449
49912,wear,O,2449
49913,contact,O,2449
49914,lenses,O,2449
49915,it,O,2450
49916,is,O,2450
49917,important,O,2450
49918,to,O,2450
49919,be,O,2450
49920,cautious,O,2450
49921,when,O,2450
49922,using,O,2450
49923,them,O,2450
49924,after,O,2450
49925,eye,O,2450
49926,surgery,O,2450
49927,Follow,O,2450
49928,your,O,2450
49929,surgeon,O,2450
49930,s,O,2450
49931,instructions,O,2450
49932,for,O,2450
49933,when,O,2451
49934,it,O,2451
49935,is,O,2451
49936,safe,O,2451
49937,to,O,2451
49938,resume,O,2451
49939,wearing,O,2451
49940,them,O,2451
49941,and,O,2451
49942,be,O,2451
49943,sure,O,2451
49944,to,O,2451
49945,properly,O,2451
49946,clean,O,2451
49947,and,O,2451
49948,disinfect,O,2451
49949,them,O,2451
49950,to,O,2451
49951,reduce,O,2451
49952,the,O,2451
49953,risk,O,2451
49954,of,O,2451
49955,infection,O,2451
49956,What,O,2451
49957,Is,O,2451
49958,Salzmann,B-NAME_OF_DISEASE,2451
49959,s,I-NAME_OF_DISEASE,2451
49960,Nodular,I-NAME_OF_DISEASE,2451
49961,Degeneration,I-NAME_OF_DISEASE,2451
49962,Salzmann,B-NAME_OF_DISEASE,2451
49963,Nodular,I-NAME_OF_DISEASE,2451
49964,degeneration,I-NAME_OF_DISEASE,2451
49965,is,O,2451
49966,an,O,2451
49967,asymmetric,O,2451
49968,noninflammatory,O,2451
49969,and,O,2451
49970,slowly,O,2451
49971,progressive,O,2451
49972,condition,O,2451
49973,associated,O,2451
49974,with,O,2451
49975,the,B-SIGN_AND_SYMPTOM,2451
49976,formation,I-SIGN_AND_SYMPTOM,2451
49977,of,I-SIGN_AND_SYMPTOM,2451
49978,fibrous,I-SIGN_AND_SYMPTOM,2451
49979,outgrowths,I-SIGN_AND_SYMPTOM,2451
49980,in,I-SIGN_AND_SYMPTOM,2451
49981,any,I-SIGN_AND_SYMPTOM,2451
49982,part,I-SIGN_AND_SYMPTOM,2451
49983,of,I-SIGN_AND_SYMPTOM,2451
49984,cornea,B-PART_OF_THE_EYES,2451
49985,It,O,2451
49986,is,O,2451
49987,usually,O,2451
49988,secondary,O,2451
49989,to,O,2451
49990,phlyctenular,B-NAME_OF_DISEASE,2451
49991,or,I-NAME_OF_DISEASE,2451
49992,trachomatous,I-NAME_OF_DISEASE,2451
49993,keratitis,I-NAME_OF_DISEASE,2451
49994,it,O,2451
49995,appears,O,2451
49996,as,O,2451
49997,3-Jan,B-SIGN_AND_SYMPTOM,2451
49998,mm,I-SIGN_AND_SYMPTOM,2451
49999,gray-white,I-SIGN_AND_SYMPTOM,2451
50000,to,I-SIGN_AND_SYMPTOM,2451
50001,bluish,I-SIGN_AND_SYMPTOM,2451
50002,nodules,I-SIGN_AND_SYMPTOM,2451
50003,beneath,I-SIGN_AND_SYMPTOM,2451
50004,the,I-SIGN_AND_SYMPTOM,2451
50005,cornea,B-PART_OF_THE_EYES,2451
50006,epithelium,I-SIGN_AND_SYMPTOM,2451
50007,or,I-SIGN_AND_SYMPTOM,2451
50008,anterior,I-SIGN_AND_SYMPTOM,2451
50009,to,I-SIGN_AND_SYMPTOM,2451
50010,Bowman,I-SIGN_AND_SYMPTOM,2451
50011,s,I-SIGN_AND_SYMPTOM,2451
50012,layer,I-SIGN_AND_SYMPTOM,2451
50013,of,I-SIGN_AND_SYMPTOM,2451
50014,the,I-SIGN_AND_SYMPTOM,2451
50015,cornea,B-PART_OF_THE_EYES,2451
50016,These,O,2451
50017,raised,O,2451
50018,nodules,B-SIGN_AND_SYMPTOM,2451
50019,may,I-SIGN_AND_SYMPTOM,2451
50020,be,I-SIGN_AND_SYMPTOM,2451
50021,found,I-SIGN_AND_SYMPTOM,2451
50022,in,I-SIGN_AND_SYMPTOM,2451
50023,the,I-SIGN_AND_SYMPTOM,2451
50024,mid-peripheral,I-SIGN_AND_SYMPTOM,2451
50025,cornea,B-PART_OF_THE_EYES,2451
50026,or,I-SIGN_AND_SYMPTOM,2451
50027,close,I-SIGN_AND_SYMPTOM,2451
50028,to,I-SIGN_AND_SYMPTOM,2451
50029,the,I-SIGN_AND_SYMPTOM,2451
50030,limbus,I-SIGN_AND_SYMPTOM,2451
50031,Causes,O,2451
50032,of,O,2451
50033,Salzmann,B-NAME_OF_DISEASE,2451
50034,s,I-NAME_OF_DISEASE,2451
50035,Nodular,I-NAME_OF_DISEASE,2451
50036,Degeneration,I-NAME_OF_DISEASE,2451
50037,Salzmann,B-NAME_OF_DISEASE,2451
50038,s,I-NAME_OF_DISEASE,2451
50039,nodular,I-NAME_OF_DISEASE,2451
50040,degeneration,I-NAME_OF_DISEASE,2451
50041,is,O,2451
50042,considered,O,2451
50043,to,O,2451
50044,be,O,2451
50045,a,O,2451
50046,disease,O,2451
50047,of,O,2451
50048,unknown,O,2451
50049,etiology,O,2451
50050,with,O,2451
50051,no,O,2451
50052,certainly,O,2451
50053,known,O,2451
50054,causes,O,2451
50055,however,O,2451
50056,there,O,2451
50057,are,O,2451
50058,a,O,2451
50059,few,O,2451
50060,conditions,O,2451
50061,associated,O,2451
50062,with,O,2451
50063,risk,O,2451
50064,of,O,2451
50065,causing,O,2451
50066,it,O,2451
50067,Meibomian,B-CAUSE_OF_DISEASE,2451
50068,gland,I-CAUSE_OF_DISEASE,2451
50069,dysfunction,I-CAUSE_OF_DISEASE,2451
50070,MGD,I-CAUSE_OF_DISEASE,2451
50071,Contact,B-CAUSE_OF_DISEASE,2451
50072,lens,I-CAUSE_OF_DISEASE,2451
50073,wear,I-CAUSE_OF_DISEASE,2451
50074,especially,I-CAUSE_OF_DISEASE,2451
50075,hard,I-CAUSE_OF_DISEASE,2451
50076,contact,I-CAUSE_OF_DISEASE,2451
50077,lenses,I-CAUSE_OF_DISEASE,2451
50078,Keratoconjunctivitis,B-CAUSE_OF_DISEASE,2451
50079,sicca,I-CAUSE_OF_DISEASE,2451
50080,causing,I-CAUSE_OF_DISEASE,2451
50081,dry,I-CAUSE_OF_DISEASE,2451
50082,eyes,I-CAUSE_OF_DISEASE,2451
50083,Exposure,B-CAUSE_OF_DISEASE,2451
50084,keratitis,I-CAUSE_OF_DISEASE,2451
50085,Trauma,B-CAUSE_OF_DISEASE,2451
50086,to,I-CAUSE_OF_DISEASE,2451
50087,eyes,I-CAUSE_OF_DISEASE,2451
50088,Chronic,B-CAUSE_OF_DISEASE,2451
50089,inflammatory,I-CAUSE_OF_DISEASE,2451
50090,diseases,I-CAUSE_OF_DISEASE,2451
50091,of,I-CAUSE_OF_DISEASE,2451
50092,cornea,B-PART_OF_THE_EYES,2451
50093,ocular,I-CAUSE_OF_DISEASE,2451
50094,surface,I-CAUSE_OF_DISEASE,2451
50095,Peripheral,B-CAUSE_OF_DISEASE,2451
50096,vascularization,I-CAUSE_OF_DISEASE,2451
50097,and,I-CAUSE_OF_DISEASE,2451
50098,pterygium,I-CAUSE_OF_DISEASE,2452
50099,Symptoms,O,2452
50100,of,O,2452
50101,Salzmann,B-NAME_OF_DISEASE,2452
50102,s,I-NAME_OF_DISEASE,2452
50103,Nodular,I-NAME_OF_DISEASE,2452
50104,Degeneration,I-NAME_OF_DISEASE,2452
50105,Generally,O,2452
50106,this,O,2452
50107,condition,O,2452
50108,affects,O,2452
50109,more,O,2452
50110,women,O,2452
50111,than,O,2452
50112,men,O,2452
50113,It,O,2452
50114,is,O,2452
50115,observed,O,2452
50116,most,O,2452
50117,commonly,O,2452
50118,in,O,2452
50119,later,O,2452
50120,years,O,2452
50121,of,O,2452
50122,life,O,2452
50123,like,O,2452
50124,the,O,2452
50125,late,O,2453
50126,fifties,O,2453
50127,Symptoms,O,2453
50128,appear,O,2453
50129,on,O,2453
50130,the,O,2453
50131,basis,O,2453
50132,of,O,2453
50133,stages,O,2454
50134,of,O,2454
50135,the,O,2454
50136,disease,O,2454
50137,earlier,O,2454
50138,stages,O,2454
50139,are,O,2454
50140,subtle,O,2454
50141,and,O,2454
50142,asymptomatic,O,2454
50143,causing,O,2454
50144,almost,O,2454
50145,zero,O,2454
50146,harm,O,2454
50147,or,O,2455
50148,trouble,O,2455
50149,to,O,2455
50150,the,O,2455
50151,patient,O,2455
50152,Mild,O,2455
50153,nodules,O,2455
50154,located,O,2455
50155,in,O,2455
50156,the,B-PART_OF_THE_EYES,2455
50157,periphery,I-PART_OF_THE_EYES,2456
50158,or,O,2456
50159,cornea,B-PART_OF_THE_EYES,2456
50160,are,O,2456
50161,often,O,2456
50162,asymptomatic,O,2456
50163,As,O,2456
50164,the,O,2456
50165,disease,O,2456
50166,progresses,O,2457
50167,it,O,2457
50168,manifests,O,2457
50169,as,O,2457
50170,Foreign,B-SIGN_AND_SYMPTOM,2457
50171,body,I-SIGN_AND_SYMPTOM,2457
50172,sensation,I-SIGN_AND_SYMPTOM,2457
50173,due,I-SIGN_AND_SYMPTOM,2457
50174,to,I-SIGN_AND_SYMPTOM,2457
50175,the,I-SIGN_AND_SYMPTOM,2457
50176,unequal,I-SIGN_AND_SYMPTOM,2457
50177,wetting,I-SIGN_AND_SYMPTOM,2457
50178,of,I-SIGN_AND_SYMPTOM,2457
50179,the,I-SIGN_AND_SYMPTOM,2457
50180,cornea,B-PART_OF_THE_EYES,2457
50181,in,I-SIGN_AND_SYMPTOM,2457
50182,the,I-SIGN_AND_SYMPTOM,2457
50183,nodular,I-SIGN_AND_SYMPTOM,2457
50184,area,I-SIGN_AND_SYMPTOM,2457
50185,Diminished,B-SIGN_AND_SYMPTOM,2457
50186,and,I-SIGN_AND_SYMPTOM,2457
50187,distorted,I-SIGN_AND_SYMPTOM,2457
50188,vision,I-SIGN_AND_SYMPTOM,2457
50189,Irregular,B-SIGN_AND_SYMPTOM,2457
50190,astigmatism,I-SIGN_AND_SYMPTOM,2457
50191,resulting,I-SIGN_AND_SYMPTOM,2457
50192,in,I-SIGN_AND_SYMPTOM,2457
50193,blurred,I-SIGN_AND_SYMPTOM,2457
50194,vision,I-SIGN_AND_SYMPTOM,2457
50195,Frequent,B-SIGN_AND_SYMPTOM,2457
50196,prescription,I-SIGN_AND_SYMPTOM,2457
50197,changes,I-SIGN_AND_SYMPTOM,2457
50198,Inability,B-SIGN_AND_SYMPTOM,2457
50199,to,I-SIGN_AND_SYMPTOM,2457
50200,have,I-SIGN_AND_SYMPTOM,2457
50201,the,I-SIGN_AND_SYMPTOM,2457
50202,best-corrected,I-SIGN_AND_SYMPTOM,2457
50203,vision,I-SIGN_AND_SYMPTOM,2457
50204,Multiple,B-SIGN_AND_SYMPTOM,2458
50205,images,I-SIGN_AND_SYMPTOM,2458
50206,or,I-SIGN_AND_SYMPTOM,2458
50207,shadows,I-SIGN_AND_SYMPTOM,2458
50208,of,I-SIGN_AND_SYMPTOM,2458
50209,images,I-SIGN_AND_SYMPTOM,2458
50210,Irritation,B-SIGN_AND_SYMPTOM,2458
50211,dryness,I-SIGN_AND_SYMPTOM,2458
50212,grittiness,I-SIGN_AND_SYMPTOM,2458
50213,and,I-SIGN_AND_SYMPTOM,2458
50214,rarely,I-SIGN_AND_SYMPTOM,2458
50215,pain,I-SIGN_AND_SYMPTOM,2458
50216,Diagnosing,O,2458
50217,Salzmann,B-NAME_OF_DISEASE,2458
50218,s,I-NAME_OF_DISEASE,2458
50219,Nodular,I-NAME_OF_DISEASE,2458
50220,Degeneration,I-NAME_OF_DISEASE,2458
50221,In,O,2458
50222,its,O,2458
50223,earliest,O,2459
50224,of,O,2459
50225,stages,O,2459
50226,Salzmann,B-SIGN_AND_SYMPTOM,2459
50227,s,I-SIGN_AND_SYMPTOM,2459
50228,nodules,I-SIGN_AND_SYMPTOM,2459
50229,are,O,2459
50230,subtle,O,2459
50231,and,O,2459
50232,not,O,2459
50233,very,O,2459
50234,bothersome,O,2459
50235,for,O,2460
50236,the,O,2460
50237,patient,O,2460
50238,In,O,2460
50239,advanced,O,2460
50240,stages,O,2460
50241,for,O,2460
50242,diagnostic,O,2460
50243,purposes,O,2460
50244,several,O,2460
50245,techniques,O,2460
50246,are,O,2460
50247,employed,O,2460
50248,The,O,2461
50249,first,O,2461
50250,step,O,2461
50251,is,O,2461
50252,usually,O,2461
50253,a,B-DIAGNOSTIC_TEST,2461
50254,slit,I-DIAGNOSTIC_TEST,2461
50255,lamp,I-DIAGNOSTIC_TEST,2461
50256,examination,I-DIAGNOSTIC_TEST,2461
50257,of,I-DIAGNOSTIC_TEST,2461
50258,the,I-DIAGNOSTIC_TEST,2461
50259,eyes,I-DIAGNOSTIC_TEST,2461
50260,of,O,2461
50261,the,O,2461
50262,patient,O,2461
50263,Ancillary,B-DIAGNOSTIC_TEST,2461
50264,testing,I-DIAGNOSTIC_TEST,2462
50265,includes,I-DIAGNOSTIC_TEST,2462
50266,corneal,I-DIAGNOSTIC_TEST,2462
50267,curvature,I-DIAGNOSTIC_TEST,2462
50268,Corneal,B-DIAGNOSTIC_TEST,2462
50269,topography,I-DIAGNOSTIC_TEST,2462
50270,and,I-DIAGNOSTIC_TEST,2462
50271,tomography,I-DIAGNOSTIC_TEST,2462
50272,Measurement,B-DIAGNOSTIC_TEST,2462
50273,of,I-DIAGNOSTIC_TEST,2462
50274,the,I-DIAGNOSTIC_TEST,2462
50275,corneal,I-DIAGNOSTIC_TEST,2462
50276,thickness,I-DIAGNOSTIC_TEST,2462
50277,pachymetry,I-DIAGNOSTIC_TEST,2462
50278,,O,2462
50279,Anterior,B-DIAGNOSTIC_TEST,2462
50280,segment,I-DIAGNOSTIC_TEST,2463
50281,optical,I-DIAGNOSTIC_TEST,2463
50282,coherence,I-DIAGNOSTIC_TEST,2463
50283,tomography,I-DIAGNOSTIC_TEST,2463
50284,AS-OCT,I-DIAGNOSTIC_TEST,2463
50285,Salzmann,B-NAME_OF_DISEASE,2463
50286,s,I-NAME_OF_DISEASE,2463
50287,Nodular,I-NAME_OF_DISEASE,2464
50288,Degeneration,I-NAME_OF_DISEASE,2464
50289,Treatment,O,2464
50290,Salzmann,B-NAME_OF_DISEASE,2464
50291,Nodular,I-NAME_OF_DISEASE,2464
50292,degeneration,I-NAME_OF_DISEASE,2464
50293,does,O,2464
50294,not,O,2464
50295,have,O,2464
50296,a,O,2464
50297,definite,O,2464
50298,treatment,O,2464
50299,It,O,2464
50300,is,O,2464
50301,either,O,2464
50302,managed,O,2465
50303,conservatively,O,2465
50304,or,O,2465
50305,surgically,O,2465
50306,Conservative,O,2465
50307,treatment,O,2465
50308,In,O,2465
50309,conservative,O,2466
50310,management,O,2466
50311,of,O,2466
50312,Salzmann,B-NAME_OF_DISEASE,2466
50313,s,I-NAME_OF_DISEASE,2466
50314,nodular,I-NAME_OF_DISEASE,2466
50315,degeneration,I-NAME_OF_DISEASE,2466
50316,treating,O,2466
50317,the,O,2466
50318,very,O,2466
50319,cause,O,2466
50320,of,O,2466
50321,it,O,2467
50322,will,O,2467
50323,resolve,O,2467
50324,the,O,2467
50325,issue,O,2467
50326,As,O,2467
50327,an,O,2467
50328,example,O,2467
50329,in,O,2468
50330,Meibomian,B-NAME_OF_DISEASE,2468
50331,Gland,I-NAME_OF_DISEASE,2468
50332,Disease,I-NAME_OF_DISEASE,2468
50333,before,B-TREATMENT,2468
50334,surgical,I-TREATMENT,2468
50335,treatment,I-TREATMENT,2468
50336,of,I-TREATMENT,2468
50337,nodules,I-TREATMENT,2468
50338,eyelid,I-TREATMENT,2468
50339,hygiene,I-TREATMENT,2468
50340,is,I-TREATMENT,2468
50341,maintained,I-TREATMENT,2469
50342,and,I-TREATMENT,2469
50343,doxycycline,I-TREATMENT,2469
50344,is,I-TREATMENT,2469
50345,given,I-TREATMENT,2469
50346,to,I-TREATMENT,2469
50347,treat,I-TREATMENT,2469
50348,MGD,I-TREATMENT,2469
50349,,O,2469
50350,Other,O,2469
50351,measures,O,2469
50352,include,O,2470
50353,Proper,B-TREATMENT,2470
50354,ocular,I-TREATMENT,2470
50355,lubrication,I-TREATMENT,2470
50356,Wearing,B-TREATMENT,2470
50357,glasses,I-TREATMENT,2470
50358,Steroid,B-NAME_OF_DRUG,2470
50359,eye,I-NAME_OF_DRUG,2470
50360,drops,I-NAME_OF_DRUG,2470
50361,as,O,2470
50362,prescribed,O,2470
50363,by,O,2471
50364,the,O,2471
50365,doctor,O,2471
50366,Warm,B-TREATMENT,2471
50367,compresses,I-TREATMENT,2471
50368,Not,B-TREATMENT,2471
50369,using,I-TREATMENT,2471
50370,Contact,I-TREATMENT,2471
50371,lenses,I-TREATMENT,2471
50372,for,I-TREATMENT,2471
50373,quite,I-TREATMENT,2471
50374,some,I-TREATMENT,2471
50375,time,I-TREATMENT,2471
50376,and,O,2471
50377,re-fitting,B-TREATMENT,2471
50378,of,I-TREATMENT,2471
50379,contact,I-TREATMENT,2471
50380,lenses,I-TREATMENT,2471
50381,Surgical,O,2471
50382,treatment,O,2471
50383,Popular,O,2472
50384,and,O,2472
50385,successful,O,2472
50386,surgical,O,2472
50387,excision,O,2472
50388,of,O,2472
50389,Salzmann,B-NAME_OF_DISEASE,2473
50390,Nodular,I-NAME_OF_DISEASE,2473
50391,degeneration,I-NAME_OF_DISEASE,2473
50392,options,O,2473
50393,include,O,2473
50394,-,O,2473
50395,Superficial,B-TREATMENT,2473
50396,keratectomy,I-TREATMENT,2473
50397,SK,I-TREATMENT,2473
50398,Phototherapeutic,B-TREATMENT,2473
50399,keratectomy,I-TREATMENT,2473
50400,PTK,I-TREATMENT,2473
50401,These,O,2473
50402,surgical,O,2473
50403,procedures,O,2473
50404,are,O,2473
50405,accompanied,O,2473
50406,by,O,2473
50407,the,O,2473
50408,application,O,2473
50409,of,O,2473
50410,the,O,2473
50411,anti-scarring,O,2473
50412,agent,O,2473
50413,called,O,2473
50414,mitomycin,B-NAME_OF_DRUG,2473
50415,C,I-NAME_OF_DRUG,2473
50416,Mitomycin-C,B-NAME_OF_DRUG,2473
50417,will,O,2474
50418,reduce,O,2474
50419,the,O,2474
50420,frequency,O,2474
50421,and,O,2474
50422,severity,O,2474
50423,of,O,2474
50424,recurrences,O,2474
50425,after,O,2474
50426,the,O,2474
50427,excision,O,2474
50428,of,O,2474
50429,nodules,O,2474
50430,The,O,2474
50431,most,O,2474
50432,accurate,O,2474
50433,way,O,2474
50434,of,O,2474
50435,preventing,O,2474
50436,any,O,2474
50437,future,O,2475
50438,ocular,B-CAUSE_OF_DISEASE,2475
50439,erosions,I-CAUSE_OF_DISEASE,2475
50440,causing,O,2475
50441,Salzmann,B-NAME_OF_DISEASE,2475
50442,s,I-NAME_OF_DISEASE,2476
50443,nodular,I-NAME_OF_DISEASE,2477
50444,degeneration,I-NAME_OF_DISEASE,2477
50445,is,O,2477
50446,to,O,2477
50447,lubricate,B-PREVENTION,2477
50448,eyes,I-PREVENTION,2477
50449,every,I-PREVENTION,2477
50450,night,I-PREVENTION,2477
50451,for,I-PREVENTION,2477
50452,a,I-PREVENTION,2477
50453,minimum,I-PREVENTION,2477
50454,6-Mar,I-PREVENTION,2477
50455,months,I-PREVENTION,2478
50456,Giant,B-NAME_OF_DISEASE,2478
50457,papillary,I-NAME_OF_DISEASE,2478
50458,conjunctivitis,I-NAME_OF_DISEASE,2478
50459,is,O,2478
50460,an,O,2479
50461,inflammatory,O,2479
50462,and,O,2479
50463,allergic,O,2479
50464,reaction,O,2479
50465,of,O,2480
50466,conjunctiva,B-PART_OF_THE_EYES,2480
50467,which,O,2480
50468,makes,O,2480
50469,the,B-SIGN_AND_SYMPTOM,2480
50470,smooth,I-SIGN_AND_SYMPTOM,2480
50471,and,I-SIGN_AND_SYMPTOM,2480
50472,even,I-SIGN_AND_SYMPTOM,2480
50473,inner,I-SIGN_AND_SYMPTOM,2480
50474,side,I-SIGN_AND_SYMPTOM,2481
50475,of,I-SIGN_AND_SYMPTOM,2481
50476,your,I-SIGN_AND_SYMPTOM,2481
50477,eyelids,I-SIGN_AND_SYMPTOM,2481
50478,swollen,I-SIGN_AND_SYMPTOM,2481
50479,bumpy,I-SIGN_AND_SYMPTOM,2481
50480,and,I-SIGN_AND_SYMPTOM,2481
50481,reddened,I-SIGN_AND_SYMPTOM,2481
50482,Types,O,2481
50483,of,O,2481
50484,Primary,B-NAME_OF_DISEASE,2481
50485,Giant,B-NAME_OF_DISEASE,2481
50486,Papillary,I-NAME_OF_DISEASE,2481
50487,Conjunctivitis,I-NAME_OF_DISEASE,2481
50488,Giant,B-NAME_OF_DISEASE,2481
50489,papillary,I-NAME_OF_DISEASE,2481
50490,conjunctivitis,I-NAME_OF_DISEASE,2481
50491,is,O,2481
50492,predominantly,O,2481
50493,divided,O,2481
50494,on,O,2482
50495,basis,O,2482
50496,on,O,2483
50497,the,O,2483
50498,elements,O,2483
50499,of,O,2484
50500,allergen,B-CAUSE_OF_DISEASE,2485
50501,GPC,B-NAME_OF_DISEASE,2485
50502,is,O,2485
50503,sourced,O,2485
50504,either,O,2485
50505,from,O,2485
50506,seasonal,B-CAUSE_OF_DISEASE,2485
50507,allergies,I-CAUSE_OF_DISEASE,2485
50508,or,O,2485
50509,external,B-CAUSE_OF_DISEASE,2485
50510,objects,I-CAUSE_OF_DISEASE,2485
50511,like,I-CAUSE_OF_DISEASE,2485
50512,wearing,I-CAUSE_OF_DISEASE,2485
50513,contact,I-CAUSE_OF_DISEASE,2485
50514,lenses,I-CAUSE_OF_DISEASE,2485
50515,or,O,2485
50516,due,O,2485
50517,to,O,2486
50518,sutures,B-CAUSE_OF_DISEASE,2486
50519,Primary,B-NAME_OF_DISEASE,2486
50520,GPC,I-NAME_OF_DISEASE,2486
50521,has,O,2486
50522,two,O,2486
50523,basic,O,2486
50524,causes,O,2486
50525,-,O,2486
50526,Vernal,B-CAUSE_OF_DISEASE,2486
50527,keratoconjunctivitis,I-CAUSE_OF_DISEASE,2486
50528,VKC,I-CAUSE_OF_DISEASE,2486
50529,Atopic,B-CAUSE_OF_DISEASE,2486
50530,keratoconjunctivitis,I-CAUSE_OF_DISEASE,2486
50531,AKC,I-CAUSE_OF_DISEASE,2487
50532,Secondary,B-NAME_OF_DISEASE,2487
50533,GPC,I-NAME_OF_DISEASE,2487
50534,originates,O,2487
50535,from,O,2487
50536,substances,B-CAUSE_OF_DISEASE,2487
50537,causing,I-CAUSE_OF_DISEASE,2487
50538,grittiness,I-CAUSE_OF_DISEASE,2487
50539,or,O,2487
50540,a,B-CAUSE_OF_DISEASE,2487
50541,foreign,I-CAUSE_OF_DISEASE,2487
50542,body,I-CAUSE_OF_DISEASE,2487
50543,sensation,I-CAUSE_OF_DISEASE,2487
50544,in,I-CAUSE_OF_DISEASE,2487
50545,eyes,I-CAUSE_OF_DISEASE,2487
50546,or,I-CAUSE_OF_DISEASE,2487
50547,eyelids,I-CAUSE_OF_DISEASE,2487
50548,like,O,2487
50549,Sutures,B-CAUSE_OF_DISEASE,2487
50550,that,I-CAUSE_OF_DISEASE,2487
50551,rub,I-CAUSE_OF_DISEASE,2488
50552,against,I-CAUSE_OF_DISEASE,2488
50553,the,I-CAUSE_OF_DISEASE,2488
50554,eye,I-CAUSE_OF_DISEASE,2488
50555,lids,I-CAUSE_OF_DISEASE,2488
50556,Contact,B-CAUSE_OF_DISEASE,2488
50557,lenses,I-CAUSE_OF_DISEASE,2488
50558,Causes,O,2488
50559,of,O,2488
50560,Giant,B-NAME_OF_DISEASE,2488
50561,Papillary,I-NAME_OF_DISEASE,2488
50562,Conjunctivitis,I-NAME_OF_DISEASE,2488
50563,Allergy,B-CAUSE_OF_DISEASE,2488
50564,either,I-CAUSE_OF_DISEASE,2488
50565,with,I-CAUSE_OF_DISEASE,2488
50566,contact,I-CAUSE_OF_DISEASE,2489
50567,lenses,I-CAUSE_OF_DISEASE,2489
50568,or,I-CAUSE_OF_DISEASE,2489
50569,its,I-CAUSE_OF_DISEASE,2489
50570,solution,I-CAUSE_OF_DISEASE,2489
50571,Positive,B-CAUSE_OF_DISEASE,2489
50572,history,I-CAUSE_OF_DISEASE,2489
50573,of,I-CAUSE_OF_DISEASE,2489
50574,asthma,I-CAUSE_OF_DISEASE,2489
50575,hay,I-CAUSE_OF_DISEASE,2489
50576,fever,I-CAUSE_OF_DISEASE,2489
50577,or,I-CAUSE_OF_DISEASE,2489
50578,other,I-CAUSE_OF_DISEASE,2489
50579,allergies,I-CAUSE_OF_DISEASE,2489
50580,An,B-CAUSE_OF_DISEASE,2489
50581,artificial,I-CAUSE_OF_DISEASE,2489
50582,eye,I-CAUSE_OF_DISEASE,2489
50583,or,I-CAUSE_OF_DISEASE,2489
50584,exposed,I-CAUSE_OF_DISEASE,2489
50585,suture,I-CAUSE_OF_DISEASE,2489
50586,rubbing,I-CAUSE_OF_DISEASE,2489
50587,against,I-CAUSE_OF_DISEASE,2489
50588,the,I-CAUSE_OF_DISEASE,2489
50589,inner,I-CAUSE_OF_DISEASE,2489
50590,side,I-CAUSE_OF_DISEASE,2489
50591,of,I-CAUSE_OF_DISEASE,2489
50592,eyelid,I-CAUSE_OF_DISEASE,2489
50593,Accumulation,B-CAUSE_OF_DISEASE,2489
50594,of,I-CAUSE_OF_DISEASE,2489
50595,substances,I-CAUSE_OF_DISEASE,2489
50596,on,I-CAUSE_OF_DISEASE,2489
50597,the,I-CAUSE_OF_DISEASE,2489
50598,contact,I-CAUSE_OF_DISEASE,2489
50599,lenses,I-CAUSE_OF_DISEASE,2489
50600,Chronic,B-CAUSE_OF_DISEASE,2489
50601,ocular,I-CAUSE_OF_DISEASE,2489
50602,allergies,I-CAUSE_OF_DISEASE,2490
50603,What,O,2490
50604,are,O,2490
50605,the,O,2490
50606,symptoms,O,2490
50607,of,O,2490
50608,GPC,B-NAME_OF_DISEASE,2490
50609,Feeling,B-SIGN_AND_SYMPTOM,2490
50610,of,I-SIGN_AND_SYMPTOM,2490
50611,sand,I-SIGN_AND_SYMPTOM,2490
50612,stuck,I-SIGN_AND_SYMPTOM,2490
50613,in,I-SIGN_AND_SYMPTOM,2490
50614,eye,I-SIGN_AND_SYMPTOM,2490
50615,Foreign,B-SIGN_AND_SYMPTOM,2490
50616,body,I-SIGN_AND_SYMPTOM,2490
50617,sensation,I-SIGN_AND_SYMPTOM,2490
50618,in,I-SIGN_AND_SYMPTOM,2490
50619,eyes,I-SIGN_AND_SYMPTOM,2491
50620,Grittiness,B-SIGN_AND_SYMPTOM,2491
50621,and,I-SIGN_AND_SYMPTOM,2491
50622,red,I-SIGN_AND_SYMPTOM,2491
50623,eyes,I-SIGN_AND_SYMPTOM,2491
50624,Intensely,B-SIGN_AND_SYMPTOM,2491
50625,itchy,I-SIGN_AND_SYMPTOM,2491
50626,eyes,I-SIGN_AND_SYMPTOM,2491
50627,Inflammation,B-SIGN_AND_SYMPTOM,2491
50628,and,I-SIGN_AND_SYMPTOM,2491
50629,drooping,I-SIGN_AND_SYMPTOM,2491
50630,eyelids,I-SIGN_AND_SYMPTOM,2491
50631,Excessive,B-SIGN_AND_SYMPTOM,2491
50632,mucus,I-SIGN_AND_SYMPTOM,2491
50633,discharge,I-SIGN_AND_SYMPTOM,2491
50634,from,I-SIGN_AND_SYMPTOM,2491
50635,the,I-SIGN_AND_SYMPTOM,2491
50636,eye,I-SIGN_AND_SYMPTOM,2491
50637,which,O,2491
50638,makes,O,2491
50639,Blurry,B-SIGN_AND_SYMPTOM,2491
50640,vision,I-SIGN_AND_SYMPTOM,2491
50641,due,I-SIGN_AND_SYMPTOM,2491
50642,to,I-SIGN_AND_SYMPTOM,2491
50643,discharge,I-SIGN_AND_SYMPTOM,2491
50644,Sensation,B-SIGN_AND_SYMPTOM,2492
50645,like,I-SIGN_AND_SYMPTOM,2492
50646,your,I-SIGN_AND_SYMPTOM,2492
50647,contact,I-SIGN_AND_SYMPTOM,2492
50648,lens,I-SIGN_AND_SYMPTOM,2492
50649,is,I-SIGN_AND_SYMPTOM,2492
50650,moving,I-SIGN_AND_SYMPTOM,2492
50651,every,I-SIGN_AND_SYMPTOM,2492
50652,time,I-SIGN_AND_SYMPTOM,2492
50653,you,I-SIGN_AND_SYMPTOM,2492
50654,blink,I-SIGN_AND_SYMPTOM,2492
50655,your,I-SIGN_AND_SYMPTOM,2493
50656,eyes,I-SIGN_AND_SYMPTOM,2493
50657,Bumpy,B-SIGN_AND_SYMPTOM,2493
50658,underside,I-SIGN_AND_SYMPTOM,2493
50659,of,I-SIGN_AND_SYMPTOM,2493
50660,your,I-SIGN_AND_SYMPTOM,2493
50661,upper,I-SIGN_AND_SYMPTOM,2493
50662,eyelid,I-SIGN_AND_SYMPTOM,2493
50663,Excess,B-SIGN_AND_SYMPTOM,2493
50664,mucus,I-SIGN_AND_SYMPTOM,2493
50665,forming,I-SIGN_AND_SYMPTOM,2493
50666,strings,I-SIGN_AND_SYMPTOM,2493
50667,or,I-SIGN_AND_SYMPTOM,2494
50668,sheets,I-SIGN_AND_SYMPTOM,2494
50669,Stages,O,2494
50670,of,O,2494
50671,Giant,B-NAME_OF_DISEASE,2494
50672,Papillary,I-NAME_OF_DISEASE,2494
50673,Conjunctivitis,I-NAME_OF_DISEASE,2494
50674,For,O,2494
50675,easy,O,2494
50676,understanding,O,2494
50677,GPC,B-NAME_OF_DISEASE,2494
50678,can,O,2495
50679,be,O,2495
50680,divided,O,2495
50681,into,O,2495
50682,several,O,2495
50683,stages,O,2495
50684,Early,O,2495
50685,stages,O,2495
50686,of,O,2495
50687,giant,B-NAME_OF_DISEASE,2495
50688,papillary,I-NAME_OF_DISEASE,2495
50689,conjunctivitis,I-NAME_OF_DISEASE,2495
50690,it,O,2495
50691,manifests,O,2495
50692,as,O,2495
50693,mild,O,2495
50694,or,O,2495
50695,no,O,2495
50696,symptoms,O,2495
50697,of,O,2495
50698,grittiness,B-SIGN_AND_SYMPTOM,2495
50699,redness,I-SIGN_AND_SYMPTOM,2495
50700,itching,I-SIGN_AND_SYMPTOM,2495
50701,inflammation,I-SIGN_AND_SYMPTOM,2495
50702,or,I-SIGN_AND_SYMPTOM,2495
50703,bumps,I-SIGN_AND_SYMPTOM,2495
50704,on,I-SIGN_AND_SYMPTOM,2495
50705,the,I-SIGN_AND_SYMPTOM,2495
50706,inner,I-SIGN_AND_SYMPTOM,2495
50707,side,I-SIGN_AND_SYMPTOM,2495
50708,of,I-SIGN_AND_SYMPTOM,2495
50709,eye,I-SIGN_AND_SYMPTOM,2495
50710,lids,I-SIGN_AND_SYMPTOM,2495
50711,There,O,2495
50712,is,O,2495
50713,little,O,2495
50714,to,O,2496
50715,no,O,2496
50716,discharge,O,2496
50717,in,O,2496
50718,it,O,2496
50719,In,O,2496
50720,severe,O,2496
50721,stages,O,2496
50722,there,O,2496
50723,is,O,2496
50724,increase,B-SIGN_AND_SYMPTOM,2496
50725,in,I-SIGN_AND_SYMPTOM,2496
50726,number,I-SIGN_AND_SYMPTOM,2496
50727,of,I-SIGN_AND_SYMPTOM,2496
50728,bumps,I-SIGN_AND_SYMPTOM,2496
50729,grittiness,I-SIGN_AND_SYMPTOM,2496
50730,itching,I-SIGN_AND_SYMPTOM,2496
50731,and,I-SIGN_AND_SYMPTOM,2496
50732,redness,I-SIGN_AND_SYMPTOM,2496
50733,The,O,2497
50734,is,O,2497
50735,good,B-SIGN_AND_SYMPTOM,2497
50736,amount,I-SIGN_AND_SYMPTOM,2497
50737,of,I-SIGN_AND_SYMPTOM,2497
50738,discharge,I-SIGN_AND_SYMPTOM,2497
50739,leading,I-SIGN_AND_SYMPTOM,2497
50740,of,I-SIGN_AND_SYMPTOM,2497
50741,blurred,I-SIGN_AND_SYMPTOM,2497
50742,vision,I-SIGN_AND_SYMPTOM,2497
50743,Mostly,O,2497
50744,in,O,2497
50745,these,O,2498
50746,cases,O,2498
50747,the,B-SIGN_AND_SYMPTOM,2498
50748,lens,I-SIGN_AND_SYMPTOM,2498
50749,moves,I-SIGN_AND_SYMPTOM,2498
50750,with,I-SIGN_AND_SYMPTOM,2498
50751,blinking,I-SIGN_AND_SYMPTOM,2498
50752,In,O,2498
50753,Advanced,O,2498
50754,stage,O,2498
50755,of,O,2498
50756,GPC,B-NAME_OF_DISEASE,2498
50757,all,O,2498
50758,the,O,2498
50759,aforementioned,O,2498
50760,symptoms,O,2498
50761,will,O,2499
50762,be,O,2499
50763,aggravated,O,2499
50764,the,B-SIGN_AND_SYMPTOM,2499
50765,discharge,I-SIGN_AND_SYMPTOM,2499
50766,will,I-SIGN_AND_SYMPTOM,2499
50767,take,I-SIGN_AND_SYMPTOM,2499
50768,shape,I-SIGN_AND_SYMPTOM,2499
50769,of,I-SIGN_AND_SYMPTOM,2499
50770,strings,I-SIGN_AND_SYMPTOM,2499
50771,deposition,I-SIGN_AND_SYMPTOM,2499
50772,on,I-SIGN_AND_SYMPTOM,2499
50773,contact,I-SIGN_AND_SYMPTOM,2499
50774,lenses,I-SIGN_AND_SYMPTOM,2499
50775,sticking,I-SIGN_AND_SYMPTOM,2499
50776,of,I-SIGN_AND_SYMPTOM,2500
50777,eyelids,I-SIGN_AND_SYMPTOM,2500
50778,and,I-SIGN_AND_SYMPTOM,2500
50779,intense,I-SIGN_AND_SYMPTOM,2500
50780,itching,I-SIGN_AND_SYMPTOM,2500
50781,due,I-SIGN_AND_SYMPTOM,2500
50782,to,I-SIGN_AND_SYMPTOM,2500
50783,immense,I-SIGN_AND_SYMPTOM,2500
50784,feeling,I-SIGN_AND_SYMPTOM,2500
50785,of,I-SIGN_AND_SYMPTOM,2500
50786,foreign,I-SIGN_AND_SYMPTOM,2500
50787,body,I-SIGN_AND_SYMPTOM,2500
50788,in,I-SIGN_AND_SYMPTOM,2500
50789,eyes,I-SIGN_AND_SYMPTOM,2500
50790,How,O,2500
50791,Can,O,2500
50792,GPC,B-NAME_OF_DISEASE,2500
50793,Treated,O,2500
50794,GPC,B-NAME_OF_DISEASE,2500
50795,needs,O,2500
50796,prompt,O,2500
50797,care,O,2501
50798,to,O,2501
50799,be,O,2501
50800,treated,O,2501
50801,as,O,2501
50802,quickly,O,2501
50803,as,O,2501
50804,possible,O,2501
50805,and,O,2501
50806,to,O,2501
50807,avoid,O,2501
50808,complications,O,2501
50809,The,O,2501
50810,approved,O,2501
50811,treatment,O,2501
50812,for,O,2501
50813,primary,B-NAME_OF_DISEASE,2501
50814,GPC,I-NAME_OF_DISEASE,2501
50815,is,O,2501
50816,cromolyn,B-NAME_OF_DRUG,2501
50817,sodium,I-NAME_OF_DRUG,2502
50818,and,O,2502
50819,lodoxamide,B-NAME_OF_DRUG,2502
50820,usually,O,2502
50821,However,O,2502
50822,other,O,2502
50823,treatment,O,2502
50824,options,O,2502
50825,primary,B-NAME_OF_DISEASE,2502
50826,GPC,I-NAME_OF_DISEASE,2502
50827,are,O,2502
50828,antihistamines,B-NAME_OF_DRUG,2502
50829,topical,B-NAME_OF_DRUG,2502
50830,steroids,I-NAME_OF_DRUG,2502
50831,and,O,2502
50832,topical,B-NAME_OF_DRUG,2502
50833,cyclosporine,I-NAME_OF_DRUG,2502
50834,To,O,2502
50835,treat,O,2502
50836,Secondary,B-NAME_OF_DISEASE,2502
50837,GPC,I-NAME_OF_DISEASE,2502
50838,you,O,2502
50839,need,O,2502
50840,to,O,2502
50841,-,O,2502
50842,Abstain,B-TREATMENT,2502
50843,from,I-TREATMENT,2502
50844,wearing,I-TREATMENT,2502
50845,contact,I-TREATMENT,2502
50846,lenses,I-TREATMENT,2502
50847,for,I-TREATMENT,2503
50848,some,I-TREATMENT,2503
50849,time,I-TREATMENT,2503
50850,This,O,2503
50851,way,O,2503
50852,your,O,2503
50853,body,O,2503
50854,is,O,2503
50855,not,O,2503
50856,exposed,O,2503
50857,to,O,2503
50858,allergen,B-CAUSE_OF_DISEASE,2503
50859,and,O,2503
50860,takes,O,2503
50861,its,O,2503
50862,time,O,2503
50863,to,O,2503
50864,heal,O,2503
50865,perfectly,O,2503
50866,Reduce,B-TREATMENT,2503
50867,the,I-TREATMENT,2503
50868,total,I-TREATMENT,2503
50869,duration,I-TREATMENT,2503
50870,of,I-TREATMENT,2503
50871,wearing,I-TREATMENT,2503
50872,lenses,I-TREATMENT,2503
50873,Clean,B-TREATMENT,2503
50874,your,I-TREATMENT,2503
50875,lens,I-TREATMENT,2503
50876,with,I-TREATMENT,2503
50877,the,I-TREATMENT,2503
50878,prescribed,I-TREATMENT,2503
50879,lens,I-TREATMENT,2503
50880,solution,I-TREATMENT,2503
50881,only,I-TREATMENT,2503
50882,avoid,B-TREATMENT,2503
50883,using,I-TREATMENT,2503
50884,lens,I-TREATMENT,2503
50885,solutions,I-TREATMENT,2503
50886,with,I-TREATMENT,2503
50887,preservatives,I-TREATMENT,2503
50888,Store,B-TREATMENT,2503
50889,your,I-TREATMENT,2503
50890,lenses,I-TREATMENT,2503
50891,properly,I-TREATMENT,2503
50892,in,I-TREATMENT,2503
50893,disinfecting,I-TREATMENT,2503
50894,solution,I-TREATMENT,2503
50895,Change,B-TREATMENT,2503
50896,your,I-TREATMENT,2503
50897,lens,I-TREATMENT,2503
50898,regular,I-TREATMENT,2504
50899,as,O,2504
50900,the,B-CAUSE_OF_DISEASE,2504
50901,very,I-CAUSE_OF_DISEASE,2504
50902,lens,I-CAUSE_OF_DISEASE,2504
50903,might,O,2504
50904,be,O,2504
50905,causing,O,2504
50906,allergy,B-SIGN_AND_SYMPTOM,2504
50907,Change,B-TREATMENT,2504
50908,the,I-TREATMENT,2504
50909,type,I-TREATMENT,2504
50910,and,I-TREATMENT,2504
50911,design,I-TREATMENT,2504
50912,of,I-TREATMENT,2504
50913,your,I-TREATMENT,2504
50914,lens,I-TREATMENT,2504
50915,Your,O,2504
50916,ophthalmologist,O,2504
50917,will,O,2504
50918,discuss,O,2504
50919,treatment,O,2504
50920,options,O,2504
50921,for,O,2504
50922,you,O,2504
50923,based,O,2504
50924,on,O,2504
50925,your,O,2505
50926,condition,O,2505
50927,Use,O,2505
50928,eye,B-TREATMENT,2505
50929,drops,I-TREATMENT,2505
50930,prescribed,O,2505
50931,by,O,2505
50932,the,O,2505
50933,ophthalmologists,O,2505
50934,to,O,2505
50935,pacify,O,2505
50936,the,O,2506
50937,situation,O,2506
50938,You,O,2506
50939,might,O,2506
50940,be,O,2506
50941,prescribed,O,2506
50942,cromolyn,B-NAME_OF_DRUG,2506
50943,sodium,I-NAME_OF_DRUG,2506
50944,drops,I-NAME_OF_DRUG,2506
50945,if,O,2506
50946,other,O,2506
50947,treatments,O,2506
50948,fail,O,2506
50949,Headaches,B-CAUSE_OF_DISEASE,2506
50950,may,O,2506
50951,increase,O,2506
50952,the,O,2507
50953,risk,O,2507
50954,for,O,2507
50955,dry,B-NAME_OF_DISEASE,2507
50956,eye,I-NAME_OF_DISEASE,2507
50957,disease,I-NAME_OF_DISEASE,2507
50958,DED,B-NAME_OF_DISEASE,2507
50959,according,O,2507
50960,to,O,2507
50961,a,O,2507
50962,systematic,O,2507
50963,review,O,2507
50964,and,O,2507
50965,meta-analysis,O,2507
50966,published,O,2507
50967,online,O,2507
50968,Oct,O,2507
50969,19,O,2507
50970,in,O,2507
50971,the,B-PUBLICATION_VENUE,2507
50972,Annals,I-PUBLICATION_VENUE,2507
50973,of,I-PUBLICATION_VENUE,2507
50974,Medicine,I-PUBLICATION_VENUE,2507
50975,To,O,2507
50976,find,O,2508
50977,research,O,2508
50978,examining,O,2508
50979,whether,O,2508
50980,headache,B-CAUSE_OF_DISEASE,2508
50981,is,O,2508
50982,linked,O,2508
50983,to,O,2508
50984,the,O,2508
50985,risk,O,2508
50986,for,O,2508
50987,DED,B-NAME_OF_DISEASE,2508
50988,Shuyi,B-PERSON,2508
50989,Liu,I-PERSON,2508
50990,and,O,2508
50991,colleagues,O,2508
50992,from,O,2508
50993,Dalian,B-ORGANIZATION,2508
50994,Medical,I-ORGANIZATION,2508
50995,University,I-ORGANIZATION,2508
50996,in,O,2508
50997,China,B-GPE,2508
50998,did,O,2509
50999,a,O,2509
51000,thorough,O,2509
51001,literature,O,2509
51002,search,O,2509
51003,The,O,2509
51004,researchers,O,2509
51005,discovered,O,2509
51006,that,O,2509
51007,all-cause,B-CAUSE_OF_DISEASE,2509
51008,headache,I-CAUSE_OF_DISEASE,2509
51009,was,O,2509
51010,connected,O,2509
51011,to,O,2509
51012,a,O,2509
51013,greater,O,2509
51014,risk,O,2509
51015,for,O,2509
51016,DED,B-NAME_OF_DISEASE,2509
51017,based,O,2509
51018,on,O,2509
51019,11,O,2509
51020,included,O,2509
51021,studies,O,2509
51022,3,O,2509
51023,million,O,2509
51024,people,O,2510
51025,odds,O,2510
51026,ratio,O,2510
51027,1.58,O,2510
51028,,O,2510
51029,In,O,2510
51030,terms,O,2510
51031,of,O,2510
51032,different,O,2510
51033,types,O,2510
51034,of,O,2510
51035,headaches,B-CAUSE_OF_DISEASE,2510
51036,cluster,B-CAUSE_OF_DISEASE,2510
51037,headaches,I-CAUSE_OF_DISEASE,2510
51038,odds,O,2510
51039,ratio,O,2510
51040,2.11,O,2510
51041,tension,B-CAUSE_OF_DISEASE,2510
51042,headaches,I-CAUSE_OF_DISEASE,2510
51043,odds,O,2510
51044,ratio,O,2510
51045,1.61,O,2510
51046,and,O,2510
51047,migraines,B-CAUSE_OF_DISEASE,2510
51048,odds,O,2510
51049,ratio,O,2510
51050,1.5,O,2510
51051,were,O,2510
51052,all,O,2510
51053,linked,O,2510
51054,to,O,2510
51055,a,O,2510
51056,higher,O,2510
51057,risk,O,2510
51058,for,O,2510
51059,DED,B-NAME_OF_DISEASE,2511
51060,Case-control,O,2511
51061,studies,O,2511
51062,were,O,2511
51063,shown,O,2511
51064,to,O,2511
51065,have,O,2511
51066,a,O,2511
51067,somewhat,O,2511
51068,higher,O,2511
51069,risk,O,2511
51070,for,O,2511
51071,DED,B-NAME_OF_DISEASE,2511
51072,than,O,2511
51073,cross-sectional,O,2511
51074,and,O,2511
51075,cohort,O,2511
51076,studies,O,2511
51077,odds,O,2511
51078,ratios,O,2511
51079,1.6,O,2511
51080,and,O,2511
51081,1.44,O,2511
51082,respectively,O,2511
51083,versus,O,2511
51084,1.7,O,2511
51085,,O,2511
51086,All,B-CAUSE_OF_DISEASE,2511
51087,headache,I-CAUSE_OF_DISEASE,2511
51088,types,I-CAUSE_OF_DISEASE,2511
51089,were,O,2511
51090,linked,O,2511
51091,to,O,2511
51092,an,O,2512
51093,increased,O,2513
51094,risk,O,2513
51095,of,O,2513
51096,DED,B-NAME_OF_DISEASE,2513
51097,across,O,2513
51098,America,B-GPE,2513
51099,Europe,B-GPE,2513
51100,Asia,B-GPE,2513
51101,and,O,2513
51102,Oceania,B-GPE,2513
51103,Our,O,2513
51104,study,O,2513
51105,indicates,O,2513
51106,that,O,2513
51107,headache,B-CAUSE_OF_DISEASE,2513
51108,increases,O,2513
51109,the,O,2513
51110,risk,O,2513
51111,of,O,2513
51112,DED,B-NAME_OF_DISEASE,2514
51113,especially,O,2514
51114,in,O,2514
51115,migraine,O,2514
51116,patients,O,2514
51117,However,O,2514
51118,more,O,2514
51119,relevant,O,2514
51120,studies,O,2514
51121,are,O,2514
51122,still,O,2514
51123,required,O,2514
51124,to,O,2514
51125,identify,O,2514
51126,the,O,2514
51127,exact,O,2514
51128,pathophysiological,O,2514
51129,process,O,2514
51130,behind,O,2515
51131,this,O,2515
51132,clinical,O,2515
51133,phenomenon,O,2515
51134,the,O,2515
51135,authors,O,2515
51136,write,O,2515
51137,The,O,2515
51138,findings,O,2515
51139,of,O,2515
51140,our,O,2515
51141,study,O,2516
51142,can,O,2516
51143,be,O,2516
51144,meaningful,O,2516
51145,in,O,2516
51146,the,O,2516
51147,prevention,O,2516
51148,and,O,2516
51149,treatment,O,2516
51150,of,O,2516
51151,DED,B-NAME_OF_DISEASE,2516
51152,Let,O,2516
51153,s,O,2516
51154,start,O,2516
51155,with,O,2516
51156,the,O,2516
51157,definition,O,2516
51158,of,O,2516
51159,the,B-PART_OF_THE_EYES,2516
51160,lacrimal,I-PART_OF_THE_EYES,2516
51161,lake,I-PART_OF_THE_EYES,2516
51162,as,O,2516
51163,you,O,2516
51164,may,O,2516
51165,guess,O,2516
51166,the,B-PART_OF_THE_EYES,2516
51167,lacrimal,I-PART_OF_THE_EYES,2516
51168,lake,I-PART_OF_THE_EYES,2516
51169,is,O,2516
51170,a,O,2516
51171,pool,O,2517
51172,of,O,2517
51173,tears,O,2517
51174,in,O,2517
51175,the,O,2517
51176,lower,O,2517
51177,section,O,2517
51178,of,O,2517
51179,the,O,2517
51180,eye,O,2517
51181,that,O,2517
51182,drains,O,2517
51183,into,O,2517
51184,the,O,2517
51185,tear,O,2517
51186,drainage,O,2517
51187,system,O,2517
51188,Actually,O,2517
51189,we,O,2517
51190,have,O,2517
51191,a,O,2517
51192,lacrimal,O,2517
51193,liquid,O,2517
51194,spread,O,2517
51195,all,O,2518
51196,over,O,2518
51197,the,O,2518
51198,eye,O,2518
51199,with,O,2518
51200,the,O,2518
51201,help,O,2518
51202,of,O,2518
51203,eye,O,2518
51204,blinks,O,2518
51205,Lacrimal,B-PART_OF_THE_EYES,2518
51206,Lake,I-PART_OF_THE_EYES,2518
51207,Function,O,2519
51208,The,O,2519
51209,lacrimal,O,2520
51210,fluid,O,2521
51211,actually,O,2521
51212,the,O,2521
51213,tears,O,2521
51214,is,O,2521
51215,water,O,2521
51216,of,O,2521
51217,antibacterial,B-CHEMICAL_COMPOUND,2521
51218,agentlysozyme,I-CHEMICAL_COMPOUND,2521
51219,that,O,2521
51220,enters,O,2521
51221,the,B-PART_OF_THE_EYES,2521
51222,upper,I-PART_OF_THE_EYES,2521
51223,eyelid,I-PART_OF_THE_EYES,2521
51224,to,O,2521
51225,wash,O,2521
51226,all,O,2521
51227,over,O,2521
51228,the,O,2521
51229,eyes,O,2521
51230,As,O,2521
51231,a,O,2521
51232,result,O,2521
51233,the,B-PART_OF_THE_EYES,2521
51234,cornea,I-PART_OF_THE_EYES,2521
51235,is,O,2521
51236,moistened,O,2521
51237,and,O,2521
51238,protected,O,2521
51239,from,O,2521
51240,dehydration,B-SIGN_AND_SYMPTOM,2521
51241,By,O,2521
51242,aging,O,2522
51243,the,B-PART_OF_THE_EYES,2522
51244,eyelids,I-PART_OF_THE_EYES,2522
51245,get,O,2522
51246,loosened,O,2522
51247,and,O,2522
51248,lacrimal,B-PART_OF_THE_EYES,2522
51249,lakes,I-PART_OF_THE_EYES,2522
51250,keep,O,2522
51251,more,O,2522
51252,fluid,O,2522
51253,The,O,2522
51254,common,O,2522
51255,issue,O,2522
51256,about,O,2522
51257,the,B-PART_OF_THE_EYES,2522
51258,lacrimal,I-PART_OF_THE_EYES,2522
51259,gland,I-PART_OF_THE_EYES,2523
51260,is,O,2523
51261,inflammation,B-SIGN_AND_SYMPTOM,2523
51262,or,I-SIGN_AND_SYMPTOM,2523
51263,swelling,I-SIGN_AND_SYMPTOM,2523
51264,What,O,2523
51265,Drains,O,2523
51266,The,B-PART_OF_THE_EYES,2523
51267,Lacrimal,I-PART_OF_THE_EYES,2523
51268,Lake,I-PART_OF_THE_EYES,2523
51269,So,O,2523
51270,if,O,2523
51271,you,O,2523
51272,look,O,2523
51273,at,O,2523
51274,the,O,2523
51275,mirror,O,2523
51276,to,O,2523
51277,your,O,2523
51278,eyes,O,2523
51279,closely,O,2523
51280,you,O,2523
51281,will,O,2523
51282,see,O,2523
51283,a,B-PART_OF_THE_EYES,2523
51284,lacrimal,I-PART_OF_THE_EYES,2523
51285,papilla,I-PART_OF_THE_EYES,2523
51286,which,O,2523
51287,is,O,2523
51288,at,O,2523
51289,the,O,2523
51290,corner,O,2523
51291,of,O,2523
51292,the,O,2523
51293,eye,O,2523
51294,and,O,2523
51295,the,O,2524
51296,nose,O,2525
51297,as,O,2525
51298,an,O,2525
51299,elevation,O,2525
51300,If,O,2525
51301,you,O,2525
51302,slightly,O,2525
51303,open,O,2525
51304,the,O,2525
51305,lower,O,2525
51306,eye,O,2525
51307,and,O,2525
51308,look,O,2525
51309,at,O,2525
51310,the,O,2525
51311,corner,O,2525
51312,point,O,2525
51313,you,O,2525
51314,will,O,2526
51315,see,O,2526
51316,the,B-PART_OF_THE_EYES,2526
51317,lacrimal,I-PART_OF_THE_EYES,2526
51318,punctum,I-PART_OF_THE_EYES,2526
51319,Don,O,2526
51320,t,O,2526
51321,worry,O,2526
51322,this,O,2526
51323,is,O,2526
51324,normal,O,2526
51325,and,O,2526
51326,your,O,2526
51327,eyes,O,2526
51328,are,O,2526
51329,not,O,2526
51330,damaged,O,2527
51331,The,B-PART_OF_THE_EYES,2527
51332,lacrimal,I-PART_OF_THE_EYES,2527
51333,punctum,I-PART_OF_THE_EYES,2527
51334,is,O,2527
51335,linked,O,2527
51336,to,O,2527
51337,the,B-PART_OF_THE_EYES,2527
51338,lacrimal,I-PART_OF_THE_EYES,2527
51339,canaliculi,I-PART_OF_THE_EYES,2527
51340,which,O,2527
51341,are,O,2527
51342,the,O,2527
51343,small,O,2527
51344,channels,O,2527
51345,for,O,2527
51346,tears,O,2527
51347,These,O,2527
51348,lacrimal,B-PART_OF_THE_EYES,2527
51349,punta,I-PART_OF_THE_EYES,2527
51350,openings,O,2527
51351,are,O,2527
51352,located,O,2527
51353,in,O,2527
51354,both,O,2527
51355,upper,O,2527
51356,and,O,2528
51357,lower,O,2528
51358,corner,O,2528
51359,of,O,2528
51360,the,B-PART_OF_THE_EYES,2528
51361,eyelids,I-PART_OF_THE_EYES,2528
51362,Lacrimal,B-PART_OF_THE_EYES,2528
51363,canaliculi,I-PART_OF_THE_EYES,2528
51364,follow,O,2528
51365,a,O,2528
51366,way,O,2528
51367,to,O,2528
51368,the,B-PART_OF_THE_EYES,2528
51369,lacrimal,I-PART_OF_THE_EYES,2528
51370,sac,I-PART_OF_THE_EYES,2528
51371,then,O,2528
51372,from,O,2528
51373,the,B-PART_OF_THE_EYES,2528
51374,lacrimal,I-PART_OF_THE_EYES,2528
51375,sac,I-PART_OF_THE_EYES,2528
51376,the,O,2528
51377,liquid,O,2528
51378,tears,O,2528
51379,reach,O,2528
51380,the,O,2528
51381,nasolacrimal,O,2529
51382,duct,O,2529
51383,The,O,2529
51384,fluid,O,2529
51385,passes,O,2529
51386,through,O,2529
51387,the,O,2529
51388,nasal,O,2529
51389,cavity,O,2530
51390,and,O,2530
51391,mixes,O,2530
51392,with,O,2530
51393,the,O,2530
51394,mucus,O,2530
51395,or,O,2530
51396,maybe,O,2530
51397,you,O,2530
51398,can,O,2530
51399,swallow,O,2530
51400,the,O,2530
51401,fluid,O,2530
51402,too,O,2530
51403,So,O,2530
51404,this,O,2530
51405,is,O,2530
51406,why,O,2530
51407,you,O,2530
51408,have,O,2530
51409,nasal,O,2530
51410,draining,O,2530
51411,while,O,2530
51412,you,O,2530
51413,are,O,2530
51414,crying,O,2530
51415,Lacrimal,B-NAME_OF_DISEASE,2530
51416,Lake,I-NAME_OF_DISEASE,2531
51417,Swelling,I-NAME_OF_DISEASE,2531
51418,Treatment,O,2531
51419,Due,O,2531
51420,to,O,2531
51421,the,O,2531
51422,conditions,O,2531
51423,of,O,2531
51424,the,B-CAUSE_OF_DISEASE,2531
51425,tear-producing,I-CAUSE_OF_DISEASE,2531
51426,your,O,2531
51427,eyes,O,2531
51428,may,O,2531
51429,have,O,2531
51430,lacrimal,B-NAME_OF_DISEASE,2531
51431,lake,I-NAME_OF_DISEASE,2531
51432,swelling,I-NAME_OF_DISEASE,2531
51433,The,O,2531
51434,symptoms,O,2532
51435,for,O,2532
51436,lacrimal,B-NAME_OF_DISEASE,2532
51437,lake,I-NAME_OF_DISEASE,2532
51438,swelling,I-NAME_OF_DISEASE,2532
51439,or,O,2532
51440,in,O,2532
51441,other,O,2532
51442,ways,O,2533
51443,lacrimal,B-NAME_OF_DISEASE,2533
51444,gland,I-NAME_OF_DISEASE,2533
51445,inflammations,I-NAME_OF_DISEASE,2533
51446,are,O,2533
51447,redness,B-SIGN_AND_SYMPTOM,2533
51448,in,I-SIGN_AND_SYMPTOM,2533
51449,the,I-SIGN_AND_SYMPTOM,2533
51450,eyelid,I-SIGN_AND_SYMPTOM,2533
51451,dry,B-SIGN_AND_SYMPTOM,2533
51452,eye,I-SIGN_AND_SYMPTOM,2533
51453,or,I-SIGN_AND_SYMPTOM,2533
51454,excessive,I-SIGN_AND_SYMPTOM,2533
51455,tearing,I-SIGN_AND_SYMPTOM,2533
51456,inflammation,B-SIGN_AND_SYMPTOM,2533
51457,in,I-SIGN_AND_SYMPTOM,2533
51458,the,I-SIGN_AND_SYMPTOM,2533
51459,eye,I-SIGN_AND_SYMPTOM,2533
51460,discomfort,B-SIGN_AND_SYMPTOM,2533
51461,in,I-SIGN_AND_SYMPTOM,2533
51462,blinking,I-SIGN_AND_SYMPTOM,2533
51463,The,O,2533
51464,symptoms,O,2533
51465,can,O,2533
51466,show,O,2533
51467,mumps,B-SIGN_AND_SYMPTOM,2533
51468,but,O,2533
51469,you,O,2533
51470,should,O,2533
51471,visit,O,2533
51472,your,O,2533
51473,doctor,O,2534
51474,and,O,2534
51475,after,O,2534
51476,having,O,2534
51477,the,O,2534
51478,diagnosis,O,2534
51479,the,O,2534
51480,treatment,O,2534
51481,should,O,2535
51482,be,O,2535
51483,applied,O,2535
51484,Generally,O,2535
51485,lacrimal,B-NAME_OF_DISEASE,2535
51486,gland,I-NAME_OF_DISEASE,2535
51487,swelling,I-NAME_OF_DISEASE,2535
51488,is,O,2535
51489,treated,O,2535
51490,easily,O,2535
51491,as,O,2535
51492,they,O,2535
51493,are,O,2535
51494,commonly,O,2535
51495,happening,O,2535
51496,acutely,O,2535
51497,due,O,2535
51498,the,B-CAUSE_OF_DISEASE,2536
51499,bacterial,I-CAUSE_OF_DISEASE,2536
51500,infection,I-CAUSE_OF_DISEASE,2536
51501,and,O,2536
51502,can,O,2536
51503,be,O,2536
51504,treated,O,2536
51505,by,O,2536
51506,the,O,2536
51507,doctor,O,2536
51508,with,O,2537
51509,warm,B-TREATMENT,2537
51510,compresses,I-TREATMENT,2537
51511,The,B-CAUSE_OF_DISEASE,2537
51512,chronic,I-CAUSE_OF_DISEASE,2537
51513,effect,I-CAUSE_OF_DISEASE,2537
51514,may,O,2537
51515,be,O,2537
51516,the,O,2537
51517,reason,O,2537
51518,for,O,2537
51519,eye,B-NAME_OF_DISEASE,2537
51520,thyroid,I-NAME_OF_DISEASE,2537
51521,disorder,I-NAME_OF_DISEASE,2537
51522,Lacrimal,B-NAME_OF_DISEASE,2537
51523,Duct,I-NAME_OF_DISEASE,2537
51524,Obstruction,I-NAME_OF_DISEASE,2537
51525,Treatment,O,2537
51526,One,O,2537
51527,of,O,2537
51528,the,O,2538
51529,problems,O,2538
51530,of,O,2538
51531,the,B-PART_OF_THE_EYES,2538
51532,lacrimal,I-PART_OF_THE_EYES,2538
51533,system,I-PART_OF_THE_EYES,2538
51534,is,O,2538
51535,Nasolacrimal,B-CAUSE_OF_DISEASE,2538
51536,duct,I-CAUSE_OF_DISEASE,2538
51537,obstruction,I-CAUSE_OF_DISEASE,2538
51538,The,O,2538
51539,problem,O,2538
51540,may,O,2538
51541,occur,O,2538
51542,in,O,2538
51543,the,O,2538
51544,first,O,2538
51545,6,O,2538
51546,months,O,2538
51547,of,O,2538
51548,the,O,2538
51549,newborns,O,2538
51550,and,O,2538
51551,can,O,2538
51552,be,O,2539
51553,treated,O,2539
51554,with,O,2539
51555,nasal,B-TREATMENT,2539
51556,massages,I-TREATMENT,2539
51557,eye,B-TREATMENT,2539
51558,drops,I-TREATMENT,2539
51559,or,O,2539
51560,topical,B-TREATMENT,2539
51561,antibiotics,I-TREATMENT,2539
51562,If,O,2539
51563,the,O,2539
51564,problem,O,2539
51565,occurs,O,2539
51566,after,O,2539
51567,12,O,2539
51568,months,O,2539
51569,then,O,2539
51570,surgery,B-TREATMENT,2539
51571,may,I-TREATMENT,2539
51572,be,I-TREATMENT,2539
51573,needed,I-TREATMENT,2539
51574,to,I-TREATMENT,2539
51575,open,I-TREATMENT,2539
51576,the,I-TREATMENT,2539
51577,drainage,I-TREATMENT,2540
51578,which,I-TREATMENT,2540
51579,is,I-TREATMENT,2540
51580,the,I-TREATMENT,2540
51581,blocked,I-TREATMENT,2540
51582,tear,I-TREATMENT,2540
51583,duct,I-TREATMENT,2540
51584,With,O,2540
51585,early,O,2540
51586,diagnosis,O,2540
51587,the,O,2540
51588,operation,O,2540
51589,can,O,2540
51590,be,O,2540
51591,done,O,2540
51592,by,O,2540
51593,the,O,2540
51594,practitioner,O,2540
51595,however,O,2540
51596,If,O,2540
51597,the,O,2541
51598,diagnoses,O,2541
51599,are,O,2541
51600,not,O,2541
51601,certain,O,2541
51602,the,O,2541
51603,child,O,2541
51604,should,O,2541
51605,be,O,2541
51606,cared,O,2541
51607,by,O,2541
51608,an,O,2541
51609,ophthalmologist,O,2541
51610,A,O,2541
51611,research,O,2541
51612,team-,O,2541
51613,led,O,2541
51614,by,O,2541
51615,Professor,B-PERSON,2541
51616,Akira,I-PERSON,2541
51617,Murakami,I-PERSON,2542
51618,and,O,2542
51619,Associate,B-PERSON,2542
51620,Professor,I-PERSON,2542
51621,Takenori,I-PERSON,2542
51622,Inomata,I-PERSON,2542
51623,of,O,2542
51624,the,O,2542
51625,Juntendo,O,2542
51626,University,O,2542
51627,Graduate,O,2542
51628,School,O,2542
51629,of,O,2542
51630,Medicine-,O,2542
51631,has,O,2542
51632,developed,O,2542
51633,DryEyeRhythm,B-DIAGNOSTIC_TEST,2542
51634,a,O,2542
51635,non-invasive,O,2542
51636,and,O,2542
51637,reliable,O,2543
51638,mobile,O,2543
51639,app,O,2543
51640,to,O,2543
51641,assess,O,2543
51642,dry,B-NAME_OF_DISEASE,2543
51643,eye,I-NAME_OF_DISEASE,2543
51644,disease,I-NAME_OF_DISEASE,2543
51645,DryEyeRhythm,B-DIAGNOSTIC_TEST,2543
51646,leverages,O,2543
51647,the,O,2543
51648,cameras,O,2543
51649,in,O,2543
51650,smartphones,O,2544
51651,to,O,2544
51652,measure,O,2544
51653,users,O,2544
51654,blink,O,2544
51655,characteristics,O,2544
51656,and,O,2544
51657,determine,O,2544
51658,maximum,B-DIAGNOSTIC_TEST,2544
51659,blink,I-DIAGNOSTIC_TEST,2544
51660,interval,I-DIAGNOSTIC_TEST,2544
51661,MBI,B-DIAGNOSTIC_TEST,2544
51662,#NAME?,O,2544
51663,substitute,O,2544
51664,for,O,2544
51665,tear,B-PART_OF_THE_EYES,2544
51666,film,I-PART_OF_THE_EYES,2544
51667,breakup,O,2544
51668,time,O,2544
51669,an,O,2544
51670,important,O,2544
51671,diagnostic,O,2544
51672,criterion,O,2544
51673,of,O,2544
51674,DED,B-NAME_OF_DISEASE,2544
51675,explains,O,2544
51676,Associate,O,2545
51677,Prof,O,2545
51678,Inomata,O,2545
51679,The,O,2545
51680,app,O,2545
51681,also,O,2545
51682,administers,O,2545
51683,Ocular,B-DIAGNOSTIC_TEST,2545
51684,Surface,I-DIAGNOSTIC_TEST,2545
51685,Disease,I-DIAGNOSTIC_TEST,2545
51686,Index,I-DIAGNOSTIC_TEST,2545
51687,OSDI,I-DIAGNOSTIC_TEST,2545
51688,questionnaires,I-DIAGNOSTIC_TEST,2545
51689,which,O,2545
51690,are,O,2545
51691,also,O,2545
51692,a,O,2545
51693,crucial,O,2545
51694,component,O,2545
51695,of,O,2545
51696,DED,B-NAME_OF_DISEASE,2545
51697,diagnosis,O,2545
51698,To,O,2546
51699,verify,O,2546
51700,the,O,2546
51701,usefulness,O,2546
51702,of,O,2546
51703,the,O,2546
51704,app,O,2546
51705,the,O,2546
51706,research,O,2546
51707,team,O,2546
51708,carried,O,2546
51709,out,O,2546
51710,a,O,2546
51711,prospective,O,2546
51712,cross-sectional,O,2547
51713,observational,O,2547
51714,single-center,O,2547
51715,study,O,2547
51716,The,O,2547
51717,findings,O,2547
51718,of,O,2547
51719,this,O,2547
51720,study,O,2547
51721,were,O,2547
51722,published,O,2547
51723,in,B-PUBLICATION_VENUE,2547
51724,The,I-PUBLICATION_VENUE,2547
51725,Ocular,I-PUBLICATION_VENUE,2547
51726,Surface,I-PUBLICATION_VENUE,2547
51727,The,O,2547
51728,study,O,2547
51729,The,O,2547
51730,researchers,O,2547
51731,enrolled,O,2547
51732,82,O,2547
51733,patients,O,2547
51734,who,O,2547
51735,visited,O,2547
51736,the,B-ORGANIZATION,2547
51737,Juntendo,I-ORGANIZATION,2547
51738,University,I-ORGANIZATION,2547
51739,Hospital,I-ORGANIZATION,2547
51740,s,I-ORGANIZATION,2547
51741,ophthalmology,I-ORGANIZATION,2547
51742,outpatient,I-ORGANIZATION,2547
51743,clinic,I-ORGANIZATION,2548
51744,between,B-TIME_DURATION,2548
51745,July,I-TIME_DURATION,2548
51746,2020,I-TIME_DURATION,2548
51747,and,I-TIME_DURATION,2548
51748,May,I-TIME_DURATION,2548
51749,2021,I-TIME_DURATION,2548
51750,and,O,2548
51751,were,O,2548
51752,at,O,2548
51753,least,O,2548
51754,20,O,2548
51755,years,O,2549
51756,old,O,2549
51757,The,O,2549
51758,participants,O,2549
51759,conducted,O,2549
51760,evaluations,O,2549
51761,for,O,2549
51762,MBI,B-DIAGNOSTIC_TEST,2549
51763,using,O,2549
51764,the,O,2549
51765,app,O,2549
51766,and,O,2549
51767,other,O,2549
51768,analysis,O,2549
51769,methods,O,2549
51770,as,O,2549
51771,well,O,2549
51772,as,O,2549
51773,completing,O,2549
51774,the,B-DIAGNOSTIC_TEST,2549
51775,OSDI,I-DIAGNOSTIC_TEST,2550
51776,questionnaire,I-DIAGNOSTIC_TEST,2550
51777,in,I-DIAGNOSTIC_TEST,2550
51778,Japanese,I-DIAGNOSTIC_TEST,2550
51779,J-OSDI,B-DIAGNOSTIC_TEST,2550
51780,,O,2550
51781,The,O,2550
51782,app,O,2550
51783,also,O,2550
51784,showed,O,2550
51785,good,O,2550
51786,positive,O,2550
51787,and,O,2550
51788,negative,O,2550
51789,predictive,O,2550
51790,values,O,2550
51791,with,O,2550
51792,91.3,O,2550
51793,and,O,2550
51794,69.1,O,2550
51795,respectively,O,2551
51796,The,O,2551
51797,area,O,2551
51798,under,O,2551
51799,the,O,2551
51800,Receiver,O,2551
51801,operating,O,2551
51802,characteristic,O,2551
51803,ROC,O,2551
51804,curve-a,O,2551
51805,measure,O,2551
51806,of,O,2551
51807,clinical,O,2551
51808,sensitivity,O,2551
51809,and,O,2551
51810,specificity-for,O,2551
51811,the,O,2551
51812,concurrent,O,2551
51813,use,O,2552
51814,of,O,2552
51815,the,O,2552
51816,app-based,O,2552
51817,J-OSDI,B-DIAGNOSTIC_TEST,2552
51818,and,O,2552
51819,MBI,B-DIAGNOSTIC_TEST,2552
51820,was,O,2552
51821,also,O,2552
51822,high,O,2552
51823,with,O,2552
51824,a,O,2552
51825,value,O,2552
51826,of,O,2552
51827,0.91,O,2552
51828,These,O,2553
51829,results,O,2553
51830,demonstrate,O,2553
51831,that,O,2553
51832,the,O,2553
51833,app,O,2553
51834,is,O,2553
51835,a,O,2553
51836,reliable,O,2553
51837,valid,O,2553
51838,and,O,2553
51839,moreover,O,2553
51840,non-invasive,O,2553
51841,instrument,O,2553
51842,for,O,2553
51843,assessing,O,2554
51844,DED,B-NAME_OF_DISEASE,2554
51845,Non-contact,O,2554
51846,and,O,2554
51847,non-invasive,O,2554
51848,DED,B-NAME_OF_DISEASE,2554
51849,diagnostic,O,2554
51850,assistance,O,2554
51851,like,O,2554
51852,the,O,2554
51853,kind,O,2554
51854,provided,O,2554
51855,by,O,2554
51856,DryEyeRhythm,B-DIAGNOSTIC_TEST,2554
51857,could,O,2554
51858,help,O,2554
51859,facilitate,O,2554
51860,the,O,2554
51861,early,O,2554
51862,diagnosis,O,2554
51863,and,O,2554
51864,treatment,O,2554
51865,of,O,2554
51866,patients,O,2554
51867,as,O,2554
51868,well,O,2554
51869,as,O,2554
51870,DED,B-NAME_OF_DISEASE,2554
51871,treatment,O,2554
51872,through,O,2554
51873,telemedicine,B-TREATMENT,2554
51874,and,I-TREATMENT,2554
51875,online,I-TREATMENT,2554
51876,medical,I-TREATMENT,2554
51877,care,I-TREATMENT,2554
51878,says,O,2554
51879,Associate,O,2554
51880,Prof,O,2554
51881,Inomata,O,2554
51882,The,O,2554
51883,research,O,2554
51884,team,O,2554
51885,plans,O,2555
51886,to,O,2555
51887,further,O,2555
51888,validate,O,2555
51889,its,O,2555
51890,results,O,2555
51891,by,O,2555
51892,conducting,O,2555
51893,a,O,2555
51894,multi-institutional,O,2555
51895,collaborative,O,2555
51896,study,O,2555
51897,in,O,2555
51898,the,O,2555
51899,future,O,2555
51900,They,O,2555
51901,are,O,2555
51902,also,O,2555
51903,planning,O,2555
51904,to,O,2555
51905,obtain,O,2555
51906,medical,O,2555
51907,device,O,2555
51908,approval,O,2555
51909,and,O,2555
51910,insurance,O,2555
51911,reimbursement,O,2555
51912,for,O,2555
51913,the,O,2555
51914,smartphone,O,2555
51915,application,O,2555
51916,What,O,2555
51917,is,O,2555
51918,dry,B-NAME_OF_DISEASE,2555
51919,eye,I-NAME_OF_DISEASE,2555
51920,disease,I-NAME_OF_DISEASE,2555
51921,Dry,B-NAME_OF_DISEASE,2556
51922,eye,I-NAME_OF_DISEASE,2556
51923,disease,I-NAME_OF_DISEASE,2556
51924,DED,I-NAME_OF_DISEASE,2556
51925,is,O,2556
51926,a,O,2556
51927,condition,O,2556
51928,characterized,O,2556
51929,by,O,2556
51930,an,O,2556
51931,array,O,2556
51932,of,O,2556
51933,symptoms,O,2556
51934,including,O,2556
51935,dryness,B-SIGN_AND_SYMPTOM,2556
51936,ocular,I-SIGN_AND_SYMPTOM,2556
51937,discomfort,I-SIGN_AND_SYMPTOM,2556
51938,fatigue,I-SIGN_AND_SYMPTOM,2556
51939,and,I-SIGN_AND_SYMPTOM,2556
51940,visual,I-SIGN_AND_SYMPTOM,2556
51941,disturbances,I-SIGN_AND_SYMPTOM,2556
51942,This,O,2556
51943,condition,O,2557
51944,has,O,2557
51945,become,O,2557
51946,more,O,2557
51947,prevalent,O,2557
51948,in,O,2557
51949,recent,O,2557
51950,years,O,2557
51951,as,O,2557
51952,a,O,2557
51953,result,O,2557
51954,of,O,2557
51955,an,B-CAUSE_OF_DISEASE,2557
51956,aging,I-CAUSE_OF_DISEASE,2557
51957,society,I-CAUSE_OF_DISEASE,2557
51958,higher,B-CAUSE_OF_DISEASE,2557
51959,screen,I-CAUSE_OF_DISEASE,2557
51960,time,I-CAUSE_OF_DISEASE,2557
51961,and,O,2557
51962,a,B-CAUSE_OF_DISEASE,2557
51963,highly,I-CAUSE_OF_DISEASE,2557
51964,stressful,I-CAUSE_OF_DISEASE,2557
51965,social,I-CAUSE_OF_DISEASE,2557
51966,environment,I-CAUSE_OF_DISEASE,2557
51967,There,O,2557
51968,are,O,2557
51969,over,O,2557
51970,1,O,2557
51971,billion,O,2557
51972,DED,B-NAME_OF_DISEASE,2557
51973,patients,O,2557
51974,globally,O,2558
51975,DED,B-NAME_OF_DISEASE,2558
51976,that,O,2558
51977,is,O,2558
51978,left,O,2558
51979,undiagnosed,O,2558
51980,and,O,2558
51981,untreated,O,2558
51982,can,O,2558
51983,cause,O,2558
51984,a,O,2558
51985,number,O,2558
51986,of,O,2558
51987,symptoms,O,2558
51988,such,O,2558
51989,as,O,2558
51990,ocular,B-SIGN_AND_SYMPTOM,2558
51991,fatigue,I-SIGN_AND_SYMPTOM,2558
51992,light,I-SIGN_AND_SYMPTOM,2558
51993,sensitivity,I-SIGN_AND_SYMPTOM,2558
51994,poor,I-SIGN_AND_SYMPTOM,2558
51995,vision,I-SIGN_AND_SYMPTOM,2558
51996,and,I-SIGN_AND_SYMPTOM,2558
51997,a,I-SIGN_AND_SYMPTOM,2558
51998,decreased,I-SIGN_AND_SYMPTOM,2558
51999,quality,I-SIGN_AND_SYMPTOM,2558
52000,of,I-SIGN_AND_SYMPTOM,2559
52001,life,I-SIGN_AND_SYMPTOM,2559
52002,Given,O,2559
52003,the,O,2559
52004,condition,O,2559
52005,s,O,2559
52006,extensive,O,2559
52007,prevalence,O,2559
52008,this,O,2559
52009,may,O,2559
52010,also,O,2559
52011,result,O,2559
52012,in,O,2559
52013,decreased,O,2559
52014,productivity,O,2559
52015,at,O,2559
52016,work,O,2559
52017,and,O,2560
52018,financial,O,2560
52019,loss,O,2560
52020,March,O,2560
52021,is,O,2560
52022,Workplace,O,2560
52023,Eye,O,2560
52024,Wellness,O,2560
52025,at,O,2560
52026,Prevent,B-ORGANIZATION,2560
52027,Blindness,I-ORGANIZATION,2560
52028,This,O,2560
52029,month,O,2560
52030,the,O,2560
52031,group,O,2560
52032,will,O,2560
52033,provide,O,2560
52034,free,O,2560
52035,resources,O,2560
52036,including,O,2560
52037,an,O,2560
52038,overview,O,2560
52039,of,O,2560
52040,proper,O,2560
52041,eye,O,2560
52042,protection,O,2560
52043,and,O,2560
52044,safety,O,2560
52045,glasses,O,2560
52046,for,O,2560
52047,various,O,2560
52048,industries,O,2560
52049,and,O,2560
52050,information,O,2561
52051,on,O,2561
52052,the,O,2561
52053,effects,O,2561
52054,of,O,2561
52055,extended,O,2561
52056,digital,O,2562
52057,screen,O,2562
52058,use,O,2562
52059,According,O,2562
52060,to,O,2562
52061,a,O,2562
52062,recent,O,2562
52063,report,O,2562
52064,from,O,2562
52065,the,O,2562
52066,U.S,O,2562
52067,Bureau,O,2562
52068,of,O,2562
52069,Labor,O,2562
52070,Statistics,O,2562
52071,there,O,2562
52072,were,O,2562
52073,15,O,2562
52074,730,O,2562
52075,eye,O,2562
52076,injuries,O,2562
52077,involving,O,2562
52078,days,O,2563
52079,away,O,2563
52080,from,O,2563
52081,work,O,2563
52082,in,O,2563
52083,2020,O,2563
52084,Proper,O,2563
52085,eye,O,2563
52086,protection,O,2563
52087,minimizes,O,2563
52088,the,O,2563
52089,risk,O,2563
52090,of,O,2563
52091,significant,O,2563
52092,eye,O,2563
52093,injury,O,2563
52094,Prevent,B-ORGANIZATION,2563
52095,Blindness,I-ORGANIZATION,2563
52096,recommends,O,2563
52097,that,O,2563
52098,the,O,2563
52099,type,O,2564
52100,of,O,2564
52101,eye,O,2564
52102,protection,O,2564
52103,that,O,2564
52104,should,O,2564
52105,be,O,2564
52106,used,O,2564
52107,depends,O,2564
52108,on,O,2564
52109,the,O,2564
52110,hazards,O,2564
52111,in,O,2564
52112,the,O,2564
52113,workplace,O,2564
52114,For,O,2564
52115,instance,O,2564
52116,someone,O,2564
52117,working,O,2564
52118,in,O,2564
52119,an,O,2564
52120,area,O,2564
52121,that,O,2564
52122,has,O,2564
52123,particles,O,2564
52124,flying,O,2564
52125,objects,O,2564
52126,or,O,2564
52127,dust,O,2564
52128,should,O,2564
52129,wear,B-PREVENTION,2565
52130,safety,I-PREVENTION,2565
52131,glasses,I-PREVENTION,2565
52132,with,I-PREVENTION,2565
52133,side,I-PREVENTION,2565
52134,protection,I-PREVENTION,2565
52135,side,I-PREVENTION,2565
52136,shields,I-PREVENTION,2565
52137,,O,2565
52138,If,O,2565
52139,working,O,2565
52140,near,O,2565
52141,hazardous,O,2565
52142,radiation,O,2565
52143,welding,O,2565
52144,lasers,O,2565
52145,or,O,2565
52146,fiber,O,2565
52147,optics,O,2565
52148,special-purpose,B-PREVENTION,2565
52149,safety,I-PREVENTION,2565
52150,glasses,I-PREVENTION,2565
52151,goggles,I-PREVENTION,2565
52152,face,I-PREVENTION,2565
52153,shields,I-PREVENTION,2565
52154,or,I-PREVENTION,2565
52155,helmets,I-PREVENTION,2565
52156,designed,O,2565
52157,for,O,2566
52158,that,O,2566
52159,task,O,2566
52160,should,O,2566
52161,be,O,2566
52162,worn,O,2566
52163,The,B-ORGANIZATION,2566
52164,Occupational,I-ORGANIZATION,2566
52165,Safety,I-ORGANIZATION,2566
52166,and,I-ORGANIZATION,2566
52167,Health,I-ORGANIZATION,2566
52168,Administration,I-ORGANIZATION,2566
52169,OSHA,B-ORGANIZATION,2566
52170,requires,O,2566
52171,employers,O,2566
52172,to,O,2566
52173,ensure,O,2566
52174,the,O,2566
52175,safety,O,2566
52176,of,O,2566
52177,all,O,2566
52178,employees,O,2566
52179,in,O,2566
52180,the,O,2566
52181,work,O,2566
52182,environment,O,2567
52183,Eye,B-PREVENTION,2567
52184,and,I-PREVENTION,2567
52185,face,I-PREVENTION,2567
52186,protection,I-PREVENTION,2567
52187,must,O,2567
52188,be,O,2567
52189,provided,O,2567
52190,whenever,O,2567
52191,necessary,O,2567
52192,to,O,2567
52193,protect,O,2567
52194,against,O,2567
52195,chemical,B-CAUSE_OF_DISEASE,2567
52196,environmental,I-CAUSE_OF_DISEASE,2567
52197,radiological,I-CAUSE_OF_DISEASE,2567
52198,or,I-CAUSE_OF_DISEASE,2567
52199,mechanical,I-CAUSE_OF_DISEASE,2567
52200,irritants,I-CAUSE_OF_DISEASE,2567
52201,and,I-CAUSE_OF_DISEASE,2567
52202,hazards,I-CAUSE_OF_DISEASE,2567
52203,Employers,O,2567
52204,must,O,2568
52205,also,O,2568
52206,give,O,2568
52207,personal,B-PREVENTION,2568
52208,protection,I-PREVENTION,2568
52209,equipment,I-PREVENTION,2568
52210,PPE,B-PREVENTION,2568
52211,to,O,2568
52212,their,O,2568
52213,employees,O,2568
52214,and,O,2568
52215,ensure,O,2568
52216,that,O,2568
52217,it,O,2568
52218,is,O,2568
52219,used,O,2568
52220,properly,O,2568
52221,OSHA,B-ORGANIZATION,2568
52222,added,O,2568
52223,Additionally,O,2568
52224,employers,O,2568
52225,are,O,2568
52226,also,O,2568
52227,required,O,2568
52228,to,O,2568
52229,train,O,2568
52230,each,O,2568
52231,worker,O,2568
52232,required,O,2568
52233,to,O,2568
52234,use,O,2568
52235,PPE,B-PREVENTION,2568
52236,According,O,2568
52237,to,O,2568
52238,the,B-ORGANIZATION,2568
52239,American,I-ORGANIZATION,2568
52240,Optometric,I-ORGANIZATION,2568
52241,Association,I-ORGANIZATION,2568
52242,the,O,2568
52243,average,O,2568
52244,American,O,2568
52245,worker,O,2568
52246,spends,O,2568
52247,seven,O,2568
52248,hours,O,2568
52249,per,O,2568
52250,day,O,2568
52251,on,O,2568
52252,the,O,2568
52253,computer,O,2569
52254,whether,O,2569
52255,in,O,2569
52256,the,O,2569
52257,workplace,O,2569
52258,or,O,2569
52259,working,O,2569
52260,from,O,2569
52261,home,O,2569
52262,Digital,B-NAME_OF_DISEASE,2569
52263,eye,B-NAME_OF_DISEASE,2569
52264,strain,I-NAME_OF_DISEASE,2570
52265,is,O,2570
52266,more,O,2570
52267,common,O,2570
52268,among,O,2570
52269,employees,O,2570
52270,who,O,2570
52271,operate,O,2570
52272,primarily,O,2570
52273,on,O,2570
52274,digital,B-CAUSE_OF_DISEASE,2570
52275,devices,I-CAUSE_OF_DISEASE,2570
52276,such,I-CAUSE_OF_DISEASE,2570
52277,as,I-CAUSE_OF_DISEASE,2570
52278,computer,I-CAUSE_OF_DISEASE,2570
52279,monitors,I-CAUSE_OF_DISEASE,2570
52280,tablets,I-CAUSE_OF_DISEASE,2570
52281,and,I-CAUSE_OF_DISEASE,2570
52282,smart,I-CAUSE_OF_DISEASE,2570
52283,phones,I-CAUSE_OF_DISEASE,2570
52284,Sore,B-SIGN_AND_SYMPTOM,2570
52285,or,I-SIGN_AND_SYMPTOM,2570
52286,irritated,I-SIGN_AND_SYMPTOM,2570
52287,eyes,I-SIGN_AND_SYMPTOM,2570
52288,blurred,I-SIGN_AND_SYMPTOM,2570
52289,vision,I-SIGN_AND_SYMPTOM,2570
52290,and,I-SIGN_AND_SYMPTOM,2570
52291,headaches,I-SIGN_AND_SYMPTOM,2570
52292,are,O,2570
52293,all,O,2570
52294,signs,O,2570
52295,of,O,2570
52296,eye,B-NAME_OF_DISEASE,2570
52297,strain,I-NAME_OF_DISEASE,2570
52298,Prevent,B-ORGANIZATION,2570
52299,Blindness,I-ORGANIZATION,2571
52300,recommends,O,2571
52301,the,O,2571
52302,following,O,2571
52303,Screen,O,2571
52304,time,O,2571
52305,Try,O,2571
52306,to,O,2571
52307,decrease,B-PREVENTION,2571
52308,the,I-PREVENTION,2571
52309,amount,I-PREVENTION,2571
52310,of,I-PREVENTION,2571
52311,time,I-PREVENTION,2571
52312,spent,I-PREVENTION,2571
52313,in,I-PREVENTION,2571
52314,front,I-PREVENTION,2571
52315,of,I-PREVENTION,2571
52316,these,I-PREVENTION,2571
52317,screens,I-PREVENTION,2571
52318,and,I-PREVENTION,2571
52319,or,I-PREVENTION,2571
52320,take,I-PREVENTION,2571
52321,frequent,I-PREVENTION,2571
52322,breaks,I-PREVENTION,2571
52323,to,O,2571
52324,give,O,2571
52325,your,O,2571
52326,eyes,O,2571
52327,a,O,2571
52328,rest,O,2571
52329,Filters,O,2571
52330,Screen,B-PREVENTION,2571
52331,filters,I-PREVENTION,2571
52332,are,I-PREVENTION,2571
52333,available,I-PREVENTION,2571
52334,for,I-PREVENTION,2571
52335,smart,I-PREVENTION,2572
52336,phones,I-PREVENTION,2572
52337,tablets,I-PREVENTION,2572
52338,and,I-PREVENTION,2572
52339,computer,I-PREVENTION,2572
52340,screens,I-PREVENTION,2572
52341,They,O,2572
52342,decrease,O,2572
52343,the,O,2572
52344,amount,O,2572
52345,of,O,2572
52346,blue,B-CAUSE_OF_DISEASE,2572
52347,light,I-CAUSE_OF_DISEASE,2572
52348,given,O,2572
52349,off,O,2572
52350,from,O,2572
52351,these,O,2572
52352,devices,O,2572
52353,that,O,2572
52354,could,O,2572
52355,reach,O,2572
52356,the,B-PART_OF_THE_EYES,2572
52357,retina,B-PART_OF_THE_EYES,2572
52358,in,I-PART_OF_THE_EYES,2573
52359,the,I-PART_OF_THE_EYES,2573
52360,eyes,I-PART_OF_THE_EYES,2573
52361,Anti-reflective,B-PREVENTION,2573
52362,lenses,I-PREVENTION,2573
52363,Anti-reflective,B-PREVENTION,2573
52364,lenses,I-PREVENTION,2573
52365,reduce,O,2573
52366,glare,O,2573
52367,and,O,2573
52368,increase,O,2573
52369,contrast,O,2573
52370,and,O,2573
52371,also,O,2573
52372,block,O,2573
52373,blue,B-CAUSE_OF_DISEASE,2573
52374,light,I-CAUSE_OF_DISEASE,2573
52375,from,I-CAUSE_OF_DISEASE,2573
52376,the,I-CAUSE_OF_DISEASE,2573
52377,sun,I-CAUSE_OF_DISEASE,2573
52378,and,I-CAUSE_OF_DISEASE,2574
52379,digital,I-CAUSE_OF_DISEASE,2574
52380,devices,I-CAUSE_OF_DISEASE,2574
52381,Intraocular,B-PREVENTION,2574
52382,lens,I-PREVENTION,2574
52383,IOL,B-PREVENTION,2574
52384,After,O,2574
52385,cataract,B-NAME_OF_DISEASE,2574
52386,surgery,O,2574
52387,the,O,2574
52388,cloudy,O,2574
52389,lens,O,2574
52390,will,O,2574
52391,be,O,2574
52392,replaced,O,2574
52393,with,O,2574
52394,an,B-PREVENTION,2574
52395,intraocular,I-PREVENTION,2574
52396,lens,I-PREVENTION,2574
52397,IOL,B-PREVENTION,2574
52398,,O,2574
52399,The,O,2574
52400,lens,O,2574
52401,naturally,O,2574
52402,protects,O,2574
52403,the,O,2574
52404,eye,O,2574
52405,from,O,2574
52406,almost,O,2574
52407,all,O,2574
52408,ultraviolet,B-CAUSE_OF_DISEASE,2574
52409,light,I-CAUSE_OF_DISEASE,2574
52410,and,I-CAUSE_OF_DISEASE,2574
52411,some,I-CAUSE_OF_DISEASE,2575
52412,blue,I-CAUSE_OF_DISEASE,2575
52413,light,I-CAUSE_OF_DISEASE,2575
52414,There,O,2575
52415,are,O,2575
52416,types,O,2575
52417,of,O,2575
52418,IOL,B-PREVENTION,2575
52419,that,O,2575
52420,can,O,2575
52421,protect,O,2575
52422,the,O,2575
52423,eye,O,2575
52424,and,O,2575
52425,retina,B-PART_OF_THE_EYES,2575
52426,from,O,2575
52427,blue,B-CAUSE_OF_DISEASE,2575
52428,light,I-CAUSE_OF_DISEASE,2575
52429,Practicing,B-PREVENTION,2575
52430,eye,I-PREVENTION,2575
52431,healthy,I-PREVENTION,2575
52432,habits,I-PREVENTION,2575
52433,in,I-PREVENTION,2575
52434,the,I-PREVENTION,2575
52435,workplace,I-PREVENTION,2575
52436,today,O,2575
52437,like,O,2575
52438,wearing,B-PREVENTION,2575
52439,proper,I-PREVENTION,2575
52440,eye,I-PREVENTION,2575
52441,protection,I-PREVENTION,2575
52442,and,O,2575
52443,decreasing,B-PREVENTION,2575
52444,the,I-PREVENTION,2575
52445,amount,I-PREVENTION,2575
52446,of,I-PREVENTION,2575
52447,screen,I-PREVENTION,2575
52448,time,I-PREVENTION,2575
52449,whenever,I-PREVENTION,2575
52450,possible,I-PREVENTION,2575
52451,can,O,2576
52452,help,O,2576
52453,save,O,2576
52454,our,O,2576
52455,sight,O,2576
52456,now,O,2576
52457,and,O,2576
52458,for,O,2576
52459,years,O,2576
52460,to,O,2576
52461,come,O,2576
52462,said,O,2576
52463,Jeff,B-PERSON,2576
52464,Todd,I-PERSON,2576
52465,president,O,2576
52466,and,O,2576
52467,CEO,O,2577
52468,of,O,2577
52469,Prevent,B-ORGANIZATION,2577
52470,Blindness,I-ORGANIZATION,2577
52471,A,O,2577
52472,team,O,2577
52473,led,O,2577
52474,by,O,2577
52475,researchers,O,2577
52476,from,O,2577
52477,the,B-ORGANIZATION,2577
52478,University,I-ORGANIZATION,2577
52479,of,I-ORGANIZATION,2577
52480,Waterloo,B-ORGANIZATION,2577
52481,discovered,O,2577
52482,that,O,2577
52483,participating,B-TREATMENT,2577
52484,in,I-TREATMENT,2577
52485,aerobic,I-TREATMENT,2577
52486,exercise,I-TREATMENT,2577
52487,can,O,2577
52488,provide,O,2577
52489,relief,O,2577
52490,for,O,2577
52491,dry,B-SIGN_AND_SYMPTOM,2577
52492,itchy,I-SIGN_AND_SYMPTOM,2577
52493,eyes,I-SIGN_AND_SYMPTOM,2577
52494,as,O,2577
52495,it,O,2577
52496,causes,O,2577
52497,a,O,2577
52498,significant,O,2577
52499,increase,O,2577
52500,in,O,2577
52501,tear,O,2577
52502,secretion,O,2577
52503,and,O,2577
52504,tear,B-PART_OF_THE_EYES,2577
52505,film,I-PART_OF_THE_EYES,2577
52506,stability,O,2577
52507,Every,O,2577
52508,time,O,2578
52509,we,O,2578
52510,blink,O,2578
52511,our,O,2578
52512,eyes,O,2578
52513,are,O,2578
52514,covered,O,2578
52515,in,O,2578
52516,tear,B-PART_OF_THE_EYES,2578
52517,film,I-PART_OF_THE_EYES,2578
52518,which,O,2578
52519,is,O,2578
52520,an,O,2578
52521,essential,O,2578
52522,protective,O,2578
52523,layer,O,2578
52524,for,O,2578
52525,preserving,O,2578
52526,proper,O,2578
52527,ocular,O,2579
52528,function,O,2579
52529,The,O,2579
52530,three,O,2579
52531,layers,O,2579
52532,of,O,2579
52533,a,O,2579
52534,healthy,O,2579
52535,tear,B-PART_OF_THE_EYES,2579
52536,film,I-PART_OF_THE_EYES,2579
52537,-,O,2579
52538,oil,O,2579
52539,water,O,2579
52540,and,O,2579
52541,mucin,O,2579
52542,-,O,2579
52543,work,O,2579
52544,together,O,2579
52545,to,O,2579
52546,moisten,O,2579
52547,the,O,2579
52548,ocular,O,2579
52549,surface,O,2579
52550,and,O,2579
52551,protect,O,2579
52552,it,O,2579
52553,from,O,2579
52554,infection-causing,B-CAUSE_OF_DISEASE,2580
52555,irritants,I-CAUSE_OF_DISEASE,2580
52556,like,I-CAUSE_OF_DISEASE,2580
52557,dust,I-CAUSE_OF_DISEASE,2580
52558,and,I-CAUSE_OF_DISEASE,2580
52559,dirt,I-CAUSE_OF_DISEASE,2580
52560,The,O,2580
52561,ocular,O,2580
52562,surface,O,2580
52563,can,O,2580
52564,develop,O,2580
52565,dry,B-SIGN_AND_SYMPTOM,2580
52566,spots,I-SIGN_AND_SYMPTOM,2580
52567,when,O,2580
52568,any,O,2580
52569,component,O,2580
52570,of,O,2580
52571,the,B-PART_OF_THE_EYES,2580
52572,tear,I-PART_OF_THE_EYES,2580
52573,film,I-PART_OF_THE_EYES,2580
52574,becomes,O,2580
52575,unstable,O,2581
52576,causing,O,2581
52577,eye,O,2581
52578,symptoms,O,2581
52579,such,O,2581
52580,as,O,2581
52581,itching,B-SIGN_AND_SYMPTOM,2581
52582,stinging,I-SIGN_AND_SYMPTOM,2581
52583,and,I-SIGN_AND_SYMPTOM,2581
52584,burning,I-SIGN_AND_SYMPTOM,2581
52585,sensations,I-SIGN_AND_SYMPTOM,2581
52586,With,O,2581
52587,so,O,2581
52588,much,O,2581
52589,of,O,2581
52590,our,O,2581
52591,activity,O,2581
52592,tied,O,2581
52593,to,O,2581
52594,screen,B-CAUSE_OF_DISEASE,2581
52595,usage,I-CAUSE_OF_DISEASE,2581
52596,dry,B-NAME_OF_DISEASE,2581
52597,eye,I-NAME_OF_DISEASE,2581
52598,symptoms,I-NAME_OF_DISEASE,2581
52599,are,O,2581
52600,becoming,O,2582
52601,increasingly,O,2582
52602,common,O,2582
52603,Instead,O,2582
52604,of,O,2582
52605,having,O,2582
52606,to,O,2582
52607,use,O,2582
52608,eye,B-TREATMENT,2582
52609,drops,I-TREATMENT,2582
52610,or,O,2582
52611,other,O,2582
52612,alternative,O,2582
52613,treatments,O,2582
52614,our,O,2582
52615,study,O,2582
52616,aimed,O,2582
52617,to,O,2582
52618,determine,O,2582
52619,if,O,2582
52620,remaining,O,2582
52621,physically,O,2582
52622,active,O,2582
52623,can,O,2583
52624,be,O,2583
52625,an,O,2583
52626,effective,O,2583
52627,preventative,O,2583
52628,measure,O,2583
52629,against,O,2583
52630,dryness,B-SIGN_AND_SYMPTOM,2583
52631,said,O,2583
52632,Heinz,O,2583
52633,Otchere,B-PERSON,2583
52634,a,O,2583
52635,Ph.D,O,2583
52636,candidate,O,2583
52637,in,O,2583
52638,vision,O,2583
52639,science,O,2583
52640,at,O,2583
52641,Waterloo,B-ORGANIZATION,2583
52642,In,O,2583
52643,the,O,2583
52644,study,O,2583
52645,a,O,2583
52646,total,O,2583
52647,of,O,2583
52648,52,O,2583
52649,people,O,2583
52650,were,O,2583
52651,divided,O,2583
52652,into,O,2583
52653,two,O,2583
52654,groups,O,2583
52655,to,O,2583
52656,engage,O,2583
52657,in,O,2583
52658,a,O,2583
52659,workout,O,2583
52660,session,O,2583
52661,athletes,O,2584
52662,and,O,2584
52663,non-athletes,O,2584
52664,The,O,2584
52665,athlete,O,2584
52666,group,O,2584
52667,exercised,O,2584
52668,at,O,2584
52669,least,O,2584
52670,five,O,2584
52671,times,O,2584
52672,per,O,2584
52673,week,O,2584
52674,while,O,2584
52675,the,O,2584
52676,non-athlete,O,2584
52677,group,O,2584
52678,exercised,O,2584
52679,no,O,2584
52680,more,O,2584
52681,than,O,2584
52682,once,O,2584
52683,per,O,2584
52684,week,O,2584
52685,Tear,O,2584
52686,secretion,O,2584
52687,and,O,2584
52688,tear,O,2584
52689,break-up,O,2584
52690,time,O,2584
52691,were,O,2584
52692,measured,O,2584
52693,before,O,2584
52694,and,O,2585
52695,five,O,2585
52696,minutes,O,2585
52697,after,O,2585
52698,each,O,2585
52699,exercise,O,2585
52700,session,O,2585
52701,by,O,2585
52702,the,O,2585
52703,researchers,O,2585
52704,which,O,2585
52705,included,O,2585
52706,experts,O,2585
52707,from,O,2585
52708,the,B-ORGANIZATION,2585
52709,University,I-ORGANIZATION,2585
52710,of,I-ORGANIZATION,2585
52711,Cape,I-ORGANIZATION,2585
52712,Coast,I-ORGANIZATION,2585
52713,in,O,2585
52714,Ghana,B-GPE,2585
52715,While,O,2585
52716,the,O,2585
52717,athletic,O,2585
52718,group,O,2585
52719,exhibited,O,2585
52720,the,O,2585
52721,greatest,O,2585
52722,improvement,O,2585
52723,Otchere,B-PERSON,2585
52724,claims,O,2585
52725,that,O,2585
52726,all,O,2585
52727,subjects,O,2585
52728,experienced,O,2585
52729,a,O,2585
52730,significant,O,2585
52731,increase,O,2585
52732,in,O,2586
52733,tear,O,2586
52734,quantity,O,2586
52735,and,O,2586
52736,tear,B-PART_OF_THE_EYES,2586
52737,film,I-PART_OF_THE_EYES,2586
52738,stability,O,2586
52739,after,O,2586
52740,the,O,2586
52741,exercise,O,2586
52742,session,O,2586
52743,It,O,2586
52744,can,O,2586
52745,be,O,2586
52746,challenging,O,2586
52747,for,O,2586
52748,people,O,2586
52749,to,O,2586
52750,regularly,O,2586
52751,exercise,O,2586
52752,when,O,2586
52753,the,O,2586
52754,demand,O,2586
52755,is,O,2586
52756,there,O,2586
52757,to,O,2586
52758,work,O,2586
52759,increasingly,O,2587
52760,longer,O,2587
52761,hours,O,2587
52762,in,O,2587
52763,front,O,2587
52764,of,O,2587
52765,screens,O,2587
52766,Otchere,B-PERSON,2587
52767,said,O,2587
52768,However,O,2587
52769,our,O,2587
52770,findings,O,2587
52771,show,O,2587
52772,physical,O,2587
52773,activity,O,2587
52774,can,O,2587
52775,be,O,2587
52776,really,O,2587
52777,important,O,2587
52778,for,O,2587
52779,not,O,2587
52780,just,O,2587
52781,our,O,2587
52782,overall,O,2587
52783,well-being,O,2587
52784,but,O,2587
52785,for,O,2588
52786,our,O,2588
52787,ocular,O,2588
52788,health,O,2588
52789,too,O,2588
52790,The,B-NAME_OF_STUDY,2588
52791,study,I-NAME_OF_STUDY,2588
52792,Differential,I-NAME_OF_STUDY,2588
52793,effect,I-NAME_OF_STUDY,2588
52794,of,I-NAME_OF_STUDY,2588
52795,maximal,I-NAME_OF_STUDY,2588
52796,incremental,I-NAME_OF_STUDY,2588
52797,treadmill,I-NAME_OF_STUDY,2588
52798,exercise,I-NAME_OF_STUDY,2588
52799,on,I-NAME_OF_STUDY,2588
52800,tear,I-NAME_OF_STUDY,2588
52801,secretion,I-NAME_OF_STUDY,2588
52802,and,I-NAME_OF_STUDY,2589
52803,tear,I-NAME_OF_STUDY,2589
52804,film,I-NAME_OF_STUDY,2589
52805,stability,I-NAME_OF_STUDY,2589
52806,in,I-NAME_OF_STUDY,2589
52807,athletes,I-NAME_OF_STUDY,2589
52808,and,I-NAME_OF_STUDY,2589
52809,non-athletes,I-NAME_OF_STUDY,2589
52810,was,O,2589
52811,co-authored,O,2589
52812,by,O,2589
52813,Otchere,B-PERSON,2589
52814,the,B-ORGANIZATION,2589
52815,University,I-ORGANIZATION,2590
52816,of,I-ORGANIZATION,2590
52817,Cape,I-ORGANIZATION,2590
52818,Coast,I-ORGANIZATION,2590
52819,s,O,2590
52820,Samuel,B-PERSON,2590
52821,Abokyi,I-PERSON,2590
52822,Sekyere,B-PERSON,2590
52823,Nyamaah,I-PERSON,2590
52824,and,O,2590
52825,Michael,B-PERSON,2590
52826,Ntodie,I-PERSON,2590
52827,and,O,2590
52828,Ghana,B-GPE,2590
52829,s,O,2590
52830,Our,B-ORGANIZATION,2590
52831,Lady,I-ORGANIZATION,2591
52832,of,I-ORGANIZATION,2591
52833,Grace,I-ORGANIZATION,2591
52834,Hospital,I-ORGANIZATION,2591
52835,s,O,2591
52836,Yaw,B-PERSON,2592
52837,Osei,I-PERSON,2592
52838,Akoto,I-PERSON,2592
52839,The,O,2592
52840,study,O,2592
52841,was,O,2592
52842,recently,O,2592
52843,published,O,2592
52844,in,O,2592
52845,the,B-PUBLICATION_VENUE,2593
52846,Experimental,I-PUBLICATION_VENUE,2594
52847,Eye,I-PUBLICATION_VENUE,2594
52848,Research,I-PUBLICATION_VENUE,2594
52849,journal,I-PUBLICATION_VENUE,2594
52850,Luminopia,B-ORGANIZATION,2594
52851,has,O,2594
52852,received,O,2594
52853,de,O,2594
52854,novo,O,2594
52855,premarket,O,2594
52856,approval,O,2594
52857,by,O,2594
52858,the,B-ORGANIZATION,2594
52859,FDA,B-ORGANIZATION,2594
52860,for,O,2594
52861,Luminopia,B-TREATMENT,2594
52862,One,I-TREATMENT,2594
52863,as,O,2594
52864,a,O,2594
52865,prescription,O,2594
52866,therapy,O,2594
52867,to,O,2594
52868,improve,O,2594
52869,vision,O,2594
52870,in,O,2594
52871,children,O,2594
52872,with,O,2595
52873,amblyopia,B-NAME_OF_DISEASE,2595
52874,lazy,I-NAME_OF_DISEASE,2595
52875,eye,I-NAME_OF_DISEASE,2595
52876,the,O,2595
52877,most,O,2595
52878,common,O,2595
52879,cause,O,2595
52880,of,O,2595
52881,vision,B-SIGN_AND_SYMPTOM,2595
52882,loss,I-SIGN_AND_SYMPTOM,2595
52883,in,O,2595
52884,children,O,2595
52885,Luminopia,B-TREATMENT,2595
52886,One,I-TREATMENT,2595
52887,is,O,2595
52888,intended,O,2595
52889,for,O,2595
52890,the,O,2595
52891,improvement,O,2595
52892,of,O,2595
52893,visual,O,2595
52894,acuity,O,2595
52895,in,O,2595
52896,children,O,2595
52897,aged,O,2595
52898,4,O,2595
52899,to,O,2595
52900,7,O,2596
52901,who,O,2596
52902,have,O,2596
52903,amblyopia,B-NAME_OF_DISEASE,2596
52904,anisometropia,B-NAME_OF_DISEASE,2596
52905,and,O,2596
52906,or,O,2596
52907,mild,O,2596
52908,strabismus,B-NAME_OF_DISEASE,2596
52909,and,O,2596
52910,who,O,2596
52911,have,O,2596
52912,followed,O,2596
52913,treatment,O,2596
52914,recommendations,O,2596
52915,given,O,2596
52916,by,O,2596
52917,a,O,2596
52918,competent,O,2596
52919,eye-care,O,2596
52920,professional,O,2596
52921,Luminopia,B-TREATMENT,2596
52922,One,I-TREATMENT,2596
52923,is,O,2596
52924,a,O,2596
52925,virtual,O,2597
52926,reality,O,2597
52927,VR,O,2597
52928,headset,O,2597
52929,that,O,2597
52930,allows,O,2597
52931,patients,O,2597
52932,to,O,2597
52933,watch,O,2597
52934,therapeutically,O,2597
52935,modified,O,2597
52936,TV,O,2597
52937,shows,O,2597
52938,and,O,2597
52939,movies,O,2598
52940,to,O,2598
52941,improve,O,2598
52942,their,O,2598
52943,vision,O,2598
52944,This,O,2598
52945,is,O,2598
52946,the,O,2598
52947,first,O,2598
52948,FDA-approved,O,2598
52949,digital,O,2598
52950,therapy,O,2598
52951,for,O,2598
52952,amblyopia,B-NAME_OF_DISEASE,2598
52953,in,O,2598
52954,children,O,2598
52955,and,O,2598
52956,more,O,2598
52957,broadly,O,2598
52958,the,O,2598
52959,first,O,2598
52960,for,O,2598
52961,a,B-NAME_OF_DISEASE,2598
52962,neuro-visual,I-NAME_OF_DISEASE,2598
52963,disorder,I-NAME_OF_DISEASE,2598
52964,Amblyopia,B-NAME_OF_DISEASE,2598
52965,develops,O,2598
52966,when,O,2598
52967,the,O,2598
52968,brain,O,2599
52969,and,O,2599
52970,the,O,2599
52971,eyes,O,2599
52972,cease,O,2599
52973,working,O,2599
52974,together,O,2599
52975,effectively,O,2600
52976,causing,O,2600
52977,the,O,2600
52978,brain,O,2600
52979,to,O,2600
52980,rely,O,2600
52981,more,O,2600
52982,heavily,O,2600
52983,on,O,2600
52984,one,O,2600
52985,eye,O,2600
52986,over,O,2600
52987,the,O,2600
52988,other,O,2600
52989,resulting,O,2600
52990,in,O,2600
52991,impaired,B-SIGN_AND_SYMPTOM,2600
52992,vision,I-SIGN_AND_SYMPTOM,2600
52993,in,O,2600
52994,the,O,2600
52995,weaker,O,2600
52996,eye,O,2600
52997,Amblyopia,B-NAME_OF_DISEASE,2600
52998,is,O,2600
52999,commonly,O,2600
53000,treated,O,2600
53001,with,O,2601
53002,spectacles,B-TREATMENT,2601
53003,and,I-TREATMENT,2601
53004,eye-patching,I-TREATMENT,2601
53005,or,I-TREATMENT,2601
53006,blurring,I-TREATMENT,2601
53007,atropine,I-TREATMENT,2601
53008,eye,I-TREATMENT,2601
53009,drops,I-TREATMENT,2601
53010,which,O,2601
53011,prohibit,O,2602
53012,the,O,2602
53013,stronger,O,2602
53014,eye,O,2602
53015,from,O,2602
53016,being,O,2602
53017,used,O,2602
53018,and,O,2602
53019,force,O,2602
53020,the,O,2602
53021,weaker,O,2602
53022,eye,O,2603
53023,to,O,2603
53024,be,O,2603
53025,used,O,2603
53026,but,O,2603
53027,these,O,2603
53028,methods,O,2603
53029,do,O,2603
53030,not,O,2603
53031,train,O,2603
53032,the,O,2603
53033,eyes,O,2603
53034,to,O,2603
53035,work,O,2603
53036,together,O,2603
53037,These,O,2603
53038,existing,O,2603
53039,therapeutic,O,2603
53040,approaches,O,2603
53041,also,O,2603
53042,face,O,2603
53043,considerable,O,2603
53044,obstacles,O,2603
53045,due,O,2603
53046,to,O,2603
53047,poor,O,2603
53048,patient,O,2603
53049,compliance,O,2604
53050,and,O,2604
53051,social,O,2604
53052,stigmas,O,2604
53053,Luminopia,B-ORGANIZATION,2604
53054,collaborated,O,2604
53055,with,O,2604
53056,top,O,2604
53057,doctors,O,2604
53058,and,O,2604
53059,researchers,O,2604
53060,at,O,2604
53061,Boston,B-ORGANIZATION,2604
53062,Children,I-ORGANIZATION,2604
53063,s,I-ORGANIZATION,2604
53064,Hospital,I-ORGANIZATION,2604
53065,and,O,2604
53066,MIT,B-ORGANIZATION,2605
53067,s,I-ORGANIZATION,2605
53068,Picower,I-ORGANIZATION,2605
53069,Institute,I-ORGANIZATION,2605
53070,for,I-ORGANIZATION,2605
53071,Learning,I-ORGANIZATION,2605
53072,and,I-ORGANIZATION,2605
53073,Memory,I-ORGANIZATION,2605
53074,as,O,2605
53075,well,O,2605
53076,as,O,2605
53077,media,O,2605
53078,firms,O,2605
53079,such,O,2605
53080,as,O,2605
53081,Sesame,B-ORGANIZATION,2605
53082,Workshop,I-ORGANIZATION,2605
53083,Nelvana,B-ORGANIZATION,2605
53084,and,O,2605
53085,Millimages,B-ORGANIZATION,2606
53086,to,O,2606
53087,develop,O,2607
53088,a,O,2607
53089,novel,O,2607
53090,therapy,O,2607
53091,strategy,O,2607
53092,for,O,2607
53093,patients,O,2607
53094,Patients,O,2607
53095,can,O,2607
53096,watch,O,2607
53097,videos,O,2607
53098,from,O,2607
53099,a,O,2607
53100,selection,O,2607
53101,of,O,2607
53102,700+,O,2607
53103,hours,O,2607
53104,of,O,2607
53105,popular,O,2607
53106,interesting,O,2608
53107,and,O,2608
53108,instructional,O,2608
53109,content,O,2608
53110,with,O,2608
53111,Luminopia,B-TREATMENT,2608
53112,One,I-TREATMENT,2608
53113,Proprietary,B-TREATMENT,2608
53114,algorithms,I-TREATMENT,2608
53115,change,O,2608
53116,the,O,2608
53117,selected,O,2608
53118,videos,O,2608
53119,in,O,2608
53120,real-time,O,2608
53121,within,O,2608
53122,a,O,2608
53123,VR,O,2608
53124,headset,O,2608
53125,to,O,2608
53126,urge,O,2608
53127,patients,O,2608
53128,brains,O,2608
53129,to,O,2608
53130,mix,O,2608
53131,input,O,2608
53132,from,O,2608
53133,both,O,2608
53134,eyes,O,2608
53135,and,O,2608
53136,increase,O,2608
53137,weaker,O,2608
53138,eye,O,2608
53139,utilization,O,2608
53140,The,B-ORGANIZATION,2608
53141,FDA,I-ORGANIZATION,2608
53142,approval,O,2608
53143,of,O,2608
53144,a,O,2608
53145,new,O,2608
53146,digital,O,2608
53147,therapy,O,2608
53148,with,O,2608
53149,robust,O,2608
53150,clinical,O,2609
53151,evidence,O,2609
53152,for,O,2609
53153,children,O,2609
53154,affected,O,2609
53155,by,O,2609
53156,amblyopia,B-NAME_OF_DISEASE,2609
53157,is,O,2609
53158,a,O,2609
53159,major,O,2609
53160,development,O,2609
53161,Amblyopia,B-NAME_OF_DISEASE,2609
53162,is,O,2609
53163,one,O,2609
53164,of,O,2609
53165,the,O,2609
53166,most,O,2609
53167,common,O,2609
53168,conditions,O,2609
53169,I,O,2609
53170,manage,O,2609
53171,as,O,2609
53172,a,O,2609
53173,clinician,O,2609
53174,and,O,2609
53175,patients,O,2609
53176,parents,O,2609
53177,and,O,2609
53178,physicians,O,2610
53179,often,O,2610
53180,struggle,O,2610
53181,with,O,2610
53182,current,O,2610
53183,therapies,O,2610
53184,David,O,2610
53185,G,O,2610
53186,Hunter,O,2610
53187,MD,O,2610
53188,PhD,O,2610
53189,Ophthalmologist-in-Chief,O,2610
53190,Richard,B-PERSON,2610
53191,Robb,I-PERSON,2610
53192,Chair,O,2611
53193,in,O,2611
53194,Ophthalmology,O,2611
53195,Boston,B-ORGANIZATION,2611
53196,Children,I-ORGANIZATION,2611
53197,s,I-ORGANIZATION,2611
53198,Hospital,I-ORGANIZATION,2611
53199,and,O,2611
53200,advisor,O,2611
53201,to,O,2611
53202,Luminopia,B-ORGANIZATION,2611
53203,said,O,2611
53204,in,O,2611
53205,a,O,2611
53206,company,O,2611
53207,news,O,2611
53208,release,O,2611
53209,Luminopia,B-TREATMENT,2611
53210,One,I-TREATMENT,2611
53211,is,O,2611
53212,expected,O,2611
53213,to,O,2612
53214,be,O,2612
53215,available,O,2612
53216,in,O,2612
53217,the,O,2612
53218,second,O,2612
53219,quarter,O,2612
53220,of,O,2612
53221,2022,O,2612
53222,with,O,2612
53223,eye,O,2612
53224,care,O,2612
53225,specialists,O,2612
53226,prescribing,O,2612
53227,it,O,2612
53228,for,O,2612
53229,one,B-TIME_DURATION,2612
53230,hour,I-TIME_DURATION,2612
53231,per,I-TIME_DURATION,2612
53232,day,I-TIME_DURATION,2612
53233,six,I-TIME_DURATION,2612
53234,days,I-TIME_DURATION,2612
53235,per,I-TIME_DURATION,2613
53236,week,I-TIME_DURATION,2613
53237,over,I-TIME_DURATION,2613
53238,a,I-TIME_DURATION,2613
53239,12-week,I-TIME_DURATION,2613
53240,period,I-TIME_DURATION,2613
53241,and,O,2613
53242,patients,O,2613
53243,using,O,2613
53244,it,O,2613
53245,at,O,2613
53246,home,O,2613
53247,Luminopia,B-ORGANIZATION,2613
53248,is,O,2613
53249,pursuing,O,2613
53250,coverage,O,2613
53251,for,O,2613
53252,the,O,2613
53253,therapy,O,2613
53254,as,O,2614
53255,a,O,2614
53256,pharmacy,O,2614
53257,benefit,O,2614
53258,with,O,2614
53259,regional,O,2614
53260,and,O,2614
53261,national,O,2614
53262,payers,O,2614
53263,across,O,2614
53264,the,B-GPE,2614
53265,United,I-GPE,2614
53266,States,I-GPE,2614
53267,to,O,2614
53268,enable,O,2615
53269,access,O,2615
53270,for,O,2615
53271,children,O,2615
53272,and,O,2615
53273,families,O,2615
53274,in,O,2615
53275,need,O,2615
53276,of,O,2615
53277,innovative,O,2615
53278,amblyopia,B-NAME_OF_DISEASE,2615
53279,medicines,O,2616
53280,Luminopia,B-TREATMENT,2616
53281,One,I-TREATMENT,2616
53282,received,O,2616
53283,FDA,B-ORGANIZATION,2616
53284,approval,O,2616
53285,based,O,2616
53286,on,O,2616
53287,positive,O,2616
53288,results,O,2617
53289,from,O,2617
53290,various,O,2617
53291,clinical,O,2617
53292,trials,O,2617
53293,including,O,2617
53294,a,O,2617
53295,phase,O,2617
53296,3,O,2617
53297,pivotal,O,2617
53298,trial,O,2617
53299,published,O,2617
53300,recently,O,2617
53301,in,O,2617
53302,Ophthalmology,B-PUBLICATION_VENUE,2617
53303,that,O,2617
53304,showed,O,2617
53305,the,O,2617
53306,therapeutic,O,2617
53307,s,O,2617
53308,safety,O,2617
53309,and,O,2617
53310,efficacy,O,2617
53311,in,O,2617
53312,amblyopia,B-NAME_OF_DISEASE,2617
53313,children,O,2617
53314,aged,O,2617
53315,4,O,2617
53316,to,O,2617
53317,7,O,2617
53318,This,O,2617
53319,was,O,2617
53320,the,O,2617
53321,first,O,2617
53322,randomized,O,2617
53323,controlled,O,2617
53324,trial,O,2617
53325,of,O,2617
53326,a,O,2617
53327,new,O,2617
53328,amblyopia,B-NAME_OF_DISEASE,2617
53329,therapy,O,2617
53330,in,O,2617
53331,over,O,2617
53332,a,O,2617
53333,decade,O,2617
53334,and,O,2617
53335,the,O,2617
53336,first,O,2618
53337,to,O,2618
53338,indicate,O,2618
53339,efficacy,O,2618
53340,of,O,2618
53341,a,O,2618
53342,novel,O,2618
53343,binocular,O,2618
53344,strategy,O,2618
53345,In,O,2618
53346,this,O,2618
53347,phase,O,2618
53348,3,O,2618
53349,trial,O,2618
53350,105,O,2618
53351,children,O,2618
53352,were,O,2618
53353,randomly,O,2618
53354,assigned,O,2618
53355,to,O,2618
53356,either,O,2618
53357,the,O,2618
53358,treatment,O,2618
53359,group,O,2618
53360,Luminopia,B-TREATMENT,2618
53361,One,I-TREATMENT,2618
53362,+,O,2619
53363,glasses,B-TREATMENT,2619
53364,or,O,2619
53365,the,O,2619
53366,control,O,2619
53367,group,O,2619
53368,glasses,B-TREATMENT,2619
53369,only,O,2619
53370,,O,2619
53371,As,O,2619
53372,early,O,2619
53373,as,O,2619
53374,four,O,2619
53375,weeks,O,2619
53376,a,O,2619
53377,statistically,O,2619
53378,significant,O,2619
53379,difference,O,2619
53380,in,O,2619
53381,visual,O,2619
53382,acuity,O,2619
53383,improvement,O,2619
53384,across,O,2619
53385,groups,O,2620
53386,was,O,2620
53387,seen,O,2620
53388,The,O,2620
53389,weak,O,2620
53390,eye,O,2620
53391,visual,O,2620
53392,acuity,O,2620
53393,of,O,2620
53394,patients,O,2620
53395,in,O,2620
53396,the,O,2620
53397,treatment,O,2620
53398,group,O,2620
53399,increased,O,2620
53400,1,O,2620
53401,lines,O,2620
53402,on,O,2621
53403,average,O,2621
53404,on,O,2621
53405,a,O,2621
53406,logMAR,O,2621
53407,eye,O,2621
53408,chart,O,2621
53409,at,O,2621
53410,the,O,2621
53411,12-week,O,2621
53412,primary,O,2621
53413,endpoint,O,2621
53414,compared,O,2621
53415,to,O,2621
53416,0,O,2621
53417,lines,O,2621
53418,in,O,2621
53419,the,O,2622
53420,control,O,2622
53421,group,O,2622
53422,The,O,2622
53423,difference,O,2622
53424,in,O,2622
53425,improvement,O,2622
53426,between,O,2622
53427,groups,O,2622
53428,was,O,2622
53429,substantial,O,2622
53430,P=0.00,O,2622
53431,,O,2622
53432,Furthermore,O,2622
53433,in,O,2622
53434,the,O,2622
53435,treatment,O,2622
53436,group,O,2622
53437,62%,O,2622
53438,of,O,2622
53439,patients,O,2622
53440,demonstrated,O,2622
53441,a,O,2622
53442,strong,O,2622
53443,response,O,2622
53444,defined,O,2623
53445,as,O,2623
53446,a,O,2623
53447,2-line,O,2623
53448,or,O,2623
53449,larger,O,2623
53450,improvement,O,2623
53451,compared,O,2624
53452,to,O,2624
53453,33%,O,2624
53454,in,O,2624
53455,the,O,2624
53456,control,O,2624
53457,group,O,2624
53458,Importantly,O,2624
53459,84%,O,2624
53460,of,O,2624
53461,patients,O,2624
53462,in,O,2624
53463,the,O,2624
53464,treatment,O,2624
53465,group,O,2624
53466,had,O,2624
53467,previously,O,2624
53468,received,O,2624
53469,patching,B-TREATMENT,2624
53470,or,I-TREATMENT,2624
53471,atropine,I-TREATMENT,2624
53472,therapy,I-TREATMENT,2624
53473,but,O,2624
53474,still,O,2624
53475,had,O,2624
53476,amblyopia,B-NAME_OF_DISEASE,2624
53477,and,O,2624
53478,Luminopia,B-TREATMENT,2624
53479,One,I-TREATMENT,2624
53480,was,O,2624
53481,as,O,2624
53482,effective,O,2624
53483,in,O,2624
53484,this,O,2624
53485,category,O,2624
53486,Over,O,2624
53487,the,O,2624
53488,course,O,2624
53489,of,O,2624
53490,the,O,2624
53491,research,O,2624
53492,the,O,2624
53493,median,O,2624
53494,adherence,O,2624
53495,to,O,2625
53496,the,O,2625
53497,prescribed,O,2625
53498,dosage,O,2625
53499,was,O,2625
53500,88%,O,2625
53501,far,O,2625
53502,greater,O,2625
53503,than,O,2625
53504,the,O,2625
53505,48%,O,2625
53506,reported,O,2625
53507,in,O,2625
53508,prior,O,2625
53509,patching,O,2625
53510,studies,O,2625
53511,The,B-ORGANIZATION,2625
53512,Cleveland,I-ORGANIZATION,2625
53513,Clinic,I-ORGANIZATION,2625
53514,UCLA,B-ORGANIZATION,2625
53515,Jules,I-ORGANIZATION,2625
53516,Stein,I-ORGANIZATION,2625
53517,Eye,I-ORGANIZATION,2625
53518,Institute,I-ORGANIZATION,2625
53519,Duke,B-ORGANIZATION,2625
53520,Eye,I-ORGANIZATION,2625
53521,Center,I-ORGANIZATION,2625
53522,Ann,O,2625
53523,Robert,O,2625
53524,H,O,2626
53525,Lurie,O,2626
53526,Children,O,2626
53527,s,O,2626
53528,Hospital,O,2626
53529,of,O,2626
53530,Chicago,O,2626
53531,Texas,B-ORGANIZATION,2626
53532,Children,I-ORGANIZATION,2626
53533,s,I-ORGANIZATION,2626
53534,Hospital,I-ORGANIZATION,2626
53535,and,O,2626
53536,Children,B-ORGANIZATION,2626
53537,s,I-ORGANIZATION,2627
53538,Hospital,I-ORGANIZATION,2627
53539,of,I-ORGANIZATION,2627
53540,Philadelphia,I-ORGANIZATION,2627
53541,were,O,2627
53542,among,O,2627
53543,the,O,2627
53544,21,O,2627
53545,academic,O,2627
53546,and,O,2627
53547,community,O,2627
53548,sites,O,2627
53549,that,O,2627
53550,participated,O,2627
53551,in,O,2627
53552,the,O,2627
53553,study,O,2627
53554,There,O,2627
53555,were,O,2627
53556,no,O,2627
53557,major,O,2627
53558,side,O,2627
53559,effects,O,2627
53560,reported,O,2627
53561,Johnson,B-ORGANIZATION,2627
53562,Johnson,I-ORGANIZATION,2628
53563,is,O,2628
53564,a,O,2628
53565,holding,O,2628
53566,company,O,2628
53567,which,O,2628
53568,is,O,2628
53569,engaged,O,2628
53570,in,O,2628
53571,the,O,2628
53572,research,O,2628
53573,and,O,2628
53574,development,O,2628
53575,manufacture,O,2628
53576,and,O,2628
53577,sale,O,2628
53578,of,O,2628
53579,a,O,2628
53580,range,O,2628
53581,of,O,2628
53582,products,O,2628
53583,in,O,2628
53584,the,O,2628
53585,healthcare,O,2629
53586,field,O,2629
53587,It,O,2629
53588,operates,O,2629
53589,through,O,2629
53590,three,O,2629
53591,segments,O,2629
53592,Consumer,O,2629
53593,Pharmaceutical,O,2629
53594,and,O,2629
53595,Medical,O,2629
53596,Devices,O,2629
53597,Its,O,2629
53598,primary,O,2629
53599,focus,O,2629
53600,is,O,2629
53601,products,O,2629
53602,related,O,2629
53603,to,O,2630
53604,human,O,2631
53605,health,O,2631
53606,and,O,2631
53607,well-being,O,2631
53608,The,O,2631
53609,Consumer,O,2632
53610,segment,O,2632
53611,includes,O,2632
53612,a,O,2632
53613,range,O,2632
53614,of,O,2632
53615,products,O,2632
53616,used,O,2632
53617,in,O,2632
53618,the,O,2632
53619,skin,O,2632
53620,health,O,2632
53621,beauty,O,2632
53622,over-the-counter,O,2632
53623,medicines,O,2632
53624,baby,O,2632
53625,care,O,2632
53626,oral,O,2632
53627,care,O,2632
53628,women,O,2632
53629,s,O,2632
53630,health,O,2632
53631,and,O,2632
53632,wound,O,2632
53633,care,O,2632
53634,markets,O,2632
53635,The,O,2632
53636,Pharmaceutical,O,2632
53637,segment,O,2632
53638,is,O,2632
53639,focused,O,2632
53640,on,O,2632
53641,six,O,2632
53642,immunology,O,2632
53643,infectious,O,2632
53644,diseases,O,2632
53645,neuroscience,O,2632
53646,oncology,O,2632
53647,cardiovascular,O,2632
53648,metabolism,O,2632
53649,and,O,2632
53650,pulmonary,O,2632
53651,hypertension,O,2632
53652,The,O,2632
53653,Medical,O,2632
53654,Devices,O,2632
53655,segment,O,2632
53656,includes,O,2633
53657,a,O,2633
53658,range,O,2633
53659,of,O,2633
53660,products,O,2633
53661,used,O,2633
53662,in,O,2633
53663,the,O,2633
53664,interventional,O,2633
53665,solutions,O,2633
53666,orthopedic,O,2633
53667,surgery,O,2633
53668,and,O,2633
53669,vision,O,2633
53670,fields,O,2633
53671,-,O,2633
53672,First,O,2633
53673,daily,B-TREATMENT,2633
53674,wear,I-TREATMENT,2633
53675,lens,I-TREATMENT,2633
53676,developed,O,2633
53677,by,O,2633
53678,Johnson,B-ORGANIZATION,2633
53679,Johnson,I-ORGANIZATION,2634
53680,Vision,I-ORGANIZATION,2635
53681,as,O,2635
53682,a,O,2635
53683,breakthrough,O,2635
53684,innovation,O,2635
53685,specifically,O,2635
53686,designed,O,2635
53687,for,O,2635
53688,slowing,O,2635
53689,the,O,2635
53690,progression,O,2635
53691,of,O,2635
53692,myopia,B-NAME_OF_DISEASE,2635
53693,in,O,2635
53694,children,O,2635
53695,-,O,2635
53696,Expands,O,2636
53697,the,O,2636
53698,growing,O,2636
53699,portfolio,O,2637
53700,of,O,2637
53701,myopia,B-NAME_OF_DISEASE,2637
53702,management,O,2637
53703,products,O,2637
53704,and,O,2637
53705,services,O,2637
53706,from,O,2637
53707,Johnson,B-ORGANIZATION,2637
53708,Johnson,I-ORGANIZATION,2637
53709,Vision,I-ORGANIZATION,2637
53710,-,O,2637
53711,Soft,B-TREATMENT,2637
53712,contact,I-TREATMENT,2637
53713,lenses,I-TREATMENT,2637
53714,with,I-TREATMENT,2637
53715,novel,I-TREATMENT,2637
53716,ring,I-TREATMENT,2637
53717,focus,I-TREATMENT,2637
53718,technology,I-TREATMENT,2637
53719,may,O,2637
53720,help,O,2637
53721,address,O,2637
53722,the,O,2637
53723,progression,O,2637
53724,of,O,2637
53725,myopia,B-NAME_OF_DISEASE,2637
53726,in,O,2637
53727,children,O,2638
53728,-,O,2638
53729,Made,O,2638
53730,of,O,2638
53731,silicone,B-TREATMENT,2638
53732,hydrogel,I-TREATMENT,2638
53733,senofilcon,I-TREATMENT,2638
53734,A,I-TREATMENT,2638
53735,lens,I-TREATMENT,2638
53736,material,O,2638
53737,the,O,2638
53738,same,O,2638
53739,material,O,2638
53740,as,O,2638
53741,ACUVUE®,B-TREATMENT,2638
53742,OASYS,I-TREATMENT,2638
53743,1-Day,I-TREATMENT,2638
53744,contact,I-TREATMENT,2638
53745,lenses,I-TREATMENT,2638
53746,which,O,2638
53747,have,O,2638
53748,never,O,2638
53749,been,O,2638
53750,beaten,O,2638
53751,in,O,2638
53752,comfort,O,2638
53753,JACKSONVILLE,O,2638
53754,Fla.-Johnso,O,2638
53755,Johnson,O,2638
53756,Vision,O,2638
53757,said,O,2638
53758,Wednesday,O,2638
53759,that,O,2638
53760,Health,B-ORGANIZATION,2638
53761,Canada,B-GPE,2638
53762,has,O,2638
53763,approved,O,2638
53764,its,O,2639
53765,Acuvue,B-TREATMENT,2639
53766,Abiliti,I-TREATMENT,2639
53767,1-Day,I-TREATMENT,2639
53768,soft,I-TREATMENT,2639
53769,therapeutic,I-TREATMENT,2640
53770,lenses,I-TREATMENT,2640
53771,for,O,2640
53772,myopia,B-NAME_OF_DISEASE,2640
53773,management,O,2640
53774,Abiliti,B-TREATMENT,2640
53775,1-Day,I-TREATMENT,2640
53776,lenses,I-TREATMENT,2640
53777,are,O,2640
53778,a,O,2640
53779,new,O,2640
53780,option,O,2640
53781,of,O,2640
53782,daily,O,2640
53783,wear,O,2640
53784,single-use,O,2640
53785,disposable,O,2640
53786,lenses,O,2640
53787,that,O,2640
53788,have,O,2640
53789,the,O,2640
53790,potential,O,2640
53791,to,O,2640
53792,slow,O,2640
53793,the,O,2640
53794,progression,O,2641
53795,of,O,2641
53796,myopia,B-NAME_OF_DISEASE,2641
53797,and,O,2641
53798,are,O,2641
53799,specifically,O,2641
53800,designed,O,2641
53801,for,O,2641
53802,children,O,2641
53803,who,O,2641
53804,are,O,2641
53805,7,O,2641
53806,to,O,2641
53807,12,O,2641
53808,years,O,2641
53809,old,O,2641
53810,at,O,2641
53811,the,O,2641
53812,start,O,2641
53813,of,O,2641
53814,treatment,O,2641
53815,the,O,2641
53816,announcement,O,2642
53817,noted,O,2642
53818,Abiliti,B-TREATMENT,2642
53819,1-Day,I-TREATMENT,2642
53820,lenses,I-TREATMENT,2642
53821,are,O,2642
53822,expected,O,2642
53823,to,O,2642
53824,become,O,2642
53825,available,O,2642
53826,in,O,2642
53827,select,O,2642
53828,areas,O,2642
53829,of,O,2642
53830,Canada,B-GPE,2642
53831,beginning,O,2642
53832,as,O,2642
53833,early,O,2642
53834,as,O,2642
53835,this,O,2642
53836,year,O,2642
53837,and,O,2642
53838,expanding,O,2642
53839,beyond,O,2642
53840,in,O,2642
53841,2022,O,2643
53842,J,B-ORGANIZATION,2643
53843,J,I-ORGANIZATION,2643
53844,Vision,I-ORGANIZATION,2643
53845,said,O,2643
53846,Parents,O,2643
53847,and,O,2643
53848,eyecare,O,2643
53849,professionals,O,2643
53850,who,O,2643
53851,want,O,2643
53852,more,O,2643
53853,information,O,2643
53854,can,O,2643
53855,visit,O,2643
53856,the,O,2643
53857,site,O,2643
53858,at,O,2644
53859,seeyourabiliti.com,O,2644
53860,The,O,2644
53861,new,O,2644
53862,lens,O,2644
53863,also,O,2644
53864,expands,O,2644
53865,the,O,2644
53866,growing,O,2644
53867,portfolio,O,2644
53868,of,O,2644
53869,myopia,B-NAME_OF_DISEASE,2644
53870,management,O,2644
53871,products,O,2644
53872,and,O,2644
53873,services,O,2644
53874,from,O,2644
53875,Johnson,B-ORGANIZATION,2644
53876,Johnson,I-ORGANIZATION,2644
53877,Vision,I-ORGANIZATION,2644
53878,the,O,2644
53879,company,O,2645
53880,said,O,2645
53881,The,B-TREATMENT,2645
53882,soft,I-TREATMENT,2645
53883,contact,I-TREATMENT,2645
53884,lenses,I-TREATMENT,2645
53885,feature,I-TREATMENT,2645
53886,a,I-TREATMENT,2645
53887,novel,I-TREATMENT,2645
53888,ring,I-TREATMENT,2645
53889,focus,I-TREATMENT,2645
53890,technology,I-TREATMENT,2645
53891,that,O,2645
53892,helps,O,2645
53893,parents,O,2645
53894,and,O,2645
53895,ECPs,O,2646
53896,address,O,2646
53897,the,O,2646
53898,progression,O,2646
53899,of,O,2646
53900,myopia,B-NAME_OF_DISEASE,2646
53901,in,O,2646
53902,children,O,2646
53903,They,O,2646
53904,are,O,2646
53905,made,O,2646
53906,of,O,2646
53907,silicone,B-TREATMENT,2646
53908,hydrogel,I-TREATMENT,2646
53909,senofilcon,I-TREATMENT,2646
53910,A,I-TREATMENT,2646
53911,lens,I-TREATMENT,2646
53912,material,O,2646
53913,the,O,2646
53914,same,O,2647
53915,material,O,2647
53916,as,O,2647
53917,Acuvue,B-TREATMENT,2647
53918,Oasys,I-TREATMENT,2647
53919,1-Day,I-TREATMENT,2647
53920,contact,I-TREATMENT,2647
53921,lenses,I-TREATMENT,2647
53922,J,B-ORGANIZATION,2647
53923,J,I-ORGANIZATION,2647
53924,Vision,I-ORGANIZATION,2647
53925,is,O,2647
53926,currently,O,2647
53927,working,O,2647
53928,with,O,2647
53929,health,O,2647
53930,and,O,2647
53931,regulatory,O,2647
53932,authorities,O,2647
53933,in,O,2647
53934,the,O,2647
53935,U.S,O,2647
53936,and,O,2647
53937,will,O,2647
53938,provide,O,2647
53939,updates,O,2647
53940,on,O,2647
53941,the,O,2647
53942,approval,O,2647
53943,process,O,2647
53944,in,O,2647
53945,the,O,2648
53946,U.S,O,2648
53947,for,O,2648
53948,the,B-TREATMENT,2648
53949,Acuvue,I-TREATMENT,2648
53950,Abiliti,B-ORGANIZATION,2648
53951,lens,I-TREATMENT,2648
53952,as,O,2648
53953,they,O,2648
53954,become,O,2648
53955,available,O,2648
53956,The,O,2648
53957,approval,O,2648
53958,from,O,2648
53959,Health,B-ORGANIZATION,2648
53960,Canada,I-ORGANIZATION,2649
53961,for,O,2649
53962,Acuvue,B-TREATMENT,2649
53963,Abiliti,B-ORGANIZATION,2649
53964,1-Day,I-TREATMENT,2649
53965,lenses,I-TREATMENT,2649
53966,marks,O,2649
53967,another,O,2649
53968,major,O,2649
53969,step,O,2649
53970,forward,O,2649
53971,in,O,2649
53972,our,O,2649
53973,collaborative,O,2649
53974,efforts,O,2649
53975,with,O,2649
53976,parents,O,2649
53977,and,O,2649
53978,eyecare,O,2649
53979,professionals,O,2649
53980,to,O,2649
53981,reshape,O,2649
53982,the,O,2649
53983,future,O,2649
53984,of,O,2649
53985,myopia,B-NAME_OF_DISEASE,2649
53986,Xiao-Yu,B-PERSON,2649
53987,Song,I-PERSON,2649
53988,MD,I-PERSON,2649
53989,PhD,I-PERSON,2649
53990,global,O,2649
53991,head,O,2649
53992,of,O,2649
53993,research,O,2649
53994,and,O,2649
53995,development,O,2649
53996,for,O,2649
53997,Johnson,B-ORGANIZATION,2649
53998,Johnson,I-ORGANIZATION,2649
53999,Vision,I-ORGANIZATION,2649
54000,said,O,2649
54001,in,O,2649
54002,the,O,2649
54003,announcement,O,2649
54004,Our,O,2649
54005,researchers,O,2649
54006,and,O,2649
54007,scientists,O,2649
54008,specifically,O,2649
54009,designed,O,2649
54010,Abiliti,B-ORGANIZATION,2649
54011,1-Day,I-TREATMENT,2649
54012,to,O,2649
54013,be,O,2649
54014,a,O,2649
54015,novel,O,2649
54016,soft,O,2650
54017,therapeutic,O,2650
54018,lens,O,2650
54019,with,O,2650
54020,the,O,2650
54021,potential,O,2650
54022,to,O,2650
54023,slow,O,2650
54024,the,O,2650
54025,progression,O,2650
54026,of,O,2650
54027,myopia,B-NAME_OF_DISEASE,2650
54028,in,O,2650
54029,children,O,2650
54030,The,B-ORGANIZATION,2650
54031,Health,I-ORGANIZATION,2650
54032,Canada,I-ORGANIZATION,2650
54033,approval,O,2650
54034,for,O,2650
54035,Abiliti,B-ORGANIZATION,2650
54036,1-Day,I-TREATMENT,2650
54037,lenses,I-TREATMENT,2650
54038,marks,O,2650
54039,another,O,2650
54040,significant,O,2650
54041,milestone,O,2651
54042,for,O,2651
54043,the,O,2651
54044,Abiliti,B-ORGANIZATION,2651
54045,brand,O,2651
54046,and,O,2651
54047,Johnson,B-ORGANIZATION,2651
54048,Johnson,I-ORGANIZATION,2651
54049,Vision,I-ORGANIZATION,2651
54050,the,O,2651
54051,company,O,2651
54052,said,O,2651
54053,Abiliti,B-ORGANIZATION,2651
54054,will,O,2651
54055,provide,O,2651
54056,parents,O,2651
54057,and,O,2651
54058,ECPs,O,2651
54059,with,O,2651
54060,a,O,2651
54061,robust,O,2651
54062,and,O,2651
54063,comprehensive,O,2651
54064,set,O,2652
54065,of,O,2652
54066,products,O,2652
54067,for,O,2652
54068,myopia,B-NAME_OF_DISEASE,2652
54069,management,O,2652
54070,Earlier,O,2652
54071,this,O,2652
54072,year,O,2652
54073,the,O,2652
54074,company,O,2652
54075,introduced,O,2652
54076,Acuvue,B-TREATMENT,2652
54077,Abiliti,I-TREATMENT,2652
54078,Overnight,I-TREATMENT,2652
54079,therapeutic,I-TREATMENT,2652
54080,lenses,I-TREATMENT,2652
54081,for,O,2652
54082,myopia,B-NAME_OF_DISEASE,2652
54083,management,O,2652
54084,in,O,2652
54085,the,O,2653
54086,U.S,O,2653
54087,Abiliti,B-ORGANIZATION,2653
54088,Overnight,I-TREATMENT,2653
54089,lenses,I-TREATMENT,2653
54090,are,O,2653
54091,specifically,O,2653
54092,designed,O,2653
54093,and,O,2653
54094,fitted,O,2653
54095,to,O,2653
54096,match,O,2653
54097,a,O,2653
54098,patient,O,2653
54099,s,O,2653
54100,eye,O,2653
54101,based,O,2653
54102,on,O,2654
54103,its,O,2654
54104,unique,O,2654
54105,corneal,O,2655
54106,shape,O,2655
54107,to,O,2655
54108,temporarily,O,2655
54109,reshape,O,2655
54110,the,B-PART_OF_THE_EYES,2655
54111,cornea,I-PART_OF_THE_EYES,2655
54112,The,O,2655
54113,lens,O,2656
54114,was,O,2656
54115,approved,O,2656
54116,by,O,2656
54117,the,B-ORGANIZATION,2656
54118,FDA,I-ORGANIZATION,2656
54119,The,O,2656
54120,company,O,2656
54121,also,O,2656
54122,announced,O,2656
54123,that,O,2656
54124,each,O,2656
54125,annual,O,2656
54126,purchase,O,2656
54127,of,O,2656
54128,an,O,2657
54129,Abiliti,B-ORGANIZATION,2658
54130,product,O,2658
54131,would,O,2658
54132,provide,O,2658
54133,a,O,2659
54134,free,O,2659
54135,comprehensive,O,2659
54136,eye,O,2659
54137,health,O,2659
54138,exam,O,2659
54139,to,O,2659
54140,a,O,2659
54141,child,O,2659
54142,in,O,2659
54143,need,O,2659
54144,through,O,2659
54145,Sight,O,2659
54146,For,O,2659
54147,Kids-a,O,2659
54148,joint,O,2659
54149,program,O,2659
54150,from,O,2659
54151,Johnson,B-ORGANIZATION,2660
54152,Johnson,I-ORGANIZATION,2660
54153,Vision,I-ORGANIZATION,2660
54154,and,O,2660
54155,the,O,2660
54156,not-for-profit,O,2660
54157,Lions,B-ORGANIZATION,2660
54158,Clubs,I-ORGANIZATION,2660
54159,International,I-ORGANIZATION,2660
54160,Foundation,I-ORGANIZATION,2660
54161,LCIF,I-ORGANIZATION,2660
54162,,O,2661
54163,Sight,O,2661
54164,For,O,2661
54165,Kids,O,2661
54166,is,O,2661
54167,one,O,2661
54168,of,O,2661
54169,the,O,2661
54170,largest-known,O,2661
54171,school-based,O,2661
54172,eye,O,2661
54173,health,O,2662
54174,programs,O,2662
54175,that,O,2662
54176,mobilizes,O,2662
54177,Lions,O,2662
54178,and,O,2662
54179,ECPs,O,2662
54180,to,O,2662
54181,provide,O,2662
54182,comprehensive,O,2662
54183,eye,O,2662
54184,health,O,2662
54185,services,O,2662
54186,in,O,2662
54187,low-income,O,2662
54188,schools,O,2662
54189,around,O,2662
54190,the,O,2662
54191,world,O,2662
54192,The,O,2662
54193,new,O,2663
54194,Abiliti,B-TREATMENT,2663
54195,1-Day,I-TREATMENT,2663
54196,lenses,I-TREATMENT,2663
54197,are,O,2663
54198,not,O,2663
54199,traditional,O,2663
54200,concentric,O,2663
54201,ring,O,2663
54202,presbyopic,O,2663
54203,design,O,2663
54204,lenses,O,2663
54205,Abiliti,B-TREATMENT,2663
54206,1-Day,I-TREATMENT,2663
54207,lenses,I-TREATMENT,2663
54208,are,O,2663
54209,a,O,2663
54210,breakthrough,O,2663
54211,innovation,O,2663
54212,specifically,O,2663
54213,designed,O,2663
54214,to,O,2663
54215,slow,O,2663
54216,myopia,B-NAME_OF_DISEASE,2663
54217,progression,O,2663
54218,in,O,2664
54219,children,O,2664
54220,and,O,2664
54221,have,O,2664
54222,been,O,2664
54223,shown,O,2664
54224,to,O,2664
54225,reduce,O,2664
54226,axial,O,2664
54227,elongation,O,2664
54228,by,O,2664
54229,0.105m,O,2664
54230,on,O,2664
54231,average,O,2664
54232,over,O,2664
54233,a,B-TIME_DURATION,2664
54234,6-month,I-TIME_DURATION,2664
54235,period,I-TIME_DURATION,2664
54236,according,O,2664
54237,to,O,2664
54238,the,O,2664
54239,J,B-ORGANIZATION,2664
54240,J,I-ORGANIZATION,2665
54241,Vision,I-ORGANIZATION,2665
54242,announcement,O,2665
54243,New,O,2665
54244,Prospective,O,2665
54245,Study,O,2665
54246,Shows,O,2665
54247,Significant,O,2665
54248,Reduction,O,2665
54249,in,O,2665
54250,Reports,O,2665
54251,of,O,2665
54252,Postoperative,O,2665
54253,Halos,B-SIGN_AND_SYMPTOM,2665
54254,From,O,2666
54255,Patients,O,2666
54256,Treated,O,2666
54257,With,O,2666
54258,TearScience,B-TREATMENT,2666
54259,LipiFlow,I-TREATMENT,2666
54260,Treatment,I-TREATMENT,2666
54261,Prior,O,2666
54262,to,O,2666
54263,Bilateral,B-TREATMENT,2666
54264,Cataract,I-TREATMENT,2666
54265,Surgery,I-TREATMENT,2667
54266,Patients,O,2667
54267,that,O,2667
54268,received,O,2667
54269,thermal,B-TREATMENT,2667
54270,pulsation,I-TREATMENT,2667
54271,treatment,I-TREATMENT,2667
54272,prior,O,2667
54273,to,O,2667
54274,cataract,B-TREATMENT,2667
54275,surgery,I-TREATMENT,2667
54276,reported,O,2667
54277,halos,B-SIGN_AND_SYMPTOM,2667
54278,significantly,O,2667
54279,less,O,2667
54280,than,O,2667
54281,control,O,2667
54282,group,O,2667
54283,58,O,2667
54284,vs,O,2667
54285,79,O,2667
54286,percent,O,2667
54287,p,O,2667
54288,=,O,2667
54289,0.01,O,2667
54290,The,O,2667
54291,study,O,2667
54292,is,O,2667
54293,one,O,2667
54294,of,O,2667
54295,21,O,2667
54296,company-sponsored,O,2667
54297,studies,O,2667
54298,being,O,2667
54299,presented,O,2667
54300,the,O,2667
54301,2021,O,2667
54302,ASCRS∙,O,2667
54303,ASOA,B-ORGANIZATION,2668
54304,Annual,O,2668
54305,Meeting,O,2668
54306,Johnson,B-ORGANIZATION,2668
54307,Johnson,I-ORGANIZATION,2668
54308,Vision,I-ORGANIZATION,2669
54309,a,O,2669
54310,global,O,2669
54311,leader,O,2669
54312,in,O,2669
54313,eye,O,2669
54314,health,O,2669
54315,and,O,2669
54316,part,O,2669
54317,of,O,2669
54318,the,B-ORGANIZATION,2669
54319,Johnson,I-ORGANIZATION,2669
54320,Johnson,I-ORGANIZATION,2670
54321,Medical,I-ORGANIZATION,2670
54322,Devices,I-ORGANIZATION,2670
54323,Companies,I-ORGANIZATION,2670
54324,revealed,O,2670
54325,new,O,2670
54326,comparative,O,2670
54327,clinical,O,2670
54328,study,O,2670
54329,findings,O,2670
54330,evaluating,O,2670
54331,TearScience,B-TREATMENT,2670
54332,LipiFlow,I-TREATMENT,2670
54333,treatment,I-TREATMENT,2670
54334,in,O,2670
54335,cataract,B-TREATMENT,2670
54336,surgery,I-TREATMENT,2670
54337,The,O,2670
54338,data,O,2670
54339,concluded,O,2670
54340,that,O,2670
54341,treating,O,2670
54342,patients,O,2670
54343,with,O,2670
54344,TearScience,B-TREATMENT,2670
54345,LipiFlow,I-TREATMENT,2670
54346,prior,O,2670
54347,to,O,2670
54348,cataract,B-TREATMENT,2670
54349,surgery,I-TREATMENT,2670
54350,significantly,O,2670
54351,reduced,O,2670
54352,patient-reports,O,2670
54353,of,O,2670
54354,halos,B-SIGN_AND_SYMPTOM,2670
54355,compared,O,2671
54356,to,O,2671
54357,control,O,2671
54358,group,O,2671
54359,58,O,2671
54360,vs,O,2671
54361,79,O,2671
54362,percent,O,2671
54363,and,O,2671
54364,showed,O,2671
54365,larger,O,2671
54366,improvements,O,2671
54367,in,O,2671
54368,Meibomian,B-DIAGNOSTIC_TEST,2671
54369,Gland,I-DIAGNOSTIC_TEST,2671
54370,Score,I-DIAGNOSTIC_TEST,2671
54371,MGD,I-DIAGNOSTIC_TEST,2671
54372,than,O,2671
54373,control,O,2671
54374,group,O,2672
54375,107,O,2673
54376,vs,O,2673
54377,66,O,2673
54378,percent,O,2673
54379,,O,2673
54380,The,O,2673
54381,results,O,2673
54382,were,O,2674
54383,shared,O,2674
54384,today,O,2674
54385,in,O,2674
54386,a,O,2674
54387,poster,O,2674
54388,presentation,O,2675
54389,at,O,2675
54390,the,B-ORGANIZATION,2675
54391,American,I-ORGANIZATION,2675
54392,Society,I-ORGANIZATION,2675
54393,of,I-ORGANIZATION,2675
54394,Cataract,I-ORGANIZATION,2675
54395,and,I-ORGANIZATION,2675
54396,Refractive,I-ORGANIZATION,2675
54397,Surgery,I-ORGANIZATION,2675
54398,ASCRS,I-ORGANIZATION,2675
54399,and,O,2675
54400,American,B-ORGANIZATION,2675
54401,Society,I-ORGANIZATION,2675
54402,of,I-ORGANIZATION,2675
54403,Ophthalmic,I-ORGANIZATION,2675
54404,Administrators,I-ORGANIZATION,2675
54405,ASOA,I-ORGANIZATION,2675
54406,Annual,O,2675
54407,Meeting,O,2675
54408,The,O,2675
54409,study,O,2675
54410,titled,O,2676
54411,Preoperative,B-NAME_OF_STUDY,2676
54412,Treatment,I-NAME_OF_STUDY,2676
54413,of,I-NAME_OF_STUDY,2676
54414,Meibomian,I-NAME_OF_STUDY,2676
54415,Gland,I-NAME_OF_STUDY,2676
54416,Dysfunction,I-NAME_OF_STUDY,2676
54417,with,I-NAME_OF_STUDY,2676
54418,Thermal,I-NAME_OF_STUDY,2676
54419,Pulsation,I-NAME_OF_STUDY,2676
54420,System,I-NAME_OF_STUDY,2676
54421,Prior,I-NAME_OF_STUDY,2676
54422,to,I-NAME_OF_STUDY,2676
54423,Extended,I-NAME_OF_STUDY,2676
54424,Depth,I-NAME_OF_STUDY,2676
54425,of,I-NAME_OF_STUDY,2676
54426,Focus,I-NAME_OF_STUDY,2676
54427,IOL,I-NAME_OF_STUDY,2676
54428,Implantation,I-NAME_OF_STUDY,2676
54429,was,O,2676
54430,a,O,2676
54431,post-market,O,2676
54432,prospective,O,2676
54433,randomized,O,2676
54434,multi,O,2676
54435,center,O,2676
54436,bilateral,O,2676
54437,open-label,O,2676
54438,cross-over,O,2676
54439,comparative,O,2676
54440,clinical,O,2676
54441,study,O,2676
54442,covering,O,2676
54443,five,O,2677
54444,U.S,O,2677
54445,sites,O,2677
54446,and,O,2677
54447,comprising,O,2677
54448,115,O,2677
54449,subjects,O,2677
54450,At,O,2677
54451,three-months,B-TIME_DURATION,2677
54452,following,O,2677
54453,surgery,O,2677
54454,there,O,2677
54455,were,O,2677
54456,notable,O,2677
54457,differences,O,2677
54458,in,O,2677
54459,the,O,2677
54460,rates,O,2677
54461,of,O,2677
54462,bothersome,O,2677
54463,ocular,O,2677
54464,symptoms,O,2678
54465,such,O,2678
54466,as,O,2678
54467,seeing,O,2678
54468,halos,B-SIGN_AND_SYMPTOM,2678
54469,between,O,2678
54470,the,O,2678
54471,study,O,2678
54472,and,O,2678
54473,control,O,2678
54474,groups,O,2678
54475,The,O,2678
54476,findings,O,2678
54477,align,O,2678
54478,with,O,2678
54479,the,O,2678
54480,recent,O,2678
54481,ASCRS,B-ORGANIZATION,2678
54482,clinical,O,2678
54483,guidelines,O,2678
54484,recommending,O,2678
54485,the,O,2679
54486,proactive,O,2679
54487,diagnosis,O,2679
54488,and,O,2679
54489,management,O,2679
54490,of,O,2679
54491,MGD,B-NAME_OF_DISEASE,2679
54492,in,O,2679
54493,the,O,2679
54494,preoperative,O,2679
54495,cataract,B-NAME_OF_DISEASE,2679
54496,patient,O,2679
54497,We,O,2679
54498,continue,O,2680
54499,to,O,2680
54500,learn,O,2680
54501,more,O,2680
54502,about,O,2680
54503,the,O,2680
54504,connection,O,2680
54505,between,O,2680
54506,the,O,2680
54507,health,O,2680
54508,of,O,2680
54509,the,O,2680
54510,ocular,O,2680
54511,surface,O,2680
54512,and,O,2680
54513,visual,O,2680
54514,outcomes,O,2680
54515,following,O,2680
54516,cataract,B-TREATMENT,2680
54517,surgery,I-TREATMENT,2680
54518,said,O,2680
54519,Daniel,B-PERSON,2680
54520,Chang,I-PERSON,2680
54521,MD,I-PERSON,2680
54522,This,O,2680
54523,new,O,2680
54524,data,O,2680
54525,reinforces,O,2680
54526,the,O,2680
54527,importance,O,2680
54528,of,O,2681
54529,proactively,O,2681
54530,screening,O,2681
54531,for,O,2681
54532,and,O,2681
54533,treating,O,2681
54534,MGD,B-NAME_OF_DISEASE,2681
54535,prior,O,2681
54536,to,O,2681
54537,cataract,B-TREATMENT,2681
54538,surgery,I-TREATMENT,2681
54539,It,O,2681
54540,s,O,2681
54541,a,O,2681
54542,simple,O,2681
54543,addition,O,2681
54544,to,O,2681
54545,the,O,2681
54546,patient,O,2681
54547,s,O,2681
54548,treatment,O,2681
54549,plan,O,2681
54550,that,O,2681
54551,may,O,2681
54552,result,O,2681
54553,in,O,2681
54554,better,O,2681
54555,visual,O,2681
54556,outcomes,O,2681
54557,for,O,2681
54558,our,O,2681
54559,patients,O,2681
54560,MGD,B-NAME_OF_DISEASE,2681
54561,is,O,2681
54562,a,O,2681
54563,prevalent,O,2681
54564,chronic,O,2682
54565,and,O,2682
54566,progressive,O,2682
54567,disease,O,2682
54568,that,O,2682
54569,becomes,O,2682
54570,worse,O,2682
54571,the,O,2682
54572,longer,O,2682
54573,it,O,2682
54574,goes,O,2682
54575,untreated,O,2682
54576,In,O,2682
54577,the,O,2682
54578,study,O,2682
54579,presurgical,O,2682
54580,TearScience,B-TREATMENT,2682
54581,LipiFlow,I-TREATMENT,2682
54582,in,O,2682
54583,cataract,B-NAME_OF_DISEASE,2683
54584,patients,O,2683
54585,improved,O,2683
54586,meibomian,B-PART_OF_THE_EYES,2683
54587,gland,I-PART_OF_THE_EYES,2683
54588,function,O,2683
54589,and,O,2683
54590,improved,O,2683
54591,postoperative,O,2683
54592,anterior,O,2683
54593,ocular,O,2683
54594,health,O,2683
54595,In,O,2683
54596,addition,O,2683
54597,to,O,2683
54598,reducing,O,2683
54599,postoperative,O,2683
54600,reports,O,2683
54601,of,O,2683
54602,halos,B-SIGN_AND_SYMPTOM,2683
54603,the,O,2683
54604,presurgical,O,2683
54605,treatment,O,2683
54606,also,O,2683
54607,showed,O,2683
54608,measurable,O,2683
54609,improvements,O,2683
54610,in,O,2683
54611,visual,O,2683
54612,acuity,O,2683
54613,20,O,2683
54614,20,O,2683
54615,at,O,2683
54616,4m,O,2683
54617,20,O,2683
54618,20,O,2683
54619,at,O,2683
54620,66cm,O,2683
54621,20,O,2683
54622,30,O,2683
54623,at,O,2684
54624,40cm,O,2684
54625,,O,2684
54626,As,O,2684
54627,clinicians,O,2684
54628,we,O,2684
54629,always,O,2684
54630,want,O,2684
54631,to,O,2684
54632,optimize,O,2684
54633,surgical,O,2684
54634,outcomes,O,2684
54635,for,O,2684
54636,cataract,B-NAME_OF_DISEASE,2684
54637,patients,O,2684
54638,including,O,2684
54639,postoperative,O,2685
54640,visits,O,2685
54641,The,O,2685
54642,data,O,2685
54643,we,O,2685
54644,unveiled,O,2685
54645,today,O,2685
54646,reinforces,O,2685
54647,the,O,2685
54648,need,O,2685
54649,for,O,2685
54650,surgeons,O,2685
54651,to,O,2685
54652,screen,O,2685
54653,for,O,2685
54654,and,O,2685
54655,treat,O,2685
54656,MGD,B-NAME_OF_DISEASE,2685
54657,prior-to,O,2685
54658,cataract,B-TREATMENT,2685
54659,surgery,I-TREATMENT,2685
54660,especially,O,2685
54661,given,O,2685
54662,the,O,2685
54663,high,O,2685
54664,incidence,O,2685
54665,and,O,2685
54666,asymptomatic,O,2685
54667,nature,O,2685
54668,of,O,2685
54669,ocular,O,2685
54670,surface,O,2685
54671,disease,O,2685
54672,in,O,2685
54673,patients,O,2686
54674,presenting,O,2686
54675,for,O,2686
54676,cataract,B-TREATMENT,2686
54677,surgery,I-TREATMENT,2686
54678,said,O,2686
54679,Rajesh,B-PERSON,2686
54680,Rajpal,I-PERSON,2686
54681,MD,I-PERSON,2686
54682,Chief,O,2686
54683,Medical,O,2686
54684,Officer,O,2686
54685,and,O,2686
54686,Global,O,2686
54687,Head,O,2686
54688,of,O,2686
54689,Clinical,O,2686
54690,and,O,2686
54691,Medical,O,2686
54692,Affairs,O,2686
54693,at,O,2686
54694,Johnson,B-ORGANIZATION,2686
54695,Johnson,I-ORGANIZATION,2686
54696,Vision,I-ORGANIZATION,2686
54697,The,O,2686
54698,study,O,2686
54699,is,O,2686
54700,available,O,2686
54701,for,O,2686
54702,on-demand,O,2686
54703,viewing,O,2686
54704,in,O,2686
54705,the,B-PUBLICATION_VENUE,2686
54706,Education,I-PUBLICATION_VENUE,2686
54707,Hub,I-PUBLICATION_VENUE,2686
54708,at,O,2686
54709,the,O,2686
54710,convention,O,2686
54711,center,O,2686
54712,during,O,2686
54713,the,O,2686
54714,meeting,O,2686
54715,and,O,2686
54716,remotely,O,2686
54717,on,O,2686
54718,the,B-ORGANIZATION,2686
54719,ASCRS,I-ORGANIZATION,2686
54720,website,O,2686
54721,post-meeting,O,2686
54722,About,O,2686
54723,TearScience,B-TREATMENT,2687
54724,LipiFlow,I-TREATMENT,2687
54725,The,B-TREATMENT,2687
54726,TearScience,I-TREATMENT,2687
54727,LipiFlow,I-TREATMENT,2687
54728,Thermal,I-TREATMENT,2687
54729,Pulsation,I-TREATMENT,2687
54730,System,I-TREATMENT,2687
54731,is,O,2687
54732,a,O,2687
54733,medical,O,2687
54734,device,O,2687
54735,used,O,2687
54736,by,O,2687
54737,physicians,O,2687
54738,in,O,2687
54739,addressing,O,2687
54740,Meibomian,B-NAME_OF_DISEASE,2687
54741,Gland,I-NAME_OF_DISEASE,2687
54742,Dysfunction,I-NAME_OF_DISEASE,2687
54743,MGD,I-NAME_OF_DISEASE,2687
54744,,O,2687
54745,It,O,2687
54746,consists,O,2687
54747,of,O,2687
54748,a,O,2687
54749,Console,O,2687
54750,and,O,2687
54751,a,O,2687
54752,single-use,O,2687
54753,sterile,O,2688
54754,device,O,2688
54755,known,O,2688
54756,as,O,2688
54757,the,O,2688
54758,Activator,O,2688
54759,and,O,2688
54760,has,O,2688
54761,a,O,2688
54762,drug-free,O,2689
54763,mechanism,O,2689
54764,of,O,2689
54765,action,O,2689
54766,Eye,O,2689
54767,care,O,2689
54768,professionals,O,2689
54769,use,O,2689
54770,the,B-TREATMENT,2689
54771,TearScience,I-TREATMENT,2689
54772,LipiFlow,I-TREATMENT,2689
54773,System,I-TREATMENT,2689
54774,to,O,2689
54775,treat,O,2689
54776,MGD,B-NAME_OF_DISEASE,2689
54777,patients,O,2689
54778,in-office,O,2690
54779,with,O,2690
54780,confidence,O,2690
54781,and,O,2690
54782,efficiency,O,2690
54783,Santen,B-ORGANIZATION,2690
54784,Receives,O,2690
54785,U.S,O,2690
54786,FDA,B-ORGANIZATION,2690
54787,Approval,O,2690
54788,for,O,2690
54789,Verkazia,O,2690
54790,Cyclosporine,O,2690
54791,Ophthalmic,O,2690
54792,Emulsion,O,2690
54793,0.1,O,2690
54794,for,O,2690
54795,the,O,2691
54796,Treatment,O,2691
54797,of,O,2691
54798,Vernal,B-NAME_OF_DISEASE,2691
54799,Keratoconjunctivitis,I-NAME_OF_DISEASE,2692
54800,in,O,2692
54801,Children,O,2692
54802,and,O,2692
54803,Adults,O,2692
54804,Osaka,O,2692
54805,Japan-,O,2692
54806,Santen,B-ORGANIZATION,2692
54807,Pharmaceutical,O,2692
54808,Co,O,2692
54809,Ltd,O,2692
54810,announced,O,2692
54811,that,O,2692
54812,the,O,2692
54813,U.S,O,2692
54814,Food,O,2692
54815,and,O,2692
54816,Drug,O,2692
54817,Administration,O,2692
54818,FDA,B-ORGANIZATION,2693
54819,has,O,2693
54820,approved,O,2693
54821,the,O,2693
54822,New,O,2693
54823,Drug,O,2693
54824,Application,O,2693
54825,NDA,O,2693
54826,for,O,2693
54827,Verkazia,O,2693
54828,Cyclosporine,O,2693
54829,ophthalmic,O,2693
54830,emulsion,O,2693
54831,0.1,O,2693
54832,for,O,2693
54833,the,O,2693
54834,treatment,O,2693
54835,of,O,2693
54836,vernal,B-NAME_OF_DISEASE,2693
54837,keratoconjunctivitis,I-NAME_OF_DISEASE,2693
54838,VKC,B-NAME_OF_DISEASE,2693
54839,in,O,2693
54840,children,O,2693
54841,and,O,2693
54842,adults,O,2693
54843,Santen,B-ORGANIZATION,2693
54844,had,O,2693
54845,received,O,2693
54846,initial,O,2693
54847,FDA,B-ORGANIZATION,2693
54848,filing,O,2693
54849,acceptance,O,2693
54850,on,O,2693
54851,October,O,2693
54852,26,O,2693
54853,2020,O,2693
54854,With,O,2693
54855,this,O,2693
54856,approval,O,2693
54857,Santen,B-ORGANIZATION,2693
54858,is,O,2693
54859,now,O,2693
54860,working,O,2693
54861,to,O,2694
54862,make,O,2694
54863,a,O,2694
54864,new,O,2694
54865,treatment,O,2695
54866,option,O,2695
54867,available,O,2695
54868,for,O,2695
54869,patients,O,2695
54870,in,O,2695
54871,the,B-GPE,2695
54872,United,I-GPE,2695
54873,States,I-GPE,2696
54874,VKC,B-NAME_OF_DISEASE,2696
54875,is,O,2696
54876,a,O,2696
54877,rare,O,2696
54878,and,O,2696
54879,recurrent,O,2696
54880,allergic,O,2696
54881,eye,O,2696
54882,condition,O,2696
54883,mainly,O,2696
54884,occurring,O,2696
54885,in,O,2696
54886,children,O,2696
54887,and,O,2696
54888,adolescents,O,2696
54889,that,O,2696
54890,causes,O,2696
54891,severe,O,2696
54892,inflammation,O,2696
54893,of,O,2696
54894,the,O,2696
54895,surface,O,2696
54896,of,O,2696
54897,the,O,2696
54898,eye,O,2696
54899,The,O,2696
54900,symptoms,O,2697
54901,of,O,2697
54902,VKC,B-NAME_OF_DISEASE,2697
54903,-,O,2697
54904,intense,B-SIGN_AND_SYMPTOM,2697
54905,itching,I-SIGN_AND_SYMPTOM,2697
54906,painful,I-SIGN_AND_SYMPTOM,2697
54907,eyes,I-SIGN_AND_SYMPTOM,2697
54908,and,I-SIGN_AND_SYMPTOM,2697
54909,light,I-SIGN_AND_SYMPTOM,2697
54910,sensitivity,I-SIGN_AND_SYMPTOM,2697
54911,-,O,2697
54912,can,O,2697
54913,prevent,O,2697
54914,those,O,2697
54915,affected,O,2697
54916,from,O,2697
54917,participating,O,2697
54918,in,O,2697
54919,everyday,O,2697
54920,activities,O,2697
54921,Without,O,2697
54922,adequate,O,2698
54923,treatment,O,2698
54924,severe,O,2698
54925,cases,O,2698
54926,may,O,2698
54927,result,O,2698
54928,in,O,2698
54929,corneal,B-SIGN_AND_SYMPTOM,2698
54930,ulcers,I-SIGN_AND_SYMPTOM,2698
54931,and,O,2698
54932,even,O,2698
54933,vision,B-SIGN_AND_SYMPTOM,2698
54934,loss,I-SIGN_AND_SYMPTOM,2698
54935,VKC,B-NAME_OF_DISEASE,2698
54936,is,O,2698
54937,a,O,2698
54938,rare,O,2698
54939,but,O,2698
54940,severe,O,2698
54941,disease,O,2698
54942,affecting,O,2698
54943,children,O,2698
54944,and,O,2698
54945,adolescents,O,2698
54946,Its,O,2699
54947,characteristics,O,2699
54948,of,O,2699
54949,allergic,B-NAME_OF_DISEASE,2699
54950,conjunctivitis,I-NAME_OF_DISEASE,2699
54951,significantly,O,2699
54952,affects,O,2699
54953,quality,O,2699
54954,of,O,2699
54955,life,O,2699
54956,such,O,2699
54957,as,O,2699
54958,limiting,O,2699
54959,academic,O,2699
54960,and,O,2699
54961,outdoor,O,2699
54962,activities,O,2699
54963,due,O,2699
54964,to,O,2700
54965,itching,B-SIGN_AND_SYMPTOM,2700
54966,and,I-SIGN_AND_SYMPTOM,2700
54967,pain,I-SIGN_AND_SYMPTOM,2700
54968,that,O,2700
54969,prevent,O,2700
54970,the,O,2700
54971,eyes,O,2700
54972,from,O,2700
54973,opening,O,2700
54974,when,O,2700
54975,symptoms,O,2700
54976,occur,O,2700
54977,said,O,2700
54978,Shigeo,B-PERSON,2700
54979,Taniuchi,I-PERSON,2700
54980,President,O,2700
54981,CEO,O,2700
54982,of,O,2700
54983,Santen,B-ORGANIZATION,2700
54984,We,O,2700
54985,will,O,2700
54986,leverage,O,2700
54987,our,O,2700
54988,U.S,O,2700
54989,business,O,2701
54990,foundation,O,2701
54991,of,O,2701
54992,Eyevance,B-ORGANIZATION,2701
54993,which,O,2701
54994,was,O,2701
54995,acquired,O,2701
54996,by,O,2701
54997,Santen,B-ORGANIZATION,2701
54998,in,O,2701
54999,September,O,2701
55000,2020,O,2701
55001,We,O,2701
55002,are,O,2701
55003,thrilled,O,2701
55004,to,O,2701
55005,be,O,2701
55006,collaborating,O,2701
55007,with,O,2701
55008,healthcare,O,2701
55009,professionals,O,2701
55010,to,O,2702
55011,deliver,O,2702
55012,treatment,O,2702
55013,to,O,2702
55014,this,O,2702
55015,underserved,O,2702
55016,population,O,2702
55017,as,O,2702
55018,soon,O,2702
55019,as,O,2702
55020,possible,O,2702
55021,and,O,2702
55022,we,O,2702
55023,hope,O,2702
55024,to,O,2702
55025,bring,O,2702
55026,smiles,O,2702
55027,back,O,2702
55028,to,O,2702
55029,children,O,2702
55030,and,O,2702
55031,patients,O,2702
55032,in,O,2702
55033,the,B-GPE,2702
55034,United,I-GPE,2702
55035,States,I-GPE,2702
55036,We,O,2702
55037,re,O,2702
55038,extremely,O,2702
55039,happy,O,2702
55040,to,O,2702
55041,have,O,2702
55042,received,O,2702
55043,FDA,B-ORGANIZATION,2702
55044,approval,O,2702
55045,as,O,2702
55046,our,O,2702
55047,first,O,2702
55048,internal,O,2703
55049,prescription,O,2703
55050,product,O,2703
55051,approval,O,2703
55052,in,O,2704
55053,the,O,2704
55054,U.S,O,2704
55055,market,O,2704
55056,stated,O,2704
55057,Tatsuya,B-PERSON,2704
55058,Kaihara,I-PERSON,2704
55059,CEO,O,2704
55060,of,O,2704
55061,Santen,B-ORGANIZATION,2704
55062,Inc,O,2705
55063,and,O,2705
55064,Head,O,2705
55065,of,O,2705
55066,Santen,B-ORGANIZATION,2705
55067,North,I-ORGANIZATION,2705
55068,America,I-ORGANIZATION,2705
55069,This,O,2705
55070,is,O,2705
55071,an,O,2705
55072,important,O,2705
55073,milestone,O,2705
55074,in,O,2705
55075,Santen,B-ORGANIZATION,2705
55076,s,O,2705
55077,aim,O,2705
55078,to,O,2705
55079,bring,O,2705
55080,innovative,O,2705
55081,solutions,O,2705
55082,that,O,2705
55083,protect,O,2705
55084,vision,O,2705
55085,for,O,2705
55086,those,O,2705
55087,affected,O,2705
55088,by,O,2705
55089,ophthalmic,O,2705
55090,conditions,O,2705
55091,With,O,2705
55092,this,O,2705
55093,approval,O,2705
55094,doctors,O,2705
55095,and,O,2705
55096,patients,O,2705
55097,in,O,2705
55098,the,B-GPE,2705
55099,United,I-GPE,2705
55100,States,I-GPE,2705
55101,now,O,2705
55102,have,O,2705
55103,an,O,2705
55104,effective,O,2706
55105,and,O,2706
55106,new,O,2706
55107,treatment,O,2706
55108,for,O,2706
55109,this,O,2706
55110,rare,O,2706
55111,condition,O,2706
55112,that,O,2706
55113,may,O,2706
55114,allow,O,2706
55115,those,O,2706
55116,affected,O,2706
55117,to,O,2706
55118,continue,O,2706
55119,taking,O,2706
55120,part,O,2706
55121,in,O,2706
55122,everyday,O,2706
55123,activities,O,2706
55124,Following,O,2706
55125,Europe,B-GPE,2706
55126,Asia,B-GPE,2706
55127,and,O,2706
55128,Canada,B-GPE,2706
55129,we,O,2706
55130,have,O,2706
55131,now,O,2706
55132,also,O,2706
55133,received,O,2706
55134,approval,O,2706
55135,in,O,2706
55136,the,B-GPE,2706
55137,United,I-GPE,2707
55138,States,I-GPE,2707
55139,demonstrating,O,2707
55140,Santen,B-ORGANIZATION,2707
55141,s,O,2707
55142,global,O,2707
55143,development,O,2707
55144,commitment,O,2707
55145,We,O,2707
55146,would,O,2707
55147,like,O,2707
55148,to,O,2707
55149,continuously,O,2707
55150,deliver,O,2707
55151,Happiness,O,2707
55152,with,O,2707
55153,Vision,O,2707
55154,to,O,2707
55155,children,O,2707
55156,around,O,2707
55157,the,O,2707
55158,world,O,2707
55159,whose,O,2707
55160,daily,O,2707
55161,activities,O,2707
55162,are,O,2707
55163,restricted,O,2707
55164,by,O,2707
55165,VKC,B-NAME_OF_DISEASE,2707
55166,said,O,2707
55167,Peter,B-PERSON,2707
55168,Sallstig,I-PERSON,2707
55169,Corporate,O,2707
55170,Officer,O,2707
55171,and,O,2707
55172,Head,O,2707
55173,of,O,2707
55174,Product,O,2708
55175,Development,O,2708
55176,Division,O,2708
55177,at,O,2708
55178,Santen,B-ORGANIZATION,2708
55179,About,O,2708
55180,Verkazia,B-NAME_OF_DRUG,2708
55181,-,O,2708
55182,Verkazia,B-NAME_OF_DRUG,2708
55183,is,O,2708
55184,a,O,2708
55185,prescription-only,O,2708
55186,uniquely-formulated,O,2708
55187,oil-in-water,O,2708
55188,cationic,O,2708
55189,emulsion,O,2708
55190,that,O,2708
55191,provides,O,2708
55192,improved,O,2708
55193,ocular,O,2708
55194,bioavailability,O,2708
55195,of,O,2708
55196,cyclosporine,B-NAME_OF_DRUG,2708
55197,which,O,2708
55198,has,O,2708
55199,been,O,2708
55200,shown,O,2708
55201,to,O,2708
55202,be,O,2708
55203,effective,O,2708
55204,in,O,2708
55205,the,O,2709
55206,management,O,2709
55207,of,O,2709
55208,VKC,B-NAME_OF_DISEASE,2709
55209,It,O,2709
55210,works,O,2709
55211,by,O,2709
55212,inhibiting,O,2709
55213,T-cell,O,2709
55214,activation,O,2709
55215,and,O,2709
55216,reducing,O,2709
55217,the,O,2709
55218,level,O,2709
55219,of,O,2709
55220,immune,O,2709
55221,cells,O,2709
55222,and,O,2709
55223,mediators,O,2709
55224,that,O,2709
55225,cause,O,2709
55226,the,O,2709
55227,chronic,O,2709
55228,severe,O,2710
55229,potentially,O,2710
55230,debilitating,O,2710
55231,allergic,B-SIGN_AND_SYMPTOM,2710
55232,inflammation,I-SIGN_AND_SYMPTOM,2710
55233,of,O,2710
55234,the,O,2710
55235,ocular,O,2710
55236,surface,O,2710
55237,that,O,2710
55238,is,O,2710
55239,seen,O,2710
55240,in,O,2710
55241,those,O,2710
55242,affected,O,2710
55243,by,O,2710
55244,VKC,B-NAME_OF_DISEASE,2710
55245,Worldwide,O,2710
55246,Verkazia,B-NAME_OF_DRUG,2710
55247,is,O,2710
55248,available,O,2710
55249,for,O,2710
55250,the,O,2710
55251,treatment,O,2710
55252,of,O,2710
55253,VKC,B-NAME_OF_DISEASE,2710
55254,in,O,2710
55255,more,O,2710
55256,than,O,2710
55257,10,O,2710
55258,countries,O,2711
55259,across,O,2711
55260,Asia,B-GPE,2711
55261,Europe,B-GPE,2711
55262,and,O,2711
55263,Canada,B-GPE,2711
55264,About,O,2712
55265,Clinical,O,2712
55266,Data,O,2712
55267,The,B-ORGANIZATION,2712
55268,FDA,I-ORGANIZATION,2712
55269,approval,O,2712
55270,for,O,2712
55271,Verkazia,B-NAME_OF_DRUG,2712
55272,was,O,2712
55273,based,O,2712
55274,on,O,2712
55275,data,O,2712
55276,from,O,2712
55277,the,B-NAME_OF_STUDY,2712
55278,pivotal,I-NAME_OF_STUDY,2713
55279,VEKTIS,I-NAME_OF_STUDY,2713
55280,study,I-NAME_OF_STUDY,2713
55281,and,O,2713
55282,the,B-NAME_OF_STUDY,2713
55283,phase,I-NAME_OF_STUDY,2713
55284,2,I-NAME_OF_STUDY,2713
55285,3,I-NAME_OF_STUDY,2714
55286,NOVATIVE,I-NAME_OF_STUDY,2714
55287,study,I-NAME_OF_STUDY,2714
55288,which,O,2714
55289,assessed,O,2714
55290,the,O,2714
55291,efficacy,O,2714
55292,and,O,2714
55293,tolerability,O,2714
55294,of,O,2714
55295,Verkazia,B-NAME_OF_DRUG,2714
55296,for,O,2714
55297,treating,O,2714
55298,active,O,2714
55299,VKC,B-NAME_OF_DISEASE,2714
55300,in,O,2714
55301,children,O,2714
55302,and,O,2714
55303,adolescents,O,2714
55304,In,O,2714
55305,the,O,2714
55306,studies,O,2714
55307,Verkazia,B-NAME_OF_DRUG,2714
55308,demonstrated,O,2714
55309,improvements,O,2714
55310,in,O,2714
55311,inflammation,B-SIGN_AND_SYMPTOM,2714
55312,of,I-SIGN_AND_SYMPTOM,2714
55313,the,I-SIGN_AND_SYMPTOM,2714
55314,cornea,I-SIGN_AND_SYMPTOM,2714
55315,keratitis,O,2714
55316,score,O,2714
55317,and,O,2715
55318,ocular,B-SIGN_AND_SYMPTOM,2715
55319,itching,I-SIGN_AND_SYMPTOM,2715
55320,About,O,2715
55321,Santen,B-ORGANIZATION,2715
55322,As,O,2715
55323,a,O,2715
55324,specialized,O,2715
55325,company,O,2715
55326,dedicated,O,2715
55327,to,O,2715
55328,ophthalmology,O,2715
55329,Santen,B-ORGANIZATION,2715
55330,carries,O,2715
55331,out,O,2715
55332,research,O,2715
55333,development,O,2715
55334,marketing,O,2715
55335,and,O,2715
55336,sales,O,2715
55337,of,O,2715
55338,pharmaceuticals,O,2715
55339,over-the-counter,O,2715
55340,products,O,2715
55341,and,O,2715
55342,medical,O,2715
55343,devices,O,2715
55344,and,O,2715
55345,its,O,2715
55346,products,O,2715
55347,now,O,2715
55348,reach,O,2715
55349,patients,O,2715
55350,in,O,2715
55351,over,O,2715
55352,60,O,2715
55353,countries,O,2715
55354,Toward,O,2715
55355,realizing,O,2715
55356,WORLD,O,2715
55357,VISION,O,2715
55358,Happiness,O,2715
55359,with,O,2715
55360,Vision,O,2715
55361,the,O,2715
55362,world,O,2716
55363,Santen,B-ORGANIZATION,2716
55364,ultimately,O,2716
55365,aspires,O,2716
55366,to,O,2716
55367,achieve,O,2716
55368,as,O,2716
55369,a,O,2716
55370,Social,O,2716
55371,Innovator,O,2716
55372,we,O,2716
55373,aim,O,2716
55374,to,O,2716
55375,reduce,O,2716
55376,the,O,2716
55377,social,O,2716
55378,and,O,2716
55379,economic,O,2716
55380,opportunity,O,2716
55381,loss,O,2716
55382,of,O,2716
55383,people,O,2716
55384,around,O,2716
55385,the,O,2716
55386,world,O,2716
55387,caused,O,2716
55388,by,O,2716
55389,eye,O,2716
55390,diseases,O,2716
55391,and,O,2716
55392,defects,O,2716
55393,by,O,2716
55394,orchestrating,O,2716
55395,and,O,2717
55396,mobilizing,O,2717
55397,key,O,2717
55398,technologies,O,2717
55399,and,O,2717
55400,players,O,2717
55401,around,O,2717
55402,the,O,2717
55403,world,O,2717
55404,With,O,2717
55405,scientific,O,2717
55406,knowledge,O,2717
55407,and,O,2717
55408,organizational,O,2717
55409,capabilities,O,2717
55410,nurtured,O,2717
55411,over,O,2717
55412,a,O,2717
55413,130-year,O,2717
55414,history,O,2717
55415,Santen,B-ORGANIZATION,2717
55416,provides,O,2717
55417,products,O,2717
55418,and,O,2717
55419,services,O,2717
55420,to,O,2717
55421,contribute,O,2717
55422,to,O,2717
55423,the,O,2717
55424,well-being,O,2717
55425,of,O,2717
55426,patients,O,2717
55427,their,O,2717
55428,loved,O,2717
55429,ones,O,2718
55430,and,O,2718
55431,consequently,O,2718
55432,to,O,2718
55433,society,O,2718
55434,For,O,2718
55435,more,O,2718
55436,information,O,2718
55437,please,O,2718
55438,visit,O,2718
55439,Santen,B-ORGANIZATION,2718
55440,s,O,2718
55441,website,O,2718
55442,www.santen.co,O,2718
55443,Avellino,B-ORGANIZATION,2718
55444,Launches,O,2718
55445,AvaGen,B-DIAGNOSTIC_TEST,2718
55446,as,O,2718
55447,First,O,2718
55448,Genetic,O,2718
55449,Test,O,2718
55450,to,O,2718
55451,Quantify,O,2718
55452,Keratoconus,B-NAME_OF_DISEASE,2718
55453,Risk,O,2718
55454,and,O,2718
55455,Presence,O,2718
55456,of,O,2718
55457,Corneal,B-NAME_OF_DISEASE,2718
55458,Dystrophies,I-NAME_OF_DISEASE,2718
55459,Novel,O,2718
55460,Test,O,2718
55461,Provides,O,2718
55462,Early,O,2718
55463,Understanding,O,2718
55464,of,O,2718
55465,Eye,O,2718
55466,Disease,O,2718
55467,to,O,2718
55468,Enable,O,2718
55469,Timely,O,2718
55470,Treatment,O,2718
55471,and,O,2718
55472,More,O,2718
55473,Informed,O,2718
55474,Patient,O,2718
55475,Management,O,2719
55476,Avellino,B-ORGANIZATION,2719
55477,Lab,O,2719
55478,USA,O,2719
55479,Inc,O,2719
55480,is,O,2719
55481,a,O,2719
55482,global,O,2719
55483,leader,O,2719
55484,in,O,2719
55485,gene,O,2719
55486,therapy,O,2719
55487,and,O,2719
55488,molecular,O,2719
55489,diagnostics,O,2719
55490,at,O,2719
55491,the,O,2719
55492,forefront,O,2719
55493,of,O,2720
55494,precision,O,2720
55495,medicine,O,2720
55496,for,O,2720
55497,eye,O,2720
55498,care,O,2720
55499,With,O,2720
55500,a,O,2720
55501,long-term,O,2720
55502,mission,O,2720
55503,to,O,2720
55504,develop,O,2720
55505,personalized,O,2720
55506,approaches,O,2720
55507,to,O,2720
55508,improve,O,2720
55509,health,O,2720
55510,and,O,2720
55511,disease,O,2720
55512,management,O,2720
55513,through,O,2720
55514,genomics,O,2720
55515,the,O,2720
55516,company,O,2720
55517,is,O,2720
55518,developing,O,2720
55519,a,O,2721
55520,transformative,O,2721
55521,genetic,O,2721
55522,diagnostics,O,2721
55523,product,O,2721
55524,pipeline,O,2721
55525,as,O,2721
55526,well,O,2721
55527,as,O,2721
55528,genetic,O,2721
55529,therapeutics,O,2721
55530,leveraging,O,2721
55531,CRISPR,B-CHEMICAL_COMPOUND,2721
55532,gene,I-CHEMICAL_COMPOUND,2721
55533,editing,O,2721
55534,to,O,2721
55535,better,O,2721
55536,manage,O,2721
55537,and,O,2721
55538,potentially,O,2722
55539,cure,O,2722
55540,inherited,O,2722
55541,diseases,O,2722
55542,Avellino,B-ORGANIZATION,2722
55543,Lab,O,2722
55544,USA,O,2722
55545,Inc,O,2722
55546,Avellino,B-ORGANIZATION,2722
55547,announced,O,2722
55548,full,O,2722
55549,nationwide,O,2722
55550,availability,O,2722
55551,in,O,2722
55552,the,O,2722
55553,U.S,O,2722
55554,of,O,2722
55555,AvaGen™,B-DIAGNOSTIC_TEST,2722
55556,The,I-DIAGNOSTIC_TEST,2722
55557,Genetic,I-DIAGNOSTIC_TEST,2722
55558,Eye,I-DIAGNOSTIC_TEST,2722
55559,Test,I-DIAGNOSTIC_TEST,2722
55560,as,O,2722
55561,the,O,2722
55562,first,O,2722
55563,genetic,O,2723
55564,test,O,2723
55565,that,O,2723
55566,helps,O,2723
55567,determine,O,2723
55568,a,O,2723
55569,patient,O,2723
55570,s,O,2723
55571,risk,O,2723
55572,of,O,2723
55573,keratoconus,B-NAME_OF_DISEASE,2723
55574,and,O,2723
55575,the,O,2723
55576,presence,O,2723
55577,of,O,2723
55578,other,O,2723
55579,corneal,B-NAME_OF_DISEASE,2723
55580,dystrophies,I-NAME_OF_DISEASE,2723
55581,The,O,2724
55582,test,O,2724
55583,allows,O,2724
55584,for,O,2724
55585,more,O,2724
55586,confident,O,2724
55587,management,O,2724
55588,and,O,2724
55589,treatment,O,2724
55590,for,O,2724
55591,patients,O,2724
55592,with,O,2724
55593,these,O,2724
55594,conditions,O,2724
55595,in,O,2724
55596,order,O,2724
55597,to,O,2724
55598,protect,O,2724
55599,and,O,2724
55600,preserve,O,2724
55601,patient,O,2724
55602,vision,O,2724
55603,The,O,2724
55604,test,O,2724
55605,is,O,2724
55606,designed,O,2724
55607,to,O,2724
55608,provide,O,2724
55609,keratoconus,B-NAME_OF_DISEASE,2724
55610,patients,O,2724
55611,with,O,2724
55612,an,O,2725
55613,earlier,O,2725
55614,benefit,O,2725
55615,from,O,2725
55616,FDA-approved,O,2725
55617,cross-linking,O,2725
55618,treatment,O,2725
55619,which,O,2725
55620,can,O,2725
55621,halt,O,2725
55622,disease,O,2725
55623,progression,O,2725
55624,and,O,2725
55625,preserve,O,2725
55626,vision,O,2725
55627,The,O,2725
55628,AvaGen,B-DIAGNOSTIC_TEST,2725
55629,results,O,2725
55630,can,O,2725
55631,also,O,2725
55632,influence,O,2725
55633,an,O,2725
55634,eye,O,2725
55635,care,O,2725
55636,professional,O,2725
55637,s,O,2725
55638,choice,O,2725
55639,of,O,2725
55640,refractive,O,2725
55641,surgery,O,2725
55642,options,O,2725
55643,for,O,2725
55644,patients,O,2725
55645,The,B-DIAGNOSTIC_TEST,2725
55646,AvaGen,I-DIAGNOSTIC_TEST,2725
55647,genetic,I-DIAGNOSTIC_TEST,2725
55648,test,I-DIAGNOSTIC_TEST,2725
55649,examines,O,2725
55650,75,O,2725
55651,keratoconus-related,O,2726
55652,genes,O,2726
55653,and,O,2726
55654,more,O,2726
55655,than,O,2726
55656,2,O,2726
55657,0,O,2726
55658,variants,O,2726
55659,of,O,2726
55660,those,O,2726
55661,genes,O,2726
55662,to,O,2726
55663,develop,O,2726
55664,an,O,2726
55665,actionable,O,2726
55666,keratoconus,B-NAME_OF_DISEASE,2726
55667,genetic,O,2726
55668,risk,O,2726
55669,score,O,2726
55670,As,O,2726
55671,certain,O,2726
55672,ethnicities,O,2726
55673,have,O,2727
55674,a,O,2727
55675,higher,O,2727
55676,prevalence,O,2727
55677,of,O,2727
55678,this,O,2727
55679,eye,O,2727
55680,condition,O,2727
55681,the,B-DIAGNOSTIC_TEST,2727
55682,AvaGen,I-DIAGNOSTIC_TEST,2727
55683,test,I-DIAGNOSTIC_TEST,2727
55684,also,O,2727
55685,factors,O,2727
55686,this,O,2727
55687,information,O,2727
55688,into,O,2727
55689,its,O,2727
55690,results,O,2727
55691,For,O,2727
55692,corneal,B-NAME_OF_DISEASE,2728
55693,dystrophies,I-NAME_OF_DISEASE,2728
55694,AvaGen,B-DIAGNOSTIC_TEST,2728
55695,determines,O,2728
55696,the,O,2728
55697,presence,O,2728
55698,of,O,2728
55699,any,O,2728
55700,of,O,2728
55701,the,O,2728
55702,70,O,2728
55703,TGFBI,B-NAME_OF_DRUG,2728
55704,gene,I-NAME_OF_DRUG,2728
55705,variants,O,2728
55706,and,O,2728
55707,provides,O,2728
55708,a,O,2728
55709,conclusive,O,2728
55710,diagnosis,O,2728
55711,of,O,2728
55712,corneal,B-NAME_OF_DISEASE,2728
55713,dystrophy,I-NAME_OF_DISEASE,2729
55714,sub-types,O,2729
55715,such,O,2729
55716,as,O,2729
55717,Epithelial,B-NAME_OF_DISEASE,2729
55718,Basement,I-NAME_OF_DISEASE,2729
55719,Membrane,I-NAME_OF_DISEASE,2729
55720,Granular,B-NAME_OF_DISEASE,2729
55721,and,I-NAME_OF_DISEASE,2729
55722,Lattice,I-NAME_OF_DISEASE,2729
55723,disease,I-NAME_OF_DISEASE,2729
55724,distinctions,I-NAME_OF_DISEASE,2729
55725,Reis-Bucklers,B-NAME_OF_DISEASE,2729
55726,Schnyder,B-NAME_OF_DISEASE,2729
55727,and,I-NAME_OF_DISEASE,2729
55728,Theill-Behnke,I-NAME_OF_DISEASE,2729
55729,Assessing,O,2729
55730,keratoconus,B-NAME_OF_DISEASE,2729
55731,is,O,2729
55732,multi-factorial,O,2729
55733,Until,O,2729
55734,now,O,2729
55735,genetic,O,2729
55736,data,O,2729
55737,has,O,2729
55738,been,O,2729
55739,missing,O,2729
55740,from,O,2729
55741,the,O,2729
55742,equation,O,2729
55743,I,O,2729
55744,order,O,2729
55745,AvaGen,B-DIAGNOSTIC_TEST,2729
55746,when,O,2729
55747,I,O,2729
55748,have,O,2729
55749,any,O,2730
55750,red,O,2730
55751,flag,O,2730
55752,concerns,O,2730
55753,in,O,2730
55754,my,O,2730
55755,refractive,O,2730
55756,surgical,O,2730
55757,evaluations,O,2730
55758,such,O,2731
55759,as,O,2731
55760,high,O,2731
55761,astigmatism,B-NAME_OF_DISEASE,2731
55762,or,O,2731
55763,steep,B-NAME_OF_DISEASE,2731
55764,corneal,I-NAME_OF_DISEASE,2731
55765,curvature,I-NAME_OF_DISEASE,2731
55766,against-the-rule,O,2731
55767,or,O,2731
55768,irregular,O,2731
55769,astigmatism,B-NAME_OF_DISEASE,2731
55770,in,O,2731
55771,younger,O,2731
55772,patients,O,2732
55773,a,O,2732
55774,thin,O,2732
55775,cornea,B-PART_OF_THE_EYES,2732
55776,or,O,2732
55777,in,O,2732
55778,family,O,2732
55779,members,O,2732
55780,of,O,2732
55781,a,O,2732
55782,known,O,2732
55783,keratoconus,B-NAME_OF_DISEASE,2732
55784,patient,O,2732
55785,AvaGen,B-DIAGNOSTIC_TEST,2732
55786,helps,O,2733
55787,me,O,2733
55788,know,O,2733
55789,earlier,O,2733
55790,about,O,2733
55791,a,O,2733
55792,patient,O,2733
55793,s,O,2733
55794,genetic,O,2733
55795,predisposition,O,2733
55796,and,O,2733
55797,allows,O,2733
55798,me,O,2733
55799,to,O,2734
55800,make,O,2734
55801,confident,O,2734
55802,treatment,O,2734
55803,and,O,2734
55804,management,O,2734
55805,decisions,O,2734
55806,says,O,2734
55807,Elizabeth,B-PERSON,2734
55808,Yeu,I-PERSON,2734
55809,MD,I-PERSON,2734
55810,of,O,2734
55811,Virginia,B-ORGANIZATION,2734
55812,Eye,I-ORGANIZATION,2734
55813,Consultants,I-ORGANIZATION,2734
55814,an,O,2734
55815,advisor,O,2734
55816,to,O,2734
55817,Avellino,B-ORGANIZATION,2734
55818,Keratoconus,B-NAME_OF_DISEASE,2734
55819,is,O,2734
55820,a,O,2734
55821,progressive,O,2734
55822,vision,O,2734
55823,disorder,O,2734
55824,affecting,O,2734
55825,approximately,O,2734
55826,885,O,2734
55827,0,O,2734
55828,Americans,O,2734
55829,1,O,2734
55830,in,O,2734
55831,375,O,2734
55832,that,O,2734
55833,is,O,2734
55834,often,O,2734
55835,underdiagnosed,O,2734
55836,or,O,2734
55837,misdiagnosed,O,2734
55838,in,O,2734
55839,its,O,2734
55840,earlier,O,2734
55841,stages,O,2734
55842,when,O,2734
55843,it,O,2734
55844,can,O,2734
55845,be,O,2734
55846,better,O,2734
55847,managed,O,2734
55848,and,O,2735
55849,treated,O,2735
55850,to,O,2735
55851,protect,O,2735
55852,and,O,2735
55853,preserve,O,2735
55854,vision,O,2735
55855,Today,O,2735
55856,s,O,2735
55857,corneal,O,2735
55858,diagnostic,O,2735
55859,imaging,O,2735
55860,tools,O,2735
55861,often,O,2735
55862,do,O,2735
55863,not,O,2735
55864,diagnose,O,2735
55865,the,O,2735
55866,disease,O,2735
55867,early,O,2735
55868,or,O,2735
55869,misdiagnose,O,2735
55870,keratoconus,B-NAME_OF_DISEASE,2735
55871,as,O,2735
55872,astigmatism,B-NAME_OF_DISEASE,2735
55873,or,O,2735
55874,myopia,B-NAME_OF_DISEASE,2736
55875,and,O,2736
55876,most,O,2736
55877,optometrists,O,2736
55878,do,O,2736
55879,not,O,2736
55880,have,O,2736
55881,access,O,2736
55882,to,O,2736
55883,these,O,2736
55884,imaging,O,2736
55885,tools,O,2736
55886,Because,O,2736
55887,of,O,2736
55888,this,O,2736
55889,patients,O,2736
55890,are,O,2737
55891,typically,O,2737
55892,managed,O,2737
55893,with,O,2737
55894,a,O,2737
55895,wait-and-see,O,2737
55896,approach,O,2737
55897,which,O,2737
55898,often,O,2737
55899,results,O,2737
55900,in,O,2737
55901,a,O,2737
55902,diagnosis,O,2737
55903,only,O,2738
55904,after,O,2738
55905,vision,O,2738
55906,has,O,2738
55907,been,O,2738
55908,impacted,O,2738
55909,Corneal,B-NAME_OF_DISEASE,2738
55910,dystrophies,I-NAME_OF_DISEASE,2738
55911,are,O,2738
55912,a,O,2738
55913,rarer,O,2738
55914,group,O,2738
55915,of,O,2738
55916,genetic,O,2738
55917,diseases,O,2738
55918,which,O,2738
55919,can,O,2738
55920,cause,O,2738
55921,not,O,2738
55922,only,O,2738
55923,vision,B-SIGN_AND_SYMPTOM,2738
55924,loss,I-SIGN_AND_SYMPTOM,2739
55925,but,O,2739
55926,also,O,2739
55927,pain,B-SIGN_AND_SYMPTOM,2739
55928,and,I-SIGN_AND_SYMPTOM,2739
55929,discomfort,I-SIGN_AND_SYMPTOM,2739
55930,for,O,2739
55931,the,O,2739
55932,nearly,O,2739
55933,280,O,2739
55934,0,O,2739
55935,patients,O,2739
55936,in,O,2739
55937,the,O,2739
55938,U.S,O,2739
55939,with,O,2739
55940,some,O,2739
55941,type,O,2739
55942,of,O,2739
55943,corneal,B-NAME_OF_DISEASE,2739
55944,dystrophy,I-NAME_OF_DISEASE,2739
55945,Other,O,2739
55946,diagnostic,O,2739
55947,tools,O,2739
55948,are,O,2740
55949,often,O,2740
55950,unable,O,2740
55951,to,O,2740
55952,provide,O,2740
55953,a,O,2740
55954,definitive,O,2740
55955,diagnosis,O,2740
55956,of,O,2740
55957,the,O,2740
55958,disease,O,2740
55959,Avellino,B-ORGANIZATION,2740
55960,Chief,O,2740
55961,Scientific,O,2740
55962,Officer,O,2740
55963,Nazneen,O,2740
55964,Aziz,O,2740
55965,Ph.D,O,2740
55966,states,O,2741
55967,We,O,2741
55968,are,O,2741
55969,pleased,O,2741
55970,to,O,2741
55971,make,O,2741
55972,an,O,2741
55973,impact,O,2741
55974,on,O,2741
55975,patients,O,2741
55976,lives,O,2741
55977,by,O,2741
55978,uncovering,O,2741
55979,the,O,2741
55980,genetic,O,2741
55981,risk,O,2741
55982,of,O,2741
55983,sight-threatening,O,2741
55984,diseases,O,2741
55985,and,O,2741
55986,enabling,O,2741
55987,doctors,O,2741
55988,to,O,2742
55989,deliver,O,2742
55990,a,O,2742
55991,higher,O,2742
55992,level,O,2742
55993,of,O,2742
55994,personalized,O,2742
55995,targeted,O,2742
55996,eye,O,2742
55997,care,O,2742
55998,AvaGen,B-DIAGNOSTIC_TEST,2742
55999,empowers,O,2742
56000,eye,O,2742
56001,care,O,2742
56002,professionals,O,2742
56003,with,O,2742
56004,genetic,O,2742
56005,data,O,2742
56006,for,O,2742
56007,everyday,O,2742
56008,use,O,2742
56009,in,O,2742
56010,their,O,2742
56011,medical,O,2742
56012,practice,O,2742
56013,so,O,2742
56014,they,O,2742
56015,can,O,2742
56016,detect,O,2742
56017,earlier,O,2742
56018,the,O,2743
56019,risk,O,2743
56020,of,O,2743
56021,developing,O,2743
56022,keratoconus,B-NAME_OF_DISEASE,2743
56023,versus,O,2743
56024,other,O,2743
56025,more,O,2743
56026,traditional,O,2743
56027,methods,O,2743
56028,and,O,2743
56029,take,O,2743
56030,actionable,O,2743
56031,decisions,O,2743
56032,on,O,2743
56033,the,O,2743
56034,best,O,2743
56035,course,O,2743
56036,of,O,2743
56037,treatment,O,2743
56038,to,O,2743
56039,protect,O,2743
56040,and,O,2743
56041,preserve,O,2743
56042,vision,O,2743
56043,Avellino,B-ORGANIZATION,2743
56044,CEO,O,2743
56045,and,O,2743
56046,President,O,2743
56047,Jim,B-PERSON,2743
56048,Mazzo,I-PERSON,2743
56049,notes,O,2743
56050,It,O,2744
56051,is,O,2744
56052,exciting,O,2744
56053,to,O,2744
56054,be,O,2744
56055,part,O,2744
56056,of,O,2744
56057,transforming,O,2744
56058,eye,O,2744
56059,care,O,2744
56060,with,O,2744
56061,the,O,2744
56062,national,O,2744
56063,introduction,O,2744
56064,of,O,2744
56065,the,O,2744
56066,first,O,2744
56067,comprehensive,O,2744
56068,genetic,O,2744
56069,test,O,2744
56070,for,O,2744
56071,patients,O,2744
56072,with,O,2744
56073,these,O,2745
56074,challenging,O,2745
56075,conditions,O,2745
56076,I,O,2745
56077,congratulate,O,2745
56078,our,O,2745
56079,Avellino,B-ORGANIZATION,2745
56080,team,O,2745
56081,on,O,2745
56082,accomplishing,O,2745
56083,this,O,2745
56084,important,O,2745
56085,commercial,O,2745
56086,milestone,O,2746
56087,for,O,2746
56088,the,O,2746
56089,company,O,2746
56090,and,O,2746
56091,for,O,2746
56092,taking,O,2746
56093,a,O,2746
56094,giant,O,2746
56095,step,O,2746
56096,on,O,2746
56097,our,O,2746
56098,path,O,2746
56099,to,O,2746
56100,developing,O,2746
56101,a,O,2746
56102,host,O,2746
56103,of,O,2746
56104,genomic,O,2746
56105,tests,O,2746
56106,for,O,2746
56107,personalized,O,2747
56108,disease,O,2747
56109,management,O,2747
56110,He,O,2747
56111,continues,O,2747
56112,While,O,2747
56113,we,O,2747
56114,made,O,2747
56115,AvaGen,B-DIAGNOSTIC_TEST,2747
56116,available,O,2747
56117,in,O,2747
56118,late,O,2747
56119,2019,O,2747
56120,we,O,2747
56121,quickly,O,2747
56122,pivoted,O,2747
56123,our,O,2747
56124,resources,O,2747
56125,to,O,2747
56126,do,O,2747
56127,our,O,2747
56128,part,O,2748
56129,to,O,2748
56130,address,O,2748
56131,the,O,2748
56132,COVID-19,B-NAME_OF_DISEASE,2748
56133,pandemic,O,2748
56134,over,O,2748
56135,the,O,2748
56136,last,O,2748
56137,year,O,2748
56138,with,O,2748
56139,the,O,2748
56140,development,O,2748
56141,of,O,2748
56142,our,O,2748
56143,widely-used,O,2748
56144,SARS-CoV-2,B-CHEMICAL_COMPOUND,2749
56145,COVID-19,B-NAME_OF_DISEASE,2749
56146,test,O,2749
56147,which,O,2749
56148,received,O,2749
56149,Emergency,O,2749
56150,Use,O,2749
56151,Authorization,O,2749
56152,EUA,O,2749
56153,from,O,2749
56154,the,B-ORGANIZATION,2749
56155,FDA,I-ORGANIZATION,2749
56156,Thanks,O,2749
56157,to,O,2749
56158,widespread,O,2750
56159,testing,O,2750
56160,and,O,2750
56161,adoption,O,2750
56162,of,O,2750
56163,the,B-TREATMENT,2750
56164,COVID-19,I-TREATMENT,2750
56165,vaccines,I-TREATMENT,2750
56166,we,O,2750
56167,are,O,2750
56168,now,O,2751
56169,able,O,2751
56170,to,O,2751
56171,offer,O,2751
56172,AvaGen,B-DIAGNOSTIC_TEST,2751
56173,nationally,O,2751
56174,AvaGen,B-DIAGNOSTIC_TEST,2751
56175,is,O,2751
56176,designed,O,2751
56177,to,O,2751
56178,be,O,2751
56179,easy,O,2751
56180,to,O,2751
56181,use,O,2751
56182,requiring,O,2751
56183,only,O,2751
56184,a,O,2751
56185,simple,O,2751
56186,cheek,O,2751
56187,swab,O,2751
56188,that,O,2751
56189,is,O,2751
56190,sent,O,2751
56191,to,O,2751
56192,Avellino,B-ORGANIZATION,2751
56193,s,O,2752
56194,high,O,2752
56195,complexity,O,2752
56196,CLIA-certified,O,2752
56197,lab,O,2752
56198,for,O,2752
56199,analysis,O,2752
56200,An,O,2752
56201,eye,O,2752
56202,care,O,2752
56203,professional,O,2752
56204,receives,O,2752
56205,results,O,2752
56206,in,O,2752
56207,days,O,2752
56208,in,O,2752
56209,an,O,2752
56210,intuitive,O,2752
56211,and,O,2752
56212,actionable,O,2752
56213,report,O,2752
56214,via,O,2753
56215,a,O,2753
56216,HIPAA-secured,O,2753
56217,patient,O,2753
56218,portal,O,2753
56219,Genetic,O,2753
56220,counsel,O,2753
56221,is,O,2753
56222,provided,O,2753
56223,alongside,O,2753
56224,test,O,2753
56225,results,O,2753
56226,to,O,2753
56227,ensure,O,2753
56228,eye,O,2753
56229,care,O,2753
56230,professionals,O,2753
56231,and,O,2753
56232,their,O,2753
56233,patients,O,2753
56234,clearly,O,2753
56235,understand,O,2753
56236,the,O,2753
56237,results,O,2753
56238,and,O,2753
56239,their,O,2753
56240,implications,O,2753
56241,for,O,2753
56242,patient,O,2753
56243,management,O,2753
56244,Santen,B-ORGANIZATION,2753
56245,launches,O,2753
56246,PURALID,B-NAME_OF_DRUG,2753
56247,LIPOGEL,I-NAME_OF_DRUG,2753
56248,an,O,2753
56249,ophthalmic,O,2754
56250,gel,O,2754
56251,for,O,2754
56252,blepharitis,B-NAME_OF_DISEASE,2754
56253,that,O,2754
56254,soothes,O,2754
56255,and,O,2754
56256,cleanses,O,2754
56257,the,B-PART_OF_THE_EYES,2754
56258,eyelids,B-PART_OF_THE_EYES,2754
56259,and,O,2754
56260,periocular,B-PART_OF_THE_EYES,2754
56261,area,I-PART_OF_THE_EYES,2754
56262,Founded,O,2754
56263,in,O,2754
56264,Japan,B-GPE,2754
56265,more,O,2754
56266,than,O,2754
56267,a,O,2754
56268,century,O,2754
56269,ago,O,2754
56270,and,O,2754
56271,currently,O,2754
56272,providing,O,2754
56273,healthcare,O,2755
56274,to,O,2755
56275,people,O,2755
56276,around,O,2755
56277,the,O,2755
56278,globe,O,2755
56279,Santen,B-ORGANIZATION,2755
56280,Pharmaceutical,I-ORGANIZATION,2755
56281,is,O,2755
56282,one,O,2755
56283,of,O,2755
56284,the,O,2755
56285,top,O,2755
56286,specialist,O,2755
56287,ophthalmic,O,2755
56288,pharmaceutical,O,2755
56289,firms,O,2755
56290,in,O,2755
56291,the,O,2755
56292,world,O,2755
56293,According,O,2755
56294,to,O,2755
56295,a,O,2755
56296,recent,O,2755
56297,Santen-commissioned,O,2755
56298,assessment,O,2755
56299,of,O,2755
56300,blepharitis,B-NAME_OF_DISEASE,2755
56301,patients,O,2755
56302,in,O,2755
56303,three,O,2755
56304,European,O,2755
56305,nations,O,2755
56306,several,O,2755
56307,of,O,2756
56308,the,O,2756
56309,most,O,2756
56310,severe,O,2756
56311,and,O,2756
56312,frequent,O,2756
56313,symptoms,O,2756
56314,observed,O,2756
56315,such,O,2756
56316,as,O,2756
56317,dry,B-SIGN_AND_SYMPTOM,2756
56318,eyes,I-SIGN_AND_SYMPTOM,2756
56319,and,I-SIGN_AND_SYMPTOM,2756
56320,red,I-SIGN_AND_SYMPTOM,2756
56321,itchy,I-SIGN_AND_SYMPTOM,2756
56322,and,I-SIGN_AND_SYMPTOM,2756
56323,irritated,I-SIGN_AND_SYMPTOM,2756
56324,eyelids,B-PART_OF_THE_EYES,2756
56325,are,O,2756
56326,not,O,2756
56327,fully,O,2756
56328,alleviated,O,2756
56329,by,O,2756
56330,current,O,2756
56331,treatments,O,2756
56332,Ophthalmologists,O,2756
56333,now,O,2756
56334,have,O,2756
56335,a,O,2756
56336,new,O,2756
56337,choice,O,2756
56338,thanks,O,2756
56339,to,O,2756
56340,PURALID,B-NAME_OF_DRUG,2756
56341,LIPOGEL,I-NAME_OF_DRUG,2756
56342,a,O,2756
56343,mild,O,2756
56344,gel,O,2757
56345,that,O,2757
56346,works,O,2757
56347,hard,O,2757
56348,to,O,2757
56349,clean,O,2757
56350,and,O,2757
56351,soothe,O,2757
56352,sore,O,2757
56353,eyelids,B-PART_OF_THE_EYES,2757
56354,For,O,2757
56355,the,O,2757
56356,majority,O,2757
56357,of,O,2757
56358,patients,O,2757
56359,blepharitis,B-NAME_OF_DISEASE,2758
56360,is,O,2758
56361,a,O,2758
56362,chronic,O,2758
56363,lifelong,O,2758
56364,disorder,O,2758
56365,marked,O,2758
56366,by,O,2758
56367,a,O,2758
56368,cycle,O,2758
56369,of,O,2758
56370,exacerbations,O,2758
56371,and,O,2758
56372,remissions,O,2758
56373,It,O,2758
56374,results,O,2758
56375,in,O,2758
56376,crusting,O,2758
56377,of,O,2758
56378,the,O,2758
56379,eyelid,B-PART_OF_THE_EYES,2758
56380,edge,O,2758
56381,and,O,2758
56382,painful,O,2758
56383,red,O,2758
56384,puffy,O,2758
56385,greasy,O,2758
56386,itchy,O,2758
56387,eyes,O,2759
56388,with,O,2759
56389,a,O,2759
56390,gritty,O,2759
56391,foreign,O,2759
56392,object,O,2759
56393,sensation,O,2759
56394,Despite,O,2759
56395,these,O,2759
56396,recognizable,O,2759
56397,signs,O,2759
56398,there,O,2759
56399,are,O,2759
56400,regional,O,2759
56401,differences,O,2759
56402,in,O,2759
56403,how,O,2759
56404,people,O,2759
56405,in,O,2760
56406,Europe,B-GPE,2760
56407,are,O,2760
56408,familiar,O,2760
56409,with,O,2760
56410,the,O,2760
56411,term,O,2760
56412,blepharitis,B-NAME_OF_DISEASE,2760
56413,with,O,2760
56414,almost,O,2760
56415,half,O,2760
56416,42%,O,2760
56417,of,O,2760
56418,patients,O,2760
56419,surveyed,O,2760
56420,admitting,O,2760
56421,they,O,2760
56422,had,O,2760
56423,never,O,2760
56424,heard,O,2760
56425,of,O,2760
56426,it,O,2760
56427,before,O,2760
56428,their,O,2760
56429,diagnosis,O,2760
56430,However,O,2760
56431,blepharitis,B-NAME_OF_DISEASE,2760
56432,is,O,2760
56433,a,O,2760
56434,prevalent,O,2760
56435,clinical,O,2760
56436,condition,O,2760
56437,among,O,2760
56438,ophthalmologists,O,2760
56439,It,O,2760
56440,can,O,2760
56441,cause,O,2760
56442,bothersome,O,2760
56443,issues,O,2760
56444,including,O,2760
56445,dry,B-SIGN_AND_SYMPTOM,2760
56446,eyes,I-SIGN_AND_SYMPTOM,2760
56447,cysts,I-SIGN_AND_SYMPTOM,2761
56448,and,O,2761
56449,conjunctivitis,B-NAME_OF_DISEASE,2761
56450,if,O,2761
56451,left,O,2761
56452,untreated,O,2761
56453,Recommending,O,2761
56454,eyelid,B-PART_OF_THE_EYES,2761
56455,cleaning,O,2761
56456,is,O,2761
56457,a,O,2761
56458,well-known,O,2761
56459,first,O,2761
56460,step,O,2761
56461,in,O,2761
56462,the,O,2761
56463,treatment,O,2761
56464,of,O,2761
56465,blepharitis,B-NAME_OF_DISEASE,2761
56466,sufferers,O,2761
56467,Blepharitis,B-NAME_OF_DISEASE,2761
56468,is,O,2761
56469,a,O,2761
56470,common,O,2761
56471,and,O,2761
56472,symptomatic,O,2761
56473,disease,O,2761
56474,and,O,2761
56475,it,O,2762
56476,has,O,2762
56477,no,O,2762
56478,established,O,2762
56479,cure,O,2762
56480,It,O,2762
56481,s,O,2762
56482,therefore,O,2762
56483,crucial,O,2762
56484,that,O,2762
56485,we,O,2762
56486,recognise,O,2762
56487,that,O,2762
56488,this,O,2762
56489,condition,O,2762
56490,needs,O,2762
56491,a,O,2762
56492,careful,O,2762
56493,diagnostic,O,2762
56494,approach,O,2762
56495,and,O,2762
56496,personalised,O,2762
56497,management,O,2762
56498,and,O,2762
56499,that,O,2762
56500,we,O,2762
56501,continue,O,2762
56502,to,O,2762
56503,educate,O,2763
56504,patients,O,2763
56505,on,O,2763
56506,the,O,2763
56507,value,O,2763
56508,of,O,2763
56509,lid,O,2763
56510,hygiene,O,2763
56511,such,O,2763
56512,as,O,2763
56513,using,B-PREVENTION,2763
56514,warm,I-PREVENTION,2763
56515,compresses,I-PREVENTION,2763
56516,and,I-PREVENTION,2764
56517,cleansing,I-PREVENTION,2764
56518,the,I-PREVENTION,2764
56519,eyelids,I-PREVENTION,2764
56520,daily,I-PREVENTION,2764
56521,said,O,2764
56522,Professor,O,2764
56523,Edoardo,B-PERSON,2764
56524,Villani,I-PERSON,2764
56525,University,B-ORGANIZATION,2764
56526,of,I-ORGANIZATION,2764
56527,Milan,I-ORGANIZATION,2764
56528,Italy,I-ORGANIZATION,2764
56529,However,O,2764
56530,we,O,2764
56531,know,O,2764
56532,that,O,2764
56533,some,O,2764
56534,patients,O,2764
56535,struggle,O,2764
56536,with,O,2764
56537,current,O,2764
56538,hygiene,O,2764
56539,options,O,2764
56540,and,O,2764
56541,that,O,2764
56542,even,O,2764
56543,mild,O,2764
56544,forms,O,2764
56545,of,O,2764
56546,blepharitis,B-NAME_OF_DISEASE,2764
56547,will,O,2764
56548,only,O,2764
56549,be,O,2764
56550,successfully,O,2764
56551,managed,O,2764
56552,if,O,2764
56553,patients,O,2764
56554,persevere,O,2764
56555,Our,O,2765
56556,survey,O,2765
56557,surprisingly,O,2765
56558,revealed,O,2765
56559,that,O,2765
56560,only,O,2765
56561,17%,O,2765
56562,of,O,2765
56563,people,O,2765
56564,were,O,2765
56565,fully,O,2765
56566,satisfied,O,2765
56567,with,O,2765
56568,their,O,2765
56569,blepharitis,B-NAME_OF_DISEASE,2765
56570,treatment,O,2765
56571,The,O,2765
56572,application,O,2765
56573,was,O,2765
56574,either,O,2765
56575,inconvenient,O,2765
56576,or,O,2765
56577,irritating,O,2765
56578,to,O,2765
56579,the,O,2765
56580,eyes,O,2765
56581,among,O,2765
56582,other,O,2765
56583,reasons,O,2765
56584,PURALID,B-NAME_OF_DRUG,2765
56585,LIPOGEL,I-NAME_OF_DRUG,2765
56586,is,O,2765
56587,an,O,2765
56588,easy-to-apply,O,2765
56589,gel,O,2765
56590,for,O,2765
56591,the,O,2765
56592,relief,O,2765
56593,of,O,2765
56594,acute,O,2765
56595,flares,O,2765
56596,aggravated,O,2765
56597,symptoms,O,2765
56598,and,O,2766
56599,long-term,O,2766
56600,maintenance,O,2766
56601,asymptomatic,O,2766
56602,symptoms,O,2766
56603,of,O,2766
56604,blepharitis,B-NAME_OF_DISEASE,2766
56605,It,O,2766
56606,contains,O,2766
56607,liposomes,B-CHEMICAL_COMPOUND,2766
56608,which,O,2766
56609,are,O,2766
56610,known,O,2766
56611,for,O,2766
56612,their,O,2766
56613,soothing,O,2766
56614,relieving,O,2766
56615,and,O,2766
56616,emollient,O,2766
56617,properties,O,2766
56618,as,O,2766
56619,well,O,2766
56620,as,O,2766
56621,their,O,2766
56622,ability,O,2766
56623,to,O,2766
56624,facilitate,O,2766
56625,the,O,2766
56626,bioavailability,O,2766
56627,of,O,2766
56628,substances,O,2766
56629,Other,O,2766
56630,ingredients,O,2766
56631,include,O,2766
56632,tea,B-CHEMICAL_COMPOUND,2766
56633,tree,I-CHEMICAL_COMPOUND,2766
56634,oil,I-CHEMICAL_COMPOUND,2767
56635,vitamin,B-CHEMICAL_COMPOUND,2767
56636,A,I-CHEMICAL_COMPOUND,2767
56637,xanthan,B-CHEMICAL_COMPOUND,2767
56638,gum,I-CHEMICAL_COMPOUND,2767
56639,ferulic,B-CHEMICAL_COMPOUND,2767
56640,acid,I-CHEMICAL_COMPOUND,2767
56641,vitamin,B-CHEMICAL_COMPOUND,2767
56642,E,I-CHEMICAL_COMPOUND,2767
56643,TPGS,I-CHEMICAL_COMPOUND,2767
56644,and,O,2767
56645,alfa,B-CHEMICAL_COMPOUND,2767
56646,bisabolol,I-CHEMICAL_COMPOUND,2767
56647,Blepharitis,B-NAME_OF_DISEASE,2767
56648,can,O,2767
56649,be,O,2767
56650,sore,O,2767
56651,troublesome,O,2767
56652,uncomfortable,O,2767
56653,and,O,2767
56654,irritating,O,2767
56655,for,O,2767
56656,people,O,2767
56657,so,O,2767
56658,it,O,2767
56659,can,O,2767
56660,have,O,2767
56661,a,O,2768
56662,serious,O,2768
56663,negative,O,2768
56664,impact,O,2768
56665,on,O,2768
56666,quality,O,2768
56667,of,O,2768
56668,life,O,2768
56669,Our,O,2768
56670,survey,O,2768
56671,demonstrated,O,2768
56672,that,O,2769
56673,blepharitis,B-NAME_OF_DISEASE,2769
56674,interferes,O,2769
56675,with,O,2769
56676,daily,O,2769
56677,activities,O,2769
56678,and,O,2769
56679,can,O,2769
56680,prevent,O,2769
56681,reading,O,2769
56682,and,O,2769
56683,normal,O,2769
56684,use,O,2769
56685,of,O,2769
56686,a,O,2769
56687,computer,O,2770
56688,or,O,2770
56689,phone,O,2770
56690,said,O,2770
56691,Luis,B-PERSON,2770
56692,Iglesias,I-PERSON,2770
56693,President,O,2770
56694,and,O,2770
56695,Head,O,2770
56696,of,O,2770
56697,Santen,B-ORGANIZATION,2770
56698,EMEA,I-ORGANIZATION,2770
56699,With,O,2770
56700,blepharitis,B-NAME_OF_DISEASE,2770
56701,impacting,O,2770
56702,how,O,2770
56703,people,O,2770
56704,can,O,2770
56705,use,O,2770
56706,screens,O,2770
56707,plus,O,2770
56708,digital,O,2770
56709,device,O,2770
56710,usage,O,2770
56711,increasing,O,2770
56712,since,O,2770
56713,the,O,2770
56714,COVID-19,B-NAME_OF_DISEASE,2770
56715,pandemic,O,2770
56716,we,O,2770
56717,hope,O,2770
56718,to,O,2770
56719,reaffirm,O,2770
56720,our,O,2770
56721,commitment,O,2770
56722,to,O,2771
56723,eye,O,2771
56724,care,O,2771
56725,with,O,2771
56726,the,O,2771
56727,launch,O,2771
56728,of,O,2771
56729,PURALID,B-NAME_OF_DRUG,2771
56730,LIPOGEL,I-NAME_OF_DRUG,2771
56731,Up,O,2771
56732,to,O,2771
56733,this,O,2771
56734,point,O,2771
56735,PURALID,B-NAME_OF_DRUG,2771
56736,LIPOGEL,I-NAME_OF_DRUG,2771
56737,has,O,2771
56738,been,O,2771
56739,introduced,O,2771
56740,in,O,2771
56741,Austria,B-GPE,2771
56742,Bulgaria,B-GPE,2771
56743,Estonia,B-GPE,2771
56744,Finland,B-GPE,2771
56745,Hungary,B-GPE,2771
56746,Italy,B-GPE,2771
56747,Latvia,B-GPE,2771
56748,Lithuania,B-GPE,2771
56749,Portugal,B-GPE,2771
56750,Spain,B-GPE,2771
56751,Sweden,B-GPE,2771
56752,and,O,2771
56753,Switzerland,B-GPE,2771
56754,Additional,O,2771
56755,introductions,O,2771
56756,are,O,2772
56757,anticipated,O,2772
56758,in,O,2772
56759,other,O,2772
56760,European,O,2772
56761,countries,O,2772
56762,in,O,2772
56763,the,O,2772
56764,months,O,2772
56765,to,O,2772
56766,come,O,2772
56767,The,O,2772
56768,healthy,O,2772
56769,human,O,2772
56770,brain,O,2772
56771,contains,O,2772
56772,tens,O,2772
56773,of,O,2772
56774,billions,O,2772
56775,of,O,2772
56776,neurons-specialized,O,2772
56777,cells,O,2772
56778,that,O,2772
56779,process,O,2772
56780,and,O,2772
56781,transmit,O,2772
56782,information,O,2772
56783,via,O,2772
56784,electrical,O,2772
56785,and,O,2773
56786,chemical,O,2773
56787,signals,O,2773
56788,They,O,2773
56789,send,O,2773
56790,messages,O,2773
56791,between,O,2773
56792,different,O,2773
56793,parts,O,2773
56794,of,O,2773
56795,the,O,2773
56796,brain,O,2773
56797,and,O,2773
56798,from,O,2773
56799,the,O,2773
56800,brain,O,2773
56801,to,O,2773
56802,the,O,2773
56803,muscles,O,2773
56804,and,O,2773
56805,organs,O,2773
56806,of,O,2773
56807,the,O,2773
56808,body,O,2773
56809,Alzheimer,B-NAME_OF_DISEASE,2773
56810,s,I-NAME_OF_DISEASE,2773
56811,disease,I-NAME_OF_DISEASE,2773
56812,disrupts,O,2773
56813,this,O,2773
56814,communication,O,2773
56815,among,O,2773
56816,neurons,O,2773
56817,resulting,O,2773
56818,in,O,2774
56819,loss,B-SIGN_AND_SYMPTOM,2774
56820,of,I-SIGN_AND_SYMPTOM,2774
56821,function,I-SIGN_AND_SYMPTOM,2774
56822,and,I-SIGN_AND_SYMPTOM,2774
56823,cell,I-SIGN_AND_SYMPTOM,2774
56824,death,I-SIGN_AND_SYMPTOM,2774
56825,It,O,2774
56826,is,O,2774
56827,formed,O,2774
56828,from,O,2774
56829,the,O,2774
56830,breakdown,O,2774
56831,of,O,2774
56832,a,O,2774
56833,larger,O,2774
56834,protein,O,2774
56835,called,O,2774
56836,amyloid,B-CHEMICAL_COMPOUND,2774
56837,precursor,I-CHEMICAL_COMPOUND,2775
56838,protein,I-CHEMICAL_COMPOUND,2775
56839,One,O,2775
56840,form,O,2775
56841,beta-amyloid,B-CHEMICAL_COMPOUND,2775
56842,42,I-CHEMICAL_COMPOUND,2775
56843,is,O,2775
56844,thought,O,2775
56845,to,O,2775
56846,be,O,2775
56847,especially,O,2775
56848,toxic,O,2775
56849,In,O,2775
56850,the,O,2775
56851,Alzheimer,B-NAME_OF_DISEASE,2775
56852,s,I-NAME_OF_DISEASE,2775
56853,brain,O,2775
56854,abnormal,O,2775
56855,levels,O,2775
56856,of,O,2775
56857,this,O,2775
56858,naturally,O,2775
56859,occurring,O,2775
56860,protein,O,2775
56861,clump,O,2775
56862,together,O,2775
56863,to,O,2775
56864,form,O,2775
56865,plaques,O,2775
56866,that,O,2775
56867,collect,O,2775
56868,between,O,2776
56869,neurons,O,2776
56870,and,O,2776
56871,disrupt,O,2776
56872,cell,O,2776
56873,function,O,2776
56874,Recent,O,2776
56875,Study,O,2776
56876,Newly,O,2776
56877,published,O,2776
56878,research,O,2776
56879,has,O,2776
56880,revealed,O,2776
56881,a,O,2776
56882,close,O,2776
56883,link,O,2776
56884,between,O,2776
56885,proteins,O,2776
56886,associated,O,2776
56887,with,O,2776
56888,Alzheimer,B-NAME_OF_DISEASE,2776
56889,s,I-NAME_OF_DISEASE,2776
56890,disease,I-NAME_OF_DISEASE,2776
56891,and,O,2776
56892,age-related,B-NAME_OF_DISEASE,2777
56893,sight,I-NAME_OF_DISEASE,2777
56894,loss,I-NAME_OF_DISEASE,2777
56895,The,O,2777
56896,findings,O,2777
56897,could,O,2777
56898,open,O,2777
56899,the,O,2777
56900,way,O,2777
56901,to,O,2777
56902,new,O,2777
56903,treatments,O,2777
56904,for,O,2777
56905,patients,O,2777
56906,with,O,2777
56907,deteriorating,B-SIGN_AND_SYMPTOM,2777
56908,vision,I-SIGN_AND_SYMPTOM,2777
56909,and,O,2778
56910,through,O,2778
56911,this,O,2778
56912,study,O,2778
56913,the,O,2778
56914,scientists,O,2778
56915,believe,O,2778
56916,they,O,2778
56917,could,O,2778
56918,reduce,O,2778
56919,the,O,2778
56920,need,O,2778
56921,for,O,2778
56922,using,O,2778
56923,animals,O,2778
56924,in,O,2778
56925,future,O,2778
56926,research,O,2778
56927,into,O,2778
56928,blinding,O,2778
56929,conditions,O,2778
56930,Amyloid,B-CHEMICAL_COMPOUND,2778
56931,beta,I-CHEMICAL_COMPOUND,2779
56932,Ab,B-CHEMICAL_COMPOUND,2779
56933,proteins,I-CHEMICAL_COMPOUND,2779
56934,are,O,2779
56935,the,O,2779
56936,primary,O,2779
56937,driver,O,2779
56938,of,O,2779
56939,Alzheimer,B-NAME_OF_DISEASE,2780
56940,s,I-NAME_OF_DISEASE,2780
56941,disease,I-NAME_OF_DISEASE,2780
56942,but,O,2780
56943,also,O,2780
56944,begin,O,2780
56945,to,O,2780
56946,collect,O,2780
56947,in,O,2780
56948,the,B-PART_OF_THE_EYES,2780
56949,retina,I-PART_OF_THE_EYES,2780
56950,as,O,2780
56951,people,O,2780
56952,get,O,2780
56953,older,O,2780
56954,Donor,O,2780
56955,eyes,O,2780
56956,from,O,2780
56957,patients,O,2780
56958,who,O,2780
56959,suffered,O,2781
56960,from,O,2781
56961,age-related,B-NAME_OF_DISEASE,2781
56962,macular,I-NAME_OF_DISEASE,2781
56963,degeneration,I-NAME_OF_DISEASE,2781
56964,AMD,B-NAME_OF_DISEASE,2781
56965,the,O,2781
56966,most,O,2781
56967,common,O,2781
56968,cause,O,2781
56969,of,O,2781
56970,blindness,B-NAME_OF_DISEASE,2781
56971,amongst,O,2781
56972,adults,O,2781
56973,in,O,2781
56974,the,B-GPE,2781
56975,UK,I-GPE,2781
56976,have,O,2782
56977,been,O,2782
56978,shown,O,2782
56979,to,O,2782
56980,contain,O,2782
56981,high,O,2782
56982,levels,O,2782
56983,of,O,2782
56984,Ab,B-CHEMICAL_COMPOUND,2782
56985,in,O,2782
56986,their,O,2782
56987,retinas,B-PART_OF_THE_EYES,2782
56988,This,O,2782
56989,new,O,2782
56990,study,O,2782
56991,published,O,2782
56992,in,O,2782
56993,the,B-PUBLICATION_VENUE,2783
56994,journal,I-PUBLICATION_VENUE,2783
56995,Cells,I-PUBLICATION_VENUE,2783
56996,builds,O,2783
56997,on,O,2783
56998,previous,O,2783
56999,research,O,2783
57000,which,O,2783
57001,shows,O,2783
57002,that,O,2783
57003,Ab,B-CHEMICAL_COMPOUND,2783
57004,collects,O,2783
57005,around,O,2783
57006,a,O,2783
57007,cell,O,2783
57008,layer,O,2784
57009,called,O,2784
57010,the,B-PART_OF_THE_EYES,2784
57011,retinal,I-PART_OF_THE_EYES,2784
57012,pigment,I-PART_OF_THE_EYES,2784
57013,epithelium,I-PART_OF_THE_EYES,2784
57014,RPE,I-PART_OF_THE_EYES,2784
57015,to,O,2784
57016,establish,O,2784
57017,what,O,2784
57018,damage,O,2784
57019,these,O,2784
57020,toxic,O,2784
57021,proteins,O,2784
57022,cause,O,2784
57023,RPE,B-PART_OF_THE_EYES,2784
57024,cells,I-PART_OF_THE_EYES,2784
57025,The,O,2784
57026,research,O,2784
57027,team,O,2784
57028,exposed,O,2784
57029,RPE,B-PART_OF_THE_EYES,2784
57030,cells,I-PART_OF_THE_EYES,2784
57031,of,O,2784
57032,normal,O,2784
57033,mouse,O,2784
57034,eyes,O,2784
57035,and,O,2784
57036,in,O,2784
57037,culture,O,2784
57038,to,O,2784
57039,Ab,B-CHEMICAL_COMPOUND,2785
57040,The,O,2785
57041,mouse,O,2785
57042,model,O,2785
57043,enabled,O,2785
57044,the,O,2785
57045,team,O,2785
57046,to,O,2785
57047,look,O,2785
57048,at,O,2785
57049,the,O,2785
57050,effect,O,2785
57051,the,O,2785
57052,protein,O,2785
57053,has,O,2785
57054,in,O,2785
57055,living,O,2785
57056,eye,B-PART_OF_THE_EYES,2785
57057,tissue,I-PART_OF_THE_EYES,2785
57058,using,O,2785
57059,non-invasive,O,2785
57060,imaging,O,2785
57061,techniques,O,2785
57062,that,O,2785
57063,are,O,2785
57064,used,O,2786
57065,in,O,2786
57066,ophthalmology,O,2786
57067,clinics,O,2786
57068,Their,O,2786
57069,findings,O,2786
57070,showed,O,2786
57071,that,O,2786
57072,the,O,2786
57073,mouse,O,2786
57074,eyes,O,2786
57075,developed,O,2786
57076,retinal,O,2786
57077,pathology,O,2786
57078,that,O,2786
57079,was,O,2786
57080,strikingly,O,2786
57081,similar,O,2786
57082,to,O,2786
57083,AMD,B-NAME_OF_DISEASE,2786
57084,in,O,2786
57085,humans,O,2786
57086,Dr,B-PERSON,2786
57087,Arjuna,I-PERSON,2787
57088,Ratnayaka,I-PERSON,2787
57089,a,O,2787
57090,Lecturer,O,2788
57091,in,O,2788
57092,Vision,O,2788
57093,Sciences,O,2788
57094,at,O,2788
57095,the,B-ORGANIZATION,2788
57096,University,I-ORGANIZATION,2788
57097,of,I-ORGANIZATION,2788
57098,Southampton,I-ORGANIZATION,2788
57099,who,O,2788
57100,led,O,2788
57101,the,O,2788
57102,study,O,2788
57103,said,O,2788
57104,This,O,2788
57105,was,O,2788
57106,an,O,2788
57107,important,O,2789
57108,study,O,2789
57109,which,O,2789
57110,also,O,2790
57111,showed,O,2790
57112,that,O,2790
57113,mouse,O,2790
57114,numbers,O,2790
57115,used,O,2790
57116,for,O,2790
57117,experiments,O,2790
57118,of,O,2790
57119,this,O,2790
57120,kind,O,2790
57121,can,O,2790
57122,be,O,2790
57123,significantly,O,2790
57124,reduced,O,2790
57125,in,O,2790
57126,the,O,2790
57127,future,O,2790
57128,We,O,2790
57129,were,O,2790
57130,able,O,2790
57131,to,O,2790
57132,develop,O,2790
57133,a,O,2790
57134,robust,O,2790
57135,model,O,2790
57136,to,O,2790
57137,study,O,2790
57138,AMD-like,O,2790
57139,retinal,O,2790
57140,pathology,O,2790
57141,driven,O,2790
57142,by,O,2790
57143,Ab,B-CHEMICAL_COMPOUND,2790
57144,without,O,2790
57145,using,O,2790
57146,transgenic,O,2790
57147,animals,O,2790
57148,which,O,2790
57149,are,O,2790
57150,often,O,2790
57151,used,O,2790
57152,by,O,2790
57153,researchers,O,2790
57154,the,O,2790
57155,field,O,2790
57156,Transgenic,O,2790
57157,or,O,2790
57158,genetically,O,2790
57159,engineered,O,2791
57160,mice,O,2791
57161,can,O,2791
57162,take,O,2791
57163,up,B-TIME_DURATION,2791
57164,to,I-TIME_DURATION,2791
57165,a,I-TIME_DURATION,2791
57166,year,I-TIME_DURATION,2791
57167,and,O,2791
57168,typically,O,2791
57169,longer,O,2791
57170,before,O,2791
57171,Ab,B-CHEMICAL_COMPOUND,2791
57172,causes,O,2791
57173,pathology,O,2791
57174,in,O,2791
57175,the,B-PART_OF_THE_EYES,2792
57176,retina,I-PART_OF_THE_EYES,2792
57177,which,O,2792
57178,we,O,2792
57179,can,O,2792
57180,achieve,O,2792
57181,within,B-TIME_DURATION,2792
57182,two,I-TIME_DURATION,2792
57183,weeks,I-TIME_DURATION,2792
57184,This,O,2792
57185,reduces,O,2792
57186,the,O,2792
57187,need,O,2792
57188,to,O,2792
57189,develop,O,2792
57190,more,O,2792
57191,transgenic,O,2792
57192,models,O,2792
57193,and,O,2792
57194,improves,O,2792
57195,animal,O,2792
57196,welfare,O,2792
57197,The,O,2792
57198,investigators,O,2792
57199,also,O,2793
57200,used,O,2793
57201,the,O,2793
57202,cell,O,2793
57203,models,O,2793
57204,which,O,2793
57205,further,O,2793
57206,reduced,O,2793
57207,the,O,2793
57208,use,O,2793
57209,of,O,2793
57210,mice,O,2793
57211,in,O,2793
57212,these,O,2793
57213,experiments,O,2793
57214,to,O,2793
57215,show,O,2793
57216,that,O,2793
57217,the,B-CHEMICAL_COMPOUND,2793
57218,toxic,I-CHEMICAL_COMPOUND,2793
57219,Ab,I-CHEMICAL_COMPOUND,2793
57220,proteins,I-CHEMICAL_COMPOUND,2793
57221,entered,O,2793
57222,RPE,B-PART_OF_THE_EYES,2793
57223,cells,I-PART_OF_THE_EYES,2793
57224,and,O,2793
57225,rapidly,O,2793
57226,collected,O,2793
57227,in,O,2793
57228,lysosomes,B-CHEMICAL_COMPOUND,2793
57229,the,O,2793
57230,waste,O,2793
57231,disposal,O,2793
57232,system,O,2793
57233,for,O,2794
57234,the,O,2794
57235,cells,O,2794
57236,Whilst,O,2794
57237,the,O,2794
57238,cells,O,2794
57239,performed,O,2794
57240,their,O,2794
57241,usual,O,2794
57242,function,O,2794
57243,of,O,2794
57244,increasing,O,2794
57245,enzymes,B-CHEMICAL_COMPOUND,2794
57246,within,I-CHEMICAL_COMPOUND,2794
57247,lysosomes,I-CHEMICAL_COMPOUND,2794
57248,to,O,2795
57249,breakdown,O,2795
57250,this,O,2796
57251,unwanted,O,2796
57252,cargo,O,2796
57253,the,O,2796
57254,study,O,2796
57255,found,O,2796
57256,that,O,2796
57257,around,O,2796
57258,85%,O,2796
57259,of,O,2796
57260,Ab,B-CHEMICAL_COMPOUND,2796
57261,still,O,2796
57262,remained,O,2796
57263,within,O,2796
57264,lysosomes,B-CHEMICAL_COMPOUND,2796
57265,meaning,O,2797
57266,that,O,2797
57267,over,O,2797
57268,time,O,2797
57269,the,O,2797
57270,toxic,O,2797
57271,molecules,O,2797
57272,would,O,2797
57273,continue,O,2797
57274,to,O,2797
57275,accumulate,O,2797
57276,inside,O,2797
57277,RPE,B-PART_OF_THE_EYES,2797
57278,cells,I-PART_OF_THE_EYES,2797
57279,Furthermore,O,2797
57280,the,O,2797
57281,researchers,O,2797
57282,discovered,O,2797
57283,that,O,2797
57284,once,O,2797
57285,lysosomes,B-CHEMICAL_COMPOUND,2797
57286,had,O,2797
57287,been,O,2797
57288,invaded,O,2797
57289,by,O,2797
57290,Ab,B-CHEMICAL_COMPOUND,2797
57291,around,O,2797
57292,20,O,2797
57293,percent,O,2797
57294,fewer,O,2797
57295,lysosomes,B-CHEMICAL_COMPOUND,2797
57296,were,O,2797
57297,available,O,2798
57298,to,O,2798
57299,breakdown,O,2798
57300,photoreceptor,O,2798
57301,outer,O,2798
57302,segments,O,2798
57303,a,O,2798
57304,role,O,2798
57305,they,O,2798
57306,routinely,O,2798
57307,perform,O,2798
57308,as,O,2798
57309,part,O,2798
57310,of,O,2798
57311,the,O,2798
57312,daily,O,2798
57313,visual,O,2798
57314,cycle,O,2798
57315,Dr,B-PERSON,2798
57316,Ratnayaka,I-PERSON,2798
57317,added,O,2798
57318,This,O,2798
57319,is,O,2798
57320,a,O,2798
57321,further,O,2798
57322,indication,O,2798
57323,of,O,2798
57324,how,O,2798
57325,cells,O,2798
57326,in,O,2798
57327,the,O,2799
57328,eye,O,2799
57329,can,O,2799
57330,deteriorate,O,2799
57331,over,O,2799
57332,time,O,2799
57333,because,O,2799
57334,of,O,2799
57335,these,O,2799
57336,toxic,O,2799
57337,molecules,O,2799
57338,collecting,O,2799
57339,inside,O,2799
57340,RPE,B-PART_OF_THE_EYES,2799
57341,cells,I-PART_OF_THE_EYES,2799
57342,This,O,2799
57343,could,O,2799
57344,be,O,2799
57345,a,O,2799
57346,new,O,2799
57347,pathway,O,2799
57348,that,O,2800
57349,no-one,O,2800
57350,has,O,2800
57351,explored,O,2800
57352,before,O,2800
57353,Our,O,2800
57354,discoveries,O,2800
57355,have,O,2800
57356,also,O,2800
57357,strengthened,O,2800
57358,the,O,2800
57359,link,O,2800
57360,between,O,2800
57361,diseases,O,2800
57362,of,O,2800
57363,the,O,2800
57364,eye,O,2800
57365,and,O,2800
57366,the,O,2800
57367,brain,O,2800
57368,The,O,2800
57369,eye,O,2800
57370,is,O,2800
57371,part,O,2800
57372,of,O,2800
57373,the,O,2800
57374,brain,O,2800
57375,and,O,2800
57376,we,O,2800
57377,have,O,2800
57378,shown,O,2801
57379,how,O,2801
57380,Ab,B-CHEMICAL_COMPOUND,2801
57381,which,O,2801
57382,is,O,2801
57383,known,O,2801
57384,to,O,2801
57385,drive,O,2801
57386,major,O,2801
57387,neurological,O,2801
57388,conditions,O,2801
57389,such,O,2801
57390,as,O,2801
57391,Alzheimer,B-NAME_OF_DISEASE,2801
57392,s,I-NAME_OF_DISEASE,2801
57393,disease,I-NAME_OF_DISEASE,2801
57394,can,O,2801
57395,also,O,2801
57396,causes,O,2802
57397,significant,O,2802
57398,damage,O,2802
57399,to,O,2802
57400,cells,B-PART_OF_THE_EYES,2802
57401,in,I-PART_OF_THE_EYES,2802
57402,retina,I-PART_OF_THE_EYES,2802
57403,The,O,2802
57404,researchers,O,2802
57405,hope,O,2802
57406,that,O,2802
57407,one,O,2802
57408,of,O,2802
57409,the,O,2802
57410,next,O,2802
57411,steps,O,2802
57412,could,O,2802
57413,be,O,2802
57414,for,O,2802
57415,anti-amyloid,B-TREATMENT,2802
57416,beta,I-TREATMENT,2802
57417,drugs,I-TREATMENT,2802
57418,previously,O,2803
57419,trialled,O,2803
57420,in,O,2803
57421,Alzheimer,B-NAME_OF_DISEASE,2803
57422,s,I-NAME_OF_DISEASE,2803
57423,patients,O,2803
57424,to,O,2803
57425,be,O,2803
57426,re-purposed,O,2803
57427,and,O,2803
57428,trialled,O,2803
57429,as,O,2803
57430,a,O,2803
57431,possible,O,2803
57432,treatment,O,2803
57433,for,O,2803
57434,age-related,B-NAME_OF_DISEASE,2803
57435,macular,I-NAME_OF_DISEASE,2803
57436,degeneration,I-NAME_OF_DISEASE,2803
57437,As,O,2803
57438,the,O,2803
57439,regulators,O,2803
57440,in,O,2803
57441,the,B-GPE,2803
57442,USA,I-GPE,2803
57443,and,O,2803
57444,the,B-ORGANIZATION,2803
57445,European,I-ORGANIZATION,2803
57446,Union,I-ORGANIZATION,2803
57447,have,O,2803
57448,already,O,2803
57449,given,O,2803
57450,approval,O,2804
57451,for,O,2804
57452,many,O,2804
57453,of,O,2804
57454,these,O,2804
57455,drugs,O,2804
57456,this,O,2804
57457,is,O,2804
57458,an,O,2804
57459,area,O,2804
57460,that,O,2804
57461,could,O,2804
57462,be,O,2804
57463,explored,O,2804
57464,relatively,O,2804
57465,quickly,O,2804
57466,The,O,2804
57467,study,O,2805
57468,may,O,2805
57469,also,O,2805
57470,help,O,2805
57471,wider,O,2805
57472,efforts,O,2805
57473,to,O,2805
57474,largely,O,2805
57475,by-pass,O,2805
57476,the,O,2805
57477,use,O,2805
57478,of,O,2805
57479,animal,O,2805
57480,experimentation,O,2805
57481,where,O,2805
57482,possible,O,2805
57483,so,O,2805
57484,some,O,2805
57485,aspects,O,2805
57486,of,O,2805
57487,testing,O,2805
57488,new,O,2805
57489,clinical,O,2805
57490,treatments,O,2805
57491,can,O,2805
57492,transition,O,2805
57493,directly,O,2805
57494,from,O,2805
57495,cell,O,2805
57496,models,O,2805
57497,to,O,2805
57498,patients,O,2805
57499,This,O,2805
57500,research,O,2805
57501,was,O,2805
57502,funded,O,2805
57503,by,O,2805
57504,the,B-ORGANIZATION,2805
57505,National,I-ORGANIZATION,2805
57506,Centre,I-ORGANIZATION,2805
57507,for,I-ORGANIZATION,2805
57508,the,I-ORGANIZATION,2805
57509,Replacement,I-ORGANIZATION,2805
57510,Refinement,I-ORGANIZATION,2805
57511,Reduction,I-ORGANIZATION,2805
57512,of,I-ORGANIZATION,2805
57513,animals,I-ORGANIZATION,2806
57514,in,I-ORGANIZATION,2806
57515,research,I-ORGANIZATION,2806
57516,NC3Rs,I-ORGANIZATION,2806
57517,,O,2806
57518,Dr,B-PERSON,2806
57519,Katie,I-PERSON,2806
57520,Bates,I-PERSON,2806
57521,Head,O,2806
57522,of,O,2806
57523,Research,O,2806
57524,Funding,O,2806
57525,at,O,2806
57526,the,B-ORGANIZATION,2806
57527,NC3Rs,I-ORGANIZATION,2806
57528,said,O,2806
57529,This,O,2806
57530,is,O,2806
57531,an,O,2806
57532,impactful,O,2806
57533,study,O,2806
57534,that,O,2806
57535,demonstrates,O,2806
57536,the,O,2806
57537,scientific,O,2806
57538,practical,O,2806
57539,and,O,2806
57540,3Rs,O,2806
57541,benefits,O,2806
57542,to,O,2806
57543,studying,O,2806
57544,AMD-like,O,2806
57545,retinal,O,2806
57546,pathology,O,2806
57547,in,O,2806
57548,vitro,O,2806
57549,Animal,O,2807
57550,studies,O,2807
57551,were,O,2807
57552,overseen,O,2807
57553,by,O,2807
57554,the,B-ORGANIZATION,2807
57555,institutions,I-ORGANIZATION,2807
57556,Ethical,I-ORGANIZATION,2807
57557,Research,I-ORGANIZATION,2807
57558,Committee,I-ORGANIZATION,2807
57559,and,O,2807
57560,carried,O,2807
57561,out,O,2807
57562,in,O,2807
57563,accordance,O,2807
57564,with,O,2807
57565,the,B-ORGANIZATION,2807
57566,UK,I-ORGANIZATION,2807
57567,Animal,I-ORGANIZATION,2807
57568,Scientific,I-ORGANIZATION,2807
57569,Procedures,I-ORGANIZATION,2807
57570,Act,I-ORGANIZATION,2807
57571,of,I-ORGANIZATION,2807
57572,1986,I-ORGANIZATION,2807
57573,Experiments,O,2808
57574,also,O,2808
57575,conformed,O,2808
57576,to,O,2808
57577,the,O,2808
57578,ARVO,B-ORGANIZATION,2808
57579,statement,O,2808
57580,for,O,2808
57581,the,O,2808
57582,Use,O,2808
57583,of,O,2808
57584,Animals,O,2808
57585,in,O,2809
57586,Ophthalmic,O,2809
57587,and,O,2809
57588,Vision,O,2809
57589,Research,O,2809
57590,The,O,2809
57591,experimental,O,2809
57592,protocol,O,2809
57593,was,O,2809
57594,approved,O,2809
57595,by,O,2809
57596,the,B-ORGANIZATION,2809
57597,University,I-ORGANIZATION,2810
57598,of,I-ORGANIZATION,2810
57599,Southampton,I-ORGANIZATION,2810
57600,Research,I-ORGANIZATION,2810
57601,Ethics,I-ORGANIZATION,2810
57602,Committee,I-ORGANIZATION,2810
57603,and,O,2810
57604,work,O,2811
57605,carried,O,2811
57606,out,O,2811
57607,under,O,2811
57608,the,B-ORGANIZATION,2811
57609,UK,I-ORGANIZATION,2812
57610,Home,I-ORGANIZATION,2812
57611,Office,I-ORGANIZATION,2812
57612,Nyxol®,B-NAME_OF_DRUG,2812
57613,is,O,2812
57614,a,O,2812
57615,preservative-free,O,2812
57616,ophthalmic,O,2812
57617,solution,O,2812
57618,containing,O,2812
57619,0.75,O,2812
57620,phentolamine,B-CHEMICAL_COMPOUND,2812
57621,or,O,2812
57622,1%,O,2812
57623,phentolamine,B-CHEMICAL_COMPOUND,2812
57624,mesylate,I-CHEMICAL_COMPOUND,2812
57625,a,O,2812
57626,nonselective,O,2812
57627,alpha,O,2812
57628,adrenergic,O,2812
57629,antagonist,O,2812
57630,that,O,2812
57631,inhibits,O,2812
57632,the,O,2812
57633,contraction,O,2813
57634,of,O,2813
57635,smooth,O,2813
57636,muscle,O,2813
57637,of,O,2813
57638,the,B-PART_OF_THE_EYES,2813
57639,iris,I-PART_OF_THE_EYES,2813
57640,In,O,2813
57641,multiple,O,2813
57642,Phase,O,2813
57643,2,O,2813
57644,trials,O,2813
57645,Nyxol,B-NAME_OF_DRUG,2813
57646,reduced,O,2813
57647,pupil,B-PART_OF_THE_EYES,2813
57648,diameter,O,2813
57649,resulting,O,2813
57650,in,O,2813
57651,better,O,2813
57652,contrast,O,2813
57653,sensitivity,O,2813
57654,and,O,2813
57655,visual,O,2813
57656,acuity,O,2813
57657,Nyxol,B-NAME_OF_DRUG,2813
57658,is,O,2813
57659,being,O,2813
57660,developed,O,2813
57661,for,O,2813
57662,dim,B-NAME_OF_DISEASE,2813
57663,or,I-NAME_OF_DISEASE,2813
57664,night,I-NAME_OF_DISEASE,2813
57665,vision,I-NAME_OF_DISEASE,2813
57666,disturbances,I-NAME_OF_DISEASE,2813
57667,DLD,I-NAME_OF_DISEASE,2813
57668,reversal,O,2813
57669,of,O,2813
57670,pharmacologically-induced,O,2814
57671,mydriasis,B-NAME_OF_DISEASE,2814
57672,and,O,2814
57673,presbyopia,B-NAME_OF_DISEASE,2814
57674,Presbyopia,B-NAME_OF_DISEASE,2814
57675,is,O,2814
57676,an,O,2814
57677,age-related,O,2814
57678,condition,O,2814
57679,with,O,2814
57680,onset,O,2814
57681,most,O,2814
57682,common,O,2814
57683,in,O,2814
57684,people,O,2814
57685,over,O,2814
57686,40,O,2814
57687,years,O,2814
57688,old,O,2814
57689,As,O,2814
57690,the,O,2814
57691,eye,O,2814
57692,ages,O,2814
57693,the,B-SIGN_AND_SYMPTOM,2814
57694,lens,I-SIGN_AND_SYMPTOM,2814
57695,becomes,I-SIGN_AND_SYMPTOM,2814
57696,stiffer,I-SIGN_AND_SYMPTOM,2814
57697,which,O,2814
57698,limits,O,2814
57699,the,O,2814
57700,eye,O,2814
57701,s,O,2814
57702,ability,O,2814
57703,to,O,2814
57704,adjust,O,2814
57705,its,O,2814
57706,focus,O,2814
57707,for,O,2814
57708,reading,O,2814
57709,or,O,2814
57710,for,O,2814
57711,other,O,2814
57712,tasks,O,2815
57713,that,O,2815
57714,require,O,2815
57715,clear,O,2815
57716,vision,O,2815
57717,at,O,2815
57718,near,O,2815
57719,distances,O,2815
57720,It,O,2815
57721,is,O,2815
57722,estimated,O,2815
57723,that,O,2815
57724,120,O,2815
57725,million,O,2815
57726,Americans,O,2815
57727,have,O,2815
57728,presbyopia,B-NAME_OF_DISEASE,2815
57729,and,O,2815
57730,this,O,2815
57731,number,O,2815
57732,is,O,2815
57733,expected,O,2815
57734,to,O,2816
57735,grow,O,2816
57736,as,O,2816
57737,the,O,2816
57738,population,O,2816
57739,above,O,2816
57740,the,O,2816
57741,age,O,2816
57742,of,O,2816
57743,45,O,2816
57744,increases,O,2816
57745,Currently,O,2816
57746,there,O,2816
57747,are,O,2816
57748,no,O,2816
57749,pharmacological,O,2816
57750,therapies,O,2816
57751,approved,O,2816
57752,for,O,2816
57753,presbyopia,B-NAME_OF_DISEASE,2816
57754,but,O,2816
57755,there,O,2816
57756,is,O,2816
57757,evidence,O,2816
57758,that,O,2816
57759,decreasing,O,2816
57760,pupil,B-PART_OF_THE_EYES,2816
57761,diameter,O,2817
57762,especially,O,2817
57763,to,O,2817
57764,a,O,2817
57765,size,O,2817
57766,of,O,2817
57767,1,O,2817
57768,mm,O,2817
57769,to,O,2817
57770,2,O,2817
57771,mm,O,2817
57772,to,O,2818
57773,create,O,2818
57774,a,O,2818
57775,pinhole,O,2818
57776,effect,O,2818
57777,can,O,2818
57778,improve,O,2818
57779,near,O,2818
57780,visual,O,2818
57781,acuity,O,2818
57782,by,O,2818
57783,increasing,O,2818
57784,the,O,2818
57785,depth,O,2818
57786,of,O,2818
57787,focus,O,2818
57788,Ocuphire,O,2818
57789,Pharma,O,2818
57790,Inc,O,2818
57791,a,O,2818
57792,clinical-stage,O,2818
57793,ophthalmic,O,2818
57794,biopharmaceutical,O,2819
57795,company,O,2819
57796,focused,O,2819
57797,on,O,2819
57798,developing,O,2819
57799,and,O,2819
57800,commercializing,O,2819
57801,therapies,O,2819
57802,for,O,2819
57803,the,O,2819
57804,treatment,O,2819
57805,of,O,2819
57806,several,O,2819
57807,eye,O,2819
57808,disorders,O,2819
57809,recently,O,2819
57810,announced,O,2820
57811,that,O,2820
57812,it,O,2820
57813,has,O,2820
57814,enrolled,O,2820
57815,the,O,2820
57816,first,O,2820
57817,patients,O,2820
57818,in,O,2820
57819,a,B-NAME_OF_STUDY,2820
57820,Phase,I-NAME_OF_STUDY,2820
57821,2,I-NAME_OF_STUDY,2820
57822,proof,I-NAME_OF_STUDY,2820
57823,of,I-NAME_OF_STUDY,2820
57824,concept,I-NAME_OF_STUDY,2820
57825,trial,I-NAME_OF_STUDY,2820
57826,titled,I-NAME_OF_STUDY,2820
57827,VEGA-1,I-NAME_OF_STUDY,2820
57828,to,O,2820
57829,evaluate,O,2820
57830,a,O,2821
57831,combination,O,2821
57832,kit,O,2821
57833,of,O,2821
57834,Nyxol,B-NAME_OF_DRUG,2821
57835,and,O,2821
57836,low-dose,B-NAME_OF_DRUG,2821
57837,pilocarpine,I-NAME_OF_DRUG,2821
57838,in,O,2821
57839,presbyopia,B-NAME_OF_DISEASE,2821
57840,Over,O,2821
57841,12,O,2821
57842,sites,O,2821
57843,representing,O,2821
57844,a,O,2821
57845,majority,O,2821
57846,of,O,2821
57847,the,O,2821
57848,planned,O,2822
57849,clinical,O,2822
57850,sites,O,2822
57851,are,O,2822
57852,activated,O,2822
57853,and,O,2822
57854,recruiting,O,2822
57855,patients,O,2822
57856,Nyxol,B-NAME_OF_DRUG,2822
57857,s,O,2822
57858,potential,O,2822
57859,to,O,2822
57860,improve,O,2822
57861,near,O,2822
57862,vision,O,2822
57863,is,O,2822
57864,based,O,2822
57865,on,O,2823
57866,its,O,2823
57867,mechanism,O,2823
57868,of,O,2823
57869,reducing,B-TREATMENT,2823
57870,pupil,I-TREATMENT,2823
57871,diameter,I-TREATMENT,2823
57872,which,I-TREATMENT,2823
57873,results,I-TREATMENT,2823
57874,in,I-TREATMENT,2823
57875,an,I-TREATMENT,2823
57876,increased,I-TREATMENT,2823
57877,depth,I-TREATMENT,2823
57878,of,I-TREATMENT,2823
57879,focus,I-TREATMENT,2823
57880,Nyxol,B-NAME_OF_DRUG,2823
57881,alone,O,2823
57882,in,O,2823
57883,multiple,O,2823
57884,Phase,O,2823
57885,2,O,2824
57886,trials,O,2824
57887,has,O,2824
57888,reduced,O,2824
57889,pupil,B-PART_OF_THE_EYES,2824
57890,diameter,O,2824
57891,by,O,2824
57892,approximately,O,2824
57893,20%,O,2824
57894,and,O,2824
57895,has,O,2824
57896,significantly,O,2824
57897,improved,O,2824
57898,near,O,2824
57899,visual,O,2824
57900,acuity,O,2824
57901,by,O,2824
57902,one,O,2824
57903,eye-chart,O,2824
57904,line,O,2824
57905,for,B-TIME_DURATION,2824
57906,over,I-TIME_DURATION,2824
57907,24,I-TIME_DURATION,2825
57908,hours,I-TIME_DURATION,2825
57909,after,O,2825
57910,an,O,2825
57911,evening,O,2825
57912,eye,O,2825
57913,drop,O,2825
57914,It,O,2825
57915,has,O,2825
57916,been,O,2825
57917,well,O,2825
57918,established,O,2825
57919,by,O,2825
57920,the,O,2825
57921,field,O,2825
57922,that,O,2825
57923,reducing,O,2825
57924,pupil,B-PART_OF_THE_EYES,2825
57925,diameter,O,2825
57926,to,O,2825
57927,the,O,2825
57928,1,O,2825
57929,to,O,2825
57930,2,O,2825
57931,mm,O,2825
57932,range,O,2825
57933,pinhole,O,2825
57934,effect,O,2825
57935,can,O,2825
57936,lead,O,2825
57937,to,O,2825
57938,significant,O,2825
57939,improvements,O,2825
57940,in,O,2825
57941,near,O,2825
57942,vision,O,2825
57943,for,O,2825
57944,presbyopic,B-NAME_OF_DISEASE,2825
57945,patients,O,2825
57946,Nyxol,B-NAME_OF_DRUG,2825
57947,is,O,2825
57948,being,O,2825
57949,evaluated,O,2825
57950,as,O,2825
57951,part,O,2825
57952,of,O,2826
57953,a,O,2826
57954,two-drug,O,2826
57955,kit,O,2826
57956,provided,O,2826
57957,to,O,2826
57958,patients,O,2826
57959,with,O,2826
57960,Nyxol,B-NAME_OF_DRUG,2826
57961,to,O,2826
57962,be,O,2826
57963,applied,O,2826
57964,once,O,2826
57965,daily,O,2826
57966,in,O,2826
57967,the,O,2826
57968,evening,O,2826
57969,and,O,2826
57970,low-dose,B-NAME_OF_DRUG,2826
57971,pilocarpine,I-NAME_OF_DRUG,2826
57972,to,O,2826
57973,be,O,2826
57974,dosed,O,2826
57975,in,O,2826
57976,the,O,2826
57977,daytime,O,2826
57978,According,O,2826
57979,to,O,2826
57980,a,O,2826
57981,market,O,2826
57982,research,O,2826
57983,report,O,2826
57984,by,O,2826
57985,GlobalData,B-ORGANIZATION,2827
57986,40%,O,2827
57987,of,O,2827
57988,patients,O,2827
57989,would,O,2827
57990,request,O,2827
57991,an,O,2827
57992,alternative,O,2827
57993,to,O,2827
57994,reading,B-TREATMENT,2827
57995,glasses,I-TREATMENT,2827
57996,if,O,2827
57997,available,O,2827
57998,and,O,2827
57999,69%,O,2827
58000,of,O,2827
58001,patients,O,2827
58002,would,O,2827
58003,consider,O,2827
58004,an,O,2827
58005,eye,B-TREATMENT,2827
58006,drop,I-TREATMENT,2827
58007,alternative,O,2827
58008,Some,O,2827
58009,key,O,2827
58010,factors,O,2827
58011,that,O,2827
58012,will,O,2827
58013,influence,O,2827
58014,patient,O,2827
58015,adoption,O,2827
58016,will,O,2827
58017,be,O,2827
58018,efficacy,O,2827
58019,tolerability,O,2827
58020,comfort,O,2827
58021,onset,O,2827
58022,of,O,2827
58023,action,O,2827
58024,durability,O,2827
58025,and,O,2827
58026,good,O,2827
58027,distance,O,2827
58028,vision,O,2827
58029,Mina,B-PERSON,2827
58030,Sooch,I-PERSON,2827
58031,MBA,I-PERSON,2827
58032,President,O,2827
58033,and,O,2827
58034,CEO,O,2827
58035,of,O,2827
58036,Ocuphire,B-ORGANIZATION,2827
58037,Pharma,I-ORGANIZATION,2827
58038,commented,O,2827
58039,Presbyopia,B-NAME_OF_DISEASE,2827
58040,could,O,2827
58041,be,O,2827
58042,one,O,2827
58043,of,O,2827
58044,the,O,2827
58045,largest,O,2827
58046,patient,O,2827
58047,populations,O,2827
58048,at,O,2827
58049,over,O,2827
58050,100,O,2827
58051,million,O,2827
58052,to,O,2827
58053,be,O,2827
58054,treated,O,2827
58055,with,O,2827
58056,a,O,2827
58057,pharmacologic,O,2827
58058,option,O,2827
58059,Many,O,2827
58060,people,O,2827
58061,with,O,2827
58062,presbyopia,B-NAME_OF_DISEASE,2827
58063,may,O,2827
58064,greatly,O,2827
58065,benefit,O,2827
58066,from,O,2827
58067,an,B-TREATMENT,2827
58068,eye,I-TREATMENT,2827
58069,drop,I-TREATMENT,2827
58070,treatment,I-TREATMENT,2827
58071,as,O,2827
58072,an,O,2827
58073,alternative,O,2827
58074,to,O,2827
58075,reading,B-TREATMENT,2827
58076,glasses,I-TREATMENT,2827
58077,We,O,2827
58078,believe,O,2827
58079,that,O,2827
58080,the,O,2827
58081,combination,O,2827
58082,of,O,2827
58083,Nyxol,B-NAME_OF_DRUG,2827
58084,and,O,2827
58085,low-dose,B-NAME_OF_DRUG,2827
58086,pilocarpine,I-NAME_OF_DRUG,2827
58087,has,O,2827
58088,an,O,2827
58089,ideal,O,2827
58090,product,O,2827
58091,profile,O,2827
58092,to,O,2827
58093,become,O,2827
58094,a,O,2827
58095,promising,O,2827
58096,treatment,O,2828
58097,for,O,2828
58098,presbyopia,B-NAME_OF_DISEASE,2828
58099,We,O,2828
58100,are,O,2828
58101,pleased,O,2828
58102,to,O,2828
58103,begin,O,2828
58104,enrollment,O,2828
58105,in,O,2828
58106,the,B-NAME_OF_STUDY,2828
58107,VEGA-1,I-NAME_OF_STUDY,2828
58108,clinical,I-NAME_OF_STUDY,2828
58109,trial,I-NAME_OF_STUDY,2828
58110,working,O,2828
58111,with,O,2828
58112,our,O,2828
58113,CRO,O,2828
58114,partner,O,2828
58115,Oculos,B-ORGANIZATION,2828
58116,and,O,2828
58117,look,O,2828
58118,forward,O,2829
58119,to,O,2829
58120,reporting,O,2829
58121,results,O,2829
58122,at,O,2829
58123,the,O,2829
58124,end,O,2829
58125,of,O,2829
58126,the,O,2829
58127,second,O,2829
58128,quarter,O,2829
58129,this,O,2829
58130,year,O,2829
58131,This,O,2829
58132,is,O,2829
58133,our,O,2829
58134,3rd,O,2829
58135,later,O,2829
58136,stage,O,2829
58137,clinical,O,2829
58138,trial,O,2829
58139,launched,O,2829
58140,for,O,2829
58141,Nyxol,B-NAME_OF_DRUG,2829
58142,in,O,2829
58143,just,O,2829
58144,the,O,2829
58145,last,O,2829
58146,few,O,2829
58147,months,O,2829
58148,I,O,2830
58149,am,O,2830
58150,very,O,2830
58151,happy,O,2830
58152,to,O,2830
58153,see,O,2830
58154,that,O,2830
58155,the,B-NAME_OF_STUDY,2830
58156,VEGA-1,I-NAME_OF_STUDY,2830
58157,trial,I-NAME_OF_STUDY,2830
58158,has,O,2830
58159,begun,O,2830
58160,enrollment,O,2830
58161,which,O,2830
58162,brings,O,2830
58163,the,O,2830
58164,potential,O,2830
58165,for,O,2830
58166,Nyxol,B-NAME_OF_DRUG,2830
58167,and,O,2831
58168,low-dose,B-NAME_OF_DRUG,2831
58169,pilocarpine,I-NAME_OF_DRUG,2831
58170,eye,O,2831
58171,drops,O,2831
58172,to,O,2831
58173,allow,O,2831
58174,presbyopia,B-NAME_OF_DISEASE,2831
58175,patients,O,2831
58176,to,O,2831
58177,experience,O,2831
58178,the,O,2831
58179,ability,O,2831
58180,to,O,2831
58181,see,O,2831
58182,both,O,2831
58183,at,O,2831
58184,near,O,2831
58185,and,O,2831
58186,at,O,2831
58187,distance,O,2831
58188,without,O,2831
58189,the,O,2831
58190,dependence,O,2831
58191,on,O,2831
58192,reading,B-TREATMENT,2831
58193,glasses,I-TREATMENT,2831
58194,The,O,2831
58195,combination,O,2831
58196,of,O,2831
58197,Nyxol,B-NAME_OF_DRUG,2831
58198,moderately,O,2831
58199,inhibiting,O,2831
58200,the,B-PART_OF_THE_EYES,2831
58201,iris,I-PART_OF_THE_EYES,2832
58202,dilator,I-PART_OF_THE_EYES,2832
58203,muscle,I-PART_OF_THE_EYES,2832
58204,and,O,2832
58205,low,B-NAME_OF_DRUG,2832
58206,dose,I-NAME_OF_DRUG,2832
58207,of,I-NAME_OF_DRUG,2832
58208,pilocarpine,I-NAME_OF_DRUG,2832
58209,an,O,2832
58210,extensively,O,2832
58211,studied,O,2832
58212,miotic,O,2832
58213,moderately,O,2832
58214,activating,O,2832
58215,the,B-PART_OF_THE_EYES,2832
58216,iris,I-PART_OF_THE_EYES,2832
58217,constrictor,I-PART_OF_THE_EYES,2832
58218,muscle,I-PART_OF_THE_EYES,2832
58219,should,O,2832
58220,allow,O,2832
58221,for,O,2832
58222,unopposed,O,2832
58223,pupil,B-PART_OF_THE_EYES,2832
58224,constriction,O,2832
58225,to,O,2832
58226,reach,O,2832
58227,the,O,2832
58228,pin-hole,O,2832
58229,,O,2832
58230,Ocuphire,B-ORGANIZATION,2832
58231,s,O,2832
58232,use,O,2832
58233,of,O,2832
58234,agents,O,2832
58235,working,O,2832
58236,on,O,2832
58237,both,O,2832
58238,iris,B-PART_OF_THE_EYES,2832
58239,muscles,I-PART_OF_THE_EYES,2832
58240,to,O,2832
58241,manage,O,2832
58242,pupil,B-PART_OF_THE_EYES,2832
58243,size,O,2832
58244,is,O,2832
58245,a,O,2832
58246,key,O,2832
58247,differentiating,O,2832
58248,factor,O,2832
58249,for,O,2832
58250,its,O,2832
58251,approach,O,2832
58252,says,O,2832
58253,Dr,O,2832
58254,Marguerite,O,2832
58255,McDonald,O,2832
58256,Clinical,O,2832
58257,Professor,O,2833
58258,of,O,2833
58259,Ophthalmology,O,2833
58260,at,O,2833
58261,the,B-ORGANIZATION,2833
58262,NYU,I-ORGANIZATION,2833
58263,Langone,I-ORGANIZATION,2833
58264,Medical,I-ORGANIZATION,2833
58265,Center,I-ORGANIZATION,2833
58266,VEGA-1,B-NAME_OF_STUDY,2833
58267,is,O,2833
58268,a,O,2833
58269,double-masked,O,2833
58270,randomized,O,2833
58271,placebo-controlled,O,2833
58272,multi-center,O,2833
58273,trial,O,2833
58274,designed,O,2834
58275,to,O,2834
58276,evaluate,O,2834
58277,0.75,O,2834
58278,Nyxol,B-NAME_OF_DRUG,2834
58279,in,O,2834
58280,combination,O,2834
58281,with,O,2834
58282,low,O,2834
58283,dose,O,2834
58284,0.4,O,2834
58285,pilocarpine,O,2834
58286,for,O,2834
58287,treatment,O,2834
58288,of,O,2834
58289,presbyopia,B-NAME_OF_DISEASE,2834
58290,The,O,2834
58291,trial,O,2834
58292,is,O,2834
58293,expected,O,2834
58294,to,O,2834
58295,enroll,O,2834
58296,approximately,O,2834
58297,152,O,2835
58298,patients,O,2835
58299,with,O,2835
58300,a,O,2835
58301,clinical,O,2835
58302,diagnosis,O,2835
58303,of,O,2835
58304,presbyopia,B-NAME_OF_DISEASE,2835
58305,near,O,2835
58306,visual,O,2835
58307,acuity,O,2835
58308,of,O,2835
58309,20,O,2835
58310,50,O,2835
58311,or,O,2836
58312,worse,O,2836
58313,,O,2836
58314,The,O,2836
58315,primary,O,2836
58316,endpoint,O,2836
58317,is,O,2836
58318,percentage,O,2836
58319,of,O,2836
58320,patients,O,2836
58321,with,O,2836
58322,at,O,2836
58323,least,O,2836
58324,3,O,2837
58325,lines,O,2837
58326,15,O,2837
58327,letters,O,2837
58328,or,O,2837
58329,more,O,2837
58330,of,O,2837
58331,binocular,O,2837
58332,distance,O,2837
58333,corrected,O,2837
58334,near,O,2837
58335,visual,O,2837
58336,acuity,O,2837
58337,DCNVA,O,2837
58338,improvement,O,2837
58339,on,O,2837
58340,a,O,2837
58341,standard,O,2838
58342,near,O,2838
58343,vision,O,2838
58344,eye,O,2838
58345,chart,O,2838
58346,in,O,2838
58347,daytime,O,2838
58348,photopic,O,2838
58349,lighting,O,2838
58350,conditions,O,2838
58351,Secondary,O,2838
58352,endpoints,O,2838
58353,at,O,2838
58354,multiple,O,2838
58355,timepoints,O,2838
58356,include,O,2838
58357,improvements,O,2838
58358,in,O,2838
58359,3,O,2838
58360,lines,O,2838
58361,of,O,2838
58362,DCNVA,O,2839
58363,without,O,2839
58364,any,O,2839
58365,loss,O,2839
58366,of,O,2839
58367,distance,O,2839
58368,vision,O,2839
58369,pupil,B-PART_OF_THE_EYES,2839
58370,diameter,O,2839
58371,and,O,2840
58372,improvements,O,2840
58373,in,O,2840
58374,DCNVA,O,2840
58375,at,O,2840
58376,1,O,2840
58377,and,O,2840
58378,2,O,2840
58379,lines,O,2840
58380,compared,O,2840
58381,to,O,2840
58382,placebo,O,2840
58383,as,O,2840
58384,well,O,2840
58385,as,O,2840
58386,to,O,2840
58387,each,O,2840
58388,Nyxol,B-NAME_OF_DRUG,2840
58389,and,O,2841
58390,low-dose,B-NAME_OF_DRUG,2841
58391,pilocarpine,I-NAME_OF_DRUG,2841
58392,alone,O,2841
58393,Johnson,B-ORGANIZATION,2841
58394,Johnson,I-ORGANIZATION,2841
58395,Vision,I-ORGANIZATION,2841
58396,a,O,2841
58397,global,O,2841
58398,leader,O,2841
58399,in,O,2841
58400,eye,O,2841
58401,health,O,2841
58402,and,O,2842
58403,part,O,2842
58404,of,O,2842
58405,the,B-ORGANIZATION,2842
58406,Johnson,I-ORGANIZATION,2842
58407,Johnson,I-ORGANIZATION,2842
58408,Medical,I-ORGANIZATION,2842
58409,Devices,I-ORGANIZATION,2842
58410,Companies,I-ORGANIZATION,2843
58411,announced,O,2843
58412,that,O,2843
58413,the,O,2843
58414,U.S,O,2843
58415,Food,O,2843
58416,and,O,2844
58417,Drug,O,2844
58418,Administration,O,2844
58419,FDA,O,2844
58420,approved,O,2844
58421,the,B-TREATMENT,2844
58422,TECNIS,I-TREATMENT,2844
58423,EyhanceTM,I-TREATMENT,2844
58424,and,I-TREATMENT,2844
58425,TECNIS,I-TREATMENT,2844
58426,EyhanceTM,I-TREATMENT,2844
58427,Toric,I-TREATMENT,2844
58428,II,I-TREATMENT,2844
58429,intraocular,I-TREATMENT,2844
58430,lens,I-TREATMENT,2844
58431,IOL,I-TREATMENT,2844
58432,for,O,2844
58433,the,O,2845
58434,treatment,O,2845
58435,of,O,2845
58436,cataract,B-NAME_OF_DISEASE,2845
58437,patients,O,2845
58438,in,O,2845
58439,the,B-GPE,2845
58440,United,I-GPE,2845
58441,States,I-GPE,2845
58442,With,O,2845
58443,this,O,2845
58444,approval,O,2845
58445,and,O,2845
58446,subsequent,O,2845
58447,commercial,O,2845
58448,launch,O,2845
58449,ophthalmologists,O,2845
58450,in,O,2845
58451,the,O,2845
58452,U.S,O,2845
58453,now,O,2845
58454,have,O,2845
58455,the,O,2845
58456,ability,O,2845
58457,to,O,2845
58458,choose,O,2845
58459,this,O,2845
58460,next,O,2845
58461,generation,O,2845
58462,monofocal,O,2845
58463,as,O,2845
58464,the,O,2845
58465,lens,O,2845
58466,of,O,2846
58467,choice,O,2846
58468,for,O,2846
58469,their,O,2846
58470,patients,O,2846
58471,with,O,2846
58472,or,O,2846
58473,without,O,2846
58474,astigmatism,B-NAME_OF_DISEASE,2846
58475,The,O,2846
58476,first,O,2846
58477,implantation,O,2846
58478,of,O,2847
58479,Tecnis,B-TREATMENT,2847
58480,Eyhance,I-TREATMENT,2847
58481,IOL,I-TREATMENT,2847
58482,in,O,2847
58483,the,B-GPE,2847
58484,US,I-GPE,2847
58485,will,O,2847
58486,happen,O,2847
58487,in,O,2847
58488,Texas,B-GPE,2847
58489,next,O,2847
58490,week,O,2847
58491,More,O,2847
58492,than,O,2847
58493,90%,O,2848
58494,of,O,2848
58495,people,O,2848
58496,develop,O,2848
58497,cataracts-the,O,2848
58498,clouding,O,2848
58499,and,O,2848
58500,yellowing,O,2848
58501,of,O,2848
58502,the,O,2848
58503,lens,O,2848
58504,in,O,2848
58505,the,O,2848
58506,eye-by,O,2848
58507,the,O,2848
58508,age,O,2848
58509,of,O,2848
58510,65,O,2848
58511,While,O,2848
58512,part,O,2848
58513,of,O,2848
58514,the,O,2848
58515,normal,O,2848
58516,aging,O,2848
58517,of,O,2848
58518,the,O,2848
58519,eye,O,2848
58520,left,O,2848
58521,untreated,O,2848
58522,cataracts,B-NAME_OF_DISEASE,2848
58523,cause,O,2848
58524,vision,B-SIGN_AND_SYMPTOM,2849
58525,to,I-SIGN_AND_SYMPTOM,2849
58526,deteriorate,I-SIGN_AND_SYMPTOM,2849
58527,over,I-SIGN_AND_SYMPTOM,2849
58528,time,I-SIGN_AND_SYMPTOM,2849
58529,In,O,2849
58530,fact,O,2849
58531,cataracts,B-NAME_OF_DISEASE,2849
58532,are,O,2849
58533,the,O,2849
58534,leading,O,2849
58535,cause,O,2849
58536,of,O,2849
58537,preventable,O,2849
58538,blindness,B-NAME_OF_DISEASE,2849
58539,worldwide,O,2849
58540,impacting,O,2849
58541,more,O,2849
58542,than,O,2849
58543,100,O,2849
58544,million,O,2849
58545,eyes,O,2850
58546,Cataract,B-TREATMENT,2850
58547,surgery,I-TREATMENT,2850
58548,is,O,2850
58549,one,O,2850
58550,of,O,2850
58551,the,O,2850
58552,most,O,2850
58553,common,O,2850
58554,outpatient,O,2850
58555,procedures,O,2850
58556,performed,O,2850
58557,today,O,2850
58558,and,O,2850
58559,has,O,2850
58560,a,O,2850
58561,success,O,2850
58562,rate,O,2850
58563,of,O,2850
58564,approximately,O,2850
58565,98%,O,2850
58566,Today,O,2850
58567,cataract,B-NAME_OF_DISEASE,2850
58568,treatments,O,2850
58569,can,O,2850
58570,also,O,2850
58571,offer,O,2850
58572,patients,O,2850
58573,vision,O,2850
58574,correction,O,2850
58575,reducing,O,2850
58576,or,O,2850
58577,eliminating,O,2850
58578,the,O,2850
58579,need,O,2850
58580,for,O,2850
58581,glasses,B-TREATMENT,2850
58582,in,O,2850
58583,addition,O,2850
58584,to,O,2850
58585,removing,O,2850
58586,the,O,2850
58587,cataract,B-NAME_OF_DISEASE,2850
58588,Eighty-four,O,2850
58589,percent,O,2851
58590,of,O,2851
58591,surgeons,O,2851
58592,choose,O,2851
58593,monofocal,B-TREATMENT,2851
58594,IOLs,I-TREATMENT,2851
58595,for,O,2851
58596,their,O,2851
58597,cataract,B-NAME_OF_DISEASE,2851
58598,patients,O,2851
58599,so,O,2851
58600,it,O,2851
58601,s,O,2851
58602,thrilling,O,2851
58603,to,O,2851
58604,see,O,2851
58605,the,O,2851
58606,first,O,2851
58607,breakthrough,O,2851
58608,in,O,2851
58609,monofocal,O,2851
58610,technology,O,2851
58611,in,O,2851
58612,decades,O,2851
58613,enter,O,2851
58614,the,O,2851
58615,market,O,2851
58616,to,O,2851
58617,add,O,2851
58618,to,O,2851
58619,our,O,2851
58620,treatment,O,2851
58621,portfolio,O,2851
58622,Douglas,B-PERSON,2851
58623,Koch,I-PERSON,2851
58624,MD,I-PERSON,2851
58625,Houston,B-GPE,2851
58626,Texas,B-GPE,2851
58627,said,O,2851
58628,in,O,2851
58629,a,O,2851
58630,company,O,2851
58631,news,O,2851
58632,release,O,2851
58633,It,O,2851
58634,s,O,2851
58635,the,O,2852
58636,first,O,2852
58637,monofocal,O,2852
58638,designed,O,2852
58639,to,O,2852
58640,provide,O,2852
58641,a,O,2852
58642,slight,O,2852
58643,increase,O,2852
58644,in,O,2852
58645,the,O,2852
58646,depth,O,2852
58647,of,O,2852
58648,focus,O,2852
58649,which,O,2852
58650,is,O,2852
58651,something,O,2852
58652,I,O,2852
58653,need,O,2852
58654,for,O,2852
58655,the,O,2852
58656,patients,O,2852
58657,in,O,2852
58658,my,O,2852
58659,practice,O,2852
58660,looking,O,2852
58661,for,O,2852
58662,more,O,2852
58663,from,O,2852
58664,a,O,2852
58665,monofocal,O,2852
58666,The,O,2852
58667,latest,O,2852
58668,innovation,O,2852
58669,in,O,2852
58670,the,B-TREATMENT,2852
58671,Tecnis,I-TREATMENT,2852
58672,family,I-TREATMENT,2852
58673,of,O,2852
58674,IOLs-Tecnis,O,2852
58675,Eyhance,O,2852
58676,and,O,2853
58677,Tecnis,B-TREATMENT,2853
58678,Eyhance,I-TREATMENT,2853
58679,Toric,I-TREATMENT,2853
58680,II,I-TREATMENT,2853
58681,IOLs-are,O,2853
58682,defining,O,2853
58683,the,O,2853
58684,future,O,2853
58685,of,O,2853
58686,monofocals,B-TREATMENT,2853
58687,with,O,2853
58688,a,O,2853
58689,breakthrough,O,2853
58690,refractive,O,2853
58691,surface,O,2853
58692,designed,O,2854
58693,to,O,2854
58694,Slightly,O,2854
58695,extend,O,2854
58696,the,O,2854
58697,depth,O,2854
58698,of,O,2854
58699,focus,O,2854
58700,through,O,2854
58701,the,O,2854
58702,unique,O,2854
58703,shape,O,2854
58704,of,O,2854
58705,the,B-PART_OF_THE_EYES,2854
58706,lens,I-PART_OF_THE_EYES,2854
58707,Deliver,O,2854
58708,better,O,2854
58709,image,O,2854
58710,contrast,O,2854
58711,in,O,2854
58712,low,O,2854
58713,light,O,2854
58714,Tecnis,B-TREATMENT,2854
58715,Eyhance,I-TREATMENT,2854
58716,IOLs,B-TREATMENT,2854
58717,deliver,O,2854
58718,30%,O,2854
58719,improvement,O,2854
58720,in,O,2854
58721,image,O,2854
58722,contrast,O,2854
58723,compared,O,2854
58724,to,O,2854
58725,AcrySof,B-TREATMENT,2854
58726,IQ,I-TREATMENT,2855
58727,SN60WF,I-TREATMENT,2855
58728,at,O,2855
58729,5mm,O,2855
58730,Provide,O,2856
58731,safe,O,2856
58732,and,O,2856
58733,easy,O,2856
58734,delivery,O,2856
58735,using,O,2856
58736,the,O,2856
58737,new,O,2856
58738,Tecnis,B-TREATMENT,2856
58739,Simplicity,O,2856
58740,system,O,2856
58741,that,O,2856
58742,streamlines,O,2856
58743,lens,O,2856
58744,delivery,O,2856
58745,and,O,2856
58746,protects,O,2856
58747,against,O,2856
58748,contamination,O,2856
58749,Built,O,2856
58750,on,O,2856
58751,the,O,2856
58752,proven,O,2856
58753,Tecnis,B-TREATMENT,2856
58754,platform,O,2856
58755,Tecnis,B-TREATMENT,2856
58756,Eyhance,I-TREATMENT,2856
58757,combines,O,2856
58758,low-light,O,2856
58759,performance,O,2856
58760,with,O,2856
58761,breakthrough,O,2856
58762,refractive,O,2856
58763,surface,O,2856
58764,design,O,2856
58765,providing,O,2856
58766,a,O,2856
58767,new,O,2857
58768,kind,O,2857
58769,of,O,2857
58770,monofocal,B-TREATMENT,2857
58771,experience,O,2857
58772,for,O,2857
58773,cataract,B-NAME_OF_DISEASE,2857
58774,patients,O,2857
58775,Rajesh,O,2857
58776,K,O,2857
58777,Rajpal,O,2857
58778,MD,O,2857
58779,Chief,O,2857
58780,Medical,O,2857
58781,Officer,O,2857
58782,and,O,2857
58783,Global,O,2857
58784,Head,O,2857
58785,of,O,2857
58786,Clinical,O,2857
58787,and,O,2857
58788,Medical,O,2857
58789,Affairs,O,2857
58790,at,O,2857
58791,Johnson,B-ORGANIZATION,2857
58792,Johnson,I-ORGANIZATION,2857
58793,Vision,I-ORGANIZATION,2857
58794,said,O,2857
58795,in,O,2857
58796,the,O,2857
58797,news,O,2857
58798,release,O,2857
58799,Additionally,O,2857
58800,the,B-TREATMENT,2857
58801,Tecnis,B-TREATMENT,2857
58802,Eyhance,I-TREATMENT,2857
58803,Toric,I-TREATMENT,2858
58804,II,I-TREATMENT,2858
58805,lens,I-TREATMENT,2858
58806,is,O,2858
58807,engineered,O,2858
58808,with,O,2858
58809,a,O,2858
58810,new,O,2858
58811,squared,O,2858
58812,and,O,2858
58813,frosted,O,2858
58814,haptic,O,2858
58815,design,O,2858
58816,for,O,2858
58817,added,O,2858
58818,friction,O,2858
58819,inside,O,2858
58820,the,O,2858
58821,capsular,O,2858
58822,bag,O,2858
58823,to,O,2858
58824,treat,O,2858
58825,cataract,B-NAME_OF_DISEASE,2858
58826,patients,O,2858
58827,with,O,2858
58828,astigmatism,B-NAME_OF_DISEASE,2858
58829,The,B-TREATMENT,2858
58830,Tecnis,B-TREATMENT,2859
58831,Eyhance,I-TREATMENT,2859
58832,IOL,I-TREATMENT,2859
58833,is,O,2859
58834,the,O,2859
58835,latest,O,2859
58836,lens,O,2859
58837,in,O,2859
58838,the,B-TREATMENT,2859
58839,Tecnis,I-TREATMENT,2859
58840,family,I-TREATMENT,2859
58841,which,O,2859
58842,celebrates,O,2860
58843,its,O,2860
58844,20th,O,2860
58845,anniversary,O,2860
58846,this,O,2860
58847,year,O,2860
58848,The,B-TREATMENT,2860
58849,Tecnis,I-TREATMENT,2860
58850,family,I-TREATMENT,2860
58851,portfolio,O,2860
58852,is,O,2860
58853,the,O,2860
58854,broadest,O,2860
58855,mix,O,2860
58856,of,O,2861
58857,IOLs,B-TREATMENT,2861
58858,for,O,2861
58859,cataract,B-NAME_OF_DISEASE,2861
58860,patients,O,2861
58861,in,O,2861
58862,need,O,2861
58863,of,O,2861
58864,monofocals,B-TREATMENT,2861
58865,multifocals,B-TREATMENT,2861
58866,extended,B-TREATMENT,2861
58867,depth,I-TREATMENT,2861
58868,of,I-TREATMENT,2861
58869,focus,I-TREATMENT,2861
58870,EDOF,I-TREATMENT,2861
58871,and,O,2861
58872,those,O,2861
58873,with,O,2861
58874,or,O,2861
58875,without,O,2862
58876,astigmatism,B-NAME_OF_DISEASE,2862
58877,according,O,2862
58878,to,O,2862
58879,J,B-NAME_OF_DISEASE,2862
58880,J,I-NAME_OF_DISEASE,2862
58881,Vision,I-NAME_OF_DISEASE,2862
58882,We,O,2862
58883,consistently,O,2862
58884,engage,O,2862
58885,with,O,2862
58886,our,O,2862
58887,surgeons,O,2862
58888,and,O,2862
58889,their,O,2862
58890,patients,O,2862
58891,to,O,2862
58892,better,O,2862
58893,understand,O,2862
58894,their,O,2862
58895,unmet,O,2862
58896,needs,O,2863
58897,and,O,2863
58898,their,O,2863
58899,feedback,O,2863
58900,drove,O,2863
58901,us,O,2863
58902,to,O,2863
58903,innovate,O,2863
58904,and,O,2863
58905,push,O,2863
58906,the,O,2863
58907,boundaries,O,2863
58908,of,O,2863
58909,the,O,2863
58910,monofocal,B-TREATMENT,2863
58911,category,O,2863
58912,-,O,2863
58913,a,O,2864
58914,category,O,2864
58915,that,O,2864
58916,s,O,2864
58917,largely,O,2864
58918,been,O,2864
58919,stagnant,O,2864
58920,for,O,2864
58921,the,O,2864
58922,last,O,2864
58923,20,O,2864
58924,years,O,2864
58925,said,O,2864
58926,Sandor,B-PERSON,2864
58927,Palfi,I-PERSON,2864
58928,Commercial,O,2864
58929,Vice,O,2864
58930,President,O,2864
58931,of,O,2864
58932,the,O,2864
58933,Americas,O,2864
58934,at,O,2864
58935,Johnson,B-ORGANIZATION,2864
58936,Johnson,I-ORGANIZATION,2864
58937,Vision,I-ORGANIZATION,2864
58938,Tecnis,B-TREATMENT,2864
58939,Eyhance,I-TREATMENT,2864
58940,IOL,I-TREATMENT,2865
58941,is,O,2865
58942,built,O,2865
58943,on,O,2865
58944,the,O,2865
58945,foundation,O,2865
58946,of,O,2865
58947,our,O,2865
58948,proven,O,2865
58949,Tecnis,B-TREATMENT,2865
58950,platform,O,2865
58951,designed,O,2865
58952,to,O,2865
58953,deliver,O,2865
58954,more,O,2865
58955,Tecnis,B-TREATMENT,2865
58956,Eyhance,I-TREATMENT,2865
58957,first,O,2865
58958,launched,O,2865
58959,in,O,2865
58960,Europe,B-GPE,2865
58961,in,O,2865
58962,February,O,2865
58963,2019,O,2865
58964,and,O,2865
58965,became,O,2865
58966,commercially,O,2865
58967,available,O,2865
58968,in,O,2865
58969,Latin,B-GPE,2865
58970,America,I-GPE,2865
58971,and,O,2865
58972,Canada,B-GPE,2865
58973,in,O,2865
58974,the,O,2865
58975,summer,O,2865
58976,of,O,2865
58977,2020,O,2865
58978,Tecnis,B-TREATMENT,2865
58979,Eyhance,I-TREATMENT,2865
58980,and,O,2865
58981,Tecnis,B-TREATMENT,2865
58982,Eyhance,I-TREATMENT,2865
58983,Toric,I-TREATMENT,2865
58984,II,I-TREATMENT,2865
58985,are,O,2865
58986,now,O,2865
58987,commercially,O,2865
58988,available,O,2865
58989,in,O,2865
58990,the,O,2865
58991,U.S,O,2865
58992,with,O,2865
58993,Tecnis,B-TREATMENT,2865
58994,Eyhance,I-TREATMENT,2865
58995,Toric,I-TREATMENT,2865
58996,II,I-TREATMENT,2865
58997,launching,O,2866
58998,in,O,2866
58999,Europe,B-GPE,2866
59000,and,O,2866
59001,Canada,B-GPE,2866
59002,later,O,2866
59003,this,O,2866
59004,year,O,2866
59005,Myopia,B-NAME_OF_DISEASE,2866
59006,is,O,2866
59007,a,O,2866
59008,disorder,O,2866
59009,with,O,2866
59010,a,O,2866
59011,spectrum,O,2866
59012,of,O,2867
59013,stages,O,2867
59014,that,O,2867
59015,should,O,2867
59016,be,O,2867
59017,evaluated,O,2867
59018,as,O,2867
59019,soon,O,2867
59020,as,O,2867
59021,feasible,O,2867
59022,The,O,2867
59023,risk,O,2867
59024,of,O,2867
59025,the,O,2867
59026,related,O,2867
59027,diseases,O,2867
59028,increasing,O,2867
59029,exponentially,O,2867
59030,with,O,2868
59031,myopia,B-NAME_OF_DISEASE,2868
59032,severity,O,2868
59033,makes,O,2868
59034,early,O,2868
59035,detection,O,2868
59036,and,O,2868
59037,treatment,O,2868
59038,essential,O,2868
59039,for,O,2868
59040,lifetime,O,2868
59041,eye,O,2868
59042,health,O,2868
59043,Myopia,B-NAME_OF_DISEASE,2868
59044,may,O,2868
59045,continue,O,2868
59046,to,O,2868
59047,worsen,O,2868
59048,through,O,2868
59049,the,O,2868
59050,teenage,O,2868
59051,years,O,2868
59052,J,B-ORGANIZATION,2868
59053,JVision,I-ORGANIZATION,2868
59054,has,O,2868
59055,released,O,2868
59056,a,O,2868
59057,new,O,2868
59058,manual,O,2868
59059,to,O,2868
59060,help,O,2868
59061,eye,O,2868
59062,care,O,2868
59063,practitioners,O,2868
59064,diagnose,O,2868
59065,track,O,2869
59066,and,O,2869
59067,treat,O,2869
59068,childhood,O,2869
59069,myopia,B-NAME_OF_DISEASE,2869
59070,You,O,2869
59071,can,O,2869
59072,download,O,2869
59073,Managing,O,2869
59074,Myopia,B-NAME_OF_DISEASE,2869
59075,A,O,2869
59076,Clinical,O,2869
59077,Response,O,2869
59078,to,O,2869
59079,the,O,2869
59080,Growing,O,2869
59081,Epidemic,O,2869
59082,here,O,2869
59083,High,B-NAME_OF_DISEASE,2869
59084,myopia,I-NAME_OF_DISEASE,2869
59085,risk,O,2869
59086,increases,O,2869
59087,with,O,2869
59088,early,O,2869
59089,myopia,B-NAME_OF_DISEASE,2869
59090,onset,O,2869
59091,Younger,O,2869
59092,kids,O,2869
59093,experience,O,2870
59094,myopia,B-NAME_OF_DISEASE,2870
59095,more,O,2870
59096,quickly,O,2870
59097,Younger,O,2870
59098,myopes,O,2870
59099,are,O,2870
59100,more,O,2870
59101,likely,O,2870
59102,to,O,2870
59103,develop,O,2870
59104,high,B-NAME_OF_DISEASE,2870
59105,myopia,I-NAME_OF_DISEASE,2870
59106,because,O,2870
59107,early,O,2870
59108,initiation,O,2870
59109,predicts,O,2870
59110,longer,O,2870
59111,years,O,2870
59112,of,O,2870
59113,development,O,2870
59114,In,O,2870
59115,order,O,2870
59116,to,O,2870
59117,obtain,O,2870
59118,baseline,O,2870
59119,measurements,O,2870
59120,it,O,2870
59121,is,O,2870
59122,crucial,O,2870
59123,to,O,2870
59124,check,O,2870
59125,children,O,2870
59126,at,O,2870
59127,least,O,2871
59128,once,O,2871
59129,between,O,2871
59130,the,O,2871
59131,ages,O,2871
59132,of,O,2871
59133,3,O,2871
59134,and,O,2871
59135,5,O,2871
59136,years,O,2871
59137,and,O,2871
59138,every,O,2871
59139,year,O,2871
59140,thereafter,O,2871
59141,until,O,2871
59142,they,O,2871
59143,are,O,2871
59144,18,O,2871
59145,years,O,2871
59146,old,O,2871
59147,Although,O,2871
59148,myopia,B-NAME_OF_DISEASE,2871
59149,is,O,2871
59150,frequently,O,2871
59151,referred,O,2871
59152,to,O,2871
59153,as,O,2871
59154,nearsightedness,B-NAME_OF_DISEASE,2872
59155,it,O,2872
59156,is,O,2872
59157,much,O,2872
59158,more,O,2872
59159,The,O,2872
59160,largest,O,2872
59161,threat,O,2872
59162,to,O,2872
59163,eye,O,2872
59164,health,O,2872
59165,in,O,2872
59166,the,O,2872
59167,twenty-first,O,2872
59168,century,O,2872
59169,is,O,2872
59170,a,O,2872
59171,chronic,O,2872
59172,progressive,O,2872
59173,condition,O,2872
59174,All,O,2872
59175,children,O,2872
59176,with,O,2872
59177,myopia,B-NAME_OF_DISEASE,2873
59178,should,O,2873
59179,be,O,2873
59180,treated,O,2873
59181,but,O,2873
59182,those,O,2873
59183,who,O,2873
59184,begin,O,2873
59185,to,O,2873
59186,experience,O,2873
59187,it,O,2873
59188,before,O,2873
59189,the,O,2873
59190,age,O,2873
59191,of,O,2873
59192,12,O,2873
59193,have,O,2873
59194,a,O,2873
59195,far,O,2874
59196,higher,O,2874
59197,risk,O,2874
59198,of,O,2874
59199,acquiring,O,2874
59200,high,B-NAME_OF_DISEASE,2875
59201,myopia,I-NAME_OF_DISEASE,2875
59202,later,O,2875
59203,in,O,2875
59204,life,O,2875
59205,In,O,2875
59206,addition,O,2875
59207,by,O,2875
59208,2050,O,2875
59209,one,O,2875
59210,billion,O,2875
59211,individuals,O,2875
59212,are,O,2875
59213,anticipated,O,2875
59214,to,O,2875
59215,have,O,2875
59216,high,B-NAME_OF_DISEASE,2875
59217,myopia,I-NAME_OF_DISEASE,2875
59218,accounting,O,2875
59219,for,O,2875
59220,half,O,2875
59221,of,O,2876
59222,the,O,2876
59223,world,O,2876
59224,s,O,2876
59225,population,O,2876
59226,As,O,2876
59227,optometrists,O,2876
59228,we,O,2876
59229,have,O,2876
59230,been,O,2876
59231,concerned,O,2876
59232,for,O,2876
59233,the,O,2876
59234,eye,O,2876
59235,health,O,2876
59236,of,O,2876
59237,children,O,2876
59238,and,O,2876
59239,the,O,2876
59240,trajectory,O,2876
59241,of,O,2876
59242,myopia,B-NAME_OF_DISEASE,2876
59243,on,O,2876
59244,a,O,2876
59245,global,O,2876
59246,level,O,2877
59247,and,O,2877
59248,COVID-19,B-NAME_OF_DISEASE,2877
59249,has,O,2877
59250,only,O,2877
59251,increased,O,2877
59252,our,O,2877
59253,concern,O,2877
59254,said,O,2877
59255,Noel,B-PERSON,2877
59256,Brennan,I-PERSON,2877
59257,MScOptom,I-PERSON,2877
59258,PhD,I-PERSON,2877
59259,FAAO,O,2877
59260,and,O,2877
59261,Clinical,O,2877
59262,Research,O,2877
59263,Fellow,O,2877
59264,Myopia,B-NAME_OF_DISEASE,2877
59265,Control,O,2877
59266,Platform,O,2877
59267,Johnson,B-ORGANIZATION,2877
59268,Johnson,I-ORGANIZATION,2877
59269,Vision,I-ORGANIZATION,2877
59270,Johnson,B-ORGANIZATION,2877
59271,Johnson,I-ORGANIZATION,2878
59272,Vision,I-ORGANIZATION,2878
59273,in,O,2878
59274,partnership,O,2878
59275,with,O,2878
59276,leaders,O,2878
59277,in,O,2878
59278,optometry,O,2878
59279,has,O,2878
59280,created,O,2878
59281,this,O,2878
59282,new,O,2878
59283,myopia,B-NAME_OF_DISEASE,2878
59284,management,O,2878
59285,guide,O,2878
59286,as,O,2878
59287,a,O,2878
59288,clinical,O,2878
59289,response,O,2879
59290,to,O,2879
59291,address,O,2879
59292,the,O,2879
59293,rising,O,2879
59294,rates,O,2879
59295,of,O,2879
59296,myopia,B-NAME_OF_DISEASE,2879
59297,globally,O,2879
59298,and,O,2879
59299,solidify,O,2879
59300,our,O,2879
59301,collective,O,2879
59302,commitment,O,2879
59303,to,O,2879
59304,combating,O,2879
59305,myopia,B-NAME_OF_DISEASE,2879
59306,as,O,2880
59307,a,O,2880
59308,major,O,2880
59309,threat,O,2880
59310,to,O,2880
59311,our,O,2880
59312,children,O,2880
59313,s,O,2880
59314,eye,O,2880
59315,health,O,2880
59316,Myopia,B-NAME_OF_DISEASE,2880
59317,may,O,2880
59318,be,O,2880
59319,inherited,O,2880
59320,or,O,2880
59321,brought,O,2880
59322,on,O,2880
59323,by,O,2880
59324,environmental,B-CAUSE_OF_DISEASE,2880
59325,or,I-CAUSE_OF_DISEASE,2880
59326,genetic,I-CAUSE_OF_DISEASE,2880
59327,factors,I-CAUSE_OF_DISEASE,2880
59328,and,O,2881
59329,it,O,2881
59330,raises,O,2881
59331,the,O,2881
59332,risk,O,2881
59333,of,O,2881
59334,cataracts,B-NAME_OF_DISEASE,2881
59335,myopic,B-NAME_OF_DISEASE,2881
59336,macular,I-NAME_OF_DISEASE,2881
59337,degeneration,I-NAME_OF_DISEASE,2881
59338,MMD,I-NAME_OF_DISEASE,2881
59339,retinal,B-NAME_OF_DISEASE,2881
59340,detachment,I-NAME_OF_DISEASE,2881
59341,staphyloma,B-NAME_OF_DISEASE,2881
59342,primary,B-NAME_OF_DISEASE,2881
59343,open-angle,I-NAME_OF_DISEASE,2881
59344,glaucoma,I-NAME_OF_DISEASE,2881
59345,and,O,2881
59346,retinal,B-NAME_OF_DISEASE,2881
59347,detachment,I-NAME_OF_DISEASE,2881
59348,all,O,2881
59349,of,O,2881
59350,which,O,2881
59351,can,O,2881
59352,cause,O,2881
59353,blindness,B-NAME_OF_DISEASE,2881
59354,and,O,2881
59355,vision,B-SIGN_AND_SYMPTOM,2881
59356,loss,I-SIGN_AND_SYMPTOM,2881
59357,The,O,2881
59358,new,O,2881
59359,recommendations,O,2881
59360,raise,O,2881
59361,awareness,O,2881
59362,of,O,2881
59363,the,O,2881
59364,essential,O,2882
59365,need,O,2882
59366,to,O,2882
59367,diagnose,O,2882
59368,track,O,2882
59369,and,O,2882
59370,treat,O,2882
59371,childhood,O,2882
59372,myopia,B-NAME_OF_DISEASE,2882
59373,Doctors,O,2882
59374,of,O,2882
59375,optometry,O,2882
59376,are,O,2882
59377,on,O,2882
59378,the,O,2882
59379,primary,O,2883
59380,eye,O,2883
59381,care,O,2883
59382,frontlines,O,2883
59383,battling,O,2883
59384,this,O,2883
59385,crisis,O,2883
59386,and,O,2883
59387,it,O,2883
59388,is,O,2883
59389,imperative,O,2883
59390,to,O,2883
59391,deliver,O,2883
59392,forward-looking,O,2883
59393,clinical,O,2883
59394,information,O,2883
59395,grounded,O,2883
59396,in,O,2883
59397,emerging,O,2883
59398,data,O,2883
59399,and,O,2883
59400,first-hand,O,2883
59401,real-world,O,2883
59402,experience,O,2884
59403,said,O,2884
59404,Robert,O,2884
59405,Layman,O,2884
59406,O.D,O,2884
59407,President-Elect,O,2884
59408,American,B-ORGANIZATION,2884
59409,Optometric,I-ORGANIZATION,2884
59410,Association,I-ORGANIZATION,2884
59411,In,O,2884
59412,collaborating,O,2884
59413,with,O,2884
59414,Johnson,B-ORGANIZATION,2884
59415,Johnson,I-ORGANIZATION,2884
59416,Vision,I-ORGANIZATION,2884
59417,and,O,2884
59418,this,O,2884
59419,group,O,2884
59420,of,O,2884
59421,leaders,O,2884
59422,we,O,2884
59423,are,O,2885
59424,providing,O,2885
59425,doctors,O,2885
59426,with,O,2885
59427,information,O,2885
59428,that,O,2885
59429,will,O,2885
59430,enable,O,2885
59431,them,O,2885
59432,to,O,2885
59433,deliver,O,2885
59434,individualized,O,2885
59435,patient,O,2885
59436,care,O,2885
59437,that,O,2885
59438,will,O,2885
59439,support,O,2886
59440,the,O,2886
59441,patient,O,2886
59442,throughout,O,2886
59443,their,O,2886
59444,childhood,O,2886
59445,and,O,2886
59446,into,O,2886
59447,adulthood,O,2887
59448,Managing,O,2887
59449,Myopia,B-NAME_OF_DISEASE,2887
59450,A,O,2887
59451,Clinical,O,2887
59452,Response,O,2887
59453,to,O,2887
59454,the,O,2887
59455,Growing,O,2887
59456,Epidemic,O,2887
59457,contributes,O,2887
59458,to,O,2887
59459,our,O,2887
59460,understanding,O,2887
59461,of,O,2888
59462,myopia,B-NAME_OF_DISEASE,2888
59463,as,O,2888
59464,a,O,2888
59465,whole,O,2888
59466,and,O,2888
59467,offers,O,2888
59468,a,O,2888
59469,research-based,O,2888
59470,justification,O,2888
59471,for,O,2888
59472,why,O,2888
59473,it,O,2888
59474,is,O,2888
59475,important,O,2888
59476,to,O,2889
59477,give,O,2889
59478,children,O,2889
59479,s,O,2889
59480,eye,O,2889
59481,health,O,2889
59482,top,O,2889
59483,priority,O,2889
59484,The,O,2889
59485,new,O,2889
59486,recommendations,O,2889
59487,to,O,2889
59488,help,O,2889
59489,slow,O,2889
59490,the,O,2890
59491,progression,O,2890
59492,of,O,2890
59493,myopia,B-NAME_OF_DISEASE,2890
59494,are,O,2890
59495,a,O,2890
59496,great,O,2890
59497,step,O,2890
59498,forward,O,2891
59499,for,O,2891
59500,our,O,2891
59501,children,O,2891
59502,said,O,2891
59503,Ken,B-PERSON,2891
59504,Tong,I-PERSON,2891
59505,BSc,I-PERSON,2891
59506,Optom,I-PERSON,2891
59507,President,O,2892
59508,Singapore,B-ORGANIZATION,2892
59509,Optometric,I-ORGANIZATION,2892
59510,Association,I-ORGANIZATION,2892
59511,Traditional,O,2892
59512,ways,O,2892
59513,have,O,2892
59514,taught,O,2892
59515,us,O,2892
59516,to,O,2892
59517,simply,O,2893
59518,change,O,2893
59519,glasses,O,2893
59520,upon,O,2893
59521,prescription,O,2893
59522,updates,O,2893
59523,However,O,2893
59524,this,O,2893
59525,is,O,2893
59526,a,O,2893
59527,risky,O,2893
59528,action,O,2893
59529,because,O,2893
59530,myopia,B-NAME_OF_DISEASE,2893
59531,will,O,2893
59532,inevitably,O,2893
59533,increase,O,2893
59534,quickly,O,2893
59535,during,O,2893
59536,childhood,O,2893
59537,This,O,2893
59538,circumstance,O,2893
59539,occurs,O,2893
59540,much,O,2893
59541,too,O,2893
59542,frequently,O,2893
59543,in,O,2893
59544,our,O,2893
59545,clinic,O,2894
59546,as,O,2894
59547,our,O,2894
59548,doctors,O,2894
59549,observe,O,2894
59550,children,O,2894
59551,s,O,2894
59552,myopia,B-NAME_OF_DISEASE,2894
59553,deteriorate,O,2894
59554,over,O,2894
59555,time,O,2894
59556,The,O,2894
59557,structure,O,2894
59558,and,O,2894
59559,health,O,2894
59560,of,O,2894
59561,the,O,2894
59562,eye,O,2894
59563,are,O,2894
59564,compromised,O,2895
59565,as,O,2895
59566,myopia,B-NAME_OF_DISEASE,2895
59567,increases,O,2895
59568,increasing,O,2895
59569,the,O,2895
59570,risk,O,2895
59571,of,O,2895
59572,eye,O,2895
59573,disease,O,2895
59574,and,O,2895
59575,vision,B-SIGN_AND_SYMPTOM,2895
59576,loss,I-SIGN_AND_SYMPTOM,2895
59577,As,O,2895
59578,a,O,2895
59579,result,O,2896
59580,myopia,B-NAME_OF_DISEASE,2896
59581,control,O,2896
59582,strategies,O,2896
59583,must,O,2896
59584,be,O,2896
59585,used,O,2896
59586,to,O,2896
59587,stop,O,2896
59588,the,O,2896
59589,progression,O,2896
59590,of,O,2896
59591,treatable,O,2896
59592,eye,O,2896
59593,illnesses,O,2896
59594,Myopia,B-NAME_OF_DISEASE,2896
59595,will,O,2896
59596,deteriorate,O,2896
59597,and,O,2896
59598,pose,O,2896
59599,more,O,2896
59600,risks,O,2896
59601,to,O,2896
59602,eye,O,2896
59603,health,O,2896
59604,during,O,2896
59605,a,O,2896
59606,person,O,2896
59607,s,O,2896
59608,lifetime,O,2896
59609,if,O,2896
59610,there,O,2896
59611,is,O,2896
59612,no,O,2896
59613,intervention,O,2896
59614,in,O,2896
59615,a,O,2896
59616,myopic,O,2896
59617,child,O,2896
59618,s,O,2896
59619,visual,O,2897
59620,system,O,2897
59621,According,O,2897
59622,to,O,2897
59623,the,O,2897
59624,revised,O,2897
59625,guidance,O,2897
59626,important,O,2897
59627,ideas,O,2897
59628,for,O,2897
59629,patients,O,2897
59630,and,O,2897
59631,eye,O,2898
59632,care,O,2898
59633,providers,O,2898
59634,to,O,2898
59635,bear,O,2898
59636,in,O,2898
59637,mind,O,2898
59638,are,O,2898
59639,as,O,2898
59640,follows,O,2898
59641,Children,B-PREVENTION,2898
59642,should,I-PREVENTION,2898
59643,get,I-PREVENTION,2898
59644,eye,I-PREVENTION,2898
59645,exams,I-PREVENTION,2899
59646,between,I-PREVENTION,2899
59647,the,I-PREVENTION,2899
59648,ages,I-PREVENTION,2899
59649,of,I-PREVENTION,2899
59650,6,I-PREVENTION,2899
59651,and,I-PREVENTION,2899
59652,12,I-PREVENTION,2899
59653,months,I-PREVENTION,2899
59654,at,I-PREVENTION,2899
59655,least,I-PREVENTION,2899
59656,once,I-PREVENTION,2899
59657,between,I-PREVENTION,2899
59658,the,I-PREVENTION,2899
59659,ages,I-PREVENTION,2899
59660,of,I-PREVENTION,2899
59661,3,I-PREVENTION,2899
59662,and,I-PREVENTION,2899
59663,5,I-PREVENTION,2899
59664,then,I-PREVENTION,2899
59665,annually,I-PREVENTION,2899
59666,through,I-PREVENTION,2899
59667,the,I-PREVENTION,2899
59668,age,I-PREVENTION,2899
59669,of,I-PREVENTION,2899
59670,17,I-PREVENTION,2899
59671,according,O,2899
59672,to,O,2899
59673,American,B-ORGANIZATION,2899
59674,Optometric,I-ORGANIZATION,2899
59675,Association,I-ORGANIZATION,2899
59676,AOA,I-ORGANIZATION,2899
59677,recommendations,O,2899
59678,Obtain,O,2899
59679,early,O,2899
59680,intervention,O,2899
59681,The,O,2899
59682,onset,O,2899
59683,of,O,2899
59684,myopia,B-NAME_OF_DISEASE,2899
59685,is,O,2899
59686,the,O,2899
59687,key,O,2899
59688,sign,O,2899
59689,that,O,2899
59690,therapy,O,2899
59691,should,O,2899
59692,start,O,2899
59693,To,O,2899
59694,stop,O,2899
59695,the,O,2899
59696,advancement,O,2899
59697,of,O,2899
59698,myopia,B-NAME_OF_DISEASE,2899
59699,it,O,2899
59700,is,O,2899
59701,essential,O,2899
59702,to,O,2899
59703,diagnose,O,2899
59704,and,O,2899
59705,treat,O,2899
59706,it,O,2900
59707,as,O,2900
59708,soon,O,2900
59709,as,O,2900
59710,feasible,O,2900
59711,Select,B-TREATMENT,2900
59712,the,I-TREATMENT,2900
59713,ideal,I-TREATMENT,2900
59714,therapy,I-TREATMENT,2900
59715,The,O,2900
59716,best,O,2901
59717,course,O,2901
59718,of,O,2901
59719,action,O,2901
59720,for,O,2901
59721,a,O,2901
59722,child,O,2901
59723,with,O,2901
59724,myopia,B-NAME_OF_DISEASE,2901
59725,depends,O,2901
59726,on,O,2901
59727,a,O,2901
59728,number,O,2901
59729,of,O,2901
59730,factors,O,2901
59731,including,O,2901
59732,the,O,2901
59733,parents,O,2901
59734,preferences,O,2901
59735,the,O,2901
59736,child,O,2901
59737,s,O,2901
59738,aptitude,O,2901
59739,and,O,2901
59740,his,O,2901
59741,or,O,2901
59742,her,O,2901
59743,level,O,2902
59744,of,O,2902
59745,development,O,2902
59746,The,O,2902
59747,optimal,O,2902
59748,solution,O,2902
59749,for,O,2902
59750,each,O,2902
59751,patient,O,2902
59752,can,O,2902
59753,be,O,2902
59754,selected,O,2902
59755,by,O,2902
59756,practitioners,O,2902
59757,and,O,2902
59758,families,O,2902
59759,based,O,2903
59760,on,O,2903
59761,efficacy,O,2903
59762,including,O,2903
59763,orthokeratology,B-TREATMENT,2903
59764,soft,B-TREATMENT,2903
59765,multifocal,I-TREATMENT,2903
59766,contacts,I-TREATMENT,2903
59767,myopia,B-TREATMENT,2903
59768,control,I-TREATMENT,2903
59769,eyewear,I-TREATMENT,2903
59770,or,O,2903
59771,atropine,B-TREATMENT,2903
59772,eye,I-TREATMENT,2903
59773,drops,I-TREATMENT,2903
59774,Monitoring,O,2903
59775,the,O,2903
59776,advancement,O,2904
59777,of,O,2904
59778,myopia,B-NAME_OF_DISEASE,2904
59779,Once,O,2904
59780,treatment,O,2904
59781,is,O,2904
59782,in,O,2904
59783,place,O,2904
59784,frequent,O,2904
59785,monitoring-at,O,2904
59786,least,O,2904
59787,every,O,2904
59788,six,O,2904
59789,months-helps,O,2904
59790,remove,O,2904
59791,barriers,O,2904
59792,to,O,2904
59793,usage,O,2904
59794,spot,O,2904
59795,dangerous,O,2905
59796,or,O,2905
59797,non-compliant,O,2905
59798,behaviors,O,2905
59799,and,O,2905
59800,deal,O,2905
59801,with,O,2905
59802,any,O,2905
59803,issues,O,2905
59804,as,O,2905
59805,soon,O,2905
59806,as,O,2905
59807,possible,O,2905
59808,Since,O,2906
59809,development,O,2906
59810,might,O,2906
59811,fluctuate,O,2906
59812,seasonally,O,2906
59813,axial,O,2906
59814,length,O,2906
59815,and,O,2906
59816,cycloplegic,O,2906
59817,refractive,O,2906
59818,error,O,2906
59819,should,O,2906
59820,be,O,2906
59821,assessed,O,2906
59822,for,O,2906
59823,a,O,2906
59824,minimum,O,2906
59825,of,O,2906
59826,one,O,2906
59827,year,O,2906
59828,before,O,2906
59829,considering,O,2906
59830,treatment,O,2907
59831,modifications,O,2907
59832,or,O,2907
59833,additional,O,2907
59834,therapy,O,2907
59835,How,O,2907
59836,to,O,2907
59837,effectively,O,2907
59838,communicate,O,2907
59839,myopia,B-NAME_OF_DISEASE,2907
59840,control,O,2907
59841,The,O,2907
59842,effect,O,2907
59843,of,O,2907
59844,myopia,B-NAME_OF_DISEASE,2907
59845,control,O,2907
59846,therapy,O,2907
59847,is,O,2907
59848,typically,O,2907
59849,more,O,2908
59850,of,O,2908
59851,an,O,2908
59852,absolute,O,2908
59853,effect,O,2908
59854,than,O,2908
59855,a,O,2908
59856,proportionate,O,2908
59857,effect,O,2908
59858,The,O,2908
59859,cumulative,O,2908
59860,absolute,O,2908
59861,reduction,O,2908
59862,in,O,2908
59863,elongation,O,2908
59864,or,O,2908
59865,refractive,O,2908
59866,error,O,2908
59867,is,O,2908
59868,the,O,2908
59869,strongest,O,2908
59870,indicator,O,2908
59871,of,O,2908
59872,myopia,B-NAME_OF_DISEASE,2909
59873,treatment,O,2909
59874,effectiveness,O,2909
59875,i.e,O,2909
59876,total,O,2909
59877,mm,O,2909
59878,or,O,2909
59879,D,O,2909
59880,,O,2909
59881,Papilledema,B-NAME_OF_DISEASE,2909
59882,is,O,2909
59883,the,B-SIGN_AND_SYMPTOM,2909
59884,swelling,I-SIGN_AND_SYMPTOM,2909
59885,of,I-SIGN_AND_SYMPTOM,2909
59886,the,I-SIGN_AND_SYMPTOM,2909
59887,optic,I-SIGN_AND_SYMPTOM,2909
59888,nerve,I-SIGN_AND_SYMPTOM,2909
59889,as,I-SIGN_AND_SYMPTOM,2909
59890,it,I-SIGN_AND_SYMPTOM,2909
59891,enters,I-SIGN_AND_SYMPTOM,2909
59892,the,I-SIGN_AND_SYMPTOM,2909
59893,back,I-SIGN_AND_SYMPTOM,2909
59894,of,I-SIGN_AND_SYMPTOM,2909
59895,the,I-SIGN_AND_SYMPTOM,2909
59896,eye,I-SIGN_AND_SYMPTOM,2910
59897,due,I-SIGN_AND_SYMPTOM,2910
59898,to,I-SIGN_AND_SYMPTOM,2910
59899,raised,I-SIGN_AND_SYMPTOM,2910
59900,intracranial,I-SIGN_AND_SYMPTOM,2910
59901,pressure,I-SIGN_AND_SYMPTOM,2910
59902,Fluid,O,2910
59903,surrounding,O,2910
59904,the,O,2910
59905,brain,O,2910
59906,is,O,2910
59907,constantly,O,2910
59908,produced,O,2910
59909,and,O,2910
59910,reabsorbed,O,2910
59911,maintaining,O,2910
59912,just,O,2910
59913,enough,O,2910
59914,intracranial,O,2910
59915,pressure,O,2910
59916,to,O,2911
59917,help,O,2911
59918,protect,O,2911
59919,the,O,2911
59920,brain,O,2911
59921,if,O,2911
59922,there,O,2911
59923,is,O,2911
59924,blunt,O,2911
59925,head,O,2911
59926,trauma,O,2911
59927,The,O,2911
59928,differential,O,2911
59929,diagnosis,O,2911
59930,of,O,2911
59931,swollen,B-SIGN_AND_SYMPTOM,2911
59932,optic,I-SIGN_AND_SYMPTOM,2911
59933,nerves,I-SIGN_AND_SYMPTOM,2911
59934,differs,O,2911
59935,according,O,2911
59936,to,O,2911
59937,whether,O,2911
59938,the,O,2911
59939,swelling,O,2911
59940,is,O,2911
59941,unilateral,O,2911
59942,or,O,2911
59943,bilateral,O,2912
59944,or,O,2912
59945,whether,O,2912
59946,visual,O,2912
59947,function,O,2912
59948,is,O,2912
59949,normal,O,2912
59950,or,O,2912
59951,affected,O,2912
59952,Patients,O,2912
59953,with,O,2912
59954,a,O,2912
59955,unilaterally,B-SIGN_AND_SYMPTOM,2912
59956,swollen,I-SIGN_AND_SYMPTOM,2912
59957,optic,I-SIGN_AND_SYMPTOM,2912
59958,nerve,I-SIGN_AND_SYMPTOM,2912
59959,and,O,2912
59960,normal,O,2912
59961,visual,O,2912
59962,function,O,2912
59963,most,O,2913
59964,likely,O,2913
59965,have,O,2913
59966,optic,B-SIGN_AND_SYMPTOM,2913
59967,nerve,I-SIGN_AND_SYMPTOM,2913
59968,head,I-SIGN_AND_SYMPTOM,2913
59969,drusen,I-SIGN_AND_SYMPTOM,2913
59970,Patients,O,2913
59971,with,O,2913
59972,abnormal,B-SIGN_AND_SYMPTOM,2913
59973,visual,I-SIGN_AND_SYMPTOM,2913
59974,function,I-SIGN_AND_SYMPTOM,2913
59975,most,O,2913
59976,likely,O,2914
59977,have,O,2914
59978,demyelinating,B-NAME_OF_DISEASE,2914
59979,optic,I-NAME_OF_DISEASE,2914
59980,neuritis,I-NAME_OF_DISEASE,2914
59981,or,O,2914
59982,non-arteritic,B-NAME_OF_DISEASE,2914
59983,anterior,I-NAME_OF_DISEASE,2914
59984,ischaemic,I-NAME_OF_DISEASE,2914
59985,optic,I-NAME_OF_DISEASE,2914
59986,neuropathy,I-NAME_OF_DISEASE,2915
59987,Patients,O,2915
59988,with,O,2915
59989,bilaterally,B-SIGN_AND_SYMPTOM,2915
59990,swollen,I-SIGN_AND_SYMPTOM,2915
59991,optic,I-SIGN_AND_SYMPTOM,2915
59992,nerve,I-SIGN_AND_SYMPTOM,2915
59993,heads,I-SIGN_AND_SYMPTOM,2915
59994,and,O,2915
59995,normal,O,2915
59996,visual,O,2916
59997,function,O,2916
59998,most,O,2916
59999,likely,O,2916
60000,have,O,2916
60001,papilloedema,B-NAME_OF_DISEASE,2916
60002,and,O,2916
60003,require,O,2916
60004,neuroimaging,B-DIAGNOSTIC_TEST,2916
60005,followed,O,2916
60006,by,O,2916
60007,lumbar,B-DIAGNOSTIC_TEST,2916
60008,puncture,I-DIAGNOSTIC_TEST,2916
60009,However,O,2916
60010,if,O,2916
60011,their,O,2916
60012,visual,O,2916
60013,function,O,2916
60014,is,O,2916
60015,affected,O,2916
60016,the,O,2916
60017,most,O,2916
60018,likely,O,2916
60019,causes,O,2916
60020,are,O,2916
60021,bilateral,B-CAUSE_OF_DISEASE,2916
60022,demyelinating,B-NAME_OF_DISEASE,2916
60023,optic,I-NAME_OF_DISEASE,2916
60024,neuritis,I-NAME_OF_DISEASE,2916
60025,neuromyelitis,I-CAUSE_OF_DISEASE,2916
60026,optica,I-CAUSE_OF_DISEASE,2916
60027,spectrum,I-CAUSE_OF_DISEASE,2916
60028,disorder,I-CAUSE_OF_DISEASE,2916
60029,and,I-CAUSE_OF_DISEASE,2916
60030,anti-myelin,I-CAUSE_OF_DISEASE,2917
60031,oligodendrocyte,I-CAUSE_OF_DISEASE,2917
60032,glycoprotein,I-CAUSE_OF_DISEASE,2917
60033,optic,I-CAUSE_OF_DISEASE,2917
60034,neuritis,I-CAUSE_OF_DISEASE,2917
60035,these,O,2917
60036,patients,O,2917
60037,require,O,2917
60038,investigating,O,2917
60039,with,O,2917
60040,contrast-enhanced,B-DIAGNOSTIC_TEST,2917
60041,MRI,I-DIAGNOSTIC_TEST,2917
60042,of,I-DIAGNOSTIC_TEST,2917
60043,the,I-DIAGNOSTIC_TEST,2917
60044,orbits,I-DIAGNOSTIC_TEST,2917
60045,Optic,O,2917
60046,nerve,O,2917
60047,swelling,O,2917
60048,or,O,2917
60049,edema,O,2917
60050,can,O,2918
60051,be,O,2918
60052,an,O,2918
60053,intimidating,O,2918
60054,finding,O,2918
60055,in,O,2918
60056,the,O,2918
60057,primary,O,2918
60058,eyecare,O,2918
60059,clinic,O,2918
60060,The,O,2918
60061,diagnosis,O,2918
60062,of,O,2918
60063,a,O,2918
60064,swollen,O,2918
60065,optic,O,2918
60066,nerve,O,2918
60067,is,O,2918
60068,based,O,2918
60069,on,O,2918
60070,clinical,O,2918
60071,diagnosis,O,2918
60072,but,O,2918
60073,the,O,2918
60074,importance,O,2918
60075,of,O,2918
60076,a,O,2918
60077,comprehensive,O,2918
60078,case,O,2919
60079,history,O,2919
60080,cannot,O,2919
60081,be,O,2919
60082,overstated,O,2919
60083,Ocular,O,2919
60084,History,O,2919
60085,During,O,2919
60086,the,O,2919
60087,history,O,2919
60088,many,O,2919
60089,important,O,2919
60090,questions,O,2919
60091,should,O,2919
60092,be,O,2919
60093,asked,O,2919
60094,to,O,2919
60095,help,O,2919
60096,determine,O,2919
60097,the,O,2919
60098,etiology,O,2919
60099,of,O,2919
60100,the,B-PART_OF_THE_EYES,2919
60101,optic,I-PART_OF_THE_EYES,2919
60102,nerve,I-PART_OF_THE_EYES,2919
60103,edema,I-NAME_OF_DISEASE,2919
60104,The,O,2919
60105,clinician,O,2919
60106,should,O,2919
60107,begin,O,2920
60108,by,O,2920
60109,questioning,O,2920
60110,if,O,2920
60111,the,O,2920
60112,condition,O,2920
60113,is,O,2920
60114,a,O,2920
60115,one,O,2920
60116,or,O,2920
60117,two,O,2920
60118,eyeball,O,2920
60119,problem,O,2920
60120,Bilateral,B-NAME_OF_DISEASE,2920
60121,optic,B-NAME_OF_DISEASE,2920
60122,nerve,I-NAME_OF_DISEASE,2920
60123,edema,I-NAME_OF_DISEASE,2920
60124,is,O,2920
60125,a,O,2920
60126,medical,O,2920
60127,emergency,O,2920
60128,The,O,2920
60129,onset,O,2920
60130,and,O,2920
60131,severity,O,2920
60132,of,O,2920
60133,vision,B-SIGN_AND_SYMPTOM,2920
60134,loss,I-SIGN_AND_SYMPTOM,2920
60135,and,O,2920
60136,symptoms,O,2920
60137,are,O,2920
60138,important,O,2920
60139,clues,O,2920
60140,to,O,2920
60141,consider,O,2920
60142,Rapid,O,2921
60143,onset,O,2921
60144,is,O,2921
60145,characteristic,O,2921
60146,of,O,2921
60147,ischemic,B-NAME_OF_DISEASE,2921
60148,optic,I-NAME_OF_DISEASE,2921
60149,neuropathy,I-NAME_OF_DISEASE,2921
60150,inflammatory,O,2921
60151,and,O,2921
60152,traumatic,O,2921
60153,causes,O,2921
60154,and,O,2921
60155,optic,B-NAME_OF_DISEASE,2921
60156,neuritis,I-NAME_OF_DISEASE,2921
60157,A,O,2921
60158,gradual,O,2922
60159,onset,O,2922
60160,over,O,2922
60161,time,O,2922
60162,is,O,2922
60163,typical,O,2922
60164,of,O,2922
60165,compressive,O,2922
60166,hereditary,O,2922
60167,toxic,O,2922
60168,and,O,2922
60169,nutritional,O,2922
60170,causes,O,2922
60171,Another,O,2922
60172,important,O,2922
60173,symptom,O,2922
60174,pain,B-SIGN_AND_SYMPTOM,2922
60175,associated,I-SIGN_AND_SYMPTOM,2922
60176,with,I-SIGN_AND_SYMPTOM,2922
60177,eye,I-SIGN_AND_SYMPTOM,2922
60178,movements,I-SIGN_AND_SYMPTOM,2922
60179,If,O,2922
60180,present,O,2922
60181,it,O,2922
60182,is,O,2922
60183,hallmark,O,2923
60184,differential,O,2923
60185,for,O,2923
60186,optic,B-NAME_OF_DISEASE,2923
60187,neuritis,I-NAME_OF_DISEASE,2923
60188,Systemic,O,2923
60189,History,O,2923
60190,A,B-DIAGNOSTIC_TEST,2923
60191,detailed,I-DIAGNOSTIC_TEST,2923
60192,history,I-DIAGNOSTIC_TEST,2923
60193,of,I-DIAGNOSTIC_TEST,2923
60194,systemic,I-DIAGNOSTIC_TEST,2923
60195,health,I-DIAGNOSTIC_TEST,2923
60196,is,O,2923
60197,important,O,2923
60198,Diabetes,B-NAME_OF_DISEASE,2923
60199,hypertension,B-NAME_OF_DISEASE,2923
60200,high,B-NAME_OF_DISEASE,2923
60201,cholesterol,I-NAME_OF_DISEASE,2923
60202,and,O,2923
60203,a,O,2923
60204,history,O,2923
60205,for,O,2924
60206,being,O,2924
60207,treated,O,2924
60208,for,O,2924
60209,or,O,2924
60210,having,O,2924
60211,malignancy,B-NAME_OF_DISEASE,2924
60212,or,I-NAME_OF_DISEASE,2924
60213,autoimmune,I-NAME_OF_DISEASE,2924
60214,disease,I-NAME_OF_DISEASE,2924
60215,is,O,2924
60216,critical,O,2924
60217,to,O,2924
60218,understand,O,2924
60219,potential,O,2924
60220,risks,O,2924
60221,associated,O,2924
60222,with,O,2924
60223,optic,B-NAME_OF_DISEASE,2924
60224,nerve,I-NAME_OF_DISEASE,2924
60225,edema,I-NAME_OF_DISEASE,2924
60226,Current,B-DIAGNOSTIC_TEST,2924
60227,and,I-DIAGNOSTIC_TEST,2924
60228,previous,I-DIAGNOSTIC_TEST,2924
60229,medications,I-DIAGNOSTIC_TEST,2924
60230,can,O,2925
60231,be,O,2925
60232,clues,O,2925
60233,because,O,2925
60234,many,O,2925
60235,can,O,2925
60236,be,O,2925
60237,directly,O,2925
60238,or,O,2925
60239,indirectly,O,2925
60240,toxic,O,2925
60241,to,O,2925
60242,the,B-PART_OF_THE_EYES,2925
60243,optic,I-PART_OF_THE_EYES,2925
60244,nerve,I-PART_OF_THE_EYES,2925
60245,These,O,2926
60246,drugs,O,2926
60247,include,O,2926
60248,tetracycline,B-NAME_OF_DRUG,2926
60249,cyclosporine,B-NAME_OF_DRUG,2926
60250,methotrexate,B-NAME_OF_DRUG,2926
60251,ethambutol,B-NAME_OF_DRUG,2926
60252,amiodarone,B-NAME_OF_DRUG,2926
60253,alcohol,B-CHEMICAL_COMPOUND,2926
60254,and,O,2926
60255,tobacco,O,2926
60256,to,O,2926
60257,name,O,2926
60258,a,O,2926
60259,few,O,2926
60260,Finally,O,2926
60261,reviewing,B-DIAGNOSTIC_TEST,2926
60262,the,I-DIAGNOSTIC_TEST,2926
60263,patient,I-DIAGNOSTIC_TEST,2926
60264,s,I-DIAGNOSTIC_TEST,2926
60265,general,I-DIAGNOSTIC_TEST,2926
60266,health,I-DIAGNOSTIC_TEST,2926
60267,including,I-DIAGNOSTIC_TEST,2926
60268,weight,I-DIAGNOSTIC_TEST,2926
60269,eating,I-DIAGNOSTIC_TEST,2926
60270,habits,I-DIAGNOSTIC_TEST,2926
60271,and,I-DIAGNOSTIC_TEST,2926
60272,social,I-DIAGNOSTIC_TEST,2927
60273,activities,I-DIAGNOSTIC_TEST,2927
60274,such,I-DIAGNOSTIC_TEST,2927
60275,as,I-DIAGNOSTIC_TEST,2927
60276,drinking,I-DIAGNOSTIC_TEST,2927
60277,smoking,I-DIAGNOSTIC_TEST,2927
60278,and,I-DIAGNOSTIC_TEST,2927
60279,illegal,I-DIAGNOSTIC_TEST,2927
60280,drugs,I-DIAGNOSTIC_TEST,2927
60281,will,O,2927
60282,help,O,2927
60283,provide,O,2927
60284,an,O,2927
60285,overall,O,2927
60286,health,O,2927
60287,picture,O,2927
60288,knowing,O,2927
60289,that,O,2927
60290,toxic,O,2927
60291,and,O,2927
60292,nutritional,O,2927
60293,causes,O,2927
60294,are,O,2927
60295,in,O,2927
60296,the,O,2928
60297,differential,O,2928
60298,diagnosis,O,2928
60299,paradigm,O,2928
60300,Clinical,B-DIAGNOSTIC_TEST,2928
60301,Exam,I-DIAGNOSTIC_TEST,2928
60302,The,B-DIAGNOSTIC_TEST,2928
60303,clinical,I-DIAGNOSTIC_TEST,2928
60304,eye,I-DIAGNOSTIC_TEST,2928
60305,exam,I-DIAGNOSTIC_TEST,2928
60306,is,O,2928
60307,the,O,2928
60308,second,O,2928
60309,step,O,2928
60310,of,O,2928
60311,process,O,2928
60312,With,O,2928
60313,any,O,2928
60314,optic,B-NAME_OF_DISEASE,2928
60315,nerve,I-NAME_OF_DISEASE,2928
60316,disease,I-NAME_OF_DISEASE,2928
60317,ODs,O,2928
60318,should,O,2928
60319,pay,O,2928
60320,close,O,2928
60321,attention,O,2928
60322,to,O,2928
60323,several,O,2928
60324,exam,O,2928
60325,elements,O,2928
60326,Important,O,2928
60327,exam,O,2928
60328,elements,O,2928
60329,include,O,2928
60330,-,O,2928
60331,Subjective,O,2928
60332,and,O,2928
60333,objective,O,2929
60334,visual,O,2929
60335,acuity,O,2929
60336,-,O,2929
60337,Pupils,B-PART_OF_THE_EYES,2929
60338,-,O,2929
60339,Extra-ocular,B-PART_OF_THE_EYES,2929
60340,muscles,I-PART_OF_THE_EYES,2929
60341,-,O,2929
60342,Color,O,2929
60343,vision,O,2929
60344,-,O,2929
60345,Contrast,O,2929
60346,sensitivity,O,2929
60347,-,O,2929
60348,Visual,B-DIAGNOSTIC_TEST,2929
60349,field,I-DIAGNOSTIC_TEST,2929
60350,testing,I-DIAGNOSTIC_TEST,2929
60351,-,O,2929
60352,Anterior,B-DIAGNOSTIC_TEST,2929
60353,and,I-DIAGNOSTIC_TEST,2929
60354,posterior,I-DIAGNOSTIC_TEST,2929
60355,chamber,I-DIAGNOSTIC_TEST,2929
60356,observation,I-DIAGNOSTIC_TEST,2929
60357,-,O,2929
60358,Optic,B-DIAGNOSTIC_TEST,2929
60359,nerve,I-DIAGNOSTIC_TEST,2929
60360,observation,I-DIAGNOSTIC_TEST,2929
60361,Visual,O,2929
60362,acuity,O,2929
60363,can,O,2929
60364,be,O,2929
60365,normal,O,2930
60366,or,O,2930
60367,impaired,O,2930
60368,and,O,2930
60369,subjectively,O,2930
60370,a,O,2930
60371,patient,O,2930
60372,may,O,2930
60373,complain,O,2930
60374,of,O,2930
60375,blurry,B-SIGN_AND_SYMPTOM,2930
60376,letters,I-SIGN_AND_SYMPTOM,2930
60377,or,I-SIGN_AND_SYMPTOM,2930
60378,shadows,I-SIGN_AND_SYMPTOM,2930
60379,around,I-SIGN_AND_SYMPTOM,2930
60380,letters,I-SIGN_AND_SYMPTOM,2930
60381,and,I-SIGN_AND_SYMPTOM,2930
60382,an,I-SIGN_AND_SYMPTOM,2930
60383,overall,I-SIGN_AND_SYMPTOM,2930
60384,decrease,I-SIGN_AND_SYMPTOM,2930
60385,in,I-SIGN_AND_SYMPTOM,2930
60386,clarity,I-SIGN_AND_SYMPTOM,2931
60387,Pupil,B-DIAGNOSTIC_TEST,2931
60388,testing,I-DIAGNOSTIC_TEST,2931
60389,is,O,2931
60390,extremely,O,2931
60391,important,O,2931
60392,in,O,2931
60393,assessing,O,2931
60394,optic,B-NAME_OF_DISEASE,2931
60395,nerve,I-NAME_OF_DISEASE,2931
60396,disease,I-NAME_OF_DISEASE,2931
60397,A,B-SIGN_AND_SYMPTOM,2931
60398,relative,I-SIGN_AND_SYMPTOM,2931
60399,afferent,I-SIGN_AND_SYMPTOM,2931
60400,pupillary,I-SIGN_AND_SYMPTOM,2932
60401,defect,I-SIGN_AND_SYMPTOM,2932
60402,RAPD,I-SIGN_AND_SYMPTOM,2932
60403,can,O,2932
60404,be,O,2932
60405,detected,O,2932
60406,performing,O,2932
60407,the,B-DIAGNOSTIC_TEST,2932
60408,swinging,I-DIAGNOSTIC_TEST,2932
60409,penlight,I-DIAGNOSTIC_TEST,2932
60410,pupil,I-DIAGNOSTIC_TEST,2932
60411,test,I-DIAGNOSTIC_TEST,2932
60412,conducted,O,2932
60413,in,O,2932
60414,a,O,2932
60415,dark,O,2933
60416,room,O,2933
60417,to,O,2933
60418,assess,O,2933
60419,full,O,2933
60420,amplitude,O,2933
60421,of,O,2933
60422,pupillary,O,2933
60423,response,O,2933
60424,Color,B-DIAGNOSTIC_TEST,2933
60425,vision,I-DIAGNOSTIC_TEST,2933
60426,and,I-DIAGNOSTIC_TEST,2933
60427,color,I-DIAGNOSTIC_TEST,2933
60428,desaturation,I-DIAGNOSTIC_TEST,2933
60429,testing,I-DIAGNOSTIC_TEST,2933
60430,can,O,2933
60431,be,O,2933
60432,performed,O,2933
60433,with,O,2933
60434,Ishihara,O,2934
60435,color,O,2934
60436,plates,O,2934
60437,and,O,2934
60438,red-capped,O,2934
60439,bottle,O,2934
60440,Dyschromatopsia,B-SIGN_AND_SYMPTOM,2934
60441,or,I-SIGN_AND_SYMPTOM,2934
60442,the,I-SIGN_AND_SYMPTOM,2934
60443,ability,I-SIGN_AND_SYMPTOM,2935
60444,to,I-SIGN_AND_SYMPTOM,2935
60445,perceive,I-SIGN_AND_SYMPTOM,2935
60446,colors,I-SIGN_AND_SYMPTOM,2935
60447,as,I-SIGN_AND_SYMPTOM,2935
60448,abnormal,I-SIGN_AND_SYMPTOM,2935
60449,is,O,2935
60450,a,O,2935
60451,sensitive,O,2935
60452,indicator,O,2935
60453,of,O,2935
60454,optic,B-NAME_OF_DISEASE,2935
60455,nerve,I-NAME_OF_DISEASE,2935
60456,disease,I-NAME_OF_DISEASE,2935
60457,During,O,2935
60458,the,B-DIAGNOSTIC_TEST,2935
60459,dilated,I-DIAGNOSTIC_TEST,2935
60460,fundus,I-DIAGNOSTIC_TEST,2935
60461,exam,I-DIAGNOSTIC_TEST,2935
60462,the,O,2935
60463,clinician,O,2935
60464,should,O,2935
60465,look,O,2935
60466,for,O,2935
60467,evidence,O,2935
60468,of,O,2935
60469,cells,O,2935
60470,in,O,2935
60471,the,B-PART_OF_THE_EYES,2935
60472,anterior,I-PART_OF_THE_EYES,2936
60473,chamber,I-PART_OF_THE_EYES,2936
60474,and,O,2936
60475,vitreous,B-PART_OF_THE_EYES,2936
60476,This,O,2936
60477,would,O,2936
60478,indicate,O,2936
60479,that,O,2936
60480,the,B-SIGN_AND_SYMPTOM,2936
60481,disc,I-SIGN_AND_SYMPTOM,2936
60482,swelling,I-SIGN_AND_SYMPTOM,2936
60483,is,O,2936
60484,secondary,O,2936
60485,to,O,2936
60486,a,O,2936
60487,uveitic,O,2936
60488,process,O,2936
60489,When,O,2936
60490,assessing,O,2936
60491,the,B-PART_OF_THE_EYES,2936
60492,optic,I-PART_OF_THE_EYES,2936
60493,nerve,I-PART_OF_THE_EYES,2936
60494,stereoscopic,O,2936
60495,views,O,2936
60496,of,O,2936
60497,the,O,2936
60498,disc,O,2936
60499,provide,O,2936
60500,the,O,2936
60501,quality,O,2936
60502,and,O,2936
60503,detail,O,2936
60504,needed,O,2936
60505,to,O,2936
60506,determine,O,2936
60507,disc,B-SIGN_AND_SYMPTOM,2936
60508,edema,I-SIGN_AND_SYMPTOM,2937
60509,from,O,2937
60510,elevation,O,2937
60511,The,O,2937
60512,optic,O,2937
60513,nerve,O,2937
60514,will,O,2937
60515,appear,O,2937
60516,elevated,O,2937
60517,and,O,2937
60518,hyperemic,O,2937
60519,with,O,2937
60520,blurred,O,2937
60521,margins,O,2937
60522,obscuring,O,2937
60523,peripapillary,O,2937
60524,vessels,O,2937
60525,as,O,2937
60526,they,O,2937
60527,leave,O,2937
60528,the,O,2937
60529,disc,O,2937
60530,It,O,2937
60531,is,O,2937
60532,important,O,2937
60533,to,O,2937
60534,assess,O,2937
60535,the,O,2937
60536,spontaneous,O,2937
60537,venous,O,2937
60538,pulsation,O,2938
60539,20,O,2938
60540,percent,O,2938
60541,of,O,2938
60542,normal,O,2938
60543,population,O,2938
60544,#NAME?,O,2938
60545,will,O,2938
60546,not,O,2938
60547,be,O,2938
60548,seen,O,2938
60549,if,O,2938
60550,swelling,O,2938
60551,is,O,2938
60552,present,O,2938
60553,Another,O,2938
60554,clinical,O,2938
60555,sign,O,2938
60556,to,O,2938
60557,look,O,2938
60558,for,O,2938
60559,is,O,2938
60560,buckling,B-SIGN_AND_SYMPTOM,2938
60561,or,I-SIGN_AND_SYMPTOM,2938
60562,retinal,I-SIGN_AND_SYMPTOM,2938
60563,folds,I-SIGN_AND_SYMPTOM,2938
60564,of,I-SIGN_AND_SYMPTOM,2938
60565,the,I-SIGN_AND_SYMPTOM,2939
60566,temporal,I-SIGN_AND_SYMPTOM,2939
60567,aspect,I-SIGN_AND_SYMPTOM,2939
60568,of,I-SIGN_AND_SYMPTOM,2939
60569,the,I-SIGN_AND_SYMPTOM,2939
60570,disc,I-SIGN_AND_SYMPTOM,2939
60571,also,I-SIGN_AND_SYMPTOM,2939
60572,known,I-SIGN_AND_SYMPTOM,2939
60573,as,I-SIGN_AND_SYMPTOM,2939
60574,Paton,I-SIGN_AND_SYMPTOM,2939
60575,s,I-SIGN_AND_SYMPTOM,2939
60576,lines,I-SIGN_AND_SYMPTOM,2939
60577,If,O,2939
60578,optic,B-NAME_OF_DISEASE,2939
60579,nerve,I-NAME_OF_DISEASE,2939
60580,edema,I-NAME_OF_DISEASE,2939
60581,is,O,2939
60582,suspected,O,2939
60583,the,O,2939
60584,standard,O,2939
60585,method,O,2939
60586,of,O,2939
60587,grading,O,2939
60588,disc,B-SIGN_AND_SYMPTOM,2939
60589,edema,I-SIGN_AND_SYMPTOM,2939
60590,by,O,2939
60591,ophthalmoscopy,O,2939
60592,is,O,2939
60593,the,B-DIAGNOSTIC_TEST,2939
60594,Modified,I-DIAGNOSTIC_TEST,2939
60595,Frisén,B-DIAGNOSTIC_TEST,2939
60596,Scale,I-DIAGNOSTIC_TEST,2939
60597,It,O,2939
60598,is,O,2939
60599,an,O,2939
60600,ordinal,O,2939
60601,scale,O,2939
60602,with,O,2939
60603,subjective,O,2939
60604,evaluation,O,2939
60605,and,O,2939
60606,grades,O,2939
60607,ranging,O,2939
60608,from,O,2939
60609,0,O,2939
60610,no,O,2939
60611,edema,O,2939
60612,to,O,2939
60613,5,O,2939
60614,severe,O,2939
60615,degree,O,2939
60616,of,O,2939
60617,edema,O,2939
60618,with,O,2939
60619,characteristic,O,2939
60620,findings,O,2939
60621,for,O,2939
60622,each,O,2940
60623,grade,O,2940
60624,Additional,O,2940
60625,testing,O,2940
60626,crucial,O,2940
60627,to,O,2940
60628,accurately,O,2940
60629,diagnosing,O,2940
60630,optic,B-NAME_OF_DISEASE,2940
60631,nerve,I-NAME_OF_DISEASE,2940
60632,swelling,I-NAME_OF_DISEASE,2940
60633,are,O,2940
60634,visual,B-DIAGNOSTIC_TEST,2940
60635,field,I-DIAGNOSTIC_TEST,2940
60636,VF,I-DIAGNOSTIC_TEST,2941
60637,testing,I-DIAGNOSTIC_TEST,2941
60638,and,O,2941
60639,optical,B-DIAGNOSTIC_TEST,2941
60640,coherence,I-DIAGNOSTIC_TEST,2941
60641,tomography,I-DIAGNOSTIC_TEST,2941
60642,OCT,B-DIAGNOSTIC_TEST,2941
60643,,O,2941
60644,VF,B-DIAGNOSTIC_TEST,2941
60645,testing,I-DIAGNOSTIC_TEST,2941
60646,can,I-DIAGNOSTIC_TEST,2941
60647,be,I-DIAGNOSTIC_TEST,2941
60648,confrontation,I-DIAGNOSTIC_TEST,2941
60649,kinetic,I-DIAGNOSTIC_TEST,2941
60650,Goldmann,I-DIAGNOSTIC_TEST,2941
60651,or,I-DIAGNOSTIC_TEST,2941
60652,automated,I-DIAGNOSTIC_TEST,2942
60653,static,I-DIAGNOSTIC_TEST,2942
60654,perimetry,I-DIAGNOSTIC_TEST,2942
60655,Humphrey,I-DIAGNOSTIC_TEST,2942
60656,,O,2942
60657,VF,B-DIAGNOSTIC_TEST,2942
60658,defects,I-DIAGNOSTIC_TEST,2942
60659,take,O,2942
60660,several,O,2942
60661,patterns,O,2942
60662,central,O,2942
60663,arcuate,O,2942
60664,altitudinal,O,2942
60665,and,O,2942
60666,generalized,O,2942
60667,Specific,O,2942
60668,patterns,O,2942
60669,can,O,2942
60670,help,O,2942
60671,the,O,2942
60672,clinician,O,2942
60673,correlate,O,2942
60674,to,O,2942
60675,specific,O,2942
60676,diagnoses,O,2942
60677,OCT,B-DIAGNOSTIC_TEST,2942
60678,uses,O,2942
60679,light,O,2942
60680,to,O,2942
60681,provide,O,2942
60682,images,O,2942
60683,to,O,2942
60684,the,O,2942
60685,micron,O,2942
60686,level,O,2943
60687,and,O,2943
60688,is,O,2943
60689,an,O,2943
60690,objective,O,2943
60691,noninvasive,O,2943
60692,alternative,O,2943
60693,to,O,2943
60694,analyze,O,2943
60695,the,B-PART_OF_THE_EYES,2943
60696,optic,I-PART_OF_THE_EYES,2943
60697,nerve,I-PART_OF_THE_EYES,2943
60698,head,I-PART_OF_THE_EYES,2943
60699,and,O,2943
60700,quantify,O,2943
60701,the,O,2943
60702,status,O,2943
60703,of,O,2943
60704,the,B-PART_OF_THE_EYES,2943
60705,retinal,I-PART_OF_THE_EYES,2943
60706,nerve,I-PART_OF_THE_EYES,2943
60707,fiber,I-PART_OF_THE_EYES,2943
60708,layer,I-PART_OF_THE_EYES,2943
60709,RNFL,I-PART_OF_THE_EYES,2943
60710,,O,2943
60711,Elevation,O,2943
60712,of,O,2943
60713,the,B-PART_OF_THE_EYES,2944
60714,RNFL,I-PART_OF_THE_EYES,2944
60715,is,O,2944
60716,compared,O,2944
60717,to,O,2944
60718,age-related,O,2944
60719,normative,O,2944
60720,values,O,2944
60721,to,O,2944
60722,help,O,2944
60723,confirm,O,2944
60724,the,O,2944
60725,already,O,2945
60726,visualized,O,2945
60727,ophthalmoscopy,O,2945
60728,Frisén,B-DIAGNOSTIC_TEST,2945
60729,Scale,I-DIAGNOSTIC_TEST,2945
60730,findings,O,2945
60731,Bilateral,B-NAME_OF_DISEASE,2945
60732,optic,I-NAME_OF_DISEASE,2945
60733,nerve,I-NAME_OF_DISEASE,2945
60734,swellling,I-NAME_OF_DISEASE,2945
60735,Papilledema,B-NAME_OF_DISEASE,2945
60736,is,O,2945
60737,acquired,O,2945
60738,bilateral,B-SIGN_AND_SYMPTOM,2945
60739,optic,I-SIGN_AND_SYMPTOM,2945
60740,nerve,I-SIGN_AND_SYMPTOM,2945
60741,swelling,I-SIGN_AND_SYMPTOM,2945
60742,due,O,2945
60743,to,O,2945
60744,increased,B-CAUSE_OF_DISEASE,2945
60745,intracranial,I-CAUSE_OF_DISEASE,2946
60746,pressure,I-CAUSE_OF_DISEASE,2946
60747,secondary,I-CAUSE_OF_DISEASE,2946
60748,to,I-CAUSE_OF_DISEASE,2946
60749,increased,I-CAUSE_OF_DISEASE,2946
60750,cerebral,I-CAUSE_OF_DISEASE,2946
60751,spinal,I-CAUSE_OF_DISEASE,2946
60752,fluid,I-CAUSE_OF_DISEASE,2946
60753,CSF,I-CAUSE_OF_DISEASE,2946
60754,which,O,2946
60755,has,O,2946
60756,specific,O,2946
60757,etiologic,O,2946
60758,implications,O,2946
60759,Papilledema,B-NAME_OF_DISEASE,2946
60760,is,O,2946
60761,a,O,2946
60762,TRUE,O,2946
60763,ocular,O,2946
60764,emergency,O,2946
60765,because,O,2946
60766,it,O,2946
60767,can,O,2947
60768,occur,O,2947
60769,from,O,2947
60770,structural,B-CAUSE_OF_DISEASE,2947
60771,space,I-CAUSE_OF_DISEASE,2947
60772,occupying,I-CAUSE_OF_DISEASE,2947
60773,lesions,I-CAUSE_OF_DISEASE,2947
60774,such,I-CAUSE_OF_DISEASE,2947
60775,as,I-CAUSE_OF_DISEASE,2947
60776,large,I-CAUSE_OF_DISEASE,2947
60777,tumors,I-CAUSE_OF_DISEASE,2947
60778,hydrocephalus,B-NAME_OF_DISEASE,2947
60779,vascular,I-CAUSE_OF_DISEASE,2947
60780,abnormalities,I-CAUSE_OF_DISEASE,2947
60781,cerebral,I-CAUSE_OF_DISEASE,2947
60782,venous,I-CAUSE_OF_DISEASE,2947
60783,sinus,I-CAUSE_OF_DISEASE,2947
60784,thrombosis,I-CAUSE_OF_DISEASE,2947
60785,and,I-CAUSE_OF_DISEASE,2947
60786,arteriovenous,I-CAUSE_OF_DISEASE,2947
60787,fistulae,I-CAUSE_OF_DISEASE,2947
60788,Due,O,2947
60789,to,O,2947
60790,these,O,2947
60791,pathologies,O,2947
60792,it,O,2947
60793,is,O,2948
60794,imperative,O,2948
60795,to,O,2948
60796,begin,O,2948
60797,the,O,2948
60798,process,O,2948
60799,of,O,2948
60800,neuroimaging,B-DIAGNOSTIC_TEST,2948
60801,including,O,2948
60802,magnetic,B-DIAGNOSTIC_TEST,2948
60803,resonance,I-DIAGNOSTIC_TEST,2948
60804,imaging,I-DIAGNOSTIC_TEST,2948
60805,MRI,I-DIAGNOSTIC_TEST,2948
60806,with,I-DIAGNOSTIC_TEST,2948
60807,contrast,I-DIAGNOSTIC_TEST,2949
60808,of,I-DIAGNOSTIC_TEST,2949
60809,the,I-DIAGNOSTIC_TEST,2949
60810,brain,I-DIAGNOSTIC_TEST,2949
60811,orbit,I-DIAGNOSTIC_TEST,2949
60812,and,I-DIAGNOSTIC_TEST,2949
60813,optic,I-DIAGNOSTIC_TEST,2949
60814,nerve,I-DIAGNOSTIC_TEST,2949
60815,and,O,2949
60816,magnetic,B-DIAGNOSTIC_TEST,2949
60817,resonance,I-DIAGNOSTIC_TEST,2949
60818,venography,I-DIAGNOSTIC_TEST,2950
60819,MRV,I-DIAGNOSTIC_TEST,2950
60820,of,I-DIAGNOSTIC_TEST,2950
60821,the,I-DIAGNOSTIC_TEST,2950
60822,brain,I-DIAGNOSTIC_TEST,2950
60823,A,O,2950
60824,referral,O,2950
60825,to,O,2950
60826,neuroophthalmology,O,2950
60827,is,O,2950
60828,warranted,O,2950
60829,to,O,2950
60830,evaluate,O,2951
60831,and,O,2951
60832,manage,O,2951
60833,findings,O,2951
60834,from,O,2951
60835,the,O,2951
60836,results,O,2951
60837,of,O,2951
60838,neuroimaging,B-DIAGNOSTIC_TEST,2951
60839,If,O,2951
60840,neuroimaging,B-DIAGNOSTIC_TEST,2951
60841,is,O,2951
60842,negative,O,2951
60843,it,O,2951
60844,is,O,2951
60845,important,O,2951
60846,to,O,2951
60847,follow,O,2952
60848,up,O,2952
60849,with,O,2952
60850,lumbar,B-DIAGNOSTIC_TEST,2952
60851,puncture,I-DIAGNOSTIC_TEST,2952
60852,to,O,2952
60853,measure,O,2952
60854,opening,O,2952
60855,pressure,O,2952
60856,and,O,2952
60857,biochemistry,O,2952
60858,microbiology,O,2952
60859,and,O,2952
60860,cytology,O,2953
60861,of,O,2953
60862,the,O,2953
60863,CSF,O,2953
60864,Note,O,2953
60865,papilledema,B-NAME_OF_DISEASE,2953
60866,in,O,2953
60867,the,O,2953
60868,pediatric,O,2953
60869,population,O,2953
60870,may,O,2953
60871,include,O,2953
60872,but,O,2953
60873,not,O,2953
60874,limited,O,2953
60875,to,O,2953
60876,Guillain-Barre,B-NAME_OF_DISEASE,2953
60877,syndrome,I-NAME_OF_DISEASE,2953
60878,spina,B-NAME_OF_DISEASE,2953
60879,bifida,I-NAME_OF_DISEASE,2953
60880,hydrocephalus,B-NAME_OF_DISEASE,2954
60881,trauma,B-NAME_OF_DISEASE,2954
60882,subdural,I-NAME_OF_DISEASE,2954
60883,hemorrhage,I-NAME_OF_DISEASE,2954
60884,and,O,2954
60885,meningitis,B-NAME_OF_DISEASE,2954
60886,After,O,2954
60887,exclusion,O,2954
60888,of,O,2954
60889,potentially,O,2954
60890,life-threatening,O,2954
60891,conditions,O,2954
60892,and,O,2954
60893,a,O,2954
60894,normal,O,2954
60895,CSF,O,2954
60896,determine,O,2954
60897,if,O,2954
60898,the,B-DIAGNOSTIC_TEST,2955
60899,opening,I-DIAGNOSTIC_TEST,2955
60900,pressure,I-DIAGNOSTIC_TEST,2955
60901,on,I-DIAGNOSTIC_TEST,2955
60902,lumbar,I-DIAGNOSTIC_TEST,2955
60903,puncture,I-DIAGNOSTIC_TEST,2955
60904,is,O,2955
60905,elevated,O,2955
60906,20,O,2955
60907,cm,O,2955
60908,H2,O,2956
60909,0,O,2956
60910,,O,2956
60911,It,O,2956
60912,is,O,2956
60913,also,O,2956
60914,important,O,2956
60915,to,O,2956
60916,note,O,2956
60917,that,O,2956
60918,the,B-DIAGNOSTIC_TEST,2956
60919,modified,I-DIAGNOSTIC_TEST,2956
60920,Dandy,I-DIAGNOSTIC_TEST,2956
60921,criteria,I-DIAGNOSTIC_TEST,2956
60922,are,O,2957
60923,still,O,2957
60924,not,O,2957
60925,met,O,2957
60926,This,O,2957
60927,diagnostic,O,2957
60928,criteria,O,2957
60929,mandate,O,2957
60930,identifying,O,2957
60931,other,O,2957
60932,potential,O,2957
60933,causes,O,2957
60934,is,O,2958
60935,necessary-idiopathic,O,2958
60936,intracranial,O,2958
60937,hypertension,O,2958
60938,IIH,B-NAME_OF_DISEASE,2958
60939,is,O,2958
60940,a,O,2958
60941,diagnosis,O,2958
60942,of,O,2958
60943,exclusion,O,2958
60944,once,O,2958
60945,all,O,2958
60946,other,O,2958
60947,potential,O,2959
60948,causes,O,2959
60949,have,O,2959
60950,been,O,2959
60951,ruled,O,2959
60952,out,O,2959
60953,The,O,2959
60954,most,O,2959
60955,common,O,2959
60956,presenting,O,2959
60957,symptoms,O,2959
60958,are,O,2959
60959,headache,B-SIGN_AND_SYMPTOM,2959
60960,occurring,O,2959
60961,in,O,2960
60962,more,O,2960
60963,than,O,2960
60964,90,O,2960
60965,percent,O,2960
60966,of,O,2960
60967,patients,O,2960
60968,as,O,2960
60969,well,O,2961
60970,as,O,2961
60971,pulsatile,B-SIGN_AND_SYMPTOM,2961
60972,tinnitus,I-SIGN_AND_SYMPTOM,2961
60973,photopsia,I-SIGN_AND_SYMPTOM,2961
60974,and,I-SIGN_AND_SYMPTOM,2961
60975,retrobulbar,I-SIGN_AND_SYMPTOM,2961
60976,pain,I-SIGN_AND_SYMPTOM,2961
60977,First-line,O,2962
60978,treatment,O,2962
60979,for,O,2962
60980,IIH,B-NAME_OF_DISEASE,2962
60981,should,O,2962
60982,concentrate,O,2962
60983,on,O,2962
60984,weight,B-TREATMENT,2962
60985,loss,I-TREATMENT,2962
60986,and,O,2962
60987,management,B-TREATMENT,2962
60988,with,I-TREATMENT,2962
60989,a,I-TREATMENT,2962
60990,neuro,I-TREATMENT,2962
60991,ophthalmologist,I-TREATMENT,2962
60992,to,I-TREATMENT,2962
60993,lower,I-TREATMENT,2962
60994,CSF,I-TREATMENT,2962
60995,with,I-TREATMENT,2962
60996,an,I-TREATMENT,2962
60997,oral,I-TREATMENT,2962
60998,carbonic,I-TREATMENT,2962
60999,anhydrase,I-TREATMENT,2962
61000,inhibitor,I-TREATMENT,2962
61001,such,I-TREATMENT,2962
61002,as,I-TREATMENT,2962
61003,acetazolamide,I-TREATMENT,2963
61004,combined,I-TREATMENT,2963
61005,with,I-TREATMENT,2963
61006,a,I-TREATMENT,2963
61007,lowsodium,I-TREATMENT,2963
61008,diet,I-TREATMENT,2963
61009,as,I-TREATMENT,2963
61010,described,I-TREATMENT,2963
61011,in,I-TREATMENT,2963
61012,the,I-TREATMENT,2963
61013,IIHTT,I-TREATMENT,2963
61014,In,O,2963
61015,patients,O,2963
61016,with,O,2963
61017,sudden,O,2963
61018,and,O,2963
61019,severe,O,2964
61020,papilledema,B-NAME_OF_DISEASE,2964
61021,who,O,2964
61022,may,O,2964
61023,be,O,2964
61024,at,O,2964
61025,risk,O,2964
61026,for,O,2964
61027,irreversible,B-SIGN_AND_SYMPTOM,2964
61028,vision,I-SIGN_AND_SYMPTOM,2964
61029,loss,I-SIGN_AND_SYMPTOM,2964
61030,surgical,B-TREATMENT,2964
61031,intervention,I-TREATMENT,2964
61032,such,I-TREATMENT,2964
61033,as,I-TREATMENT,2964
61034,optic,I-TREATMENT,2964
61035,nerve,I-TREATMENT,2964
61036,sheath,I-TREATMENT,2964
61037,fenestration,I-TREATMENT,2964
61038,and,I-TREATMENT,2964
61039,cerebrospinal,I-TREATMENT,2965
61040,fluid,I-TREATMENT,2965
61041,shunting,I-TREATMENT,2965
61042,may,O,2965
61043,be,O,2965
61044,urgently,O,2965
61045,needed,O,2965
61046,It,O,2965
61047,is,O,2965
61048,key,O,2965
61049,to,O,2965
61050,rule,O,2965
61051,out,O,2965
61052,pseudo,O,2965
61053,papilledema,B-NAME_OF_DISEASE,2965
61054,a,O,2965
61055,benign,O,2965
61056,elevation,O,2965
61057,of,O,2965
61058,the,B-PART_OF_THE_EYES,2965
61059,optic,B-PART_OF_THE_EYES,2965
61060,nerve,I-PART_OF_THE_EYES,2965
61061,head,I-PART_OF_THE_EYES,2965
61062,with,O,2965
61063,an,O,2965
61064,underlying,O,2965
61065,anomalous,O,2965
61066,condition,O,2965
61067,These,O,2965
61068,anomalies,O,2965
61069,include,O,2965
61070,optic,B-PART_OF_THE_EYES,2966
61071,nerve,I-PART_OF_THE_EYES,2966
61072,head,I-PART_OF_THE_EYES,2966
61073,drusen,B-SIGN_AND_SYMPTOM,2966
61074,ONHD,B-SIGN_AND_SYMPTOM,2966
61075,congenital,I-SIGN_AND_SYMPTOM,2966
61076,crowded,I-SIGN_AND_SYMPTOM,2966
61077,discs,I-SIGN_AND_SYMPTOM,2966
61078,and,I-SIGN_AND_SYMPTOM,2966
61079,malinserted,I-SIGN_AND_SYMPTOM,2966
61080,discs,I-SIGN_AND_SYMPTOM,2966
61081,ONHD,B-SIGN_AND_SYMPTOM,2966
61082,is,O,2966
61083,the,O,2966
61084,most,O,2966
61085,common,O,2966
61086,cause,O,2966
61087,accounting,O,2966
61088,for,O,2966
61089,75,O,2966
61090,percent,O,2966
61091,of,O,2966
61092,clinically,O,2966
61093,diagnostic,O,2966
61094,disc,O,2966
61095,anomalies,O,2966
61096,The,B-PART_OF_THE_EYES,2966
61097,scleral,I-PART_OF_THE_EYES,2966
61098,canal,I-PART_OF_THE_EYES,2966
61099,and,O,2966
61100,optic,B-PART_OF_THE_EYES,2966
61101,disc,I-PART_OF_THE_EYES,2966
61102,of,O,2967
61103,eyes,O,2967
61104,with,O,2967
61105,drusen,B-SIGN_AND_SYMPTOM,2967
61106,are,O,2967
61107,much,O,2967
61108,smaller,O,2967
61109,than,O,2967
61110,average,O,2967
61111,thus,O,2967
61112,showing,O,2968
61113,elevated,O,2968
61114,appearance,O,2968
61115,OCT,B-DIAGNOSTIC_TEST,2968
61116,can,O,2968
61117,aid,O,2968
61118,in,O,2968
61119,differentiating,O,2968
61120,disc,B-NAME_OF_DISEASE,2968
61121,drusen,I-NAME_OF_DISEASE,2968
61122,from,O,2968
61123,edema,O,2968
61124,Disc,B-NAME_OF_DISEASE,2968
61125,edema,I-NAME_OF_DISEASE,2968
61126,has,O,2969
61127,a,O,2969
61128,smooth,O,2969
61129,internal,O,2969
61130,disc,O,2969
61131,contour,O,2969
61132,and,O,2969
61133,demonstrates,O,2969
61134,a,O,2969
61135,V-shaped,O,2969
61136,hypo,O,2969
61137,reflective,O,2969
61138,space,O,2969
61139,between,O,2969
61140,sensory,B-PART_OF_THE_EYES,2969
61141,retina,I-PART_OF_THE_EYES,2969
61142,and,O,2969
61143,RPE,B-PART_OF_THE_EYES,2970
61144,compared,O,2970
61145,to,O,2970
61146,the,O,2970
61147,lumpy,O,2970
61148,appearance,O,2970
61149,found,O,2970
61150,with,O,2970
61151,disc,B-NAME_OF_DISEASE,2970
61152,drusen,I-NAME_OF_DISEASE,2970
61153,Congenital,O,2970
61154,crowded,O,2970
61155,discs,O,2970
61156,are,O,2970
61157,the,O,2971
61158,result,O,2971
61159,of,O,2971
61160,a,O,2971
61161,normal,O,2971
61162,number,O,2971
61163,of,O,2971
61164,retinal,B-PART_OF_THE_EYES,2971
61165,axons,I-PART_OF_THE_EYES,2971
61166,passing,O,2971
61167,through,O,2971
61168,a,O,2971
61169,small,O,2971
61170,posterior,B-PART_OF_THE_EYES,2971
61171,scleral,I-PART_OF_THE_EYES,2971
61172,foramen,I-PART_OF_THE_EYES,2971
61173,with,O,2971
61174,the,O,2971
61175,resulting,O,2971
61176,appearance,O,2971
61177,of,O,2971
61178,a,O,2971
61179,densely,O,2971
61180,packed,O,2971
61181,optic,B-PART_OF_THE_EYES,2971
61182,nerve,I-PART_OF_THE_EYES,2971
61183,head,I-PART_OF_THE_EYES,2971
61184,as,O,2971
61185,axons,O,2971
61186,exit,O,2971
61187,the,B-PART_OF_THE_EYES,2971
61188,globe,I-PART_OF_THE_EYES,2971
61189,A,O,2971
61190,malinserted,O,2972
61191,disc,O,2972
61192,is,O,2972
61193,due,O,2972
61194,to,O,2972
61195,oblique,O,2972
61196,insertion,O,2972
61197,of,O,2972
61198,the,O,2972
61199,nerve,O,2972
61200,to,O,2972
61201,the,B-PART_OF_THE_EYES,2972
61202,globe,I-PART_OF_THE_EYES,2972
61203,primarily,O,2972
61204,the,O,2972
61205,nasal,O,2972
61206,portion,O,2972
61207,is,O,2972
61208,elevated,O,2972
61209,with,O,2972
61210,the,O,2972
61211,temporal,O,2972
61212,portion,O,2972
61213,depressed,O,2972
61214,giving,O,2972
61215,it,O,2972
61216,a,O,2972
61217,swollen-like,O,2972
61218,appearance,O,2972
61219,Unilateral,B-NAME_OF_DISEASE,2972
61220,optic,I-NAME_OF_DISEASE,2973
61221,nerve,I-NAME_OF_DISEASE,2973
61222,swelling,I-NAME_OF_DISEASE,2973
61223,Unilateral,B-NAME_OF_DISEASE,2973
61224,optic,I-NAME_OF_DISEASE,2973
61225,nerve,I-NAME_OF_DISEASE,2973
61226,swelling,I-NAME_OF_DISEASE,2973
61227,can,O,2973
61228,be,O,2973
61229,caused,O,2973
61230,by,O,2973
61231,different,B-CAUSE_OF_DISEASE,2973
61232,pathogenic,I-CAUSE_OF_DISEASE,2973
61233,processes,I-CAUSE_OF_DISEASE,2973
61234,including,I-CAUSE_OF_DISEASE,2973
61235,demyelinating,I-CAUSE_OF_DISEASE,2973
61236,vascular,I-CAUSE_OF_DISEASE,2973
61237,compressive,I-CAUSE_OF_DISEASE,2973
61238,inflammatory,I-CAUSE_OF_DISEASE,2973
61239,infectious,I-CAUSE_OF_DISEASE,2973
61240,infiltrative,I-CAUSE_OF_DISEASE,2974
61241,toxic,I-CAUSE_OF_DISEASE,2974
61242,nutritional,I-CAUSE_OF_DISEASE,2974
61243,and,I-CAUSE_OF_DISEASE,2974
61244,hereditary,I-CAUSE_OF_DISEASE,2974
61245,causes,I-CAUSE_OF_DISEASE,2974
61246,Demyelinating,B-NAME_OF_DISEASE,2974
61247,or,O,2974
61248,optic,B-NAME_OF_DISEASE,2974
61249,neuritis,I-NAME_OF_DISEASE,2974
61250,ON,B-NAME_OF_DISEASE,2974
61251,History,O,2974
61252,of,O,2974
61253,sudden,O,2974
61254,vision,O,2974
61255,loss,O,2974
61256,in,O,2974
61257,one,O,2974
61258,eye,O,2974
61259,and,O,2974
61260,pain,O,2974
61261,associated,O,2974
61262,with,O,2974
61263,eye,O,2974
61264,movement,O,2974
61265,prior,O,2974
61266,history,O,2974
61267,of,O,2975
61268,neurological,O,2975
61269,symptoms,O,2975
61270,such,O,2975
61271,as,O,2975
61272,paresthesia,O,2975
61273,limb,O,2975
61274,weakness,O,2975
61275,ataxia,O,2975
61276,chronic,O,2975
61277,arm,O,2975
61278,paresthesia,O,2975
61279,and,O,2975
61280,diminution,O,2975
61281,of,O,2975
61282,vision,O,2975
61283,following,O,2975
61284,a,O,2975
61285,rise,O,2975
61286,in,O,2976
61287,body,O,2976
61288,temperature,O,2976
61289,such,O,2976
61290,as,O,2976
61291,after,O,2976
61292,exercise,O,2976
61293,or,O,2976
61294,a,O,2976
61295,hot,O,2976
61296,shower,O,2976
61297,Uhthoff,O,2976
61298,s,O,2976
61299,phenomenon,O,2976
61300,is,O,2976
61301,very,O,2976
61302,common,O,2976
61303,ON,B-NAME_OF_DISEASE,2976
61304,improves,O,2976
61305,in,O,2976
61306,90,O,2976
61307,percent,O,2976
61308,of,O,2976
61309,cases,O,2976
61310,over,O,2976
61311,several,O,2977
61312,weeks,O,2977
61313,to,O,2977
61314,near,O,2977
61315,normal,O,2977
61316,acuity,O,2977
61317,A,B-DIAGNOSTIC_TEST,2977
61318,brain,I-DIAGNOSTIC_TEST,2977
61319,MRI,I-DIAGNOSTIC_TEST,2977
61320,is,O,2977
61321,needed,O,2977
61322,to,O,2977
61323,identify,O,2977
61324,the,O,2977
61325,presence,O,2977
61326,of,O,2977
61327,white,O,2977
61328,matter,O,2977
61329,lesions,O,2977
61330,to,O,2977
61331,confirm,O,2977
61332,diagnosis,O,2977
61333,Arteritic,B-NAME_OF_DISEASE,2977
61334,ischemic,B-NAME_OF_DISEASE,2978
61335,optic,I-NAME_OF_DISEASE,2978
61336,neuropathy,I-NAME_OF_DISEASE,2978
61337,AION,B-NAME_OF_DISEASE,2978
61338,The,O,2978
61339,presence,O,2978
61340,of,O,2978
61341,preceding,B-SIGN_AND_SYMPTOM,2978
61342,transient,I-SIGN_AND_SYMPTOM,2978
61343,visual,B-SIGN_AND_SYMPTOM,2978
61344,loss,I-SIGN_AND_SYMPTOM,2978
61345,diplopia,I-SIGN_AND_SYMPTOM,2978
61346,temporal,I-SIGN_AND_SYMPTOM,2978
61347,pain,I-SIGN_AND_SYMPTOM,2978
61348,jaw,I-SIGN_AND_SYMPTOM,2978
61349,claudication,I-SIGN_AND_SYMPTOM,2978
61350,fatigue,I-SIGN_AND_SYMPTOM,2978
61351,weight,I-SIGN_AND_SYMPTOM,2978
61352,loss,I-SIGN_AND_SYMPTOM,2978
61353,and,I-SIGN_AND_SYMPTOM,2978
61354,myalgias,I-SIGN_AND_SYMPTOM,2978
61355,is,O,2978
61356,strongly,O,2978
61357,suggestive,O,2978
61358,of,O,2978
61359,AION,B-NAME_OF_DISEASE,2978
61360,due,O,2978
61361,to,O,2978
61362,giant,B-CAUSE_OF_DISEASE,2978
61363,cell,I-CAUSE_OF_DISEASE,2978
61364,arteritis,I-CAUSE_OF_DISEASE,2978
61365,GCA,B-CAUSE_OF_DISEASE,2978
61366,,O,2978
61367,GCA,B-CAUSE_OF_DISEASE,2978
61368,causes,O,2978
61369,only,O,2978
61370,6,O,2978
61371,percent,O,2978
61372,of,O,2978
61373,ischemic,B-NAME_OF_DISEASE,2978
61374,optic,I-NAME_OF_DISEASE,2978
61375,neuropathy,I-NAME_OF_DISEASE,2978
61376,but,O,2979
61377,it,O,2979
61378,is,O,2979
61379,visually,O,2979
61380,devastating-a,O,2979
61381,quick,O,2979
61382,diagnosis,O,2979
61383,can,O,2979
61384,initiate,O,2979
61385,treatment,O,2979
61386,and,O,2979
61387,prevent,O,2979
61388,vison,B-SIGN_AND_SYMPTOM,2979
61389,loss,I-SIGN_AND_SYMPTOM,2979
61390,in,O,2979
61391,the,O,2980
61392,lateral,O,2980
61393,eye,O,2980
61394,Other,O,2980
61395,causes,O,2980
61396,include,O,2980
61397,polyarteritis,B-CAUSE_OF_DISEASE,2980
61398,nodosa,I-CAUSE_OF_DISEASE,2980
61399,Wegener,B-CAUSE_OF_DISEASE,2980
61400,s,I-CAUSE_OF_DISEASE,2980
61401,granulomatosis,I-CAUSE_OF_DISEASE,2980
61402,and,O,2980
61403,connective,B-CAUSE_OF_DISEASE,2980
61404,tissues,I-CAUSE_OF_DISEASE,2980
61405,disorders,I-CAUSE_OF_DISEASE,2980
61406,Non-arteritic,B-NAME_OF_DISEASE,2980
61407,AION,I-NAME_OF_DISEASE,2980
61408,is,O,2980
61409,usually,O,2980
61410,less,O,2980
61411,severe,O,2980
61412,and,O,2980
61413,the,O,2980
61414,most,O,2980
61415,common,O,2980
61416,cause,O,2980
61417,of,O,2980
61418,unilateral,B-NAME_OF_DISEASE,2980
61419,optic,B-NAME_OF_DISEASE,2980
61420,nerve,I-NAME_OF_DISEASE,2980
61421,edema,I-NAME_OF_DISEASE,2980
61422,in,O,2980
61423,those,O,2980
61424,50,O,2980
61425,years,O,2981
61426,Usually,O,2981
61427,associated,O,2981
61428,with,O,2981
61429,poor,B-SIGN_AND_SYMPTOM,2981
61430,blood,I-SIGN_AND_SYMPTOM,2981
61431,circulation,I-SIGN_AND_SYMPTOM,2981
61432,to,I-SIGN_AND_SYMPTOM,2981
61433,the,I-SIGN_AND_SYMPTOM,2981
61434,optic,I-SIGN_AND_SYMPTOM,2981
61435,nerve,I-SIGN_AND_SYMPTOM,2981
61436,and,O,2981
61437,associated,O,2981
61438,with,O,2981
61439,diabetes,B-CAUSE_OF_DISEASE,2981
61440,mellitus,I-CAUSE_OF_DISEASE,2981
61441,glaucoma,B-CAUSE_OF_DISEASE,2981
61442,hypercholesterolemia,B-CAUSE_OF_DISEASE,2981
61443,and,O,2981
61444,history,B-CAUSE_OF_DISEASE,2981
61445,of,I-CAUSE_OF_DISEASE,2981
61446,drug,I-CAUSE_OF_DISEASE,2981
61447,use,I-CAUSE_OF_DISEASE,2982
61448,Compressive,O,2982
61449,Lesions,B-CAUSE_OF_DISEASE,2982
61450,of,I-CAUSE_OF_DISEASE,2982
61451,the,I-CAUSE_OF_DISEASE,2982
61452,orbit,I-CAUSE_OF_DISEASE,2982
61453,and,O,2982
61454,less,O,2983
61455,commonly,O,2983
61456,the,B-CAUSE_OF_DISEASE,2983
61457,optic,I-CAUSE_OF_DISEASE,2983
61458,canal,I-CAUSE_OF_DISEASE,2983
61459,can,O,2983
61460,lead,O,2983
61461,to,O,2983
61462,optic,B-NAME_OF_DISEASE,2983
61463,nerve,I-NAME_OF_DISEASE,2983
61464,damage,I-NAME_OF_DISEASE,2983
61465,and,O,2983
61466,the,O,2983
61467,visual,B-SIGN_AND_SYMPTOM,2983
61468,loss,I-SIGN_AND_SYMPTOM,2983
61469,is,O,2983
61470,usually,O,2983
61471,gradual,O,2983
61472,and,O,2983
61473,progressive,O,2983
61474,Common,O,2983
61475,causes,O,2983
61476,include,O,2983
61477,optic,B-CAUSE_OF_DISEASE,2983
61478,glioma,I-CAUSE_OF_DISEASE,2983
61479,meningioma,B-CAUSE_OF_DISEASE,2983
61480,lympangiomas,B-CAUSE_OF_DISEASE,2983
61481,pituitary,B-CAUSE_OF_DISEASE,2983
61482,adenomas,I-CAUSE_OF_DISEASE,2983
61483,craniophyrangiomas,B-CAUSE_OF_DISEASE,2983
61484,and,O,2984
61485,Grave,B-CAUSE_OF_DISEASE,2984
61486,s,I-CAUSE_OF_DISEASE,2984
61487,orbitopathy,I-CAUSE_OF_DISEASE,2984
61488,MRI,B-DIAGNOSTIC_TEST,2984
61489,and,I-DIAGNOSTIC_TEST,2984
61490,CT,I-DIAGNOSTIC_TEST,2984
61491,of,I-DIAGNOSTIC_TEST,2984
61492,brain,I-DIAGNOSTIC_TEST,2984
61493,and,I-DIAGNOSTIC_TEST,2984
61494,orbit,I-DIAGNOSTIC_TEST,2984
61495,are,O,2984
61496,crucial,O,2984
61497,for,O,2984
61498,diagnosis,O,2984
61499,Inflammatory,O,2984
61500,A,B-CAUSE_OF_DISEASE,2984
61501,variety,I-CAUSE_OF_DISEASE,2984
61502,of,I-CAUSE_OF_DISEASE,2984
61503,systemic,I-CAUSE_OF_DISEASE,2984
61504,auto-immune,I-CAUSE_OF_DISEASE,2984
61505,disorders,I-CAUSE_OF_DISEASE,2984
61506,can,O,2984
61507,cause,O,2985
61508,optic,B-NAME_OF_DISEASE,2985
61509,nerve,I-NAME_OF_DISEASE,2985
61510,swelling,I-NAME_OF_DISEASE,2985
61511,These,O,2985
61512,include,O,2985
61513,sarcoidosis,B-CAUSE_OF_DISEASE,2985
61514,Bechet,B-CAUSE_OF_DISEASE,2985
61515,s,I-CAUSE_OF_DISEASE,2985
61516,disease,I-CAUSE_OF_DISEASE,2985
61517,systemic,B-CAUSE_OF_DISEASE,2986
61518,lupus,I-CAUSE_OF_DISEASE,2986
61519,erythematosus,I-CAUSE_OF_DISEASE,2986
61520,Sjögren,B-CAUSE_OF_DISEASE,2986
61521,s,I-CAUSE_OF_DISEASE,2986
61522,syndrome,I-CAUSE_OF_DISEASE,2986
61523,Wegener,B-CAUSE_OF_DISEASE,2986
61524,s,I-CAUSE_OF_DISEASE,2986
61525,granulomatosis,I-CAUSE_OF_DISEASE,2986
61526,and,O,2986
61527,syphilis,B-CAUSE_OF_DISEASE,2986
61528,Laboratory,O,2986
61529,for,O,2986
61530,each,O,2986
61531,diagnosis,O,2986
61532,should,O,2986
61533,be,O,2986
61534,included,O,2986
61535,in,O,2986
61536,the,O,2986
61537,workup,O,2986
61538,on,O,2986
61539,these,O,2987
61540,patients,O,2987
61541,Infiltrative,O,2987
61542,The,O,2987
61543,optic,O,2987
61544,nerve,O,2987
61545,can,O,2987
61546,be,O,2987
61547,infiltrated,O,2987
61548,by,O,2987
61549,secondary,B-CAUSE_OF_DISEASE,2987
61550,tumors,I-CAUSE_OF_DISEASE,2987
61551,and,I-CAUSE_OF_DISEASE,2987
61552,malignancies,I-CAUSE_OF_DISEASE,2987
61553,including,I-CAUSE_OF_DISEASE,2987
61554,metastasis,I-CAUSE_OF_DISEASE,2987
61555,carcinomas,I-CAUSE_OF_DISEASE,2987
61556,leukemia,I-CAUSE_OF_DISEASE,2987
61557,lymphoma,I-CAUSE_OF_DISEASE,2987
61558,and,I-CAUSE_OF_DISEASE,2987
61559,multiple,I-CAUSE_OF_DISEASE,2987
61560,myeloma,I-CAUSE_OF_DISEASE,2988
61561,Patients,O,2988
61562,with,O,2988
61563,a,O,2988
61564,history,O,2988
61565,of,O,2988
61566,cancer,B-NAME_OF_DISEASE,2988
61567,and,O,2988
61568,acquired,O,2988
61569,optic,B-NAME_OF_DISEASE,2988
61570,nerve,I-NAME_OF_DISEASE,2988
61571,edema,I-NAME_OF_DISEASE,2988
61572,should,O,2988
61573,be,O,2988
61574,considered,O,2988
61575,cancerous,O,2988
61576,until,O,2988
61577,proven,O,2988
61578,otherwise,O,2988
61579,Neuroimaging,B-DIAGNOSTIC_TEST,2988
61580,should,O,2988
61581,be,O,2988
61582,ordered,O,2988
61583,to,O,2988
61584,help,O,2988
61585,determine,O,2988
61586,the,O,2988
61587,correct,O,2988
61588,diagnosis,O,2988
61589,Infectious,O,2988
61590,Bacterial,B-CAUSE_OF_DISEASE,2988
61591,viral,I-CAUSE_OF_DISEASE,2988
61592,and,I-CAUSE_OF_DISEASE,2988
61593,fungal,I-CAUSE_OF_DISEASE,2989
61594,infections,I-CAUSE_OF_DISEASE,2989
61595,can,O,2989
61596,lead,O,2989
61597,to,O,2989
61598,optic,B-NAME_OF_DISEASE,2989
61599,nerve,I-NAME_OF_DISEASE,2989
61600,disease,I-NAME_OF_DISEASE,2989
61601,and,I-NAME_OF_DISEASE,2989
61602,edema,I-NAME_OF_DISEASE,2989
61603,The,O,2989
61604,most,O,2990
61605,common,O,2990
61606,causes,O,2990
61607,are,O,2990
61608,toxoplasmosis,B-CAUSE_OF_DISEASE,2990
61609,Bartonella,B-CAUSE_OF_DISEASE,2990
61610,Cat-scratch,I-CAUSE_OF_DISEASE,2990
61611,disease,I-CAUSE_OF_DISEASE,2990
61612,and,O,2990
61613,Lyme,B-CAUSE_OF_DISEASE,2990
61614,disease,I-CAUSE_OF_DISEASE,2990
61615,Laboratory,O,2990
61616,testing,O,2990
61617,and,O,2990
61618,good,O,2990
61619,case,O,2990
61620,history,O,2990
61621,is,O,2990
61622,important,O,2990
61623,in,O,2990
61624,isolating,O,2990
61625,the,O,2990
61626,causative,O,2990
61627,pathogen,O,2990
61628,Nutritious,O,2990
61629,toxic,O,2990
61630,Various,B-CAUSE_OF_DISEASE,2990
61631,drugs,I-CAUSE_OF_DISEASE,2990
61632,toxins,I-CAUSE_OF_DISEASE,2990
61633,and,I-CAUSE_OF_DISEASE,2990
61634,nutritional,I-CAUSE_OF_DISEASE,2990
61635,deficiencies,I-CAUSE_OF_DISEASE,2990
61636,can,O,2990
61637,lead,O,2990
61638,to,O,2990
61639,optic,B-NAME_OF_DISEASE,2990
61640,nerve,I-NAME_OF_DISEASE,2990
61641,disease,I-NAME_OF_DISEASE,2990
61642,These,O,2990
61643,typically,O,2990
61644,mimic,O,2990
61645,and,O,2990
61646,cause,O,2990
61647,a,B-NAME_OF_DISEASE,2990
61648,secondary,I-NAME_OF_DISEASE,2990
61649,IIH,I-NAME_OF_DISEASE,2990
61650,These,O,2990
61651,include,O,2990
61652,tetracyclines,B-CAUSE_OF_DISEASE,2990
61653,Vitamin,B-CAUSE_OF_DISEASE,2990
61654,A,I-CAUSE_OF_DISEASE,2990
61655,amiodarone,B-CAUSE_OF_DISEASE,2990
61656,and,O,2990
61657,lithium,B-CAUSE_OF_DISEASE,2990
61658,Hereditary,O,2991
61659,The,B-CAUSE_OF_DISEASE,2991
61660,hereditary,I-CAUSE_OF_DISEASE,2991
61661,optic,I-CAUSE_OF_DISEASE,2991
61662,neuropathy,I-CAUSE_OF_DISEASE,2991
61663,that,O,2991
61664,causes,O,2991
61665,discs,B-SIGN_AND_SYMPTOM,2991
61666,to,I-SIGN_AND_SYMPTOM,2991
61667,appear,I-SIGN_AND_SYMPTOM,2991
61668,swollen,I-SIGN_AND_SYMPTOM,2991
61669,is,O,2991
61670,Leber,B-NAME_OF_DISEASE,2991
61671,s,I-NAME_OF_DISEASE,2991
61672,hereditary,I-NAME_OF_DISEASE,2991
61673,optic,I-NAME_OF_DISEASE,2991
61674,neuropathy,I-NAME_OF_DISEASE,2991
61675,and,O,2991
61676,typically,O,2991
61677,occurs,O,2991
61678,between,O,2992
61679,ages,O,2992
61680,of,O,2992
61681,15,O,2992
61682,and,O,2992
61683,35,O,2992
61684,Genetic,B-DIAGNOSTIC_TEST,2992
61685,testing,I-DIAGNOSTIC_TEST,2992
61686,and,O,2992
61687,counseling,O,2992
61688,should,O,2992
61689,be,O,2992
61690,considered,O,2992
61691,if,O,2992
61692,this,O,2992
61693,is,O,2992
61694,the,O,2992
61695,suspected,O,2992
61696,cause,O,2992
61697,of,O,2992
61698,optic,O,2992
61699,neuropathy,O,2993
61700,Retrobulbar,B-NAME_OF_DISEASE,2993
61701,hemorrhage,I-NAME_OF_DISEASE,2993
61702,RBH,I-NAME_OF_DISEASE,2993
61703,is,O,2993
61704,a,O,2993
61705,rapidly,O,2993
61706,progressive,O,2993
61707,sight-threatening,O,2993
61708,emergency,O,2993
61709,that,O,2993
61710,results,O,2993
61711,in,O,2993
61712,an,B-SIGN_AND_SYMPTOM,2993
61713,accumulation,I-SIGN_AND_SYMPTOM,2993
61714,of,I-SIGN_AND_SYMPTOM,2993
61715,blood,I-SIGN_AND_SYMPTOM,2993
61716,in,I-SIGN_AND_SYMPTOM,2993
61717,the,I-SIGN_AND_SYMPTOM,2993
61718,retrobulbar,I-SIGN_AND_SYMPTOM,2993
61719,space,I-SIGN_AND_SYMPTOM,2993
61720,The,O,2993
61721,blood,O,2993
61722,accumulation,O,2993
61723,can,O,2993
61724,lead,O,2993
61725,to,O,2994
61726,an,B-SIGN_AND_SYMPTOM,2994
61727,increased,I-SIGN_AND_SYMPTOM,2994
61728,IOP,I-SIGN_AND_SYMPTOM,2994
61729,that,O,2994
61730,may,O,2994
61731,result,O,2994
61732,in,O,2994
61733,stretching,B-SIGN_AND_SYMPTOM,2994
61734,of,I-SIGN_AND_SYMPTOM,2994
61735,the,I-SIGN_AND_SYMPTOM,2994
61736,optic,I-SIGN_AND_SYMPTOM,2994
61737,nerve,I-SIGN_AND_SYMPTOM,2994
61738,and,I-SIGN_AND_SYMPTOM,2994
61739,blockage,I-SIGN_AND_SYMPTOM,2994
61740,of,I-SIGN_AND_SYMPTOM,2994
61741,ocular,I-SIGN_AND_SYMPTOM,2994
61742,perfusion,I-SIGN_AND_SYMPTOM,2994
61743,leading,O,2994
61744,to,O,2994
61745,venous,B-SIGN_AND_SYMPTOM,2994
61746,and,I-SIGN_AND_SYMPTOM,2994
61747,or,I-SIGN_AND_SYMPTOM,2995
61748,arterial,I-SIGN_AND_SYMPTOM,2995
61749,occlusive,I-SIGN_AND_SYMPTOM,2995
61750,process,I-SIGN_AND_SYMPTOM,2995
61751,RBH,B-NAME_OF_DISEASE,2995
61752,can,O,2995
61753,occur,O,2995
61754,due,O,2995
61755,to,O,2995
61756,orbital,B-CAUSE_OF_DISEASE,2995
61757,trauma,I-CAUSE_OF_DISEASE,2995
61758,complication,B-CAUSE_OF_DISEASE,2996
61759,of,I-CAUSE_OF_DISEASE,2996
61760,eyelid,I-CAUSE_OF_DISEASE,2996
61761,or,I-CAUSE_OF_DISEASE,2996
61762,orbital,I-CAUSE_OF_DISEASE,2996
61763,surgery,I-CAUSE_OF_DISEASE,2996
61764,or,O,2996
61765,any,B-CAUSE_OF_DISEASE,2996
61766,process,I-CAUSE_OF_DISEASE,2996
61767,that,I-CAUSE_OF_DISEASE,2996
61768,can,I-CAUSE_OF_DISEASE,2996
61769,affect,I-CAUSE_OF_DISEASE,2996
61770,blood,I-CAUSE_OF_DISEASE,2996
61771,supply,I-CAUSE_OF_DISEASE,2996
61772,to,I-CAUSE_OF_DISEASE,2996
61773,the,I-CAUSE_OF_DISEASE,2996
61774,eye,I-CAUSE_OF_DISEASE,2996
61775,such,I-CAUSE_OF_DISEASE,2996
61776,as,I-CAUSE_OF_DISEASE,2996
61777,arteriovenous,I-CAUSE_OF_DISEASE,2997
61778,malformations,I-CAUSE_OF_DISEASE,2997
61779,orbital,I-CAUSE_OF_DISEASE,2997
61780,varicosities,I-CAUSE_OF_DISEASE,2997
61781,or,I-CAUSE_OF_DISEASE,2997
61782,lymphangiomas,I-CAUSE_OF_DISEASE,2997
61783,It,O,2997
61784,can,O,2997
61785,be,O,2997
61786,potentiated,O,2997
61787,by,O,2997
61788,the,B-CAUSE_OF_DISEASE,2998
61789,use,I-CAUSE_OF_DISEASE,2998
61790,of,I-CAUSE_OF_DISEASE,2998
61791,anticoagulation,I-CAUSE_OF_DISEASE,2998
61792,medication,I-CAUSE_OF_DISEASE,2998
61793,The,O,2998
61794,diagnosis,O,2998
61795,of,O,2998
61796,RBH,B-NAME_OF_DISEASE,2998
61797,is,O,2999
61798,clinical,O,2999
61799,and,O,2999
61800,depends,O,2999
61801,on,O,2999
61802,the,O,2999
61803,history,O,2999
61804,of,O,2999
61805,the,O,2999
61806,patient,O,2999
61807,Diagnostic,O,2999
61808,clues,O,2999
61809,of,O,2999
61810,RBH,B-NAME_OF_DISEASE,2999
61811,include,O,2999
61812,severe,B-SIGN_AND_SYMPTOM,2999
61813,pain,I-SIGN_AND_SYMPTOM,2999
61814,difficulty,I-SIGN_AND_SYMPTOM,2999
61815,opening,I-SIGN_AND_SYMPTOM,2999
61816,the,I-SIGN_AND_SYMPTOM,2999
61817,lids,I-SIGN_AND_SYMPTOM,3000
61818,proptosis,I-SIGN_AND_SYMPTOM,3000
61819,and,I-SIGN_AND_SYMPTOM,3000
61820,or,I-SIGN_AND_SYMPTOM,3000
61821,loss,I-SIGN_AND_SYMPTOM,3000
61822,of,I-SIGN_AND_SYMPTOM,3000
61823,vision,I-SIGN_AND_SYMPTOM,3000
61824,If,O,3000
61825,patients,O,3000
61826,are,O,3000
61827,victims,O,3000
61828,of,O,3000
61829,trauma,O,3000
61830,periorbital,B-SIGN_AND_SYMPTOM,3000
61831,ecchymosis,I-SIGN_AND_SYMPTOM,3000
61832,and,I-SIGN_AND_SYMPTOM,3000
61833,eyelid,I-SIGN_AND_SYMPTOM,3000
61834,hematoma,I-SIGN_AND_SYMPTOM,3000
61835,may,O,3000
61836,be,O,3000
61837,seen,O,3000
61838,Due,O,3000
61839,to,O,3000
61840,the,O,3000
61841,severity,O,3000
61842,of,O,3000
61843,RBH,B-NAME_OF_DISEASE,3000
61844,and,O,3000
61845,the,O,3000
61846,possibility,O,3000
61847,of,O,3000
61848,vision,B-SIGN_AND_SYMPTOM,3000
61849,loss,I-SIGN_AND_SYMPTOM,3000
61850,imaging,O,3000
61851,modalities,O,3000
61852,are,O,3000
61853,usually,O,3000
61854,not,O,3000
61855,recommended,O,3000
61856,for,O,3000
61857,initial,O,3000
61858,diagnostic,O,3000
61859,purposes,O,3000
61860,as,O,3000
61861,this,O,3000
61862,is,O,3000
61863,a,O,3000
61864,clinical,O,3000
61865,diagnosis,O,3000
61866,and,O,3000
61867,treatment,O,3000
61868,must,O,3000
61869,be,O,3000
61870,prompt,O,3000
61871,However,O,3000
61872,a,B-DIAGNOSTIC_TEST,3000
61873,CT,I-DIAGNOSTIC_TEST,3000
61874,scan,I-DIAGNOSTIC_TEST,3000
61875,can,O,3000
61876,be,O,3000
61877,useful,O,3000
61878,to,O,3000
61879,visualize,O,3000
61880,the,B-PART_OF_THE_EYES,3000
61881,orbits,I-PART_OF_THE_EYES,3000
61882,particularly,O,3000
61883,to,O,3000
61884,rule,O,3000
61885,out,O,3000
61886,concomitant,O,3000
61887,injuries,O,3000
61888,in,O,3001
61889,cases,O,3001
61890,of,O,3001
61891,trauma,O,3001
61892,or,O,3001
61893,when,O,3002
61894,the,O,3002
61895,origin,O,3002
61896,of,O,3002
61897,the,O,3002
61898,bleeding,O,3002
61899,is,O,3002
61900,unknown,O,3002
61901,Retrobulbar,B-NAME_OF_DISEASE,3002
61902,haemorrhage,I-NAME_OF_DISEASE,3002
61903,RBH,B-NAME_OF_DISEASE,3002
61904,is,O,3002
61905,an,O,3002
61906,ocular,O,3002
61907,emergency,O,3002
61908,that,O,3002
61909,occurs,O,3002
61910,due,O,3002
61911,to,O,3002
61912,arterial,B-CAUSE_OF_DISEASE,3002
61913,bleeding,I-CAUSE_OF_DISEASE,3002
61914,in,I-CAUSE_OF_DISEASE,3002
61915,the,I-CAUSE_OF_DISEASE,3002
61916,orbital,I-CAUSE_OF_DISEASE,3003
61917,cavity,I-CAUSE_OF_DISEASE,3003
61918,behind,I-CAUSE_OF_DISEASE,3003
61919,the,I-CAUSE_OF_DISEASE,3003
61920,eye,I-CAUSE_OF_DISEASE,3003
61921,As,O,3003
61922,the,B-PART_OF_THE_EYES,3003
61923,orbit,I-PART_OF_THE_EYES,3003
61924,is,O,3004
61925,predominantly,O,3004
61926,an,O,3004
61927,enclosed,O,3004
61928,space,O,3004
61929,the,O,3004
61930,increasing,O,3004
61931,blood,O,3004
61932,volume,O,3004
61933,leads,O,3004
61934,to,O,3004
61935,an,O,3004
61936,increase,O,3004
61937,in,O,3004
61938,intraorbital,O,3004
61939,and,O,3004
61940,intraocular,O,3005
61941,pressure,O,3005
61942,referred,O,3005
61943,to,O,3005
61944,as,O,3005
61945,orbital,B-NAME_OF_DISEASE,3005
61946,compression,I-NAME_OF_DISEASE,3005
61947,syndrome,I-NAME_OF_DISEASE,3005
61948,The,O,3005
61949,overall,O,3005
61950,incidence,O,3005
61951,of,O,3005
61952,RBH,B-NAME_OF_DISEASE,3005
61953,is,O,3005
61954,lower,O,3005
61955,than,O,3006
61956,1%,O,3006
61957,while,O,3006
61958,the,O,3006
61959,incidence,O,3006
61960,of,O,3006
61961,RBH,B-NAME_OF_DISEASE,3006
61962,in,O,3006
61963,orbital,B-CAUSE_OF_DISEASE,3006
61964,trauma,I-CAUSE_OF_DISEASE,3006
61965,is,O,3006
61966,3.60%,O,3006
61967,However,O,3006
61968,despite,O,3006
61969,a,O,3006
61970,low,O,3006
61971,rate,O,3006
61972,of,O,3006
61973,occurrence,O,3006
61974,the,O,3006
61975,lack,O,3006
61976,of,O,3006
61977,immediate,O,3006
61978,management,O,3006
61979,can,O,3006
61980,lead,O,3006
61981,to,O,3006
61982,major,O,3007
61983,morbidity,O,3007
61984,for,O,3007
61985,the,O,3007
61986,patient,O,3007
61987,most,O,3007
61988,notably,O,3007
61989,irreversible,B-SIGN_AND_SYMPTOM,3007
61990,visual,I-SIGN_AND_SYMPTOM,3007
61991,loss,I-SIGN_AND_SYMPTOM,3007
61992,Most,O,3007
61993,commonly,O,3007
61994,RBH,B-NAME_OF_DISEASE,3007
61995,can,O,3007
61996,occur,O,3007
61997,following,O,3007
61998,facial,B-CAUSE_OF_DISEASE,3007
61999,trauma,I-CAUSE_OF_DISEASE,3007
62000,resulting,I-CAUSE_OF_DISEASE,3007
62001,in,I-CAUSE_OF_DISEASE,3007
62002,orbital,I-CAUSE_OF_DISEASE,3007
62003,fractures,I-CAUSE_OF_DISEASE,3007
62004,eyelid,B-CAUSE_OF_DISEASE,3007
62005,surgery,I-CAUSE_OF_DISEASE,3007
62006,lower,I-CAUSE_OF_DISEASE,3008
62007,blepharoplasty,I-CAUSE_OF_DISEASE,3008
62008,retrobulbar,I-CAUSE_OF_DISEASE,3008
62009,anesthesia,I-CAUSE_OF_DISEASE,3008
62010,and,O,3008
62011,or,O,3008
62012,retrobulbar,B-CAUSE_OF_DISEASE,3008
62013,peribulbar,I-CAUSE_OF_DISEASE,3008
62014,injections,I-CAUSE_OF_DISEASE,3008
62015,Pathophysiology,O,3008
62016,RBH,B-NAME_OF_DISEASE,3008
62017,develops,O,3008
62018,due,O,3008
62019,to,O,3008
62020,rupture,B-CAUSE_OF_DISEASE,3008
62021,of,I-CAUSE_OF_DISEASE,3008
62022,any,I-CAUSE_OF_DISEASE,3008
62023,of,I-CAUSE_OF_DISEASE,3008
62024,the,I-CAUSE_OF_DISEASE,3008
62025,orbital,I-CAUSE_OF_DISEASE,3008
62026,arteries,I-CAUSE_OF_DISEASE,3008
62027,such,I-CAUSE_OF_DISEASE,3008
62028,as,I-CAUSE_OF_DISEASE,3008
62029,the,I-CAUSE_OF_DISEASE,3008
62030,infraorbital,I-CAUSE_OF_DISEASE,3008
62031,artery,I-CAUSE_OF_DISEASE,3008
62032,anterior,I-CAUSE_OF_DISEASE,3008
62033,ethmoidal,I-CAUSE_OF_DISEASE,3009
62034,artery,I-CAUSE_OF_DISEASE,3009
62035,or,I-CAUSE_OF_DISEASE,3009
62036,posterior,I-CAUSE_OF_DISEASE,3009
62037,ethmoidal,I-CAUSE_OF_DISEASE,3009
62038,artery,I-CAUSE_OF_DISEASE,3009
62039,that,O,3009
62040,can,O,3009
62041,cause,O,3009
62042,an,B-SIGN_AND_SYMPTOM,3009
62043,increase,I-SIGN_AND_SYMPTOM,3009
62044,in,I-SIGN_AND_SYMPTOM,3009
62045,intraorbital,I-SIGN_AND_SYMPTOM,3009
62046,pressure,I-SIGN_AND_SYMPTOM,3009
62047,and,I-SIGN_AND_SYMPTOM,3009
62048,a,I-SIGN_AND_SYMPTOM,3009
62049,reduction,I-SIGN_AND_SYMPTOM,3009
62050,in,I-SIGN_AND_SYMPTOM,3009
62051,the,I-SIGN_AND_SYMPTOM,3009
62052,perfusion,I-SIGN_AND_SYMPTOM,3009
62053,of,I-SIGN_AND_SYMPTOM,3009
62054,the,I-SIGN_AND_SYMPTOM,3010
62055,optic,I-SIGN_AND_SYMPTOM,3010
62056,nerve,I-SIGN_AND_SYMPTOM,3010
62057,This,O,3010
62058,ischaemia,O,3010
62059,can,O,3010
62060,cause,O,3010
62061,atrophy,B-SIGN_AND_SYMPTOM,3010
62062,of,I-SIGN_AND_SYMPTOM,3010
62063,the,I-SIGN_AND_SYMPTOM,3010
62064,optic,I-SIGN_AND_SYMPTOM,3010
62065,nerve,I-SIGN_AND_SYMPTOM,3010
62066,and,O,3010
62067,lead,O,3010
62068,to,O,3010
62069,irreversible,B-SIGN_AND_SYMPTOM,3010
62070,vision,I-SIGN_AND_SYMPTOM,3010
62071,loss,I-SIGN_AND_SYMPTOM,3010
62072,The,O,3010
62073,clinical,O,3010
62074,features,O,3010
62075,of,O,3010
62076,RBH,B-NAME_OF_DISEASE,3010
62077,include,O,3010
62078,proptosis,B-SIGN_AND_SYMPTOM,3010
62079,eye,I-SIGN_AND_SYMPTOM,3010
62080,pain,I-SIGN_AND_SYMPTOM,3010
62081,reduced,I-SIGN_AND_SYMPTOM,3010
62082,visual,I-SIGN_AND_SYMPTOM,3010
62083,acuity,I-SIGN_AND_SYMPTOM,3010
62084,ophthalmoplegia,I-SIGN_AND_SYMPTOM,3010
62085,periorbital,I-SIGN_AND_SYMPTOM,3010
62086,oedema,I-SIGN_AND_SYMPTOM,3010
62087,subconjunctival,I-SIGN_AND_SYMPTOM,3010
62088,ecchymosis,I-SIGN_AND_SYMPTOM,3010
62089,Cherry,I-SIGN_AND_SYMPTOM,3010
62090,red,I-SIGN_AND_SYMPTOM,3010
62091,macula,I-SIGN_AND_SYMPTOM,3010
62092,in,I-SIGN_AND_SYMPTOM,3010
62093,retina,I-SIGN_AND_SYMPTOM,3010
62094,oedematous,I-SIGN_AND_SYMPTOM,3010
62095,and,I-SIGN_AND_SYMPTOM,3010
62096,pale,I-SIGN_AND_SYMPTOM,3010
62097,optic,I-SIGN_AND_SYMPTOM,3010
62098,disc,I-SIGN_AND_SYMPTOM,3010
62099,and,I-SIGN_AND_SYMPTOM,3010
62100,relative,I-SIGN_AND_SYMPTOM,3010
62101,afferent,I-SIGN_AND_SYMPTOM,3010
62102,pupillary,I-SIGN_AND_SYMPTOM,3010
62103,defect,I-SIGN_AND_SYMPTOM,3010
62104,RAPD,I-SIGN_AND_SYMPTOM,3010
62105,,O,3010
62106,If,O,3010
62107,these,O,3010
62108,signs,O,3010
62109,are,O,3010
62110,not,O,3010
62111,recognised,O,3010
62112,early,O,3010
62113,the,O,3010
62114,outcome,O,3010
62115,can,O,3010
62116,be,O,3010
62117,devastating,O,3010
62118,leaving,O,3010
62119,a,O,3010
62120,person,O,3010
62121,visually,B-SIGN_AND_SYMPTOM,3010
62122,impaired,I-SIGN_AND_SYMPTOM,3010
62123,or,I-SIGN_AND_SYMPTOM,3010
62124,blind,I-SIGN_AND_SYMPTOM,3010
62125,in,I-SIGN_AND_SYMPTOM,3010
62126,that,I-SIGN_AND_SYMPTOM,3010
62127,eye,I-SIGN_AND_SYMPTOM,3010
62128,Prevention,O,3010
62129,recognition,O,3010
62130,and,O,3010
62131,intervention,O,3010
62132,are,O,3010
62133,therefore,O,3010
62134,imperative,O,3010
62135,Management,O,3010
62136,Prompt,O,3010
62137,recognition,O,3010
62138,of,O,3010
62139,RBH,B-NAME_OF_DISEASE,3010
62140,is,O,3011
62141,crucial,O,3011
62142,given,O,3011
62143,that,O,3011
62144,a,O,3011
62145,delay,O,3011
62146,in,O,3011
62147,surgery,O,3011
62148,of,O,3011
62149,as,O,3011
62150,little,O,3011
62151,as,O,3011
62152,90-120,O,3011
62153,minutes,O,3011
62154,from,O,3011
62155,when,O,3011
62156,symptoms,O,3011
62157,first,O,3011
62158,develop,O,3011
62159,can,O,3011
62160,result,O,3011
62161,in,O,3012
62162,permanent,B-NAME_OF_DISEASE,3012
62163,vision,I-NAME_OF_DISEASE,3012
62164,loss,I-NAME_OF_DISEASE,3012
62165,Although,O,3012
62166,a,B-DIAGNOSTIC_TEST,3012
62167,computerised,I-DIAGNOSTIC_TEST,3012
62168,tomography,I-DIAGNOSTIC_TEST,3012
62169,CT,I-DIAGNOSTIC_TEST,3012
62170,scan,I-DIAGNOSTIC_TEST,3012
62171,of,I-DIAGNOSTIC_TEST,3012
62172,the,I-DIAGNOSTIC_TEST,3012
62173,orbits,I-DIAGNOSTIC_TEST,3012
62174,is,O,3012
62175,the,O,3012
62176,diagnostic,O,3012
62177,test,O,3012
62178,of,O,3012
62179,choice,O,3012
62180,management,O,3012
62181,should,O,3012
62182,not,O,3012
62183,be,O,3012
62184,delayed,O,3012
62185,waiting,O,3012
62186,for,O,3012
62187,investigation,O,3013
62188,Management,O,3013
62189,is,O,3013
62190,based,O,3013
62191,on,O,3013
62192,the,O,3013
62193,clinical,O,3013
62194,presentation,O,3013
62195,of,O,3013
62196,the,O,3013
62197,patient,O,3013
62198,If,O,3013
62199,signs,O,3013
62200,of,O,3013
62201,visual,O,3013
62202,compromise,O,3013
62203,and,O,3013
62204,a,O,3013
62205,tense,O,3013
62206,globe,B-PART_OF_THE_EYES,3013
62207,is,O,3013
62208,observed,O,3013
62209,the,O,3013
62210,patient,O,3013
62211,should,O,3013
62212,undergo,O,3013
62213,an,B-TREATMENT,3013
62214,emergency,I-TREATMENT,3014
62215,lateral,I-TREATMENT,3014
62216,canthotomy,I-TREATMENT,3014
62217,lateral,I-TREATMENT,3014
62218,cantholysis,I-TREATMENT,3014
62219,procedure,I-TREATMENT,3014
62220,If,O,3014
62221,no,O,3014
62222,signs,O,3014
62223,of,O,3014
62224,visual,O,3014
62225,compromise,O,3014
62226,manage,O,3014
62227,conservatively,O,3014
62228,with,O,3014
62229,close,O,3014
62230,observation,O,3014
62231,refer,O,3014
62232,to,O,3014
62233,ophthalmology,O,3014
62234,and,O,3015
62235,medical,O,3015
62236,management,O,3015
62237,can,O,3015
62238,be,O,3015
62239,commenced,O,3015
62240,concurrently,O,3015
62241,Conservative,O,3015
62242,Management,O,3015
62243,Admit,O,3015
62244,patient,O,3015
62245,Position,O,3015
62246,in,O,3015
62247,a,O,3015
62248,head-up,O,3015
62249,position,O,3015
62250,Monitor,O,3015
62251,visual,O,3015
62252,acuity,O,3015
62253,intraocular,O,3015
62254,pressure,O,3015
62255,IOP,O,3015
62256,and,O,3015
62257,RAPD,O,3015
62258,every,O,3015
62259,15,B-TIME_DURATION,3015
62260,minutes,I-TIME_DURATION,3015
62261,for,O,3015
62262,two,B-TIME_DURATION,3015
62263,hours,I-TIME_DURATION,3015
62264,then,O,3015
62265,30,B-TIME_DURATION,3015
62266,minutes,I-TIME_DURATION,3016
62267,for,O,3016
62268,the,O,3016
62269,next,O,3016
62270,four,B-TIME_DURATION,3016
62271,hours,I-TIME_DURATION,3016
62272,then,O,3016
62273,hourly,O,3016
62274,Medical,O,3016
62275,Management,O,3016
62276,Acetazolamide,B-NAME_OF_DRUG,3016
62277,-,O,3016
62278,Adult,O,3016
62279,oral,O,3016
62280,IV,O,3016
62281,initial,O,3016
62282,dose,O,3016
62283,of,O,3017
62284,250-500mg,O,3017
62285,Maintenance,O,3017
62286,250mg,O,3017
62287,every,O,3017
62288,four,B-TIME_DURATION,3017
62289,hours,I-TIME_DURATION,3017
62290,as,O,3017
62291,required,O,3017
62292,to,O,3017
62293,a,O,3017
62294,maximum,O,3017
62295,of,O,3017
62296,1g,O,3017
62297,daily,O,3017
62298,see,O,3017
62299,Acetazolamide,B-NAME_OF_DRUG,3017
62300,Prescribing,O,3017
62301,and,O,3017
62302,Administration,O,3017
62303,Guideline,O,3017
62304,-,O,3017
62305,Used,O,3017
62306,to,O,3017
62307,reduce,O,3017
62308,intraocular,O,3017
62309,pressure,O,3017
62310,-,O,3017
62311,Confirm,O,3017
62312,no,O,3017
62313,allergies,O,3017
62314,to,O,3017
62315,sulfa,B-NAME_OF_DRUG,3018
62316,medications,I-NAME_OF_DRUG,3018
62317,-,O,3018
62318,Mannitol,B-NAME_OF_DRUG,3018
62319,-,O,3018
62320,Adult,O,3018
62321,1-2g,O,3018
62322,kg,O,3018
62323,5-10mL,O,3018
62324,kg,O,3018
62325,of,O,3018
62326,20%,O,3018
62327,solution,O,3018
62328,intravenously,O,3018
62329,over,B-TIME_DURATION,3018
62330,30,I-TIME_DURATION,3018
62331,to,I-TIME_DURATION,3018
62332,60,I-TIME_DURATION,3018
62333,mins,I-TIME_DURATION,3018
62334,see,O,3019
62335,Mannitol,B-NAME_OF_DRUG,3019
62336,Infusion,O,3019
62337,Procedure,O,3019
62338,,O,3019
62339,Administer,O,3019
62340,with,O,3019
62341,caution,O,3019
62342,to,O,3019
62343,patients,O,3019
62344,with,O,3019
62345,renal,B-NAME_OF_DISEASE,3019
62346,heart,I-NAME_OF_DISEASE,3019
62347,disease,I-NAME_OF_DISEASE,3019
62348,or,O,3019
62349,severe,O,3019
62350,dehydration,O,3019
62351,-,O,3019
62352,Used,O,3019
62353,to,O,3019
62354,reduce,O,3019
62355,the,O,3019
62356,volume,O,3019
62357,of,O,3019
62358,vitreous,B-PART_OF_THE_EYES,3019
62359,Surgical,O,3019
62360,Management,O,3020
62361,In,O,3020
62362,the,O,3020
62363,surgical,O,3020
62364,management,O,3020
62365,of,O,3020
62366,RBH,B-NAME_OF_DISEASE,3020
62367,patients,O,3020
62368,with,O,3020
62369,visual,O,3020
62370,compromise,O,3020
62371,should,O,3020
62372,have,O,3020
62373,a,B-TREATMENT,3020
62374,lateral,I-TREATMENT,3021
62375,canthotomy,B-TREATMENT,3021
62376,lateral,I-TREATMENT,3021
62377,cantholysis,I-TREATMENT,3021
62378,procedure,I-TREATMENT,3021
62379,done,O,3021
62380,Lateral,B-TREATMENT,3021
62381,canthotomy,B-TREATMENT,3021
62382,take,O,3021
62383,blunt,B-SURGICAL_INSTRUMENT,3021
62384,tipped,I-SURGICAL_INSTRUMENT,3021
62385,scissors,I-SURGICAL_INSTRUMENT,3021
62386,and,O,3021
62387,cut,O,3021
62388,the,B-SURGICAL_INSTRUMENT,3021
62389,lateral,B-PART_OF_THE_EYES,3021
62390,canthus,I-PART_OF_THE_EYES,3021
62391,skin,I-SURGICAL_INSTRUMENT,3021
62392,all,O,3021
62393,the,O,3021
62394,way,O,3021
62395,to,O,3022
62396,the,B-SURGICAL_INSTRUMENT,3022
62397,bony,I-SURGICAL_INSTRUMENT,3022
62398,orbit,I-SURGICAL_INSTRUMENT,3022
62399,with,O,3022
62400,the,O,3022
62401,blades,O,3022
62402,straddling,O,3022
62403,the,B-SURGICAL_INSTRUMENT,3022
62404,lateral,B-PART_OF_THE_EYES,3023
62405,canthus,I-PART_OF_THE_EYES,3023
62406,Lateral,B-TREATMENT,3023
62407,cantholysis,I-TREATMENT,3023
62408,inferior,B-PART_OF_THE_EYES,3023
62409,crus,I-PART_OF_THE_EYES,3023
62410,use,O,3023
62411,forceps,B-SURGICAL_INSTRUMENT,3023
62412,to,O,3023
62413,pull,O,3023
62414,the,O,3023
62415,outer,O,3023
62416,edge,O,3023
62417,of,O,3023
62418,the,B-PART_OF_THE_EYES,3023
62419,lower,I-PART_OF_THE_EYES,3023
62420,lid,I-PART_OF_THE_EYES,3023
62421,out,O,3023
62422,to,O,3023
62423,expose,O,3023
62424,the,B-PART_OF_THE_EYES,3023
62425,lateral,I-PART_OF_THE_EYES,3023
62426,canthal,I-PART_OF_THE_EYES,3023
62427,tendon,I-PART_OF_THE_EYES,3024
62428,Then,O,3024
62429,identify,O,3024
62430,the,B-PART_OF_THE_EYES,3024
62431,inferior,I-PART_OF_THE_EYES,3024
62432,crus,I-PART_OF_THE_EYES,3024
62433,of,I-PART_OF_THE_EYES,3024
62434,the,I-PART_OF_THE_EYES,3024
62435,lateral,I-PART_OF_THE_EYES,3024
62436,canthal,I-PART_OF_THE_EYES,3024
62437,tendon,I-PART_OF_THE_EYES,3024
62438,inferolaterally,O,3024
62439,Using,O,3024
62440,blunt,B-SURGICAL_INSTRUMENT,3024
62441,tipped,I-SURGICAL_INSTRUMENT,3024
62442,scissors,I-SURGICAL_INSTRUMENT,3024
62443,place,O,3024
62444,one,O,3024
62445,blade,O,3024
62446,on,O,3024
62447,either,O,3024
62448,side,O,3024
62449,of,O,3024
62450,the,B-PART_OF_THE_EYES,3024
62451,inferior,I-PART_OF_THE_EYES,3024
62452,crus,I-PART_OF_THE_EYES,3024
62453,of,I-PART_OF_THE_EYES,3024
62454,the,I-PART_OF_THE_EYES,3024
62455,lateral,I-PART_OF_THE_EYES,3024
62456,canthal,I-PART_OF_THE_EYES,3025
62457,tendon,I-PART_OF_THE_EYES,3025
62458,When,O,3025
62459,it,O,3025
62460,is,O,3025
62461,cut,O,3025
62462,the,B-PART_OF_THE_EYES,3025
62463,lower,I-PART_OF_THE_EYES,3025
62464,lid,I-PART_OF_THE_EYES,3025
62465,should,O,3025
62466,become,O,3025
62467,more,O,3025
62468,relaxed,O,3025
62469,A,B-TREATMENT,3025
62470,cantholysis,I-TREATMENT,3025
62471,is,O,3025
62472,usually,O,3025
62473,adequate,O,3025
62474,to,O,3025
62475,decompress,O,3025
62476,the,B-PART_OF_THE_EYES,3025
62477,orbit,I-PART_OF_THE_EYES,3025
62478,If,O,3026
62479,not,O,3026
62480,consider,O,3026
62481,whether,O,3026
62482,you,O,3026
62483,have,O,3026
62484,properly,O,3026
62485,cut,O,3026
62486,the,B-PART_OF_THE_EYES,3026
62487,inferior,I-PART_OF_THE_EYES,3026
62488,crus,I-PART_OF_THE_EYES,3026
62489,or,O,3026
62490,if,O,3026
62491,you,O,3026
62492,need,O,3026
62493,to,O,3026
62494,cut,O,3026
62495,the,B-PART_OF_THE_EYES,3026
62496,superior,I-PART_OF_THE_EYES,3026
62497,crus,I-PART_OF_THE_EYES,3026
62498,The,O,3026
62499,following,O,3026
62500,equipment,O,3026
62501,are,O,3026
62502,required,O,3026
62503,to,O,3026
62504,perform,O,3026
62505,a,B-TREATMENT,3026
62506,lateral,I-TREATMENT,3026
62507,canthotomy,B-TREATMENT,3026
62508,lateral,I-TREATMENT,3026
62509,cantholysis,I-TREATMENT,3027
62510,procedure,I-TREATMENT,3027
62511,Sterile gloves,B-SURGICAL_INSTRUMENT,3027
62512, gauze,O,3027
62513,face,B-SURGICAL_INSTRUMENT,3027
62514,shield,I-SURGICAL_INSTRUMENT,3027
62515,gown,B-SURGICAL_INSTRUMENT,3027
62516,and drapes,B-SURGICAL_INSTRUMENT,3027
62517,Antiseptic,B-NAME_OF_DRUG,3027
62518,solution,I-NAME_OF_DRUG,3027
62519,chlorhexidine,I-NAME_OF_DRUG,3027
62520,or,I-NAME_OF_DRUG,3027
62521,Betadine,I-NAME_OF_DRUG,3027
62522,Local,B-NAME_OF_DRUG,3027
62523,anaesthetic,I-NAME_OF_DRUG,3027
62524,2%,B-NAME_OF_DRUG,3027
62525,lignocaine,I-NAME_OF_DRUG,3027
62526,with,O,3027
62527,1,O,3027
62528,200,O,3028
62529,0,O,3028
62530,adrenaline,B-NAME_OF_DRUG,3028
62531,into,O,3028
62532,lateral,B-PART_OF_THE_EYES,3028
62533,canthus,I-PART_OF_THE_EYES,3028
62534,Syringe ,B-SURGICAL_INSTRUMENT,3028
62535,3ml,I-SURGICAL_INSTRUMENT,3028
62536,with small,I-SURGICAL_INSTRUMENT,3028
62537,injection,I-SURGICAL_INSTRUMENT,3028
62538,needles available,I-SURGICAL_INSTRUMENT,3028
62539,27-30,I-SURGICAL_INSTRUMENT,3028
62540,gauge,I-SURGICAL_INSTRUMENT,3028
62541,Irrigation,B-SURGICAL_INSTRUMENT,3028
62542,fluid,I-SURGICAL_INSTRUMENT,3028
62543,normal,I-SURGICAL_INSTRUMENT,3028
62544,saline,I-SURGICAL_INSTRUMENT,3028
62545,or,I-SURGICAL_INSTRUMENT,3029
62546,water,I-SURGICAL_INSTRUMENT,3029
62547,Artery,B-SURGICAL_INSTRUMENT,3029
62548,forceps,I-SURGICAL_INSTRUMENT,3029
62549,Sterile,B-SURGICAL_INSTRUMENT,3029
62550,curved,I-SURGICAL_INSTRUMENT,3029
62551,scissors,I-SURGICAL_INSTRUMENT,3029
62552,or,O,3029
62553,iris,B-SURGICAL_INSTRUMENT,3029
62554,scissors,I-SURGICAL_INSTRUMENT,3029
62555,whatever,O,3029
62556,is,O,3029
62557,available,O,3029
62558,in,O,3029
62559,the,O,3029
62560,A,O,3029
62561,E,O,3029
62562,on,O,3029
62563,the,O,3029
62564,day,O,3029
62565,Forceps ,O,3029
62566,at,O,3029
62567,least,O,3029
62568,0.3m,O,3029
62569,teeth,O,3030
62570,Antibiotic,B-NAME_OF_DRUG,3030
62571,ointment,I-NAME_OF_DRUG,3031
62572,chloramphenicol,I-NAME_OF_DRUG,3031
62573,,O,3031
62574,After,O,3031
62575,a,B-TREATMENT,3031
62576,lateral,I-TREATMENT,3031
62577,canthotomy,B-TREATMENT,3031
62578,cantholysis,I-TREATMENT,3031
62579,procedure,I-TREATMENT,3031
62580,the,O,3031
62581,patient,O,3031
62582,s,O,3031
62583,eye,O,3031
62584,may,O,3031
62585,be,O,3031
62586,left,O,3031
62587,to,O,3031
62588,spontaneously,O,3031
62589,granulate,O,3032
62590,and,O,3032
62591,heal,O,3032
62592,or,O,3032
62593,may,O,3032
62594,be,O,3032
62595,electively,O,3032
62596,repaired,O,3032
62597,Incisions,O,3032
62598,heal,O,3032
62599,on,O,3032
62600,their,O,3032
62601,own,O,3032
62602,with,O,3032
62603,minimal,O,3032
62604,scarring,O,3032
62605,Apply,O,3032
62606,ointment,B-NAME_OF_DRUG,3032
62607,1%,I-NAME_OF_DRUG,3032
62608,Chloramphenicol,I-NAME_OF_DRUG,3033
62609,to,O,3033
62610,the,O,3033
62611,eye,O,3033
62612,and,O,3033
62613,cover,O,3033
62614,with,O,3033
62615,a,O,3033
62616,sterile,O,3033
62617,dressing,O,3033
62618,to,O,3033
62619,prevent,O,3033
62620,infection,O,3033
62621,Ice,O,3033
62622,packs,O,3033
62623,may,O,3033
62624,be,O,3033
62625,used,O,3033
62626,in,O,3033
62627,the,O,3033
62628,days,O,3033
62629,following,O,3033
62630,canthotomy,B-TREATMENT,3033
62631,to,O,3033
62632,reduce,O,3033
62633,pain,O,3033
62634,and,O,3033
62635,inflammation,O,3033
62636,RBH,B-NAME_OF_DISEASE,3034
62637,is,O,3034
62638,a,O,3034
62639,site-threatening,O,3034
62640,emergency,O,3034
62641,if,O,3034
62642,the,O,3034
62643,symptoms,O,3034
62644,of,O,3034
62645,visual,O,3034
62646,compromise,O,3034
62647,are,O,3034
62648,identified,O,3034
62649,early,O,3034
62650,and,O,3034
62651,treatment,O,3034
62652,is,O,3034
62653,started,O,3035
62654,promptly,O,3036
62655,patients,O,3036
62656,will,O,3036
62657,have,O,3036
62658,the,O,3036
62659,best,O,3036
62660,chance,O,3036
62661,of,O,3036
62662,recovery,O,3036
62663,Although,O,3036
62664,the,O,3036
62665,incidence,O,3036
62666,of,O,3036
62667,RBH,B-NAME_OF_DISEASE,3036
62668,may,O,3036
62669,appear,O,3036
62670,to,O,3036
62671,be,O,3036
62672,insignificant,O,3036
62673,the,O,3036
62674,misdiagnosis,O,3037
62675,or,O,3037
62676,mismanagement,O,3037
62677,can,O,3037
62678,be,O,3037
62679,disastrous,O,3037
62680,due,O,3037
62681,to,O,3037
62682,the,O,3037
62683,risk,O,3037
62684,of,O,3037
62685,permanent,B-NAME_OF_DISEASE,3037
62686,blindness,I-NAME_OF_DISEASE,3037
62687,The,B-NAME_OF_DISEASE,3038
62688,iridocorneal,I-NAME_OF_DISEASE,3039
62689,endothelial,I-NAME_OF_DISEASE,3039
62690,ICE,I-NAME_OF_DISEASE,3039
62691,syndrome,I-NAME_OF_DISEASE,3039
62692,is,O,3039
62693,a,O,3039
62694,developmental,O,3039
62695,disorder,O,3039
62696,of,O,3039
62697,the,O,3039
62698,eye,O,3039
62699,characterized,O,3039
62700,by,O,3039
62701,acquired,B-SIGN_AND_SYMPTOM,3039
62702,nontraumatic,I-SIGN_AND_SYMPTOM,3039
62703,corneal,I-SIGN_AND_SYMPTOM,3039
62704,edema,I-SIGN_AND_SYMPTOM,3039
62705,progressive,I-SIGN_AND_SYMPTOM,3039
62706,abnormalities,I-SIGN_AND_SYMPTOM,3039
62707,of,I-SIGN_AND_SYMPTOM,3039
62708,the,I-SIGN_AND_SYMPTOM,3040
62709,iris,I-SIGN_AND_SYMPTOM,3040
62710,and,I-SIGN_AND_SYMPTOM,3040
62711,elevated,I-SIGN_AND_SYMPTOM,3040
62712,intraocular,I-SIGN_AND_SYMPTOM,3040
62713,pressure,I-SIGN_AND_SYMPTOM,3040
62714,Three,O,3040
62715,subcategories,O,3040
62716,of,O,3040
62717,ICE,B-NAME_OF_DISEASE,3040
62718,syndrome,I-NAME_OF_DISEASE,3040
62719,are,O,3040
62720,commonly,O,3040
62721,recognized,O,3040
62722,essential,B-NAME_OF_DISEASE,3040
62723,iris,I-NAME_OF_DISEASE,3040
62724,atrophy,I-NAME_OF_DISEASE,3040
62725,the,B-NAME_OF_DISEASE,3040
62726,iris,I-NAME_OF_DISEASE,3040
62727,nevus,I-NAME_OF_DISEASE,3040
62728,syndrome,I-NAME_OF_DISEASE,3040
62729,Cogan-Reese,B-NAME_OF_DISEASE,3040
62730,syndrome,I-NAME_OF_DISEASE,3040
62731,and,O,3040
62732,Chandler,B-NAME_OF_DISEASE,3040
62733,s,I-NAME_OF_DISEASE,3040
62734,syndrome,I-NAME_OF_DISEASE,3040
62735,Iridocorneal,B-NAME_OF_DISEASE,3041
62736,endothelial,I-NAME_OF_DISEASE,3041
62737,ICE,I-NAME_OF_DISEASE,3041
62738,syndrome,I-NAME_OF_DISEASE,3041
62739,describes,O,3041
62740,a,O,3041
62741,group,O,3041
62742,of,O,3041
62743,eye,O,3041
62744,diseases,O,3041
62745,that,O,3041
62746,are,O,3041
62747,characterized,O,3041
62748,by,O,3041
62749,three,O,3041
62750,main,O,3041
62751,features,O,3041
62752,Visible,B-SIGN_AND_SYMPTOM,3042
62753,changes,I-SIGN_AND_SYMPTOM,3042
62754,in,I-SIGN_AND_SYMPTOM,3042
62755,the,I-SIGN_AND_SYMPTOM,3042
62756,iris,I-SIGN_AND_SYMPTOM,3042
62757,the,O,3042
62758,colored,O,3042
62759,part,O,3042
62760,of,O,3042
62761,the,O,3042
62762,eye,O,3042
62763,that,O,3042
62764,regulates,O,3042
62765,the,O,3042
62766,amount,O,3043
62767,of,O,3043
62768,light,O,3043
62769,entering,O,3043
62770,the,O,3043
62771,eye,O,3043
62772,Swelling,B-SIGN_AND_SYMPTOM,3043
62773,of,I-SIGN_AND_SYMPTOM,3043
62774,the,I-SIGN_AND_SYMPTOM,3043
62775,cornea,I-SIGN_AND_SYMPTOM,3043
62776,and,O,3043
62777,The,B-SIGN_AND_SYMPTOM,3043
62778,development,I-SIGN_AND_SYMPTOM,3043
62779,of,I-SIGN_AND_SYMPTOM,3043
62780,glaucoma,I-SIGN_AND_SYMPTOM,3043
62781,a,O,3043
62782,disease,O,3043
62783,that,O,3043
62784,can,O,3043
62785,cause,O,3043
62786,severe,O,3043
62787,vision,B-SIGN_AND_SYMPTOM,3043
62788,loss,I-SIGN_AND_SYMPTOM,3043
62789,when,O,3043
62790,normal,O,3043
62791,fluid,O,3043
62792,inside,O,3043
62793,the,O,3043
62794,eye,O,3043
62795,cannot,O,3043
62796,drain,O,3043
62797,properly,O,3043
62798,ICE,B-NAME_OF_DISEASE,3043
62799,syndrome,I-NAME_OF_DISEASE,3043
62800,is,O,3043
62801,more,O,3043
62802,common,O,3043
62803,in,O,3043
62804,women,O,3044
62805,than,O,3044
62806,men,O,3044
62807,most,O,3044
62808,commonly,O,3044
62809,diagnosed,O,3044
62810,in,O,3044
62811,middle,O,3044
62812,age,O,3044
62813,and,O,3044
62814,is,O,3044
62815,usually,O,3044
62816,present,O,3044
62817,in,O,3044
62818,only,O,3044
62819,one,O,3044
62820,eye,O,3044
62821,The,O,3044
62822,condition,O,3044
62823,is,O,3044
62824,actually,O,3044
62825,a,O,3044
62826,grouping,O,3044
62827,of,O,3044
62828,three,O,3044
62829,closely,O,3044
62830,linked,O,3044
62831,conditions,O,3044
62832,Cogan-Reese,B-NAME_OF_DISEASE,3044
62833,syndrome,I-NAME_OF_DISEASE,3044
62834,Chandler,B-NAME_OF_DISEASE,3044
62835,s,I-NAME_OF_DISEASE,3044
62836,syndrome,I-NAME_OF_DISEASE,3044
62837,and,O,3045
62838,essential,B-NAME_OF_DISEASE,3045
62839,progressive,I-NAME_OF_DISEASE,3045
62840,iris,I-NAME_OF_DISEASE,3045
62841,atrophy,I-NAME_OF_DISEASE,3045
62842,The,O,3045
62843,cause,O,3045
62844,of,O,3045
62845,ICE,B-NAME_OF_DISEASE,3045
62846,syndrome,I-NAME_OF_DISEASE,3045
62847,is,O,3045
62848,unknown,O,3045
62849,however,O,3045
62850,there,O,3045
62851,is,O,3045
62852,a,O,3045
62853,theory,O,3045
62854,that,O,3045
62855,it,O,3045
62856,is,O,3045
62857,triggered,O,3045
62858,by,O,3046
62859,a,B-CAUSE_OF_DISEASE,3046
62860,virus,I-CAUSE_OF_DISEASE,3046
62861,that,O,3046
62862,leads,O,3046
62863,to,O,3046
62864,swelling,B-SIGN_AND_SYMPTOM,3046
62865,of,I-SIGN_AND_SYMPTOM,3046
62866,the,I-SIGN_AND_SYMPTOM,3046
62867,cornea,I-SIGN_AND_SYMPTOM,3046
62868,While,O,3046
62869,there,O,3046
62870,is,O,3046
62871,no,O,3046
62872,way,O,3046
62873,to,O,3046
62874,stop,O,3046
62875,the,O,3047
62876,progression,O,3047
62877,of,O,3047
62878,the,O,3047
62879,condition,O,3047
62880,treatment,O,3047
62881,of,O,3047
62882,the,O,3047
62883,symptoms,O,3047
62884,may,O,3047
62885,include,O,3047
62886,medication,B-TREATMENT,3047
62887,for,I-TREATMENT,3047
62888,glaucoma,I-TREATMENT,3048
62889,and,O,3048
62890,corneal,B-TREATMENT,3048
62891,transplant,I-TREATMENT,3048
62892,for,I-TREATMENT,3048
62893,corneal,I-TREATMENT,3048
62894,swelling,I-TREATMENT,3048
62895,ICE,B-NAME_OF_DISEASE,3048
62896,syndrome,I-NAME_OF_DISEASE,3048
62897,is,O,3048
62898,sporadic,O,3048
62899,in,O,3048
62900,its,O,3048
62901,presentation,O,3048
62902,as,O,3048
62903,there,O,3048
62904,is,O,3048
62905,no,O,3048
62906,correlation,O,3048
62907,or,O,3048
62908,association,O,3048
62909,with,O,3049
62910,any,O,3049
62911,ocular,O,3049
62912,or,O,3049
62913,systemic,O,3049
62914,disease,O,3049
62915,It,O,3049
62916,is,O,3049
62917,characterised,O,3049
62918,by,O,3049
62919,the,B-SIGN_AND_SYMPTOM,3049
62920,abnormal,I-SIGN_AND_SYMPTOM,3050
62921,proliferation,I-SIGN_AND_SYMPTOM,3050
62922,of,I-SIGN_AND_SYMPTOM,3050
62923,corneal,I-SIGN_AND_SYMPTOM,3050
62924,endothelium,B-PART_OF_THE_EYES,3050
62925,and,I-SIGN_AND_SYMPTOM,3050
62926,progressive,I-SIGN_AND_SYMPTOM,3050
62927,obstruction,I-SIGN_AND_SYMPTOM,3050
62928,of,I-SIGN_AND_SYMPTOM,3050
62929,the,B-PART_OF_THE_EYES,3050
62930,irido-corneal,I-PART_OF_THE_EYES,3050
62931,angle,I-PART_OF_THE_EYES,3050
62932,which,O,3050
62933,in,O,3050
62934,turn,O,3051
62935,leads,O,3051
62936,to,O,3051
62937,structural,B-SIGN_AND_SYMPTOM,3051
62938,and,I-SIGN_AND_SYMPTOM,3051
62939,functional,I-SIGN_AND_SYMPTOM,3051
62940,iris,B-PART_OF_THE_EYES,3051
62941,abnormalities,I-SIGN_AND_SYMPTOM,3051
62942,and,O,3051
62943,ultimately,O,3051
62944,visual,B-SIGN_AND_SYMPTOM,3051
62945,function,I-SIGN_AND_SYMPTOM,3051
62946,loss,I-SIGN_AND_SYMPTOM,3051
62947,It,O,3051
62948,is,O,3051
62949,usually,O,3051
62950,unilateral,O,3052
62951,and,O,3052
62952,typically,O,3052
62953,affects,O,3052
62954,women,O,3052
62955,in,O,3052
62956,the,O,3052
62957,third,O,3052
62958,to,O,3052
62959,fifth,O,3052
62960,decade,O,3052
62961,of,O,3052
62962,their,O,3052
62963,lives,O,3052
62964,The,O,3052
62965,three,O,3052
62966,variants,O,3053
62967,of,O,3053
62968,ICE,B-NAME_OF_DISEASE,3053
62969,syndromes,I-NAME_OF_DISEASE,3053
62970,share,O,3053
62971,the,O,3053
62972,same,O,3053
62973,pathogenic,O,3053
62974,mechanism,O,3053
62975,which,O,3053
62976,is,O,3053
62977,characterised,O,3053
62978,by,O,3053
62979,the,B-SIGN_AND_SYMPTOM,3053
62980,normal,I-SIGN_AND_SYMPTOM,3053
62981,corneal,I-SIGN_AND_SYMPTOM,3053
62982,endothelial,I-SIGN_AND_SYMPTOM,3053
62983,cells,I-SIGN_AND_SYMPTOM,3053
62984,being,I-SIGN_AND_SYMPTOM,3054
62985,replaced,I-SIGN_AND_SYMPTOM,3054
62986,with,I-SIGN_AND_SYMPTOM,3054
62987,more,I-SIGN_AND_SYMPTOM,3054
62988,epithelial-like,I-SIGN_AND_SYMPTOM,3054
62989,cells,I-SIGN_AND_SYMPTOM,3054
62990,that,I-SIGN_AND_SYMPTOM,3054
62991,migrate,I-SIGN_AND_SYMPTOM,3054
62992,into,I-SIGN_AND_SYMPTOM,3054
62993,the,I-SIGN_AND_SYMPTOM,3054
62994,surrounding,I-SIGN_AND_SYMPTOM,3054
62995,tissues,I-SIGN_AND_SYMPTOM,3054
62996,This,O,3054
62997,leads,O,3054
62998,to,O,3054
62999,varying,O,3054
63000,degrees,O,3054
63001,dependent,O,3054
63002,on,O,3054
63003,the,O,3054
63004,causative,O,3054
63005,subtype,O,3054
63006,of,O,3054
63007,corneal,B-NAME_OF_DISEASE,3054
63008,oedema,I-NAME_OF_DISEASE,3054
63009,iris,B-PART_OF_THE_EYES,3054
63010,atrophy,I-NAME_OF_DISEASE,3054
63011,and,O,3054
63012,secondary,B-NAME_OF_DISEASE,3054
63013,angle-closure,I-NAME_OF_DISEASE,3054
63014,glaucoma,I-NAME_OF_DISEASE,3054
63015,The,O,3054
63016,altered,O,3054
63017,endothelium,B-PART_OF_THE_EYES,3054
63018,migrates,O,3054
63019,posteriorly,O,3054
63020,beyond,O,3054
63021,the,B-PART_OF_THE_EYES,3054
63022,Schwalbe,I-PART_OF_THE_EYES,3054
63023,line,I-PART_OF_THE_EYES,3055
63024,to,O,3055
63025,obstruct,O,3055
63026,the,B-PART_OF_THE_EYES,3055
63027,irido-corneal,I-PART_OF_THE_EYES,3055
63028,angle,I-PART_OF_THE_EYES,3055
63029,and,O,3055
63030,at,O,3055
63031,times,O,3055
63032,onto,O,3055
63033,the,B-PART_OF_THE_EYES,3055
63034,peripheral,I-PART_OF_THE_EYES,3055
63035,iris,B-PART_OF_THE_EYES,3055
63036,forming,O,3055
63037,an,O,3055
63038,abnormal,O,3055
63039,basement,O,3055
63040,membrane,O,3055
63041,Subsequent,O,3055
63042,contraction,O,3055
63043,of,O,3055
63044,the,O,3055
63045,new,O,3056
63046,tissue,O,3056
63047,can,O,3056
63048,induce,O,3056
63049,pupil,B-PART_OF_THE_EYES,3056
63050,shape,O,3056
63051,anomalies,O,3056
63052,and,O,3056
63053,iris,B-PART_OF_THE_EYES,3056
63054,atrophy,I-NAME_OF_DISEASE,3056
63055,The,O,3056
63056,combination,O,3056
63057,of,O,3056
63058,angle,O,3056
63059,obstruction,O,3056
63060,and,O,3056
63061,corneal,B-NAME_OF_DISEASE,3056
63062,oedema,I-NAME_OF_DISEASE,3056
63063,leads,O,3056
63064,to,O,3056
63065,a,O,3056
63066,raised,O,3056
63067,intraocular,O,3056
63068,pressure,O,3056
63069,IOP,O,3056
63070,giving,O,3056
63071,rise,O,3056
63072,to,O,3056
63073,secondary,B-NAME_OF_DISEASE,3057
63074,angle-closure,I-NAME_OF_DISEASE,3057
63075,glaucoma,I-NAME_OF_DISEASE,3057
63076,The,O,3057
63077,TRUE,O,3057
63078,aetiology,O,3057
63079,of,O,3057
63080,ICE,B-NAME_OF_DISEASE,3057
63081,syndrome,I-NAME_OF_DISEASE,3057
63082,still,O,3057
63083,remains,O,3057
63084,unknown,O,3057
63085,Literature,O,3057
63086,has,O,3057
63087,described,O,3057
63088,a,O,3057
63089,series,O,3057
63090,of,O,3057
63091,possible,O,3057
63092,triggers,O,3057
63093,however,O,3057
63094,its,O,3057
63095,exact,O,3057
63096,aetiology,O,3057
63097,or,O,3057
63098,aetiologies,O,3057
63099,have,O,3057
63100,been,O,3057
63101,an,O,3057
63102,ongoing,O,3058
63103,debate,O,3058
63104,for,O,3058
63105,over,O,3058
63106,a,O,3058
63107,century,O,3058
63108,A,O,3058
63109,common,O,3058
63110,aetiology,O,3058
63111,however,O,3058
63112,is,O,3058
63113,thought,O,3059
63114,to,O,3059
63115,be,O,3059
63116,due,O,3059
63117,to,O,3059
63118,underlying,B-CAUSE_OF_DISEASE,3059
63119,viral,I-CAUSE_OF_DISEASE,3059
63120,infections,I-CAUSE_OF_DISEASE,3059
63121,with,I-CAUSE_OF_DISEASE,3059
63122,herpes,I-CAUSE_OF_DISEASE,3059
63123,simplex,I-CAUSE_OF_DISEASE,3059
63124,virus,I-CAUSE_OF_DISEASE,3059
63125,HSV,I-CAUSE_OF_DISEASE,3059
63126,which,O,3059
63127,can,O,3059
63128,trigger,O,3060
63129,inflammation,B-SIGN_AND_SYMPTOM,3060
63130,of,I-SIGN_AND_SYMPTOM,3061
63131,the,I-SIGN_AND_SYMPTOM,3061
63132,corneal,I-SIGN_AND_SYMPTOM,3061
63133,endothelium,I-SIGN_AND_SYMPTOM,3061
63134,and,O,3061
63135,subsequent,O,3061
63136,pathogenesis,O,3061
63137,This,O,3061
63138,was,O,3061
63139,first,O,3061
63140,hypothesised,O,3061
63141,after,O,3061
63142,a,O,3061
63143,study,O,3061
63144,carried,O,3061
63145,out,O,3061
63146,in,O,3061
63147,1994,O,3061
63148,which,O,3061
63149,found,O,3061
63150,HSV-DNA,B-CHEMICAL_COMPOUND,3061
63151,in,O,3061
63152,more,O,3061
63153,than,O,3062
63154,60%,O,3062
63155,of,O,3062
63156,the,O,3062
63157,tested,O,3062
63158,samples,O,3062
63159,First,O,3062
63160,diagnosis,O,3062
63161,might,O,3062
63162,be,O,3062
63163,obtained,O,3062
63164,from,O,3062
63165,a,O,3062
63166,routine,O,3062
63167,ocular,O,3062
63168,examination,O,3063
63169,following,O,3063
63170,visualisation,B-DIAGNOSTIC_TEST,3063
63171,of,I-DIAGNOSTIC_TEST,3063
63172,an,I-DIAGNOSTIC_TEST,3063
63173,abnormal,I-DIAGNOSTIC_TEST,3063
63174,corneal,I-DIAGNOSTIC_TEST,3063
63175,endothelium,I-DIAGNOSTIC_TEST,3063
63176,or,O,3063
63177,via,O,3063
63178,gonioscopy,B-DIAGNOSTIC_TEST,3063
63179,when,I-DIAGNOSTIC_TEST,3063
63180,evaluating,I-DIAGNOSTIC_TEST,3063
63181,the,I-DIAGNOSTIC_TEST,3063
63182,anterior,I-DIAGNOSTIC_TEST,3063
63183,chamber,I-DIAGNOSTIC_TEST,3063
63184,angle,I-DIAGNOSTIC_TEST,3063
63185,for,O,3063
63186,those,O,3063
63187,suspected,O,3063
63188,with,O,3063
63189,glaucoma,B-NAME_OF_DISEASE,3063
63190,Otherwise,O,3063
63191,the,O,3063
63192,usual,O,3063
63193,index,O,3063
63194,presentation,O,3064
63195,that,O,3064
63196,patients,O,3064
63197,may,O,3064
63198,report,O,3064
63199,is,O,3064
63200,a,B-SIGN_AND_SYMPTOM,3064
63201,change,I-SIGN_AND_SYMPTOM,3064
63202,in,I-SIGN_AND_SYMPTOM,3064
63203,shape,I-SIGN_AND_SYMPTOM,3064
63204,or,I-SIGN_AND_SYMPTOM,3064
63205,position,I-SIGN_AND_SYMPTOM,3064
63206,of,I-SIGN_AND_SYMPTOM,3064
63207,the,I-SIGN_AND_SYMPTOM,3064
63208,pupil,I-SIGN_AND_SYMPTOM,3064
63209,Alternatively,O,3064
63210,presentations,O,3064
63211,may,O,3064
63212,also,O,3064
63213,vary,O,3064
63214,from,O,3065
63215,monocular,B-SIGN_AND_SYMPTOM,3065
63216,pain,I-SIGN_AND_SYMPTOM,3065
63217,blurry,I-SIGN_AND_SYMPTOM,3065
63218,vision,I-SIGN_AND_SYMPTOM,3065
63219,or,I-SIGN_AND_SYMPTOM,3065
63220,halos,I-SIGN_AND_SYMPTOM,3065
63221,around,I-SIGN_AND_SYMPTOM,3065
63222,lights,I-SIGN_AND_SYMPTOM,3065
63223,due,O,3065
63224,to,O,3065
63225,glaucoma,B-NAME_OF_DISEASE,3066
63226,With,O,3066
63227,symptoms,O,3066
63228,overlapping,O,3066
63229,across,O,3066
63230,all,O,3066
63231,three,O,3066
63232,variants,O,3066
63233,distinction,O,3066
63234,between,O,3066
63235,each,O,3066
63236,subtype,O,3067
63237,can,O,3067
63238,only,O,3067
63239,be,O,3067
63240,established,O,3067
63241,from,O,3067
63242,a,O,3067
63243,clinical,O,3067
63244,exam,O,3067
63245,and,O,3067
63246,a,O,3067
63247,full,O,3067
63248,ophthalmic,O,3067
63249,work-up,O,3067
63250,Subtypes,O,3067
63251,1,O,3067
63252,Chandler,B-NAME_OF_DISEASE,3067
63253,Syndrome,I-NAME_OF_DISEASE,3068
63254,This,O,3068
63255,is,O,3068
63256,the,O,3068
63257,most,O,3068
63258,common,O,3068
63259,subtype,O,3068
63260,accounting,O,3068
63261,for,O,3068
63262,around,O,3068
63263,50%,O,3068
63264,of,O,3068
63265,all,O,3068
63266,cases,O,3069
63267,of,O,3069
63268,ICE,B-NAME_OF_DISEASE,3069
63269,syndrome,I-NAME_OF_DISEASE,3069
63270,In,O,3069
63271,comparison,O,3069
63272,with,O,3069
63273,the,O,3069
63274,other,O,3069
63275,entities,O,3069
63276,this,O,3069
63277,subtype,O,3069
63278,usually,O,3069
63279,presents,O,3069
63280,with,O,3069
63281,a,O,3069
63282,greater,O,3070
63283,degree,O,3070
63284,of,O,3070
63285,corneal,B-SIGN_AND_SYMPTOM,3070
63286,pathology,I-SIGN_AND_SYMPTOM,3070
63287,and,I-SIGN_AND_SYMPTOM,3070
63288,oedema,I-SIGN_AND_SYMPTOM,3070
63289,Arriving,O,3070
63290,at,O,3070
63291,the,O,3070
63292,diagnosis,O,3070
63293,can,O,3070
63294,be,O,3070
63295,a,O,3070
63296,challenging,O,3070
63297,as,O,3070
63298,majority,O,3070
63299,of,O,3070
63300,the,O,3070
63301,patients,O,3070
63302,are,O,3070
63303,found,O,3070
63304,to,O,3071
63305,not,O,3071
63306,have,O,3071
63307,any,O,3071
63308,iris,B-PART_OF_THE_EYES,3071
63309,abnormalities,I-SIGN_AND_SYMPTOM,3071
63310,until,O,3071
63311,the,O,3071
63312,later,O,3071
63313,stages,O,3071
63314,of,O,3071
63315,the,O,3071
63316,disease,O,3071
63317,However,O,3071
63318,compared,O,3071
63319,with,O,3071
63320,the,O,3071
63321,other,O,3071
63322,subtypes,O,3071
63323,it,O,3071
63324,is,O,3071
63325,least,O,3072
63326,likely,O,3072
63327,of,O,3072
63328,the,O,3072
63329,three,O,3072
63330,to,O,3072
63331,have,O,3072
63332,IOP,O,3072
63333,rise,O,3072
63334,2,O,3072
63335,Progressive,B-NAME_OF_DISEASE,3072
63336,Iris,I-NAME_OF_DISEASE,3072
63337,Atrophy,I-NAME_OF_DISEASE,3072
63338,As,O,3072
63339,opposed,O,3072
63340,to,O,3072
63341,Chandler,B-NAME_OF_DISEASE,3072
63342,syndrome,I-NAME_OF_DISEASE,3072
63343,iris,B-PART_OF_THE_EYES,3072
63344,abnormalities,I-SIGN_AND_SYMPTOM,3073
63345,in,O,3073
63346,this,O,3073
63347,particular,O,3073
63348,variant,O,3073
63349,are,O,3073
63350,robust,O,3073
63351,and,O,3073
63352,progressive,O,3073
63353,over,O,3073
63354,time,O,3073
63355,Common,O,3074
63356,findings,O,3074
63357,include,O,3074
63358,polycoria,B-SIGN_AND_SYMPTOM,3074
63359,corectopia,I-SIGN_AND_SYMPTOM,3074
63360,iris,B-PART_OF_THE_EYES,3074
63361,hole,I-SIGN_AND_SYMPTOM,3074
63362,formation,I-SIGN_AND_SYMPTOM,3074
63363,ectropian,I-SIGN_AND_SYMPTOM,3074
63364,uveae,I-SIGN_AND_SYMPTOM,3074
63365,and,I-SIGN_AND_SYMPTOM,3074
63366,iris,B-PART_OF_THE_EYES,3074
63367,atrophy,I-SIGN_AND_SYMPTOM,3074
63368,3,O,3075
63369,Cogan-Reese,B-NAME_OF_DISEASE,3075
63370,Syndrome,I-NAME_OF_DISEASE,3075
63371,Associated,O,3075
63372,with,O,3075
63373,iris,B-PART_OF_THE_EYES,3075
63374,abnormalities,I-SIGN_AND_SYMPTOM,3075
63375,the,O,3075
63376,characteristic,O,3075
63377,finding,O,3075
63378,in,O,3076
63379,this,O,3076
63380,subtype,O,3076
63381,is,O,3076
63382,the,B-SIGN_AND_SYMPTOM,3076
63383,presence,I-SIGN_AND_SYMPTOM,3076
63384,of,I-SIGN_AND_SYMPTOM,3076
63385,multiple,I-SIGN_AND_SYMPTOM,3076
63386,iris,I-SIGN_AND_SYMPTOM,3076
63387,pedunculated,I-SIGN_AND_SYMPTOM,3076
63388,nodules,I-SIGN_AND_SYMPTOM,3076
63389,ICE,B-NAME_OF_DISEASE,3076
63390,syndrome,I-NAME_OF_DISEASE,3076
63391,should,O,3076
63392,be,O,3076
63393,considered,O,3076
63394,within,O,3076
63395,the,O,3076
63396,differential,O,3077
63397,diagnosis,O,3077
63398,for,O,3077
63399,any,O,3077
63400,young,O,3077
63401,to,O,3078
63402,middle-aged,O,3078
63403,especially,O,3078
63404,female,O,3078
63405,adult,O,3078
63406,presenting,O,3078
63407,with,O,3078
63408,unilateral,B-SIGN_AND_SYMPTOM,3078
63409,glaucoma,I-SIGN_AND_SYMPTOM,3078
63410,corneal,I-SIGN_AND_SYMPTOM,3079
63411,oedema,I-SIGN_AND_SYMPTOM,3079
63412,and,I-SIGN_AND_SYMPTOM,3079
63413,or,I-SIGN_AND_SYMPTOM,3079
63414,iris,I-SIGN_AND_SYMPTOM,3079
63415,anomalies,I-SIGN_AND_SYMPTOM,3079
63416,The,O,3079
63417,key,O,3079
63418,difference,O,3079
63419,between,O,3079
63420,each,O,3079
63421,subtype,O,3080
63422,that,O,3080
63423,allow,O,3080
63424,for,O,3080
63425,distinction,O,3080
63426,is,O,3080
63427,the,O,3080
63428,type,O,3080
63429,severity,O,3080
63430,of,O,3080
63431,iris,B-PART_OF_THE_EYES,3080
63432,abnormality,O,3080
63433,A,O,3080
63434,full,O,3080
63435,ophthalmic,O,3080
63436,work-up,O,3080
63437,is,O,3081
63438,essential,O,3081
63439,in,O,3081
63440,particular,O,3081
63441,assessment,O,3081
63442,of,O,3081
63443,visual,O,3081
63444,acuity,O,3081
63445,and,O,3081
63446,IOP,O,3081
63447,Evaluation,O,3081
63448,of,O,3081
63449,the,B-PART_OF_THE_EYES,3081
63450,anterior,I-PART_OF_THE_EYES,3081
63451,chamber,I-PART_OF_THE_EYES,3081
63452,angle,I-PART_OF_THE_EYES,3081
63453,for,O,3081
63454,high,B-SIGN_AND_SYMPTOM,3081
63455,peripheral,I-SIGN_AND_SYMPTOM,3082
63456,anterior,I-SIGN_AND_SYMPTOM,3082
63457,synechia,I-SIGN_AND_SYMPTOM,3082
63458,PAS,I-SIGN_AND_SYMPTOM,3082
63459,with,O,3082
63460,gonioscopy,B-DIAGNOSTIC_TEST,3083
63461,is,O,3083
63462,also,O,3083
63463,an,O,3083
63464,important,O,3083
63465,aspect,O,3083
63466,of,O,3083
63467,the,O,3083
63468,work-up,O,3083
63469,because,O,3083
63470,as,O,3083
63471,many,O,3083
63472,as,O,3083
63473,82%,O,3083
63474,of,O,3083
63475,patients,O,3084
63476,with,O,3084
63477,ICE,B-NAME_OF_DISEASE,3084
63478,syndrome,I-NAME_OF_DISEASE,3084
63479,can,O,3084
63480,have,O,3084
63481,glaucoma,B-NAME_OF_DISEASE,3084
63482,as,O,3084
63483,a,O,3084
63484,complication,O,3084
63485,Comparatively,O,3084
63486,in,O,3084
63487,the,O,3084
63488,presence,O,3084
63489,of,O,3084
63490,corneal,B-SIGN_AND_SYMPTOM,3084
63491,oedema,I-SIGN_AND_SYMPTOM,3084
63492,changes,O,3084
63493,of,O,3084
63494,the,B-PART_OF_THE_EYES,3084
63495,anterior,I-PART_OF_THE_EYES,3085
63496,chamber,I-PART_OF_THE_EYES,3085
63497,angle,I-PART_OF_THE_EYES,3085
63498,structure,O,3085
63499,might,O,3085
63500,be,O,3085
63501,better,O,3085
63502,detected,O,3085
63503,through,O,3085
63504,the,O,3085
63505,use,O,3085
63506,of,O,3085
63507,ultrasound,B-DIAGNOSTIC_TEST,3085
63508,biomicroscopy,I-DIAGNOSTIC_TEST,3085
63509,UBM,I-DIAGNOSTIC_TEST,3085
63510,as,O,3085
63511,it,O,3085
63512,does,O,3085
63513,not,O,3085
63514,allow,O,3085
63515,visualisation,O,3085
63516,with,O,3085
63517,gonioscopy,B-DIAGNOSTIC_TEST,3085
63518,A,B-DIAGNOSTIC_TEST,3085
63519,slit-lamp,I-DIAGNOSTIC_TEST,3085
63520,examination,I-DIAGNOSTIC_TEST,3085
63521,is,O,3085
63522,also,O,3085
63523,a,O,3086
63524,vital,O,3086
63525,part,O,3086
63526,of,O,3086
63527,the,O,3086
63528,work-up,O,3086
63529,as,O,3086
63530,it,O,3086
63531,allows,O,3086
63532,identification,O,3087
63533,of,O,3087
63534,any,O,3087
63535,corneal,B-SIGN_AND_SYMPTOM,3087
63536,and,I-SIGN_AND_SYMPTOM,3087
63537,iris,I-SIGN_AND_SYMPTOM,3087
63538,abnormalities,I-SIGN_AND_SYMPTOM,3087
63539,Corneal,B-SIGN_AND_SYMPTOM,3087
63540,endothelial,I-SIGN_AND_SYMPTOM,3087
63541,irregularity,I-SIGN_AND_SYMPTOM,3087
63542,on,O,3087
63543,a,B-DIAGNOSTIC_TEST,3087
63544,slit,I-DIAGNOSTIC_TEST,3088
63545,lamp,I-DIAGNOSTIC_TEST,3088
63546,examination,I-DIAGNOSTIC_TEST,3088
63547,will,O,3088
63548,give,O,3088
63549,a,O,3088
63550,beaten,O,3089
63551,bronze,O,3089
63552,or,O,3089
63553,hammered,O,3089
63554,silver,O,3089
63555,appearance,O,3089
63556,Although,O,3089
63557,predominantly,O,3089
63558,a,O,3089
63559,unilateral,O,3089
63560,disease,O,3089
63561,bilateral,B-NAME_OF_DISEASE,3089
63562,cases,I-NAME_OF_DISEASE,3089
63563,of,I-NAME_OF_DISEASE,3089
63564,ICE,B-NAME_OF_DISEASE,3089
63565,syndrome,I-NAME_OF_DISEASE,3090
63566,have,O,3090
63567,been,O,3090
63568,reported,O,3090
63569,It,O,3090
63570,is,O,3090
63571,therefore,O,3090
63572,imperative,O,3090
63573,the,O,3090
63574,contralateral,O,3090
63575,unaffected,O,3090
63576,eye,O,3090
63577,is,O,3090
63578,given,O,3090
63579,the,O,3090
63580,same,O,3090
63581,level,O,3090
63582,of,O,3090
63583,attention,O,3091
63584,and,O,3091
63585,work-up,O,3091
63586,as,O,3091
63587,the,O,3091
63588,affected,O,3091
63589,eye,O,3091
63590,Lastly,O,3091
63591,a,O,3091
63592,useful,O,3091
63593,diagnostic,O,3091
63594,tool,O,3091
63595,used,O,3091
63596,for,O,3091
63597,confirmation,O,3091
63598,is,O,3091
63599,specular,B-DIAGNOSTIC_TEST,3091
63600,microscopy,I-DIAGNOSTIC_TEST,3091
63601,A,O,3091
63602,notable,O,3091
63603,feature,O,3091
63604,present,O,3091
63605,on,O,3091
63606,a,O,3091
63607,cellular,O,3091
63608,level,O,3091
63609,is,O,3091
63610,the,O,3092
63611,atypical,O,3092
63612,endothelial,O,3092
63613,cell,O,3092
63614,morphology,O,3092
63615,On,O,3092
63616,specular,B-DIAGNOSTIC_TEST,3092
63617,photomicrograph,I-DIAGNOSTIC_TEST,3092
63618,this,O,3092
63619,appears,O,3092
63620,as,O,3092
63621,large,O,3092
63622,dark,O,3092
63623,cells,O,3092
63624,with,O,3092
63625,light,O,3092
63626,peripheral,O,3092
63627,borders,O,3092
63628,and,O,3092
63629,central,O,3093
63630,highlights,O,3093
63631,As,O,3093
63632,it,O,3093
63633,s,O,3093
63634,specific,O,3093
63635,to,O,3093
63636,ICE,B-NAME_OF_DISEASE,3093
63637,syndrome,I-NAME_OF_DISEASE,3093
63638,it,O,3093
63639,has,O,3093
63640,been,O,3093
63641,referred,O,3093
63642,to,O,3094
63643,as,O,3094
63644,ICE,B-NAME_OF_DISEASE,3094
63645,cells,O,3094
63646,,O,3094
63647,The,O,3094
63648,main,O,3094
63649,differential,O,3094
63650,of,O,3094
63651,ICE,B-NAME_OF_DISEASE,3094
63652,syndrome,I-NAME_OF_DISEASE,3095
63653,that,O,3095
63654,must,O,3095
63655,be,O,3095
63656,ruled,O,3095
63657,out,O,3095
63658,is,O,3095
63659,posterior,B-NAME_OF_DISEASE,3095
63660,polymorphous,I-NAME_OF_DISEASE,3095
63661,corneal,I-NAME_OF_DISEASE,3096
63662,dystrophy,I-NAME_OF_DISEASE,3096
63663,PPMD,B-NAME_OF_DISEASE,3096
63664,,O,3096
63665,PPMD,B-NAME_OF_DISEASE,3096
63666,is,O,3096
63667,an,O,3096
63668,autosomal,O,3096
63669,dominant,O,3096
63670,disease,O,3096
63671,that,O,3096
63672,is,O,3096
63673,not,O,3096
63674,only,O,3096
63675,similar,O,3096
63676,on,O,3096
63677,a,O,3096
63678,microscopic,O,3096
63679,level,O,3096
63680,multi-layered,O,3096
63681,endothelial,O,3096
63682,cells,O,3096
63683,that,O,3096
63684,look,O,3096
63685,and,O,3096
63686,behave,O,3096
63687,like,O,3096
63688,epithelial,O,3096
63689,cells,O,3096
63690,but,O,3096
63691,also,O,3096
63692,share,O,3096
63693,similar,O,3096
63694,manifestations,O,3096
63695,such,O,3096
63696,as,O,3096
63697,corneal,B-SIGN_AND_SYMPTOM,3097
63698,oedema,I-SIGN_AND_SYMPTOM,3097
63699,irido-corneal,I-SIGN_AND_SYMPTOM,3097
63700,adhesion,I-SIGN_AND_SYMPTOM,3097
63701,and,I-SIGN_AND_SYMPTOM,3097
63702,raise,I-SIGN_AND_SYMPTOM,3097
63703,IOP,I-SIGN_AND_SYMPTOM,3097
63704,Factors,O,3097
63705,that,O,3098
63706,allow,O,3098
63707,for,O,3098
63708,differentiation,O,3098
63709,are,O,3098
63710,the,O,3098
63711,fact,O,3098
63712,that,O,3098
63713,PPMD,B-NAME_OF_DISEASE,3098
63714,is,O,3098
63715,inherited,O,3098
63716,and,O,3098
63717,bilateral,O,3098
63718,and,O,3098
63719,specular,B-DIAGNOSTIC_TEST,3098
63720,microscopy,I-DIAGNOSTIC_TEST,3098
63721,shows,O,3098
63722,typical,B-SIGN_AND_SYMPTOM,3098
63723,vesicles,I-SIGN_AND_SYMPTOM,3098
63724,and,I-SIGN_AND_SYMPTOM,3098
63725,bands,I-SIGN_AND_SYMPTOM,3098
63726,Although,O,3098
63727,there,O,3098
63728,are,O,3098
63729,objective,O,3098
63730,differences,O,3098
63731,between,O,3098
63732,each,O,3098
63733,subtype,O,3098
63734,the,O,3098
63735,diagnosis,O,3098
63736,can,O,3098
63737,still,O,3098
63738,pose,O,3098
63739,a,O,3098
63740,challenge,O,3098
63741,in,O,3098
63742,clinical,O,3098
63743,practice,O,3098
63744,as,O,3099
63745,a,O,3099
63746,large,O,3099
63747,percentage,O,3099
63748,of,O,3099
63749,cases,O,3099
63750,appear,O,3099
63751,in,O,3099
63752,mixed,O,3099
63753,forms,O,3099
63754,Irrespective,O,3099
63755,of,O,3099
63756,the,O,3099
63757,causative,O,3099
63758,subtype,O,3099
63759,the,O,3099
63760,mainstay,O,3099
63761,of,O,3099
63762,treatment,O,3099
63763,revolves,O,3099
63764,around,O,3099
63765,the,O,3099
63766,prevention,O,3099
63767,and,O,3099
63768,management,O,3100
63769,of,O,3100
63770,the,O,3100
63771,visual,O,3100
63772,impairing,O,3100
63773,complications,O,3100
63774,of,O,3100
63775,ICE,B-NAME_OF_DISEASE,3100
63776,syndrome,I-NAME_OF_DISEASE,3100
63777,such,O,3101
63778,as,O,3101
63779,corneal,B-SIGN_AND_SYMPTOM,3101
63780,oedema,I-SIGN_AND_SYMPTOM,3101
63781,or,O,3101
63782,glaucoma,B-NAME_OF_DISEASE,3101
63783,This,O,3101
63784,can,O,3101
63785,be,O,3101
63786,achieved,O,3101
63787,with,O,3102
63788,both,O,3102
63789,medical,O,3102
63790,and,O,3102
63791,surgical,O,3102
63792,treatment,O,3102
63793,options,O,3102
63794,Raised,B-SIGN_AND_SYMPTOM,3102
63795,IOP,I-SIGN_AND_SYMPTOM,3102
63796,and,I-SIGN_AND_SYMPTOM,3102
63797,corneal,B-SIGN_AND_SYMPTOM,3102
63798,oedema,I-SIGN_AND_SYMPTOM,3102
63799,can,O,3102
63800,be,O,3102
63801,addressed,O,3102
63802,with,O,3102
63803,topical,O,3102
63804,medications,O,3102
63805,and,O,3102
63806,aqueous,B-NAME_OF_DRUG,3103
63807,suppressants,I-NAME_OF_DRUG,3103
63808,e.g,O,3103
63809,prostaglandin,B-NAME_OF_DRUG,3103
63810,analogues,I-NAME_OF_DRUG,3103
63811,In,O,3103
63812,addition,O,3103
63813,topical,B-CHEMICAL_COMPOUND,3103
63814,hypertonic,I-CHEMICAL_COMPOUND,3103
63815,saline,I-CHEMICAL_COMPOUND,3103
63816,solutions,O,3104
63817,can,O,3104
63818,be,O,3104
63819,used,O,3104
63820,to,O,3104
63821,help,O,3104
63822,ameliorate,O,3104
63823,symptoms,O,3104
63824,of,O,3104
63825,corneal,B-SIGN_AND_SYMPTOM,3104
63826,oedema,I-SIGN_AND_SYMPTOM,3104
63827,as,O,3104
63828,it,O,3104
63829,works,O,3104
63830,by,O,3104
63831,dehydrating,O,3104
63832,the,B-PART_OF_THE_EYES,3104
63833,cornea,I-PART_OF_THE_EYES,3104
63834,If,O,3104
63835,medical,O,3104
63836,management,O,3104
63837,is,O,3104
63838,unsuccessful,O,3104
63839,in,O,3104
63840,controlling,O,3104
63841,the,B-SIGN_AND_SYMPTOM,3104
63842,raised,B-SIGN_AND_SYMPTOM,3104
63843,IOP,I-SIGN_AND_SYMPTOM,3105
63844,surgical,O,3105
63845,options,O,3105
63846,must,O,3105
63847,be,O,3105
63848,sought,O,3105
63849,Procedures,O,3105
63850,such,O,3105
63851,as,O,3105
63852,trabeculectomy,B-TREATMENT,3105
63853,with,I-TREATMENT,3105
63854,anti-fibrotic,I-TREATMENT,3105
63855,agents,I-TREATMENT,3105
63856,and,O,3105
63857,use,O,3105
63858,of,O,3105
63859,aqueous,B-TREATMENT,3105
63860,shunts,I-TREATMENT,3106
63861,have,O,3106
63862,been,O,3106
63863,found,O,3106
63864,to,O,3106
63865,be,O,3106
63866,effective,O,3106
63867,in,O,3106
63868,controlling,O,3106
63869,raised,B-SIGN_AND_SYMPTOM,3106
63870,IOP,I-SIGN_AND_SYMPTOM,3106
63871,in,O,3106
63872,ICE,B-NAME_OF_DISEASE,3106
63873,syndrome,I-NAME_OF_DISEASE,3106
63874,patients,O,3106
63875,However,O,3106
63876,the,O,3107
63877,long-term,O,3107
63878,effectiveness,O,3107
63879,of,O,3107
63880,these,O,3107
63881,procedures,O,3107
63882,is,O,3107
63883,questionable,O,3107
63884,with,O,3107
63885,the,O,3107
63886,five-year,B-TIME_DURATION,3107
63887,survival,O,3107
63888,rate,O,3107
63889,reported,O,3107
63890,as,O,3107
63891,low,O,3107
63892,as,O,3107
63893,29%,O,3108
63894,vs,O,3108
63895,53%,O,3108
63896,for,O,3108
63897,trabeculectomy,B-TREATMENT,3108
63898,with,I-TREATMENT,3108
63899,anti-fibrotic,I-TREATMENT,3108
63900,agents,I-TREATMENT,3108
63901,and,O,3108
63902,aqueous,B-TREATMENT,3108
63903,shunts,I-TREATMENT,3108
63904,patients,O,3108
63905,respectively,O,3108
63906,Similarly,O,3108
63907,keratoplasty,B-TREATMENT,3108
63908,can,O,3108
63909,be,O,3108
63910,used,O,3109
63911,for,O,3109
63912,the,O,3109
63913,treatment,O,3109
63914,of,O,3109
63915,corneal,B-NAME_OF_DISEASE,3109
63916,decompensation,I-NAME_OF_DISEASE,3109
63917,The,O,3109
63918,prognosis,O,3109
63919,of,O,3109
63920,patients,O,3109
63921,with,O,3109
63922,ICE,B-NAME_OF_DISEASE,3109
63923,syndrome,I-NAME_OF_DISEASE,3109
63924,depends,O,3109
63925,on,O,3109
63926,the,O,3109
63927,timing,O,3110
63928,of,O,3110
63929,diagnosis,O,3110
63930,and,O,3110
63931,effectiveness,O,3110
63932,of,O,3110
63933,treatment,O,3110
63934,Where,O,3110
63935,surgical,O,3110
63936,intervention,O,3110
63937,has,O,3110
63938,been,O,3110
63939,sought,O,3110
63940,the,O,3110
63941,prognosis,O,3110
63942,tends,O,3110
63943,to,O,3110
63944,be,O,3110
63945,more,O,3110
63946,guarded,O,3110
63947,In,O,3110
63948,conclusion,O,3110
63949,ICE,B-NAME_OF_DISEASE,3110
63950,syndrome,I-NAME_OF_DISEASE,3110
63951,consists,O,3110
63952,of,O,3110
63953,three,O,3111
63954,entities,O,3111
63955,Chandler,B-NAME_OF_DISEASE,3111
63956,syndrome,I-NAME_OF_DISEASE,3111
63957,progressive,O,3111
63958,iris,B-NAME_OF_DISEASE,3111
63959,atrophy,I-NAME_OF_DISEASE,3111
63960,and,O,3111
63961,Cogan-Reese,B-NAME_OF_DISEASE,3111
63962,syndrome,I-NAME_OF_DISEASE,3111
63963,A,O,3111
63964,clinical,O,3111
63965,history,O,3111
63966,and,O,3111
63967,a,O,3111
63968,full,O,3111
63969,ophthalmic,O,3111
63970,exam,O,3111
63971,including,O,3111
63972,assessment,O,3111
63973,of,O,3111
63974,visual,O,3111
63975,acuity,O,3112
63976,and,O,3112
63977,IOP,O,3112
63978,are,O,3112
63979,essential,O,3112
63980,to,O,3112
63981,reach,O,3112
63982,a,O,3112
63983,working,O,3112
63984,diagnosis,O,3112
63985,If,O,3112
63986,suspected,O,3112
63987,specular,B-DIAGNOSTIC_TEST,3112
63988,microscopy,I-DIAGNOSTIC_TEST,3112
63989,and,O,3112
63990,gonioscopy,B-DIAGNOSTIC_TEST,3112
63991,must,O,3112
63992,be,O,3112
63993,performed,O,3112
63994,to,O,3112
63995,confirm,O,3113
63996,the,O,3113
63997,presence,O,3113
63998,of,O,3113
63999,ICE,B-NAME_OF_DISEASE,3113
64000,cells,O,3113
64001,and,O,3113
64002,PAS,B-SIGN_AND_SYMPTOM,3113
64003,for,O,3113
64004,definite,O,3113
64005,diagnosis,O,3113
64006,Treatment,O,3113
64007,regardless,O,3113
64008,of,O,3114
64009,subtype,O,3114
64010,is,O,3114
64011,prevention,O,3114
64012,and,O,3114
64013,management,O,3114
64014,of,O,3114
64015,visual,O,3114
64016,impairing,O,3114
64017,complications,O,3114
64018,such,O,3114
64019,as,O,3114
64020,secondary,B-NAME_OF_DISEASE,3114
64021,glaucoma,I-NAME_OF_DISEASE,3114
64022,and,O,3115
64023,corneal,B-SIGN_AND_SYMPTOM,3115
64024,oedema,I-SIGN_AND_SYMPTOM,3115
64025,Surgical,O,3115
64026,interventions,O,3115
64027,have,O,3115
64028,variable,O,3115
64029,success,O,3115
64030,rates,O,3115
64031,thus,O,3115
64032,early,O,3115
64033,diagnosis,O,3115
64034,is,O,3115
64035,beneficial,O,3115
64036,Dry,B-NAME_OF_DISEASE,3115
64037,eye,I-NAME_OF_DISEASE,3115
64038,disease,I-NAME_OF_DISEASE,3115
64039,is,O,3115
64040,more,O,3115
64041,common,O,3115
64042,in,O,3116
64043,people,O,3116
64044,over,O,3116
64045,the,O,3116
64046,age,O,3116
64047,of,O,3116
64048,50,O,3116
64049,Hormonal,B-CAUSE_OF_DISEASE,3116
64050,changes,I-CAUSE_OF_DISEASE,3116
64051,especially,O,3116
64052,common,O,3116
64053,in,O,3116
64054,women,O,3116
64055,can,O,3116
64056,cause,O,3116
64057,dry,B-NAME_OF_DISEASE,3116
64058,eye,I-NAME_OF_DISEASE,3116
64059,Other,O,3116
64060,medical,O,3116
64061,conditions,O,3116
64062,including,O,3117
64063,diabetes,B-CAUSE_OF_DISEASE,3117
64064,glaucoma,B-CAUSE_OF_DISEASE,3117
64065,Sjogren,B-CAUSE_OF_DISEASE,3117
64066,s,I-CAUSE_OF_DISEASE,3117
64067,syndrome,I-CAUSE_OF_DISEASE,3117
64068,lupus,B-CAUSE_OF_DISEASE,3117
64069,and,O,3117
64070,rheumatoid,B-CAUSE_OF_DISEASE,3117
64071,arthritis,I-CAUSE_OF_DISEASE,3117
64072,can,O,3117
64073,exacerbate,O,3117
64074,dry,B-NAME_OF_DISEASE,3117
64075,eye,I-NAME_OF_DISEASE,3117
64076,symptoms,O,3117
64077,Some,O,3117
64078,medications,O,3117
64079,including,O,3117
64080,antihistamines,O,3117
64081,e.g,O,3117
64082,Claritin,O,3117
64083,Benadryl,O,3118
64084,Zyrtec,O,3118
64085,or,O,3118
64086,Allegra,O,3118
64087,hormonal,O,3118
64088,replacement,O,3118
64089,therapy,O,3118
64090,e.g,O,3118
64091,Estrogen,O,3118
64092,and,O,3118
64093,Progestin,O,3118
64094,and,O,3119
64095,androgen,O,3119
64096,therapy,O,3119
64097,contribute,O,3119
64098,to,O,3119
64099,dry,B-NAME_OF_DISEASE,3119
64100,eye,I-NAME_OF_DISEASE,3120
64101,symptoms,O,3120
64102,Keratoconus,B-NAME_OF_DISEASE,3120
64103,KC,I-NAME_OF_DISEASE,3120
64104,is,O,3120
64105,a,O,3120
64106,disorder,O,3120
64107,of,O,3120
64108,the,O,3120
64109,eye,O,3120
64110,that,O,3120
64111,results,O,3120
64112,in,O,3120
64113,progressive,O,3120
64114,thinning,O,3120
64115,of,O,3120
64116,the,B-PART_OF_THE_EYES,3120
64117,cornea,I-PART_OF_THE_EYES,3120
64118,This,O,3120
64119,may,O,3120
64120,result,O,3121
64121,in,O,3121
64122,blurry,B-SIGN_AND_SYMPTOM,3121
64123,vision,I-SIGN_AND_SYMPTOM,3121
64124,double,I-SIGN_AND_SYMPTOM,3121
64125,vision,I-SIGN_AND_SYMPTOM,3121
64126,nearsightedness,I-SIGN_AND_SYMPTOM,3121
64127,irregular,I-SIGN_AND_SYMPTOM,3121
64128,astigmatism,I-SIGN_AND_SYMPTOM,3121
64129,and,I-SIGN_AND_SYMPTOM,3121
64130,light,I-SIGN_AND_SYMPTOM,3122
64131,sensitivity,I-SIGN_AND_SYMPTOM,3122
64132,leading,I-SIGN_AND_SYMPTOM,3122
64133,to,I-SIGN_AND_SYMPTOM,3122
64134,poor,I-SIGN_AND_SYMPTOM,3122
64135,quality-of-life,I-SIGN_AND_SYMPTOM,3122
64136,Usually,O,3122
64137,both,O,3122
64138,eyes,O,3123
64139,are,O,3123
64140,affected,O,3123
64141,In,O,3123
64142,more,O,3123
64143,severe,O,3123
64144,cases,O,3123
64145,a,B-SIGN_AND_SYMPTOM,3123
64146,scarring,I-SIGN_AND_SYMPTOM,3123
64147,or,I-SIGN_AND_SYMPTOM,3123
64148,a,I-SIGN_AND_SYMPTOM,3123
64149,circle,I-SIGN_AND_SYMPTOM,3123
64150,may,I-SIGN_AND_SYMPTOM,3123
64151,be,I-SIGN_AND_SYMPTOM,3123
64152,seen,I-SIGN_AND_SYMPTOM,3124
64153,within,I-SIGN_AND_SYMPTOM,3124
64154,the,I-SIGN_AND_SYMPTOM,3124
64155,cornea,I-SIGN_AND_SYMPTOM,3124
64156,While,O,3124
64157,the,O,3124
64158,cause,O,3124
64159,is,O,3124
64160,unknown,O,3124
64161,it,O,3125
64162,is,O,3125
64163,believed,O,3125
64164,to,O,3125
64165,occur,O,3125
64166,due,O,3125
64167,to,O,3125
64168,a,B-CAUSE_OF_DISEASE,3125
64169,combination,I-CAUSE_OF_DISEASE,3125
64170,of,I-CAUSE_OF_DISEASE,3125
64171,genetic,I-CAUSE_OF_DISEASE,3125
64172,environmental,I-CAUSE_OF_DISEASE,3125
64173,and,I-CAUSE_OF_DISEASE,3125
64174,hormonal,I-CAUSE_OF_DISEASE,3125
64175,factors,I-CAUSE_OF_DISEASE,3125
64176,Patients,O,3125
64177,with,O,3126
64178,a,O,3126
64179,parent,O,3126
64180,sibling,O,3126
64181,or,O,3126
64182,child,O,3126
64183,who,O,3127
64184,has,O,3127
64185,keratoconus,B-NAME_OF_DISEASE,3127
64186,have,O,3127
64187,15,O,3127
64188,to,O,3127
64189,67,O,3127
64190,times,O,3127
64191,higher,O,3127
64192,risk,O,3127
64193,in,O,3127
64194,developing,O,3127
64195,corneal,O,3127
64196,ectasia,O,3127
64197,compared,O,3127
64198,to,O,3128
64199,patients,O,3128
64200,with,O,3128
64201,no,O,3128
64202,affected,O,3128
64203,relatives,O,3128
64204,Proposed,B-CAUSE_OF_DISEASE,3128
64205,environmental,I-CAUSE_OF_DISEASE,3128
64206,factors,I-CAUSE_OF_DISEASE,3128
64207,include,I-CAUSE_OF_DISEASE,3128
64208,rubbing,I-CAUSE_OF_DISEASE,3128
64209,the,I-CAUSE_OF_DISEASE,3128
64210,eyes,I-CAUSE_OF_DISEASE,3128
64211,and,I-CAUSE_OF_DISEASE,3128
64212,allergies,I-CAUSE_OF_DISEASE,3128
64213,The,O,3128
64214,underlying,O,3128
64215,mechanism,O,3128
64216,involves,O,3128
64217,changes,B-SIGN_AND_SYMPTOM,3129
64218,of,I-SIGN_AND_SYMPTOM,3129
64219,the,I-SIGN_AND_SYMPTOM,3129
64220,cornea,I-SIGN_AND_SYMPTOM,3129
64221,to,I-SIGN_AND_SYMPTOM,3129
64222,a,I-SIGN_AND_SYMPTOM,3129
64223,cone,I-SIGN_AND_SYMPTOM,3129
64224,shape,I-SIGN_AND_SYMPTOM,3129
64225,Diagnosis,O,3129
64226,is,O,3129
64227,most,O,3129
64228,often,O,3129
64229,by,O,3129
64230,topography,B-DIAGNOSTIC_TEST,3129
64231,Topography,B-DIAGNOSTIC_TEST,3129
64232,measures,O,3129
64233,the,O,3130
64234,curvature,O,3130
64235,of,O,3130
64236,the,B-PART_OF_THE_EYES,3130
64237,cornea,I-PART_OF_THE_EYES,3130
64238,and,O,3130
64239,creates,O,3130
64240,a,O,3130
64241,colored,O,3130
64242,map,O,3130
64243,of,O,3130
64244,the,B-PART_OF_THE_EYES,3130
64245,cornea,I-PART_OF_THE_EYES,3130
64246,Keratoconus,B-NAME_OF_DISEASE,3130
64247,causes,O,3130
64248,very,O,3130
64249,distinctive,O,3131
64250,changes,O,3131
64251,in,O,3131
64252,the,O,3131
64253,appearance,O,3131
64254,of,O,3131
64255,these,O,3131
64256,maps,O,3131
64257,which,O,3131
64258,allows,O,3131
64259,doctors,O,3131
64260,to,O,3131
64261,make,O,3131
64262,the,O,3132
64263,diagnosis,O,3132
64264,Keratoconus,B-NAME_OF_DISEASE,3132
64265,is,O,3132
64266,described,O,3132
64267,as,O,3132
64268,a,O,3132
64269,bilateral,O,3132
64270,but,O,3132
64271,asymmetric,O,3132
64272,noninflammatory,O,3132
64273,progressive,O,3132
64274,degeneration,O,3132
64275,of,O,3132
64276,the,B-PART_OF_THE_EYES,3132
64277,cornea,I-PART_OF_THE_EYES,3132
64278,leading,O,3132
64279,to,O,3132
64280,extreme,B-SIGN_AND_SYMPTOM,3132
64281,refractive,I-SIGN_AND_SYMPTOM,3132
64282,errors,I-SIGN_AND_SYMPTOM,3133
64283,with,I-SIGN_AND_SYMPTOM,3133
64284,impaired,I-SIGN_AND_SYMPTOM,3133
64285,visual,I-SIGN_AND_SYMPTOM,3133
64286,acuity,I-SIGN_AND_SYMPTOM,3133
64287,and,I-SIGN_AND_SYMPTOM,3133
64288,conical,I-SIGN_AND_SYMPTOM,3133
64289,corneal,I-SIGN_AND_SYMPTOM,3133
64290,protrusion,I-SIGN_AND_SYMPTOM,3133
64291,As,O,3133
64292,diagnostic,O,3133
64293,approaches,O,3133
64294,developed,O,3133
64295,the,O,3133
64296,prevalence,O,3133
64297,of,O,3133
64298,the,O,3133
64299,disease,O,3133
64300,has,O,3133
64301,increased,O,3133
64302,from,O,3133
64303,1,O,3134
64304,in,O,3134
64305,2000,O,3134
64306,to,O,3134
64307,1,O,3134
64308,in,O,3134
64309,84,O,3134
64310,Modern,O,3134
64311,diagnostic,O,3134
64312,techniques,O,3134
64313,include,O,3134
64314,Scheimpflug,B-DIAGNOSTIC_TEST,3134
64315,imaging,I-DIAGNOSTIC_TEST,3134
64316,corneal,B-DIAGNOSTIC_TEST,3134
64317,wavefront,I-DIAGNOSTIC_TEST,3134
64318,pachymetry,B-DIAGNOSTIC_TEST,3134
64319,analysis,I-DIAGNOSTIC_TEST,3134
64320,and,O,3134
64321,epithelial,B-DIAGNOSTIC_TEST,3134
64322,mapping,I-DIAGNOSTIC_TEST,3134
64323,As,O,3134
64324,diagnostic,O,3134
64325,technology,O,3134
64326,improves,O,3134
64327,management,O,3135
64328,strategies,O,3135
64329,are,O,3135
64330,evolving,O,3135
64331,as,O,3135
64332,well,O,3135
64333,Keratoconus,B-NAME_OF_DISEASE,3135
64334,has,O,3135
64335,historically,O,3135
64336,been,O,3135
64337,described,O,3135
64338,as,O,3135
64339,a,O,3135
64340,noninflammatory,O,3135
64341,degeneration,O,3135
64342,While,O,3135
64343,historically,O,3135
64344,management,O,3135
64345,was,O,3135
64346,limited,O,3135
64347,to,O,3135
64348,gas,B-TREATMENT,3135
64349,permeable,I-TREATMENT,3135
64350,contact,I-TREATMENT,3135
64351,lenses,I-TREATMENT,3135
64352,or,O,3135
64353,penetrating,B-TREATMENT,3135
64354,keratoplasty,I-TREATMENT,3135
64355,in,O,3135
64356,severe,O,3136
64357,cases,O,3136
64358,new,O,3136
64359,treatments,O,3136
64360,include,O,3136
64361,early,B-TREATMENT,3136
64362,corneal,I-TREATMENT,3136
64363,collagen,I-TREATMENT,3136
64364,cross-linking,I-TREATMENT,3136
64365,CXL,I-TREATMENT,3136
64366,scleral,B-TREATMENT,3136
64367,contact,I-TREATMENT,3136
64368,lenses,I-TREATMENT,3136
64369,Bowman,B-TREATMENT,3136
64370,s,I-TREATMENT,3136
64371,membrane,I-TREATMENT,3137
64372,transplants,I-TREATMENT,3137
64373,and,O,3137
64374,topography-guided,O,3137
64375,photokeratoplasty,O,3137
64376,with,O,3137
64377,CXL,O,3137
64378,Medical,O,3137
64379,management,O,3137
64380,includes,O,3137
64381,managing,B-TREATMENT,3137
64382,corneal,I-TREATMENT,3137
64383,microtrauma,I-TREATMENT,3137
64384,and,I-TREATMENT,3137
64385,inflammation,I-TREATMENT,3137
64386,Eye,O,3137
64387,Rubbing,O,3137
64388,Correlation,O,3137
64389,of,O,3137
64390,eye,O,3137
64391,rubbing,O,3137
64392,and,O,3137
64393,keratoconus,B-NAME_OF_DISEASE,3137
64394,progression,O,3137
64395,is,O,3137
64396,commonly,O,3137
64397,reported,O,3137
64398,in,O,3137
64399,the,O,3137
64400,literature,O,3137
64401,but,O,3137
64402,uncertainty,O,3138
64403,exists,O,3138
64404,whether,O,3138
64405,the,B-CAUSE_OF_DISEASE,3138
64406,atopy,I-CAUSE_OF_DISEASE,3138
64407,leading,I-CAUSE_OF_DISEASE,3138
64408,to,I-CAUSE_OF_DISEASE,3138
64409,the,I-CAUSE_OF_DISEASE,3138
64410,eye,I-CAUSE_OF_DISEASE,3138
64411,rubbing,I-CAUSE_OF_DISEASE,3138
64412,is,O,3138
64413,the,O,3138
64414,etiology,O,3138
64415,or,O,3138
64416,if,O,3139
64417,physical,B-CAUSE_OF_DISEASE,3139
64418,trauma,I-CAUSE_OF_DISEASE,3139
64419,from,I-CAUSE_OF_DISEASE,3139
64420,eye,I-CAUSE_OF_DISEASE,3139
64421,rubbing,I-CAUSE_OF_DISEASE,3139
64422,is,O,3139
64423,the,O,3139
64424,cause,O,3139
64425,Moran,B-PERSON,3139
64426,reported,O,3139
64427,eye,O,3139
64428,rubbing-,O,3139
64429,described,O,3139
64430,as,O,3139
64431,beneath,O,3139
64432,or,O,3139
64433,inside,O,3139
64434,the,O,3139
64435,eye,O,3139
64436,and,O,3139
64437,rubbing,O,3139
64438,with,O,3139
64439,the,O,3139
64440,knuckles,O,3140
64441,base,O,3141
64442,of,O,3141
64443,thumbs,O,3141
64444,or,O,3141
64445,fingertips-increases,O,3141
64446,risk,O,3141
64447,of,O,3141
64448,keratoconus,B-NAME_OF_DISEASE,3141
64449,Further,O,3141
64450,keratoconus,B-NAME_OF_DISEASE,3141
64451,was,O,3141
64452,more,O,3141
64453,significantly,O,3141
64454,associated,O,3141
64455,with,O,3141
64456,knuckle,O,3141
64457,rubbing,O,3141
64458,Najmi,B-PERSON,3141
64459,reported,O,3141
64460,mechanical,O,3141
64461,eye,O,3141
64462,rubbing,O,3141
64463,causes,O,3142
64464,the,B-SIGN_AND_SYMPTOM,3142
64465,thinning,I-SIGN_AND_SYMPTOM,3142
64466,of,I-SIGN_AND_SYMPTOM,3142
64467,keratocyte,I-SIGN_AND_SYMPTOM,3142
64468,Also,O,3142
64469,reported,O,3142
64470,was,O,3142
64471,that,O,3142
64472,the,O,3142
64473,corneal,O,3142
64474,effect,O,3142
64475,of,O,3142
64476,eye,O,3142
64477,rubbing,O,3142
64478,depends,O,3142
64479,on,O,3143
64480,the,O,3143
64481,period,O,3143
64482,and,O,3143
64483,force,O,3143
64484,of,O,3143
64485,eye,O,3143
64486,rubbing,O,3144
64487,Eye,O,3144
64488,rubbing,O,3144
64489,may,O,3144
64490,affect,O,3144
64491,the,B-PART_OF_THE_EYES,3144
64492,cornea,I-PART_OF_THE_EYES,3144
64493,at,O,3144
64494,a,O,3144
64495,molecular,O,3144
64496,level,O,3144
64497,Shetty,B-PERSON,3144
64498,reported,O,3144
64499,eye,O,3144
64500,rubbing,O,3144
64501,increased,O,3144
64502,the,O,3144
64503,level,O,3145
64504,of,O,3145
64505,tear,O,3145
64506,matrix,B-CHEMICAL_COMPOUND,3145
64507,metalloproteinase,I-CHEMICAL_COMPOUND,3145
64508,MMP,I-CHEMICAL_COMPOUND,3145
64509,-13,I-CHEMICAL_COMPOUND,3145
64510,IL-6,B-CHEMICAL_COMPOUND,3145
64511,and,O,3145
64512,TNF-α,B-CHEMICAL_COMPOUND,3145
64513,in,O,3145
64514,eyes,O,3145
64515,of,O,3145
64516,patients,O,3146
64517,with,O,3146
64518,keratoconus,B-NAME_OF_DISEASE,3146
64519,as,O,3146
64520,well,O,3146
64521,as,O,3146
64522,healthy,O,3146
64523,patients,O,3146
64524,Lema,B-PERSON,3146
64525,reported,O,3146
64526,patients,O,3146
64527,with,O,3146
64528,keratoconus,B-NAME_OF_DISEASE,3146
64529,had,O,3146
64530,significantly,O,3146
64531,higher,O,3146
64532,levels,O,3146
64533,of,O,3146
64534,inflammatory,O,3146
64535,markers,O,3146
64536,including,O,3146
64537,IL-6,B-CHEMICAL_COMPOUND,3146
64538,TNF-α,B-CHEMICAL_COMPOUND,3146
64539,and,O,3147
64540,MMP-9,B-CHEMICAL_COMPOUND,3147
64541,In,O,3147
64542,addition,O,3147
64543,investigators,O,3147
64544,reported,O,3147
64545,the,O,3147
64546,levels,O,3147
64547,of,O,3147
64548,these,O,3147
64549,inflammatory,O,3147
64550,markers,O,3147
64551,increased,O,3148
64552,with,O,3148
64553,the,O,3148
64554,severity,O,3148
64555,of,O,3148
64556,keratoconus,B-NAME_OF_DISEASE,3148
64557,Contact,O,3148
64558,Lens,O,3148
64559,Microtrauma,O,3148
64560,Contact,O,3148
64561,lens,O,3148
64562,wear,O,3148
64563,and,O,3148
64564,eye,O,3148
64565,rubbing,O,3148
64566,increase,O,3148
64567,incidence,O,3148
64568,of,O,3148
64569,mechanical,O,3148
64570,trauma,O,3148
64571,to,O,3148
64572,the,B-PART_OF_THE_EYES,3148
64573,cornea,I-PART_OF_THE_EYES,3148
64574,Addressing,O,3148
64575,low,O,3148
64576,levels,O,3148
64577,of,O,3148
64578,ocular,O,3148
64579,inflammation,O,3149
64580,will,O,3149
64581,also,O,3149
64582,improve,O,3149
64583,contact,O,3149
64584,lens,O,3149
64585,wearing,O,3149
64586,comfort,O,3149
64587,and,O,3149
64588,reduce,O,3149
64589,lens,O,3149
64590,complications,O,3149
64591,Erie,B-PERSON,3149
64592,reported,O,3149
64593,altered,B-SIGN_AND_SYMPTOM,3149
64594,keratocyte,I-SIGN_AND_SYMPTOM,3149
64595,morphology,I-SIGN_AND_SYMPTOM,3149
64596,and,I-SIGN_AND_SYMPTOM,3149
64597,density,I-SIGN_AND_SYMPTOM,3149
64598,within,I-SIGN_AND_SYMPTOM,3149
64599,the,I-SIGN_AND_SYMPTOM,3149
64600,anterior,I-SIGN_AND_SYMPTOM,3149
64601,stroma,I-SIGN_AND_SYMPTOM,3149
64602,in,O,3149
64603,contact,O,3149
64604,lens,O,3149
64605,wearers,O,3150
64606,with,O,3150
64607,keratoconus,B-NAME_OF_DISEASE,3150
64608,Lema,B-PERSON,3150
64609,reported,O,3150
64610,contact,O,3150
64611,lens,O,3150
64612,wear,O,3150
64613,demonstrated,O,3150
64614,upregulation,O,3150
64615,of,O,3150
64616,IL-6,B-CHEMICAL_COMPOUND,3150
64617,TNFα,B-CHEMICAL_COMPOUND,3150
64618,ICAM-1,B-CHEMICAL_COMPOUND,3151
64619,and,O,3151
64620,VCAM-1,B-CHEMICAL_COMPOUND,3151
64621,in,O,3151
64622,the,O,3151
64623,tears,O,3151
64624,of,O,3152
64625,subjects,O,3152
64626,with,O,3152
64627,keratoconus,B-NAME_OF_DISEASE,3152
64628,especially,O,3152
64629,in,O,3152
64630,gas,O,3152
64631,permeable,O,3152
64632,lens,O,3152
64633,wearers,O,3152
64634,The,O,3152
64635,authors,O,3152
64636,suggested,O,3153
64637,a,B-CAUSE_OF_DISEASE,3153
64638,progressive,I-CAUSE_OF_DISEASE,3153
64639,cycle,I-CAUSE_OF_DISEASE,3153
64640,of,I-CAUSE_OF_DISEASE,3153
64641,proinflammatory,I-CAUSE_OF_DISEASE,3153
64642,cytokines,I-CAUSE_OF_DISEASE,3153
64643,proteolytic,I-CAUSE_OF_DISEASE,3153
64644,enzymes,I-CAUSE_OF_DISEASE,3153
64645,and,I-CAUSE_OF_DISEASE,3153
64646,inhibitors,I-CAUSE_OF_DISEASE,3153
64647,may,O,3153
64648,be,O,3153
64649,responsible,O,3153
64650,for,O,3153
64651,microenvironmental,O,3154
64652,changes,O,3154
64653,found,O,3154
64654,in,O,3154
64655,keratoconus,B-NAME_OF_DISEASE,3154
64656,The,O,3154
64657,resulting,O,3154
64658,imbalance,O,3154
64659,may,O,3154
64660,initiate,O,3154
64661,and,O,3154
64662,perpetuate,O,3154
64663,corneal,O,3154
64664,inflammatory,O,3154
64665,pathways,O,3154
64666,to,O,3154
64667,result,O,3154
64668,in,O,3154
64669,the,O,3154
64670,structural,O,3154
64671,abnormalities,O,3154
64672,seen,O,3154
64673,with,O,3154
64674,disease,O,3154
64675,progression,O,3154
64676,Inflammatory,O,3154
64677,marker,O,3154
64678,evidence,O,3154
64679,suggests,O,3154
64680,dry,B-NAME_OF_DISEASE,3154
64681,eye,I-NAME_OF_DISEASE,3154
64682,management,O,3154
64683,may,O,3154
64684,be,O,3155
64685,beneficial,O,3155
64686,to,O,3155
64687,these,O,3155
64688,patients,O,3155
64689,Patients,O,3155
64690,with,O,3155
64691,keratoconus,B-NAME_OF_DISEASE,3155
64692,reportedly,O,3155
64693,experience,O,3155
64694,greater,O,3155
64695,symptoms,O,3155
64696,of,O,3155
64697,dry,B-NAME_OF_DISEASE,3155
64698,eye,I-NAME_OF_DISEASE,3155
64699,and,O,3155
64700,greater,O,3155
64701,tear,O,3155
64702,instability,O,3155
64703,Patients,O,3155
64704,with,O,3155
64705,keratoconus,B-NAME_OF_DISEASE,3155
64706,also,O,3155
64707,demonstrated,O,3155
64708,significantly,B-SIGN_AND_SYMPTOM,3155
64709,decreased,I-SIGN_AND_SYMPTOM,3155
64710,tear,I-SIGN_AND_SYMPTOM,3155
64711,secretion,I-SIGN_AND_SYMPTOM,3155
64712,and,O,3155
64713,higher,O,3155
64714,Ocular,O,3156
64715,Surface,O,3156
64716,Disease,O,3156
64717,Index,O,3156
64718,survey,O,3156
64719,scores,O,3156
64720,compared,O,3156
64721,with,O,3156
64722,controls,O,3156
64723,Patients,O,3156
64724,with,O,3156
64725,any,O,3156
64726,stage,O,3156
64727,of,O,3156
64728,keratoconus,B-NAME_OF_DISEASE,3156
64729,including,O,3156
64730,those,O,3156
64731,with,O,3156
64732,corneal,O,3156
64733,grafts,O,3156
64734,require,O,3156
64735,clinical,O,3156
64736,differentiation,O,3156
64737,between,O,3156
64738,allergic,B-NAME_OF_DISEASE,3156
64739,conjunctivitis,I-NAME_OF_DISEASE,3156
64740,and,O,3156
64741,dry,B-NAME_OF_DISEASE,3156
64742,eye,I-NAME_OF_DISEASE,3157
64743,Any,O,3157
64744,comorbidity,O,3157
64745,that,O,3157
64746,is,O,3157
64747,inflammatory,O,3157
64748,in,O,3157
64749,nature,O,3157
64750,may,O,3157
64751,add,O,3157
64752,synergistically,O,3157
64753,to,O,3158
64754,other,O,3158
64755,forms,O,3158
64756,of,O,3158
64757,keratoconus-related,O,3158
64758,inflammation,O,3158
64759,and,O,3158
64760,exacerbate,O,3158
64761,its,O,3158
64762,pathogenetic,O,3158
64763,processes,O,3158
64764,Immune,O,3158
64765,Privilege,O,3158
64766,Inflamed,O,3158
64767,grafts,O,3158
64768,commonly,O,3158
64769,reject,O,3158
64770,and,O,3158
64771,will,O,3159
64772,do,O,3159
64773,so,O,3159
64774,quickly,O,3159
64775,Immunological,O,3159
64776,privilege,O,3159
64777,is,O,3159
64778,relative,O,3159
64779,and,O,3159
64780,cumulative,O,3159
64781,Keratitis,B-NAME_OF_DISEASE,3159
64782,years,O,3159
64783,prior,O,3159
64784,to,O,3159
64785,transplantation,O,3159
64786,increases,O,3159
64787,rejection,O,3159
64788,risk,O,3159
64789,because,O,3159
64790,changes,O,3159
64791,in,O,3159
64792,an,O,3159
64793,inflamed,O,3159
64794,cornea,B-PART_OF_THE_EYES,3159
64795,contribute,O,3159
64796,to,O,3159
64797,the,O,3159
64798,reduction,O,3160
64799,of,O,3160
64800,privilege,O,3160
64801,Human,B-PART_OF_THE_EYES,3160
64802,corneas,I-PART_OF_THE_EYES,3160
64803,carry,O,3160
64804,a,O,3160
64805,limited,O,3160
64806,amount,O,3160
64807,of,O,3160
64808,bone,B-PART_OF_THE_EYES,3160
64809,marrow-derived,I-PART_OF_THE_EYES,3160
64810,cells,I-PART_OF_THE_EYES,3160
64811,These,O,3160
64812,special,O,3160
64813,cells,O,3160
64814,can,O,3160
64815,initiate,O,3160
64816,an,O,3161
64817,immune,O,3161
64818,response,O,3161
64819,The,O,3161
64820,cells,O,3161
64821,mature,O,3161
64822,and,O,3161
64823,are,O,3161
64824,recruited,O,3161
64825,into,O,3161
64826,the,B-PART_OF_THE_EYES,3161
64827,cornea,B-PART_OF_THE_EYES,3161
64828,via,O,3161
64829,limbal,B-PART_OF_THE_EYES,3161
64830,vessels,I-PART_OF_THE_EYES,3161
64831,with,O,3161
64832,inflammation,O,3161
64833,Problematically,O,3161
64834,these,O,3161
64835,cells,O,3161
64836,persist,O,3161
64837,after,O,3161
64838,the,O,3161
64839,acute,O,3161
64840,insult,O,3161
64841,resolves,O,3161
64842,The,O,3161
64843,more,O,3161
64844,bone,B-PART_OF_THE_EYES,3161
64845,marrow-derived,I-PART_OF_THE_EYES,3161
64846,cells,I-PART_OF_THE_EYES,3161
64847,present,O,3161
64848,in,O,3161
64849,the,B-PART_OF_THE_EYES,3161
64850,host,I-PART_OF_THE_EYES,3161
64851,cornea,B-PART_OF_THE_EYES,3161
64852,the,O,3161
64853,higher,O,3161
64854,the,O,3161
64855,graft,O,3161
64856,rejection,O,3161
64857,rate,O,3161
64858,The,O,3161
64859,more,O,3161
64860,inflammation,O,3161
64861,the,O,3161
64862,less,O,3161
64863,privilege,O,3161
64864,Cyclosporin,B-NAME_OF_DRUG,3161
64865,was,O,3161
64866,found,O,3161
64867,to,O,3161
64868,be,O,3161
64869,beneficial,O,3161
64870,in,O,3161
64871,eyes,O,3161
64872,with,O,3161
64873,keratoconus,B-NAME_OF_DISEASE,3161
64874,in,O,3161
64875,a,O,3161
64876,study,O,3161
64877,by,O,3161
64878,Shetty,B-PERSON,3162
64879,After,O,3162
64880,topical,B-NAME_OF_DRUG,3162
64881,cyclosporin,I-NAME_OF_DRUG,3162
64882,was,O,3162
64883,used,O,3162
64884,for,B-TIME_DURATION,3162
64885,6,I-TIME_DURATION,3162
64886,months,I-TIME_DURATION,3162
64887,an,O,3162
64888,improvement,O,3162
64889,in,O,3162
64890,levels,O,3162
64891,of,O,3162
64892,MMP9,B-CHEMICAL_COMPOUND,3162
64893,IL-6,B-CHEMICAL_COMPOUND,3162
64894,and,O,3162
64895,TNF-α,B-CHEMICAL_COMPOUND,3162
64896,was,O,3162
64897,observed,O,3162
64898,Investigators,O,3162
64899,also,O,3162
64900,noted,O,3162
64901,local,O,3162
64902,flattening,O,3162
64903,and,O,3162
64904,reduction,O,3162
64905,of,O,3162
64906,corneal,O,3163
64907,curvatures,O,3163
64908,after,O,3163
64909,treatment,O,3163
64910,measured,O,3163
64911,by,O,3163
64912,corneal,B-DIAGNOSTIC_TEST,3163
64913,topography,I-DIAGNOSTIC_TEST,3163
64914,Immunomodulators,B-NAME_OF_DRUG,3163
64915,reduce,O,3163
64916,inflammation,O,3163
64917,and,O,3163
64918,increasing,O,3163
64919,and,O,3163
64920,stabilizing,O,3163
64921,the,B-PART_OF_THE_EYES,3163
64922,tear,I-PART_OF_THE_EYES,3164
64923,film,I-PART_OF_THE_EYES,3164
64924,reduces,O,3164
64925,the,O,3164
64926,effect,O,3164
64927,of,O,3164
64928,irregular,B-NAME_OF_DISEASE,3164
64929,astigmatism,I-NAME_OF_DISEASE,3164
64930,Reducting,O,3164
64931,irregular,B-NAME_OF_DISEASE,3164
64932,astigmatism,I-NAME_OF_DISEASE,3164
64933,improves,O,3164
64934,higher,O,3164
64935,order,O,3164
64936,aberrations,O,3165
64937,which,O,3165
64938,may,O,3165
64939,subjectively,O,3165
64940,improve,O,3165
64941,visual,O,3165
64942,acuity,O,3165
64943,Despite,O,3165
64944,the,O,3165
64945,historical,O,3165
64946,description,O,3165
64947,of,O,3165
64948,keratoconus,B-NAME_OF_DISEASE,3165
64949,as,O,3165
64950,a,O,3165
64951,noninflammatory,O,3165
64952,disease,O,3165
64953,inflammation,O,3165
64954,may,O,3165
64955,play,O,3165
64956,a,O,3165
64957,role,O,3165
64958,in,O,3165
64959,the,O,3165
64960,progression,O,3165
64961,of,O,3165
64962,keratoconus,B-NAME_OF_DISEASE,3165
64963,These,O,3165
64964,data,O,3166
64965,suggest,O,3166
64966,that,O,3166
64967,an,O,3166
64968,inflammatory,O,3166
64969,cycle,O,3166
64970,much,O,3166
64971,like,O,3166
64972,that,O,3166
64973,of,O,3166
64974,dry,B-NAME_OF_DISEASE,3166
64975,eye,I-NAME_OF_DISEASE,3166
64976,may,O,3166
64977,play,O,3167
64978,an,O,3167
64979,important,O,3167
64980,role,O,3167
64981,in,O,3167
64982,keratoconus,B-NAME_OF_DISEASE,3167
64983,pathogenesis,O,3167
64984,While,O,3167
64985,causality,O,3167
64986,may,O,3167
64987,be,O,3167
64988,uncertain,O,3167
64989,managing,B-TREATMENT,3167
64990,eye,I-TREATMENT,3167
64991,rubbing,I-TREATMENT,3167
64992,reducing,I-TREATMENT,3167
64993,inflammation,I-TREATMENT,3167
64994,and,I-TREATMENT,3167
64995,reducing,I-TREATMENT,3167
64996,corneal,I-TREATMENT,3167
64997,microtrauma,I-TREATMENT,3167
64998,may,O,3167
64999,improve,O,3167
65000,the,O,3167
65001,quality,O,3167
65002,of,O,3167
65003,life,O,3167
65004,for,O,3167
65005,patients,O,3167
65006,with,O,3167
65007,keratoconus,B-NAME_OF_DISEASE,3167
65008,In,O,3167
65009,addition,O,3167
65010,to,O,3167
65011,monitoring,O,3168
65012,keratoconus,B-NAME_OF_DISEASE,3168
65013,progression,O,3168
65014,using,O,3168
65015,corneal,B-DIAGNOSTIC_TEST,3168
65016,topography,I-DIAGNOSTIC_TEST,3168
65017,refraction,O,3168
65018,and,O,3168
65019,best-corrected,O,3168
65020,visual,O,3168
65021,acuity,O,3168
65022,use,O,3168
65023,of,O,3168
65024,a,B-DIAGNOSTIC_TEST,3168
65025,dry,B-NAME_OF_DISEASE,3169
65026,eye,I-NAME_OF_DISEASE,3169
65027,screening,I-DIAGNOSTIC_TEST,3169
65028,tool,I-DIAGNOSTIC_TEST,3169
65029,and,O,3169
65030,measurement,B-DIAGNOSTIC_TEST,3169
65031,of,I-DIAGNOSTIC_TEST,3169
65032,inflammatory,I-DIAGNOSTIC_TEST,3169
65033,markers,I-DIAGNOSTIC_TEST,3169
65034,may,O,3169
65035,be,O,3169
65036,beneficial,O,3169
65037,Daily,O,3169
65038,use,O,3169
65039,of,O,3169
65040,immunomodulators,B-NAME_OF_DRUG,3169
65041,and,O,3169
65042,topical,B-NAME_OF_DRUG,3169
65043,steroids,I-NAME_OF_DRUG,3169
65044,for,O,3169
65045,symptom,O,3169
65046,flares,O,3169
65047,should,O,3169
65048,be,O,3169
65049,considered,O,3169
65050,as,O,3170
65051,well,O,3170
65052,An,B-NAME_OF_DISEASE,3170
65053,epiretinal,I-NAME_OF_DISEASE,3170
65054,membrane,I-NAME_OF_DISEASE,3170
65055,is,O,3170
65056,a,O,3170
65057,condition,O,3170
65058,where,O,3170
65059,a,O,3170
65060,very,O,3170
65061,thin,O,3170
65062,layer,O,3170
65063,of,O,3170
65064,scar,O,3170
65065,tissue,O,3170
65066,forms,O,3170
65067,on,O,3170
65068,the,O,3170
65069,surface,O,3170
65070,of,O,3170
65071,the,B-PART_OF_THE_EYES,3170
65072,retina,B-PART_OF_THE_EYES,3170
65073,in,O,3170
65074,an,O,3170
65075,area,O,3170
65076,that,O,3170
65077,is,O,3170
65078,responsible,O,3171
65079,for,O,3171
65080,our,O,3171
65081,sharpest,O,3171
65082,vision,O,3171
65083,The,O,3171
65084,part,O,3171
65085,of,O,3171
65086,the,O,3171
65087,eye,O,3171
65088,affected,O,3171
65089,by,O,3171
65090,an,B-NAME_OF_DISEASE,3171
65091,epiretinal,I-NAME_OF_DISEASE,3171
65092,membrane,I-NAME_OF_DISEASE,3171
65093,is,O,3171
65094,called,O,3171
65095,the,B-PART_OF_THE_EYES,3171
65096,macula,I-PART_OF_THE_EYES,3171
65097,The,B-PART_OF_THE_EYES,3171
65098,macula,I-PART_OF_THE_EYES,3172
65099,is,O,3172
65100,made,O,3172
65101,up,O,3172
65102,of,O,3172
65103,special,O,3172
65104,nerve,B-PART_OF_THE_EYES,3172
65105,cells,I-PART_OF_THE_EYES,3172
65106,that,O,3172
65107,provide,O,3172
65108,our,O,3172
65109,sharp,O,3172
65110,central,O,3172
65111,vision,O,3172
65112,needed,O,3172
65113,for,O,3172
65114,seeing,O,3172
65115,fine,O,3172
65116,detail,O,3172
65117,reading,O,3172
65118,and,O,3172
65119,driving,O,3173
65120,etc,O,3173
65121,,O,3173
65122,When,O,3173
65123,an,B-NAME_OF_DISEASE,3173
65124,epiretinal,I-NAME_OF_DISEASE,3173
65125,membrane,I-NAME_OF_DISEASE,3173
65126,forms,O,3173
65127,over,O,3173
65128,the,B-PART_OF_THE_EYES,3173
65129,macula,I-PART_OF_THE_EYES,3173
65130,it,O,3173
65131,may,O,3173
65132,contract,O,3173
65133,and,O,3173
65134,wrinkle,O,3173
65135,the,B-PART_OF_THE_EYES,3173
65136,macula,I-PART_OF_THE_EYES,3173
65137,resulting,O,3173
65138,in,O,3173
65139,distorted,B-SIGN_AND_SYMPTOM,3173
65140,and,I-SIGN_AND_SYMPTOM,3173
65141,or,I-SIGN_AND_SYMPTOM,3173
65142,blurred,I-SIGN_AND_SYMPTOM,3174
65143,vision,I-SIGN_AND_SYMPTOM,3174
65144,The,O,3174
65145,only,O,3174
65146,way,O,3174
65147,to,O,3174
65148,treat,O,3174
65149,an,B-NAME_OF_DISEASE,3174
65150,epiretinal,I-NAME_OF_DISEASE,3174
65151,membrane,I-NAME_OF_DISEASE,3174
65152,is,O,3174
65153,by,O,3174
65154,having,O,3174
65155,an,O,3174
65156,operation,O,3174
65157,called,O,3174
65158,a,B-TREATMENT,3174
65159,vitrectomy,I-TREATMENT,3174
65160,Eye,O,3174
65161,drops,O,3174
65162,or,O,3174
65163,glasses,O,3174
65164,are,O,3174
65165,not,O,3174
65166,effective,O,3174
65167,During,O,3174
65168,the,B-TREATMENT,3175
65169,vitrectomy,I-TREATMENT,3175
65170,the,O,3175
65171,surgeon,O,3175
65172,makes,O,3175
65173,tiny,O,3175
65174,cuts,O,3175
65175,in,O,3175
65176,the,O,3175
65177,eye,O,3175
65178,and,O,3175
65179,removes,O,3175
65180,the,B-TREATMENT,3175
65181,vitreous,I-TREATMENT,3175
65182,from,O,3175
65183,inside,O,3175
65184,They,O,3175
65185,then,O,3175
65186,grasp,O,3175
65187,and,O,3175
65188,gently,O,3175
65189,peel,O,3175
65190,away,O,3175
65191,the,B-NAME_OF_DISEASE,3175
65192,epiretinal,I-NAME_OF_DISEASE,3175
65193,membrane,I-NAME_OF_DISEASE,3175
65194,from,O,3175
65195,the,B-PART_OF_THE_EYES,3175
65196,retina,B-PART_OF_THE_EYES,3175
65197,Vitrectomy,B-TREATMENT,3175
65198,has,O,3175
65199,become,O,3175
65200,a,O,3175
65201,common,O,3175
65202,procedure,O,3175
65203,for,O,3175
65204,the,O,3175
65205,treatment,O,3175
65206,of,O,3175
65207,visual,B-SIGN_AND_SYMPTOM,3175
65208,loss,I-SIGN_AND_SYMPTOM,3175
65209,due,O,3175
65210,to,O,3176
65211,epiretinal,B-NAME_OF_DISEASE,3176
65212,membranes,I-NAME_OF_DISEASE,3176
65213,macular,B-NAME_OF_DISEASE,3176
65214,pucker,I-NAME_OF_DISEASE,3176
65215,over,O,3176
65216,the,O,3176
65217,past,O,3176
65218,two,O,3176
65219,decades,O,3176
65220,Epiretinal,B-NAME_OF_DISEASE,3176
65221,membranes,I-NAME_OF_DISEASE,3176
65222,result,O,3176
65223,from,O,3176
65224,fibroglial,B-CAUSE_OF_DISEASE,3176
65225,proliferation,I-CAUSE_OF_DISEASE,3176
65226,on,I-CAUSE_OF_DISEASE,3176
65227,the,I-CAUSE_OF_DISEASE,3176
65228,surface,I-CAUSE_OF_DISEASE,3176
65229,of,I-CAUSE_OF_DISEASE,3176
65230,the,I-CAUSE_OF_DISEASE,3176
65231,retina,B-PART_OF_THE_EYES,3176
65232,The,O,3176
65233,prevalence,O,3176
65234,of,O,3176
65235,epiretinal,B-NAME_OF_DISEASE,3176
65236,membranes,I-NAME_OF_DISEASE,3176
65237,in,O,3176
65238,the,B-PART_OF_THE_EYES,3176
65239,macula,I-PART_OF_THE_EYES,3176
65240,detectable,O,3176
65241,by,O,3176
65242,fundus,B-DIAGNOSTIC_TEST,3176
65243,photographs,I-DIAGNOSTIC_TEST,3176
65244,was,O,3176
65245,7%,O,3176
65246,in,O,3176
65247,a,O,3176
65248,study,O,3176
65249,of,O,3176
65250,3,O,3176
65251,654,O,3176
65252,persons,O,3176
65253,who,O,3177
65254,were,O,3177
65255,aged,O,3177
65256,49,O,3177
65257,years,O,3177
65258,or,O,3177
65259,more,O,3177
65260,Multiple,O,3177
65261,studies,O,3177
65262,have,O,3177
65263,reported,O,3177
65264,visual,O,3177
65265,acuity,O,3177
65266,improvement,O,3177
65267,following,O,3177
65268,this,O,3177
65269,surgery,O,3177
65270,but,O,3177
65271,most,O,3177
65272,published,O,3177
65273,series,O,3177
65274,have,O,3177
65275,reported,O,3177
65276,eyes,O,3177
65277,with,O,3177
65278,preoperative,O,3177
65279,visual,O,3177
65280,acuities,O,3177
65281,of,O,3177
65282,20,O,3177
65283,60,O,3177
65284,or,O,3177
65285,worse,O,3177
65286,Epiretinal,B-NAME_OF_DISEASE,3177
65287,membrane,I-NAME_OF_DISEASE,3177
65288,ERM,B-NAME_OF_DISEASE,3177
65289,has,O,3178
65290,become,O,3178
65291,a,O,3178
65292,more,O,3178
65293,widespread,O,3178
65294,retinal,O,3178
65295,disease,O,3178
65296,in,O,3178
65297,recent,O,3178
65298,years,O,3178
65299,The,O,3178
65300,incidence,O,3178
65301,of,O,3178
65302,ERM,B-NAME_OF_DISEASE,3178
65303,is,O,3178
65304,1.1,O,3178
65305,per,O,3178
65306,eye-year,O,3178
65307,with,O,3179
65308,estimated,O,3179
65309,prevalence,O,3179
65310,in,O,3179
65311,some,O,3179
65312,populations,O,3179
65313,as,O,3179
65314,high,O,3179
65315,as,O,3179
65316,28.90%,O,3179
65317,Epiretinal,B-NAME_OF_DISEASE,3179
65318,membranes,I-NAME_OF_DISEASE,3179
65319,occur,O,3179
65320,at,O,3179
65321,higher,O,3179
65322,rates,O,3179
65323,in,O,3179
65324,the,O,3179
65325,elderly,O,3179
65326,population,O,3179
65327,65,O,3179
65328,years,O,3179
65329,of,O,3180
65330,age,O,3180
65331,,O,3180
65332,The,O,3180
65333,number,O,3180
65334,of,O,3180
65335,people,O,3180
65336,affected,O,3180
65337,by,O,3180
65338,ERM,B-NAME_OF_DISEASE,3180
65339,is,O,3180
65340,increasing,O,3180
65341,due,O,3180
65342,to,O,3180
65343,the,O,3180
65344,growth,O,3180
65345,of,O,3180
65346,aging,O,3180
65347,populations,O,3180
65348,and,O,3180
65349,retina,B-PART_OF_THE_EYES,3180
65350,specialists,O,3180
65351,will,O,3180
65352,likely,O,3180
65353,have,O,3180
65354,more,O,3180
65355,opportunity,O,3180
65356,to,O,3180
65357,treat,O,3181
65358,patients,O,3181
65359,who,O,3181
65360,have,O,3181
65361,ERM,B-NAME_OF_DISEASE,3181
65362,in,O,3181
65363,coming,O,3181
65364,years,O,3181
65365,Optical,B-DIAGNOSTIC_TEST,3181
65366,coherence,I-DIAGNOSTIC_TEST,3181
65367,tomography,I-DIAGNOSTIC_TEST,3181
65368,OCT,B-DIAGNOSTIC_TEST,3181
65369,has,O,3181
65370,great,O,3181
65371,sensitivity,O,3181
65372,and,O,3181
65373,it,O,3181
65374,is,O,3181
65375,able,O,3181
65376,to,O,3181
65377,detect,O,3182
65378,even,O,3182
65379,subtle,O,3182
65380,changes,O,3182
65381,in,O,3182
65382,eyes,O,3182
65383,with,O,3182
65384,ERM,B-NAME_OF_DISEASE,3182
65385,helping,O,3182
65386,retina,B-PART_OF_THE_EYES,3182
65387,specialists,O,3182
65388,determine,O,3182
65389,the,O,3182
65390,optimal,O,3182
65391,timing,O,3182
65392,for,O,3182
65393,ERM,B-TREATMENT,3182
65394,surgery,I-TREATMENT,3183
65395,However,O,3183
65396,it,O,3183
65397,is,O,3183
65398,difficult,O,3183
65399,to,O,3183
65400,predict,O,3183
65401,postoperative,O,3183
65402,visual,O,3183
65403,prognosis,O,3183
65404,because,O,3183
65405,vision,O,3183
65406,changes,O,3183
65407,including,O,3183
65408,decreased,O,3183
65409,visual,O,3184
65410,acuity,O,3184
65411,visual,O,3184
65412,distortion,O,3184
65413,and,O,3184
65414,metamorphopsia,O,3184
65415,are,O,3184
65416,caused,O,3184
65417,by,O,3184
65418,several,O,3184
65419,complicated,O,3184
65420,and,O,3184
65421,intangible,O,3184
65422,factors,O,3184
65423,Therefore,O,3184
65424,postoperative,O,3184
65425,visual,O,3184
65426,function,O,3184
65427,may,O,3184
65428,not,O,3184
65429,live,O,3185
65430,up,O,3185
65431,to,O,3185
65432,preoperative,O,3185
65433,expectations,O,3185
65434,This,O,3185
65435,article,O,3185
65436,presents,O,3185
65437,a,O,3185
65438,relatively,O,3185
65439,simple,O,3185
65440,and,O,3185
65441,useful,O,3185
65442,method,O,3185
65443,of,O,3185
65444,determining,O,3185
65445,prognosis,O,3185
65446,for,O,3185
65447,ERM,B-TREATMENT,3185
65448,surgery,I-TREATMENT,3185
65449,utilizing,O,3185
65450,OCT,B-DIAGNOSTIC_TEST,3185
65451,findings,O,3185
65452,Changes,O,3185
65453,in,O,3185
65454,Configuration,O,3185
65455,of,O,3185
65456,Inner,B-PART_OF_THE_EYES,3185
65457,and,I-PART_OF_THE_EYES,3186
65458,Outer,I-PART_OF_THE_EYES,3186
65459,Retinal,I-PART_OF_THE_EYES,3186
65460,Layers,I-PART_OF_THE_EYES,3186
65461,Optical,B-DIAGNOSTIC_TEST,3186
65462,coherence,I-DIAGNOSTIC_TEST,3186
65463,tomography,I-DIAGNOSTIC_TEST,3186
65464,has,O,3186
65465,become,O,3186
65466,the,O,3186
65467,most,O,3186
65468,important,O,3186
65469,imaging,O,3186
65470,tool,O,3186
65471,for,O,3186
65472,diseases,O,3186
65473,of,O,3186
65474,the,B-PART_OF_THE_EYES,3186
65475,vitreoretinal,I-PART_OF_THE_EYES,3186
65476,interface,I-PART_OF_THE_EYES,3186
65477,including,O,3186
65478,ERM,B-NAME_OF_DISEASE,3186
65479,Spectral-domain,B-DIAGNOSTIC_TEST,3186
65480,OCT,I-DIAGNOSTIC_TEST,3186
65481,enables,O,3186
65482,a,O,3186
65483,precise,O,3187
65484,visualization,O,3187
65485,of,O,3187
65486,the,B-PART_OF_THE_EYES,3187
65487,retina,I-PART_OF_THE_EYES,3187
65488,from,O,3187
65489,the,O,3187
65490,inner,O,3187
65491,surface,O,3187
65492,to,O,3187
65493,the,O,3187
65494,most,O,3187
65495,outer,O,3187
65496,parts,O,3187
65497,Consequently,O,3187
65498,not,O,3187
65499,only,O,3187
65500,can,O,3187
65501,superficial,O,3187
65502,changes,O,3187
65503,such,O,3187
65504,as,O,3187
65505,the,B-SIGN_AND_SYMPTOM,3187
65506,ERM,I-SIGN_AND_SYMPTOM,3187
65507,folds,O,3187
65508,in,O,3188
65509,the,B-SIGN_AND_SYMPTOM,3188
65510,ILM,I-SIGN_AND_SYMPTOM,3188
65511,or,O,3188
65512,vitreomacular,O,3188
65513,traction,O,3188
65514,be,O,3188
65515,seen,O,3188
65516,but,O,3188
65517,also,O,3188
65518,associated,O,3188
65519,changes,O,3188
65520,in,O,3188
65521,the,O,3188
65522,more,O,3188
65523,outer,O,3188
65524,layers,O,3188
65525,such,O,3188
65526,as,O,3188
65527,intraretinal,O,3188
65528,cystoid,O,3188
65529,spaces,O,3188
65530,disruption,O,3188
65531,of,O,3188
65532,ellipsoid,O,3188
65533,line,O,3188
65534,disruption,O,3188
65535,of,O,3188
65536,the,O,3188
65537,cone,O,3188
65538,outersegment,O,3188
65539,tips,O,3188
65540,flattening,O,3189
65541,of,O,3189
65542,the,O,3189
65543,foveal,O,3189
65544,depression,O,3189
65545,and,O,3189
65546,formation,O,3189
65547,of,O,3189
65548,full-thickness,O,3189
65549,pseudo-,O,3189
65550,and,O,3189
65551,incomplete,O,3189
65552,macular,O,3189
65553,holes,O,3189
65554,recognized,O,3189
65555,as,O,3189
65556,lamellar,O,3189
65557,macular,O,3189
65558,hole,O,3189
65559,Predictive,O,3189
65560,Factors,O,3189
65561,for,O,3189
65562,Visual,O,3189
65563,Outcome,O,3189
65564,from,O,3189
65565,OCT,B-DIAGNOSTIC_TEST,3189
65566,Analysis,I-DIAGNOSTIC_TEST,3189
65567,for,O,3189
65568,ERM,B-NAME_OF_DISEASE,3189
65569,Disorganization,B-SIGN_AND_SYMPTOM,3189
65570,of,I-SIGN_AND_SYMPTOM,3189
65571,Inner,I-SIGN_AND_SYMPTOM,3189
65572,Retinal,I-SIGN_AND_SYMPTOM,3189
65573,Layer,I-SIGN_AND_SYMPTOM,3190
65574,Epiretinal,B-SIGN_AND_SYMPTOM,3190
65575,membrane,I-SIGN_AND_SYMPTOM,3190
65576,can,O,3190
65577,cause,O,3190
65578,distortion,B-SIGN_AND_SYMPTOM,3190
65579,and,I-SIGN_AND_SYMPTOM,3190
65580,disorganization,I-SIGN_AND_SYMPTOM,3190
65581,of,I-SIGN_AND_SYMPTOM,3190
65582,inner,I-SIGN_AND_SYMPTOM,3190
65583,retinal,I-SIGN_AND_SYMPTOM,3190
65584,layers,I-SIGN_AND_SYMPTOM,3190
65585,DRIL,B-SIGN_AND_SYMPTOM,3190
65586,,O,3190
65587,The,O,3190
65588,extent,O,3190
65589,of,O,3190
65590,DRIL,B-SIGN_AND_SYMPTOM,3190
65591,is,O,3190
65592,associated,O,3190
65593,with,O,3190
65594,preoperative,O,3190
65595,and,O,3190
65596,postoperative,O,3190
65597,visual,O,3190
65598,function,O,3190
65599,in,O,3190
65600,eyes,O,3190
65601,with,O,3190
65602,ERM,B-NAME_OF_DISEASE,3190
65603,Eyes,O,3190
65604,with,O,3190
65605,severe,O,3190
65606,DRIL,B-SIGN_AND_SYMPTOM,3191
65607,aren,O,3191
65608,t,O,3191
65609,expected,O,3191
65610,to,O,3191
65611,obtain,O,3191
65612,significant,O,3191
65613,improvement,O,3191
65614,of,O,3191
65615,visual,O,3191
65616,function,O,3191
65617,It,O,3191
65618,is,O,3191
65619,known,O,3191
65620,that,O,3191
65621,appropriate,O,3191
65622,organization,O,3191
65623,of,O,3191
65624,the,B-PART_OF_THE_EYES,3191
65625,inner,I-PART_OF_THE_EYES,3191
65626,retinal,I-PART_OF_THE_EYES,3191
65627,layer,I-PART_OF_THE_EYES,3191
65628,such,O,3191
65629,as,O,3191
65630,the,B-PART_OF_THE_EYES,3191
65631,inner,I-PART_OF_THE_EYES,3191
65632,nuclear,I-PART_OF_THE_EYES,3191
65633,layer,I-PART_OF_THE_EYES,3191
65634,INL,I-PART_OF_THE_EYES,3191
65635,is,O,3191
65636,vital,O,3191
65637,to,O,3191
65638,essential,O,3191
65639,visual,O,3191
65640,functions,O,3191
65641,such,O,3191
65642,as,O,3191
65643,visual,O,3191
65644,clarity,O,3191
65645,Therefore,O,3191
65646,DRIL,B-SIGN_AND_SYMPTOM,3191
65647,is,O,3191
65648,recognized,O,3191
65649,as,O,3191
65650,a,O,3191
65651,predictive,O,3192
65652,factor,O,3192
65653,in,O,3192
65654,determining,O,3192
65655,postoperative,O,3192
65656,visual,O,3193
65657,function,O,3193
65658,Space,O,3193
65659,Between,O,3193
65660,Epiretinal,B-SIGN_AND_SYMPTOM,3193
65661,Membrane,I-SIGN_AND_SYMPTOM,3193
65662,and,O,3193
65663,Retinal,B-PART_OF_THE_EYES,3193
65664,Surface,I-PART_OF_THE_EYES,3193
65665,Epiretinal,B-SIGN_AND_SYMPTOM,3193
65666,membrane,I-SIGN_AND_SYMPTOM,3193
65667,is,O,3193
65668,located,O,3193
65669,on,O,3193
65670,the,O,3193
65671,surface,O,3193
65672,of,O,3193
65673,the,B-PART_OF_THE_EYES,3193
65674,retina,I-PART_OF_THE_EYES,3193
65675,and,O,3193
65676,it,O,3193
65677,tends,O,3194
65678,to,O,3194
65679,spread,O,3194
65680,and,O,3194
65681,become,O,3194
65682,contracted,O,3194
65683,causing,O,3194
65684,deformation,O,3194
65685,of,O,3194
65686,the,B-PART_OF_THE_EYES,3194
65687,inner,I-PART_OF_THE_EYES,3194
65688,and,I-PART_OF_THE_EYES,3194
65689,outer,I-PART_OF_THE_EYES,3194
65690,retinal,I-PART_OF_THE_EYES,3194
65691,cells,I-PART_OF_THE_EYES,3194
65692,There,O,3194
65693,are,O,3194
65694,various,O,3194
65695,patterns,O,3194
65696,of,O,3194
65697,membranes,O,3195
65698,seen,O,3195
65699,in,O,3195
65700,OCT,B-DIAGNOSTIC_TEST,3195
65701,findings,O,3195
65702,of,O,3195
65703,eyes,O,3195
65704,with,O,3195
65705,ERM,B-SIGN_AND_SYMPTOM,3195
65706,Overall,O,3195
65707,it,O,3195
65708,is,O,3195
65709,simpler,O,3195
65710,to,O,3195
65711,identify,O,3195
65712,the,B-SIGN_AND_SYMPTOM,3195
65713,sukima,I-SIGN_AND_SYMPTOM,3195
65714,than,O,3195
65715,other,O,3195
65716,known,O,3195
65717,factors,O,3195
65718,such,O,3195
65719,as,O,3195
65720,DRIL,B-SIGN_AND_SYMPTOM,3195
65721,ellipsoid,B-PART_OF_THE_EYES,3195
65722,zone,I-PART_OF_THE_EYES,3195
65723,EZ,B-PART_OF_THE_EYES,3195
65724,and,O,3195
65725,cone,B-PART_OF_THE_EYES,3195
65726,outer-segment,I-PART_OF_THE_EYES,3195
65727,tips,I-PART_OF_THE_EYES,3196
65728,seen,O,3196
65729,in,O,3196
65730,OCT,B-DIAGNOSTIC_TEST,3196
65731,Based,O,3196
65732,on,O,3196
65733,our,O,3196
65734,research,O,3197
65735,the,O,3197
65736,pocket,O,3197
65737,of,O,3197
65738,space,O,3197
65739,between,O,3197
65740,the,B-SIGN_AND_SYMPTOM,3197
65741,ERM,I-SIGN_AND_SYMPTOM,3197
65742,and,O,3197
65743,the,B-SIGN_AND_SYMPTOM,3197
65744,ILM,I-SIGN_AND_SYMPTOM,3197
65745,is,O,3197
65746,significantly,O,3197
65747,associated,O,3197
65748,with,O,3197
65749,baseline,O,3197
65750,visual,O,3197
65751,distortion,O,3197
65752,and,O,3197
65753,improvements,O,3197
65754,in,O,3197
65755,visual,O,3197
65756,acuity,O,3197
65757,after,O,3197
65758,surgery,O,3197
65759,For,O,3197
65760,example,O,3197
65761,after,O,3197
65762,ERM,B-TREATMENT,3197
65763,surgery,I-TREATMENT,3197
65764,on,O,3197
65765,an,O,3197
65766,eye,O,3197
65767,with,O,3198
65768,a,O,3198
65769,small,O,3198
65770,sukima,B-SIGN_AND_SYMPTOM,3198
65771,there,O,3198
65772,is,O,3198
65773,not,O,3198
65774,significant,O,3198
65775,improvement,O,3198
65776,of,O,3198
65777,visual,O,3198
65778,acuity,O,3198
65779,However,O,3198
65780,following,O,3198
65781,surgery,O,3198
65782,for,O,3198
65783,an,O,3198
65784,eye,O,3198
65785,with,O,3198
65786,ERM,B-SIGN_AND_SYMPTOM,3198
65787,with,O,3198
65788,a,O,3199
65789,pronounced,O,3199
65790,sukima,B-SIGN_AND_SYMPTOM,3199
65791,there,O,3199
65792,is,O,3199
65793,the,O,3199
65794,possibility,O,3199
65795,of,O,3199
65796,obtaining,O,3199
65797,improved,O,3199
65798,visual,O,3199
65799,function,O,3199
65800,Based,O,3199
65801,on,O,3199
65802,our,O,3199
65803,results,O,3199
65804,we,O,3199
65805,concluded,O,3199
65806,that,O,3199
65807,the,O,3199
65808,presence,O,3199
65809,of,O,3199
65810,sukima,B-SIGN_AND_SYMPTOM,3199
65811,may,O,3199
65812,allow,O,3199
65813,us,O,3199
65814,to,O,3199
65815,predict,O,3199
65816,postoperative,O,3199
65817,visual,O,3199
65818,function,O,3199
65819,in,O,3199
65820,eyes,O,3199
65821,with,O,3199
65822,ERM,B-SIGN_AND_SYMPTOM,3199
65823,We,O,3199
65824,believe,O,3200
65825,there,O,3200
65826,are,O,3200
65827,2,O,3200
65828,main,O,3200
65829,reasons,O,3200
65830,for,O,3200
65831,this,O,3200
65832,the,O,3200
65833,effect,O,3200
65834,on,O,3200
65835,the,O,3200
65836,performance,O,3200
65837,of,O,3200
65838,membrane,B-TREATMENT,3200
65839,peeling,I-TREATMENT,3200
65840,and,O,3200
65841,the,O,3200
65842,strong,O,3201
65843,correlation,O,3201
65844,with,O,3201
65845,disruption,O,3201
65846,of,O,3201
65847,the,B-PART_OF_THE_EYES,3201
65848,EZ,B-PART_OF_THE_EYES,3201
65849,It,O,3201
65850,is,O,3201
65851,more,O,3201
65852,difficult,O,3201
65853,to,O,3201
65854,remove,O,3201
65855,membranes,O,3201
65856,in,O,3201
65857,an,O,3201
65858,eye,O,3201
65859,with,O,3201
65860,small,O,3201
65861,sukima,B-SIGN_AND_SYMPTOM,3201
65862,where,O,3201
65863,the,B-SIGN_AND_SYMPTOM,3201
65864,ERM,I-SIGN_AND_SYMPTOM,3201
65865,is,O,3201
65866,firmly,O,3201
65867,attached,O,3201
65868,to,O,3201
65869,the,B-SIGN_AND_SYMPTOM,3201
65870,ILM,I-SIGN_AND_SYMPTOM,3201
65871,while,O,3201
65872,it,O,3201
65873,is,O,3201
65874,easier,O,3201
65875,to,O,3202
65876,peel,B-TREATMENT,3202
65877,membrane,I-TREATMENT,3202
65878,in,O,3202
65879,eyes,O,3202
65880,with,O,3202
65881,a,O,3202
65882,large,O,3202
65883,sukima,B-SIGN_AND_SYMPTOM,3202
65884,where,O,3202
65885,the,O,3202
65886,2,O,3202
65887,layers,O,3202
65888,are,O,3202
65889,loosely,O,3202
65890,attached,O,3202
65891,Furthermore,O,3202
65892,disruption,O,3202
65893,of,O,3202
65894,EZ,B-PART_OF_THE_EYES,3202
65895,is,O,3202
65896,more,O,3202
65897,likely,O,3202
65898,to,O,3202
65899,be,O,3202
65900,seen,O,3202
65901,in,O,3202
65902,eyes,O,3202
65903,with,O,3202
65904,small,O,3202
65905,sukima,B-SIGN_AND_SYMPTOM,3202
65906,than,O,3202
65907,those,O,3202
65908,with,O,3202
65909,large,O,3202
65910,sukima,B-SIGN_AND_SYMPTOM,3202
65911,suggesting,O,3202
65912,that,O,3202
65913,persistent,O,3202
65914,traction,O,3202
65915,of,O,3202
65916,the,B-SIGN_AND_SYMPTOM,3202
65917,ERM,I-SIGN_AND_SYMPTOM,3203
65918,might,O,3203
65919,cause,O,3203
65920,damage,O,3203
65921,to,O,3203
65922,the,B-PART_OF_THE_EYES,3203
65923,outer,I-PART_OF_THE_EYES,3203
65924,retina,I-PART_OF_THE_EYES,3203
65925,including,O,3203
65926,the,B-PART_OF_THE_EYES,3203
65927,EZ,B-PART_OF_THE_EYES,3203
65928,cone,B-PART_OF_THE_EYES,3203
65929,outersegment,I-PART_OF_THE_EYES,3203
65930,tips,I-PART_OF_THE_EYES,3203
65931,and,O,3203
65932,foveal,B-PART_OF_THE_EYES,3203
65933,bulge,I-PART_OF_THE_EYES,3203
65934,The,O,3203
65935,separated,O,3203
65936,space,O,3203
65937,between,O,3203
65938,the,B-SIGN_AND_SYMPTOM,3203
65939,ERM,I-SIGN_AND_SYMPTOM,3203
65940,and,O,3203
65941,the,B-SIGN_AND_SYMPTOM,3203
65942,ILM,I-SIGN_AND_SYMPTOM,3203
65943,sukima,B-SIGN_AND_SYMPTOM,3203
65944,allows,O,3203
65945,us,O,3203
65946,to,O,3203
65947,determine,O,3204
65948,the,O,3204
65949,feasibility,O,3204
65950,of,O,3204
65951,membrane,B-TREATMENT,3204
65952,peeling,I-TREATMENT,3204
65953,because,O,3204
65954,the,O,3204
65955,presence,O,3204
65956,of,O,3204
65957,sukima,B-SIGN_AND_SYMPTOM,3204
65958,is,O,3204
65959,significantly,O,3204
65960,associated,O,3204
65961,with,O,3204
65962,improved,O,3204
65963,postoperative,O,3204
65964,visual,O,3204
65965,outcomes,O,3204
65966,in,O,3204
65967,eyes,O,3204
65968,with,O,3204
65969,ERM,B-SIGN_AND_SYMPTOM,3204
65970,Dry,B-NAME_OF_DISEASE,3205
65971,eye,I-NAME_OF_DISEASE,3205
65972,is,O,3205
65973,related,O,3205
65974,to,O,3205
65975,the,B-SIGN_AND_SYMPTOM,3205
65976,inflammation,I-SIGN_AND_SYMPTOM,3205
65977,of,I-SIGN_AND_SYMPTOM,3205
65978,ocular,I-SIGN_AND_SYMPTOM,3205
65979,surface,I-SIGN_AND_SYMPTOM,3205
65980,and,O,3205
65981,immune-mediated,B-CAUSE_OF_DISEASE,3205
65982,inflammation,I-CAUSE_OF_DISEASE,3205
65983,plays,O,3205
65984,an,O,3205
65985,important,O,3205
65986,pathogenic,O,3205
65987,role,O,3205
65988,Corticosteroid,B-NAME_OF_DRUG,3205
65989,is,O,3205
65990,an,O,3205
65991,effective,O,3205
65992,anti-inflammatory,B-NAME_OF_DRUG,3205
65993,drug,I-NAME_OF_DRUG,3205
65994,which,O,3205
65995,can,O,3206
65996,rapidly,O,3206
65997,and,O,3206
65998,effectively,O,3206
65999,relieve,O,3206
66000,the,O,3206
66001,symptoms,O,3206
66002,and,O,3206
66003,signs,O,3206
66004,of,O,3206
66005,moderate,O,3206
66006,or,O,3206
66007,severe,O,3206
66008,dry,B-NAME_OF_DISEASE,3206
66009,eye,I-NAME_OF_DISEASE,3206
66010,Dry,B-NAME_OF_DISEASE,3206
66011,eye,I-NAME_OF_DISEASE,3206
66012,disease,I-NAME_OF_DISEASE,3206
66013,DED,B-NAME_OF_DISEASE,3206
66014,is,O,3206
66015,a,O,3206
66016,multifactorial,O,3206
66017,disease,O,3206
66018,of,O,3206
66019,the,B-PART_OF_THE_EYES,3206
66020,ocular,I-PART_OF_THE_EYES,3206
66021,surface,I-PART_OF_THE_EYES,3206
66022,characterized,O,3206
66023,by,O,3206
66024,a,B-SIGN_AND_SYMPTOM,3206
66025,loss,I-SIGN_AND_SYMPTOM,3206
66026,of,I-SIGN_AND_SYMPTOM,3207
66027,homeostasis,I-SIGN_AND_SYMPTOM,3207
66028,of,I-SIGN_AND_SYMPTOM,3207
66029,the,I-SIGN_AND_SYMPTOM,3207
66030,tear,I-SIGN_AND_SYMPTOM,3207
66031,film,I-SIGN_AND_SYMPTOM,3207
66032,that,O,3207
66033,is,O,3207
66034,accompanied,O,3207
66035,by,O,3207
66036,ocular,O,3207
66037,symptoms,O,3207
66038,DED,B-NAME_OF_DISEASE,3207
66039,is,O,3207
66040,frequently,O,3207
66041,associated,O,3207
66042,with,O,3207
66043,the,B-SIGN_AND_SYMPTOM,3207
66044,instability,I-SIGN_AND_SYMPTOM,3207
66045,and,I-SIGN_AND_SYMPTOM,3207
66046,hyperosmolarity,I-SIGN_AND_SYMPTOM,3207
66047,of,I-SIGN_AND_SYMPTOM,3207
66048,tear,I-SIGN_AND_SYMPTOM,3207
66049,films,I-SIGN_AND_SYMPTOM,3207
66050,inflammation,I-SIGN_AND_SYMPTOM,3207
66051,of,I-SIGN_AND_SYMPTOM,3207
66052,the,I-SIGN_AND_SYMPTOM,3207
66053,ocular,I-SIGN_AND_SYMPTOM,3207
66054,surface,I-SIGN_AND_SYMPTOM,3207
66055,and,I-SIGN_AND_SYMPTOM,3207
66056,neurosensory,I-SIGN_AND_SYMPTOM,3207
66057,abnormalities,I-SIGN_AND_SYMPTOM,3208
66058,DED,B-NAME_OF_DISEASE,3208
66059,is,O,3208
66060,one,O,3208
66061,of,O,3208
66062,the,O,3208
66063,most,O,3208
66064,prevalent,O,3208
66065,ocular,O,3208
66066,diseases,O,3208
66067,worldwide,O,3208
66068,and,O,3208
66069,significantly,O,3208
66070,reduces,O,3208
66071,the,O,3208
66072,quality,O,3208
66073,of,O,3208
66074,life,O,3208
66075,The,B-SIGN_AND_SYMPTOM,3208
66076,inflammation,I-SIGN_AND_SYMPTOM,3208
66077,of,I-SIGN_AND_SYMPTOM,3208
66078,the,I-SIGN_AND_SYMPTOM,3208
66079,ocular,I-SIGN_AND_SYMPTOM,3208
66080,surface,I-SIGN_AND_SYMPTOM,3208
66081,is,O,3209
66082,a,O,3209
66083,key,O,3209
66084,component,O,3209
66085,of,O,3209
66086,the,O,3209
66087,pathophysiology,O,3209
66088,of,O,3209
66089,DED,B-NAME_OF_DISEASE,3209
66090,Owing,O,3209
66091,to,O,3209
66092,the,O,3210
66093,role,O,3210
66094,of,O,3210
66095,inflammation,O,3210
66096,in,O,3210
66097,DED,B-NAME_OF_DISEASE,3210
66098,numerous,O,3210
66099,novel,O,3210
66100,therapeutic,O,3210
66101,agents,O,3210
66102,have,O,3210
66103,been,O,3210
66104,investigated,O,3210
66105,for,O,3210
66106,inhibiting,O,3211
66107,various,O,3211
66108,inflammatory,O,3211
66109,cascades,O,3211
66110,To,O,3211
66111,date,O,3211
66112,the,O,3211
66113,most,O,3211
66114,well-known,O,3211
66115,anti-inflammatory,B-NAME_OF_DRUG,3212
66116,agents,I-NAME_OF_DRUG,3212
66117,approved,O,3212
66118,by,O,3212
66119,the,B-GPE,3212
66120,US,I-GPE,3212
66121,Food,B-ORGANIZATION,3212
66122,and,I-ORGANIZATION,3212
66123,Drug,I-ORGANIZATION,3212
66124,Administration,I-ORGANIZATION,3212
66125,FDA,I-ORGANIZATION,3212
66126,for,O,3212
66127,the,O,3212
66128,management,O,3212
66129,of,O,3212
66130,DED,B-NAME_OF_DISEASE,3212
66131,include,O,3212
66132,cyclosporin,B-NAME_OF_DRUG,3212
66133,A,I-NAME_OF_DRUG,3212
66134,CsA,B-NAME_OF_DRUG,3212
66135,lifitegrast,B-NAME_OF_DRUG,3212
66136,LG,B-NAME_OF_DRUG,3212
66137,corticosteroid,B-NAME_OF_DRUG,3212
66138,Corticosteroids,B-NAME_OF_DRUG,3212
66139,are,O,3212
66140,widely,O,3212
66141,used,O,3212
66142,for,O,3212
66143,the,O,3212
66144,treatment,O,3212
66145,of,O,3212
66146,both,O,3212
66147,acute,O,3212
66148,and,O,3212
66149,chronic,O,3212
66150,inflammation,O,3212
66151,and,O,3212
66152,topical,B-NAME_OF_DRUG,3212
66153,corticosteroids,B-NAME_OF_DRUG,3212
66154,are,O,3212
66155,generally,O,3212
66156,indicated,O,3212
66157,for,O,3212
66158,the,O,3212
66159,treatment,O,3212
66160,of,O,3212
66161,ocular,O,3212
66162,inflammatory,O,3212
66163,diseases,O,3212
66164,Corticosteroids,B-NAME_OF_DRUG,3212
66165,inhibit,O,3212
66166,pro-inflammatory,O,3212
66167,cytokines,B-CHEMICAL_COMPOUND,3212
66168,and,O,3212
66169,chemokines,B-CHEMICAL_COMPOUND,3212
66170,stabilize,O,3212
66171,macrophages,O,3212
66172,and,O,3212
66173,neutrophils,O,3212
66174,and,O,3213
66175,repress,O,3213
66176,the,O,3213
66177,key,O,3213
66178,enzymes,B-CHEMICAL_COMPOUND,3213
66179,involved,O,3213
66180,in,O,3213
66181,the,O,3213
66182,initiation,O,3213
66183,or,O,3213
66184,maintenance,O,3213
66185,of,O,3213
66186,the,O,3214
66187,inflammatory,O,3214
66188,response,O,3214
66189,Therefore,O,3214
66190,corticosteroids,B-NAME_OF_DRUG,3214
66191,are,O,3214
66192,generally,O,3214
66193,thought,O,3214
66194,to,O,3214
66195,be,O,3214
66196,more,O,3214
66197,potent,O,3214
66198,than,O,3214
66199,other,O,3214
66200,therapeutic,O,3214
66201,agents,O,3214
66202,for,O,3214
66203,DED,B-NAME_OF_DISEASE,3214
66204,including,O,3214
66205,CsA,B-NAME_OF_DRUG,3214
66206,LG,B-NAME_OF_DRUG,3214
66207,and,O,3214
66208,diquafosol,B-NAME_OF_DRUG,3214
66209,owing,O,3214
66210,to,O,3214
66211,acting,O,3214
66212,on,O,3214
66213,the,O,3214
66214,multiple,O,3214
66215,mechanisms,O,3214
66216,by,O,3214
66217,which,O,3215
66218,corticosteroids,B-NAME_OF_DRUG,3215
66219,inhibit,O,3215
66220,inflammation,O,3215
66221,Topical,B-NAME_OF_DRUG,3215
66222,corticosteroids,I-NAME_OF_DRUG,3215
66223,are,O,3215
66224,also,O,3215
66225,effective,O,3215
66226,in,O,3215
66227,controlling,O,3215
66228,the,O,3215
66229,signs,O,3215
66230,and,O,3215
66231,symptoms,O,3215
66232,of,O,3215
66233,chronic,O,3215
66234,severe,O,3215
66235,DED,B-NAME_OF_DISEASE,3215
66236,associated,O,3215
66237,with,O,3215
66238,the,B-NAME_OF_DISEASE,3215
66239,Sjogren,I-NAME_OF_DISEASE,3215
66240,syndrome,I-NAME_OF_DISEASE,3215
66241,and,O,3215
66242,in,O,3215
66243,the,O,3216
66244,treatment,O,3216
66245,of,O,3216
66246,moderate,O,3216
66247,and,O,3216
66248,severe,O,3216
66249,meibomian,B-NAME_OF_DISEASE,3216
66250,gland,I-NAME_OF_DISEASE,3216
66251,dysfunction,I-NAME_OF_DISEASE,3216
66252,MGD,I-NAME_OF_DISEASE,3217
66253,,O,3218
66254,Additionally,O,3218
66255,short-term,O,3218
66256,induction,O,3218
66257,therapy,O,3218
66258,before,O,3218
66259,long-term,O,3218
66260,treatment,O,3218
66261,with,O,3218
66262,CsA,B-NAME_OF_DRUG,3218
66263,or,O,3218
66264,combined,O,3218
66265,therapy,O,3218
66266,with,O,3218
66267,corticosteroids,B-NAME_OF_DRUG,3218
66268,and,O,3218
66269,CsA,B-NAME_OF_DRUG,3218
66270,shows,O,3218
66271,greater,O,3218
66272,symptomatic,O,3218
66273,relief,O,3218
66274,and,O,3218
66275,faster,O,3218
66276,recovery,O,3218
66277,from,O,3218
66278,the,O,3219
66279,signs,O,3219
66280,of,O,3219
66281,DED,B-NAME_OF_DISEASE,3219
66282,compared,O,3219
66283,to,O,3219
66284,monotherapy,O,3220
66285,with,O,3221
66286,CsA,B-NAME_OF_DRUG,3221
66287,Ophthalmologists,O,3221
66288,can,O,3221
66289,now,O,3221
66290,prescribe,O,3221
66291,a,B-NAME_OF_DRUG,3222
66292,corticosteroid,I-NAME_OF_DRUG,3222
66293,for,O,3222
66294,the,O,3222
66295,treatment,O,3222
66296,of,O,3222
66297,dry,B-NAME_OF_DISEASE,3222
66298,eye,I-NAME_OF_DISEASE,3222
66299,disease,I-NAME_OF_DISEASE,3222
66300,DED,I-NAME_OF_DISEASE,3222
66301,with,O,3222
66302,the,O,3222
66303,confidence,O,3222
66304,that,O,3222
66305,they,O,3223
66306,are,O,3224
66307,doing,O,3224
66308,so,O,3224
66309,on-label,O,3224
66310,following,O,3224
66311,the,O,3224
66312,recent,O,3224
66313,United,B-GPE,3224
66314,States,I-GPE,3224
66315,Food,B-ORGANIZATION,3224
66316,and,I-ORGANIZATION,3224
66317,Drug,I-ORGANIZATION,3224
66318,Administration,I-ORGANIZATION,3224
66319,FDA,I-ORGANIZATION,3224
66320,approval,O,3224
66321,of,O,3224
66322,a,B-NAME_OF_DRUG,3224
66323,topical,I-NAME_OF_DRUG,3224
66324,corticosteroid,I-NAME_OF_DRUG,3224
66325,for,O,3224
66326,short-term,O,3224
66327,up,B-TIME_DURATION,3224
66328,to,I-TIME_DURATION,3225
66329,2,I-TIME_DURATION,3225
66330,weeks,I-TIME_DURATION,3225
66331,use,O,3225
66332,Loteprednol,O,3225
66333,etabonate,O,3225
66334,ophthalmic,O,3225
66335,suspension,O,3225
66336,0.25,O,3225
66337,Eysuvis,O,3225
66338,Kala,O,3225
66339,Pharmaceuticals,O,3225
66340,has,O,3225
66341,a,O,3225
66342,favourable,O,3225
66343,adverse,O,3225
66344,effect,O,3225
66345,profile,O,3225
66346,and,O,3225
66347,a,O,3225
66348,unique,O,3225
66349,mechanism,O,3225
66350,of,O,3225
66351,action,O,3226
66352,that,O,3226
66353,is,O,3226
66354,worth,O,3226
66355,a,O,3226
66356,closer,O,3226
66357,look,O,3226
66358,The,O,3226
66359,drug,O,3226
66360,product,O,3226
66361,was,O,3226
66362,studied,O,3226
66363,in,O,3226
66364,the,O,3226
66365,largest,O,3227
66366,clinical,O,3227
66367,programme,O,3227
66368,in,O,3227
66369,DED,B-NAME_OF_DISEASE,3227
66370,to,O,3227
66371,date,O,3227
66372,including,O,3227
66373,more,O,3227
66374,than,O,3227
66375,2,O,3227
66376,800,O,3227
66377,patients,O,3227
66378,In,O,3227
66379,results,O,3228
66380,from,O,3228
66381,the,B-NAME_OF_STUDY,3228
66382,STRIDE,I-NAME_OF_STUDY,3228
66383,1,I-NAME_OF_STUDY,3228
66384,and,I-NAME_OF_STUDY,3228
66385,STRIDE,I-NAME_OF_STUDY,3228
66386,2,I-NAME_OF_STUDY,3228
66387,trials,I-NAME_OF_STUDY,3228
66388,conducted,O,3228
66389,by,O,3228
66390,Kala,B-ORGANIZATION,3228
66391,Pharmaceuticals,I-ORGANIZATION,3228
66392,it,O,3228
66393,illustrated,O,3228
66394,a,O,3228
66395,beneficial,O,3228
66396,safety,O,3228
66397,profile,O,3228
66398,demonstrating,O,3228
66399,similar,O,3228
66400,intraocular,O,3229
66401,pressure,O,3229
66402,IOP,O,3229
66403,levels,O,3229
66404,to,O,3229
66405,the,O,3230
66406,vehicle,O,3230
66407,arm,O,3230
66408,In,O,3230
66409,treatment,O,3230
66410,and,O,3230
66411,vehicle,O,3230
66412,groups,O,3230
66413,respectively,O,3230
66414,0.2,O,3230
66415,and,O,3230
66416,0%,O,3230
66417,of,O,3230
66418,participants,O,3230
66419,experienced,O,3230
66420,a,O,3230
66421,10,O,3230
66422,mm,O,3230
66423,Hg,O,3230
66424,or,O,3230
66425,greater,O,3231
66426,increase,O,3231
66427,from,O,3231
66428,baseline,O,3231
66429,resulting,O,3231
66430,in,O,3231
66431,an,O,3231
66432,IOP,O,3231
66433,measurement,O,3231
66434,of,O,3231
66435,21,O,3231
66436,mm,O,3231
66437,Hg,O,3231
66438,or,O,3231
66439,greater,O,3231
66440,at,O,3231
66441,any,O,3231
66442,post-baseline,O,3231
66443,visit,O,3231
66444,up,O,3231
66445,to,O,3231
66446,29,O,3231
66447,days,O,3231
66448,In,O,3231
66449,the,B-NAME_OF_STUDY,3231
66450,STRIDE,I-NAME_OF_STUDY,3231
66451,trials,I-NAME_OF_STUDY,3232
66452,investigators,O,3232
66453,observed,O,3232
66454,statistically,O,3232
66455,significant,O,3232
66456,improvement,O,3232
66457,in,O,3232
66458,the,O,3232
66459,measures,O,3232
66460,of,O,3232
66461,conjunctival,B-SIGN_AND_SYMPTOM,3232
66462,hyperaemia,I-SIGN_AND_SYMPTOM,3232
66463,and,O,3232
66464,patient-reported,O,3232
66465,ocular,O,3232
66466,discomfort,O,3232
66467,severity,O,3232
66468,scores,O,3232
66469,Participants,O,3232
66470,assigned,O,3232
66471,to,O,3232
66472,treatment,O,3232
66473,with,O,3232
66474,the,B-NAME_OF_DRUG,3232
66475,loteprednol,I-NAME_OF_DRUG,3232
66476,etabonate,I-NAME_OF_DRUG,3232
66477,suspension,I-NAME_OF_DRUG,3232
66478,product,I-NAME_OF_DRUG,3232
66479,experienced,O,3233
66480,rapid,O,3233
66481,relief,O,3233
66482,with,O,3233
66483,improvement,O,3233
66484,in,O,3233
66485,symptoms,O,3233
66486,as,O,3233
66487,early,O,3233
66488,as,O,3233
66489,Day,O,3233
66490,The,B-NAME_OF_DRUG,3233
66491,ophthalmic,I-NAME_OF_DRUG,3233
66492,suspension,I-NAME_OF_DRUG,3233
66493,has,O,3233
66494,a,O,3233
66495,novel,O,3233
66496,formulation,O,3233
66497,which,O,3233
66498,utlises,O,3233
66499,Kala,B-ORGANIZATION,3233
66500,Pharmaceuticals,I-ORGANIZATION,3233
66501,proprietary,O,3233
66502,mucus-penetrating,O,3233
66503,particle,O,3233
66504,technology,O,3233
66505,These,O,3233
66506,nanoparticles,O,3233
66507,of,O,3233
66508,approximately,O,3233
66509,300,O,3233
66510,nm,O,3233
66511,in,O,3233
66512,diameter,O,3233
66513,are,O,3234
66514,coated,O,3234
66515,to,O,3234
66516,facilitate,O,3234
66517,their,O,3234
66518,penetration,O,3234
66519,through,O,3234
66520,the,O,3234
66521,mucus,O,3234
66522,barrier,O,3235
66523,This,O,3235
66524,controlled,O,3235
66525,delivery,O,3235
66526,system,O,3235
66527,enables,O,3235
66528,the,O,3235
66529,drug,O,3235
66530,to,O,3235
66531,spread,O,3235
66532,more,O,3235
66533,uniformly,O,3235
66534,on,O,3235
66535,the,B-PART_OF_THE_EYES,3235
66536,ocular,I-PART_OF_THE_EYES,3235
66537,surface,I-PART_OF_THE_EYES,3235
66538,to,O,3235
66539,achieve,O,3235
66540,longer,O,3235
66541,retention,O,3235
66542,and,O,3235
66543,allow,O,3235
66544,enhanced,O,3235
66545,penetration,O,3235
66546,to,O,3235
66547,the,O,3235
66548,target,O,3235
66549,tissues,O,3235
66550,specifically,O,3235
66551,the,B-PART_OF_THE_EYES,3235
66552,cornea,I-PART_OF_THE_EYES,3235
66553,and,O,3235
66554,the,B-PART_OF_THE_EYES,3236
66555,conjunctiva,I-PART_OF_THE_EYES,3236
66556,The,O,3236
66557,formulation,O,3236
66558,has,O,3236
66559,demonstrated,O,3236
66560,broad-spectrum,O,3236
66561,anti-inflammatory,O,3236
66562,action,O,3236
66563,leading,O,3236
66564,to,O,3236
66565,a,O,3236
66566,more,O,3237
66567,efficient,O,3237
66568,and,O,3237
66569,effective,O,3238
66570,nanoparticle,O,3238
66571,drug,O,3238
66572,that,O,3238
66573,rapidly,O,3238
66574,reduces,O,3238
66575,the,O,3238
66576,symptoms,O,3238
66577,and,O,3238
66578,signs,O,3238
66579,of,O,3238
66580,DED,B-NAME_OF_DISEASE,3238
66581,including,O,3238
66582,in,O,3238
66583,those,O,3239
66584,patients,O,3239
66585,with,O,3239
66586,periodic,O,3239
66587,acute,O,3239
66588,exacerbations,O,3239
66589,of,O,3239
66590,worsening,O,3239
66591,symptoms,O,3240
66592,referred,O,3240
66593,to,O,3240
66594,as,O,3240
66595,dry,B-SIGN_AND_SYMPTOM,3240
66596,eye,I-SIGN_AND_SYMPTOM,3240
66597,flares,I-SIGN_AND_SYMPTOM,3240
66598,Relieving,O,3241
66599,chronic,O,3241
66600,disease,O,3241
66601,and,O,3241
66602,flares,O,3241
66603,DED,B-NAME_OF_DISEASE,3241
66604,is,O,3241
66605,an,O,3241
66606,inflammatory,O,3241
66607,disease,O,3241
66608,in,O,3242
66609,which,O,3242
66610,an,B-SIGN_AND_SYMPTOM,3242
66611,unstable,I-SIGN_AND_SYMPTOM,3242
66612,and,I-SIGN_AND_SYMPTOM,3242
66613,hyperosmolar,I-SIGN_AND_SYMPTOM,3242
66614,tear,I-SIGN_AND_SYMPTOM,3242
66615,film,I-SIGN_AND_SYMPTOM,3242
66616,sets,I-SIGN_AND_SYMPTOM,3242
66617,off,I-SIGN_AND_SYMPTOM,3242
66618,a,I-SIGN_AND_SYMPTOM,3242
66619,cascading,I-SIGN_AND_SYMPTOM,3242
66620,sequence,I-SIGN_AND_SYMPTOM,3242
66621,of,I-SIGN_AND_SYMPTOM,3242
66622,inflammatory,I-SIGN_AND_SYMPTOM,3242
66623,activity,I-SIGN_AND_SYMPTOM,3243
66624,on,I-SIGN_AND_SYMPTOM,3243
66625,the,I-SIGN_AND_SYMPTOM,3243
66626,ocular,I-SIGN_AND_SYMPTOM,3243
66627,surface,I-SIGN_AND_SYMPTOM,3243
66628,As,O,3243
66629,with,O,3243
66630,other,O,3243
66631,chronic,O,3243
66632,inflammatory,O,3243
66633,conditions,O,3243
66634,such,O,3243
66635,as,O,3243
66636,asthma,B-NAME_OF_DISEASE,3243
66637,and,O,3243
66638,rheumatoid,B-NAME_OF_DISEASE,3243
66639,arthritis,I-NAME_OF_DISEASE,3243
66640,most,O,3243
66641,patients,O,3243
66642,with,O,3244
66643,DED,B-NAME_OF_DISEASE,3244
66644,have,O,3244
66645,chronic,O,3244
66646,disease,O,3244
66647,with,O,3244
66648,dry,B-SIGN_AND_SYMPTOM,3244
66649,eye,I-SIGN_AND_SYMPTOM,3244
66650,flares,I-SIGN_AND_SYMPTOM,3244
66651,The,B-PART_OF_THE_EYES,3244
66652,Tear,I-PART_OF_THE_EYES,3244
66653,Film,I-PART_OF_THE_EYES,3244
66654,Ocular,B-PART_OF_THE_EYES,3244
66655,Surface,I-PART_OF_THE_EYES,3244
66656,Society,O,3244
66657,Dry,B-NAME_OF_DISEASE,3244
66658,Eye,I-NAME_OF_DISEASE,3244
66659,Workshop,O,3244
66660,II,O,3244
66661,notes,O,3244
66662,that,O,3244
66663,patients,O,3245
66664,can,O,3245
66665,initially,O,3245
66666,present,O,3245
66667,with,O,3245
66668,episodic,B-SIGN_AND_SYMPTOM,3245
66669,dry,B-NAME_OF_DISEASE,3245
66670,eye,I-NAME_OF_DISEASE,3245
66671,in,O,3245
66672,the,O,3245
66673,absence,O,3245
66674,of,O,3245
66675,chronicity,O,3246
66676,Myriad,O,3246
66677,triggers,O,3246
66678,with,O,3246
66679,varied,O,3246
66680,intensity,O,3246
66681,such,O,3246
66682,as,O,3246
66683,wind,B-CAUSE_OF_DISEASE,3246
66684,low,B-CAUSE_OF_DISEASE,3246
66685,humidity,I-CAUSE_OF_DISEASE,3246
66686,air,B-CAUSE_OF_DISEASE,3246
66687,conditioning,I-CAUSE_OF_DISEASE,3246
66688,prolonged,B-CAUSE_OF_DISEASE,3246
66689,reading,I-CAUSE_OF_DISEASE,3246
66690,visual,I-CAUSE_OF_DISEASE,3246
66691,tasks,I-CAUSE_OF_DISEASE,3246
66692,and,O,3246
66693,exposure,B-CAUSE_OF_DISEASE,3246
66694,to,I-CAUSE_OF_DISEASE,3246
66695,increased,I-CAUSE_OF_DISEASE,3246
66696,ozone,I-CAUSE_OF_DISEASE,3246
66697,concentrations,I-CAUSE_OF_DISEASE,3246
66698,have,O,3246
66699,been,O,3246
66700,shown,O,3246
66701,to,O,3246
66702,increase,O,3246
66703,the,O,3246
66704,incidence,O,3246
66705,of,O,3246
66706,flares,O,3246
66707,These,O,3246
66708,inflammatory,O,3246
66709,spikes,O,3247
66710,occur,O,3247
66711,in,O,3247
66712,approximately,O,3247
66713,eight,O,3247
66714,out,O,3247
66715,of,O,3247
66716,10,O,3247
66717,patients,O,3247
66718,with,O,3247
66719,dry,B-NAME_OF_DISEASE,3247
66720,eyes,I-NAME_OF_DISEASE,3247
66721,and,O,3247
66722,approximately,O,3247
66723,half,O,3248
66724,of,O,3248
66725,patients,O,3248
66726,with,O,3248
66727,DED,B-NAME_OF_DISEASE,3248
66728,experience,O,3248
66729,fl,O,3248
66730,ares,O,3248
66731,without,O,3248
66732,continuous,O,3248
66733,symptoms,O,3248
66734,fourto-six,O,3248
66735,times,O,3248
66736,per,O,3248
66737,year,O,3248
66738,Particularly,O,3248
66739,in,O,3248
66740,relation,O,3248
66741,to,O,3248
66742,the,O,3248
66743,COVID-19,B-NAME_OF_DISEASE,3248
66744,pandemic,O,3248
66745,I,O,3248
66746,have,O,3248
66747,seen,O,3249
66748,more,O,3249
66749,patients,O,3249
66750,presenting,O,3249
66751,with,O,3249
66752,acute,O,3249
66753,dry,B-NAME_OF_DISEASE,3249
66754,eye,I-NAME_OF_DISEASE,3249
66755,symptoms,O,3249
66756,who,O,3249
66757,have,O,3249
66758,never,O,3249
66759,before,O,3249
66760,been,O,3249
66761,symptomatic,O,3249
66762,Many,O,3250
66763,are,O,3250
66764,spending,O,3250
66765,12-Oct,B-TIME_DURATION,3250
66766,hours,I-TIME_DURATION,3250
66767,a,O,3250
66768,day,O,3250
66769,staring,O,3250
66770,at,O,3250
66771,computer,O,3250
66772,screens,O,3250
66773,Additionally,O,3250
66774,the,O,3250
66775,data,O,3250
66776,show,O,3250
66777,that,O,3250
66778,there,O,3250
66779,is,O,3250
66780,an,O,3250
66781,under-diagnosis,O,3250
66782,and,O,3250
66783,under-recognition,O,3251
66784,of,O,3251
66785,DED,B-NAME_OF_DISEASE,3251
66786,overall,O,3251
66787,In,O,3251
66788,general,O,3251
66789,we,O,3251
66790,prescribe,O,3251
66791,loteprednol,O,3251
66792,etabonate,O,3251
66793,ophthalmic,O,3251
66794,suspension,O,3251
66795,0.25,O,3251
66796,for,O,3251
66797,patients,O,3251
66798,who,O,3252
66799,have,O,3252
66800,periodic,O,3252
66801,exacerbations,O,3252
66802,of,O,3252
66803,dry,B-NAME_OF_DISEASE,3252
66804,eye,I-NAME_OF_DISEASE,3252
66805,including,O,3252
66806,those,O,3252
66807,who,O,3252
66808,are,O,3252
66809,self-medicating,O,3252
66810,with,O,3252
66811,artifi,O,3252
66812,cial,O,3252
66813,tears,O,3252
66814,those,O,3253
66815,with,O,3253
66816,ocular,B-NAME_OF_DISEASE,3253
66817,allergies,I-NAME_OF_DISEASE,3253
66818,or,O,3253
66819,those,O,3253
66820,with,O,3253
66821,contact,O,3253
66822,lens-associated,O,3253
66823,issues,O,3253
66824,patients,O,3253
66825,with,O,3253
66826,chronic,B-NAME_OF_DISEASE,3254
66827,DED,I-NAME_OF_DISEASE,3254
66828,who,O,3254
66829,need,O,3254
66830,induction,O,3254
66831,therapy,O,3254
66832,to,O,3254
66833,quell,O,3254
66834,surface,O,3254
66835,inflammation,O,3255
66836,quickly,O,3255
66837,in,O,3255
66838,order,O,3255
66839,to,O,3255
66840,initiate,O,3255
66841,chronic,O,3255
66842,therapy,O,3255
66843,and,O,3255
66844,patients,O,3255
66845,with,O,3255
66846,breakthrough,B-SIGN_AND_SYMPTOM,3255
66847,dry,I-SIGN_AND_SYMPTOM,3255
66848,eye,I-SIGN_AND_SYMPTOM,3256
66849,flares,I-SIGN_AND_SYMPTOM,3256
66850,who,O,3256
66851,are,O,3256
66852,on,O,3256
66853,chronic,O,3256
66854,therapy,O,3257
66855,Recent,O,3257
66856,Cases,O,3257
66857,Two,O,3257
66858,recent,O,3257
66859,examples,O,3257
66860,from,O,3257
66861,our,O,3257
66862,practice,O,3257
66863,are,O,3257
66864,discussed,O,3257
66865,as,O,3257
66866,follows,O,3257
66867,Case,O,3257
66868,1,O,3257
66869,-,O,3257
66870,A,O,3257
66871,42-year-old,O,3257
66872,female,O,3257
66873,contact,O,3257
66874,lens,O,3257
66875,wearer,O,3257
66876,was,O,3257
66877,referred,O,3257
66878,to,O,3257
66879,us,O,3258
66880,for,O,3258
66881,consultation,O,3258
66882,for,O,3258
66883,dry,B-NAME_OF_DISEASE,3258
66884,eye,I-NAME_OF_DISEASE,3258
66885,due,O,3258
66886,to,O,3258
66887,irritation,O,3258
66888,from,O,3258
66889,dust,B-CAUSE_OF_DISEASE,3258
66890,created,I-CAUSE_OF_DISEASE,3258
66891,by,I-CAUSE_OF_DISEASE,3258
66892,construction,I-CAUSE_OF_DISEASE,3258
66893,work,I-CAUSE_OF_DISEASE,3258
66894,on,I-CAUSE_OF_DISEASE,3258
66895,a,I-CAUSE_OF_DISEASE,3258
66896,nearby,I-CAUSE_OF_DISEASE,3258
66897,office,I-CAUSE_OF_DISEASE,3258
66898,She,O,3258
66899,had,O,3258
66900,swelling,B-SIGN_AND_SYMPTOM,3258
66901,in,I-SIGN_AND_SYMPTOM,3259
66902,the,I-SIGN_AND_SYMPTOM,3259
66903,left,I-SIGN_AND_SYMPTOM,3259
66904,eye,I-SIGN_AND_SYMPTOM,3259
66905,with,I-SIGN_AND_SYMPTOM,3259
66906,severe,I-SIGN_AND_SYMPTOM,3259
66907,discomfort,I-SIGN_AND_SYMPTOM,3259
66908,and,I-SIGN_AND_SYMPTOM,3259
66909,complaints,I-SIGN_AND_SYMPTOM,3259
66910,of,I-SIGN_AND_SYMPTOM,3259
66911,dryness,I-SIGN_AND_SYMPTOM,3259
66912,in,I-SIGN_AND_SYMPTOM,3259
66913,both,I-SIGN_AND_SYMPTOM,3259
66914,eyes,I-SIGN_AND_SYMPTOM,3260
66915,for,O,3260
66916,5,B-TIME_DURATION,3260
66917,weeks,I-TIME_DURATION,3260
66918,and,O,3260
66919,it,O,3260
66920,was,O,3260
66921,getting,O,3260
66922,progressively,O,3260
66923,worse,O,3260
66924,The,O,3260
66925,patient,O,3260
66926,had,O,3260
66927,initially,O,3261
66928,been,O,3261
66929,placed,O,3261
66930,on,O,3261
66931,tobramycin-dexamethasone,O,3261
66932,0.3,O,3261
66933,0.1,O,3261
66934,twice,O,3261
66935,a,O,3261
66936,day,O,3261
66937,and,O,3261
66938,had,O,3261
66939,a,O,3261
66940,95%,O,3261
66941,improvement,O,3261
66942,within,O,3261
66943,the,O,3261
66944,fi,O,3261
66945,rst,O,3261
66946,week,O,3261
66947,however,O,3261
66948,on,O,3262
66949,re-examination,O,3262
66950,her,O,3262
66951,IOP,O,3262
66952,had,O,3262
66953,gone,O,3262
66954,up,O,3262
66955,to,O,3262
66956,35,O,3262
66957,mm,O,3262
66958,Hg,O,3262
66959,She,O,3262
66960,was,O,3262
66961,then,O,3262
66962,prescribed,O,3262
66963,brimonidine-timolol,O,3262
66964,0.2,O,3262
66965,0.5,O,3262
66966,Combigan,O,3262
66967,Allergan,O,3262
66968,to,O,3263
66969,decrease,O,3263
66970,the,O,3263
66971,pressure,O,3263
66972,However,O,3263
66973,her,O,3263
66974,symptoms,O,3263
66975,worsened,O,3263
66976,when,O,3263
66977,she,O,3263
66978,had,O,3263
66979,an,O,3263
66980,allergic,O,3263
66981,reaction,O,3263
66982,to,O,3263
66983,the,O,3263
66984,brimonidine-timolol,O,3263
66985,0.2,O,3263
66986,0.50%,O,3263
66987,Although,O,3263
66988,the,O,3263
66989,drops,O,3263
66990,were,O,3263
66991,discontinued,O,3263
66992,her,O,3264
66993,symptoms,O,3264
66994,continued,O,3264
66995,to,O,3264
66996,worsen,O,3264
66997,with,O,3264
66998,significant,O,3264
66999,discomfort,B-SIGN_AND_SYMPTOM,3264
67000,and,I-SIGN_AND_SYMPTOM,3264
67001,redness,I-SIGN_AND_SYMPTOM,3264
67002,and,O,3264
67003,she,O,3264
67004,needed,O,3264
67005,artificial,B-TREATMENT,3264
67006,tears,I-TREATMENT,3264
67007,every,O,3264
67008,hour,O,3265
67009,By,O,3265
67010,the,O,3265
67011,time,O,3265
67012,she,O,3265
67013,saw,O,3265
67014,us,O,3265
67015,it,O,3265
67016,was,O,3265
67017,her,O,3265
67018,11th,O,3265
67019,visit,O,3265
67020,to,O,3265
67021,a,O,3265
67022,doctor,O,3265
67023,in,B-TIME_DURATION,3265
67024,5,I-TIME_DURATION,3265
67025,weeks,I-TIME_DURATION,3265
67026,and,O,3265
67027,she,O,3265
67028,was,O,3265
67029,desperate,O,3265
67030,for,O,3266
67031,relief,O,3266
67032,We,O,3266
67033,gave,O,3266
67034,her,O,3266
67035,a,O,3266
67036,diagnosis,O,3266
67037,of,O,3266
67038,allergic,B-NAME_OF_DISEASE,3266
67039,conjunctivitis,I-NAME_OF_DISEASE,3266
67040,contact,B-NAME_OF_DISEASE,3266
67041,lens,I-NAME_OF_DISEASE,3266
67042,overwear,I-NAME_OF_DISEASE,3266
67043,and,O,3266
67044,dry,B-NAME_OF_DISEASE,3266
67045,eyes,I-NAME_OF_DISEASE,3266
67046,We,O,3266
67047,discontinued,O,3266
67048,all,O,3267
67049,previous,O,3267
67050,drops,O,3267
67051,and,O,3267
67052,put,O,3267
67053,her,O,3267
67054,on,O,3267
67055,loteprednol,O,3267
67056,etabonate,O,3267
67057,ophthalmic,O,3267
67058,suspension,O,3267
67059,0.25,O,3268
67060,every,O,3268
67061,other,O,3268
67062,day,O,3268
67063,four,O,3268
67064,times,O,3268
67065,a,O,3268
67066,day,O,3268
67067,for,B-TIME_DURATION,3268
67068,2,I-TIME_DURATION,3268
67069,weeks,I-TIME_DURATION,3268
67070,preservative-free,B-TREATMENT,3268
67071,tears,I-TREATMENT,3268
67072,four,O,3268
67073,times,O,3268
67074,a,O,3268
67075,day,O,3268
67076,and,O,3268
67077,extra-strength,O,3268
67078,over-thecounter,O,3268
67079,olopatadine,O,3268
67080,0.7,O,3268
67081,Pataday,O,3269
67082,Alcon,O,3269
67083,twice,O,3269
67084,a,O,3269
67085,day,O,3269
67086,Within,B-TIME_DURATION,3269
67087,1,I-TIME_DURATION,3269
67088,week,I-TIME_DURATION,3269
67089,she,O,3269
67090,had,O,3269
67091,great,O,3269
67092,improvement,O,3269
67093,in,O,3269
67094,all,O,3269
67095,her,O,3269
67096,symptoms,O,3269
67097,and,O,3269
67098,felt,O,3269
67099,that,O,3269
67100,her,O,3269
67101,eyes,O,3269
67102,were,O,3269
67103,back,O,3269
67104,to,O,3269
67105,normal,O,3269
67106,She,O,3269
67107,completed,O,3269
67108,the,O,3269
67109,treatment,O,3269
67110,course,O,3269
67111,with,O,3269
67112,full,O,3269
67113,resolution,O,3270
67114,of,O,3270
67115,her,O,3270
67116,symptoms,O,3270
67117,and,O,3270
67118,much,O,3270
67119,to,O,3271
67120,her,O,3271
67121,relief,O,3271
67122,and,O,3271
67123,that,O,3271
67124,of,O,3271
67125,her,O,3271
67126,referring,O,3271
67127,provider,O,3271
67128,no,O,3271
67129,increase,O,3272
67130,in,O,3272
67131,IOP,O,3272
67132,Case,O,3272
67133,2,O,3272
67134,-,O,3272
67135,A,O,3272
67136,78-year-old,O,3272
67137,woman,O,3272
67138,with,O,3272
67139,a,O,3272
67140,variety,O,3272
67141,of,O,3273
67142,medical,O,3273
67143,problems,O,3273
67144,including,O,3273
67145,multiple,O,3273
67146,myeloma,B-NAME_OF_DISEASE,3273
67147,and,O,3273
67148,colon,B-NAME_OF_DISEASE,3273
67149,cancer,I-NAME_OF_DISEASE,3273
67150,was,O,3273
67151,referred,O,3273
67152,for,O,3273
67153,evaluation,O,3273
67154,of,O,3273
67155,severe,B-SIGN_AND_SYMPTOM,3273
67156,dryness,I-SIGN_AND_SYMPTOM,3273
67157,in,I-SIGN_AND_SYMPTOM,3273
67158,both,I-SIGN_AND_SYMPTOM,3273
67159,eyes,I-SIGN_AND_SYMPTOM,3273
67160,In,O,3273
67161,particular,O,3273
67162,she,O,3273
67163,was,O,3273
67164,experiencing,O,3273
67165,copious,B-SIGN_AND_SYMPTOM,3273
67166,tearing,I-SIGN_AND_SYMPTOM,3273
67167,from,O,3273
67168,her,O,3273
67169,right,O,3273
67170,eye,O,3273
67171,for,B-TIME_DURATION,3273
67172,the,I-TIME_DURATION,3273
67173,past,I-TIME_DURATION,3273
67174,several,I-TIME_DURATION,3273
67175,weeks,I-TIME_DURATION,3273
67176,stating,O,3273
67177,that,O,3273
67178,her,O,3273
67179,eye,O,3273
67180,watered,O,3273
67181,so,O,3273
67182,much,O,3273
67183,it,O,3273
67184,felt,O,3273
67185,as,O,3273
67186,though,O,3273
67187,she,O,3273
67188,was,O,3274
67189,looking,O,3274
67190,through,O,3274
67191,a,O,3274
67192,puddle,O,3274
67193,,O,3274
67194,The,O,3274
67195,patient,O,3274
67196,had,O,3274
67197,been,O,3274
67198,taking,O,3274
67199,cyclosporine,O,3274
67200,ophthalmic,O,3274
67201,emulsion,O,3275
67202,0.05,O,3275
67203,Restasis,B-NAME_OF_DRUG,3275
67204,Allergan,O,3275
67205,for,B-TIME_DURATION,3275
67206,years,I-TIME_DURATION,3275
67207,which,O,3275
67208,she,O,3275
67209,felt,O,3275
67210,helped,O,3275
67211,her,O,3275
67212,and,O,3275
67213,recently,O,3275
67214,had,O,3275
67215,been,O,3275
67216,given,O,3275
67217,lifitegrast,B-NAME_OF_DRUG,3275
67218,ophthalmic,I-NAME_OF_DRUG,3275
67219,solution,I-NAME_OF_DRUG,3275
67220,5%,I-NAME_OF_DRUG,3275
67221,Xiidra,I-NAME_OF_DRUG,3275
67222,Novartis,I-NAME_OF_DRUG,3275
67223,to,O,3275
67224,use,O,3275
67225,in,O,3275
67226,addition,O,3275
67227,to,O,3275
67228,Restasis,B-NAME_OF_DRUG,3275
67229,but,O,3276
67230,she,O,3276
67231,was,O,3276
67232,still,O,3276
67233,experiencing,O,3276
67234,tearing,O,3276
67235,She,O,3276
67236,was,O,3276
67237,also,O,3276
67238,using,O,3276
67239,artificial,B-TREATMENT,3277
67240,tears,I-TREATMENT,3277
67241,warm,B-TREATMENT,3277
67242,compresses,I-TREATMENT,3277
67243,and,O,3277
67244,over-the-counter,O,3277
67245,olopatadine,O,3277
67246,0.1,O,3277
67247,for,O,3277
67248,allergic,B-NAME_OF_DISEASE,3277
67249,conjunctivitis,I-NAME_OF_DISEASE,3277
67250,On,O,3277
67251,examination,O,3277
67252,the,O,3277
67253,patient,O,3277
67254,had,O,3277
67255,evidence,O,3277
67256,of,O,3277
67257,chronic,B-SIGN_AND_SYMPTOM,3277
67258,inflammation,I-SIGN_AND_SYMPTOM,3278
67259,including,I-SIGN_AND_SYMPTOM,3278
67260,conjunctivochalasis,I-SIGN_AND_SYMPTOM,3278
67261,and,I-SIGN_AND_SYMPTOM,3278
67262,corneal,I-SIGN_AND_SYMPTOM,3278
67263,staining,I-SIGN_AND_SYMPTOM,3278
67264,We,O,3278
67265,kept,O,3278
67266,her,O,3278
67267,on,O,3278
67268,cyclosporine,O,3278
67269,ophthalmic,O,3278
67270,emulsion,O,3279
67271,0.05,O,3279
67272,and,O,3279
67273,added,O,3279
67274,loteprednol,B-NAME_OF_DRUG,3279
67275,etabonate,O,3279
67276,ophthalmic,O,3279
67277,suspension,O,3279
67278,0.25,O,3279
67279,in,O,3279
67280,both,O,3279
67281,eyes,O,3279
67282,four,O,3279
67283,times,O,3279
67284,a,O,3279
67285,day,O,3279
67286,for,B-TIME_DURATION,3279
67287,2,I-TIME_DURATION,3279
67288,weeks,I-TIME_DURATION,3279
67289,Within,O,3279
67290,days,O,3279
67291,her,O,3279
67292,tearing,O,3280
67293,resolved,O,3280
67294,and,O,3280
67295,her,O,3280
67296,vision,O,3280
67297,improved,O,3280
67298,from,O,3280
67299,20,O,3280
67300,40,O,3280
67301,to,O,3280
67302,20,O,3280
67303,25,O,3280
67304,The,O,3280
67305,patient,O,3280
67306,was,O,3280
67307,very,O,3280
67308,happy,O,3280
67309,that,O,3280
67310,she,O,3280
67311,was,O,3280
67312,no,O,3280
67313,longer,O,3280
67314,tearing,O,3280
67315,and,O,3280
67316,was,O,3280
67317,thrilled,O,3280
67318,with,O,3280
67319,the,O,3280
67320,improvement,O,3280
67321,in,O,3280
67322,vision,O,3280
67323,When,O,3280
67324,it,O,3280
67325,comes,O,3280
67326,to,O,3280
67327,prescribing,O,3280
67328,corticosteroids,B-NAME_OF_DRUG,3280
67329,for,O,3281
67330,DED,B-NAME_OF_DISEASE,3281
67331,we,O,3281
67332,are,O,3281
67333,much,O,3281
67334,more,O,3281
67335,proactive,O,3281
67336,and,O,3281
67337,confident,O,3281
67338,prescribing,O,3281
67339,loteprednol,B-NAME_OF_DRUG,3281
67340,etabonate,O,3281
67341,ophthalmic,O,3281
67342,suspension,O,3281
67343,0.25,O,3281
67344,for,O,3281
67345,our,O,3281
67346,patients,O,3281
67347,because,O,3281
67348,of,O,3281
67349,its,O,3281
67350,rapid,O,3281
67351,onset,O,3281
67352,and,O,3281
67353,strong,O,3281
67354,safety,O,3281
67355,profile,O,3281
67356,We,O,3281
67357,have,O,3282
67358,had,O,3282
67359,great,O,3282
67360,success,O,3282
67361,with,O,3282
67362,the,O,3282
67363,drop,O,3282
67364,in,O,3282
67365,many,O,3282
67366,straightforward,O,3282
67367,to,O,3282
67368,complex,O,3282
67369,cases,O,3282
67370,including,O,3282
67371,patients,O,3282
67372,with,O,3282
67373,glaucoma,B-NAME_OF_DISEASE,3282
67374,and,O,3283
67375,have,O,3283
67376,had,O,3283
67377,no,O,3283
67378,pressure,O,3283
67379,increases,O,3283
67380,measured,O,3283
67381,at,O,3283
67382,follow-up,O,3283
67383,examination,O,3283
67384,in,O,3283
67385,our,O,3283
67386,clinical,O,3283
67387,experience,O,3283
67388,so,O,3283
67389,far,O,3283
67390,The,O,3283
67391,patients,O,3283
67392,are,O,3283
67393,impressed,O,3283
67394,by,O,3283
67395,how,O,3283
67396,quickly,O,3283
67397,the,O,3283
67398,ophthalmic,O,3283
67399,suspension,O,3283
67400,works,O,3283
67401,to,O,3283
67402,quieten,O,3283
67403,symptoms,O,3283
67404,Having,O,3283
67405,an,O,3283
67406,on-label,O,3283
67407,enhanced,O,3283
67408,loteprednol,B-NAME_OF_DRUG,3283
67409,formulation,O,3283
67410,for,O,3283
67411,shortterm,O,3283
67412,use,O,3283
67413,in,O,3283
67414,treating,O,3283
67415,the,O,3283
67416,signs,O,3283
67417,and,O,3283
67418,symptoms,O,3284
67419,of,O,3284
67420,DED,B-NAME_OF_DISEASE,3284
67421,is,O,3284
67422,a,O,3284
67423,welcome,O,3284
67424,addition,O,3284
67425,to,O,3284
67426,our,O,3284
67427,armamentarium,O,3284
67428,Dry,B-NAME_OF_DISEASE,3284
67429,eye,I-NAME_OF_DISEASE,3284
67430,can,O,3284
67431,have,O,3284
67432,a,O,3285
67433,significant,O,3285
67434,impact,O,3285
67435,on,O,3285
67436,patient,O,3285
67437,quality,O,3285
67438,of,O,3285
67439,life,O,3285
67440,and,O,3285
67441,daily,O,3285
67442,activities,O,3285
67443,Patients,O,3285
67444,are,O,3285
67445,extremely,O,3285
67446,grateful,O,3285
67447,and,O,3285
67448,relieved,O,3285
67449,to,O,3285
67450,feel,O,3285
67451,rapid,O,3285
67452,relief,O,3285
67453,from,O,3285
67454,their,O,3285
67455,DED,B-NAME_OF_DISEASE,3285
67456,symptoms,O,3285
67457,especially,O,3285
67458,when,O,3285
67459,they,O,3285
67460,experience,O,3285
67461,dry,B-SIGN_AND_SYMPTOM,3285
67462,eye,I-SIGN_AND_SYMPTOM,3285
67463,flares,I-SIGN_AND_SYMPTOM,3285
67464,In,O,3285
67465,posterior,B-NAME_OF_DISEASE,3285
67466,vitreous,B-PART_OF_THE_EYES,3285
67467,detachment,I-NAME_OF_DISEASE,3285
67468,PVD,B-NAME_OF_DISEASE,3285
67469,the,O,3285
67470,gel,O,3285
67471,that,O,3285
67472,fills,O,3285
67473,the,B-PART_OF_THE_EYES,3285
67474,eyeball,I-PART_OF_THE_EYES,3285
67475,separates,O,3285
67476,from,O,3286
67477,the,B-PART_OF_THE_EYES,3286
67478,retina,B-PART_OF_THE_EYES,3286
67479,The,B-PART_OF_THE_EYES,3286
67480,retina,B-PART_OF_THE_EYES,3286
67481,is,O,3286
67482,a,O,3286
67483,thin,O,3286
67484,layer,O,3286
67485,of,O,3286
67486,nerve,O,3286
67487,tissue,O,3286
67488,that,O,3286
67489,lines,O,3286
67490,the,O,3286
67491,back,O,3286
67492,of,O,3286
67493,the,B-PART_OF_THE_EYES,3286
67494,eyeball,I-PART_OF_THE_EYES,3286
67495,It,O,3286
67496,s,O,3286
67497,responsible,O,3286
67498,for,O,3286
67499,detecting,O,3286
67500,light,O,3286
67501,and,O,3286
67502,turning,O,3286
67503,it,O,3286
67504,into,O,3286
67505,visual,O,3286
67506,images,O,3286
67507,Posterior,B-NAME_OF_DISEASE,3286
67508,vitreous,B-PART_OF_THE_EYES,3287
67509,detachment,I-NAME_OF_DISEASE,3287
67510,is,O,3287
67511,a,O,3287
67512,common,O,3287
67513,condition,O,3287
67514,with,O,3287
67515,age,O,3287
67516,PVD,B-NAME_OF_DISEASE,3287
67517,can,O,3287
67518,cause,O,3287
67519,floaters,B-SIGN_AND_SYMPTOM,3287
67520,or,I-SIGN_AND_SYMPTOM,3287
67521,flashes,I-SIGN_AND_SYMPTOM,3287
67522,of,I-SIGN_AND_SYMPTOM,3287
67523,light,I-SIGN_AND_SYMPTOM,3287
67524,which,I-SIGN_AND_SYMPTOM,3287
67525,often,I-SIGN_AND_SYMPTOM,3287
67526,fade,I-SIGN_AND_SYMPTOM,3287
67527,over,I-SIGN_AND_SYMPTOM,3287
67528,time,I-SIGN_AND_SYMPTOM,3287
67529,PVD,B-NAME_OF_DISEASE,3287
67530,isn,O,3287
67531,t,O,3287
67532,painful,O,3287
67533,or,O,3287
67534,sight-threatening,O,3287
67535,The,O,3287
67536,most,O,3287
67537,common,O,3287
67538,symptom,O,3287
67539,of,O,3287
67540,vitreous,B-PART_OF_THE_EYES,3287
67541,detachment,I-NAME_OF_DISEASE,3287
67542,is,O,3287
67543,a,B-SIGN_AND_SYMPTOM,3287
67544,sudden,I-SIGN_AND_SYMPTOM,3287
67545,increase,I-SIGN_AND_SYMPTOM,3287
67546,in,I-SIGN_AND_SYMPTOM,3287
67547,floaters,B-SIGN_AND_SYMPTOM,3287
67548,small,I-SIGN_AND_SYMPTOM,3288
67549,dark,I-SIGN_AND_SYMPTOM,3288
67550,spots,I-SIGN_AND_SYMPTOM,3288
67551,or,I-SIGN_AND_SYMPTOM,3288
67552,squiggly,I-SIGN_AND_SYMPTOM,3288
67553,lines,I-SIGN_AND_SYMPTOM,3288
67554,that,I-SIGN_AND_SYMPTOM,3288
67555,float,I-SIGN_AND_SYMPTOM,3288
67556,across,I-SIGN_AND_SYMPTOM,3288
67557,your,I-SIGN_AND_SYMPTOM,3288
67558,vision,I-SIGN_AND_SYMPTOM,3288
67559,,O,3288
67560,When,O,3288
67561,your,O,3288
67562,vitreous,B-PART_OF_THE_EYES,3288
67563,detaches,O,3288
67564,strands,O,3288
67565,of,O,3288
67566,the,B-PART_OF_THE_EYES,3289
67567,vitreous,I-PART_OF_THE_EYES,3289
67568,often,O,3289
67569,cast,O,3289
67570,new,O,3289
67571,shadows,O,3289
67572,on,O,3289
67573,your,O,3289
67574,retina,B-PART_OF_THE_EYES,3289
67575,-,O,3289
67576,and,O,3289
67577,those,O,3289
67578,shadows,O,3289
67579,appear,O,3289
67580,as,O,3289
67581,floaters,B-SIGN_AND_SYMPTOM,3289
67582,The,O,3289
67583,patient,O,3289
67584,may,O,3289
67585,also,O,3289
67586,notice,O,3289
67587,flashes,B-SIGN_AND_SYMPTOM,3290
67588,of,I-SIGN_AND_SYMPTOM,3290
67589,light,I-SIGN_AND_SYMPTOM,3290
67590,in,I-SIGN_AND_SYMPTOM,3290
67591,your,I-SIGN_AND_SYMPTOM,3290
67592,side,I-SIGN_AND_SYMPTOM,3290
67593,peripheral,I-SIGN_AND_SYMPTOM,3290
67594,vision,I-SIGN_AND_SYMPTOM,3290
67595,Sometimes,O,3290
67596,vitreous,B-PART_OF_THE_EYES,3290
67597,detachment,I-NAME_OF_DISEASE,3290
67598,causes,O,3290
67599,more,O,3290
67600,serious,O,3290
67601,eye,O,3291
67602,problems,O,3291
67603,that,O,3291
67604,need,O,3291
67605,treatment,O,3291
67606,right,O,3291
67607,away,O,3291
67608,The,O,3291
67609,only,O,3291
67610,way,O,3291
67611,to,O,3291
67612,tell,O,3291
67613,if,O,3291
67614,vitreous,B-PART_OF_THE_EYES,3291
67615,detachment,I-NAME_OF_DISEASE,3291
67616,has,O,3291
67617,caused,O,3291
67618,a,O,3291
67619,serious,O,3291
67620,eye,O,3291
67621,problem,O,3291
67622,is,O,3292
67623,to,O,3292
67624,get,O,3292
67625,a,B-DIAGNOSTIC_TEST,3292
67626,dilated,I-DIAGNOSTIC_TEST,3292
67627,eye,I-DIAGNOSTIC_TEST,3292
67628,exam,I-DIAGNOSTIC_TEST,3292
67629,Managing,O,3292
67630,patients,O,3292
67631,who,O,3292
67632,attend,O,3292
67633,a,O,3292
67634,practice,O,3292
67635,with,O,3292
67636,symptoms,O,3292
67637,of,O,3292
67638,flashes,B-SIGN_AND_SYMPTOM,3292
67639,and,I-SIGN_AND_SYMPTOM,3293
67640,floaters,I-SIGN_AND_SYMPTOM,3293
67641,is,O,3293
67642,a,O,3293
67643,regular,O,3293
67644,occurrence,O,3293
67645,in,O,3293
67646,community,O,3293
67647,optometric,O,3293
67648,practice,O,3293
67649,It,O,3293
67650,s,O,3293
67651,often,O,3293
67652,very,O,3293
67653,distressing,O,3293
67654,for,O,3293
67655,patients,O,3293
67656,symptoms,O,3293
67657,can,O,3293
67658,be,O,3293
67659,quite,O,3293
67660,dramatic,O,3293
67661,and,O,3293
67662,an,O,3293
67663,internet,O,3293
67664,search,O,3293
67665,can,O,3293
67666,indicate,O,3293
67667,imminent,O,3294
67668,blindness,B-NAME_OF_DISEASE,3294
67669,from,O,3294
67670,a,B-NAME_OF_DISEASE,3294
67671,retinal,I-NAME_OF_DISEASE,3294
67672,detachment,I-NAME_OF_DISEASE,3294
67673,Patients,O,3294
67674,clearly,O,3294
67675,need,O,3294
67676,to,O,3294
67677,be,O,3294
67678,seen,O,3294
67679,swiftly,O,3294
67680,to,O,3294
67681,rule,O,3294
67682,out,O,3294
67683,the,O,3295
67684,possibility,O,3295
67685,of,O,3295
67686,sight-threatening,O,3295
67687,retinal,O,3295
67688,damage,O,3295
67689,Of,O,3295
67690,course,O,3295
67691,the,O,3295
67692,majority,O,3295
67693,of,O,3295
67694,patients,O,3295
67695,are,O,3295
67696,able,O,3295
67697,to,O,3295
67698,be,O,3295
67699,reassured,O,3295
67700,with,O,3295
67701,the,O,3295
67702,advice,O,3295
67703,that,O,3295
67704,they,O,3295
67705,should,O,3295
67706,return,O,3295
67707,immediately,O,3295
67708,if,O,3295
67709,anything,O,3295
67710,changes,O,3295
67711,A,B-NAME_OF_DISEASE,3295
67712,posterior,I-NAME_OF_DISEASE,3295
67713,vitreous,I-NAME_OF_DISEASE,3295
67714,detachment,I-NAME_OF_DISEASE,3295
67715,PVD,I-NAME_OF_DISEASE,3295
67716,is,O,3295
67717,the,O,3295
67718,most,O,3295
67719,common,O,3295
67720,cause,O,3296
67721,of,O,3296
67722,flashes,B-SIGN_AND_SYMPTOM,3296
67723,and,I-SIGN_AND_SYMPTOM,3296
67724,floaters,I-SIGN_AND_SYMPTOM,3296
67725,in,O,3296
67726,the,O,3296
67727,middle-aged,O,3296
67728,population,O,3296
67729,Throughout,O,3296
67730,life,O,3296
67731,the,B-PART_OF_THE_EYES,3296
67732,vitreous,I-PART_OF_THE_EYES,3296
67733,liquefies,O,3296
67734,and,O,3296
67735,eventually,O,3296
67736,detaches,O,3297
67737,from,O,3297
67738,the,B-PART_OF_THE_EYES,3297
67739,retina,B-PART_OF_THE_EYES,3297
67740,A,B-NAME_OF_DISEASE,3297
67741,PVD,I-NAME_OF_DISEASE,3297
67742,most,O,3298
67743,commonly,O,3298
67744,occurs,O,3298
67745,between,O,3298
67746,the,O,3298
67747,ages,O,3298
67748,of,O,3298
67749,55,O,3298
67750,and,O,3298
67751,65,O,3298
67752,years,O,3298
67753,in,O,3298
67754,general,O,3298
67755,earlier,O,3298
67756,in,O,3298
67757,myopes,O,3298
67758,and,O,3298
67759,later,O,3298
67760,in,O,3298
67761,hyperopes,O,3298
67762,About,O,3298
67763,50%,O,3298
67764,of,O,3298
67765,the,O,3299
67766,population,O,3299
67767,are,O,3299
67768,symptomatic,O,3299
67769,and,O,3299
67770,so,O,3299
67771,there,O,3299
67772,are,O,3299
67773,numerous,O,3299
67774,patients,O,3299
67775,requiring,O,3299
67776,reassurance,O,3299
67777,that,O,3299
67778,their,O,3299
67779,symptoms,O,3299
67780,are,O,3299
67781,nothing,O,3299
67782,to,O,3299
67783,be,O,3299
67784,alarmed,O,3299
67785,about,O,3299
67786,and,O,3299
67787,that,O,3299
67788,they,O,3299
67789,don,O,3299
67790,t,O,3299
67791,need,O,3299
67792,any,O,3299
67793,treatment,O,3299
67794,This,O,3299
67795,is,O,3299
67796,a,O,3300
67797,normal,O,3300
67798,ageing,O,3300
67799,process,O,3300
67800,Of,O,3300
67801,course,O,3300
67802,there,O,3300
67803,are,O,3300
67804,other,O,3300
67805,causes,O,3300
67806,of,O,3300
67807,flashes,B-SIGN_AND_SYMPTOM,3300
67808,and,I-SIGN_AND_SYMPTOM,3300
67809,floaters,I-SIGN_AND_SYMPTOM,3300
67810,The,O,3300
67811,differential,O,3300
67812,diagnosis,O,3301
67813,is,O,3301
67814,important,O,3301
67815,to,O,3301
67816,exclude,O,3301
67817,a,B-NAME_OF_DISEASE,3301
67818,retinal,I-NAME_OF_DISEASE,3301
67819,tear,I-NAME_OF_DISEASE,3301
67820,or,I-NAME_OF_DISEASE,3301
67821,detachment,I-NAME_OF_DISEASE,3301
67822,There,O,3301
67823,is,O,3301
67824,an,O,3301
67825,annual,O,3301
67826,incidence,O,3301
67827,of,O,3301
67828,about,O,3301
67829,15-Oct,O,3301
67830,per,O,3301
67831,100,O,3301
67832,0,O,3301
67833,people,O,3302
67834,per,O,3302
67835,year,O,3302
67836,who,O,3302
67837,have,O,3302
67838,a,B-NAME_OF_DISEASE,3302
67839,retinal,I-NAME_OF_DISEASE,3302
67840,detachment,I-NAME_OF_DISEASE,3302
67841,and,O,3302
67842,so,O,3302
67843,whilst,O,3302
67844,this,O,3302
67845,is,O,3302
67846,a,O,3302
67847,rare,O,3302
67848,condition,O,3302
67849,the,O,3302
67850,sight-threatening,O,3302
67851,nature,O,3302
67852,requires,O,3302
67853,a,O,3302
67854,swift,O,3303
67855,referral,O,3303
67856,for,O,3303
67857,timely,O,3303
67858,treatment,O,3303
67859,to,O,3303
67860,restore,O,3303
67861,and,O,3303
67862,or,O,3303
67863,retain,O,3303
67864,as,O,3303
67865,much,O,3303
67866,sight,O,3303
67867,as,O,3303
67868,possible,O,3303
67869,Modern,O,3303
67870,advancements,O,3303
67871,in,O,3303
67872,surgical,O,3303
67873,procedures,O,3303
67874,have,O,3303
67875,meant,O,3303
67876,that,O,3303
67877,the,O,3303
67878,results,O,3303
67879,are,O,3303
67880,often,O,3304
67881,outstanding,O,3304
67882,Taking,O,3304
67883,a,O,3304
67884,detailed,O,3304
67885,patient,O,3304
67886,history,O,3304
67887,As,O,3304
67888,with,O,3304
67889,many,O,3304
67890,conditions,O,3304
67891,a,O,3304
67892,detailed,O,3304
67893,history,O,3304
67894,from,O,3304
67895,the,O,3305
67896,patient,O,3305
67897,is,O,3305
67898,vital,O,3305
67899,to,O,3305
67900,being,O,3305
67901,able,O,3305
67902,to,O,3305
67903,exclude,O,3305
67904,many,O,3305
67905,other,O,3305
67906,causes,O,3305
67907,of,O,3305
67908,these,O,3305
67909,symptoms,O,3305
67910,For,O,3305
67911,example,O,3305
67912,migraine,B-NAME_OF_DISEASE,3305
67913,auras,I-CAUSE_OF_DISEASE,3306
67914,are,O,3306
67915,another,O,3306
67916,common,O,3306
67917,cause,O,3306
67918,of,O,3306
67919,flashes,B-SIGN_AND_SYMPTOM,3306
67920,More,O,3306
67921,frequently,O,3306
67922,associated,O,3306
67923,with,O,3306
67924,younger,O,3306
67925,patients,O,3306
67926,and,O,3306
67927,often,O,3306
67928,bilateral,O,3306
67929,they,O,3306
67930,can,O,3306
67931,be,O,3306
67932,identified,O,3306
67933,with,O,3307
67934,careful,O,3307
67935,questioning,O,3307
67936,by,O,3307
67937,the,O,3307
67938,practitioner,O,3307
67939,They,O,3307
67940,may,O,3307
67941,or,O,3307
67942,may,O,3307
67943,not,O,3307
67944,be,O,3307
67945,associated,O,3307
67946,with,O,3307
67947,a,B-SIGN_AND_SYMPTOM,3307
67948,headache,I-SIGN_AND_SYMPTOM,3307
67949,or,O,3307
67950,migraine,B-NAME_OF_DISEASE,3307
67951,Postural,B-CAUSE_OF_DISEASE,3307
67952,hypotension,I-CAUSE_OF_DISEASE,3307
67953,another,O,3307
67954,cause,O,3307
67955,of,O,3307
67956,flashes,B-SIGN_AND_SYMPTOM,3308
67957,as,O,3308
67958,the,O,3308
67959,patient,O,3308
67960,stands,O,3308
67961,can,O,3308
67962,also,O,3308
67963,be,O,3308
67964,identified,O,3308
67965,with,O,3308
67966,detailed,O,3308
67967,and,O,3308
67968,specific,O,3309
67969,questioning,O,3309
67970,of,O,3309
67971,the,O,3309
67972,patient,O,3309
67973,Alarm,O,3309
67974,bells,O,3309
67975,start,O,3309
67976,to,O,3309
67977,ring,O,3309
67978,when,O,3309
67979,patients,O,3309
67980,describe,O,3310
67981,large,O,3310
67982,and,O,3310
67983,significant,O,3310
67984,changes,O,3310
67985,in,O,3310
67986,their,O,3310
67987,vision,O,3310
67988,-,O,3310
67989,the,O,3310
67990,classic,O,3310
67991,curtain,O,3310
67992,coming,O,3310
67993,over,O,3310
67994,my,O,3310
67995,vision,O,3310
67996,or,O,3310
67997,a,O,3310
67998,dramatic,O,3310
67999,drop,O,3310
68000,in,O,3310
68001,their,O,3310
68002,vision,O,3310
68003,when,O,3310
68004,the,B-PART_OF_THE_EYES,3310
68005,macula,I-PART_OF_THE_EYES,3310
68006,may,O,3310
68007,be,O,3310
68008,off,O,3310
68009,,O,3310
68010,However,O,3310
68011,patients,O,3310
68012,are,O,3310
68013,all,O,3310
68014,different,O,3310
68015,and,O,3311
68016,a,O,3311
68017,non-descript,O,3311
68018,history,O,3311
68019,can,O,3311
68020,still,O,3311
68021,elicit,O,3311
68022,a,O,3311
68023,dramatic,O,3311
68024,finding,O,3311
68025,whilst,O,3311
68026,other,O,3311
68027,patients,O,3311
68028,are,O,3311
68029,extremely,O,3311
68030,disturbed,O,3311
68031,by,O,3311
68032,relatively,O,3311
68033,minor,O,3312
68034,changes,O,3312
68035,to,O,3312
68036,their,O,3312
68037,vitreous,B-PART_OF_THE_EYES,3312
68038,The,O,3312
68039,Ocular,O,3312
68040,Examination,O,3312
68041,Clearly,O,3312
68042,a,O,3312
68043,detailed,O,3312
68044,dilated,B-DIAGNOSTIC_TEST,3312
68045,binocular,I-DIAGNOSTIC_TEST,3312
68046,examination,I-DIAGNOSTIC_TEST,3312
68047,of,O,3313
68048,the,B-PART_OF_THE_EYES,3313
68049,vitreous,I-PART_OF_THE_EYES,3313
68050,and,O,3313
68051,the,B-PART_OF_THE_EYES,3313
68052,retina,I-PART_OF_THE_EYES,3313
68053,are,O,3313
68054,required,O,3313
68055,Alwitry,B-PERSON,3313
68056,et,O,3313
68057,al,O,3313
68058,s,O,3313
68059,study,O,3313
68060,in,O,3313
68061,2002,O,3313
68062,found,O,3313
68063,wide,O,3313
68064,variation,O,3313
68065,in,O,3313
68066,confidence,O,3313
68067,by,O,3313
68068,optometrists,O,3313
68069,to,O,3313
68070,examine,O,3313
68071,and,O,3313
68072,mange,O,3313
68073,a,O,3313
68074,patient,O,3313
68075,presenting,O,3313
68076,with,O,3313
68077,flashes,B-SIGN_AND_SYMPTOM,3313
68078,and,I-SIGN_AND_SYMPTOM,3313
68079,floaters,I-SIGN_AND_SYMPTOM,3313
68080,with,O,3313
68081,many,O,3313
68082,patients,O,3313
68083,being,O,3313
68084,examined,O,3314
68085,without,O,3314
68086,mydriasis,B-SIGN_AND_SYMPTOM,3314
68087,and,O,3314
68088,a,O,3314
68089,lack,O,3314
68090,of,O,3314
68091,understanding,O,3314
68092,about,O,3314
68093,vital,O,3314
68094,signs,O,3314
68095,of,O,3314
68096,tears,O,3314
68097,and,O,3314
68098,detachments,O,3314
68099,This,O,3314
68100,was,O,3314
68101,also,O,3314
68102,found,O,3314
68103,in,O,3314
68104,a,O,3314
68105,study,O,3314
68106,using,O,3314
68107,an,O,3314
68108,actor,O,3314
68109,as,O,3314
68110,a,O,3315
68111,model,O,3315
68112,patient,O,3315
68113,As,O,3315
68114,practice,O,3315
68115,has,O,3315
68116,developed,O,3315
68117,more,O,3315
68118,practitioners,O,3315
68119,are,O,3315
68120,using,O,3315
68121,a,B-DIAGNOSTIC_TEST,3315
68122,slit-lamp,I-DIAGNOSTIC_TEST,3315
68123,and,O,3315
68124,condensing,O,3315
68125,lens,O,3315
68126,combination,O,3315
68127,routinely,O,3315
68128,to,O,3315
68129,examine,O,3315
68130,patients,O,3315
68131,across,O,3315
68132,the,B-GPE,3315
68133,UK,I-GPE,3315
68134,in,O,3315
68135,community,O,3315
68136,optometry,O,3315
68137,indeed,O,3315
68138,equipment,O,3315
68139,funding,O,3315
68140,and,O,3315
68141,training,O,3315
68142,in,O,3315
68143,Scotland,B-GPE,3315
68144,makes,O,3315
68145,this,O,3316
68146,a,O,3316
68147,routine,O,3316
68148,part,O,3316
68149,of,O,3316
68150,the,B-ORGANIZATION,3316
68151,General,I-ORGANIZATION,3316
68152,Ophthalmic,I-ORGANIZATION,3316
68153,Services,I-ORGANIZATION,3316
68154,GOS,I-ORGANIZATION,3316
68155,eye,O,3316
68156,examination,O,3316
68157,Even,O,3316
68158,without,O,3316
68159,scleral,B-DIAGNOSTIC_TEST,3316
68160,indentation,I-DIAGNOSTIC_TEST,3316
68161,such,O,3316
68162,an,O,3316
68163,examination,O,3316
68164,will,O,3316
68165,almost,O,3316
68166,certainly,O,3316
68167,identify,O,3316
68168,all,O,3316
68169,patients,O,3316
68170,with,O,3316
68171,tears,O,3316
68172,or,O,3316
68173,full,O,3316
68174,detachments,O,3316
68175,with,O,3316
68176,those,O,3316
68177,in,O,3316
68178,the,O,3316
68179,very,O,3316
68180,far,O,3316
68181,periphery,O,3316
68182,almost,O,3316
68183,certainly,O,3316
68184,resulting,O,3316
68185,from,O,3317
68186,a,O,3317
68187,traumatic,O,3317
68188,incident,O,3317
68189,Asking,O,3317
68190,the,O,3317
68191,patient,O,3317
68192,to,O,3317
68193,move,O,3317
68194,their,O,3317
68195,eyes,O,3317
68196,in,O,3317
68197,eight,O,3317
68198,points,O,3317
68199,of,O,3317
68200,gaze,O,3317
68201,should,O,3317
68202,ensure,O,3317
68203,a,O,3317
68204,view,O,3317
68205,of,O,3317
68206,all,O,3317
68207,but,O,3317
68208,the,O,3317
68209,most,O,3317
68210,peripheral,O,3317
68211,parts,O,3317
68212,of,O,3317
68213,the,B-PART_OF_THE_EYES,3317
68214,retina,I-PART_OF_THE_EYES,3317
68215,with,O,3317
68216,particular,O,3317
68217,note,O,3317
68218,in,O,3317
68219,the,O,3317
68220,superior,O,3317
68221,temporal,O,3317
68222,quadrant,O,3317
68223,where,O,3317
68224,about,O,3317
68225,60%,O,3317
68226,of,O,3317
68227,tears,O,3317
68228,occur,O,3317
68229,A,B-DIAGNOSTIC_TEST,3317
68230,high,I-DIAGNOSTIC_TEST,3317
68231,magnification,I-DIAGNOSTIC_TEST,3317
68232,slit-lamp,I-DIAGNOSTIC_TEST,3317
68233,is,O,3317
68234,vital,O,3318
68235,to,O,3318
68236,being,O,3318
68237,able,O,3318
68238,to,O,3318
68239,closely,O,3318
68240,examine,O,3318
68241,the,B-PART_OF_THE_EYES,3318
68242,vitreous,I-PART_OF_THE_EYES,3318
68243,for,O,3318
68244,signs,O,3318
68245,of,O,3318
68246,change,O,3318
68247,Tobacco,O,3318
68248,dust,O,3318
68249,is,O,3318
68250,a,O,3318
68251,good,O,3318
68252,determinant,O,3318
68253,of,O,3318
68254,a,O,3318
68255,tear,O,3318
68256,with,O,3318
68257,pigment,O,3318
68258,from,O,3318
68259,the,B-PART_OF_THE_EYES,3318
68260,retinal,I-PART_OF_THE_EYES,3318
68261,pigment,I-PART_OF_THE_EYES,3318
68262,epithelium,I-PART_OF_THE_EYES,3318
68263,having,O,3318
68264,leaked,O,3318
68265,into,O,3318
68266,the,B-PART_OF_THE_EYES,3318
68267,vitreous,I-PART_OF_THE_EYES,3318
68268,These,O,3318
68269,brown,O,3318
68270,cells,O,3318
68271,in,O,3318
68272,the,B-PART_OF_THE_EYES,3318
68273,anterior,I-PART_OF_THE_EYES,3318
68274,vitreous,I-PART_OF_THE_EYES,3318
68275,are,O,3318
68276,known,O,3318
68277,as,O,3318
68278,Shafer,O,3318
68279,s,O,3318
68280,sign,O,3318
68281,,O,3318
68282,It,O,3318
68283,requires,O,3319
68284,good,O,3319
68285,magnification,O,3319
68286,to,O,3319
68287,see,O,3319
68288,and,O,3319
68289,is,O,3319
68290,best,O,3319
68291,observed,O,3319
68292,by,O,3319
68293,asking,O,3319
68294,the,O,3319
68295,patient,O,3319
68296,to,O,3319
68297,look,O,3319
68298,up,O,3319
68299,and,O,3319
68300,then,O,3319
68301,straight,O,3319
68302,ahead,O,3319
68303,Identifying,O,3319
68304,signs,O,3320
68305,of,O,3320
68306,a,B-NAME_OF_DISEASE,3320
68307,PVD,I-NAME_OF_DISEASE,3320
68308,also,O,3320
68309,gives,O,3320
68310,confidence,O,3320
68311,that,O,3320
68312,this,O,3320
68313,is,O,3320
68314,indeed,O,3320
68315,the,O,3320
68316,cause,O,3320
68317,of,O,3320
68318,the,O,3320
68319,symptoms,O,3320
68320,Though,O,3320
68321,Weiss,B-PART_OF_THE_EYES,3320
68322,s,I-PART_OF_THE_EYES,3320
68323,ring,I-PART_OF_THE_EYES,3320
68324,is,O,3320
68325,rarely,O,3320
68326,seen,O,3321
68327,in,O,3321
68328,full,O,3321
68329,partial,O,3321
68330,remains,O,3321
68331,may,O,3321
68332,be,O,3321
68333,viewed,O,3321
68334,in,O,3321
68335,the,B-PART_OF_THE_EYES,3321
68336,vitreous,I-PART_OF_THE_EYES,3321
68337,around,O,3321
68338,the,B-PART_OF_THE_EYES,3321
68339,disc,I-PART_OF_THE_EYES,3321
68340,near,O,3321
68341,to,O,3321
68342,where,O,3321
68343,the,B-PART_OF_THE_EYES,3322
68344,vitreous,I-PART_OF_THE_EYES,3322
68345,gel,I-PART_OF_THE_EYES,3322
68346,was,O,3322
68347,attached,O,3322
68348,Expert,O,3322
68349,opinion,O,3322
68350,informs,O,3322
68351,the,B-ORGANIZATION,3322
68352,National,I-ORGANIZATION,3322
68353,Institute,I-ORGANIZATION,3322
68354,for,I-ORGANIZATION,3322
68355,Health,I-ORGANIZATION,3322
68356,and,I-ORGANIZATION,3322
68357,Care,I-ORGANIZATION,3322
68358,Excellence,I-ORGANIZATION,3322
68359,NICE,I-ORGANIZATION,3322
68360,recommendation,O,3322
68361,on,O,3322
68362,referral,O,3322
68363,pathways,O,3322
68364,Referral,O,3322
68365,directly,O,3322
68366,to,O,3322
68367,ophthalmology,O,3322
68368,where,O,3322
68369,there,O,3322
68370,are,O,3322
68371,clear,O,3322
68372,signs,O,3322
68373,of,O,3322
68374,retinal,B-NAME_OF_DISEASE,3322
68375,detachment,I-NAME_OF_DISEASE,3322
68376,or,O,3322
68377,symptoms,O,3322
68378,such,O,3322
68379,as,O,3322
68380,distorted,B-SIGN_AND_SYMPTOM,3322
68381,or,I-SIGN_AND_SYMPTOM,3323
68382,blurred,I-SIGN_AND_SYMPTOM,3323
68383,vision,I-SIGN_AND_SYMPTOM,3323
68384,or,I-SIGN_AND_SYMPTOM,3323
68385,visual,I-SIGN_AND_SYMPTOM,3323
68386,field,I-SIGN_AND_SYMPTOM,3323
68387,loss,I-SIGN_AND_SYMPTOM,3323
68388,curtaining,I-SIGN_AND_SYMPTOM,3323
68389,or,I-SIGN_AND_SYMPTOM,3323
68390,dark,I-SIGN_AND_SYMPTOM,3323
68391,shadows,I-SIGN_AND_SYMPTOM,3323
68392,is,O,3323
68393,aimed,O,3323
68394,at,O,3323
68395,GPs,O,3323
68396,or,O,3323
68397,other,O,3323
68398,community,O,3323
68399,care,O,3323
68400,practitioners,O,3323
68401,Otherwise,O,3323
68402,refer,O,3323
68403,to,O,3323
68404,a,O,3323
68405,practitioner,O,3323
68406,competent,O,3323
68407,in,O,3323
68408,the,O,3323
68409,use,O,3323
68410,of,O,3323
68411,slit-lamp,B-DIAGNOSTIC_TEST,3323
68412,examination,I-DIAGNOSTIC_TEST,3323
68413,and,O,3324
68414,indirect,B-DIAGNOSTIC_TEST,3324
68415,ophthalmoscopy,I-DIAGNOSTIC_TEST,3324
68416,i.e,O,3324
68417,a,O,3324
68418,community,O,3324
68419,optometrist,O,3324
68420,is,O,3324
68421,the,O,3324
68422,advice,O,3324
68423,Reassurance,O,3324
68424,to,O,3324
68425,Patients,O,3324
68426,It,O,3324
68427,s,O,3324
68428,important,O,3324
68429,that,O,3324
68430,patients,O,3324
68431,diagnosed,O,3324
68432,with,O,3324
68433,a,B-NAME_OF_DISEASE,3324
68434,PVD,B-NAME_OF_DISEASE,3324
68435,are,O,3324
68436,advised,O,3324
68437,to,O,3324
68438,return,O,3324
68439,for,O,3324
68440,another,O,3324
68441,examination,O,3324
68442,if,O,3324
68443,their,O,3324
68444,symptoms,O,3324
68445,return,O,3325
68446,A,O,3325
68447,period,O,3325
68448,of,O,3325
68449,six,B-TIME_DURATION,3325
68450,to,I-TIME_DURATION,3325
68451,eight,I-TIME_DURATION,3325
68452,weeks,I-TIME_DURATION,3325
68453,appears,O,3325
68454,to,O,3325
68455,be,O,3325
68456,the,O,3325
68457,critical,O,3325
68458,time,O,3325
68459,period,O,3325
68460,over,O,3325
68461,which,O,3325
68462,a,O,3325
68463,partial,O,3325
68464,PVD,B-NAME_OF_DISEASE,3325
68465,completely,O,3326
68466,detaches,O,3326
68467,and,O,3326
68468,after,O,3326
68469,which,O,3327
68470,the,O,3327
68471,threat,O,3327
68472,of,O,3327
68473,a,O,3327
68474,retinal,O,3327
68475,tear,O,3327
68476,diminishes,O,3327
68477,There,O,3327
68478,is,O,3327
68479,still,O,3327
68480,debate,O,3327
68481,as,O,3327
68482,to,O,3327
68483,whether,O,3327
68484,a,O,3327
68485,follow-up,O,3328
68486,appointment,O,3328
68487,should,O,3328
68488,be,O,3328
68489,booked,O,3328
68490,for,O,3328
68491,the,O,3328
68492,patient,O,3328
68493,The,O,3328
68494,danger,O,3328
68495,of,O,3328
68496,this,O,3328
68497,strategy,O,3328
68498,is,O,3328
68499,that,O,3328
68500,patients,O,3328
68501,may,O,3328
68502,wait,O,3328
68503,for,O,3328
68504,their,O,3328
68505,appointment,O,3328
68506,rather,O,3328
68507,than,O,3328
68508,returning,O,3328
68509,immediately,O,3328
68510,when,O,3328
68511,new,O,3328
68512,symptoms,O,3328
68513,appear,O,3328
68514,Indeed,O,3328
68515,much,O,3328
68516,of,O,3328
68517,the,O,3328
68518,evidence,O,3328
68519,points,O,3328
68520,to,O,3328
68521,tears,O,3328
68522,developing,O,3328
68523,after,O,3329
68524,an,O,3329
68525,initial,O,3329
68526,review,O,3329
68527,only,O,3329
68528,in,O,3329
68529,patients,O,3329
68530,that,O,3329
68531,have,O,3329
68532,experienced,O,3329
68533,new,O,3329
68534,symptoms,O,3329
68535,What,O,3329
68536,is,O,3329
68537,important,O,3329
68538,is,O,3329
68539,to,O,3329
68540,provide,O,3329
68541,the,O,3329
68542,patient,O,3329
68543,with,O,3329
68544,some,O,3329
68545,written,O,3329
68546,information,O,3330
68547,about,O,3330
68548,their,O,3330
68549,condition,O,3330
68550,and,O,3330
68551,what,O,3330
68552,to,O,3330
68553,do,O,3330
68554,if,O,3330
68555,their,O,3330
68556,symptoms,O,3330
68557,should,O,3330
68558,return,O,3330
68559,or,O,3330
68560,worsen,O,3330
68561,There,O,3330
68562,is,O,3330
68563,some,O,3331
68564,very,O,3331
68565,good,O,3331
68566,information,O,3331
68567,that,O,3331
68568,is,O,3331
68569,available,O,3331
68570,for,O,3331
68571,optometrists,O,3331
68572,to,O,3331
68573,hand,O,3331
68574,to,O,3331
68575,patients,O,3331
68576,Examples,O,3331
68577,include,O,3331
68578,the,B-ORGANIZATION,3331
68579,Association,I-ORGANIZATION,3331
68580,of,I-ORGANIZATION,3331
68581,Optometrists,I-ORGANIZATION,3331
68582,Royal,B-ORGANIZATION,3331
68583,National,I-ORGANIZATION,3331
68584,Institute,I-ORGANIZATION,3331
68585,of,I-ORGANIZATION,3331
68586,Blind,I-ORGANIZATION,3331
68587,People,I-ORGANIZATION,3331
68588,RNIB,I-ORGANIZATION,3331
68589,and,O,3331
68590,the,B-ORGANIZATION,3332
68591,College,I-ORGANIZATION,3332
68592,of,I-ORGANIZATION,3332
68593,Optometrists,I-ORGANIZATION,3332
68594,Challenges,O,3332
68595,of,O,3332
68596,Managing,O,3332
68597,Patients,O,3332
68598,with,O,3332
68599,Flashes,B-SIGN_AND_SYMPTOM,3332
68600,and,I-SIGN_AND_SYMPTOM,3332
68601,Floaters,I-SIGN_AND_SYMPTOM,3332
68602,Even,O,3332
68603,if,O,3332
68604,a,O,3332
68605,practitioner,O,3332
68606,is,O,3332
68607,very,O,3332
68608,experienced,O,3332
68609,not,O,3332
68610,all,O,3332
68611,examinations,O,3333
68612,are,O,3333
68613,straightforward,O,3333
68614,Not,O,3333
68615,all,O,3333
68616,patients,O,3333
68617,have,O,3333
68618,a,O,3333
68619,clear,O,3333
68620,media,O,3333
68621,for,O,3333
68622,example,O,3333
68623,cataracts,B-NAME_OF_DISEASE,3333
68624,or,O,3333
68625,longer,O,3333
68626,standing,O,3333
68627,vitreous,O,3333
68628,changes,O,3333
68629,can,O,3333
68630,make,O,3333
68631,examining,O,3333
68632,the,B-PART_OF_THE_EYES,3333
68633,whole,I-PART_OF_THE_EYES,3333
68634,retina,I-PART_OF_THE_EYES,3333
68635,more,O,3333
68636,difficult,O,3333
68637,A,O,3334
68638,good,O,3334
68639,dilation,O,3334
68640,is,O,3334
68641,vital,O,3334
68642,leaving,O,3334
68643,the,O,3334
68644,patient,O,3334
68645,time,O,3334
68646,to,O,3334
68647,fully,O,3334
68648,dilate,O,3334
68649,Finding,O,3334
68650,adequate,O,3334
68651,time,O,3335
68652,to,O,3335
68653,see,O,3335
68654,emergency,O,3335
68655,presentations,O,3335
68656,can,O,3335
68657,also,O,3335
68658,be,O,3336
68659,a,O,3336
68660,challenge,O,3336
68661,Whilst,O,3336
68662,these,O,3336
68663,examinations,O,3336
68664,are,O,3336
68665,usually,O,3336
68666,funded,O,3336
68667,around,O,3336
68668,the,O,3336
68669,country,O,3337
68670,either,O,3337
68671,as,O,3337
68672,part,O,3337
68673,of,O,3337
68674,GOS,O,3337
68675,or,O,3337
68676,as,O,3337
68677,an,O,3337
68678,enhanced,O,3337
68679,service,O,3337
68680,there,O,3338
68681,may,O,3338
68682,not,O,3338
68683,be,O,3338
68684,an,O,3338
68685,appointment,O,3338
68686,slot,O,3338
68687,waiting,O,3338
68688,available,O,3338
68689,for,O,3338
68690,patients,O,3338
68691,to,O,3338
68692,be,O,3338
68693,seen,O,3338
68694,right,O,3338
68695,away,O,3338
68696,Patients,O,3338
68697,are,O,3338
68698,understandably,O,3338
68699,concerned,O,3338
68700,and,O,3338
68701,stressed,O,3338
68702,and,O,3338
68703,may,O,3338
68704,have,O,3338
68705,been,O,3338
68706,advised,O,3338
68707,by,O,3338
68708,their,O,3338
68709,GP,O,3338
68710,to,O,3338
68711,be,O,3338
68712,seen,O,3338
68713,urgently,O,3338
68714,Practitioners,O,3338
68715,can,O,3338
68716,often,O,3338
68717,end,O,3339
68718,up,O,3339
68719,reviewing,O,3339
68720,these,O,3339
68721,patients,O,3339
68722,into,O,3339
68723,their,O,3339
68724,lunchtimes,O,3339
68725,or,O,3339
68726,missing,O,3339
68727,breaks,O,3339
68728,Leaving,O,3339
68729,appointment,O,3339
68730,slots,O,3339
68731,available,O,3339
68732,to,O,3339
68733,manage,O,3339
68734,emergencies,O,3339
68735,may,O,3339
68736,be,O,3340
68737,a,O,3340
68738,solution,O,3340
68739,in,O,3340
68740,a,O,3340
68741,large,O,3340
68742,practice,O,3340
68743,though,O,3340
68744,it,O,3340
68745,might,O,3340
68746,not,O,3340
68747,be,O,3340
68748,practical,O,3340
68749,in,O,3340
68750,a,O,3340
68751,small,O,3340
68752,premise,O,3340
68753,where,O,3340
68754,unfilled,O,3340
68755,slots,O,3340
68756,can,O,3340
68757,impact,O,3340
68758,on,O,3340
68759,the,O,3340
68760,overall,O,3340
68761,revenue,O,3340
68762,of,O,3340
68763,a,O,3340
68764,practice,O,3340
68765,It,O,3340
68766,would,O,3340
68767,perhaps,O,3340
68768,be,O,3340
68769,timely,O,3340
68770,to,O,3340
68771,review,O,3340
68772,the,O,3341
68773,management,O,3341
68774,of,O,3341
68775,emergencies,O,3341
68776,in,O,3341
68777,optometric,O,3341
68778,practice,O,3341
68779,and,O,3341
68780,whether,O,3341
68781,staff,O,3341
68782,are,O,3341
68783,given,O,3341
68784,enough,O,3341
68785,time,O,3341
68786,to,O,3341
68787,adequately,O,3342
68788,manage,O,3342
68789,these,O,3342
68790,cases,O,3342
68791,As,O,3342
68792,more,O,3342
68793,eye,O,3342
68794,care,O,3342
68795,gets,O,3342
68796,shifted,O,3342
68797,to,O,3342
68798,the,O,3342
68799,optometrist,O,3342
68800,managing,O,3342
68801,a,O,3342
68802,diary,O,3342
68803,to,O,3342
68804,ensure,O,3342
68805,an,O,3342
68806,appropriate,O,3342
68807,duty,O,3342
68808,of,O,3342
68809,care,O,3342
68810,to,O,3342
68811,the,O,3343
68812,patient,O,3343
68813,whilst,O,3343
68814,also,O,3343
68815,supporting,O,3343
68816,our,O,3343
68817,professionals,O,3343
68818,is,O,3343
68819,something,O,3343
68820,that,O,3343
68821,will,O,3343
68822,become,O,3343
68823,an,O,3343
68824,increasing,O,3343
68825,challenge,O,3343
68826,Making,O,3343
68827,Good,O,3343
68828,Decisions,O,3343
68829,In,O,3343
68830,a,O,3343
68831,recent,O,3343
68832,paper,O,3343
68833,it,O,3343
68834,was,O,3343
68835,identified,O,3343
68836,that,O,3343
68837,managing,O,3343
68838,patients,O,3343
68839,who,O,3343
68840,attend,O,3343
68841,with,O,3343
68842,the,O,3343
68843,symptom,O,3343
68844,of,O,3343
68845,flashes,B-SIGN_AND_SYMPTOM,3343
68846,and,I-SIGN_AND_SYMPTOM,3343
68847,floaters,I-SIGN_AND_SYMPTOM,3343
68848,in,O,3343
68849,optometric,O,3343
68850,practice,O,3344
68851,was,O,3344
68852,one,O,3344
68853,area,O,3344
68854,of,O,3344
68855,practice,O,3344
68856,that,O,3344
68857,optometrists,O,3344
68858,in,O,3344
68859,Scotland,B-GPE,3344
68860,felt,O,3344
68861,was,O,3344
68862,an,O,3345
68863,area,O,3345
68864,of,O,3345
68865,concern,O,3345
68866,Barriers,O,3345
68867,to,O,3345
68868,managing,O,3345
68869,a,O,3345
68870,patient,O,3345
68871,within,O,3345
68872,the,O,3345
68873,community,O,3345
68874,and,O,3345
68875,not,O,3345
68876,referring,O,3345
68877,them,O,3345
68878,on,O,3345
68879,for,O,3346
68880,ophthalmological,O,3346
68881,view,O,3346
68882,included,O,3346
68883,pressure,O,3346
68884,from,O,3346
68885,the,O,3346
68886,patient,O,3346
68887,to,O,3346
68888,refer,O,3346
68889,them,O,3346
68890,a,O,3346
68891,general,O,3346
68892,lack,O,3346
68893,of,O,3346
68894,feedback,O,3346
68895,from,O,3346
68896,referrals,O,3346
68897,to,O,3346
68898,ophthalmology,O,3346
68899,and,O,3346
68900,concern,O,3346
68901,about,O,3346
68902,legal,O,3346
68903,action,O,3346
68904,if,O,3346
68905,the,O,3346
68906,patient,O,3346
68907,is,O,3346
68908,not,O,3346
68909,referred,O,3346
68910,and,O,3346
68911,they,O,3346
68912,should,O,3346
68913,have,O,3346
68914,been,O,3346
68915,It,O,3346
68916,is,O,3346
68917,perhaps,O,3346
68918,unsurprising,O,3346
68919,that,O,3346
68920,the,O,3346
68921,research,O,3346
68922,showed,O,3346
68923,that,O,3346
68924,optometrists,O,3346
68925,need,O,3347
68926,confidence,O,3347
68927,in,O,3347
68928,their,O,3347
68929,own,O,3347
68930,decision-making,O,3347
68931,to,O,3347
68932,ensure,O,3347
68933,that,O,3347
68934,appropriate,O,3347
68935,referrals,O,3348
68936,are,O,3348
68937,made,O,3348
68938,and,O,3348
68939,that,O,3348
68940,practitioners,O,3348
68941,who,O,3348
68942,reported,O,3348
68943,finding,O,3348
68944,these,O,3348
68945,patients,O,3348
68946,stressful,O,3348
68947,to,O,3348
68948,manage,O,3348
68949,was,O,3348
68950,a,O,3348
68951,barrier,O,3348
68952,to,O,3348
68953,making,O,3348
68954,the,O,3348
68955,correct,O,3348
68956,referral,O,3348
68957,decision,O,3348
68958,these,O,3348
68959,practitioners,O,3348
68960,may,O,3349
68961,be,O,3349
68962,over-referring,O,3349
68963,patients,O,3349
68964,Referring,O,3349
68965,patients,O,3349
68966,as,O,3349
68967,an,O,3349
68968,emergency,O,3349
68969,where,O,3349
68970,the,O,3349
68971,symptoms,O,3349
68972,are,O,3349
68973,as,O,3349
68974,a,O,3349
68975,result,O,3349
68976,of,O,3349
68977,a,B-NAME_OF_DISEASE,3349
68978,retinal,I-NAME_OF_DISEASE,3349
68979,tear,I-NAME_OF_DISEASE,3349
68980,or,I-NAME_OF_DISEASE,3349
68981,detachment,I-NAME_OF_DISEASE,3349
68982,is,O,3349
68983,clearly,O,3349
68984,important,O,3349
68985,When,O,3349
68986,there,O,3350
68987,is,O,3350
68988,doubt,O,3350
68989,about,O,3350
68990,the,O,3350
68991,diagnosis,O,3350
68992,-,O,3350
68993,when,O,3350
68994,a,O,3350
68995,detachment,O,3350
68996,can,O,3350
68997,t,O,3350
68998,be,O,3350
68999,ruled,O,3350
69000,out,O,3350
69001,an,O,3350
69002,urgent,O,3350
69003,referral,O,3350
69004,is,O,3350
69005,still,O,3350
69006,required,O,3350
69007,There,O,3350
69008,should,O,3350
69009,be,O,3350
69010,no,O,3350
69011,cases,O,3350
69012,where,O,3350
69013,these,O,3350
69014,patients,O,3351
69015,are,O,3351
69016,referred,O,3351
69017,routinely,O,3351
69018,or,O,3351
69019,even,O,3351
69020,for,O,3351
69021,a,O,3351
69022,soon,O,3351
69023,appointment,O,3351
69024,It,O,3351
69025,is,O,3351
69026,of,O,3351
69027,concern,O,3351
69028,though,O,3351
69029,perhaps,O,3351
69030,not,O,3351
69031,surprising,O,3351
69032,that,O,3352
69033,research,O,3352
69034,into,O,3352
69035,managing,O,3352
69036,these,O,3352
69037,patients,O,3352
69038,highlighted,O,3352
69039,a,O,3352
69040,group,O,3352
69041,of,O,3352
69042,practitioners,O,3352
69043,who,O,3352
69044,were,O,3352
69045,possibly,O,3352
69046,over-referring,O,3352
69047,their,O,3352
69048,patients,O,3352
69049,due,O,3352
69050,to,O,3352
69051,their,O,3352
69052,concerns,O,3352
69053,about,O,3352
69054,being,O,3352
69055,sued,O,3352
69056,if,O,3353
69057,they,O,3353
69058,made,O,3353
69059,the,O,3353
69060,wrong,O,3353
69061,decision,O,3353
69062,Even,O,3353
69063,the,O,3353
69064,most,O,3353
69065,committed,O,3353
69066,practitioner,O,3353
69067,may,O,3353
69068,have,O,3353
69069,lingering,O,3353
69070,doubts,O,3353
69071,about,O,3353
69072,a,O,3353
69073,patient,O,3354
69074,where,O,3354
69075,the,O,3354
69076,possibility,O,3354
69077,of,O,3354
69078,making,O,3354
69079,an,O,3354
69080,error,O,3354
69081,and,O,3354
69082,having,O,3354
69083,missed,O,3354
69084,a,O,3354
69085,peripheral,O,3354
69086,tear,O,3355
69087,results,O,3355
69088,in,O,3355
69089,the,O,3355
69090,patient,O,3355
69091,losing,O,3355
69092,their,O,3355
69093,eyesight,O,3355
69094,Keeping,O,3355
69095,accurate,O,3355
69096,records,O,3355
69097,conducting,O,3355
69098,a,O,3355
69099,thorough,O,3355
69100,patient,O,3355
69101,history,O,3355
69102,and,O,3355
69103,detailed,O,3355
69104,examination,O,3355
69105,discussing,O,3355
69106,with,O,3355
69107,the,O,3356
69108,patient,O,3356
69109,the,O,3356
69110,findings,O,3356
69111,and,O,3356
69112,providing,O,3356
69113,them,O,3356
69114,with,O,3356
69115,information,O,3356
69116,and,O,3356
69117,advice,O,3356
69118,to,O,3356
69119,return,O,3357
69120,if,O,3357
69121,things,O,3357
69122,change,O,3357
69123,constitute,O,3357
69124,good,O,3357
69125,care,O,3357
69126,Perhaps,O,3357
69127,not,O,3357
69128,having,O,3357
69129,any,O,3357
69130,doubts,O,3357
69131,is,O,3357
69132,a,O,3357
69133,sign,O,3357
69134,of,O,3357
69135,arrogance,O,3357
69136,-,O,3357
69137,not,O,3357
69138,being,O,3357
69139,fully,O,3358
69140,aware,O,3358
69141,that,O,3358
69142,errors,O,3358
69143,can,O,3358
69144,be,O,3359
69145,made,O,3359
69146,We,O,3359
69147,are,O,3359
69148,all,O,3359
69149,human,O,3359
69150,A,O,3359
69151,common,O,3359
69152,response,O,3359
69153,to,O,3359
69154,rising,O,3359
69155,demand,O,3359
69156,for,O,3360
69157,healthcare,O,3360
69158,is,O,3360
69159,to,O,3360
69160,extend,O,3360
69161,the,O,3360
69162,role,O,3360
69163,of,O,3361
69164,healthcare,O,3361
69165,professionals,O,3361
69166,A,O,3361
69167,good,O,3361
69168,example,O,3361
69169,of,O,3361
69170,this,O,3361
69171,is,O,3361
69172,the,O,3361
69173,developing,O,3361
69174,role,O,3361
69175,of,O,3361
69176,the,O,3361
69177,community,O,3361
69178,optometrist,O,3362
69179,and,O,3362
69180,their,O,3362
69181,requirement,O,3362
69182,to,O,3362
69183,manage,O,3362
69184,more,O,3362
69185,patients,O,3362
69186,within,O,3362
69187,their,O,3362
69188,practices,O,3362
69189,without,O,3362
69190,referring,O,3362
69191,them,O,3362
69192,on,O,3362
69193,to,O,3362
69194,the,O,3362
69195,hospital,O,3362
69196,eye,O,3362
69197,service,O,3362
69198,when,O,3362
69199,ophthalmology,O,3362
69200,care,O,3362
69201,is,O,3362
69202,not,O,3362
69203,required,O,3362
69204,Eye,O,3362
69205,care,O,3362
69206,in,O,3363
69207,the,O,3363
69208,community,O,3363
69209,needs,O,3363
69210,to,O,3363
69211,be,O,3363
69212,conducted,O,3363
69213,safely,O,3363
69214,and,O,3363
69215,the,O,3363
69216,care,O,3363
69217,that,O,3363
69218,is,O,3364
69219,provided,O,3364
69220,needs,O,3364
69221,to,O,3364
69222,be,O,3364
69223,of,O,3364
69224,the,O,3364
69225,highest,O,3364
69226,quality,O,3364
69227,A,B-NAME_OF_DISEASE,3364
69228,PVD,I-NAME_OF_DISEASE,3364
69229,is,O,3364
69230,a,O,3364
69231,normal,O,3364
69232,process,O,3364
69233,of,O,3364
69234,ageing,O,3364
69235,and,O,3364
69236,has,O,3364
69237,always,O,3364
69238,been,O,3364
69239,widely,O,3364
69240,managed,O,3364
69241,within,O,3364
69242,community,O,3364
69243,optometry,O,3364
69244,All,O,3364
69245,too,O,3364
69246,often,O,3364
69247,though,O,3364
69248,the,O,3364
69249,threshold,O,3364
69250,for,O,3364
69251,referral,O,3364
69252,to,O,3364
69253,accident,O,3364
69254,and,O,3364
69255,emergency,O,3364
69256,has,O,3364
69257,been,O,3365
69258,low,O,3365
69259,these,O,3365
69260,patients,O,3365
69261,have,O,3365
69262,been,O,3365
69263,referred,O,3365
69264,unnecessarily,O,3365
69265,across,O,3365
69266,the,O,3365
69267,country,O,3365
69268,by,O,3365
69269,many,O,3365
69270,practitioners,O,3366
69271,It,O,3366
69272,is,O,3366
69273,vital,O,3366
69274,that,O,3366
69275,these,O,3366
69276,low,O,3366
69277,risk,O,3366
69278,patients,O,3366
69279,are,O,3366
69280,retained,O,3366
69281,within,O,3366
69282,the,O,3366
69283,community,O,3366
69284,as,O,3366
69285,they,O,3366
69286,clearly,O,3366
69287,do,O,3366
69288,not,O,3366
69289,require,O,3366
69290,ophthalmology,O,3366
69291,referral,O,3366
69292,Community,O,3366
69293,optometrists,O,3366
69294,have,O,3366
69295,the,O,3366
69296,training,O,3367
69297,knowledge,O,3367
69298,and,O,3367
69299,equipment,O,3367
69300,to,O,3367
69301,safely,O,3367
69302,manage,O,3367
69303,these,O,3367
69304,patients,O,3367
69305,to,O,3367
69306,make,O,3367
69307,an,O,3368
69308,accurate,O,3368
69309,diagnosis,O,3368
69310,and,O,3368
69311,to,O,3368
69312,advise,O,3368
69313,rapid,O,3368
69314,re-assessment,O,3368
69315,if,O,3368
69316,symptoms,O,3368
69317,change,O,3368
69318,Pneumatic,B-TREATMENT,3368
69319,retinopexy,I-TREATMENT,3368
69320,is,O,3368
69321,an,O,3368
69322,in-office,O,3368
69323,procedure,O,3368
69324,used,O,3368
69325,to,O,3368
69326,repair,O,3368
69327,certain,O,3368
69328,types,O,3368
69329,of,O,3369
69330,retinal,B-NAME_OF_DISEASE,3369
69331,detachments,I-NAME_OF_DISEASE,3369
69332,Pneumatic,B-TREATMENT,3369
69333,retinopexy,I-TREATMENT,3369
69334,typically,O,3369
69335,treats,O,3369
69336,rhegmatous,B-NAME_OF_DISEASE,3369
69337,retinal,I-NAME_OF_DISEASE,3369
69338,detachments,I-NAME_OF_DISEASE,3369
69339,The,O,3369
69340,eye,O,3369
69341,is,O,3369
69342,numbed,O,3369
69343,with,O,3369
69344,anesthesia,O,3369
69345,so,O,3369
69346,there,O,3369
69347,is,O,3369
69348,no,O,3369
69349,pain,O,3369
69350,A,O,3369
69351,gas,O,3369
69352,bubble,O,3369
69353,is,O,3369
69354,injected,O,3369
69355,into,O,3369
69356,the,O,3369
69357,eye,O,3369
69358,vitreous,B-PART_OF_THE_EYES,3369
69359,cavity,I-PART_OF_THE_EYES,3370
69360,,O,3370
69361,When,O,3370
69362,the,O,3370
69363,gas,O,3370
69364,floats,O,3370
69365,up,O,3370
69366,it,O,3370
69367,pushes,O,3370
69368,the,B-PART_OF_THE_EYES,3370
69369,retina,I-PART_OF_THE_EYES,3370
69370,that,O,3370
69371,is,O,3370
69372,detached,O,3370
69373,back,O,3370
69374,into,O,3370
69375,proper,O,3370
69376,position,O,3370
69377,and,O,3371
69378,also,O,3371
69379,closes,O,3371
69380,the,O,3371
69381,retinal,O,3371
69382,tear,O,3371
69383,against,O,3371
69384,the,O,3371
69385,way,O,3371
69386,of,O,3371
69387,the,O,3371
69388,eye,O,3371
69389,at,O,3371
69390,the,O,3372
69391,same,O,3372
69392,time,O,3372
69393,thus,O,3372
69394,repairing,O,3372
69395,the,B-NAME_OF_DISEASE,3372
69396,retinal,I-NAME_OF_DISEASE,3372
69397,detachment,I-NAME_OF_DISEASE,3372
69398,Cryopexy,B-TREATMENT,3372
69399,freezing,I-TREATMENT,3372
69400,or,O,3372
69401,laser,B-TREATMENT,3372
69402,are,O,3372
69403,then,O,3372
69404,used,O,3372
69405,to,O,3372
69406,permanently,O,3373
69407,seal,O,3374
69408,the,O,3374
69409,retinal,O,3374
69410,tear,O,3374
69411,to,O,3374
69412,the,O,3374
69413,wall,O,3374
69414,of,O,3374
69415,the,O,3374
69416,eye,O,3374
69417,The,O,3374
69418,gas,O,3375
69419,bubble,O,3375
69420,goes,O,3375
69421,away,O,3375
69422,by,O,3375
69423,itself,O,3375
69424,getting,O,3375
69425,smaller,O,3375
69426,and,O,3375
69427,smaller,O,3375
69428,over,O,3375
69429,the,O,3375
69430,course,O,3375
69431,of,O,3375
69432,8-Apr,B-TIME_DURATION,3375
69433,weeks,I-TIME_DURATION,3375
69434,after,O,3375
69435,which,O,3375
69436,if,O,3375
69437,successful,O,3375
69438,the,B-PART_OF_THE_EYES,3376
69439,retina,I-PART_OF_THE_EYES,3376
69440,should,O,3376
69441,be,O,3376
69442,back,O,3376
69443,to,O,3376
69444,its,O,3376
69445,proper,O,3376
69446,position,O,3376
69447,and,O,3376
69448,the,O,3376
69449,vision,O,3376
69450,should,O,3376
69451,be,O,3376
69452,improved,O,3376
69453,Pneumatic,B-TREATMENT,3376
69454,retinopexy,I-TREATMENT,3376
69455,is,O,3376
69456,done,O,3376
69457,for,O,3376
69458,certain,O,3377
69459,types,O,3377
69460,of,O,3377
69461,retinal,B-NAME_OF_DISEASE,3377
69462,detachments,I-NAME_OF_DISEASE,3377
69463,typically,O,3377
69464,for,O,3377
69465,rhegmatous,B-NAME_OF_DISEASE,3377
69466,retinal,I-NAME_OF_DISEASE,3377
69467,detachments,I-NAME_OF_DISEASE,3377
69468,PnR,B-TREATMENT,3377
69469,offers,O,3377
69470,superior,O,3377
69471,photoreceptor,B-PART_OF_THE_EYES,3377
69472,integrity,O,3377
69473,and,O,3377
69474,less,O,3377
69475,retinal,O,3377
69476,displacement,O,3377
69477,with,O,3377
69478,better,O,3377
69479,long-term,O,3377
69480,visual,O,3377
69481,acuity,O,3377
69482,results,O,3377
69483,and,O,3377
69484,less,O,3377
69485,vertical,O,3377
69486,metamorphopsia,O,3377
69487,compared,O,3377
69488,with,O,3378
69489,other,O,3378
69490,surgical,O,3378
69491,approaches,O,3378
69492,Although,O,3378
69493,the,O,3378
69494,individual,O,3378
69495,steps,O,3378
69496,of,O,3378
69497,performing,O,3378
69498,PnR-namely,O,3378
69499,an,B-TREATMENT,3378
69500,anterior,I-TREATMENT,3378
69501,chamber,I-TREATMENT,3379
69502,paracentesis,I-TREATMENT,3379
69503,an,B-TREATMENT,3379
69504,intravitreal,I-TREATMENT,3379
69505,injection,I-TREATMENT,3379
69506,of,I-TREATMENT,3379
69507,gas,I-TREATMENT,3379
69508,and,O,3379
69509,laser,B-TREATMENT,3379
69510,retinopexy,I-TREATMENT,3379
69511,or,O,3379
69512,cryopexy-are,O,3379
69513,relatively,O,3379
69514,straightforward,O,3379
69515,there,O,3379
69516,is,O,3379
69517,an,O,3379
69518,art,O,3379
69519,to,O,3379
69520,performing,O,3379
69521,PnR,B-TREATMENT,3379
69522,that,O,3379
69523,is,O,3379
69524,acquired,O,3379
69525,only,O,3379
69526,after,O,3379
69527,performing,O,3379
69528,hundreds,O,3380
69529,of,O,3380
69530,cases,O,3380
69531,The,O,3380
69532,following,O,3380
69533,are,O,3380
69534,10,O,3380
69535,tips,O,3380
69536,and,O,3380
69537,tricks,O,3380
69538,to,O,3380
69539,maximize,O,3380
69540,outcomes,O,3380
69541,with,O,3380
69542,PnR,B-TREATMENT,3380
69543,It,O,3380
69544,s,O,3380
69545,All,O,3380
69546,About,O,3380
69547,the,B-DIAGNOSTIC_TEST,3380
69548,Scleral,I-DIAGNOSTIC_TEST,3380
69549,Depressed,I-DIAGNOSTIC_TEST,3380
69550,Examination,I-DIAGNOSTIC_TEST,3380
69551,The,O,3380
69552,clinical,O,3381
69553,exam,O,3381
69554,is,O,3381
69555,of,O,3381
69556,utmost,O,3381
69557,importance,O,3381
69558,in,O,3381
69559,PnR,B-TREATMENT,3381
69560,It,O,3381
69561,is,O,3381
69562,ideal,O,3381
69563,if,O,3381
69564,the,O,3381
69565,person,O,3381
69566,who,O,3381
69567,performs,O,3381
69568,the,O,3381
69569,procedure,O,3381
69570,is,O,3381
69571,the,O,3381
69572,one,O,3381
69573,who,O,3381
69574,will,O,3381
69575,follow,O,3382
69576,the,O,3382
69577,patient,O,3382
69578,during,O,3382
69579,the,O,3382
69580,first,O,3382
69581,week,O,3382
69582,however,O,3382
69583,if,O,3382
69584,this,O,3382
69585,is,O,3382
69586,not,O,3382
69587,possible,O,3382
69588,a,O,3382
69589,second,O,3382
69590,retina,B-PART_OF_THE_EYES,3382
69591,specialist,O,3382
69592,should,O,3383
69593,be,O,3383
69594,able,O,3383
69595,to,O,3383
69596,take,O,3383
69597,over,O,3383
69598,if,O,3383
69599,the,O,3383
69600,pathology,O,3383
69601,has,O,3383
69602,been,O,3383
69603,described,O,3383
69604,in,O,3383
69605,detail,O,3383
69606,It,O,3383
69607,is,O,3383
69608,important,O,3383
69609,to,O,3383
69610,perform,O,3383
69611,a,O,3383
69612,careful,O,3383
69613,scleral,B-DIAGNOSTIC_TEST,3383
69614,depressed,I-DIAGNOSTIC_TEST,3383
69615,examination,I-DIAGNOSTIC_TEST,3384
69616,The,O,3384
69617,surgeon,O,3384
69618,needs,O,3384
69619,to,O,3384
69620,be,O,3384
69621,aware,O,3384
69622,of,O,3384
69623,all,O,3384
69624,the,O,3384
69625,pathology,O,3384
69626,in,O,3384
69627,that,O,3384
69628,eye,O,3384
69629,including,O,3384
69630,all,O,3384
69631,retinal,B-SIGN_AND_SYMPTOM,3384
69632,breaks,I-SIGN_AND_SYMPTOM,3384
69633,but,O,3384
69634,also,O,3384
69635,areas,O,3384
69636,of,O,3384
69637,lattice,O,3384
69638,and,O,3384
69639,vitreoretinal,O,3384
69640,tags,O,3385
69641,The,O,3385
69642,accuracy,O,3385
69643,of,O,3385
69644,the,O,3385
69645,initial,O,3385
69646,exam,O,3385
69647,is,O,3385
69648,most,O,3385
69649,critical,O,3385
69650,and,O,3385
69651,careful,O,3385
69652,follow-up,O,3385
69653,exams,O,3385
69654,are,O,3385
69655,also,O,3385
69656,required,O,3385
69657,to,O,3385
69658,ensure,O,3385
69659,there,O,3385
69660,are,O,3385
69661,no,O,3385
69662,new,O,3385
69663,or,O,3385
69664,previously,O,3385
69665,missed,O,3385
69666,breaks,O,3385
69667,Maximize,O,3385
69668,the,B-TREATMENT,3385
69669,Anterior,I-TREATMENT,3385
69670,Chamber,I-TREATMENT,3385
69671,Paracentesis,I-TREATMENT,3385
69672,Volume,O,3385
69673,The,O,3385
69674,size,O,3385
69675,of,O,3386
69676,the,B-TREATMENT,3386
69677,anterior,I-TREATMENT,3386
69678,chamber,I-TREATMENT,3386
69679,paracentesis,I-TREATMENT,3386
69680,is,O,3386
69681,critical,O,3386
69682,as,O,3386
69683,it,O,3386
69684,dictates,O,3386
69685,how,O,3386
69686,much,O,3386
69687,gas,O,3386
69688,you,O,3386
69689,can,O,3386
69690,inject,O,3386
69691,into,O,3386
69692,the,B-PART_OF_THE_EYES,3386
69693,vitreous,I-PART_OF_THE_EYES,3386
69694,cavity,I-PART_OF_THE_EYES,3386
69695,If,O,3386
69696,your,O,3387
69697,outpatient,O,3387
69698,facility,O,3387
69699,has,O,3387
69700,a,O,3387
69701,basic,O,3387
69702,microscope,O,3387
69703,in,O,3387
69704,a,O,3387
69705,treatment,O,3387
69706,room,O,3387
69707,use,O,3387
69708,it,O,3387
69709,while,O,3387
69710,performing,O,3387
69711,the,B-TREATMENT,3387
69712,paracentesis,I-TREATMENT,3387
69713,This,O,3387
69714,provides,O,3387
69715,optimal,O,3387
69716,visualization,O,3387
69717,and,O,3387
69718,when,O,3387
69719,the,O,3387
69720,patient,O,3387
69721,is,O,3387
69722,lying,O,3387
69723,supine,O,3388
69724,it,O,3388
69725,is,O,3388
69726,much,O,3388
69727,more,O,3388
69728,controlled,O,3388
69729,than,O,3388
69730,performing,O,3388
69731,a,B-TREATMENT,3388
69732,paracentesis,I-TREATMENT,3388
69733,at,O,3388
69734,the,B-DIAGNOSTIC_TEST,3388
69735,slit,I-DIAGNOSTIC_TEST,3388
69736,lamp,I-DIAGNOSTIC_TEST,3388
69737,If,O,3388
69738,a,O,3388
69739,microscope,O,3388
69740,is,O,3388
69741,not,O,3388
69742,available,O,3388
69743,I,O,3388
69744,perform,O,3388
69745,the,B-TREATMENT,3388
69746,paracentesis,I-TREATMENT,3388
69747,with,O,3388
69748,the,O,3389
69749,patient,O,3389
69750,reclined,O,3389
69751,under,O,3389
69752,direct,O,3389
69753,visualization,O,3389
69754,We,O,3389
69755,use,O,3389
69756,a,B-SURGICAL_INSTRUMENT,3389
69757,30-G,I-SURGICAL_INSTRUMENT,3389
69758,needle,I-SURGICAL_INSTRUMENT,3389
69759,on,O,3389
69760,a,B-SURGICAL_INSTRUMENT,3389
69761,tuberculin,I-SURGICAL_INSTRUMENT,3389
69762,syringe,I-SURGICAL_INSTRUMENT,3389
69763,with,O,3389
69764,the,B-SURGICAL_INSTRUMENT,3389
69765,plunger,I-SURGICAL_INSTRUMENT,3390
69766,removed,O,3390
69767,We,O,3390
69768,insert,O,3390
69769,the,B-SURGICAL_INSTRUMENT,3390
69770,needle,I-SURGICAL_INSTRUMENT,3390
69771,inferotempoerally,O,3390
69772,over,O,3390
69773,iris,B-PART_OF_THE_EYES,3390
69774,in,O,3390
69775,phakic,O,3390
69776,patients,O,3390
69777,and,O,3391
69778,over,O,3391
69779,the,O,3391
69780,optic,O,3391
69781,from,O,3391
69782,the,O,3391
69783,temporal,O,3391
69784,side,O,3391
69785,in,O,3391
69786,pseudophakic,O,3391
69787,patients,O,3391
69788,We,O,3391
69789,use,O,3391
69790,the,B-SURGICAL_INSTRUMENT,3391
69791,plunger,I-SURGICAL_INSTRUMENT,3391
69792,to,O,3391
69793,apply,O,3391
69794,counter,O,3391
69795,pressure,O,3391
69796,on,O,3391
69797,the,O,3391
69798,nasal,O,3391
69799,limbus,O,3391
69800,This,O,3391
69801,creates,O,3391
69802,a,O,3391
69803,dome,O,3391
69804,over,O,3391
69805,the,B-SURGICAL_INSTRUMENT,3392
69806,needle,I-SURGICAL_INSTRUMENT,3392
69807,and,O,3392
69808,the,O,3392
69809,firm,O,3392
69810,pressure,O,3392
69811,will,O,3392
69812,force,O,3392
69813,aqueous,O,3392
69814,and,O,3392
69815,liquified,O,3392
69816,vitreous,O,3392
69817,into,O,3392
69818,the,B-SURGICAL_INSTRUMENT,3392
69819,needle,I-SURGICAL_INSTRUMENT,3392
69820,Most,O,3392
69821,of,O,3392
69822,the,O,3392
69823,time,O,3393
69824,0.2-0.,O,3393
69825,cc,O,3393
69826,is,O,3393
69827,removed,O,3393
69828,although,O,3394
69829,sometimes,O,3394
69830,a,O,3394
69831,much,O,3394
69832,larger,O,3394
69833,volume,O,3394
69834,can,O,3394
69835,be,O,3394
69836,removed,O,3394
69837,We,O,3394
69838,recommend,O,3394
69839,removing,O,3394
69840,as,O,3394
69841,much,O,3394
69842,as,O,3394
69843,possible,O,3395
69844,The,B-PART_OF_THE_EYES,3395
69845,chamber,I-PART_OF_THE_EYES,3395
69846,is,O,3395
69847,completely,O,3395
69848,flat,O,3395
69849,after,O,3395
69850,this,O,3395
69851,step,O,3395
69852,and,O,3395
69853,the,O,3395
69854,eye,O,3395
69855,is,O,3395
69856,generally,O,3396
69857,quite,O,3396
69858,soft,O,3396
69859,Use,O,3396
69860,SF6,B-CHEMICAL_COMPOUND,3396
69861,in,O,3396
69862,Most,O,3396
69863,Cases,O,3396
69864,We,O,3396
69865,prefer,O,3396
69866,SF6,B-CHEMICAL_COMPOUND,3396
69867,gas,I-CHEMICAL_COMPOUND,3396
69868,over,O,3396
69869,C3F8,B-CHEMICAL_COMPOUND,3396
69870,for,O,3396
69871,PnR,B-TREATMENT,3396
69872,in,O,3396
69873,almost,O,3396
69874,all,O,3396
69875,cases,O,3396
69876,as,O,3396
69877,it,O,3396
69878,has,O,3396
69879,favorable,O,3396
69880,properties,O,3397
69881,that,O,3397
69882,make,O,3397
69883,it,O,3397
69884,ideal,O,3397
69885,for,O,3397
69886,PnR,B-TREATMENT,3397
69887,It,O,3397
69888,reaches,O,3397
69889,maximal,O,3397
69890,expansion,O,3397
69891,in,B-TIME_DURATION,3397
69892,36,I-TIME_DURATION,3397
69893,hours,I-TIME_DURATION,3397
69894,and,O,3397
69895,dissolves,O,3397
69896,in,B-TIME_DURATION,3397
69897,12,I-TIME_DURATION,3397
69898,days,I-TIME_DURATION,3397
69899,When,O,3397
69900,we,O,3397
69901,perform,O,3397
69902,a,B-TREATMENT,3397
69903,PnR,I-TREATMENT,3397
69904,we,O,3397
69905,want,O,3397
69906,the,O,3397
69907,gas,O,3397
69908,bubble,O,3397
69909,to,O,3397
69910,expand,O,3397
69911,rapidly,O,3397
69912,so,O,3397
69913,it,O,3397
69914,is,O,3397
69915,large,O,3398
69916,enough,O,3398
69917,to,O,3398
69918,tamponade,O,3398
69919,the,O,3398
69920,break,O,3398
69921,s,O,3398
69922,and,O,3398
69923,we,O,3398
69924,can,O,3398
69925,then,O,3398
69926,quickly,O,3398
69927,determine,O,3398
69928,if,O,3398
69929,the,B-TREATMENT,3398
69930,PnR,I-TREATMENT,3398
69931,is,O,3398
69932,working,O,3398
69933,over,B-TIME_DURATION,3398
69934,the,I-TIME_DURATION,3398
69935,first,I-TIME_DURATION,3398
69936,few,I-TIME_DURATION,3398
69937,days,I-TIME_DURATION,3399
69938,With,O,3399
69939,C3F8,B-CHEMICAL_COMPOUND,3399
69940,maximal,O,3399
69941,size,O,3399
69942,of,O,3399
69943,the,O,3399
69944,gas,O,3399
69945,bubble,O,3399
69946,is,O,3399
69947,achieved,O,3399
69948,at,O,3399
69949,96,B-TIME_DURATION,3399
69950,hours,I-TIME_DURATION,3399
69951,This,O,3399
69952,is,O,3399
69953,a,O,3399
69954,long,O,3399
69955,time,O,3399
69956,to,O,3399
69957,wait,O,3399
69958,before,O,3399
69959,the,O,3399
69960,bubble,O,3400
69961,fully,O,3400
69962,expands,O,3400
69963,and,O,3400
69964,before,O,3400
69965,the,O,3400
69966,clinician,O,3400
69967,can,O,3400
69968,make,O,3400
69969,decisions,O,3400
69970,regarding,O,3400
69971,the,O,3400
69972,success,O,3400
69973,failure,O,3400
69974,of,O,3400
69975,the,O,3400
69976,procedure,O,3400
69977,Furthermore,O,3400
69978,C3F8,B-CHEMICAL_COMPOUND,3400
69979,lasts,O,3400
69980,in,O,3400
69981,the,O,3400
69982,eye,O,3400
69983,for,O,3400
69984,38,B-TIME_DURATION,3401
69985,days,I-TIME_DURATION,3401
69986,after,O,3401
69987,injection,O,3401
69988,In,O,3401
69989,most,O,3401
69990,cases,O,3401
69991,the,B-PART_OF_THE_EYES,3401
69992,retina,I-PART_OF_THE_EYES,3401
69993,is,O,3401
69994,reattached,O,3401
69995,fully,O,3401
69996,by,O,3401
69997,day,O,3401
69998,3,O,3401
69999,to,O,3401
70000,5,O,3401
70001,following,O,3401
70002,PnR,B-TREATMENT,3401
70003,and,O,3401
70004,the,O,3401
70005,retinal,O,3401
70006,breaks,O,3401
70007,are,O,3401
70008,well,O,3401
70009,lasered,O,3401
70010,Thirty-eight,B-TIME_DURATION,3401
70011,days,I-TIME_DURATION,3401
70012,of,O,3401
70013,a,O,3401
70014,gas,O,3401
70015,bubble,O,3401
70016,in,O,3401
70017,a,O,3401
70018,vitreous-filled,O,3401
70019,eye,O,3401
70020,following,O,3401
70021,retinal,B-NAME_OF_DISEASE,3401
70022,detachment,I-NAME_OF_DISEASE,3401
70023,repair,O,3401
70024,with,O,3401
70025,PnR,B-TREATMENT,3401
70026,is,O,3401
70027,not,O,3401
70028,necessary,O,3401
70029,and,O,3401
70030,it,O,3401
70031,is,O,3401
70032,possible,O,3401
70033,that,O,3401
70034,the,O,3401
70035,bubble,O,3401
70036,could,O,3401
70037,induce,O,3401
70038,other,O,3401
70039,breaks,O,3401
70040,In,O,3402
70041,rare,O,3402
70042,circumstances,O,3402
70043,in,O,3402
70044,which,O,3402
70045,an,B-TREATMENT,3402
70046,anterior,I-TREATMENT,3402
70047,chamber,I-TREATMENT,3402
70048,paracentesis,I-TREATMENT,3402
70049,is,O,3402
70050,not,O,3402
70051,possible,O,3402
70052,C3F8,B-CHEMICAL_COMPOUND,3402
70053,gas,I-CHEMICAL_COMPOUND,3402
70054,makes,O,3402
70055,the,O,3402
70056,most,O,3402
70057,sense,O,3402
70058,Maximize,O,3402
70059,the,O,3402
70060,Size,O,3402
70061,of,O,3402
70062,the,O,3402
70063,Intravitreal,O,3402
70064,Gas,O,3402
70065,Bubble,O,3403
70066,Injection,O,3403
70067,We,O,3403
70068,recommend,O,3403
70069,injecting,O,3403
70070,0,O,3403
70071,cc,O,3403
70072,more,O,3403
70073,than,O,3403
70074,what,O,3403
70075,is,O,3403
70076,removed,O,3403
70077,during,O,3403
70078,the,B-TREATMENT,3403
70079,anterior,I-TREATMENT,3403
70080,chamber,I-TREATMENT,3403
70081,paracentesis,B-TREATMENT,3403
70082,but,O,3403
70083,never,O,3403
70084,less,O,3403
70085,than,O,3403
70086,0,O,3403
70087,cc,O,3403
70088,The,O,3403
70089,larger,O,3403
70090,the,O,3403
70091,gas,O,3403
70092,bubble,O,3403
70093,the,O,3403
70094,greater,O,3403
70095,the,O,3403
70096,chance,O,3403
70097,of,O,3403
70098,success,O,3403
70099,To,O,3403
70100,minimize,O,3403
70101,fish,O,3403
70102,eggs,O,3403
70103,while,O,3403
70104,injecting,O,3404
70105,gas,O,3404
70106,we,O,3404
70107,always,O,3404
70108,like,O,3404
70109,to,O,3404
70110,inject,O,3404
70111,superotemporal,O,3404
70112,or,O,3404
70113,superonasal,O,3404
70114,with,O,3404
70115,the,O,3404
70116,patient,O,3404
70117,looking,O,3404
70118,down,O,3404
70119,We,O,3404
70120,insert,O,3404
70121,the,B-SURGICAL_INSTRUMENT,3404
70122,needle,I-SURGICAL_INSTRUMENT,3404
70123,half,O,3404
70124,way,O,3404
70125,in,O,3404
70126,and,O,3404
70127,then,O,3404
70128,pull,O,3404
70129,back,O,3404
70130,so,O,3404
70131,the,B-SURGICAL_INSTRUMENT,3404
70132,needle,I-SURGICAL_INSTRUMENT,3404
70133,tip,I-SURGICAL_INSTRUMENT,3404
70134,is,O,3404
70135,barely,O,3404
70136,in,O,3405
70137,the,O,3405
70138,eye,O,3405
70139,The,O,3405
70140,gas,O,3405
70141,is,O,3405
70142,injected,O,3405
70143,swiftly,O,3405
70144,and,O,3405
70145,the,O,3405
70146,plunger,O,3405
70147,of,O,3405
70148,the,B-SURGICAL_INSTRUMENT,3405
70149,syringe,I-SURGICAL_INSTRUMENT,3405
70150,is,O,3405
70151,kept,O,3405
70152,pressed,O,3405
70153,down,O,3405
70154,while,O,3405
70155,removing,O,3405
70156,the,B-SURGICAL_INSTRUMENT,3405
70157,needle,I-SURGICAL_INSTRUMENT,3405
70158,from,O,3405
70159,the,O,3405
70160,eye,O,3405
70161,to,O,3405
70162,prevent,O,3405
70163,reflux,O,3405
70164,of,O,3405
70165,gas,O,3405
70166,into,O,3405
70167,the,B-SURGICAL_INSTRUMENT,3405
70168,syringe,I-SURGICAL_INSTRUMENT,3405
70169,It,O,3405
70170,is,O,3405
70171,not,O,3405
70172,uncommon,O,3405
70173,to,O,3406
70174,perform,O,3406
70175,a,B-TREATMENT,3406
70176,repeat,I-TREATMENT,3406
70177,paracentesis,B-TREATMENT,3406
70178,following,O,3406
70179,the,O,3406
70180,gas,O,3406
70181,injection,O,3406
70182,Before,O,3406
70183,performing,O,3406
70184,the,B-TREATMENT,3406
70185,re-paracentesis,I-TREATMENT,3406
70186,we,O,3406
70187,usually,O,3406
70188,tell,O,3406
70189,the,O,3406
70190,patient,O,3406
70191,to,O,3406
70192,be,O,3406
70193,face,O,3406
70194,down,O,3406
70195,to,O,3406
70196,possibly,O,3406
70197,allow,O,3407
70198,more,O,3407
70199,fluid,O,3407
70200,to,O,3407
70201,enter,O,3407
70202,the,B-PART_OF_THE_EYES,3407
70203,anterior,I-PART_OF_THE_EYES,3407
70204,chamber,I-PART_OF_THE_EYES,3407
70205,from,O,3407
70206,the,B-PART_OF_THE_EYES,3407
70207,vitreous,I-PART_OF_THE_EYES,3407
70208,cavity,I-PART_OF_THE_EYES,3407
70209,The,B-TREATMENT,3407
70210,repeat,I-TREATMENT,3407
70211,paracentesis,B-TREATMENT,3407
70212,can,O,3407
70213,sometimes,O,3408
70214,be,O,3408
70215,challenging,O,3408
70216,as,O,3408
70217,the,O,3408
70218,eye,O,3408
70219,is,O,3408
70220,firm,O,3408
70221,and,O,3408
70222,the,B-PART_OF_THE_EYES,3408
70223,anterior,I-PART_OF_THE_EYES,3408
70224,chamber,I-PART_OF_THE_EYES,3408
70225,is,O,3408
70226,shallow,O,3408
70227,but,O,3408
70228,it,O,3408
70229,is,O,3408
70230,almost,O,3408
70231,always,O,3408
70232,doable,O,3408
70233,It,O,3408
70234,is,O,3408
70235,important,O,3408
70236,to,O,3408
70237,insert,O,3408
70238,and,O,3408
70239,remove,O,3408
70240,the,B-SURGICAL_INSTRUMENT,3408
70241,needle,I-SURGICAL_INSTRUMENT,3408
70242,very,O,3408
70243,slowly,O,3408
70244,to,O,3408
70245,prevent,O,3409
70246,or,O,3409
70247,lessen,O,3409
70248,trauma,O,3409
70249,and,O,3409
70250,iris,B-PART_OF_THE_EYES,3409
70251,incarceration,O,3409
70252,in,O,3409
70253,the,O,3409
70254,paracentesis,B-TREATMENT,3409
70255,wound,O,3409
70256,The,B-TREATMENT,3409
70257,Steamroller,I-TREATMENT,3409
70258,Maneuver,I-TREATMENT,3409
70259,is,O,3409
70260,Your,O,3409
70261,Friend,O,3409
70262,The,B-TREATMENT,3409
70263,steamroller,I-TREATMENT,3409
70264,maneuver,B-TREATMENT,3409
70265,is,O,3409
70266,an,O,3409
70267,important,O,3409
70268,part,O,3409
70269,of,O,3409
70270,the,B-TREATMENT,3409
70271,PnR,B-TREATMENT,3409
70272,procedure,I-TREATMENT,3409
70273,We,O,3409
70274,like,O,3409
70275,to,O,3409
70276,have,O,3409
70277,patients,O,3409
70278,position,O,3409
70279,face,O,3409
70280,down,O,3409
70281,for,B-TREATMENT,3409
70282,the,I-TREATMENT,3409
70283,first,I-TREATMENT,3409
70284,6,I-TREATMENT,3409
70285,hours,I-TREATMENT,3409
70286,in,O,3410
70287,macula-off,O,3410
70288,detachments,O,3410
70289,and,O,3410
70290,for,B-TIME_DURATION,3410
70291,4,I-TIME_DURATION,3410
70292,hours,I-TIME_DURATION,3410
70293,in,O,3410
70294,macula-on,O,3410
70295,cases,O,3410
70296,Then,O,3410
70297,for,O,3410
70298,the,B-NAME_OF_DISEASE,3410
70299,typical,I-NAME_OF_DISEASE,3410
70300,superior,I-NAME_OF_DISEASE,3410
70301,bullous,I-NAME_OF_DISEASE,3410
70302,retinal,I-NAME_OF_DISEASE,3410
70303,detachment,I-NAME_OF_DISEASE,3410
70304,I,O,3410
70305,ask,O,3410
70306,the,O,3410
70307,patient,O,3410
70308,to,O,3410
70309,raise,O,3410
70310,their,O,3410
70311,head,O,3410
70312,by,O,3410
70313,30,O,3411
70314,degrees,O,3411
70315,every,O,3411
70316,hour,O,3411
70317,until,O,3411
70318,they,O,3412
70319,are,O,3412
70320,upright,O,3412
70321,By,O,3412
70322,performing,O,3412
70323,this,O,3412
70324,maneuver,B-TREATMENT,3413
70325,the,O,3413
70326,buoyant,O,3413
70327,force,O,3413
70328,of,O,3413
70329,the,O,3413
70330,gas,O,3413
70331,bubble,O,3413
70332,causes,O,3413
70333,subretinal,O,3413
70334,fluid,O,3413
70335,to,O,3413
70336,be,O,3413
70337,displaced,O,3413
70338,through,O,3413
70339,the,B-SIGN_AND_SYMPTOM,3413
70340,retinal,I-SIGN_AND_SYMPTOM,3413
70341,break,I-SIGN_AND_SYMPTOM,3414
70342,reducing,O,3414
70343,the,O,3414
70344,amount,O,3414
70345,of,O,3414
70346,fluid,O,3414
70347,that,O,3414
70348,needs,O,3414
70349,to,O,3414
70350,be,O,3414
70351,reabsorbed,O,3414
70352,by,O,3414
70353,the,O,3414
70354,RPE,B-PART_OF_THE_EYES,3414
70355,pump,O,3414
70356,We,O,3414
70357,then,O,3414
70358,ask,O,3414
70359,them,O,3414
70360,to,O,3414
70361,tilt,O,3414
70362,their,O,3414
70363,head,O,3414
70364,or,O,3414
70365,lie,O,3414
70366,on,O,3414
70367,their,O,3414
70368,side,O,3414
70369,with,O,3414
70370,the,O,3414
70371,head,O,3414
70372,elevated,O,3414
70373,to,O,3414
70374,tamponade,O,3414
70375,the,O,3414
70376,break,O,3414
70377,In,O,3415
70378,some,O,3415
70379,cases,O,3415
70380,the,B-TREATMENT,3415
70381,steamroller,I-TREATMENT,3415
70382,maneuver,I-TREATMENT,3415
70383,can,O,3415
70384,be,O,3415
70385,used,O,3415
70386,to,O,3415
70387,prevent,O,3415
70388,the,O,3415
70389,inferior,O,3415
70390,displacement,O,3415
70391,of,O,3415
70392,fluid,O,3415
70393,in,O,3415
70394,cases,O,3415
70395,with,O,3415
70396,an,B-NAME_OF_DISEASE,3415
70397,inferior,I-NAME_OF_DISEASE,3415
70398,retinal,I-NAME_OF_DISEASE,3415
70399,break,I-NAME_OF_DISEASE,3415
70400,hole,I-NAME_OF_DISEASE,3415
70401,in,O,3416
70402,attach,O,3416
70403,retina,O,3416
70404,In,O,3416
70405,these,O,3416
70406,cases,O,3416
70407,the,O,3416
70408,patient,O,3416
70409,is,O,3416
70410,first,O,3416
70411,positioned,O,3416
70412,on,O,3416
70413,their,O,3416
70414,side,O,3416
70415,on,O,3416
70416,a,O,3416
70417,decline,O,3416
70418,and,O,3416
70419,then,O,3416
70420,they,O,3416
70421,gradually,O,3417
70422,raise,O,3417
70423,their,O,3417
70424,head,O,3417
70425,while,O,3417
70426,on,O,3417
70427,their,O,3417
70428,side,O,3417
70429,This,O,3417
70430,allows,O,3417
70431,fluid,O,3417
70432,to,O,3417
70433,be,O,3417
70434,displaced,O,3417
70435,in,O,3417
70436,a,O,3417
70437,certain,O,3418
70438,direction,O,3418
70439,away,O,3418
70440,from,O,3418
70441,the,O,3418
70442,inferior,O,3418
70443,breaks,O,3418
70444,of,O,3418
70445,concern,O,3418
70446,Positioning,O,3418
70447,The,O,3418
70448,success,O,3418
70449,of,O,3418
70450,PnR,B-TREATMENT,3418
70451,is,O,3418
70452,heavily,O,3418
70453,dependent,O,3418
70454,on,O,3418
70455,compliance,O,3418
70456,with,O,3418
70457,positioning,O,3418
70458,That,O,3418
70459,said,O,3419
70460,when,O,3419
70461,you,O,3419
70462,explain,O,3419
70463,positioning,O,3419
70464,to,O,3419
70465,patients,O,3419
70466,as,O,3419
70467,we,O,3419
70468,do,O,3419
70469,with,O,3419
70470,macular,B-TREATMENT,3419
70471,hole,I-TREATMENT,3419
70472,surgery,I-TREATMENT,3419
70473,for,O,3419
70474,example,O,3419
70475,most,O,3419
70476,of,O,3419
70477,them,O,3419
70478,are,O,3419
70479,concerned,O,3419
70480,about,O,3420
70481,their,O,3420
70482,ability,O,3420
70483,to,O,3420
70484,do,O,3420
70485,it,O,3420
70486,Despite,O,3420
70487,this,O,3420
70488,the,O,3420
70489,vast,O,3420
70490,majority,O,3420
70491,of,O,3420
70492,patients,O,3420
70493,will,O,3420
70494,position,O,3420
70495,if,O,3420
70496,their,O,3420
70497,doctor,O,3420
70498,stresses,O,3420
70499,the,O,3421
70500,importance,O,3421
70501,of,O,3421
70502,doing,O,3421
70503,it,O,3421
70504,Patients,O,3421
70505,can,O,3421
70506,often,O,3421
70507,misunderstand,O,3421
70508,instructions,O,3421
70509,For,O,3421
70510,example,O,3421
70511,in,O,3421
70512,some,O,3421
70513,cases,O,3421
70514,they,O,3421
70515,think,O,3421
70516,the,O,3421
70517,positioning,O,3421
70518,is,O,3421
70519,just,O,3421
70520,while,O,3421
70521,they,O,3421
70522,are,O,3421
70523,sleeping,O,3422
70524,In,O,3422
70525,other,O,3422
70526,cases,O,3422
70527,they,O,3422
70528,think,O,3422
70529,they,O,3422
70530,can,O,3422
70531,stop,O,3422
70532,positioning,O,3422
70533,after,O,3422
70534,the,B-TREATMENT,3422
70535,laser,I-TREATMENT,3422
70536,retinopexy,I-TREATMENT,3423
70537,I,O,3423
70538,tell,O,3423
70539,my,O,3423
70540,patients,O,3423
70541,to,O,3423
70542,position,O,3423
70543,23,B-TIME_DURATION,3423
70544,out,I-TIME_DURATION,3423
70545,of,I-TIME_DURATION,3423
70546,24,I-TIME_DURATION,3423
70547,hours,I-TIME_DURATION,3423
70548,per,O,3424
70549,day,O,3424
70550,for,B-TIME_DURATION,3424
70551,one,I-TIME_DURATION,3424
70552,week,I-TIME_DURATION,3424
70553,and,O,3424
70554,in,O,3424
70555,some,O,3424
70556,cases,O,3424
70557,until,O,3424
70558,the,O,3424
70559,bubble,O,3424
70560,disappears,O,3424
70561,Utilize,O,3424
70562,Indirect,B-TREATMENT,3424
70563,Laser,I-TREATMENT,3424
70564,Retinopexy,I-TREATMENT,3424
70565,for,O,3424
70566,Most,O,3424
70567,Cases,O,3425
70568,and,O,3425
70569,Cryopexy,B-TREATMENT,3425
70570,in,O,3425
70571,Specific,O,3425
70572,Situations,O,3425
70573,Although,O,3425
70574,laser,B-TREATMENT,3425
70575,retinopexy,I-TREATMENT,3425
70576,is,O,3425
70577,technically,O,3425
70578,more,O,3425
70579,challenging,O,3425
70580,with,O,3425
70581,gas,O,3425
70582,in,O,3425
70583,the,O,3425
70584,eye,O,3425
70585,it,O,3425
70586,is,O,3425
70587,a,O,3425
70588,more,O,3425
70589,elegant,O,3425
70590,way,O,3425
70591,to,O,3425
70592,treat,O,3425
70593,the,B-SIGN_AND_SYMPTOM,3425
70594,retinal,I-SIGN_AND_SYMPTOM,3425
70595,break,I-SIGN_AND_SYMPTOM,3425
70596,All,O,3425
70597,retinal,O,3426
70598,pathology,O,3426
70599,including,O,3426
70600,any,O,3426
70601,lattice,B-NAME_OF_DISEASE,3426
70602,degeneration,I-NAME_OF_DISEASE,3426
70603,or,O,3426
70604,retinal,B-NAME_OF_DISEASE,3426
70605,holes,I-NAME_OF_DISEASE,3426
70606,tears,I-NAME_OF_DISEASE,3426
70607,should,O,3426
70608,be,O,3426
70609,pretreated,O,3426
70610,with,O,3426
70611,laser,O,3426
70612,prior,O,3426
70613,to,O,3426
70614,the,O,3426
70615,gas,O,3426
70616,bubble,O,3426
70617,injection,O,3426
70618,The,O,3426
70619,biggest,O,3426
70620,advantage,O,3426
70621,of,O,3426
70622,laser,B-TREATMENT,3427
70623,retinopexy,I-TREATMENT,3427
70624,is,O,3427
70625,that,O,3427
70626,it,O,3427
70627,causes,O,3427
70628,some,O,3427
70629,immediate,O,3427
70630,chorioretinal,O,3427
70631,adhesion,O,3427
70632,as,O,3427
70633,opposed,O,3427
70634,to,O,3427
70635,cryopexy,B-TREATMENT,3427
70636,which,O,3427
70637,can,O,3428
70638,take,O,3428
70639,several,B-TIME_DURATION,3428
70640,days,I-TIME_DURATION,3428
70641,Laser,B-TREATMENT,3428
70642,retinopexy,I-TREATMENT,3428
70643,therefore,O,3428
70644,reduces,O,3428
70645,the,O,3428
70646,risk,O,3428
70647,of,O,3428
70648,the,B-PART_OF_THE_EYES,3428
70649,retina,I-PART_OF_THE_EYES,3428
70650,re-detaching,O,3428
70651,if,O,3428
70652,the,O,3428
70653,patient,O,3428
70654,becomes,O,3428
70655,less,O,3428
70656,compliant,O,3428
70657,with,O,3428
70658,positioning,O,3428
70659,after,O,3428
70660,the,B-SIGN_AND_SYMPTOM,3428
70661,retinal,I-SIGN_AND_SYMPTOM,3428
70662,break,I-SIGN_AND_SYMPTOM,3428
70663,is,O,3428
70664,lasered,O,3428
70665,That,O,3428
70666,said,O,3428
70667,cryopexy,B-TREATMENT,3428
70668,is,O,3428
70669,very,O,3428
70670,useful,O,3428
70671,in,O,3428
70672,specific,O,3428
70673,cases,O,3428
70674,such,O,3428
70675,as,O,3428
70676,small,B-SIGN_AND_SYMPTOM,3428
70677,pseudophakic,I-SIGN_AND_SYMPTOM,3428
70678,retinal,I-SIGN_AND_SYMPTOM,3429
70679,breaks,I-SIGN_AND_SYMPTOM,3429
70680,that,O,3429
70681,will,O,3429
70682,be,O,3429
70683,hard,O,3429
70684,to,O,3429
70685,see,O,3429
70686,following,O,3429
70687,PnR,B-TREATMENT,3429
70688,PnR,B-TREATMENT,3429
70689,in,O,3429
70690,children,O,3429
70691,where,O,3429
70692,it,O,3429
70693,is,O,3429
70694,unclear,O,3429
70695,if,O,3429
70696,they,O,3429
70697,will,O,3429
70698,be,O,3429
70699,able,O,3429
70700,to,O,3429
70701,tolerate,O,3429
70702,the,O,3429
70703,post-PnR,O,3429
70704,laser,O,3429
70705,aphakic,O,3429
70706,patients,O,3430
70707,where,O,3430
70708,intracameral,O,3430
70709,gas,O,3430
70710,will,O,3430
70711,impact,O,3430
70712,the,O,3430
70713,view,O,3430
70714,and,O,3430
70715,other,O,3430
70716,cases,O,3430
70717,where,O,3430
70718,visualization,O,3430
70719,is,O,3430
70720,limited,O,3430
70721,The,O,3430
70722,view,O,3430
70723,almost,O,3430
70724,always,O,3430
70725,is,O,3431
70726,worse,O,3431
70727,following,O,3431
70728,the,O,3431
70729,gas,O,3431
70730,injection,O,3431
70731,so,O,3431
70732,in,O,3431
70733,certain,O,3431
70734,cases,O,3431
70735,with,O,3431
70736,poor,O,3431
70737,media,O,3431
70738,cryopexy,B-TREATMENT,3431
70739,before,O,3431
70740,the,O,3431
70741,gas,O,3431
70742,injection,O,3431
70743,is,O,3432
70744,much,O,3432
70745,simpler,O,3432
70746,Physicians,O,3432
70747,in,O,3432
70748,practices,O,3432
70749,where,O,3432
70750,someone,O,3432
70751,else,O,3432
70752,will,O,3432
70753,be,O,3432
70754,following,O,3432
70755,the,O,3432
70756,patient,O,3432
70757,may,O,3432
70758,also,O,3432
70759,elect,O,3432
70760,to,O,3432
70761,perform,O,3432
70762,cryopexy,B-TREATMENT,3432
70763,so,O,3432
70764,the,O,3432
70765,physician,O,3433
70766,taking,O,3433
70767,over,O,3433
70768,will,O,3433
70769,not,O,3433
70770,need,O,3433
70771,to,O,3433
70772,treat,O,3433
70773,the,O,3433
70774,break,O,3433
70775,in,O,3433
70776,a,O,3433
70777,case,O,3433
70778,they,O,3433
70779,are,O,3433
70780,seeing,O,3433
70781,for,O,3434
70782,the,O,3434
70783,first,O,3434
70784,time,O,3434
70785,In,O,3434
70786,cases,O,3434
70787,where,O,3434
70788,we,O,3434
70789,have,O,3434
70790,performed,O,3434
70791,cryopexy,B-TREATMENT,3434
70792,we,O,3434
70793,may,O,3434
70794,also,O,3434
70795,elect,O,3434
70796,to,O,3434
70797,apply,O,3434
70798,some,O,3434
70799,laser,B-TREATMENT,3434
70800,retinopexy,I-TREATMENT,3434
70801,around,O,3434
70802,the,O,3434
70803,cryopexy,B-TREATMENT,3434
70804,scars,O,3434
70805,and,O,3434
70806,ora-ora,O,3434
70807,for,B-TIME_DURATION,3434
70808,a,I-TIME_DURATION,3434
70809,few,I-TIME_DURATION,3434
70810,clock,I-TIME_DURATION,3434
70811,hours,I-TIME_DURATION,3434
70812,to,O,3435
70813,achieve,O,3435
70814,immediate,O,3435
70815,chorioretinal,O,3435
70816,adhesion,O,3435
70817,We,O,3435
70818,also,O,3435
70819,utilize,O,3435
70820,laser,O,3435
70821,in,O,3435
70822,some,O,3435
70823,cases,O,3435
70824,to,O,3435
70825,mark,O,3435
70826,the,B-SIGN_AND_SYMPTOM,3435
70827,retinal,I-SIGN_AND_SYMPTOM,3435
70828,breaks,I-SIGN_AND_SYMPTOM,3435
70829,or,O,3435
70830,laser,O,3435
70831,the,B-PART_OF_THE_EYES,3435
70832,pars,I-PART_OF_THE_EYES,3435
70833,plana,I-PART_OF_THE_EYES,3435
70834,in,O,3435
70835,the,O,3435
70836,meridian,O,3435
70837,of,O,3435
70838,the,B-SIGN_AND_SYMPTOM,3435
70839,retinal,I-SIGN_AND_SYMPTOM,3435
70840,break,I-SIGN_AND_SYMPTOM,3435
70841,to,O,3435
70842,assist,O,3435
70843,with,O,3436
70844,subsequent,O,3436
70845,localization,O,3436
70846,once,O,3436
70847,the,O,3436
70848,gas,O,3436
70849,bubble,O,3436
70850,is,O,3436
70851,in,O,3436
70852,the,O,3436
70853,eye,O,3436
70854,Laser,B-TREATMENT,3436
70855,retinopexy,I-TREATMENT,3436
70856,can,O,3436
70857,be,O,3436
70858,challenging,O,3436
70859,but,O,3437
70860,we,O,3437
70861,recommend,O,3437
70862,getting,O,3437
70863,used,O,3437
70864,to,O,3437
70865,doing,O,3437
70866,it,O,3437
70867,with,O,3437
70868,an,B-TREATMENT,3437
70869,indirect,I-TREATMENT,3437
70870,laser,I-TREATMENT,3437
70871,and,O,3437
70872,a,B-TREATMENT,3437
70873,28D,I-TREATMENT,3437
70874,lens,I-TREATMENT,3437
70875,for,O,3437
70876,optimal,O,3437
70877,visualization,O,3437
70878,We,O,3437
70879,generally,O,3437
70880,like,O,3437
70881,to,O,3438
70882,laser,O,3438
70883,through,O,3438
70884,the,O,3438
70885,gas,O,3438
70886,bubble,O,3438
70887,as,O,3438
70888,it,O,3438
70889,provides,O,3438
70890,a,O,3438
70891,clear,O,3438
70892,minified,O,3438
70893,view,O,3438
70894,In,O,3438
70895,pseudophakic,O,3438
70896,patients,O,3438
70897,they,O,3438
70898,can,O,3438
70899,be,O,3438
70900,told,O,3438
70901,to,O,3438
70902,look,O,3438
70903,straight,O,3438
70904,up,O,3438
70905,to,O,3438
70906,the,O,3438
70907,ceiling,O,3438
70908,while,O,3438
70909,lying,O,3438
70910,supine,O,3438
70911,and,O,3438
70912,the,O,3438
70913,gas,O,3438
70914,bubble,O,3438
70915,will,O,3439
70916,cover,O,3439
70917,the,B-PART_OF_THE_EYES,3439
70918,entire,I-PART_OF_THE_EYES,3439
70919,pupil,I-PART_OF_THE_EYES,3439
70920,and,O,3439
70921,lead,O,3439
70922,to,O,3439
70923,a,O,3439
70924,panoramic,O,3439
70925,view,O,3439
70926,Add,O,3439
70927,a,O,3439
70928,Second,O,3439
70929,Bubble,O,3439
70930,When,O,3439
70931,Needed,O,3439
70932,In,O,3439
70933,some,O,3439
70934,cases,O,3440
70935,where,O,3440
70936,breaks,O,3440
70937,are,O,3440
70938,further,O,3440
70939,apart,O,3440
70940,or,O,3440
70941,perhaps,O,3440
70942,in,O,3440
70943,the,O,3440
70944,inferior,O,3440
70945,quadrants,O,3440
70946,or,O,3440
70947,a,O,3440
70948,patient,O,3440
70949,is,O,3440
70950,not,O,3440
70951,very,O,3440
70952,compliant,O,3441
70953,a,O,3441
70954,second,O,3441
70955,gas,O,3441
70956,bubble,O,3441
70957,injection,O,3441
70958,may,O,3441
70959,be,O,3441
70960,required,O,3441
70961,to,O,3441
70962,adequately,O,3441
70963,tamponade,O,3441
70964,the,B-SIGN_AND_SYMPTOM,3441
70965,retinal,I-SIGN_AND_SYMPTOM,3441
70966,breaks,I-SIGN_AND_SYMPTOM,3441
70967,The,O,3441
70968,second,O,3441
70969,injection,O,3441
70970,is,O,3441
70971,performed,O,3441
70972,in,O,3441
70973,exactly,O,3441
70974,the,O,3442
70975,same,O,3442
70976,manner,O,3442
70977,as,O,3442
70978,the,O,3442
70979,first,O,3442
70980,with,O,3442
70981,the,O,3442
70982,same,O,3442
70983,approach,O,3442
70984,regarding,O,3442
70985,the,B-PART_OF_THE_EYES,3442
70986,anterior,I-PART_OF_THE_EYES,3442
70987,chamber,I-PART_OF_THE_EYES,3442
70988,paracentesis,I-TREATMENT,3442
70989,and,O,3442
70990,the,B-TREATMENT,3442
70991,intravitreal,I-TREATMENT,3442
70992,gas,I-TREATMENT,3442
70993,injection,I-TREATMENT,3442
70994,Again,O,3442
70995,a,O,3442
70996,minimum,O,3442
70997,of,O,3442
70998,0,O,3442
70999,cc,O,3442
71000,of,O,3442
71001,SF6,B-CHEMICAL_COMPOUND,3442
71002,gas,I-CHEMICAL_COMPOUND,3442
71003,is,O,3443
71004,injected,O,3443
71005,It,O,3443
71006,is,O,3443
71007,important,O,3443
71008,to,O,3443
71009,prevent,O,3443
71010,intravitreal,O,3443
71011,gas,O,3443
71012,from,O,3443
71013,coming,O,3443
71014,into,O,3443
71015,the,B-PART_OF_THE_EYES,3443
71016,anterior,I-PART_OF_THE_EYES,3443
71017,chamber,I-PART_OF_THE_EYES,3443
71018,when,O,3443
71019,performing,O,3443
71020,the,B-TREATMENT,3443
71021,paracentesis,I-TREATMENT,3443
71022,In,O,3443
71023,patients,O,3443
71024,at,O,3443
71025,risk,O,3443
71026,for,O,3443
71027,this,O,3443
71028,such,O,3443
71029,as,O,3443
71030,sulcus,O,3443
71031,IOL,O,3443
71032,from,O,3443
71033,complicated,O,3443
71034,cataract,B-TREATMENT,3443
71035,surgery,I-TREATMENT,3443
71036,steps,O,3443
71037,can,O,3443
71038,be,O,3444
71039,taken,O,3444
71040,to,O,3444
71041,minimize,O,3444
71042,this,O,3444
71043,risk,O,3444
71044,such,O,3444
71045,as,O,3444
71046,performing,O,3444
71047,the,O,3444
71048,tap,O,3444
71049,with,O,3444
71050,the,O,3444
71051,head,O,3444
71052,raised,O,3444
71053,and,O,3444
71054,with,O,3444
71055,a,O,3444
71056,small,O,3445
71057,pupil,B-PART_OF_THE_EYES,3445
71058,When,O,3445
71059,a,B-TREATMENT,3445
71060,Pneumatic,I-TREATMENT,3445
71061,Retinopexy,I-TREATMENT,3445
71062,has,O,3445
71063,Failed,O,3445
71064,Do,O,3445
71065,Not,O,3445
71066,Delay,O,3445
71067,Surgery,O,3445
71068,Multiple,O,3445
71069,randomized,O,3445
71070,trials,O,3445
71071,have,O,3445
71072,shown,O,3445
71073,that,O,3445
71074,a,O,3445
71075,pneumatic,O,3445
71076,failure,O,3446
71077,does,O,3446
71078,not,O,3446
71079,jeopardize,O,3446
71080,future,O,3446
71081,success,O,3446
71082,First,O,3446
71083,of,O,3446
71084,all,O,3446
71085,it,O,3446
71086,is,O,3446
71087,important,O,3446
71088,to,O,3446
71089,be,O,3447
71090,absolutely,O,3447
71091,certain,O,3447
71092,that,O,3447
71093,the,O,3447
71094,pneumatic,O,3447
71095,is,O,3447
71096,truly,O,3447
71097,failing,O,3447
71098,from,O,3447
71099,an,O,3447
71100,open,O,3447
71101,break,O,3447
71102,In,O,3447
71103,many,O,3447
71104,cases,O,3447
71105,there,O,3447
71106,can,O,3447
71107,be,O,3447
71108,residual,O,3448
71109,fluid,O,3448
71110,that,O,3448
71111,is,O,3448
71112,not,O,3448
71113,associated,O,3448
71114,with,O,3448
71115,an,O,3448
71116,open,O,3448
71117,break,O,3448
71118,Subsequent,O,3448
71119,vitrectomy,O,3448
71120,in,O,3448
71121,these,O,3448
71122,cases,O,3448
71123,is,O,3449
71124,slightly,O,3449
71125,complicated,O,3449
71126,because,O,3449
71127,a,O,3449
71128,retinotomy,B-TREATMENT,3449
71129,will,O,3449
71130,need,O,3449
71131,to,O,3449
71132,be,O,3449
71133,made,O,3449
71134,to,O,3449
71135,remove,O,3449
71136,the,O,3449
71137,fluid,O,3449
71138,often,O,3449
71139,inferiorly,O,3449
71140,It,O,3449
71141,is,O,3449
71142,important,O,3450
71143,to,O,3450
71144,assess,O,3450
71145,if,O,3450
71146,residual,O,3450
71147,subretinal,O,3450
71148,fluid,O,3450
71149,after,O,3450
71150,a,B-TREATMENT,3450
71151,PnR,I-TREATMENT,3451
71152,is,O,3451
71153,getting,O,3451
71154,better,O,3451
71155,staying,O,3451
71156,the,O,3451
71157,same,O,3451
71158,or,O,3451
71159,getting,O,3451
71160,worse,O,3451
71161,If,O,3451
71162,there,O,3451
71163,is,O,3451
71164,an,O,3451
71165,open,O,3451
71166,break,O,3451
71167,then,O,3451
71168,the,O,3452
71169,fluid,O,3452
71170,should,O,3452
71171,be,O,3452
71172,worsening,O,3452
71173,and,O,3452
71174,the,O,3452
71175,patient,O,3452
71176,should,O,3452
71177,have,O,3452
71178,surgery,O,3452
71179,arranged,O,3452
71180,Performing,O,3452
71181,the,O,3452
71182,surgery,O,3452
71183,in,O,3452
71184,a,O,3452
71185,timely,O,3452
71186,manner,O,3452
71187,within,B-TIME_DURATION,3452
71188,a,I-TIME_DURATION,3452
71189,few,I-TIME_DURATION,3452
71190,days,I-TIME_DURATION,3452
71191,will,O,3452
71192,allow,O,3452
71193,the,O,3452
71194,patient,O,3453
71195,to,O,3453
71196,have,O,3453
71197,an,O,3453
71198,excellent,O,3453
71199,outcome,O,3453
71200,despite,O,3453
71201,the,O,3453
71202,pneumatic,O,3453
71203,failure,O,3453
71204,Delaying,O,3453
71205,surgery,O,3453
71206,can,O,3453
71207,result,O,3453
71208,in,O,3453
71209,proliferative,B-NAME_OF_DISEASE,3453
71210,vitreoretinopathy,I-NAME_OF_DISEASE,3453
71211,and,O,3453
71212,poor,O,3453
71213,anatomic,O,3453
71214,and,O,3453
71215,functional,O,3453
71216,outcomes,O,3453
71217,We,O,3453
71218,always,O,3454
71219,ask,O,3454
71220,patients,O,3454
71221,to,O,3454
71222,remain,O,3454
71223,face,O,3454
71224,down,O,3454
71225,while,O,3454
71226,waiting,O,3454
71227,for,O,3454
71228,surgery,O,3454
71229,This,O,3454
71230,allows,O,3454
71231,the,B-PART_OF_THE_EYES,3454
71232,macula,I-PART_OF_THE_EYES,3454
71233,to,O,3454
71234,remain,O,3454
71235,attached,O,3454
71236,and,O,3454
71237,in,O,3454
71238,phakic,O,3455
71239,patients,O,3455
71240,keeps,O,3455
71241,the,O,3455
71242,gas,O,3455
71243,bubble,O,3455
71244,away,O,3455
71245,from,O,3455
71246,the,B-PART_OF_THE_EYES,3455
71247,lens,I-PART_OF_THE_EYES,3455
71248,It,O,3455
71249,is,O,3455
71250,critical,O,3455
71251,to,O,3455
71252,tell,O,3455
71253,the,O,3455
71254,phakic,O,3455
71255,patient,O,3455
71256,to,O,3455
71257,not,O,3455
71258,lie,O,3455
71259,supine,O,3455
71260,even,O,3456
71261,in,O,3456
71262,the,O,3456
71263,preoperative,O,3456
71264,area,O,3456
71265,and,O,3456
71266,to,O,3456
71267,be,O,3457
71268,face,O,3457
71269,down,O,3457
71270,until,O,3457
71271,they,O,3457
71272,see,O,3457
71273,you,O,3457
71274,in,O,3457
71275,the,O,3457
71276,operating,O,3457
71277,room,O,3457
71278,The,O,3457
71279,patient,O,3457
71280,lying,O,3457
71281,on,O,3457
71282,their,O,3457
71283,back,O,3457
71284,even,O,3457
71285,for,B-TIME_DURATION,3457
71286,an,I-TIME_DURATION,3457
71287,hour,I-TIME_DURATION,3457
71288,on,O,3457
71289,the,O,3457
71290,day,O,3457
71291,of,O,3458
71292,surgery,O,3458
71293,can,O,3458
71294,cause,O,3458
71295,the,O,3458
71296,view,O,3458
71297,to,O,3458
71298,be,O,3458
71299,lost,O,3458
71300,during,O,3458
71301,a,B-TREATMENT,3458
71302,vitrectomy,I-TREATMENT,3458
71303,In,O,3458
71304,rescue,O,3458
71305,scleral,B-TREATMENT,3458
71306,buckle,I-TREATMENT,3458
71307,cases,O,3458
71308,gas,O,3458
71309,can,O,3458
71310,be,O,3458
71311,removed,O,3458
71312,but,O,3458
71313,usually,O,3458
71314,we,O,3458
71315,work,O,3458
71316,around,O,3459
71317,it,O,3459
71318,In,O,3459
71319,most,O,3459
71320,cases,O,3459
71321,we,O,3459
71322,try,O,3459
71323,not,O,3459
71324,to,O,3459
71325,drain,O,3459
71326,subretinal,O,3459
71327,fluid,O,3459
71328,externally,O,3459
71329,as,O,3459
71330,when,O,3459
71331,the,O,3459
71332,eye,O,3459
71333,is,O,3459
71334,rotated,O,3459
71335,the,O,3459
71336,gas,O,3459
71337,bubble,O,3459
71338,can,O,3459
71339,come,O,3460
71340,to,O,3460
71341,the,O,3460
71342,quadrant,O,3460
71343,of,O,3460
71344,drainage,O,3460
71345,and,O,3460
71346,push,O,3460
71347,on,O,3460
71348,the,O,3460
71349,detached,O,3460
71350,retina,B-PART_OF_THE_EYES,3460
71351,leading,O,3460
71352,to,O,3460
71353,retinal,B-NAME_OF_DISEASE,3460
71354,incarceration,I-NAME_OF_DISEASE,3461
71355,or,O,3461
71356,a,B-SIGN_AND_SYMPTOM,3461
71357,retinal,I-SIGN_AND_SYMPTOM,3461
71358,break,I-SIGN_AND_SYMPTOM,3461
71359,Use,O,3461
71360,Topical,B-NAME_OF_DRUG,3461
71361,Steroids,I-NAME_OF_DRUG,3461
71362,Following,O,3461
71363,the,O,3461
71364,Procedure,O,3461
71365,and,O,3461
71366,Subconjunctival,B-NAME_OF_DRUG,3461
71367,Lidocaine,I-NAME_OF_DRUG,3461
71368,for,O,3461
71369,Laser,B-TREATMENT,3461
71370,Retinopexy,I-TREATMENT,3461
71371,Laser,B-TREATMENT,3461
71372,retinopexy,I-TREATMENT,3461
71373,following,O,3461
71374,PnR,B-TREATMENT,3461
71375,can,O,3461
71376,be,O,3461
71377,difficult,O,3461
71378,for,O,3462
71379,the,O,3462
71380,patient,O,3462
71381,particularly,O,3462
71382,in,O,3462
71383,the,O,3462
71384,early,O,3462
71385,post-pneumatic,O,3462
71386,period,O,3462
71387,Without,O,3462
71388,topical,B-NAME_OF_DRUG,3462
71389,steroids,I-NAME_OF_DRUG,3462
71390,the,O,3462
71391,eye,O,3462
71392,can,O,3462
71393,be,O,3462
71394,quite,O,3462
71395,tender,O,3462
71396,on,O,3462
71397,day,O,3462
71398,1,O,3462
71399,or,O,3462
71400,2,O,3462
71401,making,O,3462
71402,the,O,3463
71403,laser,O,3463
71404,even,O,3463
71405,harder,O,3463
71406,Topical,B-NAME_OF_DRUG,3463
71407,steroids,I-NAME_OF_DRUG,3463
71408,reduce,O,3463
71409,the,O,3463
71410,inflammation,O,3463
71411,and,O,3463
71412,allow,O,3463
71413,the,O,3463
71414,patient,O,3463
71415,to,O,3463
71416,tolerate,O,3463
71417,the,B-TREATMENT,3463
71418,laser,B-TREATMENT,3463
71419,retinopexy,I-TREATMENT,3463
71420,and,O,3463
71421,scleral,O,3463
71422,depression,O,3463
71423,better,O,3463
71424,If,O,3463
71425,performing,O,3463
71426,extensive,O,3463
71427,laser,B-TREATMENT,3464
71428,retinopexy,I-TREATMENT,3464
71429,especially,O,3464
71430,temporally,O,3464
71431,or,O,3464
71432,nasally,O,3464
71433,over,O,3464
71434,the,O,3464
71435,long,O,3464
71436,ciliary,O,3464
71437,nerve,O,3464
71438,a,O,3464
71439,subconjunctival,B-NAME_OF_DRUG,3464
71440,lidocaine,I-NAME_OF_DRUG,3464
71441,injection,O,3464
71442,can,O,3464
71443,be,O,3464
71444,very,O,3464
71445,helpful,O,3464
71446,Although,O,3464
71447,there,O,3464
71448,are,O,3464
71449,a,O,3464
71450,lot,O,3464
71451,of,O,3464
71452,nuances,O,3464
71453,to,O,3464
71454,performing,O,3464
71455,PnR,B-TREATMENT,3464
71456,these,O,3464
71457,can,O,3464
71458,be,O,3464
71459,learned,O,3464
71460,with,O,3465
71461,experience,O,3465
71462,There,O,3465
71463,is,O,3465
71464,great,O,3465
71465,satisfaction,O,3465
71466,that,O,3465
71467,can,O,3465
71468,be,O,3465
71469,achieved,O,3465
71470,by,O,3465
71471,reattaching,O,3465
71472,the,B-PART_OF_THE_EYES,3465
71473,retina,I-PART_OF_THE_EYES,3465
71474,in,O,3465
71475,your,O,3465
71476,office,O,3465
71477,and,O,3465
71478,allowing,O,3466
71479,the,O,3466
71480,patient,O,3466
71481,to,O,3466
71482,avoid,O,3466
71483,surgery,O,3466
71484,with,O,3466
71485,better,O,3466
71486,anatomic,O,3466
71487,integrity,O,3466
71488,and,O,3466
71489,superior,O,3466
71490,long-term,O,3466
71491,functional,O,3466
71492,outcomes,O,3466
71493,Patients,O,3466
71494,who,O,3466
71495,have,O,3466
71496,had,O,3466
71497,successful,O,3466
71498,PnR,B-TREATMENT,3466
71499,almost,O,3466
71500,seem,O,3466
71501,like,O,3466
71502,treatment-naïve,O,3466
71503,eyes,O,3466
71504,when,O,3466
71505,they,O,3466
71506,come,O,3466
71507,back,O,3467
71508,for,O,3467
71509,follow-up,O,3467
71510,whereas,O,3467
71511,patients,O,3467
71512,who,O,3467
71513,have,O,3467
71514,had,O,3467
71515,scleral,B-TREATMENT,3467
71516,buckle,I-TREATMENT,3467
71517,or,O,3467
71518,vitrectomy,B-TREATMENT,3467
71519,are,O,3467
71520,almost,O,3467
71521,never,O,3467
71522,the,O,3467
71523,same,O,3467
71524,Patients,O,3467
71525,following,O,3467
71526,PnR,B-TREATMENT,3467
71527,are,O,3467
71528,similar,O,3468
71529,to,O,3468
71530,patients,O,3468
71531,who,O,3468
71532,have,O,3468
71533,had,O,3468
71534,laser,B-TREATMENT,3468
71535,retinopexy,I-TREATMENT,3468
71536,for,O,3468
71537,a,O,3468
71538,retinal,O,3468
71539,tear,O,3468
71540,Retinal,B-NAME_OF_DISEASE,3468
71541,detachment,I-NAME_OF_DISEASE,3468
71542,repair,O,3468
71543,is,O,3468
71544,continuously,O,3469
71545,evolving,O,3469
71546,with,O,3469
71547,advances,O,3469
71548,in,O,3469
71549,multimodal,O,3469
71550,imaging,O,3469
71551,providing,O,3469
71552,more,O,3469
71553,and,O,3469
71554,more,O,3469
71555,information,O,3469
71556,regarding,O,3469
71557,the,O,3469
71558,integrity,O,3469
71559,of,O,3469
71560,anatomic,O,3469
71561,reattachment,O,3469
71562,Current,O,3469
71563,evidence,O,3470
71564,supports,O,3470
71565,the,O,3470
71566,use,O,3470
71567,of,O,3470
71568,PnR,B-TREATMENT,3470
71569,for,O,3470
71570,cases,O,3470
71571,meeting,O,3470
71572,clinical,O,3470
71573,trial,O,3470
71574,criteria,O,3470
71575,and,O,3470
71576,every,O,3470
71577,vitreoretinal,O,3470
71578,surgeon,O,3470
71579,should,O,3470
71580,have,O,3470
71581,sufficient,O,3470
71582,experience,O,3470
71583,with,O,3470
71584,the,O,3470
71585,procedure,O,3470
71586,such,O,3470
71587,that,O,3470
71588,they,O,3470
71589,are,O,3470
71590,comfortable,O,3470
71591,offering,O,3470
71592,it,O,3470
71593,to,O,3470
71594,appropriate,O,3470
71595,patients,O,3470
71596,It,O,3470
71597,is,O,3470
71598,important,O,3470
71599,to,O,3470
71600,start,O,3470
71601,with,O,3470
71602,easier,O,3470
71603,cases,O,3470
71604,and,O,3470
71605,to,O,3470
71606,enjoy,O,3470
71607,the,O,3470
71608,process,O,3470
71609,of,O,3470
71610,learning,O,3470
71611,the,O,3470
71612,art,O,3470
71613,of,O,3470
71614,PnR,B-TREATMENT,3470
71615,Pars,B-TREATMENT,3470
71616,plana,I-TREATMENT,3470
71617,vitrectomy,B-TREATMENT,3470
71618,PPV,B-TREATMENT,3470
71619,is,O,3470
71620,a,O,3470
71621,microsurgical,O,3470
71622,procedure,O,3470
71623,used,O,3470
71624,by,O,3470
71625,retina,B-PART_OF_THE_EYES,3470
71626,surgeons,O,3470
71627,to,O,3470
71628,perform,O,3470
71629,a,O,3470
71630,variety,O,3470
71631,of,O,3470
71632,operations,O,3470
71633,The,O,3470
71634,first,O,3470
71635,step,O,3470
71636,in,O,3470
71637,this,O,3470
71638,procedure,O,3470
71639,is,O,3470
71640,to,O,3470
71641,remove,O,3470
71642,the,B-PART_OF_THE_EYES,3470
71643,vitreous,I-PART_OF_THE_EYES,3470
71644,gel,I-PART_OF_THE_EYES,3470
71645,that,O,3470
71646,fills,O,3470
71647,the,O,3470
71648,back,O,3470
71649,of,O,3470
71650,the,O,3470
71651,eye,O,3470
71652,hence,O,3470
71653,vitrectomy,B-TREATMENT,3470
71654,,O,3470
71655,While,O,3470
71656,a,O,3470
71657,lot,O,3470
71658,of,O,3470
71659,eye,O,3470
71660,surgery,O,3471
71661,is,O,3471
71662,performed,O,3471
71663,in,O,3471
71664,the,O,3471
71665,front,O,3471
71666,part,O,3471
71667,of,O,3471
71668,the,O,3471
71669,eye,O,3471
71670,ie,O,3471
71671,cataract,B-TREATMENT,3471
71672,surgery,I-TREATMENT,3471
71673,retina,B-PART_OF_THE_EYES,3471
71674,surgeons,O,3471
71675,perform,O,3471
71676,surgery,O,3471
71677,in,O,3471
71678,the,O,3471
71679,back,O,3472
71680,portion,O,3472
71681,of,O,3472
71682,the,O,3472
71683,eye,O,3472
71684,They,O,3472
71685,access,O,3472
71686,the,O,3472
71687,back,O,3472
71688,of,O,3472
71689,the,O,3472
71690,eye,O,3472
71691,through,O,3472
71692,the,B-PART_OF_THE_EYES,3472
71693,pars,I-PART_OF_THE_EYES,3472
71694,plana,I-PART_OF_THE_EYES,3472
71695,-,O,3472
71696,this,O,3472
71697,is,O,3472
71698,a,O,3472
71699,safe,O,3472
71700,zone,O,3473
71701,to,O,3473
71702,work,O,3473
71703,that,O,3473
71704,avoids,O,3473
71705,damage,O,3473
71706,to,O,3473
71707,the,B-PART_OF_THE_EYES,3473
71708,retina,I-PART_OF_THE_EYES,3473
71709,and,O,3473
71710,crystalline,B-TREATMENT,3473
71711,lens,I-TREATMENT,3474
71712,or,O,3474
71713,implant,O,3474
71714,from,O,3474
71715,prior,O,3474
71716,cataract,B-TREATMENT,3474
71717,surgery,I-TREATMENT,3474
71718,,O,3474
71719,A,O,3474
71720,variety,O,3474
71721,of,O,3474
71722,microsurgical,B-SURGICAL_INSTRUMENT,3474
71723,tools,I-SURGICAL_INSTRUMENT,3474
71724,lenses,B-SURGICAL_INSTRUMENT,3474
71725,illuminating,B-SURGICAL_INSTRUMENT,3474
71726,devices,I-SURGICAL_INSTRUMENT,3474
71727,and,O,3474
71728,lasers,B-SURGICAL_INSTRUMENT,3474
71729,are,O,3474
71730,then,O,3474
71731,used,O,3474
71732,to,O,3474
71733,achieve,O,3474
71734,the,O,3475
71735,surgical,O,3475
71736,goal,O,3475
71737,PPV,B-TREATMENT,3475
71738,s,O,3475
71739,can,O,3475
71740,typically,O,3475
71741,be,O,3475
71742,performed,O,3475
71743,under,O,3475
71744,local,O,3475
71745,anesthesia,O,3475
71746,and,O,3475
71747,most,O,3475
71748,patients,O,3475
71749,leave,O,3475
71750,the,O,3475
71751,hospital,O,3475
71752,within,B-TIME_DURATION,3475
71753,2-Jan,I-TIME_DURATION,3475
71754,hours,I-TIME_DURATION,3475
71755,after,O,3475
71756,surgery,O,3475
71757,Pars,B-TREATMENT,3475
71758,plana,I-TREATMENT,3476
71759,vitrectomy,B-TREATMENT,3476
71760,PPV,B-TREATMENT,3476
71761,is,O,3476
71762,a,O,3476
71763,surgical,O,3476
71764,technique,O,3476
71765,originally,O,3476
71766,introduced,O,3476
71767,by,O,3476
71768,Robert,B-PERSON,3476
71769,Machemer,I-PERSON,3476
71770,The,B-PART_OF_THE_EYES,3476
71771,pars,I-PART_OF_THE_EYES,3476
71772,plana,I-PART_OF_THE_EYES,3476
71773,approach,O,3476
71774,to,O,3476
71775,the,B-PART_OF_THE_EYES,3476
71776,vitreous,I-PART_OF_THE_EYES,3476
71777,cavity,I-PART_OF_THE_EYES,3476
71778,allows,O,3476
71779,access,O,3477
71780,to,O,3477
71781,the,O,3477
71782,posterior,O,3477
71783,segment,O,3477
71784,to,O,3477
71785,treat,O,3477
71786,many,O,3477
71787,vitreoretinal,B-NAME_OF_DISEASE,3477
71788,diseases,I-NAME_OF_DISEASE,3477
71789,This,O,3477
71790,procedure,O,3477
71791,requires,O,3477
71792,a,O,3477
71793,great,O,3477
71794,deal,O,3477
71795,of,O,3477
71796,technical,O,3477
71797,skill,O,3478
71798,and,O,3478
71799,knowledge,O,3478
71800,to,O,3478
71801,ensure,O,3478
71802,good,O,3478
71803,outcomes,O,3478
71804,A,O,3478
71805,successful,O,3478
71806,vitrectomy,B-TREATMENT,3478
71807,can,O,3478
71808,restore,O,3478
71809,vision,O,3478
71810,and,O,3478
71811,improve,O,3478
71812,the,O,3478
71813,quality,O,3478
71814,of,O,3478
71815,life,O,3478
71816,in,O,3478
71817,patients,O,3478
71818,suffering,O,3478
71819,from,O,3479
71820,many,O,3479
71821,vitreoretinal,B-NAME_OF_DISEASE,3479
71822,diseases,I-NAME_OF_DISEASE,3479
71823,However,O,3479
71824,the,O,3479
71825,procedure,O,3479
71826,can,O,3479
71827,also,O,3480
71828,be,O,3480
71829,associated,O,3480
71830,with,O,3480
71831,complications,O,3480
71832,Although,O,3480
71833,the,O,3480
71834,chances,O,3480
71835,are,O,3480
71836,low,O,3480
71837,when,O,3480
71838,performed,O,3480
71839,correctly,O,3480
71840,these,O,3480
71841,complications,O,3480
71842,can,O,3480
71843,cause,O,3480
71844,severe,O,3480
71845,patient,O,3480
71846,morbidity,O,3480
71847,and,O,3480
71848,blindness,B-TREATMENT,3480
71849,Therefore,O,3480
71850,it,O,3480
71851,is,O,3481
71852,essential,O,3481
71853,that,O,3481
71854,clinicians,O,3481
71855,have,O,3481
71856,thorough,O,3481
71857,knowledge,O,3481
71858,regarding,O,3481
71859,the,O,3481
71860,topic,O,3481
71861,understand,O,3481
71862,the,O,3481
71863,procedure,O,3481
71864,when,O,3481
71865,to,O,3481
71866,use,O,3481
71867,it,O,3481
71868,how,O,3481
71869,to,O,3481
71870,perform,O,3481
71871,it,O,3481
71872,and,O,3481
71873,post-operative,O,3482
71874,management,O,3482
71875,A,B-TREATMENT,3482
71876,vitrectomy,I-TREATMENT,3482
71877,can,O,3482
71878,be,O,3482
71879,considered,O,3482
71880,for,O,3482
71881,a,O,3482
71882,variety,O,3482
71883,of,O,3482
71884,clinical,O,3482
71885,scenarios,O,3482
71886,since,O,3482
71887,it,O,3483
71888,enables,O,3483
71889,the,O,3483
71890,operating,O,3483
71891,surgeon,O,3483
71892,to,O,3483
71893,access,O,3483
71894,both,O,3483
71895,the,B-PART_OF_THE_EYES,3483
71896,vitreous,I-PART_OF_THE_EYES,3483
71897,and,O,3483
71898,retina,B-PART_OF_THE_EYES,3483
71899,Below,O,3483
71900,we,O,3483
71901,list,O,3483
71902,when,O,3483
71903,PPV,B-TREATMENT,3483
71904,is,O,3483
71905,indicated,O,3483
71906,based,O,3484
71907,on,O,3484
71908,the,O,3484
71909,type,O,3484
71910,of,O,3484
71911,pathology,O,3484
71912,affecting,O,3484
71913,the,B-PART_OF_THE_EYES,3484
71914,vitreous,I-PART_OF_THE_EYES,3484
71915,and,O,3484
71916,or,O,3484
71917,the,B-PART_OF_THE_EYES,3484
71918,retina,I-PART_OF_THE_EYES,3484
71919,One,O,3484
71920,of,O,3484
71921,the,O,3484
71922,most,O,3484
71923,common,O,3484
71924,indications,O,3484
71925,for,O,3484
71926,a,B-TREATMENT,3484
71927,PPV,I-TREATMENT,3484
71928,is,O,3484
71929,when,O,3484
71930,there,O,3484
71931,is,O,3484
71932,pathology,O,3484
71933,that,O,3484
71934,opacifies,O,3484
71935,the,B-PART_OF_THE_EYES,3484
71936,vitreous,I-PART_OF_THE_EYES,3484
71937,and,O,3484
71938,thus,O,3484
71939,reduces,O,3484
71940,vision,O,3484
71941,One,O,3484
71942,example,O,3484
71943,is,O,3484
71944,a,B-SIGN_AND_SYMPTOM,3484
71945,non-clearing,I-SIGN_AND_SYMPTOM,3484
71946,vitreous,I-SIGN_AND_SYMPTOM,3484
71947,hemorrhage,I-SIGN_AND_SYMPTOM,3484
71948,Many,O,3484
71949,diseases,O,3484
71950,can,O,3485
71951,cause,O,3485
71952,vitreous,B-SIGN_AND_SYMPTOM,3485
71953,hemorrhage,I-SIGN_AND_SYMPTOM,3485
71954,such,O,3485
71955,as,O,3485
71956,proliferative,B-NAME_OF_DISEASE,3485
71957,diabetic,B-NAME_OF_DISEASE,3485
71958,retinopathy,I-NAME_OF_DISEASE,3485
71959,trauma,O,3485
71960,posterior,B-NAME_OF_DISEASE,3485
71961,vitreous,I-NAME_OF_DISEASE,3485
71962,detachment,I-NAME_OF_DISEASE,3485
71963,retinal,B-NAME_OF_DISEASE,3485
71964,detachment,I-NAME_OF_DISEASE,3485
71965,RD,I-NAME_OF_DISEASE,3485
71966,intraocular,B-NAME_OF_DISEASE,3485
71967,tumors,I-NAME_OF_DISEASE,3485
71968,and,O,3485
71969,retinal,B-NAME_OF_DISEASE,3485
71970,vascular,I-NAME_OF_DISEASE,3485
71971,diseases,I-NAME_OF_DISEASE,3486
71972,Vitreous,B-SIGN_AND_SYMPTOM,3486
71973,hemorrhage,I-SIGN_AND_SYMPTOM,3486
71974,due,O,3486
71975,to,O,3486
71976,diabetic,B-NAME_OF_DISEASE,3486
71977,retinopathy,I-NAME_OF_DISEASE,3486
71978,can,O,3486
71979,be,O,3486
71980,treated,O,3486
71981,with,O,3486
71982,intravitreal,B-TREATMENT,3486
71983,anti-VEGF,I-TREATMENT,3486
71984,injections,I-TREATMENT,3486
71985,in,O,3486
71986,some,O,3486
71987,circumstances,O,3486
71988,and,O,3486
71989,only,O,3486
71990,in,O,3486
71991,the,O,3486
71992,absence,O,3486
71993,of,O,3486
71994,traction,O,3486
71995,as,O,3486
71996,well,O,3486
71997,In,O,3486
71998,many,O,3486
71999,cases,O,3486
72000,vitreoretinal,O,3486
72001,surgeons,O,3486
72002,will,O,3486
72003,proceed,O,3486
72004,with,O,3486
72005,PPV,B-TREATMENT,3486
72006,without,O,3486
72007,an,O,3486
72008,injection,O,3486
72009,if,O,3486
72010,it,O,3486
72011,is,O,3487
72012,dense,O,3488
72013,and,O,3488
72014,unlikely,O,3488
72015,to,O,3488
72016,resolve,O,3488
72017,with,O,3488
72018,conservative,O,3488
72019,therapy,O,3488
72020,If,O,3488
72021,the,B-SIGN_AND_SYMPTOM,3488
72022,vitreous,I-SIGN_AND_SYMPTOM,3488
72023,hemorrhage,I-SIGN_AND_SYMPTOM,3488
72024,does,O,3488
72025,not,O,3488
72026,clear,O,3488
72027,despite,O,3488
72028,conservative,O,3488
72029,measures,O,3488
72030,then,O,3488
72031,a,B-TREATMENT,3488
72032,vitrectomy,I-TREATMENT,3488
72033,is,O,3488
72034,needed,O,3488
72035,Modern,O,3488
72036,day,O,3488
72037,pars,B-TREATMENT,3489
72038,plana,I-TREATMENT,3489
72039,vitrectomy,I-TREATMENT,3489
72040,PPV,I-TREATMENT,3489
72041,is,O,3489
72042,a,O,3489
72043,common,O,3489
72044,procedure,O,3489
72045,employed,O,3489
72046,by,O,3489
72047,vitreoretinal,O,3489
72048,surgeons,O,3489
72049,to,O,3489
72050,gain,O,3489
72051,access,O,3489
72052,into,O,3489
72053,the,O,3489
72054,posterior,O,3489
72055,segment,O,3489
72056,of,O,3489
72057,the,O,3489
72058,eye,O,3489
72059,This,O,3489
72060,allows,O,3489
72061,for,O,3489
72062,the,O,3489
72063,treatment,O,3489
72064,of,O,3489
72065,many,O,3489
72066,conditions,O,3489
72067,ranging,O,3490
72068,from,O,3490
72069,vitreous,B-SIGN_AND_SYMPTOM,3490
72070,debris,I-SIGN_AND_SYMPTOM,3490
72071,floaters,I-SIGN_AND_SYMPTOM,3490
72072,and,O,3490
72073,epiretinal,B-SIGN_AND_SYMPTOM,3490
72074,membranes,I-SIGN_AND_SYMPTOM,3490
72075,to,O,3490
72076,retinal,B-SIGN_AND_SYMPTOM,3490
72077,detachments,I-SIGN_AND_SYMPTOM,3490
72078,subretinal,B-SIGN_AND_SYMPTOM,3490
72079,hemorrhages,I-SIGN_AND_SYMPTOM,3490
72080,and,O,3490
72081,intraocular,B-NAME_OF_DISEASE,3490
72082,tumors,I-NAME_OF_DISEASE,3490
72083,Since,O,3490
72084,the,O,3490
72085,development,O,3490
72086,of,O,3490
72087,the,O,3490
72088,modern-day,O,3490
72089,three-port,B-TREATMENT,3490
72090,vitrectomy,I-TREATMENT,3490
72091,system,I-TREATMENT,3490
72092,by,O,3491
72093,Conor,B-PERSON,3491
72094,O,I-PERSON,3491
72095,Malley,I-PERSON,3491
72096,and,O,3491
72097,Ralph,B-PERSON,3491
72098,Heintz,I-PERSON,3491
72099,in,O,3491
72100,1974,O,3492
72101,there,O,3492
72102,have,O,3492
72103,been,O,3492
72104,multiple,O,3492
72105,advances,O,3492
72106,in,O,3492
72107,instrumentation,O,3492
72108,These,O,3492
72109,advancements,O,3492
72110,include,O,3492
72111,smaller,O,3492
72112,gauge,B-SURGICAL_INSTRUMENT,3492
72113,instruments,I-SURGICAL_INSTRUMENT,3492
72114,vitrectomy,B-SURGICAL_INSTRUMENT,3492
72115,machines,I-SURGICAL_INSTRUMENT,3493
72116,that,O,3493
72117,provide,O,3493
72118,higher,O,3493
72119,cut,O,3493
72120,rates,O,3493
72121,and,O,3493
72122,more,O,3493
72123,stable,O,3494
72124,intraocular,O,3494
72125,pressures,O,3494
72126,IOPs,O,3494
72127,and,O,3494
72128,visualization,O,3494
72129,systems,O,3494
72130,most,O,3494
72131,recently,O,3494
72132,with,O,3494
72133,heads,O,3494
72134,up,O,3494
72135,three-dimensional,O,3494
72136,viewing,O,3494
72137,systems,O,3494
72138,with,O,3494
72139,3D,O,3494
72140,glasses,O,3494
72141,It,O,3494
72142,is,O,3494
72143,necessary,O,3494
72144,to,O,3494
72145,provide,O,3494
72146,education,O,3494
72147,to,O,3494
72148,patients,O,3494
72149,who,O,3494
72150,undergo,O,3495
72151,this,O,3495
72152,procedure,O,3495
72153,and,O,3495
72154,to,O,3495
72155,participate,O,3495
72156,in,O,3495
72157,their,O,3495
72158,care,O,3495
72159,Informed,O,3495
72160,consent,O,3495
72161,-,O,3495
72162,Obtaining,O,3495
72163,informed,O,3495
72164,consent,O,3495
72165,from,O,3496
72166,the,O,3496
72167,patient,O,3496
72168,-,O,3496
72169,where,O,3496
72170,risks,O,3496
72171,benefits,O,3496
72172,and,O,3496
72173,alternatives,O,3496
72174,to,O,3496
72175,surgery,O,3496
72176,are,O,3496
72177,discussed,O,3496
72178,-,O,3496
72179,is,O,3496
72180,often,O,3496
72181,the,O,3496
72182,most,O,3496
72183,important,O,3496
72184,part,O,3496
72185,of,O,3496
72186,the,O,3496
72187,procedure,O,3496
72188,In,O,3496
72189,many,O,3496
72190,cases,O,3497
72191,such,O,3497
72192,as,O,3497
72193,vitreous,B-SIGN_AND_SYMPTOM,3497
72194,debris,I-SIGN_AND_SYMPTOM,3497
72195,or,O,3497
72196,an,B-SIGN_AND_SYMPTOM,3497
72197,epiretinal,I-SIGN_AND_SYMPTOM,3497
72198,membrane,I-SIGN_AND_SYMPTOM,3497
72199,surgery,O,3497
72200,is,O,3497
72201,not,O,3498
72202,necessary,O,3499
72203,and,O,3499
72204,therefore,O,3499
72205,is,O,3499
72206,an,O,3499
72207,elective,O,3499
72208,procedure,O,3499
72209,This,O,3499
72210,step,O,3499
72211,often,O,3499
72212,occurs,O,3499
72213,in,O,3499
72214,the,O,3499
72215,clinic,O,3499
72216,prior,O,3499
72217,to,O,3499
72218,going,O,3499
72219,to,O,3499
72220,the,O,3500
72221,operating,O,3500
72222,room,O,3500
72223,OR,O,3500
72224,,O,3500
72225,During,O,3500
72226,this,O,3500
72227,discussion,O,3500
72228,the,O,3500
72229,patient,O,3500
72230,also,O,3500
72231,must,O,3500
72232,be,O,3500
72233,made,O,3500
72234,aware,O,3500
72235,of,O,3500
72236,what,O,3501
72237,to,O,3501
72238,expect,O,3501
72239,before,O,3501
72240,during,O,3501
72241,and,O,3501
72242,after,O,3501
72243,surgery,O,3501
72244,In,O,3501
72245,addition,O,3501
72246,to,O,3501
72247,the,O,3501
72248,risks,O,3501
72249,benefits,O,3502
72250,and,O,3502
72251,alternatives,O,3502
72252,to,O,3502
72253,surgery,O,3502
72254,the,O,3502
72255,following,O,3502
72256,questions,O,3502
72257,should,O,3502
72258,be,O,3502
72259,answered,O,3502
72260,and,O,3502
72261,discussed,O,3503
72262,with,O,3503
72263,the,O,3503
72264,patient,O,3503
72265,prior,O,3503
72266,to,O,3503
72267,surgery,O,3503
72268,What,O,3503
72269,do,O,3503
72270,I,O,3503
72271,wear,O,3503
72272,When,O,3503
72273,do,O,3503
72274,I,O,3503
72275,stop,O,3503
72276,eating,O,3503
72277,drinking,O,3503
72278,Can,O,3503
72279,I,O,3503
72280,still,O,3503
72281,take,O,3503
72282,my,O,3503
72283,medications,O,3503
72284,Will,O,3504
72285,I,O,3504
72286,be,O,3504
72287,awake,O,3504
72288,or,O,3504
72289,asleep,O,3504
72290,How,O,3504
72291,long,O,3504
72292,will,O,3504
72293,the,O,3504
72294,procedure,O,3504
72295,take,O,3504
72296,How,O,3504
72297,long,O,3504
72298,is,O,3505
72299,the,O,3505
72300,recovery,O,3505
72301,period,O,3505
72302,Do,O,3505
72303,I,O,3505
72304,have,O,3505
72305,to,O,3505
72306,position,O,3505
72307,after,O,3505
72308,surgery,O,3505
72309,What,O,3505
72310,is,O,3505
72311,my,O,3505
72312,visual,O,3505
72313,prognosis,O,3505
72314,Failure,O,3505
72315,to,O,3505
72316,discuss,O,3505
72317,these,O,3505
72318,topics,O,3505
72319,with,O,3505
72320,the,O,3505
72321,patient,O,3505
72322,prior,O,3505
72323,to,O,3505
72324,surgery,O,3505
72325,can,O,3505
72326,and,O,3505
72327,likely,O,3505
72328,will,O,3505
72329,result,O,3505
72330,in,O,3505
72331,an,O,3505
72332,unhappy,O,3505
72333,patient,O,3506
72334,regardless,O,3506
72335,of,O,3506
72336,the,O,3506
72337,outcome,O,3506
72338,of,O,3506
72339,the,O,3506
72340,procedure,O,3506
72341,Retrobulbar,O,3506
72342,block,O,3506
72343,Vitreoretinal,O,3506
72344,surgical,O,3506
72345,cases,O,3506
72346,may,O,3506
72347,require,O,3506
72348,very,O,3506
72349,delicate,O,3506
72350,movements,O,3506
72351,in,O,3506
72352,close,O,3506
72353,proximity,O,3506
72354,to,O,3506
72355,the,O,3506
72356,surface,O,3506
72357,of,O,3506
72358,the,B-PART_OF_THE_EYES,3506
72359,retina,I-PART_OF_THE_EYES,3506
72360,Therefore,O,3506
72361,limiting,O,3506
72362,eye,O,3506
72363,movement,O,3506
72364,and,O,3506
72365,patient,O,3506
72366,comfort,O,3506
72367,are,O,3507
72368,addressed,O,3508
72369,in,O,3508
72370,most,O,3508
72371,scenarios,O,3508
72372,via,O,3508
72373,a,O,3508
72374,retrobulbar,O,3508
72375,block,O,3508
72376,to,O,3508
72377,obtain,O,3508
72378,akinesia,O,3508
72379,and,O,3508
72380,anesthesia,O,3508
72381,A,O,3508
72382,typical,O,3509
72383,retrobulbar,O,3509
72384,block,O,3509
72385,consists,O,3509
72386,of,O,3509
72387,50%,O,3509
72388,lidocaine,B-NAME_OF_DRUG,3509
72389,and,O,3509
72390,50%,O,3509
72391,bupivacaine,B-NAME_OF_DRUG,3509
72392,The,O,3509
72393,mixture,O,3509
72394,is,O,3509
72395,injected,O,3509
72396,in,O,3509
72397,the,O,3509
72398,retrobulbar,O,3509
72399,space,O,3509
72400,into,O,3509
72401,what,O,3509
72402,is,O,3509
72403,called,O,3509
72404,the,B-PART_OF_THE_EYES,3510
72405,muscle,I-PART_OF_THE_EYES,3510
72406,cone,I-PART_OF_THE_EYES,3510
72407,which,O,3510
72408,is,O,3510
72409,comprised,O,3510
72410,of,O,3510
72411,the,O,3510
72412,four,O,3510
72413,rectus,O,3510
72414,muscles,O,3510
72415,The,O,3510
72416,branches,O,3511
72417,of,O,3511
72418,the,O,3511
72419,oculomotor,O,3511
72420,nerve,O,3511
72421,cranial,O,3511
72422,nerve,O,3511
72423,III,O,3511
72424,run,O,3511
72425,along,O,3511
72426,the,O,3511
72427,inside,O,3512
72428,of,O,3512
72429,the,B-PART_OF_THE_EYES,3512
72430,muscle,I-PART_OF_THE_EYES,3512
72431,cone,I-PART_OF_THE_EYES,3512
72432,and,O,3512
72433,innervate,O,3512
72434,muscles,O,3512
72435,responsible,O,3512
72436,for,O,3512
72437,eye,O,3512
72438,movement,O,3512
72439,This,O,3512
72440,is,O,3512
72441,why,O,3512
72442,injecting,O,3512
72443,the,O,3512
72444,anesthetic,O,3513
72445,directly,O,3513
72446,into,O,3513
72447,the,B-PART_OF_THE_EYES,3513
72448,muscle,I-PART_OF_THE_EYES,3513
72449,cone,I-PART_OF_THE_EYES,3513
72450,does,O,3513
72451,such,O,3513
72452,a,O,3513
72453,good,O,3513
72454,job,O,3513
72455,of,O,3513
72456,providing,O,3513
72457,akinesia,O,3513
72458,and,O,3513
72459,anesthesia,O,3513
72460,However,O,3513
72461,the,B-PART_OF_THE_EYES,3513
72462,optic,I-PART_OF_THE_EYES,3513
72463,nerve,I-PART_OF_THE_EYES,3514
72464,cranial,B-PART_OF_THE_EYES,3514
72465,nerve,I-PART_OF_THE_EYES,3514
72466,II,I-PART_OF_THE_EYES,3514
72467,which,O,3514
72468,is,O,3514
72469,responsible,O,3514
72470,for,O,3514
72471,vision,O,3514
72472,also,O,3514
72473,runs,O,3514
72474,inside,O,3514
72475,the,B-PART_OF_THE_EYES,3514
72476,muscle,I-PART_OF_THE_EYES,3514
72477,cone,I-PART_OF_THE_EYES,3514
72478,Therefore,O,3514
72479,patients,O,3514
72480,frequently,O,3514
72481,lose,O,3514
72482,vision,O,3514
72483,after,O,3514
72484,receiving,O,3514
72485,a,O,3514
72486,retrobulbar,O,3515
72487,block,O,3515
72488,for,O,3515
72489,as,O,3515
72490,long,O,3515
72491,as,O,3515
72492,the,O,3515
72493,block,O,3515
72494,has,O,3515
72495,an,O,3515
72496,effect,O,3515
72497,usually,O,3515
72498,8-Jun,B-TIME_DURATION,3515
72499,hours,I-TIME_DURATION,3515
72500,PPV,B-TREATMENT,3515
72501,Now,O,3515
72502,the,O,3515
72503,patient,O,3516
72504,is,O,3516
72505,ready,O,3516
72506,for,O,3516
72507,surgery,O,3516
72508,After,O,3516
72509,entering,O,3516
72510,the,O,3516
72511,OR,O,3516
72512,everyone,O,3516
72513,in,O,3516
72514,the,O,3516
72515,room,O,3516
72516,pauses,O,3516
72517,to,O,3516
72518,agree,O,3516
72519,on,O,3516
72520,the,O,3516
72521,patient,O,3516
72522,the,O,3516
72523,eye,O,3517
72524,being,O,3517
72525,operated,O,3517
72526,on,O,3517
72527,and,O,3517
72528,the,O,3517
72529,procedure,O,3517
72530,being,O,3517
72531,performed,O,3517
72532,Next,O,3517
72533,a,O,3517
72534,sterile,O,3517
72535,preparation,O,3517
72536,is,O,3517
72537,used,O,3518
72538,to,O,3518
72539,clean,O,3518
72540,the,O,3518
72541,eye,O,3518
72542,and,O,3518
72543,surrounding,O,3518
72544,skin,O,3518
72545,and,O,3518
72546,the,O,3518
72547,areas,O,3518
72548,not,O,3518
72549,being,O,3518
72550,operated,O,3518
72551,on,O,3518
72552,are,O,3518
72553,covered,O,3518
72554,The,O,3518
72555,actual,O,3519
72556,surgery,O,3519
72557,part,O,3519
72558,of,O,3519
72559,this,O,3519
72560,procedure,O,3519
72561,is,O,3519
72562,broken,O,3519
72563,down,O,3519
72564,into,O,3519
72565,four,O,3519
72566,steps,O,3519
72567,1,O,3519
72568,Gaining,O,3519
72569,access,O,3519
72570,-,O,3519
72571,The,O,3519
72572,term,O,3519
72573,three-port,B-TREATMENT,3519
72574,PPV,I-TREATMENT,3519
72575,is,O,3519
72576,used,O,3519
72577,to,O,3519
72578,describe,O,3519
72579,the,O,3520
72580,method,O,3520
72581,of,O,3520
72582,access,O,3520
72583,to,O,3520
72584,the,O,3520
72585,posterior,O,3520
72586,segment,O,3520
72587,A,O,3520
72588,standard,O,3520
72589,vitrectomy,B-TREATMENT,3520
72590,involves,O,3520
72591,placing,O,3520
72592,three,O,3520
72593,cannulas,O,3520
72594,in,O,3520
72595,the,O,3520
72596,eye,O,3521
72597,through,O,3521
72598,the,B-PART_OF_THE_EYES,3521
72599,pars,I-PART_OF_THE_EYES,3521
72600,plana,I-PART_OF_THE_EYES,3521
72601,a,O,3521
72602,relatively,O,3521
72603,avascular,O,3521
72604,area,O,3521
72605,of,O,3521
72606,the,O,3521
72607,eye,O,3521
72608,located,O,3521
72609,approximately,O,3521
72610,3,O,3521
72611,mm,O,3521
72612,to,O,3522
72613,4,O,3522
72614,mm,O,3522
72615,posterior,O,3522
72616,to,O,3522
72617,the,B-PART_OF_THE_EYES,3522
72618,limbus,I-PART_OF_THE_EYES,3522
72619,between,O,3522
72620,the,B-PART_OF_THE_EYES,3522
72621,pars,I-PART_OF_THE_EYES,3522
72622,plicata,I-PART_OF_THE_EYES,3522
72623,and,O,3522
72624,ora,B-PART_OF_THE_EYES,3522
72625,serrata,I-PART_OF_THE_EYES,3522
72626,the,O,3522
72627,end,O,3522
72628,of,O,3522
72629,the,B-PART_OF_THE_EYES,3522
72630,retina,I-PART_OF_THE_EYES,3522
72631,The,O,3522
72632,cannulas,O,3522
72633,or,O,3522
72634,ports,O,3522
72635,allow,O,3522
72636,for,O,3522
72637,instruments,O,3522
72638,to,O,3522
72639,go,O,3522
72640,in,O,3522
72641,and,O,3522
72642,out,O,3522
72643,of,O,3522
72644,the,O,3523
72645,eye,O,3523
72646,without,O,3523
72647,the,O,3523
72648,need,O,3523
72649,for,O,3523
72650,more,O,3523
72651,incisions,O,3523
72652,The,O,3523
72653,three,O,3523
72654,ports,O,3523
72655,consist,O,3523
72656,of,O,3523
72657,an,O,3523
72658,infusion,O,3523
72659,line,O,3523
72660,placed,O,3523
72661,inferotemporally,O,3523
72662,and,O,3523
72663,two,O,3523
72664,ports,O,3523
72665,superonasally,O,3523
72666,and,O,3523
72667,superotemporally,O,3523
72668,to,O,3523
72669,allow,O,3523
72670,for,O,3523
72671,an,B-SURGICAL_INSTRUMENT,3523
72672,illumination,I-SURGICAL_INSTRUMENT,3524
72673,device,I-SURGICAL_INSTRUMENT,3524
72674,in,O,3524
72675,one,O,3524
72676,hand,O,3524
72677,and,O,3524
72678,a,O,3524
72679,working,O,3524
72680,instrument,O,3524
72681,such,O,3524
72682,as,O,3524
72683,the,B-SURGICAL_INSTRUMENT,3524
72684,vitreous,I-SURGICAL_INSTRUMENT,3524
72685,cutter,I-SURGICAL_INSTRUMENT,3524
72686,or,O,3524
72687,grasping,B-SURGICAL_INSTRUMENT,3524
72688,forceps,I-SURGICAL_INSTRUMENT,3524
72689,in,O,3524
72690,the,O,3524
72691,other,O,3524
72692,2,O,3524
72693,Performing,O,3524
72694,the,B-TREATMENT,3524
72695,vitrectomy,I-TREATMENT,3524
72696,Before,O,3524
72697,any,O,3524
72698,work,O,3525
72699,can,O,3525
72700,be,O,3525
72701,done,O,3525
72702,in,O,3525
72703,the,O,3525
72704,posterior,O,3525
72705,segment,O,3525
72706,the,B-PART_OF_THE_EYES,3525
72707,vitreous,I-PART_OF_THE_EYES,3525
72708,humour,I-PART_OF_THE_EYES,3525
72709,known,O,3525
72710,more,O,3525
72711,simply,O,3525
72712,as,O,3525
72713,the,B-PART_OF_THE_EYES,3525
72714,vitreous,I-PART_OF_THE_EYES,3525
72715,must,O,3525
72716,be,O,3526
72717,removed,O,3526
72718,The,B-PART_OF_THE_EYES,3526
72719,vitreous,I-PART_OF_THE_EYES,3526
72720,which,O,3526
72721,fills,O,3526
72722,the,O,3526
72723,eye,O,3526
72724,from,O,3526
72725,behind,O,3526
72726,the,B-PART_OF_THE_EYES,3526
72727,lens,I-PART_OF_THE_EYES,3526
72728,to,O,3526
72729,the,B-PART_OF_THE_EYES,3526
72730,retinal,I-PART_OF_THE_EYES,3526
72731,surface,I-PART_OF_THE_EYES,3526
72732,consists,O,3526
72733,mainly,O,3527
72734,of,O,3527
72735,water,O,3527
72736,but,O,3527
72737,it,O,3527
72738,also,O,3527
72739,has,O,3527
72740,a,O,3527
72741,mixture,O,3527
72742,of,O,3527
72743,collagen,B-CHEMICAL_COMPOUND,3527
72744,proteins,B-CHEMICAL_COMPOUND,3527
72745,sugars,B-CHEMICAL_COMPOUND,3527
72746,and,O,3527
72747,salts,B-CHEMICAL_COMPOUND,3527
72748,The,B-PART_OF_THE_EYES,3527
72749,vitreous,I-PART_OF_THE_EYES,3527
72750,is,O,3527
72751,attached,O,3527
72752,to,O,3527
72753,the,B-PART_OF_THE_EYES,3527
72754,retina,I-PART_OF_THE_EYES,3527
72755,so,O,3528
72756,if,O,3528
72757,you,O,3528
72758,move,O,3528
72759,through,O,3528
72760,the,O,3528
72761,posterior,O,3528
72762,segment,O,3528
72763,without,O,3528
72764,removing,O,3528
72765,the,B-PART_OF_THE_EYES,3528
72766,vitreous,I-PART_OF_THE_EYES,3528
72767,it,O,3528
72768,will,O,3528
72769,create,O,3528
72770,traction,O,3528
72771,on,O,3528
72772,both,O,3528
72773,This,O,3528
72774,can,O,3528
72775,lead,O,3528
72776,to,O,3528
72777,retinal,B-NAME_OF_DISEASE,3529
72778,tears,I-NAME_OF_DISEASE,3529
72779,or,I-NAME_OF_DISEASE,3529
72780,detachments,I-NAME_OF_DISEASE,3529
72781,Removing,O,3529
72782,the,B-PART_OF_THE_EYES,3529
72783,vitreous,I-PART_OF_THE_EYES,3529
72784,also,O,3529
72785,called,O,3529
72786,a,B-TREATMENT,3529
72787,vitrectomy,I-TREATMENT,3529
72788,is,O,3529
72789,the,O,3529
72790,first,O,3529
72791,step,O,3529
72792,of,O,3529
72793,every,O,3529
72794,vitreoretinal,O,3529
72795,procedure,O,3529
72796,The,B-TREATMENT,3529
72797,vitrectomy,I-TREATMENT,3529
72798,is,O,3529
72799,preformed,O,3529
72800,using,O,3529
72801,a,B-SURGICAL_INSTRUMENT,3529
72802,vitreous,I-SURGICAL_INSTRUMENT,3529
72803,cutter,I-SURGICAL_INSTRUMENT,3529
72804,This,O,3529
72805,instrument,O,3529
72806,has,O,3529
72807,a,O,3529
72808,small,O,3529
72809,opening,O,3529
72810,sometimes,O,3529
72811,referred,O,3529
72812,to,O,3529
72813,as,O,3529
72814,the,O,3529
72815,mouth,O,3529
72816,at,O,3529
72817,the,O,3529
72818,tip,O,3529
72819,which,O,3529
72820,opens,O,3529
72821,and,O,3529
72822,closes,O,3529
72823,5,O,3529
72824,0,O,3529
72825,to,O,3529
72826,10,O,3529
72827,0,O,3529
72828,times,O,3530
72829,per,O,3530
72830,minute,O,3530
72831,This,O,3530
72832,instrument,O,3530
72833,aspirates,O,3530
72834,vitreous,O,3530
72835,into,O,3530
72836,its,O,3530
72837,mouth,O,3530
72838,when,O,3530
72839,open,O,3530
72840,and,O,3530
72841,cuts,O,3530
72842,the,B-PART_OF_THE_EYES,3530
72843,vitreous,I-PART_OF_THE_EYES,3530
72844,when,O,3530
72845,closed,O,3530
72846,The,B-PART_OF_THE_EYES,3530
72847,vitreous,I-PART_OF_THE_EYES,3530
72848,is,O,3530
72849,most,O,3530
72850,adherent,O,3530
72851,to,O,3530
72852,the,B-PART_OF_THE_EYES,3530
72853,retina,I-PART_OF_THE_EYES,3530
72854,at,O,3530
72855,the,B-PART_OF_THE_EYES,3530
72856,optic,I-PART_OF_THE_EYES,3530
72857,disc,I-PART_OF_THE_EYES,3530
72858,the,B-PART_OF_THE_EYES,3530
72859,fovea,I-PART_OF_THE_EYES,3530
72860,the,O,3530
72861,center,O,3531
72862,of,O,3531
72863,the,B-PART_OF_THE_EYES,3531
72864,retina,I-PART_OF_THE_EYES,3531
72865,the,B-PART_OF_THE_EYES,3531
72866,vessels,I-PART_OF_THE_EYES,3531
72867,and,O,3531
72868,the,B-PART_OF_THE_EYES,3531
72869,vitreous,I-PART_OF_THE_EYES,3531
72870,base,I-PART_OF_THE_EYES,3531
72871,Care,O,3531
72872,must,O,3531
72873,be,O,3531
72874,taken,O,3531
72875,when,O,3531
72876,removing,O,3531
72877,the,B-PART_OF_THE_EYES,3531
72878,vitreous,I-PART_OF_THE_EYES,3531
72879,from,O,3531
72880,these,O,3531
72881,areas,O,3531
72882,3,O,3531
72883,Performing,O,3531
72884,the,O,3531
72885,indicated,O,3531
72886,procedure,O,3531
72887,Once,O,3531
72888,the,B-PART_OF_THE_EYES,3532
72889,vitreous,I-PART_OF_THE_EYES,3532
72890,is,O,3532
72891,removed,O,3532
72892,the,O,3532
72893,surgeon,O,3532
72894,can,O,3532
72895,perform,O,3532
72896,the,O,3532
72897,indication,O,3532
72898,for,O,3532
72899,the,O,3532
72900,procedure,O,3532
72901,Sometimes,O,3533
72902,removing,O,3533
72903,the,B-PART_OF_THE_EYES,3533
72904,vitreous,I-PART_OF_THE_EYES,3533
72905,is,O,3533
72906,all,O,3533
72907,that,O,3533
72908,is,O,3533
72909,necessary,O,3533
72910,such,O,3533
72911,as,O,3533
72912,in,O,3533
72913,cases,O,3533
72914,of,O,3533
72915,vitreous,O,3534
72916,debris,O,3534
72917,Some,O,3534
72918,examples,O,3534
72919,of,O,3534
72920,common,O,3534
72921,cases,O,3534
72922,performed,O,3534
72923,include,O,3534
72924,retinal,B-TREATMENT,3534
72925,detachment,I-TREATMENT,3534
72926,repair,I-TREATMENT,3534
72927,and,O,3534
72928,membrane,B-TREATMENT,3534
72929,peel,I-TREATMENT,3534
72930,Membrane,B-TREATMENT,3534
72931,peels,I-TREATMENT,3534
72932,are,O,3534
72933,required,O,3534
72934,to,O,3534
72935,repair,O,3535
72936,epiretinal,B-SIGN_AND_SYMPTOM,3535
72937,membranes,I-SIGN_AND_SYMPTOM,3535
72938,or,O,3535
72939,full-thickness,O,3535
72940,macular,O,3535
72941,holes,O,3535
72942,The,O,3535
72943,membranes,O,3535
72944,are,O,3535
72945,stained,O,3536
72946,with,O,3536
72947,a,O,3536
72948,green,O,3536
72949,or,O,3536
72950,blue,O,3536
72951,solution,O,3536
72952,that,O,3536
72953,helps,O,3536
72954,the,O,3536
72955,surgeon,O,3537
72956,visualize,O,3537
72957,the,O,3537
72958,membrane,O,3537
72959,and,O,3537
72960,remove,O,3537
72961,it,O,3537
72962,using,O,3537
72963,intraocular,B-SURGICAL_INSTRUMENT,3537
72964,forceps,I-SURGICAL_INSTRUMENT,3537
72965,A,B-TREATMENT,3537
72966,retinal,I-TREATMENT,3537
72967,detachment,I-TREATMENT,3537
72968,repair,I-TREATMENT,3537
72969,involves,O,3537
72970,first,O,3537
72971,locating,O,3537
72972,all,O,3537
72973,of,O,3537
72974,the,O,3537
72975,patient,O,3537
72976,s,O,3537
72977,retinal,B-PART_OF_THE_EYES,3537
72978,tears,I-PART_OF_THE_EYES,3537
72979,Once,O,3537
72980,identified,O,3537
72981,the,O,3537
72982,tears,O,3537
72983,are,O,3537
72984,marked,O,3537
72985,using,O,3537
72986,intraocular,B-SURGICAL_INSTRUMENT,3537
72987,cautery,I-SURGICAL_INSTRUMENT,3537
72988,and,O,3538
72989,the,B-PART_OF_THE_EYES,3538
72990,retina,I-PART_OF_THE_EYES,3538
72991,is,O,3538
72992,flattened,O,3538
72993,and,O,3538
72994,reattached,O,3538
72995,by,O,3538
72996,replacing,O,3538
72997,the,O,3538
72998,liquid,O,3538
72999,fluid,O,3538
73000,in,O,3538
73001,the,O,3538
73002,eye,O,3538
73003,with,O,3538
73004,an,O,3538
73005,air,O,3539
73006,bubble,O,3539
73007,this,O,3539
73008,is,O,3539
73009,called,O,3539
73010,a,O,3539
73011,fluid-air,O,3539
73012,exchange,O,3539
73013,,O,3539
73014,Laser,O,3539
73015,is,O,3539
73016,then,O,3539
73017,placed,O,3539
73018,around,O,3539
73019,the,O,3539
73020,tears,O,3539
73021,to,O,3539
73022,spot,O,3539
73023,weld,O,3539
73024,the,B-PART_OF_THE_EYES,3539
73025,retina,I-PART_OF_THE_EYES,3539
73026,down,O,3539
73027,in,O,3539
73028,these,O,3539
73029,locations,O,3539
73030,then,O,3539
73031,the,O,3539
73032,air,O,3539
73033,is,O,3539
73034,exchanged,O,3539
73035,for,O,3539
73036,an,O,3540
73037,expansile,O,3540
73038,gas,O,3540
73039,that,O,3540
73040,will,O,3540
73041,slowly,O,3540
73042,dissolve,O,3540
73043,over,B-TIME_DURATION,3540
73044,one,I-TIME_DURATION,3540
73045,to,I-TIME_DURATION,3540
73046,two,I-TIME_DURATION,3540
73047,months,I-TIME_DURATION,3540
73048,4,O,3540
73049,Closing,O,3540
73050,Once,O,3540
73051,the,O,3540
73052,procedure,O,3540
73053,is,O,3540
73054,completed,O,3540
73055,then,O,3540
73056,the,O,3540
73057,cannulas,O,3540
73058,are,O,3540
73059,removed,O,3540
73060,from,O,3540
73061,the,O,3540
73062,eye,O,3540
73063,When,O,3540
73064,the,O,3540
73065,cannulas,O,3540
73066,are,O,3540
73067,placed,O,3540
73068,they,O,3540
73069,are,O,3540
73070,usually,O,3540
73071,done,O,3540
73072,so,O,3540
73073,at,O,3541
73074,an,O,3541
73075,angle,O,3541
73076,to,O,3541
73077,create,O,3541
73078,what,O,3541
73079,becomes,O,3541
73080,a,O,3541
73081,sealed,O,3541
73082,incision,O,3541
73083,once,O,3541
73084,removed,O,3541
73085,Sometimes,O,3541
73086,however,O,3541
73087,gas,O,3541
73088,or,O,3541
73089,liquid,O,3541
73090,is,O,3541
73091,noted,O,3541
73092,to,O,3541
73093,leak,O,3542
73094,from,O,3542
73095,the,O,3542
73096,incisions,O,3542
73097,If,O,3542
73098,this,O,3542
73099,is,O,3542
73100,the,O,3542
73101,case,O,3542
73102,the,O,3542
73103,incisions,O,3542
73104,are,O,3542
73105,closed,O,3542
73106,using,O,3542
73107,sutures,B-SURGICAL_INSTRUMENT,3542
73108,It,O,3543
73109,is,O,3543
73110,important,O,3543
73111,to,O,3543
73112,make,O,3543
73113,sure,O,3543
73114,that,O,3543
73115,the,O,3543
73116,IOP,O,3543
73117,is,O,3543
73118,appropriate,O,3543
73119,at,O,3543
73120,the,O,3543
73121,end,O,3543
73122,of,O,3543
73123,the,O,3543
73124,case,O,3543
73125,If,O,3543
73126,the,O,3543
73127,pressure,O,3543
73128,is,O,3543
73129,too,O,3543
73130,high,O,3543
73131,or,O,3543
73132,too,O,3543
73133,low,O,3543
73134,there,O,3543
73135,could,O,3543
73136,be,O,3544
73137,significant,O,3544
73138,consequences,O,3544
73139,in,O,3544
73140,the,O,3544
73141,immediate,O,3544
73142,post-operative,O,3544
73143,period,O,3544
73144,Aftercare,O,3544
73145,and,O,3544
73146,head,O,3544
73147,positioning,O,3544
73148,If,O,3544
73149,there,O,3544
73150,is,O,3544
73151,no,O,3544
73152,air,O,3544
73153,or,O,3544
73154,gas,O,3544
73155,bubble,O,3544
73156,placed,O,3544
73157,in,O,3544
73158,the,O,3544
73159,eye,O,3544
73160,then,O,3544
73161,there,O,3544
73162,are,O,3544
73163,no,O,3544
73164,head,O,3544
73165,positioning,O,3544
73166,requirements,O,3544
73167,However,O,3544
73168,if,O,3544
73169,any,O,3544
73170,amount,O,3544
73171,of,O,3544
73172,gas,O,3544
73173,or,O,3544
73174,air,O,3544
73175,is,O,3544
73176,placed,O,3544
73177,in,O,3544
73178,the,O,3544
73179,eye,O,3544
73180,then,O,3545
73181,positioning,O,3545
73182,is,O,3545
73183,needed,O,3545
73184,The,O,3545
73185,location,O,3545
73186,of,O,3545
73187,the,O,3545
73188,pathology,O,3545
73189,in,O,3545
73190,the,B-PART_OF_THE_EYES,3546
73191,retina,I-PART_OF_THE_EYES,3546
73192,will,O,3546
73193,determine,O,3546
73194,what,O,3546
73195,position,O,3546
73196,and,O,3546
73197,for,O,3546
73198,how,O,3546
73199,long,O,3546
73200,the,O,3546
73201,positioning,O,3546
73202,is,O,3546
73203,required,O,3546
73204,Common,O,3546
73205,head,O,3546
73206,positions,O,3546
73207,include,O,3546
73208,face,O,3546
73209,down,O,3546
73210,head,O,3546
73211,up,O,3546
73212,left,O,3546
73213,side,O,3546
73214,down,O,3547
73215,right,O,3547
73216,side,O,3547
73217,down,O,3547
73218,These,O,3547
73219,positions,O,3547
73220,are,O,3547
73221,necessary,O,3547
73222,all,O,3547
73223,day,O,3547
73224,when,O,3547
73225,patients,O,3547
73226,are,O,3547
73227,awake,O,3548
73228,usually,O,3548
73229,with,O,3548
73230,a,O,3548
73231,15-Oct,B-TIME_DURATION,3548
73232,minute,I-TIME_DURATION,3548
73233,break,O,3548
73234,every,O,3548
73235,hour,O,3548
73236,If,O,3548
73237,a,O,3548
73238,face,O,3549
73239,down,O,3549
73240,position,O,3549
73241,is,O,3549
73242,required,O,3549
73243,for,O,3549
73244,an,O,3549
73245,extended,O,3549
73246,period,O,3549
73247,of,O,3549
73248,time,O,3549
73249,longer,B-TIME_DURATION,3549
73250,than,I-TIME_DURATION,3549
73251,three,I-TIME_DURATION,3549
73252,days,I-TIME_DURATION,3549
73253,then,O,3549
73254,a,O,3549
73255,positioning,O,3549
73256,assistance,O,3549
73257,device,O,3549
73258,is,O,3549
73259,recommended,O,3549
73260,These,O,3549
73261,devices,O,3549
73262,can,O,3549
73263,relieve,O,3549
73264,the,O,3549
73265,pressure,O,3549
73266,placed,O,3549
73267,on,O,3549
73268,the,O,3549
73269,neck,O,3549
73270,and,O,3549
73271,back,O,3549
73272,that,O,3549
73273,comes,O,3549
73274,with,O,3549
73275,prolonged,O,3549
73276,positioning,O,3549
73277,Eye,B-NAME_OF_DRUG,3549
73278,drops,I-NAME_OF_DRUG,3549
73279,consisting,I-NAME_OF_DRUG,3549
73280,of,I-NAME_OF_DRUG,3549
73281,an,I-NAME_OF_DRUG,3549
73282,antibiotic,I-NAME_OF_DRUG,3549
73283,and,I-NAME_OF_DRUG,3549
73284,a,I-NAME_OF_DRUG,3549
73285,steroid,I-NAME_OF_DRUG,3550
73286,are,O,3550
73287,used,O,3550
73288,postoperatively,O,3550
73289,in,O,3550
73290,all,O,3550
73291,vitrectomy,B-TREATMENT,3550
73292,cases,O,3550
73293,Most,O,3550
73294,patients,O,3550
73295,require,O,3550
73296,approximately,O,3550
73297,one,B-TIME_DURATION,3550
73298,week,I-TIME_DURATION,3550
73299,of,O,3550
73300,limited,O,3550
73301,activity,O,3550
73302,to,O,3550
73303,facilitate,O,3550
73304,proper,O,3550
73305,healing,O,3550
73306,after,O,3550
73307,their,O,3550
73308,surgery,O,3550
73309,and,O,3550
73310,are,O,3550
73311,typically,O,3550
73312,seen,O,3550
73313,for,O,3550
73314,follow-up,O,3550
73315,one,B-TIME_DURATION,3550
73316,day,I-TIME_DURATION,3550
73317,one,B-TIME_DURATION,3550
73318,week,I-TIME_DURATION,3550
73319,and,O,3550
73320,one,B-TIME_DURATION,3550
73321,month,I-TIME_DURATION,3550
73322,following,O,3550
73323,the,O,3551
73324,procedure,O,3551
73325,A,O,3551
73326,wonderful,O,3551
73327,tool,O,3551
73328,Modern-day,B-TREATMENT,3551
73329,retina,I-TREATMENT,3551
73330,surgery,I-TREATMENT,3551
73331,is,O,3551
73332,a,O,3551
73333,wonderful,O,3551
73334,tool,O,3551
73335,that,O,3551
73336,physicians,O,3551
73337,can,O,3551
73338,use,O,3552
73339,to,O,3552
73340,improve,O,3552
73341,maintain,O,3552
73342,and,O,3552
73343,save,O,3552
73344,vision,O,3552
73345,in,O,3552
73346,patients,O,3552
73347,who,O,3552
73348,previously,O,3552
73349,were,O,3552
73350,destined,O,3552
73351,for,O,3552
73352,blindness,B-NAME_OF_DISEASE,3552
73353,Understanding,O,3552
73354,the,O,3553
73355,basics,O,3553
73356,of,O,3553
73357,vitrectomy,B-TREATMENT,3553
73358,surgery,I-TREATMENT,3553
73359,can,O,3553
73360,greatly,O,3553
73361,improve,O,3553
73362,the,O,3553
73363,quality,O,3553
73364,of,O,3553
73365,care,O,3553
73366,provided,O,3553
73367,to,O,3553
73368,the,O,3553
73369,patient,O,3553
73370,by,O,3553
73371,all,O,3553
73372,members,O,3553
73373,involved,O,3553
73374,in,O,3553
73375,the,O,3553
73376,patient,O,3553
73377,s,O,3553
73378,care,O,3553
73379,Bardet-Biedl,B-NAME_OF_DISEASE,3554
73380,syndrome,I-NAME_OF_DISEASE,3554
73381,BBS,I-NAME_OF_DISEASE,3554
73382,is,O,3554
73383,a,O,3554
73384,ciliopathic,O,3554
73385,human,O,3554
73386,genetic,O,3554
73387,disorder,O,3554
73388,that,O,3554
73389,produces,O,3554
73390,many,O,3554
73391,effects,O,3554
73392,and,O,3554
73393,affects,O,3554
73394,many,O,3554
73395,body,O,3554
73396,systems,O,3554
73397,It,O,3555
73398,is,O,3555
73399,characterized,O,3555
73400,by,O,3555
73401,rod,B-SIGN_AND_SYMPTOM,3555
73402,cone,I-SIGN_AND_SYMPTOM,3555
73403,dystrophy,I-SIGN_AND_SYMPTOM,3555
73404,polydactyly,I-SIGN_AND_SYMPTOM,3555
73405,central,I-SIGN_AND_SYMPTOM,3555
73406,obesity,I-SIGN_AND_SYMPTOM,3555
73407,hypogonadism,I-SIGN_AND_SYMPTOM,3555
73408,and,I-SIGN_AND_SYMPTOM,3555
73409,kidney,I-SIGN_AND_SYMPTOM,3555
73410,dysfunction,I-SIGN_AND_SYMPTOM,3555
73411,in,I-SIGN_AND_SYMPTOM,3555
73412,some,I-SIGN_AND_SYMPTOM,3555
73413,cases,I-SIGN_AND_SYMPTOM,3555
73414,Bardet-Biedl,B-NAME_OF_DISEASE,3555
73415,syndrome,I-NAME_OF_DISEASE,3555
73416,is,O,3555
73417,a,O,3555
73418,pleiotropic,O,3555
73419,disorder,O,3555
73420,with,O,3555
73421,variable,O,3555
73422,expressivity,O,3555
73423,and,O,3555
73424,a,O,3555
73425,wide,O,3555
73426,range,O,3555
73427,of,O,3555
73428,clinical,O,3555
73429,variability,O,3555
73430,observed,O,3555
73431,both,O,3555
73432,within,O,3555
73433,and,O,3555
73434,between,O,3555
73435,families,O,3555
73436,Bardet-Biedl,B-NAME_OF_DISEASE,3555
73437,syndrome,I-NAME_OF_DISEASE,3555
73438,is,O,3555
73439,a,O,3555
73440,pleiotropic,O,3555
73441,disorder,O,3555
73442,with,O,3555
73443,variable,O,3556
73444,expressivity,O,3556
73445,and,O,3556
73446,a,O,3556
73447,wide,O,3556
73448,range,O,3556
73449,of,O,3556
73450,clinical,O,3556
73451,variability,O,3556
73452,observed,O,3556
73453,both,O,3556
73454,within,O,3556
73455,and,O,3556
73456,between,O,3556
73457,families,O,3556
73458,The,O,3557
73459,most,O,3557
73460,common,O,3557
73461,clinical,O,3557
73462,features,O,3557
73463,are,O,3557
73464,rod-cone,B-SIGN_AND_SYMPTOM,3557
73465,dystrophy,I-SIGN_AND_SYMPTOM,3557
73466,with,I-SIGN_AND_SYMPTOM,3557
73467,childhood-onset,I-SIGN_AND_SYMPTOM,3557
73468,night-blindness,I-SIGN_AND_SYMPTOM,3557
73469,followed,I-SIGN_AND_SYMPTOM,3557
73470,by,I-SIGN_AND_SYMPTOM,3557
73471,increasing,I-SIGN_AND_SYMPTOM,3557
73472,visual,I-SIGN_AND_SYMPTOM,3557
73473,loss,I-SIGN_AND_SYMPTOM,3558
73474,postaxial,B-SIGN_AND_SYMPTOM,3558
73475,polydactyly,I-SIGN_AND_SYMPTOM,3558
73476,truncal,B-SIGN_AND_SYMPTOM,3558
73477,obesity,I-SIGN_AND_SYMPTOM,3558
73478,that,I-SIGN_AND_SYMPTOM,3558
73479,manifests,I-SIGN_AND_SYMPTOM,3558
73480,during,I-SIGN_AND_SYMPTOM,3558
73481,infancy,I-SIGN_AND_SYMPTOM,3558
73482,and,I-SIGN_AND_SYMPTOM,3558
73483,remains,I-SIGN_AND_SYMPTOM,3559
73484,problematic,I-SIGN_AND_SYMPTOM,3559
73485,throughout,I-SIGN_AND_SYMPTOM,3559
73486,adulthood,I-SIGN_AND_SYMPTOM,3559
73487,varying,B-SIGN_AND_SYMPTOM,3559
73488,degrees,I-SIGN_AND_SYMPTOM,3559
73489,of,I-SIGN_AND_SYMPTOM,3559
73490,learning,I-SIGN_AND_SYMPTOM,3559
73491,disabilities,I-SIGN_AND_SYMPTOM,3560
73492,male,B-SIGN_AND_SYMPTOM,3560
73493,hypogenitalism,I-SIGN_AND_SYMPTOM,3560
73494,and,I-SIGN_AND_SYMPTOM,3560
73495,complex,I-SIGN_AND_SYMPTOM,3560
73496,female,I-SIGN_AND_SYMPTOM,3560
73497,genitourinary,I-SIGN_AND_SYMPTOM,3560
73498,malformations,I-SIGN_AND_SYMPTOM,3560
73499,and,O,3560
73500,renal,B-SIGN_AND_SYMPTOM,3560
73501,dysfunction,I-SIGN_AND_SYMPTOM,3560
73502,a,O,3560
73503,major,O,3560
73504,cause,O,3560
73505,of,O,3560
73506,morbidity,O,3560
73507,and,O,3560
73508,mortality,O,3560
73509,Bardet,B-NAME_OF_DISEASE,3561
73510,Biedl,I-NAME_OF_DISEASE,3561
73511,Syndrome,I-NAME_OF_DISEASE,3561
73512,is,O,3561
73513,a,O,3561
73514,rare,O,3561
73515,genetic,O,3561
73516,disorder,O,3561
73517,with,O,3561
73518,highly,O,3561
73519,variable,O,3561
73520,symptoms,O,3561
73521,which,O,3561
73522,may,O,3561
73523,include,O,3561
73524,retinal,B-SIGN_AND_SYMPTOM,3561
73525,degeneration,I-SIGN_AND_SYMPTOM,3561
73526,obesity,I-SIGN_AND_SYMPTOM,3561
73527,reduced,I-SIGN_AND_SYMPTOM,3561
73528,kidney,I-SIGN_AND_SYMPTOM,3561
73529,function,I-SIGN_AND_SYMPTOM,3561
73530,polydactyly,I-SIGN_AND_SYMPTOM,3561
73531,extra,I-SIGN_AND_SYMPTOM,3561
73532,digits,I-SIGN_AND_SYMPTOM,3561
73533,of,I-SIGN_AND_SYMPTOM,3561
73534,the,I-SIGN_AND_SYMPTOM,3561
73535,hands,I-SIGN_AND_SYMPTOM,3561
73536,or,I-SIGN_AND_SYMPTOM,3561
73537,feet,I-SIGN_AND_SYMPTOM,3561
73538,among,O,3561
73539,many,O,3561
73540,other,O,3562
73541,features,O,3562
73542,While,O,3562
73543,there,O,3562
73544,are,O,3562
73545,more,O,3562
73546,than,O,3562
73547,20,O,3562
73548,genes,B-CHEMICAL_COMPOUND,3562
73549,associated,O,3562
73550,with,O,3562
73551,BBS,B-NAME_OF_DISEASE,3562
73552,the,O,3562
73553,underlying,O,3562
73554,cause,O,3562
73555,regardless,O,3562
73556,of,O,3562
73557,gene,O,3562
73558,is,O,3563
73559,malfunction,B-CAUSE_OF_DISEASE,3563
73560,of,I-CAUSE_OF_DISEASE,3563
73561,primary,I-CAUSE_OF_DISEASE,3563
73562,cilia,I-CAUSE_OF_DISEASE,3563
73563,a,I-CAUSE_OF_DISEASE,3563
73564,key,I-CAUSE_OF_DISEASE,3563
73565,component,I-CAUSE_OF_DISEASE,3563
73566,of,I-CAUSE_OF_DISEASE,3563
73567,cellular,I-CAUSE_OF_DISEASE,3563
73568,communication,I-CAUSE_OF_DISEASE,3563
73569,BBS,B-NAME_OF_DISEASE,3563
73570,is,O,3563
73571,thus,O,3563
73572,categorized,O,3563
73573,as,O,3563
73574,a,O,3564
73575,ciliopathy,B-NAME_OF_DISEASE,3565
73576,or,O,3565
73577,a,O,3565
73578,disease,O,3565
73579,of,O,3565
73580,the,B-PART_OF_THE_EYES,3565
73581,cilia,I-PART_OF_THE_EYES,3565
73582,The,B-PART_OF_THE_EYES,3565
73583,retina,I-PART_OF_THE_EYES,3565
73584,is,O,3565
73585,a,O,3565
73586,multi-layered,O,3565
73587,sensory,O,3565
73588,tissue,O,3565
73589,that,O,3565
73590,lines,O,3565
73591,the,O,3565
73592,back,O,3565
73593,of,O,3565
73594,the,O,3566
73595,eye,O,3566
73596,Its,O,3566
73597,main,O,3566
73598,function,O,3566
73599,is,O,3566
73600,the,O,3566
73601,transduction,O,3566
73602,of,O,3566
73603,light,O,3566
73604,energy,O,3566
73605,into,O,3566
73606,an,O,3567
73607,electrical,O,3567
73608,potential,O,3567
73609,change,O,3567
73610,via,O,3567
73611,a,O,3567
73612,process,O,3567
73613,known,O,3567
73614,as,O,3567
73615,phototransduction,O,3567
73616,The,O,3567
73617,light-sensitive,O,3568
73618,elements,O,3568
73619,of,O,3568
73620,the,B-PART_OF_THE_EYES,3568
73621,retina,I-PART_OF_THE_EYES,3568
73622,are,O,3568
73623,the,B-PART_OF_THE_EYES,3568
73624,photoreceptor,I-PART_OF_THE_EYES,3568
73625,cells,I-PART_OF_THE_EYES,3568
73626,The,B-PART_OF_THE_EYES,3568
73627,retina,I-PART_OF_THE_EYES,3568
73628,contains,O,3568
73629,two,O,3569
73630,types,O,3569
73631,of,O,3569
73632,photoreceptors,B-PART_OF_THE_EYES,3569
73633,rods,B-PART_OF_THE_EYES,3569
73634,and,O,3569
73635,cones,B-PART_OF_THE_EYES,3569
73636,Rods,B-PART_OF_THE_EYES,3569
73637,approximately,O,3569
73638,120,O,3569
73639,million,O,3569
73640,in,O,3569
73641,the,O,3569
73642,human,O,3569
73643,eye,O,3569
73644,are,O,3570
73645,in,O,3570
73646,charge,O,3570
73647,of,O,3570
73648,night,O,3570
73649,vision,O,3570
73650,while,O,3570
73651,cones,B-PART_OF_THE_EYES,3570
73652,6,O,3570
73653,to,O,3570
73654,7,O,3570
73655,million,O,3570
73656,in,O,3571
73657,the,O,3571
73658,human,O,3571
73659,eye,O,3571
73660,are,O,3571
73661,in,O,3571
73662,charge,O,3571
73663,of,O,3571
73664,visual,O,3571
73665,acuity,O,3571
73666,and,O,3571
73667,color,O,3571
73668,vision,O,3571
73669,The,O,3571
73670,highest,O,3571
73671,cone,B-PART_OF_THE_EYES,3571
73672,concentration,O,3572
73673,is,O,3572
73674,found,O,3572
73675,in,O,3572
73676,the,O,3572
73677,central,O,3572
73678,region,O,3572
73679,of,O,3572
73680,the,B-PART_OF_THE_EYES,3572
73681,retina,I-PART_OF_THE_EYES,3572
73682,known,O,3572
73683,as,O,3572
73684,the,B-PART_OF_THE_EYES,3572
73685,macula,I-PART_OF_THE_EYES,3572
73686,Photoreceptors,B-PART_OF_THE_EYES,3572
73687,are,O,3572
73688,highly,O,3572
73689,compartmentalized,O,3572
73690,cells,O,3572
73691,with,O,3572
73692,the,O,3572
73693,nucleus,O,3573
73694,and,O,3573
73695,other,O,3573
73696,cellular,O,3573
73697,organs,O,3573
73698,located,O,3573
73699,in,O,3573
73700,the,O,3573
73701,inner,O,3573
73702,segment,O,3573
73703,IS,O,3573
73704,while,O,3573
73705,the,O,3573
73706,entire,O,3573
73707,phototransduction,O,3574
73708,machinery,O,3574
73709,is,O,3574
73710,included,O,3574
73711,in,O,3574
73712,the,O,3574
73713,outer,O,3574
73714,segment,O,3574
73715,OS,O,3574
73716,,O,3574
73717,Inherited,B-NAME_OF_DISEASE,3574
73718,retinal,I-NAME_OF_DISEASE,3574
73719,diseases,I-NAME_OF_DISEASE,3575
73720,IRDs,B-NAME_OF_DISEASE,3575
73721,which,O,3575
73722,are,O,3575
73723,among,O,3575
73724,the,O,3575
73725,most,O,3575
73726,common,O,3575
73727,genetic,O,3575
73728,diseases,O,3575
73729,in,O,3575
73730,humans,O,3575
73731,define,O,3575
73732,a,O,3575
73733,clinically,O,3575
73734,heterogeneous,O,3575
73735,group,O,3576
73736,of,O,3576
73737,disorders,O,3576
73738,which,O,3576
73739,cause,O,3576
73740,visual,B-SIGN_AND_SYMPTOM,3576
73741,loss,I-SIGN_AND_SYMPTOM,3576
73742,due,O,3576
73743,to,O,3576
73744,improper,O,3576
73745,development,O,3576
73746,dysfunction,O,3576
73747,or,O,3576
73748,premature,O,3576
73749,death,O,3576
73750,of,O,3576
73751,the,B-PART_OF_THE_EYES,3576
73752,retinal,I-PART_OF_THE_EYES,3576
73753,photoreceptors,I-PART_OF_THE_EYES,3576
73754,IRDs,B-NAME_OF_DISEASE,3576
73755,are,O,3576
73756,distinguished,O,3576
73757,by,O,3577
73758,several,O,3577
73759,factors,O,3577
73760,including,O,3577
73761,the,O,3577
73762,type,O,3577
73763,and,O,3577
73764,location,O,3577
73765,of,O,3577
73766,affected,O,3577
73767,cells,O,3577
73768,and,O,3577
73769,the,O,3577
73770,timing,O,3578
73771,of,O,3578
73772,disease,O,3578
73773,onset,O,3578
73774,Widefield,B-DIAGNOSTIC_TEST,3578
73775,fundus,I-DIAGNOSTIC_TEST,3578
73776,autofluorescence,I-DIAGNOSTIC_TEST,3578
73777,FAF,I-DIAGNOSTIC_TEST,3578
73778,can,O,3578
73779,be,O,3578
73780,very,O,3578
73781,useful,O,3578
73782,for,O,3578
73783,confirming,O,3578
73784,the,O,3578
73785,diagnoses,O,3578
73786,of,O,3578
73787,rare,O,3578
73788,disorders,O,3578
73789,Bardet-Biedl,B-NAME_OF_DISEASE,3578
73790,syndrome,I-NAME_OF_DISEASE,3578
73791,BBS,B-NAME_OF_DISEASE,3578
73792,is,O,3578
73793,a,O,3578
73794,disorder,O,3578
73795,in,O,3578
73796,which,O,3578
73797,the,O,3578
73798,affected,O,3578
73799,patients,O,3578
73800,can,O,3578
73801,be,O,3578
73802,obese,B-SIGN_AND_SYMPTOM,3578
73803,and,I-SIGN_AND_SYMPTOM,3578
73804,have,I-SIGN_AND_SYMPTOM,3578
73805,hypogonadotropic,I-SIGN_AND_SYMPTOM,3578
73806,hypogonadism,I-SIGN_AND_SYMPTOM,3578
73807,polydactylism,I-SIGN_AND_SYMPTOM,3578
73808,developmental,I-SIGN_AND_SYMPTOM,3578
73809,delay,I-SIGN_AND_SYMPTOM,3578
73810,genitourinary,I-SIGN_AND_SYMPTOM,3578
73811,abnormalities,I-SIGN_AND_SYMPTOM,3579
73812,renal,I-SIGN_AND_SYMPTOM,3579
73813,disease,I-SIGN_AND_SYMPTOM,3579
73814,and,I-SIGN_AND_SYMPTOM,3579
73815,retinal,I-SIGN_AND_SYMPTOM,3579
73816,degeneration,I-SIGN_AND_SYMPTOM,3579
73817,Kimberly,B-PERSON,3579
73818,Stepien,B-PERSON,3579
73819,MD,I-PERSON,3579
73820,associate,O,3579
73821,professor,O,3579
73822,of,O,3579
73823,ophthalmology,O,3579
73824,in,O,3579
73825,the,B-ORGANIZATION,3579
73826,Department,I-ORGANIZATION,3579
73827,of,I-ORGANIZATION,3579
73828,Ophthalmology,I-ORGANIZATION,3579
73829,and,I-ORGANIZATION,3579
73830,Visual,I-ORGANIZATION,3579
73831,Sciences,I-ORGANIZATION,3579
73832,at,I-ORGANIZATION,3579
73833,the,I-ORGANIZATION,3579
73834,University,I-ORGANIZATION,3580
73835,of,I-ORGANIZATION,3580
73836,Wisconsin-Madison,I-ORGANIZATION,3580
73837,explained,O,3580
73838,that,O,3580
73839,patients,O,3580
73840,with,O,3580
73841,BBS,B-NAME_OF_DISEASE,3580
73842,can,O,3580
73843,often,O,3580
73844,receive,O,3580
73845,a,O,3580
73846,misdiagnosis,O,3580
73847,of,O,3580
73848,a,O,3580
73849,nonsyndromic,O,3580
73850,disease,O,3580
73851,such,O,3580
73852,as,O,3580
73853,retinitis,B-NAME_OF_DISEASE,3580
73854,pigmentosa,I-NAME_OF_DISEASE,3581
73855,despite,O,3581
73856,having,O,3581
73857,potentially,O,3581
73858,life-threatening,O,3581
73859,syndromic,O,3581
73860,findings,O,3581
73861,These,O,3581
73862,misdiagnoses,O,3581
73863,can,O,3581
73864,result,O,3581
73865,in,O,3581
73866,delayed,O,3581
73867,screening,O,3581
73868,for,O,3581
73869,systemic,O,3581
73870,problems,O,3582
73871,The,B-PART_OF_THE_EYES,3583
73872,retinas,I-PART_OF_THE_EYES,3583
73873,in,O,3583
73874,patients,O,3583
73875,with,O,3583
73876,BBS,B-NAME_OF_DISEASE,3583
73877,can,O,3583
73878,have,O,3583
73879,findings,O,3583
73880,that,O,3583
73881,appear,O,3583
73882,similar,O,3583
73883,to,O,3583
73884,those,O,3583
73885,in,O,3583
73886,patients,O,3584
73887,with,O,3585
73888,retinitis,B-NAME_OF_DISEASE,3585
73889,pigmentosa,I-NAME_OF_DISEASE,3585
73890,such,O,3585
73891,as,O,3585
73892,classic,B-SIGN_AND_SYMPTOM,3585
73893,bone,I-SIGN_AND_SYMPTOM,3585
73894,spicules,I-SIGN_AND_SYMPTOM,3585
73895,However,O,3585
73896,more,O,3585
73897,subtle,O,3585
73898,retinal,O,3585
73899,degenerative,O,3585
73900,changes,O,3585
73901,can,O,3585
73902,be,O,3585
73903,missed,O,3585
73904,during,O,3585
73905,a,O,3585
73906,clinical,O,3586
73907,examination,O,3586
73908,Widefield,B-DIAGNOSTIC_TEST,3586
73909,FAF,B-DIAGNOSTIC_TEST,3586
73910,can,O,3586
73911,highlight,O,3586
73912,peripheral,B-NAME_OF_DISEASE,3586
73913,degeneration,I-NAME_OF_DISEASE,3586
73914,and,O,3586
73915,macular,B-NAME_OF_DISEASE,3586
73916,atrophy,I-NAME_OF_DISEASE,3586
73917,she,O,3586
73918,said,O,3587
73919,BBS,B-NAME_OF_DISEASE,3588
73920,study,O,3588
73921,Stepien,B-PERSON,3588
73922,and,O,3588
73923,colleagues,O,3588
73924,reviewed,O,3588
73925,the,O,3588
73926,charts,O,3588
73927,of,O,3588
73928,9,O,3588
73929,patients,O,3588
73930,aged,O,3588
73931,18,O,3588
73932,to,O,3588
73933,65,O,3588
73934,years,O,3588
73935,with,O,3588
73936,genetically,O,3588
73937,confirmed,O,3588
73938,BBS,B-NAME_OF_DISEASE,3588
73939,for,O,3588
73940,the,O,3588
73941,medical,O,3588
73942,and,O,3588
73943,ocular,O,3588
73944,histories,O,3588
73945,findings,O,3589
73946,from,O,3590
73947,the,O,3590
73948,clinical,O,3590
73949,examinations,O,3590
73950,and,O,3590
73951,ocular,O,3590
73952,imaging,O,3590
73953,including,O,3590
73954,widefield,B-DIAGNOSTIC_TEST,3590
73955,Optos,I-DIAGNOSTIC_TEST,3590
73956,color,I-DIAGNOSTIC_TEST,3590
73957,fundus,I-DIAGNOSTIC_TEST,3590
73958,photos,I-DIAGNOSTIC_TEST,3590
73959,FAF,B-DIAGNOSTIC_TEST,3590
73960,and,O,3590
73961,spectral,B-DIAGNOSTIC_TEST,3590
73962,domain,I-DIAGNOSTIC_TEST,3590
73963,optical,I-DIAGNOSTIC_TEST,3590
73964,coherence,I-DIAGNOSTIC_TEST,3590
73965,tomography,I-DIAGNOSTIC_TEST,3591
73966,The,O,3592
73967,investigation,O,3592
73968,found,O,3592
73969,that,O,3592
73970,before,O,3592
73971,BBS,B-NAME_OF_DISEASE,3592
73972,was,O,3592
73973,diagnosed,O,3592
73974,two-thirds,O,3592
73975,of,O,3592
73976,patients,O,3592
73977,6,O,3593
73978,of,O,3593
73979,9,O,3593
73980,received,O,3593
73981,a,O,3593
73982,diagnosis,O,3593
73983,of,O,3593
73984,a,B-NAME_OF_DISEASE,3593
73985,nonsyndromic,I-NAME_OF_DISEASE,3593
73986,inherited,I-NAME_OF_DISEASE,3593
73987,retinal,I-NAME_OF_DISEASE,3593
73988,disease,I-NAME_OF_DISEASE,3593
73989,despite,O,3593
73990,the,O,3593
73991,presence,O,3593
73992,of,O,3593
73993,systemic,O,3593
73994,abnormalities,O,3593
73995,and,O,3593
73996,or,O,3593
73997,family,O,3593
73998,histories,O,3593
73999,that,O,3593
74000,suggested,O,3593
74001,a,O,3593
74002,syndromic,O,3593
74003,disease,O,3593
74004,The,O,3593
74005,examination,O,3594
74006,of,O,3594
74007,the,O,3594
74008,6,O,3594
74009,patients,O,3594
74010,with,O,3594
74011,a,O,3594
74012,misdiagnoses,O,3594
74013,showed,O,3594
74014,only,O,3594
74015,subtle,O,3594
74016,peripheral,O,3594
74017,pigment,O,3594
74018,changes,O,3594
74019,Widefield,B-DIAGNOSTIC_TEST,3594
74020,FAF,B-DIAGNOSTIC_TEST,3594
74021,showed,O,3594
74022,varying,O,3595
74023,patterns,O,3595
74024,of,O,3595
74025,speckled,O,3595
74026,hypo-FAF,O,3595
74027,in,O,3595
74028,the,O,3595
74029,periphery,O,3595
74030,of,O,3595
74031,all,O,3595
74032,patients,O,3595
74033,with,O,3595
74034,BBS,B-NAME_OF_DISEASE,3595
74035,In,O,3595
74036,addition,O,3595
74037,macular,O,3595
74038,abnormalities,O,3595
74039,ie,O,3595
74040,macular,B-NAME_OF_DISEASE,3596
74041,atrophy,I-NAME_OF_DISEASE,3596
74042,and,O,3596
74043,bull,B-NAME_OF_DISEASE,3596
74044,s-eye,I-NAME_OF_DISEASE,3596
74045,maculopathy,I-NAME_OF_DISEASE,3596
74046,were,O,3596
74047,seen,O,3596
74048,in,O,3596
74049,all,O,3596
74050,patients,O,3596
74051,and,O,3596
74052,were,O,3597
74053,highlighted,O,3597
74054,by,O,3597
74055,variable,O,3597
74056,FAF,B-DIAGNOSTIC_TEST,3597
74057,changes,O,3597
74058,Stepien,B-PERSON,3597
74059,reported,O,3597
74060,The,O,3597
74061,investigators,O,3597
74062,concluded,O,3597
74063,Patients,O,3597
74064,with,O,3597
74065,BBS,B-NAME_OF_DISEASE,3597
74066,are,O,3597
74067,often,O,3597
74068,misdiagnosed,O,3597
74069,with,O,3597
74070,nonsyndromic,O,3598
74071,disease,O,3598
74072,despite,O,3598
74073,having,O,3598
74074,potentially,O,3598
74075,life-threatening,O,3598
74076,syndromic,O,3598
74077,findings,O,3598
74078,Along,O,3598
74079,with,O,3598
74080,detailed,O,3598
74081,medical,O,3598
74082,and,O,3598
74083,family,O,3598
74084,histories,O,3598
74085,specific,O,3598
74086,imaging,O,3598
74087,findings,O,3598
74088,on,O,3598
74089,widefield,B-DIAGNOSTIC_TEST,3598
74090,FAF,I-DIAGNOSTIC_TEST,3598
74091,can,O,3599
74092,aid,O,3599
74093,in,O,3599
74094,the,O,3599
74095,diagnosis,O,3599
74096,of,O,3599
74097,BBS,B-NAME_OF_DISEASE,3599
74098,in,O,3599
74099,adult,O,3599
74100,patients,O,3599
74101,with,O,3599
74102,suspected,O,3599
74103,inherited,B-NAME_OF_DISEASE,3599
74104,retinal,I-NAME_OF_DISEASE,3599
74105,diseases,I-NAME_OF_DISEASE,3599
74106,by,O,3599
74107,better,O,3599
74108,delineating,O,3599
74109,macular,B-NAME_OF_DISEASE,3599
74110,degeneration,I-NAME_OF_DISEASE,3599
74111,patterns,O,3599
74112,and,O,3599
74113,unearthing,O,3599
74114,extensive,O,3599
74115,peripheral,O,3599
74116,hypo-FAF,O,3599
74117,changes,O,3599
74118,when,O,3599
74119,clinical,O,3599
74120,examinations,O,3599
74121,findings,O,3599
74122,are,O,3599
74123,subtle,O,3600
74124,What,O,3600
74125,is,O,3600
74126,Endophthalmitis,B-NAME_OF_DISEASE,3600
74127,Endophthalmitis,B-NAME_OF_DISEASE,3600
74128,is,O,3600
74129,the,O,3600
74130,inflammation,O,3600
74131,of,O,3600
74132,the,O,3600
74133,internal,O,3600
74134,structures,O,3600
74135,of,O,3600
74136,the,O,3600
74137,eye,O,3600
74138,i.e,O,3600
74139,choroid,B-PART_OF_THE_EYES,3600
74140,retina,B-PART_OF_THE_EYES,3600
74141,and,O,3600
74142,vitreous,B-PART_OF_THE_EYES,3600
74143,which,O,3600
74144,most,O,3600
74145,commonly,O,3600
74146,occurs,O,3600
74147,as,O,3600
74148,an,O,3600
74149,acute,O,3600
74150,process,O,3600
74151,following,O,3600
74152,intraocular,O,3600
74153,surgery,O,3600
74154,The,O,3600
74155,term,O,3600
74156,endophthalmitis,B-NAME_OF_DISEASE,3600
74157,is,O,3601
74158,not,O,3601
74159,just,O,3601
74160,limited,O,3601
74161,to,O,3601
74162,post-operative,B-NAME_OF_DISEASE,3601
74163,endophthalmitis,I-NAME_OF_DISEASE,3601
74164,It,O,3601
74165,includes,O,3601
74166,endogenous,B-NAME_OF_DISEASE,3601
74167,and,I-NAME_OF_DISEASE,3601
74168,post-traumatic,I-NAME_OF_DISEASE,3601
74169,endophthalmitis,I-NAME_OF_DISEASE,3601
74170,as,O,3601
74171,well,O,3601
74172,Types,O,3601
74173,of,O,3602
74174,Endophthalmitis,B-NAME_OF_DISEASE,3602
74175,Endogenous,B-NAME_OF_DISEASE,3602
74176,endophthalmitis,I-NAME_OF_DISEASE,3602
74177,originates,O,3602
74178,from,O,3602
74179,sources,O,3602
74180,within,O,3602
74181,the,O,3602
74182,body,O,3602
74183,and,O,3602
74184,comprises,O,3602
74185,roughly,O,3602
74186,2-8%,O,3602
74187,of,O,3602
74188,endophthalmitis,B-NAME_OF_DISEASE,3602
74189,cases,O,3602
74190,Patients,O,3602
74191,frequently,O,3602
74192,have,O,3602
74193,an,O,3602
74194,underlying,O,3602
74195,disease,O,3602
74196,history,B-CAUSE_OF_DISEASE,3602
74197,of,I-CAUSE_OF_DISEASE,3602
74198,recent,I-CAUSE_OF_DISEASE,3602
74199,intravenous,I-CAUSE_OF_DISEASE,3603
74200,infusion,I-CAUSE_OF_DISEASE,3603
74201,Diabetes,B-CAUSE_OF_DISEASE,3603
74202,Mellitus,I-CAUSE_OF_DISEASE,3603
74203,HIV,B-CAUSE_OF_DISEASE,3603
74204,intravenous,B-CAUSE_OF_DISEASE,3603
74205,drug,I-CAUSE_OF_DISEASE,3603
74206,misuse,I-CAUSE_OF_DISEASE,3603
74207,renal,B-CAUSE_OF_DISEASE,3603
74208,failure,I-CAUSE_OF_DISEASE,3603
74209,on,I-CAUSE_OF_DISEASE,3603
74210,dialysis,I-CAUSE_OF_DISEASE,3603
74211,heart,B-CAUSE_OF_DISEASE,3603
74212,disease,I-CAUSE_OF_DISEASE,3604
74213,cancer,B-CAUSE_OF_DISEASE,3604
74214,use,B-CAUSE_OF_DISEASE,3604
74215,of,I-CAUSE_OF_DISEASE,3604
74216,immunosuppressive,I-CAUSE_OF_DISEASE,3604
74217,medication,I-CAUSE_OF_DISEASE,3604
74218,or,O,3604
74219,indwelling,B-CAUSE_OF_DISEASE,3604
74220,catheters,I-CAUSE_OF_DISEASE,3604
74221,Liver,B-CAUSE_OF_DISEASE,3604
74222,abscess,I-CAUSE_OF_DISEASE,3604
74223,is,O,3604
74224,the,O,3604
74225,most,O,3604
74226,common,O,3604
74227,extraocular,O,3604
74228,foci,O,3605
74229,of,O,3605
74230,infection,O,3605
74231,followed,O,3605
74232,by,O,3605
74233,pneumonia,B-CAUSE_OF_DISEASE,3605
74234,endocarditis,B-CAUSE_OF_DISEASE,3605
74235,and,O,3605
74236,soft,B-CAUSE_OF_DISEASE,3605
74237,tissue,I-CAUSE_OF_DISEASE,3605
74238,infection,I-CAUSE_OF_DISEASE,3605
74239,Post-operative,B-NAME_OF_DISEASE,3605
74240,endophthalmitis,I-NAME_OF_DISEASE,3605
74241,Following,O,3605
74242,cataract,B-CAUSE_OF_DISEASE,3606
74243,surgery,I-CAUSE_OF_DISEASE,3606
74244,the,O,3606
74245,incidence,O,3606
74246,rate,O,3606
74247,of,O,3606
74248,endophthalmitis,B-NAME_OF_DISEASE,3606
74249,is,O,3606
74250,1,O,3606
74251,in,O,3606
74252,1,O,3606
74253,0,O,3606
74254,0.1,O,3606
74255,,O,3606
74256,In,O,3606
74257,comparison,O,3606
74258,it,O,3606
74259,is,O,3606
74260,ten,O,3606
74261,times,O,3606
74262,greater,O,3606
74263,after,O,3606
74264,glaucoma,B-CAUSE_OF_DISEASE,3606
74265,surgery,I-CAUSE_OF_DISEASE,3606
74266,1%,O,3606
74267,and,O,3606
74268,100,O,3606
74269,times,O,3606
74270,higher,O,3606
74271,after,O,3606
74272,trauma,B-CAUSE_OF_DISEASE,3607
74273,5-10%,O,3607
74274,,O,3607
74275,After,O,3607
74276,cataract,B-CAUSE_OF_DISEASE,3607
74277,surgery,I-CAUSE_OF_DISEASE,3607
74278,post-operative,B-NAME_OF_DISEASE,3607
74279,endophthalmitis,I-NAME_OF_DISEASE,3607
74280,is,O,3607
74281,a,O,3607
74282,rare,O,3607
74283,but,O,3607
74284,potentially,O,3607
74285,blinding,O,3607
74286,complication,O,3607
74287,Endophthalmitis,B-NAME_OF_DISEASE,3607
74288,may,O,3608
74289,arise,O,3608
74290,a,O,3608
74291,few,O,3608
74292,days,O,3608
74293,about,O,3608
74294,7-Jan,O,3608
74295,following,O,3608
74296,cataract,B-CAUSE_OF_DISEASE,3608
74297,surgery,I-CAUSE_OF_DISEASE,3608
74298,It,O,3608
74299,can,O,3608
74300,swiftly,O,3609
74301,lead,O,3609
74302,to,O,3609
74303,blindness,B-NAME_OF_DISEASE,3609
74304,if,O,3609
74305,not,O,3609
74306,diagnosed,O,3609
74307,and,O,3609
74308,treated,O,3609
74309,immediately,O,3609
74310,Injections,B-TREATMENT,3609
74311,of,I-TREATMENT,3609
74312,intravitreal,I-TREATMENT,3609
74313,antibiotics,I-TREATMENT,3609
74314,and,I-TREATMENT,3609
74315,vitreous,I-TREATMENT,3609
74316,aspiration,I-TREATMENT,3609
74317,for,I-TREATMENT,3609
74318,culture,I-TREATMENT,3609
74319,and,I-TREATMENT,3609
74320,sensitivity,I-TREATMENT,3610
74321,can,O,3610
74322,treat,O,3610
74323,most,O,3610
74324,patients,O,3610
74325,Vitrectomy,B-TREATMENT,3610
74326,also,O,3610
74327,treats,O,3610
74328,extreme,O,3610
74329,situations,O,3610
74330,where,O,3611
74331,the,B-PART_OF_THE_EYES,3611
74332,retina,I-PART_OF_THE_EYES,3611
74333,can,O,3611
74334,still,O,3611
74335,be,O,3611
74336,viewed,O,3611
74337,Even,O,3611
74338,with,O,3611
74339,quick,O,3611
74340,identification,O,3611
74341,and,O,3611
74342,treatment,O,3612
74343,many,O,3612
74344,eyes,O,3612
74345,affected,O,3612
74346,by,O,3612
74347,particular,O,3612
74348,aggressive,O,3612
74349,pathogens,O,3612
74350,are,O,3612
74351,frequently,O,3612
74352,lost,O,3612
74353,Any,O,3612
74354,post-cataract,O,3612
74355,surgery,O,3612
74356,patient,O,3612
74357,experiencing,O,3612
74358,pain,B-SIGN_AND_SYMPTOM,3613
74359,impaired,I-SIGN_AND_SYMPTOM,3613
74360,vision,I-SIGN_AND_SYMPTOM,3613
74361,or,I-SIGN_AND_SYMPTOM,3613
74362,growing,I-SIGN_AND_SYMPTOM,3613
74363,inflammation,I-SIGN_AND_SYMPTOM,3613
74364,must,O,3614
74365,be,O,3614
74366,evaluated,O,3614
74367,quickly,O,3614
74368,to,O,3614
74369,establish,O,3614
74370,the,O,3614
74371,presence,O,3614
74372,of,O,3614
74373,endophthalmitis,B-NAME_OF_DISEASE,3614
74374,Post,B-NAME_OF_DISEASE,3614
74375,Traumatic,I-NAME_OF_DISEASE,3614
74376,endophthalmitis,I-NAME_OF_DISEASE,3614
74377,25%,O,3614
74378,of,O,3614
74379,all,O,3614
74380,instances,O,3614
74381,of,O,3614
74382,endophthalmitis,B-NAME_OF_DISEASE,3614
74383,are,O,3614
74384,found,O,3615
74385,in,O,3615
74386,this,O,3615
74387,group,O,3615
74388,Endophthalmitis,B-NAME_OF_DISEASE,3615
74389,has,O,3615
74390,a,O,3615
74391,7%,O,3615
74392,probability,O,3615
74393,of,O,3615
74394,occurring,O,3615
74395,after,O,3615
74396,a,B-CAUSE_OF_DISEASE,3615
74397,ruptured,I-CAUSE_OF_DISEASE,3615
74398,globe,I-CAUSE_OF_DISEASE,3615
74399,injury,I-CAUSE_OF_DISEASE,3615
74400,There,O,3615
74401,is,O,3615
74402,an,O,3615
74403,increase,O,3615
74404,in,O,3616
74405,the,O,3616
74406,incidence,O,3616
74407,of,O,3616
74408,injuries,O,3616
74409,such,O,3616
74410,as,O,3616
74411,intraocular,B-CAUSE_OF_DISEASE,3616
74412,foreign,I-CAUSE_OF_DISEASE,3617
74413,body,I-CAUSE_OF_DISEASE,3617
74414,IOFB,I-CAUSE_OF_DISEASE,3617
74415,,O,3617
74416,Other,O,3617
74417,risk,O,3617
74418,factors,O,3617
74419,include,O,3617
74420,a,B-CAUSE_OF_DISEASE,3617
74421,contaminated,I-CAUSE_OF_DISEASE,3617
74422,wound,I-CAUSE_OF_DISEASE,3617
74423,lens,B-CAUSE_OF_DISEASE,3617
74424,capsule,I-CAUSE_OF_DISEASE,3617
74425,rupture,I-CAUSE_OF_DISEASE,3618
74426,age,B-CAUSE_OF_DISEASE,3618
74427,50+,I-CAUSE_OF_DISEASE,3618
74428,or,O,3618
74429,presenting,B-CAUSE_OF_DISEASE,3618
74430,more,I-CAUSE_OF_DISEASE,3618
74431,than,I-CAUSE_OF_DISEASE,3618
74432,24,I-CAUSE_OF_DISEASE,3618
74433,hours,I-CAUSE_OF_DISEASE,3618
74434,after,I-CAUSE_OF_DISEASE,3618
74435,the,I-CAUSE_OF_DISEASE,3618
74436,initial,I-CAUSE_OF_DISEASE,3618
74437,injury,I-CAUSE_OF_DISEASE,3618
74438,Penetrating,O,3618
74439,trauma,B-CAUSE_OF_DISEASE,3618
74440,with,O,3618
74441,IOFB,O,3619
74442,frequently,O,3619
74443,causes,O,3619
74444,infections,O,3619
74445,caused,O,3619
74446,by,O,3619
74447,Bacillus,B-CAUSE_OF_DISEASE,3619
74448,and,I-CAUSE_OF_DISEASE,3619
74449,Staphylococcus,I-CAUSE_OF_DISEASE,3619
74450,species,I-CAUSE_OF_DISEASE,3619
74451,Clinical,O,3620
74452,Features,O,3620
74453,of,O,3620
74454,Endophthalmitis,B-NAME_OF_DISEASE,3620
74455,Pain,B-SIGN_AND_SYMPTOM,3620
74456,Decreased,B-SIGN_AND_SYMPTOM,3620
74457,VA,I-SIGN_AND_SYMPTOM,3620
74458,Lid,B-SIGN_AND_SYMPTOM,3620
74459,edema,I-SIGN_AND_SYMPTOM,3620
74460,and,I-SIGN_AND_SYMPTOM,3620
74461,chemosis,I-SIGN_AND_SYMPTOM,3620
74462,Corneal,B-SIGN_AND_SYMPTOM,3620
74463,haze,I-SIGN_AND_SYMPTOM,3621
74464,AC,B-SIGN_AND_SYMPTOM,3621
74465,activity,I-SIGN_AND_SYMPTOM,3621
74466,hypopyon,I-SIGN_AND_SYMPTOM,3621
74467,fibrin,I-SIGN_AND_SYMPTOM,3621
74468,Absent,B-SIGN_AND_SYMPTOM,3621
74469,red,I-SIGN_AND_SYMPTOM,3621
74470,reflex,I-SIGN_AND_SYMPTOM,3621
74471,Vitritis,B-SIGN_AND_SYMPTOM,3621
74472,Treatment,O,3621
74473,of,O,3621
74474,Endophthalmitis,B-NAME_OF_DISEASE,3621
74475,The,O,3621
74476,therapy,O,3621
74477,depends,O,3621
74478,on,O,3621
74479,the,O,3622
74480,isolation,O,3622
74481,of,O,3622
74482,the,O,3622
74483,organism,O,3622
74484,intensive,B-TREATMENT,3622
74485,medical,I-TREATMENT,3622
74486,care,I-TREATMENT,3622
74487,and,O,3622
74488,if,B-TREATMENT,3622
74489,necessary,I-TREATMENT,3622
74490,surgical,I-TREATMENT,3622
74491,intervention,I-TREATMENT,3622
74492,A,B-DIAGNOSTIC_TEST,3622
74493,B-scan,I-DIAGNOSTIC_TEST,3622
74494,Ultrasound,I-DIAGNOSTIC_TEST,3622
74495,scan,I-DIAGNOSTIC_TEST,3622
74496,to,O,3622
74497,show,O,3622
74498,the,O,3622
74499,intensity,O,3622
74500,of,O,3622
74501,vitritis,B-SIGN_AND_SYMPTOM,3622
74502,and,O,3622
74503,the,B-PART_OF_THE_EYES,3622
74504,retina,I-PART_OF_THE_EYES,3622
74505,s,O,3622
74506,status,O,3623
74507,should,O,3623
74508,be,O,3623
74509,done,O,3623
74510,before,O,3623
74511,deciding,O,3623
74512,on,O,3623
74513,further,O,3623
74514,intervention,O,3623
74515,The,O,3623
74516,first,O,3623
74517,step,O,3623
74518,in,O,3623
74519,treatment,O,3624
74520,is,O,3624
74521,to,O,3624
74522,do,B-TREATMENT,3624
74523,aqueous,I-TREATMENT,3624
74524,humor,I-TREATMENT,3624
74525,AC,I-TREATMENT,3624
74526,tap,I-TREATMENT,3624
74527,and,I-TREATMENT,3624
74528,vitreous,B-TREATMENT,3624
74529,biopsy,I-TREATMENT,3624
74530,while,I-TREATMENT,3624
74531,administering,I-TREATMENT,3624
74532,intravitreal,B-TREATMENT,3624
74533,antibiotics,I-TREATMENT,3625
74534,,O,3625
74535,When,O,3625
74536,taking,O,3625
74537,a,O,3625
74538,sample,O,3625
74539,of,O,3625
74540,the,O,3625
74541,vitreous,O,3625
74542,fluid,O,3625
74543,it,O,3625
74544,is,O,3625
74545,best,O,3625
74546,to,O,3625
74547,utilize,O,3625
74548,an,O,3626
74549,automated,O,3626
74550,vitrector,O,3626
74551,1,O,3626
74552,Admission,O,3626
74553,The,O,3626
74554,patient,O,3626
74555,must,O,3626
74556,be,O,3626
74557,admitted,O,3626
74558,to,O,3626
74559,the,O,3627
74560,infected,O,3627
74561,ward,O,3627
74562,as,O,3627
74563,part,O,3627
74564,of,O,3627
74565,the,O,3627
74566,treatment,O,3627
74567,2,O,3627
74568,Intravitreal,B-TREATMENT,3627
74569,antibiotics,I-TREATMENT,3627
74570,Under,O,3627
74571,sterile,O,3627
74572,conditions,O,3627
74573,vancomycin,B-NAME_OF_DRUG,3627
74574,Gram-positive,O,3627
74575,cover,O,3627
74576,coupled,O,3627
74577,with,O,3627
74578,either,O,3628
74579,ceftazidime,B-NAME_OF_DRUG,3628
74580,or,O,3628
74581,amikacin,B-NAME_OF_DRUG,3628
74582,Gram-negative,O,3628
74583,cover,O,3628
74584,can,O,3628
74585,be,O,3628
74586,given,O,3628
74587,Precipitation,O,3628
74588,of,O,3628
74589,ceftazidime,B-NAME_OF_DRUG,3628
74590,with,O,3628
74591,vancomycin,B-NAME_OF_DRUG,3629
74592,necessitates,O,3629
74593,the,O,3629
74594,use,O,3629
74595,of,O,3629
74596,a,O,3629
74597,separate,O,3629
74598,syringe,O,3629
74599,3,O,3629
74600,Vitrectomy,B-TREATMENT,3629
74601,Immediate,B-TREATMENT,3629
74602,vitrectomy,I-TREATMENT,3629
74603,is,O,3629
74604,only,O,3629
74605,beneficial,O,3629
74606,in,O,3629
74607,patients,O,3629
74608,with,O,3629
74609,a,O,3629
74610,perception,O,3630
74611,of,O,3630
74612,light,O,3630
74613,vision,O,3630
74614,or,O,3630
74615,worse-no,O,3630
74616,benefit,O,3630
74617,of,O,3630
74618,IV,B-NAME_OF_DRUG,3630
74619,antibiotics,I-NAME_OF_DRUG,3630
74620,as,O,3630
74621,per,O,3630
74622,the,O,3630
74623,Endophthalmitis,B-NAME_OF_DISEASE,3630
74624,vitrectomy,O,3630
74625,study,O,3630
74626,4,O,3631
74627,Topical,B-TREATMENT,3631
74628,antibiotics,I-TREATMENT,3631
74629,such,O,3631
74630,as,O,3631
74631,hourly,O,3631
74632,fortified,O,3631
74633,vancomycin,B-NAME_OF_DRUG,3631
74634,amikacin,B-NAME_OF_DRUG,3631
74635,or,O,3632
74636,ceftazidime,B-NAME_OF_DRUG,3632
74637,may,O,3632
74638,raise,O,3632
74639,intravitreal,O,3632
74640,medicines,O,3632
74641,concentration,O,3632
74642,in,O,3632
74643,the,O,3632
74644,anterior,O,3632
74645,segment,O,3632
74646,5,O,3632
74647,Corticosteroids,B-NAME_OF_DRUG,3632
74648,which,O,3632
74649,can,O,3632
74650,be,O,3632
74651,either,O,3632
74652,intravitreal,O,3632
74653,eye,O,3632
74654,drops,O,3632
74655,or,O,3632
74656,taken,O,3632
74657,orally,O,3632
74658,While,O,3632
74659,there,O,3632
74660,is,O,3632
74661,some,O,3632
74662,evidence,O,3632
74663,that,O,3633
74664,steroid,B-NAME_OF_DRUG,3633
74665,treatment,O,3633
74666,for,O,3633
74667,endophthalmitis,B-NAME_OF_DISEASE,3633
74668,can,O,3633
74669,reduce,O,3633
74670,inflammation,O,3633
74671,and,O,3633
74672,its,O,3633
74673,associated,O,3633
74674,complications,O,3633
74675,there,O,3633
74676,is,O,3633
74677,no,O,3633
74678,proof,O,3633
74679,that,O,3633
74680,this,O,3633
74681,treatment,O,3634
74682,will,O,3634
74683,enhance,O,3634
74684,visual,O,3634
74685,acuity,O,3634
74686,Failure,O,3634
74687,to,O,3634
74688,improve,O,3634
74689,beyond,O,3634
74690,24,O,3634
74691,hours,O,3635
74692,may,O,3635
74693,warrant,O,3635
74694,a,B-TREATMENT,3635
74695,second,I-TREATMENT,3635
74696,AC,I-TREATMENT,3635
74697,tap,I-TREATMENT,3635
74698,vitreous,B-TREATMENT,3635
74699,biopsy,I-TREATMENT,3635
74700,and,O,3635
74701,intravitreal,B-TREATMENT,3635
74702,antibiotics,I-TREATMENT,3635
74703,Prevention,O,3635
74704,of,O,3635
74705,Endophthalmitis,B-NAME_OF_DISEASE,3635
74706,When,O,3635
74707,care,O,3635
74708,is,O,3635
74709,taken,O,3636
74710,endophthalmitis,B-NAME_OF_DISEASE,3636
74711,can,O,3636
74712,be,O,3636
74713,avoided,O,3636
74714,just,O,3636
74715,like,O,3636
74716,any,O,3636
74717,other,O,3636
74718,soft,O,3636
74719,tissue,O,3636
74720,infection,O,3636
74721,Preventive,O,3636
74722,steps,O,3636
74723,should,O,3636
74724,be,O,3636
74725,taken,O,3636
74726,before,O,3636
74727,the,O,3637
74728,surgery,O,3637
74729,and,O,3637
74730,during,O,3637
74731,the,O,3637
74732,procedure,O,3637
74733,Preoperatively,O,3637
74734,Conjunctival,B-PREVENTION,3637
74735,sac,I-PREVENTION,3637
74736,irrigation,I-PREVENTION,3637
74737,with,I-PREVENTION,3637
74738,5%,I-PREVENTION,3637
74739,povidone-iodine,I-PREVENTION,3637
74740,Topical,B-PREVENTION,3637
74741,antibiotics,I-PREVENTION,3637
74742,Intraoperatively,O,3637
74743,The,O,3637
74744,use,O,3637
74745,of,O,3637
74746,intracameral,O,3637
74747,cefuroxime,O,3637
74748,1,O,3637
74749,mg,O,3637
74750,0,O,3637
74751,ml,O,3637
74752,linked,O,3637
74753,with,O,3637
74754,a,O,3637
74755,fivefold,O,3637
74756,reduction,O,3637
74757,in,O,3637
74758,endophthalmitis,B-NAME_OF_DISEASE,3638
74759,risk,O,3638
74760,Proper,B-PREVENTION,3638
74761,management,I-PREVENTION,3638
74762,of,I-PREVENTION,3638
74763,any,I-PREVENTION,3638
74764,complications,I-PREVENTION,3638
74765,Proper,O,3638
74766,closure,O,3638
74767,of,O,3638
74768,wound,O,3638
74769,s,O,3638
74770,using,O,3638
74771,10,O,3638
74772,nylon,O,3638
74773,Use,B-PREVENTION,3638
74774,of,I-PREVENTION,3638
74775,systemic,I-PREVENTION,3639
74776,prophylactic,I-PREVENTION,3639
74777,antibiotics,I-PREVENTION,3639
74778,Vitreous,B-PREVENTION,3639
74779,tap,I-PREVENTION,3639
74780,for,I-PREVENTION,3639
74781,organism,I-PREVENTION,3639
74782,isolation,I-PREVENTION,3639
74783,Conjunctivitis,B-NAME_OF_DISEASE,3639
74784,also,O,3639
74785,known,O,3639
74786,as,O,3639
74787,pink,B-NAME_OF_DISEASE,3639
74788,eye,I-NAME_OF_DISEASE,3639
74789,is,O,3639
74790,an,O,3640
74791,inflammation,O,3640
74792,observed,O,3640
74793,in,O,3640
74794,the,B-PART_OF_THE_EYES,3640
74795,conjunctiva,I-PART_OF_THE_EYES,3640
74796,which,O,3640
74797,is,O,3640
74798,the,O,3640
74799,clear,O,3640
74800,tissue,O,3640
74801,covering,O,3640
74802,the,O,3640
74803,white,O,3640
74804,part,O,3640
74805,of,O,3640
74806,the,O,3640
74807,eye,O,3640
74808,and,O,3640
74809,lines,O,3640
74810,the,O,3640
74811,inside,O,3640
74812,of,O,3640
74813,the,B-PART_OF_THE_EYES,3640
74814,eyelid,I-PART_OF_THE_EYES,3640
74815,What,O,3640
74816,is,O,3640
74817,allergic,B-NAME_OF_DISEASE,3640
74818,conjunctivitis,I-NAME_OF_DISEASE,3640
74819,Allergic,B-NAME_OF_DISEASE,3641
74820,conjunctivitis,I-NAME_OF_DISEASE,3641
74821,is,O,3641
74822,usually,O,3641
74823,seen,O,3641
74824,when,O,3641
74825,a,O,3641
74826,person,O,3641
74827,s,O,3641
74828,eyes,O,3641
74829,come,O,3641
74830,into,O,3642
74831,contact,O,3642
74832,with,O,3642
74833,allergens,B-CAUSE_OF_DISEASE,3642
74834,and,I-CAUSE_OF_DISEASE,3642
74835,irritants,I-CAUSE_OF_DISEASE,3642
74836,like,I-CAUSE_OF_DISEASE,3642
74837,pollen,I-CAUSE_OF_DISEASE,3642
74838,dust,I-CAUSE_OF_DISEASE,3642
74839,and,I-CAUSE_OF_DISEASE,3642
74840,mold,I-CAUSE_OF_DISEASE,3642
74841,that,O,3643
74842,make,O,3643
74843,the,O,3643
74844,body,O,3643
74845,s,O,3643
74846,immune,O,3643
74847,system,O,3643
74848,overreact,O,3643
74849,Allergic,B-NAME_OF_DISEASE,3643
74850,conjunctivitis,I-NAME_OF_DISEASE,3643
74851,can,O,3643
74852,be,O,3643
74853,observed,O,3643
74854,in,O,3643
74855,two,O,3643
74856,different,O,3643
74857,types,O,3643
74858,seasonal,B-NAME_OF_DISEASE,3643
74859,allergic,I-NAME_OF_DISEASE,3643
74860,conjunctivitis,I-NAME_OF_DISEASE,3643
74861,and,O,3643
74862,perennial,B-NAME_OF_DISEASE,3643
74863,allergic,I-NAME_OF_DISEASE,3643
74864,conjunctivitis,I-NAME_OF_DISEASE,3644
74865,Seasonal,B-NAME_OF_DISEASE,3644
74866,allergic,I-NAME_OF_DISEASE,3644
74867,conjunctivitis,I-NAME_OF_DISEASE,3644
74868,The,O,3644
74869,seasonal,O,3644
74870,form,O,3644
74871,is,O,3644
74872,generally,O,3644
74873,associated,O,3644
74874,with,O,3644
74875,seasonal,O,3644
74876,allergies,O,3644
74877,that,O,3644
74878,are,O,3644
74879,seen,O,3644
74880,in,O,3644
74881,spring,O,3644
74882,and,O,3644
74883,summer,O,3644
74884,and,O,3644
74885,sometimes,O,3644
74886,during,O,3644
74887,the,O,3644
74888,fall,O,3645
74889,as,O,3645
74890,well,O,3645
74891,Being,O,3645
74892,exposed,O,3645
74893,to,O,3645
74894,airborne,B-CAUSE_OF_DISEASE,3645
74895,allergens,I-CAUSE_OF_DISEASE,3645
74896,like,I-CAUSE_OF_DISEASE,3645
74897,pollen,I-CAUSE_OF_DISEASE,3645
74898,and,I-CAUSE_OF_DISEASE,3645
74899,grass,I-CAUSE_OF_DISEASE,3645
74900,triggers,O,3645
74901,seasonal,B-NAME_OF_DISEASE,3645
74902,allergic,I-NAME_OF_DISEASE,3645
74903,conjunctivitis,I-NAME_OF_DISEASE,3646
74904,Perennial,B-NAME_OF_DISEASE,3646
74905,allergic,I-NAME_OF_DISEASE,3646
74906,conjunctivitis,I-NAME_OF_DISEASE,3646
74907,The,O,3646
74908,perennial,O,3646
74909,form,O,3646
74910,on,O,3646
74911,the,O,3647
74912,other,O,3647
74913,hand,O,3647
74914,can,O,3647
74915,be,O,3647
74916,seen,O,3647
74917,all,O,3647
74918,year,O,3647
74919,round,O,3647
74920,It,O,3647
74921,s,O,3647
74922,mainly,O,3647
74923,triggered,O,3647
74924,by,O,3647
74925,indoor,B-CAUSE_OF_DISEASE,3647
74926,allergens,I-CAUSE_OF_DISEASE,3647
74927,like,I-CAUSE_OF_DISEASE,3647
74928,dust,I-CAUSE_OF_DISEASE,3647
74929,mold,I-CAUSE_OF_DISEASE,3647
74930,spores,I-CAUSE_OF_DISEASE,3647
74931,and,I-CAUSE_OF_DISEASE,3648
74932,animal,I-CAUSE_OF_DISEASE,3648
74933,dander,I-CAUSE_OF_DISEASE,3648
74934,What,O,3648
74935,does,O,3649
74936,pink,B-NAME_OF_DISEASE,3649
74937,eye,I-NAME_OF_DISEASE,3649
74938,look,O,3649
74939,like,O,3649
74940,When,O,3649
74941,pink,B-NAME_OF_DISEASE,3649
74942,eye,I-NAME_OF_DISEASE,3649
74943,occurs,O,3649
74944,the,B-SIGN_AND_SYMPTOM,3649
74945,white,I-SIGN_AND_SYMPTOM,3649
74946,part,I-SIGN_AND_SYMPTOM,3649
74947,of,I-SIGN_AND_SYMPTOM,3649
74948,the,I-SIGN_AND_SYMPTOM,3649
74949,eye,I-SIGN_AND_SYMPTOM,3649
74950,has,I-SIGN_AND_SYMPTOM,3649
74951,a,I-SIGN_AND_SYMPTOM,3649
74952,pinky,I-SIGN_AND_SYMPTOM,3649
74953,to,I-SIGN_AND_SYMPTOM,3649
74954,reddish,I-SIGN_AND_SYMPTOM,3649
74955,look,I-SIGN_AND_SYMPTOM,3649
74956,and,I-SIGN_AND_SYMPTOM,3649
74957,your,I-SIGN_AND_SYMPTOM,3649
74958,eyelids,I-SIGN_AND_SYMPTOM,3649
74959,are,I-SIGN_AND_SYMPTOM,3649
74960,usually,I-SIGN_AND_SYMPTOM,3649
74961,puffy,I-SIGN_AND_SYMPTOM,3649
74962,or,I-SIGN_AND_SYMPTOM,3649
74963,droopy,I-SIGN_AND_SYMPTOM,3649
74964,Some,O,3650
74965,patients,O,3650
74966,observe,O,3650
74967,fluid,B-SIGN_AND_SYMPTOM,3650
74968,discharge,I-SIGN_AND_SYMPTOM,3650
74969,coming,I-SIGN_AND_SYMPTOM,3650
74970,from,I-SIGN_AND_SYMPTOM,3650
74971,the,I-SIGN_AND_SYMPTOM,3650
74972,infected,I-SIGN_AND_SYMPTOM,3650
74973,eye,I-SIGN_AND_SYMPTOM,3650
74974,crusting,I-SIGN_AND_SYMPTOM,3650
74975,on,I-SIGN_AND_SYMPTOM,3651
74976,the,I-SIGN_AND_SYMPTOM,3651
74977,eyelashes,I-SIGN_AND_SYMPTOM,3651
74978,and,I-SIGN_AND_SYMPTOM,3651
74979,eyelids,I-SIGN_AND_SYMPTOM,3651
74980,What,O,3651
74981,causes,O,3651
74982,conjunctivitis,B-NAME_OF_DISEASE,3651
74983,When,O,3651
74984,the,O,3651
74985,blood,O,3651
74986,vessels,O,3651
74987,in,O,3652
74988,the,O,3652
74989,clear,O,3652
74990,tissue,O,3652
74991,ie,O,3652
74992,the,B-PART_OF_THE_EYES,3652
74993,conjunctiva,I-PART_OF_THE_EYES,3652
74994,get,O,3652
74995,inflamed,O,3652
74996,the,O,3652
74997,blood,O,3652
74998,vessel,O,3652
74999,become,O,3652
75000,more,O,3652
75001,visible,O,3652
75002,and,O,3653
75003,the,O,3653
75004,color,O,3653
75005,of,O,3653
75006,the,O,3653
75007,eye,O,3653
75008,becomes,O,3653
75009,reddish,B-SIGN_AND_SYMPTOM,3653
75010,or,I-SIGN_AND_SYMPTOM,3653
75011,pinky,I-SIGN_AND_SYMPTOM,3653
75012,Some,O,3653
75013,of,O,3653
75014,the,O,3653
75015,causes,O,3653
75016,of,O,3653
75017,pink,B-NAME_OF_DISEASE,3653
75018,eye,I-NAME_OF_DISEASE,3653
75019,are,O,3653
75020,listed,O,3654
75021,below,O,3654
75022,Viruses,B-CAUSE_OF_DISEASE,3654
75023,One,O,3654
75024,of,O,3654
75025,the,O,3654
75026,most,O,3654
75027,common,O,3654
75028,causes,O,3654
75029,of,O,3654
75030,pink,B-NAME_OF_DISEASE,3654
75031,eye,I-NAME_OF_DISEASE,3654
75032,is,O,3654
75033,viruses,B-CAUSE_OF_DISEASE,3654
75034,Adenoviruses,B-CAUSE_OF_DISEASE,3654
75035,Coronavirus,B-CAUSE_OF_DISEASE,3654
75036,which,O,3654
75037,is,O,3655
75038,also,O,3655
75039,known,O,3655
75040,as,O,3655
75041,COVID-19,B-NAME_OF_DISEASE,3655
75042,are,O,3655
75043,among,O,3655
75044,the,O,3655
75045,viruses,B-CAUSE_OF_DISEASE,3655
75046,that,O,3655
75047,cause,O,3655
75048,pink,B-NAME_OF_DISEASE,3655
75049,eye,I-NAME_OF_DISEASE,3655
75050,Bacteria,B-CAUSE_OF_DISEASE,3655
75051,Bacteria,B-CAUSE_OF_DISEASE,3656
75052,also,O,3656
75053,irritate,O,3656
75054,the,O,3656
75055,eye,O,3656
75056,The,O,3656
75057,most,O,3656
75058,common,O,3656
75059,types,O,3656
75060,of,O,3656
75061,bacteria,B-CAUSE_OF_DISEASE,3656
75062,that,O,3656
75063,cause,O,3656
75064,bacterial,B-NAME_OF_DISEASE,3656
75065,conjunctivitis,I-NAME_OF_DISEASE,3656
75066,include,O,3656
75067,Staphylococcus,B-CAUSE_OF_DISEASE,3656
75068,aureus,I-CAUSE_OF_DISEASE,3656
75069,Haemophilus,B-CAUSE_OF_DISEASE,3656
75070,influenzae,I-CAUSE_OF_DISEASE,3656
75071,Streptococcus,B-CAUSE_OF_DISEASE,3656
75072,pneumonia,I-CAUSE_OF_DISEASE,3656
75073,and,O,3657
75074,Pseudomonas,B-CAUSE_OF_DISEASE,3657
75075,aeruginosa,I-CAUSE_OF_DISEASE,3657
75076,Meanwhile,O,3657
75077,Chlamydia,B-CAUSE_OF_DISEASE,3657
75078,trachomatis,I-CAUSE_OF_DISEASE,3657
75079,and,O,3657
75080,Neisseria,B-CAUSE_OF_DISEASE,3657
75081,gonorrhoeae,I-CAUSE_OF_DISEASE,3657
75082,can,O,3657
75083,also,O,3657
75084,cause,O,3657
75085,pink,B-NAME_OF_DISEASE,3657
75086,eye,I-NAME_OF_DISEASE,3658
75087,but,O,3658
75088,they,O,3658
75089,re,O,3658
75090,not,O,3658
75091,as,O,3658
75092,common,O,3658
75093,as,O,3658
75094,the,O,3658
75095,others,O,3658
75096,Allergens,B-CAUSE_OF_DISEASE,3658
75097,Allergic,B-NAME_OF_DISEASE,3658
75098,conjunctivitis,I-NAME_OF_DISEASE,3658
75099,can,O,3658
75100,be,O,3658
75101,seasonal,O,3658
75102,or,O,3658
75103,perennial,O,3658
75104,Generally,O,3658
75105,they,O,3658
75106,re,O,3659
75107,caused,O,3659
75108,by,O,3659
75109,air-bone,O,3659
75110,allergens,O,3659
75111,like,O,3659
75112,pollens,O,3659
75113,grass,O,3659
75114,dust,O,3659
75115,mite,O,3659
75116,etc,O,3660
75117,Irritating,B-CAUSE_OF_DISEASE,3660
75118,substances,I-CAUSE_OF_DISEASE,3660
75119,Cosmetics,I-CAUSE_OF_DISEASE,3660
75120,products,I-CAUSE_OF_DISEASE,3660
75121,shampoo,I-CAUSE_OF_DISEASE,3660
75122,contact,I-CAUSE_OF_DISEASE,3660
75123,lenses,I-CAUSE_OF_DISEASE,3660
75124,dirt,I-CAUSE_OF_DISEASE,3660
75125,smoke,I-CAUSE_OF_DISEASE,3660
75126,and,I-CAUSE_OF_DISEASE,3660
75127,pool,I-CAUSE_OF_DISEASE,3660
75128,chlorine,I-CAUSE_OF_DISEASE,3660
75129,may,O,3660
75130,cause,O,3661
75131,pink,B-NAME_OF_DISEASE,3661
75132,eye,I-NAME_OF_DISEASE,3661
75133,A,B-CAUSE_OF_DISEASE,3661
75134,foreign,I-CAUSE_OF_DISEASE,3661
75135,object,I-CAUSE_OF_DISEASE,3661
75136,in,I-CAUSE_OF_DISEASE,3661
75137,the,I-CAUSE_OF_DISEASE,3661
75138,eye,I-CAUSE_OF_DISEASE,3661
75139,may,O,3661
75140,cause,O,3661
75141,pink,B-NAME_OF_DISEASE,3661
75142,eye,I-NAME_OF_DISEASE,3661
75143,In,O,3661
75144,babies,O,3661
75145,blocked,B-CAUSE_OF_DISEASE,3661
75146,or,I-CAUSE_OF_DISEASE,3661
75147,incompletely,I-CAUSE_OF_DISEASE,3661
75148,opened,I-CAUSE_OF_DISEASE,3661
75149,tear,I-CAUSE_OF_DISEASE,3661
75150,ducts,I-CAUSE_OF_DISEASE,3661
75151,can,O,3661
75152,cause,O,3661
75153,pink,B-NAME_OF_DISEASE,3661
75154,eye,I-NAME_OF_DISEASE,3661
75155,Autoimmune,B-CAUSE_OF_DISEASE,3661
75156,diseases,I-CAUSE_OF_DISEASE,3661
75157,that,I-CAUSE_OF_DISEASE,3661
75158,cause,I-CAUSE_OF_DISEASE,3661
75159,the,I-CAUSE_OF_DISEASE,3661
75160,immune,I-CAUSE_OF_DISEASE,3661
75161,system,I-CAUSE_OF_DISEASE,3661
75162,to,I-CAUSE_OF_DISEASE,3661
75163,overreact,I-CAUSE_OF_DISEASE,3661
75164,are,O,3661
75165,a,O,3661
75166,rare,O,3661
75167,cause,O,3661
75168,of,O,3661
75169,pink,B-NAME_OF_DISEASE,3661
75170,eye,I-NAME_OF_DISEASE,3661
75171,How,O,3661
75172,long,O,3661
75173,does,O,3661
75174,conjunctivitis,B-NAME_OF_DISEASE,3661
75175,take,O,3661
75176,to,O,3661
75177,recover,O,3661
75178,How,O,3661
75179,long,O,3661
75180,the,O,3661
75181,condition,O,3661
75182,lasts,O,3661
75183,depends,O,3661
75184,on,O,3661
75185,what,O,3662
75186,type,O,3662
75187,of,O,3662
75188,conjunctivitis,B-NAME_OF_DISEASE,3662
75189,pink,B-NAME_OF_DISEASE,3662
75190,eye,I-NAME_OF_DISEASE,3662
75191,you,O,3662
75192,have,O,3662
75193,and,O,3662
75194,how,O,3662
75195,you,O,3662
75196,treat,O,3662
75197,it,O,3662
75198,Generally,O,3662
75199,the,B-NAME_OF_DISEASE,3662
75200,pink,I-NAME_OF_DISEASE,3662
75201,eye,I-NAME_OF_DISEASE,3662
75202,should,O,3662
75203,recover,O,3662
75204,within,B-TIME_DURATION,3662
75205,a,I-TIME_DURATION,3662
75206,few,I-TIME_DURATION,3662
75207,days,I-TIME_DURATION,3662
75208,to,I-TIME_DURATION,3662
75209,two,I-TIME_DURATION,3662
75210,weeks,I-TIME_DURATION,3662
75211,As,O,3662
75212,mentioned,O,3662
75213,earlier,O,3662
75214,there,O,3662
75215,are,O,3662
75216,several,O,3662
75217,types,O,3662
75218,of,O,3662
75219,conjunctivitis,B-NAME_OF_DISEASE,3662
75220,which,O,3662
75221,are,O,3662
75222,viral,O,3662
75223,and,O,3663
75224,bacterial,O,3663
75225,If,O,3663
75226,you,O,3663
75227,are,O,3663
75228,experiencing,O,3663
75229,viral,B-NAME_OF_DISEASE,3663
75230,pink,I-NAME_OF_DISEASE,3663
75231,eye,I-NAME_OF_DISEASE,3663
75232,it,O,3663
75233,s,O,3663
75234,caused,O,3663
75235,by,O,3663
75236,the,B-CAUSE_OF_DISEASE,3663
75237,viruses,I-CAUSE_OF_DISEASE,3663
75238,mentioned,O,3663
75239,above,O,3663
75240,The,O,3663
75241,recovery,O,3663
75242,without,O,3663
75243,treatment,O,3663
75244,is,O,3663
75245,in,B-TIME_DURATION,3663
75246,about,I-TIME_DURATION,3663
75247,7,I-TIME_DURATION,3663
75248,to,I-TIME_DURATION,3663
75249,14,I-TIME_DURATION,3663
75250,days,I-TIME_DURATION,3663
75251,Bacterial,B-NAME_OF_DISEASE,3663
75252,pink,I-NAME_OF_DISEASE,3663
75253,eye,I-NAME_OF_DISEASE,3663
75254,on,O,3663
75255,the,O,3664
75256,other,O,3664
75257,hand,O,3664
75258,is,O,3664
75259,caused,O,3664
75260,by,O,3664
75261,an,B-CAUSE_OF_DISEASE,3664
75262,infection,I-CAUSE_OF_DISEASE,3664
75263,with,I-CAUSE_OF_DISEASE,3664
75264,bacteria,I-CAUSE_OF_DISEASE,3664
75265,like,O,3664
75266,the,O,3664
75267,ones,O,3664
75268,mentioned,O,3664
75269,above,O,3664
75270,The,O,3664
75271,condition,O,3664
75272,starts,O,3664
75273,to,O,3664
75274,improve,O,3664
75275,within,B-TIME_DURATION,3664
75276,24,I-TIME_DURATION,3664
75277,hours,I-TIME_DURATION,3664
75278,when,O,3664
75279,antibiotic,B-TREATMENT,3665
75280,treatment,I-TREATMENT,3666
75281,is,O,3666
75282,followed,O,3666
75283,Even,O,3666
75284,when,O,3666
75285,the,O,3666
75286,patient,O,3666
75287,doesn,O,3666
75288,t,O,3666
75289,use,O,3666
75290,antibiotics,B-TREATMENT,3666
75291,mild,O,3666
75292,pink,B-NAME_OF_DISEASE,3666
75293,eye,I-NAME_OF_DISEASE,3666
75294,generally,O,3666
75295,improves,O,3666
75296,within,B-TIME_DURATION,3667
75297,a,I-TIME_DURATION,3667
75298,span,I-TIME_DURATION,3667
75299,of,I-TIME_DURATION,3667
75300,ten,I-TIME_DURATION,3667
75301,days,I-TIME_DURATION,3667
75302,This,O,3667
75303,eye,O,3667
75304,condition,O,3667
75305,is,O,3667
75306,usually,O,3667
75307,contagious,O,3667
75308,once,O,3668
75309,you,O,3668
75310,have,O,3668
75311,the,O,3668
75312,symptoms,O,3668
75313,like,O,3668
75314,redness,B-SIGN_AND_SYMPTOM,3668
75315,tearing,I-SIGN_AND_SYMPTOM,3669
75316,and,I-SIGN_AND_SYMPTOM,3669
75317,crusting,I-SIGN_AND_SYMPTOM,3669
75318,The,O,3669
75319,symptoms,O,3669
75320,however,O,3669
75321,improve,O,3669
75322,in,B-TIME_DURATION,3669
75323,4,I-TIME_DURATION,3669
75324,to,I-TIME_DURATION,3669
75325,7,I-TIME_DURATION,3669
75326,days,I-TIME_DURATION,3669
75327,How,O,3669
75328,to,O,3669
75329,treat,O,3670
75330,conjunctivitis,B-NAME_OF_DISEASE,3670
75331,There,O,3670
75332,are,O,3670
75333,times,O,3670
75334,when,O,3670
75335,the,B-NAME_OF_DISEASE,3670
75336,pink,I-NAME_OF_DISEASE,3671
75337,eye,I-NAME_OF_DISEASE,3672
75338,is,O,3672
75339,mild,O,3672
75340,but,O,3672
75341,there,O,3672
75342,are,O,3672
75343,also,O,3672
75344,times,O,3672
75345,when,O,3672
75346,it,O,3672
75347,s,O,3672
75348,important,O,3672
75349,to,O,3672
75350,seek,O,3673
75351,medical,O,3673
75352,care,O,3673
75353,for,O,3673
75354,it,O,3673
75355,Cold,B-TREATMENT,3673
75356,compresses,I-TREATMENT,3673
75357,and,O,3673
75358,artificial,B-TREATMENT,3674
75359,tears,I-TREATMENT,3674
75360,can,O,3674
75361,be,O,3674
75362,used,O,3674
75363,to,O,3674
75364,relieve,O,3674
75365,the,B-SIGN_AND_SYMPTOM,3674
75366,inflammation,I-SIGN_AND_SYMPTOM,3674
75367,and,I-SIGN_AND_SYMPTOM,3674
75368,the,I-SIGN_AND_SYMPTOM,3674
75369,dryness,I-SIGN_AND_SYMPTOM,3674
75370,caused,O,3675
75371,by,O,3675
75372,conjunctivitis,B-NAME_OF_DISEASE,3675
75373,You,O,3675
75374,don,O,3675
75375,t,O,3675
75376,need,O,3675
75377,to,O,3675
75378,be,O,3675
75379,prescribed,O,3676
75380,to,O,3676
75381,get,O,3676
75382,them,O,3676
75383,Make,O,3676
75384,sure,O,3676
75385,to,O,3676
75386,refrain,B-TREATMENT,3676
75387,from,I-TREATMENT,3676
75388,using,I-TREATMENT,3677
75389,contact,I-TREATMENT,3678
75390,lenses,I-TREATMENT,3678
75391,until,I-TREATMENT,3678
75392,your,I-TREATMENT,3678
75393,doctor,I-TREATMENT,3678
75394,says,I-TREATMENT,3678
75395,you,I-TREATMENT,3678
75396,can,I-TREATMENT,3678
75397,start,I-TREATMENT,3678
75398,wearing,I-TREATMENT,3678
75399,them,I-TREATMENT,3678
75400,again,I-TREATMENT,3678
75401,If,O,3678
75402,you,O,3678
75403,didn,O,3678
75404,t,O,3678
75405,seek,O,3678
75406,medical,O,3679
75407,help,O,3679
75408,make,O,3679
75409,sure,O,3679
75410,your,O,3679
75411,symptoms,O,3679
75412,improve,O,3679
75413,before,O,3679
75414,you,O,3679
75415,start,O,3679
75416,wearing,O,3679
75417,them,O,3679
75418,again,O,3679
75419,How,O,3680
75420,do,O,3680
75421,you,O,3680
75422,stop,O,3680
75423,conjunctivitis,B-NAME_OF_DISEASE,3680
75424,from,O,3680
75425,spreading,O,3680
75426,If,O,3680
75427,you,O,3680
75428,are,O,3680
75429,around,O,3681
75430,someone,O,3681
75431,who,O,3681
75432,suffers,O,3681
75433,from,O,3681
75434,pink,B-NAME_OF_DISEASE,3681
75435,eye,I-NAME_OF_DISEASE,3681
75436,You,O,3681
75437,can,O,3681
75438,reduce,O,3681
75439,the,O,3681
75440,risk,O,3681
75441,of,O,3682
75442,getting,O,3682
75443,infected,O,3682
75444,by,O,3682
75445,following,O,3682
75446,the,O,3682
75447,steps,O,3682
75448,mentioned,O,3682
75449,below,O,3682
75450,Make,O,3683
75451,sure,O,3683
75452,to,O,3683
75453,wash,B-PREVENTION,3683
75454,your,I-PREVENTION,3683
75455,hands,I-PREVENTION,3683
75456,often,I-PREVENTION,3683
75457,with,I-PREVENTION,3683
75458,soap,I-PREVENTION,3683
75459,and,I-PREVENTION,3683
75460,warm,I-PREVENTION,3683
75461,water,I-PREVENTION,3683
75462,for,I-PREVENTION,3683
75463,at,I-PREVENTION,3683
75464,least,I-PREVENTION,3683
75465,25,I-PREVENTION,3683
75466,seconds,I-PREVENTION,3683
75467,If,O,3683
75468,they,O,3683
75469,are,O,3683
75470,not,O,3683
75471,available,O,3683
75472,you,O,3683
75473,can,O,3683
75474,use,B-PREVENTION,3683
75475,alcohol-based,I-PREVENTION,3683
75476,hand,I-PREVENTION,3683
75477,sanitizer,I-PREVENTION,3683
75478,to,I-PREVENTION,3683
75479,clean,I-PREVENTION,3683
75480,your,I-PREVENTION,3683
75481,hands,I-PREVENTION,3683
75482,Wash,B-PREVENTION,3684
75483,your,I-PREVENTION,3684
75484,hands,I-PREVENTION,3684
75485,when,I-PREVENTION,3684
75486,you,I-PREVENTION,3684
75487,happen,I-PREVENTION,3684
75488,to,I-PREVENTION,3684
75489,touch,I-PREVENTION,3684
75490,use,I-PREVENTION,3684
75491,the,I-PREVENTION,3684
75492,item,I-PREVENTION,3684
75493,that,I-PREVENTION,3684
75494,belongs,I-PREVENTION,3685
75495,to,I-PREVENTION,3685
75496,the,I-PREVENTION,3685
75497,infected,I-PREVENTION,3685
75498,person,I-PREVENTION,3685
75499,for,O,3685
75500,example,O,3685
75501,if,O,3685
75502,you,O,3685
75503,are,O,3685
75504,in,O,3685
75505,the,O,3685
75506,same,O,3685
75507,Office,O,3685
75508,exchanging,O,3685
75509,stationery,O,3686
75510,etc,O,3686
75511,after,O,3686
75512,helping,O,3686
75513,an,O,3686
75514,infected,O,3686
75515,person,O,3686
75516,with,O,3686
75517,applying,B-PREVENTION,3686
75518,eye,I-PREVENTION,3686
75519,drops,I-PREVENTION,3686
75520,or,I-PREVENTION,3686
75521,ointment,I-PREVENTION,3686
75522,Avoid,B-PREVENTION,3686
75523,touching,I-PREVENTION,3686
75524,your,I-PREVENTION,3686
75525,eyes,I-PREVENTION,3686
75526,if,I-PREVENTION,3686
75527,you,I-PREVENTION,3686
75528,didn,I-PREVENTION,3686
75529,t,I-PREVENTION,3686
75530,wash,I-PREVENTION,3686
75531,your,I-PREVENTION,3686
75532,hands,I-PREVENTION,3686
75533,Try,B-PREVENTION,3686
75534,not,I-PREVENTION,3686
75535,to,I-PREVENTION,3687
75536,share,I-PREVENTION,3687
75537,items,I-PREVENTION,3687
75538,used,I-PREVENTION,3687
75539,by,I-PREVENTION,3687
75540,the,I-PREVENTION,3687
75541,infected,I-PREVENTION,3687
75542,person,I-PREVENTION,3687
75543,like,I-PREVENTION,3687
75544,pillows,I-PREVENTION,3687
75545,towels,I-PREVENTION,3687
75546,eye,I-PREVENTION,3688
75547,drops,I-PREVENTION,3688
75548,cosmetics-,I-PREVENTION,3688
75549,especially,I-PREVENTION,3688
75550,makeup,I-PREVENTION,3688
75551,products-,I-PREVENTION,3688
75552,eyeglasses,I-PREVENTION,3688
75553,and,I-PREVENTION,3688
75554,contact,I-PREVENTION,3688
75555,lenses,I-PREVENTION,3688
75556,If,O,3688
75557,you,O,3688
75558,were,O,3688
75559,infected,O,3688
75560,and,O,3689
75561,trying,O,3689
75562,to,O,3689
75563,avoid,O,3689
75564,having,O,3689
75565,it,O,3689
75566,again,O,3689
75567,There,O,3689
75568,are,O,3689
75569,some,O,3689
75570,steps,O,3689
75571,you,O,3689
75572,can,O,3689
75573,take,O,3689
75574,to,O,3689
75575,avoid,O,3690
75576,having,O,3690
75577,the,O,3690
75578,infection,O,3690
75579,again,O,3690
75580,If,O,3690
75581,possible,O,3690
75582,get,B-PREVENTION,3690
75583,rid,I-PREVENTION,3690
75584,of,I-PREVENTION,3690
75585,the,I-PREVENTION,3690
75586,makeup,I-PREVENTION,3690
75587,or,I-PREVENTION,3690
75588,brushes,I-PREVENTION,3690
75589,you,I-PREVENTION,3690
75590,used,I-PREVENTION,3690
75591,when,I-PREVENTION,3690
75592,you,I-PREVENTION,3691
75593,were,I-PREVENTION,3691
75594,infected,I-PREVENTION,3691
75595,If,O,3691
75596,not,O,3691
75597,make,O,3691
75598,sure,O,3691
75599,to,O,3691
75600,sanitize,O,3691
75601,them,O,3691
75602,properly,O,3691
75603,Make,B-PREVENTION,3691
75604,sure,I-PREVENTION,3692
75605,to,I-PREVENTION,3692
75606,throw,I-PREVENTION,3692
75607,away,I-PREVENTION,3692
75608,the,I-PREVENTION,3692
75609,disposable,I-PREVENTION,3692
75610,contact,I-PREVENTION,3692
75611,lenses,I-PREVENTION,3692
75612,and,I-PREVENTION,3692
75613,cases,I-PREVENTION,3692
75614,even,O,3692
75615,the,O,3692
75616,solutions,O,3692
75617,you,O,3692
75618,used,O,3692
75619,while,O,3692
75620,you,O,3692
75621,were,O,3692
75622,infected,O,3693
75623,Clean,B-PREVENTION,3693
75624,your,I-PREVENTION,3693
75625,eyeglasses,I-PREVENTION,3693
75626,properly,I-PREVENTION,3693
75627,Does,O,3693
75628,conjunctivitis,B-NAME_OF_DISEASE,3693
75629,get,O,3693
75630,worse,O,3693
75631,before,O,3694
75632,it,O,3694
75633,gets,O,3694
75634,better,O,3694
75635,The,O,3694
75636,symptoms,O,3694
75637,of,O,3694
75638,viral,B-NAME_OF_DISEASE,3694
75639,conjunctivitis,I-NAME_OF_DISEASE,3695
75640,pink,B-NAME_OF_DISEASE,3695
75641,eye,I-NAME_OF_DISEASE,3695
75642,usually,O,3695
75643,get,O,3695
75644,worse,O,3695
75645,on,O,3695
75646,the,O,3695
75647,second,O,3695
75648,or,O,3695
75649,third,O,3695
75650,day,O,3695
75651,before,O,3695
75652,they,O,3696
75653,start,O,3696
75654,to,O,3696
75655,improve,O,3696
75656,Unlike,O,3696
75657,bacterial,B-NAME_OF_DISEASE,3696
75658,conjunctivitis,I-NAME_OF_DISEASE,3696
75659,viral,B-NAME_OF_DISEASE,3696
75660,conjunctivitis,I-NAME_OF_DISEASE,3696
75661,tends,O,3696
75662,to,O,3696
75663,spread,O,3696
75664,to,O,3696
75665,both,O,3696
75666,eyes,O,3696
75667,The,O,3696
75668,symptoms,O,3696
75669,of,O,3696
75670,bacterial,B-NAME_OF_DISEASE,3696
75671,conjunctivitis,I-NAME_OF_DISEASE,3696
75672,may,O,3696
75673,worsen,O,3696
75674,before,O,3697
75675,you,O,3698
75676,start,O,3698
75677,antibiotics,B-TREATMENT,3698
75678,treatment,I-TREATMENT,3698
75679,Once,O,3698
75680,you,O,3698
75681,start,O,3698
75682,the,O,3698
75683,proper,O,3698
75684,treatment,O,3698
75685,the,O,3698
75686,symptoms,O,3698
75687,usually,O,3699
75688,clear,O,3699
75689,up,O,3699
75690,within,B-TIME_DURATION,3699
75691,a,I-TIME_DURATION,3699
75692,few,I-TIME_DURATION,3699
75693,days,I-TIME_DURATION,3699
75694,If,O,3699
75695,your,O,3699
75696,conjunctivitis,B-NAME_OF_DISEASE,3699
75697,symptoms,O,3699
75698,only,O,3699
75699,get,O,3699
75700,worse,O,3699
75701,make,O,3699
75702,sure,O,3699
75703,to,O,3699
75704,seek,B-TREATMENT,3700
75705,medical,I-TREATMENT,3700
75706,help,I-TREATMENT,3700
75707,before,O,3700
75708,starting,O,3700
75709,to,O,3700
75710,use,O,3700
75711,antibiotics,O,3700
75712,It,O,3700
75713,s,O,3700
75714,crucial,O,3700
75715,to,O,3700
75716,see,O,3700
75717,a,O,3700
75718,doctor,O,3700
75719,again,O,3700
75720,to,O,3700
75721,check,O,3700
75722,if,O,3700
75723,you,O,3700
75724,have,O,3700
75725,other,O,3700
75726,types,O,3700
75727,of,O,3700
75728,infection,O,3701
75729,How,O,3701
75730,do,O,3701
75731,you,O,3701
75732,clean,O,3701
75733,conjunctivitis,B-NAME_OF_DISEASE,3701
75734,eyes,O,3701
75735,Boil,B-TREATMENT,3701
75736,some,I-TREATMENT,3701
75737,water,I-TREATMENT,3701
75738,and,I-TREATMENT,3701
75739,let,I-TREATMENT,3701
75740,it,I-TREATMENT,3701
75741,cool,I-TREATMENT,3701
75742,down,I-TREATMENT,3702
75743,Wet,B-TREATMENT,3702
75744,your,I-TREATMENT,3702
75745,clean,I-TREATMENT,3702
75746,cotton,I-TREATMENT,3702
75747,wool,I-TREATMENT,3702
75748,pads,I-TREATMENT,3702
75749,in,I-TREATMENT,3702
75750,the,I-TREATMENT,3702
75751,water,I-TREATMENT,3702
75752,and,I-TREATMENT,3702
75753,gently,I-TREATMENT,3702
75754,wipe,I-TREATMENT,3702
75755,your,I-TREATMENT,3702
75756,eyelashes,I-TREATMENT,3702
75757,to,I-TREATMENT,3702
75758,clean,I-TREATMENT,3702
75759,the,I-TREATMENT,3702
75760,crusts,I-TREATMENT,3702
75761,on,I-TREATMENT,3702
75762,your,I-TREATMENT,3702
75763,lash,I-TREATMENT,3702
75764,line,I-TREATMENT,3702
75765,Make,B-TREATMENT,3702
75766,sure,I-TREATMENT,3702
75767,to,I-TREATMENT,3702
75768,hold,I-TREATMENT,3702
75769,a,I-TREATMENT,3702
75770,cold,I-TREATMENT,3702
75771,flannel,I-TREATMENT,3702
75772,on,I-TREATMENT,3702
75773,your,I-TREATMENT,3702
75774,eyes,I-TREATMENT,3702
75775,to,I-TREATMENT,3702
75776,relieve,I-TREATMENT,3702
75777,them,I-TREATMENT,3702
75778,Eye,B-NAME_OF_DISEASE,3702
75779,allergies,I-NAME_OF_DISEASE,3702
75780,are,O,3702
75781,the,B-SIGN_AND_SYMPTOM,3702
75782,irritation,I-SIGN_AND_SYMPTOM,3702
75783,of,I-SIGN_AND_SYMPTOM,3702
75784,the,I-SIGN_AND_SYMPTOM,3702
75785,eyes,I-SIGN_AND_SYMPTOM,3702
75786,with,O,3702
75787,allergic,B-CAUSE_OF_DISEASE,3702
75788,factors,I-CAUSE_OF_DISEASE,3702
75789,from,I-CAUSE_OF_DISEASE,3702
75790,the,I-CAUSE_OF_DISEASE,3703
75791,outside,I-CAUSE_OF_DISEASE,3703
75792,reacting,O,3703
75793,with,O,3703
75794,redness,B-SIGN_AND_SYMPTOM,3703
75795,itching,I-SIGN_AND_SYMPTOM,3703
75796,and,I-SIGN_AND_SYMPTOM,3703
75797,watering,I-SIGN_AND_SYMPTOM,3703
75798,Approximately,O,3703
75799,20%,O,3703
75800,of,O,3703
75801,the,O,3703
75802,world,O,3703
75803,s,O,3703
75804,population,O,3703
75805,has,O,3703
75806,eye,B-NAME_OF_DISEASE,3703
75807,allergies,I-NAME_OF_DISEASE,3703
75808,Eye,B-NAME_OF_DISEASE,3703
75809,allergies,I-NAME_OF_DISEASE,3703
75810,can,O,3703
75811,be,O,3703
75812,hereditary,B-CAUSE_OF_DISEASE,3703
75813,or,O,3703
75814,occur,O,3703
75815,from,O,3703
75816,outer,B-CAUSE_OF_DISEASE,3703
75817,factors,I-CAUSE_OF_DISEASE,3703
75818,such,I-CAUSE_OF_DISEASE,3703
75819,as,I-CAUSE_OF_DISEASE,3703
75820,dusty,I-CAUSE_OF_DISEASE,3703
75821,environments,I-CAUSE_OF_DISEASE,3703
75822,Wood,O,3703
75823,dust,O,3704
75824,that,O,3704
75825,occurs,O,3704
75826,when,O,3704
75827,cutting,O,3704
75828,wood,O,3704
75829,in,O,3704
75830,the,O,3704
75831,carpenter,O,3704
75832,s,O,3704
75833,workshop,O,3704
75834,dust,O,3704
75835,that,O,3705
75836,flies,O,3705
75837,on,O,3705
75838,unpaved,O,3705
75839,roads,O,3705
75840,dust,O,3705
75841,that,O,3705
75842,occurs,O,3705
75843,on,O,3705
75844,construction,O,3705
75845,sites,O,3705
75846,in,O,3705
75847,the,O,3705
75848,city,O,3706
75849,due,O,3706
75850,to,O,3706
75851,urban,O,3706
75852,transformation,O,3706
75853,dust,O,3706
75854,formed,O,3706
75855,from,O,3706
75856,sand,O,3706
75857,in,O,3707
75858,the,O,3707
75859,jean,O,3707
75860,stone,O,3707
75861,washing,O,3707
75862,workshop,O,3707
75863,in,O,3707
75864,short,O,3707
75865,all,O,3707
75866,of,O,3707
75867,these,O,3707
75868,examples,O,3707
75869,of,O,3707
75870,dusty,B-CAUSE_OF_DISEASE,3707
75871,environments,I-CAUSE_OF_DISEASE,3707
75872,can,O,3707
75873,easily,O,3707
75874,trigger,O,3707
75875,eye,B-NAME_OF_DISEASE,3707
75876,allergies,I-NAME_OF_DISEASE,3708
75877,Other,O,3708
75878,than,O,3708
75879,these,O,3708
75880,examples,O,3708
75881,getting,B-CAUSE_OF_DISEASE,3708
75882,exposed,I-CAUSE_OF_DISEASE,3708
75883,to,I-CAUSE_OF_DISEASE,3708
75884,cigarette,I-CAUSE_OF_DISEASE,3708
75885,smoke,I-CAUSE_OF_DISEASE,3708
75886,less,B-CAUSE_OF_DISEASE,3708
75887,tear,I-CAUSE_OF_DISEASE,3708
75888,production,I-CAUSE_OF_DISEASE,3708
75889,of,I-CAUSE_OF_DISEASE,3709
75890,eyes,I-CAUSE_OF_DISEASE,3709
75891,swimming,B-CAUSE_OF_DISEASE,3709
75892,in,I-CAUSE_OF_DISEASE,3709
75893,an,I-CAUSE_OF_DISEASE,3709
75894,unhygienic,I-CAUSE_OF_DISEASE,3709
75895,pool,I-CAUSE_OF_DISEASE,3709
75896,touching,B-CAUSE_OF_DISEASE,3709
75897,eyes,I-CAUSE_OF_DISEASE,3709
75898,with,I-CAUSE_OF_DISEASE,3709
75899,unclean,I-CAUSE_OF_DISEASE,3709
75900,hands,I-CAUSE_OF_DISEASE,3709
75901,and,O,3709
75902,applying,B-CAUSE_OF_DISEASE,3709
75903,eye,I-CAUSE_OF_DISEASE,3710
75904,makeup,I-CAUSE_OF_DISEASE,3710
75905,such,I-CAUSE_OF_DISEASE,3710
75906,as,I-CAUSE_OF_DISEASE,3710
75907,mascara,I-CAUSE_OF_DISEASE,3710
75908,and,I-CAUSE_OF_DISEASE,3710
75909,eyeliner,I-CAUSE_OF_DISEASE,3710
75910,can,O,3710
75911,also,O,3710
75912,cause,O,3710
75913,eye,B-NAME_OF_DISEASE,3710
75914,allergies,I-NAME_OF_DISEASE,3710
75915,What,O,3710
75916,are,O,3710
75917,the,O,3710
75918,3,O,3710
75919,Most,O,3710
75920,Common,O,3710
75921,Eye,B-NAME_OF_DISEASE,3710
75922,Allergies,I-NAME_OF_DISEASE,3710
75923,There,O,3710
75924,are,O,3710
75925,6,O,3710
75926,types,O,3710
75927,of,O,3710
75928,eye,B-NAME_OF_DISEASE,3710
75929,allergies,I-NAME_OF_DISEASE,3710
75930,which,O,3710
75931,differ,O,3711
75932,according,O,3711
75933,to,O,3711
75934,the,O,3711
75935,probability,O,3711
75936,of,O,3711
75937,having,O,3711
75938,a,O,3711
75939,low,O,3711
75940,or,O,3711
75941,high,O,3711
75942,risk,O,3711
75943,of,O,3711
75944,damaging,O,3711
75945,the,B-PART_OF_THE_EYES,3711
75946,cornea,I-PART_OF_THE_EYES,3711
75947,The,O,3711
75948,most,O,3711
75949,common,O,3712
75950,types,O,3712
75951,of,O,3712
75952,these,O,3712
75953,eye,B-NAME_OF_DISEASE,3712
75954,allergies,I-NAME_OF_DISEASE,3712
75955,are,O,3712
75956,Perennial,B-NAME_OF_DISEASE,3712
75957,Allergic,I-NAME_OF_DISEASE,3712
75958,Conjunctivitis,I-NAME_OF_DISEASE,3712
75959,Seasonal,B-NAME_OF_DISEASE,3712
75960,Allergic,I-NAME_OF_DISEASE,3712
75961,Conjunctivitis,I-NAME_OF_DISEASE,3712
75962,allergic,B-NAME_OF_DISEASE,3712
75963,rhinoconjunctivitis,I-NAME_OF_DISEASE,3712
75964,and,O,3712
75965,Contact,B-NAME_OF_DISEASE,3712
75966,Allergic,I-NAME_OF_DISEASE,3712
75967,Conjunctivitis,I-NAME_OF_DISEASE,3712
75968,contact,B-NAME_OF_DISEASE,3713
75969,dermatoconjunctivitis,I-NAME_OF_DISEASE,3713
75970,,O,3713
75971,1,O,3713
75972,Perennial,B-NAME_OF_DISEASE,3713
75973,Allergic,I-NAME_OF_DISEASE,3713
75974,Conjunctivitis,I-NAME_OF_DISEASE,3713
75975,It,O,3713
75976,is,O,3713
75977,a,O,3713
75978,type,O,3713
75979,of,O,3713
75980,allergy,O,3713
75981,that,O,3713
75982,can,O,3713
75983,be,O,3713
75984,seen,O,3713
75985,all,O,3713
75986,year,O,3714
75987,round,O,3714
75988,Things,B-CAUSE_OF_DISEASE,3714
75989,such,I-CAUSE_OF_DISEASE,3714
75990,as,I-CAUSE_OF_DISEASE,3714
75991,pet,I-CAUSE_OF_DISEASE,3714
75992,hair,I-CAUSE_OF_DISEASE,3714
75993,dust,I-CAUSE_OF_DISEASE,3714
75994,and,I-CAUSE_OF_DISEASE,3714
75995,pollen,I-CAUSE_OF_DISEASE,3714
75996,are,O,3714
75997,causing,O,3714
75998,this,O,3714
75999,allergy,O,3714
76000,Its,O,3714
76001,symptoms,O,3714
76002,are,O,3714
76003,similar,O,3714
76004,to,O,3714
76005,seasonal,B-NAME_OF_DISEASE,3715
76006,allergies,I-NAME_OF_DISEASE,3715
76007,However,O,3715
76008,compared,O,3715
76009,to,O,3715
76010,seasonal,B-NAME_OF_DISEASE,3715
76011,allergic,I-NAME_OF_DISEASE,3715
76012,conjunctivitis,I-NAME_OF_DISEASE,3715
76013,the,O,3715
76014,symptoms,O,3715
76015,of,O,3715
76016,perennial,B-NAME_OF_DISEASE,3715
76017,allergic,I-NAME_OF_DISEASE,3715
76018,conjunctivitis,I-NAME_OF_DISEASE,3715
76019,are,O,3715
76020,milder,O,3716
76021,This,O,3716
76022,allergy,O,3716
76023,is,O,3716
76024,more,O,3716
76025,common,O,3716
76026,in,O,3716
76027,children,O,3716
76028,2,O,3716
76029,Seasonal,B-NAME_OF_DISEASE,3716
76030,Allergic,I-NAME_OF_DISEASE,3716
76031,Conjunctivitis,I-NAME_OF_DISEASE,3716
76032,This,O,3716
76033,type,O,3716
76034,of,O,3716
76035,allergy,O,3716
76036,becomes,O,3716
76037,widespread,O,3716
76038,in,O,3716
76039,the,O,3716
76040,spring,O,3716
76041,season,O,3716
76042,Because,O,3717
76043,in,O,3717
76044,this,O,3717
76045,season,O,3717
76046,the,O,3717
76047,trees,O,3717
76048,are,O,3717
76049,blooming,O,3717
76050,The,B-CAUSE_OF_DISEASE,3717
76051,pollen,I-CAUSE_OF_DISEASE,3717
76052,of,I-CAUSE_OF_DISEASE,3717
76053,these,I-CAUSE_OF_DISEASE,3717
76054,flowers,I-CAUSE_OF_DISEASE,3717
76055,is,O,3717
76056,starting,O,3717
76057,to,O,3717
76058,spread,O,3717
76059,in,O,3717
76060,the,O,3717
76061,air,O,3717
76062,It,O,3717
76063,causes,O,3717
76064,redness,B-SIGN_AND_SYMPTOM,3717
76065,itchiness,I-SIGN_AND_SYMPTOM,3717
76066,and,I-SIGN_AND_SYMPTOM,3717
76067,watering,I-SIGN_AND_SYMPTOM,3717
76068,in,I-SIGN_AND_SYMPTOM,3717
76069,the,I-SIGN_AND_SYMPTOM,3717
76070,eyes,I-SIGN_AND_SYMPTOM,3718
76071,People,O,3718
76072,with,O,3718
76073,sensitive,O,3718
76074,bodies,O,3718
76075,can,O,3718
76076,also,O,3718
76077,face,O,3718
76078,nasal,B-SIGN_AND_SYMPTOM,3718
76079,discharge,I-SIGN_AND_SYMPTOM,3718
76080,3,O,3718
76081,Contact,B-NAME_OF_DISEASE,3718
76082,Allergic,I-NAME_OF_DISEASE,3718
76083,Conjunctivitis,I-NAME_OF_DISEASE,3718
76084,As,O,3718
76085,can,O,3719
76086,be,O,3719
76087,seen,O,3719
76088,from,O,3719
76089,the,O,3719
76090,name,O,3719
76091,this,O,3719
76092,allergy,O,3719
76093,is,O,3719
76094,caused,O,3719
76095,by,O,3719
76096,contact,B-CAUSE_OF_DISEASE,3719
76097,lenses,I-CAUSE_OF_DISEASE,3719
76098,People,O,3719
76099,with,O,3719
76100,sensitive,O,3719
76101,eyes,O,3720
76102,can,O,3720
76103,have,O,3720
76104,their,O,3720
76105,eyes,O,3720
76106,irritated,O,3720
76107,by,O,3720
76108,wearing,B-CAUSE_OF_DISEASE,3721
76109,contact,I-CAUSE_OF_DISEASE,3721
76110,lenses,I-CAUSE_OF_DISEASE,3721
76111,Contact,B-CAUSE_OF_DISEASE,3721
76112,lenses,I-CAUSE_OF_DISEASE,3721
76113,will,O,3721
76114,cause,O,3721
76115,itching,B-SIGN_AND_SYMPTOM,3721
76116,and,I-SIGN_AND_SYMPTOM,3722
76117,redness,I-SIGN_AND_SYMPTOM,3722
76118,in,I-SIGN_AND_SYMPTOM,3722
76119,the,I-SIGN_AND_SYMPTOM,3722
76120,eyes,I-SIGN_AND_SYMPTOM,3722
76121,Generally,O,3722
76122,it,O,3722
76123,s,O,3722
76124,not,O,3722
76125,recommended,O,3722
76126,to,O,3722
76127,wear,B-CAUSE_OF_DISEASE,3722
76128,contact,I-CAUSE_OF_DISEASE,3722
76129,lenses,I-CAUSE_OF_DISEASE,3722
76130,for,I-CAUSE_OF_DISEASE,3722
76131,sensitive,I-CAUSE_OF_DISEASE,3722
76132,eyes,I-CAUSE_OF_DISEASE,3723
76133,Otherwise,O,3723
76134,it,O,3723
76135,may,O,3723
76136,cause,O,3723
76137,permanent,O,3723
76138,damage,O,3723
76139,to,O,3723
76140,the,O,3723
76141,eyes,O,3723
76142,What,O,3723
76143,is,O,3724
76144,best,O,3724
76145,for,O,3724
76146,eye,B-NAME_OF_DISEASE,3724
76147,allergy,I-NAME_OF_DISEASE,3724
76148,Depending,O,3724
76149,on,O,3724
76150,the,O,3724
76151,stage,O,3724
76152,and,O,3724
76153,type,O,3724
76154,of,O,3724
76155,the,O,3724
76156,allergy,O,3724
76157,eye,B-NAME_OF_DISEASE,3724
76158,allergies,I-NAME_OF_DISEASE,3724
76159,can,O,3724
76160,cause,O,3724
76161,vision,B-NAME_OF_DISEASE,3724
76162,impairment,I-NAME_OF_DISEASE,3724
76163,corneal,B-SIGN_AND_SYMPTOM,3724
76164,damage,I-SIGN_AND_SYMPTOM,3724
76165,or,O,3724
76166,even,O,3724
76167,serious,O,3724
76168,health,O,3724
76169,problems,O,3724
76170,such,O,3724
76171,as,O,3724
76172,eye,B-SIGN_AND_SYMPTOM,3724
76173,loss,I-SIGN_AND_SYMPTOM,3724
76174,Therefore,O,3724
76175,a,O,3724
76176,person,O,3724
76177,with,O,3724
76178,an,B-NAME_OF_DISEASE,3724
76179,eye,I-NAME_OF_DISEASE,3724
76180,allergy,I-NAME_OF_DISEASE,3724
76181,should,O,3724
76182,see,O,3725
76183,an,O,3725
76184,ophthalmologist,O,3725
76185,first,O,3725
76186,Antihistamine,B-TREATMENT,3725
76187,eye,I-TREATMENT,3725
76188,drops,I-TREATMENT,3725
76189,which,O,3725
76190,the,O,3725
76191,doctor,O,3725
76192,is,O,3725
76193,going,O,3725
76194,to,O,3725
76195,prescribe,O,3725
76196,will,O,3725
76197,greatly,O,3725
76198,benefit,O,3725
76199,the,O,3725
76200,patient,O,3725
76201,And,O,3725
76202,what,O,3725
76203,else,O,3726
76204,can,O,3726
76205,be,O,3726
76206,done,O,3726
76207,for,O,3726
76208,eye,B-NAME_OF_DISEASE,3726
76209,allergy,I-NAME_OF_DISEASE,3726
76210,The,O,3726
76211,recommendations,O,3726
76212,listed,O,3726
76213,below,O,3726
76214,can,O,3726
76215,also,O,3726
76216,be,O,3726
76217,applicable,O,3726
76218,It,O,3726
76219,is,O,3726
76220,necessary,O,3726
76221,to,O,3726
76222,stay,B-TREATMENT,3726
76223,away,I-TREATMENT,3726
76224,from,I-TREATMENT,3726
76225,dusty,I-TREATMENT,3726
76226,environments,I-TREATMENT,3727
76227,Person,O,3727
76228,that,O,3727
76229,has,O,3727
76230,an,B-NAME_OF_DISEASE,3727
76231,eye,I-NAME_OF_DISEASE,3727
76232,allergy,I-NAME_OF_DISEASE,3727
76233,should,O,3727
76234,not,B-TREATMENT,3727
76235,wear,I-TREATMENT,3727
76236,eye,I-TREATMENT,3727
76237,makeup,I-TREATMENT,3728
76238,Eyes,B-TREATMENT,3728
76239,should,I-TREATMENT,3728
76240,be,I-TREATMENT,3728
76241,protected,I-TREATMENT,3728
76242,from,I-TREATMENT,3728
76243,dust,I-TREATMENT,3728
76244,pollen,I-TREATMENT,3728
76245,and,I-TREATMENT,3728
76246,harmful,I-TREATMENT,3728
76247,sun,I-TREATMENT,3728
76248,rays,I-TREATMENT,3728
76249,by,I-TREATMENT,3728
76250,wearing,I-TREATMENT,3728
76251,sunglasses,I-TREATMENT,3728
76252,Eyes,B-TREATMENT,3728
76253,shouldn,I-TREATMENT,3728
76254,t,I-TREATMENT,3728
76255,be,I-TREATMENT,3728
76256,rubbed,I-TREATMENT,3728
76257,especially,I-TREATMENT,3728
76258,if,I-TREATMENT,3729
76259,the,I-TREATMENT,3729
76260,person,I-TREATMENT,3729
76261,hasn,I-TREATMENT,3729
76262,t,I-TREATMENT,3729
76263,washed,I-TREATMENT,3729
76264,their,I-TREATMENT,3729
76265,hands,I-TREATMENT,3729
76266,yet,I-TREATMENT,3729
76267,Looking,O,3729
76268,at,O,3729
76269,electronic,O,3729
76270,devices,O,3729
76271,such,O,3729
76272,as,O,3729
76273,cell,O,3729
76274,phones,O,3729
76275,and,O,3729
76276,laptops,O,3729
76277,can,O,3729
76278,also,O,3729
76279,tire,O,3729
76280,and,O,3729
76281,dry,O,3729
76282,the,O,3730
76283,eyes,O,3730
76284,Therefore,O,3730
76285,a,O,3730
76286,lot,O,3730
76287,of,O,3730
76288,time,O,3730
76289,should,O,3730
76290,not,O,3731
76291,be,O,3731
76292,spent,O,3731
76293,with,O,3731
76294,such,O,3731
76295,devices,O,3731
76296,Long,B-TREATMENT,3731
76297,hot,I-TREATMENT,3731
76298,showers,I-TREATMENT,3731
76299,should,I-TREATMENT,3732
76300,be,I-TREATMENT,3732
76301,avoided,I-TREATMENT,3732
76302,since,O,3732
76303,the,B-CAUSE_OF_DISEASE,3732
76304,vapor,I-CAUSE_OF_DISEASE,3732
76305,of,I-CAUSE_OF_DISEASE,3732
76306,chloride,I-CAUSE_OF_DISEASE,3732
76307,in,I-CAUSE_OF_DISEASE,3733
76308,tap,I-CAUSE_OF_DISEASE,3733
76309,water,I-CAUSE_OF_DISEASE,3733
76310,can,O,3733
76311,damage,O,3733
76312,the,O,3733
76313,eyes,O,3733
76314,Swimming,B-TREATMENT,3733
76315,in,I-TREATMENT,3733
76316,an,I-TREATMENT,3733
76317,unhygienic,I-TREATMENT,3733
76318,pool,I-TREATMENT,3733
76319,should,I-TREATMENT,3733
76320,also,I-TREATMENT,3733
76321,be,I-TREATMENT,3733
76322,avoided,I-TREATMENT,3734
76323,Another,B-TREATMENT,3734
76324,person,I-TREATMENT,3734
76325,s,I-TREATMENT,3734
76326,towel,I-TREATMENT,3734
76327,should,I-TREATMENT,3734
76328,never,I-TREATMENT,3734
76329,be,I-TREATMENT,3734
76330,used,I-TREATMENT,3734
76331,We,O,3734
76332,care,O,3734
76333,more,O,3734
76334,about,O,3734
76335,our,O,3734
76336,health,O,3734
76337,by,O,3734
76338,aging,O,3735
76339,Especially,O,3735
76340,we,O,3735
76341,feel,O,3735
76342,vision,O,3735
76343,problems,O,3735
76344,easily,O,3735
76345,and,O,3735
76346,it,O,3736
76347,affects,O,3736
76348,the,O,3736
76349,quality,O,3736
76350,of,O,3736
76351,life,O,3736
76352,When,O,3736
76353,it,O,3736
76354,comes,O,3736
76355,to,O,3736
76356,the,O,3736
76357,doctor,O,3736
76358,names,O,3736
76359,in,O,3736
76360,presbyopia,B-NAME_OF_DISEASE,3736
76361,we,O,3736
76362,check,O,3737
76363,publications,O,3737
76364,and,O,3737
76365,success,O,3737
76366,stories,O,3737
76367,of,O,3737
76368,them,O,3737
76369,and,O,3737
76370,decide,O,3737
76371,on,O,3737
76372,the,O,3737
76373,surgery,O,3737
76374,Dr,O,3737
76375,George,B-PERSON,3738
76376,Waring,I-PERSON,3738
76377,is,O,3738
76378,one,O,3738
76379,the,O,3738
76380,well-known,O,3738
76381,and,O,3738
76382,top,O,3738
76383,ophthalmologists,O,3738
76384,in,O,3738
76385,cataract,B-TREATMENT,3739
76386,surgery,I-TREATMENT,3739
76387,In,O,3739
76388,this,O,3739
76389,article,O,3739
76390,you,O,3739
76391,will,O,3739
76392,find,O,3739
76393,more,O,3739
76394,about,O,3739
76395,George,B-PERSON,3739
76396,Waring,I-PERSON,3739
76397,MD,I-PERSON,3739
76398,his,O,3740
76399,working,O,3740
76400,areas,O,3740
76401,specialties,O,3740
76402,and,O,3740
76403,awards,O,3740
76404,Who,O,3740
76405,is,O,3740
76406,George,B-PERSON,3740
76407,Waring,I-PERSON,3740
76408,MD,I-PERSON,3741
76409,George,B-PERSON,3741
76410,Waring,I-PERSON,3741
76411,MD,I-PERSON,3741
76412,is,O,3741
76413,an,O,3741
76414,award-winning,O,3741
76415,refractive,O,3742
76416,and,O,3742
76417,cataract,B-NAME_OF_DISEASE,3742
76418,surgeon,O,3742
76419,who,O,3742
76420,is,O,3742
76421,also,O,3742
76422,the,O,3742
76423,founder,O,3742
76424,of,O,3742
76425,Waring,B-ORGANIZATION,3742
76426,Vision,B-ORGANIZATION,3742
76427,Institute,I-ORGANIZATION,3742
76428,He,O,3743
76429,studied,O,3743
76430,Economics,O,3743
76431,and,O,3743
76432,Ecology,O,3743
76433,and,O,3743
76434,completed,O,3743
76435,his,O,3743
76436,Doctor,O,3743
76437,of,O,3743
76438,Medicine,O,3743
76439,at,O,3743
76440,Emory,B-ORGANIZATION,3744
76441,University,I-ORGANIZATION,3744
76442,Since,O,3744
76443,he,O,3744
76444,is,O,3744
76445,active,O,3744
76446,in,O,3744
76447,ophthalmology,O,3744
76448,research,O,3744
76449,and,O,3744
76450,leads,O,3744
76451,technological,O,3744
76452,surgical,O,3745
76453,operations,O,3745
76454,internationally,O,3745
76455,George,B-PERSON,3745
76456,Waring,I-PERSON,3745
76457,MD,I-PERSON,3745
76458,is,O,3745
76459,on,O,3745
76460,the,O,3745
76461,Executive,O,3745
76462,Committee,O,3746
76463,of,O,3746
76464,the,B-ORGANIZATION,3746
76465,International,I-ORGANIZATION,3746
76466,Society,I-ORGANIZATION,3746
76467,of,I-ORGANIZATION,3746
76468,Refractive,I-ORGANIZATION,3746
76469,Surgery,I-ORGANIZATION,3746
76470,and,O,3746
76471,with,O,3746
76472,his,O,3746
76473,continuous,O,3746
76474,lecturing,O,3746
76475,position,O,3746
76476,he,O,3746
76477,is,O,3746
76478,the,O,3746
76479,Director,O,3747
76480,for,O,3747
76481,the,O,3747
76482,American,B-ORGANIZATION,3747
76483,Academy,I-ORGANIZATION,3747
76484,of,I-ORGANIZATION,3747
76485,Ophthalmology,I-ORGANIZATION,3747
76486,Laser,I-ORGANIZATION,3747
76487,Refractive,I-ORGANIZATION,3747
76488,Surgery,I-ORGANIZATION,3747
76489,Course,I-ORGANIZATION,3747
76490,George,B-PERSON,3748
76491,Waring,I-PERSON,3748
76492,Research,O,3748
76493,Topics,O,3748
76494,As,O,3748
76495,George,B-PERSON,3748
76496,Waring,I-PERSON,3748
76497,and,O,3748
76498,his,O,3748
76499,Vision,B-ORGANIZATION,3748
76500,Institute,I-ORGANIZATION,3748
76501,are,O,3748
76502,actively,O,3748
76503,working,O,3748
76504,on,O,3748
76505,clinical,O,3748
76506,research,O,3748
76507,in,O,3748
76508,the,O,3748
76509,ophthalmology,O,3748
76510,area,O,3748
76511,he,O,3748
76512,is,O,3748
76513,leading,O,3748
76514,his,O,3748
76515,field,O,3748
76516,as,O,3749
76517,a,O,3749
76518,surgeon,O,3749
76519,and,O,3749
76520,latest,O,3749
76521,technology,O,3749
76522,practitioner,O,3749
76523,He,O,3749
76524,is,O,3749
76525,known,O,3749
76526,as,O,3749
76527,the,O,3749
76528,leading,O,3749
76529,figure,O,3749
76530,in,O,3749
76531,correcting,O,3749
76532,presbyopia,B-NAME_OF_DISEASE,3749
76533,with,O,3749
76534,surgery,O,3749
76535,Actually,O,3749
76536,George,B-PERSON,3749
76537,Waring,I-PERSON,3749
76538,s,O,3749
76539,father,O,3749
76540,George,B-PERSON,3750
76541,Waring,I-PERSON,3750
76542,III,I-PERSON,3750
76543,was,O,3750
76544,a,O,3750
76545,pioneer,O,3750
76546,in,O,3750
76547,ophthalmology,O,3750
76548,He,O,3750
76549,established,O,3750
76550,the,O,3750
76551,first,O,3750
76552,eye,O,3750
76553,bank,O,3750
76554,in,O,3750
76555,Northern,B-GPE,3750
76556,California,I-GPE,3750
76557,His,O,3750
76558,refractive,O,3750
76559,surgery,O,3750
76560,trial,O,3751
76561,has,O,3751
76562,still,O,3751
76563,been,O,3751
76564,recognized,O,3751
76565,as,O,3751
76566,one,O,3751
76567,of,O,3751
76568,the,O,3751
76569,best,O,3751
76570,rigorously,O,3751
76571,applied,O,3751
76572,studies,O,3751
76573,in,O,3751
76574,the,O,3751
76575,field,O,3751
76576,Briefly,O,3751
76577,George,B-PERSON,3751
76578,Waring,I-PERSON,3751
76579,IV,I-PERSON,3751
76580,s,O,3751
76581,research,O,3751
76582,and,O,3751
76583,working,O,3751
76584,topics,O,3752
76585,are,O,3752
76586,LASIK,B-TREATMENT,3752
76587,surgery,I-TREATMENT,3752
76588,procedures,O,3752
76589,he,O,3752
76590,is,O,3752
76591,also,O,3752
76592,teaching,O,3752
76593,LASIK,B-TREATMENT,3752
76594,to,O,3752
76595,surgeons,O,3752
76596,all,O,3752
76597,around,O,3752
76598,the,O,3752
76599,world,O,3752
76600,Photorefractive,B-TREATMENT,3752
76601,keratectomy,I-TREATMENT,3752
76602,vision,O,3752
76603,correction,O,3752
76604,for,O,3752
76605,myopia,B-NAME_OF_DISEASE,3752
76606,hyperopia,B-NAME_OF_DISEASE,3752
76607,astigmatism,B-NAME_OF_DISEASE,3752
76608,or,O,3752
76609,presbyopia,B-NAME_OF_DISEASE,3752
76610,Clear,B-TREATMENT,3752
76611,Lens,I-TREATMENT,3752
76612,Exchange,I-TREATMENT,3752
76613,similar,O,3752
76614,to,O,3752
76615,cataract,B-TREATMENT,3752
76616,surgery,I-TREATMENT,3752
76617,involves,O,3753
76618,lens,O,3753
76619,replacement,O,3753
76620,for,O,3753
76621,presbyopia,B-NAME_OF_DISEASE,3753
76622,VUITY,B-NAME_OF_DRUG,3753
76623,eye,I-NAME_OF_DRUG,3753
76624,drop,I-NAME_OF_DRUG,3753
76625,for,O,3753
76626,the,O,3753
76627,treatment,O,3753
76628,of,O,3753
76629,presbyopia,B-NAME_OF_DISEASE,3753
76630,What,O,3753
76631,is,O,3753
76632,the,O,3753
76633,Vuity,B-NAME_OF_DRUG,3753
76634,Eye,I-NAME_OF_DRUG,3753
76635,Drop,I-NAME_OF_DRUG,3753
76636,By,O,3753
76637,aging,O,3753
76638,the,B-SIGN_AND_SYMPTOM,3753
76639,near,I-SIGN_AND_SYMPTOM,3753
76640,vision,I-SIGN_AND_SYMPTOM,3753
76641,gets,I-SIGN_AND_SYMPTOM,3753
76642,blurry,I-SIGN_AND_SYMPTOM,3753
76643,The,O,3753
76644,recent,O,3753
76645,development,O,3753
76646,and,O,3753
76647,application,O,3753
76648,for,O,3753
76649,the,B-NAME_OF_DISEASE,3753
76650,presbyopia,I-NAME_OF_DISEASE,3753
76651,treatment,O,3753
76652,is,O,3753
76653,the,B-NAME_OF_DRUG,3753
76654,Vuity,I-NAME_OF_DRUG,3753
76655,eye,I-NAME_OF_DRUG,3753
76656,drop,I-NAME_OF_DRUG,3754
76657,Although,O,3754
76658,the,O,3754
76659,current,O,3754
76660,alternative,O,3754
76661,options,O,3754
76662,are,O,3754
76663,wearing,B-TREATMENT,3754
76664,glasses,I-TREATMENT,3754
76665,and,O,3754
76666,using,B-TREATMENT,3754
76667,contact,I-TREATMENT,3754
76668,lenses,I-TREATMENT,3754
76669,Vuity,B-NAME_OF_DRUG,3754
76670,eye,I-NAME_OF_DRUG,3754
76671,drop,I-NAME_OF_DRUG,3754
76672,is,O,3754
76673,an,O,3754
76674,innovative,O,3754
76675,treatment,O,3754
76676,for,O,3754
76677,blurry,B-SIGN_AND_SYMPTOM,3754
76678,vision,I-SIGN_AND_SYMPTOM,3754
76679,that,O,3754
76680,is,O,3754
76681,the,O,3755
76682,only,O,3755
76683,FDA-approved,O,3755
76684,treatment,O,3755
76685,One,O,3755
76686,drop,O,3755
76687,of,O,3755
76688,Vuity,B-NAME_OF_DRUG,3755
76689,eye,I-NAME_OF_DRUG,3755
76690,drop,I-NAME_OF_DRUG,3755
76691,each,O,3755
76692,day,O,3755
76693,results,O,3755
76694,in,O,3755
76695,an,O,3755
76696,amazing,O,3755
76697,vision,O,3755
76698,correction,O,3755
76699,on,O,3756
76700,closer,O,3756
76701,reading,O,3756
76702,ability,O,3756
76703,The,O,3756
76704,main,O,3756
76705,focus,O,3756
76706,of,O,3756
76707,the,B-NAME_OF_DRUG,3756
76708,Vuity,I-NAME_OF_DRUG,3756
76709,eye,I-NAME_OF_DRUG,3756
76710,drop,I-NAME_OF_DRUG,3756
76711,is,O,3756
76712,to,O,3756
76713,decrease,O,3756
76714,the,O,3756
76715,size,O,3756
76716,of,O,3756
76717,the,B-PART_OF_THE_EYES,3756
76718,pupil,B-PART_OF_THE_EYES,3756
76719,which,O,3757
76720,improves,O,3757
76721,reading,O,3757
76722,What,O,3757
76723,are,O,3757
76724,the,O,3757
76725,side,O,3757
76726,effects,O,3757
76727,of,O,3757
76728,Vuity,B-NAME_OF_DRUG,3757
76729,Vuity,B-NAME_OF_DRUG,3757
76730,eye,I-NAME_OF_DRUG,3757
76731,drop,I-NAME_OF_DRUG,3757
76732,is,O,3757
76733,a,O,3758
76734,pupil-based,O,3758
76735,treatment,O,3758
76736,that,O,3758
76737,corrects,O,3758
76738,blurry,B-SIGN_AND_SYMPTOM,3758
76739,vision,I-SIGN_AND_SYMPTOM,3758
76740,If,O,3758
76741,you,O,3758
76742,use,O,3758
76743,Vuity,B-NAME_OF_DRUG,3758
76744,eye,I-NAME_OF_DRUG,3758
76745,drop,I-NAME_OF_DRUG,3758
76746,you,O,3758
76747,should,O,3758
76748,also,O,3758
76749,consider,O,3758
76750,the,O,3759
76751,user,O,3759
76752,information,O,3759
76753,as,O,3759
76754,well,O,3759
76755,as,O,3759
76756,the,O,3759
76757,side,O,3759
76758,effects,O,3759
76759,Firstly,O,3759
76760,you,O,3759
76761,should,O,3759
76762,check,O,3759
76763,with,O,3760
76764,the,O,3760
76765,doctor,O,3760
76766,if,O,3760
76767,you,O,3760
76768,have,O,3760
76769,any,O,3760
76770,allergy,O,3760
76771,to,O,3760
76772,its,O,3760
76773,ingredients,O,3760
76774,Temporary,O,3760
76775,problems,O,3760
76776,may,O,3760
76777,occur,O,3760
76778,in,O,3760
76779,case,O,3760
76780,of,O,3760
76781,a,O,3760
76782,sudden,O,3760
76783,change,O,3760
76784,in,O,3760
76785,near,O,3760
76786,and,O,3760
76787,distant,O,3760
76788,reading,O,3760
76789,so,O,3761
76790,be,O,3761
76791,careful,O,3761
76792,in,O,3761
76793,driving,O,3761
76794,or,O,3761
76795,moving,O,3761
76796,If,O,3761
76797,you,O,3761
76798,use,O,3761
76799,contact,O,3762
76800,lenses,O,3762
76801,then,O,3762
76802,the,B-NAME_OF_DRUG,3762
76803,Vuity,I-NAME_OF_DRUG,3762
76804,eye,I-NAME_OF_DRUG,3762
76805,drop,I-NAME_OF_DRUG,3762
76806,should,O,3762
76807,be,O,3762
76808,applied,O,3762
76809,by,O,3762
76810,removing,O,3762
76811,them,O,3762
76812,and,O,3762
76813,also,O,3762
76814,10,O,3762
76815,min,O,3762
76816,would,O,3762
76817,be,O,3762
76818,needed,O,3762
76819,to,O,3762
76820,wear,O,3762
76821,the,O,3762
76822,lenses,O,3763
76823,back,O,3763
76824,The,O,3763
76825,commonly,O,3763
76826,reported,O,3763
76827,side,O,3763
76828,effects,O,3763
76829,of,O,3763
76830,using,O,3763
76831,Vuity,B-NAME_OF_DRUG,3763
76832,eye,I-NAME_OF_DRUG,3763
76833,drop,I-NAME_OF_DRUG,3763
76834,are,O,3763
76835,headaches,B-SIGN_AND_SYMPTOM,3763
76836,and,I-SIGN_AND_SYMPTOM,3763
76837,eye,I-SIGN_AND_SYMPTOM,3763
76838,redness,I-SIGN_AND_SYMPTOM,3763
76839,However,O,3763
76840,if,O,3764
76841,you,O,3764
76842,have,O,3764
76843,other,O,3764
76844,side,O,3764
76845,effects,O,3764
76846,FDA,B-ORGANIZATION,3764
76847,is,O,3764
76848,encouraging,O,3764
76849,you,O,3764
76850,to,O,3764
76851,be,O,3764
76852,reported,O,3764
76853,for,O,3764
76854,improvement,O,3764
76855,Corneal,B-TREATMENT,3764
76856,inlays,I-TREATMENT,3764
76857,treatment,I-TREATMENT,3764
76858,is,O,3764
76859,for,O,3764
76860,presbyopia,B-NAME_OF_DISEASE,3764
76861,problems,O,3764
76862,Presbyopia,B-NAME_OF_DISEASE,3764
76863,is,O,3764
76864,the,B-SIGN_AND_SYMPTOM,3764
76865,loss,I-SIGN_AND_SYMPTOM,3764
76866,of,I-SIGN_AND_SYMPTOM,3764
76867,elasticity,I-SIGN_AND_SYMPTOM,3764
76868,in,I-SIGN_AND_SYMPTOM,3764
76869,lenses,I-SIGN_AND_SYMPTOM,3764
76870,Simply,O,3764
76871,the,B-TREATMENT,3764
76872,corneal,I-TREATMENT,3764
76873,inlays,I-TREATMENT,3764
76874,are,O,3764
76875,implants,O,3765
76876,on,O,3765
76877,the,B-PART_OF_THE_EYES,3765
76878,corneal,I-PART_OF_THE_EYES,3765
76879,stroma,I-PART_OF_THE_EYES,3765
76880,to,O,3765
76881,help,O,3765
76882,see,O,3765
76883,the,O,3765
76884,closer,O,3765
76885,objects,O,3765
76886,The,O,3765
76887,reason,O,3765
76888,for,O,3765
76889,not,O,3765
76890,seeing,O,3765
76891,clearly,O,3765
76892,is,O,3765
76893,to,O,3765
76894,have,O,3765
76895,weaker,O,3765
76896,muscles,O,3765
76897,The,O,3766
76898,general,O,3766
76899,symptoms,O,3766
76900,are,O,3766
76901,observed,O,3766
76902,over,O,3766
76903,the,O,3766
76904,age,O,3766
76905,of,O,3766
76906,40,O,3766
76907,in,O,3766
76908,reading,O,3766
76909,small,O,3766
76910,prints,O,3766
76911,which,O,3766
76912,are,O,3766
76913,close,O,3766
76914,Corneal,B-TREATMENT,3766
76915,inlays,I-TREATMENT,3766
76916,treatment,I-TREATMENT,3766
76917,has,O,3767
76918,over,O,3767
76919,40,O,3767
76920,years,O,3767
76921,of,O,3767
76922,study,O,3767
76923,history,O,3767
76924,so,O,3767
76925,the,O,3767
76926,recent,O,3767
76927,improvements,O,3767
76928,and,O,3767
76929,developments,O,3767
76930,are,O,3767
76931,designed,O,3767
76932,for,O,3768
76933,human,B-PART_OF_THE_EYES,3768
76934,cornea,I-PART_OF_THE_EYES,3768
76935,tolerance,O,3768
76936,The,O,3768
76937,research,O,3768
76938,and,O,3768
76939,developments,O,3768
76940,have,O,3768
76941,been,O,3768
76942,aimed,O,3768
76943,at,O,3768
76944,the,O,3768
76945,patient,O,3768
76946,s,O,3768
76947,safety,O,3768
76948,first,O,3768
76949,and,O,3768
76950,are,O,3768
76951,more,O,3768
76952,tolerable,O,3768
76953,by,O,3768
76954,the,O,3768
76955,body,O,3768
76956,naturally,O,3768
76957,According,O,3768
76958,to,O,3768
76959,the,O,3769
76960,patient,O,3769
76961,s,O,3769
76962,request,O,3769
76963,and,O,3769
76964,the,O,3769
76965,conditions,O,3769
76966,of,O,3769
76967,the,O,3769
76968,operation,O,3769
76969,on,O,3769
76970,the,O,3769
76971,eye,O,3769
76972,there,O,3769
76973,can,O,3769
76974,be,O,3769
76975,consecutive,O,3769
76976,or,O,3769
76977,simultaneous,O,3769
76978,corneal,O,3769
76979,treatments,O,3769
76980,For,O,3769
76981,the,O,3769
76982,probable,O,3769
76983,outcomes,O,3769
76984,and,O,3769
76985,recovery,O,3770
76986,period,O,3770
76987,always,O,3770
76988,consult,O,3770
76989,your,O,3770
76990,ophthalmologists,O,3770
76991,Types,O,3770
76992,of,O,3770
76993,Corneal,B-TREATMENT,3770
76994,Inlays,I-TREATMENT,3770
76995,There,O,3770
76996,are,O,3770
76997,different,O,3770
76998,types,O,3770
76999,of,O,3770
77000,corneal,B-TREATMENT,3770
77001,inlays,I-TREATMENT,3770
77002,for,I-TREATMENT,3770
77003,corneal,I-TREATMENT,3770
77004,treatment,I-TREATMENT,3770
77005,that,O,3770
77006,differ,O,3770
77007,in,O,3770
77008,size,O,3770
77009,material,O,3770
77010,or,O,3770
77011,design,O,3771
77012,In,O,3771
77013,the,O,3771
77014,following,O,3771
77015,section,O,3771
77016,you,O,3771
77017,can,O,3771
77018,find,O,3771
77019,more,O,3771
77020,details,O,3771
77021,about,O,3771
77022,refractive,B-TREATMENT,3771
77023,corneal,I-TREATMENT,3771
77024,inlays,I-TREATMENT,3771
77025,small,B-TREATMENT,3771
77026,aperture,I-TREATMENT,3771
77027,inlays,I-TREATMENT,3771
77028,and,O,3771
77029,Kamra,B-TREATMENT,3771
77030,corneal,I-TREATMENT,3771
77031,inlays,I-TREATMENT,3771
77032,in,O,3771
77033,the,O,3772
77034,following,O,3772
77035,titles,O,3772
77036,The,O,3772
77037,surgical,O,3772
77038,operation,O,3772
77039,is,O,3772
77040,operated,O,3772
77041,on,O,3772
77042,topical,B-DIAGNOSTIC_TEST,3772
77043,anesthesia,I-DIAGNOSTIC_TEST,3772
77044,Topical,B-DIAGNOSTIC_TEST,3772
77045,anesthesia,I-DIAGNOSTIC_TEST,3772
77046,is,O,3772
77047,an,O,3772
77048,eye,O,3772
77049,drop,O,3772
77050,for,O,3772
77051,this,O,3772
77052,operation,O,3772
77053,The,B-TREATMENT,3772
77054,corneal,I-TREATMENT,3772
77055,inlays,I-TREATMENT,3772
77056,procedures,O,3772
77057,generally,O,3772
77058,take,O,3772
77059,15-Oct,B-TIME_DURATION,3772
77060,minutes,I-TIME_DURATION,3772
77061,Refractive,B-TREATMENT,3772
77062,Corneal,I-TREATMENT,3772
77063,Inlays,I-TREATMENT,3772
77064,Refractive,B-TREATMENT,3772
77065,corneal,I-TREATMENT,3772
77066,inlays,I-TREATMENT,3772
77067,aim,O,3772
77068,to,O,3773
77069,change,O,3773
77070,the,O,3773
77071,refractive,O,3773
77072,index,O,3773
77073,of,O,3773
77074,the,B-PART_OF_THE_EYES,3773
77075,cornea,I-PART_OF_THE_EYES,3773
77076,With,O,3773
77077,the,O,3773
77078,help,O,3773
77079,of,O,3773
77080,the,O,3773
77081,corneal,O,3773
77082,implan,O,3773
77083,t,O,3773
77084,the,O,3773
77085,light,O,3773
77086,can,O,3773
77087,be,O,3773
77088,focused,O,3773
77089,on,O,3773
77090,the,B-PART_OF_THE_EYES,3773
77091,retina,I-PART_OF_THE_EYES,3773
77092,Reactive,B-TREATMENT,3773
77093,corneal,I-TREATMENT,3773
77094,inlays,I-TREATMENT,3773
77095,provide,O,3773
77096,near,O,3773
77097,vision,O,3773
77098,as,O,3773
77099,well,O,3773
77100,The,O,3773
77101,most,O,3773
77102,popular,O,3773
77103,and,O,3773
77104,well-known,O,3773
77105,lenses,O,3773
77106,are,O,3773
77107,multifocal,B-TREATMENT,3773
77108,contact,I-TREATMENT,3773
77109,lenses,I-TREATMENT,3773
77110,or,O,3773
77111,in,O,3773
77112,other,O,3773
77113,ways,O,3773
77114,intraocular,B-TREATMENT,3773
77115,lenses,I-TREATMENT,3773
77116,Refractive,B-TREATMENT,3773
77117,corneal,I-TREATMENT,3773
77118,inlays,I-TREATMENT,3774
77119,also,O,3774
77120,have,O,3774
77121,a,O,3774
77122,similar,O,3774
77123,design,O,3774
77124,to,O,3774
77125,these,O,3774
77126,types,O,3774
77127,of,O,3774
77128,lenses,O,3774
77129,Customer,O,3774
77130,satisfaction,O,3774
77131,has,O,3774
77132,a,O,3775
77133,better,O,3775
77134,result,O,3775
77135,in,O,3775
77136,near,O,3775
77137,vision,O,3775
77138,improvement,O,3775
77139,Small,B-TREATMENT,3775
77140,Aperture,I-TREATMENT,3775
77141,Inlays,I-TREATMENT,3775
77142,Another,O,3775
77143,type,O,3775
77144,of,O,3775
77145,corneal,B-TREATMENT,3775
77146,inlay,I-TREATMENT,3775
77147,is,O,3775
77148,the,B-TREATMENT,3775
77149,small,I-TREATMENT,3775
77150,aperture,I-TREATMENT,3775
77151,inlays,I-TREATMENT,3775
77152,These,O,3775
77153,small,B-TREATMENT,3775
77154,aperture,I-TREATMENT,3776
77155,inlays,I-TREATMENT,3776
77156,focus,O,3776
77157,on,O,3776
77158,improving,O,3776
77159,near-vision,O,3776
77160,objects,O,3777
77161,too,O,3777
77162,They,O,3777
77163,are,O,3777
77164,designed,O,3777
77165,in,O,3777
77166,opaque,O,3777
77167,and,O,3777
77168,ring-shaped,O,3777
77169,The,O,3777
77170,function,O,3777
77171,of,O,3777
77172,the,O,3777
77173,ring,O,3777
77174,is,O,3777
77175,to,O,3777
77176,block,O,3777
77177,the,O,3777
77178,light,O,3777
77179,which,O,3777
77180,is,O,3777
77181,peripheral,O,3777
77182,Kamra,B-TREATMENT,3777
77183,small,I-TREATMENT,3777
77184,aperture,I-TREATMENT,3777
77185,inlays,I-TREATMENT,3777
77186,are,O,3777
77187,the,O,3777
77188,advanced,O,3777
77189,practice,O,3777
77190,of,O,3777
77191,refractive,B-TREATMENT,3777
77192,corneal,I-TREATMENT,3777
77193,inlays,I-TREATMENT,3777
77194,This,O,3777
77195,operation,O,3778
77196,is,O,3778
77197,suitable,O,3778
77198,for,O,3778
77199,those,O,3778
77200,who,O,3778
77201,have,O,3778
77202,not,O,3778
77203,yet,O,3778
77204,cataract,B-NAME_OF_DISEASE,3778
77205,issues,O,3778
77206,For,O,3778
77207,more,O,3778
77208,information,O,3778
77209,continue,O,3778
77210,reading,O,3778
77211,the,O,3778
77212,Kamra,B-TREATMENT,3778
77213,corneal,I-TREATMENT,3778
77214,inlays,I-TREATMENT,3778
77215,title,O,3778
77216,Corneal,B-TREATMENT,3778
77217,Inlays,I-TREATMENT,3778
77218,Presbyopia,B-NAME_OF_DISEASE,3778
77219,Treatment,O,3779
77220,Presbyopia,B-NAME_OF_DISEASE,3779
77221,treatment,O,3779
77222,helps,O,3779
77223,for,O,3779
77224,conditions,O,3779
77225,where,O,3779
77226,there,O,3779
77227,is,O,3779
77228,no,O,3779
77229,effective,O,3779
77230,reactive,O,3779
77231,surgery,O,3779
77232,treatment,O,3780
77233,Corneal,B-TREATMENT,3780
77234,inlays,I-TREATMENT,3780
77235,are,O,3780
77236,the,O,3780
77237,developed,O,3780
77238,solutions,O,3780
77239,for,O,3780
77240,improving,O,3780
77241,these,O,3780
77242,vision,O,3780
77243,issues,O,3780
77244,Although,O,3780
77245,the,O,3780
77246,progression,O,3780
77247,of,O,3780
77248,presbyopia,B-NAME_OF_DISEASE,3780
77249,can,O,3781
77250,not,O,3781
77251,be,O,3781
77252,prevented,O,3781
77253,the,O,3781
77254,good,O,3781
77255,news,O,3781
77256,is,O,3781
77257,that,O,3781
77258,with,O,3781
77259,the,O,3781
77260,help,O,3781
77261,of,O,3781
77262,advanced,O,3781
77263,technology,O,3781
77264,corneal,B-TREATMENT,3781
77265,inlays,I-TREATMENT,3781
77266,are,O,3781
77267,used,O,3781
77268,for,O,3781
77269,treatments,O,3781
77270,Kamra,B-TREATMENT,3781
77271,Corneal,I-TREATMENT,3781
77272,Inlays,I-TREATMENT,3781
77273,In,O,3781
77274,addition,O,3782
77275,to,O,3782
77276,corneal,B-TREATMENT,3782
77277,inlay,I-TREATMENT,3782
77278,treatments,I-TREATMENT,3782
77279,the,O,3782
77280,most,O,3782
77281,developed,O,3782
77282,method,O,3782
77283,was,O,3782
77284,launched,O,3783
77285,in,O,3783
77286,2005,O,3783
77287,with,O,3783
77288,Kamra,B-TREATMENT,3783
77289,corneal,I-TREATMENT,3783
77290,inlay,I-TREATMENT,3783
77291,for,O,3783
77292,presbyopia,B-NAME_OF_DISEASE,3783
77293,treatment,O,3783
77294,The,O,3783
77295,patients,O,3783
77296,should,O,3783
77297,have,O,3783
77298,non-dominant,O,3783
77299,eyes,O,3783
77300,for,O,3783
77301,this,O,3783
77302,Kamra,B-TREATMENT,3784
77303,corneal,I-TREATMENT,3784
77304,treatment,I-TREATMENT,3784
77305,generally,O,3784
77306,for,O,3784
77307,those,O,3784
77308,who,O,3784
77309,are,O,3784
77310,between,O,3784
77311,45,O,3784
77312,and,O,3784
77313,60,O,3784
77314,Kamra,B-TREATMENT,3784
77315,has,O,3784
77316,a,O,3784
77317,pinhole,O,3784
77318,technique,O,3784
77319,that,O,3784
77320,improves,O,3784
77321,focusing,O,3785
77322,the,O,3785
77323,light,O,3785
77324,so,O,3785
77325,that,O,3785
77326,it,O,3785
77327,gives,O,3785
77328,a,O,3785
77329,depth,O,3785
77330,focus,O,3785
77331,as,O,3785
77332,a,O,3785
77333,result,O,3786
77334,of,O,3786
77335,the,O,3786
77336,surgical,O,3786
77337,procedure,O,3786
77338,Even,O,3786
77339,though,O,3786
77340,it,O,3786
77341,is,O,3786
77342,a,O,3786
77343,commonly,O,3786
77344,chosen,O,3786
77345,solution,O,3786
77346,for,O,3787
77347,corneal,B-TREATMENT,3787
77348,inlay,I-TREATMENT,3787
77349,treatments,I-TREATMENT,3787
77350,Kamra,B-TREATMENT,3787
77351,may,O,3787
77352,relatively,O,3787
77353,not,O,3787
77354,be,O,3787
77355,recommended,O,3787
77356,for,O,3787
77357,patients,O,3787
77358,who,O,3787
77359,work,O,3787
77360,on,O,3787
77361,detailed,O,3787
77362,projects,O,3787
77363,data,O,3787
77364,analytics,O,3788
77365,or,O,3788
77366,any,O,3788
77367,other,O,3788
77368,vision-related,O,3788
77369,professional,O,3788
77370,positions,O,3788
77371,In,O,3788
77372,some,O,3788
77373,cases,O,3788
77374,a,O,3788
77375,consecutive,O,3788
77376,or,O,3788
77377,simultaneous,O,3788
77378,treatment,O,3788
77379,can,O,3788
77380,be,O,3788
77381,operated,O,3788
77382,according,O,3788
77383,to,O,3788
77384,the,O,3788
77385,patient,O,3788
77386,s,O,3788
77387,preference,O,3788
77388,and,O,3788
77389,conditions,O,3788
77390,so,O,3788
77391,that,O,3788
77392,the,O,3788
77393,near,O,3788
77394,and,O,3788
77395,far,O,3788
77396,vision,O,3788
77397,errors,O,3788
77398,can,O,3788
77399,also,O,3789
77400,be,O,3789
77401,corrected,O,3789
77402,at,O,3789
77403,the,O,3789
77404,same,O,3789
77405,time,O,3789
77406,or,O,3789
77407,for,O,3789
77408,some,O,3789
77409,time,O,3789
77410,Raindrop,B-TREATMENT,3789
77411,is,O,3789
77412,another,O,3789
77413,alternative,O,3789
77414,for,O,3789
77415,corneal,B-TREATMENT,3789
77416,inlays,I-TREATMENT,3789
77417,however,O,3789
77418,the,O,3789
77419,research,O,3789
77420,and,O,3789
77421,experiments,O,3789
77422,on,O,3789
77423,the,O,3789
77424,patient,O,3789
77425,give,O,3789
77426,more,O,3789
77427,importance,O,3789
77428,to,O,3790
77429,the,O,3790
77430,patient,O,3790
77431,s,O,3790
77432,safety,O,3790
77433,for,O,3790
77434,treatment,O,3790
77435,Pediatric,O,3790
77436,ophthalmology,O,3790
77437,is,O,3790
77438,a,O,3790
77439,sub-speciality,O,3790
77440,of,O,3790
77441,ophthalmology,O,3790
77442,concerned,O,3790
77443,with,O,3790
77444,eye,O,3790
77445,diseases,O,3790
77446,visual,O,3790
77447,development,O,3790
77448,and,O,3790
77449,vision,O,3790
77450,care,O,3790
77451,in,O,3790
77452,children,O,3790
77453,Pediatric,O,3790
77454,ophthalmologists,O,3790
77455,focus,O,3790
77456,on,O,3790
77457,the,O,3790
77458,development,O,3790
77459,of,O,3790
77460,the,O,3790
77461,visual,O,3790
77462,system,O,3790
77463,and,O,3790
77464,the,O,3790
77465,various,O,3790
77466,diseases,O,3790
77467,that,O,3791
77468,disrupt,O,3791
77469,visual,O,3791
77470,development,O,3791
77471,in,O,3791
77472,children,O,3791
77473,Pediatric,O,3791
77474,ophthalmologists,O,3791
77475,also,O,3791
77476,have,O,3791
77477,expertise,O,3791
77478,in,O,3791
77479,managing,O,3791
77480,the,O,3791
77481,various,O,3792
77482,ocular,O,3792
77483,diseases,O,3792
77484,that,O,3792
77485,affect,O,3792
77486,children,O,3792
77487,The,O,3792
77488,past,O,3792
77489,25,O,3792
77490,years,O,3792
77491,have,O,3792
77492,seen,O,3792
77493,remarkable,O,3792
77494,advances,O,3792
77495,in,O,3792
77496,clinical,O,3792
77497,eye,O,3792
77498,care,O,3792
77499,for,O,3792
77500,children,O,3792
77501,in,O,3792
77502,the,O,3792
77503,world,O,3792
77504,This,O,3792
77505,has,O,3792
77506,led,O,3792
77507,to,O,3792
77508,both,O,3792
77509,improved,O,3792
77510,outcomes,O,3792
77511,and,O,3792
77512,better,O,3792
77513,patient,O,3792
77514,and,O,3792
77515,family,O,3792
77516,experiences,O,3792
77517,There,O,3792
77518,have,O,3793
77519,been,O,3793
77520,substantial,O,3793
77521,changes,O,3793
77522,to,O,3793
77523,patient,O,3793
77524,pathways,O,3793
77525,major,O,3793
77526,advances,O,3793
77527,in,O,3793
77528,diagnostic,O,3793
77529,techniques,O,3793
77530,and,O,3793
77531,treatments,O,3793
77532,and,O,3793
77533,a,O,3793
77534,more,O,3793
77535,robust,O,3793
77536,evidence,O,3793
77537,base,O,3793
77538,underpinning,O,3793
77539,the,O,3793
77540,delivery,O,3793
77541,of,O,3793
77542,care,O,3793
77543,Pediatric,O,3793
77544,ophthalmology,O,3794
77545,is,O,3794
77546,now,O,3794
77547,universally,O,3794
77548,recognized,O,3794
77549,as,O,3794
77550,a,O,3794
77551,specific,O,3794
77552,sub-specialty,O,3794
77553,Ophthalmic,O,3794
77554,care,O,3794
77555,of,O,3794
77556,children,O,3794
77557,in,O,3794
77558,2020,O,3794
77559,is,O,3794
77560,no,O,3794
77561,longer,O,3794
77562,something,O,3794
77563,that,O,3794
77564,general,O,3794
77565,ophthalmologists,O,3794
77566,do,O,3794
77567,as,O,3794
77568,an,O,3794
77569,adjunct,O,3794
77570,to,O,3794
77571,their,O,3794
77572,predominantly,O,3795
77573,adult,O,3795
77574,clinical,O,3795
77575,practice,O,3795
77576,It,O,3795
77577,is,O,3795
77578,instead,O,3795
77579,delivered,O,3795
77580,in,O,3795
77581,dedicated,O,3795
77582,pediatric,O,3795
77583,ophthalmology,O,3795
77584,clinics,O,3795
77585,by,O,3795
77586,teams,O,3795
77587,with,O,3795
77588,expertise,O,3795
77589,in,O,3795
77590,the,O,3795
77591,care,O,3795
77592,of,O,3795
77593,children,O,3795
77594,Advances,O,3795
77595,in,O,3795
77596,diagnostic,O,3795
77597,and,O,3795
77598,imaging,O,3795
77599,techniques,O,3796
77600,originally,O,3796
77601,developed,O,3796
77602,for,O,3796
77603,adult,O,3796
77604,patients,O,3796
77605,such,O,3796
77606,as,O,3796
77607,optical,B-DIAGNOSTIC_TEST,3796
77608,coherence,I-DIAGNOSTIC_TEST,3796
77609,tomography,I-DIAGNOSTIC_TEST,3796
77610,OCT,I-DIAGNOSTIC_TEST,3796
77611,widescreen,B-DIAGNOSTIC_TEST,3796
77612,digital,I-DIAGNOSTIC_TEST,3796
77613,imaging,I-DIAGNOSTIC_TEST,3796
77614,Optos,I-DIAGNOSTIC_TEST,3796
77615,and,O,3796
77616,modern,B-DIAGNOSTIC_TEST,3796
77617,fluorescein,I-DIAGNOSTIC_TEST,3796
77618,angiography,I-DIAGNOSTIC_TEST,3796
77619,have,O,3796
77620,expanded,O,3796
77621,the,O,3796
77622,options,O,3796
77623,available,O,3797
77624,for,O,3797
77625,the,O,3797
77626,investigation,O,3797
77627,of,O,3797
77628,children,O,3797
77629,Readily,B-DIAGNOSTIC_TEST,3797
77630,available,I-DIAGNOSTIC_TEST,3797
77631,genetic,I-DIAGNOSTIC_TEST,3797
77632,testing,I-DIAGNOSTIC_TEST,3797
77633,has,O,3797
77634,changed,O,3797
77635,the,O,3797
77636,way,O,3797
77637,we,O,3797
77638,approach,O,3797
77639,the,O,3797
77640,investigation,O,3797
77641,and,O,3797
77642,management,O,3797
77643,of,O,3797
77644,children,O,3797
77645,with,O,3797
77646,rare,O,3797
77647,and,O,3797
77648,complex,O,3797
77649,eye,O,3797
77650,disease,O,3797
77651,Application,O,3797
77652,of,O,3797
77653,new,O,3797
77654,diagnostic,O,3797
77655,techniques,O,3797
77656,for,O,3797
77657,deep,B-DIAGNOSTIC_TEST,3797
77658,phenotyping,I-DIAGNOSTIC_TEST,3797
77659,in,I-DIAGNOSTIC_TEST,3797
77660,combination,I-DIAGNOSTIC_TEST,3797
77661,with,I-DIAGNOSTIC_TEST,3798
77662,genomic,I-DIAGNOSTIC_TEST,3798
77663,testing,I-DIAGNOSTIC_TEST,3798
77664,enhances,O,3798
77665,the,O,3798
77666,accuracy,O,3798
77667,of,O,3798
77668,diagnosis,O,3798
77669,and,O,3798
77670,prognosis,O,3798
77671,This,O,3798
77672,now,O,3798
77673,enables,O,3798
77674,the,O,3798
77675,introduction,O,3798
77676,of,O,3798
77677,TRUE,O,3798
77678,personalized,O,3798
77679,medicine,O,3798
77680,for,O,3798
77681,children,O,3798
77682,with,O,3798
77683,rare,O,3799
77684,ophthalmic,O,3799
77685,disorders,O,3799
77686,Equally,O,3799
77687,importantly,O,3799
77688,increased,O,3799
77689,awareness,O,3799
77690,of,O,3799
77691,social,O,3799
77692,and,O,3799
77693,safeguarding,O,3799
77694,issues,O,3799
77695,has,O,3799
77696,improved,O,3799
77697,child,O,3799
77698,protection,O,3799
77699,strategies,O,3799
77700,across,O,3799
77701,pediatric,O,3799
77702,healthcare,O,3799
77703,ensuring,O,3799
77704,clinicians,O,3799
77705,and,O,3799
77706,their,O,3799
77707,teams,O,3799
77708,better,O,3799
77709,protect,O,3799
77710,children,O,3800
77711,from,O,3800
77712,harm,O,3800
77713,We,O,3800
77714,believe,O,3800
77715,that,O,3800
77716,these,O,3800
77717,developments,O,3800
77718,in,O,3800
77719,medical,O,3800
77720,and,O,3800
77721,surgical,O,3800
77722,care,O,3800
77723,will,O,3800
77724,ensure,O,3800
77725,that,O,3800
77726,pediatric,O,3800
77727,ophthalmology,O,3801
77728,remains,O,3801
77729,one,O,3801
77730,of,O,3801
77731,the,O,3801
77732,most,O,3801
77733,exciting,O,3801
77734,subspecialties,O,3801
77735,well,O,3801
77736,into,O,3801
77737,the,O,3801
77738,future,O,3801
77739,Also,O,3801
77740,recent,O,3801
77741,regulatory,O,3801
77742,changes,O,3801
77743,have,O,3801
77744,meant,O,3801
77745,that,O,3801
77746,pharmaceutical,O,3801
77747,companies,O,3801
77748,must,O,3801
77749,consider,O,3801
77750,the,O,3801
77751,needs,O,3801
77752,of,O,3801
77753,children,O,3801
77754,as,O,3801
77755,well,O,3802
77756,as,O,3802
77757,adults,O,3802
77758,when,O,3802
77759,seeking,O,3802
77760,a,O,3802
77761,license,O,3802
77762,for,O,3802
77763,new,O,3802
77764,treatments,O,3802
77765,In,O,3802
77766,the,O,3802
77767,future,O,3802
77768,clinicians,O,3802
77769,should,O,3802
77770,be,O,3802
77771,thus,O,3802
77772,able,O,3802
77773,to,O,3802
77774,prescribe,O,3802
77775,medication,O,3802
77776,for,O,3803
77777,children,O,3803
77778,with,O,3803
77779,a,O,3803
77780,better,O,3803
77781,evidence,O,3803
77782,base,O,3803
77783,of,O,3803
77784,efficacy,O,3803
77785,and,O,3803
77786,safety,O,3803
77787,We,O,3803
77788,anticipate,O,3803
77789,that,O,3803
77790,the,O,3803
77791,need,O,3803
77792,to,O,3803
77793,grow,O,3803
77794,and,O,3803
77795,enhance,O,3803
77796,the,O,3804
77797,currently,O,3804
77798,limited,O,3804
77799,evidence,O,3804
77800,base,O,3804
77801,for,O,3804
77802,much,O,3804
77803,pediatric,O,3804
77804,eye,O,3804
77805,care,O,3804
77806,will,O,3804
77807,lead,O,3804
77808,to,O,3804
77809,more,O,3804
77810,research,O,3804
77811,and,O,3804
77812,specifically,O,3805
77813,the,O,3805
77814,establishment,O,3805
77815,of,O,3805
77816,new,O,3805
77817,clinical,O,3805
77818,trials,O,3805
77819,in,O,3805
77820,this,O,3805
77821,area,O,3805
77822,Changes,O,3805
77823,to,O,3805
77824,the,O,3805
77825,way,O,3805
77826,we,O,3805
77827,care,O,3805
77828,for,O,3805
77829,children,O,3805
77830,in,O,3805
77831,pediatric,O,3805
77832,ophthalmology,O,3805
77833,Children,O,3805
77834,in,O,3805
77835,2020,O,3805
77836,are,O,3805
77837,rarely,O,3806
77838,seen,O,3806
77839,within,O,3806
77840,a,O,3806
77841,general,O,3806
77842,predominantly,O,3806
77843,adult,O,3806
77844,clinic,O,3806
77845,and,O,3806
77846,are,O,3806
77847,much,O,3806
77848,more,O,3806
77849,likely,O,3806
77850,to,O,3806
77851,be,O,3806
77852,assessed,O,3806
77853,in,O,3806
77854,child-focused,O,3806
77855,dedicated,O,3806
77856,pediatric,O,3806
77857,clinics,O,3806
77858,with,O,3807
77859,facilities,O,3807
77860,specifically,O,3807
77861,pitched,O,3807
77862,towards,O,3807
77863,children,O,3807
77864,and,O,3807
77865,by,O,3807
77866,experienced,O,3807
77867,staff,O,3807
77868,with,O,3807
77869,appropriate,O,3807
77870,safeguarding,O,3807
77871,training,O,3807
77872,This,O,3807
77873,has,O,3807
77874,substantially,O,3807
77875,improved,O,3807
77876,the,O,3807
77877,experience,O,3807
77878,of,O,3807
77879,care,O,3807
77880,for,O,3807
77881,the,O,3807
77882,children,O,3807
77883,and,O,3807
77884,their,O,3807
77885,families,O,3807
77886,The,O,3807
77887,majority,O,3808
77888,of,O,3808
77889,consultants,O,3808
77890,who,O,3808
77891,regularly,O,3808
77892,deal,O,3808
77893,with,O,3808
77894,children,O,3808
77895,now,O,3808
77896,have,O,3808
77897,a,O,3808
77898,subspeciality,O,3808
77899,interest,O,3808
77900,in,O,3808
77901,pediatric,O,3808
77902,ophthalmology,O,3809
77903,usually,O,3809
77904,following,O,3809
77905,post-CCT,O,3809
77906,fellowship,O,3809
77907,training,O,3809
77908,Pediatric,O,3809
77909,ophthalmology,O,3809
77910,clinics,O,3809
77911,require,O,3809
77912,multidisciplinary,O,3809
77913,expertise,O,3809
77914,Orthoptists,O,3809
77915,have,O,3809
77916,traditionally,O,3809
77917,played,O,3809
77918,a,O,3809
77919,key,O,3809
77920,part,O,3809
77921,but,O,3809
77922,other,O,3809
77923,allied,O,3809
77924,health,O,3810
77925,professionals,O,3810
77926,AHPs,O,3810
77927,such,O,3810
77928,as,O,3810
77929,pediatric,O,3810
77930,optometrists,O,3810
77931,vision,O,3810
77932,scientists,O,3810
77933,and,O,3810
77934,eye,O,3810
77935,clinic,O,3810
77936,liaison,O,3810
77937,officers,O,3810
77938,ECLOs,O,3810
77939,have,O,3810
77940,crucial,O,3810
77941,roles,O,3810
77942,in,O,3811
77943,the,O,3811
77944,delivery,O,3811
77945,of,O,3811
77946,high-quality,O,3811
77947,pediatric,O,3811
77948,ophthalmology,O,3811
77949,AHPs,O,3811
77950,often,O,3811
77951,work,O,3811
77952,independently,O,3811
77953,both,O,3811
77954,within,O,3811
77955,the,O,3811
77956,hospital,O,3811
77957,setting,O,3811
77958,and,O,3811
77959,in,O,3811
77960,community,O,3811
77961,clinics,O,3811
77962,and,O,3811
77963,support,O,3811
77964,traditional,O,3811
77965,outpatient,O,3811
77966,clinics,O,3811
77967,by,O,3811
77968,working,O,3811
77969,closely,O,3811
77970,with,O,3811
77971,pediatric,O,3811
77972,ophthalmologists,O,3811
77973,Clinics,O,3811
77974,are,O,3812
77975,ideally,O,3812
77976,supported,O,3812
77977,by,O,3812
77978,pediatric,O,3812
77979,nurses,O,3812
77980,with,O,3812
77981,the,O,3812
77982,appropriate,O,3812
77983,training,O,3812
77984,and,O,3812
77985,expertise,O,3812
77986,Examples,O,3812
77987,of,O,3812
77988,current,O,3812
77989,modern,O,3812
77990,practice,O,3813
77991,would,O,3813
77992,be,O,3813
77993,orthoptic,O,3813
77994,optometry-led,O,3813
77995,clinics,O,3813
77996,in,O,3813
77997,both,O,3813
77998,the,O,3813
77999,community,O,3813
78000,and,O,3813
78001,in,O,3813
78002,hospital,O,3813
78003,This,O,3813
78004,could,O,3813
78005,include,O,3813
78006,specialized,O,3813
78007,follow-up,O,3813
78008,clinics,O,3813
78009,in,O,3813
78010,for,O,3813
78011,instance,O,3813
78012,pediatric,B-NAME_OF_DISEASE,3813
78013,cataract,I-NAME_OF_DISEASE,3813
78014,or,O,3813
78015,uveitis,B-NAME_OF_DISEASE,3813
78016,led,O,3813
78017,by,O,3813
78018,orthoptists,O,3813
78019,or,O,3813
78020,optometrists,O,3813
78021,running,O,3813
78022,in,O,3813
78023,parallel,O,3813
78024,with,O,3813
78025,a,O,3814
78026,consultant-led,O,3814
78027,clinic,O,3814
78028,All,O,3814
78029,staff,O,3814
78030,dealing,O,3814
78031,with,O,3814
78032,children,O,3814
78033,now,O,3815
78034,receive,O,3815
78035,mandatory,O,3815
78036,safeguarding,O,3815
78037,training,O,3815
78038,This,O,3815
78039,helps,O,3815
78040,ensure,O,3815
78041,that,O,3815
78042,child,O,3815
78043,protection,O,3815
78044,issues,O,3815
78045,or,O,3815
78046,signs,O,3815
78047,of,O,3815
78048,abuse,O,3815
78049,can,O,3815
78050,be,O,3815
78051,detected,O,3815
78052,and,O,3815
78053,acted,O,3815
78054,upon,O,3815
78055,appropriately,O,3815
78056,Advances,O,3815
78057,in,O,3815
78058,imaging,O,3815
78059,and,O,3815
78060,diagnostic,O,3815
78061,tools,O,3815
78062,Accurate,O,3815
78063,assessment,O,3815
78064,and,O,3815
78065,monitoring,O,3815
78066,of,O,3815
78067,eye,O,3815
78068,disease,O,3815
78069,in,O,3815
78070,children,O,3815
78071,has,O,3816
78072,always,O,3816
78073,been,O,3816
78074,challenging,O,3816
78075,Young,O,3816
78076,children,O,3816
78077,and,O,3816
78078,children,O,3816
78079,with,O,3816
78080,neurodevelopmental,O,3816
78081,problems,O,3816
78082,can,O,3816
78083,be,O,3816
78084,difficult,O,3816
78085,to,O,3816
78086,examine,O,3816
78087,They,O,3816
78088,may,O,3817
78089,be,O,3817
78090,anxious,O,3817
78091,upset,O,3817
78092,or,O,3817
78093,fractious,O,3817
78094,and,O,3817
78095,thus,O,3817
78096,fail,O,3817
78097,to,O,3817
78098,fully,O,3817
78099,cooperate,O,3817
78100,Physical,O,3817
78101,limitations,O,3818
78102,can,O,3818
78103,also,O,3818
78104,present,O,3818
78105,boundaries,O,3818
78106,when,O,3818
78107,using,O,3818
78108,instruments,O,3818
78109,and,O,3818
78110,techniques,O,3818
78111,that,O,3818
78112,were,O,3818
78113,designed,O,3818
78114,for,O,3818
78115,use,O,3818
78116,in,O,3818
78117,adults,O,3818
78118,In,O,3818
78119,the,O,3819
78120,past,O,3819
78121,clinicians,O,3819
78122,frequently,O,3819
78123,resorted,O,3819
78124,to,O,3819
78125,examination,B-TREATMENT,3819
78126,under,I-TREATMENT,3819
78127,anesthesia,I-TREATMENT,3819
78128,EUA,I-TREATMENT,3819
78129,for,O,3819
78130,a,O,3819
78131,child,O,3819
78132,in,O,3819
78133,whom,O,3819
78134,it,O,3819
78135,was,O,3819
78136,impossible,O,3819
78137,to,O,3819
78138,obtain,O,3819
78139,an,B-DIAGNOSTIC_TEST,3819
78140,IOP,B-DIAGNOSTIC_TEST,3819
78141,measurement,I-DIAGNOSTIC_TEST,3819
78142,or,O,3819
78143,when,O,3820
78144,a,O,3820
78145,fundal,B-DIAGNOSTIC_TEST,3820
78146,examination,I-DIAGNOSTIC_TEST,3820
78147,was,O,3820
78148,similarly,O,3820
78149,difficult,O,3820
78150,but,O,3820
78151,very,O,3820
78152,important,O,3820
78153,The,O,3820
78154,availability,O,3820
78155,of,O,3820
78156,i-Care,B-TREATMENT,3820
78157,rebound,I-TREATMENT,3820
78158,tonometry,I-TREATMENT,3820
78159,which,O,3820
78160,can,O,3820
78161,be,O,3820
78162,used,O,3820
78163,swiftly,O,3820
78164,without,O,3820
78165,eye,O,3820
78166,drops,O,3821
78167,on,O,3821
78168,a,O,3821
78169,child,O,3821
78170,with,O,3821
78171,minimal,O,3821
78172,cooperation,O,3821
78173,has,O,3821
78174,greatly,O,3821
78175,reduced,O,3821
78176,the,O,3821
78177,number,O,3821
78178,of,O,3821
78179,EUAs,B-TREATMENT,3821
78180,carried,O,3821
78181,out,O,3821
78182,This,O,3821
78183,has,O,3821
78184,been,O,3821
78185,particularly,O,3821
78186,beneficial,O,3821
78187,for,O,3821
78188,children,O,3822
78189,with,O,3822
78190,conditions,O,3822
78191,such,O,3822
78192,as,O,3822
78193,glaucoma,B-NAME_OF_DISEASE,3822
78194,aniridia,B-NAME_OF_DISEASE,3822
78195,or,O,3822
78196,facial,B-NAME_OF_DISEASE,3822
78197,port-wine,I-NAME_OF_DISEASE,3822
78198,stains,I-NAME_OF_DISEASE,3822
78199,where,O,3822
78200,regular,O,3822
78201,IOP,B-DIAGNOSTIC_TEST,3822
78202,measurement,I-DIAGNOSTIC_TEST,3822
78203,is,O,3822
78204,a,O,3822
78205,crucial,O,3822
78206,part,O,3822
78207,of,O,3822
78208,assessment,O,3822
78209,and,O,3822
78210,monitoring,O,3822
78211,but,O,3822
78212,repeated,O,3822
78213,anesthesia,O,3822
78214,carries,O,3822
78215,concerns,O,3822
78216,about,O,3822
78217,the,O,3822
78218,impact,O,3822
78219,on,O,3822
78220,neurodevelopment,O,3822
78221,OCT,B-DIAGNOSTIC_TEST,3822
78222,has,O,3822
78223,also,O,3822
78224,made,O,3822
78225,a,O,3822
78226,huge,O,3822
78227,impact,O,3822
78228,on,O,3822
78229,diagnosis,O,3822
78230,and,O,3823
78231,assessment,O,3823
78232,in,O,3823
78233,pediatric,O,3823
78234,ophthalmology,O,3823
78235,An,O,3823
78236,experienced,O,3823
78237,imaging,O,3823
78238,technician,O,3823
78239,can,O,3823
78240,successfully,O,3823
78241,obtain,O,3823
78242,useful,O,3823
78243,OCT,B-DIAGNOSTIC_TEST,3823
78244,images,O,3823
78245,in,O,3823
78246,a,O,3823
78247,cooperative,O,3823
78248,child,O,3823
78249,from,O,3823
78250,the,O,3823
78251,age,O,3823
78252,of,O,3823
78253,three,O,3823
78254,upwards,O,3823
78255,and,O,3823
78256,it,O,3824
78257,has,O,3824
78258,thus,O,3824
78259,become,O,3824
78260,invaluable,O,3824
78261,in,O,3824
78262,the,O,3824
78263,assessment,O,3824
78264,of,O,3824
78265,both,O,3824
78266,anterior,O,3824
78267,and,O,3824
78268,posterior,O,3824
78269,segment,O,3824
78270,pediatric,O,3824
78271,pathology,O,3824
78272,For,O,3824
78273,instance,O,3824
78274,OCT,B-DIAGNOSTIC_TEST,3824
78275,imaging,O,3824
78276,of,O,3824
78277,swollen,B-SIGN_AND_SYMPTOM,3824
78278,optic,I-SIGN_AND_SYMPTOM,3824
78279,discs,I-SIGN_AND_SYMPTOM,3825
78280,can,O,3825
78281,help,O,3825
78282,the,O,3825
78283,clinician,O,3825
78284,distinguish,O,3825
78285,between,O,3825
78286,anomalous,B-SIGN_AND_SYMPTOM,3825
78287,looking,I-SIGN_AND_SYMPTOM,3825
78288,discs,I-SIGN_AND_SYMPTOM,3825
78289,due,O,3825
78290,to,O,3825
78291,optic,B-NAME_OF_DISEASE,3825
78292,disc,I-NAME_OF_DISEASE,3825
78293,drusen,I-NAME_OF_DISEASE,3825
78294,as,O,3825
78295,compared,O,3825
78296,to,O,3825
78297,papilloedema,B-SIGN_AND_SYMPTOM,3825
78298,Similarly,O,3825
78299,OCT,B-DIAGNOSTIC_TEST,3825
78300,is,O,3825
78301,invaluable,O,3825
78302,for,O,3825
78303,retinal,O,3825
78304,assessment,O,3826
78305,and,O,3826
78306,diagnosis,O,3826
78307,retinal,B-NAME_OF_DISEASE,3826
78308,dystrophies,I-NAME_OF_DISEASE,3826
78309,foveal,B-NAME_OF_DISEASE,3826
78310,hypoplasia,I-NAME_OF_DISEASE,3826
78311,developmental,O,3826
78312,disorders,O,3826
78313,as,O,3826
78314,well,O,3826
78315,as,O,3826
78316,macular,B-SIGN_AND_SYMPTOM,3826
78317,edema,I-SIGN_AND_SYMPTOM,3826
78318,diagnosis,O,3826
78319,and,O,3826
78320,monitoring,O,3827
78321,in,O,3827
78322,uveitis,B-NAME_OF_DISEASE,3827
78323,and,O,3827
78324,other,O,3827
78325,conditions,O,3827
78326,The,O,3827
78327,advent,O,3827
78328,of,O,3827
78329,the,B-DIAGNOSTIC_TEST,3827
78330,handheld,I-DIAGNOSTIC_TEST,3827
78331,or,I-DIAGNOSTIC_TEST,3827
78332,microscope,I-DIAGNOSTIC_TEST,3828
78333,mounted,I-DIAGNOSTIC_TEST,3828
78334,OCT,I-DIAGNOSTIC_TEST,3828
78335,has,O,3828
78336,meant,O,3828
78337,that,O,3828
78338,images,O,3828
78339,can,O,3828
78340,now,O,3828
78341,be,O,3828
78342,obtained,O,3828
78343,both,O,3828
78344,in,O,3828
78345,infants,O,3829
78346,and,O,3829
78347,during,O,3829
78348,surgery,O,3829
78349,or,O,3829
78350,examination,O,3829
78351,under,O,3829
78352,anesthetic,O,3829
78353,This,O,3829
78354,can,O,3829
78355,be,O,3829
78356,invaluable,O,3829
78357,in,O,3829
78358,the,O,3829
78359,diagnosis,O,3829
78360,and,O,3829
78361,assessment,O,3829
78362,of,O,3829
78363,young,O,3829
78364,children,O,3829
78365,with,O,3829
78366,nystagmus,B-NAME_OF_DISEASE,3829
78367,glaucoma,B-NAME_OF_DISEASE,3829
78368,retinal,O,3829
78369,pathology,O,3830
78370,and,O,3830
78371,the,O,3830
78372,retinal,O,3830
78373,complications,O,3830
78374,of,O,3830
78375,non-accidental,O,3830
78376,injury,O,3830
78377,OCT,B-DIAGNOSTIC_TEST,3830
78378,angiography,I-DIAGNOSTIC_TEST,3830
78379,is,O,3830
78380,currently,O,3830
78381,seldom,O,3830
78382,used,O,3830
78383,in,O,3830
78384,children,O,3830
78385,but,O,3830
78386,has,O,3830
78387,the,O,3830
78388,potential,O,3830
78389,to,O,3830
78390,be,O,3830
78391,a,O,3830
78392,powerful,O,3830
78393,tool,O,3830
78394,for,O,3830
78395,non-invasive,O,3830
78396,delineation,O,3830
78397,of,O,3830
78398,pediatric,O,3830
78399,retinal,O,3830
78400,vascular,O,3830
78401,and,O,3830
78402,structural,O,3830
78403,diseases,O,3831
78404,such,O,3831
78405,as,O,3831
78406,familial,B-NAME_OF_DISEASE,3831
78407,exudative,I-NAME_OF_DISEASE,3831
78408,vitreoretinopathy,I-NAME_OF_DISEASE,3831
78409,FEVR,I-NAME_OF_DISEASE,3831
78410,Incontinentia,B-NAME_OF_DISEASE,3831
78411,Pigmentii,I-NAME_OF_DISEASE,3831
78412,and,O,3831
78413,foveal,B-NAME_OF_DISEASE,3831
78414,hypoplasia,I-NAME_OF_DISEASE,3831
78415,Advances,O,3831
78416,in,O,3831
78417,digital,B-DIAGNOSTIC_TEST,3831
78418,fundal,I-DIAGNOSTIC_TEST,3831
78419,imaging,I-DIAGNOSTIC_TEST,3831
78420,in,O,3831
78421,children,O,3831
78422,have,O,3832
78423,transformed,O,3832
78424,the,O,3832
78425,diagnosis,O,3832
78426,and,O,3832
78427,monitoring,O,3832
78428,of,O,3832
78429,a,O,3832
78430,wide,O,3832
78431,range,O,3832
78432,of,O,3832
78433,children,O,3832
78434,s,O,3832
78435,eye,O,3832
78436,diseases,O,3832
78437,RetCam,B-DIAGNOSTIC_TEST,3832
78438,and,O,3832
78439,newer,O,3832
78440,more,O,3832
78441,portable,B-DIAGNOSTIC_TEST,3832
78442,digital,I-DIAGNOSTIC_TEST,3832
78443,fundal,I-DIAGNOSTIC_TEST,3832
78444,imaging,I-DIAGNOSTIC_TEST,3832
78445,devices,I-DIAGNOSTIC_TEST,3832
78446,such,I-DIAGNOSTIC_TEST,3832
78447,as,I-DIAGNOSTIC_TEST,3833
78448,PanoCam,I-DIAGNOSTIC_TEST,3833
78449,are,O,3833
78450,now,O,3833
78451,routinely,O,3833
78452,used,O,3833
78453,in,O,3833
78454,infants,O,3833
78455,and,O,3833
78456,young,O,3833
78457,children,O,3833
78458,for,O,3833
78459,the,O,3833
78460,documentation,O,3833
78461,of,O,3833
78462,retinal,O,3833
78463,disease,O,3833
78464,Digital,B-DIAGNOSTIC_TEST,3833
78465,imaging,I-DIAGNOSTIC_TEST,3833
78466,is,O,3833
78467,particularly,O,3833
78468,important,O,3833
78469,for,O,3833
78470,the,O,3833
78471,diagnosis,O,3833
78472,monitoring,O,3833
78473,and,O,3833
78474,documentation,O,3833
78475,of,O,3833
78476,retinopathy,B-NAME_OF_DISEASE,3833
78477,of,I-NAME_OF_DISEASE,3833
78478,prematurity,I-NAME_OF_DISEASE,3834
78479,ROP,B-NAME_OF_DISEASE,3834
78480,,O,3834
78481,It,O,3834
78482,has,O,3834
78483,significantly,O,3834
78484,enabled,O,3834
78485,trained,O,3834
78486,non-medical,O,3834
78487,users,O,3834
78488,to,O,3834
78489,send,O,3834
78490,images,O,3834
78491,obtained,O,3834
78492,in,O,3834
78493,the,O,3834
78494,neonatal,O,3834
78495,intensive,O,3834
78496,care,O,3834
78497,unit,O,3834
78498,NICU,O,3834
78499,to,O,3834
78500,a,O,3834
78501,remote,O,3834
78502,expert,O,3834
78503,for,O,3835
78504,interpretation,O,3835
78505,-,O,3835
78506,TRUE,O,3835
78507,telemedicine,B-TREATMENT,3835
78508,,O,3835
78509,This,O,3835
78510,principle,O,3835
78511,may,O,3835
78512,be,O,3835
78513,transformative,O,3835
78514,for,O,3835
78515,the,O,3835
78516,delivery,O,3835
78517,of,O,3835
78518,high-quality,O,3835
78519,ROP,B-NAME_OF_DISEASE,3835
78520,care,O,3835
78521,in,O,3835
78522,the,O,3835
78523,developing,O,3835
78524,world,O,3835
78525,where,O,3835
78526,pediatric,O,3835
78527,ophthalmologists,O,3835
78528,are,O,3835
78529,scarce,O,3835
78530,Digital,O,3836
78531,documentation,O,3836
78532,of,O,3836
78533,retinal,B-NAME_OF_DISEASE,3836
78534,hemorrhages,I-NAME_OF_DISEASE,3836
78535,in,O,3836
78536,cases,O,3836
78537,of,O,3836
78538,suspected,O,3836
78539,non-accidental,O,3836
78540,injury,O,3836
78541,is,O,3836
78542,important,O,3836
78543,both,O,3836
78544,clinically,O,3836
78545,and,O,3836
78546,from,O,3836
78547,a,O,3836
78548,medico-legal,O,3836
78549,aspect,O,3836
78550,The,O,3837
78551,images,O,3837
78552,obtained,O,3837
78553,are,O,3837
78554,important,O,3837
78555,evidence,O,3837
78556,for,O,3837
78557,subsequent,O,3837
78558,hearings,O,3837
78559,in,O,3837
78560,both,O,3837
78561,the,O,3837
78562,family,O,3837
78563,and,O,3837
78564,criminal,O,3837
78565,courts,O,3837
78566,Optos,B-DIAGNOSTIC_TEST,3837
78567,widescreen,I-DIAGNOSTIC_TEST,3837
78568,digital,I-DIAGNOSTIC_TEST,3837
78569,imaging,I-DIAGNOSTIC_TEST,3837
78570,can,O,3837
78571,be,O,3837
78572,carried,O,3837
78573,out,O,3837
78574,from,O,3837
78575,at,O,3838
78576,least,O,3838
78577,four,O,3838
78578,years,O,3838
78579,of,O,3838
78580,age,O,3838
78581,in,O,3838
78582,a,O,3838
78583,cooperative,O,3838
78584,child,O,3838
78585,and,O,3838
78586,provides,O,3838
78587,quickly,O,3838
78588,captured,O,3838
78589,wide-angle,O,3838
78590,images,O,3838
78591,These,O,3838
78592,are,O,3838
78593,excellent,O,3838
78594,for,O,3838
78595,assisting,O,3838
78596,the,O,3838
78597,clinician,O,3838
78598,in,O,3838
78599,the,O,3838
78600,diagnosis,O,3838
78601,and,O,3838
78602,monitoring,O,3838
78603,of,O,3838
78604,both,O,3838
78605,pediatric,B-NAME_OF_DISEASE,3838
78606,retinal,I-NAME_OF_DISEASE,3838
78607,disease,I-NAME_OF_DISEASE,3838
78608,retinoblastoma,B-NAME_OF_DISEASE,3839
78609,and,O,3839
78610,posterior,B-NAME_OF_DISEASE,3839
78611,uveitis,I-NAME_OF_DISEASE,3839
78612,Fluorescein,B-DIAGNOSTIC_TEST,3839
78613,angiography,I-DIAGNOSTIC_TEST,3839
78614,and,O,3839
78615,the,B-DIAGNOSTIC_TEST,3839
78616,autofluorescence,I-DIAGNOSTIC_TEST,3839
78617,functions,I-DIAGNOSTIC_TEST,3839
78618,of,I-DIAGNOSTIC_TEST,3839
78619,digital,I-DIAGNOSTIC_TEST,3839
78620,imaging,I-DIAGNOSTIC_TEST,3839
78621,systems,I-DIAGNOSTIC_TEST,3839
78622,have,O,3839
78623,similarly,O,3839
78624,assisted,O,3839
78625,accurate,O,3839
78626,diagnosis,O,3839
78627,and,O,3839
78628,delineation,O,3839
78629,of,O,3839
78630,maculopathy,B-NAME_OF_DISEASE,3839
78631,retinal,B-NAME_OF_DISEASE,3839
78632,ischemia,I-NAME_OF_DISEASE,3839
78633,and,O,3840
78634,subretinal,B-NAME_OF_DISEASE,3840
78635,neovascular,I-NAME_OF_DISEASE,3840
78636,membranes,I-NAME_OF_DISEASE,3840
78637,in,O,3840
78638,pediatric,B-NAME_OF_DISEASE,3840
78639,retinal,I-NAME_OF_DISEASE,3840
78640,disease,I-NAME_OF_DISEASE,3840
78641,Digital,B-DIAGNOSTIC_TEST,3840
78642,imaging,I-DIAGNOSTIC_TEST,3840
78643,equipment,I-DIAGNOSTIC_TEST,3840
78644,for,O,3840
78645,documenting,O,3840
78646,eye,O,3840
78647,movements,O,3840
78648,using,O,3840
78649,eye-tracking,O,3840
78650,software,O,3840
78651,has,O,3840
78652,become,O,3840
78653,more,O,3840
78654,widely,O,3840
78655,available,O,3840
78656,These,O,3841
78657,instruments,O,3841
78658,provide,O,3841
78659,detailed,O,3841
78660,information,O,3841
78661,for,O,3841
78662,both,O,3841
78663,the,O,3841
78664,assessment,O,3841
78665,of,O,3841
78666,nystagmus,B-NAME_OF_DISEASE,3841
78667,and,O,3841
78668,other,O,3841
78669,neuro-ophthalmic,O,3841
78670,abnormalities,O,3841
78671,affecting,O,3841
78672,saccades,O,3842
78673,and,O,3842
78674,smooth,O,3842
78675,pursuit,O,3842
78676,eye,O,3842
78677,movements,O,3842
78678,This,O,3842
78679,has,O,3842
78680,allowed,O,3842
78681,a,O,3842
78682,more,O,3842
78683,accurate,O,3842
78684,diagnosis,O,3842
78685,and,O,3842
78686,the,O,3843
78687,planning,O,3843
78688,of,O,3843
78689,surgery,O,3843
78690,for,O,3843
78691,nystagmus,B-NAME_OF_DISEASE,3843
78692,related,O,3843
78693,abnormal,O,3843
78694,head,O,3843
78695,posture,O,3843
78696,Advances,O,3843
78697,in,O,3843
78698,treatment,O,3843
78699,options,O,3843
78700,for,O,3843
78701,children,O,3843
78702,with,O,3843
78703,eye,O,3843
78704,disease,O,3843
78705,The,O,3843
78706,last,O,3843
78707,quarter,O,3843
78708,of,O,3843
78709,a,O,3843
78710,century,O,3843
78711,has,O,3843
78712,seen,O,3843
78713,many,O,3844
78714,changes,O,3844
78715,to,O,3844
78716,the,O,3844
78717,way,O,3844
78718,we,O,3844
78719,treat,O,3844
78720,ophthalmic,O,3844
78721,disorders,O,3844
78722,in,O,3844
78723,children,O,3844
78724,both,O,3844
78725,medically,O,3844
78726,and,O,3844
78727,surgically,O,3844
78728,There,O,3844
78729,have,O,3844
78730,been,O,3844
78731,concurrent,O,3844
78732,changes,O,3844
78733,to,O,3844
78734,care,O,3844
78735,pathways,O,3844
78736,and,O,3844
78737,huge,O,3844
78738,improvements,O,3844
78739,in,O,3844
78740,surgical,O,3844
78741,equipment,O,3844
78742,and,O,3844
78743,techniques,O,3844
78744,Advances,O,3845
78745,in,O,3845
78746,our,O,3845
78747,understanding,O,3845
78748,of,O,3845
78749,the,O,3845
78750,natural,O,3845
78751,history,O,3845
78752,of,O,3845
78753,strabismus,B-NAME_OF_DISEASE,3845
78754,and,O,3845
78755,the,O,3845
78756,role,O,3845
78757,of,O,3845
78758,refractive,B-NAME_OF_DISEASE,3845
78759,error,I-NAME_OF_DISEASE,3845
78760,in,O,3845
78761,the,O,3845
78762,etiology,O,3845
78763,of,O,3845
78764,squints,O,3845
78765,have,O,3845
78766,led,O,3845
78767,to,O,3845
78768,more,O,3845
78769,conservative,O,3846
78770,management,O,3846
78771,and,O,3846
78772,less,O,3846
78773,strabismus,B-TREATMENT,3846
78774,surgery,I-TREATMENT,3846
78775,is,O,3846
78776,performed,O,3846
78777,on,O,3846
78778,children,O,3846
78779,There,O,3846
78780,has,O,3846
78781,consequently,O,3846
78782,been,O,3846
78783,less,O,3846
78784,need,O,3846
78785,for,O,3846
78786,re-operations,O,3846
78787,Alternative,O,3846
78788,treatment,O,3846
78789,options,O,3846
78790,such,O,3846
78791,as,O,3846
78792,chemodenervation,B-TREATMENT,3846
78793,of,I-TREATMENT,3846
78794,extraocular,I-TREATMENT,3846
78795,muscles,I-TREATMENT,3846
78796,via,I-TREATMENT,3846
78797,botulinum,I-TREATMENT,3846
78798,toxin,I-TREATMENT,3846
78799,Botox,B-CHEMICAL_COMPOUND,3846
78800,have,O,3846
78801,been,O,3846
78802,introduced,O,3847
78803,over,O,3847
78804,the,O,3847
78805,last,O,3847
78806,30,O,3847
78807,years,O,3847
78808,for,O,3847
78809,the,O,3847
78810,management,O,3847
78811,of,O,3847
78812,pediatric,O,3847
78813,squint,B-NAME_OF_DISEASE,3847
78814,with,O,3847
78815,comparable,O,3847
78816,results,O,3847
78817,to,O,3847
78818,surgery,O,3847
78819,for,O,3847
78820,the,O,3847
78821,management,O,3847
78822,of,O,3847
78823,infantile,B-NAME_OF_DISEASE,3848
78824,esotropia,I-NAME_OF_DISEASE,3848
78825,Botox,B-CHEMICAL_COMPOUND,3848
78826,is,O,3848
78827,particularly,O,3848
78828,helpful,O,3848
78829,for,O,3848
78830,the,O,3848
78831,management,O,3848
78832,of,O,3848
78833,acute,B-NAME_OF_DISEASE,3848
78834,esotropia,I-NAME_OF_DISEASE,3848
78835,with,O,3848
78836,or,O,3848
78837,without,O,3848
78838,sixth,B-SIGN_AND_SYMPTOM,3848
78839,nerve,I-SIGN_AND_SYMPTOM,3848
78840,palsy,I-SIGN_AND_SYMPTOM,3848
78841,,O,3848
78842,This,O,3848
78843,may,O,3848
78844,have,O,3848
78845,also,O,3848
78846,contributed,O,3848
78847,to,O,3848
78848,the,O,3848
78849,reduction,O,3848
78850,in,O,3848
78851,surgery,O,3848
78852,and,O,3848
78853,better,O,3848
78854,outcomes,O,3849
78855,Advances,O,3849
78856,in,O,3849
78857,surgical,O,3849
78858,instruments,O,3849
78859,and,O,3849
78860,techniques,O,3849
78861,used,O,3849
78862,in,O,3849
78863,pediatric,O,3849
78864,intraocular,O,3849
78865,surgery,O,3849
78866,have,O,3849
78867,reduced,O,3849
78868,complications,O,3849
78869,and,O,3849
78870,improved,O,3849
78871,surgical,O,3849
78872,outcomes,O,3849
78873,In,O,3849
78874,pediatric,O,3850
78875,cataract,B-TREATMENT,3850
78876,surgery,I-TREATMENT,3850
78877,the,O,3850
78878,performance,O,3850
78879,of,O,3850
78880,a,B-TREATMENT,3850
78881,posterior,I-TREATMENT,3850
78882,capsulotomy,I-TREATMENT,3850
78883,and,O,3850
78884,anterior,B-TREATMENT,3850
78885,vitrectomy,I-TREATMENT,3850
78886,at,O,3850
78887,the,O,3850
78888,time,O,3850
78889,of,O,3850
78890,lensectomy,O,3850
78891,has,O,3850
78892,reduced,O,3850
78893,visual,O,3850
78894,axis,O,3850
78895,re-opacification,O,3850
78896,rates,O,3850
78897,The,O,3850
78898,use,O,3850
78899,of,O,3850
78900,smaller,O,3850
78901,incisions,O,3851
78902,23,O,3851
78903,and,O,3851
78904,25,O,3851
78905,gauge,O,3851
78906,atraumatic,B-TREATMENT,3851
78907,surgical,I-TREATMENT,3851
78908,technique,I-TREATMENT,3851
78909,and,O,3851
78910,rigorous,O,3851
78911,peri,B-TREATMENT,3851
78912,and,I-TREATMENT,3851
78913,postoperative,I-TREATMENT,3851
78914,anti-inflammatory,I-TREATMENT,3851
78915,regimes,I-TREATMENT,3851
78916,have,O,3851
78917,reduced,O,3851
78918,postoperative,O,3851
78919,inflammation,O,3851
78920,It,O,3851
78921,is,O,3851
78922,likely,O,3851
78923,that,O,3851
78924,as,O,3851
78925,in,O,3851
78926,adults,O,3851
78927,the,O,3851
78928,use,O,3851
78929,of,O,3851
78930,intraocular,B-TREATMENT,3851
78931,antibiotics,I-TREATMENT,3851
78932,at,O,3851
78933,the,O,3851
78934,surgery,O,3851
78935,has,O,3851
78936,reduced,O,3851
78937,the,O,3851
78938,rate,O,3851
78939,of,O,3851
78940,postoperative,B-NAME_OF_DISEASE,3851
78941,endophthalmitis,I-NAME_OF_DISEASE,3851
78942,Other,O,3851
78943,major,O,3851
78944,advances,O,3851
78945,include,O,3851
78946,a,O,3851
78947,better,O,3852
78948,understanding,O,3852
78949,of,O,3852
78950,the,O,3852
78951,indications,O,3852
78952,in,O,3852
78953,the,O,3852
78954,management,O,3852
78955,of,O,3852
78956,infantile,O,3852
78957,and,O,3852
78958,childhood,O,3852
78959,glaucoma,B-NAME_OF_DISEASE,3852
78960,for,O,3852
78961,different,O,3853
78962,surgical,O,3853
78963,procedures,O,3853
78964,-,O,3853
78965,particularly,O,3853
78966,the,O,3853
78967,increasing,O,3853
78968,role,O,3853
78969,of,O,3853
78970,modern,O,3853
78971,Seton,B-TREATMENT,3853
78972,devices,I-TREATMENT,3853
78973,such,I-TREATMENT,3853
78974,as,I-TREATMENT,3853
78975,Baerveldt,I-TREATMENT,3853
78976,and,I-TREATMENT,3853
78977,Ahmed,I-TREATMENT,3853
78978,tubes,I-TREATMENT,3853
78979,for,O,3853
78980,congenital,B-NAME_OF_DISEASE,3853
78981,and,I-NAME_OF_DISEASE,3853
78982,aphakic,I-NAME_OF_DISEASE,3853
78983,glaucoma,I-NAME_OF_DISEASE,3853
78984,Babies,O,3853
78985,born,O,3853
78986,prematurely,O,3853
78987,are,O,3853
78988,now,O,3853
78989,not,O,3853
78990,only,O,3853
78991,more,O,3853
78992,likely,O,3853
78993,to,O,3853
78994,survive,O,3853
78995,than,O,3853
78996,25,O,3853
78997,years,O,3853
78998,ago,O,3853
78999,but,O,3853
79000,are,O,3854
79001,also,O,3854
79002,likely,O,3854
79003,to,O,3854
79004,have,O,3854
79005,better,O,3854
79006,structural,O,3854
79007,and,O,3854
79008,visual,O,3854
79009,outcomes,O,3854
79010,This,O,3854
79011,is,O,3854
79012,as,O,3854
79013,a,O,3855
79014,result,O,3855
79015,of,O,3855
79016,improved,O,3855
79017,screening,O,3855
79018,programs,O,3855
79019,for,O,3855
79020,ROP,B-NAME_OF_DISEASE,3855
79021,and,O,3855
79022,a,O,3855
79023,better,O,3855
79024,knowledge,O,3855
79025,of,O,3855
79026,when,O,3855
79027,and,O,3855
79028,how,O,3856
79029,to,O,3856
79030,treat,O,3856
79031,sight-threatening,O,3856
79032,ROP,B-NAME_OF_DISEASE,3856
79033,The,B-NAME_OF_STUDY,3856
79034,ET-ROP,I-NAME_OF_STUDY,3856
79035,study,I-NAME_OF_STUDY,3856
79036,and,O,3856
79037,BEAT-ROP,B-NAME_OF_STUDY,3856
79038,studies,I-NAME_OF_STUDY,3856
79039,have,O,3856
79040,been,O,3856
79041,key,O,3856
79042,in,O,3856
79043,guiding,O,3856
79044,clinicians,O,3856
79045,in,O,3856
79046,when,O,3856
79047,and,O,3857
79048,how,O,3857
79049,to,O,3857
79050,treat,O,3857
79051,ROP,B-NAME_OF_DISEASE,3857
79052,with,O,3857
79053,laser,B-TREATMENT,3857
79054,or,O,3857
79055,intravitreal,B-TREATMENT,3857
79056,anti-VEGF,I-TREATMENT,3857
79057,injections,I-TREATMENT,3857
79058,The,O,3857
79059,RCOphth,O,3857
79060,guidelines,O,3857
79061,for,O,3857
79062,ROP,B-NAME_OF_DISEASE,3857
79063,screening,O,3857
79064,and,O,3857
79065,treatment,O,3857
79066,in,O,3857
79067,2006,O,3857
79068,defined,O,3857
79069,optimal,O,3857
79070,screening,O,3857
79071,ages,O,3857
79072,and,O,3857
79073,intervals,O,3857
79074,These,O,3857
79075,will,O,3857
79076,evolve,O,3858
79077,as,O,3858
79078,the,O,3858
79079,use,O,3858
79080,of,O,3858
79081,anti-VEGF,B-TREATMENT,3858
79082,agents,I-TREATMENT,3858
79083,becomes,O,3858
79084,more,O,3858
79085,widespread,O,3858
79086,Surgical,O,3858
79087,management,O,3858
79088,of,O,3858
79089,stage,B-NAME_OF_DISEASE,3858
79090,IV,I-NAME_OF_DISEASE,3859
79091,ROP,I-NAME_OF_DISEASE,3859
79092,has,O,3859
79093,also,O,3859
79094,advanced,O,3859
79095,tremendously,O,3859
79096,in,O,3859
79097,recent,O,3859
79098,years,O,3859
79099,Minimally,B-TREATMENT,3859
79100,invasive,I-TREATMENT,3859
79101,endoscopic,I-TREATMENT,3859
79102,vitrectomy,I-TREATMENT,3859
79103,has,O,3859
79104,improved,O,3859
79105,anatomical,O,3859
79106,outcomes,O,3859
79107,and,O,3860
79108,reduced,O,3860
79109,the,O,3860
79110,need,O,3860
79111,for,O,3860
79112,lensectomy,O,3860
79113,in,O,3860
79114,infants,O,3860
79115,who,O,3860
79116,would,O,3860
79117,previously,O,3860
79118,have,O,3860
79119,faced,O,3860
79120,a,O,3860
79121,dismal,O,3860
79122,outcome,O,3860
79123,Anti-VEGF,B-TREATMENT,3860
79124,intravitreal,I-TREATMENT,3860
79125,injections,I-TREATMENT,3860
79126,have,O,3860
79127,also,O,3860
79128,been,O,3860
79129,utilized,O,3860
79130,in,O,3860
79131,other,O,3860
79132,areas,O,3860
79133,of,O,3860
79134,pediatric,O,3860
79135,ophthalmology,O,3860
79136,such,O,3860
79137,as,O,3860
79138,in,O,3860
79139,Coat,B-NAME_OF_DISEASE,3860
79140,s,I-NAME_OF_DISEASE,3860
79141,disease,I-NAME_OF_DISEASE,3860
79142,Best,B-NAME_OF_DISEASE,3860
79143,s,I-NAME_OF_DISEASE,3860
79144,disease,I-NAME_OF_DISEASE,3860
79145,and,O,3861
79146,in,O,3861
79147,the,O,3861
79148,treatment,O,3861
79149,of,O,3861
79150,subretinal,B-NAME_OF_DISEASE,3861
79151,neovascular,I-NAME_OF_DISEASE,3861
79152,membranes,I-NAME_OF_DISEASE,3861
79153,in,O,3861
79154,inflammatory,O,3861
79155,eye,O,3861
79156,disease,O,3861
79157,Visual,O,3861
79158,and,O,3861
79159,structural,O,3861
79160,outcomes,O,3861
79161,for,O,3861
79162,children,O,3861
79163,with,O,3861
79164,uveitis,B-NAME_OF_DISEASE,3861
79165,have,O,3861
79166,improved,O,3861
79167,over,O,3861
79168,the,O,3861
79169,last,O,3862
79170,25,O,3862
79171,years,O,3862
79172,due,O,3862
79173,to,O,3862
79174,several,O,3862
79175,factors,O,3862
79176,Better,O,3862
79177,screening,O,3862
79178,of,O,3862
79179,at-risk,O,3862
79180,patients,O,3862
79181,such,O,3862
79182,as,O,3862
79183,those,O,3862
79184,with,O,3862
79185,juvenile,B-NAME_OF_DISEASE,3862
79186,idiopathic,I-NAME_OF_DISEASE,3862
79187,arthritis,I-NAME_OF_DISEASE,3862
79188,JIA,I-NAME_OF_DISEASE,3862
79189,has,O,3862
79190,allowed,O,3862
79191,earlier,O,3862
79192,diagnosis,O,3862
79193,and,O,3862
79194,intervention,O,3862
79195,for,O,3862
79196,JIA,B-NAME_OF_DISEASE,3862
79197,uveitis,I-NAME_OF_DISEASE,3863
79198,before,O,3863
79199,complications,O,3863
79200,occur,O,3863
79201,Better,O,3863
79202,care,O,3863
79203,pathways,O,3863
79204,have,O,3863
79205,indicated,O,3863
79206,early,O,3863
79207,treatment,O,3863
79208,with,O,3863
79209,immunosuppressive,B-TREATMENT,3863
79210,drugs,I-TREATMENT,3863
79211,when,O,3863
79212,the,O,3863
79213,ocular,O,3863
79214,disease,O,3863
79215,is,O,3863
79216,not,O,3863
79217,controlled,O,3863
79218,topically,O,3863
79219,with,O,3863
79220,more,O,3863
79221,efficacious,O,3863
79222,immunosuppression,O,3863
79223,options,O,3863
79224,now,O,3863
79225,available,O,3863
79226,such,O,3863
79227,as,O,3863
79228,methotrexate,B-NAME_OF_DRUG,3864
79229,and,O,3864
79230,anti-TNF,B-TREATMENT,3864
79231,agents,I-TREATMENT,3864
79232,Multidisciplinary,O,3864
79233,care,O,3864
79234,of,O,3864
79235,children,O,3864
79236,with,O,3864
79237,uveitis,B-NAME_OF_DISEASE,3864
79238,in,O,3864
79239,conjunction,O,3864
79240,with,O,3864
79241,pediatric,O,3864
79242,rheumatologists,O,3864
79243,has,O,3864
79244,meant,O,3864
79245,that,O,3864
79246,the,O,3865
79247,incidence,O,3865
79248,of,O,3865
79249,visual,B-NAME_OF_DISEASE,3865
79250,impairment,I-NAME_OF_DISEASE,3865
79251,and,O,3865
79252,blindness,B-NAME_OF_DISEASE,3865
79253,has,O,3865
79254,been,O,3865
79255,substantially,O,3865
79256,reduced,O,3865
79257,Advances,O,3865
79258,in,O,3865
79259,evidence-based,O,3865
79260,medicine,O,3865
79261,for,O,3865
79262,pediatric,O,3865
79263,ophthalmology,O,3865
79264,Twenty-five,O,3865
79265,years,O,3865
79266,ago,O,3865
79267,there,O,3865
79268,was,O,3865
79269,little,O,3865
79270,robust,O,3866
79271,evidence,O,3866
79272,for,O,3866
79273,most,O,3866
79274,of,O,3866
79275,the,O,3866
79276,interventions,O,3866
79277,and,O,3866
79278,treatments,O,3866
79279,commonly,O,3866
79280,used,O,3866
79281,in,O,3866
79282,pediatric,O,3866
79283,ophthalmology,O,3866
79284,Complex,O,3866
79285,ethical,O,3867
79286,issues,O,3867
79287,mean,O,3867
79288,recruitment,O,3867
79289,to,O,3867
79290,research,O,3867
79291,studies,O,3867
79292,in,O,3867
79293,children,O,3867
79294,is,O,3867
79295,still,O,3867
79296,difficult,O,3867
79297,with,O,3867
79298,much,O,3867
79299,progress,O,3867
79300,still,O,3867
79301,to,O,3867
79302,be,O,3867
79303,made,O,3867
79304,New,O,3867
79305,regulatory,O,3867
79306,requirements,O,3867
79307,for,O,3867
79308,pharmaceutical,O,3868
79309,companies,O,3868
79310,requiring,O,3868
79311,evaluation,O,3868
79312,of,O,3868
79313,medicines,O,3868
79314,in,O,3868
79315,children,O,3868
79316,has,O,3868
79317,resulted,O,3868
79318,in,O,3868
79319,more,O,3868
79320,interest,O,3868
79321,in,O,3868
79322,carrying,O,3868
79323,out,O,3868
79324,clinical,O,3868
79325,trials,O,3868
79326,in,O,3868
79327,pediatric,O,3869
79328,ophthalmology,O,3869
79329,There,O,3869
79330,are,O,3869
79331,for,O,3869
79332,example,O,3869
79333,current,O,3869
79334,or,O,3869
79335,forthcoming,O,3869
79336,trials,O,3869
79337,into,O,3869
79338,the,O,3869
79339,use,O,3869
79340,of,O,3869
79341,anti-VEGF,B-NAME_OF_DRUG,3869
79342,treatment,O,3869
79343,for,O,3869
79344,ROP,B-NAME_OF_DISEASE,3869
79345,gene,O,3869
79346,therapy,O,3870
79347,for,O,3870
79348,some,O,3870
79349,retinal,B-NAME_OF_DISEASE,3870
79350,dystrophies,I-NAME_OF_DISEASE,3870
79351,and,O,3870
79352,evaluation,O,3870
79353,of,O,3870
79354,low,O,3870
79355,dose,O,3870
79356,atropine,B-NAME_OF_DRUG,3870
79357,in,O,3870
79358,retardation,O,3870
79359,of,O,3870
79360,myopia,B-NAME_OF_DISEASE,3870
79361,development,O,3870
79362,The,O,3870
79363,majority,O,3870
79364,of,O,3870
79365,drugs,O,3870
79366,used,O,3870
79367,for,O,3870
79368,children,O,3870
79369,in,O,3870
79370,the,O,3870
79371,past,O,3870
79372,were,O,3870
79373,off,O,3870
79374,label,O,3870
79375,use,O,3871
79376,-,O,3871
79377,as,O,3871
79378,they,O,3871
79379,had,O,3871
79380,not,O,3871
79381,been,O,3871
79382,licensed,O,3871
79383,for,O,3871
79384,use,O,3871
79385,in,O,3871
79386,children,O,3871
79387,There,O,3871
79388,has,O,3871
79389,recently,O,3872
79390,been,O,3872
79391,an,O,3872
79392,increase,O,3872
79393,in,O,3872
79394,the,O,3872
79395,number,O,3872
79396,of,O,3872
79397,licensed,O,3872
79398,topical,O,3872
79399,treatments,O,3872
79400,for,O,3872
79401,children,O,3872
79402,giving,O,3872
79403,clinicians,O,3872
79404,greater,O,3872
79405,confidence,O,3872
79406,when,O,3872
79407,prescribing,O,3872
79408,for,O,3872
79409,children,O,3872
79410,Evidence,O,3872
79411,provided,O,3872
79412,by,O,3872
79413,several,O,3872
79414,key,O,3872
79415,studies,O,3873
79416,has,O,3873
79417,changed,O,3873
79418,how,O,3873
79419,we,O,3873
79420,treat,O,3873
79421,children,O,3873
79422,with,O,3873
79423,certain,O,3873
79424,eye,O,3873
79425,conditions,O,3873
79426,The,B-NAME_OF_STUDY,3873
79427,Infant,I-NAME_OF_STUDY,3873
79428,Aphakia,I-NAME_OF_STUDY,3873
79429,Treatment,I-NAME_OF_STUDY,3873
79430,Study,I-NAME_OF_STUDY,3873
79431,was,O,3873
79432,an,O,3873
79433,American,O,3873
79434,randomized,O,3873
79435,prospective,O,3873
79436,study,O,3873
79437,of,O,3873
79438,114,O,3873
79439,infants,O,3873
79440,It,O,3873
79441,has,O,3873
79442,provided,O,3873
79443,outcome,O,3873
79444,data,O,3873
79445,for,O,3873
79446,children,O,3873
79447,with,O,3873
79448,unilateral,B-NAME_OF_DISEASE,3873
79449,congenital,I-NAME_OF_DISEASE,3874
79450,cataract,I-NAME_OF_DISEASE,3874
79451,who,O,3874
79452,underwent,O,3874
79453,surgery,O,3874
79454,under,O,3874
79455,the,O,3874
79456,age,O,3874
79457,of,O,3874
79458,six,O,3874
79459,months,O,3874
79460,either,O,3874
79461,with,O,3874
79462,or,O,3874
79463,without,O,3874
79464,an,B-TREATMENT,3874
79465,intraocular,I-TREATMENT,3874
79466,lens,I-TREATMENT,3874
79467,The,B-NAME_OF_STUDY,3874
79468,IOLu2,I-NAME_OF_STUDY,3874
79469,study,I-NAME_OF_STUDY,3874
79470,in,O,3874
79471,the,B-GPE,3874
79472,UK,B-GPE,3874
79473,was,O,3874
79474,a,O,3874
79475,prospective,O,3874
79476,cohort,O,3874
79477,study,O,3874
79478,looking,O,3874
79479,at,O,3874
79480,outcomes,O,3874
79481,in,O,3874
79482,children,O,3874
79483,undergoing,O,3874
79484,cataract,B-TREATMENT,3874
79485,surgery,I-TREATMENT,3874
79486,under,O,3874
79487,the,O,3874
79488,age,O,3874
79489,of,O,3874
79490,two,O,3874
79491,years,O,3874
79492,both,O,3874
79493,with,O,3875
79494,and,O,3875
79495,without,O,3875
79496,an,B-TREATMENT,3875
79497,IOL,I-TREATMENT,3875
79498,The,B-NAME_OF_STUDY,3875
79499,SYCAMORE,I-NAME_OF_STUDY,3875
79500,study,I-NAME_OF_STUDY,3875
79501,was,O,3875
79502,the,O,3875
79503,first,O,3875
79504,multicentre,O,3875
79505,UK,B-GPE,3875
79506,prospective,O,3875
79507,randomized,O,3875
79508,controlled,O,3875
79509,trial,O,3875
79510,of,O,3875
79511,the,O,3875
79512,use,O,3876
79513,of,O,3876
79514,Adalimumab,B-NAME_OF_DRUG,3876
79515,an,I-NAME_OF_DRUG,3876
79516,anti-TNF,I-NAME_OF_DRUG,3876
79517,agent,I-NAME_OF_DRUG,3876
79518,in,O,3876
79519,children,O,3876
79520,with,O,3876
79521,JIA-associated,O,3876
79522,uveitis,O,3876
79523,Diagnosis,O,3876
79524,and,O,3877
79525,testing,O,3877
79526,for,O,3877
79527,genetic,O,3877
79528,eye,O,3877
79529,conditions,O,3877
79530,in,O,3877
79531,childhood,O,3877
79532,Twenty-five,O,3877
79533,years,O,3877
79534,ago,O,3877
79535,many,O,3877
79536,children,O,3877
79537,with,O,3877
79538,complex,O,3877
79539,ocular,O,3878
79540,disease,O,3878
79541,suffered,O,3878
79542,a,O,3878
79543,significant,O,3878
79544,delay,O,3878
79545,in,O,3878
79546,diagnosis,O,3878
79547,sometimes,O,3878
79548,until,O,3878
79549,late,O,3878
79550,childhood,O,3878
79551,or,O,3878
79552,adulthood,O,3878
79553,if,O,3879
79554,at,O,3879
79555,all,O,3879
79556,The,O,3879
79557,precise,O,3879
79558,diagnosis,O,3879
79559,was,O,3879
79560,not,O,3879
79561,possible,O,3879
79562,in,O,3879
79563,many,O,3879
79564,cases,O,3879
79565,and,O,3879
79566,thus,O,3879
79567,provision,O,3879
79568,of,O,3879
79569,prognosis,O,3879
79570,and,O,3879
79571,accurate,O,3879
79572,genetic,O,3879
79573,counseling,O,3879
79574,was,O,3879
79575,not,O,3879
79576,possible,O,3879
79577,Advances,O,3879
79578,in,O,3880
79579,high,O,3880
79580,throughput,O,3880
79581,genetic,B-DIAGNOSTIC_TEST,3880
79582,testing,I-DIAGNOSTIC_TEST,3880
79583,using,I-DIAGNOSTIC_TEST,3880
79584,either,I-DIAGNOSTIC_TEST,3880
79585,multi-gene,I-DIAGNOSTIC_TEST,3880
79586,panels,I-DIAGNOSTIC_TEST,3880
79587,or,I-DIAGNOSTIC_TEST,3880
79588,via,I-DIAGNOSTIC_TEST,3880
79589,whole,I-DIAGNOSTIC_TEST,3880
79590,exome,I-DIAGNOSTIC_TEST,3880
79591,or,I-DIAGNOSTIC_TEST,3880
79592,whole,I-DIAGNOSTIC_TEST,3880
79593,genome,I-DIAGNOSTIC_TEST,3880
79594,sequencing,I-DIAGNOSTIC_TEST,3880
79595,have,O,3880
79596,meant,O,3880
79597,that,O,3880
79598,genetic,B-DIAGNOSTIC_TEST,3880
79599,testing,I-DIAGNOSTIC_TEST,3880
79600,is,O,3880
79601,now,O,3880
79602,part,O,3880
79603,of,O,3880
79604,routine,O,3880
79605,care,O,3881
79606,across,O,3881
79607,medicine,O,3881
79608,This,O,3881
79609,has,O,3881
79610,impacted,O,3881
79611,on,O,3881
79612,the,O,3881
79613,investigation,O,3881
79614,of,O,3881
79615,many,O,3881
79616,pediatric,O,3881
79617,ophthalmic,O,3881
79618,conditions,O,3881
79619,such,O,3881
79620,as,O,3881
79621,retinal,B-NAME_OF_DISEASE,3881
79622,dystrophies,I-NAME_OF_DISEASE,3881
79623,pediatric,O,3881
79624,cataracts,B-NAME_OF_DISEASE,3881
79625,and,O,3881
79626,pediatric,O,3881
79627,glaucoma,B-NAME_OF_DISEASE,3881
79628,Joint,O,3881
79629,genetic,O,3881
79630,ophthalmology,O,3881
79631,services,O,3881
79632,have,O,3881
79633,been,O,3881
79634,established,O,3881
79635,in,O,3881
79636,major,O,3881
79637,centers,O,3881
79638,to,O,3881
79639,manage,O,3881
79640,access,O,3881
79641,to,O,3882
79642,testing,O,3882
79643,laboratory,O,3882
79644,services,O,3882
79645,for,O,3882
79646,testing,O,3882
79647,analysis,O,3882
79648,and,O,3882
79649,interpretation,O,3882
79650,of,O,3882
79651,results,O,3882
79652,and,O,3882
79653,genetic,O,3882
79654,counseling,O,3882
79655,New,O,3882
79656,genomic,B-DIAGNOSTIC_TEST,3882
79657,testing,I-DIAGNOSTIC_TEST,3882
79658,techniques,O,3882
79659,now,O,3882
79660,mean,O,3882
79661,that,O,3882
79662,it,O,3883
79663,is,O,3883
79664,possible,O,3883
79665,for,O,3883
79666,a,O,3883
79667,patient,O,3883
79668,with,O,3883
79669,bilateral,B-NAME_OF_DISEASE,3883
79670,congenital,I-NAME_OF_DISEASE,3883
79671,cataract,I-NAME_OF_DISEASE,3883
79672,or,O,3883
79673,inherited,B-NAME_OF_DISEASE,3883
79674,retinal,I-NAME_OF_DISEASE,3883
79675,dystrophy,I-NAME_OF_DISEASE,3883
79676,to,O,3883
79677,receive,O,3883
79678,a,O,3883
79679,rapid,O,3883
79680,precise,O,3883
79681,diagnosis,O,3883
79682,of,O,3883
79683,the,O,3884
79684,cause,O,3884
79685,with,O,3884
79686,the,O,3884
79687,exclusion,O,3884
79688,of,O,3884
79689,associated,O,3884
79690,syndromic,O,3884
79691,and,O,3884
79692,metabolic,O,3884
79693,causes,O,3884
79694,thus,O,3884
79695,avoiding,O,3884
79696,unproductive,O,3884
79697,systemic,O,3884
79698,and,O,3884
79699,metabolic,O,3884
79700,investigations,O,3884
79701,Speculation,O,3884
79702,on,O,3884
79703,future,O,3884
79704,developments,O,3884
79705,in,O,3884
79706,pediatric,O,3885
79707,ophthalmology,O,3885
79708,Pediatric,O,3885
79709,ophthalmologists,O,3885
79710,are,O,3885
79711,the,O,3885
79712,last,O,3885
79713,generalists,O,3885
79714,,O,3885
79715,They,O,3885
79716,require,O,3885
79717,a,O,3885
79718,skill,O,3885
79719,set,O,3885
79720,that,O,3885
79721,enables,O,3885
79722,them,O,3885
79723,to,O,3885
79724,interact,O,3885
79725,with,O,3885
79726,and,O,3886
79727,put,O,3886
79728,at,O,3886
79729,ease,O,3886
79730,both,O,3886
79731,the,O,3886
79732,child,O,3886
79733,and,O,3886
79734,their,O,3886
79735,family,O,3886
79736,-,O,3886
79737,as,O,3886
79738,well,O,3886
79739,as,O,3886
79740,being,O,3886
79741,able,O,3886
79742,to,O,3886
79743,carry,O,3886
79744,out,O,3886
79745,a,O,3886
79746,thorough,O,3886
79747,and,O,3886
79748,effective,O,3886
79749,examination,O,3887
79750,in,O,3887
79751,often,O,3887
79752,sub-optimal,O,3887
79753,circumstances,O,3887
79754,It,O,3887
79755,will,O,3887
79756,remain,O,3887
79757,one,O,3887
79758,of,O,3887
79759,the,O,3887
79760,most,O,3887
79761,challenging,O,3887
79762,and,O,3888
79763,rewarding,O,3888
79764,subspecialties,O,3888
79765,in,O,3888
79766,ophthalmology,O,3888
79767,Great,O,3888
79768,advances,O,3888
79769,continue,O,3888
79770,to,O,3888
79771,be,O,3888
79772,made,O,3888
79773,in,O,3888
79774,the,O,3888
79775,diagnosis,O,3888
79776,and,O,3888
79777,management,O,3888
79778,of,O,3888
79779,pediatric,O,3888
79780,eye,O,3888
79781,disease,O,3888
79782,Advances,O,3888
79783,in,O,3888
79784,genomics,O,3888
79785,will,O,3888
79786,play,O,3888
79787,a,O,3888
79788,key,O,3888
79789,role,O,3888
79790,and,O,3888
79791,genetic,B-DIAGNOSTIC_TEST,3888
79792,testing,I-DIAGNOSTIC_TEST,3888
79793,will,O,3888
79794,become,O,3888
79795,much,O,3888
79796,more,O,3888
79797,integrated,O,3888
79798,into,O,3888
79799,clinical,O,3888
79800,care,O,3888
79801,This,O,3888
79802,will,O,3889
79803,allow,O,3889
79804,rapid,O,3889
79805,accurate,O,3889
79806,diagnosis,O,3889
79807,and,O,3889
79808,personalized,O,3889
79809,targeted,O,3889
79810,management,O,3889
79811,for,O,3889
79812,each,O,3889
79813,child,O,3889
79814,together,O,3889
79815,with,O,3889
79816,the,O,3890
79817,provision,O,3890
79818,of,O,3890
79819,prognosis,O,3890
79820,the,O,3890
79821,potential,O,3890
79822,for,O,3890
79823,treatment,O,3890
79824,and,O,3890
79825,appropriate,O,3890
79826,counseling,O,3891
79827,for,O,3891
79828,the,O,3891
79829,family,O,3891
79830,Genomic,O,3891
79831,proteomic,O,3891
79832,and,O,3891
79833,metabolomic,O,3891
79834,translational,O,3891
79835,medicine,O,3891
79836,will,O,3891
79837,enable,O,3891
79838,the,O,3891
79839,introduction,O,3891
79840,of,O,3891
79841,new,O,3891
79842,exciting,O,3891
79843,therapies,O,3891
79844,Precise,O,3891
79845,molecular,B-DIAGNOSTIC_TEST,3891
79846,diagnosis,I-DIAGNOSTIC_TEST,3891
79847,will,O,3891
79848,be,O,3891
79849,of,O,3891
79850,particular,O,3891
79851,benefit,O,3892
79852,to,O,3892
79853,children,O,3892
79854,in,O,3892
79855,whom,O,3892
79856,gene,B-TREATMENT,3892
79857,therapy,I-TREATMENT,3892
79858,may,O,3892
79859,be,O,3892
79860,indicated,O,3892
79861,The,O,3892
79862,increasing,O,3892
79863,number,O,3892
79864,of,O,3893
79865,clinical,O,3893
79866,trials,O,3893
79867,of,O,3893
79868,medication,O,3893
79869,and,O,3893
79870,treatment,O,3893
79871,for,O,3893
79872,children,O,3893
79873,will,O,3893
79874,ensure,O,3893
79875,that,O,3893
79876,the,O,3893
79877,evidence,O,3893
79878,base,O,3893
79879,will,O,3894
79880,continue,O,3894
79881,to,O,3894
79882,build,O,3894
79883,so,O,3894
79884,that,O,3894
79885,pediatric,O,3894
79886,ophthalmologists,O,3894
79887,can,O,3894
79888,be,O,3894
79889,sure,O,3894
79890,they,O,3894
79891,are,O,3894
79892,delivering,O,3894
79893,the,O,3894
79894,best,O,3894
79895,care,O,3894
79896,for,O,3894
79897,their,O,3894
79898,patients,O,3895
79899,The,O,3895
79900,results,O,3895
79901,of,O,3895
79902,such,O,3895
79903,research,O,3895
79904,will,O,3895
79905,mean,O,3895
79906,that,O,3895
79907,the,O,3895
79908,range,O,3895
79909,of,O,3895
79910,treatments,O,3895
79911,routinely,O,3896
79912,available,O,3896
79913,for,O,3896
79914,treating,O,3896
79915,eye,O,3896
79916,conditions,O,3896
79917,in,O,3896
79918,children,O,3896
79919,will,O,3896
79920,continue,O,3896
79921,to,O,3896
79922,expand,O,3896
79923,Advances,O,3896
79924,in,O,3896
79925,imaging,O,3896
79926,technology,O,3896
79927,will,O,3896
79928,continue,O,3896
79929,and,O,3896
79930,techniques,O,3896
79931,will,O,3896
79932,become,O,3896
79933,increasingly,O,3896
79934,suitable,O,3896
79935,for,O,3896
79936,use,O,3896
79937,in,O,3897
79938,children,O,3897
79939,and,O,3897
79940,therefore,O,3897
79941,used,O,3897
79942,to,O,3897
79943,assess,O,3897
79944,a,O,3897
79945,wider,O,3897
79946,range,O,3897
79947,of,O,3897
79948,pediatric,O,3897
79949,eye,O,3897
79950,conditions,O,3897
79951,Big,O,3897
79952,Data,O,3898
79953,sets,O,3898
79954,are,O,3898
79955,likely,O,3898
79956,to,O,3898
79957,be,O,3898
79958,analyzed,O,3898
79959,with,O,3898
79960,the,O,3898
79961,help,O,3898
79962,of,O,3898
79963,artificial,O,3898
79964,intelligence,O,3898
79965,techniques,O,3898
79966,further,O,3898
79967,improving,O,3898
79968,early,O,3898
79969,identification,O,3899
79970,of,O,3899
79971,potential,O,3899
79972,biomarkers,O,3899
79973,of,O,3899
79974,disease,O,3899
79975,and,O,3899
79976,thus,O,3899
79977,indicators,O,3899
79978,for,O,3899
79979,more,O,3900
79980,effective,O,3900
79981,intervention,O,3900
79982,Telemedicine,B-TREATMENT,3900
79983,based,O,3900
79984,on,O,3900
79985,digital,B-DIAGNOSTIC_TEST,3900
79986,imaging,I-DIAGNOSTIC_TEST,3900
79987,is,O,3900
79988,likely,O,3900
79989,to,O,3900
79990,be,O,3900
79991,more,O,3900
79992,widely,O,3900
79993,utilized,O,3900
79994,for,O,3900
79995,a,O,3900
79996,larger,O,3900
79997,range,O,3900
79998,of,O,3900
79999,conditions,O,3900
80000,The,O,3900
80001,clinical,O,3900
80002,expertise,O,3900
80003,of,O,3900
80004,the,O,3900
80005,pediatric,O,3900
80006,ophthalmologist,O,3900
80007,will,O,3900
80008,in,O,3901
80009,our,O,3901
80010,opinion,O,3901
80011,remain,O,3901
80012,important,O,3901
80013,but,O,3901
80014,the,O,3901
80015,role,O,3901
80016,will,O,3901
80017,evolve,O,3901
80018,and,O,3901
80019,develop,O,3901
80020,alongside,O,3901
80021,these,O,3901
80022,exciting,O,3901
80023,changes,O,3901
80024,Traditional,O,3901
80025,longitudinal,O,3901
80026,ultrasound,O,3901
80027,when,O,3901
80028,first,O,3901
80029,introduced,O,3901
80030,in,O,3901
80031,phacoemulsification,B-TREATMENT,3901
80032,was,O,3901
80033,employed,O,3901
80034,only,O,3902
80035,in,O,3902
80036,the,O,3902
80037,continuous,O,3902
80038,mode,O,3902
80039,As,O,3902
80040,the,O,3902
80041,name,O,3902
80042,implies,O,3902
80043,this,O,3902
80044,mode,O,3902
80045,provides,O,3902
80046,continuous,O,3902
80047,delivery,O,3902
80048,of,O,3902
80049,ultrasound,O,3902
80050,energy,O,3902
80051,without,O,3902
80052,any,O,3902
80053,pause,O,3902
80054,time,O,3902
80055,whenever,O,3902
80056,the,O,3902
80057,surgeon,O,3902
80058,is,O,3902
80059,in,O,3902
80060,footpedal,O,3902
80061,position,O,3902
80062,The,O,3902
80063,delivery,O,3902
80064,of,O,3902
80065,power,O,3902
80066,is,O,3902
80067,controlled,O,3902
80068,linearly,O,3903
80069,using,O,3903
80070,the,O,3903
80071,footpedal,O,3903
80072,and,O,3903
80073,the,O,3903
80074,maximum,O,3903
80075,power,O,3903
80076,is,O,3903
80077,preset,O,3903
80078,by,O,3903
80079,the,O,3903
80080,surgeon,O,3903
80081,As,O,3903
80082,the,O,3903
80083,footpedal,O,3903
80084,is,O,3903
80085,depressed,O,3903
80086,the,O,3903
80087,power,O,3903
80088,rises,O,3903
80089,from,O,3903
80090,0%,O,3903
80091,to,O,3903
80092,the,O,3903
80093,preset,O,3903
80094,maximum,O,3903
80095,power,O,3903
80096,up,O,3903
80097,to,O,3903
80098,100%,O,3903
80099,,O,3903
80100,Today,O,3903
80101,the,O,3904
80102,aim,O,3904
80103,of,O,3904
80104,cataract,B-TREATMENT,3904
80105,surgery,I-TREATMENT,3904
80106,is,O,3904
80107,not,O,3904
80108,only,O,3904
80109,to,O,3904
80110,restore,O,3904
80111,vision,O,3904
80112,by,O,3904
80113,removing,O,3904
80114,and,O,3904
80115,replacing,O,3904
80116,the,O,3904
80117,cataractous,O,3904
80118,lens,O,3904
80119,but,O,3904
80120,also,O,3904
80121,to,O,3904
80122,simultaneously,O,3904
80123,provide,O,3904
80124,instant,O,3904
80125,and,O,3904
80126,high-quality,O,3904
80127,visual,O,3904
80128,rehabilitation,O,3905
80129,Achieving,O,3905
80130,a,O,3905
80131,clear,O,3905
80132,cornea,B-PART_OF_THE_EYES,3905
80133,immediately,O,3905
80134,after,O,3905
80135,surgery,O,3905
80136,is,O,3905
80137,the,O,3905
80138,first,O,3905
80139,step,O,3905
80140,in,O,3905
80141,this,O,3905
80142,endeavor,O,3905
80143,One,O,3905
80144,of,O,3905
80145,the,O,3905
80146,most,O,3905
80147,important,O,3905
80148,barriers,O,3905
80149,to,O,3905
80150,achieving,O,3905
80151,clear,O,3905
80152,corneas,B-PART_OF_THE_EYES,3905
80153,and,O,3905
80154,sharp,O,3905
80155,vision,O,3905
80156,immediately,O,3906
80157,after,O,3906
80158,cataract,B-TREATMENT,3906
80159,surgery,I-TREATMENT,3906
80160,is,O,3906
80161,damage,O,3906
80162,from,O,3906
80163,ultrasound,O,3906
80164,energy,O,3906
80165,induced,O,3906
80166,during,O,3906
80167,the,O,3906
80168,procedure,O,3906
80169,The,O,3906
80170,advent,O,3906
80171,of,O,3906
80172,ultrasound,O,3906
80173,power,O,3906
80174,modulation,O,3906
80175,has,O,3906
80176,dramatically,O,3906
80177,increased,O,3906
80178,the,O,3906
80179,efficiency,O,3906
80180,of,O,3907
80181,ultrasound,O,3907
80182,energy,O,3907
80183,and,O,3907
80184,minimized,O,3907
80185,heat,O,3907
80186,production,O,3907
80187,thereby,O,3907
80188,decreasing,O,3907
80189,the,O,3907
80190,risk,O,3907
80191,of,O,3907
80192,thermal,O,3907
80193,injury,O,3907
80194,that,O,3907
80195,contributes,O,3907
80196,to,O,3907
80197,endothelial,B-SIGN_AND_SYMPTOM,3907
80198,cell,I-SIGN_AND_SYMPTOM,3908
80199,loss,I-SIGN_AND_SYMPTOM,3908
80200,and,O,3908
80201,corneal,B-SIGN_AND_SYMPTOM,3908
80202,edema,I-SIGN_AND_SYMPTOM,3908
80203,The,O,3908
80204,goal,O,3908
80205,in,O,3908
80206,cataract,B-TREATMENT,3908
80207,surgery,I-TREATMENT,3908
80208,is,O,3908
80209,perfection,O,3908
80210,in,O,3908
80211,nuclear,B-TREATMENT,3908
80212,disassembly,I-TREATMENT,3908
80213,performed,O,3908
80214,with,O,3908
80215,just,O,3908
80216,the,O,3908
80217,right,O,3908
80218,amount,O,3908
80219,of,O,3908
80220,phaco,O,3908
80221,energy-not,O,3908
80222,too,O,3908
80223,much,O,3908
80224,not,O,3908
80225,too,O,3908
80226,little-according,O,3908
80227,to,O,3908
80228,Dr,B-PERSON,3909
80229,Lisa,I-PERSON,3909
80230,Park,I-PERSON,3909
80231,associate,I-PERSON,3909
80232,professor,I-PERSON,3909
80233,at,O,3909
80234,Columbia,B-ORGANIZATION,3909
80235,University,I-ORGANIZATION,3909
80236,Vagelos,I-ORGANIZATION,3909
80237,College,I-ORGANIZATION,3909
80238,of,I-ORGANIZATION,3909
80239,Physicians,I-ORGANIZATION,3909
80240,and,I-ORGANIZATION,3909
80241,Surgeons,I-ORGANIZATION,3909
80242,in,O,3909
80243,New,B-GPE,3909
80244,York,I-GPE,3909
80245,United,I-GPE,3909
80246,States,I-GPE,3909
80247,Phacoemulsification,B-TREATMENT,3909
80248,is,O,3909
80249,a,O,3909
80250,surgical,O,3909
80251,procedure,O,3910
80252,that,O,3910
80253,is,O,3910
80254,used,O,3910
80255,to,O,3910
80256,remove,O,3910
80257,cataracts,B-NAME_OF_DISEASE,3910
80258,a,B-SIGN_AND_SYMPTOM,3910
80259,clouding,I-SIGN_AND_SYMPTOM,3910
80260,of,I-SIGN_AND_SYMPTOM,3910
80261,the,I-SIGN_AND_SYMPTOM,3910
80262,eye,I-SIGN_AND_SYMPTOM,3910
80263,s,I-SIGN_AND_SYMPTOM,3910
80264,natural,I-SIGN_AND_SYMPTOM,3910
80265,lens,I-SIGN_AND_SYMPTOM,3910
80266,It,O,3911
80267,is,O,3911
80268,a,O,3911
80269,minimally,O,3911
80270,invasive,O,3911
80271,procedure,O,3911
80272,that,O,3911
80273,is,O,3911
80274,performed,O,3911
80275,under,O,3911
80276,local,O,3911
80277,anesthesia,O,3911
80278,It,O,3911
80279,has,O,3911
80280,largely,O,3911
80281,replaced,O,3911
80282,traditional,O,3912
80283,cataract,B-TREATMENT,3912
80284,surgery,I-TREATMENT,3912
80285,as,O,3912
80286,the,O,3912
80287,most,O,3912
80288,common,O,3912
80289,method,O,3912
80290,for,O,3912
80291,removing,O,3912
80292,cataracts,B-NAME_OF_DISEASE,3912
80293,Excessive,O,3912
80294,ultrasound,O,3912
80295,can,O,3912
80296,result,O,3912
80297,in,O,3912
80298,endothelial,B-SIGN_AND_SYMPTOM,3912
80299,cell,I-SIGN_AND_SYMPTOM,3912
80300,loss,I-SIGN_AND_SYMPTOM,3912
80301,corneal,B-SIGN_AND_SYMPTOM,3912
80302,edema,I-SIGN_AND_SYMPTOM,3912
80303,and,O,3912
80304,corneal,B-SIGN_AND_SYMPTOM,3912
80305,wound,I-SIGN_AND_SYMPTOM,3912
80306,burn,I-SIGN_AND_SYMPTOM,3912
80307,Too,O,3912
80308,little,O,3912
80309,energy,O,3912
80310,can,O,3913
80311,result,O,3913
80312,in,O,3913
80313,movement,O,3913
80314,of,O,3913
80315,the,B-PART_OF_THE_EYES,3913
80316,capsular,I-PART_OF_THE_EYES,3913
80317,bag,I-PART_OF_THE_EYES,3913
80318,or,O,3913
80319,ophth,O,3913
80320,stress,O,3913
80321,difficult,O,3914
80322,nuclear,B-TREATMENT,3914
80323,disassembly,I-TREATMENT,3914
80324,over-use,O,3914
80325,of,O,3914
80326,irrigation,O,3914
80327,fluid,O,3914
80328,and,O,3914
80329,long,O,3914
80330,surgical,O,3914
80331,times,O,3914
80332,Transversal,B-TREATMENT,3914
80333,Torsional,I-TREATMENT,3914
80334,Phaco,I-TREATMENT,3914
80335,Traditional,B-TREATMENT,3914
80336,longitudinal,B-TREATMENT,3914
80337,phaco,I-TREATMENT,3914
80338,is,O,3914
80339,a,O,3914
80340,powerful,O,3914
80341,technology,O,3914
80342,designed,O,3914
80343,to,O,3914
80344,break,O,3914
80345,up,O,3914
80346,very,O,3914
80347,dense,O,3914
80348,nuclei,O,3914
80349,using,O,3914
80350,a,O,3914
80351,back-and-forth,O,3914
80352,jackhammer,O,3914
80353,motion,O,3914
80354,but,O,3914
80355,it,O,3914
80356,comes,O,3914
80357,with,O,3914
80358,disadvantages,O,3915
80359,Dr,B-PERSON,3915
80360,Park,I-PERSON,3915
80361,explained,O,3915
80362,that,O,3915
80363,the,O,3915
80364,procedure,O,3915
80365,with,O,3915
80366,its,O,3915
80367,long,O,3915
80368,stroke,O,3915
80369,length,O,3915
80370,and,O,3915
80371,high,O,3915
80372,power,O,3915
80373,can,O,3916
80374,result,O,3916
80375,in,O,3916
80376,repulsion,O,3916
80377,of,O,3916
80378,nuclear,O,3916
80379,fragments,O,3916
80380,at,O,3916
80381,the,B-SURGICAL_INSTRUMENT,3916
80382,phaco,I-SURGICAL_INSTRUMENT,3916
80383,tip,I-SURGICAL_INSTRUMENT,3916
80384,and,O,3916
80385,no,O,3916
80386,cutting,O,3916
80387,performed,O,3916
80388,during,O,3916
80389,the,O,3916
80390,backward,O,3916
80391,movement,O,3916
80392,of,O,3916
80393,the,O,3917
80394,tip,O,3917
80395,In,O,3917
80396,addition,O,3917
80397,it,O,3917
80398,is,O,3917
80399,important,O,3917
80400,to,O,3917
80401,limit,O,3917
80402,the,O,3917
80403,power,O,3917
80404,settings,O,3917
80405,to,O,3917
80406,avoid,O,3917
80407,excessive,O,3917
80408,heat,O,3918
80409,build-up,O,3918
80410,which,O,3918
80411,can,O,3918
80412,potentially,O,3918
80413,damage,O,3918
80414,ocular,B-PART_OF_THE_EYES,3918
80415,tissues,I-PART_OF_THE_EYES,3918
80416,New,O,3918
80417,developments,O,3918
80418,in,O,3918
80419,phaco,B-TREATMENT,3918
80420,technology,I-TREATMENT,3918
80421,involve,O,3918
80422,delivery,O,3918
80423,of,O,3918
80424,power,O,3918
80425,using,O,3918
80426,lateral,O,3918
80427,and,O,3918
80428,rotational,O,3918
80429,motions,O,3918
80430,referred,O,3918
80431,to,O,3918
80432,as,O,3919
80433,transversal,B-TREATMENT,3919
80434,and,I-TREATMENT,3919
80435,torsional,I-TREATMENT,3919
80436,phaco,I-TREATMENT,3919
80437,In,O,3919
80438,contrast,O,3919
80439,to,O,3919
80440,the,O,3919
80441,jackhammer,O,3919
80442,effect,O,3919
80443,of,O,3919
80444,longitudinal,B-TREATMENT,3919
80445,phaco,I-TREATMENT,3920
80446,a,O,3920
80447,combination,O,3920
80448,approach,O,3920
80449,combines,O,3920
80450,simultaneous,O,3920
80451,back-and-forth,O,3920
80452,motion,O,3920
80453,with,O,3920
80454,transversal,O,3920
80455,movement,O,3920
80456,in,O,3920
80457,an,O,3920
80458,elliptical,O,3920
80459,path,O,3920
80460,This,O,3920
80461,adds,O,3920
80462,to,O,3920
80463,the,O,3920
80464,cutting,O,3920
80465,efficiency,O,3920
80466,because,O,3920
80467,the,O,3920
80468,nuclear,O,3920
80469,material,O,3920
80470,is,O,3920
80471,emulsified,O,3920
80472,in,O,3920
80473,more,O,3920
80474,than,O,3920
80475,one,O,3920
80476,direction,O,3920
80477,Dr,B-PERSON,3920
80478,Park,I-PERSON,3920
80479,said,O,3921
80480,In,O,3921
80481,torsional,B-TREATMENT,3921
80482,phaco,I-TREATMENT,3921
80483,the,O,3921
80484,tip,O,3921
80485,oscillates,O,3921
80486,in,O,3921
80487,a,O,3921
80488,rotational,O,3921
80489,path,O,3921
80490,along,O,3921
80491,its,O,3921
80492,primary,O,3921
80493,axis,O,3921
80494,to,O,3921
80495,provide,O,3921
80496,an,O,3921
80497,additional,O,3921
80498,cutting,O,3921
80499,movement,O,3921
80500,through,O,3921
80501,the,O,3921
80502,nucleus,O,3921
80503,Dr,B-PERSON,3922
80504,Park,I-PERSON,3922
80505,explained,O,3922
80506,that,O,3922
80507,this,O,3922
80508,procedure,O,3922
80509,works,O,3922
80510,best,O,3922
80511,with,O,3922
80512,an,B-SURGICAL_INSTRUMENT,3922
80513,angled,I-SURGICAL_INSTRUMENT,3923
80514,phaco,I-SURGICAL_INSTRUMENT,3923
80515,needle,I-SURGICAL_INSTRUMENT,3923
80516,The,O,3923
80517,primary,O,3923
80518,advantage,O,3923
80519,is,O,3923
80520,an,O,3923
80521,increase,O,3923
80522,in,O,3923
80523,energy,O,3923
80524,efficiency,O,3923
80525,with,O,3923
80526,minimal,O,3923
80527,repulsion,O,3923
80528,at,O,3923
80529,the,O,3923
80530,tip,O,3923
80531,the,O,3924
80532,disadvantages,O,3924
80533,are,O,3924
80534,that,O,3924
80535,a,B-SURGICAL_INSTRUMENT,3924
80536,curved,I-SURGICAL_INSTRUMENT,3924
80537,phaco,I-SURGICAL_INSTRUMENT,3924
80538,tip,I-SURGICAL_INSTRUMENT,3924
80539,can,O,3924
80540,be,O,3924
80541,difficult,O,3924
80542,to,O,3924
80543,move,O,3924
80544,through,O,3925
80545,a,O,3925
80546,dense,O,3925
80547,nucleus,O,3925
80548,and,O,3925
80549,there,O,3925
80550,is,O,3925
80551,significant,O,3925
80552,movement,O,3925
80553,of,O,3925
80554,the,O,3925
80555,tip,O,3925
80556,Phaco,O,3925
80557,Timing,O,3925
80558,The,O,3925
80559,timing,O,3925
80560,of,O,3926
80561,power,O,3926
80562,delivery,O,3926
80563,can,O,3926
80564,be,O,3926
80565,modified,O,3926
80566,to,O,3926
80567,increase,O,3926
80568,phaco,O,3926
80569,efficiency,O,3926
80570,The,O,3926
80571,basic,O,3926
80572,settings,O,3926
80573,are,O,3926
80574,for,O,3926
80575,continuous,O,3927
80576,pulse,O,3927
80577,and,O,3927
80578,burst,O,3927
80579,power,O,3927
80580,When,O,3927
80581,power,O,3927
80582,is,O,3927
80583,continuous,O,3927
80584,power,O,3927
80585,delivery,O,3927
80586,is,O,3927
80587,controlled,O,3927
80588,by,O,3927
80589,depressing,O,3927
80590,the,B-SURGICAL_INSTRUMENT,3927
80591,foot,I-SURGICAL_INSTRUMENT,3927
80592,pedal,I-SURGICAL_INSTRUMENT,3927
80593,the,O,3927
80594,power,O,3927
80595,increases,O,3927
80596,with,O,3927
80597,the,O,3928
80598,degree,O,3928
80599,of,O,3928
80600,depression,O,3928
80601,of,O,3928
80602,the,B-SURGICAL_INSTRUMENT,3928
80603,foot,I-SURGICAL_INSTRUMENT,3928
80604,pedal,I-SURGICAL_INSTRUMENT,3928
80605,The,O,3928
80606,amount,O,3928
80607,of,O,3929
80608,power,O,3929
80609,delivered,O,3929
80610,can,O,3929
80611,be,O,3929
80612,limited,O,3929
80613,by,O,3929
80614,using,O,3929
80615,phaco,O,3930
80616,pulse,O,3930
80617,mode,O,3930
80618,After,O,3930
80619,each,O,3930
80620,pulse,O,3930
80621,there,O,3930
80622,is,O,3930
80623,a,O,3930
80624,period,O,3930
80625,of,O,3930
80626,time,O,3930
80627,in,O,3930
80628,which,O,3930
80629,no,O,3930
80630,energy,O,3930
80631,is,O,3930
80632,delivered,O,3930
80633,These,O,3930
80634,rest,O,3930
80635,periods,O,3930
80636,allow,O,3930
80637,cooling,O,3930
80638,of,O,3930
80639,the,B-SURGICAL_INSTRUMENT,3930
80640,phaco,I-SURGICAL_INSTRUMENT,3930
80641,needle,I-SURGICAL_INSTRUMENT,3930
80642,and,O,3930
80643,reduce,O,3930
80644,the,O,3930
80645,heat,O,3930
80646,and,O,3930
80647,energy,O,3930
80648,delivered,O,3930
80649,to,O,3931
80650,the,O,3931
80651,eye,O,3931
80652,The,O,3931
80653,on-and-off,O,3931
80654,periods,O,3931
80655,in,O,3931
80656,pulse,O,3931
80657,mode,O,3931
80658,are,O,3931
80659,referred,O,3931
80660,to,O,3931
80661,as,O,3931
80662,the,O,3931
80663,duty,O,3931
80664,cycle,O,3931
80665,Standard,O,3931
80666,pulse,O,3932
80667,has,O,3932
80668,a,O,3932
80669,50%,O,3932
80670,duty,O,3932
80671,cycle,O,3932
80672,during,O,3932
80673,which,O,3932
80674,the,O,3932
80675,ultrasound,O,3932
80676,is,O,3932
80677,on,O,3932
80678,half,O,3932
80679,of,O,3932
80680,the,O,3932
80681,time,O,3932
80682,no,O,3932
80683,matter,O,3932
80684,how,O,3933
80685,many,O,3933
80686,pulses,O,3933
80687,per,O,3933
80688,second,O,3933
80689,are,O,3933
80690,delivered,O,3933
80691,The,O,3933
80692,duty,O,3933
80693,cycle,O,3933
80694,can,O,3933
80695,be,O,3933
80696,altered,O,3933
80697,to,O,3933
80698,change,O,3933
80699,the,O,3933
80700,ratio,O,3933
80701,of,O,3933
80702,on,O,3934
80703,to,O,3934
80704,off,O,3934
80705,time,O,3934
80706,For,O,3934
80707,example,O,3934
80708,a,O,3934
80709,20%,O,3934
80710,duty,O,3934
80711,cycle,O,3934
80712,results,O,3934
80713,in,O,3934
80714,20,B-TIME_DURATION,3934
80715,milliseconds,I-TIME_DURATION,3934
80716,on,O,3934
80717,and,O,3934
80718,80,B-TIME_DURATION,3934
80719,milliseconds,I-TIME_DURATION,3934
80720,off,O,3934
80721,per,O,3934
80722,cycle,O,3934
80723,Higher,O,3935
80724,or,O,3935
80725,lower,O,3935
80726,duty,O,3935
80727,cycles,O,3935
80728,are,O,3935
80729,used,O,3935
80730,for,O,3935
80731,different,O,3935
80732,purposes,O,3935
80733,During,O,3935
80734,sculpting,O,3935
80735,energy,O,3935
80736,is,O,3935
80737,needed,O,3935
80738,to,O,3935
80739,create,O,3935
80740,a,O,3936
80741,groove,O,3936
80742,in,O,3936
80743,the,B-PART_OF_THE_EYES,3936
80744,lens,I-PART_OF_THE_EYES,3936
80745,so,O,3936
80746,higher,O,3936
80747,rates,O,3936
80748,work,O,3936
80749,better,O,3936
80750,because,O,3936
80751,the,O,3936
80752,shorter,O,3936
80753,time,O,3936
80754,between,O,3936
80755,pulses,O,3936
80756,results,O,3936
80757,in,O,3936
80758,smoother,O,3936
80759,delivery,O,3936
80760,of,O,3936
80761,energy,O,3936
80762,When,O,3936
80763,nuclear,O,3936
80764,quadrants,O,3936
80765,are,O,3936
80766,being,O,3936
80767,removed,O,3936
80768,a,O,3936
80769,lower,O,3937
80770,duty,O,3937
80771,cycle,O,3937
80772,is,O,3937
80773,better,O,3937
80774,because,O,3937
80775,the,O,3937
80776,long,O,3937
80777,interval,O,3937
80778,between,O,3937
80779,the,O,3937
80780,pulses,O,3937
80781,facilitates,O,3937
80782,emulsification,O,3937
80783,and,O,3937
80784,aspiration,O,3938
80785,of,O,3938
80786,the,O,3938
80787,fragments,O,3938
80788,Finally,O,3938
80789,using,O,3938
80790,burst,O,3938
80791,mode,O,3938
80792,each,O,3938
80793,burst,O,3938
80794,has,O,3938
80795,the,O,3938
80796,same,O,3938
80797,power,O,3938
80798,but,O,3938
80799,the,O,3938
80800,interval,O,3938
80801,between,O,3938
80802,bursts,O,3938
80803,decreases,O,3938
80804,with,O,3938
80805,foot-pedal,O,3938
80806,depression,O,3938
80807,the,O,3938
80808,more,O,3939
80809,the,B-SURGICAL_INSTRUMENT,3939
80810,foot,I-SURGICAL_INSTRUMENT,3939
80811,pedal,I-SURGICAL_INSTRUMENT,3939
80812,is,O,3939
80813,depressed,O,3939
80814,the,O,3939
80815,shorter,O,3939
80816,the,O,3939
80817,off,O,3939
80818,time,O,3939
80819,is,O,3939
80820,between,O,3939
80821,bursts,O,3939
80822,The,O,3939
80823,identical,O,3939
80824,bursts,O,3939
80825,of,O,3939
80826,energy,O,3940
80827,are,O,3940
80828,delivered,O,3940
80829,more,O,3940
80830,and,O,3940
80831,more,O,3940
80832,rapidly,O,3940
80833,with,O,3940
80834,foot-pedal,O,3940
80835,depression,O,3940
80836,with,O,3940
80837,maximal,O,3940
80838,depression,O,3940
80839,the,O,3940
80840,time,O,3940
80841,interval,O,3940
80842,between,O,3940
80843,bursts,O,3940
80844,is,O,3941
80845,very,O,3941
80846,small,O,3941
80847,making,O,3941
80848,for,O,3941
80849,continuous,O,3941
80850,energy,O,3941
80851,delivery,O,3941
80852,Dr,B-PERSON,3941
80853,Park,I-PERSON,3941
80854,said,O,3941
80855,Burst,O,3941
80856,mode,O,3941
80857,allows,O,3941
80858,for,O,3941
80859,TRUE,O,3941
80860,phaco-assisted,O,3941
80861,aspiration,O,3941
80862,of,O,3941
80863,the,O,3941
80864,nucleus,O,3941
80865,the,O,3942
80866,fluidics,O,3942
80867,and,O,3942
80868,vacuum,O,3942
80869,can,O,3942
80870,be,O,3942
80871,used,O,3942
80872,for,O,3942
80873,aspiration,O,3942
80874,and,O,3942
80875,give,O,3942
80876,small,O,3942
80877,bursts,O,3942
80878,of,O,3943
80879,power,O,3943
80880,as,O,3943
80881,needed,O,3943
80882,Lower,O,3943
80883,phaco,O,3943
80884,power,O,3943
80885,settings,O,3943
80886,should,O,3943
80887,be,O,3943
80888,used,O,3943
80889,in,O,3943
80890,burst,O,3943
80891,mode,O,3943
80892,compared,O,3943
80893,with,O,3943
80894,pulse,O,3943
80895,or,O,3943
80896,continuous,O,3943
80897,mode,O,3944
80898,because,O,3944
80899,of,O,3944
80900,the,O,3944
80901,absence,O,3944
80902,of,O,3944
80903,linear,O,3944
80904,control,O,3944
80905,at,O,3944
80906,the,O,3944
80907,phaco,O,3944
80908,power,O,3944
80909,level,O,3944
80910,Regarding,O,3944
80911,the,O,3944
80912,choice,O,3944
80913,of,O,3944
80914,these,O,3944
80915,three,O,3944
80916,modes,O,3945
80917,Dr,B-PERSON,3945
80918,Park,I-PERSON,3945
80919,noted,O,3945
80920,that,O,3945
80921,the,O,3945
80922,ability,O,3945
80923,to,O,3945
80924,programme,O,3945
80925,timing,O,3945
80926,and,O,3945
80927,duration,O,3945
80928,combined,O,3945
80929,with,O,3945
80930,the,O,3945
80931,directional,O,3945
80932,modes,O,3945
80933,i.e,O,3945
80934,transverse,B-TREATMENT,3946
80935,and,I-TREATMENT,3946
80936,torsional,I-TREATMENT,3946
80937,phaco,I-TREATMENT,3946
80938,allow,O,3946
80939,the,O,3946
80940,surgeon,O,3946
80941,to,O,3946
80942,have,O,3946
80943,highly,O,3946
80944,elegant,O,3946
80945,control,O,3946
80946,and,O,3946
80947,precise,O,3946
80948,ultrasound,O,3946
80949,power,O,3947
80950,delivery,O,3947
80951,,O,3947
80952,Femtosecond,B-TREATMENT,3947
80953,Laser-Assisted,I-TREATMENT,3947
80954,Cataract,I-TREATMENT,3947
80955,Surgery,I-TREATMENT,3947
80956,This,O,3947
80957,is,O,3947
80958,another,O,3947
80959,technology,O,3947
80960,that,O,3947
80961,has,O,3947
80962,resulted,O,3947
80963,in,O,3947
80964,increased,O,3947
80965,efficiency,O,3947
80966,in,O,3947
80967,nuclear,O,3947
80968,disassembly,O,3947
80969,femtosecond,B-TREATMENT,3947
80970,laser-assisted,I-TREATMENT,3947
80971,cataract,B-TREATMENT,3947
80972,surgery,I-TREATMENT,3947
80973,FLACS,B-TREATMENT,3947
80974,works,O,3947
80975,through,O,3947
80976,photodisruption,O,3947
80977,which,O,3947
80978,vaporises,O,3947
80979,the,O,3947
80980,targeted,O,3947
80981,tissues,O,3947
80982,This,O,3947
80983,is,O,3948
80984,similar,O,3948
80985,to,O,3948
80986,the,O,3948
80987,mechanism,O,3948
80988,of,O,3948
80989,phaco,O,3948
80990,but,O,3948
80991,it,O,3948
80992,occurs,O,3948
80993,at,O,3948
80994,the,O,3948
80995,near-infrared,O,3948
80996,wavelength,O,3948
80997,which,O,3948
80998,is,O,3948
80999,not,O,3948
81000,absorbed,O,3948
81001,by,O,3948
81002,optically,O,3949
81003,clear,O,3949
81004,tissues,O,3949
81005,The,O,3949
81006,laser,O,3949
81007,is,O,3949
81008,focused,O,3949
81009,to,O,3949
81010,3,O,3949
81011,microns,O,3949
81012,and,O,3949
81013,is,O,3949
81014,especially,O,3949
81015,useful,O,3949
81016,for,O,3949
81017,targeting,O,3949
81018,specific,O,3949
81019,depths,O,3949
81020,The,O,3949
81021,waves,O,3950
81022,dissipate,O,3950
81023,approximately,O,3950
81024,100,O,3950
81025,microns,O,3950
81026,from,O,3950
81027,the,O,3950
81028,targeted,O,3950
81029,tissue,O,3950
81030,and,O,3950
81031,the,O,3950
81032,endothelium,O,3950
81033,is,O,3950
81034,not,O,3950
81035,affected,O,3950
81036,Dr,B-PERSON,3950
81037,Park,I-PERSON,3950
81038,explained,O,3950
81039,that,O,3950
81040,femtosecond,B-TREATMENT,3950
81041,pre-treatment,I-TREATMENT,3950
81042,significantly,O,3950
81043,reduces,O,3950
81044,the,O,3950
81045,effective,O,3950
81046,phaco,O,3950
81047,time,O,3950
81048,compared,O,3950
81049,with,O,3951
81050,conventional,O,3951
81051,phaco,O,3951
81052,surgery,O,3951
81053,thus,O,3951
81054,reducing,O,3951
81055,loss,O,3951
81056,of,O,3951
81057,endothelial,O,3951
81058,cells,O,3951
81059,and,O,3951
81060,allowing,O,3951
81061,faster,O,3951
81062,visual,O,3951
81063,rehabilitation,O,3951
81064,FLACS,B-TREATMENT,3951
81065,allows,O,3952
81066,the,O,3952
81067,surgeon,O,3952
81068,to,O,3952
81069,decide,O,3952
81070,the,O,3952
81071,pattern,O,3952
81072,of,O,3952
81073,lens,O,3952
81074,fragmentation,O,3953
81075,Using,O,3953
81076,FLACS,B-TREATMENT,3953
81077,to,O,3953
81078,create,O,3953
81079,the,O,3953
81080,quadrants,O,3953
81081,there,O,3953
81082,is,O,3953
81083,no,O,3953
81084,need,O,3954
81085,to,O,3954
81086,use,O,3954
81087,phaco,O,3954
81088,to,O,3954
81089,sculpt,O,3954
81090,the,B-PART_OF_THE_EYES,3954
81091,lens,I-PART_OF_THE_EYES,3954
81092,the,O,3954
81093,surgeon,O,3954
81094,can,O,3954
81095,go,O,3954
81096,directly,O,3954
81097,to,O,3954
81098,removal,O,3954
81099,of,O,3954
81100,the,O,3954
81101,quadrants,O,3954
81102,after,O,3954
81103,nuclear,O,3954
81104,disassembly,O,3954
81105,along,O,3954
81106,the,O,3954
81107,lines,O,3955
81108,created,O,3955
81109,by,O,3955
81110,the,O,3955
81111,laser,O,3955
81112,As,O,3955
81113,a,O,3955
81114,result,O,3955
81115,lower,O,3955
81116,total,O,3955
81117,energy,O,3955
81118,is,O,3955
81119,used,O,3955
81120,in,O,3955
81121,the,O,3955
81122,eye,O,3955
81123,making,O,3955
81124,nuclear,O,3955
81125,removal,O,3955
81126,easier,O,3955
81127,The,O,3955
81128,disadvantages,O,3956
81129,of,O,3956
81130,FLACS,B-TREATMENT,3956
81131,for,O,3956
81132,experienced,O,3956
81133,high-volume,O,3956
81134,surgeons,O,3956
81135,are,O,3956
81136,the,O,3956
81137,cost,O,3956
81138,increased,O,3956
81139,surgical,O,3956
81140,time,O,3956
81141,and,O,3956
81142,minimal,O,3956
81143,long-term,O,3956
81144,enhanced,O,3956
81145,visual,O,3956
81146,outcome,O,3956
81147,However,O,3956
81148,FLACS,B-TREATMENT,3956
81149,may,O,3956
81150,be,O,3956
81151,advantageous,O,3956
81152,for,O,3956
81153,use,O,3956
81154,on,O,3956
81155,brunescent,B-SIGN_AND_SYMPTOM,3956
81156,cataracts,I-SIGN_AND_SYMPTOM,3957
81157,in,O,3957
81158,patients,O,3957
81159,with,O,3957
81160,Fuchs,B-NAME_OF_DISEASE,3957
81161,dystrophy,I-NAME_OF_DISEASE,3957
81162,There,O,3957
81163,are,O,3957
81164,many,O,3957
81165,means,O,3957
81166,of,O,3957
81167,modulating,O,3957
81168,phaco,O,3957
81169,power,O,3957
81170,to,O,3957
81171,achieve,O,3957
81172,outstanding,O,3958
81173,results,O,3958
81174,in,O,3958
81175,cataract,B-TREATMENT,3958
81176,surgery,I-TREATMENT,3958
81177,and,O,3959
81178,provide,O,3959
81179,the,O,3959
81180,best,O,3959
81181,patient,O,3959
81182,care,O,3959
81183,Dr,B-PERSON,3959
81184,Park,I-PERSON,3959
81185,concluded,O,3959
81186,Noninfectious,B-NAME_OF_DISEASE,3959
81187,uveitis,B-NAME_OF_DISEASE,3959
81188,involving,O,3959
81189,the,O,3959
81190,posterior,O,3959
81191,segment,O,3959
81192,is,O,3959
81193,an,O,3959
81194,important,O,3959
81195,cause,O,3959
81196,of,O,3960
81197,vision,B-SIGN_AND_SYMPTOM,3960
81198,loss,I-SIGN_AND_SYMPTOM,3960
81199,Oral,B-TREATMENT,3960
81200,corticosteroid,I-TREATMENT,3960
81201,therapy,I-TREATMENT,3960
81202,is,O,3960
81203,the,O,3960
81204,mainstay,O,3960
81205,for,O,3960
81206,initial,O,3960
81207,treatment,O,3960
81208,but,O,3960
81209,depending,O,3960
81210,on,O,3960
81211,its,O,3960
81212,underlying,O,3960
81213,cause,O,3960
81214,uveitis,B-NAME_OF_DISEASE,3960
81215,often,O,3960
81216,cannot,O,3960
81217,be,O,3961
81218,controlled,O,3961
81219,after,O,3961
81220,tapering,O,3961
81221,of,O,3961
81222,the,O,3961
81223,steroid,B-NAME_OF_DRUG,3961
81224,to,O,3961
81225,a,O,3961
81226,dose,O,3961
81227,that,O,3961
81228,is,O,3961
81229,safe,O,3961
81230,for,O,3961
81231,chronic,O,3961
81232,treatment,O,3961
81233,Steroid-sparing,B-TREATMENT,3961
81234,immunosuppressive,I-TREATMENT,3961
81235,therapy,I-TREATMENT,3961
81236,and,O,3961
81237,local,B-TREATMENT,3961
81238,corticosteroid,I-TREATMENT,3961
81239,injections,I-TREATMENT,3962
81240,can,O,3962
81241,have,O,3962
81242,a,O,3962
81243,role,O,3962
81244,for,O,3962
81245,providing,O,3962
81246,long-term,O,3962
81247,suppression,O,3962
81248,of,O,3962
81249,inflammation,O,3962
81250,while,O,3962
81251,mitigating,O,3962
81252,the,O,3963
81253,risks,O,3963
81254,of,O,3964
81255,systemic,O,3964
81256,steroids,B-NAME_OF_DRUG,3964
81257,Dexamethasone,B-NAME_OF_DRUG,3964
81258,has,O,3964
81259,potent,O,3964
81260,anti-inflammatory,O,3964
81261,properties,O,3964
81262,with,O,3964
81263,a,O,3964
81264,favorable,O,3964
81265,side-effect,O,3964
81266,profile,O,3964
81267,Uveitis,B-NAME_OF_DISEASE,3964
81268,of,O,3964
81269,the,O,3964
81270,posterior,O,3964
81271,segment,O,3965
81272,encompasses,O,3965
81273,a,O,3965
81274,variety,O,3965
81275,of,O,3966
81276,diagnostic,O,3966
81277,descriptions,O,3966
81278,namely,O,3966
81279,intermediate,B-NAME_OF_DISEASE,3966
81280,uveitis,I-NAME_OF_DISEASE,3967
81281,posterior,B-NAME_OF_DISEASE,3967
81282,uveitis,I-NAME_OF_DISEASE,3968
81283,and,O,3968
81284,panuveitis,B-NAME_OF_DISEASE,3968
81285,Uveitis,B-NAME_OF_DISEASE,3968
81286,affecting,O,3968
81287,the,O,3968
81288,posterior,O,3968
81289,segment,O,3968
81290,can,O,3968
81291,be,O,3968
81292,infectious,O,3968
81293,although,O,3968
81294,most,O,3968
81295,cases,O,3968
81296,are,O,3968
81297,noninfectious,O,3968
81298,Corticosteroids,B-NAME_OF_DRUG,3968
81299,and,O,3968
81300,immunomodulatory,B-NAME_OF_DRUG,3968
81301,drugs,I-NAME_OF_DRUG,3968
81302,are,O,3968
81303,the,O,3968
81304,cornerstones,O,3968
81305,for,O,3968
81306,treatment,O,3968
81307,of,O,3968
81308,noninfectious,B-NAME_OF_DISEASE,3968
81309,uveitis,I-NAME_OF_DISEASE,3968
81310,in,O,3968
81311,the,O,3969
81312,posterior,O,3969
81313,segment,O,3969
81314,Treatment,O,3969
81315,of,O,3969
81316,posterior,B-NAME_OF_DISEASE,3969
81317,uveitis,I-NAME_OF_DISEASE,3969
81318,generally,O,3969
81319,necessitates,O,3969
81320,the,O,3969
81321,use,O,3969
81322,of,O,3969
81323,intraocular,B-TREATMENT,3969
81324,injections,I-TREATMENT,3969
81325,implants,I-TREATMENT,3969
81326,or,O,3969
81327,systemic,B-TREATMENT,3969
81328,therapies,I-TREATMENT,3969
81329,Local,O,3969
81330,corticosteroids,B-NAME_OF_DRUG,3969
81331,are,O,3969
81332,used,O,3969
81333,when,O,3969
81334,inflammation,O,3969
81335,or,O,3969
81336,residual,O,3970
81337,inflammation,O,3970
81338,in,O,3970
81339,the,O,3971
81340,case,O,3971
81341,of,O,3971
81342,a,O,3971
81343,systemically,O,3971
81344,treated,O,3971
81345,patient,O,3971
81346,is,O,3972
81347,limited,O,3972
81348,to,O,3972
81349,the,O,3972
81350,eye,O,3972
81351,Subtenon,B-TREATMENT,3972
81352,triamcinolone,I-TREATMENT,3973
81353,injections,I-TREATMENT,3973
81354,are,O,3973
81355,most,O,3973
81356,commonly,O,3974
81357,used,O,3974
81358,in,O,3974
81359,clinical,O,3974
81360,practice,O,3974
81361,As,O,3974
81362,with,O,3974
81363,all,O,3974
81364,treatments,O,3974
81365,there,O,3974
81366,are,O,3974
81367,some,O,3974
81368,limitations,O,3974
81369,Clinical,O,3974
81370,experience,O,3974
81371,has,O,3974
81372,shown,O,3974
81373,that,O,3975
81374,a,O,3975
81375,percentage,O,3976
81376,of,O,3976
81377,patients,O,3977
81378,will,O,3977
81379,develop,O,3977
81380,high,B-NAME_OF_DISEASE,3977
81381,IOP,I-NAME_OF_DISEASE,3977
81382,and,O,3977
81383,or,O,3977
81384,cataract,B-NAME_OF_DISEASE,3977
81385,as,O,3977
81386,a,O,3977
81387,result,O,3977
81388,of,O,3977
81389,these,O,3977
81390,injections,O,3977
81391,and,O,3977
81392,it,O,3977
81393,is,O,3977
81394,difficult,O,3977
81395,to,O,3977
81396,predict,O,3978
81397,which,O,3978
81398,patients,O,3978
81399,will,O,3978
81400,have,O,3978
81401,that,O,3979
81402,response,O,3979
81403,As,O,3979
81404,for,O,3979
81405,systemic,O,3979
81406,treatments,O,3979
81407,corticosteroids,B-NAME_OF_DRUG,3979
81408,are,O,3979
81409,the,O,3979
81410,first-line,O,3979
81411,drug,O,3979
81412,in,O,3979
81413,noninfectious,O,3979
81414,inflammatory,O,3979
81415,conditions,O,3979
81416,including,O,3979
81417,posterior,B-NAME_OF_DISEASE,3979
81418,segment,I-NAME_OF_DISEASE,3979
81419,uveitis,I-NAME_OF_DISEASE,3979
81420,When,O,3979
81421,10,B-NAME_OF_DRUG,3979
81422,mg,I-NAME_OF_DRUG,3979
81423,d,I-NAME_OF_DRUG,3980
81424,corticosteroid,I-NAME_OF_DRUG,3980
81425,treatment,O,3980
81426,is,O,3980
81427,needed,O,3980
81428,to,O,3980
81429,keep,O,3980
81430,ocular,O,3980
81431,inflammation,O,3980
81432,controlled,O,3980
81433,immunomodulatory,B-TREATMENT,3980
81434,therapies,I-TREATMENT,3980
81435,IMTs,I-TREATMENT,3980
81436,are,O,3980
81437,used,O,3980
81438,In,O,3980
81439,Europe,B-GPE,3980
81440,cyclosporine,B-NAME_OF_DRUG,3980
81441,mycophenolate,B-NAME_OF_DRUG,3980
81442,azathioprine,B-NAME_OF_DRUG,3980
81443,and,O,3980
81444,methotrexate,B-NAME_OF_DRUG,3980
81445,are,O,3980
81446,the,O,3980
81447,most,O,3981
81448,common,O,3981
81449,IMTs,B-TREATMENT,3981
81450,used,O,3981
81451,for,O,3981
81452,noninfectious,B-NAME_OF_DISEASE,3981
81453,posterior,I-NAME_OF_DISEASE,3981
81454,segment,I-NAME_OF_DISEASE,3981
81455,uveitis,B-NAME_OF_DISEASE,3981
81456,For,O,3981
81457,patients,O,3981
81458,whose,O,3981
81459,uveitis,B-NAME_OF_DISEASE,3981
81460,is,O,3981
81461,refractory,O,3981
81462,to,O,3981
81463,traditional,O,3981
81464,immunosuppressants,B-NAME_OF_DRUG,3981
81465,infliximab,B-NAME_OF_DRUG,3982
81466,and,O,3982
81467,adalimumab,B-NAME_OF_DRUG,3982
81468,are,O,3982
81469,the,O,3982
81470,anti-TNF-a,B-CHEMICAL_COMPOUND,3982
81471,biologics,O,3982
81472,that,O,3982
81473,are,O,3982
81474,most,O,3982
81475,often,O,3982
81476,used,O,3982
81477,There,O,3982
81478,is,O,3982
81479,evidence,O,3982
81480,that,O,3982
81481,patients,O,3982
81482,with,O,3982
81483,certain,O,3982
81484,systemic,O,3982
81485,etiologies,O,3982
81486,are,O,3982
81487,best,O,3982
81488,treated,O,3983
81489,early,O,3983
81490,with,O,3983
81491,the,O,3983
81492,anti-TNF-a,B-CHEMICAL_COMPOUND,3983
81493,medications,O,3983
81494,Adamantiades-Behçet,B-NAME_OF_DISEASE,3983
81495,disease,I-NAME_OF_DISEASE,3983
81496,is,O,3983
81497,believed,O,3983
81498,to,O,3983
81499,respond,O,3983
81500,well,O,3983
81501,to,O,3983
81502,infliximab,B-NAME_OF_DRUG,3983
81503,and,O,3983
81504,pediatric,B-NAME_OF_DISEASE,3983
81505,posterior,I-NAME_OF_DISEASE,3983
81506,segment,I-NAME_OF_DISEASE,3983
81507,uveitis,I-NAME_OF_DISEASE,3983
81508,patients,O,3983
81509,including,O,3983
81510,those,O,3983
81511,whose,O,3983
81512,condition,O,3983
81513,is,O,3983
81514,associated,O,3983
81515,with,O,3983
81516,juvenile,B-NAME_OF_DISEASE,3983
81517,idiopathic,I-NAME_OF_DISEASE,3983
81518,arthritis,I-NAME_OF_DISEASE,3983
81519,do,O,3983
81520,well,O,3983
81521,on,O,3983
81522,adalimumab,B-NAME_OF_DRUG,3983
81523,Regarding,O,3983
81524,other,O,3983
81525,biologics,O,3983
81526,interferon,B-CHEMICAL_COMPOUND,3983
81527,and,O,3983
81528,the,B-CHEMICAL_COMPOUND,3984
81529,interleukin-6,I-CHEMICAL_COMPOUND,3984
81530,inhibitor,I-CHEMICAL_COMPOUND,3984
81531,tocilizumab,I-CHEMICAL_COMPOUND,3984
81532,are,O,3984
81533,beginning,O,3984
81534,to,O,3984
81535,be,O,3984
81536,used,O,3984
81537,more,O,3984
81538,The,O,3984
81539,results,O,3984
81540,of,O,3984
81541,a,O,3984
81542,small,O,3985
81543,retrospective,O,3985
81544,cohort,O,3985
81545,study,O,3985
81546,has,O,3985
81547,been,O,3985
81548,published,O,3985
81549,recently,O,3985
81550,showing,O,3985
81551,success,O,3985
81552,when,O,3985
81553,treating,O,3985
81554,inflammatory,B-SIGN_AND_SYMPTOM,3985
81555,macular,B-SIGN_AND_SYMPTOM,3985
81556,edema,I-SIGN_AND_SYMPTOM,3985
81557,refractory,O,3985
81558,to,O,3985
81559,the,O,3985
81560,anti-TNF-a,B-CHEMICAL_COMPOUND,3985
81561,medications,O,3985
81562,Interferon,B-CHEMICAL_COMPOUND,3985
81563,is,O,3985
81564,used,O,3985
81565,mostly,O,3985
81566,in,O,3985
81567,Germany,B-GPE,3986
81568,and,O,3986
81569,Turkey,B-GPE,3986
81570,mainly,O,3986
81571,in,O,3986
81572,Behçet,B-NAME_OF_DISEASE,3986
81573,disease,I-NAME_OF_DISEASE,3986
81574,and,O,3986
81575,in,O,3986
81576,cases,O,3986
81577,with,O,3986
81578,macular,B-SIGN_AND_SYMPTOM,3987
81579,edema,I-SIGN_AND_SYMPTOM,3987
81580,An,O,3987
81581,advantage,O,3987
81582,of,O,3987
81583,interferon,B-CHEMICAL_COMPOUND,3987
81584,is,O,3987
81585,that,O,3987
81586,when,O,3988
81587,treatment,O,3988
81588,is,O,3988
81589,stopped,O,3988
81590,a,O,3988
81591,high,O,3988
81592,percentage,O,3988
81593,of,O,3988
81594,patients,O,3988
81595,remain,O,3988
81596,in,O,3988
81597,remission,O,3988
81598,LOUVRE,B-NAME_OF_STUDY,3988
81599,2,I-NAME_OF_STUDY,3988
81600,STUDY,I-NAME_OF_STUDY,3989
81601,FINDINGS,O,3989
81602,IN,O,3989
81603,LOUVRE,B-NAME_OF_STUDY,3989
81604,2,I-NAME_OF_STUDY,3989
81605,a,O,3989
81606,French,O,3989
81607,postmarketing,O,3989
81608,prospective,O,3989
81609,observational,O,3989
81610,study,O,3989
81611,confirm,O,3989
81612,the,O,3989
81613,real-world,O,3989
81614,efficacy,O,3989
81615,of,O,3989
81616,the,O,3989
81617,dexamethasone,O,3989
81618,0,O,3989
81619,mg,O,3989
81620,intravitreal,O,3989
81621,implant,O,3989
81622,Ozurdex,B-NAME_OF_DRUG,3989
81623,Allergan,B-ORGANIZATION,3989
81624,for,O,3989
81625,treating,O,3989
81626,relatively,O,3990
81627,long-standing,O,3990
81628,non-infectious,B-NAME_OF_DISEASE,3990
81629,posterior,I-NAME_OF_DISEASE,3990
81630,segment,I-NAME_OF_DISEASE,3990
81631,uveitis,B-NAME_OF_DISEASE,3990
81632,The,O,3990
81633,findings,O,3990
81634,also,O,3990
81635,provide,O,3990
81636,insight,O,3990
81637,into,O,3990
81638,the,O,3990
81639,characteristics,O,3990
81640,of,O,3990
81641,patients,O,3990
81642,ophthalmologists,O,3990
81643,choose,O,3990
81644,for,O,3990
81645,treatment,O,3990
81646,with,O,3990
81647,the,O,3990
81648,sustained-release,O,3990
81649,corticosteroid,B-NAME_OF_DRUG,3990
81650,implant,O,3990
81651,Noninfectious,B-NAME_OF_DISEASE,3990
81652,posterior,I-NAME_OF_DISEASE,3990
81653,segment,I-NAME_OF_DISEASE,3990
81654,uveitis,B-NAME_OF_DISEASE,3990
81655,NIPU,B-NAME_OF_DISEASE,3991
81656,is,O,3991
81657,the,O,3991
81658,least,O,3991
81659,common,O,3991
81660,form,O,3991
81661,of,O,3991
81662,uveitis,B-NAME_OF_DISEASE,3991
81663,yet,O,3991
81664,it,O,3991
81665,is,O,3991
81666,the,O,3991
81667,most,O,3991
81668,vision-threatening,O,3991
81669,form,O,3991
81670,In,O,3991
81671,addition,O,3991
81672,to,O,3991
81673,its,O,3991
81674,potential,O,3991
81675,to,O,3991
81676,cause,O,3991
81677,sudden,B-SIGN_AND_SYMPTOM,3991
81678,severe,I-SIGN_AND_SYMPTOM,3991
81679,vision,I-SIGN_AND_SYMPTOM,3991
81680,loss,I-SIGN_AND_SYMPTOM,3991
81681,it,O,3991
81682,can,O,3991
81683,be,O,3991
81684,associated,O,3991
81685,with,O,3991
81686,painful,B-SIGN_AND_SYMPTOM,3991
81687,symptoms,O,3991
81688,Because,O,3991
81689,of,O,3992
81690,its,O,3992
81691,sequelae,O,3992
81692,NIPU,B-NAME_OF_DISEASE,3992
81693,can,O,3992
81694,lead,O,3992
81695,to,O,3992
81696,a,O,3992
81697,marked,O,3992
81698,decrease,O,3992
81699,in,O,3992
81700,quality,O,3992
81701,of,O,3992
81702,life,O,3992
81703,In,O,3992
81704,this,O,3992
81705,cohort,O,3992
81706,of,O,3992
81707,patients,O,3992
81708,seen,O,3992
81709,in,O,3992
81710,routine,O,3992
81711,clinical,O,3992
81712,practice,O,3992
81713,consisting,O,3992
81714,mostly,O,3992
81715,of,O,3992
81716,individuals,O,3992
81717,previously,O,3992
81718,treated,O,3992
81719,for,O,3992
81720,uveitis,B-NAME_OF_DISEASE,3992
81721,for,O,3992
81722,an,O,3992
81723,average,O,3992
81724,of,O,3992
81725,5,B-TIME_DURATION,3992
81726,years,I-TIME_DURATION,3992
81727,the,B-NAME_OF_DRUG,3992
81728,intravitreal,I-NAME_OF_DRUG,3992
81729,dexamethasone,I-NAME_OF_DRUG,3992
81730,implant,I-NAME_OF_DRUG,3992
81731,maintained,O,3992
81732,its,O,3993
81733,functional,O,3993
81734,and,O,3993
81735,anatomic,O,3993
81736,efficacy,O,3993
81737,In,O,3993
81738,addition,O,3993
81739,the,O,3993
81740,tolerability,O,3993
81741,of,O,3993
81742,the,B-TREATMENT,3993
81743,steroid,I-TREATMENT,3993
81744,implant,I-TREATMENT,3993
81745,treatment,I-TREATMENT,3993
81746,was,O,3993
81747,consistent,O,3993
81748,with,O,3993
81749,what,O,3993
81750,has,O,3994
81751,been,O,3994
81752,reported,O,3994
81753,in,O,3994
81754,the,O,3994
81755,literature,O,3994
81756,With,O,3994
81757,its,O,3994
81758,approval,O,3994
81759,in,O,3994
81760,July,O,3994
81761,2010,O,3994
81762,the,B-NAME_OF_DRUG,3994
81763,dexamethasone,I-NAME_OF_DRUG,3994
81764,intravitreal,I-NAME_OF_DRUG,3994
81765,implant,I-NAME_OF_DRUG,3994
81766,became,O,3994
81767,the,O,3994
81768,first,O,3994
81769,specialized,O,3994
81770,treatment,O,3994
81771,for,O,3994
81772,NIPU,B-NAME_OF_DISEASE,3994
81773,in,O,3994
81774,Europe,B-GPE,3994
81775,Thereafter,O,3994
81776,the,O,3995
81777,prospective,O,3995
81778,multicenter,O,3995
81779,observational,O,3995
81780,LOUVRE,B-NAME_OF_STUDY,3995
81781,2,I-NAME_OF_STUDY,3995
81782,study,I-NAME_OF_STUDY,3995
81783,was,O,3995
81784,implemented,O,3995
81785,in,O,3995
81786,France,B-GPE,3995
81787,to,O,3995
81788,evaluate,O,3996
81789,the,O,3996
81790,real-world,O,3996
81791,efficacy,O,3996
81792,safety,O,3996
81793,and,O,3996
81794,use,O,3996
81795,of,O,3996
81796,the,O,3996
81797,implant,O,3996
81798,in,O,3996
81799,patients,O,3996
81800,affected,O,3996
81801,by,O,3996
81802,NIPU,B-NAME_OF_DISEASE,3996
81803,The,O,3996
81804,study,O,3996
81805,enrolled,O,3996
81806,consecutively,O,3996
81807,presenting,O,3996
81808,patients,O,3996
81809,with,O,3996
81810,inflammation,B-SIGN_AND_SYMPTOM,3996
81811,of,I-SIGN_AND_SYMPTOM,3996
81812,the,I-SIGN_AND_SYMPTOM,3996
81813,posterior,I-SIGN_AND_SYMPTOM,3996
81814,ocular,I-SIGN_AND_SYMPTOM,3996
81815,segment,I-SIGN_AND_SYMPTOM,3996
81816,due,O,3996
81817,to,O,3996
81818,NIPU,B-NAME_OF_DISEASE,3996
81819,Twenty,O,3996
81820,randomly,O,3996
81821,selected,O,3996
81822,injection,O,3997
81823,centers,O,3997
81824,participated,O,3997
81825,in,O,3997
81826,the,O,3997
81827,study,O,3997
81828,Both,O,3997
81829,treatment-naive,O,3997
81830,and,O,3997
81831,previously,O,3997
81832,treated,O,3997
81833,patients,O,3997
81834,were,O,3997
81835,eligible,O,3997
81836,for,O,3997
81837,enrollment,O,3997
81838,Patients,O,3997
81839,who,O,3997
81840,were,O,3997
81841,treated,O,3997
81842,with,O,3997
81843,the,B-NAME_OF_DRUG,3997
81844,dexamethasone,B-NAME_OF_DRUG,3997
81845,implant,I-NAME_OF_DRUG,3997
81846,on,O,3997
81847,study,O,3997
81848,entry,O,3997
81849,could,O,3997
81850,be,O,3997
81851,retreated,O,3997
81852,with,O,3997
81853,the,O,3997
81854,implant,O,3997
81855,and,O,3997
81856,or,O,3997
81857,alternative,O,3997
81858,therapies,O,3998
81859,during,O,3998
81860,follow-up,O,3998
81861,According,O,3998
81862,to,O,3998
81863,the,O,3998
81864,protocol,O,3998
81865,outcomes,O,3998
81866,would,O,3998
81867,be,O,3998
81868,analyzed,O,3998
81869,using,O,3998
81870,data,O,3998
81871,from,O,3998
81872,visits,O,3998
81873,at,O,3998
81874,months,O,3998
81875,2,O,3998
81876,6,O,3998
81877,and,O,3999
81878,18,O,3999
81879,after,O,3999
81880,patient,O,3999
81881,enrollment,O,3999
81882,A,O,3999
81883,batch,O,3999
81884,recall,O,3999
81885,of,O,3999
81886,the,O,3999
81887,implant,O,3999
81888,at,O,3999
81889,the,O,3999
81890,end,O,3999
81891,of,O,3999
81892,2018,O,3999
81893,led,O,3999
81894,to,O,3999
81895,early,O,3999
81896,termination,O,3999
81897,of,O,3999
81898,the,O,3999
81899,study,O,3999
81900,and,O,3999
81901,only,O,3999
81902,a,O,3999
81903,few,O,3999
81904,patients,O,3999
81905,reached,O,3999
81906,the,O,3999
81907,month,O,3999
81908,18,O,3999
81909,visit,O,3999
81910,Efficacy,O,3999
81911,assessments,O,3999
81912,included,O,3999
81913,changes,O,3999
81914,in,O,3999
81915,best,B-DIAGNOSTIC_TEST,3999
81916,corrected,I-DIAGNOSTIC_TEST,3999
81917,visual,I-DIAGNOSTIC_TEST,4000
81918,acuity,I-DIAGNOSTIC_TEST,4000
81919,BCVA,B-DIAGNOSTIC_TEST,4000
81920,and,O,4000
81921,central,B-DIAGNOSTIC_TEST,4000
81922,retinal,I-DIAGNOSTIC_TEST,4000
81923,thickness,I-DIAGNOSTIC_TEST,4000
81924,CRT,B-DIAGNOSTIC_TEST,4000
81925,,O,4000
81926,Safety,O,4000
81927,evaluations,O,4000
81928,reviewed,O,4000
81929,AE,O,4000
81930,reports,O,4001
81931,Baseline,O,4001
81932,data,O,4001
81933,were,O,4001
81934,available,O,4001
81935,for,O,4001
81936,241,O,4001
81937,patients,O,4001
81938,including,O,4001
81939,97,O,4001
81940,who,O,4001
81941,were,O,4001
81942,treated,O,4001
81943,with,O,4001
81944,the,B-NAME_OF_DRUG,4001
81945,dexamethasone,B-NAME_OF_DRUG,4001
81946,implant,I-NAME_OF_DRUG,4001
81947,at,O,4001
81948,study,O,4001
81949,entry,O,4001
81950,The,O,4001
81951,patients,O,4001
81952,who,O,4001
81953,were,O,4001
81954,treated,O,4001
81955,with,O,4001
81956,dexamethasone,B-NAME_OF_DRUG,4001
81957,had,O,4001
81958,on,O,4002
81959,average,O,4002
81960,a,O,4002
81961,5-year,O,4002
81962,history,O,4002
81963,of,O,4002
81964,NIPU,B-NAME_OF_DISEASE,4002
81965,and,O,4002
81966,80%,O,4002
81967,had,O,4002
81968,received,O,4002
81969,prior,O,4002
81970,treatment,O,4002
81971,Compared,O,4002
81972,with,O,4002
81973,the,O,4002
81974,group,O,4002
81975,of,O,4002
81976,144,O,4003
81977,patients,O,4003
81978,that,O,4003
81979,did,O,4003
81980,not,O,4003
81981,receive,O,4003
81982,the,O,4003
81983,implant,O,4003
81984,those,O,4003
81985,treated,O,4003
81986,who,O,4003
81987,received,O,4003
81988,the,B-NAME_OF_DRUG,4003
81989,dexamethasone,B-NAME_OF_DRUG,4003
81990,implant,I-NAME_OF_DRUG,4003
81991,were,O,4003
81992,7,O,4003
81993,years,O,4003
81994,older,O,4003
81995,on,O,4003
81996,average,O,4003
81997,and,O,4003
81998,had,O,4003
81999,a,O,4003
82000,thicker,O,4003
82001,mean,O,4003
82002,CRT,B-DIAGNOSTIC_TEST,4003
82003,mean,O,4003
82004,difference,O,4003
82005,91,O,4003
82006,µm,O,4003
82007,,O,4003
82008,In,O,4003
82009,addition,O,4003
82010,the,O,4003
82011,group,O,4004
82012,treated,O,4004
82013,with,O,4004
82014,the,B-NAME_OF_DRUG,4004
82015,dexamethasone,B-NAME_OF_DRUG,4004
82016,implant,I-NAME_OF_DRUG,4004
82017,included,O,4004
82018,greater,O,4004
82019,proportions,O,4004
82020,of,O,4004
82021,patients,O,4004
82022,with,O,4004
82023,cataract,B-NAME_OF_DISEASE,4004
82024,20,O,4004
82025,difference,O,4005
82026,macular,B-SIGN_AND_SYMPTOM,4005
82027,edema,I-SIGN_AND_SYMPTOM,4005
82028,26.2,O,4005
82029,difference,O,4005
82030,and,O,4005
82031,inflammation-associated,O,4005
82032,pathology,O,4005
82033,8.8,O,4005
82034,difference,O,4005
82035,,O,4005
82036,Half,O,4005
82037,the,O,4005
82038,patients,O,4005
82039,treated,O,4005
82040,with,O,4005
82041,the,B-NAME_OF_DRUG,4005
82042,dexamethasone,B-NAME_OF_DRUG,4005
82043,implant,I-NAME_OF_DRUG,4005
82044,at,O,4005
82045,entry,O,4005
82046,into,O,4005
82047,LOUVRE,B-NAME_OF_STUDY,4005
82048,2,I-NAME_OF_STUDY,4005
82049,were,O,4005
82050,not,O,4005
82051,retreated,O,4005
82052,at,O,4005
82053,month,O,4005
82054,6,O,4005
82055,mainly,O,4006
82056,because,O,4006
82057,they,O,4006
82058,had,O,4006
82059,sufficient,O,4006
82060,improvement,O,4006
82061,of,O,4006
82062,their,O,4006
82063,disease,O,4006
82064,state,O,4006
82065,The,O,4006
82066,proportion,O,4006
82067,of,O,4006
82068,dexamethasone-treated,O,4006
82069,patients,O,4006
82070,achieving,O,4006
82071,a,O,4007
82072,greater,O,4007
82073,than,O,4007
82074,or,O,4007
82075,equal,O,4007
82076,to,O,4007
82077,15-letter,O,4007
82078,gain,O,4007
82079,in,O,4007
82080,BCVA,B-DIAGNOSTIC_TEST,4007
82081,from,O,4007
82082,baseline,O,4007
82083,was,O,4007
82084,25%,O,4007
82085,at,O,4007
82086,month,O,4007
82087,2,O,4007
82088,and,O,4007
82089,19.4,O,4007
82090,at,O,4007
82091,month,O,4007
82092,6,O,4007
82093,Mean,O,4007
82094,improvement,O,4007
82095,from,O,4007
82096,baseline,O,4007
82097,BCVA,B-DIAGNOSTIC_TEST,4007
82098,was,O,4007
82099,6,O,4008
82100,letters,O,4008
82101,at,O,4008
82102,2,B-TIME_DURATION,4008
82103,months,I-TIME_DURATION,4008
82104,and,O,4008
82105,4,O,4008
82106,letters,O,4008
82107,at,O,4008
82108,6,B-TIME_DURATION,4008
82109,months,I-TIME_DURATION,4008
82110,Central,B-SIGN_AND_SYMPTOM,4008
82111,retinal,I-SIGN_AND_SYMPTOM,4008
82112,dryness,I-SIGN_AND_SYMPTOM,4008
82113,was,O,4008
82114,maintained,O,4008
82115,at,O,4008
82116,months,O,4008
82117,2,O,4008
82118,and,O,4009
82119,6,O,4009
82120,with,O,4009
82121,mean,O,4009
82122,decreases,O,4009
82123,from,O,4009
82124,baseline,O,4009
82125,of,O,4009
82126,27,O,4009
82127,and,O,4009
82128,18,O,4009
82129,mum,O,4009
82130,respectively,O,4009
82131,The,O,4009
82132,observed,O,4009
82133,functional,O,4009
82134,gains,O,4009
82135,are,O,4009
82136,clinically,O,4010
82137,relevant,O,4010
82138,and,O,4010
82139,were,O,4010
82140,achieved,O,4010
82141,despite,O,4010
82142,prior,O,4010
82143,treatment,O,4010
82144,with,O,4010
82145,the,B-NAME_OF_DRUG,4010
82146,dexamethasone,B-NAME_OF_DRUG,4010
82147,implant,I-NAME_OF_DRUG,4010
82148,in,O,4010
82149,55.7,O,4010
82150,of,O,4010
82151,the,O,4010
82152,patients,O,4010
82153,followed,O,4010
82154,prospectively,O,4010
82155,These,O,4010
82156,findings,O,4010
82157,substantiate,O,4010
82158,the,O,4010
82159,efficacy,O,4010
82160,of,O,4010
82161,the,B-NAME_OF_DRUG,4010
82162,dexamethasone,B-NAME_OF_DRUG,4010
82163,implant,I-NAME_OF_DRUG,4010
82164,for,O,4010
82165,improving,O,4010
82166,visual,O,4010
82167,function,O,4010
82168,among,O,4010
82169,patients,O,4010
82170,with,O,4010
82171,NIPU,B-NAME_OF_DISEASE,4010
82172,in,O,4010
82173,seen,O,4010
82174,the,O,4011
82175,clinical,O,4011
82176,setting,O,4011
82177,The,O,4011
82178,most,O,4011
82179,frequently,O,4011
82180,reported,O,4011
82181,AE,O,4011
82182,occurring,O,4011
82183,in,O,4011
82184,patients,O,4011
82185,treated,O,4011
82186,with,O,4011
82187,the,B-NAME_OF_DRUG,4011
82188,dexamethasone,B-NAME_OF_DRUG,4011
82189,implant,I-NAME_OF_DRUG,4011
82190,was,O,4011
82191,transient,O,4011
82192,ocular,B-NAME_OF_DISEASE,4011
82193,hypertension,I-NAME_OF_DISEASE,4011
82194,which,O,4011
82195,occurred,O,4011
82196,at,O,4011
82197,a,O,4011
82198,rate,O,4011
82199,of,O,4011
82200,6.90%,O,4011
82201,This,O,4011
82202,finding,O,4011
82203,is,O,4011
82204,similar,O,4011
82205,to,O,4011
82206,the,O,4011
82207,experience,O,4011
82208,reported,O,4011
82209,with,O,4011
82210,the,B-NAME_OF_DRUG,4011
82211,dexamethasone,B-NAME_OF_DRUG,4011
82212,implant,I-NAME_OF_DRUG,4011
82213,in,O,4011
82214,prior,O,4011
82215,prospective,O,4011
82216,and,O,4012
82217,retrospective,O,4012
82218,studies,O,4012
82219,20-20-20,B-TREATMENT,4012
82220,screen,I-TREATMENT,4012
82221,rule,I-TREATMENT,4012
82222,has,O,4012
82223,been,O,4012
82224,suggested,O,4012
82225,for,O,4012
82226,a,O,4012
82227,long,O,4012
82228,time,O,4012
82229,as,O,4012
82230,a,O,4012
82231,strategy,O,4012
82232,to,O,4012
82233,reduce,O,4012
82234,eye,B-SIGN_AND_SYMPTOM,4012
82235,strain,I-SIGN_AND_SYMPTOM,4012
82236,while,O,4012
82237,staring,O,4012
82238,at,O,4012
82239,a,O,4012
82240,computer,O,4012
82241,screen,O,4012
82242,Scientists,O,4012
82243,at,O,4012
82244,Aston,B-ORGANIZATION,4012
82245,University,I-ORGANIZATION,4012
82246,have,O,4012
82247,now,O,4012
82248,confirmed,O,4012
82249,the,B-TREATMENT,4012
82250,20-20-20,I-TREATMENT,4012
82251,rule,I-TREATMENT,4012
82252,which,O,4012
82253,suggests,O,4012
82254,taking,O,4012
82255,breaks,O,4012
82256,of,O,4012
82257,at,O,4012
82258,least,O,4012
82259,20,O,4013
82260,seconds,O,4013
82261,every,O,4013
82262,20,O,4013
82263,minutes,O,4013
82264,to,O,4013
82265,look,O,4013
82266,at,O,4013
82267,least,O,4013
82268,20,O,4013
82269,feet,O,4013
82270,away,O,4013
82271,to,O,4013
82272,reduce,O,4013
82273,some,O,4013
82274,of,O,4013
82275,the,O,4013
82276,side,O,4013
82277,effects,O,4013
82278,of,O,4013
82279,extended,O,4013
82280,computer,O,4013
82281,use,O,4013
82282,This,O,4013
82283,is,O,4013
82284,the,O,4013
82285,first,O,4013
82286,time,O,4013
82287,that,O,4013
82288,the,B-TREATMENT,4013
82289,20-20-20,I-TREATMENT,4013
82290,guidance,I-TREATMENT,4013
82291,rule,I-TREATMENT,4013
82292,has,O,4013
82293,been,O,4013
82294,properly,O,4013
82295,validated,O,4013
82296,Digital,B-NAME_OF_DISEASE,4013
82297,eye,I-NAME_OF_DISEASE,4013
82298,strain,I-NAME_OF_DISEASE,4013
82299,which,O,4013
82300,can,O,4013
82301,cause,O,4013
82302,headaches,B-SIGN_AND_SYMPTOM,4013
82303,or,I-SIGN_AND_SYMPTOM,4013
82304,impaired,I-SIGN_AND_SYMPTOM,4013
82305,vision,I-SIGN_AND_SYMPTOM,4013
82306,is,O,4013
82307,believed,O,4013
82308,to,O,4013
82309,affect,O,4013
82310,at,O,4014
82311,least,O,4014
82312,half,O,4014
82313,of,O,4014
82314,those,O,4014
82315,who,O,4014
82316,use,O,4014
82317,computers,O,4014
82318,regularly,O,4014
82319,at,O,4014
82320,work,O,4014
82321,It,O,4014
82322,can,O,4014
82323,also,O,4014
82324,cause,O,4014
82325,irritation,B-SIGN_AND_SYMPTOM,4014
82326,and,I-SIGN_AND_SYMPTOM,4015
82327,dryness,I-SIGN_AND_SYMPTOM,4015
82328,of,I-SIGN_AND_SYMPTOM,4015
82329,the,I-SIGN_AND_SYMPTOM,4015
82330,eye,I-SIGN_AND_SYMPTOM,4015
82331,surface,I-SIGN_AND_SYMPTOM,4015
82332,Humans,O,4015
82333,normally,O,4015
82334,blink,O,4015
82335,around,O,4015
82336,15,O,4015
82337,times,O,4015
82338,each,O,4015
82339,minute,O,4015
82340,This,O,4015
82341,number,O,4015
82342,usually,O,4015
82343,drops,O,4015
82344,to,O,4015
82345,half,O,4015
82346,that,O,4015
82347,rate,O,4015
82348,or,O,4015
82349,less,O,4015
82350,when,O,4015
82351,looking,O,4015
82352,at,O,4015
82353,screens,O,4015
82354,This,O,4015
82355,can,O,4015
82356,cause,O,4015
82357,dry,B-SIGN_AND_SYMPTOM,4015
82358,itchy,I-SIGN_AND_SYMPTOM,4015
82359,and,I-SIGN_AND_SYMPTOM,4016
82360,fatigued,I-SIGN_AND_SYMPTOM,4016
82361,eyes,I-SIGN_AND_SYMPTOM,4016
82362,but,O,4016
82363,focusing,O,4016
82364,on,O,4016
82365,something,O,4016
82366,else,O,4016
82367,for,O,4016
82368,20,O,4016
82369,seconds,O,4016
82370,will,O,4016
82371,allow,O,4016
82372,the,O,4016
82373,eyes,O,4016
82374,to,O,4016
82375,relax,O,4016
82376,and,O,4016
82377,lessen,O,4016
82378,the,O,4016
82379,tension,O,4016
82380,The,O,4016
82381,study,O,4016
82382,Researchers,O,4016
82383,at,O,4016
82384,Aston,B-ORGANIZATION,4016
82385,University,I-ORGANIZATION,4016
82386,s,I-ORGANIZATION,4016
82387,College,I-ORGANIZATION,4016
82388,of,I-ORGANIZATION,4016
82389,Health,I-ORGANIZATION,4016
82390,and,I-ORGANIZATION,4016
82391,Life,I-ORGANIZATION,4016
82392,Sciences,I-ORGANIZATION,4016
82393,conducted,O,4016
82394,their,O,4016
82395,study,O,4016
82396,with,O,4016
82397,the,O,4016
82398,help,O,4016
82399,of,O,4016
82400,29,O,4016
82401,participants,O,4016
82402,who,O,4016
82403,suffer,O,4016
82404,from,O,4016
82405,symptoms,O,4016
82406,of,O,4016
82407,eye,B-SIGN_AND_SYMPTOM,4016
82408,strain,I-SIGN_AND_SYMPTOM,4016
82409,The,O,4016
82410,built-in,O,4016
82411,laptop,O,4016
82412,camera,O,4016
82413,was,O,4016
82414,employed,O,4016
82415,by,O,4016
82416,specialized,O,4016
82417,software,O,4016
82418,that,O,4017
82419,was,O,4017
82420,downloaded,O,4017
82421,onto,O,4017
82422,the,O,4017
82423,participants,O,4017
82424,personal,O,4017
82425,laptop,O,4017
82426,computers,O,4017
82427,to,O,4017
82428,periodically,O,4017
82429,check,O,4017
82430,if,O,4017
82431,a,O,4017
82432,user,O,4017
82433,was,O,4017
82434,seated,O,4017
82435,at,O,4017
82436,the,O,4017
82437,screen,O,4017
82438,and,O,4017
82439,track,O,4017
82440,their,O,4017
82441,gaze,O,4017
82442,direction,O,4017
82443,The,O,4017
82444,program,O,4017
82445,flashed,O,4017
82446,up,O,4018
82447,a,O,4018
82448,message,O,4018
82449,urging,O,4018
82450,users,O,4018
82451,to,O,4018
82452,take,O,4018
82453,a,O,4018
82454,break,O,4018
82455,for,O,4018
82456,20,O,4018
82457,seconds,O,4018
82458,while,O,4018
82459,focusing,O,4018
82460,on,O,4018
82461,any,O,4018
82462,distant,O,4018
82463,target,O,4018
82464,that,O,4018
82465,was,O,4018
82466,roughly,O,4018
82467,20,O,4018
82468,feet,O,4018
82469,away,O,4018
82470,such,O,4018
82471,as,O,4018
82472,out,O,4018
82473,the,O,4018
82474,window,O,4018
82475,or,O,4018
82476,across,O,4018
82477,the,O,4018
82478,room,O,4018
82479,after,O,4018
82480,20,O,4018
82481,minutes,O,4019
82482,of,O,4019
82483,nonstop,O,4019
82484,screen,O,4019
82485,staring,O,4019
82486,Before,O,4019
82487,the,O,4019
82488,task,O,4019
82489,had,O,4019
82490,been,O,4019
82491,completed,O,4019
82492,appropriately,O,4019
82493,as,O,4019
82494,determined,O,4019
82495,by,O,4019
82496,the,O,4019
82497,app,O,4019
82498,the,O,4019
82499,message,O,4019
82500,could,O,4019
82501,not,O,4019
82502,be,O,4019
82503,erased,O,4019
82504,Before,O,4019
82505,and,O,4019
82506,after,O,4019
82507,using,O,4019
82508,the,O,4019
82509,reminders,O,4019
82510,for,B-TIME_DURATION,4019
82511,two,I-TIME_DURATION,4019
82512,weeks,I-TIME_DURATION,4019
82513,as,O,4019
82514,well,O,4019
82515,as,O,4020
82516,one,O,4020
82517,week,O,4020
82518,after,O,4020
82519,finishing,O,4020
82520,the,O,4020
82521,research,O,4020
82522,participants,O,4020
82523,symptoms,O,4020
82524,of,O,4020
82525,digital,B-NAME_OF_DISEASE,4020
82526,eye,I-NAME_OF_DISEASE,4020
82527,strain,I-NAME_OF_DISEASE,4020
82528,were,O,4020
82529,assessed,O,4020
82530,Dryness,B-SIGN_AND_SYMPTOM,4020
82531,sensitivity,I-SIGN_AND_SYMPTOM,4020
82532,and,I-SIGN_AND_SYMPTOM,4020
82533,discomfort,I-SIGN_AND_SYMPTOM,4020
82534,were,O,4020
82535,all,O,4020
82536,significantly,O,4020
82537,decreased,O,4020
82538,according,O,4020
82539,to,O,4020
82540,the,O,4020
82541,findings,O,4020
82542,The,O,4021
82543,one,O,4021
82544,previous,O,4021
82545,study,O,4021
82546,merely,O,4021
82547,asked,O,4021
82548,people,O,4021
82549,to,O,4021
82550,carry,O,4021
82551,out,O,4021
82552,the,O,4021
82553,suggestions,O,4021
82554,but,O,4021
82555,here,O,4021
82556,the,O,4021
82557,access,O,4021
82558,control,O,4021
82559,on,O,4022
82560,the,O,4022
82561,software,O,4022
82562,meant,O,4022
82563,we,O,4022
82564,could,O,4022
82565,be,O,4022
82566,sure,O,4022
82567,that,O,4022
82568,participants,O,4022
82569,really,O,4022
82570,had,O,4022
82571,looked,O,4022
82572,away,O,4023
82573,every,O,4023
82574,20,O,4023
82575,minutes,O,4023
82576,We,O,4023
82577,saw,O,4023
82578,a,O,4023
82579,consequent,O,4023
82580,improvement,O,4023
82581,in,O,4023
82582,the,O,4023
82583,symptoms,O,4023
82584,of,O,4023
82585,the,O,4023
82586,group,O,4023
82587,as,O,4023
82588,a,O,4023
82589,whole,O,4023
82590,said,O,4024
82591,Professor,B-ORGANIZATION,4024
82592,James,I-ORGANIZATION,4024
82593,Wolffsohn,I-ORGANIZATION,4024
82594,Professor,O,4024
82595,of,O,4024
82596,Optometry,O,4024
82597,at,O,4024
82598,Aston,O,4024
82599,University,O,4024
82600,who,O,4024
82601,led,O,4024
82602,the,O,4024
82603,research,O,4024
82604,in,O,4024
82605,collaboration,O,4024
82606,with,O,4024
82607,the,B-ORGANIZATION,4024
82608,University,I-ORGANIZATION,4024
82609,of,I-ORGANIZATION,4024
82610,Valencia,I-ORGANIZATION,4024
82611,Spain,B-GPE,4024
82612,Researchers,O,4024
82613,noted,O,4024
82614,that,O,4024
82615,after,O,4024
82616,the,O,4024
82617,study,O,4024
82618,the,O,4024
82619,participants,O,4024
82620,eye,O,4024
82621,symptoms,O,4024
82622,returned,O,4024
82623,to,O,4024
82624,what,O,4024
82625,they,O,4024
82626,had,O,4024
82627,been,O,4024
82628,before,O,4024
82629,the,O,4024
82630,intervention,O,4024
82631,Professor,B-ORGANIZATION,4024
82632,Wolffsohn,I-ORGANIZATION,4024
82633,says,O,4024
82634,We,O,4024
82635,are,O,4024
82636,planning,O,4024
82637,to,O,4024
82638,conduct,O,4024
82639,longer,O,4024
82640,term,O,4024
82641,studies,O,4024
82642,to,O,4024
82643,see,O,4024
82644,whether,O,4024
82645,we,O,4024
82646,can,O,4024
82647,teach,O,4024
82648,eyelid,B-PART_OF_THE_EYES,4024
82649,muscle,I-PART_OF_THE_EYES,4024
82650,memory,I-PART_OF_THE_EYES,4024
82651,impulses,I-PART_OF_THE_EYES,4025
82652,to,O,4025
82653,blink,O,4025
82654,more,O,4025
82655,often,O,4025
82656,during,O,4025
82657,digital,O,4025
82658,viewing,O,4025
82659,to,O,4025
82660,help,O,4025
82661,mitigate,O,4025
82662,this,O,4025
82663,chronic,O,4025
82664,issue,O,4025
82665,without,O,4025
82666,long,O,4025
82667,term,O,4025
82668,use,O,4025
82669,of,O,4025
82670,reminders,O,4025
82671,The,O,4025
82672,findings,O,4026
82673,confirm,O,4026
82674,that,O,4026
82675,people,O,4026
82676,should,O,4026
82677,try,B-TREATMENT,4026
82678,and,I-TREATMENT,4026
82679,take,I-TREATMENT,4026
82680,breaks,I-TREATMENT,4026
82681,from,I-TREATMENT,4026
82682,their,I-TREATMENT,4026
82683,screens,I-TREATMENT,4026
82684,He,O,4026
82685,added,O,4026
82686,Although,O,4027
82687,we,O,4027
82688,used,O,4027
82689,sophisticated,O,4027
82690,software,O,4027
82691,it,O,4027
82692,s,O,4027
82693,easy,O,4027
82694,for,O,4027
82695,others,O,4027
82696,to,O,4027
82697,replicate,O,4027
82698,the,O,4027
82699,effect,O,4027
82700,by,O,4027
82701,setting,O,4027
82702,a,O,4027
82703,timer,O,4027
82704,on,O,4027
82705,their,O,4027
82706,phone,O,4027
82707,or,O,4027
82708,downloading,O,4027
82709,a,O,4027
82710,reminder,O,4027
82711,app,O,4027
82712,It,O,4027
82713,s,O,4027
82714,a,O,4027
82715,simple,O,4027
82716,way,O,4027
82717,of,O,4027
82718,reminding,O,4027
82719,yourself,O,4027
82720,to,O,4027
82721,take,B-TREATMENT,4027
82722,regular,I-TREATMENT,4027
82723,breaks,I-TREATMENT,4027
82724,for,O,4027
82725,the,O,4027
82726,good,O,4027
82727,of,O,4027
82728,your,O,4027
82729,eyes,O,4027
82730,Three-dimensional,B-SURGICAL_INSTRUMENT,4028
82731,3D,I-SURGICAL_INSTRUMENT,4028
82732,surgical,I-SURGICAL_INSTRUMENT,4028
82733,visualization,I-SURGICAL_INSTRUMENT,4028
82734,systems,I-SURGICAL_INSTRUMENT,4028
82735,allow,O,4028
82736,ophthalmic,O,4028
82737,surgeons,O,4028
82738,to,O,4028
82739,free,O,4028
82740,their,O,4028
82741,eyes,O,4028
82742,from,O,4028
82743,standard,B-SURGICAL_INSTRUMENT,4028
82744,surgical,I-SURGICAL_INSTRUMENT,4028
82745,microscope,I-SURGICAL_INSTRUMENT,4028
82746,eyepieces,I-SURGICAL_INSTRUMENT,4028
82747,and,O,4028
82748,replace,O,4028
82749,them,O,4028
82750,with,O,4028
82751,high-resolution,B-SURGICAL_INSTRUMENT,4028
82752,dual-camera,I-SURGICAL_INSTRUMENT,4028
82753,systems,I-SURGICAL_INSTRUMENT,4028
82754,that,O,4028
82755,will,O,4028
82756,transmit,O,4028
82757,images,O,4028
82758,on,O,4028
82759,a,O,4028
82760,panel,O,4028
82761,in,O,4029
82762,front,O,4029
82763,of,O,4029
82764,them,O,4029
82765,In,O,4029
82766,clinical,O,4029
82767,practice,O,4029
82768,surgical,O,4029
82769,visualization,O,4030
82770,consists,O,4030
82771,of,O,4030
82772,multiple,O,4030
82773,devices,O,4030
82774,designed,O,4030
82775,to,O,4030
82776,enhance,O,4030
82777,surgical,O,4030
82778,vision,O,4030
82779,These,O,4030
82780,devices,O,4030
82781,consist,O,4030
82782,of,O,4030
82783,sliding,O,4030
82784,mechanisms,O,4030
82785,mounted,O,4030
82786,at,O,4030
82787,the,O,4030
82788,juncture,O,4030
82789,of,O,4031
82790,the,O,4031
82791,first,O,4031
82792,second,O,4031
82793,and,O,4031
82794,third,O,4031
82795,moving,O,4031
82796,arms,O,4031
82797,as,O,4031
82798,well,O,4031
82799,as,O,4031
82800,a,O,4031
82801,viewing,O,4031
82802,system,O,4031
82803,mounted,O,4031
82804,on,O,4031
82805,the,O,4031
82806,second,O,4031
82807,moving,O,4031
82808,arm,O,4031
82809,Anterior,B-TREATMENT,4031
82810,segment,I-TREATMENT,4031
82811,surgical,I-TREATMENT,4031
82812,procedures,I-TREATMENT,4031
82813,address,O,4031
82814,eye,O,4031
82815,disorders,O,4031
82816,from,O,4032
82817,the,B-PART_OF_THE_EYES,4032
82818,cornea,I-PART_OF_THE_EYES,4032
82819,conjunctiva,B-PART_OF_THE_EYES,4032
82820,iridocorneal,B-PART_OF_THE_EYES,4032
82821,angle,I-PART_OF_THE_EYES,4032
82822,iris,B-PART_OF_THE_EYES,4032
82823,and,O,4032
82824,lens,B-PART_OF_THE_EYES,4032
82825,Visualization,O,4032
82826,is,O,4032
82827,paramount,O,4032
82828,for,O,4032
82829,surgical,O,4032
82830,success,O,4032
82831,in,O,4032
82832,any,O,4032
82833,operation,O,4032
82834,including,O,4032
82835,pterygium,B-TREATMENT,4032
82836,excision,I-TREATMENT,4032
82837,penetrating,B-TREATMENT,4032
82838,keratoplasty,I-TREATMENT,4032
82839,cataract,B-TREATMENT,4032
82840,removal,I-TREATMENT,4032
82841,placement,B-TREATMENT,4032
82842,of,I-TREATMENT,4032
82843,minimally,I-TREATMENT,4032
82844,invasive,I-TREATMENT,4032
82845,glaucoma,I-TREATMENT,4032
82846,devices,I-TREATMENT,4032
82847,iris,B-TREATMENT,4032
82848,repair,I-TREATMENT,4032
82849,or,O,4032
82850,combined,B-TREATMENT,4032
82851,specialty,I-TREATMENT,4032
82852,cases,I-TREATMENT,4032
82853,Supplemented,O,4032
82854,with,O,4032
82855,coaxial,O,4032
82856,illumination,O,4032
82857,and,O,4032
82858,extended,O,4032
82859,depth,O,4032
82860,of,O,4032
82861,focus,O,4032
82862,the,B-SURGICAL_INSTRUMENT,4032
82863,modern-day,I-SURGICAL_INSTRUMENT,4032
82864,microscope,I-SURGICAL_INSTRUMENT,4032
82865,evolved,O,4032
82866,into,O,4032
82867,an,O,4033
82868,irreplaceable,O,4033
82869,commodity,O,4033
82870,for,O,4033
82871,visualization,O,4033
82872,However,O,4033
82873,in,O,4033
82874,recent,O,4033
82875,years,O,4033
82876,the,O,4033
82877,improvements,O,4033
82878,in,O,4033
82879,optical,O,4033
82880,quality,O,4033
82881,illumination,O,4033
82882,and,O,4033
82883,depth,O,4033
82884,of,O,4033
82885,field,O,4034
82886,have,O,4034
82887,begun,O,4034
82888,to,O,4034
82889,plateau,O,4034
82890,Concurrently,O,4034
82891,significant,O,4034
82892,limitations,O,4034
82893,continue,O,4034
82894,to,O,4034
82895,exist,O,4034
82896,such,O,4035
82897,as,O,4035
82898,prolonged,O,4035
82899,exposure,O,4035
82900,of,O,4035
82901,the,B-PART_OF_THE_EYES,4035
82902,retina,I-PART_OF_THE_EYES,4035
82903,to,O,4035
82904,excess,O,4035
82905,illumination,O,4035
82906,linear,O,4035
82907,dependency,O,4035
82908,on,O,4035
82909,visible,O,4035
82910,light,O,4035
82911,for,O,4035
82912,visualization,O,4035
82913,limited,O,4035
82914,performance,O,4035
82915,in,O,4035
82916,high-magnification,O,4035
82917,and,O,4036
82918,potential,O,4036
82919,for,O,4036
82920,surgeon,O,4036
82921,fatigue,O,4036
82922,due,O,4036
82923,to,O,4036
82924,operating,O,4036
82925,room,O,4036
82926,ergonomic,O,4036
82927,conditions,O,4036
82928,While,O,4036
82929,digital,O,4036
82930,visualization,O,4036
82931,was,O,4036
82932,quickly,O,4036
82933,adopted,O,4036
82934,by,O,4036
82935,the,O,4036
82936,posterior,O,4036
82937,segment,O,4036
82938,surgeons,O,4036
82939,given,O,4036
82940,the,O,4036
82941,increased,O,4037
82942,depth,O,4037
82943,of,O,4037
82944,focus,O,4037
82945,greater,O,4037
82946,magnification,O,4037
82947,and,O,4037
82948,precise,O,4037
82949,focus,O,4037
82950,augmenting,O,4037
82951,measured,O,4037
82952,and,O,4037
82953,delicate,O,4037
82954,maneuvers,O,4037
82955,the,O,4037
82956,anterior,O,4038
82957,segment,O,4038
82958,surgeons,O,4038
82959,are,O,4038
82960,beginning,O,4038
82961,to,O,4038
82962,appreciate,O,4038
82963,the,O,4038
82964,conferred,O,4038
82965,benefits,O,4038
82966,to,O,4038
82967,their,O,4038
82968,respective,O,4038
82969,surgeries,O,4038
82970,In,O,4038
82971,addition,O,4038
82972,to,O,4038
82973,an,O,4038
82974,improved,O,4038
82975,binocular,O,4038
82976,disparity,O,4038
82977,reserved,O,4038
82978,almost,O,4039
82979,exclusively,O,4039
82980,for,O,4039
82981,digital,O,4039
82982,platforms,O,4039
82983,one,O,4039
82984,can,O,4039
82985,expect,O,4039
82986,an,O,4039
82987,improved,O,4039
82988,light,O,4039
82989,intensity,O,4039
82990,profile,O,4039
82991,better,O,4039
82992,data,O,4039
82993,integration,O,4039
82994,to,O,4039
82995,heads-up-display,O,4039
82996,HUD,O,4039
82997,from,O,4039
82998,surgical,O,4039
82999,suite,O,4039
83000,less,O,4039
83001,dependence,O,4039
83002,on,O,4039
83003,stains,O,4039
83004,to,O,4039
83005,highlight,O,4039
83006,structures,O,4039
83007,and,O,4039
83008,an,O,4039
83009,equivocal,O,4040
83010,high-volume,O,4040
83011,efficiency,O,4040
83012,setup,O,4040
83013,Witnessing,O,4040
83014,such,O,4040
83015,a,O,4040
83016,Ptolemaic,O,4040
83017,view,O,4040
83018,of,O,4040
83019,the,O,4040
83020,universe,O,4040
83021,a,O,4040
83022,masterfully,O,4040
83023,combined,O,4040
83024,design,O,4041
83025,of,O,4041
83026,Geometry,O,4041
83027,light,O,4041
83028,and,O,4041
83029,cosmology,O,4041
83030,Ophthalmology,O,4041
83031,News,O,4041
83032,--,O,4041
83033,Understanding,O,4041
83034,at,O,4041
83035,once,O,4041
83036,that,O,4041
83037,it,O,4041
83038,is,O,4041
83039,not,O,4041
83040,by,O,4041
83041,any,O,4041
83042,human,O,4041
83043,power,O,4041
83044,or,O,4041
83045,skill,O,4041
83046,but,O,4041
83047,by,O,4042
83048,the,O,4042
83049,influence,O,4042
83050,of,O,4042
83051,Great,O,4042
83052,Architect,O,4042
83053,Of,O,4042
83054,The,O,4042
83055,Universe,O,4042
83056,that,O,4042
83057,this,O,4042
83058,site,O,4042
83059,has,O,4042
83060,been,O,4042
83061,so,O,4042
83062,wonderfully,O,4042
83063,built,O,4042
83064,Minimally,B-TREATMENT,4042
83065,invasive,I-TREATMENT,4042
83066,glaucoma,B-NAME_OF_DISEASE,4042
83067,surgery,I-TREATMENT,4042
83068,MIGS,B-TREATMENT,4042
83069,is,O,4042
83070,a,O,4042
83071,rapidly,O,4042
83072,and,O,4042
83073,continually,O,4042
83074,evolving,O,4042
83075,sector,O,4042
83076,within,O,4043
83077,anterior,O,4043
83078,segment,O,4043
83079,ophthalmology,O,4043
83080,Filling,O,4043
83081,the,O,4043
83082,gap,O,4043
83083,between,O,4043
83084,medical,O,4043
83085,management,O,4043
83086,and,O,4043
83087,large,O,4043
83088,incisional,O,4043
83089,surgical,O,4044
83090,therapies,O,4044
83091,MIGS,B-TREATMENT,4044
83092,relies,O,4044
83093,heavily,O,4044
83094,on,O,4044
83095,intraoperative,O,4044
83096,visualization,O,4044
83097,to,O,4044
83098,identify,O,4044
83099,small,O,4044
83100,anatomic,O,4044
83101,features,O,4044
83102,to,O,4044
83103,either,O,4044
83104,place,O,4044
83105,devices,O,4044
83106,or,O,4044
83107,make,O,4044
83108,targeted,O,4044
83109,cuts,O,4044
83110,for,O,4044
83111,successful,O,4044
83112,outcomes,O,4044
83113,To,O,4044
83114,obtain,O,4044
83115,adequate,O,4044
83116,visualization,O,4044
83117,using,O,4044
83118,a,B-SURGICAL_INSTRUMENT,4044
83119,traditional,I-SURGICAL_INSTRUMENT,4044
83120,microscope,I-SURGICAL_INSTRUMENT,4044
83121,most,O,4045
83122,MIGS,B-TREATMENT,4045
83123,setups,O,4045
83124,requires,O,4045
83125,the,O,4045
83126,surgeon,O,4045
83127,to,O,4045
83128,rotate,O,4045
83129,the,B-SURGICAL_INSTRUMENT,4045
83130,microscope,I-SURGICAL_INSTRUMENT,4045
83131,35,O,4045
83132,degrees,O,4045
83133,towards,O,4045
83134,the,O,4045
83135,operator,O,4045
83136,rotate,O,4045
83137,the,O,4045
83138,patients,O,4045
83139,head,O,4045
83140,35,O,4045
83141,degrees,O,4045
83142,away,O,4045
83143,and,O,4045
83144,the,B-SURGICAL_INSTRUMENT,4045
83145,surgeons,I-SURGICAL_INSTRUMENT,4045
83146,chair,I-SURGICAL_INSTRUMENT,4046
83147,will,O,4046
83148,need,O,4046
83149,to,O,4046
83150,be,O,4046
83151,lowered,O,4046
83152,and,O,4046
83153,shifted,O,4046
83154,away,O,4046
83155,from,O,4046
83156,the,O,4046
83157,patient,O,4046
83158,ultimately,O,4046
83159,requiring,O,4046
83160,the,O,4046
83161,surgeon,O,4046
83162,to,O,4046
83163,extend,O,4046
83164,her,O,4046
83165,his,O,4046
83166,arms,O,4046
83167,to,O,4046
83168,reach,O,4046
83169,the,O,4046
83170,operative,O,4046
83171,field,O,4046
83172,When,O,4046
83173,coupled,O,4046
83174,with,O,4046
83175,a,B-SURGICAL_INSTRUMENT,4046
83176,handheld,I-SURGICAL_INSTRUMENT,4046
83177,gonioscopy,I-SURGICAL_INSTRUMENT,4046
83178,lens,I-SURGICAL_INSTRUMENT,4046
83179,the,O,4046
83180,surgeon,O,4046
83181,is,O,4046
83182,able,O,4046
83183,to,O,4046
83184,overcome,O,4046
83185,the,O,4046
83186,total,O,4046
83187,internal,O,4047
83188,reflection,O,4047
83189,optics,O,4047
83190,induced,O,4047
83191,by,O,4047
83192,the,B-PART_OF_THE_EYES,4047
83193,cornea,I-PART_OF_THE_EYES,4047
83194,in,O,4047
83195,order,O,4047
83196,to,O,4047
83197,visualize,O,4047
83198,the,O,4047
83199,angle,O,4047
83200,The,O,4047
83201,use,O,4047
83202,of,O,4047
83203,the,O,4047
83204,trabecular,O,4047
83205,bypass,O,4047
83206,concept,O,4047
83207,via,O,4047
83208,trabeculectomy,B-SURGICAL_INSTRUMENT,4047
83209,or,O,4047
83210,aqueous,B-SURGICAL_INSTRUMENT,4047
83211,shunts,I-SURGICAL_INSTRUMENT,4047
83212,for,O,4047
83213,the,O,4047
83214,surgical,O,4047
83215,treatment,O,4047
83216,of,O,4047
83217,glaucoma,B-NAME_OF_DISEASE,4047
83218,has,O,4047
83219,advanced,O,4047
83220,over,O,4047
83221,time,O,4047
83222,with,O,4047
83223,the,O,4048
83224,goal,O,4048
83225,of,O,4048
83226,providing,O,4048
83227,more,O,4048
83228,reliable,O,4048
83229,less,O,4048
83230,invasive,O,4048
83231,control,O,4048
83232,of,O,4048
83233,intraocular,O,4048
83234,pressure,O,4048
83235,In,O,4048
83236,a,O,4048
83237,study,O,4048
83238,evaluating,O,4048
83239,the,O,4048
83240,trends,O,4048
83241,of,O,4048
83242,glaucoma,B-TREATMENT,4048
83243,surgeries,I-TREATMENT,4048
83244,in,O,4048
83245,Medicare,B-ORGANIZATION,4048
83246,Patients,O,4048
83247,from,B-TIME_DURATION,4048
83248,1994-2017,I-TIME_DURATION,4048
83249,the,O,4048
83250,use,O,4049
83251,of,O,4049
83252,new,O,4049
83253,microinvasive,B-TREATMENT,4049
83254,glaucoma,I-TREATMENT,4049
83255,surgery,I-TREATMENT,4049
83256,MIGS,B-TREATMENT,4049
83257,has,O,4049
83258,rapidly,O,4049
83259,increased,O,4049
83260,now,O,4049
83261,accounting,O,4049
83262,for,O,4049
83263,a,O,4049
83264,significant,O,4049
83265,majority,O,4049
83266,of,O,4049
83267,glaucoma,B-TREATMENT,4049
83268,surgeries,I-TREATMENT,4049
83269,MIGS,B-TREATMENT,4049
83270,refers,O,4049
83271,to,O,4049
83272,procedures,O,4049
83273,that,O,4049
83274,include,O,4049
83275,the,O,4050
83276,following,O,4050
83277,5,O,4050
83278,characteristics,O,4050
83279,ab,O,4050
83280,interno,O,4050
83281,approach,O,4050
83282,minimal,O,4050
83283,disruption,O,4050
83284,of,O,4050
83285,normal,O,4050
83286,anatomy,O,4050
83287,high,O,4050
83288,safety,O,4050
83289,profile,O,4050
83290,good,O,4050
83291,efficacy,O,4050
83292,and,O,4050
83293,fast,O,4050
83294,recovery,O,4050
83295,time,O,4050
83296,These,O,4050
83297,include,O,4050
83298,various,O,4050
83299,stenting,B-TREATMENT,4050
83300,and,I-TREATMENT,4050
83301,trabecular,I-TREATMENT,4050
83302,meshwork,I-TREATMENT,4050
83303,excision,I-TREATMENT,4050
83304,procedures,I-TREATMENT,4050
83305,as,O,4050
83306,well,O,4050
83307,as,O,4050
83308,Excimer,B-TREATMENT,4050
83309,LASER,I-TREATMENT,4050
83310,Trabeculostomy,I-TREATMENT,4050
83311,ELT,I-TREATMENT,4050
83312,,O,4050
83313,Proper,O,4051
83314,visualization,O,4051
83315,of,O,4051
83316,the,O,4051
83317,angle,O,4051
83318,is,O,4051
83319,a,O,4051
83320,critical,O,4051
83321,feature,O,4051
83322,of,O,4051
83323,successful,O,4051
83324,MIGS,B-TREATMENT,4051
83325,procedures,I-TREATMENT,4052
83326,Access,O,4052
83327,to,O,4052
83328,the,B-PART_OF_THE_EYES,4052
83329,trabecular,I-PART_OF_THE_EYES,4052
83330,meshwork,I-PART_OF_THE_EYES,4052
83331,for,O,4052
83332,MIGS,B-TREATMENT,4052
83333,procedures,I-TREATMENT,4052
83334,is,O,4052
83335,via,O,4052
83336,the,B-PART_OF_THE_EYES,4052
83337,anterior,I-PART_OF_THE_EYES,4052
83338,chamber,I-PART_OF_THE_EYES,4052
83339,using,O,4052
83340,a,O,4052
83341,clear,O,4052
83342,corneal,O,4052
83343,incision,O,4052
83344,Light,O,4052
83345,passing,O,4052
83346,through,O,4052
83347,a,O,4052
83348,medium,O,4052
83349,with,O,4053
83350,a,O,4053
83351,higher,O,4053
83352,index,O,4053
83353,of,O,4053
83354,refraction,O,4053
83355,cornea,B-PART_OF_THE_EYES,4053
83356,into,O,4053
83357,one,O,4053
83358,with,O,4053
83359,a,O,4053
83360,lower,O,4053
83361,index,O,4053
83362,of,O,4053
83363,refraction,O,4053
83364,air,O,4053
83365,results,O,4053
83366,in,O,4053
83367,an,O,4053
83368,angle,O,4053
83369,of,O,4053
83370,refraction,O,4053
83371,that,O,4054
83372,is,O,4054
83373,larger,O,4054
83374,than,O,4054
83375,the,O,4054
83376,angle,O,4054
83377,of,O,4054
83378,incidence,O,4054
83379,leading,O,4054
83380,to,O,4054
83381,internal,O,4054
83382,reflection,O,4054
83383,of,O,4054
83384,light,O,4054
83385,as,O,4054
83386,a,O,4054
83387,result,O,4054
83388,the,O,4054
83389,use,O,4054
83390,of,O,4054
83391,direct,B-TREATMENT,4054
83392,surgical,I-TREATMENT,4054
83393,gonioscopy,I-TREATMENT,4054
83394,overcomes,O,4054
83395,total,O,4054
83396,internal,O,4054
83397,reflection,O,4054
83398,and,O,4054
83399,therefore,O,4054
83400,allows,O,4054
83401,visualization,O,4054
83402,of,O,4054
83403,the,O,4054
83404,angle,O,4054
83405,Although,O,4054
83406,the,O,4054
83407,use,O,4054
83408,of,O,4054
83409,intraoperative,O,4054
83410,gonioscopy,O,4054
83411,has,O,4054
83412,a,O,4054
83413,steep,O,4054
83414,learning,O,4054
83415,curve,O,4054
83416,it,O,4055
83417,is,O,4055
83418,a,O,4055
83419,necessary,O,4055
83420,tool,O,4055
83421,to,O,4055
83422,perform,O,4055
83423,microinvasive,B-TREATMENT,4055
83424,glaucoma,I-TREATMENT,4055
83425,surgery,I-TREATMENT,4055
83426,Surgical,O,4055
83427,visualization,O,4055
83428,can,O,4055
83429,be,O,4055
83430,compromised,O,4055
83431,if,O,4055
83432,proficient,O,4055
83433,bimanual,O,4055
83434,technique,O,4055
83435,with,O,4055
83436,a,B-SURGICAL_INSTRUMENT,4055
83437,goniolens,I-SURGICAL_INSTRUMENT,4055
83438,is,O,4055
83439,suboptimal,O,4055
83440,Typical,O,4055
83441,maneuvers,O,4055
83442,to,O,4055
83443,achieve,O,4055
83444,visualization,O,4055
83445,of,O,4055
83446,the,O,4055
83447,angle,O,4056
83448,structures,O,4056
83449,with,O,4056
83450,MIGS,B-TREATMENT,4056
83451,procedures,I-TREATMENT,4056
83452,using,O,4056
83453,the,B-SURGICAL_INSTRUMENT,4056
83454,standard,I-SURGICAL_INSTRUMENT,4056
83455,operating,I-SURGICAL_INSTRUMENT,4056
83456,microscope,I-SURGICAL_INSTRUMENT,4056
83457,include,O,4056
83458,the,O,4056
83459,need,O,4056
83460,to,O,4056
83461,rotate,O,4056
83462,the,O,4056
83463,patient,O,4056
83464,s,O,4056
83465,head,O,4056
83466,away,O,4056
83467,by,O,4056
83468,35,O,4056
83469,degrees,O,4056
83470,as,O,4056
83471,well,O,4056
83472,as,O,4056
83473,the,O,4057
83474,need,O,4057
83475,to,O,4057
83476,rotate,O,4057
83477,the,B-SURGICAL_INSTRUMENT,4057
83478,microscope,I-SURGICAL_INSTRUMENT,4057
83479,35,O,4057
83480,degrees,O,4057
83481,towards,O,4057
83482,the,O,4057
83483,surgeon,O,4057
83484,This,O,4057
83485,results,O,4057
83486,in,O,4057
83487,the,O,4057
83488,surgeon,O,4057
83489,s,O,4057
83490,need,O,4057
83491,to,O,4057
83492,extend,O,4057
83493,the,O,4057
83494,arms,O,4058
83495,to,O,4058
83496,perform,O,4058
83497,the,O,4058
83498,necessary,O,4058
83499,surgical,O,4058
83500,maneuvers,O,4058
83501,while,O,4058
83502,also,O,4058
83503,needing,O,4058
83504,to,O,4058
83505,maintain,O,4058
83506,the,O,4058
83507,eyes,O,4058
83508,at,O,4058
83509,the,B-SURGICAL_INSTRUMENT,4058
83510,oculars,I-SURGICAL_INSTRUMENT,4058
83511,to,O,4058
83512,see,O,4058
83513,the,O,4058
83514,procedure,O,4058
83515,This,O,4058
83516,non-physiologic,O,4058
83517,position,O,4058
83518,can,O,4058
83519,result,O,4058
83520,in,O,4058
83521,ergonomic,O,4058
83522,strain,O,4058
83523,That,O,4058
83524,ergonomic,O,4058
83525,strain,O,4058
83526,is,O,4058
83527,exaggerated,O,4058
83528,for,O,4058
83529,the,O,4058
83530,surgical,O,4058
83531,assistant,O,4058
83532,whose,O,4058
83533,head,O,4059
83534,often,O,4059
83535,needs,O,4059
83536,to,O,4059
83537,be,O,4059
83538,tilted,O,4059
83539,along,O,4059
83540,with,O,4059
83541,the,B-SURGICAL_INSTRUMENT,4059
83542,microscope,I-SURGICAL_INSTRUMENT,4059
83543,In,O,4059
83544,the,O,4059
83545,last,O,4059
83546,50,O,4059
83547,years,O,4059
83548,the,O,4059
83549,innovation,O,4059
83550,applied,O,4059
83551,to,O,4059
83552,the,B-SURGICAL_INSTRUMENT,4059
83553,standard,I-SURGICAL_INSTRUMENT,4059
83554,operating,I-SURGICAL_INSTRUMENT,4059
83555,microscope,I-SURGICAL_INSTRUMENT,4059
83556,has,O,4059
83557,been,O,4060
83558,limited,O,4060
83559,to,O,4060
83560,enhancements,O,4060
83561,in,O,4060
83562,optics,O,4060
83563,or,O,4060
83564,to,O,4060
83565,improvements,O,4060
83566,in,O,4060
83567,its,O,4060
83568,light,O,4060
83569,source,O,4060
83570,Despite,O,4060
83571,these,O,4060
83572,updates,O,4060
83573,limitations,O,4061
83574,such,O,4061
83575,as,O,4061
83576,dependence,O,4061
83577,on,O,4061
83578,oculars,O,4061
83579,and,O,4061
83580,linear,O,4061
83581,dependency,O,4061
83582,on,O,4061
83583,visible,O,4061
83584,light,O,4061
83585,for,O,4061
83586,visualization,O,4061
83587,can,O,4061
83588,lead,O,4061
83589,to,O,4061
83590,the,O,4061
83591,potential,O,4061
83592,for,O,4061
83593,surgeon,O,4061
83594,fatigue,O,4061
83595,due,O,4061
83596,to,O,4061
83597,operating,O,4062
83598,room,O,4062
83599,ergonomic,O,4062
83600,conditions,O,4062
83601,as,O,4062
83602,well,O,4062
83603,as,O,4062
83604,prolonged,O,4062
83605,light,O,4062
83606,exposure,O,4062
83607,to,O,4062
83608,the,B-PART_OF_THE_EYES,4062
83609,retina,I-PART_OF_THE_EYES,4062
83610,and,O,4062
83611,limited,O,4062
83612,performance,O,4062
83613,and,O,4062
83614,range,O,4062
83615,of,O,4062
83616,depth,O,4062
83617,with,O,4062
83618,extremes,O,4062
83619,of,O,4062
83620,high-magnification,O,4062
83621,When,O,4062
83622,it,O,4062
83623,comes,O,4062
83624,to,O,4062
83625,surgical,O,4062
83626,visualization,O,4063
83627,there,O,4063
83628,has,O,4063
83629,been,O,4063
83630,no,O,4063
83631,real,O,4063
83632,paradigm,O,4063
83633,shifting,O,4063
83634,technology,O,4063
83635,to,O,4063
83636,address,O,4063
83637,these,O,4063
83638,issues,O,4063
83639,However,O,4063
83640,these,O,4063
83641,limitations,O,4063
83642,can,O,4063
83643,actually,O,4063
83644,be,O,4063
83645,addressed,O,4063
83646,using,O,4063
83647,available,O,4063
83648,digital,O,4063
83649,technology,O,4064
83650,Some,O,4064
83651,of,O,4064
83652,the,O,4064
83653,benefits,O,4064
83654,of,O,4064
83655,digital,O,4064
83656,technology,O,4064
83657,used,O,4064
83658,to,O,4064
83659,improve,O,4064
83660,visualization,O,4064
83661,for,O,4064
83662,cataract,B-TREATMENT,4065
83663,surgery,I-TREATMENT,4065
83664,can,O,4065
83665,also,O,4065
83666,assist,O,4065
83667,visualization,O,4065
83668,during,O,4065
83669,MIGS,B-TREATMENT,4065
83670,procedures,I-TREATMENT,4065
83671,Digital,O,4065
83672,video,O,4065
83673,capability,O,4065
83674,has,O,4065
83675,undergone,O,4065
83676,tremendous,O,4065
83677,rapid,O,4065
83678,advancements,O,4065
83679,in,O,4065
83680,frame,O,4065
83681,rate,O,4065
83682,pixel,O,4065
83683,count,O,4065
83684,and,O,4065
83685,resolution,O,4065
83686,dynamic,O,4065
83687,range,O,4065
83688,and,O,4065
83689,latency,O,4065
83690,over,B-TIME_DURATION,4065
83691,the,I-TIME_DURATION,4065
83692,past,I-TIME_DURATION,4065
83693,20,I-TIME_DURATION,4066
83694,years,I-TIME_DURATION,4066
83695,Furthermore,O,4066
83696,the,O,4066
83697,use,O,4066
83698,of,O,4066
83699,3D,O,4066
83700,digital,O,4066
83701,visualization,O,4066
83702,systems,O,4066
83703,in,O,4066
83704,ophthalmic,O,4066
83705,surgery,O,4066
83706,are,O,4066
83707,certainly,O,4066
83708,not,O,4066
83709,new,O,4066
83710,Weinstock,B-PERSON,4066
83711,and,O,4066
83712,colleagues,O,4066
83713,are,O,4066
83714,the,O,4066
83715,first,O,4066
83716,to,O,4066
83717,describe,O,4066
83718,the,O,4066
83719,feasibility,O,4066
83720,of,O,4066
83721,using,O,4066
83722,3D,O,4066
83723,digital,O,4066
83724,visualization,O,4066
83725,during,O,4067
83726,anterior,B-TREATMENT,4067
83727,segment,I-TREATMENT,4067
83728,surgery,I-TREATMENT,4067
83729,back,O,4067
83730,in,O,4067
83731,2009,O,4067
83732,Weinstock,B-PERSON,4067
83733,also,O,4067
83734,recently,O,4067
83735,studied,O,4067
83736,the,B-SURGICAL_INSTRUMENT,4067
83737,NGENUITY,B-SURGICAL_INSTRUMENT,4067
83738,3D,I-SURGICAL_INSTRUMENT,4067
83739,Digital,I-SURGICAL_INSTRUMENT,4068
83740,Visualization,I-SURGICAL_INSTRUMENT,4068
83741,System,I-SURGICAL_INSTRUMENT,4068
83742,Alcon,B-ORGANIZATION,4068
83743,Vision,I-ORGANIZATION,4068
83744,LLC,I-ORGANIZATION,4068
83745,Fort,B-GPE,4068
83746,Worth,I-GPE,4068
83747,TX,I-GPE,4068
83748,USA,I-GPE,4068
83749,and,O,4068
83750,demonstrated,O,4068
83751,similar,O,4068
83752,safety,O,4068
83753,and,O,4068
83754,efficiency,O,4068
83755,between,O,4068
83756,3D,O,4068
83757,visualization,O,4068
83758,and,O,4068
83759,the,B-SURGICAL_INSTRUMENT,4068
83760,traditional,I-SURGICAL_INSTRUMENT,4068
83761,binocular,I-SURGICAL_INSTRUMENT,4068
83762,microscope,I-SURGICAL_INSTRUMENT,4069
83763,NGENUITY,B-SURGICAL_INSTRUMENT,4069
83764,is,O,4069
83765,a,O,4069
83766,real-time,O,4069
83767,digital,O,4069
83768,image,O,4069
83769,guidance,O,4069
83770,system,O,4069
83771,utilizing,O,4069
83772,an,O,4069
83773,ultra-highdefinition,O,4069
83774,3D,O,4069
83775,flat-panel,O,4069
83776,OLED,O,4069
83777,display,O,4069
83778,Using,O,4069
83779,digital,O,4069
83780,visualization,O,4069
83781,with,O,4069
83782,the,B-SURGICAL_INSTRUMENT,4069
83783,NGENUITY,I-SURGICAL_INSTRUMENT,4069
83784,platform,I-SURGICAL_INSTRUMENT,4069
83785,at,O,4069
83786,maximum,O,4069
83787,system,O,4069
83788,magnification,O,4069
83789,an,O,4069
83790,aperture,O,4069
83791,setting,O,4069
83792,of,O,4069
83793,30%,O,4069
83794,open,O,4069
83795,and,O,4069
83796,a,O,4069
83797,viewing,O,4069
83798,distance,O,4069
83799,of,O,4069
83800,1,O,4070
83801,meters,O,4070
83802,results,O,4070
83803,in,O,4070
83804,an,O,4070
83805,up,O,4070
83806,to,O,4070
83807,48%,O,4070
83808,increased,O,4070
83809,magnification,O,4070
83810,up,O,4070
83811,to,O,4070
83812,5x,O,4070
83813,extended,O,4070
83814,depth,O,4071
83815,of,O,4071
83816,field,O,4071
83817,and,O,4071
83818,up,O,4071
83819,to,O,4071
83820,42%,O,4071
83821,finer,O,4071
83822,depth,O,4071
83823,resolution,O,4071
83824,stereopsis,O,4071
83825,when,O,4071
83826,compared,O,4071
83827,to,O,4071
83828,analog,B-SURGICAL_INSTRUMENT,4071
83829,microscopes,I-SURGICAL_INSTRUMENT,4071
83830,Data,O,4071
83831,on,O,4071
83832,the,O,4071
83833,use,O,4071
83834,of,O,4071
83835,3D,O,4071
83836,digital,O,4071
83837,visualization,O,4071
83838,for,O,4071
83839,MIGS,B-TREATMENT,4071
83840,is,O,4071
83841,slowly,O,4072
83842,increasing,O,4072
83843,Ohno,B-PERSON,4072
83844,in,O,4072
83845,Japan,B-GPE,4072
83846,reported,O,4072
83847,his,O,4072
83848,findings,O,4072
83849,when,O,4072
83850,using,O,4072
83851,the,B-SURGICAL_INSTRUMENT,4072
83852,NGENUITY,I-SURGICAL_INSTRUMENT,4073
83853,3D,I-SURGICAL_INSTRUMENT,4073
83854,Visualization,I-SURGICAL_INSTRUMENT,4073
83855,System,I-SURGICAL_INSTRUMENT,4073
83856,with,O,4073
83857,surgical,O,4073
83858,navigation,O,4073
83859,for,O,4073
83860,cataract,B-TREATMENT,4073
83861,surgery,I-TREATMENT,4073
83862,as,O,4073
83863,well,O,4073
83864,as,O,4073
83865,iStent,B-TREATMENT,4073
83866,Glaukos,B-ORGANIZATION,4074
83867,Corporation,I-ORGANIZATION,4074
83868,San,B-GPE,4074
83869,Clemente,I-GPE,4074
83870,CA,I-GPE,4074
83871,USA,I-GPE,4074
83872,placement,O,4074
83873,in,O,4074
83874,2019,O,4074
83875,He,O,4074
83876,postulated,O,4074
83877,that,O,4074
83878,the,O,4074
83879,extended,O,4074
83880,depth,O,4074
83881,of,O,4074
83882,field,O,4074
83883,under,O,4074
83884,high,O,4074
83885,magnification,O,4074
83886,experienced,O,4074
83887,when,O,4074
83888,using,O,4074
83889,3D,O,4074
83890,visualization,O,4074
83891,would,O,4074
83892,be,O,4074
83893,beneficial,O,4074
83894,for,O,4074
83895,angle,O,4074
83896,inspection,O,4075
83897,using,O,4075
83898,a,B-SURGICAL_INSTRUMENT,4075
83899,gonioprism,I-SURGICAL_INSTRUMENT,4075
83900,He,O,4075
83901,ultimately,O,4075
83902,found,O,4075
83903,that,O,4075
83904,the,O,4075
83905,extended,O,4075
83906,depth,O,4075
83907,of,O,4075
83908,field,O,4075
83909,at,O,4076
83910,high,O,4076
83911,magnification,O,4076
83912,and,O,4076
83913,heightened,O,4076
83914,stereoscopic,O,4076
83915,attributes,O,4076
83916,provided,O,4076
83917,by,O,4076
83918,3D,O,4076
83919,digital,O,4076
83920,visualization,O,4076
83921,unlike,O,4076
83922,when,O,4076
83923,using,O,4076
83924,the,B-SURGICAL_INSTRUMENT,4076
83925,conventional,I-SURGICAL_INSTRUMENT,4076
83926,microscope,I-SURGICAL_INSTRUMENT,4076
83927,reduced,O,4076
83928,the,O,4076
83929,need,O,4076
83930,for,O,4076
83931,frequent,O,4076
83932,focusing,O,4076
83933,adjustments,O,4077
83934,when,O,4077
83935,used,O,4077
83936,for,O,4077
83937,trabecular,B-TREATMENT,4077
83938,microbypass,I-TREATMENT,4077
83939,stent,I-TREATMENT,4077
83940,implantation,I-TREATMENT,4077
83941,A,O,4078
83942,specific,O,4078
83943,benefit,O,4078
83944,of,O,4078
83945,the,O,4078
83946,increased,O,4078
83947,range,O,4078
83948,of,O,4078
83949,depth,O,4078
83950,in,O,4078
83951,angle,O,4078
83952,surgery,O,4078
83953,is,O,4078
83954,that,O,4078
83955,the,O,4078
83956,surgeon,O,4078
83957,is,O,4078
83958,able,O,4078
83959,to,O,4078
83960,insert,O,4078
83961,an,B-SURGICAL_INSTRUMENT,4078
83962,injector,I-SURGICAL_INSTRUMENT,4078
83963,or,O,4078
83964,blade,B-SURGICAL_INSTRUMENT,4079
83965,through,O,4079
83966,the,O,4079
83967,corneal,O,4079
83968,wound,O,4079
83969,while,O,4079
83970,still,O,4079
83971,being,O,4079
83972,in,O,4079
83973,focus,O,4079
83974,on,O,4079
83975,angle,O,4079
83976,structures,O,4079
83977,Palácios,B-PERSON,4079
83978,studied,O,4079
83979,the,O,4079
83980,experience,O,4079
83981,of,O,4079
83982,Brazilian,O,4079
83983,vitreoretinal,O,4079
83984,surgeons,O,4079
83985,who,O,4079
83986,used,O,4079
83987,3D,B-SURGICAL_INSTRUMENT,4079
83988,heads-up,I-SURGICAL_INSTRUMENT,4079
83989,display,I-SURGICAL_INSTRUMENT,4079
83990,NGENUITY,I-SURGICAL_INSTRUMENT,4079
83991,for,O,4080
83992,visualization,O,4080
83993,compared,O,4080
83994,to,O,4080
83995,the,B-SURGICAL_INSTRUMENT,4080
83996,operating,I-SURGICAL_INSTRUMENT,4080
83997,microscope,I-SURGICAL_INSTRUMENT,4080
83998,MIGS,B-TREATMENT,4080
83999,cases,O,4080
84000,iStent,B-TREATMENT,4080
84001,placement,O,4080
84002,were,O,4080
84003,included,O,4080
84004,Overall,O,4080
84005,image,O,4080
84006,resolution,O,4080
84007,depth,O,4080
84008,perception,O,4080
84009,field,O,4080
84010,of,O,4080
84011,view,O,4080
84012,ergonomics,O,4080
84013,and,O,4080
84014,educational,O,4081
84015,value,O,4081
84016,were,O,4081
84017,significantly,O,4081
84018,better,O,4081
84019,using,O,4081
84020,3D,B-SURGICAL_INSTRUMENT,4081
84021,heads-up,I-SURGICAL_INSTRUMENT,4081
84022,display,I-SURGICAL_INSTRUMENT,4081
84023,as,O,4081
84024,compared,O,4081
84025,to,O,4081
84026,the,B-SURGICAL_INSTRUMENT,4081
84027,operating,I-SURGICAL_INSTRUMENT,4081
84028,microscope,I-SURGICAL_INSTRUMENT,4082
84029,Concerning,O,4082
84030,specifically,O,4082
84031,the,O,4082
84032,MIGS,B-TREATMENT,4082
84033,cases,O,4082
84034,only,O,4082
84035,the,B-SURGICAL_INSTRUMENT,4082
84036,3D,I-SURGICAL_INSTRUMENT,4082
84037,camera,I-SURGICAL_INSTRUMENT,4082
84038,coupled,O,4082
84039,to,O,4082
84040,the,B-SURGICAL_INSTRUMENT,4082
84041,microscope,I-SURGICAL_INSTRUMENT,4082
84042,required,O,4082
84043,tilting,O,4082
84044,as,O,4082
84045,it,O,4082
84046,was,O,4082
84047,unnecessary,O,4082
84048,to,O,4082
84049,tilt,O,4082
84050,the,O,4082
84051,patient,O,4082
84052,s,O,4083
84053,head,O,4083
84054,position,O,4083
84055,according,O,4083
84056,to,O,4083
84057,the,O,4083
84058,authors,O,4083
84059,this,O,4083
84060,led,O,4083
84061,to,O,4083
84062,enhanced,O,4083
84063,patient,O,4083
84064,and,O,4083
84065,surgeon,O,4083
84066,comfort,O,4083
84067,Furthermore,O,4083
84068,a,O,4083
84069,wider,O,4083
84070,viewing,O,4083
84071,angle,O,4083
84072,was,O,4083
84073,achieved,O,4083
84074,using,O,4083
84075,the,O,4083
84076,55-inch,O,4083
84077,4K,O,4083
84078,display,O,4083
84079,With,O,4083
84080,NGENUITY,B-SURGICAL_INSTRUMENT,4083
84081,the,O,4083
84082,aspects,O,4083
84083,of,O,4083
84084,visualization,O,4083
84085,mentioned,O,4083
84086,above,O,4083
84087,are,O,4083
84088,superior,O,4083
84089,for,O,4083
84090,the,O,4084
84091,surgeon,O,4084
84092,and,O,4084
84093,equally,O,4084
84094,good,O,4084
84095,for,O,4084
84096,all,O,4084
84097,other,O,4084
84098,members,O,4084
84099,of,O,4084
84100,the,O,4084
84101,OR,O,4084
84102,team,O,4084
84103,In,O,4084
84104,an,O,4084
84105,academic,O,4084
84106,center,O,4084
84107,this,O,4084
84108,improved,O,4084
84109,view,O,4085
84110,has,O,4085
84111,allowed,O,4085
84112,all,O,4085
84113,surgeons,O,4085
84114,learning,O,4085
84115,MIGS,B-TREATMENT,4085
84116,to,O,4085
84117,notice,O,4085
84118,details,O,4085
84119,not,O,4085
84120,otherwise,O,4085
84121,noticeable,O,4085
84122,with,O,4085
84123,two-dimensional,B-SURGICAL_INSTRUMENT,4085
84124,screens,I-SURGICAL_INSTRUMENT,4085
84125,The,O,4085
84126,level,O,4085
84127,of,O,4085
84128,detail,O,4085
84129,observed,O,4086
84130,is,O,4086
84131,evidenced,O,4086
84132,by,O,4086
84133,the,O,4086
84134,types,O,4087
84135,of,O,4087
84136,comments,O,4087
84137,made,O,4087
84138,about,O,4087
84139,the,O,4087
84140,positioning,O,4087
84141,of,O,4087
84142,glaucoma,O,4087
84143,stents,O,4087
84144,the,O,4087
84145,difference,O,4087
84146,in,O,4087
84147,stent,O,4087
84148,sheen,O,4087
84149,in,O,4087
84150,the,B-PART_OF_THE_EYES,4087
84151,anterior,I-PART_OF_THE_EYES,4088
84152,chamber,I-PART_OF_THE_EYES,4088
84153,versus,O,4088
84154,in,O,4088
84155,Schlemm,B-PART_OF_THE_EYES,4088
84156,canal,I-PART_OF_THE_EYES,4088
84157,and,O,4088
84158,the,O,4088
84159,location,O,4088
84160,of,O,4088
84161,blood,O,4088
84162,reflex,O,4088
84163,in,O,4088
84164,stenting,B-TREATMENT,4088
84165,and,I-TREATMENT,4088
84166,trabecular,I-TREATMENT,4088
84167,meshwork,I-TREATMENT,4088
84168,excision,I-TREATMENT,4088
84169,procedures,I-TREATMENT,4088
84170,Furthermore,O,4088
84171,surgical,O,4088
84172,training,O,4088
84173,for,O,4088
84174,new,O,4088
84175,procedures,O,4088
84176,is,O,4088
84177,facilitated,O,4088
84178,with,O,4088
84179,NGENUITY,B-SURGICAL_INSTRUMENT,4088
84180,as,O,4088
84181,surgical,O,4088
84182,instructors,O,4088
84183,or,O,4088
84184,industry,O,4088
84185,partners,O,4088
84186,are,O,4088
84187,able,O,4088
84188,to,O,4088
84189,better,O,4088
84190,guide,O,4088
84191,the,O,4088
84192,surgeon,O,4088
84193,through,O,4088
84194,the,O,4088
84195,initial,O,4088
84196,challenges,O,4088
84197,of,O,4088
84198,a,O,4088
84199,new,O,4088
84200,procedure,O,4088
84201,The,O,4088
84202,fact,O,4088
84203,that,O,4088
84204,the,O,4088
84205,surgeon,O,4088
84206,s,O,4088
84207,view,O,4088
84208,is,O,4088
84209,exactly,O,4088
84210,the,O,4088
84211,same,O,4088
84212,as,O,4089
84213,everyone,O,4089
84214,else,O,4089
84215,in,O,4089
84216,the,O,4089
84217,OR,O,4090
84218,allows,O,4090
84219,for,O,4090
84220,an,O,4090
84221,improved,O,4090
84222,and,O,4090
84223,accelerated,O,4090
84224,knowledge,O,4090
84225,transfer,O,4090
84226,process,O,4090
84227,Finally,O,4090
84228,engagement,O,4090
84229,of,O,4090
84230,the,O,4090
84231,nursing,O,4090
84232,team,O,4090
84233,with,O,4090
84234,NGENUITY,B-SURGICAL_INSTRUMENT,4090
84235,is,O,4090
84236,unparalleled,O,4090
84237,as,O,4090
84238,they,O,4090
84239,appreciate,O,4090
84240,details,O,4090
84241,not,O,4090
84242,otherwise,O,4090
84243,noticeable,O,4090
84244,on,O,4091
84245,the,B-SURGICAL_INSTRUMENT,4091
84246,two-dimensional,I-SURGICAL_INSTRUMENT,4091
84247,screen,I-SURGICAL_INSTRUMENT,4091
84248,It,O,4091
84249,is,O,4092
84250,not,O,4092
84251,uncommon,O,4092
84252,for,O,4092
84253,nurses,O,4092
84254,that,O,4092
84255,have,O,4092
84256,spent,O,4092
84257,decades,O,4092
84258,in,O,4092
84259,the,O,4092
84260,ophthalmology,O,4092
84261,OR,O,4092
84262,to,O,4093
84263,comment,O,4093
84264,that,O,4093
84265,they,O,4093
84266,had,O,4093
84267,never,O,4093
84268,appreciated,O,4093
84269,the,O,4093
84270,various,O,4093
84271,steps,O,4093
84272,of,O,4093
84273,surgery,O,4093
84274,as,O,4093
84275,much,O,4093
84276,as,O,4093
84277,when,O,4093
84278,observing,O,4093
84279,the,O,4094
84280,3D,O,4094
84281,images,O,4094
84282,through,O,4094
84283,their,O,4094
84284,passive,B-SURGICAL_INSTRUMENT,4094
84285,polarized,I-SURGICAL_INSTRUMENT,4094
84286,glasses,I-SURGICAL_INSTRUMENT,4094
84287,Their,O,4094
84288,increased,O,4094
84289,engagement,O,4094
84290,allows,O,4094
84291,them,O,4094
84292,to,O,4094
84293,be,O,4094
84294,more,O,4094
84295,involved,O,4095
84296,in,O,4095
84297,the,O,4095
84298,surgery,O,4095
84299,and,O,4095
84300,better,O,4095
84301,anticipate,O,4095
84302,next,O,4095
84303,steps,O,4095
84304,and,O,4095
84305,therefore,O,4095
84306,what,O,4096
84307,instruments,O,4096
84308,the,O,4096
84309,surgeon,O,4096
84310,needs,O,4096
84311,Ergonomics,O,4096
84312,are,O,4096
84313,critical,O,4096
84314,for,O,4096
84315,comfort,O,4096
84316,during,O,4096
84317,a,O,4097
84318,surgical,O,4097
84319,day,O,4097
84320,for,O,4097
84321,surgeon,O,4097
84322,longevity,O,4097
84323,and,O,4097
84324,for,O,4097
84325,injury,O,4097
84326,prevention,O,4097
84327,The,O,4097
84328,ability,O,4097
84329,to,O,4097
84330,sit,O,4097
84331,more,O,4097
84332,comfortably,O,4097
84333,without,O,4098
84334,the,O,4098
84335,need,O,4098
84336,to,O,4098
84337,come,O,4098
84338,towards,O,4098
84339,the,O,4098
84340,microscope,O,4098
84341,leads,O,4098
84342,to,O,4098
84343,better,O,4098
84344,positioning,O,4098
84345,and,O,4098
84346,less,O,4098
84347,neck,O,4098
84348,and,O,4098
84349,back,O,4098
84350,strain,O,4098
84351,It,O,4098
84352,is,O,4098
84353,especially,O,4098
84354,useful,O,4098
84355,for,O,4098
84356,the,O,4098
84357,assistant,O,4099
84358,in,O,4099
84359,angle,O,4099
84360,surgery,O,4099
84361,who,O,4099
84362,is,O,4099
84363,otherwise,O,4099
84364,forced,O,4099
84365,to,O,4099
84366,tilt,O,4099
84367,their,O,4099
84368,head,O,4099
84369,significantly,O,4099
84370,to,O,4099
84371,align,O,4099
84372,themselves,O,4099
84373,with,O,4099
84374,the,B-SURGICAL_INSTRUMENT,4099
84375,tilted,I-SURGICAL_INSTRUMENT,4099
84376,microscope,I-SURGICAL_INSTRUMENT,4099
84377,during,O,4099
84378,angle,O,4099
84379,visualization,O,4099
84380,The,O,4099
84381,pandemic,O,4099
84382,has,O,4099
84383,also,O,4099
84384,highlighted,O,4099
84385,the,O,4099
84386,interest,O,4099
84387,in,O,4099
84388,maintaining,O,4099
84389,distance,O,4099
84390,between,O,4099
84391,the,O,4099
84392,surgeon,O,4100
84393,and,O,4100
84394,the,O,4100
84395,patient,O,4100
84396,and,O,4100
84397,between,O,4100
84398,members,O,4100
84399,of,O,4100
84400,the,O,4100
84401,healthcare,O,4100
84402,team,O,4100
84403,NGENUITY,B-SURGICAL_INSTRUMENT,4100
84404,allows,O,4100
84405,for,O,4100
84406,this,O,4100
84407,distance,O,4101
84408,while,O,4101
84409,maintaining,O,4101
84410,the,O,4101
84411,surgical,O,4101
84412,view,O,4101
84413,with,O,4101
84414,improved,O,4101
84415,ergonomics,O,4101
84416,The,O,4101
84417,capacity,O,4101
84418,to,O,4101
84419,digitally,O,4102
84420,enhance,O,4102
84421,the,O,4102
84422,surgical,O,4102
84423,view,O,4102
84424,will,O,4102
84425,likely,O,4102
84426,allow,O,4102
84427,for,O,4102
84428,modifications,O,4102
84429,that,O,4102
84430,can,O,4102
84431,minimize,O,4102
84432,the,O,4102
84433,impact,O,4102
84434,of,O,4102
84435,the,O,4102
84436,blood,O,4102
84437,reflex,O,4102
84438,and,O,4102
84439,also,O,4102
84440,emphasize,O,4102
84441,the,O,4102
84442,pigmentation,O,4103
84443,of,O,4103
84444,the,B-PART_OF_THE_EYES,4104
84445,trabecular,I-PART_OF_THE_EYES,4104
84446,meshwork,I-PART_OF_THE_EYES,4104
84447,Similar,O,4104
84448,to,O,4104
84449,digital,O,4104
84450,enhancements,O,4104
84451,specific,O,4104
84452,to,O,4104
84453,retinal,B-TREATMENT,4104
84454,surgery,I-TREATMENT,4104
84455,that,O,4104
84456,have,O,4104
84457,improved,O,4104
84458,the,O,4104
84459,surgical,O,4104
84460,experience,O,4104
84461,and,O,4104
84462,safety,O,4104
84463,profile,O,4104
84464,future,O,4104
84465,digital,O,4104
84466,enhancements,O,4105
84467,for,O,4105
84468,MIGS,B-TREATMENT,4105
84469,surgery,I-TREATMENT,4105
84470,may,O,4105
84471,allow,O,4105
84472,for,O,4105
84473,better,O,4105
84474,angle,O,4105
84475,visualization,O,4105
84476,and,O,4105
84477,MIGS,B-TREATMENT,4105
84478,performance,O,4106
84479,NGENUITY,B-SURGICAL_INSTRUMENT,4106
84480,for,O,4106
84481,MIGS,B-TREATMENT,4106
84482,is,O,4106
84483,in,O,4106
84484,its,O,4106
84485,infancy,O,4106
84486,and,O,4106
84487,the,O,4106
84488,future,O,4106
84489,is,O,4106
84490,therefore,O,4106
84491,very,O,4106
84492,exciting,O,4106
84493,Overall,O,4106
84494,beyond,O,4106
84495,the,O,4107
84496,visualization,O,4107
84497,benefits,O,4107
84498,of,O,4107
84499,NGENUITY,B-SURGICAL_INSTRUMENT,4107
84500,for,O,4107
84501,cataract,B-TREATMENT,4108
84502,surgery,I-TREATMENT,4108
84503,NGENUITY,B-SURGICAL_INSTRUMENT,4108
84504,also,O,4108
84505,contributes,O,4108
84506,to,O,4108
84507,a,O,4108
84508,better,O,4108
84509,experience,O,4108
84510,in,O,4108
84511,the,O,4108
84512,OR,O,4109
84513,for,O,4109
84514,MIGS,B-TREATMENT,4109
84515,procedures,I-TREATMENT,4109
84516,Better,O,4109
84517,three-dimensional,O,4109
84518,visualization,O,4109
84519,of,O,4109
84520,angle,O,4109
84521,structures,O,4109
84522,reduced,O,4109
84523,light,O,4109
84524,exposure,O,4110
84525,engagement,O,4110
84526,and,O,4110
84527,unification,O,4110
84528,of,O,4110
84529,the,O,4110
84530,entire,O,4110
84531,OR,O,4110
84532,team,O,4110
84533,improved,O,4110
84534,capacity,O,4110
84535,to,O,4110
84536,educate,O,4110
84537,and,O,4110
84538,ergonomic,O,4110
84539,positioning,O,4110
84540,are,O,4110
84541,all,O,4110
84542,features,O,4110
84543,of,O,4110
84544,NGENUITY,B-SURGICAL_INSTRUMENT,4111
84545,that,O,4111
84546,improve,O,4111
84547,the,O,4111
84548,OR,O,4111
84549,experience,O,4111
84550,and,O,4111
84551,ultimately,O,4111
84552,patient,O,4111
84553,outcomes,O,4111
84554,Neurotrophic,B-NAME_OF_DISEASE,4111
84555,keratitis,I-NAME_OF_DISEASE,4111
84556,is,O,4111
84557,a,O,4111
84558,degenerative,O,4111
84559,corneal,O,4111
84560,disease,O,4111
84561,caused,O,4111
84562,by,O,4111
84563,impairment,B-CAUSE_OF_DISEASE,4111
84564,of,I-CAUSE_OF_DISEASE,4111
84565,corneal,I-CAUSE_OF_DISEASE,4111
84566,sensory,I-CAUSE_OF_DISEASE,4111
84567,innervation,I-CAUSE_OF_DISEASE,4111
84568,It,O,4111
84569,is,O,4111
84570,characterized,O,4112
84571,by,O,4112
84572,decreased,B-SIGN_AND_SYMPTOM,4112
84573,or,I-SIGN_AND_SYMPTOM,4113
84574,absent,I-SIGN_AND_SYMPTOM,4113
84575,corneal,I-SIGN_AND_SYMPTOM,4113
84576,sensation,I-SIGN_AND_SYMPTOM,4113
84577,leading,O,4113
84578,to,O,4113
84579,epithelial,B-SIGN_AND_SYMPTOM,4113
84580,breakdown,I-SIGN_AND_SYMPTOM,4113
84581,impairment,I-SIGN_AND_SYMPTOM,4113
84582,of,I-SIGN_AND_SYMPTOM,4113
84583,healing,I-SIGN_AND_SYMPTOM,4113
84584,and,O,4113
84585,ultimately,O,4113
84586,to,O,4113
84587,the,B-SIGN_AND_SYMPTOM,4113
84588,development,I-SIGN_AND_SYMPTOM,4113
84589,of,I-SIGN_AND_SYMPTOM,4113
84590,corneal,I-SIGN_AND_SYMPTOM,4113
84591,ulceration,I-SIGN_AND_SYMPTOM,4113
84592,melting,I-SIGN_AND_SYMPTOM,4113
84593,and,I-SIGN_AND_SYMPTOM,4113
84594,perforation,I-SIGN_AND_SYMPTOM,4113
84595,The,B-PART_OF_THE_EYES,4113
84596,cornea,I-PART_OF_THE_EYES,4113
84597,is,O,4113
84598,the,O,4113
84599,clear,O,4113
84600,transparent,O,4114
84601,outer,O,4114
84602,layer,O,4114
84603,of,O,4114
84604,the,O,4114
84605,eye,O,4114
84606,It,O,4114
84607,functions,O,4114
84608,like,O,4114
84609,a,O,4114
84610,window,O,4115
84611,that,O,4115
84612,focuses,O,4115
84613,the,O,4116
84614,entry,O,4116
84615,of,O,4116
84616,light,O,4116
84617,into,O,4116
84618,the,O,4116
84619,eye,O,4116
84620,The,B-PART_OF_THE_EYES,4116
84621,cornea,I-PART_OF_THE_EYES,4116
84622,bends,O,4116
84623,light,O,4116
84624,allowing,O,4116
84625,it,O,4117
84626,to,O,4117
84627,pass,O,4117
84628,through,O,4117
84629,the,B-PART_OF_THE_EYES,4117
84630,pupil,I-PART_OF_THE_EYES,4117
84631,of,O,4117
84632,the,O,4117
84633,eye,O,4117
84634,eventually,O,4117
84635,reaching,O,4117
84636,the,B-PART_OF_THE_EYES,4117
84637,retina,I-PART_OF_THE_EYES,4117
84638,where,O,4117
84639,specialized,O,4117
84640,cells,O,4117
84641,called,O,4117
84642,cones,B-PART_OF_THE_EYES,4117
84643,and,O,4117
84644,rods,B-PART_OF_THE_EYES,4117
84645,convert,O,4117
84646,light,O,4117
84647,to,O,4117
84648,nerve,O,4117
84649,impulses,O,4117
84650,These,O,4117
84651,impulses,O,4117
84652,travel,O,4117
84653,along,O,4117
84654,the,B-PART_OF_THE_EYES,4117
84655,optic,I-PART_OF_THE_EYES,4117
84656,nerve,I-PART_OF_THE_EYES,4117
84657,to,O,4117
84658,the,O,4117
84659,brain,O,4117
84660,to,O,4117
84661,become,O,4117
84662,images,O,4117
84663,Neurotrophic,B-NAME_OF_DISEASE,4117
84664,keratitis,I-NAME_OF_DISEASE,4118
84665,is,O,4118
84666,caused,O,4118
84667,when,O,4118
84668,the,B-SIGN_AND_SYMPTOM,4118
84669,nerves,I-SIGN_AND_SYMPTOM,4118
84670,that,I-SIGN_AND_SYMPTOM,4118
84671,serve,I-SIGN_AND_SYMPTOM,4118
84672,innervate,I-SIGN_AND_SYMPTOM,4118
84673,the,B-PART_OF_THE_EYES,4118
84674,cornea,I-PART_OF_THE_EYES,4118
84675,cannot,I-SIGN_AND_SYMPTOM,4118
84676,function,I-SIGN_AND_SYMPTOM,4118
84677,properly,I-SIGN_AND_SYMPTOM,4118
84678,these,O,4118
84679,nerves,O,4118
84680,carry,O,4118
84681,impulses,O,4118
84682,that,O,4118
84683,help,O,4118
84684,the,B-PART_OF_THE_EYES,4118
84685,cornea,I-PART_OF_THE_EYES,4118
84686,function,O,4118
84687,Neurotrophic,B-NAME_OF_DISEASE,4118
84688,keratitis,I-NAME_OF_DISEASE,4118
84689,causes,O,4119
84690,reduced,B-SIGN_AND_SYMPTOM,4119
84691,sensitivity,I-SIGN_AND_SYMPTOM,4119
84692,of,I-SIGN_AND_SYMPTOM,4119
84693,the,I-SIGN_AND_SYMPTOM,4119
84694,cornea,I-SIGN_AND_SYMPTOM,4119
84695,When,O,4119
84696,the,B-PART_OF_THE_EYES,4119
84697,cornea,I-PART_OF_THE_EYES,4119
84698,senses,O,4119
84699,stimulation,O,4119
84700,or,O,4119
84701,pressure,O,4119
84702,the,B-PART_OF_THE_EYES,4119
84703,eyelids,I-PART_OF_THE_EYES,4119
84704,will,O,4119
84705,close,O,4119
84706,and,O,4119
84707,tears,O,4119
84708,will,O,4119
84709,be,O,4119
84710,produced,O,4119
84711,to,O,4119
84712,protect,O,4119
84713,the,B-PART_OF_THE_EYES,4119
84714,cornea,I-PART_OF_THE_EYES,4119
84715,and,O,4119
84716,the,O,4119
84717,eye,O,4119
84718,Because,O,4119
84719,these,O,4119
84720,nerves,O,4119
84721,do,O,4120
84722,not,O,4120
84723,function,O,4120
84724,properly,O,4120
84725,in,O,4120
84726,neurotrophic,B-NAME_OF_DISEASE,4120
84727,keratitis,I-NAME_OF_DISEASE,4120
84728,the,O,4120
84729,outer,O,4120
84730,layer,O,4120
84731,of,O,4120
84732,the,B-PART_OF_THE_EYES,4120
84733,cornea,I-PART_OF_THE_EYES,4120
84734,called,O,4120
84735,the,O,4120
84736,epithelium,B-PART_OF_THE_EYES,4120
84737,can,O,4120
84738,break,O,4120
84739,down,O,4120
84740,resulting,O,4120
84741,in,O,4120
84742,an,B-SIGN_AND_SYMPTOM,4120
84743,epithelial,I-SIGN_AND_SYMPTOM,4120
84744,defect,I-SIGN_AND_SYMPTOM,4120
84745,In,O,4120
84746,more,O,4120
84747,advanced,O,4120
84748,neurotrophic,B-NAME_OF_DISEASE,4120
84749,keratitis,I-NAME_OF_DISEASE,4120
84750,an,O,4120
84751,interior,O,4120
84752,layer,O,4120
84753,called,O,4120
84754,the,B-PART_OF_THE_EYES,4120
84755,cornea,I-PART_OF_THE_EYES,4120
84756,stroma,I-PART_OF_THE_EYES,4120
84757,can,O,4120
84758,break,O,4121
84759,down,O,4121
84760,as,O,4121
84761,well,O,4121
84762,resulting,O,4121
84763,in,O,4121
84764,thinning,B-SIGN_AND_SYMPTOM,4121
84765,of,I-SIGN_AND_SYMPTOM,4121
84766,the,I-SIGN_AND_SYMPTOM,4121
84767,cornea,I-SIGN_AND_SYMPTOM,4121
84768,Neurotrophic,B-NAME_OF_DISEASE,4121
84769,Keratitis,I-NAME_OF_DISEASE,4121
84770,is,O,4121
84771,the,B-SIGN_AND_SYMPTOM,4121
84772,impairment,I-SIGN_AND_SYMPTOM,4121
84773,of,I-SIGN_AND_SYMPTOM,4121
84774,corneal,I-SIGN_AND_SYMPTOM,4121
84775,trigeminal,I-SIGN_AND_SYMPTOM,4121
84776,innervation,I-SIGN_AND_SYMPTOM,4121
84777,which,I-SIGN_AND_SYMPTOM,4121
84778,disrupts,I-SIGN_AND_SYMPTOM,4121
84779,ocular,B-PART_OF_THE_EYES,4122
84780,surface,I-PART_OF_THE_EYES,4122
84781,homeostasis,I-SIGN_AND_SYMPTOM,4122
84782,It,O,4122
84783,is,O,4122
84784,classically,O,4122
84785,defined,O,4122
84786,by,O,4122
84787,absence,O,4122
84788,of,O,4122
84789,pain,O,4122
84790,due,O,4122
84791,to,O,4122
84792,the,O,4122
84793,abnormalities,O,4122
84794,in,O,4122
84795,the,O,4122
84796,trigeminal,O,4122
84797,pathway,O,4122
84798,that,O,4122
84799,has,O,4122
84800,caused,O,4122
84801,an,O,4122
84802,interruption,O,4122
84803,in,O,4122
84804,corneal,O,4122
84805,hemostasis,O,4122
84806,In,O,4122
84807,a,O,4122
84808,healthy,O,4122
84809,eye,O,4122
84810,that,O,4122
84811,has,O,4122
84812,a,O,4122
84813,normal,O,4122
84814,ocular,B-PART_OF_THE_EYES,4122
84815,surface,I-PART_OF_THE_EYES,4122
84816,motor,O,4122
84817,nerves,O,4122
84818,control,O,4122
84819,blinking,O,4122
84820,and,O,4122
84821,the,O,4122
84822,autonomic,O,4122
84823,system,O,4122
84824,controls,O,4122
84825,the,O,4122
84826,release,O,4122
84827,of,O,4122
84828,neuromodulators,B-CHEMICAL_COMPOUND,4122
84829,that,O,4122
84830,stimulate,O,4122
84831,tear,O,4123
84832,production,O,4123
84833,through,O,4123
84834,a,O,4123
84835,feedback,O,4123
84836,loop,O,4123
84837,that,O,4123
84838,maintains,O,4123
84839,a,O,4123
84840,healthy,O,4123
84841,ocular,B-PART_OF_THE_EYES,4123
84842,surface,I-PART_OF_THE_EYES,4123
84843,barrier,I-PART_OF_THE_EYES,4123
84844,Ultimately,O,4123
84845,corneal,O,4123
84846,epithelial,O,4123
84847,integrity,O,4123
84848,is,O,4123
84849,disrupted,O,4123
84850,in,O,4123
84851,NK,B-NAME_OF_DISEASE,4123
84852,resulting,O,4123
84853,in,O,4123
84854,an,O,4123
84855,interruption,O,4123
84856,in,O,4123
84857,the,O,4123
84858,barrier,O,4123
84859,to,O,4123
84860,the,O,4123
84861,underlying,O,4123
84862,tissue,O,4123
84863,The,O,4123
84864,condition,O,4123
84865,is,O,4123
84866,staged,O,4123
84867,according,O,4123
84868,to,O,4124
84869,the,B-DIAGNOSTIC_TEST,4124
84870,Mackie,I-DIAGNOSTIC_TEST,4124
84871,classification,I-DIAGNOSTIC_TEST,4124
84872,system,I-DIAGNOSTIC_TEST,4124
84873,for,O,4124
84874,the,O,4124
84875,purpose,O,4124
84876,of,O,4124
84877,determining,O,4124
84878,the,O,4124
84879,most,O,4124
84880,appropriate,O,4124
84881,treatment,O,4124
84882,protocol,O,4124
84883,Stage,O,4124
84884,1,O,4124
84885,NK,B-NAME_OF_DISEASE,4124
84886,mild,O,4124
84887,,O,4124
84888,This,O,4125
84889,is,O,4125
84890,the,O,4125
84891,most,O,4125
84892,common,O,4125
84893,and,O,4125
84894,is,O,4125
84895,characterized,O,4125
84896,by,O,4125
84897,the,B-SIGN_AND_SYMPTOM,4125
84898,presence,I-SIGN_AND_SYMPTOM,4125
84899,of,I-SIGN_AND_SYMPTOM,4125
84900,punctate,I-SIGN_AND_SYMPTOM,4125
84901,epithelial,I-SIGN_AND_SYMPTOM,4125
84902,keratopathy,I-SIGN_AND_SYMPTOM,4125
84903,or,I-SIGN_AND_SYMPTOM,4125
84904,erosions,I-SIGN_AND_SYMPTOM,4125
84905,It,O,4125
84906,may,O,4125
84907,occur,O,4125
84908,in,O,4125
84909,a,O,4125
84910,diffuse,O,4125
84911,pattern,O,4125
84912,such,O,4126
84913,as,O,4126
84914,is,O,4126
84915,seen,O,4126
84916,in,O,4126
84917,Sjögren,B-NAME_OF_DISEASE,4126
84918,s,I-NAME_OF_DISEASE,4126
84919,syndrome,I-NAME_OF_DISEASE,4126
84920,or,O,4126
84921,graft-versus-host,B-NAME_OF_DISEASE,4126
84922,disease,I-NAME_OF_DISEASE,4127
84923,or,O,4127
84924,it,O,4127
84925,may,O,4127
84926,be,O,4127
84927,localized,O,4127
84928,to,O,4127
84929,the,O,4127
84930,inferior,O,4127
84931,portion,O,4127
84932,of,O,4127
84933,the,B-PART_OF_THE_EYES,4127
84934,cornea,I-PART_OF_THE_EYES,4127
84935,as,O,4127
84936,we,O,4127
84937,may,O,4127
84938,see,O,4127
84939,in,O,4127
84940,patients,O,4127
84941,who,O,4127
84942,have,O,4127
84943,lagophthalmos,B-NAME_OF_DISEASE,4127
84944,after,O,4127
84945,a,B-NAME_OF_DISEASE,4127
84946,Bell,I-NAME_OF_DISEASE,4127
84947,s,I-NAME_OF_DISEASE,4127
84948,palsy,I-NAME_OF_DISEASE,4127
84949,or,O,4127
84950,in,O,4128
84951,Parkinson,B-NAME_OF_DISEASE,4128
84952,s,I-NAME_OF_DISEASE,4128
84953,disease,I-NAME_OF_DISEASE,4128
84954,in,O,4128
84955,which,O,4128
84956,the,O,4128
84957,patient,O,4128
84958,s,O,4128
84959,poor,O,4128
84960,blink,O,4129
84961,response,O,4129
84962,leads,O,4129
84963,to,O,4129
84964,corneal,B-SIGN_AND_SYMPTOM,4129
84965,breakdown,I-SIGN_AND_SYMPTOM,4129
84966,Stage,O,4129
84967,2,O,4129
84968,NK,B-NAME_OF_DISEASE,4129
84969,moderate,O,4129
84970,,O,4129
84971,This,O,4129
84972,stage,O,4129
84973,of,O,4129
84974,the,O,4129
84975,condition,O,4129
84976,is,O,4129
84977,characterized,O,4129
84978,by,O,4129
84979,the,B-SIGN_AND_SYMPTOM,4129
84980,presence,I-SIGN_AND_SYMPTOM,4129
84981,of,I-SIGN_AND_SYMPTOM,4129
84982,a,I-SIGN_AND_SYMPTOM,4129
84983,persistent,I-SIGN_AND_SYMPTOM,4129
84984,epithelial,I-SIGN_AND_SYMPTOM,4129
84985,defect,I-SIGN_AND_SYMPTOM,4129
84986,as,O,4129
84987,we,O,4129
84988,may,O,4129
84989,see,O,4129
84990,after,O,4129
84991,a,O,4129
84992,patient,O,4129
84993,has,O,4130
84994,undergone,O,4130
84995,multiple,O,4130
84996,ocular,O,4130
84997,surgeries,O,4130
84998,Stage,O,4130
84999,3,O,4130
85000,NK,B-NAME_OF_DISEASE,4130
85001,severe,O,4130
85002,,O,4130
85003,This,O,4130
85004,is,O,4130
85005,characterized,O,4130
85006,by,O,4130
85007,a,B-SIGN_AND_SYMPTOM,4130
85008,corneal,I-SIGN_AND_SYMPTOM,4130
85009,ulcer,I-SIGN_AND_SYMPTOM,4130
85010,that,I-SIGN_AND_SYMPTOM,4130
85011,has,I-SIGN_AND_SYMPTOM,4130
85012,stromal,I-SIGN_AND_SYMPTOM,4130
85013,involvement,I-SIGN_AND_SYMPTOM,4130
85014,and,I-SIGN_AND_SYMPTOM,4130
85015,thinning,I-SIGN_AND_SYMPTOM,4130
85016,This,O,4130
85017,stage,O,4130
85018,is,O,4130
85019,dangerous,O,4130
85020,as,O,4130
85021,it,O,4131
85022,has,O,4131
85023,a,O,4131
85024,significant,O,4131
85025,risk,O,4131
85026,of,O,4131
85027,progression,O,4131
85028,to,O,4131
85029,corneal,B-SIGN_AND_SYMPTOM,4131
85030,perforation,I-SIGN_AND_SYMPTOM,4131
85031,or,I-SIGN_AND_SYMPTOM,4131
85032,infection,I-SIGN_AND_SYMPTOM,4131
85033,Specifically,O,4131
85034,the,O,4131
85035,underlying,O,4131
85036,stroma,O,4131
85037,can,O,4131
85038,progressively,O,4131
85039,deteriorate,O,4131
85040,without,O,4131
85041,the,O,4131
85042,protective,O,4131
85043,barrier,O,4131
85044,provided,O,4131
85045,by,O,4131
85046,an,O,4131
85047,intact,O,4131
85048,epithelium,O,4132
85049,Neurotrophic,B-NAME_OF_DISEASE,4132
85050,keratitis,I-NAME_OF_DISEASE,4132
85051,NK,I-NAME_OF_DISEASE,4132
85052,is,O,4132
85053,a,O,4132
85054,challenging,O,4132
85055,condition,O,4132
85056,to,O,4132
85057,diagnose,O,4132
85058,and,O,4132
85059,treat,O,4132
85060,For,O,4132
85061,one,O,4132
85062,patients,O,4132
85063,who,O,4132
85064,have,O,4132
85065,it,O,4132
85066,seldom,O,4132
85067,complain,O,4132
85068,of,O,4132
85069,any,O,4132
85070,symptoms,O,4132
85071,For,O,4132
85072,another,O,4132
85073,it,O,4132
85074,is,O,4132
85075,a,O,4132
85076,degenerative,O,4132
85077,condition,O,4132
85078,that,O,4132
85079,can,O,4132
85080,alter,O,4132
85081,corneal,O,4133
85082,healing,O,4133
85083,and,O,4133
85084,cause,O,4133
85085,vision,B-SIGN_AND_SYMPTOM,4133
85086,loss,I-SIGN_AND_SYMPTOM,4133
85087,Due,O,4133
85088,to,O,4133
85089,a,O,4133
85090,recent,O,4133
85091,expanding,O,4133
85092,array,O,4133
85093,of,O,4133
85094,treatment,O,4133
85095,options,O,4133
85096,and,O,4133
85097,therefore,O,4134
85098,a,O,4134
85099,focus,O,4134
85100,on,O,4134
85101,clinician,O,4134
85102,education,O,4134
85103,there,O,4134
85104,has,O,4134
85105,been,O,4134
85106,an,O,4134
85107,increased,O,4134
85108,awareness,O,4134
85109,of,O,4134
85110,NK,B-NAME_OF_DISEASE,4134
85111,In,O,4134
85112,an,O,4134
85113,effort,O,4134
85114,to,O,4135
85115,keep,O,4135
85116,the,O,4135
85117,condition,O,4135
85118,on,O,4136
85119,our,O,4136
85120,diagnostic,O,4136
85121,radar,O,4136
85122,here,O,4136
85123,we,O,4136
85124,discuss,O,4136
85125,the,O,4136
85126,evidence,O,4136
85127,needed,O,4136
85128,for,O,4136
85129,a,O,4136
85130,definitive,O,4136
85131,diagnosis,O,4136
85132,and,O,4136
85133,the,O,4136
85134,current,O,4136
85135,treatment,O,4136
85136,options,O,4136
85137,available,O,4136
85138,to,O,4136
85139,rehabilitate,O,4136
85140,the,B-PART_OF_THE_EYES,4136
85141,ocular,B-PART_OF_THE_EYES,4136
85142,surface,I-PART_OF_THE_EYES,4136
85143,in,O,4137
85144,these,O,4137
85145,patients,O,4137
85146,The,O,4137
85147,Evidence,O,4137
85148,Needed,O,4137
85149,The,O,4137
85150,evidence,O,4137
85151,that,O,4137
85152,leads,O,4137
85153,to,O,4137
85154,a,O,4137
85155,definitive,O,4137
85156,diagnosis,O,4137
85157,of,O,4137
85158,NK,B-NAME_OF_DISEASE,4137
85159,is,O,4137
85160,Symptoms,O,4137
85161,A,O,4137
85162,lack,O,4137
85163,of,O,4137
85164,corneal,O,4137
85165,sensation,O,4137
85166,tends,O,4137
85167,to,O,4137
85168,negate,O,4138
85169,symptoms,O,4138
85170,in,O,4138
85171,these,O,4138
85172,patients,O,4138
85173,That,O,4138
85174,said,O,4138
85175,these,O,4138
85176,patients,O,4138
85177,may,O,4138
85178,complain,O,4138
85179,of,O,4138
85180,blurry,B-SIGN_AND_SYMPTOM,4138
85181,vision,I-SIGN_AND_SYMPTOM,4138
85182,resulting,I-SIGN_AND_SYMPTOM,4138
85183,from,I-SIGN_AND_SYMPTOM,4138
85184,corneal,I-SIGN_AND_SYMPTOM,4138
85185,edema,I-SIGN_AND_SYMPTOM,4138
85186,the,I-SIGN_AND_SYMPTOM,4138
85187,irregular,I-SIGN_AND_SYMPTOM,4138
85188,epithelium,I-SIGN_AND_SYMPTOM,4138
85189,persistent,I-SIGN_AND_SYMPTOM,4138
85190,epithelial,I-SIGN_AND_SYMPTOM,4138
85191,corneal,I-SIGN_AND_SYMPTOM,4138
85192,defects,I-SIGN_AND_SYMPTOM,4138
85193,or,I-SIGN_AND_SYMPTOM,4138
85194,corneal,I-SIGN_AND_SYMPTOM,4138
85195,scarring,I-SIGN_AND_SYMPTOM,4138
85196,Patient,O,4139
85197,history,O,4139
85198,NK,B-NAME_OF_DISEASE,4139
85199,is,O,4139
85200,the,O,4140
85201,end,O,4140
85202,result,O,4140
85203,of,O,4140
85204,a,O,4140
85205,variety,O,4141
85206,of,O,4141
85207,conditions,O,4141
85208,that,O,4141
85209,may,O,4141
85210,work,O,4141
85211,alone,O,4141
85212,or,O,4141
85213,in,O,4141
85214,concert,O,4141
85215,to,O,4141
85216,disrupt,O,4141
85217,the,B-PART_OF_THE_EYES,4141
85218,ocular,I-PART_OF_THE_EYES,4141
85219,surface,I-PART_OF_THE_EYES,4141
85220,Identifying,O,4141
85221,NK,B-NAME_OF_DISEASE,4141
85222,s,O,4141
85223,underlying,O,4141
85224,cause,O,4141
85225,is,O,4141
85226,the,O,4141
85227,key,O,4141
85228,to,O,4141
85229,initiation,O,4141
85230,of,O,4141
85231,treatment,O,4142
85232,The,O,4142
85233,most,O,4142
85234,common,O,4142
85235,etiologies,O,4142
85236,include,O,4142
85237,herpes,B-CAUSE_OF_DISEASE,4142
85238,simplex,I-CAUSE_OF_DISEASE,4142
85239,keratitis,I-CAUSE_OF_DISEASE,4142
85240,toxicity,O,4142
85241,from,O,4142
85242,the,O,4142
85243,long-term,O,4143
85244,use,O,4144
85245,of,O,4144
85246,ophthalmic,O,4144
85247,drops,O,4144
85248,e.g,O,4144
85249,preserved,O,4144
85250,glaucoma,O,4144
85251,drops,O,4144
85252,artificial,O,4144
85253,tears,O,4144
85254,etc,O,4144
85255,long-term,B-CAUSE_OF_DISEASE,4145
85256,contact,I-CAUSE_OF_DISEASE,4146
85257,lens,I-CAUSE_OF_DISEASE,4146
85258,wear,I-CAUSE_OF_DISEASE,4146
85259,or,O,4146
85260,a,O,4146
85261,history,O,4146
85262,of,O,4146
85263,ocular,O,4146
85264,surgery,O,4146
85265,e.g,O,4146
85266,corneal,O,4146
85267,refractive,O,4146
85268,surgery,O,4146
85269,retinal,O,4146
85270,or,O,4146
85271,glaucoma,O,4146
85272,surgery,O,4146
85273,or,O,4146
85274,multiple,O,4146
85275,ocular,O,4146
85276,procedures,O,4146
85277,,O,4146
85278,Many,O,4146
85279,of,O,4146
85280,these,O,4146
85281,conditions,O,4146
85282,develop,O,4146
85283,gradually,O,4146
85284,over,O,4146
85285,several,O,4146
85286,years,O,4146
85287,during,O,4146
85288,which,O,4147
85289,time,O,4147
85290,the,B-NAME_OF_DISEASE,4147
85291,NK,I-NAME_OF_DISEASE,4147
85292,is,O,4147
85293,not,O,4147
85294,recognized,O,4147
85295,or,O,4147
85296,treated,O,4147
85297,adequately,O,4147
85298,Oftentimes,O,4147
85299,the,O,4147
85300,condition,O,4147
85301,is,O,4147
85302,even,O,4147
85303,exacerbated,O,4147
85304,by,O,4147
85305,attempted,O,4147
85306,treatments,O,4147
85307,such,O,4147
85308,as,O,4147
85309,the,O,4148
85310,use,O,4148
85311,of,O,4148
85312,further,O,4148
85313,preserved,O,4148
85314,OTC,B-NAME_OF_DRUG,4148
85315,lubricant,I-NAME_OF_DRUG,4148
85316,drops,I-NAME_OF_DRUG,4148
85317,or,O,4148
85318,continued,O,4148
85319,insult,O,4148
85320,by,O,4148
85321,the,O,4148
85322,inciting,O,4148
85323,cause,O,4148
85324,Slit,B-DIAGNOSTIC_TEST,4148
85325,lamp,I-DIAGNOSTIC_TEST,4148
85326,exam,I-DIAGNOSTIC_TEST,4148
85327,A,B-DIAGNOSTIC_TEST,4148
85328,thorough,I-DIAGNOSTIC_TEST,4148
85329,slit,I-DIAGNOSTIC_TEST,4148
85330,lamp,I-DIAGNOSTIC_TEST,4148
85331,examination,I-DIAGNOSTIC_TEST,4148
85332,including,I-DIAGNOSTIC_TEST,4148
85333,fluorescein,I-DIAGNOSTIC_TEST,4148
85334,staining,I-DIAGNOSTIC_TEST,4148
85335,aids,O,4148
85336,in,O,4148
85337,determining,O,4148
85338,whether,O,4148
85339,there,O,4148
85340,is,O,4148
85341,a,O,4148
85342,disruption,O,4148
85343,of,O,4149
85344,the,B-PART_OF_THE_EYES,4149
85345,corneal,I-PART_OF_THE_EYES,4149
85346,epithelium,I-PART_OF_THE_EYES,4149
85347,and,O,4149
85348,defining,O,4149
85349,the,O,4149
85350,stage,O,4149
85351,of,O,4149
85352,the,B-NAME_OF_DISEASE,4149
85353,NK,I-NAME_OF_DISEASE,4149
85354,It,O,4149
85355,is,O,4149
85356,famously,O,4149
85357,said,O,4149
85358,that,O,4149
85359,NK,B-NAME_OF_DISEASE,4149
85360,causes,O,4149
85361,stain,B-SIGN_AND_SYMPTOM,4149
85362,without,I-SIGN_AND_SYMPTOM,4149
85363,pain,I-SIGN_AND_SYMPTOM,4150
85364,Corneal,B-DIAGNOSTIC_TEST,4151
85365,sensation,I-DIAGNOSTIC_TEST,4151
85366,assessment,I-DIAGNOSTIC_TEST,4151
85367,In,O,4151
85368,the,O,4151
85369,past,O,4151
85370,we,O,4151
85371,think,O,4151
85372,many,O,4151
85373,of,O,4151
85374,us,O,4151
85375,were,O,4151
85376,inattentive,O,4151
85377,to,O,4152
85378,NK,B-NAME_OF_DISEASE,4152
85379,Today,O,4152
85380,however,O,4152
85381,we,O,4152
85382,feel,O,4152
85383,we,O,4152
85384,are,O,4152
85385,collectively,O,4152
85386,doing,O,4152
85387,a,O,4152
85388,much,O,4152
85389,better,O,4152
85390,job,O,4152
85391,of,O,4152
85392,evaluating,O,4152
85393,corneal,O,4152
85394,sensation,O,4152
85395,during,O,4152
85396,exams,O,4152
85397,as,O,4152
85398,we,O,4152
85399,now,O,4152
85400,realize,O,4152
85401,the,O,4152
85402,lack,O,4152
85403,of,O,4152
85404,corneal,O,4152
85405,sensation,O,4152
85406,in,O,4152
85407,these,O,4152
85408,patients,O,4152
85409,often,O,4153
85410,precludes,O,4153
85411,them,O,4153
85412,from,O,4153
85413,seeing,O,4153
85414,us,O,4153
85415,at,O,4153
85416,the,O,4153
85417,outset,O,4153
85418,The,O,4153
85419,easiest,O,4153
85420,ways,O,4153
85421,to,O,4153
85422,test,O,4153
85423,corneal,O,4154
85424,sensitivity,O,4155
85425,include,O,4155
85426,the,B-DIAGNOSTIC_TEST,4155
85427,use,I-DIAGNOSTIC_TEST,4155
85428,of,I-DIAGNOSTIC_TEST,4155
85429,a,I-DIAGNOSTIC_TEST,4155
85430,cotton,I-DIAGNOSTIC_TEST,4155
85431,wisp,I-DIAGNOSTIC_TEST,4155
85432,from,I-DIAGNOSTIC_TEST,4155
85433,a,I-DIAGNOSTIC_TEST,4155
85434,sterile,I-DIAGNOSTIC_TEST,4155
85435,swab,I-DIAGNOSTIC_TEST,4155
85436,or,I-DIAGNOSTIC_TEST,4155
85437,from,I-DIAGNOSTIC_TEST,4155
85438,a,I-DIAGNOSTIC_TEST,4155
85439,strand,I-DIAGNOSTIC_TEST,4155
85440,of,I-DIAGNOSTIC_TEST,4155
85441,dental,I-DIAGNOSTIC_TEST,4155
85442,floss,I-DIAGNOSTIC_TEST,4155
85443,Alternatively,O,4155
85444,there,O,4155
85445,are,O,4155
85446,more,O,4155
85447,standardized,O,4155
85448,ways,O,4155
85449,to,O,4155
85450,assess,O,4155
85451,corneal,O,4155
85452,sensitivity,O,4155
85453,such,O,4155
85454,as,O,4155
85455,via,O,4156
85456,a,B-DIAGNOSTIC_TEST,4156
85457,handheld,I-DIAGNOSTIC_TEST,4156
85458,aesthesiometer,I-DIAGNOSTIC_TEST,4156
85459,like,O,4156
85460,the,B-DIAGNOSTIC_TEST,4156
85461,Cochet-Bonnet,I-DIAGNOSTIC_TEST,4156
85462,aesthesiometer,I-DIAGNOSTIC_TEST,4156
85463,however,O,4156
85464,this,O,4156
85465,is,O,4156
85466,rarely,O,4156
85467,available,O,4156
85468,or,O,4156
85469,utilized,O,4156
85470,in,O,4156
85471,standard,O,4156
85472,clinical,O,4156
85473,practice,O,4156
85474,,O,4156
85475,Something,O,4156
85476,else,O,4156
85477,to,O,4156
85478,keep,O,4156
85479,in,O,4156
85480,mind,O,4156
85481,Since,O,4156
85482,most,O,4156
85483,cases,O,4156
85484,of,O,4156
85485,NK,B-NAME_OF_DISEASE,4156
85486,are,O,4157
85487,unilateral,O,4157
85488,the,O,4157
85489,patient,O,4157
85490,s,O,4157
85491,other,O,4157
85492,eye,O,4157
85493,can,O,4157
85494,serve,O,4157
85495,as,O,4157
85496,a,O,4157
85497,built-in,O,4157
85498,control,O,4157
85499,for,O,4157
85500,comparison,O,4157
85501,and,O,4157
85502,the,O,4157
85503,patient,O,4157
85504,can,O,4158
85505,also,O,4159
85506,self-report,O,4159
85507,the,O,4159
85508,difference,O,4159
85509,during,O,4160
85510,the,O,4160
85511,test,O,4160
85512,However,O,4160
85513,there,O,4160
85514,are,O,4160
85515,some,O,4160
85516,rare,O,4160
85517,systemic,O,4160
85518,bilateral,O,4160
85519,etiologies,O,4160
85520,such,O,4160
85521,as,O,4160
85522,diabetes,B-NAME_OF_DISEASE,4160
85523,or,O,4160
85524,multiple,B-NAME_OF_DISEASE,4160
85525,sclerosis,I-NAME_OF_DISEASE,4160
85526,in,O,4160
85527,which,O,4160
85528,there,O,4160
85529,is,O,4160
85530,no,O,4160
85531,patientspecific,O,4160
85532,control,O,4160
85533,A,O,4160
85534,caveat,O,4160
85535,Anesthetic,B-NAME_OF_DRUG,4160
85536,and,O,4160
85537,dilating,B-NAME_OF_DRUG,4160
85538,drops,I-NAME_OF_DRUG,4160
85539,often,O,4160
85540,instilled,O,4161
85541,in,O,4161
85542,the,O,4161
85543,patient,O,4161
85544,by,O,4161
85545,the,O,4161
85546,technician,O,4161
85547,prior,O,4161
85548,to,O,4161
85549,the,O,4161
85550,doctor,O,4161
85551,seeing,O,4161
85552,the,O,4162
85553,patient,O,4162
85554,will,O,4162
85555,nullify,O,4162
85556,the,O,4162
85557,results,O,4162
85558,of,O,4162
85559,corneal,B-DIAGNOSTIC_TEST,4162
85560,sensitivity,I-DIAGNOSTIC_TEST,4162
85561,testing,I-DIAGNOSTIC_TEST,4162
85562,so,O,4162
85563,the,O,4162
85564,patient,O,4162
85565,should,O,4163
85566,be,O,4164
85567,scheduled,O,4164
85568,for,O,4164
85569,a,O,4164
85570,follow-up,O,4164
85571,visit,O,4164
85572,during,O,4164
85573,which,O,4164
85574,they,O,4164
85575,receive,O,4164
85576,no,O,4164
85577,anesthetic,B-NAME_OF_DRUG,4164
85578,or,O,4164
85579,dilating,B-NAME_OF_DRUG,4164
85580,drops,I-NAME_OF_DRUG,4164
85581,before,O,4164
85582,seeing,O,4164
85583,the,O,4164
85584,physician,O,4164
85585,Though,O,4164
85586,some,O,4164
85587,doctors,O,4164
85588,test,O,4164
85589,only,O,4164
85590,centrally,O,4164
85591,it,O,4165
85592,can,O,4165
85593,be,O,4165
85594,helpful,O,4165
85595,to,O,4165
85596,test,O,4165
85597,in,O,4165
85598,the,O,4165
85599,5,O,4165
85600,zones,O,4165
85601,central,O,4165
85602,superior,O,4165
85603,inferior,O,4165
85604,temporal,O,4165
85605,and,O,4165
85606,nasal,O,4165
85607,as,O,4166
85608,doing,O,4166
85609,so,O,4166
85610,documents,O,4166
85611,the,O,4166
85612,severity,O,4166
85613,of,O,4166
85614,the,B-NAME_OF_DISEASE,4166
85615,NK,I-NAME_OF_DISEASE,4166
85616,and,O,4166
85617,helps,O,4166
85618,track,O,4166
85619,response,O,4166
85620,to,O,4166
85621,treatment,O,4166
85622,In,O,4166
85623,addition,O,4166
85624,it,O,4166
85625,is,O,4166
85626,easy,O,4166
85627,to,O,4166
85628,document,O,4166
85629,whether,O,4166
85630,sensation,O,4166
85631,is,O,4167
85632,absent,O,4167
85633,normal,O,4167
85634,or,O,4167
85635,diminished,O,4167
85636,in,O,4167
85637,each,O,4167
85638,of,O,4167
85639,the,O,4167
85640,5,O,4167
85641,zones,O,4167
85642,Rehabilitating,O,4167
85643,the,B-PART_OF_THE_EYES,4167
85644,Ocular,I-PART_OF_THE_EYES,4167
85645,Surface,I-PART_OF_THE_EYES,4167
85646,Ideally,O,4167
85647,the,O,4167
85648,patient,O,4167
85649,should,O,4167
85650,be,O,4167
85651,treated,O,4167
85652,as,O,4167
85653,early,O,4167
85654,as,O,4167
85655,possible,O,4167
85656,in,O,4167
85657,the,O,4167
85658,disease,O,4167
85659,process,O,4167
85660,to,O,4167
85661,avoid,O,4167
85662,permanent,O,4167
85663,visually,O,4167
85664,debilitating,O,4167
85665,consequences,O,4167
85666,There,O,4167
85667,are,O,4167
85668,a,O,4167
85669,variety,O,4167
85670,of,O,4167
85671,treatment,O,4167
85672,options,O,4167
85673,available,O,4168
85674,for,O,4168
85675,NK,B-NAME_OF_DISEASE,4168
85676,The,O,4168
85677,protocol,O,4168
85678,is,O,4168
85679,to,O,4168
85680,treat,O,4168
85681,the,O,4168
85682,cause,O,4168
85683,of,O,4168
85684,the,O,4168
85685,patient,O,4168
85686,s,O,4169
85687,NK,B-NAME_OF_DISEASE,4169
85688,any,O,4169
85689,underlying,O,4169
85690,dry,B-NAME_OF_DISEASE,4169
85691,eye,I-NAME_OF_DISEASE,4169
85692,disease,I-NAME_OF_DISEASE,4169
85693,DED,I-NAME_OF_DISEASE,4169
85694,and,O,4169
85695,the,O,4169
85696,effect,O,4169
85697,of,O,4169
85698,the,B-NAME_OF_DISEASE,4169
85699,NK,I-NAME_OF_DISEASE,4169
85700,itself,O,4169
85701,Treatments,O,4169
85702,for,O,4169
85703,causes,O,4169
85704,A,O,4169
85705,common,O,4169
85706,condition,O,4169
85707,that,O,4169
85708,results,O,4169
85709,in,O,4169
85710,NK,B-NAME_OF_DISEASE,4169
85711,is,O,4170
85712,herpetic,B-CAUSE_OF_DISEASE,4170
85713,keratitis,I-CAUSE_OF_DISEASE,4170
85714,Once,O,4170
85715,this,O,4170
85716,disease,O,4170
85717,is,O,4170
85718,brought,O,4170
85719,under,O,4170
85720,control,O,4170
85721,with,O,4170
85722,the,B-NAME_OF_DRUG,4170
85723,use,I-NAME_OF_DRUG,4170
85724,of,I-NAME_OF_DRUG,4170
85725,oral,I-NAME_OF_DRUG,4170
85726,and,I-NAME_OF_DRUG,4170
85727,or,I-NAME_OF_DRUG,4170
85728,topical,I-NAME_OF_DRUG,4171
85729,antivirals,I-NAME_OF_DRUG,4171
85730,the,O,4171
85731,patient,O,4171
85732,may,O,4171
85733,require,O,4171
85734,topical,B-NAME_OF_DRUG,4171
85735,steroids,I-NAME_OF_DRUG,4171
85736,and,O,4171
85737,aggressive,B-TREATMENT,4171
85738,lubrication,I-TREATMENT,4171
85739,with,I-TREATMENT,4171
85740,preservative-free,I-TREATMENT,4171
85741,artificial,I-TREATMENT,4171
85742,tears,I-TREATMENT,4171
85743,for,O,4171
85744,the,B-NAME_OF_DISEASE,4171
85745,NK,I-NAME_OF_DISEASE,4171
85746,itself,O,4171
85747,In,O,4171
85748,another,O,4171
85749,case,O,4171
85750,the,O,4171
85751,underlying,O,4171
85752,cause,O,4172
85753,may,O,4172
85754,be,O,4172
85755,a,O,4172
85756,systemic,O,4172
85757,condition,O,4172
85758,such,O,4172
85759,as,O,4172
85760,graft-versus-host,B-CAUSE_OF_DISEASE,4172
85761,disease,I-CAUSE_OF_DISEASE,4172
85762,GVHD,I-CAUSE_OF_DISEASE,4172
85763,systemic,B-CAUSE_OF_DISEASE,4172
85764,lupus,I-CAUSE_OF_DISEASE,4172
85765,or,O,4172
85766,multiple,B-CAUSE_OF_DISEASE,4172
85767,sclerosis,I-CAUSE_OF_DISEASE,4172
85768,which,O,4172
85769,may,O,4172
85770,require,O,4172
85771,treatment,O,4172
85772,with,O,4172
85773,oral,B-NAME_OF_DRUG,4173
85774,steroids,I-NAME_OF_DRUG,4173
85775,In,O,4173
85776,still,O,4173
85777,other,O,4173
85778,incidences,O,4173
85779,of,O,4173
85780,NK,B-NAME_OF_DISEASE,4173
85781,the,B-TREATMENT,4173
85782,removal,I-TREATMENT,4173
85783,of,I-TREATMENT,4173
85784,an,I-TREATMENT,4173
85785,inciting,I-TREATMENT,4173
85786,toxic,I-TREATMENT,4173
85787,agent,I-TREATMENT,4173
85788,such,I-TREATMENT,4173
85789,as,I-TREATMENT,4173
85790,a,I-TREATMENT,4173
85791,glaucoma,I-TREATMENT,4173
85792,drop,I-TREATMENT,4173
85793,may,O,4173
85794,be,O,4173
85795,a,O,4173
85796,key,O,4173
85797,component,O,4173
85798,of,O,4173
85799,the,O,4173
85800,treatment,O,4173
85801,regimen,O,4173
85802,Should,O,4173
85803,the,O,4173
85804,patient,O,4173
85805,have,O,4173
85806,lagophthalmos,B-NAME_OF_DISEASE,4173
85807,or,O,4173
85808,incomplete,O,4173
85809,or,O,4173
85810,absent,O,4174
85811,blink,O,4174
85812,response,O,4174
85813,lid,B-TREATMENT,4174
85814,interventions,I-TREATMENT,4174
85815,including,I-TREATMENT,4174
85816,tape,I-TREATMENT,4174
85817,tarsorrhaphies,I-TREATMENT,4174
85818,temporary,I-TREATMENT,4174
85819,suture,I-TREATMENT,4174
85820,tarsorrhaphies,I-TREATMENT,4174
85821,or,I-TREATMENT,4174
85822,permanent,I-TREATMENT,4174
85823,tarsorrhaphies,I-TREATMENT,4174
85824,can,O,4174
85825,be,O,4174
85826,an,O,4174
85827,integral,O,4174
85828,component,O,4175
85829,of,O,4175
85830,the,O,4175
85831,treatment,O,4175
85832,and,O,4175
85833,healing,O,4175
85834,process,O,4175
85835,This,O,4175
85836,is,O,4175
85837,because,O,4175
85838,NK,B-NAME_OF_DISEASE,4175
85839,can,O,4175
85840,be,O,4175
85841,worse,O,4175
85842,in,O,4175
85843,such,O,4175
85844,patients,O,4175
85845,due,O,4175
85846,to,O,4175
85847,this,O,4176
85848,very,O,4176
85849,significant,O,4176
85850,comorbidity,O,4176
85851,The,O,4176
85852,take,O,4176
85853,home,O,4176
85854,message,O,4176
85855,The,O,4176
85856,lid,B-PART_OF_THE_EYES,4176
85857,architecture,O,4176
85858,and,O,4176
85859,position,O,4176
85860,should,O,4176
85861,always,O,4176
85862,be,O,4176
85863,thoroughly,O,4176
85864,evaluated,O,4176
85865,in,O,4176
85866,these,O,4176
85867,patients,O,4176
85868,Treatments,O,4176
85869,for,O,4176
85870,underlying,O,4176
85871,DED,B-NAME_OF_DISEASE,4176
85872,I,O,4176
85873,have,O,4176
85874,prescribed,O,4176
85875,inflammatory,B-NAME_OF_DRUG,4176
85876,inhibitors,I-NAME_OF_DRUG,4176
85877,to,O,4176
85878,stabilize,O,4177
85879,any,O,4177
85880,underlying,O,4177
85881,DED,B-NAME_OF_DISEASE,4177
85882,condition,O,4177
85883,as,O,4177
85884,doing,O,4177
85885,so,O,4177
85886,helps,O,4177
85887,improve,O,4177
85888,the,B-PART_OF_THE_EYES,4177
85889,ocular,B-PART_OF_THE_EYES,4177
85890,surface,I-PART_OF_THE_EYES,4177
85891,which,O,4177
85892,facilitates,O,4178
85893,treatment,O,4178
85894,of,O,4178
85895,the,B-NAME_OF_DISEASE,4178
85896,NK,B-NAME_OF_DISEASE,4178
85897,We,O,4178
85898,need,O,4178
85899,to,O,4178
85900,remember,O,4178
85901,that,O,4178
85902,many,O,4178
85903,of,O,4178
85904,our,O,4178
85905,NK,B-NAME_OF_DISEASE,4178
85906,patients,O,4178
85907,have,O,4178
85908,other,O,4178
85909,comorbid,O,4178
85910,ocular,O,4178
85911,conditions,O,4178
85912,such,O,4178
85913,as,O,4178
85914,DED,B-NAME_OF_DISEASE,4178
85915,and,O,4179
85916,glaucoma,B-NAME_OF_DISEASE,4179
85917,that,O,4179
85918,complicate,O,4179
85919,the,O,4179
85920,disease,O,4179
85921,course,O,4179
85922,Additionally,O,4179
85923,punctal,B-TREATMENT,4179
85924,plugs,I-TREATMENT,4179
85925,a,B-TREATMENT,4179
85926,dissolvable,I-TREATMENT,4179
85927,punctal,I-TREATMENT,4179
85928,insert,I-TREATMENT,4180
85929,in-office,B-TREATMENT,4180
85930,lid,I-TREATMENT,4180
85931,treatment,I-TREATMENT,4180
85932,procedures,I-TREATMENT,4180
85933,intense,B-TREATMENT,4180
85934,pulsed,I-TREATMENT,4180
85935,light,I-TREATMENT,4180
85936,and,O,4180
85937,ocular,B-TREATMENT,4180
85938,nutritional,I-TREATMENT,4180
85939,supplements,I-TREATMENT,4180
85940,may,O,4180
85941,be,O,4180
85942,used,O,4180
85943,to,O,4181
85944,help,O,4181
85945,control,O,4181
85946,concomitant,O,4181
85947,ocular,B-PART_OF_THE_EYES,4181
85948,surface,I-PART_OF_THE_EYES,4181
85949,disease,O,4181
85950,Treatments,O,4181
85951,for,O,4181
85952,NK,B-NAME_OF_DISEASE,4181
85953,itself,O,4181
85954,The,O,4181
85955,following,O,4181
85956,are,O,4181
85957,available,O,4181
85958,A,O,4181
85959,Artificial,B-TREATMENT,4181
85960,tears,I-TREATMENT,4181
85961,gels,I-TREATMENT,4181
85962,and,I-TREATMENT,4181
85963,ointments,I-TREATMENT,4181
85964,Aggressive,B-TREATMENT,4181
85965,6,I-TREATMENT,4181
85966,to,I-TREATMENT,4181
85967,8,I-TREATMENT,4182
85968,times,I-TREATMENT,4182
85969,a,I-TREATMENT,4182
85970,day,I-TREATMENT,4182
85971,or,I-TREATMENT,4182
85972,more,I-TREATMENT,4182
85973,lubrication,I-TREATMENT,4182
85974,with,I-TREATMENT,4182
85975,preservative-free,I-TREATMENT,4182
85976,artificial,I-TREATMENT,4182
85977,tears,I-TREATMENT,4182
85978,of,I-TREATMENT,4182
85979,increasing,I-TREATMENT,4182
85980,viscosity,I-TREATMENT,4182
85981,improves,O,4182
85982,ocular,B-PART_OF_THE_EYES,4182
85983,surface,I-PART_OF_THE_EYES,4182
85984,protection,O,4182
85985,Thick,B-TREATMENT,4182
85986,gels,I-TREATMENT,4182
85987,and,I-TREATMENT,4182
85988,ointments,I-TREATMENT,4182
85989,can,O,4182
85990,help,O,4182
85991,provide,O,4182
85992,a,O,4182
85993,barrier,O,4182
85994,to,O,4182
85995,environmental,O,4182
85996,insults,O,4182
85997,B,O,4182
85998,Amniotic,B-TREATMENT,4182
85999,membranes,I-TREATMENT,4182
86000,These,O,4183
86001,contain,O,4183
86002,anti-microbial,O,4183
86003,and,O,4183
86004,antiinflammatory,O,4183
86005,properties,O,4183
86006,and,O,4183
86007,low,O,4183
86008,immunogenicity,O,4183
86009,C,O,4183
86010,Contact,O,4183
86011,lenses,O,4183
86012,While,O,4183
86013,wearing,O,4183
86014,contact,O,4183
86015,lenses,O,4183
86016,can,O,4183
86017,cause,O,4183
86018,NK,B-NAME_OF_DISEASE,4183
86019,various,O,4183
86020,types,O,4183
86021,of,O,4183
86022,extended-wear,B-TREATMENT,4183
86023,contact,I-TREATMENT,4183
86024,lenses,I-TREATMENT,4183
86025,are,O,4183
86026,useful,O,4183
86027,in,O,4183
86028,protecting,O,4183
86029,the,B-PART_OF_THE_EYES,4183
86030,ocular,B-PART_OF_THE_EYES,4184
86031,surface,I-PART_OF_THE_EYES,4184
86032,and,O,4184
86033,temporizing,O,4184
86034,the,O,4184
86035,situation,O,4184
86036,while,O,4184
86037,other,O,4184
86038,treatments,O,4184
86039,are,O,4184
86040,taking,O,4184
86041,effect,O,4184
86042,Also,O,4184
86043,bandage,B-TREATMENT,4184
86044,lenses,I-TREATMENT,4185
86045,can,I-TREATMENT,4185
86046,be,I-TREATMENT,4185
86047,used,I-TREATMENT,4185
86048,in,I-TREATMENT,4185
86049,conjunction,I-TREATMENT,4185
86050,with,I-TREATMENT,4185
86051,dried,I-TREATMENT,4185
86052,amniotic,I-TREATMENT,4185
86053,membranes,I-TREATMENT,4185
86054,and,I-TREATMENT,4185
86055,antibiotic,I-TREATMENT,4185
86056,drops,I-TREATMENT,4185
86057,to,O,4185
86058,provide,O,4185
86059,a,O,4185
86060,matrix,O,4185
86061,for,O,4185
86062,healing,O,4185
86063,For,O,4185
86064,long-term,O,4186
86065,NK,B-NAME_OF_DISEASE,4186
86066,conditions,O,4186
86067,that,O,4186
86068,often,O,4186
86069,may,O,4186
86070,be,O,4186
86071,associated,O,4186
86072,with,O,4186
86073,chronic,O,4186
86074,systemic,O,4186
86075,and,O,4186
86076,or,O,4186
86077,ocular,O,4186
86078,diseases,O,4186
86079,such,O,4186
86080,as,O,4187
86081,GVHD,B-CAUSE_OF_DISEASE,4187
86082,and,O,4187
86083,Sjögren,B-CAUSE_OF_DISEASE,4187
86084,s,I-CAUSE_OF_DISEASE,4187
86085,syndrome,I-CAUSE_OF_DISEASE,4187
86086,respectively,O,4187
86087,scleral,B-TREATMENT,4187
86088,contact,I-TREATMENT,4187
86089,lenses,I-TREATMENT,4187
86090,are,O,4188
86091,a,O,4188
86092,very,O,4188
86093,helpful,O,4188
86094,adjunct,O,4188
86095,to,O,4188
86096,care,O,4188
86097,This,O,4188
86098,is,O,4188
86099,because,O,4188
86100,they,O,4188
86101,vault,O,4188
86102,the,B-PART_OF_THE_EYES,4188
86103,corneal,I-PART_OF_THE_EYES,4188
86104,surface,I-PART_OF_THE_EYES,4188
86105,and,O,4188
86106,provide,O,4188
86107,a,O,4189
86108,lens,O,4189
86109,fluid,O,4189
86110,reservoir,O,4189
86111,that,O,4189
86112,constantly,O,4189
86113,lubricates,O,4189
86114,the,B-PART_OF_THE_EYES,4189
86115,ocular,B-PART_OF_THE_EYES,4189
86116,surface,I-PART_OF_THE_EYES,4189
86117,D,O,4189
86118,Topical,B-NAME_OF_DRUG,4189
86119,steroids,I-NAME_OF_DRUG,4189
86120,These,O,4189
86121,are,O,4189
86122,often,O,4189
86123,an,O,4189
86124,essential,O,4189
86125,tool,O,4189
86126,in,O,4189
86127,advanced,O,4189
86128,stages,O,4189
86129,of,O,4190
86130,NK,B-NAME_OF_DISEASE,4190
86131,Of,O,4190
86132,course,O,4190
86133,while,O,4190
86134,topical,B-NAME_OF_DRUG,4190
86135,steroids,I-NAME_OF_DRUG,4190
86136,can,O,4190
86137,be,O,4190
86138,a,O,4190
86139,tremendous,O,4190
86140,tool,O,4190
86141,in,O,4190
86142,managing,O,4190
86143,inflammation,O,4190
86144,in,O,4190
86145,these,O,4190
86146,patients,O,4190
86147,they,O,4190
86148,may,O,4190
86149,be,O,4190
86150,associated,O,4190
86151,with,O,4190
86152,corneal,O,4190
86153,thinning,O,4190
86154,cataract,O,4190
86155,formation,O,4190
86156,and,O,4190
86157,elevations,O,4190
86158,in,O,4190
86159,IOP,O,4190
86160,with,O,4190
86161,long-term,O,4191
86162,use,O,4191
86163,Therefore,O,4191
86164,low-dose,B-NAME_OF_DRUG,4191
86165,preservative-free,I-NAME_OF_DRUG,4191
86166,steroids,I-NAME_OF_DRUG,4191
86167,should,O,4191
86168,be,O,4191
86169,considered,O,4191
86170,in,O,4191
86171,stabilizing,O,4191
86172,disease,O,4191
86173,progression,O,4191
86174,in,O,4191
86175,these,O,4191
86176,patients,O,4191
86177,E,O,4191
86178,Autologous,B-NAME_OF_DRUG,4191
86179,serum,I-NAME_OF_DRUG,4191
86180,tears,I-NAME_OF_DRUG,4191
86181,Autologous,B-NAME_OF_DRUG,4191
86182,serum,I-NAME_OF_DRUG,4192
86183,contains,O,4192
86184,proteins,B-CHEMICAL_COMPOUND,4192
86185,lysozyme,B-CHEMICAL_COMPOUND,4192
86186,lactoferrin,B-CHEMICAL_COMPOUND,4192
86187,albumin,B-CHEMICAL_COMPOUND,4192
86188,and,O,4192
86189,immunoglobulins,B-CHEMICAL_COMPOUND,4192
86190,growth,O,4192
86191,factors,O,4192
86192,epidermal,O,4192
86193,growth,O,4192
86194,factor,O,4192
86195,vitamins,B-CHEMICAL_COMPOUND,4192
86196,A,I-CHEMICAL_COMPOUND,4192
86197,and,I-CHEMICAL_COMPOUND,4192
86198,C,I-CHEMICAL_COMPOUND,4192
86199,antioxidants,B-CHEMICAL_COMPOUND,4192
86200,and,O,4192
86201,electrolytes,B-CHEMICAL_COMPOUND,4192
86202,sodium,B-CHEMICAL_COMPOUND,4192
86203,potassium,B-CHEMICAL_COMPOUND,4192
86204,chloride,B-CHEMICAL_COMPOUND,4192
86205,bicarbonate,B-CHEMICAL_COMPOUND,4192
86206,magnesium,B-CHEMICAL_COMPOUND,4192
86207,calcium,B-CHEMICAL_COMPOUND,4192
86208,,O,4192
86209,The,O,4192
86210,mechanism,O,4192
86211,of,O,4192
86212,action,O,4192
86213,of,O,4192
86214,autologous,B-NAME_OF_DRUG,4192
86215,serum,I-NAME_OF_DRUG,4192
86216,eye,I-NAME_OF_DRUG,4192
86217,drops,I-NAME_OF_DRUG,4193
86218,is,O,4193
86219,to,O,4193
86220,mimic,O,4193
86221,the,O,4193
86222,biochemical,O,4193
86223,properties,O,4193
86224,of,O,4193
86225,natural,O,4193
86226,basal,O,4193
86227,tears,O,4193
86228,but,O,4193
86229,in,O,4193
86230,a,O,4193
86231,highly,O,4193
86232,concentrated,O,4193
86233,form,O,4193
86234,to,O,4193
86235,heal,O,4193
86236,the,B-PART_OF_THE_EYES,4193
86237,ocular,I-PART_OF_THE_EYES,4193
86238,surface,I-PART_OF_THE_EYES,4193
86239,epithelium,I-PART_OF_THE_EYES,4193
86240,These,O,4193
86241,tears,O,4193
86242,can,O,4193
86243,be,O,4193
86244,used,O,4193
86245,alone,O,4193
86246,or,O,4193
86247,placed,O,4193
86248,within,O,4193
86249,the,O,4194
86250,reservoir,O,4194
86251,of,O,4194
86252,a,B-PART_OF_THE_EYES,4194
86253,scleral,I-PART_OF_THE_EYES,4194
86254,lens,I-PART_OF_THE_EYES,4194
86255,to,O,4194
86256,facilitate,O,4194
86257,healing,O,4194
86258,F,O,4194
86259,Cenegermin-bkbj,O,4194
86260,ophthalmic,O,4194
86261,solution,O,4194
86262,0.002,O,4194
86263,20,O,4194
86264,mcg,O,4194
86265,mL,O,4194
86266,Known,O,4194
86267,as,O,4194
86268,Oxervate,B-NAME_OF_DRUG,4194
86269,Dompé,I-NAME_OF_DRUG,4194
86270,this,O,4194
86271,is,O,4194
86272,a,O,4194
86273,recombinant,O,4194
86274,human,O,4194
86275,nerve,O,4194
86276,growth,O,4194
86277,factor,O,4194
86278,in,O,4194
86279,the,O,4194
86280,form,O,4194
86281,of,O,4194
86282,a,O,4195
86283,topical,O,4195
86284,agent,O,4195
86285,dosed,O,4195
86286,6,O,4195
86287,times,O,4195
86288,a,O,4195
86289,day,O,4195
86290,for,O,4195
86291,an,O,4195
86292,8-week,B-TIME_DURATION,4195
86293,course,O,4195
86294,Oxervate,B-NAME_OF_DRUG,4195
86295,was,O,4195
86296,approved,O,4195
86297,in,O,4195
86298,August,O,4195
86299,2018,O,4195
86300,as,O,4195
86301,an,O,4195
86302,orphan,O,4195
86303,drug,O,4195
86304,for,O,4195
86305,NK,B-NAME_OF_DISEASE,4195
86306,Oxervate,B-NAME_OF_DRUG,4195
86307,was,O,4195
86308,shown,O,4195
86309,safe,O,4195
86310,and,O,4195
86311,effective,O,4195
86312,in,O,4195
86313,the,O,4195
86314,corneal,O,4196
86315,healing,O,4196
86316,of,O,4196
86317,moderate-tosevere,O,4196
86318,NK,B-NAME_OF_DISEASE,4196
86319,G,O,4196
86320,Antibiotic,B-NAME_OF_DRUG,4196
86321,drops,I-NAME_OF_DRUG,4196
86322,NK,B-NAME_OF_DISEASE,4196
86323,patients,O,4196
86324,are,O,4196
86325,at,O,4196
86326,risk,O,4196
86327,for,O,4196
86328,developing,O,4196
86329,bacterial,O,4196
86330,superinfections,O,4196
86331,due,O,4196
86332,to,O,4196
86333,their,O,4196
86334,epithelial,O,4196
86335,defect,O,4196
86336,creating,O,4196
86337,a,O,4196
86338,break-down,O,4196
86339,of,O,4196
86340,the,O,4196
86341,natural,O,4196
86342,barrier,O,4196
86343,to,O,4196
86344,microorganisms,O,4197
86345,For,O,4197
86346,this,O,4197
86347,reason,O,4197
86348,it,O,4197
86349,is,O,4197
86350,often,O,4197
86351,helpful,O,4197
86352,to,O,4197
86353,protect,O,4197
86354,the,O,4197
86355,patient,O,4197
86356,with,O,4197
86357,a,B-NAME_OF_DRUG,4197
86358,topical,I-NAME_OF_DRUG,4197
86359,antibiotic,I-NAME_OF_DRUG,4197
86360,drop,I-NAME_OF_DRUG,4197
86361,Given,O,4197
86362,the,O,4197
86363,lack,O,4197
86364,of,O,4197
86365,sensation,O,4198
86366,in,O,4198
86367,these,O,4198
86368,cases,O,4198
86369,an,O,4198
86370,infection,O,4198
86371,could,O,4198
86372,easily,O,4198
86373,go,O,4198
86374,undiagnosed,O,4198
86375,until,O,4198
86376,it,O,4198
86377,is,O,4198
86378,advanced,O,4198
86379,due,O,4198
86380,to,O,4198
86381,the,O,4198
86382,lack,O,4198
86383,of,O,4198
86384,symptoms,O,4199
86385,Conjunctival,B-TREATMENT,4199
86386,flap,I-TREATMENT,4199
86387,Gunderson,B-TREATMENT,4199
86388,flap,I-TREATMENT,4199
86389,with,O,4199
86390,without,O,4199
86391,a,B-TREATMENT,4199
86392,tarsorrhaphy,I-TREATMENT,4199
86393,In,O,4199
86394,severe,O,4199
86395,cases,O,4199
86396,in,O,4199
86397,which,O,4199
86398,corneal,B-SIGN_AND_SYMPTOM,4199
86399,thinning,I-SIGN_AND_SYMPTOM,4199
86400,is,O,4199
86401,more,O,4199
86402,advanced,O,4199
86403,and,O,4199
86404,potentially,O,4199
86405,associated,O,4199
86406,with,O,4199
86407,Dry,B-NAME_OF_DISEASE,4671
86408,eye,I-NAME_OF_DISEASE,4671
86409,disease,I-NAME_OF_DISEASE,4671
86410,DED,B-NAME_OF_DISEASE,4671
86411,also,O,4671
86412,known,O,4671
86413,as,O,4671
86414,keratoconjunctivitis,B-NAME_OF_DISEASE,4671
86415,sicca,I-NAME_OF_DISEASE,4671
86416,KCS,B-NAME_OF_DISEASE,4671
86417,is,O,4671
86418,a,O,4671
86419,common,O,4671
86420,disorder,O,4671
86421,of,O,4671
86422,the,O,4671
86423,eye,O,4671
86424,affecting,O,4671
86425,millions,O,4671
86426,of,O,4671
86427,people,O,4671
86428,around,O,4671
86429,the,O,4671
86430,world,O,4671
86431,The,O,4672
86432,prevalence,O,4672
86433,of,O,4672
86434,DED,B-NAME_OF_DISEASE,4672
86435,ranges,O,4672
86436,from,O,4672
86437,5%,O,4672
86438,to,O,4672
86439,33%,O,4672
86440,worldwide,O,4672
86441,with,O,4672
86442,increased,O,4672
86443,prevalence,O,4672
86444,among,O,4672
86445,adult,O,4672
86446,women,O,4672
86447,and,O,4672
86448,Asians,O,4672
86449,Symptoms,O,4673
86450,of,O,4673
86451,DED,B-NAME_OF_DISEASE,4673
86452,include,O,4673
86453,discomfort,B-SIGN_AND_SYMPTOM,4673
86454,pain,I-SIGN_AND_SYMPTOM,4673
86455,burning,I-SIGN_AND_SYMPTOM,4673
86456,foreign,I-SIGN_AND_SYMPTOM,4673
86457,body,I-SIGN_AND_SYMPTOM,4673
86458,sensation,I-SIGN_AND_SYMPTOM,4673
86459,and,I-SIGN_AND_SYMPTOM,4673
86460,visual,I-SIGN_AND_SYMPTOM,4673
86461,disturbances,I-SIGN_AND_SYMPTOM,4673
86462,Dry,B-NAME_OF_DISEASE,4674
86463,eye,I-NAME_OF_DISEASE,4674
86464,negatively,O,4674
86465,affects,O,4674
86466,the,O,4674
86467,quality,O,4674
86468,of,O,4674
86469,life,O,4674
86470,and,O,4674
86471,results,O,4674
86472,in,O,4674
86473,approximately,O,4674
86474,6,O,4674
86475,billion,O,4674
86476,in,O,4674
86477,annual,O,4674
86478,costs,O,4674
86479,in,O,4674
86480,the,B-GPE,4674
86481,US,I-GPE,4674
86482,Dry,B-NAME_OF_DISEASE,4675
86483,eye,I-NAME_OF_DISEASE,4675
86484,is,O,4675
86485,commonly,O,4675
86486,seen,O,4675
86487,alongside,O,4675
86488,many,O,4675
86489,ocular,B-NAME_OF_DISEASE,4675
86490,disorders,I-NAME_OF_DISEASE,4675
86491,including,O,4675
86492,glaucoma,B-NAME_OF_DISEASE,4675
86493,cataracts,B-NAME_OF_DISEASE,4675
86494,and,O,4675
86495,refractive,B-NAME_OF_DISEASE,4675
86496,errors,I-NAME_OF_DISEASE,4675
86497,Pharmacological,O,4676
86498,treatments,O,4676
86499,for,O,4676
86500,ocular,B-NAME_OF_DISEASE,4676
86501,disorders,I-NAME_OF_DISEASE,4676
86502,often,O,4676
86503,contain,O,4676
86504,preservatives,B-CAUSE_OF_DISEASE,4676
86505,such,I-CAUSE_OF_DISEASE,4676
86506,as,I-CAUSE_OF_DISEASE,4676
86507,benzalkonium,I-CAUSE_OF_DISEASE,4676
86508,chloride,I-CAUSE_OF_DISEASE,4676
86509,These,O,4677
86510,preservatives,O,4677
86511,can,O,4677
86512,cause,O,4677
86513,DED,B-NAME_OF_DISEASE,4677
86514,signs,O,4677
86515,and,O,4677
86516,symptoms,O,4677
86517,including,O,4677
86518,decreased,B-SIGN_AND_SYMPTOM,4677
86519,epithelial,I-SIGN_AND_SYMPTOM,4677
86520,cell,I-SIGN_AND_SYMPTOM,4677
86521,integrity,I-SIGN_AND_SYMPTOM,4677
86522,increased,I-SIGN_AND_SYMPTOM,4677
86523,epithelial,I-SIGN_AND_SYMPTOM,4677
86524,cell,I-SIGN_AND_SYMPTOM,4677
86525,apoptosis,I-SIGN_AND_SYMPTOM,4677
86526,eye,I-SIGN_AND_SYMPTOM,4677
86527,irritation,I-SIGN_AND_SYMPTOM,4677
86528,and,I-SIGN_AND_SYMPTOM,4677
86529,increased,I-SIGN_AND_SYMPTOM,4677
86530,risk,I-SIGN_AND_SYMPTOM,4677
86531,for,I-SIGN_AND_SYMPTOM,4677
86532,ocular,I-SIGN_AND_SYMPTOM,4677
86533,allergies,I-SIGN_AND_SYMPTOM,4677
86534,and,I-SIGN_AND_SYMPTOM,4677
86535,delayed,I-SIGN_AND_SYMPTOM,4677
86536,hypersensitivity,I-SIGN_AND_SYMPTOM,4677
86537,reactions,I-SIGN_AND_SYMPTOM,4677
86538,Surgical,B-CAUSE_OF_DISEASE,4678
86539,interventions,I-CAUSE_OF_DISEASE,4678
86540,to,I-CAUSE_OF_DISEASE,4678
86541,treat,I-CAUSE_OF_DISEASE,4678
86542,ophthalmic,I-CAUSE_OF_DISEASE,4678
86543,disorders,I-CAUSE_OF_DISEASE,4678
86544,and,I-CAUSE_OF_DISEASE,4678
86545,diseases,I-CAUSE_OF_DISEASE,4678
86546,can,O,4678
86547,also,O,4678
86548,cause,O,4678
86549,dry,B-NAME_OF_DISEASE,4678
86550,eye,I-NAME_OF_DISEASE,4678
86551,due,O,4678
86552,to,O,4678
86553,the,B-CAUSE_OF_DISEASE,4678
86554,resultant,I-CAUSE_OF_DISEASE,4678
86555,inflammation,I-CAUSE_OF_DISEASE,4678
86556,from,I-CAUSE_OF_DISEASE,4678
86557,the,I-CAUSE_OF_DISEASE,4678
86558,length,I-CAUSE_OF_DISEASE,4678
86559,of,I-CAUSE_OF_DISEASE,4678
86560,time,I-CAUSE_OF_DISEASE,4678
86561,in,I-CAUSE_OF_DISEASE,4678
86562,surgery,I-CAUSE_OF_DISEASE,4678
86563,incision,B-CAUSE_OF_DISEASE,4678
86564,site,I-CAUSE_OF_DISEASE,4678
86565,disruption,I-CAUSE_OF_DISEASE,4678
86566,to,I-CAUSE_OF_DISEASE,4678
86567,the,I-CAUSE_OF_DISEASE,4678
86568,corneal,I-CAUSE_OF_DISEASE,4678
86569,nerves,I-CAUSE_OF_DISEASE,4678
86570,and,O,4678
86571,type,B-CAUSE_OF_DISEASE,4678
86572,of,I-CAUSE_OF_DISEASE,4678
86573,post-surgical,I-CAUSE_OF_DISEASE,4678
86574,medication,I-CAUSE_OF_DISEASE,4678
86575,Post-trabeculectomy,O,4679
86576,patients,O,4679
86577,have,O,4679
86578,elevated,B-CAUSE_OF_DISEASE,4679
86579,tear,I-CAUSE_OF_DISEASE,4679
86580,film,I-CAUSE_OF_DISEASE,4679
86581,osmolarity,I-CAUSE_OF_DISEASE,4679
86582,and,O,4679
86583,symptoms,O,4679
86584,of,O,4679
86585,dry,B-NAME_OF_DISEASE,4679
86586,eye,I-NAME_OF_DISEASE,4679
86587,intraoperative,B-TREATMENT,4679
86588,use,I-TREATMENT,4679
86589,of,I-TREATMENT,4679
86590,lubricating,I-TREATMENT,4679
86591,substances,I-TREATMENT,4679
86592,can,O,4679
86593,decrease,O,4679
86594,post-surgical,O,4679
86595,dry,B-NAME_OF_DISEASE,4679
86596,eye,I-NAME_OF_DISEASE,4679
86597,symptoms,O,4679
86598,and,O,4679
86599,treatment,O,4679
86600,with,O,4679
86601,dry,B-NAME_OF_DISEASE,4679
86602,eye,I-NAME_OF_DISEASE,4679
86603,medication,O,4679
86604,post-operatively,O,4679
86605,can,O,4679
86606,help,O,4679
86607,alleviate,O,4679
86608,surgery-induced,O,4679
86609,dry,B-NAME_OF_DISEASE,4679
86610,eye,I-NAME_OF_DISEASE,4679
86611,Dry,B-NAME_OF_DISEASE,4680
86612,eye,I-NAME_OF_DISEASE,4680
86613,symptoms,O,4680
86614,following,O,4680
86615,cataract,B-TREATMENT,4680
86616,surgery,I-TREATMENT,4680
86617,occur,O,4680
86618,in,O,4680
86619,42%,O,4680
86620,15%,O,4680
86621,and,O,4680
86622,9%,O,4680
86623,of,O,4680
86624,eyes,O,4680
86625,of,O,4680
86626,patients,O,4680
86627,at,O,4680
86628,1,B-TIME_DURATION,4680
86629,week,I-TIME_DURATION,4680
86630,1,B-TIME_DURATION,4680
86631,month,I-TIME_DURATION,4680
86632,and,O,4680
86633,3,B-TIME_DURATION,4680
86634,months,I-TIME_DURATION,4680
86635,after,O,4680
86636,surgery,O,4680
86637,respectively,O,4680
86638,Additionally,O,4681
86639,new,O,4681
86640,research,O,4681
86641,demonstrates,O,4681
86642,the,O,4681
86643,bilateral,O,4681
86644,impact,O,4681
86645,on,O,4681
86646,the,B-PART_OF_THE_EYES,4681
86647,corneal,I-PART_OF_THE_EYES,4681
86648,sub-basal,I-PART_OF_THE_EYES,4681
86649,nerve,I-PART_OF_THE_EYES,4681
86650,complex,I-PART_OF_THE_EYES,4681
86651,after,O,4681
86652,cataract,B-TREATMENT,4681
86653,surgery,I-TREATMENT,4681
86654,potentially,O,4681
86655,explaining,O,4681
86656,worse,O,4681
86657,dry,B-NAME_OF_DISEASE,4681
86658,eye,I-NAME_OF_DISEASE,4681
86659,symptoms,O,4681
86660,after,O,4681
86661,cataract,B-TREATMENT,4681
86662,surgery,I-TREATMENT,4681
86663,on,O,4681
86664,the,O,4681
86665,second,O,4681
86666,eye,O,4681
86667,Cyclosporine,B-NAME_OF_DRUG,4682
86668,Cyclosporine,B-NAME_OF_DRUG,4682
86669,A,I-NAME_OF_DRUG,4682
86670,is,O,4682
86671,a,O,4682
86672,neutrally,O,4682
86673,charged,O,4682
86674,hydrophobic,O,4682
86675,molecule,O,4682
86676,with,O,4682
86677,low,O,4682
86678,aqueous,O,4682
86679,solubility,O,4682
86680,which,O,4682
86681,poses,O,4682
86682,challenges,O,4682
86683,in,O,4682
86684,making,O,4682
86685,a,O,4682
86686,safe,O,4682
86687,and,O,4682
86688,effective,O,4682
86689,ocular,O,4682
86690,drug,O,4682
86691,delivery,O,4682
86692,system,O,4682
86693,Cyclosporine,B-NAME_OF_DRUG,4683
86694,A,I-NAME_OF_DRUG,4683
86695,reduces,O,4683
86696,the,O,4683
86697,underlying,O,4683
86698,inflammation,O,4683
86699,associated,O,4683
86700,with,O,4683
86701,DED,B-NAME_OF_DISEASE,4683
86702,that,O,4683
86703,interferes,O,4683
86704,with,O,4683
86705,tear,O,4683
86706,production,O,4683
86707,Initially,O,4684
86708,cyclosporine,B-NAME_OF_DRUG,4684
86709,A,I-NAME_OF_DRUG,4684
86710,ophthalmic,O,4684
86711,solutions,O,4684
86712,were,O,4684
86713,formulated,O,4684
86714,in,O,4684
86715,oil-based,O,4684
86716,solvents,O,4684
86717,such,O,4684
86718,as,O,4684
86719,castor,O,4684
86720,oil,O,4684
86721,or,O,4684
86722,corn,O,4684
86723,oil,O,4684
86724,however,O,4684
86725,oils,O,4684
86726,caused,O,4684
86727,side,O,4684
86728,effects,O,4684
86729,such,O,4684
86730,as,O,4684
86731,blurred,B-SIGN_AND_SYMPTOM,4684
86732,vision,I-SIGN_AND_SYMPTOM,4684
86733,burning,I-SIGN_AND_SYMPTOM,4684
86734,and,I-SIGN_AND_SYMPTOM,4684
86735,stinging,I-SIGN_AND_SYMPTOM,4684
86736,and,I-SIGN_AND_SYMPTOM,4684
86737,were,I-SIGN_AND_SYMPTOM,4684
86738,poorly,I-SIGN_AND_SYMPTOM,4684
86739,tolerated,I-SIGN_AND_SYMPTOM,4684
86740,Additionally,O,4685
86741,these,O,4685
86742,oils,O,4685
86743,provided,O,4685
86744,low,O,4685
86745,bioavailability,O,4685
86746,of,O,4685
86747,cyclosporine,B-NAME_OF_DRUG,4685
86748,A,I-NAME_OF_DRUG,4685
86749,to,O,4685
86750,the,O,4685
86751,ocular,O,4685
86752,targets,O,4685
86753,The,O,4686
86754,limitations,O,4686
86755,of,O,4686
86756,oil-based,O,4686
86757,cyclosporine,B-NAME_OF_DRUG,4686
86758,A,I-NAME_OF_DRUG,4686
86759,formulations,O,4686
86760,lead,O,4686
86761,to,O,4686
86762,a,O,4686
86763,need,O,4686
86764,for,O,4686
86765,cyclosporine,B-NAME_OF_DRUG,4686
86766,A,I-NAME_OF_DRUG,4686
86767,formulations,O,4686
86768,with,O,4686
86769,improved,O,4686
86770,tolerability,O,4686
86771,and,O,4686
86772,bioavailability,O,4686
86773,This,O,4687
86774,review,O,4687
86775,covers,O,4687
86776,the,O,4687
86777,immunopathophysiology,O,4687
86778,of,O,4687
86779,DED,B-NAME_OF_DISEASE,4687
86780,as,O,4687
86781,well,O,4687
86782,as,O,4687
86783,the,O,4687
86784,mechanism,O,4687
86785,of,O,4687
86786,action,O,4687
86787,of,O,4687
86788,cyclosporine,B-NAME_OF_DRUG,4687
86789,A,I-NAME_OF_DRUG,4687
86790,and,O,4687
86791,its,O,4687
86792,role,O,4687
86793,in,O,4687
86794,modulating,O,4687
86795,ocular,O,4687
86796,inflammation,O,4687
86797,compares,O,4687
86798,the,O,4687
86799,current,O,4687
86800,ophthalmic,O,4687
86801,cyclosporine,B-NAME_OF_DRUG,4687
86802,A,I-NAME_OF_DRUG,4687
86803,formulations,O,4687
86804,and,O,4687
86805,discusses,O,4687
86806,the,O,4687
86807,limitations,O,4687
86808,and,O,4687
86809,challenges,O,4687
86810,of,O,4687
86811,using,O,4687
86812,cyclosporine,B-NAME_OF_DRUG,4687
86813,A,I-NAME_OF_DRUG,4687
86814,for,O,4687
86815,the,O,4687
86816,treatment,O,4687
86817,of,O,4687
86818,DED,B-NAME_OF_DISEASE,4687
86819,Since,O,4688
86820,Cyclosporine,B-NAME_OF_DRUG,4688
86821,is,O,4688
86822,a,O,4688
86823,well-established,O,4688
86824,stalwart,O,4688
86825,of,O,4688
86826,long-term,O,4688
86827,management,O,4688
86828,for,O,4688
86829,dry,B-NAME_OF_DISEASE,4688
86830,eye,I-NAME_OF_DISEASE,4688
86831,disease,I-NAME_OF_DISEASE,4688
86832,DED,B-NAME_OF_DISEASE,4688
86833,Ophthalmologists,O,4688
86834,have,O,4688
86835,trusted,O,4688
86836,it,O,4688
86837,for,O,4688
86838,years,O,4688
86839,as,O,4688
86840,an,O,4688
86841,effective,O,4688
86842,immunomodulator,O,4688
86843,that,O,4688
86844,alleviates,O,4688
86845,dry,B-NAME_OF_DISEASE,4688
86846,eye,I-NAME_OF_DISEASE,4688
86847,symptoms,O,4688
86848,without,O,4688
86849,major,O,4688
86850,negative,O,4688
86851,side,O,4688
86852,effects,O,4688
86853,We,O,4689
86854,have,O,4689
86855,several,O,4689
86856,options,O,4689
86857,for,O,4689
86858,cyclosporine,B-NAME_OF_DRUG,4689
86859,Cequa,O,4689
86860,0.09,O,4689
86861,Sun,O,4690
86862,Ophthalmics,O,4690
86863,Restasis,O,4690
86864,0.05,O,4690
86865,Allergan,O,4691
86866,and,O,4691
86867,the,O,4691
86868,compounded,O,4691
86869,Klarity-C,O,4691
86870,Drops,O,4691
86871,0.1,O,4691
86872,Imprimis,O,4692
86873,,O,4692
86874,Several,O,4693
86875,more,O,4693
86876,are,O,4693
86877,in,O,4693
86878,the,O,4693
86879,pipeline,O,4693
86880,including,O,4693
86881,generic,B-NAME_OF_DRUG,4693
86882,Restasis,I-NAME_OF_DRUG,4693
86883,CyclASol,O,4693
86884,0.1,O,4693
86885,Novaliq,O,4694
86886,Ikervis,O,4694
86887,0.1,O,4694
86888,Santen,O,4695
86889,Pharmaceutical,O,4695
86890,and,O,4695
86891,OTX-CSI,O,4695
86892,ophthalmic,O,4695
86893,insert,O,4695
86894,0.3,O,4695
86895,mg,O,4696
86896,Ocular,O,4696
86897,Therapeutix,O,4696
86898,,O,4696
86899,Although,O,4697
86900,the,O,4697
86901,concentrations,O,4697
86902,range,O,4697
86903,from,O,4697
86904,0.05,O,4697
86905,to,O,4698
86906,0.1,O,4698
86907,we,O,4699
86908,have,O,4699
86909,found,O,4699
86910,cyclosporine,B-NAME_OF_DRUG,4699
86911,to,O,4699
86912,be,O,4699
86913,efficacious,O,4699
86914,at,O,4699
86915,all,O,4699
86916,levels,O,4699
86917,with,O,4699
86918,some,O,4699
86919,subtle,O,4699
86920,differences,O,4699
86921,The,O,4700
86922,choice,O,4700
86923,usually,O,4700
86924,comes,O,4700
86925,down,O,4700
86926,to,O,4700
86927,tolerability,O,4700
86928,and,O,4700
86929,affordability,O,4700
86930,As,O,4701
86931,a,O,4701
86932,topical,O,4701
86933,ophthalmic,O,4701
86934,agent,O,4701
86935,cyclosporine,B-NAME_OF_DRUG,4701
86936,poses,O,4701
86937,several,O,4701
86938,challenges,O,4701
86939,Firstly,O,4702
86940,it,O,4702
86941,is,O,4702
86942,a,O,4702
86943,hydrophobic,O,4702
86944,lipophilic,O,4702
86945,molecule,O,4702
86946,so,O,4702
86947,does,O,4702
86948,not,O,4702
86949,easily,O,4702
86950,penetrate,O,4702
86951,the,O,4702
86952,aqueous,O,4702
86953,layer,O,4702
86954,and,O,4702
86955,reach,O,4702
86956,the,O,4702
86957,eye,O,4702
86958,Secondly,O,4703
86959,it,O,4703
86960,can,O,4703
86961,cause,O,4703
86962,burning,B-SIGN_AND_SYMPTOM,4703
86963,or,I-SIGN_AND_SYMPTOM,4703
86964,stinging,I-SIGN_AND_SYMPTOM,4703
86965,on,I-SIGN_AND_SYMPTOM,4703
86966,instillation,I-SIGN_AND_SYMPTOM,4703
86967,As,O,4704
86968,a,O,4704
86969,result,O,4704
86970,manufacturers,O,4704
86971,need,O,4704
86972,to,O,4704
86973,formulate,O,4704
86974,a,O,4704
86975,vehicle,O,4704
86976,that,O,4704
86977,achieves,O,4704
86978,the,O,4704
86979,penetration,O,4704
86980,required,O,4704
86981,for,O,4704
86982,efficacy,O,4704
86983,produces,O,4704
86984,minimal,O,4704
86985,side,O,4704
86986,effects,O,4704
86987,and,O,4704
86988,feels,O,4704
86989,comfortable,O,4704
86990,for,O,4704
86991,chronic,O,4704
86992,use,O,4704
86993,-,O,4704
86994,a,O,4704
86995,notoriously,O,4704
86996,difficult,O,4704
86997,feat,O,4704
86998,The,O,4705
86999,tolerability,O,4705
87000,of,O,4705
87001,different,O,4705
87002,cyclosporine,B-NAME_OF_DRUG,4705
87003,formulations,O,4705
87004,hinges,O,4705
87005,primarily,O,4705
87006,on,O,4705
87007,the,O,4705
87008,vehicle,O,4705
87009,which,O,4705
87010,varies,O,4705
87011,among,O,4705
87012,different,O,4705
87013,products,O,4705
87014,Although,O,4706
87015,we,O,4706
87016,tend,O,4706
87017,to,O,4706
87018,favour,O,4706
87019,products,O,4706
87020,with,O,4706
87021,an,O,4706
87022,established,O,4706
87023,track,O,4706
87024,record,O,4706
87025,of,O,4706
87026,comfort,O,4706
87027,some,O,4706
87028,patients,O,4706
87029,might,O,4706
87030,tolerate,O,4706
87031,one,O,4706
87032,better,O,4706
87033,than,O,4706
87034,another,O,4706
87035,Because,O,4707
87036,we,O,4707
87037,have,O,4707
87038,used,O,4707
87039,Restasis-which,O,4707
87040,has,O,4707
87041,an,O,4707
87042,anionic,O,4707
87043,castor,O,4707
87044,oil-in-water,O,4707
87045,emulsion,O,4707
87046,vehicle1,O,4707
87047,-,O,4707
87048,for,O,4707
87049,many,O,4707
87050,years,O,4707
87051,we,O,4707
87052,know,O,4707
87053,to,O,4707
87054,expect,O,4707
87055,patients,O,4707
87056,to,O,4707
87057,be,O,4707
87058,comfortable,O,4707
87059,with,O,4707
87060,its,O,4707
87061,long-term,O,4707
87062,use,O,4707
87063,As,O,4708
87064,it,O,4708
87065,has,O,4708
87066,been,O,4708
87067,around,O,4708
87068,a,O,4708
87069,long,O,4708
87070,time,O,4708
87071,Restasis,B-NAME_OF_DRUG,4708
87072,is,O,4708
87073,also,O,4708
87074,covered,O,4708
87075,by,O,4708
87076,most,O,4708
87077,insurance,O,4708
87078,plans,O,4708
87079,Our,O,4709
87080,patients,O,4709
87081,have,O,4709
87082,also,O,4709
87083,tolerated,O,4709
87084,Cequa,B-NAME_OF_DRUG,4709
87085,well,O,4709
87086,which,O,4709
87087,has,O,4709
87088,a,O,4709
87089,nanomicelle-based,O,4709
87090,solution,O,4709
87091,Commercial,O,4710
87092,patients,O,4710
87093,can,O,4710
87094,obtain,O,4710
87095,Cequa,B-NAME_OF_DRUG,4710
87096,at,O,4710
87097,its,O,4710
87098,lowest,O,4710
87099,price,O,4710
87100,through,O,4710
87101,a,O,4710
87102,specialty,O,4710
87103,pharmacy,O,4710
87104,so,O,4710
87105,we,O,4710
87106,check,O,4710
87107,with,O,4710
87108,patients,O,4710
87109,in,O,4710
87110,advance,O,4710
87111,to,O,4710
87112,see,O,4710
87113,if,O,4710
87114,that,O,4710
87115,is,O,4710
87116,a,O,4710
87117,convenient,O,4710
87118,arrangement,O,4710
87119,The,O,4711
87120,third,O,4711
87121,current,O,4711
87122,option,O,4711
87123,Klarity-C,B-NAME_OF_DRUG,4711
87124,Drops,I-NAME_OF_DRUG,4711
87125,has,O,4711
87126,a,O,4711
87127,chondroitin,B-CHEMICAL_COMPOUND,4711
87128,sulfate,I-CHEMICAL_COMPOUND,4711
87129,glycerin,B-CHEMICAL_COMPOUND,4711
87130,and,O,4711
87131,dextran-based,O,4711
87132,solution,O,4711
87133,This,O,4712
87134,can,O,4712
87135,be,O,4712
87136,the,O,4712
87137,most,O,4712
87138,cost-effective,O,4712
87139,choice,O,4712
87140,However,O,4713
87141,in,O,4713
87142,our,O,4713
87143,limited,O,4713
87144,experience,O,4713
87145,it,O,4713
87146,also,O,4713
87147,seems,O,4713
87148,to,O,4713
87149,be,O,4713
87150,less,O,4713
87151,well,O,4713
87152,tolerated,O,4713
87153,We,O,4714
87154,use,O,4714
87155,both,O,4714
87156,cyclosporine,B-NAME_OF_DRUG,4714
87157,and,O,4714
87158,lifitegrast,B-NAME_OF_DRUG,4714
87159,Xiidra,I-NAME_OF_DRUG,4714
87160,Novartis,I-NAME_OF_DRUG,4714
87161,as,O,4714
87162,part,O,4714
87163,of,O,4714
87164,long-term,O,4714
87165,management,O,4714
87166,plans,O,4714
87167,With,O,4715
87168,cyclosporine,B-NAME_OF_DRUG,4715
87169,our,O,4715
87170,best,O,4715
87171,candidates,O,4715
87172,have,O,4715
87173,chronic,B-NAME_OF_DISEASE,4715
87174,dry,B-NAME_OF_DISEASE,4715
87175,eye,I-NAME_OF_DISEASE,4715
87176,and,O,4715
87177,possibly,O,4715
87178,wear,O,4715
87179,contact,B-TREATMENT,4715
87180,lenses,I-TREATMENT,4715
87181,so,O,4715
87182,they,O,4715
87183,need,O,4715
87184,long-term,O,4715
87185,relief,O,4715
87186,from,O,4715
87187,inflammation,O,4715
87188,It,O,4716
87189,can,O,4716
87190,take,O,4716
87191,up,B-TIME_DURATION,4716
87192,to,I-TIME_DURATION,4716
87193,3,I-TIME_DURATION,4716
87194,months,I-TIME_DURATION,4716
87195,for,O,4716
87196,cyclosporine,B-NAME_OF_DRUG,4716
87197,to,O,4716
87198,build,O,4716
87199,up,O,4716
87200,the,O,4716
87201,concentration,O,4716
87202,required,O,4716
87203,for,O,4716
87204,full,O,4716
87205,efficacy,O,4716
87206,so,O,4716
87207,we,O,4716
87208,tend,O,4716
87209,to,O,4716
87210,choose,O,4716
87211,it,O,4716
87212,for,O,4716
87213,patients,O,4716
87214,who,O,4716
87215,can,O,4716
87216,patiently,O,4716
87217,await,O,4716
87218,some,O,4716
87219,improvement,O,4716
87220,For,O,4717
87221,more,O,4717
87222,severe,O,4717
87223,cases,O,4717
87224,we,O,4717
87225,also,O,4717
87226,utilise,O,4717
87227,a,O,4717
87228,steroid,B-NAME_OF_DRUG,4717
87229,during,O,4717
87230,the,O,4717
87231,cyclosporine,B-NAME_OF_DRUG,4717
87232,induction,O,4717
87233,period,O,4717
87234,such,O,4717
87235,as,O,4717
87236,loteprednol,O,4717
87237,etabonate,O,4717
87238,ophthalmic,O,4717
87239,suspension,O,4717
87240,0.25,O,4717
87241,Eyesuvis,O,4718
87242,Kala,O,4718
87243,Pharmaceuticals,O,4718
87244,which,O,4718
87245,can,O,4718
87246,be,O,4718
87247,used,O,4718
87248,on-label,O,4718
87249,for,O,4718
87250,short,O,4718
87251,term,O,4718
87252,treatment,O,4718
87253,of,O,4718
87254,dry,B-NAME_OF_DISEASE,4718
87255,eye,I-NAME_OF_DISEASE,4718
87256,In,O,4719
87257,addition,O,4719
87258,our,O,4719
87259,patients,O,4719
87260,who,O,4719
87261,have,O,4719
87262,dry,B-NAME_OF_DISEASE,4719
87263,eye,I-NAME_OF_DISEASE,4719
87264,secondary,O,4719
87265,to,O,4719
87266,autoimmune,O,4719
87267,conditions,O,4719
87268,such,O,4719
87269,as,O,4719
87270,Sjogren,B-NAME_OF_DISEASE,4719
87271,s,I-NAME_OF_DISEASE,4719
87272,syndrome,I-NAME_OF_DISEASE,4719
87273,or,O,4719
87274,rheumatoid,B-NAME_OF_DISEASE,4719
87275,arthritis,I-NAME_OF_DISEASE,4719
87276,tend,O,4719
87277,to,O,4719
87278,respond,O,4719
87279,very,O,4719
87280,well,O,4719
87281,to,O,4719
87282,cyclosporine,B-NAME_OF_DRUG,4719
87283,From,O,4720
87284,a,O,4720
87285,clinical,O,4720
87286,standpoint,O,4720
87287,it,O,4720
87288,has,O,4720
87289,been,O,4720
87290,great,O,4720
87291,to,O,4720
87292,see,O,4720
87293,more,O,4720
87294,options,O,4720
87295,for,O,4720
87296,long-term,O,4720
87297,DED,B-NAME_OF_DISEASE,4720
87298,treatment,O,4720
87299,Whether,O,4721
87300,we,O,4721
87301,prescribe,O,4721
87302,an,B-NAME_OF_DRUG,4721
87303,immunomodulator,I-NAME_OF_DRUG,4721
87304,or,O,4721
87305,optimally,O,4721
87306,offer,O,4721
87307,some,O,4721
87308,combination,O,4721
87309,of,O,4721
87310,therapies,O,4721
87311,the,O,4721
87312,options,O,4721
87313,allow,O,4721
87314,ophthalmologists,O,4721
87315,to,O,4721
87316,tailor,O,4721
87317,effective,O,4721
87318,economical,O,4721
87319,and,O,4721
87320,comfortable,O,4721
87321,care,O,4721
87322,Myopia,B-NAME_OF_DISEASE,4722
87323,or,O,4722
87324,short-sightedness,B-NAME_OF_DISEASE,4722
87325,is,O,4722
87326,one,O,4722
87327,of,O,4722
87328,the,O,4722
87329,most,O,4722
87330,common,O,4722
87331,eye,O,4722
87332,health,O,4722
87333,issues,O,4722
87334,in,O,4722
87335,children,O,4722
87336,and,O,4722
87337,means,O,4722
87338,that,O,4722
87339,they,O,4722
87340,can,B-SIGN_AND_SYMPTOM,4722
87341,t,I-SIGN_AND_SYMPTOM,4722
87342,see,I-SIGN_AND_SYMPTOM,4722
87343,objects,I-SIGN_AND_SYMPTOM,4722
87344,that,I-SIGN_AND_SYMPTOM,4722
87345,are,I-SIGN_AND_SYMPTOM,4722
87346,far,I-SIGN_AND_SYMPTOM,4722
87347,away,I-SIGN_AND_SYMPTOM,4722
87348,causing,O,4722
87349,their,O,4722
87350,vision,B-SIGN_AND_SYMPTOM,4722
87351,to,I-SIGN_AND_SYMPTOM,4722
87352,blur,I-SIGN_AND_SYMPTOM,4722
87353,Symptoms,O,4723
87354,usually,O,4723
87355,appear,O,4723
87356,between,O,4723
87357,the,O,4723
87358,ages,O,4723
87359,of,O,4723
87360,8,O,4723
87361,and,O,4723
87362,12,O,4723
87363,and,O,4723
87364,can,O,4723
87365,get,O,4723
87366,progressively,O,4723
87367,worse,O,4723
87368,over,O,4723
87369,time,O,4723
87370,with,O,4723
87371,most,O,4723
87372,children,O,4723
87373,quickly,O,4723
87374,becoming,O,4723
87375,reliant,O,4723
87376,on,O,4723
87377,glasses,B-TREATMENT,4723
87378,to,O,4723
87379,see,O,4723
87380,clearly,O,4723
87381,into,O,4723
87382,the,O,4723
87383,distance,O,4723
87384,According,O,4724
87385,to,O,4724
87386,a,O,4724
87387,2019,O,4724
87388,study,O,4724
87389,in,O,4724
87390,the,B-PUBLICATION_VENUE,4724
87391,Investigative,I-PUBLICATION_VENUE,4724
87392,Ophthalmology,I-PUBLICATION_VENUE,4724
87393,and,I-PUBLICATION_VENUE,4724
87394,Visual,I-PUBLICATION_VENUE,4724
87395,Sciences,I-PUBLICATION_VENUE,4724
87396,journal,I-PUBLICATION_VENUE,4724
87397,more,O,4724
87398,than,O,4724
87399,32%,O,4724
87400,of,O,4724
87401,the,O,4724
87402,world,O,4724
87403,s,O,4724
87404,population,O,4724
87405,suffers,O,4724
87406,from,O,4724
87407,myopia,B-NAME_OF_DISEASE,4724
87408,with,O,4724
87409,that,O,4724
87410,figure,O,4724
87411,estimated,O,4724
87412,to,O,4724
87413,rise,O,4724
87414,to,O,4724
87415,50%,O,4724
87416,by,O,4724
87417,2050,O,4724
87418,Are,O,4725
87419,you,O,4725
87420,prescribing,O,4725
87421,contact,B-TREATMENT,4725
87422,lenses,I-TREATMENT,4725
87423,for,O,4725
87424,myopia,B-NAME_OF_DISEASE,4725
87425,management,O,4725
87426,We,O,4725
87427,ask,O,4725
87428,this,O,4725
87429,question,O,4725
87430,at,O,4725
87431,the,O,4725
87432,start,O,4725
87433,of,O,4725
87434,every,O,4725
87435,myopia,B-NAME_OF_DISEASE,4725
87436,management,O,4725
87437,lecture,O,4725
87438,we,O,4725
87439,deliver,O,4725
87440,Over,O,4726
87441,the,O,4726
87442,past,O,4726
87443,two,O,4726
87444,years,O,4726
87445,we,O,4726
87446,have,O,4726
87447,gone,O,4726
87448,from,O,4726
87449,having,O,4726
87450,audiences,O,4726
87451,with,O,4726
87452,no,O,4726
87453,hands,O,4726
87454,raised,O,4726
87455,to,O,4726
87456,now,O,4726
87457,having,O,4726
87458,audiences,O,4726
87459,with,O,4726
87460,upwards,O,4726
87461,of,O,4726
87462,20,O,4726
87463,percent,O,4726
87464,of,O,4726
87465,the,O,4726
87466,attendees,O,4726
87467,raising,O,4726
87468,their,O,4726
87469,hands,O,4726
87470,While,O,4727
87471,a,O,4727
87472,number,O,4727
87473,of,O,4727
87474,clinical,O,4727
87475,trials,O,4727
87476,are,O,4727
87477,still,O,4727
87478,ongoing,O,4727
87479,evidence,O,4727
87480,continues,O,4727
87481,to,O,4727
87482,mount,O,4727
87483,regarding,O,4727
87484,the,O,4727
87485,effectiveness,O,4727
87486,and,O,4727
87487,safety,O,4727
87488,of,O,4727
87489,soft,B-TREATMENT,4727
87490,contact,I-TREATMENT,4727
87491,lens,I-TREATMENT,4727
87492,CL,I-TREATMENT,4727
87493,#NAME?,O,4727
87494,myopia,B-NAME_OF_DISEASE,4727
87495,management,O,4727
87496,and,O,4727
87497,because,O,4727
87498,of,O,4727
87499,this,O,4727
87500,we,O,4727
87501,expect,O,4727
87502,the,O,4727
87503,number,O,4727
87504,of,O,4727
87505,eye,O,4727
87506,care,O,4727
87507,providers,O,4727
87508,prescribing,O,4727
87509,myopia,B-NAME_OF_DISEASE,4727
87510,management,O,4727
87511,to,O,4727
87512,increase,O,4727
87513,Myopia,B-NAME_OF_DISEASE,4728
87514,is,O,4728
87515,a,O,4728
87516,complex,O,4728
87517,trait,O,4728
87518,influenced,O,4728
87519,by,O,4728
87520,a,O,4728
87521,number,O,4728
87522,of,O,4728
87523,environmental,B-CAUSE_OF_DISEASE,4728
87524,and,I-CAUSE_OF_DISEASE,4728
87525,genetic,I-CAUSE_OF_DISEASE,4728
87526,factors,I-CAUSE_OF_DISEASE,4728
87527,and,O,4728
87528,the,O,4728
87529,mechanisms,O,4728
87530,underlying,O,4728
87531,onset,O,4728
87532,and,O,4728
87533,progression,O,4728
87534,are,O,4728
87535,not,O,4728
87536,fully,O,4728
87537,understood,O,4728
87538,Although,O,4729
87539,there,O,4729
87540,is,O,4729
87541,a,O,4729
87542,great,O,4729
87543,deal,O,4729
87544,to,O,4729
87545,learn,O,4729
87546,about,O,4729
87547,the,O,4729
87548,mechanisms,O,4729
87549,of,O,4729
87550,myopia,B-NAME_OF_DISEASE,4729
87551,and,O,4729
87552,why,O,4729
87553,individuals,O,4729
87554,respond,O,4729
87555,differently,O,4729
87556,to,O,4729
87557,different,O,4729
87558,stimuli,O,4729
87559,and,O,4729
87560,treatments,O,4729
87561,some,O,4729
87562,behavioral,O,4729
87563,pharmaceutical,O,4729
87564,and,O,4729
87565,optical,O,4729
87566,strategies,O,4729
87567,already,O,4729
87568,show,O,4729
87569,promise,O,4729
87570,in,O,4729
87571,clinical,O,4729
87572,trials,O,4729
87573,in,O,4729
87574,combating,O,4729
87575,myopia-many,O,4729
87576,of,O,4729
87577,which,O,4729
87578,can,O,4729
87579,be,O,4729
87580,incorporated,O,4729
87581,into,O,4729
87582,current,O,4729
87583,day,O,4729
87584,practice,O,4729
87585,Contact,B-TREATMENT,4730
87586,lenses,I-TREATMENT,4730
87587,used,I-TREATMENT,4730
87588,for,I-TREATMENT,4730
87589,myopia,I-TREATMENT,4730
87590,control,I-TREATMENT,4730
87591,can,O,4730
87592,be,O,4730
87593,either,O,4730
87594,bifocal,B-TREATMENT,4730
87595,or,I-TREATMENT,4730
87596,multifocal,I-TREATMENT,4730
87597,soft,I-TREATMENT,4730
87598,contact,I-TREATMENT,4730
87599,lenses,I-TREATMENT,4730
87600,as,O,4730
87601,well,O,4730
87602,as,O,4730
87603,the,B-TREATMENT,4730
87604,rigid,I-TREATMENT,4730
87605,contact,I-TREATMENT,4730
87606,lens,I-TREATMENT,4730
87607,designs,O,4730
87608,used,O,4730
87609,in,O,4730
87610,orthokeratology,B-TREATMENT,4730
87611,Investigators,O,4731
87612,have,O,4731
87613,proposed,O,4731
87614,several,O,4731
87615,mechanisms,O,4731
87616,to,O,4731
87617,explain,O,4731
87618,their,O,4731
87619,myopia,B-NAME_OF_DISEASE,4731
87620,control,O,4731
87621,effect,O,4731
87622,including,O,4731
87623,contact,O,4731
87624,lenses,O,4731
87625,correct,O,4731
87626,or,O,4731
87627,reduce,O,4731
87628,accommodative,O,4731
87629,lag,O,4731
87630,which,O,4731
87631,is,O,4731
87632,considered,O,4731
87633,a,O,4731
87634,stimulus,O,4731
87635,for,O,4731
87636,eye,O,4731
87637,elongation,O,4731
87638,they,O,4731
87639,reduce,O,4731
87640,the,O,4731
87641,peripheral,O,4731
87642,retinal,O,4731
87643,defocus,O,4731
87644,which,O,4731
87645,is,O,4731
87646,considered,O,4731
87647,to,O,4731
87648,increase,O,4731
87649,the,O,4731
87650,risk,O,4731
87651,of,O,4731
87652,eye,O,4731
87653,elongation,O,4731
87654,by,O,4731
87655,shifting,O,4731
87656,the,O,4731
87657,image,O,4731
87658,closer,O,4731
87659,to,O,4731
87660,the,B-PART_OF_THE_EYES,4731
87661,retina,I-PART_OF_THE_EYES,4731
87662,and,O,4731
87663,the,O,4731
87664,lenses,O,4731
87665,impose,O,4731
87666,myopic,O,4731
87667,defocus,O,4731
87668,across,O,4731
87669,areas,O,4731
87670,of,O,4731
87671,the,B-PART_OF_THE_EYES,4731
87672,retina,I-PART_OF_THE_EYES,4731
87673,which,O,4731
87674,is,O,4731
87675,considered,O,4731
87676,to,O,4731
87677,inhibit,O,4731
87678,eye,O,4731
87679,growth,O,4731
87680,Myopia,B-NAME_OF_DISEASE,4732
87681,is,O,4732
87682,a,O,4732
87683,nearly,O,4732
87684,silent,O,4732
87685,public,O,4732
87686,health,O,4732
87687,crisis,O,4732
87688,growing,O,4732
87689,in,O,4732
87690,prevalence,O,4732
87691,worldwide,O,4732
87692,year,O,4732
87693,upon,O,4732
87694,year,O,4732
87695,Preventing,O,4733
87696,high,B-NAME_OF_DISEASE,4733
87697,myopia,I-NAME_OF_DISEASE,4733
87698,with,O,4733
87699,myopia,B-NAME_OF_DISEASE,4733
87700,management,O,4733
87701,is,O,4733
87702,becoming,O,4733
87703,the,O,4733
87704,standard,O,4733
87705,of,O,4733
87706,care,O,4733
87707,for,O,4733
87708,children,O,4733
87709,and,O,4733
87710,adolescents,O,4733
87711,discovered,O,4733
87712,to,O,4733
87713,have,O,4733
87714,myopia,B-NAME_OF_DISEASE,4733
87715,Center-distance,B-TREATMENT,4734
87716,MF,I-TREATMENT,4734
87717,contact,I-TREATMENT,4734
87718,lenses,I-TREATMENT,4734
87719,including,O,4734
87720,soft,B-TREATMENT,4734
87721,lenses,I-TREATMENT,4734
87722,and,O,4734
87723,GP,B-TREATMENT,4734
87724,lenses,I-TREATMENT,4734
87725,can,O,4734
87726,provide,O,4734
87727,myopia,B-NAME_OF_DISEASE,4734
87728,control,O,4734
87729,in,O,4734
87730,children,O,4734
87731,Similar,O,4735
87732,to,O,4735
87733,daily,B-TREATMENT,4735
87734,wear,I-TREATMENT,4735
87735,contact,I-TREATMENT,4735
87736,lenses,I-TREATMENT,4735
87737,ortho-k,B-TREATMENT,4735
87738,lenses,I-TREATMENT,4735
87739,are,O,4735
87740,also,O,4735
87741,capable,O,4735
87742,of,O,4735
87743,generating,O,4735
87744,the,O,4735
87745,retinal,O,4735
87746,defocus,O,4735
87747,stimulus,O,4735
87748,that,O,4735
87749,retards,O,4735
87750,myopia,B-NAME_OF_DISEASE,4735
87751,progression,O,4735
87752,Atropine,B-NAME_OF_DRUG,4736
87753,by,O,4736
87754,itself,O,4736
87755,or,O,4736
87756,potentially,O,4736
87757,in,O,4736
87758,combination,O,4736
87759,with,O,4736
87760,myopia,B-TREATMENT,4736
87761,control,I-TREATMENT,4736
87762,contact,I-TREATMENT,4736
87763,lenses,I-TREATMENT,4736
87764,may,O,4736
87765,also,O,4736
87766,be,O,4736
87767,efficacious,O,4736
87768,With,O,4737
87769,so,O,4737
87770,many,O,4737
87771,options,O,4737
87772,already,O,4737
87773,available,O,4737
87774,and,O,4737
87775,more,O,4737
87776,forthcoming,O,4737
87777,it,O,4737
87778,is,O,4737
87779,incumbent,O,4737
87780,upon,O,4737
87781,eyecare,O,4737
87782,practitioners,O,4737
87783,to,O,4737
87784,offer,O,4737
87785,these,O,4737
87786,treatment,O,4737
87787,options,O,4737
87788,to,O,4737
87789,children,O,4737
87790,whom,O,4737
87791,they,O,4737
87792,have,O,4737
87793,diagnosed,O,4737
87794,with,O,4737
87795,myopia,B-NAME_OF_DISEASE,4737
87796,Doing,O,4738
87797,so,O,4738
87798,is,O,4738
87799,likely,O,4738
87800,to,O,4738
87801,improve,O,4738
87802,their,O,4738
87803,quality,O,4738
87804,of,O,4738
87805,life,O,4738
87806,and,O,4738
87807,also,O,4738
87808,decreases,O,4738
87809,their,O,4738
87810,likelihood,O,4738
87811,of,O,4738
87812,developing,O,4738
87813,detrimental,O,4738
87814,visual,O,4738
87815,complications,O,4738
87816,decades,O,4738
87817,in,O,4738
87818,advance,O,4738
87819,Myopia,B-NAME_OF_DISEASE,4739
87820,is,O,4739
87821,the,O,4739
87822,most,O,4739
87823,common,O,4739
87824,refractive,B-NAME_OF_DISEASE,4739
87825,error,I-NAME_OF_DISEASE,4739
87826,affecting,O,4739
87827,30%,O,4739
87828,of,O,4739
87829,adolescents,O,4739
87830,and,O,4739
87831,young,O,4739
87832,adults,O,4739
87833,worldwide,O,4739
87834,between,O,4739
87835,2000,O,4739
87836,and,O,4739
87837,2050,O,4739
87838,myopia,B-NAME_OF_DISEASE,4739
87839,s,O,4739
87840,worldwide,O,4739
87841,prevalence,O,4739
87842,is,O,4739
87843,projected,O,4739
87844,to,O,4739
87845,increase,O,4739
87846,from,O,4739
87847,23%,O,4739
87848,to,O,4739
87849,54%,O,4739
87850,The,O,4740
87851,prevalence,O,4740
87852,of,O,4740
87853,high,B-NAME_OF_DISEASE,4740
87854,myopia,I-NAME_OF_DISEASE,4740
87855,is,O,4740
87856,expected,O,4740
87857,to,O,4740
87858,increase,O,4740
87859,from,O,4740
87860,3%,O,4740
87861,to,O,4740
87862,10%,O,4740
87863,Higher,O,4741
87864,increases,O,4741
87865,in,O,4741
87866,prevalence,O,4741
87867,are,O,4741
87868,found,O,4741
87869,among,O,4741
87870,East,O,4741
87871,Asian,O,4741
87872,populations,O,4741
87873,Myopia,B-NAME_OF_DISEASE,4742
87874,is,O,4742
87875,an,O,4742
87876,abnormal,O,4742
87877,process,O,4742
87878,that,O,4742
87879,disrupts,O,4742
87880,emmetropization,O,4742
87881,Longer,O,4743
87882,axial,O,4743
87883,length,O,4743
87884,in,O,4743
87885,myopic,O,4743
87886,eyes,O,4743
87887,especially,O,4743
87888,in,O,4743
87889,high,O,4743
87890,myopes,O,4743
87891,-6,O,4743
87892,or,O,4744
87893,greater,O,4744
87894,or,O,4744
87895,axial,O,4744
87896,length,O,4744
87897,of,O,4744
87898,26mm,O,4744
87899,or,O,4744
87900,greater,O,4744
87901,increases,O,4744
87902,the,O,4744
87903,risk,O,4744
87904,for,O,4744
87905,developing,O,4744
87906,sight-threatening,O,4744
87907,complications,O,4744
87908,such,O,4744
87909,as,O,4744
87910,chorioretinal,B-NAME_OF_DISEASE,4744
87911,atrophy,I-NAME_OF_DISEASE,4744
87912,foveoschisis,B-NAME_OF_DISEASE,4744
87913,rhegmatogenous,B-NAME_OF_DISEASE,4744
87914,retinal,I-NAME_OF_DISEASE,4744
87915,detachment,I-NAME_OF_DISEASE,4744
87916,myopic,B-NAME_OF_DISEASE,4744
87917,maculopathy,I-NAME_OF_DISEASE,4744
87918,glaucoma,B-NAME_OF_DISEASE,4744
87919,and,O,4744
87920,cataract,B-NAME_OF_DISEASE,4744
87921,Progressive,O,4745
87922,myopia,B-NAME_OF_DISEASE,4745
87923,is,O,4745
87924,a,O,4745
87925,serious,O,4745
87926,ocular,O,4745
87927,condition,O,4745
87928,and,O,4745
87929,the,O,4745
87930,younger,O,4745
87931,that,O,4745
87932,children,O,4745
87933,are,O,4745
87934,when,O,4745
87935,diagnosed,O,4745
87936,with,O,4745
87937,myopia,B-NAME_OF_DISEASE,4745
87938,the,O,4745
87939,greater,O,4745
87940,the,O,4745
87941,risk,O,4745
87942,they,O,4745
87943,have,O,4745
87944,for,O,4745
87945,developing,O,4745
87946,high,B-NAME_OF_DISEASE,4745
87947,myopia,I-NAME_OF_DISEASE,4745
87948,The,O,4746
87949,burden,O,4746
87950,associated,O,4746
87951,with,O,4746
87952,visual,B-NAME_OF_DISEASE,4746
87953,impairment,I-NAME_OF_DISEASE,4746
87954,from,O,4746
87955,myopia,B-NAME_OF_DISEASE,4746
87956,complications,O,4746
87957,elevates,O,4746
87958,the,O,4746
87959,need,O,4746
87960,to,O,4746
87961,implement,O,4746
87962,myopia,B-NAME_OF_DISEASE,4746
87963,management,O,4746
87964,strategies,O,4746
87965,as,O,4746
87966,soon,O,4746
87967,as,O,4746
87968,possible,O,4746
87969,in,O,4746
87970,children,O,4746
87971,Typical,O,4747
87972,myopia,B-NAME_OF_DISEASE,4747
87973,control,O,4747
87974,strategies,O,4747
87975,include,O,4747
87976,contact,B-TREATMENT,4747
87977,lens,I-TREATMENT,4747
87978,options,O,4747
87979,such,O,4747
87980,as,O,4747
87981,soft,B-TREATMENT,4747
87982,multifocal,I-TREATMENT,4747
87983,MF,I-TREATMENT,4747
87984,lenses,I-TREATMENT,4747
87985,and,O,4747
87986,orthokeratology,B-TREATMENT,4747
87987,ortho-k,I-TREATMENT,4747
87988,and,O,4747
87989,low-dose,B-NAME_OF_DRUG,4747
87990,atropine,I-NAME_OF_DRUG,4747
87991,The,O,4748
87992,following,O,4748
87993,discussion,O,4748
87994,focuses,O,4748
87995,on,O,4748
87996,contact,B-TREATMENT,4748
87997,lens,I-TREATMENT,4748
87998,options,O,4748
87999,including,O,4748
88000,specialty,O,4748
88001,lens,O,4748
88002,options,O,4748
88003,for,O,4748
88004,myopia,B-NAME_OF_DISEASE,4748
88005,control,O,4748
88006,how,O,4748
88007,to,O,4748
88008,fit,O,4748
88009,these,O,4748
88010,lenses,O,4748
88011,and,O,4748
88012,follow-up,O,4748
88013,care,O,4748
88014,CONTACT,B-TREATMENT,4749
88015,LENS,I-TREATMENT,4749
88016,OPTIONS,O,4749
88017,FOR,O,4749
88018,MYOPIA,B-NAME_OF_DISEASE,4749
88019,CONTROL,O,4749
88020,Focusing,B-TREATMENT,4749
88021,light,I-TREATMENT,4749
88022,in,I-TREATMENT,4749
88023,front,I-TREATMENT,4749
88024,of,I-TREATMENT,4749
88025,the,I-TREATMENT,4749
88026,retina,I-TREATMENT,4749
88027,effectively,O,4749
88028,retards,O,4749
88029,axial,O,4749
88030,length,O,4749
88031,growth,O,4749
88032,in,O,4749
88033,humans,O,4749
88034,Contact,B-TREATMENT,4750
88035,lenses,I-TREATMENT,4750
88036,for,I-TREATMENT,4750
88037,myopia,I-TREATMENT,4750
88038,control,I-TREATMENT,4750
88039,function,O,4750
88040,by,O,4750
88041,simultaneously,O,4750
88042,focusing,B-TREATMENT,4750
88043,light,I-TREATMENT,4750
88044,onto-and,I-TREATMENT,4750
88045,in,I-TREATMENT,4750
88046,front,I-TREATMENT,4750
88047,of-the,I-TREATMENT,4750
88048,retina,I-TREATMENT,4750
88049,This,O,4751
88050,provides,O,4751
88051,acute,O,4751
88052,vision,O,4751
88053,for,O,4751
88054,daily,O,4751
88055,activities,O,4751
88056,and,O,4751
88057,also,O,4751
88058,a,O,4751
88059,defocus,O,4751
88060,stimulus,O,4751
88061,that,O,4751
88062,slows,O,4751
88063,axial,O,4751
88064,length,O,4751
88065,growth,O,4751
88066,Reducing,O,4752
88067,myopia,B-NAME_OF_DISEASE,4752
88068,progression,O,4752
88069,by,O,4752
88070,at,O,4752
88071,least,O,4752
88072,40%,O,4752
88073,is,O,4752
88074,considered,O,4752
88075,clinically,O,4752
88076,meaningful,O,4752
88077,On,O,4753
88078,average,O,4753
88079,soft,B-TREATMENT,4753
88080,MF,I-TREATMENT,4753
88081,contact,I-TREATMENT,4753
88082,lenses,I-TREATMENT,4753
88083,with,I-TREATMENT,4753
88084,center-distance-design,I-TREATMENT,4753
88085,optics,I-TREATMENT,4753
88086,slow,O,4753
88087,myopia,B-NAME_OF_DISEASE,4753
88088,progression,O,4753
88089,by,O,4753
88090,46%,O,4753
88091,Corneal,B-TREATMENT,4754
88092,reshaping,I-TREATMENT,4754
88093,with,I-TREATMENT,4754
88094,ortho-k,B-TREATMENT,4754
88095,lenses,I-TREATMENT,4754
88096,likely,O,4754
88097,employs,O,4754
88098,the,O,4754
88099,same,O,4754
88100,mechanism,O,4754
88101,for,O,4754
88102,slowing,O,4754
88103,myopia,B-NAME_OF_DISEASE,4754
88104,progression,O,4754
88105,As,O,4755
88106,an,O,4755
88107,alternative,O,4755
88108,to,O,4755
88109,typical,O,4755
88110,soft,B-TREATMENT,4755
88111,MF,I-TREATMENT,4755
88112,and,O,4755
88113,ortho-k,B-TREATMENT,4755
88114,designs,O,4755
88115,daytime-wear,B-TREATMENT,4755
88116,GP,I-TREATMENT,4755
88117,MF,I-TREATMENT,4755
88118,options,I-TREATMENT,4755
88119,such,I-TREATMENT,4755
88120,as,I-TREATMENT,4755
88121,corneal,I-TREATMENT,4755
88122,and,I-TREATMENT,4755
88123,scleral,I-TREATMENT,4755
88124,GP,I-TREATMENT,4755
88125,MF,I-TREATMENT,4755
88126,and,I-TREATMENT,4755
88127,hybrid,I-TREATMENT,4755
88128,lenses,I-TREATMENT,4755
88129,may,O,4755
88130,be,O,4755
88131,prescribed,O,4755
88132,for,O,4755
88133,myopia,B-NAME_OF_DISEASE,4755
88134,management,O,4755
88135,These,O,4756
88136,alternative,O,4756
88137,lens,O,4756
88138,options,O,4756
88139,may,O,4756
88140,best,O,4756
88141,suit,O,4756
88142,higher,O,4756
88143,amounts,O,4756
88144,of,O,4756
88145,refractive,B-NAME_OF_DISEASE,4756
88146,error,I-NAME_OF_DISEASE,4756
88147,and,O,4756
88148,astigmatism,B-NAME_OF_DISEASE,4756
88149,WHEN,O,4757
88150,AND,O,4757
88151,WHOM,O,4757
88152,TO,O,4757
88153,START,O,4757
88154,FITTING,O,4757
88155,Two,O,4757
88156,crucial,O,4757
88157,questions,O,4757
88158,to,O,4757
88159,consider,O,4757
88160,are,O,4757
88161,the,O,4757
88162,timing,O,4757
88163,of,O,4757
88164,myopia,B-NAME_OF_DISEASE,4757
88165,management,O,4757
88166,implementation,O,4757
88167,and,O,4757
88168,which,O,4757
88169,children,O,4757
88170,to,O,4757
88171,treat,O,4757
88172,Indeed,O,4758
88173,age,O,4758
88174,is,O,4758
88175,the,O,4758
88176,most,O,4758
88177,critical,O,4758
88178,factor,O,4758
88179,that,O,4758
88180,influences,O,4758
88181,myopia,B-NAME_OF_DISEASE,4758
88182,progression,O,4758
88183,The,O,4759
88184,younger,O,4759
88185,that,O,4759
88186,children,O,4759
88187,become,O,4759
88188,myopic,O,4759
88189,the,O,4759
88190,faster,O,4759
88191,myopia,B-NAME_OF_DISEASE,4759
88192,progresses,O,4759
88193,thereby,O,4759
88194,increasing,O,4759
88195,the,O,4759
88196,likelihood,O,4759
88197,of,O,4759
88198,developing,O,4759
88199,high,B-NAME_OF_DISEASE,4759
88200,myopia,I-NAME_OF_DISEASE,4759
88201,For,O,4760
88202,example,O,4760
88203,in,O,4760
88204,the,B-NAME_OF_STUDY,4760
88205,Correction,I-NAME_OF_STUDY,4760
88206,of,I-NAME_OF_STUDY,4760
88207,Myopia,I-NAME_OF_STUDY,4760
88208,Evaluation,I-NAME_OF_STUDY,4760
88209,Trial,I-NAME_OF_STUDY,4760
88210,COMET,I-NAME_OF_STUDY,4760
88211,study,I-NAME_OF_STUDY,4760
88212,children,O,4760
88213,6,O,4760
88214,or,O,4760
88215,7,O,4760
88216,years,O,4760
88217,old,O,4760
88218,progressed,O,4760
88219,twice,O,4760
88220,as,O,4760
88221,fast,O,4760
88222,as,O,4760
88223,the,O,4760
88224,children,O,4760
88225,who,O,4760
88226,were,O,4760
88227,11,O,4760
88228,years,O,4760
88229,of,O,4760
88230,age,O,4760
88231,Children,O,4761
88232,from,O,4761
88233,East,O,4761
88234,Asian,O,4761
88235,countries,O,4761
88236,experience,O,4761
88237,a,O,4761
88238,higher,O,4761
88239,rate,O,4761
88240,of,O,4761
88241,myopia,B-NAME_OF_DISEASE,4761
88242,progression,O,4761
88243,compared,O,4761
88244,to,O,4761
88245,Western,O,4761
88246,children,O,4761
88247,However,O,4762
88248,it,O,4762
88249,is,O,4762
88250,less,O,4762
88251,clear,O,4762
88252,whether,O,4762
88253,children,O,4762
88254,of,O,4762
88255,Asian,O,4762
88256,descent,O,4762
88257,in,O,4762
88258,North,B-GPE,4762
88259,America,I-GPE,4762
88260,progress,O,4762
88261,faster,O,4762
88262,compared,O,4762
88263,to,O,4762
88264,their,O,4762
88265,non-Asian,O,4762
88266,counterparts,O,4762
88267,For,O,4763
88268,example,O,4763
88269,the,B-NAME_OF_STUDY,4763
88270,COMET,I-NAME_OF_STUDY,4763
88271,study,I-NAME_OF_STUDY,4763
88272,reported,O,4763
88273,that,O,4763
88274,Asian-American,O,4763
88275,children,O,4763
88276,progressed,O,4763
88277,faster,O,4763
88278,compared,O,4763
88279,to,O,4763
88280,African-American,O,4763
88281,children,O,4763
88282,but,O,4763
88283,no,O,4763
88284,faster,O,4763
88285,than,O,4763
88286,Hispanic,O,4763
88287,and,O,4763
88288,Caucasian,O,4763
88289,children,O,4763
88290,In,O,4764
88291,contrast,O,4764
88292,another,O,4764
88293,study,O,4764
88294,by,O,4764
88295,Cheng,B-PERSON,4764
88296,et,O,4764
88297,al,O,4764
88298,demonstrated,O,4764
88299,an,O,4764
88300,increased,O,4764
88301,rate,O,4764
88302,of,O,4764
88303,axial,O,4764
88304,length,O,4764
88305,progression,O,4764
88306,in,O,4764
88307,Asian-American,O,4764
88308,children,O,4764
88309,consistent,O,4764
88310,with,O,4764
88311,East,O,4764
88312,Asian,O,4764
88313,counterparts,O,4764
88314,Given,O,4765
88315,the,O,4765
88316,available,O,4765
88317,evidence,O,4765
88318,there,O,4765
88319,is,O,4765
88320,a,O,4765
88321,rationale,O,4765
88322,for,O,4765
88323,preferentially,O,4765
88324,initiating,O,4765
88325,myopia,B-NAME_OF_DISEASE,4765
88326,control,O,4765
88327,in,O,4765
88328,ethnically,O,4765
88329,Asian,O,4765
88330,children,O,4765
88331,Parental,B-CAUSE_OF_DISEASE,4766
88332,history,I-CAUSE_OF_DISEASE,4766
88333,of,O,4766
88334,myopia,B-NAME_OF_DISEASE,4766
88335,is,O,4766
88336,also,O,4766
88337,a,O,4766
88338,factor,O,4766
88339,when,O,4766
88340,potentially,O,4766
88341,initiating,O,4766
88342,myopia,B-NAME_OF_DISEASE,4766
88343,control,O,4766
88344,Children,O,4767
88345,of,O,4767
88346,myopic,O,4767
88347,parents,O,4767
88348,are,O,4767
88349,at,O,4767
88350,increased,O,4767
88351,risk,O,4767
88352,of,O,4767
88353,developing,O,4767
88354,myopia,B-NAME_OF_DISEASE,4767
88355,Priority,O,4768
88356,for,O,4768
88357,initiating,O,4768
88358,myopia,B-NAME_OF_DISEASE,4768
88359,management,O,4768
88360,strategies,O,4768
88361,including,O,4768
88362,fitting,O,4768
88363,contact,B-TREATMENT,4768
88364,lenses,I-TREATMENT,4768
88365,for,I-TREATMENT,4768
88366,myopia,I-TREATMENT,4768
88367,control,I-TREATMENT,4768
88368,should,O,4768
88369,be,O,4768
88370,given,O,4768
88371,to,O,4768
88372,children,O,4768
88373,who,O,4768
88374,are,O,4768
88375,young,O,4768
88376,of,O,4768
88377,Asian,O,4768
88378,background,O,4768
88379,and,O,4768
88380,or,O,4768
88381,who,O,4768
88382,have,O,4768
88383,a,O,4768
88384,history,O,4768
88385,of,O,4768
88386,parental,O,4768
88387,myopia,B-NAME_OF_DISEASE,4768
88388,As,O,4769
88389,nearly,O,4769
88390,all,O,4769
88391,young,O,4769
88392,myopes,O,4769
88393,progress,O,4769
88394,myopia,B-NAME_OF_DISEASE,4769
88395,management,O,4769
88396,strategies,O,4769
88397,should,O,4769
88398,be,O,4769
88399,offered,O,4769
88400,to,O,4769
88401,myopic,O,4769
88402,school-aged,O,4769
88403,children,O,4769
88404,While,O,4770
88405,low-to-moderate,O,4770
88406,amounts,O,4770
88407,of,O,4770
88408,myopia,B-NAME_OF_DISEASE,4770
88409,in,O,4770
88410,children,O,4770
88411,are,O,4770
88412,well,O,4770
88413,understood,O,4770
88414,there,O,4770
88415,is,O,4770
88416,minimal,O,4770
88417,research,O,4770
88418,on,O,4770
88419,more,O,4770
88420,severe,O,4770
88421,pathological,O,4770
88422,early-onset,O,4770
88423,high,B-NAME_OF_DISEASE,4770
88424,myopia,I-NAME_OF_DISEASE,4770
88425,Young,O,4771
88426,children,O,4771
88427,usually,O,4771
88428,are,O,4771
88429,hyperopic,O,4771
88430,If,O,4772
88431,myopia,B-NAME_OF_DISEASE,4772
88432,onsets,O,4772
88433,earlier,O,4772
88434,than,O,4772
88435,5,O,4772
88436,years,O,4772
88437,of,O,4772
88438,age,O,4772
88439,consider,O,4772
88440,further,O,4772
88441,evaluation,O,4772
88442,including,O,4772
88443,genetic,B-DIAGNOSTIC_TEST,4772
88444,testing,I-DIAGNOSTIC_TEST,4772
88445,Early,O,4773
88446,myopia,B-NAME_OF_DISEASE,4773
88447,may,O,4773
88448,be,O,4773
88449,associated,O,4773
88450,with,O,4773
88451,systemic,O,4773
88452,conditions,O,4773
88453,such,O,4773
88454,as,O,4773
88455,Marfan,B-NAME_OF_DISEASE,4773
88456,syndrome,I-NAME_OF_DISEASE,4773
88457,or,O,4773
88458,Stickler,B-NAME_OF_DISEASE,4773
88459,syndrome,I-NAME_OF_DISEASE,4773
88460,Myopia,B-NAME_OF_DISEASE,4774
88461,control,O,4774
88462,strategies,O,4774
88463,can,O,4774
88464,be,O,4774
88465,offered,O,4774
88466,to,O,4774
88467,those,O,4774
88468,who,O,4774
88469,have,O,4774
88470,early-onset,O,4774
88471,high,B-NAME_OF_DISEASE,4774
88472,myopia,I-NAME_OF_DISEASE,4774
88473,However,O,4775
88474,the,O,4775
88475,parents,O,4775
88476,must,O,4775
88477,be,O,4775
88478,educated,O,4775
88479,that,O,4775
88480,their,O,4775
88481,child,O,4775
88482,s,O,4775
88483,response,O,4775
88484,to,O,4775
88485,treatment,O,4775
88486,may,O,4775
88487,not,O,4775
88488,be,O,4775
88489,as,O,4775
88490,effective,O,4775
88491,FITTING,O,4776
88492,SOFT,B-TREATMENT,4776
88493,LENSES,I-TREATMENT,4776
88494,All,O,4776
88495,soft,B-TREATMENT,4776
88496,MF,I-TREATMENT,4776
88497,lenses,I-TREATMENT,4776
88498,validated,O,4776
88499,for,O,4776
88500,myopia,B-NAME_OF_DISEASE,4776
88501,control,O,4776
88502,are,O,4776
88503,center,O,4776
88504,distance,O,4776
88505,in,O,4776
88506,design,O,4776
88507,Originally,O,4777
88508,prescribed,O,4777
88509,for,O,4777
88510,presbyopia,B-NAME_OF_DISEASE,4777
88511,both,O,4777
88512,aspheric,B-TREATMENT,4777
88513,and,I-TREATMENT,4777
88514,concentric-ring-design,B-TREATMENT,4777
88515,MF,I-TREATMENT,4777
88516,lenses,I-TREATMENT,4777
88517,can,O,4777
88518,be,O,4777
88519,prescribed,O,4777
88520,with,O,4777
88521,center-distance,B-TREATMENT,4777
88522,optics,I-TREATMENT,4777
88523,for,I-TREATMENT,4777
88524,myopia,I-TREATMENT,4777
88525,control,I-TREATMENT,4777
88526,Standard,B-TREATMENT,4778
88527,aspheric,I-TREATMENT,4778
88528,center-distance,I-TREATMENT,4778
88529,MF,I-TREATMENT,4778
88530,lenses,I-TREATMENT,4778
88531,consist,O,4778
88532,of,O,4778
88533,a,O,4778
88534,central,O,4778
88535,distance,O,4778
88536,zone,O,4778
88537,that,O,4778
88538,gradually,O,4778
88539,transitions,O,4778
88540,into,O,4778
88541,an,O,4778
88542,intermediary,O,4778
88543,add,O,4778
88544,power,O,4778
88545,before,O,4778
88546,extending,O,4778
88547,into,O,4778
88548,the,O,4778
88549,full,O,4778
88550,near,O,4778
88551,add,O,4778
88552,power,O,4778
88553,at,O,4778
88554,the,O,4778
88555,end,O,4778
88556,of,O,4778
88557,the,O,4778
88558,optic,O,4778
88559,zone,O,4778
88560,In,O,4779
88561,contrast,O,4779
88562,concentric-ring-design,B-TREATMENT,4779
88563,MF,I-TREATMENT,4779
88564,lenses,I-TREATMENT,4779
88565,have,O,4779
88566,a,O,4779
88567,central,O,4779
88568,distance,O,4779
88569,zone,O,4779
88570,surrounded,O,4779
88571,by,O,4779
88572,alternating,O,4779
88573,rings,O,4779
88574,of,O,4779
88575,near,O,4779
88576,and,O,4779
88577,distance,O,4779
88578,power,O,4779
88579,that,O,4779
88580,extend,O,4779
88581,throughout,O,4779
88582,the,O,4779
88583,remainder,O,4779
88584,of,O,4779
88585,the,O,4779
88586,optic,O,4779
88587,zone,O,4779
88588,Interestingly,O,4780
88589,the,B-TREATMENT,4780
88590,concentric-ring,I-TREATMENT,4780
88591,MF,I-TREATMENT,4780
88592,potentially,O,4780
88593,creates,O,4780
88594,optics,O,4780
88595,that,O,4780
88596,equally,O,4780
88597,balance,O,4780
88598,between,O,4780
88599,distance,O,4780
88600,and,O,4780
88601,near,O,4780
88602,correction,O,4780
88603,with,O,4780
88604,varying,O,4780
88605,pupil,B-PART_OF_THE_EYES,4780
88606,size,O,4780
88607,The,O,4781
88608,only,O,4781
88609,U.S,O,4781
88610,Food,B-ORGANIZATION,4782
88611,and,I-ORGANIZATION,4782
88612,Drug,I-ORGANIZATION,4782
88613,Administration,I-ORGANIZATION,4782
88614,FDA,B-ORGANIZATION,4782
88615,#NAME?,O,4782
88616,contact,B-TREATMENT,4782
88617,lens,I-TREATMENT,4782
88618,indicated,O,4782
88619,to,O,4782
88620,slow,O,4782
88621,the,O,4782
88622,progression,O,4782
88623,of,O,4782
88624,nearsightedness,B-NAME_OF_DISEASE,4782
88625,is,O,4782
88626,based,O,4782
88627,on,O,4782
88628,concentric-ring-design,B-TREATMENT,4782
88629,MF,I-TREATMENT,4782
88630,optics,I-TREATMENT,4782
88631,All,B-TREATMENT,4783
88632,other,I-TREATMENT,4783
88633,lens,I-TREATMENT,4783
88634,designs,I-TREATMENT,4783
88635,that,I-TREATMENT,4783
88636,create,I-TREATMENT,4783
88637,simultaneous,I-TREATMENT,4783
88638,center-distance,I-TREATMENT,4783
88639,MF,I-TREATMENT,4783
88640,optics,I-TREATMENT,4783
88641,may,O,4783
88642,be,O,4783
88643,prescribed,O,4783
88644,for,O,4783
88645,retarding,O,4783
88646,myopia,B-NAME_OF_DISEASE,4783
88647,progression,O,4783
88648,however,O,4783
88649,this,O,4783
88650,is,O,4783
88651,considered,O,4783
88652,an,O,4783
88653,off-label,O,4783
88654,use,O,4783
88655,in,O,4783
88656,the,B-GPE,4783
88657,United,I-GPE,4783
88658,States,I-GPE,4783
88659,As,O,4784
88660,the,O,4784
88661,goal,O,4784
88662,is,O,4784
88663,to,O,4784
88664,decrease,O,4784
88665,the,O,4784
88666,progression,O,4784
88667,of,O,4784
88668,myopia,B-NAME_OF_DISEASE,4784
88669,prescribing,O,4784
88670,soft,B-TREATMENT,4784
88671,MF,I-TREATMENT,4784
88672,contact,I-TREATMENT,4784
88673,lenses,I-TREATMENT,4784
88674,in,O,4784
88675,children,O,4784
88676,is,O,4784
88677,different,O,4784
88678,from,O,4784
88679,prescribing,O,4784
88680,them,O,4784
88681,to,O,4784
88682,presbyopes,O,4784
88683,In,O,4785
88684,addition,O,4785
88685,to,O,4785
88686,the,O,4785
88687,axial,O,4785
88688,length,O,4785
88689,and,O,4785
88690,refractive,B-NAME_OF_DISEASE,4785
88691,error,I-NAME_OF_DISEASE,4785
88692,other,O,4785
88693,factors,O,4785
88694,such,O,4785
88695,as,O,4785
88696,the,O,4785
88697,add,O,4785
88698,power,O,4785
88699,and,O,4785
88700,pupil,B-PART_OF_THE_EYES,4785
88701,size,O,4785
88702,need,O,4785
88703,to,O,4785
88704,be,O,4785
88705,considered,O,4785
88706,for,O,4785
88707,prescribing,O,4785
88708,lenses,O,4785
88709,that,O,4785
88710,create,O,4785
88711,effective,O,4785
88712,myopia,B-NAME_OF_DISEASE,4785
88713,control,O,4785
88714,Myopia,B-NAME_OF_DISEASE,4786
88715,control,O,4786
88716,with,O,4786
88717,soft,B-TREATMENT,4786
88718,MF,I-TREATMENT,4786
88719,contact,I-TREATMENT,4786
88720,lenses,I-TREATMENT,4786
88721,depends,O,4786
88722,on,O,4786
88723,focusing,O,4786
88724,some,O,4786
88725,light,O,4786
88726,in,O,4786
88727,front,O,4786
88728,of,O,4786
88729,the,B-PART_OF_THE_EYES,4786
88730,retina,I-PART_OF_THE_EYES,4786
88731,this,O,4786
88732,slows,O,4786
88733,growth,O,4786
88734,in,O,4786
88735,axial,O,4786
88736,length,O,4786
88737,thereby,O,4786
88738,retarding,O,4786
88739,myopia,B-NAME_OF_DISEASE,4786
88740,progression,O,4786
88741,Clinically,O,4787
88742,it,O,4787
88743,makes,O,4787
88744,sense,O,4787
88745,to,O,4787
88746,infer,O,4787
88747,that,O,4787
88748,higher,O,4787
88749,add,O,4787
88750,powers,O,4787
88751,may,O,4787
88752,provide,O,4787
88753,better,O,4787
88754,myopia,B-NAME_OF_DISEASE,4787
88755,control,O,4787
88756,because,O,4787
88757,they,O,4787
88758,can,O,4787
88759,focus,O,4787
88760,light,O,4787
88761,further,O,4787
88762,in,O,4787
88763,front,O,4787
88764,of,O,4787
88765,the,B-PART_OF_THE_EYES,4787
88766,retina,I-PART_OF_THE_EYES,4787
88767,compared,O,4787
88768,to,O,4787
88769,lower,O,4787
88770,add,O,4787
88771,powers,O,4787
88772,To,O,4788
88773,examine,O,4788
88774,this,O,4788
88775,hypothesis,O,4788
88776,the,B-NAME_OF_STUDY,4788
88777,Bifocal,I-NAME_OF_STUDY,4788
88778,Lenses,I-NAME_OF_STUDY,4788
88779,In,I-NAME_OF_STUDY,4788
88780,Nearsighted,I-NAME_OF_STUDY,4788
88781,Kids,I-NAME_OF_STUDY,4788
88782,BLINK,I-NAME_OF_STUDY,4788
88783,study,I-NAME_OF_STUDY,4788
88784,randomly,O,4788
88785,assigned,O,4788
88786,children,O,4788
88787,to,O,4788
88788,wear,O,4788
88789,either,O,4788
88790,commercially,O,4788
88791,available,O,4788
88792,single-vision,B-TREATMENT,4788
88793,contact,I-TREATMENT,4788
88794,lenses,I-TREATMENT,4788
88795,or,O,4788
88796,medium-,O,4788
88797,1.5,O,4788
88798,or,O,4789
88799,high-,O,4789
88800,2.5,O,4789
88801,add-power,O,4790
88802,soft,O,4790
88803,MF,O,4790
88804,contact,O,4790
88805,lenses,O,4790
88806,for,O,4790
88807,three,B-TIME_DURATION,4790
88808,years,I-TIME_DURATION,4790
88809,This,O,4791
88810,study,O,4791
88811,demonstrated,O,4791
88812,that,O,4791
88813,treatment,O,4791
88814,with,O,4791
88815,high-add-power,B-TREATMENT,4791
88816,MF,I-TREATMENT,4791
88817,contact,I-TREATMENT,4791
88818,lenses,I-TREATMENT,4791
88819,reduced,O,4791
88820,the,O,4791
88821,rate,O,4791
88822,of,O,4791
88823,myopia,B-NAME_OF_DISEASE,4791
88824,progression,O,4791
88825,more,O,4791
88826,effectively,O,4791
88827,compared,O,4791
88828,to,O,4791
88829,either,O,4791
88830,the,B-TREATMENT,4791
88831,medium-add-power,I-TREATMENT,4791
88832,MF,I-TREATMENT,4791
88833,or,O,4791
88834,the,B-TREATMENT,4791
88835,single-vision,I-TREATMENT,4791
88836,contact,I-TREATMENT,4791
88837,lenses,I-TREATMENT,4791
88838,Therefore,O,4792
88839,when,O,4792
88840,prescribing,O,4792
88841,soft,B-TREATMENT,4792
88842,MF,I-TREATMENT,4792
88843,lenses,I-TREATMENT,4792
88844,for,I-TREATMENT,4792
88845,myopia,I-TREATMENT,4792
88846,control,I-TREATMENT,4792
88847,consider,O,4792
88848,fitting,O,4792
88849,children,O,4792
88850,in,O,4792
88851,higher,O,4792
88852,add,O,4792
88853,powers,O,4792
88854,to,O,4792
88855,best,O,4792
88856,decrease,O,4792
88857,myopia,B-NAME_OF_DISEASE,4792
88858,progression,O,4792
88859,MF,O,4793
88860,optics,O,4793
88861,are,O,4793
88862,associated,O,4793
88863,with,O,4793
88864,increased,O,4793
88865,total,O,4793
88866,aberrations,O,4793
88867,including,O,4793
88868,higher-order,O,4793
88869,aberrations,O,4793
88870,which,O,4793
88871,disturb,O,4793
88872,visual,O,4793
88873,quality,O,4793
88874,especially,O,4793
88875,in,O,4793
88876,low-light,O,4793
88877,settings,O,4793
88878,These,O,4794
88879,visual,O,4794
88880,disturbances,O,4794
88881,increase,O,4794
88882,with,O,4794
88883,increasing,O,4794
88884,add,O,4794
88885,power,O,4794
88886,Nevertheless,O,4795
88887,most,O,4795
88888,children,O,4795
88889,easily,O,4795
88890,adapt,O,4795
88891,to,O,4795
88892,MF,O,4795
88893,optics,O,4795
88894,and,O,4795
88895,report,O,4795
88896,good-quality,O,4795
88897,visual,O,4795
88898,stereo,O,4795
88899,acuity,O,4795
88900,If,O,4796
88901,patients,O,4796
88902,are,O,4796
88903,bothered,O,4796
88904,visually,O,4796
88905,consider,O,4796
88906,prescribing,O,4796
88907,-0.25,O,4796
88908,or,O,4797
88909,-0.5,O,4797
88910,more,O,4798
88911,distance,O,4798
88912,power,O,4798
88913,to,O,4798
88914,relieve,O,4798
88915,their,O,4798
88916,symptoms,O,4798
88917,As,O,4799
88918,mentioned,O,4799
88919,above,O,4799
88920,defocused,O,4799
88921,retinal,O,4799
88922,images,O,4799
88923,induced,O,4799
88924,by,O,4799
88925,hyperopic,O,4799
88926,blur,O,4799
88927,retard,O,4799
88928,axial,O,4799
88929,length,O,4799
88930,growth,O,4799
88931,Prescribing,O,4800
88932,MF,B-TREATMENT,4800
88933,lenses,I-TREATMENT,4800
88934,that,I-TREATMENT,4800
88935,create,I-TREATMENT,4800
88936,myopic,I-TREATMENT,4800
88937,blur,I-TREATMENT,4800
88938,within,I-TREATMENT,4800
88939,the,I-TREATMENT,4800
88940,visual,I-TREATMENT,4800
88941,axis,I-TREATMENT,4800
88942,will,O,4800
88943,therefore,O,4800
88944,be,O,4800
88945,most,O,4800
88946,effective,O,4800
88947,in,O,4800
88948,retarding,O,4800
88949,myopia,B-NAME_OF_DISEASE,4800
88950,progression,O,4800
88951,To,O,4801
88952,maximize,O,4801
88953,the,O,4801
88954,myopia,B-NAME_OF_DISEASE,4801
88955,control,O,4801
88956,effect,O,4801
88957,consider,O,4801
88958,pupil,B-PART_OF_THE_EYES,4801
88959,size,O,4801
88960,when,O,4801
88961,prescribing,O,4801
88962,soft,B-TREATMENT,4801
88963,MF,I-TREATMENT,4801
88964,lenses,I-TREATMENT,4801
88965,for,I-TREATMENT,4801
88966,myopia,I-TREATMENT,4801
88967,control,I-TREATMENT,4801
88968,Ensure,O,4802
88969,that,O,4802
88970,the,O,4802
88971,near-add-power,O,4802
88972,optic,O,4802
88973,is,O,4802
88974,within,O,4802
88975,the,O,4802
88976,pupillary,O,4802
88977,visual,O,4802
88978,axis,O,4802
88979,during,O,4802
88980,normal,O,4802
88981,lighting,O,4802
88982,conditions,O,4802
88983,To,O,4803
88984,assess,O,4803
88985,this,O,4803
88986,take,O,4803
88987,a,O,4803
88988,corneal,O,4803
88989,topography,O,4803
88990,map,O,4803
88991,over,O,4803
88992,the,B-TREATMENT,4803
88993,MF,I-TREATMENT,4803
88994,soft,I-TREATMENT,4803
88995,lens,I-TREATMENT,4803
88996,on,O,4803
88997,the,O,4803
88998,eye,O,4803
88999,to,O,4803
89000,examine,O,4803
89001,the,O,4803
89002,centration,O,4803
89003,and,O,4803
89004,size,O,4803
89005,of,O,4803
89006,the,O,4803
89007,multifocal,O,4803
89008,optic,O,4803
89009,This,O,4804
89010,can,O,4804
89011,be,O,4804
89012,compared,O,4804
89013,to,O,4804
89014,the,O,4804
89015,photopic,O,4804
89016,pupil,B-PART_OF_THE_EYES,4804
89017,size,O,4804
89018,measured,O,4804
89019,under,O,4804
89020,normal,O,4804
89021,lighting,O,4804
89022,during,O,4804
89023,the,O,4804
89024,baseline,O,4804
89025,evaluation,O,4804
89026,Assessing,O,4805
89027,the,O,4805
89028,fit,O,4805
89029,of,O,4805
89030,soft,B-TREATMENT,4805
89031,MF,I-TREATMENT,4805
89032,lenses,I-TREATMENT,4805
89033,on,O,4805
89034,children,O,4805
89035,is,O,4805
89036,typical,O,4805
89037,to,O,4805
89038,assessing,O,4805
89039,any,O,4805
89040,soft,O,4805
89041,lens,O,4805
89042,on,O,4805
89043,the,O,4805
89044,eye,O,4805
89045,Ensure,O,4806
89046,that,O,4806
89047,the,O,4806
89048,lens,O,4806
89049,has,O,4806
89050,good,O,4806
89051,coverage,O,4806
89052,movement,O,4806
89053,and,O,4806
89054,on-eye,O,4806
89055,stability,O,4806
89056,The,O,4807
89057,average,O,4807
89058,corneal,O,4807
89059,diameter,O,4807
89060,and,O,4807
89061,sim,O,4807
89062,curvature,O,4807
89063,are,O,4807
89064,approximately,O,4807
89065,11.80m,O,4807
89066,and,O,4808
89067,43,O,4808
89068,respectively,O,4809
89069,however,O,4809
89070,this,O,4809
89071,may,O,4809
89072,vary,O,4809
89073,from,O,4809
89074,child,O,4809
89075,to,O,4809
89076,child,O,4809
89077,Custom,O,4810
89078,soft,B-TREATMENT,4810
89079,MF,I-TREATMENT,4810
89080,lenses,I-TREATMENT,4810
89081,are,O,4810
89082,available,O,4810
89083,in,O,4810
89084,variable,O,4810
89085,diameters,O,4810
89086,and,O,4810
89087,base,O,4810
89088,curvatures,O,4810
89089,to,O,4810
89090,fit,O,4810
89091,children,O,4810
89092,who,O,4810
89093,fall,O,4810
89094,outside,O,4810
89095,of,O,4810
89096,these,O,4810
89097,normative,O,4810
89098,parameters,O,4810
89099,Fitting,O,4811
89100,children,O,4811
89101,who,O,4811
89102,have,O,4811
89103,astigmatism,B-NAME_OF_DISEASE,4811
89104,in,O,4811
89105,soft,B-TREATMENT,4811
89106,lenses,I-TREATMENT,4811
89107,for,I-TREATMENT,4811
89108,myopia,I-TREATMENT,4811
89109,control,I-TREATMENT,4811
89110,can,O,4811
89111,be,O,4811
89112,accomplished,O,4811
89113,by,O,4811
89114,adding,O,4811
89115,a,O,4811
89116,toric,O,4811
89117,prescription,O,4811
89118,to,O,4811
89119,the,B-TREATMENT,4811
89120,MF,I-TREATMENT,4811
89121,lens,I-TREATMENT,4811
89122,Troubleshooting,O,4812
89123,visual,O,4812
89124,complaints,O,4812
89125,in,O,4812
89126,soft,B-TREATMENT,4812
89127,MF,I-TREATMENT,4812
89128,toric,I-TREATMENT,4812
89129,lenses,I-TREATMENT,4812
89130,can,O,4812
89131,be,O,4812
89132,challenging,O,4812
89133,because,O,4812
89134,it,O,4812
89135,may,O,4812
89136,not,O,4812
89137,be,O,4812
89138,apparent,O,4812
89139,whether,O,4812
89140,the,O,4812
89141,disturbance,O,4812
89142,in,O,4812
89143,vision,O,4812
89144,is,O,4812
89145,coming,O,4812
89146,from,O,4812
89147,the,O,4812
89148,MF,O,4812
89149,optics,O,4812
89150,or,O,4812
89151,from,O,4812
89152,uncorrected,O,4812
89153,astigmatism,B-NAME_OF_DISEASE,4812
89154,A,O,4813
89155,stepwise,O,4813
89156,approach,O,4813
89157,to,O,4813
89158,fitting,O,4813
89159,toric,B-TREATMENT,4813
89160,MF,I-TREATMENT,4813
89161,lenses,I-TREATMENT,4813
89162,in,O,4813
89163,children,O,4813
89164,would,O,4813
89165,start,O,4813
89166,with,O,4813
89167,fitting,O,4813
89168,a,B-TREATMENT,4813
89169,single-vision,I-TREATMENT,4813
89170,distance,I-TREATMENT,4813
89171,toric,I-TREATMENT,4813
89172,lens,I-TREATMENT,4813
89173,first,O,4813
89174,Once,O,4814
89175,it,O,4814
89176,is,O,4814
89177,established,O,4814
89178,that,O,4814
89179,the,O,4814
89180,lens,O,4814
89181,fits,O,4814
89182,well,O,4814
89183,and,O,4814
89184,that,O,4814
89185,the,O,4814
89186,patient,O,4814
89187,has,O,4814
89188,good,O,4814
89189,quality,O,4814
89190,of,O,4814
89191,vision,O,4814
89192,order,O,4814
89193,the,O,4814
89194,same,O,4814
89195,lens,O,4814
89196,with,O,4814
89197,MF,O,4814
89198,optics,O,4814
89199,FITTING,O,4815
89200,ORTHOKERATOLOGY,O,4815
89201,Overnight,B-TREATMENT,4815
89202,ortho-k,B-TREATMENT,4815
89203,received,O,4815
89204,FDA,B-ORGANIZATION,4815
89205,approval,O,4815
89206,to,O,4815
89207,correct,O,4815
89208,myopia,B-NAME_OF_DISEASE,4815
89209,in,O,4815
89210,2002,O,4815
89211,For,O,4816
89212,this,O,4816
89213,purpose,O,4816
89214,ortho-k,B-TREATMENT,4816
89215,is,O,4816
89216,highly,O,4816
89217,effective,O,4816
89218,Additionally,O,4817
89219,myopia,B-NAME_OF_DISEASE,4817
89220,management,O,4817
89221,with,O,4817
89222,ortho-k,B-TREATMENT,4817
89223,reduces,O,4817
89224,myopia,B-NAME_OF_DISEASE,4817
89225,progression,O,4817
89226,by,O,4817
89227,40%,O,4817
89228,to,O,4817
89229,60%,O,4817
89230,compared,O,4817
89231,to,O,4817
89232,spectacle,O,4817
89233,correction,O,4817
89234,alone,O,4817
89235,It,O,4818
89236,is,O,4818
89237,worth,O,4818
89238,noting,O,4818
89239,however,O,4818
89240,that,O,4818
89241,prescribing,O,4818
89242,ortho-k,B-TREATMENT,4818
89243,lenses,I-TREATMENT,4818
89244,for,O,4818
89245,myopia,B-NAME_OF_DISEASE,4818
89246,management,O,4818
89247,is,O,4818
89248,considered,O,4818
89249,an,O,4818
89250,off-label,O,4818
89251,use,O,4818
89252,This,O,4819
89253,may,O,4819
89254,be,O,4819
89255,disconcerting,O,4819
89256,to,O,4819
89257,some,O,4819
89258,parents,O,4819
89259,but,O,4819
89260,the,O,4819
89261,effectiveness,O,4819
89262,of,O,4819
89263,ortho-k,B-TREATMENT,4819
89264,is,O,4819
89265,nonetheless,O,4819
89266,well-established,O,4819
89267,for,O,4819
89268,myopia,B-NAME_OF_DISEASE,4819
89269,management,O,4819
89270,Modern,B-TREATMENT,4820
89271,ortho-k,I-TREATMENT,4820
89272,lenses,I-TREATMENT,4820
89273,have,O,4820
89274,a,O,4820
89275,reverse,O,4820
89276,geometry,O,4820
89277,design,O,4820
89278,The,O,4821
89279,primary,O,4821
89280,measurements,O,4821
89281,needed,O,4821
89282,to,O,4821
89283,order,O,4821
89284,these,O,4821
89285,lenses,O,4821
89286,empirically,O,4821
89287,include,O,4821
89288,a,O,4821
89289,manifest,O,4821
89290,refraction,O,4821
89291,horizontal,O,4821
89292,visible,O,4821
89293,iris,O,4821
89294,diameter,O,4821
89295,HVID,O,4821
89296,and,O,4821
89297,corneal,O,4821
89298,topography,O,4821
89299,Some,O,4822
89300,lenses,O,4822
89301,are,O,4822
89302,designed,O,4822
89303,from,O,4822
89304,flat,O,4822
89305,keratometry,O,4822
89306,flat,O,4822
89307,K,O,4822
89308,measurements,O,4822
89309,although,O,4822
89310,custom,O,4822
89311,lens,O,4822
89312,design,O,4822
89313,software,O,4822
89314,may,O,4822
89315,require,O,4822
89316,eccentricity,O,4822
89317,and,O,4822
89318,apical,O,4822
89319,radius,O,4822
89320,of,O,4822
89321,curvature,O,4822
89322,measurements,O,4822
89323,These,O,4823
89324,lenses,O,4823
89325,are,O,4823
89326,larger,O,4823
89327,in,O,4823
89328,overall,O,4823
89329,diameter-often,O,4823
89330,90%,O,4823
89331,to,O,4823
89332,95%,O,4823
89333,of,O,4823
89334,the,O,4823
89335,total,O,4823
89336,HVID,O,4823
89337,The,O,4824
89338,back,O,4824
89339,surface,O,4824
89340,of,O,4824
89341,an,B-TREATMENT,4824
89342,ortho-k,I-TREATMENT,4824
89343,lens,I-TREATMENT,4824
89344,has,O,4824
89345,a,O,4824
89346,minimum,O,4824
89347,of,O,4824
89348,four,O,4824
89349,curves,O,4824
89350,however,O,4824
89351,some,O,4824
89352,designs,O,4824
89353,that,O,4824
89354,correct,O,4824
89355,higher,O,4824
89356,amounts,O,4824
89357,of,O,4824
89358,myopia,B-NAME_OF_DISEASE,4824
89359,can,O,4824
89360,have,O,4824
89361,up,O,4824
89362,to,O,4824
89363,six,O,4824
89364,curves,O,4824
89365,Ortho-k,B-TREATMENT,4825
89366,lenses,I-TREATMENT,4825
89367,for,O,4825
89368,myopia,B-NAME_OF_DISEASE,4825
89369,management,O,4825
89370,should,O,4825
89371,center,O,4825
89372,well,O,4825
89373,and,O,4825
89374,the,O,4825
89375,lens,O,4825
89376,should,O,4825
89377,display,O,4825
89378,an,O,4825
89379,adequate,O,4825
89380,fluorescein,O,4825
89381,pattern,O,4825
89382,of,O,4825
89383,central,O,4825
89384,alignment,O,4825
89385,under,O,4825
89386,the,O,4825
89387,back-optic,O,4825
89388,zone,O,4825
89389,radius,O,4825
89390,BOZR,O,4825
89391,clearance,O,4825
89392,throughout,O,4825
89393,the,O,4825
89394,entire,O,4825
89395,reverse,O,4825
89396,zone,O,4825
89397,and,O,4825
89398,proper,O,4825
89399,landing,O,4825
89400,throughout,O,4825
89401,the,O,4825
89402,alignment,O,4825
89403,zone,O,4825
89404,The,O,4826
89405,lens,O,4826
89406,should,O,4826
89407,also,O,4826
89408,move,O,4826
89409,well,O,4826
89410,and,O,4826
89411,have,O,4826
89412,adequate,O,4826
89413,clearance,O,4826
89414,under,O,4826
89415,the,O,4826
89416,peripheral,O,4826
89417,zone,O,4826
89418,to,O,4826
89419,maintain,O,4826
89420,good,O,4826
89421,tear,O,4826
89422,exchange,O,4826
89423,Topographically,O,4826
89424,after,O,4826
89425,the,O,4826
89426,lens,O,4826
89427,is,O,4826
89428,removed,O,4826
89429,there,O,4826
89430,should,O,4826
89431,be,O,4826
89432,a,O,4826
89433,classic,O,4826
89434,bull,O,4826
89435,s-eye,O,4826
89436,pattern,O,4826
89437,of,O,4826
89438,an,O,4826
89439,even,O,4826
89440,flattened,O,4826
89441,treatment,O,4826
89442,zone,O,4826
89443,and,O,4826
89444,a,O,4826
89445,steepened,O,4826
89446,reverse,O,4826
89447,curve,O,4826
89448,zone,O,4826
89449,centered,O,4826
89450,within,O,4826
89451,the,O,4826
89452,pupillary,O,4826
89453,circumference,O,4826
89454,This,O,4827
89455,proper,O,4827
89456,centration,O,4827
89457,of,O,4827
89458,the,O,4827
89459,reverse,O,4827
89460,zone,O,4827
89461,allows,O,4827
89462,for,O,4827
89463,peripheral,O,4827
89464,defocus,O,4827
89465,to,O,4827
89466,be,O,4827
89467,generated,O,4827
89468,inside,O,4827
89469,the,B-TREATMENT,4827
89470,pupil,I-TREATMENT,4827
89471,thereby,O,4827
89472,maximizing,O,4827
89473,the,O,4827
89474,myopia,B-NAME_OF_DISEASE,4827
89475,control,O,4827
89476,effect,O,4827
89477,Adjacent,O,4828
89478,to,O,4828
89479,the,O,4828
89480,steepened,O,4828
89481,reverse,O,4828
89482,zone,O,4828
89483,a,O,4828
89484,more,O,4828
89485,pronounced,O,4828
89486,flattened,O,4828
89487,area,O,4828
89488,360º,O,4828
89489,around,O,4828
89490,should,O,4828
89491,be,O,4828
89492,visible,O,4828
89493,This,O,4829
89494,zone,O,4829
89495,represents,O,4829
89496,adequate,O,4829
89497,positioning,O,4829
89498,and,O,4829
89499,applanation,O,4829
89500,of,O,4829
89501,the,O,4829
89502,alignment,O,4829
89503,curve,O,4829
89504,within,O,4829
89505,the,B-TREATMENT,4829
89506,peripheral,I-TREATMENT,4829
89507,cornea,I-TREATMENT,4829
89508,With,O,4830
89509,the,B-TREATMENT,4830
89510,ortho-k,I-TREATMENT,4830
89511,lens,I-TREATMENT,4830
89512,removed,O,4830
89513,patients,O,4830
89514,should,O,4830
89515,be,O,4830
89516,able,O,4830
89517,to,O,4830
89518,achieve,O,4830
89519,their,O,4830
89520,best-corrected,O,4830
89521,visual,O,4830
89522,acuity,O,4830
89523,Any,O,4831
89524,residual,O,4831
89525,myopia,B-NAME_OF_DISEASE,4831
89526,may,O,4831
89527,be,O,4831
89528,corrected,O,4831
89529,with,O,4831
89530,regular,O,4831
89531,distance,O,4831
89532,spectacles,O,4831
89533,during,O,4831
89534,the,O,4831
89535,day,O,4831
89536,As,O,4832
89537,the,B-PART_OF_THE_EYES,4832
89538,cornea,I-PART_OF_THE_EYES,4832
89539,remains,O,4832
89540,molded,O,4832
89541,from,O,4832
89542,the,B-TREATMENT,4832
89543,ortho-k,I-TREATMENT,4832
89544,treatment,I-TREATMENT,4832
89545,the,O,4832
89546,peripheral,O,4832
89547,retinal,O,4832
89548,defocus,O,4832
89549,responsible,O,4832
89550,for,O,4832
89551,myopia,B-NAME_OF_DISEASE,4832
89552,control,O,4832
89553,remains,O,4832
89554,in,O,4832
89555,effect,O,4832
89556,even,O,4832
89557,with,O,4832
89558,over,O,4832
89559,spectacles,O,4832
89560,to,O,4832
89561,correct,O,4832
89562,residual,O,4832
89563,myopia,B-NAME_OF_DISEASE,4832
89564,After,O,4833
89565,lens,O,4833
89566,removal,O,4833
89567,the,B-PART_OF_THE_EYES,4833
89568,cornea,I-PART_OF_THE_EYES,4833
89569,should,O,4833
89570,be,O,4833
89571,clear,O,4833
89572,with,O,4833
89573,no,O,4833
89574,signs,O,4833
89575,of,O,4833
89576,punctate,O,4833
89577,epithelial,O,4833
89578,staining,O,4833
89579,negative,O,4833
89580,staining,O,4833
89581,or,O,4833
89582,stromal,O,4833
89583,opacities,O,4833
89584,Any,O,4834
89585,of,O,4834
89586,these,O,4834
89587,findings,O,4834
89588,indicates,O,4834
89589,mechanical,O,4834
89590,contact,O,4834
89591,of,O,4834
89592,the,O,4834
89593,lens,O,4834
89594,with,O,4834
89595,the,B-PART_OF_THE_EYES,4834
89596,corneal,I-PART_OF_THE_EYES,4834
89597,surface,I-PART_OF_THE_EYES,4834
89598,and,O,4834
89599,or,O,4834
89600,corneal,O,4834
89601,hypoxia,O,4834
89602,Additionally,O,4835
89603,patients,O,4835
89604,should,O,4835
89605,report,O,4835
89606,good,O,4835
89607,functional,O,4835
89608,vision,O,4835
89609,throughout,O,4835
89610,the,O,4835
89611,day,O,4835
89612,Spherical,B-TREATMENT,4836
89613,ortho-k,I-TREATMENT,4836
89614,lenses,I-TREATMENT,4836
89615,on,O,4836
89616,highly,O,4836
89617,astigmatic,O,4836
89618,corneas,B-PART_OF_THE_EYES,4836
89619,usually,O,4836
89620,result,O,4836
89621,in,O,4836
89622,poor,O,4836
89623,centration,O,4836
89624,leading,O,4836
89625,to,O,4836
89626,induced,O,4836
89627,irregular,B-NAME_OF_DISEASE,4836
89628,astigmatism,I-NAME_OF_DISEASE,4836
89629,glare,O,4836
89630,and,O,4836
89631,poor,O,4836
89632,visual,O,4836
89633,outcome,O,4836
89634,Limbus-to-limbus,B-NAME_OF_DISEASE,4837
89635,against-the-rule,B-NAME_OF_DISEASE,4837
89636,and,O,4837
89637,larger,O,4837
89638,astigmatic,O,4837
89639,errors,O,4837
89640,are,O,4837
89641,not,O,4837
89642,well,O,4837
89643,corrected,O,4837
89644,with,O,4837
89645,spherical,O,4837
89646,lens,O,4837
89647,designs,O,4837
89648,Therefore,O,4838
89649,toric,B-TREATMENT,4838
89650,ortho-k,I-TREATMENT,4838
89651,lenses,I-TREATMENT,4838
89652,are,O,4838
89653,indicated,O,4838
89654,to,O,4838
89655,achieve,O,4838
89656,effective,O,4838
89657,myopia,B-NAME_OF_DISEASE,4838
89658,treatment,O,4838
89659,and,O,4838
89660,visual,O,4838
89661,correction,O,4838
89662,in,O,4838
89663,astigmatic,O,4838
89664,patients,O,4838
89665,Corneal,B-DIAGNOSTIC_TEST,4839
89666,topography,I-DIAGNOSTIC_TEST,4839
89667,is,O,4839
89668,used,O,4839
89669,to,O,4839
89670,determine,O,4839
89671,whether,O,4839
89672,a,O,4839
89673,toric,O,4839
89674,design,O,4839
89675,is,O,4839
89676,needed,O,4839
89677,A,O,4840
89678,sagittal,O,4840
89679,height,O,4840
89680,difference,O,4840
89681,between,O,4840
89682,the,O,4840
89683,flat,O,4840
89684,and,O,4840
89685,steep,O,4840
89686,corneal,O,4840
89687,meridians,O,4840
89688,of,O,4840
89689,30,O,4840
89690,microns,O,4840
89691,or,O,4840
89692,greater,O,4840
89693,at,O,4840
89694,the,O,4840
89695,landing,O,4840
89696,chord,O,4840
89697,length,O,4840
89698,of,O,4840
89699,the,O,4840
89700,alignment,O,4840
89701,curve,O,4840
89702,suggests,O,4840
89703,that,O,4840
89704,the,O,4840
89705,treatment,O,4840
89706,may,O,4840
89707,benefit,O,4840
89708,from,O,4840
89709,adding,O,4840
89710,lens,O,4840
89711,toricity,O,4840
89712,LENS,O,4841
89713,DESIGNS,O,4841
89714,WITH,O,4841
89715,GP,O,4841
89716,OPTICS,O,4841
89717,In,O,4841
89718,general,O,4841
89719,daytime,B-TREATMENT,4841
89720,GP,B-TREATMENT,4841
89721,lenses,I-TREATMENT,4841
89722,offer,O,4841
89723,sharp,O,4841
89724,optics,O,4841
89725,and,O,4841
89726,are,O,4841
89727,a,O,4841
89728,great,O,4841
89729,option,O,4841
89730,especially,O,4841
89731,in,O,4841
89732,highly,O,4841
89733,astigmatic,O,4841
89734,children,O,4841
89735,Similar,O,4842
89736,to,O,4842
89737,soft,O,4842
89738,lens,O,4842
89739,designs,O,4842
89740,multifocal,O,4842
89741,optics,O,4842
89742,can,O,4842
89743,be,O,4842
89744,added,O,4842
89745,to,O,4842
89746,the,O,4842
89747,surface,O,4842
89748,of,O,4842
89749,a,B-TREATMENT,4842
89750,GP,I-TREATMENT,4842
89751,lens,I-TREATMENT,4842
89752,and,O,4842
89753,are,O,4842
89754,especially,O,4842
89755,useful,O,4842
89756,for,O,4842
89757,myopia,B-NAME_OF_DISEASE,4842
89758,control,O,4842
89759,in,O,4842
89760,highly,O,4842
89761,astigmatic,O,4842
89762,myopic,O,4842
89763,children,O,4842
89764,Although,O,4843
89765,this,O,4843
89766,lens,O,4843
89767,type,O,4843
89768,offers,O,4843
89769,improved,O,4843
89770,optical,O,4843
89771,quality,O,4843
89772,over,O,4843
89773,spectacles,B-TREATMENT,4843
89774,and,O,4843
89775,soft,B-TREATMENT,4843
89776,lenses,I-TREATMENT,4843
89777,in,O,4843
89778,highly,O,4843
89779,astigmatic,O,4843
89780,children,O,4843
89781,there,O,4843
89782,is,O,4843
89783,the,O,4843
89784,perception,O,4843
89785,that,O,4843
89786,it,O,4843
89787,is,O,4843
89788,difficult,O,4843
89789,to,O,4843
89790,adapt,O,4843
89791,to,O,4843
89792,GP,B-TREATMENT,4843
89793,lenses,I-TREATMENT,4843
89794,Nonetheless,O,4844
89795,80%,O,4844
89796,of,O,4844
89797,children,O,4844
89798,become,O,4844
89799,accustomed,O,4844
89800,to,O,4844
89801,corneal,B-TREATMENT,4844
89802,GP,I-TREATMENT,4844
89803,lenses,I-TREATMENT,4844
89804,which,O,4844
89805,is,O,4844
89806,the,O,4844
89807,same,O,4844
89808,adaptation,O,4844
89809,rate,O,4844
89810,as,O,4844
89811,for,O,4844
89812,adults,O,4844
89813,Additionally,O,4845
89814,with,O,4845
89815,the,O,4845
89816,availability,O,4845
89817,of,O,4845
89818,hybrid,B-TREATMENT,4845
89819,and,I-TREATMENT,4845
89820,scleral,I-TREATMENT,4845
89821,GP,I-TREATMENT,4845
89822,lenses,I-TREATMENT,4845
89823,as,O,4845
89824,well,O,4845
89825,as,O,4845
89826,improved,O,4845
89827,designs,O,4845
89828,of,O,4845
89829,newer,O,4845
89830,corneal,B-TREATMENT,4845
89831,lenses,I-TREATMENT,4845
89832,initial,O,4845
89833,lens,O,4845
89834,awareness,O,4845
89835,is,O,4845
89836,now,O,4845
89837,much,O,4845
89838,less,O,4845
89839,of,O,4845
89840,a,O,4845
89841,concern,O,4845
89842,Consider,O,4846
89843,prescribing,O,4846
89844,daytime,B-TREATMENT,4846
89845,GP,I-TREATMENT,4846
89846,multifocal,I-TREATMENT,4846
89847,lenses,I-TREATMENT,4846
89848,for,O,4846
89849,children,O,4846
89850,who,O,4846
89851,have,O,4846
89852,more,O,4846
89853,than,O,4846
89854,2.5,O,4846
89855,of,O,4847
89856,corneal,B-NAME_OF_DISEASE,4847
89857,astigmatism,B-NAME_OF_DISEASE,4847
89858,Corneal,B-TREATMENT,4848
89859,GPs,I-TREATMENT,4848
89860,Bitoric,B-TREATMENT,4848
89861,corneal,I-TREATMENT,4848
89862,GP,I-TREATMENT,4848
89863,lenses,I-TREATMENT,4848
89864,can,O,4848
89865,be,O,4848
89866,prescribed,O,4848
89867,to,O,4848
89868,correct,O,4848
89869,myopia,B-NAME_OF_DISEASE,4848
89870,and,O,4848
89871,astigmatism,B-NAME_OF_DISEASE,4848
89872,in,O,4848
89873,children,O,4848
89874,These,O,4849
89875,lenses,O,4849
89876,can,O,4849
89877,easily,O,4849
89878,be,O,4849
89879,ordered,O,4849
89880,empirically,O,4849
89881,through,O,4849
89882,a,O,4849
89883,contact,O,4849
89884,lens,O,4849
89885,laboratory,O,4849
89886,using,O,4849
89887,keratometry,O,4849
89888,values,O,4849
89889,and,O,4849
89890,cycloplegic,O,4849
89891,refraction,O,4849
89892,Similar,O,4850
89893,to,O,4850
89894,prescribing,O,4850
89895,soft,B-TREATMENT,4850
89896,toric,I-TREATMENT,4850
89897,MF,I-TREATMENT,4850
89898,lenses,I-TREATMENT,4850
89899,GP,B-TREATMENT,4850
89900,bitoric,I-TREATMENT,4850
89901,lenses,I-TREATMENT,4850
89902,must,O,4850
89903,be,O,4850
89904,well,O,4850
89905,centered,O,4850
89906,and,O,4850
89907,have,O,4850
89908,good,O,4850
89909,on-eye,O,4850
89910,stability,O,4850
89911,After,O,4851
89912,achieving,O,4851
89913,a,O,4851
89914,good,O,4851
89915,fit,O,4851
89916,the,B-TREATMENT,4851
89917,front-surface,I-TREATMENT,4851
89918,center-distance,I-TREATMENT,4851
89919,MF,I-TREATMENT,4851
89920,optics,I-TREATMENT,4851
89921,for,I-TREATMENT,4851
89922,myopia,I-TREATMENT,4851
89923,control,I-TREATMENT,4851
89924,can,O,4851
89925,be,O,4851
89926,added,O,4851
89927,Hybrid,B-TREATMENT,4852
89928,Lenses,I-TREATMENT,4852
89929,Hybrid,B-TREATMENT,4852
89930,lenses,I-TREATMENT,4852
89931,are,O,4852
89932,comprised,O,4852
89933,of,O,4852
89934,a,O,4852
89935,GP,O,4852
89936,center,O,4852
89937,surrounded,O,4852
89938,by,O,4852
89939,a,O,4852
89940,soft-lens-material,O,4852
89941,skirt,O,4852
89942,The,O,4853
89943,soft,O,4853
89944,skirt,O,4853
89945,of,O,4853
89946,the,B-TREATMENT,4853
89947,hybrid,I-TREATMENT,4853
89948,lens,I-TREATMENT,4853
89949,keeps,O,4853
89950,the,O,4853
89951,GP,O,4853
89952,lens,O,4853
89953,well,O,4853
89954,centered,O,4853
89955,and,O,4853
89956,stable,O,4853
89957,on,O,4853
89958,the,O,4853
89959,eye,O,4853
89960,This,O,4854
89961,makes,O,4854
89962,hybrid,B-TREATMENT,4854
89963,lenses,I-TREATMENT,4854
89964,a,O,4854
89965,good,O,4854
89966,choice,O,4854
89967,for,O,4854
89968,highly,O,4854
89969,astigmatic,O,4854
89970,myopic,O,4854
89971,children,O,4854
89972,who,O,4854
89973,have,O,4854
89974,active,O,4854
89975,lifestyles,O,4854
89976,and,O,4854
89977,for,O,4854
89978,whom,O,4854
89979,lens,O,4854
89980,dislodgment,O,4854
89981,may,O,4854
89982,be,O,4854
89983,a,O,4854
89984,concern,O,4854
89985,during,O,4854
89986,their,O,4854
89987,activities,O,4854
89988,Center-distance,O,4855
89989,MF,O,4855
89990,optics,O,4855
89991,are,O,4855
89992,available,O,4855
89993,on,O,4855
89994,hybrid,B-TREATMENT,4855
89995,lenses,I-TREATMENT,4855
89996,for,I-TREATMENT,4855
89997,myopia,B-NAME_OF_DISEASE,4855
89998,control,I-TREATMENT,4855
89999,As,O,4856
90000,these,O,4856
90001,lenses,O,4856
90002,generally,O,4856
90003,center,O,4856
90004,well,O,4856
90005,the,O,4856
90006,MF,O,4856
90007,optics,O,4856
90008,can,O,4856
90009,be,O,4856
90010,added,O,4856
90011,on,O,4856
90012,the,O,4856
90013,front,O,4856
90014,of,O,4856
90015,the,O,4856
90016,lens,O,4856
90017,during,O,4856
90018,empirical,O,4856
90019,ordering,O,4856
90020,Scleral,B-TREATMENT,4857
90021,Lenses,I-TREATMENT,4857
90022,Typically,O,4857
90023,fitted,O,4857
90024,in,O,4857
90025,adult,O,4857
90026,patients,O,4857
90027,scleral,B-TREATMENT,4857
90028,lenses,I-TREATMENT,4857
90029,are,O,4857
90030,indicated,O,4857
90031,in,O,4857
90032,pediatric,O,4857
90033,cases,O,4857
90034,when,O,4857
90035,it,O,4857
90036,is,O,4857
90037,difficult,O,4857
90038,to,O,4857
90039,achieve,O,4857
90040,an,O,4857
90041,acceptable,O,4857
90042,fit,O,4857
90043,or,O,4857
90044,sufficient,O,4857
90045,vision,O,4857
90046,with,O,4857
90047,other,O,4857
90048,lenses,O,4857
90049,such,O,4857
90050,as,O,4857
90051,in,O,4857
90052,cases,O,4857
90053,of,O,4857
90054,high,B-NAME_OF_DISEASE,4857
90055,myopia,B-NAME_OF_DISEASE,4857
90056,and,O,4857
90057,astigmatism,B-NAME_OF_DISEASE,4857
90058,In,O,4858
90059,such,O,4858
90060,cases,O,4858
90061,MF,O,4858
90062,center-distance,O,4858
90063,optics,O,4858
90064,may,O,4858
90065,be,O,4858
90066,placed,O,4858
90067,on,O,4858
90068,the,O,4858
90069,surface,O,4858
90070,of,O,4858
90071,a,B-TREATMENT,4858
90072,scleral,I-TREATMENT,4858
90073,lens,I-TREATMENT,4858
90074,for,I-TREATMENT,4858
90075,myopia,B-NAME_OF_DISEASE,4858
90076,control,I-TREATMENT,4858
90077,The,O,4859
90078,underlying,O,4859
90079,tear,O,4859
90080,lens,O,4859
90081,in,O,4859
90082,a,O,4859
90083,traditional,O,4859
90084,prolate-design,O,4859
90085,scleral,O,4859
90086,lens,O,4859
90087,generates,O,4859
90088,a,O,4859
90089,more,O,4859
90090,myopic,O,4859
90091,prescription,O,4859
90092,on,O,4859
90093,the,O,4859
90094,eye,O,4859
90095,However,O,4860
90096,an,O,4860
90097,oblate,O,4860
90098,reverse,O,4860
90099,geometry,O,4860
90100,design,O,4860
90101,can,O,4860
90102,be,O,4860
90103,created,O,4860
90104,in,O,4860
90105,which,O,4860
90106,the,O,4860
90107,base,O,4860
90108,curve,O,4860
90109,is,O,4860
90110,significantly,O,4860
90111,flattened,O,4860
90112,thus,O,4860
90113,creating,O,4860
90114,a,O,4860
90115,more,O,4860
90116,plus,O,4860
90117,prescription,O,4860
90118,on,O,4860
90119,the,O,4860
90120,eye,O,4860
90121,Therefore,O,4861
90122,a,B-TREATMENT,4861
90123,scleral,I-TREATMENT,4861
90124,lens,I-TREATMENT,4861
90125,that,I-TREATMENT,4861
90126,has,I-TREATMENT,4861
90127,a,I-TREATMENT,4861
90128,hyperopic,I-TREATMENT,4861
90129,or,I-TREATMENT,4861
90130,low-minus,I-TREATMENT,4861
90131,prescription,I-TREATMENT,4861
90132,with,I-TREATMENT,4861
90133,center-distance,I-TREATMENT,4861
90134,MF,I-TREATMENT,4861
90135,optics,I-TREATMENT,4861
90136,can,O,4861
90137,be,O,4861
90138,created,O,4861
90139,for,O,4861
90140,a,O,4861
90141,young,O,4861
90142,high,O,4861
90143,myope,O,4861
90144,needing,O,4861
90145,myopia,B-NAME_OF_DISEASE,4861
90146,control,O,4861
90147,COMBINATION,O,4862
90148,TREATMENTS,O,4862
90149,In,O,4862
90150,addition,O,4862
90151,to,O,4862
90152,contact,B-TREATMENT,4862
90153,lenses,I-TREATMENT,4862
90154,there,O,4862
90155,is,O,4862
90156,a,O,4862
90157,pharmacological,O,4862
90158,approach,O,4862
90159,to,O,4862
90160,myopia,B-NAME_OF_DISEASE,4862
90161,management,O,4862
90162,using,O,4862
90163,the,O,4862
90164,antimuscarinic,B-NAME_OF_DRUG,4862
90165,agent,I-NAME_OF_DRUG,4862
90166,atropine,B-NAME_OF_DRUG,4862
90167,The,O,4863
90168,mechanisms,O,4863
90169,of,O,4863
90170,both,O,4863
90171,contact,B-TREATMENT,4863
90172,lenses,I-TREATMENT,4863
90173,and,O,4863
90174,atropine,B-NAME_OF_DRUG,4863
90175,in,O,4863
90176,myopia,B-NAME_OF_DISEASE,4863
90177,management,O,4863
90178,are,O,4863
90179,not,O,4863
90180,entirely,O,4863
90181,understood,O,4863
90182,Different,O,4864
90183,mechanisms,O,4864
90184,may,O,4864
90185,be,O,4864
90186,involved,O,4864
90187,and,O,4864
90188,a,O,4864
90189,synergistic,O,4864
90190,effect,O,4864
90191,could,O,4864
90192,exist,O,4864
90193,if,O,4864
90194,contact,B-TREATMENT,4864
90195,lenses,I-TREATMENT,4864
90196,are,O,4864
90197,combined,O,4864
90198,with,O,4864
90199,low-dose,B-NAME_OF_DRUG,4864
90200,atropine,I-NAME_OF_DRUG,4864
90201,Long-term,O,4865
90202,studies,O,4865
90203,are,O,4865
90204,underway,O,4865
90205,evaluating,O,4865
90206,low-dose,B-NAME_OF_DRUG,4865
90207,atropine,I-NAME_OF_DRUG,4865
90208,combined,O,4865
90209,with,O,4865
90210,bifocal,B-TREATMENT,4865
90211,soft,I-TREATMENT,4865
90212,contact,I-TREATMENT,4865
90213,lenses,I-TREATMENT,4865
90214,and,O,4865
90215,with,O,4865
90216,ortho-k,B-TREATMENT,4865
90217,in,O,4865
90218,retarding,O,4865
90219,the,O,4865
90220,progression,O,4865
90221,of,O,4865
90222,myopia,B-NAME_OF_DISEASE,4865
90223,Regardless,O,4866
90224,of,O,4866
90225,whether,O,4866
90226,there,O,4866
90227,are,O,4866
90228,combination,O,4866
90229,effects,O,4866
90230,an,O,4866
90231,effective,O,4866
90232,strategy,O,4866
90233,may,O,4866
90234,be,O,4866
90235,to,O,4866
90236,start,O,4866
90237,young,O,4866
90238,children,O,4866
90239,on,O,4866
90240,atropine,B-NAME_OF_DRUG,4866
90241,and,O,4866
90242,then,O,4866
90243,continue,O,4866
90244,with,O,4866
90245,contact,B-TREATMENT,4866
90246,lenses,I-TREATMENT,4866
90247,as,O,4866
90248,soon,O,4866
90249,as,O,4866
90250,they,O,4866
90251,are,O,4866
90252,able,O,4866
90253,to,O,4866
90254,wear,O,4866
90255,them,O,4866
90256,FOLLOW-UP,O,4867
90257,CARE,O,4867
90258,AND,O,4867
90259,DISCONTINUATION,O,4867
90260,After,O,4867
90261,prescribing,O,4867
90262,myopia,B-NAME_OF_DISEASE,4867
90263,control,I-TREATMENT,4867
90264,contact,I-TREATMENT,4867
90265,lenses,I-TREATMENT,4867
90266,employ,O,4867
90267,follow-up,O,4867
90268,care,O,4867
90269,every,O,4867
90270,six,O,4867
90271,months,O,4867
90272,to,O,4867
90273,monitor,O,4867
90274,the,O,4867
90275,effectiveness,O,4867
90276,of,O,4867
90277,treatment,O,4867
90278,Cycloplegic,O,4868
90279,refraction,O,4868
90280,and,O,4868
90281,axial,O,4868
90282,length,O,4868
90283,measurements,O,4868
90284,are,O,4868
90285,the,O,4868
90286,standard,O,4868
90287,of,O,4868
90288,care,O,4868
90289,to,O,4868
90290,monitor,O,4868
90291,the,O,4868
90292,effectiveness,O,4868
90293,of,O,4868
90294,myopia,B-NAME_OF_DISEASE,4868
90295,control,I-TREATMENT,4868
90296,daytime,I-TREATMENT,4868
90297,use,I-TREATMENT,4868
90298,contact,I-TREATMENT,4868
90299,lenses,I-TREATMENT,4868
90300,Because,O,4869
90301,ortho-k,B-TREATMENT,4869
90302,corrects,O,4869
90303,refractive,B-NAME_OF_DISEASE,4869
90304,error,I-NAME_OF_DISEASE,4869
90305,by,O,4869
90306,reshaping,O,4869
90307,the,B-PART_OF_THE_EYES,4869
90308,cornea,I-PART_OF_THE_EYES,4869
90309,refractive,B-NAME_OF_DISEASE,4869
90310,error,I-NAME_OF_DISEASE,4869
90311,cannot,O,4869
90312,be,O,4869
90313,used,O,4869
90314,as,O,4869
90315,an,O,4869
90316,effective,O,4869
90317,treatment,O,4869
90318,indicator,O,4869
90319,If,O,4870
90320,ortho-k,B-TREATMENT,4870
90321,is,O,4870
90322,chosen,O,4870
90323,axial,O,4870
90324,length,O,4870
90325,is,O,4870
90326,the,O,4870
90327,most,O,4870
90328,accurate,O,4870
90329,measurement,O,4870
90330,for,O,4870
90331,the,O,4870
90332,evaluation,O,4870
90333,of,O,4870
90334,myopia,B-NAME_OF_DISEASE,4870
90335,progression,O,4870
90336,Based,O,4871
90337,on,O,4871
90338,currently,O,4871
90339,available,O,4871
90340,data,O,4871
90341,every,O,4871
90342,1,O,4871
90343,of,O,4872
90344,change,O,4872
90345,in,O,4872
90346,refractive,B-NAME_OF_DISEASE,4872
90347,error,I-NAME_OF_DISEASE,4872
90348,corresponds,O,4872
90349,to,O,4872
90350,a,O,4872
90351,0.28m,O,4872
90352,increase,O,4873
90353,in,O,4873
90354,axial,O,4873
90355,length,O,4873
90356,in,O,4873
90357,children,O,4873
90358,ages,O,4873
90359,6,O,4873
90360,to,O,4873
90361,7,O,4873
90362,years,O,4873
90363,and,O,4873
90364,to,O,4873
90365,a,O,4873
90366,0.32m,O,4873
90367,increase,O,4874
90368,in,O,4874
90369,axial,O,4874
90370,length,O,4874
90371,in,O,4874
90372,children,O,4874
90373,ages,O,4874
90374,12,O,4874
90375,to,O,4874
90376,13,O,4874
90377,years,O,4874
90378,There,O,4875
90379,is,O,4875
90380,evidence,O,4875
90381,for,O,4875
90382,accelerated,O,4875
90383,myopia,B-NAME_OF_DISEASE,4875
90384,progression,O,4875
90385,or,O,4875
90386,rebound,O,4875
90387,following,O,4875
90388,the,O,4875
90389,cessation,O,4875
90390,of,O,4875
90391,some,O,4875
90392,treatments,O,4875
90393,For,O,4876
90394,example,O,4876
90395,following,O,4876
90396,discontinuation,O,4876
90397,of,O,4876
90398,1%,B-NAME_OF_DRUG,4876
90399,atropine,B-NAME_OF_DRUG,4876
90400,myopia,B-NAME_OF_DISEASE,4876
90401,progressed,O,4876
90402,at,O,4876
90403,twice,O,4876
90404,the,O,4876
90405,normal,O,4876
90406,rate,O,4876
90407,but,O,4876
90408,less,O,4876
90409,acceleration,O,4876
90410,occurred,O,4876
90411,after,O,4876
90412,discontinuation,O,4876
90413,of,O,4876
90414,treatment,O,4876
90415,with,O,4876
90416,lower,O,4876
90417,atropine,B-NAME_OF_DRUG,4876
90418,concentrations,O,4876
90419,Interestingly,O,4877
90420,two,O,4877
90421,randomized,O,4877
90422,clinical,O,4877
90423,trials,O,4877
90424,showed,O,4877
90425,that,O,4877
90426,no,O,4877
90427,acceleration,O,4877
90428,occurred,O,4877
90429,when,O,4877
90430,one,O,4877
90431,year,O,4877
90432,of,O,4877
90433,treatment,O,4877
90434,with,O,4877
90435,progressive-addition,O,4877
90436,spectacles,O,4877
90437,or,O,4877
90438,MF,B-TREATMENT,4877
90439,soft,I-TREATMENT,4877
90440,lenses,I-TREATMENT,4877
90441,was,O,4877
90442,followed,O,4877
90443,by,O,4877
90444,one,O,4877
90445,year,O,4877
90446,of,O,4877
90447,their,O,4877
90448,discontinuation,O,4877
90449,With,O,4878
90450,this,O,4878
90451,in,O,4878
90452,mind,O,4878
90453,clinicians,O,4878
90454,should,O,4878
90455,be,O,4878
90456,aware,O,4878
90457,of,O,4878
90458,the,O,4878
90459,potential,O,4878
90460,for,O,4878
90461,accelerated,O,4878
90462,progression,O,4878
90463,once,O,4878
90464,myopia,B-NAME_OF_DISEASE,4878
90465,control,O,4878
90466,is,O,4878
90467,discontinued,O,4878
90468,and,O,4878
90469,should,O,4878
90470,monitor,O,4878
90471,patients,O,4878
90472,closely,O,4878
90473,CONTACT,B-TREATMENT,4879
90474,LENS,I-TREATMENT,4879
90475,RISKS,O,4879
90476,IN,O,4879
90477,CHILDREN,O,4879
90478,As,O,4879
90479,they,O,4879
90480,have,O,4879
90481,a,O,4879
90482,longer,O,4879
90483,time,O,4879
90484,to,O,4879
90485,live,O,4879
90486,with,O,4879
90487,potential,O,4879
90488,visual,O,4879
90489,consequences,O,4879
90490,contact,B-TREATMENT,4879
90491,lens,I-TREATMENT,4879
90492,safety,O,4879
90493,in,O,4879
90494,children,O,4879
90495,is,O,4879
90496,a,O,4879
90497,concern,O,4879
90498,Microbial,B-NAME_OF_DISEASE,4880
90499,keratitis,I-NAME_OF_DISEASE,4880
90500,MK,B-NAME_OF_DISEASE,4880
90501,is,O,4880
90502,the,O,4880
90503,most,O,4880
90504,severe,O,4880
90505,and,O,4880
90506,sight-threatening,O,4880
90507,complication,O,4880
90508,of,O,4880
90509,all,O,4880
90510,lens-related,O,4880
90511,adverse,O,4880
90512,events,O,4880
90513,Thankfully,O,4881
90514,the,O,4881
90515,risk,O,4881
90516,of,O,4881
90517,MK,B-NAME_OF_DISEASE,4881
90518,associated,O,4881
90519,with,O,4881
90520,soft,B-TREATMENT,4881
90521,lens,I-TREATMENT,4881
90522,wear,O,4881
90523,in,O,4881
90524,children,O,4881
90525,ages,O,4881
90526,8,O,4881
90527,to,O,4881
90528,12,O,4881
90529,years,O,4881
90530,is,O,4881
90531,no,O,4881
90532,higher,O,4881
90533,than,O,4881
90534,in,O,4881
90535,adults,O,4881
90536,and,O,4881
90537,may,O,4881
90538,be,O,4881
90539,substantially,O,4881
90540,lower,O,4881
90541,MK,B-NAME_OF_DISEASE,4882
90542,is,O,4882
90543,rare,O,4882
90544,in,O,4882
90545,soft,O,4882
90546,daily,O,4882
90547,disposable,O,4882
90548,lens,O,4882
90549,wearers,O,4882
90550,around,O,4882
90551,2,O,4882
90552,per,O,4882
90553,10,O,4882
90554,0,O,4882
90555,patient-years,O,4882
90556,of,O,4882
90557,wear,O,4882
90558,,O,4882
90559,This,O,4883
90560,risk,O,4883
90561,for,O,4883
90562,MK,B-NAME_OF_DISEASE,4883
90563,specifically,O,4883
90564,Acanthamoeba,B-NAME_OF_DISEASE,4883
90565,keratitis,I-NAME_OF_DISEASE,4883
90566,AK,B-NAME_OF_DISEASE,4883
90567,may,O,4883
90568,be,O,4883
90569,higher,O,4883
90570,in,O,4883
90571,overnight,O,4883
90572,ortho-k,B-TREATMENT,4883
90573,wearers,O,4883
90574,in,O,4883
90575,comparison,O,4883
90576,to,O,4883
90577,daily,O,4883
90578,soft,B-TREATMENT,4883
90579,lens,I-TREATMENT,4883
90580,wearers,O,4883
90581,Increased,O,4884
90582,risk,O,4884
90583,factors,O,4884
90584,for,O,4884
90585,AK,B-NAME_OF_DISEASE,4884
90586,in,O,4884
90587,overnight,O,4884
90588,ortho-k,B-TREATMENT,4884
90589,wear,O,4884
90590,include,O,4884
90591,rinsing,B-CAUSE_OF_DISEASE,4884
90592,and,I-CAUSE_OF_DISEASE,4884
90593,or,I-CAUSE_OF_DISEASE,4884
90594,storing,I-CAUSE_OF_DISEASE,4884
90595,lenses,I-CAUSE_OF_DISEASE,4884
90596,in,I-CAUSE_OF_DISEASE,4884
90597,tap,I-CAUSE_OF_DISEASE,4884
90598,water,I-CAUSE_OF_DISEASE,4884
90599,It,O,4885
90600,is,O,4885
90601,critical,O,4885
90602,to,O,4885
90603,educate,O,4885
90604,patients,O,4885
90605,about,O,4885
90606,the,O,4885
90607,hazard,O,4885
90608,that,O,4885
90609,tap,O,4885
90610,water,O,4885
90611,poses,O,4885
90612,and,O,4885
90613,to,O,4885
90614,demonstrate,O,4885
90615,the,O,4885
90616,correct,O,4885
90617,care,O,4885
90618,of,O,4885
90619,their,O,4885
90620,lenses,O,4885
90621,Uveitic,B-NAME_OF_DISEASE,4886
90622,glaucoma,B-NAME_OF_DISEASE,4886
90623,is,O,4886
90624,a,O,4886
90625,common,O,4886
90626,complication,O,4886
90627,of,O,4886
90628,uveitis,B-NAME_OF_DISEASE,4886
90629,affecting,O,4886
90630,some,O,4886
90631,20%,O,4886
90632,of,O,4886
90633,patients,O,4886
90634,The,O,4887
90635,term,O,4887
90636,uveitic,B-NAME_OF_DISEASE,4887
90637,glaucoma,B-NAME_OF_DISEASE,4887
90638,is,O,4887
90639,used,O,4887
90640,to,O,4887
90641,describe,O,4887
90642,glaucoma,B-NAME_OF_DISEASE,4887
90643,resulting,O,4887
90644,indirectly,O,4887
90645,or,O,4887
90646,directly,O,4887
90647,from,O,4887
90648,uveitis,B-NAME_OF_DISEASE,4887
90649,Glaucoma,B-NAME_OF_DISEASE,4888
90650,is,O,4888
90651,more,O,4888
90652,commonly,O,4888
90653,associated,O,4888
90654,with,O,4888
90655,anterior,B-NAME_OF_DISEASE,4888
90656,uveitis,I-NAME_OF_DISEASE,4888
90657,and,O,4888
90658,with,O,4888
90659,chronic,B-NAME_OF_DISEASE,4888
90660,forms,I-NAME_OF_DISEASE,4888
90661,of,I-NAME_OF_DISEASE,4888
90662,uveitis,I-NAME_OF_DISEASE,4888
90663,Uveitis,B-NAME_OF_DISEASE,4889
90664,and,O,4889
90665,its,O,4889
90666,treatment,O,4889
90667,can,O,4889
90668,lead,O,4889
90669,to,O,4889
90670,elevated,B-SIGN_AND_SYMPTOM,4889
90671,intraocular,I-SIGN_AND_SYMPTOM,4889
90672,pressure,I-SIGN_AND_SYMPTOM,4889
90673,IOP,I-SIGN_AND_SYMPTOM,4889
90674,,O,4889
90675,A,O,4890
90676,persistent,O,4890
90677,rise,O,4890
90678,in,O,4890
90679,IOP,O,4890
90680,can,O,4890
90681,lead,O,4890
90682,to,O,4890
90683,glaucamatous,B-NAME_OF_DISEASE,4890
90684,optic,I-NAME_OF_DISEASE,4890
90685,neuropathy,I-NAME_OF_DISEASE,4890
90686,and,O,4890
90687,visual,B-SIGN_AND_SYMPTOM,4890
90688,field,I-SIGN_AND_SYMPTOM,4890
90689,loss,I-SIGN_AND_SYMPTOM,4890
90690,Intraocular,B-SIGN_AND_SYMPTOM,4891
90691,pressure,I-SIGN_AND_SYMPTOM,4891
90692,IOP,I-SIGN_AND_SYMPTOM,4891
90693,elevation,I-SIGN_AND_SYMPTOM,4891
90694,in,O,4891
90695,uveitis,B-NAME_OF_DISEASE,4891
90696,can,O,4891
90697,be,O,4891
90698,secondary,O,4891
90699,to,O,4891
90700,open,B-CAUSE_OF_DISEASE,4891
90701,angle,I-CAUSE_OF_DISEASE,4891
90702,or,I-CAUSE_OF_DISEASE,4891
90703,angle,I-CAUSE_OF_DISEASE,4891
90704,closure,I-CAUSE_OF_DISEASE,4891
90705,mechanisms,I-CAUSE_OF_DISEASE,4891
90706,It,O,4892
90707,can,O,4892
90708,also,O,4892
90709,be,O,4892
90710,to,O,4892
90711,due,O,4892
90712,corticosteroid,B-CAUSE_OF_DISEASE,4892
90713,induced,I-CAUSE_OF_DISEASE,4892
90714,glaucoma,I-CAUSE_OF_DISEASE,4892
90715,The,O,4893
90716,pathogenesis,O,4893
90717,may,O,4893
90718,be,O,4893
90719,acute,O,4893
90720,in,O,4893
90721,onset,O,4893
90722,with,O,4893
90723,rapid,O,4893
90724,onset,O,4893
90725,inflammation,O,4893
90726,obstruction,O,4893
90727,of,O,4893
90728,intertrabecular,O,4893
90729,spaces,O,4893
90730,and,O,4893
90731,subsequent,O,4893
90732,increased,B-SIGN_AND_SYMPTOM,4893
90733,IOP,I-SIGN_AND_SYMPTOM,4893
90734,The,O,4894
90735,pathogenesis,O,4894
90736,may,O,4894
90737,also,O,4894
90738,be,O,4894
90739,chronic,O,4894
90740,with,O,4894
90741,repeated,O,4894
90742,bouts,O,4894
90743,of,O,4894
90744,uveitis,B-NAME_OF_DISEASE,4894
90745,leading,O,4894
90746,to,O,4894
90747,fibroblastic,B-SIGN_AND_SYMPTOM,4894
90748,infiltration,I-SIGN_AND_SYMPTOM,4894
90749,and,I-SIGN_AND_SYMPTOM,4894
90750,formation,I-SIGN_AND_SYMPTOM,4894
90751,of,I-SIGN_AND_SYMPTOM,4894
90752,scar,I-SIGN_AND_SYMPTOM,4894
90753,tissue,I-SIGN_AND_SYMPTOM,4894
90754,that,O,4894
90755,slowly,O,4894
90756,obstructs,O,4894
90757,the,B-PART_OF_THE_EYES,4894
90758,anterior,I-PART_OF_THE_EYES,4894
90759,chamber,I-PART_OF_THE_EYES,4894
90760,angle,I-PART_OF_THE_EYES,4894
90761,Management,O,4895
90762,of,O,4895
90763,uveitic,B-NAME_OF_DISEASE,4895
90764,glaucoma,B-NAME_OF_DISEASE,4895
90765,is,O,4895
90766,two,O,4895
90767,pronged,O,4895
90768,The,O,4896
90769,etiology,O,4896
90770,of,O,4896
90771,uveitis,B-NAME_OF_DISEASE,4896
90772,must,O,4896
90773,be,O,4896
90774,idenitifed,O,4896
90775,and,O,4896
90776,treated,O,4896
90777,Next,O,4897
90778,the,B-SIGN_AND_SYMPTOM,4897
90779,elevated,I-SIGN_AND_SYMPTOM,4897
90780,IOP,I-SIGN_AND_SYMPTOM,4897
90781,is,O,4897
90782,treated,O,4897
90783,making,O,4897
90784,sure,O,4897
90785,to,O,4897
90786,assess,O,4897
90787,for,O,4897
90788,steroid-induced,B-CAUSE_OF_DISEASE,4897
90789,ocular,I-CAUSE_OF_DISEASE,4897
90790,hypertension,I-CAUSE_OF_DISEASE,4897
90791,Medical,B-TREATMENT,4898
90792,and,I-TREATMENT,4898
90793,surgical,I-TREATMENT,4898
90794,therapy,I-TREATMENT,4898
90795,can,O,4898
90796,be,O,4898
90797,used,O,4898
90798,to,O,4898
90799,fully,O,4898
90800,treat,O,4898
90801,the,O,4898
90802,uveitis,B-NAME_OF_DISEASE,4898
90803,glaucoma,I-NAME_OF_DISEASE,4898
90804,Uveitis,B-NAME_OF_DISEASE,4899
90805,is,O,4899
90806,the,O,4899
90807,third,O,4899
90808,leading,O,4899
90809,cause,O,4899
90810,of,O,4899
90811,preventable,O,4899
90812,blindness,B-NAME_OF_DISEASE,4899
90813,but,O,4899
90814,many,O,4899
90815,people,O,4899
90816,who,O,4899
90817,suffer,O,4899
90818,from,O,4899
90819,this,O,4899
90820,group,O,4899
90821,of,O,4899
90822,diseases,O,4899
90823,lose,O,4899
90824,their,O,4899
90825,vision,O,4899
90826,via,O,4899
90827,other,O,4899
90828,another,O,4899
90829,mechanism,O,4899
90830,-,O,4899
90831,glaucoma,B-NAME_OF_DISEASE,4899
90832,Glaucoma,B-NAME_OF_DISEASE,4900
90833,is,O,4900
90834,the,O,4900
90835,sneak,O,4900
90836,thief,O,4900
90837,of,O,4900
90838,vision,O,4900
90839,a,O,4900
90840,blinding,O,4900
90841,disease,O,4900
90842,of,O,4900
90843,the,B-PART_OF_THE_EYES,4900
90844,optic,B-PART_OF_THE_EYES,4900
90845,nerve,I-PART_OF_THE_EYES,4900
90846,or,O,4900
90847,the,O,4900
90848,structure,O,4900
90849,that,O,4900
90850,connects,O,4900
90851,your,O,4900
90852,eye,O,4900
90853,and,O,4900
90854,brain,O,4900
90855,and,O,4900
90856,allows,O,4900
90857,you,O,4900
90858,to,O,4900
90859,see,O,4900
90860,It,O,4901
90861,causes,O,4901
90862,irreversible,B-SIGN_AND_SYMPTOM,4901
90863,vision,I-SIGN_AND_SYMPTOM,4901
90864,loss,I-SIGN_AND_SYMPTOM,4901
90865,which,O,4901
90866,at,O,4901
90867,first,O,4901
90868,is,O,4901
90869,usually,O,4901
90870,completely,O,4901
90871,unnoticed,O,4901
90872,by,O,4901
90873,the,O,4901
90874,patient,O,4901
90875,asymptomatic,O,4901
90876,because,O,4901
90877,it,O,4901
90878,affects,O,4901
90879,the,O,4901
90880,peripheral,O,4901
90881,vision,O,4901
90882,but,O,4901
90883,slowly,O,4901
90884,progresses,O,4901
90885,until,O,4901
90886,significant,O,4901
90887,central,B-SIGN_AND_SYMPTOM,4901
90888,vision,I-SIGN_AND_SYMPTOM,4901
90889,loss,I-SIGN_AND_SYMPTOM,4901
90890,occurs,O,4901
90891,Glaucoma,B-NAME_OF_DISEASE,4902
90892,itself,O,4902
90893,is,O,4902
90894,actually,O,4902
90895,a,O,4902
90896,much,O,4902
90897,more,O,4902
90898,common,O,4902
90899,disease,O,4902
90900,than,O,4902
90901,uveitis,B-NAME_OF_DISEASE,4902
90902,It,O,4903
90903,comes,O,4903
90904,in,O,4903
90905,many,O,4903
90906,different,O,4903
90907,forms,O,4903
90908,is,O,4903
90909,seen,O,4903
90910,on,O,4903
90911,examination,O,4903
90912,by,O,4903
90913,the,O,4903
90914,uveitis,B-NAME_OF_DISEASE,4903
90915,specialist,O,4903
90916,and,O,4903
90917,is,O,4903
90918,also,O,4903
90919,monitored,O,4903
90920,by,O,4903
90921,specialized,O,4903
90922,testing,O,4903
90923,of,O,4903
90924,optic,B-PART_OF_THE_EYES,4903
90925,nerve,I-PART_OF_THE_EYES,4903
90926,structure,O,4903
90927,OCT,B-DIAGNOSTIC_TEST,4903
90928,scan,I-DIAGNOSTIC_TEST,4903
90929,and,O,4903
90930,function,O,4903
90931,visual,B-DIAGNOSTIC_TEST,4903
90932,field,I-DIAGNOSTIC_TEST,4903
90933,testing,I-DIAGNOSTIC_TEST,4903
90934,looking,O,4903
90935,for,O,4903
90936,signs,O,4903
90937,of,O,4903
90938,progression,O,4903
90939,of,O,4903
90940,optic,B-PART_OF_THE_EYES,4903
90941,nerve,I-PART_OF_THE_EYES,4903
90942,damage,O,4903
90943,It,O,4904
90944,is,O,4904
90945,estimated,O,4904
90946,that,O,4904
90947,2,O,4904
90948,million,O,4904
90949,people,O,4904
90950,worldwide,O,4904
90951,have,O,4904
90952,uveitis,B-NAME_OF_DISEASE,4904
90953,and,O,4904
90954,that,O,4904
90955,the,O,4904
90956,percentage,O,4904
90957,of,O,4904
90958,patients,O,4904
90959,with,O,4904
90960,uveitis,B-NAME_OF_DISEASE,4904
90961,who,O,4904
90962,also,O,4904
90963,have,O,4904
90964,glaucoma,B-NAME_OF_DISEASE,4904
90965,ranges,O,4904
90966,between,O,4904
90967,10,O,4904
90968,and,O,4904
90969,40%,O,4904
90970,Just,O,4905
90971,as,O,4905
90972,in,O,4905
90973,non-uveitic,B-NAME_OF_DISEASE,4905
90974,glaucoma,I-NAME_OF_DISEASE,4905
90975,uveitic,B-NAME_OF_DISEASE,4905
90976,glaucoma,I-NAME_OF_DISEASE,4905
90977,is,O,4905
90978,more,O,4905
90979,commonly,O,4905
90980,seen,O,4905
90981,in,O,4905
90982,older,O,4905
90983,patients,O,4905
90984,Some,O,4906
90985,forms,O,4906
90986,of,O,4906
90987,uveitis,B-NAME_OF_DISEASE,4906
90988,are,O,4906
90989,more,O,4906
90990,prone,O,4906
90991,to,O,4906
90992,developing,O,4906
90993,glaucoma,B-NAME_OF_DISEASE,4906
90994,including,O,4906
90995,both,O,4906
90996,infectious,O,4906
90997,causes,O,4906
90998,such,O,4906
90999,as,O,4906
91000,some,O,4906
91001,types,O,4906
91002,of,O,4906
91003,virus,B-NAME_OF_DISEASE,4906
91004,associated,I-NAME_OF_DISEASE,4906
91005,uveitis,I-NAME_OF_DISEASE,4906
91006,and,O,4906
91007,non-infectious,O,4906
91008,causes,O,4906
91009,like,O,4906
91010,juvenile,B-NAME_OF_DISEASE,4906
91011,idiopathic,I-NAME_OF_DISEASE,4906
91012,arthritis,I-NAME_OF_DISEASE,4906
91013,associated,I-NAME_OF_DISEASE,4906
91014,uveitis,I-NAME_OF_DISEASE,4906
91015,Sometimes,O,4907
91016,uveitic,B-NAME_OF_DISEASE,4907
91017,glaucoma,I-NAME_OF_DISEASE,4907
91018,occurs,O,4907
91019,because,O,4907
91020,of,O,4907
91021,long-term,O,4907
91022,dependence,O,4907
91023,on,O,4907
91024,steroid,B-NAME_OF_DRUG,4907
91025,therapy,O,4907
91026,whether,O,4907
91027,by,O,4907
91028,oral,O,4907
91029,medication,O,4907
91030,or,O,4907
91031,eye,O,4907
91032,drops,O,4907
91033,vis-à-vis,O,4907
91034,either,O,4907
91035,poorly,O,4907
91036,controlled,O,4907
91037,inflammation,O,4907
91038,or,O,4907
91039,a,O,4907
91040,distinct,O,4907
91041,and,O,4907
91042,significant,O,4907
91043,rise,O,4907
91044,in,O,4907
91045,eye,O,4907
91046,pressure,O,4907
91047,caused,O,4907
91048,by,O,4907
91049,steroids,B-NAME_OF_DRUG,4907
91050,themselves,O,4907
91051,The,O,4908
91052,most,O,4908
91053,common,O,4908
91054,reason,O,4908
91055,why,O,4908
91056,glaucoma,B-NAME_OF_DISEASE,4908
91057,causes,O,4908
91058,vision,B-SIGN_AND_SYMPTOM,4908
91059,loss,I-SIGN_AND_SYMPTOM,4908
91060,is,O,4908
91061,because,O,4908
91062,of,O,4908
91063,high,B-SIGN_AND_SYMPTOM,4908
91064,pressure,I-SIGN_AND_SYMPTOM,4908
91065,in,I-SIGN_AND_SYMPTOM,4908
91066,the,I-SIGN_AND_SYMPTOM,4908
91067,eye,I-SIGN_AND_SYMPTOM,4908
91068,It,O,4909
91069,is,O,4909
91070,primarily,O,4909
91071,a,O,4909
91072,problem,O,4909
91073,with,O,4909
91074,fluid,B-SIGN_AND_SYMPTOM,4909
91075,balance,I-SIGN_AND_SYMPTOM,4909
91076,in,I-SIGN_AND_SYMPTOM,4909
91077,the,I-SIGN_AND_SYMPTOM,4909
91078,eye,I-SIGN_AND_SYMPTOM,4909
91079,which,O,4909
91080,creates,O,4909
91081,the,O,4909
91082,pressure,O,4909
91083,-,O,4909
91084,too,O,4909
91085,much,O,4909
91086,fluid,O,4909
91087,in,O,4909
91088,or,O,4909
91089,not,O,4909
91090,enough,O,4909
91091,fluid,O,4909
91092,out,O,4909
91093,,O,4909
91094,This,O,4910
91095,imbalance,O,4910
91096,is,O,4910
91097,then,O,4910
91098,treated,O,4910
91099,by,O,4910
91100,means,O,4910
91101,to,O,4910
91102,reduce,O,4910
91103,this,O,4910
91104,pressure,O,4910
91105,such,O,4910
91106,as,O,4910
91107,eye,B-TREATMENT,4910
91108,drops,I-TREATMENT,4910
91109,or,O,4910
91110,laser,B-TREATMENT,4910
91111,therapy,I-TREATMENT,4910
91112,and,O,4910
91113,less,O,4910
91114,commonly,O,4910
91115,surgery,B-TREATMENT,4910
91116,Cardiovascular,B-CAUSE_OF_DISEASE,4911
91117,and,I-CAUSE_OF_DISEASE,4911
91118,metabolic,I-CAUSE_OF_DISEASE,4911
91119,diseases,I-CAUSE_OF_DISEASE,4911
91120,have,O,4911
91121,also,O,4911
91122,been,O,4911
91123,thought,O,4911
91124,to,O,4911
91125,play,O,4911
91126,a,O,4911
91127,more,O,4911
91128,prominent,O,4911
91129,role,O,4911
91130,in,O,4911
91131,glaucoma,B-NAME_OF_DISEASE,4911
91132,specifically,O,4911
91133,hypertension,B-CAUSE_OF_DISEASE,4911
91134,and,O,4911
91135,diabetes,B-CAUSE_OF_DISEASE,4911
91136,But,O,4912
91137,in,O,4912
91138,uveitic,B-NAME_OF_DISEASE,4912
91139,glaucoma,I-NAME_OF_DISEASE,4912
91140,several,O,4912
91141,other,O,4912
91142,factors,O,4912
91143,may,O,4912
91144,be,O,4912
91145,in,O,4912
91146,play,O,4912
91147,including,O,4912
91148,scarring,B-CAUSE_OF_DISEASE,4912
91149,and,I-CAUSE_OF_DISEASE,4912
91150,poor,I-CAUSE_OF_DISEASE,4912
91151,blood,I-CAUSE_OF_DISEASE,4912
91152,flow,I-CAUSE_OF_DISEASE,4912
91153,due,I-CAUSE_OF_DISEASE,4912
91154,to,I-CAUSE_OF_DISEASE,4912
91155,chronic,I-CAUSE_OF_DISEASE,4912
91156,inflammation,I-CAUSE_OF_DISEASE,4912
91157,Scarring,B-CAUSE_OF_DISEASE,4913
91158,may,O,4913
91159,cause,O,4913
91160,abnormalities,O,4913
91161,in,O,4913
91162,the,O,4913
91163,outflow,O,4913
91164,pathway,O,4913
91165,of,O,4913
91166,fluid,O,4913
91167,from,O,4913
91168,the,O,4913
91169,eye,O,4913
91170,leading,O,4913
91171,to,O,4913
91172,higher,O,4913
91173,pressure,O,4913
91174,Abnormal,B-CAUSE_OF_DISEASE,4914
91175,blood,I-CAUSE_OF_DISEASE,4914
91176,flow,I-CAUSE_OF_DISEASE,4914
91177,and,I-CAUSE_OF_DISEASE,4914
91178,blood,I-CAUSE_OF_DISEASE,4914
91179,vessel,I-CAUSE_OF_DISEASE,4914
91180,inflammation,I-CAUSE_OF_DISEASE,4914
91181,can,O,4914
91182,also,O,4914
91183,damage,O,4914
91184,outflow,O,4914
91185,pathways,O,4914
91186,but,O,4914
91187,may,O,4914
91188,also,O,4914
91189,pose,O,4914
91190,a,O,4914
91191,threat,O,4914
91192,to,O,4914
91193,oxygen,O,4914
91194,delivery,O,4914
91195,to,O,4914
91196,the,B-PART_OF_THE_EYES,4914
91197,retina,I-PART_OF_THE_EYES,4914
91198,and,O,4914
91199,optic,B-PART_OF_THE_EYES,4914
91200,nerve,I-PART_OF_THE_EYES,4914
91201,ischemia,B-NAME_OF_DISEASE,4914
91202,which,O,4914
91203,can,O,4914
91204,also,O,4914
91205,cause,O,4914
91206,irreversible,O,4914
91207,damage,O,4914
91208,At,O,4915
91209,times,O,4915
91210,active,B-CAUSE_OF_DISEASE,4915
91211,inflammation,I-CAUSE_OF_DISEASE,4915
91212,is,O,4915
91213,felt,O,4915
91214,to,O,4915
91215,be,O,4915
91216,the,O,4915
91217,cause,O,4915
91218,of,O,4915
91219,high,B-SIGN_AND_SYMPTOM,4915
91220,eye,I-SIGN_AND_SYMPTOM,4915
91221,pressure,I-SIGN_AND_SYMPTOM,4915
91222,as,O,4915
91223,may,O,4915
91224,happen,O,4915
91225,in,O,4915
91226,herpes,B-NAME_OF_DISEASE,4915
91227,simplex,I-NAME_OF_DISEASE,4915
91228,iritis,I-NAME_OF_DISEASE,4915
91229,-,O,4915
91230,simply,O,4915
91231,treating,O,4915
91232,the,O,4915
91233,inflammation,O,4915
91234,causes,O,4915
91235,the,O,4915
91236,eye,O,4915
91237,pressure,O,4915
91238,to,O,4915
91239,return,O,4915
91240,to,O,4915
91241,normal,O,4915
91242,Glaucoma,B-NAME_OF_DISEASE,4916
91243,is,O,4916
91244,often,O,4916
91245,a,O,4916
91246,complicating,O,4916
91247,factor,O,4916
91248,for,O,4916
91249,patients,O,4916
91250,suffering,O,4916
91251,with,O,4916
91252,uveitis,B-NAME_OF_DISEASE,4916
91253,The,O,4917
91254,relationship,O,4917
91255,between,O,4917
91256,uveitis,B-NAME_OF_DISEASE,4917
91257,and,O,4917
91258,glaucoma,B-NAME_OF_DISEASE,4917
91259,is,O,4917
91260,quite,O,4917
91261,complex,O,4917
91262,and,O,4917
91263,often,O,4917
91264,multifactorial,O,4917
91265,which,O,4917
91266,makes,O,4917
91267,management,O,4917
91268,challenging,O,4917
91269,In,O,4918
91270,acute,B-NAME_OF_DISEASE,4918
91271,uveitis,I-NAME_OF_DISEASE,4918
91272,IOP,O,4918
91273,can,O,4918
91274,be,O,4918
91275,decreased,O,4918
91276,from,O,4918
91277,ciliary,O,4918
91278,body,O,4918
91279,shutdown,O,4918
91280,However,O,4919
91281,several,O,4919
91282,mechanisms,O,4919
91283,can,O,4919
91284,lead,O,4919
91285,to,O,4919
91286,uveitic,B-NAME_OF_DISEASE,4919
91287,glaucoma,I-NAME_OF_DISEASE,4919
91288,over,O,4919
91289,the,O,4919
91290,course,O,4919
91291,of,O,4919
91292,the,O,4919
91293,disease,O,4919
91294,such,O,4919
91295,as,O,4919
91296,open-angle,B-CAUSE_OF_DISEASE,4919
91297,mechanisms,I-CAUSE_OF_DISEASE,4919
91298,secondary,B-CAUSE_OF_DISEASE,4919
91299,angle,I-CAUSE_OF_DISEASE,4919
91300,closure,I-CAUSE_OF_DISEASE,4919
91301,and,O,4919
91302,steroid,B-CAUSE_OF_DISEASE,4919
91303,response,I-CAUSE_OF_DISEASE,4919
91304,MECHANISMS,O,4920
91305,THAT,O,4920
91306,LEAD,O,4920
91307,TO,O,4920
91308,UVEITIC,B-NAME_OF_DISEASE,4920
91309,GLAUCOMA,I-NAME_OF_DISEASE,4920
91310,Open-angle,B-CAUSE_OF_DISEASE,4920
91311,glaucoma,I-CAUSE_OF_DISEASE,4920
91312,Open-angle,B-CAUSE_OF_DISEASE,4920
91313,glaucoma,I-CAUSE_OF_DISEASE,4920
91314,is,O,4920
91315,the,O,4920
91316,most,O,4920
91317,common,O,4920
91318,cause,O,4920
91319,of,O,4920
91320,elevated,B-SIGN_AND_SYMPTOM,4920
91321,IOP,I-SIGN_AND_SYMPTOM,4920
91322,in,O,4920
91323,uveitis,B-NAME_OF_DISEASE,4920
91324,Inflammatory,O,4921
91325,cells,O,4921
91326,fibrin,O,4921
91327,and,O,4921
91328,debris,O,4921
91329,obstruct,O,4921
91330,the,B-PART_OF_THE_EYES,4921
91331,trabecular,I-PART_OF_THE_EYES,4921
91332,meshwork,I-PART_OF_THE_EYES,4921
91333,In,O,4922
91334,addition,O,4922
91335,cytokine-induced,O,4922
91336,inflammation,O,4922
91337,of,O,4922
91338,the,B-PART_OF_THE_EYES,4922
91339,trabecular,I-PART_OF_THE_EYES,4922
91340,meshwork,I-PART_OF_THE_EYES,4922
91341,can,O,4922
91342,disrupt,O,4922
91343,aqueous,O,4922
91344,outflow,O,4922
91345,as,O,4922
91346,well,O,4922
91347,Chronic,B-CAUSE_OF_DISEASE,4923
91348,inflammation,I-CAUSE_OF_DISEASE,4923
91349,leads,O,4923
91350,to,O,4923
91351,fibrovascular,B-SIGN_AND_SYMPTOM,4923
91352,proliferation,I-SIGN_AND_SYMPTOM,4923
91353,and,I-SIGN_AND_SYMPTOM,4923
91354,scarring,I-SIGN_AND_SYMPTOM,4923
91355,of,I-SIGN_AND_SYMPTOM,4923
91356,the,I-SIGN_AND_SYMPTOM,4923
91357,outflow,I-SIGN_AND_SYMPTOM,4923
91358,pathways,I-SIGN_AND_SYMPTOM,4923
91359,Closed-angle,B-CAUSE_OF_DISEASE,4924
91360,glaucoma,I-CAUSE_OF_DISEASE,4924
91361,Chronic,B-CAUSE_OF_DISEASE,4924
91362,inflammation,I-CAUSE_OF_DISEASE,4924
91363,may,O,4924
91364,induce,O,4924
91365,peripheral,B-SIGN_AND_SYMPTOM,4924
91366,anterior,I-SIGN_AND_SYMPTOM,4924
91367,synechiae,I-SIGN_AND_SYMPTOM,4924
91368,PAS,I-SIGN_AND_SYMPTOM,4924
91369,or,I-SIGN_AND_SYMPTOM,4924
91370,posterior,I-SIGN_AND_SYMPTOM,4924
91371,synechiae,I-SIGN_AND_SYMPTOM,4924
91372,PS,I-SIGN_AND_SYMPTOM,4924
91373,formation,I-SIGN_AND_SYMPTOM,4924
91374,In,O,4925
91375,the,O,4925
91376,angle,O,4925
91377,broad-based,B-CAUSE_OF_DISEASE,4925
91378,PAS,I-CAUSE_OF_DISEASE,4925
91379,can,O,4925
91380,cause,O,4925
91381,total,O,4925
91382,closure,O,4925
91383,of,O,4925
91384,the,O,4925
91385,angle,O,4925
91386,At,O,4926
91387,the,B-PART_OF_THE_EYES,4926
91388,pupil,I-PART_OF_THE_EYES,4926
91389,margin,I-PART_OF_THE_EYES,4926
91390,PS,O,4926
91391,can,O,4926
91392,block,O,4926
91393,the,O,4926
91394,flow,O,4926
91395,of,O,4926
91396,aqueous,O,4926
91397,fluid,O,4926
91398,from,O,4926
91399,the,O,4926
91400,posterior,O,4926
91401,to,O,4926
91402,anterior,O,4926
91403,chamber,O,4926
91404,which,O,4926
91405,results,O,4926
91406,in,O,4926
91407,iris,B-SIGN_AND_SYMPTOM,4926
91408,bombé,I-SIGN_AND_SYMPTOM,4926
91409,and,O,4926
91410,acute,B-SIGN_AND_SYMPTOM,4926
91411,angle,I-SIGN_AND_SYMPTOM,4926
91412,closure,I-SIGN_AND_SYMPTOM,4926
91413,Less,O,4927
91414,commonly,O,4927
91415,chronic,O,4927
91416,angle,O,4927
91417,closure,O,4927
91418,can,O,4927
91419,result,O,4927
91420,from,O,4927
91421,anterior,O,4927
91422,rotation,O,4927
91423,of,O,4927
91424,the,O,4927
91425,ciliary,O,4927
91426,body,O,4927
91427,as,O,4927
91428,a,O,4927
91429,result,O,4927
91430,of,O,4927
91431,inflammation,O,4927
91432,and,O,4927
91433,edema,O,4927
91434,Steroid-induced,B-NAME_OF_DISEASE,4928
91435,glaucoma,I-NAME_OF_DISEASE,4928
91436,Steroids,B-NAME_OF_DRUG,4928
91437,are,O,4928
91438,the,O,4928
91439,mainstay,O,4928
91440,of,O,4928
91441,treatment,O,4928
91442,of,O,4928
91443,uveitis,B-NAME_OF_DISEASE,4928
91444,Often,O,4929
91445,patients,O,4929
91446,can,O,4929
91447,develop,O,4929
91448,a,O,4929
91449,steroid,B-NAME_OF_DRUG,4929
91450,response,O,4929
91451,Corticosteroidinduced,B-SIGN_AND_SYMPTOM,4930
91452,IOP,I-SIGN_AND_SYMPTOM,4930
91453,elevation,I-SIGN_AND_SYMPTOM,4930
91454,is,O,4930
91455,primarily,O,4930
91456,due,O,4930
91457,to,O,4930
91458,increased,B-CAUSE_OF_DISEASE,4930
91459,outflow,I-CAUSE_OF_DISEASE,4930
91460,resistance,I-CAUSE_OF_DISEASE,4930
91461,and,O,4930
91462,is,O,4930
91463,thought,O,4930
91464,to,O,4930
91465,result,O,4930
91466,from,O,4930
91467,suppression,B-CAUSE_OF_DISEASE,4930
91468,of,I-CAUSE_OF_DISEASE,4930
91469,phagocytic,I-CAUSE_OF_DISEASE,4930
91470,activity,I-CAUSE_OF_DISEASE,4930
91471,which,O,4930
91472,leads,O,4930
91473,to,O,4930
91474,increased,O,4930
91475,deposition,O,4930
91476,of,O,4930
91477,glycosaminoglycans,B-CHEMICAL_COMPOUND,4930
91478,and,O,4930
91479,a,O,4930
91480,decrease,O,4930
91481,in,O,4930
91482,prostaglandin,B-CHEMICAL_COMPOUND,4930
91483,synthesis,O,4930
91484,Steroid,B-NAME_OF_DRUG,4931
91485,response,O,4931
91486,can,O,4931
91487,be,O,4931
91488,unpredictable,O,4931
91489,Often,O,4932
91490,it,O,4932
91491,is,O,4932
91492,seen,O,4932
91493,within,O,4932
91494,a,O,4932
91495,few,O,4932
91496,weeks,O,4932
91497,of,O,4932
91498,starting,O,4932
91499,therapy,O,4932
91500,However,O,4933
91501,patients,O,4933
91502,who,O,4933
91503,have,O,4933
91504,been,O,4933
91505,on,O,4933
91506,chronic,B-NAME_OF_DRUG,4933
91507,steroids,I-NAME_OF_DRUG,4933
91508,with,O,4933
91509,previously,O,4933
91510,normal,O,4933
91511,IOP,O,4933
91512,can,O,4933
91513,also,O,4933
91514,exhibit,O,4933
91515,steroid,B-NAME_OF_DRUG,4933
91516,response,O,4933
91517,EVALUATION,O,4934
91518,Just,O,4934
91519,as,O,4934
91520,the,O,4934
91521,severity,O,4934
91522,of,O,4934
91523,uveitis,B-NAME_OF_DISEASE,4934
91524,varies,O,4934
91525,widely,O,4934
91526,so,O,4934
91527,does,O,4934
91528,the,O,4934
91529,severity,O,4934
91530,of,O,4934
91531,glaucoma,B-NAME_OF_DISEASE,4934
91532,A,O,4935
91533,significant,O,4935
91534,percentage,O,4935
91535,of,O,4935
91536,patients,O,4935
91537,with,O,4935
91538,uveitis,B-NAME_OF_DISEASE,4935
91539,will,O,4935
91540,develop,O,4935
91541,glaucoma,B-NAME_OF_DISEASE,4935
91542,One,O,4936
91543,key,O,4936
91544,pearl,O,4936
91545,in,O,4936
91546,managing,O,4936
91547,patients,O,4936
91548,with,O,4936
91549,both,O,4936
91550,uveitis,B-NAME_OF_DISEASE,4936
91551,and,O,4936
91552,glaucoma,B-NAME_OF_DISEASE,4936
91553,is,O,4936
91554,to,O,4936
91555,discuss,O,4936
91556,glaucoma,B-NAME_OF_DISEASE,4936
91557,early,O,4936
91558,in,O,4936
91559,the,O,4936
91560,course,O,4936
91561,of,O,4936
91562,uveitis,B-NAME_OF_DISEASE,4936
91563,before,O,4936
91564,they,O,4936
91565,develop,O,4936
91566,glaucoma,B-NAME_OF_DISEASE,4936
91567,Set,O,4937
91568,expectations,O,4937
91569,for,O,4937
91570,the,O,4937
91571,risk,O,4937
91572,and,O,4937
91573,need,O,4937
91574,for,O,4937
91575,management,O,4937
91576,of,O,4937
91577,glaucoma,B-NAME_OF_DISEASE,4937
91578,Make,O,4938
91579,a,O,4938
91580,point,O,4938
91581,to,O,4938
91582,share,O,4938
91583,the,O,4938
91584,eye,O,4938
91585,pressure,O,4938
91586,with,O,4938
91587,the,O,4938
91588,patient,O,4938
91589,whether,O,4938
91590,it,O,4938
91591,is,O,4938
91592,of,O,4938
91593,concern,O,4938
91594,or,O,4938
91595,not,O,4938
91596,On,O,4939
91597,your,O,4939
91598,initial,O,4939
91599,exam,O,4939
91600,gonioscopy,B-DIAGNOSTIC_TEST,4939
91601,is,O,4939
91602,very,O,4939
91603,helpful,O,4939
91604,to,O,4939
91605,determine,O,4939
91606,the,O,4939
91607,extent,O,4939
91608,of,O,4939
91609,current,O,4939
91610,and,O,4939
91611,or,O,4939
91612,past,O,4939
91613,inflammation,O,4939
91614,As,O,4940
91615,you,O,4940
91616,follow,O,4940
91617,the,O,4940
91618,patient,O,4940
91619,serial,B-DIAGNOSTIC_TEST,4940
91620,gonioscopy,I-DIAGNOSTIC_TEST,4940
91621,provides,O,4940
91622,an,O,4940
91623,idea,O,4940
91624,of,O,4940
91625,whether,O,4940
91626,the,O,4940
91627,patient,O,4940
91628,has,O,4940
91629,had,O,4940
91630,flares,O,4940
91631,in,O,4940
91632,between,O,4940
91633,visits,O,4940
91634,even,O,4940
91635,if,O,4940
91636,they,O,4940
91637,may,O,4940
91638,be,O,4940
91639,symptomatic,O,4940
91640,especially,O,4940
91641,in,O,4940
91642,children,O,4940
91643,Gonioscopy,B-DIAGNOSTIC_TEST,4941
91644,should,O,4941
91645,be,O,4941
91646,performed,O,4941
91647,at,O,4941
91648,baseline,O,4941
91649,with,O,4941
91650,each,O,4941
91651,flare,O,4941
91652,and,O,4941
91653,yearly,O,4941
91654,at,O,4941
91655,minimum,O,4941
91656,If,O,4942
91657,significant,O,4942
91658,PAS,B-SIGN_AND_SYMPTOM,4942
91659,are,O,4942
91660,present,O,4942
91661,the,O,4942
91662,patient,O,4942
91663,s,O,4942
91664,risk,O,4942
91665,for,O,4942
91666,developing,O,4942
91667,chronic,B-NAME_OF_DISEASE,4942
91668,angle,I-NAME_OF_DISEASE,4942
91669,closure,I-NAME_OF_DISEASE,4942
91670,is,O,4942
91671,higher,O,4942
91672,Documenting,B-DIAGNOSTIC_TEST,4943
91673,a,I-DIAGNOSTIC_TEST,4943
91674,baseline,I-DIAGNOSTIC_TEST,4943
91675,disc,I-DIAGNOSTIC_TEST,4943
91676,photo,I-DIAGNOSTIC_TEST,4943
91677,and,O,4943
91678,optic,B-DIAGNOSTIC_TEST,4943
91679,nerve,I-DIAGNOSTIC_TEST,4943
91680,optical,I-DIAGNOSTIC_TEST,4943
91681,coherence,I-DIAGNOSTIC_TEST,4943
91682,tomography,I-DIAGNOSTIC_TEST,4943
91683,are,O,4943
91684,also,O,4943
91685,helpful,O,4943
91686,as,O,4943
91687,you,O,4943
91688,follow,O,4943
91689,patients,O,4943
91690,with,O,4943
91691,uveitis,B-NAME_OF_DISEASE,4943
91692,over,O,4943
91693,time,O,4943
91694,MEDICAL,O,4944
91695,MANAGEMENT,O,4944
91696,Glaucoma,B-NAME_OF_DISEASE,4944
91697,medications,O,4944
91698,If,O,4944
91699,a,O,4944
91700,patient,O,4944
91701,s,O,4944
91702,eye,O,4944
91703,pressure,O,4944
91704,is,O,4944
91705,elevated,O,4944
91706,-,O,4944
91707,it,O,4944
91708,varies,O,4944
91709,for,O,4944
91710,different,O,4944
91711,people,O,4944
91712,but,O,4944
91713,typically,O,4944
91714,above,O,4944
91715,22,O,4944
91716,mm,O,4944
91717,Hg,O,4944
91718,-,O,4944
91719,good,O,4944
91720,first-line,O,4944
91721,options,O,4944
91722,are,O,4944
91723,a,B-NAME_OF_DRUG,4944
91724,beta,I-NAME_OF_DRUG,4944
91725,blocker,I-NAME_OF_DRUG,4944
91726,or,O,4944
91727,carbonic,B-NAME_OF_DRUG,4944
91728,anhydrase,I-NAME_OF_DRUG,4944
91729,inhibitors,I-NAME_OF_DRUG,4944
91730,We,O,4945
91731,prefer,O,4945
91732,a,B-NAME_OF_DRUG,4945
91733,beta,I-NAME_OF_DRUG,4945
91734,blocker,I-NAME_OF_DRUG,4945
91735,if,O,4945
91736,there,O,4945
91737,is,O,4945
91738,no,O,4945
91739,contraindication,O,4945
91740,of,O,4945
91741,quick,O,4945
91742,onset,O,4945
91743,and,O,4945
91744,option,O,4945
91745,for,O,4945
91746,once,O,4945
91747,daily,O,4945
91748,dosing,O,4945
91749,Once,O,4946
91750,the,O,4946
91751,IOP,O,4946
91752,is,O,4946
91753,at,O,4946
91754,a,O,4946
91755,point,O,4946
91756,where,O,4946
91757,we,O,4946
91758,are,O,4946
91759,treating,O,4946
91760,it,O,4946
91761,with,O,4946
91762,a,B-TREATMENT,4946
91763,topical,I-TREATMENT,4946
91764,drop,I-TREATMENT,4946
91765,we,O,4946
91766,get,O,4946
91767,a,O,4946
91768,baseline,O,4946
91769,visual,O,4946
91770,field,O,4946
91771,as,O,4946
91772,soon,O,4946
91773,as,O,4946
91774,the,O,4946
91775,patient,O,4946
91776,is,O,4946
91777,over,O,4946
91778,the,O,4946
91779,acute,O,4946
91780,flare,O,4946
91781,My,O,4947
91782,second-line,O,4947
91783,choice,O,4947
91784,for,O,4947
91785,uveitic,B-NAME_OF_DISEASE,4947
91786,glaucoma,B-NAME_OF_DISEASE,4947
91787,is,O,4947
91788,a,O,4947
91789,combination,O,4947
91790,drop,O,4947
91791,with,O,4947
91792,a,B-NAME_OF_DRUG,4947
91793,beta,I-NAME_OF_DRUG,4947
91794,blocker,I-NAME_OF_DRUG,4947
91795,like,O,4947
91796,dorzolamide,B-NAME_OF_DRUG,4947
91797,hydrochloride-timolol,I-NAME_OF_DRUG,4947
91798,maleate,I-NAME_OF_DRUG,4947
91799,ophthalmic,I-NAME_OF_DRUG,4947
91800,solution,I-NAME_OF_DRUG,4947
91801,Cosopt,I-NAME_OF_DRUG,4947
91802,Akorn,I-NAME_OF_DRUG,4947
91803,or,O,4947
91804,brimonidine,B-NAME_OF_DRUG,4947
91805,tartrate-timolol,O,4947
91806,maleate,O,4947
91807,ophthalmic,O,4947
91808,solution,O,4947
91809,0.2,O,4947
91810,0.5,O,4948
91811,Combigan,O,4949
91812,Allergan,O,4949
91813,,O,4949
91814,If,O,4950
91815,a,O,4950
91816,third,O,4950
91817,agent,O,4950
91818,is,O,4950
91819,required,O,4950
91820,we,O,4950
91821,add,O,4950
91822,brimonidine,B-NAME_OF_DRUG,4950
91823,or,O,4950
91824,a,B-NAME_OF_DRUG,4950
91825,carbonic,I-NAME_OF_DRUG,4950
91826,anhydrase,I-NAME_OF_DRUG,4950
91827,inhibitor,I-NAME_OF_DRUG,4950
91828,At,O,4951
91829,this,O,4951
91830,point,O,4951
91831,we,O,4951
91832,typically,O,4951
91833,begin,O,4951
91834,collaborating,O,4951
91835,with,O,4951
91836,a,O,4951
91837,glaucoma,B-NAME_OF_DISEASE,4951
91838,colleague,O,4951
91839,If,O,4952
91840,the,O,4952
91841,patient,O,4952
91842,already,O,4952
91843,has,O,4952
91844,advanced,O,4952
91845,cupping,O,4952
91846,we,O,4952
91847,refer,O,4952
91848,to,O,4952
91849,a,O,4952
91850,glaucoma,B-NAME_OF_DISEASE,4952
91851,specialist,O,4952
91852,even,O,4952
91853,sooner,O,4952
91854,Early,O,4953
91855,collaboration,O,4953
91856,is,O,4953
91857,important,O,4953
91858,to,O,4953
91859,relieve,O,4953
91860,patient,O,4953
91861,anxiety,O,4953
91862,in,O,4953
91863,times,O,4953
91864,of,O,4953
91865,flare,O,4953
91866,as,O,4953
91867,well,O,4953
91868,as,O,4953
91869,prepare,O,4953
91870,for,O,4953
91871,surgical,O,4953
91872,options,O,4953
91873,if,O,4953
91874,needed,O,4953
91875,Often,O,4954
91876,if,O,4954
91877,the,O,4954
91878,patient,O,4954
91879,has,O,4954
91880,to,O,4954
91881,take,O,4954
91882,high-frequency,O,4954
91883,topical,B-NAME_OF_DRUG,4954
91884,steroids,I-NAME_OF_DRUG,4954
91885,-,O,4954
91886,cycloplegic,B-NAME_OF_DRUG,4954
91887,and,I-NAME_OF_DRUG,4954
91888,glaucoma,I-NAME_OF_DRUG,4954
91889,drops,I-NAME_OF_DRUG,4954
91890,-,O,4954
91891,we,O,4954
91892,look,O,4954
91893,into,O,4954
91894,preservative-free,O,4954
91895,options,O,4954
91896,eg,O,4954
91897,PF-Cosopt,B-NAME_OF_DRUG,4954
91898,Akorn,I-NAME_OF_DRUG,4954
91899,and,O,4954
91900,or,O,4954
91901,compounded,O,4954
91902,drops,O,4954
91903,from,O,4954
91904,ImprimisRx,B-ORGANIZATION,4954
91905,or,O,4954
91906,OSRX,B-ORGANIZATION,4954
91907,for,O,4954
91908,example,O,4954
91909,,O,4954
91910,The,O,4955
91911,surface,O,4955
91912,irregularity,O,4955
91913,and,O,4955
91914,discomfort,O,4955
91915,are,O,4955
91916,challenging,O,4955
91917,for,O,4955
91918,patients,O,4955
91919,and,O,4955
91920,their,O,4955
91921,drop,O,4955
91922,compliance,O,4955
91923,We,O,4956
91924,recommend,O,4956
91925,preservative-free,B-NAME_OF_DRUG,4956
91926,artificial,I-NAME_OF_DRUG,4956
91927,tears,I-NAME_OF_DRUG,4956
91928,if,O,4956
91929,the,O,4956
91930,patient,O,4956
91931,is,O,4956
91932,on,O,4956
91933,two,O,4956
91934,drops,O,4956
91935,and,O,4956
91936,has,O,4956
91937,any,O,4956
91938,signs,O,4956
91939,of,O,4956
91940,surface,B-NAME_OF_DISEASE,4956
91941,keratopathy,I-NAME_OF_DISEASE,4956
91942,It,O,4957
91943,is,O,4957
91944,important,O,4957
91945,to,O,4957
91946,monitor,O,4957
91947,and,O,4957
91948,stress,O,4957
91949,compliance,O,4957
91950,with,O,4957
91951,medications,O,4957
91952,We,O,4958
91953,routinely,O,4958
91954,inquire,O,4958
91955,about,O,4958
91956,side,O,4958
91957,effects,O,4958
91958,and,O,4958
91959,tolerance,O,4958
91960,If,O,4959
91961,intolerance,O,4959
91962,is,O,4959
91963,affecting,O,4959
91964,compliance,O,4959
91965,intervene,O,4959
91966,early,O,4959
91967,Prostaglandin,B-NAME_OF_DRUG,4960
91968,analogues,I-NAME_OF_DRUG,4960
91969,and,O,4960
91970,cholinergic,B-NAME_OF_DRUG,4960
91971,agents,I-NAME_OF_DRUG,4960
91972,are,O,4960
91973,a,O,4960
91974,relative,O,4960
91975,contraindication,O,4960
91976,because,O,4960
91977,they,O,4960
91978,can,O,4960
91979,exacerbate,O,4960
91980,inflammation,O,4960
91981,through,O,4960
91982,further,O,4960
91983,breakdown,O,4960
91984,of,O,4960
91985,the,O,4960
91986,blood-aqueous,O,4960
91987,barrier,O,4960
91988,However,O,4961
91989,a,B-NAME_OF_DRUG,4961
91990,prostaglandin,I-NAME_OF_DRUG,4961
91991,analog,I-NAME_OF_DRUG,4961
91992,can,O,4961
91993,be,O,4961
91994,added,O,4961
91995,with,O,4961
91996,close,O,4961
91997,monitoring,O,4961
91998,if,O,4961
91999,a,O,4961
92000,patient,O,4961
92001,s,O,4961
92002,IOP,O,4961
92003,requires,O,4961
92004,it,O,4961
92005,Rho,B-NAME_OF_DRUG,4962
92006,kinase,I-NAME_OF_DRUG,4962
92007,inhibitors,I-NAME_OF_DRUG,4962
92008,-,O,4962
92009,which,O,4962
92010,act,O,4962
92011,on,O,4962
92012,the,O,4962
92013,trabecular,O,4962
92014,meshwork,O,4962
92015,cells,O,4962
92016,and,O,4962
92017,endothelial,O,4962
92018,cells,O,4962
92019,in,O,4962
92020,Schlemm,B-PART_OF_THE_EYES,4962
92021,s,I-PART_OF_THE_EYES,4962
92022,canal,I-PART_OF_THE_EYES,4962
92023,to,O,4962
92024,enhance,O,4962
92025,outflow,O,4962
92026,facility,O,4962
92027,-,O,4962
92028,may,O,4962
92029,be,O,4962
92030,of,O,4962
92031,value,O,4962
92032,Typically,O,4963
92033,these,O,4963
92034,are,O,4963
92035,used,O,4963
92036,as,O,4963
92037,third-,O,4963
92038,or,O,4963
92039,fourth-line,O,4963
92040,agents,O,4963
92041,in,O,4963
92042,my,O,4963
92043,uveitis,B-NAME_OF_DISEASE,4963
92044,algorithm,O,4963
92045,because,O,4963
92046,of,O,4963
92047,the,O,4963
92048,side,O,4963
92049,effect,O,4963
92050,of,O,4963
92051,hyperemia,B-NAME_OF_DISEASE,4963
92052,potentially,O,4963
92053,clouding,O,4963
92054,the,O,4963
92055,uveitis,B-NAME_OF_DISEASE,4963
92056,picture,O,4963
92057,Oral,B-NAME_OF_DRUG,4964
92058,carbonic,I-NAME_OF_DRUG,4964
92059,anhydrase,I-NAME_OF_DRUG,4964
92060,inhibitors,I-NAME_OF_DRUG,4964
92061,are,O,4964
92062,a,O,4964
92063,good,O,4964
92064,option,O,4964
92065,especially,O,4964
92066,while,O,4964
92067,working,O,4964
92068,to,O,4964
92069,reduce,O,4964
92070,the,O,4964
92071,inflammation,O,4964
92072,in,O,4964
92073,advance,O,4964
92074,of,O,4964
92075,surgery,O,4964
92076,Caution,O,4965
92077,must,O,4965
92078,be,O,4965
92079,exercised,O,4965
92080,due,O,4965
92081,to,O,4965
92082,their,O,4965
92083,side-effect,O,4965
92084,profile,O,4965
92085,including,O,4965
92086,impaired,B-SIGN_AND_SYMPTOM,4965
92087,renal,I-SIGN_AND_SYMPTOM,4965
92088,absorption,I-SIGN_AND_SYMPTOM,4965
92089,of,I-SIGN_AND_SYMPTOM,4965
92090,bicarbonate,I-SIGN_AND_SYMPTOM,4965
92091,leading,O,4965
92092,to,O,4965
92093,a,B-SIGN_AND_SYMPTOM,4965
92094,diuretic,I-SIGN_AND_SYMPTOM,4965
92095,response,I-SIGN_AND_SYMPTOM,4965
92096,that,I-SIGN_AND_SYMPTOM,4965
92097,ultimately,I-SIGN_AND_SYMPTOM,4965
92098,lowers,I-SIGN_AND_SYMPTOM,4965
92099,IOP,I-SIGN_AND_SYMPTOM,4965
92100,Adverse,O,4966
92101,effects,O,4966
92102,such,O,4966
92103,as,O,4966
92104,hypokalemia,B-NAME_OF_DISEASE,4966
92105,kidney,B-NAME_OF_DISEASE,4966
92106,stones,I-NAME_OF_DISEASE,4966
92107,metabolic,B-NAME_OF_DISEASE,4966
92108,acidosis,I-NAME_OF_DISEASE,4966
92109,agranulocytosis,B-NAME_OF_DISEASE,4966
92110,and,O,4966
92111,renal,B-NAME_OF_DISEASE,4966
92112,hepatic,I-NAME_OF_DISEASE,4966
92113,failure,I-NAME_OF_DISEASE,4966
92114,have,O,4966
92115,been,O,4966
92116,associated,O,4966
92117,with,O,4966
92118,this,O,4966
92119,class,O,4966
92120,of,O,4966
92121,medication,O,4966
92122,Cycloplegics,B-NAME_OF_DRUG,4967
92123,Mydriatic,I-NAME_OF_DRUG,4967
92124,agents,I-NAME_OF_DRUG,4967
92125,such,O,4967
92126,as,O,4967
92127,atropine,B-NAME_OF_DRUG,4967
92128,cyclopentolate,B-NAME_OF_DRUG,4967
92129,or,O,4967
92130,homatropine,B-NAME_OF_DRUG,4967
92131,are,O,4967
92132,often,O,4967
92133,added,O,4967
92134,to,O,4967
92135,the,O,4967
92136,uveitis,B-NAME_OF_DISEASE,4967
92137,regimen,O,4967
92138,to,O,4967
92139,prevent,O,4967
92140,PS,B-SIGN_AND_SYMPTOM,4967
92141,formation,I-SIGN_AND_SYMPTOM,4967
92142,and,O,4967
92143,to,O,4967
92144,relieve,O,4967
92145,discomfort,B-SIGN_AND_SYMPTOM,4967
92146,Tropicamide,B-NAME_OF_DRUG,4968
92147,can,O,4968
92148,be,O,4968
92149,used,O,4968
92150,as,O,4968
92151,well,O,4968
92152,in,O,4968
92153,times,O,4968
92154,of,O,4968
92155,coverage,O,4968
92156,and,O,4968
92157,availability,O,4968
92158,challenges,O,4968
92159,Avoiding,O,4969
92160,anti-inflammatory,O,4969
92161,medications,O,4969
92162,Nonsteroidal,B-NAME_OF_DRUG,4969
92163,anti-inflammatory,I-NAME_OF_DRUG,4969
92164,drugs,I-NAME_OF_DRUG,4969
92165,may,O,4969
92166,counteract,O,4969
92167,the,O,4969
92168,hypotensive,O,4969
92169,effect,O,4969
92170,of,O,4969
92171,some,O,4969
92172,glaucoma,B-NAME_OF_DISEASE,4969
92173,medications,O,4969
92174,such,O,4969
92175,as,O,4969
92176,brimonidine,B-NAME_OF_DRUG,4969
92177,Educate,O,4970
92178,patients,O,4970
92179,of,O,4970
92180,the,O,4970
92181,risk,O,4970
92182,of,O,4970
92183,steroid,B-NAME_OF_DRUG,4970
92184,response,O,4970
92185,and,O,4970
92186,glaucoma,B-NAME_OF_DISEASE,4970
92187,as,O,4970
92188,well,O,4970
92189,as,O,4970
92190,cataract,B-NAME_OF_DISEASE,4970
92191,at,O,4970
92192,each,O,4970
92193,visit,O,4970
92194,Development,O,4971
92195,of,O,4971
92196,steroid,B-NAME_OF_DRUG,4971
92197,response,O,4971
92198,can,O,4971
92199,be,O,4971
92200,unpredictable,O,4971
92201,Patients,O,4972
92202,who,O,4972
92203,have,O,4972
92204,been,O,4972
92205,on,O,4972
92206,chronic,B-NAME_OF_DRUG,4972
92207,steroids,B-NAME_OF_DRUG,4972
92208,without,O,4972
92209,IOP,O,4972
92210,elevation,O,4972
92211,can,O,4972
92212,still,O,4972
92213,develop,O,4972
92214,steroid,B-NAME_OF_DRUG,4972
92215,response,O,4972
92216,later,O,4972
92217,in,O,4972
92218,their,O,4972
92219,course,O,4972
92220,Periodic,B-DIAGNOSTIC_TEST,4973
92221,monitoring,I-DIAGNOSTIC_TEST,4973
92222,of,I-DIAGNOSTIC_TEST,4973
92223,IOP,I-DIAGNOSTIC_TEST,4973
92224,in,O,4973
92225,all,O,4973
92226,patients,O,4973
92227,on,O,4973
92228,steroids,B-NAME_OF_DRUG,4973
92229,is,O,4973
92230,essential,O,4973
92231,even,O,4973
92232,without,O,4973
92233,a,O,4973
92234,history,O,4973
92235,of,O,4973
92236,IOP,O,4973
92237,elevation,O,4973
92238,and,O,4973
92239,or,O,4973
92240,inactive,O,4973
92241,disease,O,4973
92242,If,O,4974
92243,the,O,4974
92244,patient,O,4974
92245,is,O,4974
92246,on,O,4974
92247,any,O,4974
92248,steroid,B-NAME_OF_DRUG,4974
92249,the,B-DIAGNOSTIC_TEST,4974
92250,eye,I-DIAGNOSTIC_TEST,4974
92251,pressure,I-DIAGNOSTIC_TEST,4974
92252,should,O,4974
92253,be,O,4974
92254,monitored,O,4974
92255,at,O,4974
92256,a,O,4974
92257,minimum,O,4974
92258,of,O,4974
92259,every,B-TIME_DURATION,4974
92260,6,I-TIME_DURATION,4974
92261,months,I-TIME_DURATION,4974
92262,even,O,4974
92263,if,O,4974
92264,the,O,4974
92265,pressure,O,4974
92266,has,O,4974
92267,been,O,4974
92268,well,O,4974
92269,controlled,O,4974
92270,If,O,4975
92271,the,O,4975
92272,patient,O,4975
92273,is,O,4975
92274,unable,O,4975
92275,to,O,4975
92276,be,O,4975
92277,tapered,O,4975
92278,off,O,4975
92279,topical,B-NAME_OF_DRUG,4975
92280,steroids,I-NAME_OF_DRUG,4975
92281,and,O,4975
92282,continues,O,4975
92283,to,O,4975
92284,have,O,4975
92285,uncontrolled,O,4975
92286,IOP,O,4975
92287,or,O,4975
92288,the,O,4975
92289,patient,O,4975
92290,is,O,4975
92291,found,O,4975
92292,to,O,4975
92293,have,O,4975
92294,concern,O,4975
92295,for,O,4975
92296,underlying,O,4975
92297,systemic,B-NAME_OF_DISEASE,4975
92298,autoimmune,I-NAME_OF_DISEASE,4975
92299,disease,I-NAME_OF_DISEASE,4975
92300,we,O,4975
92301,refer,O,4975
92302,the,O,4975
92303,patient,O,4975
92304,to,O,4975
92305,a,O,4975
92306,rheumatologist,O,4975
92307,for,O,4975
92308,consideration,O,4975
92309,of,O,4975
92310,systemic,B-TREATMENT,4975
92311,immunosuppression,I-TREATMENT,4975
92312,This,O,4976
92313,is,O,4976
92314,done,O,4976
92315,early,O,4976
92316,to,O,4976
92317,provide,O,4976
92318,the,O,4976
92319,collaborating,O,4976
92320,rheumatologist,O,4976
92321,time,O,4976
92322,to,O,4976
92323,get,O,4976
92324,routine,O,4976
92325,labs,O,4976
92326,and,O,4976
92327,conduct,O,4976
92328,a,O,4976
92329,full,O,4976
92330,evaluation,O,4976
92331,When,O,4977
92332,the,O,4977
92333,patient,O,4977
92334,needs,O,4977
92335,systemic,B-TREATMENT,4977
92336,immunosuppression,I-TREATMENT,4977
92337,the,O,4977
92338,rheumatologist,O,4977
92339,can,O,4977
92340,be,O,4977
92341,ready,O,4977
92342,to,O,4977
92343,go,O,4977
92344,with,O,4977
92345,the,O,4977
92346,drug,O,4977
92347,and,O,4977
92348,prior,O,4977
92349,authorizations,O,4977
92350,Keep,O,4978
92351,in,O,4978
92352,mind,O,4978
92353,that,O,4978
92354,uncontrolled,O,4978
92355,glaucoma,B-NAME_OF_DISEASE,4978
92356,is,O,4978
92357,more,O,4978
92358,likely,O,4978
92359,to,O,4978
92360,cause,O,4978
92361,blindness,B-NAME_OF_DISEASE,4978
92362,than,O,4978
92363,uncontrolled,O,4978
92364,uveitis,B-NAME_OF_DISEASE,4978
92365,Systemic,O,4979
92366,immunosuppression,O,4979
92367,Oral,B-NAME_OF_DRUG,4979
92368,corticosteroids,B-NAME_OF_DRUG,4979
92369,may,O,4979
92370,be,O,4979
92371,considered,O,4979
92372,when,O,4979
92373,topical,B-NAME_OF_DRUG,4979
92374,corticosteroids,B-NAME_OF_DRUG,4979
92375,fail,O,4979
92376,to,O,4979
92377,control,O,4979
92378,intraocular,O,4979
92379,inflammation,O,4979
92380,or,O,4979
92381,in,O,4979
92382,the,O,4979
92383,perioperative,O,4979
92384,period,O,4979
92385,Education,O,4980
92386,regarding,O,4980
92387,side,O,4980
92388,effects,O,4980
92389,of,O,4980
92390,elevated,O,4980
92391,glucose,O,4980
92392,and,O,4980
92393,blood,O,4980
92394,pressure,O,4980
92395,gastritis,O,4980
92396,mood,O,4980
92397,swings,O,4980
92398,difficulty,O,4980
92399,sleeping,O,4980
92400,etc,O,4980
92401,is,O,4981
92402,key,O,4981
92403,especially,O,4981
92404,for,O,4981
92405,patients,O,4981
92406,with,O,4981
92407,diabetes,B-NAME_OF_DISEASE,4981
92408,and,O,4981
92409,hypertension,B-NAME_OF_DISEASE,4981
92410,Oral,B-NAME_OF_DRUG,4982
92411,steroids,I-NAME_OF_DRUG,4982
92412,are,O,4982
92413,typically,O,4982
92414,used,O,4982
92415,as,O,4982
92416,temporizing,O,4982
92417,agents,O,4982
92418,and,O,4982
92419,not,O,4982
92420,for,O,4982
92421,long-term,O,4982
92422,immunosuppression,O,4982
92423,because,O,4982
92424,of,O,4982
92425,the,O,4982
92426,side-effect,O,4982
92427,profile,O,4982
92428,Immunomodulatory,B-NAME_OF_DRUG,4983
92429,agents,I-NAME_OF_DRUG,4983
92430,have,O,4983
92431,a,O,4983
92432,significant,O,4983
92433,role,O,4983
92434,in,O,4983
92435,the,O,4983
92436,treatment,O,4983
92437,of,O,4983
92438,chronic,B-NAME_OF_DISEASE,4983
92439,noninfectious,I-NAME_OF_DISEASE,4983
92440,uveitis,B-NAME_OF_DISEASE,4983
92441,They,O,4984
92442,are,O,4984
92443,often,O,4984
92444,used,O,4984
92445,to,O,4984
92446,wean,O,4984
92447,patients,O,4984
92448,off,O,4984
92449,oral,B-NAME_OF_DRUG,4984
92450,steroids,I-NAME_OF_DRUG,4984
92451,and,O,4984
92452,to,O,4984
92453,reduce,O,4984
92454,risks,O,4984
92455,of,O,4984
92456,systemic,O,4984
92457,complications,O,4984
92458,of,O,4984
92459,corticosteroids,B-NAME_OF_DRUG,4984
92460,They,O,4985
92461,also,O,4985
92462,help,O,4985
92463,to,O,4985
92464,improve,O,4985
92465,long-term,O,4985
92466,control,O,4985
92467,of,O,4985
92468,uveitis,B-NAME_OF_DISEASE,4985
92469,and,O,4985
92470,thereby,O,4985
92471,glaucoma,B-NAME_OF_DISEASE,4985
92472,The,O,4986
92473,conventional,O,4986
92474,steroid-sparing,B-NAME_OF_DRUG,4986
92475,agents,I-NAME_OF_DRUG,4986
92476,include,O,4986
92477,antimetabolites,B-NAME_OF_DRUG,4986
92478,eg,O,4986
92479,methotrexate,B-NAME_OF_DRUG,4986
92480,mycophenolate,B-NAME_OF_DRUG,4986
92481,mofetil,I-NAME_OF_DRUG,4986
92482,and,O,4986
92483,azathioprine,B-NAME_OF_DRUG,4986
92484,and,O,4986
92485,T-cell,B-NAME_OF_DRUG,4986
92486,inhibitors,I-NAME_OF_DRUG,4986
92487,eg,O,4986
92488,cyclosporine,B-NAME_OF_DRUG,4986
92489,and,O,4986
92490,tacrolimus,B-NAME_OF_DRUG,4986
92491,however,O,4986
92492,these,O,4986
92493,medications,O,4986
92494,may,O,4986
92495,fail,O,4986
92496,to,O,4986
92497,control,O,4986
92498,uveitis,B-NAME_OF_DISEASE,4986
92499,in,O,4986
92500,up,O,4986
92501,to,O,4986
92502,40%,O,4986
92503,of,O,4986
92504,cases,O,4986
92505,Newer,O,4987
92506,classes,O,4987
92507,of,O,4987
92508,biologics,O,4987
92509,namely,O,4987
92510,the,O,4987
92511,TNF-α,B-NAME_OF_DRUG,4987
92512,inhibitors,I-NAME_OF_DRUG,4987
92513,have,O,4987
92514,shown,O,4987
92515,significant,O,4987
92516,success,O,4987
92517,in,O,4987
92518,the,O,4987
92519,treatment,O,4987
92520,of,O,4987
92521,chronic,B-NAME_OF_DISEASE,4987
92522,noninfectious,I-NAME_OF_DISEASE,4987
92523,uveitis,B-NAME_OF_DISEASE,4987
92524,Regular,O,4988
92525,communication,O,4988
92526,with,O,4988
92527,the,O,4988
92528,rheumatologist,O,4988
92529,is,O,4988
92530,essential,O,4988
92531,to,O,4988
92532,monitor,O,4988
92533,systemic,O,4988
92534,side,O,4988
92535,effects,O,4988
92536,SURGICAL,O,4989
92537,MANAGEMENT,O,4989
92538,When,O,4989
92539,it,O,4989
92540,s,O,4989
92541,required,O,4989
92542,-,O,4989
92543,Surgical,B-TREATMENT,4989
92544,intervention,I-TREATMENT,4989
92545,may,O,4989
92546,be,O,4989
92547,required,O,4989
92548,for,O,4989
92549,glaucoma,B-NAME_OF_DISEASE,4989
92550,when,O,4989
92551,medical,O,4989
92552,management,O,4989
92553,fails,O,4989
92554,to,O,4989
92555,control,O,4989
92556,IOP,O,4989
92557,The,O,4990
92558,success,O,4990
92559,of,O,4990
92560,surgery,O,4990
92561,depends,O,4990
92562,significantly,O,4990
92563,on,O,4990
92564,the,O,4990
92565,suppression,O,4990
92566,of,O,4990
92567,inflammation,O,4990
92568,during,O,4990
92569,the,O,4990
92570,perioperative,O,4990
92571,period,O,4990
92572,In,O,4991
92573,general,O,4991
92574,uveitic,B-NAME_OF_DISEASE,4991
92575,glaucoma,I-NAME_OF_DISEASE,4991
92576,patients,O,4991
92577,have,O,4991
92578,lower,O,4991
92579,success,O,4991
92580,rates,O,4991
92581,with,O,4991
92582,glaucoma,B-NAME_OF_DISEASE,4991
92583,surgical,B-TREATMENT,4991
92584,interventions,I-TREATMENT,4991
92585,Uveitic,B-NAME_OF_DISEASE,4992
92586,glaucoma,I-NAME_OF_DISEASE,4992
92587,patients,O,4992
92588,also,O,4992
92589,have,O,4992
92590,higher,O,4992
92591,rates,O,4992
92592,of,O,4992
92593,hypotony,B-NAME_OF_DISEASE,4992
92594,postoperatively,O,4992
92595,The,O,4993
92596,goal,O,4993
92597,is,O,4993
92598,to,O,4993
92599,not,O,4993
92600,have,O,4993
92601,to,O,4993
92602,perform,O,4993
92603,a,B-TREATMENT,4993
92604,glaucoma,I-TREATMENT,4993
92605,surgery,I-TREATMENT,4993
92606,while,O,4993
92607,the,O,4993
92608,patient,O,4993
92609,is,O,4993
92610,actively,O,4993
92611,inflamed,O,4993
92612,Oral,B-TREATMENT,4994
92613,glaucoma,I-TREATMENT,4994
92614,medications,I-TREATMENT,4994
92615,can,O,4994
92616,be,O,4994
92617,used,O,4994
92618,to,O,4994
92619,help,O,4994
92620,get,O,4994
92621,patients,O,4994
92622,through,O,4994
92623,their,O,4994
92624,active,O,4994
92625,uveitis,B-NAME_OF_DISEASE,4994
92626,phase,O,4994
92627,until,O,4994
92628,surgery,O,4994
92629,If,O,4995
92630,surgery,O,4995
92631,must,O,4995
92632,be,O,4995
92633,performed,O,4995
92634,in,O,4995
92635,an,O,4995
92636,actively,O,4995
92637,inflamed,O,4995
92638,eye,O,4995
92639,perioperative,B-NAME_OF_DRUG,4995
92640,steroids,B-NAME_OF_DRUG,4995
92641,are,O,4995
92642,essential,O,4995
92643,to,O,4995
92644,moderate,O,4995
92645,postoperative,O,4995
92646,inflammatory,O,4995
92647,response,O,4995
92648,Even,O,4996
92649,in,O,4996
92650,cases,O,4996
92651,of,O,4996
92652,quiesced,O,4996
92653,eye,O,4996
92654,perioperative,O,4996
92655,immunosuppression,O,4996
92656,is,O,4996
92657,key,O,4996
92658,to,O,4996
92659,moderating,O,4996
92660,any,O,4996
92661,postoperative,O,4996
92662,inflammatory,O,4996
92663,response,O,4996
92664,This,O,4997
92665,can,O,4997
92666,be,O,4997
92667,in,O,4997
92668,the,O,4997
92669,form,O,4997
92670,of,O,4997
92671,periocular,B-NAME_OF_DRUG,4997
92672,steroids,B-NAME_OF_DRUG,4997
92673,or,O,4997
92674,oral,B-NAME_OF_DRUG,4997
92675,steroids,B-NAME_OF_DRUG,4997
92676,In,O,4998
92677,urgent,O,4998
92678,or,O,4998
92679,emergent,O,4998
92680,cases,O,4998
92681,where,O,4998
92682,we,O,4998
92683,do,O,4998
92684,not,O,4998
92685,have,O,4998
92686,the,O,4998
92687,time,O,4998
92688,to,O,4998
92689,fully,O,4998
92690,quiet,O,4998
92691,the,O,4998
92692,eye,O,4998
92693,higher,O,4998
92694,doses,O,4998
92695,of,O,4998
92696,steroids,B-NAME_OF_DRUG,4998
92697,may,O,4998
92698,be,O,4998
92699,required,O,4998
92700,with,O,4998
92701,a,O,4998
92702,slower,O,4998
92703,postoperative,O,4998
92704,taper,O,4998
92705,Undesirable,O,4999
92706,interventions,O,4999
92707,Other,O,4999
92708,more,O,4999
92709,common,O,4999
92710,bridging,O,4999
92711,interventions,O,4999
92712,between,O,4999
92713,medical,O,4999
92714,therapy,O,4999
92715,and,O,4999
92716,surgery,O,4999
92717,such,O,4999
92718,as,O,4999
92719,selective,B-TREATMENT,4999
92720,laser,I-TREATMENT,4999
92721,trabeculoplasty,I-TREATMENT,4999
92722,and,O,4999
92723,cyclophotocoagulation,B-TREATMENT,4999
92724,are,O,4999
92725,pro-inflammatory,O,4999
92726,and,O,4999
92727,not,O,4999
92728,preferred,O,4999
92729,for,O,4999
92730,uveitic,B-NAME_OF_DISEASE,4999
92731,glaucoma,I-NAME_OF_DISEASE,4999
92732,They,O,5000
92733,include,O,5000
92734,Nd,B-TREATMENT,5000
92735,YAG,I-TREATMENT,5000
92736,laser,I-TREATMENT,5000
92737,peripheral,I-TREATMENT,5000
92738,iridotomy,I-TREATMENT,5000
92739,This,O,5001
92740,may,O,5001
92741,be,O,5001
92742,indicated,O,5001
92743,for,O,5001
92744,acute,B-SIGN_AND_SYMPTOM,5001
92745,angle,I-SIGN_AND_SYMPTOM,5001
92746,closure,I-SIGN_AND_SYMPTOM,5001
92747,secondary,O,5001
92748,to,O,5001
92749,extensive,B-SIGN_AND_SYMPTOM,5001
92750,PS,I-SIGN_AND_SYMPTOM,5001
92751,and,O,5001
92752,iris,B-SIGN_AND_SYMPTOM,5001
92753,bombé,I-SIGN_AND_SYMPTOM,5001
92754,Multiple,O,5002
92755,and,O,5002
92756,large,O,5002
92757,iridotomies,B-PART_OF_THE_EYES,5002
92758,may,O,5002
92759,be,O,5002
92760,required,O,5002
92761,due,O,5002
92762,to,O,5002
92763,closure,O,5002
92764,from,O,5002
92765,inflammation,O,5002
92766,Cycloablative,B-TREATMENT,5003
92767,procedures,I-TREATMENT,5003
92768,Either,O,5004
92769,transscleral,O,5004
92770,or,O,5004
92771,intraocular,O,5004
92772,these,O,5004
92773,procedures,O,5004
92774,can,O,5004
92775,exacerbate,O,5004
92776,inflammation,O,5004
92777,cause,O,5004
92778,hypotony,B-TREATMENT,5004
92779,and,O,5004
92780,lead,O,5004
92781,to,O,5004
92782,phthisis,B-TREATMENT,5004
92783,bulbi,I-TREATMENT,5004
92784,Thus,O,5005
92785,they,O,5005
92786,should,O,5005
92787,be,O,5005
92788,used,O,5005
92789,only,O,5005
92790,as,O,5005
92791,a,O,5005
92792,last,O,5005
92793,resort,O,5005
92794,for,O,5005
92795,refractory,B-TREATMENT,5005
92796,uveitic,I-TREATMENT,5005
92797,glaucoma,I-TREATMENT,5005
92798,and,O,5005
92799,treatment,O,5005
92800,must,O,5005
92801,be,O,5005
92802,carefully,O,5005
92803,titrated,O,5005
92804,Laser,B-TREATMENT,5006
92805,trabeculoplasty,I-TREATMENT,5006
92806,This,O,5007
92807,is,O,5007
92808,not,O,5007
92809,recommended,O,5007
92810,in,O,5007
92811,uveitic,B-NAME_OF_DISEASE,5007
92812,glaucoma,I-NAME_OF_DISEASE,5007
92813,because,O,5007
92814,of,O,5007
92815,angle,O,5007
92816,alteration,O,5007
92817,This,O,5008
92818,modality,O,5008
92819,especially,O,5008
92820,with,O,5008
92821,use,O,5008
92822,of,O,5008
92823,argon-based,B-TREATMENT,5008
92824,lasers,I-TREATMENT,5008
92825,has,O,5008
92826,the,O,5008
92827,potential,O,5008
92828,to,O,5008
92829,induce,O,5008
92830,inflammation,O,5008
92831,and,O,5008
92832,damage,O,5008
92833,the,B-PART_OF_THE_EYES,5008
92834,trabecular,I-PART_OF_THE_EYES,5008
92835,meshwork,I-PART_OF_THE_EYES,5008
92836,Minimally,B-TREATMENT,5009
92837,invasive,I-TREATMENT,5009
92838,glaucoma,I-TREATMENT,5009
92839,surgery,I-TREATMENT,5009
92840,MIGS,B-TREATMENT,5009
92841,-,O,5009
92842,The,O,5009
92843,use,O,5009
92844,of,O,5009
92845,MIGS,B-TREATMENT,5009
92846,is,O,5009
92847,becoming,O,5009
92848,popular,O,5009
92849,in,O,5009
92850,the,O,5009
92851,treatment,O,5009
92852,of,O,5009
92853,POAG,B-NAME_OF_DISEASE,5009
92854,and,O,5009
92855,is,O,5009
92856,under,O,5009
92857,evaluation,O,5009
92858,for,O,5009
92859,uveitic,B-NAME_OF_DISEASE,5009
92860,glaucoma,I-NAME_OF_DISEASE,5009
92861,patients,O,5009
92862,with,O,5009
92863,open,B-SIGN_AND_SYMPTOM,5009
92864,angles,I-SIGN_AND_SYMPTOM,5009
92865,Ab,B-TREATMENT,5010
92866,interno,I-TREATMENT,5010
92867,trabeculotomy,I-TREATMENT,5010
92868,increases,O,5010
92869,trabecular,O,5010
92870,outflow,O,5010
92871,by,O,5010
92872,removing,O,5010
92873,part,O,5010
92874,of,O,5010
92875,the,B-PART_OF_THE_EYES,5010
92876,trabecular,I-PART_OF_THE_EYES,5010
92877,meshwork,I-PART_OF_THE_EYES,5010
92878,These,O,5011
92879,procedures,O,5011
92880,may,O,5011
92881,have,O,5011
92882,an,O,5011
92883,advantage,O,5011
92884,over,O,5011
92885,small-lumen,O,5011
92886,devices,O,5011
92887,that,O,5011
92888,may,O,5011
92889,become,O,5011
92890,obstructed,O,5011
92891,from,O,5011
92892,inflammatory,O,5011
92893,debris,O,5011
92894,Canaloplasty,B-TREATMENT,5012
92895,may,O,5012
92896,be,O,5012
92897,of,O,5012
92898,special,O,5012
92899,interest,O,5012
92900,in,O,5012
92901,these,O,5012
92902,cases,O,5012
92903,because,O,5012
92904,this,O,5012
92905,procedure,O,5012
92906,dilates,O,5012
92907,and,O,5012
92908,maintains,O,5012
92909,a,O,5012
92910,patent,O,5012
92911,canal,B-PART_OF_THE_EYES,5012
92912,of,I-PART_OF_THE_EYES,5012
92913,Schlemm,I-PART_OF_THE_EYES,5012
92914,expanding,O,5012
92915,the,O,5012
92916,intertrabecular,O,5012
92917,spaces,O,5012
92918,that,O,5012
92919,are,O,5012
92920,compromised,O,5012
92921,as,O,5012
92922,a,O,5012
92923,result,O,5012
92924,of,O,5012
92925,glucocorticoids,B-NAME_OF_DRUG,5012
92926,More,O,5013
92927,investigation,O,5013
92928,is,O,5013
92929,necessary,O,5013
92930,in,O,5013
92931,regard,O,5013
92932,to,O,5013
92933,efficacy,O,5013
92934,in,O,5013
92935,patients,O,5013
92936,with,O,5013
92937,uveitic,B-NAME_OF_DISEASE,5013
92938,glaucoma,I-NAME_OF_DISEASE,5013
92939,Glaucoma,B-NAME_OF_DISEASE,5014
92940,drainage,I-TREATMENT,5014
92941,devices,I-TREATMENT,5014
92942,Glaucoma,B-NAME_OF_DISEASE,5014
92943,drainage,I-TREATMENT,5014
92944,devices,I-TREATMENT,5014
92945,are,O,5014
92946,the,O,5014
92947,preferred,O,5014
92948,first-line,O,5014
92949,surgery,O,5014
92950,in,O,5014
92951,uveitic,B-NAME_OF_DISEASE,5014
92952,glaucoma,B-NAME_OF_DISEASE,5014
92953,especially,O,5014
92954,in,O,5014
92955,cases,O,5014
92956,with,O,5014
92957,active,O,5014
92958,inflammation,O,5014
92959,The,B-TREATMENT,5015
92960,Ahmed,I-TREATMENT,5015
92961,Glaucoma,B-NAME_OF_DISEASE,5015
92962,Valve,I-TREATMENT,5015
92963,AGV,B-TREATMENT,5015
92964,is,O,5015
92965,often,O,5015
92966,favored,O,5015
92967,because,O,5015
92968,of,O,5015
92969,its,O,5015
92970,immediate,O,5015
92971,action,O,5015
92972,and,O,5015
92973,its,O,5015
92974,unidirectional,O,5015
92975,valve,O,5015
92976,mechanism,O,5015
92977,which,O,5015
92978,lowers,O,5015
92979,the,O,5015
92980,risk,O,5015
92981,of,O,5015
92982,postoperative,O,5015
92983,hypotony,B-NAME_OF_DISEASE,5015
92984,If,O,5016
92985,an,O,5016
92986,eye,O,5016
92987,can,O,5016
92988,tolerate,O,5016
92989,high,O,5016
92990,IOP,O,5016
92991,for,B-TIME_DURATION,5016
92992,6-Apr,I-TIME_DURATION,5016
92993,weeks,I-TIME_DURATION,5016
92994,a,B-TREATMENT,5016
92995,Baerveldt,B-TREATMENT,5016
92996,tube,I-TREATMENT,5016
92997,can,O,5016
92998,be,O,5016
92999,considered,O,5016
93000,because,O,5016
93001,it,O,5016
93002,has,O,5016
93003,a,O,5016
93004,lower,O,5016
93005,rate,O,5016
93006,of,O,5016
93007,reoperation,O,5016
93008,and,O,5016
93009,possible,O,5016
93010,lower,O,5016
93011,longterm,O,5016
93012,IOP,O,5016
93013,Although,O,5017
93014,no,O,5017
93015,investigations,O,5017
93016,have,O,5017
93017,formally,O,5017
93018,compared,O,5017
93019,AGV,B-TREATMENT,5017
93020,to,O,5017
93021,Baerveldt,B-TREATMENT,5017
93022,in,O,5017
93023,uveitic,B-NAME_OF_DISEASE,5017
93024,glaucoma,B-NAME_OF_DISEASE,5017
93025,studies,O,5017
93026,have,O,5017
93027,shown,O,5017
93028,positive,O,5017
93029,outcomes,O,5017
93030,for,O,5017
93031,both,O,5017
93032,Trabeculectomy,B-TREATMENT,5018
93033,Trabeculectomy,B-TREATMENT,5018
93034,should,O,5018
93035,be,O,5018
93036,avoided,O,5018
93037,in,O,5018
93038,eyes,O,5018
93039,with,O,5018
93040,active,O,5018
93041,inflammation,O,5018
93042,However,O,5019
93043,in,O,5019
93044,eyes,O,5019
93045,with,O,5019
93046,well-controlled,O,5019
93047,uveitis,B-NAME_OF_DISEASE,5019
93048,standard,B-TREATMENT,5019
93049,trabeculectomy,I-TREATMENT,5019
93050,or,O,5019
93051,the,B-TREATMENT,5019
93052,Ex-Press,I-TREATMENT,5019
93053,glaucoma,B-NAME_OF_DISEASE,5019
93054,filtration,I-TREATMENT,5019
93055,device,I-TREATMENT,5019
93056,Alcon,I-TREATMENT,5019
93057,with,O,5019
93058,anti-metabolite,B-NAME_OF_DRUG,5019
93059,agents,I-NAME_OF_DRUG,5019
93060,such,O,5019
93061,as,O,5019
93062,5-fluorouracil,B-NAME_OF_DRUG,5019
93063,and,O,5019
93064,mitomycin,B-NAME_OF_DRUG,5019
93065,C,I-NAME_OF_DRUG,5019
93066,which,O,5019
93067,help,O,5019
93068,minimize,O,5019
93069,excessive,O,5019
93070,scarring,O,5019
93071,and,O,5019
93072,decrease,O,5019
93073,failure,O,5019
93074,rates,O,5019
93075,can,O,5019
93076,be,O,5019
93077,considered,O,5019
93078,Glaucoma,B-NAME_OF_DISEASE,5020
93079,secondary,O,5020
93080,to,O,5020
93081,ocular,B-NAME_OF_DISEASE,5020
93082,inflammation,I-NAME_OF_DISEASE,5020
93083,is,O,5020
93084,potentially,O,5020
93085,blinding,O,5020
93086,and,O,5020
93087,requires,O,5020
93088,aggressive,O,5020
93089,multifaceted,O,5020
93090,management,O,5020
93091,Early,O,5021
93092,education,O,5021
93093,and,O,5021
93094,counseling,O,5021
93095,are,O,5021
93096,key,O,5021
93097,for,O,5021
93098,compliance,O,5021
93099,and,O,5021
93100,expectation,O,5021
93101,setting,O,5021
93102,Collaboration,O,5022
93103,is,O,5022
93104,often,O,5022
93105,required,O,5022
93106,with,O,5022
93107,uveitis,B-NAME_OF_DISEASE,5022
93108,glaucoma,B-NAME_OF_DISEASE,5022
93109,and,O,5022
93110,rheumatology,O,5022
93111,specialists,O,5022
93112,Increased,O,5023
93113,medical,B-TREATMENT,5023
93114,and,I-TREATMENT,5023
93115,surgical,I-TREATMENT,5023
93116,interventions,I-TREATMENT,5023
93117,are,O,5023
93118,also,O,5023
93119,creating,O,5023
93120,new,O,5023
93121,opportunities,O,5023
93122,for,O,5023
93123,vision,O,5023
93124,preservation,O,5023
93125,Inherited,B-NAME_OF_DISEASE,5024
93126,retinal,I-NAME_OF_DISEASE,5024
93127,diseases,I-NAME_OF_DISEASE,5024
93128,IRDs,B-NAME_OF_DISEASE,5024
93129,also,O,5024
93130,referred,O,5024
93131,to,O,5024
93132,as,O,5024
93133,inherited,B-NAME_OF_DISEASE,5024
93134,retinal,I-NAME_OF_DISEASE,5024
93135,dystrophies,I-NAME_OF_DISEASE,5024
93136,are,O,5024
93137,a,O,5024
93138,clinically,O,5024
93139,and,O,5024
93140,genetically,O,5024
93141,heterogeneous,O,5024
93142,group,O,5024
93143,of,O,5024
93144,neurodegenerative,O,5024
93145,disorders,O,5024
93146,primarily,O,5024
93147,involving,O,5024
93148,photoreceptors,B-PART_OF_THE_EYES,5024
93149,retinal,B-PART_OF_THE_EYES,5024
93150,pigment,I-PART_OF_THE_EYES,5024
93151,epithelium,I-PART_OF_THE_EYES,5024
93152,RPE,I-PART_OF_THE_EYES,5024
93153,and,O,5024
93154,or,O,5024
93155,the,B-PART_OF_THE_EYES,5024
93156,choroid,I-PART_OF_THE_EYES,5024
93157,Taken,O,5025
93158,as,O,5025
93159,a,O,5025
93160,whole,O,5025
93161,IRDs,B-NAME_OF_DISEASE,5025
93162,have,O,5025
93163,an,O,5025
93164,estimated,O,5025
93165,global,O,5025
93166,prevalence,O,5025
93167,of,O,5025
93168,about,O,5025
93169,1,O,5025
93170,in,O,5025
93171,2,O,5025
93172,0,O,5025
93173,individuals,O,5025
93174,affecting,O,5025
93175,more,O,5025
93176,than,O,5025
93177,two,O,5025
93178,million,O,5025
93179,people,O,5025
93180,worldwide,O,5025
93181,and,O,5025
93182,standing,O,5025
93183,out,O,5025
93184,as,O,5025
93185,the,O,5025
93186,leading,O,5025
93187,cause,O,5025
93188,of,O,5025
93189,blindness,B-NAME_OF_DISEASE,5025
93190,in,O,5025
93191,the,O,5025
93192,Western,O,5025
93193,working-age,O,5025
93194,population,O,5025
93195,AGTC-501,B-TREATMENT,5025
93196,Applied,I-TREATMENT,5025
93197,Genetic,I-TREATMENT,5025
93198,Technologies,I-TREATMENT,5025
93199,Corporation,I-TREATMENT,5025
93200,a,O,5025
93201,novel,O,5025
93202,gene,O,5025
93203,therapy,O,5025
93204,in,O,5025
93205,development,O,5025
93206,for,O,5025
93207,the,O,5025
93208,potential,O,5025
93209,treatment,O,5025
93210,of,O,5025
93211,X-linked,B-NAME_OF_DISEASE,5025
93212,retinitis,I-NAME_OF_DISEASE,5025
93213,pigmentosa,I-NAME_OF_DISEASE,5025
93214,RP,B-NAME_OF_DISEASE,5025
93215,showed,O,5025
93216,an,O,5025
93217,acceptable,O,5025
93218,safety,O,5025
93219,profile,O,5025
93220,and,O,5025
93221,visual,O,5025
93222,function,O,5025
93223,improvements,O,5025
93224,when,O,5025
93225,administered,O,5025
93226,in,O,5025
93227,the,O,5025
93228,study,O,5025
93229,s,O,5025
93230,higher,O,5025
93231,dose,O,5025
93232,groups,O,5025
93233,Patients,O,5026
93234,with,O,5026
93235,X-linked,B-NAME_OF_DISEASE,5026
93236,RP,B-NAME_OF_DISEASE,5026
93237,an,B-NAME_OF_DISEASE,5026
93238,inherited,I-NAME_OF_DISEASE,5026
93239,retinal,I-NAME_OF_DISEASE,5026
93240,disease,I-NAME_OF_DISEASE,5026
93241,that,O,5026
93242,begins,O,5026
93243,in,O,5026
93244,childhood,O,5026
93245,are,O,5026
93246,characterized,O,5026
93247,by,O,5026
93248,night,B-NAME_OF_DISEASE,5026
93249,blindness,I-NAME_OF_DISEASE,5026
93250,progressive,B-SIGN_AND_SYMPTOM,5026
93251,loss,I-SIGN_AND_SYMPTOM,5026
93252,of,I-SIGN_AND_SYMPTOM,5026
93253,peripheral,I-SIGN_AND_SYMPTOM,5026
93254,vision,I-SIGN_AND_SYMPTOM,5026
93255,and,O,5026
93256,eventual,B-SIGN_AND_SYMPTOM,5026
93257,loss,I-SIGN_AND_SYMPTOM,5026
93258,of,I-SIGN_AND_SYMPTOM,5026
93259,central,I-SIGN_AND_SYMPTOM,5026
93260,vision,I-SIGN_AND_SYMPTOM,5026
93261,Affected,O,5027
93262,patients,O,5027
93263,have,O,5027
93264,access,O,5027
93265,to,O,5027
93266,only,O,5027
93267,1,O,5027
93268,approved,O,5027
93269,treatment,O,5027
93270,voretigene,B-NAME_OF_DRUG,5027
93271,neparvovec-rzyl,I-NAME_OF_DRUG,5027
93272,Luxturna,I-NAME_OF_DRUG,5027
93273,Spark,I-NAME_OF_DRUG,5027
93274,Therapeutics,I-NAME_OF_DRUG,5027
93275,for,O,5027
93276,RPE65,B-CHEMICAL_COMPOUND,5027
93277,which,O,5027
93278,represents,O,5027
93279,about,O,5027
93280,1%,O,5027
93281,of,O,5027
93282,RP,B-NAME_OF_DISEASE,5027
93283,About,O,5028
93284,X-linked,B-NAME_OF_DISEASE,5028
93285,Retinitis,I-NAME_OF_DISEASE,5028
93286,Pigmentosa,I-NAME_OF_DISEASE,5028
93287,XLRP,B-NAME_OF_DISEASE,5028
93288,X-linked,B-NAME_OF_DISEASE,5028
93289,Retinitis,I-NAME_OF_DISEASE,5028
93290,Pigmentosa,I-NAME_OF_DISEASE,5028
93291,XLRP,B-NAME_OF_DISEASE,5028
93292,is,O,5028
93293,an,O,5028
93294,inherited,O,5028
93295,condition,O,5028
93296,that,O,5028
93297,causes,O,5028
93298,progressive,B-SIGN_AND_SYMPTOM,5028
93299,vision,I-SIGN_AND_SYMPTOM,5028
93300,loss,I-SIGN_AND_SYMPTOM,5028
93301,in,I-SIGN_AND_SYMPTOM,5028
93302,boys,I-SIGN_AND_SYMPTOM,5028
93303,and,I-SIGN_AND_SYMPTOM,5028
93304,young,I-SIGN_AND_SYMPTOM,5028
93305,men,I-SIGN_AND_SYMPTOM,5028
93306,Characteristics,O,5029
93307,of,O,5029
93308,the,O,5029
93309,disease,O,5029
93310,include,O,5029
93311,night,B-SIGN_AND_SYMPTOM,5029
93312,blindness,B-NAME_OF_DISEASE,5029
93313,in,I-SIGN_AND_SYMPTOM,5029
93314,early,I-SIGN_AND_SYMPTOM,5029
93315,childhood,I-SIGN_AND_SYMPTOM,5029
93316,and,I-SIGN_AND_SYMPTOM,5029
93317,progressive,I-SIGN_AND_SYMPTOM,5029
93318,constriction,I-SIGN_AND_SYMPTOM,5029
93319,of,I-SIGN_AND_SYMPTOM,5029
93320,the,I-SIGN_AND_SYMPTOM,5029
93321,visual,I-SIGN_AND_SYMPTOM,5029
93322,field,I-SIGN_AND_SYMPTOM,5029
93323,In,O,5030
93324,general,O,5030
93325,XLRP,B-NAME_OF_DISEASE,5030
93326,patients,O,5030
93327,experience,O,5030
93328,a,B-SIGN_AND_SYMPTOM,5030
93329,gradual,I-SIGN_AND_SYMPTOM,5030
93330,decline,I-SIGN_AND_SYMPTOM,5030
93331,in,I-SIGN_AND_SYMPTOM,5030
93332,visual,I-SIGN_AND_SYMPTOM,5030
93333,acuity,I-SIGN_AND_SYMPTOM,5030
93334,over,O,5030
93335,the,O,5030
93336,disease,O,5030
93337,course,O,5030
93338,which,O,5030
93339,results,O,5030
93340,in,O,5030
93341,legal,O,5030
93342,blindness,B-NAME_OF_DISEASE,5030
93343,around,O,5030
93344,the,O,5030
93345,4th,O,5030
93346,or,O,5030
93347,5th,O,5030
93348,decade,O,5030
93349,of,O,5030
93350,life,O,5030
93351,About,O,5031
93352,AGTC-501,B-TREATMENT,5031
93353,AGTC-501,B-TREATMENT,5031
93354,laruparetigene,I-TREATMENT,5031
93355,zosaparvovec,I-TREATMENT,5031
93356,the,O,5031
93357,Company,O,5031
93358,s,O,5031
93359,lead,O,5031
93360,gene,O,5031
93361,therapy,O,5031
93362,development,O,5031
93363,program,O,5031
93364,uses,O,5031
93365,an,O,5031
93366,engineered,O,5031
93367,AAV,B-CHEMICAL_COMPOUND,5031
93368,vector,O,5031
93369,to,O,5031
93370,insert,O,5031
93371,a,O,5031
93372,stabilized,O,5031
93373,and,O,5031
93374,functional,O,5031
93375,copy,O,5031
93376,of,O,5031
93377,the,B-CHEMICAL_COMPOUND,5031
93378,Retinitis,I-CHEMICAL_COMPOUND,5031
93379,Pigmentosa,I-CHEMICAL_COMPOUND,5031
93380,GTSase,I-CHEMICAL_COMPOUND,5031
93381,Regulator,I-CHEMICAL_COMPOUND,5031
93382,RPGR,B-CHEMICAL_COMPOUND,5031
93383,gene,I-CHEMICAL_COMPOUND,5031
93384,into,O,5031
93385,a,O,5031
93386,patient,O,5031
93387,s,O,5031
93388,photoreceptor,B-PART_OF_THE_EYES,5031
93389,cells,I-PART_OF_THE_EYES,5031
93390,AGTC-501,B-TREATMENT,5032
93391,is,O,5032
93392,comprised,O,5032
93393,of,O,5032
93394,that,O,5032
93395,stabilized,O,5032
93396,RPGR,B-CHEMICAL_COMPOUND,5032
93397,gene,I-CHEMICAL_COMPOUND,5032
93398,and,O,5032
93399,a,O,5032
93400,promoter,O,5032
93401,that,O,5032
93402,was,O,5032
93403,specifically,O,5032
93404,selected,O,5032
93405,due,O,5032
93406,to,O,5032
93407,its,O,5032
93408,ability,O,5032
93409,to,O,5032
93410,drive,O,5032
93411,efficient,O,5032
93412,gene,O,5032
93413,expression,O,5032
93414,in,O,5032
93415,rods,O,5032
93416,and,O,5032
93417,cones,O,5032
93418,maintain,O,5032
93419,photoreceptor,B-PART_OF_THE_EYES,5032
93420,function,O,5032
93421,and,O,5032
93422,delay,O,5032
93423,disease,O,5032
93424,progression,O,5032
93425,in,O,5032
93426,large,O,5032
93427,animal,O,5032
93428,naturally,O,5032
93429,occurring,O,5032
93430,preclinical,O,5032
93431,models,O,5032
93432,of,O,5032
93433,XLRP,B-NAME_OF_DISEASE,5032
93434,In,O,5033
93435,addition,O,5033
93436,published,O,5033
93437,NHP,O,5033
93438,studies,O,5033
93439,have,O,5033
93440,demonstrated,O,5033
93441,that,O,5033
93442,AGTC,B-ORGANIZATION,5033
93443,s,O,5033
93444,proprietary,O,5033
93445,AAV,B-CHEMICAL_COMPOUND,5033
93446,capsid,I-CHEMICAL_COMPOUND,5033
93447,has,O,5033
93448,as,O,5033
93449,much,O,5033
93450,as,O,5033
93451,twice,O,5033
93452,the,O,5033
93453,transfection,O,5033
93454,efficiency,O,5033
93455,in,O,5033
93456,photoreceptors,B-PART_OF_THE_EYES,5033
93457,compared,O,5033
93458,to,O,5033
93459,capsids,B-CHEMICAL_COMPOUND,5033
93460,used,O,5033
93461,in,O,5033
93462,competing,O,5033
93463,programs,O,5033
93464,AGTC,B-ORGANIZATION,5034
93465,was,O,5034
93466,granted,O,5034
93467,U.S,O,5034
93468,Food,B-ORGANIZATION,5035
93469,and,I-ORGANIZATION,5035
93470,Drug,I-ORGANIZATION,5035
93471,Administration,I-ORGANIZATION,5035
93472,FDA,I-ORGANIZATION,5035
93473,orphan,O,5035
93474,drug,O,5035
93475,designation,O,5035
93476,in,O,5035
93477,2017,O,5035
93478,as,O,5035
93479,well,O,5035
93480,as,O,5035
93481,European,O,5035
93482,Commission,O,5035
93483,orphan,O,5035
93484,medicinal,O,5035
93485,product,O,5035
93486,designation,O,5035
93487,in,O,5035
93488,2016,O,5035
93489,for,O,5035
93490,its,O,5035
93491,gene,O,5035
93492,therapy,O,5035
93493,product,O,5035
93494,candidate,O,5035
93495,to,O,5035
93496,treat,O,5035
93497,XLRP,B-NAME_OF_DISEASE,5035
93498,caused,O,5035
93499,by,O,5035
93500,mutations,B-CAUSE_OF_DISEASE,5035
93501,in,I-CAUSE_OF_DISEASE,5035
93502,the,I-CAUSE_OF_DISEASE,5035
93503,RPGR,I-CAUSE_OF_DISEASE,5035
93504,gene,I-CAUSE_OF_DISEASE,5035
93505,About,O,5036
93506,AGTC,B-ORGANIZATION,5036
93507,AGTC,B-ORGANIZATION,5036
93508,is,O,5036
93509,a,O,5036
93510,clinical-stage,O,5036
93511,biotechnology,O,5036
93512,company,O,5036
93513,developing,O,5036
93514,genetic,O,5036
93515,therapies,O,5036
93516,for,O,5036
93517,people,O,5036
93518,with,O,5036
93519,rare,O,5036
93520,and,O,5036
93521,debilitating,O,5036
93522,ophthalmic,B-NAME_OF_DISEASE,5036
93523,otologic,I-NAME_OF_DISEASE,5036
93524,and,I-NAME_OF_DISEASE,5036
93525,central,I-NAME_OF_DISEASE,5036
93526,nervous,I-NAME_OF_DISEASE,5036
93527,system,I-NAME_OF_DISEASE,5036
93528,CNS,I-NAME_OF_DISEASE,5036
93529,diseases,I-NAME_OF_DISEASE,5036
93530,AGTC,B-ORGANIZATION,5037
93531,is,O,5037
93532,a,O,5037
93533,leader,O,5037
93534,in,O,5037
93535,designing,O,5037
93536,and,O,5037
93537,constructing,O,5037
93538,all,O,5037
93539,critical,O,5037
93540,gene,O,5037
93541,therapy,O,5037
93542,elements,O,5037
93543,and,O,5037
93544,bringing,O,5037
93545,them,O,5037
93546,together,O,5037
93547,to,O,5037
93548,develop,O,5037
93549,customized,O,5037
93550,therapies,O,5037
93551,with,O,5037
93552,the,O,5037
93553,potential,O,5037
93554,to,O,5037
93555,address,O,5037
93556,real,O,5037
93557,patient,O,5037
93558,needs,O,5037
93559,AGTC,B-ORGANIZATION,5038
93560,s,O,5038
93561,most,O,5038
93562,advanced,O,5038
93563,clinical,O,5038
93564,programs,O,5038
93565,leverage,O,5038
93566,its,O,5038
93567,best-in-class,O,5038
93568,technology,O,5038
93569,platform,O,5038
93570,to,O,5038
93571,potentially,O,5038
93572,improve,O,5038
93573,vision,O,5038
93574,for,O,5038
93575,patients,O,5038
93576,with,O,5038
93577,an,O,5038
93578,inherited,O,5038
93579,retinal,O,5038
93580,disease,O,5038
93581,AGTC,B-ORGANIZATION,5039
93582,has,O,5039
93583,active,O,5039
93584,clinical,O,5039
93585,trials,O,5039
93586,in,O,5039
93587,X-linked,B-NAME_OF_DISEASE,5039
93588,retinitis,I-NAME_OF_DISEASE,5039
93589,pigmentosa,I-NAME_OF_DISEASE,5039
93590,XLRP,I-NAME_OF_DISEASE,5039
93591,and,O,5039
93592,achromatopsia,B-NAME_OF_DISEASE,5039
93593,ACHM,I-NAME_OF_DISEASE,5039
93594,CNGB3,I-NAME_OF_DISEASE,5039
93595,and,I-NAME_OF_DISEASE,5039
93596,ACHM,I-NAME_OF_DISEASE,5039
93597,CNGA3,I-NAME_OF_DISEASE,5039
93598,,O,5039
93599,Its,O,5040
93600,preclinical,O,5040
93601,programs,O,5040
93602,build,O,5040
93603,on,O,5040
93604,the,O,5040
93605,company,O,5040
93606,s,O,5040
93607,industry,O,5040
93608,leading,O,5040
93609,AAV,B-CHEMICAL_COMPOUND,5040
93610,manufacturing,O,5040
93611,technology,O,5040
93612,and,O,5040
93613,scientific,O,5040
93614,expertise,O,5040
93615,AGTC,B-ORGANIZATION,5041
93616,is,O,5041
93617,advancing,O,5041
93618,multiple,O,5041
93619,important,O,5041
93620,pipeline,O,5041
93621,candidates,O,5041
93622,to,O,5041
93623,address,O,5041
93624,substantial,O,5041
93625,unmet,O,5041
93626,clinical,O,5041
93627,need,O,5041
93628,in,O,5041
93629,optogenetics,B-NAME_OF_DISEASE,5041
93630,otology,I-NAME_OF_DISEASE,5041
93631,and,I-NAME_OF_DISEASE,5041
93632,CNS,I-NAME_OF_DISEASE,5041
93633,disorders,I-NAME_OF_DISEASE,5041
93634,and,O,5041
93635,has,O,5041
93636,entered,O,5041
93637,into,O,5041
93638,strategic,O,5041
93639,collaborations,O,5041
93640,with,O,5041
93641,companies,O,5041
93642,including,O,5041
93643,Otonomy,O,5041
93644,Inc,O,5041
93645,a,O,5042
93646,biopharmaceutical,O,5042
93647,company,O,5042
93648,dedicated,O,5042
93649,to,O,5042
93650,the,O,5042
93651,development,O,5042
93652,of,O,5042
93653,innovative,O,5042
93654,therapeutics,O,5042
93655,for,O,5042
93656,neurotology,O,5042
93657,and,O,5042
93658,Bionic,B-ORGANIZATION,5042
93659,Sight,I-ORGANIZATION,5042
93660,LLC,I-ORGANIZATION,5042
93661,an,O,5042
93662,innovator,O,5042
93663,in,O,5042
93664,the,O,5042
93665,emerging,O,5042
93666,field,O,5042
93667,of,O,5042
93668,optogenetics,O,5042
93669,and,O,5042
93670,retinal,O,5042
93671,coding,O,5042
93672,AGTC-501,B-TREATMENT,5043
93673,Applied,I-TREATMENT,5043
93674,Genetic,I-TREATMENT,5043
93675,Technologies,I-TREATMENT,5043
93676,Corporation,I-TREATMENT,5043
93677,a,O,5043
93678,novel,O,5043
93679,gene,O,5043
93680,therapy,O,5043
93681,in,O,5043
93682,development,O,5043
93683,for,O,5043
93684,the,O,5043
93685,potential,O,5043
93686,treatment,O,5043
93687,of,O,5043
93688,X-linked,B-NAME_OF_DISEASE,5043
93689,retinitis,I-NAME_OF_DISEASE,5043
93690,pigmentosa,I-NAME_OF_DISEASE,5043
93691,RP,B-NAME_OF_DISEASE,5043
93692,showed,O,5043
93693,an,O,5043
93694,acceptable,O,5043
93695,safety,O,5043
93696,profile,O,5043
93697,and,O,5043
93698,visual,O,5043
93699,function,O,5043
93700,improvements,O,5043
93701,in,O,5043
93702,the,O,5043
93703,study,O,5043
93704,s,O,5043
93705,higher,O,5043
93706,dose,O,5043
93707,groups,O,5043
93708,according,O,5043
93709,to,O,5043
93710,Robert,O,5043
93711,A,O,5043
93712,Sisk,B-PERSON,5044
93713,MD,O,5044
93714,FACS,O,5044
93715,from,O,5044
93716,the,B-ORGANIZATION,5044
93717,Cincinnati,I-ORGANIZATION,5044
93718,Eye,I-ORGANIZATION,5044
93719,Institute,I-ORGANIZATION,5044
93720,in,O,5044
93721,Ohio,B-GPE,5044
93722,Sisk,B-PERSON,5045
93723,outlined,O,5045
93724,the,O,5045
93725,safety,O,5045
93726,and,O,5045
93727,efficacy,O,5045
93728,findings,O,5045
93729,of,O,5045
93730,a,O,5045
93731,phase,O,5045
93732,1,O,5045
93733,2,O,5045
93734,study,O,5045
93735,of,O,5045
93736,AGTC-501,B-TREATMENT,5045
93737,gene,I-TREATMENT,5045
93738,therapy,I-TREATMENT,5045
93739,a,B-CHEMICAL_COMPOUND,5045
93740,recombinant,I-CHEMICAL_COMPOUND,5045
93741,adeno-associated,I-CHEMICAL_COMPOUND,5045
93742,virus,I-CHEMICAL_COMPOUND,5045
93743,AAV,I-CHEMICAL_COMPOUND,5045
93744,2,O,5045
93745,vector,O,5045
93746,for,O,5045
93747,X-linked,B-NAME_OF_DISEASE,5045
93748,RP,B-NAME_OF_DISEASE,5045
93749,resulting,O,5045
93750,from,O,5045
93751,mutations,O,5045
93752,in,O,5045
93753,the,B-CHEMICAL_COMPOUND,5045
93754,RPGR,B-CHEMICAL_COMPOUND,5045
93755,gene,I-CHEMICAL_COMPOUND,5045
93756,which,O,5045
93757,accounts,O,5045
93758,for,O,5045
93759,10%,O,5045
93760,of,O,5045
93761,RP,B-NAME_OF_DISEASE,5045
93762,cases,O,5045
93763,AGTC-501,B-TREATMENT,5046
93764,Trial,O,5046
93765,This,O,5046
93766,study,O,5046
93767,was,O,5046
93768,a,O,5046
93769,12-month,B-TIME_DURATION,5046
93770,open-label,O,5046
93771,dose-escalation,O,5046
93772,trial,O,5046
93773,that,O,5046
93774,included,O,5046
93775,29,O,5046
93776,male,O,5046
93777,patients,O,5046
93778,aged,O,5046
93779,6,O,5046
93780,years,O,5046
93781,and,O,5046
93782,older,O,5046
93783,with,O,5046
93784,the,O,5046
93785,RPGR,B-CHEMICAL_COMPOUND,5046
93786,mutation,O,5046
93787,All,O,5047
93788,patients,O,5047
93789,were,O,5047
93790,treated,O,5047
93791,with,O,5047
93792,1,O,5047
93793,subretinal,O,5047
93794,injection,O,5047
93795,in,O,5047
93796,the,O,5047
93797,study,O,5047
93798,eye,O,5047
93799,The,O,5048
93800,first,O,5048
93801,9,O,5048
93802,patients,O,5048
93803,received,O,5048
93804,peripheral,O,5048
93805,retinal,O,5048
93806,injections,O,5048
93807,as,O,5048
93808,part,O,5048
93809,of,O,5048
93810,a,O,5048
93811,safety,O,5048
93812,assessment,O,5048
93813,which,O,5048
93814,was,O,5048
93815,the,O,5048
93816,primary,O,5048
93817,outcome,O,5048
93818,and,O,5048
93819,the,O,5048
93820,rest,O,5048
93821,of,O,5048
93822,the,O,5048
93823,patients,O,5048
93824,were,O,5048
93825,treated,O,5048
93826,centrally,O,5048
93827,The,O,5049
93828,safety,O,5049
93829,assessment,O,5049
93830,also,O,5049
93831,included,O,5049
93832,immunologic,O,5049
93833,responses,O,5049
93834,to,O,5049
93835,the,B-CHEMICAL_COMPOUND,5049
93836,AAV,I-CHEMICAL_COMPOUND,5049
93837,capsid,I-CHEMICAL_COMPOUND,5049
93838,and,O,5049
93839,the,O,5049
93840,RPGR,B-CHEMICAL_COMPOUND,5049
93841,proteins,I-CHEMICAL_COMPOUND,5049
93842,expressed,O,5049
93843,Sisk,B-PERSON,5049
93844,explained,O,5049
93845,Key,O,5050
93846,secondary,O,5050
93847,outcomes,O,5050
93848,included,O,5050
93849,visual,O,5050
93850,function,O,5050
93851,measured,O,5050
93852,by,O,5050
93853,microperimetry,B-DIAGNOSTIC_TEST,5050
93854,Macular,I-DIAGNOSTIC_TEST,5050
93855,Integrity,I-DIAGNOSTIC_TEST,5050
93856,Assessment,I-DIAGNOSTIC_TEST,5050
93857,and,O,5050
93858,retinal,O,5050
93859,structure,O,5050
93860,seen,O,5050
93861,on,O,5050
93862,optical,B-DIAGNOSTIC_TEST,5050
93863,coherence,I-DIAGNOSTIC_TEST,5050
93864,tomography,I-DIAGNOSTIC_TEST,5050
93865,OCT,I-DIAGNOSTIC_TEST,5050
93866,,O,5050
93867,Safety,O,5051
93868,and,O,5051
93869,Vision,O,5051
93870,Results,O,5051
93871,with,O,5051
93872,AGTC-501,B-TREATMENT,5051
93873,The,O,5051
93874,safety,O,5051
93875,results,O,5051
93876,showed,O,5051
93877,that,O,5051
93878,no,O,5051
93879,serious,O,5051
93880,adverse,O,5051
93881,events,O,5051
93882,were,O,5051
93883,related,O,5051
93884,to,O,5051
93885,the,O,5051
93886,treatment,O,5051
93887,The,O,5052
93888,initial,O,5052
93889,surgical,O,5052
93890,approach,O,5052
93891,resulted,O,5052
93892,in,O,5052
93893,4,B-SIGN_AND_SYMPTOM,5052
93894,peripheral,I-SIGN_AND_SYMPTOM,5052
93895,retinal,I-SIGN_AND_SYMPTOM,5052
93896,detachments,I-SIGN_AND_SYMPTOM,5052
93897,related,O,5052
93898,to,O,5052
93899,dosing,O,5052
93900,targeting,O,5052
93901,the,B-PART_OF_THE_EYES,5052
93902,peripheral,I-PART_OF_THE_EYES,5052
93903,retina,I-PART_OF_THE_EYES,5052
93904,The,O,5053
93905,detachments,O,5053
93906,did,O,5053
93907,not,O,5053
93908,occur,O,5053
93909,when,O,5053
93910,the,B-PART_OF_THE_EYES,5053
93911,central,I-PART_OF_THE_EYES,5053
93912,retina,I-PART_OF_THE_EYES,5053
93913,was,O,5053
93914,targeted,O,5053
93915,Grade,O,5054
93916,1,O,5054
93917,to,O,5054
93918,2,O,5054
93919,intraocular,B-SIGN_AND_SYMPTOM,5054
93920,inflammation,I-SIGN_AND_SYMPTOM,5054
93921,developed,O,5054
93922,in,O,5054
93923,about,O,5054
93924,20%,O,5054
93925,5,O,5054
93926,29,O,5054
93927,of,O,5054
93928,patients,O,5054
93929,and,O,5054
93930,all,O,5054
93931,were,O,5054
93932,reported,O,5054
93933,as,O,5054
93934,resolved,O,5054
93935,About,O,5055
93936,one-third,O,5055
93937,of,O,5055
93938,the,O,5055
93939,patients,O,5055
93940,had,O,5055
93941,intraocular,B-SIGN_AND_SYMPTOM,5055
93942,pressure,I-SIGN_AND_SYMPTOM,5055
93943,elevations,I-SIGN_AND_SYMPTOM,5055
93944,related,O,5055
93945,to,O,5055
93946,corticosteroid,B-NAME_OF_DRUG,5055
93947,use,O,5055
93948,and,O,5055
93949,all,O,5055
93950,have,O,5055
93951,resolved,O,5055
93952,without,O,5055
93953,IOP,O,5055
93954,related,O,5055
93955,morbidities,O,5055
93956,The,O,5056
93957,immunologic,O,5056
93958,results,O,5056
93959,did,O,5056
93960,not,O,5056
93961,suggest,O,5056
93962,safety,O,5056
93963,concerns,O,5056
93964,The,O,5057
93965,microperimetry,O,5057
93966,sensitivity,O,5057
93967,improved,O,5057
93968,at,O,5057
93969,month,O,5057
93970,12,O,5057
93971,in,O,5057
93972,all,O,5057
93973,centrally,O,5057
93974,dosed,O,5057
93975,patients,O,5057
93976,across,O,5057
93977,the,O,5057
93978,central,O,5057
93979,36,O,5057
93980,points,O,5057
93981,which,O,5057
93982,corresponds,O,5057
93983,to,O,5057
93984,the,O,5057
93985,most,O,5057
93986,anatomically,O,5057
93987,and,O,5057
93988,functionally,O,5057
93989,intact,O,5057
93990,areas,O,5057
93991,in,O,5057
93992,the,O,5057
93993,patient,O,5057
93994,population,O,5057
93995,he,O,5057
93996,explained,O,5057
93997,Sisk,B-PERSON,5058
93998,also,O,5058
93999,noted,O,5058
94000,that,O,5058
94001,the,B-ORGANIZATION,5058
94002,FDA,I-ORGANIZATION,5058
94003,has,O,5058
94004,accepted,O,5058
94005,a,O,5058
94006,change,O,5058
94007,of,O,5058
94008,7,O,5058
94009,or,O,5058
94010,more,O,5058
94011,decibels,O,5058
94012,in,O,5058
94013,5,O,5058
94014,or,O,5058
94015,more,O,5058
94016,loci,O,5058
94017,in,O,5058
94018,the,O,5058
94019,central,O,5058
94020,microperimetry,O,5058
94021,as,O,5058
94022,clinically,O,5058
94023,meaningful,O,5058
94024,During,O,5059
94025,the,O,5059
94026,course,O,5059
94027,of,O,5059
94028,the,O,5059
94029,study,O,5059
94030,the,O,5059
94031,investigators,O,5059
94032,observed,O,5059
94033,that,O,5059
94034,patients,O,5059
94035,without,O,5059
94036,foveal,O,5059
94037,ellipsoid,B-PART_OF_THE_EYES,5059
94038,zone,I-PART_OF_THE_EYES,5059
94039,EZ,B-PART_OF_THE_EYES,5059
94040,integrity,O,5059
94041,before,O,5059
94042,the,O,5059
94043,treatment,O,5059
94044,did,O,5059
94045,not,O,5059
94046,have,O,5059
94047,improved,O,5059
94048,microperimetry,O,5059
94049,When,O,5060
94050,those,O,5060
94051,patients,O,5060
94052,were,O,5060
94053,excluded,O,5060
94054,from,O,5060
94055,analysis,O,5060
94056,50%,O,5060
94057,of,O,5060
94058,patients,O,5060
94059,were,O,5060
94060,responders,O,5060
94061,to,O,5060
94062,treatment,O,5060
94063,Another,O,5061
94064,2,O,5061
94065,patients,O,5061
94066,also,O,5061
94067,had,O,5061
94068,significant,O,5061
94069,improvements,O,5061
94070,in,O,5061
94071,microperimetry,O,5061
94072,compared,O,5061
94073,with,O,5061
94074,the,O,5061
94075,untreated,O,5061
94076,fellow,O,5061
94077,eye,O,5061
94078,Optimizing,O,5062
94079,Outcomes,O,5062
94080,with,O,5062
94081,AGTC-501,B-TREATMENT,5062
94082,In,O,5062
94083,addition,O,5062
94084,to,O,5062
94085,avoiding,O,5062
94086,treatment,O,5062
94087,targeting,O,5062
94088,the,B-PART_OF_THE_EYES,5062
94089,peripheral,I-PART_OF_THE_EYES,5062
94090,retina,I-PART_OF_THE_EYES,5062
94091,patient,O,5062
94092,selection,O,5062
94093,is,O,5062
94094,paramount,O,5062
94095,to,O,5062
94096,achieve,O,5062
94097,the,O,5062
94098,best,O,5062
94099,results,O,5062
94100,Advanced,O,5063
94101,disease,O,5063
94102,with,O,5063
94103,absence,O,5063
94104,of,O,5063
94105,baseline,O,5063
94106,microperimetry,O,5063
94107,or,O,5063
94108,a,O,5063
94109,foveal,O,5063
94110,EZ,B-PART_OF_THE_EYES,5063
94111,line,O,5063
94112,precluded,O,5063
94113,meaningful,O,5063
94114,microperimetry,O,5063
94115,or,O,5063
94116,visual,O,5063
94117,benefits,O,5063
94118,Sisk,B-PERSON,5063
94119,said,O,5063
94120,Clinical,O,5064
94121,trials,O,5064
94122,of,O,5064
94123,AGTC-501,B-TREATMENT,5064
94124,for,O,5064
94125,the,O,5064
94126,potential,O,5064
94127,treatment,O,5064
94128,of,O,5064
94129,X-link,B-NAME_OF_DISEASE,5064
94130,RP,I-NAME_OF_DISEASE,5064
94131,are,O,5064
94132,continuing,O,5064
94133,The,B-NAME_OF_STUDY,5065
94134,Skyline,I-NAME_OF_STUDY,5065
94135,trial,I-NAME_OF_STUDY,5065
94136,NCT03316560,I-NAME_OF_STUDY,5065
94137,is,O,5065
94138,an,O,5065
94139,expansion,O,5065
94140,of,O,5065
94141,this,O,5065
94142,phase,O,5065
94143,1,O,5065
94144,2,O,5065
94145,clinical,O,5065
94146,trial,O,5065
94147,and,O,5065
94148,the,B-NAME_OF_STUDY,5065
94149,Vista,I-NAME_OF_STUDY,5065
94150,trial,I-NAME_OF_STUDY,5065
94151,NCT04850118,I-NAME_OF_STUDY,5065
94152,is,O,5065
94153,a,O,5065
94154,phase,O,5065
94155,2,O,5065
94156,3,O,5065
94157,safety,O,5065
94158,and,O,5065
94159,efficacy,O,5065
94160,clinical,O,5065
94161,trial,O,5065
94162,Diabetes,B-NAME_OF_DISEASE,5066
94163,is,O,5066
94164,the,O,5066
94165,most,O,5066
94166,common,O,5066
94167,risk,O,5066
94168,factor,O,5066
94169,for,O,5066
94170,cataract,B-NAME_OF_DISEASE,5066
94171,Cataract,B-NAME_OF_DISEASE,5067
94172,remains,O,5067
94173,one,O,5067
94174,of,O,5067
94175,the,O,5067
94176,major,O,5067
94177,causes,O,5067
94178,of,O,5067
94179,blindness,B-NAME_OF_DISEASE,5067
94180,in,O,5067
94181,diabetic,O,5067
94182,patients,O,5067
94183,Some,O,5068
94184,studies,O,5068
94185,report,O,5068
94186,an,O,5068
94187,increased,O,5068
94188,risk,O,5068
94189,of,O,5068
94190,progression,O,5068
94191,whereas,O,5068
94192,others,O,5068
94193,report,O,5068
94194,that,O,5068
94195,this,O,5068
94196,progression,O,5068
94197,simply,O,5068
94198,represents,O,5068
94199,the,O,5068
94200,natural,O,5068
94201,course,O,5068
94202,of,O,5068
94203,the,O,5068
94204,disease,O,5068
94205,rather,O,5068
94206,than,O,5068
94207,a,O,5068
94208,surgical,O,5068
94209,outcome,O,5068
94210,The,O,5069
94211,findings,O,5069
94212,suggest,O,5069
94213,that,O,5069
94214,uncomplicated,O,5069
94215,phacoemulsification,B-TREATMENT,5069
94216,cataract,B-TREATMENT,5069
94217,surgery,I-TREATMENT,5069
94218,may,O,5069
94219,not,O,5069
94220,be,O,5069
94221,responsible,O,5069
94222,for,O,5069
94223,an,O,5069
94224,accelerated,O,5069
94225,rate,O,5069
94226,of,O,5069
94227,DR,B-NAME_OF_DISEASE,5069
94228,progression,O,5069
94229,postoperatively,O,5069
94230,Instead,O,5070
94231,the,O,5070
94232,findings,O,5070
94233,suggest,O,5070
94234,that,O,5070
94235,any,O,5070
94236,DR,B-NAME_OF_DISEASE,5070
94237,progression,O,5070
94238,that,O,5070
94239,does,O,5070
94240,occur,O,5070
94241,postoperatively,O,5070
94242,may,O,5070
94243,simply,O,5070
94244,represent,O,5070
94245,the,O,5070
94246,natural,O,5070
94247,history,O,5070
94248,of,O,5070
94249,the,O,5070
94250,disease,O,5070
94251,Although,O,5071
94252,macular,B-NAME_OF_DISEASE,5071
94253,edema,I-NAME_OF_DISEASE,5071
94254,was,O,5071
94255,common,O,5071
94256,after,O,5071
94257,cataract,B-TREATMENT,5071
94258,surgery,I-TREATMENT,5071
94259,it,O,5071
94260,often,O,5071
94261,followed,O,5071
94262,a,O,5071
94263,benign,O,5071
94264,course,O,5071
94265,and,O,5071
94266,any,O,5071
94267,progression,O,5071
94268,that,O,5071
94269,is,O,5071
94270,observed,O,5071
94271,postoperatively,O,5071
94272,probably,O,5071
94273,represents,O,5071
94274,natural,O,5071
94275,progression,O,5071
94276,rather,O,5071
94277,than,O,5071
94278,being,O,5071
94279,a,O,5071
94280,direct,O,5071
94281,effect,O,5071
94282,of,O,5071
94283,surgery,O,5071
94284,Compared,O,5072
94285,to,O,5072
94286,non-diabetic,O,5072
94287,patients,O,5072
94288,outcome,O,5072
94289,after,O,5072
94290,cataract,B-TREATMENT,5072
94291,surgery,I-TREATMENT,5072
94292,was,O,5072
94293,reported,O,5072
94294,to,O,5072
94295,be,O,5072
94296,worse,O,5072
94297,in,O,5072
94298,diabetic,O,5072
94299,patients--especially,O,5072
94300,in,O,5072
94301,those,O,5072
94302,with,O,5072
94303,diabetic,B-NAME_OF_DISEASE,5072
94304,retinopathy,I-NAME_OF_DISEASE,5072
94305,Cataracts,B-NAME_OF_DISEASE,5073
94306,and,O,5073
94307,diabetic,B-NAME_OF_DISEASE,5073
94308,retinopathy,I-NAME_OF_DISEASE,5073
94309,DR,B-NAME_OF_DISEASE,5073
94310,are,O,5073
94311,the,O,5073
94312,leading,O,5073
94313,causes,O,5073
94314,of,O,5073
94315,acquired,O,5073
94316,blindness,B-NAME_OF_DISEASE,5073
94317,worldwide,O,5073
94318,which,O,5073
94319,is,O,5073
94320,further,O,5073
94321,compounded,O,5073
94322,by,O,5073
94323,the,O,5073
94324,fact,O,5073
94325,that,O,5073
94326,patients,O,5073
94327,with,O,5073
94328,diabetes,B-NAME_OF_DISEASE,5073
94329,have,O,5073
94330,an,O,5073
94331,increased,O,5073
94332,risk,O,5073
94333,of,O,5073
94334,developing,O,5073
94335,cataracts,B-NAME_OF_DISEASE,5073
94336,Thus,O,5074
94337,many,O,5074
94338,patients,O,5074
94339,with,O,5074
94340,diabetes,B-NAME_OF_DISEASE,5074
94341,concomitantly,O,5074
94342,have,O,5074
94343,cataracts,B-NAME_OF_DISEASE,5074
94344,and,O,5074
94345,DR,B-NAME_OF_DISEASE,5074
94346,Although,O,5075
94347,extraction,O,5075
94348,is,O,5075
94349,the,O,5075
94350,standard,O,5075
94351,treatment,O,5075
94352,option,O,5075
94353,for,O,5075
94354,cataracts,B-NAME_OF_DISEASE,5075
94355,it,O,5075
94356,is,O,5075
94357,also,O,5075
94358,reported,O,5075
94359,to,O,5075
94360,worsen,O,5075
94361,existing,O,5075
94362,cases,O,5075
94363,of,O,5075
94364,DR,B-NAME_OF_DISEASE,5075
94365,a,O,5075
94366,microvascular,O,5075
94367,complication,O,5075
94368,of,O,5075
94369,diabetes,B-NAME_OF_DISEASE,5075
94370,leading,O,5075
94371,to,O,5075
94372,further,O,5075
94373,vision,B-SIGN_AND_SYMPTOM,5075
94374,loss,I-SIGN_AND_SYMPTOM,5075
94375,It,O,5076
94376,was,O,5076
94377,postulated,O,5076
94378,that,O,5076
94379,cataract,B-CAUSE_OF_DISEASE,5076
94380,extraction,I-CAUSE_OF_DISEASE,5076
94381,may,O,5076
94382,possibly,O,5076
94383,lead,O,5076
94384,to,O,5076
94385,a,B-CAUSE_OF_DISEASE,5076
94386,breakdown,I-CAUSE_OF_DISEASE,5076
94387,of,I-CAUSE_OF_DISEASE,5076
94388,the,I-CAUSE_OF_DISEASE,5076
94389,blood-retinal,I-CAUSE_OF_DISEASE,5076
94390,barrier,I-CAUSE_OF_DISEASE,5076
94391,and,I-CAUSE_OF_DISEASE,5076
94392,the,I-CAUSE_OF_DISEASE,5076
94393,blood-aqueous,I-CAUSE_OF_DISEASE,5076
94394,barrier,I-CAUSE_OF_DISEASE,5076
94395,and,I-CAUSE_OF_DISEASE,5076
94396,enhanced,I-CAUSE_OF_DISEASE,5076
94397,intraocular,I-CAUSE_OF_DISEASE,5076
94398,inflammatory,I-CAUSE_OF_DISEASE,5076
94399,response,I-CAUSE_OF_DISEASE,5076
94400,all,O,5076
94401,of,O,5076
94402,which,O,5076
94403,may,O,5076
94404,result,O,5076
94405,in,O,5076
94406,the,O,5076
94407,occurrence,O,5076
94408,of,O,5076
94409,DR,B-NAME_OF_DISEASE,5076
94410,in,O,5076
94411,patients,O,5076
94412,with,O,5076
94413,diabetes,B-NAME_OF_DISEASE,5076
94414,For,O,5077
94415,this,O,5077
94416,reason,O,5077
94417,current,O,5077
94418,DR,B-NAME_OF_DISEASE,5077
94419,care,O,5077
94420,guidelines,O,5077
94421,also,O,5077
94422,recommend,O,5077
94423,measures,O,5077
94424,of,O,5077
94425,preoperative,O,5077
94426,stabilization,O,5077
94427,for,O,5077
94428,patients,O,5077
94429,with,O,5077
94430,diabetes,B-NAME_OF_DISEASE,5077
94431,and,O,5077
94432,existing,O,5077
94433,vision-threatening,O,5077
94434,DR,B-NAME_OF_DISEASE,5077
94435,who,O,5077
94436,undergo,O,5077
94437,cataract,B-CAUSE_OF_DISEASE,5077
94438,extraction,I-CAUSE_OF_DISEASE,5077
94439,These,O,5078
94440,measures,O,5078
94441,include,O,5078
94442,optimizing,O,5078
94443,glycemic,O,5078
94444,control,O,5078
94445,and,O,5078
94446,performing,O,5078
94447,panretinal,O,5078
94448,photocoagulation,O,5078
94449,preoperatively,O,5078
94450,to,O,5078
94451,better,O,5078
94452,prevent,O,5078
94453,postsurgery,O,5078
94454,complications,O,5078
94455,such,O,5078
94456,as,O,5078
94457,neovascularization,B-SIGN_AND_SYMPTOM,5078
94458,and,O,5078
94459,vitreous,B-SIGN_AND_SYMPTOM,5078
94460,hemorrhage,I-SIGN_AND_SYMPTOM,5078
94461,among,O,5078
94462,this,O,5078
94463,group,O,5078
94464,of,O,5078
94465,patients,O,5078
94466,At,O,5079
94467,some,O,5079
94468,point,O,5079
94469,every,O,5079
94470,ophthalmologist,O,5079
94471,is,O,5079
94472,going,O,5079
94473,to,O,5079
94474,have,O,5079
94475,a,O,5079
94476,diabetic,O,5079
94477,patient,O,5079
94478,walk,O,5079
94479,into,O,5079
94480,the,O,5079
94481,office,O,5079
94482,who,O,5079
94483,is,O,5079
94484,going,O,5079
94485,to,O,5079
94486,have,O,5079
94487,a,O,5079
94488,visually,O,5079
94489,significant,O,5079
94490,cataract,B-NAME_OF_DISEASE,5079
94491,Diabetic,B-NAME_OF_DISEASE,5080
94492,retinopathy,I-NAME_OF_DISEASE,5080
94493,is,O,5080
94494,the,O,5080
94495,leading,O,5080
94496,cause,O,5080
94497,of,O,5080
94498,vision,B-SIGN_AND_SYMPTOM,5080
94499,loss,I-SIGN_AND_SYMPTOM,5080
94500,among,O,5080
94501,patients,O,5080
94502,with,O,5080
94503,diabetes,B-NAME_OF_DISEASE,5080
94504,and,O,5080
94505,a,O,5080
94506,primary,O,5080
94507,cause,O,5080
94508,of,O,5080
94509,blindness,B-NAME_OF_DISEASE,5080
94510,among,O,5080
94511,working-age,O,5080
94512,adults,O,5080
94513,As,O,5081
94514,a,O,5081
94515,result,O,5081
94516,the,O,5081
94517,purpose,O,5081
94518,of,O,5081
94519,the,O,5081
94520,study,O,5081
94521,was,O,5081
94522,to,O,5081
94523,evaluate,O,5081
94524,how,O,5081
94525,diabetic,B-NAME_OF_DISEASE,5081
94526,retinopathy,I-NAME_OF_DISEASE,5081
94527,influences,O,5081
94528,cataract,B-TREATMENT,5081
94529,surgery,I-TREATMENT,5081
94530,The,O,5082
94531,primary,O,5082
94532,aims,O,5082
94533,included,O,5082
94534,studying,O,5082
94535,preoperative,O,5082
94536,risk,O,5082
94537,factors,O,5082
94538,intraoperative,O,5082
94539,complications,O,5082
94540,and,O,5082
94541,postoperative,O,5082
94542,outcomes,O,5082
94543,Methods,O,5083
94544,The,O,5083
94545,study,O,5083
94546,examined,O,5083
94547,a,O,5083
94548,retrospective,O,5083
94549,clinical,O,5083
94550,database,O,5083
94551,study,O,5083
94552,of,O,5083
94553,217,O,5083
94554,107,O,5083
94555,eyes,O,5083
94556,that,O,5083
94557,underwent,O,5083
94558,cataract,B-TREATMENT,5083
94559,surgery,I-TREATMENT,5083
94560,at,O,5083
94561,eight,O,5083
94562,UK,B-ORGANIZATION,5083
94563,National,I-ORGANIZATION,5083
94564,Health,I-ORGANIZATION,5083
94565,Service,I-ORGANIZATION,5083
94566,hospitals,I-ORGANIZATION,5083
94567,between,B-TIME_DURATION,5083
94568,2000-2015,I-TIME_DURATION,5083
94569,Of,O,5084
94570,those,O,5084
94571,eyes,O,5084
94572,included,O,5084
94573,in,O,5084
94574,the,O,5084
94575,database,O,5084
94576,study,O,5084
94577,138,O,5084
94578,100,O,5084
94579,were,O,5084
94580,not,O,5084
94581,diabetic,O,5084
94582,41,O,5084
94583,59,O,5084
94584,were,O,5084
94585,diabetic,O,5084
94586,and,O,5084
94587,for,O,5084
94588,the,O,5084
94589,remaining,O,5084
94590,37,O,5084
94591,948,O,5084
94592,the,O,5084
94593,diabetic,O,5084
94594,status,O,5084
94595,was,O,5084
94596,not,O,5084
94597,recorded,O,5084
94598,Our,O,5085
94599,methods,O,5085
94600,for,O,5085
94601,the,O,5085
94602,evaluation,O,5085
94603,of,O,5085
94604,risk,O,5085
94605,factors,O,5085
94606,compared,O,5085
94607,prevalence,O,5085
94608,of,O,5085
94609,preoperative,O,5085
94610,risk,O,5085
94611,factors,O,5085
94612,and,O,5085
94613,co-pathology,O,5085
94614,between,O,5085
94615,diabetic,O,5085
94616,patients,O,5085
94617,and,O,5085
94618,non-diabetic,O,5085
94619,patients,O,5085
94620,In,O,5086
94621,the,O,5086
94622,evaluation,O,5086
94623,of,O,5086
94624,complications,O,5086
94625,we,O,5086
94626,compared,O,5086
94627,incidences,O,5086
94628,of,O,5086
94629,intraoperative,O,5086
94630,complications,O,5086
94631,between,O,5086
94632,diabetic,O,5086
94633,patients,O,5086
94634,and,O,5086
94635,non-diabetic,O,5086
94636,patients,O,5086
94637,during,O,5086
94638,cataract,B-TREATMENT,5086
94639,surgery,I-TREATMENT,5086
94640,Lastly,O,5087
94641,we,O,5087
94642,compared,O,5087
94643,postoperative,O,5087
94644,outcomes,O,5087
94645,between,O,5087
94646,diabetic,O,5087
94647,patients,O,5087
94648,and,O,5087
94649,non-diabetic,O,5087
94650,patients,O,5087
94651,after,O,5087
94652,cataract,B-TREATMENT,5087
94653,surgery,I-TREATMENT,5087
94654,Our,O,5088
94655,methodology,O,5088
94656,included,O,5088
94657,strict,O,5088
94658,inclusion,O,5088
94659,criteria,O,5088
94660,including,O,5088
94661,no,O,5088
94662,copathology,O,5088
94663,except,O,5088
94664,amblyopia,B-NAME_OF_DISEASE,5088
94665,no,O,5088
94666,simultaneous,O,5088
94667,surgical,O,5088
94668,procedures,O,5088
94669,except,O,5088
94670,intraocular,B-TREATMENT,5088
94671,injection,I-TREATMENT,5088
94672,and,O,5088
94673,clear,O,5088
94674,ETDRS,B-DIAGNOSTIC_TEST,5088
94675,grading,I-DIAGNOSTIC_TEST,5088
94676,of,I-DIAGNOSTIC_TEST,5088
94677,retinopathy,I-DIAGNOSTIC_TEST,5088
94678,was,O,5088
94679,required,O,5088
94680,Results,O,5089
94681,In,O,5089
94682,examining,O,5089
94683,preoperative,O,5089
94684,risk,O,5089
94685,factors,O,5089
94686,we,O,5089
94687,found,O,5089
94688,that,O,5089
94689,epiretinal,B-SIGN_AND_SYMPTOM,5089
94690,membranes,I-SIGN_AND_SYMPTOM,5089
94691,ERM,I-SIGN_AND_SYMPTOM,5089
94692,small,I-SIGN_AND_SYMPTOM,5089
94693,pupil,I-SIGN_AND_SYMPTOM,5089
94694,and,I-SIGN_AND_SYMPTOM,5089
94695,brunescent,I-SIGN_AND_SYMPTOM,5089
94696,white,I-SIGN_AND_SYMPTOM,5089
94697,cataract,B-NAME_OF_DISEASE,5089
94698,are,O,5089
94699,more,O,5089
94700,common,O,5089
94701,in,O,5089
94702,diabetics,O,5089
94703,Our,O,5090
94704,review,O,5090
94705,of,O,5090
94706,intraoperative,O,5090
94707,complications,O,5090
94708,found,O,5090
94709,that,O,5090
94710,posterior,B-SIGN_AND_SYMPTOM,5090
94711,capsular,I-SIGN_AND_SYMPTOM,5090
94712,rupture,I-SIGN_AND_SYMPTOM,5090
94713,dropped,I-SIGN_AND_SYMPTOM,5090
94714,nuclear,I-SIGN_AND_SYMPTOM,5090
94715,fragment,I-SIGN_AND_SYMPTOM,5090
94716,corneal,I-SIGN_AND_SYMPTOM,5090
94717,edema,I-SIGN_AND_SYMPTOM,5090
94718,and,O,5090
94719,overall,O,5090
94720,complication,O,5090
94721,rates,O,5090
94722,were,O,5090
94723,higher,O,5090
94724,among,O,5090
94725,diabetic,O,5090
94726,patients,O,5090
94727,In,O,5091
94728,our,O,5091
94729,examination,O,5091
94730,of,O,5091
94731,postoperative,O,5091
94732,outcomes,O,5091
94733,we,O,5091
94734,found,O,5091
94735,that,O,5091
94736,visual,O,5091
94737,acuity,O,5091
94738,good,O,5091
94739,vision,O,5091
94740,≤20,O,5091
94741,40,O,5091
94742,and,O,5091
94743,pseudophakic,B-NAME_OF_DISEASE,5091
94744,cystoid,I-NAME_OF_DISEASE,5091
94745,macular,B-NAME_OF_DISEASE,5091
94746,edema,I-NAME_OF_DISEASE,5091
94747,CME,B-NAME_OF_DISEASE,5091
94748,were,O,5091
94749,negatively,O,5091
94750,associated,O,5091
94751,with,O,5091
94752,diabetes,B-NAME_OF_DISEASE,5091
94753,and,O,5091
94754,degree,O,5091
94755,of,O,5091
94756,diabetic,B-NAME_OF_DISEASE,5091
94757,retinopathy,I-NAME_OF_DISEASE,5091
94758,The,O,5092
94759,effect,O,5092
94760,of,O,5092
94761,preoperative,O,5092
94762,diabetic,B-NAME_OF_DISEASE,5092
94763,macular,B-NAME_OF_DISEASE,5092
94764,edema,I-NAME_OF_DISEASE,5092
94765,DME,B-NAME_OF_DISEASE,5092
94766,on,O,5092
94767,visual,O,5092
94768,acuity,O,5092
94769,and,O,5092
94770,good,O,5092
94771,vision,O,5092
94772,was,O,5092
94773,similar,O,5092
94774,to,O,5092
94775,the,O,5092
94776,effect,O,5092
94777,of,O,5092
94778,having,O,5092
94779,moderate,O,5092
94780,non-proliferative,B-NAME_OF_DISEASE,5092
94781,diabetic,I-NAME_OF_DISEASE,5092
94782,retinopathy,I-NAME_OF_DISEASE,5092
94783,NPDR,I-NAME_OF_DISEASE,5092
94784,,O,5092
94785,As,O,5093
94786,we,O,5093
94787,evaluated,O,5093
94788,outcomes,O,5093
94789,we,O,5093
94790,looked,O,5093
94791,at,O,5093
94792,the,O,5093
94793,difference,O,5093
94794,in,O,5093
94795,preoperative,O,5093
94796,and,O,5093
94797,postoperative,O,5093
94798,visual,O,5093
94799,acuity,O,5093
94800,between,O,5093
94801,the,O,5093
94802,diabetic,O,5093
94803,and,O,5093
94804,non-diabetic,O,5093
94805,patients,O,5093
94806,Using,O,5094
94807,logistic,O,5094
94808,regression,O,5094
94809,analysis,O,5094
94810,for,O,5094
94811,pre-,O,5094
94812,and,O,5094
94813,postop,O,5094
94814,four,B-TIME_DURATION,5094
94815,to,I-TIME_DURATION,5094
94816,12,I-TIME_DURATION,5094
94817,weeks,I-TIME_DURATION,5094
94818,BCVA,B-DIAGNOSTIC_TEST,5094
94819,logMAR,O,5094
94820,0,O,5094
94821,with,O,5095
94822,95%,O,5095
94823,CI,O,5095
94824,we,O,5095
94825,examined,O,5095
94826,the,O,5095
94827,chance,O,5095
94828,of,O,5095
94829,having,O,5095
94830,poor,O,5095
94831,vision,O,5095
94832,postoperatively,O,5095
94833,We,O,5096
94834,examined,O,5096
94835,the,O,5096
94836,chance,O,5096
94837,of,O,5096
94838,having,O,5096
94839,pseudophakic,B-NAME_OF_DISEASE,5096
94840,cystoid,I-NAME_OF_DISEASE,5096
94841,macular,B-NAME_OF_DISEASE,5096
94842,edema,I-NAME_OF_DISEASE,5096
94843,postoperatively,O,5096
94844,using,O,5096
94845,logistic,O,5096
94846,regression,O,5096
94847,analysis,O,5096
94848,for,O,5096
94849,postop,O,5096
94850,CME,B-NAME_OF_DISEASE,5096
94851,with,O,5096
94852,95%,O,5096
94853,CI,O,5096
94854,We,O,5097
94855,also,O,5097
94856,wanted,O,5097
94857,to,O,5097
94858,determine,O,5097
94859,if,O,5097
94860,we,O,5097
94861,could,O,5097
94862,predict,O,5097
94863,postoperative,O,5097
94864,vision,O,5097
94865,based,O,5097
94866,on,O,5097
94867,preoperative,O,5097
94868,vision,O,5097
94869,and,O,5097
94870,diabetic,O,5097
94871,status,O,5097
94872,We,O,5098
94873,utilized,O,5098
94874,a,O,5098
94875,linear,O,5098
94876,regression,O,5098
94877,model,O,5098
94878,for,O,5098
94879,age,O,5098
94880,preop,O,5098
94881,DME,B-NAME_OF_DISEASE,5098
94882,diabetic,O,5098
94883,status,O,5098
94884,preop,O,5098
94885,visual,O,5098
94886,acuity,O,5098
94887,and,O,5098
94888,postop,O,5098
94889,visual,O,5098
94890,acuity,O,5098
94891,at,O,5098
94892,four,B-TIME_DURATION,5098
94893,to,I-TIME_DURATION,5098
94894,12,I-TIME_DURATION,5098
94895,weeks,I-TIME_DURATION,5098
94896,with,O,5098
94897,95%,O,5098
94898,CI,O,5098
94899,There,O,5099
94900,also,O,5099
94901,are,O,5099
94902,some,O,5099
94903,limitations,O,5099
94904,that,O,5099
94905,we,O,5099
94906,acknowledge,O,5099
94907,including,O,5099
94908,retrospective,O,5099
94909,design,O,5099
94910,missing,O,5099
94911,short-term,O,5099
94912,follow,O,5099
94913,up,O,5099
94914,data,O,5099
94915,and,O,5099
94916,missing,O,5099
94917,details,O,5099
94918,of,O,5099
94919,grading,O,5099
94920,of,O,5099
94921,cataract,B-NAME_OF_DISEASE,5099
94922,type,O,5099
94923,density,O,5099
94924,We,O,5100
94925,found,O,5100
94926,that,O,5100
94927,diabetics,O,5100
94928,are,O,5100
94929,seeing,O,5100
94930,worse,O,5100
94931,they,O,5100
94932,are,O,5100
94933,having,O,5100
94934,poor,O,5100
94935,vision,O,5100
94936,and,O,5100
94937,are,O,5100
94938,developing,O,5100
94939,more,O,5100
94940,macular,B-NAME_OF_DISEASE,5100
94941,edema,I-NAME_OF_DISEASE,5100
94942,after,O,5100
94943,surgery,O,5100
94944,The,O,5101
94945,worse,O,5101
94946,their,O,5101
94947,retinopathy,O,5101
94948,the,O,5101
94949,worse,O,5101
94950,their,O,5101
94951,outcome,O,5101
94952,This,O,5102
94953,study,O,5102
94954,provides,O,5102
94955,data,O,5102
94956,to,O,5102
94957,assist,O,5102
94958,in,O,5102
94959,the,O,5102
94960,planning,O,5102
94961,of,O,5102
94962,cataract,B-TREATMENT,5102
94963,surgery,I-TREATMENT,5102
94964,and,O,5102
94965,providing,O,5102
94966,informed,O,5102
94967,consent,O,5102
94968,in,O,5102
94969,diabetic,O,5102
94970,patients,O,5102
94971,It,O,5103
94972,would,O,5103
94973,be,O,5103
94974,reasonable,O,5103
94975,to,O,5103
94976,recommend,O,5103
94977,performing,O,5103
94978,cataract,B-NAME_OF_DISEASE,5103
94979,extraction,I-TREATMENT,5103
94980,on,O,5103
94981,diabetic,O,5103
94982,patients,O,5103
94983,early,O,5103
94984,before,O,5103
94985,the,O,5103
94986,development,O,5103
94987,of,O,5103
94988,significant,O,5103
94989,retinopathy,O,5103
94990,or,O,5103
94991,vision,O,5103
94992,decline,O,5103
94993,Individuals,O,5104
94994,with,O,5104
94995,glaucoma,B-NAME_OF_DISEASE,5104
94996,who,O,5104
94997,need,O,5104
94998,three,O,5104
94999,or,O,5104
95000,four,O,5104
95001,topical,O,5104
95002,medications,O,5104
95003,to,O,5104
95004,manage,O,5104
95005,their,O,5104
95006,pressure,O,5104
95007,are,O,5104
95008,in,O,5104
95009,a,O,5104
95010,difficult,O,5104
95011,situation,O,5104
95012,In,O,5105
95013,addition,O,5105
95014,to,O,5105
95015,battling,O,5105
95016,what,O,5105
95017,is,O,5105
95018,probably,O,5105
95019,an,O,5105
95020,aggressive,O,5105
95021,disease,O,5105
95022,they,O,5105
95023,also,O,5105
95024,struggle,O,5105
95025,with,O,5105
95026,the,O,5105
95027,tolerability,O,5105
95028,adherence,O,5105
95029,and,O,5105
95030,cost,O,5105
95031,of,O,5105
95032,multiagent,O,5105
95033,topical,O,5105
95034,therapy,O,5105
95035,Blindness,B-NAME_OF_DISEASE,5106
95036,may,O,5106
95037,develop,O,5106
95038,from,O,5106
95039,damage,B-CAUSE_OF_DISEASE,5106
95040,to,I-CAUSE_OF_DISEASE,5106
95041,the,I-CAUSE_OF_DISEASE,5106
95042,retinal,I-CAUSE_OF_DISEASE,5106
95043,ganglion,I-CAUSE_OF_DISEASE,5106
95044,cells,I-CAUSE_OF_DISEASE,5106
95045,and,I-CAUSE_OF_DISEASE,5106
95046,their,I-CAUSE_OF_DISEASE,5106
95047,axons,I-CAUSE_OF_DISEASE,5106
95048,in,I-CAUSE_OF_DISEASE,5106
95049,glaucoma,I-CAUSE_OF_DISEASE,5106
95050,an,I-CAUSE_OF_DISEASE,5106
95051,optic,I-CAUSE_OF_DISEASE,5106
95052,neuropathy,I-CAUSE_OF_DISEASE,5106
95053,It,O,5107
95054,is,O,5107
95055,the,O,5107
95056,second,O,5107
95057,most,O,5107
95058,common,O,5107
95059,cause,O,5107
95060,of,O,5107
95061,blindness,B-NAME_OF_DISEASE,5107
95062,in,O,5107
95063,the,O,5107
95064,globe,O,5107
95065,Older,B-CAUSE_OF_DISEASE,5108
95066,age,I-CAUSE_OF_DISEASE,5108
95067,a,B-CAUSE_OF_DISEASE,5108
95068,higher,I-CAUSE_OF_DISEASE,5108
95069,cup-to-disc,I-CAUSE_OF_DISEASE,5108
95070,ratio,I-CAUSE_OF_DISEASE,5108
95071,of,I-CAUSE_OF_DISEASE,5108
95072,the,I-CAUSE_OF_DISEASE,5108
95073,optic,I-CAUSE_OF_DISEASE,5108
95074,nerve,I-CAUSE_OF_DISEASE,5108
95075,a,I-CAUSE_OF_DISEASE,5108
95076,thin,I-CAUSE_OF_DISEASE,5108
95077,central,I-CAUSE_OF_DISEASE,5108
95078,cornea,I-CAUSE_OF_DISEASE,5108
95079,familial,B-CAUSE_OF_DISEASE,5108
95080,history,I-CAUSE_OF_DISEASE,5108
95081,and,O,5108
95082,higher,B-CAUSE_OF_DISEASE,5108
95083,intraocular,I-CAUSE_OF_DISEASE,5108
95084,pressure,I-CAUSE_OF_DISEASE,5108
95085,are,O,5108
95086,risk,O,5108
95087,factors,O,5108
95088,for,O,5108
95089,glaucoma,B-NAME_OF_DISEASE,5108
95090,which,O,5108
95091,has,O,5108
95092,a,O,5108
95093,complex,O,5108
95094,etiology,O,5108
95095,IOP,O,5108
95096,,O,5108
95097,The,O,5109
95098,only,O,5109
95099,known,O,5109
95100,modifiable,O,5109
95101,risk,O,5109
95102,factor,O,5109
95103,is,O,5109
95104,IOP,O,5109
95105,and,O,5109
95106,it,O,5109
95107,affects,O,5109
95108,how,O,5109
95109,quickly,O,5109
95110,damage,O,5109
95111,develops,O,5109
95112,Hence,O,5110
95113,the,O,5110
95114,goal,O,5110
95115,of,O,5110
95116,glaucoma,B-NAME_OF_DISEASE,5110
95117,treatment,O,5110
95118,is,O,5110
95119,to,B-TREATMENT,5110
95120,lower,I-TREATMENT,5110
95121,IOP,I-TREATMENT,5110
95122,through,I-TREATMENT,5110
95123,surgery,I-TREATMENT,5110
95124,laser,B-TREATMENT,5110
95125,therapy,I-TREATMENT,5110
95126,or,O,5110
95127,pharmaceutical,B-TREATMENT,5110
95128,therapy,I-TREATMENT,5110
95129,with,O,5110
95130,drugs,B-TREATMENT,5110
95131,typically,O,5110
95132,being,O,5110
95133,the,O,5110
95134,first,O,5110
95135,line,O,5110
95136,of,O,5110
95137,defense,O,5110
95138,Reducing,B-TREATMENT,5111
95139,intraocular,I-TREATMENT,5111
95140,pressure,I-TREATMENT,5111
95141,IOP,I-TREATMENT,5111
95142,to,I-TREATMENT,5111
95143,a,I-TREATMENT,5111
95144,target,I-TREATMENT,5111
95145,pressure,I-TREATMENT,5111
95146,that,I-TREATMENT,5111
95147,is,I-TREATMENT,5111
95148,sufficiently,I-TREATMENT,5111
95149,low,I-TREATMENT,5111
95150,to,I-TREATMENT,5111
95151,stop,I-TREATMENT,5111
95152,glaucomatous,I-TREATMENT,5111
95153,development,I-TREATMENT,5111
95154,is,O,5111
95155,the,O,5111
95156,aim,O,5111
95157,of,O,5111
95158,treatment,O,5111
95159,for,O,5111
95160,glaucoma,B-NAME_OF_DISEASE,5111
95161,and,O,5111
95162,ocular,B-NAME_OF_DISEASE,5111
95163,hypertension,I-NAME_OF_DISEASE,5111
95164,The,B-NAME_OF_DRUG,5112
95165,prostaglandin,I-NAME_OF_DRUG,5112
95166,analogs,I-NAME_OF_DRUG,5112
95167,beta-adrenergic,B-NAME_OF_DRUG,5112
95168,receptor,I-NAME_OF_DRUG,5112
95169,antagonists,I-NAME_OF_DRUG,5112
95170,beta-blockers,I-NAME_OF_DRUG,5112
95171,alpha,B-NAME_OF_DRUG,5112
95172,adrenergic,I-NAME_OF_DRUG,5112
95173,receptor,I-NAME_OF_DRUG,5112
95174,agonists,I-NAME_OF_DRUG,5112
95175,alpha,I-NAME_OF_DRUG,5112
95176,agonists,I-NAME_OF_DRUG,5112
95177,and,O,5112
95178,carbonic,B-NAME_OF_DRUG,5112
95179,anhydrase,I-NAME_OF_DRUG,5112
95180,inhibitors,I-NAME_OF_DRUG,5112
95181,are,O,5112
95182,the,O,5112
95183,four,O,5112
95184,most,O,5112
95185,popular,O,5112
95186,groups,O,5112
95187,of,O,5112
95188,IOP-lowering,B-NAME_OF_DRUG,5112
95189,drugs,I-NAME_OF_DRUG,5112
95190,CAIs,I-NAME_OF_DRUG,5112
95191,,O,5112
95192,For,O,5113
95193,many,O,5113
95194,individuals,O,5113
95195,a,O,5113
95196,single,O,5113
95197,medicine,O,5113
95198,is,O,5113
95199,insufficient,O,5113
95200,to,O,5113
95201,lower,O,5113
95202,IOP,O,5113
95203,to,O,5113
95204,the,O,5113
95205,desired,O,5113
95206,level,O,5113
95207,necessitating,O,5113
95208,the,O,5113
95209,use,O,5113
95210,of,O,5113
95211,two,O,5113
95212,three,O,5113
95213,or,O,5113
95214,more,O,5113
95215,drugs,B-TREATMENT,5113
95216,from,O,5113
95217,various,O,5113
95218,classes,O,5113
95219,in,O,5113
95220,the,O,5113
95221,treatment,O,5113
95222,regimen,O,5113
95223,While,O,5114
95224,early,B-TREATMENT,5114
95225,cataract,I-TREATMENT,5114
95226,extraction,I-TREATMENT,5114
95227,to,I-TREATMENT,5114
95228,lower,I-TREATMENT,5114
95229,IOP,I-TREATMENT,5114
95230,and,I-TREATMENT,5114
95231,accompanying,I-TREATMENT,5114
95232,angle,I-TREATMENT,5114
95233,surgery,I-TREATMENT,5114
95234,to,I-TREATMENT,5114
95235,restore,I-TREATMENT,5114
95236,outflow,I-TREATMENT,5114
95237,via,I-TREATMENT,5114
95238,Schlemm,I-TREATMENT,5114
95239,s,I-TREATMENT,5114
95240,canal,I-TREATMENT,5114
95241,are,O,5114
95242,common,O,5114
95243,in,O,5114
95244,the,O,5114
95245,surgical,O,5114
95246,initial,O,5114
95247,treatment,O,5114
95248,of,O,5114
95249,adult,O,5114
95250,glaucoma,B-NAME_OF_DISEASE,5114
95251,some,O,5114
95252,patients,O,5114
95253,reject,O,5114
95254,or,O,5114
95255,are,O,5114
95256,unable,O,5114
95257,to,O,5114
95258,undergo,O,5114
95259,surgery,O,5114
95260,necessitating,O,5114
95261,the,O,5114
95262,use,O,5114
95263,of,O,5114
95264,multiple,O,5114
95265,medications,O,5114
95266,to,O,5114
95267,control,O,5114
95268,the,O,5114
95269,disease,O,5114
95270,The,O,5115
95271,success,O,5115
95272,of,O,5115
95273,treatment,O,5115
95274,is,O,5115
95275,constrained,O,5115
95276,by,O,5115
95277,adherence,O,5115
95278,to,O,5115
95279,the,O,5115
95280,prescribed,O,5115
95281,regimen,O,5115
95282,as,O,5115
95283,multiple,O,5115
95284,medications,O,5115
95285,are,O,5115
95286,frequently,O,5115
95287,required,O,5115
95288,to,O,5115
95289,achieve,O,5115
95290,and,O,5115
95291,maintain,O,5115
95292,the,O,5115
95293,desired,O,5115
95294,IOP,O,5115
95295,Additionally,O,5116
95296,limiting,O,5116
95297,compliance,O,5116
95298,medications,O,5116
95299,can,O,5116
95300,cause,O,5116
95301,ocular,B-SIGN_AND_SYMPTOM,5116
95302,erythema,I-SIGN_AND_SYMPTOM,5116
95303,and,I-SIGN_AND_SYMPTOM,5116
95304,conjunctivitis,I-SIGN_AND_SYMPTOM,5116
95305,due,O,5116
95306,to,O,5116
95307,their,O,5116
95308,active,O,5116
95309,components,O,5116
95310,and,O,5116
95311,preservatives,O,5116
95312,When,O,5117
95313,opposed,O,5117
95314,to,O,5117
95315,monotherapy,O,5117
95316,combining,O,5117
95317,numerous,O,5117
95318,topical,O,5117
95319,medications,O,5117
95320,into,O,5117
95321,a,O,5117
95322,single,O,5117
95323,solution,O,5117
95324,has,O,5117
95325,a,O,5117
95326,number,O,5117
95327,of,O,5117
95328,advantages,O,5117
95329,including,O,5117
95330,a,O,5117
95331,lighter,O,5117
95332,therapeutic,O,5117
95333,load,O,5117
95334,cost,O,5117
95335,savings,O,5117
95336,less,O,5117
95337,exposure,O,5117
95338,to,O,5117
95339,preservatives,O,5117
95340,and,O,5117
95341,ease,O,5117
95342,of,O,5117
95343,administration,O,5117
95344,Our,O,5118
95345,patients,O,5118
95346,must,O,5118
95347,put,O,5118
95348,in,O,5118
95349,a,O,5118
95350,lot,O,5118
95351,of,O,5118
95352,effort,O,5118
95353,to,O,5118
95354,adhere,O,5118
95355,to,O,5118
95356,their,O,5118
95357,lifelong,O,5118
95358,glaucoma,B-NAME_OF_DISEASE,5118
95359,treatment,O,5118
95360,They,O,5119
95361,must,O,5119
95362,have,O,5119
95363,the,O,5119
95364,financial,O,5119
95365,means,O,5119
95366,to,O,5119
95367,purchase,O,5119
95368,their,O,5119
95369,prescriptions,O,5119
95370,be,O,5119
95371,able,O,5119
95372,to,O,5119
95373,recall,O,5119
95374,the,O,5119
95375,recommended,O,5119
95376,daily,O,5119
95377,dosage,O,5119
95378,be,O,5119
95379,able,O,5119
95380,to,O,5119
95381,tolerate,O,5119
95382,the,O,5119
95383,drops,O,5119
95384,well,O,5119
95385,enough,O,5119
95386,to,O,5119
95387,not,O,5119
95388,miss,O,5119
95389,doses,O,5119
95390,and,O,5119
95391,physically,O,5119
95392,be,O,5119
95393,able,O,5119
95394,to,O,5119
95395,successfully,O,5119
95396,administer,O,5119
95397,the,O,5119
95398,drops,O,5119
95399,That,O,5120
95400,is,O,5120
95401,a,O,5120
95402,lot,O,5120
95403,to,O,5120
95404,expect,O,5120
95405,of,O,5120
95406,the,O,5120
95407,patients,O,5120
95408,particularly,O,5120
95409,as,O,5120
95410,they,O,5120
95411,get,O,5120
95412,older,O,5120
95413,and,O,5120
95414,start,O,5120
95415,to,O,5120
95416,have,O,5120
95417,concurrent,O,5120
95418,health,O,5120
95419,issues,O,5120
95420,or,O,5120
95421,cognitive,O,5120
95422,decline,O,5120
95423,Several,O,5121
95424,studies,O,5121
95425,have,O,5121
95426,demonstrated,O,5121
95427,that,O,5121
95428,more,O,5121
95429,complicated,O,5121
95430,regimens,O,5121
95431,involving,O,5121
95432,more,O,5121
95433,than,O,5121
95434,1,O,5121
95435,or,O,5121
95436,2,O,5121
95437,bottles,O,5121
95438,cause,O,5121
95439,a,O,5121
95440,drop,O,5121
95441,in,O,5121
95442,adherence,O,5121
95443,Leung,B-PERSON,5122
95444,Rossi,B-PERSON,5122
95445,and,O,5122
95446,others,O,5122
95447,have,O,5122
95448,shown,O,5122
95449,us,O,5122
95450,that,O,5122
95451,when,O,5122
95452,you,O,5122
95453,add,O,5122
95454,a,O,5122
95455,second,O,5122
95456,or,O,5122
95457,third,O,5122
95458,bottle,O,5122
95459,with,O,5122
95460,preservatives,O,5122
95461,such,O,5122
95462,as,O,5122
95463,benzalkonium,B-NAME_OF_DRUG,5122
95464,chloride,I-NAME_OF_DRUG,5122
95465,the,O,5122
95466,incidence,O,5122
95467,of,O,5122
95468,ocular,B-NAME_OF_DISEASE,5122
95469,surface,I-NAME_OF_DISEASE,5122
95470,disease,I-NAME_OF_DISEASE,5122
95471,OSD,B-NAME_OF_DISEASE,5122
95472,increases,O,5122
95473,Then,O,5123
95474,in,O,5123
95475,a,O,5123
95476,vicious,O,5123
95477,cycle,O,5123
95478,patients,O,5123
95479,with,O,5123
95480,OSD,B-NAME_OF_DISEASE,5123
95481,become,O,5123
95482,even,O,5123
95483,less,O,5123
95484,adherent,O,5123
95485,More,O,5124
95486,than,O,5124
95487,ever,O,5124
95488,we,O,5124
95489,are,O,5124
95490,now,O,5124
95491,beginning,O,5124
95492,to,O,5124
95493,appreciate,O,5124
95494,the,O,5124
95495,eff,O,5124
95496,ect,O,5124
95497,of,O,5124
95498,adherence,O,5124
95499,on,O,5124
95500,longterm,O,5124
95501,IOP,O,5124
95502,control,O,5124
95503,in,O,5124
95504,our,O,5124
95505,patients,O,5124
95506,with,O,5124
95507,glaucoma,B-NAME_OF_DISEASE,5124
95508,Both,O,5125
95509,the,B-NAME_OF_STUDY,5125
95510,HORIZON,I-NAME_OF_STUDY,5125
95511,study,I-NAME_OF_STUDY,5125
95512,NCT0466445,I-NAME_OF_STUDY,5125
95513,looking,O,5125
95514,at,O,5125
95515,implantation,B-TREATMENT,5125
95516,of,I-TREATMENT,5125
95517,Hydrus,I-TREATMENT,5125
95518,Microstents,I-TREATMENT,5125
95519,at,O,5125
95520,the,O,5125
95521,time,O,5125
95522,of,O,5125
95523,cataract,B-TREATMENT,5125
95524,surgery,I-TREATMENT,5125
95525,and,O,5125
95526,the,B-NAME_OF_STUDY,5125
95527,LiGHT,I-NAME_OF_STUDY,5125
95528,study,I-NAME_OF_STUDY,5125
95529,ISRCTN32038223,I-NAME_OF_STUDY,5125
95530,in,O,5125
95531,which,O,5125
95532,first-line,O,5125
95533,selective,B-TREATMENT,5125
95534,laser,I-TREATMENT,5125
95535,trabeculoplasty,I-TREATMENT,5125
95536,SLT,B-TREATMENT,5125
95537,was,O,5125
95538,compared,O,5125
95539,with,O,5125
95540,medical,B-TREATMENT,5125
95541,therapy,I-TREATMENT,5125
95542,found,O,5125
95543,that,O,5125
95544,patients,O,5125
95545,with,O,5125
95546,the,O,5125
95547,surgical,O,5125
95548,laser,O,5125
95549,interventions,O,5125
95550,were,O,5125
95551,less,O,5125
95552,likely,O,5125
95553,to,O,5125
95554,progress,O,5125
95555,to,O,5125
95556,incisional,B-TREATMENT,5125
95557,glaucoma,B-NAME_OF_DISEASE,5125
95558,filtration,I-TREATMENT,5125
95559,surgery,I-TREATMENT,5125
95560,Despite,O,5126
95561,the,O,5126
95562,fact,O,5126
95563,that,O,5126
95564,we,O,5126
95565,have,O,5126
95566,drugs,O,5126
95567,that,O,5126
95568,theoretically,O,5126
95569,offer,O,5126
95570,the,O,5126
95571,same,O,5126
95572,IOP-lowering,O,5126
95573,impact,O,5126
95574,as,O,5126
95575,SLT,B-TREATMENT,5126
95576,or,O,5126
95577,minimally,B-TREATMENT,5126
95578,invasive,I-TREATMENT,5126
95579,glaucoma,B-NAME_OF_DISEASE,5126
95580,surgery,I-TREATMENT,5126
95581,MIGS,B-TREATMENT,5126
95582,we,O,5126
95583,aren,O,5126
95584,t,O,5126
95585,fully,O,5126
95586,using,O,5126
95587,the,O,5126
95588,benefits,O,5126
95589,of,O,5126
95590,those,O,5126
95591,medications,O,5126
95592,since,O,5126
95593,patients,O,5126
95594,aren,O,5126
95595,t,O,5126
95596,taking,O,5126
95597,them,O,5126
95598,consistently,O,5126
95599,More,O,5127
95600,MIGS,B-TREATMENT,5127
95601,and,O,5127
95602,SLT,B-TREATMENT,5127
95603,are,O,5127
95604,a,O,5127
95605,part,O,5127
95606,of,O,5127
95607,the,O,5127
95608,solution,O,5127
95609,but,O,5127
95610,certain,O,5127
95611,individuals,O,5127
95612,will,O,5127
95613,always,O,5127
95614,require,O,5127
95615,topical,B-TREATMENT,5127
95616,therapy,I-TREATMENT,5127
95617,in,O,5127
95618,place,O,5127
95619,of,O,5127
95620,or,O,5127
95621,in,O,5127
95622,addition,O,5127
95623,to,O,5127
95624,these,O,5127
95625,approaches,O,5127
95626,In,O,5128
95627,our,O,5128
95628,practice,O,5128
95629,the,O,5128
95630,initial,O,5128
95631,bottle,O,5128
95632,of,O,5128
95633,glaucoma,B-NAME_OF_DISEASE,5128
95634,medication,O,5128
95635,is,O,5128
95636,often,O,5128
95637,prescribed,O,5128
95638,as,O,5128
95639,a,O,5128
95640,branded,O,5128
95641,commercially,O,5128
95642,available,O,5128
95643,medication,O,5128
95644,These,O,5129
95645,medications,O,5129
95646,have,O,5129
95647,undergone,O,5129
95648,thorough,O,5129
95649,FDA,B-ORGANIZATION,5129
95650,testing,O,5129
95651,and,O,5129
95652,are,O,5129
95653,sold,O,5129
95654,accordingly,O,5129
95655,However,O,5130
95656,we,O,5130
95657,found,O,5130
95658,that,O,5130
95659,compounded,O,5130
95660,fixed-combination,O,5130
95661,glaucoma,B-TREATMENT,5130
95662,drops,I-TREATMENT,5130
95663,Simple,B-NAME_OF_DRUG,5130
95664,Drops,I-NAME_OF_DRUG,5130
95665,ImprimisRx,B-NAME_OF_DRUG,5130
95666,effectively,O,5130
95667,address,O,5130
95668,a,O,5130
95669,number,O,5130
95670,of,O,5130
95671,the,O,5130
95672,reasons,O,5130
95673,that,O,5130
95674,contribute,O,5130
95675,to,O,5130
95676,poor,O,5130
95677,adherence,O,5130
95678,as,O,5130
95679,the,O,5130
95680,regimens,O,5130
95681,get,O,5130
95682,more,O,5130
95683,complex,O,5130
95684,with,O,5130
95685,3,O,5130
95686,to,O,5130
95687,4,O,5130
95688,drugs,O,5130
95689,or,O,5130
95690,if,O,5130
95691,there,O,5130
95692,are,O,5130
95693,cost,O,5130
95694,and,O,5130
95695,adherence,O,5130
95696,difficulties,O,5130
95697,with,O,5130
95698,even,O,5130
95699,2,O,5130
95700,drops,O,5130
95701,Although,O,5131
95702,there,O,5131
95703,are,O,5131
95704,a,O,5131
95705,few,O,5131
95706,dual-drug,O,5131
95707,combinations,O,5131
95708,available,O,5131
95709,in,O,5131
95710,the,B-GPE,5131
95711,US,I-GPE,5131
95712,none,O,5131
95713,of,O,5131
95714,them,O,5131
95715,combine,O,5131
95716,a,B-NAME_OF_DRUG,5131
95717,prostaglandin,I-NAME_OF_DRUG,5131
95718,analogue,I-NAME_OF_DRUG,5131
95719,PGA,I-NAME_OF_DRUG,5131
95720,with,O,5131
95721,a,B-NAME_OF_DRUG,5131
95722,beta-blocker,I-NAME_OF_DRUG,5131
95723,and,O,5131
95724,none,O,5131
95725,contain,O,5131
95726,more,O,5131
95727,than,O,5131
95728,two,O,5131
95729,agents,O,5131
95730,With,O,5132
95731,Easy,B-NAME_OF_DRUG,5132
95732,Drops,I-NAME_OF_DRUG,5132
95733,I,O,5132
95734,can,O,5132
95735,reduce,O,5132
95736,the,O,5132
95737,patient,O,5132
95738,s,O,5132
95739,regimen,O,5132
95740,to,O,5132
95741,one,O,5132
95742,bottle,O,5132
95743,once,O,5132
95744,a,O,5132
95745,day,O,5132
95746,or,O,5132
95747,one,O,5132
95748,bottle,O,5132
95749,for,O,5132
95750,the,O,5132
95751,morning,O,5132
95752,and,O,5132
95753,the,O,5132
95754,evening,O,5132
95755,as,O,5132
95756,the,O,5132
95757,name,O,5132
95758,suggests,O,5132
95759,These,O,5133
95760,drugs,O,5133
95761,are,O,5133
95762,compounded,O,5133
95763,in,O,5133
95764,a,O,5133
95765,Pharmacy,B-ORGANIZATION,5133
95766,Compounding,I-ORGANIZATION,5133
95767,Accreditation,I-ORGANIZATION,5133
95768,Board-accredited,I-ORGANIZATION,5133
95769,503A,O,5133
95770,patient-specific,O,5133
95771,pharmacy,O,5133
95772,that,O,5133
95773,follows,O,5133
95774,many,O,5133
95775,of,O,5133
95776,the,O,5133
95777,same,O,5133
95778,high,O,5133
95779,manufacturing,O,5133
95780,standards,O,5133
95781,as,O,5133
95782,its,O,5133
95783,503B,O,5133
95784,facility,O,5133
95785,Every,O,5134
95786,batch,O,5134
95787,is,O,5134
95788,tested,O,5134
95789,for,O,5134
95790,potency,O,5134
95791,sterility,O,5134
95792,and,O,5134
95793,endotoxins,O,5134
95794,so,O,5134
95795,I,O,5134
95796,can,O,5134
95797,be,O,5134
95798,confi,O,5134
95799,dent,O,5134
95800,that,O,5134
95801,my,O,5134
95802,patients,O,5134
95803,get,O,5134
95804,a,O,5134
95805,high-quality,O,5134
95806,product,O,5134
95807,IOP,O,5135
95808,­,O,5135
95809,Fluctuation,O,5135
95810,is,O,5135
95811,the,O,5135
95812,Problem,O,5135
95813,The,O,5135
95814,issue,O,5135
95815,for,O,5135
95816,many,O,5135
95817,of,O,5135
95818,our,O,5135
95819,patients,O,5135
95820,who,O,5135
95821,are,O,5135
95822,using,O,5135
95823,topical,O,5135
95824,treatments,O,5135
95825,yet,O,5135
95826,are,O,5135
95827,still,O,5135
95828,advancing,O,5135
95829,or,O,5135
95830,have,O,5135
95831,poorly,O,5135
95832,managed,O,5135
95833,IOP,O,5135
95834,is,O,5135
95835,not,O,5135
95836,that,O,5135
95837,the,O,5135
95838,drops,O,5135
95839,are,O,5135
95840,not,O,5135
95841,functioning,O,5135
95842,rather,O,5135
95843,it,O,5135
95844,is,O,5135
95845,that,O,5135
95846,their,O,5135
95847,pressure,O,5135
95848,fluctuates,O,5135
95849,due,O,5135
95850,to,O,5135
95851,inconsistent,O,5135
95852,usage,O,5135
95853,of,O,5135
95854,the,O,5135
95855,drug,O,5135
95856,According,O,5136
95857,to,O,5136
95858,the,B-NAME_OF_STUDY,5136
95859,Advanced,I-NAME_OF_STUDY,5136
95860,Glaucoma,I-NAME_OF_STUDY,5136
95861,Intervention,I-NAME_OF_STUDY,5136
95862,Study,I-NAME_OF_STUDY,5136
95863,AGIS,B-NAME_OF_STUDY,5136
95864,visual,O,5136
95865,field,O,5136
95866,deterioration,O,5136
95867,is,O,5136
95868,linked,O,5136
95869,to,O,5136
95870,long-term,O,5136
95871,IOP,O,5136
95872,variation,O,5136
95873,of,O,5136
95874,more,O,5136
95875,than,O,5136
95876,3,O,5136
95877,mm,O,5137
95878,Hg,O,5137
95879,Fluctuations,O,5138
95880,more,O,5138
95881,than,O,5138
95882,triple,O,5138
95883,the,O,5138
95884,risk,O,5138
95885,of,O,5138
95886,advancement,O,5138
95887,in,O,5138
95888,AGIS,B-NAME_OF_STUDY,5138
95889,patients,O,5138
95890,with,O,5138
95891,low,O,5138
95892,mean,O,5138
95893,IOP,O,5138
95894,or,O,5138
95895,those,O,5138
95896,whose,O,5138
95897,pressure,O,5138
95898,appears,O,5138
95899,constant,O,5138
95900,when,O,5138
95901,we,O,5138
95902,meet,O,5138
95903,them,O,5138
95904,in,O,5138
95905,the,O,5138
95906,office,O,5138
95907,For,O,5139
95908,these,O,5139
95909,patients,O,5139
95910,simplifying,O,5139
95911,the,O,5139
95912,regimen,O,5139
95913,can,O,5139
95914,increase,O,5139
95915,adherence,O,5139
95916,sufficiently,O,5139
95917,to,O,5139
95918,stabilize,O,5139
95919,them,O,5139
95920,In,O,5140
95921,a,O,5140
95922,research,O,5140
95923,I,O,5140
95924,conducted,O,5140
95925,switching,O,5140
95926,my,O,5140
95927,patients,O,5140
95928,to,O,5140
95929,a,O,5140
95930,3-in-1,O,5140
95931,or,O,5140
95932,4-in-1,O,5140
95933,drop,O,5140
95934,led,O,5140
95935,to,O,5140
95936,decreased,O,5140
95937,IOP,O,5140
95938,across,O,5140
95939,the,O,5140
95940,majority,O,5140
95941,of,O,5140
95942,patient,O,5140
95943,types,O,5140
95944,especially,O,5140
95945,among,O,5140
95946,those,O,5140
95947,whose,O,5140
95948,prior,O,5140
95949,regimen,O,5140
95950,of,O,5140
95951,3,O,5140
95952,bottles,O,5140
95953,or,O,5140
95954,more,O,5140
95955,resulted,O,5140
95956,in,O,5140
95957,poor,O,5140
95958,control,O,5140
95959,8,O,5141
95960,In,O,5141
95961,the,O,5141
95962,trial,O,5141
95963,four,O,5141
95964,patients,O,5141
95965,were,O,5141
95966,able,O,5141
95967,to,O,5141
95968,postpone,O,5141
95969,scheduled,O,5141
95970,surgery,O,5141
95971,A,O,5142
95972,43-year-old,O,5142
95973,Black,O,5142
95974,American,O,5142
95975,woman,O,5142
95976,with,O,5142
95977,advanced,B-NAME_OF_DISEASE,5142
95978,glaucoma,I-NAME_OF_DISEASE,5142
95979,who,O,5142
95980,was,O,5142
95981,taking,O,5142
95982,brimonidine,B-NAME_OF_DRUG,5142
95983,timolol,I-NAME_OF_DRUG,5142
95984,Combigan,I-NAME_OF_DRUG,5142
95985,brinzolamide,B-NAME_OF_DRUG,5142
95986,Azopt,I-NAME_OF_DRUG,5142
95987,and,O,5142
95988,travoprost,B-NAME_OF_DRUG,5142
95989,was,O,5142
95990,one,O,5142
95991,of,O,5142
95992,these,O,5142
95993,patients,O,5142
95994,Travatan,B-NAME_OF_DRUG,5142
95995,,O,5142
95996,She,O,5143
95997,admitted,O,5143
95998,to,O,5143
95999,me,O,5143
96000,that,O,5143
96001,she,O,5143
96002,couldn,O,5143
96003,t,O,5143
96004,continue,O,5143
96005,taking,O,5143
96006,so,O,5143
96007,many,O,5143
96008,drops,O,5143
96009,because,O,5143
96010,her,O,5143
96011,eyes,O,5143
96012,were,O,5143
96013,always,O,5143
96014,red,O,5143
96015,We,O,5144
96016,talked,O,5144
96017,about,O,5144
96018,trabeculectomy,B-TREATMENT,5144
96019,and,O,5144
96020,I,O,5144
96021,made,O,5144
96022,the,O,5144
96023,decision,O,5144
96024,to,O,5144
96025,discontinue,O,5144
96026,the,B-NAME_OF_DRUG,5144
96027,PGA,I-NAME_OF_DRUG,5144
96028,and,O,5144
96029,start,O,5144
96030,her,O,5144
96031,on,O,5144
96032,Tim-Brim-Dor,O,5144
96033,PF,O,5144
96034,timolol,O,5144
96035,0.5,O,5144
96036,brimonidine,O,5145
96037,0.15,O,5145
96038,and,O,5146
96039,dorzolamide,O,5146
96040,2,O,5146
96041,to,O,5147
96042,help,O,5147
96043,her,O,5147
96044,ocular,O,5147
96045,surface,O,5147
96046,symptoms,O,5147
96047,before,O,5147
96048,the,O,5147
96049,procedure,O,5147
96050,Her,O,5148
96051,IOP,O,5148
96052,was,O,5148
96053,at,O,5148
96054,our,O,5148
96055,target,O,5148
96056,level,O,5148
96057,of,O,5148
96058,12,O,5148
96059,mm,O,5148
96060,Hg,O,5148
96061,at,O,5148
96062,the,O,5148
96063,next,O,5148
96064,follow-up,O,5148
96065,her,O,5148
96066,eyes,O,5148
96067,weren,O,5148
96068,t,O,5148
96069,inflamed,O,5148
96070,and,O,5148
96071,she,O,5148
96072,was,O,5148
96073,content,O,5148
96074,with,O,5148
96075,the,O,5148
96076,decreased,O,5148
96077,drop,O,5148
96078,burden,O,5148
96079,She,O,5149
96080,has,O,5149
96081,continued,O,5149
96082,using,O,5149
96083,this,O,5149
96084,routine,O,5149
96085,for,O,5149
96086,four,B-TIME_DURATION,5149
96087,years,I-TIME_DURATION,5149
96088,and,O,5149
96089,has,O,5149
96090,avoided,O,5149
96091,having,O,5149
96092,any,O,5149
96093,filtering,B-TREATMENT,5149
96094,surgery,I-TREATMENT,5149
96095,Clarity,O,5150
96096,of,O,5150
96097,Cost,O,5150
96098,and,O,5150
96099,Ingredients,O,5150
96100,Using,O,5150
96101,compounded,B-TREATMENT,5150
96102,combination,I-TREATMENT,5150
96103,drops,I-TREATMENT,5150
96104,also,O,5150
96105,allows,O,5150
96106,me,O,5150
96107,to,O,5150
96108,accurately,O,5150
96109,estimate,O,5150
96110,the,O,5150
96111,patient,O,5150
96112,s,O,5150
96113,costs,O,5150
96114,and,O,5150
96115,expectations,O,5150
96116,It,O,5151
96117,is,O,5151
96118,challenging,O,5151
96119,for,O,5151
96120,me,O,5151
96121,to,O,5151
96122,respond,O,5151
96123,to,O,5151
96124,a,O,5151
96125,patient,O,5151
96126,s,O,5151
96127,perfectly,O,5151
96128,fair,O,5151
96129,inquiry,O,5151
96130,of,O,5151
96131,How,O,5151
96132,much,O,5151
96133,is,O,5151
96134,that,O,5151
96135,going,O,5151
96136,to,O,5151
96137,cost,O,5151
96138,if,O,5151
96139,we,O,5151
96140,prescribe,O,5151
96141,three,O,5151
96142,different,O,5151
96143,drugs,O,5151
96144,to,O,5151
96145,them,O,5151
96146,in,O,5152
96147,any,O,5152
96148,manner,O,5152
96149,that,O,5152
96150,is,O,5152
96151,accurate,O,5152
96152,or,O,5152
96153,open,O,5152
96154,Depending,O,5153
96155,on,O,5153
96156,the,O,5153
96157,patient,O,5153
96158,s,O,5153
96159,insurance,O,5153
96160,coverage,O,5153
96161,co-pays,O,5153
96162,and,O,5153
96163,formulary,O,5153
96164,requirements,O,5153
96165,the,O,5153
96166,cost,O,5153
96167,to,O,5153
96168,them,O,5153
96169,might,O,5153
96170,be,O,5153
96171,15,O,5153
96172,or,O,5153
96173,300,O,5153
96174,They,O,5154
96175,are,O,5154
96176,also,O,5154
96177,very,O,5154
96178,likely,O,5154
96179,to,O,5154
96180,receive,O,5154
96181,generic,O,5154
96182,replacements,O,5154
96183,from,O,5154
96184,the,O,5154
96185,drugstore,O,5154
96186,The,O,5155
96187,bioavailability,O,5155
96188,and,O,5155
96189,effectiveness,O,5155
96190,of,O,5155
96191,the,O,5155
96192,active,O,5155
96193,ingredient,O,5155
96194,as,O,5155
96195,well,O,5155
96196,as,O,5155
96197,the,O,5155
96198,acceptability,O,5155
96199,and,O,5155
96200,safety,O,5155
96201,of,O,5155
96202,the,O,5155
96203,drop,O,5155
96204,as,O,5155
96205,a,O,5155
96206,whole,O,5155
96207,can,O,5155
96208,be,O,5155
96209,significantly,O,5155
96210,impacted,O,5155
96211,by,O,5155
96212,differences,O,5155
96213,in,O,5155
96214,the,O,5155
96215,pH,O,5155
96216,viscosity,O,5155
96217,and,O,5155
96218,other,O,5155
96219,characteristics,O,5155
96220,of,O,5155
96221,the,O,5155
96222,inactive,O,5155
96223,vehicle,O,5155
96224,ingredients,O,5155
96225,from,O,5155
96226,one,O,5155
96227,generic,O,5155
96228,to,O,5155
96229,another,O,5155
96230,Even,O,5156
96231,the,O,5156
96232,quality,O,5156
96233,of,O,5156
96234,the,O,5156
96235,dropper,O,5156
96236,container,O,5156
96237,might,O,5156
96238,vary,O,5156
96239,significantly,O,5156
96240,resulting,O,5156
96241,in,O,5156
96242,drops,O,5156
96243,spilling,O,5156
96244,out,O,5156
96245,too,O,5156
96246,quickly,O,5156
96247,and,O,5156
96248,the,O,5156
96249,patient,O,5156
96250,using,O,5156
96251,up,O,5156
96252,a,O,5156
96253,30-day,O,5156
96254,supply,O,5156
96255,much,O,5156
96256,sooner,O,5156
96257,Preservative-Free,O,5157
96258,Formulations,O,5157
96259,Finally,O,5157
96260,compounded,B-TREATMENT,5157
96261,drops,I-TREATMENT,5157
96262,enable,O,5157
96263,me,O,5157
96264,to,O,5157
96265,recommend,O,5157
96266,formulations,O,5157
96267,without,O,5157
96268,preservatives,O,5157
96269,preventing,O,5157
96270,the,O,5157
96271,glaucoma,B-NAME_OF_DISEASE,5157
96272,drugs,O,5157
96273,from,O,5157
96274,amplifying,O,5157
96275,the,O,5157
96276,toxicity,O,5157
96277,of,O,5157
96278,the,B-PART_OF_THE_EYES,5157
96279,ocular,I-PART_OF_THE_EYES,5157
96280,surface,I-PART_OF_THE_EYES,5157
96281,Approximately,O,5158
96282,half,O,5158
96283,of,O,5158
96284,our,O,5158
96285,glaucoma,B-NAME_OF_DISEASE,5158
96286,patients,O,5158
96287,also,O,5158
96288,have,O,5158
96289,OSD,B-NAME_OF_DISEASE,5158
96290,and,O,5158
96291,those,O,5158
96292,who,O,5158
96293,do,O,5158
96294,are,O,5158
96295,more,O,5158
96296,likely,O,5158
96297,to,O,5158
96298,progress,O,5158
96299,experience,O,5158
96300,negative,O,5158
96301,side,O,5158
96302,effects,O,5158
96303,from,O,5158
96304,topical,B-TREATMENT,5158
96305,glaucoma,I-TREATMENT,5158
96306,medication,I-TREATMENT,5158
96307,and,O,5158
96308,be,O,5158
96309,nonadherent,O,5158
96310,The,O,5159
96311,likelihood,O,5159
96312,of,O,5159
96313,future,O,5159
96314,Xen,B-TREATMENT,5159
96315,implantation,I-TREATMENT,5159
96316,or,I-TREATMENT,5159
96317,fusion,I-TREATMENT,5159
96318,surgery,I-TREATMENT,5159
96319,if,O,5159
96320,necessary,O,5159
96321,is,O,5159
96322,increased,O,5159
96323,if,O,5159
96324,we,O,5159
96325,can,O,5159
96326,reduce,O,5159
96327,the,O,5159
96328,impact,O,5159
96329,on,O,5159
96330,the,B-PART_OF_THE_EYES,5159
96331,ocular,I-PART_OF_THE_EYES,5159
96332,surface,I-PART_OF_THE_EYES,5159
96333,I,O,5160
96334,might,O,5160
96335,favor,O,5160
96336,separate,O,5160
96337,bottles,O,5160
96338,of,O,5160
96339,each,O,5160
96340,branded,O,5160
96341,medication,O,5160
96342,if,O,5160
96343,variables,O,5160
96344,like,O,5160
96345,cost,O,5160
96346,compliance,O,5160
96347,and,O,5160
96348,generic,O,5160
96349,substitution,O,5160
96350,were,O,5160
96351,completely,O,5160
96352,irrelevant,O,5160
96353,But,O,5161
96354,we,O,5161
96355,have,O,5161
96356,to,O,5161
96357,recognize,O,5161
96358,that,O,5161
96359,patients,O,5161
96360,are,O,5161
96361,not,O,5161
96362,getting,O,5161
96363,what,O,5161
96364,we,O,5161
96365,prescribe,O,5161
96366,and,O,5161
96367,are,O,5161
96368,not,O,5161
96369,consistently,O,5161
96370,instilling,O,5161
96371,the,O,5161
96372,medications,O,5161
96373,that,O,5161
96374,they,O,5161
96375,do,O,5161
96376,receive,O,5161
96377,with,O,5161
96378,resulting,O,5161
96379,IOP,O,5161
96380,fluctuation,O,5161
96381,and,O,5161
96382,disease,O,5161
96383,progression,O,5161
96384,A,O,5162
96385,simplified,O,5162
96386,regimen,O,5162
96387,of,O,5162
96388,compounded,B-TREATMENT,5162
96389,fixed-combination,I-TREATMENT,5162
96390,glaucoma,I-TREATMENT,5162
96391,therapy,I-TREATMENT,5162
96392,is,O,5162
96393,a,O,5162
96394,very,O,5162
96395,welcome,O,5162
96396,solution,O,5162
96397,to,O,5162
96398,these,O,5162
96399,real-world,O,5162
96400,problems,O,5162
96401,Herpes,B-NAME_OF_DISEASE,5163
96402,Zoster,I-NAME_OF_DISEASE,5163
96403,Ophthalmicus,I-NAME_OF_DISEASE,5163
96404,HZO,I-NAME_OF_DISEASE,5163
96405,commonly,O,5163
96406,known,O,5163
96407,as,O,5163
96408,shingles,B-NAME_OF_DISEASE,5163
96409,is,O,5163
96410,a,O,5163
96411,viral,O,5163
96412,disease,O,5163
96413,characterized,O,5163
96414,by,O,5163
96415,a,B-SIGN_AND_SYMPTOM,5163
96416,unilateral,I-SIGN_AND_SYMPTOM,5163
96417,painful,I-SIGN_AND_SYMPTOM,5163
96418,skin,I-SIGN_AND_SYMPTOM,5163
96419,rash,I-SIGN_AND_SYMPTOM,5163
96420,in,I-SIGN_AND_SYMPTOM,5163
96421,one,I-SIGN_AND_SYMPTOM,5163
96422,or,I-SIGN_AND_SYMPTOM,5163
96423,more,I-SIGN_AND_SYMPTOM,5163
96424,dermatome,I-SIGN_AND_SYMPTOM,5163
96425,distributions,I-SIGN_AND_SYMPTOM,5163
96426,of,I-SIGN_AND_SYMPTOM,5163
96427,the,I-SIGN_AND_SYMPTOM,5163
96428,fifth,I-SIGN_AND_SYMPTOM,5163
96429,cranial,I-SIGN_AND_SYMPTOM,5163
96430,nerve,I-SIGN_AND_SYMPTOM,5163
96431,trigeminal,I-SIGN_AND_SYMPTOM,5163
96432,nerve,I-SIGN_AND_SYMPTOM,5163
96433,shared,I-SIGN_AND_SYMPTOM,5163
96434,by,I-SIGN_AND_SYMPTOM,5163
96435,the,I-SIGN_AND_SYMPTOM,5163
96436,eye,I-SIGN_AND_SYMPTOM,5163
96437,and,I-SIGN_AND_SYMPTOM,5163
96438,ocular,I-SIGN_AND_SYMPTOM,5163
96439,adnexa,I-SIGN_AND_SYMPTOM,5163
96440,Herpes,B-NAME_OF_DISEASE,5164
96441,zoster,I-NAME_OF_DISEASE,5164
96442,ophthalmicus,I-NAME_OF_DISEASE,5164
96443,occurs,O,5164
96444,when,O,5164
96445,the,O,5164
96446,varicella-zoster,B-CHEMICAL_COMPOUND,5164
96447,virus,I-CHEMICAL_COMPOUND,5164
96448,is,O,5164
96449,reactivated,O,5164
96450,in,O,5164
96451,the,O,5164
96452,ophthalmic,O,5164
96453,division,O,5164
96454,of,O,5164
96455,the,O,5164
96456,trigeminal,O,5164
96457,nerve,O,5164
96458,Herpes,B-NAME_OF_DISEASE,5165
96459,zoster,I-NAME_OF_DISEASE,5165
96460,ophthalmicus,I-NAME_OF_DISEASE,5165
96461,represents,O,5165
96462,up,O,5165
96463,to,O,5165
96464,one,O,5165
96465,fourth,O,5165
96466,of,O,5165
96467,all,O,5165
96468,cases,O,5165
96469,of,O,5165
96470,herpes,B-NAME_OF_DISEASE,5165
96471,zoster,I-NAME_OF_DISEASE,5165
96472,Most,O,5166
96473,patients,O,5166
96474,with,O,5166
96475,herpes,B-NAME_OF_DISEASE,5166
96476,zoster,I-NAME_OF_DISEASE,5166
96477,ophthalmicus,I-NAME_OF_DISEASE,5166
96478,present,O,5166
96479,with,O,5166
96480,a,B-SIGN_AND_SYMPTOM,5166
96481,periorbital,I-SIGN_AND_SYMPTOM,5166
96482,vesicular,I-SIGN_AND_SYMPTOM,5166
96483,rash,I-SIGN_AND_SYMPTOM,5166
96484,distributed,I-SIGN_AND_SYMPTOM,5166
96485,according,I-SIGN_AND_SYMPTOM,5166
96486,to,I-SIGN_AND_SYMPTOM,5166
96487,the,I-SIGN_AND_SYMPTOM,5166
96488,affected,I-SIGN_AND_SYMPTOM,5166
96489,dermatome,I-SIGN_AND_SYMPTOM,5166
96490,A,O,5167
96491,minority,O,5167
96492,of,O,5167
96493,patients,O,5167
96494,may,O,5167
96495,also,O,5167
96496,develop,O,5167
96497,conjunctivitis,B-NAME_OF_DISEASE,5167
96498,keratitis,B-NAME_OF_DISEASE,5167
96499,uveitis,B-NAME_OF_DISEASE,5167
96500,and,O,5167
96501,ocular,B-NAME_OF_DISEASE,5167
96502,cranial-nerve,I-NAME_OF_DISEASE,5167
96503,palsies,I-NAME_OF_DISEASE,5167
96504,Permanent,O,5168
96505,sequelae,O,5168
96506,of,O,5168
96507,ophthalmic,B-NAME_OF_DISEASE,5168
96508,zoster,I-NAME_OF_DISEASE,5168
96509,infection,I-NAME_OF_DISEASE,5168
96510,may,O,5168
96511,include,O,5168
96512,chronic,B-NAME_OF_DISEASE,5168
96513,ocular,I-NAME_OF_DISEASE,5168
96514,inflammation,I-NAME_OF_DISEASE,5168
96515,loss,B-SIGN_AND_SYMPTOM,5168
96516,of,I-SIGN_AND_SYMPTOM,5168
96517,vision,I-SIGN_AND_SYMPTOM,5168
96518,and,O,5168
96519,debilitating,B-SIGN_AND_SYMPTOM,5168
96520,pain,I-SIGN_AND_SYMPTOM,5168
96521,Antiviral,B-NAME_OF_DRUG,5169
96522,medications,I-NAME_OF_DRUG,5169
96523,such,O,5169
96524,as,O,5169
96525,acyclovir,B-NAME_OF_DRUG,5169
96526,valacyclovir,B-NAME_OF_DRUG,5169
96527,and,O,5169
96528,famciclovir,B-NAME_OF_DRUG,5169
96529,remain,O,5169
96530,the,O,5169
96531,mainstay,O,5169
96532,of,O,5169
96533,therapy,O,5169
96534,and,O,5169
96535,are,O,5169
96536,most,O,5169
96537,effective,O,5169
96538,in,O,5169
96539,preventing,O,5169
96540,ocular,O,5169
96541,involvement,O,5169
96542,when,O,5169
96543,begun,O,5169
96544,within,O,5169
96545,72,O,5169
96546,hours,O,5169
96547,after,O,5169
96548,the,O,5169
96549,onset,O,5169
96550,of,O,5169
96551,the,O,5169
96552,rash,O,5169
96553,Timely,O,5170
96554,diagnosis,O,5170
96555,and,O,5170
96556,management,O,5170
96557,of,O,5170
96558,herpes,B-NAME_OF_DISEASE,5170
96559,zoster,I-NAME_OF_DISEASE,5170
96560,ophthalmicus,I-NAME_OF_DISEASE,5170
96561,with,O,5170
96562,referral,O,5170
96563,to,O,5170
96564,an,O,5170
96565,ophthalmologist,O,5170
96566,when,O,5170
96567,ophthalmic,O,5170
96568,involvement,O,5170
96569,is,O,5170
96570,present,O,5170
96571,are,O,5170
96572,critical,O,5170
96573,in,O,5170
96574,limiting,O,5170
96575,visual,O,5170
96576,morbidity,O,5170
96577,Herpes,B-NAME_OF_DISEASE,5171
96578,zoster,I-NAME_OF_DISEASE,5171
96579,also,O,5171
96580,referred,O,5171
96581,to,O,5171
96582,as,O,5171
96583,shingles,B-NAME_OF_DISEASE,5171
96584,is,O,5171
96585,a,O,5171
96586,common,O,5171
96587,infection,O,5171
96588,most,O,5171
96589,typically,O,5171
96590,caused,O,5171
96591,by,O,5171
96592,the,B-CAUSE_OF_DISEASE,5171
96593,reactivation,I-CAUSE_OF_DISEASE,5171
96594,of,I-CAUSE_OF_DISEASE,5171
96595,varicella,I-CAUSE_OF_DISEASE,5171
96596,zoster,I-CAUSE_OF_DISEASE,5171
96597,virus,I-CAUSE_OF_DISEASE,5171
96598,that,I-CAUSE_OF_DISEASE,5171
96599,lies,I-CAUSE_OF_DISEASE,5171
96600,dormant,I-CAUSE_OF_DISEASE,5171
96601,sometime,I-CAUSE_OF_DISEASE,5171
96602,for,I-CAUSE_OF_DISEASE,5171
96603,decades,I-CAUSE_OF_DISEASE,5171
96604,in,I-CAUSE_OF_DISEASE,5171
96605,the,I-CAUSE_OF_DISEASE,5171
96606,dorsal,I-CAUSE_OF_DISEASE,5171
96607,root,I-CAUSE_OF_DISEASE,5171
96608,nerve,I-CAUSE_OF_DISEASE,5171
96609,ganglion,I-CAUSE_OF_DISEASE,5171
96610,following,I-CAUSE_OF_DISEASE,5171
96611,primary,I-CAUSE_OF_DISEASE,5171
96612,chickenpox,I-CAUSE_OF_DISEASE,5171
96613,infection,I-CAUSE_OF_DISEASE,5171
96614,In,O,5172
96615,10-20%,O,5172
96616,of,O,5172
96617,cases,O,5172
96618,the,O,5172
96619,first,O,5172
96620,division,O,5172
96621,of,O,5172
96622,the,O,5172
96623,trigeminal,O,5172
96624,nerve,O,5172
96625,V1,O,5172
96626,is,O,5172
96627,involved,O,5172
96628,and,O,5172
96629,herpes,B-NAME_OF_DISEASE,5172
96630,zoster,I-NAME_OF_DISEASE,5172
96631,ophthalmicus,I-NAME_OF_DISEASE,5172
96632,occurs,O,5172
96633,A,O,5173
96634,patient,O,5173
96635,with,O,5173
96636,herpes,B-NAME_OF_DISEASE,5173
96637,zoster,I-NAME_OF_DISEASE,5173
96638,ophthalmicus,I-NAME_OF_DISEASE,5173
96639,typically,O,5173
96640,presents,O,5173
96641,with,O,5173
96642,a,B-SIGN_AND_SYMPTOM,5173
96643,painful,I-SIGN_AND_SYMPTOM,5173
96644,unilateral,I-SIGN_AND_SYMPTOM,5173
96645,vesicular,I-SIGN_AND_SYMPTOM,5173
96646,rash,I-SIGN_AND_SYMPTOM,5173
96647,in,I-SIGN_AND_SYMPTOM,5173
96648,a,I-SIGN_AND_SYMPTOM,5173
96649,dermatomal,I-SIGN_AND_SYMPTOM,5173
96650,distribution,I-SIGN_AND_SYMPTOM,5173
96651,It,O,5174
96652,may,O,5174
96653,but,O,5174
96654,not,O,5174
96655,always,O,5174
96656,present,O,5174
96657,with,O,5174
96658,ocular,O,5174
96659,involvement,O,5174
96660,including,O,5174
96661,painful,O,5174
96662,inflammation,O,5174
96663,of,O,5174
96664,the,O,5174
96665,anterior,O,5174
96666,and,O,5174
96667,rarely,O,5174
96668,posterior,O,5174
96669,structures,O,5174
96670,of,O,5174
96671,the,O,5174
96672,eye,O,5174
96673,including,O,5174
96674,conjunctivitis,B-NAME_OF_DISEASE,5174
96675,keratitis,B-NAME_OF_DISEASE,5174
96676,iritis,B-NAME_OF_DISEASE,5174
96677,and,O,5174
96678,uveitis,B-NAME_OF_DISEASE,5174
96679,This,O,5175
96680,is,O,5175
96681,a,O,5175
96682,clinical,O,5175
96683,diagnosis,O,5175
96684,but,O,5175
96685,can,O,5175
96686,be,O,5175
96687,confirmed,O,5175
96688,by,O,5175
96689,viral,B-DIAGNOSTIC_TEST,5175
96690,swabs,I-DIAGNOSTIC_TEST,5175
96691,History,O,5176
96692,Whilst,O,5176
96693,taking,O,5176
96694,a,O,5176
96695,patient,O,5176
96696,history,O,5176
96697,it,O,5176
96698,is,O,5176
96699,key,O,5176
96700,to,O,5176
96701,ascertain,O,5176
96702,when,O,5176
96703,the,B-SIGN_AND_SYMPTOM,5176
96704,rash,B-SIGN_AND_SYMPTOM,5176
96705,started,O,5176
96706,initiating,O,5176
96707,antiviral,B-TREATMENT,5176
96708,treatment,I-TREATMENT,5176
96709,within,B-TIME_DURATION,5176
96710,72,I-TIME_DURATION,5176
96711,hours,I-TIME_DURATION,5176
96712,from,O,5176
96713,the,O,5176
96714,onset,O,5176
96715,of,O,5176
96716,rash,B-SIGN_AND_SYMPTOM,5176
96717,is,O,5176
96718,essential,O,5176
96719,in,O,5176
96720,reducing,O,5176
96721,the,O,5176
96722,risk,O,5176
96723,of,O,5176
96724,long-term,O,5176
96725,ocular,O,5176
96726,complications,O,5176
96727,including,O,5176
96728,uveitis,B-NAME_OF_DISEASE,5176
96729,stromal,B-NAME_OF_DISEASE,5176
96730,keratitis,I-NAME_OF_DISEASE,5176
96731,and,O,5176
96732,pseudo-dendritis,B-NAME_OF_DISEASE,5176
96733,To,O,5177
96734,decipher,O,5177
96735,whether,O,5177
96736,there,O,5177
96737,is,O,5177
96738,an,O,5177
96739,ocular,O,5177
96740,involvement,O,5177
96741,it,O,5177
96742,is,O,5177
96743,pivotal,O,5177
96744,that,O,5177
96745,the,O,5177
96746,following,O,5177
96747,symptoms,O,5177
96748,are,O,5177
96749,enquired,O,5177
96750,about,O,5177
96751,eye,B-SIGN_AND_SYMPTOM,5177
96752,pain,I-SIGN_AND_SYMPTOM,5177
96753,diplopia,I-SIGN_AND_SYMPTOM,5177
96754,discharge,I-SIGN_AND_SYMPTOM,5177
96755,red,I-SIGN_AND_SYMPTOM,5177
96756,eye,I-SIGN_AND_SYMPTOM,5177
96757,photophobia,I-SIGN_AND_SYMPTOM,5177
96758,visual,I-SIGN_AND_SYMPTOM,5177
96759,loss,I-SIGN_AND_SYMPTOM,5177
96760,disturbance,I-SIGN_AND_SYMPTOM,5177
96761,floaters,I-SIGN_AND_SYMPTOM,5177
96762,and,I-SIGN_AND_SYMPTOM,5177
96763,flashing,I-SIGN_AND_SYMPTOM,5177
96764,lights,I-SIGN_AND_SYMPTOM,5177
96765,Systemic,O,5178
96766,symptoms,O,5178
96767,including,O,5178
96768,general,B-SIGN_AND_SYMPTOM,5178
96769,malaise,I-SIGN_AND_SYMPTOM,5178
96770,headache,I-SIGN_AND_SYMPTOM,5178
96771,and,I-SIGN_AND_SYMPTOM,5178
96772,fever,I-SIGN_AND_SYMPTOM,5178
96773,should,O,5178
96774,also,O,5178
96775,be,O,5178
96776,asked,O,5178
96777,It,O,5179
96778,is,O,5179
96779,then,O,5179
96780,important,O,5179
96781,to,O,5179
96782,enquire,O,5179
96783,about,O,5179
96784,past,O,5179
96785,medical,O,5179
96786,history,O,5179
96787,particularly,O,5179
96788,if,O,5179
96789,there,O,5179
96790,is,O,5179
96791,any,O,5179
96792,recent,O,5179
96793,systemic,O,5179
96794,illness,O,5179
96795,which,O,5179
96796,would,O,5179
96797,impair,O,5179
96798,immunity,O,5179
96799,thus,O,5179
96800,increasing,O,5179
96801,the,O,5179
96802,risk,O,5179
96803,of,O,5179
96804,developing,O,5179
96805,herpes,B-NAME_OF_DISEASE,5179
96806,zoster,I-NAME_OF_DISEASE,5179
96807,Additionally,O,5180
96808,asking,O,5180
96809,whether,O,5180
96810,there,O,5180
96811,is,O,5180
96812,any,O,5180
96813,history,O,5180
96814,of,O,5180
96815,immunosuppression,B-NAME_OF_DISEASE,5180
96816,including,O,5180
96817,malignancy,B-NAME_OF_DISEASE,5180
96818,HIV,B-NAME_OF_DISEASE,5180
96819,or,O,5180
96820,history,O,5180
96821,of,O,5180
96822,chickenpox,B-NAME_OF_DISEASE,5180
96823,would,O,5180
96824,aid,O,5180
96825,with,O,5180
96826,investigations,O,5180
96827,and,O,5180
96828,starting,O,5180
96829,stronger,O,5180
96830,antiviral,B-TREATMENT,5180
96831,treatment,I-TREATMENT,5180
96832,Likewise,O,5181
96833,asking,O,5181
96834,if,O,5181
96835,the,O,5181
96836,patient,O,5181
96837,is,O,5181
96838,on,O,5181
96839,any,O,5181
96840,immunosuppressive,B-NAME_OF_DRUG,5181
96841,medication,I-NAME_OF_DRUG,5181
96842,would,O,5181
96843,be,O,5181
96844,beneficial,O,5181
96845,Finally,O,5182
96846,taking,O,5182
96847,a,O,5182
96848,thorough,O,5182
96849,social,O,5182
96850,history,O,5182
96851,is,O,5182
96852,pivotal,O,5182
96853,to,O,5182
96854,ascertain,O,5182
96855,if,O,5182
96856,there,O,5182
96857,are,O,5182
96858,any,O,5182
96859,vulnerable,O,5182
96860,populations,O,5182
96861,including,O,5182
96862,children,O,5182
96863,and,O,5182
96864,pregnant,O,5182
96865,women,O,5182
96866,who,O,5182
96867,the,O,5182
96868,patient,O,5182
96869,has,O,5182
96870,recently,O,5182
96871,been,O,5182
96872,in,O,5182
96873,close,O,5182
96874,contact,O,5182
96875,with,O,5182
96876,that,O,5182
96877,may,O,5182
96878,require,O,5182
96879,urgent,O,5182
96880,medical,O,5182
96881,attention,O,5182
96882,if,O,5182
96883,showing,O,5182
96884,signs,O,5182
96885,of,O,5182
96886,varicella,B-NAME_OF_DISEASE,5182
96887,or,O,5182
96888,herpes,B-NAME_OF_DISEASE,5182
96889,zoster,I-NAME_OF_DISEASE,5182
96890,Examination,O,5183
96891,On,O,5183
96892,general,O,5183
96893,examination,O,5183
96894,look,O,5183
96895,at,O,5183
96896,the,O,5183
96897,pattern,O,5183
96898,and,O,5183
96899,distribution,O,5183
96900,of,O,5183
96901,the,B-SIGN_AND_SYMPTOM,5183
96902,rash,I-SIGN_AND_SYMPTOM,5183
96903,a,I-SIGN_AND_SYMPTOM,5183
96904,unilateral,I-SIGN_AND_SYMPTOM,5183
96905,not,I-SIGN_AND_SYMPTOM,5183
96906,crossing,I-SIGN_AND_SYMPTOM,5183
96907,the,I-SIGN_AND_SYMPTOM,5183
96908,midline,I-SIGN_AND_SYMPTOM,5183
96909,vesicular,I-SIGN_AND_SYMPTOM,5183
96910,rash,I-SIGN_AND_SYMPTOM,5183
96911,along,I-SIGN_AND_SYMPTOM,5183
96912,the,I-SIGN_AND_SYMPTOM,5183
96913,V1,I-SIGN_AND_SYMPTOM,5183
96914,dermatomal,I-SIGN_AND_SYMPTOM,5183
96915,distribution,I-SIGN_AND_SYMPTOM,5183
96916,would,O,5183
96917,highly,O,5183
96918,indicate,O,5183
96919,herpes,B-NAME_OF_DISEASE,5183
96920,zoster,I-NAME_OF_DISEASE,5183
96921,A,O,5184
96922,key,O,5184
96923,sign,O,5184
96924,to,O,5184
96925,be,O,5184
96926,aware,O,5184
96927,of,O,5184
96928,is,O,5184
96929,Hutchinson,B-SIGN_AND_SYMPTOM,5184
96930,s,I-SIGN_AND_SYMPTOM,5184
96931,sign,I-SIGN_AND_SYMPTOM,5184
96932,this,O,5184
96933,is,O,5184
96934,a,O,5184
96935,rash,O,5184
96936,involving,O,5184
96937,the,O,5184
96938,tip,O,5184
96939,side,O,5184
96940,or,O,5184
96941,root,O,5184
96942,of,O,5184
96943,nose,O,5184
96944,It,O,5185
96945,indicates,O,5185
96946,involvement,O,5185
96947,of,O,5185
96948,the,O,5185
96949,nasociliary,O,5185
96950,branch,O,5185
96951,of,O,5185
96952,the,O,5185
96953,trigeminal,O,5185
96954,nerve,O,5185
96955,and,O,5185
96956,is,O,5185
96957,strongly,O,5185
96958,correlated,O,5185
96959,with,O,5185
96960,ocular,B-NAME_OF_DISEASE,5185
96961,inflammation,I-NAME_OF_DISEASE,5185
96962,and,O,5185
96963,permanent,B-NAME_OF_DISEASE,5185
96964,corneal,I-NAME_OF_DISEASE,5185
96965,denervation,I-NAME_OF_DISEASE,5185
96966,Using,O,5186
96967,fluorescein,B-NAME_OF_DRUG,5186
96968,drops,I-NAME_OF_DRUG,5186
96969,to,O,5186
96970,determine,O,5186
96971,if,O,5186
96972,there,O,5186
96973,are,O,5186
96974,any,O,5186
96975,corneal,O,5186
96976,changes,O,5186
96977,is,O,5186
96978,also,O,5186
96979,essential,O,5186
96980,Finally,O,5187
96981,signs,O,5187
96982,of,O,5187
96983,infection,O,5187
96984,both,O,5187
96985,locally,O,5187
96986,purulent,O,5187
96987,discharge,O,5187
96988,and,O,5187
96989,spread,O,5187
96990,e.g,O,5187
96991,confusion,O,5188
96992,in,O,5188
96993,encephalitis,O,5188
96994,need,O,5188
96995,to,O,5188
96996,be,O,5188
96997,assessed,O,5188
96998,On,B-DIAGNOSTIC_TEST,5189
96999,ocular,I-DIAGNOSTIC_TEST,5189
97000,examination,I-DIAGNOSTIC_TEST,5189
97001,the,I-DIAGNOSTIC_TEST,5189
97002,external,I-DIAGNOSTIC_TEST,5189
97003,eye,I-DIAGNOSTIC_TEST,5189
97004,should,I-DIAGNOSTIC_TEST,5189
97005,be,I-DIAGNOSTIC_TEST,5189
97006,examined,I-DIAGNOSTIC_TEST,5189
97007,for,O,5189
97008,conjunctival,B-SIGN_AND_SYMPTOM,5189
97009,redness,I-SIGN_AND_SYMPTOM,5189
97010,acuity,B-DIAGNOSTIC_TEST,5189
97011,should,I-DIAGNOSTIC_TEST,5189
97012,be,I-DIAGNOSTIC_TEST,5189
97013,assessed,I-DIAGNOSTIC_TEST,5189
97014,using,I-DIAGNOSTIC_TEST,5189
97015,Snellen,I-DIAGNOSTIC_TEST,5189
97016,chart,I-DIAGNOSTIC_TEST,5189
97017,and,I-DIAGNOSTIC_TEST,5189
97018,viral,I-DIAGNOSTIC_TEST,5189
97019,swabs,I-DIAGNOSTIC_TEST,5189
97020,taken,O,5189
97021,for,O,5189
97022,herpes,B-NAME_OF_DISEASE,5189
97023,simplex,I-NAME_OF_DISEASE,5189
97024,varicella,B-NAME_OF_DISEASE,5189
97025,zoster,I-NAME_OF_DISEASE,5189
97026,if,O,5189
97027,there,O,5189
97028,is,O,5189
97029,diagnostic,O,5189
97030,uncertainty,O,5189
97031,e.g,O,5189
97032,if,O,5190
97033,the,B-SIGN_AND_SYMPTOM,5190
97034,rash,I-SIGN_AND_SYMPTOM,5190
97035,is,O,5190
97036,atypical,O,5190
97037,After,O,5191
97038,external,O,5191
97039,examination,O,5191
97040,of,O,5191
97041,the,O,5191
97042,eye,O,5191
97043,a,B-DIAGNOSTIC_TEST,5191
97044,dilated,I-DIAGNOSTIC_TEST,5191
97045,fundus,I-DIAGNOSTIC_TEST,5191
97046,examination,I-DIAGNOSTIC_TEST,5191
97047,can,O,5191
97048,then,O,5191
97049,be,O,5191
97050,performed,O,5191
97051,including,O,5191
97052,intraocular,O,5191
97053,pressures,O,5191
97054,Management,O,5192
97055,The,O,5192
97056,key,O,5192
97057,in,O,5192
97058,managing,O,5192
97059,patients,O,5192
97060,with,O,5192
97061,herpes,B-NAME_OF_DISEASE,5192
97062,zoster,I-NAME_OF_DISEASE,5192
97063,ophthalmicus,I-NAME_OF_DISEASE,5192
97064,regardless,O,5192
97065,of,O,5192
97066,ocular,O,5192
97067,involvement,O,5192
97068,is,O,5192
97069,initiating,O,5192
97070,antiviral,B-NAME_OF_DRUG,5192
97071,treatment,I-NAME_OF_DRUG,5192
97072,oral,B-NAME_OF_DRUG,5192
97073,aciclovir,I-NAME_OF_DRUG,5192
97074,is,O,5192
97075,first,O,5192
97076,line,O,5192
97077,within,B-TIME_DURATION,5192
97078,72,I-TIME_DURATION,5192
97079,hours,I-TIME_DURATION,5192
97080,of,O,5192
97081,the,O,5192
97082,onset,O,5192
97083,of,O,5192
97084,rash,B-SIGN_AND_SYMPTOM,5192
97085,Ocular,O,5193
97086,involvement,O,5193
97087,occurs,O,5193
97088,in,O,5193
97089,approximately,O,5193
97090,50%,O,5193
97091,of,O,5193
97092,HZ,B-NAME_OF_DISEASE,5193
97093,patients,O,5193
97094,without,O,5193
97095,the,O,5193
97096,use,O,5193
97097,of,O,5193
97098,antiviral,B-TREATMENT,5193
97099,therapy,I-TREATMENT,5193
97100,If,O,5194
97101,there,O,5194
97102,is,O,5194
97103,any,O,5194
97104,evidence,O,5194
97105,of,O,5194
97106,uveitis,B-NAME_OF_DISEASE,5194
97107,or,O,5194
97108,stromal,B-NAME_OF_DISEASE,5194
97109,keratitis,I-NAME_OF_DISEASE,5194
97110,topical,B-NAME_OF_DRUG,5194
97111,steroids,I-NAME_OF_DRUG,5194
97112,should,O,5194
97113,be,O,5194
97114,used,O,5194
97115,Immunosuppressive,B-TREATMENT,5195
97116,therapy,I-TREATMENT,5195
97117,should,O,5195
97118,be,O,5195
97119,used,O,5195
97120,for,O,5195
97121,scleritis,B-NAME_OF_DISEASE,5195
97122,Topical,O,5196
97123,anaesthesia,O,5196
97124,should,O,5196
97125,not,O,5196
97126,be,O,5196
97127,used,O,5196
97128,as,O,5196
97129,it,O,5196
97130,prevents,O,5196
97131,corneal,O,5196
97132,healing,O,5196
97133,and,O,5196
97134,may,O,5196
97135,worsen,O,5196
97136,corneal,O,5196
97137,denervation,O,5196
97138,Analgesia,B-NAME_OF_DRUG,5197
97139,and,I-NAME_OF_DRUG,5197
97140,lubricating,I-NAME_OF_DRUG,5197
97141,eye,I-NAME_OF_DRUG,5197
97142,drops,I-NAME_OF_DRUG,5197
97143,should,O,5197
97144,also,O,5197
97145,be,O,5197
97146,considered,O,5197
97147,Educating,O,5198
97148,patients,O,5198
97149,regarding,O,5198
97150,avoiding,O,5198
97151,close,O,5198
97152,contact,O,5198
97153,until,O,5198
97154,vesicles,O,5198
97155,have,O,5198
97156,fully,O,5198
97157,crusted,O,5198
97158,over,O,5198
97159,with,O,5198
97160,vulnerable,O,5198
97161,populations,O,5198
97162,particularly,O,5198
97163,children,O,5198
97164,and,O,5198
97165,pregnant,O,5198
97166,women,O,5198
97167,should,O,5198
97168,also,O,5198
97169,be,O,5198
97170,reinforced,O,5198
97171,by,O,5198
97172,healthcare,O,5198
97173,professionals,O,5198
97174,Complication,O,5199
97175,The,O,5199
97176,two,O,5199
97177,most,O,5199
97178,important,O,5199
97179,complications,O,5199
97180,of,O,5199
97181,herpes,B-NAME_OF_DISEASE,5199
97182,zoster,I-NAME_OF_DISEASE,5199
97183,ophthalmicus,I-NAME_OF_DISEASE,5199
97184,are,O,5199
97185,uveitis,B-NAME_OF_DISEASE,5199
97186,pain,B-SIGN_AND_SYMPTOM,5199
97187,and,I-SIGN_AND_SYMPTOM,5199
97188,photophobia,I-SIGN_AND_SYMPTOM,5199
97189,without,I-SIGN_AND_SYMPTOM,5199
97190,discharge,I-SIGN_AND_SYMPTOM,5199
97191,and,O,5199
97192,acute,B-NAME_OF_DISEASE,5199
97193,retinal,I-NAME_OF_DISEASE,5199
97194,necrosis,I-NAME_OF_DISEASE,5199
97195,pain,B-SIGN_AND_SYMPTOM,5199
97196,with,I-SIGN_AND_SYMPTOM,5199
97197,loss,I-SIGN_AND_SYMPTOM,5199
97198,of,I-SIGN_AND_SYMPTOM,5199
97199,vision,I-SIGN_AND_SYMPTOM,5199
97200,+,I-SIGN_AND_SYMPTOM,5199
97201,-,I-SIGN_AND_SYMPTOM,5199
97202,floaters,I-SIGN_AND_SYMPTOM,5199
97203,,O,5199
97204,Other,O,5200
97205,complications,O,5200
97206,include,O,5200
97207,conjunctivitis,B-NAME_OF_DISEASE,5200
97208,corneal,B-NAME_OF_DISEASE,5200
97209,pseudo-dendritis,I-NAME_OF_DISEASE,5200
97210,episcleritis,B-NAME_OF_DISEASE,5200
97211,post-herpetic,B-NAME_OF_DISEASE,5200
97212,neuralgia,I-NAME_OF_DISEASE,5200
97213,and,O,5200
97214,disciform,B-NAME_OF_DISEASE,5200
97215,keratitis,I-NAME_OF_DISEASE,5200
97216,Prevention,O,5201
97217,The,B-PREVENTION,5201
97218,recombinant,I-PREVENTION,5201
97219,herpes,B-NAME_OF_DISEASE,5201
97220,zoster,I-NAME_OF_DISEASE,5201
97221,vaccine,I-PREVENTION,5201
97222,is,O,5201
97223,recommended,O,5201
97224,for,O,5201
97225,adults,O,5201
97226,≥70,O,5201
97227,years,O,5201
97228,in,O,5201
97229,the,B-GPE,5201
97230,UK,I-GPE,5201
97231,and,O,5201
97232,has,O,5201
97233,been,O,5201
97234,shown,O,5201
97235,to,O,5201
97236,reduce,O,5201
97237,cases,O,5201
97238,of,O,5201
97239,herpes,B-NAME_OF_DISEASE,5201
97240,zoster,I-NAME_OF_DISEASE,5201
97241,by,O,5201
97242,38%,O,5201
97243,Public,O,5202
97244,health,O,5202
97245,education,O,5202
97246,campaigns,O,5202
97247,would,O,5202
97248,be,O,5202
97249,useful,O,5202
97250,to,O,5202
97251,highlight,O,5202
97252,the,O,5202
97253,importance,O,5202
97254,of,O,5202
97255,this,O,5202
97256,vaccination,O,5202
97257,to,O,5202
97258,this,O,5202
97259,population,O,5202
97260,given,O,5202
97261,the,O,5202
97262,severity,O,5202
97263,of,O,5202
97264,the,O,5202
97265,complications,O,5202
97266,that,O,5202
97267,may,O,5202
97268,arise,O,5202
97269,from,O,5202
97270,it,O,5202
97271,if,O,5202
97272,not,O,5202
97273,identified,O,5202
97274,or,O,5202
97275,treated,O,5202
97276,appropriately,O,5202
97277,Intraocular,O,5203
97278,pressure,O,5203
97279,IOP,O,5203
97280,is,O,5203
97281,an,O,5203
97282,important,O,5203
97283,factor,O,5203
97284,in,O,5203
97285,the,O,5203
97286,management,O,5203
97287,of,O,5203
97288,glaucoma,B-NAME_OF_DISEASE,5203
97289,Lowering,B-TREATMENT,5204
97290,of,I-TREATMENT,5204
97291,IOP,I-TREATMENT,5204
97292,delays,O,5204
97293,the,O,5204
97294,onset,O,5204
97295,and,O,5204
97296,progression,O,5204
97297,of,O,5204
97298,glaucoma,B-NAME_OF_DISEASE,5204
97299,and,O,5204
97300,remains,O,5204
97301,the,O,5204
97302,main,O,5204
97303,treatment,O,5204
97304,to,O,5204
97305,maintain,O,5204
97306,visual,O,5204
97307,function,O,5204
97308,IOP,O,5205
97309,is,O,5205
97310,usually,O,5205
97311,monitored,O,5205
97312,using,O,5205
97313,Goldmann,B-DIAGNOSTIC_TEST,5205
97314,applanation,I-DIAGNOSTIC_TEST,5205
97315,tonometer,I-DIAGNOSTIC_TEST,5205
97316,GAT,I-DIAGNOSTIC_TEST,5205
97317,,O,5205
97318,In,O,5206
97319,the,O,5206
97320,clinical,O,5206
97321,setting,O,5206
97322,despite,O,5206
97323,the,O,5206
97324,importance,O,5206
97325,of,O,5206
97326,IOP,O,5206
97327,assessment,O,5206
97328,the,O,5206
97329,efficacy,O,5206
97330,of,O,5206
97331,IOP-lowering,B-TREATMENT,5206
97332,treatment,I-TREATMENT,5206
97333,is,O,5206
97334,usually,O,5206
97335,based,O,5206
97336,on,O,5206
97337,a,O,5206
97338,few,O,5206
97339,IOP,O,5206
97340,measurements,O,5206
97341,annually,O,5206
97342,A,O,5207
97343,substantial,O,5207
97344,proportion,O,5207
97345,of,O,5207
97346,patients,O,5207
97347,show,O,5207
97348,progression,O,5207
97349,in,O,5207
97350,visual,O,5207
97351,field,O,5207
97352,defects,O,5207
97353,at,O,5207
97354,apparently,O,5207
97355,controlled,O,5207
97356,IOP,O,5207
97357,Studies,O,5208
97358,have,O,5208
97359,shown,O,5208
97360,that,O,5208
97361,IOP,O,5208
97362,fluctuates,O,5208
97363,during,O,5208
97364,the,O,5208
97365,day,O,5208
97366,and,O,5208
97367,over,O,5208
97368,longer,O,5208
97369,periods,O,5208
97370,In,O,5209
97371,one,O,5209
97372,of,O,5209
97373,the,O,5209
97374,first,O,5209
97375,studies,O,5209
97376,Drance,B-PERSON,5209
97377,found,O,5209
97378,that,O,5209
97379,the,O,5209
97380,range,O,5209
97381,of,O,5209
97382,diurnal,O,5209
97383,variation,O,5209
97384,in,O,5209
97385,patients,O,5209
97386,with,O,5209
97387,glaucoma,B-NAME_OF_DISEASE,5209
97388,was,O,5209
97389,two,O,5209
97390,to,O,5209
97391,three,O,5209
97392,times,O,5209
97393,that,O,5209
97394,of,O,5209
97395,normal,O,5209
97396,individuals,O,5209
97397,and,O,5209
97398,emphasized,O,5209
97399,that,O,5209
97400,a,O,5209
97401,single,O,5209
97402,office,O,5209
97403,IOP,O,5209
97404,reading,O,5209
97405,may,O,5209
97406,not,O,5209
97407,be,O,5209
97408,representative,O,5209
97409,of,O,5209
97410,the,O,5209
97411,IOP,O,5209
97412,most,O,5209
97413,of,O,5209
97414,the,O,5209
97415,time,O,5209
97416,Later,O,5210
97417,on,O,5210
97418,several,O,5210
97419,researchers,O,5210
97420,reported,O,5210
97421,that,O,5210
97422,highest,O,5210
97423,IOPs,O,5210
97424,were,O,5210
97425,measured,O,5210
97426,outside,O,5210
97427,office,O,5210
97428,hours,O,5210
97429,and,O,5210
97430,that,O,5210
97431,pressure,O,5210
97432,peaks,O,5210
97433,and,O,5210
97434,higher,O,5210
97435,diurnal,O,5210
97436,fluctuation,O,5210
97437,in,O,5210
97438,patients,O,5210
97439,with,O,5210
97440,controlled,O,5210
97441,office,O,5210
97442,IOP,O,5210
97443,were,O,5210
97444,associated,O,5210
97445,with,O,5210
97446,progression,O,5210
97447,of,O,5210
97448,visual,O,5210
97449,field,O,5210
97450,Intraocular,O,5211
97451,pressure,O,5211
97452,IOP,O,5211
97453,fluctuates,O,5211
97454,throughout,O,5211
97455,the,O,5211
97456,day,O,5211
97457,as,O,5211
97458,well,O,5211
97459,as,O,5211
97460,during,O,5211
97461,the,O,5211
97462,night,O,5211
97463,as,O,5211
97464,we,O,5211
97465,sleep,O,5211
97466,even,O,5211
97467,body,O,5211
97468,position,O,5211
97469,and,O,5211
97470,Circadian,O,5211
97471,rhythm,O,5211
97472,can,O,5211
97473,cause,O,5211
97474,variations,O,5211
97475,Typically,O,5212
97476,practices,O,5212
97477,measure,O,5212
97478,IOP,O,5212
97479,only,O,5212
97480,during,O,5212
97481,daytime,O,5212
97482,clinic,O,5212
97483,hours,O,5212
97484,but,O,5212
97485,high,O,5212
97486,IOP,O,5212
97487,at,O,5212
97488,night,O,5212
97489,can,O,5212
97490,contribute,O,5212
97491,to,O,5212
97492,disease,O,5212
97493,progression,O,5212
97494,even,O,5212
97495,in,O,5212
97496,cases,O,5212
97497,of,O,5212
97498,normal-tension,B-NAME_OF_DISEASE,5212
97499,glaucoma,I-NAME_OF_DISEASE,5212
97500,So,O,5213
97501,when,O,5213
97502,we,O,5213
97503,miss,O,5213
97504,nighttime,O,5213
97505,measurements,O,5213
97506,we,O,5213
97507,are,O,5213
97508,missing,O,5213
97509,important,O,5213
97510,data,O,5213
97511,that,O,5213
97512,can,O,5213
97513,help,O,5213
97514,us,O,5213
97515,understand,O,5213
97516,and,O,5213
97517,treat,O,5213
97518,our,O,5213
97519,patients,O,5213
97520,disease,O,5213
97521,Making,O,5214
97522,for,O,5214
97523,an,O,5214
97524,even,O,5214
97525,more,O,5214
97526,complicated,O,5214
97527,situation,O,5214
97528,IOP,O,5214
97529,also,O,5214
97530,varies,O,5214
97531,day,O,5214
97532,to,O,5214
97533,day,O,5214
97534,and,O,5214
97535,infrequent,O,5214
97536,measurements,O,5214
97537,-,O,5214
97538,such,O,5214
97539,as,O,5214
97540,a,O,5214
97541,single,O,5214
97542,office,O,5214
97543,visit,O,5214
97544,every,O,5214
97545,3,O,5214
97546,months,O,5214
97547,-,O,5214
97548,provide,O,5214
97549,just,O,5214
97550,a,O,5214
97551,snapshot,O,5214
97552,of,O,5214
97553,IOP,O,5214
97554,patterns,O,5214
97555,To,O,5215
97556,address,O,5215
97557,this,O,5215
97558,issue,O,5215
97559,the,O,5215
97560,eye-care,O,5215
97561,industry,O,5215
97562,has,O,5215
97563,developed,O,5215
97564,devices,O,5215
97565,to,O,5215
97566,measure,O,5215
97567,IOP,O,5215
97568,at,O,5215
97569,home,O,5215
97570,The,B-DIAGNOSTIC_TEST,5216
97571,iCare,I-DIAGNOSTIC_TEST,5216
97572,HOME,I-DIAGNOSTIC_TEST,5216
97573,tonometer,I-DIAGNOSTIC_TEST,5216
97574,became,O,5216
97575,available,O,5216
97576,in,O,5216
97577,Europe,B-GPE,5216
97578,in,O,5216
97579,2014,O,5216
97580,and,O,5216
97581,was,O,5216
97582,approved,O,5216
97583,by,O,5216
97584,the,B-ORGANIZATION,5216
97585,FDA,I-ORGANIZATION,5216
97586,as,O,5216
97587,a,O,5216
97588,prescription,O,5216
97589,medical,O,5216
97590,device,O,5216
97591,in,O,5216
97592,the,B-GPE,5216
97593,United,I-GPE,5216
97594,States,I-GPE,5216
97595,in,O,5216
97596,2017,O,5216
97597,A,O,5217
97598,handheld,O,5217
97599,device,O,5217
97600,like,O,5217
97601,the,B-DIAGNOSTIC_TEST,5217
97602,iCare,I-DIAGNOSTIC_TEST,5217
97603,tonometer,I-DIAGNOSTIC_TEST,5217
97604,used,O,5217
97605,by,O,5217
97606,health-care,O,5217
97607,professionals,O,5217
97608,in,O,5217
97609,clinics,O,5217
97610,the,B-DIAGNOSTIC_TEST,5217
97611,iCare,I-DIAGNOSTIC_TEST,5217
97612,HOME,I-DIAGNOSTIC_TEST,5217
97613,tonometer,I-DIAGNOSTIC_TEST,5217
97614,enables,O,5217
97615,patients,O,5217
97616,to,O,5217
97617,measure,O,5217
97618,their,O,5217
97619,own,O,5217
97620,IOP,O,5217
97621,Another,O,5218
97622,device,O,5218
97623,the,B-DIAGNOSTIC_TEST,5218
97624,Sensimed,I-DIAGNOSTIC_TEST,5218
97625,Triggerfish,I-DIAGNOSTIC_TEST,5218
97626,contact,I-DIAGNOSTIC_TEST,5218
97627,lens,I-DIAGNOSTIC_TEST,5218
97628,was,O,5218
97629,cleared,O,5218
97630,by,O,5218
97631,the,B-ORGANIZATION,5218
97632,FDA,I-ORGANIZATION,5218
97633,in,O,5218
97634,2016,O,5218
97635,This,O,5219
97636,contact,O,5219
97637,lens,O,5219
97638,is,O,5219
97639,worn,O,5219
97640,by,O,5219
97641,the,O,5219
97642,patient,O,5219
97643,overnight,O,5219
97644,sensors,O,5219
97645,embedded,O,5219
97646,in,O,5219
97647,the,O,5219
97648,contact,O,5219
97649,lens,O,5219
97650,measure,O,5219
97651,corneal,O,5219
97652,dimensions,O,5219
97653,which,O,5219
97654,are,O,5219
97655,then,O,5219
97656,translated,O,5219
97657,to,O,5219
97658,an,O,5219
97659,IOP,O,5219
97660,measurement,O,5219
97661,Because,O,5220
97662,our,O,5220
97663,practice,O,5220
97664,has,O,5220
97665,experience,O,5220
97666,only,O,5220
97667,with,O,5220
97668,tonometers,O,5220
97669,we,O,5220
97670,will,O,5220
97671,restrict,O,5220
97672,our,O,5220
97673,guidance,O,5220
97674,to,O,5220
97675,what,O,5220
97676,practices,O,5220
97677,and,O,5220
97678,technicians,O,5220
97679,need,O,5220
97680,to,O,5220
97681,know,O,5220
97682,as,O,5220
97683,they,O,5220
97684,train,O,5220
97685,patients,O,5220
97686,to,O,5220
97687,use,O,5220
97688,the,B-DIAGNOSTIC_TEST,5220
97689,iCare,I-DIAGNOSTIC_TEST,5220
97690,HOME,I-DIAGNOSTIC_TEST,5220
97691,device,I-DIAGNOSTIC_TEST,5220
97692,First,O,5221
97693,develop,O,5221
97694,a,O,5221
97695,protocol,O,5221
97696,Practices,O,5221
97697,interested,O,5221
97698,in,O,5221
97699,measuring,O,5221
97700,IOP,O,5221
97701,from,O,5221
97702,a,O,5221
97703,patient,O,5221
97704,s,O,5221
97705,home,O,5221
97706,must,O,5221
97707,first,O,5221
97708,determine,O,5221
97709,how,O,5221
97710,devices,O,5221
97711,will,O,5221
97712,be,O,5221
97713,purchased,O,5221
97714,and,O,5221
97715,distributed,O,5221
97716,to,O,5221
97717,patients,O,5221
97718,Will,O,5222
97719,the,O,5222
97720,patient,O,5222
97721,purchase,O,5222
97722,and,O,5222
97723,own,O,5222
97724,the,O,5222
97725,device,O,5222
97726,or,O,5222
97727,will,O,5222
97728,the,O,5222
97729,device,O,5222
97730,be,O,5222
97731,rented,O,5222
97732,either,O,5222
97733,from,O,5222
97734,the,O,5222
97735,device,O,5222
97736,company,O,5222
97737,or,O,5222
97738,a,O,5222
97739,health-care,O,5222
97740,practice,O,5222
97741,Will,O,5222
97742,patients,O,5222
97743,put,O,5222
97744,down,O,5222
97745,a,O,5222
97746,monetary,O,5222
97747,deposit,O,5222
97748,for,O,5222
97749,the,O,5222
97750,device,O,5222
97751,Will,O,5222
97752,insurance,O,5222
97753,be,O,5222
97754,billed,O,5222
97755,or,O,5222
97756,can,O,5222
97757,a,O,5222
97758,health,O,5222
97759,saving,O,5222
97760,plan,O,5222
97761,cover,O,5222
97762,the,O,5222
97763,cost,O,5222
97764,For,O,5222
97765,some,O,5222
97766,practices,O,5222
97767,a,O,5222
97768,research,O,5222
97769,grant,O,5222
97770,can,O,5222
97771,help,O,5222
97772,cover,O,5222
97773,the,O,5222
97774,cost,O,5222
97775,Also,O,5223
97776,how,O,5223
97777,will,O,5223
97778,practices,O,5223
97779,guarantee,O,5223
97780,that,O,5223
97781,patients,O,5223
97782,return,O,5223
97783,the,O,5223
97784,device,O,5223
97785,Well-established,O,5223
97786,loan,O,5223
97787,programs,O,5223
97788,in,O,5223
97789,other,O,5223
97790,specialties,O,5223
97791,eg,O,5223
97792,home,O,5223
97793,blood-pressure,O,5223
97794,cuffs,O,5223
97795,home,O,5223
97796,Holter,O,5223
97797,monitors,O,5223
97798,may,O,5223
97799,serve,O,5223
97800,as,O,5223
97801,models,O,5223
97802,for,O,5223
97803,eye-care,O,5223
97804,practices,O,5223
97805,Our,O,5224
97806,practice,O,5224
97807,is,O,5224
97808,currently,O,5224
97809,working,O,5224
97810,with,O,5224
97811,a,O,5224
97812,third-party,O,5224
97813,insurance,O,5224
97814,company,O,5224
97815,to,O,5224
97816,help,O,5224
97817,us,O,5224
97818,bridge,O,5224
97819,that,O,5224
97820,accident,O,5224
97821,gap,O,5224
97822,for,O,5224
97823,lost,O,5224
97824,or,O,5224
97825,damaged,O,5224
97826,devices,O,5224
97827,ICare,B-ORGANIZATION,5225
97828,offers,O,5225
97829,extended,O,5225
97830,warranties,O,5225
97831,with,O,5225
97832,a,O,5225
97833,deductible,O,5225
97834,to,O,5225
97835,cover,O,5225
97836,that,O,5225
97837,issue,O,5225
97838,as,O,5225
97839,well,O,5225
97840,Preparing,O,5226
97841,patients,O,5226
97842,to,O,5226
97843,measure,O,5226
97844,at,O,5226
97845,home,O,5226
97846,A,O,5226
97847,patient,O,5226
97848,s,O,5226
97849,ability,O,5226
97850,to,O,5226
97851,navigate,O,5226
97852,their,O,5226
97853,device,O,5226
97854,and,O,5226
97855,their,O,5226
97856,confidence,O,5226
97857,in,O,5226
97858,their,O,5226
97859,ability,O,5226
97860,are,O,5226
97861,critical,O,5226
97862,to,O,5226
97863,successful,O,5226
97864,measurements,O,5226
97865,Patients,O,5227
97866,should,O,5227
97867,be,O,5227
97868,trained,O,5227
97869,by,O,5227
97870,ophthalmic,O,5227
97871,professionals,O,5227
97872,who,O,5227
97873,know,O,5227
97874,the,O,5227
97875,ins,O,5227
97876,and,O,5227
97877,outs,O,5227
97878,of,O,5227
97879,the,O,5227
97880,device,O,5227
97881,This,O,5228
97882,can,O,5228
97883,be,O,5228
97884,accomplished,O,5228
97885,through,O,5228
97886,videos,O,5228
97887,teleconferences,O,5228
97888,and,O,5228
97889,or,O,5228
97890,in-person,O,5228
97891,sessions,O,5228
97892,Our,O,5229
97893,practice,O,5229
97894,utilizes,O,5229
97895,in-person,O,5229
97896,training,O,5229
97897,-,O,5229
97898,we,O,5229
97899,allot,O,5229
97900,15,O,5229
97901,minutes,O,5229
97902,for,O,5229
97903,these,O,5229
97904,sessions,O,5229
97905,-,O,5229
97906,and,O,5229
97907,videos,O,5229
97908,Links,O,5230
97909,on,O,5230
97910,MyEyes.ne,O,5230
97911,the,O,5231
97912,website,O,5231
97913,and,O,5231
97914,device,O,5231
97915,company,O,5231
97916,we,O,5231
97917,founded,O,5231
97918,to,O,5231
97919,facilitate,O,5231
97920,patients,O,5231
97921,obtaining,O,5231
97922,home,O,5231
97923,tonometers,O,5231
97924,features,O,5231
97925,three,O,5231
97926,YouTube,B-ORGANIZATION,5231
97927,training,O,5231
97928,videos,O,5231
97929,that,O,5231
97930,introduce,O,5231
97931,the,O,5231
97932,tonometer,O,5231
97933,and,O,5231
97934,provide,O,5231
97935,detailed,O,5231
97936,instructions,O,5231
97937,on,O,5231
97938,its,O,5231
97939,use,O,5231
97940,Whatever,O,5232
97941,mode,O,5232
97942,of,O,5232
97943,training,O,5232
97944,you,O,5232
97945,choose,O,5232
97946,make,O,5232
97947,sure,O,5232
97948,it,O,5232
97949,provides,O,5232
97950,instruction,O,5232
97951,on,O,5232
97952,Turning,O,5232
97953,the,O,5232
97954,device,O,5232
97955,on,O,5232
97956,and,O,5232
97957,off,O,5232
97958,The,O,5232
97959,function,O,5232
97960,of,O,5232
97961,each,O,5232
97962,of,O,5232
97963,the,O,5232
97964,buttons,O,5232
97965,on,O,5232
97966,the,O,5232
97967,device,O,5232
97968,The,O,5232
97969,meaning,O,5232
97970,of,O,5232
97971,indicator,O,5232
97972,lights,O,5232
97973,and,O,5232
97974,sounds,O,5232
97975,on,O,5232
97976,the,O,5232
97977,device,O,5232
97978,Keeping,O,5232
97979,the,O,5232
97980,device,O,5232
97981,clean,O,5232
97982,and,O,5232
97983,safe,O,5232
97984,for,O,5232
97985,use,O,5232
97986,Positioning,O,5232
97987,of,O,5232
97988,the,O,5232
97989,patient,O,5232
97990,Proper,O,5232
97991,insertion,O,5232
97992,of,O,5232
97993,the,O,5232
97994,probe,O,5232
97995,Obtaining,O,5232
97996,a,O,5232
97997,measurement,O,5232
97998,How,O,5232
97999,to,O,5232
98000,confirm,O,5232
98001,that,O,5232
98002,a,O,5232
98003,measurement,O,5232
98004,was,O,5232
98005,successful,O,5232
98006,How,O,5232
98007,to,O,5232
98008,upload,O,5232
98009,and,O,5232
98010,access,O,5232
98011,the,O,5232
98012,data,O,5232
98013,to,O,5232
98014,discuss,O,5232
98015,with,O,5232
98016,the,O,5232
98017,patient,O,5232
98018,s,O,5232
98019,eye-care,O,5232
98020,provider,O,5232
98021,Importantly,O,5233
98022,training,O,5233
98023,should,O,5233
98024,also,O,5233
98025,include,O,5233
98026,troubleshooting,O,5233
98027,for,O,5233
98028,unsuccessful,O,5233
98029,measurements,O,5233
98030,For,O,5234
98031,example,O,5234
98032,the,B-DIAGNOSTIC_TEST,5234
98033,iCare,I-DIAGNOSTIC_TEST,5234
98034,HOME,I-DIAGNOSTIC_TEST,5234
98035,must,O,5234
98036,be,O,5234
98037,held,O,5234
98038,by,O,5234
98039,the,O,5234
98040,patient,O,5234
98041,at,O,5234
98042,a,O,5234
98043,particular,O,5234
98044,distance,O,5234
98045,from,O,5234
98046,their,O,5234
98047,eye,O,5234
98048,and,O,5234
98049,at,O,5234
98050,a,O,5234
98051,particular,O,5234
98052,height,O,5234
98053,relative,O,5234
98054,to,O,5234
98055,the,B-PART_OF_THE_EYES,5234
98056,apex,I-PART_OF_THE_EYES,5234
98057,of,I-PART_OF_THE_EYES,5234
98058,their,I-PART_OF_THE_EYES,5234
98059,cornea,I-PART_OF_THE_EYES,5234
98060,We,O,5235
98061,find,O,5235
98062,that,O,5235
98063,patients,O,5235
98064,typically,O,5235
98065,need,O,5235
98066,more,O,5235
98067,instruction,O,5235
98068,in,O,5235
98069,obtaining,O,5235
98070,the,O,5235
98071,initial,O,5235
98072,alignment,O,5235
98073,adjustment,O,5235
98074,of,O,5235
98075,the,O,5235
98076,head,O,5235
98077,and,O,5235
98078,cheek,O,5235
98079,measurement,O,5235
98080,bars,O,5235
98081,and,O,5235
98082,uploading,O,5235
98083,their,O,5235
98084,data,O,5235
98085,to,O,5235
98086,the,O,5235
98087,clinic,O,5235
98088,software,O,5235
98089,In-person,O,5236
98090,training,O,5236
98091,allows,O,5236
98092,staff,O,5236
98093,to,O,5236
98094,give,O,5236
98095,patients,O,5236
98096,the,O,5236
98097,extra,O,5236
98098,help,O,5236
98099,they,O,5236
98100,may,O,5236
98101,need,O,5236
98102,Should,O,5237
98103,additional,O,5237
98104,troubleshooting,O,5237
98105,be,O,5237
98106,necessary,O,5237
98107,representatives,O,5237
98108,are,O,5237
98109,often,O,5237
98110,available,O,5237
98111,from,O,5237
98112,the,O,5237
98113,device,O,5237
98114,makers,O,5237
98115,or,O,5237
98116,company,O,5237
98117,renting,O,5237
98118,them,O,5237
98119,out,O,5237
98120,we,O,5237
98121,provide,O,5237
98122,our,O,5237
98123,patients,O,5237
98124,with,O,5237
98125,the,O,5237
98126,relevant,O,5237
98127,contact,O,5237
98128,information,O,5237
98129,Patient,O,5238
98130,education,O,5238
98131,-,O,5238
98132,Be,O,5238
98133,sure,O,5238
98134,to,O,5238
98135,inform,O,5238
98136,patients,O,5238
98137,how,O,5238
98138,and,O,5238
98139,when,O,5238
98140,they,O,5238
98141,will,O,5238
98142,receive,O,5238
98143,their,O,5238
98144,IOP,O,5238
98145,data,O,5238
98146,as,O,5238
98147,well,O,5238
98148,as,O,5238
98149,how,O,5238
98150,they,O,5238
98151,should,O,5238
98152,act,O,5238
98153,on,O,5238
98154,that,O,5238
98155,information,O,5238
98156,For,O,5239
98157,example,O,5239
98158,the,O,5239
98159,current,O,5239
98160,model,O,5239
98161,of,O,5239
98162,the,B-DIAGNOSTIC_TEST,5239
98163,iCare,I-DIAGNOSTIC_TEST,5239
98164,HOME,I-DIAGNOSTIC_TEST,5239
98165,device,I-DIAGNOSTIC_TEST,5239
98166,does,O,5239
98167,not,O,5239
98168,display,O,5239
98169,the,O,5239
98170,IOP,O,5239
98171,on,O,5239
98172,the,O,5239
98173,device,O,5239
98174,due,O,5239
98175,to,O,5239
98176,FDA,B-ORGANIZATION,5239
98177,regulations,O,5239
98178,the,O,5239
98179,IOP,O,5239
98180,data,O,5239
98181,are,O,5239
98182,stored,O,5239
98183,in,O,5239
98184,the,O,5239
98185,device,O,5239
98186,then,O,5239
98187,uploaded,O,5239
98188,to,O,5239
98189,the,O,5239
98190,clinic,O,5239
98191,software,O,5239
98192,on,O,5239
98193,the,O,5239
98194,cloud,O,5239
98195,Patients,O,5240
98196,have,O,5240
98197,immediate,O,5240
98198,access,O,5240
98199,to,O,5240
98200,their,O,5240
98201,data,O,5240
98202,on,O,5240
98203,the,O,5240
98204,cloud,O,5240
98205,if,O,5240
98206,they,O,5240
98207,own,O,5240
98208,the,O,5240
98209,device,O,5240
98210,If,O,5241
98211,however,O,5241
98212,patients,O,5241
98213,are,O,5241
98214,renting,O,5241
98215,the,O,5241
98216,device,O,5241
98217,through,O,5241
98218,a,O,5241
98219,third-party,O,5241
98220,such,O,5241
98221,as,O,5241
98222,MyEyes,B-ORGANIZATION,5241
98223,that,O,5241
98224,data,O,5241
98225,may,O,5241
98226,be,O,5241
98227,shared,O,5241
98228,with,O,5241
98229,the,O,5241
98230,doctor,O,5241
98231,and,O,5241
98232,the,O,5241
98233,patient,O,5241
98234,in,O,5241
98235,a,O,5241
98236,user-friendly,O,5241
98237,spreadsheet,O,5241
98238,once,O,5241
98239,the,O,5241
98240,rental,O,5241
98241,period,O,5241
98242,is,O,5241
98243,complete,O,5241
98244,Innovations,O,5242
98245,to,O,5242
98246,come,O,5242
98247,-,O,5242
98248,The,O,5242
98249,biggest,O,5242
98250,limitation,O,5242
98251,of,O,5242
98252,devices,O,5242
98253,that,O,5242
98254,patients,O,5242
98255,use,O,5242
98256,to,O,5242
98257,measure,O,5242
98258,their,O,5242
98259,own,O,5242
98260,IOP,O,5242
98261,is,O,5242
98262,that,O,5242
98263,they,O,5242
98264,must,O,5242
98265,wake,O,5242
98266,up,O,5242
98267,to,O,5242
98268,measure,O,5242
98269,-,O,5242
98270,so,O,5242
98271,we,O,5242
98272,still,O,5242
98273,miss,O,5242
98274,important,O,5242
98275,data,O,5242
98276,while,O,5242
98277,patients,O,5242
98278,sleep,O,5242
98279,We,O,5243
98280,might,O,5243
98281,miss,O,5243
98282,high,O,5243
98283,IOP,O,5243
98284,that,O,5243
98285,occurs,O,5243
98286,during,O,5243
98287,episodes,O,5243
98288,of,O,5243
98289,sleep,O,5243
98290,apnea,O,5243
98291,or,O,5243
98292,overnight,O,5243
98293,hypotension,B-NAME_OF_DISEASE,5243
98294,low,I-NAME_OF_DISEASE,5243
98295,blood,I-NAME_OF_DISEASE,5243
98296,pressure,I-NAME_OF_DISEASE,5243
98297,,O,5243
98298,Fortunately,O,5244
98299,surgical,O,5244
98300,implants,O,5244
98301,that,O,5244
98302,measure,O,5244
98303,IOP,O,5244
98304,are,O,5244
98305,now,O,5244
98306,in,O,5244
98307,development,O,5244
98308,The,B-DIAGNOSTIC_TEST,5245
98309,Eyemate-IO,I-DIAGNOSTIC_TEST,5245
98310,Implandata,I-DIAGNOSTIC_TEST,5245
98311,Ophthalmic,I-DIAGNOSTIC_TEST,5245
98312,Products,I-DIAGNOSTIC_TEST,5245
98313,recently,O,5245
98314,earned,O,5245
98315,Europe,B-GPE,5245
98316,s,O,5245
98317,CE,O,5245
98318,Mark,O,5245
98319,The,B-DIAGNOSTIC_TEST,5246
98320,implantable,I-DIAGNOSTIC_TEST,5246
98321,micro-sensor,I-DIAGNOSTIC_TEST,5246
98322,performs,O,5246
98323,continual,O,5246
98324,monitoring,O,5246
98325,of,O,5246
98326,IOP,O,5246
98327,in,O,5246
98328,glaucoma,B-NAME_OF_DISEASE,5246
98329,patients,O,5246
98330,Current,O,5247
98331,and,O,5247
98332,future,O,5247
98333,home,O,5247
98334,devices,O,5247
98335,can,O,5247
98336,change,O,5247
98337,the,O,5247
98338,way,O,5247
98339,we,O,5247
98340,practice,O,5247
98341,In-office,O,5248
98342,IOP,O,5248
98343,checks,O,5248
98344,might,O,5248
98345,be,O,5248
98346,reduced,O,5248
98347,clinic,O,5248
98348,flow,O,5248
98349,and,O,5248
98350,allocation,O,5248
98351,of,O,5248
98352,office,O,5248
98353,resources,O,5248
98354,would,O,5248
98355,change,O,5248
98356,and,O,5248
98357,improve,O,5248
98358,IOP,O,5249
98359,measurements,O,5249
98360,might,O,5249
98361,upload,O,5249
98362,directly,O,5249
98363,into,O,5249
98364,electronic,O,5249
98365,health,O,5249
98366,records,O,5249
98367,The,O,5250
98368,ophthalmic,O,5250
98369,professional,O,5250
98370,will,O,5250
98371,interact,O,5250
98372,with,O,5250
98373,IOP,O,5250
98374,in,O,5250
98375,a,O,5250
98376,new,O,5250
98377,and,O,5250
98378,exciting,O,5250
98379,way,O,5250
98380,that,O,5250
98381,can,O,5250
98382,save,O,5250
98383,sight,O,5250
98384,Eye,O,5251
98385,pressure,O,5251
98386,varies,O,5251
98387,separately,O,5251
98388,from,O,5251
98389,blood,O,5251
98390,pressure,O,5251
98391,IOP,O,5252
98392,management,O,5252
98393,is,O,5252
98394,not,O,5252
98395,the,O,5252
98396,same,O,5252
98397,as,O,5252
98398,blood,O,5252
98399,pressure,O,5252
98400,control,O,5252
98401,However,O,5253
98402,research,O,5253
98403,has,O,5253
98404,shown,O,5253
98405,that,O,5253
98406,those,O,5253
98407,with,O,5253
98408,high,B-CAUSE_OF_DISEASE,5253
98409,blood,I-CAUSE_OF_DISEASE,5253
98410,pressure,I-CAUSE_OF_DISEASE,5253
98411,are,O,5253
98412,more,O,5253
98413,likely,O,5253
98414,to,O,5253
98415,develop,O,5253
98416,glaucoma,B-NAME_OF_DISEASE,5253
98417,Glaucoma,B-NAME_OF_DISEASE,5254
98418,is,O,5254
98419,not,O,5254
98420,aided,O,5254
98421,by,O,5254
98422,extremely,O,5254
98423,high,B-CAUSE_OF_DISEASE,5254
98424,blood,I-CAUSE_OF_DISEASE,5254
98425,pressure,I-CAUSE_OF_DISEASE,5254
98426,Low,O,5255
98427,blood,O,5255
98428,pressure,O,5255
98429,which,O,5255
98430,must,O,5255
98431,be,O,5255
98432,moderate,O,5255
98433,to,O,5255
98434,extremely,O,5255
98435,low,O,5255
98436,for,O,5255
98437,the,O,5255
98438,visual,O,5255
98439,nerve,O,5255
98440,to,O,5255
98441,receive,O,5255
98442,enough,O,5255
98443,blood,O,5255
98444,flow,O,5255
98445,is,O,5255
98446,another,O,5255
98447,issue,O,5255
98448,Low,B-CAUSE_OF_DISEASE,5256
98449,ocular,I-CAUSE_OF_DISEASE,5256
98450,perfusion,I-CAUSE_OF_DISEASE,5256
98451,pressure,I-CAUSE_OF_DISEASE,5256
98452,appears,O,5256
98453,to,O,5256
98454,be,O,5256
98455,a,O,5256
98456,significant,O,5256
98457,risk,O,5256
98458,factor,O,5256
98459,for,O,5256
98460,glaucoma,B-NAME_OF_DISEASE,5256
98461,according,O,5256
98462,to,O,5256
98463,the,O,5256
98464,evidence,O,5256
98465,The,O,5257
98466,differential,O,5257
98467,between,O,5257
98468,blood,O,5257
98469,pressure,O,5257
98470,and,O,5257
98471,eye,O,5257
98472,pressure,O,5257
98473,can,O,5257
98474,be,O,5257
98475,thought,O,5257
98476,of,O,5257
98477,as,O,5257
98478,the,O,5257
98479,ocular,O,5257
98480,perfusion,O,5257
98481,pressure,O,5257
98482,a,O,5257
98483,complex,O,5257
98484,quantity,O,5257
98485,Blood,O,5258
98486,has,O,5258
98487,trouble,O,5258
98488,getting,O,5258
98489,into,O,5258
98490,the,O,5258
98491,eye,O,5258
98492,to,O,5258
98493,deliver,O,5258
98494,oxygen,O,5258
98495,and,O,5258
98496,vital,O,5258
98497,nutrients,O,5258
98498,if,O,5258
98499,the,O,5258
98500,blood,O,5258
98501,pressure,O,5258
98502,is,O,5258
98503,low,O,5258
98504,and,O,5258
98505,the,O,5258
98506,eye,O,5258
98507,pressure,O,5258
98508,is,O,5258
98509,high,O,5258
98510,Patients,O,5259
98511,with,O,5259
98512,high,B-CAUSE_OF_DISEASE,5259
98513,blood,I-CAUSE_OF_DISEASE,5259
98514,pressure,I-CAUSE_OF_DISEASE,5259
98515,who,O,5259
98516,take,O,5259
98517,medication,O,5259
98518,may,O,5259
98519,actually,O,5259
98520,experience,O,5259
98521,very,O,5259
98522,low,O,5259
98523,blood,O,5259
98524,pressure,O,5259
98525,readings,O,5259
98526,when,O,5259
98527,they,O,5259
98528,are,O,5259
98529,sleeping,O,5259
98530,Due,O,5260
98531,to,O,5260
98532,reduced,O,5260
98533,blood,O,5260
98534,flow,O,5260
98535,to,O,5260
98536,the,O,5260
98537,eye,O,5260
98538,and,O,5260
98539,optic,B-PART_OF_THE_EYES,5260
98540,nerve,I-PART_OF_THE_EYES,5260
98541,the,B-PART_OF_THE_EYES,5260
98542,optic,I-PART_OF_THE_EYES,5260
98543,nerve,I-PART_OF_THE_EYES,5260
98544,may,O,5260
98545,become,O,5260
98546,compromised,O,5260
98547,Research,O,5261
98548,on,O,5261
98549,how,O,5261
98550,blood,O,5261
98551,flow,O,5261
98552,affects,O,5261
98553,optic,B-PART_OF_THE_EYES,5261
98554,nerve,I-PART_OF_THE_EYES,5261
98555,injury,O,5261
98556,is,O,5261
98557,underway,O,5261
98558,We,O,5262
98559,now,O,5262
98560,know,O,5262
98561,that,O,5262
98562,there,O,5262
98563,is,O,5262
98564,a,O,5262
98565,direct,O,5262
98566,correlation,O,5262
98567,between,O,5262
98568,various,O,5262
98569,types,O,5262
98570,of,O,5262
98571,glaucoma,B-NAME_OF_DISEASE,5262
98572,and,O,5262
98573,decreased,O,5262
98574,blood,O,5262
98575,flow,O,5262
98576,to,O,5262
98577,the,B-PART_OF_THE_EYES,5262
98578,optic,I-PART_OF_THE_EYES,5262
98579,nerve,I-PART_OF_THE_EYES,5262
98580,Although,O,5263
98581,intraocular,O,5263
98582,pressure,O,5263
98583,IOP,O,5263
98584,continues,O,5263
98585,to,O,5263
98586,be,O,5263
98587,a,O,5263
98588,significant,O,5263
98589,risk,O,5263
98590,factor,O,5263
98591,for,O,5263
98592,glaucoma,B-NAME_OF_DISEASE,5263
98593,it,O,5263
98594,is,O,5263
98595,obvious,O,5263
98596,that,O,5263
98597,additional,O,5263
98598,factors,O,5263
98599,can,O,5263
98600,significantly,O,5263
98601,affect,O,5263
98602,the,O,5263
98603,onset,O,5263
98604,and,O,5263
98605,progression,O,5263
98606,of,O,5263
98607,the,O,5263
98608,condition,O,5263
98609,Blood,O,5264
98610,pressure,O,5264
98611,BP,O,5264
98612,is,O,5264
98613,a,O,5264
98614,clinically,O,5264
98615,modifiable,O,5264
98616,risk,O,5264
98617,factor,O,5264
98618,for,O,5264
98619,glaucoma,B-NAME_OF_DISEASE,5264
98620,that,O,5264
98621,has,O,5264
98622,gained,O,5264
98623,interest,O,5264
98624,more,O,5264
98625,lately,O,5264
98626,because,O,5264
98627,it,O,5264
98628,offers,O,5264
98629,the,O,5264
98630,potential,O,5264
98631,for,O,5264
98632,new,O,5264
98633,therapeutic,O,5264
98634,approaches,O,5264
98635,beyond,O,5264
98636,IOP,O,5264
98637,reduction,O,5264
98638,The,O,5265
98639,ocular,O,5265
98640,perfusion,O,5265
98641,pressure,O,5265
98642,OPP,O,5265
98643,which,O,5265
98644,controls,O,5265
98645,the,O,5265
98646,flow,O,5265
98647,of,O,5265
98648,blood,O,5265
98649,to,O,5265
98650,the,B-PART_OF_THE_EYES,5265
98651,optic,I-PART_OF_THE_EYES,5265
98652,nerve,I-PART_OF_THE_EYES,5265
98653,is,O,5265
98654,determined,O,5265
98655,by,O,5265
98656,the,O,5265
98657,interaction,O,5265
98658,between,O,5265
98659,blood,O,5265
98660,pressure,O,5265
98661,and,O,5265
98662,IOP,O,5265
98663,Hypotension,B-NAME_OF_DISEASE,5266
98664,should,O,5266
98665,enhance,O,5266
98666,the,O,5266
98667,negative,O,5266
98668,consequences,O,5266
98669,of,O,5266
98670,IOP,O,5266
98671,rise,O,5266
98672,whereas,O,5266
98673,hypertension,B-NAME_OF_DISEASE,5266
98674,should,O,5266
98675,protect,O,5266
98676,against,O,5266
98677,IOP,O,5266
98678,elevation,O,5266
98679,if,O,5266
98680,OPP,O,5266
98681,is,O,5266
98682,a,O,5266
98683,more,O,5266
98684,significant,O,5266
98685,factor,O,5266
98686,in,O,5266
98687,determining,O,5266
98688,ganglion,B-PART_OF_THE_EYES,5266
98689,cell,I-PART_OF_THE_EYES,5266
98690,injury,O,5266
98691,than,O,5266
98692,IOP,O,5266
98693,Conflicting,O,5267
98694,conclusions,O,5267
98695,about,O,5267
98696,the,O,5267
98697,contribution,O,5267
98698,of,O,5267
98699,systemic,B-NAME_OF_DISEASE,5267
98700,hypertension,I-NAME_OF_DISEASE,5267
98701,to,O,5267
98702,the,O,5267
98703,onset,O,5267
98704,and,O,5267
98705,progression,O,5267
98706,of,O,5267
98707,glaucoma,B-NAME_OF_DISEASE,5267
98708,are,O,5267
98709,drawn,O,5267
98710,from,O,5267
98711,epidemiological,O,5267
98712,studies,O,5267
98713,According,O,5268
98714,to,O,5268
98715,the,O,5268
98716,most,O,5268
98717,recent,O,5268
98718,study,O,5268
98719,glaucoma,B-NAME_OF_DISEASE,5268
98720,is,O,5268
98721,more,O,5268
98722,common,O,5268
98723,in,O,5268
98724,persons,O,5268
98725,with,O,5268
98726,blood,O,5268
98727,pressures,O,5268
98728,at,O,5268
98729,both,O,5268
98730,extremes,O,5268
98731,It,O,5269
98732,makes,O,5269
98733,sense,O,5269
98734,that,O,5269
98735,those,O,5269
98736,with,O,5269
98737,low,O,5269
98738,blood,O,5269
98739,pressure,O,5269
98740,would,O,5269
98741,have,O,5269
98742,less,O,5269
98743,OPP,O,5269
98744,and,O,5269
98745,hence,O,5269
98746,less,O,5269
98747,blood,O,5269
98748,flow,O,5269
98749,but,O,5269
98750,it,O,5269
98751,is,O,5269
98752,more,O,5269
98753,challenging,O,5269
98754,to,O,5269
98755,explain,O,5269
98756,why,O,5269
98757,people,O,5269
98758,with,O,5269
98759,high,O,5269
98760,blood,O,5269
98761,pressure,O,5269
98762,also,O,5269
98763,exhibit,O,5269
98764,elevated,O,5269
98765,risk,O,5269
98766,This,O,5270
98767,results,O,5270
98768,might,O,5270
98769,be,O,5270
98770,the,O,5270
98771,result,O,5270
98772,of,O,5270
98773,chronic,O,5270
98774,hypertension-related,O,5270
98775,intrinsic,O,5270
98776,blood,O,5270
98777,flow,O,5270
98778,dysregulation,O,5270
98779,which,O,5270
98780,would,O,5270
98781,make,O,5270
98782,retinal,O,5270
98783,blood,O,5270
98784,flow,O,5270
98785,less,O,5270
98786,resilient,O,5270
98787,to,O,5270
98788,changes,O,5270
98789,in,O,5270
98790,ocular,O,5270
98791,perfusion,O,5270
98792,pressure,O,5270
98793,Glaucoma,B-NAME_OF_DISEASE,5271
98794,is,O,5271
98795,not,O,5271
98796,a,O,5271
98797,systemic,O,5271
98798,disease,O,5271
98799,in,O,5271
98800,and,O,5271
98801,of,O,5271
98802,itself,O,5271
98803,however,O,5271
98804,it,O,5271
98805,is,O,5271
98806,known,O,5271
98807,to,O,5271
98808,have,O,5271
98809,systemic,O,5271
98810,risk,O,5271
98811,factors,O,5271
98812,The,O,5272
98813,vasculature,O,5272
98814,of,O,5272
98815,the,B-PART_OF_THE_EYES,5272
98816,optic,I-PART_OF_THE_EYES,5272
98817,nerve,I-PART_OF_THE_EYES,5272
98818,itself,O,5272
98819,plays,O,5272
98820,a,O,5272
98821,significant,O,5272
98822,role,O,5272
98823,in,O,5272
98824,the,O,5272
98825,interaction,O,5272
98826,between,O,5272
98827,glaucoma,B-NAME_OF_DISEASE,5272
98828,and,O,5272
98829,the,O,5272
98830,human,O,5272
98831,system,O,5272
98832,Similar,O,5273
98833,to,O,5273
98834,other,O,5273
98835,cells,O,5273
98836,the,O,5273
98837,approximately,O,5273
98838,1,O,5273
98839,million,O,5273
98840,ganglion,O,5273
98841,cells,O,5273
98842,that,O,5273
98843,form,O,5273
98844,the,B-PART_OF_THE_EYES,5273
98845,optic,I-PART_OF_THE_EYES,5273
98846,nerve,I-PART_OF_THE_EYES,5273
98847,must,O,5273
98848,both,O,5273
98849,breathe,O,5273
98850,and,O,5273
98851,consume,O,5273
98852,in,O,5273
98853,order,O,5273
98854,to,O,5273
98855,survive,O,5273
98856,Even,O,5274
98857,while,O,5274
98858,it,O,5274
98859,oversimplifies,O,5274
98860,the,O,5274
98861,two,O,5274
98862,processes,O,5274
98863,it,O,5274
98864,is,O,5274
98865,still,O,5274
98866,largely,O,5274
98867,TRUE,O,5274
98868,For,O,5275
98869,respiration,O,5275
98870,and,O,5275
98871,glucose,O,5275
98872,supply,O,5275
98873,which,O,5275
98874,are,O,5275
98875,both,O,5275
98876,necessary,O,5275
98877,for,O,5275
98878,the,O,5275
98879,production,O,5275
98880,of,O,5275
98881,adenosine,B-CHEMICAL_COMPOUND,5275
98882,triphosphate,I-CHEMICAL_COMPOUND,5275
98883,ATP,I-CHEMICAL_COMPOUND,5275
98884,the,O,5275
98885,visual,O,5275
98886,nerve,O,5275
98887,cells,O,5275
98888,rely,O,5275
98889,on,O,5275
98890,the,O,5275
98891,circulatory,O,5275
98892,system,O,5275
98893,Therefore,O,5276
98894,anything,O,5276
98895,that,O,5276
98896,harms,O,5276
98897,the,O,5276
98898,circulatory,O,5276
98899,system,O,5276
98900,has,O,5276
98901,the,O,5276
98902,potential,O,5276
98903,to,O,5276
98904,harm,O,5276
98905,the,O,5276
98906,visual,O,5276
98907,neurons,O,5276
98908,by,O,5276
98909,definition,O,5276
98910,Risk,O,5277
98911,Factors,O,5277
98912,For,O,5277
98913,instance,O,5277
98914,openangle,B-NAME_OF_DISEASE,5277
98915,glaucoma,B-NAME_OF_DISEASE,5277
98916,has,O,5277
98917,long,O,5277
98918,been,O,5277
98919,linked,O,5277
98920,to,O,5277
98921,diabetes,B-NAME_OF_DISEASE,5277
98922,mellitus,I-NAME_OF_DISEASE,5277
98923,as,O,5277
98924,a,O,5277
98925,risk,O,5277
98926,factor,O,5277
98927,There,O,5278
98928,may,O,5278
98929,be,O,5278
98930,more,O,5278
98931,evidence,O,5278
98932,than,O,5278
98933,ever,O,5278
98934,before,O,5278
98935,to,O,5278
98936,support,O,5278
98937,this,O,5278
98938,Having,O,5279
98939,said,O,5279
98940,that,O,5279
98941,the,O,5279
98942,connection,O,5279
98943,between,O,5279
98944,blood,O,5279
98945,pressure,O,5279
98946,and,O,5279
98947,glaucoma,B-NAME_OF_DISEASE,5279
98948,has,O,5279
98949,been,O,5279
98950,researched,O,5279
98951,for,O,5279
98952,a,O,5279
98953,long,O,5279
98954,time,O,5279
98955,Particularly,O,5280
98956,in,O,5280
98957,so-called,O,5280
98958,normal,B-NAME_OF_DISEASE,5280
98959,tension,I-NAME_OF_DISEASE,5280
98960,glaucoma,I-NAME_OF_DISEASE,5280
98961,low,B-NAME_OF_DISEASE,5280
98962,blood,I-NAME_OF_DISEASE,5280
98963,pressure,I-NAME_OF_DISEASE,5280
98964,has,O,5280
98965,been,O,5280
98966,connected,O,5280
98967,to,O,5280
98968,the,O,5280
98969,emergence,O,5280
98970,of,O,5280
98971,open-angle,B-NAME_OF_DISEASE,5280
98972,glaucoma,I-NAME_OF_DISEASE,5280
98973,It,O,5281
98974,is,O,5281
98975,appropriate,O,5281
98976,to,O,5281
98977,assess,O,5281
98978,the,O,5281
98979,connection,O,5281
98980,between,O,5281
98981,blood,O,5281
98982,pressure,O,5281
98983,and,O,5281
98984,glaucoma,B-NAME_OF_DISEASE,5281
98985,and,O,5281
98986,consider,O,5281
98987,the,O,5281
98988,role,O,5281
98989,of,O,5281
98990,optometrists,O,5281
98991,in,O,5281
98992,light,O,5281
98993,of,O,5281
98994,the,O,5281
98995,recent,O,5281
98996,publication,O,5281
98997,of,O,5281
98998,revised,O,5281
98999,blood,O,5281
99000,pressure,O,5281
99001,guidelines,O,5281
99002,established,O,5281
99003,by,O,5281
99004,the,B-ORGANIZATION,5281
99005,American,I-ORGANIZATION,5281
99006,College,I-ORGANIZATION,5281
99007,of,I-ORGANIZATION,5281
99008,Cardiology,I-ORGANIZATION,5281
99009,and,O,5281
99010,the,B-ORGANIZATION,5281
99011,American,I-ORGANIZATION,5281
99012,Heart,I-ORGANIZATION,5281
99013,Association,I-ORGANIZATION,5281
99014,Supporting,O,5282
99015,Research,O,5282
99016,An,O,5282
99017,investigation,O,5282
99018,conducted,O,5282
99019,in,O,5282
99020,2018,O,5282
99021,and,O,5282
99022,published,O,5282
99023,in,O,5282
99024,the,B-PUBLICATION_VENUE,5282
99025,American,I-PUBLICATION_VENUE,5282
99026,Journal,I-PUBLICATION_VENUE,5282
99027,of,I-PUBLICATION_VENUE,5282
99028,Hypertension,I-PUBLICATION_VENUE,5282
99029,found,O,5282
99030,a,O,5282
99031,nonlinear,O,5282
99032,association,O,5282
99033,between,O,5282
99034,the,O,5282
99035,existence,O,5282
99036,of,O,5282
99037,glaucoma,B-NAME_OF_DISEASE,5282
99038,and,O,5282
99039,systemic,O,5282
99040,blood,O,5282
99041,pressure,O,5282
99042,The,O,5283
99043,researchers,O,5283
99044,of,O,5283
99045,the,O,5283
99046,study,O,5283
99047,concluded,O,5283
99048,that,O,5283
99049,the,O,5283
99050,two,O,5283
99051,have,O,5283
99052,a,O,5283
99053,U-shaped,O,5283
99054,association,O,5283
99055,This,O,5284
99056,indicates,O,5284
99057,that,O,5284
99058,both,O,5284
99059,patients,O,5284
99060,with,O,5284
99061,low,O,5284
99062,and,O,5284
99063,high,O,5284
99064,blood,O,5284
99065,pressure,O,5284
99066,saw,O,5284
99067,a,O,5284
99068,rise,O,5284
99069,in,O,5284
99070,the,O,5284
99071,incidence,O,5284
99072,of,O,5284
99073,glaucoma,B-NAME_OF_DISEASE,5284
99074,4,O,5285
99075,137,O,5285
99076,adults,O,5285
99077,aged,O,5285
99078,40,O,5285
99079,or,O,5285
99080,older,O,5285
99081,who,O,5285
99082,participated,O,5285
99083,in,O,5285
99084,the,B-NAME_OF_STUDY,5285
99085,National,I-NAME_OF_STUDY,5285
99086,Health,I-NAME_OF_STUDY,5285
99087,and,I-NAME_OF_STUDY,5285
99088,Nutrition,I-NAME_OF_STUDY,5285
99089,Examination,I-NAME_OF_STUDY,5285
99090,Surveys,I-NAME_OF_STUDY,5285
99091,NHANES,I-NAME_OF_STUDY,5285
99092,from,B-TIME_DURATION,5285
99093,2005,I-TIME_DURATION,5285
99094,to,I-TIME_DURATION,5285
99095,2008,I-TIME_DURATION,5285
99096,were,O,5285
99097,included,O,5285
99098,in,O,5285
99099,the,O,5285
99100,study,O,5285
99101,In,O,5286
99102,the,O,5286
99103,study,O,5286
99104,sample,O,5286
99105,as,O,5286
99106,a,O,5286
99107,whole,O,5286
99108,glaucoma,B-NAME_OF_DISEASE,5286
99109,prevalence,O,5286
99110,was,O,5286
99111,1.20%,O,5286
99112,Separate,O,5287
99113,metrics,O,5287
99114,were,O,5287
99115,used,O,5287
99116,to,O,5287
99117,assess,O,5287
99118,the,O,5287
99119,association,O,5287
99120,between,O,5287
99121,these,O,5287
99122,two,O,5287
99123,chronic,O,5287
99124,diseases,O,5287
99125,systolic,B-DIAGNOSTIC_TEST,5287
99126,and,I-DIAGNOSTIC_TEST,5287
99127,diastolic,B-DIAGNOSTIC_TEST,5287
99128,blood,I-DIAGNOSTIC_TEST,5287
99129,pressure,I-DIAGNOSTIC_TEST,5287
99130,For,O,5288
99131,participants,O,5288
99132,who,O,5288
99133,did,O,5288
99134,not,O,5288
99135,take,O,5288
99136,antihypertensive,B-NAME_OF_DRUG,5288
99137,drugs,I-NAME_OF_DRUG,5288
99138,both,O,5288
99139,high,B-CAUSE_OF_DISEASE,5288
99140,systolic,I-CAUSE_OF_DISEASE,5288
99141,blood,I-CAUSE_OF_DISEASE,5288
99142,pressure,I-CAUSE_OF_DISEASE,5288
99143,more,O,5288
99144,than,O,5288
99145,or,O,5288
99146,equal,O,5288
99147,to,O,5288
99148,161,O,5288
99149,mm,O,5288
99150,Hg,O,5288
99151,and,O,5288
99152,low,B-CAUSE_OF_DISEASE,5288
99153,systolic,I-CAUSE_OF_DISEASE,5288
99154,blood,I-CAUSE_OF_DISEASE,5288
99155,pressure,I-CAUSE_OF_DISEASE,5288
99156,increased,O,5288
99157,the,O,5288
99158,risk,O,5288
99159,of,O,5288
99160,glaucoma,B-NAME_OF_DISEASE,5288
99161,less,O,5288
99162,than,O,5288
99163,or,O,5288
99164,equal,O,5288
99165,to,O,5288
99166,110,O,5288
99167,mm,O,5288
99168,Hg,O,5288
99169,,O,5288
99170,Similar,O,5289
99171,to,O,5289
99172,how,O,5289
99173,high,B-CAUSE_OF_DISEASE,5289
99174,and,I-CAUSE_OF_DISEASE,5289
99175,low,I-CAUSE_OF_DISEASE,5289
99176,diastolic,B-DIAGNOSTIC_TEST,5289
99177,blood,I-DIAGNOSTIC_TEST,5289
99178,pressure,I-DIAGNOSTIC_TEST,5289
99179,increased,O,5289
99180,the,O,5289
99181,risk,O,5289
99182,of,O,5289
99183,glaucoma,B-NAME_OF_DISEASE,5289
99184,greater,O,5289
99185,than,O,5289
99186,or,O,5289
99187,equal,O,5289
99188,to,O,5289
99189,91,O,5289
99190,mmHg,O,5289
99191,or,O,5289
99192,less,O,5289
99193,than,O,5289
99194,or,O,5289
99195,equal,O,5289
99196,to,O,5289
99197,60,O,5289
99198,mmHg,O,5289
99199,respectively,O,5289
99200,,O,5289
99201,Participants,O,5290
99202,in,O,5290
99203,the,O,5290
99204,research,O,5290
99205,with,O,5290
99206,systolic,B-DIAGNOSTIC_TEST,5290
99207,blood,I-DIAGNOSTIC_TEST,5290
99208,pressure,I-DIAGNOSTIC_TEST,5290
99209,between,O,5290
99210,11,O,5290
99211,mm,O,5290
99212,Hg,O,5290
99213,and,O,5290
99214,120,O,5290
99215,mm,O,5290
99216,Hg,O,5290
99217,and,O,5290
99218,diastolic,B-DIAGNOSTIC_TEST,5290
99219,blood,I-DIAGNOSTIC_TEST,5290
99220,pressure,I-DIAGNOSTIC_TEST,5290
99221,between,O,5290
99222,81,O,5290
99223,mm,O,5290
99224,Hg,O,5290
99225,and,O,5290
99226,90,O,5290
99227,mm,O,5290
99228,Hg,O,5290
99229,had,O,5290
99230,the,O,5290
99231,lowest,O,5290
99232,prevalence,O,5290
99233,of,O,5290
99234,glaucoma,B-NAME_OF_DISEASE,5290
99235,This,O,5291
99236,study,O,5291
99237,implies,O,5291
99238,that,O,5291
99239,in,O,5291
99240,terms,O,5291
99241,of,O,5291
99242,glaucoma,B-NAME_OF_DISEASE,5291
99243,a,O,5291
99244,blood,O,5291
99245,pressure,O,5291
99246,Goldilocks,O,5291
99247,scenario,O,5291
99248,in,O,5291
99249,which,O,5291
99250,there,O,5291
99251,is,O,5291
99252,an,O,5291
99253,ideal,O,5291
99254,range,O,5291
99255,is,O,5291
99256,recommended,O,5291
99257,Low,B-NAME_OF_DISEASE,5292
99258,blood,I-NAME_OF_DISEASE,5292
99259,pressure,I-NAME_OF_DISEASE,5292
99260,can,O,5292
99261,cause,O,5292
99262,ischemia,B-SIGN_AND_SYMPTOM,5292
99263,to,I-SIGN_AND_SYMPTOM,5292
99264,the,I-SIGN_AND_SYMPTOM,5292
99265,optic,I-SIGN_AND_SYMPTOM,5292
99266,nerve,I-SIGN_AND_SYMPTOM,5292
99267,and,I-SIGN_AND_SYMPTOM,5292
99268,decrease,I-SIGN_AND_SYMPTOM,5292
99269,ocular,I-SIGN_AND_SYMPTOM,5292
99270,perfusion,I-SIGN_AND_SYMPTOM,5292
99271,pressure,I-SIGN_AND_SYMPTOM,5292
99272,either,O,5292
99273,naturally,O,5292
99274,or,O,5292
99275,as,O,5292
99276,a,O,5292
99277,result,O,5292
99278,of,O,5292
99279,over-treating,O,5292
99280,hypertension,B-NAME_OF_DISEASE,5292
99281,This,O,5293
99282,aspect,O,5293
99283,might,O,5293
99284,be,O,5293
99285,particularly,O,5293
99286,important,O,5293
99287,in,O,5293
99288,the,O,5293
99289,context,O,5293
99290,of,O,5293
99291,normal,B-NAME_OF_DISEASE,5293
99292,tension,I-NAME_OF_DISEASE,5293
99293,glaucoma,I-NAME_OF_DISEASE,5293
99294,On,O,5294
99295,the,O,5294
99296,other,O,5294
99297,hand,O,5294
99298,systemic,B-NAME_OF_DISEASE,5294
99299,hypertension,I-NAME_OF_DISEASE,5294
99300,frequently,O,5294
99301,results,O,5294
99302,in,O,5294
99303,arteriosclerosis,B-NAME_OF_DISEASE,5294
99304,which,O,5294
99305,may,O,5294
99306,reduce,B-SIGN_AND_SYMPTOM,5294
99307,blood,I-SIGN_AND_SYMPTOM,5294
99308,flow,I-SIGN_AND_SYMPTOM,5294
99309,to,I-SIGN_AND_SYMPTOM,5294
99310,the,I-SIGN_AND_SYMPTOM,5294
99311,optic,I-SIGN_AND_SYMPTOM,5294
99312,nerve,I-SIGN_AND_SYMPTOM,5294
99313,even,O,5294
99314,if,O,5294
99315,it,O,5294
99316,may,O,5294
99317,not,O,5294
99318,be,O,5294
99319,harmful,O,5294
99320,in,O,5294
99321,the,O,5294
99322,short,O,5294
99323,term,O,5294
99324,Controversial,O,5295
99325,Link,O,5295
99326,Systemic,B-NAME_OF_DISEASE,5295
99327,hypertension,I-NAME_OF_DISEASE,5295
99328,and,O,5295
99329,glaucoma,B-NAME_OF_DISEASE,5295
99330,have,O,5295
99331,always,O,5295
99332,had,O,5295
99333,a,O,5295
99334,contentious,O,5295
99335,connection,O,5295
99336,In,O,5296
99337,fact,O,5296
99338,the,B-NAME_OF_STUDY,5296
99339,2008,I-NAME_OF_STUDY,5296
99340,Barbados,I-NAME_OF_STUDY,5296
99341,Eye,I-NAME_OF_STUDY,5296
99342,Studies,I-NAME_OF_STUDY,5296
99343,revealed,O,5296
99344,a,O,5296
99345,possible,O,5296
99346,link,O,5296
99347,between,O,5296
99348,systemic,B-NAME_OF_DISEASE,5296
99349,hypertension,I-NAME_OF_DISEASE,5296
99350,and,O,5296
99351,a,O,5296
99352,lower,O,5296
99353,incidence,O,5296
99354,of,O,5296
99355,glaucoma,B-NAME_OF_DISEASE,5296
99356,The,O,5297
99357,development,O,5297
99358,of,O,5297
99359,ocular,B-NAME_OF_DISEASE,5297
99360,hypertension,I-NAME_OF_DISEASE,5297
99361,is,O,5297
99362,thought,O,5297
99363,to,O,5297
99364,be,O,5297
99365,influenced,O,5297
99366,by,O,5297
99367,systemic,B-NAME_OF_DISEASE,5297
99368,hypertension,I-NAME_OF_DISEASE,5297
99369,according,O,5297
99370,to,O,5297
99371,more,O,5297
99372,recent,O,5297
99373,research,O,5297
99374,that,O,5297
99375,was,O,5297
99376,published,O,5297
99377,in,O,5297
99378,2014,O,5297
99379,Putting,O,5298
99380,Into,O,5298
99381,Practice,O,5298
99382,The,O,5298
99383,question,O,5298
99384,then,O,5298
99385,comes,O,5298
99386,as,O,5298
99387,to,O,5298
99388,what,O,5298
99389,eyecare,O,5298
99390,professionals,O,5298
99391,can,O,5298
99392,do,O,5298
99393,with,O,5298
99394,this,O,5298
99395,knowledge,O,5298
99396,given,O,5298
99397,that,O,5298
99398,modern,O,5298
99399,research,O,5298
99400,suggests,O,5298
99401,that,O,5298
99402,a,O,5298
99403,range,O,5298
99404,of,O,5298
99405,blood,O,5298
99406,pressure,O,5298
99407,that,O,5298
99408,is,O,5298
99409,not,O,5298
99410,too,O,5298
99411,high,O,5298
99412,and,O,5298
99413,not,O,5298
99414,too,O,5298
99415,low,O,5298
99416,is,O,5298
99417,ideal,O,5298
99418,for,O,5298
99419,the,O,5298
99420,patient,O,5298
99421,If,O,5299
99422,optometrists,O,5299
99423,are,O,5299
99424,not,O,5299
99425,already,O,5299
99426,doing,O,5299
99427,so,O,5299
99428,taking,B-DIAGNOSTIC_TEST,5299
99429,a,I-DIAGNOSTIC_TEST,5299
99430,patient,I-DIAGNOSTIC_TEST,5299
99431,s,I-DIAGNOSTIC_TEST,5299
99432,blood,I-DIAGNOSTIC_TEST,5299
99433,pressure,I-DIAGNOSTIC_TEST,5299
99434,as,O,5299
99435,part,O,5299
99436,of,O,5299
99437,a,O,5299
99438,glaucoma,B-NAME_OF_DISEASE,5299
99439,evaluation,O,5299
99440,is,O,5299
99441,a,O,5299
99442,simple,O,5299
99443,and,O,5299
99444,painless,O,5299
99445,technique,O,5299
99446,to,O,5299
99447,determine,O,5299
99448,whether,O,5299
99449,or,O,5299
99450,not,O,5299
99451,a,O,5299
99452,different,O,5299
99453,risk,O,5299
99454,factor,O,5299
99455,for,O,5299
99456,the,O,5299
99457,condition,O,5299
99458,exists,O,5299
99459,It,O,5300
99460,is,O,5300
99461,wrong,O,5300
99462,to,O,5300
99463,presume,O,5300
99464,that,O,5300
99465,just,O,5300
99466,because,O,5300
99467,a,O,5300
99468,patient,O,5300
99469,is,O,5300
99470,taking,O,5300
99471,an,B-NAME_OF_DRUG,5300
99472,oral,I-NAME_OF_DRUG,5300
99473,antihypertensive,I-NAME_OF_DRUG,5300
99474,drug,I-NAME_OF_DRUG,5300
99475,his,O,5300
99476,blood,O,5300
99477,pressure,O,5300
99478,is,O,5300
99479,managed,O,5300
99480,,O,5300
99481,In,O,5301
99482,actuality,O,5301
99483,taking,O,5301
99484,oral,B-NAME_OF_DRUG,5301
99485,antihypertensives,I-NAME_OF_DRUG,5301
99486,is,O,5301
99487,a,O,5301
99488,frequent,O,5301
99489,contributor,O,5301
99490,to,O,5301
99491,hypotension,B-NAME_OF_DISEASE,5301
99492,Nonselective,B-NAME_OF_DRUG,5302
99493,beta,I-NAME_OF_DRUG,5302
99494,blockers,I-NAME_OF_DRUG,5302
99495,such,O,5302
99496,timolol,B-NAME_OF_DRUG,5302
99497,Timoptic,I-NAME_OF_DRUG,5302
99498,Betimol,I-NAME_OF_DRUG,5302
99499,Alcon,I-NAME_OF_DRUG,5302
99500,are,O,5302
99501,known,O,5302
99502,to,O,5302
99503,have,O,5302
99504,systemic,B-NAME_OF_DISEASE,5302
99505,hypotension,I-NAME_OF_DISEASE,5302
99506,and,O,5302
99507,bradycardia,B-NAME_OF_DISEASE,5302
99508,in,O,5302
99509,their,O,5302
99510,medication,O,5302
99511,side,O,5302
99512,effect,O,5302
99513,profiles,O,5302
99514,in,O,5302
99515,addition,O,5302
99516,to,O,5302
99517,the,O,5302
99518,fact,O,5302
99519,that,O,5302
99520,low,O,5302
99521,blood,O,5302
99522,pressure,O,5302
99523,might,O,5302
99524,contribute,O,5302
99525,to,O,5302
99526,glaucoma,B-NAME_OF_DISEASE,5302
99527,Optometrists,O,5303
99528,who,O,5303
99529,treat,O,5303
99530,glaucoma,B-NAME_OF_DISEASE,5303
99531,patients,O,5303
99532,can,O,5303
99533,monitor,O,5303
99534,patient,O,5303
99535,safety,O,5303
99536,and,O,5303
99537,potential,O,5303
99538,lurking,O,5303
99539,factors,O,5303
99540,by,O,5303
99541,keeping,O,5303
99542,an,O,5303
99543,eye,O,5303
99544,on,O,5303
99545,measurements,O,5303
99546,like,O,5303
99547,systemic,O,5303
99548,blood,O,5303
99549,pressure,O,5303
99550,Proper,B-PREVENTION,5304
99551,eyelid,I-PREVENTION,5304
99552,closure,I-PREVENTION,5304
99553,and,O,5304
99554,a,B-PREVENTION,5304
99555,normal,I-PREVENTION,5304
99556,blink,I-PREVENTION,5304
99557,reflex,I-PREVENTION,5304
99558,are,O,5304
99559,essential,O,5304
99560,to,O,5304
99561,maintaining,O,5304
99562,a,O,5304
99563,stable,O,5304
99564,tear,B-PART_OF_THE_EYES,5304
99565,film,I-PART_OF_THE_EYES,5304
99566,and,O,5304
99567,a,O,5304
99568,healthy,O,5304
99569,corneal,B-PART_OF_THE_EYES,5304
99570,surface,I-PART_OF_THE_EYES,5304
99571,Patients,O,5305
99572,affected,O,5305
99573,with,O,5305
99574,lagophthalmos,B-NAME_OF_DISEASE,5305
99575,are,O,5305
99576,unable,B-SIGN_AND_SYMPTOM,5305
99577,to,I-SIGN_AND_SYMPTOM,5305
99578,fully,I-SIGN_AND_SYMPTOM,5305
99579,close,I-SIGN_AND_SYMPTOM,5305
99580,their,I-SIGN_AND_SYMPTOM,5305
99581,eyelids,I-SIGN_AND_SYMPTOM,5305
99582,and,O,5305
99583,they,O,5305
99584,may,O,5305
99585,describe,O,5305
99586,symptoms,O,5305
99587,of,O,5305
99588,dry,B-SIGN_AND_SYMPTOM,5305
99589,and,I-SIGN_AND_SYMPTOM,5305
99590,irritated,I-SIGN_AND_SYMPTOM,5305
99591,eyes,I-SIGN_AND_SYMPTOM,5305
99592,Common,O,5306
99593,morbidities,O,5306
99594,of,O,5306
99595,lagophthalmos,B-NAME_OF_DISEASE,5306
99596,are,O,5306
99597,corneal,B-NAME_OF_DISEASE,5306
99598,exposure,I-NAME_OF_DISEASE,5306
99599,and,O,5306
99600,subsequent,B-NAME_OF_DISEASE,5306
99601,keratopathy,I-NAME_OF_DISEASE,5306
99602,which,O,5306
99603,may,O,5306
99604,progress,O,5306
99605,to,O,5306
99606,corneal,B-NAME_OF_DISEASE,5306
99607,ulceration,I-NAME_OF_DISEASE,5306
99608,and,O,5306
99609,infectious,B-NAME_OF_DISEASE,5306
99610,keratitis,I-NAME_OF_DISEASE,5306
99611,It,O,5307
99612,is,O,5307
99613,important,O,5307
99614,to,O,5307
99615,recognize,O,5307
99616,lagophthalmos,B-NAME_OF_DISEASE,5307
99617,early,O,5307
99618,in,O,5307
99619,the,O,5307
99620,patient,O,5307
99621,s,O,5307
99622,course,O,5307
99623,and,O,5307
99624,begin,O,5307
99625,treatment,O,5307
99626,as,O,5307
99627,soon,O,5307
99628,as,O,5307
99629,possible,O,5307
99630,The,O,5308
99631,choice,O,5308
99632,of,O,5308
99633,therapy,O,5308
99634,requires,O,5308
99635,an,O,5308
99636,understanding,O,5308
99637,of,O,5308
99638,both,O,5308
99639,the,O,5308
99640,etiology,O,5308
99641,and,O,5308
99642,expected,O,5308
99643,duration,O,5308
99644,of,O,5308
99645,the,O,5308
99646,lagophthalmos,B-NAME_OF_DISEASE,5308
99647,Nocturnal,B-NAME_OF_DISEASE,5309
99648,lagophthalmos,I-NAME_OF_DISEASE,5309
99649,is,O,5309
99650,the,B-SIGN_AND_SYMPTOM,5309
99651,inability,I-SIGN_AND_SYMPTOM,5309
99652,to,I-SIGN_AND_SYMPTOM,5309
99653,close,I-SIGN_AND_SYMPTOM,5309
99654,the,I-SIGN_AND_SYMPTOM,5309
99655,eyelids,I-SIGN_AND_SYMPTOM,5309
99656,while,I-SIGN_AND_SYMPTOM,5309
99657,sleeping,I-SIGN_AND_SYMPTOM,5309
99658,This,O,5310
99659,can,O,5310
99660,result,O,5310
99661,in,O,5310
99662,a,O,5310
99663,range,O,5310
99664,of,O,5310
99665,conditions,O,5310
99666,from,B-SIGN_AND_SYMPTOM,5310
99667,mild,I-SIGN_AND_SYMPTOM,5310
99668,epithelial,I-SIGN_AND_SYMPTOM,5310
99669,changes,I-SIGN_AND_SYMPTOM,5310
99670,to,I-SIGN_AND_SYMPTOM,5310
99671,severe,I-SIGN_AND_SYMPTOM,5310
99672,exposure,I-SIGN_AND_SYMPTOM,5310
99673,ulcers,I-SIGN_AND_SYMPTOM,5310
99674,Katz,B-PERSON,5310
99675,and,O,5310
99676,Kaufman,B-PERSON,5310
99677,1977,O,5310
99678,,O,5310
99679,Lagophthalmos,B-NAME_OF_DISEASE,5311
99680,is,O,5311
99681,associated,O,5311
99682,with,O,5311
99683,exposure,B-CAUSE_OF_DISEASE,5311
99684,keratopathy,I-CAUSE_OF_DISEASE,5311
99685,poor,B-CAUSE_OF_DISEASE,5311
99686,sleep,I-CAUSE_OF_DISEASE,5311
99687,and,O,5311
99688,persistent,O,5311
99689,exposure-related,O,5311
99690,symptoms,O,5311
99691,There,O,5312
99692,are,O,5312
99693,a,O,5312
99694,variety,O,5312
99695,of,O,5312
99696,causes,O,5312
99697,of,O,5312
99698,lagophthalmos,B-NAME_OF_DISEASE,5312
99699,grouped,O,5312
99700,as,O,5312
99701,proptosis,B-SIGN_AND_SYMPTOM,5312
99702,eye,I-SIGN_AND_SYMPTOM,5312
99703,exposure,I-SIGN_AND_SYMPTOM,5312
99704,etiologies,O,5312
99705,and,O,5312
99706,palpebral,B-SIGN_AND_SYMPTOM,5312
99707,insufficiency,I-SIGN_AND_SYMPTOM,5312
99708,etiologies,O,5312
99709,Although,O,5313
99710,obvious,B-NAME_OF_DISEASE,5313
99711,lagophthalmos,I-NAME_OF_DISEASE,5313
99712,is,O,5313
99713,usually,O,5313
99714,detected,O,5313
99715,it,O,5313
99716,is,O,5313
99717,sometimes,O,5313
99718,difficult,O,5313
99719,to,O,5313
99720,recognize,O,5313
99721,obscure,B-NAME_OF_DISEASE,5313
99722,lagophthalmos,I-NAME_OF_DISEASE,5313
99723,due,O,5313
99724,either,O,5313
99725,to,O,5313
99726,eyelash,B-SIGN_AND_SYMPTOM,5313
99727,obstruction,I-SIGN_AND_SYMPTOM,5313
99728,or,I-SIGN_AND_SYMPTOM,5313
99729,overhang,I-SIGN_AND_SYMPTOM,5313
99730,of,I-SIGN_AND_SYMPTOM,5313
99731,the,I-SIGN_AND_SYMPTOM,5313
99732,upper,I-SIGN_AND_SYMPTOM,5313
99733,lid,I-SIGN_AND_SYMPTOM,5313
99734,anterior,I-SIGN_AND_SYMPTOM,5313
99735,and,I-SIGN_AND_SYMPTOM,5313
99736,inferior,I-SIGN_AND_SYMPTOM,5313
99737,to,I-SIGN_AND_SYMPTOM,5313
99738,the,I-SIGN_AND_SYMPTOM,5313
99739,most,I-SIGN_AND_SYMPTOM,5313
99740,superior,I-SIGN_AND_SYMPTOM,5313
99741,portion,I-SIGN_AND_SYMPTOM,5313
99742,of,I-SIGN_AND_SYMPTOM,5313
99743,the,I-SIGN_AND_SYMPTOM,5313
99744,lower,I-SIGN_AND_SYMPTOM,5313
99745,lid,I-SIGN_AND_SYMPTOM,5313
99746,in,I-SIGN_AND_SYMPTOM,5313
99747,a,I-SIGN_AND_SYMPTOM,5313
99748,closed,I-SIGN_AND_SYMPTOM,5313
99749,position,I-SIGN_AND_SYMPTOM,5313
99750,Although,O,5314
99751,obvious,B-NAME_OF_DISEASE,5314
99752,lagophthalmos,I-NAME_OF_DISEASE,5314
99753,is,O,5314
99754,usually,O,5314
99755,detected,O,5314
99756,it,O,5314
99757,is,O,5314
99758,sometimes,O,5314
99759,difficult,O,5314
99760,to,O,5314
99761,recognize,O,5314
99762,obscure,B-NAME_OF_DISEASE,5314
99763,lagophthalmos,I-NAME_OF_DISEASE,5314
99764,due,O,5314
99765,either,O,5314
99766,to,O,5314
99767,eyelash,B-SIGN_AND_SYMPTOM,5314
99768,obstruction,I-SIGN_AND_SYMPTOM,5314
99769,or,I-SIGN_AND_SYMPTOM,5314
99770,overhang,I-SIGN_AND_SYMPTOM,5314
99771,of,I-SIGN_AND_SYMPTOM,5314
99772,the,I-SIGN_AND_SYMPTOM,5314
99773,upper,I-SIGN_AND_SYMPTOM,5314
99774,lid,I-SIGN_AND_SYMPTOM,5314
99775,anterior,I-SIGN_AND_SYMPTOM,5314
99776,and,I-SIGN_AND_SYMPTOM,5314
99777,inferior,I-SIGN_AND_SYMPTOM,5314
99778,to,I-SIGN_AND_SYMPTOM,5314
99779,the,I-SIGN_AND_SYMPTOM,5314
99780,most,I-SIGN_AND_SYMPTOM,5314
99781,superior,I-SIGN_AND_SYMPTOM,5314
99782,portion,I-SIGN_AND_SYMPTOM,5314
99783,of,I-SIGN_AND_SYMPTOM,5314
99784,the,I-SIGN_AND_SYMPTOM,5314
99785,lower,I-SIGN_AND_SYMPTOM,5314
99786,lid,I-SIGN_AND_SYMPTOM,5314
99787,in,I-SIGN_AND_SYMPTOM,5314
99788,a,I-SIGN_AND_SYMPTOM,5314
99789,closed,I-SIGN_AND_SYMPTOM,5314
99790,position,I-SIGN_AND_SYMPTOM,5314
99791,A,O,5315
99792,diagnosis,O,5315
99793,can,O,5315
99794,usually,O,5315
99795,be,O,5315
99796,made,O,5315
99797,with,O,5315
99798,a,B-DIAGNOSTIC_TEST,5315
99799,focused,I-DIAGNOSTIC_TEST,5315
99800,history,I-DIAGNOSTIC_TEST,5315
99801,and,O,5315
99802,slit,B-DIAGNOSTIC_TEST,5315
99803,lamp,I-DIAGNOSTIC_TEST,5315
99804,examination,I-DIAGNOSTIC_TEST,5315
99805,Treatment,O,5316
99806,is,O,5316
99807,multipronged,O,5316
99808,and,O,5316
99809,may,O,5316
99810,include,O,5316
99811,minor,B-TREATMENT,5316
99812,procedures,I-TREATMENT,5316
99813,or,I-TREATMENT,5316
99814,ocular,I-TREATMENT,5316
99815,surgery,I-TREATMENT,5316
99816,to,I-TREATMENT,5316
99817,correct,I-TREATMENT,5316
99818,the,I-TREATMENT,5316
99819,lid,I-TREATMENT,5316
99820,malposition,I-TREATMENT,5316
99821,natural,B-TREATMENT,5316
99822,topical,I-TREATMENT,5316
99823,or,I-TREATMENT,5316
99824,oral,I-TREATMENT,5316
99825,agents,I-TREATMENT,5316
99826,and,O,5316
99827,punctal,B-TREATMENT,5316
99828,plugs,I-TREATMENT,5316
99829,to,I-TREATMENT,5316
99830,manage,I-TREATMENT,5316
99831,ocular,I-TREATMENT,5316
99832,surface,I-TREATMENT,5316
99833,effects,I-TREATMENT,5316
99834,Correct,O,5317
99835,and,O,5317
99836,timely,O,5317
99837,diagnosis,O,5317
99838,allows,O,5317
99839,greater,O,5317
99840,opportunity,O,5317
99841,for,O,5317
99842,relief,O,5317
99843,of,O,5317
99844,patient,O,5317
99845,suffering,O,5317
99846,and,O,5317
99847,prevention,O,5317
99848,of,O,5317
99849,severe,O,5317
99850,ocular,O,5317
99851,surface,O,5317
99852,pathology,O,5317
99853,as,O,5317
99854,well,O,5317
99855,as,O,5317
99856,educated,O,5317
99857,planning,O,5317
99858,for,O,5317
99859,future,O,5317
99860,ocular,O,5317
99861,surgical,O,5317
99862,procedures,O,5317
99863,While,O,5318
99864,severe,O,5318
99865,cases,O,5318
99866,can,O,5318
99867,usually,O,5318
99868,be,O,5318
99869,readily,O,5318
99870,diagnosed,O,5318
99871,we,O,5318
99872,may,O,5318
99873,find,O,5318
99874,it,O,5318
99875,challenging,O,5318
99876,to,O,5318
99877,diagnose,O,5318
99878,the,O,5318
99879,more,O,5318
99880,subtle,O,5318
99881,cases,O,5318
99882,which,O,5318
99883,can,O,5318
99884,masquerade,O,5318
99885,as,O,5318
99886,dry,B-NAME_OF_DISEASE,5318
99887,eye,I-NAME_OF_DISEASE,5318
99888,disease,I-NAME_OF_DISEASE,5318
99889,Challenges,O,5319
99890,with,O,5319
99891,Diagnosing,O,5319
99892,Mild,O,5319
99893,Cases,O,5319
99894,Unless,O,5319
99895,patients,O,5319
99896,have,O,5319
99897,been,O,5319
99898,told,O,5319
99899,by,O,5319
99900,others,O,5319
99901,quite,O,5319
99902,often,O,5319
99903,they,O,5319
99904,may,O,5319
99905,suffer,O,5319
99906,from,O,5319
99907,nocturnal,B-NAME_OF_DISEASE,5319
99908,lagophthalmos,B-NAME_OF_DISEASE,5319
99909,and,O,5319
99910,not,O,5319
99911,be,O,5319
99912,aware,O,5319
99913,of,O,5319
99914,it,O,5319
99915,Subtle,O,5320
99916,cases,O,5320
99917,are,O,5320
99918,not,O,5320
99919,easily,O,5320
99920,identified,O,5320
99921,in,O,5320
99922,our,O,5320
99923,exam,O,5320
99924,lane,O,5320
99925,either,O,5320
99926,because,O,5320
99927,many,O,5320
99928,of,O,5320
99929,these,O,5320
99930,patients,O,5320
99931,can,O,5320
99932,have,O,5320
99933,normal,O,5320
99934,voluntary,O,5320
99935,lid,O,5320
99936,closure,O,5320
99937,during,O,5320
99938,evaluation,O,5320
99939,Tsai,B-PERSON,5320
99940,et,O,5320
99941,al,O,5320
99942,2009,O,5320
99943,,O,5320
99944,In,O,5321
99945,addition,O,5321
99946,symptoms,O,5321
99947,typically,O,5321
99948,are,O,5321
99949,not,O,5321
99950,terribly,O,5321
99951,helpful,O,5321
99952,When,O,5322
99953,a,O,5322
99954,patient,O,5322
99955,presents,O,5322
99956,with,O,5322
99957,symptoms,O,5322
99958,of,O,5322
99959,foreign,B-SIGN_AND_SYMPTOM,5322
99960,body,I-SIGN_AND_SYMPTOM,5322
99961,sensation,I-SIGN_AND_SYMPTOM,5322
99962,hyperemia,I-SIGN_AND_SYMPTOM,5322
99963,and,I-SIGN_AND_SYMPTOM,5322
99964,reduced,I-SIGN_AND_SYMPTOM,5322
99965,acuity,I-SIGN_AND_SYMPTOM,5322
99966,practitioners,O,5322
99967,are,O,5322
99968,not,O,5322
99969,likely,O,5322
99970,to,O,5322
99971,routinely,O,5322
99972,jump,O,5322
99973,to,O,5322
99974,a,O,5322
99975,diagnosis,O,5322
99976,of,O,5322
99977,lagophthalmos,B-NAME_OF_DISEASE,5322
99978,In,O,5323
99979,reality,O,5323
99980,these,O,5323
99981,are,O,5323
99982,symptoms,O,5323
99983,of,O,5323
99984,almost,O,5323
99985,every,O,5323
99986,dry,B-NAME_OF_DISEASE,5323
99987,eye,I-NAME_OF_DISEASE,5323
99988,patient,O,5323
99989,Clinically,O,5324
99990,we,O,5324
99991,can,O,5324
99992,also,O,5324
99993,encounter,O,5324
99994,challenges,O,5324
99995,We,O,5325
99996,can,O,5325
99997,identify,O,5325
99998,lagophthalmos,B-NAME_OF_DISEASE,5325
99999,from,O,5325
100000,inferior,B-NAME_OF_DISEASE,5325
100001,superficial,I-NAME_OF_DISEASE,5325
100002,punctate,I-NAME_OF_DISEASE,5325
100003,keratitis,I-NAME_OF_DISEASE,5325
100004,but,O,5325
100005,if,O,5325
100006,patients,O,5325
100007,have,O,5325
100008,only,O,5325
100009,a,O,5325
100010,mild,O,5325
100011,case,O,5325
100012,and,O,5325
100013,their,O,5325
100014,appointment,O,5325
100015,time,O,5325
100016,is,O,5325
100017,late,O,5325
100018,afternoon,O,5325
100019,or,O,5325
100020,evening,O,5325
100021,those,O,5325
100022,corneal,O,5325
100023,finding,O,5325
100024,may,O,5325
100025,no,O,5325
100026,longer,O,5325
100027,be,O,5325
100028,present,O,5325
100029,To,O,5326
100030,accurately,O,5326
100031,identify,O,5326
100032,these,O,5326
100033,patients,O,5326
100034,practitioners,O,5326
100035,need,O,5326
100036,to,O,5326
100037,do,O,5326
100038,more,O,5326
100039,When,O,5327
100040,you,O,5327
100041,have,O,5327
100042,a,O,5327
100043,suspicion,O,5327
100044,of,O,5327
100045,nocturnal,B-NAME_OF_DISEASE,5327
100046,lagophthalmos,B-NAME_OF_DISEASE,5327
100047,that,O,5327
100048,a,O,5327
100049,pacurs,O,5327
100050,at,O,5327
100051,night,O,5327
100052,some,O,5327
100053,of,O,5327
100054,the,O,5327
100055,best,O,5327
100056,strategies,O,5327
100057,would,O,5327
100058,be,O,5327
100059,implemented,O,5327
100060,at,O,5327
100061,that,O,5327
100062,time,O,5327
100063,Addressing,O,5328
100064,the,O,5328
100065,environment,O,5328
100066,in,O,5328
100067,which,O,5328
100068,patients,O,5328
100069,sleep,O,5328
100070,can,O,5328
100071,be,O,5328
100072,helpful,O,5328
100073,such,O,5328
100074,as,O,5328
100075,using,O,5328
100076,a,O,5328
100077,humidifier,O,5328
100078,Taping,B-TREATMENT,5329
100079,the,I-TREATMENT,5329
100080,eyelids,I-TREATMENT,5329
100081,closed,I-TREATMENT,5329
100082,at,I-TREATMENT,5329
100083,night,I-TREATMENT,5329
100084,or,O,5329
100085,using,B-TREATMENT,5329
100086,commercially,I-TREATMENT,5329
100087,available,I-TREATMENT,5329
100088,eyelid,B-TREATMENT,5329
100089,weights,I-TREATMENT,5329
100090,can,O,5329
100091,go,O,5329
100092,a,O,5329
100093,long,O,5329
100094,way,O,5329
100095,in,O,5329
100096,addressing,O,5329
100097,exposure,B-NAME_OF_DISEASE,5329
100098,keratitis,I-NAME_OF_DISEASE,5329
100099,secondary,O,5329
100100,to,O,5329
100101,lagophthalmos,B-NAME_OF_DISEASE,5329
100102,Both,O,5330
100103,options,O,5330
100104,should,O,5330
100105,be,O,5330
100106,done,O,5330
100107,under,O,5330
100108,a,O,5330
100109,practitioner,O,5330
100110,s,O,5330
100111,supervision,O,5330
100112,While,O,5331
100113,both,O,5331
100114,artificial,B-TREATMENT,5331
100115,tears,I-TREATMENT,5331
100116,and,O,5331
100117,ointment,B-TREATMENT,5331
100118,assist,O,5331
100119,with,O,5331
100120,lubricating,O,5331
100121,the,B-PART_OF_THE_EYES,5331
100122,ocular,I-PART_OF_THE_EYES,5331
100123,surface,I-PART_OF_THE_EYES,5331
100124,ointments,B-TREATMENT,5331
100125,may,O,5331
100126,prove,O,5331
100127,to,O,5331
100128,be,O,5331
100129,more,O,5331
100130,effective,O,5331
100131,especially,O,5331
100132,when,O,5331
100133,used,O,5331
100134,in,O,5331
100135,conjunction,O,5331
100136,with,O,5331
100137,eyelid,B-TREATMENT,5331
100138,taping,I-TREATMENT,5331
100139,or,O,5331
100140,with,O,5331
100141,eyelid,B-TREATMENT,5331
100142,weights,I-TREATMENT,5331
100143,Practitioners,O,5332
100144,definitely,O,5332
100145,have,O,5332
100146,options,O,5332
100147,to,O,5332
100148,offer,O,5332
100149,to,O,5332
100150,patients,O,5332
100151,who,O,5332
100152,have,O,5332
100153,nocturnal,B-NAME_OF_DISEASE,5332
100154,lagophthalmos,B-NAME_OF_DISEASE,5332
100155,but,O,5332
100156,the,O,5332
100157,key,O,5332
100158,is,O,5332
100159,identifying,O,5332
100160,the,O,5332
100161,problem,O,5332
100162,As,O,5333
100163,always,O,5333
100164,an,O,5333
100165,effective,O,5333
100166,case,O,5333
100167,history,O,5333
100168,in,O,5333
100169,connection,O,5333
100170,with,O,5333
100171,a,O,5333
100172,problem-focused,O,5333
100173,exam,O,5333
100174,can,O,5333
100175,help,O,5333
100176,uncover,O,5333
100177,those,O,5333
100178,subtle,O,5333
100179,diagnoses,O,5333
100180,Start,O,5334
100181,by,O,5334
100182,asking,O,5334
100183,the,O,5334
100184,right,O,5334
100185,questions,O,5334
100186,Ask,O,5335
100187,patients,O,5335
100188,Do,O,5335
100189,you,O,5335
100190,notice,O,5335
100191,a,O,5335
100192,substantial,O,5335
100193,difference,O,5335
100194,in,O,5335
100195,symptoms,O,5335
100196,in,O,5335
100197,the,O,5335
100198,morning,O,5335
100199,as,O,5335
100200,opposed,O,5335
100201,to,O,5335
100202,in,O,5335
100203,the,O,5335
100204,evening,O,5335
100205,Are,O,5335
100206,there,O,5335
100207,differences,O,5335
100208,between,O,5335
100209,the,O,5335
100210,days,O,5335
100211,that,O,5335
100212,you,O,5335
100213,wear,O,5335
100214,contact,O,5335
100215,lenses,O,5335
100216,and,O,5335
100217,the,O,5335
100218,days,O,5335
100219,that,O,5335
100220,you,O,5335
100221,do,O,5335
100222,not,O,5335
100223,Can,O,5335
100224,you,O,5335
100225,come,O,5335
100226,in,O,5335
100227,for,O,5335
100228,a,O,5335
100229,morning,O,5335
100230,appointment,O,5335
100231,Practitioners,O,5335
100232,can,O,5335
100233,also,O,5335
100234,try,O,5335
100235,to,O,5335
100236,simulate,O,5335
100237,sleeping,O,5335
100238,in,O,5335
100239,the,O,5335
100240,office,O,5335
100241,by,O,5335
100242,asking,O,5335
100243,patients,O,5335
100244,to,O,5335
100245,gently,O,5335
100246,close,O,5335
100247,their,O,5335
100248,eyes,O,5335
100249,A,B-DIAGNOSTIC_TEST,5336
100250,slit,I-DIAGNOSTIC_TEST,5336
100251,lamp,I-DIAGNOSTIC_TEST,5336
100252,or,I-DIAGNOSTIC_TEST,5336
100253,transilluminator,I-DIAGNOSTIC_TEST,5336
100254,evaluation,I-DIAGNOSTIC_TEST,5336
100255,of,I-DIAGNOSTIC_TEST,5336
100256,the,I-DIAGNOSTIC_TEST,5336
100257,intrapalpebral,I-DIAGNOSTIC_TEST,5336
100258,area,I-DIAGNOSTIC_TEST,5336
100259,will,O,5336
100260,be,O,5336
100261,able,O,5336
100262,to,O,5336
100263,help,O,5336
100264,determine,O,5336
100265,whether,O,5336
100266,lagophthalmos,B-NAME_OF_DISEASE,5336
100267,is,O,5336
100268,present,O,5336
100269,Treatment,O,5337
100270,Options,O,5337
100271,Once,O,5337
100272,we,O,5337
100273,determine,O,5337
100274,that,O,5337
100275,a,O,5337
100276,patients,O,5337
100277,has,O,5337
100278,lagophthalmos,B-NAME_OF_DISEASE,5337
100279,there,O,5337
100280,are,O,5337
100281,a,O,5337
100282,few,O,5337
100283,options,O,5337
100284,for,O,5337
100285,contact,O,5337
100286,lens,O,5337
100287,patients,O,5337
100288,Because,O,5338
100289,the,O,5338
100290,condition,O,5338
100291,occurs,O,5338
100292,at,O,5338
100293,night,O,5338
100294,some,O,5338
100295,of,O,5338
100296,the,O,5338
100297,best,O,5338
100298,strategies,O,5338
100299,would,O,5338
100300,be,O,5338
100301,implemented,O,5338
100302,at,O,5338
100303,that,O,5338
100304,time,O,5338
100305,Addressing,O,5339
100306,the,O,5339
100307,environment,O,5339
100308,in,O,5339
100309,which,O,5339
100310,patients,O,5339
100311,sleep,O,5339
100312,can,O,5339
100313,be,O,5339
100314,helpful,O,5339
100315,such,O,5339
100316,as,O,5339
100317,using,O,5339
100318,a,O,5339
100319,humidifier,O,5339
100320,Taping,B-TREATMENT,5340
100321,the,I-TREATMENT,5340
100322,eyelids,I-TREATMENT,5340
100323,closed,I-TREATMENT,5340
100324,at,I-TREATMENT,5340
100325,night,I-TREATMENT,5340
100326,or,O,5340
100327,using,B-TREATMENT,5340
100328,commercially,I-TREATMENT,5340
100329,available,I-TREATMENT,5340
100330,eyelid,B-TREATMENT,5340
100331,weights,I-TREATMENT,5340
100332,can,O,5340
100333,go,O,5340
100334,a,O,5340
100335,long,O,5340
100336,way,O,5340
100337,in,O,5340
100338,addressing,O,5340
100339,exposure,B-NAME_OF_DISEASE,5340
100340,keratitis,I-NAME_OF_DISEASE,5340
100341,secondary,O,5340
100342,to,O,5340
100343,lagophthalmos,B-NAME_OF_DISEASE,5340
100344,Both,O,5341
100345,options,O,5341
100346,should,O,5341
100347,be,O,5341
100348,done,O,5341
100349,under,O,5341
100350,a,O,5341
100351,practitioner,O,5341
100352,s,O,5341
100353,supervision,O,5341
100354,While,O,5342
100355,both,O,5342
100356,artificial,B-TREATMENT,5342
100357,tears,I-TREATMENT,5342
100358,and,O,5342
100359,ointment,B-TREATMENT,5342
100360,assist,O,5342
100361,with,O,5342
100362,lubricating,O,5342
100363,the,B-PART_OF_THE_EYES,5342
100364,ocular,I-PART_OF_THE_EYES,5342
100365,surface,I-PART_OF_THE_EYES,5342
100366,ointments,B-TREATMENT,5342
100367,may,O,5342
100368,prove,O,5342
100369,to,O,5342
100370,be,O,5342
100371,more,O,5342
100372,effective,O,5342
100373,especially,O,5342
100374,when,O,5342
100375,used,O,5342
100376,in,O,5342
100377,conjunction,O,5342
100378,with,O,5342
100379,eyelid,B-TREATMENT,5342
100380,taping,I-TREATMENT,5342
100381,or,O,5342
100382,with,O,5342
100383,eyelid,B-TREATMENT,5342
100384,weights,I-TREATMENT,5342
100385,Practitioners,O,5343
100386,definitely,O,5343
100387,have,O,5343
100388,options,O,5343
100389,to,O,5343
100390,offer,O,5343
100391,to,O,5343
100392,patients,O,5343
100393,who,O,5343
100394,have,O,5343
100395,nocturnal,B-NAME_OF_DISEASE,5343
100396,lagophthalmos,I-NAME_OF_DISEASE,5343
100397,but,O,5343
100398,the,O,5343
100399,key,O,5343
100400,is,O,5343
100401,identifying,O,5343
100402,the,O,5343
100403,problem,O,5343
100404,As,O,5344
100405,always,O,5344
100406,an,O,5344
100407,effective,O,5344
100408,case,O,5344
100409,history,O,5344
100410,in,O,5344
100411,connection,O,5344
100412,with,O,5344
100413,a,O,5344
100414,problem-focused,O,5344
100415,exam,O,5344
100416,can,O,5344
100417,help,O,5344
100418,uncover,O,5344
100419,those,O,5344
100420,subtle,O,5344
100421,diagnoses,O,5344
100422,Frontera,B-ORGANIZATION,5345
100423,Therapeutics,I-ORGANIZATION,5345
100424,has,O,5345
100425,initiated,O,5345
100426,a,O,5345
100427,clinical,O,5345
100428,trial,O,5345
100429,for,O,5345
100430,its,O,5345
100431,gene,B-TREATMENT,5345
100432,therapy,I-TREATMENT,5345
100433,FT-002,B-TREATMENT,5345
100434,which,O,5345
100435,is,O,5345
100436,intended,O,5345
100437,for,O,5345
100438,the,O,5345
100439,treatment,O,5345
100440,of,O,5345
100441,X-linked,B-NAME_OF_DISEASE,5345
100442,retinitis,I-NAME_OF_DISEASE,5345
100443,pigmentosa,I-NAME_OF_DISEASE,5345
100444,XLRP,B-NAME_OF_DISEASE,5345
100445,,O,5345
100446,The,O,5346
100447,first,O,5346
100448,patient,O,5346
100449,has,O,5346
100450,already,O,5346
100451,been,O,5346
100452,given,O,5346
100453,a,O,5346
100454,dose,O,5346
100455,of,O,5346
100456,the,O,5346
100457,gene,O,5346
100458,therapy,O,5346
100459,product,O,5346
100460,FT-002,B-TREATMENT,5347
100461,is,O,5347
100462,Frontera,B-ORGANIZATION,5347
100463,s,I-ORGANIZATION,5347
100464,third,O,5347
100465,gene,O,5347
100466,therapy,O,5347
100467,product,O,5347
100468,candidate,O,5347
100469,to,O,5347
100470,enter,O,5347
100471,clinical,O,5347
100472,trials,O,5347
100473,I,O,5348
100474,am,O,5348
100475,very,O,5348
100476,pleased,O,5348
100477,with,O,5348
100478,our,O,5348
100479,speed,O,5348
100480,of,O,5348
100481,execution,O,5348
100482,and,O,5348
100483,the,O,5348
100484,rapid,O,5348
100485,buildup,O,5348
100486,of,O,5348
100487,our,O,5348
100488,medical,O,5348
100489,and,O,5348
100490,clinical,O,5348
100491,operations,O,5348
100492,capabilities,O,5348
100493,As,O,5349
100494,a,O,5349
100495,company,O,5349
100496,we,O,5349
100497,now,O,5349
100498,have,O,5349
100499,three,O,5349
100500,gene,O,5349
100501,therapy,O,5349
100502,clinical,O,5349
100503,studies,O,5349
100504,running,O,5349
100505,in,O,5349
100506,parallel,O,5349
100507,Xinyan,B-PERSON,5349
100508,Li,I-PERSON,5349
100509,PhD,I-PERSON,5349
100510,President,O,5349
100511,and,O,5349
100512,Chief,O,5349
100513,Medical,O,5349
100514,Officer,O,5349
100515,of,O,5349
100516,Frontera,B-ORGANIZATION,5349
100517,said,O,5349
100518,in,O,5349
100519,a,O,5349
100520,company,O,5349
100521,news,O,5349
100522,release,O,5349
100523,FT-002,B-TREATMENT,5350
100524,was,O,5350
100525,manufactured,O,5350
100526,entirely,O,5350
100527,in-house,O,5350
100528,and,O,5350
100529,administered,O,5350
100530,to,O,5350
100531,the,O,5350
100532,first,O,5350
100533,patient,O,5350
100534,as,O,5350
100535,a,O,5350
100536,first-in-class,O,5350
100537,product,O,5350
100538,again,O,5350
100539,validating,O,5350
100540,the,O,5350
100541,maturity,O,5350
100542,and,O,5350
100543,advancement,O,5350
100544,of,O,5350
100545,the,O,5350
100546,company,O,5350
100547,s,O,5350
100548,AAV,B-CHEMICAL_COMPOUND,5350
100549,R,O,5350
100550,D,O,5350
100551,platform,O,5350
100552,technology,O,5350
100553,said,O,5350
100554,Yong,B-PERSON,5350
100555,Dai,I-PERSON,5350
100556,PhD,I-PERSON,5350
100557,founder,O,5350
100558,and,O,5350
100559,CEO,O,5350
100560,of,O,5350
100561,Frontera,B-ORGANIZATION,5350
100562,Therapeutics,I-ORGANIZATION,5350
100563,Driven,O,5351
100564,by,O,5351
100565,our,O,5351
100566,mission,O,5351
100567,to,O,5351
100568,develop,O,5351
100569,novel,O,5351
100570,and,O,5351
100571,best-in-class,O,5351
100572,gene,O,5351
100573,therapies,O,5351
100574,the,O,5351
100575,Frontera,B-ORGANIZATION,5351
100576,team,O,5351
100577,accelerated,O,5351
100578,the,O,5351
100579,R,O,5351
100580,D,O,5351
100581,process,O,5351
100582,to,O,5351
100583,enable,O,5351
100584,FT-002,B-TREATMENT,5351
100585,to,O,5351
100586,enter,O,5351
100587,the,O,5351
100588,clinic,O,5351
100589,smoothly,O,5351
100590,and,O,5351
100591,we,O,5351
100592,believe,O,5351
100593,FT-002,B-TREATMENT,5351
100594,could,O,5351
100595,greatly,O,5351
100596,improve,O,5351
100597,the,O,5351
100598,quality,O,5351
100599,of,O,5351
100600,life,O,5351
100601,for,O,5351
100602,XLRP,B-NAME_OF_DISEASE,5351
100603,patients,O,5351
100604,for,O,5351
100605,whom,O,5351
100606,there,O,5351
100607,are,O,5351
100608,currently,O,5351
100609,no,O,5351
100610,effective,O,5351
100611,treatments,O,5351
100612,This,O,5352
100613,year,O,5352
100614,the,O,5352
100615,company,O,5352
100616,expects,O,5352
100617,to,O,5352
100618,advance,O,5352
100619,additional,O,5352
100620,product,O,5352
100621,candidates,O,5352
100622,into,O,5352
100623,preclinical,O,5352
100624,and,O,5352
100625,clinical,O,5352
100626,studies,O,5352
100627,which,O,5352
100628,we,O,5352
100629,believe,O,5352
100630,may,O,5352
100631,provide,O,5352
100632,more,O,5352
100633,patients,O,5352
100634,with,O,5352
100635,curative,O,5352
100636,opportunities,O,5352
100637,About,O,5353
100638,FT-002,B-TREATMENT,5353
100639,Gene,I-TREATMENT,5353
100640,Theraphy,I-TREATMENT,5353
100641,FT-002,B-TREATMENT,5353
100642,is,O,5353
100643,a,O,5353
100644,potential,O,5353
100645,first-in-class,O,5353
100646,gene,O,5353
100647,therapy,O,5353
100648,drug,O,5353
100649,created,O,5353
100650,using,O,5353
100651,a,O,5353
100652,recombinant,O,5353
100653,adeno-associated,O,5353
100654,virus,O,5353
100655,that,O,5353
100656,is,O,5353
100657,designed,O,5353
100658,to,O,5353
100659,treat,O,5353
100660,X-linked,B-NAME_OF_DISEASE,5353
100661,retinitis,I-NAME_OF_DISEASE,5353
100662,pigmentosa,I-NAME_OF_DISEASE,5353
100663,XLRP,B-NAME_OF_DISEASE,5353
100664,caused,O,5353
100665,by,O,5353
100666,RPGR,B-CAUSE_OF_DISEASE,5353
100667,gene,I-CAUSE_OF_DISEASE,5353
100668,mutation,I-CAUSE_OF_DISEASE,5353
100669,XLRP,B-NAME_OF_DISEASE,5354
100670,has,O,5354
100671,no,O,5354
100672,known,O,5354
100673,treatment,O,5354
100674,globally,O,5354
100675,FT-002,B-TREATMENT,5355
100676,is,O,5355
100677,administered,O,5355
100678,through,O,5355
100679,an,O,5355
100680,intraocular,O,5355
100681,injection,O,5355
100682,of,O,5355
100683,a,O,5355
100684,recombinant,O,5355
100685,AAV,B-CHEMICAL_COMPOUND,5355
100686,virus,I-CHEMICAL_COMPOUND,5355
100687,that,O,5355
100688,carries,O,5355
100689,the,O,5355
100690,gene,O,5355
100691,for,O,5355
100692,the,O,5355
100693,expression,O,5355
100694,of,O,5355
100695,active,O,5355
100696,functional,O,5355
100697,proteins,O,5355
100698,that,O,5355
100699,repair,O,5355
100700,the,O,5355
100701,damaged,O,5355
100702,retinal,O,5355
100703,cell,O,5355
100704,structure,O,5355
100705,and,O,5355
100706,function,O,5355
100707,A,O,5356
100708,single,O,5356
100709,injection,O,5356
100710,of,O,5356
100711,FT-002,B-TREATMENT,5356
100712,has,O,5356
100713,the,O,5356
100714,potential,O,5356
100715,to,O,5356
100716,delay,O,5356
100717,disease,O,5356
100718,progression,O,5356
100719,or,O,5356
100720,restore,O,5356
100721,the,O,5356
100722,patient,O,5356
100723,s,O,5356
100724,visual,O,5356
100725,function,O,5356
100726,This,O,5357
100727,gene,O,5357
100728,therapy,O,5357
100729,drug,O,5357
100730,is,O,5357
100731,being,O,5357
100732,tested,O,5357
100733,in,O,5357
100734,XLRP,B-NAME_OF_DISEASE,5357
100735,patients,O,5357
100736,in,O,5357
100737,China,B-GPE,5357
100738,and,O,5357
100739,if,O,5357
100740,successful,O,5357
100741,will,O,5357
100742,be,O,5357
100743,the,O,5357
100744,first,O,5357
100745,AAV,B-CHEMICAL_COMPOUND,5357
100746,gene,I-TREATMENT,5357
100747,therapy,I-TREATMENT,5357
100748,drug,I-TREATMENT,5357
100749,used,O,5357
100750,to,O,5357
100751,treat,O,5357
100752,this,O,5357
100753,condition,O,5357
100754,TelomEYE,B-ORGANIZATION,5358
100755,Pharmaceuticals,I-ORGANIZATION,5358
100756,Corporation,I-ORGANIZATION,5358
100757,working,O,5358
100758,on,O,5358
100759,a,O,5358
100760,new,O,5358
100761,generation,O,5358
100762,of,O,5358
100763,ophthalmologic,O,5358
100764,therapies,O,5358
100765,announced,O,5358
100766,today,O,5358
100767,the,O,5358
100768,completion,O,5358
100769,of,O,5358
100770,a,O,5358
100771,successful,O,5358
100772,1,O,5358
100773,million,O,5358
100774,post-seed,O,5358
100775,funding,O,5358
100776,round,O,5358
100777,valuing,O,5358
100778,the,O,5358
100779,company,O,5358
100780,at,O,5358
100781,10,O,5358
100782,million,O,5358
100783,USD,O,5358
100784,The,O,5359
100785,round,O,5359
100786,was,O,5359
100787,co-led,O,5359
100788,by,O,5359
100789,healthcare,O,5359
100790,mogul,O,5359
100791,Mehmet,B-PERSON,5359
100792,Ali,I-PERSON,5359
100793,Aydınlar,I-PERSON,5359
100794,Re-Pie,B-ORGANIZATION,5359
100795,Venture,I-ORGANIZATION,5359
100796,Capital,I-ORGANIZATION,5359
100797,Fund,I-ORGANIZATION,5359
100798,and,O,5359
100799,investment,O,5359
100800,banker,O,5359
100801,Kerim,B-PERSON,5359
100802,Kotan,I-PERSON,5359
100803,along,O,5359
100804,with,O,5359
100805,other,O,5359
100806,angel,O,5359
100807,investors,O,5359
100808,With,O,5360
100809,this,O,5360
100810,financing,O,5360
100811,TelomEYE,B-ORGANIZATION,5360
100812,will,O,5360
100813,be,O,5360
100814,able,O,5360
100815,to,O,5360
100816,complete,O,5360
100817,phase,O,5360
100818,I,O,5360
100819,II,O,5360
100820,human,O,5360
100821,studies,O,5360
100822,for,O,5360
100823,their,O,5360
100824,novel,O,5360
100825,patented,O,5360
100826,therapy,O,5360
100827,in,O,5360
100828,ophthalmology,O,5360
100829,This,O,5361
100830,therapy,O,5361
100831,could,O,5361
100832,be,O,5361
100833,the,O,5361
100834,start,O,5361
100835,of,O,5361
100836,a,O,5361
100837,new,O,5361
100838,era,O,5361
100839,for,O,5361
100840,treating,O,5361
100841,many,O,5361
100842,ophthalmologic,B-NAME_OF_DISEASE,5361
100843,age-related,I-NAME_OF_DISEASE,5361
100844,disorders,I-NAME_OF_DISEASE,5361
100845,including,O,5361
100846,presbyopia,B-NAME_OF_DISEASE,5361
100847,cataracts,B-NAME_OF_DISEASE,5361
100848,and,O,5361
100849,macular,B-NAME_OF_DISEASE,5361
100850,degeneration,I-NAME_OF_DISEASE,5361
100851,TelomEYE,B-ORGANIZATION,5362
100852,is,O,5362
100853,a,O,5362
100854,privately,O,5362
100855,held,O,5362
100856,Canadian,O,5362
100857,ophthalmology,O,5362
100858,biotech,O,5362
100859,company,O,5362
100860,founded,O,5362
100861,in,O,5362
100862,September,O,5362
100863,2021,O,5362
100864,by,O,5362
100865,ophthalmologists,O,5362
100866,Iskender,B-PERSON,5362
100867,Alkin,I-PERSON,5362
100868,Solmaz,I-PERSON,5362
100869,MD,I-PERSON,5362
100870,Isilay,B-PERSON,5362
100871,Kavadarli,I-PERSON,5362
100872,MD,I-PERSON,5362
100873,and,O,5362
100874,entrepreneur,O,5362
100875,Kubilay,B-PERSON,5362
100876,Turkmen,I-PERSON,5362
100877,in,O,5362
100878,Ontario,B-GPE,5362
100879,Canada,I-GPE,5362
100880,The,O,5363
100881,founders,O,5363
100882,had,O,5363
100883,initially,O,5363
100884,self-funded,O,5363
100885,TelomEYE,B-ORGANIZATION,5363
100886,for,O,5363
100887,their,O,5363
100888,novel,O,5363
100889,formulation,O,5363
100890,development,O,5363
100891,patent,O,5363
100892,applications,O,5363
100893,and,O,5363
100894,pre-human,O,5363
100895,animal,O,5363
100896,trials,O,5363
100897,What,O,5364
100898,if,O,5364
100899,we,O,5364
100900,could,O,5364
100901,read,O,5364
100902,without,O,5364
100903,glasses,O,5364
100904,in,O,5364
100905,our,O,5364
100906,40s,O,5364
100907,and,O,5364
100908,beyond,O,5364
100909,TelomEYE,B-ORGANIZATION,5364
100910,launched,O,5364
100911,to,O,5364
100912,prevent,O,5364
100913,and,O,5364
100914,improve,O,5364
100915,age-related,B-NAME_OF_DISEASE,5364
100916,ophthalmologic,I-NAME_OF_DISEASE,5364
100917,disorders,I-NAME_OF_DISEASE,5364
100918,such,O,5364
100919,as,O,5364
100920,presbyopia,B-NAME_OF_DISEASE,5364
100921,cataracts,B-NAME_OF_DISEASE,5364
100922,and,O,5364
100923,macular,B-NAME_OF_DISEASE,5364
100924,degeneration,I-NAME_OF_DISEASE,5364
100925,each,O,5364
100926,of,O,5364
100927,which,O,5364
100928,is,O,5364
100929,a,O,5364
100930,major,O,5364
100931,medical,O,5364
100932,need,O,5364
100933,Presbyopia,B-NAME_OF_DISEASE,5365
100934,a,O,5365
100935,condition,O,5365
100936,which,O,5365
100937,makes,O,5365
100938,it,O,5365
100939,harder,B-SIGN_AND_SYMPTOM,5365
100940,for,I-SIGN_AND_SYMPTOM,5365
100941,the,I-SIGN_AND_SYMPTOM,5365
100942,eyes,I-SIGN_AND_SYMPTOM,5365
100943,to,I-SIGN_AND_SYMPTOM,5365
100944,focus,I-SIGN_AND_SYMPTOM,5365
100945,on,I-SIGN_AND_SYMPTOM,5365
100946,close,I-SIGN_AND_SYMPTOM,5365
100947,objects,I-SIGN_AND_SYMPTOM,5365
100948,after,I-SIGN_AND_SYMPTOM,5365
100949,early,I-SIGN_AND_SYMPTOM,5365
100950,40s,I-SIGN_AND_SYMPTOM,5365
100951,is,O,5365
100952,one,O,5365
100953,of,O,5365
100954,the,O,5365
100955,most,O,5365
100956,common,O,5365
100957,age-related,B-NAME_OF_DISEASE,5365
100958,ophthalmologic,I-NAME_OF_DISEASE,5365
100959,disorders,I-NAME_OF_DISEASE,5365
100960,in,O,5365
100961,the,O,5365
100962,world,O,5365
100963,with,O,5365
100964,an,O,5365
100965,estimated,O,5365
100966,2,O,5365
100967,billion,O,5366
100968,sufferers,O,5366
100969,worldwide,O,5366
100970,by,O,5366
100971,2030,O,5366
100972,according,O,5366
100973,to,O,5366
100974,the,B-ORGANIZATION,5366
100975,World,I-ORGANIZATION,5366
100976,Health,I-ORGANIZATION,5366
100977,Organisation,I-ORGANIZATION,5366
100978,It,O,5367
100979,is,O,5367
100980,a,O,5367
100981,fact,O,5367
100982,that,O,5367
100983,everyone,O,5367
100984,over,O,5367
100985,the,O,5367
100986,age,O,5367
100987,of,O,5367
100988,40s,O,5367
100989,faces,O,5367
100990,the,O,5367
100991,need,O,5367
100992,for,O,5367
100993,reading,O,5367
100994,glasses,O,5367
100995,eventually,O,5367
100996,TelomEYE,B-ORGANIZATION,5368
100997,treatment,O,5368
100998,has,O,5368
100999,a,O,5368
101000,unique,O,5368
101001,formulation,O,5368
101002,that,O,5368
101003,prevents,O,5368
101004,the,B-NAME_OF_DISEASE,5368
101005,cellular,I-NAME_OF_DISEASE,5368
101006,aging,I-NAME_OF_DISEASE,5368
101007,of,O,5368
101008,the,O,5368
101009,compartments,O,5368
101010,of,O,5368
101011,the,O,5368
101012,eyes,O,5368
101013,and,O,5368
101014,may,O,5368
101015,even,O,5368
101016,rejuvenate,O,5368
101017,them,O,5368
101018,Starting,O,5369
101019,in,O,5369
101020,our,O,5369
101021,late,O,5369
101022,30s,O,5369
101023,daily,O,5369
101024,use,O,5369
101025,of,O,5369
101026,TelomEYE,B-ORGANIZATION,5369
101027,could,O,5369
101028,remove,O,5369
101029,or,O,5369
101030,delay,O,5369
101031,the,O,5369
101032,necessity,O,5369
101033,of,O,5369
101034,reading,O,5369
101035,glasses,O,5369
101036,at,O,5369
101037,later,O,5369
101038,stages,O,5369
101039,of,O,5369
101040,the,O,5369
101041,life,O,5369
101042,Patients,O,5370
101043,with,O,5370
101044,dry,B-NAME_OF_DISEASE,5370
101045,eye,I-NAME_OF_DISEASE,5370
101046,syndrome,I-NAME_OF_DISEASE,5370
101047,which,O,5370
101048,is,O,5370
101049,a,O,5370
101050,very,O,5370
101051,common,O,5370
101052,health,O,5370
101053,problem,O,5370
101054,may,O,5370
101055,have,O,5370
101056,beneficial,O,5370
101057,effects,O,5370
101058,as,O,5370
101059,well,O,5370
101060,Iskender,O,5371
101061,Alkin,O,5371
101062,Solmaz,O,5371
101063,M.D,O,5371
101064,Co-Founder,O,5372
101065,and,O,5372
101066,Chief,O,5372
101067,Medical,O,5372
101068,Officer,O,5372
101069,of,O,5372
101070,TelomEYE,B-ORGANIZATION,5372
101071,said,O,5372
101072,Advances,O,5372
101073,in,O,5372
101074,research,O,5372
101075,are,O,5372
101076,revealing,O,5372
101077,new,O,5372
101078,opportunities,O,5372
101079,to,O,5372
101080,translate,O,5372
101081,science,O,5372
101082,into,O,5372
101083,solutions,O,5372
101084,that,O,5372
101085,can,O,5372
101086,help,O,5372
101087,people,O,5372
101088,in,O,5372
101089,preventing,O,5372
101090,age-related,B-NAME_OF_DISEASE,5372
101091,ophthalmologic,I-NAME_OF_DISEASE,5372
101092,disorders,I-NAME_OF_DISEASE,5372
101093,Neither,O,5373
101094,our,O,5373
101095,scientific,O,5373
101096,platform,O,5373
101097,nor,O,5373
101098,our,O,5373
101099,patented,O,5373
101100,technology,O,5373
101101,has,O,5373
101102,ever,O,5373
101103,been,O,5373
101104,utilized,O,5373
101105,in,O,5373
101106,ophthalmology,O,5373
101107,before,O,5373
101108,We,O,5374
101109,are,O,5374
101110,fully,O,5374
101111,committed,O,5374
101112,to,O,5374
101113,delivering,O,5374
101114,this,O,5374
101115,therapy,O,5374
101116,potentially,O,5374
101117,reducing,O,5374
101118,the,O,5374
101119,magnitude,O,5374
101120,of,O,5374
101121,most,O,5374
101122,of,O,5374
101123,the,B-NAME_OF_DISEASE,5374
101124,age-related,I-NAME_OF_DISEASE,5374
101125,ophthalmologic,I-NAME_OF_DISEASE,5374
101126,disorders,I-NAME_OF_DISEASE,5374
101127,to,O,5374
101128,make,O,5374
101129,a,O,5374
101130,significant,O,5374
101131,long-term,O,5374
101132,and,O,5374
101133,sustainable,O,5374
101134,impact,O,5374
101135,on,O,5374
101136,lives,O,5374
101137,Bausch,B-ORGANIZATION,5375
101138,+,I-ORGANIZATION,5375
101139,Lomb,I-ORGANIZATION,5375
101140,and,O,5375
101141,Alfa,B-ORGANIZATION,5375
101142,Instruments,I-ORGANIZATION,5375
101143,announced,O,5375
101144,that,O,5375
101145,they,O,5375
101146,have,O,5375
101147,signed,O,5375
101148,an,O,5375
101149,exclusive,O,5375
101150,distribution,O,5375
101151,agreement,O,5375
101152,under,O,5375
101153,which,O,5375
101154,Bausch,B-ORGANIZATION,5375
101155,+,I-ORGANIZATION,5375
101156,Lomb,I-ORGANIZATION,5375
101157,will,O,5375
101158,market,O,5375
101159,and,O,5375
101160,distribute,O,5375
101161,Vitreocare,B-SURGICAL_INSTRUMENT,5375
101162,a,O,5375
101163,line,O,5375
101164,of,O,5375
101165,surgical,B-SURGICAL_INSTRUMENT,5375
101166,intraocular,B-SURGICAL_INSTRUMENT,5375
101167,dyes,I-SURGICAL_INSTRUMENT,5375
101168,from,O,5375
101169,Alfa,B-ORGANIZATION,5375
101170,Instruments,I-ORGANIZATION,5375
101171,worldwide,O,5375
101172,with,O,5375
101173,the,O,5375
101174,exception,O,5375
101175,of,O,5375
101176,Italy,B-GPE,5375
101177,where,O,5375
101178,Alfa,B-ORGANIZATION,5375
101179,Instruments,I-ORGANIZATION,5375
101180,is,O,5375
101181,headquartered,O,5375
101182,With,O,5376
101183,Alfa,B-ORGANIZATION,5376
101184,Instruments,I-ORGANIZATION,5376
101185,intraocular,B-SURGICAL_INSTRUMENT,5376
101186,dyes,I-SURGICAL_INSTRUMENT,5376
101187,the,O,5376
101188,agreement,O,5376
101189,expands,O,5376
101190,and,O,5376
101191,improves,O,5376
101192,Bausch,B-ORGANIZATION,5376
101193,+,I-ORGANIZATION,5376
101194,Lomb,I-ORGANIZATION,5376
101195,s,O,5376
101196,surgical,O,5376
101197,portfolio,O,5376
101198,offering,O,5376
101199,in,O,5376
101200,the,B-ORGANIZATION,5376
101201,European,I-ORGANIZATION,5376
101202,Union,I-ORGANIZATION,5376
101203,EU,B-ORGANIZATION,5376
101204,,O,5376
101205,Financial,O,5377
101206,terms,O,5377
101207,of,O,5377
101208,the,O,5377
101209,deal,O,5377
101210,were,O,5377
101211,not,O,5377
101212,disclosed,O,5377
101213,The,O,5378
101214,addition,O,5378
101215,of,O,5378
101216,these,O,5378
101217,clinically,O,5378
101218,proven,O,5378
101219,intraocular,B-SURGICAL_INSTRUMENT,5378
101220,dyes,I-SURGICAL_INSTRUMENT,5378
101221,to,O,5378
101222,our,O,5378
101223,already,O,5378
101224,comprehensive,O,5378
101225,surgical,O,5378
101226,portfolio,O,5378
101227,will,O,5378
101228,help,O,5378
101229,surgeons,O,5378
101230,enhance,O,5378
101231,the,O,5378
101232,visibility,O,5378
101233,of,O,5378
101234,targeted,O,5378
101235,eye,B-PART_OF_THE_EYES,5378
101236,tissues,I-PART_OF_THE_EYES,5378
101237,as,O,5378
101238,well,O,5378
101239,as,O,5378
101240,identify,O,5378
101241,transparent,B-PART_OF_THE_EYES,5378
101242,layers,I-PART_OF_THE_EYES,5378
101243,of,I-PART_OF_THE_EYES,5378
101244,the,I-PART_OF_THE_EYES,5378
101245,eye,I-PART_OF_THE_EYES,5378
101246,during,O,5378
101247,vitreoretinal,B-TREATMENT,5378
101248,corneal,I-TREATMENT,5378
101249,and,I-TREATMENT,5378
101250,cataract,I-TREATMENT,5378
101251,surgery,I-TREATMENT,5378
101252,Joe,B-PERSON,5378
101253,Gordon,I-PERSON,5378
101254,president,O,5378
101255,global,O,5378
101256,consumer,O,5378
101257,vision,O,5378
101258,care,O,5378
101259,and,O,5378
101260,surgical,O,5378
101261,Bausch,B-ORGANIZATION,5378
101262,+,I-ORGANIZATION,5378
101263,Lomb,I-ORGANIZATION,5378
101264,said,O,5378
101265,in,O,5378
101266,a,O,5378
101267,company,O,5378
101268,news,O,5378
101269,release,O,5378
101270,According,O,5379
101271,to,O,5379
101272,the,O,5379
101273,deal,O,5379
101274,Bausch,B-ORGANIZATION,5379
101275,+,I-ORGANIZATION,5379
101276,Lomb,I-ORGANIZATION,5379
101277,will,O,5379
101278,be,O,5379
101279,in,O,5379
101280,charge,O,5379
101281,of,O,5379
101282,all,O,5379
101283,sales,O,5379
101284,and,O,5379
101285,distribution,O,5379
101286,efforts,O,5379
101287,for,O,5379
101288,Vitreocare,B-SURGICAL_INSTRUMENT,5379
101289,intraocular,I-SURGICAL_INSTRUMENT,5379
101290,dyes,I-SURGICAL_INSTRUMENT,5379
101291,including,O,5379
101292,Vitreo,B-SURGICAL_INSTRUMENT,5379
101293,Lutein,I-SURGICAL_INSTRUMENT,5379
101294,for,O,5379
101295,vitreous,B-PART_OF_THE_EYES,5379
101296,staining,O,5379
101297,Single,B-SURGICAL_INSTRUMENT,5379
101298,Lutein,I-SURGICAL_INSTRUMENT,5379
101299,Blue,I-SURGICAL_INSTRUMENT,5379
101300,for,O,5379
101301,internal,B-PART_OF_THE_EYES,5379
101302,limiting,I-PART_OF_THE_EYES,5379
101303,membrane,I-PART_OF_THE_EYES,5379
101304,ILM,B-PART_OF_THE_EYES,5379
101305,staining,O,5379
101306,Double,B-SURGICAL_INSTRUMENT,5379
101307,Lutein,I-SURGICAL_INSTRUMENT,5379
101308,Blue,I-SURGICAL_INSTRUMENT,5379
101309,for,O,5379
101310,ILM,B-PART_OF_THE_EYES,5379
101311,and,O,5379
101312,epiretinal,B-PART_OF_THE_EYES,5379
101313,membrane,I-PART_OF_THE_EYES,5379
101314,ERM,I-PART_OF_THE_EYES,5379
101315,staining,O,5379
101316,Phaco,B-SURGICAL_INSTRUMENT,5379
101317,Lutein,I-SURGICAL_INSTRUMENT,5379
101318,for,O,5379
101319,anterior,B-PART_OF_THE_EYES,5379
101320,capsule,I-PART_OF_THE_EYES,5379
101321,staining,O,5379
101322,Trypan,B-SURGICAL_INSTRUMENT,5379
101323,Blue,I-SURGICAL_INSTRUMENT,5379
101324,for,O,5379
101325,anterior,B-PART_OF_THE_EYES,5379
101326,capsule,I-PART_OF_THE_EYES,5379
101327,staining,O,5379
101328,The,O,5379
101329,unique,O,5379
101330,common,O,5379
101331,thread,O,5379
101332,of,O,5379
101333,Vitreocare,B-SURGICAL_INSTRUMENT,5379
101334,intraocular,I-SURGICAL_INSTRUMENT,5379
101335,dyes,I-SURGICAL_INSTRUMENT,5379
101336,is,O,5379
101337,lutein,B-CHEMICAL_COMPOUND,5379
101338,a,O,5379
101339,natural,O,5379
101340,blue,O,5379
101341,light,O,5379
101342,filter,O,5379
101343,Research,O,5380
101344,has,O,5380
101345,shown,O,5380
101346,that,O,5380
101347,lutein,B-CHEMICAL_COMPOUND,5380
101348,is,O,5380
101349,a,O,5380
101350,safe,O,5380
101351,and,O,5380
101352,effective,O,5380
101353,dye,O,5380
101354,agent,O,5380
101355,and,O,5380
101356,its,O,5380
101357,antioxidant,O,5380
101358,properties,O,5380
101359,can,O,5380
101360,further,O,5380
101361,protect,O,5380
101362,the,B-PART_OF_THE_EYES,5380
101363,retina,I-PART_OF_THE_EYES,5380
101364,during,O,5380
101365,eye,O,5380
101366,surgery.1-,O,5380
101367,Moreover,O,5381
101368,Single,B-SURGICAL_INSTRUMENT,5381
101369,Lutein,I-SURGICAL_INSTRUMENT,5381
101370,Blue,I-SURGICAL_INSTRUMENT,5381
101371,and,O,5381
101372,Double,B-SURGICAL_INSTRUMENT,5381
101373,Lutein,I-SURGICAL_INSTRUMENT,5381
101374,Blue,I-SURGICAL_INSTRUMENT,5381
101375,are,O,5381
101376,formulated,O,5381
101377,with,O,5381
101378,the,O,5381
101379,new,O,5381
101380,high,O,5381
101381,purity,O,5381
101382,99%,O,5381
101383,molecule,B-CHEMICAL_COMPOUND,5381
101384,Pure,I-CHEMICAL_COMPOUND,5381
101385,Benzyl-Brilliant,I-CHEMICAL_COMPOUND,5381
101386,Blue,I-CHEMICAL_COMPOUND,5381
101387,PBB,I-CHEMICAL_COMPOUND,5381
101388,,O,5381
101389,PBB,B-CHEMICAL_COMPOUND,5382
101390,has,O,5382
101391,been,O,5382
101392,specifically,O,5382
101393,designed,O,5382
101394,in,O,5382
101395,order,O,5382
101396,to,O,5382
101397,improve,O,5382
101398,ILM,B-PART_OF_THE_EYES,5382
101399,binding,O,5382
101400,affinity,O,5382
101401,and,O,5382
101402,to,O,5382
101403,avoid,O,5382
101404,diffusion,O,5382
101405,into,O,5382
101406,retinal,B-PART_OF_THE_EYES,5382
101407,layers,I-PART_OF_THE_EYES,5382
101408,in,O,5382
101409,order,O,5382
101410,to,O,5382
101411,avoid,O,5382
101412,potential,O,5382
101413,cytotoxicity,O,5382
101414,on,O,5382
101415,off-target,O,5382
101416,tissues.,O,5382
101417,Currently,O,5383
101418,surgical,B-SURGICAL_INSTRUMENT,5383
101419,dyes,I-SURGICAL_INSTRUMENT,5383
101420,from,O,5383
101421,Alfa,B-ORGANIZATION,5383
101422,Instruments,I-ORGANIZATION,5383
101423,are,O,5383
101424,CE-marked,O,5383
101425,and,O,5383
101426,offered,O,5383
101427,for,O,5383
101428,sale,O,5383
101429,in,O,5383
101430,Switzerland,B-GPE,5383
101431,the,B-ORGANIZATION,5383
101432,EU,B-ORGANIZATION,5383
101433,and,O,5383
101434,the,B-GPE,5383
101435,UK,I-GPE,5383
101436,With,O,5384
101437,the,O,5384
101438,exception,O,5384
101439,of,O,5384
101440,Italy,B-GPE,5384
101441,Bausch,B-ORGANIZATION,5384
101442,+,I-ORGANIZATION,5384
101443,Lomb,I-ORGANIZATION,5384
101444,anticipates,O,5384
101445,starting,O,5384
101446,the,O,5384
101447,distribution,O,5384
101448,of,O,5384
101449,the,B-SURGICAL_INSTRUMENT,5384
101450,intraocular,I-SURGICAL_INSTRUMENT,5384
101451,dyes,I-SURGICAL_INSTRUMENT,5384
101452,in,O,5384
101453,all,O,5384
101454,EU,B-ORGANIZATION,5384
101455,nations,O,5384
101456,in,O,5384
101457,the,O,5384
101458,first,O,5384
101459,half,O,5384
101460,of,O,5384
101461,2023,O,5384
101462,Additionally,O,5385
101463,Bausch,B-ORGANIZATION,5385
101464,+,I-ORGANIZATION,5385
101465,Lomb,I-ORGANIZATION,5385
101466,and,O,5385
101467,Alfa,B-ORGANIZATION,5385
101468,Instruments,I-ORGANIZATION,5385
101469,are,O,5385
101470,investigating,O,5385
101471,the,O,5385
101472,legal,O,5385
101473,requirements,O,5385
101474,and,O,5385
101475,commercial,O,5385
101476,acceptance,O,5385
101477,of,O,5385
101478,surgical,B-SURGICAL_INSTRUMENT,5385
101479,dyes,I-SURGICAL_INSTRUMENT,5385
101480,in,O,5385
101481,other,O,5385
101482,countries,O,5385
101483,Robin,B-PERSON,5386
101484,Kuriakose,I-PERSON,5386
101485,MD,I-PERSON,5386
101486,a,O,5386
101487,fellow,O,5386
101488,physician,O,5386
101489,in,O,5386
101490,cornea,B-PART_OF_THE_EYES,5386
101491,and,O,5386
101492,refractive,O,5386
101493,surgery,O,5386
101494,at,O,5386
101495,the,O,5386
101496,Northwestern,B-ORGANIZATION,5386
101497,Memorial,I-ORGANIZATION,5386
101498,Hospital,I-ORGANIZATION,5386
101499,has,O,5386
101500,introduced,O,5386
101501,SightKick,B-TREATMENT,5386
101502,The,O,5387
101503,new,O,5387
101504,MacOS,O,5387
101505,application,O,5387
101506,is,O,5387
101507,specifically,O,5387
101508,designed,O,5387
101509,to,O,5387
101510,reduce,O,5387
101511,digital,B-NAME_OF_DISEASE,5387
101512,eye,I-NAME_OF_DISEASE,5387
101513,strain,I-NAME_OF_DISEASE,5387
101514,Digital,B-NAME_OF_DISEASE,5388
101515,eye,I-NAME_OF_DISEASE,5388
101516,strain,I-NAME_OF_DISEASE,5388
101517,is,O,5388
101518,a,O,5388
101519,growing,O,5388
101520,issue,O,5388
101521,considering,O,5388
101522,how,O,5388
101523,much,O,5388
101524,time,O,5388
101525,we,O,5388
101526,spend,O,5388
101527,in,O,5388
101528,front,O,5388
101529,of,O,5388
101530,screens,B-CAUSE_OF_DISEASE,5388
101531,tablets,I-CAUSE_OF_DISEASE,5388
101532,computers,I-CAUSE_OF_DISEASE,5388
101533,cellphones,I-CAUSE_OF_DISEASE,5388
101534,,O,5388
101535,An,O,5389
101536,average,O,5389
101537,person,O,5389
101538,blinks,O,5389
101539,15,O,5389
101540,to,O,5389
101541,20,O,5389
101542,times,O,5389
101543,each,O,5389
101544,minute,O,5389
101545,but,O,5389
101546,studies,O,5389
101547,show,O,5389
101548,that,O,5389
101549,using,B-CAUSE_OF_DISEASE,5389
101550,a,I-CAUSE_OF_DISEASE,5389
101551,screen,I-CAUSE_OF_DISEASE,5389
101552,reduces,O,5389
101553,this,O,5389
101554,by,O,5389
101555,more,O,5389
101556,than,O,5389
101557,half,O,5389
101558,When,O,5390
101559,your,O,5390
101560,blink,O,5390
101561,rate,O,5390
101562,slows,O,5390
101563,down,O,5390
101564,SightKick,B-TREATMENT,5390
101565,employs,O,5390
101566,artificial,O,5390
101567,intelligence,O,5390
101568,to,O,5390
101569,gently,O,5390
101570,prompt,O,5390
101571,you,O,5390
101572,to,O,5390
101573,look,B-TREATMENT,5390
101574,away,I-TREATMENT,5390
101575,from,I-TREATMENT,5390
101576,your,I-TREATMENT,5390
101577,screen,I-TREATMENT,5390
101578,for,I-TREATMENT,5390
101579,20,I-TREATMENT,5390
101580,feet,I-TREATMENT,5390
101581,while,I-TREATMENT,5390
101582,blinking,I-TREATMENT,5390
101583,for,I-TREATMENT,5390
101584,20,I-TREATMENT,5390
101585,seconds,I-TREATMENT,5390
101586,Additionally,O,5391
101587,it,O,5391
101588,reminds,O,5391
101589,you,O,5391
101590,to,O,5391
101591,blink,B-TREATMENT,5391
101592,every,I-TREATMENT,5391
101593,20,I-TREATMENT,5391
101594,minutes,I-TREATMENT,5391
101595,in,O,5391
101596,an,O,5391
101597,effort,O,5391
101598,to,O,5391
101599,maintain,O,5391
101600,a,O,5391
101601,healthy,O,5391
101602,tear,B-PART_OF_THE_EYES,5391
101603,film,I-PART_OF_THE_EYES,5391
101604,on,O,5391
101605,your,O,5391
101606,eyes,O,5391
101607,The,O,5392
101608,app,O,5392
101609,works,O,5392
101610,silently,O,5392
101611,in,O,5392
101612,the,O,5392
101613,background,O,5392
101614,and,O,5392
101615,offers,O,5392
101616,personalization,O,5392
101617,options,O,5392
101618,so,O,5392
101619,you,O,5392
101620,can,O,5392
101621,make,O,5392
101622,it,O,5392
101623,your,O,5392
101624,own,O,5392
101625,change,O,5392
101626,the,O,5392
101627,frequency,O,5392
101628,of,O,5392
101629,reminders,O,5392
101630,the,O,5392
101631,location,O,5392
101632,etc,O,5392
101633,,O,5392
101634,Users,O,5393
101635,may,O,5393
101636,check,O,5393
101637,how,O,5393
101638,frequently,O,5393
101639,your,O,5393
101640,blink,O,5393
101641,rate,O,5393
101642,has,O,5393
101643,been,O,5393
101644,in,O,5393
101645,the,O,5393
101646,unhealthy,O,5393
101647,or,O,5393
101648,healthy,O,5393
101649,range,O,5393
101650,thanks,O,5393
101651,to,O,5393
101652,statistics,O,5393
101653,built,O,5393
101654,into,O,5393
101655,the,O,5393
101656,device,O,5393
101657,SightKick,B-TREATMENT,5394
101658,encourages,O,5394
101659,users,O,5394
101660,to,O,5394
101661,blink,B-TREATMENT,5394
101662,at,I-TREATMENT,5394
101663,predetermined,I-TREATMENT,5394
101664,intervals,I-TREATMENT,5394
101665,especially,I-TREATMENT,5394
101666,when,I-TREATMENT,5394
101667,their,I-TREATMENT,5394
101668,blink,I-TREATMENT,5394
101669,rate,I-TREATMENT,5394
101670,is,I-TREATMENT,5394
101671,low,I-TREATMENT,5394
101672,which,O,5394
101673,helps,O,5394
101674,to,O,5394
101675,lessen,O,5394
101676,the,O,5394
101677,strain,O,5394
101678,on,O,5394
101679,their,O,5394
101680,digital,O,5394
101681,eyes,O,5394
101682,The,O,5395
101683,application,O,5395
101684,is,O,5395
101685,free,O,5395
101686,to,O,5395
101687,use,O,5395
101688,and,O,5395
101689,can,O,5395
101690,be,O,5395
101691,downloaded,O,5395
101692,from,O,5395
101693,the,O,5395
101694,Apple,B-ORGANIZATION,5395
101695,Mac,O,5395
101696,Store,O,5395
101697,LumiThera,B-ORGANIZATION,5396
101698,Inc,I-ORGANIZATION,5396
101699,a,O,5397
101700,commercial,O,5397
101701,stage,O,5397
101702,medical,O,5397
101703,device,O,5397
101704,business,O,5397
101705,that,O,5397
101706,provides,O,5397
101707,photobiomodulation,B-TREATMENT,5397
101708,PBM,I-TREATMENT,5397
101709,treatment,I-TREATMENT,5397
101710,for,O,5397
101711,ocular,O,5397
101712,disease,O,5397
101713,and,O,5397
101714,damage,O,5397
101715,announced,O,5397
101716,that,O,5397
101717,its,O,5397
101718,wholly-owned,O,5397
101719,subsidiary,O,5397
101720,acquired,O,5397
101721,the,O,5397
101722,assets,O,5397
101723,of,O,5397
101724,MacuLogix,B-ORGANIZATION,5397
101725,MacuLogix,B-ORGANIZATION,5398
101726,Inc,O,5398
101727,is,O,5399
101728,the,O,5399
101729,leader,O,5399
101730,in,O,5399
101731,early,O,5399
101732,diagnosis,O,5399
101733,of,O,5399
101734,dry,B-NAME_OF_DISEASE,5399
101735,Age-related,I-NAME_OF_DISEASE,5399
101736,Macular,I-NAME_OF_DISEASE,5399
101737,Degeneration,I-NAME_OF_DISEASE,5399
101738,AMD,I-NAME_OF_DISEASE,5399
101739,patients,O,5399
101740,and,O,5399
101741,developer,O,5399
101742,of,O,5399
101743,the,B-DIAGNOSTIC_TEST,5399
101744,wearable,I-DIAGNOSTIC_TEST,5399
101745,AdaptDX,B-DIAGNOSTIC_TEST,5399
101746,Pro®,I-DIAGNOSTIC_TEST,5399
101747,dark,I-DIAGNOSTIC_TEST,5399
101748,adaptometer,I-DIAGNOSTIC_TEST,5399
101749,With,O,5400
101750,the,O,5400
101751,use,O,5400
101752,of,O,5400
101753,the,O,5400
101754,equipment,O,5400
101755,eye,O,5400
101756,care,O,5400
101757,specialists,O,5400
101758,can,O,5400
101759,measure,O,5400
101760,dark,O,5400
101761,adaptation,O,5400
101762,which,O,5400
101763,is,O,5400
101764,utilized,O,5400
101765,to,O,5400
101766,diagnose,O,5400
101767,dry,B-NAME_OF_DISEASE,5400
101768,AMD,I-NAME_OF_DISEASE,5400
101769,in,O,5400
101770,patients,O,5400
101771,earlier,O,5400
101772,than,O,5400
101773,with,O,5400
101774,any,O,5400
101775,other,O,5400
101776,technology,O,5400
101777,The,B-DIAGNOSTIC_TEST,5401
101778,AdaptDx,I-DIAGNOSTIC_TEST,5401
101779,Pro,I-DIAGNOSTIC_TEST,5401
101780,was,O,5401
101781,introduced,O,5401
101782,in,O,5401
101783,2020,O,5401
101784,and,O,5401
101785,is,O,5401
101786,offered,O,5401
101787,for,O,5401
101788,sale,O,5401
101789,in,O,5401
101790,the,B-GPE,5401
101791,US,B-GPE,5401
101792,Canada,B-GPE,5401
101793,EU,B-ORGANIZATION,5401
101794,and,O,5401
101795,other,O,5401
101796,nations,O,5401
101797,The,O,5402
101798,core,O,5402
101799,technology,O,5402
101800,measures,O,5402
101801,the,O,5402
101802,inability,O,5402
101803,to,O,5402
101804,visually,O,5402
101805,adapt,O,5402
101806,to,O,5402
101807,low,O,5402
101808,levels,O,5402
101809,of,O,5402
101810,light,O,5402
101811,a,O,5402
101812,key,O,5402
101813,clinical,O,5402
101814,marker,O,5402
101815,seen,O,5402
101816,in,O,5402
101817,patients,O,5402
101818,with,O,5402
101819,early,B-NAME_OF_DISEASE,5402
101820,AMD,I-NAME_OF_DISEASE,5402
101821,Dark,O,5403
101822,adaptation,O,5403
101823,technology,O,5403
101824,has,O,5403
101825,been,O,5403
101826,validated,O,5403
101827,in,O,5403
101828,42,O,5403
101829,peer-reviewed,O,5403
101830,papers,O,5403
101831,stated,O,5403
101832,Greg,O,5403
101833,Jackson,O,5403
101834,Ph.D,O,5403
101835,former,O,5404
101836,MacuLogix,B-ORGANIZATION,5404
101837,Chief,O,5404
101838,Technology,O,5404
101839,Officer,O,5404
101840,and,O,5404
101841,Co-Founder,O,5404
101842,Over,O,5405
101843,1,O,5405
101844,million,O,5405
101845,AdaptDX,B-DIAGNOSTIC_TEST,5405
101846,tests,O,5405
101847,have,O,5405
101848,been,O,5405
101849,performed,O,5405
101850,and,O,5405
101851,about,O,5405
101852,200,O,5405
101853,0,O,5405
101854,patients,O,5405
101855,have,O,5405
101856,been,O,5405
101857,newly,O,5405
101858,diagnosed,O,5405
101859,The,O,5406
101860,purchase,O,5406
101861,was,O,5406
101862,made,O,5406
101863,around,O,5406
101864,four,O,5406
101865,months,O,5406
101866,after,O,5406
101867,LumiThera,B-ORGANIZATION,5406
101868,revealed,O,5406
101869,it,O,5406
101870,had,O,5406
101871,acquired,O,5406
101872,the,O,5406
101873,vision,O,5406
101874,testing,O,5406
101875,technology,O,5406
101876,from,O,5406
101877,Diopsys,B-ORGANIZATION,5406
101878,visual,B-DIAGNOSTIC_TEST,5406
101879,evoked,I-DIAGNOSTIC_TEST,5406
101880,potential,I-DIAGNOSTIC_TEST,5406
101881,VEP,I-DIAGNOSTIC_TEST,5406
101882,and,O,5406
101883,electroretinogram,B-DIAGNOSTIC_TEST,5406
101884,ERG,I-DIAGNOSTIC_TEST,5406
101885,,O,5406
101886,The,O,5407
101887,Diopsys,B-ORGANIZATION,5407
101888,product,O,5407
101889,line,O,5407
101890,is,O,5407
101891,a,O,5407
101892,diagnostic,O,5407
101893,and,O,5407
101894,monitoring,O,5407
101895,device,O,5407
101896,that,O,5407
101897,analyzes,O,5407
101898,the,O,5407
101899,electrical,O,5407
101900,activity,O,5407
101901,of,O,5407
101902,the,B-PART_OF_THE_EYES,5407
101903,retina,I-PART_OF_THE_EYES,5407
101904,in,O,5407
101905,response,O,5407
101906,to,O,5407
101907,a,O,5407
101908,light,O,5407
101909,stimulus,O,5407
101910,offering,O,5407
101911,a,O,5407
101912,quantitative,O,5407
101913,vision,O,5407
101914,measure,O,5407
101915,to,O,5407
101916,help,O,5407
101917,with,O,5407
101918,eye,O,5407
101919,illness,O,5407
101920,diagnosis,O,5407
101921,and,O,5407
101922,monitoring,O,5407
101923,AdaptDx,B-DIAGNOSTIC_TEST,5408
101924,Pro,I-DIAGNOSTIC_TEST,5408
101925,can,O,5408
101926,identify,O,5408
101927,dry,B-NAME_OF_DISEASE,5408
101928,AMD,I-NAME_OF_DISEASE,5408
101929,patients,O,5408
101930,at,O,5408
101931,the,O,5408
101932,earliest,O,5408
101933,timepoint,O,5408
101934,in,O,5408
101935,advance,O,5408
101936,of,O,5408
101937,pathology,O,5408
101938,and,O,5408
101939,before,O,5408
101940,vision,B-SIGN_AND_SYMPTOM,5408
101941,loss,I-SIGN_AND_SYMPTOM,5408
101942,stated,O,5408
101943,Clark,O,5408
101944,E,O,5408
101945,Tedford,O,5409
101946,Ph.D,O,5409
101947,President,O,5410
101948,and,O,5410
101949,CEO,O,5410
101950,LumiThera,B-ORGANIZATION,5410
101951,Inc,I-ORGANIZATION,5410
101952,The,B-DIAGNOSTIC_TEST,5411
101953,AdaptDx,I-DIAGNOSTIC_TEST,5411
101954,wearable,O,5411
101955,light-based,O,5411
101956,early,O,5411
101957,diagnostic,O,5411
101958,for,O,5411
101959,dry,B-NAME_OF_DISEASE,5411
101960,AMD,I-NAME_OF_DISEASE,5411
101961,adds,O,5411
101962,a,O,5411
101963,complementary,O,5411
101964,assessment,O,5411
101965,of,O,5411
101966,retinal,O,5411
101967,health,O,5411
101968,to,O,5411
101969,the,O,5411
101970,LumiThera,B-ORGANIZATION,5411
101971,product,O,5411
101972,line,O,5411
101973,further,O,5411
101974,expanding,O,5411
101975,LumiThera,B-ORGANIZATION,5411
101976,s,O,5411
101977,synergistic,O,5411
101978,platform,O,5411
101979,of,O,5411
101980,products,O,5411
101981,for,O,5411
101982,eye,O,5411
101983,care,O,5411
101984,professionals,O,5411
101985,We,O,5412
101986,are,O,5412
101987,excited,O,5412
101988,to,O,5412
101989,combine,O,5412
101990,diagnosis,O,5412
101991,treatment,O,5412
101992,and,O,5412
101993,monitoring,O,5412
101994,platforms,O,5412
101995,to,O,5412
101996,provide,O,5412
101997,a,O,5412
101998,complete,O,5412
101999,solution,O,5412
102000,for,O,5412
102001,dry,B-NAME_OF_DISEASE,5412
102002,AMD,I-NAME_OF_DISEASE,5412
102003,patients,O,5412
102004,The,O,5413
102005,news,O,5413
102006,from,O,5413
102007,LumiThera,B-ORGANIZATION,5413
102008,comes,O,5413
102009,after,O,5413
102010,the,O,5413
102011,company,O,5413
102012,s,O,5413
102013,13-month,B-TIME_DURATION,5413
102014,positive,O,5413
102015,U.S,O,5413
102016,LIGHTSITE,O,5414
102017,III,O,5414
102018,treatment,O,5414
102019,data,O,5414
102020,in,O,5414
102021,patients,O,5414
102022,with,O,5414
102023,intermediate,B-NAME_OF_DISEASE,5414
102024,dry,I-NAME_OF_DISEASE,5414
102025,Age-related,I-NAME_OF_DISEASE,5414
102026,Macular,I-NAME_OF_DISEASE,5414
102027,Degeneration,I-NAME_OF_DISEASE,5414
102028,AMD,I-NAME_OF_DISEASE,5414
102029,treated,O,5414
102030,with,O,5414
102031,the,O,5414
102032,Valeda®,B-TREATMENT,5414
102033,Light,I-TREATMENT,5414
102034,Delivery,I-TREATMENT,5414
102035,System,I-TREATMENT,5414
102036,were,O,5414
102037,announced,O,5414
102038,100,O,5415
102039,volunteers,O,5415
102040,were,O,5415
102041,enrolled,O,5415
102042,in,O,5415
102043,the,O,5415
102044,LIGHTSITE,O,5415
102045,III,O,5415
102046,experiment,O,5415
102047,and,O,5415
102048,they,O,5415
102049,are,O,5415
102050,receiving,O,5415
102051,Valeda,B-TREATMENT,5415
102052,treatments,O,5415
102053,every,B-TIME_DURATION,5415
102054,4,I-TIME_DURATION,5415
102055,months,I-TIME_DURATION,5415
102056,A,O,5416
102057,13-month,B-TIME_DURATION,5416
102058,efficacy,O,5416
102059,timepoint,O,5416
102060,for,O,5416
102061,all,O,5416
102062,patients,O,5416
102063,met,O,5416
102064,the,O,5416
102065,predesignated,O,5416
102066,primary,O,5416
102067,best,O,5416
102068,corrected,O,5416
102069,visual,O,5416
102070,acuity,O,5416
102071,endpoint,O,5416
102072,with,O,5416
102073,a,O,5416
102074,statistically,O,5416
102075,significant,O,5416
102076,improvement,O,5416
102077,over,O,5416
102078,the,O,5416
102079,sham,O,5416
102080,group,O,5416
102081,p,O,5416
102082,=,O,5416
102083,0,O,5416
102084,,O,5417
102085,The,O,5418
102086,study,O,5418
102087,showed,O,5418
102088,improvements,O,5418
102089,in,O,5418
102090,best,O,5418
102091,corrected,O,5418
102092,visual,O,5418
102093,acuity,O,5418
102094,in,O,5418
102095,intermediate,B-NAME_OF_DISEASE,5418
102096,dry,I-NAME_OF_DISEASE,5418
102097,AMD,I-NAME_OF_DISEASE,5418
102098,subjects,O,5418
102099,with,O,5418
102100,over,O,5418
102101,50%,O,5418
102102,showing,O,5418
102103,a,O,5418
102104,line,O,5418
102105,or,O,5418
102106,better,O,5418
102107,improvement,O,5418
102108,on,O,5418
102109,the,O,5418
102110,eyechart,O,5418
102111,with,O,5418
102112,a,O,5418
102113,mean,O,5418
102114,of,O,5418
102115,9,O,5418
102116,letters,O,5419
102117,gained,O,5419
102118,for,O,5419
102119,the,O,5419
102120,responders,O,5419
102121,Previous,O,5420
102122,clinical,O,5420
102123,trials,O,5420
102124,as,O,5420
102125,well,O,5420
102126,as,O,5420
102127,the,O,5420
102128,crucial,O,5420
102129,US,B-GPE,5420
102130,research,O,5420
102131,will,O,5420
102132,support,O,5420
102133,the,O,5420
102134,FDA,B-ORGANIZATION,5420
102135,proposal,O,5420
102136,for,O,5420
102137,potential,O,5420
102138,US,B-GPE,5420
102139,clearance,O,5420
102140,Several,O,5421
102141,nations,O,5421
102142,in,O,5421
102143,Latin,B-GPE,5421
102144,America,I-GPE,5421
102145,and,O,5421
102146,Europe,B-GPE,5421
102147,have,O,5421
102148,currently,O,5421
102149,approved,O,5421
102150,the,O,5421
102151,use,O,5421
102152,of,O,5421
102153,Valeda,B-TREATMENT,5421
102154,Lumenis,B-ORGANIZATION,5422
102155,announced,O,5422
102156,that,O,5422
102157,the,O,5422
102158,OptiLight,B-TREATMENT,5422
102159,has,O,5422
102160,received,O,5422
102161,the,O,5422
102162,MedTech,B-ORGANIZATION,5422
102163,Breakthrough,I-ORGANIZATION,5422
102164,Award,O,5422
102165,for,O,5422
102166,Best,O,5422
102167,New,O,5422
102168,Technology,O,5422
102169,Solution,O,5422
102170,for,O,5422
102171,Ophthalmology,O,5422
102172,This,O,5423
102173,year,O,5423
102174,MedTech,B-ORGANIZATION,5423
102175,s,O,5423
102176,range,O,5423
102177,of,O,5423
102178,health,O,5423
102179,and,O,5423
102180,medical,O,5423
102181,technology,O,5423
102182,categories,O,5423
102183,attracted,O,5423
102184,more,O,5423
102185,than,O,5423
102186,3,O,5423
102187,900,O,5423
102188,nominations,O,5423
102189,from,O,5423
102190,over,O,5423
102191,15,O,5423
102192,countries,O,5423
102193,from,O,5423
102194,which,O,5423
102195,MedTech,B-ORGANIZATION,5423
102196,selected,O,5423
102197,OptiLight,B-TREATMENT,5423
102198,for,O,5423
102199,this,O,5423
102200,recognition,O,5423
102201,The,O,5424
102202,win,O,5424
102203,follows,O,5424
102204,Lumenis,B-ORGANIZATION,5424
102205,MedTech,B-ORGANIZATION,5424
102206,awards,O,5424
102207,for,O,5424
102208,Best,O,5424
102209,Overall,O,5424
102210,Medical,O,5424
102211,Device,O,5424
102212,Company,O,5424
102213,in,O,5424
102214,2021,O,5424
102215,and,O,5424
102216,Best,O,5424
102217,New,O,5424
102218,Surgical,O,5424
102219,Technology,O,5424
102220,Solution,O,5424
102221,in,O,5424
102222,2020,O,5424
102223,OptiLight,B-TREATMENT,5425
102224,is,O,5425
102225,the,O,5425
102226,first,O,5425
102227,and,O,5425
102228,only,O,5425
102229,light,O,5425
102230,treatment,O,5425
102231,FDA,B-ORGANIZATION,5425
102232,approved,O,5425
102233,for,O,5425
102234,management,O,5425
102235,of,O,5425
102236,dry,B-NAME_OF_DISEASE,5425
102237,eye,I-NAME_OF_DISEASE,5425
102238,disease,I-NAME_OF_DISEASE,5425
102239,Lumenis,B-ORGANIZATION,5426
102240,patented,O,5426
102241,innovative,O,5426
102242,Optimal,B-TREATMENT,5426
102243,Pulse,I-TREATMENT,5426
102244,Technology,I-TREATMENT,5426
102245,OPT,I-TREATMENT,5426
102246,offers,O,5426
102247,targeted,O,5426
102248,uniform,O,5426
102249,precise,O,5426
102250,and,O,5426
102251,controlled,O,5426
102252,treatment,O,5426
102253,that,O,5426
102254,safely,O,5426
102255,and,O,5426
102256,effectively,O,5426
102257,breaks,O,5426
102258,the,O,5426
102259,cycle,O,5426
102260,of,O,5426
102261,inflammation,O,5426
102262,associated,O,5426
102263,with,O,5426
102264,dry,B-NAME_OF_DISEASE,5426
102265,eye,I-NAME_OF_DISEASE,5426
102266,disease,I-NAME_OF_DISEASE,5426
102267,Dry,B-NAME_OF_DISEASE,5427
102268,eye,I-NAME_OF_DISEASE,5427
102269,disease,I-NAME_OF_DISEASE,5427
102270,is,O,5427
102271,highly,O,5427
102272,prevalent,O,5427
102273,and,O,5427
102274,difficult,O,5427
102275,to,O,5427
102276,manage,O,5427
102277,and,O,5427
102278,traditional,O,5427
102279,treatments,O,5427
102280,like,O,5427
102281,warm,B-TREATMENT,5427
102282,compresses,I-TREATMENT,5427
102283,and,O,5427
102284,artificial,B-TREATMENT,5427
102285,tears,I-TREATMENT,5427
102286,treat,O,5427
102287,the,O,5427
102288,symptoms,O,5427
102289,but,O,5427
102290,not,O,5427
102291,the,O,5427
102292,underlying,O,5427
102293,pathology,O,5427
102294,said,O,5427
102295,James,B-PERSON,5427
102296,Johnson,I-PERSON,5427
102297,managing,O,5427
102298,director,O,5427
102299,MedTech,B-ORGANIZATION,5427
102300,Breakthrough,I-ORGANIZATION,5427
102301,OptiLight,B-TREATMENT,5428
102302,is,O,5428
102303,leading,O,5428
102304,a,O,5428
102305,revolution,O,5428
102306,in,O,5428
102307,managing,O,5428
102308,dry,B-NAME_OF_DISEASE,5428
102309,eye,I-NAME_OF_DISEASE,5428
102310,disease,I-NAME_OF_DISEASE,5428
102311,with,O,5428
102312,breakthrough,O,5428
102313,technology,O,5428
102314,that,O,5428
102315,allows,O,5428
102316,doctors,O,5428
102317,to,O,5428
102318,treat,O,5428
102319,patients,O,5428
102320,quickly,O,5428
102321,in-office,O,5428
102322,With,O,5429
102323,broad,O,5429
102324,potential,O,5429
102325,for,O,5429
102326,tens,O,5429
102327,of,O,5429
102328,millions,O,5429
102329,with,O,5429
102330,dry,B-NAME_OF_DISEASE,5429
102331,eye,I-NAME_OF_DISEASE,5429
102332,disease,I-NAME_OF_DISEASE,5429
102333,OptiLight,B-TREATMENT,5429
102334,stands,O,5429
102335,out,O,5429
102336,from,O,5429
102337,the,O,5429
102338,crowd,O,5429
102339,to,O,5429
102340,become,O,5429
102341,our,O,5429
102342,2022,O,5429
102343,Best,O,5429
102344,New,O,5429
102345,Technology,O,5429
102346,Solution,O,5429
102347,for,O,5429
102348,Ophthalmology,O,5429
102349,he,O,5429
102350,further,O,5429
102351,explained,O,5429
102352,Lumenis,B-ORGANIZATION,5430
102353,introduced,O,5430
102354,OptiLight,B-TREATMENT,5430
102355,in,O,5430
102356,May,O,5430
102357,2021,O,5430
102358,and,O,5430
102359,recently,O,5430
102360,launched,O,5430
102361,a,O,5430
102362,national,O,5430
102363,media,O,5430
102364,campaign,O,5430
102365,featuring,O,5430
102366,singer-songwriter,O,5430
102367,and,O,5430
102368,actress,O,5430
102369,Mandy,B-PERSON,5430
102370,Moore,I-PERSON,5430
102371,This,O,5430
102372,Is,O,5430
102373,Us,O,5430
102374,to,O,5430
102375,increase,O,5430
102376,awareness,O,5430
102377,for,O,5430
102378,dry,B-NAME_OF_DISEASE,5430
102379,eye,I-NAME_OF_DISEASE,5430
102380,disease,I-NAME_OF_DISEASE,5430
102381,and,O,5430
102382,encourage,O,5430
102383,people,O,5430
102384,who,O,5430
102385,might,O,5430
102386,be,O,5430
102387,suffering,O,5430
102388,from,O,5430
102389,this,O,5430
102390,condition,O,5430
102391,to,O,5430
102392,seek,O,5430
102393,out,O,5430
102394,a,O,5430
102395,physician,O,5430
102396,who,O,5430
102397,offers,O,5430
102398,OptiLight,B-TREATMENT,5430
102399,www.TreatMyDryEye.co,O,5430
102400,,O,5431
102401,We,O,5432
102402,re,O,5432
102403,grateful,O,5432
102404,to,O,5432
102405,MedTech,B-ORGANIZATION,5432
102406,for,O,5432
102407,honoring,O,5432
102408,OptiLight,B-TREATMENT,5432
102409,for,O,5432
102410,its,O,5432
102411,innovation,O,5432
102412,and,O,5432
102413,impact,O,5432
102414,in,O,5432
102415,eye,O,5432
102416,care,O,5432
102417,said,O,5432
102418,Lumenis,B-ORGANIZATION,5432
102419,CEO,O,5432
102420,Tzipi,B-PERSON,5432
102421,Ozer-Armon,I-PERSON,5432
102422,Lumenis,B-ORGANIZATION,5433
102423,is,O,5433
102424,committed,O,5433
102425,to,O,5433
102426,raising,O,5433
102427,the,O,5433
102428,bar,O,5433
102429,for,O,5433
102430,patients,O,5433
102431,health,O,5433
102432,by,O,5433
102433,providing,O,5433
102434,cutting-edge,O,5433
102435,solutions,O,5433
102436,and,O,5433
102437,treatment,O,5433
102438,innovations,O,5433
102439,As,O,5434
102440,the,O,5434
102441,only,O,5434
102442,light-based,O,5434
102443,treatment,O,5434
102444,for,O,5434
102445,dry,B-NAME_OF_DISEASE,5434
102446,eye,I-NAME_OF_DISEASE,5434
102447,disease,I-NAME_OF_DISEASE,5434
102448,OptiLight,B-TREATMENT,5434
102449,has,O,5434
102450,the,O,5434
102451,power,O,5434
102452,to,O,5434
102453,elevate,O,5434
102454,dry,B-NAME_OF_DISEASE,5434
102455,eye,I-NAME_OF_DISEASE,5434
102456,management,O,5434
102457,and,O,5434
102458,improve,O,5434
102459,health,O,5434
102460,and,O,5434
102461,quality,O,5434
102462,of,O,5434
102463,life,O,5434
102464,for,O,5434
102465,millions,O,5434
102466,of,O,5434
102467,people,O,5434
102468,around,O,5434
102469,the,O,5434
102470,world,O,5434
102471,Viterbi,B-ORGANIZATION,5435
102472,Family,I-ORGANIZATION,5435
102473,Department,I-ORGANIZATION,5435
102474,of,I-ORGANIZATION,5435
102475,Ophthalmology,I-ORGANIZATION,5435
102476,and,O,5435
102477,Shiley,B-ORGANIZATION,5435
102478,Eye,I-ORGANIZATION,5435
102479,Institute,I-ORGANIZATION,5435
102480,both,O,5435
102481,part,O,5435
102482,of,O,5435
102483,UC,B-ORGANIZATION,5435
102484,San,I-ORGANIZATION,5435
102485,Diego,I-ORGANIZATION,5435
102486,Health,I-ORGANIZATION,5435
102487,has,O,5435
102488,received,O,5435
102489,funding,O,5435
102490,from,O,5435
102491,the,B-ORGANIZATION,5435
102492,Nixon,I-ORGANIZATION,5435
102493,Visions,I-ORGANIZATION,5435
102494,Foundation,I-ORGANIZATION,5435
102495,led,O,5435
102496,by,O,5435
102497,philanthropists,O,5435
102498,Brandon,B-PERSON,5435
102499,and,I-PERSON,5435
102500,Janine,I-PERSON,5435
102501,Nixon,I-PERSON,5435
102502,to,O,5435
102503,launch,O,5435
102504,the,B-ORGANIZATION,5435
102505,Nixon,I-ORGANIZATION,5435
102506,Visions,I-ORGANIZATION,5435
102507,Foundation,I-ORGANIZATION,5435
102508,Macular,O,5435
102509,Dystrophy-PRPH2,O,5435
102510,Research,O,5435
102511,Fund,O,5435
102512,The,O,5436
102513,new,O,5436
102514,initiative,O,5436
102515,will,O,5436
102516,focus,O,5436
102517,studies,O,5436
102518,of,O,5436
102519,the,B-CHEMICAL_COMPOUND,5436
102520,PRPH2,I-CHEMICAL_COMPOUND,5436
102521,gene,I-CHEMICAL_COMPOUND,5436
102522,and,O,5436
102523,related,O,5436
102524,mutations,O,5436
102525,and,O,5436
102526,help,O,5436
102527,upgrade,O,5436
102528,stem,O,5436
102529,cell,O,5436
102530,technologies,O,5436
102531,that,O,5436
102532,may,O,5436
102533,eventually,O,5436
102534,provide,O,5436
102535,a,O,5436
102536,proven,O,5436
102537,therapeutic,O,5436
102538,remedy,O,5436
102539,In,O,5437
102540,healthy,O,5437
102541,vision,O,5437
102542,a,B-CHEMICAL_COMPOUND,5437
102543,gene,I-CHEMICAL_COMPOUND,5437
102544,called,I-CHEMICAL_COMPOUND,5437
102545,PRPH2,I-CHEMICAL_COMPOUND,5437
102546,provides,O,5437
102547,instructions,O,5437
102548,to,O,5437
102549,make,O,5437
102550,a,B-CHEMICAL_COMPOUND,5437
102551,protein,I-CHEMICAL_COMPOUND,5437
102552,called,I-CHEMICAL_COMPOUND,5437
102553,peripherin,I-CHEMICAL_COMPOUND,5437
102554,2,I-CHEMICAL_COMPOUND,5437
102555,PRPH2,I-CHEMICAL_COMPOUND,5437
102556,which,O,5437
102557,plays,O,5437
102558,a,O,5437
102559,key,O,5437
102560,role,O,5437
102561,in,O,5437
102562,the,O,5437
102563,normal,O,5437
102564,functioning,O,5437
102565,of,O,5437
102566,photoreceptors,B-PART_OF_THE_EYES,5437
102567,that,O,5437
102568,detect,O,5437
102569,light,O,5437
102570,and,O,5437
102571,color,O,5437
102572,and,O,5437
102573,which,O,5437
102574,line,O,5437
102575,the,B-PART_OF_THE_EYES,5437
102576,back,I-PART_OF_THE_EYES,5437
102577,of,I-PART_OF_THE_EYES,5437
102578,the,I-PART_OF_THE_EYES,5437
102579,eye,I-PART_OF_THE_EYES,5437
102580,When,O,5438
102581,there,O,5438
102582,are,O,5438
102583,mutations,O,5438
102584,in,O,5438
102585,the,B-CHEMICAL_COMPOUND,5438
102586,PRPH2,I-CHEMICAL_COMPOUND,5438
102587,gene,I-CHEMICAL_COMPOUND,5438
102588,the,O,5438
102589,result,O,5438
102590,can,O,5438
102591,be,O,5438
102592,macular,B-NAME_OF_DISEASE,5438
102593,dystrophy,I-NAME_OF_DISEASE,5438
102594,an,O,5438
102595,impairment,O,5438
102596,of,O,5438
102597,the,B-PART_OF_THE_EYES,5438
102598,retina,I-PART_OF_THE_EYES,5438
102599,that,O,5438
102600,progressively,O,5438
102601,diminishes,O,5438
102602,the,O,5438
102603,ability,O,5438
102604,to,O,5438
102605,see,O,5438
102606,clearly,O,5438
102607,and,O,5438
102608,may,O,5438
102609,eventually,O,5438
102610,result,O,5438
102611,in,O,5438
102612,vision,B-SIGN_AND_SYMPTOM,5438
102613,loss,I-SIGN_AND_SYMPTOM,5438
102614,There,O,5439
102615,are,O,5439
102616,currently,O,5439
102617,no,O,5439
102618,effective,O,5439
102619,treatments,O,5439
102620,available,O,5439
102621,to,O,5439
102622,halt,O,5439
102623,or,O,5439
102624,prevent,O,5439
102625,the,O,5439
102626,disease,O,5439
102627,As,O,5440
102628,part,O,5440
102629,of,O,5440
102630,this,O,5440
102631,effort,O,5440
102632,the,B-ORGANIZATION,5440
102633,Nixon,I-ORGANIZATION,5440
102634,Visions,I-ORGANIZATION,5440
102635,Foundation,I-ORGANIZATION,5440
102636,is,O,5440
102637,collaborating,O,5440
102638,with,O,5440
102639,the,B-ORGANIZATION,5440
102640,Foundation,I-ORGANIZATION,5440
102641,Fighting,I-ORGANIZATION,5440
102642,Blindness,I-ORGANIZATION,5440
102643,to,O,5440
102644,build,O,5440
102645,capacity,O,5440
102646,to,O,5440
102647,improve,O,5440
102648,national,O,5440
102649,and,O,5440
102650,international,O,5440
102651,research,O,5440
102652,in,O,5440
102653,this,O,5440
102654,area,O,5440
102655,We,O,5441
102656,are,O,5441
102657,impressed,O,5441
102658,with,O,5441
102659,the,O,5441
102660,impactful,O,5441
102661,work,O,5441
102662,at,O,5441
102663,UC,B-ORGANIZATION,5441
102664,San,I-ORGANIZATION,5441
102665,Diego,I-ORGANIZATION,5441
102666,and,O,5441
102667,specifically,O,5441
102668,in,O,5441
102669,the,B-ORGANIZATION,5441
102670,Department,I-ORGANIZATION,5441
102671,of,I-ORGANIZATION,5441
102672,Ophthalmology,I-ORGANIZATION,5441
102673,and,O,5441
102674,at,O,5441
102675,Shiley,B-ORGANIZATION,5441
102676,Eye,I-ORGANIZATION,5441
102677,Institute,I-ORGANIZATION,5441
102678,the,B-PERSON,5441
102679,Nixons,I-PERSON,5441
102680,said,O,5441
102681,in,O,5441
102682,a,O,5441
102683,statement,O,5441
102684,We,O,5442
102685,believe,O,5442
102686,this,O,5442
102687,gift,O,5442
102688,can,O,5442
102689,accelerate,O,5442
102690,efforts,O,5442
102691,to,O,5442
102692,make,O,5442
102693,a,O,5442
102694,tremendous,O,5442
102695,impact,O,5442
102696,for,O,5442
102697,people,O,5442
102698,with,O,5442
102699,this,O,5442
102700,inherited,O,5442
102701,eye,O,5442
102702,disease,O,5442
102703,and,O,5442
102704,will,O,5442
102705,improve,O,5442
102706,the,O,5442
102707,lives,O,5442
102708,of,O,5442
102709,others,O,5442
102710,for,O,5442
102711,generations,O,5442
102712,to,O,5442
102713,come,O,5442
102714,UC,B-ORGANIZATION,5443
102715,San,I-ORGANIZATION,5443
102716,Diego,I-ORGANIZATION,5443
102717,Chancellor,O,5443
102718,Pradeep,B-PERSON,5443
102719,Khosla,I-PERSON,5443
102720,pointed,O,5443
102721,out,O,5443
102722,that,O,5443
102723,macular,B-NAME_OF_DISEASE,5443
102724,dystrophy,I-NAME_OF_DISEASE,5443
102725,is,O,5443
102726,a,O,5443
102727,challenging,O,5443
102728,disease,O,5443
102729,for,O,5443
102730,people,O,5443
102731,who,O,5443
102732,have,O,5443
102733,it,O,5443
102734,but,O,5443
102735,noted,O,5443
102736,that,O,5443
102737,UC,B-ORGANIZATION,5443
102738,San,I-ORGANIZATION,5443
102739,Diego,I-ORGANIZATION,5443
102740,Health,I-ORGANIZATION,5443
102741,has,O,5443
102742,the,O,5443
102743,expertise,O,5443
102744,to,O,5443
102745,discover,O,5443
102746,new,O,5443
102747,ways,O,5443
102748,of,O,5443
102749,treating,O,5443
102750,this,O,5443
102751,illness,O,5443
102752,and,O,5443
102753,creating,O,5443
102754,a,O,5443
102755,healthier,O,5443
102756,world,O,5443
102757,Macular,B-NAME_OF_DISEASE,5444
102758,Dystrophy,I-NAME_OF_DISEASE,5444
102759,Macular,B-NAME_OF_DISEASE,5444
102760,dystrophy,I-NAME_OF_DISEASE,5444
102761,is,O,5444
102762,a,O,5444
102763,rare,O,5444
102764,eye,O,5444
102765,disorder,O,5444
102766,It,O,5445
102767,affects,O,5445
102768,the,B-PART_OF_THE_EYES,5445
102769,macula,B-PART_OF_THE_EYES,5445
102770,or,O,5445
102771,central,B-PART_OF_THE_EYES,5445
102772,retina,I-PART_OF_THE_EYES,5445
102773,which,O,5445
102774,contains,O,5445
102775,the,O,5445
102776,most,O,5445
102777,light-sensitive,O,5445
102778,cells,O,5445
102779,or,O,5445
102780,photoreceptors,B-PART_OF_THE_EYES,5445
102781,It,O,5446
102782,differs,O,5446
102783,from,O,5446
102784,macular,B-NAME_OF_DISEASE,5446
102785,degeneration,I-NAME_OF_DISEASE,5446
102786,a,O,5446
102787,more,O,5446
102788,prevalent,O,5446
102789,eye,O,5446
102790,condition,O,5446
102791,caused,O,5446
102792,by,O,5446
102793,the,O,5446
102794,weakening,O,5446
102795,of,O,5446
102796,the,B-PART_OF_THE_EYES,5446
102797,retina,I-PART_OF_THE_EYES,5446
102798,and,O,5446
102799,macula,B-PART_OF_THE_EYES,5446
102800,as,O,5446
102801,people,O,5446
102802,get,O,5446
102803,older,O,5446
102804,Macular,B-NAME_OF_DISEASE,5447
102805,dystrophy,I-NAME_OF_DISEASE,5447
102806,is,O,5447
102807,linked,O,5447
102808,to,O,5447
102809,genetic,B-CAUSE_OF_DISEASE,5447
102810,abnormalities,I-CAUSE_OF_DISEASE,5447
102811,that,O,5447
102812,cause,O,5447
102813,retinal,B-SIGN_AND_SYMPTOM,5447
102814,cell,I-SIGN_AND_SYMPTOM,5447
102815,degeneration,I-SIGN_AND_SYMPTOM,5447
102816,for,O,5447
102817,no,O,5447
102818,apparent,O,5447
102819,reason,O,5447
102820,Some,O,5448
102821,forms,O,5448
102822,of,O,5448
102823,the,O,5448
102824,disease,O,5448
102825,occur,O,5448
102826,in,O,5448
102827,childhood,O,5448
102828,while,O,5448
102829,others,O,5448
102830,appear,O,5448
102831,later,O,5448
102832,in,O,5448
102833,life,O,5448
102834,According,O,5449
102835,to,O,5449
102836,Shyamanga,B-PERSON,5449
102837,Borooah,I-PERSON,5449
102838,MD,I-PERSON,5449
102839,assistant,I-PERSON,5449
102840,professor,I-PERSON,5449
102841,of,I-PERSON,5449
102842,ophthalmology,I-PERSON,5449
102843,at,O,5449
102844,Shiley,B-ORGANIZATION,5449
102845,Eye,I-ORGANIZATION,5449
102846,Institute,I-ORGANIZATION,5449
102847,and,O,5449
102848,one,O,5449
102849,of,O,5449
102850,the,O,5449
102851,investigators,O,5449
102852,on,O,5449
102853,the,O,5449
102854,PRPH2,B-CHEMICAL_COMPOUND,5449
102855,research,O,5449
102856,project,O,5449
102857,there,O,5449
102858,aren,O,5449
102859,t,O,5449
102860,many,O,5449
102861,viable,O,5449
102862,therapies,O,5449
102863,for,O,5449
102864,macular,B-NAME_OF_DISEASE,5449
102865,dystrophy,I-NAME_OF_DISEASE,5449
102866,and,O,5449
102867,even,O,5449
102868,fewer,O,5449
102869,promising,O,5449
102870,leads,O,5449
102871,to,O,5449
102872,develop,O,5449
102873,them,O,5449
102874,In,O,5450
102875,our,O,5450
102876,work,O,5450
102877,we,O,5450
102878,believe,O,5450
102879,we,O,5450
102880,ve,O,5450
102881,found,O,5450
102882,one,O,5450
102883,Borooah,B-PERSON,5450
102884,said,O,5450
102885,in,O,5450
102886,a,O,5450
102887,statement,O,5450
102888,But,O,5451
102889,that,O,5451
102890,work,O,5451
102891,is,O,5451
102892,still,O,5451
102893,in,O,5451
102894,its,O,5451
102895,fairly,O,5451
102896,early,O,5451
102897,phases,O,5451
102898,so,O,5451
102899,for,O,5451
102900,myself,O,5451
102901,and,O,5451
102902,my,O,5451
102903,colleagues,O,5451
102904,such,O,5451
102905,as,O,5451
102906,Dr,O,5451
102907,Radha,O,5452
102908,Ayyagari,O,5452
102909,funding,O,5452
102910,like,O,5452
102911,this,O,5452
102912,from,O,5452
102913,the,B-ORGANIZATION,5452
102914,Nixon,I-ORGANIZATION,5452
102915,Visions,I-ORGANIZATION,5452
102916,Foundation,I-ORGANIZATION,5452
102917,is,O,5452
102918,crucial,O,5452
102919,to,O,5452
102920,understanding,O,5452
102921,causes,O,5452
102922,and,O,5452
102923,treating,O,5452
102924,the,O,5452
102925,disease,O,5452
102926,Faculty,O,5453
102927,in,O,5453
102928,the,B-ORGANIZATION,5453
102929,Viterbi,I-ORGANIZATION,5453
102930,Family,I-ORGANIZATION,5453
102931,Department,I-ORGANIZATION,5453
102932,of,I-ORGANIZATION,5453
102933,Ophthalmology,I-ORGANIZATION,5453
102934,and,O,5453
102935,at,O,5453
102936,Shiley,B-ORGANIZATION,5453
102937,Eye,I-ORGANIZATION,5453
102938,Institute,I-ORGANIZATION,5453
102939,are,O,5453
102940,among,O,5453
102941,the,O,5453
102942,leaders,O,5453
102943,in,O,5453
102944,basic,O,5453
102945,research,O,5453
102946,investigating,O,5453
102947,the,O,5453
102948,causes,O,5453
102949,of,O,5453
102950,eye,O,5453
102951,disease,O,5453
102952,and,O,5453
102953,finding,O,5453
102954,remedies,O,5453
102955,The,O,5454
102956,institute,O,5454
102957,is,O,5454
102958,home,O,5454
102959,to,O,5454
102960,the,B-ORGANIZATION,5454
102961,Joan,I-ORGANIZATION,5454
102962,and,I-ORGANIZATION,5454
102963,Irwin,I-ORGANIZATION,5454
102964,Jacobs,I-ORGANIZATION,5454
102965,Retina,I-ORGANIZATION,5454
102966,Center,I-ORGANIZATION,5454
102967,Luxembourg-based,B-ORGANIZATION,5455
102968,Mitotech,B-ORGANIZATION,5455
102969,SA,I-ORGANIZATION,5455
102970,announced,O,5455
102971,that,O,5455
102972,the,B-ORGANIZATION,5455
102973,FDA,B-ORGANIZATION,5455
102974,has,O,5455
102975,granted,O,5455
102976,orphan,O,5455
102977,drug,O,5455
102978,designation,O,5455
102979,ODD,O,5455
102980,for,O,5455
102981,the,O,5455
102982,company,O,5455
102983,s,O,5455
102984,topical,O,5455
102985,cardiolipin,O,5455
102986,peroxidation,O,5455
102987,inhibitor,O,5455
102988,Visomitin,B-NAME_OF_DRUG,5455
102989,for,O,5455
102990,the,O,5455
102991,treatment,O,5455
102992,of,O,5455
102993,Leber,B-NAME_OF_DISEASE,5455
102994,s,I-NAME_OF_DISEASE,5455
102995,Hereditary,I-NAME_OF_DISEASE,5455
102996,Optic,I-NAME_OF_DISEASE,5455
102997,Neuropathy,I-NAME_OF_DISEASE,5455
102998,LHON,B-NAME_OF_DISEASE,5455
102999,a,O,5455
103000,rare,O,5455
103001,inherited,O,5455
103002,condition,O,5455
103003,that,O,5455
103004,can,O,5455
103005,cause,O,5455
103006,blindness,B-SIGN_AND_SYMPTOM,5455
103007,In,O,5456
103008,2022,O,5456
103009,Mitotech,B-ORGANIZATION,5456
103010,plans,O,5456
103011,to,O,5456
103012,begin,O,5456
103013,a,O,5456
103014,phase,O,5456
103015,2,O,5456
103016,study,O,5456
103017,with,O,5456
103018,Visomitin,B-NAME_OF_DRUG,5456
103019,in,O,5456
103020,LHON,B-NAME_OF_DISEASE,5456
103021,in,O,5456
103022,partnership,O,5456
103023,with,O,5456
103024,the,O,5456
103025,LHON,B-NAME_OF_DISEASE,5456
103026,clinic,O,5456
103027,at,O,5456
103028,the,B-ORGANIZATION,5456
103029,University,I-ORGANIZATION,5456
103030,of,I-ORGANIZATION,5456
103031,California,I-ORGANIZATION,5456
103032,Los,I-ORGANIZATION,5456
103033,Angeles,I-ORGANIZATION,5456
103034,Doheny,I-ORGANIZATION,5456
103035,Eye,I-ORGANIZATION,5456
103036,Institute,I-ORGANIZATION,5456
103037,UCLA,I-ORGANIZATION,5456
103038,,O,5456
103039,Visomitin,B-NAME_OF_DRUG,5457
103040,demonstrated,O,5457
103041,consistent,O,5457
103042,improvement,O,5457
103043,in,O,5457
103044,visual,O,5457
103045,acuity,O,5457
103046,over,B-TIME_DURATION,5457
103047,several,I-TIME_DURATION,5457
103048,years,I-TIME_DURATION,5457
103049,in,O,5457
103050,LHON,B-NAME_OF_DISEASE,5457
103051,patients,O,5457
103052,involved,O,5457
103053,in,O,5457
103054,a,O,5457
103055,3-year,B-TIME_DURATION,5457
103056,open-label,O,5457
103057,phase,O,5457
103058,2a,O,5457
103059,study,O,5457
103060,conducted,O,5457
103061,outside,O,5457
103062,the,B-GPE,5457
103063,United,I-GPE,5457
103064,States,I-GPE,5457
103065,Improvements,O,5458
103066,were,O,5458
103067,seen,O,5458
103068,in,O,5458
103069,patients,O,5458
103070,with,O,5458
103071,a,O,5458
103072,range,O,5458
103073,of,O,5458
103074,underlying,O,5458
103075,mutations,O,5458
103076,including,O,5458
103077,those,O,5458
103078,with,O,5458
103079,variants,O,5458
103080,such,O,5458
103081,as,O,5458
103082,G11778A,O,5458
103083,where,O,5458
103084,the,O,5458
103085,chances,O,5458
103086,of,O,5458
103087,improvement,O,5458
103088,are,O,5458
103089,low,O,5458
103090,Mitotech,B-ORGANIZATION,5459
103091,s,O,5459
103092,planned,O,5459
103093,phase,O,5459
103094,2,O,5459
103095,study,O,5459
103096,aims,O,5459
103097,to,O,5459
103098,develop,O,5459
103099,Visomitin,B-NAME_OF_DRUG,5459
103100,as,O,5459
103101,a,O,5459
103102,convenient,O,5459
103103,and,O,5459
103104,potentially,O,5459
103105,high,O,5459
103106,impact,O,5459
103107,treatment,O,5459
103108,for,O,5459
103109,LHON,B-NAME_OF_DISEASE,5459
103110,The,B-ORGANIZATION,5460
103111,US,I-ORGANIZATION,5460
103112,Orphan,I-ORGANIZATION,5460
103113,Drug,I-ORGANIZATION,5460
103114,Designation,I-ORGANIZATION,5460
103115,is,O,5460
103116,highly,O,5460
103117,encouraging,O,5460
103118,for,O,5460
103119,our,O,5460
103120,efforts,O,5460
103121,to,O,5460
103122,bring,O,5460
103123,Visomitin,B-NAME_OF_DRUG,5460
103124,to,O,5460
103125,young,O,5460
103126,people,O,5460
103127,whose,O,5460
103128,lives,O,5460
103129,have,O,5460
103130,been,O,5460
103131,radically,O,5460
103132,affected,O,5460
103133,by,O,5460
103134,LHON,B-NAME_OF_DISEASE,5460
103135,Natalia,B-PERSON,5460
103136,Perekhvatova,I-PERSON,5460
103137,Chief,O,5460
103138,Executive,O,5460
103139,Officer,O,5460
103140,of,O,5460
103141,Mitotech,B-ORGANIZATION,5460
103142,said,O,5460
103143,in,O,5460
103144,a,O,5460
103145,company,O,5460
103146,news,O,5460
103147,release,O,5460
103148,Visomitin,B-NAME_OF_DRUG,5461
103149,has,O,5461
103150,an,O,5461
103151,outstanding,O,5461
103152,safety,O,5461
103153,profile,O,5461
103154,and,O,5461
103155,our,O,5461
103156,preliminary,O,5461
103157,human,O,5461
103158,studies,O,5461
103159,have,O,5461
103160,demonstrated,O,5461
103161,effectiveness,O,5461
103162,in,O,5461
103163,LHON,B-NAME_OF_DISEASE,5461
103164,We,O,5462
103165,are,O,5462
103166,looking,O,5462
103167,forward,O,5462
103168,to,O,5462
103169,progressing,O,5462
103170,the,O,5462
103171,drug,O,5462
103172,in,O,5462
103173,LHON,B-NAME_OF_DISEASE,5462
103174,as,O,5462
103175,part,O,5462
103176,of,O,5462
103177,our,O,5462
103178,wider,O,5462
103179,ophthalmology,O,5462
103180,pipeline,O,5462
103181,The,B-ORGANIZATION,5463
103182,FDA,B-ORGANIZATION,5463
103183,s,I-ORGANIZATION,5463
103184,Office,I-ORGANIZATION,5463
103185,of,I-ORGANIZATION,5463
103186,Orphan,I-ORGANIZATION,5463
103187,Products,I-ORGANIZATION,5463
103188,Development,I-ORGANIZATION,5463
103189,OOPD,I-ORGANIZATION,5463
103190,promotes,O,5463
103191,the,O,5463
103192,development,O,5463
103193,and,O,5463
103194,testing,O,5463
103195,of,O,5463
103196,novel,O,5463
103197,medicines,O,5463
103198,for,O,5463
103199,diseases,O,5463
103200,that,O,5463
103201,affect,O,5463
103202,fewer,O,5463
103203,than,O,5463
103204,200,O,5463
103205,0,O,5463
103206,persons,O,5463
103207,in,O,5463
103208,the,B-GPE,5463
103209,United,I-GPE,5463
103210,States,I-GPE,5463
103211,Orphan,O,5464
103212,drug,O,5464
103213,status,O,5464
103214,confers,O,5464
103215,a,O,5464
103216,number,O,5464
103217,of,O,5464
103218,advantages,O,5464
103219,including,O,5464
103220,seven,O,5464
103221,years,O,5464
103222,of,O,5464
103223,market,O,5464
103224,exclusivity,O,5464
103225,upon,O,5464
103226,regulatory,O,5464
103227,approval,O,5464
103228,waiver,O,5464
103229,of,O,5464
103230,FDA,B-ORGANIZATION,5464
103231,application,O,5464
103232,fees,O,5464
103233,and,O,5464
103234,tax,O,5464
103235,incentives,O,5464
103236,for,O,5464
103237,eligible,O,5464
103238,clinical,O,5464
103239,trials,O,5464
103240,Signs,O,5465
103241,Symptoms,O,5465
103242,and,O,5465
103243,Treatment,O,5465
103244,of,O,5465
103245,LHON,B-NAME_OF_DISEASE,5465
103246,Leber,B-NAME_OF_DISEASE,5465
103247,hereditary,I-NAME_OF_DISEASE,5465
103248,optic,I-NAME_OF_DISEASE,5465
103249,neuropathy,I-NAME_OF_DISEASE,5465
103250,LHON,I-NAME_OF_DISEASE,5465
103251,is,O,5465
103252,an,O,5465
103253,inherited,O,5465
103254,form,O,5465
103255,of,O,5465
103256,vision,B-SIGN_AND_SYMPTOM,5465
103257,loss,I-SIGN_AND_SYMPTOM,5465
103258,Although,O,5466
103259,this,O,5466
103260,condition,O,5466
103261,usually,O,5466
103262,begins,O,5466
103263,in,O,5466
103264,a,O,5466
103265,person,O,5466
103266,s,O,5466
103267,teens,O,5466
103268,or,O,5466
103269,twenties,O,5466
103270,rare,O,5466
103271,cases,O,5466
103272,may,O,5466
103273,appear,O,5466
103274,in,O,5466
103275,early,O,5466
103276,childhood,O,5466
103277,or,O,5466
103278,later,O,5466
103279,in,O,5466
103280,adulthood,O,5466
103281,For,O,5467
103282,unknown,O,5467
103283,reasons,O,5467
103284,males,O,5467
103285,are,O,5467
103286,affected,O,5467
103287,much,O,5467
103288,more,O,5467
103289,often,O,5467
103290,than,O,5467
103291,females,O,5467
103292,Blurring,B-SIGN_AND_SYMPTOM,5468
103293,and,I-SIGN_AND_SYMPTOM,5468
103294,clouding,I-SIGN_AND_SYMPTOM,5468
103295,of,I-SIGN_AND_SYMPTOM,5468
103296,vision,I-SIGN_AND_SYMPTOM,5468
103297,are,O,5468
103298,usually,O,5468
103299,the,O,5468
103300,first,O,5468
103301,symptoms,O,5468
103302,of,O,5468
103303,LHON,B-NAME_OF_DISEASE,5468
103304,These,O,5469
103305,vision,O,5469
103306,problems,O,5469
103307,may,O,5469
103308,begin,O,5469
103309,in,O,5469
103310,one,O,5469
103311,eye,O,5469
103312,or,O,5469
103313,simultaneously,O,5469
103314,in,O,5469
103315,both,O,5469
103316,eyes,O,5469
103317,if,O,5469
103318,vision,B-SIGN_AND_SYMPTOM,5469
103319,loss,I-SIGN_AND_SYMPTOM,5469
103320,starts,O,5469
103321,in,O,5469
103322,one,O,5469
103323,eye,O,5469
103324,the,O,5469
103325,other,O,5469
103326,eye,O,5469
103327,is,O,5469
103328,usually,O,5469
103329,affected,O,5469
103330,within,B-TIME_DURATION,5469
103331,several,I-TIME_DURATION,5469
103332,weeks,I-TIME_DURATION,5469
103333,or,I-TIME_DURATION,5469
103334,months,I-TIME_DURATION,5469
103335,Over,O,5470
103336,time,O,5470
103337,vision,B-SIGN_AND_SYMPTOM,5470
103338,in,I-SIGN_AND_SYMPTOM,5470
103339,both,I-SIGN_AND_SYMPTOM,5470
103340,eyes,I-SIGN_AND_SYMPTOM,5470
103341,worsens,I-SIGN_AND_SYMPTOM,5470
103342,with,I-SIGN_AND_SYMPTOM,5470
103343,a,I-SIGN_AND_SYMPTOM,5470
103344,severe,I-SIGN_AND_SYMPTOM,5470
103345,loss,I-SIGN_AND_SYMPTOM,5470
103346,of,I-SIGN_AND_SYMPTOM,5470
103347,sharpness,I-SIGN_AND_SYMPTOM,5470
103348,visual,I-SIGN_AND_SYMPTOM,5470
103349,acuity,I-SIGN_AND_SYMPTOM,5470
103350,and,I-SIGN_AND_SYMPTOM,5470
103351,color,I-SIGN_AND_SYMPTOM,5470
103352,vision,I-SIGN_AND_SYMPTOM,5470
103353,Mutations,B-CAUSE_OF_DISEASE,5471
103354,in,I-CAUSE_OF_DISEASE,5471
103355,the,I-CAUSE_OF_DISEASE,5471
103356,MT-ND1,I-CAUSE_OF_DISEASE,5471
103357,MT-ND4,I-CAUSE_OF_DISEASE,5471
103358,MT-ND4L,I-CAUSE_OF_DISEASE,5471
103359,or,I-CAUSE_OF_DISEASE,5471
103360,MT-ND6,I-CAUSE_OF_DISEASE,5471
103361,gene,I-CAUSE_OF_DISEASE,5471
103362,can,O,5471
103363,cause,O,5471
103364,LHON,B-NAME_OF_DISEASE,5471
103365,These,O,5472
103366,genes,O,5472
103367,are,O,5472
103368,found,O,5472
103369,in,O,5472
103370,the,O,5472
103371,DNA,B-CHEMICAL_COMPOUND,5472
103372,of,O,5472
103373,cellular,O,5472
103374,structures,O,5472
103375,called,O,5472
103376,mitochondria,O,5472
103377,which,O,5472
103378,convert,O,5472
103379,the,O,5472
103380,energy,O,5472
103381,from,O,5472
103382,food,O,5472
103383,into,O,5472
103384,a,O,5472
103385,form,O,5472
103386,that,O,5472
103387,cells,O,5472
103388,can,O,5472
103389,use,O,5472
103390,Leber,B-NAME_OF_DISEASE,5473
103391,hereditary,I-NAME_OF_DISEASE,5473
103392,optic,I-NAME_OF_DISEASE,5473
103393,neuropathy,I-NAME_OF_DISEASE,5473
103394,currently,O,5473
103395,has,O,5473
103396,no,O,5473
103397,proven,O,5473
103398,treatment,O,5473
103399,Symptomatic,O,5474
103400,treatment,O,5474
103401,and,O,5474
103402,genetic,O,5474
103403,counseling,O,5474
103404,are,O,5474
103405,important,O,5474
103406,in,O,5474
103407,the,O,5474
103408,management,O,5474
103409,of,O,5474
103410,patients,O,5474
103411,with,O,5474
103412,Leber,B-NAME_OF_DISEASE,5474
103413,hereditary,I-NAME_OF_DISEASE,5474
103414,optic,I-NAME_OF_DISEASE,5474
103415,neuropathy,I-NAME_OF_DISEASE,5474
103416,RVL,B-ORGANIZATION,5475
103417,Pharmaceutical,I-ORGANIZATION,5475
103418,s,O,5475
103419,Upneeq,B-NAME_OF_DRUG,5475
103420,eye,I-NAME_OF_DRUG,5475
103421,drops,I-NAME_OF_DRUG,5475
103422,which,O,5475
103423,temporarily,O,5475
103424,lift,O,5475
103425,low-lying,O,5475
103426,eyelids,B-PART_OF_THE_EYES,5475
103427,won,O,5475
103428,a,O,5475
103429,2021,O,5475
103430,Best,O,5475
103431,of,O,5475
103432,Beauty,O,5475
103433,Breakthrough,O,5475
103434,Award,O,5475
103435,by,O,5475
103436,Allure,B-ORGANIZATION,5475
103437,Magazine,I-ORGANIZATION,5475
103438,Upneeq,B-NAME_OF_DRUG,5476
103439,is,O,5476
103440,a,O,5476
103441,prescription,O,5476
103442,eye,O,5476
103443,drop,O,5476
103444,that,O,5476
103445,has,O,5476
103446,been,O,5476
103447,approved,O,5476
103448,by,O,5476
103449,the,B-ORGANIZATION,5476
103450,FDA,I-ORGANIZATION,5476
103451,for,O,5476
103452,the,O,5476
103453,treatment,O,5476
103454,of,O,5476
103455,acquired,B-NAME_OF_DISEASE,5476
103456,blepharoptosis,I-NAME_OF_DISEASE,5476
103457,low-lying,I-NAME_OF_DISEASE,5476
103458,lids,I-NAME_OF_DISEASE,5476
103459,in,O,5476
103460,adults,O,5476
103461,Before,O,5477
103462,Upneeq,B-NAME_OF_DRUG,5477
103463,correction,O,5477
103464,surgery,O,5477
103465,was,O,5477
103466,the,O,5477
103467,sole,O,5477
103468,option,O,5477
103469,for,O,5477
103470,people,O,5477
103471,with,O,5477
103472,ptosis,B-SIGN_AND_SYMPTOM,5477
103473,who,O,5477
103474,wanted,O,5477
103475,to,O,5477
103476,truly,O,5477
103477,lift,O,5477
103478,their,O,5477
103479,eyelids,B-PART_OF_THE_EYES,5477
103480,Upneeq,B-NAME_OF_DRUG,5478
103481,is,O,5478
103482,able,O,5478
103483,to,O,5478
103484,temporarily,O,5478
103485,lift,O,5478
103486,a,O,5478
103487,patient,O,5478
103488,s,O,5478
103489,lid,B-PART_OF_THE_EYES,5478
103490,with,O,5478
103491,just,O,5478
103492,one,O,5478
103493,drop,O,5478
103494,average,O,5478
103495,lift,O,5478
103496,in,O,5478
103497,clinical,O,5478
103498,trials,O,5478
103499,was,O,5478
103500,1mm,O,5478
103501,with,O,5478
103502,some,O,5478
103503,patients,O,5478
103504,experiencing,O,5478
103505,lift,O,5478
103506,up,O,5478
103507,to,O,5478
103508,3mm,O,5478
103509,,O,5478
103510,It,O,5479
103511,can,O,5479
103512,make,O,5479
103513,a,O,5479
103514,significant,O,5479
103515,difference,O,5479
103516,for,O,5479
103517,patients,O,5479
103518,with,O,5479
103519,acquired,B-NAME_OF_DISEASE,5479
103520,ptosis,I-NAME_OF_DISEASE,5479
103521,changing,O,5479
103522,the,O,5479
103523,game,O,5479
103524,for,O,5479
103525,eye,O,5479
103526,care,O,5479
103527,specialists,O,5479
103528,looking,O,5479
103529,to,O,5479
103530,give,O,5479
103531,comprehensive,O,5479
103532,care,O,5479
103533,to,O,5479
103534,their,O,5479
103535,patients,O,5479
103536,Allure,B-ORGANIZATION,5480
103537,editors,O,5480
103538,view,O,5480
103539,clinical,O,5480
103540,data,O,5480
103541,and,O,5480
103542,gather,O,5480
103543,solicit,O,5480
103544,feedback,O,5480
103545,from,O,5480
103546,outside,O,5480
103547,judges,O,5480
103548,in,O,5480
103549,order,O,5480
103550,to,O,5480
103551,assess,O,5480
103552,the,O,5480
103553,product,O,5480
103554,s,O,5480
103555,quality,O,5480
103556,and,O,5480
103557,determine,O,5480
103558,whether,O,5480
103559,it,O,5480
103560,is,O,5480
103561,genuinely,O,5480
103562,a,O,5480
103563,breakthrough,O,5480
103564,Of,O,5481
103565,the,O,5481
103566,2021,O,5481
103567,winners,O,5481
103568,Allure,B-ORGANIZATION,5481
103569,wrote,O,5481
103570,We,O,5481
103571,present,O,5481
103572,seven,O,5481
103573,of,O,5481
103574,the,O,5481
103575,most,O,5481
103576,revolutionary,O,5481
103577,innovations,O,5481
103578,we,O,5481
103579,ve,O,5481
103580,ever,O,5481
103581,seen,O,5481
103582,-,O,5481
103583,ones,O,5481
103584,that,O,5481
103585,have,O,5481
103586,changed,O,5481
103587,the,O,5481
103588,way,O,5481
103589,we,O,5481
103590,approach,O,5481
103591,beauty,O,5481
103592,These,O,5482
103593,new,O,5482
103594,products,O,5482
103595,boggled,O,5482
103596,our,O,5482
103597,editors,O,5482
103598,minds,O,5482
103599,and,O,5482
103600,forever,O,5482
103601,changed,O,5482
103602,our,O,5482
103603,beauty,O,5482
103604,routines,O,5482
103605,We,O,5483
103606,are,O,5483
103607,grateful,O,5483
103608,to,O,5483
103609,receive,O,5483
103610,this,O,5483
103611,important,O,5483
103612,award,O,5483
103613,and,O,5483
103614,excited,O,5483
103615,that,O,5483
103616,the,O,5483
103617,ground-breaking,O,5483
103618,innovation,O,5483
103619,in,O,5483
103620,Upneeq,B-NAME_OF_DRUG,5483
103621,is,O,5483
103622,being,O,5483
103623,recognized,O,5483
103624,said,O,5483
103625,Dr,O,5483
103626,Ray,O,5484
103627,Douglas,O,5484
103628,an,O,5484
103629,aesthetic,O,5484
103630,reconstructive,O,5484
103631,and,O,5484
103632,oculoplastic,O,5484
103633,specialist,O,5484
103634,and,O,5484
103635,Global,O,5484
103636,Head,O,5484
103637,of,O,5484
103638,Scientific,O,5484
103639,Affairs,O,5484
103640,for,O,5484
103641,RVL,B-ORGANIZATION,5484
103642,Pharmaceuticals,I-ORGANIZATION,5484
103643,Until,O,5485
103644,Upneeq,B-NAME_OF_DRUG,5485
103645,there,O,5485
103646,was,O,5485
103647,no,O,5485
103648,pharmacologic,O,5485
103649,treatment,O,5485
103650,on,O,5485
103651,the,O,5485
103652,market,O,5485
103653,RVL,B-ORGANIZATION,5486
103654,is,O,5486
103655,passionate,O,5486
103656,about,O,5486
103657,continuing,O,5486
103658,to,O,5486
103659,provide,O,5486
103660,novel,O,5486
103661,solutions,O,5486
103662,for,O,5486
103663,both,O,5486
103664,vision,O,5486
103665,and,O,5486
103666,aesthetics,O,5486
103667,Upneeq,B-NAME_OF_DRUG,5487
103668,0.1,O,5487
103669,oxymetazoline,O,5488
103670,hydrochloride,O,5488
103671,ophthalmic,O,5488
103672,solution,O,5488
103673,works,O,5488
103674,by,O,5488
103675,triggering,O,5488
103676,the,O,5488
103677,levator,O,5488
103678,muscle,O,5488
103679,which,O,5488
103680,contracts,O,5488
103681,and,O,5488
103682,lifts,O,5488
103683,the,B-PART_OF_THE_EYES,5488
103684,eyelid,B-PART_OF_THE_EYES,5488
103685,The,O,5489
103686,dosage,O,5489
103687,is,O,5489
103688,one,O,5489
103689,drop,O,5489
103690,a,O,5489
103691,day,O,5489
103692,per,O,5489
103693,affected,O,5489
103694,eye,O,5489
103695,Some,O,5490
103696,patients,O,5490
103697,reported,O,5490
103698,seeing,O,5490
103699,a,O,5490
103700,difference,O,5490
103701,in,O,5490
103702,as,O,5490
103703,little,O,5490
103704,as,O,5490
103705,five,B-TIME_DURATION,5490
103706,minutes,I-TIME_DURATION,5490
103707,in,O,5490
103708,early,O,5490
103709,studies,O,5490
103710,with,O,5490
103711,complete,O,5490
103712,responses,O,5490
103713,taking,O,5490
103714,two,B-TIME_DURATION,5490
103715,hours,I-TIME_DURATION,5490
103716,Millions,O,5491
103717,of,O,5491
103718,Americans,O,5491
103719,may,O,5491
103720,suffer,O,5491
103721,from,O,5491
103722,an,O,5491
103723,often,O,5491
103724,undiagnosed,O,5491
103725,or,O,5491
103726,overlooked,O,5491
103727,condition,O,5491
103728,called,O,5491
103729,acquired,B-NAME_OF_DISEASE,5491
103730,blepharoptosis,I-NAME_OF_DISEASE,5491
103731,also,O,5491
103732,known,O,5491
103733,as,O,5491
103734,acquired,B-NAME_OF_DISEASE,5491
103735,ptosis,I-NAME_OF_DISEASE,5491
103736,or,O,5491
103737,droopy,O,5491
103738,eyelids,B-PART_OF_THE_EYES,5491
103739,says,O,5491
103740,Dr,O,5491
103741,Douglas,O,5492
103742,The,O,5493
103743,condition,O,5493
103744,not,O,5493
103745,only,O,5493
103746,affects,O,5493
103747,the,O,5493
103748,aesthetics,O,5493
103749,of,O,5493
103750,the,O,5493
103751,face,O,5493
103752,but,O,5493
103753,may,O,5493
103754,also,O,5493
103755,cause,O,5493
103756,vision,B-NAME_OF_DISEASE,5493
103757,impairment,I-NAME_OF_DISEASE,5493
103758,that,O,5493
103759,interferes,O,5493
103760,with,O,5493
103761,day-to-day,O,5493
103762,functions,O,5493
103763,such,O,5493
103764,as,O,5493
103765,reading,O,5493
103766,and,O,5493
103767,driving,O,5493
103768,We,O,5494
103769,are,O,5494
103770,excited,O,5494
103771,to,O,5494
103772,offer,O,5494
103773,a,O,5494
103774,noninvasive,O,5494
103775,option,O,5494
103776,to,O,5494
103777,increase,O,5494
103778,eyelid,B-PART_OF_THE_EYES,5494
103779,lift,O,5494
103780,Visit,O,5495
103781,Upneeq,B-NAME_OF_DRUG,5495
103782,to,O,5495
103783,learn,O,5495
103784,more,O,5495
103785,about,O,5495
103786,the,O,5495
103787,award-winning,O,5495
103788,drops,O,5495
103789,See,O,5496
103790,below,O,5496
103791,for,O,5496
103792,Important,O,5496
103793,Safety,O,5496
103794,Information,O,5496
103795,To,O,5497
103796,read,O,5497
103797,the,O,5497
103798,Allure,B-ORGANIZATION,5497
103799,2021,O,5497
103800,Best,O,5497
103801,of,O,5497
103802,Beauty,O,5497
103803,Breakthrough,O,5497
103804,Awards,O,5497
103805,article,O,5497
103806,click,O,5497
103807,here,O,5497
103808,Oyster,B-ORGANIZATION,5498
103809,Point,I-ORGANIZATION,5498
103810,Pharma,I-ORGANIZATION,5498
103811,announced,O,5498
103812,that,O,5498
103813,the,O,5498
103814,FDA,B-ORGANIZATION,5498
103815,has,O,5498
103816,approved,O,5498
103817,Tyrvaya,B-NAME_OF_DRUG,5498
103818,varenicline,O,5498
103819,solution,O,5498
103820,Nasal,O,5498
103821,Spray,O,5498
103822,0,O,5498
103823,mg,O,5499
103824,formerly,O,5499
103825,called,O,5499
103826,OC-01,B-NAME_OF_DRUG,5499
103827,for,O,5499
103828,the,O,5499
103829,treatment,O,5499
103830,of,O,5499
103831,the,O,5499
103832,signs,O,5499
103833,and,O,5499
103834,symptoms,O,5499
103835,of,O,5499
103836,dry,B-NAME_OF_DISEASE,5499
103837,eye,I-NAME_OF_DISEASE,5499
103838,disease,I-NAME_OF_DISEASE,5499
103839,The,O,5500
103840,approval,O,5500
103841,marks,O,5500
103842,the,O,5500
103843,first,O,5500
103844,and,O,5500
103845,only,O,5500
103846,nasal,O,5500
103847,spray,O,5500
103848,approved,O,5500
103849,for,O,5500
103850,the,O,5500
103851,treatment,O,5500
103852,of,O,5500
103853,dry,B-NAME_OF_DISEASE,5500
103854,eye,I-NAME_OF_DISEASE,5500
103855,disease,I-NAME_OF_DISEASE,5500
103856,Tyrvaya,B-NAME_OF_DRUG,5501
103857,is,O,5501
103858,thought,O,5501
103859,to,O,5501
103860,activate,O,5501
103861,the,O,5501
103862,trigeminal,O,5501
103863,parasympathetic,O,5501
103864,system,O,5501
103865,by,O,5501
103866,binding,O,5501
103867,to,O,5501
103868,cholinergic,O,5501
103869,receptors,O,5501
103870,resulting,O,5501
103871,in,O,5501
103872,enhanced,O,5501
103873,production,O,5501
103874,of,O,5501
103875,basal,O,5501
103876,tear,B-PART_OF_THE_EYES,5501
103877,film,I-PART_OF_THE_EYES,5501
103878,as,O,5501
103879,a,O,5501
103880,treatment,O,5501
103881,for,O,5501
103882,dry,B-NAME_OF_DISEASE,5501
103883,eye,I-NAME_OF_DISEASE,5501
103884,disease,I-NAME_OF_DISEASE,5501
103885,The,O,5502
103886,nasal,O,5502
103887,spray,O,5502
103888,is,O,5502
103889,a,O,5502
103890,highly,O,5502
103891,specific,O,5502
103892,cholinergic,O,5502
103893,agonist,O,5502
103894,that,O,5502
103895,is,O,5502
103896,sprayed,O,5502
103897,into,O,5502
103898,each,O,5502
103899,nostril,O,5502
103900,twice,O,5502
103901,daily,O,5502
103902,to,O,5502
103903,trigger,O,5502
103904,basal,O,5502
103905,tear,O,5502
103906,production,O,5502
103907,The,O,5503
103908,use,O,5503
103909,of,O,5503
103910,a,O,5503
103911,nasal,O,5503
103912,spray,O,5503
103913,to,O,5503
103914,treat,O,5503
103915,dry,B-NAME_OF_DISEASE,5503
103916,eye,I-NAME_OF_DISEASE,5503
103917,disease,I-NAME_OF_DISEASE,5503
103918,is,O,5503
103919,a,O,5503
103920,novel,O,5503
103921,technique,O,5503
103922,to,O,5503
103923,avoid,O,5503
103924,administrating,O,5503
103925,medication,O,5503
103926,onto,O,5503
103927,an,O,5503
103928,already,O,5503
103929,irritated,O,5503
103930,ocular,O,5503
103931,surface,O,5503
103932,In,O,5504
103933,addition,O,5504
103934,nasal,O,5504
103935,delivery,O,5504
103936,may,O,5504
103937,allow,O,5504
103938,some,O,5504
103939,patients,O,5504
103940,who,O,5504
103941,have,O,5504
103942,difficulty,O,5504
103943,independently,O,5504
103944,administering,O,5504
103945,topical,O,5504
103946,eye,O,5504
103947,drops,O,5504
103948,to,O,5504
103949,administer,O,5504
103950,independently,O,5504
103951,their,O,5504
103952,prescribed,O,5504
103953,dry,B-NAME_OF_DISEASE,5504
103954,eye,I-NAME_OF_DISEASE,5504
103955,disease,I-NAME_OF_DISEASE,5504
103956,therapy,O,5504
103957,The,O,5505
103958,approval,O,5505
103959,of,O,5505
103960,Tyrvaya,B-NAME_OF_DRUG,5505
103961,Nasal,I-NAME_OF_DRUG,5505
103962,Spray,I-NAME_OF_DRUG,5505
103963,marks,O,5505
103964,a,O,5505
103965,milestone,O,5505
103966,for,O,5505
103967,patients,O,5505
103968,and,O,5505
103969,eye,O,5505
103970,care,O,5505
103971,professionals,O,5505
103972,by,O,5505
103973,providing,O,5505
103974,a,O,5505
103975,new,O,5505
103976,drug,O,5505
103977,treatment,O,5505
103978,option,O,5505
103979,for,O,5505
103980,the,O,5505
103981,signs,O,5505
103982,and,O,5505
103983,symptoms,O,5505
103984,of,O,5505
103985,dry,B-NAME_OF_DISEASE,5505
103986,eye,I-NAME_OF_DISEASE,5505
103987,disease,I-NAME_OF_DISEASE,5505
103988,with,O,5505
103989,a,O,5505
103990,differentiated,O,5505
103991,route,O,5505
103992,of,O,5505
103993,administration,O,5505
103994,that,O,5505
103995,is,O,5505
103996,believed,O,5505
103997,to,O,5505
103998,leverage,O,5505
103999,a,O,5505
104000,nerve,O,5505
104001,pathway,O,5505
104002,that,O,5505
104003,can,O,5505
104004,be,O,5505
104005,accessed,O,5505
104006,within,O,5505
104007,the,O,5505
104008,nose,O,5505
104009,Jeffrey,B-PERSON,5505
104010,Nau,I-PERSON,5505
104011,PhD,I-PERSON,5505
104012,MMS,I-PERSON,5505
104013,president,O,5505
104014,and,O,5505
104015,CEO,O,5505
104016,of,O,5505
104017,Oyster,B-ORGANIZATION,5505
104018,Point,I-ORGANIZATION,5505
104019,Pharma,I-ORGANIZATION,5505
104020,said,O,5505
104021,in,O,5505
104022,a,O,5505
104023,company,O,5505
104024,news,O,5505
104025,release,O,5505
104026,The,O,5506
104027,drug,O,5506
104028,was,O,5506
104029,tested,O,5506
104030,in,O,5506
104031,over,O,5506
104032,1,O,5506
104033,0,O,5506
104034,patients,O,5506
104035,in,O,5506
104036,the,B-NAME_OF_STUDY,5506
104037,ONSET-1,I-NAME_OF_STUDY,5506
104038,ONSET-2,I-NAME_OF_STUDY,5506
104039,and,I-NAME_OF_STUDY,5506
104040,MYSTIC,I-NAME_OF_STUDY,5506
104041,clinical,I-NAME_OF_STUDY,5506
104042,studies,I-NAME_OF_STUDY,5506
104043,According,O,5507
104044,to,O,5507
104045,Schirmer,O,5507
104046,s,O,5507
104047,score,O,5507
104048,at,O,5507
104049,week,O,5507
104050,4,O,5507
104051,individuals,O,5507
104052,treated,O,5507
104053,with,O,5507
104054,Tyrvaya,B-NAME_OF_DRUG,5507
104055,exhibited,O,5507
104056,statistically,O,5507
104057,significant,O,5507
104058,improvement,O,5507
104059,in,O,5507
104060,tear,B-PART_OF_THE_EYES,5507
104061,film,I-PART_OF_THE_EYES,5507
104062,generation,O,5507
104063,in,O,5507
104064,these,O,5507
104065,trials,O,5507
104066,Sneezing,O,5508
104067,was,O,5508
104068,the,O,5508
104069,most,O,5508
104070,common,O,5508
104071,adverse,O,5508
104072,effect,O,5508
104073,to,O,5508
104074,the,O,5508
104075,medication,O,5508
104076,reported,O,5508
104077,by,O,5508
104078,82%,O,5508
104079,of,O,5508
104080,patients,O,5508
104081,Other,O,5509
104082,minor,O,5509
104083,side,O,5509
104084,effects,O,5509
104085,such,O,5509
104086,as,O,5509
104087,cough,O,5509
104088,throat,O,5509
104089,irritation,O,5509
104090,and,O,5509
104091,nose,O,5509
104092,irritation,O,5509
104093,were,O,5509
104094,reported,O,5509
104095,by,O,5509
104096,5%,O,5509
104097,to,O,5509
104098,16%,O,5509
104099,of,O,5509
104100,patients,O,5509
104101,Tyrvaya,B-NAME_OF_DRUG,5510
104102,Nasal,I-NAME_OF_DRUG,5510
104103,Spray,I-NAME_OF_DRUG,5510
104104,will,O,5510
104105,be,O,5510
104106,available,O,5510
104107,in,O,5510
104108,November,O,5510
104109,2021,O,5510
104110,in,O,5510
104111,cartons,O,5510
104112,containing,O,5510
104113,two,O,5510
104114,multidose,O,5510
104115,nasal,O,5510
104116,spray,O,5510
104117,bottles,O,5510
104118,with,O,5510
104119,a,O,5510
104120,prescription,O,5510
104121,Each,O,5511
104122,nasal,O,5511
104123,spray,O,5511
104124,bottle,O,5511
104125,provides,O,5511
104126,15,B-TIME_DURATION,5511
104127,days,I-TIME_DURATION,5511
104128,of,O,5511
104129,treatment,O,5511
104130,when,O,5511
104131,sprayed,O,5511
104132,twice,O,5511
104133,daily,O,5511
104134,into,O,5511
104135,each,O,5511
104136,nostril,O,5511
104137,Eye,O,5512
104138,care,O,5512
104139,providers,O,5512
104140,will,O,5512
104141,also,O,5512
104142,receive,O,5512
104143,samples,O,5512
104144,that,O,5512
104145,give,O,5512
104146,15,B-TIME_DURATION,5512
104147,days,I-TIME_DURATION,5512
104148,of,O,5512
104149,treatment,O,5512
104150,Arctic,B-ORGANIZATION,5513
104151,Vision,I-ORGANIZATION,5513
104152,of,I-ORGANIZATION,5513
104153,Shanghai,I-ORGANIZATION,5513
104154,and,O,5513
104155,Japanese-based,B-ORGANIZATION,5513
104156,ActualEyes,B-ORGANIZATION,5513
104157,announced,O,5513
104158,an,O,5513
104159,exclusive,O,5513
104160,licensing,O,5513
104161,agreement,O,5513
104162,for,O,5513
104163,Arctic,B-ORGANIZATION,5513
104164,Vision,I-ORGANIZATION,5513
104165,to,O,5513
104166,develop,O,5513
104167,and,O,5513
104168,commercialize,O,5513
104169,ActualEyes,B-ORGANIZATION,5513
104170,lead,O,5513
104171,product,O,5513
104172,candidate,O,5513
104173,AE-101,B-TREATMENT,5513
104174,for,O,5513
104175,the,O,5513
104176,treatment,O,5513
104177,of,O,5513
104178,corneal,B-NAME_OF_DISEASE,5513
104179,endothelial,I-NAME_OF_DISEASE,5513
104180,dysfunction,I-NAME_OF_DISEASE,5513
104181,in,O,5513
104182,Greater,B-GPE,5513
104183,China,B-GPE,5513
104184,and,O,5513
104185,South,B-GPE,5513
104186,Korea,I-GPE,5513
104187,Under,O,5514
104188,the,O,5514
104189,accord,O,5514
104190,ActualEyes,B-ORGANIZATION,5514
104191,may,O,5514
104192,receive,O,5514
104193,up,O,5514
104194,to,O,5514
104195,more,O,5514
104196,than,O,5514
104197,35-million,O,5514
104198,U.S,O,5514
104199,including,O,5515
104200,an,O,5515
104201,upfront,O,5515
104202,payment,O,5515
104203,future,O,5515
104204,regulatory,O,5515
104205,milestones,O,5515
104206,and,O,5515
104207,tiered,O,5515
104208,royalties,O,5515
104209,on,O,5515
104210,net,O,5515
104211,sales,O,5515
104212,Corneal,B-NAME_OF_DISEASE,5516
104213,endothelial,I-NAME_OF_DISEASE,5516
104214,dysfunction,I-NAME_OF_DISEASE,5516
104215,is,O,5516
104216,the,O,5516
104217,result,O,5516
104218,of,O,5516
104219,severe,O,5516
104220,endothelium,B-SIGN_AND_SYMPTOM,5516
104221,damage,I-SIGN_AND_SYMPTOM,5516
104222,caused,O,5516
104223,by,O,5516
104224,different,O,5516
104225,pathologies,O,5516
104226,including,O,5516
104227,Fuchs,B-NAME_OF_DISEASE,5516
104228,endothelial,I-NAME_OF_DISEASE,5516
104229,corneal,I-NAME_OF_DISEASE,5516
104230,dystrophy,I-NAME_OF_DISEASE,5516
104231,pseudophakic,B-NAME_OF_DISEASE,5516
104232,bullous,I-NAME_OF_DISEASE,5516
104233,keratopathy,I-NAME_OF_DISEASE,5516
104234,trauma,B-NAME_OF_DISEASE,5516
104235,glaucoma,B-NAME_OF_DISEASE,5516
104236,and,O,5516
104237,endothelial,B-NAME_OF_DISEASE,5516
104238,keratitis,I-NAME_OF_DISEASE,5516
104239,More,O,5517
104240,than,O,5517
104241,one,O,5517
104242,million,O,5517
104243,patients,O,5517
104244,suffer,O,5517
104245,from,O,5517
104246,corneal,B-NAME_OF_DISEASE,5517
104247,endothelial,I-NAME_OF_DISEASE,5517
104248,dysfunction,I-NAME_OF_DISEASE,5517
104249,in,O,5517
104250,China,B-GPE,5517
104251,and,O,5517
104252,in,O,5517
104253,the,O,5517
104254,most,O,5517
104255,severe,O,5517
104256,cases,O,5517
104257,the,O,5517
104258,most,O,5517
104259,effective,O,5517
104260,treatment,O,5517
104261,is,O,5517
104262,corneal,B-TREATMENT,5517
104263,keratoplasty,I-TREATMENT,5517
104264,a,O,5517
104265,demanding,O,5517
104266,and,O,5517
104267,technically,O,5517
104268,challenging,O,5517
104269,procedure,O,5517
104270,for,O,5517
104271,surgeons,O,5517
104272,AE-101,B-TREATMENT,5518
104273,is,O,5518
104274,a,O,5518
104275,novel,O,5518
104276,cell-injection,O,5518
104277,therapy,O,5518
104278,developed,O,5518
104279,using,O,5518
104280,cultured,O,5518
104281,human,B-PART_OF_THE_EYES,5518
104282,corneal,I-PART_OF_THE_EYES,5518
104283,endothelial,I-PART_OF_THE_EYES,5518
104284,cells,I-PART_OF_THE_EYES,5518
104285,combined,O,5518
104286,with,O,5518
104287,a,B-CHEMICAL_COMPOUND,5518
104288,Rho-associated,I-CHEMICAL_COMPOUND,5518
104289,kinase,I-CHEMICAL_COMPOUND,5518
104290,inhibitor,I-CHEMICAL_COMPOUND,5518
104291,A,O,5519
104292,study,O,5519
104293,published,O,5519
104294,in,O,5519
104295,the,B-PUBLICATION_VENUE,5519
104296,New,I-PUBLICATION_VENUE,5519
104297,England,I-PUBLICATION_VENUE,5519
104298,Journal,I-PUBLICATION_VENUE,5519
104299,of,I-PUBLICATION_VENUE,5519
104300,Medicine,I-PUBLICATION_VENUE,5519
104301,and,I-PUBLICATION_VENUE,5519
104302,Ophthalmology,I-PUBLICATION_VENUE,5519
104303,led,O,5519
104304,by,O,5519
104305,ActualEyes,B-ORGANIZATION,5519
104306,scientific,O,5519
104307,founders,O,5519
104308,Dr,O,5519
104309,Noriko,O,5520
104310,Koizumi,O,5520
104311,and,O,5520
104312,Dr,O,5520
104313,Naoki,O,5521
104314,Okumura,O,5521
104315,demonstrated,O,5521
104316,that,O,5521
104317,AE-101,B-TREATMENT,5521
104318,can,O,5521
104319,restore,O,5521
104320,corneal,B-NAME_OF_DISEASE,5521
104321,endothelial,I-NAME_OF_DISEASE,5521
104322,function,I-NAME_OF_DISEASE,5521
104323,as,O,5521
104324,well,O,5521
104325,as,O,5521
104326,vision,O,5521
104327,with,O,5521
104328,no,O,5521
104329,major,O,5521
104330,treatment-relevant,O,5521
104331,adverse,O,5521
104332,reactions,O,5521
104333,for,O,5521
104334,up,B-TIME_DURATION,5521
104335,to,I-TIME_DURATION,5521
104336,five-years,I-TIME_DURATION,5521
104337,post-operation,O,5521
104338,which,O,5521
104339,represents,O,5521
104340,a,O,5521
104341,paradigm,O,5521
104342,shift,O,5521
104343,in,O,5521
104344,corneal,O,5521
104345,regenerative,O,5521
104346,medicine,O,5521
104347,In,O,5522
104348,a,O,5522
104349,statement,O,5522
104350,Dr,O,5522
104351,Eddy,O,5523
104352,Wu,O,5523
104353,founder,O,5523
104354,and,O,5523
104355,CEO,O,5523
104356,of,O,5523
104357,Arctic,B-ORGANIZATION,5523
104358,Vision,I-ORGANIZATION,5523
104359,said,O,5523
104360,China,B-GPE,5523
104361,is,O,5523
104362,a,O,5523
104363,market,O,5523
104364,with,O,5523
104365,high,O,5523
104366,prevalence,O,5523
104367,of,O,5523
104368,corneal,B-NAME_OF_DISEASE,5523
104369,diseases,I-NAME_OF_DISEASE,5523
104370,as,O,5523
104371,well,O,5523
104372,as,O,5523
104373,huge,O,5523
104374,unmet,O,5523
104375,clinical,O,5523
104376,need,O,5523
104377,due,O,5523
104378,to,O,5523
104379,a,O,5523
104380,shortage,O,5523
104381,of,O,5523
104382,donor,O,5523
104383,corneas,O,5523
104384,The,O,5524
104385,market,O,5524
104386,potential,O,5524
104387,is,O,5524
104388,tremendous,O,5524
104389,for,O,5524
104390,more,O,5524
104391,accessible,O,5524
104392,therapies,O,5524
104393,with,O,5524
104394,greater,O,5524
104395,safety,O,5524
104396,and,O,5524
104397,efficacy,O,5524
104398,he,O,5524
104399,added,O,5524
104400,The,O,5525
104401,licensing,O,5525
104402,of,O,5525
104403,AE-101,B-TREATMENT,5525
104404,represents,O,5525
104405,not,O,5525
104406,only,O,5525
104407,a,O,5525
104408,corporate,O,5525
104409,milestone,O,5525
104410,of,O,5525
104411,incorporating,O,5525
104412,the,O,5525
104413,first,O,5525
104414,cell,O,5525
104415,therapy,O,5525
104416,in,O,5525
104417,our,O,5525
104418,pipeline,O,5525
104419,but,O,5525
104420,also,O,5525
104421,our,O,5525
104422,commitment,O,5525
104423,to,O,5525
104424,an,O,5525
104425,overall,O,5525
104426,portfolio,O,5525
104427,strategy,O,5525
104428,aimed,O,5525
104429,to,O,5525
104430,discover,O,5525
104431,and,O,5525
104432,deliver,O,5525
104433,breakthrough,O,5525
104434,therapies,O,5525
104435,for,O,5525
104436,patients,O,5525
104437,in,O,5525
104438,China,B-GPE,5525
104439,and,O,5525
104440,Asia,B-GPE,5525
104441,Iku,B-PERSON,5526
104442,Sugioka,I-PERSON,5526
104443,President,O,5526
104444,and,O,5526
104445,Chief,O,5526
104446,Executive,O,5526
104447,Officer,O,5526
104448,of,O,5526
104449,ActualEyes,B-ORGANIZATION,5526
104450,said,O,5526
104451,We,O,5526
104452,look,O,5526
104453,forward,O,5526
104454,to,O,5526
104455,collaborating,O,5526
104456,with,O,5526
104457,Arctic,B-ORGANIZATION,5526
104458,Vision,I-ORGANIZATION,5526
104459,to,O,5526
104460,develop,O,5526
104461,our,O,5526
104462,lead,O,5526
104463,clinical,O,5526
104464,candidate,O,5526
104465,AE-101,B-TREATMENT,5526
104466,The,O,5527
104467,potential,O,5527
104468,benefits,O,5527
104469,of,O,5527
104470,cell,O,5527
104471,therapy,O,5527
104472,are,O,5527
104473,significant,O,5527
104474,for,O,5527
104475,patients,O,5527
104476,suffering,O,5527
104477,from,O,5527
104478,vison,B-SIGN_AND_SYMPTOM,5527
104479,impairment,I-SIGN_AND_SYMPTOM,5527
104480,or,I-SIGN_AND_SYMPTOM,5527
104481,loss,I-SIGN_AND_SYMPTOM,5527
104482,caused,O,5527
104483,by,O,5527
104484,corneal,B-NAME_OF_DISEASE,5527
104485,endothelial,I-NAME_OF_DISEASE,5527
104486,dysfunction,I-NAME_OF_DISEASE,5527
104487,From,O,5528
104488,our,O,5528
104489,previous,O,5528
104490,research,O,5528
104491,AE-101,B-TREATMENT,5528
104492,has,O,5528
104493,great,O,5528
104494,potential,O,5528
104495,to,O,5528
104496,provide,O,5528
104497,a,O,5528
104498,less,O,5528
104499,invasive,O,5528
104500,and,O,5528
104501,more,O,5528
104502,effective,O,5528
104503,therapeutic,O,5528
104504,modality,O,5528
104505,compared,O,5528
104506,to,O,5528
104507,conventional,O,5528
104508,surgical,O,5528
104509,therapies,O,5528
104510,With,O,5529
104511,the,O,5529
104512,compelling,O,5529
104513,track,O,5529
104514,records,O,5529
104515,of,O,5529
104516,Arctic,B-ORGANIZATION,5529
104517,Vision,I-ORGANIZATION,5529
104518,s,O,5529
104519,management,O,5529
104520,team,O,5529
104521,in,O,5529
104522,research,O,5529
104523,and,O,5529
104524,commercial,O,5529
104525,fronts,O,5529
104526,we,O,5529
104527,are,O,5529
104528,confident,O,5529
104529,that,O,5529
104530,this,O,5529
104531,partnership,O,5529
104532,is,O,5529
104533,the,O,5529
104534,start,O,5529
104535,of,O,5529
104536,a,O,5529
104537,long-term,O,5529
104538,relationship,O,5529
104539,to,O,5529
104540,bring,O,5529
104541,our,O,5529
104542,novel,O,5529
104543,AE-101,B-TREATMENT,5529
104544,therapy,O,5529
104545,to,O,5529
104546,broader,O,5529
104547,markets,O,5529
104548,in,O,5529
104549,Asia,B-GPE,5529
104550,Alcon,B-ORGANIZATION,5530
104551,the,O,5530
104552,global,O,5530
104553,leader,O,5530
104554,in,O,5530
104555,eye,O,5530
104556,care,O,5530
104557,dedicated,O,5530
104558,to,O,5530
104559,helping,O,5530
104560,people,O,5530
104561,see,O,5530
104562,brilliantly,O,5530
104563,announced,O,5530
104564,the,O,5530
104565,U.S,O,5530
104566,launch,O,5531
104567,of,O,5531
104568,PRECISION1®,B-TREATMENT,5531
104569,for,I-TREATMENT,5531
104570,Astigmatism,B-NAME_OF_DISEASE,5531
104571,a,O,5531
104572,daily,O,5531
104573,disposable,O,5531
104574,silicone,B-TREATMENT,5531
104575,hydrogel,I-TREATMENT,5531
104576,SiHy,I-TREATMENT,5531
104577,contact,B-TREATMENT,5531
104578,lens,I-TREATMENT,5531
104579,designed,O,5531
104580,for,O,5531
104581,astigmatic,O,5531
104582,patients,O,5531
104583,PRECISION1,B-TREATMENT,5532
104584,for,I-TREATMENT,5532
104585,Astigmatism,B-NAME_OF_DISEASE,5532
104586,born,O,5532
104587,from,O,5532
104588,Water,O,5532
104589,Gradient,O,5532
104590,Technology,O,5532
104591,features,O,5532
104592,the,O,5532
104593,proven,O,5532
104594,PRECISION,B-TREATMENT,5532
104595,BALANCE,I-TREATMENT,5532
104596,8|4,I-TREATMENT,5532
104597,lens,I-TREATMENT,5532
104598,design,O,5532
104599,for,O,5532
104600,a,O,5532
104601,stable,O,5532
104602,contact,O,5532
104603,lens-wearing,O,5532
104604,experience,O,5532
104605,The,O,5532
104606,lens,O,5532
104607,offers,O,5532
104608,a,O,5532
104609,significant,O,5532
104610,opportunity,O,5532
104611,to,O,5532
104612,attract,O,5532
104613,new,O,5532
104614,contact,B-TREATMENT,5532
104615,lens,I-TREATMENT,5532
104616,wearers,O,5532
104617,and,O,5532
104618,reduce,O,5532
104619,contact,B-TREATMENT,5532
104620,lens,I-TREATMENT,5532
104621,dropouts,O,5532
104622,PRECISION1,B-TREATMENT,5532
104623,and,O,5532
104624,PRECISION1,B-TREATMENT,5532
104625,for,I-TREATMENT,5532
104626,Astigmatism,B-NAME_OF_DISEASE,5532
104627,are,O,5532
104628,now,O,5532
104629,widely,O,5532
104630,available,O,5532
104631,in,O,5532
104632,the,O,5532
104633,U.S,O,5532
104634,and,O,5533
104635,will,O,5533
104636,roll,O,5533
104637,out,O,5533
104638,concurrently,O,5533
104639,worldwide,O,5533
104640,beginning,O,5533
104641,in,O,5533
104642,February,O,5533
104643,2021,O,5533
104644,PRECISION1,B-TREATMENT,5533
104645,with,O,5533
104646,its,O,5533
104647,cutting-edge,O,5533
104648,SMARTSURFACE®,O,5533
104649,technology,O,5533
104650,has,O,5533
104651,become,O,5533
104652,the,O,5533
104653,fastest-growing,O,5533
104654,daily,O,5533
104655,disposable,O,5533
104656,contact,B-TREATMENT,5533
104657,lens,I-TREATMENT,5533
104658,brand,O,5533
104659,in,O,5533
104660,the,O,5533
104661,U.S,O,5533
104662,said,O,5534
104663,Sergio,B-PERSON,5534
104664,Duplan,I-PERSON,5534
104665,President,O,5534
104666,Alcon,B-ORGANIZATION,5534
104667,North,I-ORGANIZATION,5534
104668,America,I-ORGANIZATION,5534
104669,We,O,5535
104670,are,O,5535
104671,thrilled,O,5535
104672,to,O,5535
104673,build,O,5535
104674,on,O,5535
104675,this,O,5535
104676,momentum,O,5535
104677,by,O,5535
104678,introducing,O,5535
104679,PRECISION1,B-TREATMENT,5535
104680,for,I-TREATMENT,5535
104681,Astigmatism,B-NAME_OF_DISEASE,5535
104682,Alcon,B-ORGANIZATION,5535
104683,s,O,5535
104684,first,O,5535
104685,daily,O,5535
104686,disposable,O,5535
104687,SiHy,B-TREATMENT,5535
104688,toric,I-TREATMENT,5535
104689,lens,I-TREATMENT,5535
104690,at,O,5535
104691,a,O,5535
104692,mainstream,O,5535
104693,price,O,5535
104694,This,O,5536
104695,innovation,O,5536
104696,offers,O,5536
104697,Eye,O,5536
104698,Care,O,5536
104699,Professionals,O,5536
104700,a,O,5536
104701,lens,O,5536
104702,for,O,5536
104703,more,O,5536
104704,of,O,5536
104705,their,O,5536
104706,astigmatic,O,5536
104707,patients,O,5536
104708,to,O,5536
104709,start,O,5536
104710,in,O,5536
104711,and,O,5536
104712,stay,O,5536
104713,in,O,5536
104714,PRECISION1,B-TREATMENT,5537
104715,for,I-TREATMENT,5537
104716,Astigmatism,B-NAME_OF_DISEASE,5537
104717,born,O,5537
104718,from,O,5537
104719,the,O,5537
104720,Water,O,5537
104721,Gradient,O,5537
104722,Technology,O,5537
104723,of,O,5537
104724,DAILIES,B-TREATMENT,5537
104725,TOTAL1®,I-TREATMENT,5537
104726,features,O,5537
104727,the,O,5537
104728,proven,O,5537
104729,PRECISION,B-TREATMENT,5537
104730,BALANCE,I-TREATMENT,5537
104731,8|4®,I-TREATMENT,5537
104732,lens,I-TREATMENT,5537
104733,design,O,5537
104734,for,O,5537
104735,a,O,5537
104736,stable,O,5537
104737,lens-wearing,O,5537
104738,experience,O,5537
104739,Clinical,O,5538
104740,studies,O,5538
104741,show,O,5538
104742,the,O,5538
104743,toric,O,5538
104744,lens,O,5538
104745,settles,O,5538
104746,in,O,5538
104747,less,O,5538
104748,than,O,5538
104749,60,O,5538
104750,seconds,O,5538
104751,and,O,5538
104752,3º,O,5538
104753,of,O,5538
104754,ideal,O,5538
104755,orientation,O,5538
104756,for,O,5538
104757,a,O,5538
104758,99%,O,5538
104759,first,O,5538
104760,fit,O,5538
104761,success,O,5538
104762,rate,O,5538
104763,Additionally,O,5539
104764,a,O,5539
104765,single,O,5539
104766,6,O,5539
104767,o,O,5539
104768,clock,O,5539
104769,scribe,O,5539
104770,mark,O,5539
104771,makes,O,5539
104772,fitting,O,5539
104773,exceptionally,O,5539
104774,easy,O,5539
104775,Astigmatism,B-NAME_OF_DISEASE,5540
104776,is,O,5540
104777,a,O,5540
104778,common,O,5540
104779,vision,O,5540
104780,problem,O,5540
104781,caused,O,5540
104782,by,O,5540
104783,an,O,5540
104784,irregularly,O,5540
104785,shaped,O,5540
104786,cornea,B-PART_OF_THE_EYES,5540
104787,This,O,5541
104788,can,O,5541
104789,cause,O,5541
104790,images,B-SIGN_AND_SYMPTOM,5541
104791,to,I-SIGN_AND_SYMPTOM,5541
104792,blur,I-SIGN_AND_SYMPTOM,5541
104793,or,I-SIGN_AND_SYMPTOM,5541
104794,stretch,I-SIGN_AND_SYMPTOM,5541
104795,out,I-SIGN_AND_SYMPTOM,5541
104796,Alcon,B-ORGANIZATION,5542
104797,estimates,O,5542
104798,that,O,5542
104799,toric,B-TREATMENT,5542
104800,lenses,I-TREATMENT,5542
104801,which,O,5542
104802,correct,O,5542
104803,for,O,5542
104804,astigmatism,B-NAME_OF_DISEASE,5542
104805,represent,O,5542
104806,23%,O,5542
104807,of,O,5542
104808,the,O,5542
104809,9,O,5542
104810,billion,O,5542
104811,global,O,5542
104812,contact,B-TREATMENT,5542
104813,lens,I-TREATMENT,5542
104814,market,O,5542
104815,As,O,5543
104816,a,O,5543
104817,result,O,5543
104818,there,O,5543
104819,is,O,5543
104820,a,O,5543
104821,significant,O,5543
104822,opportunity,O,5543
104823,to,O,5543
104824,attract,O,5543
104825,new,O,5543
104826,contact,B-TREATMENT,5543
104827,lens,I-TREATMENT,5543
104828,wearers,O,5543
104829,and,O,5543
104830,reduce,O,5543
104831,lens,O,5543
104832,dropouts,O,5543
104833,For,O,5544
104834,example,O,5544
104835,studies,O,5544
104836,show,O,5544
104837,that,O,5544
104838,41%,O,5544
104839,of,O,5544
104840,patients,O,5544
104841,are,O,5544
104842,astigmatic,O,5544
104843,but,O,5544
104844,only,O,5544
104845,10%,O,5544
104846,wear,O,5544
104847,toric,B-TREATMENT,5544
104848,contact,I-TREATMENT,5544
104849,lenses,I-TREATMENT,5544
104850,Further,O,5545
104851,about,O,5545
104852,65%,O,5545
104853,of,O,5545
104854,contact,B-TREATMENT,5545
104855,lens,I-TREATMENT,5545
104856,dropouts,O,5545
104857,have,O,5545
104858,astigmatism,B-NAME_OF_DISEASE,5545
104859,Born,O,5546
104860,from,O,5546
104861,Water,O,5546
104862,Gradient,O,5546
104863,Technology,O,5546
104864,PRECISION1,B-TREATMENT,5546
104865,lenses,I-TREATMENT,5546
104866,feature,O,5546
104867,SMARTSURFACE,B-TREATMENT,5546
104868,Technology,I-TREATMENT,5546
104869,a,O,5546
104870,permanent,O,5546
104871,micro-thin,O,5546
104872,high-performance,O,5546
104873,layer,O,5546
104874,of,O,5546
104875,moisture,O,5546
104876,that,O,5546
104877,steps,O,5546
104878,up,O,5546
104879,from,O,5546
104880,51%,O,5546
104881,water,O,5546
104882,at,O,5546
104883,the,O,5546
104884,core,O,5546
104885,to,O,5546
104886,greater,O,5546
104887,than,O,5546
104888,80%,O,5546
104889,water,O,5546
104890,at,O,5546
104891,the,O,5546
104892,outer,O,5546
104893,surface,O,5546
104894,These,O,5547
104895,lenses,O,5547
104896,support,O,5547
104897,a,O,5547
104898,stable,O,5547
104899,tear,B-PART_OF_THE_EYES,5547
104900,film,I-PART_OF_THE_EYES,5547
104901,to,O,5547
104902,deliver,O,5547
104903,lasting,O,5547
104904,performance,O,5547
104905,Many,O,5548
104906,of,O,5548
104907,my,O,5548
104908,patients,O,5548
104909,want,O,5548
104910,long-lasting,O,5548
104911,comfort,O,5548
104912,from,O,5548
104913,their,O,5548
104914,daily,O,5548
104915,disposable,O,5548
104916,contact,B-TREATMENT,5548
104917,lens,I-TREATMENT,5548
104918,and,O,5548
104919,that,O,5548
104920,s,O,5548
104921,led,O,5548
104922,me,O,5548
104923,to,O,5548
104924,wholeheartedly,O,5548
104925,prescribe,O,5548
104926,PRECISION1,B-TREATMENT,5548
104927,said,O,5548
104928,Aaron,B-PERSON,5548
104929,Luekenga,I-PERSON,5548
104930,OD,O,5548
104931,Heritage,B-ORGANIZATION,5548
104932,Valley,I-ORGANIZATION,5548
104933,Eye,I-ORGANIZATION,5548
104934,Care,I-ORGANIZATION,5548
104935,California,I-ORGANIZATION,5548
104936,Now,O,5549
104937,with,O,5549
104938,PRECISION1,B-TREATMENT,5549
104939,for,I-TREATMENT,5549
104940,Astigmatism,B-NAME_OF_DISEASE,5549
104941,I,O,5549
104942,can,O,5549
104943,offer,O,5549
104944,my,O,5549
104945,astigmatic,O,5549
104946,patients,O,5549
104947,a,O,5549
104948,stable,O,5549
104949,next-generation,O,5549
104950,lens-wearing,O,5549
104951,experience,O,5549
104952,PRECISION1,B-TREATMENT,5550
104953,and,O,5550
104954,PRECISION1,B-TREATMENT,5550
104955,for,I-TREATMENT,5550
104956,Astigmatism,B-NAME_OF_DISEASE,5550
104957,are,O,5550
104958,available,O,5550
104959,in,O,5550
104960,optical,O,5550
104961,retailers,O,5550
104962,practices,O,5550
104963,and,O,5550
104964,online,O,5550
104965,throughout,O,5550
104966,the,B-GPE,5550
104967,United,I-GPE,5550
104968,States,I-GPE,5550
104969,Eye,O,5551
104970,Care,O,5551
104971,Professionals,O,5551
104972,with,O,5551
104973,or,O,5551
104974,without,O,5551
104975,fit,O,5551
104976,sets,O,5551
104977,will,O,5551
104978,have,O,5551
104979,access,O,5551
104980,to,O,5551
104981,order,O,5551
104982,trial,O,5551
104983,and,O,5551
104984,revenue,O,5551
104985,lenses,O,5551
104986,directly,O,5551
104987,from,O,5551
104988,Alcon,B-ORGANIZATION,5551
104989,or,O,5551
104990,an,O,5551
104991,Alcon-authorized,O,5551
104992,distributor,O,5551
104993,In,O,5552
104994,addition,O,5552
104995,PRECISION1,B-TREATMENT,5552
104996,and,O,5552
104997,PRECISION1,B-TREATMENT,5552
104998,for,I-TREATMENT,5552
104999,Astigmatism,B-NAME_OF_DISEASE,5552
105000,will,O,5552
105001,begin,O,5552
105002,to,O,5552
105003,roll,O,5552
105004,out,O,5552
105005,concurrently,O,5552
105006,worldwide,O,5552
105007,beginning,O,5552
105008,in,O,5552
105009,February,O,5552
105010,2021,O,5552
105011,The,B-NAME_OF_DRUG,5553
105012,nonsteroidal,I-NAME_OF_DRUG,5553
105013,anti-inflammatory,I-NAME_OF_DRUG,5553
105014,drug,I-NAME_OF_DRUG,5553
105015,NSAID,I-NAME_OF_DRUG,5553
105016,aspirin,B-CHEMICAL_COMPOUND,5553
105017,a,O,5553
105018,common,O,5553
105019,medication,O,5553
105020,used,O,5553
105021,to,O,5553
105022,reduce,O,5553
105023,pain,O,5553
105024,fever,O,5553
105025,or,O,5553
105026,inflammation,O,5553
105027,has,O,5553
105028,been,O,5553
105029,developed,O,5553
105030,into,O,5553
105031,nanorods,O,5553
105032,by,O,5553
105033,a,O,5553
105034,team,O,5553
105035,of,O,5553
105036,scientists,O,5553
105037,from,O,5553
105038,the,B-ORGANIZATION,5553
105039,Institute,I-ORGANIZATION,5553
105040,of,I-ORGANIZATION,5553
105041,Nano,I-ORGANIZATION,5553
105042,Science,I-ORGANIZATION,5553
105043,Technology,I-ORGANIZATION,5553
105044,INST,I-ORGANIZATION,5553
105045,an,O,5553
105046,autonomous,O,5553
105047,institute,O,5553
105048,under,O,5553
105049,the,B-ORGANIZATION,5553
105050,Department,I-ORGANIZATION,5553
105051,of,I-ORGANIZATION,5553
105052,Science,I-ORGANIZATION,5553
105053,Technology,I-ORGANIZATION,5553
105054,Government,I-ORGANIZATION,5553
105055,of,I-ORGANIZATION,5553
105056,India,I-ORGANIZATION,5553
105057,and,O,5553
105058,they,O,5553
105059,discovered,O,5553
105060,it,O,5553
105061,to,O,5553
105062,be,O,5553
105063,an,O,5553
105064,efficient,O,5553
105065,non-invasive,B-PREVENTION,5553
105066,small,I-PREVENTION,5553
105067,molecule-based,I-PREVENTION,5553
105068,nanotherapeutics,I-PREVENTION,5553
105069,against,O,5553
105070,cataract,B-NAME_OF_DISEASE,5553
105071,The,O,5554
105072,study,O,5554
105073,that,O,5554
105074,was,O,5554
105075,published,O,5554
105076,in,O,5554
105077,the,B-PUBLICATION_VENUE,5554
105078,Journal,I-PUBLICATION_VENUE,5554
105079,of,I-PUBLICATION_VENUE,5554
105080,Materials,I-PUBLICATION_VENUE,5554
105081,Chemistry,I-PUBLICATION_VENUE,5554
105082,B,I-PUBLICATION_VENUE,5554
105083,may,O,5554
105084,provide,O,5554
105085,an,O,5554
105086,affordable,O,5554
105087,and,O,5554
105088,simple,O,5554
105089,method,O,5554
105090,for,O,5554
105091,preventing,O,5554
105092,cataracts,B-NAME_OF_DISEASE,5554
105093,They,O,5555
105094,have,O,5555
105095,employed,O,5555
105096,self-assembled,O,5555
105097,aspirin,B-CHEMICAL_COMPOUND,5555
105098,nanorods,O,5555
105099,anti-aggregation,O,5555
105100,properties,O,5555
105101,as,O,5555
105102,an,O,5555
105103,efficient,O,5555
105104,non-invasive,B-PREVENTION,5555
105105,small,I-PREVENTION,5555
105106,molecule-based,I-PREVENTION,5555
105107,nanotherapeutic,I-PREVENTION,5555
105108,against,O,5555
105109,cataract,B-NAME_OF_DISEASE,5555
105110,Aspirin,B-CHEMICAL_COMPOUND,5556
105111,nanorods,O,5556
105112,suppress,O,5556
105113,the,O,5556
105114,aggregation,O,5556
105115,of,O,5556
105116,the,B-CHEMICAL_COMPOUND,5556
105117,crystallin,B-CHEMICAL_COMPOUND,5556
105118,protein,B-CHEMICAL_COMPOUND,5556
105119,and,O,5556
105120,different,O,5556
105121,peptides,B-CHEMICAL_COMPOUND,5556
105122,produced,O,5556
105123,from,O,5556
105124,it,O,5556
105125,which,O,5556
105126,are,O,5556
105127,essential,O,5556
105128,for,O,5556
105129,the,O,5556
105130,development,O,5556
105131,of,O,5556
105132,cataracts,B-NAME_OF_DISEASE,5556
105133,Through,O,5557
105134,biomolecular,O,5557
105135,interactions,O,5557
105136,they,O,5557
105137,stop,O,5557
105138,the,O,5557
105139,protein,B-CHEMICAL_COMPOUND,5557
105140,peptide,B-CHEMICAL_COMPOUND,5557
105141,from,O,5557
105142,aggregating,O,5557
105143,by,O,5557
105144,changing,O,5557
105145,the,O,5557
105146,beta-turn-like,O,5557
105147,shape,O,5557
105148,of,O,5557
105149,the,O,5557
105150,crystallin,B-CHEMICAL_COMPOUND,5557
105151,peptides,I-CHEMICAL_COMPOUND,5557
105152,which,O,5557
105153,is,O,5557
105154,what,O,5557
105155,causes,O,5557
105156,amyloid,B-CHEMICAL_COMPOUND,5557
105157,to,O,5557
105158,develop,O,5557
105159,into,O,5557
105160,coils,O,5557
105161,and,O,5557
105162,helices,O,5557
105163,which,O,5557
105164,do,O,5557
105165,not,O,5557
105166,aggregate,O,5557
105167,These,O,5558
105168,were,O,5558
105169,discovered,O,5558
105170,to,O,5558
105171,block,O,5558
105172,the,O,5558
105173,development,O,5558
105174,of,O,5558
105175,crystallin,B-CHEMICAL_COMPOUND,5558
105176,and,O,5558
105177,crystallin-derived,B-CHEMICAL_COMPOUND,5558
105178,peptide,I-CHEMICAL_COMPOUND,5558
105179,aggregates,O,5558
105180,which,O,5558
105181,prevent,O,5558
105182,cataract,B-NAME_OF_DISEASE,5558
105183,formation,O,5558
105184,The,B-CHEMICAL_COMPOUND,5559
105185,lens,I-CHEMICAL_COMPOUND,5559
105186,protein,I-CHEMICAL_COMPOUND,5559
105187,crystallin,I-CHEMICAL_COMPOUND,5559
105188,accumulates,O,5559
105189,to,O,5559
105190,form,O,5559
105191,opaque,B-SIGN_AND_SYMPTOM,5559
105192,formations,I-SIGN_AND_SYMPTOM,5559
105193,in,I-SIGN_AND_SYMPTOM,5559
105194,the,I-SIGN_AND_SYMPTOM,5559
105195,eye,I-SIGN_AND_SYMPTOM,5559
105196,lens,I-SIGN_AND_SYMPTOM,5559
105197,with,O,5559
105198,aging,O,5559
105199,and,O,5559
105200,other,O,5559
105201,diseases,O,5559
105202,impairing,B-SIGN_AND_SYMPTOM,5559
105203,vision,I-SIGN_AND_SYMPTOM,5559
105204,and,O,5559
105205,leading,O,5559
105206,to,O,5559
105207,cataract,B-NAME_OF_DISEASE,5559
105208,One,O,5560
105209,effective,O,5560
105210,therapeutic,O,5560
105211,approach,O,5560
105212,for,O,5560
105213,the,O,5560
105214,prevention,O,5560
105215,of,O,5560
105216,cataract,B-NAME_OF_DISEASE,5560
105217,formation,O,5560
105218,is,O,5560
105219,the,O,5560
105220,targeted,O,5560
105221,disaggregation,O,5560
105222,of,O,5560
105223,the,O,5560
105224,accumulated,O,5560
105225,alpha-crystallin,B-CHEMICAL_COMPOUND,5560
105226,protein,I-CHEMICAL_COMPOUND,5560
105227,and,O,5560
105228,crystallin,B-CHEMICAL_COMPOUND,5560
105229,derived,I-CHEMICAL_COMPOUND,5560
105230,peptide,I-CHEMICAL_COMPOUND,5560
105231,aggregates,O,5560
105232,in,O,5560
105233,old,O,5560
105234,and,O,5560
105235,cataractous,O,5560
105236,human,B-PART_OF_THE_EYES,5560
105237,lenses,I-PART_OF_THE_EYES,5560
105238,In,O,5561
105239,contrast,O,5561
105240,to,O,5561
105241,the,O,5561
105242,expensive,O,5561
105243,and,O,5561
105244,time-consuming,O,5561
105245,physical,O,5561
105246,procedures,O,5561
105247,often,O,5561
105248,employed,O,5561
105249,for,O,5561
105250,the,O,5561
105251,production,O,5561
105252,of,O,5561
105253,nanoparticles,O,5561
105254,the,O,5561
105255,aspirin,B-CHEMICAL_COMPOUND,5561
105256,nanorods,O,5561
105257,are,O,5561
105258,generated,O,5561
105259,utilizing,O,5561
105260,the,O,5561
105261,molecular,O,5561
105262,self-assembly,O,5561
105263,approach,O,5561
105264,which,O,5561
105265,is,O,5561
105266,low,O,5561
105267,cost,O,5561
105268,and,O,5561
105269,high,O,5561
105270,yield,O,5561
105271,The,O,5562
105272,chemical,O,5562
105273,mechanism,O,5562
105274,behind,O,5562
105275,aspirin,B-CHEMICAL_COMPOUND,5562
105276,s,O,5562
105277,anti-aggregation,O,5562
105278,behavior,O,5562
105279,and,O,5562
105280,the,O,5562
105281,nature,O,5562
105282,of,O,5562
105283,protein,B-CHEMICAL_COMPOUND,5562
105284,peptide,I-CHEMICAL_COMPOUND,5562
105285,#NAME?,I-CHEMICAL_COMPOUND,5562
105286,interactions,O,5562
105287,between,O,5562
105288,the,O,5562
105289,synthetic,B-CHEMICAL_COMPOUND,5562
105290,peptides,I-CHEMICAL_COMPOUND,5562
105291,and,O,5562
105292,aspirin,B-CHEMICAL_COMPOUND,5562
105293,were,O,5562
105294,investigated,O,5562
105295,by,O,5562
105296,computational,O,5562
105297,research,O,5562
105298,based,O,5562
105299,on,O,5562
105300,molecular,O,5562
105301,dynamics,O,5562
105302,MD,O,5562
105303,simulations,O,5562
105304,It,O,5563
105305,was,O,5563
105306,shown,O,5563
105307,that,O,5563
105308,the,O,5563
105309,interactions,O,5563
105310,between,O,5563
105311,peptide,B-CHEMICAL_COMPOUND,5563
105312,and,I-CHEMICAL_COMPOUND,5563
105313,aspirin,I-CHEMICAL_COMPOUND,5563
105314,inhibitor,I-CHEMICAL_COMPOUND,5563
105315,ultimately,O,5563
105316,changed,O,5563
105317,the,O,5563
105318,secondary,O,5563
105319,structures,O,5563
105320,of,O,5563
105321,peptides,B-CHEMICAL_COMPOUND,5563
105322,from,O,5563
105323,beta-turns,O,5563
105324,which,O,5563
105325,are,O,5563
105326,responsible,O,5563
105327,for,O,5563
105328,the,O,5563
105329,production,O,5563
105330,of,O,5563
105331,amyloids,B-CHEMICAL_COMPOUND,5563
105332,into,O,5563
105333,other,O,5563
105334,coils,O,5563
105335,and,O,5563
105336,helixes,O,5563
105337,inhibiting,O,5563
105338,its,O,5563
105339,aggregation,O,5563
105340,The,O,5564
105341,key,O,5564
105342,of,O,5564
105343,aspirin,B-CHEMICAL_COMPOUND,5564
105344,s,O,5564
105345,capability,O,5564
105346,to,O,5564
105347,suppress,O,5564
105348,the,O,5564
105349,development,O,5564
105350,of,O,5564
105351,amyloid-like,O,5564
105352,fibrils,O,5564
105353,by,O,5564
105354,the,O,5564
105355,model,O,5564
105356,cataract,B-NAME_OF_DISEASE,5564
105357,peptides,B-CHEMICAL_COMPOUND,5564
105358,was,O,5564
105359,disclosed,O,5564
105360,by,O,5564
105361,these,O,5564
105362,simulations,O,5564
105363,Several,O,5565
105364,natural,O,5565
105365,substances,O,5565
105366,have,O,5565
105367,already,O,5565
105368,been,O,5565
105369,identified,O,5565
105370,as,O,5565
105371,possible,O,5565
105372,crystallin,B-CHEMICAL_COMPOUND,5565
105373,aggregation,O,5565
105374,inhibitors,O,5565
105375,but,O,5565
105376,the,O,5565
105377,use,O,5565
105378,of,O,5565
105379,nonsteroidal,B-NAME_OF_DRUG,5565
105380,anti-inflammatory,I-NAME_OF_DRUG,5565
105381,medicines,I-NAME_OF_DRUG,5565
105382,NSAIDs,I-NAME_OF_DRUG,5565
105383,like,O,5565
105384,aspirin,B-CHEMICAL_COMPOUND,5565
105385,in,O,5565
105386,this,O,5565
105387,context,O,5565
105388,will,O,5565
105389,usher,O,5565
105390,in,O,5565
105391,a,O,5565
105392,new,O,5565
105393,way,O,5565
105394,of,O,5565
105395,thinking,O,5565
105396,Additionally,O,5566
105397,aspirin,B-CHEMICAL_COMPOUND,5566
105398,nanorods,O,5566
105399,nano-size,O,5566
105400,will,O,5566
105401,improve,O,5566
105402,drug,O,5566
105403,loading,O,5566
105404,reduce,O,5566
105405,toxicity,O,5566
105406,and,O,5566
105407,increase,O,5566
105408,bioavailability,O,5566
105409,As,O,5567
105410,a,O,5567
105411,result,O,5567
105412,the,O,5567
105413,administration,O,5567
105414,of,O,5567
105415,aspirin,B-CHEMICAL_COMPOUND,5567
105416,nanorods,O,5567
105417,as,O,5567
105418,eye,O,5567
105419,drops,O,5567
105420,will,O,5567
105421,serve,O,5567
105422,as,O,5567
105423,a,O,5567
105424,useful,O,5567
105425,and,O,5567
105426,practical,O,5567
105427,option,O,5567
105428,for,O,5567
105429,treating,O,5567
105430,cataracts,B-NAME_OF_DISEASE,5567
105431,without,O,5567
105432,surgery,O,5567
105433,COVID-19,B-NAME_OF_DISEASE,5568
105434,vaccines,O,5568
105435,have,O,5568
105436,been,O,5568
105437,at,O,5568
105438,the,O,5568
105439,forefront,O,5568
105440,of,O,5568
105441,public,O,5568
105442,health,O,5568
105443,efforts,O,5568
105444,globally,O,5568
105445,since,O,5568
105446,their,O,5568
105447,development,O,5568
105448,in,O,5568
105449,record,O,5568
105450,time,O,5568
105451,Although,O,5569
105452,the,O,5569
105453,vaccines,O,5569
105454,have,O,5569
105455,been,O,5569
105456,shown,O,5569
105457,to,O,5569
105458,be,O,5569
105459,effective,O,5569
105460,in,O,5569
105461,preventing,O,5569
105462,COVID-19,B-NAME_OF_DISEASE,5569
105463,infection,O,5569
105464,some,O,5569
105465,people,O,5569
105466,have,O,5569
105467,reported,O,5569
105468,side,O,5569
105469,effects,O,5569
105470,that,O,5569
105471,include,O,5569
105472,ocular,B-NAME_OF_DISEASE,5569
105473,inflammation,I-NAME_OF_DISEASE,5569
105474,Ocular,B-NAME_OF_DISEASE,5570
105475,inflammation,I-NAME_OF_DISEASE,5570
105476,also,O,5570
105477,known,O,5570
105478,as,O,5570
105479,uveitis,B-NAME_OF_DISEASE,5570
105480,is,O,5570
105481,a,O,5570
105482,condition,O,5570
105483,that,O,5570
105484,affects,O,5570
105485,the,B-PART_OF_THE_EYES,5570
105486,middle,I-PART_OF_THE_EYES,5570
105487,layer,I-PART_OF_THE_EYES,5570
105488,of,I-PART_OF_THE_EYES,5570
105489,the,I-PART_OF_THE_EYES,5570
105490,eye,I-PART_OF_THE_EYES,5570
105491,causing,O,5570
105492,pain,B-SIGN_AND_SYMPTOM,5570
105493,redness,I-SIGN_AND_SYMPTOM,5570
105494,blurred,I-SIGN_AND_SYMPTOM,5570
105495,vision,I-SIGN_AND_SYMPTOM,5570
105496,and,I-SIGN_AND_SYMPTOM,5570
105497,sensitivity,I-SIGN_AND_SYMPTOM,5570
105498,to,I-SIGN_AND_SYMPTOM,5570
105499,light,I-SIGN_AND_SYMPTOM,5570
105500,The,O,5571
105501,inflammation,O,5571
105502,can,O,5571
105503,also,O,5571
105504,lead,O,5571
105505,to,O,5571
105506,complications,O,5571
105507,such,O,5571
105508,as,O,5571
105509,glaucoma,B-NAME_OF_DISEASE,5571
105510,and,O,5571
105511,cataracts,B-NAME_OF_DISEASE,5571
105512,if,O,5571
105513,left,O,5571
105514,untreated,O,5571
105515,Research,O,5572
105516,has,O,5572
105517,shown,O,5572
105518,that,O,5572
105519,ocular,B-NAME_OF_DISEASE,5572
105520,inflammation,I-NAME_OF_DISEASE,5572
105521,can,O,5572
105522,occur,O,5572
105523,as,O,5572
105524,a,O,5572
105525,rare,O,5572
105526,side,O,5572
105527,effect,O,5572
105528,of,O,5572
105529,COVID-19,B-NAME_OF_DISEASE,5572
105530,vaccination,O,5572
105531,particularly,O,5572
105532,with,O,5572
105533,the,B-NAME_OF_DRUG,5572
105534,Pfizer-BioNTech,I-NAME_OF_DRUG,5572
105535,and,I-NAME_OF_DRUG,5572
105536,Moderna,I-NAME_OF_DRUG,5572
105537,vaccines,I-NAME_OF_DRUG,5572
105538,According,O,5573
105539,to,O,5573
105540,a,O,5573
105541,study,O,5573
105542,published,O,5573
105543,in,O,5573
105544,JAMA,B-PUBLICATION_VENUE,5573
105545,Ophthalmology,I-PUBLICATION_VENUE,5573
105546,there,O,5573
105547,have,O,5573
105548,been,O,5573
105549,several,O,5573
105550,cases,O,5573
105551,of,O,5573
105552,uveitis,B-NAME_OF_DISEASE,5573
105553,reported,O,5573
105554,in,O,5573
105555,individuals,O,5573
105556,who,O,5573
105557,have,O,5573
105558,received,O,5573
105559,these,O,5573
105560,vaccines,O,5573
105561,According,O,5574
105562,to,O,5574
105563,the,B-PUBLICATION_VENUE,5574
105564,Indian,I-PUBLICATION_VENUE,5574
105565,Journal,I-PUBLICATION_VENUE,5574
105566,of,I-PUBLICATION_VENUE,5574
105567,Ophthalmology,I-PUBLICATION_VENUE,5574
105568,ocular,B-NAME_OF_DISEASE,5574
105569,inflammation,I-NAME_OF_DISEASE,5574
105570,can,O,5574
105571,present,O,5574
105572,itself,O,5574
105573,as,O,5574
105574,aside,O,5574
105575,effect,O,5574
105576,of,O,5574
105577,COVID-19,B-NAME_OF_DISEASE,5574
105578,vaccines,O,5574
105579,Symptoms,O,5575
105580,of,O,5575
105581,ocular,B-NAME_OF_DISEASE,5575
105582,inflammation,I-NAME_OF_DISEASE,5575
105583,can,O,5575
105584,include,O,5575
105585,redness,B-SIGN_AND_SYMPTOM,5575
105586,pain,I-SIGN_AND_SYMPTOM,5575
105587,light,I-SIGN_AND_SYMPTOM,5575
105588,sensitivity,I-SIGN_AND_SYMPTOM,5575
105589,blurry,I-SIGN_AND_SYMPTOM,5575
105590,vision,I-SIGN_AND_SYMPTOM,5575
105591,or,I-SIGN_AND_SYMPTOM,5575
105592,even,I-SIGN_AND_SYMPTOM,5575
105593,vision,I-SIGN_AND_SYMPTOM,5575
105594,loss,I-SIGN_AND_SYMPTOM,5575
105595,It,O,5576
105596,is,O,5576
105597,important,O,5576
105598,to,O,5576
105599,note,O,5576
105600,that,O,5576
105601,while,O,5576
105602,ocular,B-NAME_OF_DISEASE,5576
105603,inflammation,I-NAME_OF_DISEASE,5576
105604,can,O,5576
105605,be,O,5576
105606,a,O,5576
105607,side,O,5576
105608,effect,O,5576
105609,of,O,5576
105610,COVID-19,B-NAME_OF_DISEASE,5576
105611,vaccination,O,5576
105612,it,O,5576
105613,is,O,5576
105614,not,O,5576
105615,necessarily,O,5576
105616,caused,O,5576
105617,by,O,5576
105618,the,O,5576
105619,vaccine,O,5576
105620,itself,O,5576
105621,Instead,O,5577
105622,it,O,5577
105623,may,O,5577
105624,be,O,5577
105625,a,O,5577
105626,result,O,5577
105627,of,O,5577
105628,the,O,5577
105629,body,O,5577
105630,s,O,5577
105631,immune,O,5577
105632,response,O,5577
105633,to,O,5577
105634,the,O,5577
105635,vaccine,O,5577
105636,In,O,5578
105637,other,O,5578
105638,words,O,5578
105639,the,O,5578
105640,vaccine,O,5578
105641,triggers,O,5578
105642,an,O,5578
105643,immune,O,5578
105644,response,O,5578
105645,that,O,5578
105646,can,O,5578
105647,sometimes,O,5578
105648,cause,O,5578
105649,inflammation,O,5578
105650,including,O,5578
105651,in,O,5578
105652,the,O,5578
105653,eye,O,5578
105654,However,O,5579
105655,it,O,5579
105656,s,O,5579
105657,important,O,5579
105658,to,O,5579
105659,note,O,5579
105660,that,O,5579
105661,the,O,5579
105662,incidence,O,5579
105663,of,O,5579
105664,ocular,B-NAME_OF_DISEASE,5579
105665,inflammation,I-NAME_OF_DISEASE,5579
105666,following,O,5579
105667,COVID-19,B-NAME_OF_DISEASE,5579
105668,vaccination,O,5579
105669,is,O,5579
105670,rare,O,5579
105671,The,O,5580
105672,benefits,O,5580
105673,of,O,5580
105674,vaccination,O,5580
105675,in,O,5580
105676,preventing,O,5580
105677,severe,O,5580
105678,COVID-19,B-NAME_OF_DISEASE,5580
105679,far,O,5580
105680,outweigh,O,5580
105681,the,O,5580
105682,risk,O,5580
105683,of,O,5580
105684,developing,O,5580
105685,uveitis,B-NAME_OF_DISEASE,5580
105686,If,O,5581
105687,you,O,5581
105688,experience,O,5581
105689,any,O,5581
105690,symptoms,O,5581
105691,of,O,5581
105692,ocular,B-NAME_OF_DISEASE,5581
105693,inflammation,I-NAME_OF_DISEASE,5581
105694,after,O,5581
105695,receiving,O,5581
105696,the,O,5581
105697,COVID-19,B-NAME_OF_DISEASE,5581
105698,vaccine,O,5581
105699,it,O,5581
105700,s,O,5581
105701,important,O,5581
105702,to,O,5581
105703,seek,O,5581
105704,medical,O,5581
105705,attention,O,5581
105706,right,O,5581
105707,away,O,5581
105708,Your,O,5582
105709,doctor,O,5582
105710,may,O,5582
105711,recommend,O,5582
105712,treatment,O,5582
105713,options,O,5582
105714,such,O,5582
105715,as,O,5582
105716,topical,B-NAME_OF_DRUG,5582
105717,or,I-NAME_OF_DRUG,5582
105718,oral,I-NAME_OF_DRUG,5582
105719,steroids,I-NAME_OF_DRUG,5582
105720,to,O,5582
105721,reduce,O,5582
105722,inflammation,O,5582
105723,and,O,5582
105724,relieve,O,5582
105725,symptoms,O,5582
105726,It,O,5583
105727,is,O,5583
105728,also,O,5583
105729,worth,O,5583
105730,noting,O,5583
105731,that,O,5583
105732,the,O,5583
105733,risk,O,5583
105734,of,O,5583
105735,developing,O,5583
105736,ocular,B-NAME_OF_DISEASE,5583
105737,inflammation,I-NAME_OF_DISEASE,5583
105738,as,O,5583
105739,a,O,5583
105740,side,O,5583
105741,effect,O,5583
105742,of,O,5583
105743,COVID-19,B-NAME_OF_DISEASE,5583
105744,vaccination,O,5583
105745,is,O,5583
105746,much,O,5583
105747,lower,O,5583
105748,than,O,5583
105749,the,O,5583
105750,risks,O,5583
105751,associated,O,5583
105752,with,O,5583
105753,COVID-19,B-NAME_OF_DISEASE,5583
105754,infection,O,5583
105755,itself,O,5583
105756,COVID-19,B-NAME_OF_DISEASE,5584
105757,can,O,5584
105758,cause,O,5584
105759,severe,O,5584
105760,respiratory,O,5584
105761,problems,O,5584
105762,and,O,5584
105763,in,O,5584
105764,some,O,5584
105765,cases,O,5584
105766,it,O,5584
105767,can,O,5584
105768,lead,O,5584
105769,to,O,5584
105770,serious,O,5584
105771,complications,O,5584
105772,such,O,5584
105773,as,O,5584
105774,blood,B-SIGN_AND_SYMPTOM,5584
105775,clots,I-SIGN_AND_SYMPTOM,5584
105776,heart,I-SIGN_AND_SYMPTOM,5584
105777,damage,I-SIGN_AND_SYMPTOM,5584
105778,and,I-SIGN_AND_SYMPTOM,5584
105779,even,I-SIGN_AND_SYMPTOM,5584
105780,death,I-SIGN_AND_SYMPTOM,5584
105781,In,O,5585
105782,conclusion,O,5585
105783,while,O,5585
105784,there,O,5585
105785,have,O,5585
105786,been,O,5585
105787,rare,O,5585
105788,cases,O,5585
105789,of,O,5585
105790,ocular,B-NAME_OF_DISEASE,5585
105791,inflammation,I-NAME_OF_DISEASE,5585
105792,following,O,5585
105793,COVID-19,B-NAME_OF_DISEASE,5585
105794,vaccination,O,5585
105795,the,O,5585
105796,benefits,O,5585
105797,of,O,5585
105798,vaccination,O,5585
105799,in,O,5585
105800,preventing,O,5585
105801,severe,O,5585
105802,cases,O,5585
105803,of,O,5585
105804,COVID-19,B-NAME_OF_DISEASE,5585
105805,outweigh,O,5585
105806,the,O,5585
105807,risks,O,5585
105808,If,O,5586
105809,you,O,5586
105810,experience,O,5586
105811,any,O,5586
105812,symptoms,O,5586
105813,of,O,5586
105814,uveitis,B-NAME_OF_DISEASE,5586
105815,after,O,5586
105816,vaccination,O,5586
105817,seek,O,5586
105818,medical,O,5586
105819,attention,O,5586
105820,promptly,O,5586
105821,and,O,5586
105822,follow,O,5586
105823,your,O,5586
105824,doctor,O,5586
105825,s,O,5586
105826,treatment,O,5586
105827,plan,O,5586
105828,What,O,5587
105829,is,O,5587
105830,Smartphone,B-NAME_OF_DISEASE,5587
105831,Vision,I-NAME_OF_DISEASE,5587
105832,Syndrome,I-NAME_OF_DISEASE,5587
105833,Smartphone,B-NAME_OF_DISEASE,5587
105834,Vision,I-NAME_OF_DISEASE,5587
105835,Syndrome,I-NAME_OF_DISEASE,5587
105836,also,O,5587
105837,known,O,5587
105838,as,O,5587
105839,digital,B-NAME_OF_DISEASE,5587
105840,eye,B-SIGN_AND_SYMPTOM,5587
105841,strain,I-SIGN_AND_SYMPTOM,5587
105842,is,O,5587
105843,a,O,5587
105844,condition,O,5587
105845,that,O,5587
105846,affects,O,5587
105847,people,O,5587
105848,who,O,5587
105849,spend,B-CAUSE_OF_DISEASE,5587
105850,long,I-CAUSE_OF_DISEASE,5587
105851,hours,I-CAUSE_OF_DISEASE,5587
105852,using,I-CAUSE_OF_DISEASE,5587
105853,digital,I-CAUSE_OF_DISEASE,5587
105854,devices,I-CAUSE_OF_DISEASE,5587
105855,such,I-CAUSE_OF_DISEASE,5587
105856,as,I-CAUSE_OF_DISEASE,5587
105857,smartphones,I-CAUSE_OF_DISEASE,5587
105858,laptops,I-CAUSE_OF_DISEASE,5587
105859,and,I-CAUSE_OF_DISEASE,5587
105860,tablets,I-CAUSE_OF_DISEASE,5587
105861,It,O,5588
105862,occurs,O,5588
105863,when,O,5588
105864,the,B-CAUSE_OF_DISEASE,5588
105865,eyes,I-CAUSE_OF_DISEASE,5588
105866,are,I-CAUSE_OF_DISEASE,5588
105867,exposed,I-CAUSE_OF_DISEASE,5588
105868,to,I-CAUSE_OF_DISEASE,5588
105869,prolonged,I-CAUSE_OF_DISEASE,5588
105870,blue,B-CAUSE_OF_DISEASE,5588
105871,light,I-CAUSE_OF_DISEASE,5588
105872,from,I-CAUSE_OF_DISEASE,5588
105873,these,I-CAUSE_OF_DISEASE,5588
105874,devices,I-CAUSE_OF_DISEASE,5588
105875,leading,O,5588
105876,to,O,5588
105877,various,O,5588
105878,uncomfortable,O,5588
105879,symptoms,O,5588
105880,such,O,5588
105881,as,O,5588
105882,eye,B-SIGN_AND_SYMPTOM,5588
105883,strain,I-SIGN_AND_SYMPTOM,5588
105884,headaches,B-SIGN_AND_SYMPTOM,5588
105885,dry,B-SIGN_AND_SYMPTOM,5588
105886,eyes,I-SIGN_AND_SYMPTOM,5588
105887,and,I-SIGN_AND_SYMPTOM,5588
105888,blurred,I-SIGN_AND_SYMPTOM,5588
105889,vision,I-SIGN_AND_SYMPTOM,5588
105890,What,O,5589
105891,Causes,O,5589
105892,Smartphone,B-NAME_OF_DISEASE,5589
105893,Vision,I-NAME_OF_DISEASE,5589
105894,Syndrome,I-NAME_OF_DISEASE,5589
105895,Smartphone,B-NAME_OF_DISEASE,5589
105896,Vision,I-NAME_OF_DISEASE,5589
105897,Syndrome,I-NAME_OF_DISEASE,5589
105898,is,O,5589
105899,caused,O,5589
105900,by,O,5589
105901,several,O,5589
105902,factors,O,5589
105903,including,O,5589
105904,blue,B-CAUSE_OF_DISEASE,5589
105905,light,I-CAUSE_OF_DISEASE,5589
105906,exposure,I-CAUSE_OF_DISEASE,5589
105907,screen,B-CAUSE_OF_DISEASE,5589
105908,glare,I-CAUSE_OF_DISEASE,5589
105909,and,I-CAUSE_OF_DISEASE,5589
105910,reduced,B-CAUSE_OF_DISEASE,5589
105911,blinking,I-CAUSE_OF_DISEASE,5589
105912,Blue,B-CAUSE_OF_DISEASE,5590
105913,light,I-CAUSE_OF_DISEASE,5590
105914,a,I-CAUSE_OF_DISEASE,5590
105915,high-energy,I-CAUSE_OF_DISEASE,5590
105916,visible,I-CAUSE_OF_DISEASE,5590
105917,HEV,I-CAUSE_OF_DISEASE,5590
105918,light,I-CAUSE_OF_DISEASE,5590
105919,emitted,I-CAUSE_OF_DISEASE,5590
105920,by,I-CAUSE_OF_DISEASE,5590
105921,digital,I-CAUSE_OF_DISEASE,5590
105922,devices,I-CAUSE_OF_DISEASE,5590
105923,can,O,5590
105924,penetrate,O,5590
105925,the,O,5590
105926,eyes,O,5590
105927,and,O,5590
105928,cause,O,5590
105929,damage,O,5590
105930,to,O,5590
105931,the,B-PART_OF_THE_EYES,5590
105932,retina,I-PART_OF_THE_EYES,5590
105933,leading,O,5590
105934,to,O,5590
105935,various,O,5590
105936,vision,O,5590
105937,problems,O,5590
105938,Screen,B-CAUSE_OF_DISEASE,5591
105939,glare,I-CAUSE_OF_DISEASE,5591
105940,on,O,5591
105941,the,O,5591
105942,other,O,5591
105943,hand,O,5591
105944,can,O,5591
105945,strain,B-SIGN_AND_SYMPTOM,5591
105946,the,O,5591
105947,eyes,O,5591
105948,and,O,5591
105949,cause,O,5591
105950,headaches,B-SIGN_AND_SYMPTOM,5591
105951,while,O,5591
105952,reduced,B-CAUSE_OF_DISEASE,5591
105953,blinking,I-CAUSE_OF_DISEASE,5591
105954,can,O,5591
105955,cause,O,5591
105956,dry,B-SIGN_AND_SYMPTOM,5591
105957,eyes,I-SIGN_AND_SYMPTOM,5591
105958,and,I-SIGN_AND_SYMPTOM,5591
105959,discomfort,I-SIGN_AND_SYMPTOM,5591
105960,How,O,5592
105961,Long,O,5592
105962,Does,O,5592
105963,Smartphone,B-NAME_OF_DISEASE,5592
105964,Vision,I-NAME_OF_DISEASE,5592
105965,Syndrome,I-NAME_OF_DISEASE,5592
105966,Last,O,5592
105967,The,O,5592
105968,duration,O,5592
105969,of,O,5592
105970,Smartphone,B-NAME_OF_DISEASE,5592
105971,Vision,I-NAME_OF_DISEASE,5592
105972,Syndrome,I-NAME_OF_DISEASE,5592
105973,also,O,5592
105974,known,O,5592
105975,as,O,5592
105976,Digital,B-NAME_OF_DISEASE,5592
105977,Eye,I-NAME_OF_DISEASE,5592
105978,Strain,I-NAME_OF_DISEASE,5592
105979,can,O,5592
105980,vary,O,5592
105981,depending,O,5592
105982,on,O,5592
105983,the,O,5592
105984,individual,O,5592
105985,and,O,5592
105986,the,O,5592
105987,severity,O,5592
105988,of,O,5592
105989,the,O,5592
105990,symptoms,O,5592
105991,In,O,5593
105992,most,O,5593
105993,cases,O,5593
105994,the,O,5593
105995,symptoms,O,5593
105996,are,O,5593
105997,temporary,O,5593
105998,and,O,5593
105999,can,O,5593
106000,be,O,5593
106001,alleviated,O,5593
106002,by,O,5593
106003,taking,B-TREATMENT,5593
106004,regular,I-TREATMENT,5593
106005,breaks,I-TREATMENT,5593
106006,from,I-TREATMENT,5593
106007,screen,I-TREATMENT,5593
106008,time,I-TREATMENT,5593
106009,adjusting,I-TREATMENT,5593
106010,the,I-TREATMENT,5593
106011,brightness,I-TREATMENT,5593
106012,and,I-TREATMENT,5593
106013,contrast,I-TREATMENT,5593
106014,of,I-TREATMENT,5593
106015,your,I-TREATMENT,5593
106016,device,I-TREATMENT,5593
106017,and,I-TREATMENT,5593
106018,positioning,I-TREATMENT,5593
106019,the,I-TREATMENT,5593
106020,screen,I-TREATMENT,5593
106021,at,I-TREATMENT,5593
106022,a,I-TREATMENT,5593
106023,comfortable,I-TREATMENT,5593
106024,distance,I-TREATMENT,5593
106025,If,O,5594
106026,you,O,5594
106027,experience,O,5594
106028,mild,O,5594
106029,symptoms,O,5594
106030,of,O,5594
106031,eye,B-SIGN_AND_SYMPTOM,5594
106032,strain,I-SIGN_AND_SYMPTOM,5594
106033,or,I-SIGN_AND_SYMPTOM,5594
106034,discomfort,I-SIGN_AND_SYMPTOM,5594
106035,they,O,5594
106036,may,O,5594
106037,go,O,5594
106038,away,O,5594
106039,within,B-TIME_DURATION,5594
106040,a,I-TIME_DURATION,5594
106041,few,I-TIME_DURATION,5594
106042,hours,I-TIME_DURATION,5594
106043,or,I-TIME_DURATION,5594
106044,a,I-TIME_DURATION,5594
106045,day,I-TIME_DURATION,5594
106046,after,O,5594
106047,reducing,B-TREATMENT,5594
106048,your,I-TREATMENT,5594
106049,screen,I-TREATMENT,5594
106050,time,I-TREATMENT,5594
106051,and,I-TREATMENT,5594
106052,practicing,I-TREATMENT,5594
106053,good,I-TREATMENT,5594
106054,eye,I-TREATMENT,5594
106055,care,I-TREATMENT,5594
106056,habits,I-TREATMENT,5594
106057,However,O,5595
106058,if,O,5595
106059,your,O,5595
106060,symptoms,O,5595
106061,are,O,5595
106062,severe,O,5595
106063,or,O,5595
106064,persistent,O,5595
106065,it,O,5595
106066,is,O,5595
106067,important,O,5595
106068,to,O,5595
106069,seek,B-TREATMENT,5595
106070,medical,I-TREATMENT,5595
106071,attention,I-TREATMENT,5595
106072,from,I-TREATMENT,5595
106073,an,I-TREATMENT,5595
106074,eye,I-TREATMENT,5595
106075,doctor,I-TREATMENT,5595
106076,or,I-TREATMENT,5595
106077,a,I-TREATMENT,5595
106078,qualified,I-TREATMENT,5595
106079,healthcare,I-TREATMENT,5595
106080,provider,I-TREATMENT,5595
106081,to,O,5595
106082,rule,O,5595
106083,out,O,5595
106084,any,O,5595
106085,underlying,O,5595
106086,eye,O,5595
106087,conditions,O,5595
106088,What,O,5596
106089,Can,O,5596
106090,You,O,5596
106091,Do,O,5596
106092,to,O,5596
106093,Prevent,O,5596
106094,Smartphone,B-NAME_OF_DISEASE,5596
106095,Vision,I-NAME_OF_DISEASE,5596
106096,Syndrome,I-NAME_OF_DISEASE,5596
106097,Preventing,O,5596
106098,Smartphone,B-NAME_OF_DISEASE,5596
106099,Vision,I-NAME_OF_DISEASE,5596
106100,Syndrome,I-NAME_OF_DISEASE,5596
106101,is,O,5596
106102,essential,O,5596
106103,to,O,5596
106104,maintaining,B-PREVENTION,5596
106105,healthy,I-PREVENTION,5596
106106,eyes,I-PREVENTION,5596
106107,and,I-PREVENTION,5596
106108,vision,I-PREVENTION,5596
106109,Here,O,5597
106110,are,O,5597
106111,some,O,5597
106112,tips,O,5597
106113,that,O,5597
106114,can,O,5597
106115,help,O,5597
106116,reduce,O,5597
106117,the,O,5597
106118,risk,O,5597
106119,of,O,5597
106120,digital,B-NAME_OF_DISEASE,5597
106121,eye,B-SIGN_AND_SYMPTOM,5597
106122,strain,I-SIGN_AND_SYMPTOM,5597
106123,Take,B-PREVENTION,5597
106124,breaks,I-PREVENTION,5597
106125,Taking,I-PREVENTION,5597
106126,frequent,I-PREVENTION,5597
106127,breaks,I-PREVENTION,5597
106128,from,I-PREVENTION,5597
106129,digital,I-PREVENTION,5597
106130,devices,I-PREVENTION,5597
106131,can,O,5597
106132,help,O,5597
106133,reduce,O,5597
106134,eye,B-SIGN_AND_SYMPTOM,5597
106135,strain,I-SIGN_AND_SYMPTOM,5597
106136,and,O,5597
106137,prevent,O,5597
106138,digital,B-NAME_OF_DISEASE,5597
106139,eye,B-SIGN_AND_SYMPTOM,5597
106140,strain,I-SIGN_AND_SYMPTOM,5597
106141,You,O,5598
106142,can,O,5598
106143,use,O,5598
106144,the,B-PREVENTION,5598
106145,20-20-20,I-PREVENTION,5598
106146,rule,I-PREVENTION,5598
106147,The,B-PREVENTION,5598
106148,20-20-20,I-PREVENTION,5598
106149,rule,I-PREVENTION,5598
106150,which,O,5598
106151,is,O,5598
106152,a,O,5598
106153,technique,O,5598
106154,that,O,5598
106155,can,O,5598
106156,be,O,5598
106157,used,O,5598
106158,to,O,5598
106159,prevent,O,5598
106160,eye,B-SIGN_AND_SYMPTOM,5598
106161,strain,I-SIGN_AND_SYMPTOM,5598
106162,and,O,5598
106163,digital,B-NAME_OF_DISEASE,5598
106164,eye,I-NAME_OF_DISEASE,5598
106165,fatigue,I-NAME_OF_DISEASE,5598
106166,It,O,5599
106167,involves,O,5599
106168,taking,B-PREVENTION,5599
106169,a,I-PREVENTION,5599
106170,break,I-PREVENTION,5599
106171,from,I-PREVENTION,5599
106172,looking,I-PREVENTION,5599
106173,at,I-PREVENTION,5599
106174,digital,I-PREVENTION,5599
106175,screens,I-PREVENTION,5599
106176,every,I-PREVENTION,5599
106177,20,I-PREVENTION,5599
106178,minutes,I-PREVENTION,5599
106179,and,I-PREVENTION,5599
106180,focusing,I-PREVENTION,5599
106181,on,I-PREVENTION,5599
106182,an,I-PREVENTION,5599
106183,object,I-PREVENTION,5599
106184,that,I-PREVENTION,5599
106185,is,I-PREVENTION,5599
106186,at,I-PREVENTION,5599
106187,least,I-PREVENTION,5599
106188,20,I-PREVENTION,5599
106189,feet,I-PREVENTION,5599
106190,away,I-PREVENTION,5599
106191,for,I-PREVENTION,5599
106192,20,I-PREVENTION,5599
106193,seconds,I-PREVENTION,5599
106194,Adjust,B-PREVENTION,5600
106195,your,I-PREVENTION,5600
106196,screen,I-PREVENTION,5600
106197,Adjusting,I-PREVENTION,5600
106198,the,I-PREVENTION,5600
106199,brightness,I-PREVENTION,5600
106200,and,I-PREVENTION,5600
106201,contrast,I-PREVENTION,5600
106202,of,I-PREVENTION,5600
106203,your,I-PREVENTION,5600
106204,screen,I-PREVENTION,5600
106205,can,O,5600
106206,help,O,5600
106207,reduce,O,5600
106208,eye,B-SIGN_AND_SYMPTOM,5600
106209,strain,I-SIGN_AND_SYMPTOM,5600
106210,and,O,5600
106211,screen,B-CAUSE_OF_DISEASE,5600
106212,glare,I-CAUSE_OF_DISEASE,5600
106213,Use,B-PREVENTION,5601
106214,eye,I-PREVENTION,5601
106215,drops,I-PREVENTION,5601
106216,Using,I-PREVENTION,5601
106217,eye,I-PREVENTION,5601
106218,drops,I-PREVENTION,5601
106219,can,O,5601
106220,help,O,5601
106221,keep,O,5601
106222,your,O,5601
106223,eyes,O,5601
106224,moisturized,O,5601
106225,and,O,5601
106226,prevent,O,5601
106227,dry,B-SIGN_AND_SYMPTOM,5601
106228,eyes,I-SIGN_AND_SYMPTOM,5601
106229,Wear,B-PREVENTION,5602
106230,glasses,I-PREVENTION,5602
106231,Wearing,I-PREVENTION,5602
106232,specialized,I-PREVENTION,5602
106233,glasses,I-PREVENTION,5602
106234,that,O,5602
106235,block,O,5602
106236,blue,B-CAUSE_OF_DISEASE,5602
106237,light,I-CAUSE_OF_DISEASE,5602
106238,can,O,5602
106239,help,O,5602
106240,protect,O,5602
106241,your,O,5602
106242,eyes,O,5602
106243,from,O,5602
106244,the,O,5602
106245,harmful,O,5602
106246,effects,O,5602
106247,of,O,5602
106248,blue,B-CAUSE_OF_DISEASE,5602
106249,light,I-CAUSE_OF_DISEASE,5602
106250,Practice,B-PREVENTION,5603
106251,good,I-PREVENTION,5603
106252,habits,I-PREVENTION,5603
106253,Practicing,I-PREVENTION,5603
106254,good,I-PREVENTION,5603
106255,habits,I-PREVENTION,5603
106256,such,I-PREVENTION,5603
106257,as,I-PREVENTION,5603
106258,proper,I-PREVENTION,5603
106259,posture,I-PREVENTION,5603
106260,adequate,I-PREVENTION,5603
106261,lighting,I-PREVENTION,5603
106262,and,I-PREVENTION,5603
106263,avoiding,I-PREVENTION,5603
106264,digital,I-PREVENTION,5603
106265,devices,I-PREVENTION,5603
106266,before,I-PREVENTION,5603
106267,bed,I-PREVENTION,5603
106268,can,O,5603
106269,help,O,5603
106270,reduce,O,5603
106271,the,O,5603
106272,risk,O,5603
106273,of,O,5603
106274,digital,B-NAME_OF_DISEASE,5603
106275,eye,B-SIGN_AND_SYMPTOM,5603
106276,strain,I-SIGN_AND_SYMPTOM,5603
106277,In,O,5604
106278,conclusion,O,5604
106279,Smartphone,B-NAME_OF_DISEASE,5604
106280,Vision,I-NAME_OF_DISEASE,5604
106281,Syndrome,I-NAME_OF_DISEASE,5604
106282,is,O,5604
106283,a,O,5604
106284,growing,O,5604
106285,concern,O,5604
106286,for,O,5604
106287,people,O,5604
106288,who,O,5604
106289,spend,B-CAUSE_OF_DISEASE,5604
106290,long,I-CAUSE_OF_DISEASE,5604
106291,hours,I-CAUSE_OF_DISEASE,5604
106292,using,I-CAUSE_OF_DISEASE,5604
106293,digital,I-CAUSE_OF_DISEASE,5604
106294,devices,I-CAUSE_OF_DISEASE,5604
106295,By,O,5605
106296,taking,O,5605
106297,preventive,O,5605
106298,measures,O,5605
106299,and,O,5605
106300,practicing,O,5605
106301,good,O,5605
106302,habits,O,5605
106303,you,O,5605
106304,can,O,5605
106305,reduce,O,5605
106306,the,O,5605
106307,risk,O,5605
106308,of,O,5605
106309,digital,B-NAME_OF_DISEASE,5605
106310,eye,B-SIGN_AND_SYMPTOM,5605
106311,strain,I-SIGN_AND_SYMPTOM,5605
106312,and,O,5605
106313,maintain,O,5605
106314,healthy,O,5605
106315,eyes,O,5605
106316,and,O,5605
106317,vision,O,5605
106318,OcuSciences,B-ORGANIZATION,5606
106319,has,O,5606
106320,recently,O,5606
106321,revealed,O,5606
106322,the,O,5606
106323,publication,O,5606
106324,of,O,5606
106325,a,O,5606
106326,study,O,5606
106327,on,O,5606
106328,Age-related,B-NAME_OF_DISEASE,5606
106329,Macular,I-NAME_OF_DISEASE,5606
106330,Degeneration,I-NAME_OF_DISEASE,5606
106331,AMD,B-NAME_OF_DISEASE,5606
106332,in,O,5606
106333,the,O,5606
106334,journal,O,5606
106335,Ophthalmic,O,5606
106336,Surgery,O,5606
106337,Lasers,O,5606
106338,and,O,5606
106339,Imaging,O,5606
106340,Retina,O,5606
106341,This,O,5607
106342,research,O,5607
106343,evaluates,O,5607
106344,the,O,5607
106345,extent,O,5607
106346,of,O,5607
106347,oxidative,O,5607
106348,stress,O,5607
106349,in,O,5607
106350,the,B-PART_OF_THE_EYES,5607
106351,retina,I-PART_OF_THE_EYES,5607
106352,and,O,5607
106353,the,O,5607
106354,malfunction,O,5607
106355,of,O,5607
106356,mitochondria,O,5607
106357,to,O,5607
106358,suggest,O,5607
106359,that,O,5607
106360,the,B-DIAGNOSTIC_TEST,5607
106361,innovative,I-DIAGNOSTIC_TEST,5607
106362,FPF,I-DIAGNOSTIC_TEST,5607
106363,measurement,I-DIAGNOSTIC_TEST,5607
106364,can,O,5607
106365,categorize,O,5607
106366,AMD,B-NAME_OF_DISEASE,5607
106367,patients,O,5607
106368,based,O,5607
106369,on,O,5607
106370,their,O,5607
106371,stage,O,5607
106372,thereby,O,5607
106373,providing,O,5607
106374,a,O,5607
106375,deeper,O,5607
106376,understanding,O,5607
106377,of,O,5607
106378,the,O,5607
106379,physiological,O,5607
106380,process,O,5607
106381,behind,O,5607
106382,AMD,B-NAME_OF_DISEASE,5607
106383,The,O,5608
106384,study,O,5608
106385,led,O,5608
106386,by,O,5608
106387,Dr,O,5608
106388,Rishi,O,5609
106389,Singh,O,5609
106390,a,O,5609
106391,staff,O,5609
106392,ophthalmologist,O,5609
106393,at,O,5609
106394,the,B-ORGANIZATION,5609
106395,Cleveland,I-ORGANIZATION,5609
106396,Clinic,I-ORGANIZATION,5609
106397,Cole,B-ORGANIZATION,5609
106398,Eye,I-ORGANIZATION,5609
106399,Institute,I-ORGANIZATION,5609
106400,and,O,5609
106401,President,O,5609
106402,of,O,5609
106403,Cleveland,B-ORGANIZATION,5609
106404,Clinic,I-ORGANIZATION,5609
106405,Martin,I-ORGANIZATION,5609
106406,Health,I-ORGANIZATION,5609
106407,was,O,5609
106408,a,O,5609
106409,prospective,O,5609
106410,observational,O,5609
106411,one,O,5609
106412,and,O,5609
106413,included,O,5609
106414,456,O,5609
106415,eyes,O,5609
106416,with,O,5609
106417,half,O,5609
106418,being,O,5609
106419,diagnosed,O,5609
106420,with,O,5609
106421,AMD,B-NAME_OF_DISEASE,5609
106422,and,O,5609
106423,the,O,5609
106424,other,O,5609
106425,half,O,5609
106426,being,O,5609
106427,age-matched,O,5609
106428,controls,O,5609
106429,The,O,5610
106430,patients,O,5610
106431,were,O,5610
106432,divided,O,5610
106433,into,O,5610
106434,groups,O,5610
106435,based,O,5610
106436,on,O,5610
106437,their,O,5610
106438,AMD,B-NAME_OF_DISEASE,5610
106439,stage,O,5610
106440,which,O,5610
106441,included,O,5610
106442,early,B-NAME_OF_DISEASE,5610
106443,AMD,I-NAME_OF_DISEASE,5610
106444,intermediate,B-NAME_OF_DISEASE,5610
106445,AMD,I-NAME_OF_DISEASE,5610
106446,geographic,B-NAME_OF_DISEASE,5610
106447,atrophy,I-NAME_OF_DISEASE,5610
106448,GA,I-NAME_OF_DISEASE,5610
106449,and,O,5610
106450,neovascular,B-NAME_OF_DISEASE,5610
106451,AMD,I-NAME_OF_DISEASE,5610
106452,The,B-DIAGNOSTIC_TEST,5611
106453,OcuMet,I-DIAGNOSTIC_TEST,5611
106454,Beacon,I-DIAGNOSTIC_TEST,5611
106455,OcuSciences,B-ORGANIZATION,5611
106456,functional,O,5611
106457,retinal,O,5611
106458,imager,O,5611
106459,was,O,5611
106460,used,O,5611
106461,to,O,5611
106462,capture,O,5611
106463,and,O,5611
106464,quantify,O,5611
106465,the,O,5611
106466,patients,O,5611
106467,FPF,B-DIAGNOSTIC_TEST,5611
106468,intensity,I-DIAGNOSTIC_TEST,5611
106469,and,I-DIAGNOSTIC_TEST,5611
106470,heterogeneity,I-DIAGNOSTIC_TEST,5611
106471,between,B-TIME_DURATION,5611
106472,August,I-TIME_DURATION,5611
106473,2018,I-TIME_DURATION,5611
106474,and,I-TIME_DURATION,5611
106475,December,I-TIME_DURATION,5611
106476,2021,I-TIME_DURATION,5611
106477,The,O,5612
106478,results,O,5612
106479,showed,O,5612
106480,that,O,5612
106481,intermediate,B-NAME_OF_DISEASE,5612
106482,geographic,I-NAME_OF_DISEASE,5612
106483,atrophy,I-NAME_OF_DISEASE,5612
106484,and,I-NAME_OF_DISEASE,5612
106485,neovascular,I-NAME_OF_DISEASE,5612
106486,AMD,I-NAME_OF_DISEASE,5612
106487,were,O,5612
106488,correlated,O,5612
106489,with,O,5612
106490,significantly,O,5612
106491,higher,O,5612
106492,FPF,B-DIAGNOSTIC_TEST,5612
106493,intensity,I-DIAGNOSTIC_TEST,5612
106494,while,O,5612
106495,all,O,5612
106496,stages,O,5612
106497,of,O,5612
106498,AMD,B-NAME_OF_DISEASE,5612
106499,were,O,5612
106500,associated,O,5612
106501,with,O,5612
106502,increased,O,5612
106503,FPF,B-DIAGNOSTIC_TEST,5612
106504,heterogeneity,I-DIAGNOSTIC_TEST,5612
106505,These,O,5613
106506,findings,O,5613
106507,suggest,O,5613
106508,that,O,5613
106509,mitochondrial,O,5613
106510,function,O,5613
106511,plays,O,5613
106512,an,O,5613
106513,important,O,5613
106514,role,O,5613
106515,in,O,5613
106516,the,O,5613
106517,progression,O,5613
106518,of,O,5613
106519,AMD,B-NAME_OF_DISEASE,5613
106520,said,O,5613
106521,Dr,O,5613
106522,Singh,O,5614
106523,The,O,5615
106524,ability,O,5615
106525,to,O,5615
106526,quantitatively,O,5615
106527,measure,O,5615
106528,mitochondrial,O,5615
106529,dysfunction,O,5615
106530,may,O,5615
106531,give,O,5615
106532,us,O,5615
106533,better,O,5615
106534,insights,O,5615
106535,into,O,5615
106536,how,O,5615
106537,and,O,5615
106538,when,O,5615
106539,to,O,5615
106540,treat,O,5615
106541,AMD,B-NAME_OF_DISEASE,5615
106542,patients,O,5615
106543,The,B-DIAGNOSTIC_TEST,5616
106544,OcuMet,I-DIAGNOSTIC_TEST,5616
106545,Beacon,I-DIAGNOSTIC_TEST,5616
106546,is,O,5616
106547,a,O,5616
106548,rapid,O,5616
106549,retinal,O,5616
106550,imaging,O,5616
106551,system,O,5616
106552,that,O,5616
106553,evaluates,O,5616
106554,mitochondrial,O,5616
106555,function,O,5616
106556,by,O,5616
106557,analyzing,O,5616
106558,flavoproteins,B-CHEMICAL_COMPOUND,5616
106559,It,O,5617
106560,operates,O,5617
106561,by,O,5617
106562,emitting,O,5617
106563,a,O,5617
106564,specific,O,5617
106565,wavelength,O,5617
106566,of,O,5617
106567,light,O,5617
106568,that,O,5617
106569,stimulates,O,5617
106570,the,O,5617
106571,flavoproteins,B-CHEMICAL_COMPOUND,5617
106572,in,O,5617
106573,the,B-PART_OF_THE_EYES,5617
106574,retinal,I-PART_OF_THE_EYES,5617
106575,mitochondria,I-PART_OF_THE_EYES,5617
106576,when,O,5617
106577,they,O,5617
106578,are,O,5617
106579,unable,O,5617
106580,to,O,5617
106581,generate,O,5617
106582,ATP,B-CHEMICAL_COMPOUND,5617
106583,effectively,O,5617
106584,As,O,5618
106585,a,O,5618
106586,result,O,5618
106587,the,O,5618
106588,dysfunctional,O,5618
106589,flavoproteins,B-CHEMICAL_COMPOUND,5618
106590,emit,O,5618
106591,a,O,5618
106592,particular,O,5618
106593,wavelength,O,5618
106594,that,O,5618
106595,the,O,5618
106596,device,O,5618
106597,records,O,5618
106598,and,O,5618
106599,measures,O,5618
106600,Scientific,O,5619
106601,evidence,O,5619
106602,has,O,5619
106603,established,O,5619
106604,that,O,5619
106605,mitochondrial,O,5619
106606,dysfunction,O,5619
106607,precedes,O,5619
106608,apoptosis,B-SIGN_AND_SYMPTOM,5619
106609,which,O,5619
106610,is,O,5619
106611,the,O,5619
106612,death,O,5619
106613,of,O,5619
106614,cells,O,5619
106615,The,B-DIAGNOSTIC_TEST,5620
106616,OcuMet,I-DIAGNOSTIC_TEST,5620
106617,Beacon,I-DIAGNOSTIC_TEST,5620
106618,is,O,5620
106619,currently,O,5620
106620,being,O,5620
106621,used,O,5620
106622,at,O,5620
106623,Cole,B-ORGANIZATION,5620
106624,Eye,I-ORGANIZATION,5620
106625,Institute,I-ORGANIZATION,5620
106626,under,O,5620
106627,Institutional,B-ORGANIZATION,5620
106628,Review,I-ORGANIZATION,5620
106629,Board,I-ORGANIZATION,5620
106630,Snow,B-NAME_OF_DISEASE,5621
106631,blindness,I-NAME_OF_DISEASE,5621
106632,also,O,5621
106633,known,O,5621
106634,as,O,5621
106635,photokeratitis,B-NAME_OF_DISEASE,5621
106636,or,O,5621
106637,ultraviolet,B-NAME_OF_DISEASE,5621
106638,keratitis,I-NAME_OF_DISEASE,5621
106639,is,O,5621
106640,a,O,5621
106641,condition,O,5621
106642,that,O,5621
106643,affects,O,5621
106644,the,O,5621
106645,eyes,O,5621
106646,as,O,5621
106647,a,O,5621
106648,result,O,5621
106649,of,O,5621
106650,prolonged,B-CAUSE_OF_DISEASE,5621
106651,exposure,I-CAUSE_OF_DISEASE,5621
106652,to,I-CAUSE_OF_DISEASE,5621
106653,the,I-CAUSE_OF_DISEASE,5621
106654,sun,I-CAUSE_OF_DISEASE,5621
106655,s,I-CAUSE_OF_DISEASE,5621
106656,ultraviolet,I-CAUSE_OF_DISEASE,5621
106657,UV,I-CAUSE_OF_DISEASE,5621
106658,rays,I-CAUSE_OF_DISEASE,5621
106659,reflecting,I-CAUSE_OF_DISEASE,5621
106660,off,I-CAUSE_OF_DISEASE,5621
106661,of,I-CAUSE_OF_DISEASE,5621
106662,snow,I-CAUSE_OF_DISEASE,5621
106663,or,I-CAUSE_OF_DISEASE,5621
106664,other,I-CAUSE_OF_DISEASE,5621
106665,bright,I-CAUSE_OF_DISEASE,5621
106666,surfaces,I-CAUSE_OF_DISEASE,5621
106667,It,O,5622
106668,is,O,5622
106669,a,O,5622
106670,temporary,O,5622
106671,condition,O,5622
106672,that,O,5622
106673,typically,O,5622
106674,resolves,O,5622
106675,on,O,5622
106676,its,O,5622
106677,own,O,5622
106678,but,O,5622
106679,can,O,5622
106680,cause,O,5622
106681,significant,B-SIGN_AND_SYMPTOM,5622
106682,discomfort,I-SIGN_AND_SYMPTOM,5622
106683,What,O,5623
106684,Causes,O,5623
106685,Snow,B-ORGANIZATION,5623
106686,Blindness,I-ORGANIZATION,5623
106687,Prolonged,B-CAUSE_OF_DISEASE,5623
106688,exposure,I-CAUSE_OF_DISEASE,5623
106689,to,I-CAUSE_OF_DISEASE,5623
106690,UV,I-CAUSE_OF_DISEASE,5623
106691,rays,I-CAUSE_OF_DISEASE,5623
106692,reflecting,I-CAUSE_OF_DISEASE,5623
106693,off,I-CAUSE_OF_DISEASE,5623
106694,of,I-CAUSE_OF_DISEASE,5623
106695,snow,I-CAUSE_OF_DISEASE,5623
106696,or,I-CAUSE_OF_DISEASE,5623
106697,other,I-CAUSE_OF_DISEASE,5623
106698,bright,I-CAUSE_OF_DISEASE,5623
106699,surfaces,I-CAUSE_OF_DISEASE,5623
106700,This,O,5624
106701,is,O,5624
106702,because,O,5624
106703,snow,O,5624
106704,reflects,O,5624
106705,up,O,5624
106706,to,O,5624
106707,80%,O,5624
106708,of,O,5624
106709,the,B-CAUSE_OF_DISEASE,5624
106710,sun,I-CAUSE_OF_DISEASE,5624
106711,s,I-CAUSE_OF_DISEASE,5624
106712,UV,I-CAUSE_OF_DISEASE,5624
106713,rays,I-CAUSE_OF_DISEASE,5624
106714,making,O,5624
106715,it,O,5624
106716,much,O,5624
106717,more,O,5624
106718,intense,O,5624
106719,than,O,5624
106720,sunlight,O,5624
106721,on,O,5624
106722,a,O,5624
106723,clear,O,5624
106724,day,O,5624
106725,Lack,B-CAUSE_OF_DISEASE,5625
106726,of,I-CAUSE_OF_DISEASE,5625
106727,protective,I-CAUSE_OF_DISEASE,5625
106728,eyewear,I-CAUSE_OF_DISEASE,5625
106729,or,I-CAUSE_OF_DISEASE,5625
106730,proper,I-CAUSE_OF_DISEASE,5625
106731,sunscreen,I-CAUSE_OF_DISEASE,5625
106732,use,I-CAUSE_OF_DISEASE,5625
106733,This,O,5626
106734,leaves,O,5626
106735,the,B-CAUSE_OF_DISEASE,5626
106736,eyes,I-CAUSE_OF_DISEASE,5626
106737,exposed,I-CAUSE_OF_DISEASE,5626
106738,to,I-CAUSE_OF_DISEASE,5626
106739,the,I-CAUSE_OF_DISEASE,5626
106740,harmful,I-CAUSE_OF_DISEASE,5626
106741,rays,I-CAUSE_OF_DISEASE,5626
106742,Certain,B-CAUSE_OF_DISEASE,5627
106743,medical,I-CAUSE_OF_DISEASE,5627
106744,conditions,I-CAUSE_OF_DISEASE,5627
106745,that,I-CAUSE_OF_DISEASE,5627
106746,make,I-CAUSE_OF_DISEASE,5627
106747,the,I-CAUSE_OF_DISEASE,5627
106748,eyes,I-CAUSE_OF_DISEASE,5627
106749,more,I-CAUSE_OF_DISEASE,5627
106750,sensitive,I-CAUSE_OF_DISEASE,5627
106751,to,I-CAUSE_OF_DISEASE,5627
106752,light,I-CAUSE_OF_DISEASE,5627
106753,People,O,5628
106754,with,O,5628
106755,conditions,O,5628
106756,such,O,5628
106757,as,O,5628
106758,lupus,B-NAME_OF_DISEASE,5628
106759,or,O,5628
106760,certain,O,5628
106761,medications,O,5628
106762,can,O,5628
106763,make,O,5628
106764,the,O,5628
106765,eyes,O,5628
106766,more,O,5628
106767,susceptible,O,5628
106768,to,O,5628
106769,UV,O,5628
106770,damage,O,5628
106771,Symptoms,O,5629
106772,of,O,5629
106773,Snow,B-ORGANIZATION,5629
106774,Blindness,I-ORGANIZATION,5629
106775,The,O,5629
106776,below,O,5629
106777,symptoms,O,5629
106778,may,O,5629
106779,appear,O,5629
106780,immediately,O,5629
106781,or,O,5629
106782,a,O,5629
106783,few,O,5629
106784,hours,O,5629
106785,after,O,5629
106786,exposure,O,5629
106787,and,O,5629
106788,may,O,5629
106789,last,O,5629
106790,for,O,5629
106791,a,O,5629
106792,few,O,5629
106793,days,O,5629
106794,Pain,B-SIGN_AND_SYMPTOM,5630
106795,and,I-SIGN_AND_SYMPTOM,5630
106796,redness,I-SIGN_AND_SYMPTOM,5630
106797,in,I-SIGN_AND_SYMPTOM,5630
106798,the,I-SIGN_AND_SYMPTOM,5630
106799,eyes,I-SIGN_AND_SYMPTOM,5630
106800,Sensitivity,B-SIGN_AND_SYMPTOM,5630
106801,to,I-SIGN_AND_SYMPTOM,5630
106802,light,I-SIGN_AND_SYMPTOM,5630
106803,Blurred,B-SIGN_AND_SYMPTOM,5630
106804,vision,I-SIGN_AND_SYMPTOM,5630
106805,A,B-SIGN_AND_SYMPTOM,5630
106806,feeling,I-SIGN_AND_SYMPTOM,5630
106807,of,I-SIGN_AND_SYMPTOM,5630
106808,sand,I-SIGN_AND_SYMPTOM,5630
106809,or,I-SIGN_AND_SYMPTOM,5630
106810,grit,I-SIGN_AND_SYMPTOM,5630
106811,in,I-SIGN_AND_SYMPTOM,5630
106812,the,I-SIGN_AND_SYMPTOM,5630
106813,eyes,I-SIGN_AND_SYMPTOM,5630
106814,Tears,B-SIGN_AND_SYMPTOM,5630
106815,and,I-SIGN_AND_SYMPTOM,5630
106816,swelling,I-SIGN_AND_SYMPTOM,5630
106817,of,I-SIGN_AND_SYMPTOM,5630
106818,the,I-SIGN_AND_SYMPTOM,5630
106819,eyes,I-SIGN_AND_SYMPTOM,5630
106820,How,O,5630
106821,to,O,5630
106822,Manage,O,5630
106823,Snow,B-ORGANIZATION,5630
106824,Blindness,I-ORGANIZATION,5630
106825,Resting,B-TREATMENT,5630
106826,the,I-TREATMENT,5630
106827,eyes,I-TREATMENT,5630
106828,and,I-TREATMENT,5630
106829,avoiding,I-TREATMENT,5630
106830,further,I-TREATMENT,5630
106831,exposure,I-TREATMENT,5630
106832,to,I-TREATMENT,5630
106833,UV,I-TREATMENT,5630
106834,rays,I-TREATMENT,5630
106835,Using,B-TREATMENT,5631
106836,over-the-counter,I-TREATMENT,5631
106837,pain,I-TREATMENT,5631
106838,relievers,I-TREATMENT,5631
106839,to,I-TREATMENT,5631
106840,reduce,I-TREATMENT,5631
106841,pain,I-TREATMENT,5631
106842,and,I-TREATMENT,5631
106843,inflammation,I-TREATMENT,5631
106844,Applying,B-TREATMENT,5632
106845,artificial,I-TREATMENT,5632
106846,tears,I-TREATMENT,5632
106847,or,I-TREATMENT,5632
106848,lubricating,I-TREATMENT,5632
106849,eye,I-TREATMENT,5632
106850,drops,I-TREATMENT,5632
106851,to,I-TREATMENT,5632
106852,alleviate,I-TREATMENT,5632
106853,discomfort,I-TREATMENT,5632
106854,Wearing,B-TREATMENT,5633
106855,dark,I-TREATMENT,5633
106856,glasses,I-TREATMENT,5633
106857,to,I-TREATMENT,5633
106858,protect,I-TREATMENT,5633
106859,the,I-TREATMENT,5633
106860,eyes,I-TREATMENT,5633
106861,from,I-TREATMENT,5633
106862,bright,I-TREATMENT,5633
106863,light,I-TREATMENT,5633
106864,5,O,5634
106865,Tips,O,5634
106866,to,O,5634
106867,Prevent,O,5634
106868,Snow,B-ORGANIZATION,5634
106869,Blindness,I-ORGANIZATION,5634
106870,If,O,5634
106871,you,O,5634
106872,are,O,5634
106873,spending,O,5634
106874,a,O,5634
106875,significant,O,5634
106876,amount,O,5634
106877,of,O,5634
106878,time,O,5634
106879,outside,O,5634
106880,in,O,5634
106881,snowy,O,5634
106882,or,O,5634
106883,icy,O,5634
106884,conditions,O,5634
106885,wearing,B-PREVENTION,5634
106886,protective,I-PREVENTION,5634
106887,eyewear,I-PREVENTION,5634
106888,such,I-PREVENTION,5634
106889,as,I-PREVENTION,5634
106890,sunglasses,I-PREVENTION,5634
106891,or,I-PREVENTION,5634
106892,ski,I-PREVENTION,5634
106893,goggles,I-PREVENTION,5634
106894,that,I-PREVENTION,5634
106895,block,I-PREVENTION,5634
106896,out,I-PREVENTION,5634
106897,UV,I-PREVENTION,5634
106898,rays,I-PREVENTION,5634
106899,Also,O,5635
106900,be,B-PREVENTION,5635
106901,aware,I-PREVENTION,5635
106902,of,I-PREVENTION,5635
106903,the,I-PREVENTION,5635
106904,UV,I-PREVENTION,5635
106905,index,I-PREVENTION,5635
106906,and,I-PREVENTION,5635
106907,taking,I-PREVENTION,5635
106908,precautions,I-PREVENTION,5635
106909,on,I-PREVENTION,5635
106910,days,I-PREVENTION,5635
106911,when,I-PREVENTION,5635
106912,it,I-PREVENTION,5635
106913,is,I-PREVENTION,5635
106914,high,I-PREVENTION,5635
106915,Take,B-PREVENTION,5636
106916,breaks,I-PREVENTION,5636
106917,from,I-PREVENTION,5636
106918,direct,I-PREVENTION,5636
106919,sunlight,I-PREVENTION,5636
106920,to,I-PREVENTION,5636
106921,give,I-PREVENTION,5636
106922,your,I-PREVENTION,5636
106923,eyes,I-PREVENTION,5636
106924,a,I-PREVENTION,5636
106925,rest,I-PREVENTION,5636
106926,This,O,5637
106927,can,O,5637
106928,be,O,5637
106929,done,O,5637
106930,by,O,5637
106931,finding,B-PREVENTION,5637
106932,a,I-PREVENTION,5637
106933,shaded,I-PREVENTION,5637
106934,area,I-PREVENTION,5637
106935,or,O,5637
106936,by,O,5637
106937,closing,B-PREVENTION,5637
106938,your,I-PREVENTION,5637
106939,eyes,I-PREVENTION,5637
106940,for,I-PREVENTION,5637
106941,a,I-PREVENTION,5637
106942,few,I-PREVENTION,5637
106943,minutes,I-PREVENTION,5637
106944,at,I-PREVENTION,5637
106945,a,I-PREVENTION,5637
106946,time,I-PREVENTION,5637
106947,Rest,B-PREVENTION,5638
106948,your,I-PREVENTION,5638
106949,eyes,I-PREVENTION,5638
106950,as,I-PREVENTION,5638
106951,much,I-PREVENTION,5638
106952,as,I-PREVENTION,5638
106953,possible,I-PREVENTION,5638
106954,and,O,5638
106955,avoid,B-PREVENTION,5638
106956,any,I-PREVENTION,5638
106957,further,I-PREVENTION,5638
106958,exposure,I-PREVENTION,5638
106959,to,I-PREVENTION,5638
106960,UV,I-PREVENTION,5638
106961,rays,I-PREVENTION,5638
106962,Over-the-counter,B-PREVENTION,5639
106963,pain,I-PREVENTION,5639
106964,relievers,I-PREVENTION,5639
106965,can,O,5639
106966,be,O,5639
106967,taken,O,5639
106968,to,O,5639
106969,alleviate,O,5639
106970,any,O,5639
106971,discomfort,O,5639
106972,and,O,5639
106973,a,B-PREVENTION,5639
106974,cool,I-PREVENTION,5639
106975,compress,I-PREVENTION,5639
106976,can,O,5639
106977,be,O,5639
106978,applied,O,5639
106979,to,O,5639
106980,the,O,5639
106981,eyes,O,5639
106982,for,O,5639
106983,relief,O,5639
106984,Avoid,B-PREVENTION,5640
106985,rubbing,I-PREVENTION,5640
106986,or,I-PREVENTION,5640
106987,touching,I-PREVENTION,5640
106988,your,I-PREVENTION,5640
106989,eyes,I-PREVENTION,5640
106990,as,O,5640
106991,this,O,5640
106992,can,O,5640
106993,cause,O,5640
106994,further,O,5640
106995,irritation,O,5640
106996,and,O,5640
106997,delay,O,5640
106998,the,O,5640
106999,healing,O,5640
107000,process,O,5640
107001,In,O,5641
107002,severe,O,5641
107003,cases,O,5641
107004,your,O,5641
107005,doctor,O,5641
107006,may,O,5641
107007,prescribe,O,5641
107008,eye,B-PREVENTION,5641
107009,drops,I-PREVENTION,5641
107010,or,I-PREVENTION,5641
107011,ointments,I-PREVENTION,5641
107012,to,O,5641
107013,help,O,5641
107014,speed,O,5641
107015,up,O,5641
107016,the,O,5641
107017,healing,O,5641
107018,process,O,5641
107019,Make,O,5642
107020,sure,O,5642
107021,to,O,5642
107022,limit,B-PREVENTION,5642
107023,time,I-PREVENTION,5642
107024,spent,I-PREVENTION,5642
107025,in,I-PREVENTION,5642
107026,the,I-PREVENTION,5642
107027,sun,I-PREVENTION,5642
107028,during,I-PREVENTION,5642
107029,peak,I-PREVENTION,5642
107030,UV,I-PREVENTION,5642
107031,hours,I-PREVENTION,5642
107032,10,B-TIME_DURATION,5642
107033,am,I-TIME_DURATION,5642
107034,to,I-TIME_DURATION,5642
107035,4,I-TIME_DURATION,5642
107036,pm,I-TIME_DURATION,5642
107037,,O,5642
107038,The,B-ORGANIZATION,5643
107039,National,B-ORGANIZATION,5643
107040,Eye,I-ORGANIZATION,5643
107041,Institute,I-ORGANIZATION,5643
107042,NEI,B-ORGANIZATION,5643
107043,has,O,5643
107044,developed,O,5643
107045,a,O,5643
107046,zebrafish,O,5643
107047,model,O,5643
107048,of,O,5643
107049,NEDBEH,B-NAME_OF_DISEASE,5643
107050,a,O,5643
107051,rare,O,5643
107052,genetic,O,5643
107053,disease,O,5643
107054,that,O,5643
107055,can,O,5643
107056,cause,O,5643
107057,coloboma,B-NAME_OF_DISEASE,5643
107058,a,O,5643
107059,condition,O,5643
107060,in,O,5643
107061,which,O,5643
107062,parts,B-SIGN_AND_SYMPTOM,5643
107063,of,I-SIGN_AND_SYMPTOM,5643
107064,the,I-SIGN_AND_SYMPTOM,5643
107065,eye,I-SIGN_AND_SYMPTOM,5643
107066,are,I-SIGN_AND_SYMPTOM,5643
107067,absent,I-SIGN_AND_SYMPTOM,5643
107068,due,O,5643
107069,to,O,5643
107070,developmental,O,5643
107071,defects,O,5643
107072,The,O,5644
107073,model,O,5644
107074,is,O,5644
107075,a,O,5644
107076,new,O,5644
107077,tool,O,5644
107078,for,O,5644
107079,understanding,O,5644
107080,the,O,5644
107081,embryonic,O,5644
107082,development,O,5644
107083,of,O,5644
107084,the,O,5644
107085,eye,O,5644
107086,Despite,O,5645
107087,advances,O,5645
107088,in,O,5645
107089,genetics,O,5645
107090,the,O,5645
107091,underlying,O,5645
107092,cause,O,5645
107093,of,O,5645
107094,coloboma,B-NAME_OF_DISEASE,5645
107095,in,O,5645
107096,most,O,5645
107097,families,O,5645
107098,remains,O,5645
107099,unclear,O,5645
107100,said,O,5645
107101,Brian,B-PERSON,5645
107102,Brooks,B-PERSON,5645
107103,M.D,O,5645
107104,Ph.D,O,5646
107105,chief,O,5647
107106,of,O,5647
107107,the,B-ORGANIZATION,5647
107108,NEI,B-ORGANIZATION,5647
107109,Ophthalmic,I-ORGANIZATION,5647
107110,Genetics,I-ORGANIZATION,5647
107111,and,I-ORGANIZATION,5647
107112,Visual,I-ORGANIZATION,5647
107113,Function,I-ORGANIZATION,5647
107114,Branch,I-ORGANIZATION,5647
107115,The,O,5648
107116,ongoing,O,5648
107117,mystery,O,5648
107118,is,O,5648
107119,partly,O,5648
107120,due,O,5648
107121,to,O,5648
107122,the,O,5648
107123,myriad,O,5648
107124,genes,O,5648
107125,that,O,5648
107126,must,O,5648
107127,be,O,5648
107128,turned,O,5648
107129,on,O,5648
107130,and,O,5648
107131,off,O,5648
107132,at,O,5648
107133,pivotal,O,5648
107134,moments,O,5648
107135,for,O,5648
107136,the,O,5648
107137,eye,O,5648
107138,s,O,5648
107139,normal,O,5648
107140,development,O,5648
107141,Cross,O,5649
107142,section,O,5649
107143,of,O,5649
107144,an,O,5649
107145,embryonic,O,5649
107146,rerea,O,5649
107147,mutant,O,5649
107148,zebrafish,O,5649
107149,eye,O,5649
107150,showing,O,5649
107151,coloboma,B-NAME_OF_DISEASE,5649
107152,In,O,5650
107153,normal,O,5650
107154,zebrafish,O,5650
107155,the,O,5650
107156,optic,O,5650
107157,fissure,O,5650
107158,closes,O,5650
107159,Credit,O,5651
107160,Brian,B-PERSON,5651
107161,Brooks,B-PERSON,5651
107162,National,B-ORGANIZATION,5651
107163,Eye,I-ORGANIZATION,5651
107164,Institute,I-ORGANIZATION,5651
107165,Brooks,B-PERSON,5652
107166,and,O,5652
107167,George,B-PERSON,5652
107168,studied,O,5652
107169,zebrafish,O,5652
107170,with,O,5652
107171,a,O,5652
107172,mutation,O,5652
107173,in,O,5652
107174,the,O,5652
107175,gene,O,5652
107176,rerea,O,5652
107177,which,O,5652
107178,is,O,5652
107179,the,O,5652
107180,zebrafish,O,5652
107181,equivalent,O,5652
107182,of,O,5652
107183,the,O,5652
107184,human,O,5652
107185,RERE,B-CHEMICAL_COMPOUND,5652
107186,gene,I-CHEMICAL_COMPOUND,5652
107187,mutants,O,5653
107188,showed,O,5653
107189,eye,O,5653
107190,defects,O,5653
107191,including,O,5653
107192,enlarged,O,5653
107193,optic,B-PART_OF_THE_EYES,5653
107194,stalks,I-PART_OF_THE_EYES,5653
107195,eye,B-PART_OF_THE_EYES,5653
107196,tissue,I-PART_OF_THE_EYES,5653
107197,in,I-PART_OF_THE_EYES,5653
107198,the,I-PART_OF_THE_EYES,5653
107199,brain,I-PART_OF_THE_EYES,5653
107200,and,O,5653
107201,coloboma,B-NAME_OF_DISEASE,5653
107202,as,O,5653
107203,compared,O,5653
107204,to,O,5653
107205,normal,O,5653
107206,zebrafish,O,5653
107207,The,O,5654
107208,optic,B-PART_OF_THE_EYES,5654
107209,stalk,I-PART_OF_THE_EYES,5654
107210,is,O,5654
107211,a,O,5654
107212,temporary,O,5654
107213,ocular,O,5654
107214,structure,O,5654
107215,that,O,5654
107216,connects,O,5654
107217,the,O,5654
107218,eye,O,5654
107219,and,O,5654
107220,the,O,5654
107221,brain,O,5654
107222,Brian,B-PERSON,5655
107223,Brooks,B-PERSON,5655
107224,M.D,O,5655
107225,Ph.D,O,5656
107226,left,O,5657
107227,and,O,5657
107228,Aman,O,5657
107229,George,B-PERSON,5657
107230,Ph.D,O,5657
107231,NEI,B-ORGANIZATION,5658
107232,Ophthalmic,I-ORGANIZATION,5658
107233,Genetics,I-ORGANIZATION,5658
107234,Visual,I-ORGANIZATION,5658
107235,Function,I-ORGANIZATION,5658
107236,Branch,I-ORGANIZATION,5658
107237,Credit,O,5659
107238,National,B-ORGANIZATION,5659
107239,Eye,I-ORGANIZATION,5659
107240,Institute,I-ORGANIZATION,5659
107241,The,O,5660
107242,rerea,O,5660
107243,mutation,O,5660
107244,changed,O,5660
107245,the,O,5660
107246,expression,O,5660
107247,of,O,5660
107248,critical,O,5660
107249,developmental,O,5660
107250,genes,O,5660
107251,Notably,O,5661
107252,the,O,5661
107253,rerea,O,5661
107254,mutation,O,5661
107255,disrupted,O,5661
107256,sonic,B-CHEMICAL_COMPOUND,5661
107257,hedgehog,I-CHEMICAL_COMPOUND,5661
107258,shh,B-CHEMICAL_COMPOUND,5661
107259,signaling,O,5661
107260,an,O,5661
107261,important,O,5661
107262,protein,O,5661
107263,that,O,5661
107264,guides,O,5661
107265,the,O,5661
107266,development,O,5661
107267,of,O,5661
107268,a,O,5661
107269,range,O,5661
107270,of,O,5661
107271,organs,O,5661
107272,and,O,5661
107273,tissues,O,5661
107274,including,O,5661
107275,the,O,5661
107276,optic,B-PART_OF_THE_EYES,5661
107277,stalk,I-PART_OF_THE_EYES,5661
107278,and,O,5661
107279,retina,B-PART_OF_THE_EYES,5661
107280,The,O,5662
107281,scientists,O,5662
107282,saved,O,5662
107283,coloboma,B-NAME_OF_DISEASE,5662
107284,by,O,5662
107285,blocking,O,5662
107286,the,O,5662
107287,shh,B-CHEMICAL_COMPOUND,5662
107288,route,O,5662
107289,at,O,5662
107290,a,O,5662
107291,separate,O,5662
107292,site,O,5662
107293,resulting,O,5662
107294,in,O,5662
107295,correct,O,5662
107296,closure,O,5662
107297,of,O,5662
107298,the,O,5662
107299,ocular,O,5662
107300,fissure,O,5662
107301,Our,O,5663
107302,zebrafish,O,5663
107303,model,O,5663
107304,helps,O,5663
107305,clarify,O,5663
107306,the,O,5663
107307,role,O,5663
107308,of,O,5663
107309,the,O,5663
107310,RERE,B-CHEMICAL_COMPOUND,5663
107311,gene,I-CHEMICAL_COMPOUND,5663
107312,in,O,5663
107313,eye,O,5663
107314,development,O,5663
107315,said,O,5663
107316,George,B-PERSON,5663
107317,Identifying,O,5664
107318,appropriate,O,5664
107319,model,O,5664
107320,systems,O,5664
107321,for,O,5664
107322,studying,O,5664
107323,coloboma,B-NAME_OF_DISEASE,5664
107324,is,O,5664
107325,essential,O,5664
107326,to,O,5664
107327,understanding,O,5664
107328,its,O,5664
107329,underlying,O,5664
107330,mechanisms,O,5664
107331,and,O,5664
107332,finding,O,5664
107333,targets,O,5664
107334,for,O,5664
107335,rescuing,O,5664
107336,defects,O,5664
107337,For,O,5665
107338,more,O,5665
107339,information,O,5665
107340,about,O,5665
107341,coloboma,B-NAME_OF_DISEASE,5665
107342,visit,O,5665
107343,the,O,5665
107344,NEI,B-ORGANIZATION,5665
107345,website,O,5665
107346,What,O,5666
107347,Is,O,5666
107348,Monkeypox,B-NAME_OF_DISEASE,5666
107349,Monkeypox,B-NAME_OF_DISEASE,5666
107350,is,O,5666
107351,a,O,5666
107352,zoonotic,O,5666
107353,disease,O,5666
107354,transmitted,O,5666
107355,from,O,5666
107356,animals,O,5666
107357,to,O,5666
107358,humans,O,5666
107359,spread,O,5666
107360,to,O,5666
107361,humans,O,5666
107362,by,O,5666
107363,a,B-CAUSE_OF_DISEASE,5666
107364,double-stranded,I-CAUSE_OF_DISEASE,5666
107365,virus,I-CAUSE_OF_DISEASE,5666
107366,known,I-CAUSE_OF_DISEASE,5666
107367,as,I-CAUSE_OF_DISEASE,5666
107368,the,B-CAUSE_OF_DISEASE,5666
107369,monkeypox,B-NAME_OF_DISEASE,5666
107370,virus,I-CAUSE_OF_DISEASE,5666
107371,It,O,5667
107372,is,O,5667
107373,contracted,O,5667
107374,by,O,5667
107375,humans,O,5667
107376,through,O,5667
107377,non-human,O,5667
107378,primates,O,5667
107379,and,O,5667
107380,rodents,O,5667
107381,Symptoms,O,5668
107382,produced,O,5668
107383,by,O,5668
107384,the,B-CAUSE_OF_DISEASE,5668
107385,monkeypox,B-NAME_OF_DISEASE,5668
107386,virus,I-CAUSE_OF_DISEASE,5668
107387,include,O,5668
107388,fever,B-SIGN_AND_SYMPTOM,5668
107389,with,I-SIGN_AND_SYMPTOM,5668
107390,chills,I-SIGN_AND_SYMPTOM,5668
107391,headache,I-SIGN_AND_SYMPTOM,5668
107392,flu-like,I-SIGN_AND_SYMPTOM,5668
107393,symptoms,I-SIGN_AND_SYMPTOM,5668
107394,myalgia,I-SIGN_AND_SYMPTOM,5668
107395,palpable,I-SIGN_AND_SYMPTOM,5668
107396,lymph,I-SIGN_AND_SYMPTOM,5668
107397,nodes,I-SIGN_AND_SYMPTOM,5668
107398,and,I-SIGN_AND_SYMPTOM,5668
107399,blister-like,I-SIGN_AND_SYMPTOM,5668
107400,skin,I-SIGN_AND_SYMPTOM,5668
107401,rash,I-SIGN_AND_SYMPTOM,5668
107402,Patients,O,5669
107403,recover,O,5669
107404,within,B-TIME_DURATION,5669
107405,the,I-TIME_DURATION,5669
107406,interval,I-TIME_DURATION,5669
107407,of,I-TIME_DURATION,5669
107408,two,I-TIME_DURATION,5669
107409,to,I-TIME_DURATION,5669
107410,four,I-TIME_DURATION,5669
107411,weeks,I-TIME_DURATION,5669
107412,naturally,O,5669
107413,How,O,5670
107414,Does,O,5670
107415,Monkeypox,B-NAME_OF_DISEASE,5670
107416,Affect,O,5670
107417,Our,O,5670
107418,Eyes,O,5670
107419,Monkeypox,B-CAUSE_OF_DISEASE,5670
107420,virus,I-CAUSE_OF_DISEASE,5670
107421,may,O,5670
107422,spread,O,5670
107423,to,O,5670
107424,the,O,5670
107425,eye,O,5670
107426,by,O,5670
107427,autoinoculation,O,5670
107428,or,O,5670
107429,self-inoculation,O,5670
107430,Self-inoculation,O,5671
107431,ensues,O,5671
107432,when,O,5671
107433,a,B-CAUSE_OF_DISEASE,5671
107434,diseased,I-CAUSE_OF_DISEASE,5671
107435,person,I-CAUSE_OF_DISEASE,5671
107436,scratches,I-CAUSE_OF_DISEASE,5671
107437,or,I-CAUSE_OF_DISEASE,5671
107438,rubs,I-CAUSE_OF_DISEASE,5671
107439,a,I-CAUSE_OF_DISEASE,5671
107440,blister,I-CAUSE_OF_DISEASE,5671
107441,or,I-CAUSE_OF_DISEASE,5671
107442,a,I-CAUSE_OF_DISEASE,5671
107443,vesicle,I-CAUSE_OF_DISEASE,5671
107444,and,I-CAUSE_OF_DISEASE,5671
107445,then,I-CAUSE_OF_DISEASE,5671
107446,touches,I-CAUSE_OF_DISEASE,5671
107447,the,I-CAUSE_OF_DISEASE,5671
107448,eyes,I-CAUSE_OF_DISEASE,5671
107449,transmitting,O,5671
107450,the,O,5671
107451,disease,O,5671
107452,from,O,5671
107453,one,O,5671
107454,part,O,5671
107455,of,O,5671
107456,the,O,5671
107457,body,O,5671
107458,to,O,5671
107459,another,O,5671
107460,What,O,5672
107461,Signs,O,5672
107462,and,O,5672
107463,Symptoms,O,5672
107464,Are,O,5672
107465,Seen,O,5672
107466,in,O,5672
107467,the,O,5672
107468,Eyes,O,5672
107469,Ocular,O,5672
107470,Manifestations,O,5672
107471,of,O,5672
107472,the,B-CAUSE_OF_DISEASE,5672
107473,monkeypox,B-NAME_OF_DISEASE,5672
107474,virus,I-CAUSE_OF_DISEASE,5672
107475,are,O,5672
107476,Conjunctivitis,B-SIGN_AND_SYMPTOM,5672
107477,Blepharitis,B-SIGN_AND_SYMPTOM,5672
107478,or,I-SIGN_AND_SYMPTOM,5672
107479,swelling,I-SIGN_AND_SYMPTOM,5672
107480,of,I-SIGN_AND_SYMPTOM,5672
107481,eyelid,I-SIGN_AND_SYMPTOM,5672
107482,margins,I-SIGN_AND_SYMPTOM,5672
107483,Keratitis,B-SIGN_AND_SYMPTOM,5672
107484,Corneal,B-SIGN_AND_SYMPTOM,5672
107485,ulcer,I-SIGN_AND_SYMPTOM,5672
107486,Corneal,B-SIGN_AND_SYMPTOM,5672
107487,scarring,I-SIGN_AND_SYMPTOM,5672
107488,Loss,B-SIGN_AND_SYMPTOM,5672
107489,of,I-SIGN_AND_SYMPTOM,5672
107490,vision,I-SIGN_AND_SYMPTOM,5672
107491,rarely,I-SIGN_AND_SYMPTOM,5672
107492,Redness,B-SIGN_AND_SYMPTOM,5672
107493,in,I-SIGN_AND_SYMPTOM,5672
107494,eyes,I-SIGN_AND_SYMPTOM,5672
107495,pink,I-SIGN_AND_SYMPTOM,5672
107496,eyes,I-SIGN_AND_SYMPTOM,5672
107497,Itching,B-SIGN_AND_SYMPTOM,5672
107498,in,I-SIGN_AND_SYMPTOM,5672
107499,eyes,I-SIGN_AND_SYMPTOM,5672
107500,How,O,5672
107501,to,O,5672
107502,Treat,O,5672
107503,Eye,O,5672
107504,Conditions,O,5672
107505,Associated,O,5672
107506,with,O,5672
107507,Monkeypox,B-NAME_OF_DISEASE,5672
107508,First,O,5672
107509,and,O,5672
107510,foremost,O,5672
107511,isolating,B-TREATMENT,5672
107512,oneself,I-TREATMENT,5672
107513,at,I-TREATMENT,5672
107514,home,I-TREATMENT,5672
107515,when,I-TREATMENT,5672
107516,monkeypox,B-NAME_OF_DISEASE,5672
107517,symptoms,I-TREATMENT,5672
107518,appear,I-TREATMENT,5672
107519,till,I-TREATMENT,5672
107520,the,I-TREATMENT,5672
107521,rash,I-TREATMENT,5672
107522,has,I-TREATMENT,5672
107523,completely,I-TREATMENT,5672
107524,gone,I-TREATMENT,5672
107525,away,I-TREATMENT,5672
107526,As,O,5673
107527,soon,O,5673
107528,as,O,5673
107529,the,O,5673
107530,patient,O,5673
107531,starts,O,5673
107532,noticing,O,5673
107533,ocular,O,5673
107534,symptoms,O,5673
107535,an,O,5673
107536,appointment,O,5673
107537,with,O,5673
107538,an,O,5673
107539,ophthalmologist,O,5673
107540,must,O,5673
107541,be,O,5673
107542,made,O,5673
107543,There,O,5674
107544,is,O,5674
107545,no,O,5674
107546,agreed,O,5674
107547,treatment,O,5674
107548,for,O,5674
107549,Monkeypox,B-NAME_OF_DISEASE,5674
107550,it,O,5674
107551,usually,O,5674
107552,goes,O,5674
107553,away,O,5674
107554,on,O,5674
107555,its,O,5674
107556,own,O,5674
107557,within,B-TIME_DURATION,5674
107558,two,I-TIME_DURATION,5674
107559,to,I-TIME_DURATION,5674
107560,four,I-TIME_DURATION,5674
107561,weeks,I-TIME_DURATION,5674
107562,Most,O,5675
107563,people,O,5675
107564,improve,O,5675
107565,fully,O,5675
107566,without,O,5675
107567,requiring,O,5675
107568,any,O,5675
107569,treatment,O,5675
107570,but,O,5675
107571,if,O,5675
107572,a,O,5675
107573,rash,B-SIGN_AND_SYMPTOM,5675
107574,becomes,I-SIGN_AND_SYMPTOM,5675
107575,infected,I-SIGN_AND_SYMPTOM,5675
107576,Doctors,O,5675
107577,might,O,5675
107578,prescribe,O,5675
107579,antiviral,B-TREATMENT,5675
107580,antibiotic,I-TREATMENT,5675
107581,for,I-TREATMENT,5675
107582,superadded,I-TREATMENT,5675
107583,bacterial,I-TREATMENT,5675
107584,infections,I-TREATMENT,5675
107585,or,I-TREATMENT,5675
107586,anti-inflammatory,I-TREATMENT,5675
107587,medications,I-TREATMENT,5675
107588,to,O,5675
107589,treat,O,5675
107590,severe,O,5675
107591,ocular,O,5675
107592,problems,O,5675
107593,Treatment,O,5676
107594,is,O,5676
107595,given,O,5676
107596,based,O,5676
107597,on,O,5676
107598,the,O,5676
107599,symptoms,O,5676
107600,and,O,5676
107601,for,O,5676
107602,corneal,B-SIGN_AND_SYMPTOM,5676
107603,scarring,I-SIGN_AND_SYMPTOM,5676
107604,prescription,O,5676
107605,might,O,5676
107606,include,O,5676
107607,glasses,B-TREATMENT,5676
107608,and,I-TREATMENT,5676
107609,contact,I-TREATMENT,5676
107610,lenses,I-TREATMENT,5676
107611,soft,I-TREATMENT,5676
107612,or,I-TREATMENT,5676
107613,rigid,I-TREATMENT,5676
107614,for,O,5676
107615,the,O,5676
107616,protection,O,5676
107617,of,O,5676
107618,the,O,5676
107619,eyes,O,5676
107620,Laser,B-TREATMENT,5677
107621,treatment,I-TREATMENT,5677
107622,or,I-TREATMENT,5677
107623,corneal,I-TREATMENT,5677
107624,transplantation,I-TREATMENT,5677
107625,once,O,5677
107626,the,O,5677
107627,virus,O,5677
107628,has,O,5677
107629,gone,O,5677
107630,away,O,5677
107631,For,O,5678
107632,pink,B-SIGN_AND_SYMPTOM,5678
107633,eye,I-SIGN_AND_SYMPTOM,5678
107634,associated,O,5678
107635,with,O,5678
107636,monkeypox,B-NAME_OF_DISEASE,5678
107637,several,O,5678
107638,options,O,5678
107639,are,O,5678
107640,available,O,5678
107641,for,O,5678
107642,an,O,5678
107643,instance,O,5678
107644,the,O,5678
107645,use,O,5678
107646,of,O,5678
107647,Lubricant,B-TREATMENT,5678
107648,eye,I-TREATMENT,5678
107649,drops,I-TREATMENT,5678
107650,or,I-TREATMENT,5678
107651,artificial,I-TREATMENT,5678
107652,tears,I-TREATMENT,5678
107653,to,O,5678
107654,relieve,O,5678
107655,itching,B-SIGN_AND_SYMPTOM,5678
107656,in,I-SIGN_AND_SYMPTOM,5678
107657,the,I-SIGN_AND_SYMPTOM,5678
107658,eyes,I-SIGN_AND_SYMPTOM,5678
107659,Cold,B-TREATMENT,5679
107660,compresses,I-TREATMENT,5679
107661,reduce,O,5679
107662,the,O,5679
107663,swelling,B-SIGN_AND_SYMPTOM,5679
107664,in,I-SIGN_AND_SYMPTOM,5679
107665,the,I-SIGN_AND_SYMPTOM,5679
107666,eyelids,I-SIGN_AND_SYMPTOM,5679
107667,Abstinence,B-TREATMENT,5680
107668,from,I-TREATMENT,5680
107669,the,I-TREATMENT,5680
107670,use,I-TREATMENT,5680
107671,of,I-TREATMENT,5680
107672,contact,I-TREATMENT,5680
107673,lenses,I-TREATMENT,5680
107674,No,B-TREATMENT,5681
107675,makeup,I-TREATMENT,5681
107676,until,O,5681
107677,the,O,5681
107678,eyes,O,5681
107679,are,O,5681
107680,healthy,O,5681
107681,How,O,5682
107682,to,O,5682
107683,Prevent,O,5682
107684,Monkeypox,B-NAME_OF_DISEASE,5682
107685,Patients,O,5682
107686,must,O,5682
107687,isolate,B-PREVENTION,5682
107688,themselves,I-PREVENTION,5682
107689,completely,I-PREVENTION,5682
107690,till,I-PREVENTION,5682
107691,the,I-PREVENTION,5682
107692,disease,I-PREVENTION,5682
107693,disappears,I-PREVENTION,5682
107694,completely,I-PREVENTION,5682
107695,Sharing,B-PREVENTION,5683
107696,of,I-PREVENTION,5683
107697,private,I-PREVENTION,5683
107698,items,I-PREVENTION,5683
107699,like,I-PREVENTION,5683
107700,garments,I-PREVENTION,5683
107701,or,I-PREVENTION,5683
107702,towels,I-PREVENTION,5683
107703,with,I-PREVENTION,5683
107704,others,I-PREVENTION,5683
107705,must,I-PREVENTION,5683
107706,be,I-PREVENTION,5683
107707,avoided,I-PREVENTION,5683
107708,A,B-PREVENTION,5684
107709,new,I-PREVENTION,5684
107710,towel,I-PREVENTION,5684
107711,should,I-PREVENTION,5684
107712,be,I-PREVENTION,5684
107713,used,I-PREVENTION,5684
107714,every,I-PREVENTION,5684
107715,time,I-PREVENTION,5684
107716,you,I-PREVENTION,5684
107717,need,I-PREVENTION,5684
107718,one,I-PREVENTION,5684
107719,Have,B-PREVENTION,5685
107720,no,I-PREVENTION,5685
107721,physical,I-PREVENTION,5685
107722,interaction,I-PREVENTION,5685
107723,with,I-PREVENTION,5685
107724,others,I-PREVENTION,5685
107725,Rinse,B-PREVENTION,5686
107726,your,I-PREVENTION,5686
107727,hands,I-PREVENTION,5686
107728,over,I-PREVENTION,5686
107729,and,I-PREVENTION,5686
107730,over,I-PREVENTION,5686
107731,again,I-PREVENTION,5686
107732,with,I-PREVENTION,5686
107733,soap,I-PREVENTION,5686
107734,and,I-PREVENTION,5686
107735,water,I-PREVENTION,5686
107736,Do,B-PREVENTION,5687
107737,not,I-PREVENTION,5687
107738,have,I-PREVENTION,5687
107739,any,I-PREVENTION,5687
107740,sort,I-PREVENTION,5687
107741,of,I-PREVENTION,5687
107742,physical,I-PREVENTION,5687
107743,contact,I-PREVENTION,5687
107744,with,I-PREVENTION,5687
107745,pets,I-PREVENTION,5687
107746,If,B-PREVENTION,5688
107747,you,I-PREVENTION,5688
107748,are,I-PREVENTION,5688
107749,a,I-PREVENTION,5688
107750,contact,I-PREVENTION,5688
107751,lens,I-PREVENTION,5688
107752,wearer,I-PREVENTION,5688
107753,shift,I-PREVENTION,5688
107754,to,I-PREVENTION,5688
107755,glasses,I-PREVENTION,5688
107756,up,I-PREVENTION,5688
107757,until,I-PREVENTION,5688
107758,your,I-PREVENTION,5688
107759,symptoms,I-PREVENTION,5688
107760,vanish,I-PREVENTION,5688
107761,Change,B-PREVENTION,5689
107762,the,I-PREVENTION,5689
107763,pair,I-PREVENTION,5689
107764,of,I-PREVENTION,5689
107765,your,I-PREVENTION,5689
107766,contact,I-PREVENTION,5689
107767,lenses,I-PREVENTION,5689
107768,once,I-PREVENTION,5689
107769,the,I-PREVENTION,5689
107770,disease,I-PREVENTION,5689
107771,has,I-PREVENTION,5689
107772,healed,I-PREVENTION,5689
107773,Do,B-PREVENTION,5690
107774,not,I-PREVENTION,5690
107775,touch,I-PREVENTION,5690
107776,your,I-PREVENTION,5690
107777,eyes,I-PREVENTION,5690
107778,or,I-PREVENTION,5690
107779,face,I-PREVENTION,5690
107780,after,I-PREVENTION,5690
107781,touching,I-PREVENTION,5690
107782,blisters,I-PREVENTION,5690
107783,Keep,B-PREVENTION,5691
107784,yourself,I-PREVENTION,5691
107785,hydrated,I-PREVENTION,5691
107786,Vaccinations,B-PREVENTION,5692
107787,are,O,5692
107788,also,O,5692
107789,available,O,5692
107790,for,O,5692
107791,high-risk,O,5692
107792,patients,O,5692
107793,and,O,5692
107794,patients,O,5692
107795,who,O,5692
107796,have,O,5692
107797,a,O,5692
107798,disease,O,5692
107799,in,O,5692
107800,the,O,5692
107801,initial,O,5692
107802,stages,O,5692
107803,White,B-NAME_OF_DISEASE,5693
107804,dot,I-NAME_OF_DISEASE,5693
107805,syndrome,I-NAME_OF_DISEASE,5693
107806,is,O,5693
107807,a,O,5693
107808,term,O,5693
107809,used,O,5693
107810,to,O,5693
107811,describe,O,5693
107812,a,O,5693
107813,group,O,5693
107814,of,O,5693
107815,eye,O,5693
107816,conditions,O,5693
107817,that,O,5693
107818,are,O,5693
107819,characterized,O,5693
107820,by,O,5693
107821,the,B-SIGN_AND_SYMPTOM,5693
107822,presence,I-SIGN_AND_SYMPTOM,5693
107823,of,I-SIGN_AND_SYMPTOM,5693
107824,white,I-SIGN_AND_SYMPTOM,5693
107825,or,I-SIGN_AND_SYMPTOM,5693
107826,yellowish,I-SIGN_AND_SYMPTOM,5693
107827,dots,I-SIGN_AND_SYMPTOM,5693
107828,in,I-SIGN_AND_SYMPTOM,5693
107829,the,B-PART_OF_THE_EYES,5693
107830,retina,I-PART_OF_THE_EYES,5693
107831,the,I-SIGN_AND_SYMPTOM,5693
107832,light-sensitive,I-SIGN_AND_SYMPTOM,5693
107833,layer,I-SIGN_AND_SYMPTOM,5693
107834,at,I-SIGN_AND_SYMPTOM,5693
107835,the,I-SIGN_AND_SYMPTOM,5693
107836,back,I-SIGN_AND_SYMPTOM,5693
107837,of,I-SIGN_AND_SYMPTOM,5693
107838,the,I-SIGN_AND_SYMPTOM,5693
107839,eye,I-SIGN_AND_SYMPTOM,5693
107840,,O,5693
107841,These,O,5694
107842,dots,O,5694
107843,which,O,5694
107844,are,O,5694
107845,known,O,5694
107846,as,O,5694
107847,white,B-SIGN_AND_SYMPTOM,5694
107848,dot,I-SIGN_AND_SYMPTOM,5694
107849,lesions,I-SIGN_AND_SYMPTOM,5694
107850,or,I-SIGN_AND_SYMPTOM,5694
107851,chorioretinal,I-SIGN_AND_SYMPTOM,5694
107852,lesions,I-SIGN_AND_SYMPTOM,5694
107853,are,O,5694
107854,usually,O,5694
107855,seen,O,5694
107856,in,O,5694
107857,the,B-PART_OF_THE_EYES,5694
107858,macula,I-PART_OF_THE_EYES,5694
107859,the,I-PART_OF_THE_EYES,5694
107860,central,I-PART_OF_THE_EYES,5694
107861,part,I-PART_OF_THE_EYES,5694
107862,of,I-PART_OF_THE_EYES,5694
107863,the,B-PART_OF_THE_EYES,5694
107864,retina,I-PART_OF_THE_EYES,5694
107865,and,O,5694
107866,can,O,5694
107867,be,O,5694
107868,a,O,5694
107869,sign,O,5694
107870,of,O,5694
107871,an,O,5694
107872,underlying,O,5694
107873,eye,O,5694
107874,condition,O,5694
107875,or,O,5694
107876,disease,O,5694
107877,Types,O,5695
107878,of,O,5695
107879,White,B-NAME_OF_DISEASE,5695
107880,Dot,I-NAME_OF_DISEASE,5695
107881,Syndrome,I-NAME_OF_DISEASE,5695
107882,Acute,B-NAME_OF_DISEASE,5695
107883,zonal,I-NAME_OF_DISEASE,5695
107884,occult,I-NAME_OF_DISEASE,5695
107885,outer,I-NAME_OF_DISEASE,5695
107886,retinopathy,I-NAME_OF_DISEASE,5695
107887,AZOOR,I-NAME_OF_DISEASE,5695
107888,This,O,5695
107889,is,O,5695
107890,a,O,5695
107891,rare,O,5695
107892,condition,O,5695
107893,that,O,5695
107894,affects,O,5695
107895,the,B-PART_OF_THE_EYES,5695
107896,outer,I-PART_OF_THE_EYES,5695
107897,layers,I-PART_OF_THE_EYES,5695
107898,of,I-PART_OF_THE_EYES,5695
107899,the,B-PART_OF_THE_EYES,5695
107900,retina,I-PART_OF_THE_EYES,5695
107901,and,O,5695
107902,is,O,5695
107903,characterized,O,5695
107904,by,O,5695
107905,the,B-SIGN_AND_SYMPTOM,5695
107906,sudden,I-SIGN_AND_SYMPTOM,5695
107907,appearance,I-SIGN_AND_SYMPTOM,5695
107908,of,I-SIGN_AND_SYMPTOM,5695
107909,white,I-SIGN_AND_SYMPTOM,5695
107910,dots,I-SIGN_AND_SYMPTOM,5695
107911,or,I-SIGN_AND_SYMPTOM,5695
107912,patches,I-SIGN_AND_SYMPTOM,5695
107913,in,I-SIGN_AND_SYMPTOM,5695
107914,the,B-PART_OF_THE_EYES,5695
107915,retina,I-PART_OF_THE_EYES,5695
107916,It,O,5696
107917,is,O,5696
107918,often,O,5696
107919,accompanied,O,5696
107920,by,O,5696
107921,vision,B-SIGN_AND_SYMPTOM,5696
107922,loss,I-SIGN_AND_SYMPTOM,5696
107923,and,O,5696
107924,can,O,5696
107925,be,O,5696
107926,triggered,O,5696
107927,by,O,5696
107928,certain,O,5696
107929,medications,O,5696
107930,or,O,5696
107931,diseases,O,5696
107932,Multiple,B-NAME_OF_DISEASE,5697
107933,evanescent,I-NAME_OF_DISEASE,5697
107934,white,B-NAME_OF_DISEASE,5697
107935,dot,I-NAME_OF_DISEASE,5697
107936,syndrome,I-NAME_OF_DISEASE,5697
107937,MEWDS,I-NAME_OF_DISEASE,5697
107938,This,O,5697
107939,is,O,5697
107940,a,O,5697
107941,rare,O,5697
107942,condition,O,5697
107943,that,O,5697
107944,affects,O,5697
107945,young,O,5697
107946,healthy,O,5697
107947,individuals,O,5697
107948,and,O,5697
107949,is,O,5697
107950,characterized,O,5697
107951,by,O,5697
107952,the,B-SIGN_AND_SYMPTOM,5697
107953,sudden,I-SIGN_AND_SYMPTOM,5697
107954,appearance,I-SIGN_AND_SYMPTOM,5697
107955,of,I-SIGN_AND_SYMPTOM,5697
107956,multiple,I-SIGN_AND_SYMPTOM,5697
107957,small,I-SIGN_AND_SYMPTOM,5697
107958,white,I-SIGN_AND_SYMPTOM,5697
107959,dots,I-SIGN_AND_SYMPTOM,5697
107960,in,I-SIGN_AND_SYMPTOM,5697
107961,the,B-PART_OF_THE_EYES,5697
107962,retina,I-PART_OF_THE_EYES,5697
107963,It,O,5698
107964,is,O,5698
107965,often,O,5698
107966,accompanied,O,5698
107967,by,O,5698
107968,vision,B-SIGN_AND_SYMPTOM,5698
107969,loss,I-SIGN_AND_SYMPTOM,5698
107970,and,O,5698
107971,may,O,5698
107972,resolve,O,5698
107973,on,O,5698
107974,its,O,5698
107975,own,O,5698
107976,within,B-TIME_DURATION,5698
107977,a,I-TIME_DURATION,5698
107978,few,I-TIME_DURATION,5698
107979,weeks,I-TIME_DURATION,5698
107980,to,I-TIME_DURATION,5698
107981,months,I-TIME_DURATION,5698
107982,Punctate,B-NAME_OF_DISEASE,5699
107983,inner,I-NAME_OF_DISEASE,5699
107984,choroidopathy,I-NAME_OF_DISEASE,5699
107985,PIC,I-NAME_OF_DISEASE,5699
107986,This,O,5699
107987,is,O,5699
107988,a,O,5699
107989,rare,O,5699
107990,condition,O,5699
107991,that,O,5699
107992,affects,O,5699
107993,the,B-PART_OF_THE_EYES,5699
107994,choroid,I-PART_OF_THE_EYES,5699
107995,a,I-PART_OF_THE_EYES,5699
107996,layer,I-PART_OF_THE_EYES,5699
107997,of,I-PART_OF_THE_EYES,5699
107998,blood,I-PART_OF_THE_EYES,5699
107999,vessels,I-PART_OF_THE_EYES,5699
108000,and,I-PART_OF_THE_EYES,5699
108001,connective,I-PART_OF_THE_EYES,5699
108002,tissue,I-PART_OF_THE_EYES,5699
108003,under,I-PART_OF_THE_EYES,5699
108004,the,B-PART_OF_THE_EYES,5699
108005,retina,I-PART_OF_THE_EYES,5699
108006,and,O,5699
108007,is,O,5699
108008,characterized,O,5699
108009,by,O,5699
108010,the,B-SIGN_AND_SYMPTOM,5699
108011,presence,I-SIGN_AND_SYMPTOM,5699
108012,of,I-SIGN_AND_SYMPTOM,5699
108013,small,I-SIGN_AND_SYMPTOM,5699
108014,white,I-SIGN_AND_SYMPTOM,5699
108015,dots,I-SIGN_AND_SYMPTOM,5699
108016,in,I-SIGN_AND_SYMPTOM,5699
108017,the,I-SIGN_AND_SYMPTOM,5699
108018,choroid,I-SIGN_AND_SYMPTOM,5699
108019,It,O,5700
108020,is,O,5700
108021,often,O,5700
108022,accompanied,O,5700
108023,by,O,5700
108024,vision,B-SIGN_AND_SYMPTOM,5700
108025,loss,I-SIGN_AND_SYMPTOM,5700
108026,and,O,5700
108027,may,O,5700
108028,be,O,5700
108029,triggered,O,5700
108030,by,O,5700
108031,certain,O,5700
108032,medications,O,5700
108033,or,O,5700
108034,diseases,O,5700
108035,Acute,B-NAME_OF_DISEASE,5701
108036,posterior,I-NAME_OF_DISEASE,5701
108037,multifocal,I-NAME_OF_DISEASE,5701
108038,placoid,I-NAME_OF_DISEASE,5701
108039,pigment,I-NAME_OF_DISEASE,5701
108040,epitheliopathy,I-NAME_OF_DISEASE,5701
108041,APMPPE,I-NAME_OF_DISEASE,5701
108042,This,O,5701
108043,is,O,5701
108044,a,O,5701
108045,rare,O,5701
108046,condition,O,5701
108047,that,O,5701
108048,affects,O,5701
108049,the,B-PART_OF_THE_EYES,5701
108050,retina,I-PART_OF_THE_EYES,5701
108051,and,O,5701
108052,is,O,5701
108053,characterized,O,5701
108054,by,O,5701
108055,the,B-SIGN_AND_SYMPTOM,5701
108056,sudden,I-SIGN_AND_SYMPTOM,5701
108057,appearance,I-SIGN_AND_SYMPTOM,5701
108058,of,I-SIGN_AND_SYMPTOM,5701
108059,multiple,I-SIGN_AND_SYMPTOM,5701
108060,small,I-SIGN_AND_SYMPTOM,5701
108061,white,I-SIGN_AND_SYMPTOM,5701
108062,or,I-SIGN_AND_SYMPTOM,5701
108063,yellowish,I-SIGN_AND_SYMPTOM,5701
108064,dots,I-SIGN_AND_SYMPTOM,5701
108065,in,I-SIGN_AND_SYMPTOM,5701
108066,the,I-SIGN_AND_SYMPTOM,5701
108067,retina,I-SIGN_AND_SYMPTOM,5701
108068,It,O,5702
108069,is,O,5702
108070,often,O,5702
108071,accompanied,O,5702
108072,by,O,5702
108073,vision,B-SIGN_AND_SYMPTOM,5702
108074,loss,I-SIGN_AND_SYMPTOM,5702
108075,and,O,5702
108076,may,O,5702
108077,resolve,O,5702
108078,on,O,5702
108079,its,O,5702
108080,own,O,5702
108081,within,B-TIME_DURATION,5702
108082,a,I-TIME_DURATION,5702
108083,few,I-TIME_DURATION,5702
108084,weeks,I-TIME_DURATION,5702
108085,to,I-TIME_DURATION,5702
108086,months,I-TIME_DURATION,5702
108087,How,O,5703
108088,It,O,5703
108089,Is,O,5703
108090,Diagnosed,O,5703
108091,White,B-NAME_OF_DISEASE,5703
108092,dot,I-NAME_OF_DISEASE,5703
108093,syndrome,I-NAME_OF_DISEASE,5703
108094,is,O,5703
108095,typically,O,5703
108096,diagnosed,O,5703
108097,through,O,5703
108098,a,O,5703
108099,comprehensive,O,5703
108100,eye,O,5703
108101,examination,O,5703
108102,which,O,5703
108103,may,O,5703
108104,include,O,5703
108105,a,B-DIAGNOSTIC_TEST,5703
108106,dilated,I-DIAGNOSTIC_TEST,5703
108107,fundus,I-DIAGNOSTIC_TEST,5703
108108,exam,I-DIAGNOSTIC_TEST,5703
108109,an,I-DIAGNOSTIC_TEST,5703
108110,examination,I-DIAGNOSTIC_TEST,5703
108111,of,I-DIAGNOSTIC_TEST,5703
108112,the,I-DIAGNOSTIC_TEST,5703
108113,back,I-DIAGNOSTIC_TEST,5703
108114,of,I-DIAGNOSTIC_TEST,5703
108115,the,I-DIAGNOSTIC_TEST,5703
108116,eye,I-DIAGNOSTIC_TEST,5703
108117,using,I-DIAGNOSTIC_TEST,5703
108118,special,I-DIAGNOSTIC_TEST,5703
108119,instruments,I-DIAGNOSTIC_TEST,5703
108120,and,O,5703
108121,imaging,B-DIAGNOSTIC_TEST,5703
108122,tests,I-DIAGNOSTIC_TEST,5703
108123,such,I-DIAGNOSTIC_TEST,5703
108124,as,I-DIAGNOSTIC_TEST,5703
108125,optical,I-DIAGNOSTIC_TEST,5703
108126,coherence,I-DIAGNOSTIC_TEST,5703
108127,tomography,I-DIAGNOSTIC_TEST,5703
108128,OCT,I-DIAGNOSTIC_TEST,5703
108129,or,O,5703
108130,fluorescein,B-DIAGNOSTIC_TEST,5703
108131,angiography,I-DIAGNOSTIC_TEST,5703
108132,a,I-DIAGNOSTIC_TEST,5703
108133,test,I-DIAGNOSTIC_TEST,5703
108134,that,I-DIAGNOSTIC_TEST,5703
108135,involves,I-DIAGNOSTIC_TEST,5703
108136,injecting,I-DIAGNOSTIC_TEST,5703
108137,a,I-DIAGNOSTIC_TEST,5703
108138,dye,I-DIAGNOSTIC_TEST,5703
108139,into,I-DIAGNOSTIC_TEST,5703
108140,the,I-DIAGNOSTIC_TEST,5703
108141,bloodstream,I-DIAGNOSTIC_TEST,5703
108142,to,I-DIAGNOSTIC_TEST,5703
108143,visualize,I-DIAGNOSTIC_TEST,5703
108144,the,I-DIAGNOSTIC_TEST,5703
108145,blood,I-DIAGNOSTIC_TEST,5703
108146,vessels,I-DIAGNOSTIC_TEST,5703
108147,in,I-DIAGNOSTIC_TEST,5703
108148,the,I-DIAGNOSTIC_TEST,5703
108149,eye,I-DIAGNOSTIC_TEST,5703
108150,,O,5703
108151,Managing,O,5704
108152,White,B-NAME_OF_DISEASE,5704
108153,Dot,I-NAME_OF_DISEASE,5704
108154,Syndrome,I-NAME_OF_DISEASE,5704
108155,Treatment,O,5704
108156,for,O,5704
108157,white,B-NAME_OF_DISEASE,5704
108158,dot,I-NAME_OF_DISEASE,5704
108159,syndrome,I-NAME_OF_DISEASE,5704
108160,depends,O,5704
108161,on,O,5704
108162,the,O,5704
108163,underlying,O,5704
108164,cause,O,5704
108165,of,O,5704
108166,the,O,5704
108167,condition,O,5704
108168,and,O,5704
108169,may,O,5704
108170,include,O,5704
108171,the,O,5704
108172,following,O,5704
108173,Medications,O,5704
108174,Corticosteroids,B-NAME_OF_DRUG,5704
108175,or,O,5704
108176,other,O,5704
108177,immunosuppressive,B-TREATMENT,5704
108178,medications,I-TREATMENT,5704
108179,may,O,5704
108180,be,O,5704
108181,used,O,5704
108182,to,O,5704
108183,reduce,O,5704
108184,inflammation,O,5704
108185,and,O,5704
108186,improve,O,5704
108187,vision,O,5704
108188,in,O,5704
108189,some,O,5704
108190,cases,O,5704
108191,of,O,5704
108192,white,B-NAME_OF_DISEASE,5704
108193,dot,I-NAME_OF_DISEASE,5704
108194,syndrome,I-NAME_OF_DISEASE,5704
108195,Laser,B-TREATMENT,5705
108196,treatment,I-TREATMENT,5705
108197,Laser,B-TREATMENT,5705
108198,treatment,I-TREATMENT,5705
108199,may,O,5705
108200,be,O,5705
108201,used,O,5705
108202,to,O,5705
108203,destroy,O,5705
108204,abnormal,O,5705
108205,blood,O,5705
108206,vessels,O,5705
108207,or,O,5705
108208,to,O,5705
108209,seal,O,5705
108210,leaking,O,5705
108211,blood,O,5705
108212,vessels,O,5705
108213,in,O,5705
108214,some,O,5705
108215,cases,O,5705
108216,of,O,5705
108217,white,B-NAME_OF_DISEASE,5705
108218,dot,I-NAME_OF_DISEASE,5705
108219,syndrome,I-NAME_OF_DISEASE,5705
108220,Observation,O,5706
108221,In,O,5706
108222,some,O,5706
108223,cases,O,5706
108224,white,B-NAME_OF_DISEASE,5706
108225,dot,I-NAME_OF_DISEASE,5706
108226,syndrome,I-NAME_OF_DISEASE,5706
108227,may,O,5706
108228,resolve,O,5706
108229,on,O,5706
108230,its,O,5706
108231,own,O,5706
108232,without,O,5706
108233,treatment,O,5706
108234,In,O,5707
108235,these,O,5707
108236,cases,O,5707
108237,the,O,5707
108238,condition,O,5707
108239,may,O,5707
108240,be,O,5707
108241,monitored,O,5707
108242,by,O,5707
108243,an,O,5707
108244,eye,O,5707
108245,doctor,O,5707
108246,to,O,5707
108247,ensure,O,5707
108248,that,O,5707
108249,it,O,5707
108250,does,O,5707
108251,not,O,5707
108252,progress,O,5707
108253,or,O,5707
108254,cause,O,5707
108255,further,O,5707
108256,vision,B-SIGN_AND_SYMPTOM,5707
108257,loss,I-SIGN_AND_SYMPTOM,5707
108258,It,O,5708
108259,is,O,5708
108260,important,O,5708
108261,to,O,5708
108262,follow,O,5708
108263,the,O,5708
108264,treatment,O,5708
108265,plan,O,5708
108266,recommended,O,5708
108267,by,O,5708
108268,an,O,5708
108269,eye,O,5708
108270,doctor,O,5708
108271,to,O,5708
108272,manage,O,5708
108273,the,O,5708
108274,symptoms,O,5708
108275,of,O,5708
108276,white,B-NAME_OF_DISEASE,5708
108277,dot,I-NAME_OF_DISEASE,5708
108278,syndrome,I-NAME_OF_DISEASE,5708
108279,and,O,5708
108280,prevent,O,5708
108281,vision,B-SIGN_AND_SYMPTOM,5708
108282,loss,I-SIGN_AND_SYMPTOM,5708
108283,If,O,5709
108284,symptoms,O,5709
108285,persist,O,5709
108286,or,O,5709
108287,are,O,5709
108288,severe,O,5709
108289,it,O,5709
108290,is,O,5709
108291,important,O,5709
108292,to,O,5709
108293,see,O,5709
108294,a,O,5709
108295,doctor,O,5709
108296,for,O,5709
108297,further,O,5709
108298,evaluation,O,5709
108299,and,O,5709
108300,treatment,O,5709
108301,What,O,5710
108302,is,O,5710
108303,intumescent,B-NAME_OF_DISEASE,5710
108304,cataract,B-NAME_OF_DISEASE,5710
108305,Intumescent,B-NAME_OF_DISEASE,5710
108306,cataracts,I-NAME_OF_DISEASE,5710
108307,are,O,5710
108308,mature,O,5710
108309,or,O,5710
108310,older,O,5710
108311,stages,O,5710
108312,of,O,5710
108313,cataract,B-NAME_OF_DISEASE,5710
108314,This,O,5711
108315,cataract,B-NAME_OF_DISEASE,5711
108316,is,O,5711
108317,the,O,5711
108318,result,O,5711
108319,of,O,5711
108320,degeneration,B-CAUSE_OF_DISEASE,5711
108321,in,I-CAUSE_OF_DISEASE,5711
108322,lens,I-CAUSE_OF_DISEASE,5711
108323,proteins,I-CAUSE_OF_DISEASE,5711
108324,leading,O,5711
108325,to,O,5711
108326,swelling,B-SIGN_AND_SYMPTOM,5711
108327,of,I-SIGN_AND_SYMPTOM,5711
108328,lens,I-SIGN_AND_SYMPTOM,5711
108329,followed,O,5711
108330,by,O,5711
108331,shallow,B-SIGN_AND_SYMPTOM,5711
108332,Anterior,I-SIGN_AND_SYMPTOM,5711
108333,chamber,I-SIGN_AND_SYMPTOM,5711
108334,secondary,I-SIGN_AND_SYMPTOM,5711
108335,angle,I-SIGN_AND_SYMPTOM,5711
108336,closure,I-SIGN_AND_SYMPTOM,5711
108337,glaucoma,I-SIGN_AND_SYMPTOM,5711
108338,and,I-SIGN_AND_SYMPTOM,5711
108339,vision,I-SIGN_AND_SYMPTOM,5711
108340,impairment,I-SIGN_AND_SYMPTOM,5711
108341,What,O,5712
108342,are,O,5712
108343,the,O,5712
108344,causes,O,5712
108345,of,O,5712
108346,intumescent,B-NAME_OF_DISEASE,5712
108347,cataract,B-NAME_OF_DISEASE,5712
108348,Etiology,O,5712
108349,Main,O,5712
108350,Factors,O,5712
108351,leading,O,5712
108352,to,O,5712
108353,the,O,5712
108354,development,O,5712
108355,of,O,5712
108356,Intumescent,B-NAME_OF_DISEASE,5712
108357,Cataract,I-NAME_OF_DISEASE,5712
108358,are,O,5712
108359,-,O,5712
108360,Untreated,B-CAUSE_OF_DISEASE,5712
108361,immature,I-CAUSE_OF_DISEASE,5712
108362,cataracts,I-CAUSE_OF_DISEASE,5712
108363,Exposure,B-CAUSE_OF_DISEASE,5712
108364,to,I-CAUSE_OF_DISEASE,5712
108365,UV,I-CAUSE_OF_DISEASE,5712
108366,rays,I-CAUSE_OF_DISEASE,5712
108367,Heatwaves,B-CAUSE_OF_DISEASE,5712
108368,exposure,I-CAUSE_OF_DISEASE,5712
108369,Infrared,B-CAUSE_OF_DISEASE,5712
108370,light,I-CAUSE_OF_DISEASE,5712
108371,exposure,I-CAUSE_OF_DISEASE,5712
108372,Radiation,B-CAUSE_OF_DISEASE,5712
108373,exposure,I-CAUSE_OF_DISEASE,5712
108374,in,I-CAUSE_OF_DISEASE,5712
108375,eyes,I-CAUSE_OF_DISEASE,5712
108376,over,I-CAUSE_OF_DISEASE,5712
108377,long,I-CAUSE_OF_DISEASE,5712
108378,periods,I-CAUSE_OF_DISEASE,5712
108379,of,I-CAUSE_OF_DISEASE,5712
108380,time,I-CAUSE_OF_DISEASE,5712
108381,Electric,B-CAUSE_OF_DISEASE,5712
108382,Sparks,I-CAUSE_OF_DISEASE,5712
108383,Eye,B-CAUSE_OF_DISEASE,5712
108384,rupture,I-CAUSE_OF_DISEASE,5712
108385,Signs,O,5712
108386,and,O,5712
108387,symptoms,O,5712
108388,of,O,5712
108389,intumescent,B-NAME_OF_DISEASE,5712
108390,cataract,B-NAME_OF_DISEASE,5712
108391,Irritation,B-SIGN_AND_SYMPTOM,5712
108392,or,I-SIGN_AND_SYMPTOM,5712
108393,discomfort,I-SIGN_AND_SYMPTOM,5712
108394,in,I-SIGN_AND_SYMPTOM,5712
108395,eyes,I-SIGN_AND_SYMPTOM,5712
108396,Constant,B-SIGN_AND_SYMPTOM,5712
108397,fatigue,I-SIGN_AND_SYMPTOM,5712
108398,and,I-SIGN_AND_SYMPTOM,5712
108399,strain,I-SIGN_AND_SYMPTOM,5712
108400,in,I-SIGN_AND_SYMPTOM,5712
108401,eyes,I-SIGN_AND_SYMPTOM,5712
108402,Blurred,B-SIGN_AND_SYMPTOM,5712
108403,Vision,I-SIGN_AND_SYMPTOM,5712
108404,due,O,5712
108405,to,O,5712
108406,opacification,O,5712
108407,of,O,5712
108408,lens,O,5712
108409,Diminution,B-SIGN_AND_SYMPTOM,5712
108410,in,I-SIGN_AND_SYMPTOM,5712
108411,visual,I-SIGN_AND_SYMPTOM,5712
108412,acuity,I-SIGN_AND_SYMPTOM,5712
108413,Vision,B-SIGN_AND_SYMPTOM,5712
108414,may,I-SIGN_AND_SYMPTOM,5712
108415,be,I-SIGN_AND_SYMPTOM,5712
108416,reduced,I-SIGN_AND_SYMPTOM,5712
108417,to,O,5712
108418,movement,O,5712
108419,of,O,5712
108420,hands,O,5712
108421,or,O,5712
108422,counting,O,5712
108423,fingers,O,5712
108424,hindering,O,5712
108425,day,O,5712
108426,to,O,5712
108427,day,O,5712
108428,activities,O,5712
108429,of,O,5712
108430,patient,O,5712
108431,Trouble,B-SIGN_AND_SYMPTOM,5712
108432,seeing,I-SIGN_AND_SYMPTOM,5712
108433,in,I-SIGN_AND_SYMPTOM,5712
108434,dim,I-SIGN_AND_SYMPTOM,5712
108435,light,I-SIGN_AND_SYMPTOM,5712
108436,Need,B-SIGN_AND_SYMPTOM,5712
108437,brighter,I-SIGN_AND_SYMPTOM,5712
108438,than,I-SIGN_AND_SYMPTOM,5712
108439,usual,I-SIGN_AND_SYMPTOM,5712
108440,light,I-SIGN_AND_SYMPTOM,5712
108441,for,I-SIGN_AND_SYMPTOM,5712
108442,reading,I-SIGN_AND_SYMPTOM,5712
108443,Holding,B-SIGN_AND_SYMPTOM,5712
108444,objects,I-SIGN_AND_SYMPTOM,5712
108445,closer,I-SIGN_AND_SYMPTOM,5712
108446,to,I-SIGN_AND_SYMPTOM,5712
108447,the,I-SIGN_AND_SYMPTOM,5712
108448,eyes,I-SIGN_AND_SYMPTOM,5712
108449,for,I-SIGN_AND_SYMPTOM,5712
108450,clear,I-SIGN_AND_SYMPTOM,5712
108451,vision,I-SIGN_AND_SYMPTOM,5712
108452,Inability,B-SIGN_AND_SYMPTOM,5712
108453,to,I-SIGN_AND_SYMPTOM,5712
108454,differentiate,I-SIGN_AND_SYMPTOM,5712
108455,colors,I-SIGN_AND_SYMPTOM,5712
108456,Double,B-SIGN_AND_SYMPTOM,5712
108457,vision,I-SIGN_AND_SYMPTOM,5712
108458,Frequent,B-SIGN_AND_SYMPTOM,5712
108459,changes,I-SIGN_AND_SYMPTOM,5712
108460,of,I-SIGN_AND_SYMPTOM,5712
108461,eye,I-SIGN_AND_SYMPTOM,5712
108462,glasses,I-SIGN_AND_SYMPTOM,5712
108463,Managing,O,5712
108464,intumescent,B-NAME_OF_DISEASE,5712
108465,cataract,B-NAME_OF_DISEASE,5712
108466,Diagnosis,O,5712
108467,The,B-DIAGNOSTIC_TEST,5712
108468,Image,I-DIAGNOSTIC_TEST,5712
108469,Test,I-DIAGNOSTIC_TEST,5712
108470,is,O,5712
108471,used,O,5712
108472,for,O,5712
108473,sure,O,5712
108474,diagnosis,O,5712
108475,of,O,5712
108476,intumescent,B-NAME_OF_DISEASE,5712
108477,cataract,B-NAME_OF_DISEASE,5712
108478,Slit,B-DIAGNOSTIC_TEST,5713
108479,lamp,I-DIAGNOSTIC_TEST,5713
108480,bio-microscopy,I-DIAGNOSTIC_TEST,5713
108481,shows,O,5713
108482,an,B-SIGN_AND_SYMPTOM,5713
108483,opaque,I-SIGN_AND_SYMPTOM,5713
108484,white,I-SIGN_AND_SYMPTOM,5713
108485,lens,I-SIGN_AND_SYMPTOM,5713
108486,with,I-SIGN_AND_SYMPTOM,5713
108487,a,I-SIGN_AND_SYMPTOM,5713
108488,rigid,I-SIGN_AND_SYMPTOM,5713
108489,and,I-SIGN_AND_SYMPTOM,5713
108490,inflexible,I-SIGN_AND_SYMPTOM,5713
108491,anterior,I-SIGN_AND_SYMPTOM,5713
108492,capsule,I-SIGN_AND_SYMPTOM,5713
108493,Anterior,B-DIAGNOSTIC_TEST,5714
108494,segment,I-DIAGNOSTIC_TEST,5714
108495,optical,I-DIAGNOSTIC_TEST,5714
108496,coherence,I-DIAGNOSTIC_TEST,5714
108497,tomography,I-DIAGNOSTIC_TEST,5714
108498,revealing,O,5714
108499,a,O,5714
108500,lens,O,5714
108501,thickness,O,5714
108502,of,O,5714
108503,5.3,O,5714
108504,mm,O,5715
108505,or,O,5715
108506,more,O,5715
108507,Intumescent,B-NAME_OF_DISEASE,5716
108508,cataracts,I-NAME_OF_DISEASE,5716
108509,resulting,O,5716
108510,from,O,5716
108511,trauma,O,5716
108512,show,O,5716
108513,a,B-SIGN_AND_SYMPTOM,5716
108514,capsule,I-SIGN_AND_SYMPTOM,5716
108515,break,I-SIGN_AND_SYMPTOM,5716
108516,and,I-SIGN_AND_SYMPTOM,5716
108517,pigment,I-SIGN_AND_SYMPTOM,5716
108518,residues,I-SIGN_AND_SYMPTOM,5716
108519,on,I-SIGN_AND_SYMPTOM,5716
108520,the,I-SIGN_AND_SYMPTOM,5716
108521,anterior,I-SIGN_AND_SYMPTOM,5716
108522,lens,I-SIGN_AND_SYMPTOM,5716
108523,capsule,I-SIGN_AND_SYMPTOM,5716
108524,Scheimpflug,B-DIAGNOSTIC_TEST,5716
108525,densitometry,I-DIAGNOSTIC_TEST,5716
108526,is,O,5716
108527,utilized,O,5716
108528,to,O,5716
108529,measure,O,5716
108530,the,B-SIGN_AND_SYMPTOM,5716
108531,opacity,I-SIGN_AND_SYMPTOM,5716
108532,of,I-SIGN_AND_SYMPTOM,5716
108533,the,I-SIGN_AND_SYMPTOM,5716
108534,lens,I-SIGN_AND_SYMPTOM,5716
108535,high,I-SIGN_AND_SYMPTOM,5716
108536,density,I-SIGN_AND_SYMPTOM,5716
108537,means,I-SIGN_AND_SYMPTOM,5716
108538,a,I-SIGN_AND_SYMPTOM,5716
108539,large,I-SIGN_AND_SYMPTOM,5716
108540,nucleus,I-SIGN_AND_SYMPTOM,5716
108541,more,O,5716
108542,likely,O,5716
108543,to,O,5716
108544,be,O,5716
108545,intumescent,B-NAME_OF_DISEASE,5716
108546,cataract,B-NAME_OF_DISEASE,5716
108547,Physical,O,5717
108548,Examination,O,5717
108549,During,O,5717
108550,the,O,5717
108551,course,O,5717
108552,of,O,5717
108553,cataract,B-NAME_OF_DISEASE,5717
108554,development,O,5717
108555,Intumescent,B-NAME_OF_DISEASE,5717
108556,cataract,I-NAME_OF_DISEASE,5717
108557,lies,O,5717
108558,between,O,5717
108559,immature,B-NAME_OF_DISEASE,5717
108560,cortical,I-NAME_OF_DISEASE,5717
108561,and,I-NAME_OF_DISEASE,5717
108562,mature,I-NAME_OF_DISEASE,5717
108563,corticonuclear,I-NAME_OF_DISEASE,5717
108564,cataract,I-NAME_OF_DISEASE,5717
108565,stages,I-NAME_OF_DISEASE,5717
108566,Intumescent,B-NAME_OF_DISEASE,5718
108567,cataract,I-NAME_OF_DISEASE,5718
108568,is,O,5718
108569,however,O,5718
108570,somewhat,O,5718
108571,a,O,5718
108572,later,O,5718
108573,stage,O,5718
108574,of,O,5718
108575,cataract,B-NAME_OF_DISEASE,5718
108576,It,O,5719
108577,appears,O,5719
108578,clinically,O,5719
108579,as,O,5719
108580,a,B-SIGN_AND_SYMPTOM,5719
108581,white,I-SIGN_AND_SYMPTOM,5719
108582,crystalline,I-SIGN_AND_SYMPTOM,5719
108583,opacity,I-SIGN_AND_SYMPTOM,5719
108584,in,I-SIGN_AND_SYMPTOM,5719
108585,the,I-SIGN_AND_SYMPTOM,5719
108586,lens,I-SIGN_AND_SYMPTOM,5719
108587,cortex,I-SIGN_AND_SYMPTOM,5719
108588,In,O,5720
108589,intumescent,B-NAME_OF_DISEASE,5720
108590,cataract,B-NAME_OF_DISEASE,5720
108591,there,O,5720
108592,are,O,5720
108593,prominent,B-SIGN_AND_SYMPTOM,5720
108594,sectoral,I-SIGN_AND_SYMPTOM,5720
108595,markings,I-SIGN_AND_SYMPTOM,5720
108596,present,I-SIGN_AND_SYMPTOM,5720
108597,in,I-SIGN_AND_SYMPTOM,5720
108598,the,I-SIGN_AND_SYMPTOM,5720
108599,anterior,I-SIGN_AND_SYMPTOM,5720
108600,cortex,I-SIGN_AND_SYMPTOM,5720
108601,Effective,O,5721
108602,treatments,O,5721
108603,The,O,5721
108604,only,O,5721
108605,choice,O,5721
108606,is,O,5721
108607,surgery,B-TREATMENT,5721
108608,for,I-TREATMENT,5721
108609,the,I-TREATMENT,5721
108610,removal,I-TREATMENT,5721
108611,of,I-TREATMENT,5721
108612,the,I-TREATMENT,5721
108613,opacified,I-TREATMENT,5721
108614,lens,I-TREATMENT,5721
108615,this,O,5721
108616,process,O,5721
108617,is,O,5721
108618,known,O,5721
108619,as,O,5721
108620,lens,B-TREATMENT,5721
108621,extraction,I-TREATMENT,5721
108622,or,O,5721
108623,cataract,B-TREATMENT,5721
108624,removal,I-TREATMENT,5721
108625,Intracapsular,B-TREATMENT,5722
108626,extraction,I-TREATMENT,5722
108627,with,O,5722
108628,emulsification,B-TREATMENT,5722
108629,and,I-TREATMENT,5722
108630,aspiration,I-TREATMENT,5722
108631,of,I-TREATMENT,5722
108632,nucleus,I-TREATMENT,5722
108633,In,O,5723
108634,Intracapsular,B-TREATMENT,5723
108635,extraction,I-TREATMENT,5723
108636,lens,O,5723
108637,is,O,5723
108638,removed,O,5723
108639,along,O,5723
108640,with,O,5723
108641,its,O,5723
108642,capsule,O,5723
108643,Emulsification,B-TREATMENT,5724
108644,and,I-TREATMENT,5724
108645,aspiration,I-TREATMENT,5724
108646,are,O,5724
108647,used,O,5724
108648,to,O,5724
108649,remove,O,5724
108650,the,O,5724
108651,ruptured,O,5724
108652,inner,O,5724
108653,part,O,5724
108654,of,O,5724
108655,lens,O,5724
108656,Recently,O,5725
108657,the,O,5725
108658,removed,O,5725
108659,cataract,B-NAME_OF_DISEASE,5725
108660,is,O,5725
108661,replaced,O,5725
108662,by,O,5725
108663,a,B-TREATMENT,5725
108664,plastic,I-TREATMENT,5725
108665,intraocular,I-TREATMENT,5725
108666,lens,I-TREATMENT,5725
108667,In,O,5726
108668,this,O,5726
108669,scenario,O,5726
108670,the,B-PART_OF_THE_EYES,5726
108671,inner,I-PART_OF_THE_EYES,5726
108672,parts,I-PART_OF_THE_EYES,5726
108673,of,I-PART_OF_THE_EYES,5726
108674,the,I-PART_OF_THE_EYES,5726
108675,lens,I-PART_OF_THE_EYES,5726
108676,are,O,5726
108677,taken,O,5726
108678,out,O,5726
108679,leaving,O,5726
108680,the,B-PART_OF_THE_EYES,5726
108681,capsule,I-PART_OF_THE_EYES,5726
108682,intact,I-PART_OF_THE_EYES,5726
108683,and,O,5726
108684,the,O,5726
108685,intraocular,O,5726
108686,lens,O,5726
108687,is,O,5726
108688,placed,O,5726
108689,inside,O,5726
108690,the,B-PART_OF_THE_EYES,5726
108691,capsular,I-PART_OF_THE_EYES,5726
108692,bag,I-PART_OF_THE_EYES,5726
108693,How,O,5727
108694,to,O,5727
108695,prevent,O,5727
108696,intumescent,B-NAME_OF_DISEASE,5727
108697,cataract,B-NAME_OF_DISEASE,5727
108698,Getting,B-PREVENTION,5727
108699,immature,I-PREVENTION,5727
108700,and,I-PREVENTION,5727
108701,untreated,I-PREVENTION,5727
108702,cataract,I-PREVENTION,5727
108703,surgically,I-PREVENTION,5727
108704,removed,I-PREVENTION,5727
108705,before,I-PREVENTION,5727
108706,it,I-PREVENTION,5727
108707,reaches,I-PREVENTION,5727
108708,a,I-PREVENTION,5727
108709,mature,I-PREVENTION,5727
108710,age,I-PREVENTION,5727
108711,Intumescent,B-NAME_OF_DISEASE,5728
108712,Cataract,I-NAME_OF_DISEASE,5728
108713,is,O,5728
108714,chiefly,O,5728
108715,due,O,5728
108716,to,O,5728
108717,the,B-CAUSE_OF_DISEASE,5728
108718,inappropriate,I-CAUSE_OF_DISEASE,5728
108719,hydration,I-CAUSE_OF_DISEASE,5728
108720,of,I-CAUSE_OF_DISEASE,5728
108721,the,I-CAUSE_OF_DISEASE,5728
108722,lens,I-CAUSE_OF_DISEASE,5728
108723,leading,O,5728
108724,to,O,5728
108725,swelling,B-SIGN_AND_SYMPTOM,5728
108726,in,O,5728
108727,it,O,5728
108728,Factors,O,5729
108729,which,O,5729
108730,may,O,5729
108731,lead,O,5729
108732,to,O,5729
108733,it,O,5729
108734,must,O,5729
108735,be,O,5729
108736,kept,O,5729
108737,under,O,5729
108738,a,O,5729
108739,strict,O,5729
108740,surveillance,O,5729
108741,as,O,5729
108742,an,O,5729
108743,example,O,5729
108744,Diabetes,B-NAME_OF_DISEASE,5729
108745,Mellitus,I-NAME_OF_DISEASE,5729
108746,Abstinence,B-PREVENTION,5730
108747,from,I-PREVENTION,5730
108748,exposure,I-PREVENTION,5730
108749,of,I-PREVENTION,5730
108750,heat,I-PREVENTION,5730
108751,and,I-PREVENTION,5730
108752,other,I-PREVENTION,5730
108753,radiations,I-PREVENTION,5730
108754,for,I-PREVENTION,5730
108755,longer,I-PREVENTION,5730
108756,periods,I-PREVENTION,5730
108757,of,I-PREVENTION,5730
108758,time,I-PREVENTION,5730
108759,to,O,5730
108760,decrease,O,5730
108761,irritability,O,5730
108762,in,O,5730
108763,the,O,5730
108764,eye,O,5730
108765,Using,B-PREVENTION,5731
108766,glasses,I-PREVENTION,5731
108767,and,I-PREVENTION,5731
108768,eye,I-PREVENTION,5731
108769,shields,I-PREVENTION,5731
108770,while,I-PREVENTION,5731
108771,being,I-PREVENTION,5731
108772,exposed,I-PREVENTION,5731
108773,to,I-PREVENTION,5731
108774,sun,I-PREVENTION,5731
108775,This,O,5732
108776,will,O,5732
108777,diminish,O,5732
108778,the,O,5732
108779,effect,O,5732
108780,of,O,5732
108781,heat,O,5732
108782,directly,O,5732
108783,on,O,5732
108784,eyes,O,5732
108785,Prevention,B-PREVENTION,5733
108786,of,I-PREVENTION,5733
108787,eye,I-PREVENTION,5733
108788,trauma,I-PREVENTION,5733
108789,by,I-PREVENTION,5733
108790,using,I-PREVENTION,5733
108791,eye,I-PREVENTION,5733
108792,wear,I-PREVENTION,5733
108793,protection,I-PREVENTION,5733
108794,for,I-PREVENTION,5733
108795,UV,I-PREVENTION,5733
108796,and,I-PREVENTION,5733
108797,infra-red,I-PREVENTION,5733
108798,radiation,I-PREVENTION,5733
108799,Toxic,B-NAME_OF_DISEASE,5733
108800,Anterior,I-NAME_OF_DISEASE,5733
108801,Segment,I-NAME_OF_DISEASE,5733
108802,Syndrome,I-NAME_OF_DISEASE,5734
108803,TASS,B-NAME_OF_DISEASE,5734
108804,is,O,5734
108805,a,O,5734
108806,rare,O,5734
108807,but,O,5734
108808,serious,O,5734
108809,complication,O,5734
108810,that,O,5734
108811,can,O,5734
108812,occur,O,5734
108813,after,O,5734
108814,ocular,O,5734
108815,surgery,O,5734
108816,It,O,5734
108817,is,O,5734
108818,characterized,O,5734
108819,by,O,5734
108820,inflammation,B-SIGN_AND_SYMPTOM,5734
108821,and,I-SIGN_AND_SYMPTOM,5734
108822,damage,I-SIGN_AND_SYMPTOM,5734
108823,to,I-SIGN_AND_SYMPTOM,5734
108824,the,I-SIGN_AND_SYMPTOM,5734
108825,front,I-SIGN_AND_SYMPTOM,5734
108826,part,I-SIGN_AND_SYMPTOM,5735
108827,of,I-SIGN_AND_SYMPTOM,5735
108828,the,I-SIGN_AND_SYMPTOM,5735
108829,eye,I-SIGN_AND_SYMPTOM,5735
108830,the,I-SIGN_AND_SYMPTOM,5735
108831,anterior,I-SIGN_AND_SYMPTOM,5735
108832,segment,I-SIGN_AND_SYMPTOM,5735
108833,which,O,5735
108834,includes,O,5735
108835,the,O,5735
108836,cornea,B-PART_OF_THE_EYES,5735
108837,iris,B-PART_OF_THE_EYES,5735
108838,and,O,5735
108839,lens,B-PART_OF_THE_EYES,5735
108840,In,O,5735
108841,this,O,5735
108842,article,O,5736
108843,we,O,5736
108844,will,O,5736
108845,focus,O,5736
108846,on,O,5736
108847,the,O,5736
108848,symptoms,O,5736
108849,of,O,5736
108850,TASS,B-NAME_OF_DISEASE,5736
108851,and,O,5736
108852,how,O,5736
108853,to,O,5736
108854,recognize,O,5736
108855,them,O,5736
108856,Symptoms,O,5736
108857,of,O,5736
108858,TASS,B-NAME_OF_DISEASE,5736
108859,The,O,5736
108860,symptoms,O,5736
108861,of,O,5736
108862,TASS,B-NAME_OF_DISEASE,5736
108863,usually,O,5736
108864,appear,O,5736
108865,within,B-TIME_DURATION,5736
108866,a,I-TIME_DURATION,5736
108867,few,I-TIME_DURATION,5736
108868,days,I-TIME_DURATION,5736
108869,of,O,5736
108870,surgery,O,5736
108871,and,O,5736
108872,may,O,5736
108873,include,O,5736
108874,Inflammation,B-SIGN_AND_SYMPTOM,5736
108875,and,I-SIGN_AND_SYMPTOM,5736
108876,swelling,I-SIGN_AND_SYMPTOM,5737
108877,of,I-SIGN_AND_SYMPTOM,5737
108878,the,I-SIGN_AND_SYMPTOM,5737
108879,eye,I-SIGN_AND_SYMPTOM,5737
108880,This,O,5737
108881,may,O,5737
108882,cause,O,5737
108883,the,B-SIGN_AND_SYMPTOM,5737
108884,eye,I-SIGN_AND_SYMPTOM,5737
108885,to,I-SIGN_AND_SYMPTOM,5737
108886,appear,I-SIGN_AND_SYMPTOM,5737
108887,red,I-SIGN_AND_SYMPTOM,5737
108888,and,I-SIGN_AND_SYMPTOM,5737
108889,swollen,I-SIGN_AND_SYMPTOM,5737
108890,Redness,B-SIGN_AND_SYMPTOM,5737
108891,and,I-SIGN_AND_SYMPTOM,5737
108892,pain,I-SIGN_AND_SYMPTOM,5737
108893,in,I-SIGN_AND_SYMPTOM,5738
108894,the,I-SIGN_AND_SYMPTOM,5738
108895,eye,I-SIGN_AND_SYMPTOM,5738
108896,TASS,B-NAME_OF_DISEASE,5738
108897,can,O,5738
108898,cause,O,5738
108899,significant,B-SIGN_AND_SYMPTOM,5738
108900,discomfort,I-SIGN_AND_SYMPTOM,5738
108901,and,I-SIGN_AND_SYMPTOM,5738
108902,pain,I-SIGN_AND_SYMPTOM,5738
108903,in,I-SIGN_AND_SYMPTOM,5738
108904,the,I-SIGN_AND_SYMPTOM,5738
108905,affected,I-SIGN_AND_SYMPTOM,5738
108906,eye,I-SIGN_AND_SYMPTOM,5738
108907,Decreased,B-SIGN_AND_SYMPTOM,5738
108908,vision,I-SIGN_AND_SYMPTOM,5738
108909,TASS,B-NAME_OF_DISEASE,5738
108910,may,O,5738
108911,cause,O,5739
108912,a,B-SIGN_AND_SYMPTOM,5739
108913,decrease,I-SIGN_AND_SYMPTOM,5739
108914,in,I-SIGN_AND_SYMPTOM,5739
108915,vision,I-SIGN_AND_SYMPTOM,5739
108916,due,O,5739
108917,to,O,5739
108918,the,B-CAUSE_OF_DISEASE,5739
108919,inflammation,I-CAUSE_OF_DISEASE,5739
108920,and,I-CAUSE_OF_DISEASE,5739
108921,damage,I-CAUSE_OF_DISEASE,5739
108922,to,I-CAUSE_OF_DISEASE,5739
108923,the,I-CAUSE_OF_DISEASE,5739
108924,eye,I-CAUSE_OF_DISEASE,5739
108925,Discharge,B-SIGN_AND_SYMPTOM,5739
108926,from,I-SIGN_AND_SYMPTOM,5740
108927,the,I-SIGN_AND_SYMPTOM,5740
108928,eye,I-SIGN_AND_SYMPTOM,5740
108929,TASS,B-NAME_OF_DISEASE,5740
108930,may,O,5740
108931,cause,O,5740
108932,a,B-SIGN_AND_SYMPTOM,5740
108933,watery,I-SIGN_AND_SYMPTOM,5740
108934,or,I-SIGN_AND_SYMPTOM,5740
108935,purulent,I-SIGN_AND_SYMPTOM,5740
108936,discharge,I-SIGN_AND_SYMPTOM,5740
108937,from,I-SIGN_AND_SYMPTOM,5741
108938,the,I-SIGN_AND_SYMPTOM,5741
108939,eye,I-SIGN_AND_SYMPTOM,5741
108940,The,O,5741
108941,severity,O,5741
108942,of,O,5741
108943,symptoms,O,5741
108944,can,O,5741
108945,vary,O,5741
108946,widely,O,5741
108947,from,O,5741
108948,mild,O,5741
108949,to,O,5741
108950,severe,O,5741
108951,What,O,5741
108952,Causes,O,5741
108953,TASS,B-NAME_OF_DISEASE,5741
108954,Contamination,B-CAUSE_OF_DISEASE,5741
108955,of,I-CAUSE_OF_DISEASE,5741
108956,the,I-CAUSE_OF_DISEASE,5741
108957,eye,I-CAUSE_OF_DISEASE,5741
108958,or,I-CAUSE_OF_DISEASE,5741
108959,surgical,I-CAUSE_OF_DISEASE,5741
108960,instruments,I-CAUSE_OF_DISEASE,5741
108961,during,I-CAUSE_OF_DISEASE,5741
108962,surgery,I-CAUSE_OF_DISEASE,5741
108963,Poor,B-CAUSE_OF_DISEASE,5741
108964,hygiene,I-CAUSE_OF_DISEASE,5741
108965,or,I-CAUSE_OF_DISEASE,5741
108966,infection,I-CAUSE_OF_DISEASE,5741
108967,control,I-CAUSE_OF_DISEASE,5741
108968,practices,I-CAUSE_OF_DISEASE,5741
108969,during,I-CAUSE_OF_DISEASE,5741
108970,surgery,I-CAUSE_OF_DISEASE,5741
108971,A,B-CAUSE_OF_DISEASE,5741
108972,pre-existing,I-CAUSE_OF_DISEASE,5741
108973,eye,I-CAUSE_OF_DISEASE,5741
108974,infection,I-CAUSE_OF_DISEASE,5741
108975,that,I-CAUSE_OF_DISEASE,5741
108976,is,I-CAUSE_OF_DISEASE,5741
108977,not,I-CAUSE_OF_DISEASE,5741
108978,properly,I-CAUSE_OF_DISEASE,5741
108979,treated,I-CAUSE_OF_DISEASE,5741
108980,before,I-CAUSE_OF_DISEASE,5741
108981,surgery,I-CAUSE_OF_DISEASE,5741
108982,Use,B-CAUSE_OF_DISEASE,5741
108983,of,I-CAUSE_OF_DISEASE,5741
108984,contaminated,I-CAUSE_OF_DISEASE,5741
108985,solutions,I-CAUSE_OF_DISEASE,5741
108986,or,I-CAUSE_OF_DISEASE,5741
108987,medications,I-CAUSE_OF_DISEASE,5741
108988,during,I-CAUSE_OF_DISEASE,5741
108989,surgery,I-CAUSE_OF_DISEASE,5741
108990,Allergic,B-CAUSE_OF_DISEASE,5741
108991,reactions,I-CAUSE_OF_DISEASE,5741
108992,to,I-CAUSE_OF_DISEASE,5741
108993,medications,I-CAUSE_OF_DISEASE,5741
108994,or,I-CAUSE_OF_DISEASE,5741
108995,solutions,I-CAUSE_OF_DISEASE,5741
108996,used,I-CAUSE_OF_DISEASE,5741
108997,during,I-CAUSE_OF_DISEASE,5741
108998,surgery,I-CAUSE_OF_DISEASE,5741
108999,Managing,O,5741
109000,TASS,B-NAME_OF_DISEASE,5741
109001,Treatment,O,5741
109002,for,O,5741
109003,TASS,B-NAME_OF_DISEASE,5741
109004,typically,O,5742
109005,involves,O,5742
109006,medications,O,5742
109007,to,O,5742
109008,reduce,O,5742
109009,inflammation,B-SIGN_AND_SYMPTOM,5742
109010,and,I-SIGN_AND_SYMPTOM,5742
109011,swelling,I-SIGN_AND_SYMPTOM,5742
109012,such,O,5742
109013,as,O,5742
109014,topical,B-NAME_OF_DRUG,5742
109015,or,I-NAME_OF_DRUG,5742
109016,oral,I-NAME_OF_DRUG,5742
109017,corticosteroids,I-NAME_OF_DRUG,5742
109018,Other,O,5742
109019,medications,O,5742
109020,such,O,5742
109021,as,O,5742
109022,nonsteroidal,B-NAME_OF_DRUG,5742
109023,anti-inflammatory,I-NAME_OF_DRUG,5742
109024,drugs,I-NAME_OF_DRUG,5742
109025,NSAIDs,I-NAME_OF_DRUG,5742
109026,and,O,5742
109027,antibiotic,B-NAME_OF_DRUG,5743
109028,eye,I-NAME_OF_DRUG,5743
109029,drops,I-NAME_OF_DRUG,5743
109030,may,O,5743
109031,also,O,5743
109032,be,O,5743
109033,used,O,5743
109034,to,O,5743
109035,help,O,5743
109036,manage,O,5743
109037,pain,O,5743
109038,and,O,5743
109039,prevent,O,5743
109040,infection,O,5743
109041,In,O,5743
109042,severe,O,5743
109043,cases,O,5743
109044,additional,B-TREATMENT,5743
109045,surgery,I-TREATMENT,5743
109046,may,O,5743
109047,be,O,5743
109048,necessary,O,5744
109049,to,O,5744
109050,remove,O,5744
109051,any,O,5744
109052,debris,O,5744
109053,or,O,5744
109054,foreign,O,5744
109055,bodies,O,5744
109056,that,O,5744
109057,may,O,5744
109058,be,O,5744
109059,causing,O,5744
109060,the,O,5744
109061,inflammation,O,5744
109062,How,O,5744
109063,Can,O,5744
109064,TASS,B-NAME_OF_DISEASE,5744
109065,Be,O,5744
109066,Prevented,O,5744
109067,There,O,5744
109068,are,O,5744
109069,several,O,5744
109070,ways,O,5744
109071,to,O,5744
109072,help,O,5744
109073,prevent,O,5744
109074,TASS,B-NAME_OF_DISEASE,5744
109075,Use,B-PREVENTION,5744
109076,sterile,I-PREVENTION,5744
109077,technique,I-PREVENTION,5744
109078,during,I-PREVENTION,5744
109079,surgery,I-PREVENTION,5744
109080,To,O,5744
109081,reduce,O,5744
109082,the,O,5745
109083,risk,O,5745
109084,of,O,5745
109085,infection,O,5745
109086,it,O,5745
109087,is,O,5745
109088,important,O,5745
109089,to,O,5745
109090,use,B-PREVENTION,5745
109091,sterile,I-PREVENTION,5745
109092,technique,I-PREVENTION,5745
109093,during,I-PREVENTION,5745
109094,eye,I-PREVENTION,5745
109095,surgery,I-PREVENTION,5745
109096,This,O,5745
109097,includes,O,5746
109098,wearing,B-PREVENTION,5746
109099,sterile,I-PREVENTION,5746
109100,gloves,I-PREVENTION,5746
109101,using,I-PREVENTION,5746
109102,sterile,I-PREVENTION,5746
109103,instruments,I-PREVENTION,5746
109104,and,I-PREVENTION,5746
109105,solutions,I-PREVENTION,5746
109106,and,I-PREVENTION,5746
109107,properly,I-PREVENTION,5746
109108,sterilizing,I-PREVENTION,5746
109109,all,I-PREVENTION,5746
109110,equipment,I-PREVENTION,5746
109111,Choose,B-PREVENTION,5746
109112,a,I-PREVENTION,5746
109113,qualified,I-PREVENTION,5746
109114,and,I-PREVENTION,5746
109115,experienced,I-PREVENTION,5746
109116,surgeon,I-PREVENTION,5746
109117,It,O,5746
109118,is,O,5747
109119,important,O,5747
109120,to,O,5747
109121,choose,B-PREVENTION,5747
109122,a,I-PREVENTION,5747
109123,qualified,I-PREVENTION,5747
109124,and,I-PREVENTION,5747
109125,experienced,I-PREVENTION,5747
109126,surgeon,I-PREVENTION,5747
109127,to,I-PREVENTION,5747
109128,perform,I-PREVENTION,5747
109129,your,I-PREVENTION,5747
109130,eye,I-PREVENTION,5747
109131,surgery,I-PREVENTION,5747
109132,Surgeons,O,5747
109133,who,O,5747
109134,are,O,5747
109135,well-trained,O,5747
109136,and,O,5747
109137,have,O,5747
109138,experience,O,5747
109139,with,O,5747
109140,the,O,5747
109141,specific,O,5747
109142,procedure,O,5747
109143,you,O,5748
109144,are,O,5748
109145,undergoing,O,5748
109146,are,O,5748
109147,less,O,5748
109148,likely,O,5748
109149,to,O,5748
109150,make,O,5748
109151,mistakes,O,5748
109152,that,O,5748
109153,could,O,5748
109154,lead,O,5748
109155,to,O,5748
109156,complications,O,5748
109157,Follow,B-PREVENTION,5748
109158,post-operative,I-PREVENTION,5748
109159,instructions,I-PREVENTION,5748
109160,After,O,5748
109161,eye,O,5748
109162,surgery,O,5748
109163,it,O,5748
109164,is,O,5748
109165,important,O,5748
109166,to,O,5748
109167,follow,B-PREVENTION,5748
109168,your,I-PREVENTION,5748
109169,surgeon,I-PREVENTION,5749
109170,s,I-PREVENTION,5749
109171,instructions,I-PREVENTION,5749
109172,for,I-PREVENTION,5749
109173,post-operative,I-PREVENTION,5749
109174,care,I-PREVENTION,5749
109175,including,I-PREVENTION,5749
109176,taking,I-PREVENTION,5749
109177,prescribed,I-PREVENTION,5749
109178,medications,I-PREVENTION,5749
109179,and,I-PREVENTION,5749
109180,attending,I-PREVENTION,5749
109181,follow-up,I-PREVENTION,5750
109182,visits,I-PREVENTION,5750
109183,This,O,5750
109184,can,O,5750
109185,help,O,5750
109186,to,O,5750
109187,prevent,O,5750
109188,complications,O,5750
109189,and,O,5750
109190,ensure,O,5750
109191,the,O,5750
109192,best,O,5750
109193,possible,O,5750
109194,outcome,O,5750
109195,Avoid,B-PREVENTION,5750
109196,rubbing,I-PREVENTION,5750
109197,your,I-PREVENTION,5750
109198,eyes,I-PREVENTION,5750
109199,Rubbing,B-CAUSE_OF_DISEASE,5751
109200,your,I-CAUSE_OF_DISEASE,5751
109201,eyes,I-CAUSE_OF_DISEASE,5751
109202,after,I-CAUSE_OF_DISEASE,5751
109203,surgery,I-CAUSE_OF_DISEASE,5751
109204,can,O,5751
109205,increase,O,5751
109206,the,O,5751
109207,risk,O,5751
109208,of,O,5751
109209,infection,O,5751
109210,and,O,5751
109211,other,O,5751
109212,complications,O,5751
109213,It,O,5751
109214,is,O,5751
109215,important,O,5751
109216,to,O,5751
109217,resist,O,5751
109218,the,O,5751
109219,temptation,O,5751
109220,to,O,5751
109221,rub,O,5751
109222,your,O,5751
109223,eyes,O,5752
109224,and,O,5752
109225,follow,O,5752
109226,your,O,5752
109227,surgeon,O,5752
109228,s,O,5752
109229,instructions,O,5752
109230,for,O,5752
109231,caring,O,5752
109232,for,O,5752
109233,your,O,5752
109234,eyes,O,5752
109235,after,O,5752
109236,surgery,O,5752
109237,Use,B-PREVENTION,5752
109238,caution,I-PREVENTION,5752
109239,when,I-PREVENTION,5752
109240,using,I-PREVENTION,5752
109241,contact,I-PREVENTION,5752
109242,lenses,I-PREVENTION,5752
109243,If,O,5752
109244,you,O,5752
109245,wear,O,5752
109246,contact,O,5753
109247,lenses,O,5753
109248,it,O,5753
109249,is,O,5753
109250,important,O,5753
109251,to,O,5753
109252,be,O,5753
109253,cautious,O,5753
109254,when,O,5753
109255,using,O,5753
109256,them,O,5753
109257,after,O,5753
109258,eye,O,5753
109259,surgery,O,5753
109260,Follow,O,5753
109261,your,O,5753
109262,surgeon,O,5753
109263,s,O,5753
109264,instructions,O,5753
109265,for,O,5753
109266,when,O,5753
109267,it,O,5753
109268,is,O,5753
109269,safe,O,5753
109270,to,O,5753
109271,resume,O,5753
109272,wearing,O,5753
109273,them,O,5753
109274,and,O,5753
109275,be,O,5754
109276,sure,O,5754
109277,to,O,5754
109278,properly,O,5754
109279,clean,O,5754
109280,and,O,5754
109281,disinfect,O,5754
109282,them,O,5754
109283,to,O,5754
109284,reduce,O,5754
109285,the,O,5754
109286,risk,O,5754
109287,of,O,5754
109288,infection,O,5754
109289,What,O,5754
109290,Is,O,5754
109291,Salzmann,B-NAME_OF_DISEASE,5754
109292,s,I-NAME_OF_DISEASE,5754
109293,Nodular,I-NAME_OF_DISEASE,5754
109294,Degeneration,I-NAME_OF_DISEASE,5754
109295,Salzmann,B-NAME_OF_DISEASE,5754
109296,Nodular,I-NAME_OF_DISEASE,5754
109297,degeneration,I-NAME_OF_DISEASE,5754
109298,is,O,5754
109299,an,O,5754
109300,asymmetric,O,5754
109301,noninflammatory,O,5754
109302,and,O,5754
109303,slowly,O,5754
109304,progressive,O,5755
109305,condition,O,5755
109306,associated,O,5755
109307,with,O,5755
109308,the,B-SIGN_AND_SYMPTOM,5755
109309,formation,I-SIGN_AND_SYMPTOM,5755
109310,of,I-SIGN_AND_SYMPTOM,5755
109311,fibrous,I-SIGN_AND_SYMPTOM,5755
109312,outgrowths,I-SIGN_AND_SYMPTOM,5755
109313,in,I-SIGN_AND_SYMPTOM,5755
109314,any,I-SIGN_AND_SYMPTOM,5755
109315,part,I-SIGN_AND_SYMPTOM,5755
109316,of,I-SIGN_AND_SYMPTOM,5755
109317,cornea,B-PART_OF_THE_EYES,5755
109318,It,O,5755
109319,is,O,5755
109320,usually,O,5755
109321,secondary,O,5755
109322,to,O,5755
109323,phlyctenular,B-NAME_OF_DISEASE,5755
109324,or,I-NAME_OF_DISEASE,5755
109325,trachomatous,I-NAME_OF_DISEASE,5755
109326,keratitis,I-NAME_OF_DISEASE,5755
109327,it,O,5755
109328,appears,O,5755
109329,as,O,5755
109330,3-Jan,B-SIGN_AND_SYMPTOM,5755
109331,mm,I-SIGN_AND_SYMPTOM,5755
109332,gray-white,I-SIGN_AND_SYMPTOM,5755
109333,to,I-SIGN_AND_SYMPTOM,5755
109334,bluish,I-SIGN_AND_SYMPTOM,5755
109335,nodules,I-SIGN_AND_SYMPTOM,5756
109336,beneath,I-SIGN_AND_SYMPTOM,5756
109337,the,I-SIGN_AND_SYMPTOM,5756
109338,cornea,B-PART_OF_THE_EYES,5756
109339,epithelium,I-SIGN_AND_SYMPTOM,5756
109340,or,I-SIGN_AND_SYMPTOM,5756
109341,anterior,I-SIGN_AND_SYMPTOM,5756
109342,to,I-SIGN_AND_SYMPTOM,5756
109343,Bowman,I-SIGN_AND_SYMPTOM,5756
109344,s,I-SIGN_AND_SYMPTOM,5756
109345,layer,I-SIGN_AND_SYMPTOM,5756
109346,of,I-SIGN_AND_SYMPTOM,5756
109347,the,I-SIGN_AND_SYMPTOM,5756
109348,cornea,B-PART_OF_THE_EYES,5756
109349,These,O,5756
109350,raised,O,5757
109351,nodules,B-SIGN_AND_SYMPTOM,5757
109352,may,I-SIGN_AND_SYMPTOM,5757
109353,be,I-SIGN_AND_SYMPTOM,5757
109354,found,I-SIGN_AND_SYMPTOM,5757
109355,in,I-SIGN_AND_SYMPTOM,5757
109356,the,I-SIGN_AND_SYMPTOM,5757
109357,mid-peripheral,I-SIGN_AND_SYMPTOM,5757
109358,cornea,B-PART_OF_THE_EYES,5757
109359,or,I-SIGN_AND_SYMPTOM,5757
109360,close,I-SIGN_AND_SYMPTOM,5757
109361,to,I-SIGN_AND_SYMPTOM,5757
109362,the,I-SIGN_AND_SYMPTOM,5757
109363,limbus,I-SIGN_AND_SYMPTOM,5757
109364,Causes,O,5757
109365,of,O,5757
109366,Salzmann,B-NAME_OF_DISEASE,5757
109367,s,I-NAME_OF_DISEASE,5757
109368,Nodular,I-NAME_OF_DISEASE,5757
109369,Degeneration,I-NAME_OF_DISEASE,5757
109370,Salzmann,B-NAME_OF_DISEASE,5757
109371,s,I-NAME_OF_DISEASE,5757
109372,nodular,I-NAME_OF_DISEASE,5757
109373,degeneration,I-NAME_OF_DISEASE,5757
109374,is,O,5757
109375,considered,O,5757
109376,to,O,5757
109377,be,O,5757
109378,a,O,5757
109379,disease,O,5757
109380,of,O,5757
109381,unknown,O,5757
109382,etiology,O,5757
109383,with,O,5757
109384,no,O,5757
109385,certainly,O,5757
109386,known,O,5757
109387,causes,O,5757
109388,however,O,5757
109389,there,O,5757
109390,are,O,5757
109391,a,O,5757
109392,few,O,5757
109393,conditions,O,5757
109394,associated,O,5757
109395,with,O,5757
109396,risk,O,5757
109397,of,O,5757
109398,causing,O,5757
109399,it,O,5757
109400,Meibomian,B-CAUSE_OF_DISEASE,5757
109401,gland,I-CAUSE_OF_DISEASE,5757
109402,dysfunction,I-CAUSE_OF_DISEASE,5757
109403,MGD,I-CAUSE_OF_DISEASE,5757
109404,Contact,B-CAUSE_OF_DISEASE,5757
109405,lens,I-CAUSE_OF_DISEASE,5757
109406,wear,I-CAUSE_OF_DISEASE,5757
109407,especially,I-CAUSE_OF_DISEASE,5757
109408,hard,I-CAUSE_OF_DISEASE,5757
109409,contact,I-CAUSE_OF_DISEASE,5757
109410,lenses,I-CAUSE_OF_DISEASE,5757
109411,Keratoconjunctivitis,B-CAUSE_OF_DISEASE,5757
109412,sicca,I-CAUSE_OF_DISEASE,5757
109413,causing,I-CAUSE_OF_DISEASE,5757
109414,dry,I-CAUSE_OF_DISEASE,5757
109415,eyes,I-CAUSE_OF_DISEASE,5757
109416,Exposure,B-CAUSE_OF_DISEASE,5757
109417,keratitis,I-CAUSE_OF_DISEASE,5757
109418,Trauma,B-CAUSE_OF_DISEASE,5757
109419,to,I-CAUSE_OF_DISEASE,5757
109420,eyes,I-CAUSE_OF_DISEASE,5757
109421,Chronic,B-CAUSE_OF_DISEASE,5757
109422,inflammatory,I-CAUSE_OF_DISEASE,5757
109423,diseases,I-CAUSE_OF_DISEASE,5757
109424,of,I-CAUSE_OF_DISEASE,5757
109425,cornea,B-PART_OF_THE_EYES,5757
109426,ocular,I-CAUSE_OF_DISEASE,5757
109427,surface,I-CAUSE_OF_DISEASE,5757
109428,Peripheral,B-CAUSE_OF_DISEASE,5757
109429,vascularization,I-CAUSE_OF_DISEASE,5757
109430,and,I-CAUSE_OF_DISEASE,5757
109431,pterygium,I-CAUSE_OF_DISEASE,5757
109432,Symptoms,O,5758
109433,of,O,5758
109434,Salzmann,B-NAME_OF_DISEASE,5758
109435,s,I-NAME_OF_DISEASE,5758
109436,Nodular,I-NAME_OF_DISEASE,5758
109437,Degeneration,I-NAME_OF_DISEASE,5758
109438,Generally,O,5758
109439,this,O,5758
109440,condition,O,5758
109441,affects,O,5758
109442,more,O,5758
109443,women,O,5758
109444,than,O,5758
109445,men,O,5758
109446,It,O,5759
109447,is,O,5759
109448,observed,O,5759
109449,most,O,5759
109450,commonly,O,5759
109451,in,O,5759
109452,later,O,5759
109453,years,O,5759
109454,of,O,5759
109455,life,O,5759
109456,like,O,5759
109457,the,O,5759
109458,late,O,5759
109459,fifties,O,5759
109460,Symptoms,O,5759
109461,appear,O,5759
109462,on,O,5759
109463,the,O,5759
109464,basis,O,5759
109465,of,O,5759
109466,stages,O,5759
109467,of,O,5759
109468,the,O,5759
109469,disease,O,5759
109470,earlier,O,5759
109471,stages,O,5760
109472,are,O,5760
109473,subtle,O,5760
109474,and,O,5760
109475,asymptomatic,O,5760
109476,causing,O,5760
109477,almost,O,5760
109478,zero,O,5760
109479,harm,O,5760
109480,or,O,5760
109481,trouble,O,5760
109482,to,O,5761
109483,the,O,5761
109484,patient,O,5761
109485,Mild,O,5761
109486,nodules,O,5761
109487,located,O,5761
109488,in,O,5761
109489,the,B-PART_OF_THE_EYES,5761
109490,periphery,I-PART_OF_THE_EYES,5761
109491,or,O,5761
109492,cornea,B-PART_OF_THE_EYES,5761
109493,are,O,5761
109494,often,O,5761
109495,asymptomatic,O,5761
109496,As,O,5761
109497,the,O,5761
109498,disease,O,5761
109499,progresses,O,5761
109500,it,O,5761
109501,manifests,O,5761
109502,as,O,5761
109503,Foreign,B-SIGN_AND_SYMPTOM,5761
109504,body,I-SIGN_AND_SYMPTOM,5761
109505,sensation,I-SIGN_AND_SYMPTOM,5761
109506,due,I-SIGN_AND_SYMPTOM,5761
109507,to,I-SIGN_AND_SYMPTOM,5761
109508,the,I-SIGN_AND_SYMPTOM,5761
109509,unequal,I-SIGN_AND_SYMPTOM,5761
109510,wetting,I-SIGN_AND_SYMPTOM,5761
109511,of,I-SIGN_AND_SYMPTOM,5761
109512,the,I-SIGN_AND_SYMPTOM,5761
109513,cornea,B-PART_OF_THE_EYES,5761
109514,in,I-SIGN_AND_SYMPTOM,5762
109515,the,I-SIGN_AND_SYMPTOM,5762
109516,nodular,I-SIGN_AND_SYMPTOM,5762
109517,area,I-SIGN_AND_SYMPTOM,5762
109518,Diminished,B-SIGN_AND_SYMPTOM,5762
109519,and,I-SIGN_AND_SYMPTOM,5762
109520,distorted,I-SIGN_AND_SYMPTOM,5762
109521,vision,I-SIGN_AND_SYMPTOM,5762
109522,Irregular,B-SIGN_AND_SYMPTOM,5762
109523,astigmatism,I-SIGN_AND_SYMPTOM,5762
109524,resulting,I-SIGN_AND_SYMPTOM,5762
109525,in,I-SIGN_AND_SYMPTOM,5762
109526,blurred,I-SIGN_AND_SYMPTOM,5762
109527,vision,I-SIGN_AND_SYMPTOM,5762
109528,Frequent,B-SIGN_AND_SYMPTOM,5762
109529,prescription,I-SIGN_AND_SYMPTOM,5762
109530,changes,I-SIGN_AND_SYMPTOM,5762
109531,Inability,B-SIGN_AND_SYMPTOM,5762
109532,to,I-SIGN_AND_SYMPTOM,5762
109533,have,I-SIGN_AND_SYMPTOM,5762
109534,the,I-SIGN_AND_SYMPTOM,5762
109535,best-corrected,I-SIGN_AND_SYMPTOM,5762
109536,vision,I-SIGN_AND_SYMPTOM,5762
109537,Multiple,B-SIGN_AND_SYMPTOM,5762
109538,images,I-SIGN_AND_SYMPTOM,5762
109539,or,I-SIGN_AND_SYMPTOM,5762
109540,shadows,I-SIGN_AND_SYMPTOM,5762
109541,of,I-SIGN_AND_SYMPTOM,5762
109542,images,I-SIGN_AND_SYMPTOM,5762
109543,Irritation,B-SIGN_AND_SYMPTOM,5762
109544,dryness,I-SIGN_AND_SYMPTOM,5762
109545,grittiness,I-SIGN_AND_SYMPTOM,5762
109546,and,I-SIGN_AND_SYMPTOM,5762
109547,rarely,I-SIGN_AND_SYMPTOM,5762
109548,pain,I-SIGN_AND_SYMPTOM,5762
109549,Diagnosing,O,5762
109550,Salzmann,B-NAME_OF_DISEASE,5762
109551,s,I-NAME_OF_DISEASE,5762
109552,Nodular,I-NAME_OF_DISEASE,5762
109553,Degeneration,I-NAME_OF_DISEASE,5762
109554,In,O,5762
109555,its,O,5762
109556,earliest,O,5762
109557,of,O,5763
109558,stages,O,5763
109559,Salzmann,B-SIGN_AND_SYMPTOM,5763
109560,s,I-SIGN_AND_SYMPTOM,5763
109561,nodules,I-SIGN_AND_SYMPTOM,5763
109562,are,O,5763
109563,subtle,O,5763
109564,and,O,5763
109565,not,O,5763
109566,very,O,5763
109567,bothersome,O,5763
109568,for,O,5763
109569,the,O,5763
109570,patient,O,5763
109571,In,O,5763
109572,advanced,O,5763
109573,stages,O,5763
109574,for,O,5763
109575,diagnostic,O,5763
109576,purposes,O,5763
109577,several,O,5763
109578,techniques,O,5763
109579,are,O,5763
109580,employed,O,5763
109581,The,O,5763
109582,first,O,5763
109583,step,O,5763
109584,is,O,5763
109585,usually,O,5763
109586,a,B-DIAGNOSTIC_TEST,5763
109587,slit,I-DIAGNOSTIC_TEST,5763
109588,lamp,I-DIAGNOSTIC_TEST,5763
109589,examination,I-DIAGNOSTIC_TEST,5763
109590,of,I-DIAGNOSTIC_TEST,5763
109591,the,I-DIAGNOSTIC_TEST,5763
109592,eyes,I-DIAGNOSTIC_TEST,5763
109593,of,O,5763
109594,the,O,5763
109595,patient,O,5763
109596,Ancillary,B-DIAGNOSTIC_TEST,5763
109597,testing,I-DIAGNOSTIC_TEST,5763
109598,includes,I-DIAGNOSTIC_TEST,5764
109599,corneal,I-DIAGNOSTIC_TEST,5764
109600,curvature,I-DIAGNOSTIC_TEST,5764
109601,Corneal,B-DIAGNOSTIC_TEST,5764
109602,topography,I-DIAGNOSTIC_TEST,5764
109603,and,I-DIAGNOSTIC_TEST,5764
109604,tomography,I-DIAGNOSTIC_TEST,5764
109605,Measurement,B-DIAGNOSTIC_TEST,5764
109606,of,I-DIAGNOSTIC_TEST,5764
109607,the,I-DIAGNOSTIC_TEST,5764
109608,corneal,I-DIAGNOSTIC_TEST,5764
109609,thickness,I-DIAGNOSTIC_TEST,5764
109610,pachymetry,I-DIAGNOSTIC_TEST,5764
109611,,O,5764
109612,Anterior,B-DIAGNOSTIC_TEST,5764
109613,segment,I-DIAGNOSTIC_TEST,5764
109614,optical,I-DIAGNOSTIC_TEST,5764
109615,coherence,I-DIAGNOSTIC_TEST,5764
109616,tomography,I-DIAGNOSTIC_TEST,5764
109617,AS-OCT,I-DIAGNOSTIC_TEST,5764
109618,Salzmann,B-NAME_OF_DISEASE,5765
109619,s,I-NAME_OF_DISEASE,5765
109620,Nodular,I-NAME_OF_DISEASE,5765
109621,Degeneration,I-NAME_OF_DISEASE,5765
109622,Treatment,O,5765
109623,Salzmann,B-NAME_OF_DISEASE,5765
109624,Nodular,I-NAME_OF_DISEASE,5765
109625,degeneration,I-NAME_OF_DISEASE,5766
109626,does,O,5766
109627,not,O,5766
109628,have,O,5766
109629,a,O,5766
109630,definite,O,5766
109631,treatment,O,5766
109632,It,O,5766
109633,is,O,5766
109634,either,O,5766
109635,managed,O,5766
109636,conservatively,O,5766
109637,or,O,5766
109638,surgically,O,5766
109639,Conservative,O,5766
109640,treatment,O,5766
109641,In,O,5766
109642,conservative,O,5766
109643,management,O,5766
109644,of,O,5766
109645,Salzmann,B-NAME_OF_DISEASE,5767
109646,s,I-NAME_OF_DISEASE,5767
109647,nodular,I-NAME_OF_DISEASE,5767
109648,degeneration,I-NAME_OF_DISEASE,5767
109649,treating,O,5767
109650,the,O,5767
109651,very,O,5767
109652,cause,O,5767
109653,of,O,5767
109654,it,O,5767
109655,will,O,5767
109656,resolve,O,5767
109657,the,O,5767
109658,issue,O,5767
109659,As,O,5767
109660,an,O,5767
109661,example,O,5767
109662,in,O,5767
109663,Meibomian,B-NAME_OF_DISEASE,5767
109664,Gland,I-NAME_OF_DISEASE,5767
109665,Disease,I-NAME_OF_DISEASE,5767
109666,before,B-TREATMENT,5767
109667,surgical,I-TREATMENT,5767
109668,treatment,I-TREATMENT,5768
109669,of,I-TREATMENT,5769
109670,nodules,I-TREATMENT,5769
109671,eyelid,I-TREATMENT,5769
109672,hygiene,I-TREATMENT,5769
109673,is,I-TREATMENT,5769
109674,maintained,I-TREATMENT,5769
109675,and,I-TREATMENT,5770
109676,doxycycline,I-TREATMENT,5770
109677,is,I-TREATMENT,5771
109678,given,I-TREATMENT,5771
109679,to,I-TREATMENT,5771
109680,treat,I-TREATMENT,5771
109681,MGD,I-TREATMENT,5771
109682,,O,5771
109683,Other,O,5771
109684,measures,O,5771
109685,include,O,5771
109686,Proper,B-TREATMENT,5771
109687,ocular,I-TREATMENT,5771
109688,lubrication,I-TREATMENT,5771
109689,Wearing,B-TREATMENT,5771
109690,glasses,I-TREATMENT,5771
109691,Steroid,B-NAME_OF_DRUG,5771
109692,eye,I-NAME_OF_DRUG,5771
109693,drops,I-NAME_OF_DRUG,5771
109694,as,O,5771
109695,prescribed,O,5771
109696,by,O,5771
109697,the,O,5771
109698,doctor,O,5771
109699,Warm,B-TREATMENT,5771
109700,compresses,I-TREATMENT,5772
109701,Not,B-TREATMENT,5772
109702,using,I-TREATMENT,5772
109703,Contact,I-TREATMENT,5772
109704,lenses,I-TREATMENT,5772
109705,for,I-TREATMENT,5772
109706,quite,I-TREATMENT,5772
109707,some,I-TREATMENT,5772
109708,time,I-TREATMENT,5772
109709,and,O,5772
109710,re-fitting,B-TREATMENT,5772
109711,of,I-TREATMENT,5772
109712,contact,I-TREATMENT,5772
109713,lenses,I-TREATMENT,5772
109714,Surgical,O,5772
109715,treatment,O,5772
109716,Popular,O,5772
109717,and,O,5772
109718,successful,O,5772
109719,surgical,O,5772
109720,excision,O,5772
109721,of,O,5772
109722,Salzmann,B-NAME_OF_DISEASE,5772
109723,Nodular,I-NAME_OF_DISEASE,5772
109724,degeneration,I-NAME_OF_DISEASE,5772
109725,options,O,5772
109726,include,O,5772
109727,-,O,5772
109728,Superficial,B-TREATMENT,5772
109729,keratectomy,I-TREATMENT,5772
109730,SK,I-TREATMENT,5772
109731,Phototherapeutic,B-TREATMENT,5772
109732,keratectomy,I-TREATMENT,5772
109733,PTK,I-TREATMENT,5772
109734,These,O,5772
109735,surgical,O,5773
109736,procedures,O,5773
109737,are,O,5773
109738,accompanied,O,5773
109739,by,O,5773
109740,the,O,5773
109741,application,O,5773
109742,of,O,5773
109743,the,O,5773
109744,anti-scarring,O,5773
109745,agent,O,5773
109746,called,O,5773
109747,mitomycin,B-NAME_OF_DRUG,5773
109748,C,I-NAME_OF_DRUG,5773
109749,Mitomycin-C,B-NAME_OF_DRUG,5774
109750,will,O,5774
109751,reduce,O,5774
109752,the,O,5774
109753,frequency,O,5774
109754,and,O,5774
109755,severity,O,5774
109756,of,O,5774
109757,recurrences,O,5774
109758,after,O,5774
109759,the,O,5774
109760,excision,O,5774
109761,of,O,5774
109762,nodules,O,5774
109763,The,O,5774
109764,most,O,5774
109765,accurate,O,5774
109766,way,O,5774
109767,of,O,5774
109768,preventing,O,5774
109769,any,O,5774
109770,future,O,5774
109771,ocular,B-CAUSE_OF_DISEASE,5774
109772,erosions,I-CAUSE_OF_DISEASE,5774
109773,causing,O,5774
109774,Salzmann,B-NAME_OF_DISEASE,5774
109775,s,I-NAME_OF_DISEASE,5775
109776,nodular,I-NAME_OF_DISEASE,5775
109777,degeneration,I-NAME_OF_DISEASE,5775
109778,is,O,5775
109779,to,O,5775
109780,lubricate,B-PREVENTION,5775
109781,eyes,I-PREVENTION,5775
109782,every,I-PREVENTION,5775
109783,night,I-PREVENTION,5775
109784,for,I-PREVENTION,5775
109785,a,I-PREVENTION,5775
109786,minimum,I-PREVENTION,5775
109787,6-Mar,I-PREVENTION,5775
109788,months,I-PREVENTION,5775
109789,Giant,B-NAME_OF_DISEASE,5775
109790,papillary,I-NAME_OF_DISEASE,5775
109791,conjunctivitis,I-NAME_OF_DISEASE,5775
109792,is,O,5775
109793,an,O,5775
109794,inflammatory,O,5775
109795,and,O,5775
109796,allergic,O,5775
109797,reaction,O,5775
109798,of,O,5775
109799,conjunctiva,B-PART_OF_THE_EYES,5775
109800,which,O,5775
109801,makes,O,5776
109802,the,B-SIGN_AND_SYMPTOM,5776
109803,smooth,I-SIGN_AND_SYMPTOM,5776
109804,and,I-SIGN_AND_SYMPTOM,5776
109805,even,I-SIGN_AND_SYMPTOM,5776
109806,inner,I-SIGN_AND_SYMPTOM,5776
109807,side,I-SIGN_AND_SYMPTOM,5776
109808,of,I-SIGN_AND_SYMPTOM,5776
109809,your,I-SIGN_AND_SYMPTOM,5776
109810,eyelids,I-SIGN_AND_SYMPTOM,5776
109811,swollen,I-SIGN_AND_SYMPTOM,5776
109812,bumpy,I-SIGN_AND_SYMPTOM,5776
109813,and,I-SIGN_AND_SYMPTOM,5776
109814,reddened,I-SIGN_AND_SYMPTOM,5776
109815,Types,O,5776
109816,of,O,5776
109817,Primary,B-NAME_OF_DISEASE,5776
109818,Giant,B-NAME_OF_DISEASE,5776
109819,Papillary,I-NAME_OF_DISEASE,5776
109820,Conjunctivitis,I-NAME_OF_DISEASE,5777
109821,Giant,B-NAME_OF_DISEASE,5777
109822,papillary,I-NAME_OF_DISEASE,5777
109823,conjunctivitis,I-NAME_OF_DISEASE,5777
109824,is,O,5777
109825,predominantly,O,5777
109826,divided,O,5777
109827,on,O,5777
109828,basis,O,5777
109829,on,O,5777
109830,the,O,5777
109831,elements,O,5777
109832,of,O,5777
109833,allergen,B-CAUSE_OF_DISEASE,5777
109834,GPC,B-NAME_OF_DISEASE,5777
109835,is,O,5777
109836,sourced,O,5777
109837,either,O,5777
109838,from,O,5778
109839,seasonal,B-CAUSE_OF_DISEASE,5778
109840,allergies,I-CAUSE_OF_DISEASE,5778
109841,or,O,5778
109842,external,B-CAUSE_OF_DISEASE,5778
109843,objects,I-CAUSE_OF_DISEASE,5778
109844,like,I-CAUSE_OF_DISEASE,5778
109845,wearing,I-CAUSE_OF_DISEASE,5778
109846,contact,I-CAUSE_OF_DISEASE,5778
109847,lenses,I-CAUSE_OF_DISEASE,5778
109848,or,O,5778
109849,due,O,5778
109850,to,O,5778
109851,sutures,B-CAUSE_OF_DISEASE,5778
109852,Primary,B-NAME_OF_DISEASE,5778
109853,GPC,I-NAME_OF_DISEASE,5778
109854,has,O,5778
109855,two,O,5778
109856,basic,O,5778
109857,causes,O,5778
109858,-,O,5778
109859,Vernal,B-CAUSE_OF_DISEASE,5778
109860,keratoconjunctivitis,I-CAUSE_OF_DISEASE,5778
109861,VKC,I-CAUSE_OF_DISEASE,5778
109862,Atopic,B-CAUSE_OF_DISEASE,5778
109863,keratoconjunctivitis,I-CAUSE_OF_DISEASE,5778
109864,AKC,I-CAUSE_OF_DISEASE,5778
109865,Secondary,B-NAME_OF_DISEASE,5778
109866,GPC,I-NAME_OF_DISEASE,5778
109867,originates,O,5778
109868,from,O,5778
109869,substances,B-CAUSE_OF_DISEASE,5778
109870,causing,I-CAUSE_OF_DISEASE,5778
109871,grittiness,I-CAUSE_OF_DISEASE,5778
109872,or,O,5778
109873,a,B-CAUSE_OF_DISEASE,5778
109874,foreign,I-CAUSE_OF_DISEASE,5778
109875,body,I-CAUSE_OF_DISEASE,5778
109876,sensation,I-CAUSE_OF_DISEASE,5778
109877,in,I-CAUSE_OF_DISEASE,5778
109878,eyes,I-CAUSE_OF_DISEASE,5778
109879,or,I-CAUSE_OF_DISEASE,5778
109880,eyelids,I-CAUSE_OF_DISEASE,5778
109881,like,O,5778
109882,Sutures,B-CAUSE_OF_DISEASE,5778
109883,that,I-CAUSE_OF_DISEASE,5778
109884,rub,I-CAUSE_OF_DISEASE,5778
109885,against,I-CAUSE_OF_DISEASE,5778
109886,the,I-CAUSE_OF_DISEASE,5778
109887,eye,I-CAUSE_OF_DISEASE,5778
109888,lids,I-CAUSE_OF_DISEASE,5778
109889,Contact,B-CAUSE_OF_DISEASE,5778
109890,lenses,I-CAUSE_OF_DISEASE,5778
109891,Causes,O,5778
109892,of,O,5778
109893,Giant,B-NAME_OF_DISEASE,5778
109894,Papillary,I-NAME_OF_DISEASE,5778
109895,Conjunctivitis,I-NAME_OF_DISEASE,5778
109896,Allergy,B-CAUSE_OF_DISEASE,5778
109897,either,I-CAUSE_OF_DISEASE,5778
109898,with,I-CAUSE_OF_DISEASE,5778
109899,contact,I-CAUSE_OF_DISEASE,5778
109900,lenses,I-CAUSE_OF_DISEASE,5778
109901,or,I-CAUSE_OF_DISEASE,5778
109902,its,I-CAUSE_OF_DISEASE,5778
109903,solution,I-CAUSE_OF_DISEASE,5778
109904,Positive,B-CAUSE_OF_DISEASE,5778
109905,history,I-CAUSE_OF_DISEASE,5778
109906,of,I-CAUSE_OF_DISEASE,5778
109907,asthma,I-CAUSE_OF_DISEASE,5778
109908,hay,I-CAUSE_OF_DISEASE,5778
109909,fever,I-CAUSE_OF_DISEASE,5778
109910,or,I-CAUSE_OF_DISEASE,5778
109911,other,I-CAUSE_OF_DISEASE,5778
109912,allergies,I-CAUSE_OF_DISEASE,5778
109913,An,B-CAUSE_OF_DISEASE,5778
109914,artificial,I-CAUSE_OF_DISEASE,5778
109915,eye,I-CAUSE_OF_DISEASE,5778
109916,or,I-CAUSE_OF_DISEASE,5778
109917,exposed,I-CAUSE_OF_DISEASE,5778
109918,suture,I-CAUSE_OF_DISEASE,5778
109919,rubbing,I-CAUSE_OF_DISEASE,5778
109920,against,I-CAUSE_OF_DISEASE,5778
109921,the,I-CAUSE_OF_DISEASE,5778
109922,inner,I-CAUSE_OF_DISEASE,5778
109923,side,I-CAUSE_OF_DISEASE,5778
109924,of,I-CAUSE_OF_DISEASE,5778
109925,eyelid,I-CAUSE_OF_DISEASE,5778
109926,Accumulation,B-CAUSE_OF_DISEASE,5778
109927,of,I-CAUSE_OF_DISEASE,5778
109928,substances,I-CAUSE_OF_DISEASE,5778
109929,on,I-CAUSE_OF_DISEASE,5778
109930,the,I-CAUSE_OF_DISEASE,5778
109931,contact,I-CAUSE_OF_DISEASE,5778
109932,lenses,I-CAUSE_OF_DISEASE,5778
109933,Chronic,B-CAUSE_OF_DISEASE,5778
109934,ocular,I-CAUSE_OF_DISEASE,5778
109935,allergies,I-CAUSE_OF_DISEASE,5778
109936,What,O,5778
109937,are,O,5778
109938,the,O,5778
109939,symptoms,O,5778
109940,of,O,5778
109941,GPC,B-NAME_OF_DISEASE,5778
109942,Feeling,B-SIGN_AND_SYMPTOM,5778
109943,of,I-SIGN_AND_SYMPTOM,5778
109944,sand,I-SIGN_AND_SYMPTOM,5778
109945,stuck,I-SIGN_AND_SYMPTOM,5778
109946,in,I-SIGN_AND_SYMPTOM,5778
109947,eye,I-SIGN_AND_SYMPTOM,5778
109948,Foreign,B-SIGN_AND_SYMPTOM,5778
109949,body,I-SIGN_AND_SYMPTOM,5778
109950,sensation,I-SIGN_AND_SYMPTOM,5778
109951,in,I-SIGN_AND_SYMPTOM,5778
109952,eyes,I-SIGN_AND_SYMPTOM,5778
109953,Grittiness,B-SIGN_AND_SYMPTOM,5778
109954,and,I-SIGN_AND_SYMPTOM,5778
109955,red,I-SIGN_AND_SYMPTOM,5778
109956,eyes,I-SIGN_AND_SYMPTOM,5778
109957,Intensely,B-SIGN_AND_SYMPTOM,5778
109958,itchy,I-SIGN_AND_SYMPTOM,5778
109959,eyes,I-SIGN_AND_SYMPTOM,5778
109960,Inflammation,B-SIGN_AND_SYMPTOM,5778
109961,and,I-SIGN_AND_SYMPTOM,5778
109962,drooping,I-SIGN_AND_SYMPTOM,5778
109963,eyelids,I-SIGN_AND_SYMPTOM,5778
109964,Excessive,B-SIGN_AND_SYMPTOM,5778
109965,mucus,I-SIGN_AND_SYMPTOM,5778
109966,discharge,I-SIGN_AND_SYMPTOM,5778
109967,from,I-SIGN_AND_SYMPTOM,5778
109968,the,I-SIGN_AND_SYMPTOM,5778
109969,eye,I-SIGN_AND_SYMPTOM,5778
109970,which,O,5778
109971,makes,O,5778
109972,Blurry,B-SIGN_AND_SYMPTOM,5778
109973,vision,I-SIGN_AND_SYMPTOM,5778
109974,due,I-SIGN_AND_SYMPTOM,5778
109975,to,I-SIGN_AND_SYMPTOM,5778
109976,discharge,I-SIGN_AND_SYMPTOM,5778
109977,Sensation,B-SIGN_AND_SYMPTOM,5778
109978,like,I-SIGN_AND_SYMPTOM,5778
109979,your,I-SIGN_AND_SYMPTOM,5778
109980,contact,I-SIGN_AND_SYMPTOM,5778
109981,lens,I-SIGN_AND_SYMPTOM,5778
109982,is,I-SIGN_AND_SYMPTOM,5778
109983,moving,I-SIGN_AND_SYMPTOM,5778
109984,every,I-SIGN_AND_SYMPTOM,5778
109985,time,I-SIGN_AND_SYMPTOM,5778
109986,you,I-SIGN_AND_SYMPTOM,5778
109987,blink,I-SIGN_AND_SYMPTOM,5778
109988,your,I-SIGN_AND_SYMPTOM,5778
109989,eyes,I-SIGN_AND_SYMPTOM,5778
109990,Bumpy,B-SIGN_AND_SYMPTOM,5778
109991,underside,I-SIGN_AND_SYMPTOM,5778
109992,of,I-SIGN_AND_SYMPTOM,5778
109993,your,I-SIGN_AND_SYMPTOM,5778
109994,upper,I-SIGN_AND_SYMPTOM,5778
109995,eyelid,I-SIGN_AND_SYMPTOM,5778
109996,Excess,B-SIGN_AND_SYMPTOM,5778
109997,mucus,I-SIGN_AND_SYMPTOM,5778
109998,forming,I-SIGN_AND_SYMPTOM,5778
109999,strings,I-SIGN_AND_SYMPTOM,5778
110000,or,I-SIGN_AND_SYMPTOM,5778
110001,sheets,I-SIGN_AND_SYMPTOM,5778
110002,Stages,O,5778
110003,of,O,5779
110004,Giant,B-NAME_OF_DISEASE,5779
110005,Papillary,I-NAME_OF_DISEASE,5779
110006,Conjunctivitis,I-NAME_OF_DISEASE,5779
110007,For,O,5779
110008,easy,O,5779
110009,understanding,O,5779
110010,GPC,B-NAME_OF_DISEASE,5779
110011,can,O,5779
110012,be,O,5779
110013,divided,O,5779
110014,into,O,5779
110015,several,O,5779
110016,stages,O,5779
110017,Early,O,5779
110018,stages,O,5779
110019,of,O,5779
110020,giant,B-NAME_OF_DISEASE,5779
110021,papillary,I-NAME_OF_DISEASE,5779
110022,conjunctivitis,I-NAME_OF_DISEASE,5779
110023,it,O,5779
110024,manifests,O,5779
110025,as,O,5779
110026,mild,O,5779
110027,or,O,5779
110028,no,O,5779
110029,symptoms,O,5779
110030,of,O,5780
110031,grittiness,B-SIGN_AND_SYMPTOM,5780
110032,redness,I-SIGN_AND_SYMPTOM,5780
110033,itching,I-SIGN_AND_SYMPTOM,5780
110034,inflammation,I-SIGN_AND_SYMPTOM,5780
110035,or,I-SIGN_AND_SYMPTOM,5780
110036,bumps,I-SIGN_AND_SYMPTOM,5780
110037,on,I-SIGN_AND_SYMPTOM,5780
110038,the,I-SIGN_AND_SYMPTOM,5781
110039,inner,I-SIGN_AND_SYMPTOM,5781
110040,side,I-SIGN_AND_SYMPTOM,5781
110041,of,I-SIGN_AND_SYMPTOM,5781
110042,eye,I-SIGN_AND_SYMPTOM,5781
110043,lids,I-SIGN_AND_SYMPTOM,5781
110044,There,O,5781
110045,is,O,5781
110046,little,O,5781
110047,to,O,5781
110048,no,O,5781
110049,discharge,O,5781
110050,in,O,5781
110051,it,O,5781
110052,In,O,5782
110053,severe,O,5782
110054,stages,O,5782
110055,there,O,5782
110056,is,O,5782
110057,increase,B-SIGN_AND_SYMPTOM,5782
110058,in,I-SIGN_AND_SYMPTOM,5782
110059,number,I-SIGN_AND_SYMPTOM,5782
110060,of,I-SIGN_AND_SYMPTOM,5782
110061,bumps,I-SIGN_AND_SYMPTOM,5782
110062,grittiness,I-SIGN_AND_SYMPTOM,5783
110063,itching,I-SIGN_AND_SYMPTOM,5783
110064,and,I-SIGN_AND_SYMPTOM,5783
110065,redness,I-SIGN_AND_SYMPTOM,5783
110066,The,O,5783
110067,is,O,5783
110068,good,B-SIGN_AND_SYMPTOM,5783
110069,amount,I-SIGN_AND_SYMPTOM,5783
110070,of,I-SIGN_AND_SYMPTOM,5783
110071,discharge,I-SIGN_AND_SYMPTOM,5784
110072,leading,I-SIGN_AND_SYMPTOM,5784
110073,of,I-SIGN_AND_SYMPTOM,5784
110074,blurred,I-SIGN_AND_SYMPTOM,5784
110075,vision,I-SIGN_AND_SYMPTOM,5784
110076,Mostly,O,5784
110077,in,O,5784
110078,these,O,5784
110079,cases,O,5784
110080,the,B-SIGN_AND_SYMPTOM,5784
110081,lens,I-SIGN_AND_SYMPTOM,5784
110082,moves,I-SIGN_AND_SYMPTOM,5784
110083,with,I-SIGN_AND_SYMPTOM,5784
110084,blinking,I-SIGN_AND_SYMPTOM,5784
110085,In,O,5784
110086,Advanced,O,5784
110087,stage,O,5784
110088,of,O,5784
110089,GPC,B-NAME_OF_DISEASE,5784
110090,all,O,5784
110091,the,O,5784
110092,aforementioned,O,5784
110093,symptoms,O,5784
110094,will,O,5784
110095,be,O,5784
110096,aggravated,O,5784
110097,the,B-SIGN_AND_SYMPTOM,5784
110098,discharge,I-SIGN_AND_SYMPTOM,5784
110099,will,I-SIGN_AND_SYMPTOM,5784
110100,take,I-SIGN_AND_SYMPTOM,5784
110101,shape,I-SIGN_AND_SYMPTOM,5784
110102,of,I-SIGN_AND_SYMPTOM,5784
110103,strings,I-SIGN_AND_SYMPTOM,5784
110104,deposition,I-SIGN_AND_SYMPTOM,5784
110105,on,I-SIGN_AND_SYMPTOM,5784
110106,contact,I-SIGN_AND_SYMPTOM,5784
110107,lenses,I-SIGN_AND_SYMPTOM,5784
110108,sticking,I-SIGN_AND_SYMPTOM,5784
110109,of,I-SIGN_AND_SYMPTOM,5785
110110,eyelids,I-SIGN_AND_SYMPTOM,5785
110111,and,I-SIGN_AND_SYMPTOM,5785
110112,intense,I-SIGN_AND_SYMPTOM,5785
110113,itching,I-SIGN_AND_SYMPTOM,5785
110114,due,I-SIGN_AND_SYMPTOM,5785
110115,to,I-SIGN_AND_SYMPTOM,5785
110116,immense,I-SIGN_AND_SYMPTOM,5785
110117,feeling,I-SIGN_AND_SYMPTOM,5785
110118,of,I-SIGN_AND_SYMPTOM,5785
110119,foreign,I-SIGN_AND_SYMPTOM,5785
110120,body,I-SIGN_AND_SYMPTOM,5785
110121,in,I-SIGN_AND_SYMPTOM,5785
110122,eyes,I-SIGN_AND_SYMPTOM,5785
110123,How,O,5785
110124,Can,O,5785
110125,GPC,B-NAME_OF_DISEASE,5785
110126,Treated,O,5785
110127,GPC,B-NAME_OF_DISEASE,5785
110128,needs,O,5786
110129,prompt,O,5786
110130,care,O,5786
110131,to,O,5786
110132,be,O,5786
110133,treated,O,5786
110134,as,O,5786
110135,quickly,O,5786
110136,as,O,5786
110137,possible,O,5786
110138,and,O,5786
110139,to,O,5786
110140,avoid,O,5787
110141,complications,O,5787
110142,The,O,5787
110143,approved,O,5787
110144,treatment,O,5787
110145,for,O,5787
110146,primary,B-NAME_OF_DISEASE,5787
110147,GPC,I-NAME_OF_DISEASE,5787
110148,is,O,5787
110149,cromolyn,B-NAME_OF_DRUG,5787
110150,sodium,I-NAME_OF_DRUG,5787
110151,and,O,5787
110152,lodoxamide,B-NAME_OF_DRUG,5787
110153,usually,O,5788
110154,However,O,5788
110155,other,O,5788
110156,treatment,O,5788
110157,options,O,5788
110158,primary,B-NAME_OF_DISEASE,5788
110159,GPC,I-NAME_OF_DISEASE,5788
110160,are,O,5788
110161,antihistamines,B-NAME_OF_DRUG,5788
110162,topical,B-NAME_OF_DRUG,5788
110163,steroids,I-NAME_OF_DRUG,5788
110164,and,O,5788
110165,topical,B-NAME_OF_DRUG,5788
110166,cyclosporine,I-NAME_OF_DRUG,5788
110167,To,O,5788
110168,treat,O,5788
110169,Secondary,B-NAME_OF_DISEASE,5789
110170,GPC,I-NAME_OF_DISEASE,5789
110171,you,O,5789
110172,need,O,5789
110173,to,O,5789
110174,-,O,5789
110175,Abstain,B-TREATMENT,5789
110176,from,I-TREATMENT,5789
110177,wearing,I-TREATMENT,5789
110178,contact,I-TREATMENT,5789
110179,lenses,I-TREATMENT,5789
110180,for,I-TREATMENT,5789
110181,some,I-TREATMENT,5789
110182,time,I-TREATMENT,5789
110183,This,O,5789
110184,way,O,5789
110185,your,O,5790
110186,body,O,5790
110187,is,O,5790
110188,not,O,5790
110189,exposed,O,5790
110190,to,O,5790
110191,allergen,B-CAUSE_OF_DISEASE,5790
110192,and,O,5791
110193,takes,O,5791
110194,its,O,5791
110195,time,O,5791
110196,to,O,5791
110197,heal,O,5791
110198,perfectly,O,5791
110199,Reduce,B-TREATMENT,5791
110200,the,I-TREATMENT,5791
110201,total,I-TREATMENT,5791
110202,duration,I-TREATMENT,5791
110203,of,I-TREATMENT,5791
110204,wearing,I-TREATMENT,5791
110205,lenses,I-TREATMENT,5791
110206,Clean,B-TREATMENT,5791
110207,your,I-TREATMENT,5792
110208,lens,I-TREATMENT,5792
110209,with,I-TREATMENT,5792
110210,the,I-TREATMENT,5792
110211,prescribed,I-TREATMENT,5792
110212,lens,I-TREATMENT,5792
110213,solution,I-TREATMENT,5792
110214,only,I-TREATMENT,5793
110215,avoid,B-TREATMENT,5793
110216,using,I-TREATMENT,5793
110217,lens,I-TREATMENT,5793
110218,solutions,I-TREATMENT,5793
110219,with,I-TREATMENT,5793
110220,preservatives,I-TREATMENT,5793
110221,Store,B-TREATMENT,5793
110222,your,I-TREATMENT,5793
110223,lenses,I-TREATMENT,5793
110224,properly,I-TREATMENT,5793
110225,in,I-TREATMENT,5793
110226,disinfecting,I-TREATMENT,5794
110227,solution,I-TREATMENT,5794
110228,Change,B-TREATMENT,5794
110229,your,I-TREATMENT,5794
110230,lens,I-TREATMENT,5794
110231,regular,I-TREATMENT,5794
110232,as,O,5794
110233,the,B-CAUSE_OF_DISEASE,5794
110234,very,I-CAUSE_OF_DISEASE,5795
110235,lens,I-CAUSE_OF_DISEASE,5795
110236,might,O,5795
110237,be,O,5795
110238,causing,O,5795
110239,allergy,B-SIGN_AND_SYMPTOM,5795
110240,Change,B-TREATMENT,5795
110241,the,I-TREATMENT,5795
110242,type,I-TREATMENT,5795
110243,and,I-TREATMENT,5795
110244,design,I-TREATMENT,5795
110245,of,I-TREATMENT,5795
110246,your,I-TREATMENT,5796
110247,lens,I-TREATMENT,5796
110248,Your,O,5796
110249,ophthalmologist,O,5796
110250,will,O,5796
110251,discuss,O,5796
110252,treatment,O,5796
110253,options,O,5796
110254,for,O,5796
110255,you,O,5796
110256,based,O,5796
110257,on,O,5797
110258,your,O,5797
110259,condition,O,5797
110260,Use,O,5797
110261,eye,B-TREATMENT,5797
110262,drops,I-TREATMENT,5797
110263,prescribed,O,5797
110264,by,O,5797
110265,the,O,5797
110266,ophthalmologists,O,5797
110267,to,O,5797
110268,pacify,O,5798
110269,the,O,5798
110270,situation,O,5798
110271,You,O,5798
110272,might,O,5798
110273,be,O,5798
110274,prescribed,O,5798
110275,cromolyn,B-NAME_OF_DRUG,5798
110276,sodium,I-NAME_OF_DRUG,5798
110277,drops,I-NAME_OF_DRUG,5798
110278,if,O,5798
110279,other,O,5798
110280,treatments,O,5798
110281,fail,O,5798
110282,Headaches,B-CAUSE_OF_DISEASE,5798
110283,may,O,5798
110284,increase,O,5798
110285,the,O,5798
110286,risk,O,5798
110287,for,O,5798
110288,dry,B-NAME_OF_DISEASE,5799
110289,eye,I-NAME_OF_DISEASE,5799
110290,disease,I-NAME_OF_DISEASE,5799
110291,DED,B-NAME_OF_DISEASE,5799
110292,according,O,5799
110293,to,O,5799
110294,a,O,5800
110295,systematic,O,5800
110296,review,O,5800
110297,and,O,5800
110298,meta-analysis,O,5800
110299,published,O,5800
110300,online,O,5800
110301,Oct,O,5800
110302,19,O,5800
110303,in,O,5800
110304,the,B-PUBLICATION_VENUE,5800
110305,Annals,I-PUBLICATION_VENUE,5800
110306,of,I-PUBLICATION_VENUE,5800
110307,Medicine,I-PUBLICATION_VENUE,5800
110308,To,O,5800
110309,find,O,5800
110310,research,O,5800
110311,examining,O,5800
110312,whether,O,5800
110313,headache,B-CAUSE_OF_DISEASE,5800
110314,is,O,5800
110315,linked,O,5800
110316,to,O,5800
110317,the,O,5800
110318,risk,O,5800
110319,for,O,5800
110320,DED,B-NAME_OF_DISEASE,5800
110321,Shuyi,B-PERSON,5800
110322,Liu,I-PERSON,5801
110323,and,O,5801
110324,colleagues,O,5801
110325,from,O,5801
110326,Dalian,B-ORGANIZATION,5801
110327,Medical,I-ORGANIZATION,5801
110328,University,I-ORGANIZATION,5801
110329,in,O,5801
110330,China,B-GPE,5801
110331,did,O,5801
110332,a,O,5801
110333,thorough,O,5801
110334,literature,O,5801
110335,search,O,5801
110336,The,O,5801
110337,researchers,O,5801
110338,discovered,O,5801
110339,that,O,5801
110340,all-cause,B-CAUSE_OF_DISEASE,5801
110341,headache,I-CAUSE_OF_DISEASE,5801
110342,was,O,5802
110343,connected,O,5802
110344,to,O,5802
110345,a,O,5802
110346,greater,O,5802
110347,risk,O,5803
110348,for,O,5804
110349,DED,B-NAME_OF_DISEASE,5804
110350,based,O,5804
110351,on,O,5804
110352,11,O,5804
110353,included,O,5804
110354,studies,O,5804
110355,3,O,5804
110356,million,O,5804
110357,people,O,5804
110358,odds,O,5804
110359,ratio,O,5804
110360,1.58,O,5805
110361,,O,5805
110362,In,O,5805
110363,terms,O,5805
110364,of,O,5805
110365,different,O,5806
110366,types,O,5806
110367,of,O,5806
110368,headaches,B-CAUSE_OF_DISEASE,5806
110369,cluster,B-CAUSE_OF_DISEASE,5806
110370,headaches,I-CAUSE_OF_DISEASE,5807
110371,odds,O,5807
110372,ratio,O,5807
110373,2.11,O,5807
110374,tension,B-CAUSE_OF_DISEASE,5807
110375,headaches,I-CAUSE_OF_DISEASE,5807
110376,odds,O,5807
110377,ratio,O,5807
110378,1.61,O,5807
110379,and,O,5808
110380,migraines,B-CAUSE_OF_DISEASE,5808
110381,odds,O,5808
110382,ratio,O,5808
110383,1.5,O,5808
110384,were,O,5808
110385,all,O,5808
110386,linked,O,5808
110387,to,O,5808
110388,a,O,5808
110389,higher,O,5808
110390,risk,O,5808
110391,for,O,5808
110392,DED,B-NAME_OF_DISEASE,5808
110393,Case-control,O,5808
110394,studies,O,5808
110395,were,O,5808
110396,shown,O,5808
110397,to,O,5808
110398,have,O,5808
110399,a,O,5809
110400,somewhat,O,5809
110401,higher,O,5810
110402,risk,O,5810
110403,for,O,5810
110404,DED,B-NAME_OF_DISEASE,5811
110405,than,O,5812
110406,cross-sectional,O,5812
110407,and,O,5812
110408,cohort,O,5812
110409,studies,O,5812
110410,odds,O,5812
110411,ratios,O,5812
110412,1.6,O,5812
110413,and,O,5812
110414,1.44,O,5812
110415,respectively,O,5812
110416,versus,O,5812
110417,1.7,O,5812
110418,,O,5812
110419,All,B-CAUSE_OF_DISEASE,5812
110420,headache,I-CAUSE_OF_DISEASE,5812
110421,types,I-CAUSE_OF_DISEASE,5812
110422,were,O,5813
110423,linked,O,5813
110424,to,O,5813
110425,an,O,5813
110426,increased,O,5813
110427,risk,O,5813
110428,of,O,5813
110429,DED,B-NAME_OF_DISEASE,5813
110430,across,O,5813
110431,America,B-GPE,5813
110432,Europe,B-GPE,5813
110433,Asia,B-GPE,5813
110434,and,O,5813
110435,Oceania,B-GPE,5813
110436,Our,O,5814
110437,study,O,5814
110438,indicates,O,5814
110439,that,O,5814
110440,headache,B-CAUSE_OF_DISEASE,5814
110441,increases,O,5814
110442,the,O,5814
110443,risk,O,5814
110444,of,O,5814
110445,DED,B-NAME_OF_DISEASE,5814
110446,especially,O,5814
110447,in,O,5814
110448,migraine,O,5814
110449,patients,O,5814
110450,However,O,5814
110451,more,O,5814
110452,relevant,O,5814
110453,studies,O,5814
110454,are,O,5814
110455,still,O,5814
110456,required,O,5815
110457,to,O,5815
110458,identify,O,5815
110459,the,O,5815
110460,exact,O,5815
110461,pathophysiological,O,5815
110462,process,O,5815
110463,behind,O,5815
110464,this,O,5815
110465,clinical,O,5815
110466,phenomenon,O,5815
110467,the,O,5815
110468,authors,O,5815
110469,write,O,5815
110470,The,O,5815
110471,findings,O,5816
110472,of,O,5816
110473,our,O,5816
110474,study,O,5816
110475,can,O,5816
110476,be,O,5816
110477,meaningful,O,5816
110478,in,O,5816
110479,the,O,5816
110480,prevention,O,5816
110481,and,O,5816
110482,treatment,O,5816
110483,of,O,5816
110484,DED,B-NAME_OF_DISEASE,5816
110485,Let,O,5816
110486,s,O,5816
110487,start,O,5816
110488,with,O,5816
110489,the,O,5816
110490,definition,O,5816
110491,of,O,5816
110492,the,B-PART_OF_THE_EYES,5816
110493,lacrimal,I-PART_OF_THE_EYES,5816
110494,lake,I-PART_OF_THE_EYES,5816
110495,as,O,5816
110496,you,O,5816
110497,may,O,5816
110498,guess,O,5816
110499,the,B-PART_OF_THE_EYES,5816
110500,lacrimal,I-PART_OF_THE_EYES,5816
110501,lake,I-PART_OF_THE_EYES,5816
110502,is,O,5816
110503,a,O,5816
110504,pool,O,5816
110505,of,O,5816
110506,tears,O,5816
110507,in,O,5817
110508,the,O,5817
110509,lower,O,5817
110510,section,O,5817
110511,of,O,5817
110512,the,O,5817
110513,eye,O,5817
110514,that,O,5817
110515,drains,O,5817
110516,into,O,5817
110517,the,O,5817
110518,tear,O,5817
110519,drainage,O,5817
110520,system,O,5817
110521,Actually,O,5817
110522,we,O,5817
110523,have,O,5817
110524,a,O,5818
110525,lacrimal,O,5818
110526,liquid,O,5818
110527,spread,O,5818
110528,all,O,5818
110529,over,O,5818
110530,the,O,5818
110531,eye,O,5818
110532,with,O,5818
110533,the,O,5818
110534,help,O,5818
110535,of,O,5818
110536,eye,O,5818
110537,blinks,O,5818
110538,Lacrimal,B-PART_OF_THE_EYES,5818
110539,Lake,I-PART_OF_THE_EYES,5818
110540,Function,O,5818
110541,The,O,5818
110542,lacrimal,O,5818
110543,fluid,O,5818
110544,actually,O,5818
110545,the,O,5818
110546,tears,O,5818
110547,is,O,5818
110548,water,O,5818
110549,of,O,5819
110550,antibacterial,B-CHEMICAL_COMPOUND,5819
110551,agentlysozyme,I-CHEMICAL_COMPOUND,5819
110552,that,O,5819
110553,enters,O,5819
110554,the,B-PART_OF_THE_EYES,5819
110555,upper,I-PART_OF_THE_EYES,5819
110556,eyelid,I-PART_OF_THE_EYES,5819
110557,to,O,5819
110558,wash,O,5819
110559,all,O,5819
110560,over,O,5820
110561,the,O,5820
110562,eyes,O,5820
110563,As,O,5820
110564,a,O,5820
110565,result,O,5820
110566,the,B-PART_OF_THE_EYES,5820
110567,cornea,I-PART_OF_THE_EYES,5820
110568,is,O,5820
110569,moistened,O,5820
110570,and,O,5820
110571,protected,O,5820
110572,from,O,5821
110573,dehydration,B-SIGN_AND_SYMPTOM,5821
110574,By,O,5821
110575,aging,O,5821
110576,the,B-PART_OF_THE_EYES,5821
110577,eyelids,I-PART_OF_THE_EYES,5821
110578,get,O,5821
110579,loosened,O,5821
110580,and,O,5821
110581,lacrimal,B-PART_OF_THE_EYES,5821
110582,lakes,I-PART_OF_THE_EYES,5821
110583,keep,O,5822
110584,more,O,5822
110585,fluid,O,5822
110586,The,O,5822
110587,common,O,5822
110588,issue,O,5822
110589,about,O,5822
110590,the,B-PART_OF_THE_EYES,5822
110591,lacrimal,I-PART_OF_THE_EYES,5822
110592,gland,I-PART_OF_THE_EYES,5822
110593,is,O,5822
110594,inflammation,B-SIGN_AND_SYMPTOM,5822
110595,or,I-SIGN_AND_SYMPTOM,5822
110596,swelling,I-SIGN_AND_SYMPTOM,5822
110597,What,O,5822
110598,Drains,O,5822
110599,The,B-PART_OF_THE_EYES,5822
110600,Lacrimal,I-PART_OF_THE_EYES,5822
110601,Lake,I-PART_OF_THE_EYES,5822
110602,So,O,5822
110603,if,O,5822
110604,you,O,5822
110605,look,O,5822
110606,at,O,5822
110607,the,O,5822
110608,mirror,O,5822
110609,to,O,5822
110610,your,O,5822
110611,eyes,O,5822
110612,closely,O,5822
110613,you,O,5822
110614,will,O,5822
110615,see,O,5822
110616,a,B-PART_OF_THE_EYES,5822
110617,lacrimal,I-PART_OF_THE_EYES,5822
110618,papilla,I-PART_OF_THE_EYES,5822
110619,which,O,5823
110620,is,O,5823
110621,at,O,5823
110622,the,O,5823
110623,corner,O,5823
110624,of,O,5823
110625,the,O,5823
110626,eye,O,5823
110627,and,O,5823
110628,the,O,5823
110629,nose,O,5823
110630,as,O,5823
110631,an,O,5823
110632,elevation,O,5823
110633,If,O,5823
110634,you,O,5823
110635,slightly,O,5823
110636,open,O,5823
110637,the,O,5823
110638,lower,O,5824
110639,eye,O,5824
110640,and,O,5824
110641,look,O,5824
110642,at,O,5824
110643,the,O,5824
110644,corner,O,5824
110645,point,O,5824
110646,you,O,5824
110647,will,O,5824
110648,see,O,5824
110649,the,B-PART_OF_THE_EYES,5824
110650,lacrimal,I-PART_OF_THE_EYES,5825
110651,punctum,I-PART_OF_THE_EYES,5825
110652,Don,O,5825
110653,t,O,5825
110654,worry,O,5825
110655,this,O,5825
110656,is,O,5825
110657,normal,O,5825
110658,and,O,5825
110659,your,O,5825
110660,eyes,O,5825
110661,are,O,5825
110662,not,O,5825
110663,damaged,O,5825
110664,The,B-PART_OF_THE_EYES,5825
110665,lacrimal,I-PART_OF_THE_EYES,5825
110666,punctum,I-PART_OF_THE_EYES,5826
110667,is,O,5826
110668,linked,O,5826
110669,to,O,5826
110670,the,B-PART_OF_THE_EYES,5826
110671,lacrimal,I-PART_OF_THE_EYES,5826
110672,canaliculi,I-PART_OF_THE_EYES,5826
110673,which,O,5826
110674,are,O,5826
110675,the,O,5826
110676,small,O,5826
110677,channels,O,5826
110678,for,O,5826
110679,tears,O,5826
110680,These,O,5826
110681,lacrimal,B-PART_OF_THE_EYES,5827
110682,punta,I-PART_OF_THE_EYES,5827
110683,openings,O,5827
110684,are,O,5827
110685,located,O,5827
110686,in,O,5827
110687,both,O,5827
110688,upper,O,5827
110689,and,O,5827
110690,lower,O,5827
110691,corner,O,5827
110692,of,O,5827
110693,the,B-PART_OF_THE_EYES,5827
110694,eyelids,I-PART_OF_THE_EYES,5827
110695,Lacrimal,B-PART_OF_THE_EYES,5827
110696,canaliculi,I-PART_OF_THE_EYES,5827
110697,follow,O,5827
110698,a,O,5827
110699,way,O,5827
110700,to,O,5827
110701,the,B-PART_OF_THE_EYES,5827
110702,lacrimal,I-PART_OF_THE_EYES,5828
110703,sac,I-PART_OF_THE_EYES,5828
110704,then,O,5828
110705,from,O,5828
110706,the,B-PART_OF_THE_EYES,5828
110707,lacrimal,I-PART_OF_THE_EYES,5828
110708,sac,I-PART_OF_THE_EYES,5828
110709,the,O,5828
110710,liquid,O,5828
110711,tears,O,5828
110712,reach,O,5828
110713,the,O,5828
110714,nasolacrimal,O,5828
110715,duct,O,5828
110716,The,O,5828
110717,fluid,O,5828
110718,passes,O,5828
110719,through,O,5828
110720,the,O,5828
110721,nasal,O,5828
110722,cavity,O,5829
110723,and,O,5829
110724,mixes,O,5829
110725,with,O,5829
110726,the,O,5829
110727,mucus,O,5829
110728,or,O,5829
110729,maybe,O,5829
110730,you,O,5829
110731,can,O,5829
110732,swallow,O,5829
110733,the,O,5829
110734,fluid,O,5829
110735,too,O,5829
110736,So,O,5829
110737,this,O,5829
110738,is,O,5829
110739,why,O,5829
110740,you,O,5829
110741,have,O,5829
110742,nasal,O,5829
110743,draining,O,5829
110744,while,O,5829
110745,you,O,5829
110746,are,O,5829
110747,crying,O,5829
110748,Lacrimal,B-NAME_OF_DISEASE,5829
110749,Lake,I-NAME_OF_DISEASE,5829
110750,Swelling,I-NAME_OF_DISEASE,5829
110751,Treatment,O,5829
110752,Due,O,5830
110753,to,O,5830
110754,the,O,5830
110755,conditions,O,5830
110756,of,O,5830
110757,the,B-CAUSE_OF_DISEASE,5830
110758,tear-producing,I-CAUSE_OF_DISEASE,5830
110759,your,O,5830
110760,eyes,O,5830
110761,may,O,5830
110762,have,O,5830
110763,lacrimal,B-NAME_OF_DISEASE,5830
110764,lake,I-NAME_OF_DISEASE,5830
110765,swelling,I-NAME_OF_DISEASE,5830
110766,The,O,5830
110767,symptoms,O,5830
110768,for,O,5830
110769,lacrimal,B-NAME_OF_DISEASE,5830
110770,lake,I-NAME_OF_DISEASE,5830
110771,swelling,I-NAME_OF_DISEASE,5830
110772,or,O,5830
110773,in,O,5830
110774,other,O,5830
110775,ways,O,5830
110776,lacrimal,B-NAME_OF_DISEASE,5830
110777,gland,I-NAME_OF_DISEASE,5830
110778,inflammations,I-NAME_OF_DISEASE,5830
110779,are,O,5830
110780,redness,B-SIGN_AND_SYMPTOM,5830
110781,in,I-SIGN_AND_SYMPTOM,5830
110782,the,I-SIGN_AND_SYMPTOM,5830
110783,eyelid,I-SIGN_AND_SYMPTOM,5830
110784,dry,B-SIGN_AND_SYMPTOM,5830
110785,eye,I-SIGN_AND_SYMPTOM,5830
110786,or,I-SIGN_AND_SYMPTOM,5830
110787,excessive,I-SIGN_AND_SYMPTOM,5830
110788,tearing,I-SIGN_AND_SYMPTOM,5830
110789,inflammation,B-SIGN_AND_SYMPTOM,5830
110790,in,I-SIGN_AND_SYMPTOM,5830
110791,the,I-SIGN_AND_SYMPTOM,5830
110792,eye,I-SIGN_AND_SYMPTOM,5830
110793,discomfort,B-SIGN_AND_SYMPTOM,5830
110794,in,I-SIGN_AND_SYMPTOM,5830
110795,blinking,I-SIGN_AND_SYMPTOM,5830
110796,The,O,5830
110797,symptoms,O,5830
110798,can,O,5830
110799,show,O,5830
110800,mumps,B-SIGN_AND_SYMPTOM,5830
110801,but,O,5830
110802,you,O,5830
110803,should,O,5831
110804,visit,O,5831
110805,your,O,5831
110806,doctor,O,5831
110807,and,O,5831
110808,after,O,5831
110809,having,O,5831
110810,the,O,5831
110811,diagnosis,O,5831
110812,the,O,5831
110813,treatment,O,5831
110814,should,O,5831
110815,be,O,5831
110816,applied,O,5831
110817,Generally,O,5831
110818,lacrimal,B-NAME_OF_DISEASE,5831
110819,gland,I-NAME_OF_DISEASE,5831
110820,swelling,I-NAME_OF_DISEASE,5831
110821,is,O,5831
110822,treated,O,5831
110823,easily,O,5831
110824,as,O,5831
110825,they,O,5831
110826,are,O,5831
110827,commonly,O,5831
110828,happening,O,5831
110829,acutely,O,5831
110830,due,O,5832
110831,the,B-CAUSE_OF_DISEASE,5832
110832,bacterial,I-CAUSE_OF_DISEASE,5832
110833,infection,I-CAUSE_OF_DISEASE,5832
110834,and,O,5832
110835,can,O,5832
110836,be,O,5832
110837,treated,O,5832
110838,by,O,5832
110839,the,O,5832
110840,doctor,O,5832
110841,with,O,5833
110842,warm,B-TREATMENT,5833
110843,compresses,I-TREATMENT,5833
110844,The,B-CAUSE_OF_DISEASE,5833
110845,chronic,I-CAUSE_OF_DISEASE,5833
110846,effect,I-CAUSE_OF_DISEASE,5833
110847,may,O,5833
110848,be,O,5833
110849,the,O,5833
110850,reason,O,5833
110851,for,O,5833
110852,eye,B-NAME_OF_DISEASE,5833
110853,thyroid,I-NAME_OF_DISEASE,5833
110854,disorder,I-NAME_OF_DISEASE,5833
110855,Lacrimal,B-NAME_OF_DISEASE,5833
110856,Duct,I-NAME_OF_DISEASE,5833
110857,Obstruction,I-NAME_OF_DISEASE,5834
110858,Treatment,O,5834
110859,One,O,5834
110860,of,O,5834
110861,the,O,5834
110862,problems,O,5834
110863,of,O,5834
110864,the,B-PART_OF_THE_EYES,5834
110865,lacrimal,I-PART_OF_THE_EYES,5834
110866,system,I-PART_OF_THE_EYES,5834
110867,is,O,5834
110868,Nasolacrimal,B-CAUSE_OF_DISEASE,5834
110869,duct,I-CAUSE_OF_DISEASE,5834
110870,obstruction,I-CAUSE_OF_DISEASE,5834
110871,The,O,5834
110872,problem,O,5834
110873,may,O,5834
110874,occur,O,5834
110875,in,O,5834
110876,the,O,5834
110877,first,O,5834
110878,6,O,5834
110879,months,O,5834
110880,of,O,5834
110881,the,O,5835
110882,newborns,O,5835
110883,and,O,5835
110884,can,O,5835
110885,be,O,5835
110886,treated,O,5835
110887,with,O,5835
110888,nasal,B-TREATMENT,5835
110889,massages,I-TREATMENT,5835
110890,eye,B-TREATMENT,5835
110891,drops,I-TREATMENT,5835
110892,or,O,5835
110893,topical,B-TREATMENT,5835
110894,antibiotics,I-TREATMENT,5835
110895,If,O,5835
110896,the,O,5835
110897,problem,O,5835
110898,occurs,O,5835
110899,after,O,5835
110900,12,O,5835
110901,months,O,5835
110902,then,O,5835
110903,surgery,B-TREATMENT,5836
110904,may,I-TREATMENT,5836
110905,be,I-TREATMENT,5836
110906,needed,I-TREATMENT,5836
110907,to,I-TREATMENT,5836
110908,open,I-TREATMENT,5836
110909,the,I-TREATMENT,5836
110910,drainage,I-TREATMENT,5836
110911,which,I-TREATMENT,5836
110912,is,I-TREATMENT,5836
110913,the,I-TREATMENT,5836
110914,blocked,I-TREATMENT,5836
110915,tear,I-TREATMENT,5836
110916,duct,I-TREATMENT,5836
110917,With,O,5836
110918,early,O,5836
110919,diagnosis,O,5836
110920,the,O,5836
110921,operation,O,5836
110922,can,O,5836
110923,be,O,5836
110924,done,O,5836
110925,by,O,5836
110926,the,O,5836
110927,practitioner,O,5836
110928,however,O,5836
110929,If,O,5837
110930,the,O,5837
110931,diagnoses,O,5837
110932,are,O,5837
110933,not,O,5837
110934,certain,O,5837
110935,the,O,5837
110936,child,O,5837
110937,should,O,5837
110938,be,O,5837
110939,cared,O,5837
110940,by,O,5837
110941,an,O,5837
110942,ophthalmologist,O,5837
110943,A,O,5837
110944,research,O,5837
110945,team-,O,5837
110946,led,O,5837
110947,by,O,5837
110948,Professor,B-PERSON,5837
110949,Akira,I-PERSON,5837
110950,Murakami,I-PERSON,5837
110951,and,O,5837
110952,Associate,B-PERSON,5837
110953,Professor,I-PERSON,5837
110954,Takenori,I-PERSON,5837
110955,Inomata,I-PERSON,5837
110956,of,O,5837
110957,the,O,5837
110958,Juntendo,O,5837
110959,University,O,5837
110960,Graduate,O,5837
110961,School,O,5837
110962,of,O,5837
110963,Medicine-,O,5837
110964,has,O,5838
110965,developed,O,5838
110966,DryEyeRhythm,B-DIAGNOSTIC_TEST,5838
110967,a,O,5838
110968,non-invasive,O,5838
110969,and,O,5838
110970,reliable,O,5838
110971,mobile,O,5838
110972,app,O,5838
110973,to,O,5838
110974,assess,O,5838
110975,dry,B-NAME_OF_DISEASE,5838
110976,eye,I-NAME_OF_DISEASE,5838
110977,disease,I-NAME_OF_DISEASE,5838
110978,DryEyeRhythm,B-DIAGNOSTIC_TEST,5838
110979,leverages,O,5838
110980,the,O,5838
110981,cameras,O,5838
110982,in,O,5838
110983,smartphones,O,5838
110984,to,O,5838
110985,measure,O,5838
110986,users,O,5838
110987,blink,O,5838
110988,characteristics,O,5838
110989,and,O,5838
110990,determine,O,5838
110991,maximum,B-DIAGNOSTIC_TEST,5838
110992,blink,I-DIAGNOSTIC_TEST,5838
110993,interval,I-DIAGNOSTIC_TEST,5838
110994,MBI,B-DIAGNOSTIC_TEST,5838
110995,#NAME?,O,5838
110996,substitute,O,5838
110997,for,O,5839
110998,tear,B-PART_OF_THE_EYES,5840
110999,film,I-PART_OF_THE_EYES,5840
111000,breakup,O,5840
111001,time,O,5840
111002,an,O,5840
111003,important,O,5840
111004,diagnostic,O,5840
111005,criterion,O,5840
111006,of,O,5840
111007,DED,B-NAME_OF_DISEASE,5840
111008,explains,O,5840
111009,Associate,O,5840
111010,Prof,O,5840
111011,Inomata,O,5840
111012,The,O,5840
111013,app,O,5840
111014,also,O,5840
111015,administers,O,5840
111016,Ocular,B-DIAGNOSTIC_TEST,5840
111017,Surface,I-DIAGNOSTIC_TEST,5841
111018,Disease,I-DIAGNOSTIC_TEST,5841
111019,Index,I-DIAGNOSTIC_TEST,5841
111020,OSDI,I-DIAGNOSTIC_TEST,5841
111021,questionnaires,I-DIAGNOSTIC_TEST,5841
111022,which,O,5841
111023,are,O,5841
111024,also,O,5841
111025,a,O,5841
111026,crucial,O,5841
111027,component,O,5841
111028,of,O,5841
111029,DED,B-NAME_OF_DISEASE,5841
111030,diagnosis,O,5841
111031,To,O,5841
111032,verify,O,5841
111033,the,O,5841
111034,usefulness,O,5841
111035,of,O,5842
111036,the,O,5842
111037,app,O,5842
111038,the,O,5842
111039,research,O,5842
111040,team,O,5842
111041,carried,O,5842
111042,out,O,5842
111043,a,O,5842
111044,prospective,O,5842
111045,cross-sectional,O,5842
111046,observational,O,5843
111047,single-center,O,5843
111048,study,O,5843
111049,The,O,5843
111050,findings,O,5843
111051,of,O,5843
111052,this,O,5843
111053,study,O,5843
111054,were,O,5843
111055,published,O,5843
111056,in,B-PUBLICATION_VENUE,5843
111057,The,I-PUBLICATION_VENUE,5843
111058,Ocular,I-PUBLICATION_VENUE,5843
111059,Surface,I-PUBLICATION_VENUE,5843
111060,The,O,5843
111061,study,O,5843
111062,The,O,5843
111063,researchers,O,5843
111064,enrolled,O,5843
111065,82,O,5843
111066,patients,O,5843
111067,who,O,5843
111068,visited,O,5843
111069,the,B-ORGANIZATION,5843
111070,Juntendo,I-ORGANIZATION,5843
111071,University,I-ORGANIZATION,5843
111072,Hospital,I-ORGANIZATION,5843
111073,s,I-ORGANIZATION,5843
111074,ophthalmology,I-ORGANIZATION,5843
111075,outpatient,I-ORGANIZATION,5843
111076,clinic,I-ORGANIZATION,5844
111077,between,B-TIME_DURATION,5844
111078,July,I-TIME_DURATION,5844
111079,2020,I-TIME_DURATION,5844
111080,and,I-TIME_DURATION,5844
111081,May,I-TIME_DURATION,5844
111082,2021,I-TIME_DURATION,5844
111083,and,O,5844
111084,were,O,5844
111085,at,O,5844
111086,least,O,5844
111087,20,O,5844
111088,years,O,5844
111089,old,O,5844
111090,The,O,5844
111091,participants,O,5844
111092,conducted,O,5844
111093,evaluations,O,5844
111094,for,O,5844
111095,MBI,B-DIAGNOSTIC_TEST,5844
111096,using,O,5844
111097,the,O,5844
111098,app,O,5844
111099,and,O,5844
111100,other,O,5845
111101,analysis,O,5845
111102,methods,O,5845
111103,as,O,5845
111104,well,O,5845
111105,as,O,5845
111106,completing,O,5845
111107,the,B-DIAGNOSTIC_TEST,5845
111108,OSDI,I-DIAGNOSTIC_TEST,5845
111109,questionnaire,I-DIAGNOSTIC_TEST,5845
111110,in,I-DIAGNOSTIC_TEST,5845
111111,Japanese,I-DIAGNOSTIC_TEST,5845
111112,J-OSDI,B-DIAGNOSTIC_TEST,5846
111113,,O,5846
111114,The,O,5847
111115,app,O,5848
111116,also,O,5848
111117,showed,O,5848
111118,good,O,5848
111119,positive,O,5848
111120,and,O,5848
111121,negative,O,5848
111122,predictive,O,5848
111123,values,O,5848
111124,with,O,5848
111125,91.3,O,5848
111126,and,O,5848
111127,69.1,O,5848
111128,respectively,O,5848
111129,The,O,5848
111130,area,O,5848
111131,under,O,5848
111132,the,O,5848
111133,Receiver,O,5848
111134,operating,O,5848
111135,characteristic,O,5848
111136,ROC,O,5848
111137,curve-a,O,5848
111138,measure,O,5848
111139,of,O,5848
111140,clinical,O,5848
111141,sensitivity,O,5848
111142,and,O,5848
111143,specificity-for,O,5848
111144,the,O,5848
111145,concurrent,O,5848
111146,use,O,5848
111147,of,O,5849
111148,the,O,5849
111149,app-based,O,5849
111150,J-OSDI,B-DIAGNOSTIC_TEST,5849
111151,and,O,5849
111152,MBI,B-DIAGNOSTIC_TEST,5849
111153,was,O,5849
111154,also,O,5849
111155,high,O,5849
111156,with,O,5849
111157,a,O,5849
111158,value,O,5849
111159,of,O,5849
111160,0.91,O,5849
111161,These,O,5849
111162,results,O,5849
111163,demonstrate,O,5849
111164,that,O,5850
111165,the,O,5850
111166,app,O,5850
111167,is,O,5850
111168,a,O,5850
111169,reliable,O,5850
111170,valid,O,5850
111171,and,O,5850
111172,moreover,O,5850
111173,non-invasive,O,5850
111174,instrument,O,5850
111175,for,O,5850
111176,assessing,O,5850
111177,DED,B-NAME_OF_DISEASE,5850
111178,Non-contact,O,5850
111179,and,O,5850
111180,non-invasive,O,5850
111181,DED,B-NAME_OF_DISEASE,5850
111182,diagnostic,O,5850
111183,assistance,O,5850
111184,like,O,5850
111185,the,O,5850
111186,kind,O,5850
111187,provided,O,5850
111188,by,O,5850
111189,DryEyeRhythm,B-DIAGNOSTIC_TEST,5850
111190,could,O,5850
111191,help,O,5850
111192,facilitate,O,5850
111193,the,O,5850
111194,early,O,5850
111195,diagnosis,O,5850
111196,and,O,5850
111197,treatment,O,5850
111198,of,O,5850
111199,patients,O,5850
111200,as,O,5851
111201,well,O,5852
111202,as,O,5852
111203,DED,B-NAME_OF_DISEASE,5852
111204,treatment,O,5852
111205,through,O,5852
111206,telemedicine,B-TREATMENT,5852
111207,and,I-TREATMENT,5852
111208,online,I-TREATMENT,5852
111209,medical,I-TREATMENT,5852
111210,care,I-TREATMENT,5852
111211,says,O,5852
111212,Associate,O,5852
111213,Prof,O,5852
111214,Inomata,O,5852
111215,The,O,5852
111216,research,O,5852
111217,team,O,5852
111218,plans,O,5852
111219,to,O,5853
111220,further,O,5853
111221,validate,O,5853
111222,its,O,5853
111223,results,O,5853
111224,by,O,5853
111225,conducting,O,5853
111226,a,O,5853
111227,multi-institutional,O,5853
111228,collaborative,O,5853
111229,study,O,5853
111230,in,O,5853
111231,the,O,5853
111232,future,O,5853
111233,They,O,5853
111234,are,O,5853
111235,also,O,5854
111236,planning,O,5854
111237,to,O,5854
111238,obtain,O,5854
111239,medical,O,5854
111240,device,O,5854
111241,approval,O,5854
111242,and,O,5854
111243,insurance,O,5854
111244,reimbursement,O,5854
111245,for,O,5854
111246,the,O,5854
111247,smartphone,O,5854
111248,application,O,5854
111249,What,O,5854
111250,is,O,5854
111251,dry,B-NAME_OF_DISEASE,5854
111252,eye,I-NAME_OF_DISEASE,5854
111253,disease,I-NAME_OF_DISEASE,5854
111254,Dry,B-NAME_OF_DISEASE,5854
111255,eye,I-NAME_OF_DISEASE,5854
111256,disease,I-NAME_OF_DISEASE,5854
111257,DED,I-NAME_OF_DISEASE,5854
111258,is,O,5854
111259,a,O,5854
111260,condition,O,5854
111261,characterized,O,5855
111262,by,O,5855
111263,an,O,5855
111264,array,O,5855
111265,of,O,5855
111266,symptoms,O,5855
111267,including,O,5855
111268,dryness,B-SIGN_AND_SYMPTOM,5855
111269,ocular,I-SIGN_AND_SYMPTOM,5855
111270,discomfort,I-SIGN_AND_SYMPTOM,5855
111271,fatigue,I-SIGN_AND_SYMPTOM,5855
111272,and,I-SIGN_AND_SYMPTOM,5855
111273,visual,I-SIGN_AND_SYMPTOM,5855
111274,disturbances,I-SIGN_AND_SYMPTOM,5855
111275,This,O,5855
111276,condition,O,5855
111277,has,O,5855
111278,become,O,5855
111279,more,O,5855
111280,prevalent,O,5855
111281,in,O,5855
111282,recent,O,5855
111283,years,O,5855
111284,as,O,5855
111285,a,O,5855
111286,result,O,5856
111287,of,O,5856
111288,an,B-CAUSE_OF_DISEASE,5856
111289,aging,I-CAUSE_OF_DISEASE,5856
111290,society,I-CAUSE_OF_DISEASE,5856
111291,higher,B-CAUSE_OF_DISEASE,5856
111292,screen,I-CAUSE_OF_DISEASE,5856
111293,time,I-CAUSE_OF_DISEASE,5856
111294,and,O,5857
111295,a,B-CAUSE_OF_DISEASE,5857
111296,highly,I-CAUSE_OF_DISEASE,5857
111297,stressful,I-CAUSE_OF_DISEASE,5857
111298,social,I-CAUSE_OF_DISEASE,5857
111299,environment,I-CAUSE_OF_DISEASE,5857
111300,There,O,5857
111301,are,O,5857
111302,over,O,5857
111303,1,O,5857
111304,billion,O,5857
111305,DED,B-NAME_OF_DISEASE,5857
111306,patients,O,5857
111307,globally,O,5857
111308,DED,B-NAME_OF_DISEASE,5857
111309,that,O,5857
111310,is,O,5857
111311,left,O,5857
111312,undiagnosed,O,5857
111313,and,O,5857
111314,untreated,O,5857
111315,can,O,5857
111316,cause,O,5857
111317,a,O,5857
111318,number,O,5857
111319,of,O,5857
111320,symptoms,O,5857
111321,such,O,5858
111322,as,O,5858
111323,ocular,B-SIGN_AND_SYMPTOM,5858
111324,fatigue,I-SIGN_AND_SYMPTOM,5858
111325,light,I-SIGN_AND_SYMPTOM,5858
111326,sensitivity,I-SIGN_AND_SYMPTOM,5858
111327,poor,I-SIGN_AND_SYMPTOM,5858
111328,vision,I-SIGN_AND_SYMPTOM,5858
111329,and,I-SIGN_AND_SYMPTOM,5858
111330,a,I-SIGN_AND_SYMPTOM,5858
111331,decreased,I-SIGN_AND_SYMPTOM,5858
111332,quality,I-SIGN_AND_SYMPTOM,5858
111333,of,I-SIGN_AND_SYMPTOM,5858
111334,life,I-SIGN_AND_SYMPTOM,5858
111335,Given,O,5858
111336,the,O,5858
111337,condition,O,5858
111338,s,O,5858
111339,extensive,O,5859
111340,prevalence,O,5859
111341,this,O,5859
111342,may,O,5859
111343,also,O,5859
111344,result,O,5859
111345,in,O,5859
111346,decreased,O,5859
111347,productivity,O,5860
111348,at,O,5860
111349,work,O,5860
111350,and,O,5860
111351,financial,O,5860
111352,loss,O,5860
111353,March,O,5860
111354,is,O,5860
111355,Workplace,O,5860
111356,Eye,O,5860
111357,Wellness,O,5860
111358,at,O,5860
111359,Prevent,B-ORGANIZATION,5860
111360,Blindness,I-ORGANIZATION,5860
111361,This,O,5860
111362,month,O,5860
111363,the,O,5860
111364,group,O,5860
111365,will,O,5860
111366,provide,O,5860
111367,free,O,5860
111368,resources,O,5860
111369,including,O,5860
111370,an,O,5860
111371,overview,O,5860
111372,of,O,5860
111373,proper,O,5860
111374,eye,O,5860
111375,protection,O,5860
111376,and,O,5860
111377,safety,O,5860
111378,glasses,O,5861
111379,for,O,5861
111380,various,O,5861
111381,industries,O,5861
111382,and,O,5861
111383,information,O,5861
111384,on,O,5861
111385,the,O,5861
111386,effects,O,5862
111387,of,O,5862
111388,extended,O,5862
111389,digital,O,5862
111390,screen,O,5862
111391,use,O,5862
111392,According,O,5862
111393,to,O,5862
111394,a,O,5862
111395,recent,O,5862
111396,report,O,5862
111397,from,O,5862
111398,the,O,5862
111399,U.S,O,5862
111400,Bureau,O,5862
111401,of,O,5862
111402,Labor,O,5862
111403,Statistics,O,5863
111404,there,O,5863
111405,were,O,5863
111406,15,O,5863
111407,730,O,5863
111408,eye,O,5863
111409,injuries,O,5863
111410,involving,O,5863
111411,days,O,5863
111412,away,O,5863
111413,from,O,5864
111414,work,O,5864
111415,in,O,5864
111416,2020,O,5864
111417,Proper,O,5864
111418,eye,O,5864
111419,protection,O,5864
111420,minimizes,O,5864
111421,the,O,5864
111422,risk,O,5864
111423,of,O,5864
111424,significant,O,5864
111425,eye,O,5864
111426,injury,O,5864
111427,Prevent,B-ORGANIZATION,5864
111428,Blindness,I-ORGANIZATION,5864
111429,recommends,O,5864
111430,that,O,5864
111431,the,O,5864
111432,type,O,5864
111433,of,O,5865
111434,eye,O,5865
111435,protection,O,5865
111436,that,O,5865
111437,should,O,5865
111438,be,O,5865
111439,used,O,5865
111440,depends,O,5865
111441,on,O,5865
111442,the,O,5865
111443,hazards,O,5865
111444,in,O,5865
111445,the,O,5865
111446,workplace,O,5865
111447,For,O,5865
111448,instance,O,5865
111449,someone,O,5865
111450,working,O,5865
111451,in,O,5865
111452,an,O,5865
111453,area,O,5865
111454,that,O,5865
111455,has,O,5865
111456,particles,O,5865
111457,flying,O,5866
111458,objects,O,5866
111459,or,O,5866
111460,dust,O,5866
111461,should,O,5866
111462,wear,B-PREVENTION,5866
111463,safety,I-PREVENTION,5866
111464,glasses,I-PREVENTION,5866
111465,with,I-PREVENTION,5866
111466,side,I-PREVENTION,5866
111467,protection,I-PREVENTION,5866
111468,side,I-PREVENTION,5866
111469,shields,I-PREVENTION,5866
111470,,O,5866
111471,If,O,5866
111472,working,O,5866
111473,near,O,5866
111474,hazardous,O,5866
111475,radiation,O,5866
111476,welding,O,5866
111477,lasers,O,5866
111478,or,O,5866
111479,fiber,O,5866
111480,optics,O,5866
111481,special-purpose,B-PREVENTION,5866
111482,safety,I-PREVENTION,5867
111483,glasses,I-PREVENTION,5867
111484,goggles,I-PREVENTION,5867
111485,face,I-PREVENTION,5867
111486,shields,I-PREVENTION,5867
111487,or,I-PREVENTION,5867
111488,helmets,I-PREVENTION,5867
111489,designed,O,5867
111490,for,O,5867
111491,that,O,5867
111492,task,O,5867
111493,should,O,5867
111494,be,O,5867
111495,worn,O,5867
111496,The,B-ORGANIZATION,5867
111497,Occupational,I-ORGANIZATION,5867
111498,Safety,I-ORGANIZATION,5867
111499,and,I-ORGANIZATION,5867
111500,Health,I-ORGANIZATION,5867
111501,Administration,I-ORGANIZATION,5867
111502,OSHA,B-ORGANIZATION,5868
111503,requires,O,5868
111504,employers,O,5868
111505,to,O,5868
111506,ensure,O,5868
111507,the,O,5868
111508,safety,O,5868
111509,of,O,5868
111510,all,O,5868
111511,employees,O,5868
111512,in,O,5868
111513,the,O,5868
111514,work,O,5868
111515,environment,O,5868
111516,Eye,B-PREVENTION,5868
111517,and,I-PREVENTION,5868
111518,face,I-PREVENTION,5868
111519,protection,I-PREVENTION,5868
111520,must,O,5868
111521,be,O,5868
111522,provided,O,5869
111523,whenever,O,5869
111524,necessary,O,5869
111525,to,O,5869
111526,protect,O,5869
111527,against,O,5869
111528,chemical,B-CAUSE_OF_DISEASE,5869
111529,environmental,I-CAUSE_OF_DISEASE,5869
111530,radiological,I-CAUSE_OF_DISEASE,5869
111531,or,I-CAUSE_OF_DISEASE,5869
111532,mechanical,I-CAUSE_OF_DISEASE,5869
111533,irritants,I-CAUSE_OF_DISEASE,5869
111534,and,I-CAUSE_OF_DISEASE,5869
111535,hazards,I-CAUSE_OF_DISEASE,5869
111536,Employers,O,5869
111537,must,O,5869
111538,also,O,5869
111539,give,O,5869
111540,personal,B-PREVENTION,5869
111541,protection,I-PREVENTION,5869
111542,equipment,I-PREVENTION,5870
111543,PPE,B-PREVENTION,5870
111544,to,O,5870
111545,their,O,5870
111546,employees,O,5870
111547,and,O,5870
111548,ensure,O,5870
111549,that,O,5870
111550,it,O,5870
111551,is,O,5870
111552,used,O,5870
111553,properly,O,5870
111554,OSHA,B-ORGANIZATION,5870
111555,added,O,5871
111556,Additionally,O,5871
111557,employers,O,5871
111558,are,O,5871
111559,also,O,5871
111560,required,O,5871
111561,to,O,5871
111562,train,O,5871
111563,each,O,5871
111564,worker,O,5871
111565,required,O,5871
111566,to,O,5871
111567,use,O,5871
111568,PPE,B-PREVENTION,5871
111569,According,O,5871
111570,to,O,5871
111571,the,B-ORGANIZATION,5871
111572,American,I-ORGANIZATION,5871
111573,Optometric,I-ORGANIZATION,5871
111574,Association,I-ORGANIZATION,5871
111575,the,O,5871
111576,average,O,5871
111577,American,O,5871
111578,worker,O,5871
111579,spends,O,5871
111580,seven,O,5871
111581,hours,O,5872
111582,per,O,5872
111583,day,O,5872
111584,on,O,5872
111585,the,O,5872
111586,computer,O,5872
111587,whether,O,5872
111588,in,O,5872
111589,the,O,5872
111590,workplace,O,5872
111591,or,O,5872
111592,working,O,5872
111593,from,O,5872
111594,home,O,5872
111595,Digital,B-NAME_OF_DISEASE,5872
111596,eye,B-NAME_OF_DISEASE,5872
111597,strain,I-NAME_OF_DISEASE,5872
111598,is,O,5872
111599,more,O,5872
111600,common,O,5872
111601,among,O,5872
111602,employees,O,5872
111603,who,O,5873
111604,operate,O,5873
111605,primarily,O,5873
111606,on,O,5873
111607,digital,B-CAUSE_OF_DISEASE,5873
111608,devices,I-CAUSE_OF_DISEASE,5873
111609,such,I-CAUSE_OF_DISEASE,5873
111610,as,I-CAUSE_OF_DISEASE,5873
111611,computer,I-CAUSE_OF_DISEASE,5873
111612,monitors,I-CAUSE_OF_DISEASE,5873
111613,tablets,I-CAUSE_OF_DISEASE,5873
111614,and,I-CAUSE_OF_DISEASE,5873
111615,smart,I-CAUSE_OF_DISEASE,5873
111616,phones,I-CAUSE_OF_DISEASE,5873
111617,Sore,B-SIGN_AND_SYMPTOM,5874
111618,or,I-SIGN_AND_SYMPTOM,5874
111619,irritated,I-SIGN_AND_SYMPTOM,5874
111620,eyes,I-SIGN_AND_SYMPTOM,5874
111621,blurred,I-SIGN_AND_SYMPTOM,5874
111622,vision,I-SIGN_AND_SYMPTOM,5874
111623,and,I-SIGN_AND_SYMPTOM,5874
111624,headaches,I-SIGN_AND_SYMPTOM,5874
111625,are,O,5874
111626,all,O,5874
111627,signs,O,5874
111628,of,O,5874
111629,eye,B-NAME_OF_DISEASE,5874
111630,strain,I-NAME_OF_DISEASE,5874
111631,Prevent,B-ORGANIZATION,5874
111632,Blindness,I-ORGANIZATION,5874
111633,recommends,O,5874
111634,the,O,5874
111635,following,O,5874
111636,Screen,O,5874
111637,time,O,5874
111638,Try,O,5874
111639,to,O,5874
111640,decrease,B-PREVENTION,5874
111641,the,I-PREVENTION,5874
111642,amount,I-PREVENTION,5874
111643,of,I-PREVENTION,5874
111644,time,I-PREVENTION,5874
111645,spent,I-PREVENTION,5874
111646,in,I-PREVENTION,5874
111647,front,I-PREVENTION,5874
111648,of,I-PREVENTION,5875
111649,these,I-PREVENTION,5875
111650,screens,I-PREVENTION,5875
111651,and,I-PREVENTION,5875
111652,or,I-PREVENTION,5875
111653,take,I-PREVENTION,5875
111654,frequent,I-PREVENTION,5875
111655,breaks,I-PREVENTION,5875
111656,to,O,5875
111657,give,O,5875
111658,your,O,5875
111659,eyes,O,5875
111660,a,O,5876
111661,rest,O,5876
111662,Filters,O,5876
111663,Screen,B-PREVENTION,5876
111664,filters,I-PREVENTION,5876
111665,are,I-PREVENTION,5876
111666,available,I-PREVENTION,5876
111667,for,I-PREVENTION,5876
111668,smart,I-PREVENTION,5876
111669,phones,I-PREVENTION,5876
111670,tablets,I-PREVENTION,5876
111671,and,I-PREVENTION,5876
111672,computer,I-PREVENTION,5876
111673,screens,I-PREVENTION,5876
111674,They,O,5876
111675,decrease,O,5876
111676,the,O,5876
111677,amount,O,5876
111678,of,O,5876
111679,blue,B-CAUSE_OF_DISEASE,5876
111680,light,I-CAUSE_OF_DISEASE,5877
111681,given,O,5877
111682,off,O,5877
111683,from,O,5877
111684,these,O,5877
111685,devices,O,5877
111686,that,O,5877
111687,could,O,5877
111688,reach,O,5877
111689,the,B-PART_OF_THE_EYES,5877
111690,retina,B-PART_OF_THE_EYES,5877
111691,in,I-PART_OF_THE_EYES,5877
111692,the,I-PART_OF_THE_EYES,5877
111693,eyes,I-PART_OF_THE_EYES,5877
111694,Anti-reflective,B-PREVENTION,5877
111695,lenses,I-PREVENTION,5877
111696,Anti-reflective,B-PREVENTION,5877
111697,lenses,I-PREVENTION,5877
111698,reduce,O,5877
111699,glare,O,5877
111700,and,O,5878
111701,increase,O,5878
111702,contrast,O,5878
111703,and,O,5878
111704,also,O,5878
111705,block,O,5878
111706,blue,B-CAUSE_OF_DISEASE,5878
111707,light,I-CAUSE_OF_DISEASE,5878
111708,from,I-CAUSE_OF_DISEASE,5878
111709,the,I-CAUSE_OF_DISEASE,5878
111710,sun,I-CAUSE_OF_DISEASE,5878
111711,and,I-CAUSE_OF_DISEASE,5878
111712,digital,I-CAUSE_OF_DISEASE,5878
111713,devices,I-CAUSE_OF_DISEASE,5878
111714,Intraocular,B-PREVENTION,5878
111715,lens,I-PREVENTION,5878
111716,IOL,B-PREVENTION,5878
111717,After,O,5878
111718,cataract,B-NAME_OF_DISEASE,5879
111719,surgery,O,5879
111720,the,O,5879
111721,cloudy,O,5879
111722,lens,O,5879
111723,will,O,5879
111724,be,O,5879
111725,replaced,O,5879
111726,with,O,5879
111727,an,B-PREVENTION,5879
111728,intraocular,I-PREVENTION,5879
111729,lens,I-PREVENTION,5879
111730,IOL,B-PREVENTION,5879
111731,,O,5879
111732,The,O,5879
111733,lens,O,5880
111734,naturally,O,5880
111735,protects,O,5880
111736,the,O,5880
111737,eye,O,5880
111738,from,O,5880
111739,almost,O,5880
111740,all,O,5880
111741,ultraviolet,B-CAUSE_OF_DISEASE,5880
111742,light,I-CAUSE_OF_DISEASE,5880
111743,and,I-CAUSE_OF_DISEASE,5880
111744,some,I-CAUSE_OF_DISEASE,5880
111745,blue,I-CAUSE_OF_DISEASE,5880
111746,light,I-CAUSE_OF_DISEASE,5880
111747,There,O,5880
111748,are,O,5881
111749,types,O,5881
111750,of,O,5881
111751,IOL,B-PREVENTION,5881
111752,that,O,5881
111753,can,O,5881
111754,protect,O,5881
111755,the,O,5881
111756,eye,O,5881
111757,and,O,5881
111758,retina,B-PART_OF_THE_EYES,5881
111759,from,O,5881
111760,blue,B-CAUSE_OF_DISEASE,5881
111761,light,I-CAUSE_OF_DISEASE,5881
111762,Practicing,B-PREVENTION,5881
111763,eye,I-PREVENTION,5881
111764,healthy,I-PREVENTION,5881
111765,habits,I-PREVENTION,5881
111766,in,I-PREVENTION,5881
111767,the,I-PREVENTION,5881
111768,workplace,I-PREVENTION,5881
111769,today,O,5881
111770,like,O,5881
111771,wearing,B-PREVENTION,5881
111772,proper,I-PREVENTION,5881
111773,eye,I-PREVENTION,5881
111774,protection,I-PREVENTION,5881
111775,and,O,5881
111776,decreasing,B-PREVENTION,5881
111777,the,I-PREVENTION,5881
111778,amount,I-PREVENTION,5881
111779,of,I-PREVENTION,5881
111780,screen,I-PREVENTION,5881
111781,time,I-PREVENTION,5881
111782,whenever,I-PREVENTION,5881
111783,possible,I-PREVENTION,5881
111784,can,O,5881
111785,help,O,5881
111786,save,O,5881
111787,our,O,5881
111788,sight,O,5881
111789,now,O,5881
111790,and,O,5882
111791,for,O,5882
111792,years,O,5882
111793,to,O,5882
111794,come,O,5882
111795,said,O,5882
111796,Jeff,B-PERSON,5882
111797,Todd,I-PERSON,5882
111798,president,O,5882
111799,and,O,5882
111800,CEO,O,5882
111801,of,O,5882
111802,Prevent,B-ORGANIZATION,5882
111803,Blindness,I-ORGANIZATION,5882
111804,A,O,5882
111805,team,O,5882
111806,led,O,5882
111807,by,O,5882
111808,researchers,O,5882
111809,from,O,5882
111810,the,B-ORGANIZATION,5882
111811,University,I-ORGANIZATION,5882
111812,of,I-ORGANIZATION,5882
111813,Waterloo,B-ORGANIZATION,5882
111814,discovered,O,5882
111815,that,O,5882
111816,participating,B-TREATMENT,5882
111817,in,I-TREATMENT,5882
111818,aerobic,I-TREATMENT,5882
111819,exercise,I-TREATMENT,5882
111820,can,O,5882
111821,provide,O,5882
111822,relief,O,5882
111823,for,O,5882
111824,dry,B-SIGN_AND_SYMPTOM,5882
111825,itchy,I-SIGN_AND_SYMPTOM,5882
111826,eyes,I-SIGN_AND_SYMPTOM,5883
111827,as,O,5883
111828,it,O,5883
111829,causes,O,5883
111830,a,O,5883
111831,significant,O,5883
111832,increase,O,5883
111833,in,O,5883
111834,tear,O,5883
111835,secretion,O,5883
111836,and,O,5883
111837,tear,B-PART_OF_THE_EYES,5883
111838,film,I-PART_OF_THE_EYES,5883
111839,stability,O,5883
111840,Every,O,5883
111841,time,O,5883
111842,we,O,5883
111843,blink,O,5883
111844,our,O,5883
111845,eyes,O,5883
111846,are,O,5883
111847,covered,O,5883
111848,in,O,5884
111849,tear,B-PART_OF_THE_EYES,5884
111850,film,I-PART_OF_THE_EYES,5884
111851,which,O,5884
111852,is,O,5884
111853,an,O,5884
111854,essential,O,5884
111855,protective,O,5884
111856,layer,O,5884
111857,for,O,5884
111858,preserving,O,5884
111859,proper,O,5884
111860,ocular,O,5884
111861,function,O,5884
111862,The,O,5884
111863,three,O,5884
111864,layers,O,5884
111865,of,O,5884
111866,a,O,5884
111867,healthy,O,5884
111868,tear,B-PART_OF_THE_EYES,5884
111869,film,I-PART_OF_THE_EYES,5884
111870,-,O,5884
111871,oil,O,5884
111872,water,O,5884
111873,and,O,5884
111874,mucin,O,5884
111875,-,O,5884
111876,work,O,5884
111877,together,O,5884
111878,to,O,5884
111879,moisten,O,5885
111880,the,O,5885
111881,ocular,O,5885
111882,surface,O,5885
111883,and,O,5885
111884,protect,O,5885
111885,it,O,5885
111886,from,O,5885
111887,infection-causing,B-CAUSE_OF_DISEASE,5885
111888,irritants,I-CAUSE_OF_DISEASE,5885
111889,like,I-CAUSE_OF_DISEASE,5885
111890,dust,I-CAUSE_OF_DISEASE,5885
111891,and,I-CAUSE_OF_DISEASE,5885
111892,dirt,I-CAUSE_OF_DISEASE,5885
111893,The,O,5885
111894,ocular,O,5885
111895,surface,O,5885
111896,can,O,5885
111897,develop,O,5885
111898,dry,B-SIGN_AND_SYMPTOM,5885
111899,spots,I-SIGN_AND_SYMPTOM,5885
111900,when,O,5885
111901,any,O,5885
111902,component,O,5885
111903,of,O,5885
111904,the,B-PART_OF_THE_EYES,5885
111905,tear,I-PART_OF_THE_EYES,5886
111906,film,I-PART_OF_THE_EYES,5886
111907,becomes,O,5886
111908,unstable,O,5886
111909,causing,O,5886
111910,eye,O,5886
111911,symptoms,O,5886
111912,such,O,5886
111913,as,O,5886
111914,itching,B-SIGN_AND_SYMPTOM,5886
111915,stinging,I-SIGN_AND_SYMPTOM,5886
111916,and,I-SIGN_AND_SYMPTOM,5886
111917,burning,I-SIGN_AND_SYMPTOM,5886
111918,sensations,I-SIGN_AND_SYMPTOM,5886
111919,With,O,5886
111920,so,O,5886
111921,much,O,5886
111922,of,O,5887
111923,our,O,5887
111924,activity,O,5887
111925,tied,O,5887
111926,to,O,5887
111927,screen,B-CAUSE_OF_DISEASE,5887
111928,usage,I-CAUSE_OF_DISEASE,5887
111929,dry,B-NAME_OF_DISEASE,5887
111930,eye,I-NAME_OF_DISEASE,5887
111931,symptoms,I-NAME_OF_DISEASE,5887
111932,are,O,5887
111933,becoming,O,5887
111934,increasingly,O,5887
111935,common,O,5887
111936,Instead,O,5887
111937,of,O,5887
111938,having,O,5887
111939,to,O,5887
111940,use,O,5887
111941,eye,B-TREATMENT,5887
111942,drops,I-TREATMENT,5887
111943,or,O,5887
111944,other,O,5887
111945,alternative,O,5887
111946,treatments,O,5887
111947,our,O,5887
111948,study,O,5887
111949,aimed,O,5887
111950,to,O,5887
111951,determine,O,5887
111952,if,O,5887
111953,remaining,O,5887
111954,physically,O,5887
111955,active,O,5888
111956,can,O,5888
111957,be,O,5888
111958,an,O,5888
111959,effective,O,5888
111960,preventative,O,5888
111961,measure,O,5889
111962,against,O,5889
111963,dryness,B-SIGN_AND_SYMPTOM,5889
111964,said,O,5889
111965,Heinz,O,5889
111966,Otchere,B-PERSON,5889
111967,a,O,5889
111968,Ph.D,O,5889
111969,candidate,O,5889
111970,in,O,5889
111971,vision,O,5889
111972,science,O,5889
111973,at,O,5889
111974,Waterloo,B-ORGANIZATION,5889
111975,In,O,5889
111976,the,O,5889
111977,study,O,5889
111978,a,O,5889
111979,total,O,5889
111980,of,O,5889
111981,52,O,5889
111982,people,O,5889
111983,were,O,5890
111984,divided,O,5890
111985,into,O,5890
111986,two,O,5890
111987,groups,O,5890
111988,to,O,5890
111989,engage,O,5890
111990,in,O,5890
111991,a,O,5890
111992,workout,O,5890
111993,session,O,5890
111994,athletes,O,5890
111995,and,O,5890
111996,non-athletes,O,5890
111997,The,O,5890
111998,athlete,O,5890
111999,group,O,5890
112000,exercised,O,5890
112001,at,O,5890
112002,least,O,5890
112003,five,O,5890
112004,times,O,5891
112005,per,O,5891
112006,week,O,5891
112007,while,O,5891
112008,the,O,5891
112009,non-athlete,O,5891
112010,group,O,5891
112011,exercised,O,5891
112012,no,O,5891
112013,more,O,5891
112014,than,O,5891
112015,once,O,5891
112016,per,O,5891
112017,week,O,5891
112018,Tear,O,5891
112019,secretion,O,5891
112020,and,O,5891
112021,tear,O,5891
112022,break-up,O,5891
112023,time,O,5891
112024,were,O,5891
112025,measured,O,5891
112026,before,O,5891
112027,and,O,5891
112028,five,O,5891
112029,minutes,O,5891
112030,after,O,5891
112031,each,O,5891
112032,exercise,O,5891
112033,session,O,5891
112034,by,O,5892
112035,the,O,5892
112036,researchers,O,5892
112037,which,O,5892
112038,included,O,5892
112039,experts,O,5892
112040,from,O,5892
112041,the,B-ORGANIZATION,5892
112042,University,I-ORGANIZATION,5892
112043,of,I-ORGANIZATION,5892
112044,Cape,I-ORGANIZATION,5892
112045,Coast,I-ORGANIZATION,5892
112046,in,O,5892
112047,Ghana,B-GPE,5892
112048,While,O,5892
112049,the,O,5892
112050,athletic,O,5892
112051,group,O,5892
112052,exhibited,O,5892
112053,the,O,5892
112054,greatest,O,5892
112055,improvement,O,5892
112056,Otchere,B-PERSON,5892
112057,claims,O,5892
112058,that,O,5892
112059,all,O,5892
112060,subjects,O,5892
112061,experienced,O,5892
112062,a,O,5893
112063,significant,O,5893
112064,increase,O,5893
112065,in,O,5893
112066,tear,O,5893
112067,quantity,O,5893
112068,and,O,5893
112069,tear,B-PART_OF_THE_EYES,5893
112070,film,I-PART_OF_THE_EYES,5893
112071,stability,O,5893
112072,after,O,5893
112073,the,O,5893
112074,exercise,O,5893
112075,session,O,5893
112076,It,O,5893
112077,can,O,5893
112078,be,O,5893
112079,challenging,O,5893
112080,for,O,5893
112081,people,O,5893
112082,to,O,5893
112083,regularly,O,5893
112084,exercise,O,5893
112085,when,O,5893
112086,the,O,5893
112087,demand,O,5894
112088,is,O,5894
112089,there,O,5894
112090,to,O,5894
112091,work,O,5894
112092,increasingly,O,5894
112093,longer,O,5894
112094,hours,O,5894
112095,in,O,5894
112096,front,O,5894
112097,of,O,5894
112098,screens,O,5894
112099,Otchere,B-PERSON,5894
112100,said,O,5894
112101,However,O,5894
112102,our,O,5894
112103,findings,O,5894
112104,show,O,5894
112105,physical,O,5894
112106,activity,O,5894
112107,can,O,5894
112108,be,O,5894
112109,really,O,5895
112110,important,O,5895
112111,for,O,5895
112112,not,O,5895
112113,just,O,5895
112114,our,O,5895
112115,overall,O,5895
112116,well-being,O,5895
112117,but,O,5895
112118,for,O,5895
112119,our,O,5895
112120,ocular,O,5895
112121,health,O,5895
112122,too,O,5895
112123,The,B-NAME_OF_STUDY,5895
112124,study,I-NAME_OF_STUDY,5895
112125,Differential,I-NAME_OF_STUDY,5895
112126,effect,I-NAME_OF_STUDY,5895
112127,of,I-NAME_OF_STUDY,5895
112128,maximal,I-NAME_OF_STUDY,5895
112129,incremental,I-NAME_OF_STUDY,5895
112130,treadmill,I-NAME_OF_STUDY,5895
112131,exercise,I-NAME_OF_STUDY,5895
112132,on,I-NAME_OF_STUDY,5895
112133,tear,I-NAME_OF_STUDY,5895
112134,secretion,I-NAME_OF_STUDY,5895
112135,and,I-NAME_OF_STUDY,5895
112136,tear,I-NAME_OF_STUDY,5895
112137,film,I-NAME_OF_STUDY,5895
112138,stability,I-NAME_OF_STUDY,5895
112139,in,I-NAME_OF_STUDY,5895
112140,athletes,I-NAME_OF_STUDY,5895
112141,and,I-NAME_OF_STUDY,5895
112142,non-athletes,I-NAME_OF_STUDY,5895
112143,was,O,5895
112144,co-authored,O,5895
112145,by,O,5895
112146,Otchere,B-PERSON,5895
112147,the,B-ORGANIZATION,5895
112148,University,I-ORGANIZATION,5895
112149,of,I-ORGANIZATION,5895
112150,Cape,I-ORGANIZATION,5895
112151,Coast,I-ORGANIZATION,5895
112152,s,O,5895
112153,Samuel,B-PERSON,5895
112154,Abokyi,I-PERSON,5895
112155,Sekyere,B-PERSON,5895
112156,Nyamaah,I-PERSON,5895
112157,and,O,5895
112158,Michael,B-PERSON,5896
112159,Ntodie,I-PERSON,5896
112160,and,O,5896
112161,Ghana,B-GPE,5896
112162,s,O,5896
112163,Our,B-ORGANIZATION,5896
112164,Lady,I-ORGANIZATION,5896
112165,of,I-ORGANIZATION,5896
112166,Grace,I-ORGANIZATION,5896
112167,Hospital,I-ORGANIZATION,5896
112168,s,O,5896
112169,Yaw,B-PERSON,5897
112170,Osei,I-PERSON,5897
112171,Akoto,I-PERSON,5897
112172,The,O,5897
112173,study,O,5897
112174,was,O,5897
112175,recently,O,5897
112176,published,O,5897
112177,in,O,5897
112178,the,B-PUBLICATION_VENUE,5897
112179,Experimental,I-PUBLICATION_VENUE,5897
112180,Eye,I-PUBLICATION_VENUE,5897
112181,Research,I-PUBLICATION_VENUE,5897
112182,journal,I-PUBLICATION_VENUE,5897
112183,Luminopia,B-ORGANIZATION,5897
112184,has,O,5897
112185,received,O,5897
112186,de,O,5897
112187,novo,O,5897
112188,premarket,O,5897
112189,approval,O,5897
112190,by,O,5897
112191,the,B-ORGANIZATION,5897
112192,FDA,B-ORGANIZATION,5897
112193,for,O,5897
112194,Luminopia,B-TREATMENT,5897
112195,One,I-TREATMENT,5897
112196,as,O,5897
112197,a,O,5897
112198,prescription,O,5897
112199,therapy,O,5897
112200,to,O,5897
112201,improve,O,5897
112202,vision,O,5897
112203,in,O,5897
112204,children,O,5898
112205,with,O,5898
112206,amblyopia,B-NAME_OF_DISEASE,5898
112207,lazy,I-NAME_OF_DISEASE,5898
112208,eye,I-NAME_OF_DISEASE,5898
112209,the,O,5898
112210,most,O,5898
112211,common,O,5898
112212,cause,O,5898
112213,of,O,5898
112214,vision,B-SIGN_AND_SYMPTOM,5898
112215,loss,I-SIGN_AND_SYMPTOM,5898
112216,in,O,5898
112217,children,O,5898
112218,Luminopia,B-TREATMENT,5898
112219,One,I-TREATMENT,5898
112220,is,O,5898
112221,intended,O,5898
112222,for,O,5898
112223,the,O,5898
112224,improvement,O,5898
112225,of,O,5898
112226,visual,O,5898
112227,acuity,O,5898
112228,in,O,5898
112229,children,O,5898
112230,aged,O,5898
112231,4,O,5898
112232,to,O,5898
112233,7,O,5898
112234,who,O,5898
112235,have,O,5898
112236,amblyopia,B-NAME_OF_DISEASE,5898
112237,anisometropia,B-NAME_OF_DISEASE,5898
112238,and,O,5898
112239,or,O,5898
112240,mild,O,5899
112241,strabismus,B-NAME_OF_DISEASE,5899
112242,and,O,5899
112243,who,O,5899
112244,have,O,5899
112245,followed,O,5899
112246,treatment,O,5899
112247,recommendations,O,5899
112248,given,O,5899
112249,by,O,5899
112250,a,O,5899
112251,competent,O,5899
112252,eye-care,O,5899
112253,professional,O,5899
112254,Luminopia,B-TREATMENT,5899
112255,One,I-TREATMENT,5899
112256,is,O,5899
112257,a,O,5899
112258,virtual,O,5899
112259,reality,O,5899
112260,VR,O,5899
112261,headset,O,5899
112262,that,O,5899
112263,allows,O,5900
112264,patients,O,5900
112265,to,O,5900
112266,watch,O,5900
112267,therapeutically,O,5900
112268,modified,O,5900
112269,TV,O,5900
112270,shows,O,5900
112271,and,O,5900
112272,movies,O,5900
112273,to,O,5900
112274,improve,O,5900
112275,their,O,5900
112276,vision,O,5900
112277,This,O,5900
112278,is,O,5900
112279,the,O,5900
112280,first,O,5900
112281,FDA-approved,O,5900
112282,digital,O,5900
112283,therapy,O,5901
112284,for,O,5901
112285,amblyopia,B-NAME_OF_DISEASE,5901
112286,in,O,5901
112287,children,O,5901
112288,and,O,5901
112289,more,O,5901
112290,broadly,O,5901
112291,the,O,5901
112292,first,O,5901
112293,for,O,5901
112294,a,B-NAME_OF_DISEASE,5901
112295,neuro-visual,I-NAME_OF_DISEASE,5901
112296,disorder,I-NAME_OF_DISEASE,5901
112297,Amblyopia,B-NAME_OF_DISEASE,5901
112298,develops,O,5901
112299,when,O,5901
112300,the,O,5901
112301,brain,O,5901
112302,and,O,5901
112303,the,O,5901
112304,eyes,O,5901
112305,cease,O,5901
112306,working,O,5901
112307,together,O,5901
112308,effectively,O,5901
112309,causing,O,5901
112310,the,O,5901
112311,brain,O,5901
112312,to,O,5901
112313,rely,O,5901
112314,more,O,5901
112315,heavily,O,5901
112316,on,O,5902
112317,one,O,5902
112318,eye,O,5902
112319,over,O,5902
112320,the,O,5902
112321,other,O,5902
112322,resulting,O,5902
112323,in,O,5902
112324,impaired,B-SIGN_AND_SYMPTOM,5902
112325,vision,I-SIGN_AND_SYMPTOM,5902
112326,in,O,5902
112327,the,O,5902
112328,weaker,O,5902
112329,eye,O,5902
112330,Amblyopia,B-NAME_OF_DISEASE,5902
112331,is,O,5902
112332,commonly,O,5902
112333,treated,O,5902
112334,with,O,5902
112335,spectacles,B-TREATMENT,5902
112336,and,I-TREATMENT,5902
112337,eye-patching,I-TREATMENT,5902
112338,or,I-TREATMENT,5902
112339,blurring,I-TREATMENT,5902
112340,atropine,I-TREATMENT,5902
112341,eye,I-TREATMENT,5902
112342,drops,I-TREATMENT,5902
112343,which,O,5902
112344,prohibit,O,5902
112345,the,O,5902
112346,stronger,O,5902
112347,eye,O,5902
112348,from,O,5902
112349,being,O,5902
112350,used,O,5902
112351,and,O,5902
112352,force,O,5902
112353,the,O,5902
112354,weaker,O,5902
112355,eye,O,5902
112356,to,O,5903
112357,be,O,5903
112358,used,O,5903
112359,but,O,5903
112360,these,O,5903
112361,methods,O,5903
112362,do,O,5903
112363,not,O,5903
112364,train,O,5903
112365,the,O,5903
112366,eyes,O,5903
112367,to,O,5903
112368,work,O,5903
112369,together,O,5903
112370,These,O,5903
112371,existing,O,5903
112372,therapeutic,O,5904
112373,approaches,O,5904
112374,also,O,5904
112375,face,O,5904
112376,considerable,O,5904
112377,obstacles,O,5904
112378,due,O,5904
112379,to,O,5904
112380,poor,O,5904
112381,patient,O,5904
112382,compliance,O,5904
112383,and,O,5904
112384,social,O,5904
112385,stigmas,O,5904
112386,Luminopia,B-ORGANIZATION,5904
112387,collaborated,O,5904
112388,with,O,5904
112389,top,O,5904
112390,doctors,O,5904
112391,and,O,5904
112392,researchers,O,5904
112393,at,O,5904
112394,Boston,B-ORGANIZATION,5904
112395,Children,I-ORGANIZATION,5904
112396,s,I-ORGANIZATION,5904
112397,Hospital,I-ORGANIZATION,5904
112398,and,O,5904
112399,MIT,B-ORGANIZATION,5904
112400,s,I-ORGANIZATION,5904
112401,Picower,I-ORGANIZATION,5904
112402,Institute,I-ORGANIZATION,5904
112403,for,I-ORGANIZATION,5904
112404,Learning,I-ORGANIZATION,5904
112405,and,I-ORGANIZATION,5904
112406,Memory,I-ORGANIZATION,5904
112407,as,O,5904
112408,well,O,5904
112409,as,O,5904
112410,media,O,5904
112411,firms,O,5904
112412,such,O,5904
112413,as,O,5905
112414,Sesame,B-ORGANIZATION,5905
112415,Workshop,I-ORGANIZATION,5905
112416,Nelvana,B-ORGANIZATION,5905
112417,and,O,5905
112418,Millimages,B-ORGANIZATION,5905
112419,to,O,5905
112420,develop,O,5905
112421,a,O,5905
112422,novel,O,5905
112423,therapy,O,5905
112424,strategy,O,5905
112425,for,O,5905
112426,patients,O,5905
112427,Patients,O,5905
112428,can,O,5905
112429,watch,O,5905
112430,videos,O,5905
112431,from,O,5905
112432,a,O,5906
112433,selection,O,5906
112434,of,O,5906
112435,700+,O,5906
112436,hours,O,5906
112437,of,O,5906
112438,popular,O,5906
112439,interesting,O,5906
112440,and,O,5906
112441,instructional,O,5906
112442,content,O,5906
112443,with,O,5906
112444,Luminopia,B-TREATMENT,5906
112445,One,I-TREATMENT,5906
112446,Proprietary,B-TREATMENT,5906
112447,algorithms,I-TREATMENT,5906
112448,change,O,5906
112449,the,O,5906
112450,selected,O,5906
112451,videos,O,5906
112452,in,O,5906
112453,real-time,O,5906
112454,within,O,5906
112455,a,O,5906
112456,VR,O,5906
112457,headset,O,5906
112458,to,O,5906
112459,urge,O,5907
112460,patients,O,5907
112461,brains,O,5907
112462,to,O,5907
112463,mix,O,5907
112464,input,O,5907
112465,from,O,5907
112466,both,O,5907
112467,eyes,O,5907
112468,and,O,5907
112469,increase,O,5907
112470,weaker,O,5907
112471,eye,O,5907
112472,utilization,O,5907
112473,The,B-ORGANIZATION,5907
112474,FDA,I-ORGANIZATION,5907
112475,approval,O,5907
112476,of,O,5907
112477,a,O,5907
112478,new,O,5907
112479,digital,O,5907
112480,therapy,O,5908
112481,with,O,5908
112482,robust,O,5908
112483,clinical,O,5908
112484,evidence,O,5908
112485,for,O,5908
112486,children,O,5908
112487,affected,O,5908
112488,by,O,5908
112489,amblyopia,B-NAME_OF_DISEASE,5908
112490,is,O,5908
112491,a,O,5908
112492,major,O,5908
112493,development,O,5908
112494,Amblyopia,B-NAME_OF_DISEASE,5908
112495,is,O,5908
112496,one,O,5908
112497,of,O,5908
112498,the,O,5908
112499,most,O,5908
112500,common,O,5908
112501,conditions,O,5908
112502,I,O,5908
112503,manage,O,5908
112504,as,O,5908
112505,a,O,5909
112506,clinician,O,5909
112507,and,O,5909
112508,patients,O,5909
112509,parents,O,5909
112510,and,O,5909
112511,physicians,O,5909
112512,often,O,5909
112513,struggle,O,5909
112514,with,O,5909
112515,current,O,5909
112516,therapies,O,5909
112517,David,O,5909
112518,G,O,5909
112519,Hunter,O,5909
112520,MD,O,5909
112521,PhD,O,5909
112522,Ophthalmologist-in-Chief,O,5909
112523,Richard,B-PERSON,5909
112524,Robb,I-PERSON,5909
112525,Chair,O,5909
112526,in,O,5909
112527,Ophthalmology,O,5909
112528,Boston,B-ORGANIZATION,5910
112529,Children,I-ORGANIZATION,5910
112530,s,I-ORGANIZATION,5910
112531,Hospital,I-ORGANIZATION,5910
112532,and,O,5910
112533,advisor,O,5910
112534,to,O,5910
112535,Luminopia,B-ORGANIZATION,5910
112536,said,O,5910
112537,in,O,5910
112538,a,O,5910
112539,company,O,5910
112540,news,O,5910
112541,release,O,5910
112542,Luminopia,B-TREATMENT,5910
112543,One,I-TREATMENT,5910
112544,is,O,5910
112545,expected,O,5910
112546,to,O,5910
112547,be,O,5910
112548,available,O,5910
112549,in,O,5910
112550,the,O,5910
112551,second,O,5910
112552,quarter,O,5910
112553,of,O,5910
112554,2022,O,5910
112555,with,O,5910
112556,eye,O,5910
112557,care,O,5910
112558,specialists,O,5910
112559,prescribing,O,5910
112560,it,O,5910
112561,for,O,5910
112562,one,B-TIME_DURATION,5910
112563,hour,I-TIME_DURATION,5910
112564,per,I-TIME_DURATION,5910
112565,day,I-TIME_DURATION,5910
112566,six,I-TIME_DURATION,5911
112567,days,I-TIME_DURATION,5911
112568,per,I-TIME_DURATION,5911
112569,week,I-TIME_DURATION,5911
112570,over,I-TIME_DURATION,5911
112571,a,I-TIME_DURATION,5911
112572,12-week,I-TIME_DURATION,5911
112573,period,I-TIME_DURATION,5911
112574,and,O,5911
112575,patients,O,5911
112576,using,O,5911
112577,it,O,5911
112578,at,O,5911
112579,home,O,5911
112580,Luminopia,B-ORGANIZATION,5911
112581,is,O,5911
112582,pursuing,O,5911
112583,coverage,O,5911
112584,for,O,5911
112585,the,O,5911
112586,therapy,O,5911
112587,as,O,5911
112588,a,O,5911
112589,pharmacy,O,5911
112590,benefit,O,5911
112591,with,O,5911
112592,regional,O,5911
112593,and,O,5911
112594,national,O,5911
112595,payers,O,5911
112596,across,O,5911
112597,the,B-GPE,5911
112598,United,I-GPE,5911
112599,States,I-GPE,5912
112600,to,O,5912
112601,enable,O,5912
112602,access,O,5912
112603,for,O,5912
112604,children,O,5912
112605,and,O,5912
112606,families,O,5912
112607,in,O,5912
112608,need,O,5912
112609,of,O,5912
112610,innovative,O,5912
112611,amblyopia,B-NAME_OF_DISEASE,5912
112612,medicines,O,5912
112613,Luminopia,B-TREATMENT,5912
112614,One,I-TREATMENT,5912
112615,received,O,5912
112616,FDA,B-ORGANIZATION,5912
112617,approval,O,5912
112618,based,O,5912
112619,on,O,5912
112620,positive,O,5912
112621,results,O,5912
112622,from,O,5912
112623,various,O,5912
112624,clinical,O,5912
112625,trials,O,5912
112626,including,O,5912
112627,a,O,5912
112628,phase,O,5912
112629,3,O,5912
112630,pivotal,O,5912
112631,trial,O,5912
112632,published,O,5912
112633,recently,O,5912
112634,in,O,5912
112635,Ophthalmology,B-PUBLICATION_VENUE,5912
112636,that,O,5912
112637,showed,O,5913
112638,the,O,5913
112639,therapeutic,O,5913
112640,s,O,5913
112641,safety,O,5913
112642,and,O,5913
112643,efficacy,O,5913
112644,in,O,5913
112645,amblyopia,B-NAME_OF_DISEASE,5913
112646,children,O,5913
112647,aged,O,5913
112648,4,O,5913
112649,to,O,5913
112650,7,O,5913
112651,This,O,5913
112652,was,O,5913
112653,the,O,5913
112654,first,O,5913
112655,randomized,O,5913
112656,controlled,O,5913
112657,trial,O,5913
112658,of,O,5913
112659,a,O,5913
112660,new,O,5913
112661,amblyopia,B-NAME_OF_DISEASE,5913
112662,therapy,O,5913
112663,in,O,5913
112664,over,O,5914
112665,a,O,5914
112666,decade,O,5914
112667,and,O,5914
112668,the,O,5914
112669,first,O,5914
112670,to,O,5914
112671,indicate,O,5914
112672,efficacy,O,5914
112673,of,O,5914
112674,a,O,5914
112675,novel,O,5914
112676,binocular,O,5914
112677,strategy,O,5914
112678,In,O,5914
112679,this,O,5914
112680,phase,O,5914
112681,3,O,5914
112682,trial,O,5914
112683,105,O,5914
112684,children,O,5914
112685,were,O,5914
112686,randomly,O,5914
112687,assigned,O,5914
112688,to,O,5914
112689,either,O,5914
112690,the,O,5915
112691,treatment,O,5915
112692,group,O,5915
112693,Luminopia,B-TREATMENT,5915
112694,One,I-TREATMENT,5915
112695,+,O,5915
112696,glasses,B-TREATMENT,5915
112697,or,O,5915
112698,the,O,5915
112699,control,O,5915
112700,group,O,5915
112701,glasses,B-TREATMENT,5915
112702,only,O,5915
112703,,O,5915
112704,As,O,5915
112705,early,O,5915
112706,as,O,5915
112707,four,O,5916
112708,weeks,O,5916
112709,a,O,5916
112710,statistically,O,5916
112711,significant,O,5916
112712,difference,O,5916
112713,in,O,5916
112714,visual,O,5916
112715,acuity,O,5916
112716,improvement,O,5916
112717,across,O,5916
112718,groups,O,5916
112719,was,O,5916
112720,seen,O,5917
112721,The,O,5917
112722,weak,O,5917
112723,eye,O,5917
112724,visual,O,5917
112725,acuity,O,5917
112726,of,O,5917
112727,patients,O,5917
112728,in,O,5917
112729,the,O,5917
112730,treatment,O,5917
112731,group,O,5917
112732,increased,O,5917
112733,1,O,5917
112734,lines,O,5917
112735,on,O,5917
112736,average,O,5918
112737,on,O,5918
112738,a,O,5918
112739,logMAR,O,5918
112740,eye,O,5918
112741,chart,O,5919
112742,at,O,5919
112743,the,O,5919
112744,12-week,O,5919
112745,primary,O,5919
112746,endpoint,O,5919
112747,compared,O,5919
112748,to,O,5919
112749,0,O,5919
112750,lines,O,5920
112751,in,O,5921
112752,the,O,5921
112753,control,O,5921
112754,group,O,5921
112755,The,O,5921
112756,difference,O,5921
112757,in,O,5921
112758,improvement,O,5921
112759,between,O,5921
112760,groups,O,5921
112761,was,O,5921
112762,substantial,O,5921
112763,P=0.00,O,5921
112764,,O,5921
112765,Furthermore,O,5921
112766,in,O,5921
112767,the,O,5921
112768,treatment,O,5921
112769,group,O,5921
112770,62%,O,5921
112771,of,O,5921
112772,patients,O,5921
112773,demonstrated,O,5921
112774,a,O,5921
112775,strong,O,5921
112776,response,O,5921
112777,defined,O,5922
112778,as,O,5922
112779,a,O,5922
112780,2-line,O,5922
112781,or,O,5922
112782,larger,O,5922
112783,improvement,O,5922
112784,compared,O,5922
112785,to,O,5922
112786,33%,O,5922
112787,in,O,5922
112788,the,O,5922
112789,control,O,5922
112790,group,O,5922
112791,Importantly,O,5922
112792,84%,O,5922
112793,of,O,5922
112794,patients,O,5922
112795,in,O,5922
112796,the,O,5922
112797,treatment,O,5922
112798,group,O,5922
112799,had,O,5922
112800,previously,O,5922
112801,received,O,5922
112802,patching,B-TREATMENT,5922
112803,or,I-TREATMENT,5922
112804,atropine,I-TREATMENT,5922
112805,therapy,I-TREATMENT,5923
112806,but,O,5923
112807,still,O,5923
112808,had,O,5923
112809,amblyopia,B-NAME_OF_DISEASE,5923
112810,and,O,5923
112811,Luminopia,B-TREATMENT,5923
112812,One,I-TREATMENT,5923
112813,was,O,5923
112814,as,O,5923
112815,effective,O,5923
112816,in,O,5923
112817,this,O,5923
112818,category,O,5923
112819,Over,O,5923
112820,the,O,5923
112821,course,O,5923
112822,of,O,5923
112823,the,O,5923
112824,research,O,5923
112825,the,O,5923
112826,median,O,5923
112827,adherence,O,5923
112828,to,O,5923
112829,the,O,5923
112830,prescribed,O,5924
112831,dosage,O,5924
112832,was,O,5924
112833,88%,O,5924
112834,far,O,5924
112835,greater,O,5924
112836,than,O,5924
112837,the,O,5924
112838,48%,O,5924
112839,reported,O,5924
112840,in,O,5924
112841,prior,O,5924
112842,patching,O,5924
112843,studies,O,5924
112844,The,B-ORGANIZATION,5925
112845,Cleveland,I-ORGANIZATION,5925
112846,Clinic,I-ORGANIZATION,5925
112847,UCLA,B-ORGANIZATION,5925
112848,Jules,I-ORGANIZATION,5925
112849,Stein,I-ORGANIZATION,5925
112850,Eye,I-ORGANIZATION,5925
112851,Institute,I-ORGANIZATION,5925
112852,Duke,B-ORGANIZATION,5925
112853,Eye,I-ORGANIZATION,5925
112854,Center,I-ORGANIZATION,5925
112855,Ann,O,5925
112856,Robert,O,5925
112857,H,O,5925
112858,Lurie,O,5925
112859,Children,O,5925
112860,s,O,5925
112861,Hospital,O,5925
112862,of,O,5925
112863,Chicago,O,5925
112864,Texas,B-ORGANIZATION,5925
112865,Children,I-ORGANIZATION,5925
112866,s,I-ORGANIZATION,5925
112867,Hospital,I-ORGANIZATION,5925
112868,and,O,5925
112869,Children,B-ORGANIZATION,5925
112870,s,I-ORGANIZATION,5925
112871,Hospital,I-ORGANIZATION,5925
112872,of,I-ORGANIZATION,5925
112873,Philadelphia,I-ORGANIZATION,5926
112874,were,O,5926
112875,among,O,5926
112876,the,O,5926
112877,21,O,5926
112878,academic,O,5926
112879,and,O,5926
112880,community,O,5927
112881,sites,O,5927
112882,that,O,5927
112883,participated,O,5927
112884,in,O,5927
112885,the,O,5927
112886,study,O,5927
112887,There,O,5927
112888,were,O,5927
112889,no,O,5927
112890,major,O,5927
112891,side,O,5927
112892,effects,O,5927
112893,reported,O,5927
112894,Johnson,B-ORGANIZATION,5927
112895,Johnson,I-ORGANIZATION,5927
112896,is,O,5927
112897,a,O,5927
112898,holding,O,5927
112899,company,O,5927
112900,which,O,5927
112901,is,O,5927
112902,engaged,O,5927
112903,in,O,5927
112904,the,O,5927
112905,research,O,5927
112906,and,O,5928
112907,development,O,5928
112908,manufacture,O,5928
112909,and,O,5928
112910,sale,O,5928
112911,of,O,5928
112912,a,O,5928
112913,range,O,5928
112914,of,O,5928
112915,products,O,5928
112916,in,O,5929
112917,the,O,5929
112918,healthcare,O,5929
112919,field,O,5929
112920,It,O,5929
112921,operates,O,5929
112922,through,O,5929
112923,three,O,5929
112924,segments,O,5929
112925,Consumer,O,5929
112926,Pharmaceutical,O,5929
112927,and,O,5930
112928,Medical,O,5930
112929,Devices,O,5930
112930,Its,O,5930
112931,primary,O,5930
112932,focus,O,5930
112933,is,O,5930
112934,products,O,5930
112935,related,O,5930
112936,to,O,5930
112937,human,O,5930
112938,health,O,5930
112939,and,O,5930
112940,well-being,O,5930
112941,The,O,5930
112942,Consumer,O,5930
112943,segment,O,5930
112944,includes,O,5930
112945,a,O,5930
112946,range,O,5930
112947,of,O,5930
112948,products,O,5930
112949,used,O,5930
112950,in,O,5930
112951,the,O,5930
112952,skin,O,5930
112953,health,O,5930
112954,beauty,O,5931
112955,over-the-counter,O,5931
112956,medicines,O,5931
112957,baby,O,5931
112958,care,O,5931
112959,oral,O,5931
112960,care,O,5931
112961,women,O,5931
112962,s,O,5931
112963,health,O,5931
112964,and,O,5931
112965,wound,O,5931
112966,care,O,5931
112967,markets,O,5931
112968,The,O,5931
112969,Pharmaceutical,O,5931
112970,segment,O,5931
112971,is,O,5932
112972,focused,O,5932
112973,on,O,5932
112974,six,O,5932
112975,immunology,O,5932
112976,infectious,O,5932
112977,diseases,O,5932
112978,neuroscience,O,5932
112979,oncology,O,5932
112980,cardiovascular,O,5932
112981,metabolism,O,5932
112982,and,O,5932
112983,pulmonary,O,5932
112984,hypertension,O,5932
112985,The,O,5932
112986,Medical,O,5932
112987,Devices,O,5932
112988,segment,O,5932
112989,includes,O,5932
112990,a,O,5933
112991,range,O,5933
112992,of,O,5934
112993,products,O,5934
112994,used,O,5934
112995,in,O,5934
112996,the,O,5934
112997,interventional,O,5934
112998,solutions,O,5934
112999,orthopedic,O,5934
113000,surgery,O,5934
113001,and,O,5934
113002,vision,O,5934
113003,fields,O,5934
113004,-,O,5934
113005,First,O,5934
113006,daily,B-TREATMENT,5934
113007,wear,I-TREATMENT,5934
113008,lens,I-TREATMENT,5934
113009,developed,O,5934
113010,by,O,5934
113011,Johnson,B-ORGANIZATION,5935
113012,Johnson,I-ORGANIZATION,5935
113013,Vision,I-ORGANIZATION,5935
113014,as,O,5935
113015,a,O,5935
113016,breakthrough,O,5935
113017,innovation,O,5935
113018,specifically,O,5935
113019,designed,O,5935
113020,for,O,5935
113021,slowing,O,5935
113022,the,O,5935
113023,progression,O,5935
113024,of,O,5935
113025,myopia,B-NAME_OF_DISEASE,5935
113026,in,O,5935
113027,children,O,5935
113028,-,O,5935
113029,Expands,O,5935
113030,the,O,5935
113031,growing,O,5935
113032,portfolio,O,5935
113033,of,O,5935
113034,myopia,B-NAME_OF_DISEASE,5935
113035,management,O,5935
113036,products,O,5935
113037,and,O,5935
113038,services,O,5935
113039,from,O,5935
113040,Johnson,B-ORGANIZATION,5935
113041,Johnson,I-ORGANIZATION,5935
113042,Vision,I-ORGANIZATION,5935
113043,-,O,5935
113044,Soft,B-TREATMENT,5935
113045,contact,I-TREATMENT,5935
113046,lenses,I-TREATMENT,5935
113047,with,I-TREATMENT,5935
113048,novel,I-TREATMENT,5935
113049,ring,I-TREATMENT,5935
113050,focus,I-TREATMENT,5935
113051,technology,I-TREATMENT,5935
113052,may,O,5935
113053,help,O,5935
113054,address,O,5935
113055,the,O,5936
113056,progression,O,5936
113057,of,O,5936
113058,myopia,B-NAME_OF_DISEASE,5936
113059,in,O,5936
113060,children,O,5936
113061,-,O,5936
113062,Made,O,5936
113063,of,O,5936
113064,silicone,B-TREATMENT,5936
113065,hydrogel,I-TREATMENT,5936
113066,senofilcon,I-TREATMENT,5936
113067,A,I-TREATMENT,5936
113068,lens,I-TREATMENT,5936
113069,material,O,5936
113070,the,O,5936
113071,same,O,5936
113072,material,O,5936
113073,as,O,5936
113074,ACUVUE®,B-TREATMENT,5936
113075,OASYS,I-TREATMENT,5936
113076,1-Day,I-TREATMENT,5936
113077,contact,I-TREATMENT,5936
113078,lenses,I-TREATMENT,5936
113079,which,O,5936
113080,have,O,5936
113081,never,O,5936
113082,been,O,5936
113083,beaten,O,5937
113084,in,O,5937
113085,comfort,O,5937
113086,JACKSONVILLE,O,5937
113087,Fla.-Johnso,O,5937
113088,Johnson,O,5937
113089,Vision,O,5937
113090,said,O,5937
113091,Wednesday,O,5937
113092,that,O,5937
113093,Health,B-ORGANIZATION,5937
113094,Canada,B-GPE,5937
113095,has,O,5937
113096,approved,O,5937
113097,its,O,5938
113098,Acuvue,B-TREATMENT,5938
113099,Abiliti,I-TREATMENT,5938
113100,1-Day,I-TREATMENT,5938
113101,soft,I-TREATMENT,5938
113102,therapeutic,I-TREATMENT,5938
113103,lenses,I-TREATMENT,5938
113104,for,O,5938
113105,myopia,B-NAME_OF_DISEASE,5938
113106,management,O,5938
113107,Abiliti,B-TREATMENT,5938
113108,1-Day,I-TREATMENT,5938
113109,lenses,I-TREATMENT,5938
113110,are,O,5938
113111,a,O,5938
113112,new,O,5938
113113,option,O,5938
113114,of,O,5938
113115,daily,O,5938
113116,wear,O,5938
113117,single-use,O,5938
113118,disposable,O,5939
113119,lenses,O,5939
113120,that,O,5939
113121,have,O,5939
113122,the,O,5939
113123,potential,O,5939
113124,to,O,5939
113125,slow,O,5939
113126,the,O,5939
113127,progression,O,5939
113128,of,O,5939
113129,myopia,B-NAME_OF_DISEASE,5939
113130,and,O,5939
113131,are,O,5939
113132,specifically,O,5939
113133,designed,O,5939
113134,for,O,5939
113135,children,O,5939
113136,who,O,5939
113137,are,O,5939
113138,7,O,5939
113139,to,O,5939
113140,12,O,5940
113141,years,O,5940
113142,old,O,5940
113143,at,O,5940
113144,the,O,5940
113145,start,O,5940
113146,of,O,5940
113147,treatment,O,5940
113148,the,O,5940
113149,announcement,O,5940
113150,noted,O,5940
113151,Abiliti,B-TREATMENT,5940
113152,1-Day,I-TREATMENT,5940
113153,lenses,I-TREATMENT,5940
113154,are,O,5940
113155,expected,O,5940
113156,to,O,5940
113157,become,O,5940
113158,available,O,5940
113159,in,O,5941
113160,select,O,5941
113161,areas,O,5941
113162,of,O,5941
113163,Canada,B-GPE,5941
113164,beginning,O,5941
113165,as,O,5941
113166,early,O,5941
113167,as,O,5941
113168,this,O,5941
113169,year,O,5941
113170,and,O,5941
113171,expanding,O,5941
113172,beyond,O,5941
113173,in,O,5942
113174,2022,O,5942
113175,J,B-ORGANIZATION,5942
113176,J,I-ORGANIZATION,5942
113177,Vision,I-ORGANIZATION,5942
113178,said,O,5942
113179,Parents,O,5942
113180,and,O,5942
113181,eyecare,O,5942
113182,professionals,O,5942
113183,who,O,5942
113184,want,O,5943
113185,more,O,5943
113186,information,O,5943
113187,can,O,5943
113188,visit,O,5943
113189,the,O,5943
113190,site,O,5943
113191,at,O,5943
113192,seeyourabiliti.com,O,5943
113193,The,O,5944
113194,new,O,5944
113195,lens,O,5944
113196,also,O,5944
113197,expands,O,5944
113198,the,O,5944
113199,growing,O,5944
113200,portfolio,O,5944
113201,of,O,5944
113202,myopia,B-NAME_OF_DISEASE,5944
113203,management,O,5944
113204,products,O,5944
113205,and,O,5944
113206,services,O,5944
113207,from,O,5944
113208,Johnson,B-ORGANIZATION,5944
113209,Johnson,I-ORGANIZATION,5944
113210,Vision,I-ORGANIZATION,5944
113211,the,O,5944
113212,company,O,5944
113213,said,O,5944
113214,The,B-TREATMENT,5944
113215,soft,I-TREATMENT,5944
113216,contact,I-TREATMENT,5944
113217,lenses,I-TREATMENT,5944
113218,feature,I-TREATMENT,5944
113219,a,I-TREATMENT,5944
113220,novel,I-TREATMENT,5944
113221,ring,I-TREATMENT,5944
113222,focus,I-TREATMENT,5944
113223,technology,I-TREATMENT,5944
113224,that,O,5944
113225,helps,O,5944
113226,parents,O,5944
113227,and,O,5944
113228,ECPs,O,5944
113229,address,O,5944
113230,the,O,5944
113231,progression,O,5944
113232,of,O,5944
113233,myopia,B-NAME_OF_DISEASE,5944
113234,in,O,5944
113235,children,O,5944
113236,They,O,5944
113237,are,O,5944
113238,made,O,5944
113239,of,O,5944
113240,silicone,B-TREATMENT,5944
113241,hydrogel,I-TREATMENT,5945
113242,senofilcon,I-TREATMENT,5945
113243,A,I-TREATMENT,5945
113244,lens,I-TREATMENT,5945
113245,material,O,5945
113246,the,O,5945
113247,same,O,5945
113248,material,O,5945
113249,as,O,5945
113250,Acuvue,B-TREATMENT,5945
113251,Oasys,I-TREATMENT,5945
113252,1-Day,I-TREATMENT,5945
113253,contact,I-TREATMENT,5945
113254,lenses,I-TREATMENT,5945
113255,J,B-ORGANIZATION,5945
113256,J,I-ORGANIZATION,5945
113257,Vision,I-ORGANIZATION,5945
113258,is,O,5945
113259,currently,O,5945
113260,working,O,5945
113261,with,O,5945
113262,health,O,5945
113263,and,O,5945
113264,regulatory,O,5945
113265,authorities,O,5945
113266,in,O,5945
113267,the,O,5946
113268,U.S,O,5946
113269,and,O,5946
113270,will,O,5946
113271,provide,O,5946
113272,updates,O,5946
113273,on,O,5946
113274,the,O,5946
113275,approval,O,5946
113276,process,O,5946
113277,in,O,5946
113278,the,O,5946
113279,U.S,O,5946
113280,for,O,5946
113281,the,B-TREATMENT,5946
113282,Acuvue,I-TREATMENT,5946
113283,Abiliti,B-ORGANIZATION,5946
113284,lens,I-TREATMENT,5946
113285,as,O,5946
113286,they,O,5946
113287,become,O,5946
113288,available,O,5946
113289,The,O,5946
113290,approval,O,5947
113291,from,O,5947
113292,Health,B-ORGANIZATION,5947
113293,Canada,I-ORGANIZATION,5947
113294,for,O,5947
113295,Acuvue,B-TREATMENT,5947
113296,Abiliti,B-ORGANIZATION,5947
113297,1-Day,I-TREATMENT,5947
113298,lenses,I-TREATMENT,5947
113299,marks,O,5947
113300,another,O,5947
113301,major,O,5947
113302,step,O,5947
113303,forward,O,5947
113304,in,O,5947
113305,our,O,5947
113306,collaborative,O,5947
113307,efforts,O,5948
113308,with,O,5948
113309,parents,O,5948
113310,and,O,5948
113311,eyecare,O,5948
113312,professionals,O,5948
113313,to,O,5948
113314,reshape,O,5948
113315,the,O,5948
113316,future,O,5948
113317,of,O,5948
113318,myopia,B-NAME_OF_DISEASE,5948
113319,Xiao-Yu,B-PERSON,5948
113320,Song,I-PERSON,5948
113321,MD,I-PERSON,5948
113322,PhD,I-PERSON,5948
113323,global,O,5948
113324,head,O,5949
113325,of,O,5949
113326,research,O,5949
113327,and,O,5949
113328,development,O,5949
113329,for,O,5949
113330,Johnson,B-ORGANIZATION,5949
113331,Johnson,I-ORGANIZATION,5949
113332,Vision,I-ORGANIZATION,5949
113333,said,O,5949
113334,in,O,5949
113335,the,O,5949
113336,announcement,O,5949
113337,Our,O,5949
113338,researchers,O,5949
113339,and,O,5949
113340,scientists,O,5949
113341,specifically,O,5949
113342,designed,O,5949
113343,Abiliti,B-ORGANIZATION,5949
113344,1-Day,I-TREATMENT,5949
113345,to,O,5949
113346,be,O,5949
113347,a,O,5949
113348,novel,O,5949
113349,soft,O,5950
113350,therapeutic,O,5950
113351,lens,O,5950
113352,with,O,5950
113353,the,O,5950
113354,potential,O,5950
113355,to,O,5950
113356,slow,O,5951
113357,the,O,5951
113358,progression,O,5951
113359,of,O,5951
113360,myopia,B-NAME_OF_DISEASE,5951
113361,in,O,5951
113362,children,O,5951
113363,The,B-ORGANIZATION,5951
113364,Health,I-ORGANIZATION,5951
113365,Canada,I-ORGANIZATION,5951
113366,approval,O,5951
113367,for,O,5951
113368,Abiliti,B-ORGANIZATION,5951
113369,1-Day,I-TREATMENT,5951
113370,lenses,I-TREATMENT,5951
113371,marks,O,5951
113372,another,O,5951
113373,significant,O,5951
113374,milestone,O,5951
113375,for,O,5951
113376,the,O,5951
113377,Abiliti,B-ORGANIZATION,5951
113378,brand,O,5951
113379,and,O,5951
113380,Johnson,B-ORGANIZATION,5951
113381,Johnson,I-ORGANIZATION,5951
113382,Vision,I-ORGANIZATION,5951
113383,the,O,5951
113384,company,O,5951
113385,said,O,5951
113386,Abiliti,B-ORGANIZATION,5951
113387,will,O,5951
113388,provide,O,5951
113389,parents,O,5951
113390,and,O,5951
113391,ECPs,O,5951
113392,with,O,5951
113393,a,O,5951
113394,robust,O,5951
113395,and,O,5951
113396,comprehensive,O,5951
113397,set,O,5951
113398,of,O,5951
113399,products,O,5951
113400,for,O,5952
113401,myopia,B-NAME_OF_DISEASE,5952
113402,management,O,5952
113403,Earlier,O,5952
113404,this,O,5952
113405,year,O,5952
113406,the,O,5952
113407,company,O,5952
113408,introduced,O,5952
113409,Acuvue,B-TREATMENT,5952
113410,Abiliti,I-TREATMENT,5952
113411,Overnight,I-TREATMENT,5952
113412,therapeutic,I-TREATMENT,5952
113413,lenses,I-TREATMENT,5952
113414,for,O,5952
113415,myopia,B-NAME_OF_DISEASE,5952
113416,management,O,5952
113417,in,O,5952
113418,the,O,5952
113419,U.S,O,5952
113420,Abiliti,B-ORGANIZATION,5952
113421,Overnight,I-TREATMENT,5952
113422,lenses,I-TREATMENT,5952
113423,are,O,5952
113424,specifically,O,5952
113425,designed,O,5952
113426,and,O,5952
113427,fitted,O,5952
113428,to,O,5952
113429,match,O,5953
113430,a,O,5953
113431,patient,O,5953
113432,s,O,5953
113433,eye,O,5953
113434,based,O,5953
113435,on,O,5953
113436,its,O,5953
113437,unique,O,5953
113438,corneal,O,5953
113439,shape,O,5953
113440,to,O,5953
113441,temporarily,O,5953
113442,reshape,O,5954
113443,the,B-PART_OF_THE_EYES,5954
113444,cornea,I-PART_OF_THE_EYES,5954
113445,The,O,5954
113446,lens,O,5954
113447,was,O,5954
113448,approved,O,5954
113449,by,O,5954
113450,the,B-ORGANIZATION,5954
113451,FDA,I-ORGANIZATION,5954
113452,The,O,5954
113453,company,O,5954
113454,also,O,5954
113455,announced,O,5954
113456,that,O,5954
113457,each,O,5954
113458,annual,O,5954
113459,purchase,O,5954
113460,of,O,5954
113461,an,O,5954
113462,Abiliti,B-ORGANIZATION,5954
113463,product,O,5954
113464,would,O,5954
113465,provide,O,5954
113466,a,O,5954
113467,free,O,5955
113468,comprehensive,O,5955
113469,eye,O,5955
113470,health,O,5955
113471,exam,O,5955
113472,to,O,5955
113473,a,O,5955
113474,child,O,5955
113475,in,O,5955
113476,need,O,5955
113477,through,O,5955
113478,Sight,O,5955
113479,For,O,5955
113480,Kids-a,O,5955
113481,joint,O,5955
113482,program,O,5955
113483,from,O,5955
113484,Johnson,B-ORGANIZATION,5955
113485,Johnson,I-ORGANIZATION,5955
113486,Vision,I-ORGANIZATION,5955
113487,and,O,5955
113488,the,O,5955
113489,not-for-profit,O,5955
113490,Lions,B-ORGANIZATION,5956
113491,Clubs,I-ORGANIZATION,5956
113492,International,I-ORGANIZATION,5956
113493,Foundation,I-ORGANIZATION,5956
113494,LCIF,I-ORGANIZATION,5956
113495,,O,5956
113496,Sight,O,5956
113497,For,O,5956
113498,Kids,O,5956
113499,is,O,5956
113500,one,O,5956
113501,of,O,5956
113502,the,O,5956
113503,largest-known,O,5956
113504,school-based,O,5956
113505,eye,O,5956
113506,health,O,5956
113507,programs,O,5956
113508,that,O,5957
113509,mobilizes,O,5958
113510,Lions,O,5958
113511,and,O,5958
113512,ECPs,O,5958
113513,to,O,5958
113514,provide,O,5959
113515,comprehensive,O,5959
113516,eye,O,5959
113517,health,O,5959
113518,services,O,5959
113519,in,O,5959
113520,low-income,O,5959
113521,schools,O,5959
113522,around,O,5959
113523,the,O,5959
113524,world,O,5959
113525,The,O,5959
113526,new,O,5959
113527,Abiliti,B-TREATMENT,5959
113528,1-Day,I-TREATMENT,5959
113529,lenses,I-TREATMENT,5959
113530,are,O,5959
113531,not,O,5959
113532,traditional,O,5959
113533,concentric,O,5959
113534,ring,O,5959
113535,presbyopic,O,5959
113536,design,O,5959
113537,lenses,O,5959
113538,Abiliti,B-TREATMENT,5959
113539,1-Day,I-TREATMENT,5959
113540,lenses,I-TREATMENT,5959
113541,are,O,5959
113542,a,O,5959
113543,breakthrough,O,5959
113544,innovation,O,5959
113545,specifically,O,5959
113546,designed,O,5959
113547,to,O,5959
113548,slow,O,5959
113549,myopia,B-NAME_OF_DISEASE,5959
113550,progression,O,5959
113551,in,O,5959
113552,children,O,5959
113553,and,O,5959
113554,have,O,5959
113555,been,O,5959
113556,shown,O,5959
113557,to,O,5959
113558,reduce,O,5959
113559,axial,O,5959
113560,elongation,O,5959
113561,by,O,5960
113562,0.105m,O,5960
113563,on,O,5960
113564,average,O,5960
113565,over,O,5960
113566,a,B-TIME_DURATION,5960
113567,6-month,I-TIME_DURATION,5960
113568,period,I-TIME_DURATION,5960
113569,according,O,5960
113570,to,O,5960
113571,the,O,5960
113572,J,B-ORGANIZATION,5960
113573,J,I-ORGANIZATION,5960
113574,Vision,I-ORGANIZATION,5960
113575,announcement,O,5960
113576,New,O,5960
113577,Prospective,O,5960
113578,Study,O,5960
113579,Shows,O,5960
113580,Significant,O,5960
113581,Reduction,O,5960
113582,in,O,5960
113583,Reports,O,5960
113584,of,O,5961
113585,Postoperative,O,5962
113586,Halos,B-SIGN_AND_SYMPTOM,5962
113587,From,O,5962
113588,Patients,O,5962
113589,Treated,O,5962
113590,With,O,5962
113591,TearScience,B-TREATMENT,5962
113592,LipiFlow,I-TREATMENT,5962
113593,Treatment,I-TREATMENT,5962
113594,Prior,O,5962
113595,to,O,5962
113596,Bilateral,B-TREATMENT,5962
113597,Cataract,I-TREATMENT,5962
113598,Surgery,I-TREATMENT,5962
113599,Patients,O,5962
113600,that,O,5962
113601,received,O,5963
113602,thermal,B-TREATMENT,5963
113603,pulsation,I-TREATMENT,5963
113604,treatment,I-TREATMENT,5964
113605,prior,O,5964
113606,to,O,5964
113607,cataract,B-TREATMENT,5964
113608,surgery,I-TREATMENT,5964
113609,reported,O,5964
113610,halos,B-SIGN_AND_SYMPTOM,5964
113611,significantly,O,5964
113612,less,O,5964
113613,than,O,5964
113614,control,O,5964
113615,group,O,5964
113616,58,O,5964
113617,vs,O,5964
113618,79,O,5964
113619,percent,O,5964
113620,p,O,5964
113621,=,O,5964
113622,0.01,O,5964
113623,The,O,5964
113624,study,O,5964
113625,is,O,5964
113626,one,O,5964
113627,of,O,5964
113628,21,O,5964
113629,company-sponsored,O,5964
113630,studies,O,5964
113631,being,O,5964
113632,presented,O,5965
113633,the,O,5965
113634,2021,O,5965
113635,ASCRS∙,O,5965
113636,ASOA,B-ORGANIZATION,5965
113637,Annual,O,5965
113638,Meeting,O,5965
113639,Johnson,B-ORGANIZATION,5965
113640,Johnson,I-ORGANIZATION,5965
113641,Vision,I-ORGANIZATION,5965
113642,a,O,5965
113643,global,O,5965
113644,leader,O,5965
113645,in,O,5965
113646,eye,O,5965
113647,health,O,5965
113648,and,O,5965
113649,part,O,5965
113650,of,O,5965
113651,the,B-ORGANIZATION,5965
113652,Johnson,I-ORGANIZATION,5965
113653,Johnson,I-ORGANIZATION,5965
113654,Medical,I-ORGANIZATION,5965
113655,Devices,I-ORGANIZATION,5965
113656,Companies,I-ORGANIZATION,5965
113657,revealed,O,5965
113658,new,O,5965
113659,comparative,O,5965
113660,clinical,O,5965
113661,study,O,5965
113662,findings,O,5965
113663,evaluating,O,5965
113664,TearScience,B-TREATMENT,5965
113665,LipiFlow,I-TREATMENT,5965
113666,treatment,I-TREATMENT,5965
113667,in,O,5965
113668,cataract,B-TREATMENT,5965
113669,surgery,I-TREATMENT,5966
113670,The,O,5966
113671,data,O,5966
113672,concluded,O,5966
113673,that,O,5966
113674,treating,O,5967
113675,patients,O,5967
113676,with,O,5967
113677,TearScience,B-TREATMENT,5967
113678,LipiFlow,I-TREATMENT,5967
113679,prior,O,5967
113680,to,O,5967
113681,cataract,B-TREATMENT,5967
113682,surgery,I-TREATMENT,5967
113683,significantly,O,5967
113684,reduced,O,5967
113685,patient-reports,O,5967
113686,of,O,5967
113687,halos,B-SIGN_AND_SYMPTOM,5967
113688,compared,O,5967
113689,to,O,5967
113690,control,O,5967
113691,group,O,5967
113692,58,O,5967
113693,vs,O,5967
113694,79,O,5967
113695,percent,O,5967
113696,and,O,5967
113697,showed,O,5967
113698,larger,O,5967
113699,improvements,O,5968
113700,in,O,5968
113701,Meibomian,B-DIAGNOSTIC_TEST,5968
113702,Gland,I-DIAGNOSTIC_TEST,5968
113703,Score,I-DIAGNOSTIC_TEST,5968
113704,MGD,I-DIAGNOSTIC_TEST,5968
113705,than,O,5968
113706,control,O,5968
113707,group,O,5968
113708,107,O,5968
113709,vs,O,5968
113710,66,O,5968
113711,percent,O,5968
113712,,O,5968
113713,The,O,5968
113714,results,O,5968
113715,were,O,5968
113716,shared,O,5968
113717,today,O,5968
113718,in,O,5968
113719,a,O,5968
113720,poster,O,5968
113721,presentation,O,5969
113722,at,O,5969
113723,the,B-ORGANIZATION,5969
113724,American,I-ORGANIZATION,5969
113725,Society,I-ORGANIZATION,5969
113726,of,I-ORGANIZATION,5969
113727,Cataract,I-ORGANIZATION,5969
113728,and,I-ORGANIZATION,5969
113729,Refractive,I-ORGANIZATION,5969
113730,Surgery,I-ORGANIZATION,5969
113731,ASCRS,I-ORGANIZATION,5969
113732,and,O,5969
113733,American,B-ORGANIZATION,5969
113734,Society,I-ORGANIZATION,5969
113735,of,I-ORGANIZATION,5969
113736,Ophthalmic,I-ORGANIZATION,5969
113737,Administrators,I-ORGANIZATION,5969
113738,ASOA,I-ORGANIZATION,5969
113739,Annual,O,5969
113740,Meeting,O,5969
113741,The,O,5969
113742,study,O,5969
113743,titled,O,5969
113744,Preoperative,B-NAME_OF_STUDY,5969
113745,Treatment,I-NAME_OF_STUDY,5969
113746,of,I-NAME_OF_STUDY,5970
113747,Meibomian,I-NAME_OF_STUDY,5970
113748,Gland,I-NAME_OF_STUDY,5970
113749,Dysfunction,I-NAME_OF_STUDY,5970
113750,with,I-NAME_OF_STUDY,5970
113751,Thermal,I-NAME_OF_STUDY,5970
113752,Pulsation,I-NAME_OF_STUDY,5970
113753,System,I-NAME_OF_STUDY,5970
113754,Prior,I-NAME_OF_STUDY,5970
113755,to,I-NAME_OF_STUDY,5970
113756,Extended,I-NAME_OF_STUDY,5970
113757,Depth,I-NAME_OF_STUDY,5970
113758,of,I-NAME_OF_STUDY,5970
113759,Focus,I-NAME_OF_STUDY,5970
113760,IOL,I-NAME_OF_STUDY,5970
113761,Implantation,I-NAME_OF_STUDY,5970
113762,was,O,5970
113763,a,O,5971
113764,post-market,O,5971
113765,prospective,O,5971
113766,randomized,O,5971
113767,multi,O,5971
113768,center,O,5971
113769,bilateral,O,5971
113770,open-label,O,5971
113771,cross-over,O,5971
113772,comparative,O,5971
113773,clinical,O,5971
113774,study,O,5971
113775,covering,O,5971
113776,five,O,5971
113777,U.S,O,5971
113778,sites,O,5971
113779,and,O,5971
113780,comprising,O,5971
113781,115,O,5971
113782,subjects,O,5971
113783,At,O,5971
113784,three-months,B-TIME_DURATION,5972
113785,following,O,5972
113786,surgery,O,5972
113787,there,O,5972
113788,were,O,5972
113789,notable,O,5972
113790,differences,O,5972
113791,in,O,5972
113792,the,O,5972
113793,rates,O,5972
113794,of,O,5972
113795,bothersome,O,5972
113796,ocular,O,5972
113797,symptoms,O,5972
113798,such,O,5972
113799,as,O,5972
113800,seeing,O,5973
113801,halos,B-SIGN_AND_SYMPTOM,5973
113802,between,O,5973
113803,the,O,5973
113804,study,O,5973
113805,and,O,5973
113806,control,O,5973
113807,groups,O,5973
113808,The,O,5973
113809,findings,O,5973
113810,align,O,5973
113811,with,O,5973
113812,the,O,5973
113813,recent,O,5973
113814,ASCRS,B-ORGANIZATION,5973
113815,clinical,O,5973
113816,guidelines,O,5973
113817,recommending,O,5973
113818,the,O,5973
113819,proactive,O,5974
113820,diagnosis,O,5974
113821,and,O,5974
113822,management,O,5974
113823,of,O,5974
113824,MGD,B-NAME_OF_DISEASE,5974
113825,in,O,5974
113826,the,O,5974
113827,preoperative,O,5974
113828,cataract,B-NAME_OF_DISEASE,5974
113829,patient,O,5974
113830,We,O,5974
113831,continue,O,5974
113832,to,O,5974
113833,learn,O,5974
113834,more,O,5974
113835,about,O,5974
113836,the,O,5974
113837,connection,O,5974
113838,between,O,5974
113839,the,O,5974
113840,health,O,5974
113841,of,O,5974
113842,the,O,5974
113843,ocular,O,5974
113844,surface,O,5974
113845,and,O,5974
113846,visual,O,5974
113847,outcomes,O,5974
113848,following,O,5974
113849,cataract,B-TREATMENT,5974
113850,surgery,I-TREATMENT,5975
113851,said,O,5975
113852,Daniel,B-PERSON,5975
113853,Chang,I-PERSON,5975
113854,MD,I-PERSON,5975
113855,This,O,5975
113856,new,O,5975
113857,data,O,5975
113858,reinforces,O,5975
113859,the,O,5975
113860,importance,O,5975
113861,of,O,5975
113862,proactively,O,5975
113863,screening,O,5975
113864,for,O,5975
113865,and,O,5976
113866,treating,O,5976
113867,MGD,B-NAME_OF_DISEASE,5976
113868,prior,O,5976
113869,to,O,5976
113870,cataract,B-TREATMENT,5976
113871,surgery,I-TREATMENT,5976
113872,It,O,5976
113873,s,O,5976
113874,a,O,5976
113875,simple,O,5976
113876,addition,O,5976
113877,to,O,5976
113878,the,O,5976
113879,patient,O,5976
113880,s,O,5976
113881,treatment,O,5976
113882,plan,O,5976
113883,that,O,5976
113884,may,O,5976
113885,result,O,5976
113886,in,O,5976
113887,better,O,5976
113888,visual,O,5976
113889,outcomes,O,5976
113890,for,O,5976
113891,our,O,5976
113892,patients,O,5976
113893,MGD,B-NAME_OF_DISEASE,5976
113894,is,O,5976
113895,a,O,5976
113896,prevalent,O,5976
113897,chronic,O,5976
113898,and,O,5976
113899,progressive,O,5976
113900,disease,O,5976
113901,that,O,5976
113902,becomes,O,5976
113903,worse,O,5976
113904,the,O,5976
113905,longer,O,5976
113906,it,O,5976
113907,goes,O,5976
113908,untreated,O,5976
113909,In,O,5976
113910,the,O,5976
113911,study,O,5976
113912,presurgical,O,5976
113913,TearScience,B-TREATMENT,5976
113914,LipiFlow,I-TREATMENT,5976
113915,in,O,5976
113916,cataract,B-NAME_OF_DISEASE,5976
113917,patients,O,5976
113918,improved,O,5976
113919,meibomian,B-PART_OF_THE_EYES,5976
113920,gland,I-PART_OF_THE_EYES,5976
113921,function,O,5977
113922,and,O,5977
113923,improved,O,5977
113924,postoperative,O,5977
113925,anterior,O,5977
113926,ocular,O,5977
113927,health,O,5977
113928,In,O,5977
113929,addition,O,5977
113930,to,O,5977
113931,reducing,O,5977
113932,postoperative,O,5977
113933,reports,O,5977
113934,of,O,5977
113935,halos,B-SIGN_AND_SYMPTOM,5977
113936,the,O,5977
113937,presurgical,O,5977
113938,treatment,O,5977
113939,also,O,5977
113940,showed,O,5977
113941,measurable,O,5977
113942,improvements,O,5977
113943,in,O,5977
113944,visual,O,5977
113945,acuity,O,5977
113946,20,O,5978
113947,20,O,5978
113948,at,O,5978
113949,4m,O,5978
113950,20,O,5978
113951,20,O,5978
113952,at,O,5978
113953,66cm,O,5978
113954,20,O,5978
113955,30,O,5978
113956,at,O,5978
113957,40cm,O,5978
113958,,O,5978
113959,As,O,5978
113960,clinicians,O,5978
113961,we,O,5978
113962,always,O,5978
113963,want,O,5978
113964,to,O,5978
113965,optimize,O,5978
113966,surgical,O,5978
113967,outcomes,O,5978
113968,for,O,5978
113969,cataract,B-NAME_OF_DISEASE,5979
113970,patients,O,5979
113971,including,O,5979
113972,postoperative,O,5979
113973,visits,O,5979
113974,The,O,5979
113975,data,O,5979
113976,we,O,5979
113977,unveiled,O,5979
113978,today,O,5979
113979,reinforces,O,5979
113980,the,O,5979
113981,need,O,5979
113982,for,O,5979
113983,surgeons,O,5979
113984,to,O,5979
113985,screen,O,5979
113986,for,O,5979
113987,and,O,5979
113988,treat,O,5979
113989,MGD,B-NAME_OF_DISEASE,5979
113990,prior-to,O,5980
113991,cataract,B-TREATMENT,5980
113992,surgery,I-TREATMENT,5980
113993,especially,O,5980
113994,given,O,5980
113995,the,O,5980
113996,high,O,5980
113997,incidence,O,5980
113998,and,O,5980
113999,asymptomatic,O,5980
114000,nature,O,5980
114001,of,O,5980
114002,ocular,O,5980
114003,surface,O,5980
114004,disease,O,5980
114005,in,O,5980
114006,patients,O,5980
114007,presenting,O,5981
114008,for,O,5981
114009,cataract,B-TREATMENT,5981
114010,surgery,I-TREATMENT,5982
114011,said,O,5982
114012,Rajesh,B-PERSON,5982
114013,Rajpal,I-PERSON,5982
114014,MD,I-PERSON,5982
114015,Chief,O,5982
114016,Medical,O,5982
114017,Officer,O,5982
114018,and,O,5983
114019,Global,O,5983
114020,Head,O,5983
114021,of,O,5983
114022,Clinical,O,5983
114023,and,O,5983
114024,Medical,O,5983
114025,Affairs,O,5983
114026,at,O,5983
114027,Johnson,B-ORGANIZATION,5983
114028,Johnson,I-ORGANIZATION,5983
114029,Vision,I-ORGANIZATION,5983
114030,The,O,5983
114031,study,O,5983
114032,is,O,5983
114033,available,O,5984
114034,for,O,5985
114035,on-demand,O,5985
114036,viewing,O,5985
114037,in,O,5985
114038,the,B-PUBLICATION_VENUE,5986
114039,Education,I-PUBLICATION_VENUE,5986
114040,Hub,I-PUBLICATION_VENUE,5986
114041,at,O,5986
114042,the,O,5986
114043,convention,O,5986
114044,center,O,5986
114045,during,O,5986
114046,the,O,5986
114047,meeting,O,5986
114048,and,O,5986
114049,remotely,O,5986
114050,on,O,5986
114051,the,B-ORGANIZATION,5986
114052,ASCRS,I-ORGANIZATION,5986
114053,website,O,5986
114054,post-meeting,O,5986
114055,About,O,5986
114056,TearScience,B-TREATMENT,5987
114057,LipiFlow,I-TREATMENT,5987
114058,The,B-TREATMENT,5987
114059,TearScience,I-TREATMENT,5987
114060,LipiFlow,I-TREATMENT,5987
114061,Thermal,I-TREATMENT,5987
114062,Pulsation,I-TREATMENT,5987
114063,System,I-TREATMENT,5987
114064,is,O,5987
114065,a,O,5987
114066,medical,O,5987
114067,device,O,5988
114068,used,O,5988
114069,by,O,5988
114070,physicians,O,5988
114071,in,O,5988
114072,addressing,O,5988
114073,Meibomian,B-NAME_OF_DISEASE,5988
114074,Gland,I-NAME_OF_DISEASE,5988
114075,Dysfunction,I-NAME_OF_DISEASE,5988
114076,MGD,I-NAME_OF_DISEASE,5988
114077,,O,5988
114078,It,O,5989
114079,consists,O,5989
114080,of,O,5989
114081,a,O,5989
114082,Console,O,5989
114083,and,O,5989
114084,a,O,5989
114085,single-use,O,5989
114086,sterile,O,5989
114087,device,O,5989
114088,known,O,5989
114089,as,O,5989
114090,the,O,5989
114091,Activator,O,5989
114092,and,O,5989
114093,has,O,5989
114094,a,O,5989
114095,drug-free,O,5989
114096,mechanism,O,5989
114097,of,O,5989
114098,action,O,5990
114099,Eye,O,5990
114100,care,O,5990
114101,professionals,O,5990
114102,use,O,5990
114103,the,B-TREATMENT,5990
114104,TearScience,I-TREATMENT,5990
114105,LipiFlow,I-TREATMENT,5990
114106,System,I-TREATMENT,5990
114107,to,O,5990
114108,treat,O,5990
114109,MGD,B-NAME_OF_DISEASE,5990
114110,patients,O,5990
114111,in-office,O,5990
114112,with,O,5990
114113,confidence,O,5990
114114,and,O,5990
114115,efficiency,O,5990
114116,Santen,B-ORGANIZATION,5990
114117,Receives,O,5990
114118,U.S,O,5990
114119,FDA,B-ORGANIZATION,5990
114120,Approval,O,5990
114121,for,O,5990
114122,Verkazia,O,5990
114123,Cyclosporine,O,5991
114124,Ophthalmic,O,5991
114125,Emulsion,O,5991
114126,0.1,O,5991
114127,for,O,5991
114128,the,O,5991
114129,Treatment,O,5991
114130,of,O,5991
114131,Vernal,B-NAME_OF_DISEASE,5991
114132,Keratoconjunctivitis,I-NAME_OF_DISEASE,5991
114133,in,O,5991
114134,Children,O,5991
114135,and,O,5991
114136,Adults,O,5991
114137,Osaka,O,5991
114138,Japan-,O,5991
114139,Santen,B-ORGANIZATION,5991
114140,Pharmaceutical,O,5991
114141,Co,O,5991
114142,Ltd,O,5991
114143,announced,O,5991
114144,that,O,5991
114145,the,O,5992
114146,U.S,O,5992
114147,Food,O,5992
114148,and,O,5992
114149,Drug,O,5992
114150,Administration,O,5992
114151,FDA,B-ORGANIZATION,5992
114152,has,O,5992
114153,approved,O,5992
114154,the,O,5992
114155,New,O,5992
114156,Drug,O,5992
114157,Application,O,5992
114158,NDA,O,5992
114159,for,O,5993
114160,Verkazia,O,5993
114161,Cyclosporine,O,5993
114162,ophthalmic,O,5993
114163,emulsion,O,5993
114164,0.1,O,5993
114165,for,O,5993
114166,the,O,5993
114167,treatment,O,5993
114168,of,O,5993
114169,vernal,B-NAME_OF_DISEASE,5993
114170,keratoconjunctivitis,I-NAME_OF_DISEASE,5994
114171,VKC,B-NAME_OF_DISEASE,5994
114172,in,O,5994
114173,children,O,5994
114174,and,O,5994
114175,adults,O,5994
114176,Santen,B-ORGANIZATION,5994
114177,had,O,5994
114178,received,O,5994
114179,initial,O,5994
114180,FDA,B-ORGANIZATION,5994
114181,filing,O,5994
114182,acceptance,O,5994
114183,on,O,5994
114184,October,O,5994
114185,26,O,5994
114186,2020,O,5994
114187,With,O,5994
114188,this,O,5994
114189,approval,O,5994
114190,Santen,B-ORGANIZATION,5994
114191,is,O,5994
114192,now,O,5994
114193,working,O,5994
114194,to,O,5994
114195,make,O,5994
114196,a,O,5994
114197,new,O,5994
114198,treatment,O,5994
114199,option,O,5994
114200,available,O,5994
114201,for,O,5994
114202,patients,O,5994
114203,in,O,5994
114204,the,B-GPE,5994
114205,United,I-GPE,5994
114206,States,I-GPE,5994
114207,VKC,B-NAME_OF_DISEASE,5994
114208,is,O,5995
114209,a,O,5995
114210,rare,O,5995
114211,and,O,5995
114212,recurrent,O,5995
114213,allergic,O,5996
114214,eye,O,5996
114215,condition,O,5996
114216,mainly,O,5996
114217,occurring,O,5996
114218,in,O,5996
114219,children,O,5996
114220,and,O,5996
114221,adolescents,O,5996
114222,that,O,5996
114223,causes,O,5996
114224,severe,O,5996
114225,inflammation,O,5997
114226,of,O,5997
114227,the,O,5997
114228,surface,O,5997
114229,of,O,5997
114230,the,O,5997
114231,eye,O,5997
114232,The,O,5997
114233,symptoms,O,5997
114234,of,O,5997
114235,VKC,B-NAME_OF_DISEASE,5997
114236,-,O,5997
114237,intense,B-SIGN_AND_SYMPTOM,5997
114238,itching,I-SIGN_AND_SYMPTOM,5997
114239,painful,I-SIGN_AND_SYMPTOM,5997
114240,eyes,I-SIGN_AND_SYMPTOM,5997
114241,and,I-SIGN_AND_SYMPTOM,5997
114242,light,I-SIGN_AND_SYMPTOM,5997
114243,sensitivity,I-SIGN_AND_SYMPTOM,5997
114244,-,O,5997
114245,can,O,5997
114246,prevent,O,5997
114247,those,O,5997
114248,affected,O,5997
114249,from,O,5997
114250,participating,O,5997
114251,in,O,5997
114252,everyday,O,5997
114253,activities,O,5997
114254,Without,O,5997
114255,adequate,O,5997
114256,treatment,O,5997
114257,severe,O,5997
114258,cases,O,5997
114259,may,O,5997
114260,result,O,5998
114261,in,O,5998
114262,corneal,B-SIGN_AND_SYMPTOM,5998
114263,ulcers,I-SIGN_AND_SYMPTOM,5998
114264,and,O,5998
114265,even,O,5998
114266,vision,B-SIGN_AND_SYMPTOM,5998
114267,loss,I-SIGN_AND_SYMPTOM,5998
114268,VKC,B-NAME_OF_DISEASE,5998
114269,is,O,5998
114270,a,O,5998
114271,rare,O,5998
114272,but,O,5998
114273,severe,O,5998
114274,disease,O,5998
114275,affecting,O,5998
114276,children,O,5998
114277,and,O,5998
114278,adolescents,O,5998
114279,Its,O,5999
114280,characteristics,O,6000
114281,of,O,6000
114282,allergic,B-NAME_OF_DISEASE,6000
114283,conjunctivitis,I-NAME_OF_DISEASE,6000
114284,significantly,O,6000
114285,affects,O,6000
114286,quality,O,6000
114287,of,O,6001
114288,life,O,6001
114289,such,O,6001
114290,as,O,6001
114291,limiting,O,6001
114292,academic,O,6001
114293,and,O,6002
114294,outdoor,O,6002
114295,activities,O,6002
114296,due,O,6002
114297,to,O,6002
114298,itching,B-SIGN_AND_SYMPTOM,6002
114299,and,I-SIGN_AND_SYMPTOM,6002
114300,pain,I-SIGN_AND_SYMPTOM,6002
114301,that,O,6002
114302,prevent,O,6002
114303,the,O,6002
114304,eyes,O,6002
114305,from,O,6002
114306,opening,O,6002
114307,when,O,6002
114308,symptoms,O,6002
114309,occur,O,6002
114310,said,O,6002
114311,Shigeo,B-PERSON,6002
114312,Taniuchi,I-PERSON,6002
114313,President,O,6002
114314,CEO,O,6002
114315,of,O,6003
114316,Santen,B-ORGANIZATION,6003
114317,We,O,6003
114318,will,O,6003
114319,leverage,O,6003
114320,our,O,6003
114321,U.S,O,6003
114322,business,O,6003
114323,foundation,O,6003
114324,of,O,6003
114325,Eyevance,B-ORGANIZATION,6003
114326,which,O,6003
114327,was,O,6003
114328,acquired,O,6003
114329,by,O,6003
114330,Santen,B-ORGANIZATION,6003
114331,in,O,6003
114332,September,O,6003
114333,2020,O,6003
114334,We,O,6003
114335,are,O,6003
114336,thrilled,O,6003
114337,to,O,6003
114338,be,O,6003
114339,collaborating,O,6003
114340,with,O,6003
114341,healthcare,O,6003
114342,professionals,O,6003
114343,to,O,6003
114344,deliver,O,6003
114345,treatment,O,6003
114346,to,O,6003
114347,this,O,6003
114348,underserved,O,6004
114349,population,O,6004
114350,as,O,6004
114351,soon,O,6004
114352,as,O,6004
114353,possible,O,6004
114354,and,O,6004
114355,we,O,6004
114356,hope,O,6004
114357,to,O,6004
114358,bring,O,6004
114359,smiles,O,6004
114360,back,O,6004
114361,to,O,6004
114362,children,O,6004
114363,and,O,6004
114364,patients,O,6004
114365,in,O,6004
114366,the,B-GPE,6004
114367,United,I-GPE,6004
114368,States,I-GPE,6004
114369,We,O,6005
114370,re,O,6005
114371,extremely,O,6005
114372,happy,O,6005
114373,to,O,6005
114374,have,O,6005
114375,received,O,6005
114376,FDA,B-ORGANIZATION,6005
114377,approval,O,6005
114378,as,O,6005
114379,our,O,6005
114380,first,O,6005
114381,internal,O,6005
114382,prescription,O,6005
114383,product,O,6005
114384,approval,O,6005
114385,in,O,6005
114386,the,O,6005
114387,U.S,O,6005
114388,market,O,6005
114389,stated,O,6005
114390,Tatsuya,B-PERSON,6006
114391,Kaihara,I-PERSON,6006
114392,CEO,O,6006
114393,of,O,6006
114394,Santen,B-ORGANIZATION,6006
114395,Inc,O,6006
114396,and,O,6006
114397,Head,O,6006
114398,of,O,6006
114399,Santen,B-ORGANIZATION,6006
114400,North,I-ORGANIZATION,6006
114401,America,I-ORGANIZATION,6006
114402,This,O,6006
114403,is,O,6007
114404,an,O,6007
114405,important,O,6007
114406,milestone,O,6007
114407,in,O,6007
114408,Santen,B-ORGANIZATION,6007
114409,s,O,6007
114410,aim,O,6007
114411,to,O,6007
114412,bring,O,6007
114413,innovative,O,6007
114414,solutions,O,6007
114415,that,O,6007
114416,protect,O,6007
114417,vision,O,6007
114418,for,O,6007
114419,those,O,6007
114420,affected,O,6007
114421,by,O,6007
114422,ophthalmic,O,6007
114423,conditions,O,6007
114424,With,O,6007
114425,this,O,6007
114426,approval,O,6007
114427,doctors,O,6007
114428,and,O,6007
114429,patients,O,6007
114430,in,O,6007
114431,the,B-GPE,6007
114432,United,I-GPE,6007
114433,States,I-GPE,6008
114434,now,O,6008
114435,have,O,6008
114436,an,O,6008
114437,effective,O,6008
114438,and,O,6008
114439,new,O,6008
114440,treatment,O,6008
114441,for,O,6008
114442,this,O,6008
114443,rare,O,6008
114444,condition,O,6008
114445,that,O,6008
114446,may,O,6008
114447,allow,O,6008
114448,those,O,6008
114449,affected,O,6008
114450,to,O,6008
114451,continue,O,6008
114452,taking,O,6008
114453,part,O,6008
114454,in,O,6008
114455,everyday,O,6008
114456,activities,O,6008
114457,Following,O,6008
114458,Europe,B-GPE,6008
114459,Asia,B-GPE,6008
114460,and,O,6008
114461,Canada,B-GPE,6008
114462,we,O,6008
114463,have,O,6008
114464,now,O,6008
114465,also,O,6008
114466,received,O,6008
114467,approval,O,6008
114468,in,O,6008
114469,the,B-GPE,6009
114470,United,I-GPE,6009
114471,States,I-GPE,6009
114472,demonstrating,O,6009
114473,Santen,B-ORGANIZATION,6009
114474,s,O,6009
114475,global,O,6009
114476,development,O,6009
114477,commitment,O,6009
114478,We,O,6009
114479,would,O,6009
114480,like,O,6009
114481,to,O,6009
114482,continuously,O,6009
114483,deliver,O,6009
114484,Happiness,O,6009
114485,with,O,6009
114486,Vision,O,6009
114487,to,O,6009
114488,children,O,6010
114489,around,O,6010
114490,the,O,6010
114491,world,O,6010
114492,whose,O,6010
114493,daily,O,6010
114494,activities,O,6010
114495,are,O,6010
114496,restricted,O,6010
114497,by,O,6010
114498,VKC,B-NAME_OF_DISEASE,6010
114499,said,O,6010
114500,Peter,B-PERSON,6010
114501,Sallstig,I-PERSON,6010
114502,Corporate,O,6010
114503,Officer,O,6010
114504,and,O,6010
114505,Head,O,6010
114506,of,O,6010
114507,Product,O,6010
114508,Development,O,6010
114509,Division,O,6010
114510,at,O,6010
114511,Santen,B-ORGANIZATION,6010
114512,About,O,6010
114513,Verkazia,B-NAME_OF_DRUG,6010
114514,-,O,6010
114515,Verkazia,B-NAME_OF_DRUG,6010
114516,is,O,6010
114517,a,O,6010
114518,prescription-only,O,6010
114519,uniquely-formulated,O,6010
114520,oil-in-water,O,6010
114521,cationic,O,6010
114522,emulsion,O,6010
114523,that,O,6010
114524,provides,O,6010
114525,improved,O,6010
114526,ocular,O,6010
114527,bioavailability,O,6010
114528,of,O,6011
114529,cyclosporine,B-NAME_OF_DRUG,6011
114530,which,O,6011
114531,has,O,6011
114532,been,O,6011
114533,shown,O,6011
114534,to,O,6011
114535,be,O,6011
114536,effective,O,6011
114537,in,O,6011
114538,the,O,6011
114539,management,O,6011
114540,of,O,6011
114541,VKC,B-NAME_OF_DISEASE,6011
114542,It,O,6011
114543,works,O,6011
114544,by,O,6012
114545,inhibiting,O,6012
114546,T-cell,O,6012
114547,activation,O,6012
114548,and,O,6012
114549,reducing,O,6012
114550,the,O,6012
114551,level,O,6012
114552,of,O,6012
114553,immune,O,6012
114554,cells,O,6012
114555,and,O,6012
114556,mediators,O,6012
114557,that,O,6012
114558,cause,O,6012
114559,the,O,6012
114560,chronic,O,6012
114561,severe,O,6012
114562,potentially,O,6012
114563,debilitating,O,6012
114564,allergic,B-SIGN_AND_SYMPTOM,6012
114565,inflammation,I-SIGN_AND_SYMPTOM,6012
114566,of,O,6012
114567,the,O,6012
114568,ocular,O,6012
114569,surface,O,6012
114570,that,O,6012
114571,is,O,6012
114572,seen,O,6012
114573,in,O,6012
114574,those,O,6012
114575,affected,O,6012
114576,by,O,6012
114577,VKC,B-NAME_OF_DISEASE,6012
114578,Worldwide,O,6013
114579,Verkazia,B-NAME_OF_DRUG,6013
114580,is,O,6013
114581,available,O,6013
114582,for,O,6013
114583,the,O,6013
114584,treatment,O,6013
114585,of,O,6013
114586,VKC,B-NAME_OF_DISEASE,6013
114587,in,O,6013
114588,more,O,6013
114589,than,O,6013
114590,10,O,6013
114591,countries,O,6013
114592,across,O,6013
114593,Asia,B-GPE,6013
114594,Europe,B-GPE,6013
114595,and,O,6013
114596,Canada,B-GPE,6013
114597,About,O,6013
114598,Clinical,O,6013
114599,Data,O,6013
114600,The,B-ORGANIZATION,6013
114601,FDA,I-ORGANIZATION,6013
114602,approval,O,6013
114603,for,O,6013
114604,Verkazia,B-NAME_OF_DRUG,6013
114605,was,O,6013
114606,based,O,6013
114607,on,O,6013
114608,data,O,6013
114609,from,O,6013
114610,the,B-NAME_OF_STUDY,6013
114611,pivotal,I-NAME_OF_STUDY,6013
114612,VEKTIS,I-NAME_OF_STUDY,6013
114613,study,I-NAME_OF_STUDY,6013
114614,and,O,6013
114615,the,B-NAME_OF_STUDY,6013
114616,phase,I-NAME_OF_STUDY,6013
114617,2,I-NAME_OF_STUDY,6013
114618,3,I-NAME_OF_STUDY,6013
114619,NOVATIVE,I-NAME_OF_STUDY,6013
114620,study,I-NAME_OF_STUDY,6013
114621,which,O,6013
114622,assessed,O,6013
114623,the,O,6013
114624,efficacy,O,6013
114625,and,O,6013
114626,tolerability,O,6013
114627,of,O,6013
114628,Verkazia,B-NAME_OF_DRUG,6014
114629,for,O,6014
114630,treating,O,6014
114631,active,O,6014
114632,VKC,B-NAME_OF_DISEASE,6014
114633,in,O,6014
114634,children,O,6014
114635,and,O,6014
114636,adolescents,O,6014
114637,In,O,6014
114638,the,O,6014
114639,studies,O,6014
114640,Verkazia,B-NAME_OF_DRUG,6014
114641,demonstrated,O,6014
114642,improvements,O,6014
114643,in,O,6014
114644,inflammation,B-SIGN_AND_SYMPTOM,6014
114645,of,I-SIGN_AND_SYMPTOM,6014
114646,the,I-SIGN_AND_SYMPTOM,6014
114647,cornea,I-SIGN_AND_SYMPTOM,6014
114648,keratitis,O,6014
114649,score,O,6014
114650,and,O,6014
114651,ocular,B-SIGN_AND_SYMPTOM,6014
114652,itching,I-SIGN_AND_SYMPTOM,6014
114653,About,O,6014
114654,Santen,B-ORGANIZATION,6014
114655,As,O,6014
114656,a,O,6014
114657,specialized,O,6014
114658,company,O,6015
114659,dedicated,O,6015
114660,to,O,6015
114661,ophthalmology,O,6015
114662,Santen,B-ORGANIZATION,6015
114663,carries,O,6015
114664,out,O,6015
114665,research,O,6015
114666,development,O,6015
114667,marketing,O,6016
114668,and,O,6016
114669,sales,O,6016
114670,of,O,6016
114671,pharmaceuticals,O,6016
114672,over-the-counter,O,6016
114673,products,O,6016
114674,and,O,6016
114675,medical,O,6016
114676,devices,O,6016
114677,and,O,6016
114678,its,O,6016
114679,products,O,6016
114680,now,O,6016
114681,reach,O,6016
114682,patients,O,6016
114683,in,O,6017
114684,over,O,6017
114685,60,O,6017
114686,countries,O,6017
114687,Toward,O,6017
114688,realizing,O,6017
114689,WORLD,O,6017
114690,VISION,O,6017
114691,Happiness,O,6017
114692,with,O,6017
114693,Vision,O,6017
114694,the,O,6017
114695,world,O,6017
114696,Santen,B-ORGANIZATION,6017
114697,ultimately,O,6017
114698,aspires,O,6017
114699,to,O,6017
114700,achieve,O,6018
114701,as,O,6018
114702,a,O,6018
114703,Social,O,6018
114704,Innovator,O,6019
114705,we,O,6019
114706,aim,O,6019
114707,to,O,6019
114708,reduce,O,6019
114709,the,O,6019
114710,social,O,6019
114711,and,O,6019
114712,economic,O,6019
114713,opportunity,O,6019
114714,loss,O,6019
114715,of,O,6019
114716,people,O,6019
114717,around,O,6019
114718,the,O,6019
114719,world,O,6019
114720,caused,O,6019
114721,by,O,6019
114722,eye,O,6019
114723,diseases,O,6020
114724,and,O,6020
114725,defects,O,6020
114726,by,O,6020
114727,orchestrating,O,6020
114728,and,O,6020
114729,mobilizing,O,6020
114730,key,O,6020
114731,technologies,O,6020
114732,and,O,6020
114733,players,O,6020
114734,around,O,6020
114735,the,O,6020
114736,world,O,6020
114737,With,O,6020
114738,scientific,O,6020
114739,knowledge,O,6020
114740,and,O,6020
114741,organizational,O,6020
114742,capabilities,O,6020
114743,nurtured,O,6020
114744,over,O,6020
114745,a,O,6020
114746,130-year,O,6020
114747,history,O,6020
114748,Santen,B-ORGANIZATION,6020
114749,provides,O,6020
114750,products,O,6020
114751,and,O,6020
114752,services,O,6020
114753,to,O,6020
114754,contribute,O,6020
114755,to,O,6020
114756,the,O,6020
114757,well-being,O,6020
114758,of,O,6020
114759,patients,O,6020
114760,their,O,6020
114761,loved,O,6020
114762,ones,O,6020
114763,and,O,6020
114764,consequently,O,6020
114765,to,O,6020
114766,society,O,6021
114767,For,O,6021
114768,more,O,6021
114769,information,O,6021
114770,please,O,6022
114771,visit,O,6022
114772,Santen,B-ORGANIZATION,6022
114773,s,O,6022
114774,website,O,6022
114775,www.santen.co,O,6022
114776,Avellino,B-ORGANIZATION,6022
114777,Launches,O,6022
114778,AvaGen,B-DIAGNOSTIC_TEST,6023
114779,as,O,6023
114780,First,O,6023
114781,Genetic,O,6023
114782,Test,O,6023
114783,to,O,6023
114784,Quantify,O,6023
114785,Keratoconus,B-NAME_OF_DISEASE,6023
114786,Risk,O,6023
114787,and,O,6023
114788,Presence,O,6023
114789,of,O,6023
114790,Corneal,B-NAME_OF_DISEASE,6023
114791,Dystrophies,I-NAME_OF_DISEASE,6023
114792,Novel,O,6023
114793,Test,O,6023
114794,Provides,O,6023
114795,Early,O,6023
114796,Understanding,O,6023
114797,of,O,6023
114798,Eye,O,6023
114799,Disease,O,6023
114800,to,O,6023
114801,Enable,O,6023
114802,Timely,O,6023
114803,Treatment,O,6023
114804,and,O,6023
114805,More,O,6024
114806,Informed,O,6024
114807,Patient,O,6024
114808,Management,O,6024
114809,Avellino,B-ORGANIZATION,6024
114810,Lab,O,6024
114811,USA,O,6024
114812,Inc,O,6024
114813,is,O,6024
114814,a,O,6024
114815,global,O,6024
114816,leader,O,6024
114817,in,O,6024
114818,gene,O,6024
114819,therapy,O,6024
114820,and,O,6024
114821,molecular,O,6024
114822,diagnostics,O,6024
114823,at,O,6024
114824,the,O,6024
114825,forefront,O,6024
114826,of,O,6024
114827,precision,O,6025
114828,medicine,O,6025
114829,for,O,6025
114830,eye,O,6025
114831,care,O,6025
114832,With,O,6025
114833,a,O,6025
114834,long-term,O,6025
114835,mission,O,6025
114836,to,O,6025
114837,develop,O,6025
114838,personalized,O,6025
114839,approaches,O,6025
114840,to,O,6025
114841,improve,O,6025
114842,health,O,6025
114843,and,O,6025
114844,disease,O,6025
114845,management,O,6025
114846,through,O,6025
114847,genomics,O,6025
114848,the,O,6025
114849,company,O,6025
114850,is,O,6025
114851,developing,O,6026
114852,a,O,6026
114853,transformative,O,6026
114854,genetic,O,6026
114855,diagnostics,O,6026
114856,product,O,6026
114857,pipeline,O,6026
114858,as,O,6026
114859,well,O,6026
114860,as,O,6026
114861,genetic,O,6026
114862,therapeutics,O,6026
114863,leveraging,O,6026
114864,CRISPR,B-CHEMICAL_COMPOUND,6026
114865,gene,I-CHEMICAL_COMPOUND,6026
114866,editing,O,6026
114867,to,O,6026
114868,better,O,6026
114869,manage,O,6027
114870,and,O,6027
114871,potentially,O,6027
114872,cure,O,6027
114873,inherited,O,6027
114874,diseases,O,6027
114875,Avellino,B-ORGANIZATION,6027
114876,Lab,O,6027
114877,USA,O,6027
114878,Inc,O,6027
114879,Avellino,B-ORGANIZATION,6027
114880,announced,O,6027
114881,full,O,6027
114882,nationwide,O,6027
114883,availability,O,6027
114884,in,O,6027
114885,the,O,6027
114886,U.S,O,6027
114887,of,O,6027
114888,AvaGen™,B-DIAGNOSTIC_TEST,6027
114889,The,I-DIAGNOSTIC_TEST,6027
114890,Genetic,I-DIAGNOSTIC_TEST,6027
114891,Eye,I-DIAGNOSTIC_TEST,6027
114892,Test,I-DIAGNOSTIC_TEST,6027
114893,as,O,6027
114894,the,O,6028
114895,first,O,6028
114896,genetic,O,6028
114897,test,O,6028
114898,that,O,6028
114899,helps,O,6028
114900,determine,O,6028
114901,a,O,6028
114902,patient,O,6028
114903,s,O,6028
114904,risk,O,6028
114905,of,O,6028
114906,keratoconus,B-NAME_OF_DISEASE,6028
114907,and,O,6028
114908,the,O,6028
114909,presence,O,6028
114910,of,O,6028
114911,other,O,6028
114912,corneal,B-NAME_OF_DISEASE,6028
114913,dystrophies,I-NAME_OF_DISEASE,6028
114914,The,O,6028
114915,test,O,6029
114916,allows,O,6029
114917,for,O,6029
114918,more,O,6029
114919,confident,O,6029
114920,management,O,6029
114921,and,O,6029
114922,treatment,O,6029
114923,for,O,6029
114924,patients,O,6029
114925,with,O,6029
114926,these,O,6029
114927,conditions,O,6029
114928,in,O,6029
114929,order,O,6029
114930,to,O,6029
114931,protect,O,6029
114932,and,O,6029
114933,preserve,O,6029
114934,patient,O,6029
114935,vision,O,6029
114936,The,O,6029
114937,test,O,6029
114938,is,O,6029
114939,designed,O,6029
114940,to,O,6029
114941,provide,O,6029
114942,keratoconus,B-NAME_OF_DISEASE,6029
114943,patients,O,6029
114944,with,O,6029
114945,an,O,6029
114946,earlier,O,6029
114947,benefit,O,6029
114948,from,O,6029
114949,FDA-approved,O,6029
114950,cross-linking,O,6029
114951,treatment,O,6029
114952,which,O,6029
114953,can,O,6030
114954,halt,O,6030
114955,disease,O,6030
114956,progression,O,6030
114957,and,O,6031
114958,preserve,O,6031
114959,vision,O,6031
114960,The,O,6031
114961,AvaGen,B-DIAGNOSTIC_TEST,6031
114962,results,O,6031
114963,can,O,6031
114964,also,O,6031
114965,influence,O,6031
114966,an,O,6031
114967,eye,O,6032
114968,care,O,6032
114969,professional,O,6032
114970,s,O,6032
114971,choice,O,6032
114972,of,O,6032
114973,refractive,O,6032
114974,surgery,O,6032
114975,options,O,6032
114976,for,O,6032
114977,patients,O,6032
114978,The,B-DIAGNOSTIC_TEST,6032
114979,AvaGen,I-DIAGNOSTIC_TEST,6032
114980,genetic,I-DIAGNOSTIC_TEST,6032
114981,test,I-DIAGNOSTIC_TEST,6032
114982,examines,O,6032
114983,75,O,6032
114984,keratoconus-related,O,6032
114985,genes,O,6032
114986,and,O,6032
114987,more,O,6032
114988,than,O,6032
114989,2,O,6032
114990,0,O,6032
114991,variants,O,6032
114992,of,O,6032
114993,those,O,6032
114994,genes,O,6032
114995,to,O,6032
114996,develop,O,6032
114997,an,O,6032
114998,actionable,O,6032
114999,keratoconus,B-NAME_OF_DISEASE,6032
115000,genetic,O,6032
115001,risk,O,6032
115002,score,O,6032
115003,As,O,6032
115004,certain,O,6032
115005,ethnicities,O,6032
115006,have,O,6032
115007,a,O,6032
115008,higher,O,6032
115009,prevalence,O,6033
115010,of,O,6033
115011,this,O,6033
115012,eye,O,6033
115013,condition,O,6033
115014,the,B-DIAGNOSTIC_TEST,6033
115015,AvaGen,I-DIAGNOSTIC_TEST,6033
115016,test,I-DIAGNOSTIC_TEST,6033
115017,also,O,6033
115018,factors,O,6033
115019,this,O,6033
115020,information,O,6033
115021,into,O,6033
115022,its,O,6033
115023,results,O,6033
115024,For,O,6033
115025,corneal,B-NAME_OF_DISEASE,6033
115026,dystrophies,I-NAME_OF_DISEASE,6033
115027,AvaGen,B-DIAGNOSTIC_TEST,6033
115028,determines,O,6033
115029,the,O,6033
115030,presence,O,6033
115031,of,O,6033
115032,any,O,6033
115033,of,O,6033
115034,the,O,6033
115035,70,O,6033
115036,TGFBI,B-NAME_OF_DRUG,6033
115037,gene,I-NAME_OF_DRUG,6033
115038,variants,O,6033
115039,and,O,6033
115040,provides,O,6033
115041,a,O,6033
115042,conclusive,O,6034
115043,diagnosis,O,6034
115044,of,O,6034
115045,corneal,B-NAME_OF_DISEASE,6034
115046,dystrophy,I-NAME_OF_DISEASE,6034
115047,sub-types,O,6034
115048,such,O,6034
115049,as,O,6034
115050,Epithelial,B-NAME_OF_DISEASE,6034
115051,Basement,I-NAME_OF_DISEASE,6034
115052,Membrane,I-NAME_OF_DISEASE,6034
115053,Granular,B-NAME_OF_DISEASE,6034
115054,and,I-NAME_OF_DISEASE,6034
115055,Lattice,I-NAME_OF_DISEASE,6034
115056,disease,I-NAME_OF_DISEASE,6034
115057,distinctions,I-NAME_OF_DISEASE,6034
115058,Reis-Bucklers,B-NAME_OF_DISEASE,6034
115059,Schnyder,B-NAME_OF_DISEASE,6034
115060,and,I-NAME_OF_DISEASE,6034
115061,Theill-Behnke,I-NAME_OF_DISEASE,6034
115062,Assessing,O,6034
115063,keratoconus,B-NAME_OF_DISEASE,6034
115064,is,O,6034
115065,multi-factorial,O,6034
115066,Until,O,6034
115067,now,O,6034
115068,genetic,O,6034
115069,data,O,6034
115070,has,O,6034
115071,been,O,6034
115072,missing,O,6034
115073,from,O,6034
115074,the,O,6034
115075,equation,O,6034
115076,I,O,6034
115077,order,O,6034
115078,AvaGen,B-DIAGNOSTIC_TEST,6034
115079,when,O,6035
115080,I,O,6035
115081,have,O,6035
115082,any,O,6035
115083,red,O,6035
115084,flag,O,6035
115085,concerns,O,6035
115086,in,O,6035
115087,my,O,6035
115088,refractive,O,6035
115089,surgical,O,6035
115090,evaluations,O,6035
115091,such,O,6035
115092,as,O,6035
115093,high,O,6035
115094,astigmatism,B-NAME_OF_DISEASE,6035
115095,or,O,6035
115096,steep,B-NAME_OF_DISEASE,6035
115097,corneal,I-NAME_OF_DISEASE,6035
115098,curvature,I-NAME_OF_DISEASE,6035
115099,against-the-rule,O,6035
115100,or,O,6035
115101,irregular,O,6035
115102,astigmatism,B-NAME_OF_DISEASE,6035
115103,in,O,6035
115104,younger,O,6035
115105,patients,O,6035
115106,a,O,6035
115107,thin,O,6035
115108,cornea,B-PART_OF_THE_EYES,6035
115109,or,O,6035
115110,in,O,6036
115111,family,O,6036
115112,members,O,6036
115113,of,O,6036
115114,a,O,6036
115115,known,O,6036
115116,keratoconus,B-NAME_OF_DISEASE,6036
115117,patient,O,6036
115118,AvaGen,B-DIAGNOSTIC_TEST,6036
115119,helps,O,6036
115120,me,O,6036
115121,know,O,6036
115122,earlier,O,6036
115123,about,O,6036
115124,a,O,6036
115125,patient,O,6036
115126,s,O,6036
115127,genetic,O,6036
115128,predisposition,O,6036
115129,and,O,6036
115130,allows,O,6036
115131,me,O,6036
115132,to,O,6036
115133,make,O,6037
115134,confident,O,6037
115135,treatment,O,6037
115136,and,O,6037
115137,management,O,6037
115138,decisions,O,6037
115139,says,O,6037
115140,Elizabeth,B-PERSON,6037
115141,Yeu,I-PERSON,6037
115142,MD,I-PERSON,6037
115143,of,O,6037
115144,Virginia,B-ORGANIZATION,6037
115145,Eye,I-ORGANIZATION,6037
115146,Consultants,I-ORGANIZATION,6037
115147,an,O,6037
115148,advisor,O,6037
115149,to,O,6037
115150,Avellino,B-ORGANIZATION,6037
115151,Keratoconus,B-NAME_OF_DISEASE,6037
115152,is,O,6037
115153,a,O,6037
115154,progressive,O,6037
115155,vision,O,6037
115156,disorder,O,6037
115157,affecting,O,6037
115158,approximately,O,6037
115159,885,O,6037
115160,0,O,6037
115161,Americans,O,6037
115162,1,O,6037
115163,in,O,6038
115164,375,O,6038
115165,that,O,6038
115166,is,O,6038
115167,often,O,6038
115168,underdiagnosed,O,6038
115169,or,O,6039
115170,misdiagnosed,O,6039
115171,in,O,6039
115172,its,O,6039
115173,earlier,O,6039
115174,stages,O,6039
115175,when,O,6039
115176,it,O,6039
115177,can,O,6039
115178,be,O,6039
115179,better,O,6039
115180,managed,O,6039
115181,and,O,6039
115182,treated,O,6039
115183,to,O,6040
115184,protect,O,6040
115185,and,O,6040
115186,preserve,O,6040
115187,vision,O,6040
115188,Today,O,6040
115189,s,O,6040
115190,corneal,O,6041
115191,diagnostic,O,6041
115192,imaging,O,6041
115193,tools,O,6041
115194,often,O,6041
115195,do,O,6041
115196,not,O,6041
115197,diagnose,O,6041
115198,the,O,6041
115199,disease,O,6041
115200,early,O,6041
115201,or,O,6041
115202,misdiagnose,O,6041
115203,keratoconus,B-NAME_OF_DISEASE,6041
115204,as,O,6041
115205,astigmatism,B-NAME_OF_DISEASE,6041
115206,or,O,6041
115207,myopia,B-NAME_OF_DISEASE,6041
115208,and,O,6041
115209,most,O,6041
115210,optometrists,O,6041
115211,do,O,6041
115212,not,O,6041
115213,have,O,6041
115214,access,O,6041
115215,to,O,6041
115216,these,O,6041
115217,imaging,O,6041
115218,tools,O,6041
115219,Because,O,6041
115220,of,O,6041
115221,this,O,6041
115222,patients,O,6042
115223,are,O,6042
115224,typically,O,6042
115225,managed,O,6042
115226,with,O,6042
115227,a,O,6042
115228,wait-and-see,O,6042
115229,approach,O,6042
115230,which,O,6042
115231,often,O,6042
115232,results,O,6042
115233,in,O,6042
115234,a,O,6042
115235,diagnosis,O,6042
115236,only,O,6042
115237,after,O,6042
115238,vision,O,6042
115239,has,O,6042
115240,been,O,6042
115241,impacted,O,6042
115242,Corneal,B-NAME_OF_DISEASE,6042
115243,dystrophies,I-NAME_OF_DISEASE,6042
115244,are,O,6042
115245,a,O,6042
115246,rarer,O,6042
115247,group,O,6042
115248,of,O,6042
115249,genetic,O,6042
115250,diseases,O,6042
115251,which,O,6042
115252,can,O,6042
115253,cause,O,6042
115254,not,O,6042
115255,only,O,6042
115256,vision,B-SIGN_AND_SYMPTOM,6042
115257,loss,I-SIGN_AND_SYMPTOM,6042
115258,but,O,6042
115259,also,O,6042
115260,pain,B-SIGN_AND_SYMPTOM,6042
115261,and,I-SIGN_AND_SYMPTOM,6042
115262,discomfort,I-SIGN_AND_SYMPTOM,6042
115263,for,O,6042
115264,the,O,6042
115265,nearly,O,6042
115266,280,O,6042
115267,0,O,6043
115268,patients,O,6043
115269,in,O,6043
115270,the,O,6043
115271,U.S,O,6043
115272,with,O,6043
115273,some,O,6043
115274,type,O,6043
115275,of,O,6043
115276,corneal,B-NAME_OF_DISEASE,6043
115277,dystrophy,I-NAME_OF_DISEASE,6043
115278,Other,O,6043
115279,diagnostic,O,6043
115280,tools,O,6043
115281,are,O,6043
115282,often,O,6043
115283,unable,O,6043
115284,to,O,6043
115285,provide,O,6043
115286,a,O,6043
115287,definitive,O,6043
115288,diagnosis,O,6043
115289,of,O,6043
115290,the,O,6043
115291,disease,O,6043
115292,Avellino,B-ORGANIZATION,6043
115293,Chief,O,6043
115294,Scientific,O,6043
115295,Officer,O,6043
115296,Nazneen,O,6043
115297,Aziz,O,6043
115298,Ph.D,O,6043
115299,states,O,6043
115300,We,O,6044
115301,are,O,6044
115302,pleased,O,6044
115303,to,O,6044
115304,make,O,6044
115305,an,O,6044
115306,impact,O,6044
115307,on,O,6044
115308,patients,O,6044
115309,lives,O,6044
115310,by,O,6044
115311,uncovering,O,6044
115312,the,O,6044
115313,genetic,O,6044
115314,risk,O,6044
115315,of,O,6044
115316,sight-threatening,O,6044
115317,diseases,O,6044
115318,and,O,6044
115319,enabling,O,6044
115320,doctors,O,6044
115321,to,O,6044
115322,deliver,O,6044
115323,a,O,6044
115324,higher,O,6044
115325,level,O,6044
115326,of,O,6044
115327,personalized,O,6044
115328,targeted,O,6044
115329,eye,O,6044
115330,care,O,6044
115331,AvaGen,B-DIAGNOSTIC_TEST,6044
115332,empowers,O,6044
115333,eye,O,6044
115334,care,O,6045
115335,professionals,O,6045
115336,with,O,6045
115337,genetic,O,6045
115338,data,O,6045
115339,for,O,6045
115340,everyday,O,6045
115341,use,O,6045
115342,in,O,6045
115343,their,O,6045
115344,medical,O,6045
115345,practice,O,6045
115346,so,O,6045
115347,they,O,6045
115348,can,O,6045
115349,detect,O,6045
115350,earlier,O,6045
115351,the,O,6045
115352,risk,O,6045
115353,of,O,6045
115354,developing,O,6045
115355,keratoconus,B-NAME_OF_DISEASE,6045
115356,versus,O,6045
115357,other,O,6045
115358,more,O,6045
115359,traditional,O,6045
115360,methods,O,6045
115361,and,O,6045
115362,take,O,6045
115363,actionable,O,6045
115364,decisions,O,6045
115365,on,O,6045
115366,the,O,6045
115367,best,O,6045
115368,course,O,6045
115369,of,O,6045
115370,treatment,O,6045
115371,to,O,6045
115372,protect,O,6045
115373,and,O,6045
115374,preserve,O,6045
115375,vision,O,6045
115376,Avellino,B-ORGANIZATION,6045
115377,CEO,O,6045
115378,and,O,6045
115379,President,O,6045
115380,Jim,B-PERSON,6046
115381,Mazzo,I-PERSON,6046
115382,notes,O,6046
115383,It,O,6046
115384,is,O,6046
115385,exciting,O,6046
115386,to,O,6046
115387,be,O,6046
115388,part,O,6046
115389,of,O,6046
115390,transforming,O,6046
115391,eye,O,6046
115392,care,O,6046
115393,with,O,6046
115394,the,O,6046
115395,national,O,6046
115396,introduction,O,6046
115397,of,O,6046
115398,the,O,6047
115399,first,O,6047
115400,comprehensive,O,6047
115401,genetic,O,6047
115402,test,O,6047
115403,for,O,6047
115404,patients,O,6047
115405,with,O,6047
115406,these,O,6047
115407,challenging,O,6047
115408,conditions,O,6047
115409,I,O,6047
115410,congratulate,O,6047
115411,our,O,6047
115412,Avellino,B-ORGANIZATION,6047
115413,team,O,6047
115414,on,O,6047
115415,accomplishing,O,6047
115416,this,O,6047
115417,important,O,6047
115418,commercial,O,6047
115419,milestone,O,6047
115420,for,O,6047
115421,the,O,6047
115422,company,O,6047
115423,and,O,6047
115424,for,O,6048
115425,taking,O,6048
115426,a,O,6048
115427,giant,O,6048
115428,step,O,6048
115429,on,O,6048
115430,our,O,6048
115431,path,O,6048
115432,to,O,6048
115433,developing,O,6048
115434,a,O,6048
115435,host,O,6048
115436,of,O,6048
115437,genomic,O,6048
115438,tests,O,6048
115439,for,O,6048
115440,personalized,O,6048
115441,disease,O,6048
115442,management,O,6048
115443,He,O,6049
115444,continues,O,6049
115445,While,O,6049
115446,we,O,6049
115447,made,O,6049
115448,AvaGen,B-DIAGNOSTIC_TEST,6049
115449,available,O,6049
115450,in,O,6049
115451,late,O,6049
115452,2019,O,6049
115453,we,O,6049
115454,quickly,O,6049
115455,pivoted,O,6049
115456,our,O,6049
115457,resources,O,6049
115458,to,O,6049
115459,do,O,6049
115460,our,O,6049
115461,part,O,6049
115462,to,O,6049
115463,address,O,6049
115464,the,O,6049
115465,COVID-19,B-NAME_OF_DISEASE,6049
115466,pandemic,O,6049
115467,over,O,6049
115468,the,O,6050
115469,last,O,6050
115470,year,O,6050
115471,with,O,6050
115472,the,O,6050
115473,development,O,6050
115474,of,O,6050
115475,our,O,6050
115476,widely-used,O,6050
115477,SARS-CoV-2,B-CHEMICAL_COMPOUND,6050
115478,COVID-19,B-NAME_OF_DISEASE,6050
115479,test,O,6050
115480,which,O,6050
115481,received,O,6050
115482,Emergency,O,6050
115483,Use,O,6050
115484,Authorization,O,6050
115485,EUA,O,6050
115486,from,O,6051
115487,the,B-ORGANIZATION,6051
115488,FDA,I-ORGANIZATION,6051
115489,Thanks,O,6051
115490,to,O,6051
115491,widespread,O,6051
115492,testing,O,6051
115493,and,O,6051
115494,adoption,O,6051
115495,of,O,6051
115496,the,B-TREATMENT,6051
115497,COVID-19,I-TREATMENT,6051
115498,vaccines,I-TREATMENT,6051
115499,we,O,6051
115500,are,O,6051
115501,now,O,6051
115502,able,O,6051
115503,to,O,6051
115504,offer,O,6051
115505,AvaGen,B-DIAGNOSTIC_TEST,6051
115506,nationally,O,6051
115507,AvaGen,B-DIAGNOSTIC_TEST,6051
115508,is,O,6051
115509,designed,O,6051
115510,to,O,6051
115511,be,O,6051
115512,easy,O,6051
115513,to,O,6051
115514,use,O,6051
115515,requiring,O,6051
115516,only,O,6051
115517,a,O,6052
115518,simple,O,6052
115519,cheek,O,6052
115520,swab,O,6052
115521,that,O,6052
115522,is,O,6052
115523,sent,O,6052
115524,to,O,6052
115525,Avellino,B-ORGANIZATION,6052
115526,s,O,6052
115527,high,O,6052
115528,complexity,O,6052
115529,CLIA-certified,O,6052
115530,lab,O,6052
115531,for,O,6052
115532,analysis,O,6052
115533,An,O,6052
115534,eye,O,6052
115535,care,O,6052
115536,professional,O,6052
115537,receives,O,6052
115538,results,O,6052
115539,in,O,6052
115540,days,O,6052
115541,in,O,6052
115542,an,O,6052
115543,intuitive,O,6052
115544,and,O,6052
115545,actionable,O,6052
115546,report,O,6052
115547,via,O,6052
115548,a,O,6052
115549,HIPAA-secured,O,6052
115550,patient,O,6052
115551,portal,O,6052
115552,Genetic,O,6052
115553,counsel,O,6052
115554,is,O,6052
115555,provided,O,6052
115556,alongside,O,6053
115557,test,O,6053
115558,results,O,6053
115559,to,O,6053
115560,ensure,O,6053
115561,eye,O,6053
115562,care,O,6053
115563,professionals,O,6053
115564,and,O,6053
115565,their,O,6053
115566,patients,O,6053
115567,clearly,O,6053
115568,understand,O,6053
115569,the,O,6053
115570,results,O,6053
115571,and,O,6053
115572,their,O,6053
115573,implications,O,6053
115574,for,O,6053
115575,patient,O,6053
115576,management,O,6053
115577,Santen,B-ORGANIZATION,6053
115578,launches,O,6054
115579,PURALID,B-NAME_OF_DRUG,6054
115580,LIPOGEL,I-NAME_OF_DRUG,6054
115581,an,O,6054
115582,ophthalmic,O,6054
115583,gel,O,6054
115584,for,O,6054
115585,blepharitis,B-NAME_OF_DISEASE,6054
115586,that,O,6054
115587,soothes,O,6054
115588,and,O,6054
115589,cleanses,O,6054
115590,the,B-PART_OF_THE_EYES,6054
115591,eyelids,B-PART_OF_THE_EYES,6054
115592,and,O,6054
115593,periocular,B-PART_OF_THE_EYES,6054
115594,area,I-PART_OF_THE_EYES,6054
115595,Founded,O,6054
115596,in,O,6054
115597,Japan,B-GPE,6055
115598,more,O,6055
115599,than,O,6055
115600,a,O,6055
115601,century,O,6055
115602,ago,O,6055
115603,and,O,6055
115604,currently,O,6055
115605,providing,O,6055
115606,healthcare,O,6055
115607,to,O,6055
115608,people,O,6055
115609,around,O,6055
115610,the,O,6055
115611,globe,O,6055
115612,Santen,B-ORGANIZATION,6055
115613,Pharmaceutical,I-ORGANIZATION,6055
115614,is,O,6055
115615,one,O,6055
115616,of,O,6055
115617,the,O,6055
115618,top,O,6056
115619,specialist,O,6056
115620,ophthalmic,O,6056
115621,pharmaceutical,O,6056
115622,firms,O,6056
115623,in,O,6056
115624,the,O,6056
115625,world,O,6056
115626,According,O,6056
115627,to,O,6056
115628,a,O,6056
115629,recent,O,6056
115630,Santen-commissioned,O,6056
115631,assessment,O,6056
115632,of,O,6056
115633,blepharitis,B-NAME_OF_DISEASE,6056
115634,patients,O,6056
115635,in,O,6056
115636,three,O,6056
115637,European,O,6056
115638,nations,O,6056
115639,several,O,6056
115640,of,O,6056
115641,the,O,6056
115642,most,O,6056
115643,severe,O,6056
115644,and,O,6056
115645,frequent,O,6056
115646,symptoms,O,6056
115647,observed,O,6056
115648,such,O,6056
115649,as,O,6056
115650,dry,B-SIGN_AND_SYMPTOM,6056
115651,eyes,I-SIGN_AND_SYMPTOM,6056
115652,and,I-SIGN_AND_SYMPTOM,6056
115653,red,I-SIGN_AND_SYMPTOM,6056
115654,itchy,I-SIGN_AND_SYMPTOM,6057
115655,and,I-SIGN_AND_SYMPTOM,6057
115656,irritated,I-SIGN_AND_SYMPTOM,6057
115657,eyelids,B-PART_OF_THE_EYES,6057
115658,are,O,6057
115659,not,O,6057
115660,fully,O,6057
115661,alleviated,O,6057
115662,by,O,6057
115663,current,O,6058
115664,treatments,O,6058
115665,Ophthalmologists,O,6058
115666,now,O,6058
115667,have,O,6058
115668,a,O,6058
115669,new,O,6058
115670,choice,O,6058
115671,thanks,O,6058
115672,to,O,6058
115673,PURALID,B-NAME_OF_DRUG,6058
115674,LIPOGEL,I-NAME_OF_DRUG,6058
115675,a,O,6058
115676,mild,O,6058
115677,gel,O,6059
115678,that,O,6059
115679,works,O,6059
115680,hard,O,6059
115681,to,O,6059
115682,clean,O,6059
115683,and,O,6059
115684,soothe,O,6059
115685,sore,O,6059
115686,eyelids,B-PART_OF_THE_EYES,6059
115687,For,O,6059
115688,the,O,6059
115689,majority,O,6059
115690,of,O,6059
115691,patients,O,6060
115692,blepharitis,B-NAME_OF_DISEASE,6060
115693,is,O,6060
115694,a,O,6060
115695,chronic,O,6060
115696,lifelong,O,6060
115697,disorder,O,6060
115698,marked,O,6060
115699,by,O,6060
115700,a,O,6060
115701,cycle,O,6060
115702,of,O,6060
115703,exacerbations,O,6060
115704,and,O,6061
115705,remissions,O,6061
115706,It,O,6061
115707,results,O,6061
115708,in,O,6061
115709,crusting,O,6061
115710,of,O,6061
115711,the,O,6061
115712,eyelid,B-PART_OF_THE_EYES,6061
115713,edge,O,6061
115714,and,O,6061
115715,painful,O,6061
115716,red,O,6061
115717,puffy,O,6061
115718,greasy,O,6061
115719,itchy,O,6061
115720,eyes,O,6061
115721,with,O,6061
115722,a,O,6061
115723,gritty,O,6061
115724,foreign,O,6061
115725,object,O,6061
115726,sensation,O,6061
115727,Despite,O,6061
115728,these,O,6061
115729,recognizable,O,6061
115730,signs,O,6061
115731,there,O,6061
115732,are,O,6061
115733,regional,O,6061
115734,differences,O,6061
115735,in,O,6061
115736,how,O,6061
115737,people,O,6061
115738,in,O,6061
115739,Europe,B-GPE,6061
115740,are,O,6061
115741,familiar,O,6061
115742,with,O,6061
115743,the,O,6061
115744,term,O,6061
115745,blepharitis,B-NAME_OF_DISEASE,6061
115746,with,O,6061
115747,almost,O,6061
115748,half,O,6061
115749,42%,O,6061
115750,of,O,6061
115751,patients,O,6061
115752,surveyed,O,6061
115753,admitting,O,6062
115754,they,O,6062
115755,had,O,6062
115756,never,O,6062
115757,heard,O,6062
115758,of,O,6062
115759,it,O,6062
115760,before,O,6062
115761,their,O,6062
115762,diagnosis,O,6062
115763,However,O,6062
115764,blepharitis,B-NAME_OF_DISEASE,6062
115765,is,O,6062
115766,a,O,6062
115767,prevalent,O,6062
115768,clinical,O,6062
115769,condition,O,6062
115770,among,O,6062
115771,ophthalmologists,O,6062
115772,It,O,6062
115773,can,O,6062
115774,cause,O,6062
115775,bothersome,O,6062
115776,issues,O,6062
115777,including,O,6062
115778,dry,B-SIGN_AND_SYMPTOM,6062
115779,eyes,I-SIGN_AND_SYMPTOM,6063
115780,cysts,I-SIGN_AND_SYMPTOM,6063
115781,and,O,6063
115782,conjunctivitis,B-NAME_OF_DISEASE,6063
115783,if,O,6063
115784,left,O,6063
115785,untreated,O,6063
115786,Recommending,O,6063
115787,eyelid,B-PART_OF_THE_EYES,6063
115788,cleaning,O,6063
115789,is,O,6063
115790,a,O,6063
115791,well-known,O,6063
115792,first,O,6063
115793,step,O,6063
115794,in,O,6063
115795,the,O,6064
115796,treatment,O,6064
115797,of,O,6064
115798,blepharitis,B-NAME_OF_DISEASE,6064
115799,sufferers,O,6064
115800,Blepharitis,B-NAME_OF_DISEASE,6064
115801,is,O,6064
115802,a,O,6064
115803,common,O,6064
115804,and,O,6064
115805,symptomatic,O,6064
115806,disease,O,6064
115807,and,O,6064
115808,it,O,6065
115809,has,O,6065
115810,no,O,6065
115811,established,O,6065
115812,cure,O,6065
115813,It,O,6065
115814,s,O,6065
115815,therefore,O,6065
115816,crucial,O,6065
115817,that,O,6065
115818,we,O,6065
115819,recognise,O,6065
115820,that,O,6065
115821,this,O,6065
115822,condition,O,6065
115823,needs,O,6065
115824,a,O,6065
115825,careful,O,6065
115826,diagnostic,O,6065
115827,approach,O,6065
115828,and,O,6065
115829,personalised,O,6066
115830,management,O,6066
115831,and,O,6066
115832,that,O,6066
115833,we,O,6066
115834,continue,O,6066
115835,to,O,6066
115836,educate,O,6066
115837,patients,O,6066
115838,on,O,6066
115839,the,O,6066
115840,value,O,6066
115841,of,O,6066
115842,lid,O,6066
115843,hygiene,O,6066
115844,such,O,6066
115845,as,O,6066
115846,using,B-PREVENTION,6066
115847,warm,I-PREVENTION,6066
115848,compresses,I-PREVENTION,6066
115849,and,I-PREVENTION,6066
115850,cleansing,I-PREVENTION,6066
115851,the,I-PREVENTION,6066
115852,eyelids,I-PREVENTION,6066
115853,daily,I-PREVENTION,6067
115854,said,O,6067
115855,Professor,O,6067
115856,Edoardo,B-PERSON,6067
115857,Villani,I-PERSON,6067
115858,University,B-ORGANIZATION,6067
115859,of,I-ORGANIZATION,6067
115860,Milan,I-ORGANIZATION,6067
115861,Italy,I-ORGANIZATION,6067
115862,However,O,6067
115863,we,O,6067
115864,know,O,6067
115865,that,O,6067
115866,some,O,6067
115867,patients,O,6067
115868,struggle,O,6067
115869,with,O,6067
115870,current,O,6067
115871,hygiene,O,6068
115872,options,O,6068
115873,and,O,6068
115874,that,O,6068
115875,even,O,6068
115876,mild,O,6068
115877,forms,O,6068
115878,of,O,6068
115879,blepharitis,B-NAME_OF_DISEASE,6068
115880,will,O,6068
115881,only,O,6068
115882,be,O,6068
115883,successfully,O,6068
115884,managed,O,6068
115885,if,O,6068
115886,patients,O,6068
115887,persevere,O,6068
115888,Our,O,6068
115889,survey,O,6068
115890,surprisingly,O,6068
115891,revealed,O,6068
115892,that,O,6068
115893,only,O,6069
115894,17%,O,6069
115895,of,O,6069
115896,people,O,6069
115897,were,O,6069
115898,fully,O,6069
115899,satisfied,O,6069
115900,with,O,6069
115901,their,O,6069
115902,blepharitis,B-NAME_OF_DISEASE,6069
115903,treatment,O,6069
115904,The,O,6069
115905,application,O,6069
115906,was,O,6069
115907,either,O,6069
115908,inconvenient,O,6069
115909,or,O,6069
115910,irritating,O,6069
115911,to,O,6069
115912,the,O,6069
115913,eyes,O,6069
115914,among,O,6069
115915,other,O,6069
115916,reasons,O,6069
115917,PURALID,B-NAME_OF_DRUG,6069
115918,LIPOGEL,I-NAME_OF_DRUG,6069
115919,is,O,6069
115920,an,O,6069
115921,easy-to-apply,O,6069
115922,gel,O,6069
115923,for,O,6070
115924,the,O,6070
115925,relief,O,6070
115926,of,O,6070
115927,acute,O,6070
115928,flares,O,6070
115929,aggravated,O,6070
115930,symptoms,O,6070
115931,and,O,6070
115932,long-term,O,6070
115933,maintenance,O,6070
115934,asymptomatic,O,6070
115935,symptoms,O,6070
115936,of,O,6070
115937,blepharitis,B-NAME_OF_DISEASE,6070
115938,It,O,6070
115939,contains,O,6070
115940,liposomes,B-CHEMICAL_COMPOUND,6070
115941,which,O,6070
115942,are,O,6070
115943,known,O,6070
115944,for,O,6070
115945,their,O,6070
115946,soothing,O,6070
115947,relieving,O,6070
115948,and,O,6070
115949,emollient,O,6070
115950,properties,O,6070
115951,as,O,6070
115952,well,O,6070
115953,as,O,6070
115954,their,O,6070
115955,ability,O,6071
115956,to,O,6071
115957,facilitate,O,6071
115958,the,O,6071
115959,bioavailability,O,6071
115960,of,O,6071
115961,substances,O,6071
115962,Other,O,6071
115963,ingredients,O,6071
115964,include,O,6071
115965,tea,B-CHEMICAL_COMPOUND,6071
115966,tree,I-CHEMICAL_COMPOUND,6071
115967,oil,I-CHEMICAL_COMPOUND,6071
115968,vitamin,B-CHEMICAL_COMPOUND,6071
115969,A,I-CHEMICAL_COMPOUND,6071
115970,xanthan,B-CHEMICAL_COMPOUND,6071
115971,gum,I-CHEMICAL_COMPOUND,6071
115972,ferulic,B-CHEMICAL_COMPOUND,6071
115973,acid,I-CHEMICAL_COMPOUND,6071
115974,vitamin,B-CHEMICAL_COMPOUND,6071
115975,E,I-CHEMICAL_COMPOUND,6071
115976,TPGS,I-CHEMICAL_COMPOUND,6071
115977,and,O,6071
115978,alfa,B-CHEMICAL_COMPOUND,6072
115979,bisabolol,I-CHEMICAL_COMPOUND,6072
115980,Blepharitis,B-NAME_OF_DISEASE,6072
115981,can,O,6072
115982,be,O,6072
115983,sore,O,6072
115984,troublesome,O,6072
115985,uncomfortable,O,6072
115986,and,O,6072
115987,irritating,O,6072
115988,for,O,6072
115989,people,O,6072
115990,so,O,6072
115991,it,O,6073
115992,can,O,6073
115993,have,O,6073
115994,a,O,6073
115995,serious,O,6073
115996,negative,O,6073
115997,impact,O,6073
115998,on,O,6073
115999,quality,O,6073
116000,of,O,6073
116001,life,O,6073
116002,Our,O,6073
116003,survey,O,6073
116004,demonstrated,O,6073
116005,that,O,6073
116006,blepharitis,B-NAME_OF_DISEASE,6073
116007,interferes,O,6073
116008,with,O,6073
116009,daily,O,6073
116010,activities,O,6073
116011,and,O,6073
116012,can,O,6074
116013,prevent,O,6074
116014,reading,O,6074
116015,and,O,6074
116016,normal,O,6074
116017,use,O,6074
116018,of,O,6074
116019,a,O,6074
116020,computer,O,6074
116021,or,O,6074
116022,phone,O,6074
116023,said,O,6074
116024,Luis,B-PERSON,6074
116025,Iglesias,I-PERSON,6074
116026,President,O,6074
116027,and,O,6074
116028,Head,O,6074
116029,of,O,6074
116030,Santen,B-ORGANIZATION,6074
116031,EMEA,I-ORGANIZATION,6074
116032,With,O,6074
116033,blepharitis,B-NAME_OF_DISEASE,6075
116034,impacting,O,6075
116035,how,O,6075
116036,people,O,6075
116037,can,O,6075
116038,use,O,6075
116039,screens,O,6075
116040,plus,O,6075
116041,digital,O,6075
116042,device,O,6075
116043,usage,O,6075
116044,increasing,O,6075
116045,since,O,6075
116046,the,O,6075
116047,COVID-19,B-NAME_OF_DISEASE,6075
116048,pandemic,O,6075
116049,we,O,6076
116050,hope,O,6076
116051,to,O,6076
116052,reaffirm,O,6076
116053,our,O,6076
116054,commitment,O,6076
116055,to,O,6076
116056,eye,O,6076
116057,care,O,6076
116058,with,O,6076
116059,the,O,6076
116060,launch,O,6076
116061,of,O,6076
116062,PURALID,B-NAME_OF_DRUG,6076
116063,LIPOGEL,I-NAME_OF_DRUG,6077
116064,Up,O,6077
116065,to,O,6077
116066,this,O,6077
116067,point,O,6077
116068,PURALID,B-NAME_OF_DRUG,6077
116069,LIPOGEL,I-NAME_OF_DRUG,6077
116070,has,O,6077
116071,been,O,6077
116072,introduced,O,6077
116073,in,O,6078
116074,Austria,B-GPE,6078
116075,Bulgaria,B-GPE,6078
116076,Estonia,B-GPE,6078
116077,Finland,B-GPE,6078
116078,Hungary,B-GPE,6078
116079,Italy,B-GPE,6078
116080,Latvia,B-GPE,6078
116081,Lithuania,B-GPE,6078
116082,Portugal,B-GPE,6078
116083,Spain,B-GPE,6078
116084,Sweden,B-GPE,6078
116085,and,O,6078
116086,Switzerland,B-GPE,6078
116087,Additional,O,6078
116088,introductions,O,6078
116089,are,O,6078
116090,anticipated,O,6078
116091,in,O,6078
116092,other,O,6078
116093,European,O,6078
116094,countries,O,6078
116095,in,O,6078
116096,the,O,6078
116097,months,O,6078
116098,to,O,6079
116099,come,O,6079
116100,The,O,6079
116101,healthy,O,6079
116102,human,O,6079
116103,brain,O,6079
116104,contains,O,6079
116105,tens,O,6079
116106,of,O,6079
116107,billions,O,6079
116108,of,O,6079
116109,neurons-specialized,O,6079
116110,cells,O,6079
116111,that,O,6079
116112,process,O,6079
116113,and,O,6079
116114,transmit,O,6079
116115,information,O,6079
116116,via,O,6079
116117,electrical,O,6079
116118,and,O,6079
116119,chemical,O,6080
116120,signals,O,6080
116121,They,O,6080
116122,send,O,6080
116123,messages,O,6080
116124,between,O,6080
116125,different,O,6080
116126,parts,O,6080
116127,of,O,6080
116128,the,O,6080
116129,brain,O,6080
116130,and,O,6080
116131,from,O,6080
116132,the,O,6080
116133,brain,O,6080
116134,to,O,6080
116135,the,O,6080
116136,muscles,O,6080
116137,and,O,6080
116138,organs,O,6080
116139,of,O,6080
116140,the,O,6080
116141,body,O,6080
116142,Alzheimer,B-NAME_OF_DISEASE,6080
116143,s,I-NAME_OF_DISEASE,6080
116144,disease,I-NAME_OF_DISEASE,6080
116145,disrupts,O,6080
116146,this,O,6080
116147,communication,O,6080
116148,among,O,6080
116149,neurons,O,6080
116150,resulting,O,6080
116151,in,O,6080
116152,loss,B-SIGN_AND_SYMPTOM,6080
116153,of,I-SIGN_AND_SYMPTOM,6080
116154,function,I-SIGN_AND_SYMPTOM,6081
116155,and,I-SIGN_AND_SYMPTOM,6081
116156,cell,I-SIGN_AND_SYMPTOM,6081
116157,death,I-SIGN_AND_SYMPTOM,6081
116158,It,O,6081
116159,is,O,6081
116160,formed,O,6081
116161,from,O,6081
116162,the,O,6081
116163,breakdown,O,6081
116164,of,O,6081
116165,a,O,6081
116166,larger,O,6081
116167,protein,O,6081
116168,called,O,6081
116169,amyloid,B-CHEMICAL_COMPOUND,6081
116170,precursor,I-CHEMICAL_COMPOUND,6081
116171,protein,I-CHEMICAL_COMPOUND,6081
116172,One,O,6081
116173,form,O,6081
116174,beta-amyloid,B-CHEMICAL_COMPOUND,6081
116175,42,I-CHEMICAL_COMPOUND,6081
116176,is,O,6081
116177,thought,O,6081
116178,to,O,6082
116179,be,O,6082
116180,especially,O,6082
116181,toxic,O,6082
116182,In,O,6082
116183,the,O,6082
116184,Alzheimer,B-NAME_OF_DISEASE,6082
116185,s,I-NAME_OF_DISEASE,6082
116186,brain,O,6082
116187,abnormal,O,6082
116188,levels,O,6082
116189,of,O,6082
116190,this,O,6082
116191,naturally,O,6082
116192,occurring,O,6082
116193,protein,O,6082
116194,clump,O,6082
116195,together,O,6082
116196,to,O,6082
116197,form,O,6082
116198,plaques,O,6082
116199,that,O,6082
116200,collect,O,6082
116201,between,O,6082
116202,neurons,O,6082
116203,and,O,6082
116204,disrupt,O,6082
116205,cell,O,6082
116206,function,O,6082
116207,Recent,O,6082
116208,Study,O,6082
116209,Newly,O,6082
116210,published,O,6082
116211,research,O,6082
116212,has,O,6083
116213,revealed,O,6083
116214,a,O,6083
116215,close,O,6083
116216,link,O,6083
116217,between,O,6083
116218,proteins,O,6083
116219,associated,O,6083
116220,with,O,6083
116221,Alzheimer,B-NAME_OF_DISEASE,6083
116222,s,I-NAME_OF_DISEASE,6083
116223,disease,I-NAME_OF_DISEASE,6083
116224,and,O,6083
116225,age-related,B-NAME_OF_DISEASE,6083
116226,sight,I-NAME_OF_DISEASE,6083
116227,loss,I-NAME_OF_DISEASE,6083
116228,The,O,6083
116229,findings,O,6083
116230,could,O,6083
116231,open,O,6083
116232,the,O,6083
116233,way,O,6083
116234,to,O,6083
116235,new,O,6083
116236,treatments,O,6083
116237,for,O,6083
116238,patients,O,6083
116239,with,O,6083
116240,deteriorating,B-SIGN_AND_SYMPTOM,6083
116241,vision,I-SIGN_AND_SYMPTOM,6083
116242,and,O,6083
116243,through,O,6083
116244,this,O,6083
116245,study,O,6083
116246,the,O,6083
116247,scientists,O,6083
116248,believe,O,6083
116249,they,O,6084
116250,could,O,6084
116251,reduce,O,6084
116252,the,O,6084
116253,need,O,6084
116254,for,O,6084
116255,using,O,6084
116256,animals,O,6084
116257,in,O,6084
116258,future,O,6084
116259,research,O,6084
116260,into,O,6084
116261,blinding,O,6084
116262,conditions,O,6084
116263,Amyloid,B-CHEMICAL_COMPOUND,6084
116264,beta,I-CHEMICAL_COMPOUND,6085
116265,Ab,B-CHEMICAL_COMPOUND,6085
116266,proteins,I-CHEMICAL_COMPOUND,6085
116267,are,O,6085
116268,the,O,6085
116269,primary,O,6085
116270,driver,O,6085
116271,of,O,6085
116272,Alzheimer,B-NAME_OF_DISEASE,6085
116273,s,I-NAME_OF_DISEASE,6085
116274,disease,I-NAME_OF_DISEASE,6085
116275,but,O,6085
116276,also,O,6085
116277,begin,O,6085
116278,to,O,6085
116279,collect,O,6085
116280,in,O,6085
116281,the,B-PART_OF_THE_EYES,6085
116282,retina,I-PART_OF_THE_EYES,6085
116283,as,O,6085
116284,people,O,6085
116285,get,O,6085
116286,older,O,6085
116287,Donor,O,6085
116288,eyes,O,6085
116289,from,O,6085
116290,patients,O,6085
116291,who,O,6085
116292,suffered,O,6086
116293,from,O,6086
116294,age-related,B-NAME_OF_DISEASE,6086
116295,macular,I-NAME_OF_DISEASE,6086
116296,degeneration,I-NAME_OF_DISEASE,6086
116297,AMD,B-NAME_OF_DISEASE,6086
116298,the,O,6086
116299,most,O,6086
116300,common,O,6086
116301,cause,O,6086
116302,of,O,6086
116303,blindness,B-NAME_OF_DISEASE,6086
116304,amongst,O,6086
116305,adults,O,6086
116306,in,O,6086
116307,the,B-GPE,6086
116308,UK,I-GPE,6086
116309,have,O,6086
116310,been,O,6087
116311,shown,O,6087
116312,to,O,6087
116313,contain,O,6087
116314,high,O,6087
116315,levels,O,6087
116316,of,O,6087
116317,Ab,B-CHEMICAL_COMPOUND,6087
116318,in,O,6087
116319,their,O,6087
116320,retinas,B-PART_OF_THE_EYES,6087
116321,This,O,6087
116322,new,O,6087
116323,study,O,6087
116324,published,O,6087
116325,in,O,6087
116326,the,B-PUBLICATION_VENUE,6087
116327,journal,I-PUBLICATION_VENUE,6087
116328,Cells,I-PUBLICATION_VENUE,6087
116329,builds,O,6087
116330,on,O,6087
116331,previous,O,6087
116332,research,O,6087
116333,which,O,6087
116334,shows,O,6087
116335,that,O,6087
116336,Ab,B-CHEMICAL_COMPOUND,6087
116337,collects,O,6087
116338,around,O,6087
116339,a,O,6087
116340,cell,O,6087
116341,layer,O,6087
116342,called,O,6087
116343,the,B-PART_OF_THE_EYES,6087
116344,retinal,I-PART_OF_THE_EYES,6087
116345,pigment,I-PART_OF_THE_EYES,6087
116346,epithelium,I-PART_OF_THE_EYES,6087
116347,RPE,I-PART_OF_THE_EYES,6087
116348,to,O,6087
116349,establish,O,6087
116350,what,O,6087
116351,damage,O,6087
116352,these,O,6088
116353,toxic,O,6088
116354,proteins,O,6088
116355,cause,O,6088
116356,RPE,B-PART_OF_THE_EYES,6088
116357,cells,I-PART_OF_THE_EYES,6088
116358,The,O,6088
116359,research,O,6088
116360,team,O,6088
116361,exposed,O,6088
116362,RPE,B-PART_OF_THE_EYES,6088
116363,cells,I-PART_OF_THE_EYES,6088
116364,of,O,6088
116365,normal,O,6088
116366,mouse,O,6088
116367,eyes,O,6088
116368,and,O,6088
116369,in,O,6088
116370,culture,O,6088
116371,to,O,6088
116372,Ab,B-CHEMICAL_COMPOUND,6088
116373,The,O,6088
116374,mouse,O,6088
116375,model,O,6088
116376,enabled,O,6088
116377,the,O,6088
116378,team,O,6088
116379,to,O,6088
116380,look,O,6089
116381,at,O,6089
116382,the,O,6089
116383,effect,O,6089
116384,the,O,6089
116385,protein,O,6089
116386,has,O,6089
116387,in,O,6089
116388,living,O,6089
116389,eye,B-PART_OF_THE_EYES,6089
116390,tissue,I-PART_OF_THE_EYES,6089
116391,using,O,6089
116392,non-invasive,O,6089
116393,imaging,O,6089
116394,techniques,O,6089
116395,that,O,6089
116396,are,O,6089
116397,used,O,6089
116398,in,O,6089
116399,ophthalmology,O,6089
116400,clinics,O,6089
116401,Their,O,6089
116402,findings,O,6089
116403,showed,O,6089
116404,that,O,6089
116405,the,O,6089
116406,mouse,O,6089
116407,eyes,O,6089
116408,developed,O,6090
116409,retinal,O,6090
116410,pathology,O,6090
116411,that,O,6090
116412,was,O,6090
116413,strikingly,O,6090
116414,similar,O,6090
116415,to,O,6090
116416,AMD,B-NAME_OF_DISEASE,6090
116417,in,O,6090
116418,humans,O,6090
116419,Dr,B-PERSON,6090
116420,Arjuna,I-PERSON,6090
116421,Ratnayaka,I-PERSON,6091
116422,a,O,6091
116423,Lecturer,O,6091
116424,in,O,6091
116425,Vision,O,6091
116426,Sciences,O,6091
116427,at,O,6091
116428,the,B-ORGANIZATION,6091
116429,University,I-ORGANIZATION,6091
116430,of,I-ORGANIZATION,6091
116431,Southampton,I-ORGANIZATION,6091
116432,who,O,6091
116433,led,O,6091
116434,the,O,6091
116435,study,O,6091
116436,said,O,6091
116437,This,O,6091
116438,was,O,6091
116439,an,O,6091
116440,important,O,6091
116441,study,O,6091
116442,which,O,6091
116443,also,O,6091
116444,showed,O,6091
116445,that,O,6091
116446,mouse,O,6091
116447,numbers,O,6091
116448,used,O,6091
116449,for,O,6091
116450,experiments,O,6091
116451,of,O,6091
116452,this,O,6091
116453,kind,O,6091
116454,can,O,6091
116455,be,O,6091
116456,significantly,O,6091
116457,reduced,O,6091
116458,in,O,6091
116459,the,O,6091
116460,future,O,6092
116461,We,O,6092
116462,were,O,6092
116463,able,O,6092
116464,to,O,6092
116465,develop,O,6092
116466,a,O,6092
116467,robust,O,6092
116468,model,O,6092
116469,to,O,6092
116470,study,O,6092
116471,AMD-like,O,6092
116472,retinal,O,6092
116473,pathology,O,6092
116474,driven,O,6092
116475,by,O,6092
116476,Ab,B-CHEMICAL_COMPOUND,6092
116477,without,O,6092
116478,using,O,6092
116479,transgenic,O,6092
116480,animals,O,6092
116481,which,O,6092
116482,are,O,6092
116483,often,O,6092
116484,used,O,6092
116485,by,O,6092
116486,researchers,O,6092
116487,the,O,6092
116488,field,O,6092
116489,Transgenic,O,6092
116490,or,O,6092
116491,genetically,O,6092
116492,engineered,O,6092
116493,mice,O,6092
116494,can,O,6092
116495,take,O,6092
116496,up,B-CHEMICAL_COMPOUND,6092
116497,to,I-CHEMICAL_COMPOUND,6092
116498,a,I-CHEMICAL_COMPOUND,6092
116499,year,I-CHEMICAL_COMPOUND,6092
116500,and,O,6092
116501,typically,O,6092
116502,longer,O,6092
116503,before,O,6093
116504,Ab,B-CHEMICAL_COMPOUND,6093
116505,causes,O,6093
116506,pathology,O,6093
116507,in,O,6093
116508,the,B-PART_OF_THE_EYES,6093
116509,retina,I-PART_OF_THE_EYES,6093
116510,which,O,6093
116511,we,O,6093
116512,can,O,6093
116513,achieve,O,6093
116514,within,B-TIME_DURATION,6093
116515,two,I-TIME_DURATION,6093
116516,weeks,I-TIME_DURATION,6093
116517,This,O,6093
116518,reduces,O,6093
116519,the,O,6093
116520,need,O,6093
116521,to,O,6093
116522,develop,O,6093
116523,more,O,6093
116524,transgenic,O,6093
116525,models,O,6093
116526,and,O,6093
116527,improves,O,6093
116528,animal,O,6093
116529,welfare,O,6093
116530,The,O,6093
116531,investigators,O,6093
116532,also,O,6093
116533,used,O,6093
116534,the,O,6093
116535,cell,O,6093
116536,models,O,6093
116537,which,O,6093
116538,further,O,6093
116539,reduced,O,6094
116540,the,O,6094
116541,use,O,6094
116542,of,O,6094
116543,mice,O,6094
116544,in,O,6094
116545,these,O,6094
116546,experiments,O,6094
116547,to,O,6094
116548,show,O,6094
116549,that,O,6094
116550,the,B-CHEMICAL_COMPOUND,6094
116551,toxic,I-CHEMICAL_COMPOUND,6094
116552,Ab,I-CHEMICAL_COMPOUND,6094
116553,proteins,I-CHEMICAL_COMPOUND,6094
116554,entered,O,6094
116555,RPE,B-PART_OF_THE_EYES,6094
116556,cells,I-PART_OF_THE_EYES,6094
116557,and,O,6094
116558,rapidly,O,6094
116559,collected,O,6094
116560,in,O,6094
116561,lysosomes,B-CHEMICAL_COMPOUND,6094
116562,the,O,6094
116563,waste,O,6094
116564,disposal,O,6094
116565,system,O,6094
116566,for,O,6095
116567,the,O,6095
116568,cells,O,6095
116569,Whilst,O,6095
116570,the,O,6095
116571,cells,O,6095
116572,performed,O,6095
116573,their,O,6095
116574,usual,O,6095
116575,function,O,6095
116576,of,O,6095
116577,increasing,O,6096
116578,enzymes,B-CHEMICAL_COMPOUND,6096
116579,within,I-CHEMICAL_COMPOUND,6096
116580,lysosomes,I-CHEMICAL_COMPOUND,6096
116581,to,O,6096
116582,breakdown,O,6096
116583,this,O,6096
116584,unwanted,O,6096
116585,cargo,O,6096
116586,the,O,6096
116587,study,O,6096
116588,found,O,6096
116589,that,O,6096
116590,around,O,6096
116591,85%,O,6096
116592,of,O,6097
116593,Ab,B-CHEMICAL_COMPOUND,6097
116594,still,O,6097
116595,remained,O,6097
116596,within,O,6097
116597,lysosomes,B-CHEMICAL_COMPOUND,6097
116598,meaning,O,6097
116599,that,O,6097
116600,over,O,6097
116601,time,O,6097
116602,the,O,6097
116603,toxic,O,6097
116604,molecules,O,6097
116605,would,O,6097
116606,continue,O,6097
116607,to,O,6097
116608,accumulate,O,6097
116609,inside,O,6097
116610,RPE,B-PART_OF_THE_EYES,6097
116611,cells,I-PART_OF_THE_EYES,6097
116612,Furthermore,O,6097
116613,the,O,6097
116614,researchers,O,6097
116615,discovered,O,6097
116616,that,O,6097
116617,once,O,6097
116618,lysosomes,B-CHEMICAL_COMPOUND,6097
116619,had,O,6097
116620,been,O,6097
116621,invaded,O,6097
116622,by,O,6097
116623,Ab,B-CHEMICAL_COMPOUND,6097
116624,around,O,6097
116625,20,O,6097
116626,percent,O,6097
116627,fewer,O,6098
116628,lysosomes,B-CHEMICAL_COMPOUND,6098
116629,were,O,6098
116630,available,O,6098
116631,to,O,6098
116632,breakdown,O,6098
116633,photoreceptor,O,6098
116634,outer,O,6098
116635,segments,O,6098
116636,a,O,6098
116637,role,O,6098
116638,they,O,6098
116639,routinely,O,6098
116640,perform,O,6098
116641,as,O,6098
116642,part,O,6098
116643,of,O,6098
116644,the,O,6098
116645,daily,O,6098
116646,visual,O,6098
116647,cycle,O,6098
116648,Dr,B-PERSON,6098
116649,Ratnayaka,I-PERSON,6098
116650,added,O,6098
116651,This,O,6098
116652,is,O,6098
116653,a,O,6098
116654,further,O,6098
116655,indication,O,6098
116656,of,O,6098
116657,how,O,6098
116658,cells,O,6098
116659,in,O,6098
116660,the,O,6098
116661,eye,O,6099
116662,can,O,6099
116663,deteriorate,O,6099
116664,over,O,6099
116665,time,O,6099
116666,because,O,6099
116667,of,O,6099
116668,these,O,6099
116669,toxic,O,6099
116670,molecules,O,6099
116671,collecting,O,6099
116672,inside,O,6099
116673,RPE,B-PART_OF_THE_EYES,6099
116674,cells,I-PART_OF_THE_EYES,6099
116675,This,O,6099
116676,could,O,6099
116677,be,O,6099
116678,a,O,6099
116679,new,O,6099
116680,pathway,O,6099
116681,that,O,6099
116682,no-one,O,6099
116683,has,O,6099
116684,explored,O,6099
116685,before,O,6099
116686,Our,O,6099
116687,discoveries,O,6099
116688,have,O,6099
116689,also,O,6099
116690,strengthened,O,6100
116691,the,O,6100
116692,link,O,6100
116693,between,O,6100
116694,diseases,O,6100
116695,of,O,6100
116696,the,O,6100
116697,eye,O,6100
116698,and,O,6100
116699,the,O,6100
116700,brain,O,6100
116701,The,O,6100
116702,eye,O,6100
116703,is,O,6100
116704,part,O,6100
116705,of,O,6100
116706,the,O,6100
116707,brain,O,6100
116708,and,O,6100
116709,we,O,6100
116710,have,O,6100
116711,shown,O,6100
116712,how,O,6100
116713,Ab,B-CHEMICAL_COMPOUND,6100
116714,which,O,6100
116715,is,O,6100
116716,known,O,6100
116717,to,O,6100
116718,drive,O,6100
116719,major,O,6100
116720,neurological,O,6100
116721,conditions,O,6100
116722,such,O,6100
116723,as,O,6101
116724,Alzheimer,B-NAME_OF_DISEASE,6101
116725,s,I-NAME_OF_DISEASE,6101
116726,disease,I-NAME_OF_DISEASE,6101
116727,can,O,6101
116728,also,O,6101
116729,causes,O,6101
116730,significant,O,6101
116731,damage,O,6101
116732,to,O,6101
116733,cells,B-PART_OF_THE_EYES,6101
116734,in,I-PART_OF_THE_EYES,6101
116735,retina,I-PART_OF_THE_EYES,6101
116736,The,O,6101
116737,researchers,O,6101
116738,hope,O,6101
116739,that,O,6101
116740,one,O,6101
116741,of,O,6101
116742,the,O,6102
116743,next,O,6102
116744,steps,O,6102
116745,could,O,6102
116746,be,O,6102
116747,for,O,6102
116748,anti-amyloid,B-TREATMENT,6102
116749,beta,I-TREATMENT,6102
116750,drugs,I-TREATMENT,6102
116751,previously,O,6102
116752,trialled,O,6102
116753,in,O,6102
116754,Alzheimer,B-NAME_OF_DISEASE,6102
116755,s,I-NAME_OF_DISEASE,6102
116756,patients,O,6102
116757,to,O,6102
116758,be,O,6102
116759,re-purposed,O,6102
116760,and,O,6102
116761,trialled,O,6102
116762,as,O,6102
116763,a,O,6102
116764,possible,O,6102
116765,treatment,O,6102
116766,for,O,6102
116767,age-related,B-NAME_OF_DISEASE,6102
116768,macular,I-NAME_OF_DISEASE,6102
116769,degeneration,I-NAME_OF_DISEASE,6102
116770,As,O,6102
116771,the,O,6102
116772,regulators,O,6102
116773,in,O,6103
116774,the,B-GPE,6103
116775,USA,I-GPE,6103
116776,and,O,6103
116777,the,B-ORGANIZATION,6103
116778,European,I-ORGANIZATION,6103
116779,Union,I-ORGANIZATION,6103
116780,have,O,6103
116781,already,O,6103
116782,given,O,6103
116783,approval,O,6103
116784,for,O,6103
116785,many,O,6103
116786,of,O,6103
116787,these,O,6103
116788,drugs,O,6103
116789,this,O,6103
116790,is,O,6103
116791,an,O,6103
116792,area,O,6103
116793,that,O,6103
116794,could,O,6103
116795,be,O,6103
116796,explored,O,6103
116797,relatively,O,6104
116798,quickly,O,6104
116799,The,O,6104
116800,study,O,6104
116801,may,O,6104
116802,also,O,6104
116803,help,O,6104
116804,wider,O,6104
116805,efforts,O,6104
116806,to,O,6104
116807,largely,O,6104
116808,by-pass,O,6104
116809,the,O,6104
116810,use,O,6104
116811,of,O,6104
116812,animal,O,6104
116813,experimentation,O,6104
116814,where,O,6105
116815,possible,O,6105
116816,so,O,6105
116817,some,O,6105
116818,aspects,O,6105
116819,of,O,6105
116820,testing,O,6105
116821,new,O,6105
116822,clinical,O,6105
116823,treatments,O,6105
116824,can,O,6105
116825,transition,O,6105
116826,directly,O,6105
116827,from,O,6105
116828,cell,O,6105
116829,models,O,6105
116830,to,O,6105
116831,patients,O,6105
116832,This,O,6105
116833,research,O,6105
116834,was,O,6105
116835,funded,O,6105
116836,by,O,6106
116837,the,B-ORGANIZATION,6106
116838,National,I-ORGANIZATION,6106
116839,Centre,I-ORGANIZATION,6106
116840,for,I-ORGANIZATION,6106
116841,the,I-ORGANIZATION,6106
116842,Replacement,I-ORGANIZATION,6106
116843,Refinement,I-ORGANIZATION,6106
116844,Reduction,I-ORGANIZATION,6107
116845,of,I-ORGANIZATION,6107
116846,animals,I-ORGANIZATION,6107
116847,in,I-ORGANIZATION,6107
116848,research,I-ORGANIZATION,6107
116849,NC3Rs,I-ORGANIZATION,6107
116850,,O,6107
116851,Dr,B-PERSON,6107
116852,Katie,I-PERSON,6107
116853,Bates,I-PERSON,6107
116854,Head,O,6107
116855,of,O,6107
116856,Research,O,6107
116857,Funding,O,6107
116858,at,O,6107
116859,the,B-ORGANIZATION,6107
116860,NC3Rs,I-ORGANIZATION,6107
116861,said,O,6107
116862,This,O,6107
116863,is,O,6107
116864,an,O,6108
116865,impactful,O,6108
116866,study,O,6108
116867,that,O,6108
116868,demonstrates,O,6108
116869,the,O,6108
116870,scientific,O,6108
116871,practical,O,6108
116872,and,O,6108
116873,3Rs,O,6108
116874,benefits,O,6108
116875,to,O,6108
116876,studying,O,6108
116877,AMD-like,O,6108
116878,retinal,O,6108
116879,pathology,O,6108
116880,in,O,6108
116881,vitro,O,6109
116882,Animal,O,6109
116883,studies,O,6109
116884,were,O,6109
116885,overseen,O,6109
116886,by,O,6109
116887,the,B-ORGANIZATION,6109
116888,institutions,I-ORGANIZATION,6109
116889,Ethical,I-ORGANIZATION,6109
116890,Research,I-ORGANIZATION,6109
116891,Committee,I-ORGANIZATION,6109
116892,and,O,6109
116893,carried,O,6109
116894,out,O,6109
116895,in,O,6109
116896,accordance,O,6109
116897,with,O,6109
116898,the,B-ORGANIZATION,6110
116899,UK,I-ORGANIZATION,6110
116900,Animal,I-ORGANIZATION,6110
116901,Scientific,I-ORGANIZATION,6110
116902,Procedures,I-ORGANIZATION,6110
116903,Act,I-ORGANIZATION,6110
116904,of,I-ORGANIZATION,6110
116905,1986,I-ORGANIZATION,6110
116906,Experiments,O,6110
116907,also,O,6110
116908,conformed,O,6110
116909,to,O,6110
116910,the,O,6110
116911,ARVO,B-ORGANIZATION,6110
116912,statement,O,6110
116913,for,O,6111
116914,the,O,6111
116915,Use,O,6111
116916,of,O,6111
116917,Animals,O,6111
116918,in,O,6111
116919,Ophthalmic,O,6111
116920,and,O,6111
116921,Vision,O,6111
116922,Research,O,6111
116923,The,O,6111
116924,experimental,O,6111
116925,protocol,O,6111
116926,was,O,6111
116927,approved,O,6111
116928,by,O,6111
116929,the,B-ORGANIZATION,6111
116930,University,I-ORGANIZATION,6111
116931,of,I-ORGANIZATION,6111
116932,Southampton,I-ORGANIZATION,6111
116933,Research,I-ORGANIZATION,6111
116934,Ethics,I-ORGANIZATION,6111
116935,Committee,I-ORGANIZATION,6111
116936,and,O,6111
116937,work,O,6111
116938,carried,O,6111
116939,out,O,6111
116940,under,O,6111
116941,the,B-ORGANIZATION,6111
116942,UK,I-ORGANIZATION,6111
116943,Home,I-ORGANIZATION,6111
116944,Office,I-ORGANIZATION,6112
116945,Nyxol®,B-NAME_OF_DRUG,6112
116946,is,O,6112
116947,a,O,6112
116948,preservative-free,O,6112
116949,ophthalmic,O,6112
116950,solution,O,6112
116951,containing,O,6112
116952,0.75,O,6112
116953,phentolamine,B-CHEMICAL_COMPOUND,6112
116954,or,O,6112
116955,1%,O,6112
116956,phentolamine,B-CHEMICAL_COMPOUND,6112
116957,mesylate,I-CHEMICAL_COMPOUND,6112
116958,a,O,6112
116959,nonselective,O,6112
116960,alpha,O,6112
116961,adrenergic,O,6112
116962,antagonist,O,6112
116963,that,O,6112
116964,inhibits,O,6112
116965,the,O,6112
116966,contraction,O,6112
116967,of,O,6112
116968,smooth,O,6112
116969,muscle,O,6113
116970,of,O,6113
116971,the,B-PART_OF_THE_EYES,6113
116972,iris,I-PART_OF_THE_EYES,6113
116973,In,O,6113
116974,multiple,O,6113
116975,Phase,O,6113
116976,2,O,6113
116977,trials,O,6113
116978,Nyxol,B-NAME_OF_DRUG,6113
116979,reduced,O,6113
116980,pupil,B-PART_OF_THE_EYES,6113
116981,diameter,O,6113
116982,resulting,O,6113
116983,in,O,6113
116984,better,O,6113
116985,contrast,O,6113
116986,sensitivity,O,6113
116987,and,O,6113
116988,visual,O,6113
116989,acuity,O,6113
116990,Nyxol,B-NAME_OF_DRUG,6113
116991,is,O,6113
116992,being,O,6114
116993,developed,O,6114
116994,for,O,6114
116995,dim,B-NAME_OF_DISEASE,6115
116996,or,I-NAME_OF_DISEASE,6115
116997,night,I-NAME_OF_DISEASE,6115
116998,vision,I-NAME_OF_DISEASE,6115
116999,disturbances,I-NAME_OF_DISEASE,6115
117000,DLD,I-NAME_OF_DISEASE,6115
117001,reversal,O,6115
117002,of,O,6115
117003,pharmacologically-induced,O,6115
117004,mydriasis,B-NAME_OF_DISEASE,6115
117005,and,O,6115
117006,presbyopia,B-NAME_OF_DISEASE,6115
117007,Presbyopia,B-NAME_OF_DISEASE,6115
117008,is,O,6115
117009,an,O,6115
117010,age-related,O,6115
117011,condition,O,6115
117012,with,O,6116
117013,onset,O,6116
117014,most,O,6116
117015,common,O,6117
117016,in,O,6117
117017,people,O,6117
117018,over,O,6117
117019,40,O,6117
117020,years,O,6117
117021,old,O,6117
117022,As,O,6117
117023,the,O,6117
117024,eye,O,6117
117025,ages,O,6117
117026,the,B-SIGN_AND_SYMPTOM,6117
117027,lens,I-SIGN_AND_SYMPTOM,6117
117028,becomes,I-SIGN_AND_SYMPTOM,6117
117029,stiffer,I-SIGN_AND_SYMPTOM,6117
117030,which,O,6117
117031,limits,O,6117
117032,the,O,6117
117033,eye,O,6117
117034,s,O,6117
117035,ability,O,6117
117036,to,O,6117
117037,adjust,O,6117
117038,its,O,6117
117039,focus,O,6117
117040,for,O,6117
117041,reading,O,6117
117042,or,O,6117
117043,for,O,6117
117044,other,O,6117
117045,tasks,O,6117
117046,that,O,6117
117047,require,O,6117
117048,clear,O,6117
117049,vision,O,6117
117050,at,O,6117
117051,near,O,6117
117052,distances,O,6117
117053,It,O,6117
117054,is,O,6117
117055,estimated,O,6117
117056,that,O,6117
117057,120,O,6117
117058,million,O,6117
117059,Americans,O,6117
117060,have,O,6117
117061,presbyopia,B-NAME_OF_DISEASE,6117
117062,and,O,6117
117063,this,O,6117
117064,number,O,6118
117065,is,O,6118
117066,expected,O,6118
117067,to,O,6118
117068,grow,O,6118
117069,as,O,6118
117070,the,O,6118
117071,population,O,6118
117072,above,O,6118
117073,the,O,6118
117074,age,O,6118
117075,of,O,6118
117076,45,O,6118
117077,increases,O,6118
117078,Currently,O,6118
117079,there,O,6118
117080,are,O,6119
117081,no,O,6119
117082,pharmacological,O,6119
117083,therapies,O,6119
117084,approved,O,6119
117085,for,O,6119
117086,presbyopia,B-NAME_OF_DISEASE,6119
117087,but,O,6119
117088,there,O,6119
117089,is,O,6119
117090,evidence,O,6119
117091,that,O,6119
117092,decreasing,O,6119
117093,pupil,B-PART_OF_THE_EYES,6119
117094,diameter,O,6119
117095,especially,O,6119
117096,to,O,6119
117097,a,O,6119
117098,size,O,6119
117099,of,O,6119
117100,1,O,6119
117101,mm,O,6119
117102,to,O,6119
117103,2,O,6119
117104,mm,O,6120
117105,to,O,6120
117106,create,O,6120
117107,a,O,6120
117108,pinhole,O,6120
117109,effect,O,6120
117110,can,O,6120
117111,improve,O,6120
117112,near,O,6120
117113,visual,O,6120
117114,acuity,O,6120
117115,by,O,6120
117116,increasing,O,6120
117117,the,O,6120
117118,depth,O,6120
117119,of,O,6120
117120,focus,O,6120
117121,Ocuphire,O,6120
117122,Pharma,O,6120
117123,Inc,O,6120
117124,a,O,6120
117125,clinical-stage,O,6120
117126,ophthalmic,O,6120
117127,biopharmaceutical,O,6120
117128,company,O,6120
117129,focused,O,6120
117130,on,O,6120
117131,developing,O,6120
117132,and,O,6120
117133,commercializing,O,6120
117134,therapies,O,6120
117135,for,O,6120
117136,the,O,6120
117137,treatment,O,6120
117138,of,O,6121
117139,several,O,6121
117140,eye,O,6121
117141,disorders,O,6121
117142,recently,O,6121
117143,announced,O,6121
117144,that,O,6121
117145,it,O,6121
117146,has,O,6121
117147,enrolled,O,6121
117148,the,O,6121
117149,first,O,6121
117150,patients,O,6121
117151,in,O,6121
117152,a,B-NAME_OF_STUDY,6121
117153,Phase,I-NAME_OF_STUDY,6122
117154,2,I-NAME_OF_STUDY,6122
117155,proof,I-NAME_OF_STUDY,6123
117156,of,I-NAME_OF_STUDY,6123
117157,concept,I-NAME_OF_STUDY,6123
117158,trial,I-NAME_OF_STUDY,6123
117159,titled,I-NAME_OF_STUDY,6123
117160,VEGA-1,I-NAME_OF_STUDY,6123
117161,to,O,6123
117162,evaluate,O,6123
117163,a,O,6123
117164,combination,O,6123
117165,kit,O,6123
117166,of,O,6123
117167,Nyxol,B-NAME_OF_DRUG,6123
117168,and,O,6123
117169,low-dose,B-NAME_OF_DRUG,6123
117170,pilocarpine,I-NAME_OF_DRUG,6124
117171,in,O,6124
117172,presbyopia,B-NAME_OF_DISEASE,6124
117173,Over,O,6124
117174,12,O,6124
117175,sites,O,6124
117176,representing,O,6124
117177,a,O,6124
117178,majority,O,6124
117179,of,O,6124
117180,the,O,6124
117181,planned,O,6124
117182,clinical,O,6124
117183,sites,O,6124
117184,are,O,6124
117185,activated,O,6124
117186,and,O,6124
117187,recruiting,O,6124
117188,patients,O,6124
117189,Nyxol,B-NAME_OF_DRUG,6124
117190,s,O,6124
117191,potential,O,6124
117192,to,O,6124
117193,improve,O,6124
117194,near,O,6124
117195,vision,O,6124
117196,is,O,6124
117197,based,O,6124
117198,on,O,6124
117199,its,O,6124
117200,mechanism,O,6124
117201,of,O,6124
117202,reducing,B-TREATMENT,6125
117203,pupil,I-TREATMENT,6125
117204,diameter,I-TREATMENT,6125
117205,which,I-TREATMENT,6125
117206,results,I-TREATMENT,6125
117207,in,I-TREATMENT,6125
117208,an,I-TREATMENT,6125
117209,increased,I-TREATMENT,6125
117210,depth,I-TREATMENT,6125
117211,of,I-TREATMENT,6125
117212,focus,I-TREATMENT,6125
117213,Nyxol,B-NAME_OF_DRUG,6125
117214,alone,O,6125
117215,in,O,6125
117216,multiple,O,6125
117217,Phase,O,6125
117218,2,O,6125
117219,trials,O,6125
117220,has,O,6125
117221,reduced,O,6125
117222,pupil,B-PART_OF_THE_EYES,6125
117223,diameter,O,6125
117224,by,O,6125
117225,approximately,O,6125
117226,20%,O,6125
117227,and,O,6125
117228,has,O,6125
117229,significantly,O,6125
117230,improved,O,6125
117231,near,O,6125
117232,visual,O,6126
117233,acuity,O,6126
117234,by,O,6126
117235,one,O,6126
117236,eye-chart,O,6126
117237,line,O,6126
117238,for,B-TIME_DURATION,6126
117239,over,I-TIME_DURATION,6126
117240,24,I-TIME_DURATION,6126
117241,hours,I-TIME_DURATION,6126
117242,after,O,6126
117243,an,O,6126
117244,evening,O,6126
117245,eye,O,6126
117246,drop,O,6126
117247,It,O,6126
117248,has,O,6126
117249,been,O,6126
117250,well,O,6126
117251,established,O,6126
117252,by,O,6126
117253,the,O,6127
117254,field,O,6127
117255,that,O,6127
117256,reducing,O,6127
117257,pupil,B-PART_OF_THE_EYES,6127
117258,diameter,O,6127
117259,to,O,6127
117260,the,O,6127
117261,1,O,6127
117262,to,O,6127
117263,2,O,6127
117264,mm,O,6127
117265,range,O,6127
117266,pinhole,O,6127
117267,effect,O,6127
117268,can,O,6127
117269,lead,O,6127
117270,to,O,6127
117271,significant,O,6127
117272,improvements,O,6127
117273,in,O,6127
117274,near,O,6127
117275,vision,O,6127
117276,for,O,6127
117277,presbyopic,B-NAME_OF_DISEASE,6127
117278,patients,O,6127
117279,Nyxol,B-NAME_OF_DRUG,6127
117280,is,O,6127
117281,being,O,6127
117282,evaluated,O,6127
117283,as,O,6128
117284,part,O,6128
117285,of,O,6128
117286,a,O,6128
117287,two-drug,O,6128
117288,kit,O,6128
117289,provided,O,6128
117290,to,O,6128
117291,patients,O,6128
117292,with,O,6128
117293,Nyxol,B-NAME_OF_DRUG,6128
117294,to,O,6128
117295,be,O,6128
117296,applied,O,6128
117297,once,O,6128
117298,daily,O,6128
117299,in,O,6128
117300,the,O,6128
117301,evening,O,6129
117302,and,O,6129
117303,low-dose,B-NAME_OF_DRUG,6129
117304,pilocarpine,I-NAME_OF_DRUG,6129
117305,to,O,6129
117306,be,O,6129
117307,dosed,O,6129
117308,in,O,6129
117309,the,O,6129
117310,daytime,O,6129
117311,According,O,6129
117312,to,O,6129
117313,a,O,6129
117314,market,O,6129
117315,research,O,6129
117316,report,O,6129
117317,by,O,6129
117318,GlobalData,B-ORGANIZATION,6129
117319,40%,O,6129
117320,of,O,6129
117321,patients,O,6129
117322,would,O,6129
117323,request,O,6130
117324,an,O,6130
117325,alternative,O,6130
117326,to,O,6130
117327,reading,B-TREATMENT,6130
117328,glasses,I-TREATMENT,6130
117329,if,O,6130
117330,available,O,6130
117331,and,O,6130
117332,69%,O,6130
117333,of,O,6130
117334,patients,O,6130
117335,would,O,6130
117336,consider,O,6130
117337,an,O,6130
117338,eye,B-TREATMENT,6130
117339,drop,I-TREATMENT,6130
117340,alternative,O,6130
117341,Some,O,6130
117342,key,O,6130
117343,factors,O,6130
117344,that,O,6130
117345,will,O,6130
117346,influence,O,6130
117347,patient,O,6130
117348,adoption,O,6130
117349,will,O,6130
117350,be,O,6130
117351,efficacy,O,6130
117352,tolerability,O,6130
117353,comfort,O,6130
117354,onset,O,6130
117355,of,O,6131
117356,action,O,6131
117357,durability,O,6131
117358,and,O,6131
117359,good,O,6131
117360,distance,O,6131
117361,vision,O,6131
117362,Mina,B-PERSON,6131
117363,Sooch,I-PERSON,6131
117364,MBA,I-PERSON,6131
117365,President,O,6131
117366,and,O,6131
117367,CEO,O,6131
117368,of,O,6131
117369,Ocuphire,B-ORGANIZATION,6131
117370,Pharma,I-ORGANIZATION,6131
117371,commented,O,6131
117372,Presbyopia,B-NAME_OF_DISEASE,6132
117373,could,O,6132
117374,be,O,6132
117375,one,O,6132
117376,of,O,6132
117377,the,O,6132
117378,largest,O,6132
117379,patient,O,6132
117380,populations,O,6132
117381,at,O,6132
117382,over,O,6132
117383,100,O,6132
117384,million,O,6132
117385,to,O,6132
117386,be,O,6132
117387,treated,O,6132
117388,with,O,6132
117389,a,O,6132
117390,pharmacologic,O,6132
117391,option,O,6132
117392,Many,O,6132
117393,people,O,6132
117394,with,O,6132
117395,presbyopia,B-NAME_OF_DISEASE,6132
117396,may,O,6132
117397,greatly,O,6132
117398,benefit,O,6132
117399,from,O,6132
117400,an,B-TREATMENT,6132
117401,eye,I-TREATMENT,6132
117402,drop,I-TREATMENT,6132
117403,treatment,I-TREATMENT,6132
117404,as,O,6132
117405,an,O,6132
117406,alternative,O,6132
117407,to,O,6132
117408,reading,B-TREATMENT,6132
117409,glasses,I-TREATMENT,6132
117410,We,O,6132
117411,believe,O,6132
117412,that,O,6132
117413,the,O,6132
117414,combination,O,6132
117415,of,O,6132
117416,Nyxol,B-NAME_OF_DRUG,6132
117417,and,O,6132
117418,low-dose,B-NAME_OF_DRUG,6133
117419,pilocarpine,I-NAME_OF_DRUG,6133
117420,has,O,6133
117421,an,O,6133
117422,ideal,O,6133
117423,product,O,6133
117424,profile,O,6133
117425,to,O,6133
117426,become,O,6133
117427,a,O,6133
117428,promising,O,6133
117429,treatment,O,6133
117430,for,O,6133
117431,presbyopia,B-NAME_OF_DISEASE,6133
117432,We,O,6133
117433,are,O,6133
117434,pleased,O,6133
117435,to,O,6133
117436,begin,O,6133
117437,enrollment,O,6133
117438,in,O,6133
117439,the,B-NAME_OF_STUDY,6133
117440,VEGA-1,I-NAME_OF_STUDY,6133
117441,clinical,I-NAME_OF_STUDY,6133
117442,trial,I-NAME_OF_STUDY,6133
117443,working,O,6133
117444,with,O,6133
117445,our,O,6133
117446,CRO,O,6133
117447,partner,O,6133
117448,Oculos,B-ORGANIZATION,6133
117449,and,O,6133
117450,look,O,6133
117451,forward,O,6133
117452,to,O,6133
117453,reporting,O,6133
117454,results,O,6134
117455,at,O,6134
117456,the,O,6134
117457,end,O,6134
117458,of,O,6134
117459,the,O,6134
117460,second,O,6134
117461,quarter,O,6134
117462,this,O,6134
117463,year,O,6134
117464,This,O,6134
117465,is,O,6134
117466,our,O,6134
117467,3rd,O,6134
117468,later,O,6134
117469,stage,O,6134
117470,clinical,O,6134
117471,trial,O,6134
117472,launched,O,6134
117473,for,O,6134
117474,Nyxol,B-NAME_OF_DRUG,6134
117475,in,O,6134
117476,just,O,6134
117477,the,O,6134
117478,last,O,6135
117479,few,O,6135
117480,months,O,6135
117481,I,O,6135
117482,am,O,6135
117483,very,O,6135
117484,happy,O,6135
117485,to,O,6135
117486,see,O,6135
117487,that,O,6135
117488,the,B-NAME_OF_STUDY,6135
117489,VEGA-1,I-NAME_OF_STUDY,6135
117490,trial,I-NAME_OF_STUDY,6136
117491,has,O,6136
117492,begun,O,6136
117493,enrollment,O,6136
117494,which,O,6136
117495,brings,O,6136
117496,the,O,6136
117497,potential,O,6136
117498,for,O,6136
117499,Nyxol,B-NAME_OF_DRUG,6136
117500,and,O,6136
117501,low-dose,B-NAME_OF_DRUG,6136
117502,pilocarpine,I-NAME_OF_DRUG,6137
117503,eye,O,6137
117504,drops,O,6137
117505,to,O,6137
117506,allow,O,6137
117507,presbyopia,B-NAME_OF_DISEASE,6137
117508,patients,O,6137
117509,to,O,6138
117510,experience,O,6138
117511,the,O,6138
117512,ability,O,6138
117513,to,O,6138
117514,see,O,6139
117515,both,O,6139
117516,at,O,6139
117517,near,O,6139
117518,and,O,6139
117519,at,O,6139
117520,distance,O,6139
117521,without,O,6139
117522,the,O,6139
117523,dependence,O,6139
117524,on,O,6139
117525,reading,B-TREATMENT,6139
117526,glasses,I-TREATMENT,6139
117527,The,O,6139
117528,combination,O,6139
117529,of,O,6139
117530,Nyxol,B-NAME_OF_DRUG,6139
117531,moderately,O,6139
117532,inhibiting,O,6139
117533,the,B-PART_OF_THE_EYES,6139
117534,iris,I-PART_OF_THE_EYES,6139
117535,dilator,I-PART_OF_THE_EYES,6139
117536,muscle,I-PART_OF_THE_EYES,6139
117537,and,O,6139
117538,low,B-NAME_OF_DRUG,6140
117539,dose,I-NAME_OF_DRUG,6140
117540,of,I-NAME_OF_DRUG,6140
117541,pilocarpine,I-NAME_OF_DRUG,6140
117542,an,O,6140
117543,extensively,O,6140
117544,studied,O,6140
117545,miotic,O,6140
117546,moderately,O,6140
117547,activating,O,6140
117548,the,B-PART_OF_THE_EYES,6140
117549,iris,I-PART_OF_THE_EYES,6140
117550,constrictor,I-PART_OF_THE_EYES,6140
117551,muscle,I-PART_OF_THE_EYES,6140
117552,should,O,6140
117553,allow,O,6140
117554,for,O,6140
117555,unopposed,O,6140
117556,pupil,B-PART_OF_THE_EYES,6140
117557,constriction,O,6140
117558,to,O,6140
117559,reach,O,6140
117560,the,O,6140
117561,pin-hole,O,6140
117562,,O,6140
117563,Ocuphire,B-ORGANIZATION,6140
117564,s,O,6140
117565,use,O,6140
117566,of,O,6140
117567,agents,O,6140
117568,working,O,6140
117569,on,O,6140
117570,both,O,6140
117571,iris,B-PART_OF_THE_EYES,6140
117572,muscles,I-PART_OF_THE_EYES,6140
117573,to,O,6140
117574,manage,O,6140
117575,pupil,B-PART_OF_THE_EYES,6141
117576,size,O,6141
117577,is,O,6141
117578,a,O,6141
117579,key,O,6141
117580,differentiating,O,6141
117581,factor,O,6141
117582,for,O,6141
117583,its,O,6141
117584,approach,O,6141
117585,says,O,6141
117586,Dr,O,6141
117587,Marguerite,O,6141
117588,McDonald,O,6141
117589,Clinical,O,6141
117590,Professor,O,6141
117591,of,O,6141
117592,Ophthalmology,O,6141
117593,at,O,6141
117594,the,B-ORGANIZATION,6141
117595,NYU,I-ORGANIZATION,6141
117596,Langone,I-ORGANIZATION,6141
117597,Medical,I-ORGANIZATION,6141
117598,Center,I-ORGANIZATION,6141
117599,VEGA-1,B-NAME_OF_STUDY,6141
117600,is,O,6141
117601,a,O,6141
117602,double-masked,O,6141
117603,randomized,O,6141
117604,placebo-controlled,O,6141
117605,multi-center,O,6141
117606,trial,O,6141
117607,designed,O,6141
117608,to,O,6141
117609,evaluate,O,6141
117610,0.75,O,6141
117611,Nyxol,B-NAME_OF_DRUG,6141
117612,in,O,6141
117613,combination,O,6141
117614,with,O,6141
117615,low,O,6141
117616,dose,O,6141
117617,0.4,O,6142
117618,pilocarpine,O,6142
117619,for,O,6142
117620,treatment,O,6142
117621,of,O,6142
117622,presbyopia,B-NAME_OF_DISEASE,6142
117623,The,O,6142
117624,trial,O,6142
117625,is,O,6142
117626,expected,O,6142
117627,to,O,6142
117628,enroll,O,6142
117629,approximately,O,6142
117630,152,O,6142
117631,patients,O,6142
117632,with,O,6142
117633,a,O,6142
117634,clinical,O,6142
117635,diagnosis,O,6142
117636,of,O,6142
117637,presbyopia,B-NAME_OF_DISEASE,6142
117638,near,O,6142
117639,visual,O,6143
117640,acuity,O,6143
117641,of,O,6143
117642,20,O,6143
117643,50,O,6143
117644,or,O,6143
117645,worse,O,6143
117646,,O,6143
117647,The,O,6143
117648,primary,O,6143
117649,endpoint,O,6143
117650,is,O,6143
117651,percentage,O,6143
117652,of,O,6143
117653,patients,O,6143
117654,with,O,6143
117655,at,O,6143
117656,least,O,6143
117657,3,O,6143
117658,lines,O,6143
117659,15,O,6143
117660,letters,O,6143
117661,or,O,6143
117662,more,O,6143
117663,of,O,6143
117664,binocular,O,6143
117665,distance,O,6143
117666,corrected,O,6144
117667,near,O,6144
117668,visual,O,6144
117669,acuity,O,6144
117670,DCNVA,O,6144
117671,improvement,O,6144
117672,on,O,6144
117673,a,O,6144
117674,standard,O,6144
117675,near,O,6144
117676,vision,O,6144
117677,eye,O,6145
117678,chart,O,6145
117679,in,O,6145
117680,daytime,O,6145
117681,photopic,O,6145
117682,lighting,O,6145
117683,conditions,O,6145
117684,Secondary,O,6145
117685,endpoints,O,6145
117686,at,O,6145
117687,multiple,O,6145
117688,timepoints,O,6145
117689,include,O,6145
117690,improvements,O,6145
117691,in,O,6145
117692,3,O,6145
117693,lines,O,6145
117694,of,O,6145
117695,DCNVA,O,6145
117696,without,O,6145
117697,any,O,6145
117698,loss,O,6145
117699,of,O,6146
117700,distance,O,6146
117701,vision,O,6146
117702,pupil,B-PART_OF_THE_EYES,6146
117703,diameter,O,6146
117704,and,O,6146
117705,improvements,O,6146
117706,in,O,6146
117707,DCNVA,O,6146
117708,at,O,6146
117709,1,O,6146
117710,and,O,6146
117711,2,O,6146
117712,lines,O,6146
117713,compared,O,6146
117714,to,O,6146
117715,placebo,O,6147
117716,as,O,6147
117717,well,O,6147
117718,as,O,6147
117719,to,O,6147
117720,each,O,6147
117721,Nyxol,B-NAME_OF_DRUG,6147
117722,and,O,6147
117723,low-dose,B-NAME_OF_DRUG,6147
117724,pilocarpine,I-NAME_OF_DRUG,6147
117725,alone,O,6147
117726,Johnson,B-ORGANIZATION,6147
117727,Johnson,I-ORGANIZATION,6147
117728,Vision,I-ORGANIZATION,6147
117729,a,O,6147
117730,global,O,6147
117731,leader,O,6147
117732,in,O,6147
117733,eye,O,6147
117734,health,O,6147
117735,and,O,6148
117736,part,O,6148
117737,of,O,6148
117738,the,B-ORGANIZATION,6148
117739,Johnson,I-ORGANIZATION,6148
117740,Johnson,I-ORGANIZATION,6148
117741,Medical,I-ORGANIZATION,6148
117742,Devices,I-ORGANIZATION,6148
117743,Companies,I-ORGANIZATION,6148
117744,announced,O,6148
117745,that,O,6148
117746,the,O,6148
117747,U.S,O,6148
117748,Food,O,6148
117749,and,O,6148
117750,Drug,O,6148
117751,Administration,O,6148
117752,FDA,O,6148
117753,approved,O,6149
117754,the,B-TREATMENT,6149
117755,TECNIS,I-TREATMENT,6149
117756,EyhanceTM,I-TREATMENT,6149
117757,and,I-TREATMENT,6149
117758,TECNIS,I-TREATMENT,6149
117759,EyhanceTM,I-TREATMENT,6149
117760,Toric,I-TREATMENT,6149
117761,II,I-TREATMENT,6149
117762,intraocular,I-TREATMENT,6149
117763,lens,I-TREATMENT,6149
117764,IOL,I-TREATMENT,6149
117765,for,O,6149
117766,the,O,6149
117767,treatment,O,6149
117768,of,O,6149
117769,cataract,B-NAME_OF_DISEASE,6149
117770,patients,O,6150
117771,in,O,6150
117772,the,B-GPE,6150
117773,United,I-GPE,6150
117774,States,I-GPE,6150
117775,With,O,6150
117776,this,O,6150
117777,approval,O,6150
117778,and,O,6150
117779,subsequent,O,6150
117780,commercial,O,6150
117781,launch,O,6150
117782,ophthalmologists,O,6150
117783,in,O,6150
117784,the,O,6150
117785,U.S,O,6150
117786,now,O,6150
117787,have,O,6150
117788,the,O,6150
117789,ability,O,6150
117790,to,O,6151
117791,choose,O,6151
117792,this,O,6151
117793,next,O,6151
117794,generation,O,6151
117795,monofocal,O,6151
117796,as,O,6151
117797,the,O,6151
117798,lens,O,6151
117799,of,O,6151
117800,choice,O,6151
117801,for,O,6151
117802,their,O,6151
117803,patients,O,6151
117804,with,O,6151
117805,or,O,6151
117806,without,O,6151
117807,astigmatism,B-NAME_OF_DISEASE,6151
117808,The,O,6151
117809,first,O,6151
117810,implantation,O,6151
117811,of,O,6151
117812,Tecnis,B-TREATMENT,6152
117813,Eyhance,I-TREATMENT,6152
117814,IOL,I-TREATMENT,6152
117815,in,O,6152
117816,the,B-GPE,6152
117817,US,I-GPE,6152
117818,will,O,6152
117819,happen,O,6152
117820,in,O,6152
117821,Texas,B-GPE,6152
117822,next,O,6152
117823,week,O,6152
117824,More,O,6152
117825,than,O,6152
117826,90%,O,6152
117827,of,O,6152
117828,people,O,6152
117829,develop,O,6152
117830,cataracts-the,O,6152
117831,clouding,O,6152
117832,and,O,6152
117833,yellowing,O,6152
117834,of,O,6152
117835,the,O,6152
117836,lens,O,6152
117837,in,O,6152
117838,the,O,6152
117839,eye-by,O,6152
117840,the,O,6152
117841,age,O,6152
117842,of,O,6152
117843,65,O,6152
117844,While,O,6152
117845,part,O,6152
117846,of,O,6152
117847,the,O,6152
117848,normal,O,6152
117849,aging,O,6152
117850,of,O,6152
117851,the,O,6152
117852,eye,O,6152
117853,left,O,6152
117854,untreated,O,6152
117855,cataracts,B-NAME_OF_DISEASE,6152
117856,cause,O,6152
117857,vision,B-SIGN_AND_SYMPTOM,6153
117858,to,I-SIGN_AND_SYMPTOM,6153
117859,deteriorate,I-SIGN_AND_SYMPTOM,6153
117860,over,I-SIGN_AND_SYMPTOM,6153
117861,time,I-SIGN_AND_SYMPTOM,6153
117862,In,O,6153
117863,fact,O,6153
117864,cataracts,B-NAME_OF_DISEASE,6153
117865,are,O,6153
117866,the,O,6153
117867,leading,O,6153
117868,cause,O,6153
117869,of,O,6153
117870,preventable,O,6153
117871,blindness,B-NAME_OF_DISEASE,6153
117872,worldwide,O,6153
117873,impacting,O,6153
117874,more,O,6153
117875,than,O,6153
117876,100,O,6153
117877,million,O,6153
117878,eyes,O,6153
117879,Cataract,B-TREATMENT,6153
117880,surgery,I-TREATMENT,6153
117881,is,O,6153
117882,one,O,6153
117883,of,O,6153
117884,the,O,6153
117885,most,O,6153
117886,common,O,6153
117887,outpatient,O,6153
117888,procedures,O,6153
117889,performed,O,6153
117890,today,O,6154
117891,and,O,6154
117892,has,O,6154
117893,a,O,6154
117894,success,O,6154
117895,rate,O,6154
117896,of,O,6154
117897,approximately,O,6154
117898,98%,O,6154
117899,Today,O,6154
117900,cataract,B-NAME_OF_DISEASE,6154
117901,treatments,O,6154
117902,can,O,6154
117903,also,O,6154
117904,offer,O,6154
117905,patients,O,6154
117906,vision,O,6154
117907,correction,O,6154
117908,reducing,O,6154
117909,or,O,6154
117910,eliminating,O,6154
117911,the,O,6154
117912,need,O,6154
117913,for,O,6154
117914,glasses,B-TREATMENT,6154
117915,in,O,6154
117916,addition,O,6154
117917,to,O,6154
117918,removing,O,6154
117919,the,O,6154
117920,cataract,B-NAME_OF_DISEASE,6154
117921,Eighty-four,O,6154
117922,percent,O,6154
117923,of,O,6154
117924,surgeons,O,6154
117925,choose,O,6154
117926,monofocal,B-TREATMENT,6154
117927,IOLs,I-TREATMENT,6154
117928,for,O,6154
117929,their,O,6154
117930,cataract,B-NAME_OF_DISEASE,6154
117931,patients,O,6154
117932,so,O,6154
117933,it,O,6154
117934,s,O,6154
117935,thrilling,O,6154
117936,to,O,6154
117937,see,O,6154
117938,the,O,6154
117939,first,O,6154
117940,breakthrough,O,6154
117941,in,O,6154
117942,monofocal,O,6154
117943,technology,O,6154
117944,in,O,6154
117945,decades,O,6154
117946,enter,O,6154
117947,the,O,6154
117948,market,O,6154
117949,to,O,6154
117950,add,O,6154
117951,to,O,6154
117952,our,O,6154
117953,treatment,O,6154
117954,portfolio,O,6154
117955,Douglas,B-PERSON,6154
117956,Koch,I-PERSON,6154
117957,MD,I-PERSON,6154
117958,Houston,B-GPE,6154
117959,Texas,B-GPE,6154
117960,said,O,6154
117961,in,O,6154
117962,a,O,6154
117963,company,O,6154
117964,news,O,6154
117965,release,O,6154
117966,It,O,6154
117967,s,O,6154
117968,the,O,6154
117969,first,O,6154
117970,monofocal,O,6154
117971,designed,O,6154
117972,to,O,6154
117973,provide,O,6154
117974,a,O,6154
117975,slight,O,6154
117976,increase,O,6154
117977,in,O,6154
117978,the,O,6154
117979,depth,O,6154
117980,of,O,6154
117981,focus,O,6154
117982,which,O,6154
117983,is,O,6154
117984,something,O,6154
117985,I,O,6154
117986,need,O,6154
117987,for,O,6154
117988,the,O,6154
117989,patients,O,6154
117990,in,O,6154
117991,my,O,6154
117992,practice,O,6154
117993,looking,O,6154
117994,for,O,6154
117995,more,O,6154
117996,from,O,6154
117997,a,O,6154
117998,monofocal,O,6154
117999,The,O,6154
118000,latest,O,6154
118001,innovation,O,6155
118002,in,O,6155
118003,the,B-TREATMENT,6155
118004,Tecnis,I-TREATMENT,6155
118005,family,I-TREATMENT,6155
118006,of,O,6155
118007,IOLs-Tecnis,O,6155
118008,Eyhance,O,6155
118009,and,O,6155
118010,Tecnis,B-TREATMENT,6155
118011,Eyhance,I-TREATMENT,6155
118012,Toric,I-TREATMENT,6155
118013,II,I-TREATMENT,6155
118014,IOLs-are,O,6155
118015,defining,O,6155
118016,the,O,6155
118017,future,O,6155
118018,of,O,6155
118019,monofocals,B-TREATMENT,6155
118020,with,O,6155
118021,a,O,6155
118022,breakthrough,O,6155
118023,refractive,O,6156
118024,surface,O,6156
118025,designed,O,6156
118026,to,O,6156
118027,Slightly,O,6156
118028,extend,O,6156
118029,the,O,6156
118030,depth,O,6156
118031,of,O,6156
118032,focus,O,6156
118033,through,O,6156
118034,the,O,6156
118035,unique,O,6156
118036,shape,O,6156
118037,of,O,6156
118038,the,B-PART_OF_THE_EYES,6156
118039,lens,I-PART_OF_THE_EYES,6156
118040,Deliver,O,6156
118041,better,O,6156
118042,image,O,6156
118043,contrast,O,6156
118044,in,O,6156
118045,low,O,6156
118046,light,O,6156
118047,Tecnis,B-TREATMENT,6156
118048,Eyhance,I-TREATMENT,6156
118049,IOLs,B-TREATMENT,6156
118050,deliver,O,6156
118051,30%,O,6156
118052,improvement,O,6156
118053,in,O,6157
118054,image,O,6157
118055,contrast,O,6157
118056,compared,O,6157
118057,to,O,6157
118058,AcrySof,B-TREATMENT,6157
118059,IQ,I-TREATMENT,6157
118060,SN60WF,I-TREATMENT,6157
118061,at,O,6157
118062,5mm,O,6157
118063,Provide,O,6157
118064,safe,O,6157
118065,and,O,6157
118066,easy,O,6157
118067,delivery,O,6157
118068,using,O,6157
118069,the,O,6157
118070,new,O,6157
118071,Tecnis,B-TREATMENT,6157
118072,Simplicity,O,6158
118073,system,O,6158
118074,that,O,6158
118075,streamlines,O,6158
118076,lens,O,6158
118077,delivery,O,6158
118078,and,O,6158
118079,protects,O,6158
118080,against,O,6158
118081,contamination,O,6158
118082,Built,O,6158
118083,on,O,6158
118084,the,O,6158
118085,proven,O,6158
118086,Tecnis,B-TREATMENT,6158
118087,platform,O,6158
118088,Tecnis,B-TREATMENT,6158
118089,Eyhance,I-TREATMENT,6158
118090,combines,O,6158
118091,low-light,O,6158
118092,performance,O,6158
118093,with,O,6158
118094,breakthrough,O,6158
118095,refractive,O,6158
118096,surface,O,6158
118097,design,O,6158
118098,providing,O,6158
118099,a,O,6158
118100,new,O,6158
118101,kind,O,6158
118102,of,O,6158
118103,monofocal,B-TREATMENT,6158
118104,experience,O,6158
118105,for,O,6158
118106,cataract,B-NAME_OF_DISEASE,6159
118107,patients,O,6159
118108,Rajesh,O,6159
118109,K,O,6159
118110,Rajpal,O,6159
118111,MD,O,6159
118112,Chief,O,6159
118113,Medical,O,6159
118114,Officer,O,6159
118115,and,O,6159
118116,Global,O,6159
118117,Head,O,6159
118118,of,O,6159
118119,Clinical,O,6159
118120,and,O,6159
118121,Medical,O,6159
118122,Affairs,O,6159
118123,at,O,6159
118124,Johnson,B-ORGANIZATION,6159
118125,Johnson,I-ORGANIZATION,6159
118126,Vision,I-ORGANIZATION,6159
118127,said,O,6159
118128,in,O,6159
118129,the,O,6159
118130,news,O,6159
118131,release,O,6159
118132,Additionally,O,6159
118133,the,B-TREATMENT,6159
118134,Tecnis,B-TREATMENT,6159
118135,Eyhance,I-TREATMENT,6159
118136,Toric,I-TREATMENT,6159
118137,II,I-TREATMENT,6159
118138,lens,I-TREATMENT,6159
118139,is,O,6159
118140,engineered,O,6159
118141,with,O,6159
118142,a,O,6159
118143,new,O,6159
118144,squared,O,6159
118145,and,O,6159
118146,frosted,O,6159
118147,haptic,O,6159
118148,design,O,6159
118149,for,O,6159
118150,added,O,6159
118151,friction,O,6159
118152,inside,O,6159
118153,the,O,6159
118154,capsular,O,6159
118155,bag,O,6159
118156,to,O,6159
118157,treat,O,6159
118158,cataract,B-NAME_OF_DISEASE,6159
118159,patients,O,6159
118160,with,O,6159
118161,astigmatism,B-NAME_OF_DISEASE,6159
118162,The,B-TREATMENT,6160
118163,Tecnis,B-TREATMENT,6160
118164,Eyhance,I-TREATMENT,6160
118165,IOL,I-TREATMENT,6160
118166,is,O,6160
118167,the,O,6160
118168,latest,O,6160
118169,lens,O,6160
118170,in,O,6160
118171,the,B-TREATMENT,6160
118172,Tecnis,I-TREATMENT,6160
118173,family,I-TREATMENT,6160
118174,which,O,6160
118175,celebrates,O,6160
118176,its,O,6160
118177,20th,O,6160
118178,anniversary,O,6160
118179,this,O,6161
118180,year,O,6161
118181,The,B-TREATMENT,6161
118182,Tecnis,I-TREATMENT,6161
118183,family,I-TREATMENT,6161
118184,portfolio,O,6161
118185,is,O,6161
118186,the,O,6161
118187,broadest,O,6161
118188,mix,O,6161
118189,of,O,6161
118190,IOLs,B-TREATMENT,6161
118191,for,O,6161
118192,cataract,B-NAME_OF_DISEASE,6161
118193,patients,O,6161
118194,in,O,6161
118195,need,O,6161
118196,of,O,6161
118197,monofocals,B-TREATMENT,6161
118198,multifocals,B-TREATMENT,6161
118199,extended,B-TREATMENT,6161
118200,depth,I-TREATMENT,6161
118201,of,I-TREATMENT,6161
118202,focus,I-TREATMENT,6162
118203,EDOF,I-TREATMENT,6162
118204,and,O,6162
118205,those,O,6162
118206,with,O,6162
118207,or,O,6162
118208,without,O,6162
118209,astigmatism,B-NAME_OF_DISEASE,6162
118210,according,O,6162
118211,to,O,6162
118212,J,B-NAME_OF_DISEASE,6162
118213,J,I-NAME_OF_DISEASE,6162
118214,Vision,I-NAME_OF_DISEASE,6162
118215,We,O,6162
118216,consistently,O,6163
118217,engage,O,6163
118218,with,O,6163
118219,our,O,6163
118220,surgeons,O,6163
118221,and,O,6163
118222,their,O,6163
118223,patients,O,6163
118224,to,O,6163
118225,better,O,6163
118226,understand,O,6163
118227,their,O,6163
118228,unmet,O,6163
118229,needs,O,6164
118230,and,O,6164
118231,their,O,6164
118232,feedback,O,6164
118233,drove,O,6164
118234,us,O,6164
118235,to,O,6164
118236,innovate,O,6164
118237,and,O,6164
118238,push,O,6164
118239,the,O,6164
118240,boundaries,O,6164
118241,of,O,6164
118242,the,O,6164
118243,monofocal,B-TREATMENT,6164
118244,category,O,6164
118245,-,O,6164
118246,a,O,6165
118247,category,O,6165
118248,that,O,6165
118249,s,O,6165
118250,largely,O,6165
118251,been,O,6165
118252,stagnant,O,6165
118253,for,O,6165
118254,the,O,6165
118255,last,O,6165
118256,20,O,6165
118257,years,O,6165
118258,said,O,6165
118259,Sandor,B-PERSON,6165
118260,Palfi,I-PERSON,6165
118261,Commercial,O,6165
118262,Vice,O,6165
118263,President,O,6165
118264,of,O,6165
118265,the,O,6165
118266,Americas,O,6165
118267,at,O,6166
118268,Johnson,B-ORGANIZATION,6166
118269,Johnson,I-ORGANIZATION,6166
118270,Vision,I-ORGANIZATION,6166
118271,Tecnis,B-TREATMENT,6166
118272,Eyhance,I-TREATMENT,6166
118273,IOL,I-TREATMENT,6166
118274,is,O,6166
118275,built,O,6166
118276,on,O,6167
118277,the,O,6167
118278,foundation,O,6167
118279,of,O,6167
118280,our,O,6167
118281,proven,O,6167
118282,Tecnis,B-TREATMENT,6167
118283,platform,O,6167
118284,designed,O,6167
118285,to,O,6167
118286,deliver,O,6167
118287,more,O,6167
118288,Tecnis,B-TREATMENT,6167
118289,Eyhance,I-TREATMENT,6167
118290,first,O,6167
118291,launched,O,6167
118292,in,O,6167
118293,Europe,B-GPE,6167
118294,in,O,6168
118295,February,O,6168
118296,2019,O,6168
118297,and,O,6168
118298,became,O,6168
118299,commercially,O,6168
118300,available,O,6168
118301,in,O,6168
118302,Latin,B-GPE,6168
118303,America,I-GPE,6168
118304,and,O,6168
118305,Canada,B-GPE,6168
118306,in,O,6168
118307,the,O,6169
118308,summer,O,6169
118309,of,O,6169
118310,2020,O,6169
118311,Tecnis,B-TREATMENT,6169
118312,Eyhance,I-TREATMENT,6169
118313,and,O,6169
118314,Tecnis,B-TREATMENT,6169
118315,Eyhance,I-TREATMENT,6170
118316,Toric,I-TREATMENT,6170
118317,II,I-TREATMENT,6170
118318,are,O,6170
118319,now,O,6170
118320,commercially,O,6170
118321,available,O,6171
118322,in,O,6171
118323,the,O,6171
118324,U.S,O,6171
118325,with,O,6171
118326,Tecnis,B-TREATMENT,6171
118327,Eyhance,I-TREATMENT,6171
118328,Toric,I-TREATMENT,6171
118329,II,I-TREATMENT,6171
118330,launching,O,6171
118331,in,O,6171
118332,Europe,B-GPE,6171
118333,and,O,6171
118334,Canada,B-GPE,6171
118335,later,O,6171
118336,this,O,6171
118337,year,O,6171
118338,Myopia,B-NAME_OF_DISEASE,6172
118339,is,O,6172
118340,a,O,6172
118341,disorder,O,6172
118342,with,O,6172
118343,a,O,6172
118344,spectrum,O,6172
118345,of,O,6172
118346,stages,O,6172
118347,that,O,6172
118348,should,O,6172
118349,be,O,6172
118350,evaluated,O,6172
118351,as,O,6172
118352,soon,O,6172
118353,as,O,6172
118354,feasible,O,6172
118355,The,O,6172
118356,risk,O,6172
118357,of,O,6172
118358,the,O,6172
118359,related,O,6172
118360,diseases,O,6172
118361,increasing,O,6172
118362,exponentially,O,6172
118363,with,O,6172
118364,myopia,B-NAME_OF_DISEASE,6172
118365,severity,O,6172
118366,makes,O,6172
118367,early,O,6172
118368,detection,O,6172
118369,and,O,6172
118370,treatment,O,6172
118371,essential,O,6173
118372,for,O,6173
118373,lifetime,O,6173
118374,eye,O,6173
118375,health,O,6173
118376,Myopia,B-NAME_OF_DISEASE,6173
118377,may,O,6173
118378,continue,O,6173
118379,to,O,6173
118380,worsen,O,6173
118381,through,O,6173
118382,the,O,6173
118383,teenage,O,6174
118384,years,O,6174
118385,J,B-ORGANIZATION,6174
118386,JVision,I-ORGANIZATION,6174
118387,has,O,6174
118388,released,O,6174
118389,a,O,6174
118390,new,O,6174
118391,manual,O,6174
118392,to,O,6174
118393,help,O,6174
118394,eye,O,6174
118395,care,O,6174
118396,practitioners,O,6174
118397,diagnose,O,6174
118398,track,O,6175
118399,and,O,6175
118400,treat,O,6175
118401,childhood,O,6175
118402,myopia,B-NAME_OF_DISEASE,6175
118403,You,O,6175
118404,can,O,6175
118405,download,O,6175
118406,Managing,O,6175
118407,Myopia,B-NAME_OF_DISEASE,6175
118408,A,O,6175
118409,Clinical,O,6175
118410,Response,O,6175
118411,to,O,6175
118412,the,O,6175
118413,Growing,O,6175
118414,Epidemic,O,6175
118415,here,O,6175
118416,High,B-NAME_OF_DISEASE,6175
118417,myopia,I-NAME_OF_DISEASE,6175
118418,risk,O,6175
118419,increases,O,6175
118420,with,O,6175
118421,early,O,6175
118422,myopia,B-NAME_OF_DISEASE,6175
118423,onset,O,6175
118424,Younger,O,6175
118425,kids,O,6175
118426,experience,O,6175
118427,myopia,B-NAME_OF_DISEASE,6175
118428,more,O,6175
118429,quickly,O,6176
118430,Younger,O,6176
118431,myopes,O,6176
118432,are,O,6176
118433,more,O,6176
118434,likely,O,6176
118435,to,O,6176
118436,develop,O,6176
118437,high,B-NAME_OF_DISEASE,6176
118438,myopia,I-NAME_OF_DISEASE,6176
118439,because,O,6176
118440,early,O,6176
118441,initiation,O,6176
118442,predicts,O,6176
118443,longer,O,6176
118444,years,O,6176
118445,of,O,6176
118446,development,O,6176
118447,In,O,6176
118448,order,O,6176
118449,to,O,6176
118450,obtain,O,6177
118451,baseline,O,6177
118452,measurements,O,6177
118453,it,O,6177
118454,is,O,6177
118455,crucial,O,6177
118456,to,O,6177
118457,check,O,6177
118458,children,O,6177
118459,at,O,6177
118460,least,O,6177
118461,once,O,6177
118462,between,O,6177
118463,the,O,6177
118464,ages,O,6177
118465,of,O,6177
118466,3,O,6177
118467,and,O,6177
118468,5,O,6177
118469,years,O,6177
118470,and,O,6177
118471,every,O,6177
118472,year,O,6177
118473,thereafter,O,6177
118474,until,O,6177
118475,they,O,6177
118476,are,O,6177
118477,18,O,6177
118478,years,O,6177
118479,old,O,6177
118480,Although,O,6177
118481,myopia,B-NAME_OF_DISEASE,6177
118482,is,O,6177
118483,frequently,O,6177
118484,referred,O,6177
118485,to,O,6177
118486,as,O,6177
118487,nearsightedness,B-NAME_OF_DISEASE,6177
118488,it,O,6177
118489,is,O,6177
118490,much,O,6177
118491,more,O,6177
118492,The,O,6177
118493,largest,O,6177
118494,threat,O,6178
118495,to,O,6178
118496,eye,O,6178
118497,health,O,6178
118498,in,O,6178
118499,the,O,6178
118500,twenty-first,O,6178
118501,century,O,6178
118502,is,O,6178
118503,a,O,6178
118504,chronic,O,6178
118505,progressive,O,6178
118506,condition,O,6178
118507,All,O,6178
118508,children,O,6178
118509,with,O,6178
118510,myopia,B-NAME_OF_DISEASE,6178
118511,should,O,6178
118512,be,O,6178
118513,treated,O,6178
118514,but,O,6178
118515,those,O,6178
118516,who,O,6178
118517,begin,O,6178
118518,to,O,6178
118519,experience,O,6178
118520,it,O,6178
118521,before,O,6178
118522,the,O,6178
118523,age,O,6178
118524,of,O,6178
118525,12,O,6178
118526,have,O,6178
118527,a,O,6178
118528,far,O,6178
118529,higher,O,6178
118530,risk,O,6178
118531,of,O,6178
118532,acquiring,O,6178
118533,high,B-NAME_OF_DISEASE,6178
118534,myopia,I-NAME_OF_DISEASE,6178
118535,later,O,6178
118536,in,O,6178
118537,life,O,6178
118538,In,O,6178
118539,addition,O,6178
118540,by,O,6179
118541,2050,O,6179
118542,one,O,6179
118543,billion,O,6179
118544,individuals,O,6179
118545,are,O,6179
118546,anticipated,O,6179
118547,to,O,6179
118548,have,O,6179
118549,high,B-NAME_OF_DISEASE,6179
118550,myopia,I-NAME_OF_DISEASE,6179
118551,accounting,O,6179
118552,for,O,6179
118553,half,O,6179
118554,of,O,6179
118555,the,O,6179
118556,world,O,6179
118557,s,O,6179
118558,population,O,6179
118559,As,O,6179
118560,optometrists,O,6179
118561,we,O,6179
118562,have,O,6179
118563,been,O,6179
118564,concerned,O,6179
118565,for,O,6179
118566,the,O,6179
118567,eye,O,6179
118568,health,O,6179
118569,of,O,6179
118570,children,O,6179
118571,and,O,6179
118572,the,O,6179
118573,trajectory,O,6179
118574,of,O,6179
118575,myopia,B-NAME_OF_DISEASE,6179
118576,on,O,6179
118577,a,O,6179
118578,global,O,6179
118579,level,O,6179
118580,and,O,6179
118581,COVID-19,B-NAME_OF_DISEASE,6180
118582,has,O,6180
118583,only,O,6180
118584,increased,O,6180
118585,our,O,6180
118586,concern,O,6180
118587,said,O,6180
118588,Noel,B-PERSON,6180
118589,Brennan,I-PERSON,6180
118590,MScOptom,I-PERSON,6180
118591,PhD,I-PERSON,6180
118592,FAAO,O,6180
118593,and,O,6180
118594,Clinical,O,6180
118595,Research,O,6180
118596,Fellow,O,6180
118597,Myopia,B-NAME_OF_DISEASE,6181
118598,Control,O,6181
118599,Platform,O,6181
118600,Johnson,B-ORGANIZATION,6181
118601,Johnson,I-ORGANIZATION,6181
118602,Vision,I-ORGANIZATION,6181
118603,Johnson,B-ORGANIZATION,6181
118604,Johnson,I-ORGANIZATION,6181
118605,Vision,I-ORGANIZATION,6181
118606,in,O,6181
118607,partnership,O,6181
118608,with,O,6181
118609,leaders,O,6181
118610,in,O,6181
118611,optometry,O,6181
118612,has,O,6181
118613,created,O,6181
118614,this,O,6181
118615,new,O,6181
118616,myopia,B-NAME_OF_DISEASE,6181
118617,management,O,6181
118618,guide,O,6181
118619,as,O,6181
118620,a,O,6181
118621,clinical,O,6181
118622,response,O,6181
118623,to,O,6181
118624,address,O,6181
118625,the,O,6181
118626,rising,O,6181
118627,rates,O,6181
118628,of,O,6181
118629,myopia,B-NAME_OF_DISEASE,6181
118630,globally,O,6181
118631,and,O,6182
118632,solidify,O,6182
118633,our,O,6182
118634,collective,O,6182
118635,commitment,O,6183
118636,to,O,6183
118637,combating,O,6183
118638,myopia,B-NAME_OF_DISEASE,6183
118639,as,O,6183
118640,a,O,6183
118641,major,O,6183
118642,threat,O,6183
118643,to,O,6183
118644,our,O,6183
118645,children,O,6183
118646,s,O,6183
118647,eye,O,6183
118648,health,O,6183
118649,Myopia,B-NAME_OF_DISEASE,6183
118650,may,O,6183
118651,be,O,6183
118652,inherited,O,6183
118653,or,O,6183
118654,brought,O,6183
118655,on,O,6183
118656,by,O,6183
118657,environmental,B-CAUSE_OF_DISEASE,6183
118658,or,I-CAUSE_OF_DISEASE,6183
118659,genetic,I-CAUSE_OF_DISEASE,6183
118660,factors,I-CAUSE_OF_DISEASE,6183
118661,and,O,6183
118662,it,O,6183
118663,raises,O,6183
118664,the,O,6183
118665,risk,O,6183
118666,of,O,6183
118667,cataracts,B-NAME_OF_DISEASE,6183
118668,myopic,B-NAME_OF_DISEASE,6183
118669,macular,I-NAME_OF_DISEASE,6183
118670,degeneration,I-NAME_OF_DISEASE,6183
118671,MMD,I-NAME_OF_DISEASE,6183
118672,retinal,B-NAME_OF_DISEASE,6184
118673,detachment,I-NAME_OF_DISEASE,6184
118674,staphyloma,B-NAME_OF_DISEASE,6184
118675,primary,B-NAME_OF_DISEASE,6184
118676,open-angle,I-NAME_OF_DISEASE,6184
118677,glaucoma,I-NAME_OF_DISEASE,6184
118678,and,O,6184
118679,retinal,B-NAME_OF_DISEASE,6184
118680,detachment,I-NAME_OF_DISEASE,6184
118681,all,O,6184
118682,of,O,6184
118683,which,O,6184
118684,can,O,6184
118685,cause,O,6184
118686,blindness,B-NAME_OF_DISEASE,6184
118687,and,O,6184
118688,vision,B-SIGN_AND_SYMPTOM,6184
118689,loss,I-SIGN_AND_SYMPTOM,6184
118690,The,O,6184
118691,new,O,6184
118692,recommendations,O,6184
118693,raise,O,6184
118694,awareness,O,6184
118695,of,O,6184
118696,the,O,6184
118697,essential,O,6184
118698,need,O,6184
118699,to,O,6184
118700,diagnose,O,6184
118701,track,O,6184
118702,and,O,6184
118703,treat,O,6184
118704,childhood,O,6184
118705,myopia,B-NAME_OF_DISEASE,6184
118706,Doctors,O,6184
118707,of,O,6184
118708,optometry,O,6185
118709,are,O,6185
118710,on,O,6185
118711,the,O,6185
118712,primary,O,6185
118713,eye,O,6185
118714,care,O,6185
118715,frontlines,O,6185
118716,battling,O,6185
118717,this,O,6185
118718,crisis,O,6185
118719,and,O,6185
118720,it,O,6185
118721,is,O,6185
118722,imperative,O,6185
118723,to,O,6185
118724,deliver,O,6185
118725,forward-looking,O,6185
118726,clinical,O,6185
118727,information,O,6185
118728,grounded,O,6185
118729,in,O,6185
118730,emerging,O,6185
118731,data,O,6185
118732,and,O,6185
118733,first-hand,O,6185
118734,real-world,O,6185
118735,experience,O,6186
118736,said,O,6186
118737,Robert,O,6186
118738,Layman,O,6186
118739,O.D,O,6186
118740,President-Elect,O,6186
118741,American,B-ORGANIZATION,6186
118742,Optometric,I-ORGANIZATION,6186
118743,Association,I-ORGANIZATION,6186
118744,In,O,6186
118745,collaborating,O,6186
118746,with,O,6186
118747,Johnson,B-ORGANIZATION,6187
118748,Johnson,I-ORGANIZATION,6187
118749,Vision,I-ORGANIZATION,6187
118750,and,O,6187
118751,this,O,6187
118752,group,O,6187
118753,of,O,6187
118754,leaders,O,6187
118755,we,O,6187
118756,are,O,6187
118757,providing,O,6187
118758,doctors,O,6187
118759,with,O,6187
118760,information,O,6187
118761,that,O,6188
118762,will,O,6188
118763,enable,O,6188
118764,them,O,6188
118765,to,O,6188
118766,deliver,O,6188
118767,individualized,O,6188
118768,patient,O,6188
118769,care,O,6188
118770,that,O,6188
118771,will,O,6188
118772,support,O,6188
118773,the,O,6188
118774,patient,O,6188
118775,throughout,O,6188
118776,their,O,6188
118777,childhood,O,6188
118778,and,O,6188
118779,into,O,6188
118780,adulthood,O,6189
118781,Managing,O,6189
118782,Myopia,B-NAME_OF_DISEASE,6189
118783,A,O,6189
118784,Clinical,O,6189
118785,Response,O,6189
118786,to,O,6189
118787,the,O,6189
118788,Growing,O,6189
118789,Epidemic,O,6189
118790,contributes,O,6189
118791,to,O,6189
118792,our,O,6189
118793,understanding,O,6189
118794,of,O,6189
118795,myopia,B-NAME_OF_DISEASE,6189
118796,as,O,6189
118797,a,O,6189
118798,whole,O,6189
118799,and,O,6189
118800,offers,O,6189
118801,a,O,6190
118802,research-based,O,6190
118803,justification,O,6190
118804,for,O,6190
118805,why,O,6190
118806,it,O,6190
118807,is,O,6190
118808,important,O,6190
118809,to,O,6190
118810,give,O,6190
118811,children,O,6190
118812,s,O,6190
118813,eye,O,6190
118814,health,O,6190
118815,top,O,6190
118816,priority,O,6190
118817,The,O,6190
118818,new,O,6191
118819,recommendations,O,6191
118820,to,O,6191
118821,help,O,6191
118822,slow,O,6191
118823,the,O,6191
118824,progression,O,6191
118825,of,O,6191
118826,myopia,B-NAME_OF_DISEASE,6191
118827,are,O,6191
118828,a,O,6191
118829,great,O,6191
118830,step,O,6191
118831,forward,O,6191
118832,for,O,6191
118833,our,O,6191
118834,children,O,6191
118835,said,O,6191
118836,Ken,B-PERSON,6191
118837,Tong,I-PERSON,6191
118838,BSc,I-PERSON,6191
118839,Optom,I-PERSON,6191
118840,President,O,6191
118841,Singapore,B-ORGANIZATION,6191
118842,Optometric,I-ORGANIZATION,6191
118843,Association,I-ORGANIZATION,6191
118844,Traditional,O,6191
118845,ways,O,6192
118846,have,O,6192
118847,taught,O,6192
118848,us,O,6192
118849,to,O,6192
118850,simply,O,6192
118851,change,O,6192
118852,glasses,O,6192
118853,upon,O,6192
118854,prescription,O,6192
118855,updates,O,6192
118856,However,O,6192
118857,this,O,6192
118858,is,O,6192
118859,a,O,6192
118860,risky,O,6192
118861,action,O,6192
118862,because,O,6192
118863,myopia,B-NAME_OF_DISEASE,6192
118864,will,O,6192
118865,inevitably,O,6192
118866,increase,O,6192
118867,quickly,O,6192
118868,during,O,6192
118869,childhood,O,6192
118870,This,O,6192
118871,circumstance,O,6192
118872,occurs,O,6192
118873,much,O,6192
118874,too,O,6192
118875,frequently,O,6192
118876,in,O,6192
118877,our,O,6192
118878,clinic,O,6192
118879,as,O,6192
118880,our,O,6192
118881,doctors,O,6192
118882,observe,O,6192
118883,children,O,6192
118884,s,O,6192
118885,myopia,B-NAME_OF_DISEASE,6192
118886,deteriorate,O,6192
118887,over,O,6192
118888,time,O,6192
118889,The,O,6192
118890,structure,O,6192
118891,and,O,6192
118892,health,O,6192
118893,of,O,6192
118894,the,O,6192
118895,eye,O,6192
118896,are,O,6192
118897,compromised,O,6192
118898,as,O,6192
118899,myopia,B-NAME_OF_DISEASE,6192
118900,increases,O,6192
118901,increasing,O,6192
118902,the,O,6193
118903,risk,O,6193
118904,of,O,6193
118905,eye,O,6193
118906,disease,O,6193
118907,and,O,6193
118908,vision,B-SIGN_AND_SYMPTOM,6193
118909,loss,I-SIGN_AND_SYMPTOM,6193
118910,As,O,6193
118911,a,O,6193
118912,result,O,6193
118913,myopia,B-NAME_OF_DISEASE,6193
118914,control,O,6193
118915,strategies,O,6193
118916,must,O,6193
118917,be,O,6194
118918,used,O,6194
118919,to,O,6194
118920,stop,O,6194
118921,the,O,6194
118922,progression,O,6194
118923,of,O,6194
118924,treatable,O,6194
118925,eye,O,6194
118926,illnesses,O,6194
118927,Myopia,B-NAME_OF_DISEASE,6194
118928,will,O,6194
118929,deteriorate,O,6194
118930,and,O,6194
118931,pose,O,6194
118932,more,O,6194
118933,risks,O,6194
118934,to,O,6194
118935,eye,O,6195
118936,health,O,6195
118937,during,O,6195
118938,a,O,6195
118939,person,O,6195
118940,s,O,6195
118941,lifetime,O,6195
118942,if,O,6195
118943,there,O,6195
118944,is,O,6195
118945,no,O,6195
118946,intervention,O,6195
118947,in,O,6195
118948,a,O,6195
118949,myopic,O,6195
118950,child,O,6195
118951,s,O,6195
118952,visual,O,6195
118953,system,O,6195
118954,According,O,6195
118955,to,O,6195
118956,the,O,6195
118957,revised,O,6195
118958,guidance,O,6195
118959,important,O,6195
118960,ideas,O,6195
118961,for,O,6195
118962,patients,O,6195
118963,and,O,6195
118964,eye,O,6195
118965,care,O,6195
118966,providers,O,6195
118967,to,O,6195
118968,bear,O,6195
118969,in,O,6195
118970,mind,O,6196
118971,are,O,6196
118972,as,O,6196
118973,follows,O,6196
118974,Children,B-PREVENTION,6196
118975,should,I-PREVENTION,6196
118976,get,I-PREVENTION,6196
118977,eye,I-PREVENTION,6196
118978,exams,I-PREVENTION,6196
118979,between,I-PREVENTION,6196
118980,the,I-PREVENTION,6196
118981,ages,I-PREVENTION,6196
118982,of,I-PREVENTION,6196
118983,6,I-PREVENTION,6196
118984,and,I-PREVENTION,6196
118985,12,I-PREVENTION,6196
118986,months,I-PREVENTION,6196
118987,at,I-PREVENTION,6196
118988,least,I-PREVENTION,6196
118989,once,I-PREVENTION,6196
118990,between,I-PREVENTION,6196
118991,the,I-PREVENTION,6196
118992,ages,I-PREVENTION,6196
118993,of,I-PREVENTION,6196
118994,3,I-PREVENTION,6196
118995,and,I-PREVENTION,6196
118996,5,I-PREVENTION,6196
118997,then,I-PREVENTION,6196
118998,annually,I-PREVENTION,6197
118999,through,I-PREVENTION,6197
119000,the,I-PREVENTION,6197
119001,age,I-PREVENTION,6197
119002,of,I-PREVENTION,6197
119003,17,I-PREVENTION,6197
119004,according,O,6197
119005,to,O,6197
119006,American,B-ORGANIZATION,6197
119007,Optometric,I-ORGANIZATION,6197
119008,Association,I-ORGANIZATION,6197
119009,AOA,I-ORGANIZATION,6197
119010,recommendations,O,6197
119011,Obtain,O,6197
119012,early,O,6197
119013,intervention,O,6197
119014,The,O,6197
119015,onset,O,6197
119016,of,O,6197
119017,myopia,B-NAME_OF_DISEASE,6197
119018,is,O,6197
119019,the,O,6197
119020,key,O,6197
119021,sign,O,6197
119022,that,O,6197
119023,therapy,O,6197
119024,should,O,6197
119025,start,O,6197
119026,To,O,6197
119027,stop,O,6197
119028,the,O,6197
119029,advancement,O,6197
119030,of,O,6197
119031,myopia,B-NAME_OF_DISEASE,6197
119032,it,O,6198
119033,is,O,6198
119034,essential,O,6198
119035,to,O,6198
119036,diagnose,O,6198
119037,and,O,6198
119038,treat,O,6198
119039,it,O,6198
119040,as,O,6198
119041,soon,O,6198
119042,as,O,6198
119043,feasible,O,6198
119044,Select,B-TREATMENT,6198
119045,the,I-TREATMENT,6198
119046,ideal,I-TREATMENT,6198
119047,therapy,I-TREATMENT,6198
119048,The,O,6198
119049,best,O,6198
119050,course,O,6198
119051,of,O,6198
119052,action,O,6198
119053,for,O,6198
119054,a,O,6198
119055,child,O,6198
119056,with,O,6198
119057,myopia,B-NAME_OF_DISEASE,6198
119058,depends,O,6198
119059,on,O,6199
119060,a,O,6199
119061,number,O,6199
119062,of,O,6199
119063,factors,O,6199
119064,including,O,6199
119065,the,O,6199
119066,parents,O,6199
119067,preferences,O,6199
119068,the,O,6199
119069,child,O,6199
119070,s,O,6199
119071,aptitude,O,6199
119072,and,O,6199
119073,his,O,6199
119074,or,O,6199
119075,her,O,6199
119076,level,O,6199
119077,of,O,6199
119078,development,O,6199
119079,The,O,6199
119080,optimal,O,6199
119081,solution,O,6199
119082,for,O,6200
119083,each,O,6200
119084,patient,O,6200
119085,can,O,6200
119086,be,O,6200
119087,selected,O,6200
119088,by,O,6200
119089,practitioners,O,6200
119090,and,O,6200
119091,families,O,6200
119092,based,O,6200
119093,on,O,6200
119094,efficacy,O,6200
119095,including,O,6200
119096,orthokeratology,B-TREATMENT,6200
119097,soft,B-TREATMENT,6200
119098,multifocal,I-TREATMENT,6200
119099,contacts,I-TREATMENT,6200
119100,myopia,B-TREATMENT,6201
119101,control,I-TREATMENT,6201
119102,eyewear,I-TREATMENT,6201
119103,or,O,6201
119104,atropine,B-TREATMENT,6201
119105,eye,I-TREATMENT,6202
119106,drops,I-TREATMENT,6202
119107,Monitoring,O,6202
119108,the,O,6202
119109,advancement,O,6202
119110,of,O,6202
119111,myopia,B-NAME_OF_DISEASE,6202
119112,Once,O,6202
119113,treatment,O,6202
119114,is,O,6202
119115,in,O,6202
119116,place,O,6202
119117,frequent,O,6202
119118,monitoring-at,O,6202
119119,least,O,6202
119120,every,O,6202
119121,six,O,6202
119122,months-helps,O,6202
119123,remove,O,6202
119124,barriers,O,6202
119125,to,O,6202
119126,usage,O,6202
119127,spot,O,6202
119128,dangerous,O,6202
119129,or,O,6202
119130,non-compliant,O,6202
119131,behaviors,O,6202
119132,and,O,6202
119133,deal,O,6202
119134,with,O,6202
119135,any,O,6202
119136,issues,O,6203
119137,as,O,6203
119138,soon,O,6203
119139,as,O,6203
119140,possible,O,6203
119141,Since,O,6203
119142,development,O,6203
119143,might,O,6203
119144,fluctuate,O,6203
119145,seasonally,O,6203
119146,axial,O,6203
119147,length,O,6203
119148,and,O,6203
119149,cycloplegic,O,6203
119150,refractive,O,6203
119151,error,O,6203
119152,should,O,6203
119153,be,O,6203
119154,assessed,O,6203
119155,for,O,6203
119156,a,O,6203
119157,minimum,O,6203
119158,of,O,6203
119159,one,O,6203
119160,year,O,6203
119161,before,O,6203
119162,considering,O,6203
119163,treatment,O,6203
119164,modifications,O,6203
119165,or,O,6203
119166,additional,O,6203
119167,therapy,O,6204
119168,How,O,6204
119169,to,O,6204
119170,effectively,O,6204
119171,communicate,O,6204
119172,myopia,B-NAME_OF_DISEASE,6204
119173,control,O,6204
119174,The,O,6204
119175,effect,O,6205
119176,of,O,6205
119177,myopia,B-NAME_OF_DISEASE,6205
119178,control,O,6205
119179,therapy,O,6205
119180,is,O,6205
119181,typically,O,6205
119182,more,O,6205
119183,of,O,6205
119184,an,O,6205
119185,absolute,O,6206
119186,effect,O,6206
119187,than,O,6206
119188,a,O,6206
119189,proportionate,O,6206
119190,effect,O,6206
119191,The,O,6207
119192,cumulative,O,6207
119193,absolute,O,6207
119194,reduction,O,6207
119195,in,O,6207
119196,elongation,O,6207
119197,or,O,6207
119198,refractive,O,6207
119199,error,O,6207
119200,is,O,6207
119201,the,O,6208
119202,strongest,O,6208
119203,indicator,O,6209
119204,of,O,6209
119205,myopia,B-NAME_OF_DISEASE,6209
119206,treatment,O,6209
119207,effectiveness,O,6209
119208,i.e,O,6209
119209,total,O,6209
119210,mm,O,6210
119211,or,O,6210
119212,D,O,6210
119213,,O,6210
119214,Development,O,6210
119215,of,O,6211
119216,active,O,6211
119217,glasses,O,6211
119218,for,O,6211
119219,mitigating,O,6211
119220,presbyopia,B-NAME_OF_DISEASE,6211
119221,has,O,6211
119222,become,O,6211
119223,an,O,6211
119224,active,O,6211
119225,area,O,6211
119226,of,O,6212
119227,research,O,6212
119228,facilitated,O,6212
119229,by,O,6212
119230,the,O,6212
119231,miniaturization,O,6212
119232,of,O,6212
119233,focus-tunable,O,6212
119234,lenses,O,6213
119235,as,O,6213
119236,well,O,6213
119237,as,O,6213
119238,the,O,6213
119239,increased,O,6213
119240,processing,O,6213
119241,power,O,6213
119242,of,O,6213
119243,modern,O,6213
119244,computers,O,6213
119245,Alcon,B-ORGANIZATION,6213
119246,the,O,6213
119247,global,O,6213
119248,leader,O,6213
119249,in,O,6213
119250,eye,O,6213
119251,care,O,6213
119252,dedicated,O,6213
119253,to,O,6213
119254,helping,O,6213
119255,people,O,6213
119256,see,O,6213
119257,brilliantly,O,6213
119258,has,O,6213
119259,commercially,O,6214
119260,launched,O,6214
119261,the,O,6214
119262,first,O,6214
119263,and,O,6214
119264,only,O,6214
119265,non-diffractive,B-TREATMENT,6214
119266,extended,I-TREATMENT,6214
119267,depth,I-TREATMENT,6214
119268,of,I-TREATMENT,6214
119269,focus,I-TREATMENT,6214
119270,intraocular,I-TREATMENT,6214
119271,lens,I-TREATMENT,6214
119272,IOL,B-TREATMENT,6214
119273,in,O,6214
119274,the,O,6214
119275,U.S,O,6214
119276,-,O,6214
119277,the,B-TREATMENT,6214
119278,AcrySof®,I-TREATMENT,6215
119279,IQ,I-TREATMENT,6215
119280,VivityTM,I-TREATMENT,6215
119281,IOL,B-TREATMENT,6215
119282,Vivity,B-TREATMENT,6215
119283,,O,6215
119284,This,O,6215
119285,new,O,6215
119286,presbyopia-mitigating,B-TREATMENT,6215
119287,lens,I-TREATMENT,6215
119288,is,O,6215
119289,now,O,6215
119290,available,O,6215
119291,to,O,6215
119292,all,O,6215
119293,U.S,O,6215
119294,ophthalmologists,O,6215
119295,for,O,6215
119296,patients,O,6215
119297,undergoing,O,6215
119298,cataract,B-NAME_OF_DISEASE,6215
119299,surgery,I-TREATMENT,6215
119300,Cataracts,B-NAME_OF_DISEASE,6215
119301,are,O,6215
119302,the,O,6215
119303,most,O,6215
119304,common,O,6215
119305,cause,O,6215
119306,of,O,6215
119307,vision,B-SIGN_AND_SYMPTOM,6216
119308,loss,I-SIGN_AND_SYMPTOM,6216
119309,globally,O,6216
119310,The,O,6216
119311,U.S,O,6216
119312,market,O,6216
119313,is,O,6216
119314,expected,O,6216
119315,to,O,6216
119316,grow,O,6216
119317,to,O,6216
119318,5,O,6216
119319,million,O,6216
119320,cataract,B-NAME_OF_DISEASE,6216
119321,surgeries,I-TREATMENT,6216
119322,by,O,6216
119323,2025,O,6216
119324,With,O,6216
119325,the,O,6216
119326,aging,O,6216
119327,population,O,6216
119328,the,O,6216
119329,number,O,6216
119330,of,O,6216
119331,people,O,6216
119332,in,O,6216
119333,the,O,6216
119334,U.S,O,6216
119335,with,O,6216
119336,cataracts,B-NAME_OF_DISEASE,6216
119337,is,O,6216
119338,expected,O,6216
119339,to,O,6216
119340,double,O,6216
119341,by,O,6216
119342,2050,O,6217
119343,Vivity,B-TREATMENT,6217
119344,is,O,6217
119345,a,O,6217
119346,first-of-its-kind,O,6217
119347,non-diffractive,B-TREATMENT,6217
119348,extended,I-TREATMENT,6217
119349,depth,I-TREATMENT,6217
119350,of,I-TREATMENT,6217
119351,focus,I-TREATMENT,6217
119352,IOL,B-TREATMENT,6217
119353,with,O,6217
119354,Alcon,B-ORGANIZATION,6217
119355,s,O,6217
119356,proprietary,O,6217
119357,non-diffractive,O,6217
119358,X-WAVE™,O,6217
119359,technology,O,6217
119360,which,O,6217
119361,stretches,O,6217
119362,and,O,6217
119363,shifts,O,6217
119364,light,O,6217
119365,without,O,6217
119366,splitting,O,6217
119367,it,O,6217
119368,Vivity,B-TREATMENT,6217
119369,delivers,O,6217
119370,monofocal-quality,O,6217
119371,distance,O,6217
119372,far,O,6217
119373,with,O,6217
119374,excellent,O,6217
119375,intermediate,O,6217
119376,at,O,6217
119377,arm,O,6217
119378,s,O,6217
119379,length,O,6217
119380,and,O,6217
119381,functional,O,6217
119382,near,O,6217
119383,vision,O,6217
119384,up,O,6217
119385,close,O,6218
119386,,O,6218
119387,The,O,6218
119388,lens,O,6218
119389,expands,O,6218
119390,Alcon,B-ORGANIZATION,6218
119391,s,O,6218
119392,growing,O,6218
119393,portfolio,O,6218
119394,of,O,6218
119395,presbyopia-mitigating,B-TREATMENT,6218
119396,IOLs,I-TREATMENT,6218
119397,to,O,6218
119398,meet,O,6218
119399,the,O,6218
119400,needs,O,6218
119401,of,O,6218
119402,cataract,B-NAME_OF_DISEASE,6218
119403,patients,O,6218
119404,who,O,6218
119405,are,O,6218
119406,interested,O,6218
119407,in,O,6218
119408,restoring,O,6218
119409,their,O,6218
119410,visual,O,6218
119411,performance,O,6218
119412,and,O,6218
119413,improving,O,6218
119414,their,O,6219
119415,lifestyle,O,6219
119416,With,O,6219
119417,the,O,6219
119418,introduction,O,6219
119419,of,O,6219
119420,Vivity,B-TREATMENT,6220
119421,Alcon,B-ORGANIZATION,6220
119422,continues,O,6220
119423,to,O,6220
119424,demonstrate,O,6220
119425,our,O,6220
119426,ongoing,O,6220
119427,commitment,O,6220
119428,to,O,6220
119429,growing,O,6220
119430,our,O,6220
119431,IOL,B-TREATMENT,6220
119432,portfolio,O,6220
119433,and,O,6220
119434,delivering,O,6220
119435,differentiated,O,6220
119436,innovations,O,6220
119437,that,O,6220
119438,meet,O,6220
119439,surgeon,O,6220
119440,and,O,6220
119441,patient,O,6220
119442,needs,O,6220
119443,said,O,6220
119444,Sergio,B-PERSON,6220
119445,Duplan,I-PERSON,6220
119446,President,O,6220
119447,North,B-GPE,6220
119448,America,I-GPE,6220
119449,at,O,6220
119450,Alcon,B-ORGANIZATION,6220
119451,We,O,6220
119452,now,O,6220
119453,offer,O,6220
119454,two,O,6220
119455,next-generation,O,6220
119456,presbyopia-mitigating,B-TREATMENT,6220
119457,IOL,I-TREATMENT,6220
119458,options,O,6220
119459,with,O,6220
119460,the,B-TREATMENT,6220
119461,PanOptix,I-TREATMENT,6220
119462,Trifocal,I-TREATMENT,6220
119463,for,O,6220
119464,patients,O,6220
119465,who,O,6220
119466,want,O,6220
119467,to,O,6220
119468,be,O,6220
119469,more,O,6220
119470,spectacle,O,6220
119471,independent,O,6220
119472,at,O,6220
119473,all,O,6220
119474,distances,O,6221
119475,and,O,6221
119476,Vivity,B-TREATMENT,6221
119477,for,O,6221
119478,patients,O,6221
119479,who,O,6221
119480,seek,O,6221
119481,to,O,6221
119482,improve,O,6221
119483,their,O,6221
119484,intermediate,O,6221
119485,and,O,6221
119486,near,O,6221
119487,vision,O,6221
119488,with,O,6221
119489,a,O,6221
119490,monofocal-like,O,6221
119491,visual,O,6221
119492,disturbance,O,6221
119493,profile,O,6221
119494,Also,O,6221
119495,available,O,6221
119496,in,O,6221
119497,toric,O,6221
119498,designs,O,6221
119499,Vivity,B-TREATMENT,6221
119500,is,O,6221
119501,built,O,6221
119502,on,O,6221
119503,Alcon,B-ORGANIZATION,6221
119504,s,O,6221
119505,trusted,O,6221
119506,and,O,6221
119507,proven,O,6221
119508,AcrySof,B-TREATMENT,6221
119509,IQ,I-TREATMENT,6221
119510,IOL,I-TREATMENT,6221
119511,platform,O,6221
119512,that,O,6221
119513,has,O,6221
119514,been,O,6221
119515,implanted,O,6221
119516,in,O,6221
119517,more,O,6221
119518,than,O,6221
119519,125,O,6221
119520,million,O,6222
119521,eyes,O,6222
119522,globally,O,6222
119523,According,O,6222
119524,to,O,6222
119525,results,O,6222
119526,from,O,6222
119527,a,O,6222
119528,U.S,O,6222
119529,clinical,O,6222
119530,trial,O,6222
119531,patients,O,6222
119532,who,O,6222
119533,had,O,6222
119534,the,B-TREATMENT,6223
119535,Vivity,I-TREATMENT,6223
119536,lens,I-TREATMENT,6223
119537,implanted,O,6223
119538,experienced,O,6223
119539,renewed,O,6223
119540,vision,O,6223
119541,and,O,6223
119542,lifestyle,O,6223
119543,benefits,O,6223
119544,including,O,6223
119545,94%,O,6223
119546,and,O,6223
119547,92%,O,6223
119548,of,O,6223
119549,Vivity,B-TREATMENT,6223
119550,patients,O,6223
119551,reported,O,6223
119552,very,O,6223
119553,good,O,6223
119554,or,O,6223
119555,good,O,6223
119556,vision,O,6223
119557,at,O,6223
119558,distance,O,6223
119559,and,O,6223
119560,arm,O,6223
119561,s,O,6223
119562,length,O,6223
119563,respectively,O,6223
119564,without,O,6223
119565,glasses,O,6223
119566,in,O,6223
119567,bright,O,6223
119568,light,O,6223
119569,with,O,6223
119570,vision,O,6224
119571,of,O,6224
119572,20,O,6224
119573,20,O,6224
119574,at,O,6224
119575,distance,O,6224
119576,and,O,6224
119577,greater,O,6224
119578,than,O,6224
119579,20,O,6224
119580,25,O,6224
119581,at,O,6224
119582,intermediate,O,6224
119583,Comparable,O,6224
119584,visual,O,6224
119585,disturbance,O,6225
119586,profile,O,6225
119587,to,O,6225
119588,a,B-TREATMENT,6225
119589,monofocal,I-TREATMENT,6225
119590,IOL,B-TREATMENT,6225
119591,The,B-TREATMENT,6225
119592,Vivity,B-TREATMENT,6225
119593,lens,I-TREATMENT,6225
119594,is,O,6225
119595,a,O,6225
119596,disruptive,O,6225
119597,technology,O,6225
119598,that,O,6225
119599,fills,O,6226
119600,a,O,6226
119601,gap,O,6226
119602,for,O,6226
119603,eye,O,6226
119604,surgeons,O,6226
119605,as,O,6226
119606,a,O,6226
119607,presbyopia-mitigating,B-TREATMENT,6226
119608,IOL,B-TREATMENT,6226
119609,option,O,6226
119610,for,O,6226
119611,those,O,6226
119612,patients,O,6226
119613,who,O,6226
119614,are,O,6226
119615,not,O,6226
119616,candidates,O,6226
119617,for,O,6226
119618,a,O,6226
119619,diffractive,O,6226
119620,IOL,B-TREATMENT,6226
119621,platform,O,6226
119622,but,O,6227
119623,want,O,6227
119624,some,O,6227
119625,spectacle,O,6227
119626,independence,O,6227
119627,said,O,6227
119628,Dr,O,6227
119629,Cathleen,O,6227
119630,McCabe,O,6228
119631,Chief,O,6228
119632,Medical,O,6229
119633,Officer,O,6229
119634,Eye,B-ORGANIZATION,6229
119635,Health,I-ORGANIZATION,6229
119636,America,I-ORGANIZATION,6229
119637,and,O,6229
119638,Medical,O,6229
119639,Director,O,6229
119640,The,B-ORGANIZATION,6229
119641,Eye,I-ORGANIZATION,6229
119642,Associates,I-ORGANIZATION,6229
119643,This,O,6229
119644,lens,O,6229
119645,has,O,6229
119646,a,O,6229
119647,monofocal-like,O,6229
119648,visual,O,6229
119649,disturbance,O,6229
119650,profile,O,6230
119651,a,O,6230
119652,low,O,6230
119653,incidence,O,6230
119654,of,O,6230
119655,severe,O,6230
119656,or,O,6230
119657,very,O,6230
119658,bothersome,O,6230
119659,glare,O,6230
119660,and,O,6230
119661,halos,O,6230
119662,and,O,6230
119663,provides,O,6230
119664,a,O,6230
119665,continuous,O,6230
119666,extended,O,6230
119667,range,O,6230
119668,of,O,6230
119669,vision,O,6230
119670,which,O,6230
119671,can,O,6230
119672,meet,O,6230
119673,the,O,6230
119674,needs,O,6230
119675,of,O,6230
119676,many,O,6231
119677,cataract,B-NAME_OF_DISEASE,6231
119678,patients,O,6231
119679,Vivity,B-TREATMENT,6231
119680,received,O,6231
119681,FDA,B-ORGANIZATION,6231
119682,approval,O,6231
119683,in,O,6231
119684,February,O,6231
119685,2020,O,6231
119686,and,O,6231
119687,it,O,6231
119688,was,O,6231
119689,made,O,6231
119690,available,O,6231
119691,to,O,6231
119692,select,O,6231
119693,U.S,O,6231
119694,ophthalmologists,O,6231
119695,in,O,6231
119696,September,O,6231
119697,2020,O,6231
119698,during,O,6232
119699,a,O,6232
119700,pilot,O,6232
119701,phase,O,6232
119702,ahead,O,6232
119703,of,O,6232
119704,the,O,6232
119705,current,O,6232
119706,national,O,6232
119707,launch,O,6232
119708,Vivity,B-TREATMENT,6232
119709,is,O,6232
119710,already,O,6232
119711,available,O,6232
119712,in,O,6232
119713,some,O,6233
119714,European,O,6233
119715,markets,O,6233
119716,Australia,B-GPE,6233
119717,New,B-GPE,6233
119718,Zealand,I-GPE,6233
119719,and,O,6234
119720,Canada,B-GPE,6234
119721,and,O,6234
119722,has,O,6234
119723,been,O,6234
119724,introduced,O,6234
119725,to,O,6235
119726,select,O,6235
119727,ophthalmologists,O,6235
119728,in,O,6235
119729,Latin,B-GPE,6235
119730,America,I-GPE,6235
119731,For,O,6235
119732,more,O,6235
119733,information,O,6235
119734,regarding,O,6235
119735,Vivity,B-TREATMENT,6235
119736,in,O,6235
119737,the,O,6235
119738,U.S,O,6235
119739,visit,O,6235
119740,vivityview.com,O,6235
119741,About,O,6235
119742,Cataracts,B-NAME_OF_DISEASE,6235
119743,A,B-NAME_OF_DISEASE,6235
119744,cataract,I-NAME_OF_DISEASE,6235
119745,is,O,6235
119746,a,B-SIGN_AND_SYMPTOM,6236
119747,cloudy,I-SIGN_AND_SYMPTOM,6236
119748,area,I-SIGN_AND_SYMPTOM,6236
119749,in,I-SIGN_AND_SYMPTOM,6236
119750,the,I-SIGN_AND_SYMPTOM,6236
119751,natural,I-SIGN_AND_SYMPTOM,6236
119752,lens,I-SIGN_AND_SYMPTOM,6236
119753,of,I-SIGN_AND_SYMPTOM,6236
119754,the,I-SIGN_AND_SYMPTOM,6236
119755,eye,I-SIGN_AND_SYMPTOM,6236
119756,that,O,6236
119757,affects,O,6236
119758,vision,O,6236
119759,As,O,6236
119760,a,B-NAME_OF_DISEASE,6236
119761,cataract,I-NAME_OF_DISEASE,6236
119762,develops,O,6236
119763,the,B-SIGN_AND_SYMPTOM,6236
119764,eye,I-SIGN_AND_SYMPTOM,6236
119765,s,I-SIGN_AND_SYMPTOM,6236
119766,lens,I-SIGN_AND_SYMPTOM,6236
119767,gradually,I-SIGN_AND_SYMPTOM,6236
119768,becomes,I-SIGN_AND_SYMPTOM,6237
119769,hard,I-SIGN_AND_SYMPTOM,6237
119770,and,I-SIGN_AND_SYMPTOM,6237
119771,cloudy,I-SIGN_AND_SYMPTOM,6237
119772,allowing,I-SIGN_AND_SYMPTOM,6237
119773,less,I-SIGN_AND_SYMPTOM,6237
119774,light,I-SIGN_AND_SYMPTOM,6237
119775,to,I-SIGN_AND_SYMPTOM,6237
119776,pass,I-SIGN_AND_SYMPTOM,6237
119777,through,I-SIGN_AND_SYMPTOM,6237
119778,which,I-SIGN_AND_SYMPTOM,6237
119779,makes,I-SIGN_AND_SYMPTOM,6237
119780,it,I-SIGN_AND_SYMPTOM,6237
119781,more,I-SIGN_AND_SYMPTOM,6237
119782,difficult,I-SIGN_AND_SYMPTOM,6237
119783,to,I-SIGN_AND_SYMPTOM,6237
119784,see,I-SIGN_AND_SYMPTOM,6237
119785,The,O,6237
119786,vast,O,6237
119787,majority,O,6238
119788,of,O,6238
119789,cataracts,B-NAME_OF_DISEASE,6238
119790,result,O,6238
119791,from,O,6238
119792,normal,B-CAUSE_OF_DISEASE,6238
119793,aging,I-CAUSE_OF_DISEASE,6238
119794,but,O,6238
119795,radiation,B-CAUSE_OF_DISEASE,6238
119796,exposure,I-CAUSE_OF_DISEASE,6238
119797,taking,B-CAUSE_OF_DISEASE,6238
119798,steroids,I-CAUSE_OF_DISEASE,6238
119799,diabetes,B-CAUSE_OF_DISEASE,6238
119800,and,O,6238
119801,eye,B-CAUSE_OF_DISEASE,6238
119802,trauma,I-CAUSE_OF_DISEASE,6238
119803,can,O,6238
119804,accelerate,O,6238
119805,their,O,6238
119806,development,O,6238
119807,Cataracts,B-NAME_OF_DISEASE,6238
119808,are,O,6238
119809,the,O,6238
119810,most,O,6239
119811,common,O,6239
119812,age-related,O,6239
119813,eye,O,6239
119814,condition,O,6239
119815,and,O,6239
119816,the,O,6239
119817,leading,O,6239
119818,cause,O,6239
119819,of,O,6239
119820,preventable,O,6239
119821,blindness,B-NAME_OF_DISEASE,6239
119822,Twenty,O,6239
119823,million,O,6239
119824,people,O,6239
119825,in,O,6239
119826,the,O,6239
119827,U.S,O,6239
119828,age,O,6239
119829,40,O,6239
119830,and,O,6239
119831,older,O,6239
119832,have,O,6239
119833,cataracts,B-NAME_OF_DISEASE,6239
119834,Cataracts,B-NAME_OF_DISEASE,6239
119835,are,O,6239
119836,treated,O,6239
119837,by,O,6239
119838,removing,B-TREATMENT,6239
119839,the,I-TREATMENT,6240
119840,eye,I-TREATMENT,6240
119841,s,I-TREATMENT,6240
119842,cloudy,I-TREATMENT,6241
119843,natural,I-TREATMENT,6241
119844,lens,I-TREATMENT,6241
119845,and,I-TREATMENT,6241
119846,surgically,I-TREATMENT,6241
119847,replacing,I-TREATMENT,6241
119848,it,I-TREATMENT,6241
119849,with,I-TREATMENT,6241
119850,an,I-TREATMENT,6241
119851,intraocular,I-TREATMENT,6241
119852,lens,I-TREATMENT,6241
119853,or,I-TREATMENT,6241
119854,IOL,I-TREATMENT,6241
119855,More,O,6241
119856,than,O,6241
119857,98,O,6241
119858,percent,O,6241
119859,of,O,6241
119860,cataract,B-TREATMENT,6241
119861,surgeries,I-TREATMENT,6241
119862,are,O,6242
119863,considered,O,6242
119864,successful,O,6242
119865,and,O,6242
119866,patients,O,6242
119867,typically,O,6242
119868,can,O,6242
119869,return,O,6242
119870,to,O,6242
119871,their,O,6242
119872,normal,O,6242
119873,routines,O,6242
119874,within,B-TIME_DURATION,6242
119875,24,I-TIME_DURATION,6242
119876,hours,I-TIME_DURATION,6242
119877,About,O,6242
119878,Presbyopia,B-NAME_OF_DISEASE,6242
119879,Presbyopia,B-NAME_OF_DISEASE,6242
119880,is,O,6242
119881,a,O,6242
119882,common,O,6242
119883,age-related,O,6242
119884,vision,O,6242
119885,condition,O,6242
119886,in,O,6242
119887,which,O,6242
119888,people,O,6242
119889,have,O,6242
119890,difficulty,B-SIGN_AND_SYMPTOM,6242
119891,focusing,I-SIGN_AND_SYMPTOM,6243
119892,on,I-SIGN_AND_SYMPTOM,6243
119893,things,I-SIGN_AND_SYMPTOM,6243
119894,up,I-SIGN_AND_SYMPTOM,6243
119895,close,I-SIGN_AND_SYMPTOM,6243
119896,It,O,6243
119897,involves,O,6243
119898,the,B-SIGN_AND_SYMPTOM,6243
119899,gradual,I-SIGN_AND_SYMPTOM,6243
119900,loss,I-SIGN_AND_SYMPTOM,6243
119901,of,I-SIGN_AND_SYMPTOM,6243
119902,the,I-SIGN_AND_SYMPTOM,6243
119903,eye,I-SIGN_AND_SYMPTOM,6243
119904,s,I-SIGN_AND_SYMPTOM,6243
119905,ability,I-SIGN_AND_SYMPTOM,6243
119906,to,I-SIGN_AND_SYMPTOM,6243
119907,focus,I-SIGN_AND_SYMPTOM,6243
119908,on,I-SIGN_AND_SYMPTOM,6243
119909,close,I-SIGN_AND_SYMPTOM,6243
119910,objects,I-SIGN_AND_SYMPTOM,6243
119911,such,I-SIGN_AND_SYMPTOM,6243
119912,as,I-SIGN_AND_SYMPTOM,6243
119913,smart,I-SIGN_AND_SYMPTOM,6243
119914,phones,I-SIGN_AND_SYMPTOM,6243
119915,computers,I-SIGN_AND_SYMPTOM,6243
119916,books,I-SIGN_AND_SYMPTOM,6243
119917,and,I-SIGN_AND_SYMPTOM,6243
119918,menus,I-SIGN_AND_SYMPTOM,6243
119919,Almost,O,6243
119920,everyone,O,6243
119921,will,O,6243
119922,experience,O,6243
119923,presbyopia,B-NAME_OF_DISEASE,6243
119924,to,O,6243
119925,some,O,6243
119926,degree,O,6243
119927,as,O,6243
119928,they,O,6243
119929,age,O,6244
119930,with,O,6244
119931,symptoms,O,6244
119932,often,O,6244
119933,first,O,6244
119934,appearing,O,6244
119935,as,O,6244
119936,an,O,6244
119937,individual,O,6244
119938,enters,O,6244
119939,their,O,6244
119940,40s,O,6244
119941,and,O,6244
119942,continues,O,6244
119943,to,O,6244
119944,worsen,O,6244
119945,into,O,6244
119946,their,O,6244
119947,60s,O,6244
119948,In,O,6244
119949,the,O,6244
119950,U.S,O,6244
119951,an,O,6244
119952,estimated,O,6244
119953,112,O,6245
119954,million,O,6245
119955,people,O,6245
119956,experience,O,6245
119957,vision,O,6245
119958,issues,O,6245
119959,due,O,6245
119960,to,O,6245
119961,presbyopia,B-NAME_OF_DISEASE,6245
119962,-,O,6245
119963,a,O,6245
119964,number,O,6245
119965,that,O,6245
119966,s,O,6245
119967,expected,O,6245
119968,to,O,6245
119969,continue,O,6245
119970,increasing,O,6245
119971,The,O,6245
119972,condition,O,6246
119973,is,O,6246
119974,not,O,6246
119975,a,O,6246
119976,disease,O,6246
119977,so,O,6246
119978,it,O,6246
119979,cannot,O,6246
119980,be,O,6246
119981,cured,O,6246
119982,however,O,6246
119983,there,O,6246
119984,are,O,6246
119985,safe,O,6246
119986,and,O,6246
119987,effective,O,6246
119988,ways,O,6246
119989,to,O,6247
119990,correct,O,6247
119991,presbyopia,B-NAME_OF_DISEASE,6247
119992,including,O,6247
119993,eye,B-TREATMENT,6247
119994,glasses,I-TREATMENT,6247
119995,contact,B-TREATMENT,6247
119996,lenses,I-TREATMENT,6247
119997,or,O,6247
119998,refractive,B-TREATMENT,6247
119999,surgery,I-TREATMENT,6247
120000,About,O,6247
120001,the,B-TREATMENT,6247
120002,AcrySof®,I-TREATMENT,6247
120003,IQ,I-TREATMENT,6247
120004,Vivity™,I-TREATMENT,6247
120005,IOL,B-TREATMENT,6247
120006,The,B-TREATMENT,6247
120007,non-diffractive,I-TREATMENT,6247
120008,AcrySof®,I-TREATMENT,6247
120009,IQ,I-TREATMENT,6247
120010,VivityTM,I-TREATMENT,6247
120011,Extended,I-TREATMENT,6247
120012,Vision,I-TREATMENT,6247
120013,Posterior,I-TREATMENT,6248
120014,Chamber,I-TREATMENT,6248
120015,Intraocular,I-TREATMENT,6248
120016,Lens,I-TREATMENT,6248
120017,Model,I-TREATMENT,6248
120018,DFT015,I-TREATMENT,6248
120019,referred,O,6248
120020,to,O,6248
120021,as,O,6248
120022,AcrySof®,B-TREATMENT,6248
120023,IQ,I-TREATMENT,6248
120024,VivityTM,I-TREATMENT,6248
120025,IOL,B-TREATMENT,6248
120026,is,O,6248
120027,a,O,6248
120028,UV-absorbing,O,6248
120029,and,O,6248
120030,blue,O,6248
120031,light,O,6248
120032,filtering,O,6248
120033,foldable,O,6248
120034,intraocular,B-TREATMENT,6248
120035,lens,I-TREATMENT,6248
120036,IOL,B-TREATMENT,6248
120037,,O,6248
120038,This,O,6248
120039,IOL,B-TREATMENT,6248
120040,compared,O,6248
120041,to,O,6248
120042,a,B-TREATMENT,6248
120043,monofocal,I-TREATMENT,6248
120044,IOL,I-TREATMENT,6248
120045,provides,O,6248
120046,an,O,6248
120047,extended,O,6248
120048,range,O,6248
120049,of,O,6248
120050,vision,O,6248
120051,from,O,6248
120052,distance,O,6248
120053,to,O,6248
120054,near,O,6248
120055,without,O,6248
120056,increasing,O,6248
120057,the,O,6248
120058,incidence,O,6248
120059,of,O,6248
120060,visual,O,6248
120061,disturbances,O,6248
120062,Potential,O,6248
120063,side,O,6249
120064,effects,O,6249
120065,As,O,6249
120066,with,O,6249
120067,any,O,6249
120068,surgery,O,6249
120069,there,O,6249
120070,is,O,6249
120071,an,O,6249
120072,implicit,O,6249
120073,risk,O,6249
120074,whether,O,6249
120075,or,O,6249
120076,not,O,6249
120077,the,B-TREATMENT,6249
120078,IOL,I-TREATMENT,6249
120079,is,O,6249
120080,implanted,O,6249
120081,The,O,6249
120082,complications,O,6249
120083,of,O,6249
120084,the,B-TREATMENT,6249
120085,IOL,I-TREATMENT,6249
120086,implantation,I-TREATMENT,6249
120087,surgery,I-TREATMENT,6249
120088,ranges,O,6249
120089,from,O,6249
120090,minor,O,6249
120091,side,O,6249
120092,effects,O,6249
120093,usually,O,6249
120094,temporary,O,6250
120095,to,O,6250
120096,serious,O,6250
120097,complications,O,6250
120098,Patients,O,6250
120099,with,O,6250
120100,previous,O,6250
120101,illnesses,O,6250
120102,or,O,6250
120103,disorders,O,6250
120104,such,O,6250
120105,as,O,6250
120106,chronic,B-NAME_OF_DISEASE,6250
120107,infections,I-NAME_OF_DISEASE,6250
120108,of,I-NAME_OF_DISEASE,6250
120109,the,I-NAME_OF_DISEASE,6250
120110,eye,I-NAME_OF_DISEASE,6250
120111,or,I-NAME_OF_DISEASE,6250
120112,eyelids,I-NAME_OF_DISEASE,6250
120113,or,O,6250
120114,diabetes,B-NAME_OF_DISEASE,6250
120115,may,O,6250
120116,present,O,6250
120117,a,O,6250
120118,higher,O,6250
120119,risk,O,6250
120120,of,O,6250
120121,complications,O,6250
120122,Temporary,O,6250
120123,surgical,O,6250
120124,complications,O,6250
120125,include,O,6250
120126,but,O,6250
120127,are,O,6250
120128,not,O,6250
120129,limited,O,6250
120130,to,O,6250
120131,reactions,O,6250
120132,to,O,6250
120133,medications,O,6250
120134,such,O,6250
120135,as,O,6250
120136,irritation,B-SIGN_AND_SYMPTOM,6250
120137,or,I-SIGN_AND_SYMPTOM,6250
120138,mild,I-SIGN_AND_SYMPTOM,6250
120139,allergic,I-SIGN_AND_SYMPTOM,6250
120140,response,I-SIGN_AND_SYMPTOM,6250
120141,bleeding,I-SIGN_AND_SYMPTOM,6250
120142,redness,I-SIGN_AND_SYMPTOM,6250
120143,itching,I-SIGN_AND_SYMPTOM,6250
120144,of,I-SIGN_AND_SYMPTOM,6250
120145,the,I-SIGN_AND_SYMPTOM,6250
120146,eye,I-SIGN_AND_SYMPTOM,6250
120147,sensitivity,I-SIGN_AND_SYMPTOM,6250
120148,to,I-SIGN_AND_SYMPTOM,6250
120149,light,I-SIGN_AND_SYMPTOM,6250
120150,swelling,I-SIGN_AND_SYMPTOM,6250
120151,corneal,I-SIGN_AND_SYMPTOM,6250
120152,edema,I-SIGN_AND_SYMPTOM,6250
120153,swelling,I-SIGN_AND_SYMPTOM,6250
120154,of,I-SIGN_AND_SYMPTOM,6250
120155,the,I-SIGN_AND_SYMPTOM,6250
120156,cornea,I-SIGN_AND_SYMPTOM,6250
120157,problems,I-SIGN_AND_SYMPTOM,6250
120158,with,I-SIGN_AND_SYMPTOM,6250
120159,the,I-SIGN_AND_SYMPTOM,6250
120160,iris,I-SIGN_AND_SYMPTOM,6250
120161,cell,I-SIGN_AND_SYMPTOM,6250
120162,growth,I-SIGN_AND_SYMPTOM,6250
120163,in,I-SIGN_AND_SYMPTOM,6250
120164,the,I-SIGN_AND_SYMPTOM,6250
120165,IOL,I-SIGN_AND_SYMPTOM,6250
120166,and,I-SIGN_AND_SYMPTOM,6250
120167,an,I-SIGN_AND_SYMPTOM,6250
120168,increase,I-SIGN_AND_SYMPTOM,6250
120169,temporary,I-SIGN_AND_SYMPTOM,6250
120170,eye,I-SIGN_AND_SYMPTOM,6250
120171,pressure,I-SIGN_AND_SYMPTOM,6250
120172,There,O,6250
120173,is,O,6250
120174,a,O,6250
120175,small,O,6250
120176,risk,O,6250
120177,of,O,6250
120178,needing,O,6250
120179,further,O,6250
120180,surgical,B-TREATMENT,6250
120181,treatment,I-TREATMENT,6250
120182,such,O,6250
120183,as,O,6250
120184,IOL,B-TREATMENT,6250
120185,replacement,I-TREATMENT,6250
120186,implanted,O,6250
120187,by,O,6250
120188,a,O,6250
120189,different,O,6250
120190,one,O,6250
120191,or,O,6250
120192,surgery,O,6250
120193,to,O,6250
120194,improve,O,6250
120195,vision,O,6250
120196,after,O,6250
120197,the,O,6250
120198,implantation,O,6251
120199,of,O,6251
120200,the,O,6251
120201,initial,O,6251
120202,IOL,B-TREATMENT,6251
120203,Johnson,B-ORGANIZATION,6251
120204,Johnson,I-ORGANIZATION,6251
120205,Vision,I-ORGANIZATION,6251
120206,Announces,O,6251
120207,Launch,O,6251
120208,of,O,6251
120209,TECNIS,B-TREATMENT,6251
120210,Eyhance™,I-TREATMENT,6251
120211,Toric,I-TREATMENT,6251
120212,II,I-TREATMENT,6251
120213,IOL,B-TREATMENT,6251
120214,with,O,6251
120215,TECNIS,O,6251
120216,Simplicity™,O,6251
120217,Delivery,O,6251
120218,System,O,6252
120219,a,O,6252
120220,Next-Generation,O,6252
120221,Monofocal,B-TREATMENT,6252
120222,Intraocular,I-TREATMENT,6252
120223,Lens,I-TREATMENT,6252
120224,for,O,6252
120225,Cataracts,B-NAME_OF_DISEASE,6252
120226,Patients,O,6252
120227,with,O,6252
120228,Astigmatism,B-NAME_OF_DISEASE,6252
120229,in,O,6252
120230,Europe,B-GPE,6252
120231,TECNIS,B-TREATMENT,6252
120232,Eyhance™,I-TREATMENT,6252
120233,Toric,I-TREATMENT,6252
120234,II,I-TREATMENT,6252
120235,IOL,B-TREATMENT,6253
120236,offers,O,6253
120237,all,O,6253
120238,the,O,6253
120239,benefits,O,6253
120240,associated,O,6253
120241,with,O,6253
120242,the,B-TREATMENT,6253
120243,TECNIS,I-TREATMENT,6253
120244,Eyhance™,I-TREATMENT,6253
120245,IOL,B-TREATMENT,6253
120246,such,O,6253
120247,as,O,6253
120248,high-quality,O,6253
120249,intermediate,O,6253
120250,and,O,6253
120251,20,O,6253
120252,20,O,6253
120253,distance,O,6253
120254,vision,O,6253
120255,whilst,O,6253
120256,correcting,O,6253
120257,patients,O,6254
120258,astigmatism,B-NAME_OF_DISEASE,6254
120259,Johnson,B-ORGANIZATION,6254
120260,Johnson,I-ORGANIZATION,6254
120261,Vision,I-ORGANIZATION,6254
120262,a,O,6254
120263,global,O,6254
120264,leader,O,6254
120265,in,O,6254
120266,eye,O,6254
120267,health,O,6254
120268,and,O,6254
120269,part,O,6254
120270,of,O,6254
120271,the,B-ORGANIZATION,6254
120272,Johnson,I-ORGANIZATION,6254
120273,Johnson,I-ORGANIZATION,6254
120274,Medical,I-ORGANIZATION,6254
120275,Devices,I-ORGANIZATION,6254
120276,Companies,I-ORGANIZATION,6254
120277,have,O,6254
120278,announced,O,6254
120279,the,O,6254
120280,launch,O,6254
120281,and,O,6254
120282,availability,O,6254
120283,of,O,6254
120284,its,O,6254
120285,TECNIS,B-TREATMENT,6254
120286,Eyhance™,I-TREATMENT,6254
120287,Toric,I-TREATMENT,6254
120288,II,I-TREATMENT,6254
120289,intraocular,I-TREATMENT,6254
120290,lens,I-TREATMENT,6254
120291,IOL,B-TREATMENT,6254
120292,with,O,6254
120293,TECNIS,O,6254
120294,Simplicity™,O,6254
120295,Delivery,O,6254
120296,System,O,6254
120297,for,O,6254
120298,the,O,6254
120299,treatment,O,6254
120300,of,O,6254
120301,cataracts,B-NAME_OF_DISEASE,6254
120302,patients,O,6254
120303,with,O,6254
120304,astigmatism,B-NAME_OF_DISEASE,6254
120305,in,O,6255
120306,Europe,B-GPE,6255
120307,This,O,6255
120308,monofocal,B-TREATMENT,6255
120309,lens,I-TREATMENT,6255
120310,allows,O,6255
120311,for,O,6255
120312,high-quality,O,6255
120313,vision,O,6255
120314,at,O,6255
120315,both,O,6255
120316,intermediate,O,6255
120317,and,O,6255
120318,far,O,6255
120319,distances,O,6255
120320,and,O,6255
120321,is,O,6255
120322,specifically,O,6255
120323,engineered,O,6255
120324,for,O,6255
120325,rotational,O,6255
120326,stability,O,6255
120327,The,B-TREATMENT,6255
120328,TECNIS,I-TREATMENT,6255
120329,Eyhance™,I-TREATMENT,6255
120330,Toric,I-TREATMENT,6255
120331,II,I-TREATMENT,6255
120332,IOL,B-TREATMENT,6255
120333,is,O,6255
120334,the,O,6255
120335,latest,O,6255
120336,innovation,O,6255
120337,in,O,6255
120338,the,O,6255
120339,industry-leading,O,6255
120340,TECNIS®,B-TREATMENT,6255
120341,Family,I-TREATMENT,6255
120342,of,I-TREATMENT,6256
120343,IOLs,I-TREATMENT,6256
120344,It,O,6256
120345,allows,O,6256
120346,patients,O,6256
120347,to,O,6256
120348,achieve,O,6256
120349,significantly,O,6256
120350,improved,O,6256
120351,intermediate,O,6256
120352,vision,O,6256
120353,compared,O,6256
120354,with,O,6256
120355,a,O,6256
120356,standard,O,6256
120357,aspheric,B-TREATMENT,6256
120358,monofocal,I-TREATMENT,6256
120359,IOL,B-TREATMENT,6256
120360,along,O,6256
120361,with,O,6256
120362,20,O,6256
120363,20,O,6256
120364,distance,O,6256
120365,vision,O,6256
120366,With,O,6256
120367,the,O,6256
120368,novel,O,6256
120369,haptic,O,6256
120370,design,O,6256
120371,of,O,6256
120372,the,B-TREATMENT,6257
120373,TECNIS,I-TREATMENT,6257
120374,Eyhance™,I-TREATMENT,6257
120375,Toric,I-TREATMENT,6257
120376,II,I-TREATMENT,6257
120377,IOL,B-TREATMENT,6257
120378,along,O,6257
120379,with,O,6257
120380,excellent,O,6257
120381,rotational,O,6257
120382,stability,O,6257
120383,I,O,6257
120384,have,O,6257
120385,been,O,6257
120386,able,O,6257
120387,to,O,6257
120388,offer,O,6257
120389,my,O,6258
120390,patients,O,6258
120391,immediate,O,6258
120392,improvements,O,6258
120393,in,O,6258
120394,their,O,6258
120395,functional,O,6258
120396,vision,O,6258
120397,while,O,6258
120398,also,O,6258
120399,correcting,O,6258
120400,their,O,6258
120401,astigmatism,B-NAME_OF_DISEASE,6258
120402,said,O,6258
120403,Dr,B-PERSON,6258
120404,Filomena,I-PERSON,6258
120405,Ribeiro,I-PERSON,6258
120406,Head,O,6258
120407,Director,O,6258
120408,of,O,6258
120409,Ophthalmology,O,6258
120410,Hospital,B-ORGANIZATION,6258
120411,da,I-ORGANIZATION,6258
120412,Luz,I-ORGANIZATION,6258
120413,Lisbon,B-GPE,6258
120414,Having,O,6258
120415,implanted,O,6258
120416,the,B-TREATMENT,6258
120417,TECNIS,I-TREATMENT,6258
120418,Eyhance™,I-TREATMENT,6258
120419,Toric,I-TREATMENT,6258
120420,II,I-TREATMENT,6258
120421,IOL,B-TREATMENT,6258
120422,I,O,6259
120423,can,O,6259
120424,confidently,O,6259
120425,say,O,6259
120426,that,O,6259
120427,this,O,6259
120428,IOL,B-TREATMENT,6259
120429,is,O,6259
120430,a,O,6259
120431,game-changer,O,6259
120432,in,O,6259
120433,the,O,6259
120434,monofocal,O,6259
120435,category,O,6259
120436,and,O,6259
120437,in,O,6259
120438,helping,O,6259
120439,my,O,6259
120440,patients,O,6260
120441,get,O,6260
120442,back,O,6260
120443,to,O,6260
120444,spending,O,6260
120445,more,O,6260
120446,time,O,6260
120447,doing,O,6260
120448,what,O,6260
120449,they,O,6260
120450,love,O,6260
120451,In,O,6260
120452,a,O,6260
120453,survey,O,6260
120454,of,O,6260
120455,17,O,6260
120456,leading,O,6260
120457,European,O,6261
120458,ophthalmologists,O,6261
120459,who,O,6261
120460,had,O,6261
120461,early,O,6261
120462,access,O,6261
120463,to,O,6261
120464,the,B-TREATMENT,6261
120465,TECNIS,B-TREATMENT,6261
120466,Eyhance™,I-TREATMENT,6261
120467,Toric,I-TREATMENT,6261
120468,II,I-TREATMENT,6261
120469,IOL,I-TREATMENT,6261
120470,all,O,6261
120471,rated,O,6261
120472,their,O,6261
120473,patients,O,6261
120474,as,O,6261
120475,being,O,6261
120476,very,O,6261
120477,satisfied,O,6261
120478,with,O,6261
120479,the,O,6261
120480,lens,O,6261
120481,Meanwhile,O,6261
120482,more,O,6261
120483,than,O,6261
120484,79%,O,6261
120485,perceived,O,6261
120486,their,O,6261
120487,patients,O,6261
120488,as,O,6261
120489,being,O,6261
120490,very,O,6261
120491,satisfied,O,6261
120492,with,O,6261
120493,their,O,6261
120494,intermediate,O,6261
120495,and,O,6262
120496,distance,O,6262
120497,vision,O,6262
120498,Additionally,O,6262
120499,94%,O,6262
120500,of,O,6262
120501,those,O,6262
120502,surveyed,O,6262
120503,were,O,6262
120504,very,O,6262
120505,satisfied,O,6262
120506,with,O,6262
120507,the,O,6262
120508,handling,O,6262
120509,while,O,6262
120510,implanting,O,6262
120511,the,O,6262
120512,lens,O,6262
120513,while,O,6262
120514,nearly,O,6262
120515,two,O,6262
120516,thirds,O,6262
120517,rated,O,6262
120518,the,O,6262
120519,overall,O,6262
120520,performance,O,6262
120521,of,O,6262
120522,the,O,6262
120523,lens,O,6262
120524,as,O,6262
120525,excellent,O,6262
120526,compared,O,6262
120527,to,O,6262
120528,other,O,6262
120529,toric,B-TREATMENT,6262
120530,IOLs,I-TREATMENT,6262
120531,More,O,6262
120532,than,O,6262
120533,80%,O,6262
120534,also,O,6262
120535,rated,O,6262
120536,the,O,6262
120537,rotational,O,6262
120538,stability,O,6262
120539,of,O,6262
120540,the,O,6262
120541,lens,O,6262
120542,as,O,6262
120543,excellent,O,6263
120544,compared,O,6263
120545,to,O,6263
120546,other,O,6263
120547,toric,B-TREATMENT,6263
120548,IOLs,I-TREATMENT,6263
120549,All,O,6263
120550,those,O,6263
120551,surveyed,O,6263
120552,said,O,6263
120553,they,O,6263
120554,were,O,6263
120555,very,O,6263
120556,likely,O,6263
120557,to,O,6263
120558,continue,O,6263
120559,to,O,6263
120560,use,O,6263
120561,the,O,6263
120562,lens,O,6264
120563,in,O,6264
120564,the,O,6264
120565,future,O,6264
120566,With,O,6264
120567,this,O,6264
120568,rollout,O,6264
120569,of,O,6264
120570,TECNIS,B-TREATMENT,6264
120571,Eyhance™,I-TREATMENT,6264
120572,Toric,I-TREATMENT,6264
120573,II,I-TREATMENT,6264
120574,IOL,I-TREATMENT,6264
120575,we,O,6264
120576,are,O,6264
120577,thrilled,O,6264
120578,to,O,6264
120579,extend,O,6264
120580,the,O,6265
120581,benefits,O,6265
120582,of,O,6265
120583,our,O,6265
120584,most,O,6265
120585,advanced,O,6265
120586,monofocal,B-TREATMENT,6265
120587,IOL,I-TREATMENT,6265
120588,to,O,6265
120589,cataract,B-NAME_OF_DISEASE,6265
120590,patients,O,6265
120591,with,O,6265
120592,astigmatism,B-NAME_OF_DISEASE,6266
120593,said,O,6266
120594,Erin,B-PERSON,6266
120595,McEachren,I-PERSON,6266
120596,Regional,O,6266
120597,Vice,O,6266
120598,President,O,6266
120599,EMEA,B-GPE,6266
120600,Johnson,B-ORGANIZATION,6266
120601,Johnson,I-ORGANIZATION,6266
120602,Surgical,I-ORGANIZATION,6266
120603,Vision,I-ORGANIZATION,6266
120604,It,O,6266
120605,s,O,6266
120606,an,O,6266
120607,important,O,6266
120608,first,O,6266
120609,in,O,6266
120610,Europe,B-GPE,6266
120611,for,O,6267
120612,the,O,6267
120613,monofocal,B-TREATMENT,6267
120614,IOL,I-TREATMENT,6267
120615,category,O,6267
120616,as,O,6267
120617,today,O,6267
120618,most,O,6267
120619,lenses,O,6267
120620,in,O,6267
120621,this,O,6267
120622,category,O,6267
120623,only,O,6267
120624,correct,O,6268
120625,vision,O,6268
120626,to,O,6268
120627,help,O,6268
120628,patients,O,6268
120629,with,O,6268
120630,cataracts,B-NAME_OF_DISEASE,6268
120631,see,O,6268
120632,things,O,6268
120633,at,O,6268
120634,a,O,6268
120635,distance,O,6268
120636,and,O,6268
120637,therefore,O,6268
120638,don,O,6268
120639,t,O,6268
120640,improve,O,6268
120641,the,O,6268
120642,intermediate,O,6268
120643,vision,O,6268
120644,that,O,6268
120645,is,O,6268
120646,required,O,6268
120647,for,O,6268
120648,many,O,6268
120649,important,O,6268
120650,daily,O,6268
120651,tasks,O,6268
120652,This,O,6268
120653,is,O,6268
120654,another,O,6268
120655,breakthrough,O,6268
120656,in,O,6268
120657,meeting,O,6268
120658,the,O,6268
120659,ever-changing,O,6268
120660,and,O,6268
120661,evolving,O,6268
120662,needs,O,6268
120663,of,O,6268
120664,our,O,6269
120665,patients,O,6269
120666,across,O,6269
120667,Europe,B-GPE,6269
120668,and,O,6269
120669,the,O,6269
120670,world,O,6269
120671,Cataracts,B-NAME_OF_DISEASE,6269
120672,are,O,6269
120673,the,O,6269
120674,leading,O,6269
120675,cause,O,6270
120676,of,O,6270
120677,blindness,B-NAME_OF_DISEASE,6270
120678,globally,O,6270
120679,and,O,6270
120680,if,O,6270
120681,left,O,6270
120682,untreated,O,6270
120683,cause,O,6270
120684,vision,B-SIGN_AND_SYMPTOM,6270
120685,to,I-SIGN_AND_SYMPTOM,6270
120686,deteriorate,I-SIGN_AND_SYMPTOM,6270
120687,over,I-SIGN_AND_SYMPTOM,6271
120688,time,I-SIGN_AND_SYMPTOM,6271
120689,Astigmatism,B-NAME_OF_DISEASE,6271
120690,reduces,B-SIGN_AND_SYMPTOM,6271
120691,distance,I-SIGN_AND_SYMPTOM,6271
120692,and,I-SIGN_AND_SYMPTOM,6271
120693,near,I-SIGN_AND_SYMPTOM,6271
120694,visual,I-SIGN_AND_SYMPTOM,6271
120695,acuity,I-SIGN_AND_SYMPTOM,6271
120696,vision,I-SIGN_AND_SYMPTOM,6271
120697,quality,I-SIGN_AND_SYMPTOM,6271
120698,and,I-SIGN_AND_SYMPTOM,6272
120699,depth,I-SIGN_AND_SYMPTOM,6272
120700,perception,I-SIGN_AND_SYMPTOM,6272
120701,In,O,6272
120702,Europe,B-GPE,6272
120703,astigmatism,B-NAME_OF_DISEASE,6272
120704,affects,O,6272
120705,over,O,6272
120706,50%,O,6272
120707,of,O,6272
120708,those,O,6273
120709,over,O,6273
120710,the,O,6273
120711,age,O,6273
120712,of,O,6273
120713,65,O,6273
120714,and,O,6273
120715,over,O,6273
120716,20%,O,6273
120717,of,O,6273
120718,the,O,6273
120719,population,O,6273
120720,Toric,B-TREATMENT,6273
120721,IOLs,I-TREATMENT,6273
120722,are,O,6273
120723,the,O,6273
120724,most,O,6273
120725,common,O,6273
120726,method,O,6273
120727,for,O,6273
120728,astigmatism,B-NAME_OF_DISEASE,6273
120729,correction,O,6273
120730,in,O,6274
120731,cataract,B-NAME_OF_DISEASE,6274
120732,patients,O,6274
120733,TECNIS,B-TREATMENT,6274
120734,Eyhance™,I-TREATMENT,6274
120735,Toric,I-TREATMENT,6274
120736,II,I-TREATMENT,6274
120737,IOL,I-TREATMENT,6274
120738,is,O,6274
120739,part,O,6274
120740,of,O,6274
120741,the,B-TREATMENT,6274
120742,TECNIS®,I-TREATMENT,6274
120743,Family,I-TREATMENT,6274
120744,of,I-TREATMENT,6275
120745,IOLs,I-TREATMENT,6275
120746,which,O,6275
120747,offer,O,6275
120748,a,O,6275
120749,variety,O,6275
120750,of,O,6275
120751,personalized,O,6275
120752,vision,O,6275
120753,options,O,6275
120754,for,O,6275
120755,people,O,6275
120756,with,O,6275
120757,cataracts,B-NAME_OF_DISEASE,6276
120758,all,O,6276
120759,with,O,6276
120760,the,O,6276
120761,goal,O,6276
120762,of,O,6276
120763,ensuring,O,6276
120764,clear,O,6276
120765,sharp,O,6276
120766,vision,O,6276
120767,to,O,6276
120768,meet,O,6276
120769,individual,O,6276
120770,needs,O,6276
120771,and,O,6276
120772,lifestyles,O,6276
120773,The,B-TREATMENT,6276
120774,TECNIS®,I-TREATMENT,6276
120775,IOL,I-TREATMENT,6276
120776,platform,I-TREATMENT,6276
120777,celebrated,O,6276
120778,its,O,6276
120779,20th,O,6276
120780,anniversary,O,6276
120781,earlier,O,6277
120782,this,O,6277
120783,year,O,6277
120784,About,O,6277
120785,Cataracts,B-NAME_OF_DISEASE,6277
120786,and,O,6277
120787,Presbyopia,B-NAME_OF_DISEASE,6277
120788,Cataracts,B-NAME_OF_DISEASE,6277
120789,are,O,6277
120790,the,O,6277
120791,leading,O,6277
120792,cause,O,6277
120793,of,O,6277
120794,blindness,B-NAME_OF_DISEASE,6277
120795,globally,O,6277
120796,More,O,6277
120797,than,O,6277
120798,90,O,6277
120799,percent,O,6277
120800,of,O,6277
120801,people,O,6277
120802,develop,O,6277
120803,cataracts,B-NAME_OF_DISEASE,6277
120804,by,O,6277
120805,age,O,6277
120806,65,O,6277
120807,If,O,6277
120808,left,O,6277
120809,untreated,O,6277
120810,cataracts,B-NAME_OF_DISEASE,6277
120811,cause,O,6277
120812,vision,B-SIGN_AND_SYMPTOM,6277
120813,to,I-SIGN_AND_SYMPTOM,6277
120814,deteriorate,I-SIGN_AND_SYMPTOM,6277
120815,over,I-SIGN_AND_SYMPTOM,6277
120816,time,I-SIGN_AND_SYMPTOM,6277
120817,Cataract,B-TREATMENT,6277
120818,surgery,I-TREATMENT,6277
120819,is,O,6277
120820,the,O,6277
120821,most,O,6277
120822,common,O,6277
120823,surgery,O,6277
120824,performed,O,6277
120825,around,O,6277
120826,the,O,6277
120827,world,O,6277
120828,including,O,6277
120829,more,O,6277
120830,than,O,6277
120831,4,O,6277
120832,million,O,6277
120833,times,O,6277
120834,in,O,6277
120835,the,B-GPE,6278
120836,EU,I-GPE,6278
120837,in,O,6278
120838,2016,O,6278
120839,Many,O,6278
120840,people,O,6278
120841,who,O,6278
120842,have,O,6278
120843,cataracts,B-NAME_OF_DISEASE,6278
120844,experience,O,6278
120845,other,O,6278
120846,problems,O,6278
120847,with,O,6278
120848,their,O,6278
120849,vision,O,6278
120850,such,O,6278
120851,as,O,6279
120852,presbyopia,B-NAME_OF_DISEASE,6279
120853,Cataract,B-TREATMENT,6279
120854,surgery,I-TREATMENT,6279
120855,is,O,6279
120856,a,O,6279
120857,unique,O,6279
120858,opportunity,O,6279
120859,to,O,6279
120860,address,O,6279
120861,presbyopia,B-NAME_OF_DISEASE,6279
120862,without,O,6279
120863,an,O,6279
120864,additional,O,6279
120865,procedure,O,6279
120866,Presbyopia,B-NAME_OF_DISEASE,6279
120867,is,O,6279
120868,a,O,6280
120869,progressive,O,6280
120870,eye,O,6280
120871,condition,O,6280
120872,which,O,6280
120873,makes,O,6280
120874,it,O,6281
120875,difficult,B-SIGN_AND_SYMPTOM,6281
120876,to,I-SIGN_AND_SYMPTOM,6281
120877,focus,I-SIGN_AND_SYMPTOM,6281
120878,on,I-SIGN_AND_SYMPTOM,6281
120879,close,I-SIGN_AND_SYMPTOM,6281
120880,objects,I-SIGN_AND_SYMPTOM,6281
120881,and,O,6281
120882,usually,O,6281
120883,becomes,O,6281
120884,noticeable,O,6281
120885,around,O,6281
120886,40,O,6282
120887,years,O,6282
120888,of,O,6282
120889,age,O,6282
120890,According,O,6282
120891,to,O,6282
120892,the,O,6282
120893,statement,O,6282
120894,of,O,6282
120895,Erin,B-PERSON,6282
120896,McEachren,I-PERSON,6282
120897,Johnson,B-ORGANIZATION,6282
120898,Johnson,I-ORGANIZATION,6282
120899,Surgical,I-ORGANIZATION,6282
120900,Vision,I-ORGANIZATION,6282
120901,EMEA,B-GPE,6282
120902,regional,O,6282
120903,vice,O,6282
120904,president,O,6282
120905,at,O,6282
120906,the,O,6282
120907,virtual,O,6282
120908,European,O,6282
120909,Society,O,6282
120910,of,O,6282
120911,Cataract,B-NAME_OF_DISEASE,6282
120912,and,O,6282
120913,Refractive,O,6282
120914,Surgeons,O,6282
120915,meeting,O,6282
120916,In,O,6282
120917,light,O,6282
120918,of,O,6282
120919,its,O,6283
120920,rotationally,O,6283
120921,stable,O,6283
120922,design,O,6283
120923,with,O,6283
120924,continuous,O,6283
120925,vision,O,6283
120926,range,O,6283
120927,the,B-TREATMENT,6283
120928,Tecnis,I-TREATMENT,6284
120929,Synergy,I-TREATMENT,6284
120930,toric,I-TREATMENT,6284
120931,II,I-TREATMENT,6284
120932,IOL,B-TREATMENT,6284
120933,brings,O,6284
120934,the,O,6284
120935,most,O,6284
120936,advanced,O,6284
120937,IOL,B-TREATMENT,6284
120938,solution,O,6284
120939,to,O,6284
120940,cataract,B-NAME_OF_DISEASE,6284
120941,patients,O,6284
120942,with,O,6284
120943,astigmatism,B-NAME_OF_DISEASE,6284
120944,The,B-TREATMENT,6284
120945,Tecnis,I-TREATMENT,6284
120946,Synergy,I-TREATMENT,6284
120947,toric,I-TREATMENT,6284
120948,II,I-TREATMENT,6284
120949,IOL,I-TREATMENT,6285
120950,comes,O,6285
120951,with,O,6285
120952,its,O,6285
120953,low-light,O,6285
120954,capability,O,6285
120955,and,O,6285
120956,continuity,O,6285
120957,without,O,6285
120958,visual,O,6285
120959,gaps,O,6285
120960,The,O,6285
120961,second,O,6285
120962,product,O,6285
120963,introduced,O,6285
120964,by,O,6285
120965,Johnson,B-ORGANIZATION,6285
120966,Johnson,I-ORGANIZATION,6285
120967,Vision,I-ORGANIZATION,6286
120968,is,O,6286
120969,for,O,6286
120970,surgeons,O,6286
120971,using,O,6286
120972,the,B-SURGICAL_INSTRUMENT,6286
120973,CATALYS™,I-SURGICAL_INSTRUMENT,6286
120974,Precision,I-SURGICAL_INSTRUMENT,6286
120975,Laser,I-SURGICAL_INSTRUMENT,6286
120976,System,I-SURGICAL_INSTRUMENT,6286
120977,This,O,6286
120978,product,O,6286
120979,CATALYS™,O,6286
120980,System,O,6286
120981,cOS,O,6286
120982,6,O,6286
120983,software,O,6286
120984,brings,O,6286
120985,new,O,6286
120986,features,O,6287
120987,for,O,6287
120988,astigmatism,B-NAME_OF_DISEASE,6287
120989,management,O,6287
120990,such,O,6287
120991,as,O,6287
120992,speed,O,6287
120993,and,O,6287
120994,accuracy,O,6287
120995,This,O,6287
120996,software,O,6287
120997,has,O,6287
120998,been,O,6287
120999,specially,O,6287
121000,designed,O,6287
121001,to,O,6287
121002,focus,O,6287
121003,on,O,6287
121004,minimizing,O,6287
121005,data,O,6287
121006,entry,O,6287
121007,verification,O,6287
121008,and,O,6287
121009,manual,O,6287
121010,transcription,O,6287
121011,errors,O,6287
121012,while,O,6287
121013,reducing,O,6287
121014,time,O,6287
121015,spent,O,6287
121016,on,O,6287
121017,calculations,O,6287
121018,and,O,6287
121019,the,O,6287
121020,need,O,6287
121021,for,O,6287
121022,intraoperative,O,6287
121023,aberrometry,O,6287
121024,for,O,6287
121025,toric,B-TREATMENT,6287
121026,IOL,I-TREATMENT,6287
121027,alignment,O,6287
121028,It,O,6288
121029,also,O,6288
121030,includes,O,6288
121031,iris,B-PART_OF_THE_EYES,6288
121032,registration,O,6288
121033,for,O,6288
121034,automatic,O,6288
121035,cyclorotation,O,6288
121036,compensation,O,6288
121037,Cataracts,B-NAME_OF_DISEASE,6288
121038,are,O,6288
121039,the,O,6288
121040,leading,O,6288
121041,cause,O,6288
121042,of,O,6288
121043,blindness,B-NAME_OF_DISEASE,6288
121044,globally,O,6288
121045,and,O,6289
121046,if,O,6289
121047,left,O,6289
121048,untreated,O,6289
121049,they,O,6289
121050,happen,O,6289
121051,to,O,6289
121052,cause,O,6289
121053,vision,B-SIGN_AND_SYMPTOM,6289
121054,to,I-SIGN_AND_SYMPTOM,6289
121055,deteriorate,I-SIGN_AND_SYMPTOM,6289
121056,over,I-SIGN_AND_SYMPTOM,6289
121057,time,I-SIGN_AND_SYMPTOM,6289
121058,Astigmatism,B-NAME_OF_DISEASE,6289
121059,makes,O,6289
121060,a,B-SIGN_AND_SYMPTOM,6289
121061,reducing,I-SIGN_AND_SYMPTOM,6289
121062,effect,I-SIGN_AND_SYMPTOM,6289
121063,on,I-SIGN_AND_SYMPTOM,6289
121064,distance,I-SIGN_AND_SYMPTOM,6289
121065,as,I-SIGN_AND_SYMPTOM,6289
121066,well,I-SIGN_AND_SYMPTOM,6289
121067,as,I-SIGN_AND_SYMPTOM,6289
121068,near,I-SIGN_AND_SYMPTOM,6289
121069,visual,I-SIGN_AND_SYMPTOM,6289
121070,acuity,I-SIGN_AND_SYMPTOM,6289
121071,vision,I-SIGN_AND_SYMPTOM,6289
121072,quality,I-SIGN_AND_SYMPTOM,6289
121073,and,I-SIGN_AND_SYMPTOM,6289
121074,depth,I-SIGN_AND_SYMPTOM,6289
121075,perception,I-SIGN_AND_SYMPTOM,6289
121076,Throughout,O,6289
121077,Europe,B-GPE,6289
121078,astigmatism,B-NAME_OF_DISEASE,6289
121079,affects,O,6289
121080,over,O,6289
121081,50%,O,6289
121082,of,O,6289
121083,those,O,6289
121084,over,O,6289
121085,the,O,6289
121086,age,O,6289
121087,of,O,6289
121088,65,O,6289
121089,and,O,6289
121090,over,O,6289
121091,20%,O,6289
121092,of,O,6289
121093,the,O,6289
121094,population,O,6289
121095,Predictability,O,6289
121096,Level,O,6289
121097,-,O,6289
121098,Toric,B-TREATMENT,6290
121099,IOLs,I-TREATMENT,6290
121100,are,O,6290
121101,the,O,6290
121102,most,O,6290
121103,predictable,O,6290
121104,method,O,6290
121105,for,O,6290
121106,correction,O,6290
121107,however,O,6290
121108,implanting,O,6290
121109,a,B-TREATMENT,6290
121110,Toric,I-TREATMENT,6290
121111,IOL,I-TREATMENT,6290
121112,can,O,6290
121113,be,O,6290
121114,more,O,6290
121115,challenging,O,6290
121116,than,O,6290
121117,a,B-TREATMENT,6290
121118,conventional,I-TREATMENT,6290
121119,spherical,I-TREATMENT,6290
121120,IOL,I-TREATMENT,6290
121121,due,O,6290
121122,to,O,6290
121123,the,O,6290
121124,high,O,6290
121125,degree,O,6290
121126,of,O,6291
121127,precision,O,6291
121128,required,O,6291
121129,to,O,6291
121130,align,O,6291
121131,the,B-PART_OF_THE_EYES,6291
121132,lens,I-PART_OF_THE_EYES,6291
121133,properly,O,6291
121134,to,O,6291
121135,correct,O,6291
121136,astigmatism,B-NAME_OF_DISEASE,6291
121137,Movement,O,6291
121138,of,O,6291
121139,the,B-PART_OF_THE_EYES,6291
121140,lens,I-PART_OF_THE_EYES,6291
121141,after,O,6291
121142,implantation,O,6291
121143,can,O,6291
121144,also,O,6291
121145,result,O,6291
121146,in,O,6291
121147,decreased,O,6291
121148,vision,O,6291
121149,and,O,6291
121150,the,O,6291
121151,need,O,6291
121152,for,O,6291
121153,realignment,O,6291
121154,The,O,6291
121155,most,O,6291
121156,advanced,O,6291
121157,software,O,6291
121158,ever,O,6292
121159,-,O,6292
121160,In,O,6292
121161,its,O,6292
121162,press,O,6292
121163,release,O,6292
121164,Johnson,B-ORGANIZATION,6292
121165,Johnson,I-ORGANIZATION,6292
121166,Vision,I-ORGANIZATION,6292
121167,said,O,6292
121168,This,O,6292
121169,is,O,6292
121170,the,O,6292
121171,best,O,6292
121172,of,O,6292
121173,both,O,6292
121174,worlds,O,6292
121175,for,O,6292
121176,people,O,6292
121177,with,O,6292
121178,cataracts,B-NAME_OF_DISEASE,6292
121179,and,O,6292
121180,astigmatism,B-NAME_OF_DISEASE,6292
121181,-,O,6292
121182,our,O,6292
121183,best,O,6292
121184,Toric,B-TREATMENT,6292
121185,II,I-TREATMENT,6292
121186,IOL,I-TREATMENT,6292
121187,in,O,6292
121188,a,O,6292
121189,preloaded,O,6292
121190,delivery,O,6292
121191,system,O,6292
121192,with,O,6292
121193,the,O,6292
121194,most,O,6292
121195,advanced,O,6292
121196,software,O,6292
121197,tool,O,6292
121198,for,O,6292
121199,ease,O,6292
121200,speed,O,6292
121201,and,O,6292
121202,accuracy,O,6292
121203,in,O,6292
121204,aligning,O,6292
121205,the,B-PART_OF_THE_EYES,6292
121206,lens,I-PART_OF_THE_EYES,6292
121207,These,O,6292
121208,latest,O,6293
121209,additions,O,6293
121210,build,O,6293
121211,on,O,6293
121212,our,O,6293
121213,proud,O,6293
121214,history,O,6293
121215,of,O,6293
121216,raising,O,6293
121217,the,O,6293
121218,standard,O,6293
121219,of,O,6293
121220,care,O,6294
121221,for,O,6294
121222,patients,O,6294
121223,with,O,6294
121224,cataracts,B-NAME_OF_DISEASE,6294
121225,and,O,6294
121226,ensure,O,6294
121227,we,O,6294
121228,stay,O,6294
121229,TRUE,O,6294
121230,to,O,6294
121231,our,O,6294
121232,legacy,O,6294
121233,of,O,6294
121234,innovation,O,6294
121235,The,B-TREATMENT,6294
121236,TECNIS,I-TREATMENT,6294
121237,Synergy™,I-TREATMENT,6294
121238,Toric,I-TREATMENT,6294
121239,II,I-TREATMENT,6294
121240,is,O,6294
121241,a,O,6294
121242,newly,O,6294
121243,designed,O,6294
121244,innovative,O,6294
121245,lens,O,6294
121246,with,O,6294
121247,a,O,6294
121248,nearly,O,6294
121249,flat,O,6294
121250,defocus,O,6294
121251,curve,O,6294
121252,and,O,6294
121253,a,O,6294
121254,squared,O,6294
121255,and,O,6294
121256,frosted,O,6294
121257,haptic,O,6294
121258,design,O,6294
121259,which,O,6294
121260,provides,O,6294
121261,resistance,O,6294
121262,to,O,6294
121263,rotation,O,6294
121264,common,O,6294
121265,in,O,6294
121266,astigmatism,B-NAME_OF_DISEASE,6294
121267,The,O,6294
121268,new,O,6294
121269,lens,O,6294
121270,outperforms,O,6294
121271,existing,O,6294
121272,PC-IOLs,B-TREATMENT,6294
121273,on,O,6294
121274,the,O,6294
121275,market,O,6294
121276,due,O,6294
121277,to,O,6294
121278,its,O,6294
121279,key,O,6294
121280,features,O,6294
121281,which,O,6294
121282,include,O,6294
121283,A,O,6294
121284,broad,O,6294
121285,range,O,6294
121286,of,O,6294
121287,continuous,O,6294
121288,vision,O,6294
121289,Continuity,O,6294
121290,without,O,6294
121291,the,O,6294
121292,visual,O,6294
121293,gaps,O,6294
121294,present,O,6294
121295,in,O,6294
121296,trifocal,O,6294
121297,technology,O,6294
121298,covering,O,6294
121299,33,O,6295
121300,cm,O,6295
121301,to,O,6296
121302,distance,O,6296
121303,Superior,O,6296
121304,low-light,O,6296
121305,performance,O,6296
121306,for,O,6296
121307,reading,O,6296
121308,in,O,6296
121309,dim,O,6296
121310,lighting,O,6296
121311,The,O,6296
121312,new,O,6296
121313,CATALYS™,O,6296
121314,System,O,6296
121315,cOS,O,6296
121316,6,O,6296
121317,software,O,6296
121318,with,O,6297
121319,advanced,O,6297
121320,astigmatism,B-NAME_OF_DISEASE,6297
121321,management,O,6297
121322,is,O,6297
121323,a,O,6297
121324,collaboration,O,6297
121325,with,O,6297
121326,Cassini,B-ORGANIZATION,6297
121327,Technologies,I-ORGANIZATION,6297
121328,B.V,O,6297
121329,The,O,6297
121330,new,O,6297
121331,software,O,6297
121332,simplifies,O,6297
121333,astigmatism,B-NAME_OF_DISEASE,6297
121334,management,O,6298
121335,workﬂow,O,6298
121336,and,O,6298
121337,increases,O,6298
121338,operational,O,6298
121339,efficiency,O,6298
121340,by,O,6298
121341,Minimizing,O,6298
121342,data,O,6298
121343,entry,O,6298
121344,verification,O,6298
121345,and,O,6298
121346,manual,O,6298
121347,transcription,O,6298
121348,errors,O,6298
121349,through,O,6298
121350,direct,O,6298
121351,input,O,6298
121352,of,O,6298
121353,preoperative,O,6298
121354,keratometry,O,6298
121355,and,O,6298
121356,steep,O,6298
121357,axis,O,6299
121358,values,O,6299
121359,data,O,6299
121360,Reducing,O,6299
121361,time,O,6299
121362,spent,O,6299
121363,on,O,6299
121364,calculations,O,6299
121365,by,O,6299
121366,including,O,6299
121367,calculation,O,6299
121368,of,O,6299
121369,accurate,O,6300
121370,incision,O,6300
121371,parameters,O,6300
121372,using,O,6300
121373,a,O,6300
121374,built-in,O,6300
121375,nomogram,O,6300
121376,and,O,6300
121377,automatic,O,6300
121378,input,O,6300
121379,of,O,6300
121380,accurate,O,6300
121381,incision,O,6300
121382,parameters,O,6300
121383,into,O,6300
121384,the,O,6300
121385,treatment,O,6300
121386,planning,O,6300
121387,screen,O,6300
121388,Reduces,O,6300
121389,need,O,6300
121390,for,O,6300
121391,intraoperative,O,6300
121392,aberrometry,O,6300
121393,for,O,6300
121394,Toric,B-TREATMENT,6300
121395,IOL,I-TREATMENT,6300
121396,alignment,O,6300
121397,with,O,6300
121398,radial,O,6300
121399,laser,O,6300
121400,marks,O,6300
121401,placed,O,6300
121402,within,O,6301
121403,a,O,6301
121404,mean,O,6301
121405,accuracy,O,6301
121406,of,O,6301
121407,0.6,O,6301
121408,provide,O,6302
121409,5.5,O,6302
121410,greater,O,6302
121411,precision,O,6302
121412,compared,O,6302
121413,to,O,6302
121414,the,O,6302
121415,manual,O,6302
121416,marking,O,6302
121417,of,O,6302
121418,the,B-PART_OF_THE_EYES,6302
121419,cornea,I-PART_OF_THE_EYES,6302
121420,with,O,6302
121421,an,O,6302
121422,ink,O,6302
121423,pen,O,6302
121424,mean,O,6302
121425,accuracy,O,6302
121426,3.3,O,6302
121427,Iris,B-PART_OF_THE_EYES,6302
121428,registration,O,6303
121429,addition,O,6303
121430,for,O,6303
121431,automatic,O,6303
121432,cyclorotation,O,6303
121433,compensation,O,6303
121434,through,O,6303
121435,collaboration,O,6303
121436,with,O,6303
121437,Cassini,B-ORGANIZATION,6303
121438,Technologies,I-ORGANIZATION,6303
121439,Increased,O,6303
121440,levels,O,6303
121441,of,O,6303
121442,solutions,O,6303
121443,for,O,6303
121444,treating,O,6303
121445,astigmatism,B-NAME_OF_DISEASE,6304
121446,-,O,6304
121447,The,O,6304
121448,introduction,O,6304
121449,of,O,6305
121450,the,O,6305
121451,CATALYS™,O,6305
121452,System,O,6305
121453,cOS,O,6305
121454,6,O,6305
121455,along,O,6305
121456,with,O,6305
121457,the,B-TREATMENT,6305
121458,TECNIS,B-TREATMENT,6306
121459,Synergy™,I-TREATMENT,6306
121460,Toric,I-TREATMENT,6306
121461,II,I-TREATMENT,6306
121462,IOL,I-TREATMENT,6306
121463,means,O,6306
121464,that,O,6306
121465,ophthalmologists,O,6306
121466,and,O,6306
121467,patients,O,6306
121468,now,O,6306
121469,have,O,6306
121470,an,O,6306
121471,increased,O,6306
121472,range,O,6306
121473,of,O,6307
121474,solutions,O,6307
121475,for,O,6307
121476,correcting,O,6307
121477,astigmatism,B-NAME_OF_DISEASE,6307
121478,Toric,B-TREATMENT,6307
121479,IOLs,I-TREATMENT,6307
121480,are,O,6307
121481,an,O,6307
121482,excellent,O,6307
121483,option,O,6307
121484,for,O,6308
121485,correcting,O,6308
121486,astigmatism,B-NAME_OF_DISEASE,6308
121487,in,O,6308
121488,cataract,B-NAME_OF_DISEASE,6308
121489,patients,O,6308
121490,Now,O,6308
121491,these,O,6308
121492,patients,O,6308
121493,can,O,6308
121494,have,O,6308
121495,the,O,6309
121496,most,O,6309
121497,advanced,O,6309
121498,premium,O,6309
121499,IOL,B-TREATMENT,6309
121500,on,O,6309
121501,the,O,6309
121502,market,O,6309
121503,-,O,6309
121504,allowing,O,6309
121505,for,O,6309
121506,high-quality,O,6309
121507,continuous,O,6309
121508,vision,O,6309
121509,even,O,6309
121510,in,O,6309
121511,low-light,O,6309
121512,conditions,O,6309
121513,in,O,6309
121514,the,O,6309
121515,new,O,6309
121516,and,O,6309
121517,improved,O,6310
121518,TECNIS,B-TREATMENT,6310
121519,Synergy™,I-TREATMENT,6310
121520,Toric,I-TREATMENT,6310
121521,II,I-TREATMENT,6310
121522,IOL,I-TREATMENT,6310
121523,Besides,O,6310
121524,the,O,6310
121525,CATALYS™,O,6310
121526,System,O,6310
121527,cOS,O,6310
121528,6,O,6310
121529,means,O,6310
121530,that,O,6310
121531,ophthalmologists,O,6311
121532,now,O,6311
121533,have,O,6311
121534,highly,O,6311
121535,advanced,O,6311
121536,software,O,6311
121537,to,O,6311
121538,assist,O,6311
121539,with,O,6311
121540,speed,O,6311
121541,and,O,6311
121542,accuracy,O,6311
121543,across,O,6311
121544,a,O,6312
121545,range,O,6312
121546,of,O,6312
121547,astigmatism,B-NAME_OF_DISEASE,6312
121548,procedures,O,6312
121549,TECNIS,B-TREATMENT,6312
121550,Synergy™,I-TREATMENT,6312
121551,Toric,I-TREATMENT,6312
121552,II,I-TREATMENT,6312
121553,IOL,I-TREATMENT,6312
121554,has,O,6312
121555,European,O,6312
121556,CE,O,6312
121557,Mark,O,6312
121558,and,O,6312
121559,is,O,6312
121560,now,O,6312
121561,commercially,O,6312
121562,available,O,6312
121563,across,O,6312
121564,the,B-GPE,6312
121565,EU,I-GPE,6312
121566,CATALYS™,O,6312
121567,System,O,6312
121568,cOS,O,6313
121569,6,O,6313
121570,will,O,6313
121571,be,O,6313
121572,commercially,O,6313
121573,available,O,6313
121574,in,O,6313
121575,EMEA,B-GPE,6313
121576,from,O,6313
121577,Q4,O,6313
121578,2020,O,6313
121579,About,O,6313
121580,Cataracts,B-NAME_OF_DISEASE,6313
121581,and,O,6313
121582,Presbyopia,B-NAME_OF_DISEASE,6313
121583,Cataracts,B-NAME_OF_DISEASE,6313
121584,are,O,6313
121585,known,O,6313
121586,to,O,6313
121587,be,O,6313
121588,the,O,6313
121589,leading,O,6313
121590,cause,O,6313
121591,of,O,6313
121592,blindness,B-NAME_OF_DISEASE,6313
121593,globally,O,6313
121594,More,O,6313
121595,than,O,6313
121596,85,O,6313
121597,percent,O,6313
121598,of,O,6314
121599,people,O,6314
121600,develop,O,6314
121601,cataracts,B-NAME_OF_DISEASE,6314
121602,by,O,6314
121603,age,O,6314
121604,60,O,6314
121605,In,O,6314
121606,case,O,6314
121607,not,O,6314
121608,treated,O,6314
121609,cataracts,B-NAME_OF_DISEASE,6314
121610,cause,O,6314
121611,vision,B-SIGN_AND_SYMPTOM,6314
121612,to,I-SIGN_AND_SYMPTOM,6314
121613,deteriorate,I-SIGN_AND_SYMPTOM,6314
121614,over,I-SIGN_AND_SYMPTOM,6314
121615,time,I-SIGN_AND_SYMPTOM,6314
121616,Cataract,B-TREATMENT,6314
121617,surgery,I-TREATMENT,6314
121618,is,O,6314
121619,the,O,6314
121620,most,O,6314
121621,common,O,6314
121622,surgery,O,6314
121623,performed,O,6314
121624,around,O,6314
121625,the,O,6314
121626,world,O,6314
121627,including,O,6315
121628,more,O,6315
121629,than,O,6315
121630,4,O,6315
121631,million,O,6315
121632,times,O,6315
121633,in,O,6315
121634,the,B-GPE,6315
121635,EU,I-GPE,6315
121636,in,O,6315
121637,2016,O,6315
121638,Also,O,6315
121639,Presbyopia,B-NAME_OF_DISEASE,6315
121640,is,O,6315
121641,indeed,O,6315
121642,what,O,6315
121643,many,O,6315
121644,people,O,6315
121645,who,O,6315
121646,have,O,6315
121647,cataracts,B-NAME_OF_DISEASE,6315
121648,experience,O,6315
121649,with,O,6315
121650,their,O,6316
121651,vision,O,6316
121652,Cataract,B-TREATMENT,6316
121653,surgery,I-TREATMENT,6316
121654,is,O,6316
121655,a,O,6316
121656,unique,O,6316
121657,opportunity,O,6316
121658,to,O,6316
121659,address,O,6316
121660,presbyopia,B-NAME_OF_DISEASE,6316
121661,without,O,6316
121662,an,O,6316
121663,additional,O,6316
121664,procedure,O,6316
121665,Presbyopia,B-NAME_OF_DISEASE,6316
121666,is,O,6316
121667,a,O,6316
121668,progressive,O,6316
121669,eye,O,6316
121670,condition,O,6316
121671,which,O,6316
121672,makes,O,6316
121673,it,O,6316
121674,difficult,B-SIGN_AND_SYMPTOM,6316
121675,to,I-SIGN_AND_SYMPTOM,6316
121676,focus,I-SIGN_AND_SYMPTOM,6316
121677,on,I-SIGN_AND_SYMPTOM,6316
121678,close,I-SIGN_AND_SYMPTOM,6316
121679,objects,I-SIGN_AND_SYMPTOM,6316
121680,and,O,6316
121681,usually,O,6316
121682,becomes,O,6316
121683,noticeable,O,6316
121684,around,O,6316
121685,40,O,6316
121686,years,O,6316
121687,of,O,6317
121688,age,O,6317
121689,Ocugen,B-ORGANIZATION,6317
121690,Receives,O,6317
121691,Fourth,O,6317
121692,FDA,B-ORGANIZATION,6317
121693,Orphan,O,6317
121694,Drug,O,6317
121695,Designation,O,6317
121696,for,O,6317
121697,the,O,6317
121698,Same,O,6317
121699,Product,O,6317
121700,OCU400,B-TREATMENT,6317
121701,AAV-NR2E3,I-TREATMENT,6317
121702,Gene,I-TREATMENT,6317
121703,Therapy,I-TREATMENT,6317
121704,for,O,6317
121705,the,O,6317
121706,Treatment,O,6317
121707,of,O,6317
121708,Another,O,6317
121709,Key,O,6317
121710,Inherited,B-NAME_OF_DISEASE,6317
121711,Retinal,I-NAME_OF_DISEASE,6317
121712,Disease,I-NAME_OF_DISEASE,6317
121713,IRD,I-NAME_OF_DISEASE,6317
121714,PDE6B,B-NAME_OF_DISEASE,6317
121715,Gene,I-NAME_OF_DISEASE,6317
121716,Mutation-Associated,I-NAME_OF_DISEASE,6317
121717,Retinal,I-NAME_OF_DISEASE,6318
121718,Diseases,I-NAME_OF_DISEASE,6318
121719,Fourth,O,6318
121720,orphan,O,6318
121721,drug,O,6318
121722,designation,O,6318
121723,for,O,6318
121724,the,O,6318
121725,same,O,6318
121726,product,O,6318
121727,OCU400,B-TREATMENT,6318
121728,is,O,6318
121729,distinct,O,6318
121730,in,O,6318
121731,Ophthalmology,O,6318
121732,gene,O,6318
121733,therapy,O,6318
121734,and,O,6318
121735,demonstrates,O,6318
121736,its,O,6318
121737,potential,O,6319
121738,to,O,6319
121739,treat,O,6319
121740,many,O,6319
121741,Inherited,B-NAME_OF_DISEASE,6319
121742,Retinal,I-NAME_OF_DISEASE,6319
121743,Diseases,I-NAME_OF_DISEASE,6319
121744,Ocugen,B-ORGANIZATION,6319
121745,announced,O,6319
121746,the,O,6319
121747,U.S,O,6319
121748,Food,B-ORGANIZATION,6319
121749,and,I-ORGANIZATION,6319
121750,Drug,I-ORGANIZATION,6319
121751,Administration,I-ORGANIZATION,6319
121752,FDA,I-ORGANIZATION,6319
121753,granted,O,6319
121754,the,O,6319
121755,fourth,O,6319
121756,Orphan,O,6319
121757,Drug,O,6319
121758,Designation,O,6319
121759,ODD,O,6319
121760,for,O,6319
121761,OCU400,B-TREATMENT,6319
121762,in,O,6319
121763,the,O,6319
121764,treatment,O,6319
121765,of,O,6319
121766,PDE6B,B-NAME_OF_DISEASE,6320
121767,gene,I-NAME_OF_DISEASE,6320
121768,mutation-associated,I-NAME_OF_DISEASE,6320
121769,retinal,I-NAME_OF_DISEASE,6320
121770,diseases,I-NAME_OF_DISEASE,6320
121771,Retinitis,B-NAME_OF_DISEASE,6320
121772,Pigmentosa,I-NAME_OF_DISEASE,6320
121773,RP,I-NAME_OF_DISEASE,6320
121774,caused,O,6320
121775,by,O,6320
121776,PDE6B,B-CAUSE_OF_DISEASE,6320
121777,mutation,I-CAUSE_OF_DISEASE,6320
121778,is,O,6320
121779,an,O,6320
121780,inherited,O,6320
121781,retinal,O,6320
121782,dystrophy,O,6320
121783,that,O,6320
121784,leads,O,6320
121785,to,O,6320
121786,blindness,B-NAME_OF_DISEASE,6320
121787,by,O,6320
121788,midlife,O,6320
121789,and,O,6320
121790,is,O,6320
121791,characterized,O,6320
121792,by,O,6321
121793,the,B-SIGN_AND_SYMPTOM,6321
121794,progressive,I-SIGN_AND_SYMPTOM,6321
121795,loss,I-SIGN_AND_SYMPTOM,6321
121796,of,I-SIGN_AND_SYMPTOM,6321
121797,photoreceptors,I-SIGN_AND_SYMPTOM,6321
121798,with,I-SIGN_AND_SYMPTOM,6321
121799,or,I-SIGN_AND_SYMPTOM,6321
121800,without,I-SIGN_AND_SYMPTOM,6321
121801,the,I-SIGN_AND_SYMPTOM,6321
121802,loss,I-SIGN_AND_SYMPTOM,6321
121803,of,I-SIGN_AND_SYMPTOM,6321
121804,retinal,I-SIGN_AND_SYMPTOM,6321
121805,pigment,I-SIGN_AND_SYMPTOM,6321
121806,epithelium,I-SIGN_AND_SYMPTOM,6321
121807,cells,I-SIGN_AND_SYMPTOM,6321
121808,At,B-CAUSE_OF_DISEASE,6321
121809,least,I-CAUSE_OF_DISEASE,6321
121810,one,I-CAUSE_OF_DISEASE,6321
121811,mutation,I-CAUSE_OF_DISEASE,6321
121812,in,I-CAUSE_OF_DISEASE,6321
121813,the,I-CAUSE_OF_DISEASE,6321
121814,PDE6B,I-CAUSE_OF_DISEASE,6321
121815,gene,I-CAUSE_OF_DISEASE,6321
121816,has,O,6321
121817,been,O,6321
121818,found,O,6321
121819,to,O,6321
121820,cause,O,6321
121821,autosomal,B-NAME_OF_DISEASE,6321
121822,dominant,I-NAME_OF_DISEASE,6322
121823,congenital,I-NAME_OF_DISEASE,6322
121824,stationary,I-NAME_OF_DISEASE,6322
121825,night,I-NAME_OF_DISEASE,6322
121826,blindness,I-NAME_OF_DISEASE,6322
121827,which,O,6322
121828,is,O,6322
121829,characterized,O,6322
121830,by,O,6322
121831,the,B-SIGN_AND_SYMPTOM,6322
121832,inability,I-SIGN_AND_SYMPTOM,6322
121833,to,I-SIGN_AND_SYMPTOM,6322
121834,see,I-SIGN_AND_SYMPTOM,6322
121835,in,I-SIGN_AND_SYMPTOM,6322
121836,low,I-SIGN_AND_SYMPTOM,6322
121837,light,I-SIGN_AND_SYMPTOM,6322
121838,Ocugen,B-ORGANIZATION,6322
121839,s,O,6322
121840,Modifier,B-TREATMENT,6322
121841,Gene,I-TREATMENT,6322
121842,Therapy,I-TREATMENT,6322
121843,Platform,I-TREATMENT,6322
121844,offers,O,6322
121845,a,O,6322
121846,unique,O,6322
121847,approach,O,6322
121848,in,O,6322
121849,ophthalmology,O,6323
121850,by,O,6323
121851,addressing,O,6323
121852,multiple,O,6323
121853,diseases,O,6323
121854,with,O,6323
121855,a,O,6323
121856,single,O,6323
121857,product,O,6323
121858,A,O,6323
121859,novel,O,6323
121860,gene,O,6323
121861,therapy,O,6323
121862,product,O,6323
121863,candidate,O,6323
121864,OCU400,B-TREATMENT,6323
121865,has,O,6323
121866,the,O,6323
121867,potential,O,6323
121868,to,O,6323
121869,be,O,6323
121870,broadly,O,6323
121871,effective,O,6323
121872,in,O,6323
121873,restoring,O,6323
121874,retinal,O,6323
121875,integrity,O,6323
121876,and,O,6324
121877,function,O,6324
121878,across,O,6324
121879,a,O,6324
121880,range,O,6324
121881,of,O,6324
121882,genetically,O,6324
121883,diverse,O,6324
121884,inherited,B-NAME_OF_DISEASE,6324
121885,retinal,I-NAME_OF_DISEASE,6324
121886,diseases,I-NAME_OF_DISEASE,6324
121887,It,O,6324
121888,consists,O,6324
121889,of,O,6324
121890,a,O,6324
121891,functional,O,6324
121892,copy,O,6324
121893,of,O,6324
121894,a,O,6325
121895,nuclear,B-CHEMICAL_COMPOUND,6325
121896,hormone,I-CHEMICAL_COMPOUND,6325
121897,receptor,I-CHEMICAL_COMPOUND,6325
121898,NHR,I-CHEMICAL_COMPOUND,6325
121899,gene,I-CHEMICAL_COMPOUND,6325
121900,NR2E3,B-CHEMICAL_COMPOUND,6325
121901,delivered,O,6325
121902,to,O,6325
121903,target,O,6325
121904,cells,O,6325
121905,in,O,6325
121906,the,B-PART_OF_THE_EYES,6325
121907,retina,I-PART_OF_THE_EYES,6325
121908,using,O,6325
121909,an,B-CHEMICAL_COMPOUND,6325
121910,adeno-associated,I-CHEMICAL_COMPOUND,6325
121911,viral,I-CHEMICAL_COMPOUND,6325
121912,vector,I-CHEMICAL_COMPOUND,6325
121913,As,O,6325
121914,a,O,6325
121915,potent,O,6325
121916,modifier,O,6325
121917,gene,O,6325
121918,expression,O,6325
121919,of,O,6325
121920,NR2E3,B-CHEMICAL_COMPOUND,6325
121921,within,O,6325
121922,the,B-PART_OF_THE_EYES,6325
121923,retina,I-PART_OF_THE_EYES,6325
121924,may,O,6325
121925,help,O,6325
121926,reset,O,6325
121927,retinal,O,6325
121928,homeostasis,O,6325
121929,and,O,6325
121930,potentially,O,6325
121931,offer,O,6325
121932,longer,O,6325
121933,benefit,O,6325
121934,stabilizing,O,6325
121935,cells,O,6325
121936,and,O,6325
121937,rescuing,O,6325
121938,photoreceptor,B-SIGN_AND_SYMPTOM,6325
121939,degeneration,I-SIGN_AND_SYMPTOM,6325
121940,and,I-SIGN_AND_SYMPTOM,6325
121941,vision,I-SIGN_AND_SYMPTOM,6325
121942,loss,I-SIGN_AND_SYMPTOM,6325
121943,In,O,6325
121944,pre-clinical,O,6325
121945,studies,O,6325
121946,OCU400,B-TREATMENT,6325
121947,has,O,6326
121948,demonstrated,O,6326
121949,improved,O,6326
121950,vision,O,6326
121951,signals,O,6326
121952,in,O,6326
121953,the,B-PART_OF_THE_EYES,6326
121954,retina,I-PART_OF_THE_EYES,6326
121955,where,O,6326
121956,Electroretinogram,B-DIAGNOSTIC_TEST,6326
121957,response,O,6326
121958,reveals,O,6326
121959,rescue,O,6326
121960,under,O,6326
121961,both,O,6326
121962,Scotopic,O,6326
121963,dim-lit,O,6326
121964,as,O,6326
121965,well,O,6327
121966,as,O,6327
121967,Photopic,O,6327
121968,well-lit,O,6328
121969,conditions,O,6328
121970,The,O,6328
121971,Company,O,6328
121972,believes,O,6328
121973,targeting,O,6328
121974,multiple,O,6328
121975,diseases,O,6328
121976,with,O,6328
121977,one,O,6328
121978,product,O,6328
121979,could,O,6328
121980,also,O,6328
121981,offer,O,6328
121982,a,O,6328
121983,smoother,O,6328
121984,regulatory,O,6328
121985,pathway,O,6328
121986,and,O,6329
121987,the,O,6329
121988,ability,O,6329
121989,to,O,6329
121990,recover,O,6329
121991,development,O,6329
121992,costs,O,6329
121993,over,O,6329
121994,multiple,O,6329
121995,therapeutic,O,6329
121996,indications,O,6329
121997,Ocugen,B-ORGANIZATION,6329
121998,is,O,6329
121999,planning,O,6329
122000,to,O,6329
122001,initiate,O,6329
122002,two,O,6329
122003,parallel,O,6329
122004,Phase,O,6329
122005,I,O,6329
122006,II,O,6330
122007,clinical,O,6330
122008,trials,O,6330
122009,next,O,6330
122010,year,O,6330
122011,targeting,O,6330
122012,two,O,6330
122013,unique,O,6330
122014,IRDs,B-NAME_OF_DISEASE,6330
122015,Following,O,6330
122016,up,O,6330
122017,on,O,6331
122018,recent,O,6331
122019,announcement,O,6331
122020,of,O,6331
122021,an,O,6331
122022,ODD,O,6331
122023,for,O,6331
122024,RHO,B-NAME_OF_DISEASE,6331
122025,mutation-associated,I-NAME_OF_DISEASE,6331
122026,retinal,I-NAME_OF_DISEASE,6331
122027,degeneration,I-NAME_OF_DISEASE,6331
122028,and,O,6331
122029,previous,O,6331
122030,ODDs,O,6331
122031,for,O,6331
122032,both,O,6331
122033,NR2E3,B-NAME_OF_DISEASE,6331
122034,and,I-NAME_OF_DISEASE,6331
122035,CEP290,I-NAME_OF_DISEASE,6331
122036,mutation-associated,I-NAME_OF_DISEASE,6331
122037,retinal,I-NAME_OF_DISEASE,6331
122038,degeneration,I-NAME_OF_DISEASE,6331
122039,the,O,6331
122040,ODD,O,6331
122041,for,O,6331
122042,PDE6B,B-NAME_OF_DISEASE,6331
122043,gene,I-NAME_OF_DISEASE,6331
122044,mutation-associated,I-NAME_OF_DISEASE,6331
122045,retinal,I-NAME_OF_DISEASE,6332
122046,degeneration,I-NAME_OF_DISEASE,6332
122047,continues,O,6332
122048,to,O,6332
122049,support,O,6332
122050,Ocugen,B-ORGANIZATION,6332
122051,s,O,6332
122052,breakthrough,O,6332
122053,modifier,B-TREATMENT,6332
122054,gene,I-TREATMENT,6332
122055,therapy,I-TREATMENT,6332
122056,platform,I-TREATMENT,6332
122057,s,O,6332
122058,potential,O,6332
122059,to,O,6332
122060,treat,O,6332
122061,multiple,O,6332
122062,blindness,B-NAME_OF_DISEASE,6332
122063,diseases,I-NAME_OF_DISEASE,6332
122064,with,O,6332
122065,a,O,6332
122066,single,O,6332
122067,product,O,6332
122068,RP,B-NAME_OF_DISEASE,6332
122069,is,O,6332
122070,a,O,6332
122071,group,O,6332
122072,of,O,6332
122073,heterogenic,B-NAME_OF_DISEASE,6332
122074,inherited,I-NAME_OF_DISEASE,6332
122075,retinal,I-NAME_OF_DISEASE,6332
122076,diseases,I-NAME_OF_DISEASE,6333
122077,associated,O,6333
122078,with,O,6333
122079,over,O,6333
122080,150,O,6333
122081,gene,O,6333
122082,mutations,O,6333
122083,affecting,O,6333
122084,over,O,6333
122085,1,O,6333
122086,million,O,6333
122087,individuals,O,6333
122088,worldwide,O,6333
122089,In,O,6333
122090,addition,O,6333
122091,40%,O,6333
122092,of,O,6333
122093,RP,B-NAME_OF_DISEASE,6333
122094,patients,O,6333
122095,cannot,O,6333
122096,be,O,6333
122097,genetically,O,6333
122098,diagnosed,O,6333
122099,confounding,O,6333
122100,the,O,6333
122101,ability,O,6333
122102,to,O,6333
122103,develop,O,6333
122104,personalized,O,6333
122105,RP,B-NAME_OF_DISEASE,6333
122106,therapies,O,6333
122107,Traditional,O,6333
122108,gene,O,6333
122109,therapy,O,6333
122110,or,O,6333
122111,gene,O,6333
122112,editing,O,6333
122113,approaches,O,6333
122114,may,O,6333
122115,require,O,6334
122116,more,O,6334
122117,than,O,6335
122118,150,O,6336
122119,products,O,6336
122120,to,O,6336
122121,rescue,O,6336
122122,these,O,6336
122123,patients,O,6336
122124,from,O,6336
122125,vision,B-SIGN_AND_SYMPTOM,6336
122126,loss,I-SIGN_AND_SYMPTOM,6336
122127,OCU400,B-TREATMENT,6336
122128,a,O,6336
122129,single,O,6336
122130,product,O,6336
122131,candidate,O,6336
122132,has,O,6336
122133,potential,O,6336
122134,to,O,6336
122135,address,O,6336
122136,broad-spectrum,O,6336
122137,RP,B-NAME_OF_DISEASE,6336
122138,As,O,6336
122139,principal,O,6336
122140,investigator,O,6336
122141,of,O,6336
122142,numerous,O,6336
122143,major,O,6336
122144,clinical,O,6336
122145,trials,O,6336
122146,developing,O,6336
122147,new,O,6336
122148,medical,O,6336
122149,and,O,6336
122150,surgical,O,6336
122151,treatments,O,6336
122152,for,O,6336
122153,retinal,O,6336
122154,disorders,O,6336
122155,I,O,6336
122156,have,O,6336
122157,been,O,6336
122158,on,O,6336
122159,the,O,6336
122160,cutting-edge,O,6336
122161,of,O,6336
122162,many,O,6336
122163,new,O,6336
122164,ophthalmology,O,6337
122165,treatments,O,6337
122166,I,O,6337
122167,am,O,6337
122168,very,O,6337
122169,encouraged,O,6337
122170,by,O,6337
122171,the,O,6337
122172,potential,O,6337
122173,for,O,6337
122174,OCU400,B-TREATMENT,6337
122175,given,O,6337
122176,the,O,6337
122177,uniqueness,O,6337
122178,of,O,6337
122179,Ocugen,B-ORGANIZATION,6337
122180,s,O,6337
122181,Modifier,B-TREATMENT,6337
122182,Gene,I-TREATMENT,6337
122183,Therapy,I-TREATMENT,6337
122184,Platform,I-TREATMENT,6337
122185,and,O,6337
122186,the,O,6337
122187,fact,O,6337
122188,that,O,6337
122189,FDA,B-ORGANIZATION,6337
122190,has,O,6337
122191,issued,O,6337
122192,four,O,6338
122193,ODDs,O,6338
122194,for,O,6338
122195,this,O,6338
122196,product,O,6338
122197,I,O,6338
122198,look,O,6338
122199,forward,O,6338
122200,to,O,6338
122201,Ocugen,B-ORGANIZATION,6338
122202,commencing,O,6338
122203,clinical,O,6338
122204,trials,O,6338
122205,for,O,6338
122206,OCU400,B-TREATMENT,6338
122207,next,O,6338
122208,year,O,6338
122209,and,O,6338
122210,the,O,6338
122211,potential,O,6338
122212,of,O,6338
122213,helping,O,6338
122214,patients,O,6338
122215,by,O,6338
122216,restoring,O,6338
122217,retinal,O,6338
122218,integrity,O,6338
122219,and,O,6338
122220,function,O,6338
122221,across,O,6338
122222,a,O,6338
122223,range,O,6338
122224,of,O,6338
122225,genetically,B-NAME_OF_DISEASE,6338
122226,diverse,I-NAME_OF_DISEASE,6338
122227,inherited,I-NAME_OF_DISEASE,6338
122228,retinal,I-NAME_OF_DISEASE,6338
122229,diseases,I-NAME_OF_DISEASE,6338
122230,including,O,6338
122231,broad-spectrum,O,6338
122232,RP,B-NAME_OF_DISEASE,6338
122233,said,O,6338
122234,Carl,O,6338
122235,D,O,6338
122236,Regillo,O,6338
122237,M.D,O,6338
122238,F.A.C.S,O,6338
122239,member,O,6338
122240,of,O,6339
122241,Ocugen,B-ORGANIZATION,6339
122242,s,I-ORGANIZATION,6339
122243,Retina,I-ORGANIZATION,6339
122244,Scientific,I-ORGANIZATION,6339
122245,Advisory,I-ORGANIZATION,6339
122246,Board,I-ORGANIZATION,6339
122247,and,O,6339
122248,Professor,O,6339
122249,of,O,6339
122250,Ophthalmology,O,6340
122251,at,O,6340
122252,the,O,6340
122253,Sidney,B-ORGANIZATION,6340
122254,Kimmel,I-ORGANIZATION,6340
122255,Medical,I-ORGANIZATION,6340
122256,College,I-ORGANIZATION,6340
122257,at,I-ORGANIZATION,6340
122258,Thomas,I-ORGANIZATION,6340
122259,Jefferson,I-ORGANIZATION,6340
122260,University,I-ORGANIZATION,6340
122261,Chief,O,6340
122262,of,O,6340
122263,the,O,6340
122264,Retina,O,6340
122265,Service,O,6340
122266,at,O,6340
122267,Wills,B-ORGANIZATION,6340
122268,Eye,I-ORGANIZATION,6340
122269,Hospital,I-ORGANIZATION,6340
122270,and,O,6340
122271,founder,O,6340
122272,and,O,6340
122273,former,O,6340
122274,director,O,6340
122275,of,O,6340
122276,the,B-ORGANIZATION,6340
122277,Wills,I-ORGANIZATION,6340
122278,Eye,I-ORGANIZATION,6340
122279,Clinical,I-ORGANIZATION,6340
122280,Retina,I-ORGANIZATION,6340
122281,Research,I-ORGANIZATION,6341
122282,Unit,I-ORGANIZATION,6341
122283,in,O,6341
122284,Philadelphia,B-GPE,6341
122285,I,O,6341
122286,am,O,6341
122287,thrilled,O,6341
122288,to,O,6341
122289,announce,O,6341
122290,our,O,6341
122291,fourth,O,6341
122292,ODD,O,6341
122293,for,O,6341
122294,OCU400,B-TREATMENT,6341
122295,from,O,6341
122296,the,B-ORGANIZATION,6341
122297,FDA,I-ORGANIZATION,6341
122298,after,O,6341
122299,announcing,O,6341
122300,our,O,6341
122301,third,O,6341
122302,ODD,O,6341
122303,for,O,6341
122304,RHO,B-NAME_OF_DISEASE,6342
122305,mutation-associated,I-NAME_OF_DISEASE,6342
122306,retinal,I-NAME_OF_DISEASE,6342
122307,degeneration,I-NAME_OF_DISEASE,6342
122308,just,O,6342
122309,a,O,6342
122310,few,O,6342
122311,days,O,6342
122312,ago,O,6342
122313,With,O,6342
122314,no,O,6342
122315,approved,O,6342
122316,treatments,O,6342
122317,that,O,6342
122318,slow,O,6342
122319,or,O,6342
122320,stop,O,6342
122321,the,O,6342
122322,progression,O,6342
122323,of,O,6342
122324,RP,B-NAME_OF_DISEASE,6342
122325,we,O,6342
122326,are,O,6342
122327,dedicated,O,6342
122328,to,O,6342
122329,driving,O,6342
122330,the,O,6342
122331,development,O,6342
122332,of,O,6342
122333,our,O,6342
122334,Modifier,B-TREATMENT,6342
122335,Gene,I-TREATMENT,6343
122336,Therapy,I-TREATMENT,6343
122337,Platform,I-TREATMENT,6343
122338,forward,O,6343
122339,and,O,6343
122340,potentially,O,6343
122341,addressing,O,6343
122342,the,O,6343
122343,unmet,O,6343
122344,need,O,6343
122345,of,O,6343
122346,multiple,O,6343
122347,gene,O,6343
122348,mutations,O,6343
122349,including,O,6343
122350,mutations,O,6343
122351,in,O,6343
122352,the,B-CHEMICAL_COMPOUND,6343
122353,PDE6B,I-CHEMICAL_COMPOUND,6343
122354,gene,I-CHEMICAL_COMPOUND,6343
122355,with,O,6343
122356,only,O,6343
122357,one,O,6343
122358,product,O,6343
122359,said,O,6343
122360,Dr,O,6343
122361,Shankar,O,6343
122362,Musunuri,O,6343
122363,Chairman,O,6343
122364,Chief,O,6343
122365,Executive,O,6343
122366,Officer,O,6343
122367,and,O,6343
122368,Co-Founder,O,6344
122369,of,O,6344
122370,Ocugen,B-ORGANIZATION,6344
122371,The,B-ORGANIZATION,6344
122372,FDA,I-ORGANIZATION,6344
122373,Office,I-ORGANIZATION,6344
122374,of,I-ORGANIZATION,6344
122375,Orphan,I-ORGANIZATION,6344
122376,Products,I-ORGANIZATION,6344
122377,Development,I-ORGANIZATION,6344
122378,grants,O,6344
122379,orphan,O,6344
122380,designation,O,6344
122381,for,O,6344
122382,novel,O,6344
122383,drugs,O,6344
122384,or,O,6344
122385,biologics,O,6344
122386,that,O,6344
122387,treat,O,6344
122388,a,O,6344
122389,rare,O,6344
122390,disease,O,6344
122391,or,O,6344
122392,condition,O,6344
122393,affecting,O,6345
122394,fewer,O,6345
122395,than,O,6345
122396,200,O,6345
122397,0,O,6345
122398,patients,O,6345
122399,in,O,6345
122400,the,O,6345
122401,U.S,O,6345
122402,Orphan,O,6345
122403,designation,O,6345
122404,qualifies,O,6345
122405,the,O,6345
122406,sponsor,O,6345
122407,of,O,6345
122408,the,O,6345
122409,drug,O,6345
122410,for,O,6345
122411,various,O,6345
122412,development,O,6345
122413,incentives,O,6345
122414,of,O,6345
122415,the,O,6345
122416,Orphan,O,6345
122417,Drug,O,6345
122418,Act,O,6345
122419,including,O,6346
122420,a,O,6346
122421,seven-year,B-TIME_DURATION,6346
122422,period,O,6346
122423,of,O,6346
122424,U.S,O,6346
122425,marketing,O,6346
122426,exclusivity,O,6346
122427,tax,O,6346
122428,credits,O,6346
122429,for,O,6346
122430,clinical,O,6346
122431,research,O,6346
122432,costs,O,6346
122433,clinical,O,6346
122434,research,O,6346
122435,trial,O,6346
122436,design,O,6346
122437,assistance,O,6347
122438,the,O,6347
122439,ability,O,6347
122440,to,O,6347
122441,apply,O,6347
122442,for,O,6347
122443,annual,O,6347
122444,grant,O,6347
122445,funding,O,6347
122446,and,O,6347
122447,waiver,O,6347
122448,of,O,6347
122449,Prescription,O,6347
122450,Drug,O,6347
122451,User,O,6347
122452,Fee,O,6347
122453,Act,O,6347
122454,filing,O,6347
122455,fees,O,6347
122456,About,O,6347
122457,OCU400,B-TREATMENT,6348
122458,OCU400,B-TREATMENT,6348
122459,AAV-hNR2E3,I-TREATMENT,6348
122460,is,O,6348
122461,a,O,6348
122462,novel,O,6348
122463,gene,O,6348
122464,therapy,O,6348
122465,product,O,6348
122466,candidate,O,6348
122467,with,O,6348
122468,the,O,6348
122469,potential,O,6348
122470,to,O,6348
122471,be,O,6348
122472,broadly,O,6348
122473,effective,O,6348
122474,in,O,6348
122475,restoring,O,6348
122476,retinal,O,6348
122477,integrity,O,6348
122478,and,O,6348
122479,function,O,6348
122480,across,O,6348
122481,a,O,6348
122482,range,O,6348
122483,of,O,6349
122484,genetically,B-NAME_OF_DISEASE,6349
122485,diverse,I-NAME_OF_DISEASE,6349
122486,inherited,I-NAME_OF_DISEASE,6349
122487,retinal,I-NAME_OF_DISEASE,6349
122488,diseases,I-NAME_OF_DISEASE,6349
122489,It,O,6349
122490,consists,O,6349
122491,of,O,6349
122492,a,O,6349
122493,functional,O,6349
122494,copy,O,6349
122495,of,O,6349
122496,a,B-CHEMICAL_COMPOUND,6349
122497,nuclear,I-CHEMICAL_COMPOUND,6349
122498,hormone,I-CHEMICAL_COMPOUND,6349
122499,receptor,I-CHEMICAL_COMPOUND,6349
122500,gene,I-CHEMICAL_COMPOUND,6349
122501,NR2E3,B-CHEMICAL_COMPOUND,6349
122502,delivered,O,6349
122503,to,O,6349
122504,target,O,6349
122505,cells,O,6349
122506,in,O,6349
122507,the,B-PART_OF_THE_EYES,6349
122508,retina,I-PART_OF_THE_EYES,6349
122509,using,O,6350
122510,an,B-CHEMICAL_COMPOUND,6350
122511,adeno-associated,I-CHEMICAL_COMPOUND,6350
122512,viral,I-CHEMICAL_COMPOUND,6350
122513,vector,I-CHEMICAL_COMPOUND,6350
122514,As,O,6350
122515,a,O,6350
122516,potent,O,6350
122517,modifier,O,6350
122518,gene,O,6350
122519,expression,O,6350
122520,of,O,6350
122521,NR2E3,B-CHEMICAL_COMPOUND,6350
122522,within,O,6350
122523,the,B-PART_OF_THE_EYES,6350
122524,retina,I-PART_OF_THE_EYES,6350
122525,may,O,6350
122526,help,O,6350
122527,reset,O,6350
122528,retinal,O,6351
122529,homeostasis,O,6351
122530,potentially,O,6351
122531,stabilizing,O,6351
122532,cells,O,6351
122533,and,O,6351
122534,rescuing,O,6351
122535,photoreceptor,B-SIGN_AND_SYMPTOM,6351
122536,degeneration,I-SIGN_AND_SYMPTOM,6351
122537,and,I-SIGN_AND_SYMPTOM,6351
122538,vision,I-SIGN_AND_SYMPTOM,6351
122539,loss,I-SIGN_AND_SYMPTOM,6351
122540,jCell,B-TREATMENT,6351
122541,is,O,6351
122542,a,O,6351
122543,first-in-class,O,6351
122544,investigational,O,6351
122545,treatment,O,6351
122546,for,O,6351
122547,RP,B-NAME_OF_DISEASE,6351
122548,which,O,6351
122549,has,O,6351
122550,received,O,6351
122551,FDA,B-ORGANIZATION,6351
122552,Regenerative,O,6351
122553,Medicine,O,6351
122554,Advanced,O,6351
122555,Therapy,O,6352
122556,RMAT,O,6352
122557,designation,O,6352
122558,In,O,6352
122559,addition,O,6352
122560,to,O,6352
122561,RMAT,O,6352
122562,jCell,B-TREATMENT,6352
122563,has,O,6352
122564,received,O,6352
122565,Orphan,O,6352
122566,Drug,O,6352
122567,designation,O,6352
122568,from,O,6352
122569,the,B-ORGANIZATION,6352
122570,FDA,I-ORGANIZATION,6352
122571,and,O,6352
122572,the,B-ORGANIZATION,6352
122573,European,I-ORGANIZATION,6352
122574,Medicines,I-ORGANIZATION,6352
122575,Agency,I-ORGANIZATION,6352
122576,EMA,I-ORGANIZATION,6352
122577,,O,6353
122578,The,O,6353
122579,phase,O,6353
122580,2b,O,6353
122581,trial,O,6353
122582,was,O,6353
122583,a,O,6353
122584,multicenter,O,6353
122585,randomized,O,6353
122586,study,O,6353
122587,that,O,6353
122588,evaluated,O,6353
122589,the,O,6353
122590,safety,O,6353
122591,and,O,6353
122592,efficacy,O,6353
122593,of,O,6354
122594,intravitreal,O,6354
122595,injection,O,6354
122596,of,O,6354
122597,jCell,B-TREATMENT,6354
122598,therapy,I-TREATMENT,6354
122599,in,O,6354
122600,adult,O,6354
122601,subjects,O,6354
122602,with,O,6354
122603,RP,B-NAME_OF_DISEASE,6354
122604,A,O,6354
122605,large,O,6354
122606,and,O,6354
122607,broad,O,6354
122608,set,O,6354
122609,of,O,6354
122610,patients,O,6354
122611,with,O,6354
122612,RP,B-NAME_OF_DISEASE,6354
122613,with,O,6354
122614,best-corrected,B-DIAGNOSTIC_TEST,6354
122615,visual,I-DIAGNOSTIC_TEST,6354
122616,acuity,I-DIAGNOSTIC_TEST,6354
122617,BCVA,B-DIAGNOSTIC_TEST,6354
122618,between,O,6354
122619,20,O,6354
122620,80,O,6354
122621,and,O,6354
122622,20,O,6354
122623,800,O,6354
122624,were,O,6354
122625,randomized,O,6354
122626,to,O,6354
122627,treatment,O,6354
122628,versus,O,6354
122629,sham,O,6354
122630,Treatment,O,6354
122631,consisted,O,6354
122632,of,O,6354
122633,a,B-TREATMENT,6354
122634,single,I-TREATMENT,6354
122635,intravitreal,I-TREATMENT,6354
122636,injection,I-TREATMENT,6354
122637,of,I-TREATMENT,6354
122638,either,I-TREATMENT,6354
122639,3,I-TREATMENT,6354
122640,or,I-TREATMENT,6354
122641,6,I-TREATMENT,6354
122642,million,I-TREATMENT,6354
122643,human,I-TREATMENT,6354
122644,retinal,I-TREATMENT,6354
122645,progenitor,I-TREATMENT,6354
122646,cells,I-TREATMENT,6354
122647,hRPC,I-TREATMENT,6355
122648,,O,6355
122649,The,O,6355
122650,study,O,6355
122651,evaluated,O,6355
122652,changes,O,6355
122653,in,O,6355
122654,visual,O,6355
122655,function,O,6355
122656,and,O,6355
122657,functional,O,6355
122658,vision,O,6355
122659,in,O,6355
122660,subjects,O,6355
122661,with,O,6355
122662,RP,B-NAME_OF_DISEASE,6355
122663,who,O,6355
122664,received,O,6355
122665,a,O,6355
122666,single,O,6355
122667,jCell,B-TREATMENT,6355
122668,injection,O,6355
122669,in,O,6355
122670,comparison,O,6355
122671,to,O,6355
122672,a,O,6355
122673,sham-treated,O,6355
122674,control,O,6355
122675,group,O,6355
122676,The,O,6355
122677,primary,O,6355
122678,endpoint,O,6355
122679,in,O,6355
122680,the,O,6355
122681,phase,O,6355
122682,2b,O,6355
122683,study,O,6355
122684,was,O,6355
122685,mean,O,6355
122686,change,O,6355
122687,in,O,6355
122688,best,B-DIAGNOSTIC_TEST,6355
122689,corrected,I-DIAGNOSTIC_TEST,6355
122690,visual,I-DIAGNOSTIC_TEST,6355
122691,acuity,I-DIAGNOSTIC_TEST,6355
122692,BCVA,B-DIAGNOSTIC_TEST,6355
122693,from,O,6355
122694,baseline,O,6355
122695,to,O,6355
122696,month,O,6355
122697,12,O,6355
122698,Secondary,O,6355
122699,endpoints,O,6355
122700,included,O,6355
122701,low,B-DIAGNOSTIC_TEST,6355
122702,light,I-DIAGNOSTIC_TEST,6355
122703,mobility,I-DIAGNOSTIC_TEST,6355
122704,contrast,B-DIAGNOSTIC_TEST,6355
122705,sensitivity,I-DIAGNOSTIC_TEST,6355
122706,kinetic,B-DIAGNOSTIC_TEST,6355
122707,visual,I-DIAGNOSTIC_TEST,6355
122708,fields,I-DIAGNOSTIC_TEST,6355
122709,and,O,6355
122710,a,B-DIAGNOSTIC_TEST,6355
122711,visual,I-DIAGNOSTIC_TEST,6355
122712,function,I-DIAGNOSTIC_TEST,6355
122713,questionnaire,I-DIAGNOSTIC_TEST,6355
122714,In,O,6355
122715,a,O,6355
122716,post,O,6355
122717,hoc,O,6355
122718,exploratory,O,6355
122719,analysis,O,6356
122720,the,O,6356
122721,primary,O,6356
122722,and,O,6356
122723,secondary,O,6356
122724,endpoints,O,6356
122725,were,O,6356
122726,assessed,O,6356
122727,in,O,6356
122728,a,O,6356
122729,target,O,6356
122730,subgroup,O,6356
122731,of,O,6356
122732,patients,O,6356
122733,meeting,O,6356
122734,the,O,6356
122735,following,O,6356
122736,criteria,O,6356
122737,1,O,6356
122738,study,O,6356
122739,eye,O,6357
122740,with,O,6357
122741,reliable,O,6357
122742,fixation,O,6357
122743,≥12°,O,6357
122744,central,O,6357
122745,diameter,O,6357
122746,and,O,6357
122747,or,O,6357
122748,steady,O,6357
122749,central,O,6357
122750,fixation,O,6357
122751,and,O,6358
122752,2,O,6359
122753,study,O,6359
122754,eye,O,6360
122755,did,O,6360
122756,not,O,6360
122757,have,O,6360
122758,significantly,O,6360
122759,worse,O,6360
122760,BCVA,B-DIAGNOSTIC_TEST,6361
122761,than,O,6361
122762,the,O,6361
122763,fellow,O,6361
122764,eye,O,6362
122765,≤15,O,6362
122766,letters,O,6362
122767,,O,6362
122768,The,O,6362
122769,phase,O,6363
122770,2b,O,6363
122771,clinical,O,6363
122772,trial,O,6363
122773,was,O,6363
122774,specifically,O,6363
122775,designed,O,6363
122776,to,O,6363
122777,learn,O,6363
122778,more,O,6363
122779,about,O,6363
122780,the,O,6363
122781,clinical,O,6363
122782,effects,O,6363
122783,of,O,6363
122784,jCell,B-TREATMENT,6363
122785,therapy,I-TREATMENT,6363
122786,in,O,6363
122787,a,O,6363
122788,broad,O,6363
122789,set,O,6363
122790,of,O,6363
122791,patients,O,6364
122792,suffering,O,6365
122793,from,O,6365
122794,RP,B-NAME_OF_DISEASE,6366
122795,to,O,6366
122796,better,O,6366
122797,understand,O,6366
122798,three,O,6366
122799,critical,O,6366
122800,study,O,6367
122801,variables,O,6367
122802,the,O,6367
122803,optimal,O,6367
122804,jCell,B-TREATMENT,6368
122805,dose,O,6368
122806,the,O,6368
122807,performance,O,6368
122808,of,O,6368
122809,clinical,O,6368
122810,trial,O,6369
122811,endpoints,O,6369
122812,in,O,6370
122813,the,O,6370
122814,study,O,6370
122815,population,O,6370
122816,and,O,6371
122817,the,O,6371
122818,RP,B-NAME_OF_DISEASE,6371
122819,patient,O,6371
122820,population,O,6371
122821,likely,O,6372
122822,to,O,6372
122823,realize,O,6372
122824,the,O,6372
122825,most,O,6372
122826,pronounced,O,6372
122827,improvement,O,6372
122828,from,O,6372
122829,a,O,6372
122830,single,O,6372
122831,jCell,B-TREATMENT,6372
122832,treatment,O,6372
122833,during,O,6372
122834,the,O,6372
122835,12-month,B-TIME_DURATION,6372
122836,pivotal,O,6372
122837,trial,O,6372
122838,study,O,6372
122839,period,O,6372
122840,Phase,O,6372
122841,2b,O,6372
122842,Results,O,6372
122843,A,O,6372
122844,total,O,6372
122845,of,O,6372
122846,84,O,6373
122847,patients,O,6373
122848,were,O,6373
122849,randomized,O,6373
122850,of,O,6373
122851,which,O,6373
122852,74,O,6373
122853,met,O,6373
122854,criteria,O,6373
122855,for,O,6373
122856,the,O,6373
122857,per,O,6373
122858,protocol,O,6373
122859,analysis,O,6373
122860,The,O,6373
122861,mean,O,6373
122862,change,O,6374
122863,in,O,6374
122864,BCVA,B-DIAGNOSTIC_TEST,6374
122865,from,O,6374
122866,baseline,O,6374
122867,to,O,6374
122868,month,O,6374
122869,12,O,6374
122870,were,O,6374
122871,2.8,O,6374
122872,2.9,O,6374
122873,and,O,6374
122874,7.4,O,6374
122875,letters,O,6374
122876,in,O,6374
122877,the,O,6374
122878,sham,O,6374
122879,N=26,O,6374
122880,3.0×10,O,6374
122881,hRPC,B-TREATMENT,6374
122882,N=25,O,6374
122883,and,O,6374
122884,6.0×10,O,6374
122885,hRPC,B-TREATMENT,6374
122886,N=23,O,6374
122887,treatment,O,6374
122888,arms,O,6374
122889,respectively,O,6374
122890,In,O,6374
122891,a,O,6374
122892,post,O,6374
122893,hoc,O,6374
122894,exploratory,O,6374
122895,analysis,O,6374
122896,of,O,6374
122897,the,O,6374
122898,target,O,6374
122899,subgroup,O,6374
122900,n=37,O,6374
122901,mean,O,6374
122902,change,O,6374
122903,in,O,6374
122904,BCVA,B-DIAGNOSTIC_TEST,6374
122905,from,O,6374
122906,baseline,O,6374
122907,to,O,6375
122908,month,O,6375
122909,12,O,6375
122910,were,O,6375
122911,1.8,O,6375
122912,-0.1,O,6375
122913,and,O,6375
122914,16.2,O,6375
122915,letters,O,6375
122916,in,O,6375
122917,the,O,6375
122918,sham,O,6375
122919,N=13,O,6375
122920,3.0×10,O,6375
122921,hRPC,B-TREATMENT,6375
122922,N=13,O,6375
122923,and,O,6375
122924,6.0×10,O,6375
122925,hRPC,B-TREATMENT,6375
122926,N=11,O,6375
122927,treatment,O,6375
122928,arms,O,6375
122929,respectively,O,6375
122930,p=0.00,O,6375
122931,for,O,6375
122932,6.0×10,O,6375
122933,hRPC,B-TREATMENT,6375
122934,vs,O,6375
122935,sham,O,6375
122936,,O,6375
122937,Supportive,O,6375
122938,improvements,O,6375
122939,in,O,6375
122940,the,O,6375
122941,6.0×10,O,6375
122942,hRPC,B-TREATMENT,6375
122943,target,O,6375
122944,subgroup,O,6376
122945,compared,O,6376
122946,to,O,6376
122947,the,O,6376
122948,control,O,6376
122949,sham,O,6376
122950,group,O,6376
122951,were,O,6376
122952,also,O,6376
122953,observed,O,6376
122954,in,O,6376
122955,all,O,6376
122956,secondary,O,6376
122957,endpoints,O,6376
122958,which,O,6376
122959,further,O,6376
122960,support,O,6376
122961,the,O,6376
122962,BCVA,B-DIAGNOSTIC_TEST,6376
122963,findings,O,6376
122964,in,O,6376
122965,this,O,6376
122966,subpopulation,O,6376
122967,Adverse,O,6376
122968,events,O,6376
122969,were,O,6376
122970,generally,O,6376
122971,minor,O,6376
122972,and,O,6376
122973,transient,O,6376
122974,there,O,6377
122975,was,O,6377
122976,one,O,6377
122977,serious,O,6377
122978,adverse,O,6377
122979,event,O,6377
122980,in,O,6377
122981,the,O,6377
122982,3.0×10,O,6377
122983,hRPC,B-TREATMENT,6377
122984,arm,O,6377
122985,of,O,6377
122986,Grade,O,6377
122987,3,O,6377
122988,ocular,O,6377
122989,hypertension,O,6377
122990,that,O,6377
122991,resolved,O,6378
122992,with,O,6378
122993,treatment,O,6378
122994,but,O,6378
122995,no,O,6378
122996,serious,O,6378
122997,adverse,O,6378
122998,events,O,6378
122999,nor,O,6378
123000,any,O,6378
123001,adverse,O,6378
123002,events,O,6378
123003,greater,O,6378
123004,than,O,6378
123005,Grade,O,6378
123006,1,O,6378
123007,mild,O,6378
123008,in,O,6378
123009,the,O,6378
123010,higher,O,6378
123011,6,O,6378
123012,million,O,6378
123013,cell,O,6378
123014,treatment,O,6378
123015,group,O,6378
123016,during,O,6378
123017,the,O,6378
123018,12-month,B-TIME_DURATION,6378
123019,study,O,6378
123020,period,O,6378
123021,that,O,6378
123022,were,O,6378
123023,related,O,6379
123024,to,O,6379
123025,the,O,6379
123026,study,O,6379
123027,treatment,O,6379
123028,Based,O,6379
123029,on,O,6379
123030,these,O,6379
123031,results,O,6379
123032,the,O,6379
123033,company,O,6379
123034,plans,O,6379
123035,to,O,6379
123036,advance,O,6379
123037,jCell,B-TREATMENT,6379
123038,into,O,6379
123039,a,O,6379
123040,pivotal,O,6379
123041,trial,O,6379
123042,utilizing,O,6379
123043,the,O,6379
123044,data,O,6379
123045,generated,O,6379
123046,which,O,6379
123047,is,O,6379
123048,supportive,O,6379
123049,of,O,6379
123050,both,O,6379
123051,the,O,6379
123052,efficacy,O,6379
123053,and,O,6380
123054,safety,O,6380
123055,of,O,6380
123056,jCell,B-TREATMENT,6380
123057,therapy,I-TREATMENT,6380
123058,in,O,6380
123059,a,O,6380
123060,broad,O,6380
123061,set,O,6380
123062,of,O,6380
123063,RP,B-NAME_OF_DISEASE,6380
123064,patients,O,6380
123065,The,O,6380
123066,phase,O,6380
123067,2b,O,6380
123068,study,O,6380
123069,also,O,6380
123070,provides,O,6380
123071,essential,O,6380
123072,insights,O,6380
123073,into,O,6380
123074,the,O,6380
123075,three,O,6380
123076,critical,O,6380
123077,study,O,6380
123078,variables,O,6380
123079,which,O,6380
123080,are,O,6380
123081,key,O,6380
123082,to,O,6380
123083,optimizing,O,6380
123084,the,O,6380
123085,probability,O,6380
123086,of,O,6380
123087,technical,O,6380
123088,success,O,6380
123089,of,O,6380
123090,the,O,6380
123091,upcoming,O,6380
123092,jCell,B-TREATMENT,6380
123093,pivotal,O,6380
123094,trial,O,6380
123095,There,O,6380
123096,is,O,6380
123097,currently,O,6380
123098,no,O,6380
123099,effective,O,6380
123100,treatment,O,6380
123101,for,O,6380
123102,RP,B-NAME_OF_DISEASE,6381
123103,and,O,6381
123104,once,O,6381
123105,photoreceptors,B-PART_OF_THE_EYES,6381
123106,are,O,6381
123107,lost,O,6381
123108,they,O,6381
123109,do,O,6381
123110,not,O,6381
123111,regenerate,O,6381
123112,The,O,6381
123113,promising,O,6381
123114,results,O,6381
123115,from,O,6381
123116,this,O,6381
123117,phase,O,6381
123118,2b,O,6381
123119,study,O,6381
123120,suggest,O,6381
123121,that,O,6381
123122,jCell,B-TREATMENT,6381
123123,therapy,I-TREATMENT,6381
123124,in,O,6381
123125,patients,O,6381
123126,with,O,6381
123127,RP,B-NAME_OF_DISEASE,6381
123128,can,O,6381
123129,result,O,6381
123130,in,O,6381
123131,significant,O,6381
123132,slowing,O,6381
123133,of,O,6381
123134,visual,O,6381
123135,deterioration,O,6381
123136,and,O,6381
123137,an,O,6381
123138,improvement,O,6381
123139,in,O,6381
123140,function,O,6381
123141,of,O,6381
123142,existing,O,6381
123143,photoreceptors,B-PART_OF_THE_EYES,6382
123144,The,O,6382
123145,primary,O,6382
123146,goal,O,6382
123147,of,O,6382
123148,jCell,B-TREATMENT,6382
123149,therapy,I-TREATMENT,6382
123150,is,O,6382
123151,to,O,6382
123152,preserve,O,6382
123153,and,O,6382
123154,potentially,O,6382
123155,improve,O,6382
123156,vision,O,6382
123157,by,O,6382
123158,intervening,O,6382
123159,in,O,6382
123160,the,O,6382
123161,disease,O,6382
123162,process,O,6382
123163,at,O,6382
123164,a,O,6382
123165,time,O,6382
123166,when,O,6382
123167,dystrophic,O,6382
123168,photoreceptors,B-PART_OF_THE_EYES,6382
123169,can,O,6382
123170,be,O,6382
123171,protected,O,6382
123172,and,O,6382
123173,reactivated,O,6383
123174,We,O,6383
123175,are,O,6383
123176,excited,O,6383
123177,to,O,6383
123178,be,O,6383
123179,continuing,O,6383
123180,the,O,6383
123181,development,O,6383
123182,of,O,6383
123183,jCell,B-TREATMENT,6383
123184,investigational,O,6383
123185,therapy,O,6383
123186,based,O,6383
123187,on,O,6383
123188,these,O,6384
123189,promising,O,6384
123190,phase,O,6384
123191,2b,O,6384
123192,results,O,6384
123193,for,O,6384
123194,patients,O,6384
123195,with,O,6384
123196,this,O,6384
123197,degenerative,O,6384
123198,retinal,O,6384
123199,disease,O,6384
123200,Anthony,B-PERSON,6384
123201,Joseph,I-PERSON,6384
123202,MD,I-PERSON,6384
123203,Ophthalmic,O,6384
123204,Consultants,O,6384
123205,of,O,6384
123206,Boston,B-GPE,6384
123207,who,O,6384
123208,presented,O,6384
123209,the,O,6384
123210,phase,O,6384
123211,2b,O,6384
123212,data,O,6384
123213,at,O,6384
123214,the,O,6384
123215,ASRS,O,6384
123216,meeting,O,6384
123217,said,O,6384
123218,in,O,6384
123219,a,O,6384
123220,company,O,6384
123221,news,O,6384
123222,release,O,6384
123223,We,O,6384
123224,are,O,6384
123225,thrilled,O,6384
123226,to,O,6384
123227,report,O,6384
123228,these,O,6384
123229,encouraging,O,6384
123230,phase,O,6384
123231,2b,O,6384
123232,results,O,6384
123233,from,O,6384
123234,one,O,6384
123235,of,O,6385
123236,the,O,6385
123237,largest,O,6385
123238,studies,O,6385
123239,ever,O,6385
123240,conducted,O,6385
123241,in,O,6385
123242,RP,B-NAME_OF_DISEASE,6385
123243,which,O,6385
123244,indicate,O,6385
123245,significant,O,6385
123246,clinical,O,6385
123247,activity,O,6385
123248,of,O,6385
123249,jCell,B-TREATMENT,6385
123250,in,O,6385
123251,patients,O,6385
123252,agnostic,O,6385
123253,of,O,6385
123254,genetic,O,6385
123255,subtype,O,6386
123256,said,O,6386
123257,Paul,B-PERSON,6386
123258,Bresge,I-PERSON,6386
123259,Chief,O,6386
123260,Executive,O,6386
123261,Officer,O,6386
123262,jCyte,B-ORGANIZATION,6386
123263,Inc,I-ORGANIZATION,6386
123264,The,O,6386
123265,phase,O,6387
123266,2b,O,6387
123267,results,O,6387
123268,reported,O,6387
123269,that,O,6387
123270,jCell,B-TREATMENT,6387
123271,therapy,I-TREATMENT,6387
123272,had,O,6387
123273,promising,O,6387
123274,efficacy,O,6387
123275,and,O,6387
123276,was,O,6387
123277,well,O,6387
123278,tolerated,O,6387
123279,in,O,6388
123280,patients,O,6388
123281,and,O,6388
123282,we,O,6388
123283,plan,O,6388
123284,to,O,6388
123285,advance,O,6388
123286,jCell,B-TREATMENT,6388
123287,into,O,6388
123288,a,O,6388
123289,pivotal,O,6388
123290,clinical,O,6388
123291,trial,O,6388
123292,in,O,6388
123293,2021,O,6388
123294,There,O,6388
123295,is,O,6388
123296,currently,O,6388
123297,no,O,6388
123298,FDA,B-ORGANIZATION,6388
123299,approved,O,6388
123300,treatment,O,6388
123301,option,O,6388
123302,for,O,6388
123303,RP,B-NAME_OF_DISEASE,6388
123304,patients,O,6388
123305,irrespective,O,6388
123306,of,O,6388
123307,genetic,O,6388
123308,subtype,O,6388
123309,We,O,6388
123310,believe,O,6388
123311,jCell,B-TREATMENT,6388
123312,has,O,6388
123313,the,O,6388
123314,potential,O,6388
123315,to,O,6388
123316,be,O,6388
123317,the,O,6388
123318,first,O,6388
123319,approved,O,6388
123320,therapy,O,6388
123321,to,O,6388
123322,address,O,6388
123323,this,O,6388
123324,critical,O,6388
123325,unmet,O,6388
123326,medical,O,6388
123327,need,O,6388
123328,and,O,6388
123329,dramatically,O,6388
123330,improve,O,6388
123331,the,O,6388
123332,lives,O,6388
123333,of,O,6388
123334,patients,O,6389
123335,with,O,6389
123336,this,O,6389
123337,progressive,O,6389
123338,blinding,B-NAME_OF_DISEASE,6389
123339,disease,I-NAME_OF_DISEASE,6389
123340,which,O,6389
123341,typically,O,6389
123342,presents,O,6389
123343,early,O,6389
123344,in,O,6389
123345,the,O,6389
123346,lives,O,6389
123347,of,O,6389
123348,the,O,6389
123349,approximately,O,6389
123350,1,O,6389
123351,3500,O,6389
123352,people,O,6389
123353,who,O,6389
123354,are,O,6389
123355,affected,O,6389
123356,Eye,B-NAME_OF_DISEASE,6389
123357,allergies,I-NAME_OF_DISEASE,6389
123358,are,O,6389
123359,the,B-SIGN_AND_SYMPTOM,6389
123360,irritation,I-SIGN_AND_SYMPTOM,6389
123361,of,I-SIGN_AND_SYMPTOM,6389
123362,the,I-SIGN_AND_SYMPTOM,6389
123363,eyes,I-SIGN_AND_SYMPTOM,6389
123364,with,O,6389
123365,allergic,B-CAUSE_OF_DISEASE,6389
123366,factors,I-CAUSE_OF_DISEASE,6389
123367,from,I-CAUSE_OF_DISEASE,6389
123368,the,I-CAUSE_OF_DISEASE,6389
123369,outside,I-CAUSE_OF_DISEASE,6389
123370,reacting,O,6389
123371,with,O,6390
123372,redness,B-SIGN_AND_SYMPTOM,6390
123373,itching,I-SIGN_AND_SYMPTOM,6390
123374,and,I-SIGN_AND_SYMPTOM,6390
123375,watering,I-SIGN_AND_SYMPTOM,6390
123376,Approximately,O,6390
123377,20%,O,6390
123378,of,O,6390
123379,the,O,6390
123380,world,O,6390
123381,s,O,6390
123382,population,O,6390
123383,has,O,6390
123384,eye,B-NAME_OF_DISEASE,6390
123385,allergies,I-NAME_OF_DISEASE,6390
123386,Eye,B-NAME_OF_DISEASE,6390
123387,allergies,I-NAME_OF_DISEASE,6390
123388,can,O,6390
123389,be,O,6390
123390,hereditary,B-CAUSE_OF_DISEASE,6390
123391,or,O,6390
123392,occur,O,6390
123393,from,O,6390
123394,outer,B-CAUSE_OF_DISEASE,6390
123395,factors,I-CAUSE_OF_DISEASE,6390
123396,such,I-CAUSE_OF_DISEASE,6390
123397,as,I-CAUSE_OF_DISEASE,6390
123398,dusty,B-CAUSE_OF_DISEASE,6390
123399,environments,I-CAUSE_OF_DISEASE,6390
123400,Wood,O,6390
123401,dust,O,6390
123402,that,O,6390
123403,occurs,O,6391
123404,when,O,6391
123405,cutting,O,6391
123406,wood,O,6391
123407,in,O,6391
123408,the,O,6391
123409,carpenter,O,6391
123410,s,O,6391
123411,workshop,O,6391
123412,dust,O,6391
123413,that,O,6391
123414,flies,O,6391
123415,on,O,6391
123416,unpaved,O,6391
123417,roads,O,6391
123418,dust,O,6391
123419,that,O,6391
123420,occurs,O,6391
123421,on,O,6391
123422,construction,O,6391
123423,sites,O,6391
123424,in,O,6391
123425,the,O,6391
123426,city,O,6391
123427,due,O,6392
123428,to,O,6393
123429,urban,O,6393
123430,transformation,O,6393
123431,dust,O,6393
123432,formed,O,6393
123433,from,O,6393
123434,sand,O,6393
123435,in,O,6393
123436,the,O,6393
123437,jean,O,6393
123438,stone,O,6393
123439,washing,O,6393
123440,workshop,O,6393
123441,in,O,6393
123442,short,O,6393
123443,all,O,6393
123444,of,O,6394
123445,these,O,6394
123446,examples,O,6394
123447,of,O,6394
123448,dusty,B-CAUSE_OF_DISEASE,6394
123449,environments,I-CAUSE_OF_DISEASE,6394
123450,can,O,6394
123451,easily,O,6394
123452,trigger,O,6394
123453,eye,B-NAME_OF_DISEASE,6394
123454,allergies,I-NAME_OF_DISEASE,6394
123455,Other,O,6394
123456,than,O,6395
123457,these,O,6395
123458,examples,O,6395
123459,getting,B-CAUSE_OF_DISEASE,6395
123460,exposed,I-CAUSE_OF_DISEASE,6395
123461,to,I-CAUSE_OF_DISEASE,6395
123462,cigarette,I-CAUSE_OF_DISEASE,6395
123463,smoke,I-CAUSE_OF_DISEASE,6396
123464,less,B-CAUSE_OF_DISEASE,6396
123465,tear,I-CAUSE_OF_DISEASE,6396
123466,production,I-CAUSE_OF_DISEASE,6396
123467,of,I-CAUSE_OF_DISEASE,6396
123468,eyes,I-CAUSE_OF_DISEASE,6396
123469,swimming,B-CAUSE_OF_DISEASE,6396
123470,in,I-CAUSE_OF_DISEASE,6396
123471,an,I-CAUSE_OF_DISEASE,6396
123472,unhygienic,I-CAUSE_OF_DISEASE,6396
123473,pool,I-CAUSE_OF_DISEASE,6396
123474,touching,B-CAUSE_OF_DISEASE,6396
123475,eyes,I-CAUSE_OF_DISEASE,6396
123476,with,I-CAUSE_OF_DISEASE,6396
123477,unclean,I-CAUSE_OF_DISEASE,6397
123478,hands,I-CAUSE_OF_DISEASE,6397
123479,applying,B-CAUSE_OF_DISEASE,6397
123480,eye,I-CAUSE_OF_DISEASE,6397
123481,makeup,I-CAUSE_OF_DISEASE,6397
123482,such,I-CAUSE_OF_DISEASE,6397
123483,as,I-CAUSE_OF_DISEASE,6397
123484,mascara,I-CAUSE_OF_DISEASE,6398
123485,and,I-CAUSE_OF_DISEASE,6399
123486,eyeliner,I-CAUSE_OF_DISEASE,6399
123487,can,O,6399
123488,also,O,6399
123489,cause,O,6399
123490,eye,B-NAME_OF_DISEASE,6399
123491,allergies,I-NAME_OF_DISEASE,6399
123492,What,O,6399
123493,Are,O,6399
123494,the,O,6399
123495,3,O,6399
123496,Most,O,6399
123497,Common,O,6399
123498,Eye,B-NAME_OF_DISEASE,6400
123499,Allergies,I-NAME_OF_DISEASE,6400
123500,There,O,6400
123501,are,O,6400
123502,6,O,6400
123503,types,O,6400
123504,of,O,6400
123505,eye,B-NAME_OF_DISEASE,6400
123506,allergies,I-NAME_OF_DISEASE,6401
123507,which,O,6401
123508,differ,O,6401
123509,according,O,6401
123510,to,O,6401
123511,the,O,6401
123512,probability,O,6401
123513,of,O,6401
123514,having,O,6401
123515,a,O,6401
123516,low,O,6401
123517,or,O,6401
123518,high,O,6402
123519,risk,O,6402
123520,of,O,6402
123521,damaging,O,6402
123522,the,B-PART_OF_THE_EYES,6402
123523,cornea,I-PART_OF_THE_EYES,6402
123524,The,O,6402
123525,most,O,6402
123526,common,O,6402
123527,types,O,6403
123528,of,O,6403
123529,these,O,6403
123530,eye,B-NAME_OF_DISEASE,6403
123531,allergies,I-NAME_OF_DISEASE,6403
123532,are,O,6403
123533,Perennial,B-NAME_OF_DISEASE,6403
123534,Allergic,I-NAME_OF_DISEASE,6403
123535,Conjunctivitis,I-NAME_OF_DISEASE,6403
123536,Seasonal,B-NAME_OF_DISEASE,6404
123537,Allergic,I-NAME_OF_DISEASE,6405
123538,Conjunctivitis,I-NAME_OF_DISEASE,6405
123539,allergic,B-NAME_OF_DISEASE,6405
123540,rhinoconjunctivitis,I-NAME_OF_DISEASE,6405
123541,and,O,6405
123542,Contact,B-NAME_OF_DISEASE,6405
123543,Allergic,I-NAME_OF_DISEASE,6405
123544,Conjunctivitis,I-NAME_OF_DISEASE,6405
123545,contact,B-NAME_OF_DISEASE,6405
123546,dermatoconjunctivitis,I-NAME_OF_DISEASE,6405
123547,,O,6405
123548,1,O,6405
123549,Perennial,B-NAME_OF_DISEASE,6405
123550,Allergic,I-NAME_OF_DISEASE,6405
123551,Conjunctivitis,I-NAME_OF_DISEASE,6405
123552,It,O,6405
123553,is,O,6405
123554,a,O,6405
123555,type,O,6406
123556,of,O,6406
123557,allergy,O,6406
123558,that,O,6406
123559,can,O,6406
123560,be,O,6406
123561,seen,O,6406
123562,all,O,6406
123563,year,O,6406
123564,round,O,6406
123565,Things,B-CAUSE_OF_DISEASE,6406
123566,such,I-CAUSE_OF_DISEASE,6406
123567,as,I-CAUSE_OF_DISEASE,6406
123568,pet,I-CAUSE_OF_DISEASE,6407
123569,hair,I-CAUSE_OF_DISEASE,6407
123570,dust,I-CAUSE_OF_DISEASE,6407
123571,and,I-CAUSE_OF_DISEASE,6407
123572,pollen,I-CAUSE_OF_DISEASE,6407
123573,are,O,6407
123574,causing,O,6407
123575,this,O,6407
123576,allergy,O,6407
123577,Its,O,6407
123578,symptoms,O,6408
123579,are,O,6408
123580,similar,O,6408
123581,to,O,6408
123582,seasonal,B-NAME_OF_DISEASE,6408
123583,allergies,I-NAME_OF_DISEASE,6408
123584,However,O,6408
123585,compared,O,6408
123586,to,O,6408
123587,seasonal,B-NAME_OF_DISEASE,6408
123588,allergic,I-NAME_OF_DISEASE,6408
123589,conjunctivitis,I-NAME_OF_DISEASE,6408
123590,the,O,6409
123591,symptoms,O,6409
123592,of,O,6409
123593,perennial,B-NAME_OF_DISEASE,6409
123594,allergic,I-NAME_OF_DISEASE,6409
123595,conjunctivitis,I-NAME_OF_DISEASE,6409
123596,are,O,6409
123597,milder,O,6409
123598,This,O,6409
123599,allergy,O,6410
123600,is,O,6410
123601,more,O,6410
123602,common,O,6410
123603,in,O,6410
123604,children,O,6410
123605,2,O,6410
123606,Seasonal,B-NAME_OF_DISEASE,6410
123607,Allergic,I-NAME_OF_DISEASE,6410
123608,Conjunctivitis,I-NAME_OF_DISEASE,6410
123609,This,O,6410
123610,type,O,6410
123611,of,O,6410
123612,allergy,O,6410
123613,becomes,O,6410
123614,widespread,O,6410
123615,in,O,6410
123616,the,O,6410
123617,spring,O,6410
123618,season,O,6410
123619,Because,O,6410
123620,in,O,6410
123621,this,O,6410
123622,season,O,6410
123623,the,O,6410
123624,trees,O,6410
123625,are,O,6410
123626,blooming,O,6410
123627,The,B-CAUSE_OF_DISEASE,6410
123628,pollen,I-CAUSE_OF_DISEASE,6410
123629,of,I-CAUSE_OF_DISEASE,6410
123630,these,I-CAUSE_OF_DISEASE,6410
123631,flowers,I-CAUSE_OF_DISEASE,6411
123632,are,O,6411
123633,starting,O,6411
123634,to,O,6411
123635,spread,O,6411
123636,in,O,6411
123637,the,O,6411
123638,air,O,6411
123639,It,O,6411
123640,causes,O,6411
123641,redness,B-SIGN_AND_SYMPTOM,6411
123642,itchiness,I-SIGN_AND_SYMPTOM,6411
123643,and,I-SIGN_AND_SYMPTOM,6411
123644,watering,I-SIGN_AND_SYMPTOM,6412
123645,in,I-SIGN_AND_SYMPTOM,6412
123646,the,I-SIGN_AND_SYMPTOM,6412
123647,eyes,I-SIGN_AND_SYMPTOM,6412
123648,People,O,6412
123649,with,O,6412
123650,sensitive,O,6412
123651,bodies,O,6412
123652,can,O,6412
123653,also,O,6412
123654,face,O,6412
123655,nasal,B-SIGN_AND_SYMPTOM,6412
123656,discharge,I-SIGN_AND_SYMPTOM,6412
123657,3,O,6412
123658,Contact,B-NAME_OF_DISEASE,6412
123659,Allergic,I-NAME_OF_DISEASE,6413
123660,Conjunctivitis,I-NAME_OF_DISEASE,6413
123661,As,O,6413
123662,it,O,6413
123663,can,O,6413
123664,be,O,6413
123665,seen,O,6413
123666,from,O,6413
123667,the,O,6413
123668,name,O,6413
123669,this,O,6413
123670,allergy,O,6413
123671,is,O,6413
123672,caused,O,6413
123673,by,O,6413
123674,contact,B-CAUSE_OF_DISEASE,6413
123675,lenses,I-CAUSE_OF_DISEASE,6413
123676,People,O,6413
123677,with,O,6413
123678,sensitive,O,6413
123679,eyes,O,6413
123680,can,O,6413
123681,have,O,6413
123682,their,O,6413
123683,eyes,O,6413
123684,irritated,O,6413
123685,by,O,6413
123686,wearing,B-CAUSE_OF_DISEASE,6414
123687,contact,I-CAUSE_OF_DISEASE,6414
123688,lenses,I-CAUSE_OF_DISEASE,6414
123689,Contact,B-CAUSE_OF_DISEASE,6414
123690,lenses,I-CAUSE_OF_DISEASE,6414
123691,will,O,6414
123692,cause,O,6414
123693,itching,B-SIGN_AND_SYMPTOM,6414
123694,and,I-SIGN_AND_SYMPTOM,6414
123695,redness,I-SIGN_AND_SYMPTOM,6414
123696,in,I-SIGN_AND_SYMPTOM,6414
123697,the,I-SIGN_AND_SYMPTOM,6414
123698,eyes,I-SIGN_AND_SYMPTOM,6415
123699,Generally,O,6415
123700,it,O,6415
123701,s,O,6415
123702,not,O,6415
123703,recommended,O,6415
123704,to,O,6415
123705,wear,B-CAUSE_OF_DISEASE,6415
123706,contact,I-CAUSE_OF_DISEASE,6415
123707,lenses,I-CAUSE_OF_DISEASE,6415
123708,for,I-CAUSE_OF_DISEASE,6415
123709,sensitive,I-CAUSE_OF_DISEASE,6415
123710,eyes,I-CAUSE_OF_DISEASE,6415
123711,Otherwise,O,6415
123712,it,O,6415
123713,may,O,6416
123714,cause,O,6416
123715,permanent,O,6416
123716,damage,O,6416
123717,to,O,6416
123718,the,O,6416
123719,eyes,O,6416
123720,What,O,6416
123721,Is,O,6416
123722,Best,O,6416
123723,for,O,6416
123724,Eye,B-NAME_OF_DISEASE,6416
123725,Allergy,I-NAME_OF_DISEASE,6416
123726,Depending,O,6416
123727,on,O,6416
123728,the,O,6416
123729,stage,O,6417
123730,and,O,6417
123731,type,O,6417
123732,of,O,6417
123733,the,O,6417
123734,allergy,O,6417
123735,eye,B-NAME_OF_DISEASE,6417
123736,allergies,I-NAME_OF_DISEASE,6417
123737,can,O,6417
123738,cause,O,6417
123739,vision,B-NAME_OF_DISEASE,6417
123740,impairment,I-NAME_OF_DISEASE,6417
123741,corneal,B-SIGN_AND_SYMPTOM,6417
123742,damage,I-SIGN_AND_SYMPTOM,6417
123743,or,O,6417
123744,even,O,6417
123745,serious,O,6417
123746,health,O,6417
123747,problems,O,6418
123748,such,O,6418
123749,as,O,6418
123750,eye,B-SIGN_AND_SYMPTOM,6418
123751,loss,I-SIGN_AND_SYMPTOM,6418
123752,Therefore,O,6418
123753,a,O,6418
123754,person,O,6418
123755,with,O,6418
123756,an,B-NAME_OF_DISEASE,6418
123757,eye,B-NAME_OF_DISEASE,6418
123758,allergy,I-NAME_OF_DISEASE,6418
123759,should,O,6419
123760,definitely,O,6419
123761,see,O,6419
123762,an,O,6419
123763,ophthalmologist,O,6419
123764,first,O,6419
123765,Antihistamine,B-TREATMENT,6419
123766,eye,I-TREATMENT,6419
123767,drops,I-TREATMENT,6419
123768,which,O,6419
123769,the,O,6419
123770,doctor,O,6419
123771,is,O,6419
123772,going,O,6419
123773,to,O,6419
123774,prescribe,O,6419
123775,will,O,6419
123776,greatly,O,6419
123777,benefit,O,6419
123778,the,O,6420
123779,patient,O,6420
123780,And,O,6420
123781,what,O,6420
123782,else,O,6420
123783,can,O,6420
123784,be,O,6420
123785,done,O,6420
123786,for,O,6420
123787,eye,B-NAME_OF_DISEASE,6420
123788,allergy,I-NAME_OF_DISEASE,6421
123789,The,O,6421
123790,recommendations,O,6421
123791,listed,O,6421
123792,below,O,6421
123793,can,O,6421
123794,also,O,6421
123795,be,O,6421
123796,applicable,O,6421
123797,●,O,6422
123798,It,O,6422
123799,is,O,6422
123800,necessary,O,6422
123801,to,O,6422
123802,stay,B-TREATMENT,6422
123803,away,I-TREATMENT,6422
123804,from,I-TREATMENT,6422
123805,dusty,I-TREATMENT,6422
123806,environments,I-TREATMENT,6422
123807,●,O,6422
123808,Person,O,6422
123809,that,O,6422
123810,has,O,6422
123811,an,B-NAME_OF_DISEASE,6422
123812,eye,B-NAME_OF_DISEASE,6422
123813,allergy,I-NAME_OF_DISEASE,6422
123814,should,O,6422
123815,not,B-TREATMENT,6422
123816,wear,I-TREATMENT,6422
123817,eye,I-TREATMENT,6422
123818,makeup,I-TREATMENT,6422
123819,●,O,6422
123820,Eyes,B-TREATMENT,6422
123821,should,I-TREATMENT,6422
123822,be,I-TREATMENT,6422
123823,protected,I-TREATMENT,6422
123824,from,I-TREATMENT,6422
123825,dust,I-TREATMENT,6422
123826,pollen,I-TREATMENT,6422
123827,and,I-TREATMENT,6422
123828,harmful,I-TREATMENT,6422
123829,sun,I-TREATMENT,6422
123830,rays,I-TREATMENT,6422
123831,by,I-TREATMENT,6422
123832,wearing,I-TREATMENT,6422
123833,sunglasses,I-TREATMENT,6422
123834,●,O,6422
123835,Eyes,B-TREATMENT,6422
123836,shouldn,I-TREATMENT,6422
123837,t,I-TREATMENT,6422
123838,be,I-TREATMENT,6422
123839,rubbed,I-TREATMENT,6422
123840,especially,I-TREATMENT,6422
123841,if,I-TREATMENT,6423
123842,the,I-TREATMENT,6423
123843,person,I-TREATMENT,6423
123844,hasn,I-TREATMENT,6423
123845,t,I-TREATMENT,6423
123846,washed,I-TREATMENT,6423
123847,their,I-TREATMENT,6423
123848,hands,I-TREATMENT,6423
123849,yet,I-TREATMENT,6423
123850,●,O,6423
123851,Looking,O,6423
123852,at,O,6423
123853,electronic,O,6423
123854,devices,O,6423
123855,such,O,6423
123856,as,O,6423
123857,cell,O,6423
123858,phones,O,6423
123859,and,O,6423
123860,laptops,O,6423
123861,can,O,6423
123862,also,O,6423
123863,tire,O,6423
123864,and,O,6423
123865,dry,O,6423
123866,the,O,6424
123867,eyes,O,6424
123868,Therefore,O,6424
123869,a,O,6424
123870,lot,O,6424
123871,of,O,6424
123872,time,O,6424
123873,should,O,6424
123874,not,O,6424
123875,be,O,6424
123876,spent,O,6424
123877,with,O,6424
123878,such,O,6424
123879,devices,O,6424
123880,●,O,6424
123881,Long,B-TREATMENT,6424
123882,hot,I-TREATMENT,6424
123883,showers,I-TREATMENT,6424
123884,should,I-TREATMENT,6425
123885,be,I-TREATMENT,6425
123886,avoided,I-TREATMENT,6425
123887,since,O,6425
123888,the,B-CAUSE_OF_DISEASE,6425
123889,vapor,I-CAUSE_OF_DISEASE,6425
123890,of,I-CAUSE_OF_DISEASE,6425
123891,chloride,I-CAUSE_OF_DISEASE,6425
123892,in,I-CAUSE_OF_DISEASE,6425
123893,tap,I-CAUSE_OF_DISEASE,6425
123894,water,I-CAUSE_OF_DISEASE,6425
123895,can,O,6425
123896,damage,O,6425
123897,the,O,6425
123898,eyes,O,6426
123899,●,O,6426
123900,Swimming,B-TREATMENT,6426
123901,in,I-TREATMENT,6426
123902,an,I-TREATMENT,6426
123903,unhygienic,I-TREATMENT,6426
123904,pool,I-TREATMENT,6426
123905,should,I-TREATMENT,6426
123906,also,I-TREATMENT,6426
123907,be,I-TREATMENT,6426
123908,avoided,I-TREATMENT,6426
123909,●,O,6426
123910,Another,B-TREATMENT,6426
123911,person,I-TREATMENT,6426
123912,s,I-TREATMENT,6426
123913,towel,I-TREATMENT,6426
123914,should,I-TREATMENT,6426
123915,never,I-TREATMENT,6426
123916,be,I-TREATMENT,6426
123917,used,I-TREATMENT,6426
123918,According,O,6426
123919,to,O,6426
123920,a,O,6427
123921,clinical,O,6427
123922,study,O,6427
123923,conducted,O,6427
123924,by,O,6427
123925,the,B-ORGANIZATION,6427
123926,DRCR,I-ORGANIZATION,6427
123927,Retina,I-ORGANIZATION,6427
123928,Network,I-ORGANIZATION,6427
123929,early,O,6427
123930,treatment,O,6427
123931,of,O,6427
123932,diabetic,B-NAME_OF_DISEASE,6427
123933,retinopathy,I-NAME_OF_DISEASE,6427
123934,may,O,6428
123935,slow,O,6428
123936,the,O,6428
123937,progression,O,6428
123938,of,O,6428
123939,the,O,6428
123940,disease,O,6428
123941,but,O,6428
123942,it,O,6428
123943,does,O,6428
123944,not,O,6428
123945,lead,O,6428
123946,to,O,6428
123947,an,O,6428
123948,improvement,O,6428
123949,in,O,6428
123950,visual,O,6428
123951,acuity,O,6428
123952,compared,O,6428
123953,to,O,6428
123954,treating,O,6428
123955,the,O,6428
123956,disease,O,6428
123957,at,O,6428
123958,a,O,6428
123959,more,O,6428
123960,severe,O,6428
123961,stage,O,6428
123962,This,O,6428
123963,study,O,6428
123964,indicates,O,6428
123965,that,O,6428
123966,monitoring,O,6428
123967,patients,O,6428
123968,regularly,O,6429
123969,for,O,6429
123970,vision-threatening,O,6429
123971,diabetes,B-NAME_OF_DISEASE,6429
123972,complications,O,6429
123973,and,O,6429
123974,treating,O,6429
123975,eyes,O,6429
123976,only,O,6429
123977,as,O,6429
123978,needed,O,6429
123979,is,O,6429
123980,the,O,6429
123981,best,O,6429
123982,approach,O,6429
123983,said,O,6429
123984,Raj,O,6429
123985,Maturi,O,6429
123986,M.D,O,6429
123987,Indiana,B-ORGANIZATION,6429
123988,University,I-ORGANIZATION,6429
123989,School,I-ORGANIZATION,6429
123990,of,I-ORGANIZATION,6429
123991,Medicine,I-ORGANIZATION,6429
123992,and,O,6429
123993,Retina,B-ORGANIZATION,6429
123994,Partners,I-ORGANIZATION,6429
123995,Midwest,I-ORGANIZATION,6429
123996,who,O,6429
123997,is,O,6429
123998,the,O,6430
123999,protocol,O,6430
124000,chair,O,6430
124001,for,O,6430
124002,the,O,6430
124003,four-year,B-TIME_DURATION,6430
124004,study,O,6430
124005,The,O,6430
124006,report,O,6430
124007,was,O,6430
124008,published,O,6430
124009,in,O,6430
124010,the,B-PUBLICATION_VENUE,6430
124011,Journal,I-PUBLICATION_VENUE,6430
124012,of,I-PUBLICATION_VENUE,6430
124013,the,I-PUBLICATION_VENUE,6430
124014,American,I-PUBLICATION_VENUE,6430
124015,Medical,I-PUBLICATION_VENUE,6430
124016,Association,I-PUBLICATION_VENUE,6430
124017,JAMA,I-PUBLICATION_VENUE,6430
124018,,O,6430
124019,Anti-vascular,B-NAME_OF_DRUG,6430
124020,endothelial,I-NAME_OF_DRUG,6430
124021,growth,I-NAME_OF_DRUG,6430
124022,factor,I-NAME_OF_DRUG,6430
124023,anti-VEGF,I-NAME_OF_DRUG,6430
124024,drugs,I-NAME_OF_DRUG,6431
124025,have,O,6431
124026,been,O,6431
124027,shown,O,6431
124028,to,O,6431
124029,significantly,O,6431
124030,reduce,O,6431
124031,the,O,6431
124032,risk,O,6431
124033,of,O,6431
124034,vision,B-SIGN_AND_SYMPTOM,6431
124035,loss,I-SIGN_AND_SYMPTOM,6431
124036,in,O,6431
124037,patients,O,6431
124038,with,O,6431
124039,diabetic,B-NAME_OF_DISEASE,6431
124040,retinopathy,I-NAME_OF_DISEASE,6431
124041,However,O,6431
124042,eye,O,6431
124043,care,O,6431
124044,professionals,O,6431
124045,have,O,6431
124046,been,O,6431
124047,uncertain,O,6432
124048,about,O,6432
124049,the,O,6432
124050,ideal,O,6432
124051,time,O,6432
124052,to,O,6432
124053,initiate,O,6432
124054,treatment,O,6432
124055,Anti-VEGF,B-NAME_OF_DRUG,6432
124056,is,O,6432
124057,administered,O,6432
124058,through,O,6432
124059,eye,O,6432
124060,injections,O,6432
124061,so,O,6432
124062,doctors,O,6432
124063,must,O,6432
124064,consider,O,6432
124065,factors,O,6432
124066,such,O,6432
124067,as,O,6432
124068,the,O,6432
124069,potential,O,6432
124070,for,O,6432
124071,side,O,6432
124072,effects,O,6432
124073,the,O,6432
124074,cost,O,6432
124075,and,O,6433
124076,inconvenience,O,6433
124077,of,O,6433
124078,treatment,O,6433
124079,and,O,6433
124080,the,O,6433
124081,potential,O,6433
124082,benefits,O,6433
124083,before,O,6433
124084,deciding,O,6433
124085,to,O,6433
124086,proceed,O,6433
124087,with,O,6433
124088,treatment,O,6433
124089,What,O,6433
124090,Is,O,6433
124091,Diabetic,B-NAME_OF_DISEASE,6433
124092,Retinopathy,I-NAME_OF_DISEASE,6433
124093,Diabetic,B-NAME_OF_DISEASE,6433
124094,retinopathy,I-NAME_OF_DISEASE,6433
124095,refers,O,6433
124096,to,O,6433
124097,the,B-SIGN_AND_SYMPTOM,6433
124098,damage,I-SIGN_AND_SYMPTOM,6433
124099,to,I-SIGN_AND_SYMPTOM,6433
124100,the,I-SIGN_AND_SYMPTOM,6433
124101,blood,I-SIGN_AND_SYMPTOM,6433
124102,vessels,I-SIGN_AND_SYMPTOM,6433
124103,in,I-SIGN_AND_SYMPTOM,6433
124104,the,I-SIGN_AND_SYMPTOM,6433
124105,retina,I-SIGN_AND_SYMPTOM,6433
124106,which,O,6433
124107,is,O,6433
124108,the,O,6433
124109,light-sensitive,O,6433
124110,part,O,6434
124111,of,O,6434
124112,the,O,6434
124113,eye,O,6434
124114,as,O,6434
124115,a,O,6434
124116,result,O,6434
124117,of,O,6434
124118,diabetes,B-NAME_OF_DISEASE,6434
124119,In,O,6434
124120,its,O,6434
124121,early,O,6434
124122,stage,O,6434
124123,the,B-CAUSE_OF_DISEASE,6434
124124,weakening,I-CAUSE_OF_DISEASE,6434
124125,of,I-CAUSE_OF_DISEASE,6434
124126,retinal,I-CAUSE_OF_DISEASE,6434
124127,blood,I-CAUSE_OF_DISEASE,6434
124128,vessels,I-CAUSE_OF_DISEASE,6434
124129,leads,O,6434
124130,to,O,6434
124131,fluid,B-SIGN_AND_SYMPTOM,6434
124132,leakage,I-SIGN_AND_SYMPTOM,6434
124133,into,I-SIGN_AND_SYMPTOM,6434
124134,the,I-SIGN_AND_SYMPTOM,6434
124135,retina,I-SIGN_AND_SYMPTOM,6435
124136,a,O,6435
124137,condition,O,6435
124138,known,O,6435
124139,as,O,6435
124140,non-proliferative,B-NAME_OF_DISEASE,6435
124141,diabetic,B-NAME_OF_DISEASE,6435
124142,retinopathy,I-NAME_OF_DISEASE,6435
124143,NPDR,I-NAME_OF_DISEASE,6435
124144,,O,6435
124145,The,B-SIGN_AND_SYMPTOM,6435
124146,accumulation,I-SIGN_AND_SYMPTOM,6435
124147,of,I-SIGN_AND_SYMPTOM,6435
124148,fluid,I-SIGN_AND_SYMPTOM,6435
124149,in,I-SIGN_AND_SYMPTOM,6435
124150,the,I-SIGN_AND_SYMPTOM,6435
124151,retina,I-SIGN_AND_SYMPTOM,6435
124152,known,O,6435
124153,as,O,6435
124154,diabetic,B-NAME_OF_DISEASE,6435
124155,macular,I-NAME_OF_DISEASE,6435
124156,edema,I-NAME_OF_DISEASE,6435
124157,is,O,6435
124158,a,O,6435
124159,complication,O,6436
124160,of,O,6436
124161,diabetic,B-NAME_OF_DISEASE,6436
124162,retinopathy,I-NAME_OF_DISEASE,6436
124163,that,O,6436
124164,can,O,6436
124165,cause,O,6436
124166,vision,B-SIGN_AND_SYMPTOM,6436
124167,loss,I-SIGN_AND_SYMPTOM,6436
124168,As,O,6436
124169,the,O,6436
124170,disease,O,6436
124171,progresses,O,6436
124172,to,O,6436
124173,proliferative,B-NAME_OF_DISEASE,6436
124174,diabetic,I-NAME_OF_DISEASE,6437
124175,retinopathy,I-NAME_OF_DISEASE,6437
124176,PDR,I-NAME_OF_DISEASE,6437
124177,where,O,6437
124178,new,O,6437
124179,abnormal,B-SIGN_AND_SYMPTOM,6437
124180,blood,I-SIGN_AND_SYMPTOM,6437
124181,vessels,I-SIGN_AND_SYMPTOM,6437
124182,start,I-SIGN_AND_SYMPTOM,6437
124183,to,I-SIGN_AND_SYMPTOM,6437
124184,grow,I-SIGN_AND_SYMPTOM,6437
124185,in,I-SIGN_AND_SYMPTOM,6437
124186,the,I-SIGN_AND_SYMPTOM,6437
124187,retina,I-SIGN_AND_SYMPTOM,6438
124188,it,O,6438
124189,can,O,6438
124190,also,O,6438
124191,pose,O,6438
124192,a,O,6438
124193,threat,O,6438
124194,to,O,6438
124195,vision,O,6438
124196,Diabetic,B-NAME_OF_DISEASE,6438
124197,Retinopathy,I-NAME_OF_DISEASE,6438
124198,The,O,6438
124199,Study,O,6438
124200,Researchers,O,6438
124201,funded,O,6438
124202,by,O,6438
124203,the,B-ORGANIZATION,6438
124204,National,I-ORGANIZATION,6438
124205,Eye,I-ORGANIZATION,6438
124206,Institute,I-ORGANIZATION,6438
124207,NEI,I-ORGANIZATION,6438
124208,investigated,O,6438
124209,the,O,6438
124210,potential,O,6438
124211,of,O,6438
124212,the,B-NAME_OF_DRUG,6439
124213,anti-vascular,I-NAME_OF_DRUG,6439
124214,endothelial,I-NAME_OF_DRUG,6439
124215,growth,I-NAME_OF_DRUG,6439
124216,factor,I-NAME_OF_DRUG,6439
124217,anti-VEGF,B-NAME_OF_DRUG,6439
124218,drug,I-NAME_OF_DRUG,6439
124219,Eylea,I-NAME_OF_DRUG,6439
124220,aflibercept,I-NAME_OF_DRUG,6439
124221,in,O,6439
124222,preventing,O,6439
124223,vision,B-SIGN_AND_SYMPTOM,6439
124224,loss,I-SIGN_AND_SYMPTOM,6439
124225,for,O,6439
124226,people,O,6439
124227,with,O,6439
124228,non-proliferative,B-NAME_OF_DISEASE,6439
124229,diabetic,I-NAME_OF_DISEASE,6439
124230,retinopathy,I-NAME_OF_DISEASE,6439
124231,NPDR,B-NAME_OF_DISEASE,6439
124232,,O,6439
124233,The,O,6439
124234,study,O,6439
124235,enrolled,O,6439
124236,328,O,6439
124237,participants,O,6439
124238,some,O,6439
124239,of,O,6439
124240,whom,O,6439
124241,had,O,6439
124242,one,O,6439
124243,eligible,O,6439
124244,eye,O,6439
124245,and,O,6439
124246,others,O,6439
124247,had,O,6439
124248,two,O,6439
124249,eligible,O,6439
124250,eyes,O,6439
124251,for,O,6439
124252,a,O,6440
124253,total,O,6440
124254,of,O,6440
124255,399,O,6440
124256,study,O,6440
124257,eyes,O,6440
124258,The,O,6440
124259,treatment,O,6440
124260,group,O,6440
124261,received,O,6440
124262,preventive,O,6440
124263,anti-VEGF,B-NAME_OF_DRUG,6440
124264,injections,O,6440
124265,at,O,6440
124266,one,B-GPE,6440
124267,two,I-GPE,6440
124268,and,I-GPE,6441
124269,four,I-GPE,6441
124270,months,I-GPE,6441
124271,after,O,6441
124272,enrollment,O,6441
124273,followed,O,6441
124274,by,O,6441
124275,injections,O,6441
124276,every,B-GPE,6441
124277,four,I-GPE,6441
124278,months,I-GPE,6441
124279,for,I-GPE,6441
124280,two,I-GPE,6441
124281,years,I-GPE,6441
124282,The,O,6441
124283,treatment,O,6441
124284,continued,O,6441
124285,every,B-GPE,6441
124286,four,I-GPE,6441
124287,months,I-GPE,6441
124288,for,I-GPE,6441
124289,up,I-GPE,6441
124290,to,I-GPE,6441
124291,four,I-GPE,6441
124292,years,I-GPE,6441
124293,if,O,6441
124294,NPDR,B-NAME_OF_DISEASE,6441
124295,remained,O,6441
124296,mild,O,6441
124297,The,O,6441
124298,control,O,6441
124299,group,O,6441
124300,received,O,6442
124301,sham,O,6442
124302,injections,O,6442
124303,without,O,6442
124304,the,O,6442
124305,drug,O,6442
124306,over,O,6442
124307,the,O,6442
124308,same,O,6442
124309,period,O,6442
124310,In,O,6442
124311,the,O,6442
124312,event,O,6442
124313,that,O,6442
124314,a,O,6443
124315,vision-threatening,O,6443
124316,complication,O,6443
124317,such,O,6443
124318,as,O,6443
124319,diabetic,B-NAME_OF_DISEASE,6443
124320,macular,I-NAME_OF_DISEASE,6443
124321,edema,I-NAME_OF_DISEASE,6443
124322,or,O,6443
124323,proliferative,B-NAME_OF_DISEASE,6443
124324,diabetic,I-NAME_OF_DISEASE,6443
124325,retinopathy,I-NAME_OF_DISEASE,6443
124326,PDR,I-NAME_OF_DISEASE,6443
124327,developed,O,6443
124328,additional,O,6443
124329,anti-VEGF,B-NAME_OF_DRUG,6443
124330,injections,O,6443
124331,were,O,6443
124332,given,O,6443
124333,as,O,6443
124334,required,O,6443
124335,The,O,6443
124336,Findings,O,6443
124337,The,O,6443
124338,results,O,6443
124339,of,O,6443
124340,a,O,6443
124341,4-year,B-TIME_DURATION,6443
124342,study,O,6443
124343,funded,O,6443
124344,by,O,6443
124345,the,B-ORGANIZATION,6443
124346,National,I-ORGANIZATION,6443
124347,Eye,I-ORGANIZATION,6443
124348,Institute,I-ORGANIZATION,6443
124349,NEI,I-ORGANIZATION,6443
124350,evaluated,O,6443
124351,the,O,6443
124352,effectiveness,O,6443
124353,of,O,6443
124354,treating,O,6444
124355,people,O,6444
124356,with,O,6444
124357,non-proliferative,B-NAME_OF_DISEASE,6444
124358,diabetic,B-NAME_OF_DISEASE,6444
124359,retinopathy,I-NAME_OF_DISEASE,6444
124360,NPDR,B-NAME_OF_DISEASE,6444
124361,using,O,6444
124362,the,O,6444
124363,anti-vascular,B-NAME_OF_DRUG,6444
124364,endothelial,I-NAME_OF_DRUG,6444
124365,growth,I-NAME_OF_DRUG,6444
124366,factor,I-NAME_OF_DRUG,6444
124367,anti-VEGF,B-NAME_OF_DRUG,6444
124368,drug,I-NAME_OF_DRUG,6444
124369,Eylea,I-NAME_OF_DRUG,6444
124370,aflibercept,I-NAME_OF_DRUG,6444
124371,in,O,6444
124372,preventing,O,6444
124373,vision,B-SIGN_AND_SYMPTOM,6444
124374,loss,I-SIGN_AND_SYMPTOM,6444
124375,The,O,6444
124376,study,O,6444
124377,enrolled,O,6444
124378,328,O,6444
124379,participants,O,6444
124380,each,O,6444
124381,with,O,6444
124382,one,O,6444
124383,or,O,6444
124384,two,O,6444
124385,eyes,O,6444
124386,that,O,6444
124387,qualified,O,6444
124388,for,O,6444
124389,the,O,6444
124390,study,O,6444
124391,The,O,6444
124392,treatment,O,6444
124393,group,O,6444
124394,received,O,6444
124395,preventive,O,6444
124396,anti-VEGF,B-NAME_OF_DRUG,6444
124397,injections,O,6444
124398,every,B-TIME_DURATION,6444
124399,4,I-TIME_DURATION,6444
124400,months,I-TIME_DURATION,6444
124401,for,I-TIME_DURATION,6444
124402,2,I-TIME_DURATION,6444
124403,years,I-TIME_DURATION,6444
124404,and,O,6444
124405,continued,O,6444
124406,receiving,O,6444
124407,injections,O,6444
124408,every,B-TIME_DURATION,6444
124409,4,I-TIME_DURATION,6445
124410,months,I-TIME_DURATION,6445
124411,for,I-TIME_DURATION,6445
124412,up,I-TIME_DURATION,6445
124413,to,I-TIME_DURATION,6445
124414,4,I-TIME_DURATION,6445
124415,years,I-TIME_DURATION,6445
124416,if,O,6445
124417,NPDR,B-NAME_OF_DISEASE,6445
124418,remained,O,6445
124419,at,O,6445
124420,a,O,6445
124421,mild,O,6445
124422,level,O,6445
124423,Meanwhile,O,6445
124424,the,O,6445
124425,control,O,6445
124426,group,O,6445
124427,received,O,6445
124428,sham,O,6445
124429,injections,O,6445
124430,without,O,6445
124431,the,O,6445
124432,drug,O,6445
124433,over,O,6445
124434,the,O,6445
124435,same,O,6445
124436,period,O,6445
124437,We,O,6445
124438,expected,O,6445
124439,early,O,6445
124440,treatment,O,6445
124441,to,O,6445
124442,prevent,O,6445
124443,progression,O,6445
124444,of,O,6446
124445,diabetic,B-NAME_OF_DISEASE,6446
124446,retinopathy,I-NAME_OF_DISEASE,6446
124447,but,O,6446
124448,even,O,6446
124449,with,O,6446
124450,preventative,O,6446
124451,injections,O,6446
124452,about,O,6446
124453,one-third,O,6446
124454,of,O,6446
124455,eyes,O,6446
124456,developed,O,6446
124457,vision-threatening,O,6446
124458,complications,O,6446
124459,said,O,6446
124460,Adam,B-PERSON,6446
124461,Glassman,I-PERSON,6446
124462,Jaeb,B-ORGANIZATION,6446
124463,Center,I-ORGANIZATION,6446
124464,for,I-ORGANIZATION,6446
124465,Health,I-ORGANIZATION,6447
124466,Research,I-ORGANIZATION,6448
124467,Tampa,B-GPE,6448
124468,Florida,I-GPE,6448
124469,who,O,6448
124470,directs,O,6448
124471,the,B-ORGANIZATION,6448
124472,DRCR,I-ORGANIZATION,6448
124473,Retina,I-ORGANIZATION,6448
124474,Network,I-ORGANIZATION,6448
124475,coordinating,O,6448
124476,center,O,6448
124477,The,O,6448
124478,final,O,6448
124479,results,O,6448
124480,of,O,6448
124481,the,O,6448
124482,study,O,6448
124483,reinforced,O,6449
124484,the,O,6449
124485,earlier,O,6449
124486,two-year,B-TIME_DURATION,6449
124487,findings,O,6449
124488,which,O,6449
124489,suggested,O,6449
124490,that,O,6449
124491,preventive,O,6449
124492,treatment,O,6449
124493,reduced,O,6449
124494,the,O,6449
124495,risk,O,6449
124496,of,O,6449
124497,developing,O,6449
124498,diabetic,B-NAME_OF_DISEASE,6449
124499,macular,I-NAME_OF_DISEASE,6449
124500,edema,I-NAME_OF_DISEASE,6449
124501,or,O,6449
124502,proliferative,B-NAME_OF_DISEASE,6449
124503,diabetic,I-NAME_OF_DISEASE,6449
124504,retinopathy,I-NAME_OF_DISEASE,6449
124505,PDR,I-NAME_OF_DISEASE,6449
124506,but,O,6449
124507,there,O,6449
124508,was,O,6449
124509,no,O,6449
124510,evident,O,6449
124511,benefit,O,6449
124512,to,O,6449
124513,vision,O,6449
124514,with,O,6449
124515,no,O,6449
124516,statistically,O,6449
124517,significant,O,6449
124518,difference,O,6449
124519,in,O,6449
124520,either,O,6449
124521,visual,O,6449
124522,acuity,O,6449
124523,or,O,6449
124524,rates,O,6450
124525,of,O,6450
124526,vision,B-SIGN_AND_SYMPTOM,6450
124527,loss,I-SIGN_AND_SYMPTOM,6450
124528,between,O,6450
124529,the,O,6450
124530,two,O,6450
124531,groups,O,6450
124532,On,O,6450
124533,average,O,6450
124534,the,O,6450
124535,preventive,O,6450
124536,group,O,6450
124537,received,O,6450
124538,11,O,6450
124539,injections,O,6450
124540,compared,O,6450
124541,with,O,6450
124542,an,O,6450
124543,average,O,6450
124544,of,O,6450
124545,three,O,6450
124546,in,O,6450
124547,the,O,6450
124548,sham,O,6450
124549,group,O,6450
124550,and,O,6450
124551,34%,O,6450
124552,of,O,6450
124553,eyes,O,6450
124554,receiving,O,6450
124555,preventive,O,6450
124556,treatments,O,6450
124557,showed,O,6450
124558,disease,O,6450
124559,progression,O,6450
124560,compared,O,6450
124561,with,O,6450
124562,57%,O,6450
124563,in,O,6450
124564,the,O,6450
124565,sham,O,6450
124566,group,O,6451
124567,While,O,6451
124568,the,O,6451
124569,individual,O,6451
124570,risk,O,6451
124571,of,O,6451
124572,complications,O,6451
124573,per,O,6451
124574,injection,O,6451
124575,is,O,6451
124576,low,O,6451
124577,the,O,6451
124578,risk,O,6452
124579,increases,O,6452
124580,with,O,6452
124581,each,O,6452
124582,additional,O,6452
124583,injection,O,6452
124584,said,O,6452
124585,Jennifer,O,6452
124586,Sun,O,6452
124587,M.D,O,6452
124588,M.P.H,O,6452
124589,Joslin,B-ORGANIZATION,6452
124590,Diabetes,I-ORGANIZATION,6452
124591,Center,I-ORGANIZATION,6452
124592,Harvard,I-ORGANIZATION,6452
124593,Medical,I-ORGANIZATION,6452
124594,School,I-ORGANIZATION,6452
124595,Boston,B-GPE,6452
124596,and,O,6452
124597,chair,O,6452
124598,of,O,6452
124599,diabetes,B-NAME_OF_DISEASE,6452
124600,initiatives,O,6453
124601,for,O,6453
124602,the,B-ORGANIZATION,6453
124603,DRCR,I-ORGANIZATION,6453
124604,Retina,I-ORGANIZATION,6453
124605,Network,I-ORGANIZATION,6453
124606,The,O,6453
124607,results,O,6453
124608,of,O,6453
124609,this,O,6453
124610,study,O,6453
124611,indicate,O,6453
124612,that,O,6453
124613,the,O,6453
124614,anatomic,O,6453
124615,benefit,O,6453
124616,from,O,6453
124617,early,O,6453
124618,anti-VEGF,B-NAME_OF_DRUG,6453
124619,treatment,O,6453
124620,does,O,6453
124621,not,O,6453
124622,result,O,6453
124623,in,O,6453
124624,improved,O,6453
124625,visual,O,6453
124626,acuity,O,6453
124627,and,O,6453
124628,so,O,6453
124629,it,O,6454
124630,may,O,6454
124631,not,O,6454
124632,be,O,6454
124633,worth,O,6454
124634,the,O,6454
124635,risk,O,6454
124636,and,O,6454
124637,inconvenience,O,6454
124638,to,O,6454
124639,the,O,6454
124640,patient,O,6454
124641,of,O,6454
124642,repeat,O,6454
124643,preventive,O,6454
124644,injections,O,6454
124645,for,O,6454
124646,NPDR,B-NAME_OF_DISEASE,6454
124647,What,O,6454
124648,Is,O,6454
124649,Symblepharon,B-NAME_OF_DISEASE,6454
124650,Symblepharon,B-NAME_OF_DISEASE,6454
124651,is,O,6454
124652,a,O,6454
124653,medical,O,6454
124654,condition,O,6454
124655,characterized,O,6454
124656,by,O,6454
124657,the,B-SIGN_AND_SYMPTOM,6454
124658,adhesion,I-SIGN_AND_SYMPTOM,6454
124659,of,I-SIGN_AND_SYMPTOM,6454
124660,the,I-SIGN_AND_SYMPTOM,6454
124661,conjunctiva,I-SIGN_AND_SYMPTOM,6454
124662,the,O,6454
124663,clear,O,6454
124664,membrane,O,6454
124665,that,O,6454
124666,covers,O,6454
124667,the,O,6454
124668,white,O,6454
124669,part,O,6454
124670,of,O,6454
124671,the,O,6454
124672,eye,O,6454
124673,and,O,6454
124674,the,O,6454
124675,inside,O,6454
124676,of,O,6454
124677,the,B-PART_OF_THE_EYES,6454
124678,eyelids,I-PART_OF_THE_EYES,6454
124679,to,O,6454
124680,the,B-PART_OF_THE_EYES,6454
124681,cornea,I-PART_OF_THE_EYES,6455
124682,the,O,6455
124683,clear,O,6455
124684,front,O,6455
124685,part,O,6455
124686,of,O,6455
124687,the,O,6455
124688,eye,O,6455
124689,This,O,6455
124690,adhesion,O,6455
124691,can,O,6455
124692,cause,O,6455
124693,pain,B-SIGN_AND_SYMPTOM,6455
124694,vision,O,6455
124695,problems,O,6455
124696,and,O,6455
124697,increased,O,6455
124698,risk,O,6455
124699,of,O,6455
124700,infection,O,6455
124701,What,O,6455
124702,Causes,O,6455
124703,Symblepharon,B-NAME_OF_DISEASE,6455
124704,Causes,O,6455
124705,of,O,6455
124706,symblepharon,B-NAME_OF_DISEASE,6456
124707,include,O,6456
124708,inflammatory,B-CAUSE_OF_DISEASE,6456
124709,eye,I-CAUSE_OF_DISEASE,6456
124710,diseases,I-CAUSE_OF_DISEASE,6456
124711,such,O,6456
124712,as,O,6456
124713,vernal,B-CAUSE_OF_DISEASE,6456
124714,keratoconjunctivitis,I-CAUSE_OF_DISEASE,6456
124715,trachoma,B-CAUSE_OF_DISEASE,6456
124716,and,O,6456
124717,autoimmune,B-CAUSE_OF_DISEASE,6456
124718,diseases,I-CAUSE_OF_DISEASE,6456
124719,such,I-CAUSE_OF_DISEASE,6456
124720,as,I-CAUSE_OF_DISEASE,6456
124721,Stevens-Johnson,I-CAUSE_OF_DISEASE,6456
124722,syndrome,I-CAUSE_OF_DISEASE,6456
124723,Chemical,B-CAUSE_OF_DISEASE,6456
124724,or,I-CAUSE_OF_DISEASE,6456
124725,thermal,I-CAUSE_OF_DISEASE,6456
124726,burns,I-CAUSE_OF_DISEASE,6456
124727,to,I-CAUSE_OF_DISEASE,6456
124728,the,I-CAUSE_OF_DISEASE,6456
124729,eye,I-CAUSE_OF_DISEASE,6456
124730,previous,B-CAUSE_OF_DISEASE,6456
124731,ocular,I-CAUSE_OF_DISEASE,6456
124732,surgeries,I-CAUSE_OF_DISEASE,6456
124733,such,I-CAUSE_OF_DISEASE,6456
124734,as,I-CAUSE_OF_DISEASE,6456
124735,corneal,I-CAUSE_OF_DISEASE,6456
124736,transplantation,I-CAUSE_OF_DISEASE,6457
124737,or,I-CAUSE_OF_DISEASE,6457
124738,glaucoma,I-CAUSE_OF_DISEASE,6457
124739,filtration,I-CAUSE_OF_DISEASE,6457
124740,surgery,I-CAUSE_OF_DISEASE,6457
124741,and,O,6457
124742,infections,B-CAUSE_OF_DISEASE,6457
124743,such,I-CAUSE_OF_DISEASE,6457
124744,as,I-CAUSE_OF_DISEASE,6457
124745,bacterial,I-CAUSE_OF_DISEASE,6457
124746,conjunctivitis,I-CAUSE_OF_DISEASE,6457
124747,can,O,6457
124748,also,O,6457
124749,lead,O,6457
124750,to,O,6457
124751,symblepharon,B-NAME_OF_DISEASE,6458
124752,Symptoms,O,6458
124753,of,O,6458
124754,Symblepharon,B-NAME_OF_DISEASE,6458
124755,Pain,B-SIGN_AND_SYMPTOM,6458
124756,or,I-SIGN_AND_SYMPTOM,6458
124757,discomfort,I-SIGN_AND_SYMPTOM,6458
124758,in,I-SIGN_AND_SYMPTOM,6458
124759,the,I-SIGN_AND_SYMPTOM,6458
124760,affected,I-SIGN_AND_SYMPTOM,6458
124761,eye,I-SIGN_AND_SYMPTOM,6458
124762,Decreased,B-SIGN_AND_SYMPTOM,6458
124763,vision,I-SIGN_AND_SYMPTOM,6458
124764,or,I-SIGN_AND_SYMPTOM,6458
124765,blurred,I-SIGN_AND_SYMPTOM,6458
124766,vision,I-SIGN_AND_SYMPTOM,6458
124767,Redness,B-SIGN_AND_SYMPTOM,6458
124768,swelling,I-SIGN_AND_SYMPTOM,6458
124769,and,I-SIGN_AND_SYMPTOM,6458
124770,discharge,I-SIGN_AND_SYMPTOM,6458
124771,in,I-SIGN_AND_SYMPTOM,6458
124772,the,I-SIGN_AND_SYMPTOM,6458
124773,affected,I-SIGN_AND_SYMPTOM,6458
124774,eye,I-SIGN_AND_SYMPTOM,6458
124775,Sensitivity,B-SIGN_AND_SYMPTOM,6458
124776,to,I-SIGN_AND_SYMPTOM,6458
124777,light,I-SIGN_AND_SYMPTOM,6458
124778,Photographs,O,6458
124779,demonstrating,O,6458
124780,symblepharon,B-NAME_OF_DISEASE,6459
124781,grading,O,6459
124782,Credit,O,6459
124783,Research,O,6459
124784,Gate,O,6459
124785,The,O,6459
124786,symptoms,O,6459
124787,of,O,6459
124788,symblepharon,B-NAME_OF_DISEASE,6459
124789,may,O,6459
124790,resolve,O,6459
124791,on,O,6459
124792,their,O,6459
124793,own,O,6459
124794,if,O,6459
124795,the,O,6459
124796,underlying,O,6459
124797,cause,O,6459
124798,of,O,6459
124799,the,O,6459
124800,adhesion,O,6459
124801,is,O,6459
124802,treated,O,6459
124803,effectively,O,6459
124804,However,O,6460
124805,in,O,6460
124806,some,O,6460
124807,cases,O,6460
124808,the,O,6460
124809,symptoms,O,6460
124810,may,O,6460
124811,persist,O,6460
124812,even,O,6460
124813,with,O,6460
124814,treatment,O,6460
124815,particularly,O,6460
124816,if,O,6460
124817,the,O,6460
124818,adhesion,O,6460
124819,is,O,6460
124820,extensive,O,6460
124821,or,O,6460
124822,has,O,6460
124823,been,O,6460
124824,present,O,6460
124825,for,O,6460
124826,a,O,6460
124827,long,O,6460
124828,time,O,6460
124829,The,O,6461
124830,length,O,6461
124831,of,O,6461
124832,time,O,6461
124833,it,O,6461
124834,takes,O,6461
124835,for,O,6461
124836,the,O,6461
124837,symptoms,O,6461
124838,of,O,6461
124839,symblepharon,B-NAME_OF_DISEASE,6461
124840,to,O,6461
124841,pass,O,6461
124842,varies,O,6461
124843,depending,O,6461
124844,on,O,6461
124845,the,O,6461
124846,severity,O,6461
124847,of,O,6461
124848,the,O,6462
124849,condition,O,6462
124850,the,O,6462
124851,underlying,O,6462
124852,cause,O,6462
124853,and,O,6462
124854,the,O,6462
124855,type,O,6462
124856,of,O,6462
124857,treatment,O,6462
124858,received,O,6462
124859,Can,O,6462
124860,Symblepharon,B-NAME_OF_DISEASE,6462
124861,Lead,O,6462
124862,to,O,6462
124863,Other,O,6462
124864,Eye,O,6462
124865,Problems,O,6462
124866,Symblepharon,B-NAME_OF_DISEASE,6462
124867,can,O,6462
124868,definitely,O,6462
124869,lead,O,6462
124870,to,O,6462
124871,other,O,6462
124872,eye,O,6462
124873,problems,O,6463
124874,Because,O,6463
124875,the,B-PART_OF_THE_EYES,6463
124876,conjunctiva,I-PART_OF_THE_EYES,6463
124877,is,O,6463
124878,adhered,O,6463
124879,to,O,6463
124880,the,B-PART_OF_THE_EYES,6463
124881,cornea,I-PART_OF_THE_EYES,6463
124882,the,O,6463
124883,affected,O,6463
124884,eye,O,6463
124885,may,O,6463
124886,be,O,6463
124887,more,O,6463
124888,susceptible,O,6463
124889,to,O,6463
124890,infections,O,6463
124891,and,O,6463
124892,inflammation,O,6463
124893,which,O,6463
124894,can,O,6463
124895,cause,O,6463
124896,further,O,6463
124897,damage,O,6463
124898,to,O,6464
124899,the,O,6464
124900,eye,O,6464
124901,and,O,6464
124902,vision,O,6464
124903,In,O,6464
124904,addition,O,6464
124905,symblepharon,B-NAME_OF_DISEASE,6464
124906,can,O,6464
124907,cause,O,6464
124908,the,B-SIGN_AND_SYMPTOM,6464
124909,eyelid,I-SIGN_AND_SYMPTOM,6464
124910,to,I-SIGN_AND_SYMPTOM,6464
124911,turn,I-SIGN_AND_SYMPTOM,6464
124912,inward,I-SIGN_AND_SYMPTOM,6464
124913,a,O,6464
124914,condition,O,6464
124915,known,O,6464
124916,as,O,6464
124917,entropion,B-SIGN_AND_SYMPTOM,6464
124918,which,O,6464
124919,can,O,6465
124920,lead,O,6465
124921,to,O,6465
124922,further,O,6465
124923,discomfort,O,6465
124924,and,O,6465
124925,vision,O,6465
124926,problems,O,6465
124927,Symblepharon,B-NAME_OF_DISEASE,6465
124928,can,O,6465
124929,also,O,6465
124930,cause,O,6465
124931,the,B-SIGN_AND_SYMPTOM,6465
124932,cornea,I-SIGN_AND_SYMPTOM,6465
124933,to,I-SIGN_AND_SYMPTOM,6465
124934,become,I-SIGN_AND_SYMPTOM,6465
124935,thin,I-SIGN_AND_SYMPTOM,6465
124936,and,I-SIGN_AND_SYMPTOM,6465
124937,scarred,I-SIGN_AND_SYMPTOM,6465
124938,which,O,6465
124939,can,O,6465
124940,affect,O,6465
124941,vision,O,6465
124942,and,O,6465
124943,may,O,6466
124944,lead,O,6466
124945,to,O,6466
124946,a,O,6466
124947,condition,O,6466
124948,known,O,6466
124949,as,O,6466
124950,corneal,B-SIGN_AND_SYMPTOM,6466
124951,opacity,I-SIGN_AND_SYMPTOM,6466
124952,This,O,6466
124953,can,O,6466
124954,make,O,6466
124955,it,O,6466
124956,difficult,B-SIGN_AND_SYMPTOM,6466
124957,for,I-SIGN_AND_SYMPTOM,6466
124958,light,I-SIGN_AND_SYMPTOM,6466
124959,to,I-SIGN_AND_SYMPTOM,6466
124960,enter,I-SIGN_AND_SYMPTOM,6466
124961,the,I-SIGN_AND_SYMPTOM,6466
124962,eye,I-SIGN_AND_SYMPTOM,6466
124963,and,I-SIGN_AND_SYMPTOM,6466
124964,reach,I-SIGN_AND_SYMPTOM,6466
124965,the,I-SIGN_AND_SYMPTOM,6467
124966,retina,I-SIGN_AND_SYMPTOM,6467
124967,resulting,O,6467
124968,in,O,6467
124969,decreased,B-SIGN_AND_SYMPTOM,6467
124970,vision,I-SIGN_AND_SYMPTOM,6467
124971,In,O,6467
124972,severe,O,6467
124973,cases,O,6467
124974,symblepharon,B-NAME_OF_DISEASE,6467
124975,can,O,6467
124976,also,O,6467
124977,cause,O,6467
124978,a,B-SIGN_AND_SYMPTOM,6467
124979,loss,I-SIGN_AND_SYMPTOM,6467
124980,of,I-SIGN_AND_SYMPTOM,6467
124981,the,I-SIGN_AND_SYMPTOM,6467
124982,tear,I-SIGN_AND_SYMPTOM,6467
124983,film,I-SIGN_AND_SYMPTOM,6468
124984,which,O,6468
124985,is,O,6468
124986,essential,O,6468
124987,for,O,6468
124988,maintaining,O,6468
124989,the,O,6468
124990,health,O,6468
124991,of,O,6468
124992,the,O,6468
124993,eye,O,6468
124994,and,O,6468
124995,vision,O,6468
124996,This,O,6468
124997,can,O,6468
124998,lead,O,6468
124999,to,O,6468
125000,dry,B-NAME_OF_DISEASE,6468
125001,eye,I-NAME_OF_DISEASE,6468
125002,syndrome,I-NAME_OF_DISEASE,6468
125003,a,O,6468
125004,condition,O,6468
125005,in,O,6468
125006,which,O,6469
125007,the,B-SIGN_AND_SYMPTOM,6469
125008,eye,I-SIGN_AND_SYMPTOM,6469
125009,does,I-SIGN_AND_SYMPTOM,6469
125010,not,I-SIGN_AND_SYMPTOM,6469
125011,produce,I-SIGN_AND_SYMPTOM,6469
125012,enough,I-SIGN_AND_SYMPTOM,6469
125013,tears,I-SIGN_AND_SYMPTOM,6469
125014,to,I-SIGN_AND_SYMPTOM,6469
125015,keep,I-SIGN_AND_SYMPTOM,6469
125016,the,I-SIGN_AND_SYMPTOM,6469
125017,eye,I-SIGN_AND_SYMPTOM,6469
125018,moist,I-SIGN_AND_SYMPTOM,6469
125019,and,I-SIGN_AND_SYMPTOM,6469
125020,comfortable,I-SIGN_AND_SYMPTOM,6469
125021,Treatment,O,6469
125022,Options,O,6469
125023,for,O,6469
125024,Symblepharon,B-NAME_OF_DISEASE,6469
125025,Treatment,O,6469
125026,options,O,6469
125027,for,O,6470
125028,symblepharon,B-NAME_OF_DISEASE,6470
125029,may,O,6470
125030,vary,O,6470
125031,based,O,6470
125032,on,O,6470
125033,the,O,6470
125034,severity,O,6470
125035,of,O,6470
125036,the,O,6470
125037,condition,O,6470
125038,and,O,6471
125039,the,O,6471
125040,underlying,O,6471
125041,cause,O,6471
125042,The,O,6471
125043,goal,O,6471
125044,of,O,6471
125045,treatment,O,6471
125046,is,O,6471
125047,to,O,6471
125048,separate,B-TREATMENT,6471
125049,the,I-TREATMENT,6471
125050,conjunctiva,I-TREATMENT,6471
125051,from,I-TREATMENT,6471
125052,the,I-TREATMENT,6471
125053,cornea,I-TREATMENT,6471
125054,restore,I-TREATMENT,6471
125055,the,I-TREATMENT,6472
125056,normal,I-TREATMENT,6472
125057,anatomy,I-TREATMENT,6472
125058,of,I-TREATMENT,6472
125059,the,I-TREATMENT,6472
125060,eye,I-TREATMENT,6472
125061,and,O,6472
125062,prevent,O,6472
125063,further,O,6472
125064,vision,B-SIGN_AND_SYMPTOM,6472
125065,loss,I-SIGN_AND_SYMPTOM,6472
125066,Here,O,6472
125067,are,O,6472
125068,some,O,6472
125069,common,O,6472
125070,treatment,O,6472
125071,options,O,6472
125072,for,O,6472
125073,symblepharon,B-NAME_OF_DISEASE,6472
125074,Corticosteroid,B-NAME_OF_DRUG,6472
125075,eye,I-NAME_OF_DRUG,6472
125076,drops,I-NAME_OF_DRUG,6472
125077,Corticosteroid,B-NAME_OF_DRUG,6472
125078,eye,I-NAME_OF_DRUG,6472
125079,drops,I-NAME_OF_DRUG,6472
125080,can,O,6473
125081,help,O,6473
125082,reduce,O,6473
125083,inflammation,O,6473
125084,and,O,6473
125085,prevent,O,6473
125086,further,O,6473
125087,scarring,O,6473
125088,They,O,6473
125089,may,O,6473
125090,be,O,6473
125091,used,O,6473
125092,to,O,6473
125093,manage,O,6473
125094,the,O,6473
125095,symptoms,O,6473
125096,of,O,6473
125097,symblepharon,B-NAME_OF_DISEASE,6473
125098,but,O,6473
125099,are,O,6473
125100,not,O,6473
125101,a,O,6473
125102,cure,O,6473
125103,for,O,6473
125104,the,O,6473
125105,condition,O,6473
125106,Antibiotic,B-NAME_OF_DRUG,6474
125107,eye,I-NAME_OF_DRUG,6474
125108,drops,I-NAME_OF_DRUG,6474
125109,Antibiotic,B-NAME_OF_DRUG,6474
125110,eye,I-NAME_OF_DRUG,6474
125111,drops,I-NAME_OF_DRUG,6474
125112,may,O,6474
125113,be,O,6474
125114,prescribed,O,6474
125115,to,O,6474
125116,prevent,O,6474
125117,or,O,6474
125118,treat,O,6474
125119,eye,B-SIGN_AND_SYMPTOM,6474
125120,infections,I-SIGN_AND_SYMPTOM,6474
125121,which,O,6474
125122,can,O,6474
125123,be,O,6474
125124,a,O,6474
125125,common,O,6474
125126,complication,O,6474
125127,of,O,6474
125128,symblepharon,B-NAME_OF_DISEASE,6474
125129,Artificial,B-NAME_OF_DRUG,6475
125130,tears,I-NAME_OF_DRUG,6475
125131,Artificial,B-NAME_OF_DRUG,6475
125132,tears,I-NAME_OF_DRUG,6475
125133,can,O,6475
125134,help,O,6475
125135,to,O,6475
125136,maintain,O,6475
125137,the,O,6475
125138,health,O,6475
125139,of,O,6475
125140,the,O,6475
125141,eye,O,6475
125142,and,O,6475
125143,reduce,O,6475
125144,the,O,6475
125145,symptoms,O,6475
125146,of,O,6475
125147,dry,B-NAME_OF_DISEASE,6475
125148,eye,I-NAME_OF_DISEASE,6475
125149,syndrome,I-NAME_OF_DISEASE,6475
125150,They,O,6475
125151,can,O,6475
125152,also,O,6475
125153,help,O,6475
125154,to,O,6475
125155,prevent,O,6475
125156,further,O,6475
125157,scarring,O,6475
125158,and,O,6475
125159,vision,B-SIGN_AND_SYMPTOM,6475
125160,loss,I-SIGN_AND_SYMPTOM,6476
125161,Ointments,B-TREATMENT,6476
125162,Ointments,B-TREATMENT,6476
125163,may,O,6476
125164,be,O,6476
125165,prescribed,O,6476
125166,to,O,6476
125167,provide,O,6476
125168,additional,O,6476
125169,moisture,O,6476
125170,to,O,6476
125171,the,O,6476
125172,eye,O,6476
125173,and,O,6476
125174,help,O,6476
125175,prevent,O,6476
125176,further,O,6476
125177,scarring,O,6476
125178,Surgical,B-TREATMENT,6476
125179,intervention,I-TREATMENT,6476
125180,In,O,6476
125181,severe,O,6476
125182,cases,O,6476
125183,surgical,B-TREATMENT,6476
125184,intervention,I-TREATMENT,6476
125185,may,O,6477
125186,be,O,6477
125187,required,O,6477
125188,to,O,6477
125189,separate,B-TREATMENT,6477
125190,the,I-TREATMENT,6477
125191,conjunctiva,I-TREATMENT,6477
125192,from,I-TREATMENT,6477
125193,the,I-TREATMENT,6477
125194,cornea,I-TREATMENT,6477
125195,and,I-TREATMENT,6477
125196,restore,I-TREATMENT,6477
125197,the,I-TREATMENT,6477
125198,normal,I-TREATMENT,6477
125199,anatomy,I-TREATMENT,6477
125200,of,I-TREATMENT,6477
125201,the,I-TREATMENT,6477
125202,eye,I-TREATMENT,6477
125203,The,O,6477
125204,procedure,O,6477
125205,may,O,6477
125206,involve,O,6478
125207,a,B-TREATMENT,6478
125208,surgical,I-TREATMENT,6478
125209,separation,I-TREATMENT,6478
125210,of,I-TREATMENT,6478
125211,the,I-TREATMENT,6478
125212,conjunctiva,I-TREATMENT,6478
125213,from,I-TREATMENT,6478
125214,the,I-TREATMENT,6478
125215,cornea,I-TREATMENT,6478
125216,or,O,6478
125217,a,O,6478
125218,procedure,O,6478
125219,to,O,6478
125220,correct,O,6478
125221,the,O,6478
125222,underlying,O,6478
125223,cause,O,6478
125224,of,O,6478
125225,symblepharon,B-NAME_OF_DISEASE,6478
125226,such,O,6478
125227,as,O,6478
125228,entropion,B-CAUSE_OF_DISEASE,6478
125229,In,O,6478
125230,conclusion,O,6478
125231,symblepharon,B-NAME_OF_DISEASE,6478
125232,is,O,6478
125233,a,O,6478
125234,serious,O,6479
125235,medical,O,6479
125236,condition,O,6479
125237,that,O,6479
125238,can,O,6479
125239,have,O,6479
125240,a,O,6479
125241,significant,O,6479
125242,impact,O,6479
125243,on,O,6479
125244,a,O,6479
125245,person,O,6479
125246,s,O,6479
125247,vision,O,6479
125248,and,O,6479
125249,quality,O,6479
125250,of,O,6479
125251,life,O,6479
125252,By,O,6479
125253,understanding,O,6479
125254,the,O,6479
125255,causes,O,6479
125256,symptoms,O,6479
125257,and,O,6479
125258,treatments,O,6479
125259,of,O,6479
125260,symblepharon,B-NAME_OF_DISEASE,6479
125261,individuals,O,6480
125262,affected,O,6480
125263,by,O,6480
125264,this,O,6480
125265,condition,O,6480
125266,can,O,6480
125267,seek,O,6480
125268,the,O,6480
125269,support,O,6480
125270,and,O,6480
125271,care,O,6480
125272,they,O,6480
125273,need,O,6480
125274,to,O,6480
125275,manage,O,6480
125276,their,O,6480
125277,symptoms,O,6480
125278,and,O,6480
125279,improve,O,6480
125280,their,O,6480
125281,overall,O,6480
125282,well-being,O,6480
125283,An,O,6480
125284,Introduction,O,6480
125285,to,O,6480
125286,Intraretinal,B-NAME_OF_DISEASE,6480
125287,Microvascular,I-NAME_OF_DISEASE,6480
125288,Abnormalities,I-NAME_OF_DISEASE,6481
125289,Intraretinal,B-NAME_OF_DISEASE,6481
125290,microvascular,I-NAME_OF_DISEASE,6481
125291,abnormalities,I-NAME_OF_DISEASE,6481
125292,IRMAs,B-NAME_OF_DISEASE,6481
125293,are,O,6481
125294,tiny,B-SIGN_AND_SYMPTOM,6481
125295,blood,I-SIGN_AND_SYMPTOM,6481
125296,vessels,I-SIGN_AND_SYMPTOM,6481
125297,in,I-SIGN_AND_SYMPTOM,6481
125298,the,I-SIGN_AND_SYMPTOM,6481
125299,retina,I-SIGN_AND_SYMPTOM,6481
125300,that,I-SIGN_AND_SYMPTOM,6481
125301,deviate,I-SIGN_AND_SYMPTOM,6481
125302,from,I-SIGN_AND_SYMPTOM,6481
125303,their,I-SIGN_AND_SYMPTOM,6481
125304,normal,I-SIGN_AND_SYMPTOM,6481
125305,shape,I-SIGN_AND_SYMPTOM,6481
125306,and,I-SIGN_AND_SYMPTOM,6481
125307,size,I-SIGN_AND_SYMPTOM,6481
125308,These,O,6481
125309,abnormalities,O,6481
125310,are,O,6481
125311,commonly,O,6481
125312,found,O,6481
125313,in,O,6482
125314,people,O,6482
125315,with,O,6482
125316,diabetic,B-NAME_OF_DISEASE,6482
125317,retinopathy,I-NAME_OF_DISEASE,6482
125318,and,O,6482
125319,can,O,6482
125320,lead,O,6482
125321,to,O,6482
125322,vision,B-SIGN_AND_SYMPTOM,6482
125323,loss,I-SIGN_AND_SYMPTOM,6482
125324,and,O,6482
125325,blindness,B-NAME_OF_DISEASE,6482
125326,if,O,6482
125327,left,O,6482
125328,untreated,O,6482
125329,Intraretinal,B-NAME_OF_DISEASE,6482
125330,microvascular,I-NAME_OF_DISEASE,6482
125331,abnormalities,I-NAME_OF_DISEASE,6483
125332,IRMAs,B-NAME_OF_DISEASE,6483
125333,are,O,6483
125334,considered,O,6483
125335,a,O,6483
125336,defining,O,6483
125337,feature,O,6483
125338,of,O,6483
125339,severe,O,6483
125340,non-proliferative,B-NAME_OF_DISEASE,6483
125341,diabetic,I-NAME_OF_DISEASE,6483
125342,retinopathy,I-NAME_OF_DISEASE,6483
125343,according,O,6483
125344,to,O,6483
125345,the,O,6483
125346,4/2/2001,B-DIAGNOSTIC_TEST,6484
125347,criteria,I-DIAGNOSTIC_TEST,6484
125348,from,O,6484
125349,the,B-ORGANIZATION,6484
125350,Early,I-ORGANIZATION,6484
125351,Treatment,I-ORGANIZATION,6484
125352,Diabetic,I-ORGANIZATION,6484
125353,Retinopathy,I-ORGANIZATION,6484
125354,Study,I-ORGANIZATION,6484
125355,ETDRS,I-ORGANIZATION,6484
125356,,O,6484
125357,Compared,O,6484
125358,to,O,6484
125359,neovascularization,O,6484
125360,NV,O,6484
125361,in,O,6485
125362,proliferative,B-NAME_OF_DISEASE,6485
125363,disease,I-NAME_OF_DISEASE,6485
125364,IRMAs,B-NAME_OF_DISEASE,6485
125365,are,O,6485
125366,slightly,O,6485
125367,larger,O,6485
125368,in,O,6485
125369,caliber,O,6485
125370,and,O,6485
125371,have,O,6485
125372,a,O,6485
125373,more,O,6485
125374,broad,O,6485
125375,arrangement,O,6486
125376,and,O,6486
125377,are,O,6486
125378,always,O,6486
125379,contained,O,6486
125380,within,O,6486
125381,the,O,6486
125382,intraretinal,O,6486
125383,layers,O,6486
125384,The,O,6486
125385,presence,O,6486
125386,of,O,6486
125387,IRMAs,B-NAME_OF_DISEASE,6486
125388,indicates,O,6486
125389,that,O,6486
125390,the,O,6486
125391,retinal,O,6486
125392,blood,O,6486
125393,vessels,O,6486
125394,have,O,6486
125395,undergone,O,6486
125396,changes,O,6486
125397,and,O,6486
125398,can,O,6486
125399,be,O,6486
125400,an,O,6486
125401,early,O,6487
125402,warning,O,6487
125403,sign,O,6487
125404,of,O,6487
125405,more,O,6487
125406,severe,O,6487
125407,retinal,O,6487
125408,changes,O,6487
125409,to,O,6487
125410,come,O,6487
125411,4/2/2001,B-DIAGNOSTIC_TEST,6487
125412,Criteria,I-DIAGNOSTIC_TEST,6487
125413,The,B-DIAGNOSTIC_TEST,6487
125414,4/2/2001,I-DIAGNOSTIC_TEST,6487
125415,criteria,I-DIAGNOSTIC_TEST,6487
125416,is,O,6487
125417,a,O,6487
125418,classification,O,6487
125419,system,O,6487
125420,developed,O,6487
125421,by,O,6488
125422,the,B-ORGANIZATION,6488
125423,Early,I-ORGANIZATION,6488
125424,Treatment,I-ORGANIZATION,6488
125425,Diabetic,I-ORGANIZATION,6488
125426,Retinopathy,I-ORGANIZATION,6488
125427,Study,I-ORGANIZATION,6488
125428,ETDRS,I-ORGANIZATION,6488
125429,to,O,6488
125430,categorize,O,6488
125431,the,O,6488
125432,severity,O,6488
125433,of,O,6488
125434,diabetic,B-NAME_OF_DISEASE,6488
125435,retinopathy,I-NAME_OF_DISEASE,6488
125436,The,O,6488
125437,criteria,O,6488
125438,are,O,6488
125439,based,O,6488
125440,on,O,6488
125441,the,B-DIAGNOSTIC_TEST,6488
125442,presence,I-DIAGNOSTIC_TEST,6488
125443,and,I-DIAGNOSTIC_TEST,6488
125444,extent,I-DIAGNOSTIC_TEST,6488
125445,of,I-DIAGNOSTIC_TEST,6488
125446,retinal,I-DIAGNOSTIC_TEST,6488
125447,changes,I-DIAGNOSTIC_TEST,6488
125448,such,I-DIAGNOSTIC_TEST,6489
125449,as,I-DIAGNOSTIC_TEST,6489
125450,microaneurysms,I-DIAGNOSTIC_TEST,6489
125451,hemorrhages,I-DIAGNOSTIC_TEST,6489
125452,and,I-DIAGNOSTIC_TEST,6489
125453,exudates,I-DIAGNOSTIC_TEST,6489
125454,The,O,6489
125455,first,O,6489
125456,number,O,6489
125457,4,O,6489
125458,refers,O,6489
125459,to,O,6489
125460,the,O,6489
125461,number,O,6489
125462,of,O,6489
125463,quadrants,O,6489
125464,affected,O,6489
125465,by,O,6489
125466,the,O,6489
125467,retinal,O,6490
125468,changes,O,6490
125469,The,O,6490
125470,second,O,6490
125471,number,O,6490
125472,2,O,6490
125473,refers,O,6490
125474,to,O,6490
125475,the,O,6490
125476,severity,O,6490
125477,of,O,6490
125478,the,O,6490
125479,retinal,O,6490
125480,changes,O,6490
125481,within,O,6490
125482,each,O,6490
125483,quadrant,O,6490
125484,The,O,6490
125485,last,O,6490
125486,number,O,6490
125487,1,O,6490
125488,refers,O,6491
125489,to,O,6491
125490,the,O,6491
125491,presence,O,6491
125492,of,O,6491
125493,pre-proliferative,B-NAME_OF_DISEASE,6491
125494,or,I-NAME_OF_DISEASE,6491
125495,proliferative,I-NAME_OF_DISEASE,6491
125496,diabetic,I-NAME_OF_DISEASE,6491
125497,retinopathy,I-NAME_OF_DISEASE,6491
125498,The,B-DIAGNOSTIC_TEST,6491
125499,4/2/2001,I-DIAGNOSTIC_TEST,6491
125500,criteria,I-DIAGNOSTIC_TEST,6491
125501,provide,O,6491
125502,a,O,6491
125503,standardized,O,6491
125504,method,O,6491
125505,for,O,6491
125506,evaluating,O,6491
125507,the,O,6491
125508,severity,O,6491
125509,of,O,6492
125510,diabetic,B-NAME_OF_DISEASE,6492
125511,retinopathy,I-NAME_OF_DISEASE,6492
125512,which,O,6492
125513,helps,O,6492
125514,guide,O,6492
125515,the,O,6492
125516,selection,O,6492
125517,of,O,6492
125518,appropriate,O,6492
125519,treatments,O,6492
125520,and,O,6493
125521,monitor,O,6493
125522,disease,O,6493
125523,progression,O,6493
125524,What,O,6493
125525,Causes,O,6493
125526,Intraretinal,B-NAME_OF_DISEASE,6493
125527,Microvascular,I-NAME_OF_DISEASE,6493
125528,Abnormalities,I-NAME_OF_DISEASE,6493
125529,IRMAs,B-NAME_OF_DISEASE,6493
125530,are,O,6493
125531,most,O,6493
125532,commonly,O,6493
125533,caused,O,6494
125534,by,O,6494
125535,changes,B-CAUSE_OF_DISEASE,6494
125536,in,I-CAUSE_OF_DISEASE,6494
125537,blood,I-CAUSE_OF_DISEASE,6494
125538,sugar,I-CAUSE_OF_DISEASE,6494
125539,levels,I-CAUSE_OF_DISEASE,6494
125540,in,I-CAUSE_OF_DISEASE,6494
125541,people,I-CAUSE_OF_DISEASE,6494
125542,with,I-CAUSE_OF_DISEASE,6494
125543,diabetes,I-CAUSE_OF_DISEASE,6494
125544,When,O,6494
125545,blood,O,6494
125546,sugar,O,6494
125547,levels,O,6494
125548,are,O,6494
125549,elevated,O,6494
125550,for,O,6494
125551,a,O,6494
125552,prolonged,O,6494
125553,period,O,6494
125554,of,O,6494
125555,time,O,6494
125556,it,O,6494
125557,can,O,6494
125558,damage,O,6494
125559,the,O,6494
125560,tiny,O,6494
125561,blood,O,6494
125562,vessels,O,6494
125563,in,O,6494
125564,the,B-PART_OF_THE_EYES,6494
125565,retina,I-PART_OF_THE_EYES,6494
125566,and,O,6494
125567,cause,O,6494
125568,IRMAs,B-NAME_OF_DISEASE,6494
125569,to,O,6494
125570,form,O,6494
125571,High,B-CAUSE_OF_DISEASE,6494
125572,blood,I-CAUSE_OF_DISEASE,6494
125573,pressure,I-CAUSE_OF_DISEASE,6494
125574,smoking,B-CAUSE_OF_DISEASE,6494
125575,and,O,6494
125576,a,B-CAUSE_OF_DISEASE,6494
125577,family,I-CAUSE_OF_DISEASE,6494
125578,history,I-CAUSE_OF_DISEASE,6494
125579,of,I-CAUSE_OF_DISEASE,6495
125580,diabetic,I-CAUSE_OF_DISEASE,6495
125581,retinopathy,I-CAUSE_OF_DISEASE,6495
125582,can,O,6495
125583,also,O,6495
125584,increase,O,6495
125585,the,O,6495
125586,risk,O,6495
125587,of,O,6495
125588,developing,O,6495
125589,IRMAs,B-NAME_OF_DISEASE,6495
125590,What,O,6495
125591,Are,O,6495
125592,the,O,6495
125593,Symptoms,O,6495
125594,of,O,6495
125595,Intraretinal,B-NAME_OF_DISEASE,6496
125596,Microvascular,I-NAME_OF_DISEASE,6496
125597,Abnormalities,I-NAME_OF_DISEASE,6496
125598,In,O,6496
125599,many,O,6496
125600,cases,O,6496
125601,IRMAs,B-NAME_OF_DISEASE,6496
125602,do,O,6496
125603,not,O,6496
125604,cause,O,6496
125605,any,O,6496
125606,symptoms,O,6496
125607,in,O,6496
125608,the,O,6496
125609,early,O,6497
125610,stages,O,6497
125611,As,O,6497
125612,the,O,6497
125613,condition,O,6497
125614,progresses,O,6497
125615,patients,O,6497
125616,may,O,6497
125617,experience,O,6497
125618,blurred,B-SIGN_AND_SYMPTOM,6497
125619,vision,I-SIGN_AND_SYMPTOM,6497
125620,difficulty,I-SIGN_AND_SYMPTOM,6497
125621,seeing,I-SIGN_AND_SYMPTOM,6497
125622,in,I-SIGN_AND_SYMPTOM,6497
125623,low,I-SIGN_AND_SYMPTOM,6497
125624,light,I-SIGN_AND_SYMPTOM,6497
125625,and,I-SIGN_AND_SYMPTOM,6497
125626,floaters,I-SIGN_AND_SYMPTOM,6497
125627,in,I-SIGN_AND_SYMPTOM,6497
125628,their,I-SIGN_AND_SYMPTOM,6497
125629,field,I-SIGN_AND_SYMPTOM,6497
125630,of,I-SIGN_AND_SYMPTOM,6497
125631,vision,I-SIGN_AND_SYMPTOM,6498
125632,In,O,6498
125633,severe,O,6498
125634,cases,O,6498
125635,IRMAs,B-NAME_OF_DISEASE,6498
125636,can,O,6498
125637,lead,O,6498
125638,to,O,6498
125639,vision,B-SIGN_AND_SYMPTOM,6498
125640,loss,I-SIGN_AND_SYMPTOM,6498
125641,and,O,6498
125642,blindness,B-NAME_OF_DISEASE,6498
125643,Regular,O,6498
125644,comprehensive,O,6498
125645,eye,O,6498
125646,exams,O,6498
125647,are,O,6498
125648,critical,O,6498
125649,for,O,6498
125650,early,O,6498
125651,detection,O,6498
125652,and,O,6498
125653,treatment,O,6498
125654,of,O,6498
125655,IRMAs,B-NAME_OF_DISEASE,6498
125656,How,O,6498
125657,to,O,6498
125658,Manage,O,6498
125659,Intraretinal,B-NAME_OF_DISEASE,6499
125660,Microvascular,I-NAME_OF_DISEASE,6499
125661,Abnormalities,I-NAME_OF_DISEASE,6499
125662,Managing,O,6499
125663,intraretinal,B-NAME_OF_DISEASE,6499
125664,microvascular,I-NAME_OF_DISEASE,6499
125665,abnormalities,I-NAME_OF_DISEASE,6499
125666,IRMAs,B-NAME_OF_DISEASE,6499
125667,requires,O,6499
125668,a,O,6499
125669,comprehensive,O,6499
125670,approach,O,6499
125671,that,O,6499
125672,involves,O,6499
125673,the,O,6499
125674,following,O,6499
125675,steps,O,6499
125676,Monitoring,B-PREVENTION,6499
125677,blood,I-PREVENTION,6499
125678,sugar,I-PREVENTION,6499
125679,levels,I-PREVENTION,6499
125680,The,O,6499
125681,first,O,6499
125682,step,O,6499
125683,in,O,6499
125684,managing,O,6499
125685,IRMAs,B-NAME_OF_DISEASE,6499
125686,is,O,6499
125687,to,O,6499
125688,maintain,B-PREVENTION,6499
125689,good,I-PREVENTION,6499
125690,blood,I-PREVENTION,6499
125691,sugar,I-PREVENTION,6499
125692,control,I-PREVENTION,6500
125693,as,O,6500
125694,high,B-CAUSE_OF_DISEASE,6500
125695,blood,I-CAUSE_OF_DISEASE,6500
125696,sugar,I-CAUSE_OF_DISEASE,6500
125697,levels,I-CAUSE_OF_DISEASE,6500
125698,can,O,6500
125699,worsen,O,6500
125700,retinal,O,6500
125701,damage,O,6500
125702,Regular,B-PREVENTION,6500
125703,eye,I-PREVENTION,6500
125704,exams,I-PREVENTION,6500
125705,Regular,B-PREVENTION,6500
125706,comprehensive,I-PREVENTION,6500
125707,eye,I-PREVENTION,6500
125708,exams,I-PREVENTION,6500
125709,are,O,6500
125710,essential,O,6500
125711,for,O,6500
125712,early,O,6500
125713,detection,O,6500
125714,and,O,6500
125715,management,O,6500
125716,of,O,6500
125717,IRMAs,B-NAME_OF_DISEASE,6500
125718,This,O,6501
125719,includes,O,6501
125720,monitoring,O,6501
125721,the,O,6501
125722,progression,O,6501
125723,of,O,6501
125724,IRMAs,B-NAME_OF_DISEASE,6501
125725,and,O,6501
125726,other,O,6501
125727,retinal,O,6501
125728,changes,O,6501
125729,such,O,6501
125730,as,O,6501
125731,neovascularization,O,6501
125732,Treatment,O,6501
125733,for,O,6501
125734,diabetic,B-NAME_OF_DISEASE,6501
125735,retinopathy,I-NAME_OF_DISEASE,6502
125736,Depending,O,6502
125737,on,O,6502
125738,the,O,6502
125739,severity,O,6502
125740,of,O,6502
125741,diabetic,B-NAME_OF_DISEASE,6502
125742,retinopathy,I-NAME_OF_DISEASE,6502
125743,treatment,O,6502
125744,options,O,6502
125745,may,O,6502
125746,include,O,6502
125747,laser,B-TREATMENT,6502
125748,therapy,I-TREATMENT,6503
125749,intravitreal,B-TREATMENT,6503
125750,injections,I-TREATMENT,6503
125751,or,O,6503
125752,vitrectomy,B-TREATMENT,6503
125753,surgery,I-TREATMENT,6503
125754,Lifestyle,B-TREATMENT,6503
125755,changes,I-TREATMENT,6503
125756,Making,B-TREATMENT,6503
125757,lifestyle,I-TREATMENT,6503
125758,changes,I-TREATMENT,6503
125759,such,I-TREATMENT,6503
125760,as,I-TREATMENT,6503
125761,eating,I-TREATMENT,6504
125762,a,I-TREATMENT,6504
125763,healthy,I-TREATMENT,6504
125764,diet,I-TREATMENT,6504
125765,exercising,I-TREATMENT,6504
125766,regularly,I-TREATMENT,6504
125767,and,I-TREATMENT,6504
125768,quitting,I-TREATMENT,6504
125769,smoking,I-TREATMENT,6504
125770,can,O,6504
125771,help,O,6504
125772,improve,O,6504
125773,overall,O,6504
125774,health,O,6504
125775,and,O,6505
125776,slow,O,6505
125777,the,O,6505
125778,progression,O,6505
125779,of,O,6505
125780,diabetic,B-NAME_OF_DISEASE,6505
125781,retinopathy,I-NAME_OF_DISEASE,6505
125782,Monitoring,B-TREATMENT,6505
125783,for,I-TREATMENT,6505
125784,other,I-TREATMENT,6505
125785,diabetes-related,I-TREATMENT,6505
125786,complications,I-TREATMENT,6505
125787,People,O,6505
125788,with,O,6505
125789,IRMAs,B-NAME_OF_DISEASE,6505
125790,should,O,6505
125791,also,O,6505
125792,be,O,6505
125793,monitored,O,6505
125794,for,O,6505
125795,other,O,6505
125796,diabetes-related,O,6505
125797,complications,O,6505
125798,such,O,6506
125799,as,O,6506
125800,nephropathy,B-NAME_OF_DISEASE,6506
125801,and,O,6506
125802,neuropathy,B-NAME_OF_DISEASE,6506
125803,as,O,6506
125804,they,O,6506
125805,can,O,6506
125806,have,O,6506
125807,a,O,6506
125808,significant,O,6506
125809,impact,O,6506
125810,on,O,6506
125811,overall,O,6506
125812,health,O,6506
125813,and,O,6506
125814,vision,O,6506
125815,Selenium,B-CHEMICAL_COMPOUND,6506
125816,is,O,6506
125817,an,O,6506
125818,essential,O,6506
125819,mineral,O,6506
125820,that,O,6506
125821,plays,O,6506
125822,a,O,6506
125823,vital,O,6506
125824,role,O,6506
125825,in,O,6506
125826,maintaining,O,6506
125827,overall,O,6506
125828,health,O,6506
125829,and,O,6506
125830,wellness,O,6507
125831,particularly,O,6507
125832,in,O,6507
125833,regards,O,6507
125834,to,O,6507
125835,eye,O,6507
125836,health,O,6507
125837,and,O,6507
125838,thyroid,B-NAME_OF_DISEASE,6507
125839,eye,I-NAME_OF_DISEASE,6507
125840,disease,I-NAME_OF_DISEASE,6507
125841,One,O,6507
125842,of,O,6507
125843,the,O,6507
125844,main,O,6507
125845,ways,O,6507
125846,that,O,6507
125847,selenium,B-CHEMICAL_COMPOUND,6507
125848,contributes,O,6507
125849,to,O,6507
125850,eye,O,6507
125851,health,O,6507
125852,is,O,6507
125853,by,O,6507
125854,acting,O,6507
125855,as,O,6508
125856,an,O,6508
125857,antioxidant,B-TREATMENT,6508
125858,Antioxidants,B-TREATMENT,6508
125859,are,O,6508
125860,substances,O,6508
125861,that,O,6508
125862,protect,O,6508
125863,the,O,6508
125864,body,O,6508
125865,from,O,6508
125866,damage,O,6508
125867,caused,O,6508
125868,by,O,6508
125869,free,B-CAUSE_OF_DISEASE,6508
125870,radicals,I-CAUSE_OF_DISEASE,6508
125871,Free,B-CAUSE_OF_DISEASE,6508
125872,radicals,I-CAUSE_OF_DISEASE,6508
125873,are,O,6508
125874,molecules,O,6508
125875,that,O,6508
125876,can,O,6508
125877,damage,O,6508
125878,cells,O,6509
125879,leading,O,6509
125880,to,O,6509
125881,inflammation,O,6509
125882,and,O,6509
125883,disease,O,6509
125884,Selenium,B-CHEMICAL_COMPOUND,6509
125885,helps,O,6509
125886,to,O,6509
125887,neutralize,O,6509
125888,free,B-CAUSE_OF_DISEASE,6509
125889,radicals,I-CAUSE_OF_DISEASE,6509
125890,preventing,O,6509
125891,them,O,6509
125892,from,O,6509
125893,causing,O,6509
125894,harm,O,6509
125895,to,O,6509
125896,the,O,6509
125897,eyes,O,6509
125898,Furthermore,O,6509
125899,the,O,6509
125900,human,O,6509
125901,body,O,6509
125902,requires,O,6509
125903,selenium,B-CHEMICAL_COMPOUND,6510
125904,for,O,6510
125905,the,O,6510
125906,proper,O,6510
125907,functioning,O,6510
125908,of,O,6510
125909,the,O,6510
125910,thyroid,O,6510
125911,gland,O,6510
125912,and,O,6510
125913,the,O,6510
125914,production,O,6510
125915,of,O,6510
125916,the,B-CHEMICAL_COMPOUND,6510
125917,antioxidant,I-CHEMICAL_COMPOUND,6510
125918,enzyme,I-CHEMICAL_COMPOUND,6510
125919,glutathione,B-CHEMICAL_COMPOUND,6510
125920,peroxidase,I-CHEMICAL_COMPOUND,6510
125921,The,O,6510
125922,Role,O,6510
125923,of,O,6510
125924,Selenium,B-CHEMICAL_COMPOUND,6510
125925,in,O,6510
125926,Managing,O,6510
125927,Symptoms,O,6510
125928,of,O,6511
125929,Thyroid,B-NAME_OF_DISEASE,6511
125930,Eye,I-NAME_OF_DISEASE,6511
125931,Disease,I-NAME_OF_DISEASE,6511
125932,Thyroid,B-NAME_OF_DISEASE,6511
125933,eye,I-NAME_OF_DISEASE,6511
125934,disease,I-NAME_OF_DISEASE,6511
125935,also,O,6511
125936,known,O,6511
125937,as,O,6511
125938,Graves,B-NAME_OF_DISEASE,6511
125939,orbitopathy,I-NAME_OF_DISEASE,6511
125940,is,O,6511
125941,a,O,6511
125942,condition,O,6511
125943,that,O,6511
125944,occurs,O,6511
125945,as,O,6511
125946,a,O,6511
125947,result,O,6511
125948,of,O,6511
125949,an,B-SIGN_AND_SYMPTOM,6511
125950,overactive,I-SIGN_AND_SYMPTOM,6511
125951,thyroid,I-SIGN_AND_SYMPTOM,6511
125952,gland,I-SIGN_AND_SYMPTOM,6511
125953,It,O,6511
125954,causes,O,6511
125955,inflammation,B-SIGN_AND_SYMPTOM,6511
125956,and,I-SIGN_AND_SYMPTOM,6511
125957,swelling,I-SIGN_AND_SYMPTOM,6511
125958,of,I-SIGN_AND_SYMPTOM,6511
125959,the,I-SIGN_AND_SYMPTOM,6511
125960,muscles,I-SIGN_AND_SYMPTOM,6511
125961,and,I-SIGN_AND_SYMPTOM,6511
125962,tissues,I-SIGN_AND_SYMPTOM,6511
125963,surrounding,I-SIGN_AND_SYMPTOM,6511
125964,the,I-SIGN_AND_SYMPTOM,6511
125965,eyes,I-SIGN_AND_SYMPTOM,6511
125966,leading,O,6511
125967,to,O,6511
125968,symptoms,O,6511
125969,such,O,6511
125970,as,O,6511
125971,bulging,B-SIGN_AND_SYMPTOM,6511
125972,eyes,I-SIGN_AND_SYMPTOM,6511
125973,double,I-SIGN_AND_SYMPTOM,6512
125974,vision,I-SIGN_AND_SYMPTOM,6512
125975,and,I-SIGN_AND_SYMPTOM,6512
125976,dry,I-SIGN_AND_SYMPTOM,6512
125977,eyes,I-SIGN_AND_SYMPTOM,6512
125978,Studies,O,6512
125979,have,O,6512
125980,shown,O,6512
125981,that,O,6512
125982,individuals,O,6512
125983,with,O,6512
125984,thyroid,B-NAME_OF_DISEASE,6512
125985,eye,I-NAME_OF_DISEASE,6512
125986,disease,I-NAME_OF_DISEASE,6512
125987,have,O,6512
125988,lower,O,6512
125989,levels,O,6513
125990,of,O,6513
125991,selenium,B-CHEMICAL_COMPOUND,6513
125992,in,O,6513
125993,their,O,6513
125994,blood,O,6513
125995,compared,O,6513
125996,to,O,6513
125997,those,O,6513
125998,without,O,6513
125999,the,O,6513
126000,condition,O,6513
126001,Supplementation,O,6513
126002,with,O,6513
126003,selenium,B-CHEMICAL_COMPOUND,6513
126004,has,O,6513
126005,been,O,6514
126006,found,O,6514
126007,to,O,6514
126008,reduce,O,6514
126009,the,O,6514
126010,severity,O,6514
126011,of,O,6514
126012,symptoms,O,6514
126013,and,O,6514
126014,improve,O,6514
126015,the,O,6514
126016,overall,O,6514
126017,quality,O,6514
126018,of,O,6514
126019,life,O,6514
126020,in,O,6514
126021,those,O,6514
126022,with,O,6514
126023,thyroid,B-NAME_OF_DISEASE,6514
126024,eye,I-NAME_OF_DISEASE,6514
126025,disease,I-NAME_OF_DISEASE,6514
126026,Selenium,B-CHEMICAL_COMPOUND,6514
126027,is,O,6514
126028,also,O,6514
126029,essential,O,6514
126030,for,O,6514
126031,maintaining,O,6514
126032,the,O,6514
126033,health,O,6514
126034,of,O,6514
126035,the,B-PART_OF_THE_EYES,6514
126036,retina,I-PART_OF_THE_EYES,6514
126037,the,O,6514
126038,part,O,6514
126039,of,O,6515
126040,the,O,6515
126041,eye,O,6515
126042,that,O,6515
126043,detects,O,6515
126044,light,O,6515
126045,and,O,6515
126046,sends,O,6515
126047,signals,O,6515
126048,to,O,6515
126049,the,O,6515
126050,brain,O,6515
126051,The,B-PART_OF_THE_EYES,6515
126052,retina,I-PART_OF_THE_EYES,6515
126053,contains,O,6515
126054,high,O,6515
126055,levels,O,6516
126056,of,O,6516
126057,selenium,B-CHEMICAL_COMPOUND,6516
126058,and,O,6516
126059,research,O,6516
126060,has,O,6516
126061,shown,O,6516
126062,that,O,6516
126063,low,O,6516
126064,levels,O,6516
126065,of,O,6516
126066,selenium,B-CHEMICAL_COMPOUND,6517
126067,can,O,6517
126068,lead,O,6517
126069,to,O,6517
126070,damage,O,6517
126071,in,O,6517
126072,the,B-PART_OF_THE_EYES,6517
126073,retina,I-PART_OF_THE_EYES,6517
126074,increasing,O,6517
126075,the,O,6517
126076,risk,O,6517
126077,of,O,6517
126078,eye,O,6517
126079,disorders,O,6517
126080,such,O,6517
126081,as,O,6517
126082,age-related,B-NAME_OF_DISEASE,6517
126083,macular,I-NAME_OF_DISEASE,6517
126084,degeneration,I-NAME_OF_DISEASE,6517
126085,AMD,B-NAME_OF_DISEASE,6517
126086,and,O,6517
126087,cataracts,B-NAME_OF_DISEASE,6517
126088,-,O,6517
126089,two,O,6518
126090,of,O,6518
126091,the,O,6518
126092,leading,O,6518
126093,causes,O,6518
126094,of,O,6518
126095,blindness,B-NAME_OF_DISEASE,6518
126096,In,O,6518
126097,addition,O,6518
126098,to,O,6518
126099,its,O,6518
126100,role,O,6518
126101,in,O,6518
126102,eye,O,6518
126103,health,O,6518
126104,selenium,B-CHEMICAL_COMPOUND,6518
126105,also,O,6518
126106,has,O,6518
126107,a,O,6518
126108,number,O,6519
126109,of,O,6519
126110,other,O,6519
126111,benefits,O,6519
126112,It,O,6519
126113,supports,O,6519
126114,the,O,6519
126115,immune,O,6519
126116,system,O,6519
126117,helps,O,6519
126118,to,O,6519
126119,regulate,O,6519
126120,thyroid,O,6519
126121,function,O,6520
126122,and,O,6520
126123,may,O,6520
126124,even,O,6520
126125,have,O,6520
126126,anti-cancer,O,6520
126127,properties,O,6520
126128,Where,O,6520
126129,Is,O,6520
126130,Selenium,B-CHEMICAL_COMPOUND,6520
126131,Found,O,6520
126132,In,O,6520
126133,terms,O,6520
126134,of,O,6520
126135,food,O,6520
126136,sources,O,6520
126137,selenium,B-CHEMICAL_COMPOUND,6521
126138,can,O,6521
126139,be,O,6521
126140,found,O,6521
126141,in,O,6521
126142,a,O,6521
126143,variety,O,6521
126144,of,O,6521
126145,different,O,6521
126146,types,O,6521
126147,of,O,6521
126148,food,O,6521
126149,including,O,6521
126150,meats,O,6521
126151,seafood,O,6521
126152,eggs,O,6521
126153,dairy,O,6521
126154,products,O,6522
126155,and,O,6522
126156,some,O,6522
126157,types,O,6522
126158,of,O,6522
126159,nuts,O,6522
126160,and,O,6522
126161,seeds,O,6522
126162,Some,O,6522
126163,of,O,6522
126164,the,O,6522
126165,best,O,6522
126166,food,O,6523
126167,sources,O,6523
126168,of,O,6523
126169,selenium,B-CHEMICAL_COMPOUND,6523
126170,include,O,6523
126171,Brazil,B-GPE,6523
126172,nuts,O,6523
126173,tuna,O,6523
126174,shrimp,O,6523
126175,and,O,6523
126176,sunflower,O,6523
126177,seeds,O,6524
126178,Whole,O,6524
126179,grains,O,6524
126180,such,O,6524
126181,as,O,6524
126182,brown,O,6524
126183,rice,O,6524
126184,and,O,6524
126185,barley,O,6524
126186,also,O,6524
126187,contain,O,6524
126188,selenium,B-CHEMICAL_COMPOUND,6524
126189,However,O,6524
126190,the,O,6525
126191,selenium,B-CHEMICAL_COMPOUND,6525
126192,content,O,6525
126193,of,O,6525
126194,foods,O,6525
126195,can,O,6525
126196,vary,O,6525
126197,depending,O,6525
126198,on,O,6525
126199,the,O,6525
126200,selenium,B-CHEMICAL_COMPOUND,6525
126201,content,O,6525
126202,of,O,6525
126203,the,O,6525
126204,soil,O,6526
126205,in,O,6526
126206,which,O,6526
126207,they,O,6526
126208,were,O,6526
126209,grown,O,6526
126210,or,O,6526
126211,raised,O,6526
126212,Selenium,B-CHEMICAL_COMPOUND,6526
126213,is,O,6526
126214,also,O,6526
126215,found,O,6526
126216,in,O,6526
126217,water,O,6526
126218,with,O,6526
126219,the,O,6526
126220,amount,O,6526
126221,of,O,6526
126222,selenium,B-CHEMICAL_COMPOUND,6526
126223,in,O,6526
126224,water,O,6526
126225,sources,O,6526
126226,varying,O,6527
126227,depending,O,6527
126228,on,O,6527
126229,the,O,6527
126230,location,O,6527
126231,Some,O,6527
126232,groundwater,O,6527
126233,sources,O,6527
126234,contain,O,6527
126235,high,O,6527
126236,levels,O,6527
126237,of,O,6527
126238,selenium,B-CHEMICAL_COMPOUND,6527
126239,while,O,6527
126240,others,O,6527
126241,contain,O,6527
126242,very,O,6527
126243,little,O,6527
126244,Selenium,B-CHEMICAL_COMPOUND,6527
126245,can,O,6527
126246,also,O,6527
126247,be,O,6527
126248,found,O,6527
126249,in,O,6527
126250,some,O,6528
126251,types,O,6528
126252,of,O,6528
126253,seafood,O,6528
126254,such,O,6528
126255,as,O,6528
126256,tuna,O,6528
126257,halibut,O,6528
126258,and,O,6528
126259,sardines,O,6528
126260,In,O,6528
126261,terms,O,6528
126262,of,O,6528
126263,supplement,O,6528
126264,form,O,6528
126265,selenium,B-CHEMICAL_COMPOUND,6528
126266,supplements,O,6528
126267,come,O,6528
126268,in,O,6528
126269,different,O,6529
126270,forms,O,6529
126271,such,O,6529
126272,as,O,6529
126273,tablets,O,6529
126274,capsules,O,6529
126275,and,O,6529
126276,liquids,O,6529
126277,It,O,6529
126278,is,O,6529
126279,important,O,6529
126280,to,O,6529
126281,note,O,6529
126282,that,O,6529
126283,Selenium,B-CHEMICAL_COMPOUND,6530
126284,is,O,6530
126285,toxic,O,6530
126286,in,O,6530
126287,high,O,6530
126288,doses,O,6530
126289,The,O,6530
126290,recommended,O,6530
126291,daily,O,6530
126292,dose,O,6530
126293,for,O,6530
126294,adults,O,6530
126295,is,O,6530
126296,55,O,6530
126297,micrograms,O,6530
126298,for,O,6530
126299,adults,O,6530
126300,Excessive,O,6530
126301,intake,O,6530
126302,can,O,6530
126303,lead,O,6530
126304,to,O,6530
126305,hair,B-SIGN_AND_SYMPTOM,6531
126306,loss,I-SIGN_AND_SYMPTOM,6531
126307,skin,I-SIGN_AND_SYMPTOM,6531
126308,rash,I-SIGN_AND_SYMPTOM,6531
126309,and,I-SIGN_AND_SYMPTOM,6531
126310,nervous,I-SIGN_AND_SYMPTOM,6531
126311,system,I-SIGN_AND_SYMPTOM,6531
126312,problems,I-SIGN_AND_SYMPTOM,6531
126313,It,O,6531
126314,is,O,6531
126315,always,O,6531
126316,recommended,O,6531
126317,to,O,6531
126318,consult,O,6531
126319,a,O,6531
126320,healthcare,O,6531
126321,professional,O,6531
126322,before,O,6531
126323,taking,O,6531
126324,any,O,6531
126325,new,O,6532
126326,supplement.,O,6532
126327,In,O,6532
126328,conclusion,O,6532
126329,selenium,B-CHEMICAL_COMPOUND,6532
126330,plays,O,6532
126331,a,O,6532
126332,crucial,O,6532
126333,role,O,6532
126334,in,O,6532
126335,maintaining,O,6532
126336,eye,O,6532
126337,health,O,6532
126338,and,O,6533
126339,can,O,6533
126340,be,O,6533
126341,particularly,O,6533
126342,beneficial,O,6533
126343,for,O,6533
126344,individuals,O,6533
126345,with,O,6533
126346,thyroid,B-NAME_OF_DISEASE,6533
126347,eye,I-NAME_OF_DISEASE,6533
126348,disease,I-NAME_OF_DISEASE,6533
126349,Incorporating,O,6533
126350,selenium-rich,O,6533
126351,foods,O,6533
126352,into,O,6533
126353,the,O,6533
126354,diet,O,6533
126355,or,O,6533
126356,consulting,O,6533
126357,a,O,6534
126358,healthcare,O,6534
126359,professional,O,6534
126360,about,O,6534
126361,supplement,O,6534
126362,options,O,6534
126363,can,O,6534
126364,help,O,6534
126365,to,O,6534
126366,ensure,O,6534
126367,adequate,O,6534
126368,intake,O,6534
126369,of,O,6534
126370,this,O,6534
126371,essential,O,6534
126372,mineral,O,6534
126373,Panophthalmitis,B-NAME_OF_DISEASE,6534
126374,is,O,6534
126375,a,O,6534
126376,serious,O,6534
126377,and,O,6534
126378,potentially,O,6535
126379,blinding,O,6535
126380,infection,O,6535
126381,of,O,6535
126382,the,O,6535
126383,eye,O,6535
126384,that,O,6535
126385,involves,O,6535
126386,the,B-PART_OF_THE_EYES,6535
126387,entire,I-PART_OF_THE_EYES,6535
126388,globe,I-PART_OF_THE_EYES,6535
126389,of,I-PART_OF_THE_EYES,6535
126390,the,I-PART_OF_THE_EYES,6535
126391,eye,I-PART_OF_THE_EYES,6535
126392,It,O,6535
126393,is,O,6535
126394,a,O,6535
126395,rare,O,6535
126396,but,O,6535
126397,serious,O,6536
126398,condition,O,6536
126399,that,O,6536
126400,requires,O,6536
126401,prompt,O,6536
126402,medical,O,6536
126403,attention,O,6536
126404,and,O,6536
126405,treatment,O,6536
126406,Causes,O,6536
126407,of,O,6536
126408,Panophthalmitis,B-NAME_OF_DISEASE,6536
126409,Bacterial,B-CAUSE_OF_DISEASE,6536
126410,infections,I-CAUSE_OF_DISEASE,6536
126411,The,O,6536
126412,most,O,6536
126413,common,O,6536
126414,cause,O,6536
126415,of,O,6536
126416,panophthalmitis,B-NAME_OF_DISEASE,6536
126417,is,O,6536
126418,a,B-CAUSE_OF_DISEASE,6536
126419,bacterial,I-CAUSE_OF_DISEASE,6536
126420,infection,I-CAUSE_OF_DISEASE,6536
126421,such,I-CAUSE_OF_DISEASE,6537
126422,as,I-CAUSE_OF_DISEASE,6537
126423,Staphylococcus,I-CAUSE_OF_DISEASE,6537
126424,aureus,I-CAUSE_OF_DISEASE,6537
126425,or,I-CAUSE_OF_DISEASE,6537
126426,Streptococcus,I-CAUSE_OF_DISEASE,6537
126427,pneumoniae,I-CAUSE_OF_DISEASE,6537
126428,These,O,6537
126429,bacteria,O,6537
126430,can,O,6537
126431,enter,O,6537
126432,the,O,6537
126433,eye,O,6537
126434,through,O,6537
126435,a,O,6537
126436,variety,O,6537
126437,of,O,6537
126438,means,O,6537
126439,including,O,6537
126440,a,B-CAUSE_OF_DISEASE,6537
126441,penetrating,I-CAUSE_OF_DISEASE,6537
126442,injury,I-CAUSE_OF_DISEASE,6537
126443,trauma,I-CAUSE_OF_DISEASE,6537
126444,or,I-CAUSE_OF_DISEASE,6537
126445,a,I-CAUSE_OF_DISEASE,6537
126446,surgical,I-CAUSE_OF_DISEASE,6538
126447,procedure,I-CAUSE_OF_DISEASE,6538
126448,Fungal,B-CAUSE_OF_DISEASE,6538
126449,infections,I-CAUSE_OF_DISEASE,6538
126450,Fungal,B-CAUSE_OF_DISEASE,6538
126451,infections,I-CAUSE_OF_DISEASE,6538
126452,such,I-CAUSE_OF_DISEASE,6538
126453,as,I-CAUSE_OF_DISEASE,6538
126454,Aspergillosis,I-CAUSE_OF_DISEASE,6538
126455,and,I-CAUSE_OF_DISEASE,6538
126456,Candida,I-CAUSE_OF_DISEASE,6538
126457,can,O,6538
126458,also,O,6538
126459,cause,O,6538
126460,panophthalmitis,B-NAME_OF_DISEASE,6538
126461,These,O,6538
126462,infections,O,6538
126463,can,O,6538
126464,occur,O,6538
126465,in,O,6538
126466,individuals,O,6539
126467,with,O,6539
126468,weakened,O,6539
126469,immune,O,6539
126470,systems,O,6539
126471,or,O,6539
126472,in,O,6539
126473,those,O,6539
126474,who,O,6539
126475,have,O,6540
126476,had,O,6540
126477,previous,O,6540
126478,eye,O,6540
126479,surgeries,O,6540
126480,Trauma,B-CAUSE_OF_DISEASE,6540
126481,Trauma,B-CAUSE_OF_DISEASE,6540
126482,to,I-CAUSE_OF_DISEASE,6540
126483,the,I-CAUSE_OF_DISEASE,6540
126484,eye,I-CAUSE_OF_DISEASE,6541
126485,such,I-CAUSE_OF_DISEASE,6541
126486,as,I-CAUSE_OF_DISEASE,6541
126487,a,I-CAUSE_OF_DISEASE,6541
126488,penetrating,I-CAUSE_OF_DISEASE,6541
126489,injury,I-CAUSE_OF_DISEASE,6541
126490,or,I-CAUSE_OF_DISEASE,6541
126491,a,I-CAUSE_OF_DISEASE,6541
126492,foreign,I-CAUSE_OF_DISEASE,6541
126493,body,I-CAUSE_OF_DISEASE,6541
126494,in,I-CAUSE_OF_DISEASE,6541
126495,the,I-CAUSE_OF_DISEASE,6541
126496,eye,I-CAUSE_OF_DISEASE,6541
126497,can,O,6542
126498,also,O,6542
126499,cause,O,6542
126500,panophthalmitis,B-NAME_OF_DISEASE,6542
126501,In,O,6542
126502,these,O,6542
126503,cases,O,6542
126504,the,O,6542
126505,bacteria,O,6542
126506,can,O,6542
126507,enter,O,6542
126508,the,O,6542
126509,eye,O,6542
126510,through,O,6542
126511,the,O,6542
126512,site,O,6542
126513,of,O,6542
126514,the,O,6542
126515,injury,O,6542
126516,and,O,6542
126517,cause,O,6542
126518,an,O,6542
126519,infection,O,6542
126520,Systemic,B-CAUSE_OF_DISEASE,6542
126521,infections,I-CAUSE_OF_DISEASE,6542
126522,In,O,6542
126523,some,O,6543
126524,cases,O,6543
126525,panophthalmitis,B-NAME_OF_DISEASE,6543
126526,can,O,6543
126527,be,O,6543
126528,caused,O,6543
126529,by,O,6543
126530,a,B-CAUSE_OF_DISEASE,6543
126531,systemic,I-CAUSE_OF_DISEASE,6543
126532,infection,I-CAUSE_OF_DISEASE,6543
126533,such,I-CAUSE_OF_DISEASE,6543
126534,as,I-CAUSE_OF_DISEASE,6543
126535,sepsis,I-CAUSE_OF_DISEASE,6543
126536,that,O,6543
126537,spreads,O,6543
126538,to,O,6543
126539,the,O,6543
126540,eye,O,6544
126541,through,O,6544
126542,the,O,6544
126543,bloodstream,O,6544
126544,Signs,O,6544
126545,and,O,6544
126546,Symptoms,O,6544
126547,of,O,6544
126548,Panophthalmitis,B-NAME_OF_DISEASE,6544
126549,Redness,B-SIGN_AND_SYMPTOM,6544
126550,and,I-SIGN_AND_SYMPTOM,6544
126551,swelling,I-SIGN_AND_SYMPTOM,6544
126552,of,I-SIGN_AND_SYMPTOM,6544
126553,the,I-SIGN_AND_SYMPTOM,6544
126554,eye,I-SIGN_AND_SYMPTOM,6544
126555,The,I-SIGN_AND_SYMPTOM,6544
126556,eye,I-SIGN_AND_SYMPTOM,6544
126557,may,I-SIGN_AND_SYMPTOM,6544
126558,appear,I-SIGN_AND_SYMPTOM,6544
126559,red,I-SIGN_AND_SYMPTOM,6544
126560,and,I-SIGN_AND_SYMPTOM,6544
126561,swollen,I-SIGN_AND_SYMPTOM,6544
126562,with,I-SIGN_AND_SYMPTOM,6544
126563,the,I-SIGN_AND_SYMPTOM,6545
126564,eyelids,I-SIGN_AND_SYMPTOM,6545
126565,appearing,I-SIGN_AND_SYMPTOM,6545
126566,puffy,I-SIGN_AND_SYMPTOM,6545
126567,and,I-SIGN_AND_SYMPTOM,6545
126568,swollen,I-SIGN_AND_SYMPTOM,6545
126569,Pain,B-SIGN_AND_SYMPTOM,6545
126570,The,O,6545
126571,patient,O,6545
126572,may,O,6545
126573,experience,O,6545
126574,severe,B-SIGN_AND_SYMPTOM,6545
126575,pain,I-SIGN_AND_SYMPTOM,6545
126576,in,I-SIGN_AND_SYMPTOM,6545
126577,the,I-SIGN_AND_SYMPTOM,6545
126578,affected,I-SIGN_AND_SYMPTOM,6545
126579,eye,I-SIGN_AND_SYMPTOM,6545
126580,which,I-SIGN_AND_SYMPTOM,6546
126581,may,I-SIGN_AND_SYMPTOM,6546
126582,be,I-SIGN_AND_SYMPTOM,6546
126583,exacerbated,I-SIGN_AND_SYMPTOM,6546
126584,by,I-SIGN_AND_SYMPTOM,6546
126585,movement,I-SIGN_AND_SYMPTOM,6546
126586,of,I-SIGN_AND_SYMPTOM,6546
126587,the,I-SIGN_AND_SYMPTOM,6546
126588,eye,I-SIGN_AND_SYMPTOM,6546
126589,Decreased,B-SIGN_AND_SYMPTOM,6546
126590,vision,I-SIGN_AND_SYMPTOM,6546
126591,Vision,I-SIGN_AND_SYMPTOM,6546
126592,may,I-SIGN_AND_SYMPTOM,6546
126593,be,I-SIGN_AND_SYMPTOM,6546
126594,decreased,I-SIGN_AND_SYMPTOM,6546
126595,or,I-SIGN_AND_SYMPTOM,6546
126596,lost,I-SIGN_AND_SYMPTOM,6546
126597,completely,I-SIGN_AND_SYMPTOM,6546
126598,Light,B-SIGN_AND_SYMPTOM,6546
126599,sensitivity,I-SIGN_AND_SYMPTOM,6546
126600,The,O,6546
126601,patient,O,6546
126602,may,O,6546
126603,experience,O,6546
126604,sensitivity,B-SIGN_AND_SYMPTOM,6546
126605,to,I-SIGN_AND_SYMPTOM,6546
126606,light,I-SIGN_AND_SYMPTOM,6546
126607,Discharge,B-SIGN_AND_SYMPTOM,6546
126608,The,O,6546
126609,patient,O,6547
126610,may,O,6547
126611,experience,O,6547
126612,a,B-SIGN_AND_SYMPTOM,6547
126613,thick,I-SIGN_AND_SYMPTOM,6547
126614,purulent,I-SIGN_AND_SYMPTOM,6547
126615,discharge,I-SIGN_AND_SYMPTOM,6547
126616,from,I-SIGN_AND_SYMPTOM,6547
126617,the,I-SIGN_AND_SYMPTOM,6547
126618,affected,I-SIGN_AND_SYMPTOM,6547
126619,eye,I-SIGN_AND_SYMPTOM,6547
126620,Difference,O,6547
126621,Between,O,6547
126622,Panophthalmitis,B-NAME_OF_DISEASE,6547
126623,and,O,6547
126624,Endophthalmitis,B-NAME_OF_DISEASE,6547
126625,Panophthalmitis,B-NAME_OF_DISEASE,6547
126626,and,O,6547
126627,endophthalmitis,B-NAME_OF_DISEASE,6547
126628,are,O,6547
126629,both,O,6547
126630,serious,O,6548
126631,infections,O,6548
126632,that,O,6548
126633,affect,O,6548
126634,the,O,6548
126635,eye,O,6548
126636,but,O,6548
126637,there,O,6548
126638,are,O,6548
126639,some,O,6548
126640,key,O,6548
126641,differences,O,6548
126642,between,O,6548
126643,the,O,6548
126644,two,O,6548
126645,conditions,O,6548
126646,Panophthalmitis,B-NAME_OF_DISEASE,6548
126647,is,O,6548
126648,an,O,6548
126649,infection,O,6548
126650,that,O,6548
126651,affects,O,6548
126652,the,O,6548
126653,entire,O,6548
126654,eye,O,6548
126655,including,O,6548
126656,the,B-PART_OF_THE_EYES,6548
126657,eyelids,I-PART_OF_THE_EYES,6548
126658,sclera,B-PART_OF_THE_EYES,6549
126659,cornea,B-PART_OF_THE_EYES,6549
126660,iris,B-PART_OF_THE_EYES,6549
126661,and,O,6549
126662,retina,B-PART_OF_THE_EYES,6549
126663,Endophthalmitis,B-NAME_OF_DISEASE,6549
126664,on,O,6549
126665,the,O,6549
126666,other,O,6549
126667,hand,O,6549
126668,is,O,6549
126669,an,O,6549
126670,infection,O,6549
126671,that,O,6549
126672,affects,O,6549
126673,the,O,6549
126674,internal,O,6550
126675,structures,O,6550
126676,of,O,6550
126677,the,O,6550
126678,eye,O,6550
126679,including,O,6550
126680,the,B-PART_OF_THE_EYES,6550
126681,vitreous,I-PART_OF_THE_EYES,6550
126682,humor,I-PART_OF_THE_EYES,6550
126683,and,O,6550
126684,the,B-PART_OF_THE_EYES,6550
126685,retina,I-PART_OF_THE_EYES,6551
126686,How,O,6551
126687,to,O,6551
126688,Diagnose,O,6551
126689,Panophthalmitis,B-NAME_OF_DISEASE,6551
126690,To,O,6551
126691,diagnose,O,6551
126692,panophthalmitis,B-NAME_OF_DISEASE,6551
126693,an,O,6551
126694,eye,O,6551
126695,doctor,O,6551
126696,will,O,6551
126697,first,O,6551
126698,perform,O,6551
126699,a,B-DIAGNOSTIC_TEST,6551
126700,thorough,I-DIAGNOSTIC_TEST,6551
126701,eye,I-DIAGNOSTIC_TEST,6551
126702,examination,I-DIAGNOSTIC_TEST,6551
126703,This,O,6552
126704,may,O,6552
126705,include,O,6552
126706,measuring,B-DIAGNOSTIC_TEST,6552
126707,the,I-DIAGNOSTIC_TEST,6552
126708,patient,I-DIAGNOSTIC_TEST,6552
126709,s,I-DIAGNOSTIC_TEST,6552
126710,visual,I-DIAGNOSTIC_TEST,6552
126711,acuity,I-DIAGNOSTIC_TEST,6552
126712,examining,I-DIAGNOSTIC_TEST,6552
126713,the,I-DIAGNOSTIC_TEST,6552
126714,eye,I-DIAGNOSTIC_TEST,6552
126715,with,I-DIAGNOSTIC_TEST,6552
126716,a,I-DIAGNOSTIC_TEST,6552
126717,microscope,I-DIAGNOSTIC_TEST,6552
126718,and,I-DIAGNOSTIC_TEST,6552
126719,performing,I-DIAGNOSTIC_TEST,6553
126720,a,I-DIAGNOSTIC_TEST,6553
126721,test,I-DIAGNOSTIC_TEST,6553
126722,called,I-DIAGNOSTIC_TEST,6553
126723,a,I-DIAGNOSTIC_TEST,6553
126724,slit-lamp,I-DIAGNOSTIC_TEST,6553
126725,examination,I-DIAGNOSTIC_TEST,6553
126726,to,O,6553
126727,look,O,6553
126728,for,O,6553
126729,signs,O,6553
126730,of,O,6553
126731,inflammation,O,6553
126732,The,O,6553
126733,doctor,O,6553
126734,may,O,6553
126735,also,O,6553
126736,take,B-DIAGNOSTIC_TEST,6553
126737,a,I-DIAGNOSTIC_TEST,6553
126738,sample,I-DIAGNOSTIC_TEST,6553
126739,of,I-DIAGNOSTIC_TEST,6553
126740,fluid,I-DIAGNOSTIC_TEST,6553
126741,from,I-DIAGNOSTIC_TEST,6554
126742,the,I-DIAGNOSTIC_TEST,6554
126743,eye,I-DIAGNOSTIC_TEST,6554
126744,to,O,6554
126745,check,O,6554
126746,for,O,6554
126747,bacteria,O,6554
126748,or,O,6554
126749,other,O,6554
126750,signs,O,6554
126751,of,O,6554
126752,infection,O,6554
126753,In,O,6554
126754,some,O,6554
126755,cases,O,6554
126756,imaging,B-DIAGNOSTIC_TEST,6554
126757,tests,I-DIAGNOSTIC_TEST,6554
126758,such,I-DIAGNOSTIC_TEST,6554
126759,as,I-DIAGNOSTIC_TEST,6555
126760,ultrasound,I-DIAGNOSTIC_TEST,6555
126761,or,I-DIAGNOSTIC_TEST,6555
126762,computed,I-DIAGNOSTIC_TEST,6555
126763,tomography,I-DIAGNOSTIC_TEST,6555
126764,CT,I-DIAGNOSTIC_TEST,6555
126765,scans,I-DIAGNOSTIC_TEST,6555
126766,may,O,6555
126767,be,O,6555
126768,used,O,6555
126769,to,O,6555
126770,help,O,6555
126771,diagnose,O,6556
126772,panophthalmitis,B-NAME_OF_DISEASE,6556
126773,and,O,6556
126774,to,O,6556
126775,determine,O,6556
126776,the,O,6556
126777,extent,O,6556
126778,of,O,6556
126779,the,O,6556
126780,infection,O,6556
126781,Managing,O,6556
126782,Panophthalmitis,B-NAME_OF_DISEASE,6556
126783,The,O,6556
126784,primary,O,6557
126785,treatment,O,6557
126786,for,O,6557
126787,panophthalmitis,B-NAME_OF_DISEASE,6557
126788,is,O,6557
126789,antibiotics,B-TREATMENT,6557
126790,to,O,6557
126791,fight,O,6557
126792,the,O,6557
126793,infection,O,6557
126794,and,O,6557
126795,reduce,O,6557
126796,inflammation,O,6557
126797,Steroids,B-NAME_OF_DRUG,6557
126798,may,O,6557
126799,also,O,6557
126800,be,O,6557
126801,used,O,6557
126802,to,O,6557
126803,reduce,O,6558
126804,inflammation,O,6558
126805,and,O,6558
126806,prevent,O,6558
126807,complications,O,6558
126808,In,O,6558
126809,severe,O,6558
126810,cases,O,6558
126811,surgery,B-TREATMENT,6558
126812,may,O,6558
126813,be,O,6558
126814,necessary,O,6558
126815,to,O,6558
126816,remove,O,6558
126817,infected,O,6558
126818,tissue,O,6559
126819,and,O,6559
126820,prevent,O,6559
126821,the,O,6559
126822,spread,O,6559
126823,of,O,6559
126824,the,O,6559
126825,infection,O,6559
126826,It,O,6559
126827,s,O,6559
126828,important,O,6559
126829,to,O,6559
126830,follow,O,6559
126831,your,O,6559
126832,doctor,O,6559
126833,s,O,6559
126834,instructions,O,6559
126835,carefully,O,6559
126836,and,O,6559
126837,take,O,6559
126838,all,O,6560
126839,medications,O,6560
126840,as,O,6560
126841,prescribed,O,6560
126842,It,O,6560
126843,s,O,6560
126844,also,O,6560
126845,important,O,6560
126846,to,O,6560
126847,attend,O,6560
126848,all,O,6560
126849,follow-up,O,6560
126850,appointments,O,6560
126851,to,O,6560
126852,monitor,O,6560
126853,your,O,6560
126854,progress,O,6560
126855,and,O,6560
126856,ensure,O,6560
126857,that,O,6560
126858,the,O,6560
126859,infection,O,6560
126860,is,O,6560
126861,responding,O,6561
126862,to,O,6561
126863,treatment,O,6561
126864,Managing,O,6561
126865,Your,O,6561
126866,Panophthalmitis,B-NAME_OF_DISEASE,6561
126867,At,O,6561
126868,Home,O,6561
126869,Apply,B-TREATMENT,6561
126870,a,I-TREATMENT,6561
126871,warm,I-TREATMENT,6561
126872,compress,I-TREATMENT,6561
126873,to,I-TREATMENT,6561
126874,the,I-TREATMENT,6561
126875,affected,I-TREATMENT,6561
126876,eye,I-TREATMENT,6561
126877,to,O,6561
126878,reduce,O,6561
126879,pain,O,6561
126880,and,O,6562
126881,inflammation,O,6562
126882,Keep,B-TREATMENT,6562
126883,your,I-TREATMENT,6562
126884,head,I-TREATMENT,6562
126885,elevated,I-TREATMENT,6562
126886,to,O,6562
126887,reduce,O,6562
126888,swelling,O,6562
126889,and,O,6562
126890,pressure,O,6562
126891,in,O,6562
126892,the,O,6562
126893,eye,O,6562
126894,Avoid,B-TREATMENT,6562
126895,touching,I-TREATMENT,6562
126896,or,I-TREATMENT,6562
126897,rubbing,I-TREATMENT,6562
126898,your,I-TREATMENT,6562
126899,eye,I-TREATMENT,6563
126900,as,O,6563
126901,this,O,6563
126902,can,O,6563
126903,further,O,6563
126904,irritate,O,6563
126905,the,O,6563
126906,infection,O,6563
126907,Wear,B-TREATMENT,6563
126908,protective,I-TREATMENT,6563
126909,eye,I-TREATMENT,6563
126910,gear,I-TREATMENT,6563
126911,such,I-TREATMENT,6563
126912,as,I-TREATMENT,6563
126913,goggles,I-TREATMENT,6563
126914,or,I-TREATMENT,6563
126915,safety,I-TREATMENT,6563
126916,glasses,I-TREATMENT,6563
126917,to,O,6563
126918,reduce,O,6563
126919,your,O,6563
126920,risk,O,6563
126921,of,O,6563
126922,further,O,6563
126923,injury,O,6563
126924,or,O,6564
126925,infection,O,6564
126926,Avoid,B-TREATMENT,6564
126927,activities,I-TREATMENT,6564
126928,that,I-TREATMENT,6564
126929,may,I-TREATMENT,6564
126930,further,I-TREATMENT,6564
126931,irritate,I-TREATMENT,6564
126932,the,I-TREATMENT,6564
126933,eye,I-TREATMENT,6564
126934,such,I-TREATMENT,6564
126935,as,I-TREATMENT,6564
126936,swimming,I-TREATMENT,6564
126937,or,I-TREATMENT,6564
126938,using,I-TREATMENT,6564
126939,contact,I-TREATMENT,6564
126940,lenses,I-TREATMENT,6564
126941,Conclusion,O,6564
126942,It,O,6564
126943,is,O,6564
126944,important,O,6564
126945,to,O,6564
126946,note,O,6564
126947,that,O,6564
126948,panophthalmitis,B-NAME_OF_DISEASE,6564
126949,is,O,6564
126950,a,O,6565
126951,serious,O,6565
126952,condition,O,6565
126953,that,O,6565
126954,can,O,6565
126955,lead,O,6565
126956,to,O,6565
126957,severe,O,6565
126958,complications,O,6565
126959,including,O,6565
126960,blindness,B-SIGN_AND_SYMPTOM,6565
126961,If,O,6565
126962,you,O,6565
126963,suspect,O,6565
126964,that,O,6565
126965,you,O,6565
126966,or,O,6565
126967,a,O,6565
126968,loved,O,6565
126969,one,O,6565
126970,may,O,6565
126971,have,O,6565
126972,panophthalmitis,B-NAME_OF_DISEASE,6565
126973,it,O,6565
126974,is,O,6565
126975,essential,O,6566
126976,to,O,6566
126977,seek,O,6566
126978,medical,O,6566
126979,attention,O,6566
126980,as,O,6566
126981,soon,O,6566
126982,as,O,6566
126983,possible,O,6566
126984,Early,O,6566
126985,diagnosis,O,6566
126986,and,O,6566
126987,treatment,O,6566
126988,can,O,6566
126989,prevent,O,6566
126990,severe,O,6566
126991,complications,O,6566
126992,and,O,6566
126993,improve,O,6566
126994,the,O,6566
126995,chances,O,6566
126996,of,O,6566
126997,preserving,O,6566
126998,vision,O,6566
126999,in,O,6566
127000,the,O,6566
127001,affected,O,6566
127002,eye,O,6567
127003,Thygeson,B-NAME_OF_DISEASE,6567
127004,s,I-NAME_OF_DISEASE,6567
127005,Keratitis,I-NAME_OF_DISEASE,6567
127006,also,O,6567
127007,known,O,6567
127008,as,O,6567
127009,Thygeson,B-NAME_OF_DISEASE,6567
127010,s,I-NAME_OF_DISEASE,6567
127011,Superficial,I-NAME_OF_DISEASE,6567
127012,Punctate,I-NAME_OF_DISEASE,6567
127013,Keratitis,I-NAME_OF_DISEASE,6567
127014,is,O,6567
127015,a,O,6567
127016,rare,O,6567
127017,inflammatory,O,6568
127018,disorder,O,6568
127019,of,O,6568
127020,the,B-PART_OF_THE_EYES,6568
127021,cornea,I-PART_OF_THE_EYES,6568
127022,It,O,6568
127023,is,O,6568
127024,characterized,O,6568
127025,by,O,6568
127026,the,B-SIGN_AND_SYMPTOM,6568
127027,presence,I-SIGN_AND_SYMPTOM,6568
127028,of,I-SIGN_AND_SYMPTOM,6568
127029,small,I-SIGN_AND_SYMPTOM,6568
127030,superficial,I-SIGN_AND_SYMPTOM,6568
127031,lesions,I-SIGN_AND_SYMPTOM,6568
127032,on,I-SIGN_AND_SYMPTOM,6568
127033,the,I-SIGN_AND_SYMPTOM,6569
127034,surface,I-SIGN_AND_SYMPTOM,6569
127035,of,I-SIGN_AND_SYMPTOM,6569
127036,the,I-SIGN_AND_SYMPTOM,6569
127037,cornea,I-SIGN_AND_SYMPTOM,6569
127038,which,O,6569
127039,can,O,6569
127040,lead,O,6569
127041,to,O,6569
127042,vision,B-SIGN_AND_SYMPTOM,6569
127043,loss,I-SIGN_AND_SYMPTOM,6569
127044,if,O,6569
127045,left,O,6569
127046,untreated,O,6569
127047,Causes,O,6569
127048,of,O,6569
127049,Thygeson,B-NAME_OF_DISEASE,6569
127050,s,I-NAME_OF_DISEASE,6569
127051,Keratitis,I-NAME_OF_DISEASE,6569
127052,The,O,6569
127053,exact,O,6569
127054,causes,O,6569
127055,of,O,6569
127056,Thygeson,B-NAME_OF_DISEASE,6569
127057,s,I-NAME_OF_DISEASE,6569
127058,Keratitis,I-NAME_OF_DISEASE,6569
127059,are,O,6569
127060,not,O,6569
127061,fully,O,6570
127062,understood,O,6570
127063,but,O,6570
127064,several,O,6570
127065,factors,O,6570
127066,are,O,6570
127067,thought,O,6570
127068,to,O,6570
127069,contribute,O,6570
127070,to,O,6570
127071,its,O,6570
127072,development,O,6570
127073,Immune,B-CAUSE_OF_DISEASE,6570
127074,system,I-CAUSE_OF_DISEASE,6570
127075,dysfunction,I-CAUSE_OF_DISEASE,6570
127076,Thygeson,B-NAME_OF_DISEASE,6570
127077,s,I-NAME_OF_DISEASE,6570
127078,Keratitis,I-NAME_OF_DISEASE,6570
127079,is,O,6570
127080,thought,O,6570
127081,to,O,6570
127082,be,O,6570
127083,an,O,6570
127084,autoimmune,O,6570
127085,disorder,O,6570
127086,in,O,6570
127087,which,O,6570
127088,the,B-CAUSE_OF_DISEASE,6570
127089,immune,I-CAUSE_OF_DISEASE,6570
127090,system,I-CAUSE_OF_DISEASE,6570
127091,mistakenly,I-CAUSE_OF_DISEASE,6570
127092,attacks,I-CAUSE_OF_DISEASE,6570
127093,healthy,I-CAUSE_OF_DISEASE,6570
127094,cells,I-CAUSE_OF_DISEASE,6570
127095,in,I-CAUSE_OF_DISEASE,6570
127096,the,I-CAUSE_OF_DISEASE,6570
127097,cornea,I-CAUSE_OF_DISEASE,6571
127098,Viral,B-CAUSE_OF_DISEASE,6571
127099,infections,I-CAUSE_OF_DISEASE,6571
127100,Some,O,6571
127101,studies,O,6571
127102,have,O,6571
127103,suggested,O,6571
127104,that,O,6571
127105,viral,B-CAUSE_OF_DISEASE,6571
127106,infections,I-CAUSE_OF_DISEASE,6571
127107,such,I-CAUSE_OF_DISEASE,6571
127108,as,I-CAUSE_OF_DISEASE,6571
127109,adenovirus,I-CAUSE_OF_DISEASE,6571
127110,or,I-CAUSE_OF_DISEASE,6571
127111,herpes,I-CAUSE_OF_DISEASE,6571
127112,simplex,I-CAUSE_OF_DISEASE,6571
127113,virus,I-CAUSE_OF_DISEASE,6572
127114,may,O,6572
127115,play,O,6572
127116,a,O,6572
127117,role,O,6572
127118,in,O,6572
127119,the,O,6572
127120,development,O,6572
127121,of,O,6572
127122,Thygeson,B-NAME_OF_DISEASE,6572
127123,s,I-NAME_OF_DISEASE,6572
127124,Keratitis,I-NAME_OF_DISEASE,6572
127125,Genetic,B-CAUSE_OF_DISEASE,6572
127126,predisposition,I-CAUSE_OF_DISEASE,6572
127127,There,O,6573
127128,may,O,6573
127129,be,O,6573
127130,a,B-CAUSE_OF_DISEASE,6573
127131,genetic,I-CAUSE_OF_DISEASE,6573
127132,component,I-CAUSE_OF_DISEASE,6573
127133,to,O,6573
127134,the,O,6573
127135,development,O,6573
127136,of,O,6573
127137,Thygeson,B-NAME_OF_DISEASE,6573
127138,s,I-NAME_OF_DISEASE,6573
127139,Keratitis,I-NAME_OF_DISEASE,6573
127140,Some,O,6573
127141,studies,O,6573
127142,have,O,6573
127143,suggested,O,6573
127144,that,O,6574
127145,certain,B-CAUSE_OF_DISEASE,6574
127146,genetic,I-CAUSE_OF_DISEASE,6574
127147,mutations,I-CAUSE_OF_DISEASE,6574
127148,may,O,6574
127149,increase,O,6574
127150,the,O,6574
127151,risk,O,6574
127152,of,O,6574
127153,developing,O,6574
127154,the,O,6574
127155,disorder,O,6574
127156,It,O,6574
127157,s,O,6574
127158,important,O,6574
127159,to,O,6574
127160,note,O,6574
127161,that,O,6574
127162,Thygeson,B-NAME_OF_DISEASE,6574
127163,s,I-NAME_OF_DISEASE,6574
127164,Keratitis,I-NAME_OF_DISEASE,6575
127165,can,O,6575
127166,have,O,6575
127167,multiple,O,6575
127168,causes,O,6575
127169,and,O,6575
127170,thus,O,6575
127171,it,O,6575
127172,can,O,6575
127173,be,O,6575
127174,challenging,O,6575
127175,to,O,6575
127176,identify,O,6575
127177,the,O,6575
127178,exact,O,6575
127179,cause,O,6575
127180,in,O,6575
127181,an,O,6576
127182,individual,O,6576
127183,case,O,6576
127184,What,O,6576
127185,Are,O,6576
127186,The,O,6576
127187,Symptoms,O,6576
127188,of,O,6576
127189,Thygeson,B-NAME_OF_DISEASE,6576
127190,s,I-NAME_OF_DISEASE,6576
127191,Keratitis,I-NAME_OF_DISEASE,6576
127192,It,O,6576
127193,s,O,6576
127194,important,O,6576
127195,to,O,6577
127196,note,O,6577
127197,that,O,6577
127198,the,O,6577
127199,symptoms,O,6577
127200,of,O,6577
127201,Thygeson,B-NAME_OF_DISEASE,6577
127202,s,I-NAME_OF_DISEASE,6577
127203,Keratitis,I-NAME_OF_DISEASE,6577
127204,can,O,6577
127205,vary,O,6577
127206,from,O,6578
127207,person,O,6578
127208,to,O,6578
127209,person,O,6578
127210,and,O,6578
127211,not,O,6578
127212,all,O,6578
127213,individuals,O,6578
127214,will,O,6578
127215,experience,O,6578
127216,all,O,6578
127217,of,O,6578
127218,the,O,6578
127219,symptoms,O,6578
127220,In,O,6578
127221,some,O,6579
127222,cases,O,6579
127223,symptoms,O,6579
127224,may,O,6579
127225,come,O,6579
127226,and,O,6579
127227,go,O,6579
127228,or,O,6579
127229,may,O,6579
127230,be,O,6579
127231,mild,O,6579
127232,and,O,6579
127233,not,O,6579
127234,require,O,6579
127235,treatment,O,6579
127236,Eye,B-SIGN_AND_SYMPTOM,6580
127237,pain,B-SIGN_AND_SYMPTOM,6580
127238,Thygeson,B-NAME_OF_DISEASE,6580
127239,s,I-NAME_OF_DISEASE,6580
127240,Keratitis,I-NAME_OF_DISEASE,6580
127241,can,O,6580
127242,cause,O,6580
127243,pain,B-SIGN_AND_SYMPTOM,6580
127244,or,I-SIGN_AND_SYMPTOM,6580
127245,discomfort,I-SIGN_AND_SYMPTOM,6580
127246,in,I-SIGN_AND_SYMPTOM,6580
127247,the,I-SIGN_AND_SYMPTOM,6580
127248,affected,I-SIGN_AND_SYMPTOM,6580
127249,eye,I-SIGN_AND_SYMPTOM,6580
127250,This,O,6580
127251,pain,B-SIGN_AND_SYMPTOM,6581
127252,may,O,6581
127253,be,O,6581
127254,mild,O,6581
127255,or,O,6581
127256,severe,O,6581
127257,and,O,6581
127258,may,O,6581
127259,be,O,6581
127260,accompanied,O,6581
127261,by,O,6581
127262,a,B-SIGN_AND_SYMPTOM,6581
127263,burning,I-SIGN_AND_SYMPTOM,6581
127264,or,I-SIGN_AND_SYMPTOM,6581
127265,stinging,I-SIGN_AND_SYMPTOM,6581
127266,sensation,I-SIGN_AND_SYMPTOM,6581
127267,Redness,B-SIGN_AND_SYMPTOM,6581
127268,of,I-SIGN_AND_SYMPTOM,6581
127269,the,I-SIGN_AND_SYMPTOM,6581
127270,eye,I-SIGN_AND_SYMPTOM,6581
127271,The,I-SIGN_AND_SYMPTOM,6581
127272,eye,I-SIGN_AND_SYMPTOM,6581
127273,may,I-SIGN_AND_SYMPTOM,6581
127274,appear,I-SIGN_AND_SYMPTOM,6581
127275,red,I-SIGN_AND_SYMPTOM,6581
127276,or,I-SIGN_AND_SYMPTOM,6581
127277,inflamed,I-SIGN_AND_SYMPTOM,6582
127278,due,O,6582
127279,to,O,6582
127280,the,O,6582
127281,presence,O,6582
127282,of,O,6582
127283,inflammation,O,6582
127284,in,O,6582
127285,the,B-PART_OF_THE_EYES,6582
127286,cornea,I-PART_OF_THE_EYES,6582
127287,Light,B-SIGN_AND_SYMPTOM,6582
127288,sensitivity,I-SIGN_AND_SYMPTOM,6582
127289,Some,O,6582
127290,people,O,6582
127291,with,O,6582
127292,Thygeson,B-NAME_OF_DISEASE,6582
127293,s,I-NAME_OF_DISEASE,6582
127294,Keratitis,I-NAME_OF_DISEASE,6582
127295,may,O,6582
127296,experience,O,6583
127297,increased,B-SIGN_AND_SYMPTOM,6583
127298,sensitivity,I-SIGN_AND_SYMPTOM,6583
127299,to,I-SIGN_AND_SYMPTOM,6583
127300,light,I-SIGN_AND_SYMPTOM,6583
127301,known,I-SIGN_AND_SYMPTOM,6583
127302,as,I-SIGN_AND_SYMPTOM,6583
127303,photophobia,I-SIGN_AND_SYMPTOM,6583
127304,Blurred,B-SIGN_AND_SYMPTOM,6583
127305,vision,I-SIGN_AND_SYMPTOM,6583
127306,The,O,6583
127307,lesions,O,6583
127308,on,O,6583
127309,the,B-PART_OF_THE_EYES,6583
127310,cornea,I-PART_OF_THE_EYES,6583
127311,can,O,6583
127312,cause,O,6583
127313,blurriness,B-SIGN_AND_SYMPTOM,6583
127314,or,I-SIGN_AND_SYMPTOM,6583
127315,distortion,I-SIGN_AND_SYMPTOM,6583
127316,of,I-SIGN_AND_SYMPTOM,6583
127317,vision,I-SIGN_AND_SYMPTOM,6583
127318,Tearing,B-SIGN_AND_SYMPTOM,6583
127319,Some,O,6583
127320,people,O,6583
127321,may,O,6583
127322,experience,O,6583
127323,excessive,B-SIGN_AND_SYMPTOM,6583
127324,tearing,I-SIGN_AND_SYMPTOM,6583
127325,in,I-SIGN_AND_SYMPTOM,6584
127326,the,I-SIGN_AND_SYMPTOM,6584
127327,affected,I-SIGN_AND_SYMPTOM,6584
127328,eye,I-SIGN_AND_SYMPTOM,6584
127329,Foreign,B-SIGN_AND_SYMPTOM,6584
127330,body,I-SIGN_AND_SYMPTOM,6584
127331,sensation,I-SIGN_AND_SYMPTOM,6584
127332,The,O,6584
127333,patient,O,6584
127334,may,O,6584
127335,feel,O,6584
127336,a,B-SIGN_AND_SYMPTOM,6584
127337,scratchy,I-SIGN_AND_SYMPTOM,6584
127338,or,I-SIGN_AND_SYMPTOM,6584
127339,gritty,I-SIGN_AND_SYMPTOM,6584
127340,sensation,I-SIGN_AND_SYMPTOM,6584
127341,in,I-SIGN_AND_SYMPTOM,6584
127342,the,I-SIGN_AND_SYMPTOM,6584
127343,eye,I-SIGN_AND_SYMPTOM,6584
127344,Reduced,B-SIGN_AND_SYMPTOM,6584
127345,vision,I-SIGN_AND_SYMPTOM,6584
127346,In,O,6584
127347,severe,O,6584
127348,cases,O,6585
127349,Thygeson,B-NAME_OF_DISEASE,6585
127350,s,I-NAME_OF_DISEASE,6585
127351,Keratitis,I-NAME_OF_DISEASE,6585
127352,may,O,6585
127353,cause,O,6585
127354,a,B-SIGN_AND_SYMPTOM,6585
127355,significant,I-SIGN_AND_SYMPTOM,6585
127356,reduction,I-SIGN_AND_SYMPTOM,6585
127357,in,I-SIGN_AND_SYMPTOM,6585
127358,vision,I-SIGN_AND_SYMPTOM,6585
127359,Above,O,6585
127360,picture,O,6585
127361,shows,O,6585
127362,the,O,6585
127363,presence,O,6585
127364,of,O,6585
127365,small,O,6585
127366,superficial,O,6585
127367,lesions,O,6585
127368,on,O,6585
127369,the,O,6586
127370,surface,O,6586
127371,of,O,6586
127372,the,B-PART_OF_THE_EYES,6586
127373,cornea,I-PART_OF_THE_EYES,6586
127374,Is,O,6586
127375,Thygeson,B-NAME_OF_DISEASE,6586
127376,s,I-NAME_OF_DISEASE,6586
127377,Keratitis,I-NAME_OF_DISEASE,6586
127378,Contagious,I-NAME_OF_DISEASE,6586
127379,Thygeson,B-NAME_OF_DISEASE,6587
127380,s,I-NAME_OF_DISEASE,6587
127381,Keratitis,I-NAME_OF_DISEASE,6587
127382,is,O,6587
127383,not,O,6587
127384,contagious,O,6587
127385,because,O,6587
127386,it,O,6587
127387,is,O,6587
127388,not,O,6587
127389,caused,O,6587
127390,by,O,6587
127391,an,O,6587
127392,infectious,O,6587
127393,agent,O,6587
127394,such,O,6587
127395,as,O,6587
127396,a,O,6587
127397,virus,O,6587
127398,or,O,6588
127399,bacteria,O,6588
127400,There,O,6588
127401,is,O,6588
127402,no,O,6588
127403,evidence,O,6588
127404,that,O,6588
127405,the,O,6588
127406,condition,O,6588
127407,can,O,6588
127408,be,O,6588
127409,spread,O,6588
127410,from,O,6588
127411,person,O,6588
127412,to,O,6588
127413,person,O,6589
127414,through,O,6589
127415,contact,O,6589
127416,or,O,6589
127417,other,O,6589
127418,means,O,6589
127419,Treatment,O,6589
127420,for,O,6589
127421,Thygeson,B-NAME_OF_DISEASE,6589
127422,s,I-NAME_OF_DISEASE,6589
127423,Keratitis,I-NAME_OF_DISEASE,6589
127424,Treatment,O,6589
127425,for,O,6589
127426,Thygeson,B-NAME_OF_DISEASE,6589
127427,s,I-NAME_OF_DISEASE,6589
127428,Keratitis,I-NAME_OF_DISEASE,6589
127429,typically,O,6589
127430,involves,O,6589
127431,the,B-TREATMENT,6589
127432,use,I-TREATMENT,6589
127433,of,I-TREATMENT,6589
127434,topical,I-TREATMENT,6589
127435,eye,I-TREATMENT,6590
127436,drops,I-TREATMENT,6590
127437,or,I-TREATMENT,6590
127438,ointments,I-TREATMENT,6590
127439,to,O,6590
127440,reduce,O,6590
127441,inflammation,O,6590
127442,and,O,6590
127443,promote,O,6590
127444,healing,O,6590
127445,of,O,6590
127446,the,B-PART_OF_THE_EYES,6590
127447,cornea,I-PART_OF_THE_EYES,6590
127448,In,O,6590
127449,some,O,6590
127450,cases,O,6591
127451,oral,B-TREATMENT,6591
127452,or,I-TREATMENT,6591
127453,injectable,I-TREATMENT,6591
127454,medications,I-TREATMENT,6591
127455,may,O,6591
127456,also,O,6591
127457,be,O,6591
127458,used,O,6591
127459,to,O,6591
127460,suppress,O,6591
127461,the,O,6591
127462,immune,O,6591
127463,system,O,6591
127464,and,O,6592
127465,prevent,O,6592
127466,further,O,6592
127467,damage,O,6592
127468,to,O,6592
127469,the,B-PART_OF_THE_EYES,6592
127470,cornea,I-PART_OF_THE_EYES,6592
127471,Topical,B-NAME_OF_DRUG,6592
127472,corticosteroids,I-NAME_OF_DRUG,6592
127473,such,O,6592
127474,as,O,6592
127475,prednisolone,B-NAME_OF_DRUG,6592
127476,acetate,I-NAME_OF_DRUG,6592
127477,or,O,6592
127478,loteprednol,B-NAME_OF_DRUG,6592
127479,etabonate,I-NAME_OF_DRUG,6592
127480,are,O,6592
127481,often,O,6592
127482,used,O,6593
127483,to,O,6593
127484,reduce,O,6593
127485,inflammation,O,6593
127486,and,O,6593
127487,promote,O,6593
127488,healing,O,6593
127489,of,O,6593
127490,the,B-PART_OF_THE_EYES,6593
127491,cornea,I-PART_OF_THE_EYES,6593
127492,These,O,6593
127493,medications,O,6593
127494,are,O,6593
127495,typically,O,6593
127496,administered,O,6593
127497,as,O,6593
127498,eye,O,6593
127499,drops,O,6593
127500,or,O,6593
127501,ointments,O,6594
127502,A,B-TREATMENT,6594
127503,bandage,I-TREATMENT,6594
127504,contact,I-TREATMENT,6594
127505,lens,I-TREATMENT,6594
127506,can,O,6594
127507,also,O,6594
127508,be,O,6594
127509,applied,O,6594
127510,to,O,6594
127511,the,O,6594
127512,eye,O,6594
127513,to,O,6594
127514,promote,O,6594
127515,healing,O,6595
127516,and,O,6595
127517,reduce,O,6595
127518,pain,B-SIGN_AND_SYMPTOM,6595
127519,and,I-SIGN_AND_SYMPTOM,6595
127520,discomfort,I-SIGN_AND_SYMPTOM,6595
127521,Conclusion,O,6595
127522,Thygeson,B-NAME_OF_DISEASE,6595
127523,s,I-NAME_OF_DISEASE,6595
127524,Keratitis,I-NAME_OF_DISEASE,6595
127525,is,O,6595
127526,a,O,6595
127527,rare,O,6595
127528,and,O,6596
127529,chronic,O,6596
127530,inflammatory,O,6596
127531,disorder,O,6596
127532,that,O,6596
127533,affects,O,6596
127534,the,B-PART_OF_THE_EYES,6596
127535,cornea,I-PART_OF_THE_EYES,6596
127536,It,O,6596
127537,is,O,6596
127538,caused,O,6596
127539,by,O,6596
127540,an,B-CAUSE_OF_DISEASE,6596
127541,autoimmune,I-CAUSE_OF_DISEASE,6596
127542,disorder,I-CAUSE_OF_DISEASE,6596
127543,or,I-CAUSE_OF_DISEASE,6596
127544,viral,I-CAUSE_OF_DISEASE,6596
127545,infections,I-CAUSE_OF_DISEASE,6596
127546,and,O,6596
127547,symptoms,O,6597
127548,include,O,6597
127549,redness,B-SIGN_AND_SYMPTOM,6597
127550,eye,I-SIGN_AND_SYMPTOM,6597
127551,pain,I-SIGN_AND_SYMPTOM,6597
127552,light,I-SIGN_AND_SYMPTOM,6597
127553,sensitivity,I-SIGN_AND_SYMPTOM,6597
127554,tearing,I-SIGN_AND_SYMPTOM,6597
127555,and,I-SIGN_AND_SYMPTOM,6597
127556,blurred,I-SIGN_AND_SYMPTOM,6597
127557,vision,I-SIGN_AND_SYMPTOM,6597
127558,Treatment,O,6597
127559,includes,O,6597
127560,topical,B-NAME_OF_DRUG,6597
127561,steroids,I-NAME_OF_DRUG,6597
127562,and,O,6597
127563,immunomodulators,B-NAME_OF_DRUG,6598
127564,and,O,6598
127565,in,O,6598
127566,severe,O,6598
127567,cases,O,6598
127568,oral,B-TREATMENT,6598
127569,medication,I-TREATMENT,6598
127570,and,I-TREATMENT,6598
127571,corneal,I-TREATMENT,6598
127572,transplants,I-TREATMENT,6598
127573,Early,O,6598
127574,diagnosis,O,6598
127575,and,O,6598
127576,treatment,O,6598
127577,are,O,6598
127578,crucial,O,6598
127579,to,O,6598
127580,prevent,O,6598
127581,vision,B-SIGN_AND_SYMPTOM,6598
127582,loss,I-SIGN_AND_SYMPTOM,6598
127583,and,O,6599
127584,manage,O,6599
127585,the,O,6599
127586,symptoms,O,6599
127587,Sudden,B-NAME_OF_DISEASE,6599
127588,vision,B-SIGN_AND_SYMPTOM,6599
127589,loss,I-SIGN_AND_SYMPTOM,6599
127590,is,O,6599
127591,a,O,6599
127592,serious,O,6599
127593,medical,O,6600
127594,condition,O,6600
127595,that,O,6600
127596,can,O,6600
127597,be,O,6600
127598,caused,O,6600
127599,by,O,6600
127600,a,O,6600
127601,variety,O,6600
127602,of,O,6600
127603,underlying,O,6600
127604,factors,O,6600
127605,It,O,6600
127606,can,O,6600
127607,be,O,6600
127608,a,O,6600
127609,symptom,O,6600
127610,of,O,6600
127611,a,O,6600
127612,number,O,6601
127613,of,O,6601
127614,serious,O,6601
127615,conditions,O,6601
127616,including,O,6601
127617,retinal,B-CAUSE_OF_DISEASE,6601
127618,detachment,I-CAUSE_OF_DISEASE,6601
127619,stroke,B-CAUSE_OF_DISEASE,6601
127620,and,O,6601
127621,even,O,6601
127622,brain,B-CAUSE_OF_DISEASE,6601
127623,tumors,I-CAUSE_OF_DISEASE,6602
127624,Understanding,O,6602
127625,the,O,6602
127626,causes,O,6602
127627,of,O,6602
127628,sudden,B-NAME_OF_DISEASE,6602
127629,vision,B-SIGN_AND_SYMPTOM,6602
127630,loss,I-SIGN_AND_SYMPTOM,6602
127631,is,O,6602
127632,crucial,O,6602
127633,for,O,6602
127634,early,O,6602
127635,diagnosis,O,6602
127636,and,O,6602
127637,treatment,O,6602
127638,One,O,6602
127639,of,O,6603
127640,the,O,6603
127641,most,O,6603
127642,common,O,6603
127643,causes,O,6603
127644,of,O,6603
127645,sudden,B-NAME_OF_DISEASE,6603
127646,vision,B-SIGN_AND_SYMPTOM,6603
127647,loss,I-SIGN_AND_SYMPTOM,6604
127648,is,O,6604
127649,retinal,B-CAUSE_OF_DISEASE,6604
127650,detachment,I-CAUSE_OF_DISEASE,6604
127651,The,B-PART_OF_THE_EYES,6604
127652,retina,I-PART_OF_THE_EYES,6604
127653,is,O,6604
127654,the,O,6604
127655,light-sensitive,O,6604
127656,layer,O,6604
127657,at,O,6604
127658,the,O,6604
127659,back,O,6604
127660,of,O,6604
127661,the,O,6604
127662,eye,O,6604
127663,that,O,6604
127664,sends,O,6605
127665,visual,O,6605
127666,signals,O,6605
127667,to,O,6605
127668,the,O,6605
127669,brain,O,6605
127670,If,O,6605
127671,the,B-PART_OF_THE_EYES,6605
127672,retina,I-PART_OF_THE_EYES,6605
127673,becomes,O,6605
127674,detached,O,6605
127675,it,O,6606
127676,can,O,6606
127677,no,O,6606
127678,longer,O,6606
127679,function,O,6606
127680,properly,O,6606
127681,leading,O,6606
127682,to,O,6606
127683,sudden,B-NAME_OF_DISEASE,6606
127684,vision,B-SIGN_AND_SYMPTOM,6606
127685,loss,I-SIGN_AND_SYMPTOM,6606
127686,Retinal,B-CAUSE_OF_DISEASE,6606
127687,detachment,I-CAUSE_OF_DISEASE,6606
127688,can,O,6606
127689,be,O,6606
127690,caused,O,6606
127691,by,O,6606
127692,a,O,6606
127693,variety,O,6606
127694,of,O,6606
127695,factors,O,6606
127696,including,O,6606
127697,injury,B-CAUSE_OF_DISEASE,6606
127698,certain,I-CAUSE_OF_DISEASE,6607
127699,medical,I-CAUSE_OF_DISEASE,6607
127700,conditions,I-CAUSE_OF_DISEASE,6607
127701,and,I-CAUSE_OF_DISEASE,6607
127702,even,I-CAUSE_OF_DISEASE,6607
127703,certain,I-CAUSE_OF_DISEASE,6607
127704,eye,I-CAUSE_OF_DISEASE,6607
127705,surgeries,I-CAUSE_OF_DISEASE,6607
127706,Another,O,6607
127707,common,O,6607
127708,cause,O,6607
127709,of,O,6607
127710,sudden,B-NAME_OF_DISEASE,6607
127711,vision,B-SIGN_AND_SYMPTOM,6607
127712,loss,I-SIGN_AND_SYMPTOM,6607
127713,is,O,6607
127714,a,O,6607
127715,stroke,B-CAUSE_OF_DISEASE,6607
127716,A,O,6607
127717,stroke,B-CAUSE_OF_DISEASE,6607
127718,occurs,O,6607
127719,when,O,6607
127720,the,B-SIGN_AND_SYMPTOM,6607
127721,blood,I-SIGN_AND_SYMPTOM,6607
127722,flow,I-SIGN_AND_SYMPTOM,6607
127723,to,I-SIGN_AND_SYMPTOM,6607
127724,the,I-SIGN_AND_SYMPTOM,6607
127725,brain,I-SIGN_AND_SYMPTOM,6607
127726,is,I-SIGN_AND_SYMPTOM,6607
127727,interrupted,I-SIGN_AND_SYMPTOM,6607
127728,depriving,I-SIGN_AND_SYMPTOM,6607
127729,brain,I-SIGN_AND_SYMPTOM,6608
127730,cells,I-SIGN_AND_SYMPTOM,6608
127731,of,I-SIGN_AND_SYMPTOM,6608
127732,oxygen,I-SIGN_AND_SYMPTOM,6608
127733,and,I-SIGN_AND_SYMPTOM,6608
127734,nutrients,I-SIGN_AND_SYMPTOM,6608
127735,This,O,6608
127736,can,O,6608
127737,lead,O,6608
127738,to,O,6608
127739,vision,B-SIGN_AND_SYMPTOM,6608
127740,loss,I-SIGN_AND_SYMPTOM,6608
127741,in,I-SIGN_AND_SYMPTOM,6608
127742,one,I-SIGN_AND_SYMPTOM,6608
127743,or,I-SIGN_AND_SYMPTOM,6609
127744,both,I-SIGN_AND_SYMPTOM,6609
127745,eyes,I-SIGN_AND_SYMPTOM,6609
127746,Strokes,B-CAUSE_OF_DISEASE,6609
127747,can,O,6609
127748,be,O,6609
127749,caused,O,6609
127750,by,O,6609
127751,a,O,6609
127752,variety,O,6609
127753,of,O,6609
127754,factors,O,6609
127755,including,O,6609
127756,high,B-CAUSE_OF_DISEASE,6609
127757,blood,I-CAUSE_OF_DISEASE,6609
127758,pressure,I-CAUSE_OF_DISEASE,6610
127759,smoking,I-CAUSE_OF_DISEASE,6610
127760,and,I-CAUSE_OF_DISEASE,6610
127761,diabetes,I-CAUSE_OF_DISEASE,6610
127762,Brain,B-CAUSE_OF_DISEASE,6610
127763,tumors,I-CAUSE_OF_DISEASE,6610
127764,can,O,6610
127765,also,O,6610
127766,cause,O,6610
127767,sudden,B-NAME_OF_DISEASE,6610
127768,vision,B-SIGN_AND_SYMPTOM,6610
127769,loss,I-SIGN_AND_SYMPTOM,6610
127770,Tumors,O,6610
127771,can,O,6610
127772,press,O,6610
127773,on,O,6610
127774,the,B-PART_OF_THE_EYES,6610
127775,optic,I-PART_OF_THE_EYES,6610
127776,nerve,I-PART_OF_THE_EYES,6610
127777,which,O,6610
127778,carries,O,6610
127779,visual,O,6610
127780,signals,O,6610
127781,from,O,6610
127782,the,O,6610
127783,eye,O,6610
127784,to,O,6610
127785,the,O,6610
127786,brain,O,6610
127787,This,O,6610
127788,can,O,6610
127789,lead,O,6611
127790,to,O,6611
127791,vision,B-SIGN_AND_SYMPTOM,6611
127792,loss,I-SIGN_AND_SYMPTOM,6611
127793,in,I-SIGN_AND_SYMPTOM,6611
127794,one,I-SIGN_AND_SYMPTOM,6611
127795,or,I-SIGN_AND_SYMPTOM,6611
127796,both,I-SIGN_AND_SYMPTOM,6611
127797,eyes,I-SIGN_AND_SYMPTOM,6611
127798,Brain,B-CAUSE_OF_DISEASE,6611
127799,tumors,I-CAUSE_OF_DISEASE,6611
127800,can,O,6611
127801,be,O,6611
127802,benign,O,6611
127803,or,O,6611
127804,malignant,O,6611
127805,and,O,6611
127806,can,O,6611
127807,be,O,6611
127808,caused,O,6611
127809,by,O,6611
127810,a,O,6611
127811,variety,O,6611
127812,of,O,6611
127813,factors,O,6612
127814,including,O,6612
127815,genetics,B-CAUSE_OF_DISEASE,6612
127816,and,I-CAUSE_OF_DISEASE,6612
127817,exposure,I-CAUSE_OF_DISEASE,6612
127818,to,I-CAUSE_OF_DISEASE,6612
127819,certain,I-CAUSE_OF_DISEASE,6612
127820,toxins,I-CAUSE_OF_DISEASE,6612
127821,Other,O,6612
127822,causes,O,6612
127823,of,O,6612
127824,sudden,B-NAME_OF_DISEASE,6612
127825,vision,B-SIGN_AND_SYMPTOM,6612
127826,loss,I-SIGN_AND_SYMPTOM,6612
127827,include,O,6612
127828,optic,B-CAUSE_OF_DISEASE,6612
127829,neuritis,I-CAUSE_OF_DISEASE,6612
127830,which,O,6612
127831,is,O,6612
127832,inflammation,O,6612
127833,of,O,6612
127834,the,B-PART_OF_THE_EYES,6612
127835,optic,I-PART_OF_THE_EYES,6613
127836,nerve,I-PART_OF_THE_EYES,6613
127837,and,O,6613
127838,giant,B-CAUSE_OF_DISEASE,6613
127839,cell,I-CAUSE_OF_DISEASE,6613
127840,arteritis,I-CAUSE_OF_DISEASE,6613
127841,which,O,6613
127842,is,O,6613
127843,an,O,6613
127844,inflammation,O,6613
127845,of,O,6613
127846,the,O,6613
127847,blood,O,6613
127848,vessels,O,6613
127849,in,O,6613
127850,the,O,6614
127851,head,O,6614
127852,It,O,6614
127853,s,O,6614
127854,important,O,6614
127855,to,O,6614
127856,seek,O,6614
127857,medical,O,6614
127858,attention,O,6614
127859,immediately,O,6614
127860,if,O,6614
127861,you,O,6614
127862,experience,O,6614
127863,sudden,B-NAME_OF_DISEASE,6614
127864,vision,B-SIGN_AND_SYMPTOM,6614
127865,loss,I-SIGN_AND_SYMPTOM,6614
127866,Early,O,6614
127867,diagnosis,O,6614
127868,and,O,6614
127869,treatment,O,6614
127870,can,O,6614
127871,help,O,6614
127872,prevent,O,6614
127873,permanent,B-NAME_OF_DISEASE,6614
127874,vision,B-SIGN_AND_SYMPTOM,6614
127875,loss,I-SIGN_AND_SYMPTOM,6614
127876,and,O,6614
127877,improve,O,6614
127878,your,O,6615
127879,overall,O,6615
127880,outcome,O,6615
127881,Your,O,6615
127882,healthcare,O,6615
127883,provider,O,6615
127884,will,O,6615
127885,perform,O,6615
127886,a,O,6616
127887,thorough,O,6616
127888,examination,O,6616
127889,and,O,6616
127890,may,O,6616
127891,order,O,6616
127892,imaging,B-DIAGNOSTIC_TEST,6616
127893,tests,I-DIAGNOSTIC_TEST,6616
127894,such,I-DIAGNOSTIC_TEST,6616
127895,as,I-DIAGNOSTIC_TEST,6616
127896,MRI,I-DIAGNOSTIC_TEST,6616
127897,CT,I-DIAGNOSTIC_TEST,6616
127898,scan,I-DIAGNOSTIC_TEST,6616
127899,and,O,6616
127900,an,O,6616
127901,eye,O,6617
127902,examination,O,6617
127903,to,O,6617
127904,help,O,6617
127905,determine,O,6617
127906,the,O,6617
127907,cause,O,6617
127908,of,O,6617
127909,your,O,6617
127910,vision,B-SIGN_AND_SYMPTOM,6617
127911,loss,I-SIGN_AND_SYMPTOM,6617
127912,Sudden,B-NAME_OF_DISEASE,6617
127913,Vision,I-NAME_OF_DISEASE,6617
127914,Loss,I-NAME_OF_DISEASE,6617
127915,in,I-NAME_OF_DISEASE,6617
127916,One,I-NAME_OF_DISEASE,6617
127917,Eye,I-NAME_OF_DISEASE,6617
127918,The,O,6617
127919,primary,O,6617
127920,cause,O,6617
127921,of,O,6617
127922,sudden,B-NAME_OF_DISEASE,6617
127923,vision,B-SIGN_AND_SYMPTOM,6617
127924,loss,I-SIGN_AND_SYMPTOM,6617
127925,in,I-NAME_OF_DISEASE,6617
127926,one,I-NAME_OF_DISEASE,6617
127927,eye,I-NAME_OF_DISEASE,6617
127928,is,O,6617
127929,high,B-CAUSE_OF_DISEASE,6618
127930,blood,I-CAUSE_OF_DISEASE,6618
127931,pressure,I-CAUSE_OF_DISEASE,6618
127932,also,O,6618
127933,known,O,6618
127934,as,O,6618
127935,hypertension,B-CAUSE_OF_DISEASE,6618
127936,High,B-CAUSE_OF_DISEASE,6618
127937,blood,I-CAUSE_OF_DISEASE,6619
127938,pressure,I-CAUSE_OF_DISEASE,6619
127939,is,O,6619
127940,a,O,6619
127941,condition,O,6619
127942,in,O,6619
127943,which,O,6619
127944,the,O,6619
127945,force,O,6619
127946,of,O,6619
127947,blood,O,6619
127948,against,O,6619
127949,the,O,6619
127950,walls,O,6619
127951,of,O,6619
127952,the,O,6619
127953,blood,O,6619
127954,vessels,O,6619
127955,is,O,6619
127956,too,O,6619
127957,high,O,6619
127958,This,O,6619
127959,extra,O,6619
127960,force,O,6620
127961,can,O,6620
127962,damage,O,6620
127963,the,O,6620
127964,blood,O,6620
127965,vessels,O,6620
127966,in,O,6620
127967,the,O,6620
127968,eye,O,6620
127969,leading,O,6620
127970,to,O,6620
127971,vision,B-SIGN_AND_SYMPTOM,6620
127972,loss,I-SIGN_AND_SYMPTOM,6620
127973,Symptoms,O,6620
127974,of,O,6620
127975,sudden,B-NAME_OF_DISEASE,6620
127976,vision,B-SIGN_AND_SYMPTOM,6620
127977,loss,I-SIGN_AND_SYMPTOM,6620
127978,in,I-NAME_OF_DISEASE,6620
127979,one,I-NAME_OF_DISEASE,6620
127980,eye,I-NAME_OF_DISEASE,6620
127981,include,O,6620
127982,blurred,B-SIGN_AND_SYMPTOM,6620
127983,vision,I-SIGN_AND_SYMPTOM,6620
127984,loss,I-SIGN_AND_SYMPTOM,6620
127985,of,I-SIGN_AND_SYMPTOM,6620
127986,peripheral,I-SIGN_AND_SYMPTOM,6620
127987,vision,I-SIGN_AND_SYMPTOM,6621
127988,and,I-SIGN_AND_SYMPTOM,6621
127989,the,I-SIGN_AND_SYMPTOM,6621
127990,appearance,I-SIGN_AND_SYMPTOM,6621
127991,of,I-SIGN_AND_SYMPTOM,6621
127992,a,I-SIGN_AND_SYMPTOM,6621
127993,dark,I-SIGN_AND_SYMPTOM,6621
127994,spot,I-SIGN_AND_SYMPTOM,6621
127995,or,I-SIGN_AND_SYMPTOM,6621
127996,shadow,I-SIGN_AND_SYMPTOM,6621
127997,in,I-SIGN_AND_SYMPTOM,6621
127998,the,I-SIGN_AND_SYMPTOM,6621
127999,affected,I-SIGN_AND_SYMPTOM,6621
128000,eye,I-SIGN_AND_SYMPTOM,6621
128001,These,O,6621
128002,symptoms,O,6621
128003,can,O,6621
128004,occur,O,6621
128005,suddenly,O,6621
128006,and,O,6622
128007,without,O,6622
128008,warning,O,6622
128009,If,O,6622
128010,you,O,6622
128011,experience,O,6622
128012,any,O,6622
128013,of,O,6622
128014,these,O,6622
128015,symptoms,O,6622
128016,it,O,6622
128017,is,O,6622
128018,essential,O,6622
128019,to,O,6622
128020,seek,O,6622
128021,medical,O,6622
128022,attention,O,6622
128023,immediately,O,6622
128024,Risk,O,6622
128025,Factors,O,6622
128026,for,O,6623
128027,Sudden,B-NAME_OF_DISEASE,6623
128028,Vision,I-NAME_OF_DISEASE,6623
128029,Loss,I-NAME_OF_DISEASE,6623
128030,Age,B-CAUSE_OF_DISEASE,6623
128031,As,O,6623
128032,we,O,6623
128033,get,O,6623
128034,older,O,6623
128035,the,O,6623
128036,risk,O,6623
128037,of,O,6623
128038,developing,O,6623
128039,certain,O,6623
128040,eye,O,6623
128041,conditions,O,6623
128042,such,O,6623
128043,as,O,6623
128044,age-related,B-CAUSE_OF_DISEASE,6623
128045,macular,I-CAUSE_OF_DISEASE,6623
128046,degeneration,I-CAUSE_OF_DISEASE,6623
128047,cataracts,B-CAUSE_OF_DISEASE,6624
128048,and,O,6624
128049,diabetic,B-CAUSE_OF_DISEASE,6624
128050,retinopathy,I-CAUSE_OF_DISEASE,6624
128051,increases,O,6624
128052,These,O,6624
128053,conditions,O,6624
128054,can,O,6624
128055,lead,O,6624
128056,to,O,6624
128057,sudden,B-NAME_OF_DISEASE,6624
128058,vision,I-NAME_OF_DISEASE,6624
128059,loss,I-NAME_OF_DISEASE,6624
128060,Age-related,B-NAME_OF_DISEASE,6624
128061,macular,I-NAME_OF_DISEASE,6624
128062,degeneration,I-NAME_OF_DISEASE,6624
128063,AMD,I-NAME_OF_DISEASE,6624
128064,is,O,6624
128065,a,O,6624
128066,degenerative,O,6624
128067,disorder,O,6624
128068,of,O,6624
128069,the,B-PART_OF_THE_EYES,6625
128070,retina,I-PART_OF_THE_EYES,6625
128071,that,O,6625
128072,affects,O,6625
128073,older,O,6625
128074,adults,O,6625
128075,and,O,6625
128076,can,O,6625
128077,cause,O,6625
128078,a,B-SIGN_AND_SYMPTOM,6625
128079,loss,I-SIGN_AND_SYMPTOM,6625
128080,of,I-SIGN_AND_SYMPTOM,6625
128081,central,I-SIGN_AND_SYMPTOM,6625
128082,vision,I-SIGN_AND_SYMPTOM,6625
128083,Medical,B-CAUSE_OF_DISEASE,6625
128084,conditions,I-CAUSE_OF_DISEASE,6625
128085,People,O,6625
128086,with,O,6625
128087,diabetes,B-CAUSE_OF_DISEASE,6625
128088,high,I-CAUSE_OF_DISEASE,6625
128089,blood,I-CAUSE_OF_DISEASE,6626
128090,pressure,I-CAUSE_OF_DISEASE,6626
128091,and,I-CAUSE_OF_DISEASE,6626
128092,high,I-CAUSE_OF_DISEASE,6626
128093,cholesterol,I-CAUSE_OF_DISEASE,6626
128094,are,O,6626
128095,at,O,6626
128096,an,O,6626
128097,increased,O,6626
128098,risk,O,6626
128099,of,O,6626
128100,developing,O,6626
128101,eye,O,6626
128102,conditions,O,6626
128103,that,O,6626
128104,can,O,6626
128105,lead,O,6626
128106,to,O,6627
128107,sudden,B-NAME_OF_DISEASE,6627
128108,vision,I-NAME_OF_DISEASE,6627
128109,loss,I-NAME_OF_DISEASE,6627
128110,Diabetes,B-CAUSE_OF_DISEASE,6627
128111,can,O,6627
128112,damage,O,6627
128113,the,O,6627
128114,blood,O,6627
128115,vessels,O,6627
128116,in,O,6627
128117,the,B-PART_OF_THE_EYES,6627
128118,retina,I-PART_OF_THE_EYES,6627
128119,leading,O,6627
128120,to,O,6627
128121,diabetic,B-CAUSE_OF_DISEASE,6627
128122,retinopathy,I-CAUSE_OF_DISEASE,6627
128123,which,O,6627
128124,can,O,6627
128125,cause,O,6628
128126,sudden,B-NAME_OF_DISEASE,6628
128127,vision,I-NAME_OF_DISEASE,6628
128128,loss,I-NAME_OF_DISEASE,6628
128129,High,B-CAUSE_OF_DISEASE,6628
128130,blood,I-CAUSE_OF_DISEASE,6628
128131,pressure,I-CAUSE_OF_DISEASE,6628
128132,and,I-CAUSE_OF_DISEASE,6628
128133,high,I-CAUSE_OF_DISEASE,6628
128134,cholesterol,I-CAUSE_OF_DISEASE,6628
128135,can,O,6628
128136,also,O,6628
128137,damage,O,6628
128138,the,O,6628
128139,blood,O,6628
128140,vessels,O,6628
128141,in,O,6628
128142,the,O,6628
128143,eye,O,6628
128144,leading,O,6628
128145,to,O,6628
128146,sudden,B-NAME_OF_DISEASE,6628
128147,vision,I-NAME_OF_DISEASE,6628
128148,loss,I-NAME_OF_DISEASE,6628
128149,Genetics,B-CAUSE_OF_DISEASE,6629
128150,Some,O,6629
128151,eye,O,6629
128152,conditions,O,6629
128153,that,O,6629
128154,can,O,6629
128155,lead,O,6629
128156,to,O,6629
128157,sudden,B-NAME_OF_DISEASE,6629
128158,vision,I-NAME_OF_DISEASE,6629
128159,loss,I-NAME_OF_DISEASE,6629
128160,such,O,6629
128161,as,O,6629
128162,retinal,B-CAUSE_OF_DISEASE,6629
128163,detachment,I-CAUSE_OF_DISEASE,6629
128164,are,O,6629
128165,more,O,6629
128166,common,O,6630
128167,in,O,6630
128168,certain,O,6630
128169,families,O,6630
128170,If,O,6630
128171,you,O,6630
128172,have,O,6630
128173,a,O,6630
128174,family,O,6630
128175,history,O,6630
128176,of,O,6630
128177,eye,O,6630
128178,conditions,O,6630
128179,that,O,6630
128180,can,O,6630
128181,cause,O,6630
128182,sudden,B-NAME_OF_DISEASE,6630
128183,vision,I-NAME_OF_DISEASE,6630
128184,loss,I-NAME_OF_DISEASE,6631
128185,you,O,6631
128186,may,O,6631
128187,be,O,6631
128188,at,O,6631
128189,a,O,6631
128190,higher,O,6631
128191,risk,O,6631
128192,Trauma,B-CAUSE_OF_DISEASE,6631
128193,Injury,B-CAUSE_OF_DISEASE,6631
128194,or,I-CAUSE_OF_DISEASE,6631
128195,trauma,I-CAUSE_OF_DISEASE,6631
128196,to,I-CAUSE_OF_DISEASE,6631
128197,the,I-CAUSE_OF_DISEASE,6631
128198,eye,I-CAUSE_OF_DISEASE,6631
128199,such,I-CAUSE_OF_DISEASE,6631
128200,as,I-CAUSE_OF_DISEASE,6631
128201,a,I-CAUSE_OF_DISEASE,6631
128202,blow,I-CAUSE_OF_DISEASE,6631
128203,to,I-CAUSE_OF_DISEASE,6631
128204,the,I-CAUSE_OF_DISEASE,6631
128205,head,I-CAUSE_OF_DISEASE,6632
128206,can,O,6632
128207,lead,O,6632
128208,to,O,6632
128209,sudden,B-NAME_OF_DISEASE,6632
128210,vision,I-NAME_OF_DISEASE,6632
128211,loss,I-NAME_OF_DISEASE,6632
128212,Additionally,O,6632
128213,certain,B-CAUSE_OF_DISEASE,6632
128214,eye,I-CAUSE_OF_DISEASE,6632
128215,surgeries,I-CAUSE_OF_DISEASE,6632
128216,such,I-CAUSE_OF_DISEASE,6633
128217,as,I-CAUSE_OF_DISEASE,6633
128218,cataract,I-CAUSE_OF_DISEASE,6633
128219,surgery,I-CAUSE_OF_DISEASE,6633
128220,can,O,6633
128221,also,O,6633
128222,increase,O,6633
128223,the,O,6633
128224,risk,O,6633
128225,of,O,6633
128226,sudden,B-NAME_OF_DISEASE,6633
128227,vision,I-NAME_OF_DISEASE,6633
128228,loss,I-NAME_OF_DISEASE,6633
128229,Certain,B-CAUSE_OF_DISEASE,6634
128230,medications,I-CAUSE_OF_DISEASE,6634
128231,Certain,B-CAUSE_OF_DISEASE,6634
128232,medications,I-CAUSE_OF_DISEASE,6634
128233,such,I-CAUSE_OF_DISEASE,6634
128234,as,I-CAUSE_OF_DISEASE,6634
128235,blood,I-CAUSE_OF_DISEASE,6634
128236,thinners,I-CAUSE_OF_DISEASE,6634
128237,and,I-CAUSE_OF_DISEASE,6634
128238,anti-inflammatory,I-CAUSE_OF_DISEASE,6634
128239,drugs,I-CAUSE_OF_DISEASE,6634
128240,can,O,6634
128241,increase,O,6634
128242,the,O,6634
128243,risk,O,6634
128244,of,O,6634
128245,sudden,B-NAME_OF_DISEASE,6635
128246,vision,I-NAME_OF_DISEASE,6635
128247,loss,I-NAME_OF_DISEASE,6635
128248,Toxins,B-CAUSE_OF_DISEASE,6635
128249,and,I-CAUSE_OF_DISEASE,6635
128250,environmental,I-CAUSE_OF_DISEASE,6635
128251,factors,I-CAUSE_OF_DISEASE,6635
128252,Exposure,O,6635
128253,to,O,6635
128254,certain,O,6635
128255,toxins,B-CAUSE_OF_DISEASE,6635
128256,and,I-CAUSE_OF_DISEASE,6635
128257,environmental,I-CAUSE_OF_DISEASE,6635
128258,factors,I-CAUSE_OF_DISEASE,6635
128259,such,I-CAUSE_OF_DISEASE,6635
128260,as,I-CAUSE_OF_DISEASE,6635
128261,pesticides,I-CAUSE_OF_DISEASE,6635
128262,and,I-CAUSE_OF_DISEASE,6635
128263,pollutants,I-CAUSE_OF_DISEASE,6635
128264,can,O,6635
128265,increase,O,6635
128266,the,O,6635
128267,risk,O,6636
128268,of,O,6636
128269,sudden,B-NAME_OF_DISEASE,6636
128270,vision,I-NAME_OF_DISEASE,6636
128271,loss,I-NAME_OF_DISEASE,6636
128272,How,O,6636
128273,Is,O,6636
128274,Sudden,B-NAME_OF_DISEASE,6636
128275,Vision,I-NAME_OF_DISEASE,6636
128276,Loss,I-NAME_OF_DISEASE,6636
128277,Treated,O,6636
128278,Treatment,O,6636
128279,for,O,6636
128280,sudden,B-NAME_OF_DISEASE,6636
128281,vision,I-NAME_OF_DISEASE,6636
128282,loss,I-NAME_OF_DISEASE,6636
128283,will,O,6636
128284,depend,O,6636
128285,on,O,6636
128286,the,O,6636
128287,underlying,O,6636
128288,cause,O,6636
128289,For,O,6636
128290,example,O,6636
128291,retinal,B-CAUSE_OF_DISEASE,6636
128292,detachment,I-CAUSE_OF_DISEASE,6636
128293,may,O,6636
128294,require,O,6636
128295,surgery,B-TREATMENT,6636
128296,while,O,6636
128297,a,O,6636
128298,stroke,B-CAUSE_OF_DISEASE,6636
128299,may,O,6636
128300,require,O,6636
128301,medication,B-TREATMENT,6636
128302,or,I-TREATMENT,6636
128303,other,I-TREATMENT,6637
128304,types,I-TREATMENT,6637
128305,of,I-TREATMENT,6637
128306,therapy,I-TREATMENT,6637
128307,Conclusion,O,6637
128308,In,O,6637
128309,conclusion,O,6637
128310,sudden,B-NAME_OF_DISEASE,6637
128311,vision,I-NAME_OF_DISEASE,6637
128312,loss,I-NAME_OF_DISEASE,6637
128313,is,O,6637
128314,a,O,6637
128315,serious,O,6637
128316,medical,O,6637
128317,condition,O,6637
128318,that,O,6637
128319,can,O,6637
128320,be,O,6637
128321,caused,O,6637
128322,by,O,6637
128323,a,O,6637
128324,variety,O,6637
128325,of,O,6637
128326,underlying,O,6637
128327,factors,O,6637
128328,Early,O,6637
128329,diagnosis,O,6637
128330,and,O,6637
128331,treatment,O,6637
128332,are,O,6637
128333,crucial,O,6637
128334,for,O,6637
128335,preventing,O,6637
128336,permanent,B-NAME_OF_DISEASE,6637
128337,vision,I-NAME_OF_DISEASE,6637
128338,loss,I-NAME_OF_DISEASE,6637
128339,If,O,6638
128340,you,O,6638
128341,experience,O,6638
128342,sudden,B-NAME_OF_DISEASE,6638
128343,vision,I-NAME_OF_DISEASE,6638
128344,loss,I-NAME_OF_DISEASE,6638
128345,in,I-NAME_OF_DISEASE,6638
128346,one,I-NAME_OF_DISEASE,6638
128347,eye,I-NAME_OF_DISEASE,6638
128348,seek,O,6638
128349,medical,O,6638
128350,attention,O,6638
128351,immediately,O,6638
128352,Don,O,6638
128353,t,O,6638
128354,ignore,O,6638
128355,or,O,6638
128356,delay,O,6638
128357,seeking,O,6638
128358,professional,O,6639
128359,help,O,6639
128360,as,O,6639
128361,it,O,6639
128362,can,O,6639
128363,lead,O,6639
128364,to,O,6639
128365,permanent,B-NAME_OF_DISEASE,6639
128366,vision,I-NAME_OF_DISEASE,6639
128367,loss,I-NAME_OF_DISEASE,6639
128368,Tritan,B-NAME_OF_DISEASE,6639
128369,color,I-NAME_OF_DISEASE,6639
128370,blindness,I-NAME_OF_DISEASE,6640
128371,is,O,6640
128372,a,O,6640
128373,rare,O,6640
128374,form,O,6640
128375,of,O,6640
128376,color,O,6640
128377,vision,O,6640
128378,deficiency,O,6640
128379,that,O,6640
128380,affects,O,6640
128381,the,O,6640
128382,ability,O,6640
128383,to,O,6640
128384,distinguish,O,6640
128385,between,O,6640
128386,blue,O,6640
128387,and,O,6640
128388,green,O,6640
128389,colors,O,6640
128390,The,O,6640
128391,condition,O,6640
128392,is,O,6640
128393,caused,O,6641
128394,by,O,6641
128395,a,B-CAUSE_OF_DISEASE,6641
128396,genetic,I-CAUSE_OF_DISEASE,6641
128397,mutation,I-CAUSE_OF_DISEASE,6641
128398,in,I-CAUSE_OF_DISEASE,6641
128399,the,I-CAUSE_OF_DISEASE,6641
128400,S-opsin,I-CAUSE_OF_DISEASE,6641
128401,gene,I-CAUSE_OF_DISEASE,6641
128402,which,O,6641
128403,is,O,6641
128404,responsible,O,6641
128405,for,O,6641
128406,the,O,6641
128407,production,O,6641
128408,of,O,6641
128409,a,B-CHEMICAL_COMPOUND,6641
128410,protein,I-CHEMICAL_COMPOUND,6641
128411,called,I-CHEMICAL_COMPOUND,6641
128412,opsin,I-CHEMICAL_COMPOUND,6642
128413,that,O,6642
128414,is,O,6642
128415,found,O,6642
128416,in,O,6642
128417,the,O,6642
128418,light-sensitive,O,6642
128419,cells,O,6642
128420,of,O,6643
128421,the,O,6643
128422,eye,O,6643
128423,known,O,6643
128424,as,O,6643
128425,cones,B-PART_OF_THE_EYES,6643
128426,Types,O,6643
128427,of,O,6643
128428,Tritan,B-NAME_OF_DISEASE,6643
128429,Color,I-NAME_OF_DISEASE,6643
128430,Blindness,I-NAME_OF_DISEASE,6643
128431,There,O,6643
128432,are,O,6643
128433,two,O,6643
128434,main,O,6643
128435,types,O,6643
128436,of,O,6643
128437,tritan,B-NAME_OF_DISEASE,6643
128438,color,I-NAME_OF_DISEASE,6643
128439,blindness,I-NAME_OF_DISEASE,6643
128440,Tritanomaly,B-NAME_OF_DISEASE,6643
128441,This,O,6643
128442,is,O,6643
128443,the,O,6643
128444,most,O,6643
128445,common,O,6643
128446,type,O,6643
128447,of,O,6643
128448,tritan,B-NAME_OF_DISEASE,6643
128449,color,I-NAME_OF_DISEASE,6643
128450,blindness,I-NAME_OF_DISEASE,6643
128451,and,O,6643
128452,it,O,6643
128453,is,O,6643
128454,characterized,O,6643
128455,by,O,6643
128456,a,B-SIGN_AND_SYMPTOM,6643
128457,reduced,I-SIGN_AND_SYMPTOM,6643
128458,sensitivity,I-SIGN_AND_SYMPTOM,6644
128459,to,I-SIGN_AND_SYMPTOM,6644
128460,blue,I-SIGN_AND_SYMPTOM,6644
128461,light,I-SIGN_AND_SYMPTOM,6644
128462,Individuals,O,6644
128463,with,O,6644
128464,tritanomaly,B-NAME_OF_DISEASE,6644
128465,have,B-SIGN_AND_SYMPTOM,6644
128466,difficulty,I-SIGN_AND_SYMPTOM,6644
128467,distinguishing,I-SIGN_AND_SYMPTOM,6644
128468,between,I-SIGN_AND_SYMPTOM,6644
128469,blue,I-SIGN_AND_SYMPTOM,6644
128470,and,I-SIGN_AND_SYMPTOM,6644
128471,green,I-SIGN_AND_SYMPTOM,6644
128472,colors,I-SIGN_AND_SYMPTOM,6644
128473,as,I-SIGN_AND_SYMPTOM,6644
128474,well,I-SIGN_AND_SYMPTOM,6644
128475,as,I-SIGN_AND_SYMPTOM,6644
128476,between,I-SIGN_AND_SYMPTOM,6644
128477,blue,I-SIGN_AND_SYMPTOM,6644
128478,and,I-SIGN_AND_SYMPTOM,6644
128479,purple,I-SIGN_AND_SYMPTOM,6644
128480,colors,I-SIGN_AND_SYMPTOM,6644
128481,They,O,6644
128482,may,O,6644
128483,also,O,6644
128484,perceive,B-SIGN_AND_SYMPTOM,6644
128485,some,I-SIGN_AND_SYMPTOM,6644
128486,shades,I-SIGN_AND_SYMPTOM,6644
128487,of,I-SIGN_AND_SYMPTOM,6644
128488,blue,I-SIGN_AND_SYMPTOM,6644
128489,as,I-SIGN_AND_SYMPTOM,6644
128490,green,I-SIGN_AND_SYMPTOM,6644
128491,or,I-SIGN_AND_SYMPTOM,6644
128492,gray,I-SIGN_AND_SYMPTOM,6644
128493,Tritanopia,B-NAME_OF_DISEASE,6645
128494,This,O,6645
128495,is,O,6645
128496,a,O,6645
128497,rarer,O,6645
128498,type,O,6645
128499,of,O,6645
128500,tritan,B-NAME_OF_DISEASE,6645
128501,color,I-NAME_OF_DISEASE,6645
128502,blindness,I-NAME_OF_DISEASE,6645
128503,and,O,6645
128504,it,O,6645
128505,is,O,6645
128506,characterized,O,6646
128507,by,O,6646
128508,a,B-SIGN_AND_SYMPTOM,6646
128509,complete,I-SIGN_AND_SYMPTOM,6646
128510,absence,I-SIGN_AND_SYMPTOM,6646
128511,of,I-SIGN_AND_SYMPTOM,6646
128512,sensitivity,I-SIGN_AND_SYMPTOM,6646
128513,to,I-SIGN_AND_SYMPTOM,6646
128514,blue,I-SIGN_AND_SYMPTOM,6646
128515,light,I-SIGN_AND_SYMPTOM,6646
128516,Individuals,O,6646
128517,with,O,6646
128518,tritanopia,B-NAME_OF_DISEASE,6646
128519,have,B-SIGN_AND_SYMPTOM,6646
128520,difficulty,I-SIGN_AND_SYMPTOM,6646
128521,distinguishing,I-SIGN_AND_SYMPTOM,6646
128522,between,I-SIGN_AND_SYMPTOM,6646
128523,blue,I-SIGN_AND_SYMPTOM,6646
128524,and,I-SIGN_AND_SYMPTOM,6646
128525,green,I-SIGN_AND_SYMPTOM,6646
128526,colors,I-SIGN_AND_SYMPTOM,6646
128527,as,I-SIGN_AND_SYMPTOM,6646
128528,well,I-SIGN_AND_SYMPTOM,6646
128529,as,I-SIGN_AND_SYMPTOM,6646
128530,between,I-SIGN_AND_SYMPTOM,6646
128531,blue,I-SIGN_AND_SYMPTOM,6646
128532,and,I-SIGN_AND_SYMPTOM,6646
128533,purple,I-SIGN_AND_SYMPTOM,6646
128534,colors,I-SIGN_AND_SYMPTOM,6646
128535,They,O,6646
128536,may,O,6646
128537,also,O,6646
128538,perceive,B-SIGN_AND_SYMPTOM,6647
128539,blue,I-SIGN_AND_SYMPTOM,6647
128540,colors,I-SIGN_AND_SYMPTOM,6647
128541,as,I-SIGN_AND_SYMPTOM,6647
128542,black,I-SIGN_AND_SYMPTOM,6647
128543,Additionally,O,6647
128544,some,O,6647
128545,individuals,O,6647
128546,may,O,6647
128547,have,O,6647
128548,a,O,6647
128549,less,O,6647
128550,severe,O,6647
128551,form,O,6647
128552,of,O,6647
128553,tritan,B-NAME_OF_DISEASE,6647
128554,color,I-NAME_OF_DISEASE,6647
128555,blindness,I-NAME_OF_DISEASE,6647
128556,known,O,6647
128557,as,O,6647
128558,Anomalous,B-NAME_OF_DISEASE,6647
128559,trichromacy,I-NAME_OF_DISEASE,6647
128560,in,O,6647
128561,which,O,6647
128562,individuals,O,6647
128563,have,O,6648
128564,normal,B-SIGN_AND_SYMPTOM,6648
128565,trichromatic,I-SIGN_AND_SYMPTOM,6648
128566,color,I-SIGN_AND_SYMPTOM,6648
128567,vision,I-SIGN_AND_SYMPTOM,6648
128568,but,I-SIGN_AND_SYMPTOM,6648
128569,with,I-SIGN_AND_SYMPTOM,6648
128570,some,I-SIGN_AND_SYMPTOM,6648
128571,degree,I-SIGN_AND_SYMPTOM,6648
128572,of,I-SIGN_AND_SYMPTOM,6648
128573,reduction,I-SIGN_AND_SYMPTOM,6648
128574,in,I-SIGN_AND_SYMPTOM,6648
128575,the,I-SIGN_AND_SYMPTOM,6648
128576,sensitivity,I-SIGN_AND_SYMPTOM,6648
128577,of,I-SIGN_AND_SYMPTOM,6648
128578,the,I-SIGN_AND_SYMPTOM,6648
128579,blue-sensitive,I-SIGN_AND_SYMPTOM,6648
128580,cones,I-SIGN_AND_SYMPTOM,6648
128581,It,O,6648
128582,s,O,6648
128583,important,O,6649
128584,to,O,6649
128585,note,O,6649
128586,that,O,6649
128587,both,O,6649
128588,types,O,6649
128589,of,O,6649
128590,tritan,B-NAME_OF_DISEASE,6649
128591,color,I-NAME_OF_DISEASE,6649
128592,blindness,I-NAME_OF_DISEASE,6649
128593,are,O,6649
128594,inherited,O,6649
128595,in,O,6649
128596,an,O,6650
128597,autosomal,O,6650
128598,recessive,O,6650
128599,manner,O,6650
128600,which,O,6650
128601,means,O,6650
128602,that,O,6650
128603,it,O,6650
128604,is,O,6650
128605,caused,O,6650
128606,by,O,6650
128607,a,B-CAUSE_OF_DISEASE,6650
128608,mutation,I-CAUSE_OF_DISEASE,6650
128609,in,I-CAUSE_OF_DISEASE,6650
128610,both,I-CAUSE_OF_DISEASE,6650
128611,copies,I-CAUSE_OF_DISEASE,6650
128612,of,I-CAUSE_OF_DISEASE,6650
128613,the,I-CAUSE_OF_DISEASE,6651
128614,S-opsin,I-CAUSE_OF_DISEASE,6651
128615,gene,I-CAUSE_OF_DISEASE,6651
128616,However,O,6651
128617,the,O,6651
128618,degree,O,6651
128619,of,O,6651
128620,color,B-NAME_OF_DISEASE,6651
128621,vision,I-NAME_OF_DISEASE,6651
128622,loss,I-NAME_OF_DISEASE,6651
128623,can,O,6651
128624,vary,O,6651
128625,from,O,6651
128626,person,O,6651
128627,to,O,6651
128628,person,O,6651
128629,How,O,6651
128630,Do,O,6651
128631,I,O,6651
128632,Know,O,6651
128633,If,O,6651
128634,I,O,6651
128635,Have,O,6651
128636,Tritan,B-NAME_OF_DISEASE,6651
128637,Color,I-NAME_OF_DISEASE,6651
128638,Blindness,I-NAME_OF_DISEASE,6651
128639,The,O,6651
128640,best,O,6651
128641,way,O,6651
128642,to,O,6651
128643,determine,O,6652
128644,if,O,6652
128645,you,O,6652
128646,have,O,6652
128647,tritan,B-NAME_OF_DISEASE,6652
128648,color,B-NAME_OF_DISEASE,6652
128649,blindness,I-NAME_OF_DISEASE,6652
128650,is,O,6652
128651,to,O,6652
128652,visit,O,6652
128653,an,O,6652
128654,eye,O,6652
128655,doctor,O,6652
128656,for,O,6652
128657,a,B-DIAGNOSTIC_TEST,6652
128658,comprehensive,I-DIAGNOSTIC_TEST,6652
128659,eye,I-DIAGNOSTIC_TEST,6652
128660,exam,I-DIAGNOSTIC_TEST,6652
128661,During,O,6652
128662,the,O,6652
128663,exam,O,6652
128664,the,O,6652
128665,eye,O,6652
128666,doctor,O,6652
128667,will,O,6652
128668,perform,O,6652
128669,a,O,6652
128670,series,O,6652
128671,of,O,6652
128672,tests,O,6652
128673,to,O,6652
128674,check,O,6652
128675,your,O,6652
128676,vision,O,6652
128677,and,O,6652
128678,color,O,6652
128679,perception,O,6652
128680,including,O,6652
128681,a,B-DIAGNOSTIC_TEST,6652
128682,tritan,I-DIAGNOSTIC_TEST,6652
128683,color,B-NAME_OF_DISEASE,6652
128684,blindness,I-NAME_OF_DISEASE,6653
128685,test,I-DIAGNOSTIC_TEST,6653
128686,A,B-DIAGNOSTIC_TEST,6653
128687,tritan,I-DIAGNOSTIC_TEST,6653
128688,color,B-NAME_OF_DISEASE,6653
128689,blindness,I-NAME_OF_DISEASE,6653
128690,test,I-DIAGNOSTIC_TEST,6653
128691,typically,O,6653
128692,consists,O,6653
128693,of,O,6653
128694,a,O,6653
128695,series,O,6653
128696,of,O,6653
128697,images,O,6653
128698,or,O,6653
128699,patterns,O,6653
128700,that,O,6653
128701,contain,O,6653
128702,blue,O,6653
128703,and,O,6653
128704,yellow,O,6653
128705,colors,O,6653
128706,The,O,6653
128707,individual,O,6653
128708,is,O,6653
128709,asked,O,6653
128710,to,O,6653
128711,identify,O,6653
128712,the,O,6653
128713,colors,O,6654
128714,in,O,6654
128715,the,O,6654
128716,images,O,6654
128717,or,O,6654
128718,patterns,O,6654
128719,If,O,6654
128720,the,O,6654
128721,individual,O,6654
128722,has,B-CAUSE_OF_DISEASE,6654
128723,difficulty,I-CAUSE_OF_DISEASE,6654
128724,distinguishing,I-CAUSE_OF_DISEASE,6654
128725,between,I-CAUSE_OF_DISEASE,6654
128726,blue,I-CAUSE_OF_DISEASE,6654
128727,and,I-CAUSE_OF_DISEASE,6654
128728,yellow,I-CAUSE_OF_DISEASE,6654
128729,colors,I-CAUSE_OF_DISEASE,6654
128730,they,O,6654
128731,may,O,6654
128732,have,O,6654
128733,tritan,B-NAME_OF_DISEASE,6654
128734,color,B-NAME_OF_DISEASE,6654
128735,blindness,I-NAME_OF_DISEASE,6654
128736,Additionally,O,6654
128737,your,O,6654
128738,eye,O,6655
128739,doctor,O,6655
128740,may,O,6655
128741,also,O,6655
128742,use,O,6655
128743,other,O,6655
128744,tests,O,6655
128745,such,O,6655
128746,as,O,6655
128747,a,B-DIAGNOSTIC_TEST,6655
128748,visual,I-DIAGNOSTIC_TEST,6655
128749,acuity,I-DIAGNOSTIC_TEST,6655
128750,test,I-DIAGNOSTIC_TEST,6655
128751,to,O,6655
128752,check,O,6655
128753,your,O,6655
128754,overall,O,6655
128755,eye,O,6655
128756,health,O,6655
128757,and,O,6655
128758,to,O,6655
128759,rule,O,6655
128760,out,O,6655
128761,other,O,6656
128762,causes,O,6656
128763,of,O,6656
128764,color,B-NAME_OF_DISEASE,6656
128765,blindness,I-NAME_OF_DISEASE,6656
128766,It,O,6656
128767,s,O,6656
128768,also,O,6656
128769,worth,O,6656
128770,noting,O,6656
128771,that,O,6656
128772,there,O,6656
128773,are,O,6656
128774,some,B-DIAGNOSTIC_TEST,6656
128775,online,I-DIAGNOSTIC_TEST,6656
128776,tests,I-DIAGNOSTIC_TEST,6656
128777,and,I-DIAGNOSTIC_TEST,6656
128778,color,I-DIAGNOSTIC_TEST,6656
128779,vision,I-DIAGNOSTIC_TEST,6656
128780,tests,I-DIAGNOSTIC_TEST,6656
128781,available,O,6656
128782,to,O,6656
128783,check,O,6656
128784,for,O,6656
128785,color,B-NAME_OF_DISEASE,6656
128786,blindness,I-NAME_OF_DISEASE,6656
128787,however,O,6657
128788,these,O,6657
128789,are,O,6657
128790,not,O,6657
128791,always,O,6657
128792,reliable,O,6657
128793,or,O,6657
128794,accurate,O,6657
128795,and,O,6657
128796,should,O,6657
128797,not,O,6657
128798,be,O,6657
128799,considered,O,6657
128800,a,O,6657
128801,substitute,O,6657
128802,for,O,6658
128803,a,B-DIAGNOSTIC_TEST,6658
128804,professional,I-DIAGNOSTIC_TEST,6658
128805,eye,I-DIAGNOSTIC_TEST,6658
128806,examination,I-DIAGNOSTIC_TEST,6658
128807,While,O,6658
128808,tritan,B-NAME_OF_DISEASE,6658
128809,color,B-NAME_OF_DISEASE,6658
128810,blindness,I-NAME_OF_DISEASE,6658
128811,can,O,6658
128812,be,O,6658
128813,challenging,O,6658
128814,for,O,6658
128815,those,O,6658
128816,who,O,6658
128817,have,O,6658
128818,it,O,6658
128819,it,O,6658
128820,is,O,6658
128821,not,O,6658
128822,a,O,6658
128823,serious,O,6659
128824,condition,O,6659
128825,and,O,6659
128826,does,O,6659
128827,not,O,6659
128828,usually,O,6659
128829,affect,O,6659
128830,an,O,6659
128831,individual,O,6659
128832,s,O,6659
128833,quality,O,6659
128834,of,O,6659
128835,life,O,6659
128836,However,O,6659
128837,certain,O,6659
128838,occupations,O,6659
128839,such,O,6659
128840,as,O,6659
128841,those,O,6659
128842,in,O,6659
128843,the,O,6659
128844,field,O,6659
128845,of,O,6659
128846,color,O,6659
128847,design,O,6660
128848,or,O,6660
128849,graphic,O,6660
128850,design,O,6660
128851,may,O,6660
128852,be,O,6660
128853,more,O,6660
128854,challenging,O,6660
128855,for,O,6660
128856,individuals,O,6660
128857,with,O,6660
128858,tritan,B-NAME_OF_DISEASE,6660
128859,color,B-NAME_OF_DISEASE,6660
128860,blindness,I-NAME_OF_DISEASE,6660
128861,Conclusion,O,6660
128862,Tritan,B-NAME_OF_DISEASE,6660
128863,color,I-NAME_OF_DISEASE,6661
128864,blindness,I-NAME_OF_DISEASE,6661
128865,is,O,6661
128866,a,O,6661
128867,rare,O,6661
128868,form,O,6661
128869,of,O,6661
128870,color,O,6661
128871,vision,O,6661
128872,deficiency,O,6661
128873,that,O,6661
128874,affects,O,6661
128875,the,O,6661
128876,ability,O,6661
128877,to,O,6661
128878,distinguish,O,6661
128879,between,O,6661
128880,blue,O,6661
128881,and,O,6661
128882,yellow,O,6661
128883,colors,O,6661
128884,It,O,6661
128885,is,O,6661
128886,caused,O,6661
128887,by,O,6661
128888,a,B-CAUSE_OF_DISEASE,6661
128889,genetic,I-CAUSE_OF_DISEASE,6661
128890,mutation,I-CAUSE_OF_DISEASE,6661
128891,in,I-CAUSE_OF_DISEASE,6661
128892,the,I-CAUSE_OF_DISEASE,6661
128893,S-opsin,I-CAUSE_OF_DISEASE,6661
128894,gene,I-CAUSE_OF_DISEASE,6661
128895,inherited,O,6661
128896,in,O,6661
128897,an,O,6661
128898,autosomal,O,6661
128899,recessive,O,6661
128900,manner,O,6661
128901,and,O,6661
128902,it,O,6662
128903,is,O,6662
128904,more,O,6662
128905,common,O,6662
128906,in,O,6662
128907,men,O,6662
128908,than,O,6662
128909,women,O,6662
128910,The,O,6662
128911,most,O,6662
128912,important,O,6662
128913,diagnostic,O,6662
128914,tool,O,6662
128915,for,O,6662
128916,Tritan,B-NAME_OF_DISEASE,6662
128917,color,I-NAME_OF_DISEASE,6662
128918,blindness,I-NAME_OF_DISEASE,6662
128919,is,O,6662
128920,the,B-DIAGNOSTIC_TEST,6662
128921,tritan,I-DIAGNOSTIC_TEST,6662
128922,color,I-DIAGNOSTIC_TEST,6662
128923,blindness,I-DIAGNOSTIC_TEST,6662
128924,test,I-DIAGNOSTIC_TEST,6662
128925,The,O,6662
128926,condition,O,6662
128927,can,O,6662
128928,be,O,6662
128929,challenging,O,6662
128930,but,O,6662
128931,it,O,6662
128932,is,O,6662
128933,not,O,6663
128934,a,O,6663
128935,serious,O,6663
128936,one,O,6663
128937,and,O,6663
128938,it,O,6663
128939,doesn,O,6663
128940,t,O,6663
128941,affect,O,6663
128942,the,O,6663
128943,quality,O,6663
128944,of,O,6663
128945,life,O,6663
128946,Balint,B-NAME_OF_DISEASE,6663
128947,syndrome,I-NAME_OF_DISEASE,6663
128948,is,O,6663
128949,a,O,6663
128950,rare,O,6663
128951,neurological,O,6663
128952,condition,O,6663
128953,that,O,6663
128954,affects,O,6663
128955,the,O,6663
128956,ability,O,6663
128957,to,O,6663
128958,perceive,O,6664
128959,plan,O,6664
128960,and,O,6664
128961,initiate,O,6664
128962,movement,O,6664
128963,and,O,6664
128964,to,O,6664
128965,direct,O,6664
128966,attention,O,6664
128967,to,O,6664
128968,visual,O,6664
128969,stimuli,O,6664
128970,It,O,6664
128971,is,O,6664
128972,named,O,6664
128973,after,O,6664
128974,the,O,6664
128975,Hungarian,O,6664
128976,neurologist,O,6664
128977,Rezső,B-PERSON,6664
128978,Balint,I-PERSON,6664
128979,who,O,6664
128980,first,O,6664
128981,described,O,6664
128982,the,O,6664
128983,condition,O,6664
128984,in,O,6665
128985,1909,O,6665
128986,Causes,O,6665
128987,of,O,6665
128988,Balint,B-NAME_OF_DISEASE,6665
128989,Syndrome,I-NAME_OF_DISEASE,6665
128990,The,O,6665
128991,exact,O,6665
128992,cause,O,6665
128993,of,O,6665
128994,Balint,B-NAME_OF_DISEASE,6665
128995,syndrome,I-NAME_OF_DISEASE,6665
128996,is,O,6665
128997,not,O,6665
128998,well,O,6665
128999,understood,O,6665
129000,but,O,6665
129001,it,O,6665
129002,is,O,6665
129003,believed,O,6665
129004,to,O,6665
129005,be,O,6665
129006,the,O,6665
129007,result,O,6666
129008,of,O,6666
129009,damage,B-CAUSE_OF_DISEASE,6666
129010,to,I-CAUSE_OF_DISEASE,6666
129011,specific,I-CAUSE_OF_DISEASE,6666
129012,areas,I-CAUSE_OF_DISEASE,6666
129013,of,I-CAUSE_OF_DISEASE,6666
129014,the,I-CAUSE_OF_DISEASE,6666
129015,brain,I-CAUSE_OF_DISEASE,6666
129016,including,I-CAUSE_OF_DISEASE,6666
129017,the,I-CAUSE_OF_DISEASE,6666
129018,parietal,I-CAUSE_OF_DISEASE,6666
129019,lobes,I-CAUSE_OF_DISEASE,6666
129020,and,I-CAUSE_OF_DISEASE,6666
129021,the,I-CAUSE_OF_DISEASE,6666
129022,superior,I-CAUSE_OF_DISEASE,6666
129023,temporal,I-CAUSE_OF_DISEASE,6666
129024,gyrus,I-CAUSE_OF_DISEASE,6666
129025,This,O,6666
129026,damage,O,6666
129027,can,O,6666
129028,be,O,6666
129029,caused,O,6666
129030,by,O,6666
129031,a,O,6666
129032,variety,O,6666
129033,of,O,6666
129034,factors,O,6666
129035,including,O,6666
129036,Stroke,B-CAUSE_OF_DISEASE,6667
129037,A,B-CAUSE_OF_DISEASE,6667
129038,stroke,I-CAUSE_OF_DISEASE,6667
129039,or,I-CAUSE_OF_DISEASE,6667
129040,sudden,I-CAUSE_OF_DISEASE,6667
129041,loss,I-CAUSE_OF_DISEASE,6667
129042,of,I-CAUSE_OF_DISEASE,6667
129043,blood,I-CAUSE_OF_DISEASE,6667
129044,flow,I-CAUSE_OF_DISEASE,6667
129045,to,I-CAUSE_OF_DISEASE,6667
129046,the,I-CAUSE_OF_DISEASE,6667
129047,brain,I-CAUSE_OF_DISEASE,6667
129048,is,O,6667
129049,the,O,6667
129050,most,O,6667
129051,common,O,6667
129052,cause,O,6667
129053,of,O,6667
129054,Balint,B-NAME_OF_DISEASE,6667
129055,syndrome,I-NAME_OF_DISEASE,6667
129056,The,O,6667
129057,damage,O,6667
129058,caused,O,6667
129059,by,O,6667
129060,a,B-CAUSE_OF_DISEASE,6667
129061,stroke,I-CAUSE_OF_DISEASE,6667
129062,can,O,6667
129063,affect,O,6667
129064,the,O,6667
129065,areas,O,6667
129066,of,O,6667
129067,the,O,6667
129068,brain,O,6667
129069,responsible,O,6668
129070,for,O,6668
129071,movement,O,6668
129072,and,O,6668
129073,attention,O,6668
129074,leading,O,6668
129075,to,O,6668
129076,the,O,6668
129077,symptoms,O,6668
129078,of,O,6668
129079,Balint,B-NAME_OF_DISEASE,6668
129080,syndrome,I-NAME_OF_DISEASE,6668
129081,Trauma,B-CAUSE_OF_DISEASE,6668
129082,Trauma,B-CAUSE_OF_DISEASE,6668
129083,to,I-CAUSE_OF_DISEASE,6668
129084,the,I-CAUSE_OF_DISEASE,6668
129085,head,I-CAUSE_OF_DISEASE,6668
129086,such,I-CAUSE_OF_DISEASE,6668
129087,as,I-CAUSE_OF_DISEASE,6668
129088,from,I-CAUSE_OF_DISEASE,6668
129089,a,I-CAUSE_OF_DISEASE,6668
129090,car,I-CAUSE_OF_DISEASE,6668
129091,accident,I-CAUSE_OF_DISEASE,6668
129092,or,I-CAUSE_OF_DISEASE,6668
129093,fall,I-CAUSE_OF_DISEASE,6668
129094,can,O,6668
129095,also,O,6668
129096,cause,O,6668
129097,damage,O,6669
129098,to,O,6669
129099,the,O,6669
129100,brain,O,6669
129101,and,O,6669
129102,lead,O,6669
129103,to,O,6669
129104,Balint,B-NAME_OF_DISEASE,6669
129105,s,I-NAME_OF_DISEASE,6669
129106,syndrome,I-NAME_OF_DISEASE,6669
129107,Neurodegenerative,B-CAUSE_OF_DISEASE,6669
129108,disorders,I-CAUSE_OF_DISEASE,6669
129109,Some,B-CAUSE_OF_DISEASE,6669
129110,neurodegenerative,I-CAUSE_OF_DISEASE,6669
129111,disorders,I-CAUSE_OF_DISEASE,6669
129112,such,I-CAUSE_OF_DISEASE,6669
129113,as,I-CAUSE_OF_DISEASE,6669
129114,Alzheimer,I-CAUSE_OF_DISEASE,6669
129115,s,I-CAUSE_OF_DISEASE,6669
129116,disease,I-CAUSE_OF_DISEASE,6669
129117,and,I-CAUSE_OF_DISEASE,6669
129118,multiple,I-CAUSE_OF_DISEASE,6669
129119,sclerosis,I-CAUSE_OF_DISEASE,6669
129120,can,O,6669
129121,also,O,6669
129122,cause,O,6669
129123,Balint,B-NAME_OF_DISEASE,6669
129124,s,I-NAME_OF_DISEASE,6669
129125,syndrome,I-NAME_OF_DISEASE,6669
129126,by,O,6669
129127,damaging,O,6669
129128,the,O,6669
129129,brain,O,6669
129130,Psychoanatomical,O,6670
129131,substrates,O,6670
129132,of,O,6670
129133,Bálint,B-NAME_OF_DISEASE,6670
129134,s,I-NAME_OF_DISEASE,6670
129135,syndrome,I-NAME_OF_DISEASE,6670
129136,-,O,6670
129137,BMJ,B-PUBLICATION_VENUE,6670
129138,Journal,I-PUBLICATION_VENUE,6670
129139,How,O,6670
129140,Can,O,6670
129141,You,O,6670
129142,Know,O,6670
129143,If,O,6670
129144,You,O,6670
129145,Have,O,6670
129146,Balint,B-NAME_OF_DISEASE,6670
129147,s,I-NAME_OF_DISEASE,6670
129148,Syndrome,I-NAME_OF_DISEASE,6670
129149,The,O,6670
129150,symptoms,O,6670
129151,of,O,6671
129152,Balint,B-NAME_OF_DISEASE,6671
129153,syndrome,I-NAME_OF_DISEASE,6671
129154,can,O,6671
129155,vary,O,6671
129156,depending,O,6671
129157,on,O,6671
129158,the,O,6671
129159,extent,O,6671
129160,of,O,6671
129161,brain,O,6671
129162,damage,O,6671
129163,and,O,6671
129164,the,O,6671
129165,specific,O,6671
129166,areas,O,6671
129167,affected,O,6671
129168,Common,O,6671
129169,symptoms,O,6671
129170,are,O,6671
129171,listed,O,6671
129172,as,O,6671
129173,Difficulty,B-SIGN_AND_SYMPTOM,6672
129174,with,I-SIGN_AND_SYMPTOM,6672
129175,visually,I-SIGN_AND_SYMPTOM,6672
129176,guided,I-SIGN_AND_SYMPTOM,6672
129177,movements,I-SIGN_AND_SYMPTOM,6672
129178,People,O,6672
129179,with,O,6672
129180,Balint,B-NAME_OF_DISEASE,6672
129181,syndrome,I-NAME_OF_DISEASE,6672
129182,may,O,6672
129183,have,B-SIGN_AND_SYMPTOM,6672
129184,difficulty,I-SIGN_AND_SYMPTOM,6672
129185,initiating,I-SIGN_AND_SYMPTOM,6672
129186,and,I-SIGN_AND_SYMPTOM,6672
129187,executing,I-SIGN_AND_SYMPTOM,6672
129188,visually,I-SIGN_AND_SYMPTOM,6672
129189,guided,I-SIGN_AND_SYMPTOM,6672
129190,movements,I-SIGN_AND_SYMPTOM,6672
129191,such,I-SIGN_AND_SYMPTOM,6672
129192,as,I-SIGN_AND_SYMPTOM,6672
129193,reaching,I-SIGN_AND_SYMPTOM,6672
129194,for,I-SIGN_AND_SYMPTOM,6672
129195,an,I-SIGN_AND_SYMPTOM,6672
129196,object,I-SIGN_AND_SYMPTOM,6672
129197,or,I-SIGN_AND_SYMPTOM,6672
129198,buttoning,I-SIGN_AND_SYMPTOM,6673
129199,a,I-SIGN_AND_SYMPTOM,6673
129200,shirt,I-SIGN_AND_SYMPTOM,6673
129201,Difficulty,B-SIGN_AND_SYMPTOM,6673
129202,with,I-SIGN_AND_SYMPTOM,6673
129203,attention,I-SIGN_AND_SYMPTOM,6673
129204,People,O,6673
129205,with,O,6673
129206,Balint,B-NAME_OF_DISEASE,6673
129207,syndrome,I-NAME_OF_DISEASE,6673
129208,may,O,6673
129209,have,B-SIGN_AND_SYMPTOM,6673
129210,difficulty,I-SIGN_AND_SYMPTOM,6673
129211,directing,I-SIGN_AND_SYMPTOM,6673
129212,their,I-SIGN_AND_SYMPTOM,6673
129213,attention,I-SIGN_AND_SYMPTOM,6673
129214,to,I-SIGN_AND_SYMPTOM,6673
129215,specific,I-SIGN_AND_SYMPTOM,6673
129216,visual,I-SIGN_AND_SYMPTOM,6673
129217,stimuli,I-SIGN_AND_SYMPTOM,6674
129218,such,I-SIGN_AND_SYMPTOM,6674
129219,as,I-SIGN_AND_SYMPTOM,6674
129220,a,I-SIGN_AND_SYMPTOM,6674
129221,person,I-SIGN_AND_SYMPTOM,6674
129222,s,I-SIGN_AND_SYMPTOM,6674
129223,face,I-SIGN_AND_SYMPTOM,6674
129224,or,I-SIGN_AND_SYMPTOM,6674
129225,a,I-SIGN_AND_SYMPTOM,6674
129226,car,I-SIGN_AND_SYMPTOM,6674
129227,driving,I-SIGN_AND_SYMPTOM,6674
129228,by,I-SIGN_AND_SYMPTOM,6674
129229,Difficulty,B-SIGN_AND_SYMPTOM,6674
129230,with,I-SIGN_AND_SYMPTOM,6674
129231,visual,I-SIGN_AND_SYMPTOM,6674
129232,memory,I-SIGN_AND_SYMPTOM,6674
129233,People,O,6675
129234,with,O,6675
129235,Balint,B-NAME_OF_DISEASE,6675
129236,syndrome,I-NAME_OF_DISEASE,6675
129237,may,O,6675
129238,have,B-SIGN_AND_SYMPTOM,6675
129239,difficulty,I-SIGN_AND_SYMPTOM,6675
129240,remembering,I-SIGN_AND_SYMPTOM,6675
129241,what,I-SIGN_AND_SYMPTOM,6675
129242,they,I-SIGN_AND_SYMPTOM,6675
129243,have,I-SIGN_AND_SYMPTOM,6675
129244,seen,I-SIGN_AND_SYMPTOM,6675
129245,such,I-SIGN_AND_SYMPTOM,6675
129246,as,I-SIGN_AND_SYMPTOM,6675
129247,the,I-SIGN_AND_SYMPTOM,6676
129248,location,I-SIGN_AND_SYMPTOM,6676
129249,of,I-SIGN_AND_SYMPTOM,6676
129250,objects,I-SIGN_AND_SYMPTOM,6676
129251,on,I-SIGN_AND_SYMPTOM,6676
129252,a,I-SIGN_AND_SYMPTOM,6676
129253,table,I-SIGN_AND_SYMPTOM,6676
129254,or,I-SIGN_AND_SYMPTOM,6676
129255,the,I-SIGN_AND_SYMPTOM,6676
129256,features,I-SIGN_AND_SYMPTOM,6676
129257,of,I-SIGN_AND_SYMPTOM,6676
129258,a,I-SIGN_AND_SYMPTOM,6676
129259,person,I-SIGN_AND_SYMPTOM,6676
129260,s,I-SIGN_AND_SYMPTOM,6676
129261,face,I-SIGN_AND_SYMPTOM,6676
129262,Difficulty,B-SIGN_AND_SYMPTOM,6676
129263,with,I-SIGN_AND_SYMPTOM,6676
129264,visual,I-SIGN_AND_SYMPTOM,6676
129265,perception,I-SIGN_AND_SYMPTOM,6676
129266,People,O,6677
129267,with,O,6677
129268,Balint,B-NAME_OF_DISEASE,6677
129269,syndrome,I-NAME_OF_DISEASE,6677
129270,may,O,6677
129271,have,B-SIGN_AND_SYMPTOM,6677
129272,difficulty,I-SIGN_AND_SYMPTOM,6677
129273,perceiving,I-SIGN_AND_SYMPTOM,6677
129274,visual,I-SIGN_AND_SYMPTOM,6677
129275,information,I-SIGN_AND_SYMPTOM,6677
129276,such,I-SIGN_AND_SYMPTOM,6677
129277,as,I-SIGN_AND_SYMPTOM,6677
129278,difficulty,I-SIGN_AND_SYMPTOM,6677
129279,recognizing,I-SIGN_AND_SYMPTOM,6677
129280,objects,I-SIGN_AND_SYMPTOM,6677
129281,or,I-SIGN_AND_SYMPTOM,6677
129282,faces,I-SIGN_AND_SYMPTOM,6677
129283,Is,O,6677
129284,Balint,B-NAME_OF_DISEASE,6677
129285,Syndrome,I-NAME_OF_DISEASE,6677
129286,Treatable,O,6677
129287,While,O,6677
129288,there,O,6677
129289,is,O,6677
129290,no,O,6677
129291,cure,O,6678
129292,for,O,6678
129293,Balint,B-NAME_OF_DISEASE,6678
129294,syndrome,I-NAME_OF_DISEASE,6678
129295,treatment,O,6678
129296,options,O,6678
129297,can,O,6678
129298,help,O,6678
129299,to,O,6678
129300,manage,O,6678
129301,symptoms,O,6678
129302,and,O,6678
129303,improve,O,6678
129304,function,O,6679
129305,Treatment,O,6679
129306,options,O,6679
129307,include,O,6679
129308,Physical,B-TREATMENT,6679
129309,therapy,I-TREATMENT,6679
129310,Physical,B-TREATMENT,6679
129311,therapy,I-TREATMENT,6679
129312,can,O,6679
129313,help,O,6679
129314,to,O,6679
129315,improve,O,6679
129316,motor,O,6679
129317,function,O,6679
129318,and,O,6679
129319,coordination,O,6679
129320,as,O,6679
129321,well,O,6679
129322,as,O,6679
129323,help,O,6679
129324,to,O,6679
129325,prevent,O,6680
129326,muscle,O,6680
129327,weakness,O,6680
129328,and,O,6680
129329,contractures,O,6680
129330,Occupational,B-TREATMENT,6680
129331,therapy,I-TREATMENT,6680
129332,Occupational,B-TREATMENT,6680
129333,therapy,I-TREATMENT,6680
129334,can,O,6680
129335,help,O,6680
129336,to,O,6680
129337,improve,O,6680
129338,the,O,6680
129339,ability,O,6680
129340,to,O,6680
129341,perform,O,6680
129342,daily,O,6680
129343,activities,O,6680
129344,such,O,6681
129345,as,O,6681
129346,dressing,O,6681
129347,and,O,6681
129348,grooming,O,6681
129349,Speech,B-TREATMENT,6681
129350,therapy,I-TREATMENT,6681
129351,Speech,B-TREATMENT,6681
129352,therapy,I-TREATMENT,6681
129353,can,O,6681
129354,help,O,6681
129355,to,O,6681
129356,improve,O,6681
129357,communication,O,6681
129358,skills,O,6681
129359,such,O,6681
129360,as,O,6681
129361,speaking,O,6681
129362,and,O,6681
129363,understanding,O,6681
129364,language,O,6681
129365,Cognitive,B-TREATMENT,6681
129366,therapy,I-TREATMENT,6682
129367,Cognitive,B-TREATMENT,6682
129368,therapy,I-TREATMENT,6682
129369,can,O,6682
129370,help,O,6682
129371,to,O,6682
129372,improve,O,6682
129373,attention,O,6682
129374,memory,O,6682
129375,and,O,6682
129376,other,O,6682
129377,cognitive,O,6682
129378,skills,O,6682
129379,Medications,B-TREATMENT,6682
129380,Medications,B-TREATMENT,6682
129381,can,O,6682
129382,be,O,6682
129383,used,O,6682
129384,to,O,6682
129385,manage,O,6682
129386,symptoms,O,6682
129387,of,O,6682
129388,Balint,B-NAME_OF_DISEASE,6683
129389,syndrome,I-NAME_OF_DISEASE,6683
129390,such,O,6683
129391,as,O,6683
129392,reducing,O,6683
129393,muscle,O,6683
129394,spasticity,O,6683
129395,or,O,6683
129396,improving,O,6683
129397,memory,O,6683
129398,Can,O,6683
129399,Balint,B-NAME_OF_DISEASE,6683
129400,Syndrome,I-NAME_OF_DISEASE,6683
129401,Improve,O,6683
129402,Over,O,6684
129403,Time,O,6684
129404,The,O,6684
129405,prognosis,O,6684
129406,for,O,6684
129407,Balint,B-NAME_OF_DISEASE,6684
129408,syndrome,I-NAME_OF_DISEASE,6684
129409,can,O,6684
129410,vary,O,6684
129411,depending,O,6684
129412,on,O,6684
129413,the,O,6684
129414,extent,O,6684
129415,of,O,6684
129416,brain,O,6684
129417,damage,O,6684
129418,and,O,6684
129419,the,O,6684
129420,specific,O,6684
129421,areas,O,6684
129422,affected,O,6684
129423,Some,O,6685
129424,people,O,6685
129425,may,O,6685
129426,experience,O,6685
129427,improvement,O,6685
129428,in,O,6685
129429,symptoms,O,6685
129430,over,O,6685
129431,time,O,6685
129432,while,O,6685
129433,others,O,6685
129434,may,O,6685
129435,not,O,6685
129436,Conclusion,O,6685
129437,Balint,B-NAME_OF_DISEASE,6686
129438,syndrome,I-NAME_OF_DISEASE,6686
129439,is,O,6686
129440,a,O,6686
129441,rare,O,6686
129442,neurological,O,6686
129443,condition,O,6686
129444,characterized,O,6686
129445,by,O,6686
129446,difficulties,B-SIGN_AND_SYMPTOM,6686
129447,with,I-SIGN_AND_SYMPTOM,6686
129448,visually,I-SIGN_AND_SYMPTOM,6686
129449,guided,I-SIGN_AND_SYMPTOM,6686
129450,movements,I-SIGN_AND_SYMPTOM,6686
129451,attention,I-SIGN_AND_SYMPTOM,6686
129452,visual,I-SIGN_AND_SYMPTOM,6686
129453,memory,I-SIGN_AND_SYMPTOM,6686
129454,and,I-SIGN_AND_SYMPTOM,6686
129455,visual,I-SIGN_AND_SYMPTOM,6686
129456,perception,I-SIGN_AND_SYMPTOM,6687
129457,It,O,6687
129458,is,O,6687
129459,caused,O,6687
129460,by,O,6687
129461,damage,B-CAUSE_OF_DISEASE,6687
129462,to,I-CAUSE_OF_DISEASE,6687
129463,specific,I-CAUSE_OF_DISEASE,6687
129464,areas,I-CAUSE_OF_DISEASE,6687
129465,of,I-CAUSE_OF_DISEASE,6687
129466,the,I-CAUSE_OF_DISEASE,6687
129467,brain,I-CAUSE_OF_DISEASE,6687
129468,including,I-CAUSE_OF_DISEASE,6687
129469,the,I-CAUSE_OF_DISEASE,6687
129470,parietal,I-CAUSE_OF_DISEASE,6687
129471,lobes,I-CAUSE_OF_DISEASE,6687
129472,and,I-CAUSE_OF_DISEASE,6687
129473,superior,I-CAUSE_OF_DISEASE,6687
129474,temporal,I-CAUSE_OF_DISEASE,6688
129475,gyrus,I-CAUSE_OF_DISEASE,6688
129476,Treatment,O,6688
129477,options,O,6688
129478,include,O,6688
129479,physical,B-TREATMENT,6688
129480,therapy,I-TREATMENT,6688
129481,occupational,B-TREATMENT,6688
129482,therapy,I-TREATMENT,6688
129483,speech,B-TREATMENT,6688
129484,therapy,I-TREATMENT,6688
129485,cognitive,B-TREATMENT,6688
129486,therapy,I-TREATMENT,6688
129487,and,O,6688
129488,medications,B-TREATMENT,6688
129489,which,O,6688
129490,can,O,6688
129491,help,O,6688
129492,to,O,6689
129493,manage,O,6689
129494,symptoms,O,6689
129495,and,O,6689
129496,improve,O,6689
129497,function,O,6689
129498,Grades,O,6689
129499,of,O,6689
129500,Binocular,B-NAME_OF_DISEASE,6689
129501,Vision,I-NAME_OF_DISEASE,6689
129502,Dysfunction,I-NAME_OF_DISEASE,6689
129503,Binocular,O,6689
129504,vision,O,6689
129505,can,O,6689
129506,be,O,6689
129507,graded,O,6689
129508,based,O,6689
129509,on,O,6689
129510,the,O,6689
129511,degree,O,6689
129512,of,O,6689
129513,deviation,O,6689
129514,or,O,6689
129515,misalignment,O,6690
129516,between,O,6690
129517,the,O,6690
129518,two,O,6690
129519,eyes,O,6690
129520,There,O,6690
129521,are,O,6690
129522,three,O,6690
129523,grades,O,6690
129524,of,O,6690
129525,binocular,O,6690
129526,vision,O,6690
129527,first,O,6690
129528,grade,O,6690
129529,second,O,6690
129530,grade,O,6690
129531,and,O,6690
129532,third,O,6690
129533,grade,O,6690
129534,First,O,6690
129535,Grade,O,6690
129536,This,O,6690
129537,is,O,6690
129538,the,O,6690
129539,normal,O,6690
129540,state,O,6691
129541,of,O,6691
129542,binocular,O,6691
129543,vision,O,6691
129544,where,O,6691
129545,the,O,6691
129546,eyes,O,6691
129547,are,O,6691
129548,perfectly,O,6691
129549,aligned,O,6691
129550,and,O,6691
129551,there,O,6691
129552,is,O,6691
129553,no,O,6691
129554,deviation,O,6691
129555,The,O,6691
129556,eyes,O,6691
129557,work,O,6691
129558,together,O,6691
129559,to,O,6691
129560,focus,O,6692
129561,on,O,6692
129562,an,O,6692
129563,object,O,6692
129564,and,O,6692
129565,produce,O,6692
129566,a,O,6692
129567,single,O,6692
129568,image,O,6692
129569,People,O,6692
129570,with,O,6692
129571,first-grade,O,6692
129572,binocular,O,6693
129573,vision,O,6693
129574,have,O,6693
129575,good,O,6693
129576,depth,O,6693
129577,perception,O,6693
129578,and,O,6693
129579,have,O,6693
129580,no,O,6693
129581,symptoms,O,6693
129582,of,O,6693
129583,double,O,6693
129584,vision,O,6693
129585,or,O,6693
129586,eye,O,6693
129587,strain,O,6693
129588,Second,O,6693
129589,Grade,O,6693
129590,This,O,6693
129591,is,O,6693
129592,a,O,6693
129593,mild,O,6694
129594,form,O,6694
129595,of,O,6694
129596,binocular,B-NAME_OF_DISEASE,6694
129597,vision,I-NAME_OF_DISEASE,6694
129598,deviation,I-NAME_OF_DISEASE,6694
129599,where,O,6694
129600,the,B-SIGN_AND_SYMPTOM,6694
129601,eyes,I-SIGN_AND_SYMPTOM,6694
129602,tend,I-SIGN_AND_SYMPTOM,6694
129603,to,I-SIGN_AND_SYMPTOM,6694
129604,deviate,I-SIGN_AND_SYMPTOM,6694
129605,slightly,I-SIGN_AND_SYMPTOM,6694
129606,The,B-SIGN_AND_SYMPTOM,6694
129607,eyes,I-SIGN_AND_SYMPTOM,6694
129608,may,I-SIGN_AND_SYMPTOM,6694
129609,not,I-SIGN_AND_SYMPTOM,6694
129610,be,I-SIGN_AND_SYMPTOM,6694
129611,perfectly,I-SIGN_AND_SYMPTOM,6694
129612,aligned,I-SIGN_AND_SYMPTOM,6694
129613,but,O,6694
129614,they,O,6694
129615,can,O,6694
129616,still,O,6694
129617,work,O,6694
129618,together,O,6694
129619,to,O,6694
129620,produce,O,6694
129621,a,O,6694
129622,single,O,6694
129623,image,O,6694
129624,People,O,6694
129625,with,O,6694
129626,second-grade,O,6694
129627,binocular,O,6695
129628,vision,O,6695
129629,may,O,6695
129630,experience,O,6695
129631,occasional,B-SIGN_AND_SYMPTOM,6695
129632,double,I-SIGN_AND_SYMPTOM,6695
129633,vision,I-SIGN_AND_SYMPTOM,6695
129634,or,I-SIGN_AND_SYMPTOM,6695
129635,eye,I-SIGN_AND_SYMPTOM,6695
129636,strain,I-SIGN_AND_SYMPTOM,6695
129637,but,O,6695
129638,it,O,6695
129639,is,O,6695
129640,not,O,6695
129641,severe,O,6695
129642,enough,O,6696
129643,to,O,6696
129644,cause,O,6696
129645,significant,O,6696
129646,problems,O,6696
129647,Third,O,6696
129648,Grade,O,6696
129649,This,O,6696
129650,is,O,6696
129651,a,O,6696
129652,severe,O,6696
129653,form,O,6696
129654,of,O,6696
129655,binocular,B-NAME_OF_DISEASE,6696
129656,vision,I-NAME_OF_DISEASE,6696
129657,deviation,I-NAME_OF_DISEASE,6696
129658,where,O,6696
129659,the,B-SIGN_AND_SYMPTOM,6696
129660,eyes,I-SIGN_AND_SYMPTOM,6697
129661,are,I-SIGN_AND_SYMPTOM,6697
129662,misaligned,I-SIGN_AND_SYMPTOM,6697
129663,and,I-SIGN_AND_SYMPTOM,6697
129664,cannot,I-SIGN_AND_SYMPTOM,6697
129665,work,I-SIGN_AND_SYMPTOM,6697
129666,together,I-SIGN_AND_SYMPTOM,6697
129667,to,I-SIGN_AND_SYMPTOM,6697
129668,produce,I-SIGN_AND_SYMPTOM,6697
129669,a,I-SIGN_AND_SYMPTOM,6697
129670,single,I-SIGN_AND_SYMPTOM,6697
129671,image,I-SIGN_AND_SYMPTOM,6697
129672,People,O,6697
129673,with,O,6698
129674,third-grade,O,6698
129675,binocular,O,6698
129676,vision,O,6698
129677,may,O,6698
129678,experience,O,6698
129679,constant,B-SIGN_AND_SYMPTOM,6698
129680,double,I-SIGN_AND_SYMPTOM,6698
129681,vision,I-SIGN_AND_SYMPTOM,6698
129682,or,I-SIGN_AND_SYMPTOM,6698
129683,eye,I-SIGN_AND_SYMPTOM,6698
129684,strain,I-SIGN_AND_SYMPTOM,6698
129685,and,I-SIGN_AND_SYMPTOM,6698
129686,may,I-SIGN_AND_SYMPTOM,6698
129687,have,I-SIGN_AND_SYMPTOM,6698
129688,difficulty,I-SIGN_AND_SYMPTOM,6698
129689,with,I-SIGN_AND_SYMPTOM,6698
129690,depth,I-SIGN_AND_SYMPTOM,6698
129691,perception,I-SIGN_AND_SYMPTOM,6698
129692,This,O,6698
129693,condition,O,6698
129694,can,O,6699
129695,lead,O,6699
129696,to,O,6699
129697,amblyopia,B-NAME_OF_DISEASE,6699
129698,lazy,B-NAME_OF_DISEASE,6699
129699,eye,I-NAME_OF_DISEASE,6699
129700,if,O,6699
129701,not,O,6699
129702,treated,O,6699
129703,promptly,O,6699
129704,What,O,6699
129705,Causes,O,6699
129706,Binocular,B-NAME_OF_DISEASE,6699
129707,Vision,I-NAME_OF_DISEASE,6699
129708,Dysfunction,I-NAME_OF_DISEASE,6699
129709,Binocular,B-NAME_OF_DISEASE,6699
129710,vision,I-NAME_OF_DISEASE,6699
129711,dysfunction,I-NAME_OF_DISEASE,6699
129712,can,O,6699
129713,cause,O,6699
129714,a,O,6699
129715,variety,O,6699
129716,of,O,6699
129717,symptoms,O,6699
129718,including,O,6699
129719,double,B-SIGN_AND_SYMPTOM,6699
129720,vision,I-SIGN_AND_SYMPTOM,6699
129721,blurred,I-SIGN_AND_SYMPTOM,6699
129722,vision,I-SIGN_AND_SYMPTOM,6699
129723,and,I-SIGN_AND_SYMPTOM,6699
129724,headaches,I-SIGN_AND_SYMPTOM,6699
129725,The,O,6699
129726,causes,O,6699
129727,of,O,6699
129728,binocular,B-NAME_OF_DISEASE,6699
129729,vision,I-NAME_OF_DISEASE,6699
129730,dysfunction,I-NAME_OF_DISEASE,6699
129731,can,O,6699
129732,be,O,6699
129733,divided,O,6700
129734,into,O,6700
129735,several,O,6700
129736,categories,O,6700
129737,Accommodation,B-CAUSE_OF_DISEASE,6700
129738,disorders,I-CAUSE_OF_DISEASE,6700
129739,Accommodation,B-CAUSE_OF_DISEASE,6700
129740,disorders,I-CAUSE_OF_DISEASE,6700
129741,occur,O,6700
129742,when,O,6700
129743,the,O,6700
129744,eye,O,6700
129745,s,O,6700
129746,ability,O,6700
129747,to,O,6700
129748,adjust,O,6700
129749,its,O,6700
129750,focus,O,6700
129751,on,O,6700
129752,an,O,6700
129753,object,O,6700
129754,at,O,6700
129755,different,O,6700
129756,distances,O,6700
129757,is,O,6700
129758,impaired,O,6700
129759,This,O,6700
129760,can,O,6701
129761,lead,O,6701
129762,to,O,6701
129763,binocular,B-NAME_OF_DISEASE,6701
129764,vision,I-NAME_OF_DISEASE,6701
129765,dysfunction,I-NAME_OF_DISEASE,6701
129766,especially,O,6701
129767,when,O,6701
129768,trying,O,6701
129769,to,O,6701
129770,focus,O,6701
129771,on,O,6701
129772,near,O,6701
129773,objects,O,6701
129774,Neurological,B-CAUSE_OF_DISEASE,6702
129775,conditions,I-CAUSE_OF_DISEASE,6702
129776,Certain,B-CAUSE_OF_DISEASE,6702
129777,neurological,I-CAUSE_OF_DISEASE,6702
129778,conditions,I-CAUSE_OF_DISEASE,6702
129779,such,I-CAUSE_OF_DISEASE,6702
129780,as,I-CAUSE_OF_DISEASE,6702
129781,brain,I-CAUSE_OF_DISEASE,6702
129782,injury,I-CAUSE_OF_DISEASE,6702
129783,stroke,I-CAUSE_OF_DISEASE,6702
129784,or,I-CAUSE_OF_DISEASE,6702
129785,brain,I-CAUSE_OF_DISEASE,6702
129786,tumor,I-CAUSE_OF_DISEASE,6702
129787,can,O,6702
129788,cause,O,6702
129789,binocular,B-NAME_OF_DISEASE,6702
129790,vision,I-NAME_OF_DISEASE,6702
129791,dysfunction,I-NAME_OF_DISEASE,6702
129792,These,O,6702
129793,conditions,O,6702
129794,can,O,6702
129795,affect,O,6702
129796,the,O,6702
129797,nerve,O,6702
129798,pathways,O,6702
129799,that,O,6702
129800,control,O,6702
129801,eye,O,6703
129802,movement,O,6703
129803,and,O,6703
129804,alignment,O,6703
129805,Trauma,B-CAUSE_OF_DISEASE,6703
129806,Trauma,B-CAUSE_OF_DISEASE,6703
129807,to,I-CAUSE_OF_DISEASE,6703
129808,the,I-CAUSE_OF_DISEASE,6704
129809,eyes,I-CAUSE_OF_DISEASE,6704
129810,head,I-CAUSE_OF_DISEASE,6704
129811,or,I-CAUSE_OF_DISEASE,6704
129812,brain,I-CAUSE_OF_DISEASE,6704
129813,can,O,6704
129814,cause,O,6704
129815,binocular,B-NAME_OF_DISEASE,6704
129816,vision,I-NAME_OF_DISEASE,6704
129817,dysfunction,I-NAME_OF_DISEASE,6704
129818,such,O,6704
129819,as,O,6704
129820,a,B-CAUSE_OF_DISEASE,6704
129821,concussion,I-CAUSE_OF_DISEASE,6704
129822,or,I-CAUSE_OF_DISEASE,6704
129823,a,I-CAUSE_OF_DISEASE,6704
129824,skull,I-CAUSE_OF_DISEASE,6705
129825,fracture,I-CAUSE_OF_DISEASE,6705
129826,Exercises,O,6705
129827,for,O,6705
129828,Binocular,B-NAME_OF_DISEASE,6705
129829,Vision,I-NAME_OF_DISEASE,6705
129830,Dysfunction,I-NAME_OF_DISEASE,6705
129831,While,O,6705
129832,some,O,6705
129833,causes,O,6705
129834,of,O,6705
129835,binocular,B-NAME_OF_DISEASE,6705
129836,vision,I-NAME_OF_DISEASE,6705
129837,dysfunction,I-NAME_OF_DISEASE,6705
129838,may,O,6705
129839,require,O,6705
129840,medical,B-TREATMENT,6705
129841,intervention,I-TREATMENT,6705
129842,such,I-TREATMENT,6705
129843,as,I-TREATMENT,6705
129844,corrective,I-TREATMENT,6705
129845,lenses,I-TREATMENT,6705
129846,or,I-TREATMENT,6705
129847,surgery,I-TREATMENT,6705
129848,certain,B-TREATMENT,6705
129849,exercises,I-TREATMENT,6705
129850,can,O,6705
129851,help,O,6706
129852,improve,O,6706
129853,the,O,6706
129854,brain,O,6706
129855,s,O,6706
129856,ability,O,6706
129857,to,O,6706
129858,coordinate,O,6706
129859,the,O,6706
129860,eyes,O,6706
129861,and,O,6706
129862,improve,O,6706
129863,binocular,O,6706
129864,vision,O,6706
129865,Here,O,6706
129866,are,O,6707
129867,some,O,6707
129868,exercises,O,6707
129869,that,O,6707
129870,can,O,6707
129871,be,O,6707
129872,used,O,6707
129873,to,O,6707
129874,improve,O,6707
129875,binocular,B-NAME_OF_DISEASE,6707
129876,vision,I-NAME_OF_DISEASE,6707
129877,dysfunction,I-NAME_OF_DISEASE,6707
129878,Pencil,B-TREATMENT,6707
129879,push-ups,I-TREATMENT,6707
129880,Hold,O,6708
129881,a,O,6708
129882,pencil,O,6708
129883,at,O,6708
129884,arm,O,6708
129885,s,O,6708
129886,length,O,6708
129887,in,O,6708
129888,front,O,6708
129889,of,O,6708
129890,your,O,6708
129891,face,O,6708
129892,Slowly,O,6708
129893,move,O,6708
129894,the,O,6708
129895,pencil,O,6708
129896,towards,O,6708
129897,your,O,6708
129898,nose,O,6708
129899,keeping,O,6708
129900,your,O,6708
129901,eyes,O,6709
129902,focused,O,6709
129903,on,O,6709
129904,the,O,6709
129905,pencil,O,6709
129906,Once,O,6709
129907,the,O,6709
129908,pencil,O,6709
129909,is,O,6709
129910,about,O,6709
129911,six,O,6709
129912,inches,O,6709
129913,from,O,6709
129914,your,O,6709
129915,nose,O,6709
129916,hold,O,6709
129917,the,O,6709
129918,position,O,6709
129919,for,O,6709
129920,a,O,6709
129921,few,O,6710
129922,seconds,O,6710
129923,and,O,6710
129924,then,O,6710
129925,move,O,6710
129926,the,O,6710
129927,pencil,O,6710
129928,back,O,6710
129929,to,O,6710
129930,arm,O,6710
129931,s,O,6710
129932,length,O,6710
129933,Repeat,O,6711
129934,this,O,6711
129935,exercise,O,6711
129936,several,O,6711
129937,times,O,6711
129938,a,O,6711
129939,day,O,6711
129940,Near-far,B-TREATMENT,6711
129941,focus,I-TREATMENT,6711
129942,Hold,O,6711
129943,a,O,6711
129944,pen,O,6711
129945,or,O,6711
129946,pencil,O,6711
129947,at,O,6711
129948,arm,O,6711
129949,s,O,6711
129950,length,O,6712
129951,in,O,6712
129952,front,O,6712
129953,of,O,6712
129954,your,O,6712
129955,face,O,6712
129956,Focus,O,6712
129957,on,O,6712
129958,the,O,6712
129959,pen,O,6712
129960,or,O,6712
129961,pencil,O,6712
129962,for,O,6712
129963,a,O,6712
129964,few,O,6712
129965,seconds,O,6712
129966,then,O,6713
129967,shift,O,6713
129968,your,O,6713
129969,focus,O,6713
129970,to,O,6713
129971,an,O,6713
129972,object,O,6713
129973,in,O,6713
129974,the,O,6713
129975,distance,O,6713
129976,such,O,6713
129977,as,O,6713
129978,a,O,6713
129979,clock,O,6713
129980,on,O,6713
129981,the,O,6713
129982,wall,O,6713
129983,Alternate,O,6713
129984,focusing,O,6713
129985,on,O,6713
129986,the,O,6713
129987,pen,O,6713
129988,or,O,6713
129989,pencil,O,6713
129990,and,O,6713
129991,the,O,6714
129992,distant,O,6714
129993,object,O,6714
129994,for,O,6714
129995,a,O,6714
129996,few,O,6714
129997,minutes,O,6714
129998,Eye,B-TREATMENT,6714
129999,movement,I-TREATMENT,6714
130000,exercises,I-TREATMENT,6714
130001,These,O,6714
130002,exercises,O,6714
130003,are,O,6714
130004,designed,O,6714
130005,to,O,6714
130006,help,O,6714
130007,the,O,6714
130008,eyes,O,6714
130009,move,O,6714
130010,in,O,6715
130011,coordination,O,6715
130012,Examples,O,6715
130013,include,O,6715
130014,moving,O,6715
130015,the,O,6715
130016,eyes,O,6715
130017,in,O,6715
130018,the,O,6715
130019,shape,O,6715
130020,of,O,6715
130021,a,O,6715
130022,H,O,6715
130023,or,O,6715
130024,X,O,6715
130025,or,O,6715
130026,following,O,6715
130027,a,O,6715
130028,moving,O,6715
130029,object,O,6715
130030,with,O,6715
130031,the,O,6715
130032,eyes,O,6715
130033,Vision,B-TREATMENT,6715
130034,Therapy,I-TREATMENT,6715
130035,Vision,B-TREATMENT,6715
130036,therapy,I-TREATMENT,6715
130037,is,O,6715
130038,a,O,6716
130039,type,O,6716
130040,of,O,6716
130041,rehabilitation,O,6716
130042,that,O,6716
130043,helps,O,6716
130044,to,O,6716
130045,improve,O,6716
130046,visual,O,6716
130047,skills,O,6716
130048,and,O,6716
130049,coordination,O,6716
130050,of,O,6716
130051,the,O,6716
130052,eyes,O,6716
130053,This,O,6716
130054,can,O,6716
130055,include,O,6716
130056,exercises,O,6716
130057,to,O,6716
130058,improve,O,6716
130059,eye,O,6716
130060,tracking,O,6716
130061,focusing,O,6717
130062,and,O,6717
130063,eye-teaming,O,6717
130064,abilities,O,6717
130065,Prism,B-TREATMENT,6717
130066,glasses,I-TREATMENT,6717
130067,Prism,B-TREATMENT,6717
130068,glasses,I-TREATMENT,6717
130069,are,O,6717
130070,specially,O,6717
130071,designed,O,6717
130072,glasses,O,6717
130073,that,O,6717
130074,can,O,6717
130075,help,O,6717
130076,align,O,6717
130077,the,O,6717
130078,eyes,O,6717
130079,by,O,6718
130080,bending,O,6718
130081,light,O,6718
130082,They,O,6718
130083,are,O,6718
130084,often,O,6718
130085,used,O,6718
130086,in,O,6718
130087,vision,B-TREATMENT,6718
130088,therapy,I-TREATMENT,6718
130089,to,O,6718
130090,help,O,6718
130091,correct,O,6718
130092,double,O,6718
130093,vision,O,6718
130094,and,O,6718
130095,improve,O,6718
130096,eye,O,6718
130097,coordination,O,6718
130098,Palming,B-TREATMENT,6718
130099,This,O,6718
130100,exercise,O,6718
130101,involves,O,6718
130102,covering,O,6718
130103,the,O,6719
130104,eyes,O,6719
130105,with,O,6719
130106,the,O,6719
130107,palms,O,6719
130108,of,O,6719
130109,the,O,6719
130110,hands,O,6719
130111,for,O,6719
130112,a,O,6719
130113,few,O,6719
130114,minutes,O,6719
130115,to,O,6719
130116,relax,O,6719
130117,the,O,6719
130118,eyes,O,6719
130119,and,O,6719
130120,improve,O,6719
130121,eye,O,6719
130122,coordination,O,6719
130123,Conclusion,O,6720
130124,In,O,6720
130125,conclusion,O,6720
130126,binocular,B-NAME_OF_DISEASE,6720
130127,vision,I-NAME_OF_DISEASE,6720
130128,dysfunction,I-NAME_OF_DISEASE,6720
130129,can,O,6720
130130,cause,O,6720
130131,a,O,6720
130132,variety,O,6720
130133,of,O,6720
130134,symptoms,O,6720
130135,including,O,6720
130136,double,B-SIGN_AND_SYMPTOM,6720
130137,vision,I-SIGN_AND_SYMPTOM,6720
130138,blurred,I-SIGN_AND_SYMPTOM,6720
130139,vision,I-SIGN_AND_SYMPTOM,6720
130140,and,I-SIGN_AND_SYMPTOM,6720
130141,headaches,I-SIGN_AND_SYMPTOM,6720
130142,While,O,6720
130143,some,O,6720
130144,causes,O,6720
130145,of,O,6720
130146,binocular,B-NAME_OF_DISEASE,6721
130147,vision,I-NAME_OF_DISEASE,6721
130148,dysfunction,I-NAME_OF_DISEASE,6721
130149,may,O,6721
130150,require,O,6721
130151,medical,B-TREATMENT,6721
130152,intervention,I-TREATMENT,6721
130153,certain,B-TREATMENT,6721
130154,exercises,I-TREATMENT,6721
130155,can,O,6721
130156,help,O,6721
130157,improve,O,6721
130158,the,O,6721
130159,brain,O,6721
130160,s,O,6721
130161,ability,O,6721
130162,to,O,6721
130163,coordinate,O,6721
130164,the,O,6721
130165,eyes,O,6722
130166,and,O,6722
130167,improve,O,6722
130168,binocular,O,6722
130169,vision,O,6722
130170,What,O,6722
130171,Is,O,6722
130172,Ocular,B-NAME_OF_DISEASE,6722
130173,Migraine,I-NAME_OF_DISEASE,6722
130174,Ocular,B-NAME_OF_DISEASE,6722
130175,migraine,I-NAME_OF_DISEASE,6722
130176,also,O,6722
130177,known,O,6722
130178,as,O,6722
130179,retinal,B-NAME_OF_DISEASE,6722
130180,migraine,I-NAME_OF_DISEASE,6722
130181,is,O,6722
130182,a,O,6723
130183,type,O,6723
130184,of,O,6723
130185,migraine,B-NAME_OF_DISEASE,6723
130186,headache,I-NAME_OF_DISEASE,6723
130187,that,O,6723
130188,is,O,6723
130189,accompanied,O,6723
130190,by,O,6723
130191,visual,B-SIGN_AND_SYMPTOM,6723
130192,disturbances,I-SIGN_AND_SYMPTOM,6723
130193,It,O,6723
130194,affects,O,6723
130195,about,O,6723
130196,3%,O,6723
130197,of,O,6723
130198,the,O,6723
130199,general,O,6723
130200,population,O,6723
130201,and,O,6723
130202,it,O,6723
130203,is,O,6724
130204,more,O,6724
130205,common,O,6724
130206,in,O,6724
130207,women,O,6724
130208,than,O,6724
130209,in,O,6724
130210,men,O,6724
130211,What,O,6724
130212,Causes,O,6724
130213,Ocular,B-NAME_OF_DISEASE,6724
130214,Migraine,I-NAME_OF_DISEASE,6724
130215,While,O,6724
130216,the,O,6724
130217,exact,O,6724
130218,cause,O,6724
130219,of,O,6725
130220,ocular,B-NAME_OF_DISEASE,6725
130221,migraines,I-NAME_OF_DISEASE,6725
130222,is,O,6725
130223,not,O,6725
130224,fully,O,6725
130225,understood,O,6725
130226,there,O,6725
130227,are,O,6725
130228,several,O,6725
130229,factors,O,6725
130230,that,O,6725
130231,may,O,6725
130232,trigger,O,6725
130233,an,O,6725
130234,attack,O,6725
130235,Here,O,6725
130236,are,O,6725
130237,some,O,6726
130238,common,O,6726
130239,causes,O,6726
130240,of,O,6726
130241,ocular,B-NAME_OF_DISEASE,6726
130242,migraines,I-NAME_OF_DISEASE,6726
130243,Stress,B-CAUSE_OF_DISEASE,6726
130244,Stress,B-CAUSE_OF_DISEASE,6726
130245,is,O,6726
130246,one,O,6726
130247,of,O,6726
130248,the,O,6726
130249,most,O,6726
130250,common,O,6726
130251,triggers,O,6726
130252,for,O,6726
130253,ocular,B-NAME_OF_DISEASE,6726
130254,migraines,I-NAME_OF_DISEASE,6726
130255,Stress,B-CAUSE_OF_DISEASE,6726
130256,can,O,6726
130257,cause,O,6726
130258,changes,B-CAUSE_OF_DISEASE,6726
130259,in,I-CAUSE_OF_DISEASE,6726
130260,blood,I-CAUSE_OF_DISEASE,6726
130261,flow,I-CAUSE_OF_DISEASE,6727
130262,and,O,6727
130263,can,O,6727
130264,lead,O,6727
130265,to,O,6727
130266,the,B-CAUSE_OF_DISEASE,6727
130267,constriction,I-CAUSE_OF_DISEASE,6727
130268,or,I-CAUSE_OF_DISEASE,6727
130269,dilation,I-CAUSE_OF_DISEASE,6727
130270,of,I-CAUSE_OF_DISEASE,6727
130271,blood,I-CAUSE_OF_DISEASE,6727
130272,vessels,I-CAUSE_OF_DISEASE,6727
130273,which,O,6727
130274,can,O,6727
130275,trigger,O,6727
130276,a,B-NAME_OF_DISEASE,6727
130277,migraine,I-NAME_OF_DISEASE,6727
130278,Lack,B-CAUSE_OF_DISEASE,6727
130279,of,I-CAUSE_OF_DISEASE,6727
130280,sleep,I-CAUSE_OF_DISEASE,6727
130281,Not,B-CAUSE_OF_DISEASE,6727
130282,getting,I-CAUSE_OF_DISEASE,6727
130283,enough,I-CAUSE_OF_DISEASE,6727
130284,sleep,I-CAUSE_OF_DISEASE,6727
130285,or,I-CAUSE_OF_DISEASE,6727
130286,having,I-CAUSE_OF_DISEASE,6727
130287,disrupted,I-CAUSE_OF_DISEASE,6727
130288,sleep,I-CAUSE_OF_DISEASE,6727
130289,patterns,I-CAUSE_OF_DISEASE,6727
130290,can,O,6727
130291,increase,O,6727
130292,the,O,6727
130293,risk,O,6727
130294,of,O,6727
130295,ocular,B-NAME_OF_DISEASE,6727
130296,migraines,I-NAME_OF_DISEASE,6727
130297,Bright,B-CAUSE_OF_DISEASE,6727
130298,lights,I-CAUSE_OF_DISEASE,6727
130299,Bright,B-CAUSE_OF_DISEASE,6728
130300,lights,I-CAUSE_OF_DISEASE,6728
130301,especially,I-CAUSE_OF_DISEASE,6728
130302,flickering,I-CAUSE_OF_DISEASE,6728
130303,or,I-CAUSE_OF_DISEASE,6728
130304,pulsating,I-CAUSE_OF_DISEASE,6728
130305,lights,I-CAUSE_OF_DISEASE,6728
130306,can,O,6728
130307,trigger,O,6728
130308,an,O,6728
130309,ocular,B-NAME_OF_DISEASE,6728
130310,migraine,I-NAME_OF_DISEASE,6728
130311,in,O,6728
130312,some,O,6728
130313,people,O,6728
130314,Hormonal,B-CAUSE_OF_DISEASE,6728
130315,changes,I-CAUSE_OF_DISEASE,6729
130316,Ocular,B-NAME_OF_DISEASE,6729
130317,migraines,I-NAME_OF_DISEASE,6729
130318,may,O,6729
130319,be,O,6729
130320,more,O,6729
130321,common,O,6729
130322,in,O,6729
130323,women,O,6729
130324,due,O,6729
130325,to,O,6729
130326,hormonal,B-CAUSE_OF_DISEASE,6729
130327,fluctuations,I-CAUSE_OF_DISEASE,6729
130328,that,I-CAUSE_OF_DISEASE,6729
130329,occur,I-CAUSE_OF_DISEASE,6729
130330,during,I-CAUSE_OF_DISEASE,6729
130331,menstruation,I-CAUSE_OF_DISEASE,6729
130332,pregnancy,I-CAUSE_OF_DISEASE,6729
130333,and,I-CAUSE_OF_DISEASE,6729
130334,menopause,I-CAUSE_OF_DISEASE,6729
130335,Medications,B-CAUSE_OF_DISEASE,6729
130336,Some,O,6729
130337,medications,B-CAUSE_OF_DISEASE,6729
130338,such,I-CAUSE_OF_DISEASE,6729
130339,as,I-CAUSE_OF_DISEASE,6729
130340,oral,I-CAUSE_OF_DISEASE,6729
130341,contraceptives,I-CAUSE_OF_DISEASE,6729
130342,and,I-CAUSE_OF_DISEASE,6729
130343,vasodilators,I-CAUSE_OF_DISEASE,6730
130344,may,O,6730
130345,increase,O,6730
130346,the,O,6730
130347,risk,O,6730
130348,of,O,6730
130349,ocular,B-NAME_OF_DISEASE,6730
130350,migraines,I-NAME_OF_DISEASE,6730
130351,Caffeine,B-CAUSE_OF_DISEASE,6730
130352,and,I-CAUSE_OF_DISEASE,6730
130353,alcohol,I-CAUSE_OF_DISEASE,6730
130354,Consuming,B-CAUSE_OF_DISEASE,6730
130355,large,I-CAUSE_OF_DISEASE,6730
130356,amounts,I-CAUSE_OF_DISEASE,6730
130357,of,I-CAUSE_OF_DISEASE,6730
130358,caffeine,I-CAUSE_OF_DISEASE,6730
130359,or,I-CAUSE_OF_DISEASE,6730
130360,alcohol,I-CAUSE_OF_DISEASE,6730
130361,may,O,6730
130362,trigger,O,6730
130363,an,O,6730
130364,ocular,B-NAME_OF_DISEASE,6730
130365,migraine,I-NAME_OF_DISEASE,6730
130366,in,O,6730
130367,some,O,6730
130368,people,O,6730
130369,Certain,B-CAUSE_OF_DISEASE,6730
130370,foods,I-CAUSE_OF_DISEASE,6730
130371,Some,O,6730
130372,people,O,6731
130373,may,O,6731
130374,be,O,6731
130375,more,O,6731
130376,sensitive,B-CAUSE_OF_DISEASE,6731
130377,to,I-CAUSE_OF_DISEASE,6731
130378,certain,I-CAUSE_OF_DISEASE,6731
130379,foods,I-CAUSE_OF_DISEASE,6731
130380,such,I-CAUSE_OF_DISEASE,6731
130381,as,I-CAUSE_OF_DISEASE,6731
130382,aged,I-CAUSE_OF_DISEASE,6731
130383,cheeses,I-CAUSE_OF_DISEASE,6731
130384,processed,I-CAUSE_OF_DISEASE,6731
130385,meats,I-CAUSE_OF_DISEASE,6731
130386,and,I-CAUSE_OF_DISEASE,6731
130387,chocolate,I-CAUSE_OF_DISEASE,6731
130388,which,O,6731
130389,can,O,6731
130390,trigger,O,6731
130391,ocular,B-NAME_OF_DISEASE,6731
130392,migraines,I-NAME_OF_DISEASE,6731
130393,What,O,6731
130394,Are,O,6731
130395,the,O,6731
130396,Symptoms,O,6731
130397,of,O,6731
130398,an,B-NAME_OF_DISEASE,6731
130399,Ocular,B-NAME_OF_DISEASE,6731
130400,Migraine,I-NAME_OF_DISEASE,6731
130401,The,O,6732
130402,most,O,6732
130403,common,O,6732
130404,symptom,O,6732
130405,of,O,6732
130406,an,B-NAME_OF_DISEASE,6732
130407,ocular,B-NAME_OF_DISEASE,6732
130408,migraine,I-NAME_OF_DISEASE,6732
130409,is,O,6732
130410,a,B-SIGN_AND_SYMPTOM,6732
130411,visual,I-SIGN_AND_SYMPTOM,6732
130412,disturbance,I-SIGN_AND_SYMPTOM,6732
130413,which,I-SIGN_AND_SYMPTOM,6732
130414,can,I-SIGN_AND_SYMPTOM,6732
130415,take,I-SIGN_AND_SYMPTOM,6732
130416,the,I-SIGN_AND_SYMPTOM,6732
130417,form,I-SIGN_AND_SYMPTOM,6732
130418,of,I-SIGN_AND_SYMPTOM,6732
130419,flashing,I-SIGN_AND_SYMPTOM,6732
130420,lights,I-SIGN_AND_SYMPTOM,6732
130421,zigzag,I-SIGN_AND_SYMPTOM,6732
130422,lines,I-SIGN_AND_SYMPTOM,6732
130423,or,I-SIGN_AND_SYMPTOM,6732
130424,blind,I-SIGN_AND_SYMPTOM,6732
130425,spots,I-SIGN_AND_SYMPTOM,6732
130426,in,I-SIGN_AND_SYMPTOM,6732
130427,the,I-SIGN_AND_SYMPTOM,6732
130428,field,I-SIGN_AND_SYMPTOM,6732
130429,of,I-SIGN_AND_SYMPTOM,6732
130430,vision,I-SIGN_AND_SYMPTOM,6732
130431,These,O,6733
130432,visual,B-SIGN_AND_SYMPTOM,6733
130433,disturbances,I-SIGN_AND_SYMPTOM,6733
130434,are,O,6733
130435,usually,O,6733
130436,temporary,O,6733
130437,and,O,6733
130438,may,O,6733
130439,last,O,6733
130440,for,O,6733
130441,a,O,6733
130442,few,O,6733
130443,minutes,O,6733
130444,to,O,6733
130445,an,O,6733
130446,hour,O,6733
130447,Other,O,6733
130448,symptoms,O,6733
130449,of,O,6733
130450,ocular,B-NAME_OF_DISEASE,6733
130451,migraines,I-NAME_OF_DISEASE,6733
130452,may,O,6733
130453,include,O,6733
130454,Headache,B-SIGN_AND_SYMPTOM,6733
130455,Ocular,B-NAME_OF_DISEASE,6734
130456,migraines,I-NAME_OF_DISEASE,6734
130457,may,O,6734
130458,be,O,6734
130459,accompanied,O,6734
130460,by,O,6734
130461,a,B-SIGN_AND_SYMPTOM,6734
130462,headache,I-SIGN_AND_SYMPTOM,6734
130463,that,I-SIGN_AND_SYMPTOM,6734
130464,is,I-SIGN_AND_SYMPTOM,6734
130465,typically,I-SIGN_AND_SYMPTOM,6734
130466,one-sided,I-SIGN_AND_SYMPTOM,6734
130467,and,I-SIGN_AND_SYMPTOM,6734
130468,may,I-SIGN_AND_SYMPTOM,6735
130469,be,I-SIGN_AND_SYMPTOM,6735
130470,throbbing,I-SIGN_AND_SYMPTOM,6735
130471,or,I-SIGN_AND_SYMPTOM,6735
130472,pulsating,I-SIGN_AND_SYMPTOM,6735
130473,in,I-SIGN_AND_SYMPTOM,6735
130474,nature,I-SIGN_AND_SYMPTOM,6735
130475,Partial,B-SIGN_AND_SYMPTOM,6735
130476,or,I-SIGN_AND_SYMPTOM,6736
130477,total,I-SIGN_AND_SYMPTOM,6736
130478,loss,I-SIGN_AND_SYMPTOM,6736
130479,in,I-SIGN_AND_SYMPTOM,6736
130480,one,I-SIGN_AND_SYMPTOM,6736
130481,eye,I-SIGN_AND_SYMPTOM,6736
130482,This,O,6736
130483,usually,O,6736
130484,lasts,O,6736
130485,10,B-TIME_DURATION,6736
130486,to,I-TIME_DURATION,6736
130487,20,I-TIME_DURATION,6736
130488,minutes,I-TIME_DURATION,6736
130489,before,O,6736
130490,vision,O,6736
130491,gradually,O,6737
130492,returns,O,6737
130493,An,O,6737
130494,image,O,6737
130495,showing,O,6737
130496,what,O,6737
130497,happens,O,6737
130498,to,O,6737
130499,vision,O,6737
130500,when,O,6737
130501,ocular,B-NAME_OF_DISEASE,6737
130502,migraine,I-NAME_OF_DISEASE,6737
130503,occurrs,O,6737
130504,Can,O,6737
130505,Ocular,B-NAME_OF_DISEASE,6737
130506,Migraine,I-NAME_OF_DISEASE,6737
130507,Cause,O,6737
130508,Permanent,B-NAME_OF_DISEASE,6738
130509,Vision,I-NAME_OF_DISEASE,6738
130510,Loss,I-NAME_OF_DISEASE,6738
130511,Visual,B-SIGN_AND_SYMPTOM,6738
130512,disturbances,I-SIGN_AND_SYMPTOM,6738
130513,caused,O,6738
130514,by,O,6738
130515,ocular,B-NAME_OF_DISEASE,6738
130516,migraines,I-NAME_OF_DISEASE,6738
130517,are,O,6738
130518,usually,O,6738
130519,temporary,O,6739
130520,and,O,6739
130521,will,O,6739
130522,resolve,O,6739
130523,on,O,6739
130524,their,O,6739
130525,own,O,6739
130526,within,B-TIME_DURATION,6739
130527,a,I-TIME_DURATION,6739
130528,few,I-TIME_DURATION,6739
130529,minutes,I-TIME_DURATION,6739
130530,to,I-TIME_DURATION,6739
130531,an,I-TIME_DURATION,6739
130532,hour,I-TIME_DURATION,6739
130533,In,O,6739
130534,rare,O,6739
130535,cases,O,6739
130536,ocular,B-NAME_OF_DISEASE,6739
130537,migraines,I-NAME_OF_DISEASE,6739
130538,may,O,6739
130539,be,O,6739
130540,a,O,6740
130541,sign,O,6740
130542,of,O,6740
130543,a,O,6740
130544,more,O,6740
130545,serious,O,6740
130546,underlying,O,6740
130547,problem,O,6740
130548,such,O,6740
130549,as,O,6740
130550,a,B-CAUSE_OF_DISEASE,6740
130551,brain,I-CAUSE_OF_DISEASE,6740
130552,tumor,I-CAUSE_OF_DISEASE,6740
130553,or,O,6740
130554,an,B-CAUSE_OF_DISEASE,6740
130555,arterial,I-CAUSE_OF_DISEASE,6740
130556,blockage,I-CAUSE_OF_DISEASE,6740
130557,which,O,6740
130558,can,O,6740
130559,cause,O,6740
130560,permanent,B-NAME_OF_DISEASE,6740
130561,vision,I-NAME_OF_DISEASE,6740
130562,loss,I-NAME_OF_DISEASE,6740
130563,Managing,O,6740
130564,Ocular,B-NAME_OF_DISEASE,6741
130565,Migraines,I-NAME_OF_DISEASE,6741
130566,Medications,B-TREATMENT,6741
130567,There,O,6741
130568,are,O,6741
130569,several,O,6741
130570,medications,B-TREATMENT,6741
130571,that,O,6741
130572,can,O,6741
130573,be,O,6741
130574,used,O,6741
130575,to,O,6741
130576,treat,O,6741
130577,ocular,B-NAME_OF_DISEASE,6741
130578,migraines,I-NAME_OF_DISEASE,6741
130579,including,O,6741
130580,triptans,B-NAME_OF_DRUG,6741
130581,and,O,6741
130582,nonsteroidal,B-NAME_OF_DRUG,6741
130583,anti-inflammatory,I-NAME_OF_DRUG,6741
130584,drugs,I-NAME_OF_DRUG,6741
130585,NSAIDs,B-NAME_OF_DRUG,6741
130586,,O,6741
130587,Triptans,B-NAME_OF_DRUG,6742
130588,work,O,6742
130589,by,O,6742
130590,constricting,O,6742
130591,blood,O,6742
130592,vessels,O,6742
130593,in,O,6742
130594,the,O,6742
130595,brain,O,6742
130596,and,O,6742
130597,relieving,O,6742
130598,headache,B-SIGN_AND_SYMPTOM,6742
130599,pain,I-SIGN_AND_SYMPTOM,6742
130600,NSAIDs,B-NAME_OF_DRUG,6742
130601,work,O,6742
130602,by,O,6742
130603,reducing,O,6742
130604,inflammation,O,6742
130605,and,O,6742
130606,relieving,O,6742
130607,pain,O,6742
130608,Your,O,6742
130609,healthcare,O,6742
130610,provider,O,6742
130611,can,O,6742
130612,recommend,O,6742
130613,the,O,6742
130614,appropriate,O,6742
130615,medication,O,6742
130616,for,O,6742
130617,you,O,6742
130618,based,O,6742
130619,on,O,6742
130620,your,O,6742
130621,specific,O,6742
130622,needs,O,6743
130623,Preventive,O,6743
130624,medications,B-TREATMENT,6743
130625,In,O,6743
130626,some,O,6743
130627,cases,O,6743
130628,preventive,O,6743
130629,medications,B-TREATMENT,6743
130630,may,O,6743
130631,be,O,6743
130632,used,O,6743
130633,to,O,6743
130634,reduce,O,6743
130635,the,O,6744
130636,frequency,O,6744
130637,of,O,6744
130638,ocular,B-NAME_OF_DISEASE,6744
130639,migraines,I-NAME_OF_DISEASE,6744
130640,Preventive,O,6744
130641,medications,B-TREATMENT,6744
130642,may,O,6744
130643,include,O,6744
130644,beta,B-PREVENTION,6744
130645,blockers,I-PREVENTION,6744
130646,calcium,I-PREVENTION,6744
130647,channel,I-PREVENTION,6744
130648,blockers,I-PREVENTION,6744
130649,and,I-PREVENTION,6744
130650,anticonvulsants,I-PREVENTION,6744
130651,Alternative,B-TREATMENT,6744
130652,therapies,I-TREATMENT,6744
130653,Alternative,B-TREATMENT,6744
130654,therapies,I-TREATMENT,6744
130655,such,I-TREATMENT,6745
130656,as,I-TREATMENT,6745
130657,acupuncture,I-TREATMENT,6745
130658,chiropractic,I-TREATMENT,6745
130659,care,I-TREATMENT,6745
130660,and,I-TREATMENT,6745
130661,herbal,I-TREATMENT,6745
130662,remedies,I-TREATMENT,6745
130663,may,O,6745
130664,provide,O,6745
130665,relief,O,6745
130666,for,O,6745
130667,some,O,6745
130668,people,O,6745
130669,with,O,6746
130670,ocular,B-NAME_OF_DISEASE,6746
130671,migraines,I-NAME_OF_DISEASE,6746
130672,It,O,6746
130673,is,O,6746
130674,important,O,6746
130675,to,O,6746
130676,consult,O,6746
130677,with,O,6746
130678,a,O,6746
130679,healthcare,O,6746
130680,provider,O,6746
130681,before,O,6746
130682,using,O,6746
130683,any,O,6746
130684,alternative,O,6746
130685,therapies,O,6746
130686,to,O,6746
130687,ensure,O,6746
130688,that,O,6746
130689,they,O,6747
130690,are,O,6747
130691,safe,O,6747
130692,and,O,6747
130693,appropriate,O,6747
130694,for,O,6747
130695,you,O,6747
130696,Tips,O,6747
130697,to,O,6747
130698,Prevent,O,6747
130699,Ocular,B-NAME_OF_DISEASE,6747
130700,Migraines,I-NAME_OF_DISEASE,6747
130701,There,O,6747
130702,are,O,6747
130703,several,O,6747
130704,steps,O,6747
130705,that,O,6747
130706,you,O,6747
130707,can,O,6747
130708,take,O,6747
130709,to,O,6748
130710,help,O,6748
130711,prevent,O,6748
130712,or,O,6748
130713,reduce,O,6748
130714,the,O,6748
130715,frequency,O,6748
130716,of,O,6748
130717,ocular,B-NAME_OF_DISEASE,6748
130718,migraines,I-NAME_OF_DISEASE,6748
130719,Here,O,6748
130720,are,O,6748
130721,some,O,6748
130722,tips,O,6748
130723,for,O,6748
130724,preventing,O,6748
130725,ocular,B-NAME_OF_DISEASE,6748
130726,migraines,I-NAME_OF_DISEASE,6748
130727,Identify,B-PREVENTION,6749
130728,and,I-PREVENTION,6749
130729,avoid,I-PREVENTION,6749
130730,triggers,I-PREVENTION,6749
130731,Keeping,B-PREVENTION,6749
130732,a,I-PREVENTION,6749
130733,headache,I-PREVENTION,6749
130734,diary,I-PREVENTION,6749
130735,can,O,6749
130736,help,O,6749
130737,you,O,6749
130738,identify,O,6749
130739,any,O,6749
130740,potential,O,6749
130741,triggers,O,6749
130742,for,O,6749
130743,your,O,6750
130744,ocular,B-NAME_OF_DISEASE,6750
130745,migraines,I-NAME_OF_DISEASE,6750
130746,such,O,6750
130747,as,O,6750
130748,certain,B-CAUSE_OF_DISEASE,6750
130749,foods,I-CAUSE_OF_DISEASE,6750
130750,bright,I-CAUSE_OF_DISEASE,6750
130751,lights,I-CAUSE_OF_DISEASE,6750
130752,or,I-CAUSE_OF_DISEASE,6750
130753,stress,I-CAUSE_OF_DISEASE,6750
130754,Avoiding,O,6750
130755,or,O,6750
130756,minimizing,O,6750
130757,your,O,6750
130758,exposure,O,6750
130759,to,O,6750
130760,these,O,6750
130761,triggers,O,6750
130762,may,O,6750
130763,help,O,6750
130764,prevent,O,6750
130765,ocular,B-NAME_OF_DISEASE,6750
130766,migraines,I-NAME_OF_DISEASE,6750
130767,Get,B-PREVENTION,6750
130768,enough,I-PREVENTION,6750
130769,sleep,I-PREVENTION,6750
130770,Ensuring,B-PREVENTION,6750
130771,that,I-PREVENTION,6750
130772,you,I-PREVENTION,6750
130773,get,I-PREVENTION,6750
130774,enough,I-PREVENTION,6750
130775,sleep,I-PREVENTION,6750
130776,and,I-PREVENTION,6751
130777,maintaining,I-PREVENTION,6751
130778,a,I-PREVENTION,6751
130779,regular,I-PREVENTION,6751
130780,sleep,I-PREVENTION,6751
130781,schedule,I-PREVENTION,6751
130782,may,O,6751
130783,help,O,6751
130784,prevent,O,6751
130785,ocular,B-NAME_OF_DISEASE,6751
130786,migraines,I-NAME_OF_DISEASE,6751
130787,Exercise,B-PREVENTION,6751
130788,regularly,I-PREVENTION,6751
130789,Regular,B-PREVENTION,6751
130790,exercise,I-PREVENTION,6751
130791,may,O,6751
130792,help,O,6751
130793,reduce,O,6751
130794,the,O,6751
130795,frequency,O,6752
130796,and,O,6752
130797,severity,O,6752
130798,of,O,6752
130799,ocular,B-NAME_OF_DISEASE,6752
130800,migraines,I-NAME_OF_DISEASE,6752
130801,Practice,B-PREVENTION,6752
130802,stress,I-PREVENTION,6752
130803,management,I-PREVENTION,6752
130804,techniques,I-PREVENTION,6752
130805,Techniques,B-PREVENTION,6752
130806,such,I-PREVENTION,6752
130807,as,I-PREVENTION,6752
130808,deep,I-PREVENTION,6752
130809,breathing,I-PREVENTION,6752
130810,meditation,I-PREVENTION,6752
130811,and,I-PREVENTION,6752
130812,yoga,I-PREVENTION,6752
130813,may,O,6752
130814,help,O,6752
130815,reduce,O,6752
130816,stress,O,6752
130817,and,O,6753
130818,prevent,O,6753
130819,ocular,B-NAME_OF_DISEASE,6753
130820,migraines,I-NAME_OF_DISEASE,6753
130821,Eat,B-PREVENTION,6753
130822,a,I-PREVENTION,6753
130823,healthy,I-PREVENTION,6753
130824,diet,I-PREVENTION,6753
130825,A,B-PREVENTION,6753
130826,diet,I-PREVENTION,6753
130827,that,I-PREVENTION,6753
130828,is,I-PREVENTION,6753
130829,rich,I-PREVENTION,6753
130830,in,I-PREVENTION,6753
130831,fruits,I-PREVENTION,6753
130832,vegetables,I-PREVENTION,6753
130833,and,I-PREVENTION,6753
130834,whole,I-PREVENTION,6753
130835,grains,I-PREVENTION,6753
130836,may,O,6753
130837,help,O,6753
130838,prevent,O,6754
130839,ocular,B-NAME_OF_DISEASE,6754
130840,migraines,I-NAME_OF_DISEASE,6754
130841,Consider,B-PREVENTION,6754
130842,preventive,B-PREVENTION,6754
130843,medications,I-PREVENTION,6754
130844,In,O,6754
130845,some,O,6754
130846,cases,O,6754
130847,preventive,B-PREVENTION,6754
130848,medications,I-PREVENTION,6754
130849,may,O,6755
130850,be,O,6755
130851,used,O,6755
130852,to,O,6755
130853,reduce,O,6755
130854,the,O,6755
130855,frequency,O,6755
130856,of,O,6755
130857,ocular,B-NAME_OF_DISEASE,6755
130858,migraines,I-NAME_OF_DISEASE,6755
130859,Your,O,6755
130860,healthcare,O,6755
130861,provider,O,6755
130862,can,O,6755
130863,recommend,O,6755
130864,the,O,6755
130865,appropriate,O,6755
130866,preventive,O,6755
130867,medication,O,6755
130868,for,O,6755
130869,you,O,6755
130870,based,O,6755
130871,on,O,6755
130872,your,O,6755
130873,specific,O,6755
130874,needs,O,6755
130875,Durysta,B-NAME_OF_DRUG,6755
130876,bimatoprost,I-NAME_OF_DRUG,6755
130877,and,I-NAME_OF_DRUG,6755
130878,chloramphenicol,I-NAME_OF_DRUG,6756
130879,is,O,6756
130880,a,O,6756
130881,prescription,O,6756
130882,medication,O,6756
130883,produced,O,6756
130884,by,O,6756
130885,Allergan,B-ORGANIZATION,6756
130886,that,O,6756
130887,is,O,6756
130888,used,O,6756
130889,to,O,6756
130890,lower,O,6756
130891,intraocular,O,6756
130892,pressure,O,6756
130893,IOP,O,6756
130894,in,O,6757
130895,people,O,6757
130896,with,O,6757
130897,open-angle,B-NAME_OF_DISEASE,6757
130898,glaucoma,I-NAME_OF_DISEASE,6757
130899,or,O,6757
130900,ocular,B-NAME_OF_DISEASE,6757
130901,hypertension,I-NAME_OF_DISEASE,6757
130902,high,I-NAME_OF_DISEASE,6757
130903,pressure,I-NAME_OF_DISEASE,6757
130904,in,I-NAME_OF_DISEASE,6757
130905,the,I-NAME_OF_DISEASE,6757
130906,eye,I-NAME_OF_DISEASE,6757
130907,,O,6757
130908,It,O,6757
130909,is,O,6757
130910,a,O,6757
130911,combination,O,6757
130912,of,O,6757
130913,two,O,6758
130914,medications,O,6758
130915,bimatoprost,O,6758
130916,which,O,6758
130917,is,O,6758
130918,a,O,6758
130919,prostaglandin,O,6758
130920,analog,O,6758
130921,and,O,6758
130922,chloramphenicol,O,6758
130923,which,O,6758
130924,is,O,6758
130925,an,O,6758
130926,antibiotic,O,6758
130927,What,O,6758
130928,is,O,6758
130929,Chloramphenicol,B-NAME_OF_DRUG,6758
130930,Eye,I-NAME_OF_DRUG,6758
130931,Drop,I-NAME_OF_DRUG,6758
130932,Chloramphenicol,B-NAME_OF_DRUG,6758
130933,eye,I-NAME_OF_DRUG,6758
130934,drops,I-NAME_OF_DRUG,6758
130935,are,O,6758
130936,a,O,6758
130937,topical,O,6759
130938,medication,O,6759
130939,used,O,6759
130940,to,O,6759
130941,treat,O,6759
130942,infections,O,6759
130943,of,O,6759
130944,the,O,6759
130945,eye,O,6759
130946,and,O,6759
130947,surrounding,O,6759
130948,tissue,O,6759
130949,Chloramphenicol,B-NAME_OF_DRUG,6759
130950,is,O,6759
130951,an,O,6759
130952,antibiotic,O,6759
130953,that,O,6759
130954,is,O,6759
130955,effective,O,6759
130956,against,O,6759
130957,a,O,6759
130958,wide,O,6759
130959,variety,O,6760
130960,of,O,6760
130961,bacteria,O,6760
130962,including,O,6760
130963,those,O,6760
130964,that,O,6760
130965,are,O,6760
130966,resistant,O,6760
130967,to,O,6760
130968,other,O,6760
130969,antibiotics,O,6760
130970,It,O,6760
130971,works,O,6760
130972,by,O,6760
130973,inhibiting,O,6760
130974,the,O,6760
130975,growth,O,6760
130976,of,O,6760
130977,bacteria,O,6760
130978,and,O,6760
130979,killing,O,6760
130980,them,O,6760
130981,Chloramphenicol,B-NAME_OF_DRUG,6760
130982,eye,I-NAME_OF_DRUG,6760
130983,drops,I-NAME_OF_DRUG,6760
130984,are,O,6761
130985,usually,O,6761
130986,prescribed,O,6761
130987,for,O,6761
130988,infections,O,6761
130989,of,O,6761
130990,the,O,6761
130991,eye,O,6761
130992,and,O,6761
130993,surrounding,O,6761
130994,tissue,O,6761
130995,caused,O,6761
130996,by,O,6761
130997,bacteria,O,6761
130998,such,O,6761
130999,as,O,6761
131000,conjunctivitis,B-NAME_OF_DISEASE,6761
131001,pink,I-NAME_OF_DISEASE,6762
131002,eye,I-NAME_OF_DISEASE,6762
131003,and,O,6762
131004,keratitis,B-NAME_OF_DISEASE,6762
131005,inflammation,I-NAME_OF_DISEASE,6762
131006,of,I-NAME_OF_DISEASE,6762
131007,the,I-NAME_OF_DISEASE,6762
131008,cornea,I-NAME_OF_DISEASE,6762
131009,,O,6762
131010,They,O,6762
131011,are,O,6762
131012,typically,O,6762
131013,used,O,6762
131014,to,O,6762
131015,treat,O,6762
131016,severe,O,6762
131017,or,O,6762
131018,recurrent,O,6762
131019,infections,O,6762
131020,that,O,6762
131021,are,O,6763
131022,unresponsive,O,6763
131023,to,O,6763
131024,other,O,6763
131025,antibiotics,O,6763
131026,When,O,6763
131027,to,O,6763
131028,use,O,6763
131029,Chloramphenicol,B-NAME_OF_DRUG,6763
131030,Eye,I-NAME_OF_DRUG,6763
131031,Drops,I-NAME_OF_DRUG,6763
131032,Chloramphenicol,B-NAME_OF_DRUG,6763
131033,is,O,6763
131034,an,O,6763
131035,antibiotic,O,6763
131036,that,O,6763
131037,is,O,6763
131038,used,O,6763
131039,to,O,6763
131040,treat,O,6763
131041,infections,O,6763
131042,of,O,6763
131043,the,O,6763
131044,eye,O,6763
131045,It,O,6763
131046,is,O,6763
131047,typically,O,6764
131048,used,O,6764
131049,when,O,6764
131050,other,O,6764
131051,antibiotics,O,6764
131052,are,O,6764
131053,not,O,6764
131054,effective,O,6764
131055,or,O,6764
131056,when,O,6764
131057,the,O,6764
131058,infection,O,6764
131059,is,O,6764
131060,caused,O,6764
131061,by,O,6764
131062,bacteria,O,6764
131063,that,O,6764
131064,are,O,6764
131065,resistant,O,6764
131066,to,O,6764
131067,other,O,6764
131068,antibiotics,O,6764
131069,Your,O,6764
131070,doctor,O,6764
131071,may,O,6764
131072,prescribe,O,6764
131073,chloramphenicol,B-NAME_OF_DRUG,6765
131074,if,O,6765
131075,you,O,6765
131076,have,O,6765
131077,an,O,6765
131078,infection,O,6765
131079,of,O,6765
131080,the,O,6765
131081,eye,O,6765
131082,or,O,6765
131083,surrounding,O,6765
131084,tissues,O,6765
131085,such,O,6765
131086,as,O,6765
131087,conjunctivitis,B-NAME_OF_DISEASE,6765
131088,blepharitis,B-NAME_OF_DISEASE,6765
131089,or,O,6765
131090,keratitis,B-NAME_OF_DISEASE,6765
131091,It,O,6765
131092,is,O,6765
131093,important,O,6765
131094,to,O,6765
131095,use,O,6765
131096,chloramphenicol,B-NAME_OF_DRUG,6765
131097,only,O,6765
131098,as,O,6766
131099,directed,O,6766
131100,by,O,6766
131101,your,O,6766
131102,doctor,O,6766
131103,and,O,6766
131104,to,O,6766
131105,complete,O,6766
131106,the,O,6766
131107,entire,O,6766
131108,course,O,6766
131109,of,O,6766
131110,treatment,O,6766
131111,even,O,6766
131112,if,O,6766
131113,your,O,6766
131114,symptoms,O,6766
131115,improve,O,6766
131116,This,O,6766
131117,will,O,6766
131118,help,O,6766
131119,to,O,6766
131120,prevent,O,6766
131121,the,O,6766
131122,infection,O,6767
131123,from,O,6767
131124,returning,O,6767
131125,and,O,6767
131126,to,O,6767
131127,prevent,O,6767
131128,the,O,6767
131129,development,O,6767
131130,of,O,6767
131131,antibiotic,O,6767
131132,resistance,O,6767
131133,Who,O,6767
131134,Can,O,6767
131135,Use,O,6767
131136,It,O,6767
131137,It,O,6767
131138,is,O,6768
131139,usually,O,6768
131140,only,O,6768
131141,prescribed,O,6768
131142,by,O,6768
131143,doctors,O,6768
131144,for,O,6768
131145,serious,O,6768
131146,infections,O,6768
131147,that,O,6768
131148,are,O,6768
131149,resistant,O,6768
131150,to,O,6768
131151,other,O,6768
131152,antibiotics,O,6768
131153,If,O,6768
131154,you,O,6768
131155,have,O,6769
131156,an,O,6769
131157,infection,O,6769
131158,and,O,6769
131159,are,O,6769
131160,considering,O,6769
131161,taking,O,6769
131162,chloramphenicol,B-NAME_OF_DRUG,6769
131163,you,O,6769
131164,should,O,6769
131165,speak,O,6769
131166,with,O,6769
131167,a,O,6769
131168,healthcare,O,6769
131169,professional,O,6769
131170,for,O,6769
131171,guidance,O,6769
131172,on,O,6769
131173,the,O,6769
131174,appropriate,O,6769
131175,treatment,O,6769
131176,for,O,6769
131177,your,O,6769
131178,condition,O,6769
131179,Who,O,6769
131180,Can,O,6770
131181,Not,O,6770
131182,Use,O,6770
131183,It,O,6770
131184,Chloramphenicol,B-NAME_OF_DRUG,6770
131185,is,O,6770
131186,generally,O,6770
131187,not,O,6770
131188,recommended,O,6770
131189,for,O,6770
131190,use,O,6770
131191,in,O,6770
131192,children,O,6771
131193,pregnant,O,6771
131194,women,O,6771
131195,or,O,6771
131196,nursing,O,6771
131197,mothers,O,6771
131198,because,O,6771
131199,it,O,6771
131200,can,O,6771
131201,cause,O,6771
131202,serious,O,6771
131203,side,O,6771
131204,effects,O,6771
131205,It,O,6771
131206,is,O,6771
131207,also,O,6771
131208,not,O,6771
131209,recommended,O,6771
131210,for,O,6771
131211,use,O,6771
131212,in,O,6771
131213,animals,O,6771
131214,as,O,6771
131215,it,O,6771
131216,can,O,6771
131217,cause,O,6771
131218,serious,O,6771
131219,adverse,O,6771
131220,reactions,O,6771
131221,and,O,6772
131222,is,O,6772
131223,not,O,6772
131224,effective,O,6772
131225,against,O,6772
131226,certain,O,6772
131227,types,O,6772
131228,of,O,6772
131229,bacteria,O,6772
131230,Can,O,6772
131231,Chloramphenicol,B-NAME_OF_DRUG,6772
131232,Affect,O,6772
131233,Pregnancy,O,6772
131234,Fertility,O,6772
131235,or,O,6772
131236,Breastfeeding,O,6772
131237,Chloramphenicol,B-NAME_OF_DRUG,6772
131238,may,O,6772
131239,be,O,6772
131240,harmful,O,6772
131241,to,O,6772
131242,a,O,6773
131243,developing,O,6773
131244,fetus,O,6773
131245,and,O,6773
131246,it,O,6773
131247,is,O,6773
131248,not,O,6773
131249,recommended,O,6773
131250,for,O,6773
131251,use,O,6773
131252,during,O,6773
131253,pregnancy,O,6773
131254,Chloramphenicol,B-NAME_OF_DRUG,6773
131255,can,O,6773
131256,also,O,6773
131257,pass,O,6773
131258,into,O,6773
131259,breast,O,6773
131260,milk,O,6773
131261,and,O,6774
131262,may,O,6774
131263,cause,O,6774
131264,serious,O,6774
131265,side,O,6774
131266,effects,O,6774
131267,in,O,6774
131268,nursing,O,6774
131269,infants,O,6774
131270,It,O,6774
131271,is,O,6774
131272,not,O,6774
131273,recommended,O,6774
131274,for,O,6774
131275,use,O,6774
131276,by,O,6774
131277,nursing,O,6774
131278,mothers,O,6774
131279,or,O,6774
131280,women,O,6774
131281,who,O,6775
131282,are,O,6775
131283,planning,O,6775
131284,to,O,6775
131285,become,O,6775
131286,pregnant,O,6775
131287,If,O,6775
131288,you,O,6775
131289,are,O,6775
131290,pregnant,O,6775
131291,nursing,O,6775
131292,or,O,6775
131293,planning,O,6775
131294,to,O,6775
131295,become,O,6775
131296,pregnant,O,6775
131297,you,O,6775
131298,should,O,6775
131299,not,O,6775
131300,use,O,6775
131301,chloramphenicol,B-NAME_OF_DRUG,6775
131302,without,O,6776
131303,first,O,6776
131304,discussing,O,6776
131305,the,O,6776
131306,potential,O,6776
131307,risks,O,6776
131308,with,O,6776
131309,a,O,6776
131310,healthcare,O,6776
131311,professional,O,6776
131312,There,O,6776
131313,is,O,6776
131314,limited,O,6777
131315,information,O,6777
131316,available,O,6777
131317,on,O,6777
131318,the,O,6777
131319,effects,O,6777
131320,of,O,6777
131321,chloramphenicol,B-NAME_OF_DRUG,6777
131322,on,O,6777
131323,fertility,O,6777
131324,Some,O,6777
131325,studies,O,6777
131326,in,O,6777
131327,animals,O,6777
131328,have,O,6777
131329,suggested,O,6777
131330,that,O,6777
131331,chloramphenicol,B-NAME_OF_DRUG,6777
131332,may,O,6777
131333,have,O,6778
131334,an,O,6778
131335,adverse,O,6778
131336,effect,O,6778
131337,on,O,6778
131338,fertility,O,6778
131339,but,O,6778
131340,more,O,6778
131341,research,O,6778
131342,is,O,6778
131343,needed,O,6779
131344,to,O,6779
131345,determine,O,6779
131346,if,O,6779
131347,this,O,6779
131348,is,O,6779
131349,also,O,6779
131350,TRUE,O,6779
131351,in,O,6779
131352,humans,O,6780
131353,If,O,6780
131354,you,O,6780
131355,are,O,6780
131356,concerned,O,6780
131357,about,O,6780
131358,the,O,6780
131359,potential,O,6780
131360,effects,O,6780
131361,of,O,6780
131362,chloramphenicol,B-NAME_OF_DRUG,6780
131363,on,O,6780
131364,fertility,O,6780
131365,you,O,6780
131366,should,O,6781
131367,speak,O,6781
131368,with,O,6781
131369,a,O,6781
131370,healthcare,O,6781
131371,professional,O,6781
131372,for,O,6781
131373,guidance,O,6781
131374,How,O,6781
131375,to,O,6781
131376,Use,O,6781
131377,Chloramphenicol,B-NAME_OF_DRUG,6782
131378,Chloramphenicol,B-NAME_OF_DRUG,6782
131379,is,O,6782
131380,available,O,6782
131381,in,O,6782
131382,several,O,6782
131383,forms,O,6782
131384,including,O,6782
131385,tablets,O,6782
131386,capsules,O,6782
131387,and,O,6782
131388,an,O,6783
131389,oral,O,6783
131390,suspension,O,6783
131391,liquid,O,6783
131392,,O,6783
131393,It,O,6783
131394,is,O,6783
131395,usually,O,6783
131396,taken,O,6783
131397,by,O,6783
131398,mouth,O,6783
131399,but,O,6783
131400,it,O,6783
131401,can,O,6783
131402,also,O,6783
131403,be,O,6783
131404,given,O,6783
131405,intravenously,O,6783
131406,through,O,6783
131407,a,O,6784
131408,vein,O,6784
131409,in,O,6784
131410,a,O,6784
131411,hospital,O,6784
131412,setting,O,6784
131413,The,O,6784
131414,specific,O,6784
131415,dosage,O,6784
131416,and,O,6784
131417,duration,O,6784
131418,of,O,6784
131419,treatment,O,6784
131420,with,O,6784
131421,chloramphenicol,B-NAME_OF_DRUG,6784
131422,will,O,6784
131423,depend,O,6784
131424,on,O,6784
131425,the,O,6785
131426,type,O,6785
131427,and,O,6785
131428,severity,O,6785
131429,of,O,6785
131430,the,O,6785
131431,infection,O,6785
131432,being,O,6785
131433,treated,O,6785
131434,It,O,6785
131435,is,O,6785
131436,important,O,6785
131437,to,O,6785
131438,take,O,6785
131439,chloramphenicol,B-NAME_OF_DRUG,6785
131440,exactly,O,6785
131441,as,O,6785
131442,prescribed,O,6785
131443,by,O,6785
131444,your,O,6785
131445,doctor,O,6785
131446,Here,O,6785
131447,are,O,6786
131448,some,O,6786
131449,general,O,6786
131450,guidelines,O,6786
131451,for,O,6786
131452,using,O,6786
131453,chloramphenicol,B-NAME_OF_DRUG,6786
131454,Take,O,6786
131455,chloramphenicol,B-NAME_OF_DRUG,6786
131456,at,O,6786
131457,evenly,O,6786
131458,spaced,O,6786
131459,intervals,O,6786
131460,as,O,6786
131461,directed,O,6786
131462,by,O,6786
131463,your,O,6786
131464,doctor,O,6786
131465,Do,O,6786
131466,not,O,6786
131467,crush,O,6786
131468,chew,O,6786
131469,or,O,6787
131470,break,O,6787
131471,the,O,6787
131472,tablets,O,6787
131473,or,O,6787
131474,capsules,O,6787
131475,Swallow,O,6787
131476,them,O,6787
131477,whole,O,6787
131478,with,O,6787
131479,a,O,6787
131480,full,O,6787
131481,glass,O,6787
131482,of,O,6787
131483,water,O,6787
131484,If,O,6787
131485,you,O,6787
131486,are,O,6787
131487,taking,O,6788
131488,the,O,6788
131489,oral,O,6788
131490,suspension,O,6788
131491,shake,O,6788
131492,the,O,6788
131493,bottle,O,6788
131494,well,O,6788
131495,before,O,6788
131496,each,O,6788
131497,dose,O,6788
131498,Measure,O,6788
131499,the,O,6788
131500,dose,O,6788
131501,carefully,O,6788
131502,using,O,6788
131503,the,O,6788
131504,measuring,O,6788
131505,spoon,O,6788
131506,or,O,6788
131507,cup,O,6788
131508,provided,O,6788
131509,Do,O,6788
131510,not,O,6788
131511,stop,O,6788
131512,taking,O,6788
131513,chloramphenicol,B-NAME_OF_DRUG,6788
131514,early,O,6789
131515,even,O,6789
131516,if,O,6789
131517,you,O,6789
131518,feel,O,6789
131519,better,O,6789
131520,Stopping,O,6789
131521,treatment,O,6789
131522,early,O,6789
131523,can,O,6789
131524,allow,O,6789
131525,bacteria,O,6789
131526,to,O,6789
131527,continue,O,6789
131528,to,O,6789
131529,grow,O,6789
131530,which,O,6789
131531,can,O,6789
131532,lead,O,6789
131533,to,O,6790
131534,a,O,6790
131535,relapse,O,6790
131536,of,O,6790
131537,the,O,6790
131538,infection,O,6790
131539,If,O,6790
131540,you,O,6790
131541,have,O,6790
131542,any,O,6790
131543,questions,O,6790
131544,about,O,6790
131545,how,O,6790
131546,to,O,6790
131547,use,O,6790
131548,chloramphenicol,B-NAME_OF_DRUG,6790
131549,you,O,6790
131550,should,O,6790
131551,speak,O,6790
131552,with,O,6790
131553,your,O,6790
131554,doctor,O,6790
131555,or,O,6790
131556,pharmacist,O,6790
131557,What,O,6790
131558,to,O,6790
131559,Do,O,6790
131560,If,O,6790
131561,You,O,6791
131562,Miss,O,6791
131563,a,O,6791
131564,Dose,O,6791
131565,If,O,6791
131566,you,O,6791
131567,miss,O,6791
131568,a,O,6791
131569,dose,O,6791
131570,of,O,6791
131571,chloramphenicol,B-NAME_OF_DRUG,6791
131572,take,O,6792
131573,it,O,6792
131574,as,O,6792
131575,soon,O,6792
131576,as,O,6792
131577,you,O,6792
131578,remember,O,6792
131579,If,O,6792
131580,it,O,6792
131581,is,O,6792
131582,almost,O,6792
131583,time,O,6792
131584,for,O,6792
131585,your,O,6792
131586,next,O,6792
131587,dose,O,6792
131588,skip,O,6792
131589,the,O,6792
131590,missed,O,6792
131591,dose,O,6792
131592,and,O,6792
131593,take,O,6792
131594,the,O,6792
131595,next,O,6792
131596,dose,O,6792
131597,at,O,6792
131598,the,O,6793
131599,regular,O,6793
131600,time,O,6793
131601,Do,O,6793
131602,not,O,6793
131603,take,O,6793
131604,two,O,6793
131605,doses,O,6793
131606,of,O,6793
131607,chloramphenicol,B-NAME_OF_DRUG,6793
131608,at,O,6793
131609,the,O,6793
131610,same,O,6793
131611,time,O,6793
131612,to,O,6793
131613,make,O,6793
131614,up,O,6794
131615,for,O,6794
131616,a,O,6794
131617,missed,O,6794
131618,dose,O,6794
131619,If,O,6794
131620,you,O,6794
131621,miss,O,6794
131622,multiple,O,6794
131623,doses,O,6794
131624,of,O,6794
131625,chloramphenicol,B-NAME_OF_DRUG,6794
131626,or,O,6794
131627,forget,O,6794
131628,to,O,6794
131629,take,O,6794
131630,the,O,6794
131631,medication,O,6794
131632,for,O,6794
131633,an,O,6794
131634,extended,O,6794
131635,period,O,6794
131636,of,O,6794
131637,time,O,6794
131638,you,O,6794
131639,should,O,6794
131640,contact,O,6794
131641,your,O,6795
131642,doctor,O,6795
131643,for,O,6795
131644,further,O,6795
131645,instructions,O,6795
131646,It,O,6795
131647,is,O,6795
131648,important,O,6795
131649,to,O,6795
131650,follow,O,6795
131651,the,O,6795
131652,prescribed,O,6795
131653,dosing,O,6795
131654,schedule,O,6795
131655,for,O,6795
131656,chloramphenicol,B-NAME_OF_DRUG,6795
131657,to,O,6795
131658,ensure,O,6796
131659,that,O,6796
131660,the,O,6796
131661,infection,O,6796
131662,is,O,6796
131663,treated,O,6796
131664,effectively,O,6796
131665,What,O,6796
131666,to,O,6796
131667,Do,O,6796
131668,If,O,6796
131669,You,O,6796
131670,Overdose,O,6796
131671,If,O,6796
131672,you,O,6796
131673,think,O,6796
131674,you,O,6796
131675,or,O,6796
131676,someone,O,6796
131677,else,O,6797
131678,may,O,6797
131679,have,O,6797
131680,taken,O,6797
131681,an,O,6797
131682,overdose,O,6797
131683,of,O,6797
131684,chloramphenicol,B-NAME_OF_DRUG,6797
131685,you,O,6797
131686,should,O,6797
131687,seek,O,6797
131688,emergency,O,6797
131689,medical,O,6798
131690,attention,O,6798
131691,right,O,6798
131692,away,O,6798
131693,Overdose,O,6798
131694,symptoms,O,6798
131695,may,O,6798
131696,include,O,6798
131697,nausea,O,6798
131698,vomiting,O,6798
131699,stomach,O,6798
131700,pain,O,6798
131701,diarrhea,O,6798
131702,and,O,6798
131703,fever,O,6798
131704,If,O,6798
131705,the,O,6798
131706,overdose,O,6798
131707,was,O,6798
131708,recent,O,6798
131709,you,O,6798
131710,may,O,6798
131711,be,O,6798
131712,advised,O,6798
131713,to,O,6798
131714,induce,O,6798
131715,vomiting,O,6798
131716,or,O,6798
131717,undergo,O,6798
131718,gastric,O,6798
131719,lavage,O,6798
131720,stomach,O,6798
131721,pumping,O,6798
131722,to,O,6798
131723,remove,O,6798
131724,the,O,6798
131725,excess,O,6798
131726,medication,O,6798
131727,from,O,6798
131728,your,O,6798
131729,system,O,6798
131730,You,O,6798
131731,may,O,6798
131732,also,O,6798
131733,be,O,6798
131734,given,O,6798
131735,activated,O,6798
131736,charcoal,O,6798
131737,to,O,6798
131738,help,O,6798
131739,absorb,O,6798
131740,any,O,6798
131741,remaining,O,6798
131742,chloramphenicol,B-NAME_OF_DRUG,6798
131743,in,O,6798
131744,the,O,6798
131745,stomach,O,6798
131746,It,O,6798
131747,is,O,6798
131748,important,O,6798
131749,to,O,6798
131750,seek,O,6798
131751,medical,O,6798
131752,attention,O,6798
131753,immediately,O,6798
131754,if,O,6798
131755,you,O,6798
131756,suspect,O,6798
131757,an,O,6798
131758,overdose,O,6798
131759,as,O,6798
131760,chloramphenicol,B-NAME_OF_DRUG,6798
131761,overdose,O,6798
131762,can,O,6798
131763,be,O,6798
131764,serious,O,6798
131765,and,O,6798
131766,may,O,6798
131767,cause,O,6798
131768,serious,O,6798
131769,side,O,6798
131770,effects,O,6798
131771,or,O,6798
131772,death,O,6799
131773,What,O,6799
131774,Side,O,6799
131775,Effects,O,6799
131776,May,O,6799
131777,Happen,O,6799
131778,If,O,6799
131779,You,O,6799
131780,Use,O,6799
131781,Chloramphenicol,B-NAME_OF_DRUG,6799
131782,Like,O,6799
131783,all,O,6799
131784,medications,O,6799
131785,chloramphenicol,B-NAME_OF_DRUG,6799
131786,can,O,6799
131787,cause,O,6799
131788,side,O,6799
131789,effects,O,6799
131790,Some,O,6799
131791,people,O,6799
131792,may,O,6799
131793,experience,O,6799
131794,side,O,6799
131795,effects,O,6800
131796,while,O,6800
131797,taking,O,6800
131798,chloramphenicol,B-NAME_OF_DRUG,6800
131799,while,O,6800
131800,others,O,6800
131801,may,O,6800
131802,not,O,6800
131803,have,O,6800
131804,any,O,6800
131805,side,O,6800
131806,effects,O,6800
131807,at,O,6800
131808,all,O,6800
131809,The,O,6800
131810,most,O,6800
131811,common,O,6801
131812,side,O,6801
131813,effects,O,6801
131814,of,O,6801
131815,chloramphenicol,B-NAME_OF_DRUG,6801
131816,are,O,6801
131817,nausea,B-SIGN_AND_SYMPTOM,6801
131818,vomiting,I-SIGN_AND_SYMPTOM,6801
131819,and,I-SIGN_AND_SYMPTOM,6801
131820,diarrhea,I-SIGN_AND_SYMPTOM,6801
131821,Other,O,6801
131822,possible,O,6801
131823,side,O,6801
131824,effects,O,6801
131825,of,O,6801
131826,chloramphenicol,B-NAME_OF_DRUG,6801
131827,include,O,6801
131828,Loss,B-SIGN_AND_SYMPTOM,6801
131829,of,I-SIGN_AND_SYMPTOM,6801
131830,appetite,I-SIGN_AND_SYMPTOM,6802
131831,Rash,B-SIGN_AND_SYMPTOM,6802
131832,or,I-SIGN_AND_SYMPTOM,6802
131833,itching,I-SIGN_AND_SYMPTOM,6802
131834,Headache,B-SIGN_AND_SYMPTOM,6802
131835,Dizziness,B-SIGN_AND_SYMPTOM,6802
131836,Trouble,B-SIGN_AND_SYMPTOM,6802
131837,sleeping,I-SIGN_AND_SYMPTOM,6802
131838,Dry,B-SIGN_AND_SYMPTOM,6802
131839,mouth,I-SIGN_AND_SYMPTOM,6802
131840,Unusual,B-SIGN_AND_SYMPTOM,6802
131841,tiredness,I-SIGN_AND_SYMPTOM,6802
131842,or,I-SIGN_AND_SYMPTOM,6802
131843,weakness,I-SIGN_AND_SYMPTOM,6802
131844,Less,O,6802
131845,common,O,6802
131846,but,O,6802
131847,more,O,6802
131848,serious,O,6802
131849,side,O,6802
131850,effects,O,6802
131851,of,O,6802
131852,chloramphenicol,B-NAME_OF_DRUG,6802
131853,may,O,6802
131854,include,O,6802
131855,Blood,O,6802
131856,disorders,O,6803
131857,including,O,6803
131858,anemia,O,6803
131859,and,O,6803
131860,decreased,O,6803
131861,white,O,6803
131862,blood,O,6803
131863,cell,O,6803
131864,count,O,6803
131865,Allergic,B-SIGN_AND_SYMPTOM,6803
131866,reactions,I-SIGN_AND_SYMPTOM,6803
131867,including,I-SIGN_AND_SYMPTOM,6803
131868,difficulty,I-SIGN_AND_SYMPTOM,6803
131869,breathing,I-SIGN_AND_SYMPTOM,6803
131870,hives,I-SIGN_AND_SYMPTOM,6803
131871,and,I-SIGN_AND_SYMPTOM,6803
131872,swelling,I-SIGN_AND_SYMPTOM,6803
131873,of,I-SIGN_AND_SYMPTOM,6803
131874,the,I-SIGN_AND_SYMPTOM,6803
131875,face,I-SIGN_AND_SYMPTOM,6803
131876,lips,I-SIGN_AND_SYMPTOM,6803
131877,tongue,I-SIGN_AND_SYMPTOM,6803
131878,or,I-SIGN_AND_SYMPTOM,6803
131879,throat,I-SIGN_AND_SYMPTOM,6804
131880,Seizures,B-SIGN_AND_SYMPTOM,6804
131881,Confusion,B-SIGN_AND_SYMPTOM,6804
131882,or,I-SIGN_AND_SYMPTOM,6804
131883,changes,I-SIGN_AND_SYMPTOM,6804
131884,in,I-SIGN_AND_SYMPTOM,6804
131885,mental,I-SIGN_AND_SYMPTOM,6804
131886,status,I-SIGN_AND_SYMPTOM,6804
131887,If,O,6804
131888,you,O,6804
131889,experience,O,6804
131890,any,O,6804
131891,of,O,6804
131892,these,O,6804
131893,side,O,6804
131894,effects,O,6804
131895,you,O,6804
131896,should,O,6804
131897,contact,O,6804
131898,your,O,6804
131899,doctor,O,6805
131900,as,O,6805
131901,soon,O,6805
131902,as,O,6805
131903,possible,O,6805
131904,In,O,6805
131905,rare,O,6805
131906,cases,O,6805
131907,chloramphenicol,B-NAME_OF_DRUG,6805
131908,can,O,6805
131909,cause,O,6805
131910,serious,O,6805
131911,side,O,6805
131912,effects,O,6805
131913,that,O,6805
131914,may,O,6805
131915,require,O,6805
131916,immediate,O,6805
131917,medical,O,6805
131918,attention,O,6805
131919,such,O,6805
131920,as,O,6805
131921,severe,B-SIGN_AND_SYMPTOM,6805
131922,allergic,I-SIGN_AND_SYMPTOM,6805
131923,reactions,I-SIGN_AND_SYMPTOM,6805
131924,or,I-SIGN_AND_SYMPTOM,6805
131925,blood,I-SIGN_AND_SYMPTOM,6805
131926,disorders,I-SIGN_AND_SYMPTOM,6805
131927,It,O,6805
131928,is,O,6805
131929,important,O,6805
131930,to,O,6805
131931,report,O,6805
131932,any,O,6805
131933,side,O,6805
131934,effects,O,6805
131935,you,O,6805
131936,experience,O,6805
131937,while,O,6805
131938,taking,O,6805
131939,chloramphenicol,B-NAME_OF_DRUG,6805
131940,to,O,6805
131941,your,O,6805
131942,doctor,O,6805
131943,This,O,6805
131944,will,O,6805
131945,help,O,6805
131946,your,O,6805
131947,doctor,O,6805
131948,determine,O,6805
131949,the,O,6805
131950,best,O,6805
131951,course,O,6805
131952,of,O,6805
131953,treatment,O,6805
131954,for,O,6805
131955,you,O,6805
131956,and,O,6805
131957,monitor,O,6805
131958,for,O,6805
131959,any,O,6805
131960,potential,O,6805
131961,problems,O,6805
131962,Does,O,6806
131963,Chloramphenicol,B-NAME_OF_DRUG,6806
131964,Eye,I-NAME_OF_DRUG,6806
131965,Drop,I-NAME_OF_DRUG,6806
131966,Cause,O,6806
131967,Any,O,6806
131968,Interaction,O,6806
131969,with,O,6806
131970,Other,O,6806
131971,Medicines,O,6806
131972,and,O,6806
131973,Supplements,O,6806
131974,Chloramphenicol,B-NAME_OF_DRUG,6806
131975,eye,I-NAME_OF_DRUG,6806
131976,drops,I-NAME_OF_DRUG,6806
131977,may,O,6806
131978,interact,O,6806
131979,with,O,6806
131980,other,O,6806
131981,medications,O,6807
131982,and,O,6807
131983,supplements,O,6807
131984,that,O,6807
131985,you,O,6807
131986,are,O,6807
131987,taking,O,6807
131988,It,O,6807
131989,is,O,6807
131990,important,O,6807
131991,to,O,6807
131992,tell,O,6807
131993,your,O,6807
131994,doctor,O,6807
131995,about,O,6807
131996,all,O,6807
131997,the,O,6807
131998,medications,O,6807
131999,and,O,6807
132000,supplements,O,6807
132001,you,O,6807
132002,are,O,6807
132003,using,O,6807
132004,before,O,6808
132005,starting,O,6808
132006,treatment,O,6808
132007,with,O,6808
132008,chloramphenicol,B-NAME_OF_DRUG,6808
132009,eye,I-NAME_OF_DRUG,6808
132010,drops,I-NAME_OF_DRUG,6808
132011,This,O,6808
132012,will,O,6808
132013,help,O,6808
132014,your,O,6808
132015,doctor,O,6808
132016,determine,O,6808
132017,if,O,6808
132018,chloramphenicol,B-NAME_OF_DRUG,6809
132019,is,O,6809
132020,safe,O,6809
132021,for,O,6809
132022,you,O,6809
132023,and,O,6809
132024,help,O,6809
132025,to,O,6809
132026,prevent,O,6809
132027,any,O,6809
132028,potential,O,6809
132029,drug,O,6809
132030,interactions,O,6809
132031,Some,O,6809
132032,medications,O,6809
132033,that,O,6809
132034,may,O,6809
132035,interact,O,6809
132036,with,O,6809
132037,chloramphenicol,B-NAME_OF_DRUG,6809
132038,eye,I-NAME_OF_DRUG,6810
132039,drops,I-NAME_OF_DRUG,6810
132040,include,O,6810
132041,Other,O,6810
132042,antibiotics,B-NAME_OF_DRUG,6810
132043,or,I-NAME_OF_DRUG,6810
132044,antifungal,I-NAME_OF_DRUG,6810
132045,medications,I-NAME_OF_DRUG,6810
132046,Blood,O,6810
132047,thinners,O,6810
132048,such,O,6810
132049,as,O,6810
132050,warfarin,B-NAME_OF_DRUG,6810
132051,Medications,O,6810
132052,that,O,6810
132053,weaken,O,6810
132054,the,O,6810
132055,immune,O,6810
132056,system,O,6810
132057,such,O,6810
132058,as,O,6810
132059,corticosteroids,B-NAME_OF_DRUG,6810
132060,Medications,O,6810
132061,that,O,6810
132062,affect,O,6810
132063,the,O,6810
132064,blood,O,6810
132065,such,O,6810
132066,as,O,6810
132067,methotrexate,B-NAME_OF_DRUG,6810
132068,Medications,O,6810
132069,that,O,6810
132070,affect,O,6810
132071,the,O,6810
132072,liver,O,6810
132073,such,O,6810
132074,as,O,6810
132075,phenobarbital,B-NAME_OF_DRUG,6811
132076,If,O,6811
132077,you,O,6811
132078,are,O,6811
132079,taking,O,6811
132080,any,O,6811
132081,of,O,6811
132082,these,O,6811
132083,medications,O,6812
132084,you,O,6812
132085,should,O,6812
132086,tell,O,6812
132087,your,O,6812
132088,doctor,O,6812
132089,before,O,6812
132090,using,O,6812
132091,chloramphenicol,B-NAME_OF_DRUG,6812
132092,eye,I-NAME_OF_DRUG,6812
132093,drops,I-NAME_OF_DRUG,6812
132094,Your,O,6812
132095,doctor,O,6812
132096,may,O,6812
132097,need,O,6812
132098,to,O,6812
132099,adjust,O,6813
132100,the,O,6813
132101,dosage,O,6813
132102,of,O,6813
132103,your,O,6813
132104,medications,O,6813
132105,or,O,6813
132106,monitor,O,6813
132107,you,O,6813
132108,more,O,6813
132109,closely,O,6813
132110,for,O,6813
132111,side,O,6813
132112,effects,O,6813
132113,It,O,6813
132114,is,O,6813
132115,also,O,6813
132116,important,O,6813
132117,to,O,6813
132118,tell,O,6813
132119,your,O,6813
132120,doctor,O,6813
132121,about,O,6813
132122,any,O,6813
132123,supplements,O,6813
132124,you,O,6813
132125,are,O,6813
132126,taking,O,6813
132127,as,O,6813
132128,some,O,6813
132129,supplements,O,6813
132130,may,O,6813
132131,interact,O,6813
132132,with,O,6813
132133,chloramphenicol,B-NAME_OF_DRUG,6813
132134,eye,I-NAME_OF_DRUG,6813
132135,drops,I-NAME_OF_DRUG,6813
132136,For,O,6813
132137,example,O,6813
132138,some,O,6813
132139,supplements,O,6814
132140,such,O,6814
132141,as,O,6814
132142,zinc,B-NAME_OF_DRUG,6814
132143,can,O,6814
132144,interfere,O,6814
132145,with,O,6814
132146,the,O,6814
132147,absorption,O,6814
132148,of,O,6814
132149,chloramphenicol,B-NAME_OF_DRUG,6814
132150,If,O,6814
132151,you,O,6814
132152,have,O,6814
132153,any,O,6814
132154,questions,O,6814
132155,about,O,6814
132156,drug,O,6814
132157,interactions,O,6814
132158,with,O,6814
132159,chloramphenicol,B-NAME_OF_DRUG,6814
132160,eye,I-NAME_OF_DRUG,6814
132161,drops,I-NAME_OF_DRUG,6814
132162,you,O,6814
132163,should,O,6814
132164,speak,O,6814
132165,with,O,6814
132166,your,O,6814
132167,doctor,O,6814
132168,or,O,6814
132169,pharmacist,O,6814
132170,What,O,6814
132171,Is,O,6814
132172,Surfer,B-NAME_OF_DISEASE,6814
132173,s,I-NAME_OF_DISEASE,6814
132174,Eye,I-NAME_OF_DISEASE,6814
132175,Pterygium,B-NAME_OF_DISEASE,6814
132176,is,O,6814
132177,characterized,O,6814
132178,by,O,6814
132179,a,B-SIGN_AND_SYMPTOM,6814
132180,thickening,I-SIGN_AND_SYMPTOM,6814
132181,of,I-SIGN_AND_SYMPTOM,6814
132182,the,I-SIGN_AND_SYMPTOM,6814
132183,conjunctiva,I-SIGN_AND_SYMPTOM,6814
132184,tissue,I-SIGN_AND_SYMPTOM,6814
132185,that,I-SIGN_AND_SYMPTOM,6814
132186,takes,I-SIGN_AND_SYMPTOM,6814
132187,on,I-SIGN_AND_SYMPTOM,6814
132188,a,I-SIGN_AND_SYMPTOM,6815
132189,wing-like,I-SIGN_AND_SYMPTOM,6815
132190,or,I-SIGN_AND_SYMPTOM,6815
132191,triangular,I-SIGN_AND_SYMPTOM,6815
132192,shape,I-SIGN_AND_SYMPTOM,6815
132193,and,I-SIGN_AND_SYMPTOM,6815
132194,grows,I-SIGN_AND_SYMPTOM,6815
132195,from,I-SIGN_AND_SYMPTOM,6815
132196,the,I-SIGN_AND_SYMPTOM,6815
132197,inner,I-SIGN_AND_SYMPTOM,6815
132198,corners,I-SIGN_AND_SYMPTOM,6815
132199,of,I-SIGN_AND_SYMPTOM,6815
132200,the,I-SIGN_AND_SYMPTOM,6815
132201,eye,I-SIGN_AND_SYMPTOM,6815
132202,often,I-SIGN_AND_SYMPTOM,6815
132203,extending,I-SIGN_AND_SYMPTOM,6815
132204,onto,I-SIGN_AND_SYMPTOM,6815
132205,the,B-PART_OF_THE_EYES,6815
132206,cornea,I-PART_OF_THE_EYES,6815
132207,Pterygium,B-NAME_OF_DISEASE,6815
132208,can,O,6815
132209,either,O,6816
132210,affect,O,6816
132211,one,O,6816
132212,or,O,6816
132213,both,O,6816
132214,eyes,O,6816
132215,Cases,O,6816
132216,when,O,6816
132217,it,O,6816
132218,affects,O,6816
132219,both,O,6816
132220,eyes,O,6816
132221,at,O,6816
132222,the,O,6816
132223,same,O,6816
132224,time,O,6816
132225,is,O,6816
132226,referred,O,6816
132227,to,O,6816
132228,as,O,6816
132229,bilateral,B-NAME_OF_DISEASE,6816
132230,pterygium,I-NAME_OF_DISEASE,6816
132231,What,O,6816
132232,Symptoms,O,6816
132233,to,O,6816
132234,Expect,O,6816
132235,from,O,6816
132236,Pterygium,B-NAME_OF_DISEASE,6816
132237,of,O,6816
132238,the,O,6816
132239,Eye,O,6816
132240,Pterygium,B-NAME_OF_DISEASE,6816
132241,is,O,6816
132242,a,B-SIGN_AND_SYMPTOM,6816
132243,benign,I-SIGN_AND_SYMPTOM,6816
132244,non-cancerous,I-SIGN_AND_SYMPTOM,6816
132245,growth,I-SIGN_AND_SYMPTOM,6817
132246,that,I-SIGN_AND_SYMPTOM,6817
132247,appears,I-SIGN_AND_SYMPTOM,6817
132248,on,I-SIGN_AND_SYMPTOM,6817
132249,the,I-SIGN_AND_SYMPTOM,6817
132250,conjunctiva,I-SIGN_AND_SYMPTOM,6817
132251,which,O,6817
132252,is,O,6817
132253,the,O,6817
132254,clear,O,6817
132255,membrane,O,6817
132256,that,O,6817
132257,covers,O,6817
132258,the,O,6817
132259,white,O,6817
132260,part,O,6817
132261,of,O,6817
132262,the,O,6817
132263,eye,O,6817
132264,and,O,6817
132265,lines,O,6817
132266,the,O,6817
132267,inside,O,6817
132268,of,O,6817
132269,the,O,6817
132270,eyelids.Sometime,O,6817
132271,you,O,6817
132272,won,O,6818
132273,t,O,6818
132274,experience,O,6818
132275,any,O,6818
132276,symptoms,O,6818
132277,prior,O,6818
132278,to,O,6818
132279,having,O,6818
132280,pterygium,B-NAME_OF_DISEASE,6818
132281,but,O,6818
132282,it,O,6818
132283,can,O,6818
132284,also,O,6819
132285,cause,O,6819
132286,a,O,6819
132287,variety,O,6819
132288,of,O,6819
132289,symptoms,O,6819
132290,some,O,6819
132291,of,O,6819
132292,which,O,6819
132293,may,O,6819
132294,include,O,6819
132295,Dryness,B-SIGN_AND_SYMPTOM,6819
132296,and,I-SIGN_AND_SYMPTOM,6819
132297,redness,I-SIGN_AND_SYMPTOM,6819
132298,of,I-SIGN_AND_SYMPTOM,6819
132299,the,I-SIGN_AND_SYMPTOM,6819
132300,eye,I-SIGN_AND_SYMPTOM,6819
132301,Pterygium,B-NAME_OF_DISEASE,6819
132302,may,O,6819
132303,cause,O,6819
132304,the,B-SIGN_AND_SYMPTOM,6819
132305,eye,I-SIGN_AND_SYMPTOM,6819
132306,to,I-SIGN_AND_SYMPTOM,6819
132307,feel,I-SIGN_AND_SYMPTOM,6819
132308,dry,I-SIGN_AND_SYMPTOM,6819
132309,and,I-SIGN_AND_SYMPTOM,6819
132310,itchy,I-SIGN_AND_SYMPTOM,6819
132311,and,I-SIGN_AND_SYMPTOM,6819
132312,the,I-SIGN_AND_SYMPTOM,6820
132313,affected,I-SIGN_AND_SYMPTOM,6820
132314,eye,I-SIGN_AND_SYMPTOM,6820
132315,may,I-SIGN_AND_SYMPTOM,6820
132316,appear,I-SIGN_AND_SYMPTOM,6820
132317,red,I-SIGN_AND_SYMPTOM,6820
132318,and,I-SIGN_AND_SYMPTOM,6820
132319,inflamed,I-SIGN_AND_SYMPTOM,6820
132320,Sensitivity,B-SIGN_AND_SYMPTOM,6820
132321,to,I-SIGN_AND_SYMPTOM,6820
132322,light,I-SIGN_AND_SYMPTOM,6820
132323,People,O,6820
132324,with,O,6820
132325,pterygium,B-NAME_OF_DISEASE,6820
132326,may,O,6820
132327,be,O,6820
132328,more,B-SIGN_AND_SYMPTOM,6820
132329,sensitive,I-SIGN_AND_SYMPTOM,6820
132330,to,I-SIGN_AND_SYMPTOM,6820
132331,bright,I-SIGN_AND_SYMPTOM,6820
132332,light,I-SIGN_AND_SYMPTOM,6820
132333,and,I-SIGN_AND_SYMPTOM,6820
132334,may,I-SIGN_AND_SYMPTOM,6820
132335,experience,I-SIGN_AND_SYMPTOM,6820
132336,discomfort,B-SIGN_AND_SYMPTOM,6820
132337,when,I-SIGN_AND_SYMPTOM,6820
132338,exposed,I-SIGN_AND_SYMPTOM,6820
132339,to,I-SIGN_AND_SYMPTOM,6820
132340,it,I-SIGN_AND_SYMPTOM,6820
132341,Blurred,B-SIGN_AND_SYMPTOM,6820
132342,vision,I-SIGN_AND_SYMPTOM,6820
132343,Pterygium,B-NAME_OF_DISEASE,6820
132344,may,O,6820
132345,cause,O,6820
132346,the,B-SIGN_AND_SYMPTOM,6820
132347,vision,I-SIGN_AND_SYMPTOM,6820
132348,to,I-SIGN_AND_SYMPTOM,6820
132349,be,I-SIGN_AND_SYMPTOM,6821
132350,blurry,I-SIGN_AND_SYMPTOM,6821
132351,or,I-SIGN_AND_SYMPTOM,6821
132352,distorted,I-SIGN_AND_SYMPTOM,6821
132353,particularly,O,6821
132354,if,O,6821
132355,it,O,6821
132356,grows,O,6821
132357,over,O,6821
132358,the,B-PART_OF_THE_EYES,6821
132359,cornea,I-PART_OF_THE_EYES,6821
132360,which,O,6821
132361,is,O,6821
132362,the,O,6821
132363,clear,O,6821
132364,dome-shaped,O,6821
132365,surface,O,6821
132366,at,O,6821
132367,the,O,6821
132368,front,O,6821
132369,of,O,6821
132370,the,O,6821
132371,eye,O,6821
132372,that,O,6821
132373,helps,O,6821
132374,to,O,6821
132375,focus,O,6821
132376,light,O,6821
132377,Difficulty,B-SIGN_AND_SYMPTOM,6821
132378,with,I-SIGN_AND_SYMPTOM,6821
132379,contact,I-SIGN_AND_SYMPTOM,6822
132380,lenses,I-SIGN_AND_SYMPTOM,6822
132381,Pterygium,B-NAME_OF_DISEASE,6822
132382,can,O,6822
132383,make,O,6822
132384,it,O,6822
132385,troublesome,B-SIGN_AND_SYMPTOM,6822
132386,to,I-SIGN_AND_SYMPTOM,6822
132387,wear,I-SIGN_AND_SYMPTOM,6822
132388,contact,I-SIGN_AND_SYMPTOM,6822
132389,lenses,I-SIGN_AND_SYMPTOM,6822
132390,comfortably,I-SIGN_AND_SYMPTOM,6823
132391,as,O,6823
132392,they,O,6823
132393,may,O,6823
132394,not,O,6823
132395,fit,O,6823
132396,to,O,6823
132397,your,O,6823
132398,eyes,O,6823
132399,properly,O,6823
132400,and,O,6823
132401,may,O,6823
132402,cause,O,6823
132403,discomfort,B-SIGN_AND_SYMPTOM,6823
132404,Discomfort,B-SIGN_AND_SYMPTOM,6823
132405,and,I-SIGN_AND_SYMPTOM,6823
132406,foreign,I-SIGN_AND_SYMPTOM,6823
132407,body,I-SIGN_AND_SYMPTOM,6823
132408,sensation,I-SIGN_AND_SYMPTOM,6824
132409,Some,O,6824
132410,people,O,6824
132411,with,O,6824
132412,pterygium,B-NAME_OF_DISEASE,6824
132413,may,O,6824
132414,experience,O,6824
132415,discomfort,B-SIGN_AND_SYMPTOM,6824
132416,What,O,6824
132417,Causes,O,6824
132418,Pterygium,B-NAME_OF_DISEASE,6824
132419,The,O,6824
132420,exact,O,6824
132421,cause,O,6824
132422,of,O,6824
132423,pterygium,B-NAME_OF_DISEASE,6824
132424,is,O,6824
132425,not,O,6824
132426,fully,O,6824
132427,understood,O,6824
132428,but,O,6824
132429,it,O,6824
132430,is,O,6824
132431,believed,O,6824
132432,to,O,6824
132433,be,O,6824
132434,associated,O,6825
132435,with,O,6825
132436,exposure,B-CAUSE_OF_DISEASE,6825
132437,to,I-CAUSE_OF_DISEASE,6825
132438,ultraviolet,I-CAUSE_OF_DISEASE,6825
132439,UV,I-CAUSE_OF_DISEASE,6825
132440,light,I-CAUSE_OF_DISEASE,6825
132441,wind,I-CAUSE_OF_DISEASE,6825
132442,and,I-CAUSE_OF_DISEASE,6825
132443,dust,I-CAUSE_OF_DISEASE,6825
132444,Other,O,6825
132445,possible,O,6825
132446,risk,O,6825
132447,factors,O,6825
132448,for,O,6825
132449,developing,O,6825
132450,pterygium,B-NAME_OF_DISEASE,6825
132451,include,O,6825
132452,Living,B-CAUSE_OF_DISEASE,6825
132453,in,I-CAUSE_OF_DISEASE,6825
132454,a,I-CAUSE_OF_DISEASE,6825
132455,sunny,I-CAUSE_OF_DISEASE,6825
132456,or,I-CAUSE_OF_DISEASE,6825
132457,dry,I-CAUSE_OF_DISEASE,6825
132458,climate,I-CAUSE_OF_DISEASE,6825
132459,People,O,6825
132460,who,O,6825
132461,live,B-CAUSE_OF_DISEASE,6825
132462,in,I-CAUSE_OF_DISEASE,6825
132463,areas,I-CAUSE_OF_DISEASE,6825
132464,with,I-CAUSE_OF_DISEASE,6825
132465,high,I-CAUSE_OF_DISEASE,6825
132466,levels,I-CAUSE_OF_DISEASE,6826
132467,of,I-CAUSE_OF_DISEASE,6826
132468,UV,I-CAUSE_OF_DISEASE,6826
132469,light,I-CAUSE_OF_DISEASE,6826
132470,or,I-CAUSE_OF_DISEASE,6826
132471,low,I-CAUSE_OF_DISEASE,6826
132472,humidity,I-CAUSE_OF_DISEASE,6826
132473,may,O,6826
132474,be,O,6826
132475,more,O,6826
132476,at,O,6826
132477,risk,O,6826
132478,of,O,6826
132479,developing,O,6826
132480,pterygium,B-NAME_OF_DISEASE,6826
132481,Working,B-CAUSE_OF_DISEASE,6826
132482,outdoors,I-CAUSE_OF_DISEASE,6826
132483,People,O,6826
132484,who,O,6826
132485,work,B-CAUSE_OF_DISEASE,6826
132486,in,I-CAUSE_OF_DISEASE,6826
132487,occupations,I-CAUSE_OF_DISEASE,6826
132488,that,I-CAUSE_OF_DISEASE,6826
132489,involve,I-CAUSE_OF_DISEASE,6826
132490,prolonged,I-CAUSE_OF_DISEASE,6826
132491,exposure,I-CAUSE_OF_DISEASE,6826
132492,to,I-CAUSE_OF_DISEASE,6826
132493,the,I-CAUSE_OF_DISEASE,6826
132494,sun,I-CAUSE_OF_DISEASE,6826
132495,wind,I-CAUSE_OF_DISEASE,6826
132496,or,I-CAUSE_OF_DISEASE,6826
132497,dust,I-CAUSE_OF_DISEASE,6826
132498,such,I-CAUSE_OF_DISEASE,6826
132499,as,I-CAUSE_OF_DISEASE,6826
132500,farmers,I-CAUSE_OF_DISEASE,6826
132501,construction,I-CAUSE_OF_DISEASE,6827
132502,workers,I-CAUSE_OF_DISEASE,6827
132503,and,I-CAUSE_OF_DISEASE,6827
132504,sailors,I-CAUSE_OF_DISEASE,6827
132505,may,O,6827
132506,be,O,6827
132507,more,O,6827
132508,prone,O,6827
132509,to,O,6827
132510,pterygium,B-NAME_OF_DISEASE,6827
132511,Being,B-CAUSE_OF_DISEASE,6827
132512,male,I-CAUSE_OF_DISEASE,6827
132513,Men,O,6827
132514,are,O,6827
132515,more,O,6827
132516,likely,O,6827
132517,to,O,6827
132518,develop,O,6827
132519,pterygium,B-NAME_OF_DISEASE,6827
132520,than,O,6827
132521,women,O,6827
132522,Having,B-CAUSE_OF_DISEASE,6827
132523,fair,B-CAUSE_OF_DISEASE,6827
132524,skin,I-CAUSE_OF_DISEASE,6827
132525,People,O,6827
132526,with,O,6827
132527,fair,B-CAUSE_OF_DISEASE,6827
132528,skin,I-CAUSE_OF_DISEASE,6827
132529,are,O,6827
132530,more,O,6827
132531,likely,O,6827
132532,to,O,6827
132533,develop,O,6827
132534,pterygium,B-NAME_OF_DISEASE,6827
132535,than,O,6827
132536,those,O,6827
132537,with,O,6827
132538,darker,O,6828
132539,skin,O,6828
132540,Family,B-CAUSE_OF_DISEASE,6828
132541,history,I-CAUSE_OF_DISEASE,6828
132542,There,O,6828
132543,may,O,6828
132544,be,O,6828
132545,a,B-CAUSE_OF_DISEASE,6828
132546,genetic,I-CAUSE_OF_DISEASE,6828
132547,component,I-CAUSE_OF_DISEASE,6828
132548,to,O,6828
132549,pterygium,B-NAME_OF_DISEASE,6828
132550,as,O,6828
132551,some,O,6828
132552,people,O,6828
132553,may,O,6828
132554,be,O,6828
132555,more,O,6828
132556,predisposed,O,6828
132557,to,O,6828
132558,developing,O,6828
132559,the,O,6828
132560,condition,O,6828
132561,due,O,6828
132562,to,O,6828
132563,their,O,6828
132564,family,B-CAUSE_OF_DISEASE,6828
132565,history,I-CAUSE_OF_DISEASE,6828
132566,While,B-CAUSE_OF_DISEASE,6828
132567,UV,I-CAUSE_OF_DISEASE,6828
132568,light,I-CAUSE_OF_DISEASE,6828
132569,wind,I-CAUSE_OF_DISEASE,6828
132570,and,I-CAUSE_OF_DISEASE,6828
132571,dust,I-CAUSE_OF_DISEASE,6828
132572,are,O,6828
132573,thought,O,6828
132574,to,O,6828
132575,be,O,6828
132576,the,O,6828
132577,main,O,6828
132578,contributing,O,6828
132579,factors,O,6829
132580,to,O,6829
132581,pterygium,B-NAME_OF_DISEASE,6829
132582,it,O,6829
132583,is,O,6829
132584,not,O,6829
132585,clear,O,6829
132586,why,O,6829
132587,some,O,6829
132588,people,O,6829
132589,are,O,6829
132590,more,O,6829
132591,prone,O,6829
132592,to,O,6829
132593,developing,O,6829
132594,the,O,6829
132595,condition,O,6829
132596,than,O,6829
132597,others,O,6829
132598,Some,O,6829
132599,research,O,6829
132600,suggests,O,6829
132601,that,O,6829
132602,inflammation,B-CAUSE_OF_DISEASE,6829
132603,may,O,6829
132604,play,O,6829
132605,a,O,6829
132606,role,O,6829
132607,in,O,6829
132608,the,O,6829
132609,development,O,6829
132610,of,O,6830
132611,pterygium,B-NAME_OF_DISEASE,6830
132612,and,O,6830
132613,that,O,6830
132614,people,O,6830
132615,with,O,6830
132616,certain,O,6830
132617,underlying,O,6830
132618,health,O,6830
132619,conditions,O,6830
132620,such,O,6830
132621,as,O,6830
132622,dry,B-NAME_OF_DISEASE,6830
132623,eye,I-NAME_OF_DISEASE,6830
132624,syndrome,I-NAME_OF_DISEASE,6830
132625,or,O,6830
132626,autoimmune,B-NAME_OF_DISEASE,6830
132627,diseases,I-NAME_OF_DISEASE,6830
132628,may,O,6830
132629,be,O,6830
132630,more,O,6830
132631,at,O,6830
132632,risk,O,6830
132633,Pinguecula,B-NAME_OF_DISEASE,6830
132634,vs,O,6830
132635,Pterygium,B-NAME_OF_DISEASE,6830
132636,What,O,6830
132637,Are,O,6831
132638,the,O,6831
132639,Differences,O,6831
132640,Pinguecula,B-NAME_OF_DISEASE,6831
132641,and,O,6831
132642,pterygium,B-NAME_OF_DISEASE,6831
132643,are,O,6831
132644,two,O,6831
132645,conditions,O,6831
132646,that,O,6831
132647,affect,O,6831
132648,the,B-PART_OF_THE_EYES,6831
132649,conjunctiva,I-PART_OF_THE_EYES,6831
132650,which,O,6831
132651,is,O,6831
132652,the,O,6831
132653,clear,O,6831
132654,membrane,O,6831
132655,that,O,6831
132656,covers,O,6832
132657,the,O,6832
132658,white,O,6832
132659,part,O,6832
132660,of,O,6832
132661,the,O,6832
132662,eye,O,6832
132663,and,O,6832
132664,lines,O,6832
132665,the,O,6832
132666,inside,O,6832
132667,of,O,6832
132668,the,B-PART_OF_THE_EYES,6832
132669,eyelids,I-PART_OF_THE_EYES,6832
132670,While,O,6832
132671,they,O,6832
132672,have,O,6832
132673,some,O,6832
132674,similarities,O,6832
132675,they,O,6832
132676,are,O,6833
132677,two,O,6833
132678,distinct,O,6833
132679,conditions,O,6833
132680,that,O,6833
132681,differ,O,6833
132682,in,O,6833
132683,several,O,6833
132684,ways,O,6833
132685,Location,O,6833
132686,A,O,6833
132687,pinguecula,B-NAME_OF_DISEASE,6833
132688,is,O,6833
132689,a,B-SIGN_AND_SYMPTOM,6833
132690,small,I-SIGN_AND_SYMPTOM,6833
132691,yellowish,I-SIGN_AND_SYMPTOM,6833
132692,or,I-SIGN_AND_SYMPTOM,6833
132693,flesh-colored,I-SIGN_AND_SYMPTOM,6833
132694,bump,I-SIGN_AND_SYMPTOM,6833
132695,that,I-SIGN_AND_SYMPTOM,6833
132696,appears,I-SIGN_AND_SYMPTOM,6833
132697,on,I-SIGN_AND_SYMPTOM,6833
132698,the,I-SIGN_AND_SYMPTOM,6833
132699,conjunctiva,I-SIGN_AND_SYMPTOM,6833
132700,usually,I-SIGN_AND_SYMPTOM,6833
132701,on,I-SIGN_AND_SYMPTOM,6833
132702,the,I-SIGN_AND_SYMPTOM,6833
132703,side,I-SIGN_AND_SYMPTOM,6833
132704,of,I-SIGN_AND_SYMPTOM,6833
132705,the,I-SIGN_AND_SYMPTOM,6833
132706,eye,I-SIGN_AND_SYMPTOM,6833
132707,closest,I-SIGN_AND_SYMPTOM,6833
132708,to,I-SIGN_AND_SYMPTOM,6833
132709,the,I-SIGN_AND_SYMPTOM,6833
132710,nose,I-SIGN_AND_SYMPTOM,6833
132711,It,O,6834
132712,does,O,6834
132713,not,O,6834
132714,typically,O,6834
132715,grow,O,6834
132716,beyond,O,6834
132717,the,B-PART_OF_THE_EYES,6834
132718,conjunctiva,I-PART_OF_THE_EYES,6834
132719,and,O,6834
132720,does,O,6834
132721,not,O,6834
132722,affect,O,6834
132723,the,B-PART_OF_THE_EYES,6834
132724,cornea,I-PART_OF_THE_EYES,6834
132725,which,O,6834
132726,is,O,6834
132727,the,O,6834
132728,clear,O,6834
132729,dome-shaped,O,6834
132730,surface,O,6834
132731,at,O,6835
132732,the,O,6835
132733,front,O,6835
132734,of,O,6835
132735,the,O,6835
132736,eye,O,6835
132737,that,O,6835
132738,helps,O,6835
132739,to,O,6835
132740,focus,O,6835
132741,light,O,6835
132742,A,O,6835
132743,pterygium,B-NAME_OF_DISEASE,6835
132744,on,O,6835
132745,the,O,6835
132746,other,O,6835
132747,hand,O,6835
132748,is,O,6835
132749,a,B-SIGN_AND_SYMPTOM,6835
132750,raised,I-SIGN_AND_SYMPTOM,6835
132751,fleshy,I-SIGN_AND_SYMPTOM,6835
132752,growth,I-SIGN_AND_SYMPTOM,6835
132753,that,I-SIGN_AND_SYMPTOM,6835
132754,starts,I-SIGN_AND_SYMPTOM,6835
132755,on,I-SIGN_AND_SYMPTOM,6835
132756,the,I-SIGN_AND_SYMPTOM,6835
132757,conjunctiva,I-SIGN_AND_SYMPTOM,6835
132758,and,I-SIGN_AND_SYMPTOM,6836
132759,can,I-SIGN_AND_SYMPTOM,6836
132760,spread,I-SIGN_AND_SYMPTOM,6836
132761,outward,I-SIGN_AND_SYMPTOM,6836
132762,onto,I-SIGN_AND_SYMPTOM,6836
132763,the,I-SIGN_AND_SYMPTOM,6836
132764,cornea,I-SIGN_AND_SYMPTOM,6836
132765,sometimes,O,6836
132766,causing,O,6836
132767,vision,O,6836
132768,problems,O,6836
132769,Causes,O,6836
132770,Both,O,6836
132771,pinguecula,B-NAME_OF_DISEASE,6836
132772,and,O,6836
132773,pterygium,B-NAME_OF_DISEASE,6836
132774,are,O,6836
132775,thought,O,6836
132776,to,O,6837
132777,be,O,6837
132778,caused,O,6837
132779,by,O,6837
132780,exposure,B-CAUSE_OF_DISEASE,6837
132781,to,I-CAUSE_OF_DISEASE,6837
132782,ultraviolet,I-CAUSE_OF_DISEASE,6837
132783,UV,I-CAUSE_OF_DISEASE,6837
132784,light,I-CAUSE_OF_DISEASE,6837
132785,wind,I-CAUSE_OF_DISEASE,6837
132786,and,I-CAUSE_OF_DISEASE,6837
132787,dust,I-CAUSE_OF_DISEASE,6837
132788,However,O,6837
132789,pterygium,B-NAME_OF_DISEASE,6838
132790,is,O,6838
132791,more,O,6838
132792,likely,O,6838
132793,to,O,6838
132794,be,O,6838
132795,associated,O,6838
132796,with,O,6838
132797,these,O,6838
132798,factors,O,6838
132799,and,O,6838
132800,is,O,6838
132801,believed,O,6838
132802,to,O,6838
132803,be,O,6838
132804,more,O,6838
132805,aggressive,O,6839
132806,than,O,6839
132807,pinguecula,B-NAME_OF_DISEASE,6839
132808,Some,O,6839
132809,research,O,6839
132810,suggests,O,6839
132811,that,O,6839
132812,inflammation,B-CAUSE_OF_DISEASE,6839
132813,may,O,6839
132814,play,O,6839
132815,a,O,6839
132816,role,O,6839
132817,in,O,6839
132818,the,O,6839
132819,development,O,6839
132820,of,O,6839
132821,pterygium,B-NAME_OF_DISEASE,6840
132822,and,O,6840
132823,that,O,6840
132824,people,O,6840
132825,with,O,6840
132826,certain,O,6840
132827,underlying,O,6840
132828,health,O,6840
132829,conditions,O,6840
132830,such,O,6840
132831,as,O,6840
132832,dry,B-NAME_OF_DISEASE,6840
132833,eye,I-NAME_OF_DISEASE,6840
132834,syndrome,I-NAME_OF_DISEASE,6840
132835,or,O,6840
132836,autoimmune,B-NAME_OF_DISEASE,6840
132837,diseases,I-NAME_OF_DISEASE,6840
132838,may,O,6840
132839,be,O,6840
132840,more,O,6840
132841,at,O,6840
132842,risk,O,6840
132843,Symptoms,O,6841
132844,Both,O,6841
132845,pinguecula,B-NAME_OF_DISEASE,6841
132846,and,O,6841
132847,pterygium,B-NAME_OF_DISEASE,6841
132848,can,O,6841
132849,cause,O,6841
132850,dryness,B-SIGN_AND_SYMPTOM,6841
132851,redness,I-SIGN_AND_SYMPTOM,6841
132852,and,I-SIGN_AND_SYMPTOM,6841
132853,discomfort,I-SIGN_AND_SYMPTOM,6841
132854,in,I-SIGN_AND_SYMPTOM,6841
132855,the,I-SIGN_AND_SYMPTOM,6841
132856,eye,I-SIGN_AND_SYMPTOM,6841
132857,as,I-SIGN_AND_SYMPTOM,6841
132858,well,I-SIGN_AND_SYMPTOM,6842
132859,as,I-SIGN_AND_SYMPTOM,6842
132860,sensitivity,I-SIGN_AND_SYMPTOM,6842
132861,to,I-SIGN_AND_SYMPTOM,6842
132862,light,I-SIGN_AND_SYMPTOM,6842
132863,However,O,6842
132864,pterygium,B-NAME_OF_DISEASE,6842
132865,is,O,6842
132866,more,O,6842
132867,likely,O,6842
132868,to,O,6842
132869,cause,O,6842
132870,blurred,B-SIGN_AND_SYMPTOM,6842
132871,vision,I-SIGN_AND_SYMPTOM,6842
132872,particularly,O,6842
132873,if,O,6842
132874,it,O,6842
132875,grows,O,6842
132876,over,O,6842
132877,the,B-PART_OF_THE_EYES,6842
132878,cornea,I-PART_OF_THE_EYES,6843
132879,and,O,6843
132880,may,O,6843
132881,cause,O,6843
132882,the,B-SIGN_AND_SYMPTOM,6843
132883,affected,I-SIGN_AND_SYMPTOM,6843
132884,eye,I-SIGN_AND_SYMPTOM,6843
132885,to,I-SIGN_AND_SYMPTOM,6843
132886,appear,I-SIGN_AND_SYMPTOM,6843
132887,swollen,I-SIGN_AND_SYMPTOM,6843
132888,and,I-SIGN_AND_SYMPTOM,6843
132889,red,I-SIGN_AND_SYMPTOM,6843
132890,Pinguecula,B-NAME_OF_DISEASE,6843
132891,on,O,6843
132892,the,O,6843
132893,other,O,6843
132894,hand,O,6843
132895,usually,O,6843
132896,does,O,6843
132897,not,O,6843
132898,affect,O,6843
132899,vision,O,6843
132900,and,O,6843
132901,may,O,6843
132902,not,O,6844
132903,cause,O,6844
132904,any,O,6844
132905,symptoms,O,6844
132906,at,O,6844
132907,all,O,6844
132908,Treatment,O,6844
132909,Pinguecula,B-NAME_OF_DISEASE,6844
132910,is,O,6844
132911,usually,O,6844
132912,a,B-SIGN_AND_SYMPTOM,6844
132913,benign,I-SIGN_AND_SYMPTOM,6844
132914,self-limiting,O,6844
132915,condition,O,6844
132916,that,O,6844
132917,does,O,6844
132918,not,O,6844
132919,require,O,6844
132920,treatment,O,6844
132921,In,O,6844
132922,some,O,6844
132923,cases,O,6844
132924,artificial,B-TREATMENT,6844
132925,tears,I-TREATMENT,6844
132926,or,I-TREATMENT,6844
132927,eye,I-TREATMENT,6844
132928,drops,I-TREATMENT,6844
132929,may,O,6844
132930,be,O,6844
132931,used,O,6844
132932,to,O,6844
132933,relieve,O,6844
132934,dryness,B-SIGN_AND_SYMPTOM,6844
132935,and,I-SIGN_AND_SYMPTOM,6844
132936,discomfort,I-SIGN_AND_SYMPTOM,6844
132937,Pterygium,B-NAME_OF_DISEASE,6844
132938,on,O,6845
132939,the,O,6845
132940,other,O,6845
132941,hand,O,6845
132942,may,O,6845
132943,require,O,6845
132944,treatment,O,6845
132945,if,O,6845
132946,it,O,6845
132947,is,O,6845
132948,causing,O,6845
132949,vision,B-SIGN_AND_SYMPTOM,6845
132950,problems,I-SIGN_AND_SYMPTOM,6845
132951,or,I-SIGN_AND_SYMPTOM,6845
132952,discomfort,I-SIGN_AND_SYMPTOM,6845
132953,Treatment,O,6845
132954,options,O,6845
132955,may,O,6845
132956,include,O,6845
132957,artificial,B-TREATMENT,6845
132958,tears,I-TREATMENT,6845
132959,sunglasses,B-TREATMENT,6846
132960,to,I-TREATMENT,6846
132961,protect,I-TREATMENT,6846
132962,the,I-TREATMENT,6846
132963,eyes,I-TREATMENT,6846
132964,from,I-TREATMENT,6846
132965,UV,I-TREATMENT,6846
132966,rays,I-TREATMENT,6846
132967,and,O,6846
132968,a,B-TREATMENT,6846
132969,wide-brimmed,I-TREATMENT,6846
132970,hat,I-TREATMENT,6846
132971,to,O,6846
132972,shade,O,6846
132973,the,O,6846
132974,eyes,O,6846
132975,In,O,6846
132976,more,O,6846
132977,severe,O,6846
132978,cases,O,6846
132979,surgery,B-TREATMENT,6846
132980,may,O,6846
132981,be,O,6846
132982,necessary,O,6846
132983,to,O,6846
132984,remove,O,6846
132985,the,O,6846
132986,growth,O,6846
132987,and,O,6846
132988,restore,O,6846
132989,vision,O,6847
132990,How,O,6847
132991,Is,O,6847
132992,Pterygium,B-NAME_OF_DISEASE,6847
132993,Treatment,O,6847
132994,Treatment,O,6847
132995,for,O,6847
132996,pterygium,B-NAME_OF_DISEASE,6847
132997,depends,O,6847
132998,on,O,6847
132999,the,O,6847
133000,severity,O,6847
133001,of,O,6847
133002,the,O,6847
133003,condition,O,6847
133004,and,O,6847
133005,the,O,6847
133006,symptoms,O,6847
133007,it,O,6847
133008,is,O,6847
133009,causing,O,6847
133010,Some,O,6847
133011,common,O,6848
133012,treatment,O,6848
133013,options,O,6848
133014,for,O,6848
133015,pterygium,B-NAME_OF_DISEASE,6848
133016,include,O,6848
133017,Artificial,B-TREATMENT,6848
133018,tears,I-TREATMENT,6848
133019,Using,B-TREATMENT,6848
133020,artificial,B-TREATMENT,6848
133021,tears,I-TREATMENT,6848
133022,to,I-TREATMENT,6848
133023,keep,I-TREATMENT,6848
133024,the,I-TREATMENT,6848
133025,eyes,I-TREATMENT,6848
133026,moist,I-TREATMENT,6848
133027,can,O,6848
133028,help,O,6848
133029,to,O,6848
133030,relieve,O,6848
133031,dryness,B-SIGN_AND_SYMPTOM,6848
133032,and,I-SIGN_AND_SYMPTOM,6848
133033,discomfort,I-SIGN_AND_SYMPTOM,6848
133034,Sunglasses,B-TREATMENT,6848
133035,and,I-TREATMENT,6848
133036,a,I-TREATMENT,6848
133037,wide-brimmed,I-TREATMENT,6848
133038,hat,I-TREATMENT,6848
133039,Wearing,B-TREATMENT,6849
133040,sunglasses,I-TREATMENT,6849
133041,and,I-TREATMENT,6849
133042,a,I-TREATMENT,6849
133043,wide-brimmed,I-TREATMENT,6849
133044,hat,I-TREATMENT,6849
133045,when,I-TREATMENT,6849
133046,outdoors,I-TREATMENT,6849
133047,can,O,6849
133048,help,O,6849
133049,to,O,6849
133050,protect,O,6849
133051,the,O,6849
133052,eyes,O,6849
133053,from,O,6849
133054,ultraviolet,B-CAUSE_OF_DISEASE,6849
133055,UV,I-CAUSE_OF_DISEASE,6849
133056,light,I-CAUSE_OF_DISEASE,6849
133057,and,I-CAUSE_OF_DISEASE,6849
133058,wind,I-CAUSE_OF_DISEASE,6849
133059,which,O,6849
133060,may,O,6849
133061,help,O,6849
133062,to,O,6850
133063,prevent,O,6850
133064,the,O,6850
133065,pterygium,B-NAME_OF_DISEASE,6850
133066,from,O,6850
133067,growing,O,6850
133068,or,O,6850
133069,recurring,O,6850
133070,Corticosteroid,B-NAME_OF_DRUG,6850
133071,eye,I-NAME_OF_DRUG,6850
133072,drops,I-NAME_OF_DRUG,6850
133073,In,O,6850
133074,some,O,6850
133075,cases,O,6850
133076,corticosteroid,B-NAME_OF_DRUG,6850
133077,eye,I-NAME_OF_DRUG,6850
133078,drops,I-NAME_OF_DRUG,6850
133079,may,O,6850
133080,be,O,6850
133081,prescribed,O,6850
133082,to,O,6850
133083,reduce,O,6850
133084,inflammation,B-SIGN_AND_SYMPTOM,6850
133085,and,O,6850
133086,prevent,O,6850
133087,the,O,6850
133088,pterygium,B-NAME_OF_DISEASE,6850
133089,from,O,6850
133090,growing,O,6850
133091,Surgery,B-TREATMENT,6850
133092,If,O,6850
133093,the,O,6850
133094,pterygium,B-NAME_OF_DISEASE,6850
133095,is,O,6850
133096,causing,O,6850
133097,vision,B-SIGN_AND_SYMPTOM,6850
133098,problems,I-SIGN_AND_SYMPTOM,6850
133099,or,I-SIGN_AND_SYMPTOM,6850
133100,discomfort,I-SIGN_AND_SYMPTOM,6850
133101,or,O,6851
133102,if,O,6851
133103,it,O,6851
133104,has,O,6851
133105,not,O,6851
133106,responded,O,6851
133107,to,O,6851
133108,other,O,6851
133109,treatments,O,6851
133110,surgery,B-TREATMENT,6851
133111,may,O,6851
133112,be,O,6851
133113,necessary,O,6851
133114,to,O,6851
133115,remove,O,6851
133116,the,O,6851
133117,growth,O,6851
133118,and,O,6851
133119,restore,O,6851
133120,vision,O,6852
133121,There,O,6852
133122,are,O,6852
133123,several,O,6852
133124,different,O,6852
133125,surgical,O,6852
133126,techniques,O,6852
133127,that,O,6852
133128,can,O,6852
133129,be,O,6852
133130,used,O,6852
133131,to,O,6852
133132,remove,O,6852
133133,pterygium,B-NAME_OF_DISEASE,6852
133134,including,O,6853
133135,simple,B-TREATMENT,6853
133136,excision,I-TREATMENT,6853
133137,conjunctival,B-TREATMENT,6853
133138,autograft,I-TREATMENT,6853
133139,and,O,6853
133140,amniotic,B-TREATMENT,6853
133141,membrane,I-TREATMENT,6853
133142,grafting,I-TREATMENT,6853
133143,It,O,6853
133144,is,O,6853
133145,important,O,6853
133146,to,O,6853
133147,see,O,6853
133148,an,O,6853
133149,eye,O,6853
133150,doctor,O,6853
133151,for,O,6853
133152,a,O,6853
133153,proper,O,6853
133154,diagnosis,O,6853
133155,and,O,6853
133156,treatment,O,6854
133157,if,O,6854
133158,you,O,6854
133159,are,O,6854
133160,experiencing,O,6854
133161,symptoms,O,6854
133162,of,O,6854
133163,pterygium,B-NAME_OF_DISEASE,6854
133164,such,O,6854
133165,as,O,6854
133166,dryness,B-SIGN_AND_SYMPTOM,6854
133167,redness,I-SIGN_AND_SYMPTOM,6854
133168,or,I-SIGN_AND_SYMPTOM,6854
133169,blurred,I-SIGN_AND_SYMPTOM,6854
133170,vision,I-SIGN_AND_SYMPTOM,6854
133171,The,O,6854
133172,eye,O,6854
133173,doctor,O,6854
133174,will,O,6854
133175,be,O,6854
133176,able,O,6855
133177,to,O,6855
133178,recommend,O,6855
133179,the,O,6855
133180,best,O,6855
133181,treatment,O,6855
133182,plan,O,6855
133183,based,O,6855
133184,on,O,6855
133185,the,O,6855
133186,severity,O,6855
133187,of,O,6855
133188,your,O,6855
133189,condition,O,6856
133190,and,O,6856
133191,your,O,6856
133192,specific,O,6856
133193,needs,O,6856
133194,Do,O,6856
133195,I,O,6856
133196,need,O,6856
133197,Pterygium,B-TREATMENT,6856
133198,Surgery,I-TREATMENT,6856
133199,Pterygium,B-TREATMENT,6856
133200,surgery,I-TREATMENT,6856
133201,may,O,6856
133202,be,O,6856
133203,recommended,O,6856
133204,if,O,6856
133205,the,O,6856
133206,pterygium,B-NAME_OF_DISEASE,6856
133207,is,O,6856
133208,causing,O,6857
133209,vision,B-SIGN_AND_SYMPTOM,6857
133210,problems,I-SIGN_AND_SYMPTOM,6857
133211,or,I-SIGN_AND_SYMPTOM,6857
133212,discomfort,I-SIGN_AND_SYMPTOM,6857
133213,or,O,6857
133214,if,O,6857
133215,it,O,6857
133216,has,O,6857
133217,not,O,6857
133218,responded,O,6857
133219,to,O,6857
133220,other,O,6857
133221,treatments,O,6857
133222,such,O,6857
133223,as,O,6857
133224,the,O,6857
133225,use,O,6857
133226,of,O,6857
133227,artificial,B-TREATMENT,6857
133228,tears,I-TREATMENT,6857
133229,or,O,6858
133230,corticosteroid,B-NAME_OF_DRUG,6858
133231,eye,I-NAME_OF_DRUG,6858
133232,drops,I-NAME_OF_DRUG,6858
133233,Panophthalmitis,B-NAME_OF_DISEASE,6858
133234,is,O,6858
133235,a,O,6858
133236,serious,O,6858
133237,and,O,6858
133238,potentially,O,6858
133239,blinding,O,6858
133240,infection,O,6858
133241,of,O,6858
133242,the,O,6858
133243,eye,O,6858
133244,that,O,6858
133245,involves,O,6858
133246,the,B-PART_OF_THE_EYES,6858
133247,entire,I-PART_OF_THE_EYES,6858
133248,globe,I-PART_OF_THE_EYES,6859
133249,of,I-PART_OF_THE_EYES,6859
133250,the,I-PART_OF_THE_EYES,6859
133251,eye,I-PART_OF_THE_EYES,6859
133252,It,O,6859
133253,is,O,6859
133254,a,O,6859
133255,rare,O,6859
133256,but,O,6859
133257,serious,O,6859
133258,condition,O,6859
133259,that,O,6859
133260,requires,O,6859
133261,prompt,O,6859
133262,medical,O,6859
133263,attention,O,6859
133264,and,O,6859
133265,treatment,O,6859
133266,Causes,O,6859
133267,of,O,6859
133268,Panophthalmitis,B-NAME_OF_DISEASE,6859
133269,Bacterial,B-CAUSE_OF_DISEASE,6859
133270,infections,I-CAUSE_OF_DISEASE,6859
133271,The,O,6859
133272,most,O,6860
133273,common,O,6860
133274,cause,O,6860
133275,of,O,6860
133276,panophthalmitis,B-NAME_OF_DISEASE,6860
133277,is,O,6860
133278,a,B-CAUSE_OF_DISEASE,6860
133279,bacterial,I-CAUSE_OF_DISEASE,6860
133280,infection,I-CAUSE_OF_DISEASE,6860
133281,such,I-CAUSE_OF_DISEASE,6860
133282,as,I-CAUSE_OF_DISEASE,6860
133283,Staphylococcus,I-CAUSE_OF_DISEASE,6860
133284,aureus,I-CAUSE_OF_DISEASE,6860
133285,or,I-CAUSE_OF_DISEASE,6860
133286,Streptococcus,I-CAUSE_OF_DISEASE,6860
133287,pneumoniae,I-CAUSE_OF_DISEASE,6860
133288,These,O,6860
133289,bacteria,O,6860
133290,can,O,6860
133291,enter,O,6860
133292,the,O,6860
133293,eye,O,6860
133294,through,O,6860
133295,a,O,6860
133296,variety,O,6860
133297,of,O,6861
133298,means,O,6861
133299,including,O,6861
133300,a,B-CAUSE_OF_DISEASE,6861
133301,penetrating,I-CAUSE_OF_DISEASE,6861
133302,injury,I-CAUSE_OF_DISEASE,6861
133303,trauma,I-CAUSE_OF_DISEASE,6861
133304,or,I-CAUSE_OF_DISEASE,6861
133305,a,I-CAUSE_OF_DISEASE,6861
133306,surgical,I-CAUSE_OF_DISEASE,6861
133307,procedure,I-CAUSE_OF_DISEASE,6861
133308,Fungal,B-CAUSE_OF_DISEASE,6861
133309,infections,I-CAUSE_OF_DISEASE,6861
133310,Fungal,B-CAUSE_OF_DISEASE,6861
133311,infections,I-CAUSE_OF_DISEASE,6861
133312,such,I-CAUSE_OF_DISEASE,6861
133313,as,I-CAUSE_OF_DISEASE,6861
133314,Aspergillosis,I-CAUSE_OF_DISEASE,6861
133315,and,I-CAUSE_OF_DISEASE,6861
133316,Candida,I-CAUSE_OF_DISEASE,6861
133317,can,O,6862
133318,also,O,6862
133319,cause,O,6862
133320,panophthalmitis,B-NAME_OF_DISEASE,6862
133321,These,O,6862
133322,infections,O,6862
133323,can,O,6862
133324,occur,O,6862
133325,in,O,6862
133326,individuals,O,6863
133327,with,O,6863
133328,weakened,O,6863
133329,immune,O,6863
133330,systems,O,6863
133331,or,O,6863
133332,in,O,6863
133333,those,O,6863
133334,who,O,6863
133335,have,O,6864
133336,had,O,6864
133337,previous,O,6864
133338,eye,O,6864
133339,surgeries,O,6864
133340,Trauma,B-CAUSE_OF_DISEASE,6864
133341,Trauma,B-CAUSE_OF_DISEASE,6864
133342,to,I-CAUSE_OF_DISEASE,6864
133343,the,I-CAUSE_OF_DISEASE,6864
133344,eye,I-CAUSE_OF_DISEASE,6864
133345,such,I-CAUSE_OF_DISEASE,6864
133346,as,I-CAUSE_OF_DISEASE,6864
133347,a,I-CAUSE_OF_DISEASE,6864
133348,penetrating,I-CAUSE_OF_DISEASE,6865
133349,injury,I-CAUSE_OF_DISEASE,6865
133350,or,I-CAUSE_OF_DISEASE,6865
133351,a,I-CAUSE_OF_DISEASE,6865
133352,foreign,I-CAUSE_OF_DISEASE,6865
133353,body,I-CAUSE_OF_DISEASE,6865
133354,in,I-CAUSE_OF_DISEASE,6865
133355,the,I-CAUSE_OF_DISEASE,6865
133356,eye,I-CAUSE_OF_DISEASE,6865
133357,can,O,6865
133358,also,O,6865
133359,cause,O,6865
133360,panophthalmitis,B-NAME_OF_DISEASE,6865
133361,In,O,6865
133362,these,O,6865
133363,cases,O,6865
133364,the,O,6865
133365,bacteria,O,6865
133366,can,O,6865
133367,enter,O,6865
133368,the,O,6865
133369,eye,O,6865
133370,through,O,6865
133371,the,O,6865
133372,site,O,6865
133373,of,O,6865
133374,the,O,6866
133375,injury,O,6866
133376,and,O,6866
133377,cause,O,6866
133378,an,O,6866
133379,infection,O,6866
133380,Systemic,B-CAUSE_OF_DISEASE,6866
133381,infections,I-CAUSE_OF_DISEASE,6866
133382,In,O,6866
133383,some,O,6866
133384,cases,O,6866
133385,panophthalmitis,B-NAME_OF_DISEASE,6866
133386,can,O,6866
133387,be,O,6866
133388,caused,O,6866
133389,by,O,6866
133390,a,B-CAUSE_OF_DISEASE,6866
133391,systemic,I-CAUSE_OF_DISEASE,6867
133392,infection,I-CAUSE_OF_DISEASE,6867
133393,such,I-CAUSE_OF_DISEASE,6867
133394,as,I-CAUSE_OF_DISEASE,6867
133395,sepsis,I-CAUSE_OF_DISEASE,6867
133396,that,O,6867
133397,spreads,O,6867
133398,to,O,6867
133399,the,O,6867
133400,eye,O,6867
133401,through,O,6867
133402,the,O,6867
133403,bloodstream,O,6867
133404,Signs,O,6867
133405,and,O,6867
133406,Symptoms,O,6867
133407,of,O,6867
133408,Panophthalmitis,B-NAME_OF_DISEASE,6867
133409,Redness,B-SIGN_AND_SYMPTOM,6867
133410,and,I-SIGN_AND_SYMPTOM,6867
133411,swelling,I-SIGN_AND_SYMPTOM,6867
133412,of,I-SIGN_AND_SYMPTOM,6867
133413,the,I-SIGN_AND_SYMPTOM,6867
133414,eye,I-SIGN_AND_SYMPTOM,6868
133415,The,I-SIGN_AND_SYMPTOM,6868
133416,eye,I-SIGN_AND_SYMPTOM,6868
133417,may,I-SIGN_AND_SYMPTOM,6868
133418,appear,I-SIGN_AND_SYMPTOM,6868
133419,red,I-SIGN_AND_SYMPTOM,6868
133420,and,I-SIGN_AND_SYMPTOM,6868
133421,swollen,I-SIGN_AND_SYMPTOM,6868
133422,with,I-SIGN_AND_SYMPTOM,6868
133423,the,I-SIGN_AND_SYMPTOM,6868
133424,eyelids,I-SIGN_AND_SYMPTOM,6868
133425,appearing,I-SIGN_AND_SYMPTOM,6868
133426,puffy,I-SIGN_AND_SYMPTOM,6868
133427,and,I-SIGN_AND_SYMPTOM,6868
133428,swollen,I-SIGN_AND_SYMPTOM,6868
133429,Pain,B-SIGN_AND_SYMPTOM,6868
133430,The,O,6868
133431,patient,O,6869
133432,may,O,6869
133433,experience,O,6869
133434,severe,B-SIGN_AND_SYMPTOM,6869
133435,pain,I-SIGN_AND_SYMPTOM,6869
133436,in,I-SIGN_AND_SYMPTOM,6869
133437,the,I-SIGN_AND_SYMPTOM,6869
133438,affected,I-SIGN_AND_SYMPTOM,6869
133439,eye,I-SIGN_AND_SYMPTOM,6869
133440,which,I-SIGN_AND_SYMPTOM,6869
133441,may,I-SIGN_AND_SYMPTOM,6869
133442,be,I-SIGN_AND_SYMPTOM,6869
133443,exacerbated,I-SIGN_AND_SYMPTOM,6869
133444,by,I-SIGN_AND_SYMPTOM,6869
133445,movement,I-SIGN_AND_SYMPTOM,6869
133446,of,I-SIGN_AND_SYMPTOM,6869
133447,the,I-SIGN_AND_SYMPTOM,6869
133448,eye,I-SIGN_AND_SYMPTOM,6869
133449,Decreased,B-SIGN_AND_SYMPTOM,6869
133450,vision,I-SIGN_AND_SYMPTOM,6869
133451,Vision,I-SIGN_AND_SYMPTOM,6869
133452,may,I-SIGN_AND_SYMPTOM,6869
133453,be,I-SIGN_AND_SYMPTOM,6869
133454,decreased,I-SIGN_AND_SYMPTOM,6869
133455,or,I-SIGN_AND_SYMPTOM,6869
133456,lost,I-SIGN_AND_SYMPTOM,6869
133457,completely,I-SIGN_AND_SYMPTOM,6869
133458,Light,B-SIGN_AND_SYMPTOM,6869
133459,sensitivity,I-SIGN_AND_SYMPTOM,6869
133460,The,O,6870
133461,patient,O,6870
133462,may,O,6870
133463,experience,O,6870
133464,sensitivity,B-SIGN_AND_SYMPTOM,6870
133465,to,I-SIGN_AND_SYMPTOM,6870
133466,light,I-SIGN_AND_SYMPTOM,6870
133467,Discharge,B-SIGN_AND_SYMPTOM,6870
133468,The,O,6870
133469,patient,O,6870
133470,may,O,6870
133471,experience,O,6870
133472,a,B-SIGN_AND_SYMPTOM,6870
133473,thick,I-SIGN_AND_SYMPTOM,6870
133474,purulent,I-SIGN_AND_SYMPTOM,6870
133475,discharge,I-SIGN_AND_SYMPTOM,6870
133476,from,I-SIGN_AND_SYMPTOM,6870
133477,the,I-SIGN_AND_SYMPTOM,6870
133478,affected,I-SIGN_AND_SYMPTOM,6870
133479,eye,I-SIGN_AND_SYMPTOM,6870
133480,Difference,O,6870
133481,Between,O,6871
133482,Panophthalmitis,B-NAME_OF_DISEASE,6871
133483,and,O,6871
133484,Endophthalmitis,B-NAME_OF_DISEASE,6871
133485,Panophthalmitis,B-NAME_OF_DISEASE,6871
133486,and,O,6871
133487,endophthalmitis,B-NAME_OF_DISEASE,6871
133488,are,O,6871
133489,both,O,6871
133490,serious,O,6871
133491,infections,O,6871
133492,that,O,6871
133493,affect,O,6871
133494,the,O,6871
133495,eye,O,6871
133496,but,O,6871
133497,there,O,6871
133498,are,O,6871
133499,some,O,6871
133500,key,O,6871
133501,differences,O,6871
133502,between,O,6871
133503,the,O,6871
133504,two,O,6871
133505,conditions,O,6871
133506,Panophthalmitis,B-NAME_OF_DISEASE,6871
133507,is,O,6871
133508,an,O,6871
133509,infection,O,6872
133510,that,O,6872
133511,affects,O,6872
133512,the,O,6872
133513,entire,O,6872
133514,eye,O,6872
133515,including,O,6872
133516,the,B-PART_OF_THE_EYES,6872
133517,eyelids,I-PART_OF_THE_EYES,6872
133518,sclera,B-PART_OF_THE_EYES,6872
133519,cornea,B-PART_OF_THE_EYES,6872
133520,iris,B-PART_OF_THE_EYES,6872
133521,and,O,6872
133522,retina,B-PART_OF_THE_EYES,6872
133523,Endophthalmitis,B-NAME_OF_DISEASE,6872
133524,on,O,6872
133525,the,O,6873
133526,other,O,6873
133527,hand,O,6873
133528,is,O,6873
133529,an,O,6873
133530,infection,O,6873
133531,that,O,6873
133532,affects,O,6873
133533,the,O,6873
133534,internal,O,6873
133535,structures,O,6873
133536,of,O,6874
133537,the,O,6874
133538,eye,O,6874
133539,including,O,6874
133540,the,B-PART_OF_THE_EYES,6874
133541,vitreous,I-PART_OF_THE_EYES,6874
133542,humor,I-PART_OF_THE_EYES,6874
133543,and,O,6874
133544,the,B-PART_OF_THE_EYES,6874
133545,retina,I-PART_OF_THE_EYES,6874
133546,How,O,6874
133547,to,O,6874
133548,Diagnose,O,6874
133549,Panophthalmitis,B-NAME_OF_DISEASE,6874
133550,To,O,6874
133551,diagnose,O,6874
133552,panophthalmitis,B-NAME_OF_DISEASE,6874
133553,an,O,6874
133554,eye,O,6875
133555,doctor,O,6875
133556,will,O,6875
133557,first,O,6875
133558,perform,O,6875
133559,a,B-DIAGNOSTIC_TEST,6875
133560,thorough,I-DIAGNOSTIC_TEST,6875
133561,eye,I-DIAGNOSTIC_TEST,6875
133562,examination,I-DIAGNOSTIC_TEST,6875
133563,This,O,6875
133564,may,O,6875
133565,include,O,6875
133566,measuring,B-DIAGNOSTIC_TEST,6875
133567,the,I-DIAGNOSTIC_TEST,6875
133568,patient,I-DIAGNOSTIC_TEST,6875
133569,s,I-DIAGNOSTIC_TEST,6875
133570,visual,I-DIAGNOSTIC_TEST,6876
133571,acuity,I-DIAGNOSTIC_TEST,6876
133572,examining,I-DIAGNOSTIC_TEST,6876
133573,the,I-DIAGNOSTIC_TEST,6876
133574,eye,I-DIAGNOSTIC_TEST,6876
133575,with,I-DIAGNOSTIC_TEST,6876
133576,a,I-DIAGNOSTIC_TEST,6876
133577,microscope,I-DIAGNOSTIC_TEST,6876
133578,and,I-DIAGNOSTIC_TEST,6876
133579,performing,I-DIAGNOSTIC_TEST,6876
133580,a,I-DIAGNOSTIC_TEST,6876
133581,test,I-DIAGNOSTIC_TEST,6876
133582,called,I-DIAGNOSTIC_TEST,6876
133583,a,I-DIAGNOSTIC_TEST,6876
133584,slit-lamp,I-DIAGNOSTIC_TEST,6876
133585,examination,I-DIAGNOSTIC_TEST,6876
133586,to,O,6876
133587,look,O,6876
133588,for,O,6876
133589,signs,O,6876
133590,of,O,6876
133591,inflammation,O,6876
133592,The,O,6877
133593,doctor,O,6877
133594,may,O,6877
133595,also,O,6877
133596,take,B-DIAGNOSTIC_TEST,6877
133597,a,I-DIAGNOSTIC_TEST,6877
133598,sample,I-DIAGNOSTIC_TEST,6877
133599,of,I-DIAGNOSTIC_TEST,6877
133600,fluid,I-DIAGNOSTIC_TEST,6877
133601,from,I-DIAGNOSTIC_TEST,6877
133602,the,I-DIAGNOSTIC_TEST,6877
133603,eye,I-DIAGNOSTIC_TEST,6877
133604,to,O,6877
133605,check,O,6877
133606,for,O,6877
133607,bacteria,O,6877
133608,or,O,6877
133609,other,O,6877
133610,signs,O,6878
133611,of,O,6878
133612,infection,O,6878
133613,In,O,6878
133614,some,O,6878
133615,cases,O,6878
133616,imaging,B-DIAGNOSTIC_TEST,6878
133617,tests,I-DIAGNOSTIC_TEST,6878
133618,such,I-DIAGNOSTIC_TEST,6878
133619,as,I-DIAGNOSTIC_TEST,6878
133620,ultrasound,I-DIAGNOSTIC_TEST,6878
133621,or,I-DIAGNOSTIC_TEST,6878
133622,computed,I-DIAGNOSTIC_TEST,6879
133623,tomography,I-DIAGNOSTIC_TEST,6879
133624,CT,I-DIAGNOSTIC_TEST,6879
133625,scans,I-DIAGNOSTIC_TEST,6879
133626,may,O,6879
133627,be,O,6879
133628,used,O,6879
133629,to,O,6879
133630,help,O,6879
133631,diagnose,O,6879
133632,panophthalmitis,B-NAME_OF_DISEASE,6879
133633,and,O,6879
133634,to,O,6879
133635,determine,O,6880
133636,the,O,6880
133637,extent,O,6880
133638,of,O,6880
133639,the,O,6880
133640,infection,O,6880
133641,Managing,O,6880
133642,Panophthalmitis,B-NAME_OF_DISEASE,6880
133643,The,O,6880
133644,primary,O,6880
133645,treatment,O,6880
133646,for,O,6880
133647,panophthalmitis,B-NAME_OF_DISEASE,6880
133648,is,O,6880
133649,antibiotics,B-TREATMENT,6880
133650,to,O,6880
133651,fight,O,6880
133652,the,O,6880
133653,infection,O,6880
133654,and,O,6881
133655,reduce,O,6881
133656,inflammation,O,6881
133657,Steroids,B-NAME_OF_DRUG,6881
133658,may,O,6881
133659,also,O,6881
133660,be,O,6881
133661,used,O,6881
133662,to,O,6881
133663,reduce,O,6881
133664,inflammation,O,6881
133665,and,O,6881
133666,prevent,O,6881
133667,complications,O,6881
133668,In,O,6881
133669,severe,O,6882
133670,cases,O,6882
133671,surgery,B-TREATMENT,6882
133672,may,O,6882
133673,be,O,6882
133674,necessary,O,6882
133675,to,O,6882
133676,remove,O,6882
133677,infected,O,6882
133678,tissue,O,6882
133679,and,O,6882
133680,prevent,O,6882
133681,the,O,6882
133682,spread,O,6882
133683,of,O,6882
133684,the,O,6882
133685,infection,O,6882
133686,It,O,6882
133687,s,O,6882
133688,important,O,6882
133689,to,O,6883
133690,follow,O,6883
133691,your,O,6883
133692,doctor,O,6883
133693,s,O,6883
133694,instructions,O,6883
133695,carefully,O,6883
133696,and,O,6883
133697,take,O,6883
133698,all,O,6883
133699,medications,O,6883
133700,as,O,6883
133701,prescribed,O,6883
133702,It,O,6883
133703,s,O,6883
133704,also,O,6883
133705,important,O,6883
133706,to,O,6883
133707,attend,O,6883
133708,all,O,6883
133709,follow-up,O,6883
133710,appointments,O,6883
133711,to,O,6883
133712,monitor,O,6884
133713,your,O,6884
133714,progress,O,6884
133715,and,O,6884
133716,ensure,O,6884
133717,that,O,6884
133718,the,O,6884
133719,infection,O,6884
133720,is,O,6884
133721,responding,O,6884
133722,to,O,6884
133723,treatment,O,6884
133724,Managing,O,6884
133725,Your,O,6884
133726,Panophthalmitis,B-NAME_OF_DISEASE,6884
133727,At,O,6884
133728,Home,O,6884
133729,Apply,B-TREATMENT,6884
133730,a,I-TREATMENT,6884
133731,warm,I-TREATMENT,6885
133732,compress,I-TREATMENT,6885
133733,to,I-TREATMENT,6885
133734,the,I-TREATMENT,6885
133735,affected,I-TREATMENT,6885
133736,eye,I-TREATMENT,6885
133737,to,O,6885
133738,reduce,O,6885
133739,pain,O,6885
133740,and,O,6885
133741,inflammation,O,6885
133742,Keep,B-TREATMENT,6885
133743,your,I-TREATMENT,6885
133744,head,I-TREATMENT,6885
133745,elevated,I-TREATMENT,6885
133746,to,O,6885
133747,reduce,O,6885
133748,swelling,O,6885
133749,and,O,6885
133750,pressure,O,6886
133751,in,O,6886
133752,the,O,6886
133753,eye,O,6886
133754,Avoid,B-TREATMENT,6886
133755,touching,I-TREATMENT,6886
133756,or,I-TREATMENT,6886
133757,rubbing,I-TREATMENT,6886
133758,your,I-TREATMENT,6886
133759,eye,I-TREATMENT,6886
133760,as,O,6886
133761,this,O,6886
133762,can,O,6886
133763,further,O,6886
133764,irritate,O,6886
133765,the,O,6886
133766,infection,O,6886
133767,Wear,B-TREATMENT,6886
133768,protective,I-TREATMENT,6886
133769,eye,I-TREATMENT,6886
133770,gear,I-TREATMENT,6886
133771,such,I-TREATMENT,6886
133772,as,I-TREATMENT,6886
133773,goggles,I-TREATMENT,6886
133774,or,I-TREATMENT,6886
133775,safety,I-TREATMENT,6887
133776,glasses,I-TREATMENT,6887
133777,to,O,6887
133778,reduce,O,6887
133779,your,O,6887
133780,risk,O,6887
133781,of,O,6887
133782,further,O,6887
133783,injury,O,6887
133784,or,O,6887
133785,infection,O,6887
133786,Avoid,B-TREATMENT,6887
133787,activities,I-TREATMENT,6887
133788,that,I-TREATMENT,6887
133789,may,I-TREATMENT,6887
133790,further,I-TREATMENT,6887
133791,irritate,I-TREATMENT,6887
133792,the,I-TREATMENT,6887
133793,eye,I-TREATMENT,6887
133794,such,I-TREATMENT,6887
133795,as,I-TREATMENT,6887
133796,swimming,I-TREATMENT,6887
133797,or,I-TREATMENT,6887
133798,using,I-TREATMENT,6887
133799,contact,I-TREATMENT,6887
133800,lenses,I-TREATMENT,6887
133801,Conclusion,O,6888
133802,It,O,6888
133803,is,O,6888
133804,important,O,6888
133805,to,O,6888
133806,note,O,6888
133807,that,O,6888
133808,panophthalmitis,B-NAME_OF_DISEASE,6888
133809,is,O,6888
133810,a,O,6888
133811,serious,O,6888
133812,condition,O,6888
133813,that,O,6888
133814,can,O,6888
133815,lead,O,6888
133816,to,O,6888
133817,severe,O,6888
133818,complications,O,6888
133819,including,O,6888
133820,blindness,B-SIGN_AND_SYMPTOM,6888
133821,If,O,6888
133822,you,O,6888
133823,suspect,O,6888
133824,that,O,6888
133825,you,O,6888
133826,or,O,6889
133827,a,O,6889
133828,loved,O,6889
133829,one,O,6889
133830,may,O,6889
133831,have,O,6889
133832,panophthalmitis,B-NAME_OF_DISEASE,6889
133833,it,O,6889
133834,is,O,6889
133835,essential,O,6889
133836,to,O,6889
133837,seek,O,6889
133838,medical,O,6889
133839,attention,O,6889
133840,as,O,6889
133841,soon,O,6889
133842,as,O,6889
133843,possible,O,6889
133844,Early,O,6889
133845,diagnosis,O,6889
133846,and,O,6889
133847,treatment,O,6889
133848,can,O,6889
133849,prevent,O,6889
133850,severe,O,6889
133851,complications,O,6889
133852,and,O,6889
133853,improve,O,6890
133854,the,O,6890
133855,chances,O,6890
133856,of,O,6890
133857,preserving,O,6890
133858,vision,O,6890
133859,in,O,6890
133860,the,O,6890
133861,affected,O,6890
133862,eye,O,6890
133863,Thygeson,B-NAME_OF_DISEASE,6890
133864,s,I-NAME_OF_DISEASE,6890
133865,Keratitis,I-NAME_OF_DISEASE,6890
133866,also,O,6890
133867,known,O,6890
133868,as,O,6891
133869,Thygeson,B-NAME_OF_DISEASE,6891
133870,s,I-NAME_OF_DISEASE,6891
133871,Superficial,I-NAME_OF_DISEASE,6891
133872,Punctate,I-NAME_OF_DISEASE,6891
133873,Keratitis,I-NAME_OF_DISEASE,6891
133874,is,O,6891
133875,a,O,6891
133876,rare,O,6891
133877,inflammatory,O,6891
133878,disorder,O,6891
133879,of,O,6891
133880,the,B-PART_OF_THE_EYES,6891
133881,cornea,I-PART_OF_THE_EYES,6891
133882,It,O,6891
133883,is,O,6891
133884,characterized,O,6892
133885,by,O,6892
133886,the,B-SIGN_AND_SYMPTOM,6892
133887,presence,I-SIGN_AND_SYMPTOM,6892
133888,of,I-SIGN_AND_SYMPTOM,6892
133889,small,I-SIGN_AND_SYMPTOM,6892
133890,superficial,I-SIGN_AND_SYMPTOM,6892
133891,lesions,I-SIGN_AND_SYMPTOM,6892
133892,on,I-SIGN_AND_SYMPTOM,6892
133893,the,I-SIGN_AND_SYMPTOM,6892
133894,surface,I-SIGN_AND_SYMPTOM,6892
133895,of,I-SIGN_AND_SYMPTOM,6892
133896,the,I-SIGN_AND_SYMPTOM,6892
133897,cornea,I-SIGN_AND_SYMPTOM,6892
133898,which,O,6892
133899,can,O,6892
133900,lead,O,6892
133901,to,O,6892
133902,vision,B-SIGN_AND_SYMPTOM,6892
133903,loss,I-SIGN_AND_SYMPTOM,6892
133904,if,O,6892
133905,left,O,6892
133906,untreated,O,6892
133907,Causes,O,6892
133908,of,O,6892
133909,Thygeson,B-NAME_OF_DISEASE,6892
133910,s,I-NAME_OF_DISEASE,6892
133911,Keratitis,I-NAME_OF_DISEASE,6892
133912,The,O,6893
133913,exact,O,6893
133914,causes,O,6893
133915,of,O,6893
133916,Thygeson,B-NAME_OF_DISEASE,6893
133917,s,I-NAME_OF_DISEASE,6893
133918,Keratitis,I-NAME_OF_DISEASE,6893
133919,are,O,6893
133920,not,O,6893
133921,fully,O,6893
133922,understood,O,6893
133923,but,O,6893
133924,several,O,6893
133925,factors,O,6893
133926,are,O,6893
133927,thought,O,6893
133928,to,O,6893
133929,contribute,O,6893
133930,to,O,6893
133931,its,O,6893
133932,development,O,6893
133933,Immune,B-CAUSE_OF_DISEASE,6893
133934,system,I-CAUSE_OF_DISEASE,6893
133935,dysfunction,I-CAUSE_OF_DISEASE,6893
133936,Thygeson,B-NAME_OF_DISEASE,6893
133937,s,I-NAME_OF_DISEASE,6893
133938,Keratitis,I-NAME_OF_DISEASE,6893
133939,is,O,6893
133940,thought,O,6893
133941,to,O,6893
133942,be,O,6893
133943,an,O,6893
133944,autoimmune,O,6893
133945,disorder,O,6893
133946,in,O,6893
133947,which,O,6893
133948,the,B-CAUSE_OF_DISEASE,6894
133949,immune,I-CAUSE_OF_DISEASE,6894
133950,system,I-CAUSE_OF_DISEASE,6894
133951,mistakenly,I-CAUSE_OF_DISEASE,6894
133952,attacks,I-CAUSE_OF_DISEASE,6894
133953,healthy,I-CAUSE_OF_DISEASE,6894
133954,cells,I-CAUSE_OF_DISEASE,6894
133955,in,I-CAUSE_OF_DISEASE,6894
133956,the,I-CAUSE_OF_DISEASE,6894
133957,cornea,I-CAUSE_OF_DISEASE,6894
133958,Viral,B-CAUSE_OF_DISEASE,6894
133959,infections,I-CAUSE_OF_DISEASE,6894
133960,Some,O,6894
133961,studies,O,6894
133962,have,O,6894
133963,suggested,O,6894
133964,that,O,6895
133965,viral,B-CAUSE_OF_DISEASE,6895
133966,infections,I-CAUSE_OF_DISEASE,6895
133967,such,I-CAUSE_OF_DISEASE,6895
133968,as,I-CAUSE_OF_DISEASE,6895
133969,adenovirus,I-CAUSE_OF_DISEASE,6895
133970,or,I-CAUSE_OF_DISEASE,6895
133971,herpes,I-CAUSE_OF_DISEASE,6895
133972,simplex,I-CAUSE_OF_DISEASE,6895
133973,virus,I-CAUSE_OF_DISEASE,6895
133974,may,O,6895
133975,play,O,6895
133976,a,O,6895
133977,role,O,6895
133978,in,O,6896
133979,the,O,6896
133980,development,O,6896
133981,of,O,6896
133982,Thygeson,B-NAME_OF_DISEASE,6896
133983,s,I-NAME_OF_DISEASE,6896
133984,Keratitis,I-NAME_OF_DISEASE,6896
133985,Genetic,B-CAUSE_OF_DISEASE,6896
133986,predisposition,I-CAUSE_OF_DISEASE,6896
133987,There,O,6896
133988,may,O,6896
133989,be,O,6896
133990,a,B-CAUSE_OF_DISEASE,6896
133991,genetic,I-CAUSE_OF_DISEASE,6896
133992,component,I-CAUSE_OF_DISEASE,6896
133993,to,O,6896
133994,the,O,6896
133995,development,O,6897
133996,of,O,6897
133997,Thygeson,B-NAME_OF_DISEASE,6897
133998,s,I-NAME_OF_DISEASE,6897
133999,Keratitis,I-NAME_OF_DISEASE,6897
134000,Some,O,6897
134001,studies,O,6897
134002,have,O,6897
134003,suggested,O,6897
134004,that,O,6897
134005,certain,B-CAUSE_OF_DISEASE,6897
134006,genetic,I-CAUSE_OF_DISEASE,6897
134007,mutations,I-CAUSE_OF_DISEASE,6897
134008,may,O,6897
134009,increase,O,6897
134010,the,O,6897
134011,risk,O,6897
134012,of,O,6897
134013,developing,O,6897
134014,the,O,6897
134015,disorder,O,6898
134016,It,O,6898
134017,s,O,6898
134018,important,O,6898
134019,to,O,6898
134020,note,O,6898
134021,that,O,6898
134022,Thygeson,B-NAME_OF_DISEASE,6898
134023,s,I-NAME_OF_DISEASE,6898
134024,Keratitis,I-NAME_OF_DISEASE,6898
134025,can,O,6898
134026,have,O,6898
134027,multiple,O,6898
134028,causes,O,6898
134029,and,O,6898
134030,thus,O,6898
134031,it,O,6898
134032,can,O,6899
134033,be,O,6899
134034,challenging,O,6899
134035,to,O,6899
134036,identify,O,6899
134037,the,O,6899
134038,exact,O,6899
134039,cause,O,6899
134040,in,O,6899
134041,an,O,6899
134042,individual,O,6899
134043,case,O,6899
134044,What,O,6899
134045,Are,O,6899
134046,The,O,6900
134047,Symptoms,O,6900
134048,of,O,6900
134049,Thygeson,B-NAME_OF_DISEASE,6900
134050,s,I-NAME_OF_DISEASE,6900
134051,Keratitis,I-NAME_OF_DISEASE,6900
134052,It,O,6900
134053,s,O,6900
134054,important,O,6900
134055,to,O,6900
134056,note,O,6900
134057,that,O,6901
134058,the,O,6901
134059,symptoms,O,6901
134060,of,O,6901
134061,Thygeson,B-NAME_OF_DISEASE,6901
134062,s,I-NAME_OF_DISEASE,6901
134063,Keratitis,I-NAME_OF_DISEASE,6901
134064,can,O,6901
134065,vary,O,6901
134066,from,O,6901
134067,person,O,6901
134068,to,O,6901
134069,person,O,6901
134070,and,O,6901
134071,not,O,6901
134072,all,O,6902
134073,individuals,O,6902
134074,will,O,6902
134075,experience,O,6902
134076,all,O,6902
134077,of,O,6902
134078,the,O,6902
134079,symptoms,O,6902
134080,In,O,6902
134081,some,O,6902
134082,cases,O,6902
134083,symptoms,O,6902
134084,may,O,6902
134085,come,O,6902
134086,and,O,6902
134087,go,O,6903
134088,or,O,6903
134089,may,O,6903
134090,be,O,6903
134091,mild,O,6903
134092,and,O,6903
134093,not,O,6903
134094,require,O,6903
134095,treatment,O,6903
134096,Eye,B-SIGN_AND_SYMPTOM,6903
134097,pain,B-SIGN_AND_SYMPTOM,6903
134098,Thygeson,B-NAME_OF_DISEASE,6903
134099,s,I-NAME_OF_DISEASE,6903
134100,Keratitis,I-NAME_OF_DISEASE,6903
134101,can,O,6903
134102,cause,O,6904
134103,pain,B-SIGN_AND_SYMPTOM,6904
134104,or,I-SIGN_AND_SYMPTOM,6904
134105,discomfort,I-SIGN_AND_SYMPTOM,6904
134106,in,I-SIGN_AND_SYMPTOM,6904
134107,the,I-SIGN_AND_SYMPTOM,6904
134108,affected,I-SIGN_AND_SYMPTOM,6904
134109,eye,I-SIGN_AND_SYMPTOM,6904
134110,This,O,6904
134111,pain,B-SIGN_AND_SYMPTOM,6904
134112,may,O,6904
134113,be,O,6904
134114,mild,O,6904
134115,or,O,6904
134116,severe,O,6904
134117,and,O,6904
134118,may,O,6904
134119,be,O,6904
134120,accompanied,O,6904
134121,by,O,6904
134122,a,B-SIGN_AND_SYMPTOM,6904
134123,burning,I-SIGN_AND_SYMPTOM,6904
134124,or,I-SIGN_AND_SYMPTOM,6904
134125,stinging,I-SIGN_AND_SYMPTOM,6904
134126,sensation,I-SIGN_AND_SYMPTOM,6904
134127,Redness,B-SIGN_AND_SYMPTOM,6904
134128,of,I-SIGN_AND_SYMPTOM,6905
134129,the,I-SIGN_AND_SYMPTOM,6905
134130,eye,I-SIGN_AND_SYMPTOM,6905
134131,The,I-SIGN_AND_SYMPTOM,6905
134132,eye,I-SIGN_AND_SYMPTOM,6905
134133,may,I-SIGN_AND_SYMPTOM,6905
134134,appear,I-SIGN_AND_SYMPTOM,6905
134135,red,I-SIGN_AND_SYMPTOM,6905
134136,or,I-SIGN_AND_SYMPTOM,6905
134137,inflamed,I-SIGN_AND_SYMPTOM,6905
134138,due,O,6905
134139,to,O,6905
134140,the,O,6905
134141,presence,O,6905
134142,of,O,6905
134143,inflammation,O,6905
134144,in,O,6905
134145,the,B-PART_OF_THE_EYES,6905
134146,cornea,I-PART_OF_THE_EYES,6905
134147,Light,B-SIGN_AND_SYMPTOM,6906
134148,sensitivity,I-SIGN_AND_SYMPTOM,6906
134149,Some,O,6906
134150,people,O,6906
134151,with,O,6906
134152,Thygeson,B-NAME_OF_DISEASE,6906
134153,s,I-NAME_OF_DISEASE,6906
134154,Keratitis,I-NAME_OF_DISEASE,6906
134155,may,O,6906
134156,experience,O,6906
134157,increased,B-SIGN_AND_SYMPTOM,6906
134158,sensitivity,I-SIGN_AND_SYMPTOM,6906
134159,to,I-SIGN_AND_SYMPTOM,6906
134160,light,I-SIGN_AND_SYMPTOM,6906
134161,known,I-SIGN_AND_SYMPTOM,6906
134162,as,I-SIGN_AND_SYMPTOM,6906
134163,photophobia,I-SIGN_AND_SYMPTOM,6906
134164,Blurred,B-SIGN_AND_SYMPTOM,6906
134165,vision,I-SIGN_AND_SYMPTOM,6906
134166,The,O,6906
134167,lesions,O,6906
134168,on,O,6906
134169,the,B-PART_OF_THE_EYES,6906
134170,cornea,I-PART_OF_THE_EYES,6906
134171,can,O,6906
134172,cause,O,6906
134173,blurriness,B-SIGN_AND_SYMPTOM,6906
134174,or,I-SIGN_AND_SYMPTOM,6906
134175,distortion,I-SIGN_AND_SYMPTOM,6906
134176,of,I-SIGN_AND_SYMPTOM,6907
134177,vision,I-SIGN_AND_SYMPTOM,6907
134178,Tearing,B-SIGN_AND_SYMPTOM,6907
134179,Some,O,6907
134180,people,O,6907
134181,may,O,6907
134182,experience,O,6907
134183,excessive,B-SIGN_AND_SYMPTOM,6907
134184,tearing,I-SIGN_AND_SYMPTOM,6907
134185,in,I-SIGN_AND_SYMPTOM,6907
134186,the,I-SIGN_AND_SYMPTOM,6907
134187,affected,I-SIGN_AND_SYMPTOM,6907
134188,eye,I-SIGN_AND_SYMPTOM,6907
134189,Foreign,B-SIGN_AND_SYMPTOM,6907
134190,body,I-SIGN_AND_SYMPTOM,6907
134191,sensation,I-SIGN_AND_SYMPTOM,6907
134192,The,O,6907
134193,patient,O,6907
134194,may,O,6907
134195,feel,O,6907
134196,a,B-SIGN_AND_SYMPTOM,6907
134197,scratchy,I-SIGN_AND_SYMPTOM,6907
134198,or,I-SIGN_AND_SYMPTOM,6907
134199,gritty,I-SIGN_AND_SYMPTOM,6908
134200,sensation,I-SIGN_AND_SYMPTOM,6908
134201,in,I-SIGN_AND_SYMPTOM,6908
134202,the,I-SIGN_AND_SYMPTOM,6908
134203,eye,I-SIGN_AND_SYMPTOM,6908
134204,Reduced,B-SIGN_AND_SYMPTOM,6908
134205,vision,I-SIGN_AND_SYMPTOM,6908
134206,In,O,6908
134207,severe,O,6908
134208,cases,O,6908
134209,Thygeson,B-NAME_OF_DISEASE,6908
134210,s,I-NAME_OF_DISEASE,6908
134211,Keratitis,I-NAME_OF_DISEASE,6908
134212,may,O,6908
134213,cause,O,6908
134214,a,B-SIGN_AND_SYMPTOM,6908
134215,significant,I-SIGN_AND_SYMPTOM,6908
134216,reduction,I-SIGN_AND_SYMPTOM,6908
134217,in,I-SIGN_AND_SYMPTOM,6908
134218,vision,I-SIGN_AND_SYMPTOM,6908
134219,Above,O,6908
134220,picture,O,6909
134221,shows,O,6909
134222,the,O,6909
134223,presence,O,6909
134224,of,O,6909
134225,small,O,6909
134226,superficial,O,6909
134227,lesions,O,6909
134228,on,O,6909
134229,the,O,6909
134230,surface,O,6910
134231,of,O,6910
134232,the,B-PART_OF_THE_EYES,6910
134233,cornea,I-PART_OF_THE_EYES,6910
134234,Is,O,6910
134235,Thygeson,B-NAME_OF_DISEASE,6910
134236,s,I-NAME_OF_DISEASE,6910
134237,Keratitis,I-NAME_OF_DISEASE,6910
134238,Contagious,I-NAME_OF_DISEASE,6910
134239,Thygeson,B-NAME_OF_DISEASE,6910
134240,s,I-NAME_OF_DISEASE,6910
134241,Keratitis,I-NAME_OF_DISEASE,6910
134242,is,O,6910
134243,not,O,6910
134244,contagious,O,6910
134245,because,O,6910
134246,it,O,6910
134247,is,O,6910
134248,not,O,6910
134249,caused,O,6911
134250,by,O,6911
134251,an,O,6911
134252,infectious,O,6911
134253,agent,O,6911
134254,such,O,6911
134255,as,O,6911
134256,a,O,6911
134257,virus,O,6911
134258,or,O,6911
134259,bacteria,O,6911
134260,There,O,6911
134261,is,O,6911
134262,no,O,6911
134263,evidence,O,6911
134264,that,O,6912
134265,the,O,6912
134266,condition,O,6912
134267,can,O,6912
134268,be,O,6912
134269,spread,O,6912
134270,from,O,6912
134271,person,O,6912
134272,to,O,6912
134273,person,O,6912
134274,through,O,6912
134275,contact,O,6912
134276,or,O,6912
134277,other,O,6912
134278,means,O,6912
134279,Treatment,O,6912
134280,for,O,6912
134281,Thygeson,B-NAME_OF_DISEASE,6912
134282,s,I-NAME_OF_DISEASE,6912
134283,Keratitis,I-NAME_OF_DISEASE,6912
134284,Treatment,O,6912
134285,for,O,6912
134286,Thygeson,B-NAME_OF_DISEASE,6913
134287,s,I-NAME_OF_DISEASE,6913
134288,Keratitis,I-NAME_OF_DISEASE,6913
134289,typically,O,6913
134290,involves,O,6913
134291,the,B-TREATMENT,6913
134292,use,I-TREATMENT,6913
134293,of,I-TREATMENT,6913
134294,topical,I-TREATMENT,6913
134295,eye,I-TREATMENT,6913
134296,drops,I-TREATMENT,6913
134297,or,I-TREATMENT,6913
134298,ointments,I-TREATMENT,6913
134299,to,O,6913
134300,reduce,O,6913
134301,inflammation,O,6914
134302,and,O,6914
134303,promote,O,6914
134304,healing,O,6914
134305,of,O,6914
134306,the,B-PART_OF_THE_EYES,6914
134307,cornea,I-PART_OF_THE_EYES,6914
134308,In,O,6914
134309,some,O,6914
134310,cases,O,6914
134311,oral,B-TREATMENT,6914
134312,or,I-TREATMENT,6914
134313,injectable,I-TREATMENT,6914
134314,medications,I-TREATMENT,6914
134315,may,O,6915
134316,also,O,6915
134317,be,O,6915
134318,used,O,6915
134319,to,O,6915
134320,suppress,O,6915
134321,the,O,6915
134322,immune,O,6915
134323,system,O,6915
134324,and,O,6915
134325,prevent,O,6915
134326,further,O,6915
134327,damage,O,6915
134328,to,O,6915
134329,the,B-PART_OF_THE_EYES,6915
134330,cornea,I-PART_OF_THE_EYES,6915
134331,Topical,B-NAME_OF_DRUG,6915
134332,corticosteroids,I-NAME_OF_DRUG,6915
134333,such,O,6916
134334,as,O,6916
134335,prednisolone,B-NAME_OF_DRUG,6916
134336,acetate,I-NAME_OF_DRUG,6916
134337,or,O,6916
134338,loteprednol,B-NAME_OF_DRUG,6916
134339,etabonate,I-NAME_OF_DRUG,6916
134340,are,O,6916
134341,often,O,6916
134342,used,O,6916
134343,to,O,6916
134344,reduce,O,6916
134345,inflammation,O,6916
134346,and,O,6916
134347,promote,O,6916
134348,healing,O,6916
134349,of,O,6916
134350,the,B-PART_OF_THE_EYES,6916
134351,cornea,I-PART_OF_THE_EYES,6916
134352,These,O,6917
134353,medications,O,6917
134354,are,O,6917
134355,typically,O,6917
134356,administered,O,6917
134357,as,O,6917
134358,eye,O,6917
134359,drops,O,6917
134360,or,O,6917
134361,ointments,O,6917
134362,A,B-TREATMENT,6917
134363,bandage,I-TREATMENT,6917
134364,contact,I-TREATMENT,6917
134365,lens,I-TREATMENT,6917
134366,can,O,6918
134367,also,O,6918
134368,be,O,6918
134369,applied,O,6918
134370,to,O,6918
134371,the,O,6918
134372,eye,O,6918
134373,to,O,6918
134374,promote,O,6918
134375,healing,O,6918
134376,and,O,6918
134377,reduce,O,6918
134378,pain,B-SIGN_AND_SYMPTOM,6918
134379,and,I-SIGN_AND_SYMPTOM,6919
134380,discomfort,I-SIGN_AND_SYMPTOM,6919
134381,Conclusion,O,6919
134382,Thygeson,B-NAME_OF_DISEASE,6919
134383,s,I-NAME_OF_DISEASE,6919
134384,Keratitis,I-NAME_OF_DISEASE,6919
134385,is,O,6919
134386,a,O,6919
134387,rare,O,6919
134388,and,O,6919
134389,chronic,O,6919
134390,inflammatory,O,6919
134391,disorder,O,6919
134392,that,O,6919
134393,affects,O,6919
134394,the,B-PART_OF_THE_EYES,6919
134395,cornea,I-PART_OF_THE_EYES,6919
134396,It,O,6919
134397,is,O,6919
134398,caused,O,6920
134399,by,O,6920
134400,an,B-CAUSE_OF_DISEASE,6920
134401,autoimmune,I-CAUSE_OF_DISEASE,6920
134402,disorder,I-CAUSE_OF_DISEASE,6920
134403,or,I-CAUSE_OF_DISEASE,6920
134404,viral,I-CAUSE_OF_DISEASE,6920
134405,infections,I-CAUSE_OF_DISEASE,6920
134406,and,O,6920
134407,symptoms,O,6920
134408,include,O,6920
134409,redness,B-SIGN_AND_SYMPTOM,6920
134410,eye,I-SIGN_AND_SYMPTOM,6920
134411,pain,I-SIGN_AND_SYMPTOM,6920
134412,light,I-SIGN_AND_SYMPTOM,6920
134413,sensitivity,I-SIGN_AND_SYMPTOM,6920
134414,tearing,I-SIGN_AND_SYMPTOM,6921
134415,and,I-SIGN_AND_SYMPTOM,6921
134416,blurred,I-SIGN_AND_SYMPTOM,6921
134417,vision,I-SIGN_AND_SYMPTOM,6921
134418,Treatment,O,6921
134419,includes,O,6921
134420,topical,B-NAME_OF_DRUG,6921
134421,steroids,I-NAME_OF_DRUG,6921
134422,and,O,6921
134423,immunomodulators,B-NAME_OF_DRUG,6921
134424,and,O,6921
134425,in,O,6921
134426,severe,O,6921
134427,cases,O,6921
134428,oral,B-TREATMENT,6921
134429,medication,I-TREATMENT,6921
134430,and,I-TREATMENT,6921
134431,corneal,I-TREATMENT,6921
134432,transplants,I-TREATMENT,6921
134433,Early,O,6921
134434,diagnosis,O,6922
134435,and,O,6922
134436,treatment,O,6922
134437,are,O,6922
134438,crucial,O,6922
134439,to,O,6922
134440,prevent,O,6922
134441,vision,B-SIGN_AND_SYMPTOM,6922
134442,loss,I-SIGN_AND_SYMPTOM,6922
134443,and,O,6922
134444,manage,O,6923
134445,the,O,6923
134446,symptoms,O,6923
134447,Sudden,B-NAME_OF_DISEASE,6923
134448,vision,B-SIGN_AND_SYMPTOM,6923
134449,loss,I-SIGN_AND_SYMPTOM,6923
134450,is,O,6923
134451,a,O,6923
134452,serious,O,6923
134453,medical,O,6923
134454,condition,O,6923
134455,that,O,6923
134456,can,O,6923
134457,be,O,6923
134458,caused,O,6923
134459,by,O,6923
134460,a,O,6923
134461,variety,O,6923
134462,of,O,6923
134463,underlying,O,6924
134464,factors,O,6924
134465,It,O,6924
134466,can,O,6924
134467,be,O,6924
134468,a,O,6924
134469,symptom,O,6924
134470,of,O,6924
134471,a,O,6924
134472,number,O,6924
134473,of,O,6924
134474,serious,O,6925
134475,conditions,O,6925
134476,including,O,6925
134477,retinal,B-CAUSE_OF_DISEASE,6925
134478,detachment,I-CAUSE_OF_DISEASE,6925
134479,stroke,B-CAUSE_OF_DISEASE,6925
134480,and,O,6925
134481,even,O,6925
134482,brain,B-CAUSE_OF_DISEASE,6925
134483,tumors,I-CAUSE_OF_DISEASE,6925
134484,Understanding,O,6925
134485,the,O,6925
134486,causes,O,6925
134487,of,O,6925
134488,sudden,B-NAME_OF_DISEASE,6925
134489,vision,B-SIGN_AND_SYMPTOM,6925
134490,loss,I-SIGN_AND_SYMPTOM,6926
134491,is,O,6926
134492,crucial,O,6926
134493,for,O,6926
134494,early,O,6926
134495,diagnosis,O,6926
134496,and,O,6926
134497,treatment,O,6926
134498,One,O,6927
134499,of,O,6927
134500,the,O,6927
134501,most,O,6927
134502,common,O,6927
134503,causes,O,6927
134504,of,O,6927
134505,sudden,B-NAME_OF_DISEASE,6927
134506,vision,B-SIGN_AND_SYMPTOM,6927
134507,loss,I-SIGN_AND_SYMPTOM,6927
134508,is,O,6927
134509,retinal,B-CAUSE_OF_DISEASE,6927
134510,detachment,I-CAUSE_OF_DISEASE,6927
134511,The,B-PART_OF_THE_EYES,6927
134512,retina,I-PART_OF_THE_EYES,6927
134513,is,O,6927
134514,the,O,6927
134515,light-sensitive,O,6928
134516,layer,O,6928
134517,at,O,6928
134518,the,O,6928
134519,back,O,6928
134520,of,O,6928
134521,the,O,6928
134522,eye,O,6928
134523,that,O,6928
134524,sends,O,6928
134525,visual,O,6928
134526,signals,O,6929
134527,to,O,6929
134528,the,O,6929
134529,brain,O,6929
134530,If,O,6929
134531,the,B-PART_OF_THE_EYES,6929
134532,retina,I-PART_OF_THE_EYES,6929
134533,becomes,O,6929
134534,detached,O,6929
134535,it,O,6929
134536,can,O,6929
134537,no,O,6929
134538,longer,O,6929
134539,function,O,6929
134540,properly,O,6929
134541,leading,O,6929
134542,to,O,6929
134543,sudden,B-NAME_OF_DISEASE,6929
134544,vision,B-SIGN_AND_SYMPTOM,6929
134545,loss,I-SIGN_AND_SYMPTOM,6929
134546,Retinal,B-CAUSE_OF_DISEASE,6929
134547,detachment,I-CAUSE_OF_DISEASE,6929
134548,can,O,6929
134549,be,O,6930
134550,caused,O,6930
134551,by,O,6930
134552,a,O,6930
134553,variety,O,6930
134554,of,O,6930
134555,factors,O,6930
134556,including,O,6930
134557,injury,B-CAUSE_OF_DISEASE,6930
134558,certain,I-CAUSE_OF_DISEASE,6930
134559,medical,I-CAUSE_OF_DISEASE,6930
134560,conditions,I-CAUSE_OF_DISEASE,6930
134561,and,I-CAUSE_OF_DISEASE,6930
134562,even,I-CAUSE_OF_DISEASE,6930
134563,certain,I-CAUSE_OF_DISEASE,6930
134564,eye,I-CAUSE_OF_DISEASE,6930
134565,surgeries,I-CAUSE_OF_DISEASE,6930
134566,Another,O,6930
134567,common,O,6930
134568,cause,O,6930
134569,of,O,6930
134570,sudden,B-NAME_OF_DISEASE,6930
134571,vision,B-SIGN_AND_SYMPTOM,6930
134572,loss,I-SIGN_AND_SYMPTOM,6930
134573,is,O,6930
134574,a,O,6930
134575,stroke,B-CAUSE_OF_DISEASE,6930
134576,A,O,6930
134577,stroke,B-CAUSE_OF_DISEASE,6930
134578,occurs,O,6930
134579,when,O,6930
134580,the,B-SIGN_AND_SYMPTOM,6931
134581,blood,I-SIGN_AND_SYMPTOM,6931
134582,flow,I-SIGN_AND_SYMPTOM,6931
134583,to,I-SIGN_AND_SYMPTOM,6931
134584,the,I-SIGN_AND_SYMPTOM,6931
134585,brain,I-SIGN_AND_SYMPTOM,6931
134586,is,I-SIGN_AND_SYMPTOM,6931
134587,interrupted,I-SIGN_AND_SYMPTOM,6931
134588,depriving,I-SIGN_AND_SYMPTOM,6931
134589,brain,I-SIGN_AND_SYMPTOM,6931
134590,cells,I-SIGN_AND_SYMPTOM,6931
134591,of,I-SIGN_AND_SYMPTOM,6931
134592,oxygen,I-SIGN_AND_SYMPTOM,6931
134593,and,I-SIGN_AND_SYMPTOM,6931
134594,nutrients,I-SIGN_AND_SYMPTOM,6932
134595,This,O,6932
134596,can,O,6932
134597,lead,O,6932
134598,to,O,6932
134599,vision,B-SIGN_AND_SYMPTOM,6932
134600,loss,I-SIGN_AND_SYMPTOM,6932
134601,in,I-SIGN_AND_SYMPTOM,6932
134602,one,I-SIGN_AND_SYMPTOM,6932
134603,or,I-SIGN_AND_SYMPTOM,6932
134604,both,I-SIGN_AND_SYMPTOM,6932
134605,eyes,I-SIGN_AND_SYMPTOM,6932
134606,Strokes,B-CAUSE_OF_DISEASE,6932
134607,can,O,6932
134608,be,O,6932
134609,caused,O,6933
134610,by,O,6933
134611,a,O,6933
134612,variety,O,6933
134613,of,O,6933
134614,factors,O,6933
134615,including,O,6933
134616,high,B-CAUSE_OF_DISEASE,6933
134617,blood,I-CAUSE_OF_DISEASE,6933
134618,pressure,I-CAUSE_OF_DISEASE,6933
134619,smoking,I-CAUSE_OF_DISEASE,6933
134620,and,I-CAUSE_OF_DISEASE,6933
134621,diabetes,I-CAUSE_OF_DISEASE,6933
134622,Brain,B-CAUSE_OF_DISEASE,6933
134623,tumors,I-CAUSE_OF_DISEASE,6933
134624,can,O,6933
134625,also,O,6933
134626,cause,O,6933
134627,sudden,B-NAME_OF_DISEASE,6933
134628,vision,B-SIGN_AND_SYMPTOM,6933
134629,loss,I-SIGN_AND_SYMPTOM,6933
134630,Tumors,O,6933
134631,can,O,6933
134632,press,O,6933
134633,on,O,6933
134634,the,B-PART_OF_THE_EYES,6933
134635,optic,I-PART_OF_THE_EYES,6933
134636,nerve,I-PART_OF_THE_EYES,6933
134637,which,O,6933
134638,carries,O,6933
134639,visual,O,6933
134640,signals,O,6934
134641,from,O,6934
134642,the,O,6934
134643,eye,O,6934
134644,to,O,6934
134645,the,O,6934
134646,brain,O,6934
134647,This,O,6934
134648,can,O,6934
134649,lead,O,6934
134650,to,O,6934
134651,vision,B-SIGN_AND_SYMPTOM,6934
134652,loss,I-SIGN_AND_SYMPTOM,6934
134653,in,I-SIGN_AND_SYMPTOM,6934
134654,one,I-SIGN_AND_SYMPTOM,6934
134655,or,I-SIGN_AND_SYMPTOM,6934
134656,both,I-SIGN_AND_SYMPTOM,6934
134657,eyes,I-SIGN_AND_SYMPTOM,6934
134658,Brain,B-CAUSE_OF_DISEASE,6934
134659,tumors,I-CAUSE_OF_DISEASE,6934
134660,can,O,6934
134661,be,O,6934
134662,benign,O,6934
134663,or,O,6934
134664,malignant,O,6935
134665,and,O,6935
134666,can,O,6935
134667,be,O,6935
134668,caused,O,6935
134669,by,O,6935
134670,a,O,6935
134671,variety,O,6935
134672,of,O,6935
134673,factors,O,6935
134674,including,O,6935
134675,genetics,B-CAUSE_OF_DISEASE,6935
134676,and,I-CAUSE_OF_DISEASE,6935
134677,exposure,I-CAUSE_OF_DISEASE,6935
134678,to,I-CAUSE_OF_DISEASE,6935
134679,certain,I-CAUSE_OF_DISEASE,6935
134680,toxins,I-CAUSE_OF_DISEASE,6935
134681,Other,O,6935
134682,causes,O,6935
134683,of,O,6935
134684,sudden,B-NAME_OF_DISEASE,6935
134685,vision,B-SIGN_AND_SYMPTOM,6935
134686,loss,I-SIGN_AND_SYMPTOM,6936
134687,include,O,6936
134688,optic,B-CAUSE_OF_DISEASE,6936
134689,neuritis,I-CAUSE_OF_DISEASE,6936
134690,which,O,6936
134691,is,O,6936
134692,inflammation,O,6936
134693,of,O,6936
134694,the,B-PART_OF_THE_EYES,6936
134695,optic,I-PART_OF_THE_EYES,6936
134696,nerve,I-PART_OF_THE_EYES,6936
134697,and,O,6936
134698,giant,B-CAUSE_OF_DISEASE,6936
134699,cell,I-CAUSE_OF_DISEASE,6936
134700,arteritis,I-CAUSE_OF_DISEASE,6936
134701,which,O,6937
134702,is,O,6937
134703,an,O,6937
134704,inflammation,O,6937
134705,of,O,6937
134706,the,O,6937
134707,blood,O,6937
134708,vessels,O,6937
134709,in,O,6937
134710,the,O,6937
134711,head,O,6937
134712,It,O,6937
134713,s,O,6937
134714,important,O,6937
134715,to,O,6937
134716,seek,O,6937
134717,medical,O,6937
134718,attention,O,6937
134719,immediately,O,6937
134720,if,O,6937
134721,you,O,6937
134722,experience,O,6937
134723,sudden,B-NAME_OF_DISEASE,6937
134724,vision,B-SIGN_AND_SYMPTOM,6937
134725,loss,I-SIGN_AND_SYMPTOM,6937
134726,Early,O,6937
134727,diagnosis,O,6937
134728,and,O,6937
134729,treatment,O,6938
134730,can,O,6938
134731,help,O,6938
134732,prevent,O,6938
134733,permanent,B-NAME_OF_DISEASE,6938
134734,vision,B-SIGN_AND_SYMPTOM,6938
134735,loss,I-SIGN_AND_SYMPTOM,6938
134736,and,O,6938
134737,improve,O,6939
134738,your,O,6939
134739,overall,O,6939
134740,outcome,O,6939
134741,Your,O,6939
134742,healthcare,O,6939
134743,provider,O,6939
134744,will,O,6939
134745,perform,O,6939
134746,a,O,6939
134747,thorough,O,6939
134748,examination,O,6939
134749,and,O,6939
134750,may,O,6939
134751,order,O,6939
134752,imaging,B-DIAGNOSTIC_TEST,6940
134753,tests,I-DIAGNOSTIC_TEST,6940
134754,such,I-DIAGNOSTIC_TEST,6940
134755,as,I-DIAGNOSTIC_TEST,6940
134756,MRI,I-DIAGNOSTIC_TEST,6940
134757,CT,I-DIAGNOSTIC_TEST,6940
134758,scan,I-DIAGNOSTIC_TEST,6940
134759,and,O,6940
134760,an,O,6940
134761,eye,O,6940
134762,examination,O,6940
134763,to,O,6940
134764,help,O,6940
134765,determine,O,6940
134766,the,O,6940
134767,cause,O,6940
134768,of,O,6940
134769,your,O,6940
134770,vision,B-SIGN_AND_SYMPTOM,6940
134771,loss,I-SIGN_AND_SYMPTOM,6940
134772,Sudden,B-NAME_OF_DISEASE,6940
134773,Vision,I-NAME_OF_DISEASE,6940
134774,Loss,I-NAME_OF_DISEASE,6940
134775,in,I-NAME_OF_DISEASE,6940
134776,One,I-NAME_OF_DISEASE,6940
134777,Eye,I-NAME_OF_DISEASE,6940
134778,The,O,6940
134779,primary,O,6940
134780,cause,O,6941
134781,of,O,6941
134782,sudden,B-NAME_OF_DISEASE,6941
134783,vision,B-SIGN_AND_SYMPTOM,6941
134784,loss,I-SIGN_AND_SYMPTOM,6941
134785,in,I-NAME_OF_DISEASE,6941
134786,one,I-NAME_OF_DISEASE,6941
134787,eye,I-NAME_OF_DISEASE,6941
134788,is,O,6942
134789,high,B-CAUSE_OF_DISEASE,6942
134790,blood,I-CAUSE_OF_DISEASE,6942
134791,pressure,I-CAUSE_OF_DISEASE,6942
134792,also,O,6942
134793,known,O,6942
134794,as,O,6942
134795,hypertension,B-CAUSE_OF_DISEASE,6942
134796,High,B-CAUSE_OF_DISEASE,6942
134797,blood,I-CAUSE_OF_DISEASE,6942
134798,pressure,I-CAUSE_OF_DISEASE,6942
134799,is,O,6942
134800,a,O,6942
134801,condition,O,6942
134802,in,O,6942
134803,which,O,6942
134804,the,O,6942
134805,force,O,6942
134806,of,O,6942
134807,blood,O,6942
134808,against,O,6942
134809,the,O,6942
134810,walls,O,6942
134811,of,O,6943
134812,the,O,6943
134813,blood,O,6943
134814,vessels,O,6943
134815,is,O,6943
134816,too,O,6943
134817,high,O,6943
134818,This,O,6943
134819,extra,O,6943
134820,force,O,6943
134821,can,O,6943
134822,damage,O,6943
134823,the,B-PART_OF_THE_EYES,6943
134824,blood,I-PART_OF_THE_EYES,6943
134825,vessels,I-PART_OF_THE_EYES,6943
134826,in,I-PART_OF_THE_EYES,6943
134827,the,I-PART_OF_THE_EYES,6943
134828,eye,I-PART_OF_THE_EYES,6943
134829,leading,O,6943
134830,to,O,6943
134831,vision,B-SIGN_AND_SYMPTOM,6943
134832,loss,I-SIGN_AND_SYMPTOM,6943
134833,Symptoms,O,6943
134834,of,O,6943
134835,sudden,B-NAME_OF_DISEASE,6943
134836,vision,B-SIGN_AND_SYMPTOM,6943
134837,loss,I-SIGN_AND_SYMPTOM,6943
134838,in,I-NAME_OF_DISEASE,6944
134839,one,I-NAME_OF_DISEASE,6944
134840,eye,I-NAME_OF_DISEASE,6944
134841,include,O,6944
134842,blurred,B-SIGN_AND_SYMPTOM,6944
134843,vision,I-SIGN_AND_SYMPTOM,6944
134844,loss,I-SIGN_AND_SYMPTOM,6944
134845,of,I-SIGN_AND_SYMPTOM,6944
134846,peripheral,I-SIGN_AND_SYMPTOM,6944
134847,vision,I-SIGN_AND_SYMPTOM,6944
134848,and,I-SIGN_AND_SYMPTOM,6944
134849,the,I-SIGN_AND_SYMPTOM,6944
134850,appearance,I-SIGN_AND_SYMPTOM,6944
134851,of,I-SIGN_AND_SYMPTOM,6944
134852,a,I-SIGN_AND_SYMPTOM,6944
134853,dark,I-SIGN_AND_SYMPTOM,6944
134854,spot,I-SIGN_AND_SYMPTOM,6944
134855,or,I-SIGN_AND_SYMPTOM,6944
134856,shadow,I-SIGN_AND_SYMPTOM,6944
134857,in,I-SIGN_AND_SYMPTOM,6945
134858,the,I-SIGN_AND_SYMPTOM,6945
134859,affected,I-SIGN_AND_SYMPTOM,6945
134860,eye,I-SIGN_AND_SYMPTOM,6945
134861,These,O,6945
134862,symptoms,O,6945
134863,can,O,6945
134864,occur,O,6945
134865,suddenly,O,6945
134866,and,O,6945
134867,without,O,6945
134868,warning,O,6945
134869,If,O,6945
134870,you,O,6945
134871,experience,O,6945
134872,any,O,6945
134873,of,O,6945
134874,these,O,6945
134875,symptoms,O,6945
134876,it,O,6945
134877,is,O,6946
134878,essential,O,6946
134879,to,O,6946
134880,seek,O,6946
134881,medical,O,6946
134882,attention,O,6946
134883,immediately,O,6946
134884,Risk,O,6946
134885,Factors,O,6946
134886,for,O,6946
134887,Sudden,B-NAME_OF_DISEASE,6946
134888,Vision,I-NAME_OF_DISEASE,6946
134889,Loss,I-NAME_OF_DISEASE,6946
134890,Age,B-CAUSE_OF_DISEASE,6946
134891,As,O,6946
134892,we,O,6946
134893,get,O,6946
134894,older,O,6946
134895,the,O,6946
134896,risk,O,6946
134897,of,O,6946
134898,developing,O,6947
134899,certain,O,6947
134900,eye,O,6947
134901,conditions,O,6947
134902,such,O,6947
134903,as,O,6947
134904,age-related,B-CAUSE_OF_DISEASE,6947
134905,macular,I-CAUSE_OF_DISEASE,6947
134906,degeneration,I-CAUSE_OF_DISEASE,6947
134907,cataracts,B-CAUSE_OF_DISEASE,6947
134908,and,O,6947
134909,diabetic,B-CAUSE_OF_DISEASE,6947
134910,retinopathy,I-CAUSE_OF_DISEASE,6947
134911,increases,O,6947
134912,These,O,6947
134913,conditions,O,6947
134914,can,O,6947
134915,lead,O,6947
134916,to,O,6947
134917,sudden,B-NAME_OF_DISEASE,6947
134918,vision,I-NAME_OF_DISEASE,6947
134919,loss,I-NAME_OF_DISEASE,6947
134920,Age-related,B-NAME_OF_DISEASE,6948
134921,macular,I-NAME_OF_DISEASE,6948
134922,degeneration,I-NAME_OF_DISEASE,6948
134923,AMD,I-NAME_OF_DISEASE,6948
134924,is,O,6948
134925,a,O,6948
134926,degenerative,O,6948
134927,disorder,O,6948
134928,of,O,6948
134929,the,B-PART_OF_THE_EYES,6948
134930,retina,I-PART_OF_THE_EYES,6948
134931,that,O,6948
134932,affects,O,6948
134933,older,O,6948
134934,adults,O,6948
134935,and,O,6948
134936,can,O,6948
134937,cause,O,6948
134938,a,B-SIGN_AND_SYMPTOM,6948
134939,loss,I-SIGN_AND_SYMPTOM,6948
134940,of,I-SIGN_AND_SYMPTOM,6949
134941,central,I-SIGN_AND_SYMPTOM,6949
134942,vision,I-SIGN_AND_SYMPTOM,6949
134943,Medical,B-CAUSE_OF_DISEASE,6949
134944,conditions,I-CAUSE_OF_DISEASE,6949
134945,People,O,6949
134946,with,O,6949
134947,diabetes,B-CAUSE_OF_DISEASE,6949
134948,high,I-CAUSE_OF_DISEASE,6949
134949,blood,I-CAUSE_OF_DISEASE,6949
134950,pressure,I-CAUSE_OF_DISEASE,6949
134951,and,I-CAUSE_OF_DISEASE,6949
134952,high,I-CAUSE_OF_DISEASE,6949
134953,cholesterol,I-CAUSE_OF_DISEASE,6949
134954,are,O,6949
134955,at,O,6949
134956,an,O,6949
134957,increased,O,6950
134958,risk,O,6950
134959,of,O,6950
134960,developing,O,6950
134961,eye,O,6950
134962,conditions,O,6950
134963,that,O,6950
134964,can,O,6950
134965,lead,O,6950
134966,to,O,6950
134967,sudden,B-NAME_OF_DISEASE,6950
134968,vision,I-NAME_OF_DISEASE,6950
134969,loss,I-NAME_OF_DISEASE,6950
134970,Diabetes,B-CAUSE_OF_DISEASE,6950
134971,can,O,6950
134972,damage,O,6950
134973,the,O,6950
134974,blood,O,6950
134975,vessels,O,6950
134976,in,O,6951
134977,the,B-PART_OF_THE_EYES,6951
134978,retina,I-PART_OF_THE_EYES,6951
134979,leading,O,6951
134980,to,O,6951
134981,diabetic,B-CAUSE_OF_DISEASE,6951
134982,retinopathy,I-CAUSE_OF_DISEASE,6951
134983,which,O,6951
134984,can,O,6951
134985,cause,O,6951
134986,sudden,B-NAME_OF_DISEASE,6951
134987,vision,I-NAME_OF_DISEASE,6951
134988,loss,I-NAME_OF_DISEASE,6951
134989,High,B-CAUSE_OF_DISEASE,6951
134990,blood,I-CAUSE_OF_DISEASE,6951
134991,pressure,I-CAUSE_OF_DISEASE,6951
134992,and,I-CAUSE_OF_DISEASE,6951
134993,high,I-CAUSE_OF_DISEASE,6951
134994,cholesterol,I-CAUSE_OF_DISEASE,6951
134995,can,O,6951
134996,also,O,6951
134997,damage,O,6951
134998,the,O,6951
134999,blood,O,6951
135000,vessels,O,6952
135001,in,O,6952
135002,the,O,6952
135003,eye,O,6952
135004,leading,O,6952
135005,to,O,6952
135006,sudden,B-NAME_OF_DISEASE,6952
135007,vision,I-NAME_OF_DISEASE,6952
135008,loss,I-NAME_OF_DISEASE,6952
135009,Genetics,B-CAUSE_OF_DISEASE,6952
135010,Some,O,6952
135011,eye,O,6952
135012,conditions,O,6952
135013,that,O,6952
135014,can,O,6952
135015,lead,O,6952
135016,to,O,6952
135017,sudden,B-NAME_OF_DISEASE,6953
135018,vision,I-NAME_OF_DISEASE,6953
135019,loss,I-NAME_OF_DISEASE,6953
135020,such,O,6953
135021,as,O,6953
135022,retinal,B-CAUSE_OF_DISEASE,6953
135023,detachment,I-CAUSE_OF_DISEASE,6953
135024,are,O,6953
135025,more,O,6953
135026,common,O,6953
135027,in,O,6953
135028,certain,O,6953
135029,families,O,6953
135030,If,O,6953
135031,you,O,6953
135032,have,O,6953
135033,a,O,6953
135034,family,O,6953
135035,history,O,6954
135036,of,O,6954
135037,eye,O,6954
135038,conditions,O,6954
135039,that,O,6954
135040,can,O,6954
135041,cause,O,6954
135042,sudden,B-NAME_OF_DISEASE,6954
135043,vision,I-NAME_OF_DISEASE,6954
135044,loss,I-NAME_OF_DISEASE,6954
135045,you,O,6954
135046,may,O,6954
135047,be,O,6954
135048,at,O,6954
135049,a,O,6954
135050,higher,O,6954
135051,risk,O,6954
135052,Trauma,B-CAUSE_OF_DISEASE,6954
135053,Injury,B-CAUSE_OF_DISEASE,6954
135054,or,I-CAUSE_OF_DISEASE,6954
135055,trauma,I-CAUSE_OF_DISEASE,6954
135056,to,I-CAUSE_OF_DISEASE,6955
135057,the,I-CAUSE_OF_DISEASE,6955
135058,eye,I-CAUSE_OF_DISEASE,6955
135059,such,I-CAUSE_OF_DISEASE,6955
135060,as,I-CAUSE_OF_DISEASE,6955
135061,a,I-CAUSE_OF_DISEASE,6955
135062,blow,I-CAUSE_OF_DISEASE,6955
135063,to,I-CAUSE_OF_DISEASE,6955
135064,the,I-CAUSE_OF_DISEASE,6955
135065,head,I-CAUSE_OF_DISEASE,6955
135066,can,O,6955
135067,lead,O,6956
135068,to,O,6956
135069,sudden,B-NAME_OF_DISEASE,6956
135070,vision,I-NAME_OF_DISEASE,6956
135071,loss,I-NAME_OF_DISEASE,6956
135072,Additionally,O,6956
135073,certain,B-CAUSE_OF_DISEASE,6956
135074,eye,I-CAUSE_OF_DISEASE,6956
135075,surgeries,I-CAUSE_OF_DISEASE,6956
135076,such,I-CAUSE_OF_DISEASE,6956
135077,as,I-CAUSE_OF_DISEASE,6956
135078,cataract,I-CAUSE_OF_DISEASE,6956
135079,surgery,I-CAUSE_OF_DISEASE,6956
135080,can,O,6957
135081,also,O,6957
135082,increase,O,6957
135083,the,O,6957
135084,risk,O,6957
135085,of,O,6957
135086,sudden,B-NAME_OF_DISEASE,6957
135087,vision,I-NAME_OF_DISEASE,6957
135088,loss,I-NAME_OF_DISEASE,6957
135089,Certain,B-CAUSE_OF_DISEASE,6957
135090,medications,I-CAUSE_OF_DISEASE,6957
135091,Certain,B-CAUSE_OF_DISEASE,6957
135092,medications,I-CAUSE_OF_DISEASE,6957
135093,such,I-CAUSE_OF_DISEASE,6957
135094,as,I-CAUSE_OF_DISEASE,6957
135095,blood,I-CAUSE_OF_DISEASE,6957
135096,thinners,I-CAUSE_OF_DISEASE,6958
135097,and,I-CAUSE_OF_DISEASE,6958
135098,anti-inflammatory,I-CAUSE_OF_DISEASE,6958
135099,drugs,I-CAUSE_OF_DISEASE,6958
135100,can,O,6958
135101,increase,O,6958
135102,the,O,6958
135103,risk,O,6958
135104,of,O,6958
135105,sudden,B-NAME_OF_DISEASE,6958
135106,vision,I-NAME_OF_DISEASE,6958
135107,loss,I-NAME_OF_DISEASE,6958
135108,Toxins,B-CAUSE_OF_DISEASE,6958
135109,and,I-CAUSE_OF_DISEASE,6958
135110,environmental,I-CAUSE_OF_DISEASE,6958
135111,factors,I-CAUSE_OF_DISEASE,6958
135112,Exposure,O,6958
135113,to,O,6958
135114,certain,O,6958
135115,toxins,B-CAUSE_OF_DISEASE,6958
135116,and,I-CAUSE_OF_DISEASE,6958
135117,environmental,I-CAUSE_OF_DISEASE,6958
135118,factors,I-CAUSE_OF_DISEASE,6959
135119,such,I-CAUSE_OF_DISEASE,6959
135120,as,I-CAUSE_OF_DISEASE,6959
135121,pesticides,I-CAUSE_OF_DISEASE,6959
135122,and,I-CAUSE_OF_DISEASE,6959
135123,pollutants,I-CAUSE_OF_DISEASE,6959
135124,can,O,6959
135125,increase,O,6959
135126,the,O,6959
135127,risk,O,6959
135128,of,O,6959
135129,sudden,B-NAME_OF_DISEASE,6959
135130,vision,I-NAME_OF_DISEASE,6959
135131,loss,I-NAME_OF_DISEASE,6959
135132,How,O,6959
135133,Is,O,6959
135134,Sudden,B-NAME_OF_DISEASE,6959
135135,Vision,I-NAME_OF_DISEASE,6959
135136,Loss,I-NAME_OF_DISEASE,6959
135137,Treated,O,6959
135138,Treatment,O,6959
135139,for,O,6959
135140,sudden,B-NAME_OF_DISEASE,6959
135141,vision,I-NAME_OF_DISEASE,6959
135142,loss,I-NAME_OF_DISEASE,6959
135143,will,O,6959
135144,depend,O,6959
135145,on,O,6959
135146,the,O,6959
135147,underlying,O,6959
135148,cause,O,6959
135149,For,O,6959
135150,example,O,6959
135151,retinal,B-CAUSE_OF_DISEASE,6959
135152,detachment,I-CAUSE_OF_DISEASE,6959
135153,may,O,6959
135154,require,O,6960
135155,surgery,B-TREATMENT,6960
135156,while,O,6960
135157,a,O,6960
135158,stroke,B-CAUSE_OF_DISEASE,6960
135159,may,O,6960
135160,require,O,6960
135161,medication,B-TREATMENT,6960
135162,or,I-TREATMENT,6960
135163,other,I-TREATMENT,6960
135164,types,I-TREATMENT,6960
135165,of,I-TREATMENT,6960
135166,therapy,I-TREATMENT,6960
135167,Conclusion,O,6960
135168,In,O,6960
135169,conclusion,O,6960
135170,sudden,B-NAME_OF_DISEASE,6960
135171,vision,I-NAME_OF_DISEASE,6960
135172,loss,I-NAME_OF_DISEASE,6960
135173,is,O,6960
135174,a,O,6960
135175,serious,O,6960
135176,medical,O,6960
135177,condition,O,6960
135178,that,O,6960
135179,can,O,6960
135180,be,O,6960
135181,caused,O,6960
135182,by,O,6960
135183,a,O,6960
135184,variety,O,6960
135185,of,O,6960
135186,underlying,O,6960
135187,factors,O,6960
135188,Early,O,6960
135189,diagnosis,O,6960
135190,and,O,6961
135191,treatment,O,6961
135192,are,O,6961
135193,crucial,O,6961
135194,for,O,6961
135195,preventing,O,6961
135196,permanent,B-NAME_OF_DISEASE,6961
135197,vision,I-NAME_OF_DISEASE,6961
135198,loss,I-NAME_OF_DISEASE,6961
135199,If,O,6961
135200,you,O,6961
135201,experience,O,6961
135202,sudden,B-NAME_OF_DISEASE,6961
135203,vision,I-NAME_OF_DISEASE,6961
135204,loss,I-NAME_OF_DISEASE,6961
135205,in,I-NAME_OF_DISEASE,6961
135206,one,I-NAME_OF_DISEASE,6961
135207,eye,I-NAME_OF_DISEASE,6961
135208,seek,O,6961
135209,medical,O,6962
135210,attention,O,6962
135211,immediately,O,6962
135212,Don,O,6962
135213,t,O,6962
135214,ignore,O,6962
135215,or,O,6962
135216,delay,O,6962
135217,seeking,O,6962
135218,professional,O,6962
135219,help,O,6962
135220,as,O,6962
135221,it,O,6963
135222,can,O,6963
135223,lead,O,6963
135224,to,O,6963
135225,permanent,B-NAME_OF_DISEASE,6963
135226,vision,I-NAME_OF_DISEASE,6963
135227,loss,I-NAME_OF_DISEASE,6963
135228,Tritan,B-NAME_OF_DISEASE,6963
135229,color,I-NAME_OF_DISEASE,6963
135230,blindness,I-NAME_OF_DISEASE,6963
135231,is,O,6963
135232,a,O,6963
135233,rare,O,6963
135234,form,O,6963
135235,of,O,6963
135236,color,O,6963
135237,vision,O,6963
135238,deficiency,O,6963
135239,that,O,6963
135240,affects,O,6963
135241,the,O,6963
135242,ability,O,6963
135243,to,O,6963
135244,distinguish,O,6964
135245,between,O,6964
135246,blue,O,6964
135247,and,O,6964
135248,green,O,6964
135249,colors,O,6964
135250,The,O,6964
135251,condition,O,6964
135252,is,O,6964
135253,caused,O,6964
135254,by,O,6964
135255,a,B-CAUSE_OF_DISEASE,6964
135256,genetic,I-CAUSE_OF_DISEASE,6964
135257,mutation,I-CAUSE_OF_DISEASE,6964
135258,in,I-CAUSE_OF_DISEASE,6964
135259,the,I-CAUSE_OF_DISEASE,6964
135260,S-opsin,I-CAUSE_OF_DISEASE,6964
135261,gene,I-CAUSE_OF_DISEASE,6964
135262,which,O,6964
135263,is,O,6965
135264,responsible,O,6965
135265,for,O,6965
135266,the,O,6965
135267,production,O,6965
135268,of,O,6965
135269,a,B-CHEMICAL_COMPOUND,6965
135270,protein,I-CHEMICAL_COMPOUND,6965
135271,called,I-CHEMICAL_COMPOUND,6966
135272,opsin,I-CHEMICAL_COMPOUND,6966
135273,that,O,6966
135274,is,O,6966
135275,found,O,6966
135276,in,O,6966
135277,the,O,6966
135278,light-sensitive,O,6966
135279,cells,O,6966
135280,of,O,6966
135281,the,O,6966
135282,eye,O,6966
135283,known,O,6966
135284,as,O,6966
135285,cones,B-PART_OF_THE_EYES,6966
135286,Types,O,6966
135287,of,O,6966
135288,Tritan,B-NAME_OF_DISEASE,6966
135289,Color,I-NAME_OF_DISEASE,6966
135290,Blindness,I-NAME_OF_DISEASE,6966
135291,There,O,6966
135292,are,O,6966
135293,two,O,6966
135294,main,O,6966
135295,types,O,6966
135296,of,O,6966
135297,tritan,B-NAME_OF_DISEASE,6966
135298,color,I-NAME_OF_DISEASE,6966
135299,blindness,I-NAME_OF_DISEASE,6966
135300,Tritanomaly,B-NAME_OF_DISEASE,6966
135301,This,O,6966
135302,is,O,6966
135303,the,O,6966
135304,most,O,6966
135305,common,O,6966
135306,type,O,6966
135307,of,O,6966
135308,tritan,B-NAME_OF_DISEASE,6966
135309,color,I-NAME_OF_DISEASE,6967
135310,blindness,I-NAME_OF_DISEASE,6967
135311,and,O,6967
135312,it,O,6967
135313,is,O,6967
135314,characterized,O,6967
135315,by,O,6967
135316,a,B-SIGN_AND_SYMPTOM,6967
135317,reduced,I-SIGN_AND_SYMPTOM,6967
135318,sensitivity,I-SIGN_AND_SYMPTOM,6967
135319,to,I-SIGN_AND_SYMPTOM,6967
135320,blue,I-SIGN_AND_SYMPTOM,6967
135321,light,I-SIGN_AND_SYMPTOM,6967
135322,Individuals,O,6967
135323,with,O,6967
135324,tritanomaly,B-NAME_OF_DISEASE,6967
135325,have,B-SIGN_AND_SYMPTOM,6967
135326,difficulty,I-SIGN_AND_SYMPTOM,6967
135327,distinguishing,I-SIGN_AND_SYMPTOM,6967
135328,between,I-SIGN_AND_SYMPTOM,6967
135329,blue,I-SIGN_AND_SYMPTOM,6967
135330,and,I-SIGN_AND_SYMPTOM,6967
135331,green,I-SIGN_AND_SYMPTOM,6967
135332,colors,I-SIGN_AND_SYMPTOM,6967
135333,as,I-SIGN_AND_SYMPTOM,6967
135334,well,I-SIGN_AND_SYMPTOM,6967
135335,as,I-SIGN_AND_SYMPTOM,6967
135336,between,I-SIGN_AND_SYMPTOM,6967
135337,blue,I-SIGN_AND_SYMPTOM,6967
135338,and,I-SIGN_AND_SYMPTOM,6967
135339,purple,I-SIGN_AND_SYMPTOM,6967
135340,colors,I-SIGN_AND_SYMPTOM,6967
135341,They,O,6967
135342,may,O,6967
135343,also,O,6967
135344,perceive,B-SIGN_AND_SYMPTOM,6968
135345,some,I-SIGN_AND_SYMPTOM,6968
135346,shades,I-SIGN_AND_SYMPTOM,6968
135347,of,I-SIGN_AND_SYMPTOM,6968
135348,blue,I-SIGN_AND_SYMPTOM,6968
135349,as,I-SIGN_AND_SYMPTOM,6968
135350,green,I-SIGN_AND_SYMPTOM,6968
135351,or,I-SIGN_AND_SYMPTOM,6968
135352,gray,I-SIGN_AND_SYMPTOM,6968
135353,Tritanopia,B-NAME_OF_DISEASE,6968
135354,This,O,6968
135355,is,O,6968
135356,a,O,6968
135357,rarer,O,6969
135358,type,O,6969
135359,of,O,6969
135360,tritan,B-NAME_OF_DISEASE,6969
135361,color,I-NAME_OF_DISEASE,6969
135362,blindness,I-NAME_OF_DISEASE,6969
135363,and,O,6969
135364,it,O,6969
135365,is,O,6969
135366,characterized,O,6969
135367,by,O,6969
135368,a,B-SIGN_AND_SYMPTOM,6969
135369,complete,I-SIGN_AND_SYMPTOM,6969
135370,absence,I-SIGN_AND_SYMPTOM,6969
135371,of,I-SIGN_AND_SYMPTOM,6969
135372,sensitivity,I-SIGN_AND_SYMPTOM,6969
135373,to,I-SIGN_AND_SYMPTOM,6969
135374,blue,I-SIGN_AND_SYMPTOM,6969
135375,light,I-SIGN_AND_SYMPTOM,6969
135376,Individuals,O,6969
135377,with,O,6969
135378,tritanopia,B-NAME_OF_DISEASE,6969
135379,have,B-SIGN_AND_SYMPTOM,6969
135380,difficulty,I-SIGN_AND_SYMPTOM,6969
135381,distinguishing,I-SIGN_AND_SYMPTOM,6969
135382,between,I-SIGN_AND_SYMPTOM,6969
135383,blue,I-SIGN_AND_SYMPTOM,6969
135384,and,I-SIGN_AND_SYMPTOM,6969
135385,green,I-SIGN_AND_SYMPTOM,6969
135386,colors,I-SIGN_AND_SYMPTOM,6969
135387,as,I-SIGN_AND_SYMPTOM,6969
135388,well,I-SIGN_AND_SYMPTOM,6969
135389,as,I-SIGN_AND_SYMPTOM,6970
135390,between,I-SIGN_AND_SYMPTOM,6970
135391,blue,I-SIGN_AND_SYMPTOM,6970
135392,and,I-SIGN_AND_SYMPTOM,6970
135393,purple,I-SIGN_AND_SYMPTOM,6970
135394,colors,I-SIGN_AND_SYMPTOM,6970
135395,They,O,6970
135396,may,O,6970
135397,also,O,6970
135398,perceive,B-SIGN_AND_SYMPTOM,6970
135399,blue,I-SIGN_AND_SYMPTOM,6970
135400,colors,I-SIGN_AND_SYMPTOM,6970
135401,as,I-SIGN_AND_SYMPTOM,6970
135402,black,I-SIGN_AND_SYMPTOM,6970
135403,Additionally,O,6970
135404,some,O,6970
135405,individuals,O,6970
135406,may,O,6970
135407,have,O,6970
135408,a,O,6970
135409,less,O,6970
135410,severe,O,6970
135411,form,O,6970
135412,of,O,6970
135413,tritan,B-NAME_OF_DISEASE,6970
135414,color,I-NAME_OF_DISEASE,6971
135415,blindness,I-NAME_OF_DISEASE,6971
135416,known,O,6971
135417,as,O,6971
135418,Anomalous,B-NAME_OF_DISEASE,6971
135419,trichromacy,I-NAME_OF_DISEASE,6971
135420,in,O,6971
135421,which,O,6971
135422,individuals,O,6971
135423,have,O,6971
135424,normal,B-SIGN_AND_SYMPTOM,6971
135425,trichromatic,I-SIGN_AND_SYMPTOM,6971
135426,color,I-SIGN_AND_SYMPTOM,6971
135427,vision,I-SIGN_AND_SYMPTOM,6971
135428,but,I-SIGN_AND_SYMPTOM,6971
135429,with,I-SIGN_AND_SYMPTOM,6971
135430,some,I-SIGN_AND_SYMPTOM,6971
135431,degree,I-SIGN_AND_SYMPTOM,6971
135432,of,I-SIGN_AND_SYMPTOM,6971
135433,reduction,I-SIGN_AND_SYMPTOM,6971
135434,in,I-SIGN_AND_SYMPTOM,6972
135435,the,I-SIGN_AND_SYMPTOM,6972
135436,sensitivity,I-SIGN_AND_SYMPTOM,6972
135437,of,I-SIGN_AND_SYMPTOM,6972
135438,the,I-SIGN_AND_SYMPTOM,6972
135439,blue-sensitive,I-SIGN_AND_SYMPTOM,6972
135440,cones,I-SIGN_AND_SYMPTOM,6972
135441,It,O,6972
135442,s,O,6972
135443,important,O,6972
135444,to,O,6972
135445,note,O,6972
135446,that,O,6972
135447,both,O,6973
135448,types,O,6973
135449,of,O,6973
135450,tritan,B-NAME_OF_DISEASE,6973
135451,color,I-NAME_OF_DISEASE,6973
135452,blindness,I-NAME_OF_DISEASE,6973
135453,are,O,6973
135454,inherited,O,6973
135455,in,O,6973
135456,an,O,6973
135457,autosomal,O,6973
135458,recessive,O,6973
135459,manner,O,6973
135460,which,O,6973
135461,means,O,6973
135462,that,O,6973
135463,it,O,6973
135464,is,O,6974
135465,caused,O,6974
135466,by,O,6974
135467,a,B-CAUSE_OF_DISEASE,6974
135468,mutation,I-CAUSE_OF_DISEASE,6974
135469,in,I-CAUSE_OF_DISEASE,6974
135470,both,I-CAUSE_OF_DISEASE,6974
135471,copies,I-CAUSE_OF_DISEASE,6974
135472,of,I-CAUSE_OF_DISEASE,6974
135473,the,I-CAUSE_OF_DISEASE,6974
135474,S-opsin,I-CAUSE_OF_DISEASE,6974
135475,gene,I-CAUSE_OF_DISEASE,6974
135476,However,O,6974
135477,the,O,6974
135478,degree,O,6974
135479,of,O,6974
135480,color,B-NAME_OF_DISEASE,6974
135481,vision,I-NAME_OF_DISEASE,6974
135482,loss,I-NAME_OF_DISEASE,6974
135483,can,O,6974
135484,vary,O,6974
135485,from,O,6974
135486,person,O,6974
135487,to,O,6974
135488,person,O,6974
135489,How,O,6974
135490,Do,O,6974
135491,I,O,6974
135492,Know,O,6974
135493,If,O,6974
135494,I,O,6975
135495,Have,O,6975
135496,Tritan,B-NAME_OF_DISEASE,6975
135497,Color,I-NAME_OF_DISEASE,6975
135498,Blindness,I-NAME_OF_DISEASE,6975
135499,The,O,6975
135500,best,O,6975
135501,way,O,6975
135502,to,O,6975
135503,determine,O,6975
135504,if,O,6975
135505,you,O,6975
135506,have,O,6975
135507,tritan,B-NAME_OF_DISEASE,6975
135508,color,B-NAME_OF_DISEASE,6975
135509,blindness,I-NAME_OF_DISEASE,6975
135510,is,O,6975
135511,to,O,6975
135512,visit,O,6975
135513,an,O,6975
135514,eye,O,6975
135515,doctor,O,6975
135516,for,O,6975
135517,a,B-DIAGNOSTIC_TEST,6975
135518,comprehensive,I-DIAGNOSTIC_TEST,6975
135519,eye,I-DIAGNOSTIC_TEST,6975
135520,exam,I-DIAGNOSTIC_TEST,6975
135521,During,O,6975
135522,the,O,6975
135523,exam,O,6975
135524,the,O,6975
135525,eye,O,6975
135526,doctor,O,6975
135527,will,O,6975
135528,perform,O,6975
135529,a,O,6975
135530,series,O,6975
135531,of,O,6975
135532,tests,O,6975
135533,to,O,6975
135534,check,O,6975
135535,your,O,6976
135536,vision,O,6976
135537,and,O,6976
135538,color,O,6976
135539,perception,O,6976
135540,including,O,6976
135541,a,B-DIAGNOSTIC_TEST,6976
135542,tritan,I-DIAGNOSTIC_TEST,6976
135543,color,B-NAME_OF_DISEASE,6976
135544,blindness,I-NAME_OF_DISEASE,6976
135545,test,I-DIAGNOSTIC_TEST,6976
135546,A,B-DIAGNOSTIC_TEST,6976
135547,tritan,I-DIAGNOSTIC_TEST,6976
135548,color,B-NAME_OF_DISEASE,6976
135549,blindness,I-NAME_OF_DISEASE,6976
135550,test,I-DIAGNOSTIC_TEST,6976
135551,typically,O,6976
135552,consists,O,6976
135553,of,O,6976
135554,a,O,6976
135555,series,O,6976
135556,of,O,6976
135557,images,O,6976
135558,or,O,6976
135559,patterns,O,6976
135560,that,O,6976
135561,contain,O,6976
135562,blue,O,6976
135563,and,O,6976
135564,yellow,O,6977
135565,colors,O,6977
135566,The,O,6977
135567,individual,O,6977
135568,is,O,6977
135569,asked,O,6977
135570,to,O,6977
135571,identify,O,6977
135572,the,O,6977
135573,colors,O,6977
135574,in,O,6977
135575,the,O,6977
135576,images,O,6977
135577,or,O,6977
135578,patterns,O,6977
135579,If,O,6977
135580,the,O,6977
135581,individual,O,6977
135582,has,B-CAUSE_OF_DISEASE,6977
135583,difficulty,I-CAUSE_OF_DISEASE,6977
135584,distinguishing,I-CAUSE_OF_DISEASE,6977
135585,between,I-CAUSE_OF_DISEASE,6977
135586,blue,I-CAUSE_OF_DISEASE,6977
135587,and,I-CAUSE_OF_DISEASE,6977
135588,yellow,I-CAUSE_OF_DISEASE,6977
135589,colors,I-CAUSE_OF_DISEASE,6978
135590,they,O,6978
135591,may,O,6978
135592,have,O,6978
135593,tritan,B-NAME_OF_DISEASE,6978
135594,color,B-NAME_OF_DISEASE,6978
135595,blindness,I-NAME_OF_DISEASE,6978
135596,Additionally,O,6978
135597,your,O,6978
135598,eye,O,6978
135599,doctor,O,6978
135600,may,O,6978
135601,also,O,6978
135602,use,O,6978
135603,other,O,6978
135604,tests,O,6978
135605,such,O,6978
135606,as,O,6978
135607,a,B-DIAGNOSTIC_TEST,6978
135608,visual,I-DIAGNOSTIC_TEST,6978
135609,acuity,I-DIAGNOSTIC_TEST,6978
135610,test,I-DIAGNOSTIC_TEST,6978
135611,to,O,6978
135612,check,O,6979
135613,your,O,6979
135614,overall,O,6979
135615,eye,O,6979
135616,health,O,6979
135617,and,O,6979
135618,to,O,6979
135619,rule,O,6979
135620,out,O,6979
135621,other,O,6979
135622,causes,O,6979
135623,of,O,6979
135624,color,B-NAME_OF_DISEASE,6979
135625,blindness,I-NAME_OF_DISEASE,6979
135626,It,O,6979
135627,s,O,6979
135628,also,O,6979
135629,worth,O,6979
135630,noting,O,6979
135631,that,O,6979
135632,there,O,6979
135633,are,O,6979
135634,some,B-DIAGNOSTIC_TEST,6979
135635,online,I-DIAGNOSTIC_TEST,6979
135636,tests,I-DIAGNOSTIC_TEST,6979
135637,and,I-DIAGNOSTIC_TEST,6979
135638,color,I-DIAGNOSTIC_TEST,6980
135639,vision,I-DIAGNOSTIC_TEST,6980
135640,tests,I-DIAGNOSTIC_TEST,6980
135641,available,O,6980
135642,to,O,6980
135643,check,O,6980
135644,for,O,6980
135645,color,B-NAME_OF_DISEASE,6980
135646,blindness,I-NAME_OF_DISEASE,6980
135647,however,O,6980
135648,these,O,6980
135649,are,O,6980
135650,not,O,6980
135651,always,O,6980
135652,reliable,O,6980
135653,or,O,6981
135654,accurate,O,6981
135655,and,O,6981
135656,should,O,6981
135657,not,O,6981
135658,be,O,6981
135659,considered,O,6981
135660,a,O,6981
135661,substitute,O,6981
135662,for,O,6981
135663,a,B-DIAGNOSTIC_TEST,6981
135664,professional,I-DIAGNOSTIC_TEST,6981
135665,eye,I-DIAGNOSTIC_TEST,6981
135666,examination,I-DIAGNOSTIC_TEST,6981
135667,While,O,6981
135668,tritan,B-NAME_OF_DISEASE,6981
135669,color,B-NAME_OF_DISEASE,6981
135670,blindness,I-NAME_OF_DISEASE,6981
135671,can,O,6981
135672,be,O,6981
135673,challenging,O,6981
135674,for,O,6982
135675,those,O,6982
135676,who,O,6982
135677,have,O,6982
135678,it,O,6982
135679,it,O,6982
135680,is,O,6982
135681,not,O,6982
135682,a,O,6982
135683,serious,O,6982
135684,condition,O,6982
135685,and,O,6982
135686,does,O,6982
135687,not,O,6982
135688,usually,O,6982
135689,affect,O,6982
135690,an,O,6982
135691,individual,O,6982
135692,s,O,6982
135693,quality,O,6982
135694,of,O,6982
135695,life,O,6982
135696,However,O,6982
135697,certain,O,6982
135698,occupations,O,6983
135699,such,O,6983
135700,as,O,6983
135701,those,O,6983
135702,in,O,6983
135703,the,O,6983
135704,field,O,6983
135705,of,O,6983
135706,color,O,6983
135707,design,O,6983
135708,or,O,6983
135709,graphic,O,6983
135710,design,O,6983
135711,may,O,6983
135712,be,O,6983
135713,more,O,6983
135714,challenging,O,6984
135715,for,O,6984
135716,individuals,O,6984
135717,with,O,6984
135718,tritan,B-NAME_OF_DISEASE,6984
135719,color,B-NAME_OF_DISEASE,6984
135720,blindness,I-NAME_OF_DISEASE,6984
135721,Conclusion,O,6984
135722,Tritan,B-NAME_OF_DISEASE,6984
135723,color,I-NAME_OF_DISEASE,6984
135724,blindness,I-NAME_OF_DISEASE,6984
135725,is,O,6984
135726,a,O,6984
135727,rare,O,6984
135728,form,O,6984
135729,of,O,6984
135730,color,O,6984
135731,vision,O,6984
135732,deficiency,O,6984
135733,that,O,6984
135734,affects,O,6984
135735,the,O,6984
135736,ability,O,6984
135737,to,O,6984
135738,distinguish,O,6984
135739,between,O,6984
135740,blue,O,6984
135741,and,O,6984
135742,yellow,O,6984
135743,colors,O,6984
135744,It,O,6984
135745,is,O,6984
135746,caused,O,6984
135747,by,O,6984
135748,a,B-CAUSE_OF_DISEASE,6984
135749,genetic,I-CAUSE_OF_DISEASE,6984
135750,mutation,I-CAUSE_OF_DISEASE,6984
135751,in,I-CAUSE_OF_DISEASE,6984
135752,the,I-CAUSE_OF_DISEASE,6984
135753,S-opsin,I-CAUSE_OF_DISEASE,6985
135754,gene,I-CAUSE_OF_DISEASE,6985
135755,inherited,O,6985
135756,in,O,6985
135757,an,O,6985
135758,autosomal,O,6985
135759,recessive,O,6985
135760,manner,O,6985
135761,and,O,6985
135762,it,O,6985
135763,is,O,6985
135764,more,O,6985
135765,common,O,6985
135766,in,O,6985
135767,men,O,6985
135768,than,O,6985
135769,women,O,6985
135770,The,O,6985
135771,most,O,6985
135772,important,O,6985
135773,diagnostic,O,6985
135774,tool,O,6985
135775,for,O,6985
135776,Tritan,B-NAME_OF_DISEASE,6985
135777,color,I-NAME_OF_DISEASE,6985
135778,blindness,I-NAME_OF_DISEASE,6985
135779,is,O,6985
135780,the,B-DIAGNOSTIC_TEST,6985
135781,tritan,I-DIAGNOSTIC_TEST,6985
135782,color,I-DIAGNOSTIC_TEST,6985
135783,blindness,I-DIAGNOSTIC_TEST,6985
135784,test,I-DIAGNOSTIC_TEST,6986
135785,The,O,6986
135786,condition,O,6986
135787,can,O,6986
135788,be,O,6986
135789,challenging,O,6986
135790,but,O,6986
135791,it,O,6986
135792,is,O,6986
135793,not,O,6986
135794,a,O,6986
135795,serious,O,6986
135796,one,O,6986
135797,and,O,6986
135798,it,O,6986
135799,doesn,O,6986
135800,t,O,6986
135801,affect,O,6986
135802,the,O,6986
135803,quality,O,6986
135804,of,O,6986
135805,life,O,6986
135806,Balint,B-NAME_OF_DISEASE,6986
135807,syndrome,I-NAME_OF_DISEASE,6986
135808,is,O,6986
135809,a,O,6987
135810,rare,O,6987
135811,neurological,O,6987
135812,condition,O,6987
135813,that,O,6987
135814,affects,O,6987
135815,the,O,6987
135816,ability,O,6987
135817,to,O,6987
135818,perceive,O,6987
135819,plan,O,6987
135820,and,O,6987
135821,initiate,O,6987
135822,movement,O,6987
135823,and,O,6987
135824,to,O,6987
135825,direct,O,6987
135826,attention,O,6987
135827,to,O,6987
135828,visual,O,6987
135829,stimuli,O,6987
135830,It,O,6987
135831,is,O,6987
135832,named,O,6987
135833,after,O,6987
135834,the,O,6987
135835,Hungarian,O,6988
135836,neurologist,O,6988
135837,Rezső,B-PERSON,6988
135838,Balint,I-PERSON,6988
135839,who,O,6988
135840,first,O,6988
135841,described,O,6988
135842,the,O,6988
135843,condition,O,6988
135844,in,O,6988
135845,1909,O,6988
135846,Causes,O,6988
135847,of,O,6988
135848,Balint,B-NAME_OF_DISEASE,6988
135849,Syndrome,I-NAME_OF_DISEASE,6988
135850,The,O,6988
135851,exact,O,6988
135852,cause,O,6988
135853,of,O,6988
135854,Balint,B-NAME_OF_DISEASE,6988
135855,syndrome,I-NAME_OF_DISEASE,6988
135856,is,O,6988
135857,not,O,6988
135858,well,O,6989
135859,understood,O,6989
135860,but,O,6989
135861,it,O,6989
135862,is,O,6989
135863,believed,O,6989
135864,to,O,6989
135865,be,O,6989
135866,the,O,6989
135867,result,O,6989
135868,of,O,6989
135869,damage,B-CAUSE_OF_DISEASE,6989
135870,to,I-CAUSE_OF_DISEASE,6989
135871,specific,I-CAUSE_OF_DISEASE,6989
135872,areas,I-CAUSE_OF_DISEASE,6989
135873,of,I-CAUSE_OF_DISEASE,6989
135874,the,I-CAUSE_OF_DISEASE,6989
135875,brain,I-CAUSE_OF_DISEASE,6989
135876,including,I-CAUSE_OF_DISEASE,6989
135877,the,I-CAUSE_OF_DISEASE,6989
135878,parietal,I-CAUSE_OF_DISEASE,6989
135879,lobes,I-CAUSE_OF_DISEASE,6989
135880,and,I-CAUSE_OF_DISEASE,6989
135881,the,I-CAUSE_OF_DISEASE,6989
135882,superior,I-CAUSE_OF_DISEASE,6989
135883,temporal,I-CAUSE_OF_DISEASE,6989
135884,gyrus,I-CAUSE_OF_DISEASE,6989
135885,This,O,6989
135886,damage,O,6989
135887,can,O,6990
135888,be,O,6990
135889,caused,O,6990
135890,by,O,6990
135891,a,O,6990
135892,variety,O,6990
135893,of,O,6990
135894,factors,O,6990
135895,including,O,6990
135896,Stroke,B-CAUSE_OF_DISEASE,6990
135897,A,B-CAUSE_OF_DISEASE,6990
135898,stroke,I-CAUSE_OF_DISEASE,6990
135899,or,I-CAUSE_OF_DISEASE,6990
135900,sudden,I-CAUSE_OF_DISEASE,6990
135901,loss,I-CAUSE_OF_DISEASE,6990
135902,of,I-CAUSE_OF_DISEASE,6990
135903,blood,I-CAUSE_OF_DISEASE,6990
135904,flow,I-CAUSE_OF_DISEASE,6990
135905,to,I-CAUSE_OF_DISEASE,6990
135906,the,I-CAUSE_OF_DISEASE,6990
135907,brain,I-CAUSE_OF_DISEASE,6990
135908,is,O,6990
135909,the,O,6990
135910,most,O,6990
135911,common,O,6990
135912,cause,O,6990
135913,of,O,6990
135914,Balint,B-NAME_OF_DISEASE,6990
135915,syndrome,I-NAME_OF_DISEASE,6990
135916,The,O,6990
135917,damage,O,6990
135918,caused,O,6990
135919,by,O,6990
135920,a,B-CAUSE_OF_DISEASE,6991
135921,stroke,I-CAUSE_OF_DISEASE,6991
135922,can,O,6991
135923,affect,O,6991
135924,the,O,6991
135925,areas,O,6991
135926,of,O,6991
135927,the,O,6991
135928,brain,O,6991
135929,responsible,O,6991
135930,for,O,6991
135931,movement,O,6991
135932,and,O,6991
135933,attention,O,6991
135934,leading,O,6991
135935,to,O,6991
135936,the,O,6991
135937,symptoms,O,6991
135938,of,O,6991
135939,Balint,B-NAME_OF_DISEASE,6991
135940,syndrome,I-NAME_OF_DISEASE,6991
135941,Trauma,B-CAUSE_OF_DISEASE,6991
135942,Trauma,B-CAUSE_OF_DISEASE,6991
135943,to,I-CAUSE_OF_DISEASE,6991
135944,the,I-CAUSE_OF_DISEASE,6991
135945,head,I-CAUSE_OF_DISEASE,6991
135946,such,I-CAUSE_OF_DISEASE,6991
135947,as,I-CAUSE_OF_DISEASE,6991
135948,from,I-CAUSE_OF_DISEASE,6992
135949,a,I-CAUSE_OF_DISEASE,6992
135950,car,I-CAUSE_OF_DISEASE,6992
135951,accident,I-CAUSE_OF_DISEASE,6992
135952,or,I-CAUSE_OF_DISEASE,6992
135953,fall,I-CAUSE_OF_DISEASE,6992
135954,can,O,6992
135955,also,O,6992
135956,cause,O,6992
135957,damage,O,6992
135958,to,O,6992
135959,the,O,6992
135960,brain,O,6992
135961,and,O,6992
135962,lead,O,6992
135963,to,O,6992
135964,Balint,B-NAME_OF_DISEASE,6992
135965,s,I-NAME_OF_DISEASE,6992
135966,syndrome,I-NAME_OF_DISEASE,6992
135967,Neurodegenerative,B-CAUSE_OF_DISEASE,6992
135968,disorders,I-CAUSE_OF_DISEASE,6992
135969,Some,B-CAUSE_OF_DISEASE,6992
135970,neurodegenerative,I-CAUSE_OF_DISEASE,6992
135971,disorders,I-CAUSE_OF_DISEASE,6992
135972,such,I-CAUSE_OF_DISEASE,6992
135973,as,I-CAUSE_OF_DISEASE,6992
135974,Alzheimer,I-CAUSE_OF_DISEASE,6992
135975,s,I-CAUSE_OF_DISEASE,6992
135976,disease,I-CAUSE_OF_DISEASE,6992
135977,and,I-CAUSE_OF_DISEASE,6992
135978,multiple,I-CAUSE_OF_DISEASE,6992
135979,sclerosis,I-CAUSE_OF_DISEASE,6992
135980,can,O,6992
135981,also,O,6993
135982,cause,O,6993
135983,Balint,B-NAME_OF_DISEASE,6993
135984,s,I-NAME_OF_DISEASE,6993
135985,syndrome,I-NAME_OF_DISEASE,6993
135986,by,O,6993
135987,damaging,O,6993
135988,the,O,6993
135989,brain,O,6993
135990,Psychoanatomical,O,6993
135991,substrates,O,6993
135992,of,O,6993
135993,Bálint,B-NAME_OF_DISEASE,6993
135994,s,I-NAME_OF_DISEASE,6993
135995,syndrome,I-NAME_OF_DISEASE,6993
135996,-,O,6993
135997,BMJ,B-PUBLICATION_VENUE,6993
135998,Journal,I-PUBLICATION_VENUE,6993
135999,How,O,6993
136000,Can,O,6993
136001,You,O,6993
136002,Know,O,6994
136003,If,O,6994
136004,You,O,6994
136005,Have,O,6994
136006,Balint,B-NAME_OF_DISEASE,6994
136007,s,I-NAME_OF_DISEASE,6994
136008,Syndrome,I-NAME_OF_DISEASE,6994
136009,The,O,6994
136010,symptoms,O,6994
136011,of,O,6994
136012,Balint,B-NAME_OF_DISEASE,6994
136013,syndrome,I-NAME_OF_DISEASE,6994
136014,can,O,6994
136015,vary,O,6994
136016,depending,O,6994
136017,on,O,6994
136018,the,O,6994
136019,extent,O,6994
136020,of,O,6994
136021,brain,O,6994
136022,damage,O,6994
136023,and,O,6994
136024,the,O,6995
136025,specific,O,6995
136026,areas,O,6995
136027,affected,O,6995
136028,Common,O,6995
136029,symptoms,O,6995
136030,are,O,6995
136031,listed,O,6995
136032,as,O,6995
136033,Difficulty,B-SIGN_AND_SYMPTOM,6995
136034,with,I-SIGN_AND_SYMPTOM,6995
136035,visually,I-SIGN_AND_SYMPTOM,6995
136036,guided,I-SIGN_AND_SYMPTOM,6995
136037,movements,I-SIGN_AND_SYMPTOM,6995
136038,People,O,6995
136039,with,O,6995
136040,Balint,B-NAME_OF_DISEASE,6995
136041,syndrome,I-NAME_OF_DISEASE,6995
136042,may,O,6995
136043,have,B-SIGN_AND_SYMPTOM,6995
136044,difficulty,I-SIGN_AND_SYMPTOM,6995
136045,initiating,I-SIGN_AND_SYMPTOM,6995
136046,and,I-SIGN_AND_SYMPTOM,6995
136047,executing,I-SIGN_AND_SYMPTOM,6995
136048,visually,I-SIGN_AND_SYMPTOM,6995
136049,guided,I-SIGN_AND_SYMPTOM,6996
136050,movements,I-SIGN_AND_SYMPTOM,6996
136051,such,I-SIGN_AND_SYMPTOM,6996
136052,as,I-SIGN_AND_SYMPTOM,6996
136053,reaching,I-SIGN_AND_SYMPTOM,6996
136054,for,I-SIGN_AND_SYMPTOM,6996
136055,an,I-SIGN_AND_SYMPTOM,6996
136056,object,I-SIGN_AND_SYMPTOM,6996
136057,or,I-SIGN_AND_SYMPTOM,6996
136058,buttoning,I-SIGN_AND_SYMPTOM,6996
136059,a,I-SIGN_AND_SYMPTOM,6996
136060,shirt,I-SIGN_AND_SYMPTOM,6996
136061,Difficulty,B-SIGN_AND_SYMPTOM,6996
136062,with,I-SIGN_AND_SYMPTOM,6996
136063,attention,I-SIGN_AND_SYMPTOM,6996
136064,People,O,6996
136065,with,O,6996
136066,Balint,B-NAME_OF_DISEASE,6996
136067,syndrome,I-NAME_OF_DISEASE,6996
136068,may,O,6997
136069,have,B-SIGN_AND_SYMPTOM,6997
136070,difficulty,I-SIGN_AND_SYMPTOM,6997
136071,directing,I-SIGN_AND_SYMPTOM,6997
136072,their,I-SIGN_AND_SYMPTOM,6997
136073,attention,I-SIGN_AND_SYMPTOM,6997
136074,to,I-SIGN_AND_SYMPTOM,6997
136075,specific,I-SIGN_AND_SYMPTOM,6997
136076,visual,I-SIGN_AND_SYMPTOM,6997
136077,stimuli,I-SIGN_AND_SYMPTOM,6997
136078,such,I-SIGN_AND_SYMPTOM,6997
136079,as,I-SIGN_AND_SYMPTOM,6997
136080,a,I-SIGN_AND_SYMPTOM,6997
136081,person,I-SIGN_AND_SYMPTOM,6997
136082,s,I-SIGN_AND_SYMPTOM,6997
136083,face,I-SIGN_AND_SYMPTOM,6997
136084,or,I-SIGN_AND_SYMPTOM,6998
136085,a,I-SIGN_AND_SYMPTOM,6998
136086,car,I-SIGN_AND_SYMPTOM,6998
136087,driving,I-SIGN_AND_SYMPTOM,6998
136088,by,I-SIGN_AND_SYMPTOM,6998
136089,Difficulty,B-SIGN_AND_SYMPTOM,6998
136090,with,I-SIGN_AND_SYMPTOM,6998
136091,visual,I-SIGN_AND_SYMPTOM,6998
136092,memory,I-SIGN_AND_SYMPTOM,6998
136093,People,O,6998
136094,with,O,6998
136095,Balint,B-NAME_OF_DISEASE,6998
136096,syndrome,I-NAME_OF_DISEASE,6998
136097,may,O,6998
136098,have,B-SIGN_AND_SYMPTOM,6999
136099,difficulty,I-SIGN_AND_SYMPTOM,6999
136100,remembering,I-SIGN_AND_SYMPTOM,6999
136101,what,I-SIGN_AND_SYMPTOM,6999
136102,they,I-SIGN_AND_SYMPTOM,6999
136103,have,I-SIGN_AND_SYMPTOM,6999
136104,seen,I-SIGN_AND_SYMPTOM,6999
136105,such,I-SIGN_AND_SYMPTOM,6999
136106,as,I-SIGN_AND_SYMPTOM,6999
136107,the,I-SIGN_AND_SYMPTOM,6999
136108,location,I-SIGN_AND_SYMPTOM,6999
136109,of,I-SIGN_AND_SYMPTOM,6999
136110,objects,I-SIGN_AND_SYMPTOM,6999
136111,on,I-SIGN_AND_SYMPTOM,6999
136112,a,I-SIGN_AND_SYMPTOM,6999
136113,table,I-SIGN_AND_SYMPTOM,6999
136114,or,I-SIGN_AND_SYMPTOM,6999
136115,the,I-SIGN_AND_SYMPTOM,6999
136116,features,I-SIGN_AND_SYMPTOM,6999
136117,of,I-SIGN_AND_SYMPTOM,7000
136118,a,I-SIGN_AND_SYMPTOM,7000
136119,person,I-SIGN_AND_SYMPTOM,7000
136120,s,I-SIGN_AND_SYMPTOM,7000
136121,face,I-SIGN_AND_SYMPTOM,7000
136122,Difficulty,B-SIGN_AND_SYMPTOM,7000
136123,with,I-SIGN_AND_SYMPTOM,7000
136124,visual,I-SIGN_AND_SYMPTOM,7000
136125,perception,I-SIGN_AND_SYMPTOM,7000
136126,People,O,7000
136127,with,O,7000
136128,Balint,B-NAME_OF_DISEASE,7000
136129,syndrome,I-NAME_OF_DISEASE,7000
136130,may,O,7000
136131,have,B-SIGN_AND_SYMPTOM,7000
136132,difficulty,I-SIGN_AND_SYMPTOM,7000
136133,perceiving,I-SIGN_AND_SYMPTOM,7000
136134,visual,I-SIGN_AND_SYMPTOM,7000
136135,information,I-SIGN_AND_SYMPTOM,7000
136136,such,I-SIGN_AND_SYMPTOM,7000
136137,as,I-SIGN_AND_SYMPTOM,7000
136138,difficulty,I-SIGN_AND_SYMPTOM,7000
136139,recognizing,I-SIGN_AND_SYMPTOM,7000
136140,objects,I-SIGN_AND_SYMPTOM,7000
136141,or,I-SIGN_AND_SYMPTOM,7000
136142,faces,I-SIGN_AND_SYMPTOM,7001
136143,Is,O,7001
136144,Balint,B-NAME_OF_DISEASE,7001
136145,Syndrome,I-NAME_OF_DISEASE,7001
136146,Treatable,O,7001
136147,While,O,7001
136148,there,O,7001
136149,is,O,7001
136150,no,O,7001
136151,cure,O,7001
136152,for,O,7001
136153,Balint,B-NAME_OF_DISEASE,7001
136154,syndrome,I-NAME_OF_DISEASE,7001
136155,treatment,O,7002
136156,options,O,7002
136157,can,O,7002
136158,help,O,7002
136159,to,O,7002
136160,manage,O,7002
136161,symptoms,O,7002
136162,and,O,7002
136163,improve,O,7002
136164,function,O,7002
136165,Treatment,O,7002
136166,options,O,7002
136167,include,O,7002
136168,Physical,B-TREATMENT,7002
136169,therapy,I-TREATMENT,7002
136170,Physical,B-TREATMENT,7002
136171,therapy,I-TREATMENT,7002
136172,can,O,7002
136173,help,O,7002
136174,to,O,7002
136175,improve,O,7002
136176,motor,O,7003
136177,function,O,7003
136178,and,O,7003
136179,coordination,O,7003
136180,as,O,7003
136181,well,O,7003
136182,as,O,7003
136183,help,O,7003
136184,to,O,7003
136185,prevent,O,7003
136186,muscle,O,7003
136187,weakness,O,7003
136188,and,O,7003
136189,contractures,O,7003
136190,Occupational,B-TREATMENT,7003
136191,therapy,I-TREATMENT,7003
136192,Occupational,B-TREATMENT,7003
136193,therapy,I-TREATMENT,7003
136194,can,O,7003
136195,help,O,7004
136196,to,O,7004
136197,improve,O,7004
136198,the,O,7004
136199,ability,O,7004
136200,to,O,7004
136201,perform,O,7004
136202,daily,O,7004
136203,activities,O,7004
136204,such,O,7004
136205,as,O,7004
136206,dressing,O,7004
136207,and,O,7004
136208,grooming,O,7004
136209,Speech,B-TREATMENT,7004
136210,therapy,I-TREATMENT,7004
136211,Speech,B-TREATMENT,7004
136212,therapy,I-TREATMENT,7004
136213,can,O,7004
136214,help,O,7004
136215,to,O,7004
136216,improve,O,7004
136217,communication,O,7005
136218,skills,O,7005
136219,such,O,7005
136220,as,O,7005
136221,speaking,O,7005
136222,and,O,7005
136223,understanding,O,7005
136224,language,O,7005
136225,Cognitive,B-TREATMENT,7005
136226,therapy,I-TREATMENT,7005
136227,Cognitive,B-TREATMENT,7005
136228,therapy,I-TREATMENT,7005
136229,can,O,7005
136230,help,O,7005
136231,to,O,7005
136232,improve,O,7005
136233,attention,O,7005
136234,memory,O,7005
136235,and,O,7005
136236,other,O,7005
136237,cognitive,O,7005
136238,skills,O,7005
136239,Medications,B-TREATMENT,7005
136240,Medications,B-TREATMENT,7006
136241,can,O,7006
136242,be,O,7006
136243,used,O,7006
136244,to,O,7006
136245,manage,O,7006
136246,symptoms,O,7006
136247,of,O,7006
136248,Balint,B-NAME_OF_DISEASE,7006
136249,syndrome,I-NAME_OF_DISEASE,7006
136250,such,O,7006
136251,as,O,7006
136252,reducing,O,7006
136253,muscle,O,7006
136254,spasticity,O,7006
136255,or,O,7006
136256,improving,O,7007
136257,memory,O,7007
136258,Can,O,7007
136259,Balint,B-NAME_OF_DISEASE,7007
136260,Syndrome,I-NAME_OF_DISEASE,7007
136261,Improve,O,7007
136262,Over,O,7007
136263,Time,O,7007
136264,The,O,7007
136265,prognosis,O,7007
136266,for,O,7007
136267,Balint,B-NAME_OF_DISEASE,7007
136268,syndrome,I-NAME_OF_DISEASE,7007
136269,can,O,7007
136270,vary,O,7007
136271,depending,O,7007
136272,on,O,7007
136273,the,O,7007
136274,extent,O,7007
136275,of,O,7007
136276,brain,O,7007
136277,damage,O,7007
136278,and,O,7008
136279,the,O,7008
136280,specific,O,7008
136281,areas,O,7008
136282,affected,O,7008
136283,Some,O,7008
136284,people,O,7008
136285,may,O,7008
136286,experience,O,7008
136287,improvement,O,7008
136288,in,O,7008
136289,symptoms,O,7008
136290,over,O,7008
136291,time,O,7008
136292,while,O,7009
136293,others,O,7009
136294,may,O,7009
136295,not,O,7009
136296,Conclusion,O,7009
136297,Balint,B-NAME_OF_DISEASE,7009
136298,syndrome,I-NAME_OF_DISEASE,7009
136299,is,O,7009
136300,a,O,7009
136301,rare,O,7009
136302,neurological,O,7009
136303,condition,O,7009
136304,characterized,O,7009
136305,by,O,7009
136306,difficulties,B-SIGN_AND_SYMPTOM,7009
136307,with,I-SIGN_AND_SYMPTOM,7009
136308,visually,I-SIGN_AND_SYMPTOM,7009
136309,guided,I-SIGN_AND_SYMPTOM,7009
136310,movements,I-SIGN_AND_SYMPTOM,7009
136311,attention,I-SIGN_AND_SYMPTOM,7009
136312,visual,I-SIGN_AND_SYMPTOM,7009
136313,memory,I-SIGN_AND_SYMPTOM,7010
136314,and,I-SIGN_AND_SYMPTOM,7010
136315,visual,I-SIGN_AND_SYMPTOM,7010
136316,perception,I-SIGN_AND_SYMPTOM,7010
136317,It,O,7010
136318,is,O,7010
136319,caused,O,7010
136320,by,O,7010
136321,damage,B-CAUSE_OF_DISEASE,7010
136322,to,I-CAUSE_OF_DISEASE,7010
136323,specific,I-CAUSE_OF_DISEASE,7010
136324,areas,I-CAUSE_OF_DISEASE,7010
136325,of,I-CAUSE_OF_DISEASE,7010
136326,the,I-CAUSE_OF_DISEASE,7010
136327,brain,I-CAUSE_OF_DISEASE,7011
136328,including,I-CAUSE_OF_DISEASE,7011
136329,the,I-CAUSE_OF_DISEASE,7011
136330,parietal,I-CAUSE_OF_DISEASE,7011
136331,lobes,I-CAUSE_OF_DISEASE,7011
136332,and,I-CAUSE_OF_DISEASE,7011
136333,superior,I-CAUSE_OF_DISEASE,7011
136334,temporal,I-CAUSE_OF_DISEASE,7011
136335,gyrus,I-CAUSE_OF_DISEASE,7011
136336,Treatment,O,7011
136337,options,O,7011
136338,include,O,7011
136339,physical,B-TREATMENT,7011
136340,therapy,I-TREATMENT,7011
136341,occupational,B-TREATMENT,7011
136342,therapy,I-TREATMENT,7011
136343,speech,B-TREATMENT,7011
136344,therapy,I-TREATMENT,7011
136345,cognitive,B-TREATMENT,7011
136346,therapy,I-TREATMENT,7012
136347,and,O,7012
136348,medications,B-TREATMENT,7012
136349,which,O,7012
136350,can,O,7012
136351,help,O,7012
136352,to,O,7012
136353,manage,O,7012
136354,symptoms,O,7012
136355,and,O,7012
136356,improve,O,7012
136357,function,O,7012
136358,Binocular,O,7012
136359,vision,O,7012
136360,refers,O,7012
136361,to,O,7012
136362,the,O,7012
136363,ability,O,7012
136364,of,O,7013
136365,the,O,7013
136366,eyes,O,7013
136367,to,O,7013
136368,work,O,7013
136369,together,O,7013
136370,as,O,7013
136371,a,O,7013
136372,team,O,7013
136373,to,O,7013
136374,perceive,O,7013
136375,depth,O,7013
136376,and,O,7013
136377,perceive,O,7013
136378,a,O,7013
136379,single,O,7013
136380,image,O,7013
136381,Binocular,O,7013
136382,vision,O,7014
136383,is,O,7014
136384,graded,O,7014
136385,based,O,7014
136386,on,O,7014
136387,the,B-DIAGNOSTIC_TEST,7014
136388,degree,I-DIAGNOSTIC_TEST,7014
136389,of,I-DIAGNOSTIC_TEST,7014
136390,deviation,I-DIAGNOSTIC_TEST,7014
136391,or,I-DIAGNOSTIC_TEST,7014
136392,misalignment,I-DIAGNOSTIC_TEST,7014
136393,between,I-DIAGNOSTIC_TEST,7014
136394,the,I-DIAGNOSTIC_TEST,7014
136395,two,I-DIAGNOSTIC_TEST,7014
136396,eyes,I-DIAGNOSTIC_TEST,7014
136397,Grades,O,7014
136398,of,O,7014
136399,Binocular,B-NAME_OF_DISEASE,7014
136400,Vision,I-NAME_OF_DISEASE,7014
136401,Dysfunction,I-NAME_OF_DISEASE,7014
136402,Binocular,O,7014
136403,vision,O,7014
136404,can,O,7014
136405,be,O,7015
136406,graded,O,7015
136407,based,O,7015
136408,on,O,7015
136409,the,B-DIAGNOSTIC_TEST,7015
136410,degree,I-DIAGNOSTIC_TEST,7015
136411,of,I-DIAGNOSTIC_TEST,7015
136412,deviation,I-DIAGNOSTIC_TEST,7015
136413,or,I-DIAGNOSTIC_TEST,7015
136414,misalignment,I-DIAGNOSTIC_TEST,7015
136415,between,I-DIAGNOSTIC_TEST,7015
136416,the,I-DIAGNOSTIC_TEST,7015
136417,two,I-DIAGNOSTIC_TEST,7015
136418,eyes,I-DIAGNOSTIC_TEST,7015
136419,There,O,7015
136420,are,O,7015
136421,three,O,7015
136422,grades,O,7015
136423,of,O,7015
136424,binocular,O,7015
136425,vision,O,7015
136426,first,O,7015
136427,grade,O,7015
136428,second,O,7015
136429,grade,O,7015
136430,and,O,7016
136431,third,O,7016
136432,grade,O,7016
136433,First,O,7016
136434,Grade,O,7016
136435,This,O,7016
136436,is,O,7016
136437,the,O,7016
136438,normal,O,7016
136439,state,O,7016
136440,of,O,7016
136441,binocular,O,7016
136442,vision,O,7016
136443,where,O,7016
136444,the,O,7016
136445,eyes,O,7016
136446,are,O,7016
136447,perfectly,O,7016
136448,aligned,O,7016
136449,and,O,7016
136450,there,O,7017
136451,is,O,7017
136452,no,O,7017
136453,deviation,O,7017
136454,The,O,7017
136455,eyes,O,7017
136456,work,O,7017
136457,together,O,7017
136458,to,O,7017
136459,focus,O,7017
136460,on,O,7017
136461,an,O,7017
136462,object,O,7018
136463,and,O,7018
136464,produce,O,7018
136465,a,O,7018
136466,single,O,7018
136467,image,O,7018
136468,People,O,7018
136469,with,O,7018
136470,first-grade,O,7018
136471,binocular,O,7018
136472,vision,O,7018
136473,have,O,7018
136474,good,O,7018
136475,depth,O,7018
136476,perception,O,7018
136477,and,O,7018
136478,have,O,7018
136479,no,O,7018
136480,symptoms,O,7018
136481,of,O,7018
136482,double,O,7018
136483,vision,O,7019
136484,or,O,7019
136485,eye,O,7019
136486,strain,O,7019
136487,Second,O,7019
136488,Grade,O,7019
136489,This,O,7019
136490,is,O,7019
136491,a,O,7019
136492,mild,O,7019
136493,form,O,7019
136494,of,O,7019
136495,binocular,B-NAME_OF_DISEASE,7019
136496,vision,I-NAME_OF_DISEASE,7019
136497,deviation,I-NAME_OF_DISEASE,7019
136498,where,O,7019
136499,the,B-SIGN_AND_SYMPTOM,7019
136500,eyes,I-SIGN_AND_SYMPTOM,7019
136501,tend,I-SIGN_AND_SYMPTOM,7019
136502,to,I-SIGN_AND_SYMPTOM,7019
136503,deviate,I-SIGN_AND_SYMPTOM,7019
136504,slightly,I-SIGN_AND_SYMPTOM,7019
136505,The,B-SIGN_AND_SYMPTOM,7019
136506,eyes,I-SIGN_AND_SYMPTOM,7019
136507,may,I-SIGN_AND_SYMPTOM,7019
136508,not,I-SIGN_AND_SYMPTOM,7019
136509,be,I-SIGN_AND_SYMPTOM,7019
136510,perfectly,I-SIGN_AND_SYMPTOM,7019
136511,aligned,I-SIGN_AND_SYMPTOM,7019
136512,but,O,7019
136513,they,O,7019
136514,can,O,7019
136515,still,O,7019
136516,work,O,7019
136517,together,O,7020
136518,to,O,7020
136519,produce,O,7020
136520,a,O,7020
136521,single,O,7020
136522,image,O,7020
136523,People,O,7020
136524,with,O,7020
136525,second-grade,O,7020
136526,binocular,O,7020
136527,vision,O,7020
136528,may,O,7020
136529,experience,O,7020
136530,occasional,B-SIGN_AND_SYMPTOM,7020
136531,double,I-SIGN_AND_SYMPTOM,7020
136532,vision,I-SIGN_AND_SYMPTOM,7021
136533,or,I-SIGN_AND_SYMPTOM,7021
136534,eye,I-SIGN_AND_SYMPTOM,7021
136535,strain,I-SIGN_AND_SYMPTOM,7021
136536,but,O,7021
136537,it,O,7021
136538,is,O,7021
136539,not,O,7021
136540,severe,O,7021
136541,enough,O,7021
136542,to,O,7021
136543,cause,O,7021
136544,significant,O,7021
136545,problems,O,7021
136546,Third,O,7021
136547,Grade,O,7021
136548,This,O,7021
136549,is,O,7021
136550,a,O,7022
136551,severe,O,7022
136552,form,O,7022
136553,of,O,7022
136554,binocular,B-NAME_OF_DISEASE,7022
136555,vision,I-NAME_OF_DISEASE,7022
136556,deviation,I-NAME_OF_DISEASE,7022
136557,where,O,7022
136558,the,B-SIGN_AND_SYMPTOM,7022
136559,eyes,I-SIGN_AND_SYMPTOM,7022
136560,are,I-SIGN_AND_SYMPTOM,7022
136561,misaligned,I-SIGN_AND_SYMPTOM,7022
136562,and,I-SIGN_AND_SYMPTOM,7022
136563,cannot,I-SIGN_AND_SYMPTOM,7023
136564,work,I-SIGN_AND_SYMPTOM,7023
136565,together,I-SIGN_AND_SYMPTOM,7023
136566,to,I-SIGN_AND_SYMPTOM,7023
136567,produce,I-SIGN_AND_SYMPTOM,7023
136568,a,I-SIGN_AND_SYMPTOM,7023
136569,single,I-SIGN_AND_SYMPTOM,7023
136570,image,I-SIGN_AND_SYMPTOM,7023
136571,People,O,7023
136572,with,O,7023
136573,third-grade,O,7023
136574,binocular,O,7023
136575,vision,O,7023
136576,may,O,7023
136577,experience,O,7023
136578,constant,B-SIGN_AND_SYMPTOM,7023
136579,double,I-SIGN_AND_SYMPTOM,7023
136580,vision,I-SIGN_AND_SYMPTOM,7023
136581,or,I-SIGN_AND_SYMPTOM,7023
136582,eye,I-SIGN_AND_SYMPTOM,7023
136583,strain,I-SIGN_AND_SYMPTOM,7023
136584,and,I-SIGN_AND_SYMPTOM,7024
136585,may,I-SIGN_AND_SYMPTOM,7024
136586,have,I-SIGN_AND_SYMPTOM,7024
136587,difficulty,I-SIGN_AND_SYMPTOM,7024
136588,with,I-SIGN_AND_SYMPTOM,7024
136589,depth,I-SIGN_AND_SYMPTOM,7024
136590,perception,I-SIGN_AND_SYMPTOM,7024
136591,This,O,7024
136592,condition,O,7024
136593,can,O,7024
136594,lead,O,7024
136595,to,O,7024
136596,amblyopia,B-NAME_OF_DISEASE,7024
136597,lazy,B-NAME_OF_DISEASE,7024
136598,eye,I-NAME_OF_DISEASE,7024
136599,if,O,7024
136600,not,O,7024
136601,treated,O,7024
136602,promptly,O,7024
136603,What,O,7024
136604,Causes,O,7024
136605,Binocular,B-NAME_OF_DISEASE,7024
136606,Vision,I-NAME_OF_DISEASE,7024
136607,Dysfunction,I-NAME_OF_DISEASE,7024
136608,Binocular,B-NAME_OF_DISEASE,7024
136609,vision,I-NAME_OF_DISEASE,7024
136610,dysfunction,I-NAME_OF_DISEASE,7024
136611,can,O,7024
136612,cause,O,7024
136613,a,O,7024
136614,variety,O,7024
136615,of,O,7024
136616,symptoms,O,7024
136617,including,O,7024
136618,double,B-SIGN_AND_SYMPTOM,7024
136619,vision,I-SIGN_AND_SYMPTOM,7024
136620,blurred,I-SIGN_AND_SYMPTOM,7024
136621,vision,I-SIGN_AND_SYMPTOM,7024
136622,and,I-SIGN_AND_SYMPTOM,7024
136623,headaches,I-SIGN_AND_SYMPTOM,7025
136624,The,O,7025
136625,causes,O,7025
136626,of,O,7025
136627,binocular,B-NAME_OF_DISEASE,7025
136628,vision,I-NAME_OF_DISEASE,7025
136629,dysfunction,I-NAME_OF_DISEASE,7025
136630,can,O,7025
136631,be,O,7025
136632,divided,O,7025
136633,into,O,7025
136634,several,O,7025
136635,categories,O,7025
136636,Accommodation,B-CAUSE_OF_DISEASE,7025
136637,disorders,I-CAUSE_OF_DISEASE,7025
136638,Accommodation,B-CAUSE_OF_DISEASE,7025
136639,disorders,I-CAUSE_OF_DISEASE,7025
136640,occur,O,7025
136641,when,O,7025
136642,the,O,7025
136643,eye,O,7025
136644,s,O,7025
136645,ability,O,7025
136646,to,O,7025
136647,adjust,O,7025
136648,its,O,7025
136649,focus,O,7025
136650,on,O,7026
136651,an,O,7026
136652,object,O,7026
136653,at,O,7026
136654,different,O,7026
136655,distances,O,7026
136656,is,O,7026
136657,impaired,O,7026
136658,This,O,7026
136659,can,O,7026
136660,lead,O,7026
136661,to,O,7026
136662,binocular,B-NAME_OF_DISEASE,7026
136663,vision,I-NAME_OF_DISEASE,7026
136664,dysfunction,I-NAME_OF_DISEASE,7027
136665,especially,O,7027
136666,when,O,7027
136667,trying,O,7027
136668,to,O,7027
136669,focus,O,7027
136670,on,O,7027
136671,near,O,7027
136672,objects,O,7027
136673,Neurological,B-CAUSE_OF_DISEASE,7027
136674,conditions,I-CAUSE_OF_DISEASE,7027
136675,Certain,B-CAUSE_OF_DISEASE,7027
136676,neurological,I-CAUSE_OF_DISEASE,7027
136677,conditions,I-CAUSE_OF_DISEASE,7027
136678,such,I-CAUSE_OF_DISEASE,7027
136679,as,I-CAUSE_OF_DISEASE,7027
136680,brain,I-CAUSE_OF_DISEASE,7027
136681,injury,I-CAUSE_OF_DISEASE,7027
136682,stroke,I-CAUSE_OF_DISEASE,7027
136683,or,I-CAUSE_OF_DISEASE,7027
136684,brain,I-CAUSE_OF_DISEASE,7027
136685,tumor,I-CAUSE_OF_DISEASE,7027
136686,can,O,7027
136687,cause,O,7027
136688,binocular,B-NAME_OF_DISEASE,7027
136689,vision,I-NAME_OF_DISEASE,7027
136690,dysfunction,I-NAME_OF_DISEASE,7027
136691,These,O,7028
136692,conditions,O,7028
136693,can,O,7028
136694,affect,O,7028
136695,the,O,7028
136696,nerve,O,7028
136697,pathways,O,7028
136698,that,O,7029
136699,control,O,7029
136700,eye,O,7029
136701,movement,O,7029
136702,and,O,7029
136703,alignment,O,7029
136704,Trauma,B-CAUSE_OF_DISEASE,7029
136705,Trauma,B-CAUSE_OF_DISEASE,7029
136706,to,I-CAUSE_OF_DISEASE,7029
136707,the,I-CAUSE_OF_DISEASE,7029
136708,eyes,I-CAUSE_OF_DISEASE,7029
136709,head,I-CAUSE_OF_DISEASE,7029
136710,or,I-CAUSE_OF_DISEASE,7029
136711,brain,I-CAUSE_OF_DISEASE,7029
136712,can,O,7029
136713,cause,O,7029
136714,binocular,B-NAME_OF_DISEASE,7030
136715,vision,I-NAME_OF_DISEASE,7030
136716,dysfunction,I-NAME_OF_DISEASE,7030
136717,such,O,7030
136718,as,O,7030
136719,a,B-CAUSE_OF_DISEASE,7030
136720,concussion,I-CAUSE_OF_DISEASE,7030
136721,or,I-CAUSE_OF_DISEASE,7030
136722,a,I-CAUSE_OF_DISEASE,7030
136723,skull,I-CAUSE_OF_DISEASE,7030
136724,fracture,I-CAUSE_OF_DISEASE,7030
136725,Exercises,O,7030
136726,for,O,7030
136727,Binocular,B-NAME_OF_DISEASE,7030
136728,Vision,I-NAME_OF_DISEASE,7030
136729,Dysfunction,I-NAME_OF_DISEASE,7030
136730,While,O,7030
136731,some,O,7030
136732,causes,O,7030
136733,of,O,7030
136734,binocular,B-NAME_OF_DISEASE,7030
136735,vision,I-NAME_OF_DISEASE,7030
136736,dysfunction,I-NAME_OF_DISEASE,7030
136737,may,O,7030
136738,require,O,7030
136739,medical,B-TREATMENT,7030
136740,intervention,I-TREATMENT,7030
136741,such,I-TREATMENT,7031
136742,as,I-TREATMENT,7031
136743,corrective,I-TREATMENT,7031
136744,lenses,I-TREATMENT,7031
136745,or,I-TREATMENT,7031
136746,surgery,I-TREATMENT,7031
136747,certain,B-TREATMENT,7031
136748,exercises,I-TREATMENT,7031
136749,can,O,7031
136750,help,O,7031
136751,improve,O,7031
136752,the,O,7031
136753,brain,O,7031
136754,s,O,7031
136755,ability,O,7031
136756,to,O,7032
136757,coordinate,O,7032
136758,the,O,7032
136759,eyes,O,7032
136760,and,O,7032
136761,improve,O,7032
136762,binocular,O,7032
136763,vision,O,7032
136764,Here,O,7032
136765,are,O,7032
136766,some,O,7032
136767,exercises,O,7032
136768,that,O,7032
136769,can,O,7032
136770,be,O,7033
136771,used,O,7033
136772,to,O,7033
136773,improve,O,7033
136774,binocular,B-NAME_OF_DISEASE,7033
136775,vision,I-NAME_OF_DISEASE,7033
136776,dysfunction,I-NAME_OF_DISEASE,7033
136777,Pencil,B-TREATMENT,7033
136778,push-ups,I-TREATMENT,7033
136779,Hold,O,7033
136780,a,O,7033
136781,pencil,O,7033
136782,at,O,7033
136783,arm,O,7033
136784,s,O,7033
136785,length,O,7033
136786,in,O,7033
136787,front,O,7033
136788,of,O,7033
136789,your,O,7033
136790,face,O,7033
136791,Slowly,O,7034
136792,move,O,7034
136793,the,O,7034
136794,pencil,O,7034
136795,towards,O,7034
136796,your,O,7034
136797,nose,O,7034
136798,keeping,O,7034
136799,your,O,7034
136800,eyes,O,7034
136801,focused,O,7034
136802,on,O,7034
136803,the,O,7034
136804,pencil,O,7034
136805,Once,O,7034
136806,the,O,7034
136807,pencil,O,7034
136808,is,O,7034
136809,about,O,7034
136810,six,O,7034
136811,inches,O,7035
136812,from,O,7035
136813,your,O,7035
136814,nose,O,7035
136815,hold,O,7035
136816,the,O,7035
136817,position,O,7035
136818,for,O,7035
136819,a,O,7035
136820,few,O,7035
136821,seconds,O,7035
136822,and,O,7035
136823,then,O,7036
136824,move,O,7036
136825,the,O,7036
136826,pencil,O,7036
136827,back,O,7036
136828,to,O,7036
136829,arm,O,7036
136830,s,O,7036
136831,length,O,7036
136832,Repeat,O,7036
136833,this,O,7036
136834,exercise,O,7036
136835,several,O,7036
136836,times,O,7036
136837,a,O,7036
136838,day,O,7036
136839,Near-far,B-TREATMENT,7036
136840,focus,I-TREATMENT,7037
136841,Hold,O,7037
136842,a,O,7037
136843,pen,O,7037
136844,or,O,7037
136845,pencil,O,7037
136846,at,O,7037
136847,arm,O,7037
136848,s,O,7037
136849,length,O,7037
136850,in,O,7037
136851,front,O,7037
136852,of,O,7037
136853,your,O,7037
136854,face,O,7037
136855,Focus,O,7037
136856,on,O,7038
136857,the,O,7038
136858,pen,O,7038
136859,or,O,7038
136860,pencil,O,7038
136861,for,O,7038
136862,a,O,7038
136863,few,O,7038
136864,seconds,O,7038
136865,then,O,7038
136866,shift,O,7038
136867,your,O,7038
136868,focus,O,7038
136869,to,O,7038
136870,an,O,7038
136871,object,O,7038
136872,in,O,7038
136873,the,O,7038
136874,distance,O,7038
136875,such,O,7038
136876,as,O,7038
136877,a,O,7038
136878,clock,O,7038
136879,on,O,7038
136880,the,O,7038
136881,wall,O,7039
136882,Alternate,O,7039
136883,focusing,O,7039
136884,on,O,7039
136885,the,O,7039
136886,pen,O,7039
136887,or,O,7039
136888,pencil,O,7039
136889,and,O,7039
136890,the,O,7039
136891,distant,O,7039
136892,object,O,7039
136893,for,O,7039
136894,a,O,7039
136895,few,O,7039
136896,minutes,O,7039
136897,Eye,B-TREATMENT,7039
136898,movement,I-TREATMENT,7039
136899,exercises,I-TREATMENT,7039
136900,These,O,7040
136901,exercises,O,7040
136902,are,O,7040
136903,designed,O,7040
136904,to,O,7040
136905,help,O,7040
136906,the,O,7040
136907,eyes,O,7040
136908,move,O,7040
136909,in,O,7040
136910,coordination,O,7040
136911,Examples,O,7040
136912,include,O,7040
136913,moving,O,7040
136914,the,O,7040
136915,eyes,O,7040
136916,in,O,7040
136917,the,O,7040
136918,shape,O,7040
136919,of,O,7040
136920,a,O,7040
136921,H,O,7040
136922,or,O,7040
136923,X,O,7040
136924,or,O,7040
136925,following,O,7040
136926,a,O,7040
136927,moving,O,7040
136928,object,O,7041
136929,with,O,7041
136930,the,O,7041
136931,eyes,O,7041
136932,Vision,B-TREATMENT,7041
136933,Therapy,I-TREATMENT,7041
136934,Vision,B-TREATMENT,7041
136935,therapy,I-TREATMENT,7041
136936,is,O,7041
136937,a,O,7041
136938,type,O,7041
136939,of,O,7041
136940,rehabilitation,O,7041
136941,that,O,7041
136942,helps,O,7041
136943,to,O,7041
136944,improve,O,7041
136945,visual,O,7041
136946,skills,O,7041
136947,and,O,7041
136948,coordination,O,7041
136949,of,O,7041
136950,the,O,7041
136951,eyes,O,7042
136952,This,O,7042
136953,can,O,7042
136954,include,O,7042
136955,exercises,O,7042
136956,to,O,7042
136957,improve,O,7042
136958,eye,O,7042
136959,tracking,O,7042
136960,focusing,O,7042
136961,and,O,7042
136962,eye-teaming,O,7042
136963,abilities,O,7042
136964,Prism,B-TREATMENT,7042
136965,glasses,I-TREATMENT,7042
136966,Prism,B-TREATMENT,7042
136967,glasses,I-TREATMENT,7042
136968,are,O,7042
136969,specially,O,7043
136970,designed,O,7043
136971,glasses,O,7043
136972,that,O,7043
136973,can,O,7043
136974,help,O,7043
136975,align,O,7043
136976,the,O,7043
136977,eyes,O,7043
136978,by,O,7043
136979,bending,O,7043
136980,light,O,7043
136981,They,O,7043
136982,are,O,7043
136983,often,O,7043
136984,used,O,7043
136985,in,O,7043
136986,vision,B-TREATMENT,7043
136987,therapy,I-TREATMENT,7043
136988,to,O,7043
136989,help,O,7043
136990,correct,O,7043
136991,double,O,7043
136992,vision,O,7043
136993,and,O,7044
136994,improve,O,7044
136995,eye,O,7044
136996,coordination,O,7044
136997,Palming,B-TREATMENT,7044
136998,This,O,7044
136999,exercise,O,7044
137000,involves,O,7044
137001,covering,O,7044
137002,the,O,7044
137003,eyes,O,7044
137004,with,O,7044
137005,the,O,7044
137006,palms,O,7044
137007,of,O,7044
137008,the,O,7044
137009,hands,O,7044
137010,for,O,7044
137011,a,O,7044
137012,few,O,7044
137013,minutes,O,7045
137014,to,O,7045
137015,relax,O,7045
137016,the,O,7045
137017,eyes,O,7045
137018,and,O,7045
137019,improve,O,7045
137020,eye,O,7045
137021,coordination,O,7045
137022,Conclusion,O,7045
137023,In,O,7045
137024,conclusion,O,7045
137025,binocular,B-NAME_OF_DISEASE,7045
137026,vision,I-NAME_OF_DISEASE,7045
137027,dysfunction,I-NAME_OF_DISEASE,7045
137028,can,O,7045
137029,cause,O,7045
137030,a,O,7045
137031,variety,O,7045
137032,of,O,7045
137033,symptoms,O,7045
137034,including,O,7045
137035,double,B-SIGN_AND_SYMPTOM,7045
137036,vision,I-SIGN_AND_SYMPTOM,7046
137037,blurred,I-SIGN_AND_SYMPTOM,7046
137038,vision,I-SIGN_AND_SYMPTOM,7046
137039,and,I-SIGN_AND_SYMPTOM,7046
137040,headaches,I-SIGN_AND_SYMPTOM,7046
137041,While,O,7046
137042,some,O,7046
137043,causes,O,7046
137044,of,O,7046
137045,binocular,B-NAME_OF_DISEASE,7046
137046,vision,I-NAME_OF_DISEASE,7046
137047,dysfunction,I-NAME_OF_DISEASE,7046
137048,may,O,7046
137049,require,O,7046
137050,medical,B-TREATMENT,7046
137051,intervention,I-TREATMENT,7046
137052,certain,B-TREATMENT,7046
137053,exercises,I-TREATMENT,7046
137054,can,O,7046
137055,help,O,7047
137056,improve,O,7047
137057,the,O,7047
137058,brain,O,7047
137059,s,O,7047
137060,ability,O,7047
137061,to,O,7047
137062,coordinate,O,7047
137063,the,O,7047
137064,eyes,O,7047
137065,and,O,7047
137066,improve,O,7047
137067,binocular,O,7047
137068,vision,O,7047
137069,What,O,7047
137070,Is,O,7047
137071,Ocular,B-NAME_OF_DISEASE,7047
137072,Migraine,I-NAME_OF_DISEASE,7048
137073,Ocular,B-NAME_OF_DISEASE,7048
137074,migraine,I-NAME_OF_DISEASE,7048
137075,also,O,7048
137076,known,O,7048
137077,as,O,7048
137078,retinal,B-NAME_OF_DISEASE,7048
137079,migraine,I-NAME_OF_DISEASE,7048
137080,is,O,7048
137081,a,O,7048
137082,type,O,7048
137083,of,O,7048
137084,migraine,B-NAME_OF_DISEASE,7048
137085,headache,I-NAME_OF_DISEASE,7048
137086,that,O,7048
137087,is,O,7048
137088,accompanied,O,7048
137089,by,O,7048
137090,visual,B-SIGN_AND_SYMPTOM,7048
137091,disturbances,I-SIGN_AND_SYMPTOM,7048
137092,It,O,7048
137093,affects,O,7049
137094,about,O,7049
137095,3%,O,7049
137096,of,O,7049
137097,the,O,7049
137098,general,O,7049
137099,population,O,7049
137100,and,O,7049
137101,it,O,7049
137102,is,O,7049
137103,more,O,7049
137104,common,O,7049
137105,in,O,7049
137106,women,O,7049
137107,than,O,7049
137108,in,O,7049
137109,men,O,7050
137110,What,O,7050
137111,Causes,O,7050
137112,Ocular,B-NAME_OF_DISEASE,7050
137113,Migraine,I-NAME_OF_DISEASE,7050
137114,While,O,7050
137115,the,O,7050
137116,exact,O,7050
137117,cause,O,7050
137118,of,O,7050
137119,ocular,B-NAME_OF_DISEASE,7050
137120,migraines,I-NAME_OF_DISEASE,7050
137121,is,O,7050
137122,not,O,7050
137123,fully,O,7050
137124,understood,O,7050
137125,there,O,7050
137126,are,O,7050
137127,several,O,7051
137128,factors,O,7051
137129,that,O,7051
137130,may,O,7051
137131,trigger,O,7051
137132,an,O,7051
137133,attack,O,7051
137134,Here,O,7051
137135,are,O,7051
137136,some,O,7051
137137,common,O,7051
137138,causes,O,7051
137139,of,O,7051
137140,ocular,B-NAME_OF_DISEASE,7051
137141,migraines,I-NAME_OF_DISEASE,7051
137142,Stress,B-CAUSE_OF_DISEASE,7051
137143,Stress,B-CAUSE_OF_DISEASE,7051
137144,is,O,7051
137145,one,O,7051
137146,of,O,7051
137147,the,O,7051
137148,most,O,7051
137149,common,O,7051
137150,triggers,O,7051
137151,for,O,7052
137152,ocular,B-NAME_OF_DISEASE,7052
137153,migraines,I-NAME_OF_DISEASE,7052
137154,Stress,B-CAUSE_OF_DISEASE,7052
137155,can,O,7052
137156,cause,O,7052
137157,changes,B-CAUSE_OF_DISEASE,7052
137158,in,I-CAUSE_OF_DISEASE,7052
137159,blood,I-CAUSE_OF_DISEASE,7052
137160,flow,I-CAUSE_OF_DISEASE,7052
137161,and,O,7052
137162,can,O,7052
137163,lead,O,7052
137164,to,O,7052
137165,the,B-CAUSE_OF_DISEASE,7052
137166,constriction,I-CAUSE_OF_DISEASE,7052
137167,or,I-CAUSE_OF_DISEASE,7052
137168,dilation,I-CAUSE_OF_DISEASE,7052
137169,of,I-CAUSE_OF_DISEASE,7052
137170,blood,I-CAUSE_OF_DISEASE,7052
137171,vessels,I-CAUSE_OF_DISEASE,7052
137172,which,O,7052
137173,can,O,7052
137174,trigger,O,7052
137175,a,B-NAME_OF_DISEASE,7052
137176,migraine,I-NAME_OF_DISEASE,7052
137177,Lack,B-CAUSE_OF_DISEASE,7052
137178,of,I-CAUSE_OF_DISEASE,7052
137179,sleep,I-CAUSE_OF_DISEASE,7052
137180,Not,B-CAUSE_OF_DISEASE,7052
137181,getting,I-CAUSE_OF_DISEASE,7052
137182,enough,I-CAUSE_OF_DISEASE,7052
137183,sleep,I-CAUSE_OF_DISEASE,7052
137184,or,I-CAUSE_OF_DISEASE,7052
137185,having,I-CAUSE_OF_DISEASE,7052
137186,disrupted,I-CAUSE_OF_DISEASE,7052
137187,sleep,I-CAUSE_OF_DISEASE,7052
137188,patterns,I-CAUSE_OF_DISEASE,7052
137189,can,O,7053
137190,increase,O,7053
137191,the,O,7053
137192,risk,O,7053
137193,of,O,7053
137194,ocular,B-NAME_OF_DISEASE,7053
137195,migraines,I-NAME_OF_DISEASE,7053
137196,Bright,B-CAUSE_OF_DISEASE,7053
137197,lights,I-CAUSE_OF_DISEASE,7053
137198,Bright,B-CAUSE_OF_DISEASE,7053
137199,lights,I-CAUSE_OF_DISEASE,7053
137200,especially,I-CAUSE_OF_DISEASE,7053
137201,flickering,I-CAUSE_OF_DISEASE,7053
137202,or,I-CAUSE_OF_DISEASE,7053
137203,pulsating,I-CAUSE_OF_DISEASE,7053
137204,lights,I-CAUSE_OF_DISEASE,7053
137205,can,O,7054
137206,trigger,O,7054
137207,an,O,7054
137208,ocular,B-NAME_OF_DISEASE,7054
137209,migraine,I-NAME_OF_DISEASE,7054
137210,in,O,7054
137211,some,O,7054
137212,people,O,7054
137213,Hormonal,B-CAUSE_OF_DISEASE,7054
137214,changes,I-CAUSE_OF_DISEASE,7054
137215,Ocular,B-NAME_OF_DISEASE,7054
137216,migraines,I-NAME_OF_DISEASE,7054
137217,may,O,7054
137218,be,O,7054
137219,more,O,7054
137220,common,O,7054
137221,in,O,7054
137222,women,O,7054
137223,due,O,7054
137224,to,O,7054
137225,hormonal,B-CAUSE_OF_DISEASE,7054
137226,fluctuations,I-CAUSE_OF_DISEASE,7054
137227,that,I-CAUSE_OF_DISEASE,7054
137228,occur,I-CAUSE_OF_DISEASE,7054
137229,during,I-CAUSE_OF_DISEASE,7054
137230,menstruation,I-CAUSE_OF_DISEASE,7054
137231,pregnancy,I-CAUSE_OF_DISEASE,7054
137232,and,I-CAUSE_OF_DISEASE,7054
137233,menopause,I-CAUSE_OF_DISEASE,7055
137234,Medications,B-CAUSE_OF_DISEASE,7055
137235,Some,O,7055
137236,medications,B-CAUSE_OF_DISEASE,7055
137237,such,I-CAUSE_OF_DISEASE,7055
137238,as,I-CAUSE_OF_DISEASE,7055
137239,oral,I-CAUSE_OF_DISEASE,7055
137240,contraceptives,I-CAUSE_OF_DISEASE,7055
137241,and,I-CAUSE_OF_DISEASE,7055
137242,vasodilators,I-CAUSE_OF_DISEASE,7055
137243,may,O,7055
137244,increase,O,7055
137245,the,O,7055
137246,risk,O,7055
137247,of,O,7055
137248,ocular,B-NAME_OF_DISEASE,7055
137249,migraines,I-NAME_OF_DISEASE,7055
137250,Caffeine,B-CAUSE_OF_DISEASE,7055
137251,and,I-CAUSE_OF_DISEASE,7055
137252,alcohol,I-CAUSE_OF_DISEASE,7055
137253,Consuming,B-CAUSE_OF_DISEASE,7055
137254,large,I-CAUSE_OF_DISEASE,7055
137255,amounts,I-CAUSE_OF_DISEASE,7055
137256,of,I-CAUSE_OF_DISEASE,7055
137257,caffeine,I-CAUSE_OF_DISEASE,7055
137258,or,I-CAUSE_OF_DISEASE,7055
137259,alcohol,I-CAUSE_OF_DISEASE,7055
137260,may,O,7055
137261,trigger,O,7055
137262,an,O,7056
137263,ocular,B-NAME_OF_DISEASE,7056
137264,migraine,I-NAME_OF_DISEASE,7056
137265,in,O,7056
137266,some,O,7056
137267,people,O,7056
137268,Certain,B-CAUSE_OF_DISEASE,7056
137269,foods,I-CAUSE_OF_DISEASE,7056
137270,Some,O,7056
137271,people,O,7056
137272,may,O,7056
137273,be,O,7056
137274,more,O,7056
137275,sensitive,B-CAUSE_OF_DISEASE,7056
137276,to,I-CAUSE_OF_DISEASE,7056
137277,certain,I-CAUSE_OF_DISEASE,7056
137278,foods,I-CAUSE_OF_DISEASE,7056
137279,such,I-CAUSE_OF_DISEASE,7056
137280,as,I-CAUSE_OF_DISEASE,7056
137281,aged,I-CAUSE_OF_DISEASE,7056
137282,cheeses,I-CAUSE_OF_DISEASE,7056
137283,processed,I-CAUSE_OF_DISEASE,7056
137284,meats,I-CAUSE_OF_DISEASE,7056
137285,and,I-CAUSE_OF_DISEASE,7056
137286,chocolate,I-CAUSE_OF_DISEASE,7056
137287,which,O,7056
137288,can,O,7056
137289,trigger,O,7056
137290,ocular,B-NAME_OF_DISEASE,7056
137291,migraines,I-NAME_OF_DISEASE,7057
137292,What,O,7057
137293,Are,O,7057
137294,the,O,7057
137295,Symptoms,O,7057
137296,of,O,7057
137297,an,B-NAME_OF_DISEASE,7057
137298,Ocular,B-NAME_OF_DISEASE,7057
137299,Migraine,I-NAME_OF_DISEASE,7057
137300,The,O,7057
137301,most,O,7057
137302,common,O,7057
137303,symptom,O,7057
137304,of,O,7057
137305,an,B-NAME_OF_DISEASE,7057
137306,ocular,B-NAME_OF_DISEASE,7057
137307,migraine,I-NAME_OF_DISEASE,7057
137308,is,O,7057
137309,a,B-SIGN_AND_SYMPTOM,7057
137310,visual,I-SIGN_AND_SYMPTOM,7057
137311,disturbance,I-SIGN_AND_SYMPTOM,7057
137312,which,I-SIGN_AND_SYMPTOM,7057
137313,can,I-SIGN_AND_SYMPTOM,7057
137314,take,I-SIGN_AND_SYMPTOM,7057
137315,the,I-SIGN_AND_SYMPTOM,7057
137316,form,I-SIGN_AND_SYMPTOM,7057
137317,of,I-SIGN_AND_SYMPTOM,7057
137318,flashing,I-SIGN_AND_SYMPTOM,7057
137319,lights,I-SIGN_AND_SYMPTOM,7057
137320,zigzag,I-SIGN_AND_SYMPTOM,7057
137321,lines,I-SIGN_AND_SYMPTOM,7058
137322,or,I-SIGN_AND_SYMPTOM,7058
137323,blind,I-SIGN_AND_SYMPTOM,7058
137324,spots,I-SIGN_AND_SYMPTOM,7058
137325,in,I-SIGN_AND_SYMPTOM,7058
137326,the,I-SIGN_AND_SYMPTOM,7058
137327,field,I-SIGN_AND_SYMPTOM,7058
137328,of,I-SIGN_AND_SYMPTOM,7058
137329,vision,I-SIGN_AND_SYMPTOM,7058
137330,These,O,7058
137331,visual,B-SIGN_AND_SYMPTOM,7058
137332,disturbances,I-SIGN_AND_SYMPTOM,7058
137333,are,O,7058
137334,usually,O,7058
137335,temporary,O,7058
137336,and,O,7058
137337,may,O,7058
137338,last,O,7058
137339,for,O,7058
137340,a,O,7058
137341,few,O,7058
137342,minutes,O,7058
137343,to,O,7058
137344,an,O,7058
137345,hour,O,7059
137346,Other,O,7059
137347,symptoms,O,7059
137348,of,O,7059
137349,ocular,B-NAME_OF_DISEASE,7059
137350,migraines,I-NAME_OF_DISEASE,7059
137351,may,O,7059
137352,include,O,7059
137353,Headache,B-SIGN_AND_SYMPTOM,7059
137354,Ocular,B-NAME_OF_DISEASE,7059
137355,migraines,I-NAME_OF_DISEASE,7059
137356,may,O,7059
137357,be,O,7059
137358,accompanied,O,7060
137359,by,O,7060
137360,a,B-SIGN_AND_SYMPTOM,7060
137361,headache,I-SIGN_AND_SYMPTOM,7060
137362,that,I-SIGN_AND_SYMPTOM,7060
137363,is,I-SIGN_AND_SYMPTOM,7060
137364,typically,I-SIGN_AND_SYMPTOM,7060
137365,one-sided,I-SIGN_AND_SYMPTOM,7060
137366,and,I-SIGN_AND_SYMPTOM,7061
137367,may,I-SIGN_AND_SYMPTOM,7061
137368,be,I-SIGN_AND_SYMPTOM,7061
137369,throbbing,I-SIGN_AND_SYMPTOM,7061
137370,or,I-SIGN_AND_SYMPTOM,7061
137371,pulsating,I-SIGN_AND_SYMPTOM,7061
137372,in,I-SIGN_AND_SYMPTOM,7061
137373,nature,I-SIGN_AND_SYMPTOM,7061
137374,Partial,B-SIGN_AND_SYMPTOM,7061
137375,or,I-SIGN_AND_SYMPTOM,7061
137376,total,I-SIGN_AND_SYMPTOM,7061
137377,loss,I-SIGN_AND_SYMPTOM,7061
137378,in,I-SIGN_AND_SYMPTOM,7061
137379,one,I-SIGN_AND_SYMPTOM,7061
137380,eye,I-SIGN_AND_SYMPTOM,7061
137381,This,O,7062
137382,usually,O,7062
137383,lasts,O,7062
137384,10,B-TIME_DURATION,7062
137385,to,I-TIME_DURATION,7062
137386,20,I-TIME_DURATION,7062
137387,minutes,I-TIME_DURATION,7062
137388,before,O,7062
137389,vision,O,7062
137390,gradually,O,7062
137391,returns,O,7062
137392,An,O,7062
137393,image,O,7062
137394,showing,O,7062
137395,what,O,7062
137396,happens,O,7062
137397,to,O,7062
137398,vision,O,7063
137399,when,O,7063
137400,ocular,B-NAME_OF_DISEASE,7063
137401,migraine,I-NAME_OF_DISEASE,7063
137402,occurrs,O,7063
137403,Can,O,7063
137404,Ocular,B-NAME_OF_DISEASE,7063
137405,Migraine,I-NAME_OF_DISEASE,7063
137406,Cause,O,7063
137407,Permanent,B-NAME_OF_DISEASE,7063
137408,Vision,I-NAME_OF_DISEASE,7063
137409,Loss,I-NAME_OF_DISEASE,7064
137410,Visual,B-SIGN_AND_SYMPTOM,7064
137411,disturbances,I-SIGN_AND_SYMPTOM,7064
137412,caused,O,7064
137413,by,O,7064
137414,ocular,B-NAME_OF_DISEASE,7064
137415,migraines,I-NAME_OF_DISEASE,7064
137416,are,O,7064
137417,usually,O,7064
137418,temporary,O,7064
137419,and,O,7064
137420,will,O,7064
137421,resolve,O,7064
137422,on,O,7064
137423,their,O,7064
137424,own,O,7064
137425,within,B-TIME_DURATION,7064
137426,a,I-TIME_DURATION,7064
137427,few,I-TIME_DURATION,7064
137428,minutes,I-TIME_DURATION,7064
137429,to,I-TIME_DURATION,7064
137430,an,I-TIME_DURATION,7065
137431,hour,I-TIME_DURATION,7065
137432,In,O,7065
137433,rare,O,7065
137434,cases,O,7065
137435,ocular,B-NAME_OF_DISEASE,7065
137436,migraines,I-NAME_OF_DISEASE,7065
137437,may,O,7065
137438,be,O,7065
137439,a,O,7065
137440,sign,O,7065
137441,of,O,7065
137442,a,O,7065
137443,more,O,7065
137444,serious,O,7065
137445,underlying,O,7065
137446,problem,O,7065
137447,such,O,7065
137448,as,O,7065
137449,a,B-CAUSE_OF_DISEASE,7065
137450,brain,I-CAUSE_OF_DISEASE,7065
137451,tumor,I-CAUSE_OF_DISEASE,7065
137452,or,O,7065
137453,an,B-CAUSE_OF_DISEASE,7065
137454,arterial,I-CAUSE_OF_DISEASE,7066
137455,blockage,I-CAUSE_OF_DISEASE,7066
137456,which,O,7066
137457,can,O,7066
137458,cause,O,7066
137459,permanent,B-NAME_OF_DISEASE,7066
137460,vision,I-NAME_OF_DISEASE,7066
137461,loss,I-NAME_OF_DISEASE,7066
137462,Managing,O,7066
137463,Ocular,B-NAME_OF_DISEASE,7066
137464,Migraines,I-NAME_OF_DISEASE,7066
137465,Medications,B-TREATMENT,7066
137466,There,O,7066
137467,are,O,7066
137468,several,O,7066
137469,medications,B-TREATMENT,7066
137470,that,O,7066
137471,can,O,7066
137472,be,O,7066
137473,used,O,7066
137474,to,O,7066
137475,treat,O,7066
137476,ocular,B-NAME_OF_DISEASE,7066
137477,migraines,I-NAME_OF_DISEASE,7067
137478,including,O,7067
137479,triptans,B-NAME_OF_DRUG,7067
137480,and,O,7067
137481,nonsteroidal,B-NAME_OF_DRUG,7067
137482,anti-inflammatory,I-NAME_OF_DRUG,7067
137483,drugs,I-NAME_OF_DRUG,7067
137484,NSAIDs,B-NAME_OF_DRUG,7067
137485,,O,7067
137486,Triptans,B-NAME_OF_DRUG,7067
137487,work,O,7067
137488,by,O,7067
137489,constricting,O,7067
137490,blood,O,7067
137491,vessels,O,7067
137492,in,O,7067
137493,the,O,7067
137494,brain,O,7067
137495,and,O,7067
137496,relieving,O,7067
137497,headache,B-SIGN_AND_SYMPTOM,7067
137498,pain,I-SIGN_AND_SYMPTOM,7067
137499,NSAIDs,B-NAME_OF_DRUG,7067
137500,work,O,7067
137501,by,O,7067
137502,reducing,O,7067
137503,inflammation,O,7067
137504,and,O,7067
137505,relieving,O,7067
137506,pain,O,7067
137507,Your,O,7067
137508,healthcare,O,7067
137509,provider,O,7067
137510,can,O,7067
137511,recommend,O,7067
137512,the,O,7068
137513,appropriate,O,7068
137514,medication,O,7068
137515,for,O,7068
137516,you,O,7068
137517,based,O,7068
137518,on,O,7068
137519,your,O,7068
137520,specific,O,7068
137521,needs,O,7068
137522,Preventive,O,7068
137523,medications,B-TREATMENT,7068
137524,In,O,7068
137525,some,O,7069
137526,cases,O,7069
137527,preventive,O,7069
137528,medications,B-TREATMENT,7069
137529,may,O,7069
137530,be,O,7069
137531,used,O,7069
137532,to,O,7069
137533,reduce,O,7069
137534,the,O,7069
137535,frequency,O,7069
137536,of,O,7069
137537,ocular,B-NAME_OF_DISEASE,7069
137538,migraines,I-NAME_OF_DISEASE,7069
137539,Preventive,O,7069
137540,medications,B-TREATMENT,7069
137541,may,O,7069
137542,include,O,7069
137543,beta,B-PREVENTION,7069
137544,blockers,I-PREVENTION,7069
137545,calcium,I-PREVENTION,7070
137546,channel,I-PREVENTION,7070
137547,blockers,I-PREVENTION,7070
137548,and,I-PREVENTION,7070
137549,anticonvulsants,I-PREVENTION,7070
137550,Alternative,B-TREATMENT,7070
137551,therapies,I-TREATMENT,7070
137552,Alternative,B-TREATMENT,7070
137553,therapies,I-TREATMENT,7070
137554,such,I-TREATMENT,7070
137555,as,I-TREATMENT,7070
137556,acupuncture,I-TREATMENT,7070
137557,chiropractic,I-TREATMENT,7070
137558,care,I-TREATMENT,7070
137559,and,I-TREATMENT,7071
137560,herbal,I-TREATMENT,7071
137561,remedies,I-TREATMENT,7071
137562,may,O,7071
137563,provide,O,7071
137564,relief,O,7071
137565,for,O,7071
137566,some,O,7071
137567,people,O,7071
137568,with,O,7071
137569,ocular,B-NAME_OF_DISEASE,7071
137570,migraines,I-NAME_OF_DISEASE,7071
137571,It,O,7071
137572,is,O,7071
137573,important,O,7071
137574,to,O,7071
137575,consult,O,7071
137576,with,O,7071
137577,a,O,7071
137578,healthcare,O,7071
137579,provider,O,7072
137580,before,O,7072
137581,using,O,7072
137582,any,O,7072
137583,alternative,O,7072
137584,therapies,O,7072
137585,to,O,7072
137586,ensure,O,7072
137587,that,O,7072
137588,they,O,7072
137589,are,O,7072
137590,safe,O,7072
137591,and,O,7072
137592,appropriate,O,7072
137593,for,O,7072
137594,you,O,7072
137595,Tips,O,7072
137596,to,O,7072
137597,Prevent,O,7072
137598,Ocular,B-NAME_OF_DISEASE,7072
137599,Migraines,I-NAME_OF_DISEASE,7073
137600,There,O,7073
137601,are,O,7073
137602,several,O,7073
137603,steps,O,7073
137604,that,O,7073
137605,you,O,7073
137606,can,O,7073
137607,take,O,7073
137608,to,O,7073
137609,help,O,7073
137610,prevent,O,7073
137611,or,O,7073
137612,reduce,O,7073
137613,the,O,7073
137614,frequency,O,7073
137615,of,O,7073
137616,ocular,B-NAME_OF_DISEASE,7073
137617,migraines,I-NAME_OF_DISEASE,7074
137618,Here,O,7074
137619,are,O,7074
137620,some,O,7074
137621,tips,O,7074
137622,for,O,7074
137623,preventing,O,7074
137624,ocular,B-NAME_OF_DISEASE,7074
137625,migraines,I-NAME_OF_DISEASE,7074
137626,Identify,B-PREVENTION,7074
137627,and,I-PREVENTION,7074
137628,avoid,I-PREVENTION,7074
137629,triggers,I-PREVENTION,7074
137630,Keeping,B-PREVENTION,7074
137631,a,I-PREVENTION,7074
137632,headache,I-PREVENTION,7074
137633,diary,I-PREVENTION,7075
137634,can,O,7075
137635,help,O,7075
137636,you,O,7075
137637,identify,O,7075
137638,any,O,7075
137639,potential,O,7075
137640,triggers,O,7075
137641,for,O,7075
137642,your,O,7075
137643,ocular,B-NAME_OF_DISEASE,7075
137644,migraines,I-NAME_OF_DISEASE,7075
137645,such,O,7075
137646,as,O,7075
137647,certain,B-CAUSE_OF_DISEASE,7075
137648,foods,I-CAUSE_OF_DISEASE,7075
137649,bright,I-CAUSE_OF_DISEASE,7075
137650,lights,I-CAUSE_OF_DISEASE,7075
137651,or,I-CAUSE_OF_DISEASE,7075
137652,stress,I-CAUSE_OF_DISEASE,7075
137653,Avoiding,O,7075
137654,or,O,7075
137655,minimizing,O,7075
137656,your,O,7075
137657,exposure,O,7075
137658,to,O,7075
137659,these,O,7075
137660,triggers,O,7075
137661,may,O,7075
137662,help,O,7075
137663,prevent,O,7075
137664,ocular,B-NAME_OF_DISEASE,7075
137665,migraines,I-NAME_OF_DISEASE,7075
137666,Get,B-PREVENTION,7076
137667,enough,I-PREVENTION,7076
137668,sleep,I-PREVENTION,7076
137669,Ensuring,B-PREVENTION,7076
137670,that,I-PREVENTION,7076
137671,you,I-PREVENTION,7076
137672,get,I-PREVENTION,7076
137673,enough,I-PREVENTION,7076
137674,sleep,I-PREVENTION,7076
137675,and,I-PREVENTION,7076
137676,maintaining,I-PREVENTION,7076
137677,a,I-PREVENTION,7076
137678,regular,I-PREVENTION,7076
137679,sleep,I-PREVENTION,7076
137680,schedule,I-PREVENTION,7076
137681,may,O,7076
137682,help,O,7076
137683,prevent,O,7076
137684,ocular,B-NAME_OF_DISEASE,7076
137685,migraines,I-NAME_OF_DISEASE,7077
137686,Exercise,B-PREVENTION,7077
137687,regularly,I-PREVENTION,7077
137688,Regular,B-PREVENTION,7077
137689,exercise,I-PREVENTION,7077
137690,may,O,7077
137691,help,O,7077
137692,reduce,O,7077
137693,the,O,7077
137694,frequency,O,7077
137695,and,O,7077
137696,severity,O,7077
137697,of,O,7077
137698,ocular,B-NAME_OF_DISEASE,7077
137699,migraines,I-NAME_OF_DISEASE,7077
137700,Practice,B-PREVENTION,7077
137701,stress,I-PREVENTION,7077
137702,management,I-PREVENTION,7077
137703,techniques,I-PREVENTION,7077
137704,Techniques,B-PREVENTION,7077
137705,such,I-PREVENTION,7077
137706,as,I-PREVENTION,7077
137707,deep,I-PREVENTION,7078
137708,breathing,I-PREVENTION,7078
137709,meditation,I-PREVENTION,7078
137710,and,I-PREVENTION,7078
137711,yoga,I-PREVENTION,7078
137712,may,O,7078
137713,help,O,7078
137714,reduce,O,7078
137715,stress,O,7078
137716,and,O,7078
137717,prevent,O,7078
137718,ocular,B-NAME_OF_DISEASE,7078
137719,migraines,I-NAME_OF_DISEASE,7078
137720,Eat,B-PREVENTION,7078
137721,a,I-PREVENTION,7078
137722,healthy,I-PREVENTION,7078
137723,diet,I-PREVENTION,7078
137724,A,B-PREVENTION,7078
137725,diet,I-PREVENTION,7078
137726,that,I-PREVENTION,7078
137727,is,I-PREVENTION,7078
137728,rich,I-PREVENTION,7079
137729,in,I-PREVENTION,7079
137730,fruits,I-PREVENTION,7079
137731,vegetables,I-PREVENTION,7079
137732,and,I-PREVENTION,7079
137733,whole,I-PREVENTION,7079
137734,grains,I-PREVENTION,7079
137735,may,O,7079
137736,help,O,7079
137737,prevent,O,7079
137738,ocular,B-NAME_OF_DISEASE,7079
137739,migraines,I-NAME_OF_DISEASE,7080
137740,Consider,B-PREVENTION,7080
137741,preventive,B-PREVENTION,7080
137742,medications,I-PREVENTION,7080
137743,In,O,7080
137744,some,O,7080
137745,cases,O,7080
137746,preventive,B-PREVENTION,7080
137747,medications,I-PREVENTION,7080
137748,may,O,7080
137749,be,O,7080
137750,used,O,7080
137751,to,O,7080
137752,reduce,O,7080
137753,the,O,7080
137754,frequency,O,7080
137755,of,O,7080
137756,ocular,B-NAME_OF_DISEASE,7080
137757,migraines,I-NAME_OF_DISEASE,7080
137758,Your,O,7080
137759,healthcare,O,7080
137760,provider,O,7080
137761,can,O,7080
137762,recommend,O,7080
137763,the,O,7080
137764,appropriate,O,7080
137765,preventive,O,7080
137766,medication,O,7080
137767,for,O,7080
137768,you,O,7081
137769,based,O,7081
137770,on,O,7081
137771,your,O,7081
137772,specific,O,7081
137773,needs,O,7081
137774,Durysta,B-NAME_OF_DRUG,7081
137775,bimatoprost,I-NAME_OF_DRUG,7081
137776,and,I-NAME_OF_DRUG,7081
137777,chloramphenicol,I-NAME_OF_DRUG,7081
137778,is,O,7081
137779,a,O,7081
137780,prescription,O,7081
137781,medication,O,7081
137782,produced,O,7081
137783,by,O,7081
137784,Allergan,B-ORGANIZATION,7082
137785,that,O,7082
137786,is,O,7082
137787,used,O,7082
137788,to,O,7082
137789,lower,O,7082
137790,intraocular,O,7082
137791,pressure,O,7082
137792,IOP,O,7082
137793,in,O,7082
137794,people,O,7082
137795,with,O,7082
137796,open-angle,B-NAME_OF_DISEASE,7082
137797,glaucoma,I-NAME_OF_DISEASE,7082
137798,or,O,7082
137799,ocular,B-NAME_OF_DISEASE,7082
137800,hypertension,I-NAME_OF_DISEASE,7082
137801,high,I-NAME_OF_DISEASE,7082
137802,pressure,I-NAME_OF_DISEASE,7082
137803,in,I-NAME_OF_DISEASE,7083
137804,the,I-NAME_OF_DISEASE,7083
137805,eye,I-NAME_OF_DISEASE,7083
137806,,O,7083
137807,It,O,7083
137808,is,O,7083
137809,a,O,7083
137810,combination,O,7083
137811,of,O,7083
137812,two,O,7083
137813,medications,O,7083
137814,bimatoprost,O,7083
137815,which,O,7083
137816,is,O,7083
137817,a,O,7083
137818,prostaglandin,O,7083
137819,analog,O,7083
137820,and,O,7083
137821,chloramphenicol,O,7083
137822,which,O,7083
137823,is,O,7083
137824,an,O,7083
137825,antibiotic,O,7083
137826,What,O,7083
137827,is,O,7084
137828,Chloramphenicol,B-NAME_OF_DRUG,7084
137829,Eye,I-NAME_OF_DRUG,7084
137830,Drop,I-NAME_OF_DRUG,7084
137831,Chloramphenicol,B-NAME_OF_DRUG,7084
137832,eye,I-NAME_OF_DRUG,7084
137833,drops,I-NAME_OF_DRUG,7084
137834,are,O,7084
137835,a,O,7084
137836,topical,O,7084
137837,medication,O,7084
137838,used,O,7084
137839,to,O,7084
137840,treat,O,7084
137841,infections,O,7084
137842,of,O,7084
137843,the,O,7084
137844,eye,O,7084
137845,and,O,7084
137846,surrounding,O,7084
137847,tissue,O,7084
137848,Chloramphenicol,B-NAME_OF_DRUG,7084
137849,is,O,7085
137850,an,O,7085
137851,antibiotic,O,7085
137852,that,O,7085
137853,is,O,7085
137854,effective,O,7085
137855,against,O,7085
137856,a,O,7085
137857,wide,O,7085
137858,variety,O,7085
137859,of,O,7085
137860,bacteria,O,7085
137861,including,O,7085
137862,those,O,7085
137863,that,O,7085
137864,are,O,7085
137865,resistant,O,7085
137866,to,O,7085
137867,other,O,7085
137868,antibiotics,O,7085
137869,It,O,7085
137870,works,O,7085
137871,by,O,7085
137872,inhibiting,O,7085
137873,the,O,7085
137874,growth,O,7086
137875,of,O,7086
137876,bacteria,O,7086
137877,and,O,7086
137878,killing,O,7086
137879,them,O,7086
137880,Chloramphenicol,B-NAME_OF_DRUG,7086
137881,eye,I-NAME_OF_DRUG,7086
137882,drops,I-NAME_OF_DRUG,7086
137883,are,O,7086
137884,usually,O,7086
137885,prescribed,O,7086
137886,for,O,7086
137887,infections,O,7086
137888,of,O,7086
137889,the,O,7086
137890,eye,O,7086
137891,and,O,7087
137892,surrounding,O,7087
137893,tissue,O,7087
137894,caused,O,7087
137895,by,O,7087
137896,bacteria,O,7087
137897,such,O,7087
137898,as,O,7087
137899,conjunctivitis,B-NAME_OF_DISEASE,7087
137900,pink,I-NAME_OF_DISEASE,7087
137901,eye,I-NAME_OF_DISEASE,7087
137902,and,O,7087
137903,keratitis,B-NAME_OF_DISEASE,7087
137904,inflammation,I-NAME_OF_DISEASE,7087
137905,of,I-NAME_OF_DISEASE,7087
137906,the,I-NAME_OF_DISEASE,7087
137907,cornea,I-NAME_OF_DISEASE,7087
137908,,O,7087
137909,They,O,7087
137910,are,O,7087
137911,typically,O,7088
137912,used,O,7088
137913,to,O,7088
137914,treat,O,7088
137915,severe,O,7088
137916,or,O,7088
137917,recurrent,O,7088
137918,infections,O,7088
137919,that,O,7088
137920,are,O,7088
137921,unresponsive,O,7088
137922,to,O,7088
137923,other,O,7088
137924,antibiotics,O,7088
137925,When,O,7088
137926,to,O,7088
137927,use,O,7088
137928,Chloramphenicol,B-NAME_OF_DRUG,7088
137929,Eye,I-NAME_OF_DRUG,7088
137930,Drops,I-NAME_OF_DRUG,7088
137931,Chloramphenicol,B-NAME_OF_DRUG,7088
137932,is,O,7088
137933,an,O,7088
137934,antibiotic,O,7088
137935,that,O,7088
137936,is,O,7088
137937,used,O,7089
137938,to,O,7089
137939,treat,O,7089
137940,infections,O,7089
137941,of,O,7089
137942,the,O,7089
137943,eye,O,7089
137944,It,O,7089
137945,is,O,7089
137946,typically,O,7089
137947,used,O,7089
137948,when,O,7089
137949,other,O,7089
137950,antibiotics,O,7089
137951,are,O,7089
137952,not,O,7089
137953,effective,O,7089
137954,or,O,7089
137955,when,O,7089
137956,the,O,7089
137957,infection,O,7089
137958,is,O,7089
137959,caused,O,7089
137960,by,O,7089
137961,bacteria,O,7089
137962,that,O,7089
137963,are,O,7090
137964,resistant,O,7090
137965,to,O,7090
137966,other,O,7090
137967,antibiotics,O,7090
137968,Your,O,7090
137969,doctor,O,7090
137970,may,O,7090
137971,prescribe,O,7090
137972,chloramphenicol,B-NAME_OF_DRUG,7090
137973,if,O,7090
137974,you,O,7090
137975,have,O,7090
137976,an,O,7090
137977,infection,O,7090
137978,of,O,7090
137979,the,O,7090
137980,eye,O,7090
137981,or,O,7090
137982,surrounding,O,7090
137983,tissues,O,7090
137984,such,O,7090
137985,as,O,7090
137986,conjunctivitis,B-NAME_OF_DISEASE,7090
137987,blepharitis,B-NAME_OF_DISEASE,7090
137988,or,O,7091
137989,keratitis,B-NAME_OF_DISEASE,7091
137990,It,O,7091
137991,is,O,7091
137992,important,O,7091
137993,to,O,7091
137994,use,O,7091
137995,chloramphenicol,B-NAME_OF_DRUG,7091
137996,only,O,7091
137997,as,O,7091
137998,directed,O,7091
137999,by,O,7091
138000,your,O,7091
138001,doctor,O,7091
138002,and,O,7091
138003,to,O,7091
138004,complete,O,7091
138005,the,O,7091
138006,entire,O,7091
138007,course,O,7091
138008,of,O,7091
138009,treatment,O,7091
138010,even,O,7091
138011,if,O,7091
138012,your,O,7092
138013,symptoms,O,7092
138014,improve,O,7092
138015,This,O,7092
138016,will,O,7092
138017,help,O,7092
138018,to,O,7092
138019,prevent,O,7092
138020,the,O,7092
138021,infection,O,7092
138022,from,O,7092
138023,returning,O,7092
138024,and,O,7092
138025,to,O,7092
138026,prevent,O,7092
138027,the,O,7092
138028,development,O,7093
138029,of,O,7093
138030,antibiotic,O,7093
138031,resistance,O,7093
138032,Who,O,7093
138033,Can,O,7093
138034,Use,O,7093
138035,It,O,7093
138036,It,O,7093
138037,is,O,7093
138038,usually,O,7093
138039,only,O,7093
138040,prescribed,O,7093
138041,by,O,7093
138042,doctors,O,7093
138043,for,O,7093
138044,serious,O,7093
138045,infections,O,7094
138046,that,O,7094
138047,are,O,7094
138048,resistant,O,7094
138049,to,O,7094
138050,other,O,7094
138051,antibiotics,O,7094
138052,If,O,7094
138053,you,O,7094
138054,have,O,7094
138055,an,O,7094
138056,infection,O,7094
138057,and,O,7094
138058,are,O,7094
138059,considering,O,7094
138060,taking,O,7094
138061,chloramphenicol,B-NAME_OF_DRUG,7094
138062,you,O,7094
138063,should,O,7094
138064,speak,O,7094
138065,with,O,7094
138066,a,O,7094
138067,healthcare,O,7094
138068,professional,O,7094
138069,for,O,7094
138070,guidance,O,7095
138071,on,O,7095
138072,the,O,7095
138073,appropriate,O,7095
138074,treatment,O,7095
138075,for,O,7095
138076,your,O,7095
138077,condition,O,7095
138078,Who,O,7095
138079,Can,O,7095
138080,Not,O,7095
138081,Use,O,7095
138082,It,O,7096
138083,Chloramphenicol,B-NAME_OF_DRUG,7096
138084,is,O,7096
138085,generally,O,7096
138086,not,O,7096
138087,recommended,O,7096
138088,for,O,7096
138089,use,O,7096
138090,in,O,7096
138091,children,O,7096
138092,pregnant,O,7096
138093,women,O,7096
138094,or,O,7096
138095,nursing,O,7096
138096,mothers,O,7096
138097,because,O,7096
138098,it,O,7096
138099,can,O,7096
138100,cause,O,7096
138101,serious,O,7096
138102,side,O,7096
138103,effects,O,7096
138104,It,O,7096
138105,is,O,7096
138106,also,O,7096
138107,not,O,7096
138108,recommended,O,7096
138109,for,O,7096
138110,use,O,7096
138111,in,O,7097
138112,animals,O,7097
138113,as,O,7097
138114,it,O,7097
138115,can,O,7097
138116,cause,O,7097
138117,serious,O,7097
138118,adverse,O,7097
138119,reactions,O,7097
138120,and,O,7097
138121,is,O,7097
138122,not,O,7097
138123,effective,O,7097
138124,against,O,7097
138125,certain,O,7097
138126,types,O,7097
138127,of,O,7097
138128,bacteria,O,7097
138129,Can,O,7097
138130,Chloramphenicol,B-NAME_OF_DRUG,7097
138131,Affect,O,7097
138132,Pregnancy,O,7098
138133,Fertility,O,7098
138134,or,O,7098
138135,Breastfeeding,O,7098
138136,Chloramphenicol,B-NAME_OF_DRUG,7098
138137,may,O,7098
138138,be,O,7098
138139,harmful,O,7098
138140,to,O,7098
138141,a,O,7098
138142,developing,O,7098
138143,fetus,O,7098
138144,and,O,7098
138145,it,O,7098
138146,is,O,7098
138147,not,O,7098
138148,recommended,O,7098
138149,for,O,7098
138150,use,O,7098
138151,during,O,7099
138152,pregnancy,O,7099
138153,Chloramphenicol,B-NAME_OF_DRUG,7099
138154,can,O,7099
138155,also,O,7099
138156,pass,O,7099
138157,into,O,7099
138158,breast,O,7099
138159,milk,O,7099
138160,and,O,7099
138161,may,O,7099
138162,cause,O,7099
138163,serious,O,7099
138164,side,O,7099
138165,effects,O,7099
138166,in,O,7099
138167,nursing,O,7099
138168,infants,O,7099
138169,It,O,7099
138170,is,O,7099
138171,not,O,7100
138172,recommended,O,7100
138173,for,O,7100
138174,use,O,7100
138175,by,O,7100
138176,nursing,O,7100
138177,mothers,O,7100
138178,or,O,7100
138179,women,O,7100
138180,who,O,7100
138181,are,O,7100
138182,planning,O,7100
138183,to,O,7100
138184,become,O,7100
138185,pregnant,O,7100
138186,If,O,7100
138187,you,O,7100
138188,are,O,7100
138189,pregnant,O,7100
138190,nursing,O,7100
138191,or,O,7100
138192,planning,O,7101
138193,to,O,7101
138194,become,O,7101
138195,pregnant,O,7101
138196,you,O,7101
138197,should,O,7101
138198,not,O,7101
138199,use,O,7101
138200,chloramphenicol,B-NAME_OF_DRUG,7101
138201,without,O,7101
138202,first,O,7101
138203,discussing,O,7101
138204,the,O,7102
138205,potential,O,7102
138206,risks,O,7102
138207,with,O,7102
138208,a,O,7102
138209,healthcare,O,7102
138210,professional,O,7102
138211,There,O,7102
138212,is,O,7102
138213,limited,O,7102
138214,information,O,7102
138215,available,O,7102
138216,on,O,7102
138217,the,O,7102
138218,effects,O,7102
138219,of,O,7102
138220,chloramphenicol,B-NAME_OF_DRUG,7102
138221,on,O,7102
138222,fertility,O,7102
138223,Some,O,7103
138224,studies,O,7103
138225,in,O,7103
138226,animals,O,7103
138227,have,O,7103
138228,suggested,O,7103
138229,that,O,7103
138230,chloramphenicol,B-NAME_OF_DRUG,7103
138231,may,O,7103
138232,have,O,7103
138233,an,O,7104
138234,adverse,O,7104
138235,effect,O,7104
138236,on,O,7104
138237,fertility,O,7104
138238,but,O,7104
138239,more,O,7104
138240,research,O,7104
138241,is,O,7104
138242,needed,O,7105
138243,to,O,7105
138244,determine,O,7105
138245,if,O,7105
138246,this,O,7105
138247,is,O,7105
138248,also,O,7105
138249,TRUE,O,7105
138250,in,O,7105
138251,humans,O,7105
138252,If,O,7105
138253,you,O,7105
138254,are,O,7105
138255,concerned,O,7105
138256,about,O,7106
138257,the,O,7106
138258,potential,O,7106
138259,effects,O,7106
138260,of,O,7106
138261,chloramphenicol,B-NAME_OF_DRUG,7106
138262,on,O,7106
138263,fertility,O,7106
138264,you,O,7106
138265,should,O,7106
138266,speak,O,7106
138267,with,O,7107
138268,a,O,7107
138269,healthcare,O,7107
138270,professional,O,7107
138271,for,O,7107
138272,guidance,O,7107
138273,How,O,7107
138274,to,O,7107
138275,Use,O,7107
138276,Chloramphenicol,B-NAME_OF_DRUG,7107
138277,Chloramphenicol,B-NAME_OF_DRUG,7107
138278,is,O,7108
138279,available,O,7108
138280,in,O,7108
138281,several,O,7108
138282,forms,O,7108
138283,including,O,7108
138284,tablets,O,7108
138285,capsules,O,7108
138286,and,O,7108
138287,an,O,7108
138288,oral,O,7108
138289,suspension,O,7108
138290,liquid,O,7108
138291,,O,7108
138292,It,O,7108
138293,is,O,7108
138294,usually,O,7108
138295,taken,O,7108
138296,by,O,7108
138297,mouth,O,7109
138298,but,O,7109
138299,it,O,7109
138300,can,O,7109
138301,also,O,7109
138302,be,O,7109
138303,given,O,7109
138304,intravenously,O,7109
138305,through,O,7109
138306,a,O,7109
138307,vein,O,7109
138308,in,O,7109
138309,a,O,7109
138310,hospital,O,7109
138311,setting,O,7109
138312,The,O,7109
138313,specific,O,7109
138314,dosage,O,7109
138315,and,O,7110
138316,duration,O,7110
138317,of,O,7110
138318,treatment,O,7110
138319,with,O,7110
138320,chloramphenicol,B-NAME_OF_DRUG,7110
138321,will,O,7110
138322,depend,O,7110
138323,on,O,7110
138324,the,O,7110
138325,type,O,7110
138326,and,O,7110
138327,severity,O,7110
138328,of,O,7110
138329,the,O,7110
138330,infection,O,7110
138331,being,O,7110
138332,treated,O,7110
138333,It,O,7110
138334,is,O,7110
138335,important,O,7110
138336,to,O,7110
138337,take,O,7111
138338,chloramphenicol,B-NAME_OF_DRUG,7111
138339,exactly,O,7111
138340,as,O,7111
138341,prescribed,O,7111
138342,by,O,7111
138343,your,O,7111
138344,doctor,O,7111
138345,Here,O,7111
138346,are,O,7111
138347,some,O,7111
138348,general,O,7111
138349,guidelines,O,7111
138350,for,O,7111
138351,using,O,7111
138352,chloramphenicol,B-NAME_OF_DRUG,7111
138353,Take,O,7111
138354,chloramphenicol,B-NAME_OF_DRUG,7111
138355,at,O,7111
138356,evenly,O,7111
138357,spaced,O,7111
138358,intervals,O,7111
138359,as,O,7112
138360,directed,O,7112
138361,by,O,7112
138362,your,O,7112
138363,doctor,O,7112
138364,Do,O,7112
138365,not,O,7112
138366,crush,O,7112
138367,chew,O,7112
138368,or,O,7112
138369,break,O,7112
138370,the,O,7112
138371,tablets,O,7112
138372,or,O,7112
138373,capsules,O,7112
138374,Swallow,O,7112
138375,them,O,7112
138376,whole,O,7112
138377,with,O,7113
138378,a,O,7113
138379,full,O,7113
138380,glass,O,7113
138381,of,O,7113
138382,water,O,7113
138383,If,O,7113
138384,you,O,7113
138385,are,O,7113
138386,taking,O,7113
138387,the,O,7113
138388,oral,O,7113
138389,suspension,O,7113
138390,shake,O,7113
138391,the,O,7113
138392,bottle,O,7113
138393,well,O,7113
138394,before,O,7113
138395,each,O,7113
138396,dose,O,7113
138397,Measure,O,7113
138398,the,O,7113
138399,dose,O,7113
138400,carefully,O,7113
138401,using,O,7113
138402,the,O,7113
138403,measuring,O,7113
138404,spoon,O,7114
138405,or,O,7114
138406,cup,O,7114
138407,provided,O,7114
138408,Do,O,7114
138409,not,O,7114
138410,stop,O,7114
138411,taking,O,7114
138412,chloramphenicol,B-NAME_OF_DRUG,7114
138413,early,O,7114
138414,even,O,7114
138415,if,O,7114
138416,you,O,7114
138417,feel,O,7114
138418,better,O,7114
138419,Stopping,O,7114
138420,treatment,O,7114
138421,early,O,7114
138422,can,O,7114
138423,allow,O,7115
138424,bacteria,O,7115
138425,to,O,7115
138426,continue,O,7115
138427,to,O,7115
138428,grow,O,7115
138429,which,O,7115
138430,can,O,7115
138431,lead,O,7115
138432,to,O,7115
138433,a,O,7115
138434,relapse,O,7115
138435,of,O,7115
138436,the,O,7115
138437,infection,O,7115
138438,If,O,7115
138439,you,O,7115
138440,have,O,7115
138441,any,O,7115
138442,questions,O,7115
138443,about,O,7115
138444,how,O,7115
138445,to,O,7115
138446,use,O,7115
138447,chloramphenicol,B-NAME_OF_DRUG,7115
138448,you,O,7115
138449,should,O,7115
138450,speak,O,7115
138451,with,O,7116
138452,your,O,7116
138453,doctor,O,7116
138454,or,O,7116
138455,pharmacist,O,7116
138456,What,O,7116
138457,to,O,7116
138458,Do,O,7116
138459,If,O,7116
138460,You,O,7116
138461,Miss,O,7116
138462,a,O,7117
138463,Dose,O,7117
138464,If,O,7117
138465,you,O,7117
138466,miss,O,7117
138467,a,O,7117
138468,dose,O,7117
138469,of,O,7117
138470,chloramphenicol,B-NAME_OF_DRUG,7117
138471,take,O,7117
138472,it,O,7117
138473,as,O,7117
138474,soon,O,7117
138475,as,O,7117
138476,you,O,7117
138477,remember,O,7117
138478,If,O,7117
138479,it,O,7117
138480,is,O,7117
138481,almost,O,7117
138482,time,O,7117
138483,for,O,7117
138484,your,O,7117
138485,next,O,7117
138486,dose,O,7117
138487,skip,O,7117
138488,the,O,7118
138489,missed,O,7118
138490,dose,O,7118
138491,and,O,7118
138492,take,O,7118
138493,the,O,7118
138494,next,O,7118
138495,dose,O,7118
138496,at,O,7118
138497,the,O,7118
138498,regular,O,7118
138499,time,O,7118
138500,Do,O,7118
138501,not,O,7118
138502,take,O,7118
138503,two,O,7118
138504,doses,O,7119
138505,of,O,7119
138506,chloramphenicol,B-NAME_OF_DRUG,7119
138507,at,O,7119
138508,the,O,7119
138509,same,O,7119
138510,time,O,7119
138511,to,O,7119
138512,make,O,7119
138513,up,O,7119
138514,for,O,7119
138515,a,O,7119
138516,missed,O,7119
138517,dose,O,7119
138518,If,O,7119
138519,you,O,7119
138520,miss,O,7119
138521,multiple,O,7119
138522,doses,O,7119
138523,of,O,7119
138524,chloramphenicol,B-NAME_OF_DRUG,7119
138525,or,O,7119
138526,forget,O,7119
138527,to,O,7119
138528,take,O,7119
138529,the,O,7119
138530,medication,O,7119
138531,for,O,7120
138532,an,O,7120
138533,extended,O,7120
138534,period,O,7120
138535,of,O,7120
138536,time,O,7120
138537,you,O,7120
138538,should,O,7120
138539,contact,O,7120
138540,your,O,7120
138541,doctor,O,7120
138542,for,O,7120
138543,further,O,7120
138544,instructions,O,7120
138545,It,O,7120
138546,is,O,7120
138547,important,O,7120
138548,to,O,7121
138549,follow,O,7121
138550,the,O,7121
138551,prescribed,O,7121
138552,dosing,O,7121
138553,schedule,O,7121
138554,for,O,7121
138555,chloramphenicol,B-NAME_OF_DRUG,7121
138556,to,O,7121
138557,ensure,O,7121
138558,that,O,7121
138559,the,O,7121
138560,infection,O,7121
138561,is,O,7121
138562,treated,O,7121
138563,effectively,O,7121
138564,What,O,7121
138565,to,O,7121
138566,Do,O,7121
138567,If,O,7122
138568,You,O,7122
138569,Overdose,O,7122
138570,If,O,7122
138571,you,O,7122
138572,think,O,7122
138573,you,O,7122
138574,or,O,7122
138575,someone,O,7122
138576,else,O,7122
138577,may,O,7122
138578,have,O,7122
138579,taken,O,7123
138580,an,O,7123
138581,overdose,O,7123
138582,of,O,7123
138583,chloramphenicol,B-NAME_OF_DRUG,7123
138584,you,O,7123
138585,should,O,7123
138586,seek,O,7123
138587,emergency,O,7123
138588,medical,O,7123
138589,attention,O,7123
138590,right,O,7123
138591,away,O,7123
138592,Overdose,O,7123
138593,symptoms,O,7123
138594,may,O,7123
138595,include,O,7123
138596,nausea,O,7123
138597,vomiting,O,7123
138598,stomach,O,7123
138599,pain,O,7123
138600,diarrhea,O,7123
138601,and,O,7123
138602,fever,O,7123
138603,If,O,7123
138604,the,O,7123
138605,overdose,O,7123
138606,was,O,7123
138607,recent,O,7123
138608,you,O,7123
138609,may,O,7123
138610,be,O,7123
138611,advised,O,7123
138612,to,O,7123
138613,induce,O,7123
138614,vomiting,O,7123
138615,or,O,7123
138616,undergo,O,7123
138617,gastric,O,7123
138618,lavage,O,7123
138619,stomach,O,7123
138620,pumping,O,7123
138621,to,O,7123
138622,remove,O,7123
138623,the,O,7123
138624,excess,O,7123
138625,medication,O,7123
138626,from,O,7123
138627,your,O,7123
138628,system,O,7123
138629,You,O,7123
138630,may,O,7123
138631,also,O,7123
138632,be,O,7123
138633,given,O,7123
138634,activated,O,7123
138635,charcoal,O,7123
138636,to,O,7123
138637,help,O,7123
138638,absorb,O,7123
138639,any,O,7123
138640,remaining,O,7123
138641,chloramphenicol,B-NAME_OF_DRUG,7123
138642,in,O,7123
138643,the,O,7123
138644,stomach,O,7123
138645,It,O,7123
138646,is,O,7123
138647,important,O,7123
138648,to,O,7123
138649,seek,O,7123
138650,medical,O,7123
138651,attention,O,7123
138652,immediately,O,7123
138653,if,O,7123
138654,you,O,7123
138655,suspect,O,7123
138656,an,O,7123
138657,overdose,O,7123
138658,as,O,7123
138659,chloramphenicol,B-NAME_OF_DRUG,7123
138660,overdose,O,7123
138661,can,O,7123
138662,be,O,7124
138663,serious,O,7124
138664,and,O,7124
138665,may,O,7124
138666,cause,O,7124
138667,serious,O,7124
138668,side,O,7124
138669,effects,O,7124
138670,or,O,7124
138671,death,O,7124
138672,What,O,7124
138673,Side,O,7124
138674,Effects,O,7124
138675,May,O,7124
138676,Happen,O,7124
138677,If,O,7124
138678,You,O,7124
138679,Use,O,7124
138680,Chloramphenicol,B-NAME_OF_DRUG,7124
138681,Like,O,7124
138682,all,O,7124
138683,medications,O,7124
138684,chloramphenicol,B-NAME_OF_DRUG,7124
138685,can,O,7125
138686,cause,O,7125
138687,side,O,7125
138688,effects,O,7125
138689,Some,O,7125
138690,people,O,7125
138691,may,O,7125
138692,experience,O,7125
138693,side,O,7125
138694,effects,O,7125
138695,while,O,7125
138696,taking,O,7125
138697,chloramphenicol,B-NAME_OF_DRUG,7125
138698,while,O,7125
138699,others,O,7125
138700,may,O,7125
138701,not,O,7126
138702,have,O,7126
138703,any,O,7126
138704,side,O,7126
138705,effects,O,7126
138706,at,O,7126
138707,all,O,7126
138708,The,O,7126
138709,most,O,7126
138710,common,O,7126
138711,side,O,7126
138712,effects,O,7126
138713,of,O,7126
138714,chloramphenicol,B-NAME_OF_DRUG,7126
138715,are,O,7126
138716,nausea,B-SIGN_AND_SYMPTOM,7126
138717,vomiting,I-SIGN_AND_SYMPTOM,7126
138718,and,I-SIGN_AND_SYMPTOM,7126
138719,diarrhea,I-SIGN_AND_SYMPTOM,7126
138720,Other,O,7127
138721,possible,O,7127
138722,side,O,7127
138723,effects,O,7127
138724,of,O,7127
138725,chloramphenicol,B-NAME_OF_DRUG,7127
138726,include,O,7127
138727,Loss,B-SIGN_AND_SYMPTOM,7127
138728,of,I-SIGN_AND_SYMPTOM,7127
138729,appetite,I-SIGN_AND_SYMPTOM,7127
138730,Rash,B-SIGN_AND_SYMPTOM,7127
138731,or,I-SIGN_AND_SYMPTOM,7127
138732,itching,I-SIGN_AND_SYMPTOM,7127
138733,Headache,B-SIGN_AND_SYMPTOM,7127
138734,Dizziness,B-SIGN_AND_SYMPTOM,7127
138735,Trouble,B-SIGN_AND_SYMPTOM,7127
138736,sleeping,I-SIGN_AND_SYMPTOM,7127
138737,Dry,B-SIGN_AND_SYMPTOM,7127
138738,mouth,I-SIGN_AND_SYMPTOM,7127
138739,Unusual,B-SIGN_AND_SYMPTOM,7127
138740,tiredness,I-SIGN_AND_SYMPTOM,7127
138741,or,I-SIGN_AND_SYMPTOM,7127
138742,weakness,I-SIGN_AND_SYMPTOM,7127
138743,Less,O,7127
138744,common,O,7127
138745,but,O,7127
138746,more,O,7128
138747,serious,O,7128
138748,side,O,7128
138749,effects,O,7128
138750,of,O,7128
138751,chloramphenicol,B-NAME_OF_DRUG,7128
138752,may,O,7128
138753,include,O,7128
138754,Blood,O,7128
138755,disorders,O,7128
138756,including,O,7128
138757,anemia,O,7128
138758,and,O,7128
138759,decreased,O,7128
138760,white,O,7128
138761,blood,O,7128
138762,cell,O,7128
138763,count,O,7128
138764,Allergic,B-SIGN_AND_SYMPTOM,7128
138765,reactions,I-SIGN_AND_SYMPTOM,7128
138766,including,I-SIGN_AND_SYMPTOM,7128
138767,difficulty,I-SIGN_AND_SYMPTOM,7128
138768,breathing,I-SIGN_AND_SYMPTOM,7128
138769,hives,I-SIGN_AND_SYMPTOM,7129
138770,and,I-SIGN_AND_SYMPTOM,7129
138771,swelling,I-SIGN_AND_SYMPTOM,7129
138772,of,I-SIGN_AND_SYMPTOM,7129
138773,the,I-SIGN_AND_SYMPTOM,7129
138774,face,I-SIGN_AND_SYMPTOM,7129
138775,lips,I-SIGN_AND_SYMPTOM,7129
138776,tongue,I-SIGN_AND_SYMPTOM,7129
138777,or,I-SIGN_AND_SYMPTOM,7129
138778,throat,I-SIGN_AND_SYMPTOM,7129
138779,Seizures,B-SIGN_AND_SYMPTOM,7129
138780,Confusion,B-SIGN_AND_SYMPTOM,7129
138781,or,I-SIGN_AND_SYMPTOM,7129
138782,changes,I-SIGN_AND_SYMPTOM,7129
138783,in,I-SIGN_AND_SYMPTOM,7129
138784,mental,I-SIGN_AND_SYMPTOM,7129
138785,status,I-SIGN_AND_SYMPTOM,7129
138786,If,O,7129
138787,you,O,7129
138788,experience,O,7129
138789,any,O,7130
138790,of,O,7130
138791,these,O,7130
138792,side,O,7130
138793,effects,O,7130
138794,you,O,7130
138795,should,O,7130
138796,contact,O,7130
138797,your,O,7130
138798,doctor,O,7130
138799,as,O,7130
138800,soon,O,7130
138801,as,O,7130
138802,possible,O,7130
138803,In,O,7130
138804,rare,O,7130
138805,cases,O,7130
138806,chloramphenicol,B-NAME_OF_DRUG,7130
138807,can,O,7130
138808,cause,O,7130
138809,serious,O,7130
138810,side,O,7130
138811,effects,O,7130
138812,that,O,7130
138813,may,O,7130
138814,require,O,7130
138815,immediate,O,7130
138816,medical,O,7130
138817,attention,O,7130
138818,such,O,7130
138819,as,O,7130
138820,severe,B-SIGN_AND_SYMPTOM,7130
138821,allergic,I-SIGN_AND_SYMPTOM,7130
138822,reactions,I-SIGN_AND_SYMPTOM,7130
138823,or,I-SIGN_AND_SYMPTOM,7130
138824,blood,I-SIGN_AND_SYMPTOM,7130
138825,disorders,I-SIGN_AND_SYMPTOM,7130
138826,It,O,7130
138827,is,O,7130
138828,important,O,7130
138829,to,O,7130
138830,report,O,7130
138831,any,O,7130
138832,side,O,7130
138833,effects,O,7130
138834,you,O,7130
138835,experience,O,7130
138836,while,O,7130
138837,taking,O,7130
138838,chloramphenicol,B-NAME_OF_DRUG,7130
138839,to,O,7130
138840,your,O,7130
138841,doctor,O,7130
138842,This,O,7130
138843,will,O,7130
138844,help,O,7130
138845,your,O,7130
138846,doctor,O,7130
138847,determine,O,7130
138848,the,O,7130
138849,best,O,7130
138850,course,O,7130
138851,of,O,7130
138852,treatment,O,7131
138853,for,O,7131
138854,you,O,7131
138855,and,O,7131
138856,monitor,O,7131
138857,for,O,7131
138858,any,O,7131
138859,potential,O,7131
138860,problems,O,7131
138861,Does,O,7131
138862,Chloramphenicol,B-NAME_OF_DRUG,7131
138863,Eye,I-NAME_OF_DRUG,7131
138864,Drop,I-NAME_OF_DRUG,7131
138865,Cause,O,7131
138866,Any,O,7131
138867,Interaction,O,7131
138868,with,O,7131
138869,Other,O,7131
138870,Medicines,O,7131
138871,and,O,7132
138872,Supplements,O,7132
138873,Chloramphenicol,B-NAME_OF_DRUG,7132
138874,eye,I-NAME_OF_DRUG,7132
138875,drops,I-NAME_OF_DRUG,7132
138876,may,O,7132
138877,interact,O,7132
138878,with,O,7132
138879,other,O,7132
138880,medications,O,7132
138881,and,O,7132
138882,supplements,O,7132
138883,that,O,7132
138884,you,O,7132
138885,are,O,7132
138886,taking,O,7132
138887,It,O,7132
138888,is,O,7132
138889,important,O,7132
138890,to,O,7132
138891,tell,O,7132
138892,your,O,7132
138893,doctor,O,7132
138894,about,O,7133
138895,all,O,7133
138896,the,O,7133
138897,medications,O,7133
138898,and,O,7133
138899,supplements,O,7133
138900,you,O,7133
138901,are,O,7133
138902,using,O,7133
138903,before,O,7133
138904,starting,O,7133
138905,treatment,O,7133
138906,with,O,7133
138907,chloramphenicol,B-NAME_OF_DRUG,7133
138908,eye,I-NAME_OF_DRUG,7134
138909,drops,I-NAME_OF_DRUG,7134
138910,This,O,7134
138911,will,O,7134
138912,help,O,7134
138913,your,O,7134
138914,doctor,O,7134
138915,determine,O,7134
138916,if,O,7134
138917,chloramphenicol,B-NAME_OF_DRUG,7134
138918,is,O,7134
138919,safe,O,7134
138920,for,O,7134
138921,you,O,7134
138922,and,O,7134
138923,help,O,7134
138924,to,O,7134
138925,prevent,O,7134
138926,any,O,7134
138927,potential,O,7134
138928,drug,O,7135
138929,interactions,O,7135
138930,Some,O,7135
138931,medications,O,7135
138932,that,O,7135
138933,may,O,7135
138934,interact,O,7135
138935,with,O,7135
138936,chloramphenicol,B-NAME_OF_DRUG,7135
138937,eye,I-NAME_OF_DRUG,7135
138938,drops,I-NAME_OF_DRUG,7135
138939,include,O,7135
138940,Other,O,7135
138941,antibiotics,B-NAME_OF_DRUG,7135
138942,or,I-NAME_OF_DRUG,7135
138943,antifungal,I-NAME_OF_DRUG,7135
138944,medications,I-NAME_OF_DRUG,7135
138945,Blood,O,7135
138946,thinners,O,7135
138947,such,O,7135
138948,as,O,7135
138949,warfarin,B-NAME_OF_DRUG,7135
138950,Medications,O,7135
138951,that,O,7135
138952,weaken,O,7135
138953,the,O,7135
138954,immune,O,7135
138955,system,O,7135
138956,such,O,7135
138957,as,O,7135
138958,corticosteroids,B-NAME_OF_DRUG,7135
138959,Medications,O,7135
138960,that,O,7135
138961,affect,O,7135
138962,the,O,7135
138963,blood,O,7135
138964,such,O,7135
138965,as,O,7136
138966,methotrexate,B-NAME_OF_DRUG,7136
138967,Medications,O,7136
138968,that,O,7136
138969,affect,O,7136
138970,the,O,7136
138971,liver,O,7136
138972,such,O,7136
138973,as,O,7137
138974,phenobarbital,B-NAME_OF_DRUG,7137
138975,If,O,7137
138976,you,O,7137
138977,are,O,7137
138978,taking,O,7137
138979,any,O,7137
138980,of,O,7137
138981,these,O,7137
138982,medications,O,7137
138983,you,O,7137
138984,should,O,7137
138985,tell,O,7137
138986,your,O,7137
138987,doctor,O,7137
138988,before,O,7137
138989,using,O,7138
138990,chloramphenicol,B-NAME_OF_DRUG,7138
138991,eye,I-NAME_OF_DRUG,7138
138992,drops,I-NAME_OF_DRUG,7138
138993,Your,O,7138
138994,doctor,O,7138
138995,may,O,7138
138996,need,O,7138
138997,to,O,7138
138998,adjust,O,7138
138999,the,O,7138
139000,dosage,O,7138
139001,of,O,7138
139002,your,O,7138
139003,medications,O,7138
139004,or,O,7138
139005,monitor,O,7138
139006,you,O,7138
139007,more,O,7138
139008,closely,O,7138
139009,for,O,7138
139010,side,O,7138
139011,effects,O,7138
139012,It,O,7138
139013,is,O,7138
139014,also,O,7138
139015,important,O,7138
139016,to,O,7138
139017,tell,O,7138
139018,your,O,7138
139019,doctor,O,7138
139020,about,O,7138
139021,any,O,7138
139022,supplements,O,7138
139023,you,O,7138
139024,are,O,7138
139025,taking,O,7138
139026,as,O,7138
139027,some,O,7138
139028,supplements,O,7138
139029,may,O,7139
139030,interact,O,7139
139031,with,O,7139
139032,chloramphenicol,B-NAME_OF_DRUG,7139
139033,eye,I-NAME_OF_DRUG,7139
139034,drops,I-NAME_OF_DRUG,7139
139035,For,O,7139
139036,example,O,7139
139037,some,O,7139
139038,supplements,O,7139
139039,such,O,7139
139040,as,O,7139
139041,zinc,B-NAME_OF_DRUG,7139
139042,can,O,7139
139043,interfere,O,7139
139044,with,O,7139
139045,the,O,7139
139046,absorption,O,7139
139047,of,O,7139
139048,chloramphenicol,B-NAME_OF_DRUG,7139
139049,If,O,7139
139050,you,O,7139
139051,have,O,7139
139052,any,O,7139
139053,questions,O,7139
139054,about,O,7139
139055,drug,O,7139
139056,interactions,O,7139
139057,with,O,7139
139058,chloramphenicol,B-NAME_OF_DRUG,7139
139059,eye,I-NAME_OF_DRUG,7139
139060,drops,I-NAME_OF_DRUG,7139
139061,you,O,7139
139062,should,O,7139
139063,speak,O,7139
139064,with,O,7139
139065,your,O,7139
139066,doctor,O,7139
139067,or,O,7139
139068,pharmacist,O,7139
139069,What,O,7139
139070,Is,O,7139
139071,Surfer,B-NAME_OF_DISEASE,7139
139072,s,I-NAME_OF_DISEASE,7139
139073,Eye,I-NAME_OF_DISEASE,7139
139074,Pterygium,B-NAME_OF_DISEASE,7139
139075,is,O,7139
139076,characterized,O,7139
139077,by,O,7139
139078,a,B-SIGN_AND_SYMPTOM,7140
139079,thickening,I-SIGN_AND_SYMPTOM,7140
139080,of,I-SIGN_AND_SYMPTOM,7140
139081,the,I-SIGN_AND_SYMPTOM,7140
139082,conjunctiva,I-SIGN_AND_SYMPTOM,7140
139083,tissue,I-SIGN_AND_SYMPTOM,7140
139084,that,I-SIGN_AND_SYMPTOM,7140
139085,takes,I-SIGN_AND_SYMPTOM,7140
139086,on,I-SIGN_AND_SYMPTOM,7140
139087,a,I-SIGN_AND_SYMPTOM,7140
139088,wing-like,I-SIGN_AND_SYMPTOM,7140
139089,or,I-SIGN_AND_SYMPTOM,7140
139090,triangular,I-SIGN_AND_SYMPTOM,7140
139091,shape,I-SIGN_AND_SYMPTOM,7140
139092,and,I-SIGN_AND_SYMPTOM,7140
139093,grows,I-SIGN_AND_SYMPTOM,7140
139094,from,I-SIGN_AND_SYMPTOM,7140
139095,the,I-SIGN_AND_SYMPTOM,7140
139096,inner,I-SIGN_AND_SYMPTOM,7140
139097,corners,I-SIGN_AND_SYMPTOM,7140
139098,of,I-SIGN_AND_SYMPTOM,7140
139099,the,I-SIGN_AND_SYMPTOM,7141
139100,eye,I-SIGN_AND_SYMPTOM,7141
139101,often,I-SIGN_AND_SYMPTOM,7141
139102,extending,I-SIGN_AND_SYMPTOM,7141
139103,onto,I-SIGN_AND_SYMPTOM,7141
139104,the,B-PART_OF_THE_EYES,7141
139105,cornea,I-PART_OF_THE_EYES,7141
139106,Pterygium,B-NAME_OF_DISEASE,7141
139107,can,O,7141
139108,either,O,7141
139109,affect,O,7141
139110,one,O,7141
139111,or,O,7141
139112,both,O,7141
139113,eyes,O,7141
139114,Cases,O,7141
139115,when,O,7141
139116,it,O,7141
139117,affects,O,7141
139118,both,O,7141
139119,eyes,O,7141
139120,at,O,7141
139121,the,O,7141
139122,same,O,7141
139123,time,O,7141
139124,is,O,7141
139125,referred,O,7141
139126,to,O,7141
139127,as,O,7141
139128,bilateral,B-NAME_OF_DISEASE,7141
139129,pterygium,I-NAME_OF_DISEASE,7141
139130,What,O,7141
139131,Symptoms,O,7141
139132,to,O,7141
139133,Expect,O,7141
139134,from,O,7141
139135,Pterygium,B-NAME_OF_DISEASE,7142
139136,of,O,7142
139137,the,O,7142
139138,Eye,O,7142
139139,Pterygium,B-NAME_OF_DISEASE,7142
139140,is,O,7142
139141,a,B-SIGN_AND_SYMPTOM,7142
139142,benign,I-SIGN_AND_SYMPTOM,7142
139143,non-cancerous,I-SIGN_AND_SYMPTOM,7142
139144,growth,I-SIGN_AND_SYMPTOM,7142
139145,that,I-SIGN_AND_SYMPTOM,7142
139146,appears,I-SIGN_AND_SYMPTOM,7142
139147,on,I-SIGN_AND_SYMPTOM,7142
139148,the,I-SIGN_AND_SYMPTOM,7142
139149,conjunctiva,I-SIGN_AND_SYMPTOM,7142
139150,which,O,7142
139151,is,O,7142
139152,the,O,7142
139153,clear,O,7142
139154,membrane,O,7142
139155,that,O,7142
139156,covers,O,7142
139157,the,O,7142
139158,white,O,7142
139159,part,O,7142
139160,of,O,7142
139161,the,O,7142
139162,eye,O,7143
139163,and,O,7143
139164,lines,O,7143
139165,the,O,7143
139166,inside,O,7143
139167,of,O,7143
139168,the,O,7143
139169,eyelids.Sometime,O,7143
139170,you,O,7143
139171,won,O,7143
139172,t,O,7143
139173,experience,O,7143
139174,any,O,7144
139175,symptoms,O,7144
139176,prior,O,7144
139177,to,O,7144
139178,having,O,7144
139179,pterygium,B-NAME_OF_DISEASE,7144
139180,but,O,7144
139181,it,O,7144
139182,can,O,7144
139183,also,O,7144
139184,cause,O,7144
139185,a,O,7144
139186,variety,O,7144
139187,of,O,7144
139188,symptoms,O,7144
139189,some,O,7144
139190,of,O,7144
139191,which,O,7144
139192,may,O,7144
139193,include,O,7144
139194,Dryness,B-SIGN_AND_SYMPTOM,7144
139195,and,I-SIGN_AND_SYMPTOM,7144
139196,redness,I-SIGN_AND_SYMPTOM,7144
139197,of,I-SIGN_AND_SYMPTOM,7144
139198,the,I-SIGN_AND_SYMPTOM,7144
139199,eye,I-SIGN_AND_SYMPTOM,7144
139200,Pterygium,B-NAME_OF_DISEASE,7144
139201,may,O,7144
139202,cause,O,7145
139203,the,B-SIGN_AND_SYMPTOM,7145
139204,eye,I-SIGN_AND_SYMPTOM,7145
139205,to,I-SIGN_AND_SYMPTOM,7145
139206,feel,I-SIGN_AND_SYMPTOM,7145
139207,dry,I-SIGN_AND_SYMPTOM,7145
139208,and,I-SIGN_AND_SYMPTOM,7145
139209,itchy,I-SIGN_AND_SYMPTOM,7145
139210,and,I-SIGN_AND_SYMPTOM,7145
139211,the,I-SIGN_AND_SYMPTOM,7145
139212,affected,I-SIGN_AND_SYMPTOM,7145
139213,eye,I-SIGN_AND_SYMPTOM,7145
139214,may,I-SIGN_AND_SYMPTOM,7145
139215,appear,I-SIGN_AND_SYMPTOM,7145
139216,red,I-SIGN_AND_SYMPTOM,7145
139217,and,I-SIGN_AND_SYMPTOM,7145
139218,inflamed,I-SIGN_AND_SYMPTOM,7145
139219,Sensitivity,B-SIGN_AND_SYMPTOM,7145
139220,to,I-SIGN_AND_SYMPTOM,7145
139221,light,I-SIGN_AND_SYMPTOM,7145
139222,People,O,7145
139223,with,O,7145
139224,pterygium,B-NAME_OF_DISEASE,7145
139225,may,O,7145
139226,be,O,7145
139227,more,B-SIGN_AND_SYMPTOM,7145
139228,sensitive,I-SIGN_AND_SYMPTOM,7145
139229,to,I-SIGN_AND_SYMPTOM,7145
139230,bright,I-SIGN_AND_SYMPTOM,7145
139231,light,I-SIGN_AND_SYMPTOM,7145
139232,and,I-SIGN_AND_SYMPTOM,7145
139233,may,I-SIGN_AND_SYMPTOM,7145
139234,experience,I-SIGN_AND_SYMPTOM,7145
139235,discomfort,B-SIGN_AND_SYMPTOM,7145
139236,when,I-SIGN_AND_SYMPTOM,7145
139237,exposed,I-SIGN_AND_SYMPTOM,7145
139238,to,I-SIGN_AND_SYMPTOM,7145
139239,it,I-SIGN_AND_SYMPTOM,7146
139240,Blurred,B-SIGN_AND_SYMPTOM,7146
139241,vision,I-SIGN_AND_SYMPTOM,7146
139242,Pterygium,B-NAME_OF_DISEASE,7146
139243,may,O,7146
139244,cause,O,7146
139245,the,B-SIGN_AND_SYMPTOM,7146
139246,vision,I-SIGN_AND_SYMPTOM,7146
139247,to,I-SIGN_AND_SYMPTOM,7146
139248,be,I-SIGN_AND_SYMPTOM,7146
139249,blurry,I-SIGN_AND_SYMPTOM,7146
139250,or,I-SIGN_AND_SYMPTOM,7146
139251,distorted,I-SIGN_AND_SYMPTOM,7146
139252,particularly,O,7146
139253,if,O,7146
139254,it,O,7146
139255,grows,O,7146
139256,over,O,7146
139257,the,B-PART_OF_THE_EYES,7146
139258,cornea,I-PART_OF_THE_EYES,7146
139259,which,O,7146
139260,is,O,7146
139261,the,O,7146
139262,clear,O,7146
139263,dome-shaped,O,7146
139264,surface,O,7146
139265,at,O,7146
139266,the,O,7146
139267,front,O,7146
139268,of,O,7146
139269,the,O,7147
139270,eye,O,7147
139271,that,O,7147
139272,helps,O,7147
139273,to,O,7147
139274,focus,O,7147
139275,light,O,7147
139276,Difficulty,B-SIGN_AND_SYMPTOM,7147
139277,with,I-SIGN_AND_SYMPTOM,7147
139278,contact,I-SIGN_AND_SYMPTOM,7147
139279,lenses,I-SIGN_AND_SYMPTOM,7147
139280,Pterygium,B-NAME_OF_DISEASE,7148
139281,can,O,7148
139282,make,O,7148
139283,it,O,7148
139284,troublesome,B-SIGN_AND_SYMPTOM,7148
139285,to,I-SIGN_AND_SYMPTOM,7148
139286,wear,I-SIGN_AND_SYMPTOM,7148
139287,contact,I-SIGN_AND_SYMPTOM,7148
139288,lenses,I-SIGN_AND_SYMPTOM,7148
139289,comfortably,I-SIGN_AND_SYMPTOM,7148
139290,as,O,7148
139291,they,O,7148
139292,may,O,7148
139293,not,O,7148
139294,fit,O,7148
139295,to,O,7148
139296,your,O,7148
139297,eyes,O,7148
139298,properly,O,7149
139299,and,O,7149
139300,may,O,7149
139301,cause,O,7149
139302,discomfort,B-SIGN_AND_SYMPTOM,7149
139303,Discomfort,B-SIGN_AND_SYMPTOM,7149
139304,and,I-SIGN_AND_SYMPTOM,7149
139305,foreign,I-SIGN_AND_SYMPTOM,7149
139306,body,I-SIGN_AND_SYMPTOM,7149
139307,sensation,I-SIGN_AND_SYMPTOM,7149
139308,Some,O,7149
139309,people,O,7149
139310,with,O,7149
139311,pterygium,B-NAME_OF_DISEASE,7149
139312,may,O,7149
139313,experience,O,7149
139314,discomfort,B-SIGN_AND_SYMPTOM,7149
139315,What,O,7149
139316,Causes,O,7149
139317,Pterygium,B-NAME_OF_DISEASE,7149
139318,The,O,7149
139319,exact,O,7149
139320,cause,O,7149
139321,of,O,7149
139322,pterygium,B-NAME_OF_DISEASE,7149
139323,is,O,7149
139324,not,O,7150
139325,fully,O,7150
139326,understood,O,7150
139327,but,O,7150
139328,it,O,7150
139329,is,O,7150
139330,believed,O,7150
139331,to,O,7150
139332,be,O,7150
139333,associated,O,7150
139334,with,O,7150
139335,exposure,B-CAUSE_OF_DISEASE,7150
139336,to,I-CAUSE_OF_DISEASE,7150
139337,ultraviolet,I-CAUSE_OF_DISEASE,7150
139338,UV,I-CAUSE_OF_DISEASE,7150
139339,light,I-CAUSE_OF_DISEASE,7150
139340,wind,I-CAUSE_OF_DISEASE,7150
139341,and,I-CAUSE_OF_DISEASE,7150
139342,dust,I-CAUSE_OF_DISEASE,7150
139343,Other,O,7150
139344,possible,O,7150
139345,risk,O,7150
139346,factors,O,7150
139347,for,O,7150
139348,developing,O,7150
139349,pterygium,B-NAME_OF_DISEASE,7150
139350,include,O,7150
139351,Living,B-CAUSE_OF_DISEASE,7150
139352,in,I-CAUSE_OF_DISEASE,7150
139353,a,I-CAUSE_OF_DISEASE,7150
139354,sunny,I-CAUSE_OF_DISEASE,7150
139355,or,I-CAUSE_OF_DISEASE,7150
139356,dry,I-CAUSE_OF_DISEASE,7151
139357,climate,I-CAUSE_OF_DISEASE,7151
139358,People,O,7151
139359,who,O,7151
139360,live,B-CAUSE_OF_DISEASE,7151
139361,in,I-CAUSE_OF_DISEASE,7151
139362,areas,I-CAUSE_OF_DISEASE,7151
139363,with,I-CAUSE_OF_DISEASE,7151
139364,high,I-CAUSE_OF_DISEASE,7151
139365,levels,I-CAUSE_OF_DISEASE,7151
139366,of,I-CAUSE_OF_DISEASE,7151
139367,UV,I-CAUSE_OF_DISEASE,7151
139368,light,I-CAUSE_OF_DISEASE,7151
139369,or,I-CAUSE_OF_DISEASE,7151
139370,low,I-CAUSE_OF_DISEASE,7151
139371,humidity,I-CAUSE_OF_DISEASE,7151
139372,may,O,7151
139373,be,O,7151
139374,more,O,7151
139375,at,O,7151
139376,risk,O,7151
139377,of,O,7151
139378,developing,O,7151
139379,pterygium,B-NAME_OF_DISEASE,7151
139380,Working,B-CAUSE_OF_DISEASE,7151
139381,outdoors,I-CAUSE_OF_DISEASE,7151
139382,People,O,7151
139383,who,O,7151
139384,work,B-CAUSE_OF_DISEASE,7151
139385,in,I-CAUSE_OF_DISEASE,7151
139386,occupations,I-CAUSE_OF_DISEASE,7151
139387,that,I-CAUSE_OF_DISEASE,7151
139388,involve,I-CAUSE_OF_DISEASE,7151
139389,prolonged,I-CAUSE_OF_DISEASE,7151
139390,exposure,I-CAUSE_OF_DISEASE,7151
139391,to,I-CAUSE_OF_DISEASE,7152
139392,the,I-CAUSE_OF_DISEASE,7152
139393,sun,I-CAUSE_OF_DISEASE,7152
139394,wind,I-CAUSE_OF_DISEASE,7152
139395,or,I-CAUSE_OF_DISEASE,7152
139396,dust,I-CAUSE_OF_DISEASE,7152
139397,such,I-CAUSE_OF_DISEASE,7152
139398,as,I-CAUSE_OF_DISEASE,7152
139399,farmers,I-CAUSE_OF_DISEASE,7152
139400,construction,I-CAUSE_OF_DISEASE,7152
139401,workers,I-CAUSE_OF_DISEASE,7152
139402,and,I-CAUSE_OF_DISEASE,7152
139403,sailors,I-CAUSE_OF_DISEASE,7152
139404,may,O,7152
139405,be,O,7152
139406,more,O,7152
139407,prone,O,7152
139408,to,O,7152
139409,pterygium,B-NAME_OF_DISEASE,7152
139410,Being,B-CAUSE_OF_DISEASE,7152
139411,male,I-CAUSE_OF_DISEASE,7152
139412,Men,O,7152
139413,are,O,7152
139414,more,O,7152
139415,likely,O,7152
139416,to,O,7152
139417,develop,O,7152
139418,pterygium,B-NAME_OF_DISEASE,7152
139419,than,O,7152
139420,women,O,7152
139421,Having,B-CAUSE_OF_DISEASE,7152
139422,fair,B-CAUSE_OF_DISEASE,7152
139423,skin,I-CAUSE_OF_DISEASE,7152
139424,People,O,7152
139425,with,O,7152
139426,fair,B-CAUSE_OF_DISEASE,7152
139427,skin,I-CAUSE_OF_DISEASE,7152
139428,are,O,7153
139429,more,O,7153
139430,likely,O,7153
139431,to,O,7153
139432,develop,O,7153
139433,pterygium,B-NAME_OF_DISEASE,7153
139434,than,O,7153
139435,those,O,7153
139436,with,O,7153
139437,darker,O,7153
139438,skin,O,7153
139439,Family,B-CAUSE_OF_DISEASE,7153
139440,history,I-CAUSE_OF_DISEASE,7153
139441,There,O,7153
139442,may,O,7153
139443,be,O,7153
139444,a,B-CAUSE_OF_DISEASE,7153
139445,genetic,I-CAUSE_OF_DISEASE,7153
139446,component,I-CAUSE_OF_DISEASE,7153
139447,to,O,7153
139448,pterygium,B-NAME_OF_DISEASE,7153
139449,as,O,7153
139450,some,O,7153
139451,people,O,7153
139452,may,O,7153
139453,be,O,7153
139454,more,O,7153
139455,predisposed,O,7153
139456,to,O,7153
139457,developing,O,7153
139458,the,O,7153
139459,condition,O,7153
139460,due,O,7153
139461,to,O,7153
139462,their,O,7153
139463,family,B-CAUSE_OF_DISEASE,7153
139464,history,I-CAUSE_OF_DISEASE,7153
139465,While,B-CAUSE_OF_DISEASE,7153
139466,UV,I-CAUSE_OF_DISEASE,7153
139467,light,I-CAUSE_OF_DISEASE,7153
139468,wind,I-CAUSE_OF_DISEASE,7153
139469,and,I-CAUSE_OF_DISEASE,7154
139470,dust,I-CAUSE_OF_DISEASE,7154
139471,are,O,7154
139472,thought,O,7154
139473,to,O,7154
139474,be,O,7154
139475,the,O,7154
139476,main,O,7154
139477,contributing,O,7154
139478,factors,O,7154
139479,to,O,7154
139480,pterygium,B-NAME_OF_DISEASE,7154
139481,it,O,7154
139482,is,O,7154
139483,not,O,7154
139484,clear,O,7154
139485,why,O,7154
139486,some,O,7154
139487,people,O,7154
139488,are,O,7154
139489,more,O,7154
139490,prone,O,7154
139491,to,O,7154
139492,developing,O,7154
139493,the,O,7154
139494,condition,O,7154
139495,than,O,7154
139496,others,O,7154
139497,Some,O,7154
139498,research,O,7154
139499,suggests,O,7154
139500,that,O,7155
139501,inflammation,B-CAUSE_OF_DISEASE,7155
139502,may,O,7155
139503,play,O,7155
139504,a,O,7155
139505,role,O,7155
139506,in,O,7155
139507,the,O,7155
139508,development,O,7155
139509,of,O,7155
139510,pterygium,B-NAME_OF_DISEASE,7155
139511,and,O,7155
139512,that,O,7155
139513,people,O,7155
139514,with,O,7155
139515,certain,O,7155
139516,underlying,O,7155
139517,health,O,7155
139518,conditions,O,7155
139519,such,O,7155
139520,as,O,7155
139521,dry,B-NAME_OF_DISEASE,7155
139522,eye,I-NAME_OF_DISEASE,7155
139523,syndrome,I-NAME_OF_DISEASE,7155
139524,or,O,7155
139525,autoimmune,B-NAME_OF_DISEASE,7155
139526,diseases,I-NAME_OF_DISEASE,7155
139527,may,O,7156
139528,be,O,7156
139529,more,O,7156
139530,at,O,7156
139531,risk,O,7156
139532,Pinguecula,B-NAME_OF_DISEASE,7156
139533,vs,O,7156
139534,Pterygium,B-NAME_OF_DISEASE,7156
139535,What,O,7156
139536,Are,O,7156
139537,the,O,7156
139538,Differences,O,7156
139539,Pinguecula,B-NAME_OF_DISEASE,7156
139540,and,O,7156
139541,pterygium,B-NAME_OF_DISEASE,7156
139542,are,O,7156
139543,two,O,7156
139544,conditions,O,7156
139545,that,O,7156
139546,affect,O,7157
139547,the,B-PART_OF_THE_EYES,7157
139548,conjunctiva,I-PART_OF_THE_EYES,7157
139549,which,O,7157
139550,is,O,7157
139551,the,O,7157
139552,clear,O,7157
139553,membrane,O,7157
139554,that,O,7157
139555,covers,O,7157
139556,the,O,7157
139557,white,O,7157
139558,part,O,7157
139559,of,O,7157
139560,the,O,7157
139561,eye,O,7157
139562,and,O,7157
139563,lines,O,7157
139564,the,O,7157
139565,inside,O,7157
139566,of,O,7158
139567,the,B-PART_OF_THE_EYES,7158
139568,eyelids,I-PART_OF_THE_EYES,7158
139569,While,O,7158
139570,they,O,7158
139571,have,O,7158
139572,some,O,7158
139573,similarities,O,7158
139574,they,O,7158
139575,are,O,7158
139576,two,O,7158
139577,distinct,O,7158
139578,conditions,O,7158
139579,that,O,7158
139580,differ,O,7158
139581,in,O,7158
139582,several,O,7158
139583,ways,O,7158
139584,Location,O,7158
139585,A,O,7158
139586,pinguecula,B-NAME_OF_DISEASE,7158
139587,is,O,7158
139588,a,B-SIGN_AND_SYMPTOM,7158
139589,small,I-SIGN_AND_SYMPTOM,7158
139590,yellowish,I-SIGN_AND_SYMPTOM,7158
139591,or,I-SIGN_AND_SYMPTOM,7158
139592,flesh-colored,I-SIGN_AND_SYMPTOM,7158
139593,bump,I-SIGN_AND_SYMPTOM,7158
139594,that,I-SIGN_AND_SYMPTOM,7158
139595,appears,I-SIGN_AND_SYMPTOM,7158
139596,on,I-SIGN_AND_SYMPTOM,7158
139597,the,I-SIGN_AND_SYMPTOM,7158
139598,conjunctiva,I-SIGN_AND_SYMPTOM,7158
139599,usually,I-SIGN_AND_SYMPTOM,7158
139600,on,I-SIGN_AND_SYMPTOM,7158
139601,the,I-SIGN_AND_SYMPTOM,7159
139602,side,I-SIGN_AND_SYMPTOM,7159
139603,of,I-SIGN_AND_SYMPTOM,7159
139604,the,I-SIGN_AND_SYMPTOM,7159
139605,eye,I-SIGN_AND_SYMPTOM,7159
139606,closest,I-SIGN_AND_SYMPTOM,7159
139607,to,I-SIGN_AND_SYMPTOM,7159
139608,the,I-SIGN_AND_SYMPTOM,7159
139609,nose,I-SIGN_AND_SYMPTOM,7159
139610,It,O,7159
139611,does,O,7159
139612,not,O,7159
139613,typically,O,7159
139614,grow,O,7159
139615,beyond,O,7159
139616,the,B-PART_OF_THE_EYES,7159
139617,conjunctiva,I-PART_OF_THE_EYES,7159
139618,and,O,7159
139619,does,O,7159
139620,not,O,7159
139621,affect,O,7160
139622,the,B-PART_OF_THE_EYES,7160
139623,cornea,I-PART_OF_THE_EYES,7160
139624,which,O,7160
139625,is,O,7160
139626,the,O,7160
139627,clear,O,7160
139628,dome-shaped,O,7160
139629,surface,O,7160
139630,at,O,7160
139631,the,O,7160
139632,front,O,7160
139633,of,O,7160
139634,the,O,7160
139635,eye,O,7160
139636,that,O,7160
139637,helps,O,7160
139638,to,O,7160
139639,focus,O,7160
139640,light,O,7160
139641,A,O,7160
139642,pterygium,B-NAME_OF_DISEASE,7160
139643,on,O,7160
139644,the,O,7160
139645,other,O,7160
139646,hand,O,7160
139647,is,O,7160
139648,a,B-SIGN_AND_SYMPTOM,7161
139649,raised,I-SIGN_AND_SYMPTOM,7161
139650,fleshy,I-SIGN_AND_SYMPTOM,7161
139651,growth,I-SIGN_AND_SYMPTOM,7161
139652,that,I-SIGN_AND_SYMPTOM,7161
139653,starts,I-SIGN_AND_SYMPTOM,7161
139654,on,I-SIGN_AND_SYMPTOM,7161
139655,the,I-SIGN_AND_SYMPTOM,7161
139656,conjunctiva,I-SIGN_AND_SYMPTOM,7161
139657,and,I-SIGN_AND_SYMPTOM,7161
139658,can,I-SIGN_AND_SYMPTOM,7161
139659,spread,I-SIGN_AND_SYMPTOM,7161
139660,outward,I-SIGN_AND_SYMPTOM,7161
139661,onto,I-SIGN_AND_SYMPTOM,7161
139662,the,I-SIGN_AND_SYMPTOM,7161
139663,cornea,I-SIGN_AND_SYMPTOM,7161
139664,sometimes,O,7161
139665,causing,O,7161
139666,vision,O,7162
139667,problems,O,7162
139668,Causes,O,7162
139669,Both,O,7162
139670,pinguecula,B-NAME_OF_DISEASE,7162
139671,and,O,7162
139672,pterygium,B-NAME_OF_DISEASE,7162
139673,are,O,7162
139674,thought,O,7162
139675,to,O,7162
139676,be,O,7162
139677,caused,O,7162
139678,by,O,7162
139679,exposure,B-CAUSE_OF_DISEASE,7163
139680,to,I-CAUSE_OF_DISEASE,7163
139681,ultraviolet,I-CAUSE_OF_DISEASE,7163
139682,UV,I-CAUSE_OF_DISEASE,7163
139683,light,I-CAUSE_OF_DISEASE,7163
139684,wind,I-CAUSE_OF_DISEASE,7163
139685,and,I-CAUSE_OF_DISEASE,7163
139686,dust,I-CAUSE_OF_DISEASE,7163
139687,However,O,7163
139688,pterygium,B-NAME_OF_DISEASE,7163
139689,is,O,7163
139690,more,O,7163
139691,likely,O,7163
139692,to,O,7163
139693,be,O,7163
139694,associated,O,7163
139695,with,O,7164
139696,these,O,7164
139697,factors,O,7164
139698,and,O,7164
139699,is,O,7164
139700,believed,O,7164
139701,to,O,7164
139702,be,O,7164
139703,more,O,7164
139704,aggressive,O,7164
139705,than,O,7164
139706,pinguecula,B-NAME_OF_DISEASE,7164
139707,Some,O,7164
139708,research,O,7164
139709,suggests,O,7164
139710,that,O,7164
139711,inflammation,B-CAUSE_OF_DISEASE,7165
139712,may,O,7165
139713,play,O,7165
139714,a,O,7165
139715,role,O,7165
139716,in,O,7165
139717,the,O,7165
139718,development,O,7165
139719,of,O,7165
139720,pterygium,B-NAME_OF_DISEASE,7165
139721,and,O,7165
139722,that,O,7165
139723,people,O,7165
139724,with,O,7165
139725,certain,O,7165
139726,underlying,O,7165
139727,health,O,7165
139728,conditions,O,7165
139729,such,O,7165
139730,as,O,7165
139731,dry,B-NAME_OF_DISEASE,7165
139732,eye,I-NAME_OF_DISEASE,7165
139733,syndrome,I-NAME_OF_DISEASE,7166
139734,or,O,7166
139735,autoimmune,B-NAME_OF_DISEASE,7166
139736,diseases,I-NAME_OF_DISEASE,7166
139737,may,O,7166
139738,be,O,7166
139739,more,O,7166
139740,at,O,7166
139741,risk,O,7166
139742,Symptoms,O,7166
139743,Both,O,7166
139744,pinguecula,B-NAME_OF_DISEASE,7166
139745,and,O,7166
139746,pterygium,B-NAME_OF_DISEASE,7166
139747,can,O,7166
139748,cause,O,7167
139749,dryness,B-SIGN_AND_SYMPTOM,7167
139750,redness,I-SIGN_AND_SYMPTOM,7167
139751,and,I-SIGN_AND_SYMPTOM,7167
139752,discomfort,I-SIGN_AND_SYMPTOM,7167
139753,in,I-SIGN_AND_SYMPTOM,7167
139754,the,I-SIGN_AND_SYMPTOM,7167
139755,eye,I-SIGN_AND_SYMPTOM,7167
139756,as,I-SIGN_AND_SYMPTOM,7167
139757,well,I-SIGN_AND_SYMPTOM,7167
139758,as,I-SIGN_AND_SYMPTOM,7167
139759,sensitivity,I-SIGN_AND_SYMPTOM,7167
139760,to,I-SIGN_AND_SYMPTOM,7167
139761,light,I-SIGN_AND_SYMPTOM,7167
139762,However,O,7167
139763,pterygium,B-NAME_OF_DISEASE,7167
139764,is,O,7167
139765,more,O,7167
139766,likely,O,7167
139767,to,O,7167
139768,cause,O,7168
139769,blurred,B-SIGN_AND_SYMPTOM,7168
139770,vision,I-SIGN_AND_SYMPTOM,7168
139771,particularly,O,7168
139772,if,O,7168
139773,it,O,7168
139774,grows,O,7168
139775,over,O,7168
139776,the,B-PART_OF_THE_EYES,7168
139777,cornea,I-PART_OF_THE_EYES,7168
139778,and,O,7168
139779,may,O,7168
139780,cause,O,7168
139781,the,B-SIGN_AND_SYMPTOM,7168
139782,affected,I-SIGN_AND_SYMPTOM,7168
139783,eye,I-SIGN_AND_SYMPTOM,7168
139784,to,I-SIGN_AND_SYMPTOM,7168
139785,appear,I-SIGN_AND_SYMPTOM,7168
139786,swollen,I-SIGN_AND_SYMPTOM,7168
139787,and,I-SIGN_AND_SYMPTOM,7168
139788,red,I-SIGN_AND_SYMPTOM,7168
139789,Pinguecula,B-NAME_OF_DISEASE,7168
139790,on,O,7168
139791,the,O,7168
139792,other,O,7169
139793,hand,O,7169
139794,usually,O,7169
139795,does,O,7169
139796,not,O,7169
139797,affect,O,7169
139798,vision,O,7169
139799,and,O,7169
139800,may,O,7169
139801,not,O,7169
139802,cause,O,7169
139803,any,O,7169
139804,symptoms,O,7169
139805,at,O,7169
139806,all,O,7169
139807,Treatment,O,7169
139808,Pinguecula,B-NAME_OF_DISEASE,7169
139809,is,O,7169
139810,usually,O,7169
139811,a,B-SIGN_AND_SYMPTOM,7169
139812,benign,I-SIGN_AND_SYMPTOM,7169
139813,self-limiting,O,7169
139814,condition,O,7169
139815,that,O,7169
139816,does,O,7169
139817,not,O,7169
139818,require,O,7169
139819,treatment,O,7169
139820,In,O,7169
139821,some,O,7169
139822,cases,O,7169
139823,artificial,B-TREATMENT,7169
139824,tears,I-TREATMENT,7169
139825,or,I-TREATMENT,7169
139826,eye,I-TREATMENT,7169
139827,drops,I-TREATMENT,7169
139828,may,O,7170
139829,be,O,7170
139830,used,O,7170
139831,to,O,7170
139832,relieve,O,7170
139833,dryness,B-SIGN_AND_SYMPTOM,7170
139834,and,I-SIGN_AND_SYMPTOM,7170
139835,discomfort,I-SIGN_AND_SYMPTOM,7170
139836,Pterygium,B-NAME_OF_DISEASE,7170
139837,on,O,7170
139838,the,O,7170
139839,other,O,7170
139840,hand,O,7170
139841,may,O,7170
139842,require,O,7170
139843,treatment,O,7170
139844,if,O,7170
139845,it,O,7170
139846,is,O,7170
139847,causing,O,7170
139848,vision,B-SIGN_AND_SYMPTOM,7170
139849,problems,I-SIGN_AND_SYMPTOM,7171
139850,or,I-SIGN_AND_SYMPTOM,7171
139851,discomfort,I-SIGN_AND_SYMPTOM,7171
139852,Treatment,O,7171
139853,options,O,7171
139854,may,O,7171
139855,include,O,7171
139856,artificial,B-TREATMENT,7171
139857,tears,I-TREATMENT,7171
139858,sunglasses,B-TREATMENT,7171
139859,to,I-TREATMENT,7171
139860,protect,I-TREATMENT,7171
139861,the,I-TREATMENT,7171
139862,eyes,I-TREATMENT,7171
139863,from,I-TREATMENT,7171
139864,UV,I-TREATMENT,7171
139865,rays,I-TREATMENT,7171
139866,and,O,7171
139867,a,B-TREATMENT,7171
139868,wide-brimmed,I-TREATMENT,7171
139869,hat,I-TREATMENT,7171
139870,to,O,7171
139871,shade,O,7171
139872,the,O,7171
139873,eyes,O,7171
139874,In,O,7171
139875,more,O,7171
139876,severe,O,7171
139877,cases,O,7171
139878,surgery,B-TREATMENT,7171
139879,may,O,7172
139880,be,O,7172
139881,necessary,O,7172
139882,to,O,7172
139883,remove,O,7172
139884,the,O,7172
139885,growth,O,7172
139886,and,O,7172
139887,restore,O,7172
139888,vision,O,7172
139889,How,O,7172
139890,Is,O,7172
139891,Pterygium,B-NAME_OF_DISEASE,7172
139892,Treatment,O,7172
139893,Treatment,O,7172
139894,for,O,7172
139895,pterygium,B-NAME_OF_DISEASE,7172
139896,depends,O,7172
139897,on,O,7172
139898,the,O,7172
139899,severity,O,7172
139900,of,O,7172
139901,the,O,7173
139902,condition,O,7173
139903,and,O,7173
139904,the,O,7173
139905,symptoms,O,7173
139906,it,O,7173
139907,is,O,7173
139908,causing,O,7173
139909,Some,O,7173
139910,common,O,7173
139911,treatment,O,7173
139912,options,O,7173
139913,for,O,7173
139914,pterygium,B-NAME_OF_DISEASE,7173
139915,include,O,7173
139916,Artificial,B-TREATMENT,7173
139917,tears,I-TREATMENT,7173
139918,Using,B-TREATMENT,7173
139919,artificial,B-TREATMENT,7173
139920,tears,I-TREATMENT,7173
139921,to,I-TREATMENT,7173
139922,keep,I-TREATMENT,7173
139923,the,I-TREATMENT,7173
139924,eyes,I-TREATMENT,7173
139925,moist,I-TREATMENT,7173
139926,can,O,7173
139927,help,O,7173
139928,to,O,7173
139929,relieve,O,7174
139930,dryness,B-SIGN_AND_SYMPTOM,7174
139931,and,I-SIGN_AND_SYMPTOM,7174
139932,discomfort,I-SIGN_AND_SYMPTOM,7174
139933,Sunglasses,B-TREATMENT,7174
139934,and,I-TREATMENT,7174
139935,a,I-TREATMENT,7174
139936,wide-brimmed,I-TREATMENT,7174
139937,hat,I-TREATMENT,7174
139938,Wearing,B-TREATMENT,7174
139939,sunglasses,I-TREATMENT,7174
139940,and,I-TREATMENT,7174
139941,a,I-TREATMENT,7174
139942,wide-brimmed,I-TREATMENT,7174
139943,hat,I-TREATMENT,7174
139944,when,I-TREATMENT,7174
139945,outdoors,I-TREATMENT,7174
139946,can,O,7174
139947,help,O,7174
139948,to,O,7174
139949,protect,O,7174
139950,the,O,7174
139951,eyes,O,7174
139952,from,O,7175
139953,ultraviolet,B-CAUSE_OF_DISEASE,7175
139954,UV,I-CAUSE_OF_DISEASE,7175
139955,light,I-CAUSE_OF_DISEASE,7175
139956,and,I-CAUSE_OF_DISEASE,7175
139957,wind,I-CAUSE_OF_DISEASE,7175
139958,which,O,7175
139959,may,O,7175
139960,help,O,7175
139961,to,O,7175
139962,prevent,O,7175
139963,the,O,7175
139964,pterygium,B-NAME_OF_DISEASE,7175
139965,from,O,7175
139966,growing,O,7175
139967,or,O,7175
139968,recurring,O,7175
139969,Corticosteroid,B-NAME_OF_DRUG,7175
139970,eye,I-NAME_OF_DRUG,7175
139971,drops,I-NAME_OF_DRUG,7175
139972,In,O,7175
139973,some,O,7175
139974,cases,O,7175
139975,corticosteroid,B-NAME_OF_DRUG,7175
139976,eye,I-NAME_OF_DRUG,7175
139977,drops,I-NAME_OF_DRUG,7175
139978,may,O,7175
139979,be,O,7175
139980,prescribed,O,7175
139981,to,O,7175
139982,reduce,O,7175
139983,inflammation,B-SIGN_AND_SYMPTOM,7175
139984,and,O,7175
139985,prevent,O,7175
139986,the,O,7175
139987,pterygium,B-NAME_OF_DISEASE,7175
139988,from,O,7175
139989,growing,O,7175
139990,Surgery,B-TREATMENT,7175
139991,If,O,7176
139992,the,O,7176
139993,pterygium,B-NAME_OF_DISEASE,7176
139994,is,O,7176
139995,causing,O,7176
139996,vision,B-SIGN_AND_SYMPTOM,7176
139997,problems,I-SIGN_AND_SYMPTOM,7176
139998,or,I-SIGN_AND_SYMPTOM,7176
139999,discomfort,I-SIGN_AND_SYMPTOM,7176
140000,or,O,7176
140001,if,O,7176
140002,it,O,7176
140003,has,O,7176
140004,not,O,7176
140005,responded,O,7176
140006,to,O,7177
140007,other,O,7177
140008,treatments,O,7177
140009,surgery,B-TREATMENT,7177
140010,may,O,7177
140011,be,O,7177
140012,necessary,O,7177
140013,to,O,7177
140014,remove,O,7177
140015,the,O,7177
140016,growth,O,7177
140017,and,O,7177
140018,restore,O,7177
140019,vision,O,7177
140020,There,O,7177
140021,are,O,7178
140022,several,O,7178
140023,different,O,7178
140024,surgical,O,7178
140025,techniques,O,7178
140026,that,O,7178
140027,can,O,7178
140028,be,O,7178
140029,used,O,7178
140030,to,O,7178
140031,remove,O,7179
140032,pterygium,B-NAME_OF_DISEASE,7179
140033,including,O,7179
140034,simple,B-TREATMENT,7179
140035,excision,I-TREATMENT,7179
140036,conjunctival,B-TREATMENT,7179
140037,autograft,I-TREATMENT,7179
140038,and,O,7179
140039,amniotic,B-TREATMENT,7180
140040,membrane,I-TREATMENT,7180
140041,grafting,I-TREATMENT,7180
140042,It,O,7180
140043,is,O,7180
140044,important,O,7180
140045,to,O,7180
140046,see,O,7180
140047,an,O,7180
140048,eye,O,7180
140049,doctor,O,7180
140050,for,O,7180
140051,a,O,7180
140052,proper,O,7180
140053,diagnosis,O,7180
140054,and,O,7180
140055,treatment,O,7180
140056,if,O,7180
140057,you,O,7181
140058,are,O,7181
140059,experiencing,O,7181
140060,symptoms,O,7181
140061,of,O,7181
140062,pterygium,B-NAME_OF_DISEASE,7181
140063,such,O,7181
140064,as,O,7181
140065,dryness,B-SIGN_AND_SYMPTOM,7181
140066,redness,I-SIGN_AND_SYMPTOM,7181
140067,or,I-SIGN_AND_SYMPTOM,7181
140068,blurred,I-SIGN_AND_SYMPTOM,7181
140069,vision,I-SIGN_AND_SYMPTOM,7181
140070,The,O,7181
140071,eye,O,7181
140072,doctor,O,7181
140073,will,O,7181
140074,be,O,7181
140075,able,O,7181
140076,to,O,7181
140077,recommend,O,7181
140078,the,O,7181
140079,best,O,7181
140080,treatment,O,7181
140081,plan,O,7181
140082,based,O,7181
140083,on,O,7181
140084,the,O,7181
140085,severity,O,7181
140086,of,O,7181
140087,your,O,7181
140088,condition,O,7182
140089,and,O,7182
140090,your,O,7182
140091,specific,O,7182
140092,needs,O,7182
140093,Do,O,7182
140094,I,O,7182
140095,need,O,7182
140096,Pterygium,B-TREATMENT,7182
140097,Surgery,I-TREATMENT,7182
140098,Pterygium,B-TREATMENT,7182
140099,surgery,I-TREATMENT,7182
140100,may,O,7182
140101,be,O,7182
140102,recommended,O,7182
140103,if,O,7182
140104,the,O,7182
140105,pterygium,B-NAME_OF_DISEASE,7182
140106,is,O,7183
140107,causing,O,7183
140108,vision,B-SIGN_AND_SYMPTOM,7183
140109,problems,I-SIGN_AND_SYMPTOM,7183
140110,or,I-SIGN_AND_SYMPTOM,7183
140111,discomfort,I-SIGN_AND_SYMPTOM,7183
140112,or,O,7183
140113,if,O,7183
140114,it,O,7183
140115,has,O,7183
140116,not,O,7183
140117,responded,O,7183
140118,to,O,7183
140119,other,O,7183
140120,treatments,O,7183
140121,such,O,7183
140122,as,O,7184
140123,the,O,7185
140124,use,O,7185
140125,of,O,7185
140126,artificial,B-TREATMENT,7185
140127,tears,I-TREATMENT,7185
140128,or,O,7185
140129,corticosteroid,B-NAME_OF_DRUG,7185
140130,eye,I-NAME_OF_DRUG,7185
140131,drops,I-NAME_OF_DRUG,7185
140132,What,O,7185
140133,is,O,7185
140134,Endophthalmitis,B-NAME_OF_DISEASE,7185
140135,Endophthalmitis,B-NAME_OF_DISEASE,7185
140136,is,O,7185
140137,the,O,7185
140138,inflammation,O,7185
140139,of,O,7185
140140,the,O,7185
140141,internal,O,7185
140142,structures,O,7186
140143,of,O,7186
140144,the,O,7186
140145,eye,O,7186
140146,i.e,O,7186
140147,choroid,B-PART_OF_THE_EYES,7186
140148,retina,B-PART_OF_THE_EYES,7186
140149,and,O,7186
140150,vitreous,B-PART_OF_THE_EYES,7186
140151,which,O,7186
140152,most,O,7186
140153,commonly,O,7186
140154,occurs,O,7187
140155,as,O,7187
140156,an,O,7187
140157,acute,O,7187
140158,process,O,7187
140159,following,O,7187
140160,intraocular,O,7187
140161,surgery,O,7187
140162,The,O,7187
140163,term,O,7187
140164,endophthalmitis,B-NAME_OF_DISEASE,7187
140165,is,O,7188
140166,not,O,7188
140167,just,O,7188
140168,limited,O,7188
140169,to,O,7188
140170,post-operative,B-NAME_OF_DISEASE,7188
140171,endophthalmitis,I-NAME_OF_DISEASE,7188
140172,It,O,7188
140173,includes,O,7188
140174,endogenous,B-NAME_OF_DISEASE,7188
140175,and,I-NAME_OF_DISEASE,7188
140176,post-traumatic,I-NAME_OF_DISEASE,7188
140177,endophthalmitis,I-NAME_OF_DISEASE,7189
140178,as,O,7189
140179,well,O,7189
140180,Types,O,7189
140181,of,O,7189
140182,Endophthalmitis,B-NAME_OF_DISEASE,7189
140183,Endogenous,B-NAME_OF_DISEASE,7189
140184,endophthalmitis,I-NAME_OF_DISEASE,7189
140185,originates,O,7189
140186,from,O,7189
140187,sources,O,7189
140188,within,O,7189
140189,the,O,7189
140190,body,O,7189
140191,and,O,7189
140192,comprises,O,7190
140193,roughly,O,7190
140194,2-8%,O,7190
140195,of,O,7190
140196,endophthalmitis,B-NAME_OF_DISEASE,7190
140197,cases,O,7190
140198,Patients,O,7190
140199,frequently,O,7190
140200,have,O,7190
140201,an,O,7190
140202,underlying,O,7190
140203,disease,O,7190
140204,history,B-CAUSE_OF_DISEASE,7191
140205,of,I-CAUSE_OF_DISEASE,7191
140206,recent,I-CAUSE_OF_DISEASE,7191
140207,intravenous,I-CAUSE_OF_DISEASE,7191
140208,infusion,I-CAUSE_OF_DISEASE,7191
140209,Diabetes,B-CAUSE_OF_DISEASE,7191
140210,Mellitus,I-CAUSE_OF_DISEASE,7191
140211,HIV,B-CAUSE_OF_DISEASE,7191
140212,intravenous,B-CAUSE_OF_DISEASE,7191
140213,drug,I-CAUSE_OF_DISEASE,7191
140214,misuse,I-CAUSE_OF_DISEASE,7191
140215,renal,B-CAUSE_OF_DISEASE,7191
140216,failure,I-CAUSE_OF_DISEASE,7191
140217,on,I-CAUSE_OF_DISEASE,7191
140218,dialysis,I-CAUSE_OF_DISEASE,7191
140219,heart,B-CAUSE_OF_DISEASE,7191
140220,disease,I-CAUSE_OF_DISEASE,7192
140221,cancer,B-CAUSE_OF_DISEASE,7192
140222,use,B-CAUSE_OF_DISEASE,7192
140223,of,I-CAUSE_OF_DISEASE,7192
140224,immunosuppressive,I-CAUSE_OF_DISEASE,7192
140225,medication,I-CAUSE_OF_DISEASE,7192
140226,or,O,7192
140227,indwelling,B-CAUSE_OF_DISEASE,7192
140228,catheters,I-CAUSE_OF_DISEASE,7192
140229,Liver,B-CAUSE_OF_DISEASE,7192
140230,abscess,I-CAUSE_OF_DISEASE,7192
140231,is,O,7192
140232,the,O,7192
140233,most,O,7192
140234,common,O,7192
140235,extraocular,O,7192
140236,foci,O,7192
140237,of,O,7192
140238,infection,O,7192
140239,followed,O,7192
140240,by,O,7192
140241,pneumonia,B-CAUSE_OF_DISEASE,7193
140242,endocarditis,B-CAUSE_OF_DISEASE,7193
140243,and,O,7193
140244,soft,B-CAUSE_OF_DISEASE,7193
140245,tissue,I-CAUSE_OF_DISEASE,7193
140246,infection,I-CAUSE_OF_DISEASE,7193
140247,Post-operative,B-NAME_OF_DISEASE,7193
140248,endophthalmitis,I-NAME_OF_DISEASE,7193
140249,Following,O,7193
140250,cataract,B-CAUSE_OF_DISEASE,7193
140251,surgery,I-CAUSE_OF_DISEASE,7193
140252,the,O,7193
140253,incidence,O,7193
140254,rate,O,7193
140255,of,O,7194
140256,endophthalmitis,B-NAME_OF_DISEASE,7194
140257,is,O,7194
140258,1,O,7194
140259,in,O,7194
140260,1,O,7194
140261,0,O,7194
140262,0.1,O,7194
140263,,O,7194
140264,In,O,7194
140265,comparison,O,7194
140266,it,O,7194
140267,is,O,7195
140268,ten,O,7195
140269,times,O,7195
140270,greater,O,7195
140271,after,O,7195
140272,glaucoma,B-CAUSE_OF_DISEASE,7195
140273,surgery,I-CAUSE_OF_DISEASE,7195
140274,1%,O,7195
140275,and,O,7195
140276,100,O,7195
140277,times,O,7195
140278,higher,O,7195
140279,after,O,7195
140280,trauma,B-CAUSE_OF_DISEASE,7195
140281,5-10%,O,7195
140282,,O,7195
140283,After,O,7196
140284,cataract,B-CAUSE_OF_DISEASE,7196
140285,surgery,I-CAUSE_OF_DISEASE,7196
140286,post-operative,B-NAME_OF_DISEASE,7196
140287,endophthalmitis,I-NAME_OF_DISEASE,7196
140288,is,O,7196
140289,a,O,7196
140290,rare,O,7196
140291,but,O,7196
140292,potentially,O,7196
140293,blinding,O,7196
140294,complication,O,7196
140295,Endophthalmitis,B-NAME_OF_DISEASE,7196
140296,may,O,7196
140297,arise,O,7196
140298,a,O,7196
140299,few,O,7196
140300,days,O,7196
140301,about,O,7196
140302,7-Jan,O,7196
140303,following,O,7196
140304,cataract,B-CAUSE_OF_DISEASE,7196
140305,surgery,I-CAUSE_OF_DISEASE,7197
140306,It,O,7197
140307,can,O,7197
140308,swiftly,O,7197
140309,lead,O,7197
140310,to,O,7197
140311,blindness,B-NAME_OF_DISEASE,7197
140312,if,O,7197
140313,not,O,7197
140314,diagnosed,O,7197
140315,and,O,7197
140316,treated,O,7197
140317,immediately,O,7197
140318,Injections,B-TREATMENT,7198
140319,of,I-TREATMENT,7198
140320,intravitreal,I-TREATMENT,7198
140321,antibiotics,I-TREATMENT,7198
140322,and,I-TREATMENT,7198
140323,vitreous,I-TREATMENT,7198
140324,aspiration,I-TREATMENT,7198
140325,for,I-TREATMENT,7198
140326,culture,I-TREATMENT,7198
140327,and,I-TREATMENT,7198
140328,sensitivity,I-TREATMENT,7198
140329,can,O,7198
140330,treat,O,7198
140331,most,O,7198
140332,patients,O,7198
140333,Vitrectomy,B-TREATMENT,7198
140334,also,O,7198
140335,treats,O,7198
140336,extreme,O,7198
140337,situations,O,7198
140338,where,O,7198
140339,the,B-PART_OF_THE_EYES,7198
140340,retina,I-PART_OF_THE_EYES,7198
140341,can,O,7198
140342,still,O,7198
140343,be,O,7198
140344,viewed,O,7198
140345,Even,O,7198
140346,with,O,7198
140347,quick,O,7198
140348,identification,O,7198
140349,and,O,7198
140350,treatment,O,7198
140351,many,O,7198
140352,eyes,O,7198
140353,affected,O,7198
140354,by,O,7198
140355,particular,O,7198
140356,aggressive,O,7198
140357,pathogens,O,7198
140358,are,O,7198
140359,frequently,O,7199
140360,lost,O,7199
140361,Any,O,7199
140362,post-cataract,O,7199
140363,surgery,O,7199
140364,patient,O,7199
140365,experiencing,O,7199
140366,pain,B-SIGN_AND_SYMPTOM,7199
140367,impaired,I-SIGN_AND_SYMPTOM,7199
140368,vision,I-SIGN_AND_SYMPTOM,7199
140369,or,I-SIGN_AND_SYMPTOM,7199
140370,growing,I-SIGN_AND_SYMPTOM,7199
140371,inflammation,I-SIGN_AND_SYMPTOM,7199
140372,must,O,7199
140373,be,O,7199
140374,evaluated,O,7199
140375,quickly,O,7199
140376,to,O,7199
140377,establish,O,7199
140378,the,O,7199
140379,presence,O,7199
140380,of,O,7199
140381,endophthalmitis,B-NAME_OF_DISEASE,7199
140382,Post,B-NAME_OF_DISEASE,7200
140383,Traumatic,I-NAME_OF_DISEASE,7200
140384,endophthalmitis,I-NAME_OF_DISEASE,7200
140385,25%,O,7200
140386,of,O,7200
140387,all,O,7200
140388,instances,O,7200
140389,of,O,7200
140390,endophthalmitis,B-NAME_OF_DISEASE,7200
140391,are,O,7200
140392,found,O,7200
140393,in,O,7200
140394,this,O,7200
140395,group,O,7200
140396,Endophthalmitis,B-NAME_OF_DISEASE,7200
140397,has,O,7200
140398,a,O,7200
140399,7%,O,7200
140400,probability,O,7200
140401,of,O,7200
140402,occurring,O,7201
140403,after,O,7201
140404,a,B-CAUSE_OF_DISEASE,7201
140405,ruptured,I-CAUSE_OF_DISEASE,7201
140406,globe,I-CAUSE_OF_DISEASE,7201
140407,injury,I-CAUSE_OF_DISEASE,7201
140408,There,O,7201
140409,is,O,7201
140410,an,O,7201
140411,increase,O,7201
140412,in,O,7201
140413,the,O,7201
140414,incidence,O,7201
140415,of,O,7201
140416,injuries,O,7201
140417,such,O,7201
140418,as,O,7202
140419,intraocular,B-CAUSE_OF_DISEASE,7203
140420,foreign,I-CAUSE_OF_DISEASE,7203
140421,body,I-CAUSE_OF_DISEASE,7203
140422,IOFB,I-CAUSE_OF_DISEASE,7203
140423,,O,7203
140424,Other,O,7203
140425,risk,O,7203
140426,factors,O,7203
140427,include,O,7203
140428,a,B-CAUSE_OF_DISEASE,7203
140429,contaminated,I-CAUSE_OF_DISEASE,7203
140430,wound,I-CAUSE_OF_DISEASE,7203
140431,lens,B-CAUSE_OF_DISEASE,7203
140432,capsule,I-CAUSE_OF_DISEASE,7203
140433,rupture,I-CAUSE_OF_DISEASE,7203
140434,age,B-CAUSE_OF_DISEASE,7204
140435,50+,I-CAUSE_OF_DISEASE,7205
140436,or,O,7205
140437,presenting,B-CAUSE_OF_DISEASE,7205
140438,more,I-CAUSE_OF_DISEASE,7205
140439,than,I-CAUSE_OF_DISEASE,7205
140440,24,I-CAUSE_OF_DISEASE,7205
140441,hours,I-CAUSE_OF_DISEASE,7205
140442,after,I-CAUSE_OF_DISEASE,7205
140443,the,I-CAUSE_OF_DISEASE,7205
140444,initial,I-CAUSE_OF_DISEASE,7205
140445,injury,I-CAUSE_OF_DISEASE,7205
140446,Penetrating,O,7205
140447,trauma,B-CAUSE_OF_DISEASE,7205
140448,with,O,7205
140449,IOFB,O,7205
140450,frequently,O,7205
140451,causes,O,7205
140452,infections,O,7205
140453,caused,O,7205
140454,by,O,7206
140455,Bacillus,B-CAUSE_OF_DISEASE,7206
140456,and,I-CAUSE_OF_DISEASE,7206
140457,Staphylococcus,I-CAUSE_OF_DISEASE,7206
140458,species,I-CAUSE_OF_DISEASE,7206
140459,Clinical,O,7206
140460,Features,O,7206
140461,of,O,7206
140462,Endophthalmitis,B-NAME_OF_DISEASE,7206
140463,Pain,B-SIGN_AND_SYMPTOM,7206
140464,Decreased,B-SIGN_AND_SYMPTOM,7206
140465,VA,I-SIGN_AND_SYMPTOM,7206
140466,Lid,B-SIGN_AND_SYMPTOM,7207
140467,edema,I-SIGN_AND_SYMPTOM,7208
140468,and,I-SIGN_AND_SYMPTOM,7208
140469,chemosis,I-SIGN_AND_SYMPTOM,7208
140470,Corneal,B-SIGN_AND_SYMPTOM,7208
140471,haze,I-SIGN_AND_SYMPTOM,7208
140472,AC,B-SIGN_AND_SYMPTOM,7208
140473,activity,I-SIGN_AND_SYMPTOM,7208
140474,hypopyon,I-SIGN_AND_SYMPTOM,7208
140475,fibrin,I-SIGN_AND_SYMPTOM,7208
140476,Absent,B-SIGN_AND_SYMPTOM,7208
140477,red,I-SIGN_AND_SYMPTOM,7208
140478,reflex,I-SIGN_AND_SYMPTOM,7208
140479,Vitritis,B-SIGN_AND_SYMPTOM,7208
140480,Treatment,O,7208
140481,of,O,7208
140482,Endophthalmitis,B-NAME_OF_DISEASE,7208
140483,The,O,7208
140484,therapy,O,7208
140485,depends,O,7208
140486,on,O,7208
140487,the,O,7208
140488,isolation,O,7208
140489,of,O,7208
140490,the,O,7208
140491,organism,O,7208
140492,intensive,B-TREATMENT,7208
140493,medical,I-TREATMENT,7209
140494,care,I-TREATMENT,7210
140495,and,O,7210
140496,if,B-TREATMENT,7210
140497,necessary,I-TREATMENT,7210
140498,surgical,I-TREATMENT,7210
140499,intervention,I-TREATMENT,7210
140500,A,B-DIAGNOSTIC_TEST,7210
140501,B-scan,I-DIAGNOSTIC_TEST,7210
140502,Ultrasound,I-DIAGNOSTIC_TEST,7210
140503,scan,I-DIAGNOSTIC_TEST,7210
140504,to,O,7210
140505,show,O,7210
140506,the,O,7210
140507,intensity,O,7210
140508,of,O,7210
140509,vitritis,B-SIGN_AND_SYMPTOM,7210
140510,and,O,7210
140511,the,B-PART_OF_THE_EYES,7210
140512,retina,I-PART_OF_THE_EYES,7210
140513,s,O,7211
140514,status,O,7212
140515,should,O,7212
140516,be,O,7212
140517,done,O,7212
140518,before,O,7212
140519,deciding,O,7212
140520,on,O,7212
140521,further,O,7212
140522,intervention,O,7212
140523,The,O,7212
140524,first,O,7212
140525,step,O,7213
140526,in,O,7213
140527,treatment,O,7213
140528,is,O,7213
140529,to,O,7213
140530,do,B-TREATMENT,7213
140531,aqueous,I-TREATMENT,7213
140532,humor,I-TREATMENT,7213
140533,AC,I-TREATMENT,7213
140534,tap,I-TREATMENT,7213
140535,and,I-TREATMENT,7213
140536,vitreous,B-TREATMENT,7213
140537,biopsy,I-TREATMENT,7213
140538,while,I-TREATMENT,7213
140539,administering,I-TREATMENT,7213
140540,intravitreal,B-TREATMENT,7213
140541,antibiotics,I-TREATMENT,7213
140542,,O,7213
140543,When,O,7213
140544,taking,O,7213
140545,a,O,7213
140546,sample,O,7213
140547,of,O,7213
140548,the,O,7213
140549,vitreous,O,7213
140550,fluid,O,7213
140551,it,O,7213
140552,is,O,7213
140553,best,O,7214
140554,to,O,7214
140555,utilize,O,7214
140556,an,O,7214
140557,automated,O,7214
140558,vitrector,O,7214
140559,1,O,7214
140560,Admission,O,7214
140561,The,O,7214
140562,patient,O,7214
140563,must,O,7214
140564,be,O,7214
140565,admitted,O,7214
140566,to,O,7214
140567,the,O,7214
140568,infected,O,7214
140569,ward,O,7214
140570,as,O,7215
140571,part,O,7215
140572,of,O,7215
140573,the,O,7215
140574,treatment,O,7215
140575,2,O,7215
140576,Intravitreal,B-TREATMENT,7215
140577,antibiotics,I-TREATMENT,7215
140578,Under,O,7215
140579,sterile,O,7215
140580,conditions,O,7215
140581,vancomycin,B-NAME_OF_DRUG,7215
140582,Gram-positive,O,7215
140583,cover,O,7215
140584,coupled,O,7215
140585,with,O,7215
140586,either,O,7215
140587,ceftazidime,B-NAME_OF_DRUG,7215
140588,or,O,7216
140589,amikacin,B-NAME_OF_DRUG,7216
140590,Gram-negative,O,7216
140591,cover,O,7216
140592,can,O,7216
140593,be,O,7216
140594,given,O,7216
140595,Precipitation,O,7216
140596,of,O,7216
140597,ceftazidime,B-NAME_OF_DRUG,7216
140598,with,O,7216
140599,vancomycin,B-NAME_OF_DRUG,7216
140600,necessitates,O,7217
140601,the,O,7217
140602,use,O,7217
140603,of,O,7217
140604,a,O,7217
140605,separate,O,7217
140606,syringe,O,7217
140607,3,O,7217
140608,Vitrectomy,B-TREATMENT,7217
140609,Immediate,B-TREATMENT,7217
140610,vitrectomy,I-TREATMENT,7217
140611,is,O,7217
140612,only,O,7217
140613,beneficial,O,7217
140614,in,O,7217
140615,patients,O,7217
140616,with,O,7217
140617,a,O,7217
140618,perception,O,7218
140619,of,O,7218
140620,light,O,7218
140621,vision,O,7218
140622,or,O,7218
140623,worse-no,O,7218
140624,benefit,O,7218
140625,of,O,7218
140626,IV,B-NAME_OF_DRUG,7218
140627,antibiotics,I-NAME_OF_DRUG,7218
140628,as,O,7218
140629,per,O,7218
140630,the,O,7218
140631,Endophthalmitis,B-NAME_OF_DISEASE,7218
140632,vitrectomy,O,7218
140633,study,O,7218
140634,4,O,7218
140635,Topical,B-TREATMENT,7218
140636,antibiotics,I-TREATMENT,7218
140637,such,O,7218
140638,as,O,7218
140639,hourly,O,7219
140640,fortified,O,7219
140641,vancomycin,B-NAME_OF_DRUG,7219
140642,amikacin,B-NAME_OF_DRUG,7219
140643,or,O,7219
140644,ceftazidime,B-NAME_OF_DRUG,7219
140645,may,O,7219
140646,raise,O,7219
140647,intravitreal,O,7219
140648,medicines,O,7219
140649,concentration,O,7219
140650,in,O,7219
140651,the,O,7219
140652,anterior,O,7219
140653,segment,O,7219
140654,5,O,7219
140655,Corticosteroids,B-NAME_OF_DRUG,7219
140656,which,O,7219
140657,can,O,7219
140658,be,O,7219
140659,either,O,7219
140660,intravitreal,O,7219
140661,eye,O,7219
140662,drops,O,7219
140663,or,O,7219
140664,taken,O,7219
140665,orally,O,7219
140666,While,O,7219
140667,there,O,7219
140668,is,O,7219
140669,some,O,7219
140670,evidence,O,7219
140671,that,O,7220
140672,steroid,B-NAME_OF_DRUG,7220
140673,treatment,O,7220
140674,for,O,7220
140675,endophthalmitis,B-NAME_OF_DISEASE,7220
140676,can,O,7220
140677,reduce,O,7220
140678,inflammation,O,7220
140679,and,O,7220
140680,its,O,7220
140681,associated,O,7220
140682,complications,O,7220
140683,there,O,7220
140684,is,O,7220
140685,no,O,7220
140686,proof,O,7220
140687,that,O,7220
140688,this,O,7220
140689,treatment,O,7220
140690,will,O,7220
140691,enhance,O,7220
140692,visual,O,7220
140693,acuity,O,7220
140694,Failure,O,7220
140695,to,O,7220
140696,improve,O,7220
140697,beyond,O,7220
140698,24,O,7220
140699,hours,O,7220
140700,may,O,7220
140701,warrant,O,7220
140702,a,B-TREATMENT,7220
140703,second,I-TREATMENT,7220
140704,AC,I-TREATMENT,7220
140705,tap,I-TREATMENT,7221
140706,vitreous,B-TREATMENT,7221
140707,biopsy,I-TREATMENT,7221
140708,and,O,7221
140709,intravitreal,B-TREATMENT,7221
140710,antibiotics,I-TREATMENT,7221
140711,Prevention,O,7221
140712,of,O,7221
140713,Endophthalmitis,B-NAME_OF_DISEASE,7221
140714,When,O,7221
140715,care,O,7221
140716,is,O,7221
140717,taken,O,7221
140718,endophthalmitis,B-NAME_OF_DISEASE,7221
140719,can,O,7221
140720,be,O,7221
140721,avoided,O,7222
140722,just,O,7222
140723,like,O,7222
140724,any,O,7222
140725,other,O,7222
140726,soft,O,7222
140727,tissue,O,7222
140728,infection,O,7222
140729,Preventive,O,7222
140730,steps,O,7222
140731,should,O,7222
140732,be,O,7222
140733,taken,O,7222
140734,before,O,7222
140735,the,O,7222
140736,surgery,O,7222
140737,and,O,7222
140738,during,O,7222
140739,the,O,7222
140740,procedure,O,7222
140741,Preoperatively,B-PREVENTION,7222
140742,Conjunctival,I-PREVENTION,7222
140743,sac,I-PREVENTION,7222
140744,irrigation,I-PREVENTION,7222
140745,with,I-PREVENTION,7222
140746,5%,I-PREVENTION,7222
140747,povidone-iodine,I-PREVENTION,7223
140748,Topical,I-PREVENTION,7223
140749,antibiotics,I-PREVENTION,7223
140750,Intraoperatively,O,7223
140751,The,O,7223
140752,use,O,7223
140753,of,O,7223
140754,intracameral,O,7223
140755,cefuroxime,O,7223
140756,1,O,7223
140757,mg,O,7223
140758,0,O,7223
140759,ml,O,7223
140760,linked,O,7224
140761,with,O,7224
140762,a,O,7224
140763,fivefold,O,7224
140764,reduction,O,7224
140765,in,O,7224
140766,endophthalmitis,B-NAME_OF_DISEASE,7224
140767,risk,O,7224
140768,Proper,B-PREVENTION,7224
140769,management,I-PREVENTION,7224
140770,of,I-PREVENTION,7224
140771,any,I-PREVENTION,7224
140772,complications,I-PREVENTION,7224
140773,Proper,O,7224
140774,closure,O,7224
140775,of,O,7224
140776,wound,O,7225
140777,s,O,7225
140778,using,O,7225
140779,10,O,7225
140780,nylon,O,7225
140781,Use,B-PREVENTION,7225
140782,of,I-PREVENTION,7225
140783,systemic,I-PREVENTION,7225
140784,prophylactic,I-PREVENTION,7225
140785,antibiotics,I-PREVENTION,7225
140786,Vitreous,B-PREVENTION,7225
140787,tap,I-PREVENTION,7225
140788,for,I-PREVENTION,7225
140789,organism,I-PREVENTION,7225
140790,isolation,I-PREVENTION,7226
140791,Conjunctivitis,B-NAME_OF_DISEASE,7226
140792,also,O,7226
140793,known,O,7226
140794,as,O,7226
140795,pink,B-NAME_OF_DISEASE,7226
140796,eye,I-NAME_OF_DISEASE,7226
140797,is,O,7226
140798,an,O,7226
140799,inflammation,O,7226
140800,observed,O,7226
140801,in,O,7226
140802,the,B-PART_OF_THE_EYES,7226
140803,conjunctiva,I-PART_OF_THE_EYES,7226
140804,which,O,7226
140805,is,O,7226
140806,the,O,7226
140807,clear,O,7226
140808,tissue,O,7226
140809,covering,O,7226
140810,the,O,7226
140811,white,O,7226
140812,part,O,7226
140813,of,O,7226
140814,the,O,7226
140815,eye,O,7226
140816,and,O,7226
140817,lines,O,7226
140818,the,O,7226
140819,inside,O,7226
140820,of,O,7227
140821,the,B-PART_OF_THE_EYES,7227
140822,eyelid,I-PART_OF_THE_EYES,7227
140823,What,O,7227
140824,is,O,7227
140825,allergic,B-NAME_OF_DISEASE,7227
140826,conjunctivitis,I-NAME_OF_DISEASE,7227
140827,Allergic,B-NAME_OF_DISEASE,7227
140828,conjunctivitis,I-NAME_OF_DISEASE,7227
140829,is,O,7227
140830,usually,O,7227
140831,seen,O,7227
140832,when,O,7227
140833,a,O,7227
140834,person,O,7227
140835,s,O,7227
140836,eyes,O,7228
140837,come,O,7228
140838,into,O,7228
140839,contact,O,7228
140840,with,O,7228
140841,allergens,B-CAUSE_OF_DISEASE,7228
140842,and,I-CAUSE_OF_DISEASE,7228
140843,irritants,I-CAUSE_OF_DISEASE,7228
140844,like,I-CAUSE_OF_DISEASE,7228
140845,pollen,I-CAUSE_OF_DISEASE,7228
140846,dust,I-CAUSE_OF_DISEASE,7228
140847,and,I-CAUSE_OF_DISEASE,7228
140848,mold,I-CAUSE_OF_DISEASE,7229
140849,that,O,7229
140850,make,O,7229
140851,the,O,7229
140852,body,O,7229
140853,s,O,7229
140854,immune,O,7229
140855,system,O,7229
140856,overreact,O,7229
140857,Allergic,B-NAME_OF_DISEASE,7229
140858,conjunctivitis,I-NAME_OF_DISEASE,7229
140859,can,O,7229
140860,be,O,7229
140861,observed,O,7229
140862,in,O,7229
140863,two,O,7229
140864,different,O,7229
140865,types,O,7229
140866,seasonal,B-NAME_OF_DISEASE,7229
140867,allergic,I-NAME_OF_DISEASE,7229
140868,conjunctivitis,I-NAME_OF_DISEASE,7230
140869,and,O,7230
140870,perennial,B-NAME_OF_DISEASE,7230
140871,allergic,I-NAME_OF_DISEASE,7230
140872,conjunctivitis,I-NAME_OF_DISEASE,7230
140873,Seasonal,B-NAME_OF_DISEASE,7230
140874,allergic,I-NAME_OF_DISEASE,7230
140875,conjunctivitis,I-NAME_OF_DISEASE,7230
140876,The,O,7230
140877,seasonal,O,7230
140878,form,O,7231
140879,is,O,7231
140880,generally,O,7231
140881,associated,O,7231
140882,with,O,7231
140883,seasonal,O,7231
140884,allergies,O,7231
140885,that,O,7231
140886,are,O,7231
140887,seen,O,7231
140888,in,O,7231
140889,spring,O,7231
140890,and,O,7232
140891,summer,O,7232
140892,and,O,7232
140893,sometimes,O,7232
140894,during,O,7232
140895,the,O,7232
140896,fall,O,7232
140897,as,O,7232
140898,well,O,7232
140899,Being,O,7232
140900,exposed,O,7232
140901,to,O,7232
140902,airborne,B-CAUSE_OF_DISEASE,7232
140903,allergens,I-CAUSE_OF_DISEASE,7232
140904,like,I-CAUSE_OF_DISEASE,7232
140905,pollen,I-CAUSE_OF_DISEASE,7232
140906,and,I-CAUSE_OF_DISEASE,7233
140907,grass,I-CAUSE_OF_DISEASE,7233
140908,triggers,O,7233
140909,seasonal,B-NAME_OF_DISEASE,7233
140910,allergic,I-NAME_OF_DISEASE,7233
140911,conjunctivitis,I-NAME_OF_DISEASE,7233
140912,Perennial,B-NAME_OF_DISEASE,7234
140913,allergic,I-NAME_OF_DISEASE,7234
140914,conjunctivitis,I-NAME_OF_DISEASE,7234
140915,The,O,7234
140916,perennial,O,7234
140917,form,O,7234
140918,on,O,7234
140919,the,O,7234
140920,other,O,7234
140921,hand,O,7234
140922,can,O,7234
140923,be,O,7234
140924,seen,O,7234
140925,all,O,7234
140926,year,O,7234
140927,round,O,7234
140928,It,O,7234
140929,s,O,7234
140930,mainly,O,7234
140931,triggered,O,7234
140932,by,O,7235
140933,indoor,B-CAUSE_OF_DISEASE,7235
140934,allergens,I-CAUSE_OF_DISEASE,7235
140935,like,I-CAUSE_OF_DISEASE,7235
140936,dust,I-CAUSE_OF_DISEASE,7235
140937,mold,I-CAUSE_OF_DISEASE,7235
140938,spores,I-CAUSE_OF_DISEASE,7235
140939,and,I-CAUSE_OF_DISEASE,7235
140940,animal,I-CAUSE_OF_DISEASE,7235
140941,dander,I-CAUSE_OF_DISEASE,7235
140942,What,O,7235
140943,does,O,7235
140944,pink,B-NAME_OF_DISEASE,7235
140945,eye,I-NAME_OF_DISEASE,7235
140946,look,O,7235
140947,like,O,7235
140948,When,O,7235
140949,pink,B-NAME_OF_DISEASE,7235
140950,eye,I-NAME_OF_DISEASE,7235
140951,occurs,O,7235
140952,the,B-SIGN_AND_SYMPTOM,7236
140953,white,I-SIGN_AND_SYMPTOM,7236
140954,part,I-SIGN_AND_SYMPTOM,7236
140955,of,I-SIGN_AND_SYMPTOM,7236
140956,the,I-SIGN_AND_SYMPTOM,7236
140957,eye,I-SIGN_AND_SYMPTOM,7236
140958,has,I-SIGN_AND_SYMPTOM,7236
140959,a,I-SIGN_AND_SYMPTOM,7236
140960,pinky,I-SIGN_AND_SYMPTOM,7237
140961,to,I-SIGN_AND_SYMPTOM,7237
140962,reddish,I-SIGN_AND_SYMPTOM,7237
140963,look,I-SIGN_AND_SYMPTOM,7237
140964,and,I-SIGN_AND_SYMPTOM,7237
140965,your,I-SIGN_AND_SYMPTOM,7237
140966,eyelids,I-SIGN_AND_SYMPTOM,7237
140967,are,I-SIGN_AND_SYMPTOM,7237
140968,usually,I-SIGN_AND_SYMPTOM,7237
140969,puffy,I-SIGN_AND_SYMPTOM,7237
140970,or,I-SIGN_AND_SYMPTOM,7237
140971,droopy,I-SIGN_AND_SYMPTOM,7237
140972,Some,O,7237
140973,patients,O,7238
140974,observe,O,7238
140975,fluid,B-SIGN_AND_SYMPTOM,7238
140976,discharge,I-SIGN_AND_SYMPTOM,7238
140977,coming,I-SIGN_AND_SYMPTOM,7238
140978,from,I-SIGN_AND_SYMPTOM,7238
140979,the,I-SIGN_AND_SYMPTOM,7238
140980,infected,I-SIGN_AND_SYMPTOM,7238
140981,eye,I-SIGN_AND_SYMPTOM,7238
140982,crusting,I-SIGN_AND_SYMPTOM,7238
140983,on,I-SIGN_AND_SYMPTOM,7238
140984,the,I-SIGN_AND_SYMPTOM,7238
140985,eyelashes,I-SIGN_AND_SYMPTOM,7238
140986,and,I-SIGN_AND_SYMPTOM,7238
140987,eyelids,I-SIGN_AND_SYMPTOM,7238
140988,What,O,7238
140989,causes,O,7239
140990,conjunctivitis,B-NAME_OF_DISEASE,7239
140991,When,O,7239
140992,the,O,7239
140993,blood,O,7239
140994,vessels,O,7239
140995,in,O,7239
140996,the,O,7239
140997,clear,O,7239
140998,tissue,O,7239
140999,ie,O,7240
141000,the,B-PART_OF_THE_EYES,7240
141001,conjunctiva,I-PART_OF_THE_EYES,7240
141002,get,O,7240
141003,inflamed,O,7240
141004,the,O,7240
141005,blood,O,7240
141006,vessel,O,7240
141007,become,O,7240
141008,more,O,7240
141009,visible,O,7240
141010,and,O,7240
141011,the,O,7241
141012,color,O,7241
141013,of,O,7241
141014,the,O,7241
141015,eye,O,7241
141016,becomes,O,7241
141017,reddish,B-SIGN_AND_SYMPTOM,7241
141018,or,I-SIGN_AND_SYMPTOM,7241
141019,pinky,I-SIGN_AND_SYMPTOM,7241
141020,Some,O,7241
141021,of,O,7241
141022,the,O,7241
141023,causes,O,7241
141024,of,O,7241
141025,pink,B-NAME_OF_DISEASE,7241
141026,eye,I-NAME_OF_DISEASE,7241
141027,are,O,7242
141028,listed,O,7242
141029,below,O,7242
141030,Viruses,B-CAUSE_OF_DISEASE,7242
141031,One,O,7242
141032,of,O,7242
141033,the,O,7242
141034,most,O,7242
141035,common,O,7242
141036,causes,O,7242
141037,of,O,7242
141038,pink,B-NAME_OF_DISEASE,7242
141039,eye,I-NAME_OF_DISEASE,7242
141040,is,O,7242
141041,viruses,B-CAUSE_OF_DISEASE,7242
141042,Adenoviruses,B-CAUSE_OF_DISEASE,7242
141043,Coronavirus,B-CAUSE_OF_DISEASE,7242
141044,which,O,7242
141045,is,O,7242
141046,also,O,7242
141047,known,O,7242
141048,as,O,7242
141049,COVID-19,B-NAME_OF_DISEASE,7242
141050,are,O,7242
141051,among,O,7242
141052,the,O,7242
141053,viruses,B-CAUSE_OF_DISEASE,7242
141054,that,O,7243
141055,cause,O,7243
141056,pink,B-NAME_OF_DISEASE,7243
141057,eye,I-NAME_OF_DISEASE,7243
141058,Bacteria,B-CAUSE_OF_DISEASE,7243
141059,Bacteria,B-CAUSE_OF_DISEASE,7243
141060,also,O,7243
141061,irritate,O,7243
141062,the,O,7243
141063,eye,O,7243
141064,The,O,7243
141065,most,O,7243
141066,common,O,7243
141067,types,O,7244
141068,of,O,7244
141069,bacteria,B-CAUSE_OF_DISEASE,7244
141070,that,O,7244
141071,cause,O,7244
141072,bacterial,B-NAME_OF_DISEASE,7244
141073,conjunctivitis,I-NAME_OF_DISEASE,7244
141074,include,O,7244
141075,Staphylococcus,B-CAUSE_OF_DISEASE,7244
141076,aureus,I-CAUSE_OF_DISEASE,7244
141077,Haemophilus,B-CAUSE_OF_DISEASE,7244
141078,influenzae,I-CAUSE_OF_DISEASE,7244
141079,Streptococcus,B-CAUSE_OF_DISEASE,7244
141080,pneumonia,I-CAUSE_OF_DISEASE,7244
141081,and,O,7245
141082,Pseudomonas,B-CAUSE_OF_DISEASE,7245
141083,aeruginosa,I-CAUSE_OF_DISEASE,7245
141084,Meanwhile,O,7245
141085,Chlamydia,B-CAUSE_OF_DISEASE,7245
141086,trachomatis,I-CAUSE_OF_DISEASE,7245
141087,and,O,7245
141088,Neisseria,B-CAUSE_OF_DISEASE,7245
141089,gonorrhoeae,I-CAUSE_OF_DISEASE,7245
141090,can,O,7245
141091,also,O,7245
141092,cause,O,7245
141093,pink,B-NAME_OF_DISEASE,7245
141094,eye,I-NAME_OF_DISEASE,7245
141095,but,O,7245
141096,they,O,7246
141097,re,O,7246
141098,not,O,7246
141099,as,O,7246
141100,common,O,7246
141101,as,O,7246
141102,the,O,7246
141103,others,O,7246
141104,Allergens,B-CAUSE_OF_DISEASE,7246
141105,Allergic,B-NAME_OF_DISEASE,7246
141106,conjunctivitis,I-NAME_OF_DISEASE,7246
141107,can,O,7247
141108,be,O,7247
141109,seasonal,O,7247
141110,or,O,7247
141111,perennial,O,7247
141112,Generally,O,7247
141113,they,O,7247
141114,re,O,7247
141115,caused,O,7247
141116,by,O,7247
141117,air-bone,O,7247
141118,allergens,O,7247
141119,like,O,7247
141120,pollens,O,7247
141121,grass,O,7247
141122,dust,O,7247
141123,mite,O,7247
141124,etc,O,7247
141125,Irritating,B-CAUSE_OF_DISEASE,7247
141126,substances,I-CAUSE_OF_DISEASE,7248
141127,Cosmetics,I-CAUSE_OF_DISEASE,7248
141128,products,I-CAUSE_OF_DISEASE,7248
141129,shampoo,I-CAUSE_OF_DISEASE,7248
141130,contact,I-CAUSE_OF_DISEASE,7248
141131,lenses,I-CAUSE_OF_DISEASE,7248
141132,dirt,I-CAUSE_OF_DISEASE,7248
141133,smoke,I-CAUSE_OF_DISEASE,7248
141134,and,I-CAUSE_OF_DISEASE,7248
141135,pool,I-CAUSE_OF_DISEASE,7248
141136,chlorine,I-CAUSE_OF_DISEASE,7248
141137,may,O,7248
141138,cause,O,7248
141139,pink,B-NAME_OF_DISEASE,7249
141140,eye,I-NAME_OF_DISEASE,7249
141141,A,B-CAUSE_OF_DISEASE,7249
141142,foreign,I-CAUSE_OF_DISEASE,7249
141143,object,I-CAUSE_OF_DISEASE,7249
141144,in,I-CAUSE_OF_DISEASE,7249
141145,the,I-CAUSE_OF_DISEASE,7249
141146,eye,I-CAUSE_OF_DISEASE,7249
141147,may,O,7249
141148,cause,O,7249
141149,pink,B-NAME_OF_DISEASE,7249
141150,eye,I-NAME_OF_DISEASE,7249
141151,In,O,7249
141152,babies,O,7249
141153,blocked,B-CAUSE_OF_DISEASE,7249
141154,or,I-CAUSE_OF_DISEASE,7249
141155,incompletely,I-CAUSE_OF_DISEASE,7249
141156,opened,I-CAUSE_OF_DISEASE,7249
141157,tear,I-CAUSE_OF_DISEASE,7249
141158,ducts,I-CAUSE_OF_DISEASE,7250
141159,can,O,7250
141160,cause,O,7250
141161,pink,B-NAME_OF_DISEASE,7250
141162,eye,I-NAME_OF_DISEASE,7250
141163,Autoimmune,B-CAUSE_OF_DISEASE,7250
141164,diseases,I-CAUSE_OF_DISEASE,7250
141165,that,I-CAUSE_OF_DISEASE,7250
141166,cause,I-CAUSE_OF_DISEASE,7250
141167,the,I-CAUSE_OF_DISEASE,7250
141168,immune,I-CAUSE_OF_DISEASE,7250
141169,system,I-CAUSE_OF_DISEASE,7250
141170,to,I-CAUSE_OF_DISEASE,7250
141171,overreact,I-CAUSE_OF_DISEASE,7250
141172,are,O,7250
141173,a,O,7250
141174,rare,O,7251
141175,cause,O,7251
141176,of,O,7251
141177,pink,B-NAME_OF_DISEASE,7251
141178,eye,I-NAME_OF_DISEASE,7251
141179,How,O,7251
141180,long,O,7251
141181,does,O,7251
141182,conjunctivitis,B-NAME_OF_DISEASE,7251
141183,take,O,7252
141184,to,O,7252
141185,recover,O,7252
141186,How,O,7252
141187,long,O,7252
141188,the,O,7252
141189,condition,O,7252
141190,lasts,O,7252
141191,depends,O,7252
141192,on,O,7252
141193,what,O,7252
141194,type,O,7252
141195,of,O,7252
141196,conjunctivitis,B-NAME_OF_DISEASE,7252
141197,pink,B-NAME_OF_DISEASE,7252
141198,eye,I-NAME_OF_DISEASE,7252
141199,you,O,7252
141200,have,O,7252
141201,and,O,7252
141202,how,O,7252
141203,you,O,7252
141204,treat,O,7252
141205,it,O,7252
141206,Generally,O,7252
141207,the,B-NAME_OF_DISEASE,7252
141208,pink,I-NAME_OF_DISEASE,7252
141209,eye,I-NAME_OF_DISEASE,7252
141210,should,O,7252
141211,recover,O,7253
141212,within,B-TIME_DURATION,7253
141213,a,I-TIME_DURATION,7253
141214,few,I-TIME_DURATION,7253
141215,days,I-TIME_DURATION,7253
141216,to,I-TIME_DURATION,7253
141217,two,I-TIME_DURATION,7253
141218,weeks,I-TIME_DURATION,7253
141219,As,O,7253
141220,mentioned,O,7253
141221,earlier,O,7253
141222,there,O,7253
141223,are,O,7253
141224,several,O,7253
141225,types,O,7253
141226,of,O,7253
141227,conjunctivitis,B-NAME_OF_DISEASE,7253
141228,which,O,7253
141229,are,O,7254
141230,viral,O,7254
141231,and,O,7254
141232,bacterial,O,7254
141233,If,O,7254
141234,you,O,7254
141235,are,O,7254
141236,experiencing,O,7254
141237,viral,B-NAME_OF_DISEASE,7254
141238,pink,I-NAME_OF_DISEASE,7254
141239,eye,I-NAME_OF_DISEASE,7255
141240,it,O,7255
141241,s,O,7255
141242,caused,O,7255
141243,by,O,7255
141244,the,B-CAUSE_OF_DISEASE,7255
141245,viruses,I-CAUSE_OF_DISEASE,7255
141246,mentioned,O,7255
141247,above,O,7255
141248,The,O,7255
141249,recovery,O,7255
141250,without,O,7255
141251,treatment,O,7255
141252,is,O,7255
141253,in,B-TIME_DURATION,7255
141254,about,I-TIME_DURATION,7255
141255,7,I-TIME_DURATION,7255
141256,to,I-TIME_DURATION,7255
141257,14,I-TIME_DURATION,7256
141258,days,I-TIME_DURATION,7256
141259,Bacterial,B-NAME_OF_DISEASE,7256
141260,pink,I-NAME_OF_DISEASE,7256
141261,eye,I-NAME_OF_DISEASE,7256
141262,on,O,7256
141263,the,O,7256
141264,other,O,7256
141265,hand,O,7256
141266,is,O,7256
141267,caused,O,7256
141268,by,O,7256
141269,an,B-CAUSE_OF_DISEASE,7256
141270,infection,I-CAUSE_OF_DISEASE,7256
141271,with,I-CAUSE_OF_DISEASE,7256
141272,bacteria,I-CAUSE_OF_DISEASE,7256
141273,like,O,7256
141274,the,O,7256
141275,ones,O,7257
141276,mentioned,O,7257
141277,above,O,7257
141278,The,O,7257
141279,condition,O,7257
141280,starts,O,7257
141281,to,O,7257
141282,improve,O,7257
141283,within,B-TIME_DURATION,7257
141284,24,I-TIME_DURATION,7257
141285,hours,I-TIME_DURATION,7257
141286,when,O,7257
141287,antibiotic,B-TREATMENT,7257
141288,treatment,I-TREATMENT,7257
141289,is,O,7257
141290,followed,O,7257
141291,Even,O,7257
141292,when,O,7257
141293,the,O,7257
141294,patient,O,7257
141295,doesn,O,7257
141296,t,O,7257
141297,use,O,7257
141298,antibiotics,B-TREATMENT,7257
141299,mild,O,7257
141300,pink,B-NAME_OF_DISEASE,7257
141301,eye,I-NAME_OF_DISEASE,7257
141302,generally,O,7257
141303,improves,O,7257
141304,within,B-TIME_DURATION,7257
141305,a,I-TIME_DURATION,7257
141306,span,I-TIME_DURATION,7258
141307,of,I-TIME_DURATION,7258
141308,ten,I-TIME_DURATION,7258
141309,days,I-TIME_DURATION,7258
141310,This,O,7258
141311,eye,O,7258
141312,condition,O,7258
141313,is,O,7258
141314,usually,O,7258
141315,contagious,O,7258
141316,once,O,7258
141317,you,O,7258
141318,have,O,7258
141319,the,O,7258
141320,symptoms,O,7258
141321,like,O,7258
141322,redness,B-SIGN_AND_SYMPTOM,7258
141323,tearing,I-SIGN_AND_SYMPTOM,7259
141324,and,I-SIGN_AND_SYMPTOM,7259
141325,crusting,I-SIGN_AND_SYMPTOM,7259
141326,The,O,7259
141327,symptoms,O,7259
141328,however,O,7259
141329,improve,O,7259
141330,in,B-TIME_DURATION,7259
141331,4,I-TIME_DURATION,7259
141332,to,I-TIME_DURATION,7259
141333,7,I-TIME_DURATION,7259
141334,days,I-TIME_DURATION,7259
141335,How,O,7259
141336,to,O,7259
141337,treat,O,7259
141338,conjunctivitis,B-NAME_OF_DISEASE,7260
141339,There,O,7260
141340,are,O,7260
141341,times,O,7260
141342,when,O,7260
141343,the,B-NAME_OF_DISEASE,7260
141344,pink,I-NAME_OF_DISEASE,7260
141345,eye,I-NAME_OF_DISEASE,7260
141346,is,O,7260
141347,mild,O,7260
141348,but,O,7260
141349,there,O,7260
141350,are,O,7260
141351,also,O,7260
141352,times,O,7260
141353,when,O,7260
141354,it,O,7260
141355,s,O,7260
141356,important,O,7260
141357,to,O,7260
141358,seek,O,7260
141359,medical,O,7260
141360,care,O,7260
141361,for,O,7260
141362,it,O,7260
141363,Cold,B-TREATMENT,7260
141364,compresses,I-TREATMENT,7260
141365,and,O,7260
141366,artificial,B-TREATMENT,7260
141367,tears,I-TREATMENT,7261
141368,can,O,7261
141369,be,O,7261
141370,used,O,7261
141371,to,O,7261
141372,relieve,O,7261
141373,the,B-SIGN_AND_SYMPTOM,7261
141374,inflammation,I-SIGN_AND_SYMPTOM,7261
141375,and,I-SIGN_AND_SYMPTOM,7261
141376,the,I-SIGN_AND_SYMPTOM,7261
141377,dryness,I-SIGN_AND_SYMPTOM,7261
141378,caused,O,7262
141379,by,O,7262
141380,conjunctivitis,B-NAME_OF_DISEASE,7262
141381,You,O,7262
141382,don,O,7262
141383,t,O,7262
141384,need,O,7262
141385,to,O,7262
141386,be,O,7262
141387,prescribed,O,7262
141388,to,O,7262
141389,get,O,7263
141390,them,O,7263
141391,Make,O,7263
141392,sure,O,7263
141393,to,O,7263
141394,refrain,B-TREATMENT,7263
141395,from,I-TREATMENT,7263
141396,using,I-TREATMENT,7263
141397,contact,I-TREATMENT,7263
141398,lenses,I-TREATMENT,7263
141399,until,I-TREATMENT,7263
141400,your,I-TREATMENT,7263
141401,doctor,I-TREATMENT,7263
141402,says,I-TREATMENT,7263
141403,you,I-TREATMENT,7263
141404,can,I-TREATMENT,7263
141405,start,I-TREATMENT,7263
141406,wearing,I-TREATMENT,7263
141407,them,I-TREATMENT,7263
141408,again,I-TREATMENT,7263
141409,If,O,7263
141410,you,O,7263
141411,didn,O,7263
141412,t,O,7264
141413,seek,O,7264
141414,medical,O,7264
141415,help,O,7264
141416,make,O,7264
141417,sure,O,7264
141418,your,O,7264
141419,symptoms,O,7264
141420,improve,O,7264
141421,before,O,7264
141422,you,O,7264
141423,start,O,7264
141424,wearing,O,7264
141425,them,O,7264
141426,again,O,7264
141427,How,O,7264
141428,do,O,7264
141429,you,O,7264
141430,stop,O,7264
141431,conjunctivitis,B-NAME_OF_DISEASE,7264
141432,from,O,7264
141433,spreading,O,7264
141434,If,O,7264
141435,you,O,7264
141436,are,O,7265
141437,around,O,7265
141438,someone,O,7265
141439,who,O,7265
141440,suffers,O,7265
141441,from,O,7265
141442,pink,B-NAME_OF_DISEASE,7265
141443,eye,I-NAME_OF_DISEASE,7265
141444,You,O,7265
141445,can,O,7265
141446,reduce,O,7265
141447,the,O,7265
141448,risk,O,7265
141449,of,O,7265
141450,getting,O,7265
141451,infected,O,7266
141452,by,O,7266
141453,following,O,7266
141454,the,O,7266
141455,steps,O,7266
141456,mentioned,O,7266
141457,below,O,7266
141458,Make,O,7266
141459,sure,O,7267
141460,to,O,7267
141461,wash,B-PREVENTION,7267
141462,your,I-PREVENTION,7267
141463,hands,I-PREVENTION,7267
141464,often,I-PREVENTION,7267
141465,with,I-PREVENTION,7267
141466,soap,I-PREVENTION,7267
141467,and,I-PREVENTION,7267
141468,warm,I-PREVENTION,7267
141469,water,I-PREVENTION,7267
141470,for,I-PREVENTION,7267
141471,at,I-PREVENTION,7267
141472,least,I-PREVENTION,7267
141473,25,I-PREVENTION,7267
141474,seconds,I-PREVENTION,7267
141475,If,O,7267
141476,they,O,7267
141477,are,O,7267
141478,not,O,7267
141479,available,O,7268
141480,you,O,7268
141481,can,O,7268
141482,use,B-PREVENTION,7268
141483,alcohol-based,I-PREVENTION,7269
141484,hand,I-PREVENTION,7269
141485,sanitizer,I-PREVENTION,7269
141486,to,I-PREVENTION,7269
141487,clean,I-PREVENTION,7269
141488,your,I-PREVENTION,7269
141489,hands,I-PREVENTION,7269
141490,Wash,B-PREVENTION,7269
141491,your,I-PREVENTION,7269
141492,hands,I-PREVENTION,7269
141493,when,I-PREVENTION,7269
141494,you,I-PREVENTION,7269
141495,happen,I-PREVENTION,7269
141496,to,I-PREVENTION,7269
141497,touch,I-PREVENTION,7269
141498,use,I-PREVENTION,7269
141499,the,I-PREVENTION,7269
141500,item,I-PREVENTION,7269
141501,that,I-PREVENTION,7269
141502,belongs,I-PREVENTION,7269
141503,to,I-PREVENTION,7269
141504,the,I-PREVENTION,7269
141505,infected,I-PREVENTION,7269
141506,person,I-PREVENTION,7269
141507,for,O,7269
141508,example,O,7269
141509,if,O,7269
141510,you,O,7269
141511,are,O,7269
141512,in,O,7270
141513,the,O,7270
141514,same,O,7270
141515,Office,O,7270
141516,exchanging,O,7270
141517,stationery,O,7270
141518,etc,O,7270
141519,after,O,7270
141520,helping,O,7270
141521,an,O,7270
141522,infected,O,7270
141523,person,O,7271
141524,with,O,7271
141525,applying,B-PREVENTION,7271
141526,eye,I-PREVENTION,7271
141527,drops,I-PREVENTION,7271
141528,or,I-PREVENTION,7271
141529,ointment,I-PREVENTION,7271
141530,Avoid,B-PREVENTION,7271
141531,touching,I-PREVENTION,7271
141532,your,I-PREVENTION,7271
141533,eyes,I-PREVENTION,7271
141534,if,I-PREVENTION,7271
141535,you,I-PREVENTION,7272
141536,didn,I-PREVENTION,7272
141537,t,I-PREVENTION,7272
141538,wash,I-PREVENTION,7272
141539,your,I-PREVENTION,7272
141540,hands,I-PREVENTION,7272
141541,Try,B-PREVENTION,7272
141542,not,I-PREVENTION,7272
141543,to,I-PREVENTION,7272
141544,share,I-PREVENTION,7272
141545,items,I-PREVENTION,7272
141546,used,I-PREVENTION,7272
141547,by,I-PREVENTION,7272
141548,the,I-PREVENTION,7272
141549,infected,I-PREVENTION,7272
141550,person,I-PREVENTION,7273
141551,like,I-PREVENTION,7273
141552,pillows,I-PREVENTION,7273
141553,towels,I-PREVENTION,7273
141554,eye,I-PREVENTION,7273
141555,drops,I-PREVENTION,7273
141556,cosmetics-,I-PREVENTION,7273
141557,especially,I-PREVENTION,7273
141558,makeup,I-PREVENTION,7273
141559,products-,I-PREVENTION,7273
141560,eyeglasses,I-PREVENTION,7273
141561,and,I-PREVENTION,7273
141562,contact,I-PREVENTION,7273
141563,lenses,I-PREVENTION,7273
141564,If,O,7273
141565,you,O,7273
141566,were,O,7273
141567,infected,O,7273
141568,and,O,7274
141569,trying,O,7274
141570,to,O,7274
141571,avoid,O,7274
141572,having,O,7274
141573,it,O,7274
141574,again,O,7274
141575,There,O,7274
141576,are,O,7274
141577,some,O,7274
141578,steps,O,7274
141579,you,O,7274
141580,can,O,7274
141581,take,O,7274
141582,to,O,7274
141583,avoid,O,7274
141584,having,O,7274
141585,the,O,7275
141586,infection,O,7275
141587,again,O,7275
141588,If,O,7275
141589,possible,O,7275
141590,get,B-PREVENTION,7275
141591,rid,I-PREVENTION,7275
141592,of,I-PREVENTION,7275
141593,the,I-PREVENTION,7275
141594,makeup,I-PREVENTION,7275
141595,or,I-PREVENTION,7275
141596,brushes,I-PREVENTION,7275
141597,you,I-PREVENTION,7275
141598,used,I-PREVENTION,7275
141599,when,I-PREVENTION,7276
141600,you,I-PREVENTION,7276
141601,were,I-PREVENTION,7276
141602,infected,I-PREVENTION,7276
141603,If,O,7276
141604,not,O,7276
141605,make,O,7276
141606,sure,O,7276
141607,to,O,7276
141608,sanitize,O,7276
141609,them,O,7276
141610,properly,O,7276
141611,Make,B-PREVENTION,7276
141612,sure,I-PREVENTION,7276
141613,to,I-PREVENTION,7276
141614,throw,I-PREVENTION,7276
141615,away,I-PREVENTION,7276
141616,the,I-PREVENTION,7276
141617,disposable,I-PREVENTION,7276
141618,contact,I-PREVENTION,7276
141619,lenses,I-PREVENTION,7276
141620,and,I-PREVENTION,7276
141621,cases,I-PREVENTION,7277
141622,even,O,7277
141623,the,O,7277
141624,solutions,O,7277
141625,you,O,7277
141626,used,O,7277
141627,while,O,7277
141628,you,O,7277
141629,were,O,7277
141630,infected,O,7277
141631,Clean,B-PREVENTION,7277
141632,your,I-PREVENTION,7277
141633,eyeglasses,I-PREVENTION,7277
141634,properly,I-PREVENTION,7278
141635,Does,O,7278
141636,conjunctivitis,B-NAME_OF_DISEASE,7278
141637,get,O,7278
141638,worse,O,7278
141639,before,O,7278
141640,it,O,7278
141641,gets,O,7278
141642,better,O,7278
141643,The,O,7278
141644,symptoms,O,7278
141645,of,O,7278
141646,viral,B-NAME_OF_DISEASE,7278
141647,conjunctivitis,I-NAME_OF_DISEASE,7278
141648,pink,B-NAME_OF_DISEASE,7278
141649,eye,I-NAME_OF_DISEASE,7278
141650,usually,O,7278
141651,get,O,7278
141652,worse,O,7278
141653,on,O,7278
141654,the,O,7279
141655,second,O,7279
141656,or,O,7279
141657,third,O,7279
141658,day,O,7279
141659,before,O,7279
141660,they,O,7279
141661,start,O,7279
141662,to,O,7279
141663,improve,O,7279
141664,Unlike,O,7280
141665,bacterial,B-NAME_OF_DISEASE,7280
141666,conjunctivitis,I-NAME_OF_DISEASE,7280
141667,viral,B-NAME_OF_DISEASE,7280
141668,conjunctivitis,I-NAME_OF_DISEASE,7280
141669,tends,O,7280
141670,to,O,7280
141671,spread,O,7280
141672,to,O,7280
141673,both,O,7280
141674,eyes,O,7280
141675,The,O,7280
141676,symptoms,O,7280
141677,of,O,7280
141678,bacterial,B-NAME_OF_DISEASE,7281
141679,conjunctivitis,I-NAME_OF_DISEASE,7281
141680,may,O,7281
141681,worsen,O,7281
141682,before,O,7281
141683,you,O,7281
141684,start,O,7281
141685,antibiotics,B-TREATMENT,7281
141686,treatment,I-TREATMENT,7281
141687,Once,O,7281
141688,you,O,7281
141689,start,O,7281
141690,the,O,7281
141691,proper,O,7281
141692,treatment,O,7281
141693,the,O,7281
141694,symptoms,O,7281
141695,usually,O,7281
141696,clear,O,7281
141697,up,O,7281
141698,within,B-TIME_DURATION,7281
141699,a,I-TIME_DURATION,7281
141700,few,I-TIME_DURATION,7281
141701,days,I-TIME_DURATION,7281
141702,If,O,7281
141703,your,O,7281
141704,conjunctivitis,B-NAME_OF_DISEASE,7281
141705,symptoms,O,7281
141706,only,O,7281
141707,get,O,7281
141708,worse,O,7281
141709,make,O,7281
141710,sure,O,7281
141711,to,O,7281
141712,seek,B-TREATMENT,7281
141713,medical,I-TREATMENT,7281
141714,help,I-TREATMENT,7281
141715,before,O,7281
141716,starting,O,7281
141717,to,O,7281
141718,use,O,7281
141719,antibiotics,O,7281
141720,It,O,7281
141721,s,O,7281
141722,crucial,O,7281
141723,to,O,7281
141724,see,O,7281
141725,a,O,7281
141726,doctor,O,7281
141727,again,O,7281
141728,to,O,7281
141729,check,O,7281
141730,if,O,7281
141731,you,O,7281
141732,have,O,7281
141733,other,O,7282
141734,types,O,7282
141735,of,O,7282
141736,infection,O,7282
141737,How,O,7282
141738,do,O,7282
141739,you,O,7282
141740,clean,O,7282
141741,conjunctivitis,B-NAME_OF_DISEASE,7282
141742,eyes,O,7282
141743,Boil,B-TREATMENT,7282
141744,some,I-TREATMENT,7282
141745,water,I-TREATMENT,7282
141746,and,I-TREATMENT,7282
141747,let,I-TREATMENT,7282
141748,it,I-TREATMENT,7282
141749,cool,I-TREATMENT,7282
141750,down,I-TREATMENT,7282
141751,Wet,B-TREATMENT,7282
141752,your,I-TREATMENT,7282
141753,clean,I-TREATMENT,7282
141754,cotton,I-TREATMENT,7282
141755,wool,I-TREATMENT,7282
141756,pads,I-TREATMENT,7282
141757,in,I-TREATMENT,7282
141758,the,I-TREATMENT,7282
141759,water,I-TREATMENT,7282
141760,and,I-TREATMENT,7282
141761,gently,I-TREATMENT,7282
141762,wipe,I-TREATMENT,7282
141763,your,I-TREATMENT,7282
141764,eyelashes,I-TREATMENT,7282
141765,to,I-TREATMENT,7282
141766,clean,I-TREATMENT,7282
141767,the,I-TREATMENT,7282
141768,crusts,I-TREATMENT,7282
141769,on,I-TREATMENT,7282
141770,your,I-TREATMENT,7282
141771,lash,I-TREATMENT,7283
141772,line,I-TREATMENT,7283
141773,Make,B-TREATMENT,7283
141774,sure,I-TREATMENT,7283
141775,to,I-TREATMENT,7283
141776,hold,I-TREATMENT,7283
141777,a,I-TREATMENT,7283
141778,cold,I-TREATMENT,7283
141779,flannel,I-TREATMENT,7283
141780,on,I-TREATMENT,7283
141781,your,I-TREATMENT,7283
141782,eyes,I-TREATMENT,7283
141783,to,I-TREATMENT,7283
141784,relieve,I-TREATMENT,7283
141785,them,I-TREATMENT,7283
141786,Eye,B-NAME_OF_DISEASE,7283
141787,allergies,I-NAME_OF_DISEASE,7283
141788,are,O,7283
141789,the,B-SIGN_AND_SYMPTOM,7283
141790,irritation,I-SIGN_AND_SYMPTOM,7283
141791,of,I-SIGN_AND_SYMPTOM,7283
141792,the,I-SIGN_AND_SYMPTOM,7283
141793,eyes,I-SIGN_AND_SYMPTOM,7283
141794,with,O,7283
141795,allergic,B-CAUSE_OF_DISEASE,7283
141796,factors,I-CAUSE_OF_DISEASE,7283
141797,from,I-CAUSE_OF_DISEASE,7283
141798,the,I-CAUSE_OF_DISEASE,7283
141799,outside,I-CAUSE_OF_DISEASE,7283
141800,reacting,O,7283
141801,with,O,7283
141802,redness,B-SIGN_AND_SYMPTOM,7283
141803,itching,I-SIGN_AND_SYMPTOM,7284
141804,and,I-SIGN_AND_SYMPTOM,7284
141805,watering,I-SIGN_AND_SYMPTOM,7284
141806,Approximately,O,7284
141807,20%,O,7284
141808,of,O,7284
141809,the,O,7284
141810,world,O,7284
141811,s,O,7284
141812,population,O,7284
141813,has,O,7284
141814,eye,B-NAME_OF_DISEASE,7284
141815,allergies,I-NAME_OF_DISEASE,7284
141816,Eye,B-NAME_OF_DISEASE,7284
141817,allergies,I-NAME_OF_DISEASE,7284
141818,can,O,7284
141819,be,O,7284
141820,hereditary,B-CAUSE_OF_DISEASE,7284
141821,or,O,7284
141822,occur,O,7284
141823,from,O,7284
141824,outer,B-CAUSE_OF_DISEASE,7284
141825,factors,I-CAUSE_OF_DISEASE,7284
141826,such,I-CAUSE_OF_DISEASE,7284
141827,as,I-CAUSE_OF_DISEASE,7285
141828,dusty,I-CAUSE_OF_DISEASE,7286
141829,environments,I-CAUSE_OF_DISEASE,7286
141830,Wood,O,7286
141831,dust,O,7286
141832,that,O,7286
141833,occurs,O,7286
141834,when,O,7286
141835,cutting,O,7286
141836,wood,O,7286
141837,in,O,7286
141838,the,O,7286
141839,carpenter,O,7286
141840,s,O,7286
141841,workshop,O,7286
141842,dust,O,7286
141843,that,O,7286
141844,flies,O,7287
141845,on,O,7287
141846,unpaved,O,7287
141847,roads,O,7287
141848,dust,O,7287
141849,that,O,7287
141850,occurs,O,7287
141851,on,O,7287
141852,construction,O,7287
141853,sites,O,7287
141854,in,O,7287
141855,the,O,7287
141856,city,O,7288
141857,due,O,7288
141858,to,O,7288
141859,urban,O,7288
141860,transformation,O,7288
141861,dust,O,7288
141862,formed,O,7288
141863,from,O,7289
141864,sand,O,7289
141865,in,O,7289
141866,the,O,7289
141867,jean,O,7289
141868,stone,O,7289
141869,washing,O,7289
141870,workshop,O,7289
141871,in,O,7289
141872,short,O,7289
141873,all,O,7289
141874,of,O,7289
141875,these,O,7289
141876,examples,O,7289
141877,of,O,7290
141878,dusty,B-CAUSE_OF_DISEASE,7290
141879,environments,I-CAUSE_OF_DISEASE,7290
141880,can,O,7290
141881,easily,O,7290
141882,trigger,O,7290
141883,eye,B-NAME_OF_DISEASE,7290
141884,allergies,I-NAME_OF_DISEASE,7291
141885,Other,O,7292
141886,than,O,7292
141887,these,O,7292
141888,examples,O,7292
141889,getting,B-CAUSE_OF_DISEASE,7292
141890,exposed,I-CAUSE_OF_DISEASE,7292
141891,to,I-CAUSE_OF_DISEASE,7292
141892,cigarette,I-CAUSE_OF_DISEASE,7292
141893,smoke,I-CAUSE_OF_DISEASE,7292
141894,less,B-CAUSE_OF_DISEASE,7292
141895,tear,I-CAUSE_OF_DISEASE,7292
141896,production,I-CAUSE_OF_DISEASE,7292
141897,of,I-CAUSE_OF_DISEASE,7292
141898,eyes,I-CAUSE_OF_DISEASE,7293
141899,swimming,B-CAUSE_OF_DISEASE,7293
141900,in,I-CAUSE_OF_DISEASE,7293
141901,an,I-CAUSE_OF_DISEASE,7293
141902,unhygienic,I-CAUSE_OF_DISEASE,7293
141903,pool,I-CAUSE_OF_DISEASE,7293
141904,touching,B-CAUSE_OF_DISEASE,7293
141905,eyes,I-CAUSE_OF_DISEASE,7293
141906,with,I-CAUSE_OF_DISEASE,7294
141907,unclean,I-CAUSE_OF_DISEASE,7294
141908,hands,I-CAUSE_OF_DISEASE,7294
141909,and,O,7294
141910,applying,B-CAUSE_OF_DISEASE,7294
141911,eye,I-CAUSE_OF_DISEASE,7294
141912,makeup,I-CAUSE_OF_DISEASE,7294
141913,such,I-CAUSE_OF_DISEASE,7294
141914,as,I-CAUSE_OF_DISEASE,7294
141915,mascara,I-CAUSE_OF_DISEASE,7294
141916,and,I-CAUSE_OF_DISEASE,7294
141917,eyeliner,I-CAUSE_OF_DISEASE,7294
141918,can,O,7295
141919,also,O,7295
141920,cause,O,7295
141921,eye,B-NAME_OF_DISEASE,7295
141922,allergies,I-NAME_OF_DISEASE,7295
141923,What,O,7295
141924,are,O,7295
141925,the,O,7295
141926,3,O,7295
141927,Most,O,7296
141928,Common,O,7296
141929,Eye,B-NAME_OF_DISEASE,7296
141930,Allergies,I-NAME_OF_DISEASE,7296
141931,There,O,7296
141932,are,O,7296
141933,6,O,7296
141934,types,O,7296
141935,of,O,7296
141936,eye,B-NAME_OF_DISEASE,7297
141937,allergies,I-NAME_OF_DISEASE,7298
141938,which,O,7298
141939,differ,O,7298
141940,according,O,7298
141941,to,O,7298
141942,the,O,7298
141943,probability,O,7298
141944,of,O,7298
141945,having,O,7298
141946,a,O,7298
141947,low,O,7298
141948,or,O,7298
141949,high,O,7298
141950,risk,O,7298
141951,of,O,7298
141952,damaging,O,7298
141953,the,B-PART_OF_THE_EYES,7298
141954,cornea,I-PART_OF_THE_EYES,7299
141955,The,O,7299
141956,most,O,7299
141957,common,O,7299
141958,types,O,7299
141959,of,O,7299
141960,these,O,7299
141961,eye,B-NAME_OF_DISEASE,7299
141962,allergies,I-NAME_OF_DISEASE,7299
141963,are,O,7299
141964,Perennial,B-NAME_OF_DISEASE,7299
141965,Allergic,I-NAME_OF_DISEASE,7299
141966,Conjunctivitis,I-NAME_OF_DISEASE,7299
141967,Seasonal,B-NAME_OF_DISEASE,7300
141968,Allergic,I-NAME_OF_DISEASE,7300
141969,Conjunctivitis,I-NAME_OF_DISEASE,7300
141970,allergic,B-NAME_OF_DISEASE,7300
141971,rhinoconjunctivitis,I-NAME_OF_DISEASE,7300
141972,and,O,7300
141973,Contact,B-NAME_OF_DISEASE,7300
141974,Allergic,I-NAME_OF_DISEASE,7300
141975,Conjunctivitis,I-NAME_OF_DISEASE,7300
141976,contact,B-NAME_OF_DISEASE,7300
141977,dermatoconjunctivitis,I-NAME_OF_DISEASE,7301
141978,,O,7301
141979,1,O,7301
141980,Perennial,B-NAME_OF_DISEASE,7301
141981,Allergic,I-NAME_OF_DISEASE,7301
141982,Conjunctivitis,I-NAME_OF_DISEASE,7301
141983,It,O,7301
141984,is,O,7301
141985,a,O,7301
141986,type,O,7301
141987,of,O,7301
141988,allergy,O,7301
141989,that,O,7302
141990,can,O,7302
141991,be,O,7302
141992,seen,O,7302
141993,all,O,7302
141994,year,O,7302
141995,round,O,7302
141996,Things,B-CAUSE_OF_DISEASE,7302
141997,such,I-CAUSE_OF_DISEASE,7302
141998,as,I-CAUSE_OF_DISEASE,7303
141999,pet,I-CAUSE_OF_DISEASE,7303
142000,hair,I-CAUSE_OF_DISEASE,7303
142001,dust,I-CAUSE_OF_DISEASE,7303
142002,and,I-CAUSE_OF_DISEASE,7303
142003,pollen,I-CAUSE_OF_DISEASE,7303
142004,are,O,7303
142005,causing,O,7303
142006,this,O,7303
142007,allergy,O,7303
142008,Its,O,7303
142009,symptoms,O,7303
142010,are,O,7303
142011,similar,O,7303
142012,to,O,7303
142013,seasonal,B-NAME_OF_DISEASE,7303
142014,allergies,I-NAME_OF_DISEASE,7303
142015,However,O,7303
142016,compared,O,7303
142017,to,O,7303
142018,seasonal,B-NAME_OF_DISEASE,7303
142019,allergic,I-NAME_OF_DISEASE,7303
142020,conjunctivitis,I-NAME_OF_DISEASE,7303
142021,the,O,7303
142022,symptoms,O,7303
142023,of,O,7303
142024,perennial,B-NAME_OF_DISEASE,7303
142025,allergic,I-NAME_OF_DISEASE,7303
142026,conjunctivitis,I-NAME_OF_DISEASE,7303
142027,are,O,7303
142028,milder,O,7303
142029,This,O,7303
142030,allergy,O,7304
142031,is,O,7304
142032,more,O,7304
142033,common,O,7304
142034,in,O,7304
142035,children,O,7304
142036,2,O,7304
142037,Seasonal,B-NAME_OF_DISEASE,7304
142038,Allergic,I-NAME_OF_DISEASE,7304
142039,Conjunctivitis,I-NAME_OF_DISEASE,7304
142040,This,O,7304
142041,type,O,7304
142042,of,O,7305
142043,allergy,O,7305
142044,becomes,O,7305
142045,widespread,O,7305
142046,in,O,7305
142047,the,O,7305
142048,spring,O,7305
142049,season,O,7305
142050,Because,O,7305
142051,in,O,7305
142052,this,O,7305
142053,season,O,7305
142054,the,O,7305
142055,trees,O,7305
142056,are,O,7305
142057,blooming,O,7306
142058,The,B-CAUSE_OF_DISEASE,7306
142059,pollen,I-CAUSE_OF_DISEASE,7306
142060,of,I-CAUSE_OF_DISEASE,7306
142061,these,I-CAUSE_OF_DISEASE,7306
142062,flowers,I-CAUSE_OF_DISEASE,7306
142063,is,O,7306
142064,starting,O,7306
142065,to,O,7306
142066,spread,O,7306
142067,in,O,7306
142068,the,O,7306
142069,air,O,7306
142070,It,O,7306
142071,causes,O,7306
142072,redness,B-SIGN_AND_SYMPTOM,7306
142073,itchiness,I-SIGN_AND_SYMPTOM,7306
142074,and,I-SIGN_AND_SYMPTOM,7306
142075,watering,I-SIGN_AND_SYMPTOM,7306
142076,in,I-SIGN_AND_SYMPTOM,7306
142077,the,I-SIGN_AND_SYMPTOM,7306
142078,eyes,I-SIGN_AND_SYMPTOM,7306
142079,People,O,7306
142080,with,O,7306
142081,sensitive,O,7306
142082,bodies,O,7306
142083,can,O,7307
142084,also,O,7307
142085,face,O,7307
142086,nasal,B-SIGN_AND_SYMPTOM,7307
142087,discharge,I-SIGN_AND_SYMPTOM,7307
142088,3,O,7307
142089,Contact,B-NAME_OF_DISEASE,7307
142090,Allergic,I-NAME_OF_DISEASE,7307
142091,Conjunctivitis,I-NAME_OF_DISEASE,7307
142092,As,O,7307
142093,can,O,7307
142094,be,O,7308
142095,seen,O,7308
142096,from,O,7308
142097,the,O,7308
142098,name,O,7308
142099,this,O,7308
142100,allergy,O,7308
142101,is,O,7308
142102,caused,O,7308
142103,by,O,7308
142104,contact,B-CAUSE_OF_DISEASE,7308
142105,lenses,I-CAUSE_OF_DISEASE,7308
142106,People,O,7308
142107,with,O,7308
142108,sensitive,O,7309
142109,eyes,O,7309
142110,can,O,7309
142111,have,O,7309
142112,their,O,7309
142113,eyes,O,7309
142114,irritated,O,7309
142115,by,O,7309
142116,wearing,B-CAUSE_OF_DISEASE,7309
142117,contact,I-CAUSE_OF_DISEASE,7309
142118,lenses,I-CAUSE_OF_DISEASE,7309
142119,Contact,B-CAUSE_OF_DISEASE,7309
142120,lenses,I-CAUSE_OF_DISEASE,7309
142121,will,O,7309
142122,cause,O,7309
142123,itching,B-SIGN_AND_SYMPTOM,7310
142124,and,I-SIGN_AND_SYMPTOM,7310
142125,redness,I-SIGN_AND_SYMPTOM,7310
142126,in,I-SIGN_AND_SYMPTOM,7310
142127,the,I-SIGN_AND_SYMPTOM,7310
142128,eyes,I-SIGN_AND_SYMPTOM,7310
142129,Generally,O,7310
142130,it,O,7310
142131,s,O,7310
142132,not,O,7310
142133,recommended,O,7310
142134,to,O,7310
142135,wear,B-CAUSE_OF_DISEASE,7310
142136,contact,I-CAUSE_OF_DISEASE,7310
142137,lenses,I-CAUSE_OF_DISEASE,7310
142138,for,I-CAUSE_OF_DISEASE,7310
142139,sensitive,I-CAUSE_OF_DISEASE,7310
142140,eyes,I-CAUSE_OF_DISEASE,7311
142141,Otherwise,O,7311
142142,it,O,7311
142143,may,O,7311
142144,cause,O,7311
142145,permanent,O,7311
142146,damage,O,7311
142147,to,O,7311
142148,the,O,7311
142149,eyes,O,7311
142150,What,O,7311
142151,is,O,7311
142152,best,O,7312
142153,for,O,7312
142154,eye,B-NAME_OF_DISEASE,7312
142155,allergy,I-NAME_OF_DISEASE,7312
142156,Depending,O,7312
142157,on,O,7312
142158,the,O,7312
142159,stage,O,7312
142160,and,O,7312
142161,type,O,7312
142162,of,O,7312
142163,the,O,7312
142164,allergy,O,7312
142165,eye,B-NAME_OF_DISEASE,7312
142166,allergies,I-NAME_OF_DISEASE,7312
142167,can,O,7312
142168,cause,O,7312
142169,vision,B-NAME_OF_DISEASE,7312
142170,impairment,I-NAME_OF_DISEASE,7313
142171,corneal,B-SIGN_AND_SYMPTOM,7313
142172,damage,I-SIGN_AND_SYMPTOM,7313
142173,or,O,7313
142174,even,O,7313
142175,serious,O,7313
142176,health,O,7313
142177,problems,O,7313
142178,such,O,7313
142179,as,O,7314
142180,eye,B-SIGN_AND_SYMPTOM,7314
142181,loss,I-SIGN_AND_SYMPTOM,7314
142182,Therefore,O,7314
142183,a,O,7314
142184,person,O,7314
142185,with,O,7314
142186,an,B-NAME_OF_DISEASE,7314
142187,eye,I-NAME_OF_DISEASE,7315
142188,allergy,I-NAME_OF_DISEASE,7315
142189,should,O,7315
142190,see,O,7315
142191,an,O,7315
142192,ophthalmologist,O,7315
142193,first,O,7315
142194,Antihistamine,B-TREATMENT,7315
142195,eye,I-TREATMENT,7315
142196,drops,I-TREATMENT,7315
142197,which,O,7315
142198,the,O,7315
142199,doctor,O,7315
142200,is,O,7316
142201,going,O,7316
142202,to,O,7316
142203,prescribe,O,7316
142204,will,O,7316
142205,greatly,O,7316
142206,benefit,O,7316
142207,the,O,7316
142208,patient,O,7316
142209,And,O,7316
142210,what,O,7316
142211,else,O,7316
142212,can,O,7316
142213,be,O,7316
142214,done,O,7316
142215,for,O,7316
142216,eye,B-NAME_OF_DISEASE,7316
142217,allergy,I-NAME_OF_DISEASE,7316
142218,The,O,7316
142219,recommendations,O,7316
142220,listed,O,7316
142221,below,O,7316
142222,can,O,7317
142223,also,O,7318
142224,be,O,7318
142225,applicable,O,7318
142226,It,O,7318
142227,is,O,7318
142228,necessary,O,7318
142229,to,O,7318
142230,stay,B-TREATMENT,7318
142231,away,I-TREATMENT,7318
142232,from,I-TREATMENT,7318
142233,dusty,I-TREATMENT,7318
142234,environments,I-TREATMENT,7318
142235,Person,O,7319
142236,that,O,7319
142237,has,O,7319
142238,an,B-NAME_OF_DISEASE,7319
142239,eye,I-NAME_OF_DISEASE,7319
142240,allergy,I-NAME_OF_DISEASE,7319
142241,should,O,7319
142242,not,B-TREATMENT,7319
142243,wear,I-TREATMENT,7319
142244,eye,I-TREATMENT,7319
142245,makeup,I-TREATMENT,7319
142246,Eyes,B-TREATMENT,7319
142247,should,I-TREATMENT,7319
142248,be,I-TREATMENT,7319
142249,protected,I-TREATMENT,7319
142250,from,I-TREATMENT,7319
142251,dust,I-TREATMENT,7319
142252,pollen,I-TREATMENT,7320
142253,and,I-TREATMENT,7320
142254,harmful,I-TREATMENT,7320
142255,sun,I-TREATMENT,7320
142256,rays,I-TREATMENT,7320
142257,by,I-TREATMENT,7320
142258,wearing,I-TREATMENT,7320
142259,sunglasses,I-TREATMENT,7320
142260,Eyes,B-TREATMENT,7320
142261,shouldn,I-TREATMENT,7320
142262,t,I-TREATMENT,7320
142263,be,I-TREATMENT,7320
142264,rubbed,I-TREATMENT,7320
142265,especially,I-TREATMENT,7320
142266,if,I-TREATMENT,7320
142267,the,I-TREATMENT,7320
142268,person,I-TREATMENT,7320
142269,hasn,I-TREATMENT,7320
142270,t,I-TREATMENT,7320
142271,washed,I-TREATMENT,7320
142272,their,I-TREATMENT,7320
142273,hands,I-TREATMENT,7320
142274,yet,I-TREATMENT,7320
142275,Looking,O,7320
142276,at,O,7321
142277,electronic,O,7321
142278,devices,O,7321
142279,such,O,7321
142280,as,O,7321
142281,cell,O,7321
142282,phones,O,7321
142283,and,O,7321
142284,laptops,O,7321
142285,can,O,7321
142286,also,O,7321
142287,tire,O,7321
142288,and,O,7321
142289,dry,O,7321
142290,the,O,7322
142291,eyes,O,7322
142292,Therefore,O,7322
142293,a,O,7322
142294,lot,O,7322
142295,of,O,7322
142296,time,O,7322
142297,should,O,7322
142298,not,O,7322
142299,be,O,7322
142300,spent,O,7322
142301,with,O,7322
142302,such,O,7322
142303,devices,O,7322
142304,Long,B-TREATMENT,7322
142305,hot,I-TREATMENT,7322
142306,showers,I-TREATMENT,7322
142307,should,I-TREATMENT,7322
142308,be,I-TREATMENT,7322
142309,avoided,I-TREATMENT,7322
142310,since,O,7322
142311,the,B-CAUSE_OF_DISEASE,7322
142312,vapor,I-CAUSE_OF_DISEASE,7322
142313,of,I-CAUSE_OF_DISEASE,7322
142314,chloride,I-CAUSE_OF_DISEASE,7322
142315,in,I-CAUSE_OF_DISEASE,7322
142316,tap,I-CAUSE_OF_DISEASE,7322
142317,water,I-CAUSE_OF_DISEASE,7322
142318,can,O,7322
142319,damage,O,7322
142320,the,O,7322
142321,eyes,O,7322
142322,Swimming,B-TREATMENT,7322
142323,in,I-TREATMENT,7322
142324,an,I-TREATMENT,7322
142325,unhygienic,I-TREATMENT,7322
142326,pool,I-TREATMENT,7322
142327,should,I-TREATMENT,7322
142328,also,I-TREATMENT,7322
142329,be,I-TREATMENT,7322
142330,avoided,I-TREATMENT,7322
142331,Another,B-TREATMENT,7322
142332,person,I-TREATMENT,7322
142333,s,I-TREATMENT,7322
142334,towel,I-TREATMENT,7322
142335,should,I-TREATMENT,7322
142336,never,I-TREATMENT,7322
142337,be,I-TREATMENT,7322
142338,used,I-TREATMENT,7323
142339,We,O,7323
142340,care,O,7323
142341,more,O,7323
142342,about,O,7323
142343,our,O,7323
142344,health,O,7323
142345,by,O,7323
142346,aging,O,7323
142347,Especially,O,7323
142348,we,O,7323
142349,feel,O,7323
142350,vision,O,7323
142351,problems,O,7323
142352,easily,O,7323
142353,and,O,7323
142354,it,O,7323
142355,affects,O,7323
142356,the,O,7323
142357,quality,O,7323
142358,of,O,7323
142359,life,O,7323
142360,When,O,7323
142361,it,O,7323
142362,comes,O,7323
142363,to,O,7323
142364,the,O,7323
142365,doctor,O,7323
142366,names,O,7323
142367,in,O,7323
142368,presbyopia,B-NAME_OF_DISEASE,7323
142369,we,O,7323
142370,check,O,7323
142371,publications,O,7324
142372,and,O,7324
142373,success,O,7324
142374,stories,O,7324
142375,of,O,7324
142376,them,O,7324
142377,and,O,7324
142378,decide,O,7324
142379,on,O,7324
142380,the,O,7324
142381,surgery,O,7324
142382,Dr,O,7324
142383,George,B-PERSON,7325
142384,Waring,I-PERSON,7325
142385,is,O,7325
142386,one,O,7325
142387,the,O,7325
142388,well-known,O,7325
142389,and,O,7325
142390,top,O,7325
142391,ophthalmologists,O,7325
142392,in,O,7325
142393,cataract,B-TREATMENT,7325
142394,surgery,I-TREATMENT,7325
142395,In,O,7325
142396,this,O,7326
142397,article,O,7326
142398,you,O,7326
142399,will,O,7326
142400,find,O,7326
142401,more,O,7326
142402,about,O,7326
142403,George,B-PERSON,7326
142404,Waring,I-PERSON,7326
142405,MD,I-PERSON,7327
142406,his,O,7327
142407,working,O,7327
142408,areas,O,7327
142409,specialties,O,7327
142410,and,O,7327
142411,awards,O,7327
142412,Who,O,7327
142413,is,O,7327
142414,George,B-PERSON,7327
142415,Waring,I-PERSON,7327
142416,MD,I-PERSON,7327
142417,George,B-PERSON,7327
142418,Waring,I-PERSON,7327
142419,MD,I-PERSON,7327
142420,is,O,7327
142421,an,O,7327
142422,award-winning,O,7327
142423,refractive,O,7327
142424,and,O,7328
142425,cataract,B-NAME_OF_DISEASE,7328
142426,surgeon,O,7328
142427,who,O,7328
142428,is,O,7328
142429,also,O,7328
142430,the,O,7328
142431,founder,O,7328
142432,of,O,7328
142433,Waring,B-ORGANIZATION,7328
142434,Vision,B-ORGANIZATION,7328
142435,Institute,I-ORGANIZATION,7328
142436,He,O,7328
142437,studied,O,7329
142438,Economics,O,7329
142439,and,O,7329
142440,Ecology,O,7329
142441,and,O,7329
142442,completed,O,7329
142443,his,O,7329
142444,Doctor,O,7329
142445,of,O,7329
142446,Medicine,O,7329
142447,at,O,7329
142448,Emory,B-ORGANIZATION,7329
142449,University,I-ORGANIZATION,7329
142450,Since,O,7329
142451,he,O,7330
142452,is,O,7330
142453,active,O,7330
142454,in,O,7330
142455,ophthalmology,O,7330
142456,research,O,7330
142457,and,O,7330
142458,leads,O,7330
142459,technological,O,7330
142460,surgical,O,7330
142461,operations,O,7330
142462,internationally,O,7330
142463,George,B-PERSON,7330
142464,Waring,I-PERSON,7330
142465,MD,I-PERSON,7330
142466,is,O,7330
142467,on,O,7330
142468,the,O,7330
142469,Executive,O,7330
142470,Committee,O,7330
142471,of,O,7330
142472,the,B-ORGANIZATION,7330
142473,International,I-ORGANIZATION,7330
142474,Society,I-ORGANIZATION,7330
142475,of,I-ORGANIZATION,7330
142476,Refractive,I-ORGANIZATION,7330
142477,Surgery,I-ORGANIZATION,7330
142478,and,O,7330
142479,with,O,7331
142480,his,O,7331
142481,continuous,O,7331
142482,lecturing,O,7331
142483,position,O,7331
142484,he,O,7331
142485,is,O,7331
142486,the,O,7331
142487,Director,O,7331
142488,for,O,7331
142489,the,O,7331
142490,American,B-ORGANIZATION,7331
142491,Academy,I-ORGANIZATION,7331
142492,of,I-ORGANIZATION,7331
142493,Ophthalmology,I-ORGANIZATION,7331
142494,Laser,I-ORGANIZATION,7331
142495,Refractive,I-ORGANIZATION,7331
142496,Surgery,I-ORGANIZATION,7331
142497,Course,I-ORGANIZATION,7332
142498,George,B-PERSON,7332
142499,Waring,I-PERSON,7332
142500,Research,O,7332
142501,Topics,O,7332
142502,As,O,7332
142503,George,B-PERSON,7332
142504,Waring,I-PERSON,7332
142505,and,O,7332
142506,his,O,7332
142507,Vision,B-ORGANIZATION,7332
142508,Institute,I-ORGANIZATION,7332
142509,are,O,7332
142510,actively,O,7332
142511,working,O,7332
142512,on,O,7332
142513,clinical,O,7332
142514,research,O,7332
142515,in,O,7332
142516,the,O,7333
142517,ophthalmology,O,7333
142518,area,O,7333
142519,he,O,7333
142520,is,O,7333
142521,leading,O,7333
142522,his,O,7333
142523,field,O,7333
142524,as,O,7333
142525,a,O,7333
142526,surgeon,O,7333
142527,and,O,7333
142528,latest,O,7333
142529,technology,O,7333
142530,practitioner,O,7333
142531,He,O,7333
142532,is,O,7333
142533,known,O,7333
142534,as,O,7334
142535,the,O,7334
142536,leading,O,7334
142537,figure,O,7334
142538,in,O,7334
142539,correcting,O,7334
142540,presbyopia,B-NAME_OF_DISEASE,7334
142541,with,O,7334
142542,surgery,O,7334
142543,Actually,O,7334
142544,George,B-PERSON,7334
142545,Waring,I-PERSON,7334
142546,s,O,7334
142547,father,O,7334
142548,George,B-PERSON,7334
142549,Waring,I-PERSON,7334
142550,III,I-PERSON,7334
142551,was,O,7334
142552,a,O,7334
142553,pioneer,O,7335
142554,in,O,7335
142555,ophthalmology,O,7335
142556,He,O,7335
142557,established,O,7335
142558,the,O,7335
142559,first,O,7335
142560,eye,O,7335
142561,bank,O,7335
142562,in,O,7335
142563,Northern,B-GPE,7335
142564,California,I-GPE,7335
142565,His,O,7335
142566,refractive,O,7335
142567,surgery,O,7335
142568,trial,O,7336
142569,has,O,7336
142570,still,O,7336
142571,been,O,7336
142572,recognized,O,7336
142573,as,O,7336
142574,one,O,7336
142575,of,O,7336
142576,the,O,7336
142577,best,O,7336
142578,rigorously,O,7336
142579,applied,O,7336
142580,studies,O,7336
142581,in,O,7336
142582,the,O,7336
142583,field,O,7336
142584,Briefly,O,7336
142585,George,B-PERSON,7336
142586,Waring,I-PERSON,7336
142587,IV,I-PERSON,7336
142588,s,O,7336
142589,research,O,7336
142590,and,O,7337
142591,working,O,7337
142592,topics,O,7337
142593,are,O,7337
142594,LASIK,B-TREATMENT,7337
142595,surgery,I-TREATMENT,7337
142596,procedures,O,7337
142597,he,O,7337
142598,is,O,7337
142599,also,O,7337
142600,teaching,O,7337
142601,LASIK,B-TREATMENT,7337
142602,to,O,7337
142603,surgeons,O,7337
142604,all,O,7337
142605,around,O,7337
142606,the,O,7337
142607,world,O,7337
142608,Photorefractive,B-TREATMENT,7337
142609,keratectomy,I-TREATMENT,7337
142610,vision,O,7337
142611,correction,O,7337
142612,for,O,7337
142613,myopia,B-NAME_OF_DISEASE,7337
142614,hyperopia,B-NAME_OF_DISEASE,7337
142615,astigmatism,B-NAME_OF_DISEASE,7337
142616,or,O,7337
142617,presbyopia,B-NAME_OF_DISEASE,7337
142618,Clear,B-TREATMENT,7338
142619,Lens,I-TREATMENT,7338
142620,Exchange,I-TREATMENT,7338
142621,similar,O,7338
142622,to,O,7338
142623,cataract,B-TREATMENT,7338
142624,surgery,I-TREATMENT,7338
142625,involves,O,7338
142626,lens,O,7338
142627,replacement,O,7338
142628,for,O,7338
142629,presbyopia,B-NAME_OF_DISEASE,7338
142630,VUITY,B-NAME_OF_DRUG,7338
142631,eye,I-NAME_OF_DRUG,7338
142632,drop,I-NAME_OF_DRUG,7338
142633,for,O,7339
142634,the,O,7339
142635,treatment,O,7339
142636,of,O,7339
142637,presbyopia,B-NAME_OF_DISEASE,7339
142638,What,O,7339
142639,is,O,7339
142640,the,O,7339
142641,Vuity,B-NAME_OF_DRUG,7339
142642,Eye,I-NAME_OF_DRUG,7339
142643,Drop,I-NAME_OF_DRUG,7339
142644,By,O,7339
142645,aging,O,7339
142646,the,B-SIGN_AND_SYMPTOM,7339
142647,near,I-SIGN_AND_SYMPTOM,7339
142648,vision,I-SIGN_AND_SYMPTOM,7339
142649,gets,I-SIGN_AND_SYMPTOM,7340
142650,blurry,I-SIGN_AND_SYMPTOM,7340
142651,The,O,7340
142652,recent,O,7340
142653,development,O,7340
142654,and,O,7340
142655,application,O,7340
142656,for,O,7341
142657,the,B-NAME_OF_DISEASE,7341
142658,presbyopia,I-NAME_OF_DISEASE,7341
142659,treatment,O,7341
142660,is,O,7341
142661,the,B-NAME_OF_DRUG,7341
142662,Vuity,I-NAME_OF_DRUG,7341
142663,eye,I-NAME_OF_DRUG,7341
142664,drop,I-NAME_OF_DRUG,7342
142665,Although,O,7342
142666,the,O,7342
142667,current,O,7342
142668,alternative,O,7342
142669,options,O,7342
142670,are,O,7342
142671,wearing,B-TREATMENT,7342
142672,glasses,I-TREATMENT,7342
142673,and,O,7342
142674,using,B-TREATMENT,7342
142675,contact,I-TREATMENT,7342
142676,lenses,I-TREATMENT,7342
142677,Vuity,B-NAME_OF_DRUG,7342
142678,eye,I-NAME_OF_DRUG,7342
142679,drop,I-NAME_OF_DRUG,7342
142680,is,O,7343
142681,an,O,7343
142682,innovative,O,7343
142683,treatment,O,7343
142684,for,O,7343
142685,blurry,B-SIGN_AND_SYMPTOM,7343
142686,vision,I-SIGN_AND_SYMPTOM,7343
142687,that,O,7343
142688,is,O,7343
142689,the,O,7343
142690,only,O,7343
142691,FDA-approved,O,7344
142692,treatment,O,7344
142693,One,O,7344
142694,drop,O,7344
142695,of,O,7344
142696,Vuity,B-NAME_OF_DRUG,7344
142697,eye,I-NAME_OF_DRUG,7344
142698,drop,I-NAME_OF_DRUG,7344
142699,each,O,7344
142700,day,O,7344
142701,results,O,7344
142702,in,O,7344
142703,an,O,7344
142704,amazing,O,7344
142705,vision,O,7344
142706,correction,O,7344
142707,on,O,7344
142708,closer,O,7344
142709,reading,O,7344
142710,ability,O,7344
142711,The,O,7344
142712,main,O,7344
142713,focus,O,7344
142714,of,O,7344
142715,the,B-NAME_OF_DRUG,7344
142716,Vuity,I-NAME_OF_DRUG,7344
142717,eye,I-NAME_OF_DRUG,7344
142718,drop,I-NAME_OF_DRUG,7344
142719,is,O,7344
142720,to,O,7344
142721,decrease,O,7344
142722,the,O,7344
142723,size,O,7344
142724,of,O,7344
142725,the,B-PART_OF_THE_EYES,7344
142726,pupil,B-PART_OF_THE_EYES,7344
142727,which,O,7344
142728,improves,O,7344
142729,reading,O,7344
142730,What,O,7345
142731,are,O,7345
142732,the,O,7345
142733,side,O,7345
142734,effects,O,7345
142735,of,O,7345
142736,Vuity,B-NAME_OF_DRUG,7345
142737,Vuity,B-NAME_OF_DRUG,7345
142738,eye,I-NAME_OF_DRUG,7345
142739,drop,I-NAME_OF_DRUG,7345
142740,is,O,7345
142741,a,O,7345
142742,pupil-based,O,7345
142743,treatment,O,7345
142744,that,O,7345
142745,corrects,O,7345
142746,blurry,B-SIGN_AND_SYMPTOM,7345
142747,vision,I-SIGN_AND_SYMPTOM,7345
142748,If,O,7345
142749,you,O,7345
142750,use,O,7345
142751,Vuity,B-NAME_OF_DRUG,7346
142752,eye,I-NAME_OF_DRUG,7346
142753,drop,I-NAME_OF_DRUG,7346
142754,you,O,7346
142755,should,O,7346
142756,also,O,7346
142757,consider,O,7346
142758,the,O,7346
142759,user,O,7346
142760,information,O,7346
142761,as,O,7346
142762,well,O,7346
142763,as,O,7346
142764,the,O,7346
142765,side,O,7346
142766,effects,O,7346
142767,Firstly,O,7346
142768,you,O,7346
142769,should,O,7346
142770,check,O,7346
142771,with,O,7346
142772,the,O,7346
142773,doctor,O,7346
142774,if,O,7347
142775,you,O,7347
142776,have,O,7347
142777,any,O,7347
142778,allergy,O,7347
142779,to,O,7347
142780,its,O,7347
142781,ingredients,O,7347
142782,Temporary,O,7347
142783,problems,O,7347
142784,may,O,7347
142785,occur,O,7348
142786,in,O,7348
142787,case,O,7348
142788,of,O,7348
142789,a,O,7348
142790,sudden,O,7348
142791,change,O,7348
142792,in,O,7348
142793,near,O,7348
142794,and,O,7348
142795,distant,O,7348
142796,reading,O,7348
142797,so,O,7348
142798,be,O,7348
142799,careful,O,7348
142800,in,O,7348
142801,driving,O,7348
142802,or,O,7348
142803,moving,O,7348
142804,If,O,7348
142805,you,O,7348
142806,use,O,7349
142807,contact,O,7349
142808,lenses,O,7349
142809,then,O,7349
142810,the,B-NAME_OF_DRUG,7349
142811,Vuity,I-NAME_OF_DRUG,7349
142812,eye,I-NAME_OF_DRUG,7349
142813,drop,I-NAME_OF_DRUG,7349
142814,should,O,7349
142815,be,O,7349
142816,applied,O,7349
142817,by,O,7349
142818,removing,O,7349
142819,them,O,7349
142820,and,O,7349
142821,also,O,7349
142822,10,O,7349
142823,min,O,7349
142824,would,O,7349
142825,be,O,7349
142826,needed,O,7349
142827,to,O,7349
142828,wear,O,7349
142829,the,O,7349
142830,lenses,O,7350
142831,back,O,7350
142832,The,O,7350
142833,commonly,O,7350
142834,reported,O,7350
142835,side,O,7350
142836,effects,O,7350
142837,of,O,7350
142838,using,O,7351
142839,Vuity,B-NAME_OF_DRUG,7351
142840,eye,I-NAME_OF_DRUG,7351
142841,drop,I-NAME_OF_DRUG,7351
142842,are,O,7351
142843,headaches,B-SIGN_AND_SYMPTOM,7351
142844,and,I-SIGN_AND_SYMPTOM,7351
142845,eye,I-SIGN_AND_SYMPTOM,7351
142846,redness,I-SIGN_AND_SYMPTOM,7351
142847,However,O,7352
142848,if,O,7352
142849,you,O,7352
142850,have,O,7352
142851,other,O,7352
142852,side,O,7352
142853,effects,O,7352
142854,FDA,B-ORGANIZATION,7352
142855,is,O,7353
142856,encouraging,O,7353
142857,you,O,7353
142858,to,O,7353
142859,be,O,7353
142860,reported,O,7353
142861,for,O,7353
142862,improvement,O,7353
142863,Corneal,B-TREATMENT,7353
142864,inlays,I-TREATMENT,7353
142865,treatment,I-TREATMENT,7353
142866,is,O,7353
142867,for,O,7353
142868,presbyopia,B-NAME_OF_DISEASE,7353
142869,problems,O,7353
142870,Presbyopia,B-NAME_OF_DISEASE,7354
142871,is,O,7354
142872,the,B-SIGN_AND_SYMPTOM,7354
142873,loss,I-SIGN_AND_SYMPTOM,7354
142874,of,I-SIGN_AND_SYMPTOM,7354
142875,elasticity,I-SIGN_AND_SYMPTOM,7354
142876,in,I-SIGN_AND_SYMPTOM,7354
142877,lenses,I-SIGN_AND_SYMPTOM,7354
142878,Simply,O,7354
142879,the,B-TREATMENT,7354
142880,corneal,I-TREATMENT,7354
142881,inlays,I-TREATMENT,7354
142882,are,O,7354
142883,implants,O,7354
142884,on,O,7354
142885,the,B-PART_OF_THE_EYES,7354
142886,corneal,I-PART_OF_THE_EYES,7355
142887,stroma,I-PART_OF_THE_EYES,7355
142888,to,O,7355
142889,help,O,7355
142890,see,O,7355
142891,the,O,7355
142892,closer,O,7355
142893,objects,O,7355
142894,The,O,7356
142895,reason,O,7356
142896,for,O,7356
142897,not,O,7356
142898,seeing,O,7356
142899,clearly,O,7356
142900,is,O,7356
142901,to,O,7356
142902,have,O,7356
142903,weaker,O,7356
142904,muscles,O,7356
142905,The,O,7356
142906,general,O,7356
142907,symptoms,O,7356
142908,are,O,7356
142909,observed,O,7356
142910,over,O,7357
142911,the,O,7357
142912,age,O,7357
142913,of,O,7357
142914,40,O,7357
142915,in,O,7357
142916,reading,O,7357
142917,small,O,7357
142918,prints,O,7357
142919,which,O,7357
142920,are,O,7357
142921,close,O,7357
142922,Corneal,B-TREATMENT,7357
142923,inlays,I-TREATMENT,7358
142924,treatment,I-TREATMENT,7358
142925,has,O,7358
142926,over,O,7358
142927,40,O,7358
142928,years,O,7358
142929,of,O,7358
142930,study,O,7358
142931,history,O,7358
142932,so,O,7358
142933,the,O,7359
142934,recent,O,7359
142935,improvements,O,7359
142936,and,O,7359
142937,developments,O,7359
142938,are,O,7359
142939,designed,O,7359
142940,for,O,7359
142941,human,B-PART_OF_THE_EYES,7359
142942,cornea,I-PART_OF_THE_EYES,7359
142943,tolerance,O,7359
142944,The,O,7359
142945,research,O,7359
142946,and,O,7360
142947,developments,O,7360
142948,have,O,7360
142949,been,O,7360
142950,aimed,O,7360
142951,at,O,7360
142952,the,O,7360
142953,patient,O,7360
142954,s,O,7360
142955,safety,O,7360
142956,first,O,7361
142957,and,O,7361
142958,are,O,7361
142959,more,O,7361
142960,tolerable,O,7361
142961,by,O,7361
142962,the,O,7361
142963,body,O,7362
142964,naturally,O,7362
142965,According,O,7362
142966,to,O,7362
142967,the,O,7362
142968,patient,O,7362
142969,s,O,7362
142970,request,O,7362
142971,and,O,7362
142972,the,O,7362
142973,conditions,O,7362
142974,of,O,7362
142975,the,O,7362
142976,operation,O,7363
142977,on,O,7363
142978,the,O,7363
142979,eye,O,7363
142980,there,O,7363
142981,can,O,7363
142982,be,O,7363
142983,consecutive,O,7363
142984,or,O,7363
142985,simultaneous,O,7363
142986,corneal,O,7363
142987,treatments,O,7363
142988,For,O,7364
142989,the,O,7364
142990,probable,O,7364
142991,outcomes,O,7364
142992,and,O,7364
142993,recovery,O,7364
142994,period,O,7364
142995,always,O,7364
142996,consult,O,7364
142997,your,O,7364
142998,ophthalmologists,O,7364
142999,Types,O,7364
143000,of,O,7365
143001,Corneal,B-TREATMENT,7365
143002,Inlays,I-TREATMENT,7365
143003,There,O,7365
143004,are,O,7365
143005,different,O,7365
143006,types,O,7365
143007,of,O,7365
143008,corneal,B-TREATMENT,7365
143009,inlays,I-TREATMENT,7365
143010,for,I-TREATMENT,7366
143011,corneal,I-TREATMENT,7366
143012,treatment,I-TREATMENT,7366
143013,that,O,7366
143014,differ,O,7366
143015,in,O,7366
143016,size,O,7366
143017,material,O,7366
143018,or,O,7366
143019,design,O,7366
143020,In,O,7366
143021,the,O,7366
143022,following,O,7366
143023,section,O,7366
143024,you,O,7366
143025,can,O,7366
143026,find,O,7366
143027,more,O,7367
143028,details,O,7367
143029,about,O,7367
143030,refractive,B-TREATMENT,7367
143031,corneal,I-TREATMENT,7367
143032,inlays,I-TREATMENT,7367
143033,small,B-TREATMENT,7367
143034,aperture,I-TREATMENT,7367
143035,inlays,I-TREATMENT,7367
143036,and,O,7367
143037,Kamra,B-TREATMENT,7367
143038,corneal,I-TREATMENT,7368
143039,inlays,I-TREATMENT,7368
143040,in,O,7368
143041,the,O,7368
143042,following,O,7368
143043,titles,O,7368
143044,The,O,7368
143045,surgical,O,7368
143046,operation,O,7368
143047,is,O,7368
143048,operated,O,7368
143049,on,O,7368
143050,topical,B-DIAGNOSTIC_TEST,7368
143051,anesthesia,I-DIAGNOSTIC_TEST,7368
143052,Topical,B-DIAGNOSTIC_TEST,7368
143053,anesthesia,I-DIAGNOSTIC_TEST,7368
143054,is,O,7368
143055,an,O,7368
143056,eye,O,7368
143057,drop,O,7368
143058,for,O,7368
143059,this,O,7368
143060,operation,O,7368
143061,The,B-TREATMENT,7368
143062,corneal,I-TREATMENT,7368
143063,inlays,I-TREATMENT,7368
143064,procedures,O,7369
143065,generally,O,7369
143066,take,O,7369
143067,15-Oct,B-TIME_DURATION,7369
143068,minutes,I-TIME_DURATION,7369
143069,Refractive,B-TREATMENT,7369
143070,Corneal,I-TREATMENT,7369
143071,Inlays,I-TREATMENT,7369
143072,Refractive,B-TREATMENT,7369
143073,corneal,I-TREATMENT,7369
143074,inlays,I-TREATMENT,7369
143075,aim,O,7369
143076,to,O,7369
143077,change,O,7369
143078,the,O,7369
143079,refractive,O,7369
143080,index,O,7369
143081,of,O,7369
143082,the,B-PART_OF_THE_EYES,7369
143083,cornea,I-PART_OF_THE_EYES,7369
143084,With,O,7369
143085,the,O,7369
143086,help,O,7369
143087,of,O,7369
143088,the,O,7370
143089,corneal,O,7370
143090,implan,O,7370
143091,t,O,7370
143092,the,O,7370
143093,light,O,7370
143094,can,O,7370
143095,be,O,7370
143096,focused,O,7370
143097,on,O,7370
143098,the,B-PART_OF_THE_EYES,7370
143099,retina,I-PART_OF_THE_EYES,7370
143100,Reactive,B-TREATMENT,7370
143101,corneal,I-TREATMENT,7370
143102,inlays,I-TREATMENT,7370
143103,provide,O,7370
143104,near,O,7370
143105,vision,O,7370
143106,as,O,7370
143107,well,O,7370
143108,The,O,7371
143109,most,O,7371
143110,popular,O,7371
143111,and,O,7371
143112,well-known,O,7371
143113,lenses,O,7371
143114,are,O,7371
143115,multifocal,B-TREATMENT,7371
143116,contact,I-TREATMENT,7371
143117,lenses,I-TREATMENT,7371
143118,or,O,7371
143119,in,O,7371
143120,other,O,7371
143121,ways,O,7371
143122,intraocular,B-TREATMENT,7371
143123,lenses,I-TREATMENT,7371
143124,Refractive,B-TREATMENT,7371
143125,corneal,I-TREATMENT,7371
143126,inlays,I-TREATMENT,7371
143127,also,O,7371
143128,have,O,7371
143129,a,O,7371
143130,similar,O,7371
143131,design,O,7371
143132,to,O,7372
143133,these,O,7372
143134,types,O,7372
143135,of,O,7372
143136,lenses,O,7372
143137,Customer,O,7372
143138,satisfaction,O,7372
143139,has,O,7372
143140,a,O,7372
143141,better,O,7372
143142,result,O,7372
143143,in,O,7372
143144,near,O,7372
143145,vision,O,7372
143146,improvement,O,7372
143147,Small,B-TREATMENT,7372
143148,Aperture,I-TREATMENT,7372
143149,Inlays,I-TREATMENT,7372
143150,Another,O,7372
143151,type,O,7372
143152,of,O,7372
143153,corneal,B-TREATMENT,7372
143154,inlay,I-TREATMENT,7372
143155,is,O,7372
143156,the,B-TREATMENT,7372
143157,small,I-TREATMENT,7372
143158,aperture,I-TREATMENT,7372
143159,inlays,I-TREATMENT,7372
143160,These,O,7372
143161,small,B-TREATMENT,7372
143162,aperture,I-TREATMENT,7372
143163,inlays,I-TREATMENT,7372
143164,focus,O,7372
143165,on,O,7373
143166,improving,O,7373
143167,near-vision,O,7373
143168,objects,O,7373
143169,too,O,7373
143170,They,O,7373
143171,are,O,7373
143172,designed,O,7373
143173,in,O,7373
143174,opaque,O,7373
143175,and,O,7373
143176,ring-shaped,O,7373
143177,The,O,7373
143178,function,O,7373
143179,of,O,7373
143180,the,O,7373
143181,ring,O,7373
143182,is,O,7373
143183,to,O,7373
143184,block,O,7373
143185,the,O,7373
143186,light,O,7373
143187,which,O,7373
143188,is,O,7373
143189,peripheral,O,7373
143190,Kamra,B-TREATMENT,7373
143191,small,I-TREATMENT,7373
143192,aperture,I-TREATMENT,7373
143193,inlays,I-TREATMENT,7373
143194,are,O,7373
143195,the,O,7373
143196,advanced,O,7373
143197,practice,O,7373
143198,of,O,7373
143199,refractive,B-TREATMENT,7373
143200,corneal,I-TREATMENT,7373
143201,inlays,I-TREATMENT,7373
143202,This,O,7373
143203,operation,O,7373
143204,is,O,7374
143205,suitable,O,7374
143206,for,O,7374
143207,those,O,7374
143208,who,O,7374
143209,have,O,7374
143210,not,O,7374
143211,yet,O,7374
143212,cataract,B-NAME_OF_DISEASE,7374
143213,issues,O,7374
143214,For,O,7374
143215,more,O,7374
143216,information,O,7374
143217,continue,O,7374
143218,reading,O,7374
143219,the,O,7374
143220,Kamra,B-TREATMENT,7374
143221,corneal,I-TREATMENT,7374
143222,inlays,I-TREATMENT,7374
143223,title,O,7374
143224,Corneal,B-TREATMENT,7374
143225,Inlays,I-TREATMENT,7374
143226,Presbyopia,B-NAME_OF_DISEASE,7374
143227,Treatment,O,7374
143228,Presbyopia,B-NAME_OF_DISEASE,7374
143229,treatment,O,7375
143230,helps,O,7375
143231,for,O,7375
143232,conditions,O,7375
143233,where,O,7375
143234,there,O,7375
143235,is,O,7375
143236,no,O,7375
143237,effective,O,7375
143238,reactive,O,7375
143239,surgery,O,7375
143240,treatment,O,7375
143241,Corneal,B-TREATMENT,7375
143242,inlays,I-TREATMENT,7375
143243,are,O,7375
143244,the,O,7375
143245,developed,O,7375
143246,solutions,O,7375
143247,for,O,7376
143248,improving,O,7376
143249,these,O,7376
143250,vision,O,7376
143251,issues,O,7376
143252,Although,O,7376
143253,the,O,7376
143254,progression,O,7376
143255,of,O,7376
143256,presbyopia,B-NAME_OF_DISEASE,7376
143257,can,O,7376
143258,not,O,7376
143259,be,O,7376
143260,prevented,O,7376
143261,the,O,7376
143262,good,O,7376
143263,news,O,7376
143264,is,O,7376
143265,that,O,7376
143266,with,O,7376
143267,the,O,7377
143268,help,O,7377
143269,of,O,7377
143270,advanced,O,7377
143271,technology,O,7377
143272,corneal,B-TREATMENT,7377
143273,inlays,I-TREATMENT,7377
143274,are,O,7377
143275,used,O,7377
143276,for,O,7377
143277,treatments,O,7377
143278,Kamra,B-TREATMENT,7377
143279,Corneal,I-TREATMENT,7377
143280,Inlays,I-TREATMENT,7377
143281,In,O,7378
143282,addition,O,7378
143283,to,O,7378
143284,corneal,B-TREATMENT,7378
143285,inlay,I-TREATMENT,7378
143286,treatments,I-TREATMENT,7378
143287,the,O,7378
143288,most,O,7378
143289,developed,O,7378
143290,method,O,7378
143291,was,O,7378
143292,launched,O,7378
143293,in,O,7378
143294,2005,O,7378
143295,with,O,7378
143296,Kamra,B-TREATMENT,7378
143297,corneal,I-TREATMENT,7378
143298,inlay,I-TREATMENT,7379
143299,for,O,7379
143300,presbyopia,B-NAME_OF_DISEASE,7379
143301,treatment,O,7379
143302,The,O,7379
143303,patients,O,7379
143304,should,O,7379
143305,have,O,7379
143306,non-dominant,O,7379
143307,eyes,O,7379
143308,for,O,7379
143309,this,O,7379
143310,Kamra,B-TREATMENT,7379
143311,corneal,I-TREATMENT,7380
143312,treatment,I-TREATMENT,7380
143313,generally,O,7380
143314,for,O,7380
143315,those,O,7380
143316,who,O,7380
143317,are,O,7380
143318,between,O,7380
143319,45,O,7380
143320,and,O,7380
143321,60,O,7380
143322,Kamra,B-TREATMENT,7380
143323,has,O,7380
143324,a,O,7380
143325,pinhole,O,7380
143326,technique,O,7380
143327,that,O,7380
143328,improves,O,7380
143329,focusing,O,7380
143330,the,O,7380
143331,light,O,7380
143332,so,O,7380
143333,that,O,7380
143334,it,O,7380
143335,gives,O,7380
143336,a,O,7380
143337,depth,O,7381
143338,focus,O,7381
143339,as,O,7381
143340,a,O,7381
143341,result,O,7381
143342,of,O,7381
143343,the,O,7381
143344,surgical,O,7381
143345,procedure,O,7381
143346,Even,O,7381
143347,though,O,7382
143348,it,O,7382
143349,is,O,7382
143350,a,O,7382
143351,commonly,O,7382
143352,chosen,O,7382
143353,solution,O,7382
143354,for,O,7382
143355,corneal,B-TREATMENT,7382
143356,inlay,I-TREATMENT,7382
143357,treatments,I-TREATMENT,7382
143358,Kamra,B-TREATMENT,7382
143359,may,O,7382
143360,relatively,O,7382
143361,not,O,7382
143362,be,O,7382
143363,recommended,O,7382
143364,for,O,7382
143365,patients,O,7382
143366,who,O,7382
143367,work,O,7382
143368,on,O,7382
143369,detailed,O,7382
143370,projects,O,7383
143371,data,O,7383
143372,analytics,O,7383
143373,or,O,7383
143374,any,O,7383
143375,other,O,7383
143376,vision-related,O,7383
143377,professional,O,7383
143378,positions,O,7383
143379,In,O,7383
143380,some,O,7383
143381,cases,O,7383
143382,a,O,7383
143383,consecutive,O,7383
143384,or,O,7383
143385,simultaneous,O,7383
143386,treatment,O,7383
143387,can,O,7383
143388,be,O,7384
143389,operated,O,7384
143390,according,O,7384
143391,to,O,7384
143392,the,O,7384
143393,patient,O,7384
143394,s,O,7384
143395,preference,O,7384
143396,and,O,7384
143397,conditions,O,7384
143398,so,O,7384
143399,that,O,7384
143400,the,O,7384
143401,near,O,7384
143402,and,O,7384
143403,far,O,7384
143404,vision,O,7384
143405,errors,O,7384
143406,can,O,7384
143407,also,O,7384
143408,be,O,7384
143409,corrected,O,7384
143410,at,O,7384
143411,the,O,7384
143412,same,O,7384
143413,time,O,7384
143414,or,O,7384
143415,for,O,7384
143416,some,O,7384
143417,time,O,7384
143418,Raindrop,B-TREATMENT,7384
143419,is,O,7384
143420,another,O,7384
143421,alternative,O,7384
143422,for,O,7384
143423,corneal,B-TREATMENT,7385
143424,inlays,I-TREATMENT,7385
143425,however,O,7385
143426,the,O,7385
143427,research,O,7385
143428,and,O,7385
143429,experiments,O,7385
143430,on,O,7385
143431,the,O,7385
143432,patient,O,7385
143433,give,O,7385
143434,more,O,7385
143435,importance,O,7385
143436,to,O,7385
143437,the,O,7385
143438,patient,O,7385
143439,s,O,7385
143440,safety,O,7385
143441,for,O,7385
143442,treatment,O,7385
143443,Pediatric,O,7385
143444,ophthalmology,O,7385
143445,is,O,7386
143446,a,O,7386
143447,sub-speciality,O,7386
143448,of,O,7386
143449,ophthalmology,O,7386
143450,concerned,O,7386
143451,with,O,7386
143452,eye,O,7386
143453,diseases,O,7386
143454,visual,O,7386
143455,development,O,7386
143456,and,O,7386
143457,vision,O,7386
143458,care,O,7386
143459,in,O,7386
143460,children,O,7386
143461,Pediatric,O,7386
143462,ophthalmologists,O,7386
143463,focus,O,7386
143464,on,O,7386
143465,the,O,7387
143466,development,O,7387
143467,of,O,7387
143468,the,O,7387
143469,visual,O,7387
143470,system,O,7387
143471,and,O,7387
143472,the,O,7387
143473,various,O,7387
143474,diseases,O,7387
143475,that,O,7387
143476,disrupt,O,7387
143477,visual,O,7387
143478,development,O,7387
143479,in,O,7387
143480,children,O,7388
143481,Pediatric,O,7388
143482,ophthalmologists,O,7388
143483,also,O,7388
143484,have,O,7388
143485,expertise,O,7388
143486,in,O,7388
143487,managing,O,7388
143488,the,O,7388
143489,various,O,7388
143490,ocular,O,7388
143491,diseases,O,7388
143492,that,O,7388
143493,affect,O,7388
143494,children,O,7388
143495,The,O,7388
143496,past,O,7388
143497,25,O,7388
143498,years,O,7388
143499,have,O,7388
143500,seen,O,7388
143501,remarkable,O,7388
143502,advances,O,7388
143503,in,O,7388
143504,clinical,O,7388
143505,eye,O,7388
143506,care,O,7388
143507,for,O,7389
143508,children,O,7389
143509,in,O,7389
143510,the,O,7389
143511,world,O,7389
143512,This,O,7389
143513,has,O,7389
143514,led,O,7389
143515,to,O,7389
143516,both,O,7389
143517,improved,O,7389
143518,outcomes,O,7389
143519,and,O,7389
143520,better,O,7389
143521,patient,O,7389
143522,and,O,7389
143523,family,O,7389
143524,experiences,O,7389
143525,There,O,7389
143526,have,O,7389
143527,been,O,7389
143528,substantial,O,7389
143529,changes,O,7389
143530,to,O,7389
143531,patient,O,7389
143532,pathways,O,7389
143533,major,O,7390
143534,advances,O,7390
143535,in,O,7390
143536,diagnostic,O,7390
143537,techniques,O,7390
143538,and,O,7390
143539,treatments,O,7390
143540,and,O,7390
143541,a,O,7390
143542,more,O,7390
143543,robust,O,7390
143544,evidence,O,7390
143545,base,O,7390
143546,underpinning,O,7390
143547,the,O,7390
143548,delivery,O,7390
143549,of,O,7390
143550,care,O,7390
143551,Pediatric,O,7390
143552,ophthalmology,O,7390
143553,is,O,7390
143554,now,O,7390
143555,universally,O,7390
143556,recognized,O,7390
143557,as,O,7390
143558,a,O,7390
143559,specific,O,7391
143560,sub-specialty,O,7391
143561,Ophthalmic,O,7391
143562,care,O,7391
143563,of,O,7391
143564,children,O,7391
143565,in,O,7391
143566,2020,O,7391
143567,is,O,7391
143568,no,O,7391
143569,longer,O,7391
143570,something,O,7391
143571,that,O,7391
143572,general,O,7391
143573,ophthalmologists,O,7391
143574,do,O,7391
143575,as,O,7391
143576,an,O,7391
143577,adjunct,O,7391
143578,to,O,7391
143579,their,O,7391
143580,predominantly,O,7391
143581,adult,O,7392
143582,clinical,O,7392
143583,practice,O,7392
143584,It,O,7392
143585,is,O,7392
143586,instead,O,7392
143587,delivered,O,7392
143588,in,O,7392
143589,dedicated,O,7392
143590,pediatric,O,7392
143591,ophthalmology,O,7392
143592,clinics,O,7392
143593,by,O,7392
143594,teams,O,7392
143595,with,O,7392
143596,expertise,O,7392
143597,in,O,7392
143598,the,O,7392
143599,care,O,7392
143600,of,O,7392
143601,children,O,7392
143602,Advances,O,7392
143603,in,O,7392
143604,diagnostic,O,7392
143605,and,O,7392
143606,imaging,O,7392
143607,techniques,O,7392
143608,originally,O,7392
143609,developed,O,7392
143610,for,O,7392
143611,adult,O,7392
143612,patients,O,7392
143613,such,O,7392
143614,as,O,7392
143615,optical,B-DIAGNOSTIC_TEST,7392
143616,coherence,I-DIAGNOSTIC_TEST,7393
143617,tomography,I-DIAGNOSTIC_TEST,7393
143618,OCT,I-DIAGNOSTIC_TEST,7393
143619,widescreen,B-DIAGNOSTIC_TEST,7393
143620,digital,I-DIAGNOSTIC_TEST,7393
143621,imaging,I-DIAGNOSTIC_TEST,7393
143622,Optos,I-DIAGNOSTIC_TEST,7393
143623,and,O,7393
143624,modern,B-DIAGNOSTIC_TEST,7393
143625,fluorescein,I-DIAGNOSTIC_TEST,7393
143626,angiography,I-DIAGNOSTIC_TEST,7393
143627,have,O,7393
143628,expanded,O,7393
143629,the,O,7393
143630,options,O,7393
143631,available,O,7393
143632,for,O,7393
143633,the,O,7393
143634,investigation,O,7393
143635,of,O,7393
143636,children,O,7393
143637,Readily,B-DIAGNOSTIC_TEST,7393
143638,available,I-DIAGNOSTIC_TEST,7393
143639,genetic,I-DIAGNOSTIC_TEST,7393
143640,testing,I-DIAGNOSTIC_TEST,7393
143641,has,O,7393
143642,changed,O,7393
143643,the,O,7393
143644,way,O,7393
143645,we,O,7393
143646,approach,O,7393
143647,the,O,7393
143648,investigation,O,7393
143649,and,O,7393
143650,management,O,7393
143651,of,O,7393
143652,children,O,7393
143653,with,O,7393
143654,rare,O,7393
143655,and,O,7393
143656,complex,O,7393
143657,eye,O,7393
143658,disease,O,7393
143659,Application,O,7393
143660,of,O,7393
143661,new,O,7393
143662,diagnostic,O,7393
143663,techniques,O,7393
143664,for,O,7393
143665,deep,B-DIAGNOSTIC_TEST,7393
143666,phenotyping,I-DIAGNOSTIC_TEST,7394
143667,in,I-DIAGNOSTIC_TEST,7394
143668,combination,I-DIAGNOSTIC_TEST,7394
143669,with,I-DIAGNOSTIC_TEST,7394
143670,genomic,I-DIAGNOSTIC_TEST,7394
143671,testing,I-DIAGNOSTIC_TEST,7394
143672,enhances,O,7394
143673,the,O,7394
143674,accuracy,O,7394
143675,of,O,7394
143676,diagnosis,O,7394
143677,and,O,7394
143678,prognosis,O,7394
143679,This,O,7394
143680,now,O,7395
143681,enables,O,7395
143682,the,O,7395
143683,introduction,O,7395
143684,of,O,7395
143685,TRUE,O,7395
143686,personalized,O,7395
143687,medicine,O,7395
143688,for,O,7395
143689,children,O,7395
143690,with,O,7395
143691,rare,O,7395
143692,ophthalmic,O,7395
143693,disorders,O,7395
143694,Equally,O,7395
143695,importantly,O,7395
143696,increased,O,7395
143697,awareness,O,7395
143698,of,O,7395
143699,social,O,7395
143700,and,O,7395
143701,safeguarding,O,7395
143702,issues,O,7396
143703,has,O,7396
143704,improved,O,7396
143705,child,O,7396
143706,protection,O,7396
143707,strategies,O,7396
143708,across,O,7397
143709,pediatric,O,7397
143710,healthcare,O,7397
143711,ensuring,O,7397
143712,clinicians,O,7397
143713,and,O,7397
143714,their,O,7397
143715,teams,O,7397
143716,better,O,7397
143717,protect,O,7397
143718,children,O,7397
143719,from,O,7397
143720,harm,O,7397
143721,We,O,7397
143722,believe,O,7397
143723,that,O,7397
143724,these,O,7397
143725,developments,O,7397
143726,in,O,7397
143727,medical,O,7397
143728,and,O,7397
143729,surgical,O,7397
143730,care,O,7397
143731,will,O,7397
143732,ensure,O,7397
143733,that,O,7397
143734,pediatric,O,7397
143735,ophthalmology,O,7397
143736,remains,O,7397
143737,one,O,7397
143738,of,O,7397
143739,the,O,7397
143740,most,O,7397
143741,exciting,O,7397
143742,subspecialties,O,7397
143743,well,O,7398
143744,into,O,7398
143745,the,O,7398
143746,future,O,7398
143747,Also,O,7398
143748,recent,O,7398
143749,regulatory,O,7398
143750,changes,O,7398
143751,have,O,7398
143752,meant,O,7398
143753,that,O,7398
143754,pharmaceutical,O,7398
143755,companies,O,7398
143756,must,O,7398
143757,consider,O,7398
143758,the,O,7398
143759,needs,O,7398
143760,of,O,7398
143761,children,O,7398
143762,as,O,7398
143763,well,O,7398
143764,as,O,7398
143765,adults,O,7398
143766,when,O,7398
143767,seeking,O,7399
143768,a,O,7399
143769,license,O,7399
143770,for,O,7399
143771,new,O,7399
143772,treatments,O,7399
143773,In,O,7399
143774,the,O,7399
143775,future,O,7399
143776,clinicians,O,7399
143777,should,O,7399
143778,be,O,7399
143779,thus,O,7399
143780,Presbyopia,B-NAME_OF_DISEASE,10000
143781,is,O,10000
143782,a,O,10000
143783,natural,O,10000
143784,effect,O,10000
143785,of,O,10000
143786,aging,O,10000
143787,in,O,10000
143788,which,O,10000
143789,a,B-CAUSE_OF_DISEASE,10000
143790,loss,I-CAUSE_OF_DISEASE,10000
143791,of,I-CAUSE_OF_DISEASE,10000
143792,elasticity,I-CAUSE_OF_DISEASE,10000
143793,in,I-CAUSE_OF_DISEASE,10000
143794,the,I-CAUSE_OF_DISEASE,10000
143795,lens,I-CAUSE_OF_DISEASE,10000
143796,of,I-CAUSE_OF_DISEASE,10000
143797,the,I-CAUSE_OF_DISEASE,10000
143798,eye,I-CAUSE_OF_DISEASE,10000
143799,causes,O,10000
143800,far-sightedness,B-NAME_OF_DISEASE,10000
143801,As,O,10001
143802,a,O,10001
143803,result,O,10001
143804,visual,B-SIGN_AND_SYMPTOM,10001
143805,accommodation,I-SIGN_AND_SYMPTOM,10001
143806,gradually,I-SIGN_AND_SYMPTOM,10001
143807,declines,I-SIGN_AND_SYMPTOM,10001
143808,as,O,10001
143809,the,O,10001
143810,eyes,O,10001
143811,can,O,10001
143812,no,O,10001
143813,longer,O,10001
143814,effectively,O,10001
143815,change,O,10001
143816,their,O,10001
143817,optical,O,10001
143818,power,O,10001
143819,to,O,10001
143820,maintain,O,10001
143821,a,O,10001
143822,clear,O,10001
143823,image,O,10001
143824,or,O,10001
143825,focus,O,10001
143826,on,O,10001
143827,an,O,10001
143828,object,O,10001
143829,as,O,10001
143830,its,O,10001
143831,distance,O,10001
143832,varies,O,10001
143833,Presbyopia,B-NAME_OF_DISEASE,10002
143834,is,O,10002
143835,the,B-SIGN_AND_SYMPTOM,10002
143836,age-related,I-SIGN_AND_SYMPTOM,10002
143837,loss,I-SIGN_AND_SYMPTOM,10002
143838,of,I-SIGN_AND_SYMPTOM,10002
143839,the,I-SIGN_AND_SYMPTOM,10002
143840,ability,I-SIGN_AND_SYMPTOM,10002
143841,to,I-SIGN_AND_SYMPTOM,10002
143842,dynamically,I-SIGN_AND_SYMPTOM,10002
143843,focus,I-SIGN_AND_SYMPTOM,10002
143844,near,I-SIGN_AND_SYMPTOM,10002
143845,and,I-SIGN_AND_SYMPTOM,10002
143846,far,I-SIGN_AND_SYMPTOM,10002
143847,and,O,10002
143848,it,O,10002
143849,is,O,10002
143850,usually,O,10002
143851,corrected,O,10002
143852,with,O,10002
143853,an,B-TREATMENT,10002
143854,additional,I-TREATMENT,10002
143855,positive,I-TREATMENT,10002
143856,power,I-TREATMENT,10002
143857,near,I-TREATMENT,10002
143858,addition,I-TREATMENT,10002
143859,The,B-TREATMENT,10003
143860,near,I-TREATMENT,10003
143861,addition,I-TREATMENT,10003
143862,is,O,10003
143863,conventionally,O,10003
143864,provided,O,10003
143865,in,O,10003
143866,the,O,10003
143867,form,O,10003
143868,of,O,10003
143869,spectacles,O,10003
143870,providing,O,10003
143871,alternating,O,10003
143872,vision,O,10003
143873,at,O,10003
143874,far,O,10003
143875,and,O,10003
143876,near,O,10003
143877,Recently,O,10004
143878,presbyopia,B-NAME_OF_DISEASE,10004
143879,is,O,10004
143880,increasingly,O,10004
143881,corrected,O,10004
143882,with,O,10004
143883,Simultaneous,B-TREATMENT,10004
143884,Vision,I-TREATMENT,10004
143885,Monovision,B-TREATMENT,10004
143886,and,O,10004
143887,Modified,B-TREATMENT,10004
143888,Monovision,I-TREATMENT,10004
143889,corrections,I-TREATMENT,10004
143890,usually,O,10004
143891,delivered,O,10004
143892,in,O,10004
143893,the,O,10004
143894,form,O,10004
143895,of,O,10004
143896,contact,B-TREATMENT,10004
143897,lenses,I-TREATMENT,10004
143898,intraocular,B-TREATMENT,10004
143899,lenses,I-TREATMENT,10004
143900,or,O,10004
143901,corneal,B-TREATMENT,10004
143902,surgery,I-TREATMENT,10004
143903,such,O,10004
143904,as,O,10004
143905,presbyLASIK,B-TREATMENT,10004
143906,or,O,10004
143907,corneal,B-TREATMENT,10004
143908,implants,I-TREATMENT,10004
143909,Unlike,O,10005
143910,alternating,O,10005
143911,vision,O,10005
143912,corrections,O,10005
143913,as,O,10005
143914,progressive,B-TREATMENT,10005
143915,spectacle,I-TREATMENT,10005
143916,lenses,I-TREATMENT,10005
143917,these,O,10005
143918,solutions,O,10005
143919,are,O,10005
143920,not,O,10005
143921,gaze-dependent,O,10005
143922,and,O,10005
143923,aim,O,10005
143924,at,O,10005
143925,providing,O,10005
143926,clear,O,10005
143927,vision,O,10005
143928,at,O,10005
143929,all,O,10005
143930,distances,O,10005
143931,simultaneously,O,10005
143932,Multifocal,B-TREATMENT,10006
143933,corrections,I-TREATMENT,10006
143934,result,O,10006
143935,in,O,10006
143936,retinal,O,10006
143937,images,O,10006
143938,with,O,10006
143939,superimposed,O,10006
143940,blurred,O,10006
143941,and,O,10006
143942,sharp,O,10006
143943,image,O,10006
143944,components,O,10006
143945,at,O,10006
143946,all,O,10006
143947,viewing,O,10006
143948,distances,O,10006
143949,yet,O,10006
143950,they,O,10006
143951,provide,O,10006
143952,a,O,10006
143953,reasonable,O,10006
143954,visual,O,10006
143955,quality,O,10006
143956,at,O,10006
143957,all,O,10006
143958,distances,O,10006
143959,while,O,10006
143960,introducing,O,10006
143961,mild,O,10006
143962,degradations,O,10006
143963,at,O,10006
143964,all,O,10006
143965,distances,O,10006
143966,compared,O,10006
143967,to,O,10006
143968,a,O,10006
143969,single,O,10006
143970,focus,O,10006
143971,The,O,10007
143972,patients,O,10007
143973,and,O,10007
143974,their,O,10007
143975,expectations,O,10007
143976,on,O,10007
143977,the,O,10007
143978,implantation,O,10007
143979,of,O,10007
143980,multifocal,B-TREATMENT,10007
143981,intraocular,I-TREATMENT,10007
143982,lenses,I-TREATMENT,10007
143983,get,O,10007
143984,better,O,10007
143985,perspectives,O,10007
143986,with,O,10007
143987,a,O,10007
143988,visual,O,10007
143989,simulator,O,10007
143990,Simultaneous,B-TREATMENT,10008
143991,Vision,I-TREATMENT,10008
143992,SimVisGekko,I-TREATMENT,10008
143993,2EyesVision,I-TREATMENT,10008
143994,is,O,10008
143995,a,O,10008
143996,visual,O,10008
143997,simulator,O,10008
143998,that,O,10008
143999,provides,O,10008
144000,patients,O,10008
144001,with,O,10008
144002,the,O,10008
144003,experience,O,10008
144004,of,O,10008
144005,vision,O,10008
144006,with,O,10008
144007,multifocal,B-TREATMENT,10008
144008,intraocular,I-TREATMENT,10008
144009,lenses,I-TREATMENT,10008
144010,mIOLs,I-TREATMENT,10008
144011,before,O,10008
144012,actual,O,10008
144013,implantation,O,10008
144014,helping,O,10008
144015,to,O,10008
144016,manage,O,10008
144017,patients,O,10008
144018,expectations,O,10008
144019,This,O,10009
144020,innovation,O,10009
144021,arose,O,10009
144022,out,O,10009
144023,of,O,10009
144024,the,O,10009
144025,scaling,O,10009
144026,down,O,10009
144027,of,O,10009
144028,technologies,O,10009
144029,that,O,10009
144030,originated,O,10009
144031,in,O,10009
144032,astronomy,O,10009
144033,such,O,10009
144034,as,O,10009
144035,adaptive,O,10009
144036,optics,O,10009
144037,into,O,10009
144038,a,O,10009
144039,system,O,10009
144040,useful,O,10009
144041,to,O,10009
144042,ophthalmologists,O,10009
144043,for,O,10009
144044,prescribing,O,10009
144045,correction,O,10009
144046,for,O,10009
144047,presbyopia,B-NAME_OF_DISEASE,10009
144048,and,O,10009
144049,simulating,O,10009
144050,multifocal,B-TREATMENT,10009
144051,lenses,I-TREATMENT,10009
144052,Despite,O,10010
144053,the,O,10010
144054,availability,O,10010
144055,of,O,10010
144056,mIOL,B-TREATMENT,10010
144057,only,O,10010
144058,7%,O,10010
144059,of,O,10010
144060,patients,O,10010
144061,opt,O,10010
144062,for,O,10010
144063,this,O,10010
144064,correction,O,10010
144065,modality,O,10010
144066,after,O,10010
144067,cataract,B-TREATMENT,10010
144068,surgery,I-TREATMENT,10010
144069,In,O,10011
144070,addition,O,10011
144071,it,O,10011
144072,is,O,10011
144073,difficult,O,10011
144074,for,O,10011
144075,patients,O,10011
144076,to,O,10011
144077,make,O,10011
144078,a,O,10011
144079,decision,O,10011
144080,about,O,10011
144081,mIOL,B-TREATMENT,10011
144082,implantation,I-TREATMENT,10011
144083,if,O,10011
144084,they,O,10011
144085,cannot,O,10011
144086,visualise,O,10011
144087,what,O,10011
144088,their,O,10011
144089,vision,O,10011
144090,will,O,10011
144091,be,O,10011
144092,preoperatively,O,10011
144093,a,O,10011
144094,scenario,O,10011
144095,that,O,10011
144096,leaves,O,10011
144097,them,O,10011
144098,with,O,10011
144099,a,O,10011
144100,great,O,10011
144101,deal,O,10011
144102,of,O,10011
144103,uncertainty,O,10011
144104,about,O,10011
144105,both,O,10011
144106,their,O,10011
144107,expectations,O,10011
144108,and,O,10011
144109,the,O,10011
144110,actual,O,10011
144111,surgical,O,10011
144112,results,O,10011
144113,A,O,10012
144114,solution,O,10012
144115,to,O,10012
144116,this,O,10012
144117,may,O,10012
144118,be,O,10012
144119,use,O,10012
144120,of,O,10012
144121,the,B-TREATMENT,10012
144122,mobile,I-TREATMENT,10012
144123,SimVisGekko,I-TREATMENT,10012
144124,which,O,10012
144125,would,O,10012
144126,ease,O,10012
144127,their,O,10012
144128,decisionmaking,O,10012
144129,process,O,10012
144130,This,O,10013
144131,technology,O,10013
144132,would,O,10013
144133,be,O,10013
144134,valuable,O,10013
144135,for,O,10013
144136,patients,O,10013
144137,clinicians,O,10013
144138,and,O,10013
144139,IOL,B-TREATMENT,10013
144140,manufacturers,O,10013
144141,It,O,10014
144142,also,O,10014
144143,provides,O,10014
144144,business,O,10014
144145,advantages,O,10014
144146,by,O,10014
144147,reducing,O,10014
144148,patient,O,10014
144149,complaints,O,10014
144150,and,O,10014
144151,refunds,O,10014
144152,provides,O,10014
144153,a,O,10014
144154,competitive,O,10014
144155,advantage,O,10014
144156,to,O,10014
144157,doctors,O,10014
144158,who,O,10014
144159,adopt,O,10014
144160,the,O,10014
144161,device,O,10014
144162,early,O,10014
144163,and,O,10014
144164,increases,O,10014
144165,the,O,10014
144166,number,O,10014
144167,of,O,10014
144168,mIOL,B-TREATMENT,10014
144169,prescriptions,O,10014
144170,SimVisGekko,B-TREATMENT,10015
144171,is,O,10015
144172,wearable,O,10015
144173,binocular,O,10015
144174,see-through,O,10015
144175,and,O,10015
144176,provides,O,10015
144177,a,O,10015
144178,20°,O,10015
144179,field,O,10015
144180,of,O,10015
144181,view,O,10015
144182,The,O,10016
144183,map,O,10016
144184,in,O,10016
144185,the,B-TREATMENT,10016
144186,IOL,I-TREATMENT,10016
144187,is,O,10016
144188,defined,O,10016
144189,with,O,10016
144190,a,O,10016
144191,set,O,10016
144192,of,O,10016
144193,coefficients,O,10016
144194,the,O,10016
144195,data,O,10016
144196,show,O,10016
144197,how,O,10016
144198,much,O,10016
144199,time,O,10016
144200,the,O,10016
144201,lens,O,10016
144202,spends,O,10016
144203,at,O,10016
144204,the,O,10016
144205,different,O,10016
144206,power,O,10016
144207,additions,O,10016
144208,A,O,10017
144209,comparison,O,10017
144210,of,O,10017
144211,the,O,10017
144212,performance,O,10017
144213,of,O,10017
144214,an,O,10017
144215,actual,O,10017
144216,commercial,O,10017
144217,IOL,B-TREATMENT,10017
144218,with,O,10017
144219,the,O,10017
144220,simulation,O,10017
144221,showed,O,10017
144222,how,O,10017
144223,well,O,10017
144224,the,O,10017
144225,images,O,10017
144226,of,O,10017
144227,the,O,10017
144228,two,O,10017
144229,matched,O,10017
144230,When,O,10018
144231,the,B-TREATMENT,10018
144232,SimVisGekko,I-TREATMENT,10018
144233,was,O,10018
144234,taken,O,10018
144235,into,O,10018
144236,the,O,10018
144237,clinic,O,10018
144238,it,O,10018
144239,performed,O,10018
144240,well,O,10018
144241,and,O,10018
144242,the,O,10018
144243,researchers,O,10018
144244,have,O,10018
144245,found,O,10018
144246,that,O,10018
144247,the,O,10018
144248,device,O,10018
144249,replicates,O,10018
144250,mIOLs,B-TREATMENT,10018
144251,They,O,10019
144252,performed,O,10019
144253,the,O,10019
144254,test,O,10019
144255,with,O,10019
144256,a,B-TREATMENT,10019
144257,trifocal,I-TREATMENT,10019
144258,IOL,I-TREATMENT,10019
144259,in,I-TREATMENT,10019
144260,the,I-TREATMENT,10019
144261,SimVis,I-TREATMENT,10019
144262,preoperatively,O,10019
144263,and,O,10019
144264,the,O,10019
144265,patient,O,10019
144266,was,O,10019
144267,ultimately,O,10019
144268,implanted,O,10019
144269,with,O,10019
144270,the,O,10019
144271,lens,O,10019
144272,They,O,10020
144273,found,O,10020
144274,that,O,10020
144275,in,O,10020
144276,patients,O,10020
144277,with,O,10020
144278,clear,O,10020
144279,lenses,O,10020
144280,and,O,10020
144281,those,O,10020
144282,with,O,10020
144283,cataracts,B-NAME_OF_DISEASE,10020
144284,the,O,10020
144285,preoperative,O,10020
144286,with,O,10020
144287,SimVis,B-TREATMENT,10020
144288,and,O,10020
144289,postoperative,O,10020
144290,with,O,10020
144291,the,O,10020
144292,implanted,O,10020
144293,mIOL,B-TREATMENT,10020
144294,defocus,O,10020
144295,curves,O,10020
144296,matched,O,10020
144297,In,O,10021
144298,the,O,10021
144299,presence,O,10021
144300,of,O,10021
144301,a,O,10021
144302,cataract,B-NAME_OF_DISEASE,10021
144303,there,O,10021
144304,is,O,10021
144305,a,O,10021
144306,shift,O,10021
144307,down,O,10021
144308,because,O,10021
144309,of,O,10021
144310,the,O,10021
144311,light,O,10021
144312,distribution,O,10021
144313,caused,O,10021
144314,by,O,10021
144315,the,B-NAME_OF_DISEASE,10021
144316,cataract,I-NAME_OF_DISEASE,10021
144317,but,O,10021
144318,the,O,10021
144319,shape,O,10021
144320,of,O,10021
144321,the,O,10021
144322,defocus,O,10021
144323,focus,O,10021
144324,curve,O,10021
144325,is,O,10021
144326,well,O,10021
144327,captured,O,10021
144328,This,O,10022
144329,technology,O,10022
144330,is,O,10022
144331,also,O,10022
144332,useful,O,10022
144333,for,O,10022
144334,patients,O,10022
144335,opting,O,10022
144336,for,O,10022
144337,multifocal,B-TREATMENT,10022
144338,contact,I-TREATMENT,10022
144339,lenses,I-TREATMENT,10022
144340,An,O,10023
144341,excellent,O,10023
144342,replication,O,10023
144343,of,O,10023
144344,the,O,10023
144345,contact,O,10023
144346,lens,O,10023
144347,performance,O,10023
144348,on,O,10023
144349,the,O,10023
144350,eye,O,10023
144351,was,O,10023
144352,achieved,O,10023
144353,with,O,10023
144354,the,B-TREATMENT,10023
144355,SimVisGekko,I-TREATMENT,10023
144356,simulation,I-TREATMENT,10023
144357,for,O,10023
144358,different,O,10023
144359,lens,O,10023
144360,designs,O,10023
144361,with,O,10023
144362,different,O,10023
144363,power,O,10023
144364,additions,O,10023
144365,When,O,10024
144366,the,O,10024
144367,patient,O,10024
144368,is,O,10024
144369,tested,O,10024
144370,with,O,10024
144371,different,O,10024
144372,corrective,B-TREATMENT,10024
144373,options,I-TREATMENT,10024
144374,surgery,I-TREATMENT,10024
144375,can,O,10024
144376,proceed,O,10024
144377,with,O,10024
144378,much,O,10024
144379,more,O,10024
144380,certainty,O,10024
144381,regarding,O,10024
144382,the,O,10024
144383,postoperative,O,10024
144384,vision,O,10024
144385,In,O,10025
144386,addition,O,10025
144387,when,O,10025
144388,new,O,10025
144389,IOL,B-TREATMENT,10025
144390,designs,O,10025
144391,become,O,10025
144392,available,O,10025
144393,the,O,10025
144394,software,O,10025
144395,is,O,10025
144396,updated,O,10025
144397,Over,O,10026
144398,and,O,10026
144399,above,O,10026
144400,monitoring,O,10026
144401,the,O,10026
144402,use,O,10026
144403,of,O,10026
144404,the,B-TREATMENT,10026
144405,SimVis,I-TREATMENT,10026
144406,different,O,10026
144407,patient,O,10026
144408,lens,O,10026
144409,preferences,O,10026
144410,the,O,10026
144411,rates,O,10026
144412,of,O,10026
144413,actual,O,10026
144414,implantations,O,10026
144415,of,O,10026
144416,those,O,10026
144417,IOLs,B-TREATMENT,10026
144418,and,O,10026
144419,the,O,10026
144420,conversion,O,10026
144421,rate,O,10026
144422,to,O,10026
144423,multifocality,O,10026
144424,can,O,10026
144425,be,O,10026
144426,monitored,O,10026
144427,SimVisGekko,B-TREATMENT,10027
144428,represents,O,10027
144429,a,O,10027
144430,new,O,10027
144431,paradigm,O,10027
144432,in,O,10027
144433,presbyopia,B-NAME_OF_DISEASE,10027
144434,correction,O,10027
144435,it,O,10027
144436,provides,O,10027
144437,patient,O,10027
144438,education,O,10027
144439,aids,O,10027
144440,in,O,10027
144441,lens,O,10027
144442,selection,O,10027
144443,reduces,O,10027
144444,uncertainty,O,10027
144445,preoperatively,O,10027
144446,allows,O,10027
144447,for,O,10027
144448,virtual,O,10027
144449,clinical,O,10027
144450,trials,O,10027
144451,and,O,10027
144452,testing,O,10027
144453,of,O,10027
144454,multiple,O,10027
144455,lenses,O,10027
144456,and,O,10027
144457,provides,O,10027
144458,large,O,10027
144459,data,O,10027
144460,sets,O,10027
144461,of,O,10027
144462,patient,O,10027
144463,preferences,O,10027
144464,and,O,10027
144465,usage,O,10027
144466,Oxidative,B-SIGN_AND_SYMPTOM,10028
144467,stress,I-SIGN_AND_SYMPTOM,10028
144468,and,O,10028
144469,associated,O,10028
144470,mitochondrial,B-SIGN_AND_SYMPTOM,10028
144471,dysfunction,I-SIGN_AND_SYMPTOM,10028
144472,are,O,10028
144473,integral,O,10028
144474,components,O,10028
144475,of,O,10028
144476,the,O,10028
144477,pathophysiology,O,10028
144478,of,O,10028
144479,retinal,O,10028
144480,diseases,O,10028
144481,including,O,10028
144482,diabetic,B-NAME_OF_DISEASE,10028
144483,retinopathy,I-NAME_OF_DISEASE,10028
144484,DR,I-NAME_OF_DISEASE,10028
144485,age-related,B-NAME_OF_DISEASE,10028
144486,macular,I-NAME_OF_DISEASE,10028
144487,degeneration,I-NAME_OF_DISEASE,10028
144488,and,O,10028
144489,glaucoma,B-NAME_OF_DISEASE,10028
144490,Within,O,10029
144491,mitochondria,O,10029
144492,flavoproteins,B-CHEMICAL_COMPOUND,10029
144493,are,O,10029
144494,oxidized,O,10029
144495,and,O,10029
144496,reduced,O,10029
144497,and,O,10029
144498,emit,O,10029
144499,a,O,10029
144500,green,O,10029
144501,autofluorescence,O,10029
144502,when,O,10029
144503,oxidized,O,10029
144504,following,O,10029
144505,blue,O,10029
144506,light,O,10029
144507,excitation,O,10029
144508,Oxidative,O,10030
144509,phosphorylation,O,10030
144510,produces,O,10030
144511,energy,O,10030
144512,leading,O,10030
144513,to,O,10030
144514,adenosine,B-CHEMICAL_COMPOUND,10030
144515,triphosphate,I-CHEMICAL_COMPOUND,10030
144516,production,O,10030
144517,In,O,10031
144518,addition,O,10031
144519,mitochondria,O,10031
144520,perform,O,10031
144521,numerous,O,10031
144522,other,O,10031
144523,functions,O,10031
144524,in,O,10031
144525,cellular,O,10031
144526,homeostases,O,10031
144527,such,O,10031
144528,as,O,10031
144529,apoptosis,O,10031
144530,regulation,O,10031
144531,steroid,B-CHEMICAL_COMPOUND,10031
144532,biosynthesis,O,10031
144533,and,O,10031
144534,nucleotide,B-CHEMICAL_COMPOUND,10031
144535,metabolism,O,10031
144536,For,O,10032
144537,this,O,10032
144538,reason,O,10032
144539,mitochondrial,B-SIGN_AND_SYMPTOM,10032
144540,dysfunction,I-SIGN_AND_SYMPTOM,10032
144541,can,O,10032
144542,severely,O,10032
144543,compromise,O,10032
144544,cellular,O,10032
144545,homeostasis,O,10032
144546,and,O,10032
144547,has,O,10032
144548,been,O,10032
144549,highlighted,O,10032
144550,as,O,10032
144551,a,O,10032
144552,crucial,O,10032
144553,mechanism,O,10032
144554,in,O,10032
144555,the,O,10032
144556,pathophysiology,O,10032
144557,of,O,10032
144558,normal,O,10032
144559,aging,O,10032
144560,and,O,10032
144561,pathologic,O,10032
144562,processes,O,10032
144563,including,O,10032
144564,retinal,B-NAME_OF_DISEASE,10032
144565,diseases,I-NAME_OF_DISEASE,10032
144566,Mitochondrial,B-SIGN_AND_SYMPTOM,10033
144567,dysfunction,I-SIGN_AND_SYMPTOM,10033
144568,is,O,10033
144569,recognized,O,10033
144570,to,O,10033
144571,play,O,10033
144572,a,O,10033
144573,crucial,O,10033
144574,role,O,10033
144575,in,O,10033
144576,a,O,10033
144577,wide,O,10033
144578,range,O,10033
144579,of,O,10033
144580,diseases,O,10033
144581,and,O,10033
144582,organs,O,10033
144583,with,O,10033
144584,the,O,10033
144585,most,O,10033
144586,affected,O,10033
144587,organs,O,10033
144588,being,O,10033
144589,those,O,10033
144590,that,O,10033
144591,have,O,10033
144592,a,O,10033
144593,high,O,10033
144594,metabolic,O,10033
144595,rate,O,10033
144596,such,O,10033
144597,as,O,10033
144598,brain,O,10033
144599,and,O,10033
144600,heart,O,10033
144601,For,O,10034
144602,example,O,10034
144603,previous,O,10034
144604,studies,O,10034
144605,have,O,10034
144606,shown,O,10034
144607,evidence,O,10034
144608,of,O,10034
144609,mitochondrial,O,10034
144610,involvement,O,10034
144611,in,O,10034
144612,the,O,10034
144613,pathophysiology,O,10034
144614,of,O,10034
144615,neurodegenerative,B-NAME_OF_DISEASE,10034
144616,diseases,I-NAME_OF_DISEASE,10034
144617,including,O,10034
144618,Parkinsons,B-NAME_OF_DISEASE,10034
144619,disease,I-NAME_OF_DISEASE,10034
144620,Alzheimers,B-NAME_OF_DISEASE,10034
144621,disease,I-NAME_OF_DISEASE,10034
144622,and,O,10034
144623,Huntingtons,B-NAME_OF_DISEASE,10034
144624,disease,I-NAME_OF_DISEASE,10034
144625,and,O,10034
144626,in,O,10034
144627,cardiac,B-NAME_OF_DISEASE,10034
144628,ischemia-reperfusion,I-NAME_OF_DISEASE,10034
144629,injury,I-NAME_OF_DISEASE,10034
144630,Retinal,O,10035
144631,pathologies,O,10035
144632,including,O,10035
144633,diabetic,B-NAME_OF_DISEASE,10035
144634,retinopathy,I-NAME_OF_DISEASE,10035
144635,DR,I-NAME_OF_DISEASE,10035
144636,age-related,B-NAME_OF_DISEASE,10035
144637,macular,I-NAME_OF_DISEASE,10035
144638,degeneration,I-NAME_OF_DISEASE,10035
144639,AMD,I-NAME_OF_DISEASE,10035
144640,and,O,10035
144641,glaucoma,B-NAME_OF_DISEASE,10035
144642,are,O,10035
144643,leading,O,10035
144644,causes,O,10035
144645,of,O,10035
144646,ocular,O,10035
144647,morbidity,O,10035
144648,worldwide,O,10035
144649,Currently,O,10036
144650,spectral,B-DIAGNOSTIC_TEST,10036
144651,domain,I-DIAGNOSTIC_TEST,10036
144652,optical,I-DIAGNOSTIC_TEST,10036
144653,coherence,I-DIAGNOSTIC_TEST,10036
144654,tomography,I-DIAGNOSTIC_TEST,10036
144655,SD-OCT,I-DIAGNOSTIC_TEST,10036
144656,is,O,10036
144657,standard,O,10036
144658,of,O,10036
144659,care,O,10036
144660,for,O,10036
144661,imaging,O,10036
144662,and,O,10036
144663,diagnosis,O,10036
144664,of,O,10036
144665,retinal,O,10036
144666,pathologies,O,10036
144667,visualizing,O,10036
144668,structural,O,10036
144669,change,O,10036
144670,in,O,10036
144671,disease,O,10036
144672,state,O,10036
144673,with,O,10036
144674,high,O,10036
144675,resolution,O,10036
144676,and,O,10036
144677,sensitivity,O,10036
144678,However,O,10037
144679,SD-OCT,B-DIAGNOSTIC_TEST,10037
144680,is,O,10037
144681,primarily,O,10037
144682,structural,O,10037
144683,it,O,10037
144684,cannot,O,10037
144685,provide,O,10037
144686,insight,O,10037
144687,into,O,10037
144688,retinal,B-SIGN_AND_SYMPTOM,10037
144689,oxidative,I-SIGN_AND_SYMPTOM,10037
144690,stress,I-SIGN_AND_SYMPTOM,10037
144691,and,I-SIGN_AND_SYMPTOM,10037
144692,damage,I-SIGN_AND_SYMPTOM,10037
144693,nor,I-SIGN_AND_SYMPTOM,10037
144694,metabolic,I-SIGN_AND_SYMPTOM,10037
144695,function,I-SIGN_AND_SYMPTOM,10037
144696,As,O,10038
144697,a,O,10038
144698,highly,O,10038
144699,metabolic,O,10038
144700,tissue,O,10038
144701,the,B-PART_OF_THE_EYES,10038
144702,retina,I-PART_OF_THE_EYES,10038
144703,is,O,10038
144704,susceptible,O,10038
144705,to,O,10038
144706,stressors,O,10038
144707,that,O,10038
144708,limit,O,10038
144709,energy,O,10038
144710,supply,O,10038
144711,Inefficient,B-CAUSE_OF_DISEASE,10039
144712,mitochondria,I-CAUSE_OF_DISEASE,10039
144713,result,O,10039
144714,in,O,10039
144715,metabolic,B-SIGN_AND_SYMPTOM,10039
144716,dysfunction,I-SIGN_AND_SYMPTOM,10039
144717,which,O,10039
144718,has,O,10039
144719,been,O,10039
144720,implicated,O,10039
144721,in,O,10039
144722,the,O,10039
144723,pathogenesis,O,10039
144724,of,O,10039
144725,DR,B-NAME_OF_DISEASE,10039
144726,AMD,B-NAME_OF_DISEASE,10039
144727,and,O,10039
144728,glaucoma,B-NAME_OF_DISEASE,10039
144729,Oxidative,B-SIGN_AND_SYMPTOM,10040
144730,stress,I-SIGN_AND_SYMPTOM,10040
144731,is,O,10040
144732,a,O,10040
144733,primary,O,10040
144734,driver,O,10040
144735,of,O,10040
144736,mitochondrial,B-SIGN_AND_SYMPTOM,10040
144737,dysfunction,I-SIGN_AND_SYMPTOM,10040
144738,over,O,10040
144739,time,O,10040
144740,leading,O,10040
144741,to,O,10040
144742,impaired,B-SIGN_AND_SYMPTOM,10040
144743,cellular,I-SIGN_AND_SYMPTOM,10040
144744,respiration,I-SIGN_AND_SYMPTOM,10040
144745,organelle,I-SIGN_AND_SYMPTOM,10040
144746,death,I-SIGN_AND_SYMPTOM,10040
144747,Oxidized,B-CHEMICAL_COMPOUND,10041
144748,flavoproteins,I-CHEMICAL_COMPOUND,10041
144749,are,O,10041
144750,mitochondrial,O,10041
144751,proteins,O,10041
144752,that,O,10041
144753,reflect,O,10041
144754,oxidative,B-SIGN_AND_SYMPTOM,10041
144755,stress,I-SIGN_AND_SYMPTOM,10041
144756,When,O,10042
144757,excited,O,10042
144758,by,O,10042
144759,blue-spectrum,O,10042
144760,light,O,10042
144761,they,O,10042
144762,emit,O,10042
144763,green-spectrum,O,10042
144764,light,O,10042
144765,and,O,10042
144766,this,O,10042
144767,phenomenon,O,10042
144768,is,O,10042
144769,termed,O,10042
144770,flavoprotein,B-CHEMICAL_COMPOUND,10042
144771,fluorescence,I-CHEMICAL_COMPOUND,10042
144772,FPF,I-CHEMICAL_COMPOUND,10042
144773,Flavoprotein,B-CHEMICAL_COMPOUND,10043
144774,fluorescence,O,10043
144775,can,O,10043
144776,be,O,10043
144777,harnessed,O,10043
144778,with,O,10043
144779,retinal,O,10043
144780,metabolic,O,10043
144781,imaging,O,10043
144782,devices,O,10043
144783,to,O,10043
144784,detect,O,10043
144785,fluorescence,O,10043
144786,of,O,10043
144787,these,O,10043
144788,proteins,B-CHEMICAL_COMPOUND,10043
144789,and,O,10043
144790,by,O,10043
144791,extension,O,10043
144792,the,O,10043
144793,first,O,10043
144794,signs,O,10043
144795,of,O,10043
144796,retinal,O,10043
144797,pathology,O,10043
144798,before,O,10043
144799,it,O,10043
144800,manifests,O,10043
144801,in,O,10043
144802,gross,O,10043
144803,anatomic,O,10043
144804,change,O,10043
144805,This,O,10044
144806,review,O,10044
144807,article,O,10044
144808,will,O,10044
144809,summarize,O,10044
144810,FPF,O,10044
144811,physiology,O,10044
144812,and,O,10044
144813,its,O,10044
144814,application,O,10044
144815,to,O,10044
144816,retinal,O,10044
144817,imaging,O,10044
144818,by,O,10044
144819,examining,O,10044
144820,the,O,10044
144821,role,O,10044
144822,of,O,10044
144823,mitochondrial,B-SIGN_AND_SYMPTOM,10044
144824,dysfunction,I-SIGN_AND_SYMPTOM,10044
144825,in,O,10044
144826,retinal,O,10044
144827,diseases,O,10044
144828,preclinical,O,10044
144829,FPF,O,10044
144830,studies,O,10044
144831,and,O,10044
144832,recent,O,10044
144833,clinical,O,10044
144834,studies,O,10044
144835,exploring,O,10044
144836,FPF,O,10044
144837,in,O,10044
144838,patients,O,10044
144839,with,O,10044
144840,DR,B-NAME_OF_DISEASE,10044
144841,AMD,B-NAME_OF_DISEASE,10044
144842,and,O,10044
144843,glaucoma,B-NAME_OF_DISEASE,10044
144844,MITOCHONDRIAL,B-SIGN_AND_SYMPTOM,10045
144845,DYSFUNCTION,I-SIGN_AND_SYMPTOM,10045
144846,AT,O,10045
144847,THE,O,10045
144848,CELLULAR,O,10045
144849,LEVEL,O,10045
144850,Mitochondria,O,10046
144851,play,O,10046
144852,crucial,O,10046
144853,roles,O,10046
144854,in,O,10046
144855,cellular,O,10046
144856,function,O,10046
144857,including,O,10046
144858,adenosine,B-CHEMICAL_COMPOUND,10046
144859,triphosphate,I-CHEMICAL_COMPOUND,10046
144860,ATP,I-CHEMICAL_COMPOUND,10046
144861,production,O,10046
144862,regulation,O,10046
144863,of,O,10046
144864,cellular,O,10046
144865,metabolism,O,10046
144866,calcium,O,10046
144867,signaling,O,10046
144868,inflammatory,O,10046
144869,signaling,O,10046
144870,and,O,10046
144871,control,O,10046
144872,of,O,10046
144873,apoptosis,B-SIGN_AND_SYMPTOM,10046
144874,Dysfunctional,B-SIGN_AND_SYMPTOM,10047
144875,mitochondria,I-SIGN_AND_SYMPTOM,10047
144876,can,O,10047
144877,therefore,O,10047
144878,lead,O,10047
144879,to,O,10047
144880,decreased,B-SIGN_AND_SYMPTOM,10047
144881,energy,I-SIGN_AND_SYMPTOM,10047
144882,production,I-SIGN_AND_SYMPTOM,10047
144883,increased,I-SIGN_AND_SYMPTOM,10047
144884,inflammation,I-SIGN_AND_SYMPTOM,10047
144885,and,I-SIGN_AND_SYMPTOM,10047
144886,apoptosis,I-SIGN_AND_SYMPTOM,10047
144887,Increased,O,10048
144888,reactive,B-CHEMICAL_COMPOUND,10048
144889,oxidative,I-CHEMICAL_COMPOUND,10048
144890,species,I-CHEMICAL_COMPOUND,10048
144891,ROS,I-CHEMICAL_COMPOUND,10048
144892,combined,O,10048
144893,with,O,10048
144894,decreased,O,10048
144895,host,O,10048
144896,antioxidant,B-CHEMICAL_COMPOUND,10048
144897,defenses,O,10048
144898,are,O,10048
144899,known,O,10048
144900,to,O,10048
144901,generate,O,10048
144902,a,O,10048
144903,pro-oxidative,O,10048
144904,state,O,10048
144905,which,O,10048
144906,contributes,O,10048
144907,to,O,10048
144908,mitochondrial,B-SIGN_AND_SYMPTOM,10048
144909,dysfunction,I-SIGN_AND_SYMPTOM,10048
144910,through,O,10048
144911,alteration,O,10048
144912,of,O,10048
144913,mtDNA,B-CHEMICAL_COMPOUND,10048
144914,lipid,B-CHEMICAL_COMPOUND,10048
144915,oxidation,O,10048
144916,and,O,10048
144917,protein,B-CHEMICAL_COMPOUND,10048
144918,oxidation,O,10048
144919,Alterations,O,10049
144920,in,O,10049
144921,mtDNA,B-CHEMICAL_COMPOUND,10049
144922,can,O,10049
144923,produce,O,10049
144924,defective,O,10049
144925,electron,O,10049
144926,transport,O,10049
144927,chain,O,10049
144928,proteins,B-CHEMICAL_COMPOUND,10049
144929,and,O,10049
144930,protein,B-CHEMICAL_COMPOUND,10049
144931,oxidation,O,10049
144932,compounds,O,10049
144933,this,O,10049
144934,effect,O,10049
144935,causing,O,10049
144936,inefficient,O,10049
144937,cellular,O,10049
144938,respiration,O,10049
144939,and,O,10049
144940,further,O,10049
144941,favors,O,10049
144942,ROS,B-CHEMICAL_COMPOUND,10049
144943,production,O,10049
144944,Peroxidation,O,10050
144945,of,O,10050
144946,lipids,B-CHEMICAL_COMPOUND,10050
144947,can,O,10050
144948,increase,O,10050
144949,apoptosis,B-SIGN_AND_SYMPTOM,10050
144950,and,O,10050
144951,autophagy,B-SIGN_AND_SYMPTOM,10050
144952,Because,O,10051
144953,of,O,10051
144954,their,O,10051
144955,crucial,O,10051
144956,role,O,10051
144957,in,O,10051
144958,cellular,O,10051
144959,energy,O,10051
144960,production,O,10051
144961,highly,O,10051
144962,metabolic,O,10051
144963,tissues,O,10051
144964,are,O,10051
144965,susceptible,O,10051
144966,to,O,10051
144967,damage,O,10051
144968,in,O,10051
144969,the,O,10051
144970,setting,O,10051
144971,of,O,10051
144972,mitochondrial,B-SIGN_AND_SYMPTOM,10051
144973,dysfunction,I-SIGN_AND_SYMPTOM,10051
144974,The,B-PART_OF_THE_EYES,10052
144975,retina,I-PART_OF_THE_EYES,10052
144976,is,O,10052
144977,a,O,10052
144978,primary,O,10052
144979,example,O,10052
144980,of,O,10052
144981,this,O,10052
144982,due,O,10052
144983,to,O,10052
144984,high,O,10052
144985,mitochondrial,O,10052
144986,density,O,10052
144987,in,O,10052
144988,retinal,B-PART_OF_THE_EYES,10052
144989,pigment,I-PART_OF_THE_EYES,10052
144990,epithelium,I-PART_OF_THE_EYES,10052
144991,and,O,10052
144992,photoreceptor,B-PART_OF_THE_EYES,10052
144993,layers,I-PART_OF_THE_EYES,10052
144994,Mitochondrial,B-SIGN_AND_SYMPTOM,10053
144995,dysfunction,I-SIGN_AND_SYMPTOM,10053
144996,in,O,10053
144997,these,O,10053
144998,retinal,O,10053
144999,layers,O,10053
145000,has,O,10053
145001,been,O,10053
145002,implicated,O,10053
145003,in,O,10053
145004,retinal,O,10053
145005,pathogenesis,O,10053
145006,of,O,10053
145007,AMD,B-NAME_OF_DISEASE,10053
145008,DR,B-NAME_OF_DISEASE,10053
145009,and,O,10053
145010,glaucoma,B-NAME_OF_DISEASE,10053
145011,Open-angle,B-NAME_OF_DISEASE,10054
145012,glaucoma,I-NAME_OF_DISEASE,10054
145013,is,O,10054
145014,a,O,10054
145015,common,O,10054
145016,type,O,10054
145017,of,O,10054
145018,eye,O,10054
145019,disorder,O,10054
145020,that,O,10054
145021,affects,O,10054
145022,millions,O,10054
145023,of,O,10054
145024,people,O,10054
145025,worldwide,O,10054
145026,It,O,10055
145027,is,O,10055
145028,also,O,10055
145029,known,O,10055
145030,as,O,10055
145031,primary,B-NAME_OF_DISEASE,10055
145032,open-angle,I-NAME_OF_DISEASE,10055
145033,glaucoma,B-NAME_OF_DISEASE,10055
145034,and,O,10055
145035,is,O,10055
145036,the,O,10055
145037,most,O,10055
145038,common,O,10055
145039,form,O,10055
145040,of,O,10055
145041,glaucoma,B-NAME_OF_DISEASE,10055
145042,in,O,10055
145043,the,B-GPE,10055
145044,United,I-GPE,10055
145045,States,I-GPE,10055
145046,It,O,10056
145047,is,O,10056
145048,a,O,10056
145049,progressive,O,10056
145050,eye,O,10056
145051,disease,O,10056
145052,that,O,10056
145053,can,O,10056
145054,cause,O,10056
145055,permanent,B-NAME_OF_DISEASE,10056
145056,vision,I-NAME_OF_DISEASE,10056
145057,loss,I-NAME_OF_DISEASE,10056
145058,if,O,10056
145059,left,O,10056
145060,untreated,O,10056
145061,In,O,10057
145062,this,O,10057
145063,article,O,10057
145064,we,O,10057
145065,will,O,10057
145066,explore,O,10057
145067,what,O,10057
145068,open-angle,B-NAME_OF_DISEASE,10057
145069,glaucoma,I-NAME_OF_DISEASE,10057
145070,is,O,10057
145071,what,O,10057
145072,causes,O,10057
145073,it,O,10057
145074,the,O,10057
145075,symptoms,O,10057
145076,diagnosis,O,10057
145077,treatment,O,10057
145078,options,O,10057
145079,and,O,10057
145080,how,O,10057
145081,it,O,10057
145082,can,O,10057
145083,be,O,10057
145084,prevented,O,10057
145085,What,O,10058
145086,Is,O,10058
145087,Open-Angle,B-NAME_OF_DISEASE,10058
145088,Glaucoma,I-NAME_OF_DISEASE,10058
145089,Open-angle,B-NAME_OF_DISEASE,10059
145090,glaucoma,I-NAME_OF_DISEASE,10059
145091,is,O,10059
145092,a,O,10059
145093,type,O,10059
145094,of,O,10059
145095,eye,O,10059
145096,disease,O,10059
145097,that,O,10059
145098,occurs,O,10059
145099,when,O,10059
145100,the,B-SIGN_AND_SYMPTOM,10059
145101,pressure,I-SIGN_AND_SYMPTOM,10059
145102,inside,I-SIGN_AND_SYMPTOM,10059
145103,the,I-SIGN_AND_SYMPTOM,10059
145104,eye,I-SIGN_AND_SYMPTOM,10059
145105,increases,I-SIGN_AND_SYMPTOM,10059
145106,leading,O,10059
145107,to,O,10059
145108,damage,B-SIGN_AND_SYMPTOM,10059
145109,of,I-SIGN_AND_SYMPTOM,10059
145110,the,I-SIGN_AND_SYMPTOM,10059
145111,optic,I-SIGN_AND_SYMPTOM,10059
145112,nerve,I-SIGN_AND_SYMPTOM,10059
145113,The,B-PART_OF_THE_EYES,10060
145114,optic,I-PART_OF_THE_EYES,10060
145115,nerve,I-PART_OF_THE_EYES,10060
145116,is,O,10060
145117,responsible,O,10060
145118,for,O,10060
145119,carrying,O,10060
145120,visual,O,10060
145121,information,O,10060
145122,from,O,10060
145123,the,O,10060
145124,eye,O,10060
145125,to,O,10060
145126,the,O,10060
145127,brain,O,10060
145128,In,O,10061
145129,open-angle,B-NAME_OF_DISEASE,10061
145130,glaucoma,I-NAME_OF_DISEASE,10061
145131,the,B-SIGN_AND_SYMPTOM,10061
145132,drainage,I-SIGN_AND_SYMPTOM,10061
145133,system,I-SIGN_AND_SYMPTOM,10061
145134,of,I-SIGN_AND_SYMPTOM,10061
145135,the,I-SIGN_AND_SYMPTOM,10061
145136,eye,I-SIGN_AND_SYMPTOM,10061
145137,becomes,I-SIGN_AND_SYMPTOM,10061
145138,clogged,I-SIGN_AND_SYMPTOM,10061
145139,leading,O,10061
145140,to,O,10061
145141,an,B-SIGN_AND_SYMPTOM,10061
145142,increase,I-SIGN_AND_SYMPTOM,10061
145143,in,I-SIGN_AND_SYMPTOM,10061
145144,the,I-SIGN_AND_SYMPTOM,10061
145145,intraocular,I-SIGN_AND_SYMPTOM,10061
145146,pressure,I-SIGN_AND_SYMPTOM,10061
145147,The,B-SIGN_AND_SYMPTOM,10062
145148,damage,I-SIGN_AND_SYMPTOM,10062
145149,to,I-SIGN_AND_SYMPTOM,10062
145150,the,I-SIGN_AND_SYMPTOM,10062
145151,optic,I-SIGN_AND_SYMPTOM,10062
145152,nerve,I-SIGN_AND_SYMPTOM,10062
145153,caused,O,10062
145154,by,O,10062
145155,open-angle,B-NAME_OF_DISEASE,10062
145156,glaucoma,I-NAME_OF_DISEASE,10062
145157,is,O,10062
145158,irreversible,O,10062
145159,and,O,10062
145160,can,O,10062
145161,result,O,10062
145162,in,O,10062
145163,permanent,B-NAME_OF_DISEASE,10062
145164,vision,I-NAME_OF_DISEASE,10062
145165,loss,I-NAME_OF_DISEASE,10062
145166,What,O,10063
145167,Causes,O,10063
145168,Open-angle,B-NAME_OF_DISEASE,10063
145169,Glaucoma,I-NAME_OF_DISEASE,10063
145170,The,O,10064
145171,exact,O,10064
145172,cause,O,10064
145173,of,O,10064
145174,open-angle,B-NAME_OF_DISEASE,10064
145175,glaucoma,I-NAME_OF_DISEASE,10064
145176,is,O,10064
145177,not,O,10064
145178,fully,O,10064
145179,understood,O,10064
145180,Increased,B-CAUSE_OF_DISEASE,10065
145181,Intraocular,I-CAUSE_OF_DISEASE,10065
145182,Pressure,I-CAUSE_OF_DISEASE,10065
145183,The,O,10066
145184,pressure,O,10066
145185,inside,O,10066
145186,the,O,10066
145187,eye,O,10066
145188,can,O,10066
145189,increase,O,10066
145190,when,O,10066
145191,the,B-SIGN_AND_SYMPTOM,10066
145192,drainage,I-SIGN_AND_SYMPTOM,10066
145193,system,I-SIGN_AND_SYMPTOM,10066
145194,becomes,I-SIGN_AND_SYMPTOM,10066
145195,clogged,I-SIGN_AND_SYMPTOM,10066
145196,leading,O,10066
145197,to,O,10066
145198,damage,B-SIGN_AND_SYMPTOM,10066
145199,to,I-SIGN_AND_SYMPTOM,10066
145200,the,I-SIGN_AND_SYMPTOM,10066
145201,optic,I-SIGN_AND_SYMPTOM,10066
145202,nerve,I-SIGN_AND_SYMPTOM,10066
145203,Age,B-CAUSE_OF_DISEASE,10067
145204,Open-angle,B-NAME_OF_DISEASE,10068
145205,glaucoma,I-NAME_OF_DISEASE,10068
145206,is,O,10068
145207,more,O,10068
145208,common,O,10068
145209,in,O,10068
145210,individuals,O,10068
145211,over,O,10068
145212,the,O,10068
145213,age,O,10068
145214,of,O,10068
145215,40,O,10068
145216,Ethnicity,B-CAUSE_OF_DISEASE,10069
145217,African,O,10070
145218,Americans,O,10070
145219,Hispanics,O,10070
145220,and,O,10070
145221,Asians,O,10070
145222,are,O,10070
145223,at,O,10070
145224,a,O,10070
145225,higher,O,10070
145226,risk,O,10070
145227,of,O,10070
145228,developing,O,10070
145229,open-angle,B-NAME_OF_DISEASE,10070
145230,glaucoma,I-NAME_OF_DISEASE,10070
145231,Family,B-CAUSE_OF_DISEASE,10071
145232,History,I-CAUSE_OF_DISEASE,10071
145233,A,B-CAUSE_OF_DISEASE,10072
145234,family,I-CAUSE_OF_DISEASE,10072
145235,history,I-CAUSE_OF_DISEASE,10072
145236,of,I-CAUSE_OF_DISEASE,10072
145237,open-angle,I-CAUSE_OF_DISEASE,10072
145238,glaucoma,I-CAUSE_OF_DISEASE,10072
145239,can,O,10072
145240,increase,O,10072
145241,the,O,10072
145242,risk,O,10072
145243,of,O,10072
145244,developing,O,10072
145245,the,O,10072
145246,disease,O,10072
145247,Medical,B-CAUSE_OF_DISEASE,10073
145248,Conditions,I-CAUSE_OF_DISEASE,10073
145249,Certain,B-CAUSE_OF_DISEASE,10074
145250,medical,I-CAUSE_OF_DISEASE,10074
145251,conditions,I-CAUSE_OF_DISEASE,10074
145252,such,I-CAUSE_OF_DISEASE,10074
145253,as,I-CAUSE_OF_DISEASE,10074
145254,diabetes,I-CAUSE_OF_DISEASE,10074
145255,and,I-CAUSE_OF_DISEASE,10074
145256,hypertension,I-CAUSE_OF_DISEASE,10074
145257,can,O,10074
145258,increase,O,10074
145259,the,O,10074
145260,risk,O,10074
145261,of,O,10074
145262,developing,O,10074
145263,open-angle,B-NAME_OF_DISEASE,10074
145264,glaucoma,I-NAME_OF_DISEASE,10074
145265,Do,O,10075
145266,Genetics,O,10075
145267,Play,O,10075
145268,A,O,10075
145269,Role,O,10075
145270,In,O,10075
145271,Open-Angle,B-NAME_OF_DISEASE,10075
145272,Glaucoma,I-NAME_OF_DISEASE,10075
145273,Yes,O,10076
145274,genetics,O,10076
145275,can,O,10076
145276,play,O,10076
145277,a,O,10076
145278,role,O,10076
145279,in,O,10076
145280,open-angle,B-NAME_OF_DISEASE,10076
145281,glaucoma,I-NAME_OF_DISEASE,10076
145282,Individuals,O,10077
145283,with,O,10077
145284,a,B-CAUSE_OF_DISEASE,10077
145285,family,I-CAUSE_OF_DISEASE,10077
145286,history,I-CAUSE_OF_DISEASE,10077
145287,of,I-CAUSE_OF_DISEASE,10077
145288,the,I-CAUSE_OF_DISEASE,10077
145289,disease,I-CAUSE_OF_DISEASE,10077
145290,are,O,10077
145291,at,O,10077
145292,a,O,10077
145293,higher,O,10077
145294,risk,O,10077
145295,of,O,10077
145296,developing,O,10077
145297,open-angle,B-NAME_OF_DISEASE,10077
145298,glaucoma,I-NAME_OF_DISEASE,10077
145299,Researchers,O,10078
145300,have,O,10078
145301,identified,O,10078
145302,several,O,10078
145303,genes,B-CHEMICAL_COMPOUND,10078
145304,that,O,10078
145305,are,O,10078
145306,associated,O,10078
145307,with,O,10078
145308,open-angle,B-NAME_OF_DISEASE,10078
145309,glaucoma,I-NAME_OF_DISEASE,10078
145310,including,O,10078
145311,MYOC,B-CHEMICAL_COMPOUND,10078
145312,OPTN,B-CHEMICAL_COMPOUND,10078
145313,and,O,10078
145314,WDR36,B-CHEMICAL_COMPOUND,10078
145315,Does,O,10079
145316,Open-Angle,B-NAME_OF_DISEASE,10079
145317,Glaucoma,I-NAME_OF_DISEASE,10079
145318,Have,O,10079
145319,Any,O,10079
145320,Symptoms,O,10079
145321,Open-angle,B-NAME_OF_DISEASE,10080
145322,glaucoma,I-NAME_OF_DISEASE,10080
145323,is,O,10080
145324,often,O,10080
145325,called,O,10080
145326,the,O,10080
145327,silent,O,10080
145328,thief,O,10080
145329,of,O,10080
145330,sight,O,10080
145331,because,O,10080
145332,it,O,10080
145333,can,O,10080
145334,develop,O,10080
145335,slowly,O,10080
145336,and,O,10080
145337,without,O,10080
145338,any,O,10080
145339,symptoms,O,10080
145340,It,O,10081
145341,is,O,10081
145342,important,O,10081
145343,to,O,10081
145344,note,O,10081
145345,that,O,10081
145346,by,O,10081
145347,the,O,10081
145348,time,O,10081
145349,symptoms,O,10081
145350,appear,O,10081
145351,significant,O,10081
145352,damage,O,10081
145353,to,O,10081
145354,the,B-PART_OF_THE_EYES,10081
145355,optic,I-PART_OF_THE_EYES,10081
145356,nerve,I-PART_OF_THE_EYES,10081
145357,may,O,10081
145358,have,O,10081
145359,already,O,10081
145360,occurred,O,10081
145361,How,O,10082
145362,Is,O,10082
145363,Open-Angle,B-NAME_OF_DISEASE,10082
145364,Glaucoma,I-NAME_OF_DISEASE,10082
145365,Diagnosed,O,10082
145366,Open-angle,B-NAME_OF_DISEASE,10083
145367,glaucoma,I-NAME_OF_DISEASE,10083
145368,can,O,10083
145369,be,O,10083
145370,diagnosed,O,10083
145371,through,O,10083
145372,a,B-DIAGNOSTIC_TEST,10083
145373,comprehensive,I-DIAGNOSTIC_TEST,10083
145374,eye,I-DIAGNOSTIC_TEST,10083
145375,exam,I-DIAGNOSTIC_TEST,10083
145376,Tonometry,B-DIAGNOSTIC_TEST,10084
145377,Visual,B-DIAGNOSTIC_TEST,10085
145378,Field,I-DIAGNOSTIC_TEST,10085
145379,Test,I-DIAGNOSTIC_TEST,10085
145380,Dilated,B-DIAGNOSTIC_TEST,10086
145381,Eye,I-DIAGNOSTIC_TEST,10086
145382,Exam,I-DIAGNOSTIC_TEST,10086
145383,This,O,10087
145384,allows,O,10087
145385,the,O,10087
145386,ophthalmologist,O,10087
145387,to,O,10087
145388,examine,O,10087
145389,the,B-PART_OF_THE_EYES,10087
145390,optic,I-PART_OF_THE_EYES,10087
145391,nerve,I-PART_OF_THE_EYES,10087
145392,for,O,10087
145393,signs,O,10087
145394,of,O,10087
145395,damage,O,10087
145396,Optical,B-DIAGNOSTIC_TEST,10088
145397,Coherence,I-DIAGNOSTIC_TEST,10088
145398,Tomography,I-DIAGNOSTIC_TEST,10088
145399,OCT,I-DIAGNOSTIC_TEST,10088
145400,This,O,10089
145401,is,O,10089
145402,a,O,10089
145403,non-invasive,O,10089
145404,imaging,O,10089
145405,test,O,10089
145406,that,O,10089
145407,can,O,10089
145408,measure,O,10089
145409,the,O,10089
145410,thickness,O,10089
145411,of,O,10089
145412,the,B-PART_OF_THE_EYES,10089
145413,optic,I-PART_OF_THE_EYES,10089
145414,nerve,I-PART_OF_THE_EYES,10089
145415,and,O,10089
145416,changes,O,10089
145417,in,O,10089
145418,the,B-PART_OF_THE_EYES,10089
145419,retinal,I-PART_OF_THE_EYES,10089
145420,nerve,I-PART_OF_THE_EYES,10089
145421,fiber,I-PART_OF_THE_EYES,10089
145422,layer,I-PART_OF_THE_EYES,10089
145423,RNFL,I-PART_OF_THE_EYES,10089
145424,Treatment,O,10090
145425,Options,O,10090
145426,For,O,10090
145427,Open-Angle,B-NAME_OF_DISEASE,10090
145428,Glaucoma,I-NAME_OF_DISEASE,10090
145429,Primary,B-NAME_OF_DISEASE,10091
145430,open-angle,I-NAME_OF_DISEASE,10091
145431,glaucoma,I-NAME_OF_DISEASE,10091
145432,POAG,I-NAME_OF_DISEASE,10091
145433,is,O,10091
145434,a,O,10091
145435,progressive,O,10091
145436,eye,O,10091
145437,disease,O,10091
145438,that,O,10091
145439,can,O,10091
145440,cause,O,10091
145441,permanent,B-NAME_OF_DISEASE,10091
145442,vision,I-NAME_OF_DISEASE,10091
145443,loss,I-NAME_OF_DISEASE,10091
145444,if,O,10091
145445,left,O,10091
145446,untreated,O,10091
145447,The,O,10092
145448,management,O,10092
145449,of,O,10092
145450,POAG,B-NAME_OF_DISEASE,10092
145451,involves,O,10092
145452,lowering,B-TREATMENT,10092
145453,the,I-TREATMENT,10092
145454,intraocular,I-TREATMENT,10092
145455,pressure,I-TREATMENT,10092
145456,IOP,I-TREATMENT,10092
145457,to,O,10092
145458,prevent,O,10092
145459,further,O,10092
145460,damage,O,10092
145461,to,O,10092
145462,the,B-PART_OF_THE_EYES,10092
145463,optic,I-PART_OF_THE_EYES,10092
145464,nerve,I-PART_OF_THE_EYES,10092
145465,Treatment,O,10093
145466,options,O,10093
145467,include,O,10093
145468,medication,B-TREATMENT,10093
145469,laser,B-TREATMENT,10093
145470,therapy,I-TREATMENT,10093
145471,and,O,10093
145472,surgery,B-TREATMENT,10093
145473,Medications,B-TREATMENT,10094
145474,Eye,B-TREATMENT,10095
145475,drops,I-TREATMENT,10095
145476,are,O,10095
145477,the,O,10095
145478,most,O,10095
145479,common,O,10095
145480,treatment,O,10095
145481,for,O,10095
145482,POAG,B-NAME_OF_DISEASE,10095
145483,There,O,10096
145484,are,O,10096
145485,several,O,10096
145486,classes,O,10096
145487,of,O,10096
145488,medications,O,10096
145489,used,O,10096
145490,to,O,10096
145491,treat,O,10096
145492,POAG,B-NAME_OF_DISEASE,10096
145493,including,O,10096
145494,Prostaglandin,B-NAME_OF_DRUG,10097
145495,Analogs,I-NAME_OF_DRUG,10097
145496,eg,O,10097
145497,latanoprost,B-NAME_OF_DRUG,10097
145498,bimatoprost,B-NAME_OF_DRUG,10097
145499,These,O,10098
145500,medications,O,10098
145501,increase,O,10098
145502,the,O,10098
145503,outflow,O,10098
145504,of,O,10098
145505,fluid,O,10098
145506,in,O,10098
145507,the,O,10098
145508,eye,O,10098
145509,and,O,10098
145510,are,O,10098
145511,highly,O,10098
145512,effective,O,10098
145513,at,O,10098
145514,reducing,B-TREATMENT,10098
145515,IOP,I-TREATMENT,10098
145516,Beta-Blockers,B-NAME_OF_DRUG,10099
145517,eg,O,10099
145518,timolol,B-NAME_OF_DRUG,10099
145519,These,O,10100
145520,medications,O,10100
145521,reduce,O,10100
145522,the,O,10100
145523,production,O,10100
145524,of,O,10100
145525,fluid,O,10100
145526,in,O,10100
145527,the,O,10100
145528,eye,O,10100
145529,and,O,10100
145530,can,O,10100
145531,be,O,10100
145532,used,O,10100
145533,in,O,10100
145534,combination,O,10100
145535,with,O,10100
145536,prostaglandin,B-NAME_OF_DRUG,10100
145537,analogs,I-NAME_OF_DRUG,10100
145538,Alpha-Adrenergic,B-NAME_OF_DRUG,10101
145539,Agonists,I-NAME_OF_DRUG,10101
145540,eg,O,10101
145541,brimonidine,B-NAME_OF_DRUG,10101
145542,Carbonic,B-NAME_OF_DRUG,10102
145543,Anhydrase,I-NAME_OF_DRUG,10102
145544,Inhibitors,I-NAME_OF_DRUG,10102
145545,eg,O,10102
145546,dorzolamide,B-NAME_OF_DRUG,10102
145547,These,O,10103
145548,medications,O,10103
145549,reduce,O,10103
145550,the,O,10103
145551,production,O,10103
145552,of,O,10103
145553,fluid,O,10103
145554,in,O,10103
145555,the,O,10103
145556,eye,O,10103
145557,and,O,10103
145558,can,O,10103
145559,be,O,10103
145560,used,O,10103
145561,in,O,10103
145562,combination,O,10103
145563,with,O,10103
145564,other,O,10103
145565,eye,B-TREATMENT,10103
145566,drops,I-TREATMENT,10103
145567,Laser,B-TREATMENT,10104
145568,Therapy,I-TREATMENT,10104
145569,Laser,B-TREATMENT,10105
145570,therapy,I-TREATMENT,10105
145571,also,O,10105
145572,known,O,10105
145573,as,O,10105
145574,trabeculoplasty,B-TREATMENT,10105
145575,is,O,10105
145576,a,O,10105
145577,non-invasive,O,10105
145578,procedure,O,10105
145579,that,O,10105
145580,uses,O,10105
145581,a,O,10105
145582,laser,O,10105
145583,to,O,10105
145584,improve,O,10105
145585,the,O,10105
145586,drainage,O,10105
145587,of,O,10105
145588,fluid,O,10105
145589,in,O,10105
145590,the,O,10105
145591,eye,O,10105
145592,There,O,10106
145593,are,O,10106
145594,two,O,10106
145595,types,O,10106
145596,of,O,10106
145597,laser,B-TREATMENT,10106
145598,therapy,I-TREATMENT,10106
145599,used,O,10106
145600,to,O,10106
145601,treat,O,10106
145602,POAG,B-NAME_OF_DISEASE,10106
145603,Argon,B-TREATMENT,10107
145604,Laser,I-TREATMENT,10107
145605,Trabeculoplasty,I-TREATMENT,10107
145606,ALT,I-TREATMENT,10107
145607,Selective,B-TREATMENT,10108
145608,Laser,I-TREATMENT,10108
145609,Trabeculoplasty,I-TREATMENT,10108
145610,SLT,I-TREATMENT,10108
145611,Surgery,B-TREATMENT,10109
145612,If,O,10110
145613,medications,B-TREATMENT,10110
145614,and,O,10110
145615,laser,B-TREATMENT,10110
145616,therapy,I-TREATMENT,10110
145617,are,O,10110
145618,not,O,10110
145619,effective,O,10110
145620,in,O,10110
145621,controlling,O,10110
145622,IOP,O,10110
145623,surgery,B-TREATMENT,10110
145624,may,O,10110
145625,be,O,10110
145626,recommended,O,10110
145627,There,O,10111
145628,are,O,10111
145629,several,O,10111
145630,types,O,10111
145631,of,O,10111
145632,surgery,B-TREATMENT,10111
145633,used,O,10111
145634,to,O,10111
145635,treat,O,10111
145636,POAG,B-NAME_OF_DISEASE,10111
145637,including,O,10111
145638,Trabeculectomy,B-TREATMENT,10112
145639,Glaucoma,B-TREATMENT,10113
145640,Drainage,I-TREATMENT,10113
145641,Devices,I-TREATMENT,10113
145642,Minimally,B-TREATMENT,10114
145643,Invasive,I-TREATMENT,10114
145644,Glaucoma,I-TREATMENT,10114
145645,Surgery,I-TREATMENT,10114
145646,MIGS,I-TREATMENT,10114
145647,It,O,10115
145648,is,O,10115
145649,important,O,10115
145650,to,O,10115
145651,note,O,10115
145652,that,O,10115
145653,the,O,10115
145654,goal,O,10115
145655,of,O,10115
145656,treatment,O,10115
145657,is,O,10115
145658,to,B-TREATMENT,10115
145659,lower,I-TREATMENT,10115
145660,IOP,I-TREATMENT,10115
145661,to,O,10115
145662,prevent,O,10115
145663,further,O,10115
145664,damage,O,10115
145665,to,O,10115
145666,the,B-PART_OF_THE_EYES,10115
145667,optic,I-PART_OF_THE_EYES,10115
145668,nerve,I-PART_OF_THE_EYES,10115
145669,In,O,10116
145670,addition,O,10116
145671,to,O,10116
145672,medical,O,10116
145673,and,O,10116
145674,surgical,O,10116
145675,management,O,10116
145676,lifestyle,B-PREVENTION,10116
145677,changes,I-PREVENTION,10116
145678,such,I-PREVENTION,10116
145679,as,I-PREVENTION,10116
145680,regular,I-PREVENTION,10116
145681,exercise,I-PREVENTION,10116
145682,maintaining,I-PREVENTION,10116
145683,a,I-PREVENTION,10116
145684,healthy,I-PREVENTION,10116
145685,weight,I-PREVENTION,10116
145686,and,I-PREVENTION,10116
145687,avoiding,I-PREVENTION,10116
145688,smoking,I-PREVENTION,10116
145689,can,O,10116
145690,also,O,10116
145691,help,O,10116
145692,in,O,10116
145693,the,O,10116
145694,management,O,10116
145695,of,O,10116
145696,POAG,B-NAME_OF_DISEASE,10116
145697,Dietary,B-PREVENTION,10117
145698,changes,I-PREVENTION,10117
145699,such,I-PREVENTION,10117
145700,as,I-PREVENTION,10117
145701,reducing,I-PREVENTION,10117
145702,caffeine,I-PREVENTION,10117
145703,intake,I-PREVENTION,10117
145704,and,I-PREVENTION,10117
145705,increasing,I-PREVENTION,10117
145706,the,I-PREVENTION,10117
145707,consumption,I-PREVENTION,10117
145708,of,I-PREVENTION,10117
145709,green,I-PREVENTION,10117
145710,leafy,I-PREVENTION,10117
145711,vegetables,I-PREVENTION,10117
145712,may,O,10117
145713,also,O,10117
145714,be,O,10117
145715,beneficial,O,10117
145716,How,O,10118
145717,Can,O,10118
145718,Open-Angle,B-NAME_OF_DISEASE,10118
145719,Glaucoma,I-NAME_OF_DISEASE,10118
145720,Be,O,10118
145721,Prevented,O,10118
145722,Regular,B-PREVENTION,10119
145723,Eye,I-PREVENTION,10119
145724,Exams,I-PREVENTION,10119
145725,Routine,B-PREVENTION,10120
145726,eye,I-PREVENTION,10120
145727,exams,I-PREVENTION,10120
145728,can,O,10120
145729,detect,O,10120
145730,signs,O,10120
145731,of,O,10120
145732,POAG,B-NAME_OF_DISEASE,10120
145733,and,O,10120
145734,allow,O,10120
145735,for,O,10120
145736,early,O,10120
145737,diagnosis,O,10120
145738,and,O,10120
145739,treatment,O,10120
145740,The,B-ORGANIZATION,10121
145741,American,I-ORGANIZATION,10121
145742,Academy,I-ORGANIZATION,10121
145743,of,I-ORGANIZATION,10121
145744,Ophthalmology,I-ORGANIZATION,10121
145745,recommends,O,10121
145746,a,B-PREVENTION,10121
145747,comprehensive,I-PREVENTION,10121
145748,eye,I-PREVENTION,10121
145749,exam,I-PREVENTION,10121
145750,at,O,10121
145751,least,O,10121
145752,once,O,10121
145753,every,O,10121
145754,two,O,10121
145755,years,O,10121
145756,for,O,10121
145757,adults,O,10121
145758,over,O,10121
145759,40,O,10121
145760,and,O,10121
145761,more,O,10121
145762,frequently,O,10121
145763,for,O,10121
145764,those,O,10121
145765,with,O,10121
145766,risk,O,10121
145767,factors,O,10121
145768,for,O,10121
145769,glaucoma,B-NAME_OF_DISEASE,10121
145770,Lifestyle,B-PREVENTION,10122
145771,Changes,I-PREVENTION,10122
145772,Maintaining,B-PREVENTION,10123
145773,a,I-PREVENTION,10123
145774,healthy,I-PREVENTION,10123
145775,lifestyle,I-PREVENTION,10123
145776,can,O,10123
145777,help,O,10123
145778,reduce,O,10123
145779,the,O,10123
145780,risk,O,10123
145781,of,O,10123
145782,developing,O,10123
145783,POAG,B-NAME_OF_DISEASE,10123
145784,This,O,10124
145785,includes,O,10124
145786,regular,B-PREVENTION,10124
145787,exercise,I-PREVENTION,10124
145788,maintaining,B-PREVENTION,10124
145789,a,I-PREVENTION,10124
145790,healthy,I-PREVENTION,10124
145791,weight,I-PREVENTION,10124
145792,and,O,10124
145793,avoiding,B-PREVENTION,10124
145794,smoking,I-PREVENTION,10124
145795,Dietary,B-PREVENTION,10125
145796,Changes,I-PREVENTION,10125
145797,Increasing,B-PREVENTION,10126
145798,the,I-PREVENTION,10126
145799,consumption,I-PREVENTION,10126
145800,of,I-PREVENTION,10126
145801,green,I-PREVENTION,10126
145802,leafy,I-PREVENTION,10126
145803,vegetables,I-PREVENTION,10126
145804,which,O,10126
145805,are,O,10126
145806,high,O,10126
145807,in,O,10126
145808,antioxidants,B-CHEMICAL_COMPOUND,10126
145809,and,O,10126
145810,other,O,10126
145811,nutrients,B-CHEMICAL_COMPOUND,10126
145812,may,O,10126
145813,be,O,10126
145814,beneficial,O,10126
145815,for,O,10126
145816,eye,O,10126
145817,health,O,10126
145818,Some,O,10127
145819,studies,O,10127
145820,have,O,10127
145821,also,O,10127
145822,suggested,O,10127
145823,that,O,10127
145824,reducing,B-PREVENTION,10127
145825,caffeine,I-PREVENTION,10127
145826,intake,I-PREVENTION,10127
145827,may,O,10127
145828,help,O,10127
145829,to,O,10127
145830,lower,B-TREATMENT,10127
145831,intraocular,I-TREATMENT,10127
145832,pressure,I-TREATMENT,10127
145833,Managing,B-PREVENTION,10128
145834,Medical,I-PREVENTION,10128
145835,Conditions,I-PREVENTION,10128
145836,Certain,B-CAUSE_OF_DISEASE,10129
145837,medical,I-CAUSE_OF_DISEASE,10129
145838,conditions,I-CAUSE_OF_DISEASE,10129
145839,such,I-CAUSE_OF_DISEASE,10129
145840,as,I-CAUSE_OF_DISEASE,10129
145841,diabetes,I-CAUSE_OF_DISEASE,10129
145842,and,I-CAUSE_OF_DISEASE,10129
145843,hypertension,I-CAUSE_OF_DISEASE,10129
145844,can,O,10129
145845,increase,O,10129
145846,the,O,10129
145847,risk,O,10129
145848,of,O,10129
145849,developing,O,10129
145850,POAG,B-NAME_OF_DISEASE,10129
145851,Managing,B-PREVENTION,10130
145852,these,I-PREVENTION,10130
145853,conditions,I-PREVENTION,10130
145854,with,I-PREVENTION,10130
145855,regular,I-PREVENTION,10130
145856,medical,I-PREVENTION,10130
145857,care,I-PREVENTION,10130
145858,and,O,10130
145859,following,B-PREVENTION,10130
145860,recommended,I-PREVENTION,10130
145861,lifestyle,I-PREVENTION,10130
145862,changes,I-PREVENTION,10130
145863,can,O,10130
145864,help,O,10130
145865,to,O,10130
145866,reduce,O,10130
145867,the,O,10130
145868,risk,O,10130
145869,of,O,10130
145870,developing,O,10130
145871,POAG,B-NAME_OF_DISEASE,10130
145872,Eye,B-PREVENTION,10131
145873,Protection,I-PREVENTION,10131
145874,Protecting,B-PREVENTION,10132
145875,the,I-PREVENTION,10132
145876,eyes,I-PREVENTION,10132
145877,from,I-PREVENTION,10132
145878,injury,I-PREVENTION,10132
145879,is,O,10132
145880,also,O,10132
145881,important,O,10132
145882,in,O,10132
145883,preventing,O,10132
145884,POAG,B-NAME_OF_DISEASE,10132
145885,Wearing,B-PREVENTION,10133
145886,protective,I-PREVENTION,10133
145887,eyewear,I-PREVENTION,10133
145888,during,I-PREVENTION,10133
145889,certain,I-PREVENTION,10133
145890,activities,I-PREVENTION,10133
145891,such,I-PREVENTION,10133
145892,as,I-PREVENTION,10133
145893,sports,I-PREVENTION,10133
145894,or,I-PREVENTION,10133
145895,work,I-PREVENTION,10133
145896,that,I-PREVENTION,10133
145897,involves,I-PREVENTION,10133
145898,exposure,I-PREVENTION,10133
145899,to,I-PREVENTION,10133
145900,chemicals,I-PREVENTION,10133
145901,or,I-PREVENTION,10133
145902,flying,I-PREVENTION,10133
145903,debris,I-PREVENTION,10133
145904,can,O,10133
145905,help,O,10133
145906,reduce,O,10133
145907,the,O,10133
145908,risk,O,10133
145909,of,O,10133
145910,eye,O,10133
145911,injury,O,10133
145912,In,O,10134
145913,conclusion,O,10134
145914,primary,B-NAME_OF_DISEASE,10134
145915,open-angle,I-NAME_OF_DISEASE,10134
145916,glaucoma,I-NAME_OF_DISEASE,10134
145917,POAG,I-NAME_OF_DISEASE,10134
145918,is,O,10134
145919,a,O,10134
145920,progressive,O,10134
145921,eye,O,10134
145922,disease,O,10134
145923,that,O,10134
145924,can,O,10134
145925,cause,O,10134
145926,permanent,B-NAME_OF_DISEASE,10134
145927,vision,I-NAME_OF_DISEASE,10134
145928,loss,I-NAME_OF_DISEASE,10134
145929,if,O,10134
145930,left,O,10134
145931,untreated,O,10134
145932,While,O,10135
145933,the,O,10135
145934,exact,O,10135
145935,cause,O,10135
145936,of,O,10135
145937,POAG,B-NAME_OF_DISEASE,10135
145938,is,O,10135
145939,not,O,10135
145940,fully,O,10135
145941,understood,O,10135
145942,there,O,10135
145943,are,O,10135
145944,several,O,10135
145945,risk,O,10135
145946,factors,O,10135
145947,that,O,10135
145948,can,O,10135
145949,increase,O,10135
145950,the,O,10135
145951,likelihood,O,10135
145952,of,O,10135
145953,developing,O,10135
145954,the,O,10135
145955,disease,O,10135
145956,Regular,B-PREVENTION,10136
145957,eye,I-PREVENTION,10136
145958,exams,I-PREVENTION,10136
145959,lifestyle,B-PREVENTION,10136
145960,changes,I-PREVENTION,10136
145961,managing,B-PREVENTION,10136
145962,medical,I-PREVENTION,10136
145963,conditions,I-PREVENTION,10136
145964,and,O,10136
145965,eye,B-PREVENTION,10136
145966,protection,I-PREVENTION,10136
145967,are,O,10136
145968,some,O,10136
145969,of,O,10136
145970,the,O,10136
145971,ways,O,10136
145972,individuals,O,10136
145973,can,O,10136
145974,reduce,O,10136
145975,their,O,10136
145976,risk,O,10136
145977,of,O,10136
145978,developing,O,10136
145979,POAG,B-NAME_OF_DISEASE,10136
145980,or,O,10136
145981,slow,O,10136
145982,its,O,10136
145983,progression,O,10136
145984,if,O,10136
145985,already,O,10136
145986,diagnosed,O,10136
145987,Treatment,O,10137
145988,options,O,10137
145989,include,O,10137
145990,medication,B-TREATMENT,10137
145991,laser,B-TREATMENT,10137
145992,therapy,I-TREATMENT,10137
145993,and,O,10137
145994,surgery,B-TREATMENT,10137
145995,Early,O,10138
145996,diagnosis,O,10138
145997,and,O,10138
145998,treatment,O,10138
145999,are,O,10138
146000,critical,O,10138
146001,in,O,10138
146002,preventing,O,10138
146003,further,O,10138
146004,damage,O,10138
146005,to,O,10138
146006,the,B-PART_OF_THE_EYES,10138
146007,optic,I-PART_OF_THE_EYES,10138
146008,nerve,I-PART_OF_THE_EYES,10138
146009,and,O,10138
146010,preserving,O,10138
146011,vision,O,10138
146012,It,O,10139
146013,is,O,10139
146014,important,O,10139
146015,to,O,10139
146016,consult,O,10139
146017,with,O,10139
146018,an,O,10139
146019,Ophthalmologist,O,10139
146020,for,O,10139
146021,individualized,O,10139
146022,recommendations,O,10139
146023,on,O,10139
146024,preventing,O,10139
146025,and,O,10139
146026,managing,O,10139
146027,POAG,B-NAME_OF_DISEASE,10139
146028,Surgical,O,10140
146029,patients,O,10140
146030,had,O,10140
146031,a,O,10140
146032,statistically,O,10140
146033,significantly,O,10140
146034,lower,O,10140
146035,postoperative,O,10140
146036,prevalence,O,10140
146037,of,O,10140
146038,all,O,10140
146039,DR,B-NAME_OF_DISEASE,10140
146040,relative,O,10140
146041,risk,O,10140
146042,RR,O,10140
146043,0.17,O,10140
146044,95%,O,10140
146045,confidence,O,10140
146046,interval,O,10140
146047,CI,O,10140
146048,0.13-0.22,O,10140
146049,and,O,10140
146050,sight-threatening,B-NAME_OF_DISEASE,10140
146051,DR,I-NAME_OF_DISEASE,10140
146052,RR,O,10140
146053,0.47,O,10140
146054,95%,O,10140
146055,CI,O,10140
146056,0.27-0.82,O,10140
146057,Early,O,10141
146058,worsening,O,10141
146059,of,O,10141
146060,DR,B-NAME_OF_DISEASE,10141
146061,and,O,10141
146062,progression,O,10141
146063,to,O,10141
146064,sight-threatening,B-NAME_OF_DISEASE,10141
146065,DR,B-NAME_OF_DISEASE,10141
146066,had,O,10141
146067,occurred,O,10141
146068,more,O,10141
146069,often,O,10141
146070,in,O,10141
146071,those,O,10141
146072,with,O,10141
146073,more,O,10141
146074,severe,O,10141
146075,DR,B-NAME_OF_DISEASE,10141
146076,initially,O,10141
146077,However,O,10142
146078,beyond,O,10142
146079,12,B-TIME_DURATION,10142
146080,months,I-TIME_DURATION,10142
146081,bariatric,B-TREATMENT,10142
146082,surgery,I-TREATMENT,10142
146083,resulted,O,10142
146084,in,O,10142
146085,significantly,O,10142
146086,fewer,O,10142
146087,patients,O,10142
146088,with,O,10142
146089,worsened,O,10142
146090,DR,B-NAME_OF_DISEASE,10142
146091,RR,O,10142
146092,0.29,O,10142
146093,95%,O,10142
146094,CI,O,10142
146095,0.16-0.54,O,10142
146096,Bariatric,B-TREATMENT,10143
146097,surgery,I-TREATMENT,10143
146098,initially,O,10143
146099,intended,O,10143
146100,as,O,10143
146101,a,O,10143
146102,weight-loss,O,10143
146103,procedure,O,10143
146104,is,O,10143
146105,superior,O,10143
146106,to,O,10143
146107,standard,O,10143
146108,lifestyle,O,10143
146109,intervention,O,10143
146110,and,O,10143
146111,pharmacological,O,10143
146112,therapy,O,10143
146113,for,O,10143
146114,type,B-NAME_OF_DISEASE,10143
146115,2,I-NAME_OF_DISEASE,10143
146116,diabetes,I-NAME_OF_DISEASE,10143
146117,in,O,10143
146118,obese,O,10143
146119,individuals,O,10143
146120,Intensive,O,10144
146121,medical,O,10144
146122,management,O,10144
146123,of,O,10144
146124,hyperglycemia,B-NAME_OF_DISEASE,10144
146125,is,O,10144
146126,associated,O,10144
146127,with,O,10144
146128,improved,O,10144
146129,microvascular,O,10144
146130,outcomes,O,10144
146131,Whether,O,10145
146132,or,O,10145
146133,not,O,10145
146134,the,O,10145
146135,reduction,O,10145
146136,in,O,10145
146137,hyperglycemia,B-NAME_OF_DISEASE,10145
146138,observed,O,10145
146139,after,O,10145
146140,bariatric,B-TREATMENT,10145
146141,surgery,I-TREATMENT,10145
146142,translates,O,10145
146143,to,O,10145
146144,improved,O,10145
146145,microvascular,O,10145
146146,outcomes,O,10145
146147,is,O,10145
146148,yet,O,10145
146149,to,O,10145
146150,be,O,10145
146151,determined,O,10145
146152,There,O,10146
146153,is,O,10146
146154,substantial,O,10146
146155,heterogeneity,O,10146
146156,in,O,10146
146157,the,O,10146
146158,data,O,10146
146159,relating,O,10146
146160,to,O,10146
146161,the,O,10146
146162,impact,O,10146
146163,of,O,10146
146164,bariatric,B-TREATMENT,10146
146165,surgery,I-TREATMENT,10146
146166,on,O,10146
146167,diabetic,B-NAME_OF_DISEASE,10146
146168,retinopathy,I-NAME_OF_DISEASE,10146
146169,DR,I-NAME_OF_DISEASE,10146
146170,the,O,10146
146171,most,O,10146
146172,common,O,10146
146173,microvascular,O,10146
146174,complication,O,10146
146175,of,O,10146
146176,diabetes,B-NAME_OF_DISEASE,10146
146177,Diabetic,B-NAME_OF_DISEASE,10147
146178,retinopathy,I-NAME_OF_DISEASE,10147
146179,DR,I-NAME_OF_DISEASE,10147
146180,is,O,10147
146181,a,O,10147
146182,threat,O,10147
146183,to,O,10147
146184,vision,O,10147
146185,in,O,10147
146186,patients,O,10147
146187,with,O,10147
146188,type,B-NAME_OF_DISEASE,10147
146189,2,I-NAME_OF_DISEASE,10147
146190,diabetes,I-NAME_OF_DISEASE,10147
146191,and,O,10147
146192,a,O,10147
146193,cause,O,10147
146194,of,O,10147
146195,lost,O,10147
146196,sleep,O,10147
146197,for,O,10147
146198,ophthalmologists,O,10147
146199,when,O,10147
146200,they,O,10147
146201,cant,O,10147
146202,save,O,10147
146203,patients,O,10147
146204,vision,O,10147
146205,A,O,10148
146206,bright,O,10148
146207,spot,O,10148
146208,is,O,10148
146209,that,O,10148
146210,bariatric,B-TREATMENT,10148
146211,surgery,I-TREATMENT,10148
146212,is,O,10148
146213,an,O,10148
146214,effective,O,10148
146215,treatment,O,10148
146216,for,O,10148
146217,obesity,B-NAME_OF_DISEASE,10148
146218,in,O,10148
146219,patients,O,10148
146220,with,O,10148
146221,type,B-NAME_OF_DISEASE,10148
146222,2,I-NAME_OF_DISEASE,10148
146223,diabetes,I-NAME_OF_DISEASE,10148
146224,It,O,10149
146225,can,O,10149
146226,induce,O,10149
146227,remission,O,10149
146228,of,O,10149
146229,the,B-NAME_OF_DISEASE,10149
146230,diabetes,I-NAME_OF_DISEASE,10149
146231,and,O,10149
146232,reduce,O,10149
146233,other,O,10149
146234,microvascular,O,10149
146235,complications,O,10149
146236,according,O,10149
146237,to,O,10149
146238,Caberry,B-PERSON,10149
146239,Weiyang,I-PERSON,10149
146240,Yu,I-PERSON,10149
146241,MD,I-PERSON,10149
146242,of,O,10149
146243,the,B-ORGANIZATION,10149
146244,Division,I-ORGANIZATION,10149
146245,of,I-ORGANIZATION,10149
146246,Ophthalmology,I-ORGANIZATION,10149
146247,Department,I-ORGANIZATION,10149
146248,of,I-ORGANIZATION,10149
146249,Surgery,I-ORGANIZATION,10149
146250,at,I-ORGANIZATION,10149
146251,McMaster,I-ORGANIZATION,10149
146252,University,I-ORGANIZATION,10149
146253,in,O,10149
146254,Toronto,B-GPE,10149
146255,and,O,10149
146256,colleagues,O,10149
146257,One,O,10150
146258,drawback,O,10150
146259,may,O,10150
146260,be,O,10150
146261,the,O,10150
146262,suggestion,O,10150
146263,that,O,10150
146264,DR,B-NAME_OF_DISEASE,10150
146265,can,O,10150
146266,worsen,O,10150
146267,after,O,10150
146268,bariatric,B-TREATMENT,10150
146269,surgery,I-TREATMENT,10150
146270,as,O,10150
146271,a,O,10150
146272,result,O,10150
146273,of,O,10150
146274,the,O,10150
146275,rapid,O,10150
146276,improvement,O,10150
146277,in,O,10150
146278,hyperglycemia,B-NAME_OF_DISEASE,10150
146279,but,O,10150
146280,this,O,10150
146281,is,O,10150
146282,not,O,10150
146283,yet,O,10150
146284,defi,O,10150
146285,nitive,O,10150
146286,according,O,10150
146287,to,O,10150
146288,Yu,B-PERSON,10150
146289,In,O,10151
146290,light,O,10151
146291,of,O,10151
146292,this,O,10151
146293,Yu,B-PERSON,10151
146294,and,O,10151
146295,her,O,10151
146296,colleagues,O,10151
146297,performed,O,10151
146298,a,O,10151
146299,systemic,O,10151
146300,review,O,10151
146301,and,O,10151
146302,meta-analysis,O,10151
146303,to,O,10151
146304,determine,O,10151
146305,the,O,10151
146306,impact,O,10151
146307,of,O,10151
146308,bariatric,B-TREATMENT,10151
146309,surgery,I-TREATMENT,10151
146310,on,O,10151
146311,DR,B-NAME_OF_DISEASE,10151
146312,for,O,10151
146313,an,O,10151
146314,obese,O,10151
146315,diabetic,O,10151
146316,population,O,10151
146317,compared,O,10151
146318,with,O,10151
146319,controls,O,10151
146320,treated,O,10151
146321,with,O,10151
146322,medical,O,10151
146323,therapy,O,10151
146324,The,O,10152
146325,investigators,O,10152
146326,conducted,O,10152
146327,a,O,10152
146328,search,O,10152
146329,of,O,10152
146330,the,O,10152
146331,MEDLINE,O,10152
146332,Embase,O,10152
146333,Cochrane,O,10152
146334,Library,O,10152
146335,and,O,10152
146336,Web,O,10152
146337,of,O,10152
146338,Science,O,10152
146339,databases,O,10152
146340,up,O,10152
146341,to,O,10152
146342,March,O,10152
146343,2020,O,10152
146344,for,O,10152
146345,studies,O,10152
146346,that,O,10152
146347,compared,O,10152
146348,patients,O,10152
146349,with,O,10152
146350,DR,B-NAME_OF_DISEASE,10152
146351,who,O,10152
146352,had,O,10152
146353,undergone,O,10152
146354,bariatric,B-TREATMENT,10152
146355,surgery,I-TREATMENT,10152
146356,with,O,10152
146357,those,O,10152
146358,treated,O,10152
146359,medically,O,10152
146360,The,O,10153
146361,primary,O,10153
146362,outcomes,O,10153
146363,were,O,10153
146364,the,O,10153
146365,prevalence,O,10153
146366,rates,O,10153
146367,of,O,10153
146368,all,O,10153
146369,cases,O,10153
146370,of,O,10153
146371,DR,B-NAME_OF_DISEASE,10153
146372,and,O,10153
146373,sight-threatening,B-NAME_OF_DISEASE,10153
146374,DR,B-NAME_OF_DISEASE,10153
146375,postoperatively,O,10153
146376,the,O,10153
146377,secondary,O,10153
146378,outcomes,O,10153
146379,were,O,10153
146380,worsening,O,10153
146381,of,O,10153
146382,DR,B-NAME_OF_DISEASE,10153
146383,within,B-TIME_DURATION,10153
146384,12,I-TIME_DURATION,10153
146385,months,I-TIME_DURATION,10153
146386,and,O,10153
146387,thereafter,O,10153
146388,Almost,O,10154
146389,three-quarters,O,10154
146390,of,O,10154
146391,the,O,10154
146392,patients,O,10154
146393,with,O,10154
146394,type,B-NAME_OF_DISEASE,10154
146395,2,I-NAME_OF_DISEASE,10154
146396,diabetes,I-NAME_OF_DISEASE,10154
146397,were,O,10154
146398,women,O,10154
146399,mean,O,10154
146400,age,O,10154
146401,42.6,O,10154
146402,years,O,10154
146403,mean,O,10154
146404,body,O,10154
146405,mass,O,10154
146406,indices,O,10154
146407,BMIs,O,10154
146408,preoperatively,O,10154
146409,and,O,10154
146410,postoperatively,O,10154
146411,44.8,O,10154
146412,and,O,10154
146413,30.5,O,10154
146414,kgm2,O,10154
146415,,O,10154
146416,respectively,O,10154
146417,Four,O,10155
146418,types,O,10155
146419,of,O,10155
146420,bariatric,B-TREATMENT,10155
146421,surgeries,I-TREATMENT,10155
146422,were,O,10155
146423,performed,O,10155
146424,among,O,10155
146425,the,O,10155
146426,identified,O,10155
146427,studies,O,10155
146428,Roux-en-Y,B-TREATMENT,10155
146429,gastric,I-TREATMENT,10155
146430,bypass,I-TREATMENT,10155
146431,laparoscopic,B-TREATMENT,10155
146432,sleeve,I-TREATMENT,10155
146433,gastrectomy,I-TREATMENT,10155
146434,laparoscopic,B-TREATMENT,10155
146435,adjustable,I-TREATMENT,10155
146436,gastric,I-TREATMENT,10155
146437,bypass,I-TREATMENT,10155
146438,and,O,10155
146439,biliopancreatic,B-TREATMENT,10155
146440,diversion,I-TREATMENT,10155
146441,Primary,O,10156
146442,and,O,10156
146443,secondary,O,10156
146444,outcomes,O,10156
146445,At,O,10156
146446,follow-up,O,10156
146447,Yu,B-PERSON,10156
146448,reported,O,10156
146449,that,O,10156
146450,the,O,10156
146451,DR,B-NAME_OF_DISEASE,10156
146452,prevalence,O,10156
146453,rates,O,10156
146454,were,O,10156
146455,0.45%,O,10156
146456,for,O,10156
146457,bariatric,B-TREATMENT,10156
146458,surgery,I-TREATMENT,10156
146459,and,O,10156
146460,1.03%,O,10156
146461,for,O,10156
146462,medical,O,10156
146463,management,O,10156
146464,The,O,10157
146465,risk,O,10157
146466,of,O,10157
146467,having,O,10157
146468,any,O,10157
146469,DR,B-NAME_OF_DISEASE,10157
146470,for,O,10157
146471,the,O,10157
146472,surgical,O,10157
146473,patients,O,10157
146474,was,O,10157
146475,83%,O,10157
146476,compared,O,10157
146477,with,O,10157
146478,nonsurgical,O,10157
146479,patients,O,10157
146480,at,O,10157
146481,a,O,10157
146482,median,O,10157
146483,follow-up,O,10157
146484,of,O,10157
146485,8,B-TIME_DURATION,10157
146486,years,I-TIME_DURATION,10157
146487,she,O,10157
146488,reported,O,10157
146489,Moreover,O,10158
146490,undergoing,O,10158
146491,bariatric,B-TREATMENT,10158
146492,surgery,I-TREATMENT,10158
146493,was,O,10158
146494,seen,O,10158
146495,to,O,10158
146496,reduce,O,10158
146497,the,O,10158
146498,prevalence,O,10158
146499,of,O,10158
146500,sight-threatening,B-NAME_OF_DISEASE,10158
146501,DR,I-NAME_OF_DISEASE,10158
146502,by,O,10158
146503,53%,O,10158
146504,at,O,10158
146505,the,O,10158
146506,median,O,10158
146507,follow-up,O,10158
146508,of,O,10158
146509,4,B-TIME_DURATION,10158
146510,years,I-TIME_DURATION,10158
146511,compared,O,10158
146512,with,O,10158
146513,patients,O,10158
146514,treated,O,10158
146515,medically,O,10158
146516,Regarding,O,10159
146517,the,O,10159
146518,risk,O,10159
146519,of,O,10159
146520,early,O,10159
146521,progression,O,10159
146522,of,O,10159
146523,DR,B-NAME_OF_DISEASE,10159
146524,particularly,O,10159
146525,within,B-TIME_DURATION,10159
146526,12,I-TIME_DURATION,10159
146527,months,I-TIME_DURATION,10159
146528,and,O,10159
146529,associated,O,10159
146530,with,O,10159
146531,bariatric,B-TREATMENT,10159
146532,surgery,I-TREATMENT,10159
146533,Yu,B-PERSON,10159
146534,reported,O,10159
146535,that,O,10159
146536,the,B-NAME_OF_DISEASE,10159
146537,DR,B-NAME_OF_DISEASE,10159
146538,progressed,O,10159
146539,to,O,10159
146540,sight-threatening,B-NAME_OF_DISEASE,10159
146541,DR,B-NAME_OF_DISEASE,10159
146542,more,O,10159
146543,often,O,10159
146544,in,O,10159
146545,patients,O,10159
146546,whose,O,10159
146547,DR,B-NAME_OF_DISEASE,10159
146548,was,O,10159
146549,severe,O,10159
146550,at,O,10159
146551,baseline,O,10159
146552,In,O,10160
146553,patients,O,10160
146554,with,O,10160
146555,baseline,O,10160
146556,nonproliferative,B-NAME_OF_DISEASE,10160
146557,DR,B-NAME_OF_DISEASE,10160
146558,early,O,10160
146559,progression,O,10160
146560,of,O,10160
146561,all,O,10160
146562,DR,B-NAME_OF_DISEASE,10160
146563,did,O,10160
146564,not,O,10160
146565,diff,O,10160
146566,er,O,10160
146567,between,O,10160
146568,the,O,10160
146569,2,O,10160
146570,study,O,10160
146571,groups,O,10160
146572,occurring,O,10160
146573,in,O,10160
146574,about,O,10160
146575,1,O,10160
146576,of,O,10160
146577,7,O,10160
146578,patients,O,10160
146579,However,O,10161
146580,in,O,10161
146581,those,O,10161
146582,with,O,10161
146583,existing,O,10161
146584,proliferative,B-NAME_OF_DISEASE,10161
146585,DR,I-NAME_OF_DISEASE,10161
146586,at,O,10161
146587,baseline,O,10161
146588,complications,O,10161
146589,such,O,10161
146590,as,O,10161
146591,intraocular,B-SIGN_AND_SYMPTOM,10161
146592,hemorrhage,I-SIGN_AND_SYMPTOM,10161
146593,developed,O,10161
146594,in,O,10161
146595,4,O,10161
146596,of,O,10161
146597,5,O,10161
146598,patients,O,10161
146599,during,O,10161
146600,the,O,10161
146601,first,O,10161
146602,year,O,10161
146603,After,O,10162
146604,the,O,10162
146605,12-month,B-TIME_DURATION,10162
146606,time,O,10162
146607,point,O,10162
146608,significantly,O,10162
146609,fewer,O,10162
146610,patients,O,10162
146611,71%,O,10162
146612,who,O,10162
146613,underwent,O,10162
146614,bariatric,B-TREATMENT,10162
146615,surgery,I-TREATMENT,10162
146616,had,O,10162
146617,worsening,O,10162
146618,of,O,10162
146619,DR,B-NAME_OF_DISEASE,10162
146620,at,O,10162
146621,a,O,10162
146622,median,O,10162
146623,of,O,10162
146624,5,B-TIME_DURATION,10162
146625,years,I-TIME_DURATION,10162
146626,Progression,O,10163
146627,occurred,O,10163
146628,in,O,10163
146629,up,O,10163
146630,to,O,10163
146631,8%,O,10163
146632,of,O,10163
146633,patients,O,10163
146634,followed,O,10163
146635,for,O,10163
146636,between,B-TIME_DURATION,10163
146637,2,I-TIME_DURATION,10163
146638,to,I-TIME_DURATION,10163
146639,13,I-TIME_DURATION,10163
146640,years,I-TIME_DURATION,10163
146641,postoperatively,O,10163
146642,In,O,10164
146643,obese,O,10164
146644,patients,O,10164
146645,with,O,10164
146646,type,B-NAME_OF_DISEASE,10164
146647,2,I-NAME_OF_DISEASE,10164
146648,diabetes,I-NAME_OF_DISEASE,10164
146649,bariatric,B-TREATMENT,10164
146650,surgery,I-TREATMENT,10164
146651,was,O,10164
146652,associated,O,10164
146653,with,O,10164
146654,fewer,O,10164
146655,cases,O,10164
146656,of,O,10164
146657,all,O,10164
146658,and,O,10164
146659,sight-threatening,B-NAME_OF_DISEASE,10164
146660,DR,I-NAME_OF_DISEASE,10164
146661,Yu,B-PERSON,10164
146662,concluded,O,10164
146663,The,O,10165
146664,severity,O,10165
146665,of,O,10165
146666,the,O,10165
146667,baseline,O,10165
146668,DR,B-NAME_OF_DISEASE,10165
146669,was,O,10165
146670,an,O,10165
146671,important,O,10165
146672,sign,O,10165
146673,of,O,10165
146674,early,O,10165
146675,worsening,O,10165
146676,of,O,10165
146677,DR,B-NAME_OF_DISEASE,10165
146678,postoperatively,O,10165
146679,Early,O,10166
146680,screening,O,10166
146681,for,O,10166
146682,patients,O,10166
146683,with,O,10166
146684,existing,O,10166
146685,sight-threatening,B-NAME_OF_DISEASE,10166
146686,DR,I-NAME_OF_DISEASE,10166
146687,who,O,10166
146688,undergo,O,10166
146689,bariatric,B-TREATMENT,10166
146690,surgery,I-TREATMENT,10166
146691,is,O,10166
146692,needed,O,10166
146693,Elevated,B-CAUSE_OF_DISEASE,10167
146694,intraocular,I-CAUSE_OF_DISEASE,10167
146695,pressure,I-CAUSE_OF_DISEASE,10167
146696,IOP,I-CAUSE_OF_DISEASE,10167
146697,is,O,10167
146698,the,O,10167
146699,most,O,10167
146700,significant,O,10167
146701,risk,O,10167
146702,factor,O,10167
146703,for,O,10167
146704,developing,O,10167
146705,glaucoma,B-NAME_OF_DISEASE,10167
146706,and,O,10167
146707,the,O,10167
146708,only,O,10167
146709,known,O,10167
146710,risk,O,10167
146711,factor,O,10167
146712,that,O,10167
146713,is,O,10167
146714,currently,O,10167
146715,treatable,O,10167
146716,In,O,10168
146717,patients,O,10168
146718,who,O,10168
146719,already,O,10168
146720,have,O,10168
146721,glaucoma,B-NAME_OF_DISEASE,10168
146722,reducing,B-TREATMENT,10168
146723,IOP,I-TREATMENT,10168
146724,slows,O,10168
146725,the,O,10168
146726,progression,O,10168
146727,of,O,10168
146728,the,O,10168
146729,disease,O,10168
146730,New,O,10169
146731,minimally,B-TREATMENT,10169
146732,invasive,I-TREATMENT,10169
146733,surgical,I-TREATMENT,10169
146734,modalities,I-TREATMENT,10169
146735,have,O,10169
146736,shown,O,10169
146737,considerable,O,10169
146738,potential,O,10169
146739,in,O,10169
146740,intraocular,O,10169
146741,pressure,O,10169
146742,IOP,O,10169
146743,and,O,10169
146744,the,O,10169
146745,number,O,10169
146746,of,O,10169
146747,post-surgical,O,10169
146748,medications,O,10169
146749,with,O,10169
146750,rare,O,10169
146751,complications,O,10169
146752,The,O,10170
146753,rising,O,10170
146754,popularity,O,10170
146755,of,O,10170
146756,these,O,10170
146757,devices,O,10170
146758,and,O,10170
146759,procedures,O,10170
146760,may,O,10170
146761,represent,O,10170
146762,a,O,10170
146763,shift,O,10170
146764,in,O,10170
146765,treatment,O,10170
146766,paradigm,O,10170
146767,from,O,10170
146768,medical,O,10170
146769,therapy,O,10170
146770,towards,O,10170
146771,earlier,O,10170
146772,surgical,O,10170
146773,intervention,O,10170
146774,especially,O,10170
146775,in,O,10170
146776,the,O,10170
146777,treatment,O,10170
146778,of,O,10170
146779,mild-to-moderate,O,10170
146780,glaucoma,B-NAME_OF_DISEASE,10170
146781,Selective,B-TREATMENT,10171
146782,laser,I-TREATMENT,10171
146783,trabeculoplasty,I-TREATMENT,10171
146784,SLT,I-TREATMENT,10171
146785,is,O,10171
146786,as,O,10171
146787,effective,O,10171
146788,as,O,10171
146789,medication,O,10171
146790,in,O,10171
146791,controlling,O,10171
146792,IOP,O,10171
146793,which,O,10171
146794,is,O,10171
146795,why,O,10171
146796,many,O,10171
146797,physicians,O,10171
146798,have,O,10171
146799,adopted,O,10171
146800,it,O,10171
146801,as,O,10171
146802,a,O,10171
146803,first-line,O,10171
146804,treatment,O,10171
146805,to,O,10171
146806,manage,O,10171
146807,glaucoma,B-NAME_OF_DISEASE,10171
146808,without,O,10171
146809,the,O,10171
146810,compliance,O,10171
146811,problems,O,10171
146812,associated,O,10171
146813,with,O,10171
146814,medications,O,10171
146815,SLT,B-TREATMENT,10172
146816,is,O,10172
146817,also,O,10172
146818,a,O,10172
146819,valuable,O,10172
146820,adjunct,O,10172
146821,to,O,10172
146822,microinvasive,B-TREATMENT,10172
146823,glaucoma,I-TREATMENT,10172
146824,surgeries,I-TREATMENT,10172
146825,MIGS,I-TREATMENT,10172
146826,in,O,10172
146827,reducing,B-TREATMENT,10172
146828,IOP,I-TREATMENT,10172
146829,enough,O,10172
146830,to,O,10172
146831,reduce,O,10172
146832,or,O,10172
146833,eliminate,O,10172
146834,medications,O,10172
146835,Like,O,10173
146836,MIGS,B-TREATMENT,10173
146837,SLT,B-TREATMENT,10173
146838,is,O,10173
146839,a,O,10173
146840,step,O,10173
146841,in,O,10173
146842,the,O,10173
146843,treatment,O,10173
146844,paradigm,O,10173
146845,between,O,10173
146846,medications,O,10173
146847,MIGS,B-TREATMENT,10174
146848,and,O,10174
146849,SLT,B-TREATMENT,10174
146850,are,O,10174
146851,natural,O,10174
146852,partners,O,10174
146853,in,O,10174
146854,reducing,B-TREATMENT,10174
146855,IOP,I-TREATMENT,10174
146856,without,O,10174
146857,the,O,10174
146858,risk,O,10174
146859,of,O,10174
146860,traditional,B-TREATMENT,10174
146861,glaucoma,I-TREATMENT,10174
146862,surgeries,I-TREATMENT,10174
146863,such,O,10174
146864,as,O,10174
146865,trabeculectomy,B-TREATMENT,10174
146866,or,O,10174
146867,tube,B-TREATMENT,10174
146868,shunts,I-TREATMENT,10174
146869,or,O,10174
146870,the,O,10174
146871,compliance,O,10174
146872,issues,O,10174
146873,of,O,10174
146874,medications,O,10174
146875,When,O,10175
146876,we,O,10175
146877,are,O,10175
146878,already,O,10175
146879,discussing,O,10175
146880,MIGS,B-TREATMENT,10175
146881,surgery,I-TREATMENT,10175
146882,for,O,10175
146883,glaucoma,B-NAME_OF_DISEASE,10175
146884,possibly,O,10175
146885,in,O,10175
146886,addition,O,10175
146887,to,O,10175
146888,cataract,B-TREATMENT,10175
146889,surgery,I-TREATMENT,10175
146890,the,O,10175
146891,idea,O,10175
146892,of,O,10175
146893,augmenting,O,10175
146894,the,O,10175
146895,IOP-lowering,O,10175
146896,effects,O,10175
146897,of,O,10175
146898,those,O,10175
146899,surgeries,O,10175
146900,with,O,10175
146901,a,O,10175
146902,laser,O,10175
146903,treatment,O,10175
146904,makes,O,10175
146905,sense,O,10175
146906,to,O,10175
146907,patients,O,10175
146908,as,O,10175
146909,well,O,10175
146910,Elevated,B-CAUSE_OF_DISEASE,10176
146911,intraocular,I-CAUSE_OF_DISEASE,10176
146912,pressure,I-CAUSE_OF_DISEASE,10176
146913,IOP,I-CAUSE_OF_DISEASE,10176
146914,is,O,10176
146915,the,O,10176
146916,most,O,10176
146917,significant,O,10176
146918,risk,O,10176
146919,factor,O,10176
146920,for,O,10176
146921,developing,O,10176
146922,glaucoma,B-NAME_OF_DISEASE,10176
146923,and,O,10176
146924,the,O,10176
146925,only,O,10176
146926,known,O,10176
146927,risk,O,10176
146928,factor,O,10176
146929,that,O,10176
146930,is,O,10176
146931,currently,O,10176
146932,treatable,O,10176
146933,In,O,10177
146934,patients,O,10177
146935,who,O,10177
146936,already,O,10177
146937,have,O,10177
146938,glaucoma,B-NAME_OF_DISEASE,10177
146939,reducing,B-TREATMENT,10177
146940,IOP,I-TREATMENT,10177
146941,slows,O,10177
146942,the,O,10177
146943,progression,O,10177
146944,of,O,10177
146945,the,O,10177
146946,disease,O,10177
146947,When,O,10178
146948,patients,O,10178
146949,come,O,10178
146950,in,O,10178
146951,with,O,10178
146952,early-to-moderate,O,10178
146953,glaucoma,B-NAME_OF_DISEASE,10178
146954,surgeons,O,10178
146955,combine,O,10178
146956,laser,O,10178
146957,with,O,10178
146958,several,B-TREATMENT,10178
146959,minimally,I-TREATMENT,10178
146960,invasive,I-TREATMENT,10178
146961,glaucoma,I-TREATMENT,10178
146962,surgeries,I-TREATMENT,10178
146963,MIGS,I-TREATMENT,10178
146964,In,O,10179
146965,over,O,10179
146966,90%,O,10179
146967,of,O,10179
146968,cases,O,10179
146969,they,O,10179
146970,perform,O,10179
146971,MicroPulse,B-TREATMENT,10179
146972,cyclophotocoagulation,I-TREATMENT,10179
146973,CPC,I-TREATMENT,10179
146974,as,O,10179
146975,well,O,10179
146976,as,O,10179
146977,a,O,10179
146978,canaloplasty,B-TREATMENT,10179
146979,and,O,10179
146980,a,B-TREATMENT,10179
146981,trabecular,I-TREATMENT,10179
146982,meshwork,I-TREATMENT,10179
146983,TM,I-TREATMENT,10179
146984,bypass,I-TREATMENT,10179
146985,Surgeons,O,10180
146986,use,O,10180
146987,either,O,10180
146988,iStent,B-SURGICAL_INSTRUMENT,10180
146989,Glaukos,I-SURGICAL_INSTRUMENT,10180
146990,or,O,10180
146991,Hydrus,B-SURGICAL_INSTRUMENT,10180
146992,Ivantis,I-SURGICAL_INSTRUMENT,10180
146993,to,O,10180
146994,allow,O,10180
146995,aqueous,O,10180
146996,fluid,O,10180
146997,to,O,10180
146998,bypass,O,10180
146999,the,B-PART_OF_THE_EYES,10180
147000,TM,I-PART_OF_THE_EYES,10180
147001,and,O,10180
147002,flow,O,10180
147003,out,O,10180
147004,The,B-TREATMENT,10181
147005,canaloplasty,I-TREATMENT,10181
147006,using,O,10181
147007,the,B-SURGICAL_INSTRUMENT,10181
147008,Omni,I-SURGICAL_INSTRUMENT,10181
147009,Surgical,I-SURGICAL_INSTRUMENT,10181
147010,System,I-SURGICAL_INSTRUMENT,10181
147011,Sight,I-SURGICAL_INSTRUMENT,10181
147012,Sciences,I-SURGICAL_INSTRUMENT,10181
147013,dilates,O,10181
147014,Schlemms,B-PART_OF_THE_EYES,10181
147015,canal,I-PART_OF_THE_EYES,10181
147016,and,O,10181
147017,the,B-PART_OF_THE_EYES,10181
147018,collector,I-PART_OF_THE_EYES,10181
147019,channels,I-PART_OF_THE_EYES,10181
147020,to,O,10181
147021,enhance,O,10181
147022,the,O,10181
147023,natural,O,10181
147024,outflow,O,10181
147025,system,O,10181
147026,The,O,10182
147027,combination,O,10182
147028,of,O,10182
147029,TM,B-TREATMENT,10182
147030,bypass,I-TREATMENT,10182
147031,stents,I-TREATMENT,10182
147032,and,O,10182
147033,canaloplasty,B-TREATMENT,10182
147034,with,O,10182
147035,cataract,B-TREATMENT,10182
147036,extraction,I-TREATMENT,10182
147037,has,O,10182
147038,been,O,10182
147039,shown,O,10182
147040,to,O,10182
147041,be,O,10182
147042,more,O,10182
147043,eff,O,10182
147044,ective,O,10182
147045,at,O,10182
147046,lowering,B-TREATMENT,10182
147047,IOP,I-TREATMENT,10182
147048,than,O,10182
147049,the,B-TREATMENT,10182
147050,TM,I-TREATMENT,10182
147051,bypass,I-TREATMENT,10182
147052,alone,O,10182
147053,with,O,10182
147054,cataract,B-TREATMENT,10182
147055,extraction,I-TREATMENT,10182
147056,There,O,10183
147057,are,O,10183
147058,a,O,10183
147059,lot,O,10183
147060,of,O,10183
147061,misconceptions,O,10183
147062,about,O,10183
147063,CPC,B-TREATMENT,10183
147064,treatments,I-TREATMENT,10183
147065,Some,O,10184
147066,think,O,10184
147067,of,O,10184
147068,CPC,B-TREATMENT,10184
147069,as,O,10184
147070,an,O,10184
147071,aggressive,O,10184
147072,end-stage,O,10184
147073,procedure,O,10184
147074,that,O,10184
147075,can,O,10184
147076,cause,O,10184
147077,signifi,O,10184
147078,cant,O,10184
147079,adverse,O,10184
147080,eff,O,10184
147081,ects,O,10184
147082,and,O,10184
147083,inflammation,O,10184
147084,A,B-TIME_DURATION,10185
147085,decade,I-TIME_DURATION,10185
147086,ago,O,10185
147087,CPC,B-TREATMENT,10185
147088,was,O,10185
147089,seen,O,10185
147090,as,O,10185
147091,a,O,10185
147092,last,O,10185
147093,resort,O,10185
147094,Surgeons,O,10186
147095,have,O,10186
147096,not,O,10186
147097,had,O,10186
147098,issues,O,10186
147099,with,O,10186
147100,hypotony,B-SIGN_AND_SYMPTOM,10186
147101,and,O,10186
147102,inflammation,O,10186
147103,has,O,10186
147104,only,O,10186
147105,been,O,10186
147106,an,O,10186
147107,issue,O,10186
147108,in,O,10186
147109,very,O,10186
147110,limited,O,10186
147111,cases,O,10186
147112,such,O,10186
147113,as,O,10186
147114,a,O,10186
147115,patient,O,10186
147116,with,O,10186
147117,uveitic,B-NAME_OF_DISEASE,10186
147118,glaucoma,I-NAME_OF_DISEASE,10186
147119,and,O,10186
147120,these,O,10186
147121,cases,O,10186
147122,were,O,10186
147123,able,O,10186
147124,to,O,10186
147125,be,O,10186
147126,controlled,O,10186
147127,with,O,10186
147128,topical,B-NAME_OF_DRUG,10186
147129,steroids,I-NAME_OF_DRUG,10186
147130,In,O,10187
147131,more,O,10187
147132,advanced,B-NAME_OF_DISEASE,10187
147133,glaucoma,I-NAME_OF_DISEASE,10187
147134,cases,O,10187
147135,when,O,10187
147136,surgeons,O,10187
147137,are,O,10187
147138,targeting,O,10187
147139,a,O,10187
147140,bigger,O,10187
147141,reduction,O,10187
147142,in,O,10187
147143,IOP,O,10187
147144,they,O,10187
147145,use,O,10187
147146,the,B-SURGICAL_INSTRUMENT,10187
147147,Cyclo,I-SURGICAL_INSTRUMENT,10187
147148,G6,I-SURGICAL_INSTRUMENT,10187
147149,Laser,I-SURGICAL_INSTRUMENT,10187
147150,with,O,10187
147151,the,B-SURGICAL_INSTRUMENT,10187
147152,continuous,I-SURGICAL_INSTRUMENT,10187
147153,wave,I-SURGICAL_INSTRUMENT,10187
147154,G-Probe,I-SURGICAL_INSTRUMENT,10187
147155,delivery,I-SURGICAL_INSTRUMENT,10187
147156,device,I-SURGICAL_INSTRUMENT,10187
147157,both,O,10187
147158,Iridex,B-ORGANIZATION,10187
147159,The,O,10188
147160,continuous,O,10188
147161,wave,O,10188
147162,laser,O,10188
147163,energy,O,10188
147164,is,O,10188
147165,absorbed,O,10188
147166,by,O,10188
147167,melanin,B-CHEMICAL_COMPOUND,10188
147168,in,O,10188
147169,the,O,10188
147170,ciliary,O,10188
147171,processes,O,10188
147172,and,O,10188
147173,coagulative,O,10188
147174,necrosis,O,10188
147175,of,O,10188
147176,the,B-PART_OF_THE_EYES,10188
147177,ciliary,I-PART_OF_THE_EYES,10188
147178,body,I-PART_OF_THE_EYES,10188
147179,reduces,O,10188
147180,aqueous,O,10188
147181,production,O,10188
147182,The,O,10189
147183,process,O,10189
147184,is,O,10189
147185,effective,O,10189
147186,and,O,10189
147187,repeatable,O,10189
147188,but,O,10189
147189,it,O,10189
147190,involves,O,10189
147191,tissue,O,10189
147192,ablation,O,10189
147193,and,O,10189
147194,there,O,10189
147195,can,O,10189
147196,be,O,10189
147197,more,O,10189
147198,inflammation,O,10189
147199,than,O,10189
147200,with,O,10189
147201,the,B-TREATMENT,10189
147202,MicroPulse,I-TREATMENT,10189
147203,CPC,I-TREATMENT,10189
147204,Transscleral,B-TREATMENT,10190
147205,Laser,I-TREATMENT,10190
147206,More,O,10191
147207,commonly,O,10191
147208,for,O,10191
147209,mild-to-moderate,O,10191
147210,glaucoma,B-NAME_OF_DISEASE,10191
147211,I,O,10191
147212,use,O,10191
147213,the,B-SURGICAL_INSTRUMENT,10191
147214,MicroPulse,I-SURGICAL_INSTRUMENT,10191
147215,P3,I-SURGICAL_INSTRUMENT,10191
147216,delivery,I-SURGICAL_INSTRUMENT,10191
147217,device,I-SURGICAL_INSTRUMENT,10191
147218,with,O,10191
147219,the,B-SURGICAL_INSTRUMENT,10191
147220,Cyclo,I-SURGICAL_INSTRUMENT,10191
147221,G6,I-SURGICAL_INSTRUMENT,10191
147222,Laser,I-SURGICAL_INSTRUMENT,10191
147223,to,O,10191
147224,perform,O,10191
147225,transscleral,O,10191
147226,laser,B-TREATMENT,10191
147227,therapy,I-TREATMENT,10191
147228,TLT,I-TREATMENT,10191
147229,MicroPulse,B-TREATMENT,10192
147230,TLT,I-TREATMENT,10192
147231,is,O,10192
147232,an,O,10192
147233,under-utilised,O,10192
147234,non-incisional,O,10192
147235,treatment,O,10192
147236,although,O,10192
147237,its,O,10192
147238,use,O,10192
147239,is,O,10192
147240,increasing,O,10192
147241,Iridex,O,10193
147242,reports,O,10193
147243,that,O,10193
147244,180000,O,10193
147245,patients,O,10193
147246,have,O,10193
147247,been,O,10193
147248,treated,O,10193
147249,with,O,10193
147250,its,O,10193
147251,TLT,B-TREATMENT,10193
147252,in,O,10193
147253,80,O,10193
147254,countries,O,10193
147255,MicroPulse,B-TREATMENT,10194
147256,TLT,I-TREATMENT,10194
147257,is,O,10194
147258,60-80%,O,10194
147259,successful,O,10194
147260,at,O,10194
147261,lowering,B-TREATMENT,10194
147262,IOP,I-TREATMENT,10194
147263,by,O,10194
147264,at,O,10194
147265,least,O,10194
147266,20%,O,10194
147267,I,O,10195
147268,avoid,O,10195
147269,about,O,10195
147270,30,O,10195
147271,degrees,O,10195
147272,at,O,10195
147273,the,O,10195
147274,3,O,10195
147275,oclock,O,10195
147276,and,O,10195
147277,9,O,10195
147278,oclock,O,10195
147279,positions,O,10195
147280,because,O,10195
147281,there,O,10195
147282,are,O,10195
147283,long,O,10195
147284,ciliary,B-PART_OF_THE_EYES,10195
147285,nerves,I-PART_OF_THE_EYES,10195
147286,there,O,10195
147287,I,O,10196
147288,am,O,10196
147289,now,O,10196
147290,using,O,10196
147291,the,B-SURGICAL_INSTRUMENT,10196
147292,revised,I-SURGICAL_INSTRUMENT,10196
147293,MicroPulse,I-SURGICAL_INSTRUMENT,10196
147294,P3,I-SURGICAL_INSTRUMENT,10196
147295,Probe,I-SURGICAL_INSTRUMENT,10196
147296,It,O,10197
147297,has,O,10197
147298,two,O,10197
147299,plastic,O,10197
147300,pieces-which,O,10197
147301,look,O,10197
147302,a,O,10197
147303,little,O,10197
147304,like,O,10197
147305,bunny,O,10197
147306,ears-that,O,10197
147307,are,O,10197
147308,placed,O,10197
147309,on,O,10197
147310,the,B-PART_OF_THE_EYES,10197
147311,limbus,I-PART_OF_THE_EYES,10197
147312,and,O,10197
147313,help,O,10197
147314,with,O,10197
147315,alignment,O,10197
147316,I,O,10198
147317,prefer,O,10198
147318,to,O,10198
147319,operate,O,10198
147320,in,O,10198
147321,an,O,10198
147322,ambulatory,O,10198
147323,surgery,O,10198
147324,centre,O,10198
147325,and,O,10198
147326,I,O,10198
147327,do,O,10198
147328,the,B-TREATMENT,10198
147329,CPC,I-TREATMENT,10198
147330,laser,I-TREATMENT,10198
147331,in,O,10198
147332,the,O,10198
147333,preoperative,O,10198
147334,area,O,10198
147335,after,O,10198
147336,the,O,10198
147337,patient,O,10198
147338,has,O,10198
147339,received,O,10198
147340,a,O,10198
147341,peribulbar,O,10198
147342,block,O,10198
147343,while,O,10198
147344,the,O,10198
147345,operating,O,10198
147346,theatre,O,10198
147347,is,O,10198
147348,being,O,10198
147349,prepared,O,10198
147350,After,O,10199
147351,the,O,10199
147352,cataract,B-NAME_OF_DISEASE,10199
147353,extraction,O,10199
147354,and,O,10199
147355,the,O,10199
147356,other,O,10199
147357,MIGS,B-TREATMENT,10199
147358,treatments,I-TREATMENT,10199
147359,the,O,10199
147360,postoperative,O,10199
147361,procedure,O,10199
147362,is,O,10199
147363,identical,O,10199
147364,to,O,10199
147365,my,O,10199
147366,usual,O,10199
147367,cataract,B-NAME_OF_DISEASE,10199
147368,postoperative,O,10199
147369,regimen,O,10199
147370,which,O,10199
147371,is,O,10199
147372,generally,O,10199
147373,an,O,10199
147374,intracameral,O,10199
147375,corticosteroid,B-NAME_OF_DRUG,10199
147376,and,O,10199
147377,antibiotic,B-NAME_OF_DRUG,10199
147378,and,O,10199
147379,a,B-NAME_OF_DRUG,10199
147380,non-steroidal,I-NAME_OF_DRUG,10199
147381,anti-inflammatory,I-NAME_OF_DRUG,10199
147382,drop,I-NAME_OF_DRUG,10199
147383,for,B-TIME_DURATION,10199
147384,1,I-TIME_DURATION,10199
147385,month,I-TIME_DURATION,10199
147386,Slightly,O,10200
147387,fewer,O,10200
147388,than,O,10200
147389,5%,O,10200
147390,of,O,10200
147391,patients,O,10200
147392,develop,O,10200
147393,cystoid,B-NAME_OF_DISEASE,10200
147394,macular,I-NAME_OF_DISEASE,10200
147395,oedema,I-NAME_OF_DISEASE,10200
147396,CMO,I-NAME_OF_DISEASE,10200
147397,This,O,10201
147398,includes,O,10201
147399,all,O,10201
147400,patients,O,10201
147401,even,O,10201
147402,those,O,10201
147403,with,O,10201
147404,epiretinal,B-SIGN_AND_SYMPTOM,10201
147405,membrane,I-SIGN_AND_SYMPTOM,10201
147406,and,O,10201
147407,diabetes,B-NAME_OF_DISEASE,10201
147408,so,O,10201
147409,the,O,10201
147410,rate,O,10201
147411,of,O,10201
147412,CMO,B-NAME_OF_DISEASE,10201
147413,does,O,10201
147414,not,O,10201
147415,seem,O,10201
147416,to,O,10201
147417,be,O,10201
147418,any,O,10201
147419,different,O,10201
147420,from,O,10201
147421,that,O,10201
147422,for,O,10201
147423,the,O,10201
147424,standard,O,10201
147425,cataract,B-NAME_OF_DISEASE,10201
147426,populations,O,10201
147427,in,O,10201
147428,my,O,10201
147429,hands,O,10201
147430,There,O,10202
147431,is,O,10202
147432,a,O,10202
147433,less,O,10202
147434,than,O,10202
147435,a,O,10202
147436,10%,O,10202
147437,risk,O,10202
147438,of,O,10202
147439,postoperative,O,10202
147440,hyphaema,B-SIGN_AND_SYMPTOM,10202
147441,with,O,10202
147442,canaloplasty,B-TREATMENT,10202
147443,and,O,10202
147444,trabecular,B-TREATMENT,10202
147445,bypass,I-TREATMENT,10202
147446,shunts,I-TREATMENT,10202
147447,One,O,10203
147448,tip,O,10203
147449,when,O,10203
147450,using,O,10203
147451,shunts,B-TREATMENT,10203
147452,and,I-TREATMENT,10203
147453,stents,I-TREATMENT,10203
147454,is,O,10203
147455,to,O,10203
147456,leave,O,10203
147457,the,O,10203
147458,pressure,O,10203
147459,somewhat,O,10203
147460,higher,O,10203
147461,at,O,10203
147462,the,O,10203
147463,end,O,10203
147464,of,O,10203
147465,surgery,O,10203
147466,this,O,10203
147467,will,O,10203
147468,reduce,O,10203
147469,reflux,O,10203
147470,into,O,10203
147471,the,B-PART_OF_THE_EYES,10203
147472,anterior,I-PART_OF_THE_EYES,10203
147473,chamber,I-PART_OF_THE_EYES,10203
147474,Now,O,10204
147475,that,O,10204
147476,I,O,10204
147477,do,O,10204
147478,this,O,10204
147479,targeting,O,10204
147480,a,O,10204
147481,maximum,O,10204
147482,pressure,O,10204
147483,of,O,10204
147484,25,O,10204
147485,mm,O,10204
147486,Hg,O,10204
147487,my,O,10204
147488,hyphaema,B-SIGN_AND_SYMPTOM,10204
147489,rate,O,10204
147490,is,O,10204
147491,probably,O,10204
147492,between,O,10204
147493,2%,O,10204
147494,and,O,10204
147495,4%,O,10204
147496,Before,O,10205
147497,the,O,10205
147498,procedure,O,10205
147499,the,O,10205
147500,referring,O,10205
147501,doctor,O,10205
147502,should,O,10205
147503,know,O,10205
147504,that,O,10205
147505,you,O,10205
147506,perform,O,10205
147507,CPC,B-TREATMENT,10205
147508,laser,I-TREATMENT,10205
147509,and,O,10205
147510,MIGS,B-TREATMENT,10205
147511,procedures,I-TREATMENT,10205
147512,The,O,10206
147513,doctor,O,10206
147514,can,O,10206
147515,then,O,10206
147516,begin,O,10206
147517,preparing,O,10206
147518,the,O,10206
147519,patient,O,10206
147520,both,O,10206
147521,through,O,10206
147522,discussions,O,10206
147523,and,O,10206
147524,by,O,10206
147525,initiating,O,10206
147526,medication,O,10206
147527,for,O,10206
147528,patients,O,10206
147529,with,O,10206
147530,mild-to-moderate,O,10206
147531,glaucoma,B-NAME_OF_DISEASE,10206
147532,as,O,10206
147533,insurance,O,10206
147534,companies,O,10206
147535,require,O,10206
147536,that,O,10206
147537,patients,O,10206
147538,be,O,10206
147539,on,O,10206
147540,medication,O,10206
147541,before,O,10206
147542,they,O,10206
147543,have,O,10206
147544,a,B-TREATMENT,10206
147545,trabecular,I-TREATMENT,10206
147546,bypass,I-TREATMENT,10206
147547,stent,I-TREATMENT,10206
147548,procedure,I-TREATMENT,10206
147549,The,B-PART_OF_THE_EYES,10207
147550,optic,I-PART_OF_THE_EYES,10207
147551,nerve,I-PART_OF_THE_EYES,10207
147552,is,O,10207
147553,composed,O,10207
147554,of,O,10207
147555,approximately,O,10207
147556,1.5,O,10207
147557,million,O,10207
147558,nerve,O,10207
147559,fibers,O,10207
147560,at,O,10207
147561,the,O,10207
147562,back,O,10207
147563,of,O,10207
147564,the,O,10207
147565,eye,O,10207
147566,that,O,10207
147567,carry,O,10207
147568,visual,O,10207
147569,messages,O,10207
147570,from,O,10207
147571,the,B-PART_OF_THE_EYES,10207
147572,retina,I-PART_OF_THE_EYES,10207
147573,to,O,10207
147574,the,O,10207
147575,brain,O,10207
147576,When,O,10208
147577,light,O,10208
147578,hits,O,10208
147579,the,B-PART_OF_THE_EYES,10208
147580,retina,I-PART_OF_THE_EYES,10208
147581,the,B-PART_OF_THE_EYES,10208
147582,photoreceptors,I-PART_OF_THE_EYES,10208
147583,light-sensitive,I-PART_OF_THE_EYES,10208
147584,cells,I-PART_OF_THE_EYES,10208
147585,receive,O,10208
147586,and,O,10208
147587,transmit,O,10208
147588,this,O,10208
147589,information,O,10208
147590,to,O,10208
147591,other,O,10208
147592,specialized,O,10208
147593,cells,O,10208
147594,including,O,10208
147595,the,O,10208
147596,final,O,10208
147597,cell,O,10208
147598,type,O,10208
147599,in,O,10208
147600,the,O,10208
147601,chain,O,10208
147602,called,O,10208
147603,the,B-PART_OF_THE_EYES,10208
147604,retinal,I-PART_OF_THE_EYES,10208
147605,ganglion,I-PART_OF_THE_EYES,10208
147606,cells,I-PART_OF_THE_EYES,10208
147607,These,O,10209
147608,cells,O,10209
147609,reside,O,10209
147610,in,O,10209
147611,the,B-PART_OF_THE_EYES,10209
147612,retina,I-PART_OF_THE_EYES,10209
147613,but,O,10209
147614,their,O,10209
147615,output,O,10209
147616,cables,O,10209
147617,or,O,10209
147618,fibers,O,10209
147619,called,O,10209
147620,axons,O,10209
147621,extend,O,10209
147622,from,O,10209
147623,the,O,10209
147624,head,O,10209
147625,of,O,10209
147626,the,B-PART_OF_THE_EYES,10209
147627,optic,I-PART_OF_THE_EYES,10209
147628,nerve,I-PART_OF_THE_EYES,10209
147629,at,O,10209
147630,the,O,10209
147631,back,O,10209
147632,of,O,10209
147633,the,O,10209
147634,eye,O,10209
147635,to,O,10209
147636,the,O,10209
147637,brain,O,10209
147638,Therefore,O,10210
147639,the,B-PART_OF_THE_EYES,10210
147640,retinal,I-PART_OF_THE_EYES,10210
147641,ganglion,I-PART_OF_THE_EYES,10210
147642,cell,I-PART_OF_THE_EYES,10210
147643,plays,O,10210
147644,a,O,10210
147645,critical,O,10210
147646,role,O,10210
147647,as,O,10210
147648,the,O,10210
147649,output,O,10210
147650,nerve,O,10210
147651,cell,O,10210
147652,of,O,10210
147653,the,O,10210
147654,eye,O,10210
147655,that,O,10210
147656,transmits,O,10210
147657,visual,O,10210
147658,information,O,10210
147659,to,O,10210
147660,the,O,10210
147661,brain,O,10210
147662,The,B-PART_OF_THE_EYES,10211
147663,optic,I-PART_OF_THE_EYES,10211
147664,nerve,I-PART_OF_THE_EYES,10211
147665,is,O,10211
147666,a,O,10211
147667,bundle,O,10211
147668,of,O,10211
147669,more,O,10211
147670,than,O,10211
147671,1,O,10211
147672,million,O,10211
147673,nerve,O,10211
147674,fibers,O,10211
147675,that,O,10211
147676,carry,O,10211
147677,visual,O,10211
147678,messages,O,10211
147679,We,O,10212
147680,have,O,10212
147681,one,O,10212
147682,connecting,O,10212
147683,the,O,10212
147684,back,O,10212
147685,of,O,10212
147686,each,O,10212
147687,eye,O,10212
147688,your,O,10212
147689,retina,B-PART_OF_THE_EYES,10212
147690,to,O,10212
147691,your,O,10212
147692,brain,O,10212
147693,Damage,O,10213
147694,to,O,10213
147695,an,B-PART_OF_THE_EYES,10213
147696,optic,I-PART_OF_THE_EYES,10213
147697,nerve,I-PART_OF_THE_EYES,10213
147698,can,O,10213
147699,cause,O,10213
147700,vision,B-SIGN_AND_SYMPTOM,10213
147701,loss,I-SIGN_AND_SYMPTOM,10213
147702,The,O,10214
147703,type,O,10214
147704,of,O,10214
147705,vision,B-SIGN_AND_SYMPTOM,10214
147706,loss,I-SIGN_AND_SYMPTOM,10214
147707,and,O,10214
147708,how,O,10214
147709,severe,O,10214
147710,it,O,10214
147711,is,O,10214
147712,depends,O,10214
147713,on,O,10214
147714,where,O,10214
147715,the,O,10214
147716,damage,O,10214
147717,occurs,O,10214
147718,There,O,10215
147719,are,O,10215
147720,many,O,10215
147721,different,O,10215
147722,types,O,10215
147723,of,O,10215
147724,optic,B-NAME_OF_DISEASE,10215
147725,nerve,I-NAME_OF_DISEASE,10215
147726,disorders,I-NAME_OF_DISEASE,10215
147727,including,O,10215
147728,Glaucoma,B-NAME_OF_DISEASE,10216
147729,is,O,10216
147730,a,O,10216
147731,group,O,10216
147732,of,O,10216
147733,diseases,O,10216
147734,that,O,10216
147735,are,O,10216
147736,the,O,10216
147737,leading,O,10216
147738,cause,O,10216
147739,of,O,10216
147740,blindness,B-NAME_OF_DISEASE,10216
147741,in,O,10216
147742,the,B-GPE,10216
147743,United,I-GPE,10216
147744,States,I-GPE,10216
147745,Glaucoma,B-NAME_OF_DISEASE,10217
147746,usually,O,10217
147747,happens,O,10217
147748,when,O,10217
147749,the,O,10217
147750,fluid,O,10217
147751,pressure,O,10217
147752,inside,O,10217
147753,the,O,10217
147754,eyes,O,10217
147755,slowly,O,10217
147756,rises,O,10217
147757,and,O,10217
147758,damages,O,10217
147759,the,B-PART_OF_THE_EYES,10217
147760,optic,I-PART_OF_THE_EYES,10217
147761,nerve,I-PART_OF_THE_EYES,10217
147762,Optic,B-NAME_OF_DISEASE,10218
147763,neuritis,I-NAME_OF_DISEASE,10218
147764,is,O,10218
147765,an,B-SIGN_AND_SYMPTOM,10218
147766,inflammation,I-SIGN_AND_SYMPTOM,10218
147767,of,I-SIGN_AND_SYMPTOM,10218
147768,the,I-SIGN_AND_SYMPTOM,10218
147769,optic,I-SIGN_AND_SYMPTOM,10218
147770,nerve,I-SIGN_AND_SYMPTOM,10218
147771,Causes,O,10219
147772,include,O,10219
147773,infections,B-CAUSE_OF_DISEASE,10219
147774,and,O,10219
147775,immune-related,B-CAUSE_OF_DISEASE,10219
147776,illnesses,I-CAUSE_OF_DISEASE,10219
147777,such,I-CAUSE_OF_DISEASE,10219
147778,as,I-CAUSE_OF_DISEASE,10219
147779,multiple,I-CAUSE_OF_DISEASE,10219
147780,sclerosis,I-CAUSE_OF_DISEASE,10219
147781,Optic,B-NAME_OF_DISEASE,10220
147782,nerve,I-NAME_OF_DISEASE,10220
147783,atrophy,I-NAME_OF_DISEASE,10220
147784,is,O,10220
147785,damage,B-SIGN_AND_SYMPTOM,10220
147786,to,I-SIGN_AND_SYMPTOM,10220
147787,the,I-SIGN_AND_SYMPTOM,10220
147788,optic,I-SIGN_AND_SYMPTOM,10220
147789,nerve,I-SIGN_AND_SYMPTOM,10220
147790,Causes,O,10221
147791,include,O,10221
147792,poor,B-CAUSE_OF_DISEASE,10221
147793,blood,I-CAUSE_OF_DISEASE,10221
147794,flow,I-CAUSE_OF_DISEASE,10221
147795,to,I-CAUSE_OF_DISEASE,10221
147796,the,I-CAUSE_OF_DISEASE,10221
147797,eye,I-CAUSE_OF_DISEASE,10221
147798,disease,B-CAUSE_OF_DISEASE,10221
147799,trauma,B-CAUSE_OF_DISEASE,10221
147800,or,O,10221
147801,exposure,B-CAUSE_OF_DISEASE,10221
147802,to,I-CAUSE_OF_DISEASE,10221
147803,toxic,I-CAUSE_OF_DISEASE,10221
147804,substances,I-CAUSE_OF_DISEASE,10221
147805,Optic,B-SIGN_AND_SYMPTOM,10222
147806,nerve,I-SIGN_AND_SYMPTOM,10222
147807,head,I-SIGN_AND_SYMPTOM,10222
147808,drusen,I-SIGN_AND_SYMPTOM,10222
147809,are,O,10222
147810,pockets,O,10222
147811,of,O,10222
147812,protein,B-CHEMICAL_COMPOUND,10222
147813,and,O,10222
147814,calcium,B-CHEMICAL_COMPOUND,10222
147815,salts,I-CHEMICAL_COMPOUND,10222
147816,that,O,10222
147817,build,O,10222
147818,up,O,10222
147819,in,O,10222
147820,the,B-PART_OF_THE_EYES,10222
147821,optic,I-PART_OF_THE_EYES,10222
147822,nerve,I-PART_OF_THE_EYES,10222
147823,over,O,10222
147824,time,O,10222
147825,Tests,O,10223
147826,for,O,10223
147827,optic,B-NAME_OF_DISEASE,10223
147828,nerve,I-NAME_OF_DISEASE,10223
147829,disorders,I-NAME_OF_DISEASE,10223
147830,may,O,10223
147831,include,O,10223
147832,eye,B-DIAGNOSTIC_TEST,10223
147833,exams,I-DIAGNOSTIC_TEST,10223
147834,an,B-DIAGNOSTIC_TEST,10223
147835,ophthalmoscopy,I-DIAGNOSTIC_TEST,10223
147836,an,I-DIAGNOSTIC_TEST,10223
147837,examination,I-DIAGNOSTIC_TEST,10223
147838,of,I-DIAGNOSTIC_TEST,10223
147839,the,I-DIAGNOSTIC_TEST,10223
147840,back,I-DIAGNOSTIC_TEST,10223
147841,of,I-DIAGNOSTIC_TEST,10223
147842,your,I-DIAGNOSTIC_TEST,10223
147843,eye,I-DIAGNOSTIC_TEST,10223
147844,and,O,10223
147845,imaging,B-DIAGNOSTIC_TEST,10223
147846,tests,I-DIAGNOSTIC_TEST,10223
147847,With,O,10224
147848,some,O,10224
147849,optic,B-NAME_OF_DISEASE,10224
147850,nerve,I-NAME_OF_DISEASE,10224
147851,disorders,I-NAME_OF_DISEASE,10224
147852,we,O,10224
147853,may,O,10224
147854,get,O,10224
147855,your,O,10224
147856,vision,O,10224
147857,back,O,10224
147858,With,O,10225
147859,others,O,10225
147860,there,O,10225
147861,is,O,10225
147862,no,O,10225
147863,treatment,O,10225
147864,or,O,10225
147865,treatment,O,10225
147866,may,O,10225
147867,only,O,10225
147868,prevent,O,10225
147869,further,O,10225
147870,vision,B-SIGN_AND_SYMPTOM,10225
147871,loss,I-SIGN_AND_SYMPTOM,10225
147872,Approximately,O,10226
147873,1,O,10226
147874,in,O,10226
147875,2000,O,10226
147876,people,O,10226
147877,worldwide,O,10226
147878,are,O,10226
147879,affected,O,10226
147880,by,O,10226
147881,inherited,O,10226
147882,retinopathies,O,10226
147883,but,O,10226
147884,few,O,10226
147885,treatment,O,10226
147886,options,O,10226
147887,are,O,10226
147888,available,O,10226
147889,for,O,10226
147890,retinal,B-NAME_OF_DISEASE,10226
147891,degeneration,I-NAME_OF_DISEASE,10226
147892,There,O,10227
147893,is,O,10227
147894,also,O,10227
147895,no,O,10227
147896,cure,O,10227
147897,for,O,10227
147898,glaucoma,B-NAME_OF_DISEASE,10227
147899,which,O,10227
147900,affects,O,10227
147901,60,O,10227
147902,million,O,10227
147903,people,O,10227
147904,worldwide,O,10227
147905,and,O,10227
147906,is,O,10227
147907,caused,O,10227
147908,by,O,10227
147909,degeneration,B-CAUSE_OF_DISEASE,10227
147910,of,I-CAUSE_OF_DISEASE,10227
147911,retinal,I-CAUSE_OF_DISEASE,10227
147912,ganglion,I-CAUSE_OF_DISEASE,10227
147913,cells,I-CAUSE_OF_DISEASE,10227
147914,RGCs,I-CAUSE_OF_DISEASE,10227
147915,and,I-CAUSE_OF_DISEASE,10227
147916,their,I-CAUSE_OF_DISEASE,10227
147917,axon,I-CAUSE_OF_DISEASE,10227
147918,bundles,I-CAUSE_OF_DISEASE,10227
147919,that,I-CAUSE_OF_DISEASE,10227
147920,form,I-CAUSE_OF_DISEASE,10227
147921,the,I-CAUSE_OF_DISEASE,10227
147922,optic,I-CAUSE_OF_DISEASE,10227
147923,nerve,I-CAUSE_OF_DISEASE,10227
147924,The,B-ORGANIZATION,10228
147925,FDAs,I-ORGANIZATION,10228
147926,2017,O,10228
147927,approval,O,10228
147928,of,O,10228
147929,LUXTURNA,B-NAME_OF_DRUG,10228
147930,to,O,10228
147931,treat,O,10228
147932,inherited,B-NAME_OF_DISEASE,10228
147933,retinal,I-NAME_OF_DISEASE,10228
147934,degeneration,I-NAME_OF_DISEASE,10228
147935,caused,O,10228
147936,by,O,10228
147937,biallelic,B-CAUSE_OF_DISEASE,10228
147938,mutations,I-CAUSE_OF_DISEASE,10228
147939,in,I-CAUSE_OF_DISEASE,10228
147940,RPE65,I-CAUSE_OF_DISEASE,10228
147941,has,O,10228
147942,established,O,10228
147943,viral,O,10228
147944,vectors,O,10228
147945,as,O,10228
147946,a,O,10228
147947,viable,O,10228
147948,clinical,O,10228
147949,therapy,O,10228
147950,for,O,10228
147951,monogenic,B-NAME_OF_DISEASE,10228
147952,retinal,I-NAME_OF_DISEASE,10228
147953,disease,I-NAME_OF_DISEASE,10228
147954,Furthermore,O,10229
147955,advances,O,10229
147956,in,O,10229
147957,pluripotent,B-TREATMENT,10229
147958,stem,I-TREATMENT,10229
147959,cell,I-TREATMENT,10229
147960,techniques,I-TREATMENT,10229
147961,have,O,10229
147962,enabled,O,10229
147963,retinal,B-PART_OF_THE_EYES,10229
147964,pigment,I-PART_OF_THE_EYES,10229
147965,epithelium,I-PART_OF_THE_EYES,10229
147966,RPE,I-PART_OF_THE_EYES,10229
147967,to,O,10229
147968,reach,O,10229
147969,clinical,O,10229
147970,trials,O,10229
147971,as,O,10229
147972,a,O,10229
147973,cell,O,10229
147974,therapy,O,10229
147975,for,O,10229
147976,treating,O,10229
147977,age-related,B-NAME_OF_DISEASE,10229
147978,macular,I-NAME_OF_DISEASE,10229
147979,degeneration,I-NAME_OF_DISEASE,10229
147980,AMD,I-NAME_OF_DISEASE,10229
147981,Now,O,10230
147982,it,O,10230
147983,is,O,10230
147984,time,O,10230
147985,to,O,10230
147986,talk,O,10230
147987,about,O,10230
147988,in,B-TREATMENT,10230
147989,vivo,I-TREATMENT,10230
147990,reprogramming,I-TREATMENT,10230
147991,a,O,10230
147992,novel,O,10230
147993,therapeutic,O,10230
147994,approach,O,10230
147995,that,O,10230
147996,will,O,10230
147997,circumvent,O,10230
147998,the,O,10230
147999,issues,O,10230
148000,with,O,10230
148001,subretinal,O,10230
148002,transplantation,O,10230
148003,of,O,10230
148004,cell,B-TREATMENT,10230
148005,therapies,I-TREATMENT,10230
148006,and,O,10230
148007,the,O,10230
148008,challenge,O,10230
148009,of,O,10230
148010,targeting,O,10230
148011,every,O,10230
148012,monogenic,O,10230
148013,condition,O,10230
148014,with,O,10230
148015,gene,B-TREATMENT,10230
148016,therapy,I-TREATMENT,10230
148017,In,O,10231
148018,light,O,10231
148019,of,O,10231
148020,enabling,O,10231
148021,vision,B-PART_OF_THE_EYES,10231
148022,photoreceptors,I-PART_OF_THE_EYES,10231
148023,in,O,10231
148024,the,B-PART_OF_THE_EYES,10231
148025,neural,I-PART_OF_THE_EYES,10231
148026,retina,I-PART_OF_THE_EYES,10231
148027,absorb,O,10231
148028,photons,O,10231
148029,and,O,10231
148030,cascade,O,10231
148031,a,O,10231
148032,signal,O,10231
148033,through,O,10231
148034,isomerization,O,10231
148035,of,O,10231
148036,11-cis,B-CHEMICAL_COMPOUND,10231
148037,retinal,I-CHEMICAL_COMPOUND,10231
148038,and,O,10231
148039,conformational,O,10231
148040,changes,O,10231
148041,in,O,10231
148042,membrane-bound,B-CHEMICAL_COMPOUND,10231
148043,opsin,I-CHEMICAL_COMPOUND,10231
148044,proteins,I-CHEMICAL_COMPOUND,10231
148045,This,O,10232
148046,phototransduction,O,10232
148047,causes,O,10232
148048,hyperpolarization,O,10232
148049,and,O,10232
148050,closure,O,10232
148051,of,O,10232
148052,cGMP-gated,O,10232
148053,cation,O,10232
148054,channels,O,10232
148055,and,O,10232
148056,the,O,10232
148057,signal,O,10232
148058,is,O,10232
148059,propagated,O,10232
148060,to,O,10232
148061,bipolar,O,10232
148062,horizontal,O,10232
148063,then,O,10232
148064,RGCs,B-PART_OF_THE_EYES,10232
148065,in,O,10232
148066,the,B-PART_OF_THE_EYES,10232
148067,retina,I-PART_OF_THE_EYES,10232
148068,The,B-PART_OF_THE_EYES,10233
148069,photoreceptor,I-PART_OF_THE_EYES,10233
148070,outer,I-PART_OF_THE_EYES,10233
148071,segments,I-PART_OF_THE_EYES,10233
148072,where,O,10233
148073,opsins,B-CHEMICAL_COMPOUND,10233
148074,are,O,10233
148075,densely,O,10233
148076,populated,O,10233
148077,are,O,10233
148078,phagocytosed,O,10233
148079,by,O,10233
148080,the,O,10233
148081,underlying,O,10233
148082,RPE,B-PART_OF_THE_EYES,10233
148083,The,O,10234
148084,RPE,B-PART_OF_THE_EYES,10234
148085,monolayer,O,10234
148086,forms,O,10234
148087,a,O,10234
148088,blood-retina,O,10234
148089,barrier,O,10234
148090,which,O,10234
148091,means,O,10234
148092,there,O,10234
148093,is,O,10234
148094,an,O,10234
148095,immune,O,10234
148096,privilege,O,10234
148097,for,O,10234
148098,retinal,B-TREATMENT,10234
148099,cell,I-TREATMENT,10234
148100,therapies,I-TREATMENT,10234
148101,Typically,O,10235
148102,RGCs,B-PART_OF_THE_EYES,10235
148103,are,O,10235
148104,responsible,O,10235
148105,for,O,10235
148106,transmitting,O,10235
148107,the,O,10235
148108,visual,O,10235
148109,information,O,10235
148110,from,O,10235
148111,photoreceptors,B-PART_OF_THE_EYES,10235
148112,to,O,10235
148113,the,O,10235
148114,brain,O,10235
148115,however,O,10235
148116,a,O,10235
148117,subpopulation,O,10235
148118,of,O,10235
148119,RGCs,B-PART_OF_THE_EYES,10235
148120,has,O,10235
148121,been,O,10235
148122,shown,O,10235
148123,to,O,10235
148124,be,O,10235
148125,photosensitive,O,10235
148126,and,O,10235
148127,involved,O,10235
148128,in,O,10235
148129,the,O,10235
148130,regulation,O,10235
148131,of,O,10235
148132,circadian,O,10235
148133,rhythms,O,10235
148134,The,O,10236
148135,axons,O,10236
148136,of,O,10236
148137,RGCs,B-PART_OF_THE_EYES,10236
148138,form,O,10236
148139,the,B-PART_OF_THE_EYES,10236
148140,optic,I-PART_OF_THE_EYES,10236
148141,nerve,I-PART_OF_THE_EYES,10236
148142,which,O,10236
148143,is,O,10236
148144,responsible,O,10236
148145,for,O,10236
148146,transmitting,O,10236
148147,visual,O,10236
148148,information,O,10236
148149,from,O,10236
148150,the,B-PART_OF_THE_EYES,10236
148151,retina,I-PART_OF_THE_EYES,10236
148152,to,O,10236
148153,the,O,10236
148154,occipital,O,10236
148155,lobe,O,10236
148156,Out,O,10237
148157,of,O,10237
148158,the,O,10237
148159,two,O,10237
148160,photoreceptor,B-PART_OF_THE_EYES,10237
148161,types,O,10237
148162,rods,B-PART_OF_THE_EYES,10237
148163,represent,O,10237
148164,up,O,10237
148165,to,O,10237
148166,95,O,10237
148167,percent,O,10237
148168,of,O,10237
148169,the,O,10237
148170,photoreceptor,B-PART_OF_THE_EYES,10237
148171,population,O,10237
148172,and,O,10237
148173,are,O,10237
148174,responsible,O,10237
148175,for,O,10237
148176,low,O,10237
148177,light,O,10237
148178,and,O,10237
148179,peripheral,O,10237
148180,vision,O,10237
148181,while,O,10237
148182,cones,B-PART_OF_THE_EYES,10237
148183,occupy,O,10237
148184,only,O,10237
148185,5,O,10237
148186,percent,O,10237
148187,of,O,10237
148188,the,O,10237
148189,total,O,10237
148190,photoreceptor,B-PART_OF_THE_EYES,10237
148191,population,O,10237
148192,and,O,10237
148193,enable,O,10237
148194,central,O,10237
148195,vision,O,10237
148196,and,O,10237
148197,color,O,10237
148198,perception,O,10237
148199,Rods,B-PART_OF_THE_EYES,10238
148200,express,O,10238
148201,rhodopsin,B-CHEMICAL_COMPOUND,10238
148202,protein,I-CHEMICAL_COMPOUND,10238
148203,whereas,O,10238
148204,cones,B-PART_OF_THE_EYES,10238
148205,express,O,10238
148206,SML,B-CHEMICAL_COMPOUND,10238
148207,opsins,I-CHEMICAL_COMPOUND,10238
148208,and,O,10238
148209,are,O,10238
148210,primarily,O,10238
148211,found,O,10238
148212,in,O,10238
148213,the,B-PART_OF_THE_EYES,10238
148214,fovea,I-PART_OF_THE_EYES,10238
148215,for,O,10238
148216,central,O,10238
148217,visual,O,10238
148218,acuity,O,10238
148219,NRL,B-CHEMICAL_COMPOUND,10239
148220,is,O,10239
148221,a,O,10239
148222,transcription,O,10239
148223,factor,O,10239
148224,that,O,10239
148225,defines,O,10239
148226,rod,B-PART_OF_THE_EYES,10239
148227,cell,I-PART_OF_THE_EYES,10239
148228,identity,O,10239
148229,whereas,O,10239
148230,CRX,B-CHEMICAL_COMPOUND,10239
148231,is,O,10239
148232,highly,O,10239
148233,expressed,O,10239
148234,in,O,10239
148235,both,O,10239
148236,rods,B-PART_OF_THE_EYES,10239
148237,and,O,10239
148238,cones,B-PART_OF_THE_EYES,10239
148239,By,O,10240
148240,harnessing,O,10240
148241,the,O,10240
148242,power,O,10240
148243,of,O,10240
148244,transcription,O,10240
148245,factors,O,10240
148246,to,O,10240
148247,control,O,10240
148248,retinal,B-PART_OF_THE_EYES,10240
148249,cell,I-PART_OF_THE_EYES,10240
148250,identity,O,10240
148251,and,O,10240
148252,trans-differentiation,O,10240
148253,data-driven,O,10240
148254,cell,O,10240
148255,conversions,O,10240
148256,can,O,10240
148257,lead,O,10240
148258,to,O,10240
148259,the,O,10240
148260,development,O,10240
148261,of,O,10240
148262,new,O,10240
148263,cell,B-TREATMENT,10240
148264,therapies,I-TREATMENT,10240
148265,and,O,10240
148266,in,B-TREATMENT,10240
148267,vivo,I-TREATMENT,10240
148268,reprogramming,I-TREATMENT,10240
148269,approaches,O,10240
148270,to,O,10240
148271,treat,O,10240
148272,retinal,B-NAME_OF_DISEASE,10240
148273,degeneration,I-NAME_OF_DISEASE,10240
148274,The,B-NAME_OF_DISEASE,10241
148275,Retinal,I-NAME_OF_DISEASE,10241
148276,and,I-NAME_OF_DISEASE,10241
148277,Optic,I-NAME_OF_DISEASE,10241
148278,Nerve,I-NAME_OF_DISEASE,10241
148279,Degeneration,I-NAME_OF_DISEASE,10241
148280,Lets,O,10242
148281,go,O,10242
148282,through,O,10242
148283,different,O,10242
148284,types,O,10242
148285,of,O,10242
148286,the,B-NAME_OF_DISEASE,10242
148287,retina,I-NAME_OF_DISEASE,10242
148288,and,I-NAME_OF_DISEASE,10242
148289,optic,I-NAME_OF_DISEASE,10242
148290,nerve,I-NAME_OF_DISEASE,10242
148291,degeneration,I-NAME_OF_DISEASE,10242
148292,and,O,10242
148293,discuss,O,10242
148294,what,O,10242
148295,place,O,10242
148296,in,O,10242
148297,vivo,O,10242
148298,reprogramming,O,10242
148299,may,O,10242
148300,have,O,10242
148301,in,O,10242
148302,addressing,O,10242
148303,them,O,10242
148304,AMD,B-NAME_OF_DISEASE,10243
148305,is,O,10243
148306,the,O,10243
148307,most,O,10243
148308,common,O,10243
148309,form,O,10243
148310,of,O,10243
148311,retinal,B-NAME_OF_DISEASE,10243
148312,degeneration,I-NAME_OF_DISEASE,10243
148313,and,O,10243
148314,affects,O,10243
148315,up,O,10243
148316,to,O,10243
148317,170,O,10243
148318,million,O,10243
148319,people,O,10243
148320,worldwide,O,10243
148321,There,O,10244
148322,are,O,10244
148323,many,O,10244
148324,causes,O,10244
148325,and,O,10244
148326,no,O,10244
148327,approved,O,10244
148328,treatments,O,10244
148329,that,O,10244
148330,can,O,10244
148331,reverse,O,10244
148332,the,O,10244
148333,degeneration,O,10244
148334,of,O,10244
148335,both,O,10244
148336,RPE,B-PART_OF_THE_EYES,10244
148337,and,O,10244
148338,photoreceptor,B-PART_OF_THE_EYES,10244
148339,layers,I-PART_OF_THE_EYES,10244
148340,Treatments,O,10245
148341,for,O,10245
148342,wet,B-NAME_OF_DISEASE,10245
148343,AMD,I-NAME_OF_DISEASE,10245
148344,include,O,10245
148345,anti,B-TREATMENT,10245
148346,VEGF,I-TREATMENT,10245
148347,therapy,I-TREATMENT,10245
148348,that,O,10245
148349,prevents,O,10245
148350,the,O,10245
148351,formation,O,10245
148352,of,O,10245
148353,new,O,10245
148354,blood,O,10245
148355,vessels,O,10245
148356,Human,O,10246
148357,embryonic,B-NAME_OF_DISEASE,10246
148358,stem,I-NAME_OF_DISEASE,10246
148359,cell,I-NAME_OF_DISEASE,10246
148360,ESC-derived,I-NAME_OF_DISEASE,10246
148361,RPE,I-NAME_OF_DISEASE,10246
148362,has,O,10246
148363,been,O,10246
148364,in,O,10246
148365,phase,O,10246
148366,III,O,10246
148367,clinical,O,10246
148368,trials,O,10246
148369,to,O,10246
148370,evaluate,O,10246
148371,safety,O,10246
148372,and,O,10246
148373,efficacy,O,10246
148374,however,O,10246
148375,there,O,10246
148376,remains,O,10246
148377,no,O,10246
148378,approved,O,10246
148379,cell,O,10246
148380,or,O,10246
148381,gene,O,10246
148382,therapy,O,10246
148383,to,O,10246
148384,prevent,O,10246
148385,and,O,10246
148386,potentially,O,10246
148387,reverse,O,10246
148388,the,O,10246
148389,progression,O,10246
148390,of,O,10246
148391,AMD,B-NAME_OF_DISEASE,10246
148392,Inherited,B-NAME_OF_DISEASE,10247
148393,retinal,I-NAME_OF_DISEASE,10247
148394,degenerations,I-NAME_OF_DISEASE,10247
148395,are,O,10247
148396,heterogeneous,O,10247
148397,diseases,O,10247
148398,that,O,10247
148399,result,O,10247
148400,in,O,10247
148401,a,B-SIGN_AND_SYMPTOM,10247
148402,progressive,I-SIGN_AND_SYMPTOM,10247
148403,loss,I-SIGN_AND_SYMPTOM,10247
148404,of,I-SIGN_AND_SYMPTOM,10247
148405,photoreceptors,I-SIGN_AND_SYMPTOM,10247
148406,and,I-SIGN_AND_SYMPTOM,10247
148407,visual,I-SIGN_AND_SYMPTOM,10247
148408,acuity,I-SIGN_AND_SYMPTOM,10247
148409,Retinitis,B-NAME_OF_DISEASE,10248
148410,pigmentosa,I-NAME_OF_DISEASE,10248
148411,RP,I-NAME_OF_DISEASE,10248
148412,is,O,10248
148413,a,O,10248
148414,group,O,10248
148415,of,O,10248
148416,phenotypically,O,10248
148417,and,O,10248
148418,genetically,O,10248
148419,variable,O,10248
148420,inherited,B-NAME_OF_DISEASE,10248
148421,retinal,I-NAME_OF_DISEASE,10248
148422,disorders,I-NAME_OF_DISEASE,10248
148423,that,O,10248
148424,affect,O,10248
148425,up,O,10248
148426,to,O,10248
148427,1,O,10248
148428,in,O,10248
148429,4000,O,10248
148430,people,O,10248
148431,in,O,10248
148432,the,B-GPE,10248
148433,US,I-GPE,10248
148434,and,O,10248
148435,worldwide,O,10248
148436,RP,B-NAME_OF_DISEASE,10249
148437,is,O,10249
148438,typically,O,10249
148439,defined,O,10249
148440,by,O,10249
148441,mutations,O,10249
148442,in,O,10249
148443,key,O,10249
148444,photoreceptor,B-CHEMICAL_COMPOUND,10249
148445,genes,I-CHEMICAL_COMPOUND,10249
148446,with,O,10249
148447,over,O,10249
148448,50,O,10249
148449,genes,B-CHEMICAL_COMPOUND,10249
148450,known,O,10249
148451,to,O,10249
148452,be,O,10249
148453,affected,O,10249
148454,including,O,10249
148455,rhodopsin,B-CHEMICAL_COMPOUND,10249
148456,RPE65,B-CHEMICAL_COMPOUND,10249
148457,USH2A,B-CHEMICAL_COMPOUND,10249
148458,PDE6A,B-CHEMICAL_COMPOUND,10249
148459,and,O,10249
148460,PDE6B,B-CHEMICAL_COMPOUND,10249
148461,Mutations,B-CAUSE_OF_DISEASE,10250
148462,in,I-CAUSE_OF_DISEASE,10250
148463,rhodopsin,I-CAUSE_OF_DISEASE,10250
148464,are,O,10250
148465,the,O,10250
148466,most,O,10250
148467,prevalent,O,10250
148468,cause,O,10250
148469,accounting,O,10250
148470,for,O,10250
148471,under,O,10250
148472,18,O,10250
148473,percent,O,10250
148474,of,O,10250
148475,autosomal,B-NAME_OF_DISEASE,10250
148476,dominant,I-NAME_OF_DISEASE,10250
148477,RP,I-NAME_OF_DISEASE,10250
148478,Less,O,10251
148479,commonly,O,10251
148480,RP,B-NAME_OF_DISEASE,10251
148481,can,O,10251
148482,be,O,10251
148483,autosomal,O,10251
148484,recessive,O,10251
148485,or,O,10251
148486,X-linked,O,10251
148487,recessive,O,10251
148488,as,O,10251
148489,in,O,10251
148490,the,O,10251
148491,case,O,10251
148492,of,O,10251
148493,RP2,B-NAME_OF_DISEASE,10251
148494,Cone-rod,B-NAME_OF_DISEASE,10252
148495,dystrophies,I-NAME_OF_DISEASE,10252
148496,are,O,10252
148497,estimated,O,10252
148498,to,O,10252
148499,affect,O,10252
148500,1,O,10252
148501,in,O,10252
148502,30000-40000,O,10252
148503,people,O,10252
148504,and,O,10252
148505,ABCA4,B-CAUSE_OF_DISEASE,10252
148506,mutations,I-CAUSE_OF_DISEASE,10252
148507,are,O,10252
148508,responsible,O,10252
148509,for,O,10252
148510,30-60,O,10252
148511,percent,O,10252
148512,of,O,10252
148513,autosomal,O,10252
148514,recessive,O,10252
148515,cases,O,10252
148516,Meanwhile,O,10253
148517,mutations,B-CAUSE_OF_DISEASE,10253
148518,in,I-CAUSE_OF_DISEASE,10253
148519,GUCY2D,I-CAUSE_OF_DISEASE,10253
148520,and,I-CAUSE_OF_DISEASE,10253
148521,CRX,I-CAUSE_OF_DISEASE,10253
148522,genes,I-CAUSE_OF_DISEASE,10253
148523,are,O,10253
148524,responsible,O,10253
148525,for,O,10253
148526,up,O,10253
148527,to,O,10253
148528,half,O,10253
148529,of,O,10253
148530,the,O,10253
148531,cases,O,10253
148532,of,O,10253
148533,autosomal,B-NAME_OF_DISEASE,10253
148534,dominant,I-NAME_OF_DISEASE,10253
148535,cone-rod,I-NAME_OF_DISEASE,10253
148536,dystrophies,I-NAME_OF_DISEASE,10253
148537,Gene,B-TREATMENT,10254
148538,therapies,I-TREATMENT,10254
148539,have,O,10254
148540,already,O,10254
148541,proven,O,10254
148542,successful,O,10254
148543,in,O,10254
148544,treating,O,10254
148545,monogenic,B-NAME_OF_DISEASE,10254
148546,RP,B-NAME_OF_DISEASE,10254
148547,and,O,10254
148548,there,O,10254
148549,is,O,10254
148550,substantial,O,10254
148551,commercial,O,10254
148552,interest,O,10254
148553,in,O,10254
148554,retinal,B-TREATMENT,10254
148555,gene,I-TREATMENT,10254
148556,therapy,I-TREATMENT,10254
148557,while,O,10254
148558,cell,B-TREATMENT,10254
148559,therapies,I-TREATMENT,10254
148560,also,O,10254
148561,have,O,10254
148562,the,O,10254
148563,potential,O,10254
148564,to,O,10254
148565,treat,O,10254
148566,all,O,10254
148567,RP,B-NAME_OF_DISEASE,10254
148568,subtypes,O,10254
148569,However,O,10255
148570,in,B-TREATMENT,10255
148571,vivo,I-TREATMENT,10255
148572,reprogramming,I-TREATMENT,10255
148573,has,O,10255
148574,the,O,10255
148575,potential,O,10255
148576,to,O,10255
148577,be,O,10255
148578,a,O,10255
148579,more,O,10255
148580,efficacious,O,10255
148581,approach,O,10255
148582,to,O,10255
148583,late-stage,B-NAME_OF_DISEASE,10255
148584,retinal,I-NAME_OF_DISEASE,10255
148585,degeneration,I-NAME_OF_DISEASE,10255
148586,as,O,10255
148587,photoreceptor,B-PART_OF_THE_EYES,10255
148588,integration,O,10255
148589,and,O,10255
148590,synaptic,O,10255
148591,connections,O,10255
148592,are,O,10255
148593,more,O,10255
148594,likely,O,10255
148595,than,O,10255
148596,with,O,10255
148597,cell,O,10255
148598,transplantation,O,10255
148599,This,O,10256
148600,is,O,10256
148601,because,O,10256
148602,it,O,10256
148603,takes,O,10256
148604,advantage,O,10256
148605,of,O,10256
148606,Müller,B-PART_OF_THE_EYES,10256
148607,glia,I-PART_OF_THE_EYES,10256
148608,in,O,10256
148609,situ,O,10256
148610,they,O,10256
148611,are,O,10256
148612,proximal,O,10256
148613,to,O,10256
148614,photoreceptors,B-PART_OF_THE_EYES,10256
148615,and,O,10256
148616,have,O,10256
148617,existing,O,10256
148618,gap,O,10256
148619,junctions,O,10256
148620,with,O,10256
148621,retinal,B-PART_OF_THE_EYES,10256
148622,neurons,I-PART_OF_THE_EYES,10256
148623,Glaucoma,B-NAME_OF_DISEASE,10257
148624,involves,O,10257
148625,degeneration,B-SIGN_AND_SYMPTOM,10257
148626,of,I-SIGN_AND_SYMPTOM,10257
148627,the,I-SIGN_AND_SYMPTOM,10257
148628,optic,I-SIGN_AND_SYMPTOM,10257
148629,nerve,I-SIGN_AND_SYMPTOM,10257
148630,that,I-SIGN_AND_SYMPTOM,10257
148631,connects,I-SIGN_AND_SYMPTOM,10257
148632,the,I-SIGN_AND_SYMPTOM,10257
148633,retina,I-SIGN_AND_SYMPTOM,10257
148634,to,I-SIGN_AND_SYMPTOM,10257
148635,the,I-SIGN_AND_SYMPTOM,10257
148636,brain,I-SIGN_AND_SYMPTOM,10257
148637,and,O,10257
148638,accounts,O,10257
148639,for,O,10257
148640,12,O,10257
148641,percent,O,10257
148642,of,O,10257
148643,global,O,10257
148644,blindness,B-NAME_OF_DISEASE,10257
148645,making,O,10257
148646,it,O,10257
148647,the,O,10257
148648,second,O,10257
148649,most,O,10257
148650,common,O,10257
148651,cause,O,10257
148652,of,O,10257
148653,blindness,B-NAME_OF_DISEASE,10257
148654,worldwide,O,10257
148655,It,O,10258
148656,is,O,10258
148657,characterized,O,10258
148658,by,O,10258
148659,RGC,B-PART_OF_THE_EYES,10258
148660,death,O,10258
148661,most,O,10258
148662,often,O,10258
148663,caused,O,10258
148664,by,O,10258
148665,elevated,B-CAUSE_OF_DISEASE,10258
148666,intraocular,I-CAUSE_OF_DISEASE,10258
148667,pressure,I-CAUSE_OF_DISEASE,10258
148668,that,O,10258
148669,results,O,10258
148670,in,O,10258
148671,deformation,O,10258
148672,of,O,10258
148673,the,B-PART_OF_THE_EYES,10258
148674,lamina,I-PART_OF_THE_EYES,10258
148675,cribrosa,I-PART_OF_THE_EYES,10258
148676,pores,I-PART_OF_THE_EYES,10258
148677,located,O,10258
148678,at,O,10258
148679,the,B-PART_OF_THE_EYES,10258
148680,optic,I-PART_OF_THE_EYES,10258
148681,nerve,I-PART_OF_THE_EYES,10258
148682,head,I-PART_OF_THE_EYES,10258
148683,The,B-PART_OF_THE_EYES,10259
148684,lamina,I-PART_OF_THE_EYES,10259
148685,cribrosa,I-PART_OF_THE_EYES,10259
148686,is,O,10259
148687,a,O,10259
148688,porous,O,10259
148689,extra-cellular,O,10259
148690,matrix,O,10259
148691,where,O,10259
148692,the,B-PART_OF_THE_EYES,10259
148693,RGCs,I-PART_OF_THE_EYES,10259
148694,exit,O,10259
148695,the,B-PART_OF_THE_EYES,10259
148696,retina,I-PART_OF_THE_EYES,10259
148697,their,O,10259
148698,axons,O,10259
148699,form,O,10259
148700,the,B-PART_OF_THE_EYES,10259
148701,optic,I-PART_OF_THE_EYES,10259
148702,nerve,I-PART_OF_THE_EYES,10259
148703,Mutations,B-CAUSE_OF_DISEASE,10260
148704,in,I-CAUSE_OF_DISEASE,10260
148705,the,I-CAUSE_OF_DISEASE,10260
148706,MYOC,I-CAUSE_OF_DISEASE,10260
148707,gene,I-CAUSE_OF_DISEASE,10260
148708,are,O,10260
148709,the,O,10260
148710,most,O,10260
148711,common,O,10260
148712,genetic,O,10260
148713,causes,O,10260
148714,of,O,10260
148715,primary,B-NAME_OF_DISEASE,10260
148716,open-angle,I-NAME_OF_DISEASE,10260
148717,glaucoma,I-NAME_OF_DISEASE,10260
148718,Current,O,10261
148719,treatments,O,10261
148720,focus,O,10261
148721,on,O,10261
148722,lowering,B-TREATMENT,10261
148723,of,I-TREATMENT,10261
148724,intraocular,I-TREATMENT,10261
148725,pressure,I-TREATMENT,10261
148726,to,O,10261
148727,slow,O,10261
148728,the,O,10261
148729,progression,O,10261
148730,of,O,10261
148731,glaucoma,B-NAME_OF_DISEASE,10261
148732,however,O,10261
148733,cell,B-TREATMENT,10261
148734,and,I-TREATMENT,10261
148735,gene,I-TREATMENT,10261
148736,therapies,I-TREATMENT,10261
148737,offer,O,10261
148738,the,O,10261
148739,greatest,O,10261
148740,hope,O,10261
148741,for,O,10261
148742,reversing,O,10261
148743,the,B-SIGN_AND_SYMPTOM,10261
148744,damage,I-SIGN_AND_SYMPTOM,10261
148745,to,I-SIGN_AND_SYMPTOM,10261
148746,vision,I-SIGN_AND_SYMPTOM,10261
148747,caused,O,10261
148748,by,O,10261
148749,glaucoma,B-NAME_OF_DISEASE,10261
148750,Retinal,O,10262
148751,Degeneration,O,10262
148752,,O,10262
148753,Cell,O,10262
148754,Therapy,O,10262
148755,For,O,10263
148756,example,O,10263
148757,the,B-PART_OF_THE_EYES,10263
148758,retina,I-PART_OF_THE_EYES,10263
148759,can,O,10263
148760,be,O,10263
148761,clinically,O,10263
148762,monitored,O,10263
148763,using,O,10263
148764,imaging,O,10263
148765,techniques,O,10263
148766,such,O,10263
148767,as,O,10263
148768,optical,B-DIAGNOSTIC_TEST,10263
148769,coherence,I-DIAGNOSTIC_TEST,10263
148770,tomography,I-DIAGNOSTIC_TEST,10263
148771,and,O,10263
148772,fluorescence,B-DIAGNOSTIC_TEST,10263
148773,adaptive,I-DIAGNOSTIC_TEST,10263
148774,optics,I-DIAGNOSTIC_TEST,10263
148775,scanning,I-DIAGNOSTIC_TEST,10263
148776,light,I-DIAGNOSTIC_TEST,10263
148777,ophthalmoscopy,I-DIAGNOSTIC_TEST,10263
148778,imaging,I-DIAGNOSTIC_TEST,10263
148779,Therefore,O,10264
148780,the,O,10264
148781,safety,O,10264
148782,and,O,10264
148783,efficacy,O,10264
148784,of,O,10264
148785,cell,B-TREATMENT,10264
148786,and,I-TREATMENT,10264
148787,gene,I-TREATMENT,10264
148788,therapies,I-TREATMENT,10264
148789,can,O,10264
148790,be,O,10264
148791,readily,O,10264
148792,assessed,O,10264
148793,over,O,10264
148794,time,O,10264
148795,in,O,10264
148796,animals,O,10264
148797,and,O,10264
148798,human,O,10264
148799,clinical,O,10264
148800,studies,O,10264
148801,ESCs,B-PART_OF_THE_EYES,10265
148802,and,O,10265
148803,induced,B-PART_OF_THE_EYES,10265
148804,pluripotent,I-PART_OF_THE_EYES,10265
148805,stem,I-PART_OF_THE_EYES,10265
148806,cells,I-PART_OF_THE_EYES,10265
148807,iPSCs,I-PART_OF_THE_EYES,10265
148808,are,O,10265
148809,clinically,O,10265
148810,valuable,O,10265
148811,as,O,10265
148812,a,O,10265
148813,source,O,10265
148814,of,O,10265
148815,retinal,B-PART_OF_THE_EYES,10265
148816,cell,I-PART_OF_THE_EYES,10265
148817,types,O,10265
148818,for,O,10265
148819,research,O,10265
148820,and,O,10265
148821,application,O,10265
148822,Retinal,B-PART_OF_THE_EYES,10266
148823,organoids,I-PART_OF_THE_EYES,10266
148824,generated,O,10266
148825,from,O,10266
148826,these,O,10266
148827,cells,O,10266
148828,have,O,10266
148829,helped,O,10266
148830,to,O,10266
148831,significantly,O,10266
148832,advance,O,10266
148833,the,O,10266
148834,understanding,O,10266
148835,of,O,10266
148836,retina,B-PART_OF_THE_EYES,10266
148837,development,O,10266
148838,and,O,10266
148839,they,O,10266
148840,have,O,10266
148841,also,O,10266
148842,provided,O,10266
148843,an,O,10266
148844,effective,O,10266
148845,tool,O,10266
148846,to,O,10266
148847,study,O,10266
148848,photoreceptor,B-PART_OF_THE_EYES,10266
148849,isolation,O,10266
148850,and,O,10266
148851,transplantation,O,10266
148852,RPE,B-PART_OF_THE_EYES,10267
148853,can,O,10267
148854,be,O,10267
148855,spontaneously,O,10267
148856,produced,O,10267
148857,from,O,10267
148858,iPSCs,B-PART_OF_THE_EYES,10267
148859,by,O,10267
148860,removal,O,10267
148861,of,O,10267
148862,FGF2,B-CHEMICAL_COMPOUND,10267
148863,from,O,10267
148864,pluripotency,O,10267
148865,media,O,10267
148866,or,O,10267
148867,more,O,10267
148868,efficiently,O,10267
148869,generated,O,10267
148870,by,O,10267
148871,the,O,10267
148872,addition,O,10267
148873,of,O,10267
148874,small,O,10267
148875,molecules,O,10267
148876,such,O,10267
148877,as,O,10267
148878,nicotinamide,B-CHEMICAL_COMPOUND,10267
148879,and,O,10267
148880,activin,B-CHEMICAL_COMPOUND,10267
148881,A,I-CHEMICAL_COMPOUND,10267
148882,The,O,10268
148883,delivery,O,10268
148884,of,O,10268
148885,RPE,B-PART_OF_THE_EYES,10268
148886,can,O,10268
148887,be,O,10268
148888,as,O,10268
148889,a,O,10268
148890,cell,O,10268
148891,suspension,O,10268
148892,or,O,10268
148893,as,O,10268
148894,a,O,10268
148895,cell,O,10268
148896,sheet,O,10268
148897,through,O,10268
148898,subretinal,O,10268
148899,implantation,O,10268
148900,Several,O,10269
148901,studies,O,10269
148902,have,O,10269
148903,also,O,10269
148904,tried,O,10269
148905,to,O,10269
148906,transdifferentiate,O,10269
148907,fibroblasts,O,10269
148908,to,O,10269
148909,RPE,B-PART_OF_THE_EYES,10269
148910,for,O,10269
148911,clinical,O,10269
148912,transplantation,O,10269
148913,using,O,10269
148914,transcription,O,10269
148915,factors,O,10269
148916,including,O,10269
148917,MITF,B-CHEMICAL_COMPOUND,10269
148918,Clinical,O,10270
148919,trials,O,10270
148920,have,O,10270
148921,reached,O,10270
148922,phase,O,10270
148923,II,O,10270
148924,for,O,10270
148925,RPE,B-PART_OF_THE_EYES,10270
148926,transplantation,O,10270
148927,to,O,10270
148928,treat,O,10270
148929,AMD,B-NAME_OF_DISEASE,10270
148930,and,O,10270
148931,several,O,10270
148932,strategies,O,10270
148933,are,O,10270
148934,being,O,10270
148935,developed,O,10270
148936,to,O,10270
148937,more,O,10270
148938,effectively,O,10270
148939,deliver,O,10270
148940,RPE,B-PART_OF_THE_EYES,10270
148941,generated,O,10270
148942,from,O,10270
148943,pluripotent,B-PART_OF_THE_EYES,10270
148944,stem,I-PART_OF_THE_EYES,10270
148945,cells,I-PART_OF_THE_EYES,10270
148946,Cell,B-TREATMENT,10271
148947,therapies,I-TREATMENT,10271
148948,are,O,10271
148949,an,O,10271
148950,attractive,O,10271
148951,option,O,10271
148952,for,O,10271
148953,treating,O,10271
148954,inherited,B-NAME_OF_DISEASE,10271
148955,retinal,I-NAME_OF_DISEASE,10271
148956,disorders,I-NAME_OF_DISEASE,10271
148957,as,O,10271
148958,they,O,10271
148959,have,O,10271
148960,the,O,10271
148961,potential,O,10271
148962,to,O,10271
148963,treat,O,10271
148964,all,O,10271
148965,variants,O,10271
148966,of,O,10271
148967,RP,B-NAME_OF_DISEASE,10271
148968,mutations,O,10271
148969,by,O,10271
148970,regenerating,O,10271
148971,photoreceptors,B-PART_OF_THE_EYES,10271
148972,Importantly,O,10272
148973,allogeneic,O,10272
148974,therapies,O,10272
148975,would,O,10272
148976,not,O,10272
148977,carry,O,10272
148978,the,O,10272
148979,host,O,10272
148980,mutation,O,10272
148981,and,O,10272
148982,there,O,10272
148983,is,O,10272
148984,a,B-PART_OF_THE_EYES,10272
148985,blood-retina,I-PART_OF_THE_EYES,10272
148986,barrier,I-PART_OF_THE_EYES,10272
148987,formed,O,10272
148988,by,O,10272
148989,the,B-PART_OF_THE_EYES,10272
148990,RPE,I-PART_OF_THE_EYES,10272
148991,that,O,10272
148992,grants,O,10272
148993,immune,O,10272
148994,privilege,O,10272
148995,Recent,O,10273
148996,efforts,O,10273
148997,have,O,10273
148998,focused,O,10273
148999,on,O,10273
149000,generating,O,10273
149001,Müller,B-PART_OF_THE_EYES,10273
149002,glia,I-PART_OF_THE_EYES,10273
149003,that,O,10273
149004,can,O,10273
149005,be,O,10273
149006,isolated,O,10273
149007,from,O,10273
149008,organoids,O,10273
149009,for,O,10273
149010,sub-retinal,O,10273
149011,transplantation,O,10273
149012,and,O,10273
149013,improvement,O,10273
149014,of,O,10273
149015,RGC,B-PART_OF_THE_EYES,10273
149016,function,O,10273
149017,while,O,10273
149018,cone,B-PART_OF_THE_EYES,10273
149019,photoreceptor,I-PART_OF_THE_EYES,10273
149020,density,O,10273
149021,can,O,10273
149022,be,O,10273
149023,increased,O,10273
149024,in,O,10273
149025,organoids,O,10273
149026,so,O,10273
149027,they,O,10273
149028,can,O,10273
149029,be,O,10273
149030,isolated,O,10273
149031,for,O,10273
149032,transplantation,O,10273
149033,There,O,10274
149034,are,O,10274
149035,several,O,10274
149036,published,O,10274
149037,protocols,O,10274
149038,for,O,10274
149039,the,O,10274
149040,generation,O,10274
149041,of,O,10274
149042,RGCs,B-PART_OF_THE_EYES,10274
149043,from,O,10274
149044,iPSCs,B-PART_OF_THE_EYES,10274
149045,and,O,10274
149046,retinal,B-PART_OF_THE_EYES,10274
149047,organoids,I-PART_OF_THE_EYES,10274
149048,and,O,10274
149049,they,O,10274
149050,arise,O,10274
149051,early,O,10274
149052,in,O,10274
149053,retinal,O,10274
149054,development,O,10274
149055,Their,O,10275
149056,application,O,10275
149057,as,O,10275
149058,a,B-TREATMENT,10275
149059,cell,I-TREATMENT,10275
149060,therapy,I-TREATMENT,10275
149061,remains,O,10275
149062,difficult,O,10275
149063,because,O,10275
149064,of,O,10275
149065,the,O,10275
149066,axonal,O,10275
149067,length,O,10275
149068,required,O,10275
149069,to,O,10275
149070,connect,O,10275
149071,the,B-PART_OF_THE_EYES,10275
149072,retina,I-PART_OF_THE_EYES,10275
149073,and,O,10275
149074,visual,O,10275
149075,cortex,O,10275
149076,in,O,10275
149077,the,O,10275
149078,posterior,O,10275
149079,region,O,10275
149080,of,O,10275
149081,the,O,10275
149082,brain,O,10275
149083,For,O,10276
149084,RGC,B-TREATMENT,10276
149085,cell,I-TREATMENT,10276
149086,therapies,I-TREATMENT,10276
149087,to,O,10276
149088,be,O,10276
149089,successful,O,10276
149090,the,O,10276
149091,elevated,O,10276
149092,intraocular,O,10276
149093,pressure,O,10276
149094,and,O,10276
149095,lamina,B-PART_OF_THE_EYES,10276
149096,cribrosa,I-PART_OF_THE_EYES,10276
149097,defects,O,10276
149098,also,O,10276
149099,need,O,10276
149100,correcting,O,10276
149101,to,O,10276
149102,prevent,O,10276
149103,further,O,10276
149104,damage,O,10276
149105,to,O,10276
149106,the,O,10276
149107,donor,O,10276
149108,RGCs,B-PART_OF_THE_EYES,10276
149109,Though,O,10277
149110,RGC,B-TREATMENT,10277
149111,therapy,I-TREATMENT,10277
149112,is,O,10277
149113,challenging,O,10277
149114,it,O,10277
149115,offers,O,10277
149116,a,O,10277
149117,very,O,10277
149118,real,O,10277
149119,prospect,O,10277
149120,of,O,10277
149121,optic,B-PART_OF_THE_EYES,10277
149122,nerve,I-PART_OF_THE_EYES,10277
149123,regeneration,O,10277
149124,as,O,10277
149125,there,O,10277
149126,are,O,10277
149127,few,O,10277
149128,options,O,10277
149129,for,O,10277
149130,gene,B-TREATMENT,10277
149131,therapy,I-TREATMENT,10277
149132,Retinal,O,10278
149133,Degeneration,O,10278
149134,,O,10278
149135,Gene,O,10278
149136,Therapy,O,10278
149137,Gene,B-TREATMENT,10279
149138,therapy,I-TREATMENT,10279
149139,strategies,O,10279
149140,aim,O,10279
149141,to,O,10279
149142,silence,O,10279
149143,replace,O,10279
149144,or,O,10279
149145,repair,O,10279
149146,defective,O,10279
149147,genes,B-CHEMICAL_COMPOUND,10279
149148,that,O,10279
149149,form,O,10279
149150,the,O,10279
149151,basis,O,10279
149152,of,O,10279
149153,inherited,B-NAME_OF_DISEASE,10279
149154,retinal,I-NAME_OF_DISEASE,10279
149155,diseases,I-NAME_OF_DISEASE,10279
149156,or,O,10279
149157,they,O,10279
149158,may,O,10279
149159,target,O,10279
149160,pathways,O,10279
149161,involved,O,10279
149162,in,O,10279
149163,inflammation,O,10279
149164,or,O,10279
149165,visual,O,10279
149166,transduction,O,10279
149167,Adeno-associated,B-CHEMICAL_COMPOUND,10280
149168,viruses,I-CHEMICAL_COMPOUND,10280
149169,AAVs,I-CHEMICAL_COMPOUND,10280
149170,are,O,10280
149171,non-pathogenic,O,10280
149172,and,O,10280
149173,have,O,10280
149174,been,O,10280
149175,shown,O,10280
149176,to,O,10280
149177,effectively,O,10280
149178,target,O,10280
149179,retinal,B-PART_OF_THE_EYES,10280
149180,cells,I-PART_OF_THE_EYES,10280
149181,such,O,10280
149182,as,O,10280
149183,photoreceptors,B-PART_OF_THE_EYES,10280
149184,and,O,10280
149185,RPE,B-PART_OF_THE_EYES,10280
149186,after,O,10280
149187,subretinal,O,10280
149188,injection,O,10280
149189,The,B-ORGANIZATION,10281
149190,FDA,I-ORGANIZATION,10281
149191,recently,O,10281
149192,approved,O,10281
149193,LUXTURNA,B-NAME_OF_DRUG,10281
149194,for,O,10281
149195,the,O,10281
149196,treatment,O,10281
149197,of,O,10281
149198,inherited,B-NAME_OF_DISEASE,10281
149199,retinal,I-NAME_OF_DISEASE,10281
149200,disorders,I-NAME_OF_DISEASE,10281
149201,using,O,10281
149202,AAV,B-CHEMICAL_COMPOUND,10281
149203,vectors,O,10281
149204,Specifically,O,10282
149205,it,O,10282
149206,is,O,10282
149207,used,O,10282
149208,for,O,10282
149209,the,O,10282
149210,treatment,O,10282
149211,of,O,10282
149212,Lebers,B-NAME_OF_DISEASE,10282
149213,congenital,I-NAME_OF_DISEASE,10282
149214,amaurosis,I-NAME_OF_DISEASE,10282
149215,LCA,I-NAME_OF_DISEASE,10282
149216,or,O,10282
149217,RP,B-NAME_OF_DISEASE,10282
149218,caused,O,10282
149219,by,O,10282
149220,confirmed,O,10282
149221,biallelic,B-CAUSE_OF_DISEASE,10282
149222,RPE65,I-CAUSE_OF_DISEASE,10282
149223,mutations,I-CAUSE_OF_DISEASE,10282
149224,The,O,10283
149225,approval,O,10283
149226,has,O,10283
149227,led,O,10283
149228,to,O,10283
149229,great,O,10283
149230,interest,O,10283
149231,in,O,10283
149232,the,O,10283
149233,development,O,10283
149234,of,O,10283
149235,AAV,B-TREATMENT,10283
149236,gene,I-TREATMENT,10283
149237,therapies,I-TREATMENT,10283
149238,for,O,10283
149239,inherited,B-NAME_OF_DISEASE,10283
149240,retinal,I-NAME_OF_DISEASE,10283
149241,disorders,I-NAME_OF_DISEASE,10283
149242,The,B-PART_OF_THE_EYES,10284
149243,blood-retina,I-PART_OF_THE_EYES,10284
149244,barrier,I-PART_OF_THE_EYES,10284
149245,formed,O,10284
149246,by,O,10284
149247,the,B-PART_OF_THE_EYES,10284
149248,retinal,I-PART_OF_THE_EYES,10284
149249,pigment,I-PART_OF_THE_EYES,10284
149250,epithelium,I-PART_OF_THE_EYES,10284
149251,helps,O,10284
149252,to,O,10284
149253,prevent,O,10284
149254,y,O,10284
149255,g,O,10284
149256,efforts,O,10284
149257,have,O,10284
149258,focused,O,10284
149259,on,O,10284
149260,generating,O,10284
149261,can,O,10284
149262,be,O,10284
149263,isolated,O,10284
149264,from,O,10284
149265,organoids,O,10284
149266,for,O,10284
149267,sub-retinal,O,10284
149268,splantation,O,10284
149269,and,O,10284
149270,improvement,O,10284
149271,of,O,10284
149272,RGC,B-PART_OF_THE_EYES,10284
149273,function,O,10284
149274,while,O,10284
149275,cone,B-PART_OF_THE_EYES,10284
149276,photoreceptor,I-PART_OF_THE_EYES,10284
149277,density,O,10284
149278,can,O,10284
149279,be,O,10284
149280,increased,O,10284
149281,in,O,10284
149282,organoids,O,10284
149283,so,O,10284
149284,they,O,10284
149285,can,O,10284
149286,be,O,10284
149287,isolated,O,10284
149288,for,O,10284
149289,transplantation,O,10284
149290,These,O,10285
149291,genes,O,10285
149292,have,O,10285
149293,been,O,10285
149294,delivered,O,10285
149295,via,O,10285
149296,lentivirus,B-CHEMICAL_COMPOUND,10285
149297,to,O,10285
149298,test,O,10285
149299,their,O,10285
149300,safety,O,10285
149301,and,O,10285
149302,efficacy,O,10285
149303,A,O,10286
149304,dual,O,10286
149305,vector,O,10286
149306,approach,O,10286
149307,has,O,10286
149308,recently,O,10286
149309,been,O,10286
149310,used,O,10286
149311,to,O,10286
149312,restore,O,10286
149313,the,O,10286
149314,function,O,10286
149315,of,O,10286
149316,ABCA4,B-CHEMICAL_COMPOUND,10286
149317,in,O,10286
149318,homozygous,O,10286
149319,null,O,10286
149320,mice,O,10286
149321,which,O,10286
149322,is,O,10286
149323,a,O,10286
149324,novel,O,10286
149325,way,O,10286
149326,to,O,10286
149327,increase,O,10286
149328,AAV,B-CHEMICAL_COMPOUND,10286
149329,vector,O,10286
149330,capacity,O,10286
149331,but,O,10286
149332,the,O,10286
149333,level,O,10286
149334,of,O,10286
149335,expression,O,10286
149336,may,O,10286
149337,not,O,10286
149338,be,O,10286
149339,enough,O,10286
149340,to,O,10286
149341,elicit,O,10286
149342,a,O,10286
149343,therapeutic,O,10286
149344,effect,O,10286
149345,Other,O,10287
149346,strategies,O,10287
149347,to,O,10287
149348,deliver,O,10287
149349,gene,B-TREATMENT,10287
149350,therapies,I-TREATMENT,10287
149351,include,O,10287
149352,using,O,10287
149353,antisense,B-CHEMICAL_COMPOUND,10287
149354,oligonucleotides,I-CHEMICAL_COMPOUND,10287
149355,for,O,10287
149356,transient,O,10287
149357,expression,O,10287
149358,which,O,10287
149359,have,O,10287
149360,been,O,10287
149361,used,O,10287
149362,for,O,10287
149363,CEP290,B-CHEMICAL_COMPOUND,10287
149364,in,O,10287
149365,LCA,B-NAME_OF_DISEASE,10287
149366,and,O,10287
149367,QR-421a,B-CHEMICAL_COMPOUND,10287
149368,for,O,10287
149369,LCA,B-NAME_OF_DISEASE,10287
149370,involving,O,10287
149371,USH2A,B-CHEMICAL_COMPOUND,10287
149372,Retinal,B-PART_OF_THE_EYES,10288
149373,organoids,I-PART_OF_THE_EYES,10288
149374,have,O,10288
149375,recently,O,10288
149376,been,O,10288
149377,used,O,10288
149378,to,O,10288
149379,model,O,10288
149380,X-linked,B-NAME_OF_DISEASE,10288
149381,RP,I-NAME_OF_DISEASE,10288
149382,caused,O,10288
149383,by,O,10288
149384,RP2,B-CAUSE_OF_DISEASE,10288
149385,mutations,I-CAUSE_OF_DISEASE,10288
149386,Gene,B-TREATMENT,10289
149387,therapy,I-TREATMENT,10289
149388,delivered,I-TREATMENT,10289
149389,by,I-TREATMENT,10289
149390,AAVs,I-TREATMENT,10289
149391,can,O,10289
149392,correct,O,10289
149393,photoreceptor,B-SIGN_AND_SYMPTOM,10289
149394,degeneration,I-SIGN_AND_SYMPTOM,10289
149395,and,I-SIGN_AND_SYMPTOM,10289
149396,thinning,I-SIGN_AND_SYMPTOM,10289
149397,of,I-SIGN_AND_SYMPTOM,10289
149398,the,I-SIGN_AND_SYMPTOM,10289
149399,outer,I-SIGN_AND_SYMPTOM,10289
149400,nuclear,I-SIGN_AND_SYMPTOM,10289
149401,layer,I-SIGN_AND_SYMPTOM,10289
149402,in,I-SIGN_AND_SYMPTOM,10289
149403,RP2-mutated,I-SIGN_AND_SYMPTOM,10289
149404,organoids,I-SIGN_AND_SYMPTOM,10289
149405,from,O,10289
149406,patients,O,10289
149407,RPGR,B-NAME_OF_DISEASE,10290
149408,has,O,10290
149409,also,O,10290
149410,been,O,10290
149411,targeted,O,10290
149412,by,O,10290
149413,AAVs,B-CHEMICAL_COMPOUND,10290
149414,for,O,10290
149415,a,B-TREATMENT,10290
149416,gene,I-TREATMENT,10290
149417,therapy,I-TREATMENT,10290
149418,approach,O,10290
149419,to,O,10290
149420,treating,O,10290
149421,X-linked,B-NAME_OF_DISEASE,10290
149422,RP,I-NAME_OF_DISEASE,10290
149423,To,O,10291
149424,protect,O,10291
149425,cone,B-PART_OF_THE_EYES,10291
149426,photoreceptors,I-PART_OF_THE_EYES,10291
149427,in,O,10291
149428,a,O,10291
149429,mouse,O,10291
149430,model,O,10291
149431,of,O,10291
149432,retinal,B-NAME_OF_DISEASE,10291
149433,degeneration,I-NAME_OF_DISEASE,10291
149434,microglia,O,10291
149435,have,O,10291
149436,been,O,10291
149437,stimulated,O,10291
149438,with,O,10291
149439,TGF-ɴ1,B-CHEMICAL_COMPOUND,10291
149440,using,O,10291
149441,AAVs,B-CHEMICAL_COMPOUND,10291
149442,In,O,10292
149443,three,O,10292
149444,mouse,O,10292
149445,models,O,10292
149446,of,O,10292
149447,RP,B-NAME_OF_DISEASE,10292
149448,carrying,O,10292
149449,different,O,10292
149450,mutations,O,10292
149451,AAV-mediated,O,10292
149452,delivery,O,10292
149453,of,O,10292
149454,TGF-ɴ1,B-CHEMICAL_COMPOUND,10292
149455,rescued,O,10292
149456,degenerating,B-SIGN_AND_SYMPTOM,10292
149457,cones,I-SIGN_AND_SYMPTOM,10292
149458,The,O,10293
149459,results,O,10293
149460,suggest,O,10293
149461,that,O,10293
149462,TGF-ɴ1,B-CHEMICAL_COMPOUND,10293
149463,can,O,10293
149464,protect,O,10293
149465,vision,O,10293
149466,and,O,10293
149467,may,O,10293
149468,benefit,O,10293
149469,patients,O,10293
149470,with,O,10293
149471,neurodegeneration,B-NAME_OF_DISEASE,10293
149472,A,O,10294
149473,novel,O,10294
149474,gene,B-TREATMENT,10294
149475,therapy,I-TREATMENT,10294
149476,approach,O,10294
149477,to,O,10294
149478,AMD,B-NAME_OF_DISEASE,10294
149479,blocks,O,10294
149480,inflammation,O,10294
149481,caused,O,10294
149482,by,O,10294
149483,the,O,10294
149484,complement,O,10294
149485,system,O,10294
149486,Here,O,10295
149487,AAVs,B-CHEMICAL_COMPOUND,10295
149488,are,O,10295
149489,used,O,10295
149490,to,O,10295
149491,deliver,O,10295
149492,a,O,10295
149493,proprietary,O,10295
149494,protein,B-CHEMICAL_COMPOUND,10295
149495,after,O,10295
149496,vitrectomy,B-TREATMENT,10295
149497,phase,O,10295
149498,III,O,10295
149499,trials,O,10295
149500,commenced,O,10295
149501,in,O,10295
149502,January,O,10295
149503,2019,O,10295
149504,to,O,10295
149505,test,O,10295
149506,the,O,10295
149507,safety,O,10295
149508,and,O,10295
149509,efficacy,O,10295
149510,of,O,10295
149511,this,O,10295
149512,gene,B-TREATMENT,10295
149513,therapy,I-TREATMENT,10295
149514,in,O,10295
149515,humans,O,10295
149516,for,O,10295
149517,treating,O,10295
149518,dry,B-NAME_OF_DISEASE,10295
149519,AMD,I-NAME_OF_DISEASE,10295
149520,with,O,10295
149521,no,O,10295
149522,safety,O,10295
149523,concerns,O,10295
149524,to,O,10295
149525,date,O,10295
149526,There,O,10296
149527,is,O,10296
149528,also,O,10296
149529,evidence,O,10296
149530,that,O,10296
149531,gene,B-TREATMENT,10296
149532,therapies,I-TREATMENT,10296
149533,may,O,10296
149534,also,O,10296
149535,help,O,10296
149536,glaucoma,B-NAME_OF_DISEASE,10296
149537,patients,O,10296
149538,by,O,10296
149539,targeting,O,10296
149540,aquaporin-1,B-CHEMICAL_COMPOUND,10296
149541,in,O,10296
149542,the,B-PART_OF_THE_EYES,10296
149543,ciliary,I-PART_OF_THE_EYES,10296
149544,body,I-PART_OF_THE_EYES,10296
149545,using,O,10296
149546,CRISPR-Cas9,B-TREATMENT,10296
149547,to,O,10296
149548,reduce,O,10296
149549,intraocular,O,10296
149550,pressure,O,10296
149551,Other,O,10297
149552,research,O,10297
149553,highlights,O,10297
149554,a,B-TREATMENT,10297
149555,CRISPR-Cas9,I-TREATMENT,10297
149556,approach,I-TREATMENT,10297
149557,to,O,10297
149558,gene,O,10297
149559,editing,O,10297
149560,MYOC,B-SIGN_AND_SYMPTOM,10297
149561,that,O,10297
149562,has,O,10297
149563,been,O,10297
149564,able,O,10297
149565,to,O,10297
149566,lower,O,10297
149567,intraocular,O,10297
149568,pressure,O,10297
149569,in,O,10297
149570,glaucomatous,O,10297
149571,mouse,O,10297
149572,eyes,O,10297
149573,Cell,B-TREATMENT,10298
149574,and,I-TREATMENT,10298
149575,gene,I-TREATMENT,10298
149576,therapies,I-TREATMENT,10298
149577,have,O,10298
149578,the,O,10298
149579,potential,O,10298
149580,to,O,10298
149581,restore,O,10298
149582,vision,O,10298
149583,after,O,10298
149584,retinal,B-NAME_OF_DISEASE,10298
149585,degeneration,I-NAME_OF_DISEASE,10298
149586,however,O,10298
149587,the,O,10298
149588,delivery,O,10298
149589,and,O,10298
149590,integration,O,10298
149591,of,O,10298
149592,these,O,10298
149593,approaches,O,10298
149594,remains,O,10298
149595,problematic,O,10298
149596,and,O,10298
149597,the,O,10298
149598,number,O,10298
149599,of,O,10298
149600,approved,O,10298
149601,advanced,O,10298
149602,therapeutic,O,10298
149603,medicinal,O,10298
149604,products,O,10298
149605,is,O,10298
149606,few,O,10298
149607,Here,O,10299
149608,we,O,10299
149609,evaluate,O,10299
149610,in,B-TREATMENT,10299
149611,vivo,I-TREATMENT,10299
149612,reprogramming,I-TREATMENT,10299
149613,of,O,10299
149614,Müller,B-PART_OF_THE_EYES,10299
149615,glia,I-PART_OF_THE_EYES,10299
149616,as,O,10299
149617,an,O,10299
149618,innovative,O,10299
149619,approach,O,10299
149620,to,O,10299
149621,treating,O,10299
149622,late-stage,B-NAME_OF_DISEASE,10299
149623,retinal,I-NAME_OF_DISEASE,10299
149624,degeneration,I-NAME_OF_DISEASE,10299
149625,Since,O,10300
149626,the,O,10300
149627,discovery,O,10300
149628,that,O,10300
149629,4-Oct,B-CHEMICAL_COMPOUND,10300
149630,KLF4,B-CHEMICAL_COMPOUND,10300
149631,SOX2,B-CHEMICAL_COMPOUND,10300
149632,and,O,10300
149633,cMYC,B-CHEMICAL_COMPOUND,10300
149634,transcription,O,10300
149635,factors,O,10300
149636,can,O,10300
149637,reprogram,O,10300
149638,somatic,O,10300
149639,cells,O,10300
149640,into,O,10300
149641,induced,O,10300
149642,pluripotent,B-PART_OF_THE_EYES,10300
149643,stem,I-PART_OF_THE_EYES,10300
149644,cells,I-PART_OF_THE_EYES,10300
149645,there,O,10300
149646,has,O,10300
149647,been,O,10300
149648,great,O,10300
149649,interest,O,10300
149650,in,O,10300
149651,direct,O,10300
149652,reprogramming,O,10300
149653,for,O,10300
149654,the,O,10300
149655,development,O,10300
149656,of,O,10300
149657,new,O,10300
149658,cell,O,10300
149659,therapies,O,10300
149660,There,O,10301
149661,is,O,10301
149662,precedent,O,10301
149663,for,O,10301
149664,reprogramming,O,10301
149665,of,O,10301
149666,retinal,B-PART_OF_THE_EYES,10301
149667,cell,I-PART_OF_THE_EYES,10301
149668,types,O,10301
149669,such,O,10301
149670,as,O,10301
149671,fibroblasts,O,10301
149672,to,O,10301
149673,rods,B-PART_OF_THE_EYES,10301
149674,and,O,10301
149675,in,B-TREATMENT,10301
149676,vivo,I-TREATMENT,10301
149677,reprogramming,I-TREATMENT,10301
149678,of,O,10301
149679,Müller,B-PART_OF_THE_EYES,10301
149680,glia,I-PART_OF_THE_EYES,10301
149681,to,O,10301
149682,rods,B-PART_OF_THE_EYES,10301
149683,Thus,O,10302
149684,the,O,10302
149685,application,O,10302
149686,of,O,10302
149687,transcription,O,10302
149688,factors,O,10302
149689,directly,O,10302
149690,for,O,10302
149691,in,B-TREATMENT,10302
149692,vivo,I-TREATMENT,10302
149693,reprogramming,I-TREATMENT,10302
149694,of,O,10302
149695,retinal,B-PART_OF_THE_EYES,10302
149696,cell,I-PART_OF_THE_EYES,10302
149697,types,O,10302
149698,is,O,10302
149699,an,O,10302
149700,exciting,O,10302
149701,new,O,10302
149702,therapeutic,O,10302
149703,approach,O,10302
149704,to,O,10302
149705,photoreceptor,B-SIGN_AND_SYMPTOM,10302
149706,degeneration,I-SIGN_AND_SYMPTOM,10302
149707,Müller,B-PART_OF_THE_EYES,10303
149708,glia,I-PART_OF_THE_EYES,10303
149709,represents,O,10303
149710,the,O,10303
149711,best,O,10303
149712,potential,O,10303
149713,source,O,10303
149714,in,O,10303
149715,the,B-PART_OF_THE_EYES,10303
149716,retina,I-PART_OF_THE_EYES,10303
149717,for,O,10303
149718,in,O,10303
149719,vivo,O,10303
149720,conversion,O,10303
149721,to,O,10303
149722,photoreceptors,B-PART_OF_THE_EYES,10303
149723,as,O,10303
149724,they,O,10303
149725,are,O,10303
149726,the,O,10303
149727,primary,O,10303
149728,support,O,10303
149729,cell,O,10303
149730,of,O,10303
149731,the,B-PART_OF_THE_EYES,10303
149732,retina,I-PART_OF_THE_EYES,10303
149733,and,O,10303
149734,activate,O,10303
149735,on,O,10303
149736,the,O,10303
149737,injury,O,10303
149738,In,O,10304
149739,the,O,10304
149740,zebrafish,O,10304
149741,retina,B-PART_OF_THE_EYES,10304
149742,Müller,B-PART_OF_THE_EYES,10304
149743,glia,I-PART_OF_THE_EYES,10304
149744,cells,I-PART_OF_THE_EYES,10304
149745,have,O,10304
149746,been,O,10304
149747,shown,O,10304
149748,to,O,10304
149749,regenerate,O,10304
149750,other,O,10304
149751,retinal,B-PART_OF_THE_EYES,10304
149752,cell,I-PART_OF_THE_EYES,10304
149753,types,O,10304
149754,after,O,10304
149755,injury,O,10304
149756,and,O,10304
149757,this,O,10304
149758,finding,O,10304
149759,suggests,O,10304
149760,they,O,10304
149761,have,O,10304
149762,a,O,10304
149763,progenitor,O,10304
149764,capacity,O,10304
149765,The,B-CHEMICAL_COMPOUND,10305
149766,ASCL1,I-CHEMICAL_COMPOUND,10305
149767,gene,I-CHEMICAL_COMPOUND,10305
149768,was,O,10305
149769,shown,O,10305
149770,to,O,10305
149771,be,O,10305
149772,up-regulated,O,10305
149773,in,O,10305
149774,Müller,B-PART_OF_THE_EYES,10305
149775,glia,I-PART_OF_THE_EYES,10305
149776,that,O,10305
149777,contributed,O,10305
149778,to,O,10305
149779,the,O,10305
149780,regeneration,O,10305
149781,of,O,10305
149782,neurons,O,10305
149783,In,O,10306
149784,rodents,O,10306
149785,Müller,B-PART_OF_THE_EYES,10306
149786,glia,I-PART_OF_THE_EYES,10306
149787,is,O,10306
149788,not,O,10306
149789,associated,O,10306
149790,with,O,10306
149791,retinal,B-NAME_OF_DISEASE,10306
149792,regeneration,I-NAME_OF_DISEASE,10306
149793,suggested,O,10306
149794,to,O,10306
149795,be,O,10306
149796,a,O,10306
149797,result,O,10306
149798,of,O,10306
149799,epigenetic,O,10306
149800,repression,O,10306
149801,but,O,10306
149802,they,O,10306
149803,have,O,10306
149804,been,O,10306
149805,stimulated,O,10306
149806,to,O,10306
149807,generate,O,10306
149808,neurons,O,10306
149809,by,O,10306
149810,ASCL1,B-CHEMICAL_COMPOUND,10306
149811,overexpression,O,10306
149812,and,O,10306
149813,use,O,10306
149814,of,O,10306
149815,a,B-NAME_OF_DRUG,10306
149816,histone,I-NAME_OF_DRUG,10306
149817,deacetylase,I-NAME_OF_DRUG,10306
149818,inhibitor,I-NAME_OF_DRUG,10306
149819,trichostatin,I-NAME_OF_DRUG,10306
149820,A,I-NAME_OF_DRUG,10306
149821,Another,O,10307
149822,method,O,10307
149823,to,O,10307
149824,reprogram,O,10307
149825,Müller,B-PART_OF_THE_EYES,10307
149826,glia,I-PART_OF_THE_EYES,10307
149827,is,O,10307
149828,by,O,10307
149829,cell,O,10307
149830,fusion,O,10307
149831,with,O,10307
149832,hematopoietic,O,10307
149833,progenitors,O,10307
149834,which,O,10307
149835,has,O,10307
149836,been,O,10307
149837,shown,O,10307
149838,to,O,10307
149839,stimulate,O,10307
149840,their,O,10307
149841,conversion,O,10307
149842,to,O,10307
149843,photoreceptor,B-PART_OF_THE_EYES,10307
149844,precursors,O,10307
149845,More,O,10308
149846,recently,O,10308
149847,the,O,10308
149848,transcription,O,10308
149849,factors,O,10308
149850,OTX2,B-CHEMICAL_COMPOUND,10308
149851,CRX,B-CHEMICAL_COMPOUND,10308
149852,and,O,10308
149853,NRL,B-CHEMICAL_COMPOUND,10308
149854,have,O,10308
149855,been,O,10308
149856,used,O,10308
149857,to,O,10308
149858,reprogram,O,10308
149859,Müller,B-PART_OF_THE_EYES,10308
149860,glia,I-PART_OF_THE_EYES,10308
149861,to,O,10308
149862,rod,B-PART_OF_THE_EYES,10308
149863,photoreceptors,I-PART_OF_THE_EYES,10308
149864,in,O,10308
149865,Gnat1rd17Gnat2cpfl3,O,10308
149866,double,O,10308
149867,mutant,O,10308
149868,mice,O,10308
149869,This,O,10309
149870,study,O,10309
149871,used,O,10309
149872,beta-catenin,B-CHEMICAL_COMPOUND,10309
149873,to,O,10309
149874,drive,O,10309
149875,proliferation,O,10309
149876,of,O,10309
149877,Müller,B-PART_OF_THE_EYES,10309
149878,glia,I-PART_OF_THE_EYES,10309
149879,before,O,10309
149880,subsequent,O,10309
149881,reprogramming,O,10309
149882,to,O,10309
149883,rod,B-PART_OF_THE_EYES,10309
149884,photoreceptors,B-PART_OF_THE_EYES,10309
149885,in,O,10309
149886,mice,O,10309
149887,that,O,10309
149888,lack,O,10309
149889,functional,O,10309
149890,photoreceptors,B-PART_OF_THE_EYES,10309
149891,Overall,O,10310
149892,there,O,10310
149893,is,O,10310
149894,significant,O,10310
149895,promise,O,10310
149896,in,O,10310
149897,the,O,10310
149898,potential,O,10310
149899,of,O,10310
149900,converting,O,10310
149901,Müller,B-PART_OF_THE_EYES,10310
149902,glia,I-PART_OF_THE_EYES,10310
149903,to,O,10310
149904,photoreceptors,B-PART_OF_THE_EYES,10310
149905,to,O,10310
149906,reverse,O,10310
149907,retinal,B-NAME_OF_DISEASE,10310
149908,degeneration,I-NAME_OF_DISEASE,10310
149909,RPE,B-PART_OF_THE_EYES,10311
149910,has,O,10311
149911,been,O,10311
149912,shown,O,10311
149913,to,O,10311
149914,have,O,10311
149915,stem,O,10311
149916,cell,O,10311
149917,properties,O,10311
149918,in,O,10311
149919,vitro,O,10311
149920,and,O,10311
149921,is,O,10311
149922,another,O,10311
149923,candidate,O,10311
149924,to,O,10311
149925,regenerate,O,10311
149926,photoreceptors,B-PART_OF_THE_EYES,10311
149927,as,O,10311
149928,it,O,10311
149929,is,O,10311
149930,adjacently,O,10311
149931,located,O,10311
149932,to,O,10311
149933,them,O,10311
149934,in,O,10311
149935,the,O,10311
149936,outer,O,10311
149937,nuclear,O,10311
149938,layer,O,10311
149939,However,O,10312
149940,RPE,B-PART_OF_THE_EYES,10312
149941,is,O,10312
149942,a,O,10312
149943,quiescent,O,10312
149944,monolayer,O,10312
149945,and,O,10312
149946,cell,O,10312
149947,conversions,O,10312
149948,of,O,10312
149949,RPE,B-PART_OF_THE_EYES,10312
149950,to,O,10312
149951,photoreceptors,B-PART_OF_THE_EYES,10312
149952,may,O,10312
149953,be,O,10312
149954,counterintuitive,O,10312
149955,given,O,10312
149956,its,O,10312
149957,fundamental,O,10312
149958,role,O,10312
149959,in,O,10312
149960,photoreceptor,B-PART_OF_THE_EYES,10312
149961,homeostasis,O,10312
149962,In,B-TREATMENT,10313
149963,vivo,I-TREATMENT,10313
149964,reprogramming,I-TREATMENT,10313
149965,is,O,10313
149966,also,O,10313
149967,attractive,O,10313
149968,for,O,10313
149969,the,O,10313
149970,regeneration,O,10313
149971,of,O,10313
149972,RGCs,B-PART_OF_THE_EYES,10313
149973,and,O,10313
149974,the,O,10313
149975,treatment,O,10313
149976,of,O,10313
149977,glaucoma,B-NAME_OF_DISEASE,10313
149978,One,O,10314
149979,strategy,O,10314
149980,has,O,10314
149981,been,O,10314
149982,developed,O,10314
149983,to,O,10314
149984,convert,O,10314
149985,amacrine,B-PART_OF_THE_EYES,10314
149986,interneurons,I-PART_OF_THE_EYES,10314
149987,into,O,10314
149988,RGCs,B-PART_OF_THE_EYES,10314
149989,by,O,10314
149990,overexpressing,O,10314
149991,Atoh7,B-CHEMICAL_COMPOUND,10314
149992,Brn3B,B-CHEMICAL_COMPOUND,10314
149993,Sox4,B-CHEMICAL_COMPOUND,10314
149994,Sox11,B-CHEMICAL_COMPOUND,10314
149995,and,O,10314
149996,Isl1,B-CHEMICAL_COMPOUND,10314
149997,which,O,10314
149998,are,O,10314
149999,established,O,10314
150000,transcription,O,10314
150001,factors,O,10314
150002,in,O,10314
150003,RGC,B-PART_OF_THE_EYES,10314
150004,development,O,10314
150005,There,O,10315
150006,is,O,10315
150007,also,O,10315
150008,evidence,O,10315
150009,that,O,10315
150010,Ascl1,B-CHEMICAL_COMPOUND,10315
150011,Brn3b,B-CHEMICAL_COMPOUND,10315
150012,and,O,10315
150013,Isl1,B-CHEMICAL_COMPOUND,10315
150014,transcription,O,10315
150015,factors,O,10315
150016,can,O,10315
150017,convert,O,10315
150018,mouse,O,10315
150019,fibroblasts,B-PART_OF_THE_EYES,10315
150020,into,O,10315
150021,induced,O,10315
150022,RGCs,B-PART_OF_THE_EYES,10315
150023,Br,O,10316
150024,Overexpression,O,10316
150025,of,O,10316
150026,KLF4,B-CHEMICAL_COMPOUND,10316
150027,has,O,10316
150028,also,O,10316
150029,been,O,10316
150030,shown,O,10316
150031,to,O,10316
150032,induce,O,10316
150033,the,O,10316
150034,regeneration,O,10316
150035,of,O,10316
150036,RGCs,B-PART_OF_THE_EYES,10316
150037,in,O,10316
150038,vivo,O,10316
150039,even,O,10316
150040,though,O,10316
150041,it,O,10316
150042,is,O,10316
150043,not,O,10316
150044,essential,O,10316
150045,for,O,10316
150046,their,O,10316
150047,development,O,10316
150048,By,O,10317
150049,using,O,10317
150050,a,O,10317
150051,systematic,O,10317
150052,data-driven,O,10317
150053,approach,O,10317
150054,we,O,10317
150055,will,O,10317
150056,be,O,10317
150057,able,O,10317
150058,to,O,10317
150059,predict,O,10317
150060,optimal,O,10317
150061,transcription,O,10317
150062,factor,O,10317
150063,sets,O,10317
150064,for,O,10317
150065,the,O,10317
150066,conversion,O,10317
150067,of,O,10317
150068,retinal,B-PART_OF_THE_EYES,10317
150069,cell,I-PART_OF_THE_EYES,10317
150070,types,O,10317
150071,to,O,10317
150072,generate,O,10317
150073,cells,O,10317
150074,for,O,10317
150075,therapy,O,10317
150076,and,O,10317
150077,as,O,10317
150078,a,B-TREATMENT,10317
150079,gene,I-TREATMENT,10317
150080,therapy,I-TREATMENT,10317
150081,for,O,10317
150082,in,B-TREATMENT,10317
150083,vivo,I-TREATMENT,10317
150084,reprogramming,I-TREATMENT,10317
150085,Demodex,B-NAME_OF_DISEASE,10318
150086,infestation,I-NAME_OF_DISEASE,10318
150087,demodicosis,I-NAME_OF_DISEASE,10318
150088,of,O,10318
150089,the,B-PART_OF_THE_EYES,10318
150090,eyelids,I-PART_OF_THE_EYES,10318
150091,has,O,10318
150092,been,O,10318
150093,associated,O,10318
150094,with,O,10318
150095,substantial,O,10318
150096,ocular,O,10318
150097,morbidity,O,10318
150098,in,O,10318
150099,patients,O,10318
150100,of,O,10318
150101,all,O,10318
150102,ages,O,10318
150103,Demodicosis,B-NAME_OF_DISEASE,10319
150104,is,O,10319
150105,associated,O,10319
150106,with,O,10319
150107,chronic,B-SIGN_AND_SYMPTOM,10319
150108,blepharitis,I-SIGN_AND_SYMPTOM,10319
150109,lid,I-SIGN_AND_SYMPTOM,10319
150110,margin,I-SIGN_AND_SYMPTOM,10319
150111,keratinization,I-SIGN_AND_SYMPTOM,10319
150112,meibomian,I-SIGN_AND_SYMPTOM,10319
150113,gland,I-SIGN_AND_SYMPTOM,10319
150114,hyperplasia,I-SIGN_AND_SYMPTOM,10319
150115,glandular,I-SIGN_AND_SYMPTOM,10319
150116,inspissation,I-SIGN_AND_SYMPTOM,10319
150117,and,I-SIGN_AND_SYMPTOM,10319
150118,chalazia,I-SIGN_AND_SYMPTOM,10319
150119,Demodex,B-CAUSE_OF_DISEASE,10320
150120,folliculorum,I-CAUSE_OF_DISEASE,10320
150121,and,O,10320
150122,Demodex,B-CAUSE_OF_DISEASE,10320
150123,brevis,I-CAUSE_OF_DISEASE,10320
150124,are,O,10320
150125,two,O,10320
150126,mites,O,10320
150127,which,O,10320
150128,infest,O,10320
150129,the,O,10320
150130,human,O,10320
150131,eye,O,10320
150132,and,O,10320
150133,which,O,10320
150134,may,O,10320
150135,in,O,10320
150136,excess,O,10320
150137,lead,O,10320
150138,to,O,10320
150139,a,O,10320
150140,wide,O,10320
150141,range,O,10320
150142,of,O,10320
150143,anterior,O,10320
150144,segment,O,10320
150145,findings,O,10320
150146,Demodex,B-CAUSE_OF_DISEASE,10321
150147,mites,I-CAUSE_OF_DISEASE,10321
150148,have,O,10321
150149,been,O,10321
150150,implicated,O,10321
150151,in,O,10321
150152,anterior,O,10321
150153,and,O,10321
150154,posterior,O,10321
150155,blepharitis,B-NAME_OF_DISEASE,10321
150156,blepharoconjunctivitis,B-NAME_OF_DISEASE,10321
150157,blepharokeratitis,B-NAME_OF_DISEASE,10321
150158,and,O,10321
150159,beyond,O,10321
150160,Due,O,10322
150161,to,O,10322
150162,significant,O,10322
150163,overlap,O,10322
150164,with,O,10322
150165,other,O,10322
150166,anterior,O,10322
150167,segment,O,10322
150168,conditions,O,10322
150169,Demodex,B-NAME_OF_DISEASE,10322
150170,infestation,I-NAME_OF_DISEASE,10322
150171,remains,O,10322
150172,underdiagnosed,O,10322
150173,and,O,10322
150174,undertreated,O,10322
150175,Definitive,O,10323
150176,diagnosis,O,10323
150177,can,O,10323
150178,be,O,10323
150179,made,O,10323
150180,with,O,10323
150181,lash,B-DIAGNOSTIC_TEST,10323
150182,sampling,I-DIAGNOSTIC_TEST,10323
150183,and,O,10323
150184,the,O,10323
150185,most,O,10323
150186,common,O,10323
150187,mode,O,10323
150188,of,O,10323
150189,treatment,O,10323
150190,is,O,10323
150191,with,O,10323
150192,tea,B-TREATMENT,10323
150193,tree,I-TREATMENT,10323
150194,oil,I-TREATMENT,10323
150195,in,I-TREATMENT,10323
150196,varying,I-TREATMENT,10323
150197,concentrations,I-TREATMENT,10323
150198,The,B-CAUSE_OF_DISEASE,10324
150199,Demodex,I-CAUSE_OF_DISEASE,10324
150200,mite,I-CAUSE_OF_DISEASE,10324
150201,of,I-CAUSE_OF_DISEASE,10324
150202,phylum,I-CAUSE_OF_DISEASE,10324
150203,Arthropoda,I-CAUSE_OF_DISEASE,10324
150204,comes,O,10324
150205,in,O,10324
150206,two,O,10324
150207,forms,O,10324
150208,Demodex,B-CAUSE_OF_DISEASE,10324
150209,folliculorum,I-CAUSE_OF_DISEASE,10324
150210,and,O,10324
150211,Demodex,B-CAUSE_OF_DISEASE,10324
150212,brevis,I-CAUSE_OF_DISEASE,10324
150213,D.folliculorum,B-CAUSE_OF_DISEASE,10325
150214,is,O,10325
150215,larger,O,10325
150216,0.3-0.4,O,10325
150217,mm,O,10325
150218,and,O,10325
150219,tends,O,10325
150220,to,O,10325
150221,inhabit,O,10325
150222,the,B-PART_OF_THE_EYES,10325
150223,base,I-PART_OF_THE_EYES,10325
150224,of,I-PART_OF_THE_EYES,10325
150225,the,I-PART_OF_THE_EYES,10325
150226,lashes,I-PART_OF_THE_EYES,10325
150227,as,O,10325
150228,the,O,10325
150229,name,O,10325
150230,would,O,10325
150231,suggest,O,10325
150232,D,B-CAUSE_OF_DISEASE,10326
150233,brevis,I-CAUSE_OF_DISEASE,10326
150234,is,O,10326
150235,smaller,O,10326
150236,0.2-0.3,O,10326
150237,mm,O,10326
150238,and,O,10326
150239,preferentially,O,10326
150240,inhabits,O,10326
150241,the,B-PART_OF_THE_EYES,10326
150242,sebaceous,I-PART_OF_THE_EYES,10326
150243,glands,I-PART_OF_THE_EYES,10326
150244,These,O,10327
150245,are,O,10327
150246,the,O,10327
150247,only,O,10327
150248,two,O,10327
150249,mites,B-CAUSE_OF_DISEASE,10327
150250,that,O,10327
150251,affect,O,10327
150252,the,O,10327
150253,human,O,10327
150254,eye,O,10327
150255,and,O,10327
150256,in,O,10327
150257,turn,O,10327
150258,humans,O,10327
150259,are,O,10327
150260,the,O,10327
150261,only,O,10327
150262,mammals,O,10327
150263,to,O,10327
150264,host,O,10327
150265,them,O,10327
150266,Both,O,10328
150267,mites,B-CAUSE_OF_DISEASE,10328
150268,in,O,10328
150269,their,O,10328
150270,adult,O,10328
150271,form,O,10328
150272,are,O,10328
150273,cigar-shaped,O,10328
150274,with,O,10328
150275,four,O,10328
150276,pairs,O,10328
150277,of,O,10328
150278,legs,O,10328
150279,to,O,10328
150280,grip,O,10328
150281,cylindrical,O,10328
150282,structures,O,10328
150283,such,O,10328
150284,as,O,10328
150285,an,B-PART_OF_THE_EYES,10328
150286,eyelash,I-PART_OF_THE_EYES,10328
150287,The,B-CAUSE_OF_DISEASE,10329
150288,mites,I-CAUSE_OF_DISEASE,10329
150289,take,O,10329
150290,approximately,O,10329
150291,2,B-TIME_DURATION,10329
150292,weeks,I-TIME_DURATION,10329
150293,to,O,10329
150294,mature,O,10329
150295,from,O,10329
150296,the,O,10329
150297,egg,O,10329
150298,to,O,10329
150299,the,O,10329
150300,larval,O,10329
150301,stage,O,10329
150302,with,O,10329
150303,an,O,10329
150304,overall,O,10329
150305,life,O,10329
150306,span,O,10329
150307,of,O,10329
150308,up,B-TIME_DURATION,10329
150309,to,I-TIME_DURATION,10329
150310,3,I-TIME_DURATION,10329
150311,weeks,I-TIME_DURATION,10329
150312,A,O,10330
150313,retrospective,O,10330
150314,study,O,10330
150315,of,O,10330
150316,adults,O,10330
150317,with,O,10330
150318,Demodex,B-NAME_OF_DISEASE,10330
150319,blepharitis,I-NAME_OF_DISEASE,10330
150320,demonstrates,O,10330
150321,that,O,10330
150322,this,O,10330
150323,common,O,10330
150324,condition,O,10330
150325,has,O,10330
150326,important,O,10330
150327,negative,O,10330
150328,functional,O,10330
150329,and,O,10330
150330,psychosocial,O,10330
150331,effects,O,10330
150332,according,O,10330
150333,to,O,10330
150334,Elizabeth,B-PERSON,10330
150335,Yeu,I-PERSON,10330
150336,MD,I-PERSON,10330
150337,The,O,10331
150338,study,O,10331
150339,known,O,10331
150340,as,O,10331
150341,ATLAS,B-NAME_OF_STUDY,10331
150342,analyzed,O,10331
150343,data,O,10331
150344,from,O,10331
150345,questionnaires,O,10331
150346,that,O,10331
150347,were,O,10331
150348,completed,O,10331
150349,by,O,10331
150350,311,O,10331
150351,patients,O,10331
150352,who,O,10331
150353,had,O,10331
150354,objective,O,10331
150355,signs,O,10331
150356,of,O,10331
150357,Demodex,B-NAME_OF_DISEASE,10331
150358,blepharitis,I-NAME_OF_DISEASE,10331
150359,including,O,10331
150360,the,B-SIGN_AND_SYMPTOM,10331
150361,presence,I-SIGN_AND_SYMPTOM,10331
150362,of,I-SIGN_AND_SYMPTOM,10331
150363,Demodex,I-SIGN_AND_SYMPTOM,10331
150364,mites,I-SIGN_AND_SYMPTOM,10331
150365,collarettes,I-SIGN_AND_SYMPTOM,10331
150366,on,I-SIGN_AND_SYMPTOM,10331
150367,the,I-SIGN_AND_SYMPTOM,10331
150368,lashes,I-SIGN_AND_SYMPTOM,10331
150369,and,I-SIGN_AND_SYMPTOM,10331
150370,lid,I-SIGN_AND_SYMPTOM,10331
150371,margin,I-SIGN_AND_SYMPTOM,10331
150372,erythema,I-SIGN_AND_SYMPTOM,10331
150373,The,O,10332
150374,results,O,10332
150375,showed,O,10332
150376,that,O,10332
150377,80%,O,10332
150378,of,O,10332
150379,patients,O,10332
150380,said,O,10332
150381,that,O,10332
150382,blepharitis,B-NAME_OF_DISEASE,10332
150383,negatively,O,10332
150384,affected,O,10332
150385,daily,O,10332
150386,life,O,10332
150387,and,O,10332
150388,that,O,10332
150389,the,O,10332
150390,impacts,O,10332
150391,were,O,10332
150392,felt,O,10332
150393,in,O,10332
150394,multiple,O,10332
150395,ways,O,10332
150396,Many,O,10333
150397,clinicians,O,10333
150398,underestimate,O,10333
150399,the,O,10333
150400,prevalence,O,10333
150401,and,O,10333
150402,impact,O,10333
150403,of,O,10333
150404,Demodex,B-NAME_OF_DISEASE,10333
150405,blepharitis,I-NAME_OF_DISEASE,10333
150406,due,O,10333
150407,to,O,10333
150408,symptom,O,10333
150409,overlap,O,10333
150410,with,O,10333
150411,other,O,10333
150412,ocular,O,10333
150413,surface,O,10333
150414,diseases,O,10333
150415,that,O,10333
150416,are,O,10333
150417,often,O,10333
150418,comorbidities,O,10333
150419,such,O,10333
150420,as,O,10333
150421,dry,B-NAME_OF_DISEASE,10333
150422,eye,I-NAME_OF_DISEASE,10333
150423,disease,I-NAME_OF_DISEASE,10333
150424,said,O,10333
150425,Yeu,B-PERSON,10333
150426,an,O,10333
150427,assistant,O,10333
150428,professor,O,10333
150429,of,O,10333
150430,ophthalmology,O,10333
150431,at,O,10333
150432,Eastern,B-ORGANIZATION,10333
150433,Virginia,I-ORGANIZATION,10333
150434,Medical,I-ORGANIZATION,10333
150435,School,I-ORGANIZATION,10333
150436,and,O,10333
150437,a,O,10333
150438,partner,O,10333
150439,at,O,10333
150440,Virginia,B-ORGANIZATION,10333
150441,Eye,I-ORGANIZATION,10333
150442,Consultants,I-ORGANIZATION,10333
150443,in,O,10333
150444,Norfolk,B-GPE,10333
150445,However,O,10334
150446,it,O,10334
150447,has,O,10334
150448,been,O,10334
150449,estimated,O,10334
150450,that,O,10334
150451,blepharitis,B-NAME_OF_DISEASE,10334
150452,affects,O,10334
150453,approximately,O,10334
150454,20,O,10334
150455,million,O,10334
150456,Americans,O,10334
150457,of,O,10334
150458,whom,O,10334
150459,about,O,10334
150460,45%,O,10334
150461,have,O,10334
150462,an,O,10334
150463,associated,O,10334
150464,infestation,O,10334
150465,with,O,10334
150466,Demodex,B-CAUSE_OF_DISEASE,10334
150467,mites,I-CAUSE_OF_DISEASE,10334
150468,Yeu,B-ORGANIZATION,10335
150469,pointed,O,10335
150470,out,O,10335
150471,that,O,10335
150472,ATLAS,B-NAME_OF_STUDY,10335
150473,is,O,10335
150474,a,O,10335
150475,pioneering,O,10335
150476,study,O,10335
150477,investigating,O,10335
150478,the,O,10335
150479,consequences,O,10335
150480,of,O,10335
150481,Demodex,B-NAME_OF_DISEASE,10335
150482,blepharitis,I-NAME_OF_DISEASE,10335
150483,and,O,10335
150484,its,O,10335
150485,results,O,10335
150486,indicate,O,10335
150487,that,O,10335
150488,affected,O,10335
150489,patients,O,10335
150490,may,O,10335
150491,struggle,O,10335
150492,for,O,10335
150493,years,O,10335
150494,with,O,10335
150495,significant,O,10335
150496,clinical,O,10335
150497,functional,O,10335
150498,and,O,10335
150499,psychosocial,O,10335
150500,impacts,O,10335
150501,Therefore,O,10336
150502,it,O,10336
150503,is,O,10336
150504,important,O,10336
150505,that,O,10336
150506,clinicians,O,10336
150507,be,O,10336
150508,proactive,O,10336
150509,about,O,10336
150510,diagnosing,O,10336
150511,Demodex,B-NAME_OF_DISEASE,10336
150512,blepharitis,I-NAME_OF_DISEASE,10336
150513,and,O,10336
150514,offering,O,10336
150515,treatment,O,10336
150516,she,O,10336
150517,said,O,10336
150518,The,O,10337
150519,data,O,10337
150520,for,O,10337
150521,the,B-NAME_OF_STUDY,10337
150522,ATLAS,I-NAME_OF_STUDY,10337
150523,study,I-NAME_OF_STUDY,10337
150524,were,O,10337
150525,derived,O,10337
150526,from,O,10337
150527,participants,O,10337
150528,in,O,10337
150529,SATURN-1,B-NAME_OF_STUDY,10337
150530,a,O,10337
150531,multicenter,O,10337
150532,phase,O,10337
150533,2b3,O,10337
150534,clinical,O,10337
150535,trial,O,10337
150536,investigating,O,10337
150537,the,O,10337
150538,efficacy,O,10337
150539,and,O,10337
150540,safety,O,10337
150541,of,O,10337
150542,TP-03,B-NAME_OF_DRUG,10337
150543,lotilaner,I-NAME_OF_DRUG,10337
150544,0.25%,I-NAME_OF_DRUG,10337
150545,ophthalmic,I-NAME_OF_DRUG,10337
150546,solution,I-NAME_OF_DRUG,10337
150547,Tarsus,I-NAME_OF_DRUG,10337
150548,Pharmaceuticals,I-NAME_OF_DRUG,10337
150549,for,O,10337
150550,treating,O,10337
150551,Demodex,B-NAME_OF_DISEASE,10337
150552,blepharitis,I-NAME_OF_DISEASE,10337
150553,To,O,10338
150554,be,O,10338
150555,eligible,O,10338
150556,for,O,10338
150557,enrollment,O,10338
150558,in,O,10338
150559,the,B-NAME_OF_STUDY,10338
150560,SATURN-1,I-NAME_OF_STUDY,10338
150561,study,I-NAME_OF_STUDY,10338
150562,patients,O,10338
150563,had,O,10338
150564,to,O,10338
150565,have,O,10338
150566,10,O,10338
150567,or,O,10338
150568,more,O,10338
150569,collarettes,O,10338
150570,on,O,10338
150571,the,O,10338
150572,upper,O,10338
150573,lashes,O,10338
150574,1.5,O,10338
150575,or,O,10338
150576,more,O,10338
150577,mites,O,10338
150578,per,O,10338
150579,lash,O,10338
150580,and,O,10338
150581,at,O,10338
150582,least,O,10338
150583,mild,B-SIGN_AND_SYMPTOM,10338
150584,lid,I-SIGN_AND_SYMPTOM,10338
150585,margin,I-SIGN_AND_SYMPTOM,10338
150586,erythema,I-SIGN_AND_SYMPTOM,10338
150587,The,O,10339
150588,ATLAS,B-NAME_OF_STUDY,10339
150589,participants,O,10339
150590,questionnaire,O,10339
150591,responses,O,10339
150592,showed,O,10339
150593,that,O,10339
150594,women,O,10339
150595,were,O,10339
150596,more,O,10339
150597,likely,O,10339
150598,than,O,10339
150599,men,O,10339
150600,to,O,10339
150601,experience,O,10339
150602,a,O,10339
150603,negative,O,10339
150604,impact,O,10339
150605,from,O,10339
150606,their,O,10339
150607,Demodex,B-NAME_OF_DISEASE,10339
150608,blepharitis,I-NAME_OF_DISEASE,10339
150609,but,O,10339
150610,the,O,10339
150611,majority,O,10339
150612,of,O,10339
150613,both,O,10339
150614,men,O,10339
150615,72%,O,10339
150616,and,O,10339
150617,women,O,10339
150618,84%,O,10339
150619,suffered,O,10339
150620,adverse,O,10339
150621,consequences,O,10339
150622,Having,B-SIGN_AND_SYMPTOM,10340
150623,difficulty,I-SIGN_AND_SYMPTOM,10340
150624,driving,I-SIGN_AND_SYMPTOM,10340
150625,at,I-SIGN_AND_SYMPTOM,10340
150626,night,I-SIGN_AND_SYMPTOM,10340
150627,and,I-SIGN_AND_SYMPTOM,10340
150628,feeling,I-SIGN_AND_SYMPTOM,10340
150629,or,I-SIGN_AND_SYMPTOM,10340
150630,being,I-SIGN_AND_SYMPTOM,10340
150631,conscious,I-SIGN_AND_SYMPTOM,10340
150632,of,I-SIGN_AND_SYMPTOM,10340
150633,their,I-SIGN_AND_SYMPTOM,10340
150634,eyes,I-SIGN_AND_SYMPTOM,10340
150635,all,I-SIGN_AND_SYMPTOM,10340
150636,day,I-SIGN_AND_SYMPTOM,10340
150637,were,O,10340
150638,the,O,10340
150639,most,O,10340
150640,common,O,10340
150641,issues,O,10340
150642,both,O,10340
150643,noted,O,10340
150644,by,O,10340
150645,47%,O,10340
150646,of,O,10340
150647,patients,O,10340
150648,Notably,O,10341
150649,in,O,10341
150650,terms,O,10341
150651,of,O,10341
150652,emotional,O,10341
150653,impact,O,10341
150654,about,O,10341
150655,23%,O,10341
150656,of,O,10341
150657,both,O,10341
150658,males,O,10341
150659,and,O,10341
150660,females,O,10341
150661,said,O,10341
150662,they,O,10341
150663,were,O,10341
150664,constantly,O,10341
150665,worrying,O,10341
150666,about,O,10341
150667,their,O,10341
150668,eyes,O,10341
150669,and,O,10341
150670,6%,O,10341
150671,of,O,10341
150672,the,O,10341
150673,participants,O,10341
150674,indicated,O,10341
150675,that,O,10341
150676,their,O,10341
150677,blepharitis,B-NAME_OF_DISEASE,10341
150678,affected,O,10341
150679,their,O,10341
150680,mental,O,10341
150681,state,O,10341
150682,with,O,10341
150683,this,O,10341
150684,impact,O,10341
150685,felt,O,10341
150686,more,O,10341
150687,often,O,10341
150688,by,O,10341
150689,males,O,10341
150690,than,O,10341
150691,females,O,10341
150692,Yeu,B-PERSON,10341
150693,said,O,10341
150694,Approximately,O,10342
150695,30%,O,10342
150696,of,O,10342
150697,both,O,10342
150698,males,O,10342
150699,and,O,10342
150700,females,O,10342
150701,said,O,10342
150702,that,O,10342
150703,blepharitis,B-NAME_OF_DISEASE,10342
150704,added,O,10342
150705,time,O,10342
150706,to,O,10342
150707,their,O,10342
150708,daily,O,10342
150709,hygiene,O,10342
150710,routine,O,10342
150711,8%,O,10342
150712,reported,O,10342
150713,having,O,10342
150714,discomfort,O,10342
150715,with,O,10342
150716,their,O,10342
150717,contact,O,10342
150718,lenses,O,10342
150719,or,O,10342
150720,having,O,10342
150721,to,O,10342
150722,reduce,O,10342
150723,wear,O,10342
150724,time,O,10342
150725,because,O,10342
150726,of,O,10342
150727,the,O,10342
150728,condition,O,10342
150729,and,O,10342
150730,5%,O,10342
150731,noted,O,10342
150732,that,O,10342
150733,they,O,10342
150734,avoided,O,10342
150735,ocular,B-TREATMENT,10342
150736,surgery,I-TREATMENT,10342
150737,because,O,10342
150738,of,O,10342
150739,the,B-NAME_OF_DISEASE,10342
150740,blepharitis,I-NAME_OF_DISEASE,10342
150741,Twenty-three,O,10343
150742,percent,O,10343
150743,of,O,10343
150744,respondents,O,10343
150745,females,O,10343
150746,27%,O,10343
150747,males,O,10343
150748,16%,O,10343
150749,felt,O,10343
150750,blepharitis,B-NAME_OF_DISEASE,10343
150751,had,O,10343
150752,an,O,10343
150753,adverse,O,10343
150754,effect,O,10343
150755,on,O,10343
150756,the,O,10343
150757,appearance,O,10343
150758,of,O,10343
150759,their,O,10343
150760,eyes,O,10343
150761,or,O,10343
150762,eyelids,B-PART_OF_THE_EYES,10343
150763,One-third,O,10344
150764,of,O,10344
150765,women,O,10344
150766,indicated,O,10344
150767,the,O,10344
150768,condition,O,10344
150769,interfered,O,10344
150770,with,O,10344
150771,their,O,10344
150772,ability,O,10344
150773,to,O,10344
150774,wear,O,10344
150775,makeup,O,10344
150776,and,O,10344
150777,5%,O,10344
150778,of,O,10344
150779,women,O,10344
150780,noted,O,10344
150781,discomfort,O,10344
150782,when,O,10344
150783,wearing,O,10344
150784,artificial,O,10344
150785,lashes,B-PART_OF_THE_EYES,10344
150786,Clinical,O,10345
150787,care,O,10345
150788,Yeu,B-ORGANIZATION,10345
150789,also,O,10345
150790,noted,O,10345
150791,that,O,10345
150792,the,B-DIAGNOSTIC_TEST,10345
150793,identification,I-DIAGNOSTIC_TEST,10345
150794,of,I-DIAGNOSTIC_TEST,10345
150795,collarettes,I-DIAGNOSTIC_TEST,10345
150796,which,O,10345
150797,are,O,10345
150798,a,O,10345
150799,pathognomonic,O,10345
150800,sign,O,10345
150801,for,O,10345
150802,Demodex,B-NAME_OF_DISEASE,10345
150803,blepharitis,I-NAME_OF_DISEASE,10345
150804,makes,O,10345
150805,the,O,10345
150806,diagnosis,O,10345
150807,easy,O,10345
150808,and,O,10345
150809,straightforward,O,10345
150810,Itching,B-SIGN_AND_SYMPTOM,10346
150811,is,O,10346
150812,a,O,10346
150813,common,O,10346
150814,symptom,O,10346
150815,of,O,10346
150816,Demodex,B-NAME_OF_DISEASE,10346
150817,blepharitis,I-NAME_OF_DISEASE,10346
150818,and,O,10346
150819,patients,O,10346
150820,who,O,10346
150821,are,O,10346
150822,complaining,O,10346
150823,of,O,10346
150824,itching,B-SIGN_AND_SYMPTOM,10346
150825,may,O,10346
150826,be,O,10346
150827,misdiagnosed,O,10346
150828,as,O,10346
150829,having,O,10346
150830,allergic,B-NAME_OF_DISEASE,10346
150831,conjunctivitis,I-NAME_OF_DISEASE,10346
150832,she,O,10346
150833,explained,O,10346
150834,Thus,O,10347
150835,clinical,B-DIAGNOSTIC_TEST,10347
150836,examination,I-DIAGNOSTIC_TEST,10347
150837,to,I-DIAGNOSTIC_TEST,10347
150838,identify,I-DIAGNOSTIC_TEST,10347
150839,collarettes,I-DIAGNOSTIC_TEST,10347
150840,is,O,10347
150841,key,O,10347
150842,for,O,10347
150843,making,O,10347
150844,the,O,10347
150845,diagnosis,O,10347
150846,and,O,10347
150847,helping,O,10347
150848,our,O,10347
150849,patients,O,10347
150850,and,O,10347
150851,it,O,10347
150852,is,O,10347
150853,easily,O,10347
150854,done,O,10347
150855,when,O,10347
150856,patients,O,10347
150857,look,O,10347
150858,down,O,10347
150859,during,O,10347
150860,the,B-DIAGNOSTIC_TEST,10347
150861,slit-lamp,I-DIAGNOSTIC_TEST,10347
150862,examination,I-DIAGNOSTIC_TEST,10347
150863,Because,O,10348
150864,there,O,10348
150865,is,O,10348
150866,no,O,10348
150867,FDA-approved,O,10348
150868,product,O,10348
150869,for,O,10348
150870,safely,O,10348
150871,and,O,10348
150872,effectively,O,10348
150873,treating,O,10348
150874,Demodex,B-NAME_OF_DISEASE,10348
150875,blepharitis,I-NAME_OF_DISEASE,10348
150876,providing,O,10348
150877,effective,O,10348
150878,treatment,O,10348
150879,is,O,10348
150880,more,O,10348
150881,difficult,O,10348
150882,than,O,10348
150883,making,O,10348
150884,an,O,10348
150885,accurate,O,10348
150886,diagnosis,O,10348
150887,Current,O,10349
150888,management,O,10349
150889,options,O,10349
150890,do,O,10349
150891,not,O,10349
150892,treat,O,10349
150893,the,O,10349
150894,underlying,O,10349
150895,cause,O,10349
150896,of,O,10349
150897,disease,O,10349
150898,which,O,10349
150899,is,O,10349
150900,the,B-CAUSE_OF_DISEASE,10349
150901,mite,I-CAUSE_OF_DISEASE,10349
150902,infestation,I-CAUSE_OF_DISEASE,10349
150903,Yeu,B-PERSON,10349
150904,said,O,10349
150905,The,O,10350
150906,study,O,10350
150907,results,O,10350
150908,Yeu,B-PERSON,10350
150909,explained,O,10350
150910,demonstrate,O,10350
150911,that,O,10350
150912,an,O,10350
150913,easy,O,10350
150914,safe,O,10350
150915,and,O,10350
150916,effective,O,10350
150917,therapy,O,10350
150918,for,O,10350
150919,Demodex,B-NAME_OF_DISEASE,10350
150920,blepharitis,I-NAME_OF_DISEASE,10350
150921,is,O,10350
150922,greatly,O,10350
150923,needed,O,10350
150924,Lotilaner,B-NAME_OF_DRUG,10351
150925,solution,O,10351
150926,that,O,10351
150927,is,O,10351
150928,being,O,10351
150929,developed,O,10351
150930,by,O,10351
150931,Tarsus,B-ORGANIZATION,10351
150932,Pharmaceuticals,I-ORGANIZATION,10351
150933,is,O,10351
150934,a,B-NAME_OF_DRUG,10351
150935,specific,I-NAME_OF_DRUG,10351
150936,antiparasitic,I-NAME_OF_DRUG,10351
150937,agent,I-NAME_OF_DRUG,10351
150938,that,O,10351
150939,has,O,10351
150940,been,O,10351
150941,shown,O,10351
150942,to,O,10351
150943,work,O,10351
150944,well,O,10351
150945,for,O,10351
150946,eradicating,O,10351
150947,Demodex,B-CAUSE_OF_DISEASE,10351
150948,mites,I-CAUSE_OF_DISEASE,10351
150949,and,O,10351
150950,improving,O,10351
150951,signs,O,10351
150952,and,O,10351
150953,symptoms,O,10351
150954,of,O,10351
150955,Demodex,B-NAME_OF_DISEASE,10351
150956,blepharitis,I-NAME_OF_DISEASE,10351
150957,she,O,10351
150958,said,O,10351
150959,When,O,10352
150960,treating,O,10352
150961,patients,O,10352
150962,with,O,10352
150963,Demodex,B-NAME_OF_DISEASE,10352
150964,blepharitis,I-NAME_OF_DISEASE,10352
150965,Yeu,B-PERSON,10352
150966,recommended,O,10352
150967,the,O,10352
150968,use,O,10352
150969,of,O,10352
150970,tea,B-TREATMENT,10352
150971,tree,I-TREATMENT,10352
150972,oil,I-TREATMENT,10352
150973,wipes,I-TREATMENT,10352
150974,for,O,10352
150975,patients,O,10352
150976,with,O,10352
150977,no,O,10352
150978,more,O,10352
150979,than,O,10352
150980,10,O,10352
150981,collarettes,B-SIGN_AND_SYMPTOM,10352
150982,along,O,10352
150983,the,B-PART_OF_THE_EYES,10352
150984,lid,I-PART_OF_THE_EYES,10352
150985,margin,I-PART_OF_THE_EYES,10352
150986,In,O,10353
150987,cases,O,10353
150988,with,O,10353
150989,more,O,10353
150990,marked,O,10353
150991,involvement,O,10353
150992,she,O,10353
150993,recommends,O,10353
150994,in-office,O,10353
150995,microblepharoexfoliation,B-NAME_OF_DRUG,10353
150996,BlephEx,I-NAME_OF_DRUG,10353
150997,Alcon,I-NAME_OF_DRUG,10353
150998,and,O,10353
150999,topical,O,10353
151000,treatment,O,10353
151001,with,O,10353
151002,an,B-NAME_OF_DRUG,10353
151003,antibiotic-steroid,I-NAME_OF_DRUG,10353
151004,ointment,I-NAME_OF_DRUG,10353
151005,to,O,10353
151006,the,B-PART_OF_THE_EYES,10353
151007,lid,I-PART_OF_THE_EYES,10353
151008,margins,I-PART_OF_THE_EYES,10353
151009,for,B-TIME_DURATION,10353
151010,7,I-TIME_DURATION,10353
151011,days,I-TIME_DURATION,10353
151012,plus,O,10353
151013,tea,B-TREATMENT,10353
151014,tree,I-TREATMENT,10353
151015,oil,I-TREATMENT,10353
151016,wipes,I-TREATMENT,10353
151017,for,B-TIME_DURATION,10353
151018,6,I-TIME_DURATION,10353
151019,weeks,I-TIME_DURATION,10353
151020,One,O,10354
151021,of,O,10354
151022,the,O,10354
151023,most,O,10354
151024,interesting,O,10354
151025,that,O,10354
151026,is,O,10354
151027,coming,O,10354
151028,to,O,10354
151029,market,O,10354
151030,is,O,10354
151031,the,O,10354
151032,pharmaceutical,O,10354
151033,approach,O,10354
151034,to,O,10354
151035,managing,O,10354
151036,presbyopia,B-NAME_OF_DISEASE,10354
151037,Presbyopia,B-NAME_OF_DISEASE,10355
151038,is,O,10355
151039,a,O,10355
151040,common,O,10355
151041,age-related,O,10355
151042,vision,O,10355
151043,disorder,O,10355
151044,characterized,O,10355
151045,by,O,10355
151046,a,B-SIGN_AND_SYMPTOM,10355
151047,progressive,I-SIGN_AND_SYMPTOM,10355
151048,inability,I-SIGN_AND_SYMPTOM,10355
151049,to,I-SIGN_AND_SYMPTOM,10355
151050,focus,I-SIGN_AND_SYMPTOM,10355
151051,on,I-SIGN_AND_SYMPTOM,10355
151052,near,I-SIGN_AND_SYMPTOM,10355
151053,objects,I-SIGN_AND_SYMPTOM,10355
151054,If,O,10356
151055,uncorrected,O,10356
151056,or,O,10356
151057,under-corrected,O,10356
151058,presbyopia,B-NAME_OF_DISEASE,10356
151059,can,O,10356
151060,significantly,O,10356
151061,impact,O,10356
151062,patients,O,10356
151063,quality,O,10356
151064,of,O,10356
151065,life,O,10356
151066,Presbyopia,B-NAME_OF_DISEASE,10357
151067,represents,O,10357
151068,an,O,10357
151069,area,O,10357
151070,of,O,10357
151071,considerable,O,10357
151072,unmet,O,10357
151073,need,O,10357
151074,due,O,10357
151075,to,O,10357
151076,its,O,10357
151077,rising,O,10357
151078,prevalence,O,10357
151079,worldwide,O,10357
151080,as,O,10357
151081,the,O,10357
151082,population,O,10357
151083,ages,O,10357
151084,the,O,10357
151085,high,O,10357
151086,proportion,O,10357
151087,of,O,10357
151088,under-treated,O,10357
151089,individuals,O,10357
151090,in,O,10357
151091,some,O,10357
151092,parts,O,10357
151093,of,O,10357
151094,the,O,10357
151095,world,O,10357
151096,and,O,10357
151097,the,O,10357
151098,limitations,O,10357
151099,of,O,10357
151100,currently,O,10357
151101,available,O,10357
151102,corrective,O,10357
151103,methods,O,10357
151104,Contact,O,10358
151105,lens,O,10358
151106,options,O,10358
151107,can,O,10358
151108,be,O,10358
151109,difficult,O,10358
151110,to,O,10358
151111,maintain,O,10358
151112,due,O,10358
151113,to,O,10358
151114,the,O,10358
151115,development,O,10358
151116,of,O,10358
151117,age-related,B-NAME_OF_DISEASE,10358
151118,dry,I-NAME_OF_DISEASE,10358
151119,eye,I-NAME_OF_DISEASE,10358
151120,symptoms,O,10358
151121,and,O,10358
151122,reduced,O,10358
151123,manual,O,10358
151124,dexterity,O,10358
151125,Other,O,10359
151126,corrective,O,10359
151127,methods,O,10359
151128,involve,O,10359
151129,surgical,B-TREATMENT,10359
151130,interventions,I-TREATMENT,10359
151131,that,I-TREATMENT,10359
151132,modify,I-TREATMENT,10359
151133,the,I-TREATMENT,10359
151134,optics,I-TREATMENT,10359
151135,of,I-TREATMENT,10359
151136,the,I-TREATMENT,10359
151137,cornea,I-TREATMENT,10359
151138,replace,I-TREATMENT,10359
151139,the,I-TREATMENT,10359
151140,crystalline,I-TREATMENT,10359
151141,lens,I-TREATMENT,10359
151142,or,I-TREATMENT,10359
151143,attempt,I-TREATMENT,10359
151144,to,I-TREATMENT,10359
151145,restore,I-TREATMENT,10359
151146,active,I-TREATMENT,10359
151147,accommodation,I-TREATMENT,10359
151148,While,O,10360
151149,patients,O,10360
151150,undergoing,O,10360
151151,surgery,B-TREATMENT,10360
151152,report,O,10360
151153,satisfactory,O,10360
151154,outcomes,O,10360
151155,post-operatively,O,10360
151156,many,O,10360
151157,of,O,10360
151158,them,O,10360
151159,eventually,O,10360
151160,require,O,10360
151161,reading,B-TREATMENT,10360
151162,glasses,I-TREATMENT,10360
151163,Topical,B-TREATMENT,10361
151164,Therapies,I-TREATMENT,10361
151165,Topical,B-NAME_OF_DRUG,10362
151166,agents,I-NAME_OF_DRUG,10362
151167,that,O,10362
151168,temporarily,O,10362
151169,treat,O,10362
151170,presbyopia,B-NAME_OF_DISEASE,10362
151171,without,O,10362
151172,affecting,O,10362
151173,other,O,10362
151174,aspects,O,10362
151175,of,O,10362
151176,vision,O,10362
151177,are,O,10362
151178,on,O,10362
151179,the,O,10362
151180,cusp,O,10362
151181,of,O,10362
151182,becoming,O,10362
151183,approved,O,10362
151184,and,O,10362
151185,available,O,10362
151186,for,O,10362
151187,widespread,O,10362
151188,use,O,10362
151189,Presbyopia,B-NAME_OF_DISEASE,10363
151190,literally,O,10363
151191,means,O,10363
151192,old,O,10363
151193,eye,O,10363
151194,and,O,10363
151195,results,O,10363
151196,in,O,10363
151197,a,B-SIGN_AND_SYMPTOM,10363
151198,gradual,I-SIGN_AND_SYMPTOM,10363
151199,decrease,I-SIGN_AND_SYMPTOM,10363
151200,in,I-SIGN_AND_SYMPTOM,10363
151201,lens,I-SIGN_AND_SYMPTOM,10363
151202,accommodation,I-SIGN_AND_SYMPTOM,10363
151203,leading,O,10363
151204,to,O,10363
151205,a,B-SIGN_AND_SYMPTOM,10363
151206,significant,I-SIGN_AND_SYMPTOM,10363
151207,lack,I-SIGN_AND_SYMPTOM,10363
151208,of,I-SIGN_AND_SYMPTOM,10363
151209,functional,I-SIGN_AND_SYMPTOM,10363
151210,near,I-SIGN_AND_SYMPTOM,10363
151211,vision,I-SIGN_AND_SYMPTOM,10363
151212,It,O,10364
151213,affects,O,10364
151214,the,O,10364
151215,majority,O,10364
151216,of,O,10364
151217,people,O,10364
151218,over,O,10364
151219,the,O,10364
151220,age,O,10364
151221,of,O,10364
151222,40,O,10364
151223,with,O,10364
151224,a,O,10364
151225,target,O,10364
151226,population,O,10364
151227,of,O,10364
151228,30,O,10364
151229,to,O,10364
151230,40,O,10364
151231,million,O,10364
151232,in,O,10364
151233,the,B-GPE,10364
151234,United,I-GPE,10364
151235,States,I-GPE,10364
151236,and,O,10364
151237,we,O,10364
151238,have,O,10364
151239,no,O,10364
151240,approved,O,10364
151241,pharmacologic,O,10364
151242,treatment,O,10364
151243,Over,O,10365
151244,the,O,10365
151245,years,O,10365
151246,many,O,10365
151247,surgical,O,10365
151248,approaches,O,10365
151249,to,O,10365
151250,the,O,10365
151251,correction,O,10365
151252,of,O,10365
151253,the,O,10365
151254,condition,O,10365
151255,have,O,10365
151256,been,O,10365
151257,attempted,O,10365
151258,but,O,10365
151259,none,O,10365
151260,has,O,10365
151261,yet,O,10365
151262,become,O,10365
151263,widely,O,10365
151264,adopted,O,10365
151265,for,O,10365
151266,patients,O,10365
151267,without,O,10365
151268,significant,O,10365
151269,cataract,B-NAME_OF_DISEASE,10365
151270,A,O,10366
151271,review,O,10366
151272,of,O,10366
151273,available,O,10366
151274,and,O,10366
151275,emerging,O,10366
151276,treatments,O,10366
151277,for,O,10366
151278,presbyopia,B-NAME_OF_DISEASE,10366
151279,was,O,10366
151280,recently,O,10366
151281,published,O,10366
151282,Companies,O,10367
151283,have,O,10367
151284,begun,O,10367
151285,testing,O,10367
151286,topical,B-TREATMENT,10367
151287,therapies,I-TREATMENT,10367
151288,for,O,10367
151289,the,O,10367
151290,temporary,O,10367
151291,correction,O,10367
151292,of,O,10367
151293,presbyopia,B-NAME_OF_DISEASE,10367
151294,Several,O,10368
151295,of,O,10368
151296,these,O,10368
151297,drugs,O,10368
151298,may,O,10368
151299,be,O,10368
151300,approved,O,10368
151301,over,B-TIME_DURATION,10368
151302,the,I-TIME_DURATION,10368
151303,next,I-TIME_DURATION,10368
151304,1,I-TIME_DURATION,10368
151305,to,I-TIME_DURATION,10368
151306,3,I-TIME_DURATION,10368
151307,years,I-TIME_DURATION,10368
151308,opening,O,10368
151309,a,O,10368
151310,new,O,10368
151311,treatment,O,10368
151312,avenue,O,10368
151313,for,O,10368
151314,patients,O,10368
151315,who,O,10368
151316,wish,O,10368
151317,to,O,10368
151318,be,O,10368
151319,less,O,10368
151320,dependent,O,10368
151321,on,O,10368
151322,reading,B-TREATMENT,10368
151323,glasses,I-TREATMENT,10368
151324,Most,O,10369
151325,of,O,10369
151326,the,O,10369
151327,drops,O,10369
151328,being,O,10369
151329,evaluated,O,10369
151330,aim,O,10369
151331,to,O,10369
151332,modulate,O,10369
151333,the,B-PART_OF_THE_EYES,10369
151334,pupil,I-PART_OF_THE_EYES,10369
151335,for,O,10369
151336,better,O,10369
151337,near,O,10369
151338,vision,O,10369
151339,There,O,10370
151340,are,O,10370
151341,various,O,10370
151342,topical,B-NAME_OF_DRUG,10370
151343,agents,I-NAME_OF_DRUG,10370
151344,and,O,10370
151345,clinical,O,10370
151346,results,O,10370
151347,available,O,10370
151348,to,O,10370
151349,date,O,10370
151350,discussed,O,10370
151351,as,O,10370
151352,follows,O,10370
151353,PILOCARPINE,B-NAME_OF_DRUG,10371
151354,Pilocarpine,B-NAME_OF_DRUG,10372
151355,is,O,10372
151356,a,O,10372
151357,cholinergic,O,10372
151358,muscarinic,O,10372
151359,receptor,O,10372
151360,agonist,O,10372
151361,well,O,10372
151362,established,O,10372
151363,in,O,10372
151364,managing,O,10372
151365,pupillary,B-NAME_OF_DISEASE,10372
151366,miosis,I-NAME_OF_DISEASE,10372
151367,and,O,10372
151368,is,O,10372
151369,the,O,10372
151370,most,O,10372
151371,employed,O,10372
151372,agent,O,10372
151373,in,O,10372
151374,emerging,O,10372
151375,presbyopia,B-NAME_OF_DISEASE,10372
151376,therapeutics,O,10372
151377,What,O,10373
151378,distinguishes,O,10373
151379,the,O,10373
151380,emerging,O,10373
151381,presbyopia,B-NAME_OF_DISEASE,10373
151382,formulations,O,10373
151383,from,O,10373
151384,currently,O,10373
151385,available,O,10373
151386,generic,O,10373
151387,pilocarpine,B-NAME_OF_DRUG,10373
151388,is,O,10373
151389,the,O,10373
151390,lower,O,10373
151391,concentration,O,10373
151392,in,O,10373
151393,most,O,10373
151394,cases,O,10373
151395,≤,O,10373
151396,1%,O,10373
151397,vs,O,10373
151398,up,O,10373
151399,to,O,10373
151400,6%,O,10373
151401,in,O,10373
151402,generic,O,10373
151403,pilocarpine,B-NAME_OF_DRUG,10373
151404,and,O,10373
151405,that,O,10373
151406,the,O,10373
151407,investigational,O,10373
151408,agents,O,10373
151409,rely,O,10373
151410,on,O,10373
151411,sophisticated,O,10373
151412,delivery,O,10373
151413,vehicles,O,10373
151414,that,O,10373
151415,are,O,10373
151416,better,O,10373
151417,at,O,10373
151418,modulating,O,10373
151419,how,O,10373
151420,much,O,10373
151421,of,O,10373
151422,the,O,10373
151423,active,O,10373
151424,ingredient,O,10373
151425,reaches,O,10373
151426,the,B-PART_OF_THE_EYES,10373
151427,ocular,I-PART_OF_THE_EYES,10373
151428,tissues,I-PART_OF_THE_EYES,10373
151429,Several,O,10374
151430,companies,O,10374
151431,have,O,10374
151432,pilocarpine-based,B-NAME_OF_DRUG,10374
151433,drops,I-NAME_OF_DRUG,10374
151434,in,O,10374
151435,clinical,O,10374
151436,trials,O,10374
151437,No,O,10375
151438,published,O,10375
151439,studies,O,10375
151440,are,O,10375
151441,available,O,10375
151442,but,O,10375
151443,public,O,10375
151444,reports,O,10375
151445,note,O,10375
151446,that,O,10375
151447,primary,O,10375
151448,endpoints,O,10375
151449,in,O,10375
151450,both,O,10375
151451,studies,O,10375
151452,were,O,10375
151453,met,O,10375
151454,with,O,10375
151455,more,O,10375
151456,patients,O,10375
151457,in,O,10375
151458,the,O,10375
151459,treatment,O,10375
151460,group,O,10375
151461,vs,O,10375
151462,the,O,10375
151463,vehicle-controlled,O,10375
151464,group,O,10375
151465,gaining,O,10375
151466,three,O,10375
151467,or,O,10375
151468,more,O,10375
151469,lines,O,10375
151470,of,O,10375
151471,mesopic,O,10375
151472,high,O,10375
151473,contrast,O,10375
151474,binocular,O,10375
151475,distance-corrected,O,10375
151476,near,O,10375
151477,visual,O,10375
151478,acuity,O,10375
151479,DCNVA,O,10375
151480,at,O,10375
151481,3,B-TIME_DURATION,10375
151482,hours,I-TIME_DURATION,10375
151483,over,B-TIME_DURATION,10375
151484,30,I-TIME_DURATION,10375
151485,days,I-TIME_DURATION,10375
151486,of,O,10375
151487,bilateral,O,10375
151488,single-dose,O,10375
151489,use,O,10375
151490,Headache,B-SIGN_AND_SYMPTOM,10376
151491,conjunctival,I-SIGN_AND_SYMPTOM,10376
151492,hyperaemia,I-SIGN_AND_SYMPTOM,10376
151493,blurred,I-SIGN_AND_SYMPTOM,10376
151494,vision,I-SIGN_AND_SYMPTOM,10376
151495,and,I-SIGN_AND_SYMPTOM,10376
151496,eye,I-SIGN_AND_SYMPTOM,10376
151497,pain,I-SIGN_AND_SYMPTOM,10376
151498,were,O,10376
151499,each,O,10376
151500,reported,O,10376
151501,by,O,10376
151502,3%,O,10376
151503,or,O,10376
151504,fewer,O,10376
151505,of,O,10376
151506,the,O,10376
151507,patients,O,10376
151508,treated,O,10376
151509,with,O,10376
151510,AGN-190584,B-NAME_OF_STUDY,10376
151511,A,O,10377
151512,New,O,10377
151513,Drug,O,10377
151514,Application,O,10377
151515,has,O,10377
151516,been,O,10377
151517,submitted,O,10377
151518,to,O,10377
151519,the,B-GPE,10377
151520,US,I-GPE,10377
151521,Food,B-ORGANIZATION,10377
151522,and,I-ORGANIZATION,10377
151523,Drug,I-ORGANIZATION,10377
151524,Administration,I-ORGANIZATION,10377
151525,FDA,I-ORGANIZATION,10377
151526,and,O,10377
151527,approval,O,10377
151528,is,O,10377
151529,anticipated,O,10377
151530,in,O,10377
151531,late,O,10377
151532,2021,O,10377
151533,Orasis,B-NAME_OF_STUDY,10378
151534,CSF-1,I-NAME_OF_STUDY,10378
151535,A,O,10378
151536,Phase,O,10378
151537,2,O,10378
151538,study5,O,10378
151539,with,O,10378
151540,166,O,10378
151541,participants,O,10378
151542,was,O,10378
151543,completed,O,10378
151544,in,O,10378
151545,2019,O,10378
151546,with,O,10378
151547,reportedly,O,10378
151548,good,O,10378
151549,tolerability,O,10378
151550,of,O,10378
151551,the,O,10378
151552,drop,O,10378
151553,and,O,10378
151554,statistically,O,10378
151555,significant,O,10378
151556,gains,O,10378
151557,of,O,10378
151558,three,O,10378
151559,or,O,10378
151560,more,O,10378
151561,lines,O,10378
151562,of,O,10378
151563,DCNVA,O,10378
151564,when,O,10378
151565,dosed,O,10378
151566,twice,O,10378
151567,daily,O,10378
151568,Eyenovia,B-ORGANIZATION,10379
151569,Microline,I-ORGANIZATION,10379
151570,This,O,10379
151571,company,O,10379
151572,has,O,10379
151573,a,O,10379
151574,novel,O,10379
151575,microdose,O,10379
151576,dispenser,O,10379
151577,Optejet,O,10379
151578,that,O,10379
151579,sprays,O,10379
151580,the,O,10379
151581,drug,O,10379
151582,at,O,10379
151583,the,O,10379
151584,eye,O,10379
151585,A,O,10380
151586,Phase,O,10380
151587,3,O,10380
151588,trial,O,10380
151589,in,O,10380
151590,which,O,10380
151591,84,O,10380
151592,subjects,O,10380
151593,DCNVA,O,10380
151594,were,O,10380
151595,tested,O,10380
151596,2,B-TIME_DURATION,10380
151597,hours,I-TIME_DURATION,10380
151598,after,O,10380
151599,treatment,O,10380
151600,with,O,10380
151601,1%,B-CHEMICAL_COMPOUND,10380
151602,or,I-CHEMICAL_COMPOUND,10380
151603,2%,I-CHEMICAL_COMPOUND,10380
151604,pilocarpine1,I-CHEMICAL_COMPOUND,10380
151605,showed,O,10380
151606,that,O,10380
151607,a,O,10380
151608,statistically,O,10380
151609,significant,O,10380
151610,proportion,O,10380
151611,of,O,10380
151612,patients,O,10380
151613,treated,O,10380
151614,had,O,10380
151615,a,O,10380
151616,three-line,O,10380
151617,or,O,10380
151618,more,O,10380
151619,increase,O,10380
151620,in,O,10380
151621,DCNVA,O,10380
151622,vs,O,10380
151623,placebo,O,10380
151624,in,O,10380
151625,low,O,10380
151626,light,O,10380
151627,2,B-TIME_DURATION,10380
151628,hours,I-TIME_DURATION,10380
151629,after,O,10380
151630,treatment,O,10380
151631,PILOCARPINE,B-NAME_OF_DRUG,10381
151632,+,O,10381
151633,PHENTOLAMINE,B-NAME_OF_DRUG,10381
151634,Ocuphire,B-ORGANIZATION,10382
151635,Pharma,I-ORGANIZATION,10382
151636,is,O,10382
151637,evaluating,O,10382
151638,a,O,10382
151639,kit,O,10382
151640,that,O,10382
151641,combines,O,10382
151642,a,O,10382
151643,moderate,O,10382
151644,and,O,10382
151645,long-acting,O,10382
151646,evening,O,10382
151647,dose,O,10382
151648,of,O,10382
151649,the,B-NAME_OF_DRUG,10382
151650,non-selective,I-NAME_OF_DRUG,10382
151651,a-1a-2,I-NAME_OF_DRUG,10382
151652,adrenergic,I-NAME_OF_DRUG,10382
151653,antagonist,I-NAME_OF_DRUG,10382
151654,phentolamine,I-NAME_OF_DRUG,10382
151655,0.75%,I-NAME_OF_DRUG,10382
151656,with,O,10382
151657,a,O,10382
151658,morning,O,10382
151659,dose,O,10382
151660,of,O,10382
151661,pilocarpine,B-NAME_OF_DRUG,10382
151662,0.40%,I-NAME_OF_DRUG,10382
151663,Synergistically,O,10383
151664,activating,O,10383
151665,the,B-PART_OF_THE_EYES,10383
151666,iris,I-PART_OF_THE_EYES,10383
151667,sphincter,I-PART_OF_THE_EYES,10383
151668,muscle,I-PART_OF_THE_EYES,10383
151669,while,O,10383
151670,inhibiting,O,10383
151671,the,B-PART_OF_THE_EYES,10383
151672,iris,I-PART_OF_THE_EYES,10383
151673,dilator,I-PART_OF_THE_EYES,10383
151674,muscle,I-PART_OF_THE_EYES,10383
151675,allows,O,10383
151676,for,O,10383
151677,lower,O,10383
151678,concentrations,O,10383
151679,of,O,10383
151680,the,O,10383
151681,active,O,10383
151682,ingredients,O,10383
151683,and,O,10383
151684,may,O,10383
151685,reduce,O,10383
151686,the,O,10383
151687,likelihood,O,10383
151688,of,O,10383
151689,adverse,O,10383
151690,reactions,O,10383
151691,A,O,10384
151692,Phase,O,10384
151693,2,O,10384
151694,study,O,10384
151695,in,O,10384
151696,152,O,10384
151697,patients,O,10384
151698,whose,O,10384
151699,NVA,O,10384
151700,was,O,10384
151701,tested,O,10384
151702,for,B-TIME_DURATION,10384
151703,up,I-TIME_DURATION,10384
151704,to,I-TIME_DURATION,10384
151705,6,I-TIME_DURATION,10384
151706,hours,I-TIME_DURATION,10384
151707,post-dose,O,10384
151708,met,O,10384
151709,its,O,10384
151710,primary,O,10384
151711,endpoint,O,10384
151712,with,O,10384
151713,statistical,O,10384
151714,significance,O,10384
151715,at,O,10384
151716,1,B-TIME_DURATION,10384
151717,hour,I-TIME_DURATION,10384
151718,More,O,10385
151719,than,O,10385
151720,half,O,10385
151721,61%,O,10385
151722,of,O,10385
151723,patients,O,10385
151724,treated,O,10385
151725,with,O,10385
151726,Nyxol,B-NAME_OF_DRUG,10385
151727,plus,O,10385
151728,lowdose,B-NAME_OF_DRUG,10385
151729,pilocarpine,I-NAME_OF_DRUG,10385
151730,gained,O,10385
151731,15,O,10385
151732,letters,O,10385
151733,three,O,10385
151734,lines,O,10385
151735,in,O,10385
151736,near,O,10385
151737,VA,O,10385
151738,ACECLIDINE,B-NAME_OF_DRUG,10386
151739,Similar,O,10387
151740,to,O,10387
151741,pilocarpine,B-NAME_OF_DRUG,10387
151742,aceclidine,B-NAME_OF_DRUG,10387
151743,is,O,10387
151744,also,O,10387
151745,a,O,10387
151746,parasympathomimetic,O,10387
151747,cholinergic,O,10387
151748,muscarinic,O,10387
151749,receptor,O,10387
151750,agonist,O,10387
151751,A,O,10388
151752,Phase,O,10388
151753,2,O,10388
151754,study,O,10388
151755,of,O,10388
151756,an,O,10388
151757,aceclidine-based,O,10388
151758,miotic,O,10388
151759,treatment,O,10388
151760,for,O,10388
151761,presbyopia,B-NAME_OF_DISEASE,10388
151762,in,O,10388
151763,58,O,10388
151764,participants,O,10388
151765,was,O,10388
151766,completed,O,10388
151767,by,O,10388
151768,Presbyopia,B-ORGANIZATION,10388
151769,Therapies,I-ORGANIZATION,10388
151770,in,O,10388
151771,2018,O,10388
151772,At,O,10389
151773,the,O,10389
151774,time,O,10389
151775,the,O,10389
151776,company,O,10389
151777,reported,O,10389
151778,that,O,10389
151779,47%,O,10389
151780,of,O,10389
151781,study,O,10389
151782,eyes,O,10389
151783,gained,O,10389
151784,three,O,10389
151785,or,O,10389
151786,more,O,10389
151787,lines,O,10389
151788,of,O,10389
151789,near,O,10389
151790,vision,O,10389
151791,and,O,10389
151792,92%,O,10389
151793,gained,O,10389
151794,at,O,10389
151795,least,O,10389
151796,two,O,10389
151797,or,O,10389
151798,more,O,10389
151799,lines,O,10389
151800,1,B-TIME_DURATION,10389
151801,hour,I-TIME_DURATION,10389
151802,after,O,10389
151803,instillation,O,10389
151804,a,O,10389
151805,statistically,O,10389
151806,significant,O,10389
151807,benefit,O,10389
151808,over,O,10389
151809,placebo,O,10389
151810,Approximately,O,10390
151811,half,O,10390
151812,the,O,10390
151813,eyes,O,10390
151814,maintained,O,10390
151815,a,O,10390
151816,two-or-greater,O,10390
151817,line,O,10390
151818,improvement,O,10390
151819,for,B-TIME_DURATION,10390
151820,up,I-TIME_DURATION,10390
151821,to,I-TIME_DURATION,10390
151822,7,I-TIME_DURATION,10390
151823,hours,I-TIME_DURATION,10390
151824,Little,O,10391
151825,information,O,10391
151826,has,O,10391
151827,been,O,10391
151828,released,O,10391
151829,about,O,10391
151830,the,O,10391
151831,drop,O,10391
151832,since,O,10391
151833,and,O,10391
151834,no,O,10391
151835,additional,O,10391
151836,studies,O,10391
151837,have,O,10391
151838,been,O,10391
151839,registered,O,10391
151840,although,O,10391
151841,the,O,10391
151842,company,O,10391
151843,has,O,10391
151844,reorganised,O,10391
151845,and,O,10391
151846,is,O,10391
151847,moving,O,10391
151848,forward,O,10391
151849,under,O,10391
151850,its,O,10391
151851,new,O,10391
151852,name,O,10391
151853,Lenz,B-NAME_OF_STUDY,10391
151854,FIXED-COMBINATION,O,10392
151855,CARBACHOL,B-NAME_OF_DRUG,10392
151856,BRIMONIDINE,B-NAME_OF_DRUG,10392
151857,TARTRATE,I-NAME_OF_DRUG,10392
151858,Brimochol,B-NAME_OF_DRUG,10393
151859,is,O,10393
151860,a,O,10393
151861,fixed,O,10393
151862,combination,O,10393
151863,of,O,10393
151864,carbachol,B-NAME_OF_DRUG,10393
151865,and,O,10393
151866,brimonidine,B-NAME_OF_DRUG,10393
151867,invented,O,10393
151868,by,O,10393
151869,Dr,B-PERSON,10393
151870,Herbert,I-PERSON,10393
151871,Kaufman,I-PERSON,10393
151872,and,O,10393
151873,now,O,10393
151874,under,O,10393
151875,development,O,10393
151876,by,O,10393
151877,Visus,B-ORGANIZATION,10393
151878,Therapeutics,I-ORGANIZATION,10393
151879,for,O,10393
151880,the,O,10393
151881,treatment,O,10393
151882,of,O,10393
151883,presbyopia,B-NAME_OF_DISEASE,10393
151884,Carbachol,B-NAME_OF_DRUG,10394
151885,has,O,10394
151886,previously,O,10394
151887,been,O,10394
151888,shown,O,10394
151889,to,O,10394
151890,be,O,10394
151891,a,O,10394
151892,more,O,10394
151893,potent,O,10394
151894,cholinergic,O,10394
151895,miotic,O,10394
151896,than,O,10394
151897,pilocarpine,B-NAME_OF_DRUG,10394
151898,Combining,O,10395
151899,it,O,10395
151900,with,O,10395
151901,brimonidine,B-NAME_OF_DRUG,10395
151902,which,O,10395
151903,prevents,O,10395
151904,pupil,B-NAME_OF_DISEASE,10395
151905,dilation,I-NAME_OF_DISEASE,10395
151906,and,O,10395
151907,may,O,10395
151908,inhibit,O,10395
151909,ciliary,B-PART_OF_THE_EYES,10395
151910,muscle,I-PART_OF_THE_EYES,10395
151911,contraction,O,10395
151912,achieves,O,10395
151913,synergistic,O,10395
151914,effects,O,10395
151915,and,O,10395
151916,may,O,10395
151917,reduce,O,10395
151918,the,O,10395
151919,severity,O,10395
151920,of,O,10395
151921,adverse,O,10395
151922,effects,O,10395
151923,Brimonidine,B-NAME_OF_DRUG,10396
151924,also,O,10396
151925,whitens,O,10396
151926,eyes,O,10396
151927,which,O,10396
151928,may,O,10396
151929,prevent,O,10396
151930,the,B-SIGN_AND_SYMPTOM,10396
151931,redness,I-SIGN_AND_SYMPTOM,10396
151932,typically,O,10396
151933,associated,O,10396
151934,with,O,10396
151935,miotics,O,10396
151936,One,O,10397
151937,of,O,10397
151938,these,O,10397
151939,demonstrated,O,10397
151940,superiority,O,10397
151941,of,O,10397
151942,the,O,10397
151943,fixed,O,10397
151944,combination,O,10397
151945,over,O,10397
151946,the,O,10397
151947,individual,O,10397
151948,components,O,10397
151949,something,O,10397
151950,that,O,10397
151951,is,O,10397
151952,essential,O,10397
151953,for,O,10397
151954,FDA,B-ORGANIZATION,10397
151955,approval,O,10397
151956,of,O,10397
151957,any,O,10397
151958,fixed-combination,O,10397
151959,drop,O,10397
151960,Results,O,10398
151961,of,O,10398
151962,the,O,10398
151963,most,O,10398
151964,recent,O,10398
151965,study,O,10398
151966,in,O,10398
151967,2019,O,10398
151968,showed,O,10398
151969,a,B-TIME_DURATION,10398
151970,12-hour,I-TIME_DURATION,10398
151971,duration,I-TIME_DURATION,10398
151972,of,O,10398
151973,effect,O,10398
151974,on,O,10398
151975,near,O,10398
151976,vision,O,10398
151977,in,O,10398
151978,57,O,10398
151979,participants,O,10398
151980,without,O,10398
151981,any,O,10398
151982,reported,O,10398
151983,symptoms,O,10398
151984,of,O,10398
151985,headache,B-SIGN_AND_SYMPTOM,10398
151986,or,I-SIGN_AND_SYMPTOM,10398
151987,brow,I-SIGN_AND_SYMPTOM,10398
151988,ache,I-SIGN_AND_SYMPTOM,10398
151989,A,O,10399
151990,Phase,O,10399
151991,2,O,10399
151992,crossover,O,10399
151993,study,O,10399
151994,in,O,10399
151995,45,O,10399
151996,phakic,O,10399
151997,and,O,10399
151998,pseudophakic,O,10399
151999,patients,O,10399
152000,dosed,O,10399
152001,once,O,10399
152002,daily,O,10399
152003,with,O,10399
152004,one,O,10399
152005,of,O,10399
152006,two,O,10399
152007,different,O,10399
152008,Brimochol,B-NAME_OF_DRUG,10399
152009,formulations,O,10399
152010,or,O,10399
152011,carbachol,B-NAME_OF_DRUG,10399
152012,monotherapy,O,10399
152013,has,O,10399
152014,recently,O,10399
152015,begun,O,10399
152016,LIPOIC,B-CHEMICAL_COMPOUND,10400
152017,ACID,I-CHEMICAL_COMPOUND,10400
152018,CHOLINE,I-CHEMICAL_COMPOUND,10400
152019,ESTER,I-CHEMICAL_COMPOUND,10400
152020,CHLORIDE,I-CHEMICAL_COMPOUND,10400
152021,Unlike,O,10401
152022,the,O,10401
152023,other,O,10401
152024,drops,O,10401
152025,that,O,10401
152026,act,O,10401
152027,by,O,10401
152028,modulating,O,10401
152029,the,B-PART_OF_THE_EYES,10401
152030,pupil,I-PART_OF_THE_EYES,10401
152031,Novartis,B-ORGANIZATION,10401
152032,is,O,10401
152033,developing,O,10401
152034,UNR844,B-NAME_OF_DRUG,10401
152035,a,B-CHEMICAL_COMPOUND,10401
152036,lipoic,I-CHEMICAL_COMPOUND,10401
152037,acid,I-CHEMICAL_COMPOUND,10401
152038,choline,I-CHEMICAL_COMPOUND,10401
152039,ester,I-CHEMICAL_COMPOUND,10401
152040,chloride,I-CHEMICAL_COMPOUND,10401
152041,that,O,10401
152042,acts,O,10401
152043,on,O,10401
152044,disulphide,O,10401
152045,bonds,O,10401
152046,between,O,10401
152047,crystalline,B-CHEMICAL_COMPOUND,10401
152048,lens,I-CHEMICAL_COMPOUND,10401
152049,proteins,I-CHEMICAL_COMPOUND,10401
152050,The,O,10402
152051,idea,O,10402
152052,is,O,10402
152053,that,O,10402
152054,by,O,10402
152055,hydrolysing,O,10402
152056,the,O,10402
152057,disulphide,O,10402
152058,bonds,O,10402
152059,this,O,10402
152060,drug,O,10402
152061,would,O,10402
152062,soften,O,10402
152063,the,B-PART_OF_THE_EYES,10402
152064,lens,I-PART_OF_THE_EYES,10402
152065,and,O,10402
152066,restore,O,10402
152067,some,O,10402
152068,accommodative,O,10402
152069,ability,O,10402
152070,A,O,10403
152071,Phase,O,10403
152072,2,O,10403
152073,controlled,O,10403
152074,trial,O,10403
152075,evaluating,O,10403
152076,safety,O,10403
152077,and,O,10403
152078,efficacy,O,10403
152079,after,O,10403
152080,3,B-TIME_DURATION,10403
152081,months,I-TIME_DURATION,10403
152082,of,O,10403
152083,twice-daily,O,10403
152084,dosing,O,10403
152085,treatment,O,10403
152086,in,O,10403
152087,early,O,10403
152088,presbyopes,O,10403
152089,aged,O,10403
152090,45-55,O,10403
152091,has,O,10403
152092,also,O,10403
152093,been,O,10403
152094,completed,O,10403
152095,with,O,10403
152096,an,O,10403
152097,improvement,O,10403
152098,of,O,10403
152099,6.1,O,10403
152100,letters,O,10403
152101,in,O,10403
152102,the,O,10403
152103,treatment,O,10403
152104,group,O,10403
152105,vs,O,10403
152106,4.5,O,10403
152107,letters,O,10403
152108,in,O,10403
152109,the,O,10403
152110,placebo,O,10403
152111,group,O,10403
152112,The,O,10404
152113,most,O,10404
152114,common,O,10404
152115,adverse,O,10404
152116,events,O,10404
152117,reported,O,10404
152118,were,O,10404
152119,dysgeusia,B-SIGN_AND_SYMPTOM,10404
152120,and,I-SIGN_AND_SYMPTOM,10404
152121,headache,I-SIGN_AND_SYMPTOM,10404
152122,in,O,10404
152123,5%,O,10404
152124,and,O,10404
152125,3%,O,10404
152126,of,O,10404
152127,treated,O,10404
152128,participants,O,10404
152129,respectively,O,10404
152130,As,O,10405
152131,presbyopia-correcting,B-TREATMENT,10405
152132,drugs,I-TREATMENT,10405
152133,come,O,10405
152134,to,O,10405
152135,market,O,10405
152136,one,O,10405
152137,of,O,10405
152138,the,O,10405
152139,most,O,10405
152140,important,O,10405
152141,factors,O,10405
152142,for,O,10405
152143,both,O,10405
152144,physician,O,10405
152145,and,O,10405
152146,patient,O,10405
152147,acceptance,O,10405
152148,will,O,10405
152149,be,O,10405
152150,efficacy,O,10405
152151,how,O,10405
152152,well,O,10405
152153,the,O,10405
152154,patient,O,10405
152155,can,O,10405
152156,read,O,10405
152157,and,O,10405
152158,use,O,10405
152159,a,O,10405
152160,computer,O,10405
152161,Everybody,O,10406
152162,likes,O,10406
152163,to,O,10406
152164,see,O,10406
152165,J1,B-NAME_OF_STUDY,10406
152166,clinical,I-NAME_OF_STUDY,10406
152167,trial,I-NAME_OF_STUDY,10406
152168,results,O,10406
152169,but,O,10406
152170,most,O,10406
152171,individuals,O,10406
152172,do,O,10406
152173,not,O,10406
152174,actually,O,10406
152175,need,O,10406
152176,to,O,10406
152177,be,O,10406
152178,able,O,10406
152179,to,O,10406
152180,read,O,10406
152181,J1,B-NAME_OF_STUDY,10406
152182,A,O,10407
152183,drop,O,10407
152184,that,O,10407
152185,can,O,10407
152186,provide,O,10407
152187,J6,O,10407
152188,or,O,10407
152189,better,O,10407
152190,for,B-TIME_DURATION,10407
152191,12-Aug,I-TIME_DURATION,10407
152192,hours,I-TIME_DURATION,10407
152193,which,O,10407
152194,would,O,10407
152195,cover,O,10407
152196,most,O,10407
152197,of,O,10407
152198,a,O,10407
152199,persons,O,10407
152200,working,O,10407
152201,hours,O,10407
152202,would,O,10407
152203,be,O,10407
152204,a,O,10407
152205,big,O,10407
152206,advancement,O,10407
152207,for,O,10407
152208,patients,O,10407
152209,Although,O,10408
152210,most,O,10408
152211,of,O,10408
152212,the,B-NAME_OF_DRUG,10408
152213,pupilmodulating,I-NAME_OF_DRUG,10408
152214,drops,I-NAME_OF_DRUG,10408
152215,in,O,10408
152216,development,O,10408
152217,are,O,10408
152218,being,O,10408
152219,tested,O,10408
152220,for,O,10408
152221,use,O,10408
152222,in,O,10408
152223,both,O,10408
152224,eyes,O,10408
152225,patients,O,10408
152226,may,O,10408
152227,experiment,O,10408
152228,with,O,10408
152229,using,O,10408
152230,the,O,10408
152231,drops,O,10408
152232,monocularly,O,10408
152233,and,O,10408
152234,binocularly,O,10408
152235,Some,O,10409
152236,presbyopia-correcting,B-TREATMENT,10409
152237,drops,I-TREATMENT,10409
152238,may,O,10409
152239,be,O,10409
152240,available,O,10409
152241,in,O,10409
152242,preservativefree,O,10409
152243,formulations,O,10409
152244,which,O,10409
152245,will,O,10409
152246,make,O,10409
152247,them,O,10409
152248,more,O,10409
152249,comfortable,O,10409
152250,for,O,10409
152251,patients,O,10409
152252,with,O,10409
152253,pre-existing,O,10409
152254,ocular,B-PART_OF_THE_EYES,10409
152255,surface,I-PART_OF_THE_EYES,10409
152256,disease,O,10409
152257,This,O,10410
152258,was,O,10410
152259,TRUE,O,10410
152260,for,O,10410
152261,glaucoma,B-NAME_OF_DISEASE,10410
152262,patients,O,10410
152263,who,O,10410
152264,had,O,10410
152265,been,O,10410
152266,on,O,10410
152267,4%,B-NAME_OF_DRUG,10410
152268,or,I-NAME_OF_DRUG,10410
152269,6%,I-NAME_OF_DRUG,10410
152270,pilocarpine,B-NAME_OF_DRUG,10410
152271,for,B-TIME_DURATION,10410
152272,years,I-TIME_DURATION,10410
152273,which,O,10410
152274,had,O,10410
152275,a,O,10410
152276,high,O,10410
152277,concentration,O,10410
152278,of,O,10410
152279,the,O,10410
152280,active,O,10410
152281,ingredient,O,10410
152282,and,O,10410
152283,were,O,10410
152284,preserved,O,10410
152285,but,O,10410
152286,it,O,10410
152287,may,O,10410
152288,not,O,10410
152289,be,O,10410
152290,an,O,10410
152291,issue,O,10410
152292,with,O,10410
152293,the,O,10410
152294,much,O,10410
152295,lower,O,10410
152296,concentrations,O,10410
152297,of,O,10410
152298,pilocarpine,B-NAME_OF_DRUG,10410
152299,that,O,10410
152300,are,O,10410
152301,being,O,10410
152302,developed,O,10410
152303,for,O,10410
152304,presbyopia,B-NAME_OF_DISEASE,10410
152305,Although,O,10411
152306,there,O,10411
152307,are,O,10411
152308,quite,O,10411
152309,a,O,10411
152310,few,O,10411
152311,presbyopia-correcting,B-TREATMENT,10411
152312,drops,I-TREATMENT,10411
152313,in,O,10411
152314,development,O,10411
152315,there,O,10411
152316,will,O,10411
152317,probably,O,10411
152318,be,O,10411
152319,room,O,10411
152320,for,O,10411
152321,all-or,O,10411
152322,at,O,10411
152323,least,O,10411
152324,several-of,O,10411
152325,them,O,10411
152326,The,O,10412
152327,terms,O,10412
152328,intermediate,B-NAME_OF_DISEASE,10412
152329,uveitis,B-NAME_OF_DISEASE,10412
152330,posterior,B-NAME_OF_DISEASE,10412
152331,uveitis,B-NAME_OF_DISEASE,10412
152332,and,O,10412
152333,panuveitis,B-NAME_OF_DISEASE,10412
152334,are,O,10412
152335,only,O,10412
152336,a,O,10412
152337,few,O,10412
152338,of,O,10412
152339,the,O,10412
152340,diagnostic,O,10412
152341,terms,O,10412
152342,used,O,10412
152343,to,O,10412
152344,describe,O,10412
152345,uveitis,B-NAME_OF_DISEASE,10412
152346,of,O,10412
152347,the,O,10412
152348,posterior,O,10412
152349,region,O,10412
152350,Although,O,10413
152351,the,O,10413
152352,majority,O,10413
152353,of,O,10413
152354,instances,O,10413
152355,with,O,10413
152356,posterior,B-NAME_OF_DISEASE,10413
152357,segment,I-NAME_OF_DISEASE,10413
152358,uveitis,I-NAME_OF_DISEASE,10413
152359,are,O,10413
152360,noninfectious,O,10413
152361,certain,O,10413
152362,cases,O,10413
152363,can,O,10413
152364,be,O,10413
152365,contagious,O,10413
152366,The,O,10414
152367,foundations,O,10414
152368,for,O,10414
152369,treating,O,10414
152370,noninfectious,O,10414
152371,uveitis,B-NAME_OF_DISEASE,10414
152372,in,O,10414
152373,the,O,10414
152374,posterior,O,10414
152375,region,O,10414
152376,include,O,10414
152377,corticosteroids,B-NAME_OF_DRUG,10414
152378,and,O,10414
152379,immunomodulatory,B-TREATMENT,10414
152380,medications,I-TREATMENT,10414
152381,Uveitis,B-NAME_OF_DISEASE,10415
152382,is,O,10415
152383,the,O,10415
152384,third,O,10415
152385,most,O,10415
152386,common,O,10415
152387,cause,O,10415
152388,of,O,10415
152389,vision,B-SIGN_AND_SYMPTOM,10415
152390,loss,I-SIGN_AND_SYMPTOM,10415
152391,in,O,10415
152392,developed,O,10415
152393,nations,O,10415
152394,and,O,10415
152395,a,O,10415
152396,significant,O,10415
152397,contributor,O,10415
152398,to,O,10415
152399,vision,B-SIGN_AND_SYMPTOM,10415
152400,loss,I-SIGN_AND_SYMPTOM,10415
152401,worldwide,O,10415
152402,Uveitis,B-NAME_OF_DISEASE,10416
152403,is,O,10416
152404,divided,O,10416
152405,into,O,10416
152406,anterior,O,10416
152407,iritis,B-NAME_OF_DISEASE,10416
152408,iridocyclitis,B-NAME_OF_DISEASE,10416
152409,and,O,10416
152410,anterior,B-NAME_OF_DISEASE,10416
152411,cyclitis,I-NAME_OF_DISEASE,10416
152412,intermediate,O,10416
152413,pars,B-NAME_OF_DISEASE,10416
152414,planitis,I-NAME_OF_DISEASE,10416
152415,posterior,B-NAME_OF_DISEASE,10416
152416,cyclitis,I-NAME_OF_DISEASE,10416
152417,and,O,10416
152418,hyalitis,B-NAME_OF_DISEASE,10416
152419,and,O,10416
152420,posterior,O,10416
152421,categories,O,10416
152422,based,O,10416
152423,on,O,10416
152424,the,O,10416
152425,location,O,10416
152426,of,O,10416
152427,the,O,10416
152428,inflammation,O,10416
152429,focal,O,10416
152430,multifocal,O,10416
152431,or,O,10416
152432,diffuse,B-NAME_OF_DISEASE,10416
152433,choroiditis,I-NAME_OF_DISEASE,10416
152434,chorioretinitis,B-NAME_OF_DISEASE,10416
152435,retinitis,B-NAME_OF_DISEASE,10416
152436,and,O,10416
152437,neuroretinitis,B-NAME_OF_DISEASE,10416
152438,The,B-PART_OF_THE_EYES,10417
152439,vitreous,I-PART_OF_THE_EYES,10417
152440,retina,B-PART_OF_THE_EYES,10417
152441,choroid,B-PART_OF_THE_EYES,10417
152442,and,O,10417
152443,anterior,B-PART_OF_THE_EYES,10417
152444,chamber,I-PART_OF_THE_EYES,10417
152445,are,O,10417
152446,all,O,10417
152447,inflamed,O,10417
152448,in,O,10417
152449,panuveitis,O,10417
152450,The,O,10418
152451,most,O,10418
152452,frequent,O,10418
152453,type,O,10418
152454,of,O,10418
152455,uveitis,B-NAME_OF_DISEASE,10418
152456,is,O,10418
152457,anterior,B-NAME_OF_DISEASE,10418
152458,and,I-NAME_OF_DISEASE,10418
152459,posterior,I-NAME_OF_DISEASE,10418
152460,uveitis,I-NAME_OF_DISEASE,10418
152461,accounts,O,10418
152462,for,O,10418
152463,15%,O,10418
152464,to,O,10418
152465,22%,O,10418
152466,of,O,10418
152467,all,O,10418
152468,occurrences,O,10418
152469,The,O,10419
152470,most,O,10419
152471,challenging,O,10419
152472,type,O,10419
152473,of,O,10419
152474,uveitis,B-NAME_OF_DISEASE,10419
152475,to,O,10419
152476,treat,O,10419
152477,is,O,10419
152478,posterior,B-NAME_OF_DISEASE,10419
152479,uveitis,I-NAME_OF_DISEASE,10419
152480,which,O,10419
152481,can,O,10419
152482,cause,O,10419
152483,visual,B-SIGN_AND_SYMPTOM,10419
152484,morbidity,I-SIGN_AND_SYMPTOM,10419
152485,and,O,10419
152486,presents,O,10419
152487,difficulties,O,10419
152488,in,O,10419
152489,administering,O,10419
152490,treatment,O,10419
152491,medications,O,10419
152492,at,O,10419
152493,levels,O,10419
152494,that,O,10419
152495,are,O,10419
152496,effective,O,10419
152497,Chronic,B-NAME_OF_DISEASE,10420
152498,noninfectious,I-NAME_OF_DISEASE,10420
152499,posterior,I-NAME_OF_DISEASE,10420
152500,segment,I-NAME_OF_DISEASE,10420
152501,uveitis,I-NAME_OF_DISEASE,10420
152502,refers,O,10420
152503,to,O,10420
152504,inflammation,B-SIGN_AND_SYMPTOM,10420
152505,of,I-SIGN_AND_SYMPTOM,10420
152506,the,I-SIGN_AND_SYMPTOM,10420
152507,retina,I-SIGN_AND_SYMPTOM,10420
152508,choroid,I-SIGN_AND_SYMPTOM,10420
152509,vitreous,I-SIGN_AND_SYMPTOM,10420
152510,or,I-SIGN_AND_SYMPTOM,10420
152511,optic,I-SIGN_AND_SYMPTOM,10420
152512,nerve,I-SIGN_AND_SYMPTOM,10420
152513,and,O,10420
152514,may,O,10420
152515,result,O,10420
152516,in,O,10420
152517,permanent,B-NAME_OF_DISEASE,10420
152518,vision,I-NAME_OF_DISEASE,10420
152519,loss,I-NAME_OF_DISEASE,10420
152520,The,O,10421
152521,ophthalmologist,O,10421
152522,must,O,10421
152523,make,O,10421
152524,a,O,10421
152525,number,O,10421
152526,of,O,10421
152527,choices,O,10421
152528,when,O,10421
152529,a,O,10421
152530,patient,O,10421
152531,exhibits,O,10421
152532,ocular,B-SIGN_AND_SYMPTOM,10421
152533,inflammation,I-SIGN_AND_SYMPTOM,10421
152534,the,O,10421
152535,characteristic,O,10421
152536,of,O,10421
152537,uveitis,B-NAME_OF_DISEASE,10421
152538,Practitioners,O,10422
152539,have,O,10422
152540,a,O,10422
152541,choice,O,10422
152542,between,O,10422
152543,local,O,10422
152544,and,O,10422
152545,systemic,O,10422
152546,therapy,O,10422
152547,for,O,10422
152548,patients,O,10422
152549,who,O,10422
152550,have,O,10422
152551,noninfectious,B-NAME_OF_DISEASE,10422
152552,posterior,I-NAME_OF_DISEASE,10422
152553,uveitis,I-NAME_OF_DISEASE,10422
152554,Although,O,10423
152555,effective,O,10423
152556,uveitis,B-NAME_OF_DISEASE,10423
152557,management,O,10423
152558,is,O,10423
152559,challenging,O,10423
152560,todays,O,10423
152561,therapy,O,10423
152562,choices,O,10423
152563,are,O,10423
152564,safer,O,10423
152565,more,O,10423
152566,effective,O,10423
152567,and,O,10423
152568,more,O,10423
152569,streamlined,O,10423
152570,than,O,10423
152571,in,O,10423
152572,the,O,10423
152573,past,O,10423
152574,and,O,10423
152575,hold,O,10423
152576,out,O,10423
152577,the,O,10423
152578,hope,O,10423
152579,of,O,10423
152580,long-lasting,O,10423
152581,symptom,O,10423
152582,remissions,O,10423
152583,If,O,10424
152584,neglected,O,10424
152585,a,O,10424
152586,category,O,10424
152587,of,O,10424
152588,inflammatory,O,10424
152589,illnesses,O,10424
152590,known,O,10424
152591,as,O,10424
152592,uveitis,B-NAME_OF_DISEASE,10424
152593,can,O,10424
152594,cause,O,10424
152595,serious,B-SIGN_AND_SYMPTOM,10424
152596,visual,I-SIGN_AND_SYMPTOM,10424
152597,loss,I-SIGN_AND_SYMPTOM,10424
152598,According,O,10425
152599,to,O,10425
152600,estimates,O,10425
152601,there,O,10425
152602,are,O,10425
152603,between,O,10425
152604,17,O,10425
152605,and,O,10425
152606,52,O,10425
152607,cases,O,10425
152608,of,O,10425
152609,uveitis,B-NAME_OF_DISEASE,10425
152610,per,O,10425
152611,100000,O,10425
152612,people,O,10425
152613,per,O,10425
152614,year,O,10425
152615,with,O,10425
152616,a,O,10425
152617,prevalence,O,10425
152618,of,O,10425
152619,38,O,10425
152620,to,O,10425
152621,714,O,10425
152622,instances,O,10425
152623,per,O,10425
152624,100000,O,10425
152625,people,O,10425
152626,Uveitis,B-NAME_OF_DISEASE,10426
152627,can,O,10426
152628,develop,O,10426
152629,as,O,10426
152630,a,O,10426
152631,result,O,10426
152632,of,O,10426
152633,systemic,B-CAUSE_OF_DISEASE,10426
152634,inflammatory,I-CAUSE_OF_DISEASE,10426
152635,disorders,I-CAUSE_OF_DISEASE,10426
152636,or,O,10426
152637,as,O,10426
152638,a,O,10426
152639,localized,O,10426
152640,eye,O,10426
152641,condition,O,10426
152642,between,O,10426
152643,24%,O,10426
152644,and,O,10426
152645,55%,O,10426
152646,of,O,10426
152647,cases,O,10426
152648,are,O,10426
152649,thought,O,10426
152650,to,O,10426
152651,be,O,10426
152652,idiopathic,O,10426
152653,Uveitis,B-NAME_OF_DISEASE,10427
152654,can,O,10427
152655,cause,O,10427
152656,inflammation,B-SIGN_AND_SYMPTOM,10427
152657,of,I-SIGN_AND_SYMPTOM,10427
152658,the,I-SIGN_AND_SYMPTOM,10427
152659,lens,I-SIGN_AND_SYMPTOM,10427
152660,retina,I-SIGN_AND_SYMPTOM,10427
152661,optic,I-SIGN_AND_SYMPTOM,10427
152662,nerve,I-SIGN_AND_SYMPTOM,10427
152663,and,I-SIGN_AND_SYMPTOM,10427
152664,vitreous,I-SIGN_AND_SYMPTOM,10427
152665,in,I-SIGN_AND_SYMPTOM,10427
152666,addition,I-SIGN_AND_SYMPTOM,10427
152667,to,I-SIGN_AND_SYMPTOM,10427
152668,the,I-SIGN_AND_SYMPTOM,10427
152669,uvea,I-SIGN_AND_SYMPTOM,10427
152670,Uveitis,B-NAME_OF_DISEASE,10428
152671,can,O,10428
152672,also,O,10428
152673,affect,O,10428
152674,the,O,10428
152675,posterior,O,10428
152676,segment,O,10428
152677,anterior,O,10428
152678,segment,O,10428
152679,or,O,10428
152680,both,O,10428
152681,Depending,O,10429
152682,on,O,10429
152683,the,O,10429
152684,type,O,10429
152685,and,O,10429
152686,location,O,10429
152687,of,O,10429
152688,inflammation,O,10429
152689,different,O,10429
152690,symptoms,O,10429
152691,such,O,10429
152692,as,O,10429
152693,blurred,B-SIGN_AND_SYMPTOM,10429
152694,vision,I-SIGN_AND_SYMPTOM,10429
152695,floaters,I-SIGN_AND_SYMPTOM,10429
152696,eye,I-SIGN_AND_SYMPTOM,10429
152697,pain,I-SIGN_AND_SYMPTOM,10429
152698,redness,I-SIGN_AND_SYMPTOM,10429
152699,and,I-SIGN_AND_SYMPTOM,10429
152700,light,I-SIGN_AND_SYMPTOM,10429
152701,sensitivity,I-SIGN_AND_SYMPTOM,10429
152702,may,O,10429
152703,be,O,10429
152704,present,O,10429
152705,Uveitis,B-NAME_OF_DISEASE,10430
152706,must,O,10430
152707,be,O,10430
152708,treated,O,10430
152709,promptly,O,10430
152710,and,O,10430
152711,effectively,O,10430
152712,since,O,10430
152713,if,O,10430
152714,left,O,10430
152715,untreated,O,10430
152716,its,O,10430
152717,repeated,O,10430
152718,inflammation,O,10430
152719,can,O,10430
152720,affect,O,10430
152721,patients,O,10430
152722,functioning,O,10430
152723,and,O,10430
152724,quality,O,10430
152725,of,O,10430
152726,life,O,10430
152727,and,O,10430
152728,even,O,10430
152729,cause,O,10430
152730,vision,B-SIGN_AND_SYMPTOM,10430
152731,loss,I-SIGN_AND_SYMPTOM,10430
152732,Uveitis,B-NAME_OF_DISEASE,10431
152733,frequently,O,10431
152734,offers,O,10431
152735,a,O,10431
152736,diagnostic,O,10431
152737,and,O,10431
152738,therapeutic,O,10431
152739,difficulty,O,10431
152740,because,O,10431
152741,it,O,10431
152742,can,O,10431
152743,have,O,10431
152744,a,O,10431
152745,variety,O,10431
152746,of,O,10431
152747,origins,O,10431
152748,and,O,10431
152749,affect,O,10431
152750,different,O,10431
152751,types,O,10431
152752,and,O,10431
152753,amounts,O,10431
152754,of,O,10431
152755,tissue,O,10431
152756,Similar,O,10432
152757,ocular,O,10432
152758,and,O,10432
152759,neurological,O,10432
152760,symptoms,O,10432
152761,are,O,10432
152762,frequently,O,10432
152763,found,O,10432
152764,in,O,10432
152765,inflammatory,B-NAME_OF_DISEASE,10432
152766,infectious,I-NAME_OF_DISEASE,10432
152767,and,I-NAME_OF_DISEASE,10432
152768,malignant,I-NAME_OF_DISEASE,10432
152769,eye,I-NAME_OF_DISEASE,10432
152770,disorders,I-NAME_OF_DISEASE,10432
152771,Retinal,O,10433
152772,experts,O,10433
152773,who,O,10433
152774,are,O,10433
152775,knowledgeable,O,10433
152776,with,O,10433
152777,therapies,O,10433
152778,and,O,10433
152779,procedures,O,10433
152780,for,O,10433
152781,the,O,10433
152782,posterior,O,10433
152783,segment,O,10433
152784,are,O,10433
152785,typically,O,10433
152786,the,O,10433
152787,ones,O,10433
152788,who,O,10433
152789,treat,O,10433
152790,posterior,B-NAME_OF_DISEASE,10433
152791,uveitis,I-NAME_OF_DISEASE,10433
152792,Practitioners,O,10434
152793,caring,O,10434
152794,for,O,10434
152795,patients,O,10434
152796,with,O,10434
152797,uveitis,B-NAME_OF_DISEASE,10434
152798,confront,O,10434
152799,a,O,10434
152800,number,O,10434
152801,of,O,10434
152802,obstacles,O,10434
152803,including,O,10434
152804,making,O,10434
152805,an,O,10434
152806,accurate,O,10434
152807,diagnosis,O,10434
152808,treating,O,10434
152809,the,O,10434
152810,acute,O,10434
152811,phase,O,10434
152812,of,O,10434
152813,the,O,10434
152814,disease,O,10434
152815,and,O,10434
152816,preventing,O,10434
152817,symptom,O,10434
152818,recurrence,O,10434
152819,This,O,10435
152820,is,O,10435
152821,due,O,10435
152822,to,O,10435
152823,the,O,10435
152824,complexity,O,10435
152825,of,O,10435
152826,uveitis,B-NAME_OF_DISEASE,10435
152827,diagnosis,O,10435
152828,and,O,10435
152829,therapy,O,10435
152830,Therefore,O,10436
152831,it,O,10436
152832,is,O,10436
152833,crucial,O,10436
152834,to,O,10436
152835,instruct,O,10436
152836,healthcare,O,10436
152837,professionals,O,10436
152838,on,O,10436
152839,the,O,10436
152840,diagnosis,O,10436
152841,and,O,10436
152842,management,O,10436
152843,of,O,10436
152844,uveitis,B-NAME_OF_DISEASE,10436
152845,We,O,10437
152846,will,O,10437
152847,describe,O,10437
152848,significant,O,10437
152849,technological,O,10437
152850,developments,O,10437
152851,in,O,10437
152852,posterior,O,10437
152853,segment,O,10437
152854,drug,O,10437
152855,administration,O,10437
152856,and,O,10437
152857,offer,O,10437
152858,advice,O,10437
152859,for,O,10437
152860,navigating,O,10437
152861,the,O,10437
152862,noninfectious,B-NAME_OF_DISEASE,10437
152863,posterior,I-NAME_OF_DISEASE,10437
152864,uveitis,I-NAME_OF_DISEASE,10437
152865,pathway,O,10437
152866,Diagnosis,O,10438
152867,is,O,10438
152868,the,O,10438
152869,first,O,10438
152870,step,O,10438
152871,in,O,10438
152872,treating,O,10438
152873,patients,O,10438
152874,with,O,10438
152875,uveitis,B-NAME_OF_DISEASE,10438
152876,Practitioners,O,10439
152877,undertake,O,10439
152878,a,O,10439
152879,series,O,10439
152880,of,O,10439
152881,steps,O,10439
152882,and,O,10439
152883,tests,O,10439
152884,to,O,10439
152885,determine,O,10439
152886,if,O,10439
152887,a,O,10439
152888,patient,O,10439
152889,has,O,10439
152890,uveitis,B-NAME_OF_DISEASE,10439
152891,and,O,10439
152892,if,O,10439
152893,so,O,10439
152894,which,O,10439
152895,type,O,10439
152896,Classifying,O,10440
152897,Uveitis,B-NAME_OF_DISEASE,10440
152898,Uveitis,B-NAME_OF_DISEASE,10441
152899,is,O,10441
152900,characterized,O,10441
152901,in,O,10441
152902,two,O,10441
152903,ways,O,10441
152904,anatomic,O,10441
152905,and,O,10441
152906,etiologic,O,10441
152907,Ophthalmologists,O,10442
152908,perform,O,10442
152909,clinical,O,10442
152910,tests,O,10442
152911,to,O,10442
152912,categorize,O,10442
152913,suspected,O,10442
152914,instances,O,10442
152915,of,O,10442
152916,uveitis,B-NAME_OF_DISEASE,10442
152917,based,O,10442
152918,on,O,10442
152919,which,O,10442
152920,tissues,O,10442
152921,exhibit,O,10442
152922,inflammation,O,10442
152923,Anterior,B-NAME_OF_DISEASE,10443
152924,uveitis,I-NAME_OF_DISEASE,10443
152925,sometimes,O,10443
152926,called,O,10443
152927,iritis,B-NAME_OF_DISEASE,10443
152928,is,O,10443
152929,the,O,10443
152930,medical,O,10443
152931,term,O,10443
152932,for,O,10443
152933,inflammation,B-SIGN_AND_SYMPTOM,10443
152934,that,I-SIGN_AND_SYMPTOM,10443
152935,develops,I-SIGN_AND_SYMPTOM,10443
152936,at,I-SIGN_AND_SYMPTOM,10443
152937,the,I-SIGN_AND_SYMPTOM,10443
152938,front,I-SIGN_AND_SYMPTOM,10443
152939,of,I-SIGN_AND_SYMPTOM,10443
152940,the,I-SIGN_AND_SYMPTOM,10443
152941,eye,I-SIGN_AND_SYMPTOM,10443
152942,Panuveitis,B-NAME_OF_DISEASE,10444
152943,is,O,10444
152944,the,O,10444
152945,diagnosis,O,10444
152946,when,O,10444
152947,inflammation,B-SIGN_AND_SYMPTOM,10444
152948,spreads,I-SIGN_AND_SYMPTOM,10444
152949,over,I-SIGN_AND_SYMPTOM,10444
152950,the,I-SIGN_AND_SYMPTOM,10444
152951,entire,I-SIGN_AND_SYMPTOM,10444
152952,eye,I-SIGN_AND_SYMPTOM,10444
152953,as,I-SIGN_AND_SYMPTOM,10444
152954,opposed,I-SIGN_AND_SYMPTOM,10444
152955,to,I-SIGN_AND_SYMPTOM,10444
152956,just,I-SIGN_AND_SYMPTOM,10444
152957,the,I-SIGN_AND_SYMPTOM,10444
152958,back,I-SIGN_AND_SYMPTOM,10444
152959,of,I-SIGN_AND_SYMPTOM,10444
152960,the,I-SIGN_AND_SYMPTOM,10444
152961,eye,I-SIGN_AND_SYMPTOM,10444
152962,The,O,10445
152963,inspecting,O,10445
152964,physician,O,10445
152965,must,O,10445
152966,make,O,10445
152967,sure,O,10445
152968,that,O,10445
152969,any,O,10445
152970,apparent,O,10445
152971,anterior,B-NAME_OF_DISEASE,10445
152972,uveitis,I-NAME_OF_DISEASE,10445
152973,does,O,10445
152974,not,O,10445
152975,have,O,10445
152976,a,O,10445
152977,posterior,O,10445
152978,component,O,10445
152979,and,O,10445
152980,vice,O,10445
152981,versa,O,10445
152982,in,O,10445
152983,order,O,10445
152984,to,O,10445
152985,rule,O,10445
152986,out,O,10445
152987,panuveitis,B-NAME_OF_DISEASE,10445
152988,The,B-PART_OF_THE_EYES,10446
152989,retina,I-PART_OF_THE_EYES,10446
152990,and,O,10446
152991,choroid,B-PART_OF_THE_EYES,10446
152992,are,O,10446
152993,frequently,O,10446
152994,affected,O,10446
152995,when,O,10446
152996,uveitis,B-NAME_OF_DISEASE,10446
152997,develops,O,10446
152998,in,O,10446
152999,the,O,10446
153000,posterior,O,10446
153001,portion,O,10446
153002,of,O,10446
153003,the,O,10446
153004,eye,O,10446
153005,According,O,10447
153006,to,O,10447
153007,the,O,10447
153008,Standardization,O,10447
153009,of,O,10447
153010,Uveitis,O,10447
153011,Nomenclature,O,10447
153012,SUN,O,10447
153013,classification,O,10447
153014,posterior,B-NAME_OF_DISEASE,10447
153015,uveitis,I-NAME_OF_DISEASE,10447
153016,includes,O,10447
153017,focal,O,10447
153018,multifocal,O,10447
153019,or,O,10447
153020,di­,O,10447
153021,use,O,10447
153022,choroiditis,O,10447
153023,chorioretinitis,B-NAME_OF_DISEASE,10447
153024,retinochoroiditis,B-NAME_OF_DISEASE,10447
153025,retinitis,B-NAME_OF_DISEASE,10447
153026,and,O,10447
153027,neuroretinitis,B-NAME_OF_DISEASE,10447
153028,When,O,10448
153029,compared,O,10448
153030,to,O,10448
153031,anterior,B-NAME_OF_DISEASE,10448
153032,uveitis,I-NAME_OF_DISEASE,10448
153033,posterior,B-NAME_OF_DISEASE,10448
153034,uveitis,I-NAME_OF_DISEASE,10448
153035,has,O,10448
153036,a,O,10448
153037,worse,O,10448
153038,prognosis,O,10448
153039,and,O,10448
153040,higher,O,10448
153041,morbidity,O,10448
153042,Macular,B-NAME_OF_DISEASE,10449
153043,edema,I-NAME_OF_DISEASE,10449
153044,cataract,B-NAME_OF_DISEASE,10449
153045,glaucoma,B-NAME_OF_DISEASE,10449
153046,vitreous,B-NAME_OF_DISEASE,10449
153047,debris,I-NAME_OF_DISEASE,10449
153048,and,O,10449
153049,retinopathy,B-NAME_OF_DISEASE,10449
153050,are,O,10449
153051,problems,O,10449
153052,associated,O,10449
153053,with,O,10449
153054,noninfectious,B-NAME_OF_DISEASE,10449
153055,posterior,I-NAME_OF_DISEASE,10449
153056,uveitis,I-NAME_OF_DISEASE,10449
153057,that,O,10449
153058,can,O,10449
153059,be,O,10449
153060,life-threatening,O,10449
153061,to,O,10449
153062,patients,O,10449
153063,vision,O,10449
153064,Macular,B-NAME_OF_DISEASE,10450
153065,edema,I-NAME_OF_DISEASE,10450
153066,is,O,10450
153067,the,O,10450
153068,most,O,10450
153069,common,O,10450
153070,structural,O,10450
153071,complication,O,10450
153072,of,O,10450
153073,uveitis,B-NAME_OF_DISEASE,10450
153074,that,O,10450
153075,causes,O,10450
153076,central,O,10450
153077,visual,B-NAME_OF_DISEASE,10450
153078,impairment,I-NAME_OF_DISEASE,10450
153079,followed,O,10450
153080,by,O,10450
153081,epiretinal,B-SIGN_AND_SYMPTOM,10450
153082,membrane,I-SIGN_AND_SYMPTOM,10450
153083,and,O,10450
153084,glaucoma,B-NAME_OF_DISEASE,10450
153085,6.30%,O,10450
153086,and,O,10450
153087,4.20%,O,10450
153088,respectively,O,10450
153089,Macular,B-NAME_OF_DISEASE,10451
153090,edema,I-NAME_OF_DISEASE,10451
153091,was,O,10451
153092,reported,O,10451
153093,in,O,10451
153094,8.30%,O,10451
153095,of,O,10451
153096,patients,O,10451
153097,with,O,10451
153098,noninfectious,B-NAME_OF_DISEASE,10451
153099,uveitis,I-NAME_OF_DISEASE,10451
153100,in,O,10451
153101,a,O,10451
153102,retrospective,O,10451
153103,analysis,O,10451
153104,of,O,10451
153105,334,O,10451
153106,patients,O,10451
153107,from,O,10451
153108,the,B-NAME_OF_STUDY,10451
153109,Ocular,I-NAME_OF_STUDY,10451
153110,Autoimmune,I-NAME_OF_STUDY,10451
153111,Systemic,I-NAME_OF_STUDY,10451
153112,Inflammatory,I-NAME_OF_STUDY,10451
153113,Infectious,I-NAME_OF_STUDY,10451
153114,Study,I-NAME_OF_STUDY,10451
153115,OASIS,I-NAME_OF_STUDY,10451
153116,Etiologic,O,10452
153117,classification,O,10452
153118,Uveitis,B-NAME_OF_DISEASE,10452
153119,can,O,10452
153120,result,O,10452
153121,from,O,10452
153122,infectious,O,10452
153123,or,O,10452
153124,noninfectious,O,10452
153125,causes,O,10452
153126,and,O,10452
153127,the,O,10452
153128,appropriate,O,10452
153129,treatment,O,10452
153130,depends,O,10452
153131,on,O,10452
153132,the,O,10452
153133,reason,O,10452
153134,Etiological,O,10453
153135,diagnosis,O,10453
153136,is,O,10453
153137,difficult,O,10453
153138,since,O,10453
153139,infectious,B-NAME_OF_DISEASE,10453
153140,and,I-NAME_OF_DISEASE,10453
153141,noninfectious,I-NAME_OF_DISEASE,10453
153142,uveitis,I-NAME_OF_DISEASE,10453
153143,can,O,10453
153144,have,O,10453
153145,many,O,10453
153146,comparable,O,10453
153147,clinical,O,10453
153148,symptoms,O,10453
153149,and,O,10453
153150,indications,O,10453
153151,The,O,10454
153152,practitioner,O,10454
153153,can,O,10454
153154,only,O,10454
153155,shift,O,10454
153156,their,O,10454
153157,attention,O,10454
153158,from,O,10454
153159,treating,B-TREATMENT,10454
153160,infectious,I-TREATMENT,10454
153161,rather,O,10454
153162,than,O,10454
153163,inflammatory,O,10454
153164,processes,O,10454
153165,once,O,10454
153166,an,O,10454
153167,infectious,O,10454
153168,etiology,O,10454
153169,has,O,10454
153170,been,O,10454
153171,ruled,O,10454
153172,out,O,10454
153173,Clinical,O,10455
153174,Examination,O,10455
153175,The,O,10455
153176,clinical,O,10455
153177,examination,O,10455
153178,is,O,10455
153179,one,O,10455
153180,of,O,10455
153181,the,O,10455
153182,most,O,10455
153183,important,O,10455
153184,steps,O,10455
153185,in,O,10455
153186,correctly,O,10455
153187,diagnosing,O,10455
153188,and,O,10455
153189,treating,O,10455
153190,uveitis,B-NAME_OF_DISEASE,10455
153191,A,B-SIGN_AND_SYMPTOM,10456
153192,red,I-SIGN_AND_SYMPTOM,10456
153193,painful,I-SIGN_AND_SYMPTOM,10456
153194,eye,I-SIGN_AND_SYMPTOM,10456
153195,accompanied,I-SIGN_AND_SYMPTOM,10456
153196,by,I-SIGN_AND_SYMPTOM,10456
153197,anterior,I-SIGN_AND_SYMPTOM,10456
153198,chamber,I-SIGN_AND_SYMPTOM,10456
153199,cell,I-SIGN_AND_SYMPTOM,10456
153200,and,I-SIGN_AND_SYMPTOM,10456
153201,flare,I-SIGN_AND_SYMPTOM,10456
153202,posterior,I-SIGN_AND_SYMPTOM,10456
153203,synechiae,I-SIGN_AND_SYMPTOM,10456
153204,and,I-SIGN_AND_SYMPTOM,10456
153205,keratic,I-SIGN_AND_SYMPTOM,10456
153206,precipitates,I-SIGN_AND_SYMPTOM,10456
153207,are,O,10456
153208,the,O,10456
153209,clinical,O,10456
153210,signs,O,10456
153211,of,O,10456
153212,anterior,B-NAME_OF_DISEASE,10456
153213,uveitis,I-NAME_OF_DISEASE,10456
153214,In,O,10457
153215,addition,O,10457
153216,to,O,10457
153217,chorioretinal,B-SIGN_AND_SYMPTOM,10457
153218,lesions,I-SIGN_AND_SYMPTOM,10457
153219,retinal,I-SIGN_AND_SYMPTOM,10457
153220,bleaching,I-SIGN_AND_SYMPTOM,10457
153221,and,I-SIGN_AND_SYMPTOM,10457
153222,vascular,I-SIGN_AND_SYMPTOM,10457
153223,sheathing,I-SIGN_AND_SYMPTOM,10457
153224,posterior,B-NAME_OF_DISEASE,10457
153225,uveitis,I-NAME_OF_DISEASE,10457
153226,worsens,O,10457
153227,vision,O,10457
153228,and,O,10457
153229,alters,O,10457
153230,the,O,10457
153231,visual,O,10457
153232,field,O,10457
153233,An,B-PART_OF_THE_EYES,10458
153234,anterior,I-PART_OF_THE_EYES,10458
153235,chamber,I-PART_OF_THE_EYES,10458
153236,specimen,O,10458
153237,may,O,10458
153238,need,O,10458
153239,to,O,10458
153240,be,O,10458
153241,used,O,10458
153242,in,O,10458
153243,a,B-DIAGNOSTIC_TEST,10458
153244,PCR,I-DIAGNOSTIC_TEST,10458
153245,assay,I-DIAGNOSTIC_TEST,10458
153246,if,O,10458
153247,vitreous,B-SIGN_AND_SYMPTOM,10458
153248,inflammation,I-SIGN_AND_SYMPTOM,10458
153249,prevents,O,10458
153250,visibility,O,10458
153251,of,O,10458
153252,the,O,10458
153253,posterior,O,10458
153254,region,O,10458
153255,Along,O,10459
153256,with,O,10459
153257,choroidal,B-SIGN_AND_SYMPTOM,10459
153258,inflammation,I-SIGN_AND_SYMPTOM,10459
153259,inflammation,B-SIGN_AND_SYMPTOM,10459
153260,in,I-SIGN_AND_SYMPTOM,10459
153261,the,I-SIGN_AND_SYMPTOM,10459
153262,posterior,I-SIGN_AND_SYMPTOM,10459
153263,segment,I-SIGN_AND_SYMPTOM,10459
153264,may,O,10459
153265,also,O,10459
153266,affect,O,10459
153267,nearby,O,10459
153268,structures,O,10459
153269,like,O,10459
153270,the,B-PART_OF_THE_EYES,10459
153271,retina,I-PART_OF_THE_EYES,10459
153272,vitreous,B-PART_OF_THE_EYES,10459
153273,optic,B-PART_OF_THE_EYES,10459
153274,nerve,I-PART_OF_THE_EYES,10459
153275,head,I-PART_OF_THE_EYES,10459
153276,or,O,10459
153277,retinal,B-PART_OF_THE_EYES,10459
153278,arteries,I-PART_OF_THE_EYES,10459
153279,Therefore,O,10460
153280,it,O,10460
153281,may,O,10460
153282,be,O,10460
153283,useful,O,10460
153284,for,O,10460
153285,the,O,10460
153286,examining,O,10460
153287,physician,O,10460
153288,to,O,10460
153289,keep,O,10460
153290,the,O,10460
153291,following,O,10460
153292,inquiries,O,10460
153293,in,O,10460
153294,mind,O,10460
153295,as,O,10460
153296,the,O,10460
153297,investigation,O,10460
153298,progresses,O,10460
153299,Is,O,10460
153300,this,O,10460
153301,inflammation,O,10460
153302,choroiditis,B-NAME_OF_DISEASE,10460
153303,retinitis,B-NAME_OF_DISEASE,10460
153304,or,O,10460
153305,retinochoroiditis,B-NAME_OF_DISEASE,10460
153306,In,O,10461
153307,addition,O,10461
153308,to,O,10461
153309,any,O,10461
153310,known,O,10461
153311,infectious,O,10461
153312,disorders,O,10461
153313,such,O,10461
153314,as,O,10461
153315,tuberculosis,B-NAME_OF_DISEASE,10461
153316,or,O,10461
153317,Lyme,B-NAME_OF_DISEASE,10461
153318,disease,I-NAME_OF_DISEASE,10461
153319,ophthalmologists,O,10461
153320,should,O,10461
153321,inquire,O,10461
153322,about,O,10461
153323,any,O,10461
153324,prior,O,10461
153325,inflammatory,O,10461
153326,episodes,O,10461
153327,or,O,10461
153328,infections,O,10461
153329,in,O,10461
153330,the,O,10461
153331,eye,O,10461
153332,such,O,10461
153333,as,O,10461
153334,herpes,B-NAME_OF_DISEASE,10461
153335,or,O,10461
153336,varicella,B-NAME_OF_DISEASE,10461
153337,Practitioners,O,10462
153338,should,O,10462
153339,enquire,O,10462
153340,about,O,10462
153341,any,O,10462
153342,high-risk,O,10462
153343,sexual,O,10462
153344,behavior,O,10462
153345,that,O,10462
153346,can,O,10462
153347,increase,O,10462
153348,the,O,10462
153349,patients,O,10462
153350,chance,O,10462
153351,of,O,10462
153352,contracting,O,10462
153353,syphilis,B-NAME_OF_DISEASE,10462
153354,or,O,10462
153355,the,B-CHEMICAL_COMPOUND,10462
153356,human,I-CHEMICAL_COMPOUND,10462
153357,immunodeficiency,I-CHEMICAL_COMPOUND,10462
153358,virus,I-CHEMICAL_COMPOUND,10462
153359,Furthermore,O,10463
153360,contact,O,10463
153361,with,O,10463
153362,pets,O,10463
153363,or,O,10463
153364,other,O,10463
153365,animals,O,10463
153366,may,O,10463
153367,indicate,O,10463
153368,toxoplasmosis,B-NAME_OF_DISEASE,10463
153369,or,O,10463
153370,toxocaraiasis,B-NAME_OF_DISEASE,10463
153371,Syphilis,B-NAME_OF_DISEASE,10464
153372,must,O,10464
153373,be,O,10464
153374,ruled,O,10464
153375,out,O,10464
153376,in,O,10464
153377,patients,O,10464
153378,who,O,10464
153379,are,O,10464
153380,adults,O,10464
153381,and,O,10464
153382,teenagers,O,10464
153383,Age,O,10465
153384,range,O,10465
153385,Depending,O,10465
153386,on,O,10465
153387,the,O,10465
153388,patients,O,10465
153389,age,O,10465
153390,underlying,O,10465
153391,disorders,O,10465
153392,that,O,10465
153393,affect,O,10465
153394,uveitis,B-NAME_OF_DISEASE,10465
153395,etiologies,O,10465
153396,or,O,10465
153397,severity,O,10465
153398,may,O,10465
153399,manifest,O,10465
153400,more,O,10465
153401,or,O,10465
153402,less,O,10465
153403,frequently,O,10465
153404,For,O,10466
153405,instance,O,10466
153406,juvenile,B-NAME_OF_DISEASE,10466
153407,rheumatoid,I-NAME_OF_DISEASE,10466
153408,arthritis,I-NAME_OF_DISEASE,10466
153409,Behçets,B-NAME_OF_DISEASE,10466
153410,disease,I-NAME_OF_DISEASE,10466
153411,or,O,10466
153412,ankylosing,B-NAME_OF_DISEASE,10466
153413,spondylitis,I-NAME_OF_DISEASE,10466
153414,are,O,10466
153415,more,O,10466
153416,prevalent,O,10466
153417,in,O,10466
153418,younger,O,10466
153419,people,O,10466
153420,whereas,O,10466
153421,its,O,10466
153422,crucial,O,10466
153423,to,O,10466
153424,rule,O,10466
153425,out,O,10466
153426,cancer,B-NAME_OF_DISEASE,10466
153427,or,O,10466
153428,syphilis,B-NAME_OF_DISEASE,10466
153429,in,O,10466
153430,elderly,O,10466
153431,patients,O,10466
153432,Ophthalmologists,O,10467
153433,can,O,10467
153434,also,O,10467
153435,request,O,10467
153436,a,O,10467
153437,series,O,10467
153438,of,O,10467
153439,laboratory,O,10467
153440,tests,O,10467
153441,to,O,10467
153442,ascertain,O,10467
153443,whether,O,10467
153444,uveitis,B-NAME_OF_DISEASE,10467
153445,is,O,10467
153446,brought,O,10467
153447,on,O,10467
153448,by,O,10467
153449,bacteria,B-CAUSE_OF_DISEASE,10467
153450,viruses,B-CAUSE_OF_DISEASE,10467
153451,fungi,B-CAUSE_OF_DISEASE,10467
153452,or,O,10467
153453,another,O,10467
153454,source,O,10467
153455,A,O,10468
153456,full,O,10468
153457,workup,O,10468
153458,for,O,10468
153459,uveitis,B-NAME_OF_DISEASE,10468
153460,would,O,10468
153461,include,O,10468
153462,a,O,10468
153463,complete,O,10468
153464,blood,O,10468
153465,count,O,10468
153466,as,O,10468
153467,well,O,10468
153468,as,O,10468
153469,sedimentation,O,10468
153470,rate,O,10468
153471,Rheumatoid,B-DIAGNOSTIC_TEST,10469
153472,factor,I-DIAGNOSTIC_TEST,10469
153473,antinuclear,B-DIAGNOSTIC_TEST,10469
153474,antibodies,I-DIAGNOSTIC_TEST,10469
153475,to,I-DIAGNOSTIC_TEST,10469
153476,rule,I-DIAGNOSTIC_TEST,10469
153477,out,I-DIAGNOSTIC_TEST,10469
153478,rheumatoid,I-DIAGNOSTIC_TEST,10469
153479,arthritis,I-DIAGNOSTIC_TEST,10469
153480,and,O,10469
153481,angiotensin-converting,B-DIAGNOSTIC_TEST,10469
153482,enzyme,I-DIAGNOSTIC_TEST,10469
153483,for,I-DIAGNOSTIC_TEST,10469
153484,sarcoidosis,I-DIAGNOSTIC_TEST,10469
153485,are,O,10469
153486,examples,O,10469
153487,of,O,10469
153488,additional,O,10469
153489,blood,O,10469
153490,tests,O,10469
153491,To,O,10470
153492,rule,O,10470
153493,out,O,10470
153494,ankylosing,B-NAME_OF_DISEASE,10470
153495,spondylitis,I-NAME_OF_DISEASE,10470
153496,in,O,10470
153497,younger,O,10470
153498,patients,O,10470
153499,with,O,10470
153500,back,O,10470
153501,discomfort,O,10470
153502,a,B-DIAGNOSTIC_TEST,10470
153503,simple,I-DIAGNOSTIC_TEST,10470
153504,lumbo-sacral,I-DIAGNOSTIC_TEST,10470
153505,X-ray,I-DIAGNOSTIC_TEST,10470
153506,or,O,10470
153507,an,B-DIAGNOSTIC_TEST,10470
153508,HLA-B27,I-DIAGNOSTIC_TEST,10470
153509,test,O,10470
153510,would,O,10470
153511,be,O,10470
153512,beneficial,O,10470
153513,If,O,10471
153514,the,O,10471
153515,patient,O,10471
153516,has,O,10471
153517,cats,O,10471
153518,or,O,10471
153519,dogs,O,10471
153520,or,O,10471
153521,has,O,10471
153522,been,O,10471
153523,exposed,O,10471
153524,to,O,10471
153525,other,O,10471
153526,animals,O,10471
153527,the,O,10471
153528,practitioner,O,10471
153529,should,O,10471
153530,test,O,10471
153531,for,O,10471
153532,toxoplasmosis,B-NAME_OF_DISEASE,10471
153533,or,O,10471
153534,toxocaraiasis,B-NAME_OF_DISEASE,10471
153535,A,B-DIAGNOSTIC_TEST,10472
153536,skin,I-DIAGNOSTIC_TEST,10472
153537,test,I-DIAGNOSTIC_TEST,10472
153538,blood,B-DIAGNOSTIC_TEST,10472
153539,interferon-gamma,I-DIAGNOSTIC_TEST,10472
153540,release,I-DIAGNOSTIC_TEST,10472
153541,assay,I-DIAGNOSTIC_TEST,10472
153542,or,O,10472
153543,chest,B-DIAGNOSTIC_TEST,10472
153544,X-ray,I-DIAGNOSTIC_TEST,10472
153545,should,O,10472
153546,be,O,10472
153547,conducted,O,10472
153548,to,O,10472
153549,rule,O,10472
153550,out,O,10472
153551,tuberculosis,B-NAME_OF_DISEASE,10472
153552,The,O,10473
153553,presence,O,10473
153554,or,O,10473
153555,type,O,10473
153556,of,O,10473
153557,an,O,10473
153558,infection,O,10473
153559,in,O,10473
153560,the,O,10473
153561,eye,O,10473
153562,may,O,10473
153563,also,O,10473
153564,be,O,10473
153565,determined,O,10473
153566,using,O,10473
153567,imaging,O,10473
153568,techniques,O,10473
153569,such,O,10473
153570,fundus,B-DIAGNOSTIC_TEST,10473
153571,fluorescein,I-DIAGNOSTIC_TEST,10473
153572,angiography,I-DIAGNOSTIC_TEST,10473
153573,FFA,I-DIAGNOSTIC_TEST,10473
153574,indocyanine,B-DIAGNOSTIC_TEST,10473
153575,green,I-DIAGNOSTIC_TEST,10473
153576,angiography,I-DIAGNOSTIC_TEST,10473
153577,ICG,I-DIAGNOSTIC_TEST,10473
153578,ultrasonography,B-DIAGNOSTIC_TEST,10473
153579,USG,I-DIAGNOSTIC_TEST,10473
153580,and,O,10473
153581,optical,B-DIAGNOSTIC_TEST,10473
153582,coherence,I-DIAGNOSTIC_TEST,10473
153583,tomography,I-DIAGNOSTIC_TEST,10473
153584,OCT,I-DIAGNOSTIC_TEST,10473
153585,Idiopathic,B-NAME_OF_DISEASE,10474
153586,uveitis,B-NAME_OF_DISEASE,10474
153587,As,O,10474
153588,has,O,10474
153589,been,O,10474
153590,noted,O,10474
153591,up,O,10474
153592,to,O,10474
153593,half,O,10474
153594,of,O,10474
153595,uveitis,B-NAME_OF_DISEASE,10474
153596,cases,O,10474
153597,will,O,10474
153598,after,O,10474
153599,careful,O,10474
153600,workup,O,10474
153601,be,O,10474
153602,classified,O,10474
153603,as,O,10474
153604,idiopathic,O,10474
153605,However,O,10475
153606,it,O,10475
153607,has,O,10475
153608,been,O,10475
153609,suggested,O,10475
153610,that,O,10475
153611,some,O,10475
153612,idiopathic,O,10475
153613,cases,O,10475
153614,may,O,10475
153615,reflect,O,10475
153616,incomplete,O,10475
153617,patient,O,10475
153618,medical,O,10475
153619,history,O,10475
153620,or,O,10475
153621,imperfect,O,10475
153622,laboratory,O,10475
153623,testing,O,10475
153624,and,O,10475
153625,may,O,10475
153626,actually,O,10475
153627,be,O,10475
153628,uveitis,B-NAME_OF_DISEASE,10475
153629,secondary,O,10475
153630,to,O,10475
153631,sarcoidosis,B-NAME_OF_DISEASE,10475
153632,tubulointerstitial,I-NAME_OF_DISEASE,10475
153633,nephritis,I-NAME_OF_DISEASE,10475
153634,or,O,10475
153635,ankylosing,B-NAME_OF_DISEASE,10475
153636,spondylitis,I-NAME_OF_DISEASE,10475
153637,The,O,10476
153638,second,O,10476
153639,goal,O,10476
153640,is,O,10476
153641,to,O,10476
153642,prevent,O,10476
153643,recurrences,O,10476
153644,and,O,10476
153645,thereby,O,10476
153646,prevent,O,10476
153647,the,O,10476
153648,damage,O,10476
153649,to,O,10476
153650,optical,O,10476
153651,tissues,O,10476
153652,that,O,10476
153653,can,O,10476
153654,lead,O,10476
153655,to,O,10476
153656,permanent,B-NAME_OF_DISEASE,10476
153657,vision,I-NAME_OF_DISEASE,10476
153658,loss,I-NAME_OF_DISEASE,10476
153659,Treatment,O,10477
153660,Local,O,10477
153661,or,O,10477
153662,systemic,O,10477
153663,The,O,10477
153664,presence,O,10477
153665,of,O,10477
153666,unilateral,B-NAME_OF_DISEASE,10477
153667,bilateral,I-NAME_OF_DISEASE,10477
153668,or,O,10477
153669,unilateral,B-NAME_OF_DISEASE,10477
153670,alternating,I-NAME_OF_DISEASE,10477
153671,uveitis,I-NAME_OF_DISEASE,10477
153672,should,O,10477
153673,be,O,10477
153674,taken,O,10477
153675,into,O,10477
153676,account,O,10477
153677,when,O,10477
153678,selecting,O,10477
153679,whether,O,10477
153680,to,O,10477
153681,utilize,O,10477
153682,local,O,10477
153683,or,O,10477
153684,systemic,O,10477
153685,treatment,O,10477
153686,In,O,10478
153687,cases,O,10478
153688,of,O,10478
153689,unilateral,B-NAME_OF_DISEASE,10478
153690,uveitis,I-NAME_OF_DISEASE,10478
153691,local,O,10478
153692,therapy,O,10478
153693,is,O,10478
153694,more,O,10478
153695,likely,O,10478
153696,to,O,10478
153697,be,O,10478
153698,used,O,10478
153699,For,O,10479
153700,noninfectious,B-NAME_OF_DISEASE,10479
153701,uveitis,I-NAME_OF_DISEASE,10479
153702,topical,B-NAME_OF_DRUG,10479
153703,steroids,I-NAME_OF_DRUG,10479
153704,are,O,10479
153705,frequently,O,10479
153706,used,O,10479
153707,as,O,10479
153708,the,O,10479
153709,initial,O,10479
153710,treatment,O,10479
153711,The,O,10480
153712,advantage,O,10480
153713,of,O,10480
153714,topical,B-NAME_OF_DRUG,10480
153715,steroids,I-NAME_OF_DRUG,10480
153716,is,O,10480
153717,that,O,10480
153718,they,O,10480
153719,are,O,10480
153720,generally,O,10480
153721,safe,O,10480
153722,and,O,10480
153723,simple,O,10480
153724,to,O,10480
153725,stop,O,10480
153726,using,O,10480
153727,Additionally,O,10481
153728,they,O,10481
153729,dont,O,10481
153730,penetrate,O,10481
153731,very,O,10481
153732,far,O,10481
153733,past,O,10481
153734,the,B-PART_OF_THE_EYES,10481
153735,anterior,I-PART_OF_THE_EYES,10481
153736,chamber,I-PART_OF_THE_EYES,10481
153737,thus,O,10481
153738,they,O,10481
153739,wont,O,10481
153740,exacerbate,O,10481
153741,an,O,10481
153742,infectious,O,10481
153743,condition,O,10481
153744,However,O,10482
153745,because,O,10482
153746,to,O,10482
153747,their,O,10482
153748,limited,O,10482
153749,penetration,O,10482
153750,steroids,B-NAME_OF_DRUG,10482
153751,are,O,10482
153752,less,O,10482
153753,effective,O,10482
153754,than,O,10482
153755,alternative,O,10482
153756,treatments,O,10482
153757,including,O,10482
153758,injections,O,10482
153759,in,O,10482
153760,the,O,10482
153761,posterior,O,10482
153762,portion,O,10482
153763,Due,O,10483
153764,to,O,10483
153765,the,O,10483
153766,effectiveness,O,10483
153767,and,O,10483
153768,safety,O,10483
153769,of,O,10483
153770,the,B-TREATMENT,10483
153771,dexamethasone,I-TREATMENT,10483
153772,intravitreal,I-TREATMENT,10483
153773,implant,I-TREATMENT,10483
153774,patients,O,10483
153775,with,O,10483
153776,noninfectious,O,10483
153777,locally-treated,O,10483
153778,posterior,B-NAME_OF_DISEASE,10483
153779,segment,I-NAME_OF_DISEASE,10483
153780,uveitis,I-NAME_OF_DISEASE,10483
153781,are,O,10483
153782,likely,O,10483
153783,to,O,10483
153784,begin,O,10483
153785,receiving,O,10483
153786,intravitreal,O,10483
153787,steroids,B-NAME_OF_DRUG,10483
153788,Although,O,10484
153789,the,B-TREATMENT,10484
153790,dexamethasone,I-TREATMENT,10484
153791,intravitreal,I-TREATMENT,10484
153792,implant,I-TREATMENT,10484
153793,has,O,10484
153794,a,O,10484
153795,brief,O,10484
153796,duration,O,10484
153797,of,O,10484
153798,action,O,10484
153799,it,O,10484
153800,is,O,10484
153801,effective,O,10484
153802,at,O,10484
153803,large,O,10484
153804,doses,O,10484
153805,Within,B-TIME_DURATION,10485
153806,two,I-TIME_DURATION,10485
153807,weeks,I-TIME_DURATION,10485
153808,of,O,10485
153809,starting,O,10485
153810,it,O,10485
153811,reaches,O,10485
153812,its,O,10485
153813,peak,O,10485
153814,and,O,10485
153815,the,O,10485
153816,advantages,O,10485
153817,endure,O,10485
153818,for,B-TIME_DURATION,10485
153819,around,I-TIME_DURATION,10485
153820,four,I-TIME_DURATION,10485
153821,months,I-TIME_DURATION,10485
153822,The,B-TREATMENT,10486
153823,dexamethasone,I-TREATMENT,10486
153824,intravitreal,I-TREATMENT,10486
153825,implant,I-TREATMENT,10486
153826,can,O,10486
153827,raise,O,10486
153828,IOP,O,10486
153829,like,O,10486
153830,other,O,10486
153831,steroids,B-NAME_OF_DRUG,10486
153832,however,O,10486
153833,the,O,10486
153834,elevations,O,10486
153835,do,O,10486
153836,not,O,10486
153837,seem,O,10486
153838,to,O,10486
153839,be,O,10486
153840,cumulative,O,10486
153841,The,B-TREATMENT,10487
153842,fluocinolone,I-TREATMENT,10487
153843,actetonide,I-TREATMENT,10487
153844,FAc,I-TREATMENT,10487
153845,intravitreal,I-TREATMENT,10487
153846,implant,I-TREATMENT,10487
153847,is,O,10487
153848,frequently,O,10487
153849,beneficial,O,10487
153850,as,O,10487
153851,maintenance,O,10487
153852,therapy,O,10487
153853,in,O,10487
153854,patients,O,10487
153855,with,O,10487
153856,unilateral,B-NAME_OF_DISEASE,10487
153857,uveitis,I-NAME_OF_DISEASE,10487
153858,who,O,10487
153859,continue,O,10487
153860,to,O,10487
153861,have,O,10487
153862,recurrent,O,10487
153863,flare-ups,O,10487
153864,following,O,10487
153865,initial,O,10487
153866,treatment,O,10487
153867,with,O,10487
153868,an,O,10487
153869,intravitreal,O,10487
153870,steroid,B-NAME_OF_DRUG,10487
153871,Many,O,10488
153872,doctors,O,10488
153873,will,O,10488
153874,decide,O,10488
153875,to,O,10488
153876,start,O,10488
153877,noninfectious,B-NAME_OF_DISEASE,10488
153878,uveitis,I-NAME_OF_DISEASE,10488
153879,patients,O,10488
153880,on,O,10488
153881,the,B-TREATMENT,10488
153882,dexamethasone,I-TREATMENT,10488
153883,intravitreal,I-TREATMENT,10488
153884,implant,I-TREATMENT,10488
153885,then,O,10488
153886,switch,O,10488
153887,them,O,10488
153888,over,O,10488
153889,to,O,10488
153890,the,B-TREATMENT,10488
153891,FAc,I-TREATMENT,10488
153892,intravitreal,I-TREATMENT,10488
153893,implant,I-TREATMENT,10488
153894,which,O,10488
153895,is,O,10488
153896,long-acting,O,10488
153897,even,O,10488
153898,at,O,10488
153899,low,O,10488
153900,doses,O,10488
153901,once,O,10488
153902,the,O,10488
153903,inflammation,O,10488
153904,is,O,10488
153905,under,O,10488
153906,control,O,10488
153907,and,O,10488
153908,any,O,10488
153909,macular,B-NAME_OF_DISEASE,10488
153910,edema,I-NAME_OF_DISEASE,10488
153911,has,O,10488
153912,disappeared,O,10488
153913,Systemic,B-NAME_OF_DRUG,10489
153914,corticosteroids,I-NAME_OF_DRUG,10489
153915,biologics,O,10489
153916,like,O,10489
153917,adalimumab,B-NAME_OF_DRUG,10489
153918,and,O,10489
153919,infliximab,B-NAME_OF_DRUG,10489
153920,or,O,10489
153921,immunosuppressive,B-NAME_OF_DRUG,10489
153922,drugs,I-NAME_OF_DRUG,10489
153923,like,O,10489
153924,methotrexate,B-NAME_OF_DRUG,10489
153925,are,O,10489
153926,some,O,10489
153927,choices,O,10489
153928,for,O,10489
153929,systemic,O,10489
153930,treatment,O,10489
153931,When,O,10490
153932,topical,B-NAME_OF_DRUG,10490
153933,corticosteroids,I-NAME_OF_DRUG,10490
153934,are,O,10490
153935,insufficient,O,10490
153936,or,O,10490
153937,when,O,10490
153938,a,O,10490
153939,systemic,O,10490
153940,condition,O,10490
153941,that,O,10490
153942,also,O,10490
153943,requires,O,10490
153944,treatment,O,10490
153945,is,O,10490
153946,present,O,10490
153947,in,O,10490
153948,the,O,10490
153949,patient,O,10490
153950,systemic,B-NAME_OF_DRUG,10490
153951,corticosteroids,I-NAME_OF_DRUG,10490
153952,may,O,10490
153953,be,O,10490
153954,administered,O,10490
153955,for,O,10490
153956,patients,O,10490
153957,with,O,10490
153958,bilateral,O,10490
153959,symptoms,O,10490
153960,Although,O,10491
153961,extremely,O,10491
153962,effective,O,10491
153963,systemic,O,10491
153964,medication,O,10491
153965,for,O,10491
153966,noninfectious,B-NAME_OF_DISEASE,10491
153967,uveitis,I-NAME_OF_DISEASE,10491
153968,also,O,10491
153969,has,O,10491
153970,a,O,10491
153971,severe,O,10491
153972,side,O,10491
153973,effect,O,10491
153974,profile,O,10491
153975,Insurance,O,10492
153976,coverage,O,10492
153977,and,O,10492
153978,cost,O,10492
153979,are,O,10492
153980,two,O,10492
153981,other,O,10492
153982,factors,O,10492
153983,that,O,10492
153984,frequently,O,10492
153985,come,O,10492
153986,into,O,10492
153987,play,O,10492
153988,with,O,10492
153989,systemic,O,10492
153990,treatments,O,10492
153991,for,O,10492
153992,uveitis,B-NAME_OF_DISEASE,10492
153993,Questions,O,10493
153994,about,O,10493
153995,localized,O,10493
153996,treatments,O,10493
153997,Intraocular,B-NAME_OF_DISEASE,10493
153998,pressure,I-NAME_OF_DISEASE,10493
153999,IOP,I-NAME_OF_DISEASE,10493
154000,rise,I-NAME_OF_DISEASE,10493
154001,and,O,10493
154002,cataract,B-NAME_OF_DISEASE,10493
154003,are,O,10493
154004,the,O,10493
154005,two,O,10493
154006,main,O,10493
154007,issues,O,10493
154008,with,O,10493
154009,local,O,10493
154010,treatments,O,10493
154011,The,O,10494
154012,frequency,O,10494
154013,of,O,10494
154014,mild,O,10494
154015,,O,10494
154016,23,O,10494
154017,mmHg,O,10494
154018,and,O,10494
154019,moderate,O,10494
154020,,O,10494
154021,25,O,10494
154022,mmHg,O,10494
154023,ocular,O,10494
154024,hypertension,O,10494
154025,increases,O,10494
154026,with,O,10494
154027,repeated,O,10494
154028,injections,O,10494
154029,but,O,10494
154030,the,O,10494
154031,frequency,O,10494
154032,of,O,10494
154033,severe,O,10494
154034,30,O,10494
154035,mmHg,O,10494
154036,ocular,O,10494
154037,hypertension,O,10494
154038,does,O,10494
154039,not,O,10494
154040,change,O,10494
154041,with,O,10494
154042,injection,O,10494
154043,frequency,O,10494
154044,according,O,10494
154045,to,O,10494
154046,a,O,10494
154047,study,O,10494
154048,looking,O,10494
154049,at,O,10494
154050,the,O,10494
154051,frequency,O,10494
154052,and,O,10494
154053,degree,O,10494
154054,of,O,10494
154055,ocular,O,10494
154056,hypertension,O,10494
154057,associated,O,10494
154058,with,O,10494
154059,sequential,O,10494
154060,injections,O,10494
154061,of,O,10494
154062,the,B-TREATMENT,10494
154063,dexamethasone,I-TREATMENT,10494
154064,intravitreal,I-TREATMENT,10494
154065,implant,I-TREATMENT,10494
154066,Despite,O,10495
154067,the,B-TREATMENT,10495
154068,dexamethasone,I-TREATMENT,10495
154069,implants,I-TREATMENT,10495
154070,therapeutic,O,10495
154071,advantages,O,10495
154072,27%,O,10495
154073,to,O,10495
154074,32%,O,10495
154075,of,O,10495
154076,patients,O,10495
154077,have,O,10495
154078,reported,O,10495
154079,experiencing,O,10495
154080,brief,B-SIGN_AND_SYMPTOM,10495
154081,IOP,I-SIGN_AND_SYMPTOM,10495
154082,spikes,I-SIGN_AND_SYMPTOM,10495
154083,In,O,10496
154084,a,O,10496
154085,retrospective,O,10496
154086,study,O,10496
154087,of,O,10496
154088,306,O,10496
154089,charts,O,10496
154090,of,O,10496
154091,patients,O,10496
154092,who,O,10496
154093,got,O,10496
154094,the,B-TREATMENT,10496
154095,dexamethasone,I-TREATMENT,10496
154096,implant,I-TREATMENT,10496
154097,for,O,10496
154098,a,O,10496
154099,range,O,10496
154100,of,O,10496
154101,illnesses,O,10496
154102,including,O,10496
154103,posterior,B-NAME_OF_DISEASE,10496
154104,uveitis,I-NAME_OF_DISEASE,10496
154105,the,O,10496
154106,significance,O,10496
154107,of,O,10496
154108,these,O,10496
154109,spikes,O,10496
154110,in,O,10496
154111,terms,O,10496
154112,of,O,10496
154113,long-term,B-SIGN_AND_SYMPTOM,10496
154114,vision,I-SIGN_AND_SYMPTOM,10496
154115,loss,I-SIGN_AND_SYMPTOM,10496
154116,was,O,10496
154117,evaluated,O,10496
154118,Cross,O,10497
154119,sectional,O,10497
154120,IOP,B-SIGN_AND_SYMPTOM,10497
154121,spikes,I-SIGN_AND_SYMPTOM,10497
154122,≥,O,10497
154123,22,O,10497
154124,mm,O,10497
154125,Hg,O,10497
154126,up,B-TIME_DURATION,10497
154127,to,I-TIME_DURATION,10497
154128,16,I-TIME_DURATION,10497
154129,weeks,I-TIME_DURATION,10497
154130,post-implant,O,10497
154131,and,O,10497
154132,OCT,B-DIAGNOSTIC_TEST,10497
154133,retinal,I-DIAGNOSTIC_TEST,10497
154134,nerve,I-DIAGNOSTIC_TEST,10497
154135,fiber,I-DIAGNOSTIC_TEST,10497
154136,layer,I-DIAGNOSTIC_TEST,10497
154137,RNFL,I-DIAGNOSTIC_TEST,10497
154138,imaging,I-DIAGNOSTIC_TEST,10497
154139,of,O,10497
154140,both,O,10497
154141,eyes,O,10497
154142,performed,O,10497
154143,≥,O,10497
154144,3,B-TIME_DURATION,10497
154145,months,I-TIME_DURATION,10497
154146,after,O,10497
154147,the,B-SIGN_AND_SYMPTOM,10497
154148,IOP,I-SIGN_AND_SYMPTOM,10497
154149,spike,I-SIGN_AND_SYMPTOM,10497
154150,N,O,10497
154151,=,O,10497
154152,48,O,10497
154153,Prospective,O,10498
154154,OCT,B-DIAGNOSTIC_TEST,10498
154155,RNFL,I-DIAGNOSTIC_TEST,10498
154156,imaging,I-DIAGNOSTIC_TEST,10498
154157,performed,O,10498
154158,within,B-TIME_DURATION,10498
154159,one,I-TIME_DURATION,10498
154160,year,I-TIME_DURATION,10498
154161,prior,O,10498
154162,to,O,10498
154163,dexamethasone,B-TREATMENT,10498
154164,implantation,I-TREATMENT,10498
154165,IOP,B-SIGN_AND_SYMPTOM,10498
154166,spike,I-SIGN_AND_SYMPTOM,10498
154167,≥,O,10498
154168,22,O,10498
154169,mmHg,O,10498
154170,up,B-TIME_DURATION,10498
154171,to,I-TIME_DURATION,10498
154172,16,I-TIME_DURATION,10498
154173,weeks,I-TIME_DURATION,10498
154174,after,O,10498
154175,DEX,B-TREATMENT,10498
154176,implant,I-TREATMENT,10498
154177,and,O,10498
154178,OCT,B-DIAGNOSTIC_TEST,10498
154179,RNFL,I-DIAGNOSTIC_TEST,10498
154180,imaging,I-DIAGNOSTIC_TEST,10498
154181,performed,O,10498
154182,≥,O,10498
154183,3,B-TIME_DURATION,10498
154184,months,I-TIME_DURATION,10498
154185,after,O,10498
154186,the,B-SIGN_AND_SYMPTOM,10498
154187,IOP,I-SIGN_AND_SYMPTOM,10498
154188,spike,I-SIGN_AND_SYMPTOM,10498
154189,N,O,10498
154190,=,O,10498
154191,21,O,10498
154192,Up,O,10498
154193,to,O,10498
154194,48%,O,10498
154195,of,O,10498
154196,these,O,10498
154197,patients,O,10498
154198,had,O,10498
154199,a,O,10498
154200,prior,O,10498
154201,history,O,10498
154202,of,O,10498
154203,glaucoma,B-NAME_OF_DISEASE,10498
154204,In,O,10499
154205,the,O,10499
154206,cross-sectional,O,10499
154207,group,O,10499
154208,IOP,B-SIGN_AND_SYMPTOM,10499
154209,spikes,I-SIGN_AND_SYMPTOM,10499
154210,≥,O,10499
154211,22,O,10499
154212,mmHg,O,10499
154213,after,O,10499
154214,dexamethasone,B-TREATMENT,10499
154215,implantation,I-TREATMENT,10499
154216,demonstrated,O,10499
154217,no,O,10499
154218,significant,O,10499
154219,di­fference,O,10499
154220,in,O,10499
154221,average,O,10499
154222,RNFL,O,10499
154223,thickness,O,10499
154224,when,O,10499
154225,compared,O,10499
154226,with,O,10499
154227,the,O,10499
154228,contralateral,O,10499
154229,untreated,O,10499
154230,eye,O,10499
154231,regardless,O,10499
154232,of,O,10499
154233,treatment,O,10499
154234,diagnosis,O,10499
154235,magnitude,O,10499
154236,of,O,10499
154237,IOP,B-SIGN_AND_SYMPTOM,10499
154238,spike,I-SIGN_AND_SYMPTOM,10499
154239,or,O,10499
154240,history,O,10499
154241,of,O,10499
154242,glaucoma,B-NAME_OF_DISEASE,10499
154243,Similarly,O,10500
154244,the,O,10500
154245,prospective,O,10500
154246,group,O,10500
154247,also,O,10500
154248,demonstrated,O,10500
154249,no,O,10500
154250,significant,O,10500
154251,di­,O,10500
154252,erences,O,10500
154253,in,O,10500
154254,average,O,10500
154255,RNFL,O,10500
154256,thickness,O,10500
154257,when,O,10500
154258,comparing,O,10500
154259,measurements,O,10500
154260,before,O,10500
154261,and,O,10500
154262,at,B-TIME_DURATION,10500
154263,least,I-TIME_DURATION,10500
154264,3,I-TIME_DURATION,10500
154265,months,I-TIME_DURATION,10500
154266,after,O,10500
154267,the,B-SIGN_AND_SYMPTOM,10500
154268,IOP,I-SIGN_AND_SYMPTOM,10500
154269,spike,I-SIGN_AND_SYMPTOM,10500
154270,This,O,10501
154271,study,O,10501
154272,showed,O,10501
154273,that,O,10501
154274,a,B-SIGN_AND_SYMPTOM,10501
154275,temporary,I-SIGN_AND_SYMPTOM,10501
154276,elevation,I-SIGN_AND_SYMPTOM,10501
154277,of,I-SIGN_AND_SYMPTOM,10501
154278,IOP,I-SIGN_AND_SYMPTOM,10501
154279,after,O,10501
154280,dexamethasone,B-TREATMENT,10501
154281,implantation,I-TREATMENT,10501
154282,does,O,10501
154283,not,O,10501
154284,appear,O,10501
154285,to,O,10501
154286,cause,O,10501
154287,a,O,10501
154288,meaningful,O,10501
154289,change,O,10501
154290,in,O,10501
154291,RNFL,O,10501
154292,thickness,O,10501
154293,when,O,10501
154294,treated,O,10501
154295,with,O,10501
154296,IOP-lowering,B-TREATMENT,10501
154297,drops,I-TREATMENT,10501
154298,regardless,O,10501
154299,of,O,10501
154300,etiology,O,10501
154301,or,O,10501
154302,magnitude,O,10501
154303,of,O,10501
154304,IOP,O,10501
154305,increase,O,10501
154306,Additionally,O,10502
154307,even,O,10502
154308,in,O,10502
154309,patients,O,10502
154310,with,O,10502
154311,a,O,10502
154312,prior,O,10502
154313,ocular,O,10502
154314,history,O,10502
154315,of,O,10502
154316,glaucoma,B-NAME_OF_DISEASE,10502
154317,topical,B-TREATMENT,10502
154318,IOP-lowering,I-TREATMENT,10502
154319,drops,I-TREATMENT,10502
154320,appeared,O,10502
154321,to,O,10502
154322,be,O,10502
154323,sufficient,O,10502
154324,in,O,10502
154325,this,O,10502
154326,studys,O,10502
154327,management,O,10502
154328,of,O,10502
154329,transient,O,10502
154330,IOP,B-SIGN_AND_SYMPTOM,10502
154331,spikes,I-SIGN_AND_SYMPTOM,10502
154332,to,O,10502
154333,prevent,O,10502
154334,RNFL,B-SIGN_AND_SYMPTOM,10502
154335,damage,I-SIGN_AND_SYMPTOM,10502
154336,Due,O,10503
154337,to,O,10503
154338,the,O,10503
154339,possibility,O,10503
154340,of,O,10503
154341,cataracts,B-NAME_OF_DISEASE,10503
154342,with,O,10503
154343,intravitreal,O,10503
154344,steroids,B-NAME_OF_DRUG,10503
154345,topical,O,10503
154346,therapy,O,10503
154347,may,O,10503
154348,be,O,10503
154349,preferable,O,10503
154350,in,O,10503
154351,younger,O,10503
154352,patients,O,10503
154353,Contrarily,O,10504
154354,inflammation,O,10504
154355,itself,O,10504
154356,has,O,10504
154357,the,O,10504
154358,potential,O,10504
154359,to,O,10504
154360,result,O,10504
154361,in,O,10504
154362,the,O,10504
154363,formation,O,10504
154364,of,O,10504
154365,cataracts,B-NAME_OF_DISEASE,10504
154366,so,O,10504
154367,it,O,10504
154368,is,O,10504
154369,important,O,10504
154370,to,O,10504
154371,engage,O,10504
154372,these,O,10504
154373,patients,O,10504
154374,in,O,10504
154375,a,O,10504
154376,discussion,O,10504
154377,of,O,10504
154378,the,O,10504
154379,advantages,O,10504
154380,and,O,10504
154381,disadvantages,O,10504
154382,Patients,O,10505
154383,older,O,10505
154384,than,O,10505
154385,40,O,10505
154386,years,O,10505
154387,old,O,10505
154388,who,O,10505
154389,are,O,10505
154390,typically,O,10505
154391,more,O,10505
154392,prone,O,10505
154393,to,O,10505
154394,be,O,10505
154395,concerned,O,10505
154396,about,O,10505
154397,IOP,O,10505
154398,may,O,10505
154399,find,O,10505
154400,the,O,10505
154401,idea,O,10505
154402,of,O,10505
154403,cataract,B-TREATMENT,10505
154404,surgery,I-TREATMENT,10505
154405,to,O,10505
154406,be,O,10505
154407,less,O,10505
154408,intimidating,O,10505
154409,It,O,10506
154410,is,O,10506
154411,crucial,O,10506
154412,to,O,10506
154413,prevent,O,10506
154414,uveitis,B-NAME_OF_DISEASE,10506
154415,recurrences,O,10506
154416,throughout,O,10506
154417,time,O,10506
154418,regardless,O,10506
154419,of,O,10506
154420,the,O,10506
154421,patients,O,10506
154422,age,O,10506
154423,as,O,10506
154424,repeated,O,10506
154425,episodes,O,10506
154426,can,O,10506
154427,harm,O,10506
154428,ocular,O,10506
154429,structures,O,10506
154430,and,O,10506
154431,induce,O,10506
154432,vision,B-SIGN_AND_SYMPTOM,10506
154433,deterioration,I-SIGN_AND_SYMPTOM,10506
154434,Additionally,O,10507
154435,the,O,10507
154436,loss,O,10507
154437,of,O,10507
154438,retinal,B-PART_OF_THE_EYES,10507
154439,pigment,I-PART_OF_THE_EYES,10507
154440,epithelium,I-PART_OF_THE_EYES,10507
154441,brought,O,10507
154442,on,O,10507
154443,by,O,10507
154444,the,O,10507
154445,persistent,O,10507
154446,macular,B-NAME_OF_DISEASE,10507
154447,edema,I-NAME_OF_DISEASE,10507
154448,linked,O,10507
154449,to,O,10507
154450,recurrent,O,10507
154451,uveitis,B-NAME_OF_DISEASE,10507
154452,has,O,10507
154453,a,O,10507
154454,negative,O,10507
154455,impact,O,10507
154456,on,O,10507
154457,visual,O,10507
154458,acuity,O,10507
154459,When,O,10508
154460,treating,O,10508
154461,a,O,10508
154462,patient,O,10508
154463,with,O,10508
154464,noninfectious,B-NAME_OF_DISEASE,10508
154465,posterior,I-NAME_OF_DISEASE,10508
154466,uveitis,I-NAME_OF_DISEASE,10508
154467,the,O,10508
154468,right,O,10508
154469,therapy,O,10508
154470,must,O,10508
154471,be,O,10508
154472,chosen,O,10508
154473,on,O,10508
154474,an,O,10508
154475,individual,O,10508
154476,basis,O,10508
154477,much,O,10508
154478,like,O,10508
154479,the,O,10508
154480,diagnosis,O,10508
154481,Balancing,O,10509
154482,treatment,O,10509
154483,with,O,10509
154484,job,O,10509
154485,responsibilities,O,10509
154486,is,O,10509
154487,a,O,10509
154488,major,O,10509
154489,concern,O,10509
154490,for,O,10509
154491,many,O,10509
154492,adult,O,10509
154493,uveitis,B-NAME_OF_DISEASE,10509
154494,patients,O,10509
154495,Subtenon,B-TREATMENT,10510
154496,injections,I-TREATMENT,10510
154497,may,O,10510
154498,be,O,10510
154499,useful,O,10510
154500,in,O,10510
154501,some,O,10510
154502,situations,O,10510
154503,particularly,O,10510
154504,for,O,10510
154505,patients,O,10510
154506,with,O,10510
154507,cystoid,B-NAME_OF_DISEASE,10510
154508,macular,I-NAME_OF_DISEASE,10510
154509,edema,I-NAME_OF_DISEASE,10510
154510,To,O,10511
154511,provide,O,10511
154512,safe,O,10511
154513,effective,O,10511
154514,and,O,10511
154515,long-lasting,O,10511
154516,relief,O,10511
154517,from,O,10511
154518,uveitis,B-NAME_OF_DISEASE,10511
154519,symptoms,O,10511
154520,while,O,10511
154521,also,O,10511
154522,meeting,O,10511
154523,the,O,10511
154524,patients,O,10511
154525,demands,O,10511
154526,the,O,10511
154527,practitioner,O,10511
154528,must,O,10511
154529,take,O,10511
154530,into,O,10511
154531,account,O,10511
154532,all,O,10511
154533,of,O,10511
154534,these,O,10511
154535,criteria,O,10511
154536,The,B-NAME_OF_STUDY,10512
154537,Multicenter,I-NAME_OF_STUDY,10512
154538,Uveitis,I-NAME_OF_STUDY,10512
154539,Treatment,I-NAME_OF_STUDY,10512
154540,Trial,I-NAME_OF_STUDY,10512
154541,MUST,I-NAME_OF_STUDY,10512
154542,Over,O,10513
154543,a,O,10513
154544,7-year,B-TIME_DURATION,10513
154545,period,O,10513
154546,MUST,B-NAME_OF_STUDY,10513
154547,compared,O,10513
154548,the,B-TREATMENT,10513
154549,FAc,I-TREATMENT,10513
154550,0.59,O,10513
154551,mg,O,10513
154552,insert,O,10513
154553,with,O,10513
154554,systemic,O,10513
154555,therapy,O,10513
154556,prednisone,B-NAME_OF_DRUG,10513
154557,at,O,10513
154558,first,O,10513
154559,with,O,10513
154560,the,O,10513
154561,addition,O,10513
154562,of,O,10513
154563,an,B-NAME_OF_DRUG,10513
154564,immunosuppressive,I-NAME_OF_DRUG,10513
154565,drug,I-NAME_OF_DRUG,10513
154566,if,O,10513
154567,necessary,O,10513
154568,The,O,10514
154569,best,O,10514
154570,corrected,O,10514
154571,visual,O,10514
154572,acuity,O,10514
154573,BCVA,O,10514
154574,difference,O,10514
154575,between,O,10514
154576,the,B-TREATMENT,10514
154577,FAc,I-TREATMENT,10514
154578,implant,I-TREATMENT,10514
154579,and,O,10514
154580,systemic,B-TREATMENT,10514
154581,therapy,I-TREATMENT,10514
154582,groups,O,10514
154583,at,O,10514
154584,2,B-TIME_DURATION,10514
154585,years,I-TIME_DURATION,10514
154586,was,O,10514
154587,negligible,O,10514
154588,After,O,10515
154589,4.5,B-TIME_DURATION,10515
154590,years,I-TIME_DURATION,10515
154591,the,O,10515
154592,implant,O,10515
154593,offered,O,10515
154594,improved,O,10515
154595,inflammation,O,10515
154596,control,O,10515
154597,Nevertheless,O,10516
154598,after,O,10516
154599,7,B-TIME_DURATION,10516
154600,years,I-TIME_DURATION,10516
154601,180,O,10516
154602,patients,O,10516
154603,visual,O,10516
154604,outcomes,O,10516
154605,were,O,10516
154606,better,O,10516
154607,in,O,10516
154608,the,O,10516
154609,systemic,B-TREATMENT,10516
154610,therapy,I-TREATMENT,10516
154611,treatment,I-TREATMENT,10516
154612,group,O,10516
154613,despite,O,10516
154614,the,O,10516
154615,fact,O,10516
154616,that,O,10516
154617,those,O,10516
154618,getting,O,10516
154619,systemic,B-TREATMENT,10516
154620,therapy,I-TREATMENT,10516
154621,had,O,10516
154622,a,O,10516
154623,greater,O,10516
154624,risk,O,10516
154625,of,O,10516
154626,infections,O,10516
154627,that,O,10516
154628,required,O,10516
154629,antibiotic,B-TREATMENT,10516
154630,treatment,I-TREATMENT,10516
154631,At,O,10517
154632,7,B-TIME_DURATION,10517
154633,years,I-TIME_DURATION,10517
154634,45%,O,10517
154635,of,O,10517
154636,eyes,O,10517
154637,in,O,10517
154638,the,O,10517
154639,FAc,B-TREATMENT,10517
154640,implant,I-TREATMENT,10517
154641,group,O,10517
154642,had,O,10517
154643,undergone,O,10517
154644,glaucoma,B-TREATMENT,10517
154645,surgery,I-TREATMENT,10517
154646,compared,O,10517
154647,with,O,10517
154648,12%,O,10517
154649,of,O,10517
154650,eyes,O,10517
154651,in,O,10517
154652,the,O,10517
154653,systemic,B-TREATMENT,10517
154654,therapy,I-TREATMENT,10517
154655,group,O,10517
154656,In,O,10518
154657,phakic,O,10518
154658,eyes,O,10518
154659,90%,O,10518
154660,of,O,10518
154661,patients,O,10518
154662,in,O,10518
154663,the,O,10518
154664,implant,O,10518
154665,group,O,10518
154666,had,O,10518
154667,had,O,10518
154668,cataract,B-TREATMENT,10518
154669,surgery,I-TREATMENT,10518
154670,versus,O,10518
154671,50%,O,10518
154672,in,O,10518
154673,the,O,10518
154674,systemic,B-TREATMENT,10518
154675,therapy,I-TREATMENT,10518
154676,group,O,10518
154677,It,O,10519
154678,might,O,10519
154679,eventually,O,10519
154680,be,O,10519
154681,required,O,10519
154682,to,O,10519
154683,switch,O,10519
154684,patients,O,10519
154685,to,O,10519
154686,systemic,B-TREATMENT,10519
154687,therapy,I-TREATMENT,10519
154688,though,O,10519
154689,if,O,10519
154690,they,O,10519
154691,have,O,10519
154692,underlying,O,10519
154693,illnesses,O,10519
154694,such,O,10519
154695,systemic,B-NAME_OF_DISEASE,10519
154696,rheumatologic,I-NAME_OF_DISEASE,10519
154697,disease,I-NAME_OF_DISEASE,10519
154698,IOP,O,10520
154699,data,O,10520
154700,for,O,10520
154701,249,O,10520
154702,patients,O,10520
154703,were,O,10520
154704,available,O,10520
154705,in,O,10520
154706,relation,O,10520
154707,to,O,10520
154708,IOP,B-SIGN_AND_SYMPTOM,10520
154709,rises,I-SIGN_AND_SYMPTOM,10520
154710,with,O,10520
154711,FAc,B-TREATMENT,10520
154712,treatment,I-TREATMENT,10520
154713,in,O,10520
154714,MUST,B-NAME_OF_STUDY,10520
154715,IOP,O,10521
154716,was,O,10521
154717,elevated,O,10521
154718,by,O,10521
154719,at,O,10521
154720,least,O,10521
154721,10,O,10521
154722,mmHg,O,10521
154723,above,O,10521
154724,the,O,10521
154725,baseline,O,10521
154726,measurement,O,10521
154727,in,O,10521
154728,at,O,10521
154729,least,O,10521
154730,65%,O,10521
154731,of,O,10521
154732,patients,O,10521
154733,assigned,O,10521
154734,to,O,10521
154735,the,O,10521
154736,implant,O,10521
154737,and,O,10521
154738,in,O,10521
154739,only,O,10521
154740,24%,O,10521
154741,of,O,10521
154742,individuals,O,10521
154743,assigned,O,10521
154744,to,O,10521
154745,systemic,B-TREATMENT,10521
154746,medication,I-TREATMENT,10521
154747,in,O,10521
154748,the,O,10521
154749,first,O,10521
154750,two,B-TIME_DURATION,10521
154751,years,I-TIME_DURATION,10521
154752,of,O,10521
154753,follow-up,O,10521
154754,Over,O,10522
154755,the,O,10522
154756,course,O,10522
154757,of,O,10522
154758,the,O,10522
154759,two,B-TIME_DURATION,10522
154760,years,I-TIME_DURATION,10522
154761,32%,O,10522
154762,of,O,10522
154763,patients,O,10522
154764,allocated,O,10522
154765,to,O,10522
154766,the,O,10522
154767,implant,O,10522
154768,versus,O,10522
154769,5%,O,10522
154770,of,O,10522
154771,patients,O,10522
154772,assigned,O,10522
154773,to,O,10522
154774,systemic,B-TREATMENT,10522
154775,therapy,I-TREATMENT,10522
154776,underwent,O,10522
154777,surgical,O,10522
154778,intervention,O,10522
154779,P,O,10522
154780,0.001,O,10522
154781,and,O,10522
154782,69%,O,10522
154783,of,O,10522
154784,patients,O,10522
154785,assigned,O,10522
154786,to,O,10522
154787,the,O,10522
154788,implant,O,10522
154789,got,O,10522
154790,IOP-lowering,B-TREATMENT,10522
154791,therapy,I-TREATMENT,10522
154792,as,O,10522
154793,opposed,O,10522
154794,to,O,10522
154795,26%,O,10522
154796,in,O,10522
154797,the,O,10522
154798,systemic,B-TREATMENT,10522
154799,treatment,I-TREATMENT,10522
154800,arm,O,10522
154801,IOP,B-SIGN_AND_SYMPTOM,10523
154802,increases,I-SIGN_AND_SYMPTOM,10523
154803,were,O,10523
154804,frequent,O,10523
154805,in,O,10523
154806,the,O,10523
154807,first,O,10523
154808,year,O,10523
154809,for,O,10523
154810,implant,O,10523
154811,patients,O,10523
154812,58%,O,10523
154813,of,O,10523
154814,them,O,10523
154815,had,O,10523
154816,increases,O,10523
154817,of,O,10523
154818,at,O,10523
154819,least,O,10523
154820,10,O,10523
154821,mmHg,O,10523
154822,At,O,10524
154823,least,O,10524
154824,8,O,10524
154825,additional,O,10524
154826,patients,O,10524
154827,in,O,10524
154828,the,O,10524
154829,implant,O,10524
154830,group,O,10524
154831,experienced,O,10524
154832,incident,O,10524
154833,IOP,B-SIGN_AND_SYMPTOM,10524
154834,increase,I-SIGN_AND_SYMPTOM,10524
154835,of,O,10524
154836,10,O,10524
154837,mmHg,O,10524
154838,or,O,10524
154839,higher,O,10524
154840,at,O,10524
154841,12,B-TIME_DURATION,10524
154842,months,I-TIME_DURATION,10524
154843,In,O,10525
154844,patients,O,10525
154845,assigned,O,10525
154846,to,O,10525
154847,implants,O,10525
154848,the,O,10525
154849,median,O,10525
154850,period,O,10525
154851,from,O,10525
154852,implant,B-TREATMENT,10525
154853,surgery,I-TREATMENT,10525
154854,to,O,10525
154855,an,B-SIGN_AND_SYMPTOM,10525
154856,IOP,I-SIGN_AND_SYMPTOM,10525
154857,increase,I-SIGN_AND_SYMPTOM,10525
154858,of,O,10525
154859,at,O,10525
154860,least,O,10525
154861,10,O,10525
154862,mmHg,O,10525
154863,was,O,10525
154864,9,B-TIME_DURATION,10525
154865,months,I-TIME_DURATION,10525
154866,Once,O,10526
154867,an,O,10526
154868,incident,O,10526
154869,occurred,O,10526
154870,in,O,10526
154871,one,O,10526
154872,eye,O,10526
154873,of,O,10526
154874,patients,O,10526
154875,with,O,10526
154876,bilateral,O,10526
154877,implants,O,10526
154878,the,O,10526
154879,chance,O,10526
154880,of,O,10526
154881,an,B-SIGN_AND_SYMPTOM,10526
154882,IOP,I-SIGN_AND_SYMPTOM,10526
154883,increase,I-SIGN_AND_SYMPTOM,10526
154884,or,O,10526
154885,of,O,10526
154886,needing,O,10526
154887,IOP-lowering,B-TREATMENT,10526
154888,surgery,I-TREATMENT,10526
154889,was,O,10526
154890,greater,O,10526
154891,in,O,10526
154892,the,O,10526
154893,other,O,10526
154894,eye,O,10526
154895,Nine,O,10527
154896,of,O,10527
154897,the,O,10527
154898,27,O,10527
154899,23%,O,10527
154900,participants,O,10527
154901,allocated,O,10527
154902,to,O,10527
154903,receive,O,10527
154904,implants,O,10527
154905,also,O,10527
154906,developed,O,10527
154907,glaucoma,B-NAME_OF_DISEASE,10527
154908,in,O,10527
154909,both,O,10527
154910,eyes,O,10527
154911,Regardless,O,10528
154912,of,O,10528
154913,the,O,10528
154914,initial,O,10528
154915,treatment,O,10528
154916,method,O,10528
154917,all,O,10528
154918,cases,O,10528
154919,of,O,10528
154920,glaucoma,B-NAME_OF_DISEASE,10528
154921,that,O,10528
154922,were,O,10528
154923,seen,O,10528
154924,were,O,10528
154925,in,O,10528
154926,eyes,O,10528
154927,that,O,10528
154928,received,O,10528
154929,implants,O,10528
154930,with,O,10528
154931,the,O,10528
154932,exception,O,10528
154933,of,O,10528
154934,4,O,10528
154935,eyes,O,10528
154936,in,O,10528
154937,4,O,10528
154938,patients,O,10528
154939,IOP,O,10529
154940,reaction,O,10529
154941,to,O,10529
154942,steroids,B-NAME_OF_DRUG,10529
154943,is,O,10529
154944,typically,O,10529
154945,quite,O,10529
154946,predictable,O,10529
154947,It,O,10530
154948,is,O,10530
154949,improbable,O,10530
154950,that,O,10530
154951,someone,O,10530
154952,who,O,10530
154953,doesnt,O,10530
154954,respond,O,10530
154955,to,O,10530
154956,steroids,B-NAME_OF_DRUG,10530
154957,early,O,10530
154958,on,O,10530
154959,will,O,10530
154960,do,O,10530
154961,so,O,10530
154962,later,O,10530
154963,The,O,10531
154964,MUST,B-NAME_OF_STUDY,10531
154965,investigators,O,10531
154966,advised,O,10531
154967,that,O,10531
154968,all,O,10531
154969,patients,O,10531
154970,receiving,O,10531
154971,the,B-TREATMENT,10531
154972,FAc,I-TREATMENT,10531
154973,implant,I-TREATMENT,10531
154974,should,O,10531
154975,have,O,10531
154976,their,O,10531
154977,IOP,O,10531
154978,checked,O,10531
154979,at,O,10531
154980,least,O,10531
154981,every,O,10531
154982,6,O,10531
154983,weeks,O,10531
154984,and,O,10531
154985,possibly,O,10531
154986,more,O,10531
154987,frequently,O,10531
154988,due,O,10531
154989,to,O,10531
154990,the,O,10531
154991,risk,O,10531
154992,of,O,10531
154993,damage,O,10531
154994,if,O,10531
154995,left,O,10531
154996,untreated,O,10531
154997,Patients,O,10532
154998,with,O,10532
154999,non-infectious,B-NAME_OF_DISEASE,10532
155000,posterior,I-NAME_OF_DISEASE,10532
155001,uveitis,I-NAME_OF_DISEASE,10532
155002,will,O,10532
155003,probably,O,10532
155004,need,O,10532
155005,many,O,10532
155006,office,O,10532
155007,visits,O,10532
155008,and,O,10532
155009,collaboration,O,10532
155010,with,O,10532
155011,different,O,10532
155012,medical,O,10532
155013,specialists,O,10532
155014,Uveitis,B-NAME_OF_DISEASE,10533
155015,patients,O,10533
155016,now,O,10533
155017,have,O,10533
155018,more,O,10533
155019,e­,O,10533
155020,icacious,O,10533
155021,safer,O,10533
155022,and,O,10533
155023,less,O,10533
155024,expensive,O,10533
155025,treatment,O,10533
155026,alternatives,O,10533
155027,which,O,10533
155028,o­,O,10533
155029,er,O,10533
155030,a,O,10533
155031,larger,O,10533
155032,promise,O,10533
155033,for,O,10533
155034,preserving,O,10533
155035,eyesight,O,10533
155036,independence,O,10533
155037,and,O,10533
155038,quality-of-life,O,10533
155039,over,O,10533
155040,the,O,10533
155041,long,O,10533
155042,term,O,10533
155043,Carotenoids,B-CHEMICAL_COMPOUND,10534
155044,in,O,10534
155045,food,O,10534
155046,substances,O,10534
155047,are,O,10534
155048,believed,O,10534
155049,to,O,10534
155050,have,O,10534
155051,health,O,10534
155052,benefits,O,10534
155053,by,O,10534
155054,lowering,O,10534
155055,the,O,10534
155056,risk,O,10534
155057,of,O,10534
155058,diseases,O,10534
155059,Lutein,B-CHEMICAL_COMPOUND,10535
155060,a,O,10535
155061,carotenoid,B-CHEMICAL_COMPOUND,10535
155062,compound,O,10535
155063,is,O,10535
155064,one,O,10535
155065,of,O,10535
155066,the,O,10535
155067,essential,O,10535
155068,nutrients,O,10535
155069,available,O,10535
155070,in,O,10535
155071,green,O,10535
155072,leafy,O,10535
155073,vegetables,O,10535
155074,kale,O,10535
155075,broccoli,O,10535
155076,spinach,O,10535
155077,lettuce,O,10535
155078,and,O,10535
155079,peas,O,10535
155080,along,O,10535
155081,with,O,10535
155082,other,O,10535
155083,foods,O,10535
155084,such,O,10535
155085,as,O,10535
155086,eggs,O,10535
155087,As,O,10536
155088,nutrition,O,10536
155089,plays,O,10536
155090,a,O,10536
155091,pivotal,O,10536
155092,role,O,10536
155093,in,O,10536
155094,maintaining,O,10536
155095,human,O,10536
155096,health,O,10536
155097,lutein,B-CHEMICAL_COMPOUND,10536
155098,as,O,10536
155099,a,O,10536
155100,nutritional,O,10536
155101,substance,O,10536
155102,confers,O,10536
155103,promising,O,10536
155104,benefits,O,10536
155105,against,O,10536
155106,numerous,O,10536
155107,health,O,10536
155108,issues,O,10536
155109,including,O,10536
155110,neurological,B-NAME_OF_DISEASE,10536
155111,disorders,I-NAME_OF_DISEASE,10536
155112,eye,O,10536
155113,diseases,O,10536
155114,skin,O,10536
155115,irritation,O,10536
155116,etc,O,10536
155117,Lutein,B-CHEMICAL_COMPOUND,10537
155118,zeaxanthin,B-CHEMICAL_COMPOUND,10537
155119,and,O,10537
155120,meso-zeaxanthin,B-CHEMICAL_COMPOUND,10537
155121,are,O,10537
155122,the,O,10537
155123,only,O,10537
155124,carotenoids,B-CHEMICAL_COMPOUND,10537
155125,found,O,10537
155126,in,O,10537
155127,the,B-PART_OF_THE_EYES,10537
155128,human,I-PART_OF_THE_EYES,10537
155129,macula,I-PART_OF_THE_EYES,10537
155130,and,O,10537
155131,may,O,10537
155132,have,O,10537
155133,a,O,10537
155134,role,O,10537
155135,in,O,10537
155136,visual,O,10537
155137,function,O,10537
155138,These,O,10538
155139,carotenoids,B-CHEMICAL_COMPOUND,10538
155140,are,O,10538
155141,reported,O,10538
155142,to,O,10538
155143,protect,O,10538
155144,the,B-PART_OF_THE_EYES,10538
155145,retina,I-PART_OF_THE_EYES,10538
155146,and,O,10538
155147,thus,O,10538
155148,vision,O,10538
155149,as,O,10538
155150,antioxidants,B-CHEMICAL_COMPOUND,10538
155151,and,O,10538
155152,by,O,10538
155153,acting,O,10538
155154,as,O,10538
155155,a,O,10538
155156,blue,O,10538
155157,light,O,10538
155158,filter,O,10538
155159,Lutein,B-CHEMICAL_COMPOUND,10539
155160,and,O,10539
155161,zeaxanthin,B-CHEMICAL_COMPOUND,10539
155162,are,O,10539
155163,xanthophyll,B-CHEMICAL_COMPOUND,10539
155164,carotenoids,I-CHEMICAL_COMPOUND,10539
155165,Humans,O,10540
155166,cannot,O,10540
155167,synthesize,O,10540
155168,lutein,B-CHEMICAL_COMPOUND,10540
155169,and,O,10540
155170,zeaxanthin,B-CHEMICAL_COMPOUND,10540
155171,and,O,10540
155172,must,O,10540
155173,obtain,O,10540
155174,these,O,10540
155175,from,O,10540
155176,their,O,10540
155177,diet,O,10540
155178,Sources,O,10541
155179,of,O,10541
155180,lutein,B-CHEMICAL_COMPOUND,10541
155181,and,O,10541
155182,zeaxanthin,B-CHEMICAL_COMPOUND,10541
155183,include,O,10541
155184,green,O,10541
155185,leafy,O,10541
155186,vegetables,O,10541
155187,egg,O,10541
155188,yolks,O,10541
155189,corn,O,10541
155190,and,O,10541
155191,squash,O,10541
155192,Of,O,10542
155193,the,O,10542
155194,1000,O,10542
155195,carotenoids,B-CHEMICAL_COMPOUND,10542
155196,found,O,10542
155197,in,O,10542
155198,nature,O,10542
155199,only,O,10542
155200,lutein,B-CHEMICAL_COMPOUND,10542
155201,and,O,10542
155202,zeaxanthin,B-CHEMICAL_COMPOUND,10542
155203,and,O,10542
155204,their,O,10542
155205,metabolites,O,10542
155206,are,O,10542
155207,present,O,10542
155208,in,O,10542
155209,the,B-PART_OF_THE_EYES,10542
155210,human,I-PART_OF_THE_EYES,10542
155211,macula,I-PART_OF_THE_EYES,10542
155212,Collectively,O,10543
155213,lutein,B-CHEMICAL_COMPOUND,10543
155214,zeaxanthin,B-CHEMICAL_COMPOUND,10543
155215,and,O,10543
155216,meso-zeaxanthin,B-CHEMICAL_COMPOUND,10543
155217,an,O,10543
155218,isomer,O,10543
155219,of,O,10543
155220,zeaxanthin,B-CHEMICAL_COMPOUND,10543
155221,comprise,O,10543
155222,the,B-PART_OF_THE_EYES,10543
155223,macular,I-PART_OF_THE_EYES,10543
155224,pigment,I-PART_OF_THE_EYES,10543
155225,MPOD,B-DIAGNOSTIC_TEST,10544
155226,is,O,10544
155227,measured,O,10544
155228,in,O,10544
155229,optical,O,10544
155230,density,O,10544
155231,units,O,10544
155232,and,O,10544
155233,ranges,O,10544
155234,between,O,10544
155235,0,O,10544
155236,and,O,10544
155237,1,O,10544
155238,A,O,10545
155239,recent,O,10545
155240,systematic,O,10545
155241,review,O,10545
155242,reported,O,10545
155243,a,O,10545
155244,positive,O,10545
155245,association,O,10545
155246,between,O,10545
155247,MPOD,B-DIAGNOSTIC_TEST,10545
155248,and,O,10545
155249,visual,O,10545
155250,function,O,10545
155251,including,O,10545
155252,correlations,O,10545
155253,with,O,10545
155254,contrast,O,10545
155255,sensitivity,O,10545
155256,photostress,O,10545
155257,recovery,O,10545
155258,and,O,10545
155259,glare,O,10545
155260,disability,O,10545
155261,Although,O,10546
155262,the,B-CHEMICAL_COMPOUND,10546
155263,carotenoid,I-CHEMICAL_COMPOUND,10546
155264,lutein,I-CHEMICAL_COMPOUND,10546
155265,and,O,10546
155266,its,O,10546
155267,related,O,10546
155268,form,O,10546
155269,called,O,10546
155270,zeaxanthin,B-CHEMICAL_COMPOUND,10546
155271,have,O,10546
155272,been,O,10546
155273,associated,O,10546
155274,with,O,10546
155275,eye,O,10546
155276,health,O,10546
155277,for,O,10546
155278,some,O,10546
155279,time,O,10546
155280,the,O,10546
155281,amount,O,10546
155282,that,O,10546
155283,provides,O,10546
155284,benefit,O,10546
155285,has,O,10546
155286,yet,O,10546
155287,to,O,10546
155288,be,O,10546
155289,quantified,O,10546
155290,Macular,B-PART_OF_THE_EYES,10547
155291,pigment,I-PART_OF_THE_EYES,10547
155292,is,O,10547
155293,a,O,10547
155294,key,O,10547
155295,structure,O,10547
155296,in,O,10547
155297,the,O,10547
155298,eye,O,10547
155299,protecting,O,10547
155300,the,B-PART_OF_THE_EYES,10547
155301,retina,I-PART_OF_THE_EYES,10547
155302,from,O,10547
155303,damaging,O,10547
155304,blue,O,10547
155305,light,O,10547
155306,This,O,10548
155307,systematic,O,10548
155308,review,O,10548
155309,reports,O,10548
155310,that,O,10548
155311,lutein,B-CHEMICAL_COMPOUND,10548
155312,and,O,10548
155313,zeaxanthin,B-CHEMICAL_COMPOUND,10548
155314,intake,O,10548
155315,at,O,10548
155316,doses,O,10548
155317,10,O,10548
155318,mg,O,10548
155319,or,O,10548
155320,more,O,10548
155321,increases,O,10548
155322,macular,B-PART_OF_THE_EYES,10548
155323,pigment,I-PART_OF_THE_EYES,10548
155324,density,O,10548
155325,in,O,10548
155326,adults,O,10548
155327,with,O,10548
155328,healthy,O,10548
155329,eyes,O,10548
155330,An,O,10549
155331,important,O,10549
155332,gap,O,10549
155333,is,O,10549
155334,to,O,10549
155335,study,O,10549
155336,whether,O,10549
155337,levels,O,10549
155338,below,O,10549
155339,10,O,10549
155340,mg,O,10549
155341,when,O,10549
155342,consumed,O,10549
155343,regularly,O,10549
155344,as,O,10549
155345,part,O,10549
155346,of,O,10549
155347,a,O,10549
155348,diet,O,10549
155349,over,O,10549
155350,years,O,10549
155351,not,O,10549
155352,just,O,10549
155353,a,O,10549
155354,few,O,10549
155355,months,O,10549
155356,has,O,10549
155357,impact,O,10549
155358,on,O,10549
155359,macular,B-PART_OF_THE_EYES,10549
155360,pigment,I-PART_OF_THE_EYES,10549
155361,comparable,O,10549
155362,to,O,10549
155363,short-term,O,10549
155364,higher,O,10549
155365,supplementation,O,10549
155366,According,O,10550
155367,to,O,10550
155368,senior,O,10550
155369,author,O,10550
155370,Dr,B-PERSON,10550
155371,Karen,I-PERSON,10550
155372,Robinson,I-PERSON,10550
155373,Our,O,10550
155374,review,O,10550
155375,was,O,10550
155376,the,O,10550
155377,first,O,10550
155378,to,O,10550
155379,evaluate,O,10550
155380,the,O,10550
155381,effects,O,10550
155382,of,O,10550
155383,both,O,10550
155384,dietary,O,10550
155385,and,O,10550
155386,supplemental,O,10550
155387,sources,O,10550
155388,of,O,10550
155389,lutein,B-CHEMICAL_COMPOUND,10550
155390,on,O,10550
155391,healthy,O,10550
155392,eyes,O,10550
155393,According,O,20000
155394,to,O,20000
155395,a,O,20000
155396,small,O,20000
155397,randomized,O,20000
155398,trial,O,20000
155399,conducted,O,20000
155400,at,O,20000
155401,the,B-ORGANIZATION,20000
155402,University,I-ORGANIZATION,20000
155403,of,I-ORGANIZATION,20000
155404,California,I-ORGANIZATION,20000
155405,Davis,I-ORGANIZATION,20000
155406,eating,O,20000
155407,a,O,20000
155408,small,O,20000
155409,serving,O,20000
155410,of,O,20000
155411,dried,O,20000
155412,goji,O,20000
155413,berries,O,20000
155414,on,O,20000
155415,a,O,20000
155416,regular,O,20000
155417,basis,O,20000
155418,may,O,20000
155419,help,O,20000
155420,prevent,O,20000
155421,or,O,20000
155422,delay,O,20000
155423,the,O,20000
155424,development,O,20000
155425,of,O,20000
155426,age-related,B-NAME_OF_DISEASE,20000
155427,macular,I-NAME_OF_DISEASE,20000
155428,degeneration,I-NAME_OF_DISEASE,20000
155429,AMD,I-NAME_OF_DISEASE,20000
155430,in,O,20000
155431,healthy,O,20000
155432,middle-aged,O,20000
155433,people,O,20000
155434,AMD,B-NAME_OF_DISEASE,20001
155435,is,O,20001
155436,the,O,20001
155437,main,O,20001
155438,cause,O,20001
155439,of,O,20001
155440,vision,B-SIGN_AND_SYMPTOM,20001
155441,loss,I-SIGN_AND_SYMPTOM,20001
155442,in,O,20001
155443,the,O,20001
155444,elderly,O,20001
155445,affecting,O,20001
155446,more,O,20001
155447,than,O,20001
155448,11,O,20001
155449,million,O,20001
155450,people,O,20001
155451,in,O,20001
155452,the,B-GPE,20001
155453,United,I-GPE,20001
155454,States,I-GPE,20001
155455,and,O,20001
155456,170,O,20001
155457,million,O,20001
155458,worldwide,O,20001
155459,AMD,B-NAME_OF_DISEASE,20002
155460,affects,O,20002
155461,your,O,20002
155462,central,O,20002
155463,field,O,20002
155464,of,O,20002
155465,vision,O,20002
155466,and,O,20002
155467,can,O,20002
155468,affect,O,20002
155469,your,O,20002
155470,ability,O,20002
155471,to,O,20002
155472,read,O,20002
155473,or,O,20002
155474,recognize,O,20002
155475,faces,O,20002
155476,said,O,20002
155477,Glenn,B-PERSON,20002
155478,Yiu,I-PERSON,20002
155479,a,O,20002
155480,co-author,O,20002
155481,of,O,20002
155482,the,O,20002
155483,study,O,20002
155484,and,O,20002
155485,an,O,20002
155486,associate,O,20002
155487,professor,O,20002
155488,in,O,20002
155489,the,B-ORGANIZATION,20002
155490,Department,I-ORGANIZATION,20002
155491,of,I-ORGANIZATION,20002
155492,Ophthalmology,I-ORGANIZATION,20002
155493,and,I-ORGANIZATION,20002
155494,Vision,I-ORGANIZATION,20002
155495,Sciences,I-ORGANIZATION,20002
155496,The,O,20003
155497,researchers,O,20003
155498,discovered,O,20003
155499,that,O,20003
155500,eating,O,20003
155501,28,O,20003
155502,grams,O,20003
155503,about,O,20003
155504,one,O,20003
155505,ounce,O,20003
155506,or,O,20003
155507,a,O,20003
155508,handful,O,20003
155509,of,O,20003
155510,goji,O,20003
155511,berries,O,20003
155512,five,O,20003
155513,times,O,20003
155514,a,O,20003
155515,week,O,20003
155516,for,B-TIME_DURATION,20003
155517,90,I-TIME_DURATION,20003
155518,days,I-TIME_DURATION,20003
155519,increased,O,20003
155520,the,O,20003
155521,density,O,20003
155522,of,O,20003
155523,protective,O,20003
155524,pigments,O,20003
155525,in,O,20003
155526,the,O,20003
155527,eyes,O,20003
155528,of,O,20003
155529,13,O,20003
155530,healthy,O,20003
155531,volunteers,O,20003
155532,aged,O,20003
155533,45,O,20003
155534,to,O,20003
155535,65,O,20003
155536,The,O,20004
155537,pigments,O,20004
155538,lutein,B-CHEMICAL_COMPOUND,20004
155539,and,O,20004
155540,zeaxanthin,B-CHEMICAL_COMPOUND,20004
155541,which,O,20004
155542,increased,O,20004
155543,in,O,20004
155544,the,O,20004
155545,group,O,20004
155546,that,O,20004
155547,ate,O,20004
155548,goji,O,20004
155549,berries,O,20004
155550,filter,O,20004
155551,out,O,20004
155552,harmful,O,20004
155553,blue,O,20004
155554,light,O,20004
155555,and,O,20004
155556,provide,O,20004
155557,antioxidant,O,20004
155558,protection,O,20004
155559,Lutein,B-CHEMICAL_COMPOUND,20005
155560,and,O,20005
155561,zeaxanthin,B-CHEMICAL_COMPOUND,20005
155562,are,O,20005
155563,like,O,20005
155564,sunscreen,O,20005
155565,for,O,20005
155566,your,O,20005
155567,eyes,O,20005
155568,said,O,20005
155569,lead,O,20005
155570,author,O,20005
155571,Xiang,B-PERSON,20005
155572,Li,I-PERSON,20005
155573,a,O,20005
155574,doctoral,O,20005
155575,candidate,O,20005
155576,in,O,20005
155577,the,B-NAME_OF_STUDY,20005
155578,Nutritional,I-NAME_OF_STUDY,20005
155579,Biology,I-NAME_OF_STUDY,20005
155580,Program,I-NAME_OF_STUDY,20005
155581,The,O,20006
155582,higher,O,20006
155583,the,O,20006
155584,lutein,B-CHEMICAL_COMPOUND,20006
155585,and,O,20006
155586,zeaxanthin,B-CHEMICAL_COMPOUND,20006
155587,in,O,20006
155588,your,O,20006
155589,retina,B-PART_OF_THE_EYES,20006
155590,the,O,20006
155591,more,O,20006
155592,protection,O,20006
155593,you,O,20006
155594,have,O,20006
155595,Our,O,20007
155596,study,O,20007
155597,found,O,20007
155598,that,O,20007
155599,even,O,20007
155600,in,O,20007
155601,normal,O,20007
155602,healthy,O,20007
155603,eyes,O,20007
155604,these,O,20007
155605,optical,O,20007
155606,pigments,O,20007
155607,can,O,20007
155608,be,O,20007
155609,increased,O,20007
155610,with,O,20007
155611,a,O,20007
155612,small,O,20007
155613,daily,O,20007
155614,serving,O,20007
155615,of,O,20007
155616,goji,O,20007
155617,berries,O,20007
155618,said,O,20007
155619,Li,B-PERSON,20007
155620,The,O,20008
155621,study,O,20008
155622,was,O,20008
155623,published,O,20008
155624,in,O,20008
155625,the,B-PUBLICATION_VENUE,20008
155626,journal,I-PUBLICATION_VENUE,20008
155627,Nutrients,I-PUBLICATION_VENUE,20008
155628,Goji,O,20009
155629,berries,O,20009
155630,are,O,20009
155631,the,O,20009
155632,fruit,O,20009
155633,of,O,20009
155634,two,O,20009
155635,shrubby,O,20009
155636,bushes,O,20009
155637,found,O,20009
155638,in,O,20009
155639,northwest,O,20009
155640,China,B-GPE,20009
155641,Lycium,O,20009
155642,chinense,O,20009
155643,and,O,20009
155644,Lycium,O,20009
155645,barbarum,O,20009
155646,Li,B-PERSON,20010
155647,was,O,20010
155648,raised,O,20010
155649,in,O,20010
155650,northern,O,20010
155651,China,B-GPE,20010
155652,and,O,20010
155653,became,O,20010
155654,interested,O,20010
155655,in,O,20010
155656,whether,O,20010
155657,eye,O,20010
155658,lightening,O,20010
155659,had,O,20010
155660,any,O,20010
155661,physiological,O,20010
155662,properties,O,20010
155663,Many,O,20011
155664,types,O,20011
155665,of,O,20011
155666,eye,O,20011
155667,diseases,O,20011
155668,exist,O,20011
155669,so,O,20011
155670,it,O,20011
155671,is,O,20011
155672,not,O,20011
155673,clear,O,20011
155674,which,O,20011
155675,disease,O,20011
155676,eye,O,20011
155677,brightening,O,20011
155678,is,O,20011
155679,targeting,O,20011
155680,said,O,20011
155681,Li,B-PERSON,20011
155682,Li,B-PERSON,20012
155683,looked,O,20012
155684,into,O,20012
155685,the,O,20012
155686,bioactive,O,20012
155687,chemicals,O,20012
155688,in,O,20012
155689,goji,O,20012
155690,berries,O,20012
155691,and,O,20012
155692,discovered,O,20012
155693,that,O,20012
155694,they,O,20012
155695,contain,O,20012
155696,a,O,20012
155697,lot,O,20012
155698,of,O,20012
155699,lutein,B-CHEMICAL_COMPOUND,20012
155700,and,O,20012
155701,zeaxanthin,B-CHEMICAL_COMPOUND,20012
155702,which,O,20012
155703,are,O,20012
155704,known,O,20012
155705,to,O,20012
155706,lessen,O,20012
155707,the,O,20012
155708,risk,O,20012
155709,of,O,20012
155710,AMD-related,B-NAME_OF_DISEASE,20012
155711,eye,I-NAME_OF_DISEASE,20012
155712,diseases,I-NAME_OF_DISEASE,20012
155713,According,O,20013
155714,to,O,20013
155715,Li,B-PERSON,20013
155716,the,O,20013
155717,type,O,20013
155718,of,O,20013
155719,zeaxanthin,B-CHEMICAL_COMPOUND,20013
155720,found,O,20013
155721,in,O,20013
155722,goji,O,20013
155723,berries,O,20013
155724,is,O,20013
155725,also,O,20013
155726,a,O,20013
155727,highly,O,20013
155728,bioavailable,O,20013
155729,form,O,20013
155730,meaning,O,20013
155731,it,O,20013
155732,is,O,20013
155733,easily,O,20013
155734,absorbed,O,20013
155735,in,O,20013
155736,the,O,20013
155737,digestive,O,20013
155738,system,O,20013
155739,so,O,20013
155740,the,O,20013
155741,body,O,20013
155742,can,O,20013
155743,üşe,O,20013
155744,it,O,20013
155745,The,O,20014
155746,current,O,20014
155747,treatment,O,20014
155748,for,O,20014
155749,intermediate,O,20014
155750,stages,O,20014
155751,of,O,20014
155752,AMD,B-NAME_OF_DISEASE,20014
155753,is,O,20014
155754,dietary,O,20014
155755,supplements,O,20014
155756,containing,O,20014
155757,vitamins,B-CHEMICAL_COMPOUND,20014
155758,C,I-CHEMICAL_COMPOUND,20014
155759,E,I-CHEMICAL_COMPOUND,20014
155760,zinc,B-CHEMICAL_COMPOUND,20014
155761,copper,B-CHEMICAL_COMPOUND,20014
155762,lutein,B-CHEMICAL_COMPOUND,20014
155763,and,O,20014
155764,zeaxanthin,B-CHEMICAL_COMPOUND,20014
155765,known,O,20014
155766,as,O,20014
155767,AREDS,B-TREATMENT,20014
155768,There,O,20015
155769,is,O,20015
155770,no,O,20015
155771,recognized,O,20015
155772,therapy,O,20015
155773,that,O,20015
155774,has,O,20015
155775,been,O,20015
155776,shown,O,20015
155777,to,O,20015
155778,affect,O,20015
155779,AMD,B-NAME_OF_DISEASE,20015
155780,in,O,20015
155781,its,O,20015
155782,early,O,20015
155783,stages,O,20015
155784,According,O,20016
155785,to,O,20016
155786,Yiu,B-PERSON,20016
155787,the,O,20016
155788,cause,O,20016
155789,of,O,20016
155790,AMD,B-NAME_OF_DISEASE,20016
155791,is,O,20016
155792,complicated,O,20016
155793,and,O,20016
155794,multifactorial,O,20016
155795,involving,O,20016
155796,a,O,20016
155797,combination,O,20016
155798,of,O,20016
155799,inherited,B-CAUSE_OF_DISEASE,20016
155800,risks,I-CAUSE_OF_DISEASE,20016
155801,age-related,B-CAUSE_OF_DISEASE,20016
155802,changes,I-CAUSE_OF_DISEASE,20016
155803,and,O,20016
155804,environmental,B-CAUSE_OF_DISEASE,20016
155805,variables,I-CAUSE_OF_DISEASE,20016
155806,such,I-CAUSE_OF_DISEASE,20016
155807,as,I-CAUSE_OF_DISEASE,20016
155808,smoking,I-CAUSE_OF_DISEASE,20016
155809,food,I-CAUSE_OF_DISEASE,20016
155810,and,I-CAUSE_OF_DISEASE,20016
155811,sun,I-CAUSE_OF_DISEASE,20016
155812,exposure,I-CAUSE_OF_DISEASE,20016
155813,Our,O,20017
155814,study,O,20017
155815,shows,O,20017
155816,goji,O,20017
155817,berries,O,20017
155818,which,O,20017
155819,are,O,20017
155820,a,O,20017
155821,natural,O,20017
155822,food,O,20017
155823,source,O,20017
155824,can,O,20017
155825,improve,O,20017
155826,macular,O,20017
155827,pigments,O,20017
155828,of,O,20017
155829,healthy,O,20017
155830,participants,O,20017
155831,beyond,O,20017
155832,taking,O,20017
155833,high-dose,O,20017
155834,nutritional,O,20017
155835,supplements,O,20017
155836,said,O,20017
155837,Yiu,B-PERSON,20017
155838,The,O,20018
155839,next,O,20018
155840,step,O,20018
155841,for,O,20018
155842,our,O,20018
155843,research,O,20018
155844,will,O,20018
155845,be,O,20018
155846,to,O,20018
155847,examine,O,20018
155848,goji,O,20018
155849,berries,O,20018
155850,in,O,20018
155851,patients,O,20018
155852,with,O,20018
155853,early-stage,O,20018
155854,AMD,B-NAME_OF_DISEASE,20018
155855,In,O,20019
155856,posterior,B-NAME_OF_DISEASE,20019
155857,vitreous,I-NAME_OF_DISEASE,20019
155858,detachment,I-NAME_OF_DISEASE,20019
155859,PVD,I-NAME_OF_DISEASE,20019
155860,the,O,20019
155861,gel,O,20019
155862,that,O,20019
155863,fills,O,20019
155864,the,B-PART_OF_THE_EYES,20019
155865,eyeball,I-PART_OF_THE_EYES,20019
155866,separates,O,20019
155867,from,O,20019
155868,the,B-PART_OF_THE_EYES,20019
155869,retina,I-PART_OF_THE_EYES,20019
155870,The,B-PART_OF_THE_EYES,20020
155871,retina,I-PART_OF_THE_EYES,20020
155872,is,O,20020
155873,a,O,20020
155874,thin,O,20020
155875,layer,O,20020
155876,of,O,20020
155877,nerve,B-PART_OF_THE_EYES,20020
155878,tissue,I-PART_OF_THE_EYES,20020
155879,that,O,20020
155880,lines,O,20020
155881,the,O,20020
155882,back,O,20020
155883,of,O,20020
155884,the,B-PART_OF_THE_EYES,20020
155885,eyeball,I-PART_OF_THE_EYES,20020
155886,Posterior,B-NAME_OF_DISEASE,20021
155887,vitreous,I-NAME_OF_DISEASE,20021
155888,detachment,I-NAME_OF_DISEASE,20021
155889,is,O,20021
155890,a,O,20021
155891,common,O,20021
155892,condition,O,20021
155893,with,O,20021
155894,age,O,20021
155895,PVD,B-NAME_OF_DISEASE,20022
155896,can,O,20022
155897,cause,O,20022
155898,floaters,B-SIGN_AND_SYMPTOM,20022
155899,or,I-SIGN_AND_SYMPTOM,20022
155900,flashes,I-SIGN_AND_SYMPTOM,20022
155901,of,I-SIGN_AND_SYMPTOM,20022
155902,light,I-SIGN_AND_SYMPTOM,20022
155903,which,I-SIGN_AND_SYMPTOM,20022
155904,often,I-SIGN_AND_SYMPTOM,20022
155905,fade,I-SIGN_AND_SYMPTOM,20022
155906,over,I-SIGN_AND_SYMPTOM,20022
155907,time,I-SIGN_AND_SYMPTOM,20022
155908,PVD,B-NAME_OF_DISEASE,20023
155909,isnt,O,20023
155910,painful,O,20023
155911,or,O,20023
155912,sight-threatening,O,20023
155913,The,O,20024
155914,most,O,20024
155915,common,O,20024
155916,symptom,O,20024
155917,of,O,20024
155918,vitreous,B-NAME_OF_DISEASE,20024
155919,detachment,I-NAME_OF_DISEASE,20024
155920,is,O,20024
155921,a,B-SIGN_AND_SYMPTOM,20024
155922,sudden,I-SIGN_AND_SYMPTOM,20024
155923,increase,I-SIGN_AND_SYMPTOM,20024
155924,in,I-SIGN_AND_SYMPTOM,20024
155925,floaters,I-SIGN_AND_SYMPTOM,20024
155926,small,I-SIGN_AND_SYMPTOM,20024
155927,dark,I-SIGN_AND_SYMPTOM,20024
155928,spots,I-SIGN_AND_SYMPTOM,20024
155929,or,I-SIGN_AND_SYMPTOM,20024
155930,squiggly,I-SIGN_AND_SYMPTOM,20024
155931,lines,I-SIGN_AND_SYMPTOM,20024
155932,that,I-SIGN_AND_SYMPTOM,20024
155933,float,I-SIGN_AND_SYMPTOM,20024
155934,across,I-SIGN_AND_SYMPTOM,20024
155935,your,I-SIGN_AND_SYMPTOM,20024
155936,vision,I-SIGN_AND_SYMPTOM,20024
155937,When,O,20025
155938,your,O,20025
155939,vitreous,O,20025
155940,detaches,O,20025
155941,strands,O,20025
155942,of,O,20025
155943,the,O,20025
155944,vitreous,O,20025
155945,often,O,20025
155946,cast,O,20025
155947,new,O,20025
155948,shadows,O,20025
155949,on,O,20025
155950,your,O,20025
155951,retina,B-PART_OF_THE_EYES,20025
155952,and,O,20025
155953,those,O,20025
155954,shadows,O,20025
155955,appear,O,20025
155956,as,O,20025
155957,floaters,B-SIGN_AND_SYMPTOM,20025
155958,The,O,20026
155959,patient,O,20026
155960,may,O,20026
155961,also,O,20026
155962,notice,O,20026
155963,flashes,B-SIGN_AND_SYMPTOM,20026
155964,of,I-SIGN_AND_SYMPTOM,20026
155965,light,I-SIGN_AND_SYMPTOM,20026
155966,in,I-SIGN_AND_SYMPTOM,20026
155967,your,I-SIGN_AND_SYMPTOM,20026
155968,side,I-SIGN_AND_SYMPTOM,20026
155969,peripheral,I-SIGN_AND_SYMPTOM,20026
155970,vision,I-SIGN_AND_SYMPTOM,20026
155971,Sometimes,O,20027
155972,vitreous,B-NAME_OF_DISEASE,20027
155973,detachment,I-NAME_OF_DISEASE,20027
155974,causes,O,20027
155975,more,O,20027
155976,serious,O,20027
155977,eye,O,20027
155978,problems,O,20027
155979,that,O,20027
155980,need,O,20027
155981,treatment,O,20027
155982,right,O,20027
155983,away,O,20027
155984,The,O,20028
155985,only,O,20028
155986,way,O,20028
155987,to,O,20028
155988,tell,O,20028
155989,if,O,20028
155990,vitreous,B-NAME_OF_DISEASE,20028
155991,detachment,I-NAME_OF_DISEASE,20028
155992,has,O,20028
155993,caused,O,20028
155994,a,O,20028
155995,serious,O,20028
155996,eye,O,20028
155997,problem,O,20028
155998,is,O,20028
155999,to,O,20028
156000,get,O,20028
156001,a,B-DIAGNOSTIC_TEST,20028
156002,dilated,I-DIAGNOSTIC_TEST,20028
156003,eye,I-DIAGNOSTIC_TEST,20028
156004,exam,I-DIAGNOSTIC_TEST,20028
156005,Managing,O,20029
156006,patients,O,20029
156007,who,O,20029
156008,attend,O,20029
156009,a,O,20029
156010,practice,O,20029
156011,with,O,20029
156012,symptoms,O,20029
156013,of,O,20029
156014,flashes,B-SIGN_AND_SYMPTOM,20029
156015,and,I-SIGN_AND_SYMPTOM,20029
156016,floaters,I-SIGN_AND_SYMPTOM,20029
156017,is,O,20029
156018,a,O,20029
156019,regular,O,20029
156020,occurrence,O,20029
156021,in,O,20029
156022,community,O,20029
156023,optometric,O,20029
156024,practice,O,20029
156025,Its,O,20030
156026,often,O,20030
156027,very,O,20030
156028,distressing,O,20030
156029,for,O,20030
156030,patients,O,20030
156031,symptoms,O,20030
156032,can,O,20030
156033,be,O,20030
156034,quite,O,20030
156035,dramatic,O,20030
156036,and,O,20030
156037,an,O,20030
156038,internet,O,20030
156039,search,O,20030
156040,can,O,20030
156041,indicate,O,20030
156042,imminent,O,20030
156043,blindness,B-NAME_OF_DISEASE,20030
156044,from,O,20030
156045,a,B-NAME_OF_DISEASE,20030
156046,retinal,I-NAME_OF_DISEASE,20030
156047,detachment,I-NAME_OF_DISEASE,20030
156048,A,B-NAME_OF_DISEASE,20031
156049,posterior,I-NAME_OF_DISEASE,20031
156050,vitreous,I-NAME_OF_DISEASE,20031
156051,detachment,I-NAME_OF_DISEASE,20031
156052,PVD,I-NAME_OF_DISEASE,20031
156053,is,O,20031
156054,the,O,20031
156055,most,O,20031
156056,common,O,20031
156057,cause,O,20031
156058,of,O,20031
156059,flashes,B-SIGN_AND_SYMPTOM,20031
156060,and,I-SIGN_AND_SYMPTOM,20031
156061,floaters,I-SIGN_AND_SYMPTOM,20031
156062,in,O,20031
156063,the,O,20031
156064,middle-aged,O,20031
156065,population,O,20031
156066,Throughout,O,20032
156067,life,O,20032
156068,the,O,20032
156069,vitreous,O,20032
156070,liquefies,O,20032
156071,and,O,20032
156072,eventually,O,20032
156073,detaches,O,20032
156074,from,O,20032
156075,the,B-PART_OF_THE_EYES,20032
156076,retina,I-PART_OF_THE_EYES,20032
156077,A,B-NAME_OF_DISEASE,20033
156078,PVD,I-NAME_OF_DISEASE,20033
156079,most,O,20033
156080,commonly,O,20033
156081,occurs,O,20033
156082,between,O,20033
156083,the,O,20033
156084,ages,O,20033
156085,of,O,20033
156086,55,O,20033
156087,and,O,20033
156088,65,O,20033
156089,years,O,20033
156090,in,O,20033
156091,general,O,20033
156092,earlier,O,20033
156093,in,O,20033
156094,myopes,O,20033
156095,and,O,20033
156096,later,O,20033
156097,in,O,20033
156098,hyperopes,O,20033
156099,Of,O,20034
156100,course,O,20034
156101,there,O,20034
156102,are,O,20034
156103,other,O,20034
156104,causes,O,20034
156105,of,O,20034
156106,flashes,B-SIGN_AND_SYMPTOM,20034
156107,and,I-SIGN_AND_SYMPTOM,20034
156108,floaters,I-SIGN_AND_SYMPTOM,20034
156109,The,O,20035
156110,differential,O,20035
156111,diagnosis,O,20035
156112,is,O,20035
156113,important,O,20035
156114,to,O,20035
156115,exclude,O,20035
156116,a,B-NAME_OF_DISEASE,20035
156117,retinal,I-NAME_OF_DISEASE,20035
156118,tear,I-NAME_OF_DISEASE,20035
156119,or,I-NAME_OF_DISEASE,20035
156120,detachment,I-NAME_OF_DISEASE,20035
156121,There,O,20036
156122,is,O,20036
156123,an,O,20036
156124,annual,O,20036
156125,incidence,O,20036
156126,of,O,20036
156127,about,O,20036
156128,15-Oct,O,20036
156129,per,O,20036
156130,100000,O,20036
156131,people,O,20036
156132,per,O,20036
156133,year,O,20036
156134,who,O,20036
156135,have,O,20036
156136,a,B-NAME_OF_DISEASE,20036
156137,retinal,I-NAME_OF_DISEASE,20036
156138,detachment,I-NAME_OF_DISEASE,20036
156139,and,O,20036
156140,so,O,20036
156141,whilst,O,20036
156142,this,O,20036
156143,is,O,20036
156144,a,O,20036
156145,rare,O,20036
156146,condition,O,20036
156147,the,O,20036
156148,sight-threatening,O,20036
156149,nature,O,20036
156150,requires,O,20036
156151,a,O,20036
156152,swift,O,20036
156153,referral,O,20036
156154,for,O,20036
156155,timely,O,20036
156156,treatment,O,20036
156157,to,O,20036
156158,restore,O,20036
156159,and,O,20036
156160,or,O,20036
156161,retain,O,20036
156162,as,O,20036
156163,much,O,20036
156164,sight,O,20036
156165,as,O,20036
156166,possible,O,20036
156167,For,O,20037
156168,example,O,20037
156169,migraine,B-NAME_OF_DISEASE,20037
156170,auras,I-NAME_OF_DISEASE,20037
156171,are,O,20037
156172,another,O,20037
156173,common,O,20037
156174,cause,O,20037
156175,of,O,20037
156176,flashes,B-SIGN_AND_SYMPTOM,20037
156177,They,O,20038
156178,may,O,20038
156179,or,O,20038
156180,may,O,20038
156181,not,O,20038
156182,be,O,20038
156183,associated,O,20038
156184,with,O,20038
156185,a,B-SIGN_AND_SYMPTOM,20038
156186,headache,I-SIGN_AND_SYMPTOM,20038
156187,or,O,20038
156188,migraine,B-NAME_OF_DISEASE,20038
156189,Postural,B-NAME_OF_DISEASE,20039
156190,hypotension,I-NAME_OF_DISEASE,20039
156191,another,O,20039
156192,cause,O,20039
156193,of,O,20039
156194,flashes,B-SIGN_AND_SYMPTOM,20039
156195,as,O,20039
156196,the,O,20039
156197,patient,O,20039
156198,stands,O,20039
156199,can,O,20039
156200,also,O,20039
156201,be,O,20039
156202,identified,O,20039
156203,with,O,20039
156204,detailed,O,20039
156205,and,O,20039
156206,specific,O,20039
156207,questioning,O,20039
156208,of,O,20039
156209,the,O,20039
156210,patient,O,20039
156211,Alarm,O,20040
156212,bells,O,20040
156213,start,O,20040
156214,to,O,20040
156215,ring,O,20040
156216,when,O,20040
156217,patients,O,20040
156218,describe,O,20040
156219,large,O,20040
156220,and,O,20040
156221,significant,O,20040
156222,changes,O,20040
156223,in,O,20040
156224,their,O,20040
156225,vision,O,20040
156226,the,O,20040
156227,classic,O,20040
156228,curtain,O,20040
156229,coming,O,20040
156230,over,O,20040
156231,my,O,20040
156232,vision,O,20040
156233,or,O,20040
156234,a,O,20040
156235,dramatic,O,20040
156236,drop,O,20040
156237,in,O,20040
156238,their,O,20040
156239,vision,O,20040
156240,when,O,20040
156241,the,B-PART_OF_THE_EYES,20040
156242,macula,I-PART_OF_THE_EYES,20040
156243,may,O,20040
156244,be,O,20040
156245,off,O,20040
156246,However,O,20041
156247,patients,O,20041
156248,are,O,20041
156249,all,O,20041
156250,different,O,20041
156251,and,O,20041
156252,a,O,20041
156253,non-descript,O,20041
156254,history,O,20041
156255,can,O,20041
156256,still,O,20041
156257,elicit,O,20041
156258,a,O,20041
156259,dramatic,O,20041
156260,finding,O,20041
156261,whilst,O,20041
156262,other,O,20041
156263,patients,O,20041
156264,are,O,20041
156265,extremely,O,20041
156266,disturbed,O,20041
156267,by,O,20041
156268,relatively,O,20041
156269,minor,O,20041
156270,changes,O,20041
156271,to,O,20041
156272,their,O,20041
156273,vitreous,B-PART_OF_THE_EYES,20041
156274,Clearly,O,20042
156275,a,B-DIAGNOSTIC_TEST,20042
156276,detailed,I-DIAGNOSTIC_TEST,20042
156277,dilated,I-DIAGNOSTIC_TEST,20042
156278,binocular,I-DIAGNOSTIC_TEST,20042
156279,examination,I-DIAGNOSTIC_TEST,20042
156280,of,I-DIAGNOSTIC_TEST,20042
156281,the,I-DIAGNOSTIC_TEST,20042
156282,vitreous,I-DIAGNOSTIC_TEST,20042
156283,and,I-DIAGNOSTIC_TEST,20042
156284,the,I-DIAGNOSTIC_TEST,20042
156285,retina,I-DIAGNOSTIC_TEST,20042
156286,are,O,20042
156287,required,O,20042
156288,Alwitry,B-PERSON,20043
156289,et,O,20043
156290,als,O,20043
156291,study,O,20043
156292,in,O,20043
156293,2002,O,20043
156294,found,O,20043
156295,wide,O,20043
156296,variation,O,20043
156297,in,O,20043
156298,confidence,O,20043
156299,by,O,20043
156300,optometrists,O,20043
156301,to,O,20043
156302,examine,O,20043
156303,and,O,20043
156304,mange,O,20043
156305,a,O,20043
156306,patient,O,20043
156307,presenting,O,20043
156308,with,O,20043
156309,flashes,B-SIGN_AND_SYMPTOM,20043
156310,and,I-SIGN_AND_SYMPTOM,20043
156311,floaters,I-SIGN_AND_SYMPTOM,20043
156312,with,O,20043
156313,many,O,20043
156314,patients,O,20043
156315,being,O,20043
156316,examined,O,20043
156317,without,O,20043
156318,mydriasis,B-SIGN_AND_SYMPTOM,20043
156319,and,O,20043
156320,a,O,20043
156321,lack,O,20043
156322,of,O,20043
156323,understanding,O,20043
156324,about,O,20043
156325,vital,O,20043
156326,signs,O,20043
156327,of,O,20043
156328,tears,O,20043
156329,and,O,20043
156330,detachments,O,20043
156331,As,O,20044
156332,practice,O,20044
156333,has,O,20044
156334,developed,O,20044
156335,more,O,20044
156336,practitioners,O,20044
156337,are,O,20044
156338,using,O,20044
156339,a,B-DIAGNOSTIC_TEST,20044
156340,slit-lamp,I-DIAGNOSTIC_TEST,20044
156341,and,O,20044
156342,condensing,O,20044
156343,lens,O,20044
156344,combination,O,20044
156345,routinely,O,20044
156346,to,O,20044
156347,examine,O,20044
156348,patients,O,20044
156349,across,O,20044
156350,the,B-GPE,20044
156351,UK,I-GPE,20044
156352,in,O,20044
156353,community,O,20044
156354,optometry,O,20044
156355,indeed,O,20044
156356,equipment,O,20044
156357,funding,O,20044
156358,and,O,20044
156359,training,O,20044
156360,in,O,20044
156361,Scotland,B-GPE,20044
156362,makes,O,20044
156363,this,O,20044
156364,a,O,20044
156365,routine,O,20044
156366,part,O,20044
156367,of,O,20044
156368,the,O,20044
156369,General,O,20044
156370,Ophthalmic,O,20044
156371,Services,O,20044
156372,GOS,O,20044
156373,eye,O,20044
156374,examination,O,20044
156375,Even,O,20045
156376,without,O,20045
156377,scleral,B-SIGN_AND_SYMPTOM,20045
156378,indentation,I-SIGN_AND_SYMPTOM,20045
156379,such,O,20045
156380,an,O,20045
156381,examination,O,20045
156382,will,O,20045
156383,almost,O,20045
156384,certainly,O,20045
156385,identify,O,20045
156386,all,O,20045
156387,patients,O,20045
156388,with,O,20045
156389,tears,O,20045
156390,or,O,20045
156391,full,O,20045
156392,detachments,O,20045
156393,with,O,20045
156394,those,O,20045
156395,in,O,20045
156396,the,O,20045
156397,very,O,20045
156398,far,O,20045
156399,periphery,O,20045
156400,almost,O,20045
156401,certainly,O,20045
156402,resulting,O,20045
156403,from,O,20045
156404,a,B-CAUSE_OF_DISEASE,20045
156405,traumatic,I-CAUSE_OF_DISEASE,20045
156406,incident,I-CAUSE_OF_DISEASE,20045
156407,Asking,O,20046
156408,the,O,20046
156409,patient,O,20046
156410,to,O,20046
156411,move,O,20046
156412,their,O,20046
156413,eyes,O,20046
156414,in,O,20046
156415,eight,O,20046
156416,points,O,20046
156417,of,O,20046
156418,gaze,O,20046
156419,should,O,20046
156420,ensure,O,20046
156421,a,O,20046
156422,view,O,20046
156423,of,O,20046
156424,all,O,20046
156425,but,O,20046
156426,the,O,20046
156427,most,O,20046
156428,peripheral,O,20046
156429,parts,O,20046
156430,of,O,20046
156431,the,B-PART_OF_THE_EYES,20046
156432,retina,I-PART_OF_THE_EYES,20046
156433,with,O,20046
156434,particular,O,20046
156435,note,O,20046
156436,in,O,20046
156437,the,O,20046
156438,superior,O,20046
156439,temporal,O,20046
156440,quadrant,O,20046
156441,where,O,20046
156442,about,O,20046
156443,60%,O,20046
156444,of,O,20046
156445,tears,O,20046
156446,occur,O,20046
156447,A,O,20047
156448,high,O,20047
156449,magnification,O,20047
156450,slit-lamp,B-DIAGNOSTIC_TEST,20047
156451,is,O,20047
156452,vital,O,20047
156453,to,O,20047
156454,being,O,20047
156455,able,O,20047
156456,to,O,20047
156457,closely,O,20047
156458,examine,O,20047
156459,the,B-PART_OF_THE_EYES,20047
156460,vitreous,I-PART_OF_THE_EYES,20047
156461,for,O,20047
156462,signs,O,20047
156463,of,O,20047
156464,change,O,20047
156465,Tobacco,O,20048
156466,dust,O,20048
156467,is,O,20048
156468,a,O,20048
156469,good,O,20048
156470,determinant,O,20048
156471,of,O,20048
156472,a,O,20048
156473,tear,O,20048
156474,with,O,20048
156475,pigment,O,20048
156476,from,O,20048
156477,the,B-PART_OF_THE_EYES,20048
156478,retinal,I-PART_OF_THE_EYES,20048
156479,pigment,I-PART_OF_THE_EYES,20048
156480,epithelium,I-PART_OF_THE_EYES,20048
156481,having,O,20048
156482,leaked,O,20048
156483,into,O,20048
156484,the,B-PART_OF_THE_EYES,20048
156485,vitreous,I-PART_OF_THE_EYES,20048
156486,These,O,20049
156487,brown,O,20049
156488,cells,O,20049
156489,in,O,20049
156490,the,B-PART_OF_THE_EYES,20049
156491,anterior,I-PART_OF_THE_EYES,20049
156492,vitreous,I-PART_OF_THE_EYES,20049
156493,are,O,20049
156494,known,O,20049
156495,as,O,20049
156496,Shafers,B-SIGN_AND_SYMPTOM,20049
156497,sign,I-SIGN_AND_SYMPTOM,20049
156498,Identifying,O,20050
156499,signs,O,20050
156500,of,O,20050
156501,a,B-NAME_OF_DISEASE,20050
156502,PVD,I-NAME_OF_DISEASE,20050
156503,also,O,20050
156504,gives,O,20050
156505,confidence,O,20050
156506,that,O,20050
156507,this,O,20050
156508,is,O,20050
156509,indeed,O,20050
156510,the,O,20050
156511,cause,O,20050
156512,of,O,20050
156513,the,O,20050
156514,symptoms,O,20050
156515,Though,O,20051
156516,Weisss,B-SIGN_AND_SYMPTOM,20051
156517,ring,I-SIGN_AND_SYMPTOM,20051
156518,is,O,20051
156519,rarely,O,20051
156520,seen,O,20051
156521,in,O,20051
156522,full,O,20051
156523,partial,O,20051
156524,remains,O,20051
156525,may,O,20051
156526,be,O,20051
156527,viewed,O,20051
156528,in,O,20051
156529,the,B-PART_OF_THE_EYES,20051
156530,vitreous,I-PART_OF_THE_EYES,20051
156531,around,O,20051
156532,the,B-PART_OF_THE_EYES,20051
156533,disc,I-PART_OF_THE_EYES,20051
156534,near,O,20051
156535,to,O,20051
156536,where,O,20051
156537,the,B-PART_OF_THE_EYES,20051
156538,vitreous,I-PART_OF_THE_EYES,20051
156539,gel,I-PART_OF_THE_EYES,20051
156540,was,O,20051
156541,attached,O,20051
156542,Expert,O,20052
156543,opinion,O,20052
156544,informs,O,20052
156545,the,B-ORGANIZATION,20052
156546,National,I-ORGANIZATION,20052
156547,Institute,I-ORGANIZATION,20052
156548,for,I-ORGANIZATION,20052
156549,Health,I-ORGANIZATION,20052
156550,and,I-ORGANIZATION,20052
156551,Care,I-ORGANIZATION,20052
156552,Excellence,I-ORGANIZATION,20052
156553,NICE,I-ORGANIZATION,20052
156554,recommendation,O,20052
156555,on,O,20052
156556,referral,O,20052
156557,pathways,O,20052
156558,Referral,O,20053
156559,directly,O,20053
156560,to,O,20053
156561,ophthalmology,O,20053
156562,where,O,20053
156563,there,O,20053
156564,are,O,20053
156565,clear,O,20053
156566,signs,O,20053
156567,of,O,20053
156568,retinal,B-NAME_OF_DISEASE,20053
156569,detachment,I-NAME_OF_DISEASE,20053
156570,or,O,20053
156571,symptoms,O,20053
156572,such,O,20053
156573,as,O,20053
156574,distorted,B-SIGN_AND_SYMPTOM,20053
156575,or,I-SIGN_AND_SYMPTOM,20053
156576,blurred,I-SIGN_AND_SYMPTOM,20053
156577,vision,I-SIGN_AND_SYMPTOM,20053
156578,or,I-SIGN_AND_SYMPTOM,20053
156579,visual,I-SIGN_AND_SYMPTOM,20053
156580,field,I-SIGN_AND_SYMPTOM,20053
156581,loss,I-SIGN_AND_SYMPTOM,20053
156582,curtaining,I-SIGN_AND_SYMPTOM,20053
156583,or,I-SIGN_AND_SYMPTOM,20053
156584,dark,I-SIGN_AND_SYMPTOM,20053
156585,shadows,I-SIGN_AND_SYMPTOM,20053
156586,is,O,20053
156587,aimed,O,20053
156588,at,O,20053
156589,GPs,O,20053
156590,or,O,20053
156591,other,O,20053
156592,community,O,20053
156593,care,O,20053
156594,practitioners,O,20053
156595,Otherwise,O,20054
156596,refer,O,20054
156597,to,O,20054
156598,a,O,20054
156599,practitioner,O,20054
156600,competent,O,20054
156601,in,O,20054
156602,the,O,20054
156603,use,O,20054
156604,of,O,20054
156605,slit-lamp,B-DIAGNOSTIC_TEST,20054
156606,examination,I-DIAGNOSTIC_TEST,20054
156607,and,O,20054
156608,indirect,B-DIAGNOSTIC_TEST,20054
156609,ophthalmoscopy,I-DIAGNOSTIC_TEST,20054
156610,ie,O,20054
156611,a,O,20054
156612,community,O,20054
156613,optometrist,O,20054
156614,is,O,20054
156615,the,O,20054
156616,advice,O,20054
156617,Its,O,20055
156618,important,O,20055
156619,that,O,20055
156620,patients,O,20055
156621,diagnosed,O,20055
156622,with,O,20055
156623,a,B-NAME_OF_DISEASE,20055
156624,PVD,I-NAME_OF_DISEASE,20055
156625,are,O,20055
156626,advised,O,20055
156627,to,O,20055
156628,return,O,20055
156629,for,O,20055
156630,another,O,20055
156631,examination,O,20055
156632,if,O,20055
156633,their,O,20055
156634,symptoms,O,20055
156635,return,O,20055
156636,A,O,20056
156637,period,O,20056
156638,of,O,20056
156639,six,B-TIME_DURATION,20056
156640,to,I-TIME_DURATION,20056
156641,eight,I-TIME_DURATION,20056
156642,weeks,I-TIME_DURATION,20056
156643,appears,O,20056
156644,to,O,20056
156645,be,O,20056
156646,the,O,20056
156647,critical,O,20056
156648,time,O,20056
156649,period,O,20056
156650,over,O,20056
156651,which,O,20056
156652,a,O,20056
156653,partial,O,20056
156654,PVD,B-NAME_OF_DISEASE,20056
156655,completely,O,20056
156656,detaches,O,20056
156657,and,O,20056
156658,after,O,20056
156659,which,O,20056
156660,the,O,20056
156661,threat,O,20056
156662,of,O,20056
156663,a,B-SIGN_AND_SYMPTOM,20056
156664,retinal,I-SIGN_AND_SYMPTOM,20056
156665,tear,I-SIGN_AND_SYMPTOM,20056
156666,diminishes,O,20056
156667,Examples,O,20057
156668,include,O,20057
156669,the,B-ORGANIZATION,20057
156670,Association,I-ORGANIZATION,20057
156671,of,I-ORGANIZATION,20057
156672,Optometrists,I-ORGANIZATION,20057
156673,Royal,B-ORGANIZATION,20057
156674,National,I-ORGANIZATION,20057
156675,Institute,I-ORGANIZATION,20057
156676,of,I-ORGANIZATION,20057
156677,Blind,I-ORGANIZATION,20057
156678,People,I-ORGANIZATION,20057
156679,RNIB,I-ORGANIZATION,20057
156680,and,O,20057
156681,the,B-ORGANIZATION,20057
156682,College,I-ORGANIZATION,20057
156683,of,I-ORGANIZATION,20057
156684,Optometrists,I-ORGANIZATION,20057
156685,Challenges,O,20058
156686,of,O,20058
156687,Managing,O,20058
156688,Patients,O,20058
156689,with,O,20058
156690,Flashes,B-SIGN_AND_SYMPTOM,20058
156691,and,I-SIGN_AND_SYMPTOM,20058
156692,Floaters,I-SIGN_AND_SYMPTOM,20058
156693,Not,O,20059
156694,all,O,20059
156695,patients,O,20059
156696,have,O,20059
156697,a,O,20059
156698,clear,O,20059
156699,media,O,20059
156700,for,O,20059
156701,example,O,20059
156702,cataracts,B-NAME_OF_DISEASE,20059
156703,or,O,20059
156704,longer,O,20059
156705,standing,O,20059
156706,vitreous,B-PART_OF_THE_EYES,20059
156707,changes,O,20059
156708,can,O,20059
156709,make,O,20059
156710,examining,O,20059
156711,the,B-PART_OF_THE_EYES,20059
156712,whole,I-PART_OF_THE_EYES,20059
156713,retina,I-PART_OF_THE_EYES,20059
156714,more,O,20059
156715,difficult,O,20059
156716,In,O,20060
156717,a,O,20060
156718,recent,O,20060
156719,paper,O,20060
156720,it,O,20060
156721,was,O,20060
156722,identified,O,20060
156723,that,O,20060
156724,managing,O,20060
156725,patients,O,20060
156726,who,O,20060
156727,attend,O,20060
156728,with,O,20060
156729,the,O,20060
156730,symptom,O,20060
156731,of,O,20060
156732,flashes,B-SIGN_AND_SYMPTOM,20060
156733,and,I-SIGN_AND_SYMPTOM,20060
156734,floaters,I-SIGN_AND_SYMPTOM,20060
156735,in,O,20060
156736,optometric,O,20060
156737,practice,O,20060
156738,was,O,20060
156739,one,O,20060
156740,area,O,20060
156741,of,O,20060
156742,practice,O,20060
156743,that,O,20060
156744,optometrists,O,20060
156745,in,O,20060
156746,Scotland,B-GPE,20060
156747,felt,O,20060
156748,was,O,20060
156749,an,O,20060
156750,area,O,20060
156751,of,O,20060
156752,concern,O,20060
156753,Referring,O,20061
156754,patients,O,20061
156755,as,O,20061
156756,an,O,20061
156757,emergency,O,20061
156758,where,O,20061
156759,the,O,20061
156760,symptoms,O,20061
156761,are,O,20061
156762,as,O,20061
156763,a,O,20061
156764,result,O,20061
156765,of,O,20061
156766,a,B-NAME_OF_DISEASE,20061
156767,retinal,I-NAME_OF_DISEASE,20061
156768,tear,I-NAME_OF_DISEASE,20061
156769,or,I-NAME_OF_DISEASE,20061
156770,detachment,I-NAME_OF_DISEASE,20061
156771,is,O,20061
156772,clearly,O,20061
156773,important,O,20061
156774,Even,O,20062
156775,the,O,20062
156776,most,O,20062
156777,committed,O,20062
156778,practitioner,O,20062
156779,may,O,20062
156780,have,O,20062
156781,lingering,O,20062
156782,doubts,O,20062
156783,about,O,20062
156784,a,O,20062
156785,patient,O,20062
156786,where,O,20062
156787,the,O,20062
156788,possibility,O,20062
156789,of,O,20062
156790,making,O,20062
156791,an,O,20062
156792,error,O,20062
156793,and,O,20062
156794,having,O,20062
156795,missed,O,20062
156796,a,B-SIGN_AND_SYMPTOM,20062
156797,peripheral,I-SIGN_AND_SYMPTOM,20062
156798,tear,I-SIGN_AND_SYMPTOM,20062
156799,results,O,20062
156800,in,O,20062
156801,the,O,20062
156802,patient,O,20062
156803,losing,O,20062
156804,their,O,20062
156805,eyesight,O,20062
156806,A,B-NAME_OF_DISEASE,20063
156807,PVD,I-NAME_OF_DISEASE,20063
156808,is,O,20063
156809,a,O,20063
156810,normal,O,20063
156811,process,O,20063
156812,of,O,20063
156813,ageing,O,20063
156814,and,O,20063
156815,has,O,20063
156816,always,O,20063
156817,been,O,20063
156818,widely,O,20063
156819,managed,O,20063
156820,within,O,20063
156821,community,O,20063
156822,optometry,O,20063
156823,TED,B-NAME_OF_DISEASE,20064
156824,is,O,20064
156825,an,O,20064
156826,autoimmune,O,20064
156827,disease,O,20064
156828,in,O,20064
156829,which,O,20064
156830,the,B-SIGN_AND_SYMPTOM,20064
156831,eye,I-SIGN_AND_SYMPTOM,20064
156832,muscles,I-SIGN_AND_SYMPTOM,20064
156833,and,I-SIGN_AND_SYMPTOM,20064
156834,fatty,I-SIGN_AND_SYMPTOM,20064
156835,tissue,I-SIGN_AND_SYMPTOM,20064
156836,behind,I-SIGN_AND_SYMPTOM,20064
156837,the,I-SIGN_AND_SYMPTOM,20064
156838,eye,I-SIGN_AND_SYMPTOM,20064
156839,become,I-SIGN_AND_SYMPTOM,20064
156840,inflamed,I-SIGN_AND_SYMPTOM,20064
156841,This,O,20065
156842,inflammation,O,20065
156843,can,O,20065
156844,push,B-SIGN_AND_SYMPTOM,20065
156845,the,I-SIGN_AND_SYMPTOM,20065
156846,eyes,I-SIGN_AND_SYMPTOM,20065
156847,forward,I-SIGN_AND_SYMPTOM,20065
156848,staring,I-SIGN_AND_SYMPTOM,20065
156849,or,I-SIGN_AND_SYMPTOM,20065
156850,bulging,I-SIGN_AND_SYMPTOM,20065
156851,or,I-SIGN_AND_SYMPTOM,20065
156852,cause,I-SIGN_AND_SYMPTOM,20065
156853,the,I-SIGN_AND_SYMPTOM,20065
156854,eyes,I-SIGN_AND_SYMPTOM,20065
156855,and,I-SIGN_AND_SYMPTOM,20065
156856,eyelids,I-SIGN_AND_SYMPTOM,20065
156857,to,I-SIGN_AND_SYMPTOM,20065
156858,become,I-SIGN_AND_SYMPTOM,20065
156859,red,I-SIGN_AND_SYMPTOM,20065
156860,and,I-SIGN_AND_SYMPTOM,20065
156861,swollen,I-SIGN_AND_SYMPTOM,20065
156862,In,O,20066
156863,some,O,20066
156864,individuals,O,20066
156865,the,O,20066
156866,inflammation,O,20066
156867,may,O,20066
156868,involve,O,20066
156869,the,B-PART_OF_THE_EYES,20066
156870,eye,I-PART_OF_THE_EYES,20066
156871,muscles,I-PART_OF_THE_EYES,20066
156872,causing,O,20066
156873,the,B-SIGN_AND_SYMPTOM,20066
156874,eyes,I-SIGN_AND_SYMPTOM,20066
156875,to,I-SIGN_AND_SYMPTOM,20066
156876,become,I-SIGN_AND_SYMPTOM,20066
156877,out,I-SIGN_AND_SYMPTOM,20066
156878,of,I-SIGN_AND_SYMPTOM,20066
156879,line,I-SIGN_AND_SYMPTOM,20066
156880,leading,I-SIGN_AND_SYMPTOM,20066
156881,to,I-SIGN_AND_SYMPTOM,20066
156882,double,I-SIGN_AND_SYMPTOM,20066
156883,vision,I-SIGN_AND_SYMPTOM,20066
156884,In,O,20067
156885,rare,O,20067
156886,cases,O,20067
156887,TED,B-NAME_OF_DISEASE,20067
156888,can,O,20067
156889,cause,O,20067
156890,blindness,B-NAME_OF_DISEASE,20067
156891,from,O,20067
156892,pressure,B-SIGN_AND_SYMPTOM,20067
156893,on,I-SIGN_AND_SYMPTOM,20067
156894,the,I-SIGN_AND_SYMPTOM,20067
156895,nerve,I-SIGN_AND_SYMPTOM,20067
156896,in,I-SIGN_AND_SYMPTOM,20067
156897,the,I-SIGN_AND_SYMPTOM,20067
156898,back,I-SIGN_AND_SYMPTOM,20067
156899,of,I-SIGN_AND_SYMPTOM,20067
156900,the,I-SIGN_AND_SYMPTOM,20067
156901,eye,I-SIGN_AND_SYMPTOM,20067
156902,or,I-SIGN_AND_SYMPTOM,20067
156903,ulcers,I-SIGN_AND_SYMPTOM,20067
156904,that,I-SIGN_AND_SYMPTOM,20067
156905,form,I-SIGN_AND_SYMPTOM,20067
156906,on,I-SIGN_AND_SYMPTOM,20067
156907,the,I-SIGN_AND_SYMPTOM,20067
156908,front,I-SIGN_AND_SYMPTOM,20067
156909,of,I-SIGN_AND_SYMPTOM,20067
156910,the,I-SIGN_AND_SYMPTOM,20067
156911,eye,I-SIGN_AND_SYMPTOM,20067
156912,cornea,I-SIGN_AND_SYMPTOM,20067
156913,TED,B-NAME_OF_DISEASE,20068
156914,is,O,20068
156915,an,O,20068
156916,autoimmune,O,20068
156917,disease,O,20068
156918,meaning,O,20068
156919,that,O,20068
156920,the,B-SIGN_AND_SYMPTOM,20068
156921,inflammation,I-SIGN_AND_SYMPTOM,20068
156922,and,I-SIGN_AND_SYMPTOM,20068
156923,scarring,I-SIGN_AND_SYMPTOM,20068
156924,are,O,20068
156925,caused,O,20068
156926,by,O,20068
156927,an,O,20068
156928,attack,O,20068
156929,from,O,20068
156930,the,O,20068
156931,bodys,O,20068
156932,immune,O,20068
156933,system,O,20068
156934,TED,B-NAME_OF_DISEASE,20069
156935,is,O,20069
156936,primarily,O,20069
156937,associated,O,20069
156938,with,O,20069
156939,an,B-SIGN_AND_SYMPTOM,20069
156940,over-active,I-SIGN_AND_SYMPTOM,20069
156941,thyroid,I-SIGN_AND_SYMPTOM,20069
156942,gland,I-SIGN_AND_SYMPTOM,20069
156943,due,O,20069
156944,to,O,20069
156945,Graves,B-NAME_OF_DISEASE,20069
156946,disease,I-NAME_OF_DISEASE,20069
156947,although,O,20069
156948,it,O,20069
156949,can,O,20069
156950,rarely,O,20069
156951,occur,O,20069
156952,in,O,20069
156953,patients,O,20069
156954,with,O,20069
156955,an,O,20069
156956,under-active,O,20069
156957,or,O,20069
156958,normally,O,20069
156959,functioning,O,20069
156960,thyroid,O,20069
156961,gland,O,20069
156962,About,O,20070
156963,a,O,20070
156964,quarter,O,20070
156965,of,O,20070
156966,patients,O,20070
156967,with,O,20070
156968,Graves,B-NAME_OF_DISEASE,20070
156969,disease,I-NAME_OF_DISEASE,20070
156970,develop,O,20070
156971,TED,B-NAME_OF_DISEASE,20070
156972,before,O,20070
156973,during,O,20070
156974,or,O,20070
156975,after,O,20070
156976,the,O,20070
156977,diagnosis,O,20070
156978,of,O,20070
156979,a,B-NAME_OF_DISEASE,20070
156980,thyroid,I-NAME_OF_DISEASE,20070
156981,disorder,I-NAME_OF_DISEASE,20070
156982,TED,B-NAME_OF_DISEASE,20071
156983,is,O,20071
156984,also,O,20071
156985,known,O,20071
156986,as,O,20071
156987,Graves,B-NAME_OF_DISEASE,20071
156988,orbitopathy,I-NAME_OF_DISEASE,20071
156989,GO,I-NAME_OF_DISEASE,20071
156990,or,O,20071
156991,Graves,B-NAME_OF_DISEASE,20071
156992,eye,I-NAME_OF_DISEASE,20071
156993,disease,I-NAME_OF_DISEASE,20071
156994,GED,I-NAME_OF_DISEASE,20071
156995,Smokers,O,20072
156996,are,O,20072
156997,two,O,20072
156998,to,O,20072
156999,eight,O,20072
157000,times,O,20072
157001,more,O,20072
157002,likely,O,20072
157003,to,O,20072
157004,develop,O,20072
157005,TED,B-NAME_OF_DISEASE,20072
157006,Thyroid,B-NAME_OF_DISEASE,20073
157007,eye,I-NAME_OF_DISEASE,20073
157008,disease,I-NAME_OF_DISEASE,20073
157009,TED,I-NAME_OF_DISEASE,20073
157010,is,O,20073
157011,vision-threatening,O,20073
157012,making,O,20073
157013,its,O,20073
157014,identification,O,20073
157015,all,O,20073
157016,the,O,20073
157017,more,O,20073
157018,important,O,20073
157019,according,O,20073
157020,to,O,20073
157021,Gary,B-PERSON,20073
157022,Lelli,I-PERSON,20073
157023,MD,I-PERSON,20073
157024,vice,O,20073
157025,chair,O,20073
157026,of,O,20073
157027,ophthalmology,O,20073
157028,at,O,20073
157029,Weill,B-ORGANIZATION,20073
157030,Cornell,I-ORGANIZATION,20073
157031,Medical,I-ORGANIZATION,20073
157032,College,I-ORGANIZATION,20073
157033,in,I-ORGANIZATION,20073
157034,New,B-GPE,20073
157035,York,I-GPE,20073
157036,New,B-GPE,20073
157037,York,I-GPE,20073
157038,Although,O,20074
157039,this,O,20074
157040,association,O,20074
157041,is,O,20074
157042,recognized,O,20074
157043,TED,B-NAME_OF_DISEASE,20074
157044,and,O,20074
157045,Graves,B-NAME_OF_DISEASE,20074
157046,disease,I-NAME_OF_DISEASE,20074
157047,are,O,20074
157048,2,O,20074
157049,separate,O,20074
157050,entities,O,20074
157051,The,O,20075
157052,TED,B-NAME_OF_DISEASE,20075
157053,component,O,20075
157054,Lelli,B-PERSON,20075
157055,said,O,20075
157056,can,O,20075
157057,occur,O,20075
157058,in,O,20075
157059,up,O,20075
157060,to,O,20075
157061,50%,O,20075
157062,of,O,20075
157063,patients,O,20075
157064,with,O,20075
157065,Graves,B-NAME_OF_DISEASE,20075
157066,disease,I-NAME_OF_DISEASE,20075
157067,but,O,20075
157068,also,O,20075
157069,in,O,20075
157070,hypothyroid,O,20075
157071,and,O,20075
157072,normal,O,20075
157073,thyroid,O,20075
157074,levels,O,20075
157075,In,O,20076
157076,addition,O,20076
157077,TED,B-NAME_OF_DISEASE,20076
157078,occurs,O,20076
157079,much,O,20076
157080,more,O,20076
157081,often,O,20076
157082,in,O,20076
157083,women-that,O,20076
157084,is,O,20076
157085,as,O,20076
157086,much,O,20076
157087,as,O,20076
157088,5,O,20076
157089,times,O,20076
157090,more,O,20076
157091,often-and,O,20076
157092,more,O,20076
157093,so,O,20076
157094,in,O,20076
157095,the,O,20076
157096,fourth,O,20076
157097,decade,O,20076
157098,of,O,20076
157099,life,O,20076
157100,Smokers,O,20077
157101,are,O,20077
157102,also,O,20077
157103,much,O,20077
157104,more,O,20077
157105,likely,O,20077
157106,to,O,20077
157107,develop,O,20077
157108,TED,B-NAME_OF_DISEASE,20077
157109,and,O,20077
157110,have,O,20077
157111,a,O,20077
157112,longer,O,20077
157113,period,O,20077
157114,of,O,20077
157115,inflammation,O,20077
157116,from,O,20077
157117,TED,B-NAME_OF_DISEASE,20077
157118,as,O,20077
157119,well,O,20077
157120,as,O,20077
157121,a,O,20077
157122,more,O,20077
157123,severe,O,20077
157124,disease,O,20077
157125,course,O,20077
157126,The,O,20078
157127,inflammation,O,20078
157128,that,O,20078
157129,develops,O,20078
157130,in,O,20078
157131,TED,B-NAME_OF_DISEASE,20078
157132,around,O,20078
157133,the,O,20078
157134,eye,O,20078
157135,and,O,20078
157136,eye,O,20078
157137,socket,O,20078
157138,can,O,20078
157139,cause,O,20078
157140,progressive,O,20078
157141,changes,O,20078
157142,resulting,O,20078
157143,in,O,20078
157144,functional,O,20078
157145,vision,O,20078
157146,disorders,O,20078
157147,patient,O,20078
157148,discomfort,O,20078
157149,and,O,20078
157150,changes,O,20078
157151,in,O,20078
157152,patient,O,20078
157153,appearance,O,20078
157154,over,O,20078
157155,relatively,O,20078
157156,short,O,20078
157157,periods,O,20078
157158,of,O,20078
157159,weeks,O,20078
157160,to,O,20078
157161,months,O,20078
157162,Lelli,B-PERSON,20078
157163,explained,O,20078
157164,A,O,20079
157165,menu,O,20079
157166,of,O,20079
157167,symptoms,O,20079
157168,accompanies,O,20079
157169,TED,B-NAME_OF_DISEASE,20079
157170,such,O,20079
157171,as,O,20079
157172,severe,B-NAME_OF_DISEASE,20079
157173,dry,I-NAME_OF_DISEASE,20079
157174,eye,I-NAME_OF_DISEASE,20079
157175,ocular,B-SIGN_AND_SYMPTOM,20079
157176,redness,I-SIGN_AND_SYMPTOM,20079
157177,and,I-SIGN_AND_SYMPTOM,20079
157178,irritation,I-SIGN_AND_SYMPTOM,20079
157179,ocular,I-SIGN_AND_SYMPTOM,20079
157180,bulging,I-SIGN_AND_SYMPTOM,20079
157181,eyelid,I-SIGN_AND_SYMPTOM,20079
157182,retraction,I-SIGN_AND_SYMPTOM,20079
157183,and,I-SIGN_AND_SYMPTOM,20079
157184,blurry,I-SIGN_AND_SYMPTOM,20079
157185,vision,I-SIGN_AND_SYMPTOM,20079
157186,The,O,20080
157187,characteristic,O,20080
157188,inflammation,O,20080
157189,associated,O,20080
157190,with,O,20080
157191,TED,B-NAME_OF_DISEASE,20080
157192,can,O,20080
157193,impact,O,20080
157194,the,B-PART_OF_THE_EYES,20080
157195,ocular,I-PART_OF_THE_EYES,20080
157196,muscles,I-PART_OF_THE_EYES,20080
157197,resulting,O,20080
157198,in,O,20080
157199,diplopia,B-NAME_OF_DISEASE,20080
157200,and,O,20080
157201,a,O,20080
157202,detrimental,O,20080
157203,effect,O,20080
157204,on,O,20080
157205,daily,O,20080
157206,activities,O,20080
157207,such,O,20080
157208,as,O,20080
157209,reading,O,20080
157210,and,O,20080
157211,driving,O,20080
157212,In,O,20081
157213,the,O,20081
157214,most,O,20081
157215,severe,O,20081
157216,cases,O,20081
157217,inflammation,O,20081
157218,can,O,20081
157219,cause,O,20081
157220,compression,O,20081
157221,of,O,20081
157222,the,B-PART_OF_THE_EYES,20081
157223,optic,I-PART_OF_THE_EYES,20081
157224,nerve,I-PART_OF_THE_EYES,20081
157225,resulting,O,20081
157226,in,O,20081
157227,visual,B-SIGN_AND_SYMPTOM,20081
157228,loss,I-SIGN_AND_SYMPTOM,20081
157229,Inflammation,O,20082
157230,also,O,20082
157231,can,O,20082
157232,affect,O,20082
157233,the,O,20082
157234,normal,O,20082
157235,fat,O,20082
157236,behind,O,20082
157237,the,O,20082
157238,eyes,O,20082
157239,and,O,20082
157240,cause,O,20082
157241,hypertrophy,B-SIGN_AND_SYMPTOM,20082
157242,This,O,20083
157243,scenario,O,20083
157244,is,O,20083
157245,involved,O,20083
157246,with,O,20083
157247,ocular,B-SIGN_AND_SYMPTOM,20083
157248,bulging,I-SIGN_AND_SYMPTOM,20083
157249,Swelling,B-SIGN_AND_SYMPTOM,20084
157250,that,I-SIGN_AND_SYMPTOM,20084
157251,is,I-SIGN_AND_SYMPTOM,20084
157252,related,I-SIGN_AND_SYMPTOM,20084
157253,to,I-SIGN_AND_SYMPTOM,20084
157254,the,I-SIGN_AND_SYMPTOM,20084
157255,fat,I-SIGN_AND_SYMPTOM,20084
157256,hypertrophy,I-SIGN_AND_SYMPTOM,20084
157257,can,O,20084
157258,be,O,20084
157259,apparent,O,20084
157260,in,O,20084
157261,the,B-PART_OF_THE_EYES,20084
157262,lower,I-PART_OF_THE_EYES,20084
157263,and,I-PART_OF_THE_EYES,20084
157264,upper,I-PART_OF_THE_EYES,20084
157265,eyelids,I-PART_OF_THE_EYES,20084
157266,The,O,20085
157267,TED,B-NAME_OF_DISEASE,20085
157268,team,O,20085
157269,Lelli,B-PERSON,20085
157270,emphasized,O,20085
157271,that,O,20085
157272,an,O,20085
157273,evaluation,O,20085
157274,conducted,O,20085
157275,by,O,20085
157276,the,O,20085
157277,appropriate,O,20085
157278,specialist,O,20085
157279,is,O,20085
157280,the,O,20085
157281,most,O,20085
157282,important,O,20085
157283,factor,O,20085
157284,in,O,20085
157285,diagnosing,O,20085
157286,and,O,20085
157287,managing,O,20085
157288,this,O,20085
157289,patient,O,20085
157290,population,O,20085
157291,A,O,20086
157292,history,O,20086
157293,of,O,20086
157294,any,O,20086
157295,thyroid,O,20086
157296,imbalance,O,20086
157297,especially,O,20086
157298,a,O,20086
157299,history,O,20086
157300,of,O,20086
157301,Graves,B-NAME_OF_DISEASE,20086
157302,disease,I-NAME_OF_DISEASE,20086
157303,should,O,20086
157304,signal,O,20086
157305,an,O,20086
157306,evaluation,O,20086
157307,by,O,20086
157308,an,O,20086
157309,oculoplastic,O,20086
157310,surgeon,O,20086
157311,or,O,20086
157312,a,O,20086
157313,neuro-ophthalmologist,O,20086
157314,Early,O,20087
157315,treatment,O,20087
157316,and,O,20087
157317,putting,O,20087
157318,a,O,20087
157319,team,O,20087
157320,of,O,20087
157321,clinicians,O,20087
157322,in,O,20087
157323,place,O,20087
157324,that,O,20087
157325,includes,O,20087
157326,an,O,20087
157327,oculoplastic,O,20087
157328,surgeon,O,20087
157329,a,O,20087
157330,neuro-ophthalmologist,O,20087
157331,an,O,20087
157332,endocrinologist,O,20087
157333,a,O,20087
157334,strabismus,O,20087
157335,specialist,O,20087
157336,and,O,20087
157337,in,O,20087
157338,some,O,20087
157339,cases,O,20087
157340,a,O,20087
157341,psychiatrist,O,20087
157342,or,O,20087
157343,psychologist,O,20087
157344,to,O,20087
157345,assist,O,20087
157346,with,O,20087
157347,the,O,20087
157348,emotional,O,20087
157349,problems,O,20087
157350,that,O,20087
157351,accompany,O,20087
157352,drastic,O,20087
157353,changes,O,20087
157354,in,O,20087
157355,appearance,O,20087
157356,are,O,20087
157357,most,O,20087
157358,beneficial,O,20087
157359,Lelli,B-PERSON,20087
157360,advised,O,20087
157361,Early,O,20088
157362,treatment,O,20088
157363,steps,O,20088
157364,Because,O,20088
157365,TED,B-NAME_OF_DISEASE,20088
157366,has,O,20088
157367,a,O,20088
157368,variety,O,20088
157369,of,O,20088
157370,presentations,O,20088
157371,the,O,20088
157372,first,O,20088
157373,step,O,20088
157374,is,O,20088
157375,categorization,O,20088
157376,of,O,20088
157377,the,O,20088
157378,patient,O,20088
157379,regarding,O,20088
157380,the,O,20088
157381,disease,O,20088
157382,stage,O,20088
157383,degree,O,20088
157384,of,O,20088
157385,inflammation,O,20088
157386,specific,O,20088
157387,ocular,O,20088
157388,symptoms,O,20088
157389,and,O,20088
157390,presence,O,20088
157391,of,O,20088
157392,any,O,20088
157393,aesthetic,O,20088
157394,changes,O,20088
157395,Establishing,O,20089
157396,this,O,20089
157397,base,O,20089
157398,of,O,20089
157399,information,O,20089
157400,then,O,20089
157401,leads,O,20089
157402,to,O,20089
157403,determination,O,20089
157404,of,O,20089
157405,the,O,20089
157406,appropriate,O,20089
157407,treatment,O,20089
157408,Lelli,B-PERSON,20089
157409,said,O,20089
157410,Treatment,O,20090
157411,ranges,O,20090
157412,from,O,20090
157413,addressing,O,20090
157414,symptoms,O,20090
157415,with,O,20090
157416,dry,B-TREATMENT,20090
157417,eye,I-TREATMENT,20090
157418,drops,I-TREATMENT,20090
157419,for,O,20090
157420,example,O,20090
157421,antioxidants,B-TREATMENT,20090
157422,to,O,20090
157423,decrease,O,20090
157424,inflammation,O,20090
157425,oral,B-TREATMENT,20090
157426,or,I-TREATMENT,20090
157427,intravenous,I-TREATMENT,20090
157428,anti-inflammatories,I-TREATMENT,20090
157429,and,O,20090
157430,surgery,B-TREATMENT,20090
157431,to,O,20090
157432,relieve,O,20090
157433,ocular,B-SIGN_AND_SYMPTOM,20090
157434,bulging,I-SIGN_AND_SYMPTOM,20090
157435,eyelid,I-SIGN_AND_SYMPTOM,20090
157436,retraction,I-SIGN_AND_SYMPTOM,20090
157437,and,I-SIGN_AND_SYMPTOM,20090
157438,diplopia,I-SIGN_AND_SYMPTOM,20090
157439,Although,O,20091
157440,there,O,20091
157441,currently,O,20091
157442,is,O,20091
157443,no,O,20091
157444,cure,O,20091
157445,for,O,20091
157446,TED,B-NAME_OF_DISEASE,20091
157447,Lelli,B-PERSON,20091
157448,reported,O,20091
157449,that,O,20091
157450,more,O,20091
157451,targeted,O,20091
157452,treatments,O,20091
157453,are,O,20091
157454,in,O,20091
157455,the,O,20091
157456,offing,O,20091
157457,A,O,20092
157458,lot,O,20092
157459,of,O,20092
157460,the,O,20092
157461,disease,O,20092
157462,and,O,20092
157463,orbital,O,20092
157464,inflammation,O,20092
157465,occur,O,20092
157466,at,O,20092
157467,the,O,20092
157468,level,O,20092
157469,of,O,20092
157470,the,B-PART_OF_THE_EYES,20092
157471,orbital,I-PART_OF_THE_EYES,20092
157472,fibroblasts,I-PART_OF_THE_EYES,20092
157473,receptors,I-PART_OF_THE_EYES,20092
157474,that,O,20092
157475,are,O,20092
157476,targeted,O,20092
157477,by,O,20092
157478,the,O,20092
157479,autoimmune,O,20092
157480,process,O,20092
157481,to,O,20092
157482,create,O,20092
157483,inflammation,O,20092
157484,TED,B-NAME_OF_DISEASE,20093
157485,awareness,O,20093
157486,In,O,20093
157487,2021,O,20093
157488,the,O,20093
157489,second,O,20093
157490,TED,B-NAME_OF_DISEASE,20093
157491,Awareness,O,20093
157492,Week,O,20093
157493,was,O,20093
157494,held,O,20093
157495,in,O,20093
157496,November,O,20093
157497,focusing,O,20093
157498,on,O,20093
157499,the,O,20093
157500,dissemination,O,20093
157501,of,O,20093
157502,information,O,20093
157503,about,O,20093
157504,TED,B-NAME_OF_DISEASE,20093
157505,to,O,20093
157506,patients,O,20093
157507,and,O,20093
157508,clinicians,O,20093
157509,alike,O,20093
157510,A,O,20094
157511,small,O,20094
157512,percentage,O,20094
157513,of,O,20094
157514,patients,O,20094
157515,with,O,20094
157516,TED,B-NAME_OF_DISEASE,20094
157517,ie,O,20094
157518,5%-10%,O,20094
157519,have,O,20094
157520,hypothyroidism,B-NAME_OF_DISEASE,20094
157521,and,O,20094
157522,a,O,20094
157523,baseline,O,20094
157524,examination,O,20094
157525,is,O,20094
157526,warranted,O,20094
157527,The,O,20095
157528,goal,O,20095
157529,is,O,20095
157530,to,O,20095
157531,provide,O,20095
157532,information,O,20095
157533,to,O,20095
157534,patients,O,20095
157535,ophthalmologists,O,20095
157536,and,O,20095
157537,other,O,20095
157538,eye,O,20095
157539,care,O,20095
157540,clinicians,O,20095
157541,to,O,20095
157542,raise,O,20095
157543,their,O,20095
157544,awareness,O,20095
157545,of,O,20095
157546,TED,B-NAME_OF_DISEASE,20095
157547,signs,O,20095
157548,and,O,20095
157549,symptoms,O,20095
157550,in,O,20095
157551,patients,O,20095
157552,who,O,20095
157553,have,O,20095
157554,a,O,20095
157555,history,O,20095
157556,of,O,20095
157557,thyroid,B-NAME_OF_DISEASE,20095
157558,disease,I-NAME_OF_DISEASE,20095
157559,Lelli,B-PERSON,20095
157560,explained,O,20095
157561,Lelli,B-PERSON,20096
157562,advises,O,20096
157563,that,O,20096
157564,clinicians,O,20096
157565,who,O,20096
157566,have,O,20096
157567,patients,O,20096
157568,with,O,20096
157569,Graves,B-NAME_OF_DISEASE,20096
157570,disease,I-NAME_OF_DISEASE,20096
157571,or,O,20096
157572,a,O,20096
157573,thyroid,O,20096
157574,condition,O,20096
157575,should,O,20096
157576,look,O,20096
157577,for,O,20096
157578,the,O,20096
157579,signs,O,20096
157580,and,O,20096
157581,symptoms,O,20096
157582,of,O,20096
157583,TED,B-NAME_OF_DISEASE,20096
157584,If,O,20097
157585,a,O,20097
157586,clinician,O,20097
157587,is,O,20097
157588,suspicious,O,20097
157589,that,O,20097
157590,a,O,20097
157591,patient,O,20097
157592,may,O,20097
157593,have,O,20097
157594,TED,B-NAME_OF_DISEASE,20097
157595,speed,O,20097
157596,is,O,20097
157597,of,O,20097
157598,the,O,20097
157599,essence,O,20097
157600,Lelli,B-PERSON,20098
157601,suggested,O,20098
157602,the,O,20098
157603,website,O,20098
157604,focusontedcom,O,20098
157605,to,O,20098
157606,provide,O,20098
157607,useful,O,20098
157608,information,O,20098
157609,about,O,20098
157610,the,O,20098
157611,disease,O,20098
157612,for,O,20098
157613,patients,O,20098
157614,and,O,20098
157615,doctors,O,20098
157616,as,O,20098
157617,well,O,20098
157618,as,O,20098
157619,specialists,O,20098
157620,listed,O,20098
157621,by,O,20098
157622,ZIP,O,20098
157623,code,O,20098
157624,An,B-NAME_OF_DISEASE,20099
157625,epiretinal,I-NAME_OF_DISEASE,20099
157626,membrane,I-NAME_OF_DISEASE,20099
157627,is,O,20099
157628,a,O,20099
157629,condition,O,20099
157630,where,O,20099
157631,a,B-SIGN_AND_SYMPTOM,20099
157632,very,I-SIGN_AND_SYMPTOM,20099
157633,thin,I-SIGN_AND_SYMPTOM,20099
157634,layer,I-SIGN_AND_SYMPTOM,20099
157635,of,I-SIGN_AND_SYMPTOM,20099
157636,scar,I-SIGN_AND_SYMPTOM,20099
157637,tissue,I-SIGN_AND_SYMPTOM,20099
157638,forms,I-SIGN_AND_SYMPTOM,20099
157639,on,I-SIGN_AND_SYMPTOM,20099
157640,the,I-SIGN_AND_SYMPTOM,20099
157641,surface,I-SIGN_AND_SYMPTOM,20099
157642,of,I-SIGN_AND_SYMPTOM,20099
157643,the,I-SIGN_AND_SYMPTOM,20099
157644,retina,I-SIGN_AND_SYMPTOM,20099
157645,in,I-SIGN_AND_SYMPTOM,20099
157646,an,I-SIGN_AND_SYMPTOM,20099
157647,area,I-SIGN_AND_SYMPTOM,20099
157648,that,I-SIGN_AND_SYMPTOM,20099
157649,is,I-SIGN_AND_SYMPTOM,20099
157650,responsible,I-SIGN_AND_SYMPTOM,20099
157651,for,I-SIGN_AND_SYMPTOM,20099
157652,our,I-SIGN_AND_SYMPTOM,20099
157653,sharpest,I-SIGN_AND_SYMPTOM,20099
157654,vision,I-SIGN_AND_SYMPTOM,20099
157655,The,O,20100
157656,part,O,20100
157657,of,O,20100
157658,the,O,20100
157659,eye,O,20100
157660,affected,O,20100
157661,by,O,20100
157662,an,B-NAME_OF_DISEASE,20100
157663,epiretinal,I-NAME_OF_DISEASE,20100
157664,membrane,I-NAME_OF_DISEASE,20100
157665,is,O,20100
157666,called,O,20100
157667,the,B-PART_OF_THE_EYES,20100
157668,macula,I-PART_OF_THE_EYES,20100
157669,The,B-PART_OF_THE_EYES,20101
157670,macula,I-PART_OF_THE_EYES,20101
157671,is,O,20101
157672,made,O,20101
157673,up,O,20101
157674,of,O,20101
157675,special,O,20101
157676,nerve,O,20101
157677,cells,O,20101
157678,that,O,20101
157679,provide,O,20101
157680,our,O,20101
157681,sharp,O,20101
157682,central,O,20101
157683,vision,O,20101
157684,needed,O,20101
157685,for,O,20101
157686,seeing,O,20101
157687,fine,O,20101
157688,detail,O,20101
157689,reading,O,20101
157690,and,O,20101
157691,driving,O,20101
157692,etc,O,20101
157693,When,O,20102
157694,an,B-NAME_OF_DISEASE,20102
157695,epiretinal,I-NAME_OF_DISEASE,20102
157696,membrane,I-NAME_OF_DISEASE,20102
157697,forms,O,20102
157698,over,O,20102
157699,the,B-PART_OF_THE_EYES,20102
157700,macula,I-PART_OF_THE_EYES,20102
157701,it,O,20102
157702,may,O,20102
157703,contract,O,20102
157704,and,O,20102
157705,wrinkle,O,20102
157706,the,B-PART_OF_THE_EYES,20102
157707,macula,I-PART_OF_THE_EYES,20102
157708,resulting,O,20102
157709,in,O,20102
157710,distorted,B-SIGN_AND_SYMPTOM,20102
157711,and,I-SIGN_AND_SYMPTOM,20102
157712,or,I-SIGN_AND_SYMPTOM,20102
157713,blurred,I-SIGN_AND_SYMPTOM,20102
157714,vision,I-SIGN_AND_SYMPTOM,20102
157715,The,O,20103
157716,only,O,20103
157717,way,O,20103
157718,to,O,20103
157719,treat,O,20103
157720,an,B-NAME_OF_DISEASE,20103
157721,epiretinal,I-NAME_OF_DISEASE,20103
157722,membrane,I-NAME_OF_DISEASE,20103
157723,is,O,20103
157724,by,O,20103
157725,having,O,20103
157726,an,O,20103
157727,operation,O,20103
157728,called,O,20103
157729,a,B-TREATMENT,20103
157730,vitrectomy,I-TREATMENT,20103
157731,During,O,20104
157732,the,B-TREATMENT,20104
157733,vitrectomy,I-TREATMENT,20104
157734,the,O,20104
157735,surgeon,O,20104
157736,makes,O,20104
157737,tiny,O,20104
157738,cuts,O,20104
157739,in,O,20104
157740,the,O,20104
157741,eye,O,20104
157742,and,O,20104
157743,removes,O,20104
157744,the,B-PART_OF_THE_EYES,20104
157745,vitreous,I-PART_OF_THE_EYES,20104
157746,from,O,20104
157747,inside,O,20104
157748,They,O,20105
157749,then,O,20105
157750,grasp,O,20105
157751,and,O,20105
157752,gently,O,20105
157753,peel,O,20105
157754,away,O,20105
157755,the,B-NAME_OF_DISEASE,20105
157756,epiretinal,I-NAME_OF_DISEASE,20105
157757,membrane,I-NAME_OF_DISEASE,20105
157758,from,O,20105
157759,the,B-PART_OF_THE_EYES,20105
157760,retina,I-PART_OF_THE_EYES,20105
157761,Vitrectomy,B-TREATMENT,20106
157762,has,O,20106
157763,become,O,20106
157764,a,O,20106
157765,common,O,20106
157766,procedure,O,20106
157767,for,O,20106
157768,the,O,20106
157769,treatment,O,20106
157770,of,O,20106
157771,visual,B-SIGN_AND_SYMPTOM,20106
157772,loss,I-SIGN_AND_SYMPTOM,20106
157773,due,O,20106
157774,to,O,20106
157775,epiretinal,B-NAME_OF_DISEASE,20106
157776,membranes,I-NAME_OF_DISEASE,20106
157777,macular,B-NAME_OF_DISEASE,20106
157778,pucker,I-NAME_OF_DISEASE,20106
157779,over,O,20106
157780,the,O,20106
157781,past,O,20106
157782,two,B-TIME_DURATION,20106
157783,decades,I-TIME_DURATION,20106
157784,Epiretinal,B-NAME_OF_DISEASE,20107
157785,membranes,I-NAME_OF_DISEASE,20107
157786,result,O,20107
157787,from,O,20107
157788,fibroglial,B-CAUSE_OF_DISEASE,20107
157789,proliferation,I-CAUSE_OF_DISEASE,20107
157790,on,I-CAUSE_OF_DISEASE,20107
157791,the,I-CAUSE_OF_DISEASE,20107
157792,surface,I-CAUSE_OF_DISEASE,20107
157793,of,I-CAUSE_OF_DISEASE,20107
157794,the,I-CAUSE_OF_DISEASE,20107
157795,retina,I-CAUSE_OF_DISEASE,20107
157796,The,O,20108
157797,prevalence,O,20108
157798,of,O,20108
157799,epiretinal,B-NAME_OF_DISEASE,20108
157800,membranes,I-NAME_OF_DISEASE,20108
157801,in,O,20108
157802,the,B-PART_OF_THE_EYES,20108
157803,macula,I-PART_OF_THE_EYES,20108
157804,detectable,O,20108
157805,by,O,20108
157806,fundus,B-DIAGNOSTIC_TEST,20108
157807,photographs,I-DIAGNOSTIC_TEST,20108
157808,was,O,20108
157809,7%,O,20108
157810,in,O,20108
157811,a,O,20108
157812,study,O,20108
157813,of,O,20108
157814,3654,O,20108
157815,persons,O,20108
157816,who,O,20108
157817,were,O,20108
157818,aged,O,20108
157819,49,O,20108
157820,years,O,20108
157821,or,O,20108
157822,more,O,20108
157823,Epiretinal,B-NAME_OF_DISEASE,20109
157824,membrane,I-NAME_OF_DISEASE,20109
157825,ERM,I-NAME_OF_DISEASE,20109
157826,has,O,20109
157827,become,O,20109
157828,a,O,20109
157829,more,O,20109
157830,widespread,O,20109
157831,retinal,O,20109
157832,disease,O,20109
157833,in,O,20109
157834,recent,O,20109
157835,years,O,20109
157836,The,O,20110
157837,incidence,O,20110
157838,of,O,20110
157839,ERM,B-NAME_OF_DISEASE,20110
157840,is,O,20110
157841,1.10%,O,20110
157842,per,O,20110
157843,eye-year,O,20110
157844,with,O,20110
157845,estimated,O,20110
157846,prevalence,O,20110
157847,in,O,20110
157848,some,O,20110
157849,populations,O,20110
157850,as,O,20110
157851,high,O,20110
157852,as,O,20110
157853,28.90%,O,20110
157854,Epiretinal,B-NAME_OF_DISEASE,20111
157855,membranes,I-NAME_OF_DISEASE,20111
157856,occur,O,20111
157857,at,O,20111
157858,higher,O,20111
157859,rates,O,20111
157860,in,O,20111
157861,the,O,20111
157862,elderly,O,20111
157863,population,O,20111
157864,65,O,20111
157865,years,O,20111
157866,of,O,20111
157867,age,O,20111
157868,The,O,20112
157869,number,O,20112
157870,of,O,20112
157871,people,O,20112
157872,affected,O,20112
157873,by,O,20112
157874,ERM,B-NAME_OF_DISEASE,20112
157875,is,O,20112
157876,increasing,O,20112
157877,due,O,20112
157878,to,O,20112
157879,the,O,20112
157880,growth,O,20112
157881,of,O,20112
157882,aging,O,20112
157883,populations,O,20112
157884,and,O,20112
157885,retina,B-PART_OF_THE_EYES,20112
157886,specialists,O,20112
157887,will,O,20112
157888,likely,O,20112
157889,have,O,20112
157890,more,O,20112
157891,opportunity,O,20112
157892,to,O,20112
157893,treat,O,20112
157894,patients,O,20112
157895,who,O,20112
157896,have,O,20112
157897,ERM,B-NAME_OF_DISEASE,20112
157898,in,O,20112
157899,coming,O,20112
157900,years,O,20112
157901,Optical,B-DIAGNOSTIC_TEST,20113
157902,coherence,I-DIAGNOSTIC_TEST,20113
157903,tomography,I-DIAGNOSTIC_TEST,20113
157904,OCT,I-DIAGNOSTIC_TEST,20113
157905,has,O,20113
157906,great,O,20113
157907,sensitivity,O,20113
157908,and,O,20113
157909,it,O,20113
157910,is,O,20113
157911,able,O,20113
157912,to,O,20113
157913,detect,O,20113
157914,even,O,20113
157915,subtle,O,20113
157916,changes,O,20113
157917,in,O,20113
157918,eyes,O,20113
157919,with,O,20113
157920,ERM,B-NAME_OF_DISEASE,20113
157921,helping,O,20113
157922,retina,B-PART_OF_THE_EYES,20113
157923,specialists,O,20113
157924,determine,O,20113
157925,the,O,20113
157926,optimal,O,20113
157927,timing,O,20113
157928,for,O,20113
157929,ERM,B-TREATMENT,20113
157930,surgery,I-TREATMENT,20113
157931,However,O,20114
157932,it,O,20114
157933,is,O,20114
157934,difficult,O,20114
157935,to,O,20114
157936,predict,O,20114
157937,postoperative,O,20114
157938,visual,O,20114
157939,prognosis,O,20114
157940,because,O,20114
157941,vision,B-SIGN_AND_SYMPTOM,20114
157942,changes,I-SIGN_AND_SYMPTOM,20114
157943,including,I-SIGN_AND_SYMPTOM,20114
157944,decreased,I-SIGN_AND_SYMPTOM,20114
157945,visual,I-SIGN_AND_SYMPTOM,20114
157946,acuity,I-SIGN_AND_SYMPTOM,20114
157947,visual,I-SIGN_AND_SYMPTOM,20114
157948,distortion,I-SIGN_AND_SYMPTOM,20114
157949,and,I-SIGN_AND_SYMPTOM,20114
157950,metamorphopsia,I-SIGN_AND_SYMPTOM,20114
157951,are,O,20114
157952,caused,O,20114
157953,by,O,20114
157954,several,O,20114
157955,complicated,O,20114
157956,and,O,20114
157957,intangible,O,20114
157958,factors,O,20114
157959,This,O,20115
157960,article,O,20115
157961,presents,O,20115
157962,a,O,20115
157963,relatively,O,20115
157964,simple,O,20115
157965,and,O,20115
157966,useful,O,20115
157967,method,O,20115
157968,of,O,20115
157969,determining,O,20115
157970,prognosis,O,20115
157971,for,O,20115
157972,ERM,B-TREATMENT,20115
157973,surgery,I-TREATMENT,20115
157974,utilizing,O,20115
157975,OCT,B-DIAGNOSTIC_TEST,20115
157976,findings,O,20115
157977,Changes,O,20116
157978,in,O,20116
157979,Configuration,O,20116
157980,of,O,20116
157981,Inner,B-PART_OF_THE_EYES,20116
157982,and,I-PART_OF_THE_EYES,20116
157983,Outer,I-PART_OF_THE_EYES,20116
157984,Retinal,I-PART_OF_THE_EYES,20116
157985,Layers,I-PART_OF_THE_EYES,20116
157986,Optical,B-DIAGNOSTIC_TEST,20117
157987,coherence,I-DIAGNOSTIC_TEST,20117
157988,tomography,I-DIAGNOSTIC_TEST,20117
157989,has,O,20117
157990,become,O,20117
157991,the,O,20117
157992,most,O,20117
157993,important,O,20117
157994,imaging,O,20117
157995,tool,O,20117
157996,for,O,20117
157997,diseases,O,20117
157998,of,O,20117
157999,the,O,20117
158000,vitreoretinal,O,20117
158001,interface,O,20117
158002,including,O,20117
158003,ERM,B-NAME_OF_DISEASE,20117
158004,Spectral-domain,B-DIAGNOSTIC_TEST,20118
158005,OCT,I-DIAGNOSTIC_TEST,20118
158006,enables,O,20118
158007,a,O,20118
158008,precise,O,20118
158009,visualization,O,20118
158010,of,O,20118
158011,the,B-PART_OF_THE_EYES,20118
158012,retina,I-PART_OF_THE_EYES,20118
158013,from,O,20118
158014,the,O,20118
158015,inner,O,20118
158016,surface,O,20118
158017,to,O,20118
158018,the,O,20118
158019,most,O,20118
158020,outer,O,20118
158021,parts,O,20118
158022,Consequently,O,20119
158023,not,O,20119
158024,only,O,20119
158025,can,O,20119
158026,superficial,O,20119
158027,changes,O,20119
158028,such,O,20119
158029,as,O,20119
158030,the,B-NAME_OF_DISEASE,20119
158031,ERM,I-NAME_OF_DISEASE,20119
158032,folds,O,20119
158033,in,O,20119
158034,the,B-PART_OF_THE_EYES,20119
158035,ILM,I-PART_OF_THE_EYES,20119
158036,or,O,20119
158037,vitreomacular,O,20119
158038,traction,O,20119
158039,be,O,20119
158040,seen,O,20119
158041,but,O,20119
158042,also,O,20119
158043,associated,O,20119
158044,changes,O,20119
158045,in,O,20119
158046,the,O,20119
158047,more,O,20119
158048,outer,O,20119
158049,layers,O,20119
158050,such,O,20119
158051,as,O,20119
158052,intraretinal,B-PART_OF_THE_EYES,20119
158053,cystoid,I-PART_OF_THE_EYES,20119
158054,spaces,I-PART_OF_THE_EYES,20119
158055,disruption,O,20119
158056,of,O,20119
158057,ellipsoid,O,20119
158058,line,O,20119
158059,disruption,O,20119
158060,of,O,20119
158061,the,B-PART_OF_THE_EYES,20119
158062,cone,I-PART_OF_THE_EYES,20119
158063,outersegment,O,20119
158064,tips,O,20119
158065,flattening,O,20119
158066,of,O,20119
158067,the,O,20119
158068,foveal,O,20119
158069,depression,O,20119
158070,and,O,20119
158071,formation,O,20119
158072,of,O,20119
158073,full-thickness,O,20119
158074,pseudo,O,20119
158075,and,O,20119
158076,incomplete,O,20119
158077,macular,B-PART_OF_THE_EYES,20119
158078,holes,I-PART_OF_THE_EYES,20119
158079,recognized,O,20119
158080,as,O,20119
158081,lamellar,O,20119
158082,macular,B-PART_OF_THE_EYES,20119
158083,hole,I-PART_OF_THE_EYES,20119
158084,Predictive,O,20120
158085,Factors,O,20120
158086,for,O,20120
158087,Visual,O,20120
158088,Outcome,O,20120
158089,from,O,20120
158090,OCT,B-DIAGNOSTIC_TEST,20120
158091,Analysis,I-DIAGNOSTIC_TEST,20120
158092,for,O,20120
158093,ERM,B-NAME_OF_DISEASE,20120
158094,Disorganization,O,20121
158095,of,O,20121
158096,Inner,B-PART_OF_THE_EYES,20121
158097,Retinal,I-PART_OF_THE_EYES,20121
158098,Layer,I-PART_OF_THE_EYES,20121
158099,Epiretinal,B-NAME_OF_DISEASE,20121
158100,membrane,I-NAME_OF_DISEASE,20121
158101,can,O,20121
158102,cause,O,20121
158103,distortion,B-SIGN_AND_SYMPTOM,20121
158104,and,I-SIGN_AND_SYMPTOM,20121
158105,disorganization,I-SIGN_AND_SYMPTOM,20121
158106,of,I-SIGN_AND_SYMPTOM,20121
158107,inner,I-SIGN_AND_SYMPTOM,20121
158108,retinal,I-SIGN_AND_SYMPTOM,20121
158109,layers,I-SIGN_AND_SYMPTOM,20121
158110,DRIL,I-SIGN_AND_SYMPTOM,20121
158111,The,O,20122
158112,extent,O,20122
158113,of,O,20122
158114,DRIL,B-SIGN_AND_SYMPTOM,20122
158115,is,O,20122
158116,associated,O,20122
158117,with,O,20122
158118,preoperative,O,20122
158119,and,O,20122
158120,postoperative,O,20122
158121,visual,O,20122
158122,function,O,20122
158123,in,O,20122
158124,eyes,O,20122
158125,with,O,20122
158126,ERM,B-NAME_OF_DISEASE,20122
158127,Eyes,O,20123
158128,with,O,20123
158129,severe,B-SIGN_AND_SYMPTOM,20123
158130,DRIL,I-SIGN_AND_SYMPTOM,20123
158131,arent,O,20123
158132,expected,O,20123
158133,to,O,20123
158134,obtain,O,20123
158135,significant,O,20123
158136,improvement,O,20123
158137,of,O,20123
158138,visual,O,20123
158139,function,O,20123
158140,It,O,20124
158141,is,O,20124
158142,known,O,20124
158143,that,O,20124
158144,appropriate,O,20124
158145,organization,O,20124
158146,of,O,20124
158147,the,B-PART_OF_THE_EYES,20124
158148,inner,I-PART_OF_THE_EYES,20124
158149,retinal,I-PART_OF_THE_EYES,20124
158150,layer,I-PART_OF_THE_EYES,20124
158151,such,O,20124
158152,as,O,20124
158153,the,B-PART_OF_THE_EYES,20124
158154,inner,I-PART_OF_THE_EYES,20124
158155,nuclear,I-PART_OF_THE_EYES,20124
158156,layer,I-PART_OF_THE_EYES,20124
158157,INL,I-PART_OF_THE_EYES,20124
158158,is,O,20124
158159,vital,O,20124
158160,to,O,20124
158161,essential,O,20124
158162,visual,O,20124
158163,functions,O,20124
158164,such,O,20124
158165,as,O,20124
158166,visual,O,20124
158167,clarity,O,20124
158168,Therefore,O,20125
158169,DRIL,B-SIGN_AND_SYMPTOM,20125
158170,is,O,20125
158171,recognized,O,20125
158172,as,O,20125
158173,a,O,20125
158174,predictive,O,20125
158175,factor,O,20125
158176,in,O,20125
158177,determining,O,20125
158178,postoperative,O,20125
158179,visual,O,20125
158180,function,O,20125
158181,Space,O,20126
158182,Between,O,20126
158183,Epiretinal,B-NAME_OF_DISEASE,20126
158184,Membrane,I-NAME_OF_DISEASE,20126
158185,and,O,20126
158186,Retinal,B-PART_OF_THE_EYES,20126
158187,Surface,I-PART_OF_THE_EYES,20126
158188,Epiretinal,B-NAME_OF_DISEASE,20127
158189,membrane,I-NAME_OF_DISEASE,20127
158190,is,O,20127
158191,located,O,20127
158192,on,O,20127
158193,the,O,20127
158194,surface,O,20127
158195,of,O,20127
158196,the,B-PART_OF_THE_EYES,20127
158197,retina,I-PART_OF_THE_EYES,20127
158198,and,O,20127
158199,it,O,20127
158200,tends,O,20127
158201,to,O,20127
158202,spread,O,20127
158203,and,O,20127
158204,become,O,20127
158205,contracted,O,20127
158206,causing,O,20127
158207,deformation,O,20127
158208,of,O,20127
158209,the,B-PART_OF_THE_EYES,20127
158210,inner,I-PART_OF_THE_EYES,20127
158211,and,I-PART_OF_THE_EYES,20127
158212,outer,I-PART_OF_THE_EYES,20127
158213,retinal,I-PART_OF_THE_EYES,20127
158214,cells,I-PART_OF_THE_EYES,20127
158215,There,O,20128
158216,are,O,20128
158217,various,O,20128
158218,patterns,O,20128
158219,of,O,20128
158220,membranes,O,20128
158221,seen,O,20128
158222,in,O,20128
158223,OCT,B-DIAGNOSTIC_TEST,20128
158224,findings,O,20128
158225,of,O,20128
158226,eyes,O,20128
158227,with,O,20128
158228,ERM,B-NAME_OF_DISEASE,20128
158229,Overall,O,20129
158230,it,O,20129
158231,is,O,20129
158232,simpler,O,20129
158233,to,O,20129
158234,identify,O,20129
158235,the,B-SIGN_AND_SYMPTOM,20129
158236,sukima,I-SIGN_AND_SYMPTOM,20129
158237,than,O,20129
158238,other,O,20129
158239,known,O,20129
158240,factors,O,20129
158241,such,O,20129
158242,as,O,20129
158243,DRIL,B-SIGN_AND_SYMPTOM,20129
158244,ellipsoid,B-PART_OF_THE_EYES,20129
158245,zone,I-PART_OF_THE_EYES,20129
158246,EZ,I-PART_OF_THE_EYES,20129
158247,and,O,20129
158248,cone,B-PART_OF_THE_EYES,20129
158249,outer-segment,I-PART_OF_THE_EYES,20129
158250,tips,I-PART_OF_THE_EYES,20129
158251,seen,O,20129
158252,in,O,20129
158253,OCT,B-DIAGNOSTIC_TEST,20129
158254,Based,O,20130
158255,on,O,20130
158256,our,O,20130
158257,research,O,20130
158258,the,O,20130
158259,pocket,O,20130
158260,of,O,20130
158261,space,O,20130
158262,between,O,20130
158263,the,B-NAME_OF_DISEASE,20130
158264,ERM,I-NAME_OF_DISEASE,20130
158265,and,O,20130
158266,the,B-PART_OF_THE_EYES,20130
158267,ILM,I-PART_OF_THE_EYES,20130
158268,is,O,20130
158269,significantly,O,20130
158270,associated,O,20130
158271,with,O,20130
158272,baseline,O,20130
158273,visual,O,20130
158274,distortion,O,20130
158275,and,O,20130
158276,improvements,O,20130
158277,in,O,20130
158278,visual,O,20130
158279,acuity,O,20130
158280,after,O,20130
158281,surgery,O,20130
158282,For,O,20131
158283,example,O,20131
158284,after,O,20131
158285,ERM,B-TREATMENT,20131
158286,surgery,I-TREATMENT,20131
158287,on,O,20131
158288,an,O,20131
158289,eye,O,20131
158290,with,O,20131
158291,a,B-SIGN_AND_SYMPTOM,20131
158292,small,I-SIGN_AND_SYMPTOM,20131
158293,sukima,I-SIGN_AND_SYMPTOM,20131
158294,there,O,20131
158295,is,O,20131
158296,not,O,20131
158297,significant,O,20131
158298,improvement,O,20131
158299,of,O,20131
158300,visual,O,20131
158301,acuity,O,20131
158302,However,O,20132
158303,following,O,20132
158304,surgery,O,20132
158305,for,O,20132
158306,an,O,20132
158307,eye,O,20132
158308,with,O,20132
158309,ERM,B-NAME_OF_DISEASE,20132
158310,with,O,20132
158311,a,O,20132
158312,pronounced,O,20132
158313,sukima,B-SIGN_AND_SYMPTOM,20132
158314,there,O,20132
158315,is,O,20132
158316,the,O,20132
158317,possibility,O,20132
158318,of,O,20132
158319,obtaining,O,20132
158320,improved,O,20132
158321,visual,O,20132
158322,function,O,20132
158323,Based,O,20133
158324,on,O,20133
158325,our,O,20133
158326,results,O,20133
158327,we,O,20133
158328,concluded,O,20133
158329,that,O,20133
158330,the,O,20133
158331,presence,O,20133
158332,of,O,20133
158333,sukima,B-SIGN_AND_SYMPTOM,20133
158334,may,O,20133
158335,allow,O,20133
158336,us,O,20133
158337,to,O,20133
158338,predict,O,20133
158339,postoperative,O,20133
158340,visual,O,20133
158341,function,O,20133
158342,in,O,20133
158343,eyes,O,20133
158344,with,O,20133
158345,ERM,B-NAME_OF_DISEASE,20133
158346,We,O,20134
158347,believe,O,20134
158348,there,O,20134
158349,are,O,20134
158350,2,O,20134
158351,main,O,20134
158352,reasons,O,20134
158353,for,O,20134
158354,this,O,20134
158355,the,O,20134
158356,effect,O,20134
158357,on,O,20134
158358,the,O,20134
158359,performance,O,20134
158360,of,O,20134
158361,membrane,O,20134
158362,peeling,O,20134
158363,and,O,20134
158364,the,O,20134
158365,strong,O,20134
158366,correlation,O,20134
158367,with,O,20134
158368,disruption,O,20134
158369,of,O,20134
158370,the,B-PART_OF_THE_EYES,20134
158371,EZ,I-PART_OF_THE_EYES,20134
158372,It,O,20135
158373,is,O,20135
158374,more,O,20135
158375,difficult,O,20135
158376,to,O,20135
158377,remove,O,20135
158378,membranes,O,20135
158379,in,O,20135
158380,an,O,20135
158381,eye,O,20135
158382,with,O,20135
158383,small,B-SIGN_AND_SYMPTOM,20135
158384,sukima,I-SIGN_AND_SYMPTOM,20135
158385,where,O,20135
158386,the,B-NAME_OF_DISEASE,20135
158387,ERM,I-NAME_OF_DISEASE,20135
158388,is,O,20135
158389,firmly,O,20135
158390,attached,O,20135
158391,to,O,20135
158392,the,B-PART_OF_THE_EYES,20135
158393,ILM,I-PART_OF_THE_EYES,20135
158394,while,O,20135
158395,it,O,20135
158396,is,O,20135
158397,easier,O,20135
158398,to,O,20135
158399,peel,O,20135
158400,membrane,O,20135
158401,in,O,20135
158402,eyes,O,20135
158403,with,O,20135
158404,a,B-SIGN_AND_SYMPTOM,20135
158405,large,I-SIGN_AND_SYMPTOM,20135
158406,sukima,I-SIGN_AND_SYMPTOM,20135
158407,where,O,20135
158408,the,O,20135
158409,2,O,20135
158410,layers,O,20135
158411,are,O,20135
158412,loosely,O,20135
158413,attached,O,20135
158414,Furthermore,O,20136
158415,disruption,O,20136
158416,of,O,20136
158417,EZ,B-PART_OF_THE_EYES,20136
158418,is,O,20136
158419,more,O,20136
158420,likely,O,20136
158421,to,O,20136
158422,be,O,20136
158423,seen,O,20136
158424,in,O,20136
158425,eyes,O,20136
158426,with,O,20136
158427,small,B-SIGN_AND_SYMPTOM,20136
158428,sukima,I-SIGN_AND_SYMPTOM,20136
158429,than,O,20136
158430,those,O,20136
158431,with,O,20136
158432,large,B-SIGN_AND_SYMPTOM,20136
158433,sukima,I-SIGN_AND_SYMPTOM,20136
158434,suggesting,O,20136
158435,that,O,20136
158436,persistent,O,20136
158437,traction,O,20136
158438,of,O,20136
158439,the,B-NAME_OF_DISEASE,20136
158440,ERM,I-NAME_OF_DISEASE,20136
158441,might,O,20136
158442,cause,O,20136
158443,damage,O,20136
158444,to,O,20136
158445,the,B-PART_OF_THE_EYES,20136
158446,outer,I-PART_OF_THE_EYES,20136
158447,retina,I-PART_OF_THE_EYES,20136
158448,including,O,20136
158449,the,B-PART_OF_THE_EYES,20136
158450,EZ,I-PART_OF_THE_EYES,20136
158451,cone,B-PART_OF_THE_EYES,20136
158452,outersegment,I-PART_OF_THE_EYES,20136
158453,tips,I-PART_OF_THE_EYES,20136
158454,and,O,20136
158455,foveal,B-PART_OF_THE_EYES,20136
158456,bulge,I-PART_OF_THE_EYES,20136
158457,The,O,20137
158458,separated,O,20137
158459,space,O,20137
158460,between,O,20137
158461,the,B-NAME_OF_DISEASE,20137
158462,ERM,B-NAME_OF_DISEASE,20137
158463,and,O,20137
158464,the,B-PART_OF_THE_EYES,20137
158465,ILM,I-PART_OF_THE_EYES,20137
158466,sukima,B-SIGN_AND_SYMPTOM,20137
158467,allows,O,20137
158468,us,O,20137
158469,to,O,20137
158470,determine,O,20137
158471,the,O,20137
158472,feasibility,O,20137
158473,of,O,20137
158474,membrane,O,20137
158475,peeling,O,20137
158476,because,O,20137
158477,the,O,20137
158478,presence,O,20137
158479,of,O,20137
158480,sukima,B-SIGN_AND_SYMPTOM,20137
158481,is,O,20137
158482,significantly,O,20137
158483,associated,O,20137
158484,with,O,20137
158485,improved,O,20137
158486,postoperative,O,20137
158487,visual,O,20137
158488,outcomes,O,20137
158489,in,O,20137
158490,eyes,O,20137
158491,with,O,20137
158492,ERM,B-NAME_OF_DISEASE,20137
158493,The,O,20138
158494,most,O,20138
158495,common,O,20138
158496,treatments,O,20138
158497,for,O,20138
158498,glaucoma,B-NAME_OF_DISEASE,20138
158499,are,O,20138
158500,eye,B-TREATMENT,20138
158501,drops,I-TREATMENT,20138
158502,and,O,20138
158503,rarely,O,20138
158504,pills,B-TREATMENT,20138
158505,They,O,20139
158506,work,O,20139
158507,by,O,20139
158508,lowering,O,20139
158509,the,O,20139
158510,pressure,O,20139
158511,in,O,20139
158512,the,O,20139
158513,eye,O,20139
158514,and,O,20139
158515,preventing,O,20139
158516,damage,O,20139
158517,to,O,20139
158518,the,B-PART_OF_THE_EYES,20139
158519,optic,I-PART_OF_THE_EYES,20139
158520,nerve,I-PART_OF_THE_EYES,20139
158521,These,O,20140
158522,eye,B-TREATMENT,20140
158523,drops,I-TREATMENT,20140
158524,wont,O,20140
158525,cure,O,20140
158526,glaucoma,B-NAME_OF_DISEASE,20140
158527,or,O,20140
158528,reverse,B-SIGN_AND_SYMPTOM,20140
158529,vision,I-SIGN_AND_SYMPTOM,20140
158530,loss,I-SIGN_AND_SYMPTOM,20140
158531,but,O,20140
158532,they,O,20140
158533,can,O,20140
158534,keep,O,20140
158535,glaucoma,B-NAME_OF_DISEASE,20140
158536,from,O,20140
158537,getting,O,20140
158538,worse,O,20140
158539,There,O,20141
158540,are,O,20141
158541,a,O,20141
158542,number,O,20141
158543,of,O,20141
158544,different,O,20141
158545,categories,O,20141
158546,of,O,20141
158547,eye,B-TREATMENT,20141
158548,drops,I-TREATMENT,20141
158549,but,O,20141
158550,all,O,20141
158551,are,O,20141
158552,used,O,20141
158553,to,O,20141
158554,either,O,20141
158555,decrease,O,20141
158556,the,O,20141
158557,amount,O,20141
158558,of,O,20141
158559,fluid,O,20141
158560,aqueous,O,20141
158561,humor,O,20141
158562,in,O,20141
158563,the,O,20141
158564,eye,O,20141
158565,or,O,20141
158566,improve,O,20141
158567,its,O,20141
158568,outward,O,20141
158569,flow,O,20141
158570,Sometimes,O,20142
158571,doctors,O,20142
158572,will,O,20142
158573,prescribe,O,20142
158574,a,O,20142
158575,combination,O,20142
158576,of,O,20142
158577,eye,B-TREATMENT,20142
158578,drops,I-TREATMENT,20142
158579,Since,O,20143
158580,the,O,20143
158581,approval,O,20143
158582,of,O,20143
158583,the,O,20143
158584,first,O,20143
158585,prostaglandin,B-NAME_OF_DRUG,20143
158586,analogue,I-NAME_OF_DRUG,20143
158587,in,O,20143
158588,the,O,20143
158589,1990s,O,20143
158590,this,O,20143
158591,class,O,20143
158592,of,O,20143
158593,medication,O,20143
158594,has,O,20143
158595,been,O,20143
158596,the,O,20143
158597,first-line,O,20143
158598,treatment,O,20143
158599,choice,O,20143
158600,for,O,20143
158601,doctors,O,20143
158602,and,O,20143
158603,patients,O,20143
158604,with,O,20143
158605,newly,O,20143
158606,diagnosed,O,20143
158607,glaucoma,B-NAME_OF_DISEASE,20143
158608,Today,O,20144
158609,we,O,20144
158610,have,O,20144
158611,more,O,20144
158612,treatment,O,20144
158613,choices,O,20144
158614,including,O,20144
158615,new,O,20144
158616,categories,O,20144
158617,of,O,20144
158618,glaucoma,B-NAME_OF_DISEASE,20144
158619,medications,O,20144
158620,safer,O,20144
158621,surgical,O,20144
158622,options,O,20144
158623,and,O,20144
158624,novel,O,20144
158625,drug-delivery,O,20144
158626,systems,O,20144
158627,Although,O,20145
158628,laser,O,20145
158629,and,O,20145
158630,surgical,O,20145
158631,options,O,20145
158632,may,O,20145
158633,play,O,20145
158634,a,O,20145
158635,role,O,20145
158636,in,O,20145
158637,glaucoma,B-NAME_OF_DISEASE,20145
158638,treatment,O,20145
158639,the,O,20145
158640,majority,O,20145
158641,of,O,20145
158642,glaucoma,B-NAME_OF_DISEASE,20145
158643,patients,O,20145
158644,and,O,20145
158645,those,O,20145
158646,at,O,20145
158647,risk,O,20145
158648,of,O,20145
158649,developing,O,20145
158650,the,O,20145
158651,disease,O,20145
158652,are,O,20145
158653,managed,O,20145
158654,medically,O,20145
158655,When,O,20146
158656,drops,O,20146
158657,are,O,20146
158658,prescribed,O,20146
158659,for,O,20146
158660,glaucoma,B-NAME_OF_DISEASE,20146
158661,there,O,20146
158662,are,O,20146
158663,several,O,20146
158664,factors,O,20146
158665,to,O,20146
158666,consider,O,20146
158667,When,O,20147
158668,a,O,20147
158669,new,O,20147
158670,class,O,20147
158671,of,O,20147
158672,glaucoma,B-NAME_OF_DISEASE,20147
158673,medication,O,20147
158674,is,O,20147
158675,developed,O,20147
158676,they,O,20147
158677,typically,O,20147
158678,become,O,20147
158679,first,O,20147
158680,available,O,20147
158681,as,O,20147
158682,a,O,20147
158683,brand-name,O,20147
158684,medication,O,20147
158685,The,O,20148
158686,Phase,O,20148
158687,1,O,20148
158688,clinical,O,20148
158689,studies,O,20148
158690,begin,O,20148
158691,human,O,20148
158692,dosing,O,20148
158693,of,O,20148
158694,the,O,20148
158695,drug,O,20148
158696,in,O,20148
158697,which,O,20148
158698,there,O,20148
158699,is,O,20148
158700,testing,O,20148
158701,for,O,20148
158702,tolerability,O,20148
158703,in,O,20148
158704,healthy,O,20148
158705,individuals,O,20148
158706,ocular,O,20148
158707,hypertensive,O,20148
158708,patients,O,20148
158709,or,O,20148
158710,patients,O,20148
158711,with,O,20148
158712,primary,B-NAME_OF_DISEASE,20148
158713,open-angle,I-NAME_OF_DISEASE,20148
158714,glaucoma,I-NAME_OF_DISEASE,20148
158715,The,O,20149
158716,new,O,20149
158717,agent,O,20149
158718,must,O,20149
158719,demonstrate,O,20149
158720,equivalence,O,20149
158721,or,O,20149
158722,superiority,O,20149
158723,to,O,20149
158724,an,O,20149
158725,active,O,20149
158726,control,O,20149
158727,such,O,20149
158728,as,O,20149
158729,timolol,B-NAME_OF_DRUG,20149
158730,To,O,20150
158731,be,O,20150
158732,approved,O,20150
158733,FDA,B-ORGANIZATION,20150
158734,generic,O,20150
158735,drug,O,20150
158736,applicants,O,20150
158737,must,O,20150
158738,show,O,20150
158739,the,O,20150
158740,generic,O,20150
158741,medicine,O,20150
158742,is,O,20150
158743,the,O,20150
158744,same,O,20150
158745,as,O,20150
158746,the,O,20150
158747,brand-name,O,20150
158748,in,O,20150
158749,the,O,20150
158750,following,O,20150
158751,ways,O,20150
158752,per,O,20150
158753,FDAgov,O,20150
158754,This,O,20151
158755,includes,O,20151
158756,the,O,20151
158757,combining,O,20151
158758,of,O,20151
158759,two,O,20151
158760,or,O,20151
158761,more,O,20151
158762,classes,O,20151
158763,of,O,20151
158764,FDA-approved,O,20151
158765,glaucoma,B-NAME_OF_DISEASE,20151
158766,medication,O,20151
158767,into,O,20151
158768,one,O,20151
158769,bottle,O,20151
158770,Compounded,O,20152
158771,drugs,O,20152
158772,are,O,20152
158773,not,O,20152
158774,FDA-approved,O,20152
158775,and,O,20152
158776,typically,O,20152
158777,not,O,20152
158778,covered,O,20152
158779,by,O,20152
158780,insurance,O,20152
158781,There,O,20153
158782,are,O,20153
158783,five,O,20153
158784,commonly,O,20153
158785,available,O,20153
158786,types,O,20153
158787,of,O,20153
158788,glaucoma,B-NAME_OF_DISEASE,20153
158789,medication,O,20153
158790,and,O,20153
158791,each,O,20153
158792,lower,O,20153
158793,IOP,O,20153
158794,via,O,20153
158795,different,O,20153
158796,mechanisms,O,20153
158797,Prostaglandin,B-NAME_OF_DRUG,20154
158798,Analogues,I-NAME_OF_DRUG,20154
158799,Generic,O,20155
158800,medication,O,20155
158801,latanoprost,B-NAME_OF_DRUG,20155
158802,has,O,20155
158803,been,O,20155
158804,available,O,20155
158805,since,O,20155
158806,1996,O,20155
158807,Amongst,O,20156
158808,all,O,20156
158809,classes,O,20156
158810,it,O,20156
158811,demonstrates,O,20156
158812,the,O,20156
158813,greatest,O,20156
158814,IOP,O,20156
158815,lowering,O,20156
158816,via,O,20156
158817,increased,O,20156
158818,aqueous,B-PART_OF_THE_EYES,20156
158819,humor,I-PART_OF_THE_EYES,20156
158820,outflow,O,20156
158821,through,O,20156
158822,the,O,20156
158823,uveoscleral,O,20156
158824,pathway,O,20156
158825,Latanoprostene,B-NAME_OF_DRUG,20157
158826,bunod,I-NAME_OF_DRUG,20157
158827,approved,O,20157
158828,in,O,20157
158829,2017,O,20157
158830,is,O,20157
158831,a,O,20157
158832,once-daily,O,20157
158833,drop,O,20157
158834,that,O,20157
158835,releases,O,20157
158836,latanoprost,B-NAME_OF_DRUG,20157
158837,and,O,20157
158838,nitric,B-CHEMICAL_COMPOUND,20157
158839,oxide,I-CHEMICAL_COMPOUND,20157
158840,NO,I-CHEMICAL_COMPOUND,20157
158841,on,O,20157
158842,administration,O,20157
158843,In,O,20158
158844,addition,O,20158
158845,to,O,20158
158846,the,O,20158
158847,action,O,20158
158848,of,O,20158
158849,latanoprost,B-NAME_OF_DRUG,20158
158850,NO,B-CHEMICAL_COMPOUND,20158
158851,increases,O,20158
158852,conventional,O,20158
158853,trabecular,O,20158
158854,outflow,O,20158
158855,a,O,20158
158856,novel,O,20158
158857,mechanism,O,20158
158858,of,O,20158
158859,action,O,20158
158860,Known,O,20159
158861,side,O,20159
158862,effects,O,20159
158863,of,O,20159
158864,latanoprost,B-NAME_OF_DRUG,20159
158865,include,O,20159
158866,iris,B-SIGN_AND_SYMPTOM,20159
158867,pigmentation,I-SIGN_AND_SYMPTOM,20159
158868,changes,I-SIGN_AND_SYMPTOM,20159
158869,darkening,I-SIGN_AND_SYMPTOM,20159
158870,of,I-SIGN_AND_SYMPTOM,20159
158871,the,I-SIGN_AND_SYMPTOM,20159
158872,eyelid,I-SIGN_AND_SYMPTOM,20159
158873,skin,I-SIGN_AND_SYMPTOM,20159
158874,eyelash,I-SIGN_AND_SYMPTOM,20159
158875,growth,I-SIGN_AND_SYMPTOM,20159
158876,and,I-SIGN_AND_SYMPTOM,20159
158877,periorbital,I-SIGN_AND_SYMPTOM,20159
158878,fat,I-SIGN_AND_SYMPTOM,20159
158879,atrophy,I-SIGN_AND_SYMPTOM,20159
158880,For,O,20160
158881,most,O,20160
158882,practitioners,O,20160
158883,prostaglandins,B-NAME_OF_DRUG,20160
158884,are,O,20160
158885,considered,O,20160
158886,first-line,O,20160
158887,treatment,O,20160
158888,in,O,20160
158889,the,O,20160
158890,treatment,O,20160
158891,paradigm,O,20160
158892,Beta,B-NAME_OF_DRUG,20161
158893,Blockers,I-NAME_OF_DRUG,20161
158894,Timolol,B-NAME_OF_DRUG,20162
158895,first,O,20162
158896,approved,O,20162
158897,by,O,20162
158898,the,B-ORGANIZATION,20162
158899,FDA,I-ORGANIZATION,20162
158900,in,O,20162
158901,1978,O,20162
158902,reduces,O,20162
158903,IOP,O,20162
158904,by,O,20162
158905,decreasing,O,20162
158906,the,O,20162
158907,production,O,20162
158908,of,O,20162
158909,aqueous,O,20162
158910,in,O,20162
158911,the,B-PART_OF_THE_EYES,20162
158912,ciliary,I-PART_OF_THE_EYES,20162
158913,body,I-PART_OF_THE_EYES,20162
158914,Possible,O,20163
158915,rare,O,20163
158916,but,O,20163
158917,serious,O,20163
158918,side,O,20163
158919,effects,O,20163
158920,could,O,20163
158921,include,O,20163
158922,dizziness,B-SIGN_AND_SYMPTOM,20163
158923,eye,I-SIGN_AND_SYMPTOM,20163
158924,pain,I-SIGN_AND_SYMPTOM,20163
158925,swelling,I-SIGN_AND_SYMPTOM,20163
158926,discharge,I-SIGN_AND_SYMPTOM,20163
158927,slow,I-SIGN_AND_SYMPTOM,20163
158928,or,I-SIGN_AND_SYMPTOM,20163
158929,irregular,I-SIGN_AND_SYMPTOM,20163
158930,heartbeat,I-SIGN_AND_SYMPTOM,20163
158931,muscle,I-SIGN_AND_SYMPTOM,20163
158932,weakness,I-SIGN_AND_SYMPTOM,20163
158933,mood,I-SIGN_AND_SYMPTOM,20163
158934,changes,I-SIGN_AND_SYMPTOM,20163
158935,and,I-SIGN_AND_SYMPTOM,20163
158936,coldness,I-SIGN_AND_SYMPTOM,20163
158937,numbness,I-SIGN_AND_SYMPTOM,20163
158938,pain,I-SIGN_AND_SYMPTOM,20163
158939,in,I-SIGN_AND_SYMPTOM,20163
158940,the,I-SIGN_AND_SYMPTOM,20163
158941,hands,I-SIGN_AND_SYMPTOM,20163
158942,or,I-SIGN_AND_SYMPTOM,20163
158943,feet,I-SIGN_AND_SYMPTOM,20163
158944,Avoid,O,20164
158945,these,O,20164
158946,medications,O,20164
158947,in,O,20164
158948,patients,O,20164
158949,who,O,20164
158950,have,O,20164
158951,an,B-NAME_OF_DISEASE,20164
158952,asthma,I-NAME_OF_DISEASE,20164
158953,or,O,20164
158954,COPD,B-NAME_OF_DISEASE,20164
158955,history,O,20164
158956,or,O,20164
158957,those,O,20164
158958,with,O,20164
158959,cardiac,O,20164
158960,conditions,O,20164
158961,such,O,20164
158962,as,O,20164
158963,heart,B-NAME_OF_DISEASE,20164
158964,block,I-NAME_OF_DISEASE,20164
158965,or,O,20164
158966,severe,B-NAME_OF_DISEASE,20164
158967,heart,I-NAME_OF_DISEASE,20164
158968,failure,I-NAME_OF_DISEASE,20164
158969,Alpha,B-NAME_OF_DRUG,20165
158970,Agonists,I-NAME_OF_DRUG,20165
158971,The,O,20166
158972,most,O,20166
158973,commonly,O,20166
158974,utilized,O,20166
158975,alpha,B-NAME_OF_DRUG,20166
158976,agonist,I-NAME_OF_DRUG,20166
158977,for,O,20166
158978,the,O,20166
158979,routine,O,20166
158980,treatment,O,20166
158981,of,O,20166
158982,glaucoma,B-NAME_OF_DISEASE,20166
158983,is,O,20166
158984,brimonidine,B-NAME_OF_DRUG,20166
158985,Approved,O,20167
158986,in,O,20167
158987,1996,O,20167
158988,it,O,20167
158989,both,O,20167
158990,reduces,O,20167
158991,aqueous,B-PART_OF_THE_EYES,20167
158992,humor,I-PART_OF_THE_EYES,20167
158993,production,O,20167
158994,and,O,20167
158995,stimulates,O,20167
158996,aqueous,B-PART_OF_THE_EYES,20167
158997,humor,I-PART_OF_THE_EYES,20167
158998,outflow,O,20167
158999,through,O,20167
159000,the,O,20167
159001,uveoscleral,O,20167
159002,pathway,O,20167
159003,Dosed,O,20168
159004,at,O,20168
159005,two,O,20168
159006,or,O,20168
159007,three,O,20168
159008,times,O,20168
159009,daily,O,20168
159010,it,O,20168
159011,can,O,20168
159012,be,O,20168
159013,associated,O,20168
159014,with,O,20168
159015,dry,B-SIGN_AND_SYMPTOM,20168
159016,mouth,I-SIGN_AND_SYMPTOM,20168
159017,ocular,I-SIGN_AND_SYMPTOM,20168
159018,allergy,I-SIGN_AND_SYMPTOM,20168
159019,with,I-SIGN_AND_SYMPTOM,20168
159020,a,I-SIGN_AND_SYMPTOM,20168
159021,red,I-SIGN_AND_SYMPTOM,20168
159022,eye,I-SIGN_AND_SYMPTOM,20168
159023,or,I-SIGN_AND_SYMPTOM,20168
159024,red,I-SIGN_AND_SYMPTOM,20168
159025,eyelids,I-SIGN_AND_SYMPTOM,20168
159026,tiredness,I-SIGN_AND_SYMPTOM,20168
159027,or,I-SIGN_AND_SYMPTOM,20168
159028,fatigue,I-SIGN_AND_SYMPTOM,20168
159029,low,I-SIGN_AND_SYMPTOM,20168
159030,or,I-SIGN_AND_SYMPTOM,20168
159031,high,I-SIGN_AND_SYMPTOM,20168
159032,blood,I-SIGN_AND_SYMPTOM,20168
159033,pressure,I-SIGN_AND_SYMPTOM,20168
159034,and,I-SIGN_AND_SYMPTOM,20168
159035,possible,I-SIGN_AND_SYMPTOM,20168
159036,slowing,I-SIGN_AND_SYMPTOM,20168
159037,of,I-SIGN_AND_SYMPTOM,20168
159038,heart,I-SIGN_AND_SYMPTOM,20168
159039,rate,I-SIGN_AND_SYMPTOM,20168
159040,less,O,20168
159041,than,O,20168
159042,with,O,20168
159043,beta,B-NAME_OF_DRUG,20168
159044,blockers,I-NAME_OF_DRUG,20168
159045,blurred,B-SIGN_AND_SYMPTOM,20168
159046,vision,I-SIGN_AND_SYMPTOM,20168
159047,sensitivity,I-SIGN_AND_SYMPTOM,20168
159048,to,I-SIGN_AND_SYMPTOM,20168
159049,bright,I-SIGN_AND_SYMPTOM,20168
159050,light,I-SIGN_AND_SYMPTOM,20168
159051,and,I-SIGN_AND_SYMPTOM,20168
159052,headache,I-SIGN_AND_SYMPTOM,20168
159053,Carbonic,B-NAME_OF_DRUG,20169
159054,Anhydrase,I-NAME_OF_DRUG,20169
159055,Inhibitors,I-NAME_OF_DRUG,20169
159056,Brinzolamide,B-NAME_OF_DRUG,20170
159057,approved,O,20170
159058,in,O,20170
159059,1998,O,20170
159060,and,O,20170
159061,dorzolamide,B-NAME_OF_DRUG,20170
159062,approved,O,20170
159063,in,O,20170
159064,1994,O,20170
159065,inhibit,O,20170
159066,carbonic,B-CHEMICAL_COMPOUND,20170
159067,anhydrase,I-CHEMICAL_COMPOUND,20170
159068,isoenzymes,I-CHEMICAL_COMPOUND,20170
159069,present,O,20170
159070,in,O,20170
159071,ciliary,O,20170
159072,processes,O,20170
159073,of,O,20170
159074,the,O,20170
159075,eye,O,20170
159076,with,O,20170
159077,the,O,20170
159078,consequent,O,20170
159079,reduction,O,20170
159080,of,O,20170
159081,bicarbonate,B-CHEMICAL_COMPOUND,20170
159082,and,O,20170
159083,aqueous,B-PART_OF_THE_EYES,20170
159084,humor,I-PART_OF_THE_EYES,20170
159085,secretion,O,20170
159086,Adverse,O,20171
159087,effects,O,20171
159088,of,O,20171
159089,topical,B-NAME_OF_DRUG,20171
159090,carbonic,I-NAME_OF_DRUG,20171
159091,anhydrase,I-NAME_OF_DRUG,20171
159092,inhibitors,I-NAME_OF_DRUG,20171
159093,are,O,20171
159094,rare,O,20171
159095,but,O,20171
159096,include,O,20171
159097,superficial,B-NAME_OF_DISEASE,20171
159098,punctate,I-NAME_OF_DISEASE,20171
159099,keratitis,I-NAME_OF_DISEASE,20171
159100,acidosis,B-SIGN_AND_SYMPTOM,20171
159101,paresthesias,I-SIGN_AND_SYMPTOM,20171
159102,nausea,I-SIGN_AND_SYMPTOM,20171
159103,depression,I-SIGN_AND_SYMPTOM,20171
159104,and,I-SIGN_AND_SYMPTOM,20171
159105,fatigue,I-SIGN_AND_SYMPTOM,20171
159106,Rho-Kinase,B-NAME_OF_DRUG,20172
159107,Inhibitors,I-NAME_OF_DRUG,20172
159108,Also,O,20173
159109,known,O,20173
159110,as,O,20173
159111,ROCK,B-NAME_OF_DRUG,20173
159112,inhibitors,I-NAME_OF_DRUG,20173
159113,this,O,20173
159114,class,O,20173
159115,of,O,20173
159116,medication,O,20173
159117,became,O,20173
159118,available,O,20173
159119,in,O,20173
159120,2017,O,20173
159121,It,O,20174
159122,targets,O,20174
159123,aqueous,O,20174
159124,outflow,O,20174
159125,at,O,20174
159126,the,O,20174
159127,level,O,20174
159128,of,O,20174
159129,the,B-PART_OF_THE_EYES,20174
159130,trabecular,I-PART_OF_THE_EYES,20174
159131,meshwork,I-PART_OF_THE_EYES,20174
159132,and,O,20174
159133,has,O,20174
159134,also,O,20174
159135,been,O,20174
159136,demonstrated,O,20174
159137,in,O,20174
159138,some,O,20174
159139,studies,O,20174
159140,to,O,20174
159141,reduce,O,20174
159142,the,O,20174
159143,episcleral,O,20174
159144,venous,O,20174
159145,pressure,O,20174
159146,the,O,20174
159147,venous,O,20174
159148,pressure,O,20174
159149,system,O,20174
159150,surrounding,O,20174
159151,the,O,20174
159152,eye,O,20174
159153,Netarsudil,B-NAME_OF_DRUG,20175
159154,is,O,20175
159155,used,O,20175
159156,once,O,20175
159157,daily,O,20175
159158,typically,O,20175
159159,in,O,20175
159160,the,O,20175
159161,evening,O,20175
159162,The,O,20176
159163,most,O,20176
159164,common,O,20176
159165,side,O,20176
159166,effect,O,20176
159167,seen,O,20176
159168,is,O,20176
159169,eye,B-SIGN_AND_SYMPTOM,20176
159170,redness,I-SIGN_AND_SYMPTOM,20176
159171,sometimes,O,20176
159172,significant,O,20176
159173,Other,O,20177
159174,potential,O,20177
159175,sequelae,O,20177
159176,include,O,20177
159177,instillation,B-SIGN_AND_SYMPTOM,20177
159178,site,I-SIGN_AND_SYMPTOM,20177
159179,pain,I-SIGN_AND_SYMPTOM,20177
159180,corneal,O,20177
159181,changes,O,20177
159182,known,O,20177
159183,as,O,20177
159184,verticillata,B-NAME_OF_DISEASE,20177
159185,and,O,20177
159186,subconjunctival,B-SIGN_AND_SYMPTOM,20177
159187,hemorrhage,I-SIGN_AND_SYMPTOM,20177
159188,Doctors,O,20178
159189,consider,O,20178
159190,multiple,O,20178
159191,factors,O,20178
159192,when,O,20178
159193,prescribing,O,20178
159194,topical,O,20178
159195,therapy,O,20178
159196,for,O,20178
159197,glaucoma,B-NAME_OF_DISEASE,20178
159198,In,O,20179
159199,dry,B-NAME_OF_DISEASE,20179
159200,eye,I-NAME_OF_DISEASE,20179
159201,disease,I-NAME_OF_DISEASE,20179
159202,the,B-SIGN_AND_SYMPTOM,20179
159203,loss,I-SIGN_AND_SYMPTOM,20179
159204,of,I-SIGN_AND_SYMPTOM,20179
159205,tear,I-SIGN_AND_SYMPTOM,20179
159206,film,I-SIGN_AND_SYMPTOM,20179
159207,homeostasis,I-SIGN_AND_SYMPTOM,20179
159208,triggers,O,20179
159209,a,O,20179
159210,vicious,O,20179
159211,cycle,O,20179
159212,that,O,20179
159213,involves,O,20179
159214,inflammation,O,20179
159215,and,O,20179
159216,cellular,O,20179
159217,damage,O,20179
159218,as,O,20179
159219,both,O,20179
159220,sequellae,O,20179
159221,of,O,20179
159222,disease,O,20179
159223,as,O,20179
159224,well,O,20179
159225,as,O,20179
159226,primary,O,20179
159227,components,O,20179
159228,contributing,O,20179
159229,to,O,20179
159230,progression,O,20179
159231,which,O,20179
159232,in,O,20179
159233,turn,O,20179
159234,leads,O,20179
159235,to,O,20179
159236,further,O,20179
159237,tear,B-PART_OF_THE_EYES,20179
159238,film,I-PART_OF_THE_EYES,20179
159239,destabilization,O,20179
159240,Among,O,20180
159241,current,O,20180
159242,medications,O,20180
159243,for,O,20180
159244,dry,B-NAME_OF_DISEASE,20180
159245,eye,I-NAME_OF_DISEASE,20180
159246,disease,I-NAME_OF_DISEASE,20180
159247,most,O,20180
159248,focus,O,20180
159249,on,O,20180
159250,modulating,O,20180
159251,the,O,20180
159252,inflammatory,O,20180
159253,part,O,20180
159254,of,O,20180
159255,the,O,20180
159256,cycle,O,20180
159257,reducing,O,20180
159258,inflammation,O,20180
159259,to,O,20180
159260,promote,O,20180
159261,better,O,20180
159262,tear,B-PART_OF_THE_EYES,20180
159263,film,I-PART_OF_THE_EYES,20180
159264,production,O,20180
159265,However,O,20181
159266,if,O,20181
159267,the,O,20181
159268,eye,O,20181
159269,could,O,20181
159270,produce,O,20181
159271,a,O,20181
159272,healthy,O,20181
159273,natural,O,20181
159274,tear,B-PART_OF_THE_EYES,20181
159275,film,I-PART_OF_THE_EYES,20181
159276,that,O,20181
159277,is,O,20181
159278,not,O,20181
159279,compromised,O,20181
159280,by,O,20181
159281,inflammation,O,20181
159282,and,O,20181
159283,cell,O,20181
159284,damage,O,20181
159285,ocular,B-PART_OF_THE_EYES,20181
159286,surface,I-PART_OF_THE_EYES,20181
159287,health,O,20181
159288,could,O,20181
159289,be,O,20181
159290,more,O,20181
159291,easily,O,20181
159292,maintained,O,20181
159293,The,B-PART_OF_THE_EYES,20182
159294,tear,I-PART_OF_THE_EYES,20182
159295,films,I-PART_OF_THE_EYES,20182
159296,natural,O,20182
159297,composition,O,20182
159298,includes,O,20182
159299,not,O,20182
159300,only,O,20182
159301,the,B-PART_OF_THE_EYES,20182
159302,muco-aqueous,I-PART_OF_THE_EYES,20182
159303,and,I-PART_OF_THE_EYES,20182
159304,lipid,I-PART_OF_THE_EYES,20182
159305,layers,I-PART_OF_THE_EYES,20182
159306,but,O,20182
159307,also,O,20182
159308,a,O,20182
159309,complex,O,20182
159310,mixture,O,20182
159311,of,O,20182
159312,more,O,20182
159313,than,O,20182
159314,1500,O,20182
159315,different,O,20182
159316,proteins,B-CHEMICAL_COMPOUND,20182
159317,nerve,O,20182
159318,and,O,20182
159319,epidermal,O,20182
159320,growth,O,20182
159321,factors,O,20182
159322,for,O,20182
159323,healing,O,20182
159324,and,O,20182
159325,anti-inflammatory,O,20182
159326,and,O,20182
159327,antimicrobial,O,20182
159328,components,O,20182
159329,There,O,20183
159330,is,O,20183
159331,no,O,20183
159332,substitute,O,20183
159333,for,O,20183
159334,natural,O,20183
159335,tears,O,20183
159336,and,O,20183
159337,a,O,20183
159338,healthy,O,20183
159339,natural,B-PART_OF_THE_EYES,20183
159340,tear,I-PART_OF_THE_EYES,20183
159341,film,I-PART_OF_THE_EYES,20183
159342,both,O,20183
159343,of,O,20183
159344,which,O,20183
159345,protect,O,20183
159346,and,O,20183
159347,lubricate,O,20183
159348,the,O,20183
159349,eye,O,20183
159350,improving,O,20183
159351,ocular,O,20183
159352,comfort,O,20183
159353,and,O,20183
159354,helping,O,20183
159355,to,O,20183
159356,maintain,O,20183
159357,consistently,O,20183
159358,clear,O,20183
159359,vision,O,20183
159360,Millions,O,20184
159361,of,O,20184
159362,people,O,20184
159363,worldwide,O,20184
159364,suffer,O,20184
159365,from,O,20184
159366,the,B-SIGN_AND_SYMPTOM,20184
159367,itching,I-SIGN_AND_SYMPTOM,20184
159368,burning,I-SIGN_AND_SYMPTOM,20184
159369,and,I-SIGN_AND_SYMPTOM,20184
159370,other,I-SIGN_AND_SYMPTOM,20184
159371,discomforts,I-SIGN_AND_SYMPTOM,20184
159372,of,O,20184
159373,dry,B-NAME_OF_DISEASE,20184
159374,eye,I-NAME_OF_DISEASE,20184
159375,disease,I-NAME_OF_DISEASE,20184
159376,DED,I-NAME_OF_DISEASE,20184
159377,Ophthalmologists,O,20185
159378,can,O,20185
159379,now,O,20185
159380,offer,O,20185
159381,this,O,20185
159382,patient,O,20185
159383,population,O,20185
159384,a,O,20185
159385,new,O,20185
159386,and,O,20185
159387,unique,O,20185
159388,treatment,O,20185
159389,alternative,O,20185
159390,to,O,20185
159391,artificial,B-TREATMENT,20185
159392,tears,I-TREATMENT,20185
159393,Oyster,B-ORGANIZATION,20186
159394,Point,I-ORGANIZATION,20186
159395,Pharmas,I-ORGANIZATION,20186
159396,Tyrvaya,B-NAME_OF_DRUG,20186
159397,varenicline,I-NAME_OF_DRUG,20186
159398,tartrate,I-NAME_OF_DRUG,20186
159399,solution,I-NAME_OF_DRUG,20186
159400,0.03,I-NAME_OF_DRUG,20186
159401,mg,I-NAME_OF_DRUG,20186
159402,received,O,20186
159403,FDA,B-ORGANIZATION,20186
159404,marketing,O,20186
159405,approval,O,20186
159406,in,O,20186
159407,September,O,20186
159408,as,O,20186
159409,the,O,20186
159410,first,O,20186
159411,and,O,20186
159412,only,O,20186
159413,nasal,O,20186
159414,spray,O,20186
159415,for,O,20186
159416,the,O,20186
159417,treatment,O,20186
159418,of,O,20186
159419,the,O,20186
159420,signs,O,20186
159421,and,O,20186
159422,symptoms,O,20186
159423,of,O,20186
159424,DED,B-NAME_OF_DISEASE,20186
159425,Unlike,O,20187
159426,artificial,B-TREATMENT,20187
159427,tears,I-TREATMENT,20187
159428,which,O,20187
159429,work,O,20187
159430,directly,O,20187
159431,on,O,20187
159432,the,B-PART_OF_THE_EYES,20187
159433,cornea,I-PART_OF_THE_EYES,20187
159434,to,O,20187
159435,reduce,O,20187
159436,inflammation,O,20187
159437,Tyrvaya,B-NAME_OF_DRUG,20187
159438,is,O,20187
159439,a,O,20187
159440,highly,O,20187
159441,selective,O,20187
159442,cholinergic,O,20187
159443,agonist,O,20187
159444,that,O,20187
159445,stimulates,O,20187
159446,the,O,20187
159447,trigeminal,O,20187
159448,parasympathetic,O,20187
159449,pathway,O,20187
159450,Accessible,O,20188
159451,through,O,20188
159452,the,O,20188
159453,nose,O,20188
159454,the,O,20188
159455,pathway,O,20188
159456,plays,O,20188
159457,an,O,20188
159458,important,O,20188
159459,role,O,20188
159460,in,O,20188
159461,basal,B-PART_OF_THE_EYES,20188
159462,tear,I-PART_OF_THE_EYES,20188
159463,film,I-PART_OF_THE_EYES,20188
159464,production,O,20188
159465,by,O,20188
159466,the,B-PART_OF_THE_EYES,20188
159467,lacrimal,I-PART_OF_THE_EYES,20188
159468,glands,I-PART_OF_THE_EYES,20188
159469,goblet,B-PART_OF_THE_EYES,20188
159470,cells,I-PART_OF_THE_EYES,20188
159471,and,O,20188
159472,meibomian,B-PART_OF_THE_EYES,20188
159473,glands,I-PART_OF_THE_EYES,20188
159474,With,O,20189
159475,this,O,20189
159476,new,O,20189
159477,nasal,O,20189
159478,spray,O,20189
159479,we,O,20189
159480,can,O,20189
159481,take,O,20189
159482,advantage,O,20189
159483,of,O,20189
159484,the,O,20189
159485,knowledge,O,20189
159486,of,O,20189
159487,this,O,20189
159488,trigeminal,O,20189
159489,parasympathetic,O,20189
159490,pathway,O,20189
159491,that,O,20189
159492,integrates,O,20189
159493,all,O,20189
159494,three,O,20189
159495,structures,O,20189
159496,in,O,20189
159497,the,O,20189
159498,lacrimal,O,20189
159499,functional,O,20189
159500,unit,O,20189
159501,to,O,20189
159502,help,O,20189
159503,with,O,20189
159504,tear,O,20189
159505,homeostasis,O,20189
159506,by,O,20189
159507,improving,O,20189
159508,that,O,20189
159509,basal,B-PART_OF_THE_EYES,20189
159510,tear,I-PART_OF_THE_EYES,20189
159511,film,I-PART_OF_THE_EYES,20189
159512,says,O,20189
159513,Vance,B-PERSON,20189
159514,Thompson,I-PERSON,20189
159515,MD,I-PERSON,20189
159516,director,O,20189
159517,of,O,20189
159518,refractive,O,20189
159519,surgery,O,20189
159520,for,O,20189
159521,Vance,B-ORGANIZATION,20189
159522,Thompson,I-ORGANIZATION,20189
159523,Vision,I-ORGANIZATION,20189
159524,in,O,20189
159525,Sioux,B-GPE,20189
159526,Falls,I-GPE,20189
159527,SD,I-GPE,20189
159528,There,O,20190
159529,are,O,20190
159530,over,O,20190
159531,1500,O,20190
159532,proteins,B-CHEMICAL_COMPOUND,20190
159533,in,O,20190
159534,tears,O,20190
159535,along,O,20190
159536,with,O,20190
159537,multiple,O,20190
159538,other,O,20190
159539,lipids,B-CHEMICAL_COMPOUND,20190
159540,and,O,20190
159541,mucins,O,20190
159542,that,O,20190
159543,provide,O,20190
159544,strong,O,20190
159545,antiinflammatory,O,20190
159546,and,O,20190
159547,strong,O,20190
159548,antimicrobial,O,20190
159549,abilities,O,20190
159550,Dr,B-PERSON,20190
159551,Thompson,I-PERSON,20190
159552,adds,O,20190
159553,Theyre,O,20191
159554,very,O,20191
159555,complicated,O,20191
159556,and,O,20191
159557,it,O,20191
159558,is,O,20191
159559,something,O,20191
159560,that,O,20191
159561,is,O,20191
159562,revolutionary,O,20191
159563,in,O,20191
159564,dry,B-NAME_OF_DISEASE,20191
159565,eye,I-NAME_OF_DISEASE,20191
159566,therapy,O,20191
159567,The,O,20192
159568,approval,O,20192
159569,of,O,20192
159570,Tyrvaya,B-NAME_OF_DRUG,20192
159571,nasal,I-NAME_OF_DRUG,20192
159572,spray,I-NAME_OF_DRUG,20192
159573,marks,O,20192
159574,a,O,20192
159575,milestone,O,20192
159576,for,O,20192
159577,patients,O,20192
159578,and,O,20192
159579,eyecare,O,20192
159580,professionals,O,20192
159581,by,O,20192
159582,providing,O,20192
159583,a,O,20192
159584,new,O,20192
159585,drug,O,20192
159586,treatment,O,20192
159587,option,O,20192
159588,for,O,20192
159589,the,O,20192
159590,signs,O,20192
159591,and,O,20192
159592,symptoms,O,20192
159593,of,O,20192
159594,DED,B-NAME_OF_DISEASE,20192
159595,with,O,20192
159596,a,O,20192
159597,differentiated,O,20192
159598,route,O,20192
159599,of,O,20192
159600,administration,O,20192
159601,that,O,20192
159602,is,O,20192
159603,believed,O,20192
159604,to,O,20192
159605,leverage,O,20192
159606,a,O,20192
159607,nerve,O,20192
159608,pathway,O,20192
159609,that,O,20192
159610,can,O,20192
159611,be,O,20192
159612,accessed,O,20192
159613,within,O,20192
159614,the,O,20192
159615,nose,O,20192
159616,says,O,20192
159617,Jeffrey,B-PERSON,20192
159618,Nau,I-PERSON,20192
159619,PhD,I-PERSON,20192
159620,MMS,I-PERSON,20192
159621,president,O,20192
159622,and,O,20192
159623,CEO,O,20192
159624,Oyster,B-ORGANIZATION,20192
159625,Point,I-ORGANIZATION,20192
159626,Pharma,I-ORGANIZATION,20192
159627,Administered,O,20193
159628,twice,O,20193
159629,daily,O,20193
159630,into,O,20193
159631,each,O,20193
159632,nostril,O,20193
159633,Tyrvayas,B-NAME_OF_DRUG,20193
159634,advantages,O,20193
159635,over,O,20193
159636,eyedrops,B-TREATMENT,20193
159637,include,O,20193
159638,a,O,20193
159639,milder,O,20193
159640,side-effect,O,20193
159641,profile,O,20193
159642,In,O,20194
159643,clinical,O,20194
159644,trials,O,20194
159645,a,B-SIGN_AND_SYMPTOM,20194
159646,brief,I-SIGN_AND_SYMPTOM,20194
159647,sneeze,I-SIGN_AND_SYMPTOM,20194
159648,82%,O,20194
159649,and,O,20194
159650,cough,B-SIGN_AND_SYMPTOM,20194
159651,between,O,20194
159652,5%,O,20194
159653,and,O,20194
159654,16%,O,20194
159655,were,O,20194
159656,the,O,20194
159657,most,O,20194
159658,common,O,20194
159659,side,O,20194
159660,effects,O,20194
159661,along,O,20194
159662,with,O,20194
159663,mild,B-SIGN_AND_SYMPTOM,20194
159664,throat,I-SIGN_AND_SYMPTOM,20194
159665,and,I-SIGN_AND_SYMPTOM,20194
159666,nasal,I-SIGN_AND_SYMPTOM,20194
159667,irritation,I-SIGN_AND_SYMPTOM,20194
159668,One,O,20195
159669,of,O,20195
159670,the,O,20195
159671,problems,O,20195
159672,with,O,20195
159673,drops,O,20195
159674,is,O,20195
159675,that,O,20195
159676,patients,O,20195
159677,already,O,20195
159678,have,O,20195
159679,an,B-SIGN_AND_SYMPTOM,20195
159680,irritated,I-SIGN_AND_SYMPTOM,20195
159681,corneal,I-SIGN_AND_SYMPTOM,20195
159682,surface,I-SIGN_AND_SYMPTOM,20195
159683,and,O,20195
159684,a,O,20195
159685,lot,O,20195
159686,of,O,20195
159687,drops,O,20195
159688,involve,O,20195
159689,burning,B-SIGN_AND_SYMPTOM,20195
159690,and,I-SIGN_AND_SYMPTOM,20195
159691,stinging,I-SIGN_AND_SYMPTOM,20195
159692,Dr,B-PERSON,20195
159693,Thompson,I-PERSON,20195
159694,says,O,20195
159695,He,O,20196
159696,notes,O,20196
159697,that,O,20196
159698,a,O,20196
159699,2019,O,20196
159700,study,O,20196
159701,by,O,20196
159702,White,B-PERSON,20196
159703,et,O,20196
159704,al,O,20196
159705,found,O,20196
159706,some,O,20196
159707,60%,O,20196
159708,of,O,20196
159709,DED,B-NAME_OF_DISEASE,20196
159710,patients,O,20196
159711,discontinue,O,20196
159712,treatment,O,20196
159713,within,B-TIME_DURATION,20196
159714,12,I-TIME_DURATION,20196
159715,months,I-TIME_DURATION,20196
159716,The,O,20197
159717,idea,O,20197
159718,of,O,20197
159719,being,O,20197
159720,treated,O,20197
159721,so,O,20197
159722,effectively,O,20197
159723,without,O,20197
159724,having,O,20197
159725,to,O,20197
159726,use,O,20197
159727,eyedrops,B-TREATMENT,20197
159728,is,O,20197
159729,very,O,20197
159730,attractive,O,20197
159731,to,O,20197
159732,patients,O,20197
159733,Postapproval,O,20198
159734,we,O,20198
159735,are,O,20198
159736,finding,O,20198
159737,that,O,20198
159738,patients,O,20198
159739,are,O,20198
159740,very,O,20198
159741,interested,O,20198
159742,in,O,20198
159743,this,O,20198
159744,treatment,O,20198
159745,and,O,20198
159746,I,O,20198
159747,think,O,20198
159748,the,O,20198
159749,novel,O,20198
159750,delivery,O,20198
159751,is,O,20198
159752,very,O,20198
159753,powerful,O,20198
159754,because,O,20198
159755,dry,B-NAME_OF_DISEASE,20198
159756,eye,I-NAME_OF_DISEASE,20198
159757,patients,O,20198
159758,dont,O,20198
159759,always,O,20198
159760,like,O,20198
159761,putting,O,20198
159762,drops,O,20198
159763,on,O,20198
159764,their,O,20198
159765,irritated,O,20198
159766,eyes,O,20198
159767,he,O,20198
159768,says,O,20198
159769,A,O,20199
159770,Tear,B-PART_OF_THE_EYES,20199
159771,Film,I-PART_OF_THE_EYES,20199
159772,Trifecta,O,20199
159773,Currently,O,20200
159774,Tyrvaya,B-NAME_OF_DRUG,20200
159775,is,O,20200
159776,not,O,20200
159777,reimbursed,O,20200
159778,by,O,20200
159779,most,O,20200
159780,payers,O,20200
159781,but,O,20200
159782,the,O,20200
159783,company,O,20200
159784,does,O,20200
159785,offer,O,20200
159786,financial,O,20200
159787,assistance,O,20200
159788,to,O,20200
159789,eligible,O,20200
159790,patients,O,20200
159791,according,O,20200
159792,to,O,20200
159793,Dr,B-PERSON,20200
159794,Thompson,I-PERSON,20200
159795,With,O,20201
159796,its,O,20201
159797,rapid,O,20201
159798,and,O,20201
159799,consistent,O,20201
159800,increase,O,20201
159801,in,O,20201
159802,basal,O,20201
159803,tear,O,20201
159804,secretion,O,20201
159805,its,O,20201
159806,novel,O,20201
159807,route,O,20201
159808,of,O,20201
159809,administration,O,20201
159810,and,O,20201
159811,the,O,20201
159812,biological,O,20201
159813,benefits,O,20201
159814,of,O,20201
159815,stimulating,O,20201
159816,the,O,20201
159817,body,O,20201
159818,to,O,20201
159819,heal,O,20201
159820,itself,O,20201
159821,from,O,20201
159822,within,O,20201
159823,Dr,B-PERSON,20201
159824,Thompson,I-PERSON,20201
159825,believes,O,20201
159826,that,O,20201
159827,Tyrvaya,B-NAME_OF_DRUG,20201
159828,is,O,20201
159829,poised,O,20201
159830,to,O,20201
159831,become,O,20201
159832,a,O,20201
159833,major,O,20201
159834,addition,O,20201
159835,to,O,20201
159836,dry,B-NAME_OF_DISEASE,20201
159837,eye,I-NAME_OF_DISEASE,20201
159838,treatment,O,20201
159839,We,O,20202
159840,have,O,20202
159841,what,O,20202
159842,I,O,20202
159843,call,O,20202
159844,a,O,20202
159845,tear,B-PART_OF_THE_EYES,20202
159846,film,I-PART_OF_THE_EYES,20202
159847,trifecta,O,20202
159848,he,O,20202
159849,says,O,20202
159850,I,O,20203
159851,think,O,20203
159852,this,O,20203
159853,will,O,20203
159854,revolutionize,O,20203
159855,dry,B-NAME_OF_DISEASE,20203
159856,eye,I-NAME_OF_DISEASE,20203
159857,care,O,20203
159858,Lupus,B-NAME_OF_DISEASE,20204
159859,an,O,20204
159860,autoimmune,O,20204
159861,disease,O,20204
159862,and,O,20204
159863,macular,B-NAME_OF_DISEASE,20204
159864,degeneration,I-NAME_OF_DISEASE,20204
159865,a,O,20204
159866,leading,O,20204
159867,cause,O,20204
159868,of,O,20204
159869,vision,B-SIGN_AND_SYMPTOM,20204
159870,loss,I-SIGN_AND_SYMPTOM,20204
159871,share,O,20204
159872,a,O,20204
159873,common,O,20204
159874,contributor,O,20204
159875,to,O,20204
159876,harmful,O,20204
159877,inflammation,O,20204
159878,researchers,O,20204
159879,found,O,20204
159880,Lupus,B-NAME_OF_DISEASE,20205
159881,is,O,20205
159882,a,O,20205
159883,chronic,O,20205
159884,inflammatory,O,20205
159885,autoimmune,O,20205
159886,disease,O,20205
159887,with,O,20205
159888,a,O,20205
159889,wide,O,20205
159890,range,O,20205
159891,of,O,20205
159892,clinical,O,20205
159893,presentations,O,20205
159894,resulting,O,20205
159895,from,O,20205
159896,its,O,20205
159897,effect,O,20205
159898,on,O,20205
159899,multiple,O,20205
159900,organ,O,20205
159901,systems,O,20205
159902,There,O,20206
159903,are,O,20206
159904,four,O,20206
159905,main,O,20206
159906,types,O,20206
159907,of,O,20206
159908,lupus,B-NAME_OF_DISEASE,20206
159909,neonatal,O,20206
159910,discoid,O,20206
159911,drug-induced,O,20206
159912,and,O,20206
159913,systemic,B-NAME_OF_DISEASE,20206
159914,lupus,B-NAME_OF_DISEASE,20206
159915,erythematosus,I-NAME_OF_DISEASE,20206
159916,SLE,I-NAME_OF_DISEASE,20206
159917,the,O,20206
159918,type,O,20206
159919,that,O,20206
159920,affects,O,20206
159921,the,O,20206
159922,majority,O,20206
159923,of,O,20206
159924,patients,O,20206
159925,Patients,O,20207
159926,with,O,20207
159927,lupus,B-NAME_OF_DISEASE,20207
159928,experience,O,20207
159929,a,B-SIGN_AND_SYMPTOM,20207
159930,loss,I-SIGN_AND_SYMPTOM,20207
159931,of,I-SIGN_AND_SYMPTOM,20207
159932,self-tolerance,I-SIGN_AND_SYMPTOM,20207
159933,as,I-SIGN_AND_SYMPTOM,20207
159934,a,I-SIGN_AND_SYMPTOM,20207
159935,result,I-SIGN_AND_SYMPTOM,20207
159936,of,I-SIGN_AND_SYMPTOM,20207
159937,abnormal,I-SIGN_AND_SYMPTOM,20207
159938,immunological,I-SIGN_AND_SYMPTOM,20207
159939,function,I-SIGN_AND_SYMPTOM,20207
159940,and,I-SIGN_AND_SYMPTOM,20207
159941,the,I-SIGN_AND_SYMPTOM,20207
159942,production,I-SIGN_AND_SYMPTOM,20207
159943,of,I-SIGN_AND_SYMPTOM,20207
159944,autoantibodies,I-SIGN_AND_SYMPTOM,20207
159945,which,O,20207
159946,lead,O,20207
159947,to,O,20207
159948,the,B-SIGN_AND_SYMPTOM,20207
159949,formation,I-SIGN_AND_SYMPTOM,20207
159950,of,I-SIGN_AND_SYMPTOM,20207
159951,immune,I-SIGN_AND_SYMPTOM,20207
159952,complexes,I-SIGN_AND_SYMPTOM,20207
159953,that,I-SIGN_AND_SYMPTOM,20207
159954,may,I-SIGN_AND_SYMPTOM,20207
159955,adversely,I-SIGN_AND_SYMPTOM,20207
159956,affect,I-SIGN_AND_SYMPTOM,20207
159957,healthy,I-SIGN_AND_SYMPTOM,20207
159958,tissue,I-SIGN_AND_SYMPTOM,20207
159959,Age-Related,B-NAME_OF_DISEASE,20208
159960,Macular,I-NAME_OF_DISEASE,20208
159961,Degeneration,I-NAME_OF_DISEASE,20208
159962,AMD,I-NAME_OF_DISEASE,20208
159963,is,O,20208
159964,the,O,20208
159965,leading,O,20208
159966,cause,O,20208
159967,of,O,20208
159968,severe,B-SIGN_AND_SYMPTOM,20208
159969,vision,I-SIGN_AND_SYMPTOM,20208
159970,loss,I-SIGN_AND_SYMPTOM,20208
159971,in,O,20208
159972,adults,O,20208
159973,over,O,20208
159974,age,O,20208
159975,50,O,20208
159976,The,B-ORGANIZATION,20209
159977,Centers,I-ORGANIZATION,20209
159978,for,I-ORGANIZATION,20209
159979,Disease,I-ORGANIZATION,20209
159980,Control,I-ORGANIZATION,20209
159981,and,I-ORGANIZATION,20209
159982,Prevention,I-ORGANIZATION,20209
159983,estimate,O,20209
159984,that,O,20209
159985,1.8,O,20209
159986,million,O,20209
159987,people,O,20209
159988,have,O,20209
159989,AMD,B-NAME_OF_DISEASE,20209
159990,and,O,20209
159991,another,O,20209
159992,7.3,O,20209
159993,million,O,20209
159994,are,O,20209
159995,at,O,20209
159996,substantial,O,20209
159997,risk,O,20209
159998,for,O,20209
159999,vision,B-SIGN_AND_SYMPTOM,20209
160000,loss,I-SIGN_AND_SYMPTOM,20209
160001,from,O,20209
160002,AMD,B-NAME_OF_DISEASE,20209
160003,Caucasians,O,20210
160004,are,O,20210
160005,at,O,20210
160006,higher,O,20210
160007,risk,O,20210
160008,for,O,20210
160009,developing,O,20210
160010,AMD,B-NAME_OF_DISEASE,20210
160011,than,O,20210
160012,other,O,20210
160013,races,O,20210
160014,Women,O,20211
160015,also,O,20211
160016,develop,O,20211
160017,AMD,B-NAME_OF_DISEASE,20211
160018,at,O,20211
160019,an,O,20211
160020,earlier,O,20211
160021,age,O,20211
160022,than,O,20211
160023,men,O,20211
160024,This,O,20212
160025,eye,O,20212
160026,disease,O,20212
160027,occurs,O,20212
160028,when,O,20212
160029,there,O,20212
160030,are,O,20212
160031,changes,O,20212
160032,to,O,20212
160033,the,B-PART_OF_THE_EYES,20212
160034,macula,I-PART_OF_THE_EYES,20212
160035,a,O,20212
160036,small,O,20212
160037,portion,O,20212
160038,of,O,20212
160039,the,B-PART_OF_THE_EYES,20212
160040,retina,I-PART_OF_THE_EYES,20212
160041,that,O,20212
160042,is,O,20212
160043,located,O,20212
160044,on,O,20212
160045,the,O,20212
160046,inside,O,20212
160047,back,O,20212
160048,layer,O,20212
160049,of,O,20212
160050,the,O,20212
160051,eye,O,20212
160052,AMD,B-NAME_OF_DISEASE,20213
160053,is,O,20213
160054,a,B-SIGN_AND_SYMPTOM,20213
160055,loss,I-SIGN_AND_SYMPTOM,20213
160056,of,I-SIGN_AND_SYMPTOM,20213
160057,central,I-SIGN_AND_SYMPTOM,20213
160058,vision,I-SIGN_AND_SYMPTOM,20213
160059,that,O,20213
160060,can,O,20213
160061,occur,O,20213
160062,in,O,20213
160063,two,O,20213
160064,forms,O,20213
160065,dry,O,20213
160066,atrophic,O,20213
160067,and,O,20213
160068,wet,O,20213
160069,exudative,O,20213
160070,Most,O,20214
160071,people,O,20214
160072,with,O,20214
160073,macular,B-NAME_OF_DISEASE,20214
160074,degeneration,I-NAME_OF_DISEASE,20214
160075,have,O,20214
160076,the,O,20214
160077,dry,O,20214
160078,form,O,20214
160079,While,O,20215
160080,there,O,20215
160081,is,O,20215
160082,no,O,20215
160083,specific,O,20215
160084,treatment,O,20215
160085,for,O,20215
160086,dry,B-NAME_OF_DISEASE,20215
160087,AMD,I-NAME_OF_DISEASE,20215
160088,studies,O,20215
160089,have,O,20215
160090,shown,O,20215
160091,a,O,20215
160092,potential,O,20215
160093,benefit,O,20215
160094,from,O,20215
160095,vitamin,B-TREATMENT,20215
160096,supplements,I-TREATMENT,20215
160097,a,B-TREATMENT,20215
160098,Mediterranean,I-TREATMENT,20215
160099,diet,I-TREATMENT,20215
160100,protection,B-TREATMENT,20215
160101,from,I-TREATMENT,20215
160102,the,I-TREATMENT,20215
160103,ultraviolet,I-TREATMENT,20215
160104,light,I-TREATMENT,20215
160105,of,I-TREATMENT,20215
160106,the,I-TREATMENT,20215
160107,sun,I-TREATMENT,20215
160108,and,O,20215
160109,cessation,B-TREATMENT,20215
160110,of,I-TREATMENT,20215
160111,smoking,I-TREATMENT,20215
160112,The,O,20216
160113,less,O,20216
160114,common,O,20216
160115,wet,O,20216
160116,form,O,20216
160117,may,O,20216
160118,respond,O,20216
160119,to,O,20216
160120,intraocular,O,20216
160121,injections,O,20216
160122,of,O,20216
160123,anti-VEGF,B-NAME_OF_DRUG,20216
160124,medications,O,20216
160125,if,O,20216
160126,detected,O,20216
160127,and,O,20216
160128,treated,O,20216
160129,early,O,20216
160130,Researchers,O,20217
160131,at,O,20217
160132,the,B-ORGANIZATION,20217
160133,University,I-ORGANIZATION,20217
160134,of,I-ORGANIZATION,20217
160135,Virginia,I-ORGANIZATION,20217
160136,School,I-ORGANIZATION,20217
160137,of,I-ORGANIZATION,20217
160138,Medicine,I-ORGANIZATION,20217
160139,have,O,20217
160140,made,O,20217
160141,a,O,20217
160142,discovery,O,20217
160143,linking,O,20217
160144,lupus,B-NAME_OF_DISEASE,20217
160145,a,O,20217
160146,potentially,O,20217
160147,debilitating,O,20217
160148,autoimmune,O,20217
160149,disorder,O,20217
160150,and,O,20217
160151,macular,B-NAME_OF_DISEASE,20217
160152,degeneration,I-NAME_OF_DISEASE,20217
160153,a,O,20217
160154,leading,O,20217
160155,cause,O,20217
160156,of,O,20217
160157,blindness,B-NAME_OF_DISEASE,20217
160158,We,O,20218
160159,were,O,20218
160160,quite,O,20218
160161,surprised,O,20218
160162,at,O,20218
160163,the,O,20218
160164,common,O,20218
160165,link,O,20218
160166,between,O,20218
160167,lupus,B-NAME_OF_DISEASE,20218
160168,and,O,20218
160169,macular,B-NAME_OF_DISEASE,20218
160170,degeneration,I-NAME_OF_DISEASE,20218
160171,said,O,20218
160172,Jayakrishna,B-PERSON,20218
160173,Ambati,I-PERSON,20218
160174,MD,I-PERSON,20218
160175,of,O,20218
160176,UVAs,B-ORGANIZATION,20218
160177,Department,I-ORGANIZATION,20218
160178,of,I-ORGANIZATION,20218
160179,Ophthalmology,I-ORGANIZATION,20218
160180,and,O,20218
160181,the,O,20218
160182,founding,O,20218
160183,director,O,20218
160184,of,O,20218
160185,UVAs,B-ORGANIZATION,20218
160186,Center,I-ORGANIZATION,20218
160187,for,I-ORGANIZATION,20218
160188,Advanced,I-ORGANIZATION,20218
160189,Vision,I-ORGANIZATION,20218
160190,Science,I-ORGANIZATION,20218
160191,Macular,B-NAME_OF_DISEASE,20219
160192,Degeneration,I-NAME_OF_DISEASE,20219
160193,and,O,20219
160194,Lupus,B-NAME_OF_DISEASE,20219
160195,Ambati,B-PERSON,20220
160196,and,O,20220
160197,his,O,20220
160198,collaborators,O,20220
160199,have,O,20220
160200,discovered,O,20220
160201,an,O,20220
160202,unknown,O,20220
160203,role,O,20220
160204,for,O,20220
160205,an,O,20220
160206,inflammasome,O,20220
160207,an,O,20220
160208,agent,O,20220
160209,of,O,20220
160210,the,O,20220
160211,immune,O,20220
160212,system,O,20220
160213,called,O,20220
160214,NLRC4-NLRP3,O,20220
160215,In,O,20221
160216,lupus,B-NAME_OF_DISEASE,20221
160217,and,O,20221
160218,atrophic,B-NAME_OF_DISEASE,20221
160219,macular,I-NAME_OF_DISEASE,20221
160220,degeneration,I-NAME_OF_DISEASE,20221
160221,however,O,20221
160222,it,O,20221
160223,appears,O,20221
160224,that,O,20221
160225,NLRC4-NLRP3,O,20221
160226,contributes,O,20221
160227,to,O,20221
160228,harmful,O,20221
160229,inflammation,O,20221
160230,the,B-ORGANIZATION,20221
160231,UVA,I-ORGANIZATION,20221
160232,researchers,O,20221
160233,found,O,20221
160234,In,O,20222
160235,lupus,B-NAME_OF_DISEASE,20222
160236,it,O,20222
160237,helps,O,20222
160238,drive,O,20222
160239,the,O,20222
160240,hyperactive,O,20222
160241,immune,O,20222
160242,response,O,20222
160243,that,O,20222
160244,leads,O,20222
160245,to,O,20222
160246,symptoms,O,20222
160247,such,O,20222
160248,as,O,20222
160249,joint,B-SIGN_AND_SYMPTOM,20222
160250,pain,I-SIGN_AND_SYMPTOM,20222
160251,rash,I-SIGN_AND_SYMPTOM,20222
160252,fever,I-SIGN_AND_SYMPTOM,20222
160253,and,I-SIGN_AND_SYMPTOM,20222
160254,more,I-SIGN_AND_SYMPTOM,20222
160255,In,O,20223
160256,macular,B-NAME_OF_DISEASE,20223
160257,degeneration,I-NAME_OF_DISEASE,20223
160258,meanwhile,O,20223
160259,NRC4-NLRP3,O,20223
160260,appears,O,20223
160261,to,O,20223
160262,contribute,O,20223
160263,to,O,20223
160264,inflammation,O,20223
160265,that,O,20223
160266,destroys,O,20223
160267,the,O,20223
160268,vital,O,20223
160269,light-sensing,O,20223
160270,cells,O,20223
160271,in,O,20223
160272,the,B-PART_OF_THE_EYES,20223
160273,eyes,I-PART_OF_THE_EYES,20223
160274,retina,I-PART_OF_THE_EYES,20223
160275,Ambatis,B-PERSON,20224
160276,new,O,20224
160277,work,O,20224
160278,helps,O,20224
160279,explain,O,20224
160280,why,O,20224
160281,The,B-CHEMICAL_COMPOUND,20225
160282,inflammasome,I-CHEMICAL_COMPOUND,20225
160283,he,O,20225
160284,found,O,20225
160285,is,O,20225
160286,sent,O,20225
160287,into,O,20225
160288,action,O,20225
160289,by,O,20225
160290,a,O,20225
160291,special,O,20225
160292,class,O,20225
160293,of,O,20225
160294,genetic,O,20225
160295,material,O,20225
160296,called,O,20225
160297,short,O,20225
160298,interspersed,O,20225
160299,nuclear,O,20225
160300,element,O,20225
160301,RNAs,B-CHEMICAL_COMPOUND,20225
160302,or,O,20225
160303,SINE,B-CHEMICAL_COMPOUND,20225
160304,RNAs,I-CHEMICAL_COMPOUND,20225
160305,This,O,20226
160306,type,O,20226
160307,of,O,20226
160308,RNA,B-CHEMICAL_COMPOUND,20226
160309,makes,O,20226
160310,up,O,20226
160311,more,O,20226
160312,than,O,20226
160313,10%,O,20226
160314,of,O,20226
160315,our,O,20226
160316,genomes,O,20226
160317,and,O,20226
160318,it,O,20226
160319,activates,O,20226
160320,in,O,20226
160321,response,O,20226
160322,to,O,20226
160323,cell,O,20226
160324,stresses,O,20226
160325,such,O,20226
160326,as,O,20226
160327,infection,O,20226
160328,genetic,O,20226
160329,damage,O,20226
160330,and,O,20226
160331,aging,O,20226
160332,The,O,20227
160333,resulting,O,20227
160334,inflammation,O,20227
160335,caused,O,20227
160336,by,O,20227
160337,SINE,B-CHEMICAL_COMPOUND,20227
160338,RNAs,I-CHEMICAL_COMPOUND,20227
160339,can,O,20227
160340,be,O,20227
160341,harmful,O,20227
160342,in,O,20227
160343,many,O,20227
160344,chronic,O,20227
160345,diseases,O,20227
160346,SINE,B-CHEMICAL_COMPOUND,20228
160347,RNAs,I-CHEMICAL_COMPOUND,20228
160348,are,O,20228
160349,elevated,O,20228
160350,in,O,20228
160351,both,O,20228
160352,macular,B-NAME_OF_DISEASE,20228
160353,degeneration,I-NAME_OF_DISEASE,20228
160354,and,O,20228
160355,lupus,B-NAME_OF_DISEASE,20228
160356,Ambati,B-PERSON,20228
160357,found,O,20228
160358,In,O,20229
160359,addition,O,20229
160360,to,O,20229
160361,discovering,O,20229
160362,the,O,20229
160363,role,O,20229
160364,of,O,20229
160365,SINE,B-CHEMICAL_COMPOUND,20229
160366,RNA,I-CHEMICAL_COMPOUND,20229
160367,in,O,20229
160368,the,O,20229
160369,two,O,20229
160370,diseases,O,20229
160371,Ambati,B-PERSON,20229
160372,and,O,20229
160373,his,O,20229
160374,colleagues,O,20229
160375,identified,O,20229
160376,an,O,20229
160377,unknown,O,20229
160378,receptor,O,20229
160379,for,O,20229
160380,the,O,20229
160381,SINE,B-CHEMICAL_COMPOUND,20229
160382,RNAs,I-CHEMICAL_COMPOUND,20229
160383,called,O,20229
160384,DDX17,B-CHEMICAL_COMPOUND,20229
160385,These,O,20230
160386,findings,O,20230
160387,indicate,O,20230
160388,that,O,20230
160389,blocking,O,20230
160390,a,O,20230
160391,single,O,20230
160392,inflammasome,B-CHEMICAL_COMPOUND,20230
160393,might,O,20230
160394,not,O,20230
160395,be,O,20230
160396,enough,O,20230
160397,and,O,20230
160398,that,O,20230
160399,targeting,O,20230
160400,both,O,20230
160401,the,O,20230
160402,NLRC4,B-CHEMICAL_COMPOUND,20230
160403,and,O,20230
160404,NLRP3,B-CHEMICAL_COMPOUND,20230
160405,inflammasomes,O,20230
160406,would,O,20230
160407,be,O,20230
160408,a,O,20230
160409,superior,O,20230
160410,strategy,O,20230
160411,Ambati,B-PERSON,20230
160412,said,O,20230
160413,Using,O,20231
160414,this,O,20231
160415,new,O,20231
160416,information,O,20231
160417,scientists,O,20231
160418,may,O,20231
160419,be,O,20231
160420,able,O,20231
160421,to,O,20231
160422,target,O,20231
160423,the,O,20231
160424,source,O,20231
160425,of,O,20231
160426,harmful,O,20231
160427,inflammation,O,20231
160428,in,O,20231
160429,lupus,B-NAME_OF_DISEASE,20231
160430,macular,B-NAME_OF_DISEASE,20231
160431,degeneration,I-NAME_OF_DISEASE,20231
160432,and,O,20231
160433,other,O,20231
160434,diseases,O,20231
160435,driven,O,20231
160436,by,O,20231
160437,SINE,B-CHEMICAL_COMPOUND,20231
160438,RNAs,I-CHEMICAL_COMPOUND,20231
160439,That,O,20232
160440,could,O,20232
160441,lead,O,20232
160442,to,O,20232
160443,new,O,20232
160444,treatments,O,20232
160445,to,O,20232
160446,benefit,O,20232
160447,patients,O,20232
160448,the,B-ORGANIZATION,20232
160449,UVA,I-ORGANIZATION,20232
160450,researchers,O,20232
160451,say,O,20232
160452,Were,O,20233
160453,excited,O,20233
160454,to,O,20233
160455,have,O,20233
160456,developed,O,20233
160457,drugs,O,20233
160458,called,O,20233
160459,Kamuvudines,B-NAME_OF_DRUG,20233
160460,that,O,20233
160461,block,O,20233
160462,this,O,20233
160463,dual,O,20233
160464,inflammasome,O,20233
160465,which,O,20233
160466,we,O,20233
160467,anticipate,O,20233
160468,will,O,20233
160469,be,O,20233
160470,in,O,20233
160471,clinical,O,20233
160472,trials,O,20233
160473,next,O,20233
160474,year,O,20233
160475,Ambati,B-PERSON,20233
160476,said,O,20233
160477,Intraoperative,B-SURGICAL_INSTRUMENT,20234
160478,optical,I-SURGICAL_INSTRUMENT,20234
160479,coherence,I-SURGICAL_INSTRUMENT,20234
160480,tomography,I-SURGICAL_INSTRUMENT,20234
160481,iOCT,I-SURGICAL_INSTRUMENT,20234
160482,is,O,20234
160483,a,O,20234
160484,noninvasive,O,20234
160485,imaging,O,20234
160486,modality,O,20234
160487,that,O,20234
160488,provides,O,20234
160489,a,O,20234
160490,real-time,O,20234
160491,dynamic,O,20234
160492,feedback,O,20234
160493,of,O,20234
160494,the,O,20234
160495,various,O,20234
160496,surgical,O,20234
160497,steps,O,20234
160498,The,O,20235
160499,use,O,20235
160500,of,O,20235
160501,iOCT,B-SURGICAL_INSTRUMENT,20235
160502,as,O,20235
160503,an,O,20235
160504,aid,O,20235
160505,to,O,20235
160506,decision-making,O,20235
160507,has,O,20235
160508,been,O,20235
160509,successfully,O,20235
160510,reported,O,20235
160511,in,O,20235
160512,cases,O,20235
160513,undergoing,O,20235
160514,keratoplasty,B-TREATMENT,20235
160515,implantable,B-TREATMENT,20235
160516,Collamer,I-TREATMENT,20235
160517,lens,I-TREATMENT,20235
160518,ICL,I-TREATMENT,20235
160519,implantation,I-TREATMENT,20235
160520,as,O,20235
160521,well,O,20235
160522,as,O,20235
160523,cataract,B-TREATMENT,20235
160524,surgery,I-TREATMENT,20235
160525,iOCT,B-SURGICAL_INSTRUMENT,20236
160526,helps,O,20236
160527,to,O,20236
160528,assess,O,20236
160529,the,O,20236
160530,graft-host,O,20236
160531,relationship,O,20236
160532,in,O,20236
160533,penetrating,B-TREATMENT,20236
160534,keratoplasty,I-TREATMENT,20236
160535,It,O,20237
160536,helps,O,20237
160537,confirm,O,20237
160538,the,O,20237
160539,presence,O,20237
160540,of,O,20237
160541,a,O,20237
160542,big,O,20237
160543,bubble,O,20237
160544,detect,O,20237
160545,subclinical,O,20237
160546,big,O,20237
160547,bubbles,O,20237
160548,and,O,20237
160549,guide,O,20237
160550,layer,O,20237
160551,by,O,20237
160552,layer,O,20237
160553,stromal,O,20237
160554,dissection,O,20237
160555,in,O,20237
160556,cases,O,20237
160557,of,O,20237
160558,deep,B-TREATMENT,20237
160559,anterior,I-TREATMENT,20237
160560,lamellar,I-TREATMENT,20237
160561,keratoplasty,I-TREATMENT,20237
160562,It,O,20238
160563,acts,O,20238
160564,as,O,20238
160565,a,O,20238
160566,guide,O,20238
160567,during,O,20238
160568,crucial,O,20238
160569,surgical,O,20238
160570,steps,O,20238
160571,in,O,20238
160572,endothelial,B-TREATMENT,20238
160573,keratoplasty,I-TREATMENT,20238
160574,right,O,20238
160575,from,O,20238
160576,scoring,O,20238
160577,of,O,20238
160578,the,B-PART_OF_THE_EYES,20238
160579,Descemet,I-PART_OF_THE_EYES,20238
160580,membrane,I-PART_OF_THE_EYES,20238
160581,to,O,20238
160582,ensuring,O,20238
160583,graft,O,20238
160584,apposition,O,20238
160585,at,O,20238
160586,the,O,20238
160587,end,O,20238
160588,of,O,20238
160589,surgery,O,20238
160590,The,O,20239
160591,morphological,O,20239
160592,features,O,20239
160593,of,O,20239
160594,the,O,20239
160595,corneal,O,20239
160596,incision,O,20239
160597,in,O,20239
160598,phacoemulsification,B-TREATMENT,20239
160599,may,O,20239
160600,be,O,20239
160601,assessed,O,20239
160602,iOCT,B-SURGICAL_INSTRUMENT,20240
160603,is,O,20240
160604,a,O,20240
160605,useful,O,20240
160606,tool,O,20240
160607,in,O,20240
160608,assessing,O,20240
160609,the,O,20240
160610,status,O,20240
160611,of,O,20240
160612,the,B-PART_OF_THE_EYES,20240
160613,posterior,I-PART_OF_THE_EYES,20240
160614,capsule,I-PART_OF_THE_EYES,20240
160615,and,O,20240
160616,may,O,20240
160617,help,O,20240
160618,identify,O,20240
160619,preexisting,O,20240
160620,posterior,O,20240
160621,capsular,O,20240
160622,defects,O,20240
160623,during,O,20240
160624,cataract,B-TREATMENT,20240
160625,surgery,I-TREATMENT,20240
160626,in,O,20240
160627,various,O,20240
160628,clinical,O,20240
160629,scenarios,O,20240
160630,such,O,20240
160631,as,O,20240
160632,posterior,B-NAME_OF_DISEASE,20240
160633,polar,I-NAME_OF_DISEASE,20240
160634,cataract,I-NAME_OF_DISEASE,20240
160635,traumatic,B-NAME_OF_DISEASE,20240
160636,cataract,I-NAME_OF_DISEASE,20240
160637,and,O,20240
160638,vitrectomized,O,20240
160639,eyes,O,20240
160640,It,O,20241
160641,allows,O,20241
160642,on-table,O,20241
160643,assessment,O,20241
160644,of,O,20241
160645,the,B-TREATMENT,20241
160646,ICL,B-TREATMENT,20241
160647,vault,O,20241
160648,and,O,20241
160649,potentially,O,20241
160650,facilitates,O,20241
160651,exchange,O,20241
160652,of,O,20241
160653,ICL,B-TREATMENT,20241
160654,in,O,20241
160655,the,O,20241
160656,same,O,20241
160657,sitting,O,20241
160658,in,O,20241
160659,extremes,O,20241
160660,of,O,20241
160661,vault,O,20241
160662,Ocular,B-PART_OF_THE_EYES,20242
160663,surface,I-PART_OF_THE_EYES,20242
160664,disorders,O,20242
160665,such,O,20242
160666,as,O,20242
160667,ocular,B-NAME_OF_DISEASE,20242
160668,surface,I-NAME_OF_DISEASE,20242
160669,squamous,I-NAME_OF_DISEASE,20242
160670,neoplasia,I-NAME_OF_DISEASE,20242
160671,pterygium,B-NAME_OF_DISEASE,20242
160672,and,O,20242
160673,dermoid,B-NAME_OF_DISEASE,20242
160674,may,O,20242
160675,find,O,20242
160676,an,O,20242
160677,application,O,20242
160678,for,O,20242
160679,iOCT,B-SURGICAL_INSTRUMENT,20242
160680,wherein,O,20242
160681,an,O,20242
160682,iOCT-guided,O,20242
160683,stromal,O,20242
160684,dissection,O,20242
160685,will,O,20242
160686,ensure,O,20242
160687,adequate,O,20242
160688,depth,O,20242
160689,of,O,20242
160690,dissection,O,20242
160691,Having,O,20243
160692,optical,B-SURGICAL_INSTRUMENT,20243
160693,coherence,I-SURGICAL_INSTRUMENT,20243
160694,tomography,I-SURGICAL_INSTRUMENT,20243
160695,OCT,I-SURGICAL_INSTRUMENT,20243
160696,in,I-SURGICAL_INSTRUMENT,20243
160697,the,I-SURGICAL_INSTRUMENT,20243
160698,operating,I-SURGICAL_INSTRUMENT,20243
160699,room,I-SURGICAL_INSTRUMENT,20243
160700,can,O,20243
160701,save,O,20243
160702,time,O,20243
160703,and,O,20243
160704,money,O,20243
160705,reduce,O,20243
160706,revisions,O,20243
160707,and,O,20243
160708,improve,O,20243
160709,patient,O,20243
160710,outcomes,O,20243
160711,Just,O,20244
160712,like,O,20244
160713,in,O,20244
160714,the,O,20244
160715,office,O,20244
160716,setting,O,20244
160717,intraoperative,B-SURGICAL_INSTRUMENT,20244
160718,OCT,I-SURGICAL_INSTRUMENT,20244
160719,can,O,20244
160720,allow,O,20244
160721,you,O,20244
160722,to,O,20244
160723,see,O,20244
160724,structures,O,20244
160725,you,O,20244
160726,cant,O,20244
160727,normally,O,20244
160728,see,O,20244
160729,with,O,20244
160730,the,O,20244
160731,typical,O,20244
160732,light,O,20244
160733,microscope,O,20244
160734,said,O,20244
160735,Dr,B-PERSON,20244
160736,Francis,I-PERSON,20244
160737,W,I-PERSON,20244
160738,Price,I-PERSON,20244
160739,Jr,I-PERSON,20244
160740,founder,O,20244
160741,of,O,20244
160742,Price,B-ORGANIZATION,20244
160743,Vision,I-ORGANIZATION,20244
160744,Group,I-ORGANIZATION,20244
160745,Indianapolis,I-ORGANIZATION,20244
160746,United,B-GPE,20244
160747,States,I-GPE,20244
160748,and,O,20244
160749,founder,O,20244
160750,president,O,20244
160751,of,O,20244
160752,the,B-ORGANIZATION,20244
160753,Cornea,I-ORGANIZATION,20244
160754,Research,I-ORGANIZATION,20244
160755,Foundation,I-ORGANIZATION,20244
160756,of,I-ORGANIZATION,20244
160757,America,I-ORGANIZATION,20244
160758,Thats,O,20245
160759,why,O,20245
160760,it,O,20245
160761,shines,O,20245
160762,with,O,20245
160763,endothelial,B-TREATMENT,20245
160764,keratoplasty,I-TREATMENT,20245
160765,and,O,20245
160766,anterior,B-TREATMENT,20245
160767,lamellar,I-TREATMENT,20245
160768,surgery,I-TREATMENT,20245
160769,Manufacturers,O,20246
160770,may,O,20246
160771,have,O,20246
160772,expected,O,20246
160773,intraoperative,B-SURGICAL_INSTRUMENT,20246
160774,OCT,I-SURGICAL_INSTRUMENT,20246
160775,to,O,20246
160776,find,O,20246
160777,its,O,20246
160778,widest,O,20246
160779,application,O,20246
160780,in,O,20246
160781,retina,B-PART_OF_THE_EYES,20246
160782,procedures,O,20246
160783,but,O,20246
160784,Dr,B-PERSON,20246
160785,Price,I-PERSON,20246
160786,said,O,20246
160787,it,O,20246
160788,can,O,20246
160789,be,O,20246
160790,invaluable,O,20246
160791,in,O,20246
160792,the,B-PART_OF_THE_EYES,20246
160793,cornea,I-PART_OF_THE_EYES,20246
160794,and,O,20246
160795,anterior,B-PART_OF_THE_EYES,20246
160796,chamber,I-PART_OF_THE_EYES,20246
160797,procedures,O,20246
160798,which,O,20246
160799,fill,O,20246
160800,most,O,20246
160801,of,O,20246
160802,his,O,20246
160803,operating,O,20246
160804,schedule,O,20246
160805,Intraoperative,B-SURGICAL_INSTRUMENT,20247
160806,OCT,I-SURGICAL_INSTRUMENT,20247
160807,can,O,20247
160808,also,O,20247
160809,be,O,20247
160810,helpful,O,20247
160811,in,O,20247
160812,some,O,20247
160813,cataract,B-NAME_OF_DISEASE,20247
160814,surgeries,O,20247
160815,he,O,20247
160816,noted,O,20247
160817,Lamellar,B-TREATMENT,20248
160818,transplants,I-TREATMENT,20248
160819,can,O,20248
160820,benefit,O,20248
160821,greatly,O,20248
160822,from,O,20248
160823,the,O,20248
160824,improved,O,20248
160825,imaging,O,20248
160826,provided,O,20248
160827,by,O,20248
160828,intraoperative,B-SURGICAL_INSTRUMENT,20248
160829,OCT,I-SURGICAL_INSTRUMENT,20248
160830,OCT,B-SURGICAL_INSTRUMENT,20249
160831,can,O,20249
160832,reduce,O,20249
160833,surgical,O,20249
160834,time,O,20249
160835,for,O,20249
160836,endothelial,B-TREATMENT,20249
160837,keratoplasty,I-TREATMENT,20249
160838,particularly,O,20249
160839,Descemets,B-TREATMENT,20249
160840,stripping,I-TREATMENT,20249
160841,endothelial,I-TREATMENT,20249
160842,keratoplasty,I-TREATMENT,20249
160843,DSEK,I-TREATMENT,20249
160844,and,O,20249
160845,Descemets,B-TREATMENT,20249
160846,membrane,I-TREATMENT,20249
160847,endothelial,I-TREATMENT,20249
160848,keratoplasty,I-TREATMENT,20249
160849,DMEK,I-TREATMENT,20249
160850,Intraoperative,B-SURGICAL_INSTRUMENT,20250
160851,OCT,I-SURGICAL_INSTRUMENT,20250
160852,can,O,20250
160853,be,O,20250
160854,helpful,O,20250
160855,in,O,20250
160856,DSEK,B-TREATMENT,20250
160857,by,O,20250
160858,making,O,20250
160859,sure,O,20250
160860,that,O,20250
160861,the,O,20250
160862,graft,O,20250
160863,is,O,20250
160864,in,O,20250
160865,total,O,20250
160866,apposition,O,20250
160867,with,O,20250
160868,the,O,20250
160869,recipient,O,20250
160870,cornea,B-PART_OF_THE_EYES,20250
160871,Dr,B-PERSON,20250
160872,Price,I-PERSON,20250
160873,explained,O,20250
160874,OCT,B-SURGICAL_INSTRUMENT,20251
160875,helps,O,20251
160876,you,O,20251
160877,ensure,O,20251
160878,there,O,20251
160879,are,O,20251
160880,no,O,20251
160881,spaces,O,20251
160882,no,O,20251
160883,abnormalities,O,20251
160884,like,O,20251
160885,Descemets,B-PART_OF_THE_EYES,20251
160886,membrane,I-PART_OF_THE_EYES,20251
160887,that,O,20251
160888,is,O,20251
160889,curled,O,20251
160890,up,O,20251
160891,or,O,20251
160892,stroma,O,20251
160893,that,O,20251
160894,is,O,20251
160895,keeping,O,20251
160896,the,O,20251
160897,graft,O,20251
160898,from,O,20251
160899,adhering,O,20251
160900,In,O,20252
160901,DMEK,B-TREATMENT,20252
160902,Intraoperative,B-SURGICAL_INSTRUMENT,20252
160903,OCT,I-SURGICAL_INSTRUMENT,20252
160904,quickly,O,20252
160905,identifies,O,20252
160906,the,O,20252
160907,orientation,O,20252
160908,of,O,20252
160909,the,O,20252
160910,graft,O,20252
160911,even,O,20252
160912,in,O,20252
160913,cloudy,O,20252
160914,corneas,B-PART_OF_THE_EYES,20252
160915,Dr,B-PERSON,20252
160916,Price,I-PERSON,20252
160917,said,O,20252
160918,The,O,20253
160919,third,O,20253
160920,type,O,20253
160921,of,O,20253
160922,transplant,O,20253
160923,where,O,20253
160924,intraoperative,B-SURGICAL_INSTRUMENT,20253
160925,OCT,I-SURGICAL_INSTRUMENT,20253
160926,extremely,O,20253
160927,helpful,O,20253
160928,is,O,20253
160929,deep,B-TREATMENT,20253
160930,anterior,I-TREATMENT,20253
160931,lamellar,I-TREATMENT,20253
160932,keratoplasty,I-TREATMENT,20253
160933,Dr,B-PERSON,20253
160934,Price,I-PERSON,20253
160935,said,O,20253
160936,But,O,20254
160937,there,O,20254
160938,are,O,20254
160939,cases,O,20254
160940,where,O,20254
160941,you,O,20254
160942,cant,O,20254
160943,use,O,20254
160944,a,O,20254
160945,big,O,20254
160946,bubble,O,20254
160947,to,O,20254
160948,separate,O,20254
160949,Descemets,B-PART_OF_THE_EYES,20254
160950,membrane,I-PART_OF_THE_EYES,20254
160951,from,O,20254
160952,the,O,20254
160953,rest,O,20254
160954,of,O,20254
160955,the,B-PART_OF_THE_EYES,20254
160956,cornea,I-PART_OF_THE_EYES,20254
160957,Eyes,O,20255
160958,that,O,20255
160959,have,O,20255
160960,scars,O,20255
160961,from,O,20255
160962,previous,O,20255
160963,cataract,B-TREATMENT,20255
160964,surgery,I-TREATMENT,20255
160965,are,O,20255
160966,not,O,20255
160967,good,O,20255
160968,candidates,O,20255
160969,for,O,20255
160970,big,O,20255
160971,bubble,O,20255
160972,formation,O,20255
160973,Eyes,O,20256
160974,with,O,20256
160975,hydrops,O,20256
160976,commonly,O,20256
160977,seen,O,20256
160978,with,O,20256
160979,keratoconus,B-NAME_OF_DISEASE,20256
160980,do,O,20256
160981,not,O,20256
160982,do,O,20256
160983,well,O,20256
160984,with,O,20256
160985,big,O,20256
160986,bubbles,O,20256
160987,Nor,O,20257
160988,do,O,20257
160989,eyes,O,20257
160990,that,O,20257
160991,have,O,20257
160992,had,O,20257
160993,previous,O,20257
160994,radial,B-TREATMENT,20257
160995,keratotomy,I-TREATMENT,20257
160996,or,O,20257
160997,other,O,20257
160998,procedures,O,20257
160999,that,O,20257
161000,form,O,20257
161001,scars,O,20257
161002,including,O,20257
161003,Descemets,B-PART_OF_THE_EYES,20257
161004,membrane,I-PART_OF_THE_EYES,20257
161005,The,O,20258
161006,dissection,O,20258
161007,bed,O,20258
161008,must,O,20258
161009,be,O,20258
161010,less,O,20258
161011,than,O,20258
161012,100,O,20258
161013,mum,O,20258
161014,deep,O,20258
161015,for,O,20258
161016,excellent,O,20258
161017,visual,O,20258
161018,results,O,20258
161019,following,O,20258
161020,deep,B-TREATMENT,20258
161021,anterior,I-TREATMENT,20258
161022,lamellar,I-TREATMENT,20258
161023,grafts,I-TREATMENT,20258
161024,If,O,20259
161025,you,O,20259
161026,have,O,20259
161027,variable,O,20259
161028,thickness,O,20259
161029,your,O,20259
161030,visual,O,20259
161031,outcome,O,20259
161032,will,O,20259
161033,be,O,20259
161034,poor,O,20259
161035,Dr,B-PERSON,20259
161036,Price,I-PERSON,20259
161037,cautioned,O,20259
161038,By,O,20260
161039,using,O,20260
161040,intraoperative,B-SURGICAL_INSTRUMENT,20260
161041,OCT,I-SURGICAL_INSTRUMENT,20260
161042,you,O,20260
161043,can,O,20260
161044,have,O,20260
161045,excellent,O,20260
161046,results,O,20260
161047,with,O,20260
161048,your,O,20260
161049,manual,O,20260
161050,dissection,O,20260
161051,without,O,20260
161052,using,O,20260
161053,a,O,20260
161054,big,O,20260
161055,bubble,O,20260
161056,Use,O,20261
161057,in,O,20261
161058,Cataract,B-TREATMENT,20261
161059,Surgery,I-TREATMENT,20261
161060,Most,O,20262
161061,ophthalmic,O,20262
161062,surgeons,O,20262
161063,work,O,20262
161064,on,O,20262
161065,cataracts,B-NAME_OF_DISEASE,20262
161066,Dr,B-PERSON,20262
161067,Price,I-PERSON,20262
161068,noted,O,20262
161069,Cataract,B-NAME_OF_DISEASE,20263
161070,surgeons,O,20263
161071,too,O,20263
161072,can,O,20263
161073,work,O,20263
161074,more,O,20263
161075,effectively,O,20263
161076,using,O,20263
161077,intraoperative,B-SURGICAL_INSTRUMENT,20263
161078,OCT,I-SURGICAL_INSTRUMENT,20263
161079,OCT,B-SURGICAL_INSTRUMENT,20264
161080,does,O,20264
161081,not,O,20264
161082,go,O,20264
161083,through,O,20264
161084,the,B-PART_OF_THE_EYES,20264
161085,iris,I-PART_OF_THE_EYES,20264
161086,he,O,20264
161087,said,O,20264
161088,but,O,20264
161089,it,O,20264
161090,gives,O,20264
161091,a,O,20264
161092,clear,O,20264
161093,view,O,20264
161094,into,O,20264
161095,the,B-PART_OF_THE_EYES,20264
161096,anterior,I-PART_OF_THE_EYES,20264
161097,chamber,I-PART_OF_THE_EYES,20264
161098,That,O,20265
161099,gives,O,20265
161100,OCT,B-SURGICAL_INSTRUMENT,20265
161101,an,O,20265
161102,advantage,O,20265
161103,in,O,20265
161104,spotting,O,20265
161105,nuclear,O,20265
161106,fragments,O,20265
161107,from,O,20265
161108,very,O,20265
161109,dense,O,20265
161110,cataracts,B-NAME_OF_DISEASE,20265
161111,that,O,20265
161112,have,O,20265
161113,lodged,O,20265
161114,in,O,20265
161115,the,O,20265
161116,angle,O,20265
161117,and,O,20265
161118,are,O,20265
161119,less,O,20265
161120,visible,O,20265
161121,through,O,20265
161122,conventional,O,20265
161123,imaging,O,20265
161124,Dr,B-PERSON,20266
161125,Price,I-PERSON,20266
161126,added,O,20266
161127,that,O,20266
161128,OCT,B-SURGICAL_INSTRUMENT,20266
161129,is,O,20266
161130,especially,O,20266
161131,useful,O,20266
161132,when,O,20266
161133,the,O,20266
161134,surgeon,O,20266
161135,has,O,20266
161136,used,O,20266
161137,dispersive,O,20266
161138,viscoelastics,O,20266
161139,Improved,O,20267
161140,imaging,O,20267
161141,can,O,20267
161142,save,O,20267
161143,time,O,20267
161144,in,O,20267
161145,many,O,20267
161146,different,O,20267
161147,transplant,O,20267
161148,procedures,O,20267
161149,Dr,B-PERSON,20267
161150,Price,I-PERSON,20267
161151,said,O,20267
161152,He,O,20268
161153,sees,O,20268
161154,the,O,20268
161155,greatest,O,20268
161156,time,O,20268
161157,savings,O,20268
161158,in,O,20268
161159,endothelial,B-TREATMENT,20268
161160,keratoplasty,I-TREATMENT,20268
161161,But,O,20269
161162,the,O,20269
161163,stamp,O,20269
161164,can,O,20269
161165,be,O,20269
161166,difficult,O,20269
161167,to,O,20269
161168,see,O,20269
161169,before,O,20269
161170,the,O,20269
161171,graft,O,20269
161172,is,O,20269
161173,unscrolled,O,20269
161174,particularly,O,20269
161175,through,O,20269
161176,a,O,20269
161177,cloudy,O,20269
161178,cornea,B-PART_OF_THE_EYES,20269
161179,Intraoperative,B-SURGICAL_INSTRUMENT,20270
161180,OCT,I-SURGICAL_INSTRUMENT,20270
161181,clearly,O,20270
161182,images,O,20270
161183,the,O,20270
161184,graft,O,20270
161185,orientation,O,20270
161186,and,O,20270
161187,speeds,O,20270
161188,the,O,20270
161189,procedure,O,20270
161190,Deep,B-TREATMENT,20271
161191,anterior,I-TREATMENT,20271
161192,lamellar,I-TREATMENT,20271
161193,transplants,I-TREATMENT,20271
161194,may,O,20271
161195,not,O,20271
161196,move,O,20271
161197,more,O,20271
161198,quickly,O,20271
161199,using,O,20271
161200,intraoperative,B-SURGICAL_INSTRUMENT,20271
161201,OCT,I-SURGICAL_INSTRUMENT,20271
161202,but,O,20271
161203,using,O,20271
161204,it,O,20271
161205,does,O,20271
161206,not,O,20271
161207,slow,O,20271
161208,the,O,20271
161209,surgeon,O,20271
161210,down,O,20271
161211,Dr,B-PERSON,20271
161212,Price,I-PERSON,20271
161213,said,O,20271
161214,The,O,20272
161215,improved,O,20272
161216,imaging,O,20272
161217,enhances,O,20272
161218,outcomes,O,20272
161219,and,O,20272
161220,sharply,O,20272
161221,reduces,O,20272
161222,the,O,20272
161223,need,O,20272
161224,to,O,20272
161225,return,O,20272
161226,to,O,20272
161227,the,O,20272
161228,eye,O,20272
161229,with,O,20272
161230,penetrating,B-TREATMENT,20272
161231,keratoplasty,I-TREATMENT,20272
161232,Reducing,O,20273
161233,the,O,20273
161234,need,O,20273
161235,for,O,20273
161236,PK,B-TREATMENT,20273
161237,revisions,O,20273
161238,gives,O,20273
161239,intraoperative,B-SURGICAL_INSTRUMENT,20273
161240,OCT,I-SURGICAL_INSTRUMENT,20273
161241,an,O,20273
161242,advantage,O,20273
161243,over,O,20273
161244,conventional,O,20273
161245,imaging,O,20273
161246,One,O,20274
161247,advantage,O,20274
161248,of,O,20274
161249,current,O,20274
161250,intraoperative,B-SURGICAL_INSTRUMENT,20274
161251,OCT,I-SURGICAL_INSTRUMENT,20274
161252,application,O,20274
161253,is,O,20274
161254,the,O,20274
161255,ability,O,20274
161256,to,O,20274
161257,display,O,20274
161258,the,O,20274
161259,image,O,20274
161260,in,O,20274
161261,the,O,20274
161262,ocular,O,20274
161263,Another,O,20275
161264,useful,O,20275
161265,piece,O,20275
161266,of,O,20275
161267,implementation,O,20275
161268,is,O,20275
161269,the,O,20275
161270,ability,O,20275
161271,to,O,20275
161272,view,O,20275
161273,OCT,B-SURGICAL_INSTRUMENT,20275
161274,images,O,20275
161275,as,O,20275
161276,picture,O,20275
161277,in,O,20275
161278,picture,O,20275
161279,with,O,20275
161280,microscope,O,20275
161281,view,O,20275
161282,Deep,B-TREATMENT,20276
161283,anterior,I-TREATMENT,20276
161284,lamellar,I-TREATMENT,20276
161285,keratoplasty,I-TREATMENT,20276
161286,DALK,I-TREATMENT,20276
161287,is,O,20276
161288,a,O,20276
161289,surgical,O,20276
161290,procedure,O,20276
161291,for,O,20276
161292,removing,O,20276
161293,the,B-PART_OF_THE_EYES,20276
161294,corneal,I-PART_OF_THE_EYES,20276
161295,stroma,I-PART_OF_THE_EYES,20276
161296,down,O,20276
161297,to,O,20276
161298,Descemets,B-PART_OF_THE_EYES,20276
161299,membrane,I-PART_OF_THE_EYES,20276
161300,It,O,20277
161301,is,O,20277
161302,most,O,20277
161303,useful,O,20277
161304,for,O,20277
161305,the,O,20277
161306,treatment,O,20277
161307,of,O,20277
161308,corneal,B-NAME_OF_DISEASE,20277
161309,disease,I-NAME_OF_DISEASE,20277
161310,in,O,20277
161311,the,O,20277
161312,setting,O,20277
161313,of,O,20277
161314,a,O,20277
161315,normally,O,20277
161316,functioning,O,20277
161317,endothelium,O,20277
161318,A,B-SURGICAL_INSTRUMENT,20278
161319,trephine,I-SURGICAL_INSTRUMENT,20278
161320,of,O,20278
161321,an,O,20278
161322,appropriate,O,20278
161323,diameter,O,20278
161324,is,O,20278
161325,used,O,20278
161326,to,O,20278
161327,make,O,20278
161328,a,O,20278
161329,partial-thickness,O,20278
161330,incision,O,20278
161331,into,O,20278
161332,the,O,20278
161333,patients,O,20278
161334,cornea,B-PART_OF_THE_EYES,20278
161335,followed,O,20278
161336,by,O,20278
161337,pneumodissection,B-TREATMENT,20278
161338,or,O,20278
161339,manual,O,20278
161340,dissection,O,20278
161341,of,O,20278
161342,the,B-PART_OF_THE_EYES,20278
161343,anterior,I-PART_OF_THE_EYES,20278
161344,stroma,I-PART_OF_THE_EYES,20278
161345,This,O,20279
161346,is,O,20279
161347,followed,O,20279
161348,by,O,20279
161349,placement,O,20279
161350,of,O,20279
161351,a,O,20279
161352,graft,O,20279
161353,prepared,O,20279
161354,from,O,20279
161355,a,O,20279
161356,full-thickness,O,20279
161357,punch,O,20279
161358,in,O,20279
161359,which,O,20279
161360,the,O,20279
161361,donor,O,20279
161362,endothelium-Descemet,O,20279
161363,membrane,O,20279
161364,complex,O,20279
161365,has,O,20279
161366,been,O,20279
161367,removed,O,20279
161368,The,O,20280
161369,intention,O,20280
161370,is,O,20280
161371,to,O,20280
161372,preserve,O,20280
161373,the,O,20280
161374,patients,O,20280
161375,Descemet,B-PART_OF_THE_EYES,20280
161376,membrane,I-PART_OF_THE_EYES,20280
161377,and,O,20280
161378,endothelium,O,20280
161379,Similar,O,20281
161380,to,O,20281
161381,PK,B-TREATMENT,20281
161382,the,O,20281
161383,graft,O,20281
161384,is,O,20281
161385,secured,O,20281
161386,with,O,20281
161387,interrupted,O,20281
161388,and,O,20281
161389,or,O,20281
161390,running,O,20281
161391,sutures,O,20281
161392,and,O,20281
161393,these,O,20281
161394,are,O,20281
161395,then,O,20281
161396,selectively,O,20281
161397,removed,O,20281
161398,post-operatively,O,20281
161399,Traditionally,O,20282
161400,penetrating,B-TREATMENT,20282
161401,keratoplasty,I-TREATMENT,20282
161402,PK,I-TREATMENT,20282
161403,which,O,20282
161404,involves,O,20282
161405,a,B-TREATMENT,20282
161406,full-thickness,I-TREATMENT,20282
161407,corneal,I-TREATMENT,20282
161408,graft,I-TREATMENT,20282
161409,has,O,20282
161410,been,O,20282
161411,the,O,20282
161412,treatment,O,20282
161413,of,O,20282
161414,choice,O,20282
161415,for,O,20282
161416,corneal,B-NAME_OF_DISEASE,20282
161417,stromal,I-NAME_OF_DISEASE,20282
161418,diseases,I-NAME_OF_DISEASE,20282
161419,But,O,20283
161420,PK,B-TREATMENT,20283
161421,can,O,20283
161422,be,O,20283
161423,complicated,O,20283
161424,by,O,20283
161425,graft,O,20283
161426,rejection,O,20283
161427,irregular,B-NAME_OF_DISEASE,20283
161428,astigmatism,I-NAME_OF_DISEASE,20283
161429,and,O,20283
161430,corneal,B-NAME_OF_DISEASE,20283
161431,opacification,I-NAME_OF_DISEASE,20283
161432,thus,O,20283
161433,resulting,O,20283
161434,in,O,20283
161435,visual,B-NAME_OF_DISEASE,20283
161436,impairment,I-NAME_OF_DISEASE,20283
161437,DALK,B-TREATMENT,20284
161438,offers,O,20284
161439,an,O,20284
161440,alternative,O,20284
161441,procedure,O,20284
161442,that,O,20284
161443,may,O,20284
161444,lessen,O,20284
161445,those,O,20284
161446,risks,O,20284
161447,because,O,20284
161448,the,O,20284
161449,recipient,O,20284
161450,Descemets,B-PART_OF_THE_EYES,20284
161451,membrane,I-PART_OF_THE_EYES,20284
161452,and,O,20284
161453,endothelium,O,20284
161454,are,O,20284
161455,preserved,O,20284
161456,At,O,20285
161457,the,O,20285
161458,same,O,20285
161459,time,O,20285
161460,DALK,B-TREATMENT,20285
161461,carries,O,20285
161462,the,O,20285
161463,potential,O,20285
161464,danger,O,20285
161465,of,O,20285
161466,decreased,O,20285
161467,visual,O,20285
161468,acuity,O,20285
161469,due,O,20285
161470,to,O,20285
161471,possible,O,20285
161472,opacification,O,20285
161473,at,O,20285
161474,the,O,20285
161475,interface,O,20285
161476,layers,O,20285
161477,DALK,B-TREATMENT,20286
161478,can,O,20286
161479,be,O,20286
161480,an,O,20286
161481,effective,O,20286
161482,treatment,O,20286
161483,for,O,20286
161484,any,O,20286
161485,pathology,O,20286
161486,of,O,20286
161487,the,B-PART_OF_THE_EYES,20286
161488,anterior,I-PART_OF_THE_EYES,20286
161489,cornea,I-PART_OF_THE_EYES,20286
161490,epithelium,O,20286
161491,Bowmans,O,20286
161492,layer,O,20286
161493,and,O,20286
161494,stroma,O,20286
161495,as,O,20286
161496,long,O,20286
161497,as,O,20286
161498,the,O,20286
161499,patient,O,20286
161500,has,O,20286
161501,an,O,20286
161502,intact,O,20286
161503,functioning,O,20286
161504,endothelium,O,20286
161505,Common,O,20287
161506,indications,O,20287
161507,for,O,20287
161508,DALK,B-TREATMENT,20287
161509,include,O,20287
161510,keratoconus,B-NAME_OF_DISEASE,20287
161511,and,O,20287
161512,corneal,B-SIGN_AND_SYMPTOM,20287
161513,scars,I-SIGN_AND_SYMPTOM,20287
161514,Patients,O,20288
161515,with,O,20288
161516,keratoconus,B-NAME_OF_DISEASE,20288
161517,are,O,20288
161518,good,O,20288
161519,candidates,O,20288
161520,for,O,20288
161521,DALK,B-TREATMENT,20288
161522,because,O,20288
161523,they,O,20288
161524,are,O,20288
161525,typically,O,20288
161526,young,O,20288
161527,and,O,20288
161528,have,O,20288
161529,healthy,O,20288
161530,endothelium,O,20288
161531,These,O,20289
161532,patients,O,20289
161533,stand,O,20289
161534,to,O,20289
161535,lose,O,20289
161536,the,O,20289
161537,most,O,20289
161538,from,O,20289
161539,the,O,20289
161540,occurrence,O,20289
161541,of,O,20289
161542,post-PK,O,20289
161543,immunological,O,20289
161544,reactions,O,20289
161545,that,O,20289
161546,can,O,20289
161547,compromise,O,20289
161548,endothelial,O,20289
161549,function,O,20289
161550,in,O,20289
161551,up,O,20289
161552,to,O,20289
161553,20,O,20289
161554,percent,O,20289
161555,of,O,20289
161556,cases,O,20289
161557,Less,O,20290
161558,common,O,20290
161559,indications,O,20290
161560,for,O,20290
161561,DALK,B-TREATMENT,20290
161562,include,O,20290
161563,vernal,B-NAME_OF_DISEASE,20290
161564,keratoconjunctivitis,I-NAME_OF_DISEASE,20290
161565,corneal,B-NAME_OF_DISEASE,20290
161566,dystrophies,I-NAME_OF_DISEASE,20290
161567,and,O,20290
161568,ocular,B-NAME_OF_DISEASE,20290
161569,surface,I-NAME_OF_DISEASE,20290
161570,diseases,I-NAME_OF_DISEASE,20290
161571,with,O,20290
161572,limbal,O,20290
161573,stem,O,20290
161574,cell,O,20290
161575,deficiency,O,20290
161576,including,O,20290
161577,Stevens-Johnson,B-NAME_OF_DISEASE,20290
161578,syndrome,I-NAME_OF_DISEASE,20290
161579,ocular,B-NAME_OF_DISEASE,20290
161580,cicatricial,I-NAME_OF_DISEASE,20290
161581,pemphigoid,I-NAME_OF_DISEASE,20290
161582,and,O,20290
161583,chemical,B-SIGN_AND_SYMPTOM,20290
161584,thermal,I-SIGN_AND_SYMPTOM,20290
161585,burns,I-SIGN_AND_SYMPTOM,20290
161586,Knowledge,O,20291
161587,of,O,20291
161588,corneal,O,20291
161589,ultrastructural,O,20291
161590,anatomy,O,20291
161591,that,O,20291
161592,recognizes,O,20291
161593,the,O,20291
161594,presence,O,20291
161595,of,O,20291
161596,the,B-PART_OF_THE_EYES,20291
161597,pre-Descemets,I-PART_OF_THE_EYES,20291
161598,layer,I-PART_OF_THE_EYES,20291
161599,PDL,I-PART_OF_THE_EYES,20291
161600,brings,O,20291
161601,a,O,20291
161602,new,O,20291
161603,understanding,O,20291
161604,to,O,20291
161605,deep,B-TREATMENT,20291
161606,anterior,I-TREATMENT,20291
161607,lamellar,I-TREATMENT,20291
161608,keratoplasty,I-TREATMENT,20291
161609,DALK,I-TREATMENT,20291
161610,and,O,20291
161611,its,O,20291
161612,successful,O,20291
161613,completion,O,20291
161614,The,B-PART_OF_THE_EYES,20292
161615,PDL,I-PART_OF_THE_EYES,20292
161616,which,O,20292
161617,was,O,20292
161618,first,O,20292
161619,described,O,20292
161620,by,O,20292
161621,Professor,B-PERSON,20292
161622,Harminder,I-PERSON,20292
161623,Dua,I-PERSON,20292
161624,and,O,20292
161625,colleagues,O,20292
161626,in,O,20292
161627,2013,O,20292
161628,lies,O,20292
161629,immediately,O,20292
161630,anterior,O,20292
161631,to,O,20292
161632,Descemets,B-PART_OF_THE_EYES,20292
161633,membrane,I-PART_OF_THE_EYES,20292
161634,DM,I-PART_OF_THE_EYES,20292
161635,beneath,O,20292
161636,the,B-PART_OF_THE_EYES,20292
161637,posterior,I-PART_OF_THE_EYES,20292
161638,stroma,I-PART_OF_THE_EYES,20292
161639,Although,O,20293
161640,it,O,20293
161641,is,O,20293
161642,only,O,20293
161643,5,O,20293
161644,to,O,20293
161645,15,O,20293
161646,mum,O,20293
161647,thick,O,20293
161648,the,B-PART_OF_THE_EYES,20293
161649,PDL,I-PART_OF_THE_EYES,20293
161650,has,O,20293
161651,a,O,20293
161652,high,O,20293
161653,bursting,O,20293
161654,pressure,O,20293
161655,of,O,20293
161656,500,O,20293
161657,mm,O,20293
161658,Hg,O,20293
161659,Whether,O,20294
161660,or,O,20294
161661,not,O,20294
161662,the,B-PART_OF_THE_EYES,20294
161663,PDL,I-PART_OF_THE_EYES,20294
161664,is,O,20294
161665,left,O,20294
161666,behind,O,20294
161667,with,O,20294
161668,the,B-PART_OF_THE_EYES,20294
161669,DM,I-PART_OF_THE_EYES,20294
161670,and,O,20294
161671,endothelium,O,20294
161672,after,O,20294
161673,air,O,20294
161674,injection,O,20294
161675,to,O,20294
161676,create,O,20294
161677,the,O,20294
161678,Big,O,20294
161679,Bubble,O,20294
161680,BB,O,20294
161681,in,O,20294
161682,DALK,B-TREATMENT,20294
161683,determines,O,20294
161684,the,O,20294
161685,risk,O,20294
161686,of,O,20294
161687,rupture,O,20294
161688,into,O,20294
161689,the,B-PART_OF_THE_EYES,20294
161690,anterior,I-PART_OF_THE_EYES,20294
161691,chamber,I-PART_OF_THE_EYES,20294
161692,A,O,20295
161693,BB,O,20295
161694,type,O,20295
161695,1,O,20295
161696,BB1,O,20295
161697,cleaves,O,20295
161698,off,O,20295
161699,or,O,20295
161700,separates,O,20295
161701,the,B-PART_OF_THE_EYES,20295
161702,posterior,I-PART_OF_THE_EYES,20295
161703,stroma,I-PART_OF_THE_EYES,20295
161704,from,O,20295
161705,the,B-PART_OF_THE_EYES,20295
161706,PDL,I-PART_OF_THE_EYES,20295
161707,leaving,O,20295
161708,the,B-PART_OF_THE_EYES,20295
161709,PDL,I-PART_OF_THE_EYES,20295
161710,behind,O,20295
161711,with,O,20295
161712,DM,B-PART_OF_THE_EYES,20295
161713,and,O,20295
161714,endothelium,O,20295
161715,In,O,20296
161716,this,O,20296
161717,scenario,O,20296
161718,there,O,20296
161719,is,O,20296
161720,little,O,20296
161721,risk,O,20296
161722,of,O,20296
161723,perforation,O,20296
161724,into,O,20296
161725,the,B-PART_OF_THE_EYES,20296
161726,anterior,I-PART_OF_THE_EYES,20296
161727,chamber,I-PART_OF_THE_EYES,20296
161728,because,O,20296
161729,the,B-PART_OF_THE_EYES,20296
161730,PDL,I-PART_OF_THE_EYES,20296
161731,has,O,20296
161732,such,O,20296
161733,a,O,20296
161734,high,O,20296
161735,bursting,O,20296
161736,pressure,O,20296
161737,A,O,20297
161738,Big,O,20297
161739,Bubble,O,20297
161740,type,O,20297
161741,2,O,20297
161742,BB2,O,20297
161743,forms,O,20297
161744,between,O,20297
161745,PDL,B-PART_OF_THE_EYES,20297
161746,and,O,20297
161747,DM,B-PART_OF_THE_EYES,20297
161748,leaving,O,20297
161749,behind,O,20297
161750,DM,B-PART_OF_THE_EYES,20297
161751,and,O,20297
161752,endothelium,O,20297
161753,In,O,20298
161754,this,O,20298
161755,situation,O,20298
161756,the,O,20298
161757,risk,O,20298
161758,of,O,20298
161759,rupture,O,20298
161760,into,O,20298
161761,the,B-PART_OF_THE_EYES,20298
161762,anterior,I-PART_OF_THE_EYES,20298
161763,chamber,I-PART_OF_THE_EYES,20298
161764,is,O,20298
161765,greater,O,20298
161766,because,O,20298
161767,the,O,20298
161768,bursting,O,20298
161769,pressure,O,20298
161770,of,O,20298
161771,DM,B-PART_OF_THE_EYES,20298
161772,is,O,20298
161773,only,O,20298
161774,around,O,20298
161775,30,O,20298
161776,mm,O,20298
161777,Hg,O,20298
161778,and,O,20298
161779,this,O,20298
161780,risk,O,20298
161781,remains,O,20298
161782,increased,O,20298
161783,during,O,20298
161784,the,O,20298
161785,remainder,O,20298
161786,of,O,20298
161787,the,O,20298
161788,procedure,O,20298
161789,due,O,20298
161790,to,O,20298
161791,the,O,20298
161792,fragility,O,20298
161793,of,O,20298
161794,DM,B-PART_OF_THE_EYES,20298
161795,By,O,20299
161796,allowing,O,20299
161797,surgeons,O,20299
161798,to,O,20299
161799,identify,O,20299
161800,the,O,20299
161801,location,O,20299
161802,of,O,20299
161803,the,O,20299
161804,cannula,O,20299
161805,before,O,20299
161806,injecting,O,20299
161807,air,O,20299
161808,to,O,20299
161809,create,O,20299
161810,the,O,20299
161811,BB,O,20299
161812,intraoperative,B-SURGICAL_INSTRUMENT,20299
161813,OCT,I-SURGICAL_INSTRUMENT,20299
161814,is,O,20299
161815,helpful,O,20299
161816,for,O,20299
161817,achieving,O,20299
161818,a,O,20299
161819,BB1,O,20299
161820,If,O,20300
161821,there,O,20300
161822,is,O,20300
161823,a,O,20300
161824,BB2,O,20300
161825,surgeons,O,20300
161826,do,O,20300
161827,not,O,20300
161828,need,O,20300
161829,to,O,20300
161830,abort,O,20300
161831,the,B-TREATMENT,20300
161832,DALK,I-TREATMENT,20300
161833,procedure,I-TREATMENT,20300
161834,and,O,20300
161835,convert,O,20300
161836,to,O,20300
161837,penetrating,B-TREATMENT,20300
161838,keratoplasty,I-TREATMENT,20300
161839,In,O,20301
161840,this,O,20301
161841,instance,O,20301
161842,surgeons,O,20301
161843,need,O,20301
161844,to,O,20301
161845,recognize,O,20301
161846,that,O,20301
161847,they,O,20301
161848,are,O,20301
161849,dealing,O,20301
161850,with,O,20301
161851,a,O,20301
161852,more,O,20301
161853,tenuous,O,20301
161854,situation,O,20301
161855,that,O,20301
161856,requires,O,20301
161857,patience,O,20301
161858,and,O,20301
161859,attention,O,20301
161860,to,O,20301
161861,detail,O,20301
161862,in,O,20301
161863,order,O,20301
161864,to,O,20301
161865,bring,O,20301
161866,DALK,B-TREATMENT,20301
161867,to,O,20301
161868,a,O,20301
161869,successful,O,20301
161870,completion,O,20301
161871,Dr,B-PERSON,20302
161872,Hannush,I-PERSON,20302
161873,offered,O,20302
161874,several,O,20302
161875,pearls,O,20302
161876,for,O,20302
161877,proceeding,O,20302
161878,in,O,20302
161879,the,O,20302
161880,setting,O,20302
161881,of,O,20302
161882,a,O,20302
161883,BB2,O,20302
161884,To,O,20303
161885,minimize,O,20303
161886,the,O,20303
161887,risk,O,20303
161888,of,O,20303
161889,DM,B-PART_OF_THE_EYES,20303
161890,rupture,O,20303
161891,it,O,20303
161892,is,O,20303
161893,important,O,20303
161894,to,O,20303
161895,be,O,20303
161896,watcful,O,20303
161897,against,O,20303
161898,touching,O,20303
161899,DM,B-PART_OF_THE_EYES,20303
161900,with,O,20303
161901,any,O,20303
161902,instrument,O,20303
161903,or,O,20303
161904,squirting,O,20303
161905,it,O,20303
161906,with,O,20303
161907,BSS,O,20303
161908,Also,O,20304
161909,it,O,20304
161910,is,O,20304
161911,recommended,O,20304
161912,to,O,20304
161913,inject,O,20304
161914,a,O,20304
161915,cohesive,O,20304
161916,viscoelastic,O,20304
161917,between,O,20304
161918,PDL,B-PART_OF_THE_EYES,20304
161919,and,O,20304
161920,DM,B-PART_OF_THE_EYES,20304
161921,to,O,20304
161922,create,O,20304
161923,space,O,20304
161924,and,O,20304
161925,avoid,O,20304
161926,inadvertent,O,20304
161927,contact,O,20304
161928,between,O,20304
161929,the,B-SURGICAL_INSTRUMENT,20304
161930,scissors,I-SURGICAL_INSTRUMENT,20304
161931,and,O,20304
161932,DM,B-PART_OF_THE_EYES,20304
161933,while,O,20304
161934,removing,O,20304
161935,the,B-PART_OF_THE_EYES,20304
161936,posterior,I-PART_OF_THE_EYES,20304
161937,stroma,I-PART_OF_THE_EYES,20304
161938,is,O,20304
161939,important,O,20304
161940,Ideally,O,20305
161941,the,O,20305
161942,viscoelastic,O,20305
161943,device,O,20305
161944,cannula,O,20305
161945,may,O,20305
161946,be,O,20305
161947,replaced,O,20305
161948,with,O,20305
161949,the,O,20305
161950,same,O,20305
161951,cannula,O,20305
161952,used,O,20305
161953,to,O,20305
161954,create,O,20305
161955,the,O,20305
161956,BB,O,20305
161957,eg,O,20305
161958,Sarnicola,O,20305
161959,Fogla,O,20305
161960,Tan,O,20305
161961,etc,O,20305
161962,these,O,20305
161963,cannulas,O,20305
161964,are,O,20305
161965,preferred,O,20305
161966,because,O,20305
161967,they,O,20305
161968,have,O,20305
161969,a,O,20305
161970,smooth,O,20305
161971,contour,O,20305
161972,and,O,20305
161973,a,O,20305
161974,posterior,O,20305
161975,opening,O,20305
161976,that,O,20305
161977,will,O,20305
161978,push,O,20305
161979,DM,B-PART_OF_THE_EYES,20305
161980,away,O,20305
161981,from,O,20305
161982,the,O,20305
161983,cannula,O,20305
161984,It,O,20306
161985,is,O,20306
161986,also,O,20306
161987,advised,O,20306
161988,to,O,20306
161989,use,O,20306
161990,of,O,20306
161991,rounded,B-SURGICAL_INSTRUMENT,20306
161992,scissors,I-SURGICAL_INSTRUMENT,20306
161993,to,O,20306
161994,remove,O,20306
161995,the,B-PART_OF_THE_EYES,20306
161996,posterior,I-PART_OF_THE_EYES,20306
161997,stroma,I-PART_OF_THE_EYES,20306
161998,PDL,B-PART_OF_THE_EYES,20306
161999,after,O,20306
162000,creation,O,20306
162001,of,O,20306
162002,BB2,O,20306
162003,and,O,20306
162004,cautioned,O,20306
162005,against,O,20306
162006,leaning,O,20306
162007,on,O,20306
162008,DM,B-PART_OF_THE_EYES,20306
162009,with,O,20306
162010,the,O,20306
162011,posterior,O,20306
162012,blade,O,20306
162013,of,O,20306
162014,the,B-SURGICAL_INSTRUMENT,20306
162015,scissors,I-SURGICAL_INSTRUMENT,20306
162016,The,B-SURGICAL_INSTRUMENT,20307
162017,Tan,I-SURGICAL_INSTRUMENT,20307
162018,DALK,I-SURGICAL_INSTRUMENT,20307
162019,scissors,I-SURGICAL_INSTRUMENT,20307
162020,which,O,20307
162021,features,O,20307
162022,a,O,20307
162023,platform,O,20307
162024,on,O,20307
162025,the,O,20307
162026,posterior,O,20307
162027,blade,O,20307
162028,is,O,20307
162029,designed,O,20307
162030,specifically,O,20307
162031,for,O,20307
162032,this,O,20307
162033,maneuver,O,20307
162034,in,O,20307
162035,cases,O,20307
162036,of,O,20307
162037,both,O,20307
162038,BB1,O,20307
162039,and,O,20307
162040,BB2,O,20307
162041,Before,O,20308
162042,proceeding,O,20308
162043,however,O,20308
162044,ensure,O,20308
162045,that,O,20308
162046,the,O,20308
162047,big,O,20308
162048,bubble,O,20308
162049,1,O,20308
162050,or,O,20308
162051,2,O,20308
162052,extends,O,20308
162053,to,O,20308
162054,or,O,20308
162055,beyond,O,20308
162056,the,O,20308
162057,trephination,O,20308
162058,mark,O,20308
162059,and,O,20308
162060,that,O,20308
162061,there,O,20308
162062,are,O,20308
162063,no,O,20308
162064,adhesions,O,20308
162065,between,O,20308
162066,PDL,B-PART_OF_THE_EYES,20308
162067,and,O,20308
162068,DM,B-PART_OF_THE_EYES,20308
162069,They,O,20309
162070,can,O,20309
162071,lead,O,20309
162072,to,O,20309
162073,rupture,O,20309
162074,during,O,20309
162075,removal,O,20309
162076,of,O,20309
162077,the,B-PART_OF_THE_EYES,20309
162078,posterior,I-PART_OF_THE_EYES,20309
162079,stroma,I-PART_OF_THE_EYES,20309
162080,BB1,O,20309
162081,or,O,20309
162082,the,B-PART_OF_THE_EYES,20309
162083,posterior,I-PART_OF_THE_EYES,20309
162084,stroma,I-PART_OF_THE_EYES,20309
162085,PDL,B-PART_OF_THE_EYES,20309
162086,BB2,O,20309
162087,Trying,O,20310
162088,to,O,20310
162089,slow,O,20310
162090,down,O,20310
162091,how,O,20310
162092,quickly,O,20310
162093,myopia,B-NAME_OF_DISEASE,20310
162094,gets,O,20310
162095,worse,O,20310
162096,is,O,20310
162097,called,O,20310
162098,myopia,B-NAME_OF_DISEASE,20310
162099,management,O,20310
162100,A,O,20311
162101,number,O,20311
162102,of,O,20311
162103,treatments,O,20311
162104,have,O,20311
162105,been,O,20311
162106,developed,O,20311
162107,for,O,20311
162108,this,O,20311
162109,including,O,20311
162110,specially,B-TREATMENT,20311
162111,designed,I-TREATMENT,20311
162112,contact,I-TREATMENT,20311
162113,lenses,I-TREATMENT,20311
162114,or,I-TREATMENT,20311
162115,glasses,I-TREATMENT,20311
162116,and,O,20311
162117,atropine,B-TREATMENT,20311
162118,eye,I-TREATMENT,20311
162119,drops,I-TREATMENT,20311
162120,Current,O,20312
162121,evidence,O,20312
162122,suggests,O,20312
162123,that,O,20312
162124,using,O,20312
162125,special,O,20312
162126,contact,B-TREATMENT,20312
162127,lenses,I-TREATMENT,20312
162128,or,O,20312
162129,atropine,B-TREATMENT,20312
162130,eye,I-TREATMENT,20312
162131,drops,I-TREATMENT,20312
162132,may,O,20312
162133,reduce,O,20312
162134,the,O,20312
162135,progression,O,20312
162136,of,O,20312
162137,myopia,B-NAME_OF_DISEASE,20312
162138,by,O,20312
162139,40%,O,20312
162140,to,O,20312
162141,60%,O,20312
162142,after,O,20312
162143,one,B-TIME_DURATION,20312
162144,to,I-TIME_DURATION,20312
162145,two,I-TIME_DURATION,20312
162146,years,I-TIME_DURATION,20312
162147,some,O,20312
162148,manufacturers,O,20312
162149,studies,O,20312
162150,suggest,O,20312
162151,a,O,20312
162152,reduction,O,20312
162153,in,O,20312
162154,its,O,20312
162155,progression,O,20312
162156,over,O,20312
162157,three,B-TIME_DURATION,20312
162158,years,I-TIME_DURATION,20312
162159,Using,O,20313
162160,specially,B-TREATMENT,20313
162161,designed,I-TREATMENT,20313
162162,glasses,I-TREATMENT,20313
162163,can,O,20313
162164,also,O,20313
162165,help,O,20313
162166,to,O,20313
162167,slow,O,20313
162168,down,O,20313
162169,the,O,20313
162170,progression,O,20313
162171,of,O,20313
162172,myopia,B-NAME_OF_DISEASE,20313
162173,Myopia,B-NAME_OF_DISEASE,20314
162174,develops,O,20314
162175,during,O,20314
162176,childhood,O,20314
162177,when,O,20314
162178,the,B-PART_OF_THE_EYES,20314
162179,eyeballs,I-PART_OF_THE_EYES,20314
162180,are,O,20314
162181,experiencing,O,20314
162182,rapid,O,20314
162183,growth,O,20314
162184,The,O,20315
162185,degree,O,20315
162186,of,O,20315
162187,myopia,B-NAME_OF_DISEASE,20315
162188,can,O,20315
162189,progress,O,20315
162190,gradually,O,20315
162191,or,O,20315
162192,rapidly,O,20315
162193,especially,O,20315
162194,from,O,20315
162195,ages,O,20315
162196,18-Aug,O,20315
162197,This,O,20316
162198,is,O,20316
162199,not,O,20316
162200,just,O,20316
162201,a,O,20316
162202,matter,O,20316
162203,of,O,20316
162204,needing,O,20316
162205,stronger,B-TREATMENT,20316
162206,glasses,I-TREATMENT,20316
162207,if,O,20316
162208,the,O,20316
162209,myopia,B-NAME_OF_DISEASE,20316
162210,continues,O,20316
162211,to,O,20316
162212,progress,O,20316
162213,the,O,20316
162214,child,O,20316
162215,is,O,20316
162216,at,O,20316
162217,a,O,20316
162218,higher,O,20316
162219,risk,O,20316
162220,of,O,20316
162221,developing,O,20316
162222,dangerous,O,20316
162223,eye,O,20316
162224,diseases,O,20316
162225,such,O,20316
162226,as,O,20316
162227,cataracts,B-NAME_OF_DISEASE,20316
162228,retinal,B-NAME_OF_DISEASE,20316
162229,detachment,I-NAME_OF_DISEASE,20316
162230,macular,B-NAME_OF_DISEASE,20316
162231,degeneration,I-NAME_OF_DISEASE,20316
162232,and,O,20316
162233,glaucoma,B-NAME_OF_DISEASE,20316
162234,later,O,20316
162235,in,O,20316
162236,life,O,20316
162237,These,O,20317
162238,conditions,O,20317
162239,can,O,20317
162240,lead,O,20317
162241,to,O,20317
162242,permanent,B-NAME_OF_DISEASE,20317
162243,loss,I-NAME_OF_DISEASE,20317
162244,of,I-NAME_OF_DISEASE,20317
162245,vision,I-NAME_OF_DISEASE,20317
162246,and,O,20317
162247,even,O,20317
162248,blindness,B-NAME_OF_DISEASE,20317
162249,Effective,O,20318
162250,interventions,O,20318
162251,for,O,20318
162252,myopia,B-NAME_OF_DISEASE,20318
162253,include,O,20318
162254,atropine,B-TREATMENT,20318
162255,eye,I-TREATMENT,20318
162256,drops,I-TREATMENT,20318
162257,of,O,20318
162258,high,O,20318
162259,moderate,O,20318
162260,and,O,20318
162261,low,O,20318
162262,dose,O,20318
162263,pirenzepine,B-NAME_OF_DRUG,20318
162264,cyclopentolate,B-NAME_OF_DRUG,20318
162265,peripheral,B-TREATMENT,20318
162266,defocus,I-TREATMENT,20318
162267,modifying,I-TREATMENT,20318
162268,contact,I-TREATMENT,20318
162269,lenses,I-TREATMENT,20318
162270,peripheral,B-TREATMENT,20318
162271,defocus,I-TREATMENT,20318
162272,modifying,I-TREATMENT,20318
162273,spectacle,I-TREATMENT,20318
162274,lenses,I-TREATMENT,20318
162275,orthokeratology,B-TREATMENT,20318
162276,progressive,B-TREATMENT,20318
162277,addition,I-TREATMENT,20318
162278,spectacle,I-TREATMENT,20318
162279,lens,I-TREATMENT,20318
162280,prism,B-TREATMENT,20318
162281,bifocal,B-TREATMENT,20318
162282,spectacle,I-TREATMENT,20318
162283,lenses,I-TREATMENT,20318
162284,bifocal,B-TREATMENT,20318
162285,spectacle,I-TREATMENT,20318
162286,lenses,I-TREATMENT,20318
162287,and,O,20318
162288,more,B-TREATMENT,20318
162289,outdoor,I-TREATMENT,20318
162290,activities,I-TREATMENT,20318
162291,In,O,20319
162292,the,O,20319
162293,setting,O,20319
162294,of,O,20319
162295,randomized,O,20319
162296,controlled,O,20319
162297,trial,O,20319
162298,atropine,B-NAME_OF_DRUG,20319
162299,is,O,20319
162300,the,O,20319
162301,only,O,20319
162302,treatment,O,20319
162303,that,O,20319
162304,manifests,O,20319
162305,strong,O,20319
162306,effect,O,20319
162307,Bifocal,B-TREATMENT,20320
162308,spectacles,I-TREATMENT,20320
162309,and,O,20320
162310,outdoor,B-TREATMENT,20320
162311,time,I-TREATMENT,20320
162312,tend,O,20320
162313,to,O,20320
162314,provide,O,20320
162315,low,O,20320
162316,myopia,B-NAME_OF_DISEASE,20320
162317,control,O,20320
162318,effect,O,20320
162319,Myopia,B-NAME_OF_DISEASE,20321
162320,is,O,20321
162321,not,O,20321
162322,a,O,20321
162323,new,O,20321
162324,vision,O,20321
162325,condition,O,20321
162326,but,O,20321
162327,the,O,20321
162328,growing,O,20321
162329,awareness,O,20321
162330,of,O,20321
162331,the,O,20321
162332,eye,O,20321
162333,health,O,20321
162334,risks,O,20321
162335,associated,O,20321
162336,with,O,20321
162337,this,O,20321
162338,common,O,20321
162339,ophthalmic,O,20321
162340,disorder,O,20321
162341,especially,O,20321
162342,among,O,20321
162343,eyecare,O,20321
162344,professionals,O,20321
162345,is,O,20321
162346,a,O,20321
162347,somewhat,O,20321
162348,contemporary,O,20321
162349,phenomenon,O,20321
162350,Indeed,O,20322
162351,myopia,B-NAME_OF_DISEASE,20322
162352,is,O,20322
162353,the,O,20322
162354,most,O,20322
162355,common,O,20322
162356,ophthalmic,O,20322
162357,condition,O,20322
162358,in,O,20322
162359,the,O,20322
162360,world,O,20322
162361,with,O,20322
162362,an,O,20322
162363,estimated,O,20322
162364,34,O,20322
162365,percent,O,20322
162366,of,O,20322
162367,the,O,20322
162368,worlds,O,20322
162369,population,O,20322
162370,or,O,20322
162371,roughly,O,20322
162372,2.62,O,20322
162373,billion,O,20322
162374,people,O,20322
162375,affected,O,20322
162376,by,O,20322
162377,this,O,20322
162378,condition,O,20322
162379,according,O,20322
162380,to,O,20322
162381,recent,O,20322
162382,research,O,20322
162383,A,O,20323
162384,specialty,O,20323
162385,such,O,20323
162386,as,O,20323
162387,myopia,B-NAME_OF_DISEASE,20323
162388,management-or,O,20323
162389,any,O,20323
162390,of,O,20323
162391,the,O,20323
162392,myriad,O,20323
162393,of,O,20323
162394,other,O,20323
162395,areas,O,20323
162396,of,O,20323
162397,care,O,20323
162398,that,O,20323
162399,ECPs,O,20323
162400,are,O,20323
162401,exploring,O,20323
162402,today-can,O,20323
162403,open,O,20323
162404,up,O,20323
162405,or,O,20323
162406,even,O,20323
162407,deepen,O,20323
162408,relationships,O,20323
162409,with,O,20323
162410,patients,O,20323
162411,and,O,20323
162412,families,O,20323
162413,in,O,20323
162414,a,O,20323
162415,local,O,20323
162416,or,O,20323
162417,regional,O,20323
162418,practice,O,20323
162419,area,O,20323
162420,And,O,20324
162421,because,O,20324
162422,myopia,B-NAME_OF_DISEASE,20324
162423,is,O,20324
162424,often,O,20324
162425,progressive,O,20324
162426,there,O,20324
162427,is,O,20324
162428,concern,O,20324
162429,that,O,20324
162430,the,O,20324
162431,condition,O,20324
162432,will,O,20324
162433,lead,O,20324
162434,to,O,20324
162435,higher,O,20324
162436,and,O,20324
162437,higher,O,20324
162438,degrees,O,20324
162439,of,O,20324
162440,myopia,B-NAME_OF_DISEASE,20324
162441,or,O,20324
162442,high,B-NAME_OF_DISEASE,20324
162443,myopia,I-NAME_OF_DISEASE,20324
162444,There,O,20325
162445,are,O,20325
162446,an,O,20325
162447,estimated,O,20325
162448,163,O,20325
162449,million,O,20325
162450,people,O,20325
162451,worldwide,O,20325
162452,who,O,20325
162453,have,O,20325
162454,high,B-NAME_OF_DISEASE,20325
162455,myopia,I-NAME_OF_DISEASE,20325
162456,usually,O,20325
162457,above,O,20325
162458,-6,O,20325
162459,diopters,O,20325
162460,and,O,20325
162461,worse,O,20325
162462,than,O,20325
162463,20,O,20325
162464,400,O,20325
162465,uncorrected,O,20325
162466,vision,O,20325
162467,Myopia,B-NAME_OF_DISEASE,20326
162468,management,O,20326
162469,is,O,20326
162470,white,O,20326
162471,space,O,20326
162472,said,O,20326
162473,Dwight,B-PERSON,20326
162474,Akerman,I-PERSON,20326
162475,OD,I-PERSON,20326
162476,FAAO,O,20326
162477,chief,O,20326
162478,medical,O,20326
162479,editor,O,20326
162480,of,O,20326
162481,Review,B-ORGANIZATION,20326
162482,of,I-ORGANIZATION,20326
162483,Myopia,I-ORGANIZATION,20326
162484,Management,I-ORGANIZATION,20326
162485,To,O,20327
162486,date,O,20327
162487,most,O,20327
162488,eyecare,O,20327
162489,professionals,O,20327
162490,have,O,20327
162491,not,O,20327
162492,incorporated,O,20327
162493,myopia,B-NAME_OF_DISEASE,20327
162494,management,O,20327
162495,into,O,20327
162496,their,O,20327
162497,practices,O,20327
162498,to,O,20327
162499,any,O,20327
162500,significant,O,20327
162501,extent,O,20327
162502,primarily,O,20327
162503,due,O,20327
162504,to,O,20327
162505,a,O,20327
162506,lack,O,20327
162507,of,O,20327
162508,knowledge,O,20327
162509,about,O,20327
162510,how,O,20327
162511,to,O,20327
162512,integrate,O,20327
162513,pediatric,O,20327
162514,myopia,B-NAME_OF_DISEASE,20327
162515,management,O,20327
162516,into,O,20327
162517,a,O,20327
162518,primary,O,20327
162519,care,O,20327
162520,optometric,O,20327
162521,practice,O,20327
162522,With,O,20328
162523,many,O,20328
162524,treatment,O,20328
162525,options,O,20328
162526,available,O,20328
162527,that,O,20328
162528,have,O,20328
162529,demonstrated,O,20328
162530,effi,O,20328
162531,cacy,O,20328
162532,ECPs,O,20328
162533,have,O,20328
162534,a,O,20328
162535,professional,O,20328
162536,responsibility,O,20328
162537,to,O,20328
162538,discuss,O,20328
162539,myopia,B-NAME_OF_DISEASE,20328
162540,management,O,20328
162541,options,O,20328
162542,with,O,20328
162543,all,O,20328
162544,parents,O,20328
162545,of,O,20328
162546,children,O,20328
162547,at,O,20328
162548,risk,O,20328
162549,for,O,20328
162550,progressive,O,20328
162551,myopia,B-NAME_OF_DISEASE,20328
162552,Sounding,O,20329
162553,the,O,20329
162554,Alarm,O,20329
162555,on,O,20329
162556,Myopia,B-NAME_OF_DISEASE,20329
162557,The,O,20329
162558,growing,O,20329
162559,prevalence,O,20329
162560,of,O,20329
162561,myopia-which,O,20329
162562,according,O,20329
162563,to,O,20329
162564,many,O,20329
162565,eyecare,O,20329
162566,professionals,O,20329
162567,has,O,20329
162568,risen,O,20329
162569,to,O,20329
162570,the,O,20329
162571,level,O,20329
162572,of,O,20329
162573,a,O,20329
162574,pandemic-came,O,20329
162575,to,O,20329
162576,the,O,20329
162577,fore,O,20329
162578,in,O,20329
162579,2016,O,20329
162580,in,O,20329
162581,a,O,20329
162582,paper,O,20329
162583,published,O,20329
162584,in,O,20329
162585,Ophthalmology,B-PUBLICATION_VENUE,20329
162586,the,O,20329
162587,official,O,20329
162588,journal,O,20329
162589,of,O,20329
162590,the,B-ORGANIZATION,20329
162591,American,I-ORGANIZATION,20329
162592,Academy,I-ORGANIZATION,20329
162593,of,I-ORGANIZATION,20329
162594,Ophthalmology,I-ORGANIZATION,20329
162595,according,O,20329
162596,to,O,20329
162597,Akerman,B-PERSON,20329
162598,The,O,20330
162599,Holden,B-PERSON,20330
162600,et,O,20330
162601,al,O,20330
162602,paper,O,20330
162603,published,O,20330
162604,in,O,20330
162605,the,B-PUBLICATION_VENUE,20330
162606,journal,I-PUBLICATION_VENUE,20330
162607,Ophthalmology,I-PUBLICATION_VENUE,20330
162608,sounded,O,20330
162609,the,O,20330
162610,alarm,O,20330
162611,on,O,20330
162612,the,O,20330
162613,global,O,20330
162614,pandemic,O,20330
162615,of,O,20330
162616,myopia,B-NAME_OF_DISEASE,20330
162617,he,O,20330
162618,said,O,20330
162619,noting,O,20330
162620,that,O,20330
162621,this,O,20330
162622,paper,O,20330
162623,projected,O,20330
162624,that,O,20330
162625,by,O,20330
162626,2050,O,20330
162627,there,O,20330
162628,would,O,20330
162629,be,O,20330
162630,50,O,20330
162631,percent,O,20330
162632,of,O,20330
162633,the,O,20330
162634,worlds,O,20330
162635,population,O,20330
162636,who,O,20330
162637,would,O,20330
162638,be,O,20330
162639,myopic,O,20330
162640,The,O,20331
162641,issue,O,20331
162642,there,O,20331
162643,is,O,20331
162644,that,O,20331
162645,highly,O,20331
162646,myopic,O,20331
162647,people,O,20331
162648,are,O,20331
162649,more,O,20331
162650,prone,O,20331
162651,to,O,20331
162652,retinal,B-NAME_OF_DISEASE,20331
162653,detachment,I-NAME_OF_DISEASE,20331
162654,myopic,B-NAME_OF_DISEASE,20331
162655,macular,I-NAME_OF_DISEASE,20331
162656,degeneration,I-NAME_OF_DISEASE,20331
162657,glaucoma,B-NAME_OF_DISEASE,20331
162658,and,O,20331
162659,premature,B-NAME_OF_DISEASE,20331
162660,cataracts,I-NAME_OF_DISEASE,20331
162661,among,O,20331
162662,other,O,20331
162663,issues,O,20331
162664,Akerman,B-PERSON,20331
162665,said,O,20331
162666,He,O,20332
162667,added,O,20332
162668,There,O,20332
162669,had,O,20332
162670,been,O,20332
162671,a,O,20332
162672,lot,O,20332
162673,of,O,20332
162674,papers,O,20332
162675,published,O,20332
162676,but,O,20332
162677,this,O,20332
162678,paper,O,20332
162679,was,O,20332
162680,really,O,20332
162681,the,O,20332
162682,alarm,O,20332
162683,bell,O,20332
162684,for,O,20332
162685,the,O,20332
162686,world,O,20332
162687,to,O,20332
162688,say,O,20332
162689,We,O,20332
162690,need,O,20332
162691,to,O,20332
162692,take,O,20332
162693,notice,O,20332
162694,of,O,20332
162695,this,O,20332
162696,and,O,20332
162697,we,O,20332
162698,need,O,20332
162699,to,O,20332
162700,develop,O,20332
162701,treatments,O,20332
162702,to,O,20332
162703,slow,O,20332
162704,or,O,20332
162705,stop,O,20332
162706,the,O,20332
162707,progression,O,20332
162708,of,O,20332
162709,myopia,B-NAME_OF_DISEASE,20332
162710,The,O,20333
162711,economic,O,20333
162712,costs,O,20333
162713,of,O,20333
162714,myopia,B-NAME_OF_DISEASE,20333
162715,are,O,20333
162716,high,O,20333
162717,also,O,20333
162718,with,O,20333
162719,an,O,20333
162720,economic,O,20333
162721,impact,O,20333
162722,of,O,20333
162723,uncorrected,O,20333
162724,refractive,B-NAME_OF_DISEASE,20333
162725,error,I-NAME_OF_DISEASE,20333
162726,estimated,O,20333
162727,at,O,20333
162728,a,O,20333
162729,loss,O,20333
162730,of,O,20333
162731,202,O,20333
162732,billion,O,20333
162733,in,O,20333
162734,global,O,20333
162735,GDP,O,20333
162736,While,O,20334
162737,there,O,20334
162738,is,O,20334
162739,not,O,20334
162740,universal,O,20334
162741,agreement,O,20334
162742,about,O,20334
162743,the,O,20334
162744,causes,O,20334
162745,nor,O,20334
162746,the,O,20334
162747,best,O,20334
162748,treatment,O,20334
162749,options,O,20334
162750,for,O,20334
162751,myopia,B-NAME_OF_DISEASE,20334
162752,there,O,20334
162753,is,O,20334
162754,increasing,O,20334
162755,evidence,O,20334
162756,that,O,20334
162757,creeping,O,20334
162758,myopia,B-NAME_OF_DISEASE,20334
162759,can,O,20334
162760,be,O,20334
162761,managed,O,20334
162762,Recently,O,20335
162763,groups,O,20335
162764,such,O,20335
162765,as,O,20335
162766,the,B-ORGANIZATION,20335
162767,Global,I-ORGANIZATION,20335
162768,Myopia,I-ORGANIZATION,20335
162769,Awareness,I-ORGANIZATION,20335
162770,Coalition,I-ORGANIZATION,20335
162771,GMAC,I-ORGANIZATION,20335
162772,and,O,20335
162773,the,B-ORGANIZATION,20335
162774,Brien,I-ORGANIZATION,20335
162775,Holden,I-ORGANIZATION,20335
162776,Vision,I-ORGANIZATION,20335
162777,Institute,I-ORGANIZATION,20335
162778,have,O,20335
162779,been,O,20335
162780,working,O,20335
162781,to,O,20335
162782,raise,O,20335
162783,awareness,O,20335
162784,among,O,20335
162785,optometrists,O,20335
162786,about,O,20335
162787,the,O,20335
162788,prevalence,O,20335
162789,of,O,20335
162790,myopia-not,O,20335
162791,only,O,20335
162792,in,O,20335
162793,the,B-GPE,20335
162794,US,I-GPE,20335
162795,but,O,20335
162796,worldwide,O,20335
162797,And,O,20336
162798,the,O,20336
162799,prevalence,O,20336
162800,of,O,20336
162801,myopia,B-NAME_OF_DISEASE,20336
162802,is,O,20336
162803,rising,O,20336
162804,rapidly,O,20336
162805,while,O,20336
162806,the,O,20336
162807,age,O,20336
162808,of,O,20336
162809,onset,O,20336
162810,is,O,20336
162811,coming,O,20336
162812,earlier,O,20336
162813,for,O,20336
162814,many,O,20336
162815,children,O,20336
162816,Myopia,B-NAME_OF_DISEASE,20337
162817,prevalence,O,20337
162818,in,O,20337
162819,the,O,20337
162820,5,O,20337
162821,to,O,20337
162822,19-years-old,O,20337
162823,age,O,20337
162824,group,O,20337
162825,of,O,20337
162826,American,O,20337
162827,children,O,20337
162828,is,O,20337
162829,42,O,20337
162830,percent,O,20337
162831,according,O,20337
162832,to,O,20337
162833,recent,O,20337
162834,research,O,20337
162835,Genetics,O,20338
162836,play,O,20338
162837,a,O,20338
162838,key,O,20338
162839,role,O,20338
162840,in,O,20338
162841,the,O,20338
162842,onset,O,20338
162843,of,O,20338
162844,myopia,B-NAME_OF_DISEASE,20338
162845,such,O,20338
162846,as,O,20338
162847,a,B-CAUSE_OF_DISEASE,20338
162848,family,I-CAUSE_OF_DISEASE,20338
162849,history,I-CAUSE_OF_DISEASE,20338
162850,of,I-CAUSE_OF_DISEASE,20338
162851,eyesight,I-CAUSE_OF_DISEASE,20338
162852,issues,I-CAUSE_OF_DISEASE,20338
162853,increasing,O,20338
162854,the,O,20338
162855,likelihood,O,20338
162856,of,O,20338
162857,a,O,20338
162858,childs,O,20338
162859,risk,O,20338
162860,of,O,20338
162861,myopia,B-NAME_OF_DISEASE,20338
162862,If,O,20339
162863,neither,O,20339
162864,parent,O,20339
162865,is,O,20339
162866,myopic,O,20339
162867,the,O,20339
162868,chance,O,20339
162869,the,O,20339
162870,child,O,20339
162871,will,O,20339
162872,develop,O,20339
162873,myopia,B-NAME_OF_DISEASE,20339
162874,is,O,20339
162875,lower,O,20339
162876,according,O,20339
162877,to,O,20339
162878,recent,O,20339
162879,research,O,20339
162880,But,O,20340
162881,if,O,20340
162882,one,O,20340
162883,parent,O,20340
162884,is,O,20340
162885,myopic,O,20340
162886,it,O,20340
162887,increases,O,20340
162888,the,O,20340
162889,childs,O,20340
162890,chance,O,20340
162891,of,O,20340
162892,developing,O,20340
162893,myopia,B-NAME_OF_DISEASE,20340
162894,by,O,20340
162895,three,O,20340
162896,times,O,20340
162897,and,O,20340
162898,this,O,20340
162899,doubles,O,20340
162900,to,O,20340
162901,six,O,20340
162902,times,O,20340
162903,if,O,20340
162904,both,O,20340
162905,parents,O,20340
162906,are,O,20340
162907,myopic,O,20340
162908,Myopia,B-NAME_OF_DISEASE,20341
162909,Management,O,20341
162910,in,O,20341
162911,Practice,O,20341
162912,What,O,20342
162913,all,O,20342
162914,these,O,20342
162915,statistics,O,20342
162916,mean,O,20342
162917,is,O,20342
162918,that,O,20342
162919,myopia,B-NAME_OF_DISEASE,20342
162920,management,O,20342
162921,represents,O,20342
162922,an,O,20342
162923,enormous,O,20342
162924,opportunity,O,20342
162925,for,O,20342
162926,optometry,O,20342
162927,a,O,20342
162928,health,O,20342
162929,care,O,20342
162930,profession,O,20342
162931,that,O,20342
162932,is,O,20342
162933,appropriately,O,20342
162934,positioned,O,20342
162935,with,O,20342
162936,clinical,O,20342
162937,skills,O,20342
162938,staffing,O,20342
162939,structure,O,20342
162940,and,O,20342
162941,professional,O,20342
162942,organization,O,20342
162943,and,O,20342
162944,support,O,20342
162945,to,O,20342
162946,defi,O,20342
162947,ne,O,20342
162948,and,O,20342
162949,deliver,O,20342
162950,the,O,20342
162951,highest,O,20342
162952,standards,O,20342
162953,of,O,20342
162954,care,O,20342
162955,According,O,20343
162956,to,O,20343
162957,Akerman,B-PERSON,20343
162958,there,O,20343
162959,are,O,20343
162960,a,O,20343
162961,few,O,20343
162962,key,O,20343
162963,principles,O,20343
162964,for,O,20343
162965,ODs,O,20343
162966,to,O,20343
162967,follow,O,20343
162968,on,O,20343
162969,the,O,20343
162970,path,O,20343
162971,to,O,20343
162972,an,O,20343
162973,effective,O,20343
162974,myopia,B-NAME_OF_DISEASE,20343
162975,management,O,20343
162976,program,O,20343
162977,They,O,20344
162978,are,O,20344
162979,being,O,20344
162980,proactive,O,20344
162981,identifying,O,20344
162982,risk,O,20344
162983,factors,O,20344
162984,providing,O,20344
162985,information,O,20344
162986,advice,O,20344
162987,and,O,20344
162988,recommendations,O,20344
162989,and,O,20344
162990,prescribing,O,20344
162991,appropriate,O,20344
162992,treatments,O,20344
162993,to,O,20344
162994,slow,O,20344
162995,progression,O,20344
162996,and,O,20344
162997,avoid,O,20344
162998,high,B-NAME_OF_DISEASE,20344
162999,myopia,I-NAME_OF_DISEASE,20344
163000,The,O,20345
163001,communication,O,20345
163002,approach,O,20345
163003,with,O,20345
163004,parents,O,20345
163005,and,O,20345
163006,children,O,20345
163007,also,O,20345
163008,plays,O,20345
163009,a,O,20345
163010,critical,O,20345
163011,role,O,20345
163012,in,O,20345
163013,a,O,20345
163014,myopia,B-NAME_OF_DISEASE,20345
163015,management,O,20345
163016,method,O,20345
163017,Akerman,B-PERSON,20346
163018,recommended,O,20346
163019,using,O,20346
163020,language,O,20346
163021,that,O,20346
163022,parents,O,20346
163023,can,O,20346
163024,easily,O,20346
163025,understand,O,20346
163026,and,O,20346
163027,creating,O,20346
163028,a,O,20346
163029,package,O,20346
163030,of,O,20346
163031,written,O,20346
163032,material,O,20346
163033,that,O,20346
163034,explains,O,20346
163035,the,O,20346
163036,eye,O,20346
163037,health,O,20346
163038,risks,O,20346
163039,of,O,20346
163040,myopia,B-NAME_OF_DISEASE,20346
163041,and,O,20346
163042,treatment,O,20346
163043,options,O,20346
163044,in,O,20346
163045,plain,O,20346
163046,language,O,20346
163047,The,O,20347
163048,materials,O,20347
163049,might,O,20347
163050,include,O,20347
163051,peer-reviewed,O,20347
163052,articles,O,20347
163053,but,O,20347
163054,not,O,20347
163055,too,O,20347
163056,many,O,20347
163057,he,O,20347
163058,said,O,20347
163059,and,O,20347
163060,its,O,20347
163061,also,O,20347
163062,important,O,20347
163063,to,O,20347
163064,explain,O,20347
163065,to,O,20347
163066,parents,O,20347
163067,that,O,20347
163068,myopia,B-NAME_OF_DISEASE,20347
163069,care,O,20347
163070,similar,O,20347
163071,to,O,20347
163072,orthodontia,O,20347
163073,may,O,20347
163074,not,O,20347
163075,be,O,20347
163076,covered,O,20347
163077,by,O,20347
163078,insurance,O,20347
163079,Research,O,20348
163080,indicates,O,20348
163081,that,O,20348
163082,each,O,20348
163083,diopter,O,20348
163084,in,O,20348
163085,treatment,O,20348
163086,regimens,O,20348
163087,matters,O,20348
163088,and,O,20348
163089,that,O,20348
163090,slowing,O,20348
163091,myopia,B-NAME_OF_DISEASE,20348
163092,by,O,20348
163093,1,O,20348
163094,diopter,O,20348
163095,should,O,20348
163096,reduce,O,20348
163097,the,O,20348
163098,likelihood,O,20348
163099,of,O,20348
163100,a,O,20348
163101,patient,O,20348
163102,developing,O,20348
163103,myopic,B-NAME_OF_DISEASE,20348
163104,maculopathy,I-NAME_OF_DISEASE,20348
163105,by,O,20348
163106,40,O,20348
163107,percent,O,20348
163108,Additionally,O,20349
163109,this,O,20349
163110,treatment,O,20349
163111,benefi,O,20349
163112,t,O,20349
163113,accrues,O,20349
163114,regardless,O,20349
163115,of,O,20349
163116,the,O,20349
163117,level,O,20349
163118,of,O,20349
163119,myopia,B-NAME_OF_DISEASE,20349
163120,the,O,20349
163121,research,O,20349
163122,notes,O,20349
163123,Akerman,B-PERSON,20350
163124,noted,O,20350
163125,that,O,20350
163126,this,O,20350
163127,myopia,B-NAME_OF_DISEASE,20350
163128,pandemic,O,20350
163129,is,O,20350
163130,global,O,20350
163131,and,O,20350
163132,increasingly,O,20350
163133,affects,O,20350
163134,children,O,20350
163135,in,O,20350
163136,the,B-GPE,20350
163137,US,I-GPE,20350
163138,as,O,20350
163139,well,O,20350
163140,A,O,20351
163141,journal,O,20351
163142,paper,O,20351
163143,published,O,20351
163144,two,O,20351
163145,years,O,20351
163146,ago,O,20351
163147,that,O,20351
163148,looked,O,20351
163149,at,O,20351
163150,the,O,20351
163151,prevalence,O,20351
163152,of,O,20351
163153,myopia,B-NAME_OF_DISEASE,20351
163154,among,O,20351
163155,teenagers,O,20351
163156,found,O,20351
163157,that,O,20351
163158,rate,O,20351
163159,at,O,20351
163160,42,O,20351
163161,percent,O,20351
163162,This,O,20352
163163,is,O,20352
163164,not,O,20352
163165,just,O,20352
163166,an,O,20352
163167,East,O,20352
163168,Asian,O,20352
163169,problem,O,20352
163170,its,O,20352
163171,a,O,20352
163172,global,O,20352
163173,problem,O,20352
163174,and,O,20352
163175,it,O,20352
163176,is,O,20352
163177,affecting,O,20352
163178,the,B-GPE,20352
163179,US,I-GPE,20352
163180,practitioners,O,20352
163181,as,O,20352
163182,well,O,20352
163183,Akerman,B-PERSON,20352
163184,said,O,20352
163185,So,O,20353
163186,slowly,O,20353
163187,but,O,20353
163188,surely,O,20353
163189,US,B-GPE,20353
163190,practitioners,O,20353
163191,are,O,20353
163192,realizing,O,20353
163193,that,O,20353
163194,Ok,O,20353
163195,I,O,20353
163196,am,O,20353
163197,seeing,O,20353
163198,these,O,20353
163199,patients,O,20353
163200,in,O,20353
163201,my,O,20353
163202,practice,O,20353
163203,and,O,20353
163204,perhaps,O,20353
163205,I,O,20353
163206,should,O,20353
163207,do,O,20353
163208,something,O,20353
163209,The,O,20354
163210,First,O,20354
163211,FDA,B-ORGANIZATION,20354
163212,Approved,O,20354
163213,Treatment,O,20354
163214,Before,O,20354
163215,Nov,O,20354
163216,15,O,20354
163217,2019,O,20354
163218,the,O,20354
163219,date,O,20354
163220,the,B-ORGANIZATION,20354
163221,Food,I-ORGANIZATION,20354
163222,and,I-ORGANIZATION,20354
163223,Drug,I-ORGANIZATION,20354
163224,Administration,I-ORGANIZATION,20354
163225,approved,O,20354
163226,the,B-TREATMENT,20354
163227,CooperVision,I-TREATMENT,20354
163228,MiSight,I-TREATMENT,20354
163229,1,I-TREATMENT,20354
163230,day,I-TREATMENT,20354
163231,lens,I-TREATMENT,20354
163232,the,O,20354
163233,treatments,O,20354
163234,for,O,20354
163235,myopia,B-NAME_OF_DISEASE,20354
163236,in,O,20354
163237,the,B-GPE,20354
163238,US,I-GPE,20354
163239,were,O,20354
163240,considered,O,20354
163241,off-label,O,20354
163242,prescribing,O,20354
163243,So,O,20355
163244,whether,O,20355
163245,an,O,20355
163246,ECP,O,20355
163247,wanted,O,20355
163248,to,O,20355
163249,prescribe,O,20355
163250,orthokeratology,B-TREATMENT,20355
163251,or,O,20355
163252,myopia,B-TREATMENT,20355
163253,control,I-TREATMENT,20355
163254,soft,I-TREATMENT,20355
163255,lenses,I-TREATMENT,20355
163256,or,O,20355
163257,even,O,20355
163258,low-dose,B-NAME_OF_DRUG,20355
163259,atropine,I-NAME_OF_DRUG,20355
163260,it,O,20355
163261,had,O,20355
163262,to,O,20355
163263,be,O,20355
163264,done,O,20355
163265,in,O,20355
163266,an,O,20355
163267,offlabel,O,20355
163268,process,O,20355
163269,which,O,20355
163270,requires,O,20355
163271,a,O,20355
163272,signed,O,20355
163273,consent,O,20355
163274,form,O,20355
163275,Practitioners,O,20356
163276,are,O,20356
163277,hesitant,O,20356
163278,to,O,20356
163279,pull,O,20356
163280,out,O,20356
163281,these,O,20356
163282,informed,O,20356
163283,consent,O,20356
163284,forms,O,20356
163285,and,O,20356
163286,ask,O,20356
163287,the,O,20356
163288,parents,O,20356
163289,to,O,20356
163290,sign,O,20356
163291,it,O,20356
163292,Akerman,B-PERSON,20356
163293,noted,O,20356
163294,This,O,20357
163295,has,O,20357
163296,slowed,O,20357
163297,the,O,20357
163298,progress,O,20357
163299,and,O,20357
163300,uptake,O,20357
163301,of,O,20357
163302,myopia,B-NAME_OF_DISEASE,20357
163303,control,O,20357
163304,Most,O,20358
163305,practitioners,O,20358
163306,today,O,20358
163307,in,O,20358
163308,the,B-GPE,20358
163309,US,I-GPE,20358
163310,are,O,20358
163311,taking,O,20358
163312,a,O,20358
163313,kind,O,20358
163314,of,O,20358
163315,wait,O,20358
163316,and,O,20358
163317,see,O,20358
163318,attitude,O,20358
163319,but,O,20358
163320,awareness,O,20358
163321,is,O,20358
163322,growing,O,20358
163323,he,O,20358
163324,said,O,20358
163325,And,O,20359
163326,now,O,20359
163327,that,O,20359
163328,CooperVision,B-ORGANIZATION,20359
163329,has,O,20359
163330,FDA,B-ORGANIZATION,20359
163331,approval,O,20359
163332,for,O,20359
163333,the,B-TREATMENT,20359
163334,MiSight,I-TREATMENT,20359
163335,lens,I-TREATMENT,20359
163336,I,O,20359
163337,think,O,20359
163338,that,O,20359
163339,will,O,20359
163340,go,O,20359
163341,a,O,20359
163342,long,O,20359
163343,way,O,20359
163344,toward,O,20359
163345,getting,O,20359
163346,practitioners,O,20359
163347,behind,O,20359
163348,myopia,B-NAME_OF_DISEASE,20359
163349,control,O,20359
163350,and,O,20359
163351,proactively,O,20359
163352,prescribing,O,20359
163353,We,O,20360
163354,now,O,20360
163355,have,O,20360
163356,a,O,20360
163357,product,O,20360
163358,a,O,20360
163359,specifi,O,20360
163360,c,O,20360
163361,product,O,20360
163362,that,O,20360
163363,has,O,20360
163364,been,O,20360
163365,well-tested,O,20360
163366,and,O,20360
163367,approved,O,20360
163368,by,O,20360
163369,the,B-ORGANIZATION,20360
163370,FDA,I-ORGANIZATION,20360
163371,with,O,20360
163372,a,O,20360
163373,specifi,O,20360
163374,c,O,20360
163375,labeling,O,20360
163376,indication,O,20360
163377,for,O,20360
163378,myopia,B-NAME_OF_DISEASE,20360
163379,control,O,20360
163380,There,O,20361
163381,are,O,20361
163382,several,O,20361
163383,other,O,20361
163384,products,O,20361
163385,for,O,20361
163386,the,O,20361
163387,treatment,O,20361
163388,of,O,20361
163389,myopia,B-NAME_OF_DISEASE,20361
163390,that,O,20361
163391,are,O,20361
163392,seeking,O,20361
163393,regulatory,O,20361
163394,approval,O,20361
163395,These,O,20362
163396,include,O,20362
163397,three,O,20362
163398,topical,B-NAME_OF_DRUG,20362
163399,low-dose,I-NAME_OF_DRUG,20362
163400,atropine,I-NAME_OF_DRUG,20362
163401,products,O,20362
163402,that,O,20362
163403,are,O,20362
163404,in,O,20362
163405,clinical,O,20362
163406,trials,O,20362
163407,in,O,20362
163408,their,O,20362
163409,efforts,O,20362
163410,to,O,20362
163411,gain,O,20362
163412,a,O,20362
163413,labeling,O,20362
163414,indication,O,20362
163415,for,O,20362
163416,myopia,B-NAME_OF_DISEASE,20362
163417,management,O,20362
163418,Once,O,20363
163419,any,O,20363
163420,of,O,20363
163421,these,O,20363
163422,three,O,20363
163423,topical,O,20363
163424,products,O,20363
163425,are,O,20363
163426,commercially,O,20363
163427,available,O,20363
163428,with,O,20363
163429,a,O,20363
163430,labeling,O,20363
163431,indication,O,20363
163432,that,O,20363
163433,will,O,20363
163434,support,O,20363
163435,the,O,20363
163436,effort,O,20363
163437,to,O,20363
163438,increase,O,20363
163439,myopia,B-NAME_OF_DISEASE,20363
163440,awareness,O,20363
163441,In,O,20364
163442,addition,O,20364
163443,Visioneering,B-ORGANIZATION,20364
163444,Technologies,I-ORGANIZATION,20364
163445,Inc,I-ORGANIZATION,20364
163446,has,O,20364
163447,developed,O,20364
163448,a,B-TREATMENT,20364
163449,one-day,I-TREATMENT,20364
163450,multifocal,I-TREATMENT,20364
163451,contact,I-TREATMENT,20364
163452,lens,I-TREATMENT,20364
163453,that,O,20364
163454,has,O,20364
163455,been,O,20364
163456,shown,O,20364
163457,to,O,20364
163458,slow,O,20364
163459,the,O,20364
163460,progression,O,20364
163461,of,O,20364
163462,myopia,B-NAME_OF_DISEASE,20364
163463,This,O,20365
163464,lens,O,20365
163465,has,O,20365
163466,a,O,20365
163467,CE,O,20365
163468,mark-which,O,20365
163469,means,O,20365
163470,it,O,20365
163471,is,O,20365
163472,a,O,20365
163473,medical,O,20365
163474,device,O,20365
163475,made,O,20365
163476,to,O,20365
163477,meet,O,20365
163478,the,O,20365
163479,requirements,O,20365
163480,of,O,20365
163481,the,O,20365
163482,Medical,O,20365
163483,Devices,O,20365
163484,Directive,O,20365
163485,MDD,O,20365
163486,but,O,20365
163487,it,O,20365
163488,does,O,20365
163489,not,O,20365
163490,have,O,20365
163491,an,O,20365
163492,approved,O,20365
163493,FDA,B-ORGANIZATION,20365
163494,indication,O,20365
163495,for,O,20365
163496,myopia,B-NAME_OF_DISEASE,20365
163497,An,O,20366
163498,often-used,O,20366
163499,approach,O,20366
163500,to,O,20366
163501,treating,O,20366
163502,myopia,B-NAME_OF_DISEASE,20366
163503,in,O,20366
163504,the,B-GPE,20366
163505,US,I-GPE,20366
163506,is,O,20366
163507,the,O,20366
163508,specialty,O,20366
163509,rigid,O,20366
163510,lenses,O,20366
163511,that,O,20366
163512,have,O,20366
163513,been,O,20366
163514,shown,O,20366
163515,to,O,20366
163516,lessen,O,20366
163517,progression,O,20366
163518,in,O,20366
163519,children,O,20366
163520,Orthokeratology,B-TREATMENT,20367
163521,ortho-k,I-TREATMENT,20367
163522,lenses,I-TREATMENT,20367
163523,are,O,20367
163524,worn,O,20367
163525,at,O,20367
163526,night,O,20367
163527,and,O,20367
163528,change,O,20367
163529,the,O,20367
163530,corneal,O,20367
163531,topography,O,20367
163532,to,O,20367
163533,correct,O,20367
163534,low,O,20367
163535,to,O,20367
163536,moderate,O,20367
163537,amounts,O,20367
163538,of,O,20367
163539,myopia,B-NAME_OF_DISEASE,20367
163540,Also,O,20368
163541,Hoya,B-ORGANIZATION,20368
163542,Essilor,B-ORGANIZATION,20368
163543,and,O,20368
163544,Zeiss,B-ORGANIZATION,20368
163545,are,O,20368
163546,all,O,20368
163547,actively,O,20368
163548,conducting,O,20368
163549,research,O,20368
163550,on,O,20368
163551,whether,O,20368
163552,spectacle,O,20368
163553,lenses,O,20368
163554,can,O,20368
163555,be,O,20368
163556,used,O,20368
163557,to,O,20368
163558,treat,O,20368
163559,myopia,B-NAME_OF_DISEASE,20368
163560,Hoya,B-ORGANIZATION,20369
163561,has,O,20369
163562,licensed,O,20369
163563,technology,O,20369
163564,that,O,20369
163565,it,O,20369
163566,calls,O,20369
163567,MyoSmart,B-TREATMENT,20369
163568,spectacle,I-TREATMENT,20369
163569,lens,I-TREATMENT,20369
163570,This,B-TREATMENT,20370
163571,lens,I-TREATMENT,20370
163572,with,I-TREATMENT,20370
163573,Defocus,I-TREATMENT,20370
163574,Incorporated,I-TREATMENT,20370
163575,Multiple,I-TREATMENT,20370
163576,Segments,I-TREATMENT,20370
163577,or,I-TREATMENT,20370
163578,DIMS,I-TREATMENT,20370
163579,has,O,20370
163580,been,O,20370
163581,shown,O,20370
163582,in,O,20370
163583,a,O,20370
163584,randomized,O,20370
163585,clinical,O,20370
163586,trial,O,20370
163587,conducted,O,20370
163588,in,O,20370
163589,Hong,B-GPE,20370
163590,Kong,I-GPE,20370
163591,to,O,20370
163592,slow,O,20370
163593,progression,O,20370
163594,of,O,20370
163595,myopia,B-NAME_OF_DISEASE,20370
163596,by,O,20370
163597,about,O,20370
163598,60,O,20370
163599,percent,O,20370
163600,according,O,20370
163601,to,O,20370
163602,Akerman,B-PERSON,20370
163603,People,O,20371
163604,are,O,20371
163605,really,O,20371
163606,excited,O,20371
163607,about,O,20371
163608,this,O,20371
163609,he,O,20371
163610,added,O,20371
163611,noting,O,20371
163612,that,O,20371
163613,the,O,20371
163614,lens,O,20371
163615,is,O,20371
163616,commercially,O,20371
163617,available,O,20371
163618,in,O,20371
163619,China,B-GPE,20371
163620,and,O,20371
163621,Hong,B-GPE,20371
163622,Kong,I-GPE,20371
163623,now,O,20371
163624,Time,O,20372
163625,spent,O,20372
163626,outdoors,O,20372
163627,has,O,20372
163628,been,O,20372
163629,shown,O,20372
163630,to,O,20372
163631,be,O,20372
163632,protective,O,20372
163633,against,O,20372
163634,myopia,B-NAME_OF_DISEASE,20372
163635,also,O,20372
163636,potentially,O,20372
163637,due,O,20372
163638,to,O,20372
163639,light,O,20372
163640,stimulation,O,20372
163641,of,O,20372
163642,retinal,O,20372
163643,dopamine,B-NAME_OF_DRUG,20372
163644,Most,O,20373
163645,people,O,20373
163646,who,O,20373
163647,have,O,20373
163648,open-angle,B-NAME_OF_DISEASE,20373
163649,glaucoma,I-NAME_OF_DISEASE,20373
163650,feel,O,20373
163651,fine,O,20373
163652,and,O,20373
163653,do,O,20373
163654,not,O,20373
163655,notice,O,20373
163656,a,O,20373
163657,change,O,20373
163658,in,O,20373
163659,their,O,20373
163660,vision,O,20373
163661,at,O,20373
163662,first,O,20373
163663,because,O,20373
163664,the,O,20373
163665,initial,O,20373
163666,loss,O,20373
163667,of,O,20373
163668,vision,O,20373
163669,is,O,20373
163670,of,O,20373
163671,side,O,20373
163672,or,O,20373
163673,peripheral,O,20373
163674,vision,O,20373
163675,and,O,20373
163676,the,O,20373
163677,visual,O,20373
163678,acuity,O,20373
163679,or,O,20373
163680,sharpness,O,20373
163681,of,O,20373
163682,vision,O,20373
163683,is,O,20373
163684,maintained,O,20373
163685,until,O,20373
163686,late,O,20373
163687,in,O,20373
163688,the,O,20373
163689,disease,O,20373
163690,By,O,20374
163691,the,O,20374
163692,time,O,20374
163693,a,O,20374
163694,patient,O,20374
163695,is,O,20374
163696,aware,O,20374
163697,of,O,20374
163698,vision,B-SIGN_AND_SYMPTOM,20374
163699,loss,I-SIGN_AND_SYMPTOM,20374
163700,the,O,20374
163701,disease,O,20374
163702,is,O,20374
163703,usually,O,20374
163704,quite,O,20374
163705,advanced,O,20374
163706,Without,O,20375
163707,proper,O,20375
163708,treatment,O,20375
163709,glaucoma,B-NAME_OF_DISEASE,20375
163710,can,O,20375
163711,lead,O,20375
163712,to,O,20375
163713,blindness,B-NAME_OF_DISEASE,20375
163714,Because,O,20376
163715,open-angle,B-NAME_OF_DISEASE,20376
163716,glaucoma,I-NAME_OF_DISEASE,20376
163717,has,O,20376
163718,few,O,20376
163719,warning,O,20376
163720,signs,O,20376
163721,or,O,20376
163722,symptoms,O,20376
163723,before,O,20376
163724,damage,O,20376
163725,has,O,20376
163726,occurred,O,20376
163727,it,O,20376
163728,is,O,20376
163729,important,O,20376
163730,to,O,20376
163731,see,O,20376
163732,a,O,20376
163733,doctor,O,20376
163734,for,O,20376
163735,regular,O,20376
163736,eye,B-DIAGNOSTIC_TEST,20376
163737,examinations,I-DIAGNOSTIC_TEST,20376
163738,If,O,20377
163739,glaucoma,B-NAME_OF_DISEASE,20377
163740,is,O,20377
163741,detected,O,20377
163742,during,O,20377
163743,an,B-DIAGNOSTIC_TEST,20377
163744,eye,I-DIAGNOSTIC_TEST,20377
163745,exam,I-DIAGNOSTIC_TEST,20377
163746,the,O,20377
163747,eye,O,20377
163748,doctor,O,20377
163749,can,O,20377
163750,prescribe,O,20377
163751,a,O,20377
163752,preventative,O,20377
163753,treatment,O,20377
163754,to,O,20377
163755,help,O,20377
163756,protect,O,20377
163757,vision,O,20377
163758,In,O,20378
163759,open-angle,B-NAME_OF_DISEASE,20378
163760,glaucoma,I-NAME_OF_DISEASE,20378
163761,the,O,20378
163762,angle,O,20378
163763,in,O,20378
163764,the,O,20378
163765,eye,O,20378
163766,where,O,20378
163767,the,B-PART_OF_THE_EYES,20378
163768,iris,I-PART_OF_THE_EYES,20378
163769,meets,O,20378
163770,the,B-PART_OF_THE_EYES,20378
163771,cornea,I-PART_OF_THE_EYES,20378
163772,is,O,20378
163773,as,O,20378
163774,wide,O,20378
163775,and,O,20378
163776,open,O,20378
163777,as,O,20378
163778,it,O,20378
163779,should,O,20378
163780,be,O,20378
163781,but,O,20378
163782,the,B-PART_OF_THE_EYES,20378
163783,eyes,I-PART_OF_THE_EYES,20378
163784,drainage,I-PART_OF_THE_EYES,20378
163785,canals,I-PART_OF_THE_EYES,20378
163786,become,O,20378
163787,clogged,O,20378
163788,over,O,20378
163789,time,O,20378
163790,causing,O,20378
163791,an,B-SIGN_AND_SYMPTOM,20378
163792,increase,I-SIGN_AND_SYMPTOM,20378
163793,in,I-SIGN_AND_SYMPTOM,20378
163794,internal,I-SIGN_AND_SYMPTOM,20378
163795,eye,I-SIGN_AND_SYMPTOM,20378
163796,pressure,I-SIGN_AND_SYMPTOM,20378
163797,and,O,20378
163798,subsequent,O,20378
163799,damage,B-SIGN_AND_SYMPTOM,20378
163800,to,I-SIGN_AND_SYMPTOM,20378
163801,the,I-SIGN_AND_SYMPTOM,20378
163802,optic,I-SIGN_AND_SYMPTOM,20378
163803,nerve,I-SIGN_AND_SYMPTOM,20378
163804,It,O,20379
163805,is,O,20379
163806,the,O,20379
163807,most,O,20379
163808,common,O,20379
163809,type,O,20379
163810,of,O,20379
163811,glaucoma,B-NAME_OF_DISEASE,20379
163812,affecting,O,20379
163813,millions,O,20379
163814,many,O,20379
163815,of,O,20379
163816,whom,O,20379
163817,do,O,20379
163818,not,O,20379
163819,know,O,20379
163820,they,O,20379
163821,have,O,20379
163822,the,O,20379
163823,disease,O,20379
163824,There,O,20380
163825,are,O,20380
163826,many,O,20380
163827,effective,O,20380
163828,and,O,20380
163829,different,O,20380
163830,treatments,O,20380
163831,for,O,20380
163832,open-angle,B-NAME_OF_DISEASE,20380
163833,glaucoma,I-NAME_OF_DISEASE,20380
163834,but,O,20380
163835,the,O,20380
163836,one,O,20380
163837,unifying,O,20380
163838,concept,O,20380
163839,is,O,20380
163840,that,O,20380
163841,all,O,20380
163842,current,O,20380
163843,treatments,O,20380
163844,are,O,20380
163845,designed,O,20380
163846,to,O,20380
163847,lower,B-TREATMENT,20380
163848,eye,I-TREATMENT,20380
163849,pressure,I-TREATMENT,20380
163850,Treatments,O,20381
163851,for,O,20381
163852,open-angle,B-NAME_OF_DISEASE,20381
163853,glaucoma,I-NAME_OF_DISEASE,20381
163854,include,O,20381
163855,medications,B-TREATMENT,20381
163856,usually,O,20381
163857,eye,B-TREATMENT,20381
163858,drops,I-TREATMENT,20381
163859,laser,B-TREATMENT,20381
163860,trabeculoplasty,I-TREATMENT,20381
163861,a,O,20381
163862,procedure,O,20381
163863,that,O,20381
163864,improves,O,20381
163865,drainage,O,20381
163866,of,O,20381
163867,eye,O,20381
163868,fluid,O,20381
163869,through,O,20381
163870,the,O,20381
163871,spongy,O,20381
163872,tissue,O,20381
163873,located,O,20381
163874,near,O,20381
163875,the,B-PART_OF_THE_EYES,20381
163876,cornea,I-PART_OF_THE_EYES,20381
163877,called,O,20381
163878,the,B-PART_OF_THE_EYES,20381
163879,trabecular,I-PART_OF_THE_EYES,20381
163880,meshwork,I-PART_OF_THE_EYES,20381
163881,and,O,20381
163882,surgery,B-TREATMENT,20381
163883,There,O,20382
163884,is,O,20382
163885,also,O,20382
163886,research,O,20382
163887,some,O,20382
163888,in,O,20382
163889,clinical,O,20382
163890,trials,O,20382
163891,already,O,20382
163892,for,O,20382
163893,new,O,20382
163894,treatments,O,20382
163895,that,O,20382
163896,do,O,20382
163897,not,O,20382
163898,focus,O,20382
163899,only,O,20382
163900,on,O,20382
163901,lowering,B-TREATMENT,20382
163902,eye,I-TREATMENT,20382
163903,pressure,I-TREATMENT,20382
163904,but,O,20382
163905,also,O,20382
163906,on,O,20382
163907,promoting,O,20382
163908,the,O,20382
163909,health,O,20382
163910,of,O,20382
163911,the,B-PART_OF_THE_EYES,20382
163912,optic,I-PART_OF_THE_EYES,20382
163913,nerve,I-PART_OF_THE_EYES,20382
163914,Glaucoma,B-NAME_OF_DISEASE,20383
163915,causes,O,20383
163916,irreversible,B-NAME_OF_DISEASE,20383
163917,blindness,I-NAME_OF_DISEASE,20383
163918,and,O,20383
163919,it,O,20383
163920,is,O,20383
163921,caused,O,20383
163922,by,O,20383
163923,ocular,B-CAUSE_OF_DISEASE,20383
163924,hypertension,I-CAUSE_OF_DISEASE,20383
163925,which,O,20383
163926,damages,B-SIGN_AND_SYMPTOM,20383
163927,the,I-SIGN_AND_SYMPTOM,20383
163928,optic,I-SIGN_AND_SYMPTOM,20383
163929,nerve,I-SIGN_AND_SYMPTOM,20383
163930,and,O,20383
163931,results,O,20383
163932,in,O,20383
163933,visual,B-SIGN_AND_SYMPTOM,20383
163934,field,I-SIGN_AND_SYMPTOM,20383
163935,loss,I-SIGN_AND_SYMPTOM,20383
163936,There,O,20384
163937,is,O,20384
163938,no,O,20384
163939,cure,O,20384
163940,but,O,20384
163941,the,O,20384
163942,disease,O,20384
163943,can,O,20384
163944,be,O,20384
163945,managed,O,20384
163946,with,O,20384
163947,pharmacologic,B-TREATMENT,20384
163948,therapies,I-TREATMENT,20384
163949,among,O,20384
163950,other,O,20384
163951,more,O,20384
163952,invasive,B-TREATMENT,20384
163953,treatments,I-TREATMENT,20384
163954,that,I-TREATMENT,20384
163955,lower,I-TREATMENT,20384
163956,and,I-TREATMENT,20384
163957,stabilize,I-TREATMENT,20384
163958,intraocular,I-TREATMENT,20384
163959,pressure,I-TREATMENT,20384
163960,IOP,I-TREATMENT,20384
163961,Joseph,B-PERSON,20385
163962,F,I-PERSON,20385
163963,Panarelli,I-PERSON,20385
163964,MD,I-PERSON,20385
163965,associate,I-PERSON,20385
163966,professor,I-PERSON,20385
163967,in,O,20385
163968,the,B-ORGANIZATION,20385
163969,Department,I-ORGANIZATION,20385
163970,of,I-ORGANIZATION,20385
163971,Ophthalmology,I-ORGANIZATION,20385
163972,at,I-ORGANIZATION,20385
163973,NYU,I-ORGANIZATION,20385
163974,Langone,I-ORGANIZATION,20385
163975,Medical,I-ORGANIZATION,20385
163976,Center,I-ORGANIZATION,20385
163977,New,B-GPE,20385
163978,York,I-GPE,20385
163979,and,O,20385
163980,Sahar,B-PERSON,20385
163981,Bedrood,I-PERSON,20385
163982,MD,I-PERSON,20385
163983,PhD,I-PERSON,20385
163984,a,O,20385
163985,glaucoma,B-NAME_OF_DISEASE,20385
163986,specialist,O,20385
163987,at,O,20385
163988,Acuity,B-ORGANIZATION,20385
163989,Eye,I-ORGANIZATION,20385
163990,Group,I-ORGANIZATION,20385
163991,and,O,20385
163992,assistant,O,20385
163993,professor,O,20385
163994,of,O,20385
163995,clinical,O,20385
163996,ophthalmology,O,20385
163997,at,O,20385
163998,the,B-TREATMENT,20385
163999,USC,I-TREATMENT,20385
164000,Roski,I-TREATMENT,20385
164001,Eye,I-TREATMENT,20385
164002,Institute,I-TREATMENT,20385
164003,Los,B-GPE,20385
164004,Angeles,I-GPE,20385
164005,recently,O,20385
164006,spoke,O,20385
164007,on,O,20385
164008,the,O,20385
164009,current,O,20385
164010,state,O,20385
164011,and,O,20385
164012,future,O,20385
164013,of,O,20385
164014,glaucoma,B-TREATMENT,20385
164015,therapy,I-TREATMENT,20385
164016,and,O,20385
164017,how,O,20385
164018,compliance,O,20385
164019,may,O,20385
164020,not,O,20385
164021,be,O,20385
164022,an,O,20385
164023,issue,O,20385
164024,in,O,20385
164025,the,O,20385
164026,coming,O,20385
164027,years,O,20385
164028,IOP,O,20386
164029,Glaucoma,B-NAME_OF_DISEASE,20386
164030,Progression,O,20386
164031,IOP,B-CAUSE_OF_DISEASE,20387
164032,reduction,I-CAUSE_OF_DISEASE,20387
164033,is,O,20387
164034,the,O,20387
164035,only,O,20387
164036,known,O,20387
164037,modifiable,O,20387
164038,risk,O,20387
164039,factor,O,20387
164040,for,O,20387
164041,open-angle,B-NAME_OF_DISEASE,20387
164042,glaucoma,I-NAME_OF_DISEASE,20387
164043,However,O,20388
164044,studies,O,20388
164045,have,O,20388
164046,shown,O,20388
164047,that,O,20388
164048,disease,O,20388
164049,progression,O,20388
164050,and,O,20388
164051,blindness,B-NAME_OF_DISEASE,20388
164052,are,O,20388
164053,still,O,20388
164054,possible,O,20388
164055,even,O,20388
164056,in,O,20388
164057,patients,O,20388
164058,on,O,20388
164059,maximum,O,20388
164060,medical,O,20388
164061,therapy,O,20388
164062,How,O,20389
164063,IOP,O,20389
164064,factors,O,20389
164065,into,O,20389
164066,visual,B-SIGN_AND_SYMPTOM,20389
164067,field,I-SIGN_AND_SYMPTOM,20389
164068,loss,I-SIGN_AND_SYMPTOM,20389
164069,isnt,O,20389
164070,entirely,O,20389
164071,clear,O,20389
164072,According,O,20390
164073,to,O,20390
164074,Dr,B-PERSON,20390
164075,Bedrood,I-PERSON,20390
164076,one,O,20390
164077,theory-known,O,20390
164078,as,O,20390
164079,the,O,20390
164080,stress,O,20390
164081,strain,O,20390
164082,model-is,O,20390
164083,that,O,20390
164084,IOP,O,20390
164085,strains,O,20390
164086,the,B-PART_OF_THE_EYES,20390
164087,sclera,I-PART_OF_THE_EYES,20390
164088,and,O,20390
164089,optic,B-PART_OF_THE_EYES,20390
164090,nerve,I-PART_OF_THE_EYES,20390
164091,causing,O,20390
164092,apoptosis,B-SIGN_AND_SYMPTOM,20390
164093,and,I-SIGN_AND_SYMPTOM,20390
164094,loss,I-SIGN_AND_SYMPTOM,20390
164095,of,I-SIGN_AND_SYMPTOM,20390
164096,retinal,I-SIGN_AND_SYMPTOM,20390
164097,ganglion,I-SIGN_AND_SYMPTOM,20390
164098,cells,I-SIGN_AND_SYMPTOM,20390
164099,Another,O,20391
164100,theory-the,O,20391
164101,vascular,O,20391
164102,theory-is,O,20391
164103,when,O,20391
164104,the,O,20391
164105,blood,O,20391
164106,vessels,O,20391
164107,in,O,20391
164108,the,B-PART_OF_THE_EYES,20391
164109,optic,I-PART_OF_THE_EYES,20391
164110,nerve,I-PART_OF_THE_EYES,20391
164111,dont,O,20391
164112,get,O,20391
164113,enough,O,20391
164114,oxygen,B-CHEMICAL_COMPOUND,20391
164115,which,O,20391
164116,leads,O,20391
164117,to,O,20391
164118,apoptosis,B-SIGN_AND_SYMPTOM,20391
164119,nerve,I-SIGN_AND_SYMPTOM,20391
164120,fiber,I-SIGN_AND_SYMPTOM,20391
164121,layer,I-SIGN_AND_SYMPTOM,20391
164122,loss,I-SIGN_AND_SYMPTOM,20391
164123,and,I-SIGN_AND_SYMPTOM,20391
164124,eventually,I-SIGN_AND_SYMPTOM,20391
164125,visual,I-SIGN_AND_SYMPTOM,20391
164126,field,I-SIGN_AND_SYMPTOM,20391
164127,loss,I-SIGN_AND_SYMPTOM,20391
164128,No,O,20392
164129,two,O,20392
164130,cases,O,20392
164131,of,O,20392
164132,glaucoma,B-NAME_OF_DISEASE,20392
164133,are,O,20392
164134,alike,O,20392
164135,and,O,20392
164136,progression,O,20392
164137,rates,O,20392
164138,vary,O,20392
164139,from,O,20392
164140,person,O,20392
164141,to,O,20392
164142,person,O,20392
164143,Some,O,20393
164144,patients,O,20393
164145,who,O,20393
164146,have,O,20393
164147,a,O,20393
164148,very,O,20393
164149,strong,O,20393
164150,genetic,O,20393
164151,component,O,20393
164152,are,O,20393
164153,going,O,20393
164154,to,O,20393
164155,progress,O,20393
164156,very,O,20393
164157,quickly,O,20393
164158,and,O,20393
164159,some,O,20393
164160,not,O,20393
164161,so,O,20393
164162,much,O,20393
164163,Dr,B-PERSON,20393
164164,Bedrood,I-PERSON,20393
164165,said,O,20393
164166,Co-morbidities,O,20394
164167,such,O,20394
164168,as,O,20394
164169,sleep,B-CAUSE_OF_DISEASE,20394
164170,apnea,I-CAUSE_OF_DISEASE,20394
164171,and,O,20394
164172,IOP,B-CAUSE_OF_DISEASE,20394
164173,fluctuations,I-CAUSE_OF_DISEASE,20394
164174,are,O,20394
164175,other,O,20394
164176,risk,O,20394
164177,factors,O,20394
164178,for,O,20394
164179,visual,O,20394
164180,field,O,20394
164181,progression,O,20394
164182,and,O,20394
164183,greater,O,20394
164184,visual,B-SIGN_AND_SYMPTOM,20394
164185,field,I-SIGN_AND_SYMPTOM,20394
164186,loss,I-SIGN_AND_SYMPTOM,20394
164187,in,O,20394
164188,certain,O,20394
164189,patients,O,20394
164190,After,O,20395
164191,10-plus,B-TIME_DURATION,20395
164192,years,I-TIME_DURATION,20395
164193,of,O,20395
164194,treatment,O,20395
164195,some,O,20395
164196,of,O,20395
164197,those,O,20395
164198,treatments,O,20395
164199,that,O,20395
164200,initially,O,20395
164201,worked,O,20395
164202,may,O,20395
164203,not,O,20395
164204,work,O,20395
164205,as,O,20395
164206,well,O,20395
164207,Dr,B-PERSON,20395
164208,Bedrood,I-PERSON,20395
164209,said,O,20395
164210,Sometimes,O,20396
164211,patients,O,20396
164212,respond,O,20396
164213,really,O,20396
164214,well,O,20396
164215,in,O,20396
164216,the,O,20396
164217,beginning,O,20396
164218,and,O,20396
164219,then,O,20396
164220,over,B-TIME_DURATION,20396
164221,a,I-TIME_DURATION,20396
164222,couple,I-TIME_DURATION,20396
164223,of,I-TIME_DURATION,20396
164224,months,I-TIME_DURATION,20396
164225,or,I-TIME_DURATION,20396
164226,years,I-TIME_DURATION,20396
164227,they,O,20396
164228,dont,O,20396
164229,and,O,20396
164230,then,O,20396
164231,they,O,20396
164232,fluctuate,O,20396
164233,their,O,20396
164234,IOP,O,20396
164235,Over,B-TIME_DURATION,20397
164236,a,I-TIME_DURATION,20397
164237,decade,I-TIME_DURATION,20397
164238,selective,B-TREATMENT,20397
164239,laser,I-TREATMENT,20397
164240,trabeculoplasty,I-TREATMENT,20397
164241,SLT,I-TREATMENT,20397
164242,will,O,20397
164243,wear,O,20397
164244,off,O,20397
164245,requiring,O,20397
164246,patients,O,20397
164247,to,O,20397
164248,have,O,20397
164249,a,O,20397
164250,touchup,O,20397
164251,or,O,20397
164252,a,O,20397
164253,second,O,20397
164254,round,O,20397
164255,of,O,20397
164256,treatment,O,20397
164257,Patients,O,20398
164258,may,O,20398
164259,develop,O,20398
164260,an,O,20398
164261,allergy,O,20398
164262,or,O,20398
164263,intolerance,O,20398
164264,to,O,20398
164265,glaucoma,B-TREATMENT,20398
164266,drops,I-TREATMENT,20398
164267,as,O,20398
164268,well,O,20398
164269,Over,O,20399
164270,a,O,20399
164271,course,O,20399
164272,of,O,20399
164273,10,B-TIME_DURATION,20399
164274,years,I-TIME_DURATION,20399
164275,a,O,20399
164276,lot,O,20399
164277,can,O,20399
164278,change,O,20399
164279,Dr,B-PERSON,20399
164280,Bedrood,I-PERSON,20399
164281,said,O,20399
164282,Oftentimes,O,20400
164283,after,O,20400
164284,10,B-TIME_DURATION,20400
164285,15,I-TIME_DURATION,20400
164286,or,I-TIME_DURATION,20400
164287,20,I-TIME_DURATION,20400
164288,years,I-TIME_DURATION,20400
164289,were,O,20400
164290,looking,O,20400
164291,at,O,20400
164292,other,O,20400
164293,modalities,O,20400
164294,of,O,20400
164295,treatment,O,20400
164296,like,O,20400
164297,surgery,B-TREATMENT,20400
164298,or,O,20400
164299,something,O,20400
164300,that,O,20400
164301,can,O,20400
164302,regulate,O,20400
164303,their,O,20400
164304,pressure,O,20400
164305,a,O,20400
164306,little,O,20400
164307,bit,O,20400
164308,better-other,O,20400
164309,additional,O,20400
164310,drugs,O,20400
164311,for,O,20400
164312,instance,O,20400
164313,Prostaglandin,O,20401
164314,analogues-such,O,20401
164315,as,O,20401
164316,bimatoprost,B-NAME_OF_DRUG,20401
164317,latanoprost,B-NAME_OF_DRUG,20401
164318,tafluprost,B-NAME_OF_DRUG,20401
164319,and,O,20401
164320,travoprost-are,O,20401
164321,common,O,20401
164322,first-line,O,20401
164323,treatments,O,20401
164324,for,O,20401
164325,patients,O,20401
164326,with,O,20401
164327,newly,O,20401
164328,diagnosed,O,20401
164329,glaucoma,B-NAME_OF_DISEASE,20401
164330,Clinical,O,20402
164331,trials,O,20402
164332,have,O,20402
164333,shown,O,20402
164334,that,O,20402
164335,SLT,B-TREATMENT,20402
164336,is,O,20402
164337,just,O,20402
164338,as,O,20402
164339,safe,O,20402
164340,and,O,20402
164341,effective,O,20402
164342,as,O,20402
164343,drops,O,20402
164344,with,O,20402
164345,a,O,20402
164346,20%,O,20402
164347,reduction,O,20402
164348,in,O,20402
164349,IOP,O,20402
164350,that,O,20402
164351,lasts,O,20402
164352,for,B-TIME_DURATION,20402
164353,up,I-TIME_DURATION,20402
164354,to,I-TIME_DURATION,20402
164355,three,I-TIME_DURATION,20402
164356,years,I-TIME_DURATION,20402
164357,without,O,20402
164358,the,O,20402
164359,hassle,O,20402
164360,of,O,20402
164361,daily,O,20402
164362,medication,O,20402
164363,Dr,B-PERSON,20403
164364,Panarelli,I-PERSON,20403
164365,believes,O,20403
164366,the,O,20403
164367,pros,O,20403
164368,and,O,20403
164369,cons,O,20403
164370,of,O,20403
164371,SLT,B-TREATMENT,20403
164372,versus,O,20403
164373,daily,O,20403
164374,drops,O,20403
164375,is,O,20403
164376,a,O,20403
164377,conversation,O,20403
164378,worth,O,20403
164379,having,O,20403
164380,with,O,20403
164381,patients,O,20403
164382,early,O,20403
164383,on,O,20403
164384,in,O,20403
164385,the,O,20403
164386,treatment,O,20403
164387,process,O,20403
164388,I,O,20404
164389,think,O,20404
164390,its,O,20404
164391,worth,O,20404
164392,having,O,20404
164393,a,O,20404
164394,discussion,O,20404
164395,with,O,20404
164396,them,O,20404
164397,regarding,O,20404
164398,whether,O,20404
164399,they,O,20404
164400,prefer,O,20404
164401,to,O,20404
164402,start,O,20404
164403,topical,B-TREATMENT,20404
164404,therapy,I-TREATMENT,20404
164405,or,O,20404
164406,whether,O,20404
164407,they,O,20404
164408,would,O,20404
164409,like,O,20404
164410,to,O,20404
164411,proceed,O,20404
164412,with,O,20404
164413,laser,B-TREATMENT,20404
164414,trabeculoplasty,I-TREATMENT,20404
164415,especially,O,20404
164416,now,O,20404
164417,with,O,20404
164418,data,O,20404
164419,from,O,20404
164420,the,B-NAME_OF_STUDY,20404
164421,LiGHT,I-NAME_OF_STUDY,20404
164422,trial,I-NAME_OF_STUDY,20404
164423,he,O,20404
164424,said,O,20404
164425,For,O,20405
164426,example,O,20405
164427,patients,O,20405
164428,with,O,20405
164429,advanced,B-NAME_OF_DISEASE,20405
164430,glaucoma,I-NAME_OF_DISEASE,20405
164431,may,O,20405
164432,be,O,20405
164433,taking,O,20405
164434,six,O,20405
164435,to,O,20405
164436,10,O,20405
164437,drops,O,20405
164438,a,O,20405
164439,day,O,20405
164440,Drops,O,20406
164441,that,O,20406
164442,contain,O,20406
164443,preservatives,O,20406
164444,may,O,20406
164445,cause,O,20406
164446,ocular,B-NAME_OF_DISEASE,20406
164447,surface,I-NAME_OF_DISEASE,20406
164448,disease,I-NAME_OF_DISEASE,20406
164449,such,O,20406
164450,as,O,20406
164451,dry,B-NAME_OF_DISEASE,20406
164452,eye,I-NAME_OF_DISEASE,20406
164453,leading,O,20406
164454,to,O,20406
164455,patient,O,20406
164456,discomfort,O,20406
164457,and,O,20406
164458,decline,O,20406
164459,in,O,20406
164460,quality,O,20406
164461,of,O,20406
164462,life,O,20406
164463,A,O,20407
164464,lot,O,20407
164465,of,O,20407
164466,us,O,20407
164467,are,O,20407
164468,trying,O,20407
164469,to,O,20407
164470,decrease,O,20407
164471,the,O,20407
164472,number,O,20407
164473,of,O,20407
164474,total,O,20407
164475,drops,O,20407
164476,and,O,20407
164477,maybe,O,20407
164478,even,O,20407
164479,move,O,20407
164480,toward,O,20407
164481,some,O,20407
164482,of,O,20407
164483,the,O,20407
164484,preservative-free,O,20407
164485,agents,O,20407
164486,for,O,20407
164487,a,O,20407
164488,lot,O,20407
164489,of,O,20407
164490,our,O,20407
164491,patients,O,20407
164492,Dr,B-PERSON,20407
164493,Panarelli,I-PERSON,20407
164494,said,O,20407
164495,For,O,20408
164496,the,O,20408
164497,first,O,20408
164498,time,O,20408
164499,in,O,20408
164500,decades,B-TIME_DURATION,20408
164501,two,O,20408
164502,new,O,20408
164503,classes,O,20408
164504,of,O,20408
164505,drugs,O,20408
164506,have,O,20408
164507,been,O,20408
164508,introduced,O,20408
164509,for,O,20408
164510,the,O,20408
164511,treatment,O,20408
164512,of,O,20408
164513,open-angle,B-NAME_OF_DISEASE,20408
164514,glaucoma,I-NAME_OF_DISEASE,20408
164515,latanoprostene,B-NAME_OF_DRUG,20408
164516,bunod,I-NAME_OF_DRUG,20408
164517,and,O,20408
164518,netarsudil,B-NAME_OF_DRUG,20408
164519,Netarsudil,B-NAME_OF_DRUG,20409
164520,is,O,20409
164521,a,B-NAME_OF_DRUG,20409
164522,Rho-kinase,I-NAME_OF_DRUG,20409
164523,inhibitor,I-NAME_OF_DRUG,20409
164524,that,O,20409
164525,targets,O,20409
164526,the,O,20409
164527,outflow,O,20409
164528,pathway,O,20409
164529,Netarsudil,B-NAME_OF_DRUG,20410
164530,is,O,20410
164531,a,O,20410
164532,drug,O,20410
164533,for,O,20410
164534,the,O,20410
164535,treatment,O,20410
164536,of,O,20410
164537,glaucoma,B-NAME_OF_DISEASE,20410
164538,In,O,20411
164539,the,B-GPE,20411
164540,United,I-GPE,20411
164541,States,I-GPE,20411
164542,in,O,20411
164543,2017,O,20411
164544,the,B-ORGANIZATION,20411
164545,FDA,I-ORGANIZATION,20411
164546,approved,O,20411
164547,a,O,20411
164548,0.02%,O,20411
164549,ophthalmic,O,20411
164550,solution,O,20411
164551,for,O,20411
164552,the,B-TREATMENT,20411
164553,lowering,I-TREATMENT,20411
164554,of,I-TREATMENT,20411
164555,elevated,I-TREATMENT,20411
164556,IOP,I-TREATMENT,20411
164557,in,O,20411
164558,patients,O,20411
164559,with,O,20411
164560,open-angle,B-NAME_OF_DISEASE,20411
164561,glaucoma,I-NAME_OF_DISEASE,20411
164562,or,O,20411
164563,ocular,B-NAME_OF_DISEASE,20411
164564,hypertension,I-NAME_OF_DISEASE,20411
164565,targeting,O,20411
164566,the,B-PART_OF_THE_EYES,20411
164567,trabecular,I-PART_OF_THE_EYES,20411
164568,meshwork,I-PART_OF_THE_EYES,20411
164569,directly,O,20411
164570,Netarsudil,B-NAME_OF_DRUG,20412
164571,is,O,20412
164572,unique,O,20412
164573,in,O,20412
164574,that,O,20412
164575,none,O,20412
164576,of,O,20412
164577,the,O,20412
164578,other,O,20412
164579,medicines,O,20412
164580,out,O,20412
164581,there,O,20412
164582,on,O,20412
164583,the,O,20412
164584,market,O,20412
164585,actually,O,20412
164586,work,O,20412
164587,at,O,20412
164588,the,O,20412
164589,level,O,20412
164590,of,O,20412
164591,the,B-PART_OF_THE_EYES,20412
164592,trabecular,I-PART_OF_THE_EYES,20412
164593,meshwork,I-PART_OF_THE_EYES,20412
164594,Dr,B-PERSON,20412
164595,Panarelli,I-PERSON,20412
164596,said,O,20412
164597,By,O,20413
164598,inhibiting,O,20413
164599,Rho-kinase,B-CHEMICAL_COMPOUND,20413
164600,were,O,20413
164601,able,O,20413
164602,to,O,20413
164603,relax,O,20413
164604,some,O,20413
164605,of,O,20413
164606,the,O,20413
164607,actin,B-CHEMICAL_COMPOUND,20413
164608,and,O,20413
164609,myosin,B-CHEMICAL_COMPOUND,20413
164610,contractions,O,20413
164611,This,O,20414
164612,is,O,20414
164613,something,O,20414
164614,that,O,20414
164615,we,O,20414
164616,do,O,20414
164617,not,O,20414
164618,see,O,20414
164619,with,O,20414
164620,other,O,20414
164621,medication,O,20414
164622,classes,O,20414
164623,Dr,B-PERSON,20414
164624,Panarelli,I-PERSON,20414
164625,said,O,20414
164626,Latanoprostene,B-NAME_OF_DRUG,20415
164627,bunod,I-NAME_OF_DRUG,20415
164628,is,O,20415
164629,a,O,20415
164630,new,O,20415
164631,version,O,20415
164632,of,O,20415
164633,a,B-NAME_OF_DRUG,20415
164634,prostaglandin,I-NAME_OF_DRUG,20415
164635,that,O,20415
164636,also,O,20415
164637,has,O,20415
164638,a,O,20415
164639,nitric,B-CHEMICAL_COMPOUND,20415
164640,oxide,I-CHEMICAL_COMPOUND,20415
164641,donating,O,20415
164642,moiety,O,20415
164643,The,O,20416
164644,exact,O,20416
164645,mechanism,O,20416
164646,of,O,20416
164647,action,O,20416
164648,is,O,20416
164649,somewhat,O,20416
164650,complex,O,20416
164651,according,O,20416
164652,to,O,20416
164653,Dr,B-PERSON,20416
164654,Panarelli,I-PERSON,20416
164655,but,O,20416
164656,its,O,20416
164657,believed,O,20416
164658,to,O,20416
164659,have,O,20416
164660,a,O,20416
164661,number,O,20416
164662,of,O,20416
164663,benefits,O,20416
164664,including,O,20416
164665,smooth,O,20416
164666,muscle,O,20416
164667,relaxation,O,20416
164668,enhanced,O,20416
164669,outflow,O,20416
164670,through,O,20416
164671,the,O,20416
164672,trabecular,O,20416
164673,pathway,O,20416
164674,as,O,20416
164675,well,O,20416
164676,as,O,20416
164677,increased,O,20416
164678,uveoscleral,O,20416
164679,outflow,O,20416
164680,Fixed-combination,B-NAME_OF_DRUG,20417
164681,netarsudil,I-NAME_OF_DRUG,20417
164682,latanoprost,I-NAME_OF_DRUG,20417
164683,is,O,20417
164684,another,O,20417
164685,new,O,20417
164686,drug,O,20417
164687,on,O,20417
164688,the,O,20417
164689,market,O,20417
164690,which,O,20417
164691,was,O,20417
164692,approved,O,20417
164693,by,O,20417
164694,the,B-GPE,20417
164695,US,I-GPE,20417
164696,Food,B-ORGANIZATION,20417
164697,and,I-ORGANIZATION,20417
164698,Drug,I-ORGANIZATION,20417
164699,Administration,I-ORGANIZATION,20417
164700,in,O,20417
164701,2019,O,20417
164702,The,O,20418
164703,once-daily,O,20418
164704,drug,O,20418
164705,also,O,20418
164706,reduces,B-TREATMENT,20418
164707,IOP,I-TREATMENT,20418
164708,by,O,20418
164709,enhancing,O,20418
164710,aqueous,O,20418
164711,outflow,O,20418
164712,through,O,20418
164713,both,O,20418
164714,the,O,20418
164715,trabecular,O,20418
164716,and,O,20418
164717,uveoscleral,O,20418
164718,pathways,O,20418
164719,What,O,20419
164720,is,O,20419
164721,unique,O,20419
164722,about,O,20419
164723,the,B-NAME_OF_DRUG,20419
164724,netarsudil,I-NAME_OF_DRUG,20419
164725,latanoprost,B-NAME_OF_DRUG,20419
164726,combination,I-NAME_OF_DRUG,20419
164727,is,O,20419
164728,this,O,20419
164729,is,O,20419
164730,really,O,20419
164731,one,O,20419
164732,of,O,20419
164733,the,O,20419
164734,first,O,20419
164735,times,O,20419
164736,we,O,20419
164737,actually,O,20419
164738,had,O,20419
164739,a,O,20419
164740,medicine,O,20419
164741,go,O,20419
164742,up,O,20419
164743,against,O,20419
164744,latanoprost,B-NAME_OF_DRUG,20419
164745,alone,O,20419
164746,Dr,B-PERSON,20419
164747,Panarelli,I-PERSON,20419
164748,said,O,20419
164749,Latanoprost,B-NAME_OF_DRUG,20420
164750,is,O,20420
164751,one,O,20420
164752,of,O,20420
164753,our,O,20420
164754,bigger,O,20420
164755,guns,O,20420
164756,out,O,20420
164757,there,O,20420
164758,so,O,20420
164759,it,O,20420
164760,is,O,20420
164761,encouraging,O,20420
164762,to,O,20420
164763,see,O,20420
164764,that,O,20420
164765,we,O,20420
164766,have,O,20420
164767,these,O,20420
164768,new,O,20420
164769,medicines,O,20420
164770,and,O,20420
164771,its,O,20420
164772,nice,O,20420
164773,to,O,20420
164774,see,O,20420
164775,data,O,20420
164776,that,O,20420
164777,does,O,20420
164778,support,O,20420
164779,good,O,20420
164780,efficacy,O,20420
164781,with,O,20420
164782,these,O,20420
164783,different,O,20420
164784,agents,O,20420
164785,Its,O,20421
164786,nice,O,20421
164787,to,O,20421
164788,have,O,20421
164789,some,O,20421
164790,new,O,20421
164791,medicines,O,20421
164792,that,O,20421
164793,are,O,20421
164794,out,O,20421
164795,there,O,20421
164796,on,O,20421
164797,the,O,20421
164798,market,O,20421
164799,because,O,20421
164800,I,O,20421
164801,think,O,20421
164802,they,O,20421
164803,all,O,20421
164804,fit,O,20421
164805,into,O,20421
164806,our,O,20421
164807,armamentarium,O,20421
164808,somewhere,O,20421
164809,Dr,B-PERSON,20421
164810,Panarelli,I-PERSON,20421
164811,explained,O,20421
164812,If,O,20422
164813,a,O,20422
164814,patient,O,20422
164815,is,O,20422
164816,not,O,20422
164817,responding,O,20422
164818,on,O,20422
164819,a,B-NAME_OF_DRUG,20422
164820,prostaglandin,I-NAME_OF_DRUG,20422
164821,analogue,I-NAME_OF_DRUG,20422
164822,Dr,B-PERSON,20422
164823,Panarelli,I-PERSON,20422
164824,will,O,20422
164825,switch,O,20422
164826,them,O,20422
164827,from,O,20422
164828,either,O,20422
164829,latanoprost,B-NAME_OF_DRUG,20422
164830,to,O,20422
164831,latanoprostene,B-NAME_OF_DRUG,20422
164832,bunod,I-NAME_OF_DRUG,20422
164833,or,O,20422
164834,from,O,20422
164835,latanoprost,B-NAME_OF_DRUG,20422
164836,to,O,20422
164837,combination,B-NAME_OF_DRUG,20422
164838,latanoprost,I-NAME_OF_DRUG,20422
164839,netarsudil,I-NAME_OF_DRUG,20422
164840,He,O,20423
164841,also,O,20423
164842,believes,O,20423
164843,there,O,20423
164844,is,O,20423
164845,a,O,20423
164846,place,O,20423
164847,for,O,20423
164848,the,O,20423
164849,medications,O,20423
164850,in,O,20423
164851,patients,O,20423
164852,with,O,20423
164853,low-tension,B-NAME_OF_DISEASE,20423
164854,glaucoma,I-NAME_OF_DISEASE,20423
164855,who,O,20423
164856,are,O,20423
164857,traditionally,O,20423
164858,some,O,20423
164859,of,O,20423
164860,the,O,20423
164861,most,O,20423
164862,difficult,O,20423
164863,patients,O,20423
164864,to,O,20423
164865,treat,O,20423
164866,Dr,B-PERSON,20424
164867,Panarelli,I-PERSON,20424
164868,has,O,20424
164869,found,O,20424
164870,netarsudil,B-NAME_OF_DRUG,20424
164871,to,O,20424
164872,be,O,20424
164873,particularly,O,20424
164874,useful,O,20424
164875,in,O,20424
164876,these,O,20424
164877,patients,O,20424
164878,because,O,20424
164879,it,O,20424
164880,lowers,B-TREATMENT,20424
164881,EVP,I-TREATMENT,20424
164882,Some,O,20425
164883,of,O,20425
164884,my,O,20425
164885,patients,O,20425
164886,can,O,20425
164887,get,O,20425
164888,down,O,20425
164889,to,O,20425
164890,that,O,20425
164891,singledigit,O,20425
164892,range,O,20425
164893,which,O,20425
164894,is,O,20425
164895,a,O,20425
164896,number,O,20425
164897,I,O,20425
164898,often,O,20425
164899,cannot,O,20425
164900,get,O,20425
164901,with,O,20425
164902,traditional,O,20425
164903,carbonic,B-NAME_OF_DRUG,20425
164904,anhydrase,I-NAME_OF_DRUG,20425
164905,inhibitors,I-NAME_OF_DRUG,20425
164906,or,O,20425
164907,alpha-2,B-NAME_OF_DRUG,20425
164908,agonists,I-NAME_OF_DRUG,20425
164909,or,O,20425
164910,even,O,20425
164911,beta,B-NAME_OF_DRUG,20425
164912,blockers,I-NAME_OF_DRUG,20425
164913,he,O,20425
164914,said,O,20425
164915,There,O,20426
164916,are,O,20426
164917,some,O,20426
164918,situations,O,20426
164919,in,O,20426
164920,which,O,20426
164921,Dr,B-PERSON,20426
164922,Panarelli,I-PERSON,20426
164923,will,O,20426
164924,use,O,20426
164925,netarsudil,B-NAME_OF_DRUG,20426
164926,as,O,20426
164927,a,O,20426
164928,first-line,O,20426
164929,agent,O,20426
164930,For,O,20427
164931,example,O,20427
164932,if,O,20427
164933,a,O,20427
164934,patient,O,20427
164935,is,O,20427
164936,uncomfortable,O,20427
164937,with,O,20427
164938,the,O,20427
164939,potential,O,20427
164940,side,O,20427
164941,effects,O,20427
164942,of,O,20427
164943,increased,B-SIGN_AND_SYMPTOM,20427
164944,iris,I-SIGN_AND_SYMPTOM,20427
164945,pigmentation,I-SIGN_AND_SYMPTOM,20427
164946,and,O,20427
164947,periorbital,B-NAME_OF_DISEASE,20427
164948,fat,I-NAME_OF_DISEASE,20427
164949,atrophy,I-NAME_OF_DISEASE,20427
164950,that,O,20427
164951,come,O,20427
164952,with,O,20427
164953,a,B-NAME_OF_DRUG,20427
164954,prostaglandin,I-NAME_OF_DRUG,20427
164955,analogue,I-NAME_OF_DRUG,20427
164956,he,O,20427
164957,may,O,20427
164958,recommend,O,20427
164959,netarsudil,B-NAME_OF_DRUG,20427
164960,He,O,20428
164961,may,O,20428
164962,also,O,20428
164963,recommend,O,20428
164964,netarsudil,B-NAME_OF_DRUG,20428
164965,if,O,20428
164966,the,O,20428
164967,patient,O,20428
164968,is,O,20428
164969,already,O,20428
164970,on,O,20428
164971,an,B-NAME_OF_DRUG,20428
164972,oral,I-NAME_OF_DRUG,20428
164973,beta,I-NAME_OF_DRUG,20428
164974,blocker,I-NAME_OF_DRUG,20428
164975,or,O,20428
164976,is,O,20428
164977,hesitant,O,20428
164978,to,O,20428
164979,start,O,20428
164980,on,O,20428
164981,a,B-NAME_OF_DRUG,20428
164982,beta,I-NAME_OF_DRUG,20428
164983,blocker,I-NAME_OF_DRUG,20428
164984,generally,O,20428
164985,We,O,20429
164986,started,O,20429
164987,netarsudil,B-NAME_OF_DRUG,20429
164988,and,O,20429
164989,its,O,20429
164990,actually,O,20429
164991,been,O,20429
164992,great,O,20429
164993,in,O,20429
164994,that,O,20429
164995,they,O,20429
164996,have,O,20429
164997,gotten,O,20429
164998,to,O,20429
164999,their,O,20429
165000,target,O,20429
165001,IOP,O,20429
165002,without,O,20429
165003,me,O,20429
165004,having,O,20429
165005,to,O,20429
165006,perform,O,20429
165007,a,B-TREATMENT,20429
165008,trabeculectomy,I-TREATMENT,20429
165009,which,O,20429
165010,is,O,20429
165011,huge,O,20429
165012,for,O,20429
165013,my,O,20429
165014,patients,O,20429
165015,A,O,20430
165016,number,O,20430
165017,of,O,20430
165018,treatments,O,20430
165019,for,O,20430
165020,glaucoma,B-NAME_OF_DISEASE,20430
165021,are,O,20430
165022,not,O,20430
165023,yet,O,20430
165024,approved,O,20430
165025,but,O,20430
165026,currently,O,20430
165027,in,O,20430
165028,development,O,20430
165029,For,O,20431
165030,example,O,20431
165031,bimatoprost,B-TREATMENT,20431
165032,sustained,I-TREATMENT,20431
165033,release,I-TREATMENT,20431
165034,bimatoprost,B-TREATMENT,20431
165035,SR,I-TREATMENT,20431
165036,is,O,20431
165037,a,O,20431
165038,first-in-class,O,20431
165039,sustained-release,O,20431
165040,investigational,O,20431
165041,biodegradable,O,20431
165042,implant,O,20431
165043,for,O,20431
165044,the,O,20431
165045,treatment,O,20431
165046,of,O,20431
165047,open-angle,B-NAME_OF_DISEASE,20431
165048,glaucoma,I-NAME_OF_DISEASE,20431
165049,If,O,20432
165050,approved,O,20432
165051,Dr,B-PERSON,20432
165052,Panarelli,I-PERSON,20432
165053,said,O,20432
165054,he,O,20432
165055,believes,O,20432
165056,bimatoprost,B-TREATMENT,20432
165057,SR,I-TREATMENT,20432
165058,could,O,20432
165059,be,O,20432
165060,a,O,20432
165061,game-changer,O,20432
165062,in,O,20432
165063,that,O,20432
165064,it,O,20432
165065,completely,O,20432
165066,takes,O,20432
165067,patient,O,20432
165068,compliance,O,20432
165069,out,O,20432
165070,of,O,20432
165071,the,O,20432
165072,equation,O,20432
165073,and,O,20432
165074,significantly,O,20432
165075,reduces,O,20432
165076,the,O,20432
165077,overall,O,20432
165078,treatment,O,20432
165079,burden,O,20432
165080,glaucoma,B-NAME_OF_DISEASE,20432
165081,patients,O,20432
165082,face,O,20432
165083,With,O,20433
165084,bimatoprost,B-TREATMENT,20433
165085,SR,I-TREATMENT,20433
165086,all,O,20433
165087,we,O,20433
165088,ask,O,20433
165089,patients,O,20433
165090,to,O,20433
165091,do,O,20433
165092,is,O,20433
165093,to,O,20433
165094,come,O,20433
165095,once,O,20433
165096,every,O,20433
165097,several,B-TIME_DURATION,20433
165098,months,I-TIME_DURATION,20433
165099,to,O,20433
165100,get,O,20433
165101,their,O,20433
165102,treatment,O,20433
165103,Dr,B-PERSON,20433
165104,Panarelli,I-PERSON,20433
165105,said,O,20433
165106,It,O,20434
165107,is,O,20434
165108,one,O,20434
165109,thing,O,20434
165110,to,O,20434
165111,talk,O,20434
165112,to,O,20434
165113,a,O,20434
165114,patient,O,20434
165115,and,O,20434
165116,tell,O,20434
165117,them,O,20434
165118,that,O,20434
165119,they,O,20434
165120,are,O,20434
165121,going,O,20434
165122,to,O,20434
165123,have,O,20434
165124,an,O,20434
165125,injection,O,20434
165126,once,O,20434
165127,every,O,20434
165128,four,B-TIME_DURATION,20434
165129,to,I-TIME_DURATION,20434
165130,six,I-TIME_DURATION,20434
165131,months,I-TIME_DURATION,20434
165132,for,O,20434
165133,the,O,20434
165134,rest,O,20434
165135,of,O,20434
165136,their,O,20434
165137,lives,O,20434
165138,but,O,20434
165139,if,O,20434
165140,we,O,20434
165141,can,O,20434
165142,give,O,20434
165143,a,O,20434
165144,patient,O,20434
165145,a,O,20434
165146,loading,O,20434
165147,dose,O,20434
165148,of,O,20434
165149,a,O,20434
165150,medicine,O,20434
165151,and,O,20434
165152,not,O,20434
165153,need,O,20434
165154,to,O,20434
165155,reinject,O,20434
165156,them,O,20434
165157,from,O,20434
165158,anywhere,O,20434
165159,from,B-TIME_DURATION,20434
165160,one,I-TIME_DURATION,20434
165161,to,I-TIME_DURATION,20434
165162,maybe,I-TIME_DURATION,20434
165163,three,I-TIME_DURATION,20434
165164,years,I-TIME_DURATION,20434
165165,that,O,20434
165166,will,O,20434
165167,resonate,O,20434
165168,well,O,20434
165169,Will,O,20435
165170,there,O,20435
165171,be,O,20435
165172,any,O,20435
165173,complications,O,20435
165174,or,O,20435
165175,adverse,O,20435
165176,effects,O,20435
165177,from,O,20435
165178,an,O,20435
165179,injectable,O,20435
165180,form,O,20435
165181,of,O,20435
165182,medicine,O,20435
165183,delivered,O,20435
165184,into,O,20435
165185,the,O,20435
165186,eye,O,20435
165187,every,O,20435
165188,six,B-TIME_DURATION,20435
165189,months,I-TIME_DURATION,20435
165190,Although,O,20436
165191,data,O,20436
165192,are,O,20436
165193,limited,O,20436
165194,to,O,20436
165195,abstracts,O,20436
165196,presented,O,20436
165197,during,O,20436
165198,conferences,O,20436
165199,such,O,20436
165200,as,O,20436
165201,the,B-ORGANIZATION,20436
165202,Academy,I-ORGANIZATION,20436
165203,of,I-ORGANIZATION,20436
165204,Ophthalmology,I-ORGANIZATION,20436
165205,and,O,20436
165206,American,B-ORGANIZATION,20436
165207,Glaucoma,I-ORGANIZATION,20436
165208,Society,I-ORGANIZATION,20436
165209,Dr,B-PERSON,20436
165210,Panarelli,I-PERSON,20436
165211,considers,O,20436
165212,the,O,20436
165213,safety,O,20436
165214,and,O,20436
165215,efficacy,O,20436
165216,of,O,20436
165217,bimatoprost,B-TREATMENT,20436
165218,SR,I-TREATMENT,20436
165219,to,O,20436
165220,be,O,20436
165221,positive,O,20436
165222,so,O,20436
165223,far,O,20436
165224,We,O,20437
165225,have,O,20437
165226,questions,O,20437
165227,regarding,O,20437
165228,issues,O,20437
165229,with,O,20437
165230,the,B-PART_OF_THE_EYES,20437
165231,cornea,I-PART_OF_THE_EYES,20437
165232,and,O,20437
165233,we,O,20437
165234,have,O,20437
165235,concerns,O,20437
165236,about,O,20437
165237,infection,O,20437
165238,Dr,B-PERSON,20437
165239,Panarelli,I-PERSON,20437
165240,said,O,20437
165241,Initially,O,20438
165242,Dr,B-PERSON,20438
165243,Panarelli,I-PERSON,20438
165244,sees,O,20438
165245,a,O,20438
165246,place,O,20438
165247,for,O,20438
165248,bimatoprost,B-TREATMENT,20438
165249,SR,I-TREATMENT,20438
165250,as,O,20438
165251,a,O,20438
165252,second-line,O,20438
165253,treatment,O,20438
165254,when,O,20438
165255,a,O,20438
165256,patient,O,20438
165257,is,O,20438
165258,progressing,O,20438
165259,or,O,20438
165260,not,O,20438
165261,achieving,O,20438
165262,the,O,20438
165263,IOP,O,20438
165264,reduction,O,20438
165265,needed,O,20438
165266,on,O,20438
165267,a,B-NAME_OF_DRUG,20438
165268,prostaglandin,I-NAME_OF_DRUG,20438
165269,or,O,20438
165270,after,O,20438
165271,SLT,B-TREATMENT,20438
165272,One,O,20439
165273,of,O,20439
165274,the,O,20439
165275,primary,O,20439
165276,issues,O,20439
165277,in,O,20439
165278,glaucoma,B-NAME_OF_DISEASE,20439
165279,is,O,20439
165280,patient,O,20439
165281,compliance,O,20439
165282,Up,O,20440
165283,to,O,20440
165284,60%,O,20440
165285,of,O,20440
165286,glaucoma,B-NAME_OF_DISEASE,20440
165287,patients,O,20440
165288,are,O,20440
165289,non-compliant,O,20440
165290,with,O,20440
165291,daily,O,20440
165292,drops,O,20440
165293,First,O,20441
165294,glaucoma,B-NAME_OF_DISEASE,20441
165295,patients,O,20441
165296,are,O,20441
165297,generally,O,20441
165298,older,O,20441
165299,people,O,20441
165300,over,O,20441
165301,age,O,20441
165302,60,O,20441
165303,are,O,20441
165304,at,O,20441
165305,increased,O,20441
165306,risk,O,20441
165307,for,O,20441
165308,the,O,20441
165309,disease,O,20441
165310,Second,O,20442
165311,glaucoma,B-NAME_OF_DISEASE,20442
165312,is,O,20442
165313,a,O,20442
165314,life-long,O,20442
165315,disease,O,20442
165316,They,O,20443
165317,physically,O,20443
165318,have,O,20443
165319,to,O,20443
165320,open,O,20443
165321,up,O,20443
165322,the,O,20443
165323,bottles,O,20443
165324,and,O,20443
165325,place,O,20443
165326,it,O,20443
165327,in,O,20443
165328,their,O,20443
165329,eyes,O,20443
165330,every,O,20443
165331,single,O,20443
165332,day,O,20443
165333,Dr,B-PERSON,20443
165334,Bedrood,I-PERSON,20443
165335,said,O,20443
165336,Cost,O,20444
165337,is,O,20444
165338,a,O,20444
165339,frequent,O,20444
165340,issue,O,20444
165341,as,O,20444
165342,well,O,20444
165343,as,O,20444
165344,eye,B-TREATMENT,20444
165345,drops,I-TREATMENT,20444
165346,are,O,20444
165347,often,O,20444
165348,more,O,20444
165349,expensive,O,20444
165350,than,O,20444
165351,generic,O,20444
165352,medications,O,20444
165353,for,O,20444
165354,other,O,20444
165355,conditions,O,20444
165356,To,O,20445
165357,address,O,20445
165358,this,O,20445
165359,Dr,B-PERSON,20445
165360,Bedrood,I-PERSON,20445
165361,suggests,O,20445
165362,providing,O,20445
165363,patients,O,20445
165364,with,O,20445
165365,coupons,O,20445
165366,and,O,20445
165367,enrolling,O,20445
165368,them,O,20445
165369,onto,O,20445
165370,special,O,20445
165371,programs,O,20445
165372,where,O,20445
165373,they,O,20445
165374,can,O,20445
165375,get,O,20445
165376,lower,O,20445
165377,prices,O,20445
165378,Glaucoma,B-NAME_OF_DISEASE,20446
165379,is,O,20446
165380,also,O,20446
165381,asymptomatic,O,20446
165382,causing,O,20446
165383,patients,O,20446
165384,to,O,20446
165385,be,O,20446
165386,less,O,20446
165387,aware,O,20446
165388,of,O,20446
165389,their,O,20446
165390,disease,O,20446
165391,I,O,20447
165392,am,O,20447
165393,not,O,20447
165394,feeling,O,20447
165395,anything,O,20447
165396,I,O,20447
165397,am,O,20447
165398,not,O,20447
165399,seeing,O,20447
165400,any,O,20447
165401,differently,O,20447
165402,and,O,20447
165403,I,O,20447
165404,will,O,20447
165405,skip,O,20447
165406,my,O,20447
165407,dose,O,20447
165408,today,O,20447
165409,Dr,B-PERSON,20447
165410,Bedrood,I-PERSON,20447
165411,pointed,O,20447
165412,out,O,20447
165413,Dr,B-PERSON,20448
165414,Panarelli,I-PERSON,20448
165415,said,O,20448
165416,ophthalmologists,O,20448
165417,talk,O,20448
165418,about,O,20448
165419,glaucoma,B-NAME_OF_DISEASE,20448
165420,being,O,20448
165421,a,O,20448
165422,silent,O,20448
165423,thief,O,20448
165424,Dr,B-PERSON,20449
165425,Bedrood,I-PERSON,20449
165426,stresses,O,20449
165427,the,O,20449
165428,importance,O,20449
165429,of,O,20449
165430,having,O,20449
165431,frank,O,20449
165432,conversations,O,20449
165433,with,O,20449
165434,patients,O,20449
165435,on,O,20449
165436,the,O,20449
165437,importance,O,20449
165438,of,O,20449
165439,compliance,O,20449
165440,and,O,20449
165441,if,O,20449
165442,compliance,O,20449
165443,remains,O,20449
165444,an,O,20449
165445,issue,O,20449
165446,telling,O,20449
165447,them,O,20449
165448,pointblank,O,20449
165449,they,O,20449
165450,could,O,20449
165451,face,O,20449
165452,surgery,O,20449
165453,According,O,20450
165454,to,O,20450
165455,Drt,B-PERSON,20450
165456,Bedrood,I-PERSON,20450
165457,clinicians,O,20450
165458,can,O,20450
165459,also,O,20450
165460,involve,O,20450
165461,family,O,20450
165462,members,O,20450
165463,and,O,20450
165464,or,O,20450
165465,caregivers,O,20450
165466,to,O,20450
165467,help,O,20450
165468,as,O,20450
165469,well,O,20450
165470,If,O,20451
165471,compliance,O,20451
165472,issues,O,20451
165473,on,O,20451
165474,drops,O,20451
165475,persist,O,20451
165476,despite,O,20451
165477,these,O,20451
165478,strategies,O,20451
165479,for,O,20451
165480,improvement,O,20451
165481,the,O,20451
165482,patient,O,20451
165483,is,O,20451
165484,left,O,20451
165485,SLT,B-TREATMENT,20451
165486,or,O,20451
165487,minimally,B-TREATMENT,20451
165488,invasive,I-TREATMENT,20451
165489,surgery,I-TREATMENT,20451
165490,I,O,20452
165491,talk,O,20452
165492,about,O,20452
165493,surgery,O,20452
165494,with,O,20452
165495,patients,O,20452
165496,because,O,20452
165497,it,O,20452
165498,perks,O,20452
165499,their,O,20452
165500,ears,O,20452
165501,up,O,20452
165502,and,O,20452
165503,they,O,20452
165504,say,O,20452
165505,Oh,O,20452
165506,wait,O,20452
165507,I,O,20452
165508,do,O,20452
165509,not,O,20452
165510,want,O,20452
165511,surgery,O,20452
165512,Dr,B-PERSON,20452
165513,Bedrood,I-PERSON,20452
165514,said,O,20452
165515,Despite,O,20453
165516,these,O,20453
165517,potential,O,20453
165518,challenges,O,20453
165519,both,O,20453
165520,physicians,O,20453
165521,agree,O,20453
165522,that,O,20453
165523,with,O,20453
165524,all,O,20453
165525,the,O,20453
165526,new,O,20453
165527,agents,O,20453
165528,on,O,20453
165529,the,O,20453
165530,horizon,O,20453
165531,it,O,20453
165532,is,O,20453
165533,an,O,20453
165534,exciting,O,20453
165535,time,O,20453
165536,in,O,20453
165537,the,O,20453
165538,field,O,20453
165539,of,O,20453
165540,glaucoma,B-NAME_OF_DISEASE,20453
165541,The,O,20454
165542,sustained,O,20454
165543,release,O,20454
165544,the,O,20454
165545,implants,O,20454
165546,the,O,20454
165547,ocular,O,20454
165548,inserts,O,20454
165549,all,O,20454
165550,of,O,20454
165551,these,O,20454
165552,things,O,20454
165553,promise,O,20454
165554,a,O,20454
165555,way,O,20454
165556,to,O,20454
165557,deliver,O,20454
165558,medications,O,20454
165559,without,O,20454
165560,having,O,20454
165561,the,O,20454
165562,patients,O,20454
165563,do,O,20454
165564,it,O,20454
165565,Dr,B-PERSON,20454
165566,Bedrood,I-PERSON,20454
165567,said,O,20454
165568,Having,O,20455
165569,it,O,20455
165570,in,O,20455
165571,a,O,20455
165572,very,O,20455
165573,sustained,O,20455
165574,steady,O,20455
165575,way,O,20455
165576,is,O,20455
165577,a,O,20455
165578,really,O,20455
165579,exciting,O,20455
165580,part,O,20455
165581,of,O,20455
165582,our,O,20455
165583,future,O,20455
165584,in,O,20455
165585,glaucoma,B-NAME_OF_DISEASE,20455
165586,Dry,B-NAME_OF_DISEASE,20456
165587,Eye,I-NAME_OF_DISEASE,20456
165588,Disease,I-NAME_OF_DISEASE,20456
165589,DED,I-NAME_OF_DISEASE,20456
165590,is,O,20456
165591,a,O,20456
165592,common,O,20456
165593,ocular,O,20456
165594,condition,O,20456
165595,that,O,20456
165596,needs,O,20456
165597,prompt,O,20456
165598,diagnosis,O,20456
165599,and,O,20456
165600,careful,O,20456
165601,treatment,O,20456
165602,interventions,O,20456
165603,If,O,20457
165604,left,O,20457
165605,untreated,O,20457
165606,it,O,20457
165607,can,O,20457
165608,lead,O,20457
165609,to,O,20457
165610,numerous,O,20457
165611,sight-threatening,O,20457
165612,complications,O,20457
165613,including,O,20457
165614,ulceration,B-NAME_OF_DISEASE,20457
165615,of,I-NAME_OF_DISEASE,20457
165616,the,I-NAME_OF_DISEASE,20457
165617,cornea,I-NAME_OF_DISEASE,20457
165618,blepharitis,B-NAME_OF_DISEASE,20457
165619,alterations,B-SIGN_AND_SYMPTOM,20457
165620,of,I-SIGN_AND_SYMPTOM,20457
165621,the,I-SIGN_AND_SYMPTOM,20457
165622,tear,I-SIGN_AND_SYMPTOM,20457
165623,film,I-SIGN_AND_SYMPTOM,20457
165624,conjunctivitis,B-NAME_OF_DISEASE,20457
165625,and,O,20457
165626,in,O,20457
165627,severe,O,20457
165628,cases,O,20457
165629,may,O,20457
165630,lead,O,20457
165631,to,O,20457
165632,scarring,B-SIGN_AND_SYMPTOM,20457
165633,thinning,I-SIGN_AND_SYMPTOM,20457
165634,and,I-SIGN_AND_SYMPTOM,20457
165635,even,I-SIGN_AND_SYMPTOM,20457
165636,perforation,I-SIGN_AND_SYMPTOM,20457
165637,of,I-SIGN_AND_SYMPTOM,20457
165638,the,I-SIGN_AND_SYMPTOM,20457
165639,cornea,I-SIGN_AND_SYMPTOM,20457
165640,Intense,B-TREATMENT,20458
165641,pulsed,I-TREATMENT,20458
165642,light,I-TREATMENT,20458
165643,IPL,I-TREATMENT,20458
165644,is,O,20458
165645,a,O,20458
165646,non-laser,O,20458
165647,high-intensity,O,20458
165648,light,O,20458
165649,source,O,20458
165650,that,O,20458
165651,has,O,20458
165652,shown,O,20458
165653,to,O,20458
165654,play,O,20458
165655,a,O,20458
165656,valuable,O,20458
165657,role,O,20458
165658,in,O,20458
165659,dry,B-NAME_OF_DISEASE,20458
165660,eye,I-NAME_OF_DISEASE,20458
165661,disease,I-NAME_OF_DISEASE,20458
165662,Recent,O,20459
165663,evidence,O,20459
165664,from,O,20459
165665,various,O,20459
165666,research,O,20459
165667,works,O,20459
165668,has,O,20459
165669,shown,O,20459
165670,that,O,20459
165671,IPL,B-TREATMENT,20459
165672,modifies,O,20459
165673,the,O,20459
165674,mechanism,O,20459
165675,of,O,20459
165676,meibomian,B-NAME_OF_DISEASE,20459
165677,gland,I-NAME_OF_DISEASE,20459
165678,dysfunction,I-NAME_OF_DISEASE,20459
165679,MGD,I-NAME_OF_DISEASE,20459
165680,which,O,20459
165681,helps,O,20459
165682,to,O,20459
165683,relieve,O,20459
165684,the,O,20459
165685,symptoms,O,20459
165686,of,O,20459
165687,DED,B-NAME_OF_DISEASE,20459
165688,The,O,20460
165689,emerging,O,20460
165690,evidence,O,20460
165691,shows,O,20460
165692,that,O,20460
165693,the,O,20460
165694,role,O,20460
165695,of,O,20460
165696,IPL,B-TREATMENT,20460
165697,in,O,20460
165698,DED,B-NAME_OF_DISEASE,20460
165699,is,O,20460
165700,novel,O,20460
165701,and,O,20460
165702,therapeutic,O,20460
165703,These,O,20461
165704,results,O,20461
165705,direct,O,20461
165706,us,O,20461
165707,to,O,20461
165708,conclude,O,20461
165709,that,O,20461
165710,IPL,B-TREATMENT,20461
165711,is,O,20461
165712,a,O,20461
165713,potentially,O,20461
165714,beneficial,O,20461
165715,tool,O,20461
165716,and,O,20461
165717,essential,O,20461
165718,future,O,20461
165719,therapy,O,20461
165720,for,O,20461
165721,dry,B-NAME_OF_DISEASE,20461
165722,eye,I-NAME_OF_DISEASE,20461
165723,disease,I-NAME_OF_DISEASE,20461
165724,Advances,O,20462
165725,in,O,20462
165726,the,O,20462
165727,treatment,O,20462
165728,of,O,20462
165729,DED,B-NAME_OF_DISEASE,20462
165730,will,O,20462
165731,lead,O,20462
165732,to,O,20462
165733,a,O,20462
165734,better,O,20462
165735,quality,O,20462
165736,of,O,20462
165737,life,O,20462
165738,However,O,20463
165739,tools,O,20463
165740,to,O,20463
165741,recognize,O,20463
165742,potentially,O,20463
165743,severe,O,20463
165744,side,O,20463
165745,effects,O,20463
165746,of,O,20463
165747,DED,B-NAME_OF_DISEASE,20463
165748,earlier,O,20463
165749,in,O,20463
165750,order,O,20463
165751,to,O,20463
165752,treat,O,20463
165753,or,O,20463
165754,prevent,O,20463
165755,them,O,20463
165756,must,O,20463
165757,be,O,20463
165758,developed,O,20463
165759,IPL,B-TREATMENT,20464
165760,uses,O,20464
165761,electromagnetic,O,20464
165762,waves,O,20464
165763,of,O,20464
165764,desired,O,20464
165765,wavelengths,O,20464
165766,to,O,20464
165767,dilate,O,20464
165768,the,O,20464
165769,capillaries,O,20464
165770,causing,O,20464
165771,them,O,20464
165772,to,O,20464
165773,involute,O,20464
165774,This,O,20465
165775,results,O,20465
165776,in,O,20465
165777,the,O,20465
165778,suppression,O,20465
165779,of,O,20465
165780,the,O,20465
165781,leaked,O,20465
165782,inflammatory,O,20465
165783,mediators,O,20465
165784,which,O,20465
165785,interrupts,O,20465
165786,the,O,20465
165787,vicious,O,20465
165788,cycle,O,20465
165789,of,O,20465
165790,inflammation,O,20465
165791,and,O,20465
165792,improving,O,20465
165793,symptoms,O,20465
165794,of,O,20465
165795,dry,B-NAME_OF_DISEASE,20465
165796,eye,I-NAME_OF_DISEASE,20465
165797,It,O,20466
165798,also,O,20466
165799,works,O,20466
165800,with,O,20466
165801,the,O,20466
165802,help,O,20466
165803,of,O,20466
165804,thermal,B-TREATMENT,20466
165805,pulsation,I-TREATMENT,20466
165806,for,O,20466
165807,many,O,20466
165808,patients,O,20466
165809,This,O,20467
165810,meibum,O,20467
165811,does,O,20467
165812,not,O,20467
165813,melt,O,20467
165814,into,O,20467
165815,the,B-PART_OF_THE_EYES,20467
165816,tear,I-PART_OF_THE_EYES,20467
165817,films,I-PART_OF_THE_EYES,20467
165818,lipid,B-CHEMICAL_COMPOUND,20467
165819,layer,O,20467
165820,as,O,20467
165821,it,O,20467
165822,should,O,20467
165823,and,O,20467
165824,it,O,20467
165825,clogs,O,20467
165826,the,O,20467
165827,glands,O,20467
165828,Thermal,B-TREATMENT,20468
165829,pulsation,I-TREATMENT,20468
165830,therapy,I-TREATMENT,20468
165831,combines,O,20468
165832,sustained,O,20468
165833,heat,O,20468
165834,and,O,20468
165835,pressure,O,20468
165836,to,O,20468
165837,liquefy,O,20468
165838,the,O,20468
165839,meibum,O,20468
165840,and,O,20468
165841,clear,O,20468
165842,the,O,20468
165843,glands,O,20468
165844,Thermal,B-TREATMENT,20469
165845,pulsation,I-TREATMENT,20469
165846,is,O,20469
165847,gentle,O,20469
165848,and,O,20469
165849,effective,O,20469
165850,Inflammation,O,20470
165851,is,O,20470
165852,an,O,20470
165853,integral,O,20470
165854,component,O,20470
165855,in,O,20470
165856,chronic,B-NAME_OF_DISEASE,20470
165857,dry,I-NAME_OF_DISEASE,20470
165858,eye,I-NAME_OF_DISEASE,20470
165859,disease,I-NAME_OF_DISEASE,20470
165860,DED,I-NAME_OF_DISEASE,20470
165861,More,B-TIME_DURATION,20471
165862,than,I-TIME_DURATION,20471
165863,two,I-TIME_DURATION,20471
165864,decades,I-TIME_DURATION,20471
165865,of,O,20471
165866,research,O,20471
165867,has,O,20471
165868,helped,O,20471
165869,elucidate,O,20471
165870,the,O,20471
165871,role,O,20471
165872,of,O,20471
165873,inflammation,O,20471
165874,in,O,20471
165875,instigating,O,20471
165876,and,O,20471
165877,perpetuating,O,20471
165878,chronic,B-NAME_OF_DISEASE,20471
165879,dry,I-NAME_OF_DISEASE,20471
165880,eye,I-NAME_OF_DISEASE,20471
165881,It,O,20472
165882,is,O,20472
165883,now,O,20472
165884,considered,O,20472
165885,an,O,20472
165886,accepted,O,20472
165887,fact,O,20472
165888,that,O,20472
165889,chronic,B-NAME_OF_DISEASE,20472
165890,dry,I-NAME_OF_DISEASE,20472
165891,eye,I-NAME_OF_DISEASE,20472
165892,is,O,20472
165893,a,O,20472
165894,cyclical,O,20472
165895,inflammatory,O,20472
165896,process,O,20472
165897,Even,O,20473
165898,short-term,O,20473
165899,desiccating,O,20473
165900,stress,O,20473
165901,at,O,20473
165902,the,B-PART_OF_THE_EYES,20473
165903,ocular,I-PART_OF_THE_EYES,20473
165904,surface,I-PART_OF_THE_EYES,20473
165905,increases,O,20473
165906,osmolarity,O,20473
165907,causing,O,20473
165908,an,O,20473
165909,outflux,O,20473
165910,of,O,20473
165911,intracellular,O,20473
165912,fluid,O,20473
165913,and,O,20473
165914,thereby,O,20473
165915,yielding,O,20473
165916,cell,O,20473
165917,shrinkage,O,20473
165918,that,O,20473
165919,leads,O,20473
165920,to,O,20473
165921,the,O,20473
165922,release,O,20473
165923,of,O,20473
165924,inflammatory,O,20473
165925,mediators,O,20473
165926,such,O,20473
165927,as,O,20473
165928,interleukin-6,B-CHEMICAL_COMPOUND,20473
165929,and,I-CHEMICAL_COMPOUND,20473
165930,8,I-CHEMICAL_COMPOUND,20473
165931,These,O,20474
165932,mediators,O,20474
165933,further,O,20474
165934,decrease,O,20474
165935,tear,O,20474
165936,production,O,20474
165937,while,O,20474
165938,increasing,O,20474
165939,osmolarity-which,O,20474
165940,then,O,20474
165941,restarts,O,20474
165942,the,O,20474
165943,cycle,O,20474
165944,that,O,20474
165945,culminates,O,20474
165946,in,O,20474
165947,hallmark,O,20474
165948,symptoms,O,20474
165949,of,O,20474
165950,ocular,B-SIGN_AND_SYMPTOM,20474
165951,surface,I-SIGN_AND_SYMPTOM,20474
165952,discomfort,I-SIGN_AND_SYMPTOM,20474
165953,and,I-SIGN_AND_SYMPTOM,20474
165954,fluctuating,I-SIGN_AND_SYMPTOM,20474
165955,visual,I-SIGN_AND_SYMPTOM,20474
165956,acuity,I-SIGN_AND_SYMPTOM,20474
165957,Meanwhile,O,20475
165958,a,O,20475
165959,host,O,20475
165960,of,O,20475
165961,pro-inflammatory,O,20475
165962,cytokines,B-CHEMICAL_COMPOUND,20475
165963,chemokines,B-CHEMICAL_COMPOUND,20475
165964,and,O,20475
165965,their,O,20475
165966,receptors,O,20475
165967,have,O,20475
165968,been,O,20475
165969,implicated,O,20475
165970,in,O,20475
165971,playing,O,20475
165972,a,O,20475
165973,central,O,20475
165974,role,O,20475
165975,in,O,20475
165976,disease,O,20475
165977,progression,O,20475
165978,The,O,20476
165979,prevailing,O,20476
165980,theory,O,20476
165981,at,O,20476
165982,the,O,20476
165983,current,O,20476
165984,time,O,20476
165985,regarding,O,20476
165986,the,O,20476
165987,initial,O,20476
165988,cause,O,20476
165989,of,O,20476
165990,dry,B-NAME_OF_DISEASE,20476
165991,eye,I-NAME_OF_DISEASE,20476
165992,is,O,20476
165993,that,O,20476
165994,dysregulated,O,20476
165995,immune,O,20476
165996,system,O,20476
165997,responses-in,O,20476
165998,reaction,O,20476
165999,to,O,20476
166000,environmental,O,20476
166001,or,O,20476
166002,physiologic,O,20476
166003,stressors-initiate,O,20476
166004,and,O,20476
166005,sustain,O,20476
166006,the,O,20476
166007,abnormal,O,20476
166008,inflammatory,O,20476
166009,cycle,O,20476
166010,inherent,O,20476
166011,to,O,20476
166012,dry,B-NAME_OF_DISEASE,20476
166013,eye,I-NAME_OF_DISEASE,20476
166014,What,O,20477
166015,those,O,20477
166016,of,O,20477
166017,us,O,20477
166018,who,O,20477
166019,manage,O,20477
166020,patients,O,20477
166021,with,O,20477
166022,dry,B-NAME_OF_DISEASE,20477
166023,eye,I-NAME_OF_DISEASE,20477
166024,can,O,20477
166025,take,O,20477
166026,away,O,20477
166027,from,O,20477
166028,all,O,20477
166029,of,O,20477
166030,this,O,20477
166031,is,O,20477
166032,that,O,20477
166033,inflammation,O,20477
166034,plays,O,20477
166035,a,O,20477
166036,key,O,20477
166037,role,O,20477
166038,in,O,20477
166039,initiating,O,20477
166040,perpetuating,O,20477
166041,and,O,20477
166042,causing,O,20477
166043,dry,B-NAME_OF_DISEASE,20477
166044,eye,I-NAME_OF_DISEASE,20477
166045,progression,O,20477
166046,WHY,O,20478
166047,IPL,B-TREATMENT,20478
166048,MAKES,O,20478
166049,SENSE,O,20478
166050,The,O,20479
166051,classic,O,20479
166052,thinking,O,20479
166053,by,O,20479
166054,physicians,O,20479
166055,centered,O,20479
166056,around,O,20479
166057,the,O,20479
166058,use,O,20479
166059,of,O,20479
166060,intense,B-TREATMENT,20479
166061,pulsed,I-TREATMENT,20479
166062,light,I-TREATMENT,20479
166063,IPL,I-TREATMENT,20479
166064,in,O,20479
166065,treating,O,20479
166066,dry,B-NAME_OF_DISEASE,20479
166067,eye,I-NAME_OF_DISEASE,20479
166068,is,O,20479
166069,that,O,20479
166070,active,O,20479
166071,signs,O,20479
166072,of,O,20479
166073,inflammation,O,20479
166074,such,O,20479
166075,as,O,20479
166076,facial,O,20479
166077,and,O,20479
166078,or,O,20479
166079,ocular,B-NAME_OF_DISEASE,20479
166080,rosacea,I-NAME_OF_DISEASE,20479
166081,and,O,20479
166082,telangiectasia,B-SIGN_AND_SYMPTOM,20479
166083,or,O,20479
166084,meibomian,B-NAME_OF_DISEASE,20479
166085,gland,I-NAME_OF_DISEASE,20479
166086,dysfunction,I-NAME_OF_DISEASE,20479
166087,MGD,I-NAME_OF_DISEASE,20479
166088,indicate,O,20479
166089,the,O,20479
166090,treatment,O,20479
166091,might,O,20479
166092,be,O,20479
166093,successful,O,20479
166094,While,O,20480
166095,TRUE,O,20480
166096,there,O,20480
166097,is,O,20480
166098,a,O,20480
166099,wide,O,20480
166100,range,O,20480
166101,of,O,20480
166102,patients,O,20480
166103,for,O,20480
166104,whom,O,20480
166105,IPL,B-TREATMENT,20480
166106,is,O,20480
166107,a,O,20480
166108,good,O,20480
166109,option,O,20480
166110,As,O,20481
166111,has,O,20481
166112,been,O,20481
166113,learned,O,20481
166114,over,O,20481
166115,the,O,20481
166116,past,O,20481
166117,two,B-TIME_DURATION,20481
166118,decades,I-TIME_DURATION,20481
166119,inflammatory,O,20481
166120,processes,O,20481
166121,are,O,20481
166122,a,O,20481
166123,common,O,20481
166124,factor,O,20481
166125,in,O,20481
166126,all,O,20481
166127,forms,O,20481
166128,of,O,20481
166129,dry,O,20481
166130,eye-evaporative,O,20481
166131,and,O,20481
166132,aqueous,O,20481
166133,deficient,O,20481
166134,alike,O,20481
166135,In,O,20482
166136,short,O,20482
166137,IPL,B-TREATMENT,20482
166138,works,O,20482
166139,for,O,20482
166140,dry,B-NAME_OF_DISEASE,20482
166141,eye,I-NAME_OF_DISEASE,20482
166142,because,O,20482
166143,it,O,20482
166144,has,O,20482
166145,multiple,O,20482
166146,mechanisms,O,20482
166147,of,O,20482
166148,action,O,20482
166149,many,O,20482
166150,of,O,20482
166151,which,O,20482
166152,are,O,20482
166153,important,O,20482
166154,regardless,O,20482
166155,of,O,20482
166156,etiology,O,20482
166157,Light,O,20483
166158,energy,O,20483
166159,from,O,20483
166160,IPL,B-TREATMENT,20483
166161,warms,O,20483
166162,the,B-PART_OF_THE_EYES,20483
166163,meibomian,I-PART_OF_THE_EYES,20483
166164,glands,I-PART_OF_THE_EYES,20483
166165,thereby,O,20483
166166,facilitating,O,20483
166167,expression,O,20483
166168,of,O,20483
166169,meibum,O,20483
166170,There,O,20484
166171,is,O,20484
166172,evidence,O,20484
166173,that,O,20484
166174,IPL,B-TREATMENT,20484
166175,helps,O,20484
166176,restore,O,20484
166177,the,O,20484
166178,function,O,20484
166179,and,O,20484
166180,morphology,O,20484
166181,of,O,20484
166182,the,B-PART_OF_THE_EYES,20484
166183,meibomian,I-PART_OF_THE_EYES,20484
166184,glands,I-PART_OF_THE_EYES,20484
166185,The,O,20485
166186,wavelength,O,20485
166187,of,O,20485
166188,light,O,20485
166189,used,O,20485
166190,in,O,20485
166191,IPL,B-TREATMENT,20485
166192,is,O,20485
166193,selectively,O,20485
166194,absorbed,O,20485
166195,by,O,20485
166196,telangiectatic,O,20485
166197,blood,O,20485
166198,vessels,O,20485
166199,which,O,20485
166200,coagulates,O,20485
166201,them,O,20485
166202,This,O,20486
166203,has,O,20486
166204,a,O,20486
166205,dual,O,20486
166206,outcome,O,20486
166207,both,O,20486
166208,destroying,O,20486
166209,blood,O,20486
166210,vessels,O,20486
166211,that,O,20486
166212,perpetuate,O,20486
166213,inflammation,O,20486
166214,and,O,20486
166215,decreasing,O,20486
166216,the,O,20486
166217,levels,O,20486
166218,of,O,20486
166219,pro-inflammatory,O,20486
166220,mediators,O,20486
166221,that,O,20486
166222,contribute,O,20486
166223,to,O,20486
166224,dry,B-NAME_OF_DISEASE,20486
166225,eye,I-NAME_OF_DISEASE,20486
166226,IPL,B-TREATMENT,20487
166227,reduces,O,20487
166228,the,O,20487
166229,load,O,20487
166230,of,O,20487
166231,demodex,B-CAUSE_OF_DISEASE,20487
166232,mites,I-CAUSE_OF_DISEASE,20487
166233,that,O,20487
166234,stimulate,O,20487
166235,infection,O,20487
166236,The,O,20488
166237,light,O,20488
166238,energy,O,20488
166239,in,O,20488
166240,IPL,B-TREATMENT,20488
166241,is,O,20488
166242,absorbed,O,20488
166243,by,O,20488
166244,cytochrome,B-CHEMICAL_COMPOUND,20488
166245,C,I-CHEMICAL_COMPOUND,20488
166246,within,O,20488
166247,the,O,20488
166248,mitochondria,O,20488
166249,which,O,20488
166250,is,O,20488
166251,active,O,20488
166252,in,O,20488
166253,the,O,20488
166254,electron,O,20488
166255,transport,O,20488
166256,chain,O,20488
166257,ETC,O,20488
166258,In,O,20489
166259,turn,O,20489
166260,this,O,20489
166261,improves,O,20489
166262,adenosine,B-CHEMICAL_COMPOUND,20489
166263,triphosphate,I-CHEMICAL_COMPOUND,20489
166264,ATP,I-CHEMICAL_COMPOUND,20489
166265,production,O,20489
166266,which,O,20489
166267,facilitates,O,20489
166268,important,O,20489
166269,cellular,O,20489
166270,functions,O,20489
166271,such,O,20489
166272,as,O,20489
166273,collagen,B-CHEMICAL_COMPOUND,20489
166274,synthesis,O,20489
166275,in,O,20489
166276,fibroblasts,B-PART_OF_THE_EYES,20489
166277,and,O,20489
166278,motility,O,20489
166279,in,O,20489
166280,immunoregulatory,O,20489
166281,cells,O,20489
166282,As,O,20490
166283,an,O,20490
166284,additional,O,20490
166285,note,O,20490
166286,IPL,B-TREATMENT,20490
166287,treatment,I-TREATMENT,20490
166288,also,O,20490
166289,indirectly,O,20490
166290,interrupts,O,20490
166291,the,O,20490
166292,dry,B-NAME_OF_DISEASE,20490
166293,eye,I-NAME_OF_DISEASE,20490
166294,inflammation,O,20490
166295,cycle,O,20490
166296,by,O,20490
166297,reducing,O,20490
166298,the,O,20490
166299,osmolarity,O,20490
166300,of,O,20490
166301,the,B-PART_OF_THE_EYES,20490
166302,tear,I-PART_OF_THE_EYES,20490
166303,film,I-PART_OF_THE_EYES,20490
166304,to,O,20490
166305,normal,O,20490
166306,levels,O,20490
166307,Over,B-TIME_DURATION,20491
166308,the,I-TIME_DURATION,20491
166309,past,I-TIME_DURATION,20491
166310,decade,I-TIME_DURATION,20491
166311,clinical,O,20491
166312,studies,O,20491
166313,have,O,20491
166314,demonstrated,O,20491
166315,the,O,20491
166316,effectiveness,O,20491
166317,of,O,20491
166318,Lumenis,B-ORGANIZATION,20491
166319,IPL,B-TREATMENT,20491
166320,platforms,O,20491
166321,for,O,20491
166322,treating,O,20491
166323,DED,B-NAME_OF_DISEASE,20491
166324,In,O,20492
166325,our,O,20492
166326,view,O,20492
166327,using,O,20492
166328,Lumenis,B-ORGANIZATION,20492
166329,IPL,B-TREATMENT,20492
166330,technology,I-TREATMENT,20492
166331,has,O,20492
166332,several,O,20492
166333,advantages,O,20492
166334,First,O,20493
166335,the,O,20493
166336,company,O,20493
166337,has,O,20493
166338,been,O,20493
166339,in,O,20493
166340,the,O,20493
166341,space,O,20493
166342,for,O,20493
166343,decades,B-TIME_DURATION,20493
166344,For,O,20494
166345,those,O,20494
166346,interested,O,20494
166347,in,O,20494
166348,using,O,20494
166349,IPL,B-TREATMENT,20494
166350,in,O,20494
166351,applications,O,20494
166352,outside,O,20494
166353,of,O,20494
166354,eye,O,20494
166355,care-including,O,20494
166356,medical,O,20494
166357,aesthetic,O,20494
166358,the,B-TREATMENT,20494
166359,Optima,I-TREATMENT,20494
166360,IPL,I-TREATMENT,20494
166361,is,O,20494
166362,part,O,20494
166363,of,O,20494
166364,the,O,20494
166365,modular,O,20494
166366,aesthetic,O,20494
166367,laser,O,20494
166368,multi-application,O,20494
166369,platform,O,20494
166370,M22,O,20494
166371,which,O,20494
166372,allows,O,20494
166373,a,O,20494
166374,user,O,20494
166375,to,O,20494
166376,select,O,20494
166377,and,O,20494
166378,use,O,20494
166379,different,O,20494
166380,wavelengths,O,20494
166381,of,O,20494
166382,light,O,20494
166383,With,O,20495
166384,regard,O,20495
166385,to,O,20495
166386,the,B-TREATMENT,20495
166387,Optima,I-TREATMENT,20495
166388,IPL,I-TREATMENT,20495
166389,specifically,O,20495
166390,the,O,20495
166391,platform,O,20495
166392,permits,O,20495
166393,higher,O,20495
166394,energy,O,20495
166395,levels,O,20495
166396,for,O,20495
166397,effective,O,20495
166398,treatment,O,20495
166399,of,O,20495
166400,inflammation,O,20495
166401,while,O,20495
166402,maintaining,O,20495
166403,patient,O,20495
166404,comfort,O,20495
166405,with,O,20495
166406,a,O,20495
166407,unique,O,20495
166408,cooling,O,20495
166409,system,O,20495
166410,Some,O,20496
166411,of,O,20496
166412,the,O,20496
166413,features,O,20496
166414,noted,O,20496
166415,above,O,20496
166416,speak,O,20496
166417,to,O,20496
166418,the,O,20496
166419,broad,O,20496
166420,applications,O,20496
166421,of,O,20496
166422,IPL,B-TREATMENT,20496
166423,in,O,20496
166424,treating,O,20496
166425,the,O,20496
166426,skin,O,20496
166427,on,O,20496
166428,the,O,20496
166429,face,O,20496
166430,and,O,20496
166431,around,O,20496
166432,the,O,20496
166433,eye,O,20496
166434,as,O,20496
166435,well,O,20496
166436,as,O,20496
166437,for,O,20496
166438,treating,O,20496
166439,the,B-PART_OF_THE_EYES,20496
166440,ocular,I-PART_OF_THE_EYES,20496
166441,surface,I-PART_OF_THE_EYES,20496
166442,But,O,20497
166443,even,O,20497
166444,within,O,20497
166445,the,O,20497
166446,category,O,20497
166447,of,O,20497
166448,ocular,B-NAME_OF_DISEASE,20497
166449,surface,I-NAME_OF_DISEASE,20497
166450,disease,I-NAME_OF_DISEASE,20497
166451,OSD,I-NAME_OF_DISEASE,20497
166452,there,O,20497
166453,is,O,20497
166454,wide,O,20497
166455,range,O,20497
166456,of,O,20497
166457,patients,O,20497
166458,for,O,20497
166459,whom,O,20497
166460,IPL,B-TREATMENT,20497
166461,makes,O,20497
166462,sense,O,20497
166463,Generally,O,20498
166464,speaking,O,20498
166465,patients,O,20498
166466,who,O,20498
166467,have,O,20498
166468,tried,O,20498
166469,traditional,O,20498
166470,therapies,O,20498
166471,and,O,20498
166472,are,O,20498
166473,still,O,20498
166474,struggling,O,20498
166475,may,O,20498
166476,get,O,20498
166477,relief,O,20498
166478,from,O,20498
166479,their,O,20498
166480,dry,B-NAME_OF_DISEASE,20498
166481,eye,I-NAME_OF_DISEASE,20498
166482,symptoms,O,20498
166483,with,O,20498
166484,IPL,B-TREATMENT,20498
166485,The,O,20499
166486,fundamental,O,20499
166487,reason,O,20499
166488,IPL,B-TREATMENT,20499
166489,is,O,20499
166490,successful,O,20499
166491,for,O,20499
166492,dry,B-NAME_OF_DISEASE,20499
166493,eye,I-NAME_OF_DISEASE,20499
166494,is,O,20499
166495,that,O,20499
166496,it,O,20499
166497,treats,O,20499
166498,the,O,20499
166499,upstream,O,20499
166500,inflammatory,O,20499
166501,root,O,20499
166502,cause,O,20499
166503,of,O,20499
166504,DED-not,O,20499
166505,just,O,20499
166506,the,O,20499
166507,downstream,O,20499
166508,consequences,O,20499
166509,as,O,20499
166510,its,O,20499
166511,multiple,O,20499
166512,mechanisms,O,20499
166513,of,O,20499
166514,action,O,20499
166515,collectively,O,20499
166516,interrupt,O,20499
166517,the,O,20499
166518,vicious,O,20499
166519,inflammatory,O,20499
166520,cycle,O,20499
166521,that,O,20499
166522,instigates,O,20499
166523,and,O,20499
166524,perpetuates,O,20499
166525,dry,B-NAME_OF_DISEASE,20499
166526,eye,I-NAME_OF_DISEASE,20499
166527,It,O,20500
166528,is,O,20500
166529,an,O,20500
166530,effective,O,20500
166531,standalone,O,20500
166532,procedure,O,20500
166533,for,O,20500
166534,patients,O,20500
166535,suffering,O,20500
166536,with,O,20500
166537,aqueous,O,20500
166538,deficient,O,20500
166539,evaporative,O,20500
166540,or,O,20500
166541,mixed,O,20500
166542,modal,O,20500
166543,etiology,O,20500
166544,dry,B-NAME_OF_DISEASE,20500
166545,eye,I-NAME_OF_DISEASE,20500
166546,IPL,B-TREATMENT,20501
166547,can,O,20501
166548,also,O,20501
166549,easily,O,20501
166550,be,O,20501
166551,added,O,20501
166552,to,O,20501
166553,pharmacology,O,20501
166554,or,O,20501
166555,other,O,20501
166556,device-based,O,20501
166557,treatments,O,20501
166558,in,O,20501
166559,a,O,20501
166560,multimodality,O,20501
166561,approach,O,20501
166562,to,O,20501
166563,treating,O,20501
166564,the,O,20501
166565,multifactorial,O,20501
166566,entity,O,20501
166567,of,O,20501
166568,DED,B-NAME_OF_DISEASE,20501
166569,Ocular,B-NAME_OF_DISEASE,20502
166570,melanoma,I-NAME_OF_DISEASE,20502
166571,is,O,20502
166572,the,O,20502
166573,most,O,20502
166574,common,O,20502
166575,primary,O,20502
166576,cancer,B-NAME_OF_DISEASE,20502
166577,of,I-NAME_OF_DISEASE,20502
166578,the,I-NAME_OF_DISEASE,20502
166579,eye,I-NAME_OF_DISEASE,20502
166580,in,O,20502
166581,adults,O,20502
166582,Called,O,20503
166583,OM,B-NAME_OF_DISEASE,20503
166584,for,O,20503
166585,short,O,20503
166586,ocular,B-NAME_OF_DISEASE,20503
166587,melanoma,I-NAME_OF_DISEASE,20503
166588,is,O,20503
166589,a,O,20503
166590,malignant,O,20503
166591,tumor,O,20503
166592,that,O,20503
166593,can,O,20503
166594,grow,O,20503
166595,and,O,20503
166596,spread,O,20503
166597,to,O,20503
166598,other,O,20503
166599,parts,O,20503
166600,of,O,20503
166601,the,O,20503
166602,body,O,20503
166603,this,O,20503
166604,process,O,20503
166605,known,O,20503
166606,as,O,20503
166607,metastasis,O,20503
166608,is,O,20503
166609,often,O,20503
166610,fatal,O,20503
166611,and,O,20503
166612,occurs,O,20503
166613,in,O,20503
166614,about,O,20503
166615,half,O,20503
166616,of,O,20503
166617,all,O,20503
166618,cases,O,20503
166619,Although,O,20504
166620,produced,O,20504
166621,from,O,20504
166622,the,O,20504
166623,same,O,20504
166624,cells,O,20504
166625,in,O,20504
166626,the,O,20504
166627,body,O,20504
166628,called,O,20504
166629,melanocytes,O,20504
166630,OM,B-NAME_OF_DISEASE,20504
166631,is,O,20504
166632,different,O,20504
166633,from,O,20504
166634,skin,B-NAME_OF_DISEASE,20504
166635,or,I-NAME_OF_DISEASE,20504
166636,cutaneous,I-NAME_OF_DISEASE,20504
166637,melanoma,I-NAME_OF_DISEASE,20504
166638,and,O,20504
166639,is,O,20504
166640,not,O,20504
166641,related,O,20504
166642,to,O,20504
166643,sun,O,20504
166644,exposure,O,20504
166645,Ocular,B-NAME_OF_DISEASE,20505
166646,Melanoma,I-NAME_OF_DISEASE,20505
166647,is,O,20505
166648,the,O,20505
166649,second,O,20505
166650,most,O,20505
166651,common,O,20505
166652,type,O,20505
166653,of,O,20505
166654,melanoma,B-NAME_OF_DISEASE,20505
166655,after,O,20505
166656,cutaneous,O,20505
166657,and,O,20505
166658,represents,O,20505
166659,about,O,20505
166660,5%,O,20505
166661,of,O,20505
166662,all,O,20505
166663,melanomas,B-NAME_OF_DISEASE,20505
166664,Similar,O,20506
166665,to,O,20506
166666,melanoma,B-NAME_OF_DISEASE,20506
166667,of,I-NAME_OF_DISEASE,20506
166668,the,I-NAME_OF_DISEASE,20506
166669,skin,I-NAME_OF_DISEASE,20506
166670,OM,B-NAME_OF_DISEASE,20506
166671,is,O,20506
166672,a,O,20506
166673,little,O,20506
166674,understood,O,20506
166675,and,O,20506
166676,silent,O,20506
166677,killer,O,20506
166678,In,O,20507
166679,the,O,20507
166680,majority,O,20507
166681,of,O,20507
166682,cases,O,20507
166683,ocular,B-NAME_OF_DISEASE,20507
166684,melanoma,I-NAME_OF_DISEASE,20507
166685,develops,O,20507
166686,slowly,O,20507
166687,from,O,20507
166688,the,O,20507
166689,pigmented,O,20507
166690,cells,O,20507
166691,of,O,20507
166692,the,O,20507
166693,choroid,O,20507
166694,choroidal,B-NAME_OF_DISEASE,20507
166695,melanoma,I-NAME_OF_DISEASE,20507
166696,but,O,20507
166697,it,O,20507
166698,also,O,20507
166699,can,O,20507
166700,develop,O,20507
166701,from,O,20507
166702,the,O,20507
166703,pigmented,O,20507
166704,cells,O,20507
166705,of,O,20507
166706,the,B-PART_OF_THE_EYES,20507
166707,iris,I-PART_OF_THE_EYES,20507
166708,and,O,20507
166709,ciliary,B-PART_OF_THE_EYES,20507
166710,body,I-PART_OF_THE_EYES,20507
166711,It,O,20508
166712,is,O,20508
166713,also,O,20508
166714,called,O,20508
166715,uveal,B-NAME_OF_DISEASE,20508
166716,melanoma,I-NAME_OF_DISEASE,20508
166717,because,O,20508
166718,the,B-PART_OF_THE_EYES,20508
166719,uvea,I-PART_OF_THE_EYES,20508
166720,is,O,20508
166721,a,O,20508
166722,part,O,20508
166723,of,O,20508
166724,the,O,20508
166725,eye,O,20508
166726,containing,O,20508
166727,two,O,20508
166728,areas,O,20508
166729,in,O,20508
166730,which,O,20508
166731,OM,B-NAME_OF_DISEASE,20508
166732,can,O,20508
166733,commonly,O,20508
166734,occur,O,20508
166735,OM,B-NAME_OF_DISEASE,20509
166736,is,O,20509
166737,an,O,20509
166738,aggressive,O,20509
166739,form,O,20509
166740,of,O,20509
166741,cancer,B-NAME_OF_DISEASE,20509
166742,that,O,20509
166743,can,O,20509
166744,involve,O,20509
166745,any,O,20509
166746,of,O,20509
166747,three,O,20509
166748,areas,O,20509
166749,of,O,20509
166750,the,O,20509
166751,eye,O,20509
166752,the,B-PART_OF_THE_EYES,20509
166753,iris,I-PART_OF_THE_EYES,20509
166754,the,O,20509
166755,pigmented,O,20509
166756,area,O,20509
166757,surrounding,O,20509
166758,your,O,20509
166759,pupil,B-PART_OF_THE_EYES,20509
166760,the,B-PART_OF_THE_EYES,20509
166761,ciliary,I-PART_OF_THE_EYES,20509
166762,body,I-PART_OF_THE_EYES,20509
166763,a,O,20509
166764,thin,O,20509
166765,tissue,O,20509
166766,layer,O,20509
166767,in,O,20509
166768,your,O,20509
166769,eye,O,20509
166770,responsible,O,20509
166771,for,O,20509
166772,aqueous,B-PART_OF_THE_EYES,20509
166773,humor,I-PART_OF_THE_EYES,20509
166774,production,O,20509
166775,and,O,20509
166776,or,O,20509
166777,the,B-PART_OF_THE_EYES,20509
166778,choroid,I-PART_OF_THE_EYES,20509
166779,or,O,20509
166780,posterior,B-PART_OF_THE_EYES,20509
166781,uvea,I-PART_OF_THE_EYES,20509
166782,the,O,20509
166783,vascular,O,20509
166784,layer,O,20509
166785,of,O,20509
166786,the,O,20509
166787,eye,O,20509
166788,between,O,20509
166789,the,B-PART_OF_THE_EYES,20509
166790,retina,I-PART_OF_THE_EYES,20509
166791,and,O,20509
166792,the,O,20509
166793,white,O,20509
166794,outer,O,20509
166795,layer,O,20509
166796,known,O,20509
166797,as,O,20509
166798,the,B-PART_OF_THE_EYES,20509
166799,sclera,I-PART_OF_THE_EYES,20509
166800,this,O,20509
166801,pigmented,O,20509
166802,tissue,O,20509
166803,full,O,20509
166804,of,O,20509
166805,blood,O,20509
166806,vessels,O,20509
166807,nourishes,O,20509
166808,the,B-PART_OF_THE_EYES,20509
166809,retina,I-PART_OF_THE_EYES,20509
166810,These,O,20510
166811,three,O,20510
166812,areas,O,20510
166813,are,O,20510
166814,collectively,O,20510
166815,known,O,20510
166816,as,O,20510
166817,the,B-PART_OF_THE_EYES,20510
166818,uvea,I-PART_OF_THE_EYES,20510
166819,or,O,20510
166820,uveal,B-PART_OF_THE_EYES,20510
166821,tract,I-PART_OF_THE_EYES,20510
166822,and,O,20510
166823,OM,B-NAME_OF_DISEASE,20510
166824,can,O,20510
166825,occur,O,20510
166826,in,O,20510
166827,any,O,20510
166828,combination,O,20510
166829,of,O,20510
166830,the,O,20510
166831,three,O,20510
166832,Iris,B-NAME_OF_DISEASE,20511
166833,melanomas,I-NAME_OF_DISEASE,20511
166834,have,O,20511
166835,the,O,20511
166836,best,O,20511
166837,prognosis,O,20511
166838,whereas,O,20511
166839,melanomas,B-NAME_OF_DISEASE,20511
166840,of,O,20511
166841,the,B-PART_OF_THE_EYES,20511
166842,ciliary,I-PART_OF_THE_EYES,20511
166843,body,I-PART_OF_THE_EYES,20511
166844,have,O,20511
166845,the,O,20511
166846,worst,O,20511
166847,Most,O,20512
166848,uveal,B-NAME_OF_DISEASE,20512
166849,tract,I-NAME_OF_DISEASE,20512
166850,melanomas,I-NAME_OF_DISEASE,20512
166851,originate,O,20512
166852,in,O,20512
166853,the,B-PART_OF_THE_EYES,20512
166854,choroid,I-PART_OF_THE_EYES,20512
166855,the,B-PART_OF_THE_EYES,20512
166856,ciliary,I-PART_OF_THE_EYES,20512
166857,body,I-PART_OF_THE_EYES,20512
166858,is,O,20512
166859,less,O,20512
166860,commonly,O,20512
166861,a,O,20512
166862,site,O,20512
166863,of,O,20512
166864,origin,O,20512
166865,and,O,20512
166866,the,B-PART_OF_THE_EYES,20512
166867,iris,I-PART_OF_THE_EYES,20512
166868,is,O,20512
166869,the,O,20512
166870,least,O,20512
166871,common,O,20512
166872,Melanoma,B-NAME_OF_DISEASE,20513
166873,can,O,20513
166874,also,O,20513
166875,occur,O,20513
166876,in,O,20513
166877,the,O,20513
166878,thin,O,20513
166879,lining,O,20513
166880,over,O,20513
166881,the,O,20513
166882,white,O,20513
166883,part,O,20513
166884,of,O,20513
166885,the,O,20513
166886,eye,O,20513
166887,the,B-PART_OF_THE_EYES,20513
166888,conjunctiva,I-PART_OF_THE_EYES,20513
166889,or,O,20513
166890,on,O,20513
166891,the,B-PART_OF_THE_EYES,20513
166892,eyelid,I-PART_OF_THE_EYES,20513
166893,but,O,20513
166894,this,O,20513
166895,is,O,20513
166896,very,O,20513
166897,rare,O,20513
166898,OM,B-NAME_OF_DISEASE,20514
166899,tumors,O,20514
166900,arise,O,20514
166901,from,O,20514
166902,the,O,20514
166903,pigment,O,20514
166904,cells,O,20514
166905,melanocytes,O,20514
166906,that,O,20514
166907,give,O,20514
166908,color,O,20514
166909,to,O,20514
166910,the,O,20514
166911,eye,O,20514
166912,Formation,O,20515
166913,of,O,20515
166914,these,O,20515
166915,tumors,O,20515
166916,is,O,20515
166917,quite,O,20515
166918,rare,O,20515
166919,and,O,20515
166920,as,O,20515
166921,for,O,20515
166922,many,O,20515
166923,other,O,20515
166924,forms,O,20515
166925,of,O,20515
166926,cancer,B-NAME_OF_DISEASE,20515
166927,the,O,20515
166928,exact,O,20515
166929,cause,O,20515
166930,is,O,20515
166931,unknown,O,20515
166932,It,O,20516
166933,is,O,20516
166934,known,O,20516
166935,that,O,20516
166936,exposure,B-CAUSE_OF_DISEASE,20516
166937,to,I-CAUSE_OF_DISEASE,20516
166938,ultraviolet,I-CAUSE_OF_DISEASE,20516
166939,UV,I-CAUSE_OF_DISEASE,20516
166940,rays,I-CAUSE_OF_DISEASE,20516
166941,either,I-CAUSE_OF_DISEASE,20516
166942,from,I-CAUSE_OF_DISEASE,20516
166943,the,I-CAUSE_OF_DISEASE,20516
166944,sun,I-CAUSE_OF_DISEASE,20516
166945,or,I-CAUSE_OF_DISEASE,20516
166946,sunbeds,I-CAUSE_OF_DISEASE,20516
166947,increases,O,20516
166948,the,O,20516
166949,risk,O,20516
166950,of,O,20516
166951,developing,O,20516
166952,melanoma,B-NAME_OF_DISEASE,20516
166953,of,I-NAME_OF_DISEASE,20516
166954,the,I-NAME_OF_DISEASE,20516
166955,skin,I-NAME_OF_DISEASE,20516
166956,However,O,20517
166957,there,O,20517
166958,has,O,20517
166959,no,O,20517
166960,conclusive,O,20517
166961,evidence,O,20517
166962,linking,O,20517
166963,UV,O,20517
166964,exposure,O,20517
166965,and,O,20517
166966,OM,B-NAME_OF_DISEASE,20517
166967,LIGHT-ACTIVATED,B-TREATMENT,20518
166968,AU-011,I-TREATMENT,20518
166969,has,O,20518
166970,the,O,20518
166971,potential,O,20518
166972,to,O,20518
166973,be,O,20518
166974,the,O,20518
166975,first,O,20518
166976,targeted,O,20518
166977,therapy,O,20518
166978,ever,O,20518
166979,developed,O,20518
166980,for,O,20518
166981,the,O,20518
166982,primary,O,20518
166983,treatment,O,20518
166984,of,O,20518
166985,ocular,B-NAME_OF_DISEASE,20518
166986,melanoma,I-NAME_OF_DISEASE,20518
166987,the,O,20518
166988,most,O,20518
166989,common,O,20518
166990,primary,O,20518
166991,cancer,B-NAME_OF_DISEASE,20518
166992,of,I-NAME_OF_DISEASE,20518
166993,the,I-NAME_OF_DISEASE,20518
166994,eye,I-NAME_OF_DISEASE,20518
166995,said,O,20518
166996,Amy,B-PERSON,20518
166997,C,I-PERSON,20518
166998,Schefler,I-PERSON,20518
166999,MD,I-PERSON,20518
167000,with,O,20518
167001,Retina,O,20518
167002,Consultants,O,20518
167003,of,O,20518
167004,Houston,O,20518
167005,People,O,20519
167006,diagnosed,O,20519
167007,with,O,20519
167008,ocular,B-NAME_OF_DISEASE,20519
167009,melanoma,I-NAME_OF_DISEASE,20519
167010,confront,O,20519
167011,an,O,20519
167012,array,O,20519
167013,of,O,20519
167014,poor,O,20519
167015,treatment,O,20519
167016,options,O,20519
167017,which,O,20519
167018,often,O,20519
167019,result,O,20519
167020,in,O,20519
167021,severe,B-SIGN_AND_SYMPTOM,20519
167022,vision,I-SIGN_AND_SYMPTOM,20519
167023,loss,I-SIGN_AND_SYMPTOM,20519
167024,removal,O,20519
167025,of,O,20519
167026,the,O,20519
167027,eye,O,20519
167028,and,O,20519
167029,in,O,20519
167030,about,O,20519
167031,half,O,20519
167032,of,O,20519
167033,all,O,20519
167034,cases,O,20519
167035,metastasis,O,20519
167036,to,O,20519
167037,the,O,20519
167038,liver,O,20519
167039,where,O,20519
167040,the,O,20519
167041,disease,O,20519
167042,is,O,20519
167043,nearly,O,20519
167044,always,O,20519
167045,fatal,O,20519
167046,according,O,20519
167047,to,O,20519
167048,Aura,B-ORGANIZATION,20519
167049,Biosciences,I-ORGANIZATION,20519
167050,which,O,20519
167051,developed,O,20519
167052,this,O,20519
167053,light-activated,O,20519
167054,technology,O,20519
167055,AU-011,B-TREATMENT,20520
167056,is,O,20520
167057,a,O,20520
167058,first-in-class,O,20520
167059,targeted,O,20520
167060,therapy,O,20520
167061,a,O,20520
167062,novel,O,20520
167063,protein,O,20520
167064,capsid-dye,O,20520
167065,conjugate,O,20520
167066,recombinantly,O,20520
167067,derived,O,20520
167068,from,O,20520
167069,the,B-CHEMICAL_COMPOUND,20520
167070,capsid,I-CHEMICAL_COMPOUND,20520
167071,proteins,I-CHEMICAL_COMPOUND,20520
167072,of,O,20520
167073,the,O,20520
167074,papilloma,O,20520
167075,virus,O,20520
167076,the,B-PERSON,20520
167077,FDA,B-PERSON,20520
167078,has,O,20520
167079,already,O,20520
167080,granted,O,20520
167081,Fast,O,20520
167082,Track,O,20520
167083,Designation,O,20520
167084,and,O,20520
167085,Orphan,O,20520
167086,Drug,O,20520
167087,Designation,O,20520
167088,recognizing,O,20520
167089,that,O,20520
167090,there,O,20520
167091,are,O,20520
167092,no,O,20520
167093,FDA-approved,O,20520
167094,therapies,O,20520
167095,and,O,20520
167096,that,O,20520
167097,the,O,20520
167098,disease,O,20520
167099,is,O,20520
167100,serious,O,20520
167101,and,O,20520
167102,life-threatening,O,20520
167103,Dr,B-PERSON,20520
167104,Schefler,I-PERSON,20520
167105,said,O,20520
167106,The,O,20521
167107,mechanism,O,20521
167108,of,O,20521
167109,action,O,20521
167110,of,O,20521
167111,AU-011,B-TREATMENT,20521
167112,is,O,20521
167113,targeted,O,20521
167114,acute,O,20521
167115,tumor,O,20521
167116,cellular,O,20521
167117,necrosis,O,20521
167118,upon,O,20521
167119,light,O,20521
167120,activation,O,20521
167121,The,B-CHEMICAL_COMPOUND,20522
167122,capsid,I-CHEMICAL_COMPOUND,20522
167123,conjugates,I-CHEMICAL_COMPOUND,20522
167124,are,O,20522
167125,delivered,O,20522
167126,by,O,20522
167127,intravitreal,O,20522
167128,injection,O,20522
167129,and,O,20522
167130,selectively,O,20522
167131,target,O,20522
167132,the,O,20522
167133,tumor,O,20522
167134,cells,O,20522
167135,in,O,20522
167136,the,B-PART_OF_THE_EYES,20522
167137,choroid,I-PART_OF_THE_EYES,20522
167138,sparing,O,20522
167139,the,B-PART_OF_THE_EYES,20522
167140,retina,I-PART_OF_THE_EYES,20522
167141,and,O,20522
167142,other,O,20522
167143,key,O,20522
167144,ocular,O,20522
167145,structures,O,20522
167146,This,O,20523
167147,unique,O,20523
167148,selectivity,O,20523
167149,is,O,20523
167150,due,O,20523
167151,to,O,20523
167152,the,O,20523
167153,binding,O,20523
167154,of,O,20523
167155,the,B-CHEMICAL_COMPOUND,20523
167156,capsid,I-CHEMICAL_COMPOUND,20523
167157,conjugates,I-CHEMICAL_COMPOUND,20523
167158,to,O,20523
167159,modified,O,20523
167160,heparan,B-CHEMICAL_COMPOUND,20523
167161,sulfate,I-CHEMICAL_COMPOUND,20523
167162,proteoglycans,I-CHEMICAL_COMPOUND,20523
167163,HSPGs,I-CHEMICAL_COMPOUND,20523
167164,that,O,20523
167165,are,O,20523
167166,expressed,O,20523
167167,on,O,20523
167168,the,O,20523
167169,tumor,O,20523
167170,cell,O,20523
167171,surface,O,20523
167172,The,B-CHEMICAL_COMPOUND,20524
167173,capsid,I-CHEMICAL_COMPOUND,20524
167174,protein,I-CHEMICAL_COMPOUND,20524
167175,is,O,20524
167176,conjugated,O,20524
167177,with,O,20524
167178,a,O,20524
167179,potent,O,20524
167180,phthalocyanine,O,20524
167181,photosensitizer,O,20524
167182,IRDye,B-CHEMICAL_COMPOUND,20524
167183,700DX,I-CHEMICAL_COMPOUND,20524
167184,that,O,20524
167185,exerts,O,20524
167186,its,O,20524
167187,tumor,O,20524
167188,cytotoxic,O,20524
167189,effect,O,20524
167190,through,O,20524
167191,light-activation,O,20524
167192,with,O,20524
167193,a,O,20524
167194,near-infrared,O,20524
167195,689-nm,O,20524
167196,laser,O,20524
167197,First,O,20525
167198,the,B-CHEMICAL_COMPOUND,20525
167199,capsid,I-CHEMICAL_COMPOUND,20525
167200,conjugates,I-CHEMICAL_COMPOUND,20525
167201,bind,O,20525
167202,tumor,O,20525
167203,cells,O,20525
167204,selectively,O,20525
167205,without,O,20525
167206,binding,O,20525
167207,other,O,20525
167208,key,O,20525
167209,eye,O,20525
167210,structures,O,20525
167211,and,O,20525
167212,second,O,20525
167213,the,O,20525
167214,laser,O,20525
167215,beam,O,20525
167216,activates,O,20525
167217,the,O,20525
167218,conjugated,O,20525
167219,dye,O,20525
167220,exclusively,O,20525
167221,within,O,20525
167222,the,O,20525
167223,tumor,O,20525
167224,generating,O,20525
167225,potent,O,20525
167226,cytotoxic,O,20525
167227,oxygen,B-CHEMICAL_COMPOUND,20525
167228,free,O,20525
167229,radical,O,20525
167230,species,O,20525
167231,that,O,20525
167232,disrupt,O,20525
167233,the,O,20525
167234,tumor,O,20525
167235,cell,O,20525
167236,membrane,O,20525
167237,leading,O,20525
167238,to,O,20525
167239,targeted,O,20525
167240,and,O,20525
167241,acute,O,20525
167242,tumor,O,20525
167243,cellular,O,20525
167244,necrosis,O,20525
167245,Dr,B-PERSON,20525
167246,Schefler,I-PERSON,20525
167247,said,O,20525
167248,In,O,20526
167249,preclinical,O,20526
167250,ocular,O,20526
167251,tumor,O,20526
167252,rabbit,O,20526
167253,models,O,20526
167254,animals,O,20526
167255,were,O,20526
167256,treated,O,20526
167257,with,O,20526
167258,two,O,20526
167259,weekly,O,20526
167260,doses,O,20526
167261,of,O,20526
167262,light,B-TREATMENT,20526
167263,activated,I-TREATMENT,20526
167264,AU-011,I-TREATMENT,20526
167265,on,O,20526
167266,day,O,20526
167267,1,O,20526
167268,and,O,20526
167269,day,O,20526
167270,8,O,20526
167271,The,O,20527
167272,results,O,20527
167273,demonstrated,O,20527
167274,complete,O,20527
167275,necrosis,O,20527
167276,in,O,20527
167277,the,O,20527
167278,tumors,O,20527
167279,implanted,O,20527
167280,in,O,20527
167281,the,B-PART_OF_THE_EYES,20527
167282,choroid,I-PART_OF_THE_EYES,20527
167283,with,O,20527
167284,no,O,20527
167285,damage,O,20527
167286,to,O,20527
167287,the,B-PART_OF_THE_EYES,20527
167288,adjacent,I-PART_OF_THE_EYES,20527
167289,retina,I-PART_OF_THE_EYES,20527
167290,even,O,20527
167291,in,O,20527
167292,tumors,O,20527
167293,measuring,O,20527
167294,10mm,O,20527
167295,in,O,20527
167296,thickness,O,20527
167297,Dr,B-PERSON,20527
167298,Schefler,I-PERSON,20527
167299,said,O,20527
167300,The,O,20528
167301,animal,O,20528
167302,data,O,20528
167303,showed,O,20528
167304,a,O,20528
167305,dose,O,20528
167306,response,O,20528
167307,effect,O,20528
167308,which,O,20528
167309,means,O,20528
167310,that,O,20528
167311,with,O,20528
167312,higher,O,20528
167313,doses,O,20528
167314,of,O,20528
167315,the,O,20528
167316,drug,O,20528
167317,the,O,20528
167318,tumor,O,20528
167319,necrosis,O,20528
167320,increased,O,20528
167321,while,O,20528
167322,the,B-PART_OF_THE_EYES,20528
167323,retina,I-PART_OF_THE_EYES,20528
167324,and,O,20528
167325,other,O,20528
167326,healthy,O,20528
167327,tissue,O,20528
167328,were,O,20528
167329,not,O,20528
167330,affected,O,20528
167331,she,O,20528
167332,said,O,20528
167333,The,O,20529
167334,strength,O,20529
167335,of,O,20529
167336,this,O,20529
167337,preclinical,O,20529
167338,data,O,20529
167339,enabled,O,20529
167340,the,O,20529
167341,Orphan,O,20529
167342,Drug,O,20529
167343,Designation,O,20529
167344,by,O,20529
167345,the,B-ORGANIZATION,20529
167346,FDA,I-ORGANIZATION,20529
167347,in,O,20529
167348,2015,O,20529
167349,Dr,B-PERSON,20530
167350,Schefler,I-PERSON,20530
167351,presented,O,20530
167352,the,O,20530
167353,interim,O,20530
167354,6-month,B-TIME_DURATION,20530
167355,results,O,20530
167356,on,O,20530
167357,AU-011,B-TREATMENT,20530
167358,Three,O,20531
167359,patients,O,20531
167360,with,O,20531
167361,choroidal,B-NAME_OF_DISEASE,20531
167362,melanoma,I-NAME_OF_DISEASE,20531
167363,received,O,20531
167364,a,O,20531
167365,single,O,20531
167366,intravitreal,O,20531
167367,administration,O,20531
167368,of,O,20531
167369,the,B-CHEMICAL_COMPOUND,20531
167370,capsid,I-CHEMICAL_COMPOUND,20531
167371,conjugate,I-CHEMICAL_COMPOUND,20531
167372,at,O,20531
167373,each,O,20531
167374,of,O,20531
167375,three,O,20531
167376,subtherapeutic,O,20531
167377,dose-escalating,O,20531
167378,levels,O,20531
167379,20,O,20531
167380,mug,O,20531
167381,40,O,20531
167382,mug,O,20531
167383,or,O,20531
167384,80,O,20531
167385,mug,O,20531
167386,followed,O,20531
167387,by,O,20531
167388,light-activation,O,20531
167389,with,O,20531
167390,a,O,20531
167391,689-nm,O,20531
167392,laser,O,20531
167393,at,O,20531
167394,a,O,20531
167395,fluence,O,20531
167396,of,O,20531
167397,50,O,20531
167398,J,O,20531
167399,cm2,O,20531
167400,In,O,20532
167401,each,O,20532
167402,cohort,O,20532
167403,the,O,20532
167404,number,O,20532
167405,of,O,20532
167406,intravitreal,O,20532
167407,administrations,O,20532
167408,was,O,20532
167409,increased,O,20532
167410,up,O,20532
167411,to,O,20532
167412,three,O,20532
167413,weekly,O,20532
167414,treatments,O,20532
167415,and,O,20532
167416,the,O,20532
167417,number,O,20532
167418,of,O,20532
167419,laser,O,20532
167420,activations,O,20532
167421,was,O,20532
167422,increased,O,20532
167423,to,O,20532
167424,two,O,20532
167425,applications,O,20532
167426,on,O,20532
167427,the,O,20532
167428,same,O,20532
167429,day,O,20532
167430,separated,O,20532
167431,by,O,20532
167432,30,B-TIME_DURATION,20532
167433,minutes,I-TIME_DURATION,20532
167434,There,O,20533
167435,were,O,20533
167436,no,O,20533
167437,treatment-related,O,20533
167438,serious,O,20533
167439,events,O,20533
167440,or,O,20533
167441,severe,O,20533
167442,adverse,O,20533
167443,events,O,20533
167444,Dr,B-PERSON,20533
167445,Schefler,I-PERSON,20533
167446,said,O,20533
167447,Pre-treatment,O,20534
167448,visual,O,20534
167449,acuity,O,20534
167450,was,O,20534
167451,maintained,O,20534
167452,in,O,20534
167453,all,O,20534
167454,subjects,O,20534
167455,that,O,20534
167456,have,O,20534
167457,been,O,20534
167458,followed,O,20534
167459,for,B-TIME_DURATION,20534
167460,6,I-TIME_DURATION,20534
167461,to,I-TIME_DURATION,20534
167462,12,I-TIME_DURATION,20534
167463,months,I-TIME_DURATION,20534
167464,Dr,B-PERSON,20534
167465,Schefler,I-PERSON,20534
167466,said,O,20534
167467,All,O,20535
167468,adverse,O,20535
167469,events,O,20535
167470,were,O,20535
167471,deemed,O,20535
167472,mild,O,20535
167473,to,O,20535
167474,moderate,O,20535
167475,and,O,20535
167476,included,O,20535
167477,anterior,O,20535
167478,or,O,20535
167479,posterior,O,20535
167480,inflammation,O,20535
167481,in,O,20535
167482,10,O,20535
167483,and,O,20535
167484,11,O,20535
167485,patients,O,20535
167486,n,O,20535
167487,=,O,20535
167488,18,O,20535
167489,respectively,O,20535
167490,which,O,20535
167491,started,O,20535
167492,about,O,20535
167493,4,B-TIME_DURATION,20535
167494,weeks,I-TIME_DURATION,20535
167495,after,O,20535
167496,treatment,O,20535
167497,Interestingly,O,20536
167498,inflammation,O,20536
167499,is,O,20536
167500,an,O,20536
167501,expected,O,20536
167502,response,O,20536
167503,to,O,20536
167504,the,O,20536
167505,mechanism,O,20536
167506,of,O,20536
167507,action,O,20536
167508,of,O,20536
167509,AU011,B-TREATMENT,20536
167510,as,O,20536
167511,a,O,20536
167512,result,O,20536
167513,of,O,20536
167514,the,O,20536
167515,acute,O,20536
167516,tumor,O,20536
167517,cell,O,20536
167518,necrosis,O,20536
167519,and,O,20536
167520,may,O,20536
167521,actually,O,20536
167522,be,O,20536
167523,beneficial,O,20536
167524,in,O,20536
167525,terms,O,20536
167526,of,O,20536
167527,creating,O,20536
167528,a,O,20536
167529,tumor-specific,O,20536
167530,T-cell,O,20536
167531,immune,O,20536
167532,response,O,20536
167533,she,O,20536
167534,said,O,20536
167535,There,O,20537
167536,was,O,20537
167537,virtually,O,20537
167538,no,O,20537
167539,change,O,20537
167540,in,O,20537
167541,visual,O,20537
167542,acuity,O,20537
167543,all,O,20537
167544,patients,O,20537
167545,followed,O,20537
167546,for,O,20537
167547,6,B-TIME_DURATION,20537
167548,months,I-TIME_DURATION,20537
167549,or,I-TIME_DURATION,20537
167550,longer,I-TIME_DURATION,20537
167551,were,O,20537
167552,within,O,20537
167553,one,O,20537
167554,letter,O,20537
167555,of,O,20537
167556,baseline,O,20537
167557,This,O,20538
167558,was,O,20538
167559,regardless,O,20538
167560,of,O,20538
167561,where,O,20538
167562,the,O,20538
167563,tumor,O,20538
167564,was,O,20538
167565,located,O,20538
167566,including,O,20538
167567,those,O,20538
167568,that,O,20538
167569,were,O,20538
167570,right,O,20538
167571,in,O,20538
167572,the,O,20538
167573,middle,O,20538
167574,of,O,20538
167575,the,B-PART_OF_THE_EYES,20538
167576,fovea,I-PART_OF_THE_EYES,20538
167577,or,O,20538
167578,touching,O,20538
167579,the,B-PART_OF_THE_EYES,20538
167580,optic,I-PART_OF_THE_EYES,20538
167581,nerve,I-PART_OF_THE_EYES,20538
167582,she,O,20538
167583,said,O,20538
167584,In,O,20539
167585,the,O,20539
167586,three,O,20539
167587,single-dose,O,20539
167588,cohorts,O,20539
167589,several,O,20539
167590,patients,O,20539
167591,had,O,20539
167592,stable,O,20539
167593,disease,O,20539
167594,at,O,20539
167595,12,B-TIME_DURATION,20539
167596,months,I-TIME_DURATION,20539
167597,even,O,20539
167598,though,O,20539
167599,this,O,20539
167600,had,O,20539
167601,been,O,20539
167602,considered,O,20539
167603,the,O,20539
167604,sub-therapeutic,O,20539
167605,dose,O,20539
167606,Dr,B-PERSON,20539
167607,Schefler,I-PERSON,20539
167608,said,O,20539
167609,Dr,B-PERSON,20540
167610,Schefler,I-PERSON,20540
167611,said,O,20540
167612,investigators,O,20540
167613,are,O,20540
167614,measuring,O,20540
167615,tumor,O,20540
167616,growth,O,20540
167617,and,O,20540
167618,presuming,O,20540
167619,that,O,20540
167620,when,O,20540
167621,there,O,20540
167622,is,O,20540
167623,no,O,20540
167624,further,O,20540
167625,growth,O,20540
167626,the,O,20540
167627,tumor,O,20540
167628,is,O,20540
167629,undergoing,O,20540
167630,necrosis,O,20540
167631,with,O,20540
167632,no,O,20540
167633,malignant,O,20540
167634,potential,O,20540
167635,any,O,20540
167636,longer,O,20540
167637,Certainly,O,20541
167638,seeing,O,20541
167639,tumor,O,20541
167640,shrinkage,O,20541
167641,and,O,20541
167642,inflammation,O,20541
167643,around,O,20541
167644,the,O,20541
167645,tumor,O,20541
167646,at,O,20541
167647,early,O,20541
167648,time,O,20541
167649,points,O,20541
167650,is,O,20541
167651,encouraging,O,20541
167652,to,O,20541
167653,confirm,O,20541
167654,the,O,20541
167655,biological,O,20541
167656,activity,O,20541
167657,of,O,20541
167658,the,O,20541
167659,drug,O,20541
167660,but,O,20541
167661,the,O,20541
167662,most,O,20541
167663,important,O,20541
167664,measure,O,20541
167665,for,O,20541
167666,efficacy,O,20541
167667,is,O,20541
167668,that,O,20541
167669,the,O,20541
167670,tumors,O,20541
167671,have,O,20541
167672,no,O,20541
167673,further,O,20541
167674,growth,O,20541
167675,at,O,20541
167676,longer,O,20541
167677,follow,O,20541
167678,up,O,20541
167679,times,O,20541
167680,with,O,20541
167681,good,O,20541
167682,vision,O,20541
167683,preservation,O,20541
167684,Dr,B-PERSON,20541
167685,Schefler,I-PERSON,20541
167686,said,O,20541
167687,Glaucoma,B-NAME_OF_DISEASE,20542
167688,is,O,20542
167689,a,O,20542
167690,disease,O,20542
167691,where,O,20542
167692,the,B-SIGN_AND_SYMPTOM,20542
167693,optic,I-SIGN_AND_SYMPTOM,20542
167694,nerve,I-SIGN_AND_SYMPTOM,20542
167695,gets,I-SIGN_AND_SYMPTOM,20542
167696,damaged,I-SIGN_AND_SYMPTOM,20542
167697,and,O,20542
167698,the,O,20542
167699,main,O,20542
167700,risk,O,20542
167701,factor,O,20542
167702,is,O,20542
167703,elevated,B-CAUSE_OF_DISEASE,20542
167704,eye,I-CAUSE_OF_DISEASE,20542
167705,pressure,I-CAUSE_OF_DISEASE,20542
167706,also,I-CAUSE_OF_DISEASE,20542
167707,called,I-CAUSE_OF_DISEASE,20542
167708,intraocular,I-CAUSE_OF_DISEASE,20542
167709,pressure,I-CAUSE_OF_DISEASE,20542
167710,IOP,I-CAUSE_OF_DISEASE,20542
167711,The,O,20543
167712,only,O,20543
167713,treatment,O,20543
167714,is,O,20543
167715,to,B-TREATMENT,20543
167716,lower,I-TREATMENT,20543
167717,the,I-TREATMENT,20543
167718,IOP,I-TREATMENT,20543
167719,This,O,20544
167720,fluid,O,20544
167721,is,O,20544
167722,called,O,20544
167723,the,O,20544
167724,aqueous,O,20544
167725,and,O,20544
167726,when,O,20544
167727,we,O,20544
167728,consider,O,20544
167729,various,O,20544
167730,treatment,O,20544
167731,options,O,20544
167732,to,B-TREATMENT,20544
167733,lower,I-TREATMENT,20544
167734,IOP,I-TREATMENT,20544
167735,we,O,20544
167736,can,O,20544
167737,either,O,20544
167738,decrease,O,20544
167739,the,O,20544
167740,amount,O,20544
167741,of,O,20544
167742,aqueous,O,20544
167743,the,O,20544
167744,eye,O,20544
167745,makes,O,20544
167746,or,O,20544
167747,increase,O,20544
167748,the,O,20544
167749,drainage,O,20544
167750,of,O,20544
167751,aqueous,O,20544
167752,from,O,20544
167753,inside,O,20544
167754,the,O,20544
167755,eye,O,20544
167756,This,O,20545
167757,goal,O,20545
167758,can,O,20545
167759,be,O,20545
167760,accomplished,O,20545
167761,with,O,20545
167762,medications,B-TREATMENT,20545
167763,laser,B-TREATMENT,20545
167764,or,O,20545
167765,surgery,B-TREATMENT,20545
167766,The,O,20546
167767,traditional,O,20546
167768,glaucoma,B-TREATMENT,20546
167769,surgeries,I-TREATMENT,20546
167770,trabeculectomy,B-TREATMENT,20546
167771,and,O,20546
167772,glaucoma,B-TREATMENT,20546
167773,drainage,I-TREATMENT,20546
167774,devices,I-TREATMENT,20546
167775,while,O,20546
167776,very,O,20546
167777,effective,O,20546
167778,are,O,20546
167779,associated,O,20546
167780,with,O,20546
167781,risks,O,20546
167782,such,O,20546
167783,as,O,20546
167784,double,B-SIGN_AND_SYMPTOM,20546
167785,vision,I-SIGN_AND_SYMPTOM,20546
167786,devastating,I-SIGN_AND_SYMPTOM,20546
167787,eye,I-SIGN_AND_SYMPTOM,20546
167788,infections,I-SIGN_AND_SYMPTOM,20546
167789,exposure,I-SIGN_AND_SYMPTOM,20546
167790,of,I-SIGN_AND_SYMPTOM,20546
167791,a,I-SIGN_AND_SYMPTOM,20546
167792,drainage,I-SIGN_AND_SYMPTOM,20546
167793,implant,I-SIGN_AND_SYMPTOM,20546
167794,swelling,I-SIGN_AND_SYMPTOM,20546
167795,of,I-SIGN_AND_SYMPTOM,20546
167796,the,I-SIGN_AND_SYMPTOM,20546
167797,cornea,I-SIGN_AND_SYMPTOM,20546
167798,and,I-SIGN_AND_SYMPTOM,20546
167799,excessively,I-SIGN_AND_SYMPTOM,20546
167800,low,I-SIGN_AND_SYMPTOM,20546
167801,IOP,I-SIGN_AND_SYMPTOM,20546
167802,Although,O,20547
167803,these,O,20547
167804,risks,O,20547
167805,are,O,20547
167806,relatively,O,20547
167807,infrequent,O,20547
167808,they,O,20547
167809,make,O,20547
167810,most,O,20547
167811,surgeons,O,20547
167812,delay,O,20547
167813,glaucoma,B-NAME_OF_DISEASE,20547
167814,surgery,I-TREATMENT,20547
167815,until,O,20547
167816,all,O,20547
167817,other,O,20547
167818,less,O,20547
167819,invasive,O,20547
167820,treatment,O,20547
167821,options,O,20547
167822,are,O,20547
167823,maximized,O,20547
167824,medications,B-TREATMENT,20547
167825,and,O,20547
167826,laser,B-TREATMENT,20547
167827,treatment,I-TREATMENT,20547
167828,and,O,20547
167829,the,O,20547
167830,patient,O,20547
167831,has,O,20547
167832,definitive,O,20547
167833,glaucoma,B-NAME_OF_DISEASE,20547
167834,worsening,O,20547
167835,Over,O,20548
167836,the,O,20548
167837,past,O,20548
167838,10-May,B-TIME_DURATION,20548
167839,years,I-TIME_DURATION,20548
167840,there,O,20548
167841,has,O,20548
167842,been,O,20548
167843,a,O,20548
167844,revolution,O,20548
167845,in,O,20548
167846,glaucoma,B-TREATMENT,20548
167847,surgery,I-TREATMENT,20548
167848,specifically,O,20548
167849,Micro-Invasive,B-TREATMENT,20548
167850,Glaucoma,I-TREATMENT,20548
167851,Surgery,I-TREATMENT,20548
167852,commonly,O,20548
167853,called,O,20548
167854,MIGS,B-TREATMENT,20548
167855,The,O,20549
167856,Last,O,20549
167857,25,B-TIME_DURATION,20549
167858,Years,I-TIME_DURATION,20549
167859,Of,O,20550
167860,all,O,20550
167861,the,O,20550
167862,subspecialties,O,20550
167863,in,O,20550
167864,ophthalmology,O,20550
167865,it,O,20550
167866,could,O,20550
167867,be,O,20550
167868,said,O,20550
167869,that,O,20550
167870,glaucoma,B-NAME_OF_DISEASE,20550
167871,has,O,20550
167872,seen,O,20550
167873,the,O,20550
167874,most,O,20550
167875,disruptive,O,20550
167876,change,O,20550
167877,over,O,20550
167878,the,O,20550
167879,last,O,20550
167880,25,B-TIME_DURATION,20550
167881,years,I-TIME_DURATION,20550
167882,Glaucoma,B-NAME_OF_DISEASE,20551
167883,has,O,20551
167884,shifted,O,20551
167885,from,O,20551
167886,a,O,20551
167887,disease,O,20551
167888,treated,O,20551
167889,primarily,O,20551
167890,with,O,20551
167891,pharmaceuticals,O,20551
167892,to,O,20551
167893,a,O,20551
167894,disease,O,20551
167895,treated,O,20551
167896,surgically,O,20551
167897,It,O,20552
167898,is,O,20552
167899,the,B-TREATMENT,20552
167900,MIGS,I-TREATMENT,20552
167901,for,O,20552
167902,minimally,B-TREATMENT,20552
167903,invasive,I-TREATMENT,20552
167904,glaucoma,I-TREATMENT,20552
167905,surgery,I-TREATMENT,20552
167906,revolution,O,20552
167907,that,O,20552
167908,has,O,20552
167909,initiated,O,20552
167910,this,O,20552
167911,change,O,20552
167912,In,O,20553
167913,1992,O,20553
167914,Martin,B-PERSON,20553
167915,Uram,I-PERSON,20553
167916,MD,I-PERSON,20553
167917,MPH,I-PERSON,20553
167918,developed,O,20553
167919,endoscopic,B-TREATMENT,20553
167920,cyclophotocoagulation,I-TREATMENT,20553
167921,ECP,I-TREATMENT,20553
167922,and,O,20553
167923,it,O,20553
167924,became,O,20553
167925,adopted,O,20553
167926,by,O,20553
167927,general,O,20553
167928,ophthalmologists,O,20553
167929,glaucoma,B-NAME_OF_DISEASE,20553
167930,specialists,O,20553
167931,and,O,20553
167932,even,O,20553
167933,retinal,O,20553
167934,specialists,O,20553
167935,around,O,20553
167936,the,O,20553
167937,world,O,20553
167938,to,O,20553
167939,treat,O,20553
167940,glaucoma,B-NAME_OF_DISEASE,20553
167941,at,O,20553
167942,the,O,20553
167943,time,O,20553
167944,of,O,20553
167945,cataract,B-TREATMENT,20553
167946,surgery,I-TREATMENT,20553
167947,or,O,20553
167948,for,O,20553
167949,refractory,B-NAME_OF_DISEASE,20553
167950,glaucoma,I-NAME_OF_DISEASE,20553
167951,In,O,20554
167952,many,O,20554
167953,ways,O,20554
167954,ECP,B-TREATMENT,20554
167955,was,O,20554
167956,the,O,20554
167957,first,O,20554
167958,MIGS,B-TREATMENT,20554
167959,procedure,I-TREATMENT,20554
167960,because,O,20554
167961,it,O,20554
167962,was,O,20554
167963,bleb-free,O,20554
167964,and,O,20554
167965,could,O,20554
167966,be,O,20554
167967,used,O,20554
167968,to,O,20554
167969,treat,O,20554
167970,all,O,20554
167971,stages,O,20554
167972,of,O,20554
167973,glaucoma,B-NAME_OF_DISEASE,20554
167974,and,O,20554
167975,multiple,O,20554
167976,types,O,20554
167977,of,O,20554
167978,glaucoma,B-NAME_OF_DISEASE,20554
167979,including,O,20554
167980,angle-closure,B-NAME_OF_DISEASE,20554
167981,glaucoma,I-NAME_OF_DISEASE,20554
167982,Then,O,20555
167983,in,O,20555
167984,the,O,20555
167985,early,O,20555
167986,2000s,O,20555
167987,George,B-PERSON,20555
167988,Baerveldt,I-PERSON,20555
167989,MD,I-PERSON,20555
167990,developed,O,20555
167991,the,B-TREATMENT,20555
167992,Trabectome,I-TREATMENT,20555
167993,procedure,I-TREATMENT,20555
167994,MST,I-TREATMENT,20555
167995,which,O,20555
167996,was,O,20555
167997,used,O,20555
167998,to,O,20555
167999,remove,O,20555
168000,a,O,20555
168001,strip,O,20555
168002,of,O,20555
168003,trabecular,B-PART_OF_THE_EYES,20555
168004,meshwork,I-PART_OF_THE_EYES,20555
168005,TM,I-PART_OF_THE_EYES,20555
168006,with,O,20555
168007,a,O,20555
168008,bipolar,O,20555
168009,electrode,O,20555
168010,under,O,20555
168011,direct,O,20555
168012,gonioscopic,O,20555
168013,view,O,20555
168014,The,O,20556
168015,first,O,20556
168016,Trabectome,B-TREATMENT,20556
168017,procedure,I-TREATMENT,20556
168018,in,O,20556
168019,the,B-GPE,20556
168020,United,I-GPE,20556
168021,States,I-GPE,20556
168022,was,O,20556
168023,in,O,20556
168024,2006,O,20556
168025,The,O,20557
168026,2010s,O,20557
168027,were,O,20557
168028,in,O,20557
168029,many,O,20557
168030,ways,O,20557
168031,the,O,20557
168032,decade,O,20557
168033,of,O,20557
168034,MIGS,B-TREATMENT,20557
168035,In,O,20558
168036,2012,O,20558
168037,the,B-ORGANIZATION,20558
168038,FDA,I-ORGANIZATION,20558
168039,approved,O,20558
168040,the,B-TREATMENT,20558
168041,iStent,I-TREATMENT,20558
168042,Glaukos,I-TREATMENT,20558
168043,to,O,20558
168044,bypass,O,20558
168045,the,B-PART_OF_THE_EYES,20558
168046,TM,I-PART_OF_THE_EYES,20558
168047,followed,O,20558
168048,by,O,20558
168049,the,B-TREATMENT,20558
168050,iStent,I-TREATMENT,20558
168051,inject,I-TREATMENT,20558
168052,and,O,20558
168053,the,B-TREATMENT,20558
168054,Hydrus,I-TREATMENT,20558
168055,implant,I-TREATMENT,20558
168056,Ivantis,I-TREATMENT,20558
168057,in,O,20558
168058,2018,O,20558
168059,The,O,20559
168060,last,O,20559
168061,decade,O,20559
168062,also,O,20559
168063,saw,O,20559
168064,the,O,20559
168065,increase,O,20559
168066,in,O,20559
168067,ab,B-TREATMENT,20559
168068,interno,I-TREATMENT,20559
168069,canaloplasty,I-TREATMENT,20559
168070,and,O,20559
168071,goniotomy,B-TREATMENT,20559
168072,with,O,20559
168073,a,O,20559
168074,variety,O,20559
168075,of,O,20559
168076,devices,O,20559
168077,such,O,20559
168078,as,O,20559
168079,the,B-SURGICAL_INSTRUMENT,20559
168080,OMNI,I-SURGICAL_INSTRUMENT,20559
168081,Surgical,I-SURGICAL_INSTRUMENT,20559
168082,System,I-SURGICAL_INSTRUMENT,20559
168083,Sight,I-SURGICAL_INSTRUMENT,20559
168084,Sciences,I-SURGICAL_INSTRUMENT,20559
168085,and,O,20559
168086,its,O,20559
168087,predicate,O,20559
168088,devices,O,20559
168089,the,O,20559
168090,TRAB360,B-SURGICAL_INSTRUMENT,20559
168091,and,O,20559
168092,VISCO360,B-SURGICAL_INSTRUMENT,20559
168093,the,B-SURGICAL_INSTRUMENT,20559
168094,Kahook,I-SURGICAL_INSTRUMENT,20559
168095,Dual,I-SURGICAL_INSTRUMENT,20559
168096,Blade,I-SURGICAL_INSTRUMENT,20559
168097,New,I-SURGICAL_INSTRUMENT,20559
168098,World,I-SURGICAL_INSTRUMENT,20559
168099,Medical,I-SURGICAL_INSTRUMENT,20559
168100,and,O,20559
168101,the,B-SURGICAL_INSTRUMENT,20559
168102,Trab-Ex,I-SURGICAL_INSTRUMENT,20559
168103,goniotomy,I-SURGICAL_INSTRUMENT,20559
168104,system,I-SURGICAL_INSTRUMENT,20559
168105,MST,I-SURGICAL_INSTRUMENT,20559
168106,Also,O,20560
168107,we,O,20560
168108,saw,O,20560
168109,the,O,20560
168110,resurrection,O,20560
168111,of,O,20560
168112,the,B-SURGICAL_INSTRUMENT,20560
168113,iTrack,I-SURGICAL_INSTRUMENT,20560
168114,microcatheter,I-SURGICAL_INSTRUMENT,20560
168115,a,O,20560
168116,device,O,20560
168117,intended,O,20560
168118,for,O,20560
168119,ab,B-TREATMENT,20560
168120,externo,I-TREATMENT,20560
168121,canaloplasty,I-TREATMENT,20560
168122,and,O,20560
168123,repurposed,O,20560
168124,as,O,20560
168125,an,O,20560
168126,ab,O,20560
168127,interno,O,20560
168128,technique,O,20560
168129,to,O,20560
168130,perform,O,20560
168131,360°,O,20560
168132,of,O,20560
168133,canal,O,20560
168134,viscodilation,O,20560
168135,In,O,20561
168136,addition,O,20561
168137,Allergan,B-ORGANIZATION,20561
168138,released,O,20561
168139,the,B-TREATMENT,20561
168140,XEN,I-TREATMENT,20561
168141,Gel,I-TREATMENT,20561
168142,Stent,I-TREATMENT,20561
168143,Although,O,20562
168144,not,O,20562
168145,a,O,20562
168146,TRUE,O,20562
168147,MIGS,B-TREATMENT,20562
168148,procedure,I-TREATMENT,20562
168149,because,O,20562
168150,it,O,20562
168151,is,O,20562
168152,bleb-forming,O,20562
168153,it,O,20562
168154,is,O,20562
168155,certainly,O,20562
168156,a,O,20562
168157,less-invasive,O,20562
168158,procedure,O,20562
168159,especially,O,20562
168160,with,O,20562
168161,clinically,O,20562
168162,significant,O,20562
168163,hypotony,O,20562
168164,being,O,20562
168165,truly,O,20562
168166,rare,O,20562
168167,Other,O,20563
168168,new,O,20563
168169,surgical,O,20563
168170,MIGS,B-TREATMENT,20563
168171,devices,O,20563
168172,are,O,20563
168173,currently,O,20563
168174,in,O,20563
168175,clinical,O,20563
168176,trials,O,20563
168177,Combined,O,20564
168178,with,O,20564
168179,the,O,20564
168180,advent,O,20564
168181,of,O,20564
168182,sustained-release,O,20564
168183,implant,O,20564
168184,of,O,20564
168185,drugs,O,20564
168186,these,O,20564
168187,should,O,20564
168188,lead,O,20564
168189,to,O,20564
168190,the,O,20564
168191,full,O,20564
168192,manifestation,O,20564
168193,of,O,20564
168194,the,O,20564
168195,interventional,O,20564
168196,glaucoma,B-NAME_OF_DISEASE,20564
168197,revolution,O,20564
168198,and,O,20564
168199,the,O,20564
168200,potential,O,20564
168201,for,O,20564
168202,the,O,20564
168203,near-cessation,O,20564
168204,of,O,20564
168205,eyedrops,B-TREATMENT,20564
168206,to,O,20564
168207,treat,O,20564
168208,glaucoma,B-NAME_OF_DISEASE,20564
168209,Diabetic,B-NAME_OF_DISEASE,20565
168210,macular,I-NAME_OF_DISEASE,20565
168211,edema,I-NAME_OF_DISEASE,20565
168212,DME,I-NAME_OF_DISEASE,20565
168213,is,O,20565
168214,caused,O,20565
168215,by,O,20565
168216,a,O,20565
168217,complication,O,20565
168218,of,O,20565
168219,diabetes,B-NAME_OF_DISEASE,20565
168220,called,O,20565
168221,diabetic,B-NAME_OF_DISEASE,20565
168222,retinopathy,I-NAME_OF_DISEASE,20565
168223,Diabetic,B-NAME_OF_DISEASE,20566
168224,retinopathy,I-NAME_OF_DISEASE,20566
168225,is,O,20566
168226,the,O,20566
168227,most,O,20566
168228,common,O,20566
168229,diabetic,B-NAME_OF_DISEASE,20566
168230,eye,I-NAME_OF_DISEASE,20566
168231,disease,I-NAME_OF_DISEASE,20566
168232,and,O,20566
168233,the,O,20566
168234,leading,O,20566
168235,cause,O,20566
168236,of,O,20566
168237,irreversible,B-NAME_OF_DISEASE,20566
168238,blindness,I-NAME_OF_DISEASE,20566
168239,Diabetic,B-NAME_OF_DISEASE,20567
168240,retinopathy,I-NAME_OF_DISEASE,20567
168241,usually,O,20567
168242,affects,O,20567
168243,both,O,20567
168244,eyes,O,20567
168245,Diabetic,B-NAME_OF_DISEASE,20568
168246,retinopathy,I-NAME_OF_DISEASE,20568
168247,is,O,20568
168248,caused,O,20568
168249,by,O,20568
168250,ongoing,O,20568
168251,damage,O,20568
168252,to,O,20568
168253,the,O,20568
168254,small,O,20568
168255,blood,O,20568
168256,vessels,O,20568
168257,of,O,20568
168258,the,B-PART_OF_THE_EYES,20568
168259,retina,I-PART_OF_THE_EYES,20568
168260,The,O,20569
168261,leakage,O,20569
168262,of,O,20569
168263,fluid,O,20569
168264,into,O,20569
168265,the,B-PART_OF_THE_EYES,20569
168266,retina,I-PART_OF_THE_EYES,20569
168267,may,O,20569
168268,lead,O,20569
168269,to,O,20569
168270,swelling,B-SIGN_AND_SYMPTOM,20569
168271,of,I-SIGN_AND_SYMPTOM,20569
168272,the,I-SIGN_AND_SYMPTOM,20569
168273,surrounding,I-SIGN_AND_SYMPTOM,20569
168274,tissue,I-SIGN_AND_SYMPTOM,20569
168275,including,I-SIGN_AND_SYMPTOM,20569
168276,the,I-SIGN_AND_SYMPTOM,20569
168277,macula,I-SIGN_AND_SYMPTOM,20569
168278,DME,B-NAME_OF_DISEASE,20570
168279,is,O,20570
168280,the,O,20570
168281,most,O,20570
168282,common,O,20570
168283,cause,O,20570
168284,of,O,20570
168285,vision,B-SIGN_AND_SYMPTOM,20570
168286,loss,I-SIGN_AND_SYMPTOM,20570
168287,in,O,20570
168288,people,O,20570
168289,with,O,20570
168290,diabetic,B-NAME_OF_DISEASE,20570
168291,retinopathy,I-NAME_OF_DISEASE,20570
168292,Poor,B-CAUSE_OF_DISEASE,20571
168293,blood,I-CAUSE_OF_DISEASE,20571
168294,sugar,I-CAUSE_OF_DISEASE,20571
168295,control,I-CAUSE_OF_DISEASE,20571
168296,and,O,20571
168297,additional,B-CAUSE_OF_DISEASE,20571
168298,medical,I-CAUSE_OF_DISEASE,20571
168299,conditions,I-CAUSE_OF_DISEASE,20571
168300,such,I-CAUSE_OF_DISEASE,20571
168301,as,I-CAUSE_OF_DISEASE,20571
168302,high,I-CAUSE_OF_DISEASE,20571
168303,blood,I-CAUSE_OF_DISEASE,20571
168304,pressure,I-CAUSE_OF_DISEASE,20571
168305,increase,O,20571
168306,the,O,20571
168307,risk,O,20571
168308,of,O,20571
168309,blindness,B-NAME_OF_DISEASE,20571
168310,for,O,20571
168311,people,O,20571
168312,with,O,20571
168313,DME,B-NAME_OF_DISEASE,20571
168314,DME,B-NAME_OF_DISEASE,20572
168315,can,O,20572
168316,occur,O,20572
168317,at,O,20572
168318,any,O,20572
168319,stage,O,20572
168320,of,O,20572
168321,diabetic,B-NAME_OF_DISEASE,20572
168322,retinopathy,I-NAME_OF_DISEASE,20572
168323,although,O,20572
168324,it,O,20572
168325,is,O,20572
168326,more,O,20572
168327,likely,O,20572
168328,to,O,20572
168329,occur,O,20572
168330,later,O,20572
168331,as,O,20572
168332,the,O,20572
168333,disease,O,20572
168334,goes,O,20572
168335,on,O,20572
168336,DME,B-NAME_OF_DISEASE,20573
168337,occurs,O,20573
168338,when,O,20573
168339,excess,O,20573
168340,fluid,O,20573
168341,starts,O,20573
168342,to,O,20573
168343,build,O,20573
168344,up,O,20573
168345,in,O,20573
168346,the,B-PART_OF_THE_EYES,20573
168347,macula,I-PART_OF_THE_EYES,20573
168348,of,O,20573
168349,the,O,20573
168350,eye,O,20573
168351,The,B-PART_OF_THE_EYES,20574
168352,macula,I-PART_OF_THE_EYES,20574
168353,allows,O,20574
168354,us,O,20574
168355,to,O,20574
168356,focus,O,20574
168357,and,O,20574
168358,see,O,20574
168359,fine,O,20574
168360,details,O,20574
168361,Its,O,20575
168362,located,O,20575
168363,in,O,20575
168364,the,O,20575
168365,center,O,20575
168366,of,O,20575
168367,the,B-PART_OF_THE_EYES,20575
168368,retina,I-PART_OF_THE_EYES,20575
168369,the,O,20575
168370,lining,O,20575
168371,at,O,20575
168372,the,O,20575
168373,back,O,20575
168374,of,O,20575
168375,the,O,20575
168376,eye,O,20575
168377,thats,O,20575
168378,full,O,20575
168379,of,O,20575
168380,blood,O,20575
168381,vessels,O,20575
168382,When,O,20576
168383,excess,O,20576
168384,fluid,O,20576
168385,builds,O,20576
168386,up,O,20576
168387,in,O,20576
168388,the,B-PART_OF_THE_EYES,20576
168389,macula,I-PART_OF_THE_EYES,20576
168390,it,O,20576
168391,causes,O,20576
168392,vision,O,20576
168393,problems,O,20576
168394,DME,B-NAME_OF_DISEASE,20577
168395,generally,O,20577
168396,develops,O,20577
168397,over,O,20577
168398,time,O,20577
168399,High,B-CAUSE_OF_DISEASE,20578
168400,blood,I-CAUSE_OF_DISEASE,20578
168401,sugar,I-CAUSE_OF_DISEASE,20578
168402,levels,I-CAUSE_OF_DISEASE,20578
168403,can,O,20578
168404,damage,O,20578
168405,the,O,20578
168406,blood,O,20578
168407,vessels,O,20578
168408,in,O,20578
168409,the,B-PART_OF_THE_EYES,20578
168410,retina,I-PART_OF_THE_EYES,20578
168411,Damaged,B-SIGN_AND_SYMPTOM,20579
168412,blood,I-SIGN_AND_SYMPTOM,20579
168413,vessels,I-SIGN_AND_SYMPTOM,20579
168414,can,O,20579
168415,leak,O,20579
168416,fluid,O,20579
168417,which,O,20579
168418,causes,O,20579
168419,swelling,B-SIGN_AND_SYMPTOM,20579
168420,and,O,20579
168421,other,O,20579
168422,issues,O,20579
168423,This,O,20580
168424,damage,O,20580
168425,is,O,20580
168426,called,O,20580
168427,retinopathy,B-NAME_OF_DISEASE,20580
168428,During,O,20581
168429,the,O,20581
168430,earliest,O,20581
168431,stages,O,20581
168432,of,O,20581
168433,the,O,20581
168434,COVID-19,B-NAME_OF_DISEASE,20581
168435,pandemic,O,20581
168436,some,O,20581
168437,patients,O,20581
168438,with,O,20581
168439,diabetic,B-NAME_OF_DISEASE,20581
168440,macular,I-NAME_OF_DISEASE,20581
168441,edema,I-NAME_OF_DISEASE,20581
168442,DME,I-NAME_OF_DISEASE,20581
168443,were,O,20581
168444,reluctant,O,20581
168445,to,O,20581
168446,visit,O,20581
168447,the,O,20581
168448,office,O,20581
168449,for,O,20581
168450,therapy,O,20581
168451,or,O,20581
168452,monitoring,O,20581
168453,The,O,20582
168454,risks,O,20582
168455,of,O,20582
168456,complications,O,20582
168457,secondary,O,20582
168458,to,O,20582
168459,COVID-19,B-NAME_OF_DISEASE,20582
168460,infection,O,20582
168461,are,O,20582
168462,elevated,O,20582
168463,among,O,20582
168464,patients,O,20582
168465,with,O,20582
168466,comorbidities,O,20582
168467,such,O,20582
168468,as,O,20582
168469,diabetes,B-NAME_OF_DISEASE,20582
168470,Further,O,20583
168471,the,O,20583
168472,high,O,20583
168473,burden,O,20583
168474,of,O,20583
168475,care,O,20583
168476,associated,O,20583
168477,with,O,20583
168478,DME,B-NAME_OF_DISEASE,20583
168479,has,O,20583
168480,led,O,20583
168481,to,O,20583
168482,undertreatment,O,20583
168483,among,O,20583
168484,real-world,O,20583
168485,patients,O,20583
168486,a,O,20583
168487,dynamic,O,20583
168488,almost,O,20583
168489,certainly,O,20583
168490,exacerbated,O,20583
168491,by,O,20583
168492,the,O,20583
168493,aforementioned,O,20583
168494,reluctance,O,20583
168495,to,O,20583
168496,visit,O,20583
168497,the,O,20583
168498,clinic,O,20583
168499,Given,O,20584
168500,these,O,20584
168501,facts,O,20584
168502,retina,B-PART_OF_THE_EYES,20584
168503,specialists,O,20584
168504,should,O,20584
168505,strive,O,20584
168506,to,O,20584
168507,optimize,O,20584
168508,therapy,O,20584
168509,that,O,20584
168510,reduces,O,20584
168511,exposure,O,20584
168512,risk,O,20584
168513,and,O,20584
168514,burden,O,20584
168515,while,O,20584
168516,still,O,20584
168517,providing,O,20584
168518,excellent,O,20584
168519,outcomes,O,20584
168520,Patients,O,20585
168521,with,O,20585
168522,DME,B-NAME_OF_DISEASE,20585
168523,commonly,O,20585
168524,undergo,O,20585
168525,therapy,O,20585
168526,with,O,20585
168527,anti-VEGF,B-NAME_OF_DRUG,20585
168528,agents,I-NAME_OF_DRUG,20585
168529,focal,B-TREATMENT,20585
168530,laser,I-TREATMENT,20585
168531,application,I-TREATMENT,20585
168532,or,O,20585
168533,steroids,B-NAME_OF_DRUG,20585
168534,Retina,B-PART_OF_THE_EYES,20586
168535,specialists,O,20586
168536,need,O,20586
168537,to,O,20586
168538,weigh,O,20586
168539,the,O,20586
168540,benefits,O,20586
168541,of,O,20586
168542,each,O,20586
168543,treatment,O,20586
168544,option,O,20586
168545,in,O,20586
168546,light,O,20586
168547,of,O,20586
168548,the,O,20586
168549,ongoing,O,20586
168550,pandemic,O,20586
168551,Anti-VEGF,B-TREATMENT,20587
168552,therapy,I-TREATMENT,20587
168553,Patients,O,20588
168554,with,O,20588
168555,DME,B-NAME_OF_DISEASE,20588
168556,undergoing,O,20588
168557,therapy,O,20588
168558,with,O,20588
168559,anti-VEGF,B-NAME_OF_DRUG,20588
168560,agents,I-NAME_OF_DRUG,20588
168561,may,O,20588
168562,need,O,20588
168563,to,O,20588
168564,make,O,20588
168565,frequent,O,20588
168566,visits,O,20588
168567,to,O,20588
168568,the,O,20588
168569,clinic,O,20588
168570,to,O,20588
168571,get,O,20588
168572,effective,O,20588
168573,outcomes,O,20588
168574,increasing,O,20588
168575,the,O,20588
168576,risk,O,20588
168577,of,O,20588
168578,exposure,O,20588
168579,and,O,20588
168580,causing,O,20588
168581,inconvenience,O,20588
168582,for,O,20588
168583,those,O,20588
168584,who,O,20588
168585,are,O,20588
168586,of,O,20588
168587,working,O,20588
168588,age,O,20588
168589,Data,O,20589
168590,show,O,20589
168591,that,O,20589
168592,regardless,O,20589
168593,of,O,20589
168594,the,B-NAME_OF_DRUG,20589
168595,anti-VEGF,I-NAME_OF_DRUG,20589
168596,agent,I-NAME_OF_DRUG,20589
168597,they,O,20589
168598,choose,O,20589
168599,real-world,O,20589
168600,patients,O,20589
168601,have,O,20589
168602,visual,O,20589
168603,outcomes,O,20589
168604,that,O,20589
168605,are,O,20589
168606,inferior,O,20589
168607,to,O,20589
168608,those,O,20589
168609,of,O,20589
168610,patients,O,20589
168611,in,O,20589
168612,randomized,O,20589
168613,controlled,O,20589
168614,trials,O,20589
168615,In,O,20590
168616,the,B-NAME_OF_STUDY,20590
168617,LUMINOUS,I-NAME_OF_STUDY,20590
168618,trial,I-NAME_OF_STUDY,20590
168619,NCT01318941,I-NAME_OF_STUDY,20590
168620,patients,O,20590
168621,who,O,20590
168622,received,O,20590
168623,at,O,20590
168624,least,O,20590
168625,5,O,20590
168626,injections,O,20590
168627,per,O,20590
168628,year,O,20590
168629,gained,O,20590
168630,significantly,O,20590
168631,more,O,20590
168632,letters,O,20590
168633,than,O,20590
168634,those,O,20590
168635,who,O,20590
168636,received,O,20590
168637,4,O,20590
168638,or,O,20590
168639,fewer,O,20590
168640,injections,O,20590
168641,per,O,20590
168642,year,O,20590
168643,6.9,O,20590
168644,vs,O,20590
168645,0.5,O,20590
168646,These,O,20591
168647,results,O,20591
168648,were,O,20591
168649,underscored,O,20591
168650,by,O,20591
168651,those,O,20591
168652,of,O,20591
168653,a,O,20591
168654,later,O,20591
168655,study,O,20591
168656,by,O,20591
168657,Pitcher,B-PERSON,20591
168658,et,O,20591
168659,al,O,20591
168660,who,O,20591
168661,found,O,20591
168662,that,O,20591
168663,patients,O,20591
168664,with,O,20591
168665,DME,B-NAME_OF_DISEASE,20591
168666,who,O,20591
168667,received,O,20591
168668,7,O,20591
168669,injections,O,20591
168670,gained,O,20591
168671,8,O,20591
168672,mean,O,20591
168673,letters,O,20591
168674,whereas,O,20591
168675,those,O,20591
168676,who,O,20591
168677,received,O,20591
168678,less,O,20591
168679,therapy,O,20591
168680,gained,O,20591
168681,only,O,20591
168682,3.7,O,20591
168683,letters,O,20591
168684,P,O,20591
168685,0.001,O,20591
168686,Focal,B-TREATMENT,20592
168687,laser,I-TREATMENT,20592
168688,application,I-TREATMENT,20592
168689,In,O,20592
168690,a,O,20592
168691,tightly,O,20592
168692,controlled,O,20592
168693,clinical,O,20592
168694,trial,O,20592
168695,patients,O,20592
168696,return,O,20592
168697,to,O,20592
168698,the,O,20592
168699,clinic,O,20592
168700,for,O,20592
168701,treatment,O,20592
168702,according,O,20592
168703,to,O,20592
168704,the,O,20592
168705,study,O,20592
168706,protocol,O,20592
168707,Patients,O,20593
168708,and,O,20593
168709,clinicians,O,20593
168710,who,O,20593
168711,wish,O,20593
168712,to,O,20593
168713,avoid,O,20593
168714,frequent,O,20593
168715,office,O,20593
168716,visits,O,20593
168717,might,O,20593
168718,turn,O,20593
168719,to,O,20593
168720,focal,B-TREATMENT,20593
168721,laser,I-TREATMENT,20593
168722,therapy,I-TREATMENT,20593
168723,for,O,20593
168724,DME,B-NAME_OF_DISEASE,20593
168725,Although,O,20594
168726,focal,B-TREATMENT,20594
168727,laser,I-TREATMENT,20594
168728,is,O,20594
168729,effective,O,20594
168730,in,O,20594
168731,some,O,20594
168732,cases,O,20594
168733,for,O,20594
168734,treating,O,20594
168735,DME,B-NAME_OF_DISEASE,20594
168736,its,O,20594
168737,inability,O,20594
168738,to,O,20594
168739,treat,O,20594
168740,the,O,20594
168741,surrounding,O,20594
168742,tissue,O,20594
168743,creates,O,20594
168744,an,O,20594
168745,environment,O,20594
168746,in,O,20594
168747,which,O,20594
168748,extrafoveal,O,20594
168749,fluid,O,20594
168750,associated,O,20594
168751,with,O,20594
168752,DME,B-NAME_OF_DISEASE,20594
168753,resolves,O,20594
168754,while,O,20594
168755,DR,O,20594
168756,remains,O,20594
168757,active,O,20594
168758,in,O,20594
168759,the,O,20594
168760,periphery,O,20594
168761,Steroid,B-NAME_OF_DRUG,20595
168762,options,O,20595
168763,If,O,20595
168764,reducing,O,20595
168765,treatment,O,20595
168766,burden,O,20595
168767,is,O,20595
168768,part,O,20595
168769,of,O,20595
168770,what,O,20595
168771,drives,O,20595
168772,decision-making,O,20595
168773,then,O,20595
168774,retina,B-PART_OF_THE_EYES,20595
168775,specialists,O,20595
168776,may,O,20595
168777,wish,O,20595
168778,to,O,20595
168779,explore,O,20595
168780,steroid,B-TREATMENT,20595
168781,therapy,I-TREATMENT,20595
168782,Pivotal,O,20596
168783,trials,O,20596
168784,for,O,20596
168785,both,O,20596
168786,the,B-TREATMENT,20596
168787,intravitreal,I-TREATMENT,20596
168788,fluocinolone,I-TREATMENT,20596
168789,acetonide,I-TREATMENT,20596
168790,implant,I-TREATMENT,20596
168791,0.19,I-TREATMENT,20596
168792,mg,I-TREATMENT,20596
168793,Iluvien,I-TREATMENT,20596
168794,Alimera,I-TREATMENT,20596
168795,Sciences,I-TREATMENT,20596
168796,and,O,20596
168797,the,B-TREATMENT,20596
168798,intravitreal,I-TREATMENT,20596
168799,dexamethasone,I-TREATMENT,20596
168800,implant,I-TREATMENT,20596
168801,0.7,I-TREATMENT,20596
168802,mg,I-TREATMENT,20596
168803,Ozurdex,I-TREATMENT,20596
168804,Allergan,I-TREATMENT,20596
168805,showed,O,20596
168806,that,O,20596
168807,sustained-release,B-TREATMENT,20596
168808,steroid,I-TREATMENT,20596
168809,implants,I-TREATMENT,20596
168810,were,O,20596
168811,superior,O,20596
168812,to,O,20596
168813,sham,O,20596
168814,therapy,O,20596
168815,for,O,20596
168816,DME,B-NAME_OF_DISEASE,20596
168817,Ozurdex,B-TREATMENT,20597
168818,which,O,20597
168819,was,O,20597
168820,studied,O,20597
168821,as,O,20597
168822,a,O,20597
168823,6-month,B-TIME_DURATION,20597
168824,therapy,O,20597
168825,is,O,20597
168826,approved,O,20597
168827,for,O,20597
168828,the,O,20597
168829,treatment,O,20597
168830,of,O,20597
168831,DME,B-NAME_OF_DISEASE,20597
168832,in,O,20597
168833,pseudophakic,O,20597
168834,patients,O,20597
168835,or,O,20597
168836,in,O,20597
168837,those,O,20597
168838,who,O,20597
168839,are,O,20597
168840,scheduled,O,20597
168841,for,O,20597
168842,cataract,B-TREATMENT,20597
168843,surgery,I-TREATMENT,20597
168844,Iluvien,B-TREATMENT,20598
168845,which,O,20598
168846,is,O,20598
168847,designed,O,20598
168848,to,O,20598
168849,elute,O,20598
168850,fluocinolone,B-NAME_OF_DRUG,20598
168851,acetonide,I-NAME_OF_DRUG,20598
168852,for,O,20598
168853,approximately,O,20598
168854,36,B-TIME_DURATION,20598
168855,months,I-TIME_DURATION,20598
168856,is,O,20598
168857,indicated,O,20598
168858,for,O,20598
168859,patients,O,20598
168860,with,O,20598
168861,DME,B-NAME_OF_DISEASE,20598
168862,who,O,20598
168863,have,O,20598
168864,previously,O,20598
168865,been,O,20598
168866,treated,O,20598
168867,with,O,20598
168868,a,O,20598
168869,course,O,20598
168870,of,O,20598
168871,corticosteroids,B-NAME_OF_DRUG,20598
168872,and,O,20598
168873,did,O,20598
168874,not,O,20598
168875,have,O,20598
168876,a,O,20598
168877,clinically,O,20598
168878,significant,O,20598
168879,rise,O,20598
168880,in,O,20598
168881,IOP,O,20598
168882,Often,O,20599
168883,clinicians,O,20599
168884,will,O,20599
168885,administer,O,20599
168886,Iluvien,B-TREATMENT,20599
168887,after,O,20599
168888,determining,O,20599
168889,that,O,20599
168890,the,O,20599
168891,patients,O,20599
168892,disease,O,20599
168893,responds,O,20599
168894,to,O,20599
168895,corticosteroids,B-NAME_OF_DRUG,20599
168896,allowing,O,20599
168897,for,O,20599
168898,a,O,20599
168899,longer,O,20599
168900,duration,O,20599
168901,of,O,20599
168902,treatment-and,O,20599
168903,in,O,20599
168904,the,O,20599
168905,COVID-19,B-NAME_OF_DISEASE,20599
168906,era,O,20599
168907,reduced,O,20599
168908,risk,O,20599
168909,of,O,20599
168910,transmission,O,20599
168911,in,O,20599
168912,the,B-PART_OF_THE_EYES,20599
168913,retina,I-PART_OF_THE_EYES,20599
168914,clinic,O,20599
168915,Clinicians,O,20600
168916,may,O,20600
168917,wish,O,20600
168918,to,O,20600
168919,consider,O,20600
168920,moving,O,20600
168921,Iluvien,B-TREATMENT,20600
168922,further,O,20600
168923,up,O,20600
168924,in,O,20600
168925,their,O,20600
168926,decision,O,20600
168927,tree,O,20600
168928,for,O,20600
168929,the,O,20600
168930,treatment,O,20600
168931,of,O,20600
168932,DME,B-NAME_OF_DISEASE,20600
168933,In,O,20601
168934,a,O,20601
168935,24-month,B-TIME_DURATION,20601
168936,interim,O,20601
168937,analysis,O,20601
168938,of,O,20601
168939,the,B-NAME_OF_STUDY,20601
168940,prospective,I-NAME_OF_STUDY,20601
168941,observational,I-NAME_OF_STUDY,20601
168942,real-world,I-NAME_OF_STUDY,20601
168943,study,I-NAME_OF_STUDY,20601
168944,PALADIN,I-NAME_OF_STUDY,20601
168945,NCT02424019,I-NAME_OF_STUDY,20601
168946,investigators,O,20601
168947,found,O,20601
168948,that,O,20601
168949,treatment,O,20601
168950,with,O,20601
168951,Iluvien,B-TREATMENT,20601
168952,resulted,O,20601
168953,in,O,20601
168954,a,O,20601
168955,mean,O,20601
168956,visual,O,20601
168957,improvement,O,20601
168958,of,O,20601
168959,1,O,20601
168960,to,O,20601
168961,3,O,20601
168962,letters,O,20601
168963,improved,O,20601
168964,central,O,20601
168965,subfield,O,20601
168966,thickness,O,20601
168967,and,O,20601
168968,fewer,O,20601
168969,DME,B-NAME_OF_DISEASE,20601
168970,treatments,O,20601
168971,Fifty-one,O,20602
168972,percent,O,20602
168973,of,O,20602
168974,patients,O,20602
168975,required,O,20602
168976,no,O,20602
168977,treatment,O,20602
168978,or,O,20602
168979,1,O,20602
168980,treatment,O,20602
168981,during,O,20602
168982,the,O,20602
168983,follow-up,O,20602
168984,period,O,20602
168985,and,O,20602
168986,a,O,20602
168987,majority,O,20602
168988,of,O,20602
168989,patients,O,20602
168990,required,O,20602
168991,no,O,20602
168992,rescue,O,20602
168993,treatment,O,20602
168994,at,O,20602
168995,1,B-TIME_DURATION,20602
168996,year,I-TIME_DURATION,20602
168997,The,O,20603
168998,case,O,20603
168999,below,O,20603
169000,illustrates,O,20603
169001,how,O,20603
169002,Iluvien,B-TREATMENT,20603
169003,therapy,I-TREATMENT,20603
169004,may,O,20603
169005,result,O,20603
169006,in,O,20603
169007,no,O,20603
169008,need,O,20603
169009,for,O,20603
169010,further,O,20603
169011,treatment,O,20603
169012,Among,O,20604
169013,DME,B-NAME_OF_DISEASE,20604
169014,patients,O,20604
169015,who,O,20604
169016,struggle,O,20604
169017,with,O,20604
169018,follow-up,O,20604
169019,appointments,O,20604
169020,Iluvien,B-TREATMENT,20604
169021,therapy,I-TREATMENT,20604
169022,may,O,20604
169023,be,O,20604
169024,more,O,20604
169025,effective,O,20604
169026,than,O,20604
169027,anti-VEGF,B-TREATMENT,20604
169028,therapy,I-TREATMENT,20604
169029,at,O,20604
169030,reducing,O,20604
169031,the,O,20604
169032,risk,O,20604
169033,of,O,20604
169034,vision-threatening,O,20604
169035,complications,O,20604
169036,of,O,20604
169037,proliferative,B-NAME_OF_DISEASE,20604
169038,retinopathy,I-NAME_OF_DISEASE,20604
169039,In,O,20605
169040,a,O,20605
169041,time-matched,O,20605
169042,consecutive,O,20605
169043,series,O,20605
169044,of,O,20605
169045,the,O,20605
169046,aggregated,O,20605
169047,Vestrum,B-ORGANIZATION,20605
169048,database,O,20605
169049,from,B-TIME_DURATION,20605
169050,January,I-TIME_DURATION,20605
169051,2013,I-TIME_DURATION,20605
169052,to,I-TIME_DURATION,20605
169053,February,I-TIME_DURATION,20605
169054,2021,I-TIME_DURATION,20605
169055,our,O,20605
169056,research,O,20605
169057,team,O,20605
169058,found,O,20605
169059,that,O,20605
169060,patients,O,20605
169061,with,O,20605
169062,DME,B-NAME_OF_DISEASE,20605
169063,who,O,20605
169064,had,O,20605
169065,at,O,20605
169066,least,O,20605
169067,a,O,20605
169068,6-month,B-TIME_DURATION,20605
169069,break,O,20605
169070,in,O,20605
169071,follow-up,O,20605
169072,progressed,O,20605
169073,to,O,20605
169074,proliferative,B-NAME_OF_DISEASE,20605
169075,diabetic,I-NAME_OF_DISEASE,20605
169076,retinopathy,I-NAME_OF_DISEASE,20605
169077,at,O,20605
169078,rates,O,20605
169079,of,O,20605
169080,1%,O,20605
169081,and,O,20605
169082,10%,O,20605
169083,for,O,20605
169084,those,O,20605
169085,undergoing,O,20605
169086,Iluvien,B-TREATMENT,20605
169087,or,O,20605
169088,anti-VEGF,B-TREATMENT,20605
169089,therapy,I-TREATMENT,20605
169090,respectively,O,20605
169091,Also,O,20606
169092,new,O,20606
169093,vitreous,B-SIGN_AND_SYMPTOM,20606
169094,hemorrhage,I-SIGN_AND_SYMPTOM,20606
169095,was,O,20606
169096,present,O,20606
169097,upon,O,20606
169098,return,O,20606
169099,in,O,20606
169100,more,O,20606
169101,patients,O,20606
169102,undergoing,O,20606
169103,anti-VEGF,B-TREATMENT,20606
169104,therapy,I-TREATMENT,20606
169105,6%,O,20606
169106,compared,O,20606
169107,with,O,20606
169108,Iluvien,B-TREATMENT,20606
169109,therapy,I-TREATMENT,20606
169110,1%,O,20606
169111,In,O,20607
169112,light,O,20607
169113,of,O,20607
169114,these,O,20607
169115,new,O,20607
169116,data,O,20607
169117,it,O,20607
169118,is,O,20607
169119,important,O,20607
169120,that,O,20607
169121,clinicians,O,20607
169122,give,O,20607
169123,careful,O,20607
169124,consideration,O,20607
169125,and,O,20607
169126,weigh,O,20607
169127,the,O,20607
169128,high,O,20607
169129,treatment,O,20607
169130,burden,O,20607
169131,of,O,20607
169132,frequent,O,20607
169133,anti-VEGF,B-TREATMENT,20607
169134,therapy,I-TREATMENT,20607
169135,against,O,20607
169136,the,O,20607
169137,benefits,O,20607
169138,of,O,20607
169139,36-month,B-TIME_DURATION,20607
169140,sustained,O,20607
169141,treatment,O,20607
169142,with,O,20607
169143,Iluvien,B-TREATMENT,20607
169144,Increasing,O,20608
169145,our,O,20608
169146,fields,O,20608
169147,use,O,20608
169148,of,O,20608
169149,Iluvien,B-TREATMENT,20608
169150,in,O,20608
169151,the,O,20608
169152,treatment,O,20608
169153,of,O,20608
169154,DME,B-NAME_OF_DISEASE,20608
169155,may,O,20608
169156,satisfy,O,20608
169157,our,O,20608
169158,patients,O,20608
169159,request,O,20608
169160,for,O,20608
169161,fewer,O,20608
169162,office,O,20608
169163,visits,O,20608
169164,while,O,20608
169165,also,O,20608
169166,maximizing,O,20608
169167,patient,O,20608
169168,therapy,O,20608
169169,Case,O,20609
169170,A,O,20609
169171,73-year-old,O,20609
169172,woman,O,20609
169173,with,O,20609
169174,a,O,20609
169175,history,O,20609
169176,of,O,20609
169177,vitrectomy,B-TREATMENT,20609
169178,and,O,20609
169179,membrane,B-TREATMENT,20609
169180,peel,I-TREATMENT,20609
169181,presented,O,20609
169182,in,O,20609
169183,2017,O,20609
169184,with,O,20609
169185,20,O,20609
169186,50,O,20609
169187,VA,O,20609
169188,and,O,20609
169189,DME,B-NAME_OF_DISEASE,20609
169190,The,O,20610
169191,patient,O,20610
169192,was,O,20610
169193,lost,O,20610
169194,to,O,20610
169195,follow-up,O,20610
169196,and,O,20610
169197,returned,O,20610
169198,in,O,20610
169199,6,B-TIME_DURATION,20610
169200,months,I-TIME_DURATION,20610
169201,with,O,20610
169202,20,O,20610
169203,60,O,20610
169204,VA,O,20610
169205,and,O,20610
169206,worsened,O,20610
169207,edema,O,20610
169208,I,O,20611
169209,elected,O,20611
169210,to,O,20611
169211,administer,O,20611
169212,Ozurdex,B-TREATMENT,20611
169213,and,O,20611
169214,she,O,20611
169215,returned,O,20611
169216,in,O,20611
169217,1,O,20611
169218,month,O,20611
169219,with,O,20611
169220,20,O,20611
169221,40,O,20611
169222,VA,O,20611
169223,and,O,20611
169224,improved,O,20611
169225,edema,B-SIGN_AND_SYMPTOM,20611
169226,Five,B-TIME_DURATION,20612
169227,months,I-TIME_DURATION,20612
169228,after,O,20612
169229,she,O,20612
169230,received,O,20612
169231,the,B-TREATMENT,20612
169232,Ozurdex,I-TREATMENT,20612
169233,her,O,20612
169234,DME,B-NAME_OF_DISEASE,20612
169235,had,O,20612
169236,recurred,O,20612
169237,and,O,20612
169238,VA,O,20612
169239,dipped,O,20612
169240,to,O,20612
169241,20,O,20612
169242,80,O,20612
169243,Given,O,20613
169244,her,O,20613
169245,previous,O,20613
169246,positive,O,20613
169247,functional,O,20613
169248,and,O,20613
169249,anatomic,O,20613
169250,response,O,20613
169251,to,O,20613
169252,steroid,B-TREATMENT,20613
169253,therapy,I-TREATMENT,20613
169254,we,O,20613
169255,proceeded,O,20613
169256,with,O,20613
169257,Iluvien,B-TREATMENT,20613
169258,administration,O,20613
169259,Her,O,20614
169260,IOP,O,20614
169261,at,O,20614
169262,the,O,20614
169263,time,O,20614
169264,of,O,20614
169265,the,O,20614
169266,Iluvien,B-TREATMENT,20614
169267,administration,O,20614
169268,was,O,20614
169269,18,O,20614
169270,with,O,20614
169271,a,O,20614
169272,cup,O,20614
169273,to,O,20614
169274,disc,O,20614
169275,ratio,O,20614
169276,of,O,20614
169277,0.4,O,20614
169278,She,O,20615
169279,returned,O,20615
169280,in,O,20615
169281,1,B-TIME_DURATION,20615
169282,month,I-TIME_DURATION,20615
169283,with,O,20615
169284,20,O,20615
169285,40,O,20615
169286,VA,O,20615
169287,and,O,20615
169288,resolution,O,20615
169289,of,O,20615
169290,the,B-NAME_OF_DISEASE,20615
169291,macular,I-NAME_OF_DISEASE,20615
169292,edema,I-NAME_OF_DISEASE,20615
169293,At,O,20616
169294,her,O,20616
169295,most,O,20616
169296,recent,O,20616
169297,visit,O,20616
169298,September,O,20616
169299,2021,O,20616
169300,which,O,20616
169301,was,O,20616
169302,3,B-TIME_DURATION,20616
169303,years,I-TIME_DURATION,20616
169304,after,O,20616
169305,receiving,O,20616
169306,Iluvien,B-TREATMENT,20616
169307,her,O,20616
169308,VA,O,20616
169309,was,O,20616
169310,20,O,20616
169311,25,O,20616
169312,and,O,20616
169313,her,O,20616
169314,anatomy,O,20616
169315,showed,O,20616
169316,evidence,O,20616
169317,of,O,20616
169318,disease,O,20616
169319,quiescence,O,20616
169320,Part,O,20617
169321,of,O,20617
169322,the,O,20617
169323,reason,O,20617
169324,this,O,20617
169325,patient,O,20617
169326,is,O,20617
169327,noteworthy,O,20617
169328,is,O,20617
169329,that,O,20617
169330,she,O,20617
169331,was,O,20617
169332,lost,O,20617
169333,to,O,20617
169334,follow-up,O,20617
169335,for,O,20617
169336,nearly,O,20617
169337,a,O,20617
169338,year,O,20617
169339,during,O,20617
169340,the,O,20617
169341,COVID-19,B-NAME_OF_DISEASE,20617
169342,pandemic,O,20617
169343,largely,O,20617
169344,due,O,20617
169345,to,O,20617
169346,her,O,20617
169347,discomfort,O,20617
169348,with,O,20617
169349,coming,O,20617
169350,in,O,20617
169351,to,O,20617
169352,the,O,20617
169353,office,O,20617
169354,During,O,20618
169355,that,O,20618
169356,period,O,20618
169357,her,O,20618
169358,macular,B-NAME_OF_DISEASE,20618
169359,edema,I-NAME_OF_DISEASE,20618
169360,was,O,20618
169361,controlled,O,20618
169362,with,O,20618
169363,Iluvien,B-TREATMENT,20618
169364,therapy,I-TREATMENT,20618
169365,and,O,20618
169366,her,O,20618
169367,VA,O,20618
169368,had,O,20618
169369,actually,O,20618
169370,improved,O,20618
169371,from,O,20618
169372,20,O,20618
169373,40,O,20618
169374,to,O,20618
169375,20,O,20618
169376,25,O,20618
169377,Neurotrophic,B-NAME_OF_DISEASE,20619
169378,Keratitis,I-NAME_OF_DISEASE,20619
169379,is,O,20619
169380,the,B-SIGN_AND_SYMPTOM,20619
169381,impairment,I-SIGN_AND_SYMPTOM,20619
169382,of,I-SIGN_AND_SYMPTOM,20619
169383,corneal,I-SIGN_AND_SYMPTOM,20619
169384,trigeminal,I-SIGN_AND_SYMPTOM,20619
169385,innervation,I-SIGN_AND_SYMPTOM,20619
169386,which,I-SIGN_AND_SYMPTOM,20619
169387,disrupts,I-SIGN_AND_SYMPTOM,20619
169388,ocular,I-SIGN_AND_SYMPTOM,20619
169389,surface,I-SIGN_AND_SYMPTOM,20619
169390,homeostasis,I-SIGN_AND_SYMPTOM,20619
169391,It,O,20620
169392,is,O,20620
169393,classically,O,20620
169394,defined,O,20620
169395,by,O,20620
169396,absence,O,20620
169397,of,O,20620
169398,pain,O,20620
169399,due,O,20620
169400,to,O,20620
169401,the,B-CAUSE_OF_DISEASE,20620
169402,abnormalities,I-CAUSE_OF_DISEASE,20620
169403,in,I-CAUSE_OF_DISEASE,20620
169404,the,I-CAUSE_OF_DISEASE,20620
169405,trigeminal,I-CAUSE_OF_DISEASE,20620
169406,pathway,I-CAUSE_OF_DISEASE,20620
169407,that,O,20620
169408,has,O,20620
169409,caused,O,20620
169410,an,B-SIGN_AND_SYMPTOM,20620
169411,interruption,I-SIGN_AND_SYMPTOM,20620
169412,in,I-SIGN_AND_SYMPTOM,20620
169413,corneal,I-SIGN_AND_SYMPTOM,20620
169414,hemostasis,I-SIGN_AND_SYMPTOM,20620
169415,In,O,20621
169416,a,O,20621
169417,healthy,O,20621
169418,eye,O,20621
169419,that,O,20621
169420,has,O,20621
169421,a,O,20621
169422,normal,O,20621
169423,ocular,B-PART_OF_THE_EYES,20621
169424,surface,I-PART_OF_THE_EYES,20621
169425,motor,O,20621
169426,nerves,O,20621
169427,control,O,20621
169428,blinking,O,20621
169429,and,O,20621
169430,the,O,20621
169431,autonomic,O,20621
169432,system,O,20621
169433,controls,O,20621
169434,the,O,20621
169435,release,O,20621
169436,of,O,20621
169437,neuromodulators,O,20621
169438,that,O,20621
169439,stimulate,O,20621
169440,tear,O,20621
169441,production,O,20621
169442,through,O,20621
169443,a,O,20621
169444,feedback,O,20621
169445,loop,O,20621
169446,that,O,20621
169447,maintains,O,20621
169448,a,O,20621
169449,healthy,O,20621
169450,ocular,B-PART_OF_THE_EYES,20621
169451,surface,I-PART_OF_THE_EYES,20621
169452,barrier,O,20621
169453,Ultimately,O,20622
169454,corneal,O,20622
169455,epithelial,O,20622
169456,integrity,O,20622
169457,is,O,20622
169458,disrupted,O,20622
169459,in,O,20622
169460,NK,B-NAME_OF_DISEASE,20622
169461,resulting,O,20622
169462,in,O,20622
169463,an,O,20622
169464,interruption,O,20622
169465,in,O,20622
169466,the,O,20622
169467,barrier,O,20622
169468,to,O,20622
169469,the,O,20622
169470,underlying,O,20622
169471,tissue,O,20622
169472,Stage,O,20623
169473,1,O,20623
169474,NK,B-NAME_OF_DISEASE,20623
169475,mild,O,20623
169476,This,O,20624
169477,is,O,20624
169478,the,O,20624
169479,most,O,20624
169480,common,O,20624
169481,and,O,20624
169482,is,O,20624
169483,characterized,O,20624
169484,by,O,20624
169485,the,O,20624
169486,presence,O,20624
169487,of,O,20624
169488,punctate,B-SIGN_AND_SYMPTOM,20624
169489,epithelial,I-SIGN_AND_SYMPTOM,20624
169490,keratopathy,I-SIGN_AND_SYMPTOM,20624
169491,or,I-SIGN_AND_SYMPTOM,20624
169492,erosions,I-SIGN_AND_SYMPTOM,20624
169493,It,O,20625
169494,may,O,20625
169495,occur,O,20625
169496,in,O,20625
169497,a,O,20625
169498,diffuse,O,20625
169499,pattern,O,20625
169500,such,O,20625
169501,as,O,20625
169502,is,O,20625
169503,seen,O,20625
169504,in,O,20625
169505,Sjögrens,B-NAME_OF_DISEASE,20625
169506,syndrome,I-NAME_OF_DISEASE,20625
169507,or,O,20625
169508,graft-versus-host,B-NAME_OF_DISEASE,20625
169509,disease,I-NAME_OF_DISEASE,20625
169510,or,O,20625
169511,it,O,20625
169512,may,O,20625
169513,be,O,20625
169514,localized,O,20625
169515,to,O,20625
169516,the,O,20625
169517,inferior,O,20625
169518,portion,O,20625
169519,of,O,20625
169520,the,B-PART_OF_THE_EYES,20625
169521,cornea,I-PART_OF_THE_EYES,20625
169522,as,O,20625
169523,we,O,20625
169524,may,O,20625
169525,see,O,20625
169526,in,O,20625
169527,patients,O,20625
169528,who,O,20625
169529,have,O,20625
169530,lagophthalmos,B-NAME_OF_DISEASE,20625
169531,after,O,20625
169532,a,B-NAME_OF_DISEASE,20625
169533,Bells,I-NAME_OF_DISEASE,20625
169534,palsy,I-NAME_OF_DISEASE,20625
169535,or,O,20625
169536,in,O,20625
169537,Parkinsons,B-NAME_OF_DISEASE,20625
169538,disease,I-NAME_OF_DISEASE,20625
169539,in,O,20625
169540,which,O,20625
169541,the,O,20625
169542,patients,O,20625
169543,poor,O,20625
169544,blink,O,20625
169545,response,O,20625
169546,leads,O,20625
169547,to,O,20625
169548,corneal,B-SIGN_AND_SYMPTOM,20625
169549,breakdown,I-SIGN_AND_SYMPTOM,20625
169550,Stage,O,20626
169551,2,O,20626
169552,NK,B-NAME_OF_DISEASE,20626
169553,moderate,O,20626
169554,This,O,20627
169555,stage,O,20627
169556,of,O,20627
169557,the,O,20627
169558,condition,O,20627
169559,is,O,20627
169560,characterized,O,20627
169561,by,O,20627
169562,the,O,20627
169563,presence,O,20627
169564,of,O,20627
169565,a,B-SIGN_AND_SYMPTOM,20627
169566,persistent,I-SIGN_AND_SYMPTOM,20627
169567,epithelial,I-SIGN_AND_SYMPTOM,20627
169568,defect,I-SIGN_AND_SYMPTOM,20627
169569,as,O,20627
169570,we,O,20627
169571,may,O,20627
169572,see,O,20627
169573,after,O,20627
169574,a,O,20627
169575,patient,O,20627
169576,has,O,20627
169577,undergone,O,20627
169578,multiple,O,20627
169579,ocular,O,20627
169580,surgeries,O,20627
169581,Stage,O,20628
169582,3,O,20628
169583,NK,B-NAME_OF_DISEASE,20628
169584,severe,O,20628
169585,This,O,20629
169586,is,O,20629
169587,characterized,O,20629
169588,by,O,20629
169589,a,B-SIGN_AND_SYMPTOM,20629
169590,corneal,I-SIGN_AND_SYMPTOM,20629
169591,ulcer,I-SIGN_AND_SYMPTOM,20629
169592,that,I-SIGN_AND_SYMPTOM,20629
169593,has,I-SIGN_AND_SYMPTOM,20629
169594,stromal,I-SIGN_AND_SYMPTOM,20629
169595,involvement,I-SIGN_AND_SYMPTOM,20629
169596,and,I-SIGN_AND_SYMPTOM,20629
169597,thinning,I-SIGN_AND_SYMPTOM,20629
169598,This,O,20630
169599,stage,O,20630
169600,is,O,20630
169601,dangerous,O,20630
169602,as,O,20630
169603,it,O,20630
169604,has,O,20630
169605,a,O,20630
169606,significant,O,20630
169607,risk,O,20630
169608,of,O,20630
169609,progression,O,20630
169610,to,O,20630
169611,corneal,B-SIGN_AND_SYMPTOM,20630
169612,perforation,I-SIGN_AND_SYMPTOM,20630
169613,or,I-SIGN_AND_SYMPTOM,20630
169614,infection,I-SIGN_AND_SYMPTOM,20630
169615,Neurotrophic,B-NAME_OF_DISEASE,20631
169616,keratitis,I-NAME_OF_DISEASE,20631
169617,NK,I-NAME_OF_DISEASE,20631
169618,is,O,20631
169619,a,O,20631
169620,challenging,O,20631
169621,condition,O,20631
169622,to,O,20631
169623,diagnose,O,20631
169624,and,O,20631
169625,treat,O,20631
169626,For,O,20632
169627,another,O,20632
169628,it,O,20632
169629,is,O,20632
169630,a,O,20632
169631,degenerative,O,20632
169632,condition,O,20632
169633,that,O,20632
169634,can,O,20632
169635,alter,O,20632
169636,corneal,O,20632
169637,healing,O,20632
169638,and,O,20632
169639,cause,O,20632
169640,vision,B-SIGN_AND_SYMPTOM,20632
169641,loss,I-SIGN_AND_SYMPTOM,20632
169642,Due,O,20633
169643,to,O,20633
169644,a,O,20633
169645,recent,O,20633
169646,expanding,O,20633
169647,array,O,20633
169648,of,O,20633
169649,treatment,O,20633
169650,options,O,20633
169651,and,O,20633
169652,therefore,O,20633
169653,a,O,20633
169654,focus,O,20633
169655,on,O,20633
169656,clinician,O,20633
169657,education,O,20633
169658,there,O,20633
169659,has,O,20633
169660,been,O,20633
169661,an,O,20633
169662,increased,O,20633
169663,awareness,O,20633
169664,of,O,20633
169665,NK,B-NAME_OF_DISEASE,20633
169666,In,O,20634
169667,an,O,20634
169668,effort,O,20634
169669,to,O,20634
169670,keep,O,20634
169671,the,O,20634
169672,condition,O,20634
169673,on,O,20634
169674,our,O,20634
169675,diagnostic,O,20634
169676,radar,O,20634
169677,here,O,20634
169678,we,O,20634
169679,discuss,O,20634
169680,the,O,20634
169681,evidence,O,20634
169682,needed,O,20634
169683,for,O,20634
169684,a,O,20634
169685,definitive,O,20634
169686,diagnosis,O,20634
169687,and,O,20634
169688,the,O,20634
169689,current,O,20634
169690,treatment,O,20634
169691,options,O,20634
169692,available,O,20634
169693,to,O,20634
169694,rehabilitate,O,20634
169695,the,B-PART_OF_THE_EYES,20634
169696,ocular,I-PART_OF_THE_EYES,20634
169697,surface,I-PART_OF_THE_EYES,20634
169698,in,O,20634
169699,these,O,20634
169700,patients,O,20634
169701,The,O,20635
169702,evidence,O,20635
169703,that,O,20635
169704,leads,O,20635
169705,to,O,20635
169706,a,O,20635
169707,definitive,O,20635
169708,diagnosis,O,20635
169709,of,O,20635
169710,NK,B-NAME_OF_DISEASE,20635
169711,is,O,20635
169712,That,O,20636
169713,said,O,20636
169714,these,O,20636
169715,patients,O,20636
169716,may,O,20636
169717,complain,O,20636
169718,of,O,20636
169719,blurry,B-SIGN_AND_SYMPTOM,20636
169720,vision,I-SIGN_AND_SYMPTOM,20636
169721,resulting,I-SIGN_AND_SYMPTOM,20636
169722,from,I-SIGN_AND_SYMPTOM,20636
169723,corneal,I-SIGN_AND_SYMPTOM,20636
169724,edema,I-SIGN_AND_SYMPTOM,20636
169725,the,I-SIGN_AND_SYMPTOM,20636
169726,irregular,I-SIGN_AND_SYMPTOM,20636
169727,epithelium,I-SIGN_AND_SYMPTOM,20636
169728,persistent,I-SIGN_AND_SYMPTOM,20636
169729,epithelial,I-SIGN_AND_SYMPTOM,20636
169730,corneal,I-SIGN_AND_SYMPTOM,20636
169731,defects,I-SIGN_AND_SYMPTOM,20636
169732,or,I-SIGN_AND_SYMPTOM,20636
169733,corneal,I-SIGN_AND_SYMPTOM,20636
169734,scarring,I-SIGN_AND_SYMPTOM,20636
169735,NK,B-NAME_OF_DISEASE,20637
169736,is,O,20637
169737,the,O,20637
169738,end,O,20637
169739,result,O,20637
169740,of,O,20637
169741,a,O,20637
169742,variety,O,20637
169743,of,O,20637
169744,conditions,O,20637
169745,that,O,20637
169746,may,O,20637
169747,work,O,20637
169748,alone,O,20637
169749,or,O,20637
169750,in,O,20637
169751,concert,O,20637
169752,to,O,20637
169753,disrupt,O,20637
169754,the,B-PART_OF_THE_EYES,20637
169755,ocular,I-PART_OF_THE_EYES,20637
169756,surface,I-PART_OF_THE_EYES,20637
169757,Identifying,O,20638
169758,NKs,B-NAME_OF_DISEASE,20638
169759,underlying,O,20638
169760,cause,O,20638
169761,is,O,20638
169762,the,O,20638
169763,key,O,20638
169764,to,O,20638
169765,initiation,O,20638
169766,of,O,20638
169767,treatment,O,20638
169768,The,O,20639
169769,most,O,20639
169770,common,O,20639
169771,etiologies,O,20639
169772,include,O,20639
169773,herpes,B-CAUSE_OF_DISEASE,20639
169774,simplex,I-CAUSE_OF_DISEASE,20639
169775,keratitis,I-CAUSE_OF_DISEASE,20639
169776,toxicity,B-CAUSE_OF_DISEASE,20639
169777,from,I-CAUSE_OF_DISEASE,20639
169778,the,I-CAUSE_OF_DISEASE,20639
169779,long-term,I-CAUSE_OF_DISEASE,20639
169780,use,I-CAUSE_OF_DISEASE,20639
169781,of,I-CAUSE_OF_DISEASE,20639
169782,ophthalmic,I-CAUSE_OF_DISEASE,20639
169783,drops,I-CAUSE_OF_DISEASE,20639
169784,eg,I-CAUSE_OF_DISEASE,20639
169785,preserved,I-CAUSE_OF_DISEASE,20639
169786,glaucoma,I-CAUSE_OF_DISEASE,20639
169787,drops,I-CAUSE_OF_DISEASE,20639
169788,artificial,I-CAUSE_OF_DISEASE,20639
169789,tears,I-CAUSE_OF_DISEASE,20639
169790,etc,I-CAUSE_OF_DISEASE,20639
169791,long-term,B-CAUSE_OF_DISEASE,20639
169792,contact,I-CAUSE_OF_DISEASE,20639
169793,lens,I-CAUSE_OF_DISEASE,20639
169794,wear,I-CAUSE_OF_DISEASE,20639
169795,or,O,20639
169796,a,B-CAUSE_OF_DISEASE,20639
169797,history,I-CAUSE_OF_DISEASE,20639
169798,of,I-CAUSE_OF_DISEASE,20639
169799,ocular,I-CAUSE_OF_DISEASE,20639
169800,surgery,I-CAUSE_OF_DISEASE,20639
169801,eg,I-CAUSE_OF_DISEASE,20639
169802,corneal,I-CAUSE_OF_DISEASE,20639
169803,refractive,I-CAUSE_OF_DISEASE,20639
169804,surgery,I-CAUSE_OF_DISEASE,20639
169805,retinal,I-CAUSE_OF_DISEASE,20639
169806,or,I-CAUSE_OF_DISEASE,20639
169807,glaucoma,I-CAUSE_OF_DISEASE,20639
169808,surgery,I-CAUSE_OF_DISEASE,20639
169809,or,I-CAUSE_OF_DISEASE,20639
169810,multiple,I-CAUSE_OF_DISEASE,20639
169811,ocular,I-CAUSE_OF_DISEASE,20639
169812,procedures,I-CAUSE_OF_DISEASE,20639
169813,Many,O,20640
169814,of,O,20640
169815,these,O,20640
169816,conditions,O,20640
169817,develop,O,20640
169818,gradually,O,20640
169819,over,O,20640
169820,several,O,20640
169821,years,O,20640
169822,during,O,20640
169823,which,O,20640
169824,time,O,20640
169825,the,B-NAME_OF_DISEASE,20640
169826,NK,I-NAME_OF_DISEASE,20640
169827,is,O,20640
169828,not,O,20640
169829,recognized,O,20640
169830,or,O,20640
169831,treated,O,20640
169832,adequately,O,20640
169833,Oftentimes,O,20641
169834,the,O,20641
169835,condition,O,20641
169836,is,O,20641
169837,even,O,20641
169838,exacerbated,O,20641
169839,by,O,20641
169840,attempted,O,20641
169841,treatments,O,20641
169842,such,O,20641
169843,as,O,20641
169844,the,O,20641
169845,use,O,20641
169846,of,O,20641
169847,further,O,20641
169848,preserved,O,20641
169849,OTC,B-NAME_OF_DRUG,20641
169850,lubricant,I-NAME_OF_DRUG,20641
169851,drops,I-NAME_OF_DRUG,20641
169852,or,O,20641
169853,continued,O,20641
169854,insult,O,20641
169855,by,O,20641
169856,the,O,20641
169857,inciting,O,20641
169858,cause,O,20641
169859,Slit,B-DIAGNOSTIC_TEST,20642
169860,lamp,I-DIAGNOSTIC_TEST,20642
169861,exam,I-DIAGNOSTIC_TEST,20642
169862,A,B-DIAGNOSTIC_TEST,20643
169863,thorough,I-DIAGNOSTIC_TEST,20643
169864,slit,I-DIAGNOSTIC_TEST,20643
169865,lamp,I-DIAGNOSTIC_TEST,20643
169866,examination,I-DIAGNOSTIC_TEST,20643
169867,including,O,20643
169868,fluorescein,B-DIAGNOSTIC_TEST,20643
169869,staining,I-DIAGNOSTIC_TEST,20643
169870,aids,O,20643
169871,in,O,20643
169872,determining,O,20643
169873,whether,O,20643
169874,there,O,20643
169875,is,O,20643
169876,a,B-SIGN_AND_SYMPTOM,20643
169877,disruption,I-SIGN_AND_SYMPTOM,20643
169878,of,I-SIGN_AND_SYMPTOM,20643
169879,the,I-SIGN_AND_SYMPTOM,20643
169880,corneal,I-SIGN_AND_SYMPTOM,20643
169881,epithelium,I-SIGN_AND_SYMPTOM,20643
169882,and,O,20643
169883,defining,O,20643
169884,the,O,20643
169885,stage,O,20643
169886,of,O,20643
169887,the,B-NAME_OF_DISEASE,20643
169888,NK,I-NAME_OF_DISEASE,20643
169889,It,O,20644
169890,is,O,20644
169891,famously,O,20644
169892,said,O,20644
169893,that,O,20644
169894,NK,B-NAME_OF_DISEASE,20644
169895,causes,O,20644
169896,stain,B-SIGN_AND_SYMPTOM,20644
169897,without,I-SIGN_AND_SYMPTOM,20644
169898,pain,I-SIGN_AND_SYMPTOM,20644
169899,Corneal,B-DIAGNOSTIC_TEST,20645
169900,sensation,I-DIAGNOSTIC_TEST,20645
169901,assessment,I-DIAGNOSTIC_TEST,20645
169902,In,O,20646
169903,the,O,20646
169904,past,O,20646
169905,we,O,20646
169906,think,O,20646
169907,many,O,20646
169908,of,O,20646
169909,us,O,20646
169910,were,O,20646
169911,inattentive,O,20646
169912,to,O,20646
169913,NK,B-NAME_OF_DISEASE,20646
169914,Today,O,20647
169915,however,O,20647
169916,we,O,20647
169917,feel,O,20647
169918,we,O,20647
169919,are,O,20647
169920,collectively,O,20647
169921,doing,O,20647
169922,a,O,20647
169923,much,O,20647
169924,better,O,20647
169925,job,O,20647
169926,of,O,20647
169927,evaluating,B-DIAGNOSTIC_TEST,20647
169928,corneal,I-DIAGNOSTIC_TEST,20647
169929,sensation,I-DIAGNOSTIC_TEST,20647
169930,during,I-DIAGNOSTIC_TEST,20647
169931,exams,I-DIAGNOSTIC_TEST,20647
169932,as,O,20647
169933,we,O,20647
169934,now,O,20647
169935,realize,O,20647
169936,the,O,20647
169937,lack,O,20647
169938,of,O,20647
169939,corneal,O,20647
169940,sensation,O,20647
169941,in,O,20647
169942,these,O,20647
169943,patients,O,20647
169944,often,O,20647
169945,precludes,O,20647
169946,them,O,20647
169947,from,O,20647
169948,seeing,O,20647
169949,us,O,20647
169950,at,O,20647
169951,the,O,20647
169952,outset,O,20647
169953,The,O,20648
169954,easiest,O,20648
169955,ways,O,20648
169956,to,O,20648
169957,test,B-DIAGNOSTIC_TEST,20648
169958,corneal,I-DIAGNOSTIC_TEST,20648
169959,sensitivity,I-DIAGNOSTIC_TEST,20648
169960,include,O,20648
169961,the,B-DIAGNOSTIC_TEST,20648
169962,use,I-DIAGNOSTIC_TEST,20648
169963,of,I-DIAGNOSTIC_TEST,20648
169964,a,I-DIAGNOSTIC_TEST,20648
169965,cotton,I-DIAGNOSTIC_TEST,20648
169966,wisp,I-DIAGNOSTIC_TEST,20648
169967,from,I-DIAGNOSTIC_TEST,20648
169968,a,I-DIAGNOSTIC_TEST,20648
169969,sterile,I-DIAGNOSTIC_TEST,20648
169970,swab,I-DIAGNOSTIC_TEST,20648
169971,or,I-DIAGNOSTIC_TEST,20648
169972,from,I-DIAGNOSTIC_TEST,20648
169973,a,I-DIAGNOSTIC_TEST,20648
169974,strand,I-DIAGNOSTIC_TEST,20648
169975,of,I-DIAGNOSTIC_TEST,20648
169976,dental,I-DIAGNOSTIC_TEST,20648
169977,floss,I-DIAGNOSTIC_TEST,20648
169978,Alternatively,O,20649
169979,there,O,20649
169980,are,O,20649
169981,more,O,20649
169982,standardized,O,20649
169983,ways,O,20649
169984,to,O,20649
169985,assess,O,20649
169986,corneal,O,20649
169987,sensitivity,O,20649
169988,such,O,20649
169989,as,O,20649
169990,via,O,20649
169991,a,B-DIAGNOSTIC_TEST,20649
169992,handheld,I-DIAGNOSTIC_TEST,20649
169993,aesthesiometer,I-DIAGNOSTIC_TEST,20649
169994,like,O,20649
169995,the,B-DIAGNOSTIC_TEST,20649
169996,Cochet-Bonnet,I-DIAGNOSTIC_TEST,20649
169997,aesthesiometer,I-DIAGNOSTIC_TEST,20649
169998,however,O,20649
169999,this,O,20649
170000,is,O,20649
170001,rarely,O,20649
170002,available,O,20649
170003,or,O,20649
170004,utilized,O,20649
170005,in,O,20649
170006,standard,O,20649
170007,clinical,O,20649
170008,practice,O,20649
170009,Something,O,20650
170010,else,O,20650
170011,to,O,20650
170012,keep,O,20650
170013,in,O,20650
170014,mind,O,20650
170015,Since,O,20650
170016,most,O,20650
170017,cases,O,20650
170018,of,O,20650
170019,NK,B-NAME_OF_DISEASE,20650
170020,are,O,20650
170021,unilateral,O,20650
170022,the,O,20650
170023,patients,O,20650
170024,other,O,20650
170025,eye,O,20650
170026,can,O,20650
170027,serve,O,20650
170028,as,O,20650
170029,a,O,20650
170030,built-in,O,20650
170031,control,O,20650
170032,for,O,20650
170033,comparison,O,20650
170034,and,O,20650
170035,the,O,20650
170036,patient,O,20650
170037,can,O,20650
170038,also,O,20650
170039,self-report,O,20650
170040,the,O,20650
170041,difference,O,20650
170042,during,O,20650
170043,the,O,20650
170044,test,O,20650
170045,However,O,20651
170046,there,O,20651
170047,are,O,20651
170048,some,O,20651
170049,rare,O,20651
170050,systemic,O,20651
170051,bilateral,O,20651
170052,etiologies,O,20651
170053,such,O,20651
170054,as,O,20651
170055,diabetes,B-CAUSE_OF_DISEASE,20651
170056,or,O,20651
170057,multiple,B-CAUSE_OF_DISEASE,20651
170058,sclerosis,I-CAUSE_OF_DISEASE,20651
170059,in,O,20651
170060,which,O,20651
170061,there,O,20651
170062,is,O,20651
170063,no,O,20651
170064,patientspecific,O,20651
170065,control,O,20651
170066,A,O,20652
170067,caveat,O,20652
170068,Anesthetic,B-NAME_OF_DRUG,20652
170069,and,I-NAME_OF_DRUG,20652
170070,dilating,I-NAME_OF_DRUG,20652
170071,drops,I-NAME_OF_DRUG,20652
170072,often,O,20652
170073,instilled,O,20652
170074,in,O,20652
170075,the,O,20652
170076,patient,O,20652
170077,by,O,20652
170078,the,O,20652
170079,technician,O,20652
170080,prior,O,20652
170081,to,O,20652
170082,the,O,20652
170083,doctor,O,20652
170084,seeing,O,20652
170085,the,O,20652
170086,patient,O,20652
170087,will,O,20652
170088,nullify,O,20652
170089,the,O,20652
170090,results,O,20652
170091,of,O,20652
170092,corneal,B-DIAGNOSTIC_TEST,20652
170093,sensitivity,I-DIAGNOSTIC_TEST,20652
170094,testing,I-DIAGNOSTIC_TEST,20652
170095,so,O,20652
170096,the,O,20652
170097,patient,O,20652
170098,should,O,20652
170099,be,O,20652
170100,scheduled,O,20652
170101,for,O,20652
170102,a,O,20652
170103,follow-up,O,20652
170104,visit,O,20652
170105,during,O,20652
170106,which,O,20652
170107,they,O,20652
170108,receive,O,20652
170109,no,O,20652
170110,anesthetic,B-NAME_OF_DRUG,20652
170111,or,I-NAME_OF_DRUG,20652
170112,dilating,I-NAME_OF_DRUG,20652
170113,drops,I-NAME_OF_DRUG,20652
170114,before,O,20652
170115,seeing,O,20652
170116,the,O,20652
170117,physician,O,20652
170118,Though,O,20653
170119,some,O,20653
170120,doctors,O,20653
170121,test,O,20653
170122,only,O,20653
170123,centrally,O,20653
170124,it,O,20653
170125,can,O,20653
170126,be,O,20653
170127,helpful,O,20653
170128,to,O,20653
170129,test,O,20653
170130,in,O,20653
170131,the,O,20653
170132,5,O,20653
170133,zones,O,20653
170134,central,O,20653
170135,superior,O,20653
170136,inferior,O,20653
170137,temporal,O,20653
170138,and,O,20653
170139,nasal,O,20653
170140,as,O,20653
170141,doing,O,20653
170142,so,O,20653
170143,documents,O,20653
170144,the,O,20653
170145,severity,O,20653
170146,of,O,20653
170147,the,O,20653
170148,NK,B-NAME_OF_DISEASE,20653
170149,and,O,20653
170150,helps,O,20653
170151,track,O,20653
170152,response,O,20653
170153,to,O,20653
170154,treatment,O,20653
170155,Rehabilitating,O,20654
170156,the,B-PART_OF_THE_EYES,20654
170157,Ocular,I-PART_OF_THE_EYES,20654
170158,Surface,I-PART_OF_THE_EYES,20654
170159,There,O,20655
170160,are,O,20655
170161,a,O,20655
170162,variety,O,20655
170163,of,O,20655
170164,treatment,O,20655
170165,options,O,20655
170166,available,O,20655
170167,for,O,20655
170168,NK,B-NAME_OF_DISEASE,20655
170169,The,O,20656
170170,protocol,O,20656
170171,is,O,20656
170172,to,O,20656
170173,treat,O,20656
170174,the,O,20656
170175,cause,O,20656
170176,of,O,20656
170177,the,O,20656
170178,patients,O,20656
170179,NK,B-NAME_OF_DISEASE,20656
170180,any,O,20656
170181,underlying,O,20656
170182,dry,B-NAME_OF_DISEASE,20656
170183,eye,I-NAME_OF_DISEASE,20656
170184,disease,I-NAME_OF_DISEASE,20656
170185,DED,I-NAME_OF_DISEASE,20656
170186,and,O,20656
170187,the,O,20656
170188,effect,O,20656
170189,of,O,20656
170190,the,B-NAME_OF_DISEASE,20656
170191,NK,I-NAME_OF_DISEASE,20656
170192,itself,O,20656
170193,A,O,20657
170194,common,O,20657
170195,condition,O,20657
170196,that,O,20657
170197,results,O,20657
170198,in,O,20657
170199,NK,B-NAME_OF_DISEASE,20657
170200,is,O,20657
170201,herpetic,B-CAUSE_OF_DISEASE,20657
170202,keratitis,I-CAUSE_OF_DISEASE,20657
170203,Once,O,20658
170204,this,O,20658
170205,disease,O,20658
170206,is,O,20658
170207,brought,O,20658
170208,under,O,20658
170209,control,O,20658
170210,with,O,20658
170211,the,O,20658
170212,use,O,20658
170213,of,O,20658
170214,oral,B-NAME_OF_DRUG,20658
170215,and,I-NAME_OF_DRUG,20658
170216,or,I-NAME_OF_DRUG,20658
170217,topical,I-NAME_OF_DRUG,20658
170218,antivirals,I-NAME_OF_DRUG,20658
170219,the,O,20658
170220,patient,O,20658
170221,may,O,20658
170222,require,O,20658
170223,topical,B-NAME_OF_DRUG,20658
170224,steroids,I-NAME_OF_DRUG,20658
170225,and,O,20658
170226,aggressive,B-TREATMENT,20658
170227,lubrication,I-TREATMENT,20658
170228,with,I-TREATMENT,20658
170229,preservative-free,I-TREATMENT,20658
170230,artificial,I-TREATMENT,20658
170231,tears,I-TREATMENT,20658
170232,for,O,20658
170233,the,B-NAME_OF_DISEASE,20658
170234,NK,I-NAME_OF_DISEASE,20658
170235,itself,O,20658
170236,In,O,20659
170237,another,O,20659
170238,case,O,20659
170239,the,O,20659
170240,underlying,O,20659
170241,cause,O,20659
170242,may,O,20659
170243,be,O,20659
170244,a,B-CAUSE_OF_DISEASE,20659
170245,systemic,I-CAUSE_OF_DISEASE,20659
170246,condition,I-CAUSE_OF_DISEASE,20659
170247,such,I-CAUSE_OF_DISEASE,20659
170248,as,I-CAUSE_OF_DISEASE,20659
170249,graft-versus-host,I-CAUSE_OF_DISEASE,20659
170250,disease,I-CAUSE_OF_DISEASE,20659
170251,GVHD,I-CAUSE_OF_DISEASE,20659
170252,systemic,I-CAUSE_OF_DISEASE,20659
170253,lupus,I-CAUSE_OF_DISEASE,20659
170254,or,I-CAUSE_OF_DISEASE,20659
170255,multiple,I-CAUSE_OF_DISEASE,20659
170256,sclerosis,I-CAUSE_OF_DISEASE,20659
170257,which,O,20659
170258,may,O,20659
170259,require,O,20659
170260,treatment,O,20659
170261,with,O,20659
170262,oral,B-NAME_OF_DRUG,20659
170263,steroids,I-NAME_OF_DRUG,20659
170264,In,O,20660
170265,still,O,20660
170266,other,O,20660
170267,incidences,O,20660
170268,of,O,20660
170269,NK,B-NAME_OF_DISEASE,20660
170270,the,B-TREATMENT,20660
170271,removal,I-TREATMENT,20660
170272,of,I-TREATMENT,20660
170273,an,I-TREATMENT,20660
170274,inciting,I-TREATMENT,20660
170275,toxic,I-TREATMENT,20660
170276,agent,I-TREATMENT,20660
170277,such,I-TREATMENT,20660
170278,as,I-TREATMENT,20660
170279,a,I-TREATMENT,20660
170280,glaucoma,I-TREATMENT,20660
170281,drop,I-TREATMENT,20660
170282,may,O,20660
170283,be,O,20660
170284,a,O,20660
170285,key,O,20660
170286,component,O,20660
170287,of,O,20660
170288,the,O,20660
170289,treatment,O,20660
170290,regimen,O,20660
170291,Should,O,20661
170292,the,O,20661
170293,patient,O,20661
170294,have,O,20661
170295,lagophthalmos,B-NAME_OF_DISEASE,20661
170296,or,O,20661
170297,incomplete,B-SIGN_AND_SYMPTOM,20661
170298,or,I-SIGN_AND_SYMPTOM,20661
170299,absent,I-SIGN_AND_SYMPTOM,20661
170300,blink,I-SIGN_AND_SYMPTOM,20661
170301,response,I-SIGN_AND_SYMPTOM,20661
170302,lid,B-TREATMENT,20661
170303,interventions,I-TREATMENT,20661
170304,including,I-TREATMENT,20661
170305,tape,I-TREATMENT,20661
170306,tarsorrhaphies,I-TREATMENT,20661
170307,temporary,I-TREATMENT,20661
170308,suture,I-TREATMENT,20661
170309,tarsorrhaphies,I-TREATMENT,20661
170310,or,I-TREATMENT,20661
170311,permanent,I-TREATMENT,20661
170312,tarsorrhaphies,I-TREATMENT,20661
170313,can,O,20661
170314,be,O,20661
170315,an,O,20661
170316,integral,O,20661
170317,component,O,20661
170318,of,O,20661
170319,the,O,20661
170320,treatment,O,20661
170321,and,O,20661
170322,healing,O,20661
170323,process,O,20661
170324,This,O,20662
170325,is,O,20662
170326,because,O,20662
170327,NK,B-NAME_OF_DISEASE,20662
170328,can,O,20662
170329,be,O,20662
170330,worse,O,20662
170331,in,O,20662
170332,such,O,20662
170333,patients,O,20662
170334,due,O,20662
170335,to,O,20662
170336,this,O,20662
170337,very,O,20662
170338,significant,O,20662
170339,comorbidity,O,20662
170340,The,O,20663
170341,take,O,20663
170342,home,O,20663
170343,message,O,20663
170344,The,B-PART_OF_THE_EYES,20663
170345,lid,I-PART_OF_THE_EYES,20663
170346,architecture,O,20663
170347,and,O,20663
170348,position,O,20663
170349,should,O,20663
170350,always,O,20663
170351,be,O,20663
170352,thoroughly,O,20663
170353,evaluated,O,20663
170354,in,O,20663
170355,these,O,20663
170356,patients,O,20663
170357,Treatments,O,20664
170358,for,O,20664
170359,underlying,O,20664
170360,DED,B-NAME_OF_DISEASE,20664
170361,I,O,20665
170362,have,O,20665
170363,prescribed,O,20665
170364,inflammatory,B-NAME_OF_DRUG,20665
170365,inhibitors,I-NAME_OF_DRUG,20665
170366,to,O,20665
170367,stabilize,O,20665
170368,any,O,20665
170369,underlying,O,20665
170370,DED,B-NAME_OF_DISEASE,20665
170371,condition,O,20665
170372,as,O,20665
170373,doing,O,20665
170374,so,O,20665
170375,helps,O,20665
170376,improve,O,20665
170377,the,B-PART_OF_THE_EYES,20665
170378,ocular,I-PART_OF_THE_EYES,20665
170379,surface,I-PART_OF_THE_EYES,20665
170380,which,O,20665
170381,facilitates,O,20665
170382,treatment,O,20665
170383,of,O,20665
170384,the,B-NAME_OF_DISEASE,20665
170385,NK,I-NAME_OF_DISEASE,20665
170386,We,O,20666
170387,need,O,20666
170388,to,O,20666
170389,remember,O,20666
170390,that,O,20666
170391,many,O,20666
170392,of,O,20666
170393,our,O,20666
170394,NK,B-NAME_OF_DISEASE,20666
170395,patients,O,20666
170396,have,O,20666
170397,other,O,20666
170398,comorbid,O,20666
170399,ocular,O,20666
170400,conditions,O,20666
170401,such,O,20666
170402,as,O,20666
170403,DED,B-NAME_OF_DISEASE,20666
170404,and,O,20666
170405,glaucoma,B-NAME_OF_DISEASE,20666
170406,that,O,20666
170407,complicate,O,20666
170408,the,O,20666
170409,disease,O,20666
170410,course,O,20666
170411,Additionally,O,20667
170412,punctal,B-TREATMENT,20667
170413,plugs,I-TREATMENT,20667
170414,a,B-TREATMENT,20667
170415,dissolvable,I-TREATMENT,20667
170416,punctal,I-TREATMENT,20667
170417,insert,I-TREATMENT,20667
170418,in-office,B-TREATMENT,20667
170419,lid,I-TREATMENT,20667
170420,treatment,I-TREATMENT,20667
170421,procedures,I-TREATMENT,20667
170422,intense,B-TREATMENT,20667
170423,pulsed,I-TREATMENT,20667
170424,light,I-TREATMENT,20667
170425,and,O,20667
170426,ocular,B-TREATMENT,20667
170427,nutritional,I-TREATMENT,20667
170428,supplements,I-TREATMENT,20667
170429,may,O,20667
170430,be,O,20667
170431,used,O,20667
170432,to,O,20667
170433,help,O,20667
170434,control,O,20667
170435,concomitant,O,20667
170436,ocular,B-NAME_OF_DISEASE,20667
170437,surface,I-NAME_OF_DISEASE,20667
170438,disease,I-NAME_OF_DISEASE,20667
170439,Treatments,O,20668
170440,for,O,20668
170441,NK,B-NAME_OF_DISEASE,20668
170442,itself,O,20668
170443,The,O,20669
170444,following,O,20669
170445,are,O,20669
170446,available,O,20669
170447,Artificial,B-TREATMENT,20669
170448,tears,I-TREATMENT,20669
170449,gels,I-TREATMENT,20669
170450,and,I-TREATMENT,20669
170451,ointments,I-TREATMENT,20669
170452,Aggressive,O,20669
170453,6,O,20669
170454,to,O,20669
170455,8,O,20669
170456,times,O,20669
170457,a,O,20669
170458,day,O,20669
170459,or,O,20669
170460,more,O,20669
170461,lubrication,B-TREATMENT,20669
170462,with,I-TREATMENT,20669
170463,preservative-free,I-TREATMENT,20669
170464,artificial,I-TREATMENT,20669
170465,tears,I-TREATMENT,20669
170466,of,I-TREATMENT,20669
170467,increasing,I-TREATMENT,20669
170468,viscosity,I-TREATMENT,20669
170469,improves,O,20669
170470,ocular,O,20669
170471,surface,O,20669
170472,protection,O,20669
170473,Thick,B-TREATMENT,20670
170474,gels,I-TREATMENT,20670
170475,and,I-TREATMENT,20670
170476,ointments,I-TREATMENT,20670
170477,can,O,20670
170478,help,O,20670
170479,provide,O,20670
170480,a,O,20670
170481,barrier,O,20670
170482,to,O,20670
170483,environmental,O,20670
170484,insults,O,20670
170485,Amniotic,B-TREATMENT,20671
170486,membranes,I-TREATMENT,20671
170487,These,O,20671
170488,contain,O,20671
170489,anti-microbial,O,20671
170490,and,O,20671
170491,antiinflammatory,O,20671
170492,properties,O,20671
170493,and,O,20671
170494,low,O,20671
170495,immunogenicity,O,20671
170496,Contact,B-TREATMENT,20672
170497,lenses,I-TREATMENT,20672
170498,While,O,20672
170499,wearing,B-TREATMENT,20672
170500,contact,I-TREATMENT,20672
170501,lenses,I-TREATMENT,20672
170502,can,O,20672
170503,cause,O,20672
170504,NK,B-NAME_OF_DISEASE,20672
170505,various,O,20672
170506,types,O,20672
170507,of,O,20672
170508,extended-wear,O,20672
170509,contact,O,20672
170510,lenses,O,20672
170511,are,O,20672
170512,useful,O,20672
170513,in,O,20672
170514,protecting,O,20672
170515,the,B-PART_OF_THE_EYES,20672
170516,ocular,I-PART_OF_THE_EYES,20672
170517,surface,I-PART_OF_THE_EYES,20672
170518,and,O,20672
170519,temporizing,O,20672
170520,the,O,20672
170521,situation,O,20672
170522,while,O,20672
170523,other,O,20672
170524,treatments,O,20672
170525,are,O,20672
170526,taking,O,20672
170527,effect,O,20672
170528,Also,O,20673
170529,bandage,B-TREATMENT,20673
170530,lenses,I-TREATMENT,20673
170531,can,I-TREATMENT,20673
170532,be,I-TREATMENT,20673
170533,used,I-TREATMENT,20673
170534,in,I-TREATMENT,20673
170535,conjunction,I-TREATMENT,20673
170536,with,I-TREATMENT,20673
170537,dried,I-TREATMENT,20673
170538,amniotic,I-TREATMENT,20673
170539,membranes,I-TREATMENT,20673
170540,and,I-TREATMENT,20673
170541,antibiotic,I-TREATMENT,20673
170542,drops,I-TREATMENT,20673
170543,to,O,20673
170544,provide,O,20673
170545,a,O,20673
170546,matrix,O,20673
170547,for,O,20673
170548,healing,O,20673
170549,For,O,20674
170550,long-term,O,20674
170551,NK,B-NAME_OF_DISEASE,20674
170552,conditions,O,20674
170553,that,O,20674
170554,often,O,20674
170555,may,O,20674
170556,be,O,20674
170557,associated,O,20674
170558,with,O,20674
170559,chronic,O,20674
170560,systemic,O,20674
170561,and,O,20674
170562,or,O,20674
170563,ocular,O,20674
170564,diseases,O,20674
170565,such,O,20674
170566,as,O,20674
170567,GVHD,B-NAME_OF_DISEASE,20674
170568,and,O,20674
170569,Sjögrens,B-NAME_OF_DISEASE,20674
170570,syndrome,I-NAME_OF_DISEASE,20674
170571,respectively,O,20674
170572,scleral,B-TREATMENT,20674
170573,contact,I-TREATMENT,20674
170574,lenses,I-TREATMENT,20674
170575,are,O,20674
170576,a,O,20674
170577,very,O,20674
170578,helpful,O,20674
170579,adjunct,O,20674
170580,to,O,20674
170581,care,O,20674
170582,This,O,20675
170583,is,O,20675
170584,because,O,20675
170585,they,O,20675
170586,vault,O,20675
170587,the,B-PART_OF_THE_EYES,20675
170588,corneal,I-PART_OF_THE_EYES,20675
170589,surface,I-PART_OF_THE_EYES,20675
170590,and,O,20675
170591,provide,O,20675
170592,a,O,20675
170593,lens,O,20675
170594,fluid,O,20675
170595,reservoir,O,20675
170596,that,O,20675
170597,constantly,O,20675
170598,lubricates,O,20675
170599,the,B-PART_OF_THE_EYES,20675
170600,ocular,I-PART_OF_THE_EYES,20675
170601,surface,I-PART_OF_THE_EYES,20675
